id|nct_id|result_group_id|ctgov_group_code|period|reason|count
4647722|NCT04534491|15931278|P1|Overall Study|Non-verifiable users|58
4647723|NCT04534491|15931278|P1|Overall Study|Non-users|70
4647724|NCT04534491|15931278|P1|Overall Study|Not completed end-of-study interview|24
4647725|NCT04531813|15931287|P1|Overall Study|Withdrawal by Subject|1
4647726|NCT04531813|15931287|P1|Overall Study|Protocol Violation|1
4647727|NCT04531540|15931291|P1|Overall Study|Found to be Ineligible|1
4647728|NCT04531540|15931291|P1|Overall Study|Withdrawal by Subject|4
4647729|NCT04531540|15931291|P1|Overall Study|Protocol Violation|3
4647730|NCT04531540|15931291|P1|Overall Study|Adverse Event|1
4647731|NCT04531527|15931298|P1|Overall Study|Found to be Ineligible|3
4647732|NCT04523831|15931305|P2|Overall Study|Adverse Event|0
4647733|NCT04523831|15931306|P1|Overall Study|Adverse Event|2
4647734|NCT04523831|15931305|P2|Overall Study|Death|3
4647735|NCT04523831|15931306|P1|Overall Study|Death|0
4647736|NCT04523831|15931305|P2|Overall Study|Lost to Follow-up|17
4647737|NCT04523831|15931306|P1|Overall Study|Lost to Follow-up|15
4647738|NCT04502979|15931320|P2|Overall Study|Withdrawal by Subject|1
4647739|NCT04502979|15931321|P1|Overall Study|Withdrawal by Subject|2
4647740|NCT04502979|15931320|P2|Overall Study|Lost to Follow-up|3
4647741|NCT04502979|15931321|P1|Overall Study|Lost to Follow-up|1
4647742|NCT04491994|15931350|P2|Overall Study|Lost to Follow-up|3
4647743|NCT04491994|15931351|P1|Overall Study|Lost to Follow-up|4
4647744|NCT04491994|15931350|P2|Overall Study|Protocol Violation|2
4647745|NCT04491994|15931351|P1|Overall Study|Protocol Violation|11
4647746|NCT04491994|15931350|P2|Overall Study|developed fever > 3 days|1
4647747|NCT04491994|15931351|P1|Overall Study|developed fever > 3 days|4
4647748|NCT04491994|15931350|P2|Overall Study|Withdrawal by Subject|5
4647749|NCT04491994|15931351|P1|Overall Study|Withdrawal by Subject|10
4647750|NCT04474405|15931363|P6|Overall Study|Other|0
4647751|NCT04474405|15931364|P5|Overall Study|Other|3
4647752|NCT04474405|15931365|P4|Overall Study|Other|0
4647753|NCT04474405|15931366|P3|Overall Study|Other|0
4647754|NCT04474405|15931367|P2|Overall Study|Other|0
4647755|NCT04474405|15931368|P1|Overall Study|Other|0
4647756|NCT04474405|15931363|P6|Overall Study|Withdrawal by Subject|0
4647757|NCT04474405|15931364|P5|Overall Study|Withdrawal by Subject|1
4647758|NCT04474405|15931365|P4|Overall Study|Withdrawal by Subject|0
4647759|NCT04474405|15931366|P3|Overall Study|Withdrawal by Subject|1
4647760|NCT04474405|15931367|P2|Overall Study|Withdrawal by Subject|0
4647761|NCT04474405|15931368|P1|Overall Study|Withdrawal by Subject|0
4647762|NCT04468347|15931389|P4|Overall Study|Protocol Violation|0
4647763|NCT04468347|15931390|P3|Overall Study|Protocol Violation|0
4647764|NCT04468347|15931391|P2|Overall Study|Protocol Violation|0
4647765|NCT04468347|15931392|P1|Overall Study|Protocol Violation|1
4647766|NCT04468347|15931389|P4|Overall Study|Physician Decision|0
4647767|NCT04468347|15931390|P3|Overall Study|Physician Decision|2
4647768|NCT04468347|15931391|P2|Overall Study|Physician Decision|0
4647769|NCT04468347|15931392|P1|Overall Study|Physician Decision|1
4647770|NCT04468347|15931389|P4|Overall Study|Lost to Follow-up|1
4647771|NCT04468347|15931390|P3|Overall Study|Lost to Follow-up|1
4647772|NCT04468347|15931391|P2|Overall Study|Lost to Follow-up|0
4647773|NCT04468347|15931392|P1|Overall Study|Lost to Follow-up|0
4647774|NCT04468347|15931389|P4|Overall Study|Withdrawal by Subject|3
4647775|NCT04468347|15931390|P3|Overall Study|Withdrawal by Subject|3
4647776|NCT04468347|15931391|P2|Overall Study|Withdrawal by Subject|1
4647777|NCT04468347|15931392|P1|Overall Study|Withdrawal by Subject|0
4647778|NCT04425863|15931470|P3|Overall Study|Death|1
4647779|NCT04425863|15931471|P2|Overall Study|Death|0
4647780|NCT04425863|15931472|P1|Overall Study|Death|0
4647781|NCT04422561|15931505|P2|Overall Study|Lost to Follow-up|11
4647782|NCT04422561|15931506|P1|Overall Study|Lost to Follow-up|25
4647783|NCT04406194|15931547|P2|Period 1|Withdrawal by Subject|1
4647784|NCT04406194|15931548|P1|Period 1|Withdrawal by Subject|0
4647785|NCT04400682|15931562|P2|Period 1|Withdrawal by Subject|4
4647786|NCT04400682|15931563|P1|Period 1|Withdrawal by Subject|1
4647787|NCT04399161|15931578|P3|Overall Study|Protocol Violation|0
4647788|NCT04399161|15931579|P2|Overall Study|Protocol Violation|2
4647789|NCT04399161|15931580|P1|Overall Study|Protocol Violation|1
4647790|NCT04399161|15931578|P3|Overall Study|Withdrawal by Subject|2
4647791|NCT04399161|15931579|P2|Overall Study|Withdrawal by Subject|0
4647792|NCT04399161|15931580|P1|Overall Study|Withdrawal by Subject|1
4647793|NCT04393493|15931601|P2|First 4 Days of Intervention|Early improvement|7
4647794|NCT04393493|15931602|P1|First 4 Days of Intervention|Early improvement|5
4647795|NCT04376060|15931654|P1|Overall Study|Physician Decision|1
4647796|NCT04359771|15931719|P2|Overall Study|Lack of Efficacy|2
4647797|NCT04359771|15931720|P1|Overall Study|Lack of Efficacy|2
4647798|NCT04355663|15931735|P3|Overall Study|Withdrawal by Subject|3
4647799|NCT04355663|15931736|P2|Overall Study|Withdrawal by Subject|8
4647800|NCT04355663|15931737|P1|Overall Study|Withdrawal by Subject|0
4647801|NCT04355663|15931735|P3|Overall Study|Adverse Event|1
4647802|NCT04355663|15931736|P2|Overall Study|Adverse Event|0
4647803|NCT04355663|15931737|P1|Overall Study|Adverse Event|0
4647804|NCT04355663|15931735|P3|Overall Study|Physician Decision|0
4647805|NCT04355663|15931736|P2|Overall Study|Physician Decision|7
4647806|NCT04355663|15931737|P1|Overall Study|Physician Decision|2
4647807|NCT04350788|15931780|P2|Overall Study|Protocol Violation|0
4647808|NCT04350788|15931781|P1|Overall Study|Protocol Violation|4
4647809|NCT04350788|15931780|P2|Overall Study|Withdrawal by Subject|4
4647810|NCT04350788|15931781|P1|Overall Study|Withdrawal by Subject|2
4647811|NCT04350788|15931780|P2|Overall Study|Lost to Follow-up|2
4647812|NCT04350788|15931781|P1|Overall Study|Lost to Follow-up|6
4647813|NCT04348851|15931837|P4|Post-Test 2|Stroke survivor death|1
4647814|NCT04348851|15931838|P3|Post-Test 2|Stroke survivor death|0
4647815|NCT04348851|15931839|P2|Post-Test 2|Stroke survivor death|1
4647816|NCT04348851|15931840|P1|Post-Test 2|Stroke survivor death|0
4647817|NCT04348851|15931837|P4|Post-Test 1|Lost to Follow-up|0
4647818|NCT04348851|15931838|P3|Post-Test 1|Lost to Follow-up|0
4647819|NCT04348851|15931839|P2|Post-Test 1|Lost to Follow-up|1
4647820|NCT04348851|15931840|P1|Post-Test 1|Lost to Follow-up|0
4647821|NCT04348851|15931837|P4|Post-Test 1|Withdrawal by Subject|0
4647822|NCT04348851|15931838|P3|Post-Test 1|Withdrawal by Subject|0
4647823|NCT04348851|15931839|P2|Post-Test 1|Withdrawal by Subject|1
4647824|NCT04348851|15931840|P1|Post-Test 1|Withdrawal by Subject|0
4647825|NCT04343261|15931947|P1|Overall Study|received inadequate amount of antibodies|7
4647826|NCT04343261|15931947|P1|Overall Study|Adverse Event|1
4647827|NCT04339296|15931983|P2|Overall Study|Discontinued intervention|3
4647828|NCT04339296|15931984|P1|Overall Study|Discontinued intervention|5
4647829|NCT04339296|15931983|P2|Overall Study|Lost to Follow-up|4
4647830|NCT04339296|15931984|P1|Overall Study|Lost to Follow-up|0
4647831|NCT04339296|15931983|P2|Overall Study|Withdrew after completion of baseline|1
4647832|NCT04339296|15931984|P1|Overall Study|Withdrew after completion of baseline|2
4647833|NCT04339296|15931983|P2|Overall Study|Refuse to participate after allocation|1
4647834|NCT04339296|15931984|P1|Overall Study|Refuse to participate after allocation|1
4647835|NCT04336475|15931994|P2|Overall Study|Lost to Follow-up|2
4647836|NCT04336475|15931995|P1|Overall Study|Lost to Follow-up|0
4647837|NCT04336475|15931994|P2|Overall Study|upper respiratory infection|0
4647838|NCT04336475|15931995|P1|Overall Study|upper respiratory infection|1
4647839|NCT04336475|15931994|P2|Overall Study|pain|0
4647840|NCT04336475|15931995|P1|Overall Study|pain|1
4647841|NCT04322526|15932047|P2|Washout (1 Week)|Lost to Follow-up|2
4647842|NCT04322526|15932048|P1|Washout (1 Week)|Lost to Follow-up|1
4647843|NCT04322526|15932047|P2|First Intervention (1 Day)|Withdrawal by Subject|1
4647844|NCT04322526|15932048|P1|First Intervention (1 Day)|Withdrawal by Subject|1
4647845|NCT04308239|15932067|P2|Post-intervention Evaluation (1 Week)|testing error during evaluation|2
4647846|NCT04308239|15932068|P1|Post-intervention Evaluation (1 Week)|testing error during evaluation|0
4647847|NCT04308239|15932067|P2|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2
4647848|NCT04308239|15932068|P1|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1
4647849|NCT04308239|15932067|P2|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2
4647850|NCT04308239|15932068|P1|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1
4647851|NCT04308239|15932067|P2|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1
4647852|NCT04308239|15932068|P1|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2
4647853|NCT04287517|15932134|P2|Overall Study|Withdrawal by Subject|1
4647854|NCT04287517|15932135|P1|Overall Study|Withdrawal by Subject|1
4647855|NCT04280705|15932169|P2|Overall Study|Transferred to another hospital|1
4647856|NCT04280705|15932170|P1|Overall Study|Transferred to another hospital|1
4647857|NCT04280705|15932169|P2|Overall Study|Adverse Event|4
4647858|NCT04280705|15932170|P1|Overall Study|Adverse Event|0
4647859|NCT04280705|15932169|P2|Overall Study|Withdrawal by Subject|9
4647860|NCT04280705|15932170|P1|Overall Study|Withdrawal by Subject|7
4647861|NCT04280705|15932169|P2|Overall Study|Physician Decision|0
4647862|NCT04280705|15932170|P1|Overall Study|Physician Decision|1
4647863|NCT04280705|15932169|P2|Overall Study|Enrolled but not treated|10
4647864|NCT04280705|15932170|P1|Overall Study|Enrolled but not treated|4
4647865|NCT04272775|15932262|P2|Overall Study|Progressive Disease|1
4647866|NCT04272775|15932263|P1|Overall Study|Progressive Disease|3
4647867|NCT04272775|15932262|P2|Overall Study|Adverse Event|2
4647868|NCT04272775|15932263|P1|Overall Study|Adverse Event|1
4647869|NCT04272775|15932262|P2|Overall Study|Withdrawal by Subject|2
4647870|NCT04272775|15932263|P1|Overall Study|Withdrawal by Subject|1
4647871|NCT04272775|15932262|P2|Overall Study|Symptomatic Deterioration|1
4647872|NCT04272775|15932263|P1|Overall Study|Symptomatic Deterioration|1
4647873|NCT04272775|15932262|P2|Overall Study|Protocol Violation|1
4647874|NCT04272775|15932263|P1|Overall Study|Protocol Violation|0
4647875|NCT04272775|15932262|P2|Overall Study|Study Terminated by Sponsor|0
4647876|NCT04272775|15932263|P1|Overall Study|Study Terminated by Sponsor|1
4647877|NCT04222699|15932450|P1|Overall Study|Lost to Follow-up|2
4647878|NCT04195893|15932542|P2|Second Intervention|Withdrawal by Subject|0
4647879|NCT04195893|15932543|P1|Second Intervention|Withdrawal by Subject|1
4647880|NCT04194151|15932602|P6|Overall Study|Monitorization problem|0
4647881|NCT04194151|15932603|P5|Overall Study|Monitorization problem|0
4647882|NCT04194151|15932604|P4|Overall Study|Monitorization problem|0
4647883|NCT04194151|15932605|P3|Overall Study|Monitorization problem|0
4647884|NCT04194151|15932606|P2|Overall Study|Monitorization problem|1
4647885|NCT04194151|15932607|P1|Overall Study|Monitorization problem|0
4647886|NCT04194151|15932602|P6|Overall Study|Physician Decision|1
4647887|NCT04194151|15932603|P5|Overall Study|Physician Decision|0
4647888|NCT04194151|15932604|P4|Overall Study|Physician Decision|1
4647889|NCT04194151|15932605|P3|Overall Study|Physician Decision|1
4647890|NCT04194151|15932606|P2|Overall Study|Physician Decision|1
4647891|NCT04194151|15932607|P1|Overall Study|Physician Decision|1
4647892|NCT04179838|15932700|P2|Second Intervention (1 Day)|Protocol Violation|1
4647893|NCT04179838|15932701|P1|Second Intervention (1 Day)|Protocol Violation|0
4647894|NCT04179838|15932700|P2|First Intervention (1 Day)|Withdrawal by Subject|3
4647895|NCT04179838|15932701|P1|First Intervention (1 Day)|Withdrawal by Subject|0
4647896|NCT04178590|15932719|P1|Overall Study|Lost to Follow-up|1
4647897|NCT04178590|15932719|P1|Overall Study|Pregnancy|1
4647898|NCT04173741|15932829|P2|Overall Study|IVC measurement cannot be done|1
4647899|NCT04173741|15932830|P1|Overall Study|IVC measurement cannot be done|1
4647900|NCT04161079|15932894|P1|Clinical Investigation 2010-040|Adverse Event|1
4647901|NCT04149353|15933043|P1|Overall Study|Study terminated|1
4647902|NCT04142216|15933071|P2|Overall Study|Use of clove|1
4647903|NCT04142216|15933072|P1|Overall Study|Use of clove|0
4647904|NCT04142216|15933071|P2|Overall Study|Referral to another hemodialysis unit|2
4647905|NCT04142216|15933072|P1|Overall Study|Referral to another hemodialysis unit|3
4647906|NCT04142216|15933071|P2|Overall Study|Death|1
4647907|NCT04142216|15933072|P1|Overall Study|Death|3
4647908|NCT04142216|15933071|P2|Overall Study|Hospitalization|2
4647909|NCT04142216|15933072|P1|Overall Study|Hospitalization|0
4647910|NCT04138810|15933094|P2|Overall Study|Subject cancelled surgery|0
4647911|NCT04138810|15933095|P1|Overall Study|Subject cancelled surgery|1
4647912|NCT04138810|15933094|P2|Overall Study|Withdrawal by Subject|1
4647913|NCT04138810|15933095|P1|Overall Study|Withdrawal by Subject|0
4647914|NCT04128293|15933122|P4|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4647915|NCT04128293|15933123|P3|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4647916|NCT04128293|15933124|P2|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4647917|NCT04128293|15933125|P1|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4
4647918|NCT04123665|15933325|P2|Overall Study|Lost to Follow-up|0
4647919|NCT04123665|15933326|P1|Overall Study|Lost to Follow-up|1
4647920|NCT04123665|15933325|P2|Overall Study|Withdrawal by Subject|0
4647921|NCT04123665|15933326|P1|Overall Study|Withdrawal by Subject|7
4647922|NCT04106817|15933409|P3|Overall Study|Lost to Follow-up|0
4647923|NCT04106817|15933410|P2|Overall Study|Lost to Follow-up|0
4647924|NCT04106817|15933411|P1|Overall Study|Lost to Follow-up|1
4647925|NCT04098809|15933427|P2|Overall Study|Physician Decision|1
4647926|NCT04098809|15933428|P1|Overall Study|Physician Decision|2
4647927|NCT04098809|15933427|P2|Overall Study|Withdrawal by Subject|3
4647928|NCT04098809|15933428|P1|Overall Study|Withdrawal by Subject|1
4647929|NCT04095286|15933454|P6|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4647930|NCT04095286|15933455|P5|Period 2 (4 Days) + Washout (7days)|Adverse Event|1
4647931|NCT04095286|15933456|P4|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4647932|NCT04095286|15933457|P3|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4647933|NCT04095286|15933458|P2|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4647934|NCT04095286|15933459|P1|Period 2 (4 Days) + Washout (7days)|Adverse Event|0
4647935|NCT04095286|15933454|P6|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647936|NCT04095286|15933455|P5|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647937|NCT04095286|15933456|P4|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647938|NCT04095286|15933457|P3|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2
4647939|NCT04095286|15933458|P2|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647940|NCT04095286|15933459|P1|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647941|NCT04095286|15933454|P6|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4647942|NCT04095286|15933455|P5|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4647943|NCT04095286|15933456|P4|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4647944|NCT04095286|15933457|P3|Period 1 (4 Days) + Washout (7days)|Adverse Event|1
4647945|NCT04095286|15933458|P2|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4647946|NCT04095286|15933459|P1|Period 1 (4 Days) + Washout (7days)|Adverse Event|0
4647947|NCT04095286|15933454|P6|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4647948|NCT04095286|15933455|P5|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4647949|NCT04095286|15933456|P4|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4647950|NCT04095286|15933457|P3|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4647951|NCT04095286|15933458|P2|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0
4647952|NCT04095286|15933459|P1|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1
4647953|NCT04095286|15933454|P6|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647954|NCT04095286|15933455|P5|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647955|NCT04095286|15933456|P4|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647956|NCT04095286|15933457|P3|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647957|NCT04095286|15933458|P2|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1
4647958|NCT04095286|15933459|P1|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0
4647959|NCT04091659|15933502|P2|Overall Study|Lost to Follow-up|1
4647960|NCT04091659|15933503|P1|Overall Study|Lost to Follow-up|0
4647961|NCT04091659|15933502|P2|Overall Study|Protocol Violation|0
4647962|NCT04091659|15933503|P1|Overall Study|Protocol Violation|3
4647963|NCT04090164|15933513|P2|Overall Study|incomplete data on file|0
4647964|NCT04090164|15933514|P1|Overall Study|incomplete data on file|245
4647965|NCT04080297|15933601|P2|Overall Study|concurrent illness|0
4647966|NCT04080297|15933602|P1|Overall Study|concurrent illness|1
4647967|NCT04080297|15933601|P2|Overall Study|Adverse Event|3
4647968|NCT04080297|15933602|P1|Overall Study|Adverse Event|1
4647969|NCT04079790|15933624|P4|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
4647970|NCT04079790|15933625|P3|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2
4647971|NCT04079790|15933626|P2|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
4939321|NCT00385827|16995231|P1|Part 2|Other|0
4647972|NCT04079790|15933627|P1|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0
4647973|NCT04079790|15933624|P4|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
4647974|NCT04079790|15933625|P3|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1
4647975|NCT04079790|15933626|P2|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
4647976|NCT04079790|15933627|P1|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0
4647977|NCT04079790|15933624|P4|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
4647978|NCT04079790|15933625|P3|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
4647979|NCT04079790|15933626|P2|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0
4647980|NCT04079790|15933627|P1|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1
4647981|NCT04079114|15933771|P1|Overall Study|Study prematuely terminated.|166
4647982|NCT04067401|15933856|P2|Overall Study|no data provided|0
4647983|NCT04067401|15933857|P1|Overall Study|no data provided|1
4647984|NCT04067401|15933856|P2|Overall Study|Withdrawal by Subject|0
4647985|NCT04067401|15933857|P1|Overall Study|Withdrawal by Subject|7
4647986|NCT04053465|15933916|P2|Overall Study|Withdrawal by Subject|4
4647987|NCT04053465|15933917|P1|Overall Study|Withdrawal by Subject|4
4647988|NCT04053023|15933946|P2|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0
4647989|NCT04053023|15933947|P1|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1
4647990|NCT04050618|15934126|P2|Second Intervention|Withdrawal by Subject|0
4647991|NCT04050618|15934127|P1|Second Intervention|Withdrawal by Subject|1
4647992|NCT04050618|15934126|P2|First Intervention|Withdrawal by Subject|0
4647993|NCT04050618|15934127|P1|First Intervention|Withdrawal by Subject|2
4647994|NCT04049578|15934295|P1|Overall Study|Physician Decision|1
4647995|NCT04048681|15934305|P5|Overall Study|family emergency|0
4647996|NCT04048681|15934306|P4|Overall Study|family emergency|1
4647997|NCT04048681|15934307|P3|Overall Study|family emergency|0
4647998|NCT04048681|15934308|P2|Overall Study|family emergency|0
4647999|NCT04048681|15934309|P1|Overall Study|family emergency|0
4648000|NCT04043416|15934625|P2|Washout|Change in health condition|1
4648001|NCT04043416|15934626|P1|Washout|Change in health condition|0
4648002|NCT04037748|15934720|P2|Treatment Period 2|Protocol Violation|0
4648003|NCT04037748|15934721|P1|Treatment Period 2|Protocol Violation|2
4648004|NCT04037748|15934720|P2|Treatment Period 2|Adverse Event|1
4648005|NCT04037748|15934721|P1|Treatment Period 2|Adverse Event|0
4648006|NCT04037748|15934720|P2|Treatment Period 1|Protocol Violation|5
4648007|NCT04037748|15934721|P1|Treatment Period 1|Protocol Violation|4
4648008|NCT04037748|15934720|P2|Treatment Period 1|Adverse Event|1
4648009|NCT04037748|15934721|P1|Treatment Period 1|Adverse Event|1
4648010|NCT04037748|15934720|P2|Treatment Period 1|Withdrawal by Subject|0
4648011|NCT04037748|15934721|P1|Treatment Period 1|Withdrawal by Subject|3
4648012|NCT04035577|15934739|P1|Overall Study|Withdrawal by Subject|1
4648013|NCT04035577|15934739|P1|Overall Study|Lost to Follow-up|1
4648014|NCT04035564|15934759|P2|Overall Study|Guardian declined consent|2
4648015|NCT04035564|15934760|P1|Overall Study|Guardian declined consent|1
4648016|NCT04035564|15934759|P2|Overall Study|No laboratory available|2
4648017|NCT04035564|15934760|P1|Overall Study|No laboratory available|2
4648018|NCT04035564|15934759|P2|Overall Study|Protocol Violation|2
4648019|NCT04035564|15934760|P1|Overall Study|Protocol Violation|1
4648020|NCT04032652|15934791|P2|Overall Study|The study was terminated and the PI has|1
4648021|NCT04032652|15934792|P1|Overall Study|The study was terminated and the PI has|1
4648022|NCT04017611|15935037|P1|Overall Study|Withdrawn prior to completion|1
4648023|NCT04015232|15935099|P2|Overall Study|Medical Grounds|3
4648024|NCT04015232|15935100|P1|Overall Study|Medical Grounds|3
4648025|NCT04015232|15935099|P2|Overall Study|Protocol Violation|0
4648026|NCT04015232|15935100|P1|Overall Study|Protocol Violation|1
4648027|NCT04015232|15935099|P2|Overall Study|Withdrawal by Subject|4
4648028|NCT04015232|15935100|P1|Overall Study|Withdrawal by Subject|7
4648029|NCT04014062|15935172|P2|Period I: Dosing|Withdrawal by Subject|1
4648030|NCT04014062|15935173|P1|Period I: Dosing|Withdrawal by Subject|3
4648031|NCT04014062|15935172|P2|Period I: Dosing|Medical Grounds|5
4648032|NCT04014062|15935173|P1|Period I: Dosing|Medical Grounds|4
4648033|NCT04007107|15935247|P4|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
4648034|NCT04007107|15935248|P3|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
4648035|NCT04007107|15935249|P2|Treatment Period 2 (Day 1)|Withdrawal by Subject|1
4648036|NCT04007107|15935250|P1|Treatment Period 2 (Day 1)|Withdrawal by Subject|0
4648037|NCT04006366|15935255|P1|Overall Study|Withdrawal by Subject|1
4648038|NCT04002960|15935265|P1|Overall Study|Withdrawn prior to Completion|2
4648039|NCT04002648|15935271|P2|Overall Study|Lost to Follow-up|0
4648040|NCT04002648|15935272|P1|Overall Study|Lost to Follow-up|2
4648041|NCT04000815|15935283|P3|Overall Study|Hypertension occured on follow up|2
4648042|NCT04000815|15935284|P2|Overall Study|Hypertension occured on follow up|0
4648043|NCT04000815|15935285|P1|Overall Study|Hypertension occured on follow up|0
4648044|NCT04000815|15935283|P3|Overall Study|Right ovarian cyst occured|0
4648045|NCT04000815|15935284|P2|Overall Study|Right ovarian cyst occured|0
4648046|NCT04000815|15935285|P1|Overall Study|Right ovarian cyst occured|1
4648047|NCT04000815|15935283|P3|Overall Study|Withdrawal by Subject|2
4648048|NCT04000815|15935284|P2|Overall Study|Withdrawal by Subject|3
4648049|NCT04000815|15935285|P1|Overall Study|Withdrawal by Subject|4
4648050|NCT04000815|15935283|P3|Overall Study|Lost to Follow-up|3
4648051|NCT04000815|15935284|P2|Overall Study|Lost to Follow-up|2
4648052|NCT04000815|15935285|P1|Overall Study|Lost to Follow-up|9
4648053|NCT03988907|15935442|P2|Overall Study|Unable to complete visit|1
4648054|NCT03988907|15935443|P1|Overall Study|Unable to complete visit|0
4648055|NCT03988088|15935499|P4|Open-Label Addendum|Lost to Follow-up|0
4648056|NCT03988088|15935500|P3|Open-Label Addendum|Lost to Follow-up|1
4648057|NCT03988088|15935501|P2|Open-Label Addendum|Lost to Follow-up|0
4648058|NCT03988088|15935502|P1|Open-Label Addendum|Lost to Follow-up|0
4648059|NCT03988088|15935499|P4|Single-Dose Pharmacokinetic Study|Adverse Event|0
4648060|NCT03988088|15935500|P3|Single-Dose Pharmacokinetic Study|Adverse Event|0
4648061|NCT03988088|15935501|P2|Single-Dose Pharmacokinetic Study|Adverse Event|1
4648062|NCT03988088|15935502|P1|Single-Dose Pharmacokinetic Study|Adverse Event|0
4648063|NCT03984825|15935572|P1|Treatment Period 2 (Day 11 to 21)|Adverse Event|3
4648064|NCT03984825|15935572|P1|Treatment Period 2 (Day 11 to 21)|Physician Decision|1
4648065|NCT03984825|15935572|P1|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2
4648066|NCT03983317|15935686|P1|Overall Study|Physician Decision|5
4648067|NCT03982433|15935693|P1|Overall Study|Lost to Follow-up|1
4648068|NCT03977727|15935744|P2|Second Treatment|Lost to Follow-up|3
4648069|NCT03977727|15935745|P1|Second Treatment|Lost to Follow-up|0
4648070|NCT03976466|15935791|P2|Overall Study|Lost to Follow-up|3
4648071|NCT03976466|15935792|P1|Overall Study|Lost to Follow-up|1
4648072|NCT03972137|15936141|P1|Overall Study|Withdrawal by Subject|4
4648073|NCT03972137|15936141|P1|Overall Study|Lost to Follow-up|2
4648074|NCT03970395|15936165|P2|Overall Study|Lost to Follow-up|8
4648075|NCT03970395|15936166|P1|Overall Study|Lost to Follow-up|4
4648076|NCT03970395|15936165|P2|Overall Study|Withdrawal by Subject|4
4648077|NCT03970395|15936166|P1|Overall Study|Withdrawal by Subject|3
4648078|NCT03966365|15936184|P2|Overall Study|Protocol Violation|0
4648079|NCT03966365|15936185|P1|Overall Study|Protocol Violation|1
4648080|NCT03965403|15936224|P1|Overall Study|Subject not meeting eligibility criteria|1
4648081|NCT03965052|15936237|P2|Overall Study|Protocol Violation|0
4648082|NCT03965052|15936238|P1|Overall Study|Protocol Violation|1
4648083|NCT03962790|15936334|P2|Period 1|Withdrawal by Subject|0
4648084|NCT03962790|15936335|P1|Period 1|Withdrawal by Subject|1
4648085|NCT03962790|15936334|P2|Period 1|No Longer Meets Eligibility Criteria|0
4648086|NCT03962790|15936335|P1|Period 1|No Longer Meets Eligibility Criteria|1
4648087|NCT03962790|15936334|P2|Period 1|Failed to meet all eligibility criteria|1
4648088|NCT03962790|15936335|P1|Period 1|Failed to meet all eligibility criteria|1
4648089|NCT03962790|15936334|P2|Period 1|Adverse Event|1
4648090|NCT03962790|15936335|P1|Period 1|Adverse Event|0
4648091|NCT03961308|15936349|P2|Overall Study|Adverse Event|1
4648092|NCT03961308|15936350|P1|Overall Study|Adverse Event|0
4648093|NCT03961308|15936349|P2|Overall Study|Lost to Follow-up|1
4648094|NCT03961308|15936350|P1|Overall Study|Lost to Follow-up|0
4648095|NCT03961308|15936349|P2|Overall Study|Other|0
4648096|NCT03961308|15936350|P1|Overall Study|Other|1
4648097|NCT03961308|15936349|P2|Overall Study|Withdrawal by Subject|0
4648098|NCT03961308|15936350|P1|Overall Study|Withdrawal by Subject|1
4648099|NCT03953820|15936514|P3|Two-Sequence, Two-Way Crossover|Physician Decision|0
4648100|NCT03953820|15936515|P2|Two-Sequence, Two-Way Crossover|Physician Decision|0
4648101|NCT03953820|15936516|P1|Two-Sequence, Two-Way Crossover|Physician Decision|1
4648102|NCT03953820|15936514|P3|Two-Sequence, Two-Way Crossover|Adverse Event|0
4648103|NCT03953820|15936515|P2|Two-Sequence, Two-Way Crossover|Adverse Event|0
4648104|NCT03953820|15936516|P1|Two-Sequence, Two-Way Crossover|Adverse Event|1
4648105|NCT03950674|15936569|P2|Overall Study|Ongoing in Study|8
4648106|NCT03950674|15936570|P1|Overall Study|Ongoing in Study|22
4648107|NCT03950674|15936569|P2|Overall Study|Death|7
4648108|NCT03950674|15936570|P1|Overall Study|Death|3
4648109|NCT03948581|15936604|P2|Overall Study|Lost to Follow-up|1
4648110|NCT03948581|15936605|P1|Overall Study|Lost to Follow-up|0
4648111|NCT03946124|15936615|P1|Overall Study|Withdrawal by Subject|19
4648112|NCT03943095|15936621|P2|Overall Study|Withdrawal by Subject|0
4648113|NCT03943095|15936622|P1|Overall Study|Withdrawal by Subject|1
4648114|NCT03943095|15936621|P2|Overall Study|Incorrectly dispensed wrong box kit|1
4648115|NCT03943095|15936622|P1|Overall Study|Incorrectly dispensed wrong box kit|0
4648116|NCT03937479|15936671|P5|Overall Study|Physician Decision|1
4648117|NCT03937479|15936672|P4|Overall Study|Physician Decision|0
4648118|NCT03937479|15936673|P3|Overall Study|Physician Decision|1
4648119|NCT03937479|15936674|P2|Overall Study|Physician Decision|0
4648120|NCT03937479|15936675|P1|Overall Study|Physician Decision|0
4648121|NCT03937479|15936671|P5|Overall Study|Lost to Follow-up|0
4648122|NCT03937479|15936672|P4|Overall Study|Lost to Follow-up|1
4648123|NCT03937479|15936673|P3|Overall Study|Lost to Follow-up|0
4648124|NCT03937479|15936674|P2|Overall Study|Lost to Follow-up|1
4648125|NCT03937479|15936675|P1|Overall Study|Lost to Follow-up|0
4648126|NCT03937479|15936671|P5|Overall Study|Protocol Violation|2
4648127|NCT03937479|15936672|P4|Overall Study|Protocol Violation|3
4648128|NCT03937479|15936673|P3|Overall Study|Protocol Violation|4
4648129|NCT03937479|15936674|P2|Overall Study|Protocol Violation|6
4648130|NCT03937479|15936675|P1|Overall Study|Protocol Violation|5
4648131|NCT03937479|15936671|P5|Overall Study|Withdrawal by Subject|1
4648132|NCT03937479|15936672|P4|Overall Study|Withdrawal by Subject|2
4648133|NCT03937479|15936673|P3|Overall Study|Withdrawal by Subject|2
4648134|NCT03937479|15936674|P2|Overall Study|Withdrawal by Subject|5
4648135|NCT03937479|15936675|P1|Overall Study|Withdrawal by Subject|3
4648136|NCT03937479|15936671|P5|Overall Study|Adverse Event|1
4648137|NCT03937479|15936672|P4|Overall Study|Adverse Event|0
4648138|NCT03937479|15936673|P3|Overall Study|Adverse Event|0
4648139|NCT03937479|15936674|P2|Overall Study|Adverse Event|3
4648140|NCT03937479|15936675|P1|Overall Study|Adverse Event|2
4648141|NCT03936244|15936769|P2|Overall Study|Physician Decision|3
4648142|NCT03936244|15936770|P1|Overall Study|Physician Decision|7
4648143|NCT03936244|15936769|P2|Overall Study|Lost to Follow-up|1
4648144|NCT03936244|15936770|P1|Overall Study|Lost to Follow-up|5
4648145|NCT03933449|15937108|P2|Overall Study|Ongoing in Study|6
4648146|NCT03933449|15937109|P1|Overall Study|Ongoing in Study|20
4648147|NCT03933449|15937108|P2|Overall Study|Death|51
4648148|NCT03933449|15937109|P1|Overall Study|Death|36
4648149|NCT03933449|15937108|P2|Overall Study|Adverse Event|4
4648150|NCT03933449|15937109|P1|Overall Study|Adverse Event|6
4648151|NCT03927950|15937164|P1|Overall Study|Adverse Event|9
4648152|NCT03923933|15937197|P2|Overall Study|Withdrawal by Subject|1
4648153|NCT03923933|15937198|P1|Overall Study|Withdrawal by Subject|0
4648154|NCT03923933|15937197|P2|Overall Study|Lost to Follow-up|0
4648155|NCT03923933|15937198|P1|Overall Study|Lost to Follow-up|1
4648156|NCT03923530|15937216|P1|Overall Study|screen failure|3
4648157|NCT03923530|15937216|P1|Overall Study|Withdrawal by Subject|1
4648158|NCT03921723|15937226|P1|Period 3 (4 Days)|Withdrawal by Subject|1
4648159|NCT03921723|15937226|P1|Period 2 (4 Days)|Withdrawal by Subject|3
4648160|NCT03914950|15937294|P1|Overall Study|Physician Decision|54
4648161|NCT03914417|15937304|P1|Overall Study|Withdrawal by Subject|2
4648162|NCT03913377|15937311|P3|Period 1|No Longer Meets Eligibility Criteria|1
4648163|NCT03913377|15937312|P2|Period 1|No Longer Meets Eligibility Criteria|0
4648164|NCT03913377|15937313|P1|Period 1|No Longer Meets Eligibility Criteria|0
4648165|NCT03913377|15937311|P3|Period 1|Test Article no longer available|0
4648166|NCT03913377|15937312|P2|Period 1|Test Article no longer available|1
4648167|NCT03913377|15937313|P1|Period 1|Test Article no longer available|0
4648168|NCT03911960|15937330|P2|Overall Study|Lost to Follow-up|3
4648169|NCT03911960|15937331|P1|Overall Study|Lost to Follow-up|5
4648170|NCT03905642|15937530|P1|Overall Study|Completed study but not 24 of 28 days|2
4648171|NCT03905642|15937530|P1|Overall Study|Lack of Efficacy|1
4648172|NCT03905642|15937530|P1|Overall Study|Adverse Event|1
4648173|NCT03905642|15937530|P1|Overall Study|Pregnancy|1
4648174|NCT03905642|15937530|P1|Overall Study|Withdrawal by Subject|3
4648175|NCT03904420|15937541|P2|Overall Study|Study terminated|2
4648176|NCT03904420|15937542|P1|Overall Study|Study terminated|2
4648177|NCT03902613|15937548|P1|Overall Study|Physician Decision|1
4648178|NCT03902392|15937554|P2|Overall Study|Lost to Follow-up|7
4648179|NCT03902392|15937555|P1|Overall Study|Lost to Follow-up|7
4648180|NCT03899064|15937621|P1|Overall Study|Other|2
4648181|NCT03899064|15937621|P1|Overall Study|Withdrawal by Subject|2
4648182|NCT03899064|15937621|P1|Overall Study|Protocol Violation|2
4648183|NCT03899064|15937621|P1|Overall Study|Lost to Follow-up|1
4648184|NCT03897179|15937636|P1|Overall Study|Withdrawal by Subject|1
4648185|NCT03892564|15937862|P1|Overall Study|Withdrawal by Subject|2
4648186|NCT03888482|15937901|P2|Second Wear (8 -1/+2 Days)|Other|0
4648187|NCT03888482|15937902|P1|Second Wear (8 -1/+2 Days)|Other|1
4648188|NCT03888482|15937901|P2|Second Wear (8 -1/+2 Days)|Adverse Event|1
4648189|NCT03888482|15937902|P1|Second Wear (8 -1/+2 Days)|Adverse Event|0
4648190|NCT03888391|15937921|P1|Overall Study|Lost to Follow-up|15
4648191|NCT03885726|15937985|P1|Overall Study|Early discharge from hospital|3
4648192|NCT03885726|15937985|P1|Overall Study|Staffing issues/lost interest|1
4648193|NCT03883386|15938051|P2|First Assignment|Withdrawal by Subject|1
4648194|NCT03883386|15938052|P1|First Assignment|Withdrawal by Subject|1
4648195|NCT03883386|15938051|P2|First Assignment|Lost to Follow-up|0
4648196|NCT03883386|15938052|P1|First Assignment|Lost to Follow-up|1
4648197|NCT03882424|15938063|P3|Overall Study|schedule conflict|0
4648198|NCT03882424|15938064|P2|Overall Study|schedule conflict|0
4648199|NCT03882424|15938065|P1|Overall Study|schedule conflict|1
4648200|NCT03882424|15938063|P3|Overall Study|Lost to Follow-up|0
4648201|NCT03882424|15938064|P2|Overall Study|Lost to Follow-up|0
4648202|NCT03882424|15938065|P1|Overall Study|Lost to Follow-up|3
4648203|NCT03882047|15938088|P3|Overall Study|Did Not Meet Eligibility|1
4648204|NCT03882047|15938089|P2|Overall Study|Did Not Meet Eligibility|0
4648205|NCT03882047|15938090|P1|Overall Study|Did Not Meet Eligibility|0
4648206|NCT03882047|15938088|P3|Overall Study|Noncompliance With Protocol|0
4648207|NCT03882047|15938089|P2|Overall Study|Noncompliance With Protocol|0
4648208|NCT03882047|15938090|P1|Overall Study|Noncompliance With Protocol|2
4648209|NCT03882047|15938088|P3|Overall Study|Did Not Wish to Continue|1
4648210|NCT03882047|15938089|P2|Overall Study|Did Not Wish to Continue|4
4648211|NCT03882047|15938090|P1|Overall Study|Did Not Wish to Continue|1
4648212|NCT03882047|15938088|P3|Overall Study|Lost to Follow-up|0
4648213|NCT03882047|15938089|P2|Overall Study|Lost to Follow-up|1
4648214|NCT03882047|15938090|P1|Overall Study|Lost to Follow-up|0
4648215|NCT03882047|15938088|P3|Overall Study|Treatment Failure|12
4648216|NCT03882047|15938089|P2|Overall Study|Treatment Failure|3
4648217|NCT03882047|15938090|P1|Overall Study|Treatment Failure|3
4648218|NCT03882047|15938088|P3|Overall Study|Adverse Event|2
4648219|NCT03882047|15938089|P2|Overall Study|Adverse Event|2
4648220|NCT03882047|15938090|P1|Overall Study|Adverse Event|0
4648221|NCT03879772|15938146|P5|Overall Study|Did Not Meet Entry Requirements|0
4648222|NCT03879772|15938147|P4|Overall Study|Did Not Meet Entry Requirements|0
4648223|NCT03879772|15938148|P3|Overall Study|Did Not Meet Entry Requirements|1
4648224|NCT03879772|15938149|P2|Overall Study|Did Not Meet Entry Requirements|0
4648225|NCT03879772|15938150|P1|Overall Study|Did Not Meet Entry Requirements|1
4648226|NCT03879772|15938146|P5|Overall Study|Protocol Violation|2
4648227|NCT03879772|15938147|P4|Overall Study|Protocol Violation|1
4648228|NCT03879772|15938148|P3|Overall Study|Protocol Violation|3
4648229|NCT03879772|15938149|P2|Overall Study|Protocol Violation|0
4648230|NCT03879772|15938150|P1|Overall Study|Protocol Violation|0
4648231|NCT03879772|15938146|P5|Overall Study|Withdrawal by Subject|1
4648232|NCT03879772|15938147|P4|Overall Study|Withdrawal by Subject|1
4648233|NCT03879772|15938148|P3|Overall Study|Withdrawal by Subject|3
4648234|NCT03879772|15938149|P2|Overall Study|Withdrawal by Subject|1
4648235|NCT03879772|15938150|P1|Overall Study|Withdrawal by Subject|0
4648236|NCT03879772|15938146|P5|Overall Study|Lost to Follow-up|1
4648237|NCT03879772|15938147|P4|Overall Study|Lost to Follow-up|0
4648238|NCT03879772|15938148|P3|Overall Study|Lost to Follow-up|0
4648239|NCT03879772|15938149|P2|Overall Study|Lost to Follow-up|0
4648240|NCT03879772|15938150|P1|Overall Study|Lost to Follow-up|0
4648241|NCT03879772|15938146|P5|Overall Study|Treatment Failure|1
4648242|NCT03879772|15938147|P4|Overall Study|Treatment Failure|2
4648243|NCT03879772|15938148|P3|Overall Study|Treatment Failure|0
4648244|NCT03879772|15938149|P2|Overall Study|Treatment Failure|0
4648245|NCT03879772|15938150|P1|Overall Study|Treatment Failure|1
4648246|NCT03879772|15938146|P5|Overall Study|Adverse Event|3
4648247|NCT03879772|15938147|P4|Overall Study|Adverse Event|4
4648248|NCT03879772|15938148|P3|Overall Study|Adverse Event|3
4648249|NCT03879772|15938149|P2|Overall Study|Adverse Event|2
4648250|NCT03879772|15938150|P1|Overall Study|Adverse Event|2
4648251|NCT03878758|15938187|P1|Overall Study|Improper consent documentation|1
4648252|NCT03878758|15938187|P1|Overall Study|Protocol defined|2
4648253|NCT03878758|15938187|P1|Overall Study|Withdrawal by Subject|1
4648254|NCT03876743|15938228|P4|Overall Study|Lost to Follow-up|7
4648255|NCT03876743|15938229|P3|Overall Study|Lost to Follow-up|4
4648256|NCT03876743|15938230|P2|Overall Study|Lost to Follow-up|4
4648257|NCT03876743|15938231|P1|Overall Study|Lost to Follow-up|6
4648258|NCT03870997|15938326|P6|Overall Study|Did not complete mid-study/final survey|10531
4648259|NCT03870997|15938327|P5|Overall Study|Did not complete mid-study/final survey|10588
4648260|NCT03870997|15938328|P4|Overall Study|Did not complete mid-study/final survey|10947
4648261|NCT03870997|15938329|P3|Overall Study|Did not complete mid-study/final survey|10978
4648262|NCT03870997|15938330|P2|Overall Study|Did not complete mid-study/final survey|10431
4648263|NCT03870997|15938331|P1|Overall Study|Did not complete mid-study/final survey|10544
4648264|NCT03870555|15938398|P3|Period 3 (2 Days)|Adverse Event|0
4648265|NCT03870555|15938399|P2|Period 3 (2 Days)|Adverse Event|0
4648266|NCT03870555|15938400|P1|Period 3 (2 Days)|Adverse Event|1
4648267|NCT03868631|15938486|P2|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
4648268|NCT03868631|15938487|P1|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1
4648269|NCT03868631|15938486|P2|Week 6 to Week 12 (Study Completion)|Protocol Violation|0
4648270|NCT03868631|15938487|P1|Week 6 to Week 12 (Study Completion)|Protocol Violation|1
4648271|NCT03868631|15938486|P2|Week 6 to Week 12 (Study Completion)|Adverse Event|0
4648272|NCT03868631|15938487|P1|Week 6 to Week 12 (Study Completion)|Adverse Event|2
4648273|NCT03868631|15938486|P2|Baseline to Week 6|Withdrawal by Subject|0
4648274|NCT03868631|15938487|P1|Baseline to Week 6|Withdrawal by Subject|3
4648275|NCT03868631|15938486|P2|Baseline to Week 6|Protocol Violation|1
4648276|NCT03868631|15938487|P1|Baseline to Week 6|Protocol Violation|1
4648277|NCT03868631|15938486|P2|Baseline to Week 6|Adverse Event|3
4648278|NCT03868631|15938487|P1|Baseline to Week 6|Adverse Event|0
4648279|NCT03864653|15938527|P1|Overall Study|Withdrawal by Subject|1
4648280|NCT03861559|15938562|P2|Overall Study|Did not meet eligibility requirements|0
4648281|NCT03861559|15938563|P1|Overall Study|Did not meet eligibility requirements|1
4648282|NCT03861559|15938562|P2|Overall Study|Noncompliance|1
4648283|NCT03861559|15938563|P1|Overall Study|Noncompliance|1
4648284|NCT03861559|15938562|P2|Overall Study|Treatment failure|2
4648285|NCT03861559|15938563|P1|Overall Study|Treatment failure|0
4648286|NCT03861559|15938562|P2|Overall Study|Adverse Event|2
4648287|NCT03861559|15938563|P1|Overall Study|Adverse Event|0
4648288|NCT03855228|15938746|P4|Overall Study|Did Not Meet Entry Requirements|1
4648289|NCT03855228|15938747|P3|Overall Study|Did Not Meet Entry Requirements|1
4648290|NCT03855228|15938748|P2|Overall Study|Did Not Meet Entry Requirements|2
4648291|NCT03855228|15938749|P1|Overall Study|Did Not Meet Entry Requirements|0
4648292|NCT03855228|15938746|P4|Overall Study|Protocol Violation|1
4648293|NCT03855228|15938747|P3|Overall Study|Protocol Violation|2
4648294|NCT03855228|15938748|P2|Overall Study|Protocol Violation|1
4648295|NCT03855228|15938749|P1|Overall Study|Protocol Violation|0
4648296|NCT03855228|15938746|P4|Overall Study|Lost to Follow-up|1
4648297|NCT03855228|15938747|P3|Overall Study|Lost to Follow-up|0
4648298|NCT03855228|15938748|P2|Overall Study|Lost to Follow-up|0
4648299|NCT03855228|15938749|P1|Overall Study|Lost to Follow-up|0
4648300|NCT03855228|15938746|P4|Overall Study|Treatment Failure|8
4648301|NCT03855228|15938747|P3|Overall Study|Treatment Failure|1
4648302|NCT03855228|15938748|P2|Overall Study|Treatment Failure|2
4648303|NCT03855228|15938749|P1|Overall Study|Treatment Failure|1
4648304|NCT03855228|15938746|P4|Overall Study|Adverse Event|8
4648305|NCT03855228|15938747|P3|Overall Study|Adverse Event|4
4648306|NCT03855228|15938748|P2|Overall Study|Adverse Event|4
4648307|NCT03855228|15938749|P1|Overall Study|Adverse Event|2
4648308|NCT03855189|15938798|P3|Overall Study|Did Not Return|0
4648309|NCT03855189|15938799|P2|Overall Study|Did Not Return|3
4648310|NCT03855189|15938800|P1|Overall Study|Did Not Return|4
4648311|NCT03855189|15938798|P3|Overall Study|Noncompliance with Protocol|0
4648312|NCT03855189|15938799|P2|Overall Study|Noncompliance with Protocol|1
4648313|NCT03855189|15938800|P1|Overall Study|Noncompliance with Protocol|0
4648314|NCT03855189|15938798|P3|Overall Study|Treatment Failure|2
4648315|NCT03855189|15938799|P2|Overall Study|Treatment Failure|1
4648316|NCT03855189|15938800|P1|Overall Study|Treatment Failure|1
4648317|NCT03855189|15938798|P3|Overall Study|Adverse Event|4
4648318|NCT03855189|15938799|P2|Overall Study|Adverse Event|2
4648319|NCT03855189|15938800|P1|Overall Study|Adverse Event|5
4648320|NCT03851016|15938918|P2|First Intervention (3 Weeks)|Withdrawal by Subject|2
4648321|NCT03851016|15938919|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
4648322|NCT03850496|15938932|P3|Overall Study|Lost to Follow-up|4
4648323|NCT03850496|15938933|P2|Overall Study|Lost to Follow-up|1
4648324|NCT03850496|15938934|P1|Overall Study|Lost to Follow-up|0
4648325|NCT03850496|15938932|P3|Overall Study|Withdrawal by Subject|0
4648326|NCT03850496|15938933|P2|Overall Study|Withdrawal by Subject|0
4648327|NCT03850496|15938934|P1|Overall Study|Withdrawal by Subject|1
4648328|NCT03850444|15938956|P2|Overall Study|Ongoing in Study|59
4648329|NCT03850444|15938957|P1|Overall Study|Ongoing in Study|78
4648330|NCT03850444|15938956|P2|Overall Study|Withdrawal by Subject|1
4648331|NCT03850444|15938957|P1|Overall Study|Withdrawal by Subject|0
4648332|NCT03850444|15938956|P2|Overall Study|Lost to Follow-up|1
4648333|NCT03850444|15938957|P1|Overall Study|Lost to Follow-up|0
4648334|NCT03850444|15938956|P2|Overall Study|Death|64
4648335|NCT03850444|15938957|P1|Overall Study|Death|38
4648336|NCT03850444|15938956|P2|Overall Study|Adverse Event|9
4648337|NCT03850444|15938957|P1|Overall Study|Adverse Event|12
4648338|NCT03850093|15938986|P3|Overall Study|Withdrawal by Subject|2
4648339|NCT03850093|15938987|P2|Overall Study|Withdrawal by Subject|0
4648340|NCT03850093|15938988|P1|Overall Study|Withdrawal by Subject|1
4648341|NCT03849300|15939050|P4|Overall Study|scheduling/transportation conflict|2
4648342|NCT03849300|15939051|P3|Overall Study|scheduling/transportation conflict|3
4648343|NCT03849300|15939052|P2|Overall Study|scheduling/transportation conflict|4
4648344|NCT03849300|15939053|P1|Overall Study|scheduling/transportation conflict|4
4648345|NCT03849300|15939050|P4|Overall Study|move out to different area|4
4648346|NCT03849300|15939051|P3|Overall Study|move out to different area|1
4648347|NCT03849300|15939052|P2|Overall Study|move out to different area|3
4648348|NCT03849300|15939053|P1|Overall Study|move out to different area|1
4648349|NCT03848416|15939155|P3|Overall Study|Death|1
4648350|NCT03848416|15939156|P2|Overall Study|Death|0
4648351|NCT03848416|15939157|P1|Overall Study|Death|0
4648352|NCT03848416|15939155|P3|Overall Study|Withdrawal by Subject|0
4648353|NCT03848416|15939156|P2|Overall Study|Withdrawal by Subject|0
4648354|NCT03848416|15939157|P1|Overall Study|Withdrawal by Subject|1
4648355|NCT03848403|15939171|P3|Period 2 (Day 8)|Sponsor Decision|5
4648356|NCT03848403|15939172|P2|Period 2 (Day 8)|Sponsor Decision|6
4648357|NCT03848403|15939173|P1|Period 2 (Day 8)|Sponsor Decision|8
4648358|NCT03848403|15939171|P3|Period 2 (Day 8)|Physician Decision|0
4648359|NCT03848403|15939172|P2|Period 2 (Day 8)|Physician Decision|1
4648360|NCT03848403|15939173|P1|Period 2 (Day 8)|Physician Decision|0
4648361|NCT03848403|15939171|P3|Period 2 (Day 8)|Adverse Event|2
4648362|NCT03848403|15939172|P2|Period 2 (Day 8)|Adverse Event|2
4648363|NCT03848403|15939173|P1|Period 2 (Day 8)|Adverse Event|1
4648364|NCT03847987|15939258|P2|Overall Study|Adverse Event|0
4648365|NCT03847987|15939259|P1|Overall Study|Adverse Event|2
4648366|NCT03847987|15939258|P2|Overall Study|Lost to Follow-up|0
4648367|NCT03847987|15939259|P1|Overall Study|Lost to Follow-up|1
4648368|NCT03844945|15939295|P4|Overall Study|Lack of Efficacy|1
4648369|NCT03844945|15939296|P3|Overall Study|Lack of Efficacy|0
4648370|NCT03844945|15939297|P2|Overall Study|Lack of Efficacy|0
4648371|NCT03844945|15939298|P1|Overall Study|Lack of Efficacy|0
4648372|NCT03844945|15939295|P4|Overall Study|Withdrawal by Subject|0
4648373|NCT03844945|15939296|P3|Overall Study|Withdrawal by Subject|1
4648374|NCT03844945|15939297|P2|Overall Study|Withdrawal by Subject|0
4648375|NCT03844945|15939298|P1|Overall Study|Withdrawal by Subject|0
4648376|NCT03844945|15939295|P4|Overall Study|Adverse Event|0
4648377|NCT03844945|15939296|P3|Overall Study|Adverse Event|4
4648378|NCT03844945|15939297|P2|Overall Study|Adverse Event|1
4648379|NCT03844945|15939298|P1|Overall Study|Adverse Event|1
4648380|NCT03841331|15939315|P2|Overall Study|Lost to Follow-up|1
4648381|NCT03841331|15939316|P1|Overall Study|Lost to Follow-up|5
4648382|NCT03841331|15939315|P2|Overall Study|Withdrawal by Subject|9
4648383|NCT03841331|15939316|P1|Overall Study|Withdrawal by Subject|4
4648384|NCT03840135|15939357|P2|Overall Study|Withdrawal by Subject|0
4648385|NCT03840135|15939358|P1|Overall Study|Withdrawal by Subject|1
4648386|NCT03840135|15939357|P2|Overall Study|Protocol Violation|1
4648387|NCT03840135|15939358|P1|Overall Study|Protocol Violation|6
4648388|NCT03837028|15939388|P4|Overall Study|Withdrawal by Subject|7
4648389|NCT03837028|15939389|P3|Overall Study|Withdrawal by Subject|11
4648390|NCT03837028|15939390|P2|Overall Study|Withdrawal by Subject|11
4648391|NCT03837028|15939391|P1|Overall Study|Withdrawal by Subject|12
4648392|NCT03837028|15939388|P4|Overall Study|Lost to Follow-up|0
4648393|NCT03837028|15939389|P3|Overall Study|Lost to Follow-up|2
4648394|NCT03837028|15939390|P2|Overall Study|Lost to Follow-up|0
4648395|NCT03837028|15939391|P1|Overall Study|Lost to Follow-up|4
4648396|NCT03836729|15939444|P1|Treatment Period 2 (Up to Day 7)|Adverse Event|1
4648397|NCT03836664|15939558|P2|Overall Study|Didn't complete forms and lost drug|3
4648398|NCT03836664|15939559|P1|Overall Study|Didn't complete forms and lost drug|3
4648399|NCT03835221|15939600|P1|Methafilcon A|Withdrawal by Subject|1
4648400|NCT03832387|15939682|P2|Overall Study|EXCLUSION CRITERIA|1
4648401|NCT03832387|15939683|P1|Overall Study|EXCLUSION CRITERIA|3
4648402|NCT03832387|15939682|P2|Overall Study|Protocol Violation|6
4648403|NCT03832387|15939683|P1|Overall Study|Protocol Violation|2
4648404|NCT03832322|15939713|P2|Overall Study|Failed cecal intubation in 2nd exam|1
4648405|NCT03832322|15939714|P1|Overall Study|Failed cecal intubation in 2nd exam|3
4648406|NCT03831282|15939750|P1|Overall Study|Could not place sensor|1
4648407|NCT03827473|15939786|P2|Overall Study|Withdrawal by Subject|0
4648408|NCT03827473|15939787|P1|Overall Study|Withdrawal by Subject|1
4648409|NCT03826914|15939803|P2|Overall Study|Withdrawal by Subject|1
4648410|NCT03826914|15939804|P1|Overall Study|Withdrawal by Subject|1
4648411|NCT03825042|15939827|P2|Overall Study|Withdrawal by Subject|0
4648412|NCT03825042|15939828|P1|Overall Study|Withdrawal by Subject|1
4648413|NCT03825042|15939827|P2|Overall Study|Adverse Event|0
4648414|NCT03825042|15939828|P1|Overall Study|Adverse Event|1
4648415|NCT03824912|15939841|P3|Overall Study|Participation in another study|0
4648416|NCT03824912|15939842|P2|Overall Study|Participation in another study|1
4648417|NCT03824912|15939843|P1|Overall Study|Participation in another study|0
4648418|NCT03824912|15939841|P3|Overall Study|Withdrawal by Subject|1
4648419|NCT03824912|15939842|P2|Overall Study|Withdrawal by Subject|2
4648420|NCT03824912|15939843|P1|Overall Study|Withdrawal by Subject|3
4648421|NCT03824912|15939841|P3|Overall Study|Protocol Violation|1
4648422|NCT03824912|15939842|P2|Overall Study|Protocol Violation|4
4648423|NCT03824912|15939843|P1|Overall Study|Protocol Violation|1
4648424|NCT03824912|15939841|P3|Overall Study|Non-Compliance with Study Drug|1
4648425|NCT03824912|15939842|P2|Overall Study|Non-Compliance with Study Drug|0
4648426|NCT03824912|15939843|P1|Overall Study|Non-Compliance with Study Drug|0
4648427|NCT03824912|15939841|P3|Overall Study|Negative Baseline Culture Result|57
4648428|NCT03824912|15939842|P2|Overall Study|Negative Baseline Culture Result|112
4648429|NCT03824912|15939843|P1|Overall Study|Negative Baseline Culture Result|118
4648430|NCT03824912|15939841|P3|Overall Study|Lost to Follow-up|8
4648431|NCT03824912|15939842|P2|Overall Study|Lost to Follow-up|15
4648432|NCT03824912|15939843|P1|Overall Study|Lost to Follow-up|18
4648433|NCT03824236|15939866|P3|Overall Study|Lost to Follow-up|1
4648434|NCT03824236|15939867|P2|Overall Study|Lost to Follow-up|0
4648435|NCT03824236|15939868|P1|Overall Study|Lost to Follow-up|0
4648436|NCT03822884|15939932|P6|Overall Study|Withdrawal by Subject|0
4648437|NCT03822884|15939933|P5|Overall Study|Withdrawal by Subject|1
4648438|NCT03822884|15939934|P4|Overall Study|Withdrawal by Subject|0
4648439|NCT03822884|15939935|P3|Overall Study|Withdrawal by Subject|0
4648440|NCT03822884|15939936|P2|Overall Study|Withdrawal by Subject|0
4648441|NCT03822884|15939937|P1|Overall Study|Withdrawal by Subject|0
4648442|NCT03822182|15939969|P3|Overall Study|Protocol Violation|1
4648443|NCT03822182|15939970|P2|Overall Study|Protocol Violation|1
4648444|NCT03822182|15939971|P1|Overall Study|Protocol Violation|0
4648445|NCT03817879|15940126|P2|Overall Study|Withdrawal by Subject|1
4648446|NCT03817879|15940127|P1|Overall Study|Withdrawal by Subject|0
4648447|NCT03817879|15940126|P2|Overall Study|Drop out|12
4648448|NCT03817879|15940127|P1|Overall Study|Drop out|5
4648449|NCT03816761|15940163|P6|Second Treatment Period (7 Days)|Unclassified|0
4648450|NCT03816761|15940164|P5|Second Treatment Period (7 Days)|Unclassified|0
4648451|NCT03816761|15940165|P4|Second Treatment Period (7 Days)|Unclassified|1
4648452|NCT03816761|15940166|P3|Second Treatment Period (7 Days)|Unclassified|0
4648453|NCT03816761|15940167|P2|Second Treatment Period (7 Days)|Unclassified|0
4648454|NCT03816761|15940168|P1|Second Treatment Period (7 Days)|Unclassified|0
4648455|NCT03816761|15940163|P6|First Treatment Period (7 Days)|Withdrawal by Subject|1
4648456|NCT03816761|15940164|P5|First Treatment Period (7 Days)|Withdrawal by Subject|0
4648457|NCT03816761|15940165|P4|First Treatment Period (7 Days)|Withdrawal by Subject|0
4648458|NCT03816761|15940166|P3|First Treatment Period (7 Days)|Withdrawal by Subject|0
4648459|NCT03816761|15940167|P2|First Treatment Period (7 Days)|Withdrawal by Subject|0
4648460|NCT03816761|15940168|P1|First Treatment Period (7 Days)|Withdrawal by Subject|0
4648461|NCT03811093|15940473|P2|Overall Study|Unable to measure body fat percentage|0
4648462|NCT03811093|15940474|P1|Overall Study|Unable to measure body fat percentage|2
4648463|NCT03811093|15940473|P2|Overall Study|Lack of Efficacy, Withdrawal by Subject|4
4648464|NCT03811093|15940474|P1|Overall Study|Lack of Efficacy, Withdrawal by Subject|0
4648465|NCT03810235|15940486|P2|Overall Study|Withdrawal by Subject|0
4648466|NCT03810235|15940487|P1|Overall Study|Withdrawal by Subject|2
4648467|NCT03809104|15940569|P1|Overall Study|Withdrawal by Subject|3
4648468|NCT03808688|15940580|P2|Overall Study|Medication Non-Compliance|1
4648469|NCT03808688|15940581|P1|Overall Study|Medication Non-Compliance|0
4648470|NCT03808688|15940580|P2|Overall Study|Visit Out of Window|1
4648471|NCT03808688|15940581|P1|Overall Study|Visit Out of Window|0
4648472|NCT03808688|15940580|P2|Overall Study|IOP Too High, Nerve/Visual Field Changes|1
4648473|NCT03808688|15940581|P1|Overall Study|IOP Too High, Nerve/Visual Field Changes|0
4648474|NCT03808688|15940580|P2|Overall Study|IOP Too High|1
4648475|NCT03808688|15940581|P1|Overall Study|IOP Too High|1
4648476|NCT03808688|15940580|P2|Overall Study|Intolerance to Conjunctival Hyperemia|0
4648477|NCT03808688|15940581|P1|Overall Study|Intolerance to Conjunctival Hyperemia|1
4648478|NCT03808688|15940580|P2|Overall Study|Withdrawal by Subject|0
4648479|NCT03808688|15940581|P1|Overall Study|Withdrawal by Subject|1
4648480|NCT03808688|15940580|P2|Overall Study|Lost to Follow-up|2
4648481|NCT03808688|15940581|P1|Overall Study|Lost to Follow-up|0
4648482|NCT03808688|15940580|P2|Overall Study|Lack of Efficacy|0
4648483|NCT03808688|15940581|P1|Overall Study|Lack of Efficacy|2
4648484|NCT03808688|15940580|P2|Overall Study|Adverse Event|17
4648485|NCT03808688|15940581|P1|Overall Study|Adverse Event|13
4648486|NCT03808298|15940626|P1|Overall Study|Positive Urine Drug Screen at Check-in|3
4648487|NCT03808298|15940626|P1|Overall Study|Withdrawal by Subject|1
4648488|NCT03808298|15940626|P1|Overall Study|Physician Decision|1
4648489|NCT03808298|15940626|P1|Overall Study|Adverse Event|3
4648490|NCT03807739|15940703|P4|Overall Study|Withdrawal by Subject|0
4648491|NCT03807739|15940704|P3|Overall Study|Withdrawal by Subject|0
4648492|NCT03807739|15940705|P2|Overall Study|Withdrawal by Subject|0
4648493|NCT03807739|15940706|P1|Overall Study|Withdrawal by Subject|1
4648494|NCT03807739|15940703|P4|Overall Study|Adverse Event|0
4648495|NCT03807739|15940704|P3|Overall Study|Adverse Event|0
4648496|NCT03807739|15940705|P2|Overall Study|Adverse Event|0
4648497|NCT03807739|15940706|P1|Overall Study|Adverse Event|1
4648498|NCT03807700|15940722|P2|Overall Study|Withdrawal by Subject|1
4648499|NCT03807700|15940723|P1|Overall Study|Withdrawal by Subject|2
4648500|NCT03805971|15940799|P1|Overall Study|Protocol Violation|2
4648501|NCT03805971|15940799|P1|Overall Study|Withdrawal by Subject|1
4648502|NCT03804918|15940821|P1|Overall Study|Participant did not use the app|1
4648503|NCT03804710|15940828|P2|Overall Study|Other|1
4648504|NCT03804710|15940829|P1|Overall Study|Other|0
4648505|NCT03804710|15940828|P2|Overall Study|Withdrawal by Subject|1
4648506|NCT03804710|15940829|P1|Overall Study|Withdrawal by Subject|2
4648507|NCT03804710|15940828|P2|Overall Study|Adverse Event|3
4648508|NCT03804710|15940829|P1|Overall Study|Adverse Event|0
4648509|NCT03801148|15940888|P4|Follow-Up (12 Days)|Lost to Follow-up|0
4648510|NCT03801148|15940889|P3|Follow-Up (12 Days)|Lost to Follow-up|1
4648511|NCT03801148|15940890|P2|Follow-Up (12 Days)|Lost to Follow-up|1
4648512|NCT03801148|15940891|P1|Follow-Up (12 Days)|Lost to Follow-up|0
4648513|NCT03801148|15940888|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4648514|NCT03801148|15940889|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4648515|NCT03801148|15940890|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4648516|NCT03801148|15940891|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4648517|NCT03801148|15940888|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|1
4648518|NCT03801148|15940889|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4648519|NCT03801148|15940890|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4648520|NCT03801148|15940891|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4648521|NCT03801148|15940888|P4|Period 1 (2 Days)|Adverse Event|0
4648522|NCT03801148|15940889|P3|Period 1 (2 Days)|Adverse Event|0
4648523|NCT03801148|15940890|P2|Period 1 (2 Days)|Adverse Event|1
4648524|NCT03801148|15940891|P1|Period 1 (2 Days)|Adverse Event|1
4648525|NCT03799211|15940990|P2|Overall Study|Withdrawal by Subject|0
4648526|NCT03799211|15940991|P1|Overall Study|Withdrawal by Subject|2
4648527|NCT03799211|15940990|P2|Overall Study|Lost to Follow-up|13
4648528|NCT03799211|15940991|P1|Overall Study|Lost to Follow-up|2
4648529|NCT03793556|15941125|P2|Overall Study|Lost to Follow-up|1
4648530|NCT03793556|15941126|P1|Overall Study|Lost to Follow-up|1
4648531|NCT03793556|15941125|P2|Overall Study|Withdrawal by Subject|1
4648532|NCT03793556|15941126|P1|Overall Study|Withdrawal by Subject|12
4648533|NCT03793010|15941170|P2|Overall Study|Did not meet eligibility criteria|0
4648534|NCT03793010|15941171|P1|Overall Study|Did not meet eligibility criteria|1
4648535|NCT03793010|15941170|P2|Overall Study|Withdrew to pursue other treatment|0
4648536|NCT03793010|15941171|P1|Overall Study|Withdrew to pursue other treatment|1
4648537|NCT03793010|15941170|P2|Overall Study|Patient couldn't sit still for injection|0
4648538|NCT03793010|15941171|P1|Overall Study|Patient couldn't sit still for injection|1
4648539|NCT03793010|15941170|P2|Overall Study|Lost to Follow-up|2
4648540|NCT03793010|15941171|P1|Overall Study|Lost to Follow-up|1
4648541|NCT03793010|15941170|P2|Overall Study|Withdrawn by Investigator or Sponsor|18
4648542|NCT03793010|15941171|P1|Overall Study|Withdrawn by Investigator or Sponsor|19
4648543|NCT03793010|15941170|P2|Overall Study|Withdrawal by Subject|7
4648544|NCT03793010|15941171|P1|Overall Study|Withdrawal by Subject|5
4648545|NCT03792672|15941181|P6|Treatment Period 4 (2 Days)|Other|0
4648546|NCT03792672|15941182|P5|Treatment Period 4 (2 Days)|Other|0
4648547|NCT03792672|15941183|P4|Treatment Period 4 (2 Days)|Other|0
4648548|NCT03792672|15941184|P3|Treatment Period 4 (2 Days)|Other|0
4648549|NCT03792672|15941185|P2|Treatment Period 4 (2 Days)|Other|0
4648550|NCT03792672|15941186|P1|Treatment Period 4 (2 Days)|Other|1
4648551|NCT03792672|15941181|P6|Washout Period 3 (10 Days)|Physician Decision|0
4648552|NCT03792672|15941182|P5|Washout Period 3 (10 Days)|Physician Decision|0
4648553|NCT03792672|15941183|P4|Washout Period 3 (10 Days)|Physician Decision|0
4648554|NCT03792672|15941184|P3|Washout Period 3 (10 Days)|Physician Decision|1
4648555|NCT03792672|15941185|P2|Washout Period 3 (10 Days)|Physician Decision|0
4648556|NCT03792672|15941186|P1|Washout Period 3 (10 Days)|Physician Decision|0
4648557|NCT03792672|15941181|P6|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4648558|NCT03792672|15941182|P5|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4648559|NCT03792672|15941183|P4|Washout Period 3 (10 Days)|Withdrawal by Subject|2
4648560|NCT03792672|15941184|P3|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4648561|NCT03792672|15941185|P2|Washout Period 3 (10 Days)|Withdrawal by Subject|0
4648562|NCT03792672|15941186|P1|Washout Period 3 (10 Days)|Withdrawal by Subject|1
4648563|NCT03790917|15941213|P1|Overall Study|Death|1
4648564|NCT03787212|15941344|P2|Period 1|Study Termination|2
4648565|NCT03787212|15941345|P1|Period 1|Study Termination|2
4648566|NCT03786718|15941351|P1|Overall Study|diagnosis changed from type 2 to type 1|1
4648567|NCT03786718|15941351|P1|Overall Study|Did not use the intervention|2
4648568|NCT03786718|15941351|P1|Overall Study|Withdrawal by Subject|1
4648569|NCT03786718|15941351|P1|Overall Study|Lost to Follow-up|3
4648570|NCT03785548|15941368|P2|Overall Study|no Postop queries|0
4648571|NCT03785548|15941369|P1|Overall Study|no Postop queries|1
4648572|NCT03785548|15941368|P2|Overall Study|age > 80|0
4648573|NCT03785548|15941369|P1|Overall Study|age > 80|1
4648574|NCT03783780|15941418|P1|Overall Study|Withdrawn prior to completion|1
4648575|NCT03782571|15941423|P4|Period 3|Adverse Event|0
4648576|NCT03782571|15941424|P3|Period 3|Adverse Event|0
4648577|NCT03782571|15941425|P2|Period 3|Adverse Event|0
4648578|NCT03782571|15941426|P1|Period 3|Adverse Event|1
4648579|NCT03782571|15941423|P4|Period 3|Subject Unable to Attend V5|0
4648580|NCT03782571|15941424|P3|Period 3|Subject Unable to Attend V5|0
4648581|NCT03782571|15941425|P2|Period 3|Subject Unable to Attend V5|0
4648582|NCT03782571|15941426|P1|Period 3|Subject Unable to Attend V5|1
4648583|NCT03782571|15941423|P4|Period 1|Withdrawal by Subject|0
4648584|NCT03782571|15941424|P3|Period 1|Withdrawal by Subject|0
4648585|NCT03782571|15941425|P2|Period 1|Withdrawal by Subject|0
4648586|NCT03782571|15941426|P1|Period 1|Withdrawal by Subject|1
4648587|NCT03781375|15941524|P2|Open-label Phase|Other|2
4648588|NCT03781375|15941525|P1|Open-label Phase|Other|2
4648589|NCT03781375|15941524|P2|Open-label Phase|Suboptimal Clinical Response|0
4648590|NCT03781375|15941525|P1|Open-label Phase|Suboptimal Clinical Response|1
4648591|NCT03781375|15941524|P2|Open-label Phase|Protocol Issues|1
4648592|NCT03781375|15941525|P1|Open-label Phase|Protocol Issues|0
4648593|NCT03781375|15941524|P2|Double-blind Phase|Other|3
4648594|NCT03781375|15941525|P1|Double-blind Phase|Other|1
4648595|NCT03781375|15941524|P2|Double-blind Phase|Lack of Response|2
4648596|NCT03781375|15941525|P1|Double-blind Phase|Lack of Response|6
4648597|NCT03781375|15941524|P2|Double-blind Phase|Adverse Event|1
4648598|NCT03781375|15941525|P1|Double-blind Phase|Adverse Event|0
4648599|NCT03780959|15941539|P3|Part 2|Response Status|6
4648600|NCT03780959|15941540|P2|Part 2|Response Status|18
4648601|NCT03780959|15941541|P1|Part 2|Response Status|0
4648602|NCT03780959|15941539|P3|Part 2|Withdrawal by Parent/Guardian|0
4648603|NCT03780959|15941540|P2|Part 2|Withdrawal by Parent/Guardian|1
4648604|NCT03780959|15941541|P1|Part 2|Withdrawal by Parent/Guardian|0
4648605|NCT03780959|15941539|P3|Part 1|Response Status|0
4648606|NCT03780959|15941540|P2|Part 1|Response Status|0
4648607|NCT03780959|15941541|P1|Part 1|Response Status|2
4648608|NCT03780959|15941539|P3|Part 1|Withdrawal by Parent/Guardian|0
4648609|NCT03780959|15941540|P2|Part 1|Withdrawal by Parent/Guardian|0
4648610|NCT03780959|15941541|P1|Part 1|Withdrawal by Parent/Guardian|1
4648611|NCT03780959|15941539|P3|Part 1|Withdrawal by Subject|0
4648612|NCT03780959|15941540|P2|Part 1|Withdrawal by Subject|0
4648613|NCT03780959|15941541|P1|Part 1|Withdrawal by Subject|1
4648614|NCT03780959|15941539|P3|Part 1|Adverse Event|0
4648615|NCT03780959|15941540|P2|Part 1|Adverse Event|0
4648616|NCT03780959|15941541|P1|Part 1|Adverse Event|1
4648617|NCT03780400|15941553|P1|Overall Study|Withdrawal by Subject|2
4648618|NCT03780400|15941553|P1|Overall Study|Lost to Follow-up|5
4648619|NCT03779503|15941616|P2|First Intervention|Withdrawal by Subject|0
4648620|NCT03779503|15941617|P1|First Intervention|Withdrawal by Subject|1
4648621|NCT03779503|15941616|P2|First Intervention|Adverse Event|1
4648622|NCT03779503|15941617|P1|First Intervention|Adverse Event|0
4648623|NCT03776175|15941656|P4|Follow-Up Period (35 Days)|Lost to Follow-up|2
4648624|NCT03776175|15941657|P3|Follow-Up Period (35 Days)|Lost to Follow-up|0
4648625|NCT03776175|15941658|P2|Follow-Up Period (35 Days)|Lost to Follow-up|0
4648626|NCT03776175|15941659|P1|Follow-Up Period (35 Days)|Lost to Follow-up|0
4648627|NCT03776175|15941656|P4|Treatment Period (42 Days)|Unable to attend study visits|0
4648628|NCT03776175|15941657|P3|Treatment Period (42 Days)|Unable to attend study visits|0
4648629|NCT03776175|15941658|P2|Treatment Period (42 Days)|Unable to attend study visits|2
4648630|NCT03776175|15941659|P1|Treatment Period (42 Days)|Unable to attend study visits|0
4648631|NCT03776175|15941656|P4|Treatment Period (42 Days)|Withdrawal by Subject|0
4648632|NCT03776175|15941657|P3|Treatment Period (42 Days)|Withdrawal by Subject|3
4648633|NCT03776175|15941658|P2|Treatment Period (42 Days)|Withdrawal by Subject|2
4648634|NCT03776175|15941659|P1|Treatment Period (42 Days)|Withdrawal by Subject|1
4648635|NCT03776175|15941656|P4|Treatment Period (42 Days)|Participants screened at other site|0
4648636|NCT03776175|15941657|P3|Treatment Period (42 Days)|Participants screened at other site|0
4648637|NCT03776175|15941658|P2|Treatment Period (42 Days)|Participants screened at other site|2
4648638|NCT03776175|15941659|P1|Treatment Period (42 Days)|Participants screened at other site|0
4648639|NCT03776175|15941656|P4|Treatment Period (42 Days)|Lost to Follow-up|2
4648640|NCT03776175|15941657|P3|Treatment Period (42 Days)|Lost to Follow-up|0
4648641|NCT03776175|15941658|P2|Treatment Period (42 Days)|Lost to Follow-up|0
4648642|NCT03776175|15941659|P1|Treatment Period (42 Days)|Lost to Follow-up|0
4648643|NCT03776175|15941656|P4|Treatment Period (42 Days)|Adverse Event|0
4648644|NCT03776175|15941657|P3|Treatment Period (42 Days)|Adverse Event|1
4648645|NCT03776175|15941658|P2|Treatment Period (42 Days)|Adverse Event|1
4648646|NCT03776175|15941659|P1|Treatment Period (42 Days)|Adverse Event|0
4648647|NCT03774576|15941706|P1|Period 2|Adverse Event|1
4648648|NCT03773133|15941719|P1|Overall Study|Screen Failure|8
4648649|NCT03772522|15941726|P2|Post-intervention Follow-up|Lost to Follow-up|0
4648650|NCT03772522|15941727|P1|Post-intervention Follow-up|Lost to Follow-up|1
4648651|NCT03772522|15941726|P2|Intervention|Withdrawal by Subject|0
4648652|NCT03772522|15941727|P1|Intervention|Withdrawal by Subject|1
4648653|NCT03772522|15941726|P2|Pre-intervention|Withdrawal by Subject|4
4648654|NCT03772522|15941727|P1|Pre-intervention|Withdrawal by Subject|3
4648655|NCT03772327|15941750|P2|Overall Study|Withdrawal by Subject|3
4648656|NCT03772327|15941751|P1|Overall Study|Withdrawal by Subject|2
4648657|NCT03772327|15941750|P2|Overall Study|Lost to Follow-up|4
4648658|NCT03772327|15941751|P1|Overall Study|Lost to Follow-up|3
4648659|NCT03767894|15941797|P1|Overall Study|Withdrawal by Subject|1
4648660|NCT03766646|15941819|P2|Overall Study|Protocol Violation|3
4648661|NCT03766646|15941820|P1|Overall Study|Protocol Violation|0
4648662|NCT03766646|15941819|P2|Overall Study|Withdrawal by Subject|0
4648663|NCT03766646|15941820|P1|Overall Study|Withdrawal by Subject|1
4648664|NCT03765164|15941900|P2|Pre-intervention|Withdrawal by Subject|6
4648665|NCT03765164|15941901|P1|Pre-intervention|Withdrawal by Subject|5
4648666|NCT03765138|15941911|P1|Overall Study|Lost to Follow-up|1
4648667|NCT03764813|15941921|P4|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
4648668|NCT03764813|15941922|P3|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
4648669|NCT03764813|15941923|P2|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1
4648670|NCT03764813|15941924|P1|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0
4648671|NCT03762668|15942045|P2|Period 1, First Week of Wear|Withdrawal by Subject|1
4648672|NCT03762668|15942046|P1|Period 1, First Week of Wear|Withdrawal by Subject|0
4648673|NCT03760510|15942088|P2|Overall Study|Not ventilated for 24 hours|97
4648674|NCT03760510|15942089|P1|Overall Study|Not ventilated for 24 hours|105
4648675|NCT03759600|15942101|P1|Overall Study|Progressive Disease|3
4648676|NCT03759600|15942101|P1|Overall Study|Adverse Event|1
4648677|NCT03759600|15942101|P1|Overall Study|Ongoing at Data Cut-off|16
4648678|NCT03759587|15942115|P1|Overall Study|Ongoing|19
4648679|NCT03759340|15942128|P1|Overall Study|Study Terminated by Sponsor|38
4648680|NCT03759340|15942128|P1|Overall Study|Withdrawal by Subject|15
4648681|NCT03759340|15942128|P1|Overall Study|Lost to Follow-up|1
4648682|NCT03759340|15942128|P1|Overall Study|Adverse Event|2
4648683|NCT03757988|15942148|P1|Overall Study|Withdrawal by Subject|1
4648684|NCT03757234|15942171|P5|Overall Study|Other|0
4648685|NCT03757234|15942172|P4|Overall Study|Other|0
4648686|NCT03757234|15942173|P3|Overall Study|Other|0
4648687|NCT03757234|15942174|P2|Overall Study|Other|1
4648688|NCT03757234|15942175|P1|Overall Study|Other|1
4648689|NCT03757234|15942171|P5|Overall Study|Withdrawal by Subject|2
4648690|NCT03757234|15942172|P4|Overall Study|Withdrawal by Subject|1
4648691|NCT03757234|15942173|P3|Overall Study|Withdrawal by Subject|0
4648692|NCT03757234|15942174|P2|Overall Study|Withdrawal by Subject|1
4648693|NCT03757234|15942175|P1|Overall Study|Withdrawal by Subject|1
4648694|NCT03757234|15942171|P5|Overall Study|Lost to Follow-up|1
4648695|NCT03757234|15942172|P4|Overall Study|Lost to Follow-up|0
4648696|NCT03757234|15942173|P3|Overall Study|Lost to Follow-up|0
4648697|NCT03757234|15942174|P2|Overall Study|Lost to Follow-up|0
4648698|NCT03757234|15942175|P1|Overall Study|Lost to Follow-up|1
4648699|NCT03757234|15942171|P5|Overall Study|Adverse Event|1
4648700|NCT03757234|15942172|P4|Overall Study|Adverse Event|0
4648701|NCT03757234|15942173|P3|Overall Study|Adverse Event|0
4648702|NCT03757234|15942174|P2|Overall Study|Adverse Event|0
4648703|NCT03757234|15942175|P1|Overall Study|Adverse Event|0
4648704|NCT03755882|15942242|P2|Period 1|Unsatisfactory Lens Fitting Test Article|0
4648705|NCT03755882|15942243|P1|Period 1|Unsatisfactory Lens Fitting Test Article|3
4648706|NCT03755882|15942242|P2|Period 1|Protocol Violation|0
4648707|NCT03755882|15942243|P1|Period 1|Protocol Violation|1
4648708|NCT03752528|15942271|P1|Part B|Study terminated by sponsor|3
4648709|NCT03752528|15942271|P1|Part B|Protocol Violation|1
4648710|NCT03752528|15942271|P1|Part A|Protocol Violation|1
4648711|NCT03752528|15942271|P1|Part A|Lost to Follow-up|1
4648712|NCT03752151|15942290|P1|Overall Study|Protocol Violation|1
4648713|NCT03752151|15942290|P1|Overall Study|Withdrawal by Subject|1
4648714|NCT03751020|15942299|P3|Overall Study|Lost to Follow-up|10
4648715|NCT03751020|15942300|P2|Overall Study|Lost to Follow-up|4
4648716|NCT03751020|15942301|P1|Overall Study|Lost to Follow-up|7
4648717|NCT03751020|15942299|P3|Overall Study|Withdrawal by Subject|0
4648718|NCT03751020|15942300|P2|Overall Study|Withdrawal by Subject|0
4648719|NCT03751020|15942301|P1|Overall Study|Withdrawal by Subject|2
4648720|NCT03745937|15942457|P4|Overall Study|Not-specifed|1
4648721|NCT03745937|15942458|P3|Overall Study|Not-specifed|0
4648722|NCT03745937|15942459|P2|Overall Study|Not-specifed|1
4648723|NCT03745937|15942460|P1|Overall Study|Not-specifed|0
4648724|NCT03745937|15942457|P4|Overall Study|Withdrawal by Subject|1
4648725|NCT03745937|15942458|P3|Overall Study|Withdrawal by Subject|0
4648726|NCT03745937|15942459|P2|Overall Study|Withdrawal by Subject|0
4648727|NCT03745937|15942460|P1|Overall Study|Withdrawal by Subject|0
4648728|NCT03745222|15942574|P3|Overall Study|Withdrawal by Subject|0
4648729|NCT03745222|15942575|P2|Overall Study|Withdrawal by Subject|1
4648730|NCT03745222|15942576|P1|Overall Study|Withdrawal by Subject|0
4648731|NCT03742271|15942671|P1|Overall Study|Protocol Violation|1
4648732|NCT03742271|15942671|P1|Overall Study|Failed Insertion & removal|3
4648733|NCT03742271|15942671|P1|Overall Study|Lost to Follow-up|4
4648734|NCT03742271|15942671|P1|Overall Study|Withdrawal by Subject|3
4648735|NCT03742271|15942671|P1|Overall Study|Unsatisfactory Visual Response|1
4648736|NCT03739528|15942740|P2|Overall Study|Treatment discontinued + study completed|3
4648737|NCT03739528|15942741|P1|Overall Study|Treatment discontinued + study completed|1
4648738|NCT03739528|15942740|P2|Overall Study|Treatment and study discontinued|2
4648739|NCT03739528|15942741|P1|Overall Study|Treatment and study discontinued|6
4648740|NCT03739528|15942740|P2|Overall Study|Not treated|12
4648741|NCT03739528|15942741|P1|Overall Study|Not treated|8
4648742|NCT03739242|15942773|P2|Overall Study|Protocol Violation|1
4648743|NCT03739242|15942774|P1|Overall Study|Protocol Violation|0
4648744|NCT03739242|15942773|P2|Overall Study|Withdrawal by Subject|1
4648745|NCT03739242|15942774|P1|Overall Study|Withdrawal by Subject|1
4648746|NCT03738865|15942812|P2|Overall Study|Physician Decision|1
4648747|NCT03738865|15942813|P1|Overall Study|Physician Decision|0
4648748|NCT03738865|15942812|P2|Overall Study|Adverse Event|0
4648749|NCT03738865|15942813|P1|Overall Study|Adverse Event|2
4648750|NCT03738865|15942812|P2|Overall Study|Withdrawal by Subject|3
4648751|NCT03738865|15942813|P1|Overall Study|Withdrawal by Subject|3
4648752|NCT03738475|15942829|P2|Overall Study|Participant Non-Compliance|0
4648753|NCT03738475|15942830|P1|Overall Study|Participant Non-Compliance|1
4648754|NCT03736031|15942876|P2|Overall Study|Withdrawal by Subject|0
4648755|NCT03736031|15942877|P1|Overall Study|Withdrawal by Subject|9
4648756|NCT03736031|15942876|P2|Overall Study|Lost to Follow-up|2
4648757|NCT03736031|15942877|P1|Overall Study|Lost to Follow-up|21
4648758|NCT03736031|15942876|P2|Overall Study|Death|4
4648759|NCT03736031|15942877|P1|Overall Study|Death|2
4648760|NCT03733899|15942901|P6|Period 3|Withdrawal by Subject|0
4648761|NCT03733899|15942902|P5|Period 3|Withdrawal by Subject|0
4648762|NCT03733899|15942903|P4|Period 3|Withdrawal by Subject|0
4648763|NCT03733899|15942904|P3|Period 3|Withdrawal by Subject|0
4648764|NCT03733899|15942905|P2|Period 3|Withdrawal by Subject|0
4648765|NCT03733899|15942906|P1|Period 3|Withdrawal by Subject|1
4648766|NCT03733899|15942901|P6|Period 2|Unscuccessful Treatment|0
4648767|NCT03733899|15942902|P5|Period 2|Unscuccessful Treatment|0
4648768|NCT03733899|15942903|P4|Period 2|Unscuccessful Treatment|0
4648769|NCT03733899|15942904|P3|Period 2|Unscuccessful Treatment|0
4648770|NCT03733899|15942905|P2|Period 2|Unscuccessful Treatment|1
4648771|NCT03733899|15942906|P1|Period 2|Unscuccessful Treatment|0
4648772|NCT03733899|15942901|P6|Period 1|Protocol Violation|1
4648773|NCT03733899|15942902|P5|Period 1|Protocol Violation|0
4648774|NCT03733899|15942903|P4|Period 1|Protocol Violation|0
4648775|NCT03733899|15942904|P3|Period 1|Protocol Violation|0
4648776|NCT03733899|15942905|P2|Period 1|Protocol Violation|0
4648777|NCT03733899|15942906|P1|Period 1|Protocol Violation|0
4648778|NCT03733470|15942934|P2|Overall Study|PI Decision|1
4648779|NCT03733470|15942935|P1|Overall Study|PI Decision|1
4648780|NCT03733301|15942944|P3|Overall Study|Withdrawal by Subject|1
4648781|NCT03733301|15942945|P2|Overall Study|Withdrawal by Subject|5
4648782|NCT03733301|15942946|P1|Overall Study|Withdrawal by Subject|3
4648783|NCT03733301|15942944|P3|Overall Study|Adverse Event|3
4648784|NCT03733301|15942945|P2|Overall Study|Adverse Event|1
4648785|NCT03733301|15942946|P1|Overall Study|Adverse Event|0
4648786|NCT03733301|15942944|P3|Overall Study|Lack of Efficacy|0
4648787|NCT03733301|15942945|P2|Overall Study|Lack of Efficacy|3
4648788|NCT03733301|15942946|P1|Overall Study|Lack of Efficacy|2
4648789|NCT03733301|15942944|P3|Overall Study|Non-compliance|0
4648790|NCT03733301|15942945|P2|Overall Study|Non-compliance|0
4648791|NCT03733301|15942946|P1|Overall Study|Non-compliance|1
4648792|NCT03733301|15942944|P3|Overall Study|Screen Fail|0
4648793|NCT03733301|15942945|P2|Overall Study|Screen Fail|0
4648794|NCT03733301|15942946|P1|Overall Study|Screen Fail|1
4648795|NCT03730103|15943028|P2|Overall Study|Did not meet inclusion criteria|5
4648796|NCT03730103|15943029|P1|Overall Study|Did not meet inclusion criteria|0
4648797|NCT03728140|15943077|P2|Overall Study|Abnormal embryo transfer operation|7
4648798|NCT03728140|15943078|P1|Overall Study|Abnormal embryo transfer operation|10
4648799|NCT03726996|15943122|P1|Overall Study|Study early termination|2
4648800|NCT03726996|15943122|P1|Overall Study|Parent's decision|2
4648801|NCT03725982|15943132|P2|First Intervention|Physician Decision|1
4648802|NCT03725982|15943133|P1|First Intervention|Physician Decision|1
4648803|NCT03725982|15943132|P2|First Intervention|Withdrawal by Subject|1
4648804|NCT03725982|15943133|P1|First Intervention|Withdrawal by Subject|0
4648805|NCT03725085|15943166|P1|Overall Study|Lost to Follow-up|2
4648806|NCT03724981|15943174|P2|First Device|Protocol Violation|1
4648807|NCT03724981|15943175|P1|First Device|Protocol Violation|1
4648808|NCT03722784|15943321|P2|Overall Study|Protocol Violation|1
4648809|NCT03722784|15943322|P1|Overall Study|Protocol Violation|0
4648810|NCT03722784|15943321|P2|Overall Study|Physician Decision|1
4648811|NCT03722784|15943322|P1|Overall Study|Physician Decision|1
4648812|NCT03722784|15943321|P2|Overall Study|Withdrawal by Subject|0
4648813|NCT03722784|15943322|P1|Overall Study|Withdrawal by Subject|1
4648814|NCT03722446|15943366|P2|Overall Study|Protocol Violation|2
4648815|NCT03722446|15943367|P1|Overall Study|Protocol Violation|15
4648816|NCT03722264|15943383|P1|Overall Study|Physician Decision|3
4648817|NCT03722030|15943395|P2|Overall Study|Withdrawal by Subject|0
4648818|NCT03722030|15943396|P1|Overall Study|Withdrawal by Subject|1
4648819|NCT03720847|15943466|P2|Washout|Physician Decision|2
4648820|NCT03720847|15943467|P1|Washout|Physician Decision|1
4648821|NCT03718143|15943515|P3|Overall Study|Withdrawal of Informed Consent|1
4648822|NCT03718143|15943516|P2|Overall Study|Withdrawal of Informed Consent|2
4648823|NCT03718143|15943517|P1|Overall Study|Withdrawal of Informed Consent|1
4648824|NCT03718143|15943515|P3|Overall Study|Progression of Disease|0
4648825|NCT03718143|15943516|P2|Overall Study|Progression of Disease|0
4648826|NCT03718143|15943517|P1|Overall Study|Progression of Disease|1
4648827|NCT03718143|15943515|P3|Overall Study|Death|0
4648828|NCT03718143|15943516|P2|Overall Study|Death|0
4648829|NCT03718143|15943517|P1|Overall Study|Death|1
4648830|NCT03718000|15943533|P2|Overall Study|Pregnancy|1
4648831|NCT03718000|15943534|P1|Overall Study|Pregnancy|0
4648832|NCT03718000|15943533|P2|Overall Study|Relocation|4
4648833|NCT03718000|15943534|P1|Overall Study|Relocation|2
4648834|NCT03717064|15943556|P1|Period 2|Adverse Event|1
4648835|NCT03716050|15943588|P8|Overall Study|Protocol Violation|2
4648836|NCT03716050|15943589|P7|Overall Study|Protocol Violation|0
4648837|NCT03716050|15943590|P6|Overall Study|Protocol Violation|0
4648838|NCT03716050|15943591|P5|Overall Study|Protocol Violation|0
4648839|NCT03716050|15943592|P4|Overall Study|Protocol Violation|1
4648840|NCT03716050|15943593|P3|Overall Study|Protocol Violation|0
4648841|NCT03716050|15943594|P2|Overall Study|Protocol Violation|0
4648842|NCT03716050|15943595|P1|Overall Study|Protocol Violation|0
4648843|NCT03716050|15943588|P8|Overall Study|Physician Decision|0
4648844|NCT03716050|15943589|P7|Overall Study|Physician Decision|0
4648845|NCT03716050|15943590|P6|Overall Study|Physician Decision|0
4648846|NCT03716050|15943591|P5|Overall Study|Physician Decision|0
4648847|NCT03716050|15943592|P4|Overall Study|Physician Decision|1
4648848|NCT03716050|15943593|P3|Overall Study|Physician Decision|0
4648849|NCT03716050|15943594|P2|Overall Study|Physician Decision|0
4648850|NCT03716050|15943595|P1|Overall Study|Physician Decision|0
4648851|NCT03716050|15943588|P8|Overall Study|Lost to Follow-up|0
4648852|NCT03716050|15943589|P7|Overall Study|Lost to Follow-up|0
4648853|NCT03716050|15943590|P6|Overall Study|Lost to Follow-up|0
4648854|NCT03716050|15943591|P5|Overall Study|Lost to Follow-up|0
4648855|NCT03716050|15943592|P4|Overall Study|Lost to Follow-up|0
4648856|NCT03716050|15943593|P3|Overall Study|Lost to Follow-up|1
4648857|NCT03716050|15943594|P2|Overall Study|Lost to Follow-up|0
4648858|NCT03716050|15943595|P1|Overall Study|Lost to Follow-up|0
4648859|NCT03716024|15943649|P2|Overall Study|Missing Reason|1
4648860|NCT03716024|15943650|P1|Overall Study|Missing Reason|0
4648861|NCT03716024|15943649|P2|Overall Study|Withdrawal by Subject|1
4648862|NCT03716024|15943650|P1|Overall Study|Withdrawal by Subject|0
4648863|NCT03716024|15943649|P2|Overall Study|Lost to Follow-up|6
4648864|NCT03716024|15943650|P1|Overall Study|Lost to Follow-up|2
4648865|NCT03716024|15943649|P2|Overall Study|Treatment Failure|0
4648866|NCT03716024|15943650|P1|Overall Study|Treatment Failure|1
4648867|NCT03716024|15943649|P2|Overall Study|Adverse Event|2
4648868|NCT03716024|15943650|P1|Overall Study|Adverse Event|1
4648869|NCT03716024|15943649|P2|Overall Study|Randomized, not Treated|8
4648870|NCT03716024|15943650|P1|Overall Study|Randomized, not Treated|7
4648871|NCT03715530|15943684|P3|Overall Study|Lost to Follow-up|2
4648872|NCT03715530|15943685|P2|Overall Study|Lost to Follow-up|1
4648873|NCT03715530|15943686|P1|Overall Study|Lost to Follow-up|3
4648874|NCT03714672|15943746|P4|Overall Study|Lost to Follow-up|0
4648875|NCT03714672|15943747|P3|Overall Study|Lost to Follow-up|0
4648876|NCT03714672|15943748|P2|Overall Study|Lost to Follow-up|1
4648877|NCT03714672|15943749|P1|Overall Study|Lost to Follow-up|1
4648878|NCT03714672|15943746|P4|Overall Study|Other Reason|1
4648879|NCT03714672|15943747|P3|Overall Study|Other Reason|1
4648880|NCT03714672|15943748|P2|Overall Study|Other Reason|2
4648881|NCT03714672|15943749|P1|Overall Study|Other Reason|1
4648882|NCT03714672|15943746|P4|Overall Study|Physician Decision|0
4648883|NCT03714672|15943747|P3|Overall Study|Physician Decision|0
4648884|NCT03714672|15943748|P2|Overall Study|Physician Decision|1
4648885|NCT03714672|15943749|P1|Overall Study|Physician Decision|0
4648886|NCT03714672|15943746|P4|Overall Study|Adverse Event|0
4648887|NCT03714672|15943747|P3|Overall Study|Adverse Event|3
4648888|NCT03714672|15943748|P2|Overall Study|Adverse Event|0
4648889|NCT03714672|15943749|P1|Overall Study|Adverse Event|0
4648890|NCT03712917|15943803|P3|Overall Study|Lost to Follow-up|5
4648891|NCT03712917|15943804|P2|Overall Study|Lost to Follow-up|4
4648892|NCT03712917|15943805|P1|Overall Study|Lost to Follow-up|9
4648893|NCT03712917|15943803|P3|Overall Study|Adverse Event|3
4648894|NCT03712917|15943804|P2|Overall Study|Adverse Event|4
4648895|NCT03712917|15943805|P1|Overall Study|Adverse Event|0
4648896|NCT03712917|15943803|P3|Overall Study|Pregnancy|1
4648897|NCT03712917|15943804|P2|Overall Study|Pregnancy|0
4648898|NCT03712917|15943805|P1|Overall Study|Pregnancy|0
4648899|NCT03710083|15943833|P1|Overall Study|Unsuccessful Procedure|1
4648900|NCT03710083|15943833|P1|Overall Study|Withdrawal by Subject|2
4648901|NCT03709823|15943846|P6|Overall Study|Other, Not Specified|0
4648902|NCT03709823|15943847|P5|Overall Study|Other, Not Specified|0
4648903|NCT03709823|15943848|P4|Overall Study|Other, Not Specified|1
4648904|NCT03709823|15943849|P3|Overall Study|Other, Not Specified|0
4648905|NCT03709823|15943850|P2|Overall Study|Other, Not Specified|0
4648906|NCT03709823|15943851|P1|Overall Study|Other, Not Specified|0
4648907|NCT03709823|15943846|P6|Overall Study|Withdrawal by Subject|0
4648908|NCT03709823|15943847|P5|Overall Study|Withdrawal by Subject|0
4648909|NCT03709823|15943848|P4|Overall Study|Withdrawal by Subject|0
4648910|NCT03709823|15943849|P3|Overall Study|Withdrawal by Subject|0
4648911|NCT03709823|15943850|P2|Overall Study|Withdrawal by Subject|3
4648912|NCT03709823|15943851|P1|Overall Study|Withdrawal by Subject|1
4648913|NCT03709823|15943846|P6|Overall Study|Lost to Follow-up|0
4648914|NCT03709823|15943847|P5|Overall Study|Lost to Follow-up|1
4648915|NCT03709823|15943848|P4|Overall Study|Lost to Follow-up|1
4648916|NCT03709823|15943849|P3|Overall Study|Lost to Follow-up|2
4648917|NCT03709823|15943850|P2|Overall Study|Lost to Follow-up|2
4648918|NCT03709823|15943851|P1|Overall Study|Lost to Follow-up|2
4648919|NCT03709823|15943846|P6|Overall Study|Adverse Event|0
4648920|NCT03709823|15943847|P5|Overall Study|Adverse Event|0
4648921|NCT03709823|15943848|P4|Overall Study|Adverse Event|0
4648922|NCT03709823|15943849|P3|Overall Study|Adverse Event|1
4648923|NCT03709823|15943850|P2|Overall Study|Adverse Event|0
4648924|NCT03709823|15943851|P1|Overall Study|Adverse Event|0
4648925|NCT03709654|15943888|P2|Overall Study|Adverse Event|0
4648926|NCT03709654|15943889|P1|Overall Study|Adverse Event|1
4648927|NCT03709654|15943888|P2|Overall Study|Withdrawal by Subject|1
4648928|NCT03709654|15943889|P1|Overall Study|Withdrawal by Subject|1
4648929|NCT03709654|15943888|P2|Overall Study|Lost to Follow-up|1
4648930|NCT03709654|15943889|P1|Overall Study|Lost to Follow-up|1
4648931|NCT03709576|15943926|P1|Overall Study|progression prior to enrollment|1
4648932|NCT03708744|15943949|P4|Overall Study|Withdrawal by Subject|0
4648933|NCT03708744|15943950|P3|Overall Study|Withdrawal by Subject|1
4648934|NCT03708744|15943951|P2|Overall Study|Withdrawal by Subject|0
4648935|NCT03708744|15943952|P1|Overall Study|Withdrawal by Subject|0
4648936|NCT03707912|15943986|P2|Overall Study|Violation of inclusion criteria|0
4648937|NCT03707912|15943987|P1|Overall Study|Violation of inclusion criteria|1
4648938|NCT03707821|15944007|P2|Overall Study|Unsatisfactory Lens Fitting|0
4648939|NCT03707821|15944008|P1|Overall Study|Unsatisfactory Lens Fitting|1
4648940|NCT03707821|15944007|P2|Overall Study|Unsatisfactory Visual Response|0
4648941|NCT03707821|15944008|P1|Overall Study|Unsatisfactory Visual Response|1
4648942|NCT03707821|15944007|P2|Overall Study|Protocol Violation|1
4648943|NCT03707821|15944008|P1|Overall Study|Protocol Violation|0
4648944|NCT03707587|15944028|P2|Overall Study|Death|1
4648945|NCT03707587|15944029|P1|Overall Study|Death|0
4648946|NCT03707522|15944045|P4|Overall Study|Lost to Follow-up|36
4648947|NCT03707522|15944046|P3|Overall Study|Lost to Follow-up|41
4648948|NCT03707522|15944047|P2|Overall Study|Lost to Follow-up|27
4648949|NCT03707522|15944048|P1|Overall Study|Lost to Follow-up|24
4648950|NCT03704194|15944162|P2|Overall Study|Withdrawal by Subject|1
4648951|NCT03704194|15944163|P1|Overall Study|Withdrawal by Subject|0
4648952|NCT03703466|15944191|P3|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
4648953|NCT03703466|15944192|P2|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|2
4648954|NCT03703466|15944193|P1|Overall Study|Completed < 3 Cycles As Of Data Cut-Off|1
4648955|NCT03703466|15944191|P3|Overall Study|Withdrawal by Subject|0
4648956|NCT03703466|15944192|P2|Overall Study|Withdrawal by Subject|3
4648957|NCT03703466|15944193|P1|Overall Study|Withdrawal by Subject|0
4648958|NCT03703466|15944191|P3|Overall Study|Protocol Violation|0
4648959|NCT03703466|15944192|P2|Overall Study|Protocol Violation|0
4648960|NCT03703466|15944193|P1|Overall Study|Protocol Violation|1
4648961|NCT03703466|15944191|P3|Overall Study|Death|0
4648962|NCT03703466|15944192|P2|Overall Study|Death|1
4648963|NCT03703466|15944193|P1|Overall Study|Death|2
4648964|NCT03700671|15944247|P2|Overall Study|Lack of Efficacy|2
4648965|NCT03700671|15944248|P1|Overall Study|Lack of Efficacy|1
4648966|NCT03700385|15944260|P1|Overall Study|Lost to Follow-up|1
4648967|NCT03698591|15944267|P2|Overall Study|Could not establish TMS dosage|1
4648968|NCT03698591|15944268|P1|Overall Study|Could not establish TMS dosage|0
4648969|NCT03698591|15944267|P2|Overall Study|Equipment Error|0
4648970|NCT03698591|15944268|P1|Overall Study|Equipment Error|1
4648971|NCT03698591|15944267|P2|Overall Study|Ineligible for financial compensation|0
4648972|NCT03698591|15944268|P1|Overall Study|Ineligible for financial compensation|1
4648973|NCT03698591|15944267|P2|Overall Study|Failed health screen|1
4648974|NCT03698591|15944268|P1|Overall Study|Failed health screen|0
4648975|NCT03698591|15944267|P2|Overall Study|Failed drug screen|1
4648976|NCT03698591|15944268|P1|Overall Study|Failed drug screen|1
4648977|NCT03698591|15944267|P2|Overall Study|Withdrawal by Subject|2
4648978|NCT03698591|15944268|P1|Overall Study|Withdrawal by Subject|2
4648979|NCT03698331|15944282|P2|Overall Study|Non-compliance with study drug|0
4648980|NCT03698331|15944283|P1|Overall Study|Non-compliance with study drug|1
4648981|NCT03698331|15944282|P2|Overall Study|Lost to Follow-up|2
4648982|NCT03698331|15944283|P1|Overall Study|Lost to Follow-up|0
4648983|NCT03698331|15944282|P2|Overall Study|Withdrawal by Subject|1
4648984|NCT03698331|15944283|P1|Overall Study|Withdrawal by Subject|1
4648985|NCT03698331|15944282|P2|Overall Study|Adverse Event|3
4648986|NCT03698331|15944283|P1|Overall Study|Adverse Event|2
4648987|NCT03698279|15944305|P6|Overall Study|Lost to Follow-up|0
4648988|NCT03698279|15944306|P5|Overall Study|Lost to Follow-up|0
4648989|NCT03698279|15944307|P4|Overall Study|Lost to Follow-up|5
4648990|NCT03698279|15944308|P3|Overall Study|Lost to Follow-up|4
4648991|NCT03698279|15944309|P2|Overall Study|Lost to Follow-up|1
4648992|NCT03698279|15944310|P1|Overall Study|Lost to Follow-up|3
4648993|NCT03698279|15944305|P6|Overall Study|Withdrawal by Subject|0
4648994|NCT03698279|15944306|P5|Overall Study|Withdrawal by Subject|0
4648995|NCT03698279|15944307|P4|Overall Study|Withdrawal by Subject|0
4648996|NCT03698279|15944308|P3|Overall Study|Withdrawal by Subject|1
4648997|NCT03698279|15944309|P2|Overall Study|Withdrawal by Subject|0
4648998|NCT03698279|15944310|P1|Overall Study|Withdrawal by Subject|0
4648999|NCT03698279|15944305|P6|Overall Study|Protocol deviation|0
4649000|NCT03698279|15944306|P5|Overall Study|Protocol deviation|0
4649001|NCT03698279|15944307|P4|Overall Study|Protocol deviation|0
4649002|NCT03698279|15944308|P3|Overall Study|Protocol deviation|1
4649003|NCT03698279|15944309|P2|Overall Study|Protocol deviation|0
4649004|NCT03698279|15944310|P1|Overall Study|Protocol deviation|1
4649005|NCT03698279|15944305|P6|Overall Study|Withdrawal by parent/guardian|0
4649006|NCT03698279|15944306|P5|Overall Study|Withdrawal by parent/guardian|0
4649007|NCT03698279|15944307|P4|Overall Study|Withdrawal by parent/guardian|1
4649008|NCT03698279|15944308|P3|Overall Study|Withdrawal by parent/guardian|1
4649009|NCT03698279|15944309|P2|Overall Study|Withdrawal by parent/guardian|1
4649010|NCT03698279|15944310|P1|Overall Study|Withdrawal by parent/guardian|1
4649011|NCT03697252|15944411|P2|Overall Study|Other|1
4649012|NCT03697252|15944412|P1|Overall Study|Other|0
4649013|NCT03697252|15944411|P2|Overall Study|Physician Decision|1
4649014|NCT03697252|15944412|P1|Overall Study|Physician Decision|1
4649015|NCT03697252|15944411|P2|Overall Study|Lost to Follow-up|1
4649016|NCT03697252|15944412|P1|Overall Study|Lost to Follow-up|0
4649017|NCT03697252|15944411|P2|Overall Study|Withdrawal by Subject|14
4649018|NCT03697252|15944412|P1|Overall Study|Withdrawal by Subject|14
4649019|NCT03697252|15944411|P2|Overall Study|Adverse Event|2
4649020|NCT03697252|15944412|P1|Overall Study|Adverse Event|3
4649021|NCT03695094|15944493|P2|Overall Study|Withdrawal by Subject|0
4649022|NCT03695094|15944494|P1|Overall Study|Withdrawal by Subject|1
4649023|NCT03695094|15944493|P2|Overall Study|Adverse Event|1
4649024|NCT03695094|15944494|P1|Overall Study|Adverse Event|1
4649025|NCT03694821|15944530|P3|Overall Study|Study terminated|4
4649026|NCT03694821|15944531|P2|Overall Study|Study terminated|8
4649027|NCT03694821|15944532|P1|Overall Study|Study terminated|4
4649028|NCT03693989|15944563|P2|Overall Study|Protocol Violation|4
4649029|NCT03693989|15944564|P1|Overall Study|Protocol Violation|3
4649030|NCT03693950|15944588|P2|Overall Study|Withdrawal by Subject|0
4649031|NCT03693950|15944589|P1|Overall Study|Withdrawal by Subject|1
4649032|NCT03693625|15944613|P2|Overall Study|Withdrawal by Subject|1
4649033|NCT03693625|15944614|P1|Overall Study|Withdrawal by Subject|1
4649034|NCT03693625|15944613|P2|Overall Study|Study Terminated By Sponsor|7
4649035|NCT03693625|15944614|P1|Overall Study|Study Terminated By Sponsor|20
4649036|NCT03693625|15944613|P2|Overall Study|Adverse Event|0
4649037|NCT03693625|15944614|P1|Overall Study|Adverse Event|2
4649038|NCT03691831|15944694|P2|Overall Study|Investigator Decision|2
4649039|NCT03691831|15944695|P1|Overall Study|Investigator Decision|2
4649040|NCT03691831|15944694|P2|Overall Study|Withdrawal by Subject|17
4649041|NCT03691831|15944695|P1|Overall Study|Withdrawal by Subject|9
4649042|NCT03691831|15944694|P2|Overall Study|Lost to Follow-up|12
4649043|NCT03691831|15944695|P1|Overall Study|Lost to Follow-up|16
4649044|NCT03689452|15944711|P2|Overall Study|Lost to Follow-up|1
4649045|NCT03689452|15944712|P1|Overall Study|Lost to Follow-up|1
4649046|NCT03688880|15944730|P2|Overall Study|Other|16
4649047|NCT03688880|15944731|P1|Overall Study|Other|10
4649048|NCT03688880|15944730|P2|Overall Study|Device deficiencies|2
4649049|NCT03688880|15944731|P1|Overall Study|Device deficiencies|0
4649050|NCT03688880|15944730|P2|Overall Study|Adverse Event|2
4649051|NCT03688880|15944731|P1|Overall Study|Adverse Event|0
4649052|NCT03688880|15944730|P2|Overall Study|Lost to Follow-up|7
4649053|NCT03688880|15944731|P1|Overall Study|Lost to Follow-up|4
4649054|NCT03688880|15944730|P2|Overall Study|Use of non-permitted concurrent therapy|2
4649055|NCT03688880|15944731|P1|Overall Study|Use of non-permitted concurrent therapy|0
4649056|NCT03688880|15944730|P2|Overall Study|Withdrawal by Subject|2
4649057|NCT03688880|15944731|P1|Overall Study|Withdrawal by Subject|0
4649058|NCT03688620|15944758|P3|Overall Study|Withdrawal by Subject|6
4649059|NCT03688620|15944759|P2|Overall Study|Withdrawal by Subject|0
4649060|NCT03688620|15944760|P1|Overall Study|Withdrawal by Subject|0
4649061|NCT03688620|15944758|P3|Overall Study|Lost to Follow-up|1
4649062|NCT03688620|15944759|P2|Overall Study|Lost to Follow-up|0
4649063|NCT03688620|15944760|P1|Overall Study|Lost to Follow-up|16
4649064|NCT03688620|15944758|P3|Overall Study|Unwilling to attend the scheduled visit|0
4649065|NCT03688620|15944759|P2|Overall Study|Unwilling to attend the scheduled visit|1
4649066|NCT03688620|15944760|P1|Overall Study|Unwilling to attend the scheduled visit|0
4649067|NCT03688620|15944758|P3|Overall Study|Other|1
4649068|NCT03688620|15944759|P2|Overall Study|Other|0
4649069|NCT03688620|15944760|P1|Overall Study|Other|0
4649070|NCT03687970|15945243|P2|Overall Study|visit scheduling conflicts|0
4649071|NCT03687970|15945244|P1|Overall Study|visit scheduling conflicts|2
4649072|NCT03687736|15945254|P1|Overall Study|Withdrawal by Subject|3
4649073|NCT03687736|15945254|P1|Overall Study|Lost to Follow-up|7
4649074|NCT03687372|15945400|P2|Overall Study|Investigator Decision|1
4649075|NCT03687372|15945401|P1|Overall Study|Investigator Decision|1
4649076|NCT03687372|15945400|P2|Overall Study|Withdrawal by Subject|17
4649077|NCT03687372|15945401|P1|Overall Study|Withdrawal by Subject|4
4649078|NCT03687372|15945400|P2|Overall Study|Lost to Follow-up|21
4649079|NCT03687372|15945401|P1|Overall Study|Lost to Follow-up|12
4649080|NCT03686176|15945418|P3|Overall Study|VR Malfunction|0
4649081|NCT03686176|15945419|P2|Overall Study|VR Malfunction|0
4649082|NCT03686176|15945420|P1|Overall Study|VR Malfunction|1
4649083|NCT03686176|15945418|P3|Overall Study|Procedure cancelled|0
4649084|NCT03686176|15945419|P2|Overall Study|Procedure cancelled|0
4649085|NCT03686176|15945420|P1|Overall Study|Procedure cancelled|1
4649086|NCT03686033|15945459|P6|Treatment Period 2 (1 Day)|Adverse Event|0
4649087|NCT03686033|15945460|P5|Treatment Period 2 (1 Day)|Adverse Event|1
4649088|NCT03686033|15945461|P4|Treatment Period 2 (1 Day)|Adverse Event|0
4649089|NCT03686033|15945462|P3|Treatment Period 2 (1 Day)|Adverse Event|0
4649090|NCT03686033|15945463|P2|Treatment Period 2 (1 Day)|Adverse Event|0
4649091|NCT03686033|15945464|P1|Treatment Period 2 (1 Day)|Adverse Event|0
4649092|NCT03685643|15945540|P2|Overall Study|Lost to Follow-up|22
4649093|NCT03685643|15945541|P1|Overall Study|Lost to Follow-up|14
4649094|NCT03684928|15945566|P2|Second Intervention|Soft Tissue Injury|0
4649095|NCT03684928|15945567|P1|Second Intervention|Soft Tissue Injury|1
4649096|NCT03684928|15945566|P2|First Intervention|Withdrawal by Subject|2
4649097|NCT03684928|15945567|P1|First Intervention|Withdrawal by Subject|0
4649098|NCT03684928|15945566|P2|First Intervention|Lost to Follow-up|1
4649099|NCT03684928|15945567|P1|First Intervention|Lost to Follow-up|0
4649100|NCT03683758|15945605|P2|Overall Study|Adverse Event|0
4649101|NCT03683758|15945606|P1|Overall Study|Adverse Event|1
4649102|NCT03683758|15945605|P2|Overall Study|Illness preventing participation|0
4649103|NCT03683758|15945606|P1|Overall Study|Illness preventing participation|1
4649104|NCT03683758|15945605|P2|Overall Study|Non-study commitment conflict|3
4649105|NCT03683758|15945606|P1|Overall Study|Non-study commitment conflict|1
4649106|NCT03681951|15945643|P8|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649107|NCT03681951|15945644|P7|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649108|NCT03681951|15945645|P6|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649109|NCT03681951|15945646|P5|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649110|NCT03681951|15945647|P4|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649111|NCT03681951|15945648|P3|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649112|NCT03681951|15945649|P2|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0
4649113|NCT03681951|15945650|P1|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3
4649114|NCT03681951|15945643|P8|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649115|NCT03681951|15945644|P7|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649116|NCT03681951|15945645|P6|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649117|NCT03681951|15945646|P5|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649118|NCT03681951|15945647|P4|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649119|NCT03681951|15945648|P3|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649120|NCT03681951|15945649|P2|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0
4649121|NCT03681951|15945650|P1|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4
4649122|NCT03681951|15945643|P8|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649123|NCT03681951|15945644|P7|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649124|NCT03681951|15945645|P6|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649125|NCT03681951|15945646|P5|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649126|NCT03681951|15945647|P4|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649127|NCT03681951|15945648|P3|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649128|NCT03681951|15945649|P2|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0
4649129|NCT03681951|15945650|P1|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1
4649130|NCT03681119|15945843|P2|Overall Study|Sickness|0
4649131|NCT03681119|15945844|P1|Overall Study|Sickness|2
4649132|NCT03681119|15945843|P2|Overall Study|No specific reason|0
4649133|NCT03681119|15945844|P1|Overall Study|No specific reason|4
4649134|NCT03679741|15945915|P2|Period 2|Withdrawal by Subject|1
4649135|NCT03679741|15945916|P1|Period 2|Withdrawal by Subject|1
4649136|NCT03679741|15945915|P2|Period 2|Adverse Event|1
4649137|NCT03679741|15945916|P1|Period 2|Adverse Event|2
4649138|NCT03679741|15945915|P2|Period 1|Withdrawal by Subject|1
4649139|NCT03679741|15945916|P1|Period 1|Withdrawal by Subject|0
4649140|NCT03679741|15945915|P2|Period 1|Adverse Event|1
4649141|NCT03679741|15945916|P1|Period 1|Adverse Event|1
4649142|NCT03679741|15945915|P2|Period 1|Lost to Follow-up|1
4649143|NCT03679741|15945916|P1|Period 1|Lost to Follow-up|0
4649144|NCT03679741|15945915|P2|Period 1|No longer meet eligibility criteria|0
4649145|NCT03679741|15945916|P1|Period 1|No longer meet eligibility criteria|1
4649146|NCT03678870|15945959|P2|Overall Study|Lost to Follow-up|2
4649147|NCT03678870|15945960|P1|Overall Study|Lost to Follow-up|3
4649148|NCT03678870|15945959|P2|Overall Study|prescribed non- protocol medications|6
4649149|NCT03678870|15945960|P1|Overall Study|prescribed non- protocol medications|10
4649150|NCT03677401|15945980|P2|Overall Study|Reason Unspecified|0
4649151|NCT03677401|15945981|P1|Overall Study|Reason Unspecified|1
4649152|NCT03677401|15945980|P2|Overall Study|Sponsor decision|1
4649153|NCT03677401|15945981|P1|Overall Study|Sponsor decision|0
4649154|NCT03677401|15945980|P2|Overall Study|Withdrawal by Subject|2
4649155|NCT03677401|15945981|P1|Overall Study|Withdrawal by Subject|2
4649156|NCT03677401|15945980|P2|Overall Study|Lack of Efficacy|1
4649157|NCT03677401|15945981|P1|Overall Study|Lack of Efficacy|3
4649158|NCT03677401|15945980|P2|Overall Study|Adverse Event|14
4649159|NCT03677401|15945981|P1|Overall Study|Adverse Event|4
4649160|NCT03677375|15946005|P1|Overall Study|Physician Decision|1
4649161|NCT03677375|15946005|P1|Overall Study|Adverse Event|3
4649162|NCT03677375|15946005|P1|Overall Study|Incomplete procedure|8
4649163|NCT03675776|15946059|P3|Double Blind Treatment Period|Lack of Efficacy|0
4649164|NCT03675776|15946060|P2|Double Blind Treatment Period|Lack of Efficacy|0
4649165|NCT03675776|15946061|P1|Double Blind Treatment Period|Lack of Efficacy|1
4649166|NCT03675776|15946059|P3|Double Blind Treatment Period|Study Terminated by Sponsor|8
4649167|NCT03675776|15946060|P2|Double Blind Treatment Period|Study Terminated by Sponsor|6
4649168|NCT03675776|15946061|P1|Double Blind Treatment Period|Study Terminated by Sponsor|5
4649169|NCT03674177|15946109|P4|Overall Study|Lost to Follow-up|2
4649170|NCT03674177|15946110|P3|Overall Study|Lost to Follow-up|0
4649171|NCT03674177|15946111|P2|Overall Study|Lost to Follow-up|1
4649172|NCT03674177|15946112|P1|Overall Study|Lost to Follow-up|2
4649173|NCT03673670|15946176|P6|Treatment Period 3 (3 Days)|Adverse Event|0
4649174|NCT03673670|15946177|P5|Treatment Period 3 (3 Days)|Adverse Event|1
4649175|NCT03673670|15946178|P4|Treatment Period 3 (3 Days)|Adverse Event|0
4649176|NCT03673670|15946179|P3|Treatment Period 3 (3 Days)|Adverse Event|0
4649177|NCT03673670|15946180|P2|Treatment Period 3 (3 Days)|Adverse Event|0
4649178|NCT03673670|15946181|P1|Treatment Period 3 (3 Days)|Adverse Event|0
4649179|NCT03673670|15946176|P6|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4649180|NCT03673670|15946177|P5|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1
4649181|NCT03673670|15946178|P4|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4649182|NCT03673670|15946179|P3|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4649183|NCT03673670|15946180|P2|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4649184|NCT03673670|15946181|P1|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0
4649185|NCT03673670|15946176|P6|Treatment Period 2 (3 Days)|Adverse Event|0
4649186|NCT03673670|15946177|P5|Treatment Period 2 (3 Days)|Adverse Event|1
4649187|NCT03673670|15946178|P4|Treatment Period 2 (3 Days)|Adverse Event|0
4649188|NCT03673670|15946179|P3|Treatment Period 2 (3 Days)|Adverse Event|1
4649189|NCT03673670|15946180|P2|Treatment Period 2 (3 Days)|Adverse Event|0
4649190|NCT03673670|15946181|P1|Treatment Period 2 (3 Days)|Adverse Event|0
4649191|NCT03673670|15946176|P6|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1
4649192|NCT03673670|15946177|P5|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4649193|NCT03673670|15946178|P4|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4649194|NCT03673670|15946179|P3|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4649195|NCT03673670|15946180|P2|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4649196|NCT03673670|15946181|P1|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0
4649197|NCT03673670|15946176|P6|Treatment Period 1 (3 Days)|Adverse Event|1
4649198|NCT03673670|15946177|P5|Treatment Period 1 (3 Days)|Adverse Event|0
4649199|NCT03673670|15946178|P4|Treatment Period 1 (3 Days)|Adverse Event|0
4649200|NCT03673670|15946179|P3|Treatment Period 1 (3 Days)|Adverse Event|0
4649201|NCT03673670|15946180|P2|Treatment Period 1 (3 Days)|Adverse Event|0
4649202|NCT03673670|15946181|P1|Treatment Period 1 (3 Days)|Adverse Event|0
4649203|NCT03673670|15946176|P6|Treatment Period 1 (3 Days)|Physician Decision|0
4649204|NCT03673670|15946177|P5|Treatment Period 1 (3 Days)|Physician Decision|0
4649205|NCT03673670|15946178|P4|Treatment Period 1 (3 Days)|Physician Decision|0
4649206|NCT03673670|15946179|P3|Treatment Period 1 (3 Days)|Physician Decision|1
4649207|NCT03673670|15946180|P2|Treatment Period 1 (3 Days)|Physician Decision|0
4649208|NCT03673670|15946181|P1|Treatment Period 1 (3 Days)|Physician Decision|0
4649209|NCT03673670|15946176|P6|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4649210|NCT03673670|15946177|P5|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4649211|NCT03673670|15946178|P4|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4649212|NCT03673670|15946179|P3|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4649213|NCT03673670|15946180|P2|Treatment Period 1 (3 Days)|Withdrawal by Subject|0
4649214|NCT03673670|15946181|P1|Treatment Period 1 (3 Days)|Withdrawal by Subject|1
4649215|NCT03670537|15946228|P1|Overall Study|Protocol Violation|1
4649216|NCT03669081|15946234|P2|Overall Study|Data could not be validated|1
4649217|NCT03669081|15946235|P1|Overall Study|Data could not be validated|1
4649218|NCT03668600|15946251|P1|Overall Study|Adverse Event|1
4649219|NCT03668600|15946251|P1|Overall Study|Lack of Efficacy|7
4649220|NCT03668600|15946251|P1|Overall Study|Withdrawal by Subject|56
4649221|NCT03668600|15946251|P1|Overall Study|Lost to Follow-up|7
4649222|NCT03668600|15946251|P1|Overall Study|Pregnancy|1
4649223|NCT03668600|15946251|P1|Overall Study|Protocol Violation|1
4649224|NCT03668600|15946251|P1|Overall Study|Study Terminated by the Sponsor|157
4649225|NCT03663582|15946302|P1|Overall Study|Physician Decision|1
4649226|NCT03663569|15946334|P1|Overall Study|Serious adverse event|1
4649227|NCT03663569|15946334|P1|Overall Study|Not meet inclusion / exclusion criterion|3
4649228|NCT03663569|15946334|P1|Overall Study|Not come to second visit|3
4649229|NCT03663569|15946334|P1|Overall Study|Adverse Event|4
4649230|NCT03663569|15946334|P1|Overall Study|Patient's request|11
4649231|NCT03663569|15946334|P1|Overall Study|Withdrawal of consent|5
4649232|NCT03663569|15946334|P1|Overall Study|Lost to Follow-up|18
4649233|NCT03663569|15946334|P1|Overall Study|Deceased patient|6
4649234|NCT03663569|15946334|P1|Overall Study|Never taken Spiolto® Respimat®|1
4649235|NCT03663569|15946334|P1|Overall Study|Discontinuation of study|11
4649236|NCT03663179|15946347|P2|Overall Study|Revealed exclusionary condition|0
4649237|NCT03663179|15946348|P1|Overall Study|Revealed exclusionary condition|1
4649238|NCT03663179|15946347|P2|Overall Study|Lost to Follow-up|1
4649239|NCT03663179|15946348|P1|Overall Study|Lost to Follow-up|1
4649240|NCT03663179|15946347|P2|Overall Study|Withdrawal by Subject|0
4649241|NCT03663179|15946348|P1|Overall Study|Withdrawal by Subject|2
4649242|NCT03662334|15946358|P2|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0
4649243|NCT03662334|15946359|P1|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1
4649244|NCT03658889|15946472|P2|Overall Study|Protocol Violation|0
4649245|NCT03658889|15946473|P1|Overall Study|Protocol Violation|2
4649246|NCT03658876|15946504|P2|Overall Study|Transplantation/other operation|5
4649247|NCT03658876|15946505|P1|Overall Study|Transplantation/other operation|1
4649248|NCT03658876|15946504|P2|Overall Study|Intercurrent illness|4
4649249|NCT03658876|15946505|P1|Overall Study|Intercurrent illness|6
4649250|NCT03658876|15946504|P2|Overall Study|Death|1
4649251|NCT03658876|15946505|P1|Overall Study|Death|0
4649252|NCT03658876|15946504|P2|Overall Study|Withdrawal by Subject|0
4649253|NCT03658876|15946505|P1|Overall Study|Withdrawal by Subject|2
4649254|NCT03658876|15946504|P2|Overall Study|Protocol Violation|2
4649255|NCT03658876|15946505|P1|Overall Study|Protocol Violation|3
4649256|NCT03658811|15946511|P1|Overall Study|Lost to Follow-up|3
4649257|NCT03657095|15946555|P2|Overall Study|Study Terminated by Sponsor|49
4649258|NCT03657095|15946556|P1|Overall Study|Study Terminated by Sponsor|58
4649259|NCT03657095|15946555|P2|Overall Study|Adverse Event|3
4649260|NCT03657095|15946556|P1|Overall Study|Adverse Event|0
4649261|NCT03657095|15946555|P2|Overall Study|Withdrawal by Subject|1
4649262|NCT03657095|15946556|P1|Overall Study|Withdrawal by Subject|1
4649263|NCT03655106|15946582|P2|Overall Study|Protocol Violation|0
4649264|NCT03655106|15946583|P1|Overall Study|Protocol Violation|3
4649265|NCT03655106|15946582|P2|Overall Study|Duplicate Enrollment|1
4649266|NCT03655106|15946583|P1|Overall Study|Duplicate Enrollment|1
4649267|NCT03655106|15946582|P2|Overall Study|Lost to Follow-up|1
4649268|NCT03655106|15946583|P1|Overall Study|Lost to Follow-up|2
4649269|NCT03655106|15946582|P2|Overall Study|Withdrawal by Subject|2
4649270|NCT03655106|15946583|P1|Overall Study|Withdrawal by Subject|3
4649271|NCT03654560|15946595|P2|Overall Study|Lost to Follow-up|0
4649272|NCT03654560|15946596|P1|Overall Study|Lost to Follow-up|1
4649273|NCT03654560|15946595|P2|Overall Study|Death|1
4649274|NCT03654560|15946596|P1|Overall Study|Death|3
4649275|NCT03653429|15946637|P2|Overall Study|Physician Decision|10
4649276|NCT03653429|15946638|P1|Overall Study|Physician Decision|4
4649277|NCT03650400|15946682|P2|Overall Study|Study terminated by sponsor|5
4649278|NCT03650400|15946683|P1|Overall Study|Study terminated by sponsor|0
4649279|NCT03649412|15946743|P2|Part B, Washout Period 5 (7 Days)|Adverse Event|1
4649280|NCT03649412|15946744|P1|Part B, Washout Period 5 (7 Days)|Adverse Event|0
4649281|NCT03649412|15946743|P2|Part B, Washout Period 1 (7 Days)|Adverse Event|1
4649282|NCT03649412|15946744|P1|Part B, Washout Period 1 (7 Days)|Adverse Event|0
4649283|NCT03649412|15946743|P2|Part A, Washout Period 5 (7 Days)|Adverse Event|0
4649284|NCT03649412|15946744|P1|Part A, Washout Period 5 (7 Days)|Adverse Event|1
4649285|NCT03649412|15946743|P2|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0
4649286|NCT03649412|15946744|P1|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1
4649287|NCT03649412|15946743|P2|Part A, Washout Period 4 (7 Days)|Adverse Event|0
4649288|NCT03649412|15946744|P1|Part A, Washout Period 4 (7 Days)|Adverse Event|1
4649289|NCT03649412|15946743|P2|Part A, Washout Period 1 (7 Days)|Physician Decision|0
4649290|NCT03649412|15946744|P1|Part A, Washout Period 1 (7 Days)|Physician Decision|1
4649291|NCT03648983|15946902|P1|Overall Study|Study was terminated due to PI departure|95
4649292|NCT03647709|15946912|P1|Overall Study|Withdrawal by Subject|3
4649293|NCT03647709|15946912|P1|Overall Study|Physician Decision|6
4649294|NCT03647709|15946912|P1|Overall Study|Lost to Follow-up|5
4649295|NCT03646656|15946945|P2|Overall Study|Withdrawal by Subject|0
4649296|NCT03646656|15946946|P1|Overall Study|Withdrawal by Subject|2
4649297|NCT03646656|15946945|P2|Overall Study|Lost to Follow-up|0
4649298|NCT03646656|15946946|P1|Overall Study|Lost to Follow-up|1
4649299|NCT03645421|15946980|P4|Overall Study|Study specific withdrawal criteria|0
4649300|NCT03645421|15946981|P3|Overall Study|Study specific withdrawal criteria|1
4649301|NCT03645421|15946982|P2|Overall Study|Study specific withdrawal criteria|0
4649302|NCT03645421|15946983|P1|Overall Study|Study specific withdrawal criteria|0
4649303|NCT03645421|15946980|P4|Overall Study|Withdrawal by patient|3
4649304|NCT03645421|15946981|P3|Overall Study|Withdrawal by patient|0
4649305|NCT03645421|15946982|P2|Overall Study|Withdrawal by patient|0
4649306|NCT03645421|15946983|P1|Overall Study|Withdrawal by patient|0
4649307|NCT03645421|15946980|P4|Overall Study|Adverse Event|1
4649308|NCT03645421|15946981|P3|Overall Study|Adverse Event|4
4649309|NCT03645421|15946982|P2|Overall Study|Adverse Event|0
4649310|NCT03645421|15946983|P1|Overall Study|Adverse Event|0
4649311|NCT03643575|15947092|P6|Washout: 7 Days|Non compliance check in|0
4649312|NCT03643575|15947093|P5|Washout: 7 Days|Non compliance check in|0
4649313|NCT03643575|15947094|P4|Washout: 7 Days|Non compliance check in|0
4649314|NCT03643575|15947095|P3|Washout: 7 Days|Non compliance check in|0
4649315|NCT03643575|15947096|P2|Washout: 7 Days|Non compliance check in|1
4649316|NCT03643575|15947097|P1|Washout: 7 Days|Non compliance check in|0
4649317|NCT03643575|15947092|P6|Washout: 7 Days|Adverse Event|0
4649318|NCT03643575|15947093|P5|Washout: 7 Days|Adverse Event|0
4649319|NCT03643575|15947094|P4|Washout: 7 Days|Adverse Event|0
4649320|NCT03643575|15947095|P3|Washout: 7 Days|Adverse Event|0
4649321|NCT03643575|15947096|P2|Washout: 7 Days|Adverse Event|0
4649322|NCT03643575|15947097|P1|Washout: 7 Days|Adverse Event|1
4649323|NCT03643575|15947092|P6|Washout: 7 Days|Withdrew consent due to illness|0
4649324|NCT03643575|15947093|P5|Washout: 7 Days|Withdrew consent due to illness|0
4649325|NCT03643575|15947094|P4|Washout: 7 Days|Withdrew consent due to illness|1
4649326|NCT03643575|15947095|P3|Washout: 7 Days|Withdrew consent due to illness|0
4649327|NCT03643575|15947096|P2|Washout: 7 Days|Withdrew consent due to illness|0
4649328|NCT03643575|15947097|P1|Washout: 7 Days|Withdrew consent due to illness|0
4649329|NCT03643432|15947155|P2|Overall Study|Lost to Follow-up|0
4649330|NCT03643432|15947156|P1|Overall Study|Lost to Follow-up|1
4649331|NCT03643159|15947180|P1|Overall Study|Withdrawal by Subject|1
4649332|NCT03643159|15947180|P1|Overall Study|Adverse Event|1
4649333|NCT03642873|15947187|P6|Third Intervention (1 Day)|Screen failure|0
4649334|NCT03642873|15947188|P5|Third Intervention (1 Day)|Screen failure|1
4649335|NCT03642873|15947189|P4|Third Intervention (1 Day)|Screen failure|0
4649336|NCT03642873|15947190|P3|Third Intervention (1 Day)|Screen failure|0
4649337|NCT03642873|15947191|P2|Third Intervention (1 Day)|Screen failure|0
4649338|NCT03642873|15947192|P1|Third Intervention (1 Day)|Screen failure|0
4649339|NCT03642262|15947243|P2|Period 1|Adverse Event|1
4649340|NCT03642262|15947244|P1|Period 1|Adverse Event|0
4649341|NCT03642262|15947243|P2|Period 1|Withdrawal by Subject|1
4649342|NCT03642262|15947244|P1|Period 1|Withdrawal by Subject|1
4649343|NCT03641508|15947265|P2|First Injection|Lost to Follow-up|0
4649344|NCT03641508|15947266|P1|First Injection|Lost to Follow-up|2
4649345|NCT03640559|15947293|P2|Overall Study|Withdrawal by Subject|0
4649346|NCT03640559|15947294|P1|Overall Study|Withdrawal by Subject|1
4649347|NCT03640559|15947293|P2|Overall Study|Physician Decision|1
4649348|NCT03640559|15947294|P1|Overall Study|Physician Decision|1
4649349|NCT03640507|15947303|P3|Overall Study|Withdrawal by Subject|1
4649350|NCT03640507|15947304|P2|Overall Study|Withdrawal by Subject|0
4649351|NCT03640507|15947305|P1|Overall Study|Withdrawal by Subject|0
4649352|NCT03640052|15947325|P5|Overall Study|Lost to Follow-up|0
4649353|NCT03640052|15947326|P4|Overall Study|Lost to Follow-up|0
4649354|NCT03640052|15947327|P3|Overall Study|Lost to Follow-up|0
4649355|NCT03640052|15947328|P2|Overall Study|Lost to Follow-up|1
4649356|NCT03640052|15947329|P1|Overall Study|Lost to Follow-up|0
4649357|NCT03639675|15947346|P1|Overall Study|Withdrawal by Subject|1
4649358|NCT03638635|15947368|P2|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22
4649359|NCT03638635|15947369|P1|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39
4649360|NCT03638635|15947368|P2|Initial Hospitalization|Withdrawal by study personnel|1
4649361|NCT03638635|15947369|P1|Initial Hospitalization|Withdrawal by study personnel|0
4649362|NCT03638635|15947368|P2|Initial Hospitalization|Study terminated prematurely|1
4649363|NCT03638635|15947369|P1|Initial Hospitalization|Study terminated prematurely|0
4649364|NCT03636893|15947458|P2|Overall Study|Adverse Event|1
4649365|NCT03636893|15947459|P1|Overall Study|Adverse Event|1
4649366|NCT03636893|15947458|P2|Overall Study|Early surgery (for acute bleeding)|0
4649367|NCT03636893|15947459|P1|Overall Study|Early surgery (for acute bleeding)|3
4649368|NCT03636893|15947458|P2|Overall Study|Refusal to surgery|3
4649369|NCT03636893|15947459|P1|Overall Study|Refusal to surgery|4
4649370|NCT03636893|15947458|P2|Overall Study|Withdrawal by Subject|2
4649371|NCT03636893|15947459|P1|Overall Study|Withdrawal by Subject|1
4649372|NCT03636893|15947458|P2|Overall Study|Protocol Violation|3
4649373|NCT03636893|15947459|P1|Overall Study|Protocol Violation|0
4649374|NCT03636893|15947458|P2|Overall Study|Death|1
4649375|NCT03636893|15947459|P1|Overall Study|Death|0
4649376|NCT03634579|15947476|P1|Overall Study|study termination|9
4649377|NCT03634085|15947574|P2|Overall Study|Withdrawal by Subject|2
4649378|NCT03634085|15947575|P1|Overall Study|Withdrawal by Subject|0
4649379|NCT03634085|15947574|P2|Overall Study|Adverse Event|0
4649380|NCT03634085|15947575|P1|Overall Study|Adverse Event|1
4649381|NCT03633825|15947590|P2|Follow up|Lost to Follow-up|450
4649382|NCT03633825|15947591|P1|Follow up|Lost to Follow-up|478
4649383|NCT03633825|15947590|P2|Enrollment|Post not classified as crisis|13757
4649384|NCT03633825|15947591|P1|Enrollment|Post not classified as crisis|13967
4649385|NCT03633825|15947590|P2|Enrollment|Did not post on network|5080
4649386|NCT03633825|15947591|P1|Enrollment|Did not post on network|5066
4649387|NCT03631732|15947776|P2|Overall Study|Lost to Follow-up|1
4649388|NCT03631732|15947777|P1|Overall Study|Lost to Follow-up|5
4649389|NCT03631732|15947776|P2|Overall Study|Withdrew consent|4
4649390|NCT03631732|15947777|P1|Overall Study|Withdrew consent|3
4649391|NCT03631732|15947776|P2|Overall Study|Investigator's Discretion|0
4649392|NCT03631732|15947777|P1|Overall Study|Investigator's Discretion|1
4649393|NCT03631732|15947776|P2|Overall Study|Lack of Efficacy|0
4649394|NCT03631732|15947777|P1|Overall Study|Lack of Efficacy|1
4649395|NCT03631732|15947776|P2|Overall Study|Death|0
4649396|NCT03631732|15947777|P1|Overall Study|Death|1
4649397|NCT03631732|15947776|P2|Overall Study|Adverse Event|0
4649398|NCT03631732|15947777|P1|Overall Study|Adverse Event|3
4649399|NCT03631732|15947776|P2|Overall Study|Still in Study|148
4649400|NCT03631732|15947777|P1|Overall Study|Still in Study|285
4649401|NCT03631732|15947776|P2|Overall Study|Randomized and Never Treated|0
4649402|NCT03631732|15947777|P1|Overall Study|Randomized and Never Treated|1
4649403|NCT03630016|15947863|P1|Overall Study|Poor Sensor Placement|1
4649404|NCT03629184|15947869|P2|Overall Study|Physician Decision|0
4649405|NCT03629184|15947870|P1|Overall Study|Physician Decision|1
4649406|NCT03629184|15947869|P2|Overall Study|Withdrawal by Subject|1
4649407|NCT03629184|15947870|P1|Overall Study|Withdrawal by Subject|2
4649408|NCT03629054|15947920|P2|Period 2 (4 Days)|Not treated|1
4649409|NCT03629054|15947921|P1|Period 2 (4 Days)|Not treated|0
4649410|NCT03629041|15947945|P4|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
4649411|NCT03629041|15947946|P3|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
4649412|NCT03629041|15947947|P2|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1
4649413|NCT03629041|15947948|P1|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0
4649414|NCT03629028|15947976|P2|Overall Study|intolerance to examination|0
4649415|NCT03629028|15947977|P1|Overall Study|intolerance to examination|2
4649416|NCT03629028|15947976|P2|Overall Study|Pregnancy|2
4649417|NCT03629028|15947977|P1|Overall Study|Pregnancy|4
4649418|NCT03629028|15947976|P2|Overall Study|Lost to Follow-up|23
4649419|NCT03629028|15947977|P1|Overall Study|Lost to Follow-up|26
4649420|NCT03628599|15948008|P2|Overall Study|Adverse Event|1
4649421|NCT03628599|15948009|P1|Overall Study|Adverse Event|0
4649422|NCT03628417|15948039|P2|Overall Study|Death|1
4649423|NCT03628417|15948040|P1|Overall Study|Death|1
4649424|NCT03627832|15948052|P2|Overall Study|Withdrawal by Subject|1
4649425|NCT03627832|15948053|P1|Overall Study|Withdrawal by Subject|10
4649426|NCT03627494|15948087|P12|Part C Washout 1 (7 Days)|Adverse Event|1
4649427|NCT03627494|15948088|P11|Part C Washout 1 (7 Days)|Adverse Event|1
4649428|NCT03627494|15948089|P10|Part C Washout 1 (7 Days)|Adverse Event|0
4649429|NCT03627494|15948090|P9|Part C Washout 1 (7 Days)|Adverse Event|0
4649430|NCT03627494|15948091|P8|Part C Washout 1 (7 Days)|Adverse Event|0
4649431|NCT03627494|15948092|P7|Part C Washout 1 (7 Days)|Adverse Event|0
4649432|NCT03627494|15948093|P6|Part C Washout 1 (7 Days)|Adverse Event|0
4649433|NCT03627494|15948094|P5|Part C Washout 1 (7 Days)|Adverse Event|0
4649434|NCT03627494|15948095|P4|Part C Washout 1 (7 Days)|Adverse Event|0
4649435|NCT03627494|15948096|P3|Part C Washout 1 (7 Days)|Adverse Event|0
4649436|NCT03627494|15948097|P2|Part C Washout 1 (7 Days)|Adverse Event|0
4649437|NCT03627494|15948098|P1|Part C Washout 1 (7 Days)|Adverse Event|0
4649438|NCT03627494|15948087|P12|Part B (Maximum of 34 Days)|Adverse Event|0
4649439|NCT03627494|15948088|P11|Part B (Maximum of 34 Days)|Adverse Event|0
4649440|NCT03627494|15948089|P10|Part B (Maximum of 34 Days)|Adverse Event|0
4649441|NCT03627494|15948090|P9|Part B (Maximum of 34 Days)|Adverse Event|2
4649442|NCT03627494|15948091|P8|Part B (Maximum of 34 Days)|Adverse Event|0
4649443|NCT03627494|15948092|P7|Part B (Maximum of 34 Days)|Adverse Event|0
4649444|NCT03627494|15948093|P6|Part B (Maximum of 34 Days)|Adverse Event|0
4649445|NCT03627494|15948094|P5|Part B (Maximum of 34 Days)|Adverse Event|0
4649446|NCT03627494|15948095|P4|Part B (Maximum of 34 Days)|Adverse Event|0
4649447|NCT03627494|15948096|P3|Part B (Maximum of 34 Days)|Adverse Event|0
4649448|NCT03627494|15948097|P2|Part B (Maximum of 34 Days)|Adverse Event|0
4649449|NCT03627494|15948098|P1|Part B (Maximum of 34 Days)|Adverse Event|0
4649450|NCT03627494|15948087|P12|Part A Washout 2 (7 Days)|Adverse Event|0
4649451|NCT03627494|15948088|P11|Part A Washout 2 (7 Days)|Adverse Event|0
4649452|NCT03627494|15948089|P10|Part A Washout 2 (7 Days)|Adverse Event|0
4649453|NCT03627494|15948090|P9|Part A Washout 2 (7 Days)|Adverse Event|0
4649454|NCT03627494|15948091|P8|Part A Washout 2 (7 Days)|Adverse Event|0
4649455|NCT03627494|15948092|P7|Part A Washout 2 (7 Days)|Adverse Event|0
4649456|NCT03627494|15948093|P6|Part A Washout 2 (7 Days)|Adverse Event|0
4649457|NCT03627494|15948094|P5|Part A Washout 2 (7 Days)|Adverse Event|0
4649458|NCT03627494|15948095|P4|Part A Washout 2 (7 Days)|Adverse Event|0
4649459|NCT03627494|15948096|P3|Part A Washout 2 (7 Days)|Adverse Event|1
4649460|NCT03627494|15948097|P2|Part A Washout 2 (7 Days)|Adverse Event|0
4649461|NCT03627494|15948098|P1|Part A Washout 2 (7 Days)|Adverse Event|1
4649462|NCT03627195|15948312|P6|Overall Study|OTHER (LACK OF EFFICACY)|0
4649463|NCT03627195|15948313|P5|Overall Study|OTHER (LACK OF EFFICACY)|0
4649464|NCT03627195|15948314|P4|Overall Study|OTHER (LACK OF EFFICACY)|0
4649465|NCT03627195|15948315|P3|Overall Study|OTHER (LACK OF EFFICACY)|0
4649466|NCT03627195|15948316|P2|Overall Study|OTHER (LACK OF EFFICACY)|0
4649467|NCT03627195|15948317|P1|Overall Study|OTHER (LACK OF EFFICACY)|1
4649468|NCT03624946|15948388|P2|Overall Study|Lost to Follow-up|1
4649469|NCT03624946|15948389|P1|Overall Study|Lost to Follow-up|0
4649470|NCT03624504|15948409|P1|Overall Study|Unsuccessful Implant|1
4649471|NCT03620708|15948482|P3|Overall Study|Withdrawal by Subject|1
4649472|NCT03620708|15948483|P2|Overall Study|Withdrawal by Subject|0
4649473|NCT03620708|15948484|P1|Overall Study|Withdrawal by Subject|0
4649474|NCT03620708|15948482|P3|Overall Study|Lost to Follow-up|2
4649475|NCT03620708|15948483|P2|Overall Study|Lost to Follow-up|1
4649476|NCT03620708|15948484|P1|Overall Study|Lost to Follow-up|1
4649477|NCT03618628|15948565|P1|Overall Study|Lost to Follow-up|1
4649478|NCT03618628|15948565|P1|Overall Study|Death|1
4649479|NCT03617861|15948576|P4|Second Intervention (1 Day)|Adverse Event|0
4649480|NCT03617861|15948577|P3|Second Intervention (1 Day)|Adverse Event|1
4649481|NCT03617861|15948578|P2|Second Intervention (1 Day)|Adverse Event|0
4649482|NCT03617861|15948579|P1|Second Intervention (1 Day)|Adverse Event|0
4649483|NCT03617588|15948611|P2|Overall Study|Withdrawal by Subject|0
4649484|NCT03617588|15948612|P1|Overall Study|Withdrawal by Subject|1
4649485|NCT03616977|15948673|P2|Period 3|Adverse Event|1
4649486|NCT03616977|15948674|P1|Period 3|Adverse Event|1
4649487|NCT03616977|15948673|P2|Period 1|Physician Decision|1
4649488|NCT03616977|15948674|P1|Period 1|Physician Decision|0
4649489|NCT03616600|15948684|P2|Overall Study|Withdrawal by Subject|0
4649490|NCT03616600|15948685|P1|Overall Study|Withdrawal by Subject|1
4649491|NCT03616106|15948719|P2|Overall Study|Lost to Follow-up|0
4649492|NCT03616106|15948720|P1|Overall Study|Lost to Follow-up|7
4649493|NCT03616106|15948719|P2|Overall Study|Withdrawal by Subject|1
4649494|NCT03616106|15948720|P1|Overall Study|Withdrawal by Subject|1
4649495|NCT03616106|15948719|P2|Overall Study|Removed by PI|0
4649496|NCT03616106|15948720|P1|Overall Study|Removed by PI|6
4649497|NCT03615482|15948840|P2|Overall Study|Withdrawal by Subject|7
4649498|NCT03615482|15948841|P1|Overall Study|Withdrawal by Subject|7
4649499|NCT03615482|15948840|P2|Overall Study|Physician Decision|3
4649500|NCT03615482|15948841|P1|Overall Study|Physician Decision|2
4649501|NCT03615482|15948840|P2|Overall Study|Lost to Follow-up|7
4649502|NCT03615482|15948841|P1|Overall Study|Lost to Follow-up|7
4649503|NCT03615482|15948840|P2|Overall Study|Death|0
4649504|NCT03615482|15948841|P1|Overall Study|Death|1
4649505|NCT03614975|15948943|P2|Overall Study|Specimens not in lab batch shipment|1
4649506|NCT03614975|15948944|P1|Overall Study|Specimens not in lab batch shipment|1
4649507|NCT03614975|15948943|P2|Overall Study|Withdrawal by Subject|2
4649508|NCT03614975|15948944|P1|Overall Study|Withdrawal by Subject|2
4649509|NCT03614975|15948943|P2|Overall Study|Physician Decision|5
4649510|NCT03614975|15948944|P1|Overall Study|Physician Decision|7
4649511|NCT03614156|15948957|P4|Safety Follow-Up Period|Lost to Follow-up|1
4649512|NCT03614156|15948958|P3|Safety Follow-Up Period|Lost to Follow-up|0
4649513|NCT03614156|15948959|P2|Safety Follow-Up Period|Lost to Follow-up|0
4649514|NCT03614156|15948960|P1|Safety Follow-Up Period|Lost to Follow-up|1
4649515|NCT03614156|15948957|P4|Safety Follow-Up Period|Withdrawal by Subject|0
4649516|NCT03614156|15948958|P3|Safety Follow-Up Period|Withdrawal by Subject|1
4649517|NCT03614156|15948959|P2|Safety Follow-Up Period|Withdrawal by Subject|0
4649518|NCT03614156|15948960|P1|Safety Follow-Up Period|Withdrawal by Subject|0
4649519|NCT03614156|15948957|P4|Safety Follow-Up Period|Miscellaneous Reasons|0
4649520|NCT03614156|15948958|P3|Safety Follow-Up Period|Miscellaneous Reasons|0
4649521|NCT03614156|15948959|P2|Safety Follow-Up Period|Miscellaneous Reasons|0
4649522|NCT03614156|15948960|P1|Safety Follow-Up Period|Miscellaneous Reasons|2
4649523|NCT03614156|15948957|P4|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
4649524|NCT03614156|15948958|P3|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
4649525|NCT03614156|15948959|P2|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1
4649526|NCT03614156|15948960|P1|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0
4649527|NCT03614156|15948957|P4|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38
4649528|NCT03614156|15948958|P3|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26
4649529|NCT03614156|15948959|P2|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22
4649530|NCT03614156|15948960|P1|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0
4649531|NCT03614156|15948957|P4|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
4649532|NCT03614156|15948958|P3|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
4649533|NCT03614156|15948959|P2|Double-Blind Treatment Period (DBTP)|Protocol Violation|1
4649534|NCT03614156|15948960|P1|Double-Blind Treatment Period (DBTP)|Protocol Violation|0
4649535|NCT03614156|15948957|P4|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4
4649536|NCT03614156|15948958|P3|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3
4649537|NCT03614156|15948959|P2|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
4649538|NCT03614156|15948960|P1|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0
4649539|NCT03614156|15948957|P4|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
4649540|NCT03614156|15948958|P3|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1
4649541|NCT03614156|15948959|P2|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4
4649542|NCT03614156|15948960|P1|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0
4649543|NCT03614156|15948957|P4|Double-Blind Treatment Period (DBTP)|Adverse Event|1
4649544|NCT03614156|15948958|P3|Double-Blind Treatment Period (DBTP)|Adverse Event|0
4649545|NCT03614156|15948959|P2|Double-Blind Treatment Period (DBTP)|Adverse Event|2
4649546|NCT03614156|15948960|P1|Double-Blind Treatment Period (DBTP)|Adverse Event|0
4649547|NCT03614156|15948957|P4|Open-Label Treatment Period|Study terminated by sponsor|0
4649548|NCT03614156|15948958|P3|Open-Label Treatment Period|Study terminated by sponsor|0
4649549|NCT03614156|15948959|P2|Open-Label Treatment Period|Study terminated by sponsor|0
4649550|NCT03614156|15948960|P1|Open-Label Treatment Period|Study terminated by sponsor|74
4649551|NCT03614156|15948957|P4|Open-Label Treatment Period|Non-compliance with study drug|0
4649552|NCT03614156|15948958|P3|Open-Label Treatment Period|Non-compliance with study drug|0
4649553|NCT03614156|15948959|P2|Open-Label Treatment Period|Non-compliance with study drug|0
4649554|NCT03614156|15948960|P1|Open-Label Treatment Period|Non-compliance with study drug|1
4649555|NCT03614156|15948957|P4|Open-Label Treatment Period|Protocol Violation|0
4649556|NCT03614156|15948958|P3|Open-Label Treatment Period|Protocol Violation|0
4649557|NCT03614156|15948959|P2|Open-Label Treatment Period|Protocol Violation|0
4649558|NCT03614156|15948960|P1|Open-Label Treatment Period|Protocol Violation|2
4649559|NCT03614156|15948957|P4|Open-Label Treatment Period|Lost to Follow-up|0
4649560|NCT03614156|15948958|P3|Open-Label Treatment Period|Lost to Follow-up|0
4649561|NCT03614156|15948959|P2|Open-Label Treatment Period|Lost to Follow-up|0
4649562|NCT03614156|15948960|P1|Open-Label Treatment Period|Lost to Follow-up|10
4649563|NCT03614156|15948957|P4|Open-Label Treatment Period|Withdrawal by Subject|0
4649564|NCT03614156|15948958|P3|Open-Label Treatment Period|Withdrawal by Subject|0
4649565|NCT03614156|15948959|P2|Open-Label Treatment Period|Withdrawal by Subject|0
4649566|NCT03614156|15948960|P1|Open-Label Treatment Period|Withdrawal by Subject|36
4649567|NCT03614156|15948957|P4|Open-Label Treatment Period|Lack of Efficacy|0
4649568|NCT03614156|15948958|P3|Open-Label Treatment Period|Lack of Efficacy|0
4649569|NCT03614156|15948959|P2|Open-Label Treatment Period|Lack of Efficacy|0
4649570|NCT03614156|15948960|P1|Open-Label Treatment Period|Lack of Efficacy|18
4649571|NCT03614156|15948957|P4|Open-Label Treatment Period|Adverse Event|0
4649572|NCT03614156|15948958|P3|Open-Label Treatment Period|Adverse Event|0
4649573|NCT03614156|15948959|P2|Open-Label Treatment Period|Adverse Event|0
4649574|NCT03614156|15948960|P1|Open-Label Treatment Period|Adverse Event|7
4649575|NCT03614156|15948957|P4|Open-Label Treatment Period|Protocol-specified withdrawal met|0
4649576|NCT03614156|15948958|P3|Open-Label Treatment Period|Protocol-specified withdrawal met|0
4649577|NCT03614156|15948959|P2|Open-Label Treatment Period|Protocol-specified withdrawal met|0
4649578|NCT03614156|15948960|P1|Open-Label Treatment Period|Protocol-specified withdrawal met|6
4649579|NCT03614078|15948972|P3|Overall Study|Dizziness and Rash|0
4649580|NCT03614078|15948973|P2|Overall Study|Dizziness and Rash|1
4649581|NCT03614078|15948974|P1|Overall Study|Dizziness and Rash|0
4649582|NCT03614078|15948972|P3|Overall Study|Adverse Event|0
4649583|NCT03614078|15948973|P2|Overall Study|Adverse Event|2
4649584|NCT03614078|15948974|P1|Overall Study|Adverse Event|0
4649585|NCT03614078|15948972|P3|Overall Study|Exacerbation of Psoriasis|0
4649586|NCT03614078|15948973|P2|Overall Study|Exacerbation of Psoriasis|1
4649587|NCT03614078|15948974|P1|Overall Study|Exacerbation of Psoriasis|0
4649588|NCT03614078|15948972|P3|Overall Study|Patient Did Not Meet Eligibility|0
4649589|NCT03614078|15948973|P2|Overall Study|Patient Did Not Meet Eligibility|0
4649590|NCT03614078|15948974|P1|Overall Study|Patient Did Not Meet Eligibility|1
4649591|NCT03614078|15948972|P3|Overall Study|High Neutrophils|2
4649592|NCT03614078|15948973|P2|Overall Study|High Neutrophils|0
4649593|NCT03614078|15948974|P1|Overall Study|High Neutrophils|0
4649594|NCT03614078|15948972|P3|Overall Study|Participant Did Not Return for Visit|0
4649595|NCT03614078|15948973|P2|Overall Study|Participant Did Not Return for Visit|1
4649596|NCT03614078|15948974|P1|Overall Study|Participant Did Not Return for Visit|0
4649597|NCT03614078|15948972|P3|Overall Study|Withdrawal by Subject|3
4649598|NCT03614078|15948973|P2|Overall Study|Withdrawal by Subject|2
4649599|NCT03614078|15948974|P1|Overall Study|Withdrawal by Subject|2
4649600|NCT03613649|15949003|P12|Fourth Treatment|Physician Decision|0
4649601|NCT03613649|15949004|P11|Fourth Treatment|Physician Decision|0
4649602|NCT03613649|15949005|P10|Fourth Treatment|Physician Decision|0
4649603|NCT03613649|15949006|P9|Fourth Treatment|Physician Decision|0
4649604|NCT03613649|15949007|P8|Fourth Treatment|Physician Decision|0
4649605|NCT03613649|15949008|P7|Fourth Treatment|Physician Decision|1
4649606|NCT03613649|15949009|P6|Fourth Treatment|Physician Decision|0
4649607|NCT03613649|15949010|P5|Fourth Treatment|Physician Decision|0
4649608|NCT03613649|15949011|P4|Fourth Treatment|Physician Decision|0
4649609|NCT03613649|15949012|P3|Fourth Treatment|Physician Decision|0
4649610|NCT03613649|15949013|P2|Fourth Treatment|Physician Decision|0
4649611|NCT03613649|15949014|P1|Fourth Treatment|Physician Decision|0
4649612|NCT03613649|15949003|P12|Fourth Treatment|Protocol Violation|0
4649613|NCT03613649|15949004|P11|Fourth Treatment|Protocol Violation|0
4649614|NCT03613649|15949005|P10|Fourth Treatment|Protocol Violation|0
4649615|NCT03613649|15949006|P9|Fourth Treatment|Protocol Violation|0
4649616|NCT03613649|15949007|P8|Fourth Treatment|Protocol Violation|0
4649617|NCT03613649|15949008|P7|Fourth Treatment|Protocol Violation|0
4649618|NCT03613649|15949009|P6|Fourth Treatment|Protocol Violation|0
4649619|NCT03613649|15949010|P5|Fourth Treatment|Protocol Violation|1
4649620|NCT03613649|15949011|P4|Fourth Treatment|Protocol Violation|0
4649621|NCT03613649|15949012|P3|Fourth Treatment|Protocol Violation|0
4649622|NCT03613649|15949013|P2|Fourth Treatment|Protocol Violation|0
4649623|NCT03613649|15949014|P1|Fourth Treatment|Protocol Violation|1
4649624|NCT03613649|15949003|P12|Third Treatment|Protocol Violation|1
4649625|NCT03613649|15949004|P11|Third Treatment|Protocol Violation|0
4649626|NCT03613649|15949005|P10|Third Treatment|Protocol Violation|0
4649627|NCT03613649|15949006|P9|Third Treatment|Protocol Violation|0
4649628|NCT03613649|15949007|P8|Third Treatment|Protocol Violation|0
4649629|NCT03613649|15949008|P7|Third Treatment|Protocol Violation|1
4649630|NCT03613649|15949009|P6|Third Treatment|Protocol Violation|0
4649631|NCT03613649|15949010|P5|Third Treatment|Protocol Violation|0
4649632|NCT03613649|15949011|P4|Third Treatment|Protocol Violation|0
4649633|NCT03613649|15949012|P3|Third Treatment|Protocol Violation|0
4649634|NCT03613649|15949013|P2|Third Treatment|Protocol Violation|0
4649635|NCT03613649|15949014|P1|Third Treatment|Protocol Violation|0
4649636|NCT03613649|15949003|P12|Third Treatment|Lost to Follow-up|1
4649637|NCT03613649|15949004|P11|Third Treatment|Lost to Follow-up|0
4649638|NCT03613649|15949005|P10|Third Treatment|Lost to Follow-up|0
4649639|NCT03613649|15949006|P9|Third Treatment|Lost to Follow-up|0
4649640|NCT03613649|15949007|P8|Third Treatment|Lost to Follow-up|0
4649641|NCT03613649|15949008|P7|Third Treatment|Lost to Follow-up|0
4649642|NCT03613649|15949009|P6|Third Treatment|Lost to Follow-up|0
4649643|NCT03613649|15949010|P5|Third Treatment|Lost to Follow-up|1
4649644|NCT03613649|15949011|P4|Third Treatment|Lost to Follow-up|0
4649645|NCT03613649|15949012|P3|Third Treatment|Lost to Follow-up|0
4649646|NCT03613649|15949013|P2|Third Treatment|Lost to Follow-up|0
4649647|NCT03613649|15949014|P1|Third Treatment|Lost to Follow-up|0
4649648|NCT03613649|15949003|P12|Second Treatment|Withdrawal by Subject|0
4649649|NCT03613649|15949004|P11|Second Treatment|Withdrawal by Subject|0
4649650|NCT03613649|15949005|P10|Second Treatment|Withdrawal by Subject|0
4649651|NCT03613649|15949006|P9|Second Treatment|Withdrawal by Subject|0
4649652|NCT03613649|15949007|P8|Second Treatment|Withdrawal by Subject|0
4649653|NCT03613649|15949008|P7|Second Treatment|Withdrawal by Subject|0
4649654|NCT03613649|15949009|P6|Second Treatment|Withdrawal by Subject|0
4649655|NCT03613649|15949010|P5|Second Treatment|Withdrawal by Subject|1
4649656|NCT03613649|15949011|P4|Second Treatment|Withdrawal by Subject|0
4649657|NCT03613649|15949012|P3|Second Treatment|Withdrawal by Subject|0
4649658|NCT03613649|15949013|P2|Second Treatment|Withdrawal by Subject|0
4649659|NCT03613649|15949014|P1|Second Treatment|Withdrawal by Subject|0
4649660|NCT03613649|15949003|P12|Second Treatment|Lost to Follow-up|0
4649661|NCT03613649|15949004|P11|Second Treatment|Lost to Follow-up|0
4649662|NCT03613649|15949005|P10|Second Treatment|Lost to Follow-up|0
4649663|NCT03613649|15949006|P9|Second Treatment|Lost to Follow-up|0
4649664|NCT03613649|15949007|P8|Second Treatment|Lost to Follow-up|0
4649665|NCT03613649|15949008|P7|Second Treatment|Lost to Follow-up|0
4649666|NCT03613649|15949009|P6|Second Treatment|Lost to Follow-up|0
4649667|NCT03613649|15949010|P5|Second Treatment|Lost to Follow-up|0
4649668|NCT03613649|15949011|P4|Second Treatment|Lost to Follow-up|0
4649669|NCT03613649|15949012|P3|Second Treatment|Lost to Follow-up|1
4649670|NCT03613649|15949013|P2|Second Treatment|Lost to Follow-up|0
4649671|NCT03613649|15949014|P1|Second Treatment|Lost to Follow-up|0
4649672|NCT03613129|15949159|P5|Pre-treatment Assessment|Withdrawal by Subject|0
4649673|NCT03613129|15949160|P4|Pre-treatment Assessment|Withdrawal by Subject|0
4649674|NCT03613129|15949161|P3|Pre-treatment Assessment|Withdrawal by Subject|0
4649675|NCT03613129|15949162|P2|Pre-treatment Assessment|Withdrawal by Subject|0
4649676|NCT03613129|15949163|P1|Pre-treatment Assessment|Withdrawal by Subject|1
4649677|NCT03613129|15949159|P5|Pre-treatment Assessment|Protocol Violation|0
4649678|NCT03613129|15949160|P4|Pre-treatment Assessment|Protocol Violation|0
4649679|NCT03613129|15949161|P3|Pre-treatment Assessment|Protocol Violation|0
4649680|NCT03613129|15949162|P2|Pre-treatment Assessment|Protocol Violation|0
4649681|NCT03613129|15949163|P1|Pre-treatment Assessment|Protocol Violation|2
4649682|NCT03612856|15949188|P3|Pre-dose Period|Withdrawal by Subject|0
4649683|NCT03612856|15949189|P2|Pre-dose Period|Withdrawal by Subject|1
4649684|NCT03612856|15949190|P1|Pre-dose Period|Withdrawal by Subject|0
4649685|NCT03612856|15949188|P3|Pre-dose Period|Physician Decision|1
4649686|NCT03612856|15949189|P2|Pre-dose Period|Physician Decision|1
4649687|NCT03612856|15949190|P1|Pre-dose Period|Physician Decision|0
4649688|NCT03610269|15949390|P1|Overall Study|Screen fail|4
4649689|NCT03610269|15949390|P1|Overall Study|Unable to draw blood|1
4649690|NCT03610269|15949390|P1|Overall Study|Protocol Violation|1
4649691|NCT03610269|15949390|P1|Overall Study|Physician Decision|10
4649692|NCT03609619|15949396|P2|Overall Study|Lost to Follow-up|1
4649693|NCT03609619|15949397|P1|Overall Study|Lost to Follow-up|1
4649694|NCT03609619|15949396|P2|Overall Study|Withdrawal by Subject|3
4649695|NCT03609619|15949397|P1|Overall Study|Withdrawal by Subject|2
4649696|NCT03609619|15949396|P2|Overall Study|Protocol Violation|0
4649697|NCT03609619|15949397|P1|Overall Study|Protocol Violation|5
4649698|NCT03609619|15949396|P2|Overall Study|Lack of Efficacy|2
4649699|NCT03609619|15949397|P1|Overall Study|Lack of Efficacy|1
4649700|NCT03609619|15949396|P2|Overall Study|Adverse Event|0
4649701|NCT03609619|15949397|P1|Overall Study|Adverse Event|1
4649702|NCT03607682|15949478|P1|Overall Study|Disease progression|1
4649703|NCT03607682|15949478|P1|Overall Study|Withdrawal by Subject|1
4649704|NCT03607487|15949494|P4|Overall Study|Withdrawal by Subject|1
4649705|NCT03607487|15949495|P3|Overall Study|Withdrawal by Subject|0
4649706|NCT03607487|15949496|P2|Overall Study|Withdrawal by Subject|0
4649707|NCT03607487|15949497|P1|Overall Study|Withdrawal by Subject|2
4649708|NCT03606460|15949548|P2|Overall Study|Lost to Follow-up|8
4649709|NCT03606460|15949549|P1|Overall Study|Lost to Follow-up|1
4649710|NCT03605693|15949559|P2|Overall Study|Physician Decision|0
4649711|NCT03605693|15949560|P1|Overall Study|Physician Decision|1
4649712|NCT03605693|15949559|P2|Overall Study|Lost to Follow-up|0
4649713|NCT03605693|15949560|P1|Overall Study|Lost to Follow-up|4
4649714|NCT03605303|15949574|P2|Period 1|Study Terminated|1
4649715|NCT03605303|15949575|P1|Period 1|Study Terminated|2
4649716|NCT03604341|15949585|P2|Overall Study|Protocol Violation|1
4649717|NCT03604341|15949586|P1|Overall Study|Protocol Violation|0
4649718|NCT03604341|15949585|P2|Overall Study|Adverse Event|0
4649719|NCT03604341|15949586|P1|Overall Study|Adverse Event|1
4649720|NCT03604341|15949585|P2|Overall Study|Withdrawal by Subject|1
4649721|NCT03604341|15949586|P1|Overall Study|Withdrawal by Subject|1
4649722|NCT03603028|15949670|P1|Overall Study|Withdrawal by Subject|1
4649723|NCT03601715|15949678|P3|Second Intervention|Lost to Follow-up|0
4649724|NCT03601715|15949679|P2|Second Intervention|Lost to Follow-up|1
4649725|NCT03601715|15949680|P1|Second Intervention|Lost to Follow-up|1
4649726|NCT03599349|15949713|P1|Overall Study|Lost to Follow-up|1
4649727|NCT03599193|15949727|P2|Overall Study|Lost to Follow-up|1
4649728|NCT03599193|15949728|P1|Overall Study|Lost to Follow-up|0
4649729|NCT03599193|15949727|P2|Overall Study|Protocol Violation|0
4649730|NCT03599193|15949728|P1|Overall Study|Protocol Violation|1
4649731|NCT03599193|15949727|P2|Overall Study|Withdrawal by Subject|0
4649732|NCT03599193|15949728|P1|Overall Study|Withdrawal by Subject|1
4649733|NCT03599193|15949727|P2|Overall Study|Adverse Event|2
4649734|NCT03599193|15949728|P1|Overall Study|Adverse Event|0
4649735|NCT03594227|15949763|P4|Overall Study|Programmatic Analysis Non-completer|1
4649736|NCT03594227|15949764|P3|Overall Study|Programmatic Analysis Non-completer|1
4649737|NCT03594227|15949765|P2|Overall Study|Programmatic Analysis Non-completer|0
4649738|NCT03594227|15949766|P1|Overall Study|Programmatic Analysis Non-completer|1
4649739|NCT03594227|15949763|P4|Overall Study|Sponsor Decision|1
4649740|NCT03594227|15949764|P3|Overall Study|Sponsor Decision|0
4649741|NCT03594227|15949765|P2|Overall Study|Sponsor Decision|0
4649742|NCT03594227|15949766|P1|Overall Study|Sponsor Decision|0
4649743|NCT03594227|15949763|P4|Overall Study|Pregnancy|0
4649744|NCT03594227|15949764|P3|Overall Study|Pregnancy|0
4649745|NCT03594227|15949765|P2|Overall Study|Pregnancy|1
4649746|NCT03594227|15949766|P1|Overall Study|Pregnancy|0
4649747|NCT03594227|15949763|P4|Overall Study|Withdrawal by Subject|1
4649748|NCT03594227|15949764|P3|Overall Study|Withdrawal by Subject|1
4649749|NCT03594227|15949765|P2|Overall Study|Withdrawal by Subject|1
4649750|NCT03594227|15949766|P1|Overall Study|Withdrawal by Subject|1
4649751|NCT03594227|15949763|P4|Overall Study|Lost to Follow-up|0
4649752|NCT03594227|15949764|P3|Overall Study|Lost to Follow-up|1
4649753|NCT03594227|15949765|P2|Overall Study|Lost to Follow-up|1
4649754|NCT03594227|15949766|P1|Overall Study|Lost to Follow-up|1
4649755|NCT03594227|15949763|P4|Overall Study|Adverse Event|2
4649756|NCT03594227|15949764|P3|Overall Study|Adverse Event|0
4649757|NCT03594227|15949765|P2|Overall Study|Adverse Event|1
4649758|NCT03594227|15949766|P1|Overall Study|Adverse Event|2
4649759|NCT03591406|15949947|P2|Overall Study|Withdrawal by Subject|5
4649760|NCT03591406|15949948|P1|Overall Study|Withdrawal by Subject|0
4649761|NCT03591406|15949947|P2|Overall Study|Protocol Violation|1
4649762|NCT03591406|15949948|P1|Overall Study|Protocol Violation|2
4649763|NCT03591406|15949947|P2|Overall Study|Adverse Event|3
4649764|NCT03591406|15949948|P1|Overall Study|Adverse Event|5
4649765|NCT03590743|15949994|P2|Overall Study|Withdrawal by Subject|1
4649766|NCT03590743|15949995|P1|Overall Study|Withdrawal by Subject|0
4649767|NCT03590613|15950007|P4|Period 2, 4 Days|Physician Decision|1
4649768|NCT03590613|15950008|P3|Period 2, 4 Days|Physician Decision|0
4649769|NCT03590613|15950009|P2|Period 2, 4 Days|Physician Decision|0
4649770|NCT03590613|15950010|P1|Period 2, 4 Days|Physician Decision|0
4649771|NCT03588741|15950139|P1|Overall Study|Withdrawal by Subject|1
4649772|NCT03588572|15950146|P2|Visitation 3|Withdrawal by Subject|0
4649773|NCT03588572|15950147|P1|Visitation 3|Withdrawal by Subject|1
4649774|NCT03588572|15950146|P2|Visitation 3|Physician Decision|1
4649775|NCT03588572|15950147|P1|Visitation 3|Physician Decision|1
4649776|NCT03588572|15950146|P2|Visitation 3|Lost to Follow-up|1
4649777|NCT03588572|15950147|P1|Visitation 3|Lost to Follow-up|1
4649778|NCT03588572|15950146|P2|Visitation 2|Withdrawal by Subject|0
4649779|NCT03588572|15950147|P1|Visitation 2|Withdrawal by Subject|1
4649780|NCT03588572|15950146|P2|Visitation 2|Lack of Efficacy|1
4649781|NCT03588572|15950147|P1|Visitation 2|Lack of Efficacy|0
4649782|NCT03588572|15950146|P2|Visitation 2|Lost to Follow-up|1
4649783|NCT03588572|15950147|P1|Visitation 2|Lost to Follow-up|1
4649784|NCT03588572|15950146|P2|Visitation 1|Lack of Efficacy|1
4649785|NCT03588572|15950147|P1|Visitation 1|Lack of Efficacy|1
4649786|NCT03587974|15950165|P2|Overall Study|Withdrawal by Subject|1
4649787|NCT03587974|15950166|P1|Overall Study|Withdrawal by Subject|2
4649788|NCT03587974|15950165|P2|Overall Study|caregiver demented, care recipient died|3
4649789|NCT03587974|15950166|P1|Overall Study|caregiver demented, care recipient died|3
4649790|NCT03586830|15950282|P4|Overall Study|Withdrawal by Subject|1
4649791|NCT03586830|15950283|P3|Overall Study|Withdrawal by Subject|3
4649792|NCT03586830|15950284|P2|Overall Study|Withdrawal by Subject|0
4649793|NCT03586830|15950285|P1|Overall Study|Withdrawal by Subject|1
4649794|NCT03586830|15950282|P4|Overall Study|Lost to Follow-up|1
4649795|NCT03586830|15950283|P3|Overall Study|Lost to Follow-up|2
4649796|NCT03586830|15950284|P2|Overall Study|Lost to Follow-up|2
4649797|NCT03586830|15950285|P1|Overall Study|Lost to Follow-up|0
4649798|NCT03586830|15950282|P4|Overall Study|Site terminated by Sponsor|3
4649799|NCT03586830|15950283|P3|Overall Study|Site terminated by Sponsor|3
4649800|NCT03586830|15950284|P2|Overall Study|Site terminated by Sponsor|4
4649801|NCT03586830|15950285|P1|Overall Study|Site terminated by Sponsor|1
4649802|NCT03586726|15950307|P1|Overall Study|Withdrawal by Subject|1
4649803|NCT03586648|15950324|P2|Period 2|Adverse Event|0
4649804|NCT03586648|15950325|P1|Period 2|Adverse Event|1
4649805|NCT03586648|15950324|P2|Period 1|Physician Decision|1
4649806|NCT03586648|15950325|P1|Period 1|Physician Decision|0
4649807|NCT03586648|15950324|P2|Period 1|Study related symptoms or complaints|1
4649808|NCT03586648|15950325|P1|Period 1|Study related symptoms or complaints|2
4649809|NCT03586648|15950324|P2|Period 1|Adverse Event|0
4649810|NCT03586648|15950325|P1|Period 1|Adverse Event|1
4649811|NCT03586648|15950324|P2|Period 1|Lost to Follow-up|1
4649812|NCT03586648|15950325|P1|Period 1|Lost to Follow-up|1
4649813|NCT03586648|15950324|P2|Period 1|Withdrawal by Subject|1
4649814|NCT03586648|15950325|P1|Period 1|Withdrawal by Subject|0
4649815|NCT03585959|15950338|P1|Overall Study|Unsuccessful Procedure|2
4649816|NCT03585959|15950338|P1|Overall Study|Physician Decision|1
4649817|NCT03585504|15950379|P2|Overall Study|Lost to Follow-up|29
4649818|NCT03585504|15950380|P1|Overall Study|Lost to Follow-up|26
4649819|NCT03585296|15950390|P1|Overall Study|Withdrawal by Subject|2
4649820|NCT03585296|15950390|P1|Overall Study|Lost to Follow-up|2
4649821|NCT03585296|15950390|P1|Overall Study|Adverse Event|1
4649822|NCT03583450|15950396|P2|Overall Study|hardware malfunction (battery depletion)|0
4649823|NCT03583450|15950397|P1|Overall Study|hardware malfunction (battery depletion)|1
4649824|NCT03583385|15950419|P2|Treatment Period 2|Adverse Event|0
4649825|NCT03583385|15950420|P1|Treatment Period 2|Adverse Event|1
4649826|NCT03583385|15950419|P2|Treatment Period 1|Withdrawal by Subject|1
4649827|NCT03583385|15950420|P1|Treatment Period 1|Withdrawal by Subject|1
4649828|NCT03582943|15950438|P2|Analyzed|Protocol Violation|1
4649829|NCT03582943|15950439|P1|Analyzed|Protocol Violation|4
4649830|NCT03582943|15950438|P2|Intervention and Follow up|Withdrawal by Subject|2
4649831|NCT03582943|15950439|P1|Intervention and Follow up|Withdrawal by Subject|4
4649832|NCT03582943|15950438|P2|Allocated to Groups|Withdrawal by Subject|1
4649833|NCT03582943|15950439|P1|Allocated to Groups|Withdrawal by Subject|1
4649834|NCT03582813|15950447|P2|Overall Study|Withdrawal by Subject|0
4649835|NCT03582813|15950448|P1|Overall Study|Withdrawal by Subject|1
4649836|NCT03582813|15950447|P2|Overall Study|Lost to Follow-up|21
4649837|NCT03582813|15950448|P1|Overall Study|Lost to Follow-up|18
4649838|NCT03582215|15950515|P8|Overall Study|Adverse Event|2
4649839|NCT03582215|15950516|P7|Overall Study|Adverse Event|2
4649840|NCT03582215|15950517|P6|Overall Study|Adverse Event|0
4649841|NCT03582215|15950518|P5|Overall Study|Adverse Event|0
4649842|NCT03582215|15950519|P4|Overall Study|Adverse Event|0
4649843|NCT03582215|15950520|P3|Overall Study|Adverse Event|0
4649844|NCT03582215|15950521|P2|Overall Study|Adverse Event|0
4649845|NCT03582215|15950522|P1|Overall Study|Adverse Event|1
4649846|NCT03581825|15950563|P2|Period 2|Unsatisfactory Vision to Test|1
4649847|NCT03581825|15950564|P1|Period 2|Unsatisfactory Vision to Test|0
4649848|NCT03581825|15950563|P2|Period 1|Lens Discomfort|0
4649849|NCT03581825|15950564|P1|Period 1|Lens Discomfort|1
4649850|NCT03580382|15950600|P2|Overall Study|Early Termination of Study|3
4649851|NCT03580382|15950601|P1|Overall Study|Early Termination of Study|0
4649852|NCT03579940|15950619|P11|Period 2|Withdrawal by Subject|0
4649853|NCT03579940|15950620|P10|Period 2|Withdrawal by Subject|0
4649854|NCT03579940|15950621|P9|Period 2|Withdrawal by Subject|0
4649855|NCT03579940|15950622|P8|Period 2|Withdrawal by Subject|0
4649856|NCT03579940|15950623|P7|Period 2|Withdrawal by Subject|0
4649857|NCT03579940|15950624|P6|Period 2|Withdrawal by Subject|0
4649858|NCT03579940|15950625|P5|Period 2|Withdrawal by Subject|0
4649859|NCT03579940|15950626|P4|Period 2|Withdrawal by Subject|0
4649860|NCT03579940|15950627|P3|Period 2|Withdrawal by Subject|1
4649861|NCT03579940|15950628|P2|Period 2|Withdrawal by Subject|0
4649862|NCT03579940|15950629|P1|Period 2|Withdrawal by Subject|0
4649863|NCT03579719|15950669|P1|Overall Study|Protocol deviation, pre-existent disease|1
4649864|NCT03578146|15950726|P6|Overall Study|Lost to Follow-up|1
4649865|NCT03578146|15950727|P5|Overall Study|Lost to Follow-up|0
4649866|NCT03578146|15950728|P4|Overall Study|Lost to Follow-up|0
4649867|NCT03578146|15950729|P3|Overall Study|Lost to Follow-up|1
4649868|NCT03578146|15950730|P2|Overall Study|Lost to Follow-up|1
4649869|NCT03578146|15950731|P1|Overall Study|Lost to Follow-up|0
4649870|NCT03578146|15950726|P6|Overall Study|Did Not Receive Treatment|2
4649871|NCT03578146|15950727|P5|Overall Study|Did Not Receive Treatment|0
4649872|NCT03578146|15950728|P4|Overall Study|Did Not Receive Treatment|0
4649873|NCT03578146|15950729|P3|Overall Study|Did Not Receive Treatment|0
4649874|NCT03578146|15950730|P2|Overall Study|Did Not Receive Treatment|0
4649875|NCT03578146|15950731|P1|Overall Study|Did Not Receive Treatment|1
4649876|NCT03575871|15950872|P3|Overall Study|Other than specified|0
4649877|NCT03575871|15950873|P2|Overall Study|Other than specified|2
4649878|NCT03575871|15950874|P1|Overall Study|Other than specified|2
4649879|NCT03575871|15950872|P3|Overall Study|Withdrawal by Subject|9
4649880|NCT03575871|15950873|P2|Overall Study|Withdrawal by Subject|1
4649881|NCT03575871|15950874|P1|Overall Study|Withdrawal by Subject|6
4649882|NCT03575871|15950872|P3|Overall Study|Protocol Deviation|1
4649883|NCT03575871|15950873|P2|Overall Study|Protocol Deviation|1
4649884|NCT03575871|15950874|P1|Overall Study|Protocol Deviation|1
4649885|NCT03575871|15950872|P3|Overall Study|Lost to Follow-up|1
4649886|NCT03575871|15950873|P2|Overall Study|Lost to Follow-up|1
4649887|NCT03575871|15950874|P1|Overall Study|Lost to Follow-up|1
4649888|NCT03575871|15950872|P3|Overall Study|Lack of Efficacy|7
4649889|NCT03575871|15950873|P2|Overall Study|Lack of Efficacy|4
4649890|NCT03575871|15950874|P1|Overall Study|Lack of Efficacy|5
4649891|NCT03575871|15950872|P3|Overall Study|Death|0
4649892|NCT03575871|15950873|P2|Overall Study|Death|0
4649893|NCT03575871|15950874|P1|Overall Study|Death|1
4649894|NCT03575871|15950872|P3|Overall Study|Adverse Event|8
4649895|NCT03575871|15950873|P2|Overall Study|Adverse Event|5
4649896|NCT03575871|15950874|P1|Overall Study|Adverse Event|5
4649897|NCT03575806|15950938|P2|Overall Study|Protocol Violation|2
4649898|NCT03575806|15950939|P1|Overall Study|Protocol Violation|0
4649899|NCT03575806|15950938|P2|Overall Study|Withdrawal by Subject|2
4649900|NCT03575806|15950939|P1|Overall Study|Withdrawal by Subject|0
4649901|NCT03575702|15950949|P2|Overall Study|Patient non compliance|0
4649902|NCT03575702|15950950|P1|Overall Study|Patient non compliance|4
4649903|NCT03575702|15950949|P2|Overall Study|Protocol Violation|1
4649904|NCT03575702|15950950|P1|Overall Study|Protocol Violation|0
4649905|NCT03575702|15950949|P2|Overall Study|Lost to Follow-up|2
4649906|NCT03575702|15950950|P1|Overall Study|Lost to Follow-up|1
4649907|NCT03575702|15950949|P2|Overall Study|Withdrawal by Subject|1
4649908|NCT03575702|15950950|P1|Overall Study|Withdrawal by Subject|1
4649909|NCT03573817|15951006|P2|Overall Study|Withdrawal by Subject|1
4649910|NCT03573817|15951007|P1|Overall Study|Withdrawal by Subject|1
4649911|NCT03573817|15951006|P2|Overall Study|Protocol Violation|1
4649912|NCT03573817|15951007|P1|Overall Study|Protocol Violation|0
4649913|NCT03573817|15951006|P2|Overall Study|Adverse Event|2
4649914|NCT03573817|15951007|P1|Overall Study|Adverse Event|0
4649915|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1
4649916|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0
4649917|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1
4649918|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0
4649919|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11
4649920|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8
4649921|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8
4649922|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14
4649923|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2
4649924|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3
4649925|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3
4649926|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4
4649927|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19
4649928|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8
4649929|NCT03573323|15951035|P2|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12
4649930|NCT03573323|15951036|P1|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22
4649931|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2
4649932|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1
4649933|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1
4649934|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0
4649935|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1
4649936|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0
4649937|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13
4649938|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14
4649939|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0
4649940|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1
4649941|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2
4649942|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1
4649943|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3
4649944|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2
4649945|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9
4649946|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17
4649947|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8
4649948|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3
4649949|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8
4649950|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15
4649951|NCT03573323|15951035|P2|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
4649952|NCT03573323|15951036|P1|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1
4649953|NCT03572218|15951184|P2|Overall Study|No longer interested|2
4649954|NCT03572218|15951185|P1|Overall Study|No longer interested|1
4649955|NCT03572218|15951184|P2|Overall Study|No longer available for study visits|1
4649956|NCT03572218|15951185|P1|Overall Study|No longer available for study visits|2
4649957|NCT03572218|15951184|P2|Overall Study|Lost to Follow-up|2
4649958|NCT03572218|15951185|P1|Overall Study|Lost to Follow-up|3
4649959|NCT03571256|15951435|P3|Overall Study|Protocol Violation|1
4649960|NCT03571256|15951436|P2|Overall Study|Protocol Violation|1
4649961|NCT03571256|15951437|P1|Overall Study|Protocol Violation|0
4649962|NCT03571256|15951435|P3|Overall Study|Other than specified|1
4649963|NCT03571256|15951436|P2|Overall Study|Other than specified|1
4649964|NCT03571256|15951437|P1|Overall Study|Other than specified|0
4649965|NCT03571256|15951435|P3|Overall Study|Withdrawal by Subject|1
4649966|NCT03571256|15951436|P2|Overall Study|Withdrawal by Subject|1
4649967|NCT03571256|15951437|P1|Overall Study|Withdrawal by Subject|3
4649968|NCT03571256|15951435|P3|Overall Study|Adverse Event|1
4649969|NCT03571256|15951436|P2|Overall Study|Adverse Event|0
4649970|NCT03571256|15951437|P1|Overall Study|Adverse Event|3
4649971|NCT03570554|15951525|P4|Overall Study|Adverse Event|1
4649972|NCT03570554|15951526|P3|Overall Study|Adverse Event|0
4649973|NCT03570554|15951527|P2|Overall Study|Adverse Event|0
4649974|NCT03570554|15951528|P1|Overall Study|Adverse Event|0
4649975|NCT03570554|15951525|P4|Overall Study|Non-compliance with study drug|0
4649976|NCT03570554|15951526|P3|Overall Study|Non-compliance with study drug|1
4649977|NCT03570554|15951527|P2|Overall Study|Non-compliance with study drug|0
4649978|NCT03570554|15951528|P1|Overall Study|Non-compliance with study drug|0
4649979|NCT03569371|15951642|P1|Overall Study|Adverse Event|1
4649980|NCT03569371|15951642|P1|Overall Study|Lost to Follow-up|1
4649981|NCT03569371|15951642|P1|Overall Study|Lack of Efficacy|1
4649982|NCT03569202|15951663|P2|Part 3|Other|1
4649983|NCT03569202|15951664|P1|Part 3|Other|1
4649984|NCT03569202|15951663|P2|Part 3|Physician Decision|0
4649985|NCT03569202|15951664|P1|Part 3|Physician Decision|1
4649986|NCT03568942|15951713|P1|Overall Study|Lost to Follow-up|1
4649987|NCT03568942|15951713|P1|Overall Study|Family emergency|1
4649988|NCT03568500|15951751|P3|Overall Study|Participant Noncompliance|0
4649989|NCT03568500|15951752|P2|Overall Study|Participant Noncompliance|1
4649990|NCT03568500|15951753|P1|Overall Study|Participant Noncompliance|1
4649991|NCT03568500|15951751|P3|Overall Study|Technical Problems|0
4649992|NCT03568500|15951752|P2|Overall Study|Technical Problems|1
4649993|NCT03568500|15951753|P1|Overall Study|Technical Problems|2
4649994|NCT03568500|15951751|P3|Overall Study|Withdrawal by Subject|0
4649995|NCT03568500|15951752|P2|Overall Study|Withdrawal by Subject|2
4649996|NCT03568500|15951753|P1|Overall Study|Withdrawal by Subject|4
4649997|NCT03568500|15951751|P3|Overall Study|Physician Decision|0
4649998|NCT03568500|15951752|P2|Overall Study|Physician Decision|0
4649999|NCT03568500|15951753|P1|Overall Study|Physician Decision|1
4650000|NCT03568500|15951751|P3|Overall Study|Adverse Event|2
4650001|NCT03568500|15951752|P2|Overall Study|Adverse Event|1
4650002|NCT03568500|15951753|P1|Overall Study|Adverse Event|1
4650003|NCT03568500|15951751|P3|Overall Study|Lost to Follow-up|2
4650004|NCT03568500|15951752|P2|Overall Study|Lost to Follow-up|1
4650005|NCT03568500|15951753|P1|Overall Study|Lost to Follow-up|1
4650006|NCT03566979|15951780|P4|Overall Study|Adverse Event|0
4650007|NCT03566979|15951781|P3|Overall Study|Adverse Event|0
4650008|NCT03566979|15951782|P2|Overall Study|Adverse Event|0
4650009|NCT03566979|15951783|P1|Overall Study|Adverse Event|1
4650010|NCT03566979|15951780|P4|Overall Study|Lost to Follow-up|5
4650011|NCT03566979|15951781|P3|Overall Study|Lost to Follow-up|9
4650012|NCT03566979|15951782|P2|Overall Study|Lost to Follow-up|7
4650013|NCT03566979|15951783|P1|Overall Study|Lost to Follow-up|2
4650014|NCT03566979|15951780|P4|Overall Study|Withdrawal by Subject|1
4650015|NCT03566979|15951781|P3|Overall Study|Withdrawal by Subject|1
4650016|NCT03566979|15951782|P2|Overall Study|Withdrawal by Subject|0
4650017|NCT03566979|15951783|P1|Overall Study|Withdrawal by Subject|2
4650018|NCT03566810|15951799|P4|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
4650019|NCT03566810|15951800|P3|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
4650020|NCT03566810|15951801|P2|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1
4650021|NCT03566810|15951802|P1|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0
4650022|NCT03566680|15951864|P1|Overall Study|Withdrawal by Subject|3
4650023|NCT03566680|15951864|P1|Overall Study|Lost to Follow-up|13
4650024|NCT03566680|15951864|P1|Overall Study|Pregnancy|1
4650025|NCT03565887|15951875|P2|Overall Study|Withdrawal by Subject|2
4650026|NCT03565887|15951876|P1|Overall Study|Withdrawal by Subject|0
4650027|NCT03565887|15951875|P2|Overall Study|Adverse Event|0
4650028|NCT03565887|15951876|P1|Overall Study|Adverse Event|1
4650029|NCT03563716|15952002|P2|Overall Study|Still on Study|50
4650030|NCT03563716|15952003|P1|Overall Study|Still on Study|45
4650031|NCT03563716|15952002|P2|Overall Study|Withdrawal by Subject|3
4650032|NCT03563716|15952003|P1|Overall Study|Withdrawal by Subject|3
4650033|NCT03563716|15952002|P2|Overall Study|Death|14
4650034|NCT03563716|15952003|P1|Overall Study|Death|20
4650035|NCT03562481|15952235|P2|First Intervention|Lost to Follow-up|0
4650036|NCT03562481|15952236|P1|First Intervention|Lost to Follow-up|1
4650037|NCT03562117|15952261|P3|Part 1, Up to 3 Days|Adverse Event|0
4650038|NCT03562117|15952262|P2|Part 1, Up to 3 Days|Adverse Event|0
4650039|NCT03562117|15952263|P1|Part 1, Up to 3 Days|Adverse Event|1
4650040|NCT03560986|15952351|P2|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
4650041|NCT03560986|15952352|P1|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7
4650042|NCT03560986|15952351|P2|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1
4650043|NCT03560986|15952352|P1|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0
4650044|NCT03560986|15952351|P2|Treatment Period B/Follow-up Period 2|Adverse Event|0
4650045|NCT03560986|15952352|P1|Treatment Period B/Follow-up Period 2|Adverse Event|1
4650046|NCT03560986|15952351|P2|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35
4650047|NCT03560986|15952352|P1|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32
4650048|NCT03560986|15952351|P2|Treatment Period A/Follow-up Period 1|Protocol Violation|1
4650049|NCT03560986|15952352|P1|Treatment Period A/Follow-up Period 1|Protocol Violation|0
4650050|NCT03560986|15952351|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
4650051|NCT03560986|15952352|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
4650052|NCT03560986|15952351|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
4650053|NCT03560986|15952352|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
4650054|NCT03560739|15952378|P4|Overall Study|Adverse Event|0
4650055|NCT03560739|15952379|P3|Overall Study|Adverse Event|0
4650056|NCT03560739|15952380|P2|Overall Study|Adverse Event|1
4650057|NCT03560739|15952381|P1|Overall Study|Adverse Event|0
4650058|NCT03560518|15952410|P3|Double Blind Treatment Period|Adverse Event|1
4650059|NCT03560518|15952411|P2|Double Blind Treatment Period|Adverse Event|3
4650060|NCT03560518|15952412|P1|Double Blind Treatment Period|Adverse Event|0
4650061|NCT03560518|15952410|P3|Double Blind Treatment Period|Lack of Efficacy|1
4650062|NCT03560518|15952411|P2|Double Blind Treatment Period|Lack of Efficacy|1
4650063|NCT03560518|15952412|P1|Double Blind Treatment Period|Lack of Efficacy|2
4650064|NCT03560518|15952410|P3|Double Blind Treatment Period|Withdrawal by Subject|5
4650065|NCT03560518|15952411|P2|Double Blind Treatment Period|Withdrawal by Subject|6
4650066|NCT03560518|15952412|P1|Double Blind Treatment Period|Withdrawal by Subject|10
4650067|NCT03560518|15952410|P3|Double Blind Treatment Period|Lost to Follow-up|6
4650068|NCT03560518|15952411|P2|Double Blind Treatment Period|Lost to Follow-up|6
4650069|NCT03560518|15952412|P1|Double Blind Treatment Period|Lost to Follow-up|5
4650070|NCT03560518|15952410|P3|Double Blind Treatment Period|Pregnancy|0
4650071|NCT03560518|15952411|P2|Double Blind Treatment Period|Pregnancy|2
4650072|NCT03560518|15952412|P1|Double Blind Treatment Period|Pregnancy|0
4650073|NCT03560518|15952410|P3|Double Blind Treatment Period|Protocol Violation|0
4650074|NCT03560518|15952411|P2|Double Blind Treatment Period|Protocol Violation|2
4650075|NCT03560518|15952412|P1|Double Blind Treatment Period|Protocol Violation|1
4650076|NCT03560518|15952410|P3|Double Blind Treatment Period|Study Terminated by the Sponsor|10
4650077|NCT03560518|15952411|P2|Double Blind Treatment Period|Study Terminated by the Sponsor|9
4650078|NCT03560518|15952412|P1|Double Blind Treatment Period|Study Terminated by the Sponsor|6
4650079|NCT03560518|15952410|P3|Double Blind Treatment Period|Miscellaneous Reasons|0
4650080|NCT03560518|15952411|P2|Double Blind Treatment Period|Miscellaneous Reasons|0
4650081|NCT03560518|15952412|P1|Double Blind Treatment Period|Miscellaneous Reasons|1
4650082|NCT03560245|15952425|P2|Overall Study|Other|1
4650083|NCT03560245|15952426|P1|Overall Study|Other|0
4650084|NCT03560245|15952425|P2|Overall Study|Physician Decision|1
4650085|NCT03560245|15952426|P1|Overall Study|Physician Decision|0
4650086|NCT03560245|15952425|P2|Overall Study|Lost to Follow-up|1
4650087|NCT03560245|15952426|P1|Overall Study|Lost to Follow-up|0
4650088|NCT03560245|15952425|P2|Overall Study|Death|1
4650089|NCT03560245|15952426|P1|Overall Study|Death|0
4650090|NCT03560245|15952425|P2|Overall Study|Protocol Violation|0
4650091|NCT03560245|15952426|P1|Overall Study|Protocol Violation|1
4650092|NCT03560245|15952425|P2|Overall Study|Adverse Event|1
4650093|NCT03560245|15952426|P1|Overall Study|Adverse Event|1
4650094|NCT03560245|15952425|P2|Overall Study|Withdrawal by Subject|2
4650095|NCT03560245|15952426|P1|Overall Study|Withdrawal by Subject|3
4650096|NCT03559257|15952480|P2|Open-label Treatment Period|Physician Decision|1
4650097|NCT03559257|15952481|P1|Open-label Treatment Period|Physician Decision|0
4650098|NCT03559257|15952480|P2|Open-label Treatment Period|Lost to Follow-up|0
4650099|NCT03559257|15952481|P1|Open-label Treatment Period|Lost to Follow-up|1
4650100|NCT03559257|15952480|P2|Open-label Treatment Period|Protocol Violation|0
4650101|NCT03559257|15952481|P1|Open-label Treatment Period|Protocol Violation|2
4650102|NCT03559257|15952480|P2|Open-label Treatment Period|Withdrawal by Subject|0
4650103|NCT03559257|15952481|P1|Open-label Treatment Period|Withdrawal by Subject|3
4650104|NCT03559257|15952480|P2|Open-label Treatment Period|Lack of Efficacy|2
4650105|NCT03559257|15952481|P1|Open-label Treatment Period|Lack of Efficacy|3
4650106|NCT03559257|15952480|P2|Open-label Treatment Period|Adverse Event|4
4650107|NCT03559257|15952481|P1|Open-label Treatment Period|Adverse Event|1
4650108|NCT03559257|15952480|P2|Double Blind Treatment Period|Screen Failure|1
4650109|NCT03559257|15952481|P1|Double Blind Treatment Period|Screen Failure|0
4650110|NCT03559257|15952480|P2|Double Blind Treatment Period|Adverse Event|1
4650111|NCT03559257|15952481|P1|Double Blind Treatment Period|Adverse Event|0
4650112|NCT03559257|15952480|P2|Double Blind Treatment Period|Lack of Efficacy|1
4650113|NCT03559257|15952481|P1|Double Blind Treatment Period|Lack of Efficacy|1
4650114|NCT03559257|15952480|P2|Double Blind Treatment Period|Protocol Violation|4
4650115|NCT03559257|15952481|P1|Double Blind Treatment Period|Protocol Violation|1
4650116|NCT03559257|15952480|P2|Double Blind Treatment Period|Withdrawal by Subject|1
4650117|NCT03559257|15952481|P1|Double Blind Treatment Period|Withdrawal by Subject|2
4650118|NCT03559062|15952551|P3|Overall Study|Other|0
4650119|NCT03559062|15952552|P2|Overall Study|Other|1
4650120|NCT03559062|15952553|P1|Overall Study|Other|0
4650121|NCT03558997|15952568|P4|Overall Study|Lost to Follow-up|0
4650122|NCT03558997|15952569|P3|Overall Study|Lost to Follow-up|1
4650123|NCT03558997|15952570|P2|Overall Study|Lost to Follow-up|0
4650124|NCT03558997|15952571|P1|Overall Study|Lost to Follow-up|0
4650125|NCT03558997|15952568|P4|Overall Study|Withdrawal by Subject|1
4650126|NCT03558997|15952569|P3|Overall Study|Withdrawal by Subject|1
4650127|NCT03558997|15952570|P2|Overall Study|Withdrawal by Subject|0
4650128|NCT03558997|15952571|P1|Overall Study|Withdrawal by Subject|1
4650129|NCT03558997|15952568|P4|Overall Study|Physician Decision|0
4650130|NCT03558997|15952569|P3|Overall Study|Physician Decision|1
4650131|NCT03558997|15952570|P2|Overall Study|Physician Decision|0
4650132|NCT03558997|15952571|P1|Overall Study|Physician Decision|0
4650133|NCT03558997|15952568|P4|Overall Study|Adverse Event|1
4650134|NCT03558997|15952569|P3|Overall Study|Adverse Event|5
4650135|NCT03558997|15952570|P2|Overall Study|Adverse Event|2
4650136|NCT03558997|15952571|P1|Overall Study|Adverse Event|0
4650137|NCT03558672|15952603|P1|Overall Study|Study Early Termination|10
4650138|NCT03558555|15952615|P2|Overall Study|Lost to Follow-up|1
4650139|NCT03558555|15952616|P1|Overall Study|Lost to Follow-up|2
4650140|NCT03558516|15952634|P2|Overall Study|Protocol Violation|2
4650141|NCT03558516|15952635|P1|Overall Study|Protocol Violation|2
4650142|NCT03557931|15952675|P3|Overall Study|Miscellaneous|3
4650143|NCT03557931|15952676|P2|Overall Study|Miscellaneous|5
4650144|NCT03557931|15952677|P1|Overall Study|Miscellaneous|8
4650145|NCT03557931|15952675|P3|Overall Study|Withdrawal by Subject|7
4650146|NCT03557931|15952676|P2|Overall Study|Withdrawal by Subject|0
4650147|NCT03557931|15952677|P1|Overall Study|Withdrawal by Subject|14
4650148|NCT03557931|15952675|P3|Overall Study|Protocol Violation|1
4650149|NCT03557931|15952676|P2|Overall Study|Protocol Violation|4
4650150|NCT03557931|15952677|P1|Overall Study|Protocol Violation|1
4650151|NCT03557931|15952675|P3|Overall Study|Lost to Follow-up|1
4650152|NCT03557931|15952676|P2|Overall Study|Lost to Follow-up|4
4650153|NCT03557931|15952677|P1|Overall Study|Lost to Follow-up|4
4650154|NCT03557931|15952675|P3|Overall Study|Adverse Event|1
4650155|NCT03557931|15952676|P2|Overall Study|Adverse Event|6
4650156|NCT03557931|15952677|P1|Overall Study|Adverse Event|4
4650157|NCT03557801|15952708|P3|Overall Study|Lost to Follow-up|0
4650158|NCT03557801|15952709|P2|Overall Study|Lost to Follow-up|1
4650159|NCT03557801|15952710|P1|Overall Study|Lost to Follow-up|0
4650160|NCT03557801|15952708|P3|Overall Study|Withdrawal by Subject|3
4650161|NCT03557801|15952709|P2|Overall Study|Withdrawal by Subject|0
4650162|NCT03557801|15952710|P1|Overall Study|Withdrawal by Subject|1
4650163|NCT03557801|15952708|P3|Overall Study|Protocol Violation|0
4650164|NCT03557801|15952709|P2|Overall Study|Protocol Violation|0
4650165|NCT03557801|15952710|P1|Overall Study|Protocol Violation|1
4650166|NCT03557775|15952727|P3|Overall Study|Physician Decision|0
4650167|NCT03557775|15952728|P2|Overall Study|Physician Decision|1
4650168|NCT03557775|15952729|P1|Overall Study|Physician Decision|0
4650169|NCT03557775|15952727|P3|Overall Study|Withdrawal by Subject|4
4650170|NCT03557775|15952728|P2|Overall Study|Withdrawal by Subject|2
4650171|NCT03557775|15952729|P1|Overall Study|Withdrawal by Subject|1
4650172|NCT03555890|15952860|P4|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4650173|NCT03555890|15952861|P3|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4650174|NCT03555890|15952862|P2|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4650175|NCT03555890|15952863|P1|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4650176|NCT03554005|15953073|P6|Overall Study|Other|1
4650177|NCT03554005|15953074|P5|Overall Study|Other|0
4650178|NCT03554005|15953075|P4|Overall Study|Other|0
4650179|NCT03554005|15953076|P3|Overall Study|Other|0
4650180|NCT03554005|15953077|P2|Overall Study|Other|0
4650181|NCT03554005|15953078|P1|Overall Study|Other|0
4650182|NCT03554005|15953073|P6|Overall Study|Physician Decision|0
4650183|NCT03554005|15953074|P5|Overall Study|Physician Decision|1
4650184|NCT03554005|15953075|P4|Overall Study|Physician Decision|0
4650185|NCT03554005|15953076|P3|Overall Study|Physician Decision|0
4650186|NCT03554005|15953077|P2|Overall Study|Physician Decision|0
4650187|NCT03554005|15953078|P1|Overall Study|Physician Decision|0
4650188|NCT03554005|15953073|P6|Overall Study|Adverse Event|3
4650189|NCT03554005|15953074|P5|Overall Study|Adverse Event|0
4650190|NCT03554005|15953075|P4|Overall Study|Adverse Event|0
4650191|NCT03554005|15953076|P3|Overall Study|Adverse Event|0
4650192|NCT03554005|15953077|P2|Overall Study|Adverse Event|0
4650193|NCT03554005|15953078|P1|Overall Study|Adverse Event|0
4650194|NCT03554005|15953073|P6|Overall Study|Disease Progression|6
4650195|NCT03554005|15953074|P5|Overall Study|Disease Progression|5
4650196|NCT03554005|15953075|P4|Overall Study|Disease Progression|1
4650197|NCT03554005|15953076|P3|Overall Study|Disease Progression|1
4650198|NCT03554005|15953077|P2|Overall Study|Disease Progression|1
4650199|NCT03554005|15953078|P1|Overall Study|Disease Progression|1
4650200|NCT03554005|15953073|P6|Overall Study|Not in participant's best interest|1
4650201|NCT03554005|15953074|P5|Overall Study|Not in participant's best interest|0
4650202|NCT03554005|15953075|P4|Overall Study|Not in participant's best interest|0
4650203|NCT03554005|15953076|P3|Overall Study|Not in participant's best interest|0
4650204|NCT03554005|15953077|P2|Overall Study|Not in participant's best interest|0
4650205|NCT03554005|15953078|P1|Overall Study|Not in participant's best interest|0
4650206|NCT03553758|15953104|P1|Overall Study|Lost to Follow-up|1
4650207|NCT03552549|15953112|P2|Overall Study|Administrative|14
4650208|NCT03552549|15953113|P1|Overall Study|Administrative|0
4650209|NCT03552549|15953112|P2|Overall Study|Did not meet eligibility criteria|0
4650210|NCT03552549|15953113|P1|Overall Study|Did not meet eligibility criteria|1
4650211|NCT03552549|15953112|P2|Overall Study|Did not complete study treatment|3
4650212|NCT03552549|15953113|P1|Overall Study|Did not complete study treatment|2
4650213|NCT03552549|15953112|P2|Overall Study|Not in participant's best interest|1
4650214|NCT03552549|15953113|P1|Overall Study|Not in participant's best interest|2
4650215|NCT03552549|15953112|P2|Overall Study|Unknown (no reason provided)|2
4650216|NCT03552549|15953113|P1|Overall Study|Unknown (no reason provided)|4
4650217|NCT03552549|15953112|P2|Overall Study|Withdrawal by Subject|7
4650218|NCT03552549|15953113|P1|Overall Study|Withdrawal by Subject|7
4650219|NCT03552549|15953112|P2|Overall Study|Adverse event in first 12 months|8
4650220|NCT03552549|15953113|P1|Overall Study|Adverse event in first 12 months|12
4650221|NCT03552549|15953112|P2|Overall Study|Disease progression|17
4650222|NCT03552549|15953113|P1|Overall Study|Disease progression|25
4650223|NCT03552523|15953151|P2|Overall Study|Withdrawal by Subject|1
4650224|NCT03552523|15953152|P1|Overall Study|Withdrawal by Subject|1
4650225|NCT03551743|15953178|P4|Overall Study|Withdrawal by Subject|0
4650226|NCT03551743|15953179|P3|Overall Study|Withdrawal by Subject|0
4650227|NCT03551743|15953180|P2|Overall Study|Withdrawal by Subject|0
4650228|NCT03551743|15953181|P1|Overall Study|Withdrawal by Subject|1
4650229|NCT03551743|15953178|P4|Overall Study|Adverse Event|0
4650230|NCT03551743|15953179|P3|Overall Study|Adverse Event|0
4650231|NCT03551743|15953180|P2|Overall Study|Adverse Event|0
4650232|NCT03551743|15953181|P1|Overall Study|Adverse Event|1
4650233|NCT03551730|15953227|P4|Overall Study|Adverse Event|0
4650234|NCT03551730|15953228|P3|Overall Study|Adverse Event|0
4650235|NCT03551730|15953229|P2|Overall Study|Adverse Event|0
4650236|NCT03551730|15953230|P1|Overall Study|Adverse Event|1
4650237|NCT03550378|15953352|P2|Overall Study|Death|1
4650238|NCT03550378|15953353|P1|Overall Study|Death|0
4650239|NCT03549429|15953416|P2|Overall Study|Protocol Violation|3
4650240|NCT03549429|15953417|P1|Overall Study|Protocol Violation|5
4650241|NCT03549338|15953430|P3|Overall Study|Clinical Progression|0
4650242|NCT03549338|15953431|P2|Overall Study|Clinical Progression|1
4650243|NCT03549338|15953432|P1|Overall Study|Clinical Progression|0
4650244|NCT03549338|15953430|P3|Overall Study|Progressive Disease|0
4650245|NCT03549338|15953431|P2|Overall Study|Progressive Disease|0
4650246|NCT03549338|15953432|P1|Overall Study|Progressive Disease|1
4650247|NCT03549130|15953459|P2|Overall Study|Lost to Follow-up|1
4650248|NCT03549130|15953460|P1|Overall Study|Lost to Follow-up|0
4650249|NCT03549130|15953459|P2|Overall Study|Adverse Event|1
4650250|NCT03549130|15953460|P1|Overall Study|Adverse Event|0
4650251|NCT03549117|15953478|P2|Overall Study|Withdrawal by Subject|0
4650252|NCT03549117|15953479|P1|Overall Study|Withdrawal by Subject|1
4650253|NCT03548337|15953507|P2|Toddler Dose|Withdrawal by parent/guardian|1
4650254|NCT03548337|15953508|P1|Toddler Dose|Withdrawal by parent/guardian|1
4650255|NCT03548337|15953507|P2|Infant Series|Randomized but Not Vaccinated|0
4650256|NCT03548337|15953508|P1|Infant Series|Randomized but Not Vaccinated|1
4650257|NCT03548337|15953507|P2|Infant Series|Adverse Event|2
4650258|NCT03548337|15953508|P1|Infant Series|Adverse Event|0
4650259|NCT03548337|15953507|P2|Infant Series|Lost to Follow-up|1
4650260|NCT03548337|15953508|P1|Infant Series|Lost to Follow-up|2
4650261|NCT03548337|15953507|P2|Infant Series|No Longer Met Eligibility Criteria|0
4650262|NCT03548337|15953508|P1|Infant Series|No Longer Met Eligibility Criteria|1
4650263|NCT03548337|15953507|P2|Infant Series|Withdrawal by Parent/Guardian|8
4650264|NCT03548337|15953508|P1|Infant Series|Withdrawal by Parent/Guardian|8
4650265|NCT03547635|15953559|P3|Overall Study|Withdrawal by Subject|0
4650266|NCT03547635|15953560|P2|Overall Study|Withdrawal by Subject|0
4650267|NCT03547635|15953561|P1|Overall Study|Withdrawal by Subject|1
4650268|NCT03547635|15953559|P3|Overall Study|Errant Randomization before Treatment|0
4650269|NCT03547635|15953560|P2|Overall Study|Errant Randomization before Treatment|1
4650270|NCT03547635|15953561|P1|Overall Study|Errant Randomization before Treatment|0
4650271|NCT03547635|15953559|P3|Overall Study|Withdrawal by Sponsor|1
4650272|NCT03547635|15953560|P2|Overall Study|Withdrawal by Sponsor|0
4650273|NCT03547635|15953561|P1|Overall Study|Withdrawal by Sponsor|0
4650274|NCT03547635|15953559|P3|Overall Study|Withdrawal By PI|0
4650275|NCT03547635|15953560|P2|Overall Study|Withdrawal By PI|1
4650276|NCT03547635|15953561|P1|Overall Study|Withdrawal By PI|0
4650277|NCT03547635|15953559|P3|Overall Study|Withdrawal by Subject|0
4650278|NCT03547635|15953560|P2|Overall Study|Withdrawal by Subject|0
4650279|NCT03547635|15953561|P1|Overall Study|Withdrawal by Subject|1
4650280|NCT03547635|15953559|P3|Overall Study|Lost to Follow-up|4
4650281|NCT03547635|15953560|P2|Overall Study|Lost to Follow-up|3
4650282|NCT03547635|15953561|P1|Overall Study|Lost to Follow-up|1
4650283|NCT03547635|15953559|P3|Overall Study|Adverse Event|3
4650284|NCT03547635|15953560|P2|Overall Study|Adverse Event|2
4650285|NCT03547635|15953561|P1|Overall Study|Adverse Event|5
4650286|NCT03547531|15953571|P2|Overall Study|having family occasion|2
4650287|NCT03547531|15953572|P1|Overall Study|having family occasion|0
4650288|NCT03547531|15953571|P2|Overall Study|not coming in data collection : sick|2
4650289|NCT03547531|15953572|P1|Overall Study|not coming in data collection : sick|2
4650290|NCT03547154|15953586|P2|Overall Study|Continued treatment beyond 12 mo.|50
4650291|NCT03547154|15953587|P1|Overall Study|Continued treatment beyond 12 mo.|58
4650292|NCT03547154|15953586|P2|Overall Study|Not Selected|1
4650293|NCT03547154|15953587|P1|Overall Study|Not Selected|0
4650294|NCT03547154|15953586|P2|Overall Study|Withdrawal by Subject|6
4650295|NCT03547154|15953587|P1|Overall Study|Withdrawal by Subject|10
4650296|NCT03547154|15953586|P2|Overall Study|Insufficient Therapeutic Response|10
4650297|NCT03547154|15953587|P1|Overall Study|Insufficient Therapeutic Response|13
4650298|NCT03547154|15953586|P2|Overall Study|Physician Decision|3
4650299|NCT03547154|15953587|P1|Overall Study|Physician Decision|4
4650300|NCT03547154|15953586|P2|Overall Study|Protocol Violation|1
4650301|NCT03547154|15953587|P1|Overall Study|Protocol Violation|6
4650302|NCT03547154|15953586|P2|Overall Study|Adverse Event|31
4650303|NCT03547154|15953587|P1|Overall Study|Adverse Event|26
4650304|NCT03547154|15953586|P2|Overall Study|Disease Progression/Recurrence|14
4650305|NCT03547154|15953587|P1|Overall Study|Disease Progression/Recurrence|6
4650306|NCT03546842|15953599|P1|Overall Study|Withdrawal by Subject|2
4650307|NCT03546842|15953599|P1|Overall Study|Protocol Violation|1
4650308|NCT03546816|15953610|P2|Overall Study|Lost to Follow-up|2
4650309|NCT03546816|15953611|P1|Overall Study|Lost to Follow-up|3
4650310|NCT03546816|15953610|P2|Overall Study|Withdrawal by Subject|10
4650311|NCT03546816|15953611|P1|Overall Study|Withdrawal by Subject|8
4650312|NCT03546816|15953610|P2|Overall Study|Physician Decision|0
4650313|NCT03546816|15953611|P1|Overall Study|Physician Decision|2
4650314|NCT03546816|15953610|P2|Overall Study|Pregnancy|0
4650315|NCT03546816|15953611|P1|Overall Study|Pregnancy|1
4650316|NCT03546816|15953610|P2|Overall Study|Lack of Efficacy|4
4650317|NCT03546816|15953611|P1|Overall Study|Lack of Efficacy|2
4650318|NCT03546816|15953610|P2|Overall Study|Adverse Event|3
4650319|NCT03546816|15953611|P1|Overall Study|Adverse Event|5
4650320|NCT03546621|15953639|P4|Overall Study|Progressive disease|1
4650321|NCT03546621|15953640|P3|Overall Study|Progressive disease|0
4650322|NCT03546621|15953641|P2|Overall Study|Progressive disease|0
4650323|NCT03546621|15953642|P1|Overall Study|Progressive disease|0
4650324|NCT03546621|15953639|P4|Overall Study|Adverse Event|1
4650325|NCT03546621|15953640|P3|Overall Study|Adverse Event|0
4650326|NCT03546621|15953641|P2|Overall Study|Adverse Event|1
4650327|NCT03546621|15953642|P1|Overall Study|Adverse Event|0
4650328|NCT03546621|15953639|P4|Overall Study|Lost to Follow-up|0
4650329|NCT03546621|15953640|P3|Overall Study|Lost to Follow-up|0
4650330|NCT03546621|15953641|P2|Overall Study|Lost to Follow-up|1
4650331|NCT03546621|15953642|P1|Overall Study|Lost to Follow-up|0
4650332|NCT03546621|15953639|P4|Overall Study|Withdrawal by Subject|1
4650333|NCT03546621|15953640|P3|Overall Study|Withdrawal by Subject|2
4650334|NCT03546621|15953641|P2|Overall Study|Withdrawal by Subject|1
4650335|NCT03546621|15953642|P1|Overall Study|Withdrawal by Subject|0
4650336|NCT03545984|15953732|P2|Overall Study|CSF cases not present during rotation|9
4650337|NCT03545984|15953733|P1|Overall Study|CSF cases not present during rotation|11
4650338|NCT03543137|15953897|P2|Study Period 2: Up to Day 8|Adverse Event|1
4650339|NCT03543137|15953898|P1|Study Period 2: Up to Day 8|Adverse Event|0
4650340|NCT03543137|15953897|P2|Study Period 2: Up to Day 8|Protocol Violation|0
4650341|NCT03543137|15953898|P1|Study Period 2: Up to Day 8|Protocol Violation|1
4650342|NCT03543137|15953897|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
4650343|NCT03543137|15953898|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
4650344|NCT03541044|15953999|P2|Study Period 2: Up to Day 8|Withdrawal by Subject|0
4650345|NCT03541044|15954000|P1|Study Period 2: Up to Day 8|Withdrawal by Subject|1
4650346|NCT03541044|15953999|P2|Study Period 2: Up to Day 8|Protocol Violation|0
4650347|NCT03541044|15954000|P1|Study Period 2: Up to Day 8|Protocol Violation|1
4650348|NCT03540030|15954022|P2|Overall Study|never had surgery after signing consent|1
4650349|NCT03540030|15954023|P1|Overall Study|never had surgery after signing consent|9
4650350|NCT03540030|15954022|P2|Overall Study|screen fail|1
4650351|NCT03540030|15954023|P1|Overall Study|screen fail|7
4650352|NCT03540030|15954022|P2|Overall Study|Withdrawal by Subject|1
4650353|NCT03540030|15954023|P1|Overall Study|Withdrawal by Subject|2
4650354|NCT03539549|15954059|P1|Overall Study|Reason not Specified|1
4650355|NCT03539549|15954059|P1|Overall Study|Progressive Disease|1
4650356|NCT03539549|15954059|P1|Overall Study|Death|2
4650357|NCT03539549|15954059|P1|Overall Study|Lost to Follow-up|1
4650358|NCT03539549|15954059|P1|Overall Study|Adverse Event|12
4650359|NCT03539484|15954074|P7|Overall Study|Study Terminated by Sponsor|1
4650360|NCT03539484|15954075|P6|Overall Study|Study Terminated by Sponsor|2
4650361|NCT03539484|15954076|P5|Overall Study|Study Terminated by Sponsor|2
4650362|NCT03539484|15954077|P4|Overall Study|Study Terminated by Sponsor|1
4650363|NCT03539484|15954078|P3|Overall Study|Study Terminated by Sponsor|1
4650364|NCT03539484|15954079|P2|Overall Study|Study Terminated by Sponsor|0
4650365|NCT03539484|15954080|P1|Overall Study|Study Terminated by Sponsor|0
4650366|NCT03539484|15954074|P7|Overall Study|Withdrawal by Subject|1
4650367|NCT03539484|15954075|P6|Overall Study|Withdrawal by Subject|0
4650368|NCT03539484|15954076|P5|Overall Study|Withdrawal by Subject|2
4650369|NCT03539484|15954077|P4|Overall Study|Withdrawal by Subject|0
4650370|NCT03539484|15954078|P3|Overall Study|Withdrawal by Subject|0
4650371|NCT03539484|15954079|P2|Overall Study|Withdrawal by Subject|0
4650372|NCT03539484|15954080|P1|Overall Study|Withdrawal by Subject|0
4650373|NCT03539484|15954074|P7|Overall Study|Lost to Follow-up|0
4650374|NCT03539484|15954075|P6|Overall Study|Lost to Follow-up|0
4650375|NCT03539484|15954076|P5|Overall Study|Lost to Follow-up|1
4650376|NCT03539484|15954077|P4|Overall Study|Lost to Follow-up|0
4650377|NCT03539484|15954078|P3|Overall Study|Lost to Follow-up|0
4650378|NCT03539484|15954079|P2|Overall Study|Lost to Follow-up|1
4650379|NCT03539484|15954080|P1|Overall Study|Lost to Follow-up|0
4650380|NCT03539484|15954074|P7|Overall Study|Death|0
4650381|NCT03539484|15954075|P6|Overall Study|Death|3
4650382|NCT03539484|15954076|P5|Overall Study|Death|8
4650383|NCT03539484|15954077|P4|Overall Study|Death|2
4650384|NCT03539484|15954078|P3|Overall Study|Death|0
4650385|NCT03539484|15954079|P2|Overall Study|Death|0
4650386|NCT03539484|15954080|P1|Overall Study|Death|1
4650387|NCT03538743|15954234|P9|Overall Study|Withdrawal by Subject|0
4650388|NCT03538743|15954235|P8|Overall Study|Withdrawal by Subject|0
4650389|NCT03538743|15954236|P7|Overall Study|Withdrawal by Subject|0
4650390|NCT03538743|15954237|P6|Overall Study|Withdrawal by Subject|0
4650391|NCT03538743|15954238|P5|Overall Study|Withdrawal by Subject|0
4650392|NCT03538743|15954239|P4|Overall Study|Withdrawal by Subject|1
4650393|NCT03538743|15954240|P3|Overall Study|Withdrawal by Subject|0
4650394|NCT03538743|15954241|P2|Overall Study|Withdrawal by Subject|0
4650395|NCT03538743|15954242|P1|Overall Study|Withdrawal by Subject|0
4650396|NCT03538743|15954234|P9|Overall Study|Non-Treatment-Related Reasons|3
4650397|NCT03538743|15954235|P8|Overall Study|Non-Treatment-Related Reasons|0
4650398|NCT03538743|15954236|P7|Overall Study|Non-Treatment-Related Reasons|0
4650399|NCT03538743|15954237|P6|Overall Study|Non-Treatment-Related Reasons|0
4650400|NCT03538743|15954238|P5|Overall Study|Non-Treatment-Related Reasons|0
4650401|NCT03538743|15954239|P4|Overall Study|Non-Treatment-Related Reasons|0
4650402|NCT03538743|15954240|P3|Overall Study|Non-Treatment-Related Reasons|0
4650403|NCT03538743|15954241|P2|Overall Study|Non-Treatment-Related Reasons|0
4650404|NCT03538743|15954242|P1|Overall Study|Non-Treatment-Related Reasons|0
4650405|NCT03538743|15954234|P9|Overall Study|Adverse Event|0
4650406|NCT03538743|15954235|P8|Overall Study|Adverse Event|0
4650407|NCT03538743|15954236|P7|Overall Study|Adverse Event|0
4650408|NCT03538743|15954237|P6|Overall Study|Adverse Event|0
4650409|NCT03538743|15954238|P5|Overall Study|Adverse Event|0
4650410|NCT03538743|15954239|P4|Overall Study|Adverse Event|1
4650411|NCT03538743|15954240|P3|Overall Study|Adverse Event|1
4650412|NCT03538743|15954241|P2|Overall Study|Adverse Event|0
4650413|NCT03538743|15954242|P1|Overall Study|Adverse Event|0
4650414|NCT03536949|15954522|P2|Overall Study|Non-compliance|1
4650415|NCT03536949|15954523|P1|Overall Study|Non-compliance|2
4650416|NCT03536949|15954522|P2|Overall Study|Withdrawal by Subject|0
4650417|NCT03536949|15954523|P1|Overall Study|Withdrawal by Subject|6
4650418|NCT03536949|15954522|P2|Overall Study|Lost to Follow-up|1
4650419|NCT03536949|15954523|P1|Overall Study|Lost to Follow-up|2
4650420|NCT03536949|15954522|P2|Overall Study|Adverse Event|0
4650421|NCT03536949|15954523|P1|Overall Study|Adverse Event|4
4650422|NCT03535974|15954589|P3|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0
4650423|NCT03535974|15954590|P2|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1
4650424|NCT03535974|15954591|P1|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2
4650425|NCT03535974|15954589|P3|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
4650426|NCT03535974|15954590|P2|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1
4650427|NCT03535974|15954591|P1|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0
4650428|NCT03535844|15954601|P2|Overall Study|Withdrawal by Subject|1
4650429|NCT03535844|15954602|P1|Overall Study|Withdrawal by Subject|0
4650430|NCT03532048|15954871|P2|Overall Study|Withdrawal by Subject|0
4650431|NCT03532048|15954872|P1|Overall Study|Withdrawal by Subject|7
4650432|NCT03532048|15954871|P2|Overall Study|Lost to Follow-up|17
4650433|NCT03532048|15954872|P1|Overall Study|Lost to Follow-up|12
4650434|NCT03531905|15954889|P3|Overall Study|Could not speak with the participant|0
4650435|NCT03531905|15954890|P2|Overall Study|Could not speak with the participant|0
4650436|NCT03531905|15954891|P1|Overall Study|Could not speak with the participant|1
4650437|NCT03531905|15954889|P3|Overall Study|Participant was out of town|0
4650438|NCT03531905|15954890|P2|Overall Study|Participant was out of town|0
4650439|NCT03531905|15954891|P1|Overall Study|Participant was out of town|1
4650440|NCT03531905|15954889|P3|Overall Study|Lost to Follow-up|1
4650441|NCT03531905|15954890|P2|Overall Study|Lost to Follow-up|2
4650442|NCT03531905|15954891|P1|Overall Study|Lost to Follow-up|2
4650443|NCT03531905|15954889|P3|Overall Study|Withdrawal by Subject|2
4650444|NCT03531905|15954890|P2|Overall Study|Withdrawal by Subject|3
4650445|NCT03531905|15954891|P1|Overall Study|Withdrawal by Subject|3
4650446|NCT03530345|15955054|P2|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7
4650447|NCT03530345|15955055|P1|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5
4650448|NCT03530345|15955054|P2|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21
4650449|NCT03530345|15955055|P1|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17
4650450|NCT03530345|15955054|P2|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1
4650451|NCT03530345|15955055|P1|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3
4650452|NCT03530345|15955054|P2|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0
4650453|NCT03530345|15955055|P1|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1
4650454|NCT03528369|15955103|P3|Overall Study|Adverse Event|0
4650455|NCT03528369|15955104|P2|Overall Study|Adverse Event|1
4650456|NCT03528369|15955105|P1|Overall Study|Adverse Event|0
4650457|NCT03528369|15955103|P3|Overall Study|Lost to Follow-up|0
4650458|NCT03528369|15955104|P2|Overall Study|Lost to Follow-up|0
4650459|NCT03528369|15955105|P1|Overall Study|Lost to Follow-up|1
4650460|NCT03528369|15955103|P3|Overall Study|Withdrawal by Subject|0
4650461|NCT03528369|15955104|P2|Overall Study|Withdrawal by Subject|0
4650462|NCT03528369|15955105|P1|Overall Study|Withdrawal by Subject|2
4650463|NCT03528174|15955134|P1|Overall Study|sensors dislodged|1
4650464|NCT03528174|15955134|P1|Overall Study|Adverse Event|1
4650465|NCT03527966|15955154|P2|Overall Study|Lost to Follow-up|0
4650466|NCT03527966|15955155|P1|Overall Study|Lost to Follow-up|3
4650467|NCT03527173|15955169|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0
4650468|NCT03527173|15955170|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1
4650469|NCT03527173|15955169|P2|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5
4650470|NCT03527173|15955170|P1|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1
4650471|NCT03527173|15955169|P2|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0
4650472|NCT03527173|15955170|P1|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1
4650473|NCT03527173|15955169|P2|Overall Study|Lost to Follow-up|2
4650474|NCT03527173|15955170|P1|Overall Study|Lost to Follow-up|4
4650475|NCT03525678|15955230|P3|Overall Study|Death|4
4650476|NCT03525678|15955231|P2|Overall Study|Death|31
4650477|NCT03525678|15955232|P1|Overall Study|Death|32
4650478|NCT03525678|15955230|P3|Overall Study|Lost to Follow-up|0
4650479|NCT03525678|15955231|P2|Overall Study|Lost to Follow-up|0
4650480|NCT03525678|15955232|P1|Overall Study|Lost to Follow-up|1
4650481|NCT03525678|15955230|P3|Overall Study|Physician Decision|0
4650482|NCT03525678|15955231|P2|Overall Study|Physician Decision|2
4650483|NCT03525678|15955232|P1|Overall Study|Physician Decision|1
4650484|NCT03525678|15955230|P3|Overall Study|Withdrawal by Subject|0
4650485|NCT03525678|15955231|P2|Overall Study|Withdrawal by Subject|1
4650486|NCT03525678|15955232|P1|Overall Study|Withdrawal by Subject|3
4650487|NCT03525678|15955230|P3|Overall Study|Ongoing at the time of interim analysis|21
4650488|NCT03525678|15955231|P2|Overall Study|Ongoing at the time of interim analysis|65
4650489|NCT03525678|15955232|P1|Overall Study|Ongoing at the time of interim analysis|60
4650490|NCT03525444|15955434|P2|Overall Study|Other|1
4650491|NCT03525444|15955435|P1|Overall Study|Other|0
4650492|NCT03525444|15955434|P2|Overall Study|Withdrawal of consent (not due to AE)|1
4650493|NCT03525444|15955435|P1|Overall Study|Withdrawal of consent (not due to AE)|0
4650494|NCT03525444|15955434|P2|Overall Study|Adverse Event|1
4650495|NCT03525444|15955435|P1|Overall Study|Adverse Event|0
4650496|NCT03525119|15955467|P3|Overall Study|Randomized but not Vaccinated|2
4650497|NCT03525119|15955468|P2|Overall Study|Randomized but not Vaccinated|0
4650498|NCT03525119|15955469|P1|Overall Study|Randomized but not Vaccinated|1
4650499|NCT03525119|15955467|P3|Overall Study|Reason not Specified|2
4650500|NCT03525119|15955468|P2|Overall Study|Reason not Specified|1
4650501|NCT03525119|15955469|P1|Overall Study|Reason not Specified|2
4650502|NCT03525119|15955467|P3|Overall Study|Withdrawal by Subject|2
4650503|NCT03525119|15955468|P2|Overall Study|Withdrawal by Subject|4
4650504|NCT03525119|15955469|P1|Overall Study|Withdrawal by Subject|5
4650505|NCT03525119|15955467|P3|Overall Study|Lost to Follow-up|37
4650506|NCT03525119|15955468|P2|Overall Study|Lost to Follow-up|33
4650507|NCT03525119|15955469|P1|Overall Study|Lost to Follow-up|32
4650508|NCT03525119|15955467|P3|Overall Study|Adverse Event|0
4650509|NCT03525119|15955468|P2|Overall Study|Adverse Event|1
4650510|NCT03525119|15955469|P1|Overall Study|Adverse Event|0
4650511|NCT03524157|15955504|P3|Overall Study|cytology not readable|1
4650512|NCT03524157|15955505|P2|Overall Study|cytology not readable|0
4650513|NCT03524157|15955506|P1|Overall Study|cytology not readable|0
4650514|NCT03522675|15955560|P1|Overall Study|Non-reactive to histamine|1
4650515|NCT03522675|15955560|P1|Overall Study|Screen fail|1
4650516|NCT03522506|15955578|P4|Washout Period 2 (7 Days)|Withdrawal by Subject|1
4650517|NCT03522506|15955579|P3|Washout Period 2 (7 Days)|Withdrawal by Subject|0
4650518|NCT03522506|15955580|P2|Washout Period 2 (7 Days)|Withdrawal by Subject|0
4650519|NCT03522506|15955581|P1|Washout Period 2 (7 Days)|Withdrawal by Subject|0
4650520|NCT03522506|15955578|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4650521|NCT03522506|15955579|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4650522|NCT03522506|15955580|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4650523|NCT03522506|15955581|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4650524|NCT03521817|15955659|P2|Overall Study|Protocol Violation|1
4650525|NCT03521817|15955660|P1|Overall Study|Protocol Violation|0
4650526|NCT03521791|15955668|P2|Overall Study|Protocol Violation|17
4650527|NCT03521791|15955669|P1|Overall Study|Protocol Violation|7
4650528|NCT03521141|15955696|P3|Overall Study|Death|1
4650529|NCT03521141|15955697|P2|Overall Study|Death|0
4650530|NCT03521141|15955698|P1|Overall Study|Death|1
4650531|NCT03520959|15955744|P2|Overall Study|Study terminated by Sponsor|1
4650532|NCT03520959|15955745|P1|Overall Study|Study terminated by Sponsor|0
4650533|NCT03519932|15955792|P2|First Intervention|Adverse Event|3
4650534|NCT03519932|15955793|P1|First Intervention|Adverse Event|1
4650535|NCT03519919|15955819|P1|Overall Study|Screen Failure|1
4650536|NCT03519919|15955819|P1|Overall Study|Lack of Efficacy|1
4650537|NCT03519919|15955819|P1|Overall Study|Withdrawal by Subject|1
4650538|NCT03519867|15955871|P10|Overall Study|Reason not provided|0
4650539|NCT03519867|15955872|P9|Overall Study|Reason not provided|1
4650540|NCT03519867|15955873|P8|Overall Study|Reason not provided|1
4650541|NCT03519867|15955874|P7|Overall Study|Reason not provided|0
4650542|NCT03519867|15955875|P6|Overall Study|Reason not provided|1
4650543|NCT03519867|15955876|P5|Overall Study|Reason not provided|0
4650544|NCT03519867|15955877|P4|Overall Study|Reason not provided|1
4650545|NCT03519867|15955878|P3|Overall Study|Reason not provided|1
4650546|NCT03519867|15955879|P2|Overall Study|Reason not provided|1
4650547|NCT03519867|15955880|P1|Overall Study|Reason not provided|1
4650548|NCT03519867|15955871|P10|Overall Study|Admin. of other reversal agent|0
4650549|NCT03519867|15955872|P9|Overall Study|Admin. of other reversal agent|0
4650550|NCT03519867|15955873|P8|Overall Study|Admin. of other reversal agent|0
4650551|NCT03519867|15955874|P7|Overall Study|Admin. of other reversal agent|0
4650552|NCT03519867|15955875|P6|Overall Study|Admin. of other reversal agent|1
4650553|NCT03519867|15955876|P5|Overall Study|Admin. of other reversal agent|0
4650554|NCT03519867|15955877|P4|Overall Study|Admin. of other reversal agent|0
4650555|NCT03519867|15955878|P3|Overall Study|Admin. of other reversal agent|0
4650556|NCT03519867|15955879|P2|Overall Study|Admin. of other reversal agent|1
4650557|NCT03519867|15955880|P1|Overall Study|Admin. of other reversal agent|1
4650558|NCT03519867|15955871|P10|Overall Study|Admin. of relaxant other than Zemuron®|0
4650559|NCT03519867|15955872|P9|Overall Study|Admin. of relaxant other than Zemuron®|0
4650560|NCT03519867|15955873|P8|Overall Study|Admin. of relaxant other than Zemuron®|0
4650561|NCT03519867|15955874|P7|Overall Study|Admin. of relaxant other than Zemuron®|1
4650562|NCT03519867|15955875|P6|Overall Study|Admin. of relaxant other than Zemuron®|0
4650563|NCT03519867|15955876|P5|Overall Study|Admin. of relaxant other than Zemuron®|0
4650564|NCT03519867|15955877|P4|Overall Study|Admin. of relaxant other than Zemuron®|0
4650565|NCT03519867|15955878|P3|Overall Study|Admin. of relaxant other than Zemuron®|0
4650566|NCT03519867|15955879|P2|Overall Study|Admin. of relaxant other than Zemuron®|0
4650567|NCT03519867|15955880|P1|Overall Study|Admin. of relaxant other than Zemuron®|0
4650568|NCT03519867|15955871|P10|Overall Study|Protocol Violation|0
4650569|NCT03519867|15955872|P9|Overall Study|Protocol Violation|0
4650570|NCT03519867|15955873|P8|Overall Study|Protocol Violation|0
4650571|NCT03519867|15955874|P7|Overall Study|Protocol Violation|0
4650572|NCT03519867|15955875|P6|Overall Study|Protocol Violation|1
4650573|NCT03519867|15955876|P5|Overall Study|Protocol Violation|0
4650574|NCT03519867|15955877|P4|Overall Study|Protocol Violation|0
4650575|NCT03519867|15955878|P3|Overall Study|Protocol Violation|0
4650576|NCT03519867|15955879|P2|Overall Study|Protocol Violation|0
4650577|NCT03519867|15955880|P1|Overall Study|Protocol Violation|0
4650578|NCT03519867|15955871|P10|Overall Study|Adverse Event|0
4650579|NCT03519867|15955872|P9|Overall Study|Adverse Event|0
4650580|NCT03519867|15955873|P8|Overall Study|Adverse Event|0
4650581|NCT03519867|15955874|P7|Overall Study|Adverse Event|0
4650582|NCT03519867|15955875|P6|Overall Study|Adverse Event|0
4650583|NCT03519867|15955876|P5|Overall Study|Adverse Event|0
4650584|NCT03519867|15955877|P4|Overall Study|Adverse Event|0
4650585|NCT03519867|15955878|P3|Overall Study|Adverse Event|0
4650586|NCT03519867|15955879|P2|Overall Study|Adverse Event|1
4650587|NCT03519867|15955880|P1|Overall Study|Adverse Event|1
4650588|NCT03519854|15955930|P18|Overall Study|Technical Error|0
4650589|NCT03519854|15955931|P17|Overall Study|Technical Error|0
4650590|NCT03519854|15955932|P16|Overall Study|Technical Error|0
4650591|NCT03519854|15955933|P15|Overall Study|Technical Error|0
4650592|NCT03519854|15955934|P14|Overall Study|Technical Error|0
4650593|NCT03519854|15955935|P13|Overall Study|Technical Error|0
4650594|NCT03519854|15955936|P12|Overall Study|Technical Error|0
4650595|NCT03519854|15955937|P11|Overall Study|Technical Error|0
4650596|NCT03519854|15955938|P10|Overall Study|Technical Error|0
4650597|NCT03519854|15955939|P9|Overall Study|Technical Error|0
4650598|NCT03519854|15955940|P8|Overall Study|Technical Error|0
4650599|NCT03519854|15955941|P7|Overall Study|Technical Error|0
4650600|NCT03519854|15955942|P6|Overall Study|Technical Error|0
4650601|NCT03519854|15955943|P5|Overall Study|Technical Error|0
4650602|NCT03519854|15955944|P4|Overall Study|Technical Error|0
4650603|NCT03519854|15955945|P3|Overall Study|Technical Error|1
4650604|NCT03519854|15955946|P2|Overall Study|Technical Error|0
4650605|NCT03519854|15955947|P1|Overall Study|Technical Error|0
4650606|NCT03519516|15956113|P2|Overall Study|Adverse Event|1
4650607|NCT03519516|15956114|P1|Overall Study|Adverse Event|0
4650608|NCT03519204|15956188|P2|Overall Study|Other Miscellaneous Reasons|0
4650609|NCT03519204|15956189|P1|Overall Study|Other Miscellaneous Reasons|1
4650610|NCT03519204|15956188|P2|Overall Study|Withdrawal by Subject|7
4650611|NCT03519204|15956189|P1|Overall Study|Withdrawal by Subject|9
4650612|NCT03519204|15956188|P2|Overall Study|Lost to Follow-up|8
4650613|NCT03519204|15956189|P1|Overall Study|Lost to Follow-up|3
4650614|NCT03519087|15956208|P5|Laboratory Testing|Protocol Violation|0
4650615|NCT03519087|15956209|P4|Laboratory Testing|Protocol Violation|1
4650616|NCT03519087|15956210|P3|Laboratory Testing|Protocol Violation|0
4650617|NCT03519087|15956211|P2|Laboratory Testing|Protocol Violation|0
4650618|NCT03519087|15956212|P1|Laboratory Testing|Protocol Violation|0
4650619|NCT03519087|15956208|P5|Laboratory Testing|Lost to Follow-up|6
4650620|NCT03519087|15956209|P4|Laboratory Testing|Lost to Follow-up|3
4650621|NCT03519087|15956210|P3|Laboratory Testing|Lost to Follow-up|2
4650622|NCT03519087|15956211|P2|Laboratory Testing|Lost to Follow-up|0
4650623|NCT03519087|15956212|P1|Laboratory Testing|Lost to Follow-up|0
4650624|NCT03519087|15956208|P5|Re-randomization for Treatment|Not appropriate|0
4650625|NCT03519087|15956209|P4|Re-randomization for Treatment|Not appropriate|0
4650626|NCT03519087|15956210|P3|Re-randomization for Treatment|Not appropriate|0
4650627|NCT03519087|15956211|P2|Re-randomization for Treatment|Not appropriate|3
4650628|NCT03519087|15956212|P1|Re-randomization for Treatment|Not appropriate|2
4650629|NCT03519087|15956208|P5|Re-randomization for Treatment|Withdrawal by Subject|0
4650630|NCT03519087|15956209|P4|Re-randomization for Treatment|Withdrawal by Subject|0
4650631|NCT03519087|15956210|P3|Re-randomization for Treatment|Withdrawal by Subject|0
4650632|NCT03519087|15956211|P2|Re-randomization for Treatment|Withdrawal by Subject|29
4650633|NCT03519087|15956212|P1|Re-randomization for Treatment|Withdrawal by Subject|25
4650634|NCT03519087|15956208|P5|Clinic Evaluation|Protocol Violation|0
4650635|NCT03519087|15956209|P4|Clinic Evaluation|Protocol Violation|0
4650636|NCT03519087|15956210|P3|Clinic Evaluation|Protocol Violation|0
4650637|NCT03519087|15956211|P2|Clinic Evaluation|Protocol Violation|0
4650638|NCT03519087|15956212|P1|Clinic Evaluation|Protocol Violation|1
4650639|NCT03519087|15956208|P5|Clinic Evaluation|Physician Decision|0
4650640|NCT03519087|15956209|P4|Clinic Evaluation|Physician Decision|0
4650641|NCT03519087|15956210|P3|Clinic Evaluation|Physician Decision|0
4650642|NCT03519087|15956211|P2|Clinic Evaluation|Physician Decision|18
4650643|NCT03519087|15956212|P1|Clinic Evaluation|Physician Decision|15
4650644|NCT03518840|15956248|P1|Overall Study|Lost to Follow-up|6
4650645|NCT03518125|15956261|P6|Overall Study|Missed Day 394 Visit|0
4650646|NCT03518125|15956262|P5|Overall Study|Missed Day 394 Visit|0
4650647|NCT03518125|15956263|P4|Overall Study|Missed Day 394 Visit|0
4650648|NCT03518125|15956264|P3|Overall Study|Missed Day 394 Visit|0
4650649|NCT03518125|15956265|P2|Overall Study|Missed Day 394 Visit|0
4650650|NCT03518125|15956266|P1|Overall Study|Missed Day 394 Visit|1
4650651|NCT03518125|15956261|P6|Overall Study|Withdrawal by Subject|3
4650652|NCT03518125|15956262|P5|Overall Study|Withdrawal by Subject|1
4650653|NCT03518125|15956263|P4|Overall Study|Withdrawal by Subject|1
4650654|NCT03518125|15956264|P3|Overall Study|Withdrawal by Subject|0
4650655|NCT03518125|15956265|P2|Overall Study|Withdrawal by Subject|1
4650656|NCT03518125|15956266|P1|Overall Study|Withdrawal by Subject|1
4650657|NCT03518125|15956261|P6|Overall Study|Physician Decision|0
4650658|NCT03518125|15956262|P5|Overall Study|Physician Decision|0
4650659|NCT03518125|15956263|P4|Overall Study|Physician Decision|0
4650660|NCT03518125|15956264|P3|Overall Study|Physician Decision|0
4650661|NCT03518125|15956265|P2|Overall Study|Physician Decision|1
4650662|NCT03518125|15956266|P1|Overall Study|Physician Decision|0
4650663|NCT03518125|15956261|P6|Overall Study|Lost to Follow-up|5
4650664|NCT03518125|15956262|P5|Overall Study|Lost to Follow-up|3
4650665|NCT03518125|15956263|P4|Overall Study|Lost to Follow-up|0
4650666|NCT03518125|15956264|P3|Overall Study|Lost to Follow-up|0
4650667|NCT03518125|15956265|P2|Overall Study|Lost to Follow-up|2
4650668|NCT03518125|15956266|P1|Overall Study|Lost to Follow-up|0
4650669|NCT03518008|15956364|P2|Period 2, Second Week of Wear|Family emergency|1
4650670|NCT03518008|15956365|P1|Period 2, Second Week of Wear|Family emergency|0
4650671|NCT03515941|15956390|P2|Overall Study|Adverse Event|0
4650672|NCT03515941|15956391|P1|Overall Study|Adverse Event|1
4650673|NCT03513588|15956459|P3|Overall Study|Death|1
4650674|NCT03513588|15956460|P2|Overall Study|Death|0
4650675|NCT03513588|15956461|P1|Overall Study|Death|0
4650676|NCT03513588|15956459|P3|Overall Study|Study dosing paused by sponsor|0
4650677|NCT03513588|15956460|P2|Overall Study|Study dosing paused by sponsor|1
4650678|NCT03513588|15956461|P1|Overall Study|Study dosing paused by sponsor|1
4650679|NCT03513588|15956459|P3|Overall Study|Lost to Follow-up|1
4650680|NCT03513588|15956460|P2|Overall Study|Lost to Follow-up|1
4650681|NCT03513588|15956461|P1|Overall Study|Lost to Follow-up|0
4650682|NCT03512028|15956536|P2|Overall Study|Protocol Violation|0
4650683|NCT03512028|15956537|P1|Overall Study|Protocol Violation|2
4650684|NCT03512028|15956536|P2|Overall Study|Withdrawal by Subject|0
4650685|NCT03512028|15956537|P1|Overall Study|Withdrawal by Subject|2
4650686|NCT03511105|15956558|P2|Overall Study|Withdrew consent|0
4650687|NCT03511105|15956559|P1|Overall Study|Withdrew consent|1
4650688|NCT03511105|15956558|P2|Overall Study|Adverse Event|0
4650689|NCT03511105|15956559|P1|Overall Study|Adverse Event|1
4650690|NCT03510273|15956613|P1|Overall Study|Moved away from study area|4
4650691|NCT03510273|15956613|P1|Overall Study|Care outside study, ineligible to cont.|3
4650692|NCT03510273|15956613|P1|Overall Study|Withdrawal by Subject|2
4650693|NCT03509948|15956632|P2|Overall Study|Protocol Violation|1
4650694|NCT03509948|15956633|P1|Overall Study|Protocol Violation|0
4650695|NCT03509675|15956701|P2|Second Intervention )7 Days)|Lost Rinse B|0
4650696|NCT03509675|15956702|P1|Second Intervention )7 Days)|Lost Rinse B|1
4650697|NCT03509675|15956701|P2|Second Intervention )7 Days)|Withdrawal by Subject|0
4650698|NCT03509675|15956702|P1|Second Intervention )7 Days)|Withdrawal by Subject|1
4650699|NCT03509675|15956701|P2|First Intervention (7 Days)|Lack of Efficacy|1
4650700|NCT03509675|15956702|P1|First Intervention (7 Days)|Lack of Efficacy|2
4650701|NCT03509675|15956701|P2|First Intervention (7 Days)|Lost to Follow-up|3
4650702|NCT03509675|15956702|P1|First Intervention (7 Days)|Lost to Follow-up|3
4650703|NCT03509350|15956710|P2|Overall Study|Withdrawal by Subject|2
4650704|NCT03509350|15956711|P1|Overall Study|Withdrawal by Subject|0
4650705|NCT03509207|15956717|P1|Overall Study|Death|2
4650706|NCT03508843|15956722|P1|Overall Study|technical difficulties|2
4650707|NCT03508843|15956722|P1|Overall Study|Withdrawal by Subject|1
4650708|NCT03508050|15956789|P2|Overall Study|Sustained desaturation|1
4650709|NCT03508050|15956790|P1|Overall Study|Sustained desaturation|0
4650710|NCT03508050|15956789|P2|Overall Study|Negative biopsy, surgery cancelled|1
4650711|NCT03508050|15956790|P1|Overall Study|Negative biopsy, surgery cancelled|3
4650712|NCT03508050|15956789|P2|Overall Study|Mucus plug|0
4650713|NCT03508050|15956790|P1|Overall Study|Mucus plug|1
4650714|NCT03508050|15956789|P2|Overall Study|Pleural adhesions|0
4650715|NCT03508050|15956790|P1|Overall Study|Pleural adhesions|1
4650716|NCT03506425|15956848|P3|Overall Study|Withdrawal by Subject|1
4650717|NCT03506425|15956849|P2|Overall Study|Withdrawal by Subject|0
4650718|NCT03506425|15956850|P1|Overall Study|Withdrawal by Subject|0
4650719|NCT03506425|15956848|P3|Overall Study|Death|0
4650720|NCT03506425|15956849|P2|Overall Study|Death|0
4650721|NCT03506425|15956850|P1|Overall Study|Death|1
4650722|NCT03506425|15956848|P3|Overall Study|Adverse Event|0
4650723|NCT03506425|15956849|P2|Overall Study|Adverse Event|3
4650724|NCT03506425|15956850|P1|Overall Study|Adverse Event|1
4650725|NCT03505593|15956885|P1|Overall Study|Obstruction by Endotracheal tube|1
4650726|NCT03505593|15956885|P1|Overall Study|Unable to pass through esophagus|1
4650727|NCT03505593|15956885|P1|Overall Study|Anatomical abnormality|1
4650728|NCT03505593|15956885|P1|Overall Study|Died before procedure|1
4650729|NCT03505593|15956885|P1|Overall Study|Withdrawal by Subject|1
4650730|NCT03504189|15956982|P1|Overall Study|Device Failure|2
4650731|NCT03504189|15956982|P1|Overall Study|Screening Failure|1
4650732|NCT03504189|15956982|P1|Overall Study|Withdrawal by Subject|1
4650733|NCT03503188|15957008|P2|Overall Study|Non eligible in the sub study|1
4650734|NCT03503188|15957009|P1|Overall Study|Non eligible in the sub study|0
4650735|NCT03502681|15957044|P2|Overall Study|Disease Progression|1
4650736|NCT03502681|15957045|P1|Overall Study|Disease Progression|2
4650737|NCT03502681|15957044|P2|Overall Study|Adverse Event|1
4650738|NCT03502681|15957045|P1|Overall Study|Adverse Event|1
4650739|NCT03502070|15957064|P1|Overall Study|Screen Failure|1
4650740|NCT03502070|15957064|P1|Overall Study|Withdrawal by Subject|1
4650741|NCT03501277|15957085|P4|Intervention Period 3 (4 Days)|Adverse Event|1
4650742|NCT03501277|15957086|P3|Intervention Period 3 (4 Days)|Adverse Event|0
4650743|NCT03501277|15957087|P2|Intervention Period 3 (4 Days)|Adverse Event|0
4650744|NCT03501277|15957088|P1|Intervention Period 3 (4 Days)|Adverse Event|0
4650745|NCT03501277|15957085|P4|Intervention Period 2 (4 Days)|Adverse Event|1
4650746|NCT03501277|15957086|P3|Intervention Period 2 (4 Days)|Adverse Event|0
4650747|NCT03501277|15957087|P2|Intervention Period 2 (4 Days)|Adverse Event|0
4650748|NCT03501277|15957088|P1|Intervention Period 2 (4 Days)|Adverse Event|0
4650749|NCT03501277|15957085|P4|Intervention Period 1 (4 Days)|Adverse Event|1
4650750|NCT03501277|15957086|P3|Intervention Period 1 (4 Days)|Adverse Event|0
4650751|NCT03501277|15957087|P2|Intervention Period 1 (4 Days)|Adverse Event|0
4650752|NCT03501277|15957088|P1|Intervention Period 1 (4 Days)|Adverse Event|0
4650753|NCT03501277|15957085|P4|Intervention Period 1 (4 Days)|Other|0
4650754|NCT03501277|15957086|P3|Intervention Period 1 (4 Days)|Other|1
4650755|NCT03501277|15957087|P2|Intervention Period 1 (4 Days)|Other|0
4650756|NCT03501277|15957088|P1|Intervention Period 1 (4 Days)|Other|0
4650757|NCT03500679|15957215|P2|Overall Study|Withdrawal by Subject|0
4650758|NCT03500679|15957216|P1|Overall Study|Withdrawal by Subject|3
4650759|NCT03500679|15957215|P2|Overall Study|Lost to Follow-up|3
4650760|NCT03500679|15957216|P1|Overall Study|Lost to Follow-up|6
4650761|NCT03500224|15957307|P1|Overall Study|Withdrawal by Subject|2
4650762|NCT03500211|15957346|P2|Overall Study|Withdrawal by Subject|1
4650763|NCT03500211|15957347|P1|Overall Study|Withdrawal by Subject|1
4650764|NCT03500198|15957363|P2|Overall Study|Lost to Follow-up|1
4650765|NCT03500198|15957364|P1|Overall Study|Lost to Follow-up|0
4650766|NCT03500159|15957380|P2|Overall Study|Study Terminated|1
4650767|NCT03500159|15957381|P1|Overall Study|Study Terminated|2
4650768|NCT03499067|15957387|P2|First Intervention|Withdrawal by Subject|6
4650769|NCT03499067|15957388|P1|First Intervention|Withdrawal by Subject|3
4650770|NCT03499067|15957387|P2|First Intervention|Physician Decision|1
4650771|NCT03499067|15957388|P1|First Intervention|Physician Decision|2
4650772|NCT03498560|15957428|P1|Overall Study|Death|1
4650773|NCT03498560|15957428|P1|Overall Study|Lost to Follow-up|4
4650774|NCT03498560|15957428|P1|Overall Study|Withdrawal by Subject|14
4650775|NCT03498560|15957428|P1|Overall Study|Found Ineligible|2
4650776|NCT03498287|15957445|P2|Overall Study|Adverse Event|1
4650777|NCT03498287|15957446|P1|Overall Study|Adverse Event|0
4650778|NCT03498287|15957445|P2|Overall Study|Protocol Violation|4
4650779|NCT03498287|15957446|P1|Overall Study|Protocol Violation|0
4650780|NCT03498287|15957445|P2|Overall Study|Withdrawal by Subject|0
4650781|NCT03498287|15957446|P1|Overall Study|Withdrawal by Subject|3
4650782|NCT03497130|15957540|P2|Overall Study|Lost to Follow-up|1
4650783|NCT03497130|15957541|P1|Overall Study|Lost to Follow-up|1
4650784|NCT03497039|15957553|P2|Overall Study|Protocol Violation|1
4650785|NCT03497039|15957554|P1|Overall Study|Protocol Violation|0
4650786|NCT03497039|15957553|P2|Overall Study|Withdrawal by Subject|0
4650787|NCT03497039|15957554|P1|Overall Study|Withdrawal by Subject|1
4650788|NCT03495102|15957691|P3|Overall Study|Participant was in Rehabilitation|0
4650789|NCT03495102|15957692|P2|Overall Study|Participant was in Rehabilitation|0
4650790|NCT03495102|15957693|P1|Overall Study|Participant was in Rehabilitation|1
4650791|NCT03495102|15957691|P3|Overall Study|Relocated to Another Country|0
4650792|NCT03495102|15957692|P2|Overall Study|Relocated to Another Country|1
4650793|NCT03495102|15957693|P1|Overall Study|Relocated to Another Country|0
4650794|NCT03495102|15957691|P3|Overall Study|Primary Care Physician Recommendation|0
4650795|NCT03495102|15957692|P2|Overall Study|Primary Care Physician Recommendation|1
4650796|NCT03495102|15957693|P1|Overall Study|Primary Care Physician Recommendation|0
4650797|NCT03495102|15957691|P3|Overall Study|Participant Duplicated at Another Site|1
4650798|NCT03495102|15957692|P2|Overall Study|Participant Duplicated at Another Site|0
4650799|NCT03495102|15957693|P1|Overall Study|Participant Duplicated at Another Site|0
4650800|NCT03495102|15957691|P3|Overall Study|Non-compliance|0
4650801|NCT03495102|15957692|P2|Overall Study|Non-compliance|0
4650802|NCT03495102|15957693|P1|Overall Study|Non-compliance|1
4650803|NCT03495102|15957691|P3|Overall Study|Site Closure|2
4650804|NCT03495102|15957692|P2|Overall Study|Site Closure|1
4650805|NCT03495102|15957693|P1|Overall Study|Site Closure|3
4650806|NCT03495102|15957691|P3|Overall Study|Protocol Violation|0
4650807|NCT03495102|15957692|P2|Overall Study|Protocol Violation|1
4650808|NCT03495102|15957693|P1|Overall Study|Protocol Violation|1
4650809|NCT03495102|15957691|P3|Overall Study|Withdrawal by Subject|18
4650810|NCT03495102|15957692|P2|Overall Study|Withdrawal by Subject|36
4650811|NCT03495102|15957693|P1|Overall Study|Withdrawal by Subject|25
4650812|NCT03495102|15957691|P3|Overall Study|Physician Decision|2
4650813|NCT03495102|15957692|P2|Overall Study|Physician Decision|0
4650814|NCT03495102|15957693|P1|Overall Study|Physician Decision|2
4650815|NCT03495102|15957691|P3|Overall Study|Lost to Follow-up|17
4650816|NCT03495102|15957692|P2|Overall Study|Lost to Follow-up|16
4650817|NCT03495102|15957693|P1|Overall Study|Lost to Follow-up|15
4650818|NCT03495102|15957691|P3|Overall Study|Death|4
4650819|NCT03495102|15957692|P2|Overall Study|Death|4
4650820|NCT03495102|15957693|P1|Overall Study|Death|3
4650821|NCT03495102|15957691|P3|Overall Study|Adverse Event|10
4650822|NCT03495102|15957692|P2|Overall Study|Adverse Event|7
4650823|NCT03495102|15957693|P1|Overall Study|Adverse Event|5
4650824|NCT03494985|15957723|P4|Overall Study|Other (Not specified)|0
4650825|NCT03494985|15957724|P3|Overall Study|Other (Not specified)|1
4650826|NCT03494985|15957725|P2|Overall Study|Other (Not specified)|1
4650827|NCT03494985|15957726|P1|Overall Study|Other (Not specified)|0
4650828|NCT03494985|15957723|P4|Overall Study|Other (Withdrawal of consent)|5
4650829|NCT03494985|15957724|P3|Overall Study|Other (Withdrawal of consent)|2
4650830|NCT03494985|15957725|P2|Overall Study|Other (Withdrawal of consent)|3
4650831|NCT03494985|15957726|P1|Overall Study|Other (Withdrawal of consent)|2
4650832|NCT03494985|15957723|P4|Overall Study|Adverse Event|0
4650833|NCT03494985|15957724|P3|Overall Study|Adverse Event|3
4650834|NCT03494985|15957725|P2|Overall Study|Adverse Event|2
4650835|NCT03494985|15957726|P1|Overall Study|Adverse Event|3
4650836|NCT03493854|15957762|P2|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|16
4650837|NCT03493854|15957763|P1|Treatment-Free Follow-Up (up to 3 Years)|Ongoing in Follow-Up|18
4650838|NCT03493854|15957762|P2|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
4650839|NCT03493854|15957763|P1|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|1
4650840|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Other|3
4650841|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Other|5
4650842|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|0
4650843|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2
4650844|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|0
4650845|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Protocol Violation|1
4650846|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0
4650847|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|3
4650848|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|1
4650849|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0
4650850|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
4650851|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|2
4650852|NCT03493854|15957762|P2|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|228
4650853|NCT03493854|15957763|P1|Surgery & Adjuvant Treatment (42 Weeks)|Ongoing Adjuvant Treatment|229
4650854|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|0
4650855|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
4650856|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Other|2
4650857|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Other|1
4650858|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
4650859|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3
4650860|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2
4650861|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1
4650862|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1
4650863|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0
4650864|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
4650865|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Death|1
4650866|NCT03493854|15957762|P2|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5
4650867|NCT03493854|15957763|P1|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3
4650868|NCT03493698|15957809|P1|Treatment Period C|Withdrawal by Subject|1
4650869|NCT03493698|15957809|P1|Treatment Period C|Adverse Event|1
4650870|NCT03493542|15957834|P2|Overall Study|Withdrawal by Subject|6
4650871|NCT03493542|15957835|P1|Overall Study|Withdrawal by Subject|2
4650872|NCT03493542|15957834|P2|Overall Study|Withdrawal by parent or guardian|0
4650873|NCT03493542|15957835|P1|Overall Study|Withdrawal by parent or guardian|3
4650874|NCT03493542|15957834|P2|Overall Study|Ongoing|3
4650875|NCT03493542|15957835|P1|Overall Study|Ongoing|2
4650876|NCT03493386|15957859|P4|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4650877|NCT03493386|15957860|P3|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4650878|NCT03493386|15957861|P2|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4650879|NCT03493386|15957862|P1|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4650880|NCT03492554|15957982|P2|Overall Study|Protocol Violation|14
4650881|NCT03492554|15957983|P1|Overall Study|Protocol Violation|0
4650882|NCT03492398|15958004|P9|Overall Study|Withdrawal by Subject|0
4650883|NCT03492398|15958005|P8|Overall Study|Withdrawal by Subject|1
4650884|NCT03492398|15958006|P7|Overall Study|Withdrawal by Subject|0
4650885|NCT03492398|15958007|P6|Overall Study|Withdrawal by Subject|0
4650886|NCT03492398|15958008|P5|Overall Study|Withdrawal by Subject|0
4650887|NCT03492398|15958009|P4|Overall Study|Withdrawal by Subject|0
4650888|NCT03492398|15958010|P3|Overall Study|Withdrawal by Subject|0
4650889|NCT03492398|15958011|P2|Overall Study|Withdrawal by Subject|0
4650890|NCT03492398|15958012|P1|Overall Study|Withdrawal by Subject|0
4650891|NCT03492398|15958004|P9|Overall Study|Protocol Violation|0
4650892|NCT03492398|15958005|P8|Overall Study|Protocol Violation|0
4650893|NCT03492398|15958006|P7|Overall Study|Protocol Violation|1
4650894|NCT03492398|15958007|P6|Overall Study|Protocol Violation|0
4650895|NCT03492398|15958008|P5|Overall Study|Protocol Violation|0
4650896|NCT03492398|15958009|P4|Overall Study|Protocol Violation|0
4650897|NCT03492398|15958010|P3|Overall Study|Protocol Violation|0
4650898|NCT03492398|15958011|P2|Overall Study|Protocol Violation|0
4650899|NCT03492398|15958012|P1|Overall Study|Protocol Violation|0
4650900|NCT03491553|15958132|P6|Overall Study|Withdrew Consent|0
4650901|NCT03491553|15958133|P5|Overall Study|Withdrew Consent|0
4650902|NCT03491553|15958134|P4|Overall Study|Withdrew Consent|0
4650903|NCT03491553|15958135|P3|Overall Study|Withdrew Consent|0
4650904|NCT03491553|15958136|P2|Overall Study|Withdrew Consent|1
4650905|NCT03491553|15958137|P1|Overall Study|Withdrew Consent|1
4650906|NCT03491553|15958132|P6|Overall Study|Adverse Event|0
4650907|NCT03491553|15958133|P5|Overall Study|Adverse Event|0
4650908|NCT03491553|15958134|P4|Overall Study|Adverse Event|1
4650909|NCT03491553|15958135|P3|Overall Study|Adverse Event|0
4650910|NCT03491553|15958136|P2|Overall Study|Adverse Event|0
4650911|NCT03491553|15958137|P1|Overall Study|Adverse Event|0
4650912|NCT03491150|15958252|P2|Overall Study|Withdrawal by Subject|2
4650913|NCT03491150|15958253|P1|Overall Study|Withdrawal by Subject|1
4650914|NCT03491150|15958252|P2|Overall Study|Other|1
4650915|NCT03491150|15958253|P1|Overall Study|Other|0
4650916|NCT03491150|15958252|P2|Overall Study|Study Terminated by Sponsor|70
4650917|NCT03491150|15958253|P1|Overall Study|Study Terminated by Sponsor|74
4650918|NCT03491150|15958252|P2|Overall Study|Adverse Event|0
4650919|NCT03491150|15958253|P1|Overall Study|Adverse Event|1
4650920|NCT03489863|15958291|P2|Overall Study|Withdrawal by Subject|1
4650921|NCT03489863|15958292|P1|Overall Study|Withdrawal by Subject|0
4650922|NCT03489720|15958300|P2|Overall Study|Withdrawal by Subject|0
4650923|NCT03489720|15958301|P1|Overall Study|Withdrawal by Subject|2
4650924|NCT03489551|15958326|P1|Overall Study|Withdrawal by Subject|2
4650925|NCT03489304|15958330|P1|Overall Study|Lost to Follow-up|4
4650926|NCT03488927|15958339|P3|Overall Study|Withdrawal by Subject|217
4650927|NCT03488927|15958340|P2|Overall Study|Withdrawal by Subject|118
4650928|NCT03488927|15958341|P1|Overall Study|Withdrawal by Subject|44
4650929|NCT03488108|15958354|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
4650930|NCT03488108|15958355|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
4650931|NCT03488108|15958354|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
4650932|NCT03488108|15958355|P1|First Intervention (12 Weeks)|Withdrawal by Subject|0
4650933|NCT03486392|15958624|P5|Overall Study|Death|1
4650934|NCT03486392|15958625|P4|Overall Study|Death|0
4650935|NCT03486392|15958626|P3|Overall Study|Death|0
4650936|NCT03486392|15958627|P2|Overall Study|Death|0
4650937|NCT03486392|15958628|P1|Overall Study|Death|0
4650938|NCT03486392|15958624|P5|Overall Study|Withdrawal by Subject|1
4650939|NCT03486392|15958625|P4|Overall Study|Withdrawal by Subject|4
4650940|NCT03486392|15958626|P3|Overall Study|Withdrawal by Subject|6
4650941|NCT03486392|15958627|P2|Overall Study|Withdrawal by Subject|0
4650942|NCT03486392|15958628|P1|Overall Study|Withdrawal by Subject|3
4650943|NCT03486392|15958624|P5|Overall Study|Lost to Follow-up|2
4650944|NCT03486392|15958625|P4|Overall Study|Lost to Follow-up|5
4650945|NCT03486392|15958626|P3|Overall Study|Lost to Follow-up|8
4650946|NCT03486392|15958627|P2|Overall Study|Lost to Follow-up|0
4650947|NCT03486392|15958628|P1|Overall Study|Lost to Follow-up|0
4650948|NCT03483623|15958677|P1|Overall Study|43 complete sets achieved|1
4650949|NCT03482882|15958726|P1|Overall Study|Not further specified|1
4650950|NCT03482882|15958726|P1|Overall Study|Protocol Violation|2
4650951|NCT03482882|15958726|P1|Overall Study|Lost to Follow-up|1
4650952|NCT03482882|15958726|P1|Overall Study|Adverse Event|3
4650953|NCT03482453|15958787|P12|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650954|NCT03482453|15958788|P11|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1
4650955|NCT03482453|15958789|P10|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650956|NCT03482453|15958790|P9|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650957|NCT03482453|15958791|P8|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650958|NCT03482453|15958792|P7|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650959|NCT03482453|15958793|P6|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650960|NCT03482453|15958794|P5|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650961|NCT03482453|15958795|P4|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650962|NCT03482453|15958796|P3|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650963|NCT03482453|15958797|P2|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650964|NCT03482453|15958798|P1|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0
4650965|NCT03482011|15958917|P8|Follow-up Period (12 Weeks)|Lost to Follow-up|1
4650966|NCT03482011|15958918|P7|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650967|NCT03482011|15958919|P6|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650968|NCT03482011|15958920|P5|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650969|NCT03482011|15958921|P4|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650970|NCT03482011|15958922|P3|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650971|NCT03482011|15958923|P2|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650972|NCT03482011|15958924|P1|Follow-up Period (12 Weeks)|Lost to Follow-up|0
4650973|NCT03482011|15958917|P8|Follow-up Period (12 Weeks)|Physician Decision|1
4650974|NCT03482011|15958918|P7|Follow-up Period (12 Weeks)|Physician Decision|0
4650975|NCT03482011|15958919|P6|Follow-up Period (12 Weeks)|Physician Decision|0
4650976|NCT03482011|15958920|P5|Follow-up Period (12 Weeks)|Physician Decision|0
4650977|NCT03482011|15958921|P4|Follow-up Period (12 Weeks)|Physician Decision|0
4650978|NCT03482011|15958922|P3|Follow-up Period (12 Weeks)|Physician Decision|0
4650979|NCT03482011|15958923|P2|Follow-up Period (12 Weeks)|Physician Decision|0
4650980|NCT03482011|15958924|P1|Follow-up Period (12 Weeks)|Physician Decision|0
4650981|NCT03482011|15958917|P8|Follow-up Period (12 Weeks)|Lack of Efficacy|6
4650982|NCT03482011|15958918|P7|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4650983|NCT03482011|15958919|P6|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4650984|NCT03482011|15958920|P5|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4650985|NCT03482011|15958921|P4|Follow-up Period (12 Weeks)|Lack of Efficacy|3
4650986|NCT03482011|15958922|P3|Follow-up Period (12 Weeks)|Lack of Efficacy|1
4650987|NCT03482011|15958923|P2|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4650988|NCT03482011|15958924|P1|Follow-up Period (12 Weeks)|Lack of Efficacy|0
4650989|NCT03482011|15958917|P8|Follow-up Period (12 Weeks)|Adverse Event|4
4650990|NCT03482011|15958918|P7|Follow-up Period (12 Weeks)|Adverse Event|1
4650991|NCT03482011|15958919|P6|Follow-up Period (12 Weeks)|Adverse Event|0
4650992|NCT03482011|15958920|P5|Follow-up Period (12 Weeks)|Adverse Event|0
4650993|NCT03482011|15958921|P4|Follow-up Period (12 Weeks)|Adverse Event|0
4650994|NCT03482011|15958922|P3|Follow-up Period (12 Weeks)|Adverse Event|0
4650995|NCT03482011|15958923|P2|Follow-up Period (12 Weeks)|Adverse Event|0
4650996|NCT03482011|15958924|P1|Follow-up Period (12 Weeks)|Adverse Event|0
4650997|NCT03482011|15958917|P8|Follow-up Period (12 Weeks)|Withdrawal by Subject|5
4650998|NCT03482011|15958918|P7|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
4650999|NCT03482011|15958919|P6|Follow-up Period (12 Weeks)|Withdrawal by Subject|1
4651000|NCT03482011|15958920|P5|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4651001|NCT03482011|15958921|P4|Follow-up Period (12 Weeks)|Withdrawal by Subject|2
4651002|NCT03482011|15958922|P3|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4651003|NCT03482011|15958923|P2|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4651004|NCT03482011|15958924|P1|Follow-up Period (12 Weeks)|Withdrawal by Subject|0
4651005|NCT03482011|15958917|P8|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4651006|NCT03482011|15958918|P7|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4651007|NCT03482011|15958919|P6|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
4651008|NCT03482011|15958920|P5|Maintenance Period (36 Weeks)|Withdrawal by Subject|2
4651009|NCT03482011|15958921|P4|Maintenance Period (36 Weeks)|Withdrawal by Subject|1
4651010|NCT03482011|15958922|P3|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4651011|NCT03482011|15958923|P2|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4651012|NCT03482011|15958924|P1|Maintenance Period (36 Weeks)|Withdrawal by Subject|0
4651013|NCT03482011|15958917|P8|Maintenance Period (36 Weeks)|Physician Decision|1
4651014|NCT03482011|15958918|P7|Maintenance Period (36 Weeks)|Physician Decision|1
4651015|NCT03482011|15958919|P6|Maintenance Period (36 Weeks)|Physician Decision|1
4651016|NCT03482011|15958920|P5|Maintenance Period (36 Weeks)|Physician Decision|0
4651017|NCT03482011|15958921|P4|Maintenance Period (36 Weeks)|Physician Decision|1
4651018|NCT03482011|15958922|P3|Maintenance Period (36 Weeks)|Physician Decision|0
4651019|NCT03482011|15958923|P2|Maintenance Period (36 Weeks)|Physician Decision|0
4651020|NCT03482011|15958924|P1|Maintenance Period (36 Weeks)|Physician Decision|0
4651021|NCT03482011|15958917|P8|Maintenance Period (36 Weeks)|Lost to Follow-up|1
4651022|NCT03482011|15958918|P7|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4651023|NCT03482011|15958919|P6|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4651024|NCT03482011|15958920|P5|Maintenance Period (36 Weeks)|Lost to Follow-up|2
4651025|NCT03482011|15958921|P4|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4651026|NCT03482011|15958922|P3|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4651027|NCT03482011|15958923|P2|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4651028|NCT03482011|15958924|P1|Maintenance Period (36 Weeks)|Lost to Follow-up|0
4651029|NCT03482011|15958917|P8|Maintenance Period (36 Weeks)|Lack of Efficacy|9
4651030|NCT03482011|15958918|P7|Maintenance Period (36 Weeks)|Lack of Efficacy|0
4651031|NCT03482011|15958919|P6|Maintenance Period (36 Weeks)|Lack of Efficacy|1
4651032|NCT03482011|15958920|P5|Maintenance Period (36 Weeks)|Lack of Efficacy|1
4651033|NCT03482011|15958921|P4|Maintenance Period (36 Weeks)|Lack of Efficacy|2
4651034|NCT03482011|15958922|P3|Maintenance Period (36 Weeks)|Lack of Efficacy|1
4651035|NCT03482011|15958923|P2|Maintenance Period (36 Weeks)|Lack of Efficacy|0
4651036|NCT03482011|15958924|P1|Maintenance Period (36 Weeks)|Lack of Efficacy|0
4651037|NCT03482011|15958917|P8|Maintenance Period (36 Weeks)|Adverse Event|4
4651038|NCT03482011|15958918|P7|Maintenance Period (36 Weeks)|Adverse Event|1
4651039|NCT03482011|15958919|P6|Maintenance Period (36 Weeks)|Adverse Event|1
4651040|NCT03482011|15958920|P5|Maintenance Period (36 Weeks)|Adverse Event|0
4651041|NCT03482011|15958921|P4|Maintenance Period (36 Weeks)|Adverse Event|0
4651042|NCT03482011|15958922|P3|Maintenance Period (36 Weeks)|Adverse Event|0
4651043|NCT03482011|15958923|P2|Maintenance Period (36 Weeks)|Adverse Event|0
4651044|NCT03482011|15958924|P1|Maintenance Period (36 Weeks)|Adverse Event|0
4651045|NCT03482011|15958917|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
4651046|NCT03482011|15958918|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
4651047|NCT03482011|15958919|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
4651048|NCT03482011|15958920|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
4651049|NCT03482011|15958921|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
4651050|NCT03482011|15958922|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
4651051|NCT03482011|15958923|P2|Induction Period (16 Weeks)|Withdrawal by Subject|5
4651052|NCT03482011|15958924|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
4651053|NCT03482011|15958917|P8|Induction Period (16 Weeks)|Screen Failure|0
4651054|NCT03482011|15958918|P7|Induction Period (16 Weeks)|Screen Failure|0
4651055|NCT03482011|15958919|P6|Induction Period (16 Weeks)|Screen Failure|0
4651056|NCT03482011|15958920|P5|Induction Period (16 Weeks)|Screen Failure|0
4651057|NCT03482011|15958921|P4|Induction Period (16 Weeks)|Screen Failure|0
4651058|NCT03482011|15958922|P3|Induction Period (16 Weeks)|Screen Failure|0
4651059|NCT03482011|15958923|P2|Induction Period (16 Weeks)|Screen Failure|1
4651060|NCT03482011|15958924|P1|Induction Period (16 Weeks)|Screen Failure|0
4651061|NCT03482011|15958917|P8|Induction Period (16 Weeks)|Lost to Follow-up|0
4651062|NCT03482011|15958918|P7|Induction Period (16 Weeks)|Lost to Follow-up|0
4651063|NCT03482011|15958919|P6|Induction Period (16 Weeks)|Lost to Follow-up|0
4651064|NCT03482011|15958920|P5|Induction Period (16 Weeks)|Lost to Follow-up|0
4651065|NCT03482011|15958921|P4|Induction Period (16 Weeks)|Lost to Follow-up|0
4651066|NCT03482011|15958922|P3|Induction Period (16 Weeks)|Lost to Follow-up|0
4651067|NCT03482011|15958923|P2|Induction Period (16 Weeks)|Lost to Follow-up|1
4651068|NCT03482011|15958924|P1|Induction Period (16 Weeks)|Lost to Follow-up|0
4651069|NCT03482011|15958917|P8|Induction Period (16 Weeks)|Lack of Efficacy|0
4651070|NCT03482011|15958918|P7|Induction Period (16 Weeks)|Lack of Efficacy|0
4651071|NCT03482011|15958919|P6|Induction Period (16 Weeks)|Lack of Efficacy|0
4651072|NCT03482011|15958920|P5|Induction Period (16 Weeks)|Lack of Efficacy|0
4651073|NCT03482011|15958921|P4|Induction Period (16 Weeks)|Lack of Efficacy|0
4651074|NCT03482011|15958922|P3|Induction Period (16 Weeks)|Lack of Efficacy|0
4651075|NCT03482011|15958923|P2|Induction Period (16 Weeks)|Lack of Efficacy|1
4651076|NCT03482011|15958924|P1|Induction Period (16 Weeks)|Lack of Efficacy|3
4651077|NCT03482011|15958917|P8|Induction Period (16 Weeks)|Adverse Event|0
4651078|NCT03482011|15958918|P7|Induction Period (16 Weeks)|Adverse Event|0
4651079|NCT03482011|15958919|P6|Induction Period (16 Weeks)|Adverse Event|0
4651080|NCT03482011|15958920|P5|Induction Period (16 Weeks)|Adverse Event|0
4651081|NCT03482011|15958921|P4|Induction Period (16 Weeks)|Adverse Event|0
4651082|NCT03482011|15958922|P3|Induction Period (16 Weeks)|Adverse Event|0
4651083|NCT03482011|15958923|P2|Induction Period (16 Weeks)|Adverse Event|3
4651084|NCT03482011|15958924|P1|Induction Period (16 Weeks)|Adverse Event|1
4651085|NCT03481309|15958987|P6|Washout (at Least 3 Days)|Withdrawal by Subject|0
4651086|NCT03481309|15958988|P5|Washout (at Least 3 Days)|Withdrawal by Subject|0
4651087|NCT03481309|15958989|P4|Washout (at Least 3 Days)|Withdrawal by Subject|0
4651088|NCT03481309|15958990|P3|Washout (at Least 3 Days)|Withdrawal by Subject|0
4651089|NCT03481309|15958991|P2|Washout (at Least 3 Days)|Withdrawal by Subject|0
4651090|NCT03481309|15958992|P1|Washout (at Least 3 Days)|Withdrawal by Subject|1
4651091|NCT03480841|15959034|P1|Overall Study|Lost to Follow-up|2
4651092|NCT03480425|15959043|P1|Overall Study|Force transducer technical failure|1
4651093|NCT03480152|15959049|P3|Phase I|Signed consent. Died before treatment.|0
4651094|NCT03480152|15959050|P2|Phase I|Signed consent. Died before treatment.|0
4651095|NCT03480152|15959051|P1|Phase I|Signed consent. Died before treatment.|1
4651096|NCT03480009|15959081|P4|Overall Study|Lost to Follow-up|0
4651097|NCT03480009|15959082|P3|Overall Study|Lost to Follow-up|4
4651098|NCT03480009|15959083|P2|Overall Study|Lost to Follow-up|5
4651099|NCT03480009|15959084|P1|Overall Study|Lost to Follow-up|4
4651100|NCT03479216|15959119|P2|Overall Study|Physician Decision|3
4651101|NCT03479216|15959120|P1|Overall Study|Physician Decision|2
4651102|NCT03479216|15959119|P2|Overall Study|Withdrawal by Subject|2
4651103|NCT03479216|15959120|P1|Overall Study|Withdrawal by Subject|3
4651104|NCT03478956|15959140|P2|Overall Study|Ongoing in the Study|11
4651105|NCT03478956|15959141|P1|Overall Study|Ongoing in the Study|11
4651106|NCT03478956|15959140|P2|Overall Study|Withdrawal by Subject|1
4651107|NCT03478956|15959141|P1|Overall Study|Withdrawal by Subject|0
4651108|NCT03478956|15959140|P2|Overall Study|Adverse Event|0
4651109|NCT03478956|15959141|P1|Overall Study|Adverse Event|1
4651110|NCT03478891|15959170|P3|Overall Study|Lost to Follow-up|1
4651111|NCT03478891|15959171|P2|Overall Study|Lost to Follow-up|0
4651112|NCT03478891|15959172|P1|Overall Study|Lost to Follow-up|1
4651113|NCT03478891|15959170|P3|Overall Study|Moved from area|1
4651114|NCT03478891|15959171|P2|Overall Study|Moved from area|0
4651115|NCT03478891|15959172|P1|Overall Study|Moved from area|0
4651116|NCT03478891|15959170|P3|Overall Study|Enrolled, but product never administered|1
4651117|NCT03478891|15959171|P2|Overall Study|Enrolled, but product never administered|0
4651118|NCT03478891|15959172|P1|Overall Study|Enrolled, but product never administered|0
4651119|NCT03478696|15959223|P2|Overall Study|Withdrawal by Subject|4
4651120|NCT03478696|15959224|P1|Overall Study|Withdrawal by Subject|9
4651121|NCT03478696|15959223|P2|Overall Study|Physician Decision|3
4651122|NCT03478696|15959224|P1|Overall Study|Physician Decision|6
4651123|NCT03478696|15959223|P2|Overall Study|Lost to Follow-up|0
4651124|NCT03478696|15959224|P1|Overall Study|Lost to Follow-up|1
4651125|NCT03478696|15959223|P2|Overall Study|Adverse Event|5
4651126|NCT03478696|15959224|P1|Overall Study|Adverse Event|1
4651127|NCT03478683|15959238|P2|Overall Study|Withdrawal by Subject|7
4651128|NCT03478683|15959239|P1|Overall Study|Withdrawal by Subject|7
4651129|NCT03478683|15959238|P2|Overall Study|Physician Decision|3
4651130|NCT03478683|15959239|P1|Overall Study|Physician Decision|1
4651131|NCT03478683|15959238|P2|Overall Study|Lost to Follow-up|5
4651132|NCT03478683|15959239|P1|Overall Study|Lost to Follow-up|0
4651133|NCT03478683|15959238|P2|Overall Study|Adverse Event|3
4651134|NCT03478683|15959239|P1|Overall Study|Adverse Event|5
4651135|NCT03478657|15959253|P2|Overall Study|Withdrawal by Subject|1
4651136|NCT03478657|15959254|P1|Overall Study|Withdrawal by Subject|0
4651137|NCT03478644|15959269|P2|Phase 2|Lost to Follow-up|0
4651138|NCT03478644|15959270|P1|Phase 2|Lost to Follow-up|1
4651139|NCT03478644|15959269|P2|Phase 2|Withdrawal by Subject|1
4651140|NCT03478644|15959270|P1|Phase 2|Withdrawal by Subject|2
4651141|NCT03478371|15959282|P1|Overall Study|Lost to Follow-up|4
4651142|NCT03478371|15959282|P1|Overall Study|non-compliance|1
4651143|NCT03477903|15959304|P1|Overall Study|Study Terminated by Sponsor|1
4651144|NCT03476239|15959380|P1|Overall Study|Did not receive study drug|1
4651145|NCT03476239|15959380|P1|Overall Study|Data Not Available|15
4651146|NCT03476239|15959380|P1|Overall Study|Lost to Follow-up|2
4651147|NCT03476239|15959380|P1|Overall Study|Death|39
4651148|NCT03476239|15959380|P1|Overall Study|Withdrawal by Subject|6
4651149|NCT03476239|15959380|P1|Overall Study|Continuing study|43
4651150|NCT03475875|15959430|P2|Period 2|Protocol Violation|1
4651151|NCT03475875|15959431|P1|Period 2|Protocol Violation|0
4651152|NCT03475875|15959430|P2|Period 2|Adverse Event|0
4651153|NCT03475875|15959431|P1|Period 2|Adverse Event|3
4651154|NCT03475875|15959430|P2|Period 1|Adverse Event|1
4651155|NCT03475875|15959431|P1|Period 1|Adverse Event|2
4651156|NCT03475875|15959430|P2|Period 1|Lost to Follow-up|0
4651157|NCT03475875|15959431|P1|Period 1|Lost to Follow-up|1
4651158|NCT03474081|15959469|P2|Overall Study|Investigator site closed|0
4651159|NCT03474081|15959470|P1|Overall Study|Investigator site closed|1
4651160|NCT03474081|15959469|P2|Overall Study|Withdrawal by Subject|7
4651161|NCT03474081|15959470|P1|Overall Study|Withdrawal by Subject|5
4651162|NCT03474081|15959469|P2|Overall Study|Physician Decision|2
4651163|NCT03474081|15959470|P1|Overall Study|Physician Decision|3
4651164|NCT03474081|15959469|P2|Overall Study|Lost to Follow-up|1
4651165|NCT03474081|15959470|P1|Overall Study|Lost to Follow-up|2
4651166|NCT03474081|15959469|P2|Overall Study|Adverse Event|3
4651167|NCT03474081|15959470|P1|Overall Study|Adverse Event|6
4651168|NCT03473808|15959511|P1|Overall Study|Withdrawal by Subject|1
4651169|NCT03473236|15959543|P10|Overall Study|Withdrawal by Subject|0
4651170|NCT03473236|15959544|P9|Overall Study|Withdrawal by Subject|1
4651171|NCT03473236|15959545|P8|Overall Study|Withdrawal by Subject|0
4651172|NCT03473236|15959546|P7|Overall Study|Withdrawal by Subject|0
4651173|NCT03473236|15959547|P6|Overall Study|Withdrawal by Subject|1
4651174|NCT03473236|15959548|P5|Overall Study|Withdrawal by Subject|0
4651175|NCT03473236|15959549|P4|Overall Study|Withdrawal by Subject|0
4651176|NCT03473236|15959550|P3|Overall Study|Withdrawal by Subject|0
4651177|NCT03473236|15959551|P2|Overall Study|Withdrawal by Subject|0
4651178|NCT03473236|15959552|P1|Overall Study|Withdrawal by Subject|0
4651179|NCT03473197|15959719|P1|Overall Study|Withdrawal by Subject|5
4651180|NCT03473197|15959719|P1|Overall Study|Lost to Follow-up|1
4651181|NCT03473197|15959719|P1|Overall Study|Adverse Event|4
4651182|NCT03472547|15959731|P1|Overall Study|Withdrawal by Subject|30
4651183|NCT03472534|15959735|P1|Overall Study|Adverse Event|2
4651184|NCT03472534|15959735|P1|Overall Study|Withdrawal by Subject|9
4651185|NCT03472014|15959748|P1|Overall Study|Lost to Follow-up|4
4651186|NCT03471871|15959770|P5|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4651187|NCT03471871|15959771|P4|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1
4651188|NCT03471871|15959772|P3|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4651189|NCT03471871|15959773|P2|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4651190|NCT03471871|15959774|P1|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0
4651191|NCT03471871|15959770|P5|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1
4651192|NCT03471871|15959771|P4|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4651193|NCT03471871|15959772|P3|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4651194|NCT03471871|15959773|P2|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4651195|NCT03471871|15959774|P1|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0
4651196|NCT03471871|15959770|P5|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1
4651197|NCT03471871|15959771|P4|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4651198|NCT03471871|15959772|P3|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4651199|NCT03471871|15959773|P2|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4651200|NCT03471871|15959774|P1|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0
4651201|NCT03471871|15959770|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
4651202|NCT03471871|15959771|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1
4651203|NCT03471871|15959772|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
4651204|NCT03471871|15959773|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
4651205|NCT03471871|15959774|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0
4651206|NCT03471871|15959770|P5|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4651207|NCT03471871|15959771|P4|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4651208|NCT03471871|15959772|P3|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1
4651209|NCT03471871|15959773|P2|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4651210|NCT03471871|15959774|P1|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0
4651211|NCT03469349|15959888|P2|Overall Study|Adverse Event|4
4651212|NCT03469349|15959889|P1|Overall Study|Adverse Event|2
4651213|NCT03469349|15959888|P2|Overall Study|Lost to Follow-up|2
4651214|NCT03469349|15959889|P1|Overall Study|Lost to Follow-up|2
4651215|NCT03469349|15959888|P2|Overall Study|Progressive Disease|1
4651216|NCT03469349|15959889|P1|Overall Study|Progressive Disease|0
4651217|NCT03469349|15959888|P2|Overall Study|Withdrawal by Subject|3
4651218|NCT03469349|15959889|P1|Overall Study|Withdrawal by Subject|1
4651219|NCT03469336|15959905|P1|Overall Study|Adverse Event|1
4651220|NCT03469258|15959928|P1|Overall Study|Upon surgery, did not meet criteria|4
4651221|NCT03468543|15959977|P1|Overall Study|Protocol stopping rules met|3
4651222|NCT03467971|15959989|P2|Treatment Period 2|Withdrawal by Subject|1
4651223|NCT03467971|15959990|P1|Treatment Period 2|Withdrawal by Subject|0
4651224|NCT03467945|15960014|P4|Treatment Period 3|Withdrawal by Subject|1
4651225|NCT03467945|15960015|P3|Treatment Period 3|Withdrawal by Subject|2
4651226|NCT03467945|15960016|P2|Treatment Period 3|Withdrawal by Subject|0
4651227|NCT03467945|15960017|P1|Treatment Period 3|Withdrawal by Subject|1
4651228|NCT03467945|15960014|P4|Treatment Period 2|Withdrawal by Subject|0
4651229|NCT03467945|15960015|P3|Treatment Period 2|Withdrawal by Subject|0
4651230|NCT03467945|15960016|P2|Treatment Period 2|Withdrawal by Subject|1
4651231|NCT03467945|15960017|P1|Treatment Period 2|Withdrawal by Subject|0
4651232|NCT03467425|15960091|P2|Overall Study|Withdrawal by Subject|17
4651233|NCT03467425|15960092|P1|Overall Study|Withdrawal by Subject|15
4651234|NCT03467425|15960091|P2|Overall Study|Physician Decision|1
4651235|NCT03467425|15960092|P1|Overall Study|Physician Decision|2
4651236|NCT03467425|15960091|P2|Overall Study|Lost to Follow-up|25
4651237|NCT03467425|15960092|P1|Overall Study|Lost to Follow-up|18
4651238|NCT03467425|15960091|P2|Overall Study|Protocol Violation|1
4651239|NCT03467425|15960092|P1|Overall Study|Protocol Violation|0
4651240|NCT03467425|15960091|P2|Overall Study|Lack of Efficacy|1
4651241|NCT03467425|15960092|P1|Overall Study|Lack of Efficacy|3
4651242|NCT03467425|15960091|P2|Overall Study|Adverse Event|9
4651243|NCT03467425|15960092|P1|Overall Study|Adverse Event|9
4651244|NCT03466658|15960122|P1|Overall Study|Withdrawal by Subject|3
4651245|NCT03466086|15960128|P2|Period 1|Withdrawal by Subject|0
4651246|NCT03466086|15960129|P1|Period 1|Withdrawal by Subject|1
4651247|NCT03466086|15960128|P2|Period 1|Sponsor decision due to study timeline|0
4651248|NCT03466086|15960129|P1|Period 1|Sponsor decision due to study timeline|1
4651249|NCT03466073|15960143|P6|Overall Study|Death|1
4651250|NCT03466073|15960144|P5|Overall Study|Death|0
4651251|NCT03466073|15960145|P4|Overall Study|Death|0
4651252|NCT03466073|15960146|P3|Overall Study|Death|0
4651253|NCT03466073|15960147|P2|Overall Study|Death|0
4651254|NCT03466073|15960148|P1|Overall Study|Death|1
4651255|NCT03466060|15960181|P6|Period 2|Lens Handling Difficulties|0
4651256|NCT03466060|15960182|P5|Period 2|Lens Handling Difficulties|0
4651257|NCT03466060|15960183|P4|Period 2|Lens Handling Difficulties|0
4651258|NCT03466060|15960184|P3|Period 2|Lens Handling Difficulties|1
4651259|NCT03466060|15960185|P2|Period 2|Lens Handling Difficulties|0
4651260|NCT03466060|15960186|P1|Period 2|Lens Handling Difficulties|0
4651261|NCT03466060|15960181|P6|Period 1|Grade 2 Conjunctivitis|0
4651262|NCT03466060|15960182|P5|Period 1|Grade 2 Conjunctivitis|0
4651263|NCT03466060|15960183|P4|Period 1|Grade 2 Conjunctivitis|0
4651264|NCT03466060|15960184|P3|Period 1|Grade 2 Conjunctivitis|1
4651265|NCT03466060|15960185|P2|Period 1|Grade 2 Conjunctivitis|0
4651266|NCT03466060|15960186|P1|Period 1|Grade 2 Conjunctivitis|0
4651267|NCT03466060|15960181|P6|Period 1|Lost to Follow-up|0
4651268|NCT03466060|15960182|P5|Period 1|Lost to Follow-up|0
4651269|NCT03466060|15960183|P4|Period 1|Lost to Follow-up|1
4651270|NCT03466060|15960184|P3|Period 1|Lost to Follow-up|0
4651271|NCT03466060|15960185|P2|Period 1|Lost to Follow-up|0
4651272|NCT03466060|15960186|P1|Period 1|Lost to Follow-up|0
4651273|NCT03466060|15960181|P6|Period 1|Withdrawal by Subject|0
4651274|NCT03466060|15960182|P5|Period 1|Withdrawal by Subject|0
4651275|NCT03466060|15960183|P4|Period 1|Withdrawal by Subject|0
4651276|NCT03466060|15960184|P3|Period 1|Withdrawal by Subject|2
4651277|NCT03466060|15960185|P2|Period 1|Withdrawal by Subject|0
4651278|NCT03466060|15960186|P1|Period 1|Withdrawal by Subject|0
4651279|NCT03466060|15960181|P6|Period 1|Test Lens Damage|0
4651280|NCT03466060|15960182|P5|Period 1|Test Lens Damage|0
4651281|NCT03466060|15960183|P4|Period 1|Test Lens Damage|0
4651282|NCT03466060|15960184|P3|Period 1|Test Lens Damage|0
4651283|NCT03466060|15960185|P2|Period 1|Test Lens Damage|2
4651284|NCT03466060|15960186|P1|Period 1|Test Lens Damage|0
4651285|NCT03465904|15960228|P2|Overall Study|Ineligible for mITT analysis|47
4651286|NCT03465904|15960229|P1|Overall Study|Ineligible for mITT analysis|62
4651287|NCT03465904|15960228|P2|Overall Study|Protocol Violation|5
4651288|NCT03465904|15960229|P1|Overall Study|Protocol Violation|8
4651289|NCT03465904|15960228|P2|Overall Study|Lost to Follow-up|9
4651290|NCT03465904|15960229|P1|Overall Study|Lost to Follow-up|10
4651291|NCT03465904|15960228|P2|Overall Study|Withdrawal by Subject|5
4651292|NCT03465904|15960229|P1|Overall Study|Withdrawal by Subject|9
4651293|NCT03465878|15960249|P4|Period 1-Part B First Intervention Day 1|Physician Decision|1
4651294|NCT03465878|15960250|P3|Period 1-Part B First Intervention Day 1|Physician Decision|0
4651295|NCT03465878|15960251|P2|Period 1-Part B First Intervention Day 1|Physician Decision|0
4651296|NCT03465878|15960252|P1|Period 1-Part B First Intervention Day 1|Physician Decision|0
4651297|NCT03465878|15960249|P4|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1
4651298|NCT03465878|15960250|P3|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
4651299|NCT03465878|15960251|P2|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
4651300|NCT03465878|15960252|P1|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0
4651301|NCT03465878|15960249|P4|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
4651302|NCT03465878|15960250|P3|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
4651303|NCT03465878|15960251|P2|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1
4651304|NCT03465878|15960252|P1|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0
4651305|NCT03465709|15960299|P1|Overall Study|Withdrawal by Subject|3
4651306|NCT03465709|15960299|P1|Overall Study|Study/Site Terminated by Sponsor|14
4651307|NCT03465436|15960311|P4|Period 4|Protocol Violation|0
4651308|NCT03465436|15960312|P3|Period 4|Protocol Violation|1
4651309|NCT03465436|15960313|P2|Period 4|Protocol Violation|0
4651310|NCT03465436|15960314|P1|Period 4|Protocol Violation|0
4651311|NCT03465436|15960311|P4|Period 3|Protocol Violation|0
4651312|NCT03465436|15960312|P3|Period 3|Protocol Violation|0
4651313|NCT03465436|15960313|P2|Period 3|Protocol Violation|1
4651314|NCT03465436|15960314|P1|Period 3|Protocol Violation|1
4651315|NCT03465436|15960311|P4|Period 2|Protocol Violation|0
4651316|NCT03465436|15960312|P3|Period 2|Protocol Violation|0
4651317|NCT03465436|15960313|P2|Period 2|Protocol Violation|1
4651318|NCT03465436|15960314|P1|Period 2|Protocol Violation|0
4651319|NCT03465436|15960311|P4|Period 1|Protocol Violation|0
4651320|NCT03465436|15960312|P3|Period 1|Protocol Violation|1
4651321|NCT03465436|15960313|P2|Period 1|Protocol Violation|0
4651322|NCT03465436|15960314|P1|Period 1|Protocol Violation|0
4651323|NCT03464383|15960351|P3|Overall Study|Withdrawal by Subject|0
4651324|NCT03464383|15960352|P2|Overall Study|Withdrawal by Subject|1
4651325|NCT03464383|15960353|P1|Overall Study|Withdrawal by Subject|0
4651326|NCT03464383|15960351|P3|Overall Study|Lost to Follow-up|0
4651327|NCT03464383|15960352|P2|Overall Study|Lost to Follow-up|0
4651328|NCT03464383|15960353|P1|Overall Study|Lost to Follow-up|1
4651329|NCT03463031|15960410|P2|Overall Study|Use of prohibited medication by subject|0
4651330|NCT03463031|15960411|P1|Overall Study|Use of prohibited medication by subject|1
4651331|NCT03463031|15960410|P2|Overall Study|Adverse Event|1
4651332|NCT03463031|15960411|P1|Overall Study|Adverse Event|4
4651333|NCT03463031|15960410|P2|Overall Study|Lost to Follow-up|1
4651334|NCT03463031|15960411|P1|Overall Study|Lost to Follow-up|1
4651335|NCT03463031|15960410|P2|Overall Study|Investigator/Sponsor Decision|1
4651336|NCT03463031|15960411|P1|Overall Study|Investigator/Sponsor Decision|0
4651337|NCT03463031|15960410|P2|Overall Study|Withdrawal by Subject|2
4651338|NCT03463031|15960411|P1|Overall Study|Withdrawal by Subject|4
4651339|NCT03461757|15960461|P2|Overall Study|Other Reasons|4
4651340|NCT03461757|15960462|P1|Overall Study|Other Reasons|1
4651341|NCT03461757|15960461|P2|Overall Study|Withdrawal by Subject|7
4651342|NCT03461757|15960462|P1|Overall Study|Withdrawal by Subject|7
4651343|NCT03461757|15960461|P2|Overall Study|Protocol Violation|1
4651344|NCT03461757|15960462|P1|Overall Study|Protocol Violation|1
4651345|NCT03461757|15960461|P2|Overall Study|Pregnancy|0
4651346|NCT03461757|15960462|P1|Overall Study|Pregnancy|2
4651347|NCT03461757|15960461|P2|Overall Study|Non-compliance with study treatment|1
4651348|NCT03461757|15960462|P1|Overall Study|Non-compliance with study treatment|0
4651349|NCT03461757|15960461|P2|Overall Study|Not Experienced Moderate/Severe Migraine|25
4651350|NCT03461757|15960462|P1|Overall Study|Not Experienced Moderate/Severe Migraine|28
4651351|NCT03461757|15960461|P2|Overall Study|Lost to Follow-up|7
4651352|NCT03461757|15960462|P1|Overall Study|Lost to Follow-up|13
4651353|NCT03461757|15960461|P2|Overall Study|Adverse Event|0
4651354|NCT03461757|15960462|P1|Overall Study|Adverse Event|1
4651355|NCT03459196|15960631|P1|Overall Study|Subject didn't receive study catheter|2
4651356|NCT03458702|15960675|P2|Study Condition B (Yoga or Rest)|Lost to Follow-up|2
4651357|NCT03458702|15960676|P1|Study Condition B (Yoga or Rest)|Lost to Follow-up|4
4651358|NCT03458702|15960675|P2|Study Condition A (Yoga or Rest)|Lost to Follow-up|6
4651359|NCT03458702|15960676|P1|Study Condition A (Yoga or Rest)|Lost to Follow-up|4
4651360|NCT03457727|15960705|P4|Part 2, Washout Period 1 (5 Days)|Adverse Event|1
4651361|NCT03457727|15960706|P3|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
4651362|NCT03457727|15960707|P2|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
4651363|NCT03457727|15960708|P1|Part 2, Washout Period 1 (5 Days)|Adverse Event|0
4651364|NCT03457636|15960905|P1|Overall Study|Lost to Follow-up|2
4651365|NCT03456960|15960918|P6|Period 2 (1 Day)|Adverse Event|0
4651366|NCT03456960|15960919|P5|Period 2 (1 Day)|Adverse Event|0
4651367|NCT03456960|15960920|P4|Period 2 (1 Day)|Adverse Event|1
4651368|NCT03456960|15960921|P3|Period 2 (1 Day)|Adverse Event|0
4651369|NCT03456960|15960922|P2|Period 2 (1 Day)|Adverse Event|0
4651370|NCT03456960|15960923|P1|Period 2 (1 Day)|Adverse Event|1
4651371|NCT03456960|15960918|P6|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4651372|NCT03456960|15960919|P5|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4651373|NCT03456960|15960920|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|2
4651374|NCT03456960|15960921|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
4651375|NCT03456960|15960922|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4651376|NCT03456960|15960923|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4651377|NCT03456856|15961015|P1|Overall Study|Withdrawal by Subject|1
4651378|NCT03456856|15961015|P1|Overall Study|Lost to Follow-up|2
4651379|NCT03456700|15961019|P1|Overall Study|Withdrawal by Subject|1
4651380|NCT03455543|15961051|P3|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1
4651381|NCT03455543|15961052|P2|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
4651382|NCT03455543|15961053|P1|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0
4651383|NCT03455543|15961051|P3|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2
4651384|NCT03455543|15961052|P2|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
4651385|NCT03455543|15961053|P1|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0
4651386|NCT03455543|15961051|P3|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4
4651387|NCT03455543|15961052|P2|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
4651388|NCT03455543|15961053|P1|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0
4651389|NCT03455543|15961051|P3|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7
4651390|NCT03455543|15961052|P2|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
4651391|NCT03455543|15961053|P1|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0
4651392|NCT03455543|15961051|P3|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20
4651393|NCT03455543|15961052|P2|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
4651394|NCT03455543|15961053|P1|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0
4651395|NCT03455543|15961051|P3|Part B: Open-label Extension (24 Weeks)|Adverse Event|3
4651396|NCT03455543|15961052|P2|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
4651397|NCT03455543|15961053|P1|Part B: Open-label Extension (24 Weeks)|Adverse Event|0
4651398|NCT03455543|15961051|P3|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
4651399|NCT03455543|15961052|P2|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0
4651400|NCT03455543|15961053|P1|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2
4651401|NCT03455543|15961051|P3|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0
4651402|NCT03455543|15961052|P2|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2
4651403|NCT03455543|15961053|P1|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7
4651404|NCT03455543|15961051|P3|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0
4651405|NCT03455543|15961052|P2|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5
4651406|NCT03455543|15961053|P1|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2
4651407|NCT03453151|15961242|P1|Overall Study|Physician Decision|3
4651408|NCT03453151|15961242|P1|Overall Study|Withdrawal by Subject|1
4651409|NCT03452943|15961479|P2|Maintenance Period (5 Weeks)|Withdrawal by Subject|0
4651410|NCT03452943|15961480|P1|Maintenance Period (5 Weeks)|Withdrawal by Subject|2
4651411|NCT03452943|15961479|P2|Maintenance Period (5 Weeks)|Adverse Event|0
4651412|NCT03452943|15961480|P1|Maintenance Period (5 Weeks)|Adverse Event|1
4651413|NCT03452943|15961479|P2|Titration Period (7 Weeks)|Lost to Follow-up|0
4651414|NCT03452943|15961480|P1|Titration Period (7 Weeks)|Lost to Follow-up|1
4651415|NCT03452943|15961479|P2|Titration Period (7 Weeks)|Withdrawal by Subject|2
4651416|NCT03452943|15961480|P1|Titration Period (7 Weeks)|Withdrawal by Subject|3
4651417|NCT03452943|15961479|P2|Titration Period (7 Weeks)|Protocol Violation|1
4651418|NCT03452943|15961480|P1|Titration Period (7 Weeks)|Protocol Violation|0
4651419|NCT03452943|15961479|P2|Titration Period (7 Weeks)|Adverse Event|1
4651420|NCT03452943|15961480|P1|Titration Period (7 Weeks)|Adverse Event|1
4651421|NCT03451721|15961532|P1|Overall Study|Death|1
4651422|NCT03450070|15961572|P1|Overall Study|Withdrawal by Subject|8
4651423|NCT03449979|15961580|P4|Overall Study|Technical difficulty|1
4651424|NCT03449979|15961581|P3|Overall Study|Technical difficulty|0
4651425|NCT03449979|15961582|P2|Overall Study|Technical difficulty|0
4651426|NCT03449979|15961583|P1|Overall Study|Technical difficulty|0
4651427|NCT03449758|15961593|P1|Overall Study|Other unspecified reason|3
4651428|NCT03449758|15961593|P1|Overall Study|Consent withdrawal|1
4651429|NCT03449758|15961593|P1|Overall Study|Adverse Event|9
4651430|NCT03449758|15961593|P1|Overall Study|Treatment inefficacy|5
4651431|NCT03449758|15961593|P1|Overall Study|Major protocol deviation|1
4651432|NCT03448536|15961667|P2|Overall Study|Physician Decision|0
4651433|NCT03448536|15961668|P1|Overall Study|Physician Decision|1
4651434|NCT03448536|15961667|P2|Overall Study|Other|0
4651435|NCT03448536|15961668|P1|Overall Study|Other|3
4651436|NCT03448536|15961667|P2|Overall Study|Inadequate pain reporter|0
4651437|NCT03448536|15961668|P1|Overall Study|Inadequate pain reporter|1
4651438|NCT03448536|15961667|P2|Overall Study|Lost to Follow-up|2
4651439|NCT03448536|15961668|P1|Overall Study|Lost to Follow-up|3
4651440|NCT03448536|15961667|P2|Overall Study|Withdrawal by Subject|2
4651441|NCT03448536|15961668|P1|Overall Study|Withdrawal by Subject|1
4651442|NCT03448536|15961667|P2|Overall Study|Pregnancy|0
4651443|NCT03448536|15961668|P1|Overall Study|Pregnancy|1
4651444|NCT03448536|15961667|P2|Overall Study|Protocol Violation|0
4651445|NCT03448536|15961668|P1|Overall Study|Protocol Violation|2
4651446|NCT03448419|15961694|P2|Overall Study|Withdrawn by Sponsor|1
4651447|NCT03448419|15961695|P1|Overall Study|Withdrawn by Sponsor|0
4651448|NCT03448419|15961694|P2|Overall Study|Patient did not attend all visits|2
4651449|NCT03448419|15961695|P1|Overall Study|Patient did not attend all visits|0
4651450|NCT03448419|15961694|P2|Overall Study|Not treated|1
4651451|NCT03448419|15961695|P1|Overall Study|Not treated|0
4651452|NCT03448419|15961694|P2|Overall Study|Withdrawal by Subject|1
4651453|NCT03448419|15961695|P1|Overall Study|Withdrawal by Subject|3
4651454|NCT03448419|15961694|P2|Overall Study|Lost to Follow-up|2
4651455|NCT03448419|15961695|P1|Overall Study|Lost to Follow-up|0
4651456|NCT03448419|15961694|P2|Overall Study|Adverse Event|9
4651457|NCT03448419|15961695|P1|Overall Study|Adverse Event|10
4651458|NCT03448224|15961721|P2|Overall Study|Provided same answer to every question|0
4651459|NCT03448224|15961722|P1|Overall Study|Provided same answer to every question|1
4651460|NCT03447821|15961739|P3|Overall Study|Lost to Follow-up|1
4651461|NCT03447821|15961740|P2|Overall Study|Lost to Follow-up|0
4651462|NCT03447821|15961741|P1|Overall Study|Lost to Follow-up|0
4651463|NCT03447821|15961739|P3|Overall Study|Withdrawal by Subject|0
4651464|NCT03447821|15961740|P2|Overall Study|Withdrawal by Subject|1
4651465|NCT03447821|15961741|P1|Overall Study|Withdrawal by Subject|1
4651466|NCT03447730|15961767|P3|Overall Study|Adverse Event|0
4651467|NCT03447730|15961768|P2|Overall Study|Adverse Event|2
4651468|NCT03447730|15961769|P1|Overall Study|Adverse Event|0
4651469|NCT03447353|15961796|P1|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1
4651470|NCT03447353|15961796|P1|Overall Study|Scheduling Conflicts|3
4651471|NCT03447353|15961796|P1|Overall Study|Lost to Follow-up|4
4651472|NCT03447353|15961796|P1|Overall Study|Failure at Screening Visit|2
4651473|NCT03447249|15961812|P2|Overall Study|Other|0
4651474|NCT03447249|15961813|P1|Overall Study|Other|3
4651475|NCT03447249|15961812|P2|Overall Study|Withdrawal of consent (not due to AE)|0
4651476|NCT03447249|15961813|P1|Overall Study|Withdrawal of consent (not due to AE)|1
4651477|NCT03447249|15961812|P2|Overall Study|Adverse Event|0
4651478|NCT03447249|15961813|P1|Overall Study|Adverse Event|1
4651479|NCT03446781|15961863|P2|Overall Study|Protocol Violation|3
4651480|NCT03446781|15961864|P1|Overall Study|Protocol Violation|0
4651481|NCT03446781|15961863|P2|Overall Study|Adverse Event|2
4651482|NCT03446781|15961864|P1|Overall Study|Adverse Event|8
4651483|NCT03446781|15961863|P2|Overall Study|Withdrawal by Subject|7
4651484|NCT03446781|15961864|P1|Overall Study|Withdrawal by Subject|9
4651485|NCT03446781|15961863|P2|Overall Study|Lost to Follow-up|5
4651486|NCT03446781|15961864|P1|Overall Study|Lost to Follow-up|11
4651487|NCT03446573|15961922|P2|Overall Study|Ongoing at the time of interim analysis|343
4651488|NCT03446573|15961923|P1|Overall Study|Ongoing at the time of interim analysis|342
4651489|NCT03446573|15961922|P2|Overall Study|Adverse Event|2
4651490|NCT03446573|15961923|P1|Overall Study|Adverse Event|13
4651491|NCT03446573|15961922|P2|Overall Study|Lack of Efficacy|3
4651492|NCT03446573|15961923|P1|Overall Study|Lack of Efficacy|0
4651493|NCT03446573|15961922|P2|Overall Study|Protocol Violation|2
4651494|NCT03446573|15961923|P1|Overall Study|Protocol Violation|3
4651495|NCT03446573|15961922|P2|Overall Study|Lost to Follow-up|5
4651496|NCT03446573|15961923|P1|Overall Study|Lost to Follow-up|3
4651497|NCT03446573|15961922|P2|Overall Study|Physician Decision|1
4651498|NCT03446573|15961923|P1|Overall Study|Physician Decision|1
4651499|NCT03446573|15961922|P2|Overall Study|Withdrawal by Subject|16
4651500|NCT03446573|15961923|P1|Overall Study|Withdrawal by Subject|7
4651501|NCT03444584|15962045|P2|Overall Study|Other|1
4651502|NCT03444584|15962046|P1|Overall Study|Other|0
4651503|NCT03444584|15962045|P2|Overall Study|Withdrawal by Subject|1
4651504|NCT03444584|15962046|P1|Overall Study|Withdrawal by Subject|0
4651505|NCT03443713|15962116|P3|First at Home Period (9-14 Days)|Withdrawal by Subject|1
4651506|NCT03443713|15962117|P2|First at Home Period (9-14 Days)|Withdrawal by Subject|0
4651507|NCT03443713|15962118|P1|First at Home Period (9-14 Days)|Withdrawal by Subject|0
4651508|NCT03443414|15962152|P5|Overall Study|Reason not specified|1
4651509|NCT03443414|15962153|P4|Overall Study|Reason not specified|0
4651510|NCT03443414|15962154|P3|Overall Study|Reason not specified|0
4651511|NCT03443414|15962155|P2|Overall Study|Reason not specified|0
4651512|NCT03443414|15962156|P1|Overall Study|Reason not specified|2
4651513|NCT03443414|15962152|P5|Overall Study|Death|0
4651514|NCT03443414|15962153|P4|Overall Study|Death|1
4651515|NCT03443414|15962154|P3|Overall Study|Death|0
4651516|NCT03443414|15962155|P2|Overall Study|Death|1
4651517|NCT03443414|15962156|P1|Overall Study|Death|0
4651518|NCT03443414|15962152|P5|Overall Study|Withdrawal by Subject|1
4651519|NCT03443414|15962153|P4|Overall Study|Withdrawal by Subject|2
4651520|NCT03443414|15962154|P3|Overall Study|Withdrawal by Subject|2
4651521|NCT03443414|15962155|P2|Overall Study|Withdrawal by Subject|2
4651522|NCT03443414|15962156|P1|Overall Study|Withdrawal by Subject|3
4651523|NCT03443414|15962152|P5|Overall Study|Adverse Event|3
4651524|NCT03443414|15962153|P4|Overall Study|Adverse Event|2
4651525|NCT03443414|15962154|P3|Overall Study|Adverse Event|4
4651526|NCT03443414|15962155|P2|Overall Study|Adverse Event|0
4651527|NCT03443414|15962156|P1|Overall Study|Adverse Event|6
4651528|NCT03442829|15962260|P2|Overall Study|Illness unrelated to study|1
4651529|NCT03442829|15962261|P1|Overall Study|Illness unrelated to study|1
4651530|NCT03442829|15962260|P2|Overall Study|Scheduling clash|1
4651531|NCT03442829|15962261|P1|Overall Study|Scheduling clash|3
4651532|NCT03442595|15962320|P2|Overall Study|Lost to Follow-up|0
4651533|NCT03442595|15962321|P1|Overall Study|Lost to Follow-up|94
4651534|NCT03441984|15962353|P12|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651535|NCT03441984|15962354|P11|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651536|NCT03441984|15962355|P10|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651537|NCT03441984|15962356|P9|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651538|NCT03441984|15962357|P8|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651539|NCT03441984|15962358|P7|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651540|NCT03441984|15962359|P6|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651541|NCT03441984|15962360|P5|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651542|NCT03441984|15962361|P4|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651543|NCT03441984|15962362|P3|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1
4651544|NCT03441984|15962363|P2|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651545|NCT03441984|15962364|P1|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0
4651546|NCT03441789|15962725|P2|Overall Study|Lost to Follow-up|1
4651547|NCT03441789|15962726|P1|Overall Study|Lost to Follow-up|0
4651548|NCT03441789|15962725|P2|Overall Study|Protocol Violation|1
4651549|NCT03441789|15962726|P1|Overall Study|Protocol Violation|0
4651550|NCT03441789|15962725|P2|Overall Study|Adverse Event|1
4651551|NCT03441789|15962726|P1|Overall Study|Adverse Event|0
4651552|NCT03441789|15962725|P2|Overall Study|Withdrawal by Subject|1
4651553|NCT03441789|15962726|P1|Overall Study|Withdrawal by Subject|1
4651554|NCT03440918|15962947|P2|Overall Study|Protocol Violation|16
4651555|NCT03440918|15962948|P1|Overall Study|Protocol Violation|0
4651556|NCT03439124|15963046|P2|Overall Study|Other reasons|0
4651557|NCT03439124|15963047|P1|Overall Study|Other reasons|1
4651558|NCT03439124|15963046|P2|Overall Study|Lost to Follow-up|0
4651559|NCT03439124|15963047|P1|Overall Study|Lost to Follow-up|1
4651560|NCT03439124|15963046|P2|Overall Study|Adverse Event|0
4651561|NCT03439124|15963047|P1|Overall Study|Adverse Event|2
4651562|NCT03439072|15963061|P2|Overall Study|Physician Decision|1
4651563|NCT03439072|15963062|P1|Overall Study|Physician Decision|0
4651564|NCT03439072|15963061|P2|Overall Study|Withdrawal by Subject|3
4651565|NCT03439072|15963062|P1|Overall Study|Withdrawal by Subject|2
4651566|NCT03438539|15963113|P6|Overall Study|Lost to Follow-up|8
4651567|NCT03438539|15963114|P5|Overall Study|Lost to Follow-up|3
4651568|NCT03438539|15963115|P4|Overall Study|Lost to Follow-up|9
4651569|NCT03438539|15963116|P3|Overall Study|Lost to Follow-up|10
4651570|NCT03438539|15963117|P2|Overall Study|Lost to Follow-up|4
4651571|NCT03438539|15963118|P1|Overall Study|Lost to Follow-up|8
4651572|NCT03438383|15963146|P2|Overall Study|Protocol Violation|3
4651573|NCT03438383|15963147|P1|Overall Study|Protocol Violation|9
4651574|NCT03437733|15963178|P2|Overall Study|Eligibility criteria not met|3
4651575|NCT03437733|15963179|P1|Overall Study|Eligibility criteria not met|0
4651576|NCT03437447|15963219|P3|Treatment Period 1|Withdrawal by Subject|1
4651577|NCT03437447|15963220|P2|Treatment Period 1|Withdrawal by Subject|0
4651578|NCT03437447|15963221|P1|Treatment Period 1|Withdrawal by Subject|0
4651579|NCT03436732|15963276|P2|Overall Study|Death|1
4651580|NCT03436732|15963277|P1|Overall Study|Death|0
4651581|NCT03436732|15963276|P2|Overall Study|Adverse Event|0
4651582|NCT03436732|15963277|P1|Overall Study|Adverse Event|2
4651583|NCT03436732|15963276|P2|Overall Study|Off study after cycle 1|0
4651584|NCT03436732|15963277|P1|Overall Study|Off study after cycle 1|1
4651585|NCT03436732|15963276|P2|Overall Study|Not treated-enrolled in different study|0
4651586|NCT03436732|15963277|P1|Overall Study|Not treated-enrolled in different study|1
4651587|NCT03435497|15963402|P2|Overall Study|Wrong survey administered|2
4651588|NCT03435497|15963403|P1|Overall Study|Wrong survey administered|0
4651589|NCT03435497|15963402|P2|Overall Study|Withdrawal by Subject|4
4651590|NCT03435497|15963403|P1|Overall Study|Withdrawal by Subject|0
4651591|NCT03435497|15963402|P2|Overall Study|Death|0
4651592|NCT03435497|15963403|P1|Overall Study|Death|1
4651593|NCT03435497|15963402|P2|Overall Study|Lost to Follow-up|0
4651594|NCT03435497|15963403|P1|Overall Study|Lost to Follow-up|1
4651595|NCT03434977|15963430|P2|Washout Period (at Least 6 Days)|Adverse Event|1
4651596|NCT03434977|15963431|P1|Washout Period (at Least 6 Days)|Adverse Event|0
4651597|NCT03434249|15963498|P2|Overall Study|Difficulties in completing daily diary|1
4651598|NCT03434249|15963499|P1|Overall Study|Difficulties in completing daily diary|2
4651599|NCT03434249|15963498|P2|Overall Study|Non-compliance of family|1
4651600|NCT03434249|15963499|P1|Overall Study|Non-compliance of family|2
4651601|NCT03434249|15963498|P2|Overall Study|Lost to Follow-up|1
4651602|NCT03434249|15963499|P1|Overall Study|Lost to Follow-up|0
4651603|NCT03434249|15963498|P2|Overall Study|Adverse Event|0
4651604|NCT03434249|15963499|P1|Overall Study|Adverse Event|1
4651605|NCT03434119|15963533|P2|Overall Study|Other than specified|5
4651606|NCT03434119|15963534|P1|Overall Study|Other than specified|7
4651607|NCT03434119|15963533|P2|Overall Study|Withdrawal by Subject|5
4651608|NCT03434119|15963534|P1|Overall Study|Withdrawal by Subject|7
4651609|NCT03434119|15963533|P2|Overall Study|Study Terminated by Sponsor|102
4651610|NCT03434119|15963534|P1|Overall Study|Study Terminated by Sponsor|91
4651611|NCT03434119|15963533|P2|Overall Study|Poor Compliance to Protocol|1
4651612|NCT03434119|15963534|P1|Overall Study|Poor Compliance to Protocol|0
4651613|NCT03434119|15963533|P2|Overall Study|Adverse Event|0
4651614|NCT03434119|15963534|P1|Overall Study|Adverse Event|1
4651615|NCT03434119|15963533|P2|Overall Study|Randomized but not treated|0
4651616|NCT03434119|15963534|P1|Overall Study|Randomized but not treated|1
4651617|NCT03433703|15963568|P1|Overall Study|Study terminated by Sponsor|2
4651618|NCT03433677|15963577|P2|Period 2|Withdrawal by Subject|1
4651619|NCT03433677|15963578|P1|Period 2|Withdrawal by Subject|1
4651620|NCT03433677|15963577|P2|Period 1|Protocol Violation|0
4651621|NCT03433677|15963578|P1|Period 1|Protocol Violation|1
4651622|NCT03432533|15963598|P2|Overall Study|Withdrawal by Subject|9
4651623|NCT03432533|15963599|P1|Overall Study|Withdrawal by Subject|14
4651624|NCT03432533|15963598|P2|Overall Study|Lost to Follow-up|2
4651625|NCT03432533|15963599|P1|Overall Study|Lost to Follow-up|1
4651626|NCT03432390|15963615|P2|Apnea Period|Protocol Violation|2
4651627|NCT03432390|15963616|P1|Apnea Period|Protocol Violation|2
4651628|NCT03431441|15963626|P1|Overall Study|Dispensed Incorrect Replacement Lens|1
4651629|NCT03431441|15963626|P1|Overall Study|Adverse Event|2
4651630|NCT03431441|15963626|P1|Overall Study|Withdrawal by Subject|2
4651631|NCT03430856|15963662|P3|Overall Study|Voluntary withdrawal of consent|1
4651632|NCT03430856|15963663|P2|Overall Study|Voluntary withdrawal of consent|1
4651633|NCT03430856|15963664|P1|Overall Study|Voluntary withdrawal of consent|1
4651634|NCT03430856|15963662|P3|Overall Study|Rescue criteria|0
4651635|NCT03430856|15963663|P2|Overall Study|Rescue criteria|1
4651636|NCT03430856|15963664|P1|Overall Study|Rescue criteria|1
4651637|NCT03430856|15963662|P3|Overall Study|Adverse Event|0
4651638|NCT03430856|15963663|P2|Overall Study|Adverse Event|1
4651639|NCT03430856|15963664|P1|Overall Study|Adverse Event|0
4651640|NCT03430245|15963702|P1|Overall Study|Lost to Follow-up|1
4651641|NCT03430245|15963702|P1|Overall Study|Withdrawal by Subject|6
4651642|NCT03429556|15963749|P4|Overall Study|Lost to Follow-up|0
4651643|NCT03429556|15963750|P3|Overall Study|Lost to Follow-up|0
4651644|NCT03429556|15963751|P2|Overall Study|Lost to Follow-up|1
4651645|NCT03429556|15963752|P1|Overall Study|Lost to Follow-up|0
4651646|NCT03428997|15963803|P1|Overall Study|Lost to Follow-up|4
4651647|NCT03428997|15963803|P1|Overall Study|Withdrawal by Subject|3
4651648|NCT03428997|15963803|P1|Overall Study|Sponsor decision.|1
4651649|NCT03428750|15963811|P2|Overall Study|Administrative|1
4651650|NCT03428750|15963812|P1|Overall Study|Administrative|0
4651651|NCT03428750|15963811|P2|Overall Study|Protocol Violation|0
4651652|NCT03428750|15963812|P1|Overall Study|Protocol Violation|1
4651653|NCT03428750|15963811|P2|Overall Study|Adverse Event|1
4651654|NCT03428750|15963812|P1|Overall Study|Adverse Event|9
4651655|NCT03428750|15963811|P2|Overall Study|Lost to Follow-up|9
4651656|NCT03428750|15963812|P1|Overall Study|Lost to Follow-up|3
4651657|NCT03428750|15963811|P2|Overall Study|Withdrawal by Subject|10
4651658|NCT03428750|15963812|P1|Overall Study|Withdrawal by Subject|11
4651659|NCT03428152|15963861|P2|Overall Study|Lack of Efficacy|4
4651660|NCT03428152|15963862|P1|Overall Study|Lack of Efficacy|0
4651661|NCT03428152|15963861|P2|Overall Study|Protocol Violation|5
4651662|NCT03428152|15963862|P1|Overall Study|Protocol Violation|3
4651663|NCT03428152|15963861|P2|Overall Study|Physician Decision|2
4651664|NCT03428152|15963862|P1|Overall Study|Physician Decision|4
4651665|NCT03427892|15963883|P1|Overall Study|Lost to Follow-up|2
4651666|NCT03427073|15963907|P8|Overall Study|Physician Decision|1
4651667|NCT03427073|15963908|P7|Overall Study|Physician Decision|1
4651668|NCT03427073|15963909|P6|Overall Study|Physician Decision|0
4651669|NCT03427073|15963910|P5|Overall Study|Physician Decision|0
4651670|NCT03427073|15963911|P4|Overall Study|Physician Decision|0
4651671|NCT03427073|15963912|P3|Overall Study|Physician Decision|0
4651672|NCT03427073|15963913|P2|Overall Study|Physician Decision|0
4651673|NCT03427073|15963914|P1|Overall Study|Physician Decision|0
4651674|NCT03427073|15963907|P8|Overall Study|Disease Progression|3
4651675|NCT03427073|15963908|P7|Overall Study|Disease Progression|2
4651676|NCT03427073|15963909|P6|Overall Study|Disease Progression|4
4651677|NCT03427073|15963910|P5|Overall Study|Disease Progression|3
4651678|NCT03427073|15963911|P4|Overall Study|Disease Progression|3
4651679|NCT03427073|15963912|P3|Overall Study|Disease Progression|1
4651680|NCT03427073|15963913|P2|Overall Study|Disease Progression|1
4651681|NCT03427073|15963914|P1|Overall Study|Disease Progression|1
4651682|NCT03426787|15963964|P1|Overall Study|Unrelated to intervention death|1
4651683|NCT03426787|15963964|P1|Overall Study|Lost to Follow-up|7
4651684|NCT03426787|15963964|P1|Overall Study|Withdrawal by Subject|6
4651685|NCT03426631|15963974|P2|Overall Study|Lost to Follow-up|1
4651686|NCT03426631|15963975|P1|Overall Study|Lost to Follow-up|0
4651687|NCT03426436|15963987|P1|Overall Study|ECGs not saved|4
4651688|NCT03426436|15963987|P1|Overall Study|Consent issue|1
4651689|NCT03426436|15963987|P1|Overall Study|Withdrawal by Subject|2
4651690|NCT03426436|15963987|P1|Overall Study|Incorrect lead placement|12
4651691|NCT03426137|15963995|P3|Overall Study|Withdrawal by Subject|0
4651692|NCT03426137|15963996|P2|Overall Study|Withdrawal by Subject|0
4651693|NCT03426137|15963997|P1|Overall Study|Withdrawal by Subject|3
4651694|NCT03425396|15964010|P5|Overall Study|Other|1
4651695|NCT03425396|15964011|P4|Overall Study|Other|0
4651696|NCT03425396|15964012|P3|Overall Study|Other|1
4651697|NCT03425396|15964013|P2|Overall Study|Other|1
4651698|NCT03425396|15964014|P1|Overall Study|Other|0
4651699|NCT03425396|15964010|P5|Overall Study|Withdrawal by Subject|0
4651700|NCT03425396|15964011|P4|Overall Study|Withdrawal by Subject|1
4651701|NCT03425396|15964012|P3|Overall Study|Withdrawal by Subject|0
4651702|NCT03425396|15964013|P2|Overall Study|Withdrawal by Subject|1
4651703|NCT03425396|15964014|P1|Overall Study|Withdrawal by Subject|0
4651704|NCT03425396|15964010|P5|Overall Study|Lost to Follow-up|0
4651705|NCT03425396|15964011|P4|Overall Study|Lost to Follow-up|0
4651706|NCT03425396|15964012|P3|Overall Study|Lost to Follow-up|2
4651707|NCT03425396|15964013|P2|Overall Study|Lost to Follow-up|5
4651708|NCT03425396|15964014|P1|Overall Study|Lost to Follow-up|2
4651709|NCT03424265|15964113|P2|Overall Study|Withdrawal by Subject|2
4651710|NCT03424265|15964114|P1|Overall Study|Withdrawal by Subject|0
4651711|NCT03424265|15964113|P2|Overall Study|screening failure|0
4651712|NCT03424265|15964114|P1|Overall Study|screening failure|1
4651713|NCT03424044|15964120|P9|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651714|NCT03424044|15964121|P8|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651715|NCT03424044|15964122|P7|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651716|NCT03424044|15964123|P6|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651717|NCT03424044|15964124|P5|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651718|NCT03424044|15964125|P4|Third Intervention (76 Hours)|Withdrawal by Subject|1
4651719|NCT03424044|15964126|P3|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651720|NCT03424044|15964127|P2|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651721|NCT03424044|15964128|P1|Third Intervention (76 Hours)|Withdrawal by Subject|0
4651722|NCT03424044|15964120|P9|Third Intervention (76 Hours)|Adverse Event|0
4651723|NCT03424044|15964121|P8|Third Intervention (76 Hours)|Adverse Event|0
4651724|NCT03424044|15964122|P7|Third Intervention (76 Hours)|Adverse Event|1
4651725|NCT03424044|15964123|P6|Third Intervention (76 Hours)|Adverse Event|0
4651726|NCT03424044|15964124|P5|Third Intervention (76 Hours)|Adverse Event|0
4651727|NCT03424044|15964125|P4|Third Intervention (76 Hours)|Adverse Event|0
4651728|NCT03424044|15964126|P3|Third Intervention (76 Hours)|Adverse Event|0
4651729|NCT03424044|15964127|P2|Third Intervention (76 Hours)|Adverse Event|0
4651730|NCT03424044|15964128|P1|Third Intervention (76 Hours)|Adverse Event|1
4651731|NCT03424044|15964120|P9|First Intervention (76 Hours)|device issues|1
4651732|NCT03424044|15964121|P8|First Intervention (76 Hours)|device issues|1
4651733|NCT03424044|15964122|P7|First Intervention (76 Hours)|device issues|1
4651734|NCT03424044|15964123|P6|First Intervention (76 Hours)|device issues|0
4651735|NCT03424044|15964124|P5|First Intervention (76 Hours)|device issues|0
4651736|NCT03424044|15964125|P4|First Intervention (76 Hours)|device issues|0
4651737|NCT03424044|15964126|P3|First Intervention (76 Hours)|device issues|0
4651738|NCT03424044|15964127|P2|First Intervention (76 Hours)|device issues|0
4651739|NCT03424044|15964128|P1|First Intervention (76 Hours)|device issues|0
4651740|NCT03424044|15964120|P9|First Intervention (76 Hours)|Adverse Event|0
4651741|NCT03424044|15964121|P8|First Intervention (76 Hours)|Adverse Event|0
4651742|NCT03424044|15964122|P7|First Intervention (76 Hours)|Adverse Event|0
4651743|NCT03424044|15964123|P6|First Intervention (76 Hours)|Adverse Event|0
4651744|NCT03424044|15964124|P5|First Intervention (76 Hours)|Adverse Event|1
4651745|NCT03424044|15964125|P4|First Intervention (76 Hours)|Adverse Event|0
4651746|NCT03424044|15964126|P3|First Intervention (76 Hours)|Adverse Event|0
4651747|NCT03424044|15964127|P2|First Intervention (76 Hours)|Adverse Event|0
4651748|NCT03424044|15964128|P1|First Intervention (76 Hours)|Adverse Event|0
4651749|NCT03424044|15964120|P9|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651750|NCT03424044|15964121|P8|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651751|NCT03424044|15964122|P7|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651752|NCT03424044|15964123|P6|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651753|NCT03424044|15964124|P5|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651754|NCT03424044|15964125|P4|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651755|NCT03424044|15964126|P3|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1
4651756|NCT03424044|15964127|P2|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651757|NCT03424044|15964128|P1|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0
4651758|NCT03423173|15964200|P4|Overall Study|Reason not Specified|1
4651759|NCT03423173|15964201|P3|Overall Study|Reason not Specified|3
4651760|NCT03423173|15964202|P2|Overall Study|Reason not Specified|5
4651761|NCT03423173|15964203|P1|Overall Study|Reason not Specified|2
4651762|NCT03423173|15964200|P4|Overall Study|Death|0
4651763|NCT03423173|15964201|P3|Overall Study|Death|0
4651764|NCT03423173|15964202|P2|Overall Study|Death|0
4651765|NCT03423173|15964203|P1|Overall Study|Death|1
4651766|NCT03423173|15964200|P4|Overall Study|Withdrawal of consent|5
4651767|NCT03423173|15964201|P3|Overall Study|Withdrawal of consent|4
4651768|NCT03423173|15964202|P2|Overall Study|Withdrawal of consent|10
4651769|NCT03423173|15964203|P1|Overall Study|Withdrawal of consent|4
4651770|NCT03423173|15964200|P4|Overall Study|Lost to Follow-up|22
4651771|NCT03423173|15964201|P3|Overall Study|Lost to Follow-up|17
4651772|NCT03423173|15964202|P2|Overall Study|Lost to Follow-up|19
4651773|NCT03423173|15964203|P1|Overall Study|Lost to Follow-up|10
4651774|NCT03423173|15964200|P4|Overall Study|Adverse Event|1
4651775|NCT03423173|15964201|P3|Overall Study|Adverse Event|1
4651776|NCT03423173|15964202|P2|Overall Study|Adverse Event|1
4651777|NCT03423173|15964203|P1|Overall Study|Adverse Event|1
4651778|NCT03423173|15964200|P4|Overall Study|Randomized but not vaccinated|1
4651779|NCT03423173|15964201|P3|Overall Study|Randomized but not vaccinated|2
4651780|NCT03423173|15964202|P2|Overall Study|Randomized but not vaccinated|0
4651781|NCT03423173|15964203|P1|Overall Study|Randomized but not vaccinated|1
4651782|NCT03421730|15964248|P12|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651783|NCT03421730|15964249|P11|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651784|NCT03421730|15964250|P10|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651785|NCT03421730|15964251|P9|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651786|NCT03421730|15964252|P8|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651787|NCT03421730|15964253|P7|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651788|NCT03421730|15964254|P6|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651789|NCT03421730|15964255|P5|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2
4651790|NCT03421730|15964256|P4|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651791|NCT03421730|15964257|P3|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651792|NCT03421730|15964258|P2|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651793|NCT03421730|15964259|P1|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0
4651794|NCT03421730|15964248|P12|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651795|NCT03421730|15964249|P11|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651796|NCT03421730|15964250|P10|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651797|NCT03421730|15964251|P9|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651798|NCT03421730|15964252|P8|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651799|NCT03421730|15964253|P7|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651800|NCT03421730|15964254|P6|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651801|NCT03421730|15964255|P5|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651802|NCT03421730|15964256|P4|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651803|NCT03421730|15964257|P3|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651804|NCT03421730|15964258|P2|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2
4651805|NCT03421730|15964259|P1|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0
4651806|NCT03421379|15964332|P2|Period 1|Did not receive treatment|2
4651807|NCT03421379|15964333|P1|Period 1|Did not receive treatment|1
4651808|NCT03421379|15964332|P2|Period 1|Physician Decision|1
4651809|NCT03421379|15964333|P1|Period 1|Physician Decision|1
4651810|NCT03421379|15964332|P2|Period 1|Withdrawal by Subject|1
4651811|NCT03421379|15964333|P1|Period 1|Withdrawal by Subject|0
4651812|NCT03420300|15964379|P1|Overall Study|Death|2
4651813|NCT03419962|15964388|P1|Overall Study|Missing completion data|31
4651814|NCT03419962|15964388|P1|Overall Study|Difficulty in inhaling the doses|1
4651815|NCT03419962|15964388|P1|Overall Study|Lost to Follow-up|3
4651816|NCT03419962|15964388|P1|Overall Study|Refusal of continuing with trial drug|1
4651817|NCT03419962|15964388|P1|Overall Study|Change to other medication|1
4651818|NCT03418571|15964447|P2|Overall Study|Consent withdrawn by legal guardian|0
4651819|NCT03418571|15964448|P1|Overall Study|Consent withdrawn by legal guardian|1
4651820|NCT03418376|15964460|P4|Overall Study|Exacerbation|0
4651821|NCT03418376|15964461|P3|Overall Study|Exacerbation|0
4651822|NCT03418376|15964462|P2|Overall Study|Exacerbation|1
4651823|NCT03418376|15964463|P1|Overall Study|Exacerbation|0
4651824|NCT03418376|15964460|P4|Overall Study|Personal reasons|1
4651825|NCT03418376|15964461|P3|Overall Study|Personal reasons|2
4651826|NCT03418376|15964462|P2|Overall Study|Personal reasons|2
4651827|NCT03418376|15964463|P1|Overall Study|Personal reasons|0
4651828|NCT03418376|15964460|P4|Overall Study|Musculoskeletal injury|0
4651829|NCT03418376|15964461|P3|Overall Study|Musculoskeletal injury|1
4651830|NCT03418376|15964462|P2|Overall Study|Musculoskeletal injury|2
4651831|NCT03418376|15964463|P1|Overall Study|Musculoskeletal injury|1
4651832|NCT03417830|15964521|P2|Part A (up to 26 Days)|Study Closed/Terminated|0
4651833|NCT03417830|15964522|P1|Part A (up to 26 Days)|Study Closed/Terminated|1
4651834|NCT03417505|15964656|P2|First Lens Type (30 Days)|Lost to Follow-up|1
4651835|NCT03417505|15964657|P1|First Lens Type (30 Days)|Lost to Follow-up|1
4651836|NCT03417219|15964688|P2|Overall Study|Lost to Follow-up|3
4651837|NCT03417219|15964689|P1|Overall Study|Lost to Follow-up|0
4651838|NCT03417141|15964699|P1|Overall Study|Protocol Violation|3
4651839|NCT03417141|15964699|P1|Overall Study|Withdrawal by Subject|1
4651840|NCT03417024|15964706|P1|Overall Study|Physician Decision|2
4651841|NCT03417024|15964706|P1|Overall Study|Study Termination prior to follow-up|11
4651842|NCT03416127|15964731|P3|Overall Study|Withdrawal by Subject|1
4651843|NCT03416127|15964732|P2|Overall Study|Withdrawal by Subject|1
4651844|NCT03416127|15964733|P1|Overall Study|Withdrawal by Subject|0
4651845|NCT03415178|15964877|P2|Single Arm Period (up to Week 16)|Adverse Event|1
4651846|NCT03415178|15964878|P1|Single Arm Period (up to Week 16)|Adverse Event|0
4651847|NCT03415178|15964877|P2|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2
4651848|NCT03415178|15964878|P1|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0
4651849|NCT03415022|15964932|P2|Overall Study|Lost to Follow-up|0
4651850|NCT03415022|15964933|P1|Overall Study|Lost to Follow-up|2
4651851|NCT03415022|15964932|P2|Overall Study|COVID-19 Suspension|3
4651852|NCT03415022|15964933|P1|Overall Study|COVID-19 Suspension|2
4651853|NCT03415022|15964932|P2|Overall Study|Withdrawal by Subject|2
4651854|NCT03415022|15964933|P1|Overall Study|Withdrawal by Subject|1
4651855|NCT03414359|15964943|P2|Overall Study|Protocol Violation|1
4651856|NCT03414359|15964944|P1|Overall Study|Protocol Violation|0
4651857|NCT03414359|15964943|P2|Overall Study|Lack of Efficacy|1
4651858|NCT03414359|15964944|P1|Overall Study|Lack of Efficacy|1
4651859|NCT03414047|15964956|P4|Overall Study|Withdrawal by Subject|2
4651860|NCT03414047|15964957|P3|Overall Study|Withdrawal by Subject|0
4651861|NCT03414047|15964958|P2|Overall Study|Withdrawal by Subject|0
4651862|NCT03414047|15964959|P1|Overall Study|Withdrawal by Subject|1
4651863|NCT03414047|15964956|P4|Overall Study|Adverse Event|1
4651864|NCT03414047|15964957|P3|Overall Study|Adverse Event|0
4651865|NCT03414047|15964958|P2|Overall Study|Adverse Event|0
4651866|NCT03414047|15964959|P1|Overall Study|Adverse Event|0
4651867|NCT03412929|15965019|P1|Overall Study|Protocol Violation|3
4651868|NCT03412019|15965030|P2|Overall Study|Withdrawal by Subject|1
4651869|NCT03412019|15965031|P1|Overall Study|Withdrawal by Subject|1
4651870|NCT03409796|15965048|P2|Overall Study|Other|1
4651871|NCT03409796|15965049|P1|Overall Study|Other|0
4651872|NCT03409796|15965048|P2|Overall Study|Adverse Event|0
4651873|NCT03409796|15965049|P1|Overall Study|Adverse Event|2
4651874|NCT03408639|15965117|P2|Overall Study|Physician Decision|6
4651875|NCT03408639|15965118|P1|Overall Study|Physician Decision|3
4651876|NCT03408639|15965117|P2|Overall Study|Withdrawal by Subject|7
4651877|NCT03408639|15965118|P1|Overall Study|Withdrawal by Subject|2
4651878|NCT03408639|15965117|P2|Overall Study|Lost to Follow-up|4
4651879|NCT03408639|15965118|P1|Overall Study|Lost to Follow-up|1
4651880|NCT03408639|15965117|P2|Overall Study|Death|5
4651881|NCT03408639|15965118|P1|Overall Study|Death|5
4651882|NCT03408483|15965148|P2|Overall Study|Lost to Follow-up|0
4651883|NCT03408483|15965149|P1|Overall Study|Lost to Follow-up|3
4651884|NCT03408483|15965148|P2|Overall Study|Physician Decision|3
4651885|NCT03408483|15965149|P1|Overall Study|Physician Decision|3
4651886|NCT03407430|15965272|P2|Washout|Protocol Violation|0
4651887|NCT03407430|15965273|P1|Washout|Protocol Violation|1
4651888|NCT03407170|15965305|P1|Overall Study|Adverse Event|1
4651889|NCT03407118|15965318|P2|Period 2|Withdrawal by Subject|0
4651890|NCT03407118|15965319|P1|Period 2|Withdrawal by Subject|1
4651891|NCT03406260|15965396|P6|Period 1|Adverse Event|0
4651892|NCT03406260|15965397|P5|Period 1|Adverse Event|1
4651893|NCT03406260|15965398|P4|Period 1|Adverse Event|0
4651894|NCT03406260|15965399|P3|Period 1|Adverse Event|0
4651895|NCT03406260|15965400|P2|Period 1|Adverse Event|0
4651896|NCT03406260|15965401|P1|Period 1|Adverse Event|0
4651897|NCT03405935|15965413|P1|Overall Study|Still on Study|83
4651898|NCT03405935|15965413|P1|Overall Study|Adverse Event|3
4651899|NCT03405818|15965424|P1|Overall Study|Lost to Follow-up|4
4651900|NCT03405818|15965424|P1|Overall Study|Withdrawal by Subject|4
4651901|NCT03404843|15965478|P2|Overall Study|Study difficulties unrelated to Tx|1
4651902|NCT03404843|15965479|P1|Overall Study|Study difficulties unrelated to Tx|4
4651903|NCT03404206|15965508|P3|Overall Study|Lost to Follow-up|0
4651904|NCT03404206|15965509|P2|Overall Study|Lost to Follow-up|1
4651905|NCT03404206|15965510|P1|Overall Study|Lost to Follow-up|3
4651906|NCT03404206|15965508|P3|Overall Study|Withdrawal by Subject|0
4651907|NCT03404206|15965509|P2|Overall Study|Withdrawal by Subject|1
4651908|NCT03404206|15965510|P1|Overall Study|Withdrawal by Subject|1
4651909|NCT03403413|15965638|P1|Overall Study|Lack of Efficacy|2
4651910|NCT03403400|15965656|P3|Overall Study|Benign Paroxysmal Positional Vertigo|1
4651911|NCT03403400|15965657|P2|Overall Study|Benign Paroxysmal Positional Vertigo|0
4651912|NCT03403400|15965658|P1|Overall Study|Benign Paroxysmal Positional Vertigo|0
4651913|NCT03403400|15965656|P3|Overall Study|Hospitalization|0
4651914|NCT03403400|15965657|P2|Overall Study|Hospitalization|0
4651915|NCT03403400|15965658|P1|Overall Study|Hospitalization|1
4651916|NCT03403400|15965656|P3|Overall Study|Lost to Follow-up|1
4651917|NCT03403400|15965657|P2|Overall Study|Lost to Follow-up|0
4651918|NCT03403400|15965658|P1|Overall Study|Lost to Follow-up|1
4651919|NCT03403036|15965690|P1|Overall Study|Lack of Efficacy|5
4651920|NCT03402893|15965717|P1|Overall Study|Withdrawal by Subject|1
4651921|NCT03402750|15965728|P2|Overall Study|Lost to Follow-up|1
4651922|NCT03402750|15965729|P1|Overall Study|Lost to Follow-up|2
4651923|NCT03400787|15965817|P2|Overall Study|Unblinded before 3-month follow-upa-|6
4651924|NCT03400787|15965818|P1|Overall Study|Unblinded before 3-month follow-upa-|0
4651925|NCT03400787|15965817|P2|Overall Study|Protocol Violation|2
4651926|NCT03400787|15965818|P1|Overall Study|Protocol Violation|0
4651927|NCT03400787|15965817|P2|Overall Study|Death|0
4651928|NCT03400787|15965818|P1|Overall Study|Death|1
4651929|NCT03400787|15965817|P2|Overall Study|Lost to Follow-up|0
4651930|NCT03400787|15965818|P1|Overall Study|Lost to Follow-up|1
4651931|NCT03398356|15966081|P3|After 6 Weeks of Treatment|Physician Decision|0
4651932|NCT03398356|15966082|P2|After 6 Weeks of Treatment|Physician Decision|2
4651933|NCT03398356|15966083|P1|After 6 Weeks of Treatment|Physician Decision|0
4651934|NCT03398356|15966081|P3|Before Treatment|Physician Decision|11
4651935|NCT03398356|15966082|P2|Before Treatment|Physician Decision|0
4651936|NCT03398356|15966083|P1|Before Treatment|Physician Decision|0
4651937|NCT03398356|15966081|P3|Before Treatment|Withdrawal by Subject|0
4651938|NCT03398356|15966082|P2|Before Treatment|Withdrawal by Subject|5
4651939|NCT03398356|15966083|P1|Before Treatment|Withdrawal by Subject|0
4651940|NCT03398356|15966081|P3|Before Treatment|drug intolerance|0
4651941|NCT03398356|15966082|P2|Before Treatment|drug intolerance|1
4651942|NCT03398356|15966083|P1|Before Treatment|drug intolerance|2
4651943|NCT03398356|15966081|P3|Before Treatment|Lost to Follow-up|0
4651944|NCT03398356|15966082|P2|Before Treatment|Lost to Follow-up|2
4651945|NCT03398356|15966083|P1|Before Treatment|Lost to Follow-up|1
4651946|NCT03397771|15966188|P2|Overall Study|Adverse Event|1
4651947|NCT03397771|15966189|P1|Overall Study|Adverse Event|2
4651948|NCT03397771|15966188|P2|Overall Study|Protocol Violation|2
4651949|NCT03397771|15966189|P1|Overall Study|Protocol Violation|2
4651950|NCT03397771|15966188|P2|Overall Study|Withdrawal by Subject|3
4651951|NCT03397771|15966189|P1|Overall Study|Withdrawal by Subject|1
4651952|NCT03397771|15966188|P2|Overall Study|2 erroneously randomized, never treated|1
4651953|NCT03397771|15966189|P1|Overall Study|2 erroneously randomized, never treated|3
4651954|NCT03396835|15966247|P1|Overall Study|Did not meet criteria for data analysis|1
4651955|NCT03396835|15966247|P1|Overall Study|Withdrawn prior to completion|1
4651956|NCT03394508|15966282|P2|Overall Study|Lost to Follow-up|0
4651957|NCT03394508|15966283|P1|Overall Study|Lost to Follow-up|1
4651958|NCT03394508|15966282|P2|Overall Study|Protocol Violation|3
4651959|NCT03394508|15966283|P1|Overall Study|Protocol Violation|0
4651960|NCT03394391|15966309|P2|Overall Study|Lost to Follow-up|2
4651961|NCT03394391|15966310|P1|Overall Study|Lost to Follow-up|1
4651962|NCT03393806|15966328|P2|Overall Study|Physician Decision|0
4651963|NCT03393806|15966329|P1|Overall Study|Physician Decision|1
4651964|NCT03392194|15966455|P2|Overall Study|Conflicts with personal schedule|0
4651965|NCT03392194|15966456|P1|Overall Study|Conflicts with personal schedule|1
4651966|NCT03392194|15966455|P2|Overall Study|Withdrawal by Subject|2
4651967|NCT03392194|15966456|P1|Overall Study|Withdrawal by Subject|1
4651968|NCT03390426|15966491|P2|Overall Study|Protocol Violation|1
4651969|NCT03390426|15966492|P1|Overall Study|Protocol Violation|0
4651970|NCT03390166|15966506|P2|Overall Study|Move to work oversea|1
4651971|NCT03390166|15966507|P1|Overall Study|Move to work oversea|0
4651972|NCT03390166|15966506|P2|Overall Study|To drug therapy course|1
4651973|NCT03390166|15966507|P1|Overall Study|To drug therapy course|0
4651974|NCT03390166|15966506|P2|Overall Study|To militarycamp for conscript|0
4651975|NCT03390166|15966507|P1|Overall Study|To militarycamp for conscript|1
4651976|NCT03390166|15966506|P2|Overall Study|Move from study area|2
4651977|NCT03390166|15966507|P1|Overall Study|Move from study area|3
4651978|NCT03390166|15966506|P2|Overall Study|Physician Decision|1
4651979|NCT03390166|15966507|P1|Overall Study|Physician Decision|2
4651980|NCT03390166|15966506|P2|Overall Study|Lost to Follow-up|4
4651981|NCT03390166|15966507|P1|Overall Study|Lost to Follow-up|6
4651982|NCT03390166|15966506|P2|Overall Study|Death|1
4651983|NCT03390166|15966507|P1|Overall Study|Death|0
4651984|NCT03389308|15966561|P1|Overall Study|Sponsor Request|2
4651985|NCT03389308|15966561|P1|Overall Study|Adverse Event|2
4651986|NCT03389308|15966561|P1|Overall Study|Lost to Follow-up|3
4651987|NCT03389308|15966561|P1|Overall Study|Withdrawal by Subject|5
4651988|NCT03387683|15966567|P2|Overall Study|Did not receive treatment|0
4651989|NCT03387683|15966568|P1|Overall Study|Did not receive treatment|1
4651990|NCT03387683|15966567|P2|Overall Study|In receipt of disallowed medication|0
4651991|NCT03387683|15966568|P1|Overall Study|In receipt of disallowed medication|1
4651992|NCT03387462|15966576|P1|Overall Study|Lost to Follow-up|1
4651993|NCT03387059|15966606|P2|Overall Study|Study termination|4
4651994|NCT03387059|15966607|P1|Overall Study|Study termination|5
4651995|NCT03387046|15966621|P2|Overall Study|Adverse Event|1
4651996|NCT03387046|15966622|P1|Overall Study|Adverse Event|1
4651997|NCT03386994|15966649|P1|Overall Study|Death|16
4651998|NCT03386994|15966649|P1|Overall Study|Withdrawal by Subject|3
4651999|NCT03386994|15966649|P1|Overall Study|Lost to Follow-up|4
4652000|NCT03386994|15966649|P1|Overall Study|Adverse Event|14
4652001|NCT03386994|15966649|P1|Overall Study|Lung transplant|1
4652002|NCT03386474|15966709|P2|Overall Study|Adverse Event|1
4652003|NCT03386474|15966710|P1|Overall Study|Adverse Event|0
4652004|NCT03386474|15966709|P2|Overall Study|Death|0
4652005|NCT03386474|15966710|P1|Overall Study|Death|1
4652006|NCT03386448|15966732|P2|Overall Study|Adverse Event|2
4652007|NCT03386448|15966733|P1|Overall Study|Adverse Event|0
4652008|NCT03386435|15966741|P2|Overall Study|Protocol Violation|7
4652009|NCT03386435|15966742|P1|Overall Study|Protocol Violation|5
4652010|NCT03384316|15966765|P2|Overall Study|Screen failure|1
4652011|NCT03384316|15966766|P1|Overall Study|Screen failure|0
4652012|NCT03383887|15966789|P2|Overall Study|Lost to Follow-up|1
4652013|NCT03383887|15966790|P1|Overall Study|Lost to Follow-up|0
4652014|NCT03383783|15966798|P1|Overall Study|Withdrawal by Subject|2
4652015|NCT03383614|15966876|P4|Overall Study|Withdrawal by Subject|0
4652016|NCT03383614|15966877|P3|Overall Study|Withdrawal by Subject|0
4652017|NCT03383614|15966878|P2|Overall Study|Withdrawal by Subject|1
4652018|NCT03383614|15966879|P1|Overall Study|Withdrawal by Subject|0
4652019|NCT03382912|15967136|P2|Overall Study|Withdrawal by Subject|5
4652020|NCT03382912|15967137|P1|Overall Study|Withdrawal by Subject|0
4652021|NCT03382912|15967136|P2|Overall Study|Sponsor Decision|6
4652022|NCT03382912|15967137|P1|Overall Study|Sponsor Decision|6
4652023|NCT03382912|15967136|P2|Overall Study|Physician Decision|1
4652024|NCT03382912|15967137|P1|Overall Study|Physician Decision|0
4652025|NCT03382834|15967153|P2|Overall Study|Withdrawal by Subject|1
4652026|NCT03382834|15967154|P1|Overall Study|Withdrawal by Subject|0
4652027|NCT03382834|15967153|P2|Overall Study|Lost to Follow-up|0
4652028|NCT03382834|15967154|P1|Overall Study|Lost to Follow-up|1
4652029|NCT03382262|15967178|P4|Overall Study|Withdrawal by Subject|1
4652030|NCT03382262|15967179|P3|Overall Study|Withdrawal by Subject|0
4652031|NCT03382262|15967180|P2|Overall Study|Withdrawal by Subject|0
4652032|NCT03382262|15967181|P1|Overall Study|Withdrawal by Subject|0
4652033|NCT03382262|15967178|P4|Overall Study|Physician Decision|0
4652034|NCT03382262|15967179|P3|Overall Study|Physician Decision|1
4652035|NCT03382262|15967180|P2|Overall Study|Physician Decision|0
4652036|NCT03382262|15967181|P1|Overall Study|Physician Decision|0
4652037|NCT03381248|15967239|P2|Overall Study|Protocol Violation|1
4652038|NCT03381248|15967240|P1|Overall Study|Protocol Violation|2
4652039|NCT03381248|15967239|P2|Overall Study|Adverse Event|0
4652040|NCT03381248|15967240|P1|Overall Study|Adverse Event|2
4652041|NCT03381248|15967239|P2|Overall Study|Lack of Efficacy|0
4652042|NCT03381248|15967240|P1|Overall Study|Lack of Efficacy|1
4652043|NCT03381248|15967239|P2|Overall Study|Lost to Follow-up|2
4652044|NCT03381248|15967240|P1|Overall Study|Lost to Follow-up|3
4652045|NCT03381248|15967239|P2|Overall Study|Withdrawal by Subject|3
4652046|NCT03381248|15967240|P1|Overall Study|Withdrawal by Subject|5
4652047|NCT03380429|15967347|P5|Overall Study|Adverse Event|0
4652048|NCT03380429|15967348|P4|Overall Study|Adverse Event|2
4652049|NCT03380429|15967349|P3|Overall Study|Adverse Event|1
4652050|NCT03380429|15967350|P2|Overall Study|Adverse Event|1
4652051|NCT03380429|15967351|P1|Overall Study|Adverse Event|1
4652052|NCT03380429|15967347|P5|Overall Study|Lack of Efficacy|1
4652053|NCT03380429|15967348|P4|Overall Study|Lack of Efficacy|2
4652054|NCT03380429|15967349|P3|Overall Study|Lack of Efficacy|0
4652055|NCT03380429|15967350|P2|Overall Study|Lack of Efficacy|0
4652056|NCT03380429|15967351|P1|Overall Study|Lack of Efficacy|0
4652057|NCT03380429|15967347|P5|Overall Study|Protocol Violation|1
4652058|NCT03380429|15967348|P4|Overall Study|Protocol Violation|0
4652059|NCT03380429|15967349|P3|Overall Study|Protocol Violation|1
4652060|NCT03380429|15967350|P2|Overall Study|Protocol Violation|0
4652061|NCT03380429|15967351|P1|Overall Study|Protocol Violation|1
4652062|NCT03380429|15967347|P5|Overall Study|Lost to Follow-up|1
4652063|NCT03380429|15967348|P4|Overall Study|Lost to Follow-up|3
4652064|NCT03380429|15967349|P3|Overall Study|Lost to Follow-up|4
4652065|NCT03380429|15967350|P2|Overall Study|Lost to Follow-up|2
4652066|NCT03380429|15967351|P1|Overall Study|Lost to Follow-up|0
4652067|NCT03380429|15967347|P5|Overall Study|Withdrawal by Subject|1
4652068|NCT03380429|15967348|P4|Overall Study|Withdrawal by Subject|2
4652069|NCT03380429|15967349|P3|Overall Study|Withdrawal by Subject|5
4652070|NCT03380429|15967350|P2|Overall Study|Withdrawal by Subject|3
4652071|NCT03380429|15967351|P1|Overall Study|Withdrawal by Subject|3
4652072|NCT03380429|15967347|P5|Overall Study|Physician Decision|1
4652073|NCT03380429|15967348|P4|Overall Study|Physician Decision|1
4652074|NCT03380429|15967349|P3|Overall Study|Physician Decision|0
4652075|NCT03380429|15967350|P2|Overall Study|Physician Decision|1
4652076|NCT03380429|15967351|P1|Overall Study|Physician Decision|0
4652077|NCT03380390|15967404|P1|Overall Study|Adverse Event|3
4652078|NCT03379506|15967500|P4|Overall Study|Ongoing in study|11
4652079|NCT03379506|15967501|P3|Overall Study|Ongoing in study|0
4652080|NCT03379506|15967502|P2|Overall Study|Ongoing in study|9
4652081|NCT03379506|15967503|P1|Overall Study|Ongoing in study|0
4652082|NCT03379376|15967553|P1|Overall Study|Death|1
4652083|NCT03379376|15967553|P1|Overall Study|Overwhelmed, didn't want to continue|1
4652084|NCT03379376|15967553|P1|Overall Study|Did not wish to complete follow up|1
4652085|NCT03379376|15967553|P1|Overall Study|Lost to Follow-up|2
4652086|NCT03379233|15967563|P2|Overall Study|Technical issues with Concept 2 inhalers|6
4652087|NCT03379233|15967564|P1|Overall Study|Technical issues with Concept 2 inhalers|1
4652088|NCT03376516|15967596|P1|Overall Study|Consent withdrawn|1
4652089|NCT03376516|15967596|P1|Overall Study|Not treated|1
4652090|NCT03374995|15967666|P2|Overall Study|Withdrawal by Subject|1
4652091|NCT03374995|15967667|P1|Overall Study|Withdrawal by Subject|0
4652092|NCT03374488|15967681|P2|Overall Study|On-going at clinical cut off date|28
4652093|NCT03374488|15967682|P1|Overall Study|On-going at clinical cut off date|30
4652094|NCT03374488|15967681|P2|Overall Study|Withdrawal by Subject|1
4652095|NCT03374488|15967682|P1|Overall Study|Withdrawal by Subject|1
4652096|NCT03374488|15967681|P2|Overall Study|Death|8
4652097|NCT03374488|15967682|P1|Overall Study|Death|10
4652098|NCT03374189|15967694|P2|Overall Study|Lost to Follow-up|0
4652099|NCT03374189|15967695|P1|Overall Study|Lost to Follow-up|1
4652100|NCT03372603|15967795|P2|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0
4652101|NCT03372603|15967796|P1|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1
4652102|NCT03372603|15967795|P2|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0
4652103|NCT03372603|15967796|P1|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1
4652104|NCT03372551|15967838|P2|First Intervention (1 Week)|Withdrawal by Subject|0
4652105|NCT03372551|15967839|P1|First Intervention (1 Week)|Withdrawal by Subject|1
4652106|NCT03372369|15967869|P2|Intervention and Follow-Up Period|Withdrawal by Subject|3
4652107|NCT03372369|15967870|P1|Intervention and Follow-Up Period|Withdrawal by Subject|3
4652108|NCT03372369|15967869|P2|Qualification Period|Inconsistent Eligibility Results|9
4652109|NCT03372369|15967870|P1|Qualification Period|Inconsistent Eligibility Results|10
4652110|NCT03372369|15967869|P2|Qualification Period|Withdrawal by Subject|13
4652111|NCT03372369|15967870|P1|Qualification Period|Withdrawal by Subject|16
4652112|NCT03372083|15967882|P1|Overall Study|Withdrawal by Subject|1
4652113|NCT03372083|15967882|P1|Overall Study|Physician Decision|1
4652114|NCT03372083|15967882|P1|Overall Study|Adverse Event|3
4652115|NCT03371459|15967914|P2|Washout|Lost to Follow-up|1
4652116|NCT03371459|15967915|P1|Washout|Lost to Follow-up|0
4652117|NCT03371381|15967923|P1|Overall Study|Other|4
4652118|NCT03371381|15967923|P1|Overall Study|Study terminated by sponsor|3
4652119|NCT03371381|15967923|P1|Overall Study|Death|5
4652120|NCT03370419|15967944|P1|Overall Study|Lost to Follow-up|16
4652121|NCT03370302|15967954|P6|Dose Expansion Phase|Progressive Disease|0
4652122|NCT03370302|15967955|P5|Dose Expansion Phase|Progressive Disease|0
4652123|NCT03370302|15967956|P4|Dose Expansion Phase|Progressive Disease|6
4652124|NCT03370302|15967957|P3|Dose Expansion Phase|Progressive Disease|0
4652125|NCT03370302|15967958|P2|Dose Expansion Phase|Progressive Disease|0
4652126|NCT03370302|15967959|P1|Dose Expansion Phase|Progressive Disease|0
4652127|NCT03370302|15967954|P6|Dose Escalation Phase|Progressive Disease|1
4652128|NCT03370302|15967955|P5|Dose Escalation Phase|Progressive Disease|3
4652129|NCT03370302|15967956|P4|Dose Escalation Phase|Progressive Disease|0
4652130|NCT03370302|15967957|P3|Dose Escalation Phase|Progressive Disease|2
4652131|NCT03370302|15967958|P2|Dose Escalation Phase|Progressive Disease|4
4652132|NCT03370302|15967959|P1|Dose Escalation Phase|Progressive Disease|2
4652133|NCT03370302|15967954|P6|Dose Escalation Phase|Adverse Event|0
4652134|NCT03370302|15967955|P5|Dose Escalation Phase|Adverse Event|0
4652135|NCT03370302|15967956|P4|Dose Escalation Phase|Adverse Event|0
4652136|NCT03370302|15967957|P3|Dose Escalation Phase|Adverse Event|2
4652137|NCT03370302|15967958|P2|Dose Escalation Phase|Adverse Event|0
4652138|NCT03370302|15967959|P1|Dose Escalation Phase|Adverse Event|1
4652139|NCT03370302|15967954|P6|Dose Escalation Phase|Withdrawal by Subject|2
4652140|NCT03370302|15967955|P5|Dose Escalation Phase|Withdrawal by Subject|0
4652141|NCT03370302|15967956|P4|Dose Escalation Phase|Withdrawal by Subject|0
4652142|NCT03370302|15967957|P3|Dose Escalation Phase|Withdrawal by Subject|2
4652143|NCT03370302|15967958|P2|Dose Escalation Phase|Withdrawal by Subject|1
4652144|NCT03370302|15967959|P1|Dose Escalation Phase|Withdrawal by Subject|0
4652145|NCT03370302|15967954|P6|Dose Escalation Phase|Other|0
4652146|NCT03370302|15967955|P5|Dose Escalation Phase|Other|0
4652147|NCT03370302|15967956|P4|Dose Escalation Phase|Other|0
4652148|NCT03370302|15967957|P3|Dose Escalation Phase|Other|1
4652149|NCT03370302|15967958|P2|Dose Escalation Phase|Other|1
4652150|NCT03370302|15967959|P1|Dose Escalation Phase|Other|0
4652151|NCT03370289|15968056|P1|Overall Study|Sample Size Sufficient|4
4652152|NCT03370289|15968056|P1|Overall Study|Screen Failure|1
4652153|NCT03369951|15968090|P1|Overall Study|Protocol Violation|1
4652154|NCT03369951|15968090|P1|Overall Study|Lost to Follow-up|1
4652155|NCT03369951|15968090|P1|Overall Study|Death|1
4652156|NCT03369951|15968090|P1|Overall Study|Withdrawal by Subject|3
4652157|NCT03369704|15968117|P2|Follow-up Epoch|Lost to Follow-up|0
4652158|NCT03369704|15968118|P1|Follow-up Epoch|Lost to Follow-up|1
4652159|NCT03369704|15968117|P2|Treatment Epoch|Adverse Event|0
4652160|NCT03369704|15968118|P1|Treatment Epoch|Adverse Event|2
4652161|NCT03369704|15968117|P2|Treatment Epoch|Lack of Efficacy|2
4652162|NCT03369704|15968118|P1|Treatment Epoch|Lack of Efficacy|0
4652163|NCT03369704|15968117|P2|Treatment Epoch|Lost to Follow-up|1
4652164|NCT03369704|15968118|P1|Treatment Epoch|Lost to Follow-up|0
4652165|NCT03369704|15968117|P2|Treatment Epoch|Protocol Violation|0
4652166|NCT03369704|15968118|P1|Treatment Epoch|Protocol Violation|1
4652167|NCT03369704|15968117|P2|Treatment Epoch|technical problems|0
4652168|NCT03369704|15968118|P1|Treatment Epoch|technical problems|1
4652169|NCT03369418|15968153|P2|Overall Study|Withdrawal by Subject|3
4652170|NCT03369418|15968154|P1|Overall Study|Withdrawal by Subject|3
4652171|NCT03368807|15968289|P1|Period 1 (Blinded CGM)|Lost to Follow-up|1
4652172|NCT03368807|15968289|P1|Period 1 (Blinded CGM)|Sponsor Decision|1
4652173|NCT03368807|15968289|P1|Period 1 (Blinded CGM)|Protocol Violation|1
4652174|NCT03368807|15968289|P1|Period 1 (Blinded CGM)|Withdrawal by Subject|3
4652175|NCT03368170|15968339|P2|Overall Study|Adverse Event|1
4652176|NCT03368170|15968340|P1|Overall Study|Adverse Event|2
4652177|NCT03365934|15968372|P1|Overall Study|Withdrawal by Subject|1
4652178|NCT03365934|15968372|P1|Overall Study|Adverse Event|1
4652179|NCT03365011|15968662|P2|Overall Study|Withdrawal by Subject|2
4652180|NCT03365011|15968663|P1|Overall Study|Withdrawal by Subject|1
4652181|NCT03364608|15968673|P1|Overall Study|Lost to Follow-up|2
4652182|NCT03364608|15968673|P1|Overall Study|Protocol Violation|2
4652183|NCT03364608|15968673|P1|Overall Study|Withdrawal by Subject|4
4652184|NCT03364335|15968700|P5|Overall Study|Lost to Follow-up|11
4652185|NCT03364335|15968701|P4|Overall Study|Lost to Follow-up|11
4652186|NCT03364335|15968702|P3|Overall Study|Lost to Follow-up|10
4652187|NCT03364335|15968703|P2|Overall Study|Lost to Follow-up|7
4652188|NCT03364335|15968704|P1|Overall Study|Lost to Follow-up|7
4652189|NCT03364335|15968700|P5|Overall Study|Adverse Event|0
4652190|NCT03364335|15968701|P4|Overall Study|Adverse Event|2
4652191|NCT03364335|15968702|P3|Overall Study|Adverse Event|1
4652192|NCT03364335|15968703|P2|Overall Study|Adverse Event|4
4652193|NCT03364335|15968704|P1|Overall Study|Adverse Event|3
4652194|NCT03364023|15968776|P1|Overall Study|Death|14
4652195|NCT03364023|15968776|P1|Overall Study|Lost to Follow-up|3
4652196|NCT03363906|15968783|P2|Period 2 (Test or Reference)|Lost to Follow-up|0
4652197|NCT03363906|15968784|P1|Period 2 (Test or Reference)|Lost to Follow-up|1
4652198|NCT03363906|15968783|P2|Period 2 (Test or Reference)|Withdrawal by Subject|1
4652199|NCT03363906|15968784|P1|Period 2 (Test or Reference)|Withdrawal by Subject|1
4652200|NCT03363906|15968783|P2|Period 2 (Test or Reference)|Adverse Event|0
4652201|NCT03363906|15968784|P1|Period 2 (Test or Reference)|Adverse Event|2
4652202|NCT03363906|15968783|P2|Period 1 (Reference or Test)|Adverse Event|2
4652203|NCT03363906|15968784|P1|Period 1 (Reference or Test)|Adverse Event|1
4652204|NCT03361865|15968854|P2|Overall Study|On-going at clinical cut off date|39
4652205|NCT03361865|15968855|P1|Overall Study|On-going at clinical cut off date|29
4652206|NCT03361865|15968854|P2|Overall Study|Physician Decision|0
4652207|NCT03361865|15968855|P1|Overall Study|Physician Decision|1
4652208|NCT03361865|15968854|P2|Overall Study|Death|10
4652209|NCT03361865|15968855|P1|Overall Study|Death|13
4652210|NCT03361605|15968865|P1|Overall Study|Analyzable data not available|3
4652211|NCT03361228|15968872|P2|Overall Study|Death|0
4652212|NCT03361228|15968873|P1|Overall Study|Death|3
4652213|NCT03361228|15968872|P2|Overall Study|Other|1
4652214|NCT03361228|15968873|P1|Overall Study|Other|1
4652215|NCT03361176|15968895|P2|Overall Study|Withdrawal by Subject|1
4652216|NCT03361176|15968896|P1|Overall Study|Withdrawal by Subject|0
4652217|NCT03361176|15968895|P2|Overall Study|Adverse Event|2
4652218|NCT03361176|15968896|P1|Overall Study|Adverse Event|0
4652219|NCT03361176|15968895|P2|Overall Study|Lost to Follow-up|2
4652220|NCT03361176|15968896|P1|Overall Study|Lost to Follow-up|1
4652221|NCT03360344|15968930|P3|Overall Study|Withdrawal by Subject|1
4652222|NCT03360344|15968931|P2|Overall Study|Withdrawal by Subject|1
4652223|NCT03360344|15968932|P1|Overall Study|Withdrawal by Subject|0
4652224|NCT03360071|15968995|P2|Overall Study|Lost to Follow-up|0
4652225|NCT03360071|15968996|P1|Overall Study|Lost to Follow-up|1
4652226|NCT03359473|15969021|P4|Overall Study|Protocol-defined stopping criteria|1
4652227|NCT03359473|15969022|P3|Overall Study|Protocol-defined stopping criteria|0
4652228|NCT03359473|15969023|P2|Overall Study|Protocol-defined stopping criteria|0
4652229|NCT03359473|15969024|P1|Overall Study|Protocol-defined stopping criteria|1
4652230|NCT03359473|15969021|P4|Overall Study|Withdrawal by Subject|0
4652231|NCT03359473|15969022|P3|Overall Study|Withdrawal by Subject|1
4652232|NCT03359473|15969023|P2|Overall Study|Withdrawal by Subject|2
4652233|NCT03359473|15969024|P1|Overall Study|Withdrawal by Subject|1
4652234|NCT03359473|15969021|P4|Overall Study|Physician Decision|1
4652235|NCT03359473|15969022|P3|Overall Study|Physician Decision|0
4652236|NCT03359473|15969023|P2|Overall Study|Physician Decision|1
4652237|NCT03359473|15969024|P1|Overall Study|Physician Decision|0
4652238|NCT03359473|15969021|P4|Overall Study|Lost to Follow-up|0
4652239|NCT03359473|15969022|P3|Overall Study|Lost to Follow-up|0
4652240|NCT03359473|15969023|P2|Overall Study|Lost to Follow-up|1
4652241|NCT03359473|15969024|P1|Overall Study|Lost to Follow-up|0
4652242|NCT03359473|15969021|P4|Overall Study|Adverse Event|3
4652243|NCT03359473|15969022|P3|Overall Study|Adverse Event|5
4652244|NCT03359473|15969023|P2|Overall Study|Adverse Event|2
4652245|NCT03359473|15969024|P1|Overall Study|Adverse Event|0
4652246|NCT03358472|15969237|P3|Overall Study|On-going at clinical cut off date|5
4652247|NCT03358472|15969238|P2|Overall Study|On-going at clinical cut off date|6
4652248|NCT03358472|15969239|P1|Overall Study|On-going at clinical cut off date|9
4652249|NCT03358472|15969237|P3|Overall Study|Withdrawal by Subject|1
4652250|NCT03358472|15969238|P2|Overall Study|Withdrawal by Subject|0
4652251|NCT03358472|15969239|P1|Overall Study|Withdrawal by Subject|0
4652252|NCT03358472|15969237|P3|Overall Study|Physician Decision|0
4652253|NCT03358472|15969238|P2|Overall Study|Physician Decision|1
4652254|NCT03358472|15969239|P1|Overall Study|Physician Decision|0
4652255|NCT03358472|15969237|P3|Overall Study|Death|10
4652256|NCT03358472|15969238|P2|Overall Study|Death|3
4652257|NCT03358472|15969239|P1|Overall Study|Death|6
4652258|NCT03358407|15969263|P10|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652259|NCT03358407|15969264|P9|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652260|NCT03358407|15969265|P8|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6
4652261|NCT03358407|15969266|P7|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
4652262|NCT03358407|15969267|P6|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3
4652263|NCT03358407|15969268|P5|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652264|NCT03358407|15969269|P4|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652265|NCT03358407|15969270|P3|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652266|NCT03358407|15969271|P2|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652267|NCT03358407|15969272|P1|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0
4652268|NCT03358407|15969263|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652269|NCT03358407|15969264|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652270|NCT03358407|15969265|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652271|NCT03358407|15969266|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
4652272|NCT03358407|15969267|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1
4652273|NCT03358407|15969268|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652274|NCT03358407|15969269|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652275|NCT03358407|15969270|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652276|NCT03358407|15969271|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652277|NCT03358407|15969272|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0
4652278|NCT03358407|15969263|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652279|NCT03358407|15969264|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652280|NCT03358407|15969265|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
4652281|NCT03358407|15969266|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652282|NCT03358407|15969267|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1
4652283|NCT03358407|15969268|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652284|NCT03358407|15969269|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652285|NCT03358407|15969270|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652286|NCT03358407|15969271|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652287|NCT03358407|15969272|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0
4652288|NCT03358407|15969263|P10|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652289|NCT03358407|15969264|P9|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652290|NCT03358407|15969265|P8|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2
4652291|NCT03358407|15969266|P7|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652292|NCT03358407|15969267|P6|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1
4652293|NCT03358407|15969268|P5|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652294|NCT03358407|15969269|P4|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652295|NCT03358407|15969270|P3|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652296|NCT03358407|15969271|P2|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652297|NCT03358407|15969272|P1|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0
4652298|NCT03358407|15969263|P10|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652299|NCT03358407|15969264|P9|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652300|NCT03358407|15969265|P8|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652301|NCT03358407|15969266|P7|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652302|NCT03358407|15969267|P6|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652303|NCT03358407|15969268|P5|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1
4652304|NCT03358407|15969269|P4|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652305|NCT03358407|15969270|P3|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652306|NCT03358407|15969271|P2|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652307|NCT03358407|15969272|P1|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0
4652308|NCT03358407|15969263|P10|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652309|NCT03358407|15969264|P9|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652310|NCT03358407|15969265|P8|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652311|NCT03358407|15969266|P7|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652312|NCT03358407|15969267|P6|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652313|NCT03358407|15969268|P5|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652314|NCT03358407|15969269|P4|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652315|NCT03358407|15969270|P3|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1
4652316|NCT03358407|15969271|P2|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652317|NCT03358407|15969272|P1|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0
4652318|NCT03358329|15969549|P1|Overall Study|Withdrawal by Subject|2
4652319|NCT03358329|15969549|P1|Overall Study|Lost to Follow-up|2
4652320|NCT03358238|15969580|P2|Overall Study|Withdrawal by Subject|1
4652321|NCT03358238|15969581|P1|Overall Study|Withdrawal by Subject|0
4652322|NCT03358147|15969601|P5|Overall Study|Lack of Efficacy|0
4652323|NCT03358147|15969602|P4|Overall Study|Lack of Efficacy|0
4652324|NCT03358147|15969603|P3|Overall Study|Lack of Efficacy|1
4652325|NCT03358147|15969604|P2|Overall Study|Lack of Efficacy|1
4652326|NCT03358147|15969605|P1|Overall Study|Lack of Efficacy|0
4652327|NCT03358147|15969601|P5|Overall Study|Administrative reasons|0
4652328|NCT03358147|15969602|P4|Overall Study|Administrative reasons|3
4652329|NCT03358147|15969603|P3|Overall Study|Administrative reasons|0
4652330|NCT03358147|15969604|P2|Overall Study|Administrative reasons|1
4652331|NCT03358147|15969605|P1|Overall Study|Administrative reasons|0
4652332|NCT03358147|15969601|P5|Overall Study|Physician Decision|1
4652333|NCT03358147|15969602|P4|Overall Study|Physician Decision|6
4652334|NCT03358147|15969603|P3|Overall Study|Physician Decision|1
4652335|NCT03358147|15969604|P2|Overall Study|Physician Decision|0
4652336|NCT03358147|15969605|P1|Overall Study|Physician Decision|1
4652337|NCT03358147|15969601|P5|Overall Study|Protocol specified criteria|1
4652338|NCT03358147|15969602|P4|Overall Study|Protocol specified criteria|3
4652339|NCT03358147|15969603|P3|Overall Study|Protocol specified criteria|0
4652340|NCT03358147|15969604|P2|Overall Study|Protocol specified criteria|3
4652341|NCT03358147|15969605|P1|Overall Study|Protocol specified criteria|2
4652342|NCT03358147|15969601|P5|Overall Study|Major Protocol Deviation|1
4652343|NCT03358147|15969602|P4|Overall Study|Major Protocol Deviation|3
4652344|NCT03358147|15969603|P3|Overall Study|Major Protocol Deviation|2
4652345|NCT03358147|15969604|P2|Overall Study|Major Protocol Deviation|3
4652346|NCT03358147|15969605|P1|Overall Study|Major Protocol Deviation|11
4652347|NCT03358147|15969601|P5|Overall Study|Lost to Follow-up|4
4652348|NCT03358147|15969602|P4|Overall Study|Lost to Follow-up|6
4652349|NCT03358147|15969603|P3|Overall Study|Lost to Follow-up|7
4652350|NCT03358147|15969604|P2|Overall Study|Lost to Follow-up|3
4652351|NCT03358147|15969605|P1|Overall Study|Lost to Follow-up|4
4652352|NCT03358147|15969601|P5|Overall Study|Adverse Event|2
4652353|NCT03358147|15969602|P4|Overall Study|Adverse Event|5
4652354|NCT03358147|15969603|P3|Overall Study|Adverse Event|7
4652355|NCT03358147|15969604|P2|Overall Study|Adverse Event|9
4652356|NCT03358147|15969605|P1|Overall Study|Adverse Event|3
4652357|NCT03358147|15969601|P5|Overall Study|Withdrawal by Subject|5
4652358|NCT03358147|15969602|P4|Overall Study|Withdrawal by Subject|10
4652359|NCT03358147|15969603|P3|Overall Study|Withdrawal by Subject|16
4652360|NCT03358147|15969604|P2|Overall Study|Withdrawal by Subject|19
4652361|NCT03358147|15969605|P1|Overall Study|Withdrawal by Subject|13
4652362|NCT03357952|15969644|P2|Overall Study|Sponsor Decision|0
4652363|NCT03357952|15969645|P1|Overall Study|Sponsor Decision|9
4652364|NCT03357952|15969644|P2|Overall Study|Withdrawal by Subject|1
4652365|NCT03357952|15969645|P1|Overall Study|Withdrawal by Subject|0
4652366|NCT03357731|15969652|P6|Overall Study|Lost to Follow-up|0
4652367|NCT03357731|15969653|P5|Overall Study|Lost to Follow-up|0
4652368|NCT03357731|15969654|P4|Overall Study|Lost to Follow-up|1
4652369|NCT03357731|15969655|P3|Overall Study|Lost to Follow-up|0
4652370|NCT03357731|15969656|P2|Overall Study|Lost to Follow-up|0
4652371|NCT03357731|15969657|P1|Overall Study|Lost to Follow-up|0
4652372|NCT03357731|15969652|P6|Overall Study|Hypotension|0
4652373|NCT03357731|15969653|P5|Overall Study|Hypotension|0
4652374|NCT03357731|15969654|P4|Overall Study|Hypotension|1
4652375|NCT03357731|15969655|P3|Overall Study|Hypotension|1
4652376|NCT03357731|15969656|P2|Overall Study|Hypotension|0
4652377|NCT03357731|15969657|P1|Overall Study|Hypotension|0
4652378|NCT03357731|15969652|P6|Overall Study|Adverse Event|1
4652379|NCT03357731|15969653|P5|Overall Study|Adverse Event|0
4652380|NCT03357731|15969654|P4|Overall Study|Adverse Event|0
4652381|NCT03357731|15969655|P3|Overall Study|Adverse Event|0
4652382|NCT03357731|15969656|P2|Overall Study|Adverse Event|0
4652383|NCT03357731|15969657|P1|Overall Study|Adverse Event|0
4652384|NCT03357731|15969652|P6|Overall Study|Acute bradycardia and hypotension|0
4652385|NCT03357731|15969653|P5|Overall Study|Acute bradycardia and hypotension|0
4652386|NCT03357731|15969654|P4|Overall Study|Acute bradycardia and hypotension|1
4652387|NCT03357731|15969655|P3|Overall Study|Acute bradycardia and hypotension|0
4652388|NCT03357731|15969656|P2|Overall Study|Acute bradycardia and hypotension|0
4652389|NCT03357731|15969657|P1|Overall Study|Acute bradycardia and hypotension|0
4652390|NCT03357731|15969652|P6|Overall Study|Withdrew consent due to personal reasons|0
4652391|NCT03357731|15969653|P5|Overall Study|Withdrew consent due to personal reasons|1
4652392|NCT03357731|15969654|P4|Overall Study|Withdrew consent due to personal reasons|0
4652393|NCT03357731|15969655|P3|Overall Study|Withdrew consent due to personal reasons|0
4652394|NCT03357731|15969656|P2|Overall Study|Withdrew consent due to personal reasons|0
4652395|NCT03357731|15969657|P1|Overall Study|Withdrew consent due to personal reasons|0
4652396|NCT03357471|15969685|P2|Overall Study|Lost to Follow-up|0
4652397|NCT03357471|15969686|P1|Overall Study|Lost to Follow-up|1
4652398|NCT03357471|15969685|P2|Overall Study|Adverse Event|0
4652399|NCT03357471|15969686|P1|Overall Study|Adverse Event|1
4652400|NCT03356977|15969710|P1|Overall Study|Withdrawal by parent/guardian|2
4652401|NCT03356977|15969710|P1|Overall Study|Lost to Follow-up|3
4652402|NCT03354663|15969758|P1|Completed 30-day Visit|Missed Visit|1
4652403|NCT03354663|15969758|P1|Completed 30-day Visit|Withdrawal by Subject|1
4652404|NCT03354663|15969758|P1|Enrollment to Catheter Insertion|Adverse Event|1
4652405|NCT03354663|15969758|P1|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4
4652406|NCT03354637|15969785|P3|Open Label Extension|Physician Decision|1
4652407|NCT03354637|15969786|P2|Open Label Extension|Physician Decision|0
4652408|NCT03354637|15969787|P1|Open Label Extension|Physician Decision|0
4652409|NCT03354637|15969785|P3|Open Label Extension|Lack of Efficacy|1
4652410|NCT03354637|15969786|P2|Open Label Extension|Lack of Efficacy|0
4652411|NCT03354637|15969787|P1|Open Label Extension|Lack of Efficacy|0
4652412|NCT03354637|15969785|P3|Open Label Extension|Subject Noncompliance|1
4652413|NCT03354637|15969786|P2|Open Label Extension|Subject Noncompliance|0
4652414|NCT03354637|15969787|P1|Open Label Extension|Subject Noncompliance|0
4652415|NCT03354637|15969785|P3|Open Label Extension|Study Terminated by Sponsor|17
4652416|NCT03354637|15969786|P2|Open Label Extension|Study Terminated by Sponsor|0
4652417|NCT03354637|15969787|P1|Open Label Extension|Study Terminated by Sponsor|0
4652418|NCT03354637|15969785|P3|Open Label Extension|Withdrawal by Subject|5
4652419|NCT03354637|15969786|P2|Open Label Extension|Withdrawal by Subject|0
4652420|NCT03354637|15969787|P1|Open Label Extension|Withdrawal by Subject|0
4652421|NCT03354637|15969785|P3|Open Label Extension|Lost to Follow-up|2
4652422|NCT03354637|15969786|P2|Open Label Extension|Lost to Follow-up|0
4652423|NCT03354637|15969787|P1|Open Label Extension|Lost to Follow-up|0
4652424|NCT03354637|15969785|P3|Open Label Extension|Adverse Event|1
4652425|NCT03354637|15969786|P2|Open Label Extension|Adverse Event|0
4652426|NCT03354637|15969787|P1|Open Label Extension|Adverse Event|0
4652427|NCT03354637|15969785|P3|Double-blind Period|Incomplete Efficacy Data Collection|0
4652428|NCT03354637|15969786|P2|Double-blind Period|Incomplete Efficacy Data Collection|1
4652429|NCT03354637|15969787|P1|Double-blind Period|Incomplete Efficacy Data Collection|1
4652430|NCT03354637|15969785|P3|Double-blind Period|Withdrawal by Subject|4
4652431|NCT03354637|15969786|P2|Double-blind Period|Withdrawal by Subject|6
4652432|NCT03354637|15969787|P1|Double-blind Period|Withdrawal by Subject|10
4652433|NCT03354637|15969785|P3|Double-blind Period|Lost to Follow-up|3
4652434|NCT03354637|15969786|P2|Double-blind Period|Lost to Follow-up|4
4652435|NCT03354637|15969787|P1|Double-blind Period|Lost to Follow-up|3
4652436|NCT03354637|15969785|P3|Double-blind Period|Adverse Event|0
4652437|NCT03354637|15969786|P2|Double-blind Period|Adverse Event|2
4652438|NCT03354637|15969787|P1|Double-blind Period|Adverse Event|1
4652439|NCT03354637|15969785|P3|Double-blind Period|Protocol Violation|0
4652440|NCT03354637|15969786|P2|Double-blind Period|Protocol Violation|0
4652441|NCT03354637|15969787|P1|Double-blind Period|Protocol Violation|2
4652442|NCT03353922|15969877|P6|Overall Study|Adverse Event|0
4652443|NCT03353922|15969878|P5|Overall Study|Adverse Event|0
4652444|NCT03353922|15969879|P4|Overall Study|Adverse Event|0
4652445|NCT03353922|15969880|P3|Overall Study|Adverse Event|0
4652446|NCT03353922|15969881|P2|Overall Study|Adverse Event|1
4652447|NCT03353922|15969882|P1|Overall Study|Adverse Event|0
4652448|NCT03353922|15969877|P6|Overall Study|Withdrawal by Subject|0
4652449|NCT03353922|15969878|P5|Overall Study|Withdrawal by Subject|0
4652450|NCT03353922|15969879|P4|Overall Study|Withdrawal by Subject|1
4652451|NCT03353922|15969880|P3|Overall Study|Withdrawal by Subject|1
4652452|NCT03353922|15969881|P2|Overall Study|Withdrawal by Subject|0
4652453|NCT03353922|15969882|P1|Overall Study|Withdrawal by Subject|1
4652454|NCT03352713|15969924|P1|Overall Study|Device incompatible/stolen|5
4652455|NCT03352713|15969924|P1|Overall Study|Completed 0 EMAs|8
4652456|NCT03352713|15969924|P1|Overall Study|Withdrawn by investigator|5
4652457|NCT03352713|15969924|P1|Overall Study|Lost to Follow-up|8
4652458|NCT03352453|15969945|P2|Overall Study|Adverse Event|9
4652459|NCT03352453|15969946|P1|Overall Study|Adverse Event|2
4652460|NCT03352453|15969945|P2|Overall Study|Lost to Follow-up|6
4652461|NCT03352453|15969946|P1|Overall Study|Lost to Follow-up|7
4652462|NCT03352453|15969945|P2|Overall Study|Protocol Deviation|0
4652463|NCT03352453|15969946|P1|Overall Study|Protocol Deviation|1
4652464|NCT03352453|15969945|P2|Overall Study|Study Terminated by Sponsor|1
4652465|NCT03352453|15969946|P1|Overall Study|Study Terminated by Sponsor|2
4652466|NCT03352453|15969945|P2|Overall Study|Withdrawal by Subject|14
4652467|NCT03352453|15969946|P1|Overall Study|Withdrawal by Subject|8
4652468|NCT03352453|15969945|P2|Overall Study|Lack of Efficacy|0
4652469|NCT03352453|15969946|P1|Overall Study|Lack of Efficacy|1
4652470|NCT03352453|15969945|P2|Overall Study|Miscellaneous Reasons|2
4652471|NCT03352453|15969946|P1|Overall Study|Miscellaneous Reasons|1
4652472|NCT03351738|15969968|P6|Overall Study|Withdrawal by Subject|0
4652473|NCT03351738|15969969|P5|Overall Study|Withdrawal by Subject|0
4652474|NCT03351738|15969970|P4|Overall Study|Withdrawal by Subject|1
4652475|NCT03351738|15969971|P3|Overall Study|Withdrawal by Subject|0
4652476|NCT03351738|15969972|P2|Overall Study|Withdrawal by Subject|1
4652477|NCT03351738|15969973|P1|Overall Study|Withdrawal by Subject|0
4652478|NCT03351335|15970125|P3|Overall Study|Failure to maintain inclusion/exclusion|4
4652479|NCT03351335|15970126|P2|Overall Study|Failure to maintain inclusion/exclusion|0
4652480|NCT03351335|15970127|P1|Overall Study|Failure to maintain inclusion/exclusion|0
4652481|NCT03351231|15970147|P1|Safety Follow-Up Period|Other reason|2
4652482|NCT03351231|15970147|P1|Safety Follow-Up Period|Participant withdrew consent|1
4652483|NCT03351231|15970147|P1|Combination Therapy Period|Adverse Event unrelated to study drug|1
4652484|NCT03351231|15970147|P1|Combination Therapy Period|Study drug toxicity|1
4652485|NCT03351231|15970147|P1|Combination Therapy Period|Disease progression|2
4652486|NCT03351231|15970147|P1|Combination Therapy Period|Administrative reason by the Sponsor|1
4652487|NCT03350984|15970182|P2|Overall Study|Physician Decision|0
4652488|NCT03350984|15970183|P1|Overall Study|Physician Decision|1
4652489|NCT03350984|15970182|P2|Overall Study|Protocol Violation|2
4652490|NCT03350984|15970183|P1|Overall Study|Protocol Violation|1
4652491|NCT03350984|15970182|P2|Overall Study|Lost to Follow-up|6
4652492|NCT03350984|15970183|P1|Overall Study|Lost to Follow-up|5
4652493|NCT03350984|15970182|P2|Overall Study|Death|0
4652494|NCT03350984|15970183|P1|Overall Study|Death|1
4652495|NCT03350503|15970250|P1|Overall Study|Subject Wishes|2
4652496|NCT03350503|15970250|P1|Overall Study|Hospital Transfer or Removal|2
4652497|NCT03350503|15970250|P1|Overall Study|Adverse Event|1
4652498|NCT03350256|15970254|P1|Overall Study|Lack of Efficacy|2
4652499|NCT03350256|15970254|P1|Overall Study|Lost to Follow-up|1
4652500|NCT03350256|15970254|P1|Overall Study|Subject moving out of state|1
4652501|NCT03350256|15970254|P1|Overall Study|Withdrawal by Subject|3
4652502|NCT03350256|15970254|P1|Overall Study|Did not proceed to permanent implant|3
4652503|NCT03350256|15970254|P1|Overall Study|Trial failure|12
4652504|NCT03350256|15970254|P1|Overall Study|Adverse Event|2
4652505|NCT03350256|15970254|P1|Overall Study|Denial by insurance|1
4652506|NCT03350256|15970254|P1|Overall Study|Non compliance|2
4652507|NCT03350256|15970254|P1|Overall Study|Protocol Violation|3
4652508|NCT03350256|15970254|P1|Overall Study|Recommended for other therapies|2
4652509|NCT03350256|15970254|P1|Overall Study|Inclusion/exclusion violation|4
4652510|NCT03349515|15970328|P2|Overall Study|Physician Decision|1
4652511|NCT03349515|15970329|P1|Overall Study|Physician Decision|3
4652512|NCT03349515|15970328|P2|Overall Study|Lack of Efficacy|0
4652513|NCT03349515|15970329|P1|Overall Study|Lack of Efficacy|2
4652514|NCT03349437|15970335|P3|Screening|Withdrawn|0
4652515|NCT03349437|15970336|P2|Screening|Withdrawn|0
4652516|NCT03349437|15970337|P1|Screening|Withdrawn|1
4652517|NCT03349437|15970335|P3|Screening|Screen Fail|0
4652518|NCT03349437|15970336|P2|Screening|Screen Fail|0
4652519|NCT03349437|15970337|P1|Screening|Screen Fail|4
4652520|NCT03349333|15970344|P1|Overall Study|Patients in treatment less than 24 month|8
4652521|NCT03349333|15970344|P1|Overall Study|3-week lapse between pralatrexate doses|1
4652522|NCT03349333|15970344|P1|Overall Study|Physician Decision|2
4652523|NCT03349333|15970344|P1|Overall Study|Conditions interfere with participation|2
4652524|NCT03349333|15970344|P1|Overall Study|Withdrawal by Subject|5
4652525|NCT03349333|15970344|P1|Overall Study|Other|6
4652526|NCT03349333|15970344|P1|Overall Study|Adverse Event|11
4652527|NCT03349333|15970344|P1|Overall Study|Progression of Disease|36
4652528|NCT03349099|15970367|P2|Overall Study|Stone migrated from the kidney|0
4652529|NCT03349099|15970368|P1|Overall Study|Stone migrated from the kidney|1
4652530|NCT03349099|15970367|P2|Overall Study|Physician Decision|4
4652531|NCT03349099|15970368|P1|Overall Study|Physician Decision|3
4652532|NCT03349060|15970381|P3|Overall Study|Other|0
4652533|NCT03349060|15970382|P2|Overall Study|Other|1
4652534|NCT03349060|15970383|P1|Overall Study|Other|2
4652535|NCT03349060|15970381|P3|Overall Study|Withdrawal By Parent/Guardian|0
4652536|NCT03349060|15970382|P2|Overall Study|Withdrawal By Parent/Guardian|1
4652537|NCT03349060|15970383|P1|Overall Study|Withdrawal By Parent/Guardian|0
4652538|NCT03349060|15970381|P3|Overall Study|Medication error,no linked adverse event|1
4652539|NCT03349060|15970382|P2|Overall Study|Medication error,no linked adverse event|0
4652540|NCT03349060|15970383|P1|Overall Study|Medication error,no linked adverse event|0
4652541|NCT03349060|15970381|P3|Overall Study|Withdrawal by Subject|4
4652542|NCT03349060|15970382|P2|Overall Study|Withdrawal by Subject|3
4652543|NCT03349060|15970383|P1|Overall Study|Withdrawal by Subject|5
4652544|NCT03349060|15970381|P3|Overall Study|Protocol Violation|1
4652545|NCT03349060|15970382|P2|Overall Study|Protocol Violation|2
4652546|NCT03349060|15970383|P1|Overall Study|Protocol Violation|2
4652547|NCT03349060|15970381|P3|Overall Study|Lost to Follow-up|1
4652548|NCT03349060|15970382|P2|Overall Study|Lost to Follow-up|1
4652549|NCT03349060|15970383|P1|Overall Study|Lost to Follow-up|2
4652550|NCT03349060|15970381|P3|Overall Study|Lack of Efficacy|2
4652551|NCT03349060|15970382|P2|Overall Study|Lack of Efficacy|0
4652552|NCT03349060|15970383|P1|Overall Study|Lack of Efficacy|1
4652553|NCT03349060|15970381|P3|Overall Study|Adverse Event|7
4652554|NCT03349060|15970382|P2|Overall Study|Adverse Event|9
4652555|NCT03349060|15970383|P1|Overall Study|Adverse Event|9
4652556|NCT03348904|15970525|P3|Overall Study|Administrative reason by the sponsor|0
4652557|NCT03348904|15970526|P2|Overall Study|Administrative reason by the sponsor|1
4652558|NCT03348904|15970527|P1|Overall Study|Administrative reason by the sponsor|0
4652559|NCT03346759|15970603|P2|Second Menstrual Cycle|Lost to Follow-up|0
4652560|NCT03346759|15970604|P1|Second Menstrual Cycle|Lost to Follow-up|1
4652561|NCT03346759|15970603|P2|First Menstrual Cycle|Withdrawal by Subject|0
4652562|NCT03346759|15970604|P1|First Menstrual Cycle|Withdrawal by Subject|1
4652563|NCT03346759|15970603|P2|Enrollment to Baseline Data Collected|Lost to Follow-up|3
4652564|NCT03346759|15970604|P1|Enrollment to Baseline Data Collected|Lost to Follow-up|2
4652565|NCT03346070|15970649|P5|Overall Study|Screen Failure|1
4652566|NCT03346070|15970650|P4|Overall Study|Screen Failure|1
4652567|NCT03346070|15970651|P3|Overall Study|Screen Failure|0
4652568|NCT03346070|15970652|P2|Overall Study|Screen Failure|0
4652569|NCT03346070|15970653|P1|Overall Study|Screen Failure|0
4652570|NCT03346070|15970649|P5|Overall Study|Study medication not received as planned|2
4652571|NCT03346070|15970650|P4|Overall Study|Study medication not received as planned|3
4652572|NCT03346070|15970651|P3|Overall Study|Study medication not received as planned|2
4652573|NCT03346070|15970652|P2|Overall Study|Study medication not received as planned|3
4652574|NCT03346070|15970653|P1|Overall Study|Study medication not received as planned|2
4652575|NCT03346070|15970649|P5|Overall Study|Withdrawal by Subject|0
4652576|NCT03346070|15970650|P4|Overall Study|Withdrawal by Subject|1
4652577|NCT03346070|15970651|P3|Overall Study|Withdrawal by Subject|0
4652578|NCT03346070|15970652|P2|Overall Study|Withdrawal by Subject|0
4652579|NCT03346070|15970653|P1|Overall Study|Withdrawal by Subject|1
4652580|NCT03346070|15970649|P5|Overall Study|Physician Decision|1
4652581|NCT03346070|15970650|P4|Overall Study|Physician Decision|1
4652582|NCT03346070|15970651|P3|Overall Study|Physician Decision|0
4652583|NCT03346070|15970652|P2|Overall Study|Physician Decision|0
4652584|NCT03346070|15970653|P1|Overall Study|Physician Decision|0
4652585|NCT03346070|15970649|P5|Overall Study|Lost to Follow-up|0
4652586|NCT03346070|15970650|P4|Overall Study|Lost to Follow-up|0
4652587|NCT03346070|15970651|P3|Overall Study|Lost to Follow-up|2
4652588|NCT03346070|15970652|P2|Overall Study|Lost to Follow-up|1
4652589|NCT03346070|15970653|P1|Overall Study|Lost to Follow-up|0
4652590|NCT03346070|15970649|P5|Overall Study|Death|1
4652591|NCT03346070|15970650|P4|Overall Study|Death|0
4652592|NCT03346070|15970651|P3|Overall Study|Death|0
4652593|NCT03346070|15970652|P2|Overall Study|Death|0
4652594|NCT03346070|15970653|P1|Overall Study|Death|0
4652595|NCT03346057|15970741|P4|Overall Study|Withdrawal by Subject|0
4652596|NCT03346057|15970742|P3|Overall Study|Withdrawal by Subject|0
4652597|NCT03346057|15970743|P2|Overall Study|Withdrawal by Subject|0
4652598|NCT03346057|15970744|P1|Overall Study|Withdrawal by Subject|1
4652599|NCT03346057|15970741|P4|Overall Study|Randomization Mistake - Not Treated|0
4652600|NCT03346057|15970742|P3|Overall Study|Randomization Mistake - Not Treated|0
4652601|NCT03346057|15970743|P2|Overall Study|Randomization Mistake - Not Treated|1
4652602|NCT03346057|15970744|P1|Overall Study|Randomization Mistake - Not Treated|1
4652603|NCT03346057|15970741|P4|Overall Study|Physician Decision|2
4652604|NCT03346057|15970742|P3|Overall Study|Physician Decision|0
4652605|NCT03346057|15970743|P2|Overall Study|Physician Decision|2
4652606|NCT03346057|15970744|P1|Overall Study|Physician Decision|3
4652607|NCT03346057|15970741|P4|Overall Study|Renal Insufficiency - Not Treated|0
4652608|NCT03346057|15970742|P3|Overall Study|Renal Insufficiency - Not Treated|0
4652609|NCT03346057|15970743|P2|Overall Study|Renal Insufficiency - Not Treated|0
4652610|NCT03346057|15970744|P1|Overall Study|Renal Insufficiency - Not Treated|1
4652611|NCT03346057|15970741|P4|Overall Study|Ineligible For Study - Not Treated|0
4652612|NCT03346057|15970742|P3|Overall Study|Ineligible For Study - Not Treated|0
4652613|NCT03346057|15970743|P2|Overall Study|Ineligible For Study - Not Treated|1
4652614|NCT03346057|15970744|P1|Overall Study|Ineligible For Study - Not Treated|0
4652615|NCT03346057|15970741|P4|Overall Study|Lost to Follow-up|0
4652616|NCT03346057|15970742|P3|Overall Study|Lost to Follow-up|1
4652617|NCT03346057|15970743|P2|Overall Study|Lost to Follow-up|2
4652618|NCT03346057|15970744|P1|Overall Study|Lost to Follow-up|0
4652619|NCT03346057|15970741|P4|Overall Study|Death|0
4652620|NCT03346057|15970742|P3|Overall Study|Death|0
4652621|NCT03346057|15970743|P2|Overall Study|Death|2
4652622|NCT03346057|15970744|P1|Overall Study|Death|1
4652623|NCT03345979|15970776|P2|Overall Study|Physician Decision|2
4652624|NCT03345979|15970777|P1|Overall Study|Physician Decision|0
4652625|NCT03345979|15970776|P2|Overall Study|Protocol Violation|3
4652626|NCT03345979|15970777|P1|Overall Study|Protocol Violation|1
4652627|NCT03345979|15970776|P2|Overall Study|Lack of Efficacy|2
4652628|NCT03345979|15970777|P1|Overall Study|Lack of Efficacy|4
4652629|NCT03345979|15970776|P2|Overall Study|Lost to Follow-up|9
4652630|NCT03345979|15970777|P1|Overall Study|Lost to Follow-up|8
4652631|NCT03345979|15970776|P2|Overall Study|Adverse Event|11
4652632|NCT03345979|15970777|P1|Overall Study|Adverse Event|10
4652633|NCT03345979|15970776|P2|Overall Study|Withdrawal by Subject|31
4652634|NCT03345979|15970777|P1|Overall Study|Withdrawal by Subject|20
4652635|NCT03345914|15970798|P3|Overall Study|Ongoing|1
4652636|NCT03345914|15970799|P2|Overall Study|Ongoing|0
4652637|NCT03345914|15970800|P1|Overall Study|Ongoing|0
4652638|NCT03345914|15970798|P3|Overall Study|Other|1
4652639|NCT03345914|15970799|P2|Overall Study|Other|1
4652640|NCT03345914|15970800|P1|Overall Study|Other|1
4652641|NCT03345914|15970798|P3|Overall Study|Withdrawal by Subject|2
4652642|NCT03345914|15970799|P2|Overall Study|Withdrawal by Subject|1
4652643|NCT03345914|15970800|P1|Overall Study|Withdrawal by Subject|5
4652644|NCT03345914|15970798|P3|Overall Study|Physician Decision|1
4652645|NCT03345914|15970799|P2|Overall Study|Physician Decision|1
4652646|NCT03345914|15970800|P1|Overall Study|Physician Decision|0
4652647|NCT03345914|15970798|P3|Overall Study|Transition to OLE during follow-up|39
4652648|NCT03345914|15970799|P2|Overall Study|Transition to OLE during follow-up|33
4652649|NCT03345914|15970800|P1|Overall Study|Transition to OLE during follow-up|37
4652650|NCT03345914|15970798|P3|Overall Study|Transition to another study at week 16|78
4652651|NCT03345914|15970799|P2|Overall Study|Transition to another study at week 16|86
4652652|NCT03345914|15970800|P1|Overall Study|Transition to another study at week 16|80
4652653|NCT03345901|15970871|P1|Overall Study|The study was terminated|18
4652654|NCT03345472|15970876|P1|3 Months to 12 Months|Death|1
4652655|NCT03345472|15970876|P1|3 Months to 12 Months|Adverse Event|1
4652656|NCT03345472|15970876|P1|3 Months to 12 Months|Withdrawal by Subject|1
4652657|NCT03345472|15970876|P1|3 Months to 12 Months|Lost to Follow-up|2
4652658|NCT03345472|15970876|P1|3 Months to 12 Months|Physician Decision|3
4652659|NCT03345472|15970876|P1|Implant to 3 Months|Adverse Event|1
4652660|NCT03345472|15970876|P1|Implant to 3 Months|Physician Decision|1
4652661|NCT03345472|15970876|P1|Implant to 3 Months|Withdrawal by Subject|2
4652662|NCT03345407|15970890|P7|Overall Study|Adverse Event|16
4652663|NCT03345407|15970891|P6|Overall Study|Adverse Event|5
4652664|NCT03345407|15970892|P5|Overall Study|Adverse Event|6
4652665|NCT03345407|15970893|P4|Overall Study|Adverse Event|4
4652666|NCT03345407|15970894|P3|Overall Study|Adverse Event|5
4652667|NCT03345407|15970895|P2|Overall Study|Adverse Event|0
4652668|NCT03345407|15970896|P1|Overall Study|Adverse Event|4
4652669|NCT03345407|15970890|P7|Overall Study|Lack of Efficacy|3
4652670|NCT03345407|15970891|P6|Overall Study|Lack of Efficacy|0
4652671|NCT03345407|15970892|P5|Overall Study|Lack of Efficacy|1
4652672|NCT03345407|15970893|P4|Overall Study|Lack of Efficacy|1
4652673|NCT03345407|15970894|P3|Overall Study|Lack of Efficacy|1
4652674|NCT03345407|15970895|P2|Overall Study|Lack of Efficacy|1
4652675|NCT03345407|15970896|P1|Overall Study|Lack of Efficacy|1
4652676|NCT03345407|15970890|P7|Overall Study|Protocol Violation|3
4652677|NCT03345407|15970891|P6|Overall Study|Protocol Violation|0
4652678|NCT03345407|15970892|P5|Overall Study|Protocol Violation|1
4652679|NCT03345407|15970893|P4|Overall Study|Protocol Violation|0
4652680|NCT03345407|15970894|P3|Overall Study|Protocol Violation|0
4652681|NCT03345407|15970895|P2|Overall Study|Protocol Violation|0
4652682|NCT03345407|15970896|P1|Overall Study|Protocol Violation|2
4652683|NCT03345407|15970890|P7|Overall Study|Protocol-defined stopping criteria|1
4652684|NCT03345407|15970891|P6|Overall Study|Protocol-defined stopping criteria|1
4652685|NCT03345407|15970892|P5|Overall Study|Protocol-defined stopping criteria|2
4652686|NCT03345407|15970893|P4|Overall Study|Protocol-defined stopping criteria|0
4652687|NCT03345407|15970894|P3|Overall Study|Protocol-defined stopping criteria|0
4652688|NCT03345407|15970895|P2|Overall Study|Protocol-defined stopping criteria|0
4652689|NCT03345407|15970896|P1|Overall Study|Protocol-defined stopping criteria|9
4652690|NCT03345407|15970890|P7|Overall Study|Lost to Follow-up|3
4652691|NCT03345407|15970891|P6|Overall Study|Lost to Follow-up|2
4652692|NCT03345407|15970892|P5|Overall Study|Lost to Follow-up|1
4652693|NCT03345407|15970893|P4|Overall Study|Lost to Follow-up|0
4652694|NCT03345407|15970894|P3|Overall Study|Lost to Follow-up|1
4652695|NCT03345407|15970895|P2|Overall Study|Lost to Follow-up|0
4652696|NCT03345407|15970896|P1|Overall Study|Lost to Follow-up|2
4652697|NCT03345407|15970890|P7|Overall Study|Physician Decision|3
4652698|NCT03345407|15970891|P6|Overall Study|Physician Decision|2
4652699|NCT03345407|15970892|P5|Overall Study|Physician Decision|1
4652700|NCT03345407|15970893|P4|Overall Study|Physician Decision|0
4652701|NCT03345407|15970894|P3|Overall Study|Physician Decision|0
4652702|NCT03345407|15970895|P2|Overall Study|Physician Decision|1
4652703|NCT03345407|15970896|P1|Overall Study|Physician Decision|3
4652704|NCT03345407|15970890|P7|Overall Study|Withdrawal by Subject|16
4652705|NCT03345407|15970891|P6|Overall Study|Withdrawal by Subject|6
4652706|NCT03345407|15970892|P5|Overall Study|Withdrawal by Subject|3
4652707|NCT03345407|15970893|P4|Overall Study|Withdrawal by Subject|6
4652708|NCT03345407|15970894|P3|Overall Study|Withdrawal by Subject|5
4652709|NCT03345407|15970895|P2|Overall Study|Withdrawal by Subject|1
4652710|NCT03345407|15970896|P1|Overall Study|Withdrawal by Subject|11
4652711|NCT03344172|15971133|P2|Overall Study|Received <1 dose of treatment|0
4652712|NCT03344172|15971134|P1|Overall Study|Received <1 dose of treatment|1
4652713|NCT03343639|15971152|P2|Overall Study|Protocol Violation|1
4652714|NCT03343639|15971153|P1|Overall Study|Protocol Violation|0
4652715|NCT03343639|15971152|P2|Overall Study|Lost to Follow-up|5
4652716|NCT03343639|15971153|P1|Overall Study|Lost to Follow-up|4
4652717|NCT03343639|15971152|P2|Overall Study|Withdrawal by Subject|6
4652718|NCT03343639|15971153|P1|Overall Study|Withdrawal by Subject|10
4652719|NCT03343067|15971181|P3|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1
4652720|NCT03343067|15971182|P2|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3
4652721|NCT03343067|15971183|P1|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0
4652722|NCT03342898|15971311|P3|Overall Study|Reason not Specified|0
4652723|NCT03342898|15971312|P2|Overall Study|Reason not Specified|2
4652724|NCT03342898|15971313|P1|Overall Study|Reason not Specified|2
4652725|NCT03342898|15971311|P3|Overall Study|Death|1
4652726|NCT03342898|15971312|P2|Overall Study|Death|1
4652727|NCT03342898|15971313|P1|Overall Study|Death|0
4652728|NCT03342898|15971311|P3|Overall Study|Withdrawal of Consent|11
4652729|NCT03342898|15971312|P2|Overall Study|Withdrawal of Consent|9
4652730|NCT03342898|15971313|P1|Overall Study|Withdrawal of Consent|5
4652731|NCT03342898|15971311|P3|Overall Study|Lost to Follow-up|42
4652732|NCT03342898|15971312|P2|Overall Study|Lost to Follow-up|40
4652733|NCT03342898|15971313|P1|Overall Study|Lost to Follow-up|44
4652734|NCT03342898|15971311|P3|Overall Study|Adverse Event|0
4652735|NCT03342898|15971312|P2|Overall Study|Adverse Event|1
4652736|NCT03342898|15971313|P1|Overall Study|Adverse Event|3
4652737|NCT03342560|15971354|P1|Overall Study|Lost to Follow-up|2
4652738|NCT03342469|15971364|P4|Overall Study|Withdrawal by Subject|0
4652739|NCT03342469|15971365|P3|Overall Study|Withdrawal by Subject|0
4652740|NCT03342469|15971366|P2|Overall Study|Withdrawal by Subject|1
4652741|NCT03342469|15971367|P1|Overall Study|Withdrawal by Subject|0
4652742|NCT03341923|15971396|P2|Period 2, Second 14 Days of Wear|Adverse Event|1
4652743|NCT03341923|15971397|P1|Period 2, Second 14 Days of Wear|Adverse Event|0
4652744|NCT03341637|15971441|P2|Overall Study|Reason not Specified|1
4652745|NCT03341637|15971442|P1|Overall Study|Reason not Specified|1
4652746|NCT03341637|15971441|P2|Overall Study|Withdrawal by Subject|3
4652747|NCT03341637|15971442|P1|Overall Study|Withdrawal by Subject|3
4652748|NCT03341637|15971441|P2|Overall Study|Lost to Follow-up|0
4652749|NCT03341637|15971442|P1|Overall Study|Lost to Follow-up|1
4652750|NCT03341533|15971470|P2|Overall Study|Not eligible after randomization|1
4652751|NCT03341533|15971471|P1|Overall Study|Not eligible after randomization|2
4652752|NCT03341533|15971470|P2|Overall Study|Withdrawal by Subject|1
4652753|NCT03341533|15971471|P1|Overall Study|Withdrawal by Subject|1
4652754|NCT03341312|15971483|P4|Period 1|Withdrawal by Subject|0
4652755|NCT03341312|15971484|P3|Period 1|Withdrawal by Subject|0
4652756|NCT03341312|15971485|P2|Period 1|Withdrawal by Subject|1
4652757|NCT03341312|15971486|P1|Period 1|Withdrawal by Subject|0
4652758|NCT03341299|15971498|P4|Washout (A Minimum of 21 Hours)|Adverse Event|0
4652759|NCT03341299|15971499|P3|Washout (A Minimum of 21 Hours)|Adverse Event|1
4652760|NCT03341299|15971500|P2|Washout (A Minimum of 21 Hours)|Adverse Event|0
4652761|NCT03341299|15971501|P1|Washout (A Minimum of 21 Hours)|Adverse Event|0
4652762|NCT03340961|15971517|P4|Overall Study|Other|3
4652763|NCT03340961|15971518|P3|Overall Study|Other|1
4652764|NCT03340961|15971519|P2|Overall Study|Other|2
4652765|NCT03340961|15971520|P1|Overall Study|Other|0
4652766|NCT03340961|15971517|P4|Overall Study|Adverse Event|0
4652767|NCT03340961|15971518|P3|Overall Study|Adverse Event|0
4652768|NCT03340961|15971519|P2|Overall Study|Adverse Event|1
4652769|NCT03340961|15971520|P1|Overall Study|Adverse Event|1
4652770|NCT03340961|15971517|P4|Overall Study|Protocol Violation|0
4652771|NCT03340961|15971518|P3|Overall Study|Protocol Violation|1
4652772|NCT03340961|15971519|P2|Overall Study|Protocol Violation|0
4652773|NCT03340961|15971520|P1|Overall Study|Protocol Violation|1
4652774|NCT03340961|15971517|P4|Overall Study|Subject developed an exclusion criterion|0
4652775|NCT03340961|15971518|P3|Overall Study|Subject developed an exclusion criterion|0
4652776|NCT03340961|15971519|P2|Overall Study|Subject developed an exclusion criterion|1
4652777|NCT03340961|15971520|P1|Overall Study|Subject developed an exclusion criterion|0
4652778|NCT03340961|15971517|P4|Overall Study|rongful enrollment (I/E criteria not me|1
4652779|NCT03340961|15971518|P3|Overall Study|rongful enrollment (I/E criteria not me|0
4652780|NCT03340961|15971519|P2|Overall Study|rongful enrollment (I/E criteria not me|0
4652781|NCT03340961|15971520|P1|Overall Study|rongful enrollment (I/E criteria not me|0
4652782|NCT03340961|15971517|P4|Overall Study|Use of prohibited treatment|3
4652783|NCT03340961|15971518|P3|Overall Study|Use of prohibited treatment|2
4652784|NCT03340961|15971519|P2|Overall Study|Use of prohibited treatment|3
4652785|NCT03340961|15971520|P1|Overall Study|Use of prohibited treatment|0
4652786|NCT03340961|15971517|P4|Overall Study|Withdrawal by Subject|6
4652787|NCT03340961|15971518|P3|Overall Study|Withdrawal by Subject|3
4652788|NCT03340961|15971519|P2|Overall Study|Withdrawal by Subject|1
4652789|NCT03340961|15971520|P1|Overall Study|Withdrawal by Subject|3
4652790|NCT03340961|15971517|P4|Overall Study|Lost to Follow-up|1
4652791|NCT03340961|15971518|P3|Overall Study|Lost to Follow-up|0
4652792|NCT03340961|15971519|P2|Overall Study|Lost to Follow-up|1
4652793|NCT03340961|15971520|P1|Overall Study|Lost to Follow-up|0
4652794|NCT03340961|15971517|P4|Overall Study|Adverse Event|4
4652795|NCT03340961|15971518|P3|Overall Study|Adverse Event|2
4652796|NCT03340961|15971519|P2|Overall Study|Adverse Event|3
4652797|NCT03340961|15971520|P1|Overall Study|Adverse Event|1
4652798|NCT03339726|15971641|P3|Overall Study|Lost to Follow-up|0
4652799|NCT03339726|15971642|P2|Overall Study|Lost to Follow-up|1
4652800|NCT03339726|15971643|P1|Overall Study|Lost to Follow-up|0
4652801|NCT03339726|15971641|P3|Overall Study|Withdrawal by Subject|0
4652802|NCT03339726|15971642|P2|Overall Study|Withdrawal by Subject|0
4652803|NCT03339726|15971643|P1|Overall Study|Withdrawal by Subject|1
4652804|NCT03339583|15971701|P2|Follow-up (14 Days)|Physician Decision|3
4652805|NCT03339583|15971702|P1|Follow-up (14 Days)|Physician Decision|6
4652806|NCT03339583|15971701|P2|Second Intervention (14 Days)|Adverse Event|1
4652807|NCT03339583|15971702|P1|Second Intervention (14 Days)|Adverse Event|0
4652808|NCT03339583|15971701|P2|Second Intervention (14 Days)|unrelated acute exacerbation|1
4652809|NCT03339583|15971702|P1|Second Intervention (14 Days)|unrelated acute exacerbation|0
4652810|NCT03339583|15971701|P2|First Intervention (14 Days)|Adverse Event|0
4652811|NCT03339583|15971702|P1|First Intervention (14 Days)|Adverse Event|1
4652812|NCT03339453|15971740|P2|First Visit of Glucagon Treatment|Adverse Event|1
4652813|NCT03339453|15971741|P1|First Visit of Glucagon Treatment|Adverse Event|0
4652814|NCT03338816|15971759|P2|Open-Label Extension Period|Ongoing in Study|47
4652815|NCT03338816|15971760|P1|Open-Label Extension Period|Ongoing in Study|46
4652816|NCT03338816|15971759|P2|6-Month Double-blind Period|Adverse Event|1
4652817|NCT03338816|15971760|P1|6-Month Double-blind Period|Adverse Event|0
4652818|NCT03338673|15971797|P2|Overall Study|Lost to Follow-up|1
4652819|NCT03338673|15971798|P1|Overall Study|Lost to Follow-up|1
4652820|NCT03338400|15971833|P2|Overall Study|Lost to Follow-up|2
4652821|NCT03338400|15971834|P1|Overall Study|Lost to Follow-up|1
4652822|NCT03337490|15971870|P3|Overall Study|Lost to Follow-up|0
4652823|NCT03337490|15971871|P2|Overall Study|Lost to Follow-up|1
4652824|NCT03337490|15971872|P1|Overall Study|Lost to Follow-up|0
4652825|NCT03337490|15971870|P3|Overall Study|Physician Decision|0
4652826|NCT03337490|15971871|P2|Overall Study|Physician Decision|1
4652827|NCT03337490|15971872|P1|Overall Study|Physician Decision|0
4652828|NCT03337490|15971870|P3|Overall Study|Lack of Efficacy|35
4652829|NCT03337490|15971871|P2|Overall Study|Lack of Efficacy|12
4652830|NCT03337490|15971872|P1|Overall Study|Lack of Efficacy|10
4652831|NCT03337490|15971870|P3|Overall Study|Withdrawal by Subject|0
4652832|NCT03337490|15971871|P2|Overall Study|Withdrawal by Subject|0
4652833|NCT03337490|15971872|P1|Overall Study|Withdrawal by Subject|1
4652834|NCT03337477|15971885|P2|Overall Study|Lost to Follow-up|2
4652835|NCT03337477|15971886|P1|Overall Study|Lost to Follow-up|0
4652836|NCT03337477|15971885|P2|Overall Study|Death|1
4652837|NCT03337477|15971886|P1|Overall Study|Death|0
4652838|NCT03337477|15971885|P2|Overall Study|Withdrawal by Subject|1
4652839|NCT03337477|15971886|P1|Overall Study|Withdrawal by Subject|0
4652840|NCT03337477|15971885|P2|Overall Study|not categorized into the listed ones|9
4652841|NCT03337477|15971886|P1|Overall Study|not categorized into the listed ones|11
4652842|NCT03337308|15971910|P4|Overall Study|Protocol Violation|0
4652843|NCT03337308|15971911|P3|Overall Study|Protocol Violation|0
4652844|NCT03337308|15971912|P2|Overall Study|Protocol Violation|1
4652845|NCT03337308|15971913|P1|Overall Study|Protocol Violation|0
4652846|NCT03337308|15971910|P4|Overall Study|Withdrawal by Subject|1
4652847|NCT03337308|15971911|P3|Overall Study|Withdrawal by Subject|2
4652848|NCT03337308|15971912|P2|Overall Study|Withdrawal by Subject|1
4652849|NCT03337308|15971913|P1|Overall Study|Withdrawal by Subject|2
4652850|NCT03337308|15971910|P4|Overall Study|Lost to Follow-up|0
4652851|NCT03337308|15971911|P3|Overall Study|Lost to Follow-up|0
4652852|NCT03337308|15971912|P2|Overall Study|Lost to Follow-up|2
4652853|NCT03337308|15971913|P1|Overall Study|Lost to Follow-up|1
4652854|NCT03337308|15971910|P4|Overall Study|Adverse Event|1
4652855|NCT03337308|15971911|P3|Overall Study|Adverse Event|3
4652856|NCT03337308|15971912|P2|Overall Study|Adverse Event|3
4652857|NCT03337308|15971913|P1|Overall Study|Adverse Event|2
4652858|NCT03336502|15971980|P2|Overall Study|Adverse Event|5
4652859|NCT03336502|15971981|P1|Overall Study|Adverse Event|2
4652860|NCT03336502|15971980|P2|Overall Study|Death|2
4652861|NCT03336502|15971981|P1|Overall Study|Death|1
4652862|NCT03336502|15971980|P2|Overall Study|Prohibited Drugs|1
4652863|NCT03336502|15971981|P1|Overall Study|Prohibited Drugs|1
4652864|NCT03336502|15971980|P2|Overall Study|Physician Decision|1
4652865|NCT03336502|15971981|P1|Overall Study|Physician Decision|0
4652866|NCT03335566|15972017|P2|Overall Study|Other than specified above|2
4652867|NCT03335566|15972018|P1|Overall Study|Other than specified above|1
4652868|NCT03335566|15972017|P2|Overall Study|Protocol Violation|0
4652869|NCT03335566|15972018|P1|Overall Study|Protocol Violation|1
4652870|NCT03335566|15972017|P2|Overall Study|Technical Problems|0
4652871|NCT03335566|15972018|P1|Overall Study|Technical Problems|1
4652872|NCT03335566|15972017|P2|Overall Study|Lost to Follow-up|0
4652873|NCT03335566|15972018|P1|Overall Study|Lost to Follow-up|1
4652874|NCT03335566|15972017|P2|Overall Study|Adverse Event|1
4652875|NCT03335566|15972018|P1|Overall Study|Adverse Event|0
4652876|NCT03335150|15972100|P2|Overall Study|Adverse Event|1
4652877|NCT03335150|15972101|P1|Overall Study|Adverse Event|0
4652878|NCT03335150|15972100|P2|Overall Study|Withdrawal by Subject|4
4652879|NCT03335150|15972101|P1|Overall Study|Withdrawal by Subject|10
4652880|NCT03334747|15972172|P9|Follow-Up Phase|Subject/guardian decision|1
4652881|NCT03334747|15972173|P8|Follow-Up Phase|Subject/guardian decision|0
4652882|NCT03334747|15972174|P7|Follow-Up Phase|Subject/guardian decision|1
4652883|NCT03334747|15972175|P6|Follow-Up Phase|Subject/guardian decision|0
4652884|NCT03334747|15972176|P5|Follow-Up Phase|Subject/guardian decision|0
4652885|NCT03334747|15972177|P4|Follow-Up Phase|Subject/guardian decision|0
4652886|NCT03334747|15972178|P3|Follow-Up Phase|Subject/guardian decision|0
4652887|NCT03334747|15972179|P2|Follow-Up Phase|Subject/guardian decision|0
4652888|NCT03334747|15972180|P1|Follow-Up Phase|Subject/guardian decision|0
4652889|NCT03334747|15972172|P9|Treatment Phase|Subject/guardian decision|0
4652890|NCT03334747|15972173|P8|Treatment Phase|Subject/guardian decision|0
4652891|NCT03334747|15972174|P7|Treatment Phase|Subject/guardian decision|0
4652892|NCT03334747|15972175|P6|Treatment Phase|Subject/guardian decision|1
4652893|NCT03334747|15972176|P5|Treatment Phase|Subject/guardian decision|0
4652894|NCT03334747|15972177|P4|Treatment Phase|Subject/guardian decision|0
4652895|NCT03334747|15972178|P3|Treatment Phase|Subject/guardian decision|0
4652896|NCT03334747|15972179|P2|Treatment Phase|Subject/guardian decision|0
4652897|NCT03334747|15972180|P1|Treatment Phase|Subject/guardian decision|1
4652898|NCT03334747|15972172|P9|Treatment Phase|Technical problems|0
4652899|NCT03334747|15972173|P8|Treatment Phase|Technical problems|0
4652900|NCT03334747|15972174|P7|Treatment Phase|Technical problems|0
4652901|NCT03334747|15972175|P6|Treatment Phase|Technical problems|0
4652902|NCT03334747|15972176|P5|Treatment Phase|Technical problems|1
4652903|NCT03334747|15972177|P4|Treatment Phase|Technical problems|0
4652904|NCT03334747|15972178|P3|Treatment Phase|Technical problems|0
4652905|NCT03334747|15972179|P2|Treatment Phase|Technical problems|0
4652906|NCT03334747|15972180|P1|Treatment Phase|Technical problems|0
4652907|NCT03334448|15972368|P4|Washout|Protocol Violation|1
4652908|NCT03334448|15972369|P3|Washout|Protocol Violation|0
4652909|NCT03334448|15972370|P2|Washout|Protocol Violation|0
4652910|NCT03334448|15972371|P1|Washout|Protocol Violation|0
4652911|NCT03334448|15972368|P4|Washout|Personal Reason|0
4652912|NCT03334448|15972369|P3|Washout|Personal Reason|0
4652913|NCT03334448|15972370|P2|Washout|Personal Reason|1
4652914|NCT03334448|15972371|P1|Washout|Personal Reason|0
4652915|NCT03334422|15972383|P4|Overall Study|Pregnancy|0
4652916|NCT03334422|15972384|P3|Overall Study|Pregnancy|0
4652917|NCT03334422|15972385|P2|Overall Study|Pregnancy|1
4652918|NCT03334422|15972386|P1|Overall Study|Pregnancy|0
4652919|NCT03334422|15972383|P4|Overall Study|Inability to obtain laboratory samples|0
4652920|NCT03334422|15972384|P3|Overall Study|Inability to obtain laboratory samples|0
4652921|NCT03334422|15972385|P2|Overall Study|Inability to obtain laboratory samples|1
4652922|NCT03334422|15972386|P1|Overall Study|Inability to obtain laboratory samples|0
4652923|NCT03334422|15972383|P4|Overall Study|Lost to Follow-up|1
4652924|NCT03334422|15972384|P3|Overall Study|Lost to Follow-up|0
4652925|NCT03334422|15972385|P2|Overall Study|Lost to Follow-up|0
4652926|NCT03334422|15972386|P1|Overall Study|Lost to Follow-up|0
4652927|NCT03334422|15972383|P4|Overall Study|Withdrawal by Subject|0
4652928|NCT03334422|15972384|P3|Overall Study|Withdrawal by Subject|1
4652929|NCT03334422|15972385|P2|Overall Study|Withdrawal by Subject|3
4652930|NCT03334422|15972386|P1|Overall Study|Withdrawal by Subject|8
4652931|NCT03334422|15972383|P4|Overall Study|Lack of Efficacy|3
4652932|NCT03334422|15972384|P3|Overall Study|Lack of Efficacy|7
4652933|NCT03334422|15972385|P2|Overall Study|Lack of Efficacy|2
4652934|NCT03334422|15972386|P1|Overall Study|Lack of Efficacy|10
4652935|NCT03334422|15972383|P4|Overall Study|Adverse Event|2
4652936|NCT03334422|15972384|P3|Overall Study|Adverse Event|2
4652937|NCT03334422|15972385|P2|Overall Study|Adverse Event|3
4652938|NCT03334422|15972386|P1|Overall Study|Adverse Event|1
4652939|NCT03334396|15972493|P8|Overall Study|Started New Job|0
4652940|NCT03334396|15972494|P7|Overall Study|Started New Job|0
4652941|NCT03334396|15972495|P6|Overall Study|Started New Job|0
4652942|NCT03334396|15972496|P5|Overall Study|Started New Job|0
4652943|NCT03334396|15972497|P4|Overall Study|Started New Job|0
4652944|NCT03334396|15972498|P3|Overall Study|Started New Job|0
4652945|NCT03334396|15972499|P2|Overall Study|Started New Job|0
4652946|NCT03334396|15972500|P1|Overall Study|Started New Job|1
4652947|NCT03334396|15972493|P8|Overall Study|Ineligible|0
4652948|NCT03334396|15972494|P7|Overall Study|Ineligible|0
4652949|NCT03334396|15972495|P6|Overall Study|Ineligible|0
4652950|NCT03334396|15972496|P5|Overall Study|Ineligible|0
4652951|NCT03334396|15972497|P4|Overall Study|Ineligible|0
4652952|NCT03334396|15972498|P3|Overall Study|Ineligible|0
4652953|NCT03334396|15972499|P2|Overall Study|Ineligible|1
4652954|NCT03334396|15972500|P1|Overall Study|Ineligible|0
4652955|NCT03334396|15972493|P8|Overall Study|Pregnancy|0
4652956|NCT03334396|15972494|P7|Overall Study|Pregnancy|0
4652957|NCT03334396|15972495|P6|Overall Study|Pregnancy|0
4652958|NCT03334396|15972496|P5|Overall Study|Pregnancy|0
4652959|NCT03334396|15972497|P4|Overall Study|Pregnancy|0
4652960|NCT03334396|15972498|P3|Overall Study|Pregnancy|0
4652961|NCT03334396|15972499|P2|Overall Study|Pregnancy|1
4652962|NCT03334396|15972500|P1|Overall Study|Pregnancy|0
4652963|NCT03334396|15972493|P8|Overall Study|Withdrawal by Subject|0
4652964|NCT03334396|15972494|P7|Overall Study|Withdrawal by Subject|2
4652965|NCT03334396|15972495|P6|Overall Study|Withdrawal by Subject|1
4652966|NCT03334396|15972496|P5|Overall Study|Withdrawal by Subject|2
4652967|NCT03334396|15972497|P4|Overall Study|Withdrawal by Subject|2
4652968|NCT03334396|15972498|P3|Overall Study|Withdrawal by Subject|7
4652969|NCT03334396|15972499|P2|Overall Study|Withdrawal by Subject|5
4652970|NCT03334396|15972500|P1|Overall Study|Withdrawal by Subject|10
4652971|NCT03334396|15972493|P8|Overall Study|Physician Decision|0
4652972|NCT03334396|15972494|P7|Overall Study|Physician Decision|0
4652973|NCT03334396|15972495|P6|Overall Study|Physician Decision|0
4652974|NCT03334396|15972496|P5|Overall Study|Physician Decision|0
4652975|NCT03334396|15972497|P4|Overall Study|Physician Decision|0
4652976|NCT03334396|15972498|P3|Overall Study|Physician Decision|0
4652977|NCT03334396|15972499|P2|Overall Study|Physician Decision|0
4652978|NCT03334396|15972500|P1|Overall Study|Physician Decision|1
4652979|NCT03334396|15972493|P8|Overall Study|Lost to Follow-up|0
4652980|NCT03334396|15972494|P7|Overall Study|Lost to Follow-up|1
4652981|NCT03334396|15972495|P6|Overall Study|Lost to Follow-up|0
4652982|NCT03334396|15972496|P5|Overall Study|Lost to Follow-up|0
4652983|NCT03334396|15972497|P4|Overall Study|Lost to Follow-up|0
4652984|NCT03334396|15972498|P3|Overall Study|Lost to Follow-up|1
4652985|NCT03334396|15972499|P2|Overall Study|Lost to Follow-up|0
4652986|NCT03334396|15972500|P1|Overall Study|Lost to Follow-up|0
4652987|NCT03334396|15972493|P8|Overall Study|Lack of Efficacy|1
4652988|NCT03334396|15972494|P7|Overall Study|Lack of Efficacy|0
4652989|NCT03334396|15972495|P6|Overall Study|Lack of Efficacy|0
4652990|NCT03334396|15972496|P5|Overall Study|Lack of Efficacy|1
4652991|NCT03334396|15972497|P4|Overall Study|Lack of Efficacy|3
4652992|NCT03334396|15972498|P3|Overall Study|Lack of Efficacy|1
4652993|NCT03334396|15972499|P2|Overall Study|Lack of Efficacy|4
4652994|NCT03334396|15972500|P1|Overall Study|Lack of Efficacy|10
4652995|NCT03334396|15972493|P8|Overall Study|Adverse Event|0
4652996|NCT03334396|15972494|P7|Overall Study|Adverse Event|0
4652997|NCT03334396|15972495|P6|Overall Study|Adverse Event|0
4652998|NCT03334396|15972496|P5|Overall Study|Adverse Event|0
4652999|NCT03334396|15972497|P4|Overall Study|Adverse Event|0
4653000|NCT03334396|15972498|P3|Overall Study|Adverse Event|1
4653001|NCT03334396|15972499|P2|Overall Study|Adverse Event|0
4653002|NCT03334396|15972500|P1|Overall Study|Adverse Event|1
4653003|NCT03334214|15972605|P2|Overall Study|Other|0
4653004|NCT03334214|15972606|P1|Overall Study|Other|1
4653005|NCT03334214|15972605|P2|Overall Study|Withdrawal by Subject|1
4653006|NCT03334214|15972606|P1|Overall Study|Withdrawal by Subject|0
4653007|NCT03334214|15972605|P2|Overall Study|Adverse Event or Serious Adverse Event|1
4653008|NCT03334214|15972606|P1|Overall Study|Adverse Event or Serious Adverse Event|0
4653009|NCT03334175|15972632|P2|Overall Study|Lost to Follow-up|1
4653010|NCT03334175|15972633|P1|Overall Study|Lost to Follow-up|0
4653011|NCT03333876|15972655|P1|Mandibular Advancement|Product Damage|2
4653012|NCT03333876|15972655|P1|Mandibular Advancement|Adverse Event|2
4653013|NCT03333876|15972655|P1|Nasal Dilator|Bed Partner Lost to follow up|6
4653014|NCT03333876|15972655|P1|Screening Period|Screen Failure|4
4653015|NCT03332160|15972828|P2|Overall Study|Non-adherence to treatment|2
4653016|NCT03332160|15972829|P1|Overall Study|Non-adherence to treatment|0
4653017|NCT03332160|15972828|P2|Overall Study|Developed Exclusion Criteria|1
4653018|NCT03332160|15972829|P1|Overall Study|Developed Exclusion Criteria|0
4653019|NCT03332160|15972828|P2|Overall Study|Adverse Event|1
4653020|NCT03332160|15972829|P1|Overall Study|Adverse Event|0
4653021|NCT03332160|15972828|P2|Overall Study|Withdrawal by Subject|1
4653022|NCT03332160|15972829|P1|Overall Study|Withdrawal by Subject|1
4653023|NCT03331315|15972913|P2|Overall Study|Physician Decision|14
4653024|NCT03331315|15972914|P1|Overall Study|Physician Decision|18
4653025|NCT03331042|15972951|P4|Overall Study|Lost to Follow-up|1
4653026|NCT03331042|15972952|P3|Overall Study|Lost to Follow-up|0
4653027|NCT03331042|15972953|P2|Overall Study|Lost to Follow-up|0
4653028|NCT03331042|15972954|P1|Overall Study|Lost to Follow-up|0
4653029|NCT03331042|15972951|P4|Overall Study|Physician Decision|0
4653030|NCT03331042|15972952|P3|Overall Study|Physician Decision|1
4653031|NCT03331042|15972953|P2|Overall Study|Physician Decision|0
4653032|NCT03331042|15972954|P1|Overall Study|Physician Decision|0
4653033|NCT03331042|15972951|P4|Overall Study|Protocol Violation|0
4653034|NCT03331042|15972952|P3|Overall Study|Protocol Violation|0
4653035|NCT03331042|15972953|P2|Overall Study|Protocol Violation|0
4653036|NCT03331042|15972954|P1|Overall Study|Protocol Violation|1
4653037|NCT03329885|15973078|P9|Overall Study|Sponsor discontinued the study early|0
4653038|NCT03329885|15973079|P8|Overall Study|Sponsor discontinued the study early|1
4653039|NCT03329885|15973080|P7|Overall Study|Sponsor discontinued the study early|1
4653040|NCT03329885|15973081|P6|Overall Study|Sponsor discontinued the study early|0
4653041|NCT03329885|15973082|P5|Overall Study|Sponsor discontinued the study early|0
4653042|NCT03329885|15973083|P4|Overall Study|Sponsor discontinued the study early|0
4653043|NCT03329885|15973084|P3|Overall Study|Sponsor discontinued the study early|0
4653044|NCT03329885|15973085|P2|Overall Study|Sponsor discontinued the study early|0
4653045|NCT03329885|15973086|P1|Overall Study|Sponsor discontinued the study early|0
4653046|NCT03329573|15973254|P4|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
4653047|NCT03329573|15973255|P3|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
4653048|NCT03329573|15973256|P2|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1
4653049|NCT03329573|15973257|P1|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0
4653050|NCT03329573|15973254|P4|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
4653051|NCT03329573|15973255|P3|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
4653052|NCT03329573|15973256|P2|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0
4653053|NCT03329573|15973257|P1|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1
4653054|NCT03329573|15973254|P4|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
4653055|NCT03329573|15973255|P3|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0
4653056|NCT03329573|15973256|P2|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2
4653057|NCT03329573|15973257|P1|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1
4653058|NCT03329573|15973254|P4|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
4653059|NCT03329573|15973255|P3|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
4653060|NCT03329573|15973256|P2|Treatment Period 1 (Up to 5 Days)|Adverse Event|1
4653061|NCT03329573|15973257|P1|Treatment Period 1 (Up to 5 Days)|Adverse Event|0
4653062|NCT03328182|15973371|P1|Overall Study|No Product Evaluated|1
4653063|NCT03328182|15973371|P1|Overall Study|Protocol Violation|2
4653064|NCT03328182|15973371|P1|Overall Study|Withdrawal by Subject|1
4653065|NCT03327402|15973376|P1|Overall Study|Other (Visit Out-Of-Window)|1
4653066|NCT03327402|15973376|P1|Overall Study|Withdrawal by Subject|1
4653067|NCT03326869|15973690|P2|Overall Study|Study data has been lost to natural disa|1
4653068|NCT03326869|15973691|P1|Overall Study|Study data has been lost to natural disa|1
4653069|NCT03326518|15973707|P3|Overall Study|Lost to Follow-up|1
4653070|NCT03326518|15973708|P2|Overall Study|Lost to Follow-up|0
4653071|NCT03326518|15973709|P1|Overall Study|Lost to Follow-up|1
4653072|NCT03326518|15973707|P3|Overall Study|Withdrawal by Subject|0
4653073|NCT03326518|15973708|P2|Overall Study|Withdrawal by Subject|0
4653074|NCT03326518|15973709|P1|Overall Study|Withdrawal by Subject|1
4653075|NCT03326518|15973707|P3|Overall Study|Protocol Violation|0
4653076|NCT03326518|15973708|P2|Overall Study|Protocol Violation|0
4653077|NCT03326518|15973709|P1|Overall Study|Protocol Violation|1
4653078|NCT03326323|15973744|P1|Overall Study|Unable to receive ANH protocol|3
4653079|NCT03325894|15973751|P2|Overall Study|Other (Not received Treatment)|0
4653080|NCT03325894|15973752|P1|Overall Study|Other (Not received Treatment)|1
4653081|NCT03325894|15973751|P2|Overall Study|Study Terminated by Sponsor|43
4653082|NCT03325894|15973752|P1|Overall Study|Study Terminated by Sponsor|38
4653083|NCT03325894|15973751|P2|Overall Study|Lack of Efficacy|14
4653084|NCT03325894|15973752|P1|Overall Study|Lack of Efficacy|8
4653085|NCT03325894|15973751|P2|Overall Study|Lost to Follow-up|9
4653086|NCT03325894|15973752|P1|Overall Study|Lost to Follow-up|4
4653087|NCT03325894|15973751|P2|Overall Study|Withdrawal by Subject|6
4653088|NCT03325894|15973752|P1|Overall Study|Withdrawal by Subject|10
4653089|NCT03325894|15973751|P2|Overall Study|Protocol Violation|2
4653090|NCT03325894|15973752|P1|Overall Study|Protocol Violation|1
4653091|NCT03325894|15973751|P2|Overall Study|Adverse Event|3
4653092|NCT03325894|15973752|P1|Overall Study|Adverse Event|2
4653093|NCT03325881|15973820|P2|Overall Study|Not treated|0
4653094|NCT03325881|15973821|P1|Overall Study|Not treated|1
4653095|NCT03325881|15973820|P2|Overall Study|Lack of Efficacy|0
4653096|NCT03325881|15973821|P1|Overall Study|Lack of Efficacy|2
4653097|NCT03325881|15973820|P2|Overall Study|Withdrawal by Subject|2
4653098|NCT03325881|15973821|P1|Overall Study|Withdrawal by Subject|0
4653099|NCT03325881|15973820|P2|Overall Study|Protocol Violation|1
4653100|NCT03325881|15973821|P1|Overall Study|Protocol Violation|0
4653101|NCT03325673|15973849|P2|Overall Study|Adverse Event|0
4653102|NCT03325673|15973850|P1|Overall Study|Adverse Event|4
4653103|NCT03323736|15973882|P3|Overall Study|Iontophoresis fill/no iontophoresis|0
4653104|NCT03323736|15973883|P2|Overall Study|Iontophoresis fill/no iontophoresis|2
4653105|NCT03323736|15973884|P1|Overall Study|Iontophoresis fill/no iontophoresis|2
4653106|NCT03323736|15973882|P3|Overall Study|Withdrawal Before Treatment|1
4653107|NCT03323736|15973883|P2|Overall Study|Withdrawal Before Treatment|1
4653108|NCT03323736|15973884|P1|Overall Study|Withdrawal Before Treatment|3
4653109|NCT03323736|15973882|P3|Overall Study|Screen Failure|1
4653110|NCT03323736|15973883|P2|Overall Study|Screen Failure|9
4653111|NCT03323736|15973884|P1|Overall Study|Screen Failure|14
4653112|NCT03323086|15973911|P2|Overall Study|Lost to Follow-up|2
4653113|NCT03323086|15973912|P1|Overall Study|Lost to Follow-up|3
4653114|NCT03322566|15973940|P3|Overall Study|On-going at clinical cut off date|36
4653115|NCT03322566|15973941|P2|Overall Study|On-going at clinical cut off date|74
4653116|NCT03322566|15973942|P1|Overall Study|On-going at clinical cut off date|68
4653117|NCT03322566|15973940|P3|Overall Study|Withdrawal by Subject|5
4653118|NCT03322566|15973941|P2|Overall Study|Withdrawal by Subject|1
4653119|NCT03322566|15973942|P1|Overall Study|Withdrawal by Subject|3
4653120|NCT03322566|15973940|P3|Overall Study|Physician Decision|1
4653121|NCT03322566|15973941|P2|Overall Study|Physician Decision|0
4653122|NCT03322566|15973942|P1|Overall Study|Physician Decision|0
4653123|NCT03322566|15973940|P3|Overall Study|Death|13
4653124|NCT03322566|15973941|P2|Overall Study|Death|12
4653125|NCT03322566|15973942|P1|Overall Study|Death|20
4653126|NCT03322540|15973961|P2|Overall Study|Participants Ongoing|59
4653127|NCT03322540|15973962|P1|Overall Study|Participants Ongoing|63
4653128|NCT03322540|15973961|P2|Overall Study|Withdrawal by Subject|1
4653129|NCT03322540|15973962|P1|Overall Study|Withdrawal by Subject|2
4653130|NCT03322540|15973961|P2|Overall Study|Physician Decision|1
4653131|NCT03322540|15973962|P1|Overall Study|Physician Decision|0
4653132|NCT03322540|15973961|P2|Overall Study|Lost to Follow-up|1
4653133|NCT03322540|15973962|P1|Overall Study|Lost to Follow-up|0
4653134|NCT03322540|15973961|P2|Overall Study|Death|15
4653135|NCT03322540|15973962|P1|Overall Study|Death|12
4653136|NCT03322514|15973970|P2|Overall Study|Withdrawal by Subject|1
4653137|NCT03322514|15973971|P1|Overall Study|Withdrawal by Subject|1
4653138|NCT03322462|15973981|P1|Overall Study|Other|1
4653139|NCT03322462|15973981|P1|Overall Study|Technical difficulties|2
4653140|NCT03322423|15973990|P2|Period 2|Subject not eligible for Pytergiumectomy|1
4653141|NCT03322423|15973991|P1|Period 2|Subject not eligible for Pytergiumectomy|0
4653142|NCT03322423|15973990|P2|Period 2|Protocol Violation|0
4653143|NCT03322423|15973991|P1|Period 2|Protocol Violation|1
4653144|NCT03322423|15973990|P2|Period 2|Dispensed incorrect lens in left eye|1
4653145|NCT03322423|15973991|P1|Period 2|Dispensed incorrect lens in left eye|0
4653146|NCT03322423|15973990|P2|Period 1|Unsatisfactory Lens Fitting|0
4653147|NCT03322423|15973991|P1|Period 1|Unsatisfactory Lens Fitting|1
4653148|NCT03322423|15973990|P2|Period 1|Incorrect Lens Dispensed|0
4653149|NCT03322423|15973991|P1|Period 1|Incorrect Lens Dispensed|1
4653150|NCT03322423|15973990|P2|Period 1|Withdrawal by Subject|1
4653151|NCT03322423|15973991|P1|Period 1|Withdrawal by Subject|0
4653152|NCT03322423|15973990|P2|Period 1|Subject no longer eligible|1
4653153|NCT03322423|15973991|P1|Period 1|Subject no longer eligible|0
4653154|NCT03322293|15974004|P3|Overall Study|Lost to Follow-up|1
4653155|NCT03322293|15974005|P2|Overall Study|Lost to Follow-up|0
4653156|NCT03322293|15974006|P1|Overall Study|Lost to Follow-up|0
4653157|NCT03321721|15974029|P3|Overall Study|Lost to Follow-up|11
4653158|NCT03321721|15974030|P2|Overall Study|Lost to Follow-up|8
4653159|NCT03321721|15974031|P1|Overall Study|Lost to Follow-up|4
4653160|NCT03321396|15974048|P1|Overall Study|Physician Decision|1
4653161|NCT03320941|15974086|P5|Overall Study|subject/guardian decision|0
4653162|NCT03320941|15974087|P4|Overall Study|subject/guardian decision|1
4653163|NCT03320941|15974088|P3|Overall Study|subject/guardian decision|0
4653164|NCT03320941|15974089|P2|Overall Study|subject/guardian decision|0
4653165|NCT03320941|15974090|P1|Overall Study|subject/guardian decision|0
4653166|NCT03320824|15974193|P2|Overall Study|could not complete final visit|1
4653167|NCT03320824|15974194|P1|Overall Study|could not complete final visit|0
4653168|NCT03320824|15974193|P2|Overall Study|moved out of state|1
4653169|NCT03320824|15974194|P1|Overall Study|moved out of state|0
4653170|NCT03320824|15974193|P2|Overall Study|Lost to Follow-up|1
4653171|NCT03320824|15974194|P1|Overall Study|Lost to Follow-up|10
4653172|NCT03320824|15974193|P2|Overall Study|Withdrawal by Subject|1
4653173|NCT03320824|15974194|P1|Overall Study|Withdrawal by Subject|8
4653174|NCT03320564|15974210|P1|Overall Study|Protocol Violation|1
4653175|NCT03320369|15974214|P1|Overall Study|Withdrawal by Subject|2
4653176|NCT03320369|15974214|P1|Overall Study|Adverse Event|1
4653177|NCT03319719|15974235|P1|Overall Study|Lost to Follow-up|1
4653178|NCT03319212|15974268|P2|Overall Study|Physician Decision|0
4653179|NCT03319212|15974269|P1|Overall Study|Physician Decision|1
4653180|NCT03319212|15974268|P2|Overall Study|Lost to Follow-up|1
4653181|NCT03319212|15974269|P1|Overall Study|Lost to Follow-up|0
4653182|NCT03319212|15974268|P2|Overall Study|Withdrawal by Subject|1
4653183|NCT03319212|15974269|P1|Overall Study|Withdrawal by Subject|0
4653184|NCT03319212|15974268|P2|Overall Study|Adverse Event|2
4653185|NCT03319212|15974269|P1|Overall Study|Adverse Event|2
4653186|NCT03319212|15974268|P2|Overall Study|Discontinued as moving out of local area|1
4653187|NCT03319212|15974269|P1|Overall Study|Discontinued as moving out of local area|0
4653188|NCT03318861|15974351|P5|Overall Study|Enrolled But Did Not Initiate KITE-585|1
4653189|NCT03318861|15974352|P4|Overall Study|Enrolled But Did Not Initiate KITE-585|1
4653190|NCT03318861|15974353|P3|Overall Study|Enrolled But Did Not Initiate KITE-585|0
4653191|NCT03318861|15974354|P2|Overall Study|Enrolled But Did Not Initiate KITE-585|1
4653192|NCT03318861|15974355|P1|Overall Study|Enrolled But Did Not Initiate KITE-585|0
4653193|NCT03318861|15974351|P5|Overall Study|Still on Study|1
4653194|NCT03318861|15974352|P4|Overall Study|Still on Study|2
4653195|NCT03318861|15974353|P3|Overall Study|Still on Study|1
4653196|NCT03318861|15974354|P2|Overall Study|Still on Study|1
4653197|NCT03318861|15974355|P1|Overall Study|Still on Study|2
4653198|NCT03318861|15974351|P5|Overall Study|Death|1
4653199|NCT03318861|15974352|P4|Overall Study|Death|1
4653200|NCT03318861|15974353|P3|Overall Study|Death|2
4653201|NCT03318861|15974354|P2|Overall Study|Death|2
4653202|NCT03318861|15974355|P1|Overall Study|Death|1
4653203|NCT03318315|15974417|P3|Overall Study|Withdrawal by Subject|2
4653204|NCT03318315|15974418|P2|Overall Study|Withdrawal by Subject|0
4653205|NCT03318315|15974419|P1|Overall Study|Withdrawal by Subject|0
4653206|NCT03318315|15974417|P3|Overall Study|Protocol Violation|1
4653207|NCT03318315|15974418|P2|Overall Study|Protocol Violation|1
4653208|NCT03318315|15974419|P1|Overall Study|Protocol Violation|1
4653209|NCT03318315|15974417|P3|Overall Study|Lost to Follow-up|1
4653210|NCT03318315|15974418|P2|Overall Study|Lost to Follow-up|2
4653211|NCT03318315|15974419|P1|Overall Study|Lost to Follow-up|3
4653212|NCT03316911|15974533|P2|Overall Study|Lost to Follow-up|29
4653213|NCT03316911|15974534|P1|Overall Study|Lost to Follow-up|33
4653214|NCT03316131|15974579|P2|Treatment Period 2|Protocol deviation|0
4653215|NCT03316131|15974580|P1|Treatment Period 2|Protocol deviation|1
4653216|NCT03315689|15974646|P2|Open Label Extension = 52 Weeks|Lost to Follow-up|1
4653217|NCT03315689|15974647|P1|Open Label Extension = 52 Weeks|Lost to Follow-up|0
4653218|NCT03315689|15974646|P2|Open Label Extension = 52 Weeks|Withdrawal by Subject|2
4653219|NCT03315689|15974647|P1|Open Label Extension = 52 Weeks|Withdrawal by Subject|0
4653220|NCT03315689|15974646|P2|Double-blind Period = 28 Days|Withdrawal by Subject|0
4653221|NCT03315689|15974647|P1|Double-blind Period = 28 Days|Withdrawal by Subject|1
4653222|NCT03315286|15974741|P2|Overall Study|Protocol Violation|1
4653223|NCT03315286|15974742|P1|Overall Study|Protocol Violation|0
4653224|NCT03315286|15974741|P2|Overall Study|Withdrawal by Subject|0
4653225|NCT03315286|15974742|P1|Overall Study|Withdrawal by Subject|1
4653226|NCT03315286|15974741|P2|Overall Study|Lost to Follow-up|3
4653227|NCT03315286|15974742|P1|Overall Study|Lost to Follow-up|0
4653228|NCT03314857|15974783|P1|Overall Study|Physician Decision|1
4653229|NCT03314857|15974783|P1|Overall Study|Death|4
4653230|NCT03314662|15974817|P3|Overall Study|Death|0
4653231|NCT03314662|15974818|P2|Overall Study|Death|0
4653232|NCT03314662|15974819|P1|Overall Study|Death|2
4653233|NCT03314662|15974817|P3|Overall Study|Lost to Follow-up|4
4653234|NCT03314662|15974818|P2|Overall Study|Lost to Follow-up|4
4653235|NCT03314662|15974819|P1|Overall Study|Lost to Follow-up|5
4653236|NCT03314662|15974817|P3|Overall Study|Withdrawal by Subject|1
4653237|NCT03314662|15974818|P2|Overall Study|Withdrawal by Subject|1
4653238|NCT03314662|15974819|P1|Overall Study|Withdrawal by Subject|1
4653239|NCT03314519|15974864|P2|Overall Study|Protocol Violation|2
4653240|NCT03314519|15974865|P1|Overall Study|Protocol Violation|3
4653241|NCT03314233|15974875|P1|Overall Study|No longer eligible at time of delivery|1
4653242|NCT03313050|15974890|P4|Stage 2: 12 Months|Other|1
4653243|NCT03313050|15974891|P3|Stage 2: 12 Months|Other|0
4653244|NCT03313050|15974892|P2|Stage 2: 12 Months|Other|0
4653245|NCT03313050|15974893|P1|Stage 2: 12 Months|Other|0
4653246|NCT03313050|15974890|P4|Stage 2: 12 Months|Withdrawal by Subject|3
4653247|NCT03313050|15974891|P3|Stage 2: 12 Months|Withdrawal by Subject|0
4653248|NCT03313050|15974892|P2|Stage 2: 12 Months|Withdrawal by Subject|0
4653249|NCT03313050|15974893|P1|Stage 2: 12 Months|Withdrawal by Subject|0
4653250|NCT03313050|15974890|P4|Stage 2: 12 Months|Protocol deviation|7
4653251|NCT03313050|15974891|P3|Stage 2: 12 Months|Protocol deviation|7
4653252|NCT03313050|15974892|P2|Stage 2: 12 Months|Protocol deviation|0
4653253|NCT03313050|15974893|P1|Stage 2: 12 Months|Protocol deviation|0
4653254|NCT03313050|15974890|P4|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3
4653255|NCT03313050|15974891|P3|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
4653256|NCT03313050|15974892|P2|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
4653257|NCT03313050|15974893|P1|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0
4653258|NCT03313050|15974890|P4|Stage 2: 12 Months|Lost to Follow-up|5
4653259|NCT03313050|15974891|P3|Stage 2: 12 Months|Lost to Follow-up|1
4653260|NCT03313050|15974892|P2|Stage 2: 12 Months|Lost to Follow-up|0
4653261|NCT03313050|15974893|P1|Stage 2: 12 Months|Lost to Follow-up|0
4653262|NCT03313050|15974890|P4|Stage 2: 12 Months|Death|0
4653263|NCT03313050|15974891|P3|Stage 2: 12 Months|Death|3
4653264|NCT03313050|15974892|P2|Stage 2: 12 Months|Death|0
4653265|NCT03313050|15974893|P1|Stage 2: 12 Months|Death|0
4653266|NCT03313050|15974890|P4|Stage 2: 12 Months|Adverse Event|1
4653267|NCT03313050|15974891|P3|Stage 2: 12 Months|Adverse Event|0
4653268|NCT03313050|15974892|P2|Stage 2: 12 Months|Adverse Event|0
4653269|NCT03313050|15974893|P1|Stage 2: 12 Months|Adverse Event|0
4653270|NCT03313037|15974933|P2|Overall Study|Randomized but not treated|0
4653271|NCT03313037|15974934|P1|Overall Study|Randomized but not treated|1
4653272|NCT03313037|15974933|P2|Overall Study|Lost to Follow-up|8
4653273|NCT03313037|15974934|P1|Overall Study|Lost to Follow-up|9
4653274|NCT03313037|15974933|P2|Overall Study|No longer meets eligibility criteria|7
4653275|NCT03313037|15974934|P1|Overall Study|No longer meets eligibility criteria|1
4653276|NCT03313037|15974933|P2|Overall Study|Withdrawal by Subject|3
4653277|NCT03313037|15974934|P1|Overall Study|Withdrawal by Subject|4
4653278|NCT03313037|15974933|P2|Overall Study|Other|1
4653279|NCT03313037|15974934|P1|Overall Study|Other|1
4653280|NCT03313037|15974933|P2|Overall Study|Protocol Violation|1
4653281|NCT03313037|15974934|P1|Overall Study|Protocol Violation|4
4653282|NCT03312933|15974956|P1|Overall Study|Withdrawal by Subject|3
4653283|NCT03312933|15974956|P1|Overall Study|Lost to Follow-up|36
4653284|NCT03312933|15974956|P1|Overall Study|Protocol Violation|15
4653285|NCT03312543|15974962|P2|Regression (Week 12 to Week 24)|Death|1
4653286|NCT03312543|15974963|P1|Regression (Week 12 to Week 24)|Death|0
4653287|NCT03312543|15974962|P2|Regression (Week 12 to Week 24)|Protocol Violation|1
4653288|NCT03312543|15974963|P1|Regression (Week 12 to Week 24)|Protocol Violation|1
4653289|NCT03312543|15974962|P2|Treatment (Baseline to Week 12)|Protocol Violation|1
4653290|NCT03312543|15974963|P1|Treatment (Baseline to Week 12)|Protocol Violation|1
4653291|NCT03312543|15974962|P2|Treatment (Baseline to Week 12)|Withdrawal by Subject|4
4653292|NCT03312543|15974963|P1|Treatment (Baseline to Week 12)|Withdrawal by Subject|3
4653293|NCT03312543|15974962|P2|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2
4653294|NCT03312543|15974963|P1|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1
4653295|NCT03312543|15974962|P2|Before Treatment (Screening to Baseline)|Lost to Follow-up|2
4653296|NCT03312543|15974963|P1|Before Treatment (Screening to Baseline)|Lost to Follow-up|0
4653297|NCT03312231|15975059|P5|Overall Study|Study Vaccination not Received|0
4653298|NCT03312231|15975060|P4|Overall Study|Study Vaccination not Received|0
4653299|NCT03312231|15975061|P3|Overall Study|Study Vaccination not Received|1
4653300|NCT03312231|15975062|P2|Overall Study|Study Vaccination not Received|1
4653301|NCT03312231|15975063|P1|Overall Study|Study Vaccination not Received|1
4653302|NCT03312231|15975059|P5|Overall Study|Death|0
4653303|NCT03312231|15975060|P4|Overall Study|Death|0
4653304|NCT03312231|15975061|P3|Overall Study|Death|1
4653305|NCT03312231|15975062|P2|Overall Study|Death|1
4653306|NCT03312231|15975063|P1|Overall Study|Death|0
4653307|NCT03312231|15975059|P5|Overall Study|Withdrawal by Subject|0
4653308|NCT03312231|15975060|P4|Overall Study|Withdrawal by Subject|0
4653309|NCT03312231|15975061|P3|Overall Study|Withdrawal by Subject|1
4653310|NCT03312231|15975062|P2|Overall Study|Withdrawal by Subject|3
4653311|NCT03312231|15975063|P1|Overall Study|Withdrawal by Subject|0
4653312|NCT03312231|15975059|P5|Overall Study|Lost to Follow-up|1
4653313|NCT03312231|15975060|P4|Overall Study|Lost to Follow-up|3
4653314|NCT03312231|15975061|P3|Overall Study|Lost to Follow-up|1
4653315|NCT03312231|15975062|P2|Overall Study|Lost to Follow-up|6
4653316|NCT03312231|15975063|P1|Overall Study|Lost to Follow-up|2
4653317|NCT03311841|15975270|P5|14-day Wash-out|Non-Compliance With Study Drug|0
4653318|NCT03311841|15975271|P4|14-day Wash-out|Non-Compliance With Study Drug|1
4653319|NCT03311841|15975272|P3|14-day Wash-out|Non-Compliance With Study Drug|0
4653320|NCT03311841|15975273|P2|14-day Wash-out|Non-Compliance With Study Drug|0
4653321|NCT03311841|15975274|P1|14-day Wash-out|Non-Compliance With Study Drug|0
4653322|NCT03311841|15975270|P5|14-day Wash-out|Adverse Event|0
4653323|NCT03311841|15975271|P4|14-day Wash-out|Adverse Event|0
4653324|NCT03311841|15975272|P3|14-day Wash-out|Adverse Event|0
4653325|NCT03311841|15975273|P2|14-day Wash-out|Adverse Event|1
4653326|NCT03311841|15975274|P1|14-day Wash-out|Adverse Event|0
4653327|NCT03311659|15975375|P1|Overall Study|Protocol Violation|1
4653328|NCT03311646|15975390|P1|Overall Study|PI Withdrawal for Positive Drug Screen|4
4653329|NCT03311646|15975390|P1|Overall Study|Lost to Follow-up|5
4653330|NCT03311646|15975390|P1|Overall Study|Withdrawal by Subject|5
4653331|NCT03311646|15975390|P1|Overall Study|Physician Decision|1
4653332|NCT03311373|15975397|P1|Overall Study|Withdrawal by Subject|3
4653333|NCT03311373|15975397|P1|Overall Study|Physician Decision|1
4653334|NCT03311373|15975397|P1|Overall Study|Lost to Follow-up|1
4653335|NCT03311373|15975397|P1|Overall Study|Protocol Discontinuation Criteria|3
4653336|NCT03311373|15975397|P1|Overall Study|Adverse Event|1
4653337|NCT03311230|15975455|P4|Overall Study|Unrelated injury|0
4653338|NCT03311230|15975456|P3|Overall Study|Unrelated injury|0
4653339|NCT03311230|15975457|P2|Overall Study|Unrelated injury|1
4653340|NCT03311230|15975458|P1|Overall Study|Unrelated injury|0
4653341|NCT03311230|15975455|P4|Overall Study|Withdrawal by Subject|7
4653342|NCT03311230|15975456|P3|Overall Study|Withdrawal by Subject|2
4653343|NCT03311230|15975457|P2|Overall Study|Withdrawal by Subject|4
4653344|NCT03311230|15975458|P1|Overall Study|Withdrawal by Subject|1
4653345|NCT03310775|15975482|P2|Overall Study|aggravation of depression|1
4653346|NCT03310775|15975483|P1|Overall Study|aggravation of depression|0
4653347|NCT03310775|15975482|P2|Overall Study|Lost to Follow-up|3
4653348|NCT03310775|15975483|P1|Overall Study|Lost to Follow-up|2
4653349|NCT03310723|15975501|P2|Overall Study|Protocol Violation|2
4653350|NCT03310723|15975502|P1|Overall Study|Protocol Violation|0
4653351|NCT03310723|15975501|P2|Overall Study|Withdrawal by Subject|1
4653352|NCT03310723|15975502|P1|Overall Study|Withdrawal by Subject|0
4653353|NCT03310580|15975513|P3|Overall Study|Adverse Event|0
4653354|NCT03310580|15975514|P2|Overall Study|Adverse Event|1
4653355|NCT03310580|15975515|P1|Overall Study|Adverse Event|0
4653356|NCT03310411|15975548|P4|Period 1|Adverse Event|1
4653357|NCT03310411|15975549|P3|Period 1|Adverse Event|0
4653358|NCT03310411|15975550|P2|Period 1|Adverse Event|0
4653359|NCT03310411|15975551|P1|Period 1|Adverse Event|0
4653360|NCT03310268|15975572|P3|Overall Study|(Not specified)|0
4653361|NCT03310268|15975573|P2|Overall Study|(Not specified)|5
4653362|NCT03310268|15975574|P1|Overall Study|(Not specified)|1
4653363|NCT03310021|15975605|P20|Overall Study|Lost to Follow-up|0
4653364|NCT03310021|15975606|P19|Overall Study|Lost to Follow-up|0
4653365|NCT03310021|15975607|P18|Overall Study|Lost to Follow-up|0
4653366|NCT03310021|15975608|P17|Overall Study|Lost to Follow-up|0
4653367|NCT03310021|15975609|P16|Overall Study|Lost to Follow-up|0
4653368|NCT03310021|15975610|P15|Overall Study|Lost to Follow-up|0
4653369|NCT03310021|15975611|P14|Overall Study|Lost to Follow-up|0
4653370|NCT03310021|15975612|P13|Overall Study|Lost to Follow-up|0
4653371|NCT03310021|15975613|P12|Overall Study|Lost to Follow-up|0
4653372|NCT03310021|15975614|P11|Overall Study|Lost to Follow-up|1
4653373|NCT03310021|15975615|P10|Overall Study|Lost to Follow-up|0
4653374|NCT03310021|15975616|P9|Overall Study|Lost to Follow-up|0
4653375|NCT03310021|15975617|P8|Overall Study|Lost to Follow-up|0
4653376|NCT03310021|15975618|P7|Overall Study|Lost to Follow-up|0
4653377|NCT03310021|15975619|P6|Overall Study|Lost to Follow-up|0
4653378|NCT03310021|15975620|P5|Overall Study|Lost to Follow-up|0
4653379|NCT03310021|15975621|P4|Overall Study|Lost to Follow-up|0
4653380|NCT03310021|15975622|P3|Overall Study|Lost to Follow-up|0
4653381|NCT03310021|15975623|P2|Overall Study|Lost to Follow-up|0
4653382|NCT03310021|15975624|P1|Overall Study|Lost to Follow-up|0
4653383|NCT03310021|15975605|P20|Overall Study|Withdrawal by Subject|0
4653384|NCT03310021|15975606|P19|Overall Study|Withdrawal by Subject|0
4653385|NCT03310021|15975607|P18|Overall Study|Withdrawal by Subject|0
4653386|NCT03310021|15975608|P17|Overall Study|Withdrawal by Subject|0
4653387|NCT03310021|15975609|P16|Overall Study|Withdrawal by Subject|0
4653388|NCT03310021|15975610|P15|Overall Study|Withdrawal by Subject|0
4653389|NCT03310021|15975611|P14|Overall Study|Withdrawal by Subject|0
4653390|NCT03310021|15975612|P13|Overall Study|Withdrawal by Subject|0
4653391|NCT03310021|15975613|P12|Overall Study|Withdrawal by Subject|0
4653392|NCT03310021|15975614|P11|Overall Study|Withdrawal by Subject|0
4653393|NCT03310021|15975615|P10|Overall Study|Withdrawal by Subject|0
4653394|NCT03310021|15975616|P9|Overall Study|Withdrawal by Subject|0
4653395|NCT03310021|15975617|P8|Overall Study|Withdrawal by Subject|0
4653396|NCT03310021|15975618|P7|Overall Study|Withdrawal by Subject|1
4653397|NCT03310021|15975619|P6|Overall Study|Withdrawal by Subject|0
4653398|NCT03310021|15975620|P5|Overall Study|Withdrawal by Subject|0
4653399|NCT03310021|15975621|P4|Overall Study|Withdrawal by Subject|0
4653400|NCT03310021|15975622|P3|Overall Study|Withdrawal by Subject|0
4653401|NCT03310021|15975623|P2|Overall Study|Withdrawal by Subject|0
4653402|NCT03310021|15975624|P1|Overall Study|Withdrawal by Subject|0
4653403|NCT03309943|15975768|P2|Overall Study|Inappropriate behavior towards staff|1
4653404|NCT03309943|15975769|P1|Overall Study|Inappropriate behavior towards staff|0
4653405|NCT03309943|15975768|P2|Overall Study|Withdrawal by Subject|1
4653406|NCT03309943|15975769|P1|Overall Study|Withdrawal by Subject|0
4653407|NCT03309202|15975841|P4|Overall Study|Lost to Follow-up|0
4653408|NCT03309202|15975842|P3|Overall Study|Lost to Follow-up|0
4653409|NCT03309202|15975843|P2|Overall Study|Lost to Follow-up|0
4653410|NCT03309202|15975844|P1|Overall Study|Lost to Follow-up|1
4653411|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Lack of Efficacy|0
4653412|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Lack of Efficacy|2
4653413|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Lack of Efficacy|1
4653414|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Lost to Follow-up|1
4653415|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Lost to Follow-up|1
4653416|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Lost to Follow-up|0
4653417|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1
4653418|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
4653419|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0
4653420|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Protocol Violation|1
4653421|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Protocol Violation|1
4653422|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Protocol Violation|0
4653423|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Withdrawal by Subject|7
4653424|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
4653425|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Withdrawal by Subject|5
4653426|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Adverse Event|1
4653427|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Adverse Event|1
4653428|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Adverse Event|4
4653429|NCT03308968|15975938|P3|Open-Label Period (12 Weeks)|Other than specified|1
4653430|NCT03308968|15975939|P2|Open-Label Period (12 Weeks)|Other than specified|2
4653431|NCT03308968|15975940|P1|Open-Label Period (12 Weeks)|Other than specified|1
4653432|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Other than specified|2
4653433|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Other than specified|0
4653434|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Other than specified|1
4653435|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Lack of Efficacy|0
4653436|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
4653437|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Lack of Efficacy|1
4653438|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
4653439|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Lost to Follow-up|0
4653440|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Lost to Follow-up|1
4653441|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0
4653442|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
4653443|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1
4653444|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Protocol Violation|2
4653445|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Protocol Violation|0
4653446|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Protocol Violation|6
4653447|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3
4653448|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
4653449|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2
4653450|NCT03308968|15975938|P3|Double-Blind Period (12 Weeks)|Adverse Event|4
4653451|NCT03308968|15975939|P2|Double-Blind Period (12 Weeks)|Adverse Event|1
4653452|NCT03308968|15975940|P1|Double-Blind Period (12 Weeks)|Adverse Event|3
4653453|NCT03308825|15976018|P4|Overall Study|Protocol Violation|0
4653454|NCT03308825|15976019|P3|Overall Study|Protocol Violation|0
4653455|NCT03308825|15976020|P2|Overall Study|Protocol Violation|2
4653456|NCT03308825|15976021|P1|Overall Study|Protocol Violation|0
4653457|NCT03308825|15976018|P4|Overall Study|Lost to Follow-up|0
4653458|NCT03308825|15976019|P3|Overall Study|Lost to Follow-up|1
4653459|NCT03308825|15976020|P2|Overall Study|Lost to Follow-up|2
4653460|NCT03308825|15976021|P1|Overall Study|Lost to Follow-up|2
4653461|NCT03307252|15976109|P11|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1
4653462|NCT03307252|15976110|P10|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653463|NCT03307252|15976111|P9|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653464|NCT03307252|15976112|P8|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653465|NCT03307252|15976113|P7|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653466|NCT03307252|15976114|P6|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653467|NCT03307252|15976115|P5|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653468|NCT03307252|15976116|P4|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653469|NCT03307252|15976117|P3|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653470|NCT03307252|15976118|P2|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653471|NCT03307252|15976119|P1|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0
4653472|NCT03307252|15976109|P11|Part 2, Period 4|Other than listed|0
4653473|NCT03307252|15976110|P10|Part 2, Period 4|Other than listed|0
4653474|NCT03307252|15976111|P9|Part 2, Period 4|Other than listed|0
4653475|NCT03307252|15976112|P8|Part 2, Period 4|Other than listed|0
4653476|NCT03307252|15976113|P7|Part 2, Period 4|Other than listed|1
4653477|NCT03307252|15976114|P6|Part 2, Period 4|Other than listed|0
4653478|NCT03307252|15976115|P5|Part 2, Period 4|Other than listed|0
4653479|NCT03307252|15976116|P4|Part 2, Period 4|Other than listed|0
4653480|NCT03307252|15976117|P3|Part 2, Period 4|Other than listed|0
4653481|NCT03307252|15976118|P2|Part 2, Period 4|Other than listed|0
4653482|NCT03307252|15976119|P1|Part 2, Period 4|Other than listed|0
4653483|NCT03307252|15976109|P11|Part 2, Period 3|Other than listed|0
4653484|NCT03307252|15976110|P10|Part 2, Period 3|Other than listed|0
4653485|NCT03307252|15976111|P9|Part 2, Period 3|Other than listed|0
4653486|NCT03307252|15976112|P8|Part 2, Period 3|Other than listed|0
4653487|NCT03307252|15976113|P7|Part 2, Period 3|Other than listed|0
4653488|NCT03307252|15976114|P6|Part 2, Period 3|Other than listed|0
4653489|NCT03307252|15976115|P5|Part 2, Period 3|Other than listed|1
4653490|NCT03307252|15976116|P4|Part 2, Period 3|Other than listed|0
4653491|NCT03307252|15976117|P3|Part 2, Period 3|Other than listed|0
4653492|NCT03307252|15976118|P2|Part 2, Period 3|Other than listed|0
4653493|NCT03307252|15976119|P1|Part 2, Period 3|Other than listed|0
4653494|NCT03307252|15976109|P11|Part 2, Period 1|Treatment not received|0
4653495|NCT03307252|15976110|P10|Part 2, Period 1|Treatment not received|0
4653496|NCT03307252|15976111|P9|Part 2, Period 1|Treatment not received|0
4653497|NCT03307252|15976112|P8|Part 2, Period 1|Treatment not received|0
4653498|NCT03307252|15976113|P7|Part 2, Period 1|Treatment not received|0
4653499|NCT03307252|15976114|P6|Part 2, Period 1|Treatment not received|1
4653500|NCT03307252|15976115|P5|Part 2, Period 1|Treatment not received|0
4653501|NCT03307252|15976116|P4|Part 2, Period 1|Treatment not received|0
4653502|NCT03307252|15976117|P3|Part 2, Period 1|Treatment not received|0
4653503|NCT03307252|15976118|P2|Part 2, Period 1|Treatment not received|0
4653504|NCT03307252|15976119|P1|Part 2, Period 1|Treatment not received|0
4653505|NCT03307174|15976156|P2|Overall Study|Intrathecal catheter placement|1
4653506|NCT03307174|15976157|P1|Overall Study|Intrathecal catheter placement|0
4653507|NCT03307174|15976156|P2|Overall Study|Planned epidural removal|0
4653508|NCT03307174|15976157|P1|Overall Study|Planned epidural removal|1
4653509|NCT03307174|15976156|P2|Overall Study|Nonfunctional epidural|1
4653510|NCT03307174|15976157|P1|Overall Study|Nonfunctional epidural|1
4653511|NCT03307174|15976156|P2|Overall Study|Hypotension|0
4653512|NCT03307174|15976157|P1|Overall Study|Hypotension|6
4653513|NCT03307174|15976156|P2|Overall Study|Aborted Surgery|2
4653514|NCT03307174|15976157|P1|Overall Study|Aborted Surgery|1
4653515|NCT03307174|15976156|P2|Overall Study|Unplanned ICU Administrion|3
4653516|NCT03307174|15976157|P1|Overall Study|Unplanned ICU Administrion|5
4653517|NCT03306277|15976438|P1|Overall Study|Withdrawal by Subject|1
4653518|NCT03306277|15976438|P1|Overall Study|Adverse Event|1
4653519|NCT03306277|15976438|P1|Overall Study|Death|1
4653520|NCT03306043|15976449|P1|Overall Study|Withdrawal by Subject|2
4653521|NCT03306043|15976449|P1|Overall Study|Lost to Follow-up|1
4653522|NCT03306043|15976449|P1|Overall Study|Adverse Event|1
4653523|NCT03305770|15976475|P2|Overall Study|Subject moved|0
4653524|NCT03305770|15976476|P1|Overall Study|Subject moved|1
4653525|NCT03305770|15976475|P2|Overall Study|Physician Decision - prior to dispense|1
4653526|NCT03305770|15976476|P1|Overall Study|Physician Decision - prior to dispense|0
4653527|NCT03305731|15976484|P1|Overall Study|Protocol Violation|1
4653528|NCT03305575|15976495|P2|Overall Study|Physician Decision|0
4653529|NCT03305575|15976496|P1|Overall Study|Physician Decision|1
4653530|NCT03305419|15976516|P8|Part B (14 Days)|Physician Decision|0
4653531|NCT03305419|15976517|P7|Part B (14 Days)|Physician Decision|1
4653532|NCT03305419|15976518|P6|Part B (14 Days)|Physician Decision|8
4653533|NCT03305419|15976519|P5|Part B (14 Days)|Physician Decision|2
4653534|NCT03305419|15976520|P4|Part B (14 Days)|Physician Decision|0
4653535|NCT03305419|15976521|P3|Part B (14 Days)|Physician Decision|0
4653536|NCT03305419|15976522|P2|Part B (14 Days)|Physician Decision|0
4653537|NCT03305419|15976523|P1|Part B (14 Days)|Physician Decision|0
4653538|NCT03305419|15976516|P8|Part B (14 Days)|Adverse Event|0
4653539|NCT03305419|15976517|P7|Part B (14 Days)|Adverse Event|4
4653540|NCT03305419|15976518|P6|Part B (14 Days)|Adverse Event|2
4653541|NCT03305419|15976519|P5|Part B (14 Days)|Adverse Event|1
4653542|NCT03305419|15976520|P4|Part B (14 Days)|Adverse Event|0
4653543|NCT03305419|15976521|P3|Part B (14 Days)|Adverse Event|0
4653544|NCT03305419|15976522|P2|Part B (14 Days)|Adverse Event|0
4653545|NCT03305419|15976523|P1|Part B (14 Days)|Adverse Event|0
4653546|NCT03305419|15976516|P8|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653547|NCT03305419|15976517|P7|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653548|NCT03305419|15976518|P6|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653549|NCT03305419|15976519|P5|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653550|NCT03305419|15976520|P4|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653551|NCT03305419|15976521|P3|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653552|NCT03305419|15976522|P2|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0
4653553|NCT03305419|15976523|P1|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1
4653554|NCT03305419|15976516|P8|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653555|NCT03305419|15976517|P7|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653556|NCT03305419|15976518|P6|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653557|NCT03305419|15976519|P5|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653558|NCT03305419|15976520|P4|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653559|NCT03305419|15976521|P3|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653560|NCT03305419|15976522|P2|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0
4653561|NCT03305419|15976523|P1|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1
4653562|NCT03305419|15976516|P8|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653563|NCT03305419|15976517|P7|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653564|NCT03305419|15976518|P6|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653565|NCT03305419|15976519|P5|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653566|NCT03305419|15976520|P4|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653567|NCT03305419|15976521|P3|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653568|NCT03305419|15976522|P2|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1
4653569|NCT03305419|15976523|P1|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0
4653570|NCT03305055|15976664|P2|Overall Study|Adverse Event|1
4653571|NCT03305055|15976665|P1|Overall Study|Adverse Event|1
4653572|NCT03305055|15976664|P2|Overall Study|Withdrawal by Subject|1
4653573|NCT03305055|15976665|P1|Overall Study|Withdrawal by Subject|0
4653574|NCT03304873|15976683|P2|Overall Study|Lost to Follow-up|8
4653575|NCT03304873|15976684|P1|Overall Study|Lost to Follow-up|1
4653576|NCT03303521|15976790|P2|Overall Study|Adverse Event|0
4653577|NCT03303521|15976791|P1|Overall Study|Adverse Event|1
4653578|NCT03303521|15976790|P2|Overall Study|Non-comliance to study protocol|1
4653579|NCT03303521|15976791|P1|Overall Study|Non-comliance to study protocol|0
4653580|NCT03303521|15976790|P2|Overall Study|Transferred to non-study dialysis center|0
4653581|NCT03303521|15976791|P1|Overall Study|Transferred to non-study dialysis center|1
4653582|NCT03303521|15976790|P2|Overall Study|Investigational product discontinuation|1
4653583|NCT03303521|15976791|P1|Overall Study|Investigational product discontinuation|0
4653584|NCT03303521|15976790|P2|Overall Study|Kidney transplantation|1
4653585|NCT03303521|15976791|P1|Overall Study|Kidney transplantation|0
4653586|NCT03303521|15976790|P2|Overall Study|Death|0
4653587|NCT03303521|15976791|P1|Overall Study|Death|1
4653588|NCT03303521|15976790|P2|Overall Study|Withdrawal by Subject|0
4653589|NCT03303521|15976791|P1|Overall Study|Withdrawal by Subject|2
4653590|NCT03303417|15976801|P2|Overall Study|Withdrawal by Subject|1
4653591|NCT03303417|15976802|P1|Overall Study|Withdrawal by Subject|1
4653592|NCT03302975|15976822|P1|Overall Study|Lost to Follow-up|4
4653593|NCT03302936|15976830|P2|Overall Study|Protocol Violation|4
4653594|NCT03302936|15976831|P1|Overall Study|Protocol Violation|3
4653595|NCT03302559|15976852|P1|Overall Study|Withdrew Consent|3
4653596|NCT03302559|15976852|P1|Overall Study|Lost to Follow-up|1
4653597|NCT03302559|15976852|P1|Overall Study|Adverse Event|2
4653598|NCT03302247|15976870|P1|Overall Study|Death|1
4653599|NCT03302247|15976870|P1|Overall Study|the study has closed prematurely|2
4653600|NCT03301844|15976877|P2|Overall Study|suspected colon cancer|1
4653601|NCT03301844|15976878|P1|Overall Study|suspected colon cancer|1
4653602|NCT03301740|15976905|P2|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0
4653603|NCT03301740|15976906|P1|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1
4653604|NCT03301740|15976905|P2|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0
4653605|NCT03301740|15976906|P1|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1
4653606|NCT03301714|15976949|P3|Overall Study|Did not receive allocated intervention|3
4653607|NCT03301714|15976950|P2|Overall Study|Did not receive allocated intervention|2
4653608|NCT03301714|15976951|P1|Overall Study|Did not receive allocated intervention|0
4653609|NCT03301714|15976949|P3|Overall Study|Lost to Follow-up|4
4653610|NCT03301714|15976950|P2|Overall Study|Lost to Follow-up|4
4653611|NCT03301714|15976951|P1|Overall Study|Lost to Follow-up|10
4653612|NCT03301649|15976968|P3|Overall Study|Other than specified|0
4653613|NCT03301649|15976969|P2|Overall Study|Other than specified|3
4653614|NCT03301649|15976970|P1|Overall Study|Other than specified|5
4653615|NCT03301649|15976968|P3|Overall Study|Withdrawal by Subject|0
4653616|NCT03301649|15976969|P2|Overall Study|Withdrawal by Subject|4
4653617|NCT03301649|15976970|P1|Overall Study|Withdrawal by Subject|10
4653618|NCT03301649|15976968|P3|Overall Study|Protocol Violation|1
4653619|NCT03301649|15976969|P2|Overall Study|Protocol Violation|1
4653620|NCT03301649|15976970|P1|Overall Study|Protocol Violation|0
4653621|NCT03301649|15976968|P3|Overall Study|Lost to Follow-up|3
4653622|NCT03301649|15976969|P2|Overall Study|Lost to Follow-up|11
4653623|NCT03301649|15976970|P1|Overall Study|Lost to Follow-up|11
4653624|NCT03301649|15976968|P3|Overall Study|Need alternate therapy due to live lice|81
4653625|NCT03301649|15976969|P2|Overall Study|Need alternate therapy due to live lice|25
4653626|NCT03301649|15976970|P1|Overall Study|Need alternate therapy due to live lice|17
4653627|NCT03301155|15977053|P2|Overall Study|Сompliance with exclusion criteria|7
4653628|NCT03301155|15977054|P1|Overall Study|Сompliance with exclusion criteria|8
4653629|NCT03300570|15977089|P2|Overall Study|Inadequate bowel prep|0
4653630|NCT03300570|15977090|P1|Overall Study|Inadequate bowel prep|1
4653631|NCT03300570|15977089|P2|Overall Study|Withdrawal by Subject|0
4653632|NCT03300570|15977090|P1|Overall Study|Withdrawal by Subject|1
4653633|NCT03300570|15977089|P2|Overall Study|Adverse Event|1
4653634|NCT03300570|15977090|P1|Overall Study|Adverse Event|0
4653635|NCT03300024|15977113|P2|Overall Study|Physician Decision|6
4653636|NCT03300024|15977114|P1|Overall Study|Physician Decision|4
4653637|NCT03299686|15977168|P2|Follow-up Epoch|Subject/Guardian Decision|1
4653638|NCT03299686|15977169|P1|Follow-up Epoch|Subject/Guardian Decision|0
4653639|NCT03299686|15977168|P2|Treatment Epoch|Adverse Event|4
4653640|NCT03299686|15977169|P1|Treatment Epoch|Adverse Event|8
4653641|NCT03299686|15977168|P2|Treatment Epoch|Physician Decision|0
4653642|NCT03299686|15977169|P1|Treatment Epoch|Physician Decision|1
4653643|NCT03299686|15977168|P2|Treatment Epoch|Subject/Guardian Decision|0
4653644|NCT03299686|15977169|P1|Treatment Epoch|Subject/Guardian Decision|2
4653645|NCT03299049|15977187|P2|Overall Study|Adverse Event|13
4653646|NCT03299049|15977188|P1|Overall Study|Adverse Event|12
4653647|NCT03299049|15977187|P2|Overall Study|Lack of Efficacy|3
4653648|NCT03299049|15977188|P1|Overall Study|Lack of Efficacy|9
4653649|NCT03299049|15977187|P2|Overall Study|Protocol Violation|1
4653650|NCT03299049|15977188|P1|Overall Study|Protocol Violation|1
4653651|NCT03299049|15977187|P2|Overall Study|Pregnancy|3
4653652|NCT03299049|15977188|P1|Overall Study|Pregnancy|1
4653653|NCT03299049|15977187|P2|Overall Study|Lost to Follow-up|0
4653654|NCT03299049|15977188|P1|Overall Study|Lost to Follow-up|2
4653655|NCT03299049|15977187|P2|Overall Study|Physician Decision|1
4653656|NCT03299049|15977188|P1|Overall Study|Physician Decision|5
4653657|NCT03299049|15977187|P2|Overall Study|Withdrawal by Subject|21
4653658|NCT03299049|15977188|P1|Overall Study|Withdrawal by Subject|6
4653659|NCT03299049|15977187|P2|Overall Study|On-going|481
4653660|NCT03299049|15977188|P1|Overall Study|On-going|486
4653661|NCT03298867|15977287|P2|Overall Study|Continued in the Follow-Up Period|1
4653662|NCT03298867|15977288|P1|Overall Study|Continued in the Follow-Up Period|0
4653663|NCT03298867|15977287|P2|Overall Study|Did not Continue in the Follow-Up Period|1
4653664|NCT03298867|15977288|P1|Overall Study|Did not Continue in the Follow-Up Period|2
4653665|NCT03298412|15977304|P1|Run-in Period|Decision by Sponsor|6
4653666|NCT03298412|15977304|P1|Run-in Period|Ineligibility Determined|1
4653667|NCT03298412|15977304|P1|Run-in Period|Disease Progression|1
4653668|NCT03298412|15977304|P1|Run-in Period|Other, Not Specified|1
4653669|NCT03297294|15977415|P5|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4653670|NCT03297294|15977416|P4|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1
4653671|NCT03297294|15977417|P3|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4653672|NCT03297294|15977418|P2|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4653673|NCT03297294|15977419|P1|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0
4653674|NCT03297294|15977415|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
4653675|NCT03297294|15977416|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
4653676|NCT03297294|15977417|P3|Double-Blind Treatment Period (DB)|Physician Decision|0
4653677|NCT03297294|15977418|P2|Double-Blind Treatment Period (DB)|Physician Decision|1
4653678|NCT03297294|15977419|P1|Double-Blind Treatment Period (DB)|Physician Decision|1
4653679|NCT03297294|15977415|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
4653680|NCT03297294|15977416|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
4653681|NCT03297294|15977417|P3|Double-Blind Treatment Period (DB)|Adverse Event|0
4653682|NCT03297294|15977418|P2|Double-Blind Treatment Period (DB)|Adverse Event|1
4653683|NCT03297294|15977419|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
4653684|NCT03297294|15977415|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4653685|NCT03297294|15977416|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4653686|NCT03297294|15977417|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4653687|NCT03297294|15977418|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
4653688|NCT03297294|15977419|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4
4653689|NCT03297294|15977415|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4653690|NCT03297294|15977416|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4653691|NCT03297294|15977417|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4653692|NCT03297294|15977418|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31
4653693|NCT03297294|15977419|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30
4653694|NCT03297021|15977461|P3|Overall Study|Missing Post-Op Data|1
4653695|NCT03297021|15977462|P2|Overall Study|Missing Post-Op Data|2
4653696|NCT03297021|15977463|P1|Overall Study|Missing Post-Op Data|1
4653697|NCT03297021|15977461|P3|Overall Study|Incomplete/illegible data sheet|3
4653698|NCT03297021|15977462|P2|Overall Study|Incomplete/illegible data sheet|2
4653699|NCT03297021|15977463|P1|Overall Study|Incomplete/illegible data sheet|4
4653700|NCT03296566|15977527|P2|Overall Study|Withdrawal by Subject|3
4653701|NCT03296566|15977528|P1|Overall Study|Withdrawal by Subject|0
4653702|NCT03296566|15977527|P2|Overall Study|Lost to Follow-up|46
4653703|NCT03296566|15977528|P1|Overall Study|Lost to Follow-up|19
4653704|NCT03295201|15977625|P2|Overall Study|Hospital admission|1
4653705|NCT03295201|15977626|P1|Overall Study|Hospital admission|0
4653706|NCT03295201|15977625|P2|Overall Study|Lost to Follow-up|1
4653707|NCT03295201|15977626|P1|Overall Study|Lost to Follow-up|1
4653708|NCT03294681|15977678|P1|Overall Study|Withdrawal by Subject|1
4653709|NCT03294538|15977716|P3|Overall Study|Outside of Visit Window|1
4653710|NCT03294538|15977717|P2|Overall Study|Outside of Visit Window|4
4653711|NCT03294538|15977718|P1|Overall Study|Outside of Visit Window|4
4653712|NCT03294538|15977716|P3|Overall Study|Lost to Follow-up|0
4653713|NCT03294538|15977717|P2|Overall Study|Lost to Follow-up|0
4653714|NCT03294538|15977718|P1|Overall Study|Lost to Follow-up|1
4653715|NCT03294538|15977716|P3|Overall Study|Adverse Event|1
4653716|NCT03294538|15977717|P2|Overall Study|Adverse Event|1
4653717|NCT03294538|15977718|P1|Overall Study|Adverse Event|0
4653718|NCT03293654|15977736|P3|Overall Study|Lost to Follow-up|0
4653719|NCT03293654|15977737|P2|Overall Study|Lost to Follow-up|1
4653720|NCT03293654|15977738|P1|Overall Study|Lost to Follow-up|0
4653721|NCT03293485|15977776|P1|Overall Study|Withdrawal by Subject|2
4653722|NCT03293485|15977776|P1|Overall Study|Screen Failure|2
4653723|NCT03293485|15977776|P1|Overall Study|Death|1
4653724|NCT03293394|15977787|P2|Follow-up (6 Months)|Adverse Event|2
4653725|NCT03293394|15977788|P1|Follow-up (6 Months)|Adverse Event|4
4653726|NCT03292640|15977850|P2|Overall Study|Lost to Follow-up|24
4653727|NCT03292640|15977851|P1|Overall Study|Lost to Follow-up|24
4653728|NCT03292640|15977850|P2|Overall Study|Adverse Event|2
4653729|NCT03292640|15977851|P1|Overall Study|Adverse Event|20
4653730|NCT03292640|15977850|P2|Overall Study|Withdrawal by Subject|16
4653731|NCT03292640|15977851|P1|Overall Study|Withdrawal by Subject|17
4653732|NCT03292016|15977894|P6|Second Washout|Adverse Event|0
4653733|NCT03292016|15977895|P5|Second Washout|Adverse Event|0
4653734|NCT03292016|15977896|P4|Second Washout|Adverse Event|0
4653735|NCT03292016|15977897|P3|Second Washout|Adverse Event|0
4653736|NCT03292016|15977898|P2|Second Washout|Adverse Event|1
4653737|NCT03292016|15977899|P1|Second Washout|Adverse Event|0
4653738|NCT03291288|15977941|P2|Pexidartinib Only|Ongoing|13
4653739|NCT03291288|15977942|P1|Pexidartinib Only|Ongoing|0
4653740|NCT03291288|15977941|P2|Pexidartinib Only|Other|2
4653741|NCT03291288|15977942|P1|Pexidartinib Only|Other|0
4653742|NCT03291288|15977941|P2|Pexidartinib Only|Patient request|1
4653743|NCT03291288|15977942|P1|Pexidartinib Only|Patient request|0
4653744|NCT03291288|15977941|P2|Pexidartinib Only|Disease progression|8
4653745|NCT03291288|15977942|P1|Pexidartinib Only|Disease progression|0
4653746|NCT03291288|15977941|P2|Pexidartinib Only|Adverse Event|1
4653747|NCT03291288|15977942|P1|Pexidartinib Only|Adverse Event|0
4653748|NCT03291288|15977941|P2|Drug-drug Interaction Phase|Did not receive treatment|0
4653749|NCT03291288|15977942|P1|Drug-drug Interaction Phase|Did not receive treatment|2
4653750|NCT03291288|15977941|P2|Drug-drug Interaction Phase|Disease progression|0
4653751|NCT03291288|15977942|P1|Drug-drug Interaction Phase|Disease progression|2
4653752|NCT03291288|15977941|P2|Drug-drug Interaction Phase|Adverse Event|0
4653753|NCT03291288|15977942|P1|Drug-drug Interaction Phase|Adverse Event|3
4653754|NCT03290300|15978016|P1|Overall Study|Lost to Follow-up|3
4653755|NCT03289676|15978049|P2|Overall Study|Lost to Follow-up|1
4653756|NCT03289676|15978050|P1|Overall Study|Lost to Follow-up|0
4653757|NCT03289676|15978049|P2|Overall Study|Protocol Violation|0
4653758|NCT03289676|15978050|P1|Overall Study|Protocol Violation|2
4653759|NCT03289676|15978049|P2|Overall Study|Withdrawal by Subject|0
4653760|NCT03289676|15978050|P1|Overall Study|Withdrawal by Subject|2
4653761|NCT03289533|15978060|P1|Overall Study|Terminated from study by sponsor|10
4653762|NCT03289533|15978060|P1|Overall Study|Death|12
4653763|NCT03289208|15978121|P3|Overall Study|Adverse Event|0
4653764|NCT03289208|15978122|P2|Overall Study|Adverse Event|0
4653765|NCT03289208|15978123|P1|Overall Study|Adverse Event|1
4653766|NCT03288779|15978140|P1|Overall Study|Withdrawal by Subject|3
4653767|NCT03287869|15978147|P2|Overall Study|Reason not Specified|3
4653768|NCT03287869|15978148|P1|Overall Study|Reason not Specified|6
4653769|NCT03287869|15978147|P2|Overall Study|Physician Decision|5
4653770|NCT03287869|15978148|P1|Overall Study|Physician Decision|5
4653771|NCT03287869|15978147|P2|Overall Study|Early Closure of the Site|1
4653772|NCT03287869|15978148|P1|Overall Study|Early Closure of the Site|0
4653773|NCT03287869|15978147|P2|Overall Study|Withdrawal by Subject|43
4653774|NCT03287869|15978148|P1|Overall Study|Withdrawal by Subject|36
4653775|NCT03287869|15978147|P2|Overall Study|Protocol Deviation|1
4653776|NCT03287869|15978148|P1|Overall Study|Protocol Deviation|2
4653777|NCT03287869|15978147|P2|Overall Study|Progressive Disease|0
4653778|NCT03287869|15978148|P1|Overall Study|Progressive Disease|1
4653779|NCT03287869|15978147|P2|Overall Study|Non-Compliance With Study Drug|9
4653780|NCT03287869|15978148|P1|Overall Study|Non-Compliance With Study Drug|5
4653781|NCT03287869|15978147|P2|Overall Study|Lost to Follow-up|19
4653782|NCT03287869|15978148|P1|Overall Study|Lost to Follow-up|13
4653783|NCT03287869|15978147|P2|Overall Study|Lack of Efficacy|0
4653784|NCT03287869|15978148|P1|Overall Study|Lack of Efficacy|1
4653785|NCT03287869|15978147|P2|Overall Study|Adverse Event|12
4653786|NCT03287869|15978148|P1|Overall Study|Adverse Event|14
4653787|NCT03287804|15978169|P1|Overall Study|Progressive disease|8
4653788|NCT03287804|15978169|P1|Overall Study|Physician Decision|2
4653789|NCT03287804|15978169|P1|Overall Study|Death|1
4653790|NCT03287791|15978185|P3|Overall Study|Did not meet inclusion criteria|0
4653791|NCT03287791|15978186|P2|Overall Study|Did not meet inclusion criteria|0
4653792|NCT03287791|15978187|P1|Overall Study|Did not meet inclusion criteria|1
4653793|NCT03287791|15978185|P3|Overall Study|Non-compliance|0
4653794|NCT03287791|15978186|P2|Overall Study|Non-compliance|1
4653795|NCT03287791|15978187|P1|Overall Study|Non-compliance|0
4653796|NCT03287791|15978185|P3|Overall Study|Too much time between 2 visits|0
4653797|NCT03287791|15978186|P2|Overall Study|Too much time between 2 visits|1
4653798|NCT03287791|15978187|P1|Overall Study|Too much time between 2 visits|0
4653799|NCT03287791|15978185|P3|Overall Study|Participant was enrolled at 2 sites|1
4653800|NCT03287791|15978186|P2|Overall Study|Participant was enrolled at 2 sites|0
4653801|NCT03287791|15978187|P1|Overall Study|Participant was enrolled at 2 sites|1
4653802|NCT03287791|15978185|P3|Overall Study|Protocol Violation|1
4653803|NCT03287791|15978186|P2|Overall Study|Protocol Violation|2
4653804|NCT03287791|15978187|P1|Overall Study|Protocol Violation|7
4653805|NCT03287791|15978185|P3|Overall Study|Lost to Follow-up|11
4653806|NCT03287791|15978186|P2|Overall Study|Lost to Follow-up|14
4653807|NCT03287791|15978187|P1|Overall Study|Lost to Follow-up|8
4653808|NCT03287791|15978185|P3|Overall Study|Missed more than 6 consecutive doses|2
4653809|NCT03287791|15978186|P2|Overall Study|Missed more than 6 consecutive doses|2
4653810|NCT03287791|15978187|P1|Overall Study|Missed more than 6 consecutive doses|3
4653811|NCT03287791|15978185|P3|Overall Study|Withdrawal by Subject|17
4653812|NCT03287791|15978186|P2|Overall Study|Withdrawal by Subject|12
4653813|NCT03287791|15978187|P1|Overall Study|Withdrawal by Subject|12
4653814|NCT03287791|15978185|P3|Overall Study|Adverse Event|3
4653815|NCT03287791|15978186|P2|Overall Study|Adverse Event|4
4653816|NCT03287791|15978187|P1|Overall Study|Adverse Event|0
4653817|NCT03287791|15978185|P3|Overall Study|Insufficient Therapeutic Response|1
4653818|NCT03287791|15978186|P2|Overall Study|Insufficient Therapeutic Response|0
4653819|NCT03287791|15978187|P1|Overall Study|Insufficient Therapeutic Response|0
4653820|NCT03287089|15978200|P2|Overall Study|Withdrawal by Subject|2
4653821|NCT03287089|15978201|P1|Overall Study|Withdrawal by Subject|0
4653822|NCT03287089|15978200|P2|Overall Study|Physician Decision|2
4653823|NCT03287089|15978201|P1|Overall Study|Physician Decision|0
4653824|NCT03287089|15978200|P2|Overall Study|Lost to Follow-up|2
4653825|NCT03287089|15978201|P1|Overall Study|Lost to Follow-up|0
4653826|NCT03286751|15978236|P6|Washout Period 5|Adverse Event|0
4653827|NCT03286751|15978237|P5|Washout Period 5|Adverse Event|1
4653828|NCT03286751|15978238|P4|Washout Period 5|Adverse Event|0
4653829|NCT03286751|15978239|P3|Washout Period 5|Adverse Event|0
4653830|NCT03286751|15978240|P2|Washout Period 5|Adverse Event|0
4653831|NCT03286751|15978241|P1|Washout Period 5|Adverse Event|0
4653832|NCT03286751|15978236|P6|Washout Period 2|Personal Reasons|0
4653833|NCT03286751|15978237|P5|Washout Period 2|Personal Reasons|0
4653834|NCT03286751|15978238|P4|Washout Period 2|Personal Reasons|0
4653835|NCT03286751|15978239|P3|Washout Period 2|Personal Reasons|0
4653836|NCT03286751|15978240|P2|Washout Period 2|Personal Reasons|1
4653837|NCT03286751|15978241|P1|Washout Period 2|Personal Reasons|0
4653838|NCT03286751|15978236|P6|Washout Period 1|Withdrawal by Subject|0
4653839|NCT03286751|15978237|P5|Washout Period 1|Withdrawal by Subject|1
4653840|NCT03286751|15978238|P4|Washout Period 1|Withdrawal by Subject|0
4653841|NCT03286751|15978239|P3|Washout Period 1|Withdrawal by Subject|0
4653842|NCT03286751|15978240|P2|Washout Period 1|Withdrawal by Subject|0
4653843|NCT03286751|15978241|P1|Washout Period 1|Withdrawal by Subject|0
4653844|NCT03286218|15978277|P12|Treatment Phase Period 4|Withdrawal by Subject|1
4653845|NCT03286218|15978278|P11|Treatment Phase Period 4|Withdrawal by Subject|0
4653846|NCT03286218|15978279|P10|Treatment Phase Period 4|Withdrawal by Subject|0
4653847|NCT03286218|15978280|P9|Treatment Phase Period 4|Withdrawal by Subject|0
4653848|NCT03286218|15978281|P8|Treatment Phase Period 4|Withdrawal by Subject|0
4653849|NCT03286218|15978282|P7|Treatment Phase Period 4|Withdrawal by Subject|0
4653850|NCT03286218|15978283|P6|Treatment Phase Period 4|Withdrawal by Subject|0
4653851|NCT03286218|15978284|P5|Treatment Phase Period 4|Withdrawal by Subject|0
4653852|NCT03286218|15978285|P4|Treatment Phase Period 4|Withdrawal by Subject|0
4653853|NCT03286218|15978286|P3|Treatment Phase Period 4|Withdrawal by Subject|0
4653854|NCT03286218|15978287|P2|Treatment Phase Period 4|Withdrawal by Subject|0
4653855|NCT03286218|15978288|P1|Treatment Phase Period 4|Withdrawal by Subject|0
4653856|NCT03286218|15978277|P12|Treatment Phase Period 1|Withdrawal by Subject|1
4653857|NCT03286218|15978278|P11|Treatment Phase Period 1|Withdrawal by Subject|0
4653858|NCT03286218|15978279|P10|Treatment Phase Period 1|Withdrawal by Subject|0
4653859|NCT03286218|15978280|P9|Treatment Phase Period 1|Withdrawal by Subject|0
4653860|NCT03286218|15978281|P8|Treatment Phase Period 1|Withdrawal by Subject|0
4653861|NCT03286218|15978282|P7|Treatment Phase Period 1|Withdrawal by Subject|0
4653862|NCT03286218|15978283|P6|Treatment Phase Period 1|Withdrawal by Subject|1
4653863|NCT03286218|15978284|P5|Treatment Phase Period 1|Withdrawal by Subject|0
4653864|NCT03286218|15978285|P4|Treatment Phase Period 1|Withdrawal by Subject|1
4653865|NCT03286218|15978286|P3|Treatment Phase Period 1|Withdrawal by Subject|1
4653866|NCT03286218|15978287|P2|Treatment Phase Period 1|Withdrawal by Subject|0
4653867|NCT03286218|15978288|P1|Treatment Phase Period 1|Withdrawal by Subject|0
4653868|NCT03286218|15978277|P12|Qualification Phase Period 2|Withdrawal by Subject|0
4653869|NCT03286218|15978278|P11|Qualification Phase Period 2|Withdrawal by Subject|0
4653870|NCT03286218|15978279|P10|Qualification Phase Period 2|Withdrawal by Subject|0
4653871|NCT03286218|15978280|P9|Qualification Phase Period 2|Withdrawal by Subject|0
4653872|NCT03286218|15978281|P8|Qualification Phase Period 2|Withdrawal by Subject|0
4653873|NCT03286218|15978282|P7|Qualification Phase Period 2|Withdrawal by Subject|0
4653874|NCT03286218|15978283|P6|Qualification Phase Period 2|Withdrawal by Subject|0
4653875|NCT03286218|15978284|P5|Qualification Phase Period 2|Withdrawal by Subject|0
4653876|NCT03286218|15978285|P4|Qualification Phase Period 2|Withdrawal by Subject|0
4653877|NCT03286218|15978286|P3|Qualification Phase Period 2|Withdrawal by Subject|0
4653878|NCT03286218|15978287|P2|Qualification Phase Period 2|Withdrawal by Subject|2
4653879|NCT03286218|15978288|P1|Qualification Phase Period 2|Withdrawal by Subject|1
4653880|NCT03286218|15978277|P12|Qualification Phase Period 2|Protocol Violation|0
4653881|NCT03286218|15978278|P11|Qualification Phase Period 2|Protocol Violation|0
4653882|NCT03286218|15978279|P10|Qualification Phase Period 2|Protocol Violation|0
4653883|NCT03286218|15978280|P9|Qualification Phase Period 2|Protocol Violation|0
4653884|NCT03286218|15978281|P8|Qualification Phase Period 2|Protocol Violation|0
4653885|NCT03286218|15978282|P7|Qualification Phase Period 2|Protocol Violation|0
4653886|NCT03286218|15978283|P6|Qualification Phase Period 2|Protocol Violation|0
4653887|NCT03286218|15978284|P5|Qualification Phase Period 2|Protocol Violation|0
4653888|NCT03286218|15978285|P4|Qualification Phase Period 2|Protocol Violation|0
4653889|NCT03286218|15978286|P3|Qualification Phase Period 2|Protocol Violation|0
4653890|NCT03286218|15978287|P2|Qualification Phase Period 2|Protocol Violation|0
4653891|NCT03286218|15978288|P1|Qualification Phase Period 2|Protocol Violation|2
4653892|NCT03286218|15978277|P12|Qualification Phase Period 2|Lost to Follow-up|0
4653893|NCT03286218|15978278|P11|Qualification Phase Period 2|Lost to Follow-up|0
4653894|NCT03286218|15978279|P10|Qualification Phase Period 2|Lost to Follow-up|0
4653895|NCT03286218|15978280|P9|Qualification Phase Period 2|Lost to Follow-up|0
4653896|NCT03286218|15978281|P8|Qualification Phase Period 2|Lost to Follow-up|0
4653897|NCT03286218|15978282|P7|Qualification Phase Period 2|Lost to Follow-up|0
4653898|NCT03286218|15978283|P6|Qualification Phase Period 2|Lost to Follow-up|0
4653899|NCT03286218|15978284|P5|Qualification Phase Period 2|Lost to Follow-up|0
4653900|NCT03286218|15978285|P4|Qualification Phase Period 2|Lost to Follow-up|0
4653901|NCT03286218|15978286|P3|Qualification Phase Period 2|Lost to Follow-up|0
4653902|NCT03286218|15978287|P2|Qualification Phase Period 2|Lost to Follow-up|1
4653903|NCT03286218|15978288|P1|Qualification Phase Period 2|Lost to Follow-up|0
4653904|NCT03286218|15978277|P12|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653905|NCT03286218|15978278|P11|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653906|NCT03286218|15978279|P10|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653907|NCT03286218|15978280|P9|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653908|NCT03286218|15978281|P8|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653909|NCT03286218|15978282|P7|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653910|NCT03286218|15978283|P6|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653911|NCT03286218|15978284|P5|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653912|NCT03286218|15978285|P4|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653913|NCT03286218|15978286|P3|Qualification Phase Period 2|Failure to meet randomization criteria|0
4653914|NCT03286218|15978287|P2|Qualification Phase Period 2|Failure to meet randomization criteria|15
4653915|NCT03286218|15978288|P1|Qualification Phase Period 2|Failure to meet randomization criteria|14
4653916|NCT03286218|15978277|P12|Qualification Phase Period 2|Adverse Event|0
4653917|NCT03286218|15978278|P11|Qualification Phase Period 2|Adverse Event|0
4653918|NCT03286218|15978279|P10|Qualification Phase Period 2|Adverse Event|0
4653919|NCT03286218|15978280|P9|Qualification Phase Period 2|Adverse Event|0
4653920|NCT03286218|15978281|P8|Qualification Phase Period 2|Adverse Event|0
4653921|NCT03286218|15978282|P7|Qualification Phase Period 2|Adverse Event|0
4653922|NCT03286218|15978283|P6|Qualification Phase Period 2|Adverse Event|0
4653923|NCT03286218|15978284|P5|Qualification Phase Period 2|Adverse Event|0
4653924|NCT03286218|15978285|P4|Qualification Phase Period 2|Adverse Event|0
4653925|NCT03286218|15978286|P3|Qualification Phase Period 2|Adverse Event|0
4653926|NCT03286218|15978287|P2|Qualification Phase Period 2|Adverse Event|1
4653927|NCT03286218|15978288|P1|Qualification Phase Period 2|Adverse Event|0
4653928|NCT03286218|15978277|P12|Qualification Phase Period 1|Withdrawal by Subject|0
4653929|NCT03286218|15978278|P11|Qualification Phase Period 1|Withdrawal by Subject|0
4653930|NCT03286218|15978279|P10|Qualification Phase Period 1|Withdrawal by Subject|0
4653931|NCT03286218|15978280|P9|Qualification Phase Period 1|Withdrawal by Subject|0
4653932|NCT03286218|15978281|P8|Qualification Phase Period 1|Withdrawal by Subject|0
4653933|NCT03286218|15978282|P7|Qualification Phase Period 1|Withdrawal by Subject|0
4653934|NCT03286218|15978283|P6|Qualification Phase Period 1|Withdrawal by Subject|0
4653935|NCT03286218|15978284|P5|Qualification Phase Period 1|Withdrawal by Subject|0
4653936|NCT03286218|15978285|P4|Qualification Phase Period 1|Withdrawal by Subject|0
4653937|NCT03286218|15978286|P3|Qualification Phase Period 1|Withdrawal by Subject|0
4653938|NCT03286218|15978287|P2|Qualification Phase Period 1|Withdrawal by Subject|1
4653939|NCT03286218|15978288|P1|Qualification Phase Period 1|Withdrawal by Subject|0
4653940|NCT03286218|15978277|P12|Qualification Phase Period 1|Adverse Event|0
4653941|NCT03286218|15978278|P11|Qualification Phase Period 1|Adverse Event|0
4653942|NCT03286218|15978279|P10|Qualification Phase Period 1|Adverse Event|0
4653943|NCT03286218|15978280|P9|Qualification Phase Period 1|Adverse Event|0
4653944|NCT03286218|15978281|P8|Qualification Phase Period 1|Adverse Event|0
4653945|NCT03286218|15978282|P7|Qualification Phase Period 1|Adverse Event|0
4653946|NCT03286218|15978283|P6|Qualification Phase Period 1|Adverse Event|0
4653947|NCT03286218|15978284|P5|Qualification Phase Period 1|Adverse Event|0
4653948|NCT03286218|15978285|P4|Qualification Phase Period 1|Adverse Event|0
4653949|NCT03286218|15978286|P3|Qualification Phase Period 1|Adverse Event|0
4653950|NCT03286218|15978287|P2|Qualification Phase Period 1|Adverse Event|0
4653951|NCT03286218|15978288|P1|Qualification Phase Period 1|Adverse Event|1
4653952|NCT03285711|15978351|P4|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
4653953|NCT03285711|15978352|P3|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
4653954|NCT03285711|15978353|P2|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1
4653955|NCT03285711|15978354|P1|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0
4653956|NCT03285711|15978351|P4|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
4653957|NCT03285711|15978352|P3|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1
4653958|NCT03285711|15978353|P2|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
4653959|NCT03285711|15978354|P1|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0
4653960|NCT03285711|15978351|P4|Blinded Phase (Up to Week 16)|Protocol Violation|0
4653961|NCT03285711|15978352|P3|Blinded Phase (Up to Week 16)|Protocol Violation|0
4653962|NCT03285711|15978353|P2|Blinded Phase (Up to Week 16)|Protocol Violation|0
4653963|NCT03285711|15978354|P1|Blinded Phase (Up to Week 16)|Protocol Violation|1
4653964|NCT03285711|15978351|P4|Blinded Phase (Up to Week 16)|Adverse Event|0
4653965|NCT03285711|15978352|P3|Blinded Phase (Up to Week 16)|Adverse Event|0
4653966|NCT03285711|15978353|P2|Blinded Phase (Up to Week 16)|Adverse Event|1
4653967|NCT03285711|15978354|P1|Blinded Phase (Up to Week 16)|Adverse Event|2
4653968|NCT03285295|15978438|P5|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4653969|NCT03285295|15978439|P4|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4653970|NCT03285295|15978440|P3|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4653971|NCT03285295|15978441|P2|Alinity s Chagas Follow-Up|Lost to Follow-up|0
4653972|NCT03285295|15978442|P1|Alinity s Chagas Follow-Up|Lost to Follow-up|13
4653973|NCT03285295|15978438|P5|Alinity s Chagas|No Results Generated|0
4653974|NCT03285295|15978439|P4|Alinity s Chagas|No Results Generated|0
4653975|NCT03285295|15978440|P3|Alinity s Chagas|No Results Generated|0
4653976|NCT03285295|15978441|P2|Alinity s Chagas|No Results Generated|0
4653977|NCT03285295|15978442|P1|Alinity s Chagas|No Results Generated|105
4653978|NCT03285295|15978438|P5|Alinity s Chagas|No Results on Comparator Assay|0
4653979|NCT03285295|15978439|P4|Alinity s Chagas|No Results on Comparator Assay|0
4653980|NCT03285295|15978440|P3|Alinity s Chagas|No Results on Comparator Assay|0
4653981|NCT03285295|15978441|P2|Alinity s Chagas|No Results on Comparator Assay|0
4653982|NCT03285295|15978442|P1|Alinity s Chagas|No Results on Comparator Assay|38
4653983|NCT03285295|15978438|P5|Alinity s Chagas|Protocol Violation|0
4653984|NCT03285295|15978439|P4|Alinity s Chagas|Protocol Violation|0
4653985|NCT03285295|15978440|P3|Alinity s Chagas|Protocol Violation|0
4653986|NCT03285295|15978441|P2|Alinity s Chagas|Protocol Violation|0
4653987|NCT03285295|15978442|P1|Alinity s Chagas|Protocol Violation|76
4653988|NCT03285295|15978438|P5|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4653989|NCT03285295|15978439|P4|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4653990|NCT03285295|15978440|P3|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4653991|NCT03285295|15978441|P2|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0
4653992|NCT03285295|15978442|P1|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14
4653993|NCT03285295|15978438|P5|Alinity s Anti-HBc|No Results Generated|0
4653994|NCT03285295|15978439|P4|Alinity s Anti-HBc|No Results Generated|0
4653995|NCT03285295|15978440|P3|Alinity s Anti-HBc|No Results Generated|0
4653996|NCT03285295|15978441|P2|Alinity s Anti-HBc|No Results Generated|0
4653997|NCT03285295|15978442|P1|Alinity s Anti-HBc|No Results Generated|70
4653998|NCT03285295|15978438|P5|Alinity s Anti-HBc|No Results on Comparator Assay|0
4653999|NCT03285295|15978439|P4|Alinity s Anti-HBc|No Results on Comparator Assay|0
4654000|NCT03285295|15978440|P3|Alinity s Anti-HBc|No Results on Comparator Assay|0
4654001|NCT03285295|15978441|P2|Alinity s Anti-HBc|No Results on Comparator Assay|1
4654002|NCT03285295|15978442|P1|Alinity s Anti-HBc|No Results on Comparator Assay|13
4654003|NCT03285295|15978438|P5|Alinity s Anti-HBc|Protocol Violation|0
4654004|NCT03285295|15978439|P4|Alinity s Anti-HBc|Protocol Violation|0
4654005|NCT03285295|15978440|P3|Alinity s Anti-HBc|Protocol Violation|0
4654006|NCT03285295|15978441|P2|Alinity s Anti-HBc|Protocol Violation|0
4654007|NCT03285295|15978442|P1|Alinity s Anti-HBc|Protocol Violation|8
4654008|NCT03285295|15978438|P5|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4654009|NCT03285295|15978439|P4|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4654010|NCT03285295|15978440|P3|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4654011|NCT03285295|15978441|P2|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0
4654012|NCT03285295|15978442|P1|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11
4654013|NCT03285295|15978438|P5|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4654014|NCT03285295|15978439|P4|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4654015|NCT03285295|15978440|P3|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4654016|NCT03285295|15978441|P2|Alinity s HIV Ag/Ab Combo|No Results Generated|0
4654017|NCT03285295|15978442|P1|Alinity s HIV Ag/Ab Combo|No Results Generated|72
4654018|NCT03285295|15978438|P5|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4654019|NCT03285295|15978439|P4|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4654020|NCT03285295|15978440|P3|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4654021|NCT03285295|15978441|P2|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0
4654022|NCT03285295|15978442|P1|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16
4654023|NCT03285295|15978438|P5|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4654024|NCT03285295|15978439|P4|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4654025|NCT03285295|15978440|P3|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4654026|NCT03285295|15978441|P2|Alinity s HIV Ag/Ab Combo|Protocol Violation|0
4654027|NCT03285295|15978442|P1|Alinity s HIV Ag/Ab Combo|Protocol Violation|11
4654028|NCT03285295|15978438|P5|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4654029|NCT03285295|15978439|P4|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4654030|NCT03285295|15978440|P3|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4654031|NCT03285295|15978441|P2|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0
4654032|NCT03285295|15978442|P1|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18
4654033|NCT03285295|15978438|P5|Alinity s Anti-HCV|No Results Generated|0
4654034|NCT03285295|15978439|P4|Alinity s Anti-HCV|No Results Generated|0
4654035|NCT03285295|15978440|P3|Alinity s Anti-HCV|No Results Generated|0
4654036|NCT03285295|15978441|P2|Alinity s Anti-HCV|No Results Generated|0
4654037|NCT03285295|15978442|P1|Alinity s Anti-HCV|No Results Generated|71
4654038|NCT03285295|15978438|P5|Alinity s Anti-HCV|No Results on Comparator Assay|0
4654039|NCT03285295|15978439|P4|Alinity s Anti-HCV|No Results on Comparator Assay|0
4654040|NCT03285295|15978440|P3|Alinity s Anti-HCV|No Results on Comparator Assay|0
4654041|NCT03285295|15978441|P2|Alinity s Anti-HCV|No Results on Comparator Assay|0
4654042|NCT03285295|15978442|P1|Alinity s Anti-HCV|No Results on Comparator Assay|13
4654043|NCT03285295|15978438|P5|Alinity s Anti-HCV|Protocol Violation|0
4654044|NCT03285295|15978439|P4|Alinity s Anti-HCV|Protocol Violation|0
4654045|NCT03285295|15978440|P3|Alinity s Anti-HCV|Protocol Violation|0
4654046|NCT03285295|15978441|P2|Alinity s Anti-HCV|Protocol Violation|0
4654047|NCT03285295|15978442|P1|Alinity s Anti-HCV|Protocol Violation|12
4654048|NCT03285295|15978438|P5|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4654049|NCT03285295|15978439|P4|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4654050|NCT03285295|15978440|P3|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4654051|NCT03285295|15978441|P2|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0
4654052|NCT03285295|15978442|P1|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4
4654053|NCT03285295|15978438|P5|Alinity s HTLV I/II|No Results Generated|0
4654054|NCT03285295|15978439|P4|Alinity s HTLV I/II|No Results Generated|0
4654055|NCT03285295|15978440|P3|Alinity s HTLV I/II|No Results Generated|0
4654056|NCT03285295|15978441|P2|Alinity s HTLV I/II|No Results Generated|0
4654057|NCT03285295|15978442|P1|Alinity s HTLV I/II|No Results Generated|70
4654058|NCT03285295|15978438|P5|Alinity s HTLV I/II|No Result on Comparator Assay|0
4654059|NCT03285295|15978439|P4|Alinity s HTLV I/II|No Result on Comparator Assay|0
4654060|NCT03285295|15978440|P3|Alinity s HTLV I/II|No Result on Comparator Assay|0
4654061|NCT03285295|15978441|P2|Alinity s HTLV I/II|No Result on Comparator Assay|0
4654062|NCT03285295|15978442|P1|Alinity s HTLV I/II|No Result on Comparator Assay|15
4654063|NCT03285295|15978438|P5|Alinity s HTLV I/II|Protocol Violation|0
4654064|NCT03285295|15978439|P4|Alinity s HTLV I/II|Protocol Violation|0
4654065|NCT03285295|15978440|P3|Alinity s HTLV I/II|Protocol Violation|0
4654066|NCT03285295|15978441|P2|Alinity s HTLV I/II|Protocol Violation|0
4654067|NCT03285295|15978442|P1|Alinity s HTLV I/II|Protocol Violation|6
4654068|NCT03285295|15978438|P5|Alinity s HBsAg|No Results Generated|0
4654069|NCT03285295|15978439|P4|Alinity s HBsAg|No Results Generated|0
4654070|NCT03285295|15978440|P3|Alinity s HBsAg|No Results Generated|0
4654071|NCT03285295|15978441|P2|Alinity s HBsAg|No Results Generated|6
4654072|NCT03285295|15978442|P1|Alinity s HBsAg|No Results Generated|74
4654073|NCT03285295|15978438|P5|Alinity s HBsAg|No Result on Comparator Assay|0
4654074|NCT03285295|15978439|P4|Alinity s HBsAg|No Result on Comparator Assay|0
4654075|NCT03285295|15978440|P3|Alinity s HBsAg|No Result on Comparator Assay|0
4654076|NCT03285295|15978441|P2|Alinity s HBsAg|No Result on Comparator Assay|0
4654077|NCT03285295|15978442|P1|Alinity s HBsAg|No Result on Comparator Assay|17
4654078|NCT03285295|15978438|P5|Alinity s HBsAg|Protocol Violation|0
4654079|NCT03285295|15978439|P4|Alinity s HBsAg|Protocol Violation|0
4654080|NCT03285295|15978440|P3|Alinity s HBsAg|Protocol Violation|0
4654081|NCT03285295|15978441|P2|Alinity s HBsAg|Protocol Violation|0
4654082|NCT03285295|15978442|P1|Alinity s HBsAg|Protocol Violation|11
4654083|NCT03284229|15978476|P1|Overall Study|Lost to Follow-up|3
4654084|NCT03283709|15978491|P2|Overall Study|trial terminated|1
4654085|NCT03283709|15978492|P1|Overall Study|trial terminated|0
4654086|NCT03283696|15978524|P2|Overall Study|Withdrawal by Subject|0
4654087|NCT03283696|15978525|P1|Overall Study|Withdrawal by Subject|2
4654088|NCT03283696|15978524|P2|Overall Study|Physician Decision|6
4654089|NCT03283696|15978525|P1|Overall Study|Physician Decision|5
4654090|NCT03283319|15978570|P6|Overall Study|BARDA regulatory agency or IRB decision|0
4654091|NCT03283319|15978571|P5|Overall Study|BARDA regulatory agency or IRB decision|0
4654092|NCT03283319|15978572|P4|Overall Study|BARDA regulatory agency or IRB decision|1
4654093|NCT03283319|15978573|P3|Overall Study|BARDA regulatory agency or IRB decision|0
4654094|NCT03283319|15978574|P2|Overall Study|BARDA regulatory agency or IRB decision|0
4654095|NCT03283319|15978575|P1|Overall Study|BARDA regulatory agency or IRB decision|0
4654096|NCT03283319|15978570|P6|Overall Study|Withdrawal by Subject|1
4654097|NCT03283319|15978571|P5|Overall Study|Withdrawal by Subject|0
4654098|NCT03283319|15978572|P4|Overall Study|Withdrawal by Subject|1
4654099|NCT03283319|15978573|P3|Overall Study|Withdrawal by Subject|2
4654100|NCT03283319|15978574|P2|Overall Study|Withdrawal by Subject|2
4654101|NCT03283319|15978575|P1|Overall Study|Withdrawal by Subject|2
4654102|NCT03283319|15978570|P6|Overall Study|Lost to Follow-up|3
4654103|NCT03283319|15978571|P5|Overall Study|Lost to Follow-up|4
4654104|NCT03283319|15978572|P4|Overall Study|Lost to Follow-up|5
4654105|NCT03283319|15978573|P3|Overall Study|Lost to Follow-up|5
4654106|NCT03283319|15978574|P2|Overall Study|Lost to Follow-up|4
4654107|NCT03283319|15978575|P1|Overall Study|Lost to Follow-up|5
4654108|NCT03283098|15978717|P2|Overall Study|Withdrawal by Subject|1
4654109|NCT03283098|15978718|P1|Overall Study|Withdrawal by Subject|0
4654110|NCT03282240|15978838|P3|Overall Study|Withdrawal by Subject|1
4654111|NCT03282240|15978839|P2|Overall Study|Withdrawal by Subject|0
4654112|NCT03282240|15978840|P1|Overall Study|Withdrawal by Subject|1
4654113|NCT03282240|15978838|P3|Overall Study|Protocol Deviation|2
4654114|NCT03282240|15978839|P2|Overall Study|Protocol Deviation|1
4654115|NCT03282240|15978840|P1|Overall Study|Protocol Deviation|4
4654116|NCT03282240|15978838|P3|Overall Study|Lost to Follow-up|0
4654117|NCT03282240|15978839|P2|Overall Study|Lost to Follow-up|0
4654118|NCT03282240|15978840|P1|Overall Study|Lost to Follow-up|3
4654119|NCT03282240|15978838|P3|Overall Study|Adverse Event|0
4654120|NCT03282240|15978839|P2|Overall Study|Adverse Event|2
4654121|NCT03282240|15978840|P1|Overall Study|Adverse Event|2
4654122|NCT03282227|15978892|P1|Overall Study|Other|1
4654123|NCT03282227|15978892|P1|Overall Study|Pregnancy|2
4654124|NCT03282227|15978892|P1|Overall Study|Physician Decision|2
4654125|NCT03282227|15978892|P1|Overall Study|Sponsor decision|3
4654126|NCT03282227|15978892|P1|Overall Study|Lack of Efficacy|12
4654127|NCT03282227|15978892|P1|Overall Study|Withdrawal by Subject|20
4654128|NCT03282227|15978892|P1|Overall Study|Lost to Follow-up|21
4654129|NCT03282227|15978892|P1|Overall Study|Adverse Event|15
4654130|NCT03282227|15978892|P1|Overall Study|Non-compliance w/ protocol requirements|79
4654131|NCT03282227|15978892|P1|Overall Study|Exposure Goals Achieved|60
4654132|NCT03281668|15978902|P1|Overall Study|Lost to Follow-up|1
4654133|NCT03281668|15978902|P1|Overall Study|Withdrawal by Subject|4
4654134|NCT03281668|15978902|P1|Overall Study|scheduling conflict, family circumstance|2
4654135|NCT03281668|15978902|P1|Overall Study|Physician Decision|1
4654136|NCT03281577|15978930|P4|Overall Study|Withdrawal by Subject|0
4654137|NCT03281577|15978931|P3|Overall Study|Withdrawal by Subject|0
4654138|NCT03281577|15978932|P2|Overall Study|Withdrawal by Subject|0
4654139|NCT03281577|15978933|P1|Overall Study|Withdrawal by Subject|1
4654140|NCT03281577|15978930|P4|Overall Study|Adverse Event|1
4654141|NCT03281577|15978931|P3|Overall Study|Adverse Event|0
4654142|NCT03281577|15978932|P2|Overall Study|Adverse Event|0
4654143|NCT03281577|15978933|P1|Overall Study|Adverse Event|0
4654144|NCT03280615|15978988|P2|Overall Study|Withdrawal by Subject|2
4654145|NCT03280615|15978989|P1|Overall Study|Withdrawal by Subject|2
4654146|NCT03280615|15978988|P2|Overall Study|Adverse Event|1
4654147|NCT03280615|15978989|P1|Overall Study|Adverse Event|1
4654148|NCT03280615|15978988|P2|Overall Study|Lost to Follow-up|2
4654149|NCT03280615|15978989|P1|Overall Study|Lost to Follow-up|1
4654150|NCT03280550|15979001|P2|Overall Study|Physician Decision|1
4654151|NCT03280550|15979002|P1|Overall Study|Physician Decision|0
4654152|NCT03280550|15979001|P2|Overall Study|Withdrawal by Subject|2
4654153|NCT03280550|15979002|P1|Overall Study|Withdrawal by Subject|2
4654154|NCT03280537|15979054|P2|Overall Study|Withdrawal by Subject|4
4654155|NCT03280537|15979055|P1|Overall Study|Withdrawal by Subject|2
4654156|NCT03280381|15979107|P2|Overall Study|Physician Decision|2
4654157|NCT03280381|15979108|P1|Overall Study|Physician Decision|0
4654158|NCT03280108|15979118|P2|Overall Study|Lost to Follow-up|0
4654159|NCT03280108|15979119|P1|Overall Study|Lost to Follow-up|2
4654160|NCT03278106|15979186|P1|Overall Study|No protocol treatment|1
4654161|NCT03278028|15979602|P2|Overall Study|Pregnancy|1
4654162|NCT03278028|15979603|P1|Overall Study|Pregnancy|0
4654163|NCT03278028|15979602|P2|Overall Study|Withdrawal by Subject|1
4654164|NCT03278028|15979603|P1|Overall Study|Withdrawal by Subject|3
4654165|NCT03278028|15979602|P2|Overall Study|Lost to Follow-up|0
4654166|NCT03278028|15979603|P1|Overall Study|Lost to Follow-up|1
4654167|NCT03277846|15979611|P2|Overall Study|Inpatient stay too brief|11
4654168|NCT03277846|15979612|P1|Overall Study|Inpatient stay too brief|12
4654169|NCT03277105|15979669|P2|Overall Study|Ongoing|175
4654170|NCT03277105|15979670|P1|Overall Study|Ongoing|171
4654171|NCT03277105|15979669|P2|Overall Study|Other|3
4654172|NCT03277105|15979670|P1|Overall Study|Other|1
4654173|NCT03277105|15979669|P2|Overall Study|Withdrawal by Subject|9
4654174|NCT03277105|15979670|P1|Overall Study|Withdrawal by Subject|10
4654175|NCT03277105|15979669|P2|Overall Study|Lost to Follow-up|3
4654176|NCT03277105|15979670|P1|Overall Study|Lost to Follow-up|0
4654177|NCT03277105|15979669|P2|Overall Study|Death|73
4654178|NCT03277105|15979670|P1|Overall Study|Death|77
4654179|NCT03276078|15979720|P1|Overall Study|Adverse Event|1
4654180|NCT03276026|15979749|P2|Overall Study|Protocol Violation|0
4654181|NCT03276026|15979750|P1|Overall Study|Protocol Violation|1
4654182|NCT03274986|15979778|P2|Overall Study|Lost to Follow-up|1
4654183|NCT03274986|15979779|P1|Overall Study|Lost to Follow-up|0
4654184|NCT03274986|15979778|P2|Overall Study|Withdrawal by Subject|1
4654185|NCT03274986|15979779|P1|Overall Study|Withdrawal by Subject|0
4654186|NCT03274453|15979846|P4|Overall Study|Surgery Cancelled|0
4654187|NCT03274453|15979847|P3|Overall Study|Surgery Cancelled|0
4654188|NCT03274453|15979848|P2|Overall Study|Surgery Cancelled|1
4654189|NCT03274453|15979849|P1|Overall Study|Surgery Cancelled|0
4654190|NCT03274453|15979846|P4|Overall Study|Physician Decision|3
4654191|NCT03274453|15979847|P3|Overall Study|Physician Decision|0
4654192|NCT03274453|15979848|P2|Overall Study|Physician Decision|0
4654193|NCT03274453|15979849|P1|Overall Study|Physician Decision|2
4654194|NCT03274453|15979846|P4|Overall Study|Lost to Follow-up|1
4654195|NCT03274453|15979847|P3|Overall Study|Lost to Follow-up|4
4654196|NCT03274453|15979848|P2|Overall Study|Lost to Follow-up|5
4654197|NCT03274453|15979849|P1|Overall Study|Lost to Follow-up|2
4654198|NCT03274440|15979859|P6|Overall Study|Time commitment too great|0
4654199|NCT03274440|15979860|P5|Overall Study|Time commitment too great|0
4654200|NCT03274440|15979861|P4|Overall Study|Time commitment too great|1
4654201|NCT03274440|15979862|P3|Overall Study|Time commitment too great|0
4654202|NCT03274440|15979863|P2|Overall Study|Time commitment too great|0
4654203|NCT03274440|15979864|P1|Overall Study|Time commitment too great|1
4654204|NCT03274076|15979877|P4|24 Weeks Open Label|Withdrawal by Subject|1
4654205|NCT03274076|15979878|P3|24 Weeks Open Label|Withdrawal by Subject|0
4654206|NCT03274076|15979879|P2|24 Weeks Open Label|Withdrawal by Subject|0
4654207|NCT03274076|15979880|P1|24 Weeks Open Label|Withdrawal by Subject|0
4654208|NCT03274076|15979877|P4|24 Weeks Open Label|Adverse Event|0
4654209|NCT03274076|15979878|P3|24 Weeks Open Label|Adverse Event|2
4654210|NCT03274076|15979879|P2|24 Weeks Open Label|Adverse Event|0
4654211|NCT03274076|15979880|P1|24 Weeks Open Label|Adverse Event|0
4654212|NCT03274076|15979877|P4|24 Weeks Double Blind|Withdrawal by Subject|0
4654213|NCT03274076|15979878|P3|24 Weeks Double Blind|Withdrawal by Subject|0
4654214|NCT03274076|15979879|P2|24 Weeks Double Blind|Withdrawal by Subject|1
4654215|NCT03274076|15979880|P1|24 Weeks Double Blind|Withdrawal by Subject|0
4654216|NCT03273946|15979908|P1|Overall Study|Participant relative refused to use drug|1
4654217|NCT03273946|15979908|P1|Overall Study|Participant refused to use the drug|2
4654218|NCT03273946|15979908|P1|Overall Study|Unwillingness of the guardian|1
4654219|NCT03273946|15979908|P1|Overall Study|Withdrawal by Subject|5
4654220|NCT03273387|15979937|P2|Overall Study|Withdrawal by Subject|1
4654221|NCT03273387|15979938|P1|Overall Study|Withdrawal by Subject|1
4654222|NCT03273387|15979937|P2|Overall Study|Death|2
4654223|NCT03273387|15979938|P1|Overall Study|Death|2
4654224|NCT03273166|15979959|P1|Overall Study|Withdrawn prior to Completion|31
4654225|NCT03273153|15979966|P2|Overall Study|Other|1
4654226|NCT03273153|15979967|P1|Overall Study|Other|0
4654227|NCT03273153|15979966|P2|Overall Study|Symptomatic Deterioration|1
4654228|NCT03273153|15979967|P1|Overall Study|Symptomatic Deterioration|0
4654229|NCT03273153|15979966|P2|Overall Study|Withdrawal by Subject|13
4654230|NCT03273153|15979967|P1|Overall Study|Withdrawal by Subject|16
4654231|NCT03273153|15979966|P2|Overall Study|Protocol Violation|0
4654232|NCT03273153|15979967|P1|Overall Study|Protocol Violation|3
4654233|NCT03273153|15979966|P2|Overall Study|Lost to Follow-up|3
4654234|NCT03273153|15979967|P1|Overall Study|Lost to Follow-up|3
4654235|NCT03273153|15979966|P2|Overall Study|Death|45
4654236|NCT03273153|15979967|P1|Overall Study|Death|41
4654237|NCT03273153|15979966|P2|Overall Study|Remain on Study|159
4654238|NCT03273153|15979967|P1|Overall Study|Remain on Study|161
4654239|NCT03271021|15980030|P2|Overall Study|Miscellaneous|8
4654240|NCT03271021|15980031|P1|Overall Study|Miscellaneous|9
4654241|NCT03271021|15980030|P2|Overall Study|Abnormal Lab Results|0
4654242|NCT03271021|15980031|P1|Overall Study|Abnormal Lab Results|1
4654243|NCT03271021|15980030|P2|Overall Study|Protocol Violation|4
4654244|NCT03271021|15980031|P1|Overall Study|Protocol Violation|6
4654245|NCT03271021|15980030|P2|Overall Study|Lost to Follow-up|39
4654246|NCT03271021|15980031|P1|Overall Study|Lost to Follow-up|34
4654247|NCT03271021|15980030|P2|Overall Study|Withdrawal by Subject|53
4654248|NCT03271021|15980031|P1|Overall Study|Withdrawal by Subject|36
4654249|NCT03271021|15980030|P2|Overall Study|Adverse Event|2
4654250|NCT03271021|15980031|P1|Overall Study|Adverse Event|3
4654251|NCT03270657|15980049|P1|Overall Study|Withdrawal by Subject|1
4654252|NCT03270644|15980055|P1|Day 4 - 10 Propranolol Reference|Adverse Event|1
4654253|NCT03270644|15980055|P1|Day 1 Lasmiditan Reference|Physician Decision|1
4654254|NCT03270085|15980078|P2|Overall Study|Withdrawal by Subject|0
4654255|NCT03270085|15980079|P1|Overall Study|Withdrawal by Subject|1
4654256|NCT03269552|15980100|P1|Overall Study|Adverse Event|2
4654257|NCT03268941|15980111|P7|Part 2: Days 17 to 25|Withdrawal by Subject|1
4654258|NCT03268941|15980112|P6|Part 2: Days 17 to 25|Withdrawal by Subject|0
4654259|NCT03268941|15980113|P5|Part 2: Days 17 to 25|Withdrawal by Subject|0
4654260|NCT03268941|15980114|P4|Part 2: Days 17 to 25|Withdrawal by Subject|0
4654261|NCT03268941|15980115|P3|Part 2: Days 17 to 25|Withdrawal by Subject|0
4654262|NCT03268941|15980116|P2|Part 2: Days 17 to 25|Withdrawal by Subject|0
4654263|NCT03268941|15980117|P1|Part 2: Days 17 to 25|Withdrawal by Subject|0
4654264|NCT03268941|15980111|P7|Part 2: Days 17 to 25|Reason not specified|1
4654265|NCT03268941|15980112|P6|Part 2: Days 17 to 25|Reason not specified|0
4654266|NCT03268941|15980113|P5|Part 2: Days 17 to 25|Reason not specified|0
4654267|NCT03268941|15980114|P4|Part 2: Days 17 to 25|Reason not specified|0
4654268|NCT03268941|15980115|P3|Part 2: Days 17 to 25|Reason not specified|0
4654269|NCT03268941|15980116|P2|Part 2: Days 17 to 25|Reason not specified|0
4654270|NCT03268941|15980117|P1|Part 2: Days 17 to 25|Reason not specified|0
4654271|NCT03268941|15980111|P7|Part 1 (Days 1 to 9)|Protocol Deviation|0
4654272|NCT03268941|15980112|P6|Part 1 (Days 1 to 9)|Protocol Deviation|0
4654273|NCT03268941|15980113|P5|Part 1 (Days 1 to 9)|Protocol Deviation|0
4654274|NCT03268941|15980114|P4|Part 1 (Days 1 to 9)|Protocol Deviation|0
4654275|NCT03268941|15980115|P3|Part 1 (Days 1 to 9)|Protocol Deviation|0
4654276|NCT03268941|15980116|P2|Part 1 (Days 1 to 9)|Protocol Deviation|0
4654277|NCT03268941|15980117|P1|Part 1 (Days 1 to 9)|Protocol Deviation|1
4654278|NCT03268941|15980111|P7|Part 1 (Days 1 to 9)|Adverse Event|0
4654279|NCT03268941|15980112|P6|Part 1 (Days 1 to 9)|Adverse Event|0
4654280|NCT03268941|15980113|P5|Part 1 (Days 1 to 9)|Adverse Event|0
4654281|NCT03268941|15980114|P4|Part 1 (Days 1 to 9)|Adverse Event|1
4654282|NCT03268941|15980115|P3|Part 1 (Days 1 to 9)|Adverse Event|0
4654283|NCT03268941|15980116|P2|Part 1 (Days 1 to 9)|Adverse Event|0
4654284|NCT03268941|15980117|P1|Part 1 (Days 1 to 9)|Adverse Event|0
4654285|NCT03268941|15980111|P7|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4654286|NCT03268941|15980112|P6|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4654287|NCT03268941|15980113|P5|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4654288|NCT03268941|15980114|P4|Part 1 (Days 1 to 9)|Withdrawal by Subject|1
4654289|NCT03268941|15980115|P3|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4654290|NCT03268941|15980116|P2|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4654291|NCT03268941|15980117|P1|Part 1 (Days 1 to 9)|Withdrawal by Subject|0
4654292|NCT03268746|15980179|P1|Overall Study|Withdrawal by Subject|1
4654293|NCT03268590|15980201|P1|Overall Study|Previously unknown exclusion criteria|1
4654294|NCT03268005|15980236|P2|Overall Study|Withdrawal by Subject|11
4654295|NCT03268005|15980237|P1|Overall Study|Withdrawal by Subject|11
4654296|NCT03268005|15980236|P2|Overall Study|Lost to Follow-up|2
4654297|NCT03268005|15980237|P1|Overall Study|Lost to Follow-up|2
4654298|NCT03268005|15980236|P2|Overall Study|Death|1
4654299|NCT03268005|15980237|P1|Overall Study|Death|2
4654300|NCT03267940|15980351|P6|Expansion (Maximum Exposure: 421 Days)|Death|6
4654301|NCT03267940|15980352|P5|Expansion (Maximum Exposure: 421 Days)|Death|0
4654302|NCT03267940|15980353|P4|Expansion (Maximum Exposure: 421 Days)|Death|13
4654303|NCT03267940|15980354|P3|Expansion (Maximum Exposure: 421 Days)|Death|10
4654304|NCT03267940|15980355|P2|Expansion (Maximum Exposure: 421 Days)|Death|0
4654305|NCT03267940|15980356|P1|Expansion (Maximum Exposure: 421 Days)|Death|0
4654306|NCT03267940|15980351|P6|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3
4654307|NCT03267940|15980352|P5|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5
4654308|NCT03267940|15980353|P4|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4
4654309|NCT03267940|15980354|P3|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7
4654310|NCT03267940|15980355|P2|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
4654311|NCT03267940|15980356|P1|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0
4654312|NCT03267940|15980351|P6|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
4654313|NCT03267940|15980352|P5|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
4654314|NCT03267940|15980353|P4|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1
4654315|NCT03267940|15980354|P3|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2
4654316|NCT03267940|15980355|P2|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
4654317|NCT03267940|15980356|P1|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0
4654318|NCT03267940|15980351|P6|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
4654319|NCT03267940|15980352|P5|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
4654320|NCT03267940|15980353|P4|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1
4654321|NCT03267940|15980354|P3|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2
4654322|NCT03267940|15980355|P2|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
4654323|NCT03267940|15980356|P1|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0
4654324|NCT03267940|15980351|P6|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4654325|NCT03267940|15980352|P5|Expansion (Maximum Exposure: 421 Days)|Other than specified|2
4654326|NCT03267940|15980353|P4|Expansion (Maximum Exposure: 421 Days)|Other than specified|3
4654327|NCT03267940|15980354|P3|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4654328|NCT03267940|15980355|P2|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4654329|NCT03267940|15980356|P1|Expansion (Maximum Exposure: 421 Days)|Other than specified|0
4654330|NCT03267940|15980351|P6|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4654331|NCT03267940|15980352|P5|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4654332|NCT03267940|15980353|P4|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4654333|NCT03267940|15980354|P3|Run-in Portion (Max. Exposure: 508 Days)|Death|0
4654334|NCT03267940|15980355|P2|Run-in Portion (Max. Exposure: 508 Days)|Death|3
4654335|NCT03267940|15980356|P1|Run-in Portion (Max. Exposure: 508 Days)|Death|7
4654336|NCT03267940|15980351|P6|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4654337|NCT03267940|15980352|P5|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4654338|NCT03267940|15980353|P4|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4654339|NCT03267940|15980354|P3|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4654340|NCT03267940|15980355|P2|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1
4654341|NCT03267940|15980356|P1|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0
4654342|NCT03267940|15980351|P6|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4654343|NCT03267940|15980352|P5|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4654344|NCT03267940|15980353|P4|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4654345|NCT03267940|15980354|P3|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4654346|NCT03267940|15980355|P2|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1
4654347|NCT03267940|15980356|P1|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0
4654348|NCT03267940|15980351|P6|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4654349|NCT03267940|15980352|P5|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4654350|NCT03267940|15980353|P4|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4654351|NCT03267940|15980354|P3|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0
4654352|NCT03267940|15980355|P2|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2
4654353|NCT03267940|15980356|P1|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1
4654354|NCT03267576|15980458|P2|Period 2: Day 44 to 71|Withdrawal by Subject|1
4654355|NCT03267576|15980459|P1|Period 2: Day 44 to 71|Withdrawal by Subject|1
4654356|NCT03267576|15980458|P2|Period 2: Day 44 to 71|Lost to Follow-up|1
4654357|NCT03267576|15980459|P1|Period 2: Day 44 to 71|Lost to Follow-up|0
4654358|NCT03267511|15980497|P4|Overall Study|Lost to Follow-up|1
4654359|NCT03267511|15980498|P3|Overall Study|Lost to Follow-up|0
4654360|NCT03267511|15980499|P2|Overall Study|Lost to Follow-up|0
4654361|NCT03267511|15980500|P1|Overall Study|Lost to Follow-up|0
4654362|NCT03267264|15980516|P4|Overall Study|Withdrawal by Subject|4
4654363|NCT03267264|15980517|P3|Overall Study|Withdrawal by Subject|2
4654364|NCT03267264|15980518|P2|Overall Study|Withdrawal by Subject|0
4654365|NCT03267264|15980519|P1|Overall Study|Withdrawal by Subject|1
4654366|NCT03267212|15980536|P2|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0
4654367|NCT03267212|15980537|P1|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1
4654368|NCT03267212|15980536|P2|First Intervention|Withdrawal by Subject|1
4654369|NCT03267212|15980537|P1|First Intervention|Withdrawal by Subject|1
4654370|NCT03267212|15980536|P2|First Intervention|Lost to Follow-up|2
4654371|NCT03267212|15980537|P1|First Intervention|Lost to Follow-up|0
4654372|NCT03266588|15980552|P3|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
4654373|NCT03266588|15980553|P2|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1
4654374|NCT03266588|15980554|P1|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0
4654375|NCT03266588|15980552|P3|Long-term Treatment Period|Other Reasons|0
4654376|NCT03266588|15980553|P2|Long-term Treatment Period|Other Reasons|0
4654377|NCT03266588|15980554|P1|Long-term Treatment Period|Other Reasons|5
4654378|NCT03266588|15980552|P3|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0
4654379|NCT03266588|15980553|P2|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2
4654380|NCT03266588|15980554|P1|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1
4654381|NCT03266588|15980552|P3|Long-term Treatment Period|Withdrawal by Subject|16
4654382|NCT03266588|15980553|P2|Long-term Treatment Period|Withdrawal by Subject|63
4654383|NCT03266588|15980554|P1|Long-term Treatment Period|Withdrawal by Subject|100
4654384|NCT03266588|15980552|P3|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
4654385|NCT03266588|15980553|P2|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17
4654386|NCT03266588|15980554|P1|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33
4654387|NCT03266588|15980552|P3|Long-term Treatment Period|Protocol Deviation|4
4654388|NCT03266588|15980553|P2|Long-term Treatment Period|Protocol Deviation|10
4654389|NCT03266588|15980554|P1|Long-term Treatment Period|Protocol Deviation|17
4654390|NCT03266588|15980552|P3|Long-term Treatment Period|Pregnancy|0
4654391|NCT03266588|15980553|P2|Long-term Treatment Period|Pregnancy|5
4654392|NCT03266588|15980554|P1|Long-term Treatment Period|Pregnancy|11
4654393|NCT03266588|15980552|P3|Long-term Treatment Period|Non-Compliance|7
4654394|NCT03266588|15980553|P2|Long-term Treatment Period|Non-Compliance|57
4654395|NCT03266588|15980554|P1|Long-term Treatment Period|Non-Compliance|126
4654396|NCT03266588|15980552|P3|Long-term Treatment Period|Lost to Follow-up|8
4654397|NCT03266588|15980553|P2|Long-term Treatment Period|Lost to Follow-up|37
4654398|NCT03266588|15980554|P1|Long-term Treatment Period|Lost to Follow-up|39
4654399|NCT03266588|15980552|P3|Long-term Treatment Period|Lack of Efficacy|5
4654400|NCT03266588|15980553|P2|Long-term Treatment Period|Lack of Efficacy|31
4654401|NCT03266588|15980554|P1|Long-term Treatment Period|Lack of Efficacy|41
4654402|NCT03266588|15980552|P3|Long-term Treatment Period|Adverse Event|8
4654403|NCT03266588|15980553|P2|Long-term Treatment Period|Adverse Event|17
4654404|NCT03266588|15980554|P1|Long-term Treatment Period|Adverse Event|33
4654405|NCT03266588|15980552|P3|Observational Period|Other Reasons|1
4654406|NCT03266588|15980553|P2|Observational Period|Other Reasons|0
4654407|NCT03266588|15980554|P1|Observational Period|Other Reasons|3
4654408|NCT03266588|15980552|P3|Observational Period|Protocol Deviation|0
4654409|NCT03266588|15980553|P2|Observational Period|Protocol Deviation|0
4654410|NCT03266588|15980554|P1|Observational Period|Protocol Deviation|1
4654411|NCT03266588|15980552|P3|Observational Period|Eligibility Failure- Baseline Lab Values|0
4654412|NCT03266588|15980553|P2|Observational Period|Eligibility Failure- Baseline Lab Values|1
4654413|NCT03266588|15980554|P1|Observational Period|Eligibility Failure- Baseline Lab Values|3
4654414|NCT03266588|15980552|P3|Observational Period|Lost to Follow-up|4
4654415|NCT03266588|15980553|P2|Observational Period|Lost to Follow-up|12
4654416|NCT03266588|15980554|P1|Observational Period|Lost to Follow-up|8
4654417|NCT03266588|15980552|P3|Observational Period|Non-compliance|10
4654418|NCT03266588|15980553|P2|Observational Period|Non-compliance|12
4654419|NCT03266588|15980554|P1|Observational Period|Non-compliance|18
4654420|NCT03266588|15980552|P3|Observational Period|Withdrawal by Subject|13
4654421|NCT03266588|15980553|P2|Observational Period|Withdrawal by Subject|22
4654422|NCT03266588|15980554|P1|Observational Period|Withdrawal by Subject|44
4654423|NCT03266588|15980552|P3|Observational Period|Screen Failure: Eligibility Criteria|140
4654424|NCT03266588|15980553|P2|Observational Period|Screen Failure: Eligibility Criteria|228
4654425|NCT03266588|15980554|P1|Observational Period|Screen Failure: Eligibility Criteria|439
4654426|NCT03266172|15980585|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
4654427|NCT03266172|15980586|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4654428|NCT03266172|15980587|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4654429|NCT03266172|15980585|P3|Part C Washout Period (7 Days)|Withdrawal by Subject|1
4654430|NCT03266172|15980586|P2|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4654431|NCT03266172|15980587|P1|Part C Washout Period (7 Days)|Withdrawal by Subject|0
4654432|NCT03266172|15980585|P3|Part B: Washout (7 Days)|Withdrawal by Subject|0
4654433|NCT03266172|15980586|P2|Part B: Washout (7 Days)|Withdrawal by Subject|2
4654434|NCT03266172|15980587|P1|Part B: Washout (7 Days)|Withdrawal by Subject|0
4654435|NCT03266172|15980585|P3|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
4654436|NCT03266172|15980586|P2|Part A: Washout Period (7 Days)|Withdrawal by Subject|0
4654437|NCT03266172|15980587|P1|Part A: Washout Period (7 Days)|Withdrawal by Subject|1
4654438|NCT03266172|15980585|P3|Part A: Washout Period (7 Days)|Adverse Event|0
4654439|NCT03266172|15980586|P2|Part A: Washout Period (7 Days)|Adverse Event|0
4654440|NCT03266172|15980587|P1|Part A: Washout Period (7 Days)|Adverse Event|1
4654441|NCT03266172|15980585|P3|Part A: Period 1(2 Days)|Withdrawal by Subject|0
4654442|NCT03266172|15980586|P2|Part A: Period 1(2 Days)|Withdrawal by Subject|0
4654443|NCT03266172|15980587|P1|Part A: Period 1(2 Days)|Withdrawal by Subject|1
4654444|NCT03266094|15980832|P1|Overall Study|Withdrawal by Subject|1
4654445|NCT03266094|15980832|P1|Overall Study|Lost to Follow-up|1
4654446|NCT03265938|15980850|P1|Overall Study|friable mass|6
4654447|NCT03265938|15980850|P1|Overall Study|Physician Decision|1
4654448|NCT03265938|15980850|P1|Overall Study|Withdrawal by Subject|1
4654449|NCT03265600|15980863|P2|Overall Study|Partially completed 8 wk or 24 wk survey|5
4654450|NCT03265600|15980864|P1|Overall Study|Partially completed 8 wk or 24 wk survey|3
4654451|NCT03265600|15980863|P2|Overall Study|Withdrawal by Subject|2
4654452|NCT03265600|15980864|P1|Overall Study|Withdrawal by Subject|4
4654453|NCT03265600|15980863|P2|Overall Study|Lost to Follow-up|5
4654454|NCT03265600|15980864|P1|Overall Study|Lost to Follow-up|17
4654455|NCT03265132|15980890|P2|Overall Study|Withdrawal by Subject|1
4654456|NCT03265132|15980891|P1|Overall Study|Withdrawal by Subject|0
4654457|NCT03265132|15980890|P2|Overall Study|Progressive disease|2
4654458|NCT03265132|15980891|P1|Overall Study|Progressive disease|0
4654459|NCT03265132|15980890|P2|Overall Study|Lack of Efficacy|2
4654460|NCT03265132|15980891|P1|Overall Study|Lack of Efficacy|0
4654461|NCT03265132|15980890|P2|Overall Study|Adverse Event|1
4654462|NCT03265132|15980891|P1|Overall Study|Adverse Event|0
4654463|NCT03265119|15980989|P2|Overall Study|Lack of Compliance|0
4654464|NCT03265119|15980990|P1|Overall Study|Lack of Compliance|1
4654465|NCT03265119|15980989|P2|Overall Study|Lost to Follow-up|0
4654466|NCT03265119|15980990|P1|Overall Study|Lost to Follow-up|1
4654467|NCT03265119|15980989|P2|Overall Study|Withdrawal by Subject|4
4654468|NCT03265119|15980990|P1|Overall Study|Withdrawal by Subject|2
4654469|NCT03265119|15980989|P2|Overall Study|Protocol Violation|2
4654470|NCT03265119|15980990|P1|Overall Study|Protocol Violation|1
4654471|NCT03265119|15980989|P2|Overall Study|Lack of Efficacy|0
4654472|NCT03265119|15980990|P1|Overall Study|Lack of Efficacy|3
4654473|NCT03265119|15980989|P2|Overall Study|Adverse Event|1
4654474|NCT03265119|15980990|P1|Overall Study|Adverse Event|2
4654475|NCT03264456|15980998|P1|Overall Study|Lost to Follow-up|1
4654476|NCT03264456|15980998|P1|Overall Study|Withdrawal by Subject|3
4654477|NCT03263806|15981033|P2|Overall Study|Study Termination|6
4654478|NCT03263806|15981034|P1|Overall Study|Study Termination|5
4654479|NCT03263806|15981033|P2|Overall Study|Withdrawal by Subject|1
4654480|NCT03263806|15981034|P1|Overall Study|Withdrawal by Subject|0
4654481|NCT03263806|15981033|P2|Overall Study|Elevated Troponin (failed screen)|0
4654482|NCT03263806|15981034|P1|Overall Study|Elevated Troponin (failed screen)|1
4654483|NCT03263702|15981048|P2|Overall Study|Withdrawal by Subject|2
4654484|NCT03263702|15981049|P1|Overall Study|Withdrawal by Subject|1
4654485|NCT03263702|15981048|P2|Overall Study|Lost to Follow-up|2
4654486|NCT03263702|15981049|P1|Overall Study|Lost to Follow-up|2
4654487|NCT03262233|15981079|P4|Overall Study|data collection artifact|0
4654488|NCT03262233|15981080|P3|Overall Study|data collection artifact|0
4654489|NCT03262233|15981081|P2|Overall Study|data collection artifact|1
4654490|NCT03262233|15981082|P1|Overall Study|data collection artifact|0
4654491|NCT03262233|15981079|P4|Overall Study|Protocol Violation|13
4654492|NCT03262233|15981080|P3|Overall Study|Protocol Violation|2
4654493|NCT03262233|15981081|P2|Overall Study|Protocol Violation|10
4654494|NCT03262233|15981082|P1|Overall Study|Protocol Violation|5
4654495|NCT03262233|15981079|P4|Overall Study|Declined due to shock|3
4654496|NCT03262233|15981080|P3|Overall Study|Declined due to shock|2
4654497|NCT03262233|15981081|P2|Overall Study|Declined due to shock|2
4654498|NCT03262233|15981082|P1|Overall Study|Declined due to shock|1
4654499|NCT03262233|15981079|P4|Overall Study|Withdrawal by Subject|13
4654500|NCT03262233|15981080|P3|Overall Study|Withdrawal by Subject|21
4654501|NCT03262233|15981081|P2|Overall Study|Withdrawal by Subject|8
4654502|NCT03262233|15981082|P1|Overall Study|Withdrawal by Subject|12
4654503|NCT03262012|15981108|P4|Overall Study|Protocol Discontinuation Criteria|0
4654504|NCT03262012|15981109|P3|Overall Study|Protocol Discontinuation Criteria|0
4654505|NCT03262012|15981110|P2|Overall Study|Protocol Discontinuation Criteria|1
4654506|NCT03262012|15981111|P1|Overall Study|Protocol Discontinuation Criteria|0
4654507|NCT03262012|15981108|P4|Overall Study|Lack of Efficacy|2
4654508|NCT03262012|15981109|P3|Overall Study|Lack of Efficacy|1
4654509|NCT03262012|15981110|P2|Overall Study|Lack of Efficacy|5
4654510|NCT03262012|15981111|P1|Overall Study|Lack of Efficacy|0
4654511|NCT03262012|15981108|P4|Overall Study|Physician Decision|0
4654512|NCT03262012|15981109|P3|Overall Study|Physician Decision|1
4654513|NCT03262012|15981110|P2|Overall Study|Physician Decision|5
4654514|NCT03262012|15981111|P1|Overall Study|Physician Decision|2
4654515|NCT03262012|15981108|P4|Overall Study|Adverse Event|6
4654516|NCT03262012|15981109|P3|Overall Study|Adverse Event|4
4654517|NCT03262012|15981110|P2|Overall Study|Adverse Event|12
4654518|NCT03262012|15981111|P1|Overall Study|Adverse Event|10
4654519|NCT03262012|15981108|P4|Overall Study|Withdrawal by Subject|7
4654520|NCT03262012|15981109|P3|Overall Study|Withdrawal by Subject|8
4654521|NCT03262012|15981110|P2|Overall Study|Withdrawal by Subject|13
4654522|NCT03262012|15981111|P1|Overall Study|Withdrawal by Subject|15
4654523|NCT03261531|15981134|P1|Overall Study|Withdrawal by Subject|4
4654524|NCT03261167|15981152|P2|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
4654525|NCT03261167|15981153|P1|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1
4654526|NCT03261167|15981152|P2|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0
4654527|NCT03261167|15981153|P1|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1
4654528|NCT03261167|15981152|P2|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0
4654529|NCT03261167|15981153|P1|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1
4654530|NCT03261167|15981152|P2|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1
4654531|NCT03261167|15981153|P1|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3
4654532|NCT03261167|15981152|P2|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3
4654533|NCT03261167|15981153|P1|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0
4654534|NCT03260894|15981191|P2|Overall Study|On-going at clinical cut off date|31
4654535|NCT03260894|15981192|P1|Overall Study|On-going at clinical cut off date|36
4654536|NCT03260894|15981191|P2|Overall Study|Withdrawal by Subject|11
4654537|NCT03260894|15981192|P1|Overall Study|Withdrawal by Subject|4
4654538|NCT03260894|15981191|P2|Overall Study|Death|8
4654539|NCT03260894|15981192|P1|Overall Study|Death|6
4654540|NCT03260868|15981204|P2|Overall Study|Other than specified above|0
4654541|NCT03260868|15981205|P1|Overall Study|Other than specified above|1
4654542|NCT03260868|15981204|P2|Overall Study|Study Terminated By Sponsor|1
4654543|NCT03260868|15981205|P1|Overall Study|Study Terminated By Sponsor|2
4654544|NCT03260868|15981204|P2|Overall Study|Poor Compliance to Protocol|2
4654545|NCT03260868|15981205|P1|Overall Study|Poor Compliance to Protocol|0
4654546|NCT03260205|15981327|P5|Overall Study|Participant Who Did Not Received AnyDose|1
4654547|NCT03260205|15981328|P4|Overall Study|Participant Who Did Not Received AnyDose|3
4654548|NCT03260205|15981329|P3|Overall Study|Participant Who Did Not Received AnyDose|2
4654549|NCT03260205|15981330|P2|Overall Study|Participant Who Did Not Received AnyDose|1
4654550|NCT03260205|15981331|P1|Overall Study|Participant Who Did Not Received AnyDose|1
4654551|NCT03260205|15981327|P5|Overall Study|Other: Unspecified|1
4654552|NCT03260205|15981328|P4|Overall Study|Other: Unspecified|1
4654553|NCT03260205|15981329|P3|Overall Study|Other: Unspecified|3
4654554|NCT03260205|15981330|P2|Overall Study|Other: Unspecified|0
4654555|NCT03260205|15981331|P1|Overall Study|Other: Unspecified|0
4654556|NCT03260205|15981327|P5|Overall Study|Withdrawal by Participant or Parent/LAR|2
4654557|NCT03260205|15981328|P4|Overall Study|Withdrawal by Participant or Parent/LAR|0
4654558|NCT03260205|15981329|P3|Overall Study|Withdrawal by Participant or Parent/LAR|1
4654559|NCT03260205|15981330|P2|Overall Study|Withdrawal by Participant or Parent/LAR|5
4654560|NCT03260205|15981331|P1|Overall Study|Withdrawal by Participant or Parent/LAR|4
4654561|NCT03260205|15981327|P5|Overall Study|Protocol Violation|1
4654562|NCT03260205|15981328|P4|Overall Study|Protocol Violation|0
4654563|NCT03260205|15981329|P3|Overall Study|Protocol Violation|2
4654564|NCT03260205|15981330|P2|Overall Study|Protocol Violation|0
4654565|NCT03260205|15981331|P1|Overall Study|Protocol Violation|0
4654566|NCT03260205|15981327|P5|Overall Study|Lost to Follow-up|5
4654567|NCT03260205|15981328|P4|Overall Study|Lost to Follow-up|1
4654568|NCT03260205|15981329|P3|Overall Study|Lost to Follow-up|1
4654569|NCT03260205|15981330|P2|Overall Study|Lost to Follow-up|2
4654570|NCT03260205|15981331|P1|Overall Study|Lost to Follow-up|2
4654571|NCT03260205|15981327|P5|Overall Study|Adverse Event|4
4654572|NCT03260205|15981328|P4|Overall Study|Adverse Event|2
4654573|NCT03260205|15981329|P3|Overall Study|Adverse Event|2
4654574|NCT03260205|15981330|P2|Overall Study|Adverse Event|0
4654575|NCT03260205|15981331|P1|Overall Study|Adverse Event|2
4654576|NCT03259555|15981394|P2|Overall Study|Other|0
4654577|NCT03259555|15981395|P1|Overall Study|Other|1
4654578|NCT03259555|15981394|P2|Overall Study|Physician Decision|2
4654579|NCT03259555|15981395|P1|Overall Study|Physician Decision|1
4654580|NCT03259555|15981394|P2|Overall Study|Withdrawal by Subject|16
4654581|NCT03259555|15981395|P1|Overall Study|Withdrawal by Subject|19
4654582|NCT03259555|15981394|P2|Overall Study|Progressive Disease|2
4654583|NCT03259555|15981395|P1|Overall Study|Progressive Disease|0
4654584|NCT03259555|15981394|P2|Overall Study|Non-Compliance With Study Drug|0
4654585|NCT03259555|15981395|P1|Overall Study|Non-Compliance With Study Drug|1
4654586|NCT03259555|15981394|P2|Overall Study|Lost to Follow-up|2
4654587|NCT03259555|15981395|P1|Overall Study|Lost to Follow-up|0
4654588|NCT03259555|15981394|P2|Overall Study|Lack of Efficacy|4
4654589|NCT03259555|15981395|P1|Overall Study|Lack of Efficacy|6
4654590|NCT03259555|15981394|P2|Overall Study|Adverse Event|4
4654591|NCT03259555|15981395|P1|Overall Study|Adverse Event|6
4654592|NCT03259490|15981405|P2|Period 2|Protocol Violation|0
4654593|NCT03259490|15981406|P1|Period 2|Protocol Violation|1
4654594|NCT03259490|15981405|P2|Period 1|Withdrawal by Subject|1
4654595|NCT03259490|15981406|P1|Period 1|Withdrawal by Subject|0
4654596|NCT03259087|15981474|P5|Period 2 of Part 2|Adverse Event|1
4654597|NCT03259087|15981475|P4|Period 2 of Part 2|Adverse Event|0
4654598|NCT03259087|15981476|P3|Period 2 of Part 2|Adverse Event|0
4654599|NCT03259087|15981477|P2|Period 2 of Part 2|Adverse Event|0
4654600|NCT03259087|15981478|P1|Period 2 of Part 2|Adverse Event|0
4654601|NCT03259087|15981474|P5|Part 1 and Period 1 of Part 2|Adverse Event|1
4654602|NCT03259087|15981475|P4|Part 1 and Period 1 of Part 2|Adverse Event|0
4654603|NCT03259087|15981476|P3|Part 1 and Period 1 of Part 2|Adverse Event|0
4654604|NCT03259087|15981477|P2|Part 1 and Period 1 of Part 2|Adverse Event|0
4654605|NCT03259087|15981478|P1|Part 1 and Period 1 of Part 2|Adverse Event|0
4654606|NCT03258814|15981606|P3|Overall Study|Early Termination|10
4654607|NCT03258814|15981607|P2|Overall Study|Early Termination|3
4654608|NCT03258814|15981608|P1|Overall Study|Early Termination|4
4654609|NCT03258762|15981663|P2|Overall Study|Lost to Follow-up|1
4654610|NCT03258762|15981664|P1|Overall Study|Lost to Follow-up|0
4654611|NCT03258710|15981724|P1|Overall Study|Physician Decision|1
4654612|NCT03258710|15981724|P1|Overall Study|Protocol-defined stopping criteria|1
4654613|NCT03258710|15981724|P1|Overall Study|Adverse Event|1
4654614|NCT03257995|15981818|P6|Overall Study|Protocol deviation|2
4654615|NCT03257995|15981819|P5|Overall Study|Protocol deviation|0
4654616|NCT03257995|15981820|P4|Overall Study|Protocol deviation|0
4654617|NCT03257995|15981821|P3|Overall Study|Protocol deviation|0
4654618|NCT03257995|15981822|P2|Overall Study|Protocol deviation|0
4654619|NCT03257995|15981823|P1|Overall Study|Protocol deviation|0
4654620|NCT03257995|15981818|P6|Overall Study|Adverse Event|0
4654621|NCT03257995|15981819|P5|Overall Study|Adverse Event|0
4654622|NCT03257995|15981820|P4|Overall Study|Adverse Event|0
4654623|NCT03257995|15981821|P3|Overall Study|Adverse Event|0
4654624|NCT03257995|15981822|P2|Overall Study|Adverse Event|1
4654625|NCT03257995|15981823|P1|Overall Study|Adverse Event|0
4654626|NCT03257865|15981873|P2|Overall Study|Lost to Follow-up|4
4654627|NCT03257865|15981874|P1|Overall Study|Lost to Follow-up|4
4654628|NCT03257865|15981873|P2|Overall Study|Other|1
4654629|NCT03257865|15981874|P1|Overall Study|Other|0
4654630|NCT03257865|15981873|P2|Overall Study|Physician Decision|1
4654631|NCT03257865|15981874|P1|Overall Study|Physician Decision|3
4654632|NCT03257865|15981873|P2|Overall Study|Withdrawal by Subject|17
4654633|NCT03257865|15981874|P1|Overall Study|Withdrawal by Subject|23
4654634|NCT03257865|15981873|P2|Overall Study|Non-compliance with Study Drug|2
4654635|NCT03257865|15981874|P1|Overall Study|Non-compliance with Study Drug|0
4654636|NCT03257865|15981873|P2|Overall Study|Lack of Efficacy|2
4654637|NCT03257865|15981874|P1|Overall Study|Lack of Efficacy|1
4654638|NCT03257865|15981873|P2|Overall Study|Adverse Event|8
4654639|NCT03257865|15981874|P1|Overall Study|Adverse Event|4
4654640|NCT03257813|15981884|P2|Overall Study|Protocol Violation|3
4654641|NCT03257813|15981885|P1|Overall Study|Protocol Violation|6
4654642|NCT03257657|15981907|P2|Overall Study|Noted not eligible right after enrolled|1
4654643|NCT03257657|15981908|P1|Overall Study|Noted not eligible right after enrolled|0
4654644|NCT03257657|15981907|P2|Overall Study|Withdrawn|1
4654645|NCT03257657|15981908|P1|Overall Study|Withdrawn|0
4654646|NCT03257657|15981907|P2|Overall Study|Lost to Follow-up|3
4654647|NCT03257657|15981908|P1|Overall Study|Lost to Follow-up|0
4654648|NCT03257631|15981939|P4|Overall Study|Still on Study|4
4654649|NCT03257631|15981940|P3|Overall Study|Still on Study|4
4654650|NCT03257631|15981941|P2|Overall Study|Still on Study|2
4654651|NCT03257631|15981942|P1|Overall Study|Still on Study|3
4654652|NCT03257631|15981939|P4|Overall Study|Lost to Follow-up|0
4654653|NCT03257631|15981940|P3|Overall Study|Lost to Follow-up|1
4654654|NCT03257631|15981941|P2|Overall Study|Lost to Follow-up|0
4654655|NCT03257631|15981942|P1|Overall Study|Lost to Follow-up|0
4654656|NCT03257631|15981939|P4|Overall Study|Withdrawal by Parent/Guardian|1
4654657|NCT03257631|15981940|P3|Overall Study|Withdrawal by Parent/Guardian|4
4654658|NCT03257631|15981941|P2|Overall Study|Withdrawal by Parent/Guardian|2
4654659|NCT03257631|15981942|P1|Overall Study|Withdrawal by Parent/Guardian|0
4654660|NCT03257631|15981939|P4|Overall Study|Progressive Disease|0
4654661|NCT03257631|15981940|P3|Overall Study|Progressive Disease|1
4654662|NCT03257631|15981941|P2|Overall Study|Progressive Disease|0
4654663|NCT03257631|15981942|P1|Overall Study|Progressive Disease|0
4654664|NCT03257631|15981939|P4|Overall Study|Death|5
4654665|NCT03257631|15981940|P3|Overall Study|Death|13
4654666|NCT03257631|15981941|P2|Overall Study|Death|5
4654667|NCT03257631|15981942|P1|Overall Study|Death|8
4654668|NCT03257358|15981978|P2|Overall Study|No longer requires treatment|1
4654669|NCT03257358|15981979|P1|Overall Study|No longer requires treatment|0
4654670|NCT03257358|15981978|P2|Overall Study|New therapy for study indication|0
4654671|NCT03257358|15981979|P1|Overall Study|New therapy for study indication|1
4654672|NCT03257358|15981978|P2|Overall Study|Withdrawal of informed consent|5
4654673|NCT03257358|15981979|P1|Overall Study|Withdrawal of informed consent|9
4654674|NCT03257358|15981978|P2|Overall Study|Withdrawal by Subject|3
4654675|NCT03257358|15981979|P1|Overall Study|Withdrawal by Subject|8
4654676|NCT03257358|15981978|P2|Overall Study|Technical problems|1
4654677|NCT03257358|15981979|P1|Overall Study|Technical problems|4
4654678|NCT03257358|15981978|P2|Overall Study|Protocol Violation|3
4654679|NCT03257358|15981979|P1|Overall Study|Protocol Violation|5
4654680|NCT03257358|15981978|P2|Overall Study|Physician Decision|2
4654681|NCT03257358|15981979|P1|Overall Study|Physician Decision|2
4654682|NCT03257358|15981978|P2|Overall Study|Non-compliance with fingolimod treatment|2
4654683|NCT03257358|15981979|P1|Overall Study|Non-compliance with fingolimod treatment|4
4654684|NCT03257358|15981978|P2|Overall Study|Lost to Follow-up|4
4654685|NCT03257358|15981979|P1|Overall Study|Lost to Follow-up|12
4654686|NCT03257358|15981978|P2|Overall Study|Lack of Efficacy|1
4654687|NCT03257358|15981979|P1|Overall Study|Lack of Efficacy|1
4654688|NCT03257358|15981978|P2|Overall Study|Adverse Event|12
4654689|NCT03257358|15981979|P1|Overall Study|Adverse Event|25
4654690|NCT03256851|15982107|P2|Overall Study|Withdrawal by Subject|0
4654691|NCT03256851|15982108|P1|Overall Study|Withdrawal by Subject|1
4654692|NCT03256695|15982120|P1|Overall Study|Other than specified|3
4654693|NCT03256695|15982120|P1|Overall Study|Protocol Violation|5
4654694|NCT03256695|15982120|P1|Overall Study|Lack of Efficacy|3
4654695|NCT03256695|15982120|P1|Overall Study|Lost to Follow-up|3
4654696|NCT03256695|15982120|P1|Overall Study|Non-compliance with study drug|1
4654697|NCT03256695|15982120|P1|Overall Study|Withdrawal by Subject|14
4654698|NCT03256695|15982120|P1|Overall Study|Death|2
4654699|NCT03256695|15982120|P1|Overall Study|Adverse Event|8
4654700|NCT03256552|15982128|P1|Overall Study|Withdrawal by Subject|2
4654701|NCT03256552|15982128|P1|Overall Study|Adverse Event|1
4654702|NCT03256552|15982128|P1|Overall Study|Physician Decision|1
4654703|NCT03256552|15982128|P1|Overall Study|Protocol Violation|1
4654704|NCT03256526|15982153|P3|Overall Study|Lost to Follow-up|2
4654705|NCT03256526|15982154|P2|Overall Study|Lost to Follow-up|0
4654706|NCT03256526|15982155|P1|Overall Study|Lost to Follow-up|1
4654707|NCT03256526|15982153|P3|Overall Study|Adverse Event|1
4654708|NCT03256526|15982154|P2|Overall Study|Adverse Event|0
4654709|NCT03256526|15982155|P1|Overall Study|Adverse Event|1
4654710|NCT03255824|15982240|P2|Overall Study|Under-sedation|1
4654711|NCT03255824|15982241|P1|Overall Study|Under-sedation|2
4654712|NCT03255733|15982269|P1|Overall Study|Lost to Follow-up|4
4654713|NCT03255655|15982276|P2|Overall Study|Lost to Follow-up|4
4654714|NCT03255655|15982277|P1|Overall Study|Lost to Follow-up|7
4654715|NCT03255382|15982287|P2|Overall Study|Other|0
4654716|NCT03255382|15982288|P1|Overall Study|Other|6
4654717|NCT03255382|15982287|P2|Overall Study|Withdrawal by Subject|0
4654718|NCT03255382|15982288|P1|Overall Study|Withdrawal by Subject|2
4654719|NCT03255382|15982287|P2|Overall Study|Lost to Follow-up|0
4654720|NCT03255382|15982288|P1|Overall Study|Lost to Follow-up|2
4654721|NCT03255382|15982287|P2|Overall Study|Adverse Event|0
4654722|NCT03255382|15982288|P1|Overall Study|Adverse Event|3
4654723|NCT03255291|15982462|P6|Overall Study|Baseline data collection issues|0
4654724|NCT03255291|15982463|P5|Overall Study|Baseline data collection issues|2
4654725|NCT03255291|15982464|P4|Overall Study|Baseline data collection issues|0
4654726|NCT03255291|15982465|P3|Overall Study|Baseline data collection issues|0
4654727|NCT03255291|15982466|P2|Overall Study|Baseline data collection issues|0
4654728|NCT03255291|15982467|P1|Overall Study|Baseline data collection issues|3
4654729|NCT03255291|15982462|P6|Overall Study|Determined to be ineligible|10
4654730|NCT03255291|15982463|P5|Overall Study|Determined to be ineligible|5
4654731|NCT03255291|15982464|P4|Overall Study|Determined to be ineligible|6
4654732|NCT03255291|15982465|P3|Overall Study|Determined to be ineligible|6
4654733|NCT03255291|15982466|P2|Overall Study|Determined to be ineligible|12
4654734|NCT03255291|15982467|P1|Overall Study|Determined to be ineligible|10
4654735|NCT03255187|15982500|P2|Period From First to Second Follow-up|Withdrawal by Subject|1
4654736|NCT03255187|15982501|P1|Period From First to Second Follow-up|Withdrawal by Subject|0
4654737|NCT03255187|15982500|P2|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3
4654738|NCT03255187|15982501|P1|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1
4654739|NCT03254602|15982560|P1|Overall Study|Lost to Follow-up|4
4654740|NCT03254459|15982568|P2|Overall Study|Miscellaneous|1
4654741|NCT03254459|15982569|P1|Overall Study|Miscellaneous|0
4654742|NCT03254459|15982568|P2|Overall Study|Lost to Follow-up|1
4654743|NCT03254459|15982569|P1|Overall Study|Lost to Follow-up|0
4654744|NCT03254459|15982568|P2|Overall Study|Withdrawal by Subject Consent|1
4654745|NCT03254459|15982569|P1|Overall Study|Withdrawal by Subject Consent|3
4654746|NCT03254459|15982568|P2|Overall Study|Adverse Event|20
4654747|NCT03254459|15982569|P1|Overall Study|Adverse Event|7
4654748|NCT03254134|15982594|P2|Overall Study|Not eligible patients|3630
4654749|NCT03254134|15982595|P1|Overall Study|Not eligible patients|599
4654750|NCT03252015|15982634|P4|Overall Study|Adverse Event|1
4654751|NCT03252015|15982635|P3|Overall Study|Adverse Event|0
4654752|NCT03252015|15982636|P2|Overall Study|Adverse Event|0
4654753|NCT03252015|15982637|P1|Overall Study|Adverse Event|1
4654754|NCT03252015|15982634|P4|Overall Study|Withdrawal by Subject|0
4654755|NCT03252015|15982635|P3|Overall Study|Withdrawal by Subject|1
4654756|NCT03252015|15982636|P2|Overall Study|Withdrawal by Subject|1
4654757|NCT03252015|15982637|P1|Overall Study|Withdrawal by Subject|0
4654758|NCT03251963|15982675|P2|Overall Study|bled prior to Xa level|2
4654759|NCT03251963|15982676|P1|Overall Study|bled prior to Xa level|1
4654760|NCT03251963|15982675|P2|Overall Study|no peak Xa level drawn|0
4654761|NCT03251963|15982676|P1|Overall Study|no peak Xa level drawn|2
4654762|NCT03251963|15982675|P2|Overall Study|inappropriate Xa level timing|3
4654763|NCT03251963|15982676|P1|Overall Study|inappropriate Xa level timing|6
4654764|NCT03251482|15982695|P5|Overall Study|Withdrawal by Subject|0
4654765|NCT03251482|15982696|P4|Overall Study|Withdrawal by Subject|0
4654766|NCT03251482|15982697|P3|Overall Study|Withdrawal by Subject|0
4654767|NCT03251482|15982698|P2|Overall Study|Withdrawal by Subject|1
4654768|NCT03251482|15982699|P1|Overall Study|Withdrawal by Subject|0
4654769|NCT03250182|15982856|P1|Overall Study|Withdrawal by Subject|1
4654770|NCT03249935|15982880|P1|Overall Study|Protocol Violation|5
4654771|NCT03249935|15982880|P1|Overall Study|Negative for chlamydia at enrollment|4
4654772|NCT03249935|15982880|P1|Overall Study|Discharged from facility early|36
4654773|NCT03249909|15982889|P3|Overall Study|Lost to Follow-up|0
4654774|NCT03249909|15982890|P2|Overall Study|Lost to Follow-up|1
4654775|NCT03249909|15982891|P1|Overall Study|Lost to Follow-up|0
4654776|NCT03249909|15982889|P3|Overall Study|Adverse Event|0
4654777|NCT03249909|15982890|P2|Overall Study|Adverse Event|0
4654778|NCT03249909|15982891|P1|Overall Study|Adverse Event|3
4654779|NCT03249909|15982889|P3|Overall Study|Withdrawal by Subject|0
4654780|NCT03249909|15982890|P2|Overall Study|Withdrawal by Subject|0
4654781|NCT03249909|15982891|P1|Overall Study|Withdrawal by Subject|3
4654782|NCT03249454|15982935|P11|Overall Study|Withdrawal by Subject|1
4654783|NCT03249454|15982936|P10|Overall Study|Withdrawal by Subject|1
4654784|NCT03249454|15982937|P9|Overall Study|Withdrawal by Subject|0
4654785|NCT03249454|15982938|P8|Overall Study|Withdrawal by Subject|0
4654786|NCT03249454|15982939|P7|Overall Study|Withdrawal by Subject|0
4654787|NCT03249454|15982940|P6|Overall Study|Withdrawal by Subject|0
4654788|NCT03249454|15982941|P5|Overall Study|Withdrawal by Subject|0
4654789|NCT03249454|15982942|P4|Overall Study|Withdrawal by Subject|0
4654790|NCT03249454|15982943|P3|Overall Study|Withdrawal by Subject|0
4654791|NCT03249454|15982944|P2|Overall Study|Withdrawal by Subject|0
4654792|NCT03249454|15982945|P1|Overall Study|Withdrawal by Subject|0
4654793|NCT03248882|15983033|P5|Overall Study|Withdrawal by Subject|2
4654794|NCT03248882|15983034|P4|Overall Study|Withdrawal by Subject|4
4654795|NCT03248882|15983035|P3|Overall Study|Withdrawal by Subject|3
4654796|NCT03248882|15983036|P2|Overall Study|Withdrawal by Subject|2
4654797|NCT03248882|15983037|P1|Overall Study|Withdrawal by Subject|2
4654798|NCT03248882|15983033|P5|Overall Study|Protocol Violation|1
4654799|NCT03248882|15983034|P4|Overall Study|Protocol Violation|0
4654800|NCT03248882|15983035|P3|Overall Study|Protocol Violation|2
4654801|NCT03248882|15983036|P2|Overall Study|Protocol Violation|0
4654802|NCT03248882|15983037|P1|Overall Study|Protocol Violation|2
4654803|NCT03248882|15983033|P5|Overall Study|Lost to Follow-up|1
4654804|NCT03248882|15983034|P4|Overall Study|Lost to Follow-up|0
4654805|NCT03248882|15983035|P3|Overall Study|Lost to Follow-up|0
4654806|NCT03248882|15983036|P2|Overall Study|Lost to Follow-up|0
4654807|NCT03248882|15983037|P1|Overall Study|Lost to Follow-up|0
4654808|NCT03248882|15983033|P5|Overall Study|Adverse Event|9
4654809|NCT03248882|15983034|P4|Overall Study|Adverse Event|6
4654810|NCT03248882|15983035|P3|Overall Study|Adverse Event|2
4654811|NCT03248882|15983036|P2|Overall Study|Adverse Event|3
4654812|NCT03248882|15983037|P1|Overall Study|Adverse Event|3
4654813|NCT03248492|15983079|P5|Overall Study|Other|0
4654814|NCT03248492|15983080|P4|Overall Study|Other|4
4654815|NCT03248492|15983081|P3|Overall Study|Other|0
4654816|NCT03248492|15983082|P2|Overall Study|Other|1
4654817|NCT03248492|15983083|P1|Overall Study|Other|0
4654818|NCT03248492|15983079|P5|Overall Study|Death|0
4654819|NCT03248492|15983080|P4|Overall Study|Death|6
4654820|NCT03248492|15983081|P3|Overall Study|Death|0
4654821|NCT03248492|15983082|P2|Overall Study|Death|0
4654822|NCT03248492|15983083|P1|Overall Study|Death|1
4654823|NCT03248492|15983079|P5|Overall Study|Physician Decision|0
4654824|NCT03248492|15983080|P4|Overall Study|Physician Decision|2
4654825|NCT03248492|15983081|P3|Overall Study|Physician Decision|1
4654826|NCT03248492|15983082|P2|Overall Study|Physician Decision|0
4654827|NCT03248492|15983083|P1|Overall Study|Physician Decision|1
4654828|NCT03248492|15983079|P5|Overall Study|Withdrawal by Subject|1
4654829|NCT03248492|15983080|P4|Overall Study|Withdrawal by Subject|3
4654830|NCT03248492|15983081|P3|Overall Study|Withdrawal by Subject|0
4654831|NCT03248492|15983082|P2|Overall Study|Withdrawal by Subject|3
4654832|NCT03248492|15983083|P1|Overall Study|Withdrawal by Subject|3
4654833|NCT03248492|15983079|P5|Overall Study|Adverse Event|1
4654834|NCT03248492|15983080|P4|Overall Study|Adverse Event|8
4654835|NCT03248492|15983081|P3|Overall Study|Adverse Event|8
4654836|NCT03248492|15983082|P2|Overall Study|Adverse Event|6
4654837|NCT03248492|15983083|P1|Overall Study|Adverse Event|6
4654838|NCT03248492|15983079|P5|Overall Study|Progressive disease per RECIST v1.1|0
4654839|NCT03248492|15983080|P4|Overall Study|Progressive disease per RECIST v1.1|22
4654840|NCT03248492|15983081|P3|Overall Study|Progressive disease per RECIST v1.1|9
4654841|NCT03248492|15983082|P2|Overall Study|Progressive disease per RECIST v1.1|12
4654842|NCT03248492|15983083|P1|Overall Study|Progressive disease per RECIST v1.1|16
4654843|NCT03248492|15983079|P5|Overall Study|Ongoing|2
4654844|NCT03248492|15983080|P4|Overall Study|Ongoing|85
4654845|NCT03248492|15983081|P3|Overall Study|Ongoing|3
4654846|NCT03248492|15983082|P2|Overall Study|Ongoing|26
4654847|NCT03248492|15983083|P1|Overall Study|Ongoing|23
4654848|NCT03247816|15983149|P1|Overall Study|Missing Feraccru stop date|3
4654849|NCT03247816|15983149|P1|Overall Study|Lost to Follow-up|10
4654850|NCT03247816|15983149|P1|Overall Study|Lack of Efficacy|1
4654851|NCT03247816|15983149|P1|Overall Study|Physician Decision|3
4654852|NCT03247816|15983149|P1|Overall Study|Adverse Event|12
4654853|NCT03247673|15983205|P3|Overall Study|Lost to Follow-up|1
4654854|NCT03247673|15983206|P2|Overall Study|Lost to Follow-up|0
4654855|NCT03247673|15983207|P1|Overall Study|Lost to Follow-up|0
4654856|NCT03247673|15983205|P3|Overall Study|Withdrawal by Subject|3
4654857|NCT03247673|15983206|P2|Overall Study|Withdrawal by Subject|0
4654858|NCT03247673|15983207|P1|Overall Study|Withdrawal by Subject|1
4654859|NCT03246724|15983231|P4|Overall Study|Re-consented to participate|1
4654860|NCT03246724|15983232|P3|Overall Study|Re-consented to participate|0
4654861|NCT03246724|15983233|P2|Overall Study|Re-consented to participate|0
4654862|NCT03246724|15983234|P1|Overall Study|Re-consented to participate|0
4654863|NCT03246724|15983231|P4|Overall Study|Unable to obtain medication timely|1
4654864|NCT03246724|15983232|P3|Overall Study|Unable to obtain medication timely|2
4654865|NCT03246724|15983233|P2|Overall Study|Unable to obtain medication timely|2
4654866|NCT03246724|15983234|P1|Overall Study|Unable to obtain medication timely|0
4654867|NCT03246724|15983231|P4|Overall Study|Transferred to other arm|0
4654868|NCT03246724|15983232|P3|Overall Study|Transferred to other arm|1
4654869|NCT03246724|15983233|P2|Overall Study|Transferred to other arm|0
4654870|NCT03246724|15983234|P1|Overall Study|Transferred to other arm|0
4654871|NCT03246724|15983231|P4|Overall Study|Study completed before surgical date|1
4654872|NCT03246724|15983232|P3|Overall Study|Study completed before surgical date|8
4654873|NCT03246724|15983233|P2|Overall Study|Study completed before surgical date|1
4654874|NCT03246724|15983234|P1|Overall Study|Study completed before surgical date|2
4654875|NCT03246724|15983231|P4|Overall Study|Ineligible on day of surgery|3
4654876|NCT03246724|15983232|P3|Overall Study|Ineligible on day of surgery|0
4654877|NCT03246724|15983233|P2|Overall Study|Ineligible on day of surgery|2
4654878|NCT03246724|15983234|P1|Overall Study|Ineligible on day of surgery|7
4654879|NCT03246724|15983231|P4|Overall Study|Withdrawal by Subject|2
4654880|NCT03246724|15983232|P3|Overall Study|Withdrawal by Subject|4
4654881|NCT03246724|15983233|P2|Overall Study|Withdrawal by Subject|2
4654882|NCT03246724|15983234|P1|Overall Study|Withdrawal by Subject|5
4654883|NCT03246672|15983260|P1|Overall Study|Lost to Follow-up|2
4654884|NCT03246152|15983266|P1|Overall Study|Protocol Violation|1
4654885|NCT03246152|15983266|P1|Overall Study|Lost to Follow-up|2
4654886|NCT03245619|15983298|P17|Part A (Up to Day 22)|Physician Decision|0
4654887|NCT03245619|15983299|P16|Part A (Up to Day 22)|Physician Decision|0
4654888|NCT03245619|15983300|P15|Part A (Up to Day 22)|Physician Decision|0
4654889|NCT03245619|15983301|P14|Part A (Up to Day 22)|Physician Decision|0
4654890|NCT03245619|15983302|P13|Part A (Up to Day 22)|Physician Decision|0
4654891|NCT03245619|15983303|P12|Part A (Up to Day 22)|Physician Decision|0
4654892|NCT03245619|15983304|P11|Part A (Up to Day 22)|Physician Decision|0
4654893|NCT03245619|15983305|P10|Part A (Up to Day 22)|Physician Decision|0
4654894|NCT03245619|15983306|P9|Part A (Up to Day 22)|Physician Decision|0
4654895|NCT03245619|15983307|P8|Part A (Up to Day 22)|Physician Decision|0
4654896|NCT03245619|15983308|P7|Part A (Up to Day 22)|Physician Decision|0
4654897|NCT03245619|15983309|P6|Part A (Up to Day 22)|Physician Decision|0
4654898|NCT03245619|15983310|P5|Part A (Up to Day 22)|Physician Decision|0
4654899|NCT03245619|15983311|P4|Part A (Up to Day 22)|Physician Decision|0
4654900|NCT03245619|15983312|P3|Part A (Up to Day 22)|Physician Decision|6
4654901|NCT03245619|15983313|P2|Part A (Up to Day 22)|Physician Decision|6
4654902|NCT03245619|15983314|P1|Part A (Up to Day 22)|Physician Decision|4
4654903|NCT03245398|15983588|P2|Overall Study|Travelled to another island|0
4654904|NCT03245398|15983589|P1|Overall Study|Travelled to another island|1
4654905|NCT03244800|15983619|P4|Overall Study|Withdrew treatment|1
4654906|NCT03244800|15983620|P3|Overall Study|Withdrew treatment|0
4654907|NCT03244800|15983621|P2|Overall Study|Withdrew treatment|0
4654908|NCT03244800|15983622|P1|Overall Study|Withdrew treatment|0
4654909|NCT03244800|15983619|P4|Overall Study|Adverse Event|1
4654910|NCT03244800|15983620|P3|Overall Study|Adverse Event|0
4654911|NCT03244800|15983621|P2|Overall Study|Adverse Event|1
4654912|NCT03244800|15983622|P1|Overall Study|Adverse Event|0
4654913|NCT03244618|15983682|P2|Overall Study|Withdrawal by Subject|2
4654914|NCT03244618|15983683|P1|Overall Study|Withdrawal by Subject|0
4654915|NCT03244618|15983682|P2|Overall Study|Protocol Violation|3
4654916|NCT03244618|15983683|P1|Overall Study|Protocol Violation|4
4654917|NCT03244618|15983682|P2|Overall Study|Lost to Follow-up|4
4654918|NCT03244618|15983683|P1|Overall Study|Lost to Follow-up|3
4654919|NCT03243305|15983718|P1|Overall Study|Early terminations|267
4654920|NCT03243305|15983718|P1|Overall Study|Study Terminated by Sponsor|1
4654921|NCT03243305|15983718|P1|Overall Study|Study method no longer primary method|12
4654922|NCT03243305|15983718|P1|Overall Study|Protocol Violation|22
4654923|NCT03243305|15983718|P1|Overall Study|Physician Decision|22
4654924|NCT03243305|15983718|P1|Overall Study|No sexually active|26
4654925|NCT03243305|15983718|P1|Overall Study|Adverse Event|23
4654926|NCT03243305|15983718|P1|Overall Study|Non-Compliance with Study Drug|38
4654927|NCT03243305|15983718|P1|Overall Study|Pregnancy|104
4654928|NCT03243305|15983718|P1|Overall Study|Withdrawal by Subject|170
4654929|NCT03243305|15983718|P1|Overall Study|Lost to Follow-up|250
4654930|NCT03243084|15983725|P2|Washout (1-3 Weeks)|Lost to Follow-up|0
4654931|NCT03243084|15983726|P1|Washout (1-3 Weeks)|Lost to Follow-up|1
4654932|NCT03242863|15983742|P6|Study Week 1|Withdrawal by Subject|0
4654933|NCT03242863|15983743|P5|Study Week 1|Withdrawal by Subject|3
4654934|NCT03242863|15983744|P4|Study Week 1|Withdrawal by Subject|0
4654935|NCT03242863|15983745|P3|Study Week 1|Withdrawal by Subject|0
4654936|NCT03242863|15983746|P2|Study Week 1|Withdrawal by Subject|1
4654937|NCT03242863|15983747|P1|Study Week 1|Withdrawal by Subject|0
4654938|NCT03242434|15983770|P2|Overall Study|Death|2
4654939|NCT03242434|15983771|P1|Overall Study|Death|0
4654940|NCT03241368|15983804|P1|Overall Study|Protocol Violation|1
4654941|NCT03241368|15983804|P1|Overall Study|Withdrawal by Subject|6
4654942|NCT03241368|15983804|P1|Overall Study|Physician Decision|6
4654943|NCT03241368|15983804|P1|Overall Study|Lost to Follow-up|1
4654944|NCT03241368|15983804|P1|Overall Study|MRE Stricture or Patency Capsule Failure|25
4654945|NCT03240575|15983815|P4|Overall Study|Other|0
4654946|NCT03240575|15983816|P3|Overall Study|Other|0
4654947|NCT03240575|15983817|P2|Overall Study|Other|1
4654948|NCT03240575|15983818|P1|Overall Study|Other|0
4654949|NCT03240575|15983815|P4|Overall Study|Withdrawal by Subject|1
4654950|NCT03240575|15983816|P3|Overall Study|Withdrawal by Subject|0
4654951|NCT03240575|15983817|P2|Overall Study|Withdrawal by Subject|11
4654952|NCT03240575|15983818|P1|Overall Study|Withdrawal by Subject|2
4654953|NCT03240575|15983815|P4|Overall Study|Adverse Event|1
4654954|NCT03240575|15983816|P3|Overall Study|Adverse Event|0
4654955|NCT03240575|15983817|P2|Overall Study|Adverse Event|2
4654956|NCT03240575|15983818|P1|Overall Study|Adverse Event|0
4654957|NCT03239873|15983840|P2|Overall Study|Protocol Violation|0
4654958|NCT03239873|15983841|P1|Overall Study|Protocol Violation|1
4654959|NCT03239873|15983840|P2|Overall Study|Contraindication to study medication|0
4654960|NCT03239873|15983841|P1|Overall Study|Contraindication to study medication|1
4654961|NCT03239873|15983840|P2|Overall Study|Withdrawal by Subject|0
4654962|NCT03239873|15983841|P1|Overall Study|Withdrawal by Subject|2
4654963|NCT03239873|15983840|P2|Overall Study|Withdrawal by Parent/Guardian|11
4654964|NCT03239873|15983841|P1|Overall Study|Withdrawal by Parent/Guardian|12
4654965|NCT03239873|15983840|P2|Overall Study|Physician Decision|0
4654966|NCT03239873|15983841|P1|Overall Study|Physician Decision|1
4654967|NCT03239873|15983840|P2|Overall Study|Lost to Follow-up|16
4654968|NCT03239873|15983841|P1|Overall Study|Lost to Follow-up|15
4654969|NCT03239483|15984033|P2|Overall Study|Withdrawal by Subject|0
4654970|NCT03239483|15984034|P1|Overall Study|Withdrawal by Subject|1
4654971|NCT03239483|15984033|P2|Overall Study|Lost to Follow-up|0
4654972|NCT03239483|15984034|P1|Overall Study|Lost to Follow-up|1
4654973|NCT03238924|15984055|P2|Overall Study|Withdrawal by Subject|2
4654974|NCT03238924|15984056|P1|Overall Study|Withdrawal by Subject|2
4654975|NCT03238911|15984068|P2|Overall Study|Lost to Follow-up|1
4654976|NCT03238911|15984069|P1|Overall Study|Lost to Follow-up|2
4654977|NCT03238911|15984068|P2|Overall Study|Withdrawal by Subject|2
4654978|NCT03238911|15984069|P1|Overall Study|Withdrawal by Subject|1
4654979|NCT03238781|15984112|P3|Overall Study|Decision by sponsor|0
4654980|NCT03238781|15984113|P2|Overall Study|Decision by sponsor|1
4654981|NCT03238781|15984114|P1|Overall Study|Decision by sponsor|0
4654982|NCT03238781|15984112|P3|Overall Study|Withdrawal by Subject|16
4654983|NCT03238781|15984113|P2|Overall Study|Withdrawal by Subject|14
4654984|NCT03238781|15984114|P1|Overall Study|Withdrawal by Subject|23
4654985|NCT03238781|15984112|P3|Overall Study|Lost to Follow-up|2
4654986|NCT03238781|15984113|P2|Overall Study|Lost to Follow-up|1
4654987|NCT03238781|15984114|P1|Overall Study|Lost to Follow-up|2
4654988|NCT03238781|15984112|P3|Overall Study|Adverse Event|2
4654989|NCT03238781|15984113|P2|Overall Study|Adverse Event|1
4654990|NCT03238781|15984114|P1|Overall Study|Adverse Event|1
4654991|NCT03238352|15984164|P3|Overall Study|Withdrawal by Subject|0
4654992|NCT03238352|15984165|P2|Overall Study|Withdrawal by Subject|1
4654993|NCT03238352|15984166|P1|Overall Study|Withdrawal by Subject|0
4654994|NCT03238352|15984164|P3|Overall Study|Lost to Follow-up|1
4654995|NCT03238352|15984165|P2|Overall Study|Lost to Follow-up|2
4654996|NCT03238352|15984166|P1|Overall Study|Lost to Follow-up|0
4654997|NCT03238001|15984177|P1|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4
4654998|NCT03238001|15984177|P1|Visit 2 (Secondary Endpoint Cohort)|Study completion|1
4654999|NCT03238001|15984177|P1|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3
4655000|NCT03238001|15984177|P1|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3
4655001|NCT03238001|15984177|P1|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2
4655002|NCT03238001|15984177|P1|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16
4655003|NCT03238001|15984177|P1|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2
4655004|NCT03238001|15984177|P1|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2
4655005|NCT03237065|15984306|P2|Overall Study|Unable to obtain venous access|1
4655006|NCT03237065|15984307|P1|Overall Study|Unable to obtain venous access|0
4655007|NCT03237065|15984306|P2|Overall Study|Lost to Follow-up|0
4655008|NCT03237065|15984307|P1|Overall Study|Lost to Follow-up|1
4655009|NCT03237065|15984306|P2|Overall Study|Withdrawal by Subject|0
4655010|NCT03237065|15984307|P1|Overall Study|Withdrawal by Subject|3
4655011|NCT03237065|15984306|P2|Overall Study|Protocol Violation|1
4655012|NCT03237065|15984307|P1|Overall Study|Protocol Violation|0
4655013|NCT03237065|15984306|P2|Overall Study|Adverse Event|2
4655014|NCT03237065|15984307|P1|Overall Study|Adverse Event|0
4655015|NCT03237013|15984350|P3|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37
4655016|NCT03237013|15984351|P2|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30
4655017|NCT03237013|15984352|P1|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43
4655018|NCT03236311|15984401|P2|Overall Study|Adverse Event|1
4655019|NCT03236311|15984402|P1|Overall Study|Adverse Event|0
4655020|NCT03236311|15984401|P2|Overall Study|Study terminated by sponsor|2
4655021|NCT03236311|15984402|P1|Overall Study|Study terminated by sponsor|0
4655022|NCT03235726|15984446|P10|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655023|NCT03235726|15984447|P9|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655024|NCT03235726|15984448|P8|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655025|NCT03235726|15984449|P7|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655026|NCT03235726|15984450|P6|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655027|NCT03235726|15984451|P5|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1
4655028|NCT03235726|15984452|P4|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655029|NCT03235726|15984453|P3|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655030|NCT03235726|15984454|P2|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655031|NCT03235726|15984455|P1|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0
4655032|NCT03235726|15984446|P10|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655033|NCT03235726|15984447|P9|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655034|NCT03235726|15984448|P8|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655035|NCT03235726|15984449|P7|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655036|NCT03235726|15984450|P6|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655037|NCT03235726|15984451|P5|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1
4655038|NCT03235726|15984452|P4|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655039|NCT03235726|15984453|P3|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655040|NCT03235726|15984454|P2|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655041|NCT03235726|15984455|P1|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0
4655042|NCT03235349|15984614|P1|Overall Study|Other|1
4655043|NCT03235349|15984614|P1|Overall Study|Adverse Event|1
4655044|NCT03235284|15984624|P3|Overall Study|Adverse Event|1
4655045|NCT03235284|15984625|P2|Overall Study|Adverse Event|2
4655046|NCT03235284|15984626|P1|Overall Study|Adverse Event|1
4655047|NCT03235115|15984643|P6|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1
4655048|NCT03235115|15984644|P5|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4655049|NCT03235115|15984645|P4|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4655050|NCT03235115|15984646|P3|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4655051|NCT03235115|15984647|P2|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4655052|NCT03235115|15984648|P1|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0
4655053|NCT03235089|15984668|P2|Overall Study|Physician Decision|2
4655054|NCT03235089|15984669|P1|Overall Study|Physician Decision|2
4655055|NCT03235089|15984668|P2|Overall Study|Lost to Follow-up|1
4655056|NCT03235089|15984669|P1|Overall Study|Lost to Follow-up|1
4655057|NCT03235050|15984710|P5|Overall Study|Other reasons|2
4655058|NCT03235050|15984711|P4|Overall Study|Other reasons|1
4655059|NCT03235050|15984712|P3|Overall Study|Other reasons|0
4655060|NCT03235050|15984713|P2|Overall Study|Other reasons|1
4655061|NCT03235050|15984714|P1|Overall Study|Other reasons|0
4655062|NCT03235050|15984710|P5|Overall Study|Withdrawal by Subject|7
4655063|NCT03235050|15984711|P4|Overall Study|Withdrawal by Subject|5
4655064|NCT03235050|15984712|P3|Overall Study|Withdrawal by Subject|2
4655065|NCT03235050|15984713|P2|Overall Study|Withdrawal by Subject|2
4655066|NCT03235050|15984714|P1|Overall Study|Withdrawal by Subject|3
4655067|NCT03235050|15984710|P5|Overall Study|Lost to Follow-up|0
4655068|NCT03235050|15984711|P4|Overall Study|Lost to Follow-up|2
4655069|NCT03235050|15984712|P3|Overall Study|Lost to Follow-up|1
4655070|NCT03235050|15984713|P2|Overall Study|Lost to Follow-up|2
4655071|NCT03235050|15984714|P1|Overall Study|Lost to Follow-up|1
4655072|NCT03235050|15984710|P5|Overall Study|Death|1
4655073|NCT03235050|15984711|P4|Overall Study|Death|2
4655074|NCT03235050|15984712|P3|Overall Study|Death|0
4655075|NCT03235050|15984713|P2|Overall Study|Death|0
4655076|NCT03235050|15984714|P1|Overall Study|Death|0
4655077|NCT03235050|15984710|P5|Overall Study|Adverse Event|1
4655078|NCT03235050|15984711|P4|Overall Study|Adverse Event|4
4655079|NCT03235050|15984712|P3|Overall Study|Adverse Event|1
4655080|NCT03235050|15984713|P2|Overall Study|Adverse Event|0
4655081|NCT03235050|15984714|P1|Overall Study|Adverse Event|0
4655082|NCT03234036|15984776|P4|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
4655083|NCT03234036|15984777|P3|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0
4655084|NCT03234036|15984778|P2|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
4655085|NCT03234036|15984779|P1|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1
4655086|NCT03233529|15984950|P1|Open-Label Period (Day 15 to Day 71)|Adverse Event|1
4655087|NCT03233529|15984950|P1|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1
4655088|NCT03233438|15984994|P2|Overall Study|No recording of dalbavancin|1
4655089|NCT03233438|15984995|P1|Overall Study|No recording of dalbavancin|0
4655090|NCT03233438|15984994|P2|Overall Study|Withdrawal by Subject|1
4655091|NCT03233438|15984995|P1|Overall Study|Withdrawal by Subject|2
4655092|NCT03233438|15984994|P2|Overall Study|Lost to Follow-up|9
4655093|NCT03233438|15984995|P1|Overall Study|Lost to Follow-up|4
4655094|NCT03233308|15985061|P1|Overall Study|Protocol Violation|1
4655095|NCT03233308|15985061|P1|Overall Study|Adverse Event|1
4655096|NCT03233230|15985077|P4|Overall Study|Lost to Follow-up|0
4655097|NCT03233230|15985078|P3|Overall Study|Lost to Follow-up|0
4655098|NCT03233230|15985079|P2|Overall Study|Lost to Follow-up|3
4655099|NCT03233230|15985080|P1|Overall Study|Lost to Follow-up|0
4655100|NCT03233230|15985077|P4|Overall Study|Withdrawal by Subject|1
4655101|NCT03233230|15985078|P3|Overall Study|Withdrawal by Subject|0
4655102|NCT03233230|15985079|P2|Overall Study|Withdrawal by Subject|2
4655103|NCT03233230|15985080|P1|Overall Study|Withdrawal by Subject|2
4655104|NCT03233230|15985077|P4|Overall Study|Other|3
4655105|NCT03233230|15985078|P3|Overall Study|Other|5
4655106|NCT03233230|15985079|P2|Overall Study|Other|5
4655107|NCT03233230|15985080|P1|Overall Study|Other|5
4655108|NCT03233230|15985077|P4|Overall Study|Lack of Efficacy|0
4655109|NCT03233230|15985078|P3|Overall Study|Lack of Efficacy|0
4655110|NCT03233230|15985079|P2|Overall Study|Lack of Efficacy|0
4655111|NCT03233230|15985080|P1|Overall Study|Lack of Efficacy|1
4655112|NCT03233230|15985077|P4|Overall Study|Protocol Violation|1
4655113|NCT03233230|15985078|P3|Overall Study|Protocol Violation|1
4655114|NCT03233230|15985079|P2|Overall Study|Protocol Violation|2
4655115|NCT03233230|15985080|P1|Overall Study|Protocol Violation|1
4655116|NCT03233230|15985077|P4|Overall Study|Adverse Event|3
4655117|NCT03233230|15985078|P3|Overall Study|Adverse Event|6
4655118|NCT03233230|15985079|P2|Overall Study|Adverse Event|3
4655119|NCT03233230|15985080|P1|Overall Study|Adverse Event|6
4655120|NCT03233009|15985272|P1|Overall Study|Lost to Follow-up|1
4655121|NCT03232983|15985315|P4|Period 4|Withdrawal by Subject|0
4655122|NCT03232983|15985316|P3|Period 4|Withdrawal by Subject|0
4655123|NCT03232983|15985317|P2|Period 4|Withdrawal by Subject|0
4655124|NCT03232983|15985318|P1|Period 4|Withdrawal by Subject|1
4655125|NCT03232983|15985315|P4|Washout Period 2|Withdrawal by Subject|1
4655126|NCT03232983|15985316|P3|Washout Period 2|Withdrawal by Subject|0
4655127|NCT03232983|15985317|P2|Washout Period 2|Withdrawal by Subject|0
4655128|NCT03232983|15985318|P1|Washout Period 2|Withdrawal by Subject|0
4655129|NCT03232983|15985315|P4|Washout Period 2|Physician Decision|0
4655130|NCT03232983|15985316|P3|Washout Period 2|Physician Decision|1
4655131|NCT03232983|15985317|P2|Washout Period 2|Physician Decision|0
4655132|NCT03232983|15985318|P1|Washout Period 2|Physician Decision|0
4655133|NCT03232983|15985315|P4|Period 1|Physician Decision|0
4655134|NCT03232983|15985316|P3|Period 1|Physician Decision|1
4655135|NCT03232983|15985317|P2|Period 1|Physician Decision|0
4655136|NCT03232983|15985318|P1|Period 1|Physician Decision|0
4655137|NCT03232567|15985362|P4|Overall Study|Withdrawal by Subject|0
4655138|NCT03232567|15985363|P3|Overall Study|Withdrawal by Subject|0
4655139|NCT03232567|15985364|P2|Overall Study|Withdrawal by Subject|1
4655140|NCT03232567|15985365|P1|Overall Study|Withdrawal by Subject|0
4655141|NCT03232333|15985387|P1|Overall Study|Withdrawal by Subject|2
4655142|NCT03232333|15985387|P1|Overall Study|Lost to Follow-up|4
4655143|NCT03232333|15985387|P1|Overall Study|Infection or Osteomyelitis|9
4655144|NCT03231943|15985404|P13|Part 2|Withdrawal by Subject|0
4655145|NCT03231943|15985405|P12|Part 2|Withdrawal by Subject|1
4655146|NCT03231943|15985406|P11|Part 2|Withdrawal by Subject|0
4655147|NCT03231943|15985407|P10|Part 2|Withdrawal by Subject|0
4655148|NCT03231943|15985408|P9|Part 2|Withdrawal by Subject|0
4655149|NCT03231943|15985409|P8|Part 2|Withdrawal by Subject|0
4655150|NCT03231943|15985410|P7|Part 2|Withdrawal by Subject|0
4655151|NCT03231943|15985411|P6|Part 2|Withdrawal by Subject|0
4655152|NCT03231943|15985412|P5|Part 2|Withdrawal by Subject|0
4655153|NCT03231943|15985413|P4|Part 2|Withdrawal by Subject|0
4655154|NCT03231943|15985414|P3|Part 2|Withdrawal by Subject|0
4655155|NCT03231943|15985415|P2|Part 2|Withdrawal by Subject|0
4655156|NCT03231943|15985416|P1|Part 2|Withdrawal by Subject|0
4655157|NCT03231943|15985404|P13|Part 2|Adverse Event|0
4655158|NCT03231943|15985405|P12|Part 2|Adverse Event|0
4655159|NCT03231943|15985406|P11|Part 2|Adverse Event|1
4655160|NCT03231943|15985407|P10|Part 2|Adverse Event|0
4655161|NCT03231943|15985408|P9|Part 2|Adverse Event|0
4655162|NCT03231943|15985409|P8|Part 2|Adverse Event|0
4655163|NCT03231943|15985410|P7|Part 2|Adverse Event|0
4655164|NCT03231943|15985411|P6|Part 2|Adverse Event|0
4655165|NCT03231943|15985412|P5|Part 2|Adverse Event|0
4655166|NCT03231943|15985413|P4|Part 2|Adverse Event|0
4655167|NCT03231943|15985414|P3|Part 2|Adverse Event|0
4655168|NCT03231943|15985415|P2|Part 2|Adverse Event|0
4655169|NCT03231943|15985416|P1|Part 2|Adverse Event|0
4655170|NCT03231943|15985404|P13|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655171|NCT03231943|15985405|P12|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655172|NCT03231943|15985406|P11|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655173|NCT03231943|15985407|P10|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655174|NCT03231943|15985408|P9|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655175|NCT03231943|15985409|P8|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655176|NCT03231943|15985410|P7|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655177|NCT03231943|15985411|P6|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655178|NCT03231943|15985412|P5|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655179|NCT03231943|15985413|P4|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655180|NCT03231943|15985414|P3|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655181|NCT03231943|15985415|P2|Part 1, Period 3 (up to Day 45)|Adverse Event|0
4655182|NCT03231943|15985416|P1|Part 1, Period 3 (up to Day 45)|Adverse Event|1
4655183|NCT03231943|15985404|P13|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655184|NCT03231943|15985405|P12|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655185|NCT03231943|15985406|P11|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655186|NCT03231943|15985407|P10|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655187|NCT03231943|15985408|P9|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655188|NCT03231943|15985409|P8|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655189|NCT03231943|15985410|P7|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655190|NCT03231943|15985411|P6|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655191|NCT03231943|15985412|P5|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655192|NCT03231943|15985413|P4|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655193|NCT03231943|15985414|P3|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655194|NCT03231943|15985415|P2|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1
4655195|NCT03231943|15985416|P1|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0
4655196|NCT03231943|15985404|P13|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655197|NCT03231943|15985405|P12|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655198|NCT03231943|15985406|P11|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655199|NCT03231943|15985407|P10|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655200|NCT03231943|15985408|P9|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655201|NCT03231943|15985409|P8|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655202|NCT03231943|15985410|P7|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655203|NCT03231943|15985411|P6|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655204|NCT03231943|15985412|P5|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655205|NCT03231943|15985413|P4|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655206|NCT03231943|15985414|P3|Part 1, Period 2 (up to Day 30)|Adverse Event|1
4655207|NCT03231943|15985415|P2|Part 1, Period 2 (up to Day 30)|Adverse Event|1
4655208|NCT03231943|15985416|P1|Part 1, Period 2 (up to Day 30)|Adverse Event|0
4655209|NCT03231800|15985879|P2|Overall Study|reason not provided|0
4655210|NCT03231800|15985880|P1|Overall Study|reason not provided|2
4655211|NCT03231800|15985879|P2|Overall Study|Protocol Violation|1
4655212|NCT03231800|15985880|P1|Overall Study|Protocol Violation|1
4655213|NCT03231800|15985879|P2|Overall Study|Lost to Follow-up|2
4655214|NCT03231800|15985880|P1|Overall Study|Lost to Follow-up|0
4655215|NCT03231709|15985896|P2|Treatment Period 2|Pretreatment Event/Adverse Event|1
4655216|NCT03231709|15985897|P1|Treatment Period 2|Pretreatment Event/Adverse Event|0
4655217|NCT03231709|15985896|P2|Treatment Period 1|Reason not Specified|1
4655218|NCT03231709|15985897|P1|Treatment Period 1|Reason not Specified|0
4655219|NCT03231371|15985915|P1|Overall Study|chose or were ineligible to have MRI|12
4655220|NCT03231371|15985915|P1|Overall Study|Withdrawal by Subject|1
4655221|NCT03231228|15985928|P2|Overall Study|Physician Decision|0
4655222|NCT03231228|15985929|P1|Overall Study|Physician Decision|1
4655223|NCT03231228|15985928|P2|Overall Study|Lost to Follow-up|0
4655224|NCT03231228|15985929|P1|Overall Study|Lost to Follow-up|2
4655225|NCT03230864|15985940|P4|Double Blind Treatment (DBT) Period|Sponsor Decision|0
4655226|NCT03230864|15985941|P3|Double Blind Treatment (DBT) Period|Sponsor Decision|2
4655227|NCT03230864|15985942|P2|Double Blind Treatment (DBT) Period|Sponsor Decision|0
4655228|NCT03230864|15985943|P1|Double Blind Treatment (DBT) Period|Sponsor Decision|0
4655229|NCT03230864|15985940|P4|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
4655230|NCT03230864|15985941|P3|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1
4655231|NCT03230864|15985942|P2|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
4655232|NCT03230864|15985943|P1|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0
4655233|NCT03230864|15985940|P4|Double Blind Treatment (DBT) Period|Adverse Event|1
4655234|NCT03230864|15985941|P3|Double Blind Treatment (DBT) Period|Adverse Event|5
4655235|NCT03230864|15985942|P2|Double Blind Treatment (DBT) Period|Adverse Event|0
4655236|NCT03230864|15985943|P1|Double Blind Treatment (DBT) Period|Adverse Event|0
4655237|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Study Personnel Decision|0
4655238|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Study Personnel Decision|0
4655239|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Study Personnel Decision|0
4655240|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Study Personnel Decision|1
4655241|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Sponsor Decision|0
4655242|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Sponsor Decision|0
4655243|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Sponsor Decision|9
4655244|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Sponsor Decision|9
4655245|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
4655246|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0
4655247|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5
4655248|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14
4655249|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4655250|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4655251|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|1
4655252|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|4
4655253|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
4655254|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
4655255|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Protocol Violation|2
4655256|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Protocol Violation|1
4655257|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4655258|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4655259|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|2
4655260|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4655261|NCT03230864|15985940|P4|Prospective Confirmation (PC) Period|Adverse Event|0
4655262|NCT03230864|15985941|P3|Prospective Confirmation (PC) Period|Adverse Event|0
4655263|NCT03230864|15985942|P2|Prospective Confirmation (PC) Period|Adverse Event|0
4655264|NCT03230864|15985943|P1|Prospective Confirmation (PC) Period|Adverse Event|3
4655265|NCT03229486|15985961|P2|Overall Study|Protocol Violation|1
4655266|NCT03229486|15985962|P1|Overall Study|Protocol Violation|0
4655267|NCT03229109|15986003|P4|Overall Study|Withdrawal by Subject|1
4655268|NCT03229109|15986004|P3|Overall Study|Withdrawal by Subject|0
4655269|NCT03229109|15986005|P2|Overall Study|Withdrawal by Subject|0
4655270|NCT03229109|15986006|P1|Overall Study|Withdrawal by Subject|0
4655271|NCT03228433|15986022|P6|Overall Study|Positive alcohol test|0
4655272|NCT03228433|15986023|P5|Overall Study|Positive alcohol test|0
4655273|NCT03228433|15986024|P4|Overall Study|Positive alcohol test|1
4655274|NCT03228433|15986025|P3|Overall Study|Positive alcohol test|0
4655275|NCT03228433|15986026|P2|Overall Study|Positive alcohol test|0
4655276|NCT03228433|15986027|P1|Overall Study|Positive alcohol test|0
4655277|NCT03228433|15986022|P6|Overall Study|Lost to Follow-up|0
4655278|NCT03228433|15986023|P5|Overall Study|Lost to Follow-up|0
4655279|NCT03228433|15986024|P4|Overall Study|Lost to Follow-up|0
4655280|NCT03228433|15986025|P3|Overall Study|Lost to Follow-up|0
4655281|NCT03228433|15986026|P2|Overall Study|Lost to Follow-up|0
4655282|NCT03228433|15986027|P1|Overall Study|Lost to Follow-up|1
4655283|NCT03228212|15986102|P2|Period 2|Lost to Follow-up|0
4655284|NCT03228212|15986103|P1|Period 2|Lost to Follow-up|1
4655285|NCT03228212|15986102|P2|Period 1|no longer meets eligibility criteria|1
4655286|NCT03228212|15986103|P1|Period 1|no longer meets eligibility criteria|0
4655287|NCT03228212|15986102|P2|Period 1|Adverse Event|0
4655288|NCT03228212|15986103|P1|Period 1|Adverse Event|1
4655289|NCT03227861|15986119|P1|Extension Period (Week 48 to Week 96)|Other|2
4655290|NCT03227861|15986119|P1|Extension Period (Week 48 to Week 96)|Adverse Event|1
4655291|NCT03227861|15986119|P1|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6
4655292|NCT03227861|15986119|P1|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16
4655293|NCT03227861|15986119|P1|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55
4655294|NCT03227861|15986119|P1|Main Study Period (Week 0 to Week 48)|Other|5
4655295|NCT03227861|15986119|P1|Main Study Period (Week 0 to Week 48)|Protocol Violation|1
4655296|NCT03227861|15986119|P1|Main Study Period (Week 0 to Week 48)|Adverse Event|1
4655297|NCT03227861|15986119|P1|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1
4655298|NCT03227861|15986119|P1|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4
4655299|NCT03227692|15986151|P2|Overall Study|Adverse Event|2
4655300|NCT03227692|15986152|P1|Overall Study|Adverse Event|0
4655301|NCT03227692|15986151|P2|Overall Study|Lost to Follow-up|2
4655302|NCT03227692|15986152|P1|Overall Study|Lost to Follow-up|4
4655303|NCT03227692|15986151|P2|Overall Study|Protocol Violation|1
4655304|NCT03227692|15986152|P1|Overall Study|Protocol Violation|1
4655305|NCT03227445|15986180|P4|Period 2 (28 Days)|Withdrawal by Subject|1
4655306|NCT03227445|15986181|P3|Period 2 (28 Days)|Withdrawal by Subject|0
4655307|NCT03227445|15986182|P2|Period 2 (28 Days)|Withdrawal by Subject|1
4655308|NCT03227445|15986183|P1|Period 2 (28 Days)|Withdrawal by Subject|0
4655309|NCT03227445|15986180|P4|Period 2 (28 Days)|Protocol Violation|1
4655310|NCT03227445|15986181|P3|Period 2 (28 Days)|Protocol Violation|0
4655311|NCT03227445|15986182|P2|Period 2 (28 Days)|Protocol Violation|0
4655312|NCT03227445|15986183|P1|Period 2 (28 Days)|Protocol Violation|0
4655313|NCT03227445|15986180|P4|Period 2 (28 Days)|Adverse Event|1
4655314|NCT03227445|15986181|P3|Period 2 (28 Days)|Adverse Event|2
4655315|NCT03227445|15986182|P2|Period 2 (28 Days)|Adverse Event|0
4655316|NCT03227445|15986183|P1|Period 2 (28 Days)|Adverse Event|1
4655317|NCT03227445|15986180|P4|Period 1 (28 Days)|Withdrawal by Subject|1
4655318|NCT03227445|15986181|P3|Period 1 (28 Days)|Withdrawal by Subject|1
4655319|NCT03227445|15986182|P2|Period 1 (28 Days)|Withdrawal by Subject|0
4655320|NCT03227445|15986183|P1|Period 1 (28 Days)|Withdrawal by Subject|0
4655321|NCT03227445|15986180|P4|Period 1 (28 Days)|Protocol Violation|0
4655322|NCT03227445|15986181|P3|Period 1 (28 Days)|Protocol Violation|0
4655323|NCT03227445|15986182|P2|Period 1 (28 Days)|Protocol Violation|0
4655324|NCT03227445|15986183|P1|Period 1 (28 Days)|Protocol Violation|1
4655325|NCT03227445|15986180|P4|Period 1 (28 Days)|Adverse Event|1
4655326|NCT03227445|15986181|P3|Period 1 (28 Days)|Adverse Event|0
4655327|NCT03227445|15986182|P2|Period 1 (28 Days)|Adverse Event|2
4655328|NCT03227445|15986183|P1|Period 1 (28 Days)|Adverse Event|1
4655329|NCT03226769|15986209|P2|Overall Study|Withdrawal by Subject|1
4655330|NCT03226769|15986210|P1|Overall Study|Withdrawal by Subject|0
4655331|NCT03226392|15986224|P2|Overall Study|Subject/Guardian Decision|6
4655332|NCT03226392|15986225|P1|Overall Study|Subject/Guardian Decision|7
4655333|NCT03226392|15986224|P2|Overall Study|Technical Problems|2
4655334|NCT03226392|15986225|P1|Overall Study|Technical Problems|0
4655335|NCT03226392|15986224|P2|Overall Study|Adverse Event|0
4655336|NCT03226392|15986225|P1|Overall Study|Adverse Event|1
4655337|NCT03226392|15986224|P2|Overall Study|Lost to Follow-up|0
4655338|NCT03226392|15986225|P1|Overall Study|Lost to Follow-up|1
4655339|NCT03226392|15986224|P2|Overall Study|Physician Decision|0
4655340|NCT03226392|15986225|P1|Overall Study|Physician Decision|1
4655341|NCT03226392|15986224|P2|Overall Study|Protocol Deviation|0
4655342|NCT03226392|15986225|P1|Overall Study|Protocol Deviation|1
4655343|NCT03226353|15986266|P1|Overall Study|Screen Failure|5
4655344|NCT03226353|15986266|P1|Overall Study|Withdrawal by Subject|1
4655345|NCT03226275|15986290|P4|Treatment Period 1 (8 Days)|Protocol non-compliance|1
4655346|NCT03226275|15986291|P3|Treatment Period 1 (8 Days)|Protocol non-compliance|0
4655347|NCT03226275|15986292|P2|Treatment Period 1 (8 Days)|Protocol non-compliance|0
4655348|NCT03226275|15986293|P1|Treatment Period 1 (8 Days)|Protocol non-compliance|0
4655349|NCT03226275|15986290|P4|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
4655350|NCT03226275|15986291|P3|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1
4655351|NCT03226275|15986292|P2|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
4655352|NCT03226275|15986293|P1|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0
4655353|NCT03226249|15986339|P1|Survival Follow-up|Patients still in follow-up.|30
4655354|NCT03226249|15986339|P1|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29
4655355|NCT03226249|15986339|P1|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1
4655356|NCT03224598|15986409|P3|Overall Study|Other|0
4655357|NCT03224598|15986410|P2|Overall Study|Other|1
4655358|NCT03224598|15986411|P1|Overall Study|Other|0
4655359|NCT03224598|15986409|P3|Overall Study|Lost to Follow-up|0
4655360|NCT03224598|15986410|P2|Overall Study|Lost to Follow-up|2
4655361|NCT03224598|15986411|P1|Overall Study|Lost to Follow-up|0
4655362|NCT03224325|15986437|P7|Overall Study|Withdrawal by Subject|0
4655363|NCT03224325|15986438|P6|Overall Study|Withdrawal by Subject|0
4655364|NCT03224325|15986439|P5|Overall Study|Withdrawal by Subject|0
4655365|NCT03224325|15986440|P4|Overall Study|Withdrawal by Subject|1
4655366|NCT03224325|15986441|P3|Overall Study|Withdrawal by Subject|0
4655367|NCT03224325|15986442|P2|Overall Study|Withdrawal by Subject|0
4655368|NCT03224325|15986443|P1|Overall Study|Withdrawal by Subject|0
4655369|NCT03224325|15986437|P7|Overall Study|Adverse Event|1
4655370|NCT03224325|15986438|P6|Overall Study|Adverse Event|0
4655371|NCT03224325|15986439|P5|Overall Study|Adverse Event|0
4655372|NCT03224325|15986440|P4|Overall Study|Adverse Event|0
4655373|NCT03224325|15986441|P3|Overall Study|Adverse Event|0
4655374|NCT03224325|15986442|P2|Overall Study|Adverse Event|0
4655375|NCT03224325|15986443|P1|Overall Study|Adverse Event|1
4655376|NCT03224130|15986506|P2|Overall Study|consent issue|1
4655377|NCT03224130|15986507|P1|Overall Study|consent issue|0
4655378|NCT03223909|15986528|P3|Overall Study|Protocol Violation|16
4655379|NCT03223909|15986529|P2|Overall Study|Protocol Violation|45
4655380|NCT03223909|15986530|P1|Overall Study|Protocol Violation|48
4655381|NCT03223662|15986559|P1|Overall Study|Study closure|1
4655382|NCT03223662|15986559|P1|Overall Study|Physician Decision|1
4655383|NCT03222583|15986644|P2|Overall Study|Other|3
4655384|NCT03222583|15986645|P1|Overall Study|Other|1
4655385|NCT03222583|15986644|P2|Overall Study|Lost to Follow-up|0
4655386|NCT03222583|15986645|P1|Overall Study|Lost to Follow-up|1
4655387|NCT03222583|15986644|P2|Overall Study|Withdrawal by Subject|3
4655388|NCT03222583|15986645|P1|Overall Study|Withdrawal by Subject|3
4655389|NCT03222141|15986695|P1|Overall Study|Lost to Follow-up|3
4655390|NCT03222141|15986695|P1|Overall Study|Death|15
4655391|NCT03219723|15986867|P1|Overall Study|Protocol Deviation|4
4655392|NCT03219723|15986867|P1|Overall Study|Case Report Forms Uncollected|6
4655393|NCT03219216|15986910|P2|Overall Study|Lost to Follow-up|1
4655394|NCT03219216|15986911|P1|Overall Study|Lost to Follow-up|0
4655395|NCT03218397|15986957|P2|Overall Study|Randomized during laboratory off hours|1
4655396|NCT03218397|15986958|P1|Overall Study|Randomized during laboratory off hours|2
4655397|NCT03218397|15986957|P2|Overall Study|No gram-negative bacilli (GNB)|2
4655398|NCT03218397|15986958|P1|Overall Study|No gram-negative bacilli (GNB)|0
4655399|NCT03218397|15986957|P2|Overall Study|Inaccessible hospital records|5
4655400|NCT03218397|15986958|P1|Overall Study|Inaccessible hospital records|2
4655401|NCT03218397|15986957|P2|Overall Study|Mixed culture|2
4655402|NCT03218397|15986958|P1|Overall Study|Mixed culture|2
4655403|NCT03218397|15986957|P2|Overall Study|Comfort care and mixed culture|1
4655404|NCT03218397|15986958|P1|Overall Study|Comfort care and mixed culture|0
4655405|NCT03218397|15986957|P2|Overall Study|Comfort care and positive blood culture|0
4655406|NCT03218397|15986958|P1|Overall Study|Comfort care and positive blood culture|1
4655407|NCT03218397|15986957|P2|Overall Study|Comfort care|5
4655408|NCT03218397|15986958|P1|Overall Study|Comfort care|8
4655409|NCT03218397|15986957|P2|Overall Study|Prior positive blood culture|13
4655410|NCT03218397|15986958|P1|Overall Study|Prior positive blood culture|8
4655411|NCT03217968|15986990|P1|Overall Study|Protocol Violation|6
4655412|NCT03217968|15986990|P1|Overall Study|Lost to Follow-up|1
4655413|NCT03217968|15986990|P1|Overall Study|Withdrawal by Subject|4
4655414|NCT03217175|15986999|P2|Overall Study|Physician Decision|1
4655415|NCT03217175|15987000|P1|Overall Study|Physician Decision|4
4655416|NCT03216850|15987095|P1|Overall Study|Pre-analytical error|6
4655417|NCT03216746|15987103|P4|Overall Study|Lost to Follow-up|6
4655418|NCT03216746|15987104|P3|Overall Study|Lost to Follow-up|5
4655419|NCT03216746|15987105|P2|Overall Study|Lost to Follow-up|8
4655420|NCT03216746|15987106|P1|Overall Study|Lost to Follow-up|6
4655421|NCT03216265|15987147|P3|Overall Study|Withdrawal by Subject|1
4655422|NCT03216265|15987148|P2|Overall Study|Withdrawal by Subject|0
4655423|NCT03216265|15987149|P1|Overall Study|Withdrawal by Subject|0
4655424|NCT03216265|15987147|P3|Overall Study|Lost to Follow-up|0
4655425|NCT03216265|15987148|P2|Overall Study|Lost to Follow-up|1
4655426|NCT03216265|15987149|P1|Overall Study|Lost to Follow-up|0
4655427|NCT03216265|15987147|P3|Overall Study|Adverse Event|2
4655428|NCT03216265|15987148|P2|Overall Study|Adverse Event|0
4655429|NCT03216265|15987149|P1|Overall Study|Adverse Event|2
4655430|NCT03215758|15987240|P2|Overall Study|Subject/Guardian Decision|3
4655431|NCT03215758|15987241|P1|Overall Study|Subject/Guardian Decision|3
4655432|NCT03215758|15987240|P2|Overall Study|Adverse Event|2
4655433|NCT03215758|15987241|P1|Overall Study|Adverse Event|1
4655434|NCT03215758|15987240|P2|Overall Study|Death|1
4655435|NCT03215758|15987241|P1|Overall Study|Death|0
4655436|NCT03215758|15987240|P2|Overall Study|Physician Decision|1
4655437|NCT03215758|15987241|P1|Overall Study|Physician Decision|0
4655438|NCT03215758|15987240|P2|Overall Study|Protocol deviation|1
4655439|NCT03215758|15987241|P1|Overall Study|Protocol deviation|0
4655440|NCT03215758|15987240|P2|Overall Study|Technical Problems|0
4655441|NCT03215758|15987241|P1|Overall Study|Technical Problems|1
4655442|NCT03215706|15987255|P2|Treatment Period|Ongoing in the treatment period|43
4655443|NCT03215706|15987256|P1|Treatment Period|Ongoing in the treatment period|105
4655444|NCT03215706|15987255|P2|Treatment Period|Other Reasons|5
4655445|NCT03215706|15987256|P1|Treatment Period|Other Reasons|4
4655446|NCT03215706|15987255|P2|Treatment Period|Lost to Follow-up|1
4655447|NCT03215706|15987256|P1|Treatment Period|Lost to Follow-up|0
4655448|NCT03215706|15987255|P2|Treatment Period|Participant withdrew consent|4
4655449|NCT03215706|15987256|P1|Treatment Period|Participant withdrew consent|3
4655450|NCT03215706|15987255|P2|Treatment Period|Request to D/C treatment|6
4655451|NCT03215706|15987256|P1|Treatment Period|Request to D/C treatment|1
4655452|NCT03215706|15987255|P2|Treatment Period|Adverse event unrelated to study drug|23
4655453|NCT03215706|15987256|P1|Treatment Period|Adverse event unrelated to study drug|24
4655454|NCT03215706|15987255|P2|Treatment Period|Death|1
4655455|NCT03215706|15987256|P1|Treatment Period|Death|2
4655456|NCT03215706|15987255|P2|Treatment Period|Study Drug Toxicity|21
4655457|NCT03215706|15987256|P1|Treatment Period|Study Drug Toxicity|53
4655458|NCT03215706|15987255|P2|Treatment Period|Disease Progression|142
4655459|NCT03215706|15987256|P1|Treatment Period|Disease Progression|150
4655460|NCT03215706|15987255|P2|Randomization|other reasons|2
4655461|NCT03215706|15987256|P1|Randomization|other reasons|0
4655462|NCT03215706|15987255|P2|Randomization|no longer meets study criteria|4
4655463|NCT03215706|15987256|P1|Randomization|no longer meets study criteria|1
4655464|NCT03215706|15987255|P2|Randomization|participant withdrew consent|3
4655465|NCT03215706|15987256|P1|Randomization|participant withdrew consent|1
4655466|NCT03215706|15987255|P2|Randomization|Adverse Event unrelated to study drug|0
4655467|NCT03215706|15987256|P1|Randomization|Adverse Event unrelated to study drug|1
4655468|NCT03214952|15987276|P1|Overall Study|Case Report Forms Uncollected|13
4655469|NCT03214952|15987276|P1|Overall Study|Protocol Deviation|45
4655470|NCT03214588|15987291|P3|Overall Study|Reason Not Specified|0
4655471|NCT03214588|15987292|P2|Overall Study|Reason Not Specified|1
4655472|NCT03214588|15987293|P1|Overall Study|Reason Not Specified|0
4655473|NCT03214588|15987291|P3|Overall Study|Adverse Event|2
4655474|NCT03214588|15987292|P2|Overall Study|Adverse Event|0
4655475|NCT03214588|15987293|P1|Overall Study|Adverse Event|1
4655476|NCT03214406|15987360|P2|Overall Study|Lost to Follow-up|2
4655477|NCT03214406|15987361|P1|Overall Study|Lost to Follow-up|0
4655478|NCT03214406|15987360|P2|Overall Study|Withdrawal by Subject|0
4655479|NCT03214406|15987361|P1|Overall Study|Withdrawal by Subject|1
4655480|NCT03214406|15987360|P2|Overall Study|did not meet enrollment criteria|13
4655481|NCT03214406|15987361|P1|Overall Study|did not meet enrollment criteria|9
4655482|NCT03214380|15987375|P6|Treatment Period|Treatment Interruption|0
4655483|NCT03214380|15987376|P5|Treatment Period|Treatment Interruption|0
4655484|NCT03214380|15987377|P4|Treatment Period|Treatment Interruption|0
4655485|NCT03214380|15987378|P3|Treatment Period|Treatment Interruption|1
4655486|NCT03214380|15987379|P2|Treatment Period|Treatment Interruption|0
4655487|NCT03214380|15987380|P1|Treatment Period|Treatment Interruption|0
4655488|NCT03214380|15987375|P6|Treatment Period|Participant schedule|0
4655489|NCT03214380|15987376|P5|Treatment Period|Participant schedule|0
4655490|NCT03214380|15987377|P4|Treatment Period|Participant schedule|0
4655491|NCT03214380|15987378|P3|Treatment Period|Participant schedule|1
4655492|NCT03214380|15987379|P2|Treatment Period|Participant schedule|0
4655493|NCT03214380|15987380|P1|Treatment Period|Participant schedule|0
4655494|NCT03214380|15987375|P6|Treatment Period|Lost to Follow-up|0
4655495|NCT03214380|15987376|P5|Treatment Period|Lost to Follow-up|0
4655496|NCT03214380|15987377|P4|Treatment Period|Lost to Follow-up|0
4655497|NCT03214380|15987378|P3|Treatment Period|Lost to Follow-up|3
4655498|NCT03214380|15987379|P2|Treatment Period|Lost to Follow-up|6
4655499|NCT03214380|15987380|P1|Treatment Period|Lost to Follow-up|0
4655500|NCT03214380|15987375|P6|Treatment Period|Death|0
4655501|NCT03214380|15987376|P5|Treatment Period|Death|0
4655502|NCT03214380|15987377|P4|Treatment Period|Death|0
4655503|NCT03214380|15987378|P3|Treatment Period|Death|2
4655504|NCT03214380|15987379|P2|Treatment Period|Death|1
4655505|NCT03214380|15987380|P1|Treatment Period|Death|0
4655506|NCT03214380|15987375|P6|Treatment Period|Withdrawal by Subject|11
4655507|NCT03214380|15987376|P5|Treatment Period|Withdrawal by Subject|7
4655508|NCT03214380|15987377|P4|Treatment Period|Withdrawal by Subject|0
4655509|NCT03214380|15987378|P3|Treatment Period|Withdrawal by Subject|8
4655510|NCT03214380|15987379|P2|Treatment Period|Withdrawal by Subject|10
4655511|NCT03214380|15987380|P1|Treatment Period|Withdrawal by Subject|0
4655512|NCT03214380|15987375|P6|Treatment Period|Non-Compliance with Study Drug|0
4655513|NCT03214380|15987376|P5|Treatment Period|Non-Compliance with Study Drug|1
4655514|NCT03214380|15987377|P4|Treatment Period|Non-Compliance with Study Drug|0
4655515|NCT03214380|15987378|P3|Treatment Period|Non-Compliance with Study Drug|0
4655516|NCT03214380|15987379|P2|Treatment Period|Non-Compliance with Study Drug|0
4655517|NCT03214380|15987380|P1|Treatment Period|Non-Compliance with Study Drug|0
4655518|NCT03214380|15987375|P6|Treatment Period|Adverse Event|0
4655519|NCT03214380|15987376|P5|Treatment Period|Adverse Event|1
4655520|NCT03214380|15987377|P4|Treatment Period|Adverse Event|0
4655521|NCT03214380|15987378|P3|Treatment Period|Adverse Event|1
4655522|NCT03214380|15987379|P2|Treatment Period|Adverse Event|1
4655523|NCT03214380|15987380|P1|Treatment Period|Adverse Event|0
4655524|NCT03214380|15987375|P6|Lead-in|Participant Schedule|0
4655525|NCT03214380|15987376|P5|Lead-in|Participant Schedule|0
4655526|NCT03214380|15987377|P4|Lead-in|Participant Schedule|0
4655527|NCT03214380|15987378|P3|Lead-in|Participant Schedule|0
4655528|NCT03214380|15987379|P2|Lead-in|Participant Schedule|0
4655529|NCT03214380|15987380|P1|Lead-in|Participant Schedule|2
4655530|NCT03214380|15987375|P6|Lead-in|Non Compliance|0
4655531|NCT03214380|15987376|P5|Lead-in|Non Compliance|0
4655532|NCT03214380|15987377|P4|Lead-in|Non Compliance|0
4655533|NCT03214380|15987378|P3|Lead-in|Non Compliance|0
4655534|NCT03214380|15987379|P2|Lead-in|Non Compliance|0
4655535|NCT03214380|15987380|P1|Lead-in|Non Compliance|1
4655536|NCT03214380|15987375|P6|Lead-in|Natural Disaster|0
4655537|NCT03214380|15987376|P5|Lead-in|Natural Disaster|0
4655538|NCT03214380|15987377|P4|Lead-in|Natural Disaster|0
4655539|NCT03214380|15987378|P3|Lead-in|Natural Disaster|0
4655540|NCT03214380|15987379|P2|Lead-in|Natural Disaster|0
4655541|NCT03214380|15987380|P1|Lead-in|Natural Disaster|9
4655542|NCT03214380|15987375|P6|Lead-in|Family Emergency|0
4655543|NCT03214380|15987376|P5|Lead-in|Family Emergency|0
4655544|NCT03214380|15987377|P4|Lead-in|Family Emergency|0
4655545|NCT03214380|15987378|P3|Lead-in|Family Emergency|0
4655546|NCT03214380|15987379|P2|Lead-in|Family Emergency|0
4655547|NCT03214380|15987380|P1|Lead-in|Family Emergency|1
4655548|NCT03214380|15987375|P6|Lead-in|Withdrawal by Subject|0
4655549|NCT03214380|15987376|P5|Lead-in|Withdrawal by Subject|0
4655550|NCT03214380|15987377|P4|Lead-in|Withdrawal by Subject|14
4655551|NCT03214380|15987378|P3|Lead-in|Withdrawal by Subject|0
4655552|NCT03214380|15987379|P2|Lead-in|Withdrawal by Subject|0
4655553|NCT03214380|15987380|P1|Lead-in|Withdrawal by Subject|41
4655554|NCT03214380|15987375|P6|Lead-in|Protocol Deviation|0
4655555|NCT03214380|15987376|P5|Lead-in|Protocol Deviation|0
4655556|NCT03214380|15987377|P4|Lead-in|Protocol Deviation|3
4655557|NCT03214380|15987378|P3|Lead-in|Protocol Deviation|0
4655558|NCT03214380|15987379|P2|Lead-in|Protocol Deviation|0
4655559|NCT03214380|15987380|P1|Lead-in|Protocol Deviation|7
4655560|NCT03214380|15987375|P6|Lead-in|Physician Decision|0
4655561|NCT03214380|15987376|P5|Lead-in|Physician Decision|0
4655562|NCT03214380|15987377|P4|Lead-in|Physician Decision|0
4655563|NCT03214380|15987378|P3|Lead-in|Physician Decision|0
4655564|NCT03214380|15987379|P2|Lead-in|Physician Decision|0
4655565|NCT03214380|15987380|P1|Lead-in|Physician Decision|6
4655566|NCT03214380|15987375|P6|Lead-in|Eligibility Criteria|0
4655567|NCT03214380|15987376|P5|Lead-in|Eligibility Criteria|0
4655568|NCT03214380|15987377|P4|Lead-in|Eligibility Criteria|0
4655569|NCT03214380|15987378|P3|Lead-in|Eligibility Criteria|0
4655570|NCT03214380|15987379|P2|Lead-in|Eligibility Criteria|0
4655571|NCT03214380|15987380|P1|Lead-in|Eligibility Criteria|3
4655572|NCT03214380|15987375|P6|Lead-in|Lost to Follow-up|0
4655573|NCT03214380|15987376|P5|Lead-in|Lost to Follow-up|0
4655574|NCT03214380|15987377|P4|Lead-in|Lost to Follow-up|1
4655575|NCT03214380|15987378|P3|Lead-in|Lost to Follow-up|0
4655576|NCT03214380|15987379|P2|Lead-in|Lost to Follow-up|0
4655577|NCT03214380|15987380|P1|Lead-in|Lost to Follow-up|4
4655578|NCT03214380|15987375|P6|Lead-in|Adverse Event|0
4655579|NCT03214380|15987376|P5|Lead-in|Adverse Event|0
4655580|NCT03214380|15987377|P4|Lead-in|Adverse Event|1
4655581|NCT03214380|15987378|P3|Lead-in|Adverse Event|0
4655582|NCT03214380|15987379|P2|Lead-in|Adverse Event|0
4655583|NCT03214380|15987380|P1|Lead-in|Adverse Event|3
4655584|NCT03214367|15987416|P8|Treatment Period|Withdrawal by Subject|1
4655585|NCT03214367|15987417|P7|Treatment Period|Withdrawal by Subject|1
4655586|NCT03214367|15987418|P6|Treatment Period|Withdrawal by Subject|1
4655587|NCT03214367|15987419|P5|Treatment Period|Withdrawal by Subject|0
4655588|NCT03214367|15987420|P4|Treatment Period|Withdrawal by Subject|14
4655589|NCT03214367|15987421|P3|Treatment Period|Withdrawal by Subject|23
4655590|NCT03214367|15987422|P2|Treatment Period|Withdrawal by Subject|20
4655591|NCT03214367|15987423|P1|Treatment Period|Withdrawal by Subject|0
4655592|NCT03214367|15987416|P8|Treatment Period|Protocol Violation|0
4655593|NCT03214367|15987417|P7|Treatment Period|Protocol Violation|0
4655594|NCT03214367|15987418|P6|Treatment Period|Protocol Violation|0
4655595|NCT03214367|15987419|P5|Treatment Period|Protocol Violation|0
4655596|NCT03214367|15987420|P4|Treatment Period|Protocol Violation|0
4655597|NCT03214367|15987421|P3|Treatment Period|Protocol Violation|0
4655598|NCT03214367|15987422|P2|Treatment Period|Protocol Violation|3
4655599|NCT03214367|15987423|P1|Treatment Period|Protocol Violation|0
4655600|NCT03214367|15987416|P8|Treatment Period|Physician Decision|0
4655601|NCT03214367|15987417|P7|Treatment Period|Physician Decision|0
4655602|NCT03214367|15987418|P6|Treatment Period|Physician Decision|0
4655603|NCT03214367|15987419|P5|Treatment Period|Physician Decision|0
4655604|NCT03214367|15987420|P4|Treatment Period|Physician Decision|0
4655605|NCT03214367|15987421|P3|Treatment Period|Physician Decision|2
4655606|NCT03214367|15987422|P2|Treatment Period|Physician Decision|1
4655607|NCT03214367|15987423|P1|Treatment Period|Physician Decision|0
4655608|NCT03214367|15987416|P8|Treatment Period|Sponsor Decision|0
4655609|NCT03214367|15987417|P7|Treatment Period|Sponsor Decision|0
4655610|NCT03214367|15987418|P6|Treatment Period|Sponsor Decision|0
4655611|NCT03214367|15987419|P5|Treatment Period|Sponsor Decision|0
4655612|NCT03214367|15987420|P4|Treatment Period|Sponsor Decision|0
4655613|NCT03214367|15987421|P3|Treatment Period|Sponsor Decision|0
4655614|NCT03214367|15987422|P2|Treatment Period|Sponsor Decision|3
4655615|NCT03214367|15987423|P1|Treatment Period|Sponsor Decision|0
4655616|NCT03214367|15987416|P8|Treatment Period|Lost to Follow-up|0
4655617|NCT03214367|15987417|P7|Treatment Period|Lost to Follow-up|1
4655618|NCT03214367|15987418|P6|Treatment Period|Lost to Follow-up|2
4655619|NCT03214367|15987419|P5|Treatment Period|Lost to Follow-up|0
4655620|NCT03214367|15987420|P4|Treatment Period|Lost to Follow-up|2
4655621|NCT03214367|15987421|P3|Treatment Period|Lost to Follow-up|3
4655622|NCT03214367|15987422|P2|Treatment Period|Lost to Follow-up|5
4655623|NCT03214367|15987423|P1|Treatment Period|Lost to Follow-up|0
4655624|NCT03214367|15987416|P8|Treatment Period|Death|0
4655625|NCT03214367|15987417|P7|Treatment Period|Death|0
4655626|NCT03214367|15987418|P6|Treatment Period|Death|0
4655627|NCT03214367|15987419|P5|Treatment Period|Death|0
4655628|NCT03214367|15987420|P4|Treatment Period|Death|1
4655629|NCT03214367|15987421|P3|Treatment Period|Death|1
4655630|NCT03214367|15987422|P2|Treatment Period|Death|1
4655631|NCT03214367|15987423|P1|Treatment Period|Death|0
4655632|NCT03214367|15987416|P8|Treatment Period|Adverse Event|0
4655633|NCT03214367|15987417|P7|Treatment Period|Adverse Event|0
4655634|NCT03214367|15987418|P6|Treatment Period|Adverse Event|0
4655635|NCT03214367|15987419|P5|Treatment Period|Adverse Event|0
4655636|NCT03214367|15987420|P4|Treatment Period|Adverse Event|2
4655637|NCT03214367|15987421|P3|Treatment Period|Adverse Event|4
4655638|NCT03214367|15987422|P2|Treatment Period|Adverse Event|1
4655639|NCT03214367|15987423|P1|Treatment Period|Adverse Event|0
4655640|NCT03214367|15987416|P8|Lead-in Period|Treatment Interruption|0
4655641|NCT03214367|15987417|P7|Lead-in Period|Treatment Interruption|0
4655642|NCT03214367|15987418|P6|Lead-in Period|Treatment Interruption|0
4655643|NCT03214367|15987419|P5|Lead-in Period|Treatment Interruption|0
4655644|NCT03214367|15987420|P4|Lead-in Period|Treatment Interruption|0
4655645|NCT03214367|15987421|P3|Lead-in Period|Treatment Interruption|0
4655646|NCT03214367|15987422|P2|Lead-in Period|Treatment Interruption|0
4655647|NCT03214367|15987423|P1|Lead-in Period|Treatment Interruption|1
4655648|NCT03214367|15987416|P8|Lead-in Period|Protocol Violation|0
4655649|NCT03214367|15987417|P7|Lead-in Period|Protocol Violation|0
4655650|NCT03214367|15987418|P6|Lead-in Period|Protocol Violation|0
4655651|NCT03214367|15987419|P5|Lead-in Period|Protocol Violation|0
4655652|NCT03214367|15987420|P4|Lead-in Period|Protocol Violation|0
4655653|NCT03214367|15987421|P3|Lead-in Period|Protocol Violation|0
4655654|NCT03214367|15987422|P2|Lead-in Period|Protocol Violation|0
4655655|NCT03214367|15987423|P1|Lead-in Period|Protocol Violation|5
4655656|NCT03214367|15987416|P8|Lead-in Period|Physician Decision|0
4655657|NCT03214367|15987417|P7|Lead-in Period|Physician Decision|0
4655658|NCT03214367|15987418|P6|Lead-in Period|Physician Decision|0
4655659|NCT03214367|15987419|P5|Lead-in Period|Physician Decision|0
4655660|NCT03214367|15987420|P4|Lead-in Period|Physician Decision|0
4655661|NCT03214367|15987421|P3|Lead-in Period|Physician Decision|0
4655662|NCT03214367|15987422|P2|Lead-in Period|Physician Decision|0
4655663|NCT03214367|15987423|P1|Lead-in Period|Physician Decision|12
4655664|NCT03214367|15987416|P8|Lead-in Period|Sponsor Decision|0
4655665|NCT03214367|15987417|P7|Lead-in Period|Sponsor Decision|0
4655666|NCT03214367|15987418|P6|Lead-in Period|Sponsor Decision|0
4655667|NCT03214367|15987419|P5|Lead-in Period|Sponsor Decision|0
4655668|NCT03214367|15987420|P4|Lead-in Period|Sponsor Decision|0
4655669|NCT03214367|15987421|P3|Lead-in Period|Sponsor Decision|0
4655670|NCT03214367|15987422|P2|Lead-in Period|Sponsor Decision|0
4655671|NCT03214367|15987423|P1|Lead-in Period|Sponsor Decision|11
4655672|NCT03214367|15987416|P8|Lead-in Period|Lost to Follow-up|0
4655673|NCT03214367|15987417|P7|Lead-in Period|Lost to Follow-up|0
4655674|NCT03214367|15987418|P6|Lead-in Period|Lost to Follow-up|0
4655675|NCT03214367|15987419|P5|Lead-in Period|Lost to Follow-up|0
4655676|NCT03214367|15987420|P4|Lead-in Period|Lost to Follow-up|0
4655677|NCT03214367|15987421|P3|Lead-in Period|Lost to Follow-up|0
4655678|NCT03214367|15987422|P2|Lead-in Period|Lost to Follow-up|0
4655679|NCT03214367|15987423|P1|Lead-in Period|Lost to Follow-up|12
4655680|NCT03214367|15987416|P8|Lead-in Period|Adverse Event|0
4655681|NCT03214367|15987417|P7|Lead-in Period|Adverse Event|0
4655682|NCT03214367|15987418|P6|Lead-in Period|Adverse Event|0
4655683|NCT03214367|15987419|P5|Lead-in Period|Adverse Event|0
4655684|NCT03214367|15987420|P4|Lead-in Period|Adverse Event|0
4655685|NCT03214367|15987421|P3|Lead-in Period|Adverse Event|0
4655686|NCT03214367|15987422|P2|Lead-in Period|Adverse Event|0
4655687|NCT03214367|15987423|P1|Lead-in Period|Adverse Event|3
4655688|NCT03214367|15987416|P8|Lead-in Period|Withdrawal by Subject|0
4655689|NCT03214367|15987417|P7|Lead-in Period|Withdrawal by Subject|0
4655690|NCT03214367|15987418|P6|Lead-in Period|Withdrawal by Subject|0
4655691|NCT03214367|15987419|P5|Lead-in Period|Withdrawal by Subject|2
4655692|NCT03214367|15987420|P4|Lead-in Period|Withdrawal by Subject|0
4655693|NCT03214367|15987421|P3|Lead-in Period|Withdrawal by Subject|0
4655694|NCT03214367|15987422|P2|Lead-in Period|Withdrawal by Subject|0
4655695|NCT03214367|15987423|P1|Lead-in Period|Withdrawal by Subject|50
4655696|NCT03214224|15987468|P1|Overall Study|Practice controls or therapists|6
4655697|NCT03214224|15987468|P1|Overall Study|Withdrawal by Subject|2
4655698|NCT03214224|15987468|P1|Overall Study|Protocol Violation|1
4655699|NCT03214094|15987477|P1|Overall Study|Protocol Deviation|46
4655700|NCT03214094|15987477|P1|Overall Study|Case Report Forms Uncollected|14
4655701|NCT03214081|15987485|P1|Overall Study|Protocol Deviation|54
4655702|NCT03214081|15987485|P1|Overall Study|Case Report Forms Uncollected|9
4655703|NCT03213626|15987500|P1|Overall Study|Progressive Disease|6
4655704|NCT03213626|15987500|P1|Overall Study|Adverse Event|1
4655705|NCT03213509|15987510|P2|Overall Study|Did not consent for verbal autopsy|5
4655706|NCT03213509|15987511|P1|Overall Study|Did not consent for verbal autopsy|4
4655707|NCT03213366|15987524|P2|Overall Study|Lost to Follow-up|4
4655708|NCT03213366|15987525|P1|Overall Study|Lost to Follow-up|9
4655709|NCT03212690|15987551|P1|Overall Study|Protocol Violation|1
4655710|NCT03212521|15987599|P1|Overall Study|Other|1
4655711|NCT03212521|15987599|P1|Overall Study|Withdrawal by Subject|1
4655712|NCT03212521|15987599|P1|Overall Study|Lost to Follow-up|4
4655713|NCT03212521|15987599|P1|Overall Study|Adverse Event|1
4655714|NCT03212365|15987608|P2|Overall Study|developed acute renal failure|1
4655715|NCT03212365|15987609|P1|Overall Study|developed acute renal failure|0
4655716|NCT03212365|15987608|P2|Overall Study|Withdrawal by Subject|1
4655717|NCT03212365|15987609|P1|Overall Study|Withdrawal by Subject|0
4655718|NCT03212365|15987608|P2|Overall Study|Required epidural placement|0
4655719|NCT03212365|15987609|P1|Overall Study|Required epidural placement|1
4655720|NCT03212365|15987608|P2|Overall Study|Medication distribution error|0
4655721|NCT03212365|15987609|P1|Overall Study|Medication distribution error|1
4655722|NCT03212365|15987608|P2|Overall Study|Unexpected return to OR|1
4655723|NCT03212365|15987609|P1|Overall Study|Unexpected return to OR|1
4655724|NCT03212365|15987608|P2|Overall Study|Initiated heparin infusion on floor|1
4655725|NCT03212365|15987609|P1|Overall Study|Initiated heparin infusion on floor|1
4655726|NCT03212365|15987608|P2|Overall Study|Refused study medication|0
4655727|NCT03212365|15987609|P1|Overall Study|Refused study medication|3
4655728|NCT03212365|15987608|P2|Overall Study|Bled requiring enoxaparin cessation|2
4655729|NCT03212365|15987609|P1|Overall Study|Bled requiring enoxaparin cessation|4
4655730|NCT03212365|15987608|P2|Overall Study|Discharged prior to Xa level|8
4655731|NCT03212365|15987609|P1|Overall Study|Discharged prior to Xa level|12
4655732|NCT03212326|15987621|P1|Overall Study|Physician Decision|4
4655733|NCT03212261|15987626|P1|Overall Study|Too busy/ No time|5
4655734|NCT03212261|15987626|P1|Overall Study|Family Emergency|1
4655735|NCT03212261|15987626|P1|Overall Study|Lost to Follow-up|7
4655736|NCT03212261|15987626|P1|Overall Study|Tech Trouble- No first study visit|1
4655737|NCT03212261|15987626|P1|Overall Study|Became ineligible d/t tech|2
4655738|NCT03212144|15987634|P2|Second Sequence (4 Weeks)|Lost to Follow-up|1
4655739|NCT03212144|15987635|P1|Second Sequence (4 Weeks)|Lost to Follow-up|1
4655740|NCT03212144|15987634|P2|First Sequence (4 Weeks)|Lost to Follow-up|0
4655741|NCT03212144|15987635|P1|First Sequence (4 Weeks)|Lost to Follow-up|1
4655742|NCT03211858|15987643|P2|Overall Study|Other than specified above|21
4655743|NCT03211858|15987644|P1|Overall Study|Other than specified above|22
4655744|NCT03211858|15987643|P2|Overall Study|Non-serious Hypoglycemia|0
4655745|NCT03211858|15987644|P1|Overall Study|Non-serious Hypoglycemia|1
4655746|NCT03211858|15987643|P2|Overall Study|Poor compliance to protocol|2
4655747|NCT03211858|15987644|P1|Overall Study|Poor compliance to protocol|6
4655748|NCT03211858|15987643|P2|Overall Study|Lack of Efficacy|4
4655749|NCT03211858|15987644|P1|Overall Study|Lack of Efficacy|0
4655750|NCT03211858|15987643|P2|Overall Study|Adverse Event|6
4655751|NCT03211858|15987644|P1|Overall Study|Adverse Event|8
4655752|NCT03211156|15987696|P2|Overall Study|Adverse Event|0
4655753|NCT03211156|15987697|P1|Overall Study|Adverse Event|1
4655754|NCT03211156|15987696|P2|Overall Study|Lost to Follow-up|1
4655755|NCT03211156|15987697|P1|Overall Study|Lost to Follow-up|1
4655756|NCT03211156|15987696|P2|Overall Study|Withdrawal by Subject|2
4655757|NCT03211156|15987697|P1|Overall Study|Withdrawal by Subject|0
4655758|NCT03210961|15987728|P15|Overall Study|Other|0
4655759|NCT03210961|15987729|P14|Overall Study|Other|2
4655760|NCT03210961|15987730|P13|Overall Study|Other|2
4655761|NCT03210961|15987731|P12|Overall Study|Other|0
4655762|NCT03210961|15987732|P11|Overall Study|Other|1
4655763|NCT03210961|15987733|P10|Overall Study|Other|0
4655764|NCT03210961|15987734|P9|Overall Study|Other|0
4655765|NCT03210961|15987735|P8|Overall Study|Other|0
4655766|NCT03210961|15987736|P7|Overall Study|Other|1
4655767|NCT03210961|15987737|P6|Overall Study|Other|0
4655768|NCT03210961|15987738|P5|Overall Study|Other|0
4655769|NCT03210961|15987739|P4|Overall Study|Other|1
4655770|NCT03210961|15987740|P3|Overall Study|Other|0
4655771|NCT03210961|15987741|P2|Overall Study|Other|0
4655772|NCT03210961|15987742|P1|Overall Study|Other|0
4655773|NCT03210961|15987728|P15|Overall Study|No Longer Meets Eligibility Criteria|0
4655774|NCT03210961|15987729|P14|Overall Study|No Longer Meets Eligibility Criteria|1
4655775|NCT03210961|15987730|P13|Overall Study|No Longer Meets Eligibility Criteria|0
4655776|NCT03210961|15987731|P12|Overall Study|No Longer Meets Eligibility Criteria|0
4655777|NCT03210961|15987732|P11|Overall Study|No Longer Meets Eligibility Criteria|0
4655778|NCT03210961|15987733|P10|Overall Study|No Longer Meets Eligibility Criteria|0
4655779|NCT03210961|15987734|P9|Overall Study|No Longer Meets Eligibility Criteria|0
4655780|NCT03210961|15987735|P8|Overall Study|No Longer Meets Eligibility Criteria|0
4655781|NCT03210961|15987736|P7|Overall Study|No Longer Meets Eligibility Criteria|0
4655782|NCT03210961|15987737|P6|Overall Study|No Longer Meets Eligibility Criteria|0
4655783|NCT03210961|15987738|P5|Overall Study|No Longer Meets Eligibility Criteria|0
4655784|NCT03210961|15987739|P4|Overall Study|No Longer Meets Eligibility Criteria|0
4655785|NCT03210961|15987740|P3|Overall Study|No Longer Meets Eligibility Criteria|0
4655786|NCT03210961|15987741|P2|Overall Study|No Longer Meets Eligibility Criteria|0
4655787|NCT03210961|15987742|P1|Overall Study|No Longer Meets Eligibility Criteria|0
4655788|NCT03210961|15987728|P15|Overall Study|Withdrawal by Subject|1
4655789|NCT03210961|15987729|P14|Overall Study|Withdrawal by Subject|0
4655790|NCT03210961|15987730|P13|Overall Study|Withdrawal by Subject|0
4655791|NCT03210961|15987731|P12|Overall Study|Withdrawal by Subject|0
4655792|NCT03210961|15987732|P11|Overall Study|Withdrawal by Subject|0
4655793|NCT03210961|15987733|P10|Overall Study|Withdrawal by Subject|0
4655794|NCT03210961|15987734|P9|Overall Study|Withdrawal by Subject|0
4655795|NCT03210961|15987735|P8|Overall Study|Withdrawal by Subject|0
4655796|NCT03210961|15987736|P7|Overall Study|Withdrawal by Subject|0
4655797|NCT03210961|15987737|P6|Overall Study|Withdrawal by Subject|0
4655798|NCT03210961|15987738|P5|Overall Study|Withdrawal by Subject|0
4655799|NCT03210961|15987739|P4|Overall Study|Withdrawal by Subject|0
4655800|NCT03210961|15987740|P3|Overall Study|Withdrawal by Subject|0
4655801|NCT03210961|15987741|P2|Overall Study|Withdrawal by Subject|0
4655802|NCT03210961|15987742|P1|Overall Study|Withdrawal by Subject|0
4655803|NCT03210961|15987728|P15|Overall Study|Lost to Follow-up|1
4655804|NCT03210961|15987729|P14|Overall Study|Lost to Follow-up|0
4655805|NCT03210961|15987730|P13|Overall Study|Lost to Follow-up|0
4655806|NCT03210961|15987731|P12|Overall Study|Lost to Follow-up|0
4655807|NCT03210961|15987732|P11|Overall Study|Lost to Follow-up|0
4655808|NCT03210961|15987733|P10|Overall Study|Lost to Follow-up|0
4655809|NCT03210961|15987734|P9|Overall Study|Lost to Follow-up|0
4655810|NCT03210961|15987735|P8|Overall Study|Lost to Follow-up|0
4655811|NCT03210961|15987736|P7|Overall Study|Lost to Follow-up|0
4655812|NCT03210961|15987737|P6|Overall Study|Lost to Follow-up|0
4655813|NCT03210961|15987738|P5|Overall Study|Lost to Follow-up|0
4655814|NCT03210961|15987739|P4|Overall Study|Lost to Follow-up|0
4655815|NCT03210961|15987740|P3|Overall Study|Lost to Follow-up|0
4655816|NCT03210961|15987741|P2|Overall Study|Lost to Follow-up|0
4655817|NCT03210961|15987742|P1|Overall Study|Lost to Follow-up|0
4655818|NCT03210961|15987728|P15|Overall Study|Adverse Event|0
4655819|NCT03210961|15987729|P14|Overall Study|Adverse Event|1
4655820|NCT03210961|15987730|P13|Overall Study|Adverse Event|0
4655821|NCT03210961|15987731|P12|Overall Study|Adverse Event|0
4655822|NCT03210961|15987732|P11|Overall Study|Adverse Event|0
4655823|NCT03210961|15987733|P10|Overall Study|Adverse Event|0
4655824|NCT03210961|15987734|P9|Overall Study|Adverse Event|0
4655825|NCT03210961|15987735|P8|Overall Study|Adverse Event|0
4655826|NCT03210961|15987736|P7|Overall Study|Adverse Event|0
4655827|NCT03210961|15987737|P6|Overall Study|Adverse Event|0
4655828|NCT03210961|15987738|P5|Overall Study|Adverse Event|0
4655829|NCT03210961|15987739|P4|Overall Study|Adverse Event|0
4655830|NCT03210961|15987740|P3|Overall Study|Adverse Event|0
4655831|NCT03210961|15987741|P2|Overall Study|Adverse Event|0
4655832|NCT03210961|15987742|P1|Overall Study|Adverse Event|0
4655833|NCT03210519|15988101|P2|Overall Study|Adverse Event|0
4655834|NCT03210519|15988102|P1|Overall Study|Adverse Event|2
4655835|NCT03210220|15988158|P2|Overall Study|Physician Decision|0
4655836|NCT03210220|15988159|P1|Overall Study|Physician Decision|1
4655837|NCT03209973|15988182|P1|Overall Study|Death|1
4655838|NCT03209973|15988182|P1|Overall Study|Patient withdrew consent|3
4655839|NCT03209570|15988188|P2|Overall Study|Withdrawal by Subject|3
4655840|NCT03209570|15988189|P1|Overall Study|Withdrawal by Subject|0
4655841|NCT03209570|15988188|P2|Overall Study|Protocol Violation|0
4655842|NCT03209570|15988189|P1|Overall Study|Protocol Violation|1
4655843|NCT03209570|15988188|P2|Overall Study|Incomplete Data|10
4655844|NCT03209570|15988189|P1|Overall Study|Incomplete Data|8
4655845|NCT03209570|15988188|P2|Overall Study|Death|0
4655846|NCT03209570|15988189|P1|Overall Study|Death|1
4655847|NCT03209518|15988199|P1|Overall Study|Protocol Deviation|1
4655848|NCT03209518|15988199|P1|Overall Study|Case Report Forms Uncollected|1
4655849|NCT03209492|15988204|P1|Overall Study|Case Report Forms Uncollected|5
4655850|NCT03208088|15988247|P10|Period 4|Unsatisfactory Test Article|0
4655851|NCT03208088|15988248|P9|Period 4|Unsatisfactory Test Article|0
4655852|NCT03208088|15988249|P8|Period 4|Unsatisfactory Test Article|0
4655853|NCT03208088|15988250|P7|Period 4|Unsatisfactory Test Article|0
4655854|NCT03208088|15988251|P6|Period 4|Unsatisfactory Test Article|0
4655855|NCT03208088|15988252|P5|Period 4|Unsatisfactory Test Article|0
4655856|NCT03208088|15988253|P4|Period 4|Unsatisfactory Test Article|1
4655857|NCT03208088|15988254|P3|Period 4|Unsatisfactory Test Article|0
4655858|NCT03208088|15988255|P2|Period 4|Unsatisfactory Test Article|0
4655859|NCT03208088|15988256|P1|Period 4|Unsatisfactory Test Article|0
4655860|NCT03208088|15988247|P10|Period 3|Unsatisfactory Test Article|0
4655861|NCT03208088|15988248|P9|Period 3|Unsatisfactory Test Article|0
4655862|NCT03208088|15988249|P8|Period 3|Unsatisfactory Test Article|0
4655863|NCT03208088|15988250|P7|Period 3|Unsatisfactory Test Article|0
4655864|NCT03208088|15988251|P6|Period 3|Unsatisfactory Test Article|0
4655865|NCT03208088|15988252|P5|Period 3|Unsatisfactory Test Article|0
4655866|NCT03208088|15988253|P4|Period 3|Unsatisfactory Test Article|1
4655867|NCT03208088|15988254|P3|Period 3|Unsatisfactory Test Article|0
4655868|NCT03208088|15988255|P2|Period 3|Unsatisfactory Test Article|0
4655869|NCT03208088|15988256|P1|Period 3|Unsatisfactory Test Article|0
4655870|NCT03208088|15988247|P10|Period 2|Withdrawal by Subject|0
4655871|NCT03208088|15988248|P9|Period 2|Withdrawal by Subject|1
4655872|NCT03208088|15988249|P8|Period 2|Withdrawal by Subject|0
4655873|NCT03208088|15988250|P7|Period 2|Withdrawal by Subject|0
4655874|NCT03208088|15988251|P6|Period 2|Withdrawal by Subject|0
4655875|NCT03208088|15988252|P5|Period 2|Withdrawal by Subject|0
4655876|NCT03208088|15988253|P4|Period 2|Withdrawal by Subject|0
4655877|NCT03208088|15988254|P3|Period 2|Withdrawal by Subject|0
4655878|NCT03208088|15988255|P2|Period 2|Withdrawal by Subject|0
4655879|NCT03208088|15988256|P1|Period 2|Withdrawal by Subject|0
4655880|NCT03207763|15988286|P2|Overall Study|Lost to Follow-up|0
4655881|NCT03207763|15988287|P1|Overall Study|Lost to Follow-up|1
4655882|NCT03207750|15988313|P2|Overall Study|OTHER, NOT SPECIFIED|4
4655883|NCT03207750|15988314|P1|Overall Study|OTHER, NOT SPECIFIED|5
4655884|NCT03207750|15988313|P2|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2
4655885|NCT03207750|15988314|P1|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1
4655886|NCT03207750|15988313|P2|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5
4655887|NCT03207750|15988314|P1|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10
4655888|NCT03207750|15988313|P2|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10
4655889|NCT03207750|15988314|P1|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7
4655890|NCT03207750|15988313|P2|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13
4655891|NCT03207750|15988314|P1|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11
4655892|NCT03207750|15988313|P2|Overall Study|Protocol Violation|1
4655893|NCT03207750|15988314|P1|Overall Study|Protocol Violation|0
4655894|NCT03207750|15988313|P2|Overall Study|Lost to Follow-up|29
4655895|NCT03207750|15988314|P1|Overall Study|Lost to Follow-up|21
4655896|NCT03207750|15988313|P2|Overall Study|Adverse Event|2
4655897|NCT03207750|15988314|P1|Overall Study|Adverse Event|3
4655898|NCT03207243|15988394|P2|Overall Study|Protocol Violation|3
4655899|NCT03207243|15988395|P1|Overall Study|Protocol Violation|0
4655900|NCT03207243|15988394|P2|Overall Study|Protocol Specified Withdrawal Criteria|2
4655901|NCT03207243|15988395|P1|Overall Study|Protocol Specified Withdrawal Criteria|7
4655902|NCT03207243|15988394|P2|Overall Study|Lost to Follow-up|1
4655903|NCT03207243|15988395|P1|Overall Study|Lost to Follow-up|0
4655904|NCT03207243|15988394|P2|Overall Study|Physician Decision|1
4655905|NCT03207243|15988395|P1|Overall Study|Physician Decision|1
4655906|NCT03207243|15988394|P2|Overall Study|Withdrawal by Subject|4
4655907|NCT03207243|15988395|P1|Overall Study|Withdrawal by Subject|2
4655908|NCT03207243|15988394|P2|Overall Study|Loss of Asthma Control|31
4655909|NCT03207243|15988395|P1|Overall Study|Loss of Asthma Control|47
4655910|NCT03207243|15988394|P2|Overall Study|Adverse Event|2
4655911|NCT03207243|15988395|P1|Overall Study|Adverse Event|2
4655912|NCT03206970|15988506|P1|Overall Study|Lost to Follow-up|3
4655913|NCT03206970|15988506|P1|Overall Study|Withdrawal by Subject|9
4655914|NCT03206970|15988506|P1|Overall Study|Death|14
4655915|NCT03206918|15988510|P1|Overall Study|Withdrawal by Subject|2
4655916|NCT03206918|15988510|P1|Overall Study|Death|4
4655917|NCT03206216|15988516|P2|Overall Study|Withdrawal by Subject|1
4655918|NCT03206216|15988517|P1|Overall Study|Withdrawal by Subject|0
4655919|NCT03205488|15988528|P3|Overall Study|Protocol Violation|1
4655920|NCT03205488|15988529|P2|Overall Study|Protocol Violation|0
4655921|NCT03205488|15988530|P1|Overall Study|Protocol Violation|0
4655922|NCT03205488|15988528|P3|Overall Study|Adverse Event|4
4655923|NCT03205488|15988529|P2|Overall Study|Adverse Event|2
4655924|NCT03205488|15988530|P1|Overall Study|Adverse Event|1
4655925|NCT03205371|15988556|P12|Overall Study|Adverse Event|0
4655926|NCT03205371|15988557|P11|Overall Study|Adverse Event|0
4655927|NCT03205371|15988558|P10|Overall Study|Adverse Event|0
4655928|NCT03205371|15988559|P9|Overall Study|Adverse Event|0
4655929|NCT03205371|15988560|P8|Overall Study|Adverse Event|1
4655930|NCT03205371|15988561|P7|Overall Study|Adverse Event|0
4655931|NCT03205371|15988562|P6|Overall Study|Adverse Event|0
4655932|NCT03205371|15988563|P5|Overall Study|Adverse Event|0
4655933|NCT03205371|15988564|P4|Overall Study|Adverse Event|0
4655934|NCT03205371|15988565|P3|Overall Study|Adverse Event|0
4655935|NCT03205371|15988566|P2|Overall Study|Adverse Event|0
4655936|NCT03205371|15988567|P1|Overall Study|Adverse Event|0
4655937|NCT03205371|15988556|P12|Overall Study|Protocol Violation|0
4655938|NCT03205371|15988557|P11|Overall Study|Protocol Violation|0
4655939|NCT03205371|15988558|P10|Overall Study|Protocol Violation|0
4655940|NCT03205371|15988559|P9|Overall Study|Protocol Violation|0
4655941|NCT03205371|15988560|P8|Overall Study|Protocol Violation|0
4655942|NCT03205371|15988561|P7|Overall Study|Protocol Violation|1
4655943|NCT03205371|15988562|P6|Overall Study|Protocol Violation|0
4655944|NCT03205371|15988563|P5|Overall Study|Protocol Violation|0
4655945|NCT03205371|15988564|P4|Overall Study|Protocol Violation|0
4655946|NCT03205371|15988565|P3|Overall Study|Protocol Violation|0
4655947|NCT03205371|15988566|P2|Overall Study|Protocol Violation|0
4655948|NCT03205371|15988567|P1|Overall Study|Protocol Violation|0
4655949|NCT03205371|15988556|P12|Overall Study|Lost to Follow-up|0
4655950|NCT03205371|15988557|P11|Overall Study|Lost to Follow-up|0
4655951|NCT03205371|15988558|P10|Overall Study|Lost to Follow-up|0
4655952|NCT03205371|15988559|P9|Overall Study|Lost to Follow-up|3
4655953|NCT03205371|15988560|P8|Overall Study|Lost to Follow-up|2
4655954|NCT03205371|15988561|P7|Overall Study|Lost to Follow-up|5
4655955|NCT03205371|15988562|P6|Overall Study|Lost to Follow-up|0
4655956|NCT03205371|15988563|P5|Overall Study|Lost to Follow-up|0
4655957|NCT03205371|15988564|P4|Overall Study|Lost to Follow-up|0
4655958|NCT03205371|15988565|P3|Overall Study|Lost to Follow-up|0
4655959|NCT03205371|15988566|P2|Overall Study|Lost to Follow-up|0
4655960|NCT03205371|15988567|P1|Overall Study|Lost to Follow-up|0
4655961|NCT03205371|15988556|P12|Overall Study|Withdrawal by Subject|1
4655962|NCT03205371|15988557|P11|Overall Study|Withdrawal by Subject|0
4655963|NCT03205371|15988558|P10|Overall Study|Withdrawal by Subject|0
4655964|NCT03205371|15988559|P9|Overall Study|Withdrawal by Subject|2
4655965|NCT03205371|15988560|P8|Overall Study|Withdrawal by Subject|0
4655966|NCT03205371|15988561|P7|Overall Study|Withdrawal by Subject|4
4655967|NCT03205371|15988562|P6|Overall Study|Withdrawal by Subject|0
4655968|NCT03205371|15988563|P5|Overall Study|Withdrawal by Subject|0
4655969|NCT03205371|15988564|P4|Overall Study|Withdrawal by Subject|0
4655970|NCT03205371|15988565|P3|Overall Study|Withdrawal by Subject|0
4655971|NCT03205371|15988566|P2|Overall Study|Withdrawal by Subject|1
4655972|NCT03205371|15988567|P1|Overall Study|Withdrawal by Subject|4
4655973|NCT03205163|15988656|P2|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0
4655974|NCT03205163|15988657|P1|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1
4655975|NCT03204539|15988753|P2|Overall Study|Loss of funding|1
4655976|NCT03204539|15988754|P1|Overall Study|Loss of funding|0
4655977|NCT03203291|15988892|P1|Overall Study|Withdrawal by Subject|1
4655978|NCT03201900|15988940|P1|Extension Phase (Up to 124 Weeks)|Ongoing|41
4655979|NCT03201900|15988940|P1|Extension Phase (Up to 124 Weeks)|Withdrawal of consent|1
4655980|NCT03201900|15988940|P1|Extension Phase (Up to 124 Weeks)|Lost to Follow-up|1
4655981|NCT03201900|15988940|P1|Extension Phase (Up to 124 Weeks)|Inadequate therapeutic effect|1
4655982|NCT03201900|15988940|P1|Extension Phase (Up to 124 Weeks)|Pregnancy|1
4655983|NCT03201900|15988940|P1|Extension Phase (Up to 124 Weeks)|Subject choice|1
4655984|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Not treated|2
4655985|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Other than specified|11
4655986|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6
4655987|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2
4655988|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6
4655989|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Subject Choice|1
4655990|NCT03201900|15988940|P1|Treatment Phase (Up to 62 Weeks)|Adverse Event|9
4655991|NCT03200912|15988962|P3|Overall Study|Non-compliance with study drug|0
4655992|NCT03200912|15988963|P2|Overall Study|Non-compliance with study drug|1
4655993|NCT03200912|15988964|P1|Overall Study|Non-compliance with study drug|0
4655994|NCT03200912|15988962|P3|Overall Study|Withdrawal by Subject|4
4655995|NCT03200912|15988963|P2|Overall Study|Withdrawal by Subject|2
4655996|NCT03200912|15988964|P1|Overall Study|Withdrawal by Subject|1
4655997|NCT03200912|15988962|P3|Overall Study|Adverse Event|0
4655998|NCT03200912|15988963|P2|Overall Study|Adverse Event|0
4655999|NCT03200912|15988964|P1|Overall Study|Adverse Event|3
4656000|NCT03200860|15988974|P2|Overall Study|Withdrawal by Subject|0
4656001|NCT03200860|15988975|P1|Overall Study|Withdrawal by Subject|1
4656002|NCT03199911|15989018|P2|Overall Study|Did not proceed with surgery|1
4656003|NCT03199911|15989019|P1|Overall Study|Did not proceed with surgery|2
4656004|NCT03199911|15989018|P2|Overall Study|Lost to Follow-up|5
4656005|NCT03199911|15989019|P1|Overall Study|Lost to Follow-up|5
4656006|NCT03198767|15989070|P7|Overall Study|Protocol Violation|0
4656007|NCT03198767|15989071|P6|Overall Study|Protocol Violation|0
4656008|NCT03198767|15989072|P5|Overall Study|Protocol Violation|0
4656009|NCT03198767|15989073|P4|Overall Study|Protocol Violation|6
4656010|NCT03198767|15989074|P3|Overall Study|Protocol Violation|0
4656011|NCT03198767|15989075|P2|Overall Study|Protocol Violation|0
4656012|NCT03198767|15989076|P1|Overall Study|Protocol Violation|0
4656013|NCT03198754|15989117|P2|Overall Study|Ineligible|1
4656014|NCT03198754|15989118|P1|Overall Study|Ineligible|2
4656015|NCT03198754|15989117|P2|Overall Study|Lost to Follow-up|3
4656016|NCT03198754|15989118|P1|Overall Study|Lost to Follow-up|4
4656017|NCT03198754|15989117|P2|Overall Study|Withdrawal by Subject|4
4656018|NCT03198754|15989118|P1|Overall Study|Withdrawal by Subject|5
4656019|NCT03198507|15989158|P2|Overall Study|Withdrawal by Subject|0
4656020|NCT03198507|15989159|P1|Overall Study|Withdrawal by Subject|1
4656021|NCT03197883|15989285|P2|Overall Study|Other (Not Specified)|5
4656022|NCT03197883|15989286|P1|Overall Study|Other (Not Specified)|0
4656023|NCT03197883|15989285|P2|Overall Study|Protocol Violation|0
4656024|NCT03197883|15989286|P1|Overall Study|Protocol Violation|1
4656025|NCT03197883|15989285|P2|Overall Study|Lost to Follow-up|0
4656026|NCT03197883|15989286|P1|Overall Study|Lost to Follow-up|1
4656027|NCT03197883|15989285|P2|Overall Study|Adverse Event|1
4656028|NCT03197883|15989286|P1|Overall Study|Adverse Event|1
4656029|NCT03197558|15989316|P1|Overall Study|Tubes not placed|1
4656030|NCT03197376|15989324|P4|Immune Persistence Phase|Not vaccine related|1
4656031|NCT03197376|15989325|P3|Immune Persistence Phase|Not vaccine related|1
4656032|NCT03197376|15989326|P2|Immune Persistence Phase|Not vaccine related|0
4656033|NCT03197376|15989327|P1|Immune Persistence Phase|Not vaccine related|1
4656034|NCT03197376|15989324|P4|Immune Persistence Phase|Withdrawal by subject's parents|3
4656035|NCT03197376|15989325|P3|Immune Persistence Phase|Withdrawal by subject's parents|2
4656036|NCT03197376|15989326|P2|Immune Persistence Phase|Withdrawal by subject's parents|4
4656037|NCT03197376|15989327|P1|Immune Persistence Phase|Withdrawal by subject's parents|4
4656038|NCT03197376|15989324|P4|Immune Persistence Phase|Lost to Follow-up|1
4656039|NCT03197376|15989325|P3|Immune Persistence Phase|Lost to Follow-up|2
4656040|NCT03197376|15989326|P2|Immune Persistence Phase|Lost to Follow-up|0
4656041|NCT03197376|15989327|P1|Immune Persistence Phase|Lost to Follow-up|0
4656042|NCT03197376|15989324|P4|Primary and Booster Phase|Not vaccine related|6
4656043|NCT03197376|15989325|P3|Primary and Booster Phase|Not vaccine related|0
4656044|NCT03197376|15989326|P2|Primary and Booster Phase|Not vaccine related|2
4656045|NCT03197376|15989327|P1|Primary and Booster Phase|Not vaccine related|1
4656046|NCT03197376|15989324|P4|Primary and Booster Phase|Ineligibility criteria|2
4656047|NCT03197376|15989325|P3|Primary and Booster Phase|Ineligibility criteria|4
4656048|NCT03197376|15989326|P2|Primary and Booster Phase|Ineligibility criteria|1
4656049|NCT03197376|15989327|P1|Primary and Booster Phase|Ineligibility criteria|1
4656050|NCT03197376|15989324|P4|Primary and Booster Phase|Withdrawal by subject's parents|11
4656051|NCT03197376|15989325|P3|Primary and Booster Phase|Withdrawal by subject's parents|14
4656052|NCT03197376|15989326|P2|Primary and Booster Phase|Withdrawal by subject's parents|10
4656053|NCT03197376|15989327|P1|Primary and Booster Phase|Withdrawal by subject's parents|11
4656054|NCT03197376|15989324|P4|Primary and Booster Phase|Physician Decision|3
4656055|NCT03197376|15989325|P3|Primary and Booster Phase|Physician Decision|1
4656056|NCT03197376|15989326|P2|Primary and Booster Phase|Physician Decision|0
4656057|NCT03197376|15989327|P1|Primary and Booster Phase|Physician Decision|1
4656058|NCT03197376|15989324|P4|Primary and Booster Phase|Lost to Follow-up|0
4656059|NCT03197376|15989325|P3|Primary and Booster Phase|Lost to Follow-up|1
4656060|NCT03197376|15989326|P2|Primary and Booster Phase|Lost to Follow-up|0
4656061|NCT03197376|15989327|P1|Primary and Booster Phase|Lost to Follow-up|0
4656062|NCT03197376|15989324|P4|Primary and Booster Phase|Death|2
4656063|NCT03197376|15989325|P3|Primary and Booster Phase|Death|0
4656064|NCT03197376|15989326|P2|Primary and Booster Phase|Death|0
4656065|NCT03197376|15989327|P1|Primary and Booster Phase|Death|1
4656066|NCT03197376|15989324|P4|Primary and Booster Phase|Adverse Event|1
4656067|NCT03197376|15989325|P3|Primary and Booster Phase|Adverse Event|0
4656068|NCT03197376|15989326|P2|Primary and Booster Phase|Adverse Event|0
4656069|NCT03197376|15989327|P1|Primary and Booster Phase|Adverse Event|0
4656070|NCT03196635|15989401|P1|Overall Study|Withdrawal by Subject|1
4656071|NCT03196349|15989422|P3|Overall Study|Study Terminated early|11
4656072|NCT03196349|15989423|P2|Overall Study|Study Terminated early|9
4656073|NCT03196349|15989424|P1|Overall Study|Study Terminated early|15
4656074|NCT03196349|15989422|P3|Overall Study|No data entered|0
4656075|NCT03196349|15989423|P2|Overall Study|No data entered|4
4656076|NCT03196349|15989424|P1|Overall Study|No data entered|2
4656077|NCT03196349|15989422|P3|Overall Study|Did not receive study drug|2
4656078|NCT03196349|15989423|P2|Overall Study|Did not receive study drug|1
4656079|NCT03196349|15989424|P1|Overall Study|Did not receive study drug|0
4656080|NCT03196193|15989461|P2|Overall Study|Computed Tomography (CT) data missing|0
4656081|NCT03196193|15989462|P1|Overall Study|Computed Tomography (CT) data missing|2
4656082|NCT03196193|15989461|P2|Overall Study|Adverse Event|0
4656083|NCT03196193|15989462|P1|Overall Study|Adverse Event|1
4656084|NCT03194490|15989560|P2|Overall Study|participant developed specific neck pain|0
4656085|NCT03194490|15989561|P1|Overall Study|participant developed specific neck pain|1
4656086|NCT03194490|15989560|P2|Overall Study|Lost to Follow-up|3
4656087|NCT03194490|15989561|P1|Overall Study|Lost to Follow-up|1
4656088|NCT03194464|15989603|P1|Overall Study|data not usable|2
4656089|NCT03193047|15989721|P2|Overall Study|Participant Left State|0
4656090|NCT03193047|15989722|P1|Overall Study|Participant Left State|1
4656091|NCT03193047|15989721|P2|Overall Study|Physician Decision|0
4656092|NCT03193047|15989722|P1|Overall Study|Physician Decision|1
4656093|NCT03193021|15989742|P2|Overall Study|Lost to Follow-up|1
4656094|NCT03193021|15989743|P1|Overall Study|Lost to Follow-up|1
4656095|NCT03192904|15989768|P2|Overall Study|Lost to Follow-up|1
4656096|NCT03192904|15989769|P1|Overall Study|Lost to Follow-up|0
4656097|NCT03192904|15989768|P2|Overall Study|Physician Decision|1
4656098|NCT03192904|15989769|P1|Overall Study|Physician Decision|3
4656099|NCT03192488|15989825|P6|Third Intervention (d1)|Adverse Event|0
4656100|NCT03192488|15989826|P5|Third Intervention (d1)|Adverse Event|1
4656101|NCT03192488|15989827|P4|Third Intervention (d1)|Adverse Event|0
4656102|NCT03192488|15989828|P3|Third Intervention (d1)|Adverse Event|0
4656103|NCT03192488|15989829|P2|Third Intervention (d1)|Adverse Event|0
4656104|NCT03192488|15989830|P1|Third Intervention (d1)|Adverse Event|0
4656105|NCT03192488|15989825|P6|First Washout (>6d)|Withdrawal by Subject|1
4656106|NCT03192488|15989826|P5|First Washout (>6d)|Withdrawal by Subject|0
4656107|NCT03192488|15989827|P4|First Washout (>6d)|Withdrawal by Subject|0
4656108|NCT03192488|15989828|P3|First Washout (>6d)|Withdrawal by Subject|1
4656109|NCT03192488|15989829|P2|First Washout (>6d)|Withdrawal by Subject|0
4656110|NCT03192488|15989830|P1|First Washout (>6d)|Withdrawal by Subject|0
4656111|NCT03192475|15989846|P2|Overall Study|Lost to Follow-up|8
4656112|NCT03192475|15989847|P1|Overall Study|Lost to Follow-up|13
4656113|NCT03192475|15989846|P2|Overall Study|Death|1
4656114|NCT03192475|15989847|P1|Overall Study|Death|0
4656115|NCT03192306|15989883|P2|Overall Study|Protocol Violation|1
4656116|NCT03192306|15989884|P1|Overall Study|Protocol Violation|1
4656117|NCT03192306|15989883|P2|Overall Study|Lost to Follow-up|0
4656118|NCT03192306|15989884|P1|Overall Study|Lost to Follow-up|1
4656119|NCT03192306|15989883|P2|Overall Study|Withdrawal by Subject|1
4656120|NCT03192306|15989884|P1|Overall Study|Withdrawal by Subject|1
4656121|NCT03192306|15989883|P2|Overall Study|Did not treat cold sore during study|143
4656122|NCT03192306|15989884|P1|Overall Study|Did not treat cold sore during study|149
4656123|NCT03192137|15989904|P2|Overall Study|Other - Various Administrative Reasons|3
4656124|NCT03192137|15989905|P1|Overall Study|Other - Various Administrative Reasons|8
4656125|NCT03192137|15989904|P2|Overall Study|Surgery Cancelled|1
4656126|NCT03192137|15989905|P1|Overall Study|Surgery Cancelled|4
4656127|NCT03192137|15989904|P2|Overall Study|Protocol Violation|3
4656128|NCT03192137|15989905|P1|Overall Study|Protocol Violation|4
4656129|NCT03192137|15989904|P2|Overall Study|Withdrawal by Subject|3
4656130|NCT03192137|15989905|P1|Overall Study|Withdrawal by Subject|3
4656131|NCT03192137|15989904|P2|Overall Study|Lack of Efficacy|37
4656132|NCT03192137|15989905|P1|Overall Study|Lack of Efficacy|20
4656133|NCT03192137|15989904|P2|Overall Study|Physician Decision|0
4656134|NCT03192137|15989905|P1|Overall Study|Physician Decision|1
4656135|NCT03192137|15989904|P2|Overall Study|Adverse Event|11
4656136|NCT03192137|15989905|P1|Overall Study|Adverse Event|10
4656137|NCT03191552|15989916|P3|Overall Study|Undergone surgery (Progressive hip dyspl|0
4656138|NCT03191552|15989917|P2|Overall Study|Undergone surgery (Progressive hip dyspl|1
4656139|NCT03191552|15989918|P1|Overall Study|Undergone surgery (Progressive hip dyspl|0
4656140|NCT03191552|15989916|P3|Overall Study|Lost to Follow-up|0
4656141|NCT03191552|15989917|P2|Overall Study|Lost to Follow-up|0
4656142|NCT03191552|15989918|P1|Overall Study|Lost to Follow-up|1
4656143|NCT03191396|15989971|P2|Overall Study|Withdrawal by Subject|2
4656144|NCT03191396|15989972|P1|Overall Study|Withdrawal by Subject|3
4656145|NCT03191396|15989971|P2|Overall Study|Lost to Follow-up|3
4656146|NCT03191396|15989972|P1|Overall Study|Lost to Follow-up|0
4656147|NCT03190369|15990069|P2|Overall Study|Randomized but not treated|2
4656148|NCT03190369|15990070|P1|Overall Study|Randomized but not treated|0
4656149|NCT03190369|15990069|P2|Overall Study|Withdraw before treatment|5
4656150|NCT03190369|15990070|P1|Overall Study|Withdraw before treatment|1
4656151|NCT03190369|15990069|P2|Overall Study|Poor compliance to protocol|1
4656152|NCT03190369|15990070|P1|Overall Study|Poor compliance to protocol|0
4656153|NCT03189745|15990131|P2|Overall Study|Conflict in work schedule of participant|1
4656154|NCT03189745|15990132|P1|Overall Study|Conflict in work schedule of participant|1
4656155|NCT03188536|15990191|P1|Overall Study|Not participated/met inclusion criteria|1
4656156|NCT03188536|15990191|P1|Overall Study|No relapse/refractoriness(last 6 months)|5
4656157|NCT03188120|15990258|P1|Overall Study|No visit after the first visit|13
4656158|NCT03188120|15990258|P1|Overall Study|Other than specified|3
4656159|NCT03188120|15990258|P1|Overall Study|Lost to Follow-up|7
4656160|NCT03188120|15990258|P1|Overall Study|Improved|12
4656161|NCT03188120|15990258|P1|Overall Study|Insufficient Effectiveness|8
4656162|NCT03188120|15990258|P1|Overall Study|Adverse Event|4
4656163|NCT03187756|15990263|P1|Overall Study|Termination of study|4
4656164|NCT03187301|15990281|P7|Pre-Intervention|Withdrawal by Subject|0
4656165|NCT03187301|15990282|P6|Pre-Intervention|Withdrawal by Subject|0
4656166|NCT03187301|15990283|P5|Pre-Intervention|Withdrawal by Subject|0
4656167|NCT03187301|15990284|P4|Pre-Intervention|Withdrawal by Subject|0
4656168|NCT03187301|15990285|P3|Pre-Intervention|Withdrawal by Subject|0
4656169|NCT03187301|15990286|P2|Pre-Intervention|Withdrawal by Subject|0
4656170|NCT03187301|15990287|P1|Pre-Intervention|Withdrawal by Subject|1
4656171|NCT03187301|15990281|P7|Titration Period|Exclusion Criteria Met|1
4656172|NCT03187301|15990282|P6|Titration Period|Exclusion Criteria Met|0
4656173|NCT03187301|15990283|P5|Titration Period|Exclusion Criteria Met|0
4656174|NCT03187301|15990284|P4|Titration Period|Exclusion Criteria Met|0
4656175|NCT03187301|15990285|P3|Titration Period|Exclusion Criteria Met|0
4656176|NCT03187301|15990286|P2|Titration Period|Exclusion Criteria Met|0
4656177|NCT03187301|15990287|P1|Titration Period|Exclusion Criteria Met|0
4656178|NCT03187301|15990281|P7|Titration Period|Withdrawal by Subject|1
4656179|NCT03187301|15990282|P6|Titration Period|Withdrawal by Subject|0
4656180|NCT03187301|15990283|P5|Titration Period|Withdrawal by Subject|0
4656181|NCT03187301|15990284|P4|Titration Period|Withdrawal by Subject|0
4656182|NCT03187301|15990285|P3|Titration Period|Withdrawal by Subject|0
4656183|NCT03187301|15990286|P2|Titration Period|Withdrawal by Subject|0
4656184|NCT03187301|15990287|P1|Titration Period|Withdrawal by Subject|0
4656185|NCT03187301|15990281|P7|Titration Period|Adverse Event|5
4656186|NCT03187301|15990282|P6|Titration Period|Adverse Event|0
4656187|NCT03187301|15990283|P5|Titration Period|Adverse Event|0
4656188|NCT03187301|15990284|P4|Titration Period|Adverse Event|0
4656189|NCT03187301|15990285|P3|Titration Period|Adverse Event|0
4656190|NCT03187301|15990286|P2|Titration Period|Adverse Event|0
4656191|NCT03187301|15990287|P1|Titration Period|Adverse Event|0
4656192|NCT03187197|15990339|P3|Overall Study|NA in incl/excl criteria, not analyzed.|1
4656193|NCT03187197|15990340|P2|Overall Study|NA in incl/excl criteria, not analyzed.|45
4656194|NCT03187197|15990341|P1|Overall Study|NA in incl/excl criteria, not analyzed.|14
4656195|NCT03187197|15990339|P3|Overall Study|Status missing|3
4656196|NCT03187197|15990340|P2|Overall Study|Status missing|33
4656197|NCT03187197|15990341|P1|Overall Study|Status missing|2
4656198|NCT03187197|15990339|P3|Overall Study|Missing|3
4656199|NCT03187197|15990340|P2|Overall Study|Missing|32
4656200|NCT03187197|15990341|P1|Overall Study|Missing|1
4656201|NCT03187197|15990339|P3|Overall Study|Reason not listed|1
4656202|NCT03187197|15990340|P2|Overall Study|Reason not listed|54
4656203|NCT03187197|15990341|P1|Overall Study|Reason not listed|2
4656204|NCT03187197|15990339|P3|Overall Study|Administrative problem|0
4656205|NCT03187197|15990340|P2|Overall Study|Administrative problem|1
4656206|NCT03187197|15990341|P1|Overall Study|Administrative problem|1
4656207|NCT03187197|15990339|P3|Overall Study|Death|0
4656208|NCT03187197|15990340|P2|Overall Study|Death|11
4656209|NCT03187197|15990341|P1|Overall Study|Death|0
4656210|NCT03187197|15990339|P3|Overall Study|Adverse Event|0
4656211|NCT03187197|15990340|P2|Overall Study|Adverse Event|29
4656212|NCT03187197|15990341|P1|Overall Study|Adverse Event|6
4656213|NCT03187197|15990339|P3|Overall Study|Lost to Follow-up|7
4656214|NCT03187197|15990340|P2|Overall Study|Lost to Follow-up|60
4656215|NCT03187197|15990341|P1|Overall Study|Lost to Follow-up|1
4656216|NCT03187197|15990339|P3|Overall Study|Withdrawal by Subject|4
4656217|NCT03187197|15990340|P2|Overall Study|Withdrawal by Subject|63
4656218|NCT03187197|15990341|P1|Overall Study|Withdrawal by Subject|8
4656219|NCT03187197|15990339|P3|Overall Study|Stopped Pradaxa®/VKA|4
4656220|NCT03187197|15990340|P2|Overall Study|Stopped Pradaxa®/VKA|65
4656221|NCT03187197|15990341|P1|Overall Study|Stopped Pradaxa®/VKA|11
4656222|NCT03186781|15990358|P6|Overall Study|Withdrawal by Subject|0
4656223|NCT03186781|15990359|P5|Overall Study|Withdrawal by Subject|1
4656224|NCT03186781|15990360|P4|Overall Study|Withdrawal by Subject|0
4656225|NCT03186781|15990361|P3|Overall Study|Withdrawal by Subject|0
4656226|NCT03186781|15990362|P2|Overall Study|Withdrawal by Subject|0
4656227|NCT03186781|15990363|P1|Overall Study|Withdrawal by Subject|0
4656228|NCT03186781|15990358|P6|Overall Study|Moved from Area|0
4656229|NCT03186781|15990359|P5|Overall Study|Moved from Area|1
4656230|NCT03186781|15990360|P4|Overall Study|Moved from Area|0
4656231|NCT03186781|15990361|P3|Overall Study|Moved from Area|0
4656232|NCT03186781|15990362|P2|Overall Study|Moved from Area|0
4656233|NCT03186781|15990363|P1|Overall Study|Moved from Area|0
4656234|NCT03186781|15990358|P6|Overall Study|Lost to Follow-up|0
4656235|NCT03186781|15990359|P5|Overall Study|Lost to Follow-up|1
4656236|NCT03186781|15990360|P4|Overall Study|Lost to Follow-up|0
4656237|NCT03186781|15990361|P3|Overall Study|Lost to Follow-up|1
4656238|NCT03186781|15990362|P2|Overall Study|Lost to Follow-up|0
4656239|NCT03186781|15990363|P1|Overall Study|Lost to Follow-up|0
4656240|NCT03185481|15990429|P1|Overall Study|Study Terminated by Sponsor|4
4656241|NCT03185481|15990429|P1|Overall Study|Adverse Event|1
4656242|NCT03184987|15990500|P3|Overall Study|Adverse Event|1
4656243|NCT03184987|15990501|P2|Overall Study|Adverse Event|0
4656244|NCT03184987|15990502|P1|Overall Study|Adverse Event|1
4656245|NCT03184987|15990500|P3|Overall Study|Physician Decision|1
4656246|NCT03184987|15990501|P2|Overall Study|Physician Decision|0
4656247|NCT03184987|15990502|P1|Overall Study|Physician Decision|0
4656248|NCT03184987|15990500|P3|Overall Study|Withdrawal by Subject|2
4656249|NCT03184987|15990501|P2|Overall Study|Withdrawal by Subject|1
4656250|NCT03184987|15990502|P1|Overall Study|Withdrawal by Subject|0
4656251|NCT03184701|15990567|P1|Overall Study|Lost to Follow-up|5
4656252|NCT03184701|15990567|P1|Overall Study|Withdrawal by Subject|6
4656253|NCT03184701|15990567|P1|Overall Study|Physician Decision|3
4656254|NCT03184701|15990567|P1|Overall Study|Death|3
4656255|NCT03184519|15990571|P1|Overall Study|Physician Decision|21
4656256|NCT03184519|15990571|P1|Overall Study|Lost to Follow-up|6
4656257|NCT03184441|15990575|P1|Overall Study|Withdrawal by Subject|1
4656258|NCT03184077|15990601|P2|Overall Study|Lost to Follow-up|21
4656259|NCT03184077|15990602|P1|Overall Study|Lost to Follow-up|21
4656260|NCT03183518|15990621|P1|Overall Study|Other (Withdrawal of consent)|1
4656261|NCT03183518|15990621|P1|Overall Study|Other (Not specified)|2
4656262|NCT03183063|15990655|P3|Overall Study|Physician Decision|4
4656263|NCT03183063|15990656|P2|Overall Study|Physician Decision|4
4656264|NCT03183063|15990657|P1|Overall Study|Physician Decision|3
4656265|NCT03183063|15990655|P3|Overall Study|Withdrawal by Subject|0
4656266|NCT03183063|15990656|P2|Overall Study|Withdrawal by Subject|0
4656267|NCT03183063|15990657|P1|Overall Study|Withdrawal by Subject|2
4656268|NCT03182738|15990712|P2|Overall Study|Withdrawal by Subject|1
4656269|NCT03182738|15990713|P1|Overall Study|Withdrawal by Subject|0
4656270|NCT03182738|15990712|P2|Overall Study|Pregnancy|1
4656271|NCT03182738|15990713|P1|Overall Study|Pregnancy|0
4656272|NCT03182738|15990712|P2|Overall Study|Lost to Follow-up|3
4656273|NCT03182738|15990713|P1|Overall Study|Lost to Follow-up|9
4656274|NCT03181594|15990762|P1|Overall Study|Physician Decision|1
4656275|NCT03181594|15990762|P1|Overall Study|Lost to Follow-up|1
4656276|NCT03181503|15990770|P2|Overall Study|Lost to Follow-up|1
4656277|NCT03181503|15990771|P1|Overall Study|Lost to Follow-up|1
4656278|NCT03181503|15990770|P2|Overall Study|Withdrawal by Subject|0
4656279|NCT03181503|15990771|P1|Overall Study|Withdrawal by Subject|3
4656280|NCT03181503|15990770|P2|Overall Study|Protocol Violation|0
4656281|NCT03181503|15990771|P1|Overall Study|Protocol Violation|1
4656282|NCT03181503|15990770|P2|Overall Study|Adverse Event|2
4656283|NCT03181503|15990771|P1|Overall Study|Adverse Event|2
4656284|NCT03181451|15990810|P3|Overall Study|Withdrawal by Subject|0
4656285|NCT03181451|15990811|P2|Overall Study|Withdrawal by Subject|1
4656286|NCT03181451|15990812|P1|Overall Study|Withdrawal by Subject|0
4656287|NCT03181451|15990810|P3|Overall Study|Adverse Event|0
4656288|NCT03181451|15990811|P2|Overall Study|Adverse Event|1
4656289|NCT03181451|15990812|P1|Overall Study|Adverse Event|0
4656290|NCT03180801|15990999|P3|Overall Study|Lost to Follow-up|3
4656291|NCT03180801|15991000|P2|Overall Study|Lost to Follow-up|2
4656292|NCT03180801|15991001|P1|Overall Study|Lost to Follow-up|0
4656293|NCT03180801|15990999|P3|Overall Study|Withdrawal by Subject|1
4656294|NCT03180801|15991000|P2|Overall Study|Withdrawal by Subject|2
4656295|NCT03180801|15991001|P1|Overall Study|Withdrawal by Subject|2
4656296|NCT03180801|15990999|P3|Overall Study|Adverse Event|2
4656297|NCT03180801|15991000|P2|Overall Study|Adverse Event|0
4656298|NCT03180801|15991001|P1|Overall Study|Adverse Event|1
4656299|NCT03180801|15990999|P3|Overall Study|Inoculation Target Reached|3
4656300|NCT03180801|15991000|P2|Overall Study|Inoculation Target Reached|1
4656301|NCT03180801|15991001|P1|Overall Study|Inoculation Target Reached|1
4656302|NCT03180801|15990999|P3|Overall Study|Non-compliance|0
4656303|NCT03180801|15991000|P2|Overall Study|Non-compliance|4
4656304|NCT03180801|15991001|P1|Overall Study|Non-compliance|1
4656305|NCT03180801|15990999|P3|Overall Study|Physician Decision|1
4656306|NCT03180801|15991000|P2|Overall Study|Physician Decision|3
4656307|NCT03180801|15991001|P1|Overall Study|Physician Decision|3
4656308|NCT03180645|15991045|P3|Overall Study|Adverse Event|2
4656309|NCT03180645|15991046|P2|Overall Study|Adverse Event|1
4656310|NCT03180645|15991047|P1|Overall Study|Adverse Event|0
4656311|NCT03180619|15991089|P3|Overall Study|Investigator's discretion|1
4656312|NCT03180619|15991090|P2|Overall Study|Investigator's discretion|0
4656313|NCT03180619|15991091|P1|Overall Study|Investigator's discretion|1
4656314|NCT03180619|15991089|P3|Overall Study|Adverse Event|1
4656315|NCT03180619|15991090|P2|Overall Study|Adverse Event|0
4656316|NCT03180619|15991091|P1|Overall Study|Adverse Event|2
4656317|NCT03180619|15991089|P3|Overall Study|Still on Study|25
4656318|NCT03180619|15991090|P2|Overall Study|Still on Study|14
4656319|NCT03180619|15991091|P1|Overall Study|Still on Study|64
4656320|NCT03180619|15991089|P3|Overall Study|Death|0
4656321|NCT03180619|15991090|P2|Overall Study|Death|1
4656322|NCT03180619|15991091|P1|Overall Study|Death|1
4656323|NCT03180619|15991089|P3|Overall Study|Withdrew Consent|1
4656324|NCT03180619|15991090|P2|Overall Study|Withdrew Consent|0
4656325|NCT03180619|15991091|P1|Overall Study|Withdrew Consent|5
4656326|NCT03180138|15991294|P3|Overall Study|Found to be >24 mon after randomization|3
4656327|NCT03180138|15991295|P2|Overall Study|Found to be >24 mon after randomization|0
4656328|NCT03180138|15991296|P1|Overall Study|Found to be >24 mon after randomization|3
4656329|NCT03180138|15991294|P3|Overall Study|No prior immunization records|6
4656330|NCT03180138|15991295|P2|Overall Study|No prior immunization records|0
4656331|NCT03180138|15991296|P1|Overall Study|No prior immunization records|17
4656332|NCT03180138|15991294|P3|Overall Study|Mobile-phone could not be verified|15
4656333|NCT03180138|15991295|P2|Overall Study|Mobile-phone could not be verified|13
4656334|NCT03180138|15991296|P1|Overall Study|Mobile-phone could not be verified|2
4656335|NCT03179891|15991307|P2|First Intervention|Protocol Violation|1
4656336|NCT03179891|15991308|P1|First Intervention|Protocol Violation|0
4656337|NCT03179891|15991307|P2|First Intervention|Unspecified reason|0
4656338|NCT03179891|15991308|P1|First Intervention|Unspecified reason|1
4656339|NCT03179891|15991307|P2|First Intervention|Withdrawal by Subject|1
4656340|NCT03179891|15991308|P1|First Intervention|Withdrawal by Subject|1
4656341|NCT03178942|15991387|P2|Overall Study|Lost to Follow-up|2
4656342|NCT03178942|15991388|P1|Overall Study|Lost to Follow-up|1
4656343|NCT03178942|15991387|P2|Overall Study|Withdrawal by Subject|0
4656344|NCT03178942|15991388|P1|Overall Study|Withdrawal by Subject|2
4656345|NCT03178851|15991403|P3|Overall Study|Lost to Follow-up|0
4656346|NCT03178851|15991404|P2|Overall Study|Lost to Follow-up|1
4656347|NCT03178851|15991405|P1|Overall Study|Lost to Follow-up|2
4656348|NCT03178851|15991403|P3|Overall Study|Withdrawal by Subject|0
4656349|NCT03178851|15991404|P2|Overall Study|Withdrawal by Subject|0
4656350|NCT03178851|15991405|P1|Overall Study|Withdrawal by Subject|8
4656351|NCT03178851|15991403|P3|Overall Study|Death|10
4656352|NCT03178851|15991404|P2|Overall Study|Death|1
4656353|NCT03178851|15991405|P1|Overall Study|Death|35
4656354|NCT03178851|15991403|P3|Overall Study|Continuing on Study|42
4656355|NCT03178851|15991404|P2|Overall Study|Continuing on Study|9
4656356|NCT03178851|15991405|P1|Overall Study|Continuing on Study|47
4656357|NCT03178266|15991452|P2|Overall Study|Withdrawal by Subject|2
4656358|NCT03178266|15991453|P1|Overall Study|Withdrawal by Subject|0
4656359|NCT03178266|15991452|P2|Overall Study|Disont. Early|1
4656360|NCT03178266|15991453|P1|Overall Study|Disont. Early|0
4656361|NCT03178266|15991452|P2|Overall Study|Death|1
4656362|NCT03178266|15991453|P1|Overall Study|Death|0
4656363|NCT03176407|15991777|P1|Overall Study|EGD showed esophageal varices=excl. crit|1
4656364|NCT03176407|15991777|P1|Overall Study|human failure|1
4656365|NCT03176407|15991777|P1|Overall Study|Protocol Violation|1
4656366|NCT03176238|15991787|P2|Overall Study|Everolimus dose interrupt > 4 wks|0
4656367|NCT03176238|15991788|P1|Overall Study|Everolimus dose interrupt > 4 wks|9
4656368|NCT03176238|15991787|P2|Overall Study|Changes in the patient's condition|1
4656369|NCT03176238|15991788|P1|Overall Study|Changes in the patient's condition|2
4656370|NCT03176238|15991787|P2|Overall Study|Protocol Violation|0
4656371|NCT03176238|15991788|P1|Overall Study|Protocol Violation|1
4656372|NCT03176238|15991787|P2|Overall Study|Patient is switched to commercial drug|1
4656373|NCT03176238|15991788|P1|Overall Study|Patient is switched to commercial drug|16
4656374|NCT03176238|15991787|P2|Overall Study|Tx duration completed per EAP|1
4656375|NCT03176238|15991788|P1|Overall Study|Tx duration completed per EAP|0
4656376|NCT03176238|15991787|P2|Overall Study|Disease Progression|22
4656377|NCT03176238|15991788|P1|Overall Study|Disease Progression|133
4656378|NCT03176238|15991787|P2|Overall Study|Death|0
4656379|NCT03176238|15991788|P1|Overall Study|Death|3
4656380|NCT03176238|15991787|P2|Overall Study|Administrative problems|0
4656381|NCT03176238|15991788|P1|Overall Study|Administrative problems|1
4656382|NCT03176238|15991787|P2|Overall Study|Lost to Follow-up|0
4656383|NCT03176238|15991788|P1|Overall Study|Lost to Follow-up|3
4656384|NCT03176238|15991787|P2|Overall Study|Consent withdrawal|2
4656385|NCT03176238|15991788|P1|Overall Study|Consent withdrawal|14
4656386|NCT03176238|15991787|P2|Overall Study|Inter-current illness|1
4656387|NCT03176238|15991788|P1|Overall Study|Inter-current illness|0
4656388|NCT03176238|15991787|P2|Overall Study|Abnormal lab value(s)|0
4656389|NCT03176238|15991788|P1|Overall Study|Abnormal lab value(s)|2
4656390|NCT03176238|15991787|P2|Overall Study|Unacceptable AEs|8
4656391|NCT03176238|15991788|P1|Overall Study|Unacceptable AEs|15
4656392|NCT03175562|15991807|P1|Overall Study|Other (Not Specified)|5
4656393|NCT03175562|15991807|P1|Overall Study|Withdrawal by Subject|7
4656394|NCT03175562|15991807|P1|Overall Study|Lost to Follow-up|3
4656395|NCT03175562|15991807|P1|Overall Study|Adverse Event|1
4656396|NCT03175172|15991832|P1|Overall Study|Study Terminated by Sponsor|3
4656397|NCT03175172|15991832|P1|Overall Study|Lost to Follow-up|1
4656398|NCT03175172|15991832|P1|Overall Study|Withdrawal by Subject|3
4656399|NCT03175172|15991832|P1|Overall Study|Death|3
4656400|NCT03175120|15991842|P2|Overall Study|Other|3
4656401|NCT03175120|15991843|P1|Overall Study|Other|2
4656402|NCT03175120|15991842|P2|Overall Study|Withdrawal by Subject|5
4656403|NCT03175120|15991843|P1|Overall Study|Withdrawal by Subject|2
4656404|NCT03175120|15991842|P2|Overall Study|Lost to Follow-up|0
4656405|NCT03175120|15991843|P1|Overall Study|Lost to Follow-up|1
4656406|NCT03175120|15991842|P2|Overall Study|Protocol Violation|2
4656407|NCT03175120|15991843|P1|Overall Study|Protocol Violation|5
4656408|NCT03175120|15991842|P2|Overall Study|Adverse Event|2
4656409|NCT03175120|15991843|P1|Overall Study|Adverse Event|2
4656410|NCT03172702|15992027|P1|Overall Study|Other|2
4656411|NCT03172702|15992027|P1|Overall Study|Withdrawal by Subject|5
4656412|NCT03172702|15992027|P1|Overall Study|Study-specific Withdrawal Criteria|10
4656413|NCT03172702|15992027|P1|Overall Study|Death|2
4656414|NCT03172702|15992027|P1|Overall Study|Adverse Event|9
4656415|NCT03172494|15992055|P3|Overall Study|Non-compliance towards treatment|0
4656416|NCT03172494|15992056|P2|Overall Study|Non-compliance towards treatment|0
4656417|NCT03172494|15992057|P1|Overall Study|Non-compliance towards treatment|2
4656418|NCT03172494|15992055|P3|Overall Study|Severe hypoglycaemic episode|1
4656419|NCT03172494|15992056|P2|Overall Study|Severe hypoglycaemic episode|0
4656420|NCT03172494|15992057|P1|Overall Study|Severe hypoglycaemic episode|0
4656421|NCT03172494|15992055|P3|Overall Study|Withdrawal by Subject|8
4656422|NCT03172494|15992056|P2|Overall Study|Withdrawal by Subject|8
4656423|NCT03172494|15992057|P1|Overall Study|Withdrawal by Subject|10
4656424|NCT03172494|15992055|P3|Overall Study|Pregnancy|0
4656425|NCT03172494|15992056|P2|Overall Study|Pregnancy|1
4656426|NCT03172494|15992057|P1|Overall Study|Pregnancy|0
4656427|NCT03172494|15992055|P3|Overall Study|Lack of Efficacy|4
4656428|NCT03172494|15992056|P2|Overall Study|Lack of Efficacy|0
4656429|NCT03172494|15992057|P1|Overall Study|Lack of Efficacy|0
4656430|NCT03172494|15992055|P3|Overall Study|Protocol Violation|1
4656431|NCT03172494|15992056|P2|Overall Study|Protocol Violation|2
4656432|NCT03172494|15992057|P1|Overall Study|Protocol Violation|3
4656433|NCT03172494|15992055|P3|Overall Study|Adverse Event|15
4656434|NCT03172494|15992056|P2|Overall Study|Adverse Event|1
4656435|NCT03172494|15992057|P1|Overall Study|Adverse Event|5
4656436|NCT03172481|15992240|P2|Double-blind|Withdrawal by Subject|0
4656437|NCT03172481|15992241|P1|Double-blind|Withdrawal by Subject|1
4656438|NCT03172364|15992249|P2|Overall Study|Protocol Violation|0
4656439|NCT03172364|15992250|P1|Overall Study|Protocol Violation|1
4656440|NCT03172364|15992249|P2|Overall Study|Adverse Event|1
4656441|NCT03172364|15992250|P1|Overall Study|Adverse Event|1
4656442|NCT03172130|15992268|P2|Overall Study|Failure to tolerate CPAP/Sham CPAP|1
4656443|NCT03172130|15992269|P1|Overall Study|Failure to tolerate CPAP/Sham CPAP|3
4656444|NCT03171415|15992294|P5|Overall Study|Lost to Follow-up|2
4656445|NCT03171415|15992295|P4|Overall Study|Lost to Follow-up|0
4656446|NCT03171415|15992296|P3|Overall Study|Lost to Follow-up|0
4656447|NCT03171415|15992297|P2|Overall Study|Lost to Follow-up|0
4656448|NCT03171415|15992298|P1|Overall Study|Lost to Follow-up|0
4656449|NCT03170609|15992371|P7|Overall Study|Other|0
4656450|NCT03170609|15992372|P6|Overall Study|Other|1
4656451|NCT03170609|15992373|P5|Overall Study|Other|0
4656452|NCT03170609|15992374|P4|Overall Study|Other|0
4656453|NCT03170609|15992375|P3|Overall Study|Other|0
4656454|NCT03170609|15992376|P2|Overall Study|Other|0
4656455|NCT03170609|15992377|P1|Overall Study|Other|1
4656456|NCT03170609|15992371|P7|Overall Study|Lost to Follow-up|0
4656457|NCT03170609|15992372|P6|Overall Study|Lost to Follow-up|1
4656458|NCT03170609|15992373|P5|Overall Study|Lost to Follow-up|1
4656459|NCT03170609|15992374|P4|Overall Study|Lost to Follow-up|2
4656460|NCT03170609|15992375|P3|Overall Study|Lost to Follow-up|5
4656461|NCT03170609|15992376|P2|Overall Study|Lost to Follow-up|0
4656462|NCT03170609|15992377|P1|Overall Study|Lost to Follow-up|1
4656463|NCT03170609|15992371|P7|Overall Study|Withdrawal by Subject|1
4656464|NCT03170609|15992372|P6|Overall Study|Withdrawal by Subject|0
4656465|NCT03170609|15992373|P5|Overall Study|Withdrawal by Subject|0
4656466|NCT03170609|15992374|P4|Overall Study|Withdrawal by Subject|0
4656467|NCT03170609|15992375|P3|Overall Study|Withdrawal by Subject|0
4656468|NCT03170609|15992376|P2|Overall Study|Withdrawal by Subject|2
4656469|NCT03170609|15992377|P1|Overall Study|Withdrawal by Subject|1
4656470|NCT03170609|15992371|P7|Overall Study|Death|0
4656471|NCT03170609|15992372|P6|Overall Study|Death|0
4656472|NCT03170609|15992373|P5|Overall Study|Death|0
4656473|NCT03170609|15992374|P4|Overall Study|Death|0
4656474|NCT03170609|15992375|P3|Overall Study|Death|1
4656475|NCT03170609|15992376|P2|Overall Study|Death|0
4656476|NCT03170609|15992377|P1|Overall Study|Death|0
4656477|NCT03170544|15992447|P12|Part 1|Not treated|0
4656478|NCT03170544|15992448|P11|Part 1|Not treated|0
4656479|NCT03170544|15992449|P10|Part 1|Not treated|0
4656480|NCT03170544|15992450|P9|Part 1|Not treated|0
4656481|NCT03170544|15992451|P8|Part 1|Not treated|0
4656482|NCT03170544|15992452|P7|Part 1|Not treated|0
4656483|NCT03170544|15992453|P6|Part 1|Not treated|0
4656484|NCT03170544|15992454|P5|Part 1|Not treated|0
4656485|NCT03170544|15992455|P4|Part 1|Not treated|1
4656486|NCT03170544|15992456|P3|Part 1|Not treated|0
4656487|NCT03170544|15992457|P2|Part 1|Not treated|0
4656488|NCT03170544|15992458|P1|Part 1|Not treated|0
4656489|NCT03170544|15992447|P12|Part 1|Lost to Follow-up|0
4656490|NCT03170544|15992448|P11|Part 1|Lost to Follow-up|0
4656491|NCT03170544|15992449|P10|Part 1|Lost to Follow-up|0
4656492|NCT03170544|15992450|P9|Part 1|Lost to Follow-up|0
4656493|NCT03170544|15992451|P8|Part 1|Lost to Follow-up|0
4656494|NCT03170544|15992452|P7|Part 1|Lost to Follow-up|0
4656495|NCT03170544|15992453|P6|Part 1|Lost to Follow-up|0
4656496|NCT03170544|15992454|P5|Part 1|Lost to Follow-up|0
4656497|NCT03170544|15992455|P4|Part 1|Lost to Follow-up|0
4656498|NCT03170544|15992456|P3|Part 1|Lost to Follow-up|0
4656499|NCT03170544|15992457|P2|Part 1|Lost to Follow-up|0
4656500|NCT03170544|15992458|P1|Part 1|Lost to Follow-up|1
4656501|NCT03170232|15992622|P2|Overall Study|Withdrawal by Subject|1
4656502|NCT03170232|15992623|P1|Overall Study|Withdrawal by Subject|0
4656503|NCT03170232|15992622|P2|Overall Study|Lost to Follow-up|0
4656504|NCT03170232|15992623|P1|Overall Study|Lost to Follow-up|1
4656505|NCT03170232|15992622|P2|Overall Study|Study closed/terminated|23
4656506|NCT03170232|15992623|P1|Overall Study|Study closed/terminated|26
4656507|NCT03170232|15992622|P2|Overall Study|Lack of Efficacy|1
4656508|NCT03170232|15992623|P1|Overall Study|Lack of Efficacy|0
4656509|NCT03170232|15992622|P2|Overall Study|Protocol Violation|1
4656510|NCT03170232|15992623|P1|Overall Study|Protocol Violation|0
4656511|NCT03170232|15992622|P2|Overall Study|Adverse Event|1
4656512|NCT03170232|15992623|P1|Overall Study|Adverse Event|0
4656513|NCT03170193|15992701|P7|Overall Study|Lost to Follow-up|0
4656514|NCT03170193|15992702|P6|Overall Study|Lost to Follow-up|0
4656515|NCT03170193|15992703|P5|Overall Study|Lost to Follow-up|0
4656516|NCT03170193|15992704|P4|Overall Study|Lost to Follow-up|0
4656517|NCT03170193|15992705|P3|Overall Study|Lost to Follow-up|0
4656518|NCT03170193|15992706|P2|Overall Study|Lost to Follow-up|1
4656519|NCT03170193|15992707|P1|Overall Study|Lost to Follow-up|1
4656520|NCT03170193|15992701|P7|Overall Study|Withdrawal by Subject|0
4656521|NCT03170193|15992702|P6|Overall Study|Withdrawal by Subject|0
4656522|NCT03170193|15992703|P5|Overall Study|Withdrawal by Subject|0
4656523|NCT03170193|15992704|P4|Overall Study|Withdrawal by Subject|1
4656524|NCT03170193|15992705|P3|Overall Study|Withdrawal by Subject|0
4656525|NCT03170193|15992706|P2|Overall Study|Withdrawal by Subject|0
4656526|NCT03170193|15992707|P1|Overall Study|Withdrawal by Subject|0
4656527|NCT03170154|15992776|P1|Overall Study|Withdrawal by Subject|2
4656528|NCT03170154|15992776|P1|Overall Study|Death|2
4656529|NCT03170154|15992776|P1|Overall Study|Lost to Follow-up|4
4656530|NCT03169530|15992800|P2|Overall Study|Study ended by NIH|17
4656531|NCT03169530|15992801|P1|Overall Study|Study ended by NIH|15
4656532|NCT03169244|15992821|P2|Overall Study|Physician Decision|0
4656533|NCT03169244|15992822|P1|Overall Study|Physician Decision|1
4656534|NCT03169244|15992821|P2|Overall Study|Withdrawal by Subject|2
4656535|NCT03169244|15992822|P1|Overall Study|Withdrawal by Subject|2
4656536|NCT03169244|15992821|P2|Overall Study|Adverse Event|0
4656537|NCT03169244|15992822|P1|Overall Study|Adverse Event|1
4656538|NCT03169244|15992821|P2|Overall Study|Lost to Follow-up|2
4656539|NCT03169244|15992822|P1|Overall Study|Lost to Follow-up|1
4656540|NCT03169153|15992832|P2|Period 2, Second 30 Days of Wear|Could not attend visit|0
4656541|NCT03169153|15992833|P1|Period 2, Second 30 Days of Wear|Could not attend visit|1
4656542|NCT03169153|15992832|P2|Period 2, Second 30 Days of Wear|Adverse Event|2
4656543|NCT03169153|15992833|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
4656544|NCT03169153|15992832|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|3
4656545|NCT03169153|15992833|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|2
4656546|NCT03169153|15992832|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4656547|NCT03169153|15992833|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4656548|NCT03168919|15992844|P1|Overall Study|Withdrawal by Subject|2
4656549|NCT03168906|15992854|P2|Overall Study|Lack of Efficacy|6
4656550|NCT03168906|15992855|P1|Overall Study|Lack of Efficacy|6
4656551|NCT03168425|15992901|P2|Overall Study|unable to confirm post op opioids|3
4656552|NCT03168425|15992902|P1|Overall Study|unable to confirm post op opioids|2
4656553|NCT03168425|15992901|P2|Overall Study|Lost to Follow-up|8
4656554|NCT03168425|15992902|P1|Overall Study|Lost to Follow-up|5
4656555|NCT03167151|15992979|P3|Overall Study|No evidence of tumour at surgery|1
4656556|NCT03167151|15992980|P2|Overall Study|No evidence of tumour at surgery|1
4656557|NCT03167151|15992981|P1|Overall Study|No evidence of tumour at surgery|0
4656558|NCT03167151|15992979|P3|Overall Study|Withdrawal by Subject|0
4656559|NCT03167151|15992980|P2|Overall Study|Withdrawal by Subject|0
4656560|NCT03167151|15992981|P1|Overall Study|Withdrawal by Subject|1
4656561|NCT03166735|15992994|P5|Overall Study|Lost to Follow-up|1
4656562|NCT03166735|15992995|P4|Overall Study|Lost to Follow-up|0
4656563|NCT03166735|15992996|P3|Overall Study|Lost to Follow-up|1
4656564|NCT03166735|15992997|P2|Overall Study|Lost to Follow-up|2
4656565|NCT03166735|15992998|P1|Overall Study|Lost to Follow-up|0
4656566|NCT03166735|15992994|P5|Overall Study|Withdrawal by Subject|2
4656567|NCT03166735|15992995|P4|Overall Study|Withdrawal by Subject|1
4656568|NCT03166735|15992996|P3|Overall Study|Withdrawal by Subject|1
4656569|NCT03166735|15992997|P2|Overall Study|Withdrawal by Subject|0
4656570|NCT03166735|15992998|P1|Overall Study|Withdrawal by Subject|0
4656571|NCT03166735|15992994|P5|Overall Study|follow-up not completed as planned|1
4656572|NCT03166735|15992995|P4|Overall Study|follow-up not completed as planned|0
4656573|NCT03166735|15992996|P3|Overall Study|follow-up not completed as planned|1
4656574|NCT03166735|15992997|P2|Overall Study|follow-up not completed as planned|1
4656575|NCT03166735|15992998|P1|Overall Study|follow-up not completed as planned|0
4656576|NCT03166735|15992994|P5|Overall Study|Not Treated|0
4656577|NCT03166735|15992995|P4|Overall Study|Not Treated|0
4656578|NCT03166735|15992996|P3|Overall Study|Not Treated|0
4656579|NCT03166735|15992997|P2|Overall Study|Not Treated|0
4656580|NCT03166735|15992998|P1|Overall Study|Not Treated|1
4656581|NCT03166618|15993048|P2|Overall Study|Study was Terminated|1
4656582|NCT03166618|15993049|P1|Overall Study|Study was Terminated|0
4656583|NCT03166215|15993061|P3|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2
4656584|NCT03166215|15993062|P2|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
4656585|NCT03166215|15993063|P1|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0
4656586|NCT03166215|15993061|P3|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
4656587|NCT03166215|15993062|P2|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2
4656588|NCT03166215|15993063|P1|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0
4656589|NCT03166124|15993103|P4|Wash-out Period|Adverse Event|0
4656590|NCT03166124|15993104|P3|Wash-out Period|Adverse Event|1
4656591|NCT03166124|15993105|P2|Wash-out Period|Adverse Event|1
4656592|NCT03166124|15993106|P1|Wash-out Period|Adverse Event|0
4656593|NCT03166124|15993103|P4|Wash-out Period|Withdrawal by Subject|1
4656594|NCT03166124|15993104|P3|Wash-out Period|Withdrawal by Subject|0
4656595|NCT03166124|15993105|P2|Wash-out Period|Withdrawal by Subject|1
4656596|NCT03166124|15993106|P1|Wash-out Period|Withdrawal by Subject|0
4656597|NCT03166124|15993103|P4|Treatment Period 1|Adverse Event|0
4656598|NCT03166124|15993104|P3|Treatment Period 1|Adverse Event|1
4656599|NCT03166124|15993105|P2|Treatment Period 1|Adverse Event|0
4656600|NCT03166124|15993106|P1|Treatment Period 1|Adverse Event|0
4656601|NCT03165955|15993151|P1|Treatment|Progressive disease|3
4656602|NCT03165955|15993151|P1|Treatment|Adverse Event|1
4656603|NCT03165955|15993151|P1|Treatment|Death|1
4656604|NCT03165955|15993151|P1|Treatment|Withdrawal by Subject|3
4656605|NCT03165110|15993288|P1|Overall Study|Anroid phone software incompatibility|1
4656606|NCT03165045|15993310|P1|Visit 2|Available total CCQ score at vist 2 only|44
4656607|NCT03165045|15993310|P1|Visit 2|No available total CCQ score at all|29
4656608|NCT03165045|15993310|P1|Visit 2|Available CCQ score at visit 1 only|109
4656609|NCT03165045|15993310|P1|Visit 1|No visit 1|10
4656610|NCT03165045|15993310|P1|Visit 1|No treatment documented|10
4656611|NCT03165045|15993310|P1|Visit 1|No registration after visit 1|9
4656612|NCT03162796|15993415|P3|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
4656613|NCT03162796|15993416|P2|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2
4656614|NCT03162796|15993417|P1|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1
4656615|NCT03162796|15993415|P3|Active Treatment Period: Week 24 - 52|Adverse Event|0
4656616|NCT03162796|15993416|P2|Active Treatment Period: Week 24 - 52|Adverse Event|2
4656617|NCT03162796|15993417|P1|Active Treatment Period: Week 24 - 52|Adverse Event|3
4656618|NCT03162796|15993415|P3|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1
4656619|NCT03162796|15993416|P2|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3
4656620|NCT03162796|15993417|P1|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4
4656621|NCT03162796|15993415|P3|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
4656622|NCT03162796|15993416|P2|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2
4656623|NCT03162796|15993417|P1|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0
4656624|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Adverse Event|1
4656625|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Adverse Event|3
4656626|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Adverse Event|2
4656627|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
4656628|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0
4656629|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4
4656630|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1
4656631|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0
4656632|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3
4656633|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
4656634|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0
4656635|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1
4656636|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Death|0
4656637|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Death|0
4656638|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Death|1
4656639|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
4656640|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0
4656641|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1
4656642|NCT03162796|15993415|P3|Placebo Controlled Period: Week 0 - 24|Other|1
4656643|NCT03162796|15993416|P2|Placebo Controlled Period: Week 0 - 24|Other|1
4656644|NCT03162796|15993417|P1|Placebo Controlled Period: Week 0 - 24|Other|0
4656645|NCT03162614|15993727|P6|Overall Study|Missed vaccination, exclusion criteria|0
4656646|NCT03162614|15993728|P5|Overall Study|Missed vaccination, exclusion criteria|3
4656647|NCT03162614|15993729|P4|Overall Study|Missed vaccination, exclusion criteria|4
4656648|NCT03162614|15993730|P3|Overall Study|Missed vaccination, exclusion criteria|2
4656649|NCT03162614|15993731|P2|Overall Study|Missed vaccination, exclusion criteria|2
4656650|NCT03162614|15993732|P1|Overall Study|Missed vaccination, exclusion criteria|2
4656651|NCT03162614|15993727|P6|Overall Study|Withdrawal by Subject|0
4656652|NCT03162614|15993728|P5|Overall Study|Withdrawal by Subject|0
4656653|NCT03162614|15993729|P4|Overall Study|Withdrawal by Subject|1
4656654|NCT03162614|15993730|P3|Overall Study|Withdrawal by Subject|1
4656655|NCT03162614|15993731|P2|Overall Study|Withdrawal by Subject|1
4656656|NCT03162614|15993732|P1|Overall Study|Withdrawal by Subject|2
4656657|NCT03162614|15993727|P6|Overall Study|Protocol Violation|0
4656658|NCT03162614|15993728|P5|Overall Study|Protocol Violation|0
4656659|NCT03162614|15993729|P4|Overall Study|Protocol Violation|1
4656660|NCT03162614|15993730|P3|Overall Study|Protocol Violation|0
4656661|NCT03162614|15993731|P2|Overall Study|Protocol Violation|1
4656662|NCT03162614|15993732|P1|Overall Study|Protocol Violation|0
4656663|NCT03162614|15993727|P6|Overall Study|Lost to Follow-up|0
4656664|NCT03162614|15993728|P5|Overall Study|Lost to Follow-up|2
4656665|NCT03162614|15993729|P4|Overall Study|Lost to Follow-up|1
4656666|NCT03162614|15993730|P3|Overall Study|Lost to Follow-up|1
4656667|NCT03162614|15993731|P2|Overall Study|Lost to Follow-up|1
4656668|NCT03162614|15993732|P1|Overall Study|Lost to Follow-up|2
4656669|NCT03162328|15993851|P3|Study Period|Withdrawal by Subject|1
4656670|NCT03162328|15993852|P2|Study Period|Withdrawal by Subject|0
4656671|NCT03162328|15993853|P1|Study Period|Withdrawal by Subject|0
4656672|NCT03162328|15993851|P3|Screening Period|Withdrawal by Subject|0
4656673|NCT03162328|15993852|P2|Screening Period|Withdrawal by Subject|0
4656674|NCT03162328|15993853|P1|Screening Period|Withdrawal by Subject|1
4656675|NCT03162328|15993851|P3|Screening Period|Did not meet inclusion/exclusion|0
4656676|NCT03162328|15993852|P2|Screening Period|Did not meet inclusion/exclusion|0
4656677|NCT03162328|15993853|P1|Screening Period|Did not meet inclusion/exclusion|21
4656678|NCT03162055|15993882|P2|Overall Study|Other|15
4656679|NCT03162055|15993883|P1|Overall Study|Other|8
4656680|NCT03162055|15993882|P2|Overall Study|Incorrect randomization|3
4656681|NCT03162055|15993883|P1|Overall Study|Incorrect randomization|4
4656682|NCT03162055|15993882|P2|Overall Study|Did not receive treatment|0
4656683|NCT03162055|15993883|P1|Overall Study|Did not receive treatment|2
4656684|NCT03162055|15993882|P2|Overall Study|Withdrawal by Subject|2
4656685|NCT03162055|15993883|P1|Overall Study|Withdrawal by Subject|17
4656686|NCT03162055|15993882|P2|Overall Study|Study-specific withdrawal criteria|14
4656687|NCT03162055|15993883|P1|Overall Study|Study-specific withdrawal criteria|22
4656688|NCT03162055|15993882|P2|Overall Study|Lost to Follow-up|1
4656689|NCT03162055|15993883|P1|Overall Study|Lost to Follow-up|0
4656690|NCT03162055|15993882|P2|Overall Study|Death|3
4656691|NCT03162055|15993883|P1|Overall Study|Death|3
4656692|NCT03162055|15993882|P2|Overall Study|Adverse Event|5
4656693|NCT03162055|15993883|P1|Overall Study|Adverse Event|6
4656694|NCT03161405|15993975|P1|Second Intervention Period (6 Days)|Positive urine drug screen|1
4656695|NCT03160898|15993995|P4|Overall Study|Other|2
4656696|NCT03160898|15993996|P3|Overall Study|Other|2
4656697|NCT03160898|15993997|P2|Overall Study|Other|0
4656698|NCT03160898|15993998|P1|Overall Study|Other|2
4656699|NCT03160898|15993995|P4|Overall Study|Withdrawal by Subject|1
4656700|NCT03160898|15993996|P3|Overall Study|Withdrawal by Subject|2
4656701|NCT03160898|15993997|P2|Overall Study|Withdrawal by Subject|3
4656702|NCT03160898|15993998|P1|Overall Study|Withdrawal by Subject|1
4656703|NCT03160898|15993995|P4|Overall Study|Sponsor Discretion|0
4656704|NCT03160898|15993996|P3|Overall Study|Sponsor Discretion|0
4656705|NCT03160898|15993997|P2|Overall Study|Sponsor Discretion|0
4656706|NCT03160898|15993998|P1|Overall Study|Sponsor Discretion|2
4656707|NCT03160898|15993995|P4|Overall Study|Protocol Violation|0
4656708|NCT03160898|15993996|P3|Overall Study|Protocol Violation|2
4656709|NCT03160898|15993997|P2|Overall Study|Protocol Violation|0
4656710|NCT03160898|15993998|P1|Overall Study|Protocol Violation|1
4656711|NCT03160898|15993995|P4|Overall Study|Progressive Disease|1
4656712|NCT03160898|15993996|P3|Overall Study|Progressive Disease|2
4656713|NCT03160898|15993997|P2|Overall Study|Progressive Disease|1
4656714|NCT03160898|15993998|P1|Overall Study|Progressive Disease|4
4656715|NCT03160898|15993995|P4|Overall Study|Physician Decision|1
4656716|NCT03160898|15993996|P3|Overall Study|Physician Decision|0
4656717|NCT03160898|15993997|P2|Overall Study|Physician Decision|0
4656718|NCT03160898|15993998|P1|Overall Study|Physician Decision|1
4656719|NCT03160898|15993995|P4|Overall Study|Lost to Follow-up|2
4656720|NCT03160898|15993996|P3|Overall Study|Lost to Follow-up|1
4656721|NCT03160898|15993997|P2|Overall Study|Lost to Follow-up|1
4656722|NCT03160898|15993998|P1|Overall Study|Lost to Follow-up|1
4656723|NCT03160898|15993995|P4|Overall Study|Difficulty Traveling to Clinic Visits|1
4656724|NCT03160898|15993996|P3|Overall Study|Difficulty Traveling to Clinic Visits|0
4656725|NCT03160898|15993997|P2|Overall Study|Difficulty Traveling to Clinic Visits|0
4656726|NCT03160898|15993998|P1|Overall Study|Difficulty Traveling to Clinic Visits|3
4656727|NCT03160898|15993995|P4|Overall Study|Death|1
4656728|NCT03160898|15993996|P3|Overall Study|Death|0
4656729|NCT03160898|15993997|P2|Overall Study|Death|0
4656730|NCT03160898|15993998|P1|Overall Study|Death|1
4656731|NCT03160898|15993995|P4|Overall Study|Adverse Event|10
4656732|NCT03160898|15993996|P3|Overall Study|Adverse Event|7
4656733|NCT03160898|15993997|P2|Overall Study|Adverse Event|8
4656734|NCT03160898|15993998|P1|Overall Study|Adverse Event|4
4656735|NCT03160885|15994021|P7|Maintenance Treatment Period|Completed Week 50|0
4656736|NCT03160885|15994022|P6|Maintenance Treatment Period|Completed Week 50|0
4656737|NCT03160885|15994023|P5|Maintenance Treatment Period|Completed Week 50|0
4656738|NCT03160885|15994024|P4|Maintenance Treatment Period|Completed Week 50|0
4656739|NCT03160885|15994025|P3|Maintenance Treatment Period|Completed Week 50|1
4656740|NCT03160885|15994026|P2|Maintenance Treatment Period|Completed Week 50|0
4656741|NCT03160885|15994027|P1|Maintenance Treatment Period|Completed Week 50|0
4656742|NCT03160885|15994021|P7|Maintenance Treatment Period|Transfer to open-label treatment|0
4656743|NCT03160885|15994022|P6|Maintenance Treatment Period|Transfer to open-label treatment|8
4656744|NCT03160885|15994023|P5|Maintenance Treatment Period|Transfer to open-label treatment|26
4656745|NCT03160885|15994024|P4|Maintenance Treatment Period|Transfer to open-label treatment|26
4656746|NCT03160885|15994025|P3|Maintenance Treatment Period|Transfer to open-label treatment|29
4656747|NCT03160885|15994026|P2|Maintenance Treatment Period|Transfer to open-label treatment|0
4656748|NCT03160885|15994027|P1|Maintenance Treatment Period|Transfer to open-label treatment|0
4656749|NCT03160885|15994021|P7|Maintenance Treatment Period|Discontinued IMP|0
4656750|NCT03160885|15994022|P6|Maintenance Treatment Period|Discontinued IMP|7
4656751|NCT03160885|15994023|P5|Maintenance Treatment Period|Discontinued IMP|5
4656752|NCT03160885|15994024|P4|Maintenance Treatment Period|Discontinued IMP|13
4656753|NCT03160885|15994025|P3|Maintenance Treatment Period|Discontinued IMP|9
4656754|NCT03160885|15994026|P2|Maintenance Treatment Period|Discontinued IMP|0
4656755|NCT03160885|15994027|P1|Maintenance Treatment Period|Discontinued IMP|0
4656756|NCT03160885|15994021|P7|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4656757|NCT03160885|15994022|P6|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4656758|NCT03160885|15994023|P5|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4656759|NCT03160885|15994024|P4|Maintenance Treatment Period|Not dosed - transfer to open-label|1
4656760|NCT03160885|15994025|P3|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4656761|NCT03160885|15994026|P2|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4656762|NCT03160885|15994027|P1|Maintenance Treatment Period|Not dosed - transfer to open-label|0
4656763|NCT03160885|15994021|P7|Open-label Treatment|Completed Week 50|4
4656764|NCT03160885|15994022|P6|Open-label Treatment|Completed Week 50|0
4656765|NCT03160885|15994023|P5|Open-label Treatment|Completed Week 50|0
4656766|NCT03160885|15994024|P4|Open-label Treatment|Completed Week 50|0
4656767|NCT03160885|15994025|P3|Open-label Treatment|Completed Week 50|0
4656768|NCT03160885|15994026|P2|Open-label Treatment|Completed Week 50|0
4656769|NCT03160885|15994027|P1|Open-label Treatment|Completed Week 50|0
4656770|NCT03160885|15994021|P7|Open-label Treatment|Discontinued IMP|131
4656771|NCT03160885|15994022|P6|Open-label Treatment|Discontinued IMP|0
4656772|NCT03160885|15994023|P5|Open-label Treatment|Discontinued IMP|0
4656773|NCT03160885|15994024|P4|Open-label Treatment|Discontinued IMP|0
4656774|NCT03160885|15994025|P3|Open-label Treatment|Discontinued IMP|0
4656775|NCT03160885|15994026|P2|Open-label Treatment|Discontinued IMP|0
4656776|NCT03160885|15994027|P1|Open-label Treatment|Discontinued IMP|0
4656777|NCT03160885|15994021|P7|Open-label Treatment|Not dosed|2
4656778|NCT03160885|15994022|P6|Open-label Treatment|Not dosed|0
4656779|NCT03160885|15994023|P5|Open-label Treatment|Not dosed|0
4656780|NCT03160885|15994024|P4|Open-label Treatment|Not dosed|0
4656781|NCT03160885|15994025|P3|Open-label Treatment|Not dosed|0
4656782|NCT03160885|15994026|P2|Open-label Treatment|Not dosed|0
4656783|NCT03160885|15994027|P1|Open-label Treatment|Not dosed|0
4656784|NCT03160885|15994021|P7|Initial Treatment Period|Discontinued IMP before Week 16|0
4656785|NCT03160885|15994022|P6|Initial Treatment Period|Discontinued IMP before Week 16|0
4656786|NCT03160885|15994023|P5|Initial Treatment Period|Discontinued IMP before Week 16|0
4656787|NCT03160885|15994024|P4|Initial Treatment Period|Discontinued IMP before Week 16|0
4656788|NCT03160885|15994025|P3|Initial Treatment Period|Discontinued IMP before Week 16|0
4656789|NCT03160885|15994026|P2|Initial Treatment Period|Discontinued IMP before Week 16|22
4656790|NCT03160885|15994027|P1|Initial Treatment Period|Discontinued IMP before Week 16|33
4656791|NCT03160885|15994021|P7|Initial Treatment Period|Not dosed|0
4656792|NCT03160885|15994022|P6|Initial Treatment Period|Not dosed|0
4656793|NCT03160885|15994023|P5|Initial Treatment Period|Not dosed|0
4656794|NCT03160885|15994024|P4|Initial Treatment Period|Not dosed|0
4656795|NCT03160885|15994025|P3|Initial Treatment Period|Not dosed|0
4656796|NCT03160885|15994026|P2|Initial Treatment Period|Not dosed|0
4656797|NCT03160885|15994027|P1|Initial Treatment Period|Not dosed|2
4656798|NCT03160716|15994073|P1|Overall Study|Lost to Follow-up|1
4656799|NCT03160703|15994084|P4|Overall Study|Withdrawal by Subject|1
4656800|NCT03160703|15994085|P3|Overall Study|Withdrawal by Subject|0
4656801|NCT03160703|15994086|P2|Overall Study|Withdrawal by Subject|0
4656802|NCT03160703|15994087|P1|Overall Study|Withdrawal by Subject|0
4656803|NCT03159611|15994165|P2|Overall Study|Inability to perform procedures|0
4656804|NCT03159611|15994166|P1|Overall Study|Inability to perform procedures|1
4656805|NCT03159611|15994165|P2|Overall Study|Non-compliance with protocol requirement|2
4656806|NCT03159611|15994166|P1|Overall Study|Non-compliance with protocol requirement|3
4656807|NCT03159611|15994165|P2|Overall Study|Withdrawal by Subject|1
4656808|NCT03159611|15994166|P1|Overall Study|Withdrawal by Subject|1
4656809|NCT03159611|15994165|P2|Overall Study|Adverse Event|0
4656810|NCT03159611|15994166|P1|Overall Study|Adverse Event|1
4656811|NCT03159611|15994165|P2|Overall Study|Protocol Violation|4
4656812|NCT03159611|15994166|P1|Overall Study|Protocol Violation|7
4656813|NCT03159611|15994165|P2|Overall Study|Did Not Meet Exclusion Criteria|3
4656814|NCT03159611|15994166|P1|Overall Study|Did Not Meet Exclusion Criteria|1
4656815|NCT03159611|15994165|P2|Overall Study|Did Not Meet Inclusion Criteria|5
4656816|NCT03159611|15994166|P1|Overall Study|Did Not Meet Inclusion Criteria|9
4656817|NCT03159468|15994186|P6|Overall Study|Withdrawal by Subject|0
4656818|NCT03159468|15994187|P5|Overall Study|Withdrawal by Subject|0
4656819|NCT03159468|15994188|P4|Overall Study|Withdrawal by Subject|0
4656820|NCT03159468|15994189|P3|Overall Study|Withdrawal by Subject|3
4656821|NCT03159468|15994190|P2|Overall Study|Withdrawal by Subject|0
4656822|NCT03159468|15994191|P1|Overall Study|Withdrawal by Subject|0
4656823|NCT03158688|15994240|P2|Overall Study|Lost to Follow-up|3
4656824|NCT03158688|15994241|P1|Overall Study|Lost to Follow-up|0
4656825|NCT03158688|15994240|P2|Overall Study|Decision by sponsor|3
4656826|NCT03158688|15994241|P1|Overall Study|Decision by sponsor|2
4656827|NCT03158688|15994240|P2|Overall Study|Withdrawal by Subject|14
4656828|NCT03158688|15994241|P1|Overall Study|Withdrawal by Subject|9
4656829|NCT03158688|15994240|P2|Overall Study|Death|59
4656830|NCT03158688|15994241|P1|Overall Study|Death|36
4656831|NCT03158688|15994240|P2|Overall Study|Continuing in study|233
4656832|NCT03158688|15994241|P1|Overall Study|Continuing in study|107
4656833|NCT03158311|15994274|P3|Overall Study|Randomized in error|1
4656834|NCT03158311|15994275|P2|Overall Study|Randomized in error|0
4656835|NCT03158311|15994276|P1|Overall Study|Randomized in error|0
4656836|NCT03158311|15994274|P3|Overall Study|Pregnancy|0
4656837|NCT03158311|15994275|P2|Overall Study|Pregnancy|2
4656838|NCT03158311|15994276|P1|Overall Study|Pregnancy|0
4656839|NCT03158311|15994274|P3|Overall Study|Sponsor decision|0
4656840|NCT03158311|15994275|P2|Overall Study|Sponsor decision|0
4656841|NCT03158311|15994276|P1|Overall Study|Sponsor decision|1
4656842|NCT03158311|15994274|P3|Overall Study|Lost to Follow-up|1
4656843|NCT03158311|15994275|P2|Overall Study|Lost to Follow-up|1
4656844|NCT03158311|15994276|P1|Overall Study|Lost to Follow-up|1
4656845|NCT03158311|15994274|P3|Overall Study|Physician Decision|7
4656846|NCT03158311|15994275|P2|Overall Study|Physician Decision|3
4656847|NCT03158311|15994276|P1|Overall Study|Physician Decision|2
4656848|NCT03158311|15994274|P3|Overall Study|Techinical Problems|5
4656849|NCT03158311|15994275|P2|Overall Study|Techinical Problems|1
4656850|NCT03158311|15994276|P1|Overall Study|Techinical Problems|3
4656851|NCT03158311|15994274|P3|Overall Study|Adverse Event|3
4656852|NCT03158311|15994275|P2|Overall Study|Adverse Event|3
4656853|NCT03158311|15994276|P1|Overall Study|Adverse Event|5
4656854|NCT03158311|15994274|P3|Overall Study|Subject/Guardian Decision|11
4656855|NCT03158311|15994275|P2|Overall Study|Subject/Guardian Decision|6
4656856|NCT03158311|15994276|P1|Overall Study|Subject/Guardian Decision|10
4656857|NCT03158220|15994307|P2|Overall Study|Physician Decision|0
4656858|NCT03158220|15994308|P1|Overall Study|Physician Decision|1
4656859|NCT03158220|15994307|P2|Overall Study|Lost to Follow-up|5
4656860|NCT03158220|15994308|P1|Overall Study|Lost to Follow-up|8
4656861|NCT03158220|15994307|P2|Overall Study|Status unknown|1
4656862|NCT03158220|15994308|P1|Overall Study|Status unknown|0
4656863|NCT03158220|15994307|P2|Overall Study|Withdrawal by Subject|9
4656864|NCT03158220|15994308|P1|Overall Study|Withdrawal by Subject|8
4656865|NCT03158220|15994307|P2|Overall Study|Screen Failure|1
4656866|NCT03158220|15994308|P1|Overall Study|Screen Failure|0
4656867|NCT03158012|15994345|P2|Overall Study|Withdrawal by Subject|1
4656868|NCT03158012|15994346|P1|Overall Study|Withdrawal by Subject|0
4656869|NCT03157583|15994352|P1|Overall Study|Other (did not meet study criteria)|1
4656870|NCT03157531|15994370|P1|Overall Study|Lost to Follow-up|4
4656871|NCT03157531|15994370|P1|Overall Study|Death|2
4656872|NCT03156543|15994391|P2|Overall Study|Withdrawal by Subject|0
4656873|NCT03156543|15994392|P1|Overall Study|Withdrawal by Subject|1
4656874|NCT03155269|15994402|P2|Overall Study|Lost to Follow-up|2
4656875|NCT03155269|15994403|P1|Overall Study|Lost to Follow-up|1
4656876|NCT03155269|15994402|P2|Overall Study|Withdrawal by Subject|5
4656877|NCT03155269|15994403|P1|Overall Study|Withdrawal by Subject|4
4656878|NCT03155178|15994449|P4|Overall Study|Did not meet treatment day baseline|7
4656879|NCT03155178|15994450|P3|Overall Study|Did not meet treatment day baseline|7
4656880|NCT03155178|15994451|P2|Overall Study|Did not meet treatment day baseline|7
4656881|NCT03155178|15994452|P1|Overall Study|Did not meet treatment day baseline|7
4656882|NCT03154086|15994496|P15|Part B (Up to 25 Days)|Adverse Event|0
4656883|NCT03154086|15994497|P14|Part B (Up to 25 Days)|Adverse Event|0
4656884|NCT03154086|15994498|P13|Part B (Up to 25 Days)|Adverse Event|0
4656885|NCT03154086|15994499|P12|Part B (Up to 25 Days)|Adverse Event|0
4656886|NCT03154086|15994500|P11|Part B (Up to 25 Days)|Adverse Event|1
4656887|NCT03154086|15994501|P10|Part B (Up to 25 Days)|Adverse Event|0
4656888|NCT03154086|15994502|P9|Part B (Up to 25 Days)|Adverse Event|0
4656889|NCT03154086|15994503|P8|Part B (Up to 25 Days)|Adverse Event|0
4656890|NCT03154086|15994504|P7|Part B (Up to 25 Days)|Adverse Event|0
4656891|NCT03154086|15994505|P6|Part B (Up to 25 Days)|Adverse Event|0
4656892|NCT03154086|15994506|P5|Part B (Up to 25 Days)|Adverse Event|0
4656893|NCT03154086|15994507|P4|Part B (Up to 25 Days)|Adverse Event|0
4656894|NCT03154086|15994508|P3|Part B (Up to 25 Days)|Adverse Event|0
4656895|NCT03154086|15994509|P2|Part B (Up to 25 Days)|Adverse Event|0
4656896|NCT03154086|15994510|P1|Part B (Up to 25 Days)|Adverse Event|0
4656897|NCT03154086|15994496|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656898|NCT03154086|15994497|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656899|NCT03154086|15994498|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656900|NCT03154086|15994499|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656901|NCT03154086|15994500|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656902|NCT03154086|15994501|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656903|NCT03154086|15994502|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656904|NCT03154086|15994503|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1
4656905|NCT03154086|15994504|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656906|NCT03154086|15994505|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656907|NCT03154086|15994506|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656908|NCT03154086|15994507|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656909|NCT03154086|15994508|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656910|NCT03154086|15994509|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656911|NCT03154086|15994510|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0
4656912|NCT03154086|15994496|P15|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656913|NCT03154086|15994497|P14|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656914|NCT03154086|15994498|P13|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656915|NCT03154086|15994499|P12|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656916|NCT03154086|15994500|P11|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656917|NCT03154086|15994501|P10|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656918|NCT03154086|15994502|P9|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1
4656919|NCT03154086|15994503|P8|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656920|NCT03154086|15994504|P7|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656921|NCT03154086|15994505|P6|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656922|NCT03154086|15994506|P5|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656923|NCT03154086|15994507|P4|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656924|NCT03154086|15994508|P3|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656925|NCT03154086|15994509|P2|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656926|NCT03154086|15994510|P1|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0
4656927|NCT03154086|15994496|P15|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656928|NCT03154086|15994497|P14|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656929|NCT03154086|15994498|P13|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656930|NCT03154086|15994499|P12|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656931|NCT03154086|15994500|P11|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656932|NCT03154086|15994501|P10|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656933|NCT03154086|15994502|P9|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656934|NCT03154086|15994503|P8|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656935|NCT03154086|15994504|P7|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656936|NCT03154086|15994505|P6|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656937|NCT03154086|15994506|P5|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656938|NCT03154086|15994507|P4|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656939|NCT03154086|15994508|P3|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656940|NCT03154086|15994509|P2|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0
4656941|NCT03154086|15994510|P1|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1
4656942|NCT03154086|15994496|P15|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656943|NCT03154086|15994497|P14|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656944|NCT03154086|15994498|P13|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656945|NCT03154086|15994499|P12|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656946|NCT03154086|15994500|P11|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656947|NCT03154086|15994501|P10|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656948|NCT03154086|15994502|P9|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656949|NCT03154086|15994503|P8|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656950|NCT03154086|15994504|P7|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656951|NCT03154086|15994505|P6|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656952|NCT03154086|15994506|P5|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656953|NCT03154086|15994507|P4|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656954|NCT03154086|15994508|P3|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1
4656955|NCT03154086|15994509|P2|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656956|NCT03154086|15994510|P1|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0
4656957|NCT03154086|15994496|P15|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656958|NCT03154086|15994497|P14|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656959|NCT03154086|15994498|P13|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656960|NCT03154086|15994499|P12|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656961|NCT03154086|15994500|P11|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656962|NCT03154086|15994501|P10|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656963|NCT03154086|15994502|P9|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656964|NCT03154086|15994503|P8|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656965|NCT03154086|15994504|P7|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656966|NCT03154086|15994505|P6|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656967|NCT03154086|15994506|P5|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656968|NCT03154086|15994507|P4|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656969|NCT03154086|15994508|P3|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656970|NCT03154086|15994509|P2|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1
4656971|NCT03154086|15994510|P1|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0
4656972|NCT03154086|15994496|P15|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656973|NCT03154086|15994497|P14|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656974|NCT03154086|15994498|P13|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656975|NCT03154086|15994499|P12|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656976|NCT03154086|15994500|P11|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656977|NCT03154086|15994501|P10|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656978|NCT03154086|15994502|P9|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656979|NCT03154086|15994503|P8|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656980|NCT03154086|15994504|P7|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656981|NCT03154086|15994505|P6|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656982|NCT03154086|15994506|P5|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656983|NCT03154086|15994507|P4|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1
4656984|NCT03154086|15994508|P3|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656985|NCT03154086|15994509|P2|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656986|NCT03154086|15994510|P1|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0
4656987|NCT03154047|15994910|P1|Overall Study|Withdrawal by Subject|3
4656988|NCT03154047|15994910|P1|Overall Study|Study terminated by sponsor|76
4656989|NCT03154047|15994910|P1|Overall Study|Death|1
4656990|NCT03152552|15994957|P5|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11
4656991|NCT03152552|15994958|P4|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
4656992|NCT03152552|15994959|P3|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9
4656993|NCT03152552|15994960|P2|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5
4656994|NCT03152552|15994961|P1|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6
4656995|NCT03152552|15994957|P5|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4656996|NCT03152552|15994958|P4|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1
4656997|NCT03152552|15994959|P3|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4656998|NCT03152552|15994960|P2|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4656999|NCT03152552|15994961|P1|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0
4657000|NCT03152552|15994957|P5|Treatment Period 1 (12 Weeks)|Technical problems|0
4657001|NCT03152552|15994958|P4|Treatment Period 1 (12 Weeks)|Technical problems|0
4657002|NCT03152552|15994959|P3|Treatment Period 1 (12 Weeks)|Technical problems|1
4657003|NCT03152552|15994960|P2|Treatment Period 1 (12 Weeks)|Technical problems|0
4657004|NCT03152552|15994961|P1|Treatment Period 1 (12 Weeks)|Technical problems|0
4657005|NCT03152552|15994957|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4657006|NCT03152552|15994958|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4657007|NCT03152552|15994959|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4657008|NCT03152552|15994960|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4657009|NCT03152552|15994961|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4657010|NCT03152552|15994957|P5|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20
4657011|NCT03152552|15994958|P4|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
4657012|NCT03152552|15994959|P3|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19
4657013|NCT03152552|15994960|P2|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9
4657014|NCT03152552|15994961|P1|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8
4657015|NCT03152552|15994957|P5|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4657016|NCT03152552|15994958|P4|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4657017|NCT03152552|15994959|P3|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4657018|NCT03152552|15994960|P2|Treatment Period 1 (12 Weeks)|Protocol deviation|1
4657019|NCT03152552|15994961|P1|Treatment Period 1 (12 Weeks)|Protocol deviation|0
4657020|NCT03152552|15994957|P5|Treatment Period 1 (12 Weeks)|Death|1
4657021|NCT03152552|15994958|P4|Treatment Period 1 (12 Weeks)|Death|0
4657022|NCT03152552|15994959|P3|Treatment Period 1 (12 Weeks)|Death|0
4657023|NCT03152552|15994960|P2|Treatment Period 1 (12 Weeks)|Death|1
4657024|NCT03152552|15994961|P1|Treatment Period 1 (12 Weeks)|Death|0
4657025|NCT03152526|15995094|P2|Overall Study|Withdrawal by Subject|1
4657026|NCT03152526|15995095|P1|Overall Study|Withdrawal by Subject|0
4657027|NCT03152019|15995117|P2|Overall Study|Adverse Event|1
4657028|NCT03152019|15995118|P1|Overall Study|Adverse Event|0
4657029|NCT03151551|15995126|P2|Overall Study|Ongoing|266
4657030|NCT03151551|15995127|P1|Overall Study|Ongoing|262
4657031|NCT03151551|15995126|P2|Overall Study|Physician Decision|0
4657032|NCT03151551|15995127|P1|Overall Study|Physician Decision|2
4657033|NCT03151551|15995126|P2|Overall Study|Lack of Efficacy|1
4657034|NCT03151551|15995127|P1|Overall Study|Lack of Efficacy|2
4657035|NCT03151551|15995126|P2|Overall Study|Protocol Violation|2
4657036|NCT03151551|15995127|P1|Overall Study|Protocol Violation|1
4657037|NCT03151551|15995126|P2|Overall Study|Withdrawal by Subject|6
4657038|NCT03151551|15995127|P1|Overall Study|Withdrawal by Subject|7
4657039|NCT03151551|15995126|P2|Overall Study|Adverse Event|1
4657040|NCT03151551|15995127|P1|Overall Study|Adverse Event|1
4657041|NCT03151226|15995162|P1|Overall Study|not wear device correctly|1
4657042|NCT03151226|15995162|P1|Overall Study|Withdrawal by Subject|2
4657043|NCT03151148|15995168|P2|Overall Study|Withdrawal by Subject|0
4657044|NCT03151148|15995169|P1|Overall Study|Withdrawal by Subject|1
4657045|NCT03151148|15995168|P2|Overall Study|Lost to Follow-up|0
4657046|NCT03151148|15995169|P1|Overall Study|Lost to Follow-up|1
4657047|NCT03150719|15995223|P2|Overall Study|Other|0
4657048|NCT03150719|15995224|P1|Overall Study|Other|1
4657049|NCT03150719|15995223|P2|Overall Study|Death|1
4657050|NCT03150719|15995224|P1|Overall Study|Death|0
4657051|NCT03150719|15995223|P2|Overall Study|Adverse Event|1
4657052|NCT03150719|15995224|P1|Overall Study|Adverse Event|0
4657053|NCT03150485|15995240|P6|Overall Study|Unsatisfactory Lens Fitting|0
4657054|NCT03150485|15995241|P5|Overall Study|Unsatisfactory Lens Fitting|0
4657055|NCT03150485|15995242|P4|Overall Study|Unsatisfactory Lens Fitting|0
4657056|NCT03150485|15995243|P3|Overall Study|Unsatisfactory Lens Fitting|0
4657057|NCT03150485|15995244|P2|Overall Study|Unsatisfactory Lens Fitting|1
4657058|NCT03150485|15995245|P1|Overall Study|Unsatisfactory Lens Fitting|0
4657059|NCT03150082|15995422|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
4657060|NCT03150082|15995423|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1
4657061|NCT03149848|15995529|P1|Period 2 (Day 15 to Day 28)|Adverse Event|2
4657062|NCT03149848|15995529|P1|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1
4657063|NCT03149055|15995582|P1|Overall Study|Not treated|4
4657064|NCT03149042|15995587|P1|Overall Study|Invasive FFR Measurement cancelled|1
4657065|NCT03149042|15995587|P1|Overall Study|Poor CT Image Quality|1
4657066|NCT03149042|15995587|P1|Overall Study|Invasive FFR not performed|21
4657067|NCT03148756|15995601|P2|Overall Study|Study Terminated|1
4657068|NCT03148756|15995602|P1|Overall Study|Study Terminated|0
4657069|NCT03148691|15995635|P3|Overall Study|Withdrawal by Subject|0
4657070|NCT03148691|15995636|P2|Overall Study|Withdrawal by Subject|0
4657071|NCT03148691|15995637|P1|Overall Study|Withdrawal by Subject|1
4657072|NCT03148691|15995635|P3|Overall Study|Other|0
4657073|NCT03148691|15995636|P2|Overall Study|Other|0
4657074|NCT03148691|15995637|P1|Overall Study|Other|1
4657075|NCT03148691|15995635|P3|Overall Study|Lost to Follow-up|1
4657076|NCT03148691|15995636|P2|Overall Study|Lost to Follow-up|0
4657077|NCT03148691|15995637|P1|Overall Study|Lost to Follow-up|0
4657078|NCT03148691|15995635|P3|Overall Study|Protocol Violation|7
4657079|NCT03148691|15995636|P2|Overall Study|Protocol Violation|2
4657080|NCT03148691|15995637|P1|Overall Study|Protocol Violation|1
4657081|NCT03148067|15995700|P1|Overall Study|Death|1
4657082|NCT03148067|15995700|P1|Overall Study|Lost to Follow-up|3
4657083|NCT03147248|15995711|P6|Overall Study|Prolonged Dosing Interval|1
4657084|NCT03147248|15995712|P5|Overall Study|Prolonged Dosing Interval|1
4657085|NCT03147248|15995713|P4|Overall Study|Prolonged Dosing Interval|0
4657086|NCT03147248|15995714|P3|Overall Study|Prolonged Dosing Interval|0
4657087|NCT03147248|15995715|P2|Overall Study|Prolonged Dosing Interval|0
4657088|NCT03147248|15995716|P1|Overall Study|Prolonged Dosing Interval|0
4657089|NCT03147248|15995711|P6|Overall Study|Physician Decision|4
4657090|NCT03147248|15995712|P5|Overall Study|Physician Decision|2
4657091|NCT03147248|15995713|P4|Overall Study|Physician Decision|0
4657092|NCT03147248|15995714|P3|Overall Study|Physician Decision|0
4657093|NCT03147248|15995715|P2|Overall Study|Physician Decision|0
4657094|NCT03147248|15995716|P1|Overall Study|Physician Decision|0
4657095|NCT03147248|15995711|P6|Overall Study|Death|4
4657096|NCT03147248|15995712|P5|Overall Study|Death|0
4657097|NCT03147248|15995713|P4|Overall Study|Death|0
4657098|NCT03147248|15995714|P3|Overall Study|Death|0
4657099|NCT03147248|15995715|P2|Overall Study|Death|0
4657100|NCT03147248|15995716|P1|Overall Study|Death|0
4657101|NCT03147248|15995711|P6|Overall Study|Pregnancy|0
4657102|NCT03147248|15995712|P5|Overall Study|Pregnancy|1
4657103|NCT03147248|15995713|P4|Overall Study|Pregnancy|0
4657104|NCT03147248|15995714|P3|Overall Study|Pregnancy|0
4657105|NCT03147248|15995715|P2|Overall Study|Pregnancy|0
4657106|NCT03147248|15995716|P1|Overall Study|Pregnancy|0
4657107|NCT03147248|15995711|P6|Overall Study|Lost to Follow-up|0
4657108|NCT03147248|15995712|P5|Overall Study|Lost to Follow-up|2
4657109|NCT03147248|15995713|P4|Overall Study|Lost to Follow-up|0
4657110|NCT03147248|15995714|P3|Overall Study|Lost to Follow-up|0
4657111|NCT03147248|15995715|P2|Overall Study|Lost to Follow-up|0
4657112|NCT03147248|15995716|P1|Overall Study|Lost to Follow-up|0
4657113|NCT03147248|15995711|P6|Overall Study|Protocol Violation|0
4657114|NCT03147248|15995712|P5|Overall Study|Protocol Violation|2
4657115|NCT03147248|15995713|P4|Overall Study|Protocol Violation|0
4657116|NCT03147248|15995714|P3|Overall Study|Protocol Violation|0
4657117|NCT03147248|15995715|P2|Overall Study|Protocol Violation|0
4657118|NCT03147248|15995716|P1|Overall Study|Protocol Violation|0
4657119|NCT03147248|15995711|P6|Overall Study|Withdrawal by Subject|9
4657120|NCT03147248|15995712|P5|Overall Study|Withdrawal by Subject|12
4657121|NCT03147248|15995713|P4|Overall Study|Withdrawal by Subject|0
4657122|NCT03147248|15995714|P3|Overall Study|Withdrawal by Subject|0
4657123|NCT03147248|15995715|P2|Overall Study|Withdrawal by Subject|0
4657124|NCT03147248|15995716|P1|Overall Study|Withdrawal by Subject|0
4657125|NCT03147248|15995711|P6|Overall Study|Disease progression|2
4657126|NCT03147248|15995712|P5|Overall Study|Disease progression|0
4657127|NCT03147248|15995713|P4|Overall Study|Disease progression|0
4657128|NCT03147248|15995714|P3|Overall Study|Disease progression|0
4657129|NCT03147248|15995715|P2|Overall Study|Disease progression|0
4657130|NCT03147248|15995716|P1|Overall Study|Disease progression|1
4657131|NCT03147248|15995711|P6|Overall Study|Adverse Event|11
4657132|NCT03147248|15995712|P5|Overall Study|Adverse Event|6
4657133|NCT03147248|15995713|P4|Overall Study|Adverse Event|2
4657134|NCT03147248|15995714|P3|Overall Study|Adverse Event|2
4657135|NCT03147248|15995715|P2|Overall Study|Adverse Event|2
4657136|NCT03147248|15995716|P1|Overall Study|Adverse Event|0
4657137|NCT03146741|15995738|P1|Overall Study|Awaiting txp|2
4657138|NCT03146741|15995738|P1|Overall Study|Physician Decision|2
4657139|NCT03146741|15995738|P1|Overall Study|Listeted for MOT|2
4657140|NCT03146741|15995738|P1|Overall Study|Txp with non-HCV+ heart|4
4657141|NCT03146403|15995758|P2|Overall Study|Lost to Follow-up|0
4657142|NCT03146403|15995759|P1|Overall Study|Lost to Follow-up|2
4657143|NCT03146403|15995758|P2|Overall Study|Withdrawal by Subject|3
4657144|NCT03146403|15995759|P1|Overall Study|Withdrawal by Subject|0
4657145|NCT03145207|15995780|P1|Overall Study|baseline blood pressure high|1
4657146|NCT03145207|15995780|P1|Overall Study|volunteer started taking allergy shots|1
4657147|NCT03144180|15995825|P2|Overall Study|Scrub tech removed tube cap|1
4657148|NCT03144180|15995826|P1|Overall Study|Scrub tech removed tube cap|0
4657149|NCT03144180|15995825|P2|Overall Study|Provider forgot to use the Q-cup|1
4657150|NCT03144180|15995826|P1|Overall Study|Provider forgot to use the Q-cup|0
4657151|NCT03144180|15995825|P2|Overall Study|Provider forgot to fill out forms|3
4657152|NCT03144180|15995826|P1|Overall Study|Provider forgot to fill out forms|1
4657153|NCT03144180|15995825|P2|Overall Study|STAT Delivery|1
4657154|NCT03144180|15995826|P1|Overall Study|STAT Delivery|1
4657155|NCT03143166|15995861|P1|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1
4657156|NCT03143101|15995880|P3|Overall Study|Lost to Follow-up|0
4657157|NCT03143101|15995881|P2|Overall Study|Lost to Follow-up|2
4657158|NCT03143101|15995882|P1|Overall Study|Lost to Follow-up|2
4657159|NCT03143101|15995880|P3|Overall Study|Withdrawal by Subject|0
4657160|NCT03143101|15995881|P2|Overall Study|Withdrawal by Subject|1
4657161|NCT03143101|15995882|P1|Overall Study|Withdrawal by Subject|0
4657162|NCT03142932|15995937|P2|Overall Study|Lost to Follow-up|11
4657163|NCT03142932|15995938|P1|Overall Study|Lost to Follow-up|2
4657164|NCT03142750|15995954|P2|Overall Study|Lost to Follow-up|1
4657165|NCT03142750|15995955|P1|Overall Study|Lost to Follow-up|4
4657166|NCT03141307|15996055|P2|Follow-Up|Lost to Follow-up|54
4657167|NCT03141307|15996056|P1|Follow-Up|Lost to Follow-up|97
4657168|NCT03141307|15996055|P2|In-Hospital|Protocol Violation|0
4657169|NCT03141307|15996056|P1|In-Hospital|Protocol Violation|4
4657170|NCT03141307|15996055|P2|In-Hospital|Withdrawal by Subject|2
4657171|NCT03141307|15996056|P1|In-Hospital|Withdrawal by Subject|0
4657172|NCT03141151|15996074|P2|Overall Study|Withdrawal by Subject|2
4657173|NCT03141151|15996075|P1|Overall Study|Withdrawal by Subject|3
4657174|NCT03141151|15996074|P2|Overall Study|Lost to Follow-up|2
4657175|NCT03141151|15996075|P1|Overall Study|Lost to Follow-up|3
4657176|NCT03141086|15996093|P2|Overall Study|Adverse Event|2
4657177|NCT03141086|15996094|P1|Overall Study|Adverse Event|0
4657178|NCT03141086|15996093|P2|Overall Study|Protocol Violation|1
4657179|NCT03141086|15996094|P1|Overall Study|Protocol Violation|0
4657180|NCT03141086|15996093|P2|Overall Study|Withdrawal by Subject|1
4657181|NCT03141086|15996094|P1|Overall Study|Withdrawal by Subject|0
4657182|NCT03141086|15996093|P2|Overall Study|Study Terminated By Sponsor|1
4657183|NCT03141086|15996094|P1|Overall Study|Study Terminated By Sponsor|1
4657184|NCT03139604|15996134|P2|Overall Study|Continuing on Study|136
4657185|NCT03139604|15996135|P1|Overall Study|Continuing on Study|134
4657186|NCT03139604|15996134|P2|Overall Study|Death|64
4657187|NCT03139604|15996135|P1|Overall Study|Death|60
4657188|NCT03139604|15996134|P2|Overall Study|Lost to Follow-up|1
4657189|NCT03139604|15996135|P1|Overall Study|Lost to Follow-up|1
4657190|NCT03139604|15996134|P2|Overall Study|Physician Decision|2
4657191|NCT03139604|15996135|P1|Overall Study|Physician Decision|1
4657192|NCT03139604|15996134|P2|Overall Study|Withdrawal by Subject|15
4657193|NCT03139604|15996135|P1|Overall Study|Withdrawal by Subject|16
4657194|NCT03139604|15996134|P2|Overall Study|Other|2
4657195|NCT03139604|15996135|P1|Overall Study|Other|7
4657196|NCT03139552|15996184|P1|Overall Study|unable to attend tasting due to schedule|3
4657197|NCT03139448|15996227|P2|Overall Study|Physician Decision|2
4657198|NCT03139448|15996228|P1|Overall Study|Physician Decision|0
4657199|NCT03139448|15996227|P2|Overall Study|Screen fail|3
4657200|NCT03139448|15996228|P1|Overall Study|Screen fail|1
4657201|NCT03139448|15996227|P2|Overall Study|Withdrawal by Subject|6
4657202|NCT03139448|15996228|P1|Overall Study|Withdrawal by Subject|3
4657203|NCT03139448|15996227|P2|Overall Study|Location of procedure changed|8
4657204|NCT03139448|15996228|P1|Overall Study|Location of procedure changed|2
4657205|NCT03139448|15996227|P2|Overall Study|Lack of Efficacy|7
4657206|NCT03139448|15996228|P1|Overall Study|Lack of Efficacy|6
4657207|NCT03139279|15996252|P2|Overall Study|Withdrawal by Subject|2
4657208|NCT03139279|15996253|P1|Overall Study|Withdrawal by Subject|0
4657209|NCT03139279|15996252|P2|Overall Study|Protocol Violation|4
4657210|NCT03139279|15996253|P1|Overall Study|Protocol Violation|5
4657211|NCT03139279|15996252|P2|Overall Study|Physician Decision|0
4657212|NCT03139279|15996253|P1|Overall Study|Physician Decision|2
4657213|NCT03139240|15996271|P4|Overall Study|Lost to Follow-up|0
4657214|NCT03139240|15996272|P3|Overall Study|Lost to Follow-up|1
4657215|NCT03139240|15996273|P2|Overall Study|Lost to Follow-up|1
4657216|NCT03139240|15996274|P1|Overall Study|Lost to Follow-up|0
4657217|NCT03138967|15996286|P2|Overall Study|Physician Decision|3
4657218|NCT03138967|15996287|P1|Overall Study|Physician Decision|1
4657219|NCT03138967|15996286|P2|Overall Study|Death|1
4657220|NCT03138967|15996287|P1|Overall Study|Death|0
4657221|NCT03137784|15996411|P6|Overall Study|Non-compliance with study treatment|0
4657222|NCT03137784|15996412|P5|Overall Study|Non-compliance with study treatment|1
4657223|NCT03137784|15996413|P4|Overall Study|Non-compliance with study treatment|0
4657224|NCT03137784|15996414|P3|Overall Study|Non-compliance with study treatment|0
4657225|NCT03137784|15996415|P2|Overall Study|Non-compliance with study treatment|0
4657226|NCT03137784|15996416|P1|Overall Study|Non-compliance with study treatment|0
4657227|NCT03137784|15996411|P6|Overall Study|Subject/guardian decision|0
4657228|NCT03137784|15996412|P5|Overall Study|Subject/guardian decision|0
4657229|NCT03137784|15996413|P4|Overall Study|Subject/guardian decision|0
4657230|NCT03137784|15996414|P3|Overall Study|Subject/guardian decision|0
4657231|NCT03137784|15996415|P2|Overall Study|Subject/guardian decision|0
4657232|NCT03137784|15996416|P1|Overall Study|Subject/guardian decision|1
4657233|NCT03137784|15996411|P6|Overall Study|Adverse Event|0
4657234|NCT03137784|15996412|P5|Overall Study|Adverse Event|0
4657235|NCT03137784|15996413|P4|Overall Study|Adverse Event|0
4657236|NCT03137784|15996414|P3|Overall Study|Adverse Event|0
4657237|NCT03137784|15996415|P2|Overall Study|Adverse Event|1
4657238|NCT03137784|15996416|P1|Overall Study|Adverse Event|1
4657239|NCT03137173|15996468|P2|Overall Study|Other reasons|2
4657240|NCT03137173|15996469|P1|Overall Study|Other reasons|3
4657241|NCT03137173|15996468|P2|Overall Study|Lost to Follow-up|18
4657242|NCT03137173|15996469|P1|Overall Study|Lost to Follow-up|13
4657243|NCT03137173|15996468|P2|Overall Study|Physician Decision|0
4657244|NCT03137173|15996469|P1|Overall Study|Physician Decision|1
4657245|NCT03137173|15996468|P2|Overall Study|Death|3
4657246|NCT03137173|15996469|P1|Overall Study|Death|1
4657247|NCT03137173|15996468|P2|Overall Study|Withdrawal by Subject|13
4657248|NCT03137173|15996469|P1|Overall Study|Withdrawal by Subject|8
4657249|NCT03137069|15996485|P6|Overall Study|Data Entry Error|0
4657250|NCT03137069|15996486|P5|Overall Study|Data Entry Error|0
4657251|NCT03137069|15996487|P4|Overall Study|Data Entry Error|1
4657252|NCT03137069|15996488|P3|Overall Study|Data Entry Error|0
4657253|NCT03137069|15996489|P2|Overall Study|Data Entry Error|0
4657254|NCT03137069|15996490|P1|Overall Study|Data Entry Error|0
4657255|NCT03137069|15996485|P6|Overall Study|Study Terminated by Sponsor|0
4657256|NCT03137069|15996486|P5|Overall Study|Study Terminated by Sponsor|1
4657257|NCT03137069|15996487|P4|Overall Study|Study Terminated by Sponsor|0
4657258|NCT03137069|15996488|P3|Overall Study|Study Terminated by Sponsor|0
4657259|NCT03137069|15996489|P2|Overall Study|Study Terminated by Sponsor|0
4657260|NCT03137069|15996490|P1|Overall Study|Study Terminated by Sponsor|0
4657261|NCT03137069|15996485|P6|Overall Study|Physician Decision|0
4657262|NCT03137069|15996486|P5|Overall Study|Physician Decision|0
4657263|NCT03137069|15996487|P4|Overall Study|Physician Decision|1
4657264|NCT03137069|15996488|P3|Overall Study|Physician Decision|0
4657265|NCT03137069|15996489|P2|Overall Study|Physician Decision|0
4657266|NCT03137069|15996490|P1|Overall Study|Physician Decision|0
4657267|NCT03137069|15996485|P6|Overall Study|Protocol Violation|1
4657268|NCT03137069|15996486|P5|Overall Study|Protocol Violation|1
4657269|NCT03137069|15996487|P4|Overall Study|Protocol Violation|1
4657270|NCT03137069|15996488|P3|Overall Study|Protocol Violation|0
4657271|NCT03137069|15996489|P2|Overall Study|Protocol Violation|1
4657272|NCT03137069|15996490|P1|Overall Study|Protocol Violation|0
4657273|NCT03137069|15996485|P6|Overall Study|Adverse Event|1
4657274|NCT03137069|15996486|P5|Overall Study|Adverse Event|0
4657275|NCT03137069|15996487|P4|Overall Study|Adverse Event|1
4657276|NCT03137069|15996488|P3|Overall Study|Adverse Event|1
4657277|NCT03137069|15996489|P2|Overall Study|Adverse Event|3
4657278|NCT03137069|15996490|P1|Overall Study|Adverse Event|0
4657279|NCT03137069|15996485|P6|Overall Study|Withdrawal by Subject|0
4657280|NCT03137069|15996486|P5|Overall Study|Withdrawal by Subject|0
4657281|NCT03137069|15996487|P4|Overall Study|Withdrawal by Subject|2
4657282|NCT03137069|15996488|P3|Overall Study|Withdrawal by Subject|2
4657283|NCT03137069|15996489|P2|Overall Study|Withdrawal by Subject|2
4657284|NCT03137069|15996490|P1|Overall Study|Withdrawal by Subject|1
4657285|NCT03136861|15996533|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4657286|NCT03136861|15996534|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4657287|NCT03136861|15996535|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4657288|NCT03136861|15996536|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4657289|NCT03136861|15996537|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1
4657290|NCT03136861|15996538|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4657291|NCT03136861|15996539|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0
4657292|NCT03136861|15996533|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4657293|NCT03136861|15996534|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4657294|NCT03136861|15996535|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4657295|NCT03136861|15996536|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4657296|NCT03136861|15996537|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1
4657297|NCT03136861|15996538|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4657298|NCT03136861|15996539|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0
4657299|NCT03136861|15996533|P7|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
4657300|NCT03136861|15996534|P6|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4657301|NCT03136861|15996535|P5|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2
4657302|NCT03136861|15996536|P4|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1
4657303|NCT03136861|15996537|P3|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4657304|NCT03136861|15996538|P2|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4657305|NCT03136861|15996539|P1|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0
4657306|NCT03136861|15996533|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4657307|NCT03136861|15996534|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4657308|NCT03136861|15996535|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4657309|NCT03136861|15996536|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4657310|NCT03136861|15996537|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0
4657311|NCT03136861|15996538|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
4657312|NCT03136861|15996539|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1
4657313|NCT03136861|15996533|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4657314|NCT03136861|15996534|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4657315|NCT03136861|15996535|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4657316|NCT03136861|15996536|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4657317|NCT03136861|15996537|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4657318|NCT03136861|15996538|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1
4657319|NCT03136861|15996539|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0
4657320|NCT03136861|15996533|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4657321|NCT03136861|15996534|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4657322|NCT03136861|15996535|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4657323|NCT03136861|15996536|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4657324|NCT03136861|15996537|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0
4657325|NCT03136861|15996538|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1
4657326|NCT03136861|15996539|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2
4657327|NCT03136861|15996533|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4657328|NCT03136861|15996534|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4657329|NCT03136861|15996535|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4657330|NCT03136861|15996536|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4657331|NCT03136861|15996537|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0
4657332|NCT03136861|15996538|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
4657333|NCT03136861|15996539|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1
4657334|NCT03136861|15996533|P7|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4657335|NCT03136861|15996534|P6|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4657336|NCT03136861|15996535|P5|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4657337|NCT03136861|15996536|P4|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4657338|NCT03136861|15996537|P3|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0
4657339|NCT03136861|15996538|P2|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2
4657340|NCT03136861|15996539|P1|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3
4657341|NCT03136484|15996554|P2|Overall Study|Death|0
4657342|NCT03136484|15996555|P1|Overall Study|Death|1
4657343|NCT03136484|15996554|P2|Overall Study|Lost to Follow-up|8
4657344|NCT03136484|15996555|P1|Overall Study|Lost to Follow-up|7
4657345|NCT03136484|15996554|P2|Overall Study|Withdrawal by Subject|14
4657346|NCT03136484|15996555|P1|Overall Study|Withdrawal by Subject|19
4657347|NCT03136380|15996683|P5|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4657348|NCT03136380|15996684|P4|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4657349|NCT03136380|15996685|P3|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4657350|NCT03136380|15996686|P2|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1
4657351|NCT03136380|15996687|P1|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0
4657352|NCT03136198|15996868|P2|Overall Study|Withdrawal by Subject|1
4657353|NCT03136198|15996869|P1|Overall Study|Withdrawal by Subject|0
4657354|NCT03136107|15996875|P1|Overall Study|Other (Not specified)|1
4657355|NCT03136068|15996885|P2|Overall Study|Protocol Violation|0
4657356|NCT03136068|15996886|P1|Overall Study|Protocol Violation|1
4657357|NCT03136068|15996885|P2|Overall Study|Lost to Follow-up|1
4657358|NCT03136068|15996886|P1|Overall Study|Lost to Follow-up|1
4657359|NCT03135899|15996908|P8|Overall Study|Withdrawal by Subject|0
4657360|NCT03135899|15996909|P7|Overall Study|Withdrawal by Subject|0
4657361|NCT03135899|15996910|P6|Overall Study|Withdrawal by Subject|2
4657362|NCT03135899|15996911|P5|Overall Study|Withdrawal by Subject|0
4657363|NCT03135899|15996912|P4|Overall Study|Withdrawal by Subject|0
4657364|NCT03135899|15996913|P3|Overall Study|Withdrawal by Subject|0
4657365|NCT03135899|15996914|P2|Overall Study|Withdrawal by Subject|0
4657366|NCT03135899|15996915|P1|Overall Study|Withdrawal by Subject|0
4657367|NCT03135899|15996908|P8|Overall Study|Failed spirometry,unable to repeat visit|0
4657368|NCT03135899|15996909|P7|Overall Study|Failed spirometry,unable to repeat visit|1
4657369|NCT03135899|15996910|P6|Overall Study|Failed spirometry,unable to repeat visit|0
4657370|NCT03135899|15996911|P5|Overall Study|Failed spirometry,unable to repeat visit|0
4657371|NCT03135899|15996912|P4|Overall Study|Failed spirometry,unable to repeat visit|0
4657372|NCT03135899|15996913|P3|Overall Study|Failed spirometry,unable to repeat visit|0
4657373|NCT03135899|15996914|P2|Overall Study|Failed spirometry,unable to repeat visit|0
4657374|NCT03135899|15996915|P1|Overall Study|Failed spirometry,unable to repeat visit|0
4657375|NCT03135548|15996948|P3|Overall Study|Other than listed|2
4657376|NCT03135548|15996949|P2|Overall Study|Other than listed|2
4657377|NCT03135548|15996950|P1|Overall Study|Other than listed|0
4657378|NCT03135548|15996948|P3|Overall Study|Withdrawal by Subject|1
4657379|NCT03135548|15996949|P2|Overall Study|Withdrawal by Subject|2
4657380|NCT03135548|15996950|P1|Overall Study|Withdrawal by Subject|2
4657381|NCT03135548|15996948|P3|Overall Study|Lost to Follow-up|0
4657382|NCT03135548|15996949|P2|Overall Study|Lost to Follow-up|0
4657383|NCT03135548|15996950|P1|Overall Study|Lost to Follow-up|3
4657384|NCT03135431|15996980|P2|Overall Study|Study Surgeon not available|0
4657385|NCT03135431|15996981|P1|Overall Study|Study Surgeon not available|2
4657386|NCT03135028|15997002|P1|Overall Study|Withdrew Consent|1
4657387|NCT03135028|15997002|P1|Overall Study|Study Terminated by Sponsor|2
4657388|NCT03135028|15997002|P1|Overall Study|Death|6
4657389|NCT03134911|15997119|P1|Overall Study|Not meeting inclusion/exclusion criteria|3
4657390|NCT03134911|15997119|P1|Overall Study|Screen failure|31
4657391|NCT03134599|15997181|P6|Week 3|Lost to Follow-up|1
4657392|NCT03134599|15997182|P5|Week 3|Lost to Follow-up|0
4657393|NCT03134599|15997183|P4|Week 3|Lost to Follow-up|1
4657394|NCT03134599|15997184|P3|Week 3|Lost to Follow-up|0
4657395|NCT03134599|15997185|P2|Week 3|Lost to Follow-up|0
4657396|NCT03134599|15997186|P1|Week 3|Lost to Follow-up|0
4657397|NCT03134599|15997181|P6|Week 2|Lost to Follow-up|0
4657398|NCT03134599|15997182|P5|Week 2|Lost to Follow-up|1
4657399|NCT03134599|15997183|P4|Week 2|Lost to Follow-up|1
4657400|NCT03134599|15997184|P3|Week 2|Lost to Follow-up|0
4657401|NCT03134599|15997185|P2|Week 2|Lost to Follow-up|0
4657402|NCT03134599|15997186|P1|Week 2|Lost to Follow-up|1
4657403|NCT03134599|15997181|P6|Week 1|Lost to Follow-up|0
4657404|NCT03134599|15997182|P5|Week 1|Lost to Follow-up|1
4657405|NCT03134599|15997183|P4|Week 1|Lost to Follow-up|0
4657406|NCT03134599|15997184|P3|Week 1|Lost to Follow-up|0
4657407|NCT03134599|15997185|P2|Week 1|Lost to Follow-up|0
4657408|NCT03134599|15997186|P1|Week 1|Lost to Follow-up|0
4657409|NCT03134222|15997226|P5|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4657410|NCT03134222|15997227|P4|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4657411|NCT03134222|15997228|P3|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4657412|NCT03134222|15997229|P2|Treatment Period (Week 12 to 48)|Lost to Follow-up|1
4657413|NCT03134222|15997230|P1|Treatment Period (Week 12 to 48)|Lost to Follow-up|0
4657414|NCT03134222|15997226|P5|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4657415|NCT03134222|15997227|P4|Treatment Period (Week 12 to 48)|Investigator's Discretion|1
4657416|NCT03134222|15997228|P3|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4657417|NCT03134222|15997229|P2|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4657418|NCT03134222|15997230|P1|Treatment Period (Week 12 to 48)|Investigator's Discretion|0
4657419|NCT03134222|15997226|P5|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4657420|NCT03134222|15997227|P4|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4657421|NCT03134222|15997228|P3|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4657422|NCT03134222|15997229|P2|Treatment Period (Week 12 to 48)|Lack of Efficacy|0
4657423|NCT03134222|15997230|P1|Treatment Period (Week 12 to 48)|Lack of Efficacy|2
4657424|NCT03134222|15997226|P5|Treatment Period (Week 12 to 48)|Withdrew Consent|1
4657425|NCT03134222|15997227|P4|Treatment Period (Week 12 to 48)|Withdrew Consent|0
4657426|NCT03134222|15997228|P3|Treatment Period (Week 12 to 48)|Withdrew Consent|0
4657427|NCT03134222|15997229|P2|Treatment Period (Week 12 to 48)|Withdrew Consent|2
4657428|NCT03134222|15997230|P1|Treatment Period (Week 12 to 48)|Withdrew Consent|0
4657429|NCT03134222|15997226|P5|Treatment Period (Up to Week 12)|Randomized but not treated|0
4657430|NCT03134222|15997227|P4|Treatment Period (Up to Week 12)|Randomized but not treated|0
4657431|NCT03134222|15997228|P3|Treatment Period (Up to Week 12)|Randomized but not treated|1
4657432|NCT03134222|15997229|P2|Treatment Period (Up to Week 12)|Randomized but not treated|1
4657433|NCT03134222|15997230|P1|Treatment Period (Up to Week 12)|Randomized but not treated|0
4657434|NCT03134222|15997226|P5|Treatment Period (Up to Week 12)|Withdrew Consent|0
4657435|NCT03134222|15997227|P4|Treatment Period (Up to Week 12)|Withdrew Consent|0
4657436|NCT03134222|15997228|P3|Treatment Period (Up to Week 12)|Withdrew Consent|0
4657437|NCT03134222|15997229|P2|Treatment Period (Up to Week 12)|Withdrew Consent|1
4657438|NCT03134222|15997230|P1|Treatment Period (Up to Week 12)|Withdrew Consent|0
4657439|NCT03134222|15997226|P5|Treatment Period (Up to Week 12)|Lost to Follow-up|0
4657440|NCT03134222|15997227|P4|Treatment Period (Up to Week 12)|Lost to Follow-up|0
4657441|NCT03134222|15997228|P3|Treatment Period (Up to Week 12)|Lost to Follow-up|1
4657442|NCT03134222|15997229|P2|Treatment Period (Up to Week 12)|Lost to Follow-up|1
4657443|NCT03134222|15997230|P1|Treatment Period (Up to Week 12)|Lost to Follow-up|1
4657444|NCT03134222|15997226|P5|Treatment Period (Up to Week 12)|Adverse Event|0
4657445|NCT03134222|15997227|P4|Treatment Period (Up to Week 12)|Adverse Event|0
4657446|NCT03134222|15997228|P3|Treatment Period (Up to Week 12)|Adverse Event|0
4657447|NCT03134222|15997229|P2|Treatment Period (Up to Week 12)|Adverse Event|1
4657448|NCT03134222|15997230|P1|Treatment Period (Up to Week 12)|Adverse Event|4
4657449|NCT03134183|15997252|P2|Overall Study|Withdrawal by Subject|1
4657450|NCT03134183|15997253|P1|Overall Study|Withdrawal by Subject|1
4657451|NCT03133767|15997304|P2|Overall Study|Protocol Violation|1
4657452|NCT03133767|15997305|P1|Overall Study|Protocol Violation|0
4657453|NCT03133767|15997304|P2|Overall Study|Lost to Follow-up|24
4657454|NCT03133767|15997305|P1|Overall Study|Lost to Follow-up|38
4657455|NCT03133481|15997321|P2|Overall Study|FC Catheter fell out post operative day1|4
4657456|NCT03133481|15997322|P1|Overall Study|FC Catheter fell out post operative day1|0
4657457|NCT03132753|15997352|P2|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2
4657458|NCT03132753|15997353|P1|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6
4657459|NCT03132753|15997352|P2|Baseline - 6 Month Follow-Up|Lost to Follow-up|32
4657460|NCT03132753|15997353|P1|Baseline - 6 Month Follow-Up|Lost to Follow-up|27
4657461|NCT03132220|15997498|P2|Overall Study|Withdrawal by Subject|4
4657462|NCT03132220|15997499|P1|Overall Study|Withdrawal by Subject|1
4657463|NCT03132220|15997498|P2|Overall Study|Lost to Follow-up|8
4657464|NCT03132220|15997499|P1|Overall Study|Lost to Follow-up|17
4657465|NCT03131999|15997527|P2|Overall Study|Withdrawal by Subject|1
4657466|NCT03131999|15997528|P1|Overall Study|Withdrawal by Subject|0
4657467|NCT03131895|15997540|P4|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
4657468|NCT03131895|15997541|P3|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
4657469|NCT03131895|15997542|P2|Intervention Period 2 (2 Days)|Withdrawal by Subject|0
4657470|NCT03131895|15997543|P1|Intervention Period 2 (2 Days)|Withdrawal by Subject|1
4657471|NCT03131895|15997540|P4|Intervention Period 2 (2 Days)|Lost to Follow-up|0
4657472|NCT03131895|15997541|P3|Intervention Period 2 (2 Days)|Lost to Follow-up|0
4657473|NCT03131895|15997542|P2|Intervention Period 2 (2 Days)|Lost to Follow-up|1
4657474|NCT03131895|15997543|P1|Intervention Period 2 (2 Days)|Lost to Follow-up|0
4657475|NCT03131895|15997540|P4|Washout Period (at Least 5 Days)|Other|0
4657476|NCT03131895|15997541|P3|Washout Period (at Least 5 Days)|Other|2
4657477|NCT03131895|15997542|P2|Washout Period (at Least 5 Days)|Other|0
4657478|NCT03131895|15997543|P1|Washout Period (at Least 5 Days)|Other|0
4657479|NCT03131895|15997540|P4|Washout Period (at Least 5 Days)|Withdrawal by Subject|1
4657480|NCT03131895|15997541|P3|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4657481|NCT03131895|15997542|P2|Washout Period (at Least 5 Days)|Withdrawal by Subject|2
4657482|NCT03131895|15997543|P1|Washout Period (at Least 5 Days)|Withdrawal by Subject|0
4657483|NCT03131895|15997540|P4|Washout Period (at Least 5 Days)|Lost to Follow-up|3
4657484|NCT03131895|15997541|P3|Washout Period (at Least 5 Days)|Lost to Follow-up|2
4657485|NCT03131895|15997542|P2|Washout Period (at Least 5 Days)|Lost to Follow-up|3
4657486|NCT03131895|15997543|P1|Washout Period (at Least 5 Days)|Lost to Follow-up|0
4657487|NCT03131895|15997540|P4|Washout Period (at Least 5 Days)|Adverse Event|1
4657488|NCT03131895|15997541|P3|Washout Period (at Least 5 Days)|Adverse Event|0
4657489|NCT03131895|15997542|P2|Washout Period (at Least 5 Days)|Adverse Event|0
4657490|NCT03131895|15997543|P1|Washout Period (at Least 5 Days)|Adverse Event|1
4657491|NCT03131713|15997563|P2|Overall Study|Lost to Follow-up|0
4657492|NCT03131713|15997564|P1|Overall Study|Lost to Follow-up|5
4657493|NCT03131687|15997588|P6|Overall Study|Inadvertent Enrollment|0
4657494|NCT03131687|15997589|P5|Overall Study|Inadvertent Enrollment|0
4657495|NCT03131687|15997590|P4|Overall Study|Inadvertent Enrollment|1
4657496|NCT03131687|15997591|P3|Overall Study|Inadvertent Enrollment|0
4657497|NCT03131687|15997592|P2|Overall Study|Inadvertent Enrollment|0
4657498|NCT03131687|15997593|P1|Overall Study|Inadvertent Enrollment|0
4657499|NCT03131687|15997588|P6|Overall Study|Principle Investigator Decision|0
4657500|NCT03131687|15997589|P5|Overall Study|Principle Investigator Decision|0
4657501|NCT03131687|15997590|P4|Overall Study|Principle Investigator Decision|0
4657502|NCT03131687|15997591|P3|Overall Study|Principle Investigator Decision|0
4657503|NCT03131687|15997592|P2|Overall Study|Principle Investigator Decision|1
4657504|NCT03131687|15997593|P1|Overall Study|Principle Investigator Decision|0
4657505|NCT03131687|15997588|P6|Overall Study|Participant Started New Diabetic Drug|0
4657506|NCT03131687|15997589|P5|Overall Study|Participant Started New Diabetic Drug|0
4657507|NCT03131687|15997590|P4|Overall Study|Participant Started New Diabetic Drug|0
4657508|NCT03131687|15997591|P3|Overall Study|Participant Started New Diabetic Drug|0
4657509|NCT03131687|15997592|P2|Overall Study|Participant Started New Diabetic Drug|0
4657510|NCT03131687|15997593|P1|Overall Study|Participant Started New Diabetic Drug|1
4657511|NCT03131687|15997588|P6|Overall Study|Lost to Follow-up|2
4657512|NCT03131687|15997589|P5|Overall Study|Lost to Follow-up|4
4657513|NCT03131687|15997590|P4|Overall Study|Lost to Follow-up|1
4657514|NCT03131687|15997591|P3|Overall Study|Lost to Follow-up|0
4657515|NCT03131687|15997592|P2|Overall Study|Lost to Follow-up|4
4657516|NCT03131687|15997593|P1|Overall Study|Lost to Follow-up|1
4657517|NCT03131687|15997588|P6|Overall Study|Withdrawal by Subject|1
4657518|NCT03131687|15997589|P5|Overall Study|Withdrawal by Subject|2
4657519|NCT03131687|15997590|P4|Overall Study|Withdrawal by Subject|1
4657520|NCT03131687|15997591|P3|Overall Study|Withdrawal by Subject|3
4657521|NCT03131687|15997592|P2|Overall Study|Withdrawal by Subject|3
4657522|NCT03131687|15997593|P1|Overall Study|Withdrawal by Subject|3
4657523|NCT03131687|15997588|P6|Overall Study|Death|0
4657524|NCT03131687|15997589|P5|Overall Study|Death|0
4657525|NCT03131687|15997590|P4|Overall Study|Death|0
4657526|NCT03131687|15997591|P3|Overall Study|Death|0
4657527|NCT03131687|15997592|P2|Overall Study|Death|0
4657528|NCT03131687|15997593|P1|Overall Study|Death|1
4657529|NCT03131687|15997588|P6|Overall Study|Adverse Event|2
4657530|NCT03131687|15997589|P5|Overall Study|Adverse Event|2
4657531|NCT03131687|15997590|P4|Overall Study|Adverse Event|1
4657532|NCT03131687|15997591|P3|Overall Study|Adverse Event|0
4657533|NCT03131687|15997592|P2|Overall Study|Adverse Event|1
4657534|NCT03131687|15997593|P1|Overall Study|Adverse Event|0
4657535|NCT03131596|15997703|P2|Overall Study|Lost to Follow-up|0
4657536|NCT03131596|15997704|P1|Overall Study|Lost to Follow-up|3
4657537|NCT03131596|15997703|P2|Overall Study|Protocol Violation|3
4657538|NCT03131596|15997704|P1|Overall Study|Protocol Violation|3
4657539|NCT03131479|15997721|P5|Overall Study|Subject/Guardian Decision|0
4657540|NCT03131479|15997722|P4|Overall Study|Subject/Guardian Decision|1
4657541|NCT03131479|15997723|P3|Overall Study|Subject/Guardian Decision|0
4657542|NCT03131479|15997724|P2|Overall Study|Subject/Guardian Decision|0
4657543|NCT03131479|15997725|P1|Overall Study|Subject/Guardian Decision|0
4657544|NCT03131479|15997721|P5|Overall Study|Adverse Event|0
4657545|NCT03131479|15997722|P4|Overall Study|Adverse Event|1
4657546|NCT03131479|15997723|P3|Overall Study|Adverse Event|1
4657547|NCT03131479|15997724|P2|Overall Study|Adverse Event|0
4657548|NCT03131479|15997725|P1|Overall Study|Adverse Event|0
4657549|NCT03131219|15997784|P2|Initial Evaluation Period|Deemed ineligible post treatment|0
4657550|NCT03131219|15997785|P1|Initial Evaluation Period|Deemed ineligible post treatment|2
4657551|NCT03131219|15997784|P2|Initial Evaluation Period|Protocol Violation|0
4657552|NCT03131219|15997785|P1|Initial Evaluation Period|Protocol Violation|1
4657553|NCT03131219|15997784|P2|Initial Evaluation Period|Adverse Event|0
4657554|NCT03131219|15997785|P1|Initial Evaluation Period|Adverse Event|1
4657555|NCT03131167|15997845|P13|Overall Study|Other (Unspecified)|0
4657556|NCT03131167|15997846|P12|Overall Study|Other (Unspecified)|0
4657557|NCT03131167|15997847|P11|Overall Study|Other (Unspecified)|0
4657558|NCT03131167|15997848|P10|Overall Study|Other (Unspecified)|0
4657559|NCT03131167|15997849|P9|Overall Study|Other (Unspecified)|0
4657560|NCT03131167|15997850|P8|Overall Study|Other (Unspecified)|0
4657561|NCT03131167|15997851|P7|Overall Study|Other (Unspecified)|0
4657562|NCT03131167|15997852|P6|Overall Study|Other (Unspecified)|1
4657563|NCT03131167|15997853|P5|Overall Study|Other (Unspecified)|0
4657564|NCT03131167|15997854|P4|Overall Study|Other (Unspecified)|0
4657565|NCT03131167|15997855|P3|Overall Study|Other (Unspecified)|0
4657566|NCT03131167|15997856|P2|Overall Study|Other (Unspecified)|0
4657567|NCT03131167|15997857|P1|Overall Study|Other (Unspecified)|0
4657568|NCT03128931|15997960|P1|Overall Study|Equipment Issues|3
4657569|NCT03128931|15997960|P1|Overall Study|Physician Decision|1
4657570|NCT03128892|15997964|P1|Overall Study|Physician Decision|1
4657571|NCT03128892|15997964|P1|Overall Study|Withdrawal by Subject|2
4657572|NCT03128723|15997970|P1|Overall Study|Withdrawal by Subject|2
4657573|NCT03128307|15997989|P1|Overall Study|Withdrawal by Subject|5
4657574|NCT03128307|15997989|P1|Overall Study|Lost to Follow-up|29
4657575|NCT03128099|15997997|P3|Overall Study|Did not complete all the assessments|1
4657576|NCT03128099|15997998|P2|Overall Study|Did not complete all the assessments|0
4657577|NCT03128099|15997999|P1|Overall Study|Did not complete all the assessments|0
4657578|NCT03128099|15997997|P3|Overall Study|Became homeless and lost contact|0
4657579|NCT03128099|15997998|P2|Overall Study|Became homeless and lost contact|0
4657580|NCT03128099|15997999|P1|Overall Study|Became homeless and lost contact|1
4657581|NCT03128099|15997997|P3|Overall Study|Participant got a full time job.|0
4657582|NCT03128099|15997998|P2|Overall Study|Participant got a full time job.|0
4657583|NCT03128099|15997999|P1|Overall Study|Participant got a full time job.|1
4657584|NCT03128099|15997997|P3|Overall Study|High dose task was too long|0
4657585|NCT03128099|15997998|P2|Overall Study|High dose task was too long|4
4657586|NCT03128099|15997999|P1|Overall Study|High dose task was too long|0
4657587|NCT03127644|15998049|P3|Overall Study|Study-specific withdrawal criteria|2
4657588|NCT03127644|15998050|P2|Overall Study|Study-specific withdrawal criteria|0
4657589|NCT03127644|15998051|P1|Overall Study|Study-specific withdrawal criteria|0
4657590|NCT03127384|15998083|P1|Overall Study|Subject request|2
4657591|NCT03127384|15998083|P1|Overall Study|Lost to Follow-up|4
4657592|NCT03126539|15998119|P5|Overall Study|Lost to Follow-up|0
4657593|NCT03126539|15998120|P4|Overall Study|Lost to Follow-up|0
4657594|NCT03126539|15998121|P3|Overall Study|Lost to Follow-up|1
4657595|NCT03126539|15998122|P2|Overall Study|Lost to Follow-up|1
4657596|NCT03126539|15998123|P1|Overall Study|Lost to Follow-up|1
4657597|NCT03126344|15998152|P3|Overall Study|Lost to Follow-up|5
4657598|NCT03126344|15998153|P2|Overall Study|Lost to Follow-up|0
4657599|NCT03126344|15998154|P1|Overall Study|Lost to Follow-up|0
4657600|NCT03125941|15998170|P2|Overall Study|did not receive intervention|2
4657601|NCT03125941|15998171|P1|Overall Study|did not receive intervention|1
4657602|NCT03125915|15998207|P4|6 Month Follow-up|Lost to Follow-up|3
4657603|NCT03125915|15998208|P3|6 Month Follow-up|Lost to Follow-up|6
4657604|NCT03125915|15998209|P2|6 Month Follow-up|Lost to Follow-up|3
4657605|NCT03125915|15998210|P1|6 Month Follow-up|Lost to Follow-up|7
4657606|NCT03125915|15998207|P4|3 Month Follow-up|Lost to Follow-up|2
4657607|NCT03125915|15998208|P3|3 Month Follow-up|Lost to Follow-up|4
4657608|NCT03125915|15998209|P2|3 Month Follow-up|Lost to Follow-up|4
4657609|NCT03125915|15998210|P1|3 Month Follow-up|Lost to Follow-up|6
4657610|NCT03125915|15998207|P4|1 Month Follow up|Lost to Follow-up|3
4657611|NCT03125915|15998208|P3|1 Month Follow up|Lost to Follow-up|2
4657612|NCT03125915|15998209|P2|1 Month Follow up|Lost to Follow-up|3
4657613|NCT03125915|15998210|P1|1 Month Follow up|Lost to Follow-up|3
4657614|NCT03125395|15998228|P1|Overall Study|Commercial drug is available|5
4657615|NCT03125395|15998228|P1|Overall Study|Physician Decision|2
4657616|NCT03125395|15998228|P1|Overall Study|Withdrawal of consent (not due to AE)|1
4657617|NCT03125395|15998228|P1|Overall Study|Adverse Event|2
4657618|NCT03125200|15998254|P7|Overall Study|Consent Withdrawn by Subject|1
4657619|NCT03125200|15998255|P6|Overall Study|Consent Withdrawn by Subject|0
4657620|NCT03125200|15998256|P5|Overall Study|Consent Withdrawn by Subject|1
4657621|NCT03125200|15998257|P4|Overall Study|Consent Withdrawn by Subject|0
4657622|NCT03125200|15998258|P3|Overall Study|Consent Withdrawn by Subject|0
4657623|NCT03125200|15998259|P2|Overall Study|Consent Withdrawn by Subject|1
4657624|NCT03125200|15998260|P1|Overall Study|Consent Withdrawn by Subject|0
4657625|NCT03125200|15998254|P7|Overall Study|Toxicity|0
4657626|NCT03125200|15998255|P6|Overall Study|Toxicity|0
4657627|NCT03125200|15998256|P5|Overall Study|Toxicity|0
4657628|NCT03125200|15998257|P4|Overall Study|Toxicity|1
4657629|NCT03125200|15998258|P3|Overall Study|Toxicity|0
4657630|NCT03125200|15998259|P2|Overall Study|Toxicity|0
4657631|NCT03125200|15998260|P1|Overall Study|Toxicity|0
4657632|NCT03125200|15998254|P7|Overall Study|Lack of Efficacy|0
4657633|NCT03125200|15998255|P6|Overall Study|Lack of Efficacy|0
4657634|NCT03125200|15998256|P5|Overall Study|Lack of Efficacy|0
4657635|NCT03125200|15998257|P4|Overall Study|Lack of Efficacy|1
4657636|NCT03125200|15998258|P3|Overall Study|Lack of Efficacy|0
4657637|NCT03125200|15998259|P2|Overall Study|Lack of Efficacy|0
4657638|NCT03125200|15998260|P1|Overall Study|Lack of Efficacy|0
4657639|NCT03125200|15998254|P7|Overall Study|Progressive Disease|1
4657640|NCT03125200|15998255|P6|Overall Study|Progressive Disease|0
4657641|NCT03125200|15998256|P5|Overall Study|Progressive Disease|2
4657642|NCT03125200|15998257|P4|Overall Study|Progressive Disease|1
4657643|NCT03125200|15998258|P3|Overall Study|Progressive Disease|2
4657644|NCT03125200|15998259|P2|Overall Study|Progressive Disease|1
4657645|NCT03125200|15998260|P1|Overall Study|Progressive Disease|2
4657646|NCT03125200|15998254|P7|Overall Study|Clinical Progression|0
4657647|NCT03125200|15998255|P6|Overall Study|Clinical Progression|1
4657648|NCT03125200|15998256|P5|Overall Study|Clinical Progression|0
4657649|NCT03125200|15998257|P4|Overall Study|Clinical Progression|1
4657650|NCT03125200|15998258|P3|Overall Study|Clinical Progression|0
4657651|NCT03125200|15998259|P2|Overall Study|Clinical Progression|0
4657652|NCT03125200|15998260|P1|Overall Study|Clinical Progression|0
4657653|NCT03125200|15998254|P7|Overall Study|Study Termination|1
4657654|NCT03125200|15998255|P6|Overall Study|Study Termination|2
4657655|NCT03125200|15998256|P5|Overall Study|Study Termination|1
4657656|NCT03125200|15998257|P4|Overall Study|Study Termination|1
4657657|NCT03125200|15998258|P3|Overall Study|Study Termination|0
4657658|NCT03125200|15998259|P2|Overall Study|Study Termination|0
4657659|NCT03125200|15998260|P1|Overall Study|Study Termination|0
4657660|NCT03124784|15998500|P1|Overall Study|Computer/Equip Malfunction|1
4657661|NCT03124784|15998500|P1|Overall Study|Adverse Event|1
4657662|NCT03124563|15998522|P2|Overall Study|Withdrawal by Subject|1
4657663|NCT03124563|15998523|P1|Overall Study|Withdrawal by Subject|1
4657664|NCT03124563|15998522|P2|Overall Study|Lost to Follow-up|1
4657665|NCT03124563|15998523|P1|Overall Study|Lost to Follow-up|1
4657666|NCT03124537|15998548|P2|Overall Study|App Crash, Incomplete Data|8
4657667|NCT03124537|15998549|P1|Overall Study|App Crash, Incomplete Data|7
4657668|NCT03124537|15998548|P2|Overall Study|Lost to Follow-up|5
4657669|NCT03124537|15998549|P1|Overall Study|Lost to Follow-up|3
4657670|NCT03124407|15998573|P4|Overall Study|Adverse Event|0
4657671|NCT03124407|15998574|P3|Overall Study|Adverse Event|1
4657672|NCT03124407|15998575|P2|Overall Study|Adverse Event|0
4657673|NCT03124407|15998576|P1|Overall Study|Adverse Event|0
4657674|NCT03124407|15998573|P4|Overall Study|Lost to Follow-up|0
4657675|NCT03124407|15998574|P3|Overall Study|Lost to Follow-up|0
4657676|NCT03124407|15998575|P2|Overall Study|Lost to Follow-up|0
4657677|NCT03124407|15998576|P1|Overall Study|Lost to Follow-up|1
4657678|NCT03124381|15998596|P2|Overall Study|Non-Compliance with Study Treatment|0
4657679|NCT03124381|15998597|P1|Overall Study|Non-Compliance with Study Treatment|1
4657680|NCT03124381|15998596|P2|Overall Study|Adverse Event|1
4657681|NCT03124381|15998597|P1|Overall Study|Adverse Event|1
4657682|NCT03124381|15998596|P2|Overall Study|Protocol Violation|1
4657683|NCT03124381|15998597|P1|Overall Study|Protocol Violation|0
4657684|NCT03124381|15998596|P2|Overall Study|Withdrawal by Subject|3
4657685|NCT03124381|15998597|P1|Overall Study|Withdrawal by Subject|6
4657686|NCT03124381|15998596|P2|Overall Study|Lost to Follow-up|1
4657687|NCT03124381|15998597|P1|Overall Study|Lost to Follow-up|1
4657688|NCT03124199|15998704|P1|Overall Study|Lost to Follow-up|4
4657689|NCT03124108|15998713|P3|Overall Study|Adverse Event|0
4657690|NCT03124108|15998714|P2|Overall Study|Adverse Event|1
4657691|NCT03124108|15998715|P1|Overall Study|Adverse Event|0
4657692|NCT03123861|15998861|P2|Overall Study|Withdrawal by Subject|2
4657693|NCT03123861|15998862|P1|Overall Study|Withdrawal by Subject|2
4657694|NCT03123861|15998861|P2|Overall Study|Protocol Violation|1
4657695|NCT03123861|15998862|P1|Overall Study|Protocol Violation|1
4657696|NCT03123471|15998898|P2|Apremilast Extension Phase|Withdrawal by Subject|7
4657697|NCT03123471|15998899|P1|Apremilast Extension Phase|Withdrawal by Subject|3
4657698|NCT03123471|15998898|P2|Apremilast Extension Phase|Lack of Efficacy|8
4657699|NCT03123471|15998899|P1|Apremilast Extension Phase|Lack of Efficacy|2
4657700|NCT03123471|15998898|P2|Apremilast Extension Phase|Adverse Event|5
4657701|NCT03123471|15998899|P1|Apremilast Extension Phase|Adverse Event|1
4657702|NCT03123471|15998898|P2|Apremilast Extension Phase|Lost to Follow-up|5
4657703|NCT03123471|15998899|P1|Apremilast Extension Phase|Lost to Follow-up|2
4657704|NCT03123471|15998898|P2|Placebo-controlled Phase|Miscellaneous|1
4657705|NCT03123471|15998899|P1|Placebo-controlled Phase|Miscellaneous|0
4657706|NCT03123471|15998898|P2|Placebo-controlled Phase|Protocol Deviation|1
4657707|NCT03123471|15998899|P1|Placebo-controlled Phase|Protocol Deviation|2
4657708|NCT03123471|15998898|P2|Placebo-controlled Phase|Lost to Follow-up|3
4657709|NCT03123471|15998899|P1|Placebo-controlled Phase|Lost to Follow-up|1
4657710|NCT03123471|15998898|P2|Placebo-controlled Phase|Non-compliance with Study Drug|0
4657711|NCT03123471|15998899|P1|Placebo-controlled Phase|Non-compliance with Study Drug|3
4657712|NCT03123471|15998898|P2|Placebo-controlled Phase|Withdrawal by Subject|16
4657713|NCT03123471|15998899|P1|Placebo-controlled Phase|Withdrawal by Subject|6
4657714|NCT03123471|15998898|P2|Placebo-controlled Phase|Lack of Efficacy|4
4657715|NCT03123471|15998899|P1|Placebo-controlled Phase|Lack of Efficacy|3
4657716|NCT03123471|15998898|P2|Placebo-controlled Phase|Adverse Event|8
4657717|NCT03123471|15998899|P1|Placebo-controlled Phase|Adverse Event|3
4657718|NCT03123393|15998926|P2|Overall Study|Reason not Specified|13
4657719|NCT03123393|15998927|P1|Overall Study|Reason not Specified|13
4657720|NCT03123393|15998926|P2|Overall Study|Withdrawal by Subject|1
4657721|NCT03123393|15998927|P1|Overall Study|Withdrawal by Subject|2
4657722|NCT03123393|15998926|P2|Overall Study|Study Terminated by Sponsor|9
4657723|NCT03123393|15998927|P1|Overall Study|Study Terminated by Sponsor|6
4657724|NCT03123354|15998955|P1|Overall Study|Physician Decision|6
4657725|NCT03122886|15998980|P2|Overall Study|Withdrawal by Subject|2
4657726|NCT03122886|15998981|P1|Overall Study|Withdrawal by Subject|1
4657727|NCT03122548|15999003|P1|Overall Study|Study Terminated by Sponsor|2
4657728|NCT03122548|15999003|P1|Overall Study|Progression - subject went into hospice|1
4657729|NCT03122548|15999003|P1|Overall Study|Death|2
4657730|NCT03122457|15999011|P1|Overall Study|Withdrawal by Subject|6
4657731|NCT03122184|15999018|P2|Overall Study|Terminated due to cognitive problem|0
4657732|NCT03122184|15999019|P1|Overall Study|Terminated due to cognitive problem|1
4657733|NCT03122184|15999018|P2|Overall Study|Withdrawal by Subject|0
4657734|NCT03122184|15999019|P1|Overall Study|Withdrawal by Subject|3
4657735|NCT03122184|15999018|P2|Overall Study|Lost to Follow-up|6
4657736|NCT03122184|15999019|P1|Overall Study|Lost to Follow-up|4
4657737|NCT03122145|15999058|P2|Overall Study|Concurrent respiratory disease|0
4657738|NCT03122145|15999059|P1|Overall Study|Concurrent respiratory disease|3
4657739|NCT03121950|15999069|P2|Overall Study|Withdrawal by Subject|2
4657740|NCT03121950|15999070|P1|Overall Study|Withdrawal by Subject|11
4657741|NCT03120676|15999171|P1|Overall Study|Not treated|1
4657742|NCT03120520|15999179|P4|Overall Study|Other|0
4657743|NCT03120520|15999180|P3|Overall Study|Other|0
4657744|NCT03120520|15999181|P2|Overall Study|Other|1
4657745|NCT03120520|15999182|P1|Overall Study|Other|0
4657746|NCT03120520|15999179|P4|Overall Study|Withdrawal by Subject|2
4657747|NCT03120520|15999180|P3|Overall Study|Withdrawal by Subject|3
4657748|NCT03120520|15999181|P2|Overall Study|Withdrawal by Subject|2
4657749|NCT03120520|15999182|P1|Overall Study|Withdrawal by Subject|3
4657750|NCT03120520|15999179|P4|Overall Study|Lost to Follow-up|1
4657751|NCT03120520|15999180|P3|Overall Study|Lost to Follow-up|1
4657752|NCT03120520|15999181|P2|Overall Study|Lost to Follow-up|1
4657753|NCT03120520|15999182|P1|Overall Study|Lost to Follow-up|1
4657754|NCT03120351|15999206|P2|Overall Study|Physician Decision|1
4657755|NCT03120351|15999207|P1|Overall Study|Physician Decision|1
4657756|NCT03120013|15999213|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
4657757|NCT03120013|15999214|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
4657758|NCT03119688|15999256|P1|Overall Study|Adverse Event|4
4657759|NCT03119662|15999289|P2|Overall Study|Withdrawal by Subject|1
4657760|NCT03119662|15999290|P1|Overall Study|Withdrawal by Subject|0
4657761|NCT03119610|15999360|P2|Overall Study|Lost to Follow-up|1
4657762|NCT03119610|15999361|P1|Overall Study|Lost to Follow-up|0
4657763|NCT03119610|15999360|P2|Overall Study|Adverse Event|0
4657764|NCT03119610|15999361|P1|Overall Study|Adverse Event|1
4657765|NCT03118947|15999439|P1|Overall Study|Lost to Follow-up|2
4657766|NCT03118947|15999439|P1|Overall Study|Change in patient's living situation|4
4657767|NCT03118947|15999439|P1|Overall Study|Withdrawal by caregiver|3
4657768|NCT03118947|15999439|P1|Overall Study|Withdrawal by Subject|3
4657769|NCT03118947|15999439|P1|Overall Study|Protocol Violation|2
4657770|NCT03118947|15999439|P1|Overall Study|Non-compliance with study drug|1
4657771|NCT03118947|15999439|P1|Overall Study|Lack of Efficacy|4
4657772|NCT03118947|15999439|P1|Overall Study|Death|3
4657773|NCT03118947|15999439|P1|Overall Study|Adverse Event|7
4657774|NCT03118934|15999446|P6|Overall Study|Discontinued prior to exposure|0
4657775|NCT03118934|15999447|P5|Overall Study|Discontinued prior to exposure|2
4657776|NCT03118934|15999448|P4|Overall Study|Discontinued prior to exposure|1
4657777|NCT03118934|15999449|P3|Overall Study|Discontinued prior to exposure|1
4657778|NCT03118934|15999450|P2|Overall Study|Discontinued prior to exposure|1
4657779|NCT03118934|15999451|P1|Overall Study|Discontinued prior to exposure|0
4657780|NCT03118934|15999446|P6|Overall Study|Physician Decision|1
4657781|NCT03118934|15999447|P5|Overall Study|Physician Decision|0
4657782|NCT03118934|15999448|P4|Overall Study|Physician Decision|0
4657783|NCT03118934|15999449|P3|Overall Study|Physician Decision|0
4657784|NCT03118934|15999450|P2|Overall Study|Physician Decision|0
4657785|NCT03118934|15999451|P1|Overall Study|Physician Decision|0
4657786|NCT03118934|15999446|P6|Overall Study|Adverse Event|1
4657787|NCT03118934|15999447|P5|Overall Study|Adverse Event|0
4657788|NCT03118934|15999448|P4|Overall Study|Adverse Event|0
4657789|NCT03118934|15999449|P3|Overall Study|Adverse Event|0
4657790|NCT03118934|15999450|P2|Overall Study|Adverse Event|0
4657791|NCT03118934|15999451|P1|Overall Study|Adverse Event|0
4657792|NCT03118765|15999475|P5|Overall Study|Sponsor Decision|1
4657793|NCT03118765|15999476|P4|Overall Study|Sponsor Decision|0
4657794|NCT03118765|15999477|P3|Overall Study|Sponsor Decision|1
4657795|NCT03118765|15999478|P2|Overall Study|Sponsor Decision|0
4657796|NCT03118765|15999479|P1|Overall Study|Sponsor Decision|1
4657797|NCT03118765|15999475|P5|Overall Study|Lost to Follow-up|0
4657798|NCT03118765|15999476|P4|Overall Study|Lost to Follow-up|0
4657799|NCT03118765|15999477|P3|Overall Study|Lost to Follow-up|1
4657800|NCT03118765|15999478|P2|Overall Study|Lost to Follow-up|0
4657801|NCT03118765|15999479|P1|Overall Study|Lost to Follow-up|1
4657802|NCT03118765|15999475|P5|Overall Study|COPD Exacerbation|0
4657803|NCT03118765|15999476|P4|Overall Study|COPD Exacerbation|1
4657804|NCT03118765|15999477|P3|Overall Study|COPD Exacerbation|0
4657805|NCT03118765|15999478|P2|Overall Study|COPD Exacerbation|0
4657806|NCT03118765|15999479|P1|Overall Study|COPD Exacerbation|1
4657807|NCT03118765|15999475|P5|Overall Study|Violation of Inclusion/ExclusionCriteria|0
4657808|NCT03118765|15999476|P4|Overall Study|Violation of Inclusion/ExclusionCriteria|0
4657809|NCT03118765|15999477|P3|Overall Study|Violation of Inclusion/ExclusionCriteria|1
4657810|NCT03118765|15999478|P2|Overall Study|Violation of Inclusion/ExclusionCriteria|1
4657811|NCT03118765|15999479|P1|Overall Study|Violation of Inclusion/ExclusionCriteria|0
4657812|NCT03118765|15999475|P5|Overall Study|Non compliance with Study Procedures|0
4657813|NCT03118765|15999476|P4|Overall Study|Non compliance with Study Procedures|1
4657814|NCT03118765|15999477|P3|Overall Study|Non compliance with Study Procedures|0
4657815|NCT03118765|15999478|P2|Overall Study|Non compliance with Study Procedures|0
4657816|NCT03118765|15999479|P1|Overall Study|Non compliance with Study Procedures|0
4657817|NCT03118765|15999475|P5|Overall Study|Adverse Event|1
4657818|NCT03118765|15999476|P4|Overall Study|Adverse Event|1
4657819|NCT03118765|15999477|P3|Overall Study|Adverse Event|1
4657820|NCT03118765|15999478|P2|Overall Study|Adverse Event|1
4657821|NCT03118765|15999479|P1|Overall Study|Adverse Event|1
4657822|NCT03118765|15999475|P5|Overall Study|Withdrawal by Subject|0
4657823|NCT03118765|15999476|P4|Overall Study|Withdrawal by Subject|0
4657824|NCT03118765|15999477|P3|Overall Study|Withdrawal by Subject|1
4657825|NCT03118765|15999478|P2|Overall Study|Withdrawal by Subject|0
4657826|NCT03118765|15999479|P1|Overall Study|Withdrawal by Subject|0
4657827|NCT03118739|15999575|P2|Overall Study|Lost to Follow-up|0
4657828|NCT03118739|15999576|P1|Overall Study|Lost to Follow-up|2
4657829|NCT03118739|15999575|P2|Overall Study|Withdrawal by Subject|3
4657830|NCT03118739|15999576|P1|Overall Study|Withdrawal by Subject|5
4657831|NCT03118739|15999575|P2|Overall Study|Physician Decision|1
4657832|NCT03118739|15999576|P1|Overall Study|Physician Decision|0
4657833|NCT03118297|15999689|P2|Overall Study|Lost to Follow-up|2
4657834|NCT03118297|15999690|P1|Overall Study|Lost to Follow-up|0
4657835|NCT03116828|15999834|P2|Overall Study|OTHER|3
4657836|NCT03116828|15999835|P1|Overall Study|OTHER|3
4657837|NCT03116828|15999834|P2|Overall Study|Withdrawal by Subject|8
4657838|NCT03116828|15999835|P1|Overall Study|Withdrawal by Subject|4
4657839|NCT03116828|15999834|P2|Overall Study|Adverse Event|10
4657840|NCT03116828|15999835|P1|Overall Study|Adverse Event|1
4657841|NCT03116698|15999845|P4|Overall Study|Death|0
4657842|NCT03116698|15999846|P3|Overall Study|Death|2
4657843|NCT03116698|15999847|P2|Overall Study|Death|0
4657844|NCT03116698|15999848|P1|Overall Study|Death|0
4657845|NCT03116698|15999845|P4|Overall Study|Protocol Violation|0
4657846|NCT03116698|15999846|P3|Overall Study|Protocol Violation|0
4657847|NCT03116698|15999847|P2|Overall Study|Protocol Violation|0
4657848|NCT03116698|15999848|P1|Overall Study|Protocol Violation|1
4657849|NCT03116698|15999845|P4|Overall Study|Physician Decision|0
4657850|NCT03116698|15999846|P3|Overall Study|Physician Decision|0
4657851|NCT03116698|15999847|P2|Overall Study|Physician Decision|1
4657852|NCT03116698|15999848|P1|Overall Study|Physician Decision|1
4657853|NCT03116698|15999845|P4|Overall Study|Lost to Follow-up|0
4657854|NCT03116698|15999846|P3|Overall Study|Lost to Follow-up|0
4657855|NCT03116698|15999847|P2|Overall Study|Lost to Follow-up|0
4657856|NCT03116698|15999848|P1|Overall Study|Lost to Follow-up|2
4657857|NCT03116698|15999845|P4|Overall Study|Withdrawal by Subject|2
4657858|NCT03116698|15999846|P3|Overall Study|Withdrawal by Subject|5
4657859|NCT03116698|15999847|P2|Overall Study|Withdrawal by Subject|4
4657860|NCT03116698|15999848|P1|Overall Study|Withdrawal by Subject|1
4657861|NCT03116698|15999845|P4|Overall Study|Adverse Event|0
4657862|NCT03116698|15999846|P3|Overall Study|Adverse Event|1
4657863|NCT03116698|15999847|P2|Overall Study|Adverse Event|1
4657864|NCT03116698|15999848|P1|Overall Study|Adverse Event|1
4657865|NCT03115476|15999910|P3|LP0084-1369|Trial terminated by Sponsor|160
4657866|NCT03115476|15999911|P2|LP0084-1369|Trial terminated by Sponsor|210
4657867|NCT03115476|15999912|P1|LP0084-1369|Trial terminated by Sponsor|190
4657868|NCT03115476|15999910|P3|LP0084-1369|Death|2
4657869|NCT03115476|15999911|P2|LP0084-1369|Death|0
4657870|NCT03115476|15999912|P1|LP0084-1369|Death|1
4657871|NCT03114969|15999961|P9|Overall Study|Adverse Event|2
4657872|NCT03114969|15999962|P8|Overall Study|Adverse Event|0
4657873|NCT03114969|15999963|P7|Overall Study|Adverse Event|1
4657874|NCT03114969|15999964|P6|Overall Study|Adverse Event|1
4657875|NCT03114969|15999965|P5|Overall Study|Adverse Event|0
4657876|NCT03114969|15999966|P4|Overall Study|Adverse Event|0
4657877|NCT03114969|15999967|P3|Overall Study|Adverse Event|1
4657878|NCT03114969|15999968|P2|Overall Study|Adverse Event|0
4657879|NCT03114969|15999969|P1|Overall Study|Adverse Event|0
4657880|NCT03114969|15999961|P9|Overall Study|Lost to Follow-up|0
4657881|NCT03114969|15999962|P8|Overall Study|Lost to Follow-up|0
4657882|NCT03114969|15999963|P7|Overall Study|Lost to Follow-up|0
4657883|NCT03114969|15999964|P6|Overall Study|Lost to Follow-up|0
4657884|NCT03114969|15999965|P5|Overall Study|Lost to Follow-up|0
4657885|NCT03114969|15999966|P4|Overall Study|Lost to Follow-up|2
4657886|NCT03114969|15999967|P3|Overall Study|Lost to Follow-up|3
4657887|NCT03114969|15999968|P2|Overall Study|Lost to Follow-up|0
4657888|NCT03114969|15999969|P1|Overall Study|Lost to Follow-up|0
4657889|NCT03114657|16000066|P2|Overall Study|Withdrawal by Subject|22
4657890|NCT03114657|16000067|P1|Overall Study|Withdrawal by Subject|28
4657891|NCT03114657|16000066|P2|Overall Study|Symptomatic Deterioration|1
4657892|NCT03114657|16000067|P1|Overall Study|Symptomatic Deterioration|0
4657893|NCT03114657|16000066|P2|Overall Study|Study Terminated By Sponsor|374
4657894|NCT03114657|16000067|P1|Overall Study|Study Terminated By Sponsor|355
4657895|NCT03114657|16000066|P2|Overall Study|Physician Decision|2
4657896|NCT03114657|16000067|P1|Overall Study|Physician Decision|2
4657897|NCT03114657|16000066|P2|Overall Study|Multiple Reasons|2
4657898|NCT03114657|16000067|P1|Overall Study|Multiple Reasons|1
4657899|NCT03114657|16000066|P2|Overall Study|Death|0
4657900|NCT03114657|16000067|P1|Overall Study|Death|4
4657901|NCT03114657|16000066|P2|Overall Study|Adverse Event|6
4657902|NCT03114657|16000067|P1|Overall Study|Adverse Event|9
4657903|NCT03114488|16000112|P2|Time Period 2|Withdrawal by Subject|3
4657904|NCT03114488|16000113|P1|Time Period 2|Withdrawal by Subject|1
4657905|NCT03113916|16000125|P2|Overall Study|Lost to Follow-up|2
4657906|NCT03113916|16000126|P1|Overall Study|Lost to Follow-up|1
4657907|NCT03113916|16000125|P2|Overall Study|Pregnancy|3
4657908|NCT03113916|16000126|P1|Overall Study|Pregnancy|1
4657909|NCT03113916|16000125|P2|Overall Study|Withdrawal by Subject|7
4657910|NCT03113916|16000126|P1|Overall Study|Withdrawal by Subject|9
4657911|NCT03111108|16000223|P2|Overall Study|Withdrawal by Subject|0
4657912|NCT03111108|16000224|P1|Overall Study|Withdrawal by Subject|1
4657913|NCT03111108|16000223|P2|Overall Study|Death|1
4657914|NCT03111108|16000224|P1|Overall Study|Death|0
4657915|NCT03110900|16000242|P2|Overall Study|Sponsor withdrew|1
4657916|NCT03110900|16000243|P1|Overall Study|Sponsor withdrew|1
4657917|NCT03110380|16000310|P2|Overall Study|Lost to Follow-up|1
4657918|NCT03110380|16000311|P1|Overall Study|Lost to Follow-up|4
4657919|NCT03110380|16000310|P2|Overall Study|Withdrew Consent|16
4657920|NCT03110380|16000311|P1|Overall Study|Withdrew Consent|9
4657921|NCT03110380|16000310|P2|Overall Study|Protocol Violation|1
4657922|NCT03110380|16000311|P1|Overall Study|Protocol Violation|0
4657923|NCT03110380|16000310|P2|Overall Study|Non-Compliance with Study Drug|1
4657924|NCT03110380|16000311|P1|Overall Study|Non-Compliance with Study Drug|1
4657925|NCT03110380|16000310|P2|Overall Study|Investigator's Discretion|2
4657926|NCT03110380|16000311|P1|Overall Study|Investigator's Discretion|1
4657927|NCT03110380|16000310|P2|Overall Study|Death|1
4657928|NCT03110380|16000311|P1|Overall Study|Death|2
4657929|NCT03110380|16000310|P2|Overall Study|Adverse Event|3
4657930|NCT03110380|16000311|P1|Overall Study|Adverse Event|3
4657931|NCT03110380|16000310|P2|Overall Study|Still in Study|256
4657932|NCT03110380|16000311|P1|Overall Study|Still in Study|264
4657933|NCT03110380|16000310|P2|Overall Study|Randomized and Never Treated|2
4657934|NCT03110380|16000311|P1|Overall Study|Randomized and Never Treated|0
4657935|NCT03110185|16000323|P2|Overall Study|Patient Refusal|1
4657936|NCT03110185|16000324|P1|Overall Study|Patient Refusal|0
4657937|NCT03110185|16000323|P2|Overall Study|MRI Incompatible|0
4657938|NCT03110185|16000324|P1|Overall Study|MRI Incompatible|2
4657939|NCT03110185|16000323|P2|Overall Study|Protocol Violation|4
4657940|NCT03110185|16000324|P1|Overall Study|Protocol Violation|1
4657941|NCT03110185|16000323|P2|Overall Study|Conflict with care|12
4657942|NCT03110185|16000324|P1|Overall Study|Conflict with care|5
4657943|NCT03110185|16000323|P2|Overall Study|Time Constraints|6
4657944|NCT03110185|16000324|P1|Overall Study|Time Constraints|0
4657945|NCT03110185|16000323|P2|Overall Study|Withdrawal by Subject|7
4657946|NCT03110185|16000324|P1|Overall Study|Withdrawal by Subject|2
4657947|NCT03110185|16000323|P2|Overall Study|Death|1
4657948|NCT03110185|16000324|P1|Overall Study|Death|0
4657949|NCT03110159|16000334|P1|Overall Study|Study termination|1
4657950|NCT03110029|16000345|P2|Overall Study|Withdrawal by Subject|1
4657951|NCT03110029|16000346|P1|Overall Study|Withdrawal by Subject|1
4657952|NCT03109184|16000420|P2|Overall Study|Withdrawal by Subject|1
4657953|NCT03109184|16000421|P1|Overall Study|Withdrawal by Subject|1
4657954|NCT03109184|16000420|P2|Overall Study|Lost to Follow-up|6
4657955|NCT03109184|16000421|P1|Overall Study|Lost to Follow-up|6
4657956|NCT03108521|16000542|P2|Overall Study|Adverse Event|0
4657957|NCT03108521|16000543|P1|Overall Study|Adverse Event|3
4657958|NCT03108521|16000542|P2|Overall Study|Physician Decision|0
4657959|NCT03108521|16000543|P1|Overall Study|Physician Decision|4
4657960|NCT03108521|16000542|P2|Overall Study|Lack of Efficacy|0
4657961|NCT03108521|16000543|P1|Overall Study|Lack of Efficacy|2
4657962|NCT03108521|16000542|P2|Overall Study|Lost to Follow-up|0
4657963|NCT03108521|16000543|P1|Overall Study|Lost to Follow-up|3
4657964|NCT03108157|16000595|P2|Overall Study|Protocol Violation|4
4657965|NCT03108157|16000596|P1|Overall Study|Protocol Violation|15
4657966|NCT03108027|16000606|P6|Period 3|Adverse Event|0
4657967|NCT03108027|16000607|P5|Period 3|Adverse Event|0
4657968|NCT03108027|16000608|P4|Period 3|Adverse Event|0
4657969|NCT03108027|16000609|P3|Period 3|Adverse Event|0
4657970|NCT03108027|16000610|P2|Period 3|Adverse Event|1
4657971|NCT03108027|16000611|P1|Period 3|Adverse Event|0
4657972|NCT03108027|16000606|P6|Period 1|Subject/Guardian Decision|0
4657973|NCT03108027|16000607|P5|Period 1|Subject/Guardian Decision|0
4657974|NCT03108027|16000608|P4|Period 1|Subject/Guardian Decision|2
4657975|NCT03108027|16000609|P3|Period 1|Subject/Guardian Decision|0
4657976|NCT03108027|16000610|P2|Period 1|Subject/Guardian Decision|0
4657977|NCT03108027|16000611|P1|Period 1|Subject/Guardian Decision|0
4657978|NCT03107715|16000638|P2|Overall Study|infant stillborn|1
4657979|NCT03107715|16000639|P1|Overall Study|infant stillborn|0
4657980|NCT03107715|16000638|P2|Overall Study|did not deliver at the home hospital|6
4657981|NCT03107715|16000639|P1|Overall Study|did not deliver at the home hospital|4
4657982|NCT03107611|16000654|P3|Overall Study|Worsening signs/symptoms|2
4657983|NCT03107611|16000655|P2|Overall Study|Worsening signs/symptoms|1
4657984|NCT03107611|16000656|P1|Overall Study|Worsening signs/symptoms|2
4657985|NCT03107611|16000654|P3|Overall Study|Withdrawal by Subject|1
4657986|NCT03107611|16000655|P2|Overall Study|Withdrawal by Subject|0
4657987|NCT03107611|16000656|P1|Overall Study|Withdrawal by Subject|1
4657988|NCT03107611|16000654|P3|Overall Study|Protocol Violation|1
4657989|NCT03107611|16000655|P2|Overall Study|Protocol Violation|0
4657990|NCT03107611|16000656|P1|Overall Study|Protocol Violation|0
4657991|NCT03107611|16000654|P3|Overall Study|Lost to Follow-up|3
4657992|NCT03107611|16000655|P2|Overall Study|Lost to Follow-up|3
4657993|NCT03107611|16000656|P1|Overall Study|Lost to Follow-up|3
4657994|NCT03107611|16000654|P3|Overall Study|Adverse Event|2
4657995|NCT03107611|16000655|P2|Overall Study|Adverse Event|0
4657996|NCT03107611|16000656|P1|Overall Study|Adverse Event|1
4657997|NCT03107377|16000675|P2|Overall Study|Other reason not specified|15
4657998|NCT03107377|16000676|P1|Overall Study|Other reason not specified|16
4657999|NCT03107377|16000675|P2|Overall Study|Lost to Follow-up|34
4658000|NCT03107377|16000676|P1|Overall Study|Lost to Follow-up|37
4658001|NCT03107377|16000675|P2|Overall Study|Withdrawal by Subject|22
4658002|NCT03107377|16000676|P1|Overall Study|Withdrawal by Subject|16
4658003|NCT03107377|16000675|P2|Overall Study|Pregnancy|7
4658004|NCT03107377|16000676|P1|Overall Study|Pregnancy|7
4658005|NCT03107377|16000675|P2|Overall Study|Physician Decision|6
4658006|NCT03107377|16000676|P1|Overall Study|Physician Decision|3
4658007|NCT03107377|16000675|P2|Overall Study|Protocol Violation|12
4658008|NCT03107377|16000676|P1|Overall Study|Protocol Violation|9
4658009|NCT03107377|16000675|P2|Overall Study|Adverse Event|3
4658010|NCT03107377|16000676|P1|Overall Study|Adverse Event|3
4658011|NCT03107052|16000701|P3|Overall Study|Study terminated due to futility|23
4658012|NCT03107052|16000702|P2|Overall Study|Study terminated due to futility|31
4658013|NCT03107052|16000703|P1|Overall Study|Study terminated due to futility|67
4658014|NCT03107052|16000701|P3|Overall Study|Other than specified|0
4658015|NCT03107052|16000702|P2|Overall Study|Other than specified|2
4658016|NCT03107052|16000703|P1|Overall Study|Other than specified|4
4658017|NCT03107052|16000701|P3|Overall Study|Lack of Efficacy|4
4658018|NCT03107052|16000702|P2|Overall Study|Lack of Efficacy|7
4658019|NCT03107052|16000703|P1|Overall Study|Lack of Efficacy|23
4658020|NCT03107052|16000701|P3|Overall Study|Lost to Follow-up|1
4658021|NCT03107052|16000702|P2|Overall Study|Lost to Follow-up|0
4658022|NCT03107052|16000703|P1|Overall Study|Lost to Follow-up|4
4658023|NCT03107052|16000701|P3|Overall Study|Protocol Violation|3
4658024|NCT03107052|16000702|P2|Overall Study|Protocol Violation|0
4658025|NCT03107052|16000703|P1|Overall Study|Protocol Violation|6
4658026|NCT03107052|16000701|P3|Overall Study|Withdrawal by Subject|8
4658027|NCT03107052|16000702|P2|Overall Study|Withdrawal by Subject|5
4658028|NCT03107052|16000703|P1|Overall Study|Withdrawal by Subject|9
4658029|NCT03107052|16000701|P3|Overall Study|Adverse Event|2
4658030|NCT03107052|16000702|P2|Overall Study|Adverse Event|1
4658031|NCT03107052|16000703|P1|Overall Study|Adverse Event|6
4658032|NCT03107026|16000747|P3|Overall Study|Physician Decision|0
4658033|NCT03107026|16000748|P2|Overall Study|Physician Decision|1
4658034|NCT03107026|16000749|P1|Overall Study|Physician Decision|0
4658035|NCT03107026|16000747|P3|Overall Study|non-compliance with study drug|3
4658036|NCT03107026|16000748|P2|Overall Study|non-compliance with study drug|2
4658037|NCT03107026|16000749|P1|Overall Study|non-compliance with study drug|2
4658038|NCT03107026|16000747|P3|Overall Study|non compliance with study visits|0
4658039|NCT03107026|16000748|P2|Overall Study|non compliance with study visits|2
4658040|NCT03107026|16000749|P1|Overall Study|non compliance with study visits|1
4658041|NCT03107026|16000747|P3|Overall Study|Withdrawal by Subject|17
4658042|NCT03107026|16000748|P2|Overall Study|Withdrawal by Subject|5
4658043|NCT03107026|16000749|P1|Overall Study|Withdrawal by Subject|13
4658044|NCT03107026|16000747|P3|Overall Study|Pregnancy|0
4658045|NCT03107026|16000748|P2|Overall Study|Pregnancy|0
4658046|NCT03107026|16000749|P1|Overall Study|Pregnancy|1
4658047|NCT03107026|16000747|P3|Overall Study|Protocol Violation|0
4658048|NCT03107026|16000748|P2|Overall Study|Protocol Violation|2
4658049|NCT03107026|16000749|P1|Overall Study|Protocol Violation|1
4658050|NCT03107026|16000747|P3|Overall Study|Lost to Follow-up|13
4658051|NCT03107026|16000748|P2|Overall Study|Lost to Follow-up|12
4658052|NCT03107026|16000749|P1|Overall Study|Lost to Follow-up|12
4658053|NCT03107026|16000747|P3|Overall Study|Adverse Event|23
4658054|NCT03107026|16000748|P2|Overall Study|Adverse Event|14
4658055|NCT03107026|16000749|P1|Overall Study|Adverse Event|2
4658056|NCT03106753|16000816|P2|Overall Study|Withdrawal by Subject|1
4658057|NCT03106753|16000817|P1|Overall Study|Withdrawal by Subject|0
4658058|NCT03105362|16000917|P1|Overall Study|Lost to Follow-up|1
4658059|NCT03105362|16000917|P1|Overall Study|Withdrawal by Subject|1
4658060|NCT03105297|16000924|P1|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7
4658061|NCT03105297|16000924|P1|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1
4658062|NCT03105297|16000924|P1|Baseline Phase (Day 1)|Other|21
4658063|NCT03104816|16000968|P3|Overall Study|Protocol Violation|2
4658064|NCT03104816|16000969|P2|Overall Study|Protocol Violation|0
4658065|NCT03104816|16000970|P1|Overall Study|Protocol Violation|2
4658066|NCT03104816|16000968|P3|Overall Study|Lack of Efficacy|0
4658067|NCT03104816|16000969|P2|Overall Study|Lack of Efficacy|2
4658068|NCT03104816|16000970|P1|Overall Study|Lack of Efficacy|0
4658069|NCT03103919|16001078|P2|Overall Study|Adverse Event|2
4658070|NCT03103919|16001079|P1|Overall Study|Adverse Event|2
4658071|NCT03103906|16001115|P2|Overall Study|Other|0
4658072|NCT03103906|16001116|P1|Overall Study|Other|2
4658073|NCT03103906|16001115|P2|Overall Study|Adverse Event|3
4658074|NCT03103906|16001116|P1|Overall Study|Adverse Event|2
4658075|NCT03103763|16001139|P3|Overall Study|Withdrawal by Subject|2
4658076|NCT03103763|16001140|P2|Overall Study|Withdrawal by Subject|3
4658077|NCT03103763|16001141|P1|Overall Study|Withdrawal by Subject|0
4658078|NCT03103763|16001139|P3|Overall Study|Death|5
4658079|NCT03103763|16001140|P2|Overall Study|Death|5
4658080|NCT03103763|16001141|P1|Overall Study|Death|15
4658081|NCT03103503|16001170|P1|Overall Study|Study Closure|757
4658082|NCT03103503|16001170|P1|Overall Study|Lost to Follow-up|3
4658083|NCT03103503|16001170|P1|Overall Study|Plexa Lead or Pulse Generator Extraction|10
4658084|NCT03103503|16001170|P1|Overall Study|Withdrawal by Subject|10
4658085|NCT03103503|16001170|P1|Overall Study|Physician Decision|57
4658086|NCT03103503|16001170|P1|Overall Study|Death|64
4658087|NCT03103100|16001183|P3|Overall Study|Physician Decision|2
4658088|NCT03103100|16001184|P2|Overall Study|Physician Decision|0
4658089|NCT03103100|16001185|P1|Overall Study|Physician Decision|1
4658090|NCT03103100|16001183|P3|Overall Study|Adverse Event|0
4658091|NCT03103100|16001184|P2|Overall Study|Adverse Event|0
4658092|NCT03103100|16001185|P1|Overall Study|Adverse Event|1
4658093|NCT03102918|16001209|P2|Overall Study|Protocol Violation|0
4658094|NCT03102918|16001210|P1|Overall Study|Protocol Violation|1
4658095|NCT03102762|16001236|P2|Overall Study|Lost to Follow-up|0
4658096|NCT03102762|16001237|P1|Overall Study|Lost to Follow-up|1
4658097|NCT03102710|16001281|P3|Overall Study|Subject unable to attend final session|0
4658098|NCT03102710|16001282|P2|Overall Study|Subject unable to attend final session|1
4658099|NCT03102710|16001283|P1|Overall Study|Subject unable to attend final session|0
4658100|NCT03102710|16001281|P3|Overall Study|Nausea during MRI scan|0
4658101|NCT03102710|16001282|P2|Overall Study|Nausea during MRI scan|1
4658102|NCT03102710|16001283|P1|Overall Study|Nausea during MRI scan|0
4658103|NCT03102710|16001281|P3|Overall Study|Technical issues during final MRI scan|0
4658104|NCT03102710|16001282|P2|Overall Study|Technical issues during final MRI scan|1
4658105|NCT03102710|16001283|P1|Overall Study|Technical issues during final MRI scan|0
4658106|NCT03102710|16001281|P3|Overall Study|Dental metal affected MRI scan quality|0
4658107|NCT03102710|16001282|P2|Overall Study|Dental metal affected MRI scan quality|0
4658108|NCT03102710|16001283|P1|Overall Study|Dental metal affected MRI scan quality|1
4658109|NCT03102034|16001308|P2|Overall Study|Withdrawal by Subject|0
4658110|NCT03102034|16001309|P1|Overall Study|Withdrawal by Subject|1
4658111|NCT03101592|16001338|P3|Overall Study|participant files could not be located|118
4658112|NCT03101592|16001339|P2|Overall Study|participant files could not be located|170
4658113|NCT03101592|16001340|P1|Overall Study|participant files could not be located|111
4658114|NCT03101462|16001359|P2|Overall Study|Missed Visit 02 and/or Visit 03|1
4658115|NCT03101462|16001360|P1|Overall Study|Missed Visit 02 and/or Visit 03|1
4658116|NCT03101371|16001376|P2|Overall Study|Did not meet eligibility criteria|1
4658117|NCT03101371|16001377|P1|Overall Study|Did not meet eligibility criteria|2
4658118|NCT03101371|16001376|P2|Overall Study|Lost to Follow-up|4
4658119|NCT03101371|16001377|P1|Overall Study|Lost to Follow-up|1
4658120|NCT03101371|16001376|P2|Overall Study|Physician Decision|1
4658121|NCT03101371|16001377|P1|Overall Study|Physician Decision|0
4658122|NCT03101293|16001397|P2|Washout Period (at Least 7 Days)|Positive drug urine screen|0
4658123|NCT03101293|16001398|P1|Washout Period (at Least 7 Days)|Positive drug urine screen|1
4658124|NCT03101267|16001413|P3|Primary Study Period|Miscellaneous|0
4658125|NCT03101267|16001414|P2|Primary Study Period|Miscellaneous|0
4658126|NCT03101267|16001415|P1|Primary Study Period|Miscellaneous|2
4658127|NCT03101267|16001413|P3|Primary Study Period|Withdrawal by Subject|3
4658128|NCT03101267|16001414|P2|Primary Study Period|Withdrawal by Subject|2
4658129|NCT03101267|16001415|P1|Primary Study Period|Withdrawal by Subject|1
4658130|NCT03101150|16001470|P2|Overall Study|Miscarriage|6
4658131|NCT03101150|16001471|P1|Overall Study|Miscarriage|3
4658132|NCT03101150|16001470|P2|Overall Study|Lost to Follow-up|4
4658133|NCT03101150|16001471|P1|Overall Study|Lost to Follow-up|2
4658134|NCT03101020|16001506|P2|Overall Study|Withdrawal by Subject|2
4658135|NCT03101020|16001507|P1|Overall Study|Withdrawal by Subject|0
4658136|NCT03101020|16001506|P2|Overall Study|Ran over by a car|1
4658137|NCT03101020|16001507|P1|Overall Study|Ran over by a car|0
4658138|NCT03101020|16001506|P2|Overall Study|Lack of time to participate|0
4658139|NCT03101020|16001507|P1|Overall Study|Lack of time to participate|1
4658140|NCT03100942|16001542|P7|Placebo Arm Re-Randomized|Withdrew Consent|1
4658141|NCT03100942|16001543|P6|Placebo Arm Re-Randomized|Withdrew Consent|0
4658142|NCT03100942|16001544|P5|Placebo Arm Re-Randomized|Withdrew Consent|0
4658143|NCT03100942|16001545|P4|Placebo Arm Re-Randomized|Withdrew Consent|0
4658144|NCT03100942|16001546|P3|Placebo Arm Re-Randomized|Withdrew Consent|0
4658145|NCT03100942|16001547|P2|Placebo Arm Re-Randomized|Withdrew Consent|0
4658146|NCT03100942|16001548|P1|Placebo Arm Re-Randomized|Withdrew Consent|0
4658147|NCT03100942|16001542|P7|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4658148|NCT03100942|16001543|P6|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4658149|NCT03100942|16001544|P5|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4658150|NCT03100942|16001545|P4|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
4658151|NCT03100942|16001546|P3|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4658152|NCT03100942|16001547|P2|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0
4658153|NCT03100942|16001548|P1|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1
4658154|NCT03100942|16001542|P7|Randomized Treatment Period|Lost to Follow-up|0
4658155|NCT03100942|16001543|P6|Randomized Treatment Period|Lost to Follow-up|0
4658156|NCT03100942|16001544|P5|Randomized Treatment Period|Lost to Follow-up|0
4658157|NCT03100942|16001545|P4|Randomized Treatment Period|Lost to Follow-up|0
4658158|NCT03100942|16001546|P3|Randomized Treatment Period|Lost to Follow-up|1
4658159|NCT03100942|16001547|P2|Randomized Treatment Period|Lost to Follow-up|0
4658160|NCT03100942|16001548|P1|Randomized Treatment Period|Lost to Follow-up|0
4658161|NCT03100942|16001542|P7|Randomized Treatment Period|Protocol Violation|0
4658162|NCT03100942|16001543|P6|Randomized Treatment Period|Protocol Violation|0
4658163|NCT03100942|16001544|P5|Randomized Treatment Period|Protocol Violation|0
4658164|NCT03100942|16001545|P4|Randomized Treatment Period|Protocol Violation|1
4658165|NCT03100942|16001546|P3|Randomized Treatment Period|Protocol Violation|1
4658166|NCT03100942|16001547|P2|Randomized Treatment Period|Protocol Violation|1
4658167|NCT03100942|16001548|P1|Randomized Treatment Period|Protocol Violation|0
4658168|NCT03100942|16001542|P7|Randomized Treatment Period|Investigator's Discretion|0
4658169|NCT03100942|16001543|P6|Randomized Treatment Period|Investigator's Discretion|0
4658170|NCT03100942|16001544|P5|Randomized Treatment Period|Investigator's Discretion|0
4658171|NCT03100942|16001545|P4|Randomized Treatment Period|Investigator's Discretion|0
4658172|NCT03100942|16001546|P3|Randomized Treatment Period|Investigator's Discretion|0
4658173|NCT03100942|16001547|P2|Randomized Treatment Period|Investigator's Discretion|1
4658174|NCT03100942|16001548|P1|Randomized Treatment Period|Investigator's Discretion|2
4658175|NCT03100942|16001542|P7|Randomized Treatment Period|Adverse Event|0
4658176|NCT03100942|16001543|P6|Randomized Treatment Period|Adverse Event|0
4658177|NCT03100942|16001544|P5|Randomized Treatment Period|Adverse Event|0
4658178|NCT03100942|16001545|P4|Randomized Treatment Period|Adverse Event|0
4658179|NCT03100942|16001546|P3|Randomized Treatment Period|Adverse Event|1
4658180|NCT03100942|16001547|P2|Randomized Treatment Period|Adverse Event|2
4658181|NCT03100942|16001548|P1|Randomized Treatment Period|Adverse Event|5
4658182|NCT03100942|16001542|P7|Randomized Treatment Period|Withdrew Consent|0
4658183|NCT03100942|16001543|P6|Randomized Treatment Period|Withdrew Consent|0
4658184|NCT03100942|16001544|P5|Randomized Treatment Period|Withdrew Consent|0
4658185|NCT03100942|16001545|P4|Randomized Treatment Period|Withdrew Consent|3
4658186|NCT03100942|16001546|P3|Randomized Treatment Period|Withdrew Consent|3
4658187|NCT03100942|16001547|P2|Randomized Treatment Period|Withdrew Consent|5
4658188|NCT03100942|16001548|P1|Randomized Treatment Period|Withdrew Consent|4
4658189|NCT03100838|16001577|P4|Overall Study|Lost to Follow-up|0
4658190|NCT03100838|16001578|P3|Overall Study|Lost to Follow-up|1
4658191|NCT03100838|16001579|P2|Overall Study|Lost to Follow-up|0
4658192|NCT03100838|16001580|P1|Overall Study|Lost to Follow-up|0
4658193|NCT03100838|16001577|P4|Overall Study|Pregnancy|0
4658194|NCT03100838|16001578|P3|Overall Study|Pregnancy|0
4658195|NCT03100838|16001579|P2|Overall Study|Pregnancy|1
4658196|NCT03100838|16001580|P1|Overall Study|Pregnancy|0
4658197|NCT03100838|16001577|P4|Overall Study|Physician Decision|1
4658198|NCT03100838|16001578|P3|Overall Study|Physician Decision|1
4658199|NCT03100838|16001579|P2|Overall Study|Physician Decision|1
4658200|NCT03100838|16001580|P1|Overall Study|Physician Decision|1
4658201|NCT03100838|16001577|P4|Overall Study|Adverse Event|0
4658202|NCT03100838|16001578|P3|Overall Study|Adverse Event|0
4658203|NCT03100838|16001579|P2|Overall Study|Adverse Event|0
4658204|NCT03100838|16001580|P1|Overall Study|Adverse Event|1
4658205|NCT03100825|16001606|P1|Overall Study|Physician Decision|1
4658206|NCT03100825|16001606|P1|Overall Study|Participant/Guardian Decision|7
4658207|NCT03100344|16001633|P4|Overall Study|Lost to Follow-up|1
4658208|NCT03100344|16001634|P3|Overall Study|Lost to Follow-up|1
4658209|NCT03100344|16001635|P2|Overall Study|Lost to Follow-up|1
4658210|NCT03100344|16001636|P1|Overall Study|Lost to Follow-up|1
4658211|NCT03100344|16001633|P4|Overall Study|Withdrawal by Subject|8
4658212|NCT03100344|16001634|P3|Overall Study|Withdrawal by Subject|4
4658213|NCT03100344|16001635|P2|Overall Study|Withdrawal by Subject|7
4658214|NCT03100344|16001636|P1|Overall Study|Withdrawal by Subject|10
4658215|NCT03100344|16001633|P4|Overall Study|Protocol Violation|0
4658216|NCT03100344|16001634|P3|Overall Study|Protocol Violation|0
4658217|NCT03100344|16001635|P2|Overall Study|Protocol Violation|0
4658218|NCT03100344|16001636|P1|Overall Study|Protocol Violation|1
4658219|NCT03100344|16001633|P4|Overall Study|Lack of Efficacy|0
4658220|NCT03100344|16001634|P3|Overall Study|Lack of Efficacy|0
4658221|NCT03100344|16001635|P2|Overall Study|Lack of Efficacy|0
4658222|NCT03100344|16001636|P1|Overall Study|Lack of Efficacy|2
4658223|NCT03100344|16001633|P4|Overall Study|Adverse Event|3
4658224|NCT03100344|16001634|P3|Overall Study|Adverse Event|2
4658225|NCT03100344|16001635|P2|Overall Study|Adverse Event|3
4658226|NCT03100344|16001636|P1|Overall Study|Adverse Event|0
4658227|NCT03100058|16001739|P13|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658228|NCT03100058|16001740|P12|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658229|NCT03100058|16001741|P11|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658230|NCT03100058|16001742|P10|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1
4658231|NCT03100058|16001743|P9|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658232|NCT03100058|16001744|P8|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658233|NCT03100058|16001745|P7|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658234|NCT03100058|16001746|P6|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658235|NCT03100058|16001747|P5|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658236|NCT03100058|16001748|P4|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658237|NCT03100058|16001749|P3|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658238|NCT03100058|16001750|P2|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658239|NCT03100058|16001751|P1|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0
4658240|NCT03100058|16001739|P13|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1
4658241|NCT03100058|16001740|P12|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658242|NCT03100058|16001741|P11|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658243|NCT03100058|16001742|P10|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658244|NCT03100058|16001743|P9|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658245|NCT03100058|16001744|P8|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658246|NCT03100058|16001745|P7|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658247|NCT03100058|16001746|P6|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658248|NCT03100058|16001747|P5|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658249|NCT03100058|16001748|P4|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658250|NCT03100058|16001749|P3|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658251|NCT03100058|16001750|P2|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658252|NCT03100058|16001751|P1|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0
4658253|NCT03100058|16001739|P13|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658254|NCT03100058|16001740|P12|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658255|NCT03100058|16001741|P11|Epoch 4 (Last 24 Weeks of the Study)|Death|1
4658256|NCT03100058|16001742|P10|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658257|NCT03100058|16001743|P9|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658258|NCT03100058|16001744|P8|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658259|NCT03100058|16001745|P7|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658260|NCT03100058|16001746|P6|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658261|NCT03100058|16001747|P5|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658262|NCT03100058|16001748|P4|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658263|NCT03100058|16001749|P3|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658264|NCT03100058|16001750|P2|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658265|NCT03100058|16001751|P1|Epoch 4 (Last 24 Weeks of the Study)|Death|0
4658266|NCT03100058|16001739|P13|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2
4658267|NCT03100058|16001740|P12|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658268|NCT03100058|16001741|P11|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7
4658269|NCT03100058|16001742|P10|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4
4658270|NCT03100058|16001743|P9|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658271|NCT03100058|16001744|P8|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658272|NCT03100058|16001745|P7|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658273|NCT03100058|16001746|P6|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658274|NCT03100058|16001747|P5|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658275|NCT03100058|16001748|P4|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658276|NCT03100058|16001749|P3|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658277|NCT03100058|16001750|P2|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658278|NCT03100058|16001751|P1|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0
4658279|NCT03100058|16001739|P13|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658280|NCT03100058|16001740|P12|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1
4658281|NCT03100058|16001741|P11|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3
4658282|NCT03100058|16001742|P10|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658283|NCT03100058|16001743|P9|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658284|NCT03100058|16001744|P8|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658285|NCT03100058|16001745|P7|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658286|NCT03100058|16001746|P6|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658287|NCT03100058|16001747|P5|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658288|NCT03100058|16001748|P4|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658289|NCT03100058|16001749|P3|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658290|NCT03100058|16001750|P2|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658291|NCT03100058|16001751|P1|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0
4658292|NCT03100058|16001739|P13|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1
4658293|NCT03100058|16001740|P12|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2
4658294|NCT03100058|16001741|P11|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4
4658295|NCT03100058|16001742|P10|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658296|NCT03100058|16001743|P9|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658297|NCT03100058|16001744|P8|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658298|NCT03100058|16001745|P7|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658299|NCT03100058|16001746|P6|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658300|NCT03100058|16001747|P5|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658301|NCT03100058|16001748|P4|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658302|NCT03100058|16001749|P3|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658303|NCT03100058|16001750|P2|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658304|NCT03100058|16001751|P1|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0
4658305|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658306|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658307|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658308|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658309|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658310|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658311|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1
4658312|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658313|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658314|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658315|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658316|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658317|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0
4658318|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658319|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658320|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658321|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658322|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658323|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658324|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658325|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658326|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658327|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658328|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658329|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0
4658330|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1
4658331|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Death|0
4658332|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Death|0
4658333|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Death|0
4658334|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Death|0
4658335|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Death|0
4658336|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Death|0
4658337|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Death|0
4658338|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Death|0
4658339|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Death|0
4658340|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Death|0
4658341|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Death|0
4658342|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Death|1
4658343|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Death|0
4658344|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658345|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658346|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658347|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658348|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658349|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658350|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
4658351|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658352|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658353|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1
4658354|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658355|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658356|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0
4658357|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658358|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658359|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658360|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658361|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658362|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
4658363|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658364|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658365|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658366|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1
4658367|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658368|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658369|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0
4658370|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658371|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658372|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658373|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658374|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4658375|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658376|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4658377|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658378|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658379|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658380|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4658381|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1
4658382|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0
4658383|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658384|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658385|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658386|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658387|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658388|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658389|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4658390|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4658391|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658392|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658393|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4658394|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1
4658395|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0
4658396|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4658397|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4658398|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4658399|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0
4658400|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
4658401|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
4658402|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
4658403|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
4658404|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1
4658405|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
4658406|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3
4658407|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4
4658408|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2
4658409|NCT03100058|16001739|P13|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658410|NCT03100058|16001740|P12|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658411|NCT03100058|16001741|P11|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658412|NCT03100058|16001742|P10|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658502|NCT03097861|16002252|P3|Overall Study|Lost to Follow-up|1
4658413|NCT03100058|16001743|P9|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2
4658414|NCT03100058|16001744|P8|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11
4658415|NCT03100058|16001745|P7|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3
4658416|NCT03100058|16001746|P6|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658417|NCT03100058|16001747|P5|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1
4658418|NCT03100058|16001748|P4|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8
4658419|NCT03100058|16001749|P3|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4
4658420|NCT03100058|16001750|P2|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658421|NCT03100058|16001751|P1|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0
4658422|NCT03099694|16001958|P2|Overall Study|Lost to Follow-up|5
4658423|NCT03099694|16001959|P1|Overall Study|Lost to Follow-up|9
4658424|NCT03099694|16001958|P2|Overall Study|Withdrawal by Subject|13
4658425|NCT03099694|16001959|P1|Overall Study|Withdrawal by Subject|11
4658426|NCT03099538|16001998|P1|Overall Study|Lack of Efficacy|3
4658427|NCT03099187|16002023|P2|Overall Study|Non-compliance with Protocol procedure|2
4658428|NCT03099187|16002024|P1|Overall Study|Non-compliance with Protocol procedure|1
4658429|NCT03099187|16002023|P2|Overall Study|Randomization error|2
4658430|NCT03099187|16002024|P1|Overall Study|Randomization error|0
4658431|NCT03099187|16002023|P2|Overall Study|Symptomatic deterioration|1
4658432|NCT03099187|16002024|P1|Overall Study|Symptomatic deterioration|0
4658433|NCT03099187|16002023|P2|Overall Study|Disease progression|1
4658434|NCT03099187|16002024|P1|Overall Study|Disease progression|0
4658435|NCT03099187|16002023|P2|Overall Study|Non-compliance with study drug|1
4658436|NCT03099187|16002024|P1|Overall Study|Non-compliance with study drug|0
4658437|NCT03099187|16002023|P2|Overall Study|Lung transplantation|3
4658438|NCT03099187|16002024|P1|Overall Study|Lung transplantation|1
4658439|NCT03099187|16002023|P2|Overall Study|Withdrawal by Subject|6
4658440|NCT03099187|16002024|P1|Overall Study|Withdrawal by Subject|11
4658441|NCT03099187|16002023|P2|Overall Study|Physician Decision|2
4658442|NCT03099187|16002024|P1|Overall Study|Physician Decision|2
4658443|NCT03099187|16002023|P2|Overall Study|Lack of Efficacy|0
4658444|NCT03099187|16002024|P1|Overall Study|Lack of Efficacy|1
4658445|NCT03099187|16002023|P2|Overall Study|Death|7
4658446|NCT03099187|16002024|P1|Overall Study|Death|4
4658447|NCT03099187|16002023|P2|Overall Study|Adverse Event|9
4658448|NCT03099187|16002024|P1|Overall Study|Adverse Event|23
4658449|NCT03099161|16002073|P3|Overall Study|Progressive Disease|1
4658450|NCT03099161|16002074|P2|Overall Study|Progressive Disease|4
4658451|NCT03099161|16002075|P1|Overall Study|Progressive Disease|1
4658452|NCT03099161|16002073|P3|Overall Study|Physician Decision|0
4658453|NCT03099161|16002074|P2|Overall Study|Physician Decision|0
4658454|NCT03099161|16002075|P1|Overall Study|Physician Decision|2
4658455|NCT03099161|16002073|P3|Overall Study|Adverse Event|2
4658456|NCT03099161|16002074|P2|Overall Study|Adverse Event|0
4658457|NCT03099161|16002075|P1|Overall Study|Adverse Event|0
4658458|NCT03099096|16002092|P1|Overall Study|Physician Decision|1
4658459|NCT03099096|16002092|P1|Overall Study|Adverse Event|1
4658460|NCT03098979|16002105|P6|Overall Study|Protocol Violation|1
4658461|NCT03098979|16002106|P5|Overall Study|Protocol Violation|0
4658462|NCT03098979|16002107|P4|Overall Study|Protocol Violation|0
4658463|NCT03098979|16002108|P3|Overall Study|Protocol Violation|0
4658464|NCT03098979|16002109|P2|Overall Study|Protocol Violation|0
4658465|NCT03098979|16002110|P1|Overall Study|Protocol Violation|0
4658466|NCT03098979|16002105|P6|Overall Study|Non-compliance|1
4658467|NCT03098979|16002106|P5|Overall Study|Non-compliance|0
4658468|NCT03098979|16002107|P4|Overall Study|Non-compliance|0
4658469|NCT03098979|16002108|P3|Overall Study|Non-compliance|0
4658470|NCT03098979|16002109|P2|Overall Study|Non-compliance|0
4658471|NCT03098979|16002110|P1|Overall Study|Non-compliance|0
4658472|NCT03098979|16002105|P6|Overall Study|Physician Decision|0
4658473|NCT03098979|16002106|P5|Overall Study|Physician Decision|0
4658474|NCT03098979|16002107|P4|Overall Study|Physician Decision|0
4658475|NCT03098979|16002108|P3|Overall Study|Physician Decision|0
4658476|NCT03098979|16002109|P2|Overall Study|Physician Decision|1
4658477|NCT03098979|16002110|P1|Overall Study|Physician Decision|2
4658478|NCT03098979|16002105|P6|Overall Study|Death|0
4658479|NCT03098979|16002106|P5|Overall Study|Death|1
4658480|NCT03098979|16002107|P4|Overall Study|Death|0
4658481|NCT03098979|16002108|P3|Overall Study|Death|2
4658482|NCT03098979|16002109|P2|Overall Study|Death|0
4658483|NCT03098979|16002110|P1|Overall Study|Death|1
4658484|NCT03098979|16002105|P6|Overall Study|Withdrawal by Subject|1
4658485|NCT03098979|16002106|P5|Overall Study|Withdrawal by Subject|2
4658486|NCT03098979|16002107|P4|Overall Study|Withdrawal by Subject|1
4658487|NCT03098979|16002108|P3|Overall Study|Withdrawal by Subject|1
4658488|NCT03098979|16002109|P2|Overall Study|Withdrawal by Subject|1
4658489|NCT03098979|16002110|P1|Overall Study|Withdrawal by Subject|2
4658490|NCT03098979|16002105|P6|Overall Study|Adverse Event|1
4658491|NCT03098979|16002106|P5|Overall Study|Adverse Event|6
4658492|NCT03098979|16002107|P4|Overall Study|Adverse Event|4
4658493|NCT03098979|16002108|P3|Overall Study|Adverse Event|1
4658494|NCT03098979|16002109|P2|Overall Study|Adverse Event|0
4658495|NCT03098979|16002110|P1|Overall Study|Adverse Event|1
4658496|NCT03097861|16002252|P3|Overall Study|Reason not provided|1
4658497|NCT03097861|16002253|P2|Overall Study|Reason not provided|1
4658498|NCT03097861|16002254|P1|Overall Study|Reason not provided|3
4658499|NCT03097861|16002252|P3|Overall Study|Withdrawal by Subject|3
4658500|NCT03097861|16002253|P2|Overall Study|Withdrawal by Subject|5
4658501|NCT03097861|16002254|P1|Overall Study|Withdrawal by Subject|1
4658503|NCT03097861|16002253|P2|Overall Study|Lost to Follow-up|7
4658504|NCT03097861|16002254|P1|Overall Study|Lost to Follow-up|0
4658505|NCT03097861|16002252|P3|Overall Study|Investigator Decision|0
4658506|NCT03097861|16002253|P2|Overall Study|Investigator Decision|1
4658507|NCT03097861|16002254|P1|Overall Study|Investigator Decision|0
4658508|NCT03097861|16002252|P3|Overall Study|Adverse Event|4
4658509|NCT03097861|16002253|P2|Overall Study|Adverse Event|8
4658510|NCT03097861|16002254|P1|Overall Study|Adverse Event|3
4658511|NCT03097614|16002271|P1|Overall Study|Adverse Event|3
4658512|NCT03097289|16002373|P1|Overall Study|Collected platelet product unusable|3
4658513|NCT03097289|16002373|P1|Overall Study|Equipment failure|2
4658514|NCT03097289|16002373|P1|Overall Study|Adverse Event|1
4658515|NCT03097133|16002382|P2|Overall Study|Adverse Event|0
4658516|NCT03097133|16002383|P1|Overall Study|Adverse Event|1
4658517|NCT03097133|16002382|P2|Overall Study|Other|2
4658518|NCT03097133|16002383|P1|Overall Study|Other|3
4658519|NCT03097133|16002382|P2|Overall Study|Discontinued DB, not entered FU Phase|25
4658520|NCT03097133|16002383|P1|Overall Study|Discontinued DB, not entered FU Phase|21
4658521|NCT03097133|16002382|P2|Overall Study|Withdrawal by Subject|5
4658522|NCT03097133|16002383|P1|Overall Study|Withdrawal by Subject|2
4658523|NCT03097133|16002382|P2|Overall Study|Lost to Follow-up|2
4658524|NCT03097133|16002383|P1|Overall Study|Lost to Follow-up|3
4658525|NCT03097029|16002433|P1|Overall Study|Withdrawal by Subject|1
4658526|NCT03096483|16002477|P1|Overall Study|Withdrawal by site|1
4658527|NCT03096314|16002506|P2|Screened Vitamin D Deficient|Lost to Follow-up|12
4658528|NCT03096314|16002507|P1|Screened Vitamin D Deficient|Lost to Follow-up|9
4658529|NCT03095651|16002569|P8|Overall Study|Withdrawal by Subject|0
4658530|NCT03095651|16002570|P7|Overall Study|Withdrawal by Subject|0
4658531|NCT03095651|16002571|P6|Overall Study|Withdrawal by Subject|1
4658532|NCT03095651|16002572|P5|Overall Study|Withdrawal by Subject|0
4658533|NCT03095651|16002573|P4|Overall Study|Withdrawal by Subject|0
4658534|NCT03095651|16002574|P3|Overall Study|Withdrawal by Subject|0
4658535|NCT03095651|16002575|P2|Overall Study|Withdrawal by Subject|0
4658536|NCT03095651|16002576|P1|Overall Study|Withdrawal by Subject|0
4658537|NCT03095651|16002569|P8|Overall Study|Lost to Follow-up|0
4658538|NCT03095651|16002570|P7|Overall Study|Lost to Follow-up|0
4658539|NCT03095651|16002571|P6|Overall Study|Lost to Follow-up|0
4658540|NCT03095651|16002572|P5|Overall Study|Lost to Follow-up|0
4658541|NCT03095651|16002573|P4|Overall Study|Lost to Follow-up|1
4658542|NCT03095651|16002574|P3|Overall Study|Lost to Follow-up|0
4658543|NCT03095651|16002575|P2|Overall Study|Lost to Follow-up|1
4658544|NCT03095651|16002576|P1|Overall Study|Lost to Follow-up|1
4658545|NCT03095599|16002855|P2|Overall Study|Withdrawal prior to vaccination|0
4658546|NCT03095599|16002856|P1|Overall Study|Withdrawal prior to vaccination|1
4658547|NCT03095599|16002855|P2|Overall Study|Lost to Follow-up|0
4658548|NCT03095599|16002856|P1|Overall Study|Lost to Follow-up|1
4658549|NCT03095599|16002855|P2|Overall Study|Withdrawal by Subject|0
4658550|NCT03095599|16002856|P1|Overall Study|Withdrawal by Subject|1
4658551|NCT03095521|16002892|P2|Overall Study|Lost to Follow-up|1
4658552|NCT03095521|16002893|P1|Overall Study|Lost to Follow-up|0
4658553|NCT03095521|16002892|P2|Overall Study|Withdrawal by Subject|1
4658554|NCT03095521|16002893|P1|Overall Study|Withdrawal by Subject|0
4658555|NCT03095508|16002911|P2|Overall Study|Adverse Event|1
4658556|NCT03095508|16002912|P1|Overall Study|Adverse Event|0
4658557|NCT03095027|16002960|P2|Period 2, Second Week of Wear|Adverse Event|0
4658558|NCT03095027|16002961|P1|Period 2, Second Week of Wear|Adverse Event|1
4658559|NCT03094195|16002997|P8|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4658560|NCT03094195|16002998|P7|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4658561|NCT03094195|16002999|P6|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4658562|NCT03094195|16003000|P5|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4658563|NCT03094195|16003001|P4|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4658564|NCT03094195|16003002|P3|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
4658565|NCT03094195|16003003|P2|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1
4658566|NCT03094195|16003004|P1|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0
4658567|NCT03094195|16002997|P8|Double-Blind Treatment Period (DB)|Physician Decision|0
4658568|NCT03094195|16002998|P7|Double-Blind Treatment Period (DB)|Physician Decision|0
4658569|NCT03094195|16002999|P6|Double-Blind Treatment Period (DB)|Physician Decision|0
4658570|NCT03094195|16003000|P5|Double-Blind Treatment Period (DB)|Physician Decision|0
4658571|NCT03094195|16003001|P4|Double-Blind Treatment Period (DB)|Physician Decision|0
4658572|NCT03094195|16003002|P3|Double-Blind Treatment Period (DB)|Physician Decision|1
4658573|NCT03094195|16003003|P2|Double-Blind Treatment Period (DB)|Physician Decision|0
4658574|NCT03094195|16003004|P1|Double-Blind Treatment Period (DB)|Physician Decision|0
4658575|NCT03094195|16002997|P8|Double-Blind Treatment Period (DB)|Adverse Event|0
4658576|NCT03094195|16002998|P7|Double-Blind Treatment Period (DB)|Adverse Event|0
4658577|NCT03094195|16002999|P6|Double-Blind Treatment Period (DB)|Adverse Event|0
4658578|NCT03094195|16003000|P5|Double-Blind Treatment Period (DB)|Adverse Event|0
4658579|NCT03094195|16003001|P4|Double-Blind Treatment Period (DB)|Adverse Event|0
4658580|NCT03094195|16003002|P3|Double-Blind Treatment Period (DB)|Adverse Event|1
4658581|NCT03094195|16003003|P2|Double-Blind Treatment Period (DB)|Adverse Event|2
4658582|NCT03094195|16003004|P1|Double-Blind Treatment Period (DB)|Adverse Event|3
4658583|NCT03094195|16002997|P8|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4658584|NCT03094195|16002998|P7|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4658585|NCT03094195|16002999|P6|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4658586|NCT03094195|16003000|P5|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4658587|NCT03094195|16003001|P4|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0
4658588|NCT03094195|16003002|P3|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11
4658589|NCT03094195|16003003|P2|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10
4658590|NCT03094195|16003004|P1|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12
4658591|NCT03093350|16003050|P1|Overall Study|Signed consent, never began treartment|1
4658592|NCT03093350|16003050|P1|Overall Study|Death|1
4658593|NCT03093324|16003058|P2|Overall Study|Withdrawal by Subject|2
4658594|NCT03093324|16003059|P1|Overall Study|Withdrawal by Subject|2
4658595|NCT03093324|16003058|P2|Overall Study|Protocol Deviation|2
4658596|NCT03093324|16003059|P1|Overall Study|Protocol Deviation|2
4658597|NCT03093324|16003058|P2|Overall Study|Lost to Follow-up|0
4658598|NCT03093324|16003059|P1|Overall Study|Lost to Follow-up|1
4658599|NCT03093324|16003058|P2|Overall Study|Adverse Event|15
4658600|NCT03093324|16003059|P1|Overall Study|Adverse Event|4
4658601|NCT03093181|16003093|P3|Overall Study|Other (Protocol violation)|1
4658602|NCT03093181|16003094|P2|Overall Study|Other (Protocol violation)|0
4658603|NCT03093181|16003095|P1|Overall Study|Other (Protocol violation)|0
4658604|NCT03093181|16003093|P3|Overall Study|Adverse Event|0
4658605|NCT03093181|16003094|P2|Overall Study|Adverse Event|1
4658606|NCT03093181|16003095|P1|Overall Study|Adverse Event|0
4658607|NCT03093181|16003093|P3|Overall Study|Other (Not specified)|0
4658608|NCT03093181|16003094|P2|Overall Study|Other (Not specified)|0
4658609|NCT03093181|16003095|P1|Overall Study|Other (Not specified)|1
4658610|NCT03093181|16003093|P3|Overall Study|Withdrawal by Subject|2
4658611|NCT03093181|16003094|P2|Overall Study|Withdrawal by Subject|1
4658612|NCT03093181|16003095|P1|Overall Study|Withdrawal by Subject|2
4658613|NCT03092791|16003157|P8|Overall Study|Reason Not Specified|0
4658614|NCT03092791|16003158|P7|Overall Study|Reason Not Specified|0
4658615|NCT03092791|16003159|P6|Overall Study|Reason Not Specified|1
4658616|NCT03092791|16003160|P5|Overall Study|Reason Not Specified|1
4658617|NCT03092791|16003161|P4|Overall Study|Reason Not Specified|0
4658618|NCT03092791|16003162|P3|Overall Study|Reason Not Specified|0
4658619|NCT03092791|16003163|P2|Overall Study|Reason Not Specified|0
4658620|NCT03092791|16003164|P1|Overall Study|Reason Not Specified|0
4658621|NCT03092791|16003157|P8|Overall Study|Death|1
4658622|NCT03092791|16003158|P7|Overall Study|Death|0
4658623|NCT03092791|16003159|P6|Overall Study|Death|1
4658624|NCT03092791|16003160|P5|Overall Study|Death|0
4658625|NCT03092791|16003161|P4|Overall Study|Death|0
4658626|NCT03092791|16003162|P3|Overall Study|Death|0
4658627|NCT03092791|16003163|P2|Overall Study|Death|0
4658628|NCT03092791|16003164|P1|Overall Study|Death|0
4658629|NCT03092791|16003157|P8|Overall Study|Study Termination|55
4658630|NCT03092791|16003158|P7|Overall Study|Study Termination|53
4658631|NCT03092791|16003159|P6|Overall Study|Study Termination|46
4658632|NCT03092791|16003160|P5|Overall Study|Study Termination|55
4658633|NCT03092791|16003161|P4|Overall Study|Study Termination|0
4658634|NCT03092791|16003162|P3|Overall Study|Study Termination|0
4658635|NCT03092791|16003163|P2|Overall Study|Study Termination|0
4658636|NCT03092791|16003164|P1|Overall Study|Study Termination|0
4658637|NCT03092791|16003157|P8|Overall Study|Withdrawal of Consent|4
4658638|NCT03092791|16003158|P7|Overall Study|Withdrawal of Consent|6
4658639|NCT03092791|16003159|P6|Overall Study|Withdrawal of Consent|12
4658640|NCT03092791|16003160|P5|Overall Study|Withdrawal of Consent|4
4658641|NCT03092791|16003161|P4|Overall Study|Withdrawal of Consent|0
4658642|NCT03092791|16003162|P3|Overall Study|Withdrawal of Consent|0
4658643|NCT03092791|16003163|P2|Overall Study|Withdrawal of Consent|0
4658644|NCT03092791|16003164|P1|Overall Study|Withdrawal of Consent|0
4658645|NCT03092791|16003157|P8|Overall Study|Lost to Follow-up|0
4658646|NCT03092791|16003158|P7|Overall Study|Lost to Follow-up|1
4658647|NCT03092791|16003159|P6|Overall Study|Lost to Follow-up|0
4658648|NCT03092791|16003160|P5|Overall Study|Lost to Follow-up|0
4658649|NCT03092791|16003161|P4|Overall Study|Lost to Follow-up|0
4658650|NCT03092791|16003162|P3|Overall Study|Lost to Follow-up|0
4658651|NCT03092791|16003163|P2|Overall Study|Lost to Follow-up|0
4658652|NCT03092791|16003164|P1|Overall Study|Lost to Follow-up|0
4658653|NCT03092752|16003279|P1|Overall Study|<6 month history|245900
4658654|NCT03092752|16003279|P1|Overall Study|Average hospital visit interval >92 days|10779
4658655|NCT03092752|16003279|P1|Overall Study|Having no claim of study drugs|29282
4658656|NCT03092752|16003279|P1|Overall Study|At least one claim with T2DM|61299
4658657|NCT03092752|16003279|P1|Overall Study|Aged <40 years|14209
4658658|NCT03092726|16003344|P2|Overall Study|Withdrawal by Subject|3
4658659|NCT03092726|16003345|P1|Overall Study|Withdrawal by Subject|5
4658660|NCT03092726|16003344|P2|Overall Study|Lost to Follow-up|0
4658661|NCT03092726|16003345|P1|Overall Study|Lost to Follow-up|1
4658662|NCT03092726|16003344|P2|Overall Study|Lack of Efficacy|1
4658663|NCT03092726|16003345|P1|Overall Study|Lack of Efficacy|0
4658664|NCT03092726|16003344|P2|Overall Study|Adverse Event|10
4658665|NCT03092726|16003345|P1|Overall Study|Adverse Event|3
4658666|NCT03092479|16003371|P2|Overall Study|Withdrawal by Subject|0
4658667|NCT03092479|16003372|P1|Overall Study|Withdrawal by Subject|4
4658668|NCT03092479|16003371|P2|Overall Study|Lost to Follow-up|2
4658669|NCT03092479|16003372|P1|Overall Study|Lost to Follow-up|3
4658670|NCT03092375|16003394|P4|Overall Study|Lack of Efficacy|0
4658671|NCT03092375|16003395|P3|Overall Study|Lack of Efficacy|1
4658672|NCT03092375|16003396|P2|Overall Study|Lack of Efficacy|1
4658673|NCT03092375|16003397|P1|Overall Study|Lack of Efficacy|0
4658674|NCT03092219|16003425|P2|Overall Study|Protocol Violation|4
4658675|NCT03092219|16003426|P1|Overall Study|Protocol Violation|7
4658676|NCT03091920|16003470|P3|Overall Study|Adverse Event|0
4658677|NCT03091920|16003471|P2|Overall Study|Adverse Event|1
4658678|NCT03091920|16003472|P1|Overall Study|Adverse Event|0
4658679|NCT03091777|16003619|P3|Overall Study|Abnormal Laboratory Value|12
4658680|NCT03091777|16003620|P2|Overall Study|Abnormal Laboratory Value|11
4658681|NCT03091777|16003621|P1|Overall Study|Abnormal Laboratory Value|7
4658682|NCT03091777|16003619|P3|Overall Study|Physician Decision|1
4658683|NCT03091777|16003620|P2|Overall Study|Physician Decision|0
4658684|NCT03091777|16003621|P1|Overall Study|Physician Decision|1
4658685|NCT03091777|16003619|P3|Overall Study|Noncompliance with study drug|1
4658686|NCT03091777|16003620|P2|Overall Study|Noncompliance with study drug|3
4658687|NCT03091777|16003621|P1|Overall Study|Noncompliance with study drug|2
4658688|NCT03091777|16003619|P3|Overall Study|Lack of Efficacy|5
4658689|NCT03091777|16003620|P2|Overall Study|Lack of Efficacy|0
4658690|NCT03091777|16003621|P1|Overall Study|Lack of Efficacy|0
4658691|NCT03091777|16003619|P3|Overall Study|Lost to Follow-up|7
4658692|NCT03091777|16003620|P2|Overall Study|Lost to Follow-up|14
4658693|NCT03091777|16003621|P1|Overall Study|Lost to Follow-up|12
4658694|NCT03091777|16003619|P3|Overall Study|Protocol Violation|1
4658695|NCT03091777|16003620|P2|Overall Study|Protocol Violation|1
4658696|NCT03091777|16003621|P1|Overall Study|Protocol Violation|2
4658697|NCT03091777|16003619|P3|Overall Study|Withdrawal by Subject|6
4658698|NCT03091777|16003620|P2|Overall Study|Withdrawal by Subject|2
4658699|NCT03091777|16003621|P1|Overall Study|Withdrawal by Subject|4
4658700|NCT03091777|16003619|P3|Overall Study|Adverse Event|4
4658701|NCT03091777|16003620|P2|Overall Study|Adverse Event|1
4658702|NCT03091777|16003621|P1|Overall Study|Adverse Event|2
4658703|NCT03091777|16003619|P3|Overall Study|Pregnancy|0
4658704|NCT03091777|16003620|P2|Overall Study|Pregnancy|1
4658705|NCT03091777|16003621|P1|Overall Study|Pregnancy|2
4658706|NCT03091439|16003663|P2|Overall Study|Study Terminated by the Sponsor|0
4658707|NCT03091439|16003664|P1|Overall Study|Study Terminated by the Sponsor|1
4658708|NCT03091400|16003688|P2|Washout - 2 Weeks|Withdrawal by Subject|0
4658709|NCT03091400|16003689|P1|Washout - 2 Weeks|Withdrawal by Subject|1
4658710|NCT03091348|16003711|P2|Overall Study|Lost to Follow-up|1
4658711|NCT03091348|16003712|P1|Overall Study|Lost to Follow-up|2
4658712|NCT03091192|16003738|P2|Overall Study|Lost to Follow-up|0
4658713|NCT03091192|16003739|P1|Overall Study|Lost to Follow-up|1
4658714|NCT03091192|16003738|P2|Overall Study|Withdrawal by Subject|0
4658715|NCT03091192|16003739|P1|Overall Study|Withdrawal by Subject|2
4658716|NCT03091192|16003738|P2|Overall Study|Death|13
4658717|NCT03091192|16003739|P1|Overall Study|Death|9
4658718|NCT03091192|16003738|P2|Overall Study|Study terminated by sponsor|14
4658719|NCT03091192|16003739|P1|Overall Study|Study terminated by sponsor|21
4658720|NCT03090100|16003807|P2|Overall Study|Other|2
4658721|NCT03090100|16003808|P1|Overall Study|Other|2
4658722|NCT03090100|16003807|P2|Overall Study|Non-compliance|0
4658723|NCT03090100|16003808|P1|Overall Study|Non-compliance|2
4658724|NCT03090100|16003807|P2|Overall Study|Protocol Violation|6
4658725|NCT03090100|16003808|P1|Overall Study|Protocol Violation|2
4658726|NCT03090100|16003807|P2|Overall Study|Withdrawal by Subject|19
4658727|NCT03090100|16003808|P1|Overall Study|Withdrawal by Subject|7
4658728|NCT03090100|16003807|P2|Overall Study|Lost to Follow-up|2
4658729|NCT03090100|16003808|P1|Overall Study|Lost to Follow-up|2
4658730|NCT03090100|16003807|P2|Overall Study|Lack of Efficacy|7
4658731|NCT03090100|16003808|P1|Overall Study|Lack of Efficacy|2
4658732|NCT03090100|16003807|P2|Overall Study|Pregnancy|1
4658733|NCT03090100|16003808|P1|Overall Study|Pregnancy|1
4658734|NCT03090100|16003807|P2|Overall Study|Adverse Event|11
4658735|NCT03090100|16003808|P1|Overall Study|Adverse Event|9
4658736|NCT03089944|16003848|P1|Overall Study|Other|1
4658737|NCT03089944|16003848|P1|Overall Study|Adverse Event|1
4658738|NCT03089944|16003848|P1|Overall Study|Withdrew Consent|2
4658739|NCT03089944|16003848|P1|Overall Study|Lost to Follow-up|8
4658740|NCT03089853|16003895|P2|Overall Study|Lost to Follow-up|1
4658741|NCT03089853|16003896|P1|Overall Study|Lost to Follow-up|2
4658742|NCT03089580|16003918|P1|Overall Study|Lost to Follow-up|2
4658743|NCT03089216|16003929|P4|Overall Study|Adverse Event|1
4658744|NCT03089216|16003930|P3|Overall Study|Adverse Event|0
4658745|NCT03089216|16003931|P2|Overall Study|Adverse Event|0
4658746|NCT03089216|16003932|P1|Overall Study|Adverse Event|0
4658747|NCT03088917|16003946|P1|Overall Study|Moved outside study region|50
4658748|NCT03088917|16003946|P1|Overall Study|Severe comorbidity/short life expectancy|5
4658749|NCT03088917|16003946|P1|Overall Study|Contact not established|13
4658750|NCT03088917|16003946|P1|Overall Study|Refuse re-evaluation|13
4658751|NCT03088917|16003946|P1|Overall Study|In care/cured elsewhere|15
4658752|NCT03087643|16004016|P2|Overall Study|Death|2
4658753|NCT03087643|16004017|P1|Overall Study|Death|2
4658754|NCT03087643|16004016|P2|Overall Study|Withdrawal by Subject|4
4658755|NCT03087643|16004017|P1|Overall Study|Withdrawal by Subject|2
4658756|NCT03087513|16004044|P1|Second Intervention After 3 hr Washout|Equipment malfunction|2
4658757|NCT03086551|16004091|P2|Washout|Withdrawal by Subject|1
4658758|NCT03086551|16004092|P1|Washout|Withdrawal by Subject|2
4658759|NCT03086551|16004091|P2|Washout|Lost to Follow-up|2
4658760|NCT03086551|16004092|P1|Washout|Lost to Follow-up|1
4658761|NCT03086551|16004091|P2|First Intervention|Lost to Follow-up|1
4658762|NCT03086551|16004092|P1|First Intervention|Lost to Follow-up|0
4658763|NCT03086551|16004091|P2|First Intervention|Failure to meet inclusion criterion|0
4658764|NCT03086551|16004092|P1|First Intervention|Failure to meet inclusion criterion|1
4658765|NCT03086447|16004108|P2|Overall Study|Lens Discomfort|1
4658766|NCT03086447|16004109|P1|Overall Study|Lens Discomfort|2
4658767|NCT03086447|16004108|P2|Overall Study|Adverse Event|0
4658768|NCT03086447|16004109|P1|Overall Study|Adverse Event|3
4658769|NCT03086447|16004108|P2|Overall Study|Lost to Follow-up|1
4658770|NCT03086447|16004109|P1|Overall Study|Lost to Follow-up|0
4658771|NCT03086447|16004108|P2|Overall Study|Protocol Violation|4
4658772|NCT03086447|16004109|P1|Overall Study|Protocol Violation|2
4658773|NCT03086447|16004108|P2|Overall Study|Test Article No Longer Available|0
4658774|NCT03086447|16004109|P1|Overall Study|Test Article No Longer Available|1
4658775|NCT03086447|16004108|P2|Overall Study|Unsatisfactory Lens Fitting|1
4658776|NCT03086447|16004109|P1|Overall Study|Unsatisfactory Lens Fitting|0
4658777|NCT03086447|16004108|P2|Overall Study|Lens Damage|6
4658778|NCT03086447|16004109|P1|Overall Study|Lens Damage|1
4658779|NCT03086447|16004108|P2|Overall Study|Product quality complaint|1
4658780|NCT03086447|16004109|P1|Overall Study|Product quality complaint|0
4658781|NCT03086447|16004108|P2|Overall Study|Lost Lens|5
4658782|NCT03086447|16004109|P1|Overall Study|Lost Lens|2
4658783|NCT03086447|16004108|P2|Overall Study|No Longer Meets Eligibility Criteria|1
4658784|NCT03086447|16004109|P1|Overall Study|No Longer Meets Eligibility Criteria|0
4658785|NCT03086343|16004167|P2|Overall Study|Missing|1
4658786|NCT03086343|16004168|P1|Overall Study|Missing|0
4658787|NCT03086343|16004167|P2|Overall Study|Other, not specified|4
4658788|NCT03086343|16004168|P1|Overall Study|Other, not specified|8
4658789|NCT03086343|16004167|P2|Overall Study|Lack of Efficacy|6
4658790|NCT03086343|16004168|P1|Overall Study|Lack of Efficacy|4
4658791|NCT03086343|16004167|P2|Overall Study|Lost to Follow-up|1
4658792|NCT03086343|16004168|P1|Overall Study|Lost to Follow-up|3
4658793|NCT03086343|16004167|P2|Overall Study|Withdrawal by Subject|6
4658794|NCT03086343|16004168|P1|Overall Study|Withdrawal by Subject|10
4658795|NCT03086343|16004167|P2|Overall Study|Adverse Event|7
4658796|NCT03086343|16004168|P1|Overall Study|Adverse Event|7
4658797|NCT03086330|16004180|P2|Overall Study|Lost to Follow-up|2
4658798|NCT03086330|16004181|P1|Overall Study|Lost to Follow-up|1
4658799|NCT03086330|16004180|P2|Overall Study|Withdrawal by Subject|2
4658800|NCT03086330|16004181|P1|Overall Study|Withdrawal by Subject|3
4658801|NCT03086135|16004378|P1|Overall Study|Lost to Follow-up|2
4658802|NCT03086135|16004378|P1|Overall Study|Adverse Event|1
4658803|NCT03086018|16004405|P1|Final Testing for End of Trial|Withdrawal by Subject|1
4658804|NCT03086018|16004405|P1|Final Testing for End of Trial|Adverse Event|1
4658805|NCT03085914|16004420|P7|Overall Study|Ongoing in Trial|3
4658806|NCT03085914|16004421|P6|Overall Study|Ongoing in Trial|3
4658807|NCT03085914|16004422|P5|Overall Study|Ongoing in Trial|4
4658808|NCT03085914|16004423|P4|Overall Study|Ongoing in Trial|3
4658809|NCT03085914|16004424|P3|Overall Study|Ongoing in Trial|5
4658810|NCT03085914|16004425|P2|Overall Study|Ongoing in Trial|0
4658811|NCT03085914|16004426|P1|Overall Study|Ongoing in Trial|1
4658812|NCT03085914|16004420|P7|Overall Study|Other Unspecified|4
4658813|NCT03085914|16004421|P6|Overall Study|Other Unspecified|2
4658814|NCT03085914|16004422|P5|Overall Study|Other Unspecified|2
4658815|NCT03085914|16004423|P4|Overall Study|Other Unspecified|3
4658816|NCT03085914|16004424|P3|Overall Study|Other Unspecified|1
4658817|NCT03085914|16004425|P2|Overall Study|Other Unspecified|2
4658818|NCT03085914|16004426|P1|Overall Study|Other Unspecified|2
4658819|NCT03085914|16004420|P7|Overall Study|Withdrawal by Subject|1
4658820|NCT03085914|16004421|P6|Overall Study|Withdrawal by Subject|0
4658821|NCT03085914|16004422|P5|Overall Study|Withdrawal by Subject|2
4658822|NCT03085914|16004423|P4|Overall Study|Withdrawal by Subject|2
4658823|NCT03085914|16004424|P3|Overall Study|Withdrawal by Subject|0
4658824|NCT03085914|16004425|P2|Overall Study|Withdrawal by Subject|1
4658825|NCT03085914|16004426|P1|Overall Study|Withdrawal by Subject|1
4658826|NCT03085914|16004420|P7|Overall Study|Lost to Follow-up|1
4658827|NCT03085914|16004421|P6|Overall Study|Lost to Follow-up|1
4658828|NCT03085914|16004422|P5|Overall Study|Lost to Follow-up|0
4658829|NCT03085914|16004423|P4|Overall Study|Lost to Follow-up|0
4658830|NCT03085914|16004424|P3|Overall Study|Lost to Follow-up|1
4658831|NCT03085914|16004425|P2|Overall Study|Lost to Follow-up|0
4658832|NCT03085914|16004426|P1|Overall Study|Lost to Follow-up|1
4658833|NCT03085914|16004420|P7|Overall Study|Death|2
4658834|NCT03085914|16004421|P6|Overall Study|Death|2
4658835|NCT03085914|16004422|P5|Overall Study|Death|5
4658836|NCT03085914|16004423|P4|Overall Study|Death|1
4658837|NCT03085914|16004424|P3|Overall Study|Death|4
4658838|NCT03085914|16004425|P2|Overall Study|Death|6
4658839|NCT03085914|16004426|P1|Overall Study|Death|4
4658840|NCT03085238|16004508|P1|Overall Study|Death|2
4658841|NCT03085238|16004508|P1|Overall Study|Adverse Event|2
4658842|NCT03085017|16004535|P2|Overall Study|Death|3
4658843|NCT03085017|16004536|P1|Overall Study|Death|0
4658844|NCT03084315|16004562|P2|Overall Study|Withdrawal by Subject|2
4658845|NCT03084315|16004563|P1|Overall Study|Withdrawal by Subject|2
4658846|NCT03084315|16004562|P2|Overall Study|Lost to Follow-up|7
4658847|NCT03084315|16004563|P1|Overall Study|Lost to Follow-up|8
4658848|NCT03083639|16004625|P2|Washout Period (at Least 6 Days)|Lost to Follow-up|0
4658849|NCT03083639|16004626|P1|Washout Period (at Least 6 Days)|Lost to Follow-up|1
4658850|NCT03083639|16004625|P2|Washout Period (at Least 6 Days)|Pregnancy|1
4658851|NCT03083639|16004626|P1|Washout Period (at Least 6 Days)|Pregnancy|0
4658852|NCT03083483|16004639|P3|Overall Study|technological issues|1
4658853|NCT03083483|16004640|P2|Overall Study|technological issues|0
4658854|NCT03083483|16004641|P1|Overall Study|technological issues|1
4658855|NCT03083483|16004639|P3|Overall Study|Lost to Follow-up|1
4658856|NCT03083483|16004640|P2|Overall Study|Lost to Follow-up|1
4658857|NCT03083483|16004641|P1|Overall Study|Lost to Follow-up|2
4658858|NCT03083483|16004639|P3|Overall Study|Adverse Event|1
4658859|NCT03083483|16004640|P2|Overall Study|Adverse Event|1
4658860|NCT03083483|16004641|P1|Overall Study|Adverse Event|1
4658861|NCT03083470|16004660|P5|Overall Study|Withdrawal by Subject|1
4658862|NCT03083470|16004661|P4|Overall Study|Withdrawal by Subject|0
4658863|NCT03083470|16004662|P3|Overall Study|Withdrawal by Subject|0
4658864|NCT03083470|16004663|P2|Overall Study|Withdrawal by Subject|0
4658865|NCT03083470|16004664|P1|Overall Study|Withdrawal by Subject|0
4658866|NCT03083470|16004660|P5|Overall Study|Lost to Follow-up|1
4658867|NCT03083470|16004661|P4|Overall Study|Lost to Follow-up|0
4658868|NCT03083470|16004662|P3|Overall Study|Lost to Follow-up|0
4658869|NCT03083470|16004663|P2|Overall Study|Lost to Follow-up|0
4658870|NCT03083470|16004664|P1|Overall Study|Lost to Follow-up|0
4658871|NCT03082599|16004712|P2|Overall Study|Lost to Follow-up|0
4658872|NCT03082599|16004713|P1|Overall Study|Lost to Follow-up|1
4658873|NCT03080961|16004779|P1|Overall Study|Withdrawal by Subject|3
4658874|NCT03080493|16004790|P2|Overall Study|Randomization error (parity group)|1
4658875|NCT03080493|16004791|P1|Overall Study|Randomization error (parity group)|0
4658876|NCT03080493|16004790|P2|Overall Study|Adverse Event|1
4658877|NCT03080493|16004791|P1|Overall Study|Adverse Event|0
4658878|NCT03080493|16004790|P2|Overall Study|Did not provide NRS pain results|0
4658879|NCT03080493|16004791|P1|Overall Study|Did not provide NRS pain results|1
4658880|NCT03080454|16004807|P1|Anodal FU (7 Days)|Lost to Follow-up|4
4658881|NCT03080454|16004807|P1|Anodal Doublestim (5 Days)|Adverse Event|1
4658882|NCT03080454|16004807|P1|Baseline|Adverse Event|2
4658883|NCT03078816|16004874|P1|Overall Study|Withdrawal by Subject|1
4658884|NCT03078582|16004924|P2|Overall Study|Adverse Event|8
4658885|NCT03078582|16004925|P1|Overall Study|Adverse Event|0
4658886|NCT03078556|16004945|P4|Washout Period 1 (7 Days)|Physician Decision|0
4658887|NCT03078556|16004946|P3|Washout Period 1 (7 Days)|Physician Decision|0
4658888|NCT03078556|16004947|P2|Washout Period 1 (7 Days)|Physician Decision|1
4658889|NCT03078556|16004948|P1|Washout Period 1 (7 Days)|Physician Decision|0
4658890|NCT03078556|16004945|P4|Washout Period 1 (7 Days)|Adverse Event|1
4658891|NCT03078556|16004946|P3|Washout Period 1 (7 Days)|Adverse Event|0
4658892|NCT03078556|16004947|P2|Washout Period 1 (7 Days)|Adverse Event|1
4658893|NCT03078556|16004948|P1|Washout Period 1 (7 Days)|Adverse Event|0
4658894|NCT03078556|16004945|P4|Washout Period 1 (7 Days)|Lost to Follow-up|0
4658895|NCT03078556|16004946|P3|Washout Period 1 (7 Days)|Lost to Follow-up|1
4658896|NCT03078556|16004947|P2|Washout Period 1 (7 Days)|Lost to Follow-up|0
4658897|NCT03078556|16004948|P1|Washout Period 1 (7 Days)|Lost to Follow-up|2
4658898|NCT03078556|16004945|P4|Treatment Period 1 (4 Days)|Adverse Event|0
4658899|NCT03078556|16004946|P3|Treatment Period 1 (4 Days)|Adverse Event|0
4658900|NCT03078556|16004947|P2|Treatment Period 1 (4 Days)|Adverse Event|1
4658901|NCT03078556|16004948|P1|Treatment Period 1 (4 Days)|Adverse Event|0
4658902|NCT03078478|16005092|P2|Maintencance Period 2 (36 Weeks)|Not reconsenting|2
4658903|NCT03078478|16005093|P1|Maintencance Period 2 (36 Weeks)|Not reconsenting|0
4658904|NCT03078478|16005092|P2|Maintencance Period 2 (36 Weeks)|Death|6
4658905|NCT03078478|16005093|P1|Maintencance Period 2 (36 Weeks)|Death|4
4658906|NCT03078478|16005092|P2|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6
4658907|NCT03078478|16005093|P1|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3
4658908|NCT03078478|16005092|P2|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13
4658909|NCT03078478|16005093|P1|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18
4658910|NCT03078478|16005092|P2|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0
4658911|NCT03078478|16005093|P1|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1
4658912|NCT03078478|16005092|P2|Maintenance Period 1 (36 Weeks)|Death|3
4658913|NCT03078478|16005093|P1|Maintenance Period 1 (36 Weeks)|Death|3
4658914|NCT03078478|16005092|P2|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4
4658915|NCT03078478|16005093|P1|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7
4658916|NCT03078478|16005092|P2|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
4658917|NCT03078478|16005093|P1|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36
4658918|NCT03077919|16005179|P2|Overall Study|Lost to Follow-up|1
4658919|NCT03077919|16005180|P1|Overall Study|Lost to Follow-up|4
4658920|NCT03077724|16005240|P2|Overall Study|Withdrawal by Subject|1
4658921|NCT03077724|16005241|P1|Overall Study|Withdrawal by Subject|3
4658922|NCT03077724|16005240|P2|Overall Study|Lost to Follow-up|1
4658923|NCT03077724|16005241|P1|Overall Study|Lost to Follow-up|5
4658924|NCT03077711|16005253|P2|Overall Study|noncompliant taking medication|0
4658925|NCT03077711|16005254|P1|Overall Study|noncompliant taking medication|2
4658926|NCT03077711|16005253|P2|Overall Study|Lost to Follow-up|2
4658927|NCT03077711|16005254|P1|Overall Study|Lost to Follow-up|2
4658928|NCT03077659|16005273|P3|Overall Study|Withdrawal by Subject|1
4658929|NCT03077659|16005274|P2|Overall Study|Withdrawal by Subject|0
4658930|NCT03077659|16005275|P1|Overall Study|Withdrawal by Subject|0
4658931|NCT03077607|16005306|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
4658932|NCT03077607|16005307|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2
4658933|NCT03077607|16005306|P2|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0
4658934|NCT03077607|16005307|P1|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1
4658935|NCT03077607|16005306|P2|Period 1 (15 Days)|Death|0
4658936|NCT03077607|16005307|P1|Period 1 (15 Days)|Death|1
4658937|NCT03077607|16005306|P2|Period 1 (15 Days)|Adverse Event|0
4658938|NCT03077607|16005307|P1|Period 1 (15 Days)|Adverse Event|1
4658939|NCT03077438|16005375|P2|Overall Study|Lost to Follow-up|3
4658940|NCT03077438|16005376|P1|Overall Study|Lost to Follow-up|6
4658941|NCT03077438|16005375|P2|Overall Study|Withdrawal by Subject|6
4658942|NCT03077438|16005376|P1|Overall Study|Withdrawal by Subject|3
4658943|NCT03077438|16005375|P2|Overall Study|Protocol Violation|5
4658944|NCT03077438|16005376|P1|Overall Study|Protocol Violation|3
4658945|NCT03076996|16005417|P1|Overall Study|Literacy precluded participation|1
4658946|NCT03076996|16005417|P1|Overall Study|Lost to Follow-up|3
4658947|NCT03076996|16005417|P1|Overall Study|Withdrawal by Subject|2
4658948|NCT03076970|16005443|P6|Period 3|Failure to meet I/E criteria|0
4658949|NCT03076970|16005444|P5|Period 3|Failure to meet I/E criteria|1
4658950|NCT03076970|16005445|P4|Period 3|Failure to meet I/E criteria|0
4658951|NCT03076970|16005446|P3|Period 3|Failure to meet I/E criteria|0
4658952|NCT03076970|16005447|P2|Period 3|Failure to meet I/E criteria|0
4658953|NCT03076970|16005448|P1|Period 3|Failure to meet I/E criteria|0
4658954|NCT03076970|16005443|P6|Period 3|Withdrawal by Subject|1
4658955|NCT03076970|16005444|P5|Period 3|Withdrawal by Subject|0
4658956|NCT03076970|16005445|P4|Period 3|Withdrawal by Subject|0
4658957|NCT03076970|16005446|P3|Period 3|Withdrawal by Subject|0
4658958|NCT03076970|16005447|P2|Period 3|Withdrawal by Subject|0
4658959|NCT03076970|16005448|P1|Period 3|Withdrawal by Subject|0
4658960|NCT03076970|16005443|P6|Washout Period 2|Adverse Event|0
4658961|NCT03076970|16005444|P5|Washout Period 2|Adverse Event|1
4658962|NCT03076970|16005445|P4|Washout Period 2|Adverse Event|0
4658963|NCT03076970|16005446|P3|Washout Period 2|Adverse Event|0
4658964|NCT03076970|16005447|P2|Washout Period 2|Adverse Event|0
4658965|NCT03076970|16005448|P1|Washout Period 2|Adverse Event|0
4658966|NCT03076515|16005500|P2|Overall Study|DMC decision based on interim analysis|29
4658967|NCT03076515|16005501|P1|Overall Study|DMC decision based on interim analysis|25
4658968|NCT03076190|16005520|P2|Overall Study|Excluded from Analysis (zero duration ev|7
4658969|NCT03076190|16005521|P1|Overall Study|Excluded from Analysis (zero duration ev|9
4658970|NCT03076190|16005520|P2|Overall Study|Lost to Follow-up|34
4658971|NCT03076190|16005521|P1|Overall Study|Lost to Follow-up|9
4658972|NCT03075904|16005534|P1|Overall Study|Need for Medication not Permitted|1
4658973|NCT03075904|16005534|P1|Overall Study|Physician Decision|3
4658974|NCT03075891|16005544|P2|Overall Study|Drug abuse relapse issue|1
4658975|NCT03075891|16005545|P1|Overall Study|Drug abuse relapse issue|0
4658976|NCT03075891|16005544|P2|Overall Study|Patient requiring study withdrawal|1
4658977|NCT03075891|16005545|P1|Overall Study|Patient requiring study withdrawal|0
4658978|NCT03075891|16005544|P2|Overall Study|Other visits not performed (no time)|0
4658979|NCT03075891|16005545|P1|Overall Study|Other visits not performed (no time)|1
4658980|NCT03075891|16005544|P2|Overall Study|Pregnancy|1
4658981|NCT03075891|16005545|P1|Overall Study|Pregnancy|3
4658982|NCT03075891|16005544|P2|Overall Study|Lost to Follow-up|0
4658983|NCT03075891|16005545|P1|Overall Study|Lost to Follow-up|1
4658984|NCT03075891|16005544|P2|Overall Study|Withdrawal by Subject|6
4658985|NCT03075891|16005545|P1|Overall Study|Withdrawal by Subject|3
4658986|NCT03075891|16005544|P2|Overall Study|Adverse Event|4
4658987|NCT03075891|16005545|P1|Overall Study|Adverse Event|1
4658988|NCT03075878|16005551|P1|Overall Study|Physician Decision|1
4658989|NCT03075839|16005559|P1|Overall Study|Lost to Follow-up|4
4658990|NCT03075644|16005567|P2|Overall Study|Withdrawal by Subject|1
4658991|NCT03075644|16005568|P1|Overall Study|Withdrawal by Subject|1
4658992|NCT03075527|16005638|P1|Overall Study|Ongoing treatment|2
4658993|NCT03075410|16005662|P9|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4658994|NCT03075410|16005663|P8|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4658995|NCT03075410|16005664|P7|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4658996|NCT03075410|16005665|P6|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4658997|NCT03075410|16005666|P5|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4658998|NCT03075410|16005667|P4|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4658999|NCT03075410|16005668|P3|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4659000|NCT03075410|16005669|P2|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0
4659001|NCT03075410|16005670|P1|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1
4659002|NCT03075410|16005662|P9|Part A-Period 2 (14 Days)|Personal reasons|0
4659003|NCT03075410|16005663|P8|Part A-Period 2 (14 Days)|Personal reasons|0
4659004|NCT03075410|16005664|P7|Part A-Period 2 (14 Days)|Personal reasons|0
4659005|NCT03075410|16005665|P6|Part A-Period 2 (14 Days)|Personal reasons|0
4659006|NCT03075410|16005666|P5|Part A-Period 2 (14 Days)|Personal reasons|0
4659007|NCT03075410|16005667|P4|Part A-Period 2 (14 Days)|Personal reasons|0
4659008|NCT03075410|16005668|P3|Part A-Period 2 (14 Days)|Personal reasons|1
4659009|NCT03075410|16005669|P2|Part A-Period 2 (14 Days)|Personal reasons|0
4659010|NCT03075410|16005670|P1|Part A-Period 2 (14 Days)|Personal reasons|1
4659011|NCT03075163|16005836|P2|Overall Study|not eligible for treatment limb|138
4659012|NCT03075163|16005837|P1|Overall Study|not eligible for treatment limb|138
4659013|NCT03074500|16005884|P3|Overall Study|Adverse Event|1
4659014|NCT03074500|16005885|P2|Overall Study|Adverse Event|0
4659015|NCT03074500|16005886|P1|Overall Study|Adverse Event|0
4659016|NCT03074500|16005884|P3|Overall Study|Lack of Efficacy|0
4659017|NCT03074500|16005885|P2|Overall Study|Lack of Efficacy|1
4659018|NCT03074500|16005886|P1|Overall Study|Lack of Efficacy|0
4659019|NCT03074500|16005884|P3|Overall Study|Lost to Follow-up|0
4659020|NCT03074500|16005885|P2|Overall Study|Lost to Follow-up|0
4659021|NCT03074500|16005886|P1|Overall Study|Lost to Follow-up|1
4659022|NCT03074331|16005923|P1|Overall Study|Withdrew Consent|1
4659023|NCT03074331|16005923|P1|Overall Study|Lost to Follow-up|5
4659024|NCT03074331|16005923|P1|Overall Study|Enrolled but Not Treated|1
4659025|NCT03074162|16005935|P6|Period 3|Withdrawal by Subject|0
4659026|NCT03074162|16005936|P5|Period 3|Withdrawal by Subject|1
4659027|NCT03074162|16005937|P4|Period 3|Withdrawal by Subject|0
4659028|NCT03074162|16005938|P3|Period 3|Withdrawal by Subject|0
4659029|NCT03074162|16005939|P2|Period 3|Withdrawal by Subject|0
4659030|NCT03074162|16005940|P1|Period 3|Withdrawal by Subject|1
4659031|NCT03074162|16005935|P6|Period 2 Including Washout 2|Withdrawal by Subject|1
4659032|NCT03074162|16005936|P5|Period 2 Including Washout 2|Withdrawal by Subject|0
4659033|NCT03074162|16005937|P4|Period 2 Including Washout 2|Withdrawal by Subject|0
4659034|NCT03074162|16005938|P3|Period 2 Including Washout 2|Withdrawal by Subject|1
4659035|NCT03074162|16005939|P2|Period 2 Including Washout 2|Withdrawal by Subject|0
4659036|NCT03074162|16005940|P1|Period 2 Including Washout 2|Withdrawal by Subject|0
4659037|NCT03074162|16005935|P6|Period 1 Including Washout 1|Withdrawal by Subject|0
4659038|NCT03074162|16005936|P5|Period 1 Including Washout 1|Withdrawal by Subject|0
4659039|NCT03074162|16005937|P4|Period 1 Including Washout 1|Withdrawal by Subject|0
4659040|NCT03074162|16005938|P3|Period 1 Including Washout 1|Withdrawal by Subject|1
4659041|NCT03074162|16005939|P2|Period 1 Including Washout 1|Withdrawal by Subject|0
4659042|NCT03074162|16005940|P1|Period 1 Including Washout 1|Withdrawal by Subject|0
4659043|NCT03073798|16006002|P1|Overall Study|Withdrawal by Subject|1
4659044|NCT03073798|16006002|P1|Overall Study|Adverse Event|1
4659045|NCT03073213|16006040|P3|Multiple Dose Period|Protocol Violation|1
4659046|NCT03073213|16006041|P2|Multiple Dose Period|Protocol Violation|0
4659047|NCT03073213|16006042|P1|Multiple Dose Period|Protocol Violation|0
4659048|NCT03073200|16006057|P3|Overall Study|Lack of Efficacy|0
4659049|NCT03073200|16006058|P2|Overall Study|Lack of Efficacy|0
4659050|NCT03073200|16006059|P1|Overall Study|Lack of Efficacy|1
4659051|NCT03073200|16006057|P3|Overall Study|Protocol Violation|0
4659052|NCT03073200|16006058|P2|Overall Study|Protocol Violation|0
4659053|NCT03073200|16006059|P1|Overall Study|Protocol Violation|2
4659054|NCT03073200|16006057|P3|Overall Study|Site closed by sponsor|1
4659055|NCT03073200|16006058|P2|Overall Study|Site closed by sponsor|0
4659056|NCT03073200|16006059|P1|Overall Study|Site closed by sponsor|0
4659057|NCT03073200|16006057|P3|Overall Study|Withdrawal by parent/guardian|1
4659058|NCT03073200|16006058|P2|Overall Study|Withdrawal by parent/guardian|1
4659059|NCT03073200|16006059|P1|Overall Study|Withdrawal by parent/guardian|0
4659060|NCT03073200|16006057|P3|Overall Study|Continuing treatment (Ongoing)|28
4659061|NCT03073200|16006058|P2|Overall Study|Continuing treatment (Ongoing)|106
4659062|NCT03073200|16006059|P1|Overall Study|Continuing treatment (Ongoing)|48
4659063|NCT03073200|16006057|P3|Overall Study|Withdrawal by Subject|0
4659064|NCT03073200|16006058|P2|Overall Study|Withdrawal by Subject|3
4659065|NCT03073200|16006059|P1|Overall Study|Withdrawal by Subject|3
4659066|NCT03073200|16006057|P3|Overall Study|Participant had Crohns disease|0
4659067|NCT03073200|16006058|P2|Overall Study|Participant had Crohns disease|1
4659068|NCT03073200|16006059|P1|Overall Study|Participant had Crohns disease|0
4659069|NCT03073200|16006057|P3|Overall Study|Lost to Follow-up|0
4659070|NCT03073200|16006058|P2|Overall Study|Lost to Follow-up|2
4659071|NCT03073200|16006059|P1|Overall Study|Lost to Follow-up|1
4659072|NCT03073200|16006057|P3|Overall Study|Adverse Event|0
4659073|NCT03073200|16006058|P2|Overall Study|Adverse Event|2
4659074|NCT03073200|16006059|P1|Overall Study|Adverse Event|0
4659075|NCT03073109|16006097|P2|Overall Study|Lost to Follow-up|1
4659076|NCT03073109|16006098|P1|Overall Study|Lost to Follow-up|8
4659077|NCT03073109|16006097|P2|Overall Study|Other|0
4659078|NCT03073109|16006098|P1|Overall Study|Other|2
4659079|NCT03073109|16006097|P2|Overall Study|Adverse Event|1
4659080|NCT03073109|16006098|P1|Overall Study|Adverse Event|0
4659081|NCT03072875|16006126|P1|Overall Study|Lost to Follow-up|1
4659082|NCT03072719|16006133|P2|Overall Study|Adverse Event|1
4659083|NCT03072719|16006134|P1|Overall Study|Adverse Event|1
4659084|NCT03071276|16006159|P1|Overall Study|Lack of Efficacy|14
4659085|NCT03071276|16006159|P1|Overall Study|Adverse Event|1
4659086|NCT03071263|16006167|P2|Overall Study|Participant moved to another city|1
4659087|NCT03071263|16006168|P1|Overall Study|Participant moved to another city|0
4659088|NCT03071263|16006167|P2|Overall Study|Physician Decision|0
4659089|NCT03071263|16006168|P1|Overall Study|Physician Decision|1
4659090|NCT03071263|16006167|P2|Overall Study|Withdrawal by Subject|3
4659091|NCT03071263|16006168|P1|Overall Study|Withdrawal by Subject|1
4659092|NCT03071263|16006167|P2|Overall Study|Adverse Event|3
4659093|NCT03071263|16006168|P1|Overall Study|Adverse Event|1
4659094|NCT03070964|16006192|P1|Overall Study|Adverse Event|1
4659095|NCT03070964|16006192|P1|Overall Study|Withdrawal by Subject|1
4659096|NCT03070964|16006192|P1|Overall Study|Physician Decision|1
4659097|NCT03070964|16006192|P1|Overall Study|Never treated|1
4659098|NCT03070964|16006192|P1|Overall Study|Treatment-unrelated adverse event|2
4659099|NCT03070964|16006192|P1|Overall Study|Progressive disease|8
4659100|NCT03070782|16006203|P6|Overall Study|Investigator Judgement|0
4659101|NCT03070782|16006204|P5|Overall Study|Investigator Judgement|0
4659102|NCT03070782|16006205|P4|Overall Study|Investigator Judgement|1
4659103|NCT03070782|16006206|P3|Overall Study|Investigator Judgement|0
4659104|NCT03070782|16006207|P2|Overall Study|Investigator Judgement|0
4659105|NCT03070782|16006208|P1|Overall Study|Investigator Judgement|0
4659106|NCT03070782|16006203|P6|Overall Study|Pregnancy|0
4659107|NCT03070782|16006204|P5|Overall Study|Pregnancy|0
4659108|NCT03070782|16006205|P4|Overall Study|Pregnancy|1
4659109|NCT03070782|16006206|P3|Overall Study|Pregnancy|0
4659110|NCT03070782|16006207|P2|Overall Study|Pregnancy|0
4659111|NCT03070782|16006208|P1|Overall Study|Pregnancy|0
4659112|NCT03070782|16006203|P6|Overall Study|Ineligibility|1
4659113|NCT03070782|16006204|P5|Overall Study|Ineligibility|0
4659114|NCT03070782|16006205|P4|Overall Study|Ineligibility|1
4659115|NCT03070782|16006206|P3|Overall Study|Ineligibility|0
4659116|NCT03070782|16006207|P2|Overall Study|Ineligibility|0
4659117|NCT03070782|16006208|P1|Overall Study|Ineligibility|0
4659118|NCT03070782|16006203|P6|Overall Study|Reason Not Specified|1
4659119|NCT03070782|16006204|P5|Overall Study|Reason Not Specified|2
4659120|NCT03070782|16006205|P4|Overall Study|Reason Not Specified|1
4659121|NCT03070782|16006206|P3|Overall Study|Reason Not Specified|0
4659122|NCT03070782|16006207|P2|Overall Study|Reason Not Specified|0
4659123|NCT03070782|16006208|P1|Overall Study|Reason Not Specified|2
4659124|NCT03070782|16006203|P6|Overall Study|Withdrawal by Subject|3
4659125|NCT03070782|16006204|P5|Overall Study|Withdrawal by Subject|4
4659126|NCT03070782|16006205|P4|Overall Study|Withdrawal by Subject|0
4659127|NCT03070782|16006206|P3|Overall Study|Withdrawal by Subject|1
4659128|NCT03070782|16006207|P2|Overall Study|Withdrawal by Subject|1
4659129|NCT03070782|16006208|P1|Overall Study|Withdrawal by Subject|2
4659130|NCT03070782|16006203|P6|Overall Study|Adverse Event|2
4659131|NCT03070782|16006204|P5|Overall Study|Adverse Event|6
4659132|NCT03070782|16006205|P4|Overall Study|Adverse Event|1
4659133|NCT03070782|16006206|P3|Overall Study|Adverse Event|3
4659134|NCT03070782|16006207|P2|Overall Study|Adverse Event|0
4659135|NCT03070782|16006208|P1|Overall Study|Adverse Event|3
4659136|NCT03070483|16006448|P1|Overall Study|Lost to Follow-up|2
4659137|NCT03070431|16006495|P1|Overall Study|Lost to Follow-up|2
4659138|NCT03070431|16006495|P1|Overall Study|Withdrawal by Subject|2
4659139|NCT03070171|16006517|P2|Treatment Period 4 + Washout|Withdrawal by Subject|1
4659140|NCT03070171|16006518|P1|Treatment Period 4 + Washout|Withdrawal by Subject|0
4659141|NCT03070171|16006517|P2|Treatment Period 2 + Washout|Other Adverse Event|1
4659142|NCT03070171|16006518|P1|Treatment Period 2 + Washout|Other Adverse Event|0
4659143|NCT03070002|16006534|P1|Follow up for 2 Years|Death|1
4659144|NCT03069989|16006542|P2|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0
4659145|NCT03069989|16006543|P1|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1
4659146|NCT03069482|16006650|P2|Overall Study|Physician Decision|0
4659147|NCT03069482|16006651|P1|Overall Study|Physician Decision|1
4659148|NCT03069482|16006650|P2|Overall Study|Lost to Follow-up|1
4659149|NCT03069482|16006651|P1|Overall Study|Lost to Follow-up|0
4659150|NCT03069365|16006761|P1|Overall Study|Adverse Event|1
4659151|NCT03069352|16006769|P2|Overall Study|Ongoing|40
4659152|NCT03069352|16006770|P1|Overall Study|Ongoing|12
4659153|NCT03069313|16006812|P1|Overall Study|Adverse Event|5
4659154|NCT03068767|16006850|P2|Overall Study|Protocol Violation|0
4659155|NCT03068767|16006851|P1|Overall Study|Protocol Violation|3
4659156|NCT03068767|16006850|P2|Overall Study|Lost to Follow-up|3
4659157|NCT03068767|16006851|P1|Overall Study|Lost to Follow-up|7
4659158|NCT03068754|16006861|P4|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3
4659159|NCT03068754|16006862|P3|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12
4659160|NCT03068754|16006863|P2|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
4659161|NCT03068754|16006864|P1|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0
4659162|NCT03068754|16006861|P4|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
4659163|NCT03068754|16006862|P3|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1
4659164|NCT03068754|16006863|P2|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
4659165|NCT03068754|16006864|P1|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0
4659166|NCT03068754|16006861|P4|Open Label Extension Period (OLE)|Withdrawal by Subject|0
4659167|NCT03068754|16006862|P3|Open Label Extension Period (OLE)|Withdrawal by Subject|5
4659168|NCT03068754|16006863|P2|Open Label Extension Period (OLE)|Withdrawal by Subject|0
4659169|NCT03068754|16006864|P1|Open Label Extension Period (OLE)|Withdrawal by Subject|0
4659170|NCT03068754|16006861|P4|Open Label Extension Period (OLE)|Disease progression|1
4659171|NCT03068754|16006862|P3|Open Label Extension Period (OLE)|Disease progression|3
4659172|NCT03068754|16006863|P2|Open Label Extension Period (OLE)|Disease progression|0
4659173|NCT03068754|16006864|P1|Open Label Extension Period (OLE)|Disease progression|0
4659174|NCT03068754|16006861|P4|Open Label Extension Period (OLE)|Death|1
4659175|NCT03068754|16006862|P3|Open Label Extension Period (OLE)|Death|0
4659176|NCT03068754|16006863|P2|Open Label Extension Period (OLE)|Death|0
4659177|NCT03068754|16006864|P1|Open Label Extension Period (OLE)|Death|0
4659178|NCT03068754|16006861|P4|Open Label Extension Period (OLE)|Adverse Event|1
4659179|NCT03068754|16006862|P3|Open Label Extension Period (OLE)|Adverse Event|0
4659180|NCT03068754|16006863|P2|Open Label Extension Period (OLE)|Adverse Event|0
4659181|NCT03068754|16006864|P1|Open Label Extension Period (OLE)|Adverse Event|0
4659182|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
4659183|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0
4659184|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29
4659185|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55
4659186|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
4659187|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
4659188|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1
4659189|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0
4659190|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Discontinued by Physician|0
4659191|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Discontinued by Physician|0
4659192|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Discontinued by Physician|0
4659193|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Discontinued by Physician|1
4659194|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
4659195|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Withdrawal by Subject|0
4659196|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Withdrawal by Subject|2
4659197|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Withdrawal by Subject|6
4659198|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Lost to Follow-up|0
4659199|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Lost to Follow-up|0
4659200|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Lost to Follow-up|0
4659201|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Lost to Follow-up|1
4659202|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Disease progression|0
4659203|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Disease progression|0
4659204|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Disease progression|2
4659205|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Disease progression|1
4659206|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Death|0
4659207|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Death|0
4659208|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Death|2
4659209|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Death|2
4659210|NCT03068754|16006861|P4|Randomized Treatment Period (RTP)|Adverse Event|0
4659211|NCT03068754|16006862|P3|Randomized Treatment Period (RTP)|Adverse Event|0
4659212|NCT03068754|16006863|P2|Randomized Treatment Period (RTP)|Adverse Event|3
4659213|NCT03068754|16006864|P1|Randomized Treatment Period (RTP)|Adverse Event|1
4659214|NCT03067987|16006913|P2|Overall Study|Withdrawal by Subject|1
4659215|NCT03067987|16006914|P1|Overall Study|Withdrawal by Subject|2
4659216|NCT03067987|16006913|P2|Overall Study|Protocol Violation|2
4659217|NCT03067987|16006914|P1|Overall Study|Protocol Violation|1
4659218|NCT03067987|16006913|P2|Overall Study|Lost to Follow-up|10
4659219|NCT03067987|16006914|P1|Overall Study|Lost to Follow-up|7
4659220|NCT03066999|16006940|P2|Overall Study|abnormal urethraBladder neck contracture|2
4659221|NCT03066999|16006941|P1|Overall Study|abnormal urethraBladder neck contracture|0
4659222|NCT03066622|16006961|P2|Overall Study|Withdrawal by Subject|1
4659223|NCT03066622|16006962|P1|Overall Study|Withdrawal by Subject|2
4659224|NCT03066622|16006961|P2|Overall Study|Lost to Follow-up|25
4659225|NCT03066622|16006962|P1|Overall Study|Lost to Follow-up|24
4659226|NCT03066609|16006975|P4|OVERALL STUDY|discontinued follow up|0
4659227|NCT03066609|16006976|P3|OVERALL STUDY|discontinued follow up|0
4659228|NCT03066609|16006977|P2|OVERALL STUDY|discontinued follow up|2
4659229|NCT03066609|16006978|P1|OVERALL STUDY|discontinued follow up|0
4659230|NCT03066609|16006975|P4|OVERALL STUDY|Lack of Efficacy|1
4659231|NCT03066609|16006976|P3|OVERALL STUDY|Lack of Efficacy|1
4659232|NCT03066609|16006977|P2|OVERALL STUDY|Lack of Efficacy|1
4659233|NCT03066609|16006978|P1|OVERALL STUDY|Lack of Efficacy|2
4659234|NCT03066609|16006975|P4|OVERALL STUDY|Pregnancy|0
4659235|NCT03066609|16006976|P3|OVERALL STUDY|Pregnancy|1
4659236|NCT03066609|16006977|P2|OVERALL STUDY|Pregnancy|0
4659237|NCT03066609|16006978|P1|OVERALL STUDY|Pregnancy|1
4659238|NCT03066609|16006975|P4|OVERALL STUDY|Lost to Follow-up|1
4659239|NCT03066609|16006976|P3|OVERALL STUDY|Lost to Follow-up|1
4659240|NCT03066609|16006977|P2|OVERALL STUDY|Lost to Follow-up|1
4659241|NCT03066609|16006978|P1|OVERALL STUDY|Lost to Follow-up|1
4659242|NCT03066609|16006975|P4|OVERALL STUDY|Withdrawal by Subject|2
4659243|NCT03066609|16006976|P3|OVERALL STUDY|Withdrawal by Subject|1
4659244|NCT03066609|16006977|P2|OVERALL STUDY|Withdrawal by Subject|2
4659245|NCT03066609|16006978|P1|OVERALL STUDY|Withdrawal by Subject|4
4659246|NCT03066609|16006975|P4|OVERALL STUDY|Adverse Event|1
4659247|NCT03066609|16006976|P3|OVERALL STUDY|Adverse Event|0
4659248|NCT03066609|16006977|P2|OVERALL STUDY|Adverse Event|2
4659249|NCT03066609|16006978|P1|OVERALL STUDY|Adverse Event|2
4659250|NCT03066609|16006975|P4|MAINTENANCE|Lack of Efficacy|1
4659251|NCT03066609|16006976|P3|MAINTENANCE|Lack of Efficacy|0
4659252|NCT03066609|16006977|P2|MAINTENANCE|Lack of Efficacy|1
4659253|NCT03066609|16006978|P1|MAINTENANCE|Lack of Efficacy|2
4659254|NCT03066609|16006975|P4|MAINTENANCE|Pregnancy|0
4659255|NCT03066609|16006976|P3|MAINTENANCE|Pregnancy|0
4659256|NCT03066609|16006977|P2|MAINTENANCE|Pregnancy|0
4659257|NCT03066609|16006978|P1|MAINTENANCE|Pregnancy|1
4659258|NCT03066609|16006975|P4|MAINTENANCE|Lost to Follow-up|0
4659259|NCT03066609|16006976|P3|MAINTENANCE|Lost to Follow-up|1
4659260|NCT03066609|16006977|P2|MAINTENANCE|Lost to Follow-up|1
4659261|NCT03066609|16006978|P1|MAINTENANCE|Lost to Follow-up|0
4659262|NCT03066609|16006975|P4|MAINTENANCE|Withdrawal by Subject|1
4659263|NCT03066609|16006976|P3|MAINTENANCE|Withdrawal by Subject|1
4659264|NCT03066609|16006977|P2|MAINTENANCE|Withdrawal by Subject|2
4659265|NCT03066609|16006978|P1|MAINTENANCE|Withdrawal by Subject|4
4659266|NCT03066609|16006975|P4|MAINTENANCE|Adverse Event|1
4659267|NCT03066609|16006976|P3|MAINTENANCE|Adverse Event|0
4659268|NCT03066609|16006977|P2|MAINTENANCE|Adverse Event|0
4659269|NCT03066609|16006978|P1|MAINTENANCE|Adverse Event|0
4659270|NCT03066609|16006975|P4|INDUCTION|Adverse Event|0
4659271|NCT03066609|16006976|P3|INDUCTION|Adverse Event|0
4659272|NCT03066609|16006977|P2|INDUCTION|Adverse Event|2
4659273|NCT03066609|16006978|P1|INDUCTION|Adverse Event|2
4659274|NCT03066609|16006975|P4|INDUCTION|Lack of Efficacy|0
4659275|NCT03066609|16006976|P3|INDUCTION|Lack of Efficacy|1
4659276|NCT03066609|16006977|P2|INDUCTION|Lack of Efficacy|0
4659277|NCT03066609|16006978|P1|INDUCTION|Lack of Efficacy|0
4659278|NCT03066609|16006975|P4|INDUCTION|Pregnancy|0
4659279|NCT03066609|16006976|P3|INDUCTION|Pregnancy|1
4659280|NCT03066609|16006977|P2|INDUCTION|Pregnancy|0
4659281|NCT03066609|16006978|P1|INDUCTION|Pregnancy|0
4659282|NCT03066193|16007008|P1|Overall Study|Withdrawal by Subject|1
4659283|NCT03065933|16007021|P1|Overall Study|study terminated|5
4659284|NCT03065530|16007029|P4|Overall Study|Protocol Violation|1
4659285|NCT03065530|16007030|P3|Overall Study|Protocol Violation|1
4659286|NCT03065530|16007031|P2|Overall Study|Protocol Violation|0
4659287|NCT03065530|16007032|P1|Overall Study|Protocol Violation|1
4659288|NCT03065530|16007029|P4|Overall Study|Lack of Efficacy|1
4659289|NCT03065530|16007030|P3|Overall Study|Lack of Efficacy|0
4659290|NCT03065530|16007031|P2|Overall Study|Lack of Efficacy|1
4659291|NCT03065530|16007032|P1|Overall Study|Lack of Efficacy|1
4659292|NCT03065023|16007140|P5|Overall Study|Withdrawal by Subject|0
4659293|NCT03065023|16007141|P4|Overall Study|Withdrawal by Subject|1
4659294|NCT03065023|16007142|P3|Overall Study|Withdrawal by Subject|0
4659295|NCT03065023|16007143|P2|Overall Study|Withdrawal by Subject|0
4659296|NCT03065023|16007144|P1|Overall Study|Withdrawal by Subject|0
4659297|NCT03065023|16007140|P5|Overall Study|Participant Decision|0
4659298|NCT03065023|16007141|P4|Overall Study|Participant Decision|1
4659299|NCT03065023|16007142|P3|Overall Study|Participant Decision|0
4659300|NCT03065023|16007143|P2|Overall Study|Participant Decision|0
4659301|NCT03065023|16007144|P1|Overall Study|Participant Decision|0
4659302|NCT03065023|16007140|P5|Overall Study|Lost to Follow-up|0
4659303|NCT03065023|16007141|P4|Overall Study|Lost to Follow-up|0
4659304|NCT03065023|16007142|P3|Overall Study|Lost to Follow-up|0
4659305|NCT03065023|16007143|P2|Overall Study|Lost to Follow-up|1
4659306|NCT03065023|16007144|P1|Overall Study|Lost to Follow-up|0
4659307|NCT03065023|16007140|P5|Overall Study|Death|0
4659308|NCT03065023|16007141|P4|Overall Study|Death|1
4659309|NCT03065023|16007142|P3|Overall Study|Death|1
4659310|NCT03065023|16007143|P2|Overall Study|Death|0
4659311|NCT03065023|16007144|P1|Overall Study|Death|2
4659312|NCT03065023|16007140|P5|Overall Study|Progressive Disease|0
4659313|NCT03065023|16007141|P4|Overall Study|Progressive Disease|0
4659314|NCT03065023|16007142|P3|Overall Study|Progressive Disease|0
4659315|NCT03065023|16007143|P2|Overall Study|Progressive Disease|1
4659316|NCT03065023|16007144|P1|Overall Study|Progressive Disease|0
4659317|NCT03064841|16007210|P1|Overall Study|Screen failure|2
4659318|NCT03064841|16007210|P1|Overall Study|No glycated haemoglobinA1c measurement|11
4659319|NCT03064841|16007210|P1|Overall Study|Inclusion/exclusion criteria violation|4
4659320|NCT03064451|16007225|P1|Overall Study|Withdrew consent: 3-month FU visit|1
4659321|NCT03064451|16007225|P1|Overall Study|Exited prior to procedure|8
4659322|NCT03064451|16007225|P1|Overall Study|Mapping Failure|4
4659323|NCT03064451|16007225|P1|Overall Study|Lost to Follow-up|1
4659324|NCT03064126|16007243|P4|Overall Study|Protocol Violation|0
4659325|NCT03064126|16007244|P3|Overall Study|Protocol Violation|1
4659326|NCT03064126|16007245|P2|Overall Study|Protocol Violation|1
4659327|NCT03064126|16007246|P1|Overall Study|Protocol Violation|11
4659328|NCT03064126|16007243|P4|Overall Study|Subject moved|0
4659329|NCT03064126|16007244|P3|Overall Study|Subject moved|0
4659330|NCT03064126|16007245|P2|Overall Study|Subject moved|0
4659331|NCT03064126|16007246|P1|Overall Study|Subject moved|1
4659332|NCT03064126|16007243|P4|Overall Study|Withdrawal by Subject|0
4659333|NCT03064126|16007244|P3|Overall Study|Withdrawal by Subject|0
4659334|NCT03064126|16007245|P2|Overall Study|Withdrawal by Subject|4
4659335|NCT03064126|16007246|P1|Overall Study|Withdrawal by Subject|7
4659336|NCT03064126|16007243|P4|Overall Study|Investigator Discretion|0
4659337|NCT03064126|16007244|P3|Overall Study|Investigator Discretion|0
4659338|NCT03064126|16007245|P2|Overall Study|Investigator Discretion|0
4659339|NCT03064126|16007246|P1|Overall Study|Investigator Discretion|1
4659340|NCT03064126|16007243|P4|Overall Study|Death|1
4659341|NCT03064126|16007244|P3|Overall Study|Death|2
4659342|NCT03064126|16007245|P2|Overall Study|Death|2
4659343|NCT03064126|16007246|P1|Overall Study|Death|6
4659344|NCT03063086|16007379|P6|Overall Study|Physician Decision|0
4659345|NCT03063086|16007380|P5|Overall Study|Physician Decision|0
4659346|NCT03063086|16007381|P4|Overall Study|Physician Decision|1
4659347|NCT03063086|16007382|P3|Overall Study|Physician Decision|0
4659348|NCT03063086|16007383|P2|Overall Study|Physician Decision|0
4659349|NCT03063086|16007384|P1|Overall Study|Physician Decision|0
4659350|NCT03063086|16007379|P6|Overall Study|Non-compliance with study treatment|1
4659351|NCT03063086|16007380|P5|Overall Study|Non-compliance with study treatment|0
4659352|NCT03063086|16007381|P4|Overall Study|Non-compliance with study treatment|1
4659353|NCT03063086|16007382|P3|Overall Study|Non-compliance with study treatment|0
4659354|NCT03063086|16007383|P2|Overall Study|Non-compliance with study treatment|0
4659355|NCT03063086|16007384|P1|Overall Study|Non-compliance with study treatment|0
4659356|NCT03063086|16007379|P6|Overall Study|subject/guardian decision|0
4659357|NCT03063086|16007380|P5|Overall Study|subject/guardian decision|0
4659358|NCT03063086|16007381|P4|Overall Study|subject/guardian decision|0
4659359|NCT03063086|16007382|P3|Overall Study|subject/guardian decision|0
4659360|NCT03063086|16007383|P2|Overall Study|subject/guardian decision|0
4659361|NCT03063086|16007384|P1|Overall Study|subject/guardian decision|1
4659362|NCT03063086|16007379|P6|Overall Study|Adverse Event|0
4659363|NCT03063086|16007380|P5|Overall Study|Adverse Event|0
4659364|NCT03063086|16007381|P4|Overall Study|Adverse Event|1
4659365|NCT03063086|16007382|P3|Overall Study|Adverse Event|1
4659366|NCT03063086|16007383|P2|Overall Study|Adverse Event|1
4659367|NCT03063086|16007384|P1|Overall Study|Adverse Event|1
4659368|NCT03063086|16007379|P6|Overall Study|technical problems|0
4659369|NCT03063086|16007380|P5|Overall Study|technical problems|0
4659370|NCT03063086|16007381|P4|Overall Study|technical problems|0
4659371|NCT03063086|16007382|P3|Overall Study|technical problems|0
4659372|NCT03063086|16007383|P2|Overall Study|technical problems|0
4659373|NCT03063086|16007384|P1|Overall Study|technical problems|1
4659374|NCT03062891|16007430|P2|Overall Study|Lost to Follow-up|38
4659375|NCT03062891|16007431|P1|Overall Study|Lost to Follow-up|50
4659376|NCT03062891|16007430|P2|Overall Study|Withdrawal by Subject|0
4659377|NCT03062891|16007431|P1|Overall Study|Withdrawal by Subject|2
4659378|NCT03061331|16007526|P2|Washout Period (8 Weeks)|Adverse Event|1
4659379|NCT03061331|16007527|P1|Washout Period (8 Weeks)|Adverse Event|2
4659380|NCT03061214|16007557|P3|Overall Study|Death|0
4659381|NCT03061214|16007558|P2|Overall Study|Death|1
4659382|NCT03061214|16007559|P1|Overall Study|Death|1
4659383|NCT03061214|16007557|P3|Overall Study|Lost to Follow-up|1
4659384|NCT03061214|16007558|P2|Overall Study|Lost to Follow-up|1
4659385|NCT03061214|16007559|P1|Overall Study|Lost to Follow-up|3
4659386|NCT03061214|16007557|P3|Overall Study|Withdrawal by Subject|9
4659387|NCT03061214|16007558|P2|Overall Study|Withdrawal by Subject|26
4659388|NCT03061214|16007559|P1|Overall Study|Withdrawal by Subject|21
4659389|NCT03061175|16007783|P2|Followup 2 at 6 Months|Lost to Follow-up|7
4659390|NCT03061175|16007784|P1|Followup 2 at 6 Months|Lost to Follow-up|4
4659391|NCT03061175|16007783|P2|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1
4659392|NCT03061175|16007784|P1|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0
4659393|NCT03061175|16007783|P2|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2
4659394|NCT03061175|16007784|P1|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6
4659395|NCT03061175|16007783|P2|Baseline|Participant was deemed ineligible|0
4659396|NCT03061175|16007784|P1|Baseline|Participant was deemed ineligible|1
4659397|NCT03060551|16007815|P1|Overall Study|Adverse Event|1
4659398|NCT03060551|16007815|P1|Overall Study|Withdrawal by Subject|1
4659399|NCT03060512|16007836|P2|Overall Study|Non-compliance with study medication|2
4659400|NCT03060512|16007837|P1|Overall Study|Non-compliance with study medication|1
4659401|NCT03060512|16007836|P2|Overall Study|Withdrawal by Subject|0
4659402|NCT03060512|16007837|P1|Overall Study|Withdrawal by Subject|1
4659403|NCT03060512|16007836|P2|Overall Study|Lost to Follow-up|1
4659404|NCT03060512|16007837|P1|Overall Study|Lost to Follow-up|1
4659405|NCT03060512|16007836|P2|Overall Study|Adverse Event|6
4659406|NCT03060512|16007837|P1|Overall Study|Adverse Event|4
4659407|NCT03058991|16007874|P3|Overall Study|Withdrawal by Subject|0
4659408|NCT03058991|16007875|P2|Overall Study|Withdrawal by Subject|0
4659409|NCT03058991|16007876|P1|Overall Study|Withdrawal by Subject|1
4659410|NCT03058991|16007874|P3|Overall Study|Lost to Follow-up|12
4659411|NCT03058991|16007875|P2|Overall Study|Lost to Follow-up|12
4659412|NCT03058991|16007876|P1|Overall Study|Lost to Follow-up|17
4659413|NCT03058705|16007902|P1|Overall Study|Physician Decision|2
4659414|NCT03058705|16007902|P1|Overall Study|Withdrawal by Subject|2
4659415|NCT03058692|16007908|P2|Overall Study|Withdrawal by Subject|1
4659416|NCT03058692|16007909|P1|Overall Study|Withdrawal by Subject|1
4659417|NCT03058692|16007908|P2|Overall Study|Lost to Follow-up|1
4659418|NCT03058692|16007909|P1|Overall Study|Lost to Follow-up|2
4659419|NCT03056573|16008070|P2|Overall Study|Lost to Follow-up|1
4659420|NCT03056573|16008071|P1|Overall Study|Lost to Follow-up|1
4659421|NCT03056573|16008070|P2|Overall Study|Withdrawal by Subject|0
4659422|NCT03056573|16008071|P1|Overall Study|Withdrawal by Subject|2
4659423|NCT03056573|16008070|P2|Overall Study|Death|4
4659424|NCT03056573|16008071|P1|Overall Study|Death|2
4659425|NCT03056352|16008131|P1|Overall Study|Lost to Follow-up|1
4659426|NCT03056300|16008137|P1|Overall Study|Surgical reason per study protocol|3
4659427|NCT03056040|16008154|P2|Primary Evaluation Period|Pregnancy|1
4659428|NCT03056040|16008155|P1|Primary Evaluation Period|Pregnancy|0
4659429|NCT03056040|16008154|P2|Primary Evaluation Period|Lack of Efficacy|1
4659430|NCT03056040|16008155|P1|Primary Evaluation Period|Lack of Efficacy|0
4659431|NCT03056040|16008154|P2|Primary Evaluation Period|Withdrawal by Subject|1
4659432|NCT03056040|16008155|P1|Primary Evaluation Period|Withdrawal by Subject|1
4659433|NCT03055988|16008169|P2|Period 2|Other than listed|1
4659434|NCT03055988|16008170|P1|Period 2|Other than listed|1
4659435|NCT03055988|16008169|P2|Period 2|Adverse Event|1
4659436|NCT03055988|16008170|P1|Period 2|Adverse Event|0
4659437|NCT03055988|16008169|P2|Period 1|Withdrawal by Subject|4
4659438|NCT03055988|16008170|P1|Period 1|Withdrawal by Subject|0
4659439|NCT03055988|16008169|P2|Period 1|Lost to Follow-up|0
4659440|NCT03055988|16008170|P1|Period 1|Lost to Follow-up|1
4659441|NCT03055988|16008169|P2|Period 1|Adverse Event|1
4659442|NCT03055988|16008170|P1|Period 1|Adverse Event|0
4659443|NCT03055858|16008192|P1|Overall Study|Adverse Event|1
4659444|NCT03055858|16008192|P1|Overall Study|Death|5
4659445|NCT03055832|16008200|P2|Week 2|Withdrawal by Subject|0
4659446|NCT03055832|16008201|P1|Week 2|Withdrawal by Subject|1
4659447|NCT03055806|16008261|P4|Overall Study|Partner not willing to try intercourse|0
4659448|NCT03055806|16008262|P3|Overall Study|Partner not willing to try intercourse|0
4659449|NCT03055806|16008263|P2|Overall Study|Partner not willing to try intercourse|0
4659450|NCT03055806|16008264|P1|Overall Study|Partner not willing to try intercourse|1
4659451|NCT03055806|16008261|P4|Overall Study|Withdrawal of consent to continue study|6
4659452|NCT03055806|16008262|P3|Overall Study|Withdrawal of consent to continue study|4
4659453|NCT03055806|16008263|P2|Overall Study|Withdrawal of consent to continue study|3
4659454|NCT03055806|16008264|P1|Overall Study|Withdrawal of consent to continue study|2
4659455|NCT03055806|16008261|P4|Overall Study|Withdrawal of consent to continue drug|0
4659456|NCT03055806|16008262|P3|Overall Study|Withdrawal of consent to continue drug|2
4659457|NCT03055806|16008263|P2|Overall Study|Withdrawal of consent to continue drug|1
4659458|NCT03055806|16008264|P1|Overall Study|Withdrawal of consent to continue drug|1
4659459|NCT03055806|16008261|P4|Overall Study|Protocol Violation|0
4659460|NCT03055806|16008262|P3|Overall Study|Protocol Violation|0
4659461|NCT03055806|16008263|P2|Overall Study|Protocol Violation|0
4659462|NCT03055806|16008264|P1|Overall Study|Protocol Violation|1
4659463|NCT03055806|16008261|P4|Overall Study|Physician Decision|1
4659464|NCT03055806|16008262|P3|Overall Study|Physician Decision|0
4659465|NCT03055806|16008263|P2|Overall Study|Physician Decision|0
4659466|NCT03055806|16008264|P1|Overall Study|Physician Decision|1
4659467|NCT03055806|16008261|P4|Overall Study|Lost to Follow-up|7
4659468|NCT03055806|16008262|P3|Overall Study|Lost to Follow-up|6
4659469|NCT03055806|16008263|P2|Overall Study|Lost to Follow-up|3
4659470|NCT03055806|16008264|P1|Overall Study|Lost to Follow-up|0
4659471|NCT03055806|16008261|P4|Overall Study|Adverse Event|1
4659472|NCT03055806|16008262|P3|Overall Study|Adverse Event|1
4659473|NCT03055806|16008263|P2|Overall Study|Adverse Event|0
4659474|NCT03055806|16008264|P1|Overall Study|Adverse Event|0
4659475|NCT03055624|16008306|P1|Overall Study|Study closed|9
4659476|NCT03055494|16008317|P2|Overall Study|Non-compliance with study treatment|0
4659477|NCT03055494|16008318|P1|Overall Study|Non-compliance with study treatment|1
4659478|NCT03055494|16008317|P2|Overall Study|Adverse Event|1
4659479|NCT03055494|16008318|P1|Overall Study|Adverse Event|0
4659480|NCT03055494|16008317|P2|Overall Study|Withdrawal by Subject|0
4659481|NCT03055494|16008318|P1|Overall Study|Withdrawal by Subject|1
4659482|NCT03055494|16008317|P2|Overall Study|Physician Decision|0
4659483|NCT03055494|16008318|P1|Overall Study|Physician Decision|2
4659484|NCT03055494|16008317|P2|Overall Study|Lost to Follow-up|0
4659485|NCT03055494|16008318|P1|Overall Study|Lost to Follow-up|6
4659486|NCT03055338|16008349|P3|Overall Study|Withdrawal by Subject|7
4659487|NCT03055338|16008350|P2|Overall Study|Withdrawal by Subject|8
4659488|NCT03055338|16008351|P1|Overall Study|Withdrawal by Subject|9
4659489|NCT03055338|16008349|P3|Overall Study|Physician Decision|2
4659490|NCT03055338|16008350|P2|Overall Study|Physician Decision|0
4659491|NCT03055338|16008351|P1|Overall Study|Physician Decision|0
4659492|NCT03055338|16008349|P3|Overall Study|No Post-treatment Protocol Contact|0
4659493|NCT03055338|16008350|P2|Overall Study|No Post-treatment Protocol Contact|1
4659494|NCT03055338|16008351|P1|Overall Study|No Post-treatment Protocol Contact|0
4659495|NCT03055338|16008349|P3|Overall Study|Lost to Follow-up|3
4659496|NCT03055338|16008350|P2|Overall Study|Lost to Follow-up|2
4659497|NCT03055338|16008351|P1|Overall Study|Lost to Follow-up|9
4659498|NCT03055260|16008370|P2|Overall Study|Withdrawal by Subject|0
4659499|NCT03055260|16008371|P1|Overall Study|Withdrawal by Subject|1
4659500|NCT03055221|16008379|P1|Overall Study|Study terminated by Sponsor|3
4659501|NCT03055221|16008379|P1|Overall Study|Physician Decision|1
4659502|NCT03055221|16008379|P1|Overall Study|Death|6
4659503|NCT03055221|16008379|P1|Overall Study|Withdrawal by Subject|4
4659504|NCT03055221|16008379|P1|Overall Study|Adverse Event|2
4659505|NCT03055195|16008386|P2|Overall Study|Physician Decision|0
4659506|NCT03055195|16008387|P1|Overall Study|Physician Decision|1
4659507|NCT03055195|16008386|P2|Overall Study|Protocol Violation|1
4659508|NCT03055195|16008387|P1|Overall Study|Protocol Violation|2
4659509|NCT03055195|16008386|P2|Overall Study|Study Terminated by Sponsor|6
4659510|NCT03055195|16008387|P1|Overall Study|Study Terminated by Sponsor|2
4659511|NCT03055195|16008386|P2|Overall Study|Withdrawal by Subject|7
4659512|NCT03055195|16008387|P1|Overall Study|Withdrawal by Subject|6
4659513|NCT03055195|16008386|P2|Overall Study|Lack of Efficacy|0
4659514|NCT03055195|16008387|P1|Overall Study|Lack of Efficacy|1
4659515|NCT03054428|16008722|P3|Overall Study|Lost to Follow-up|1
4659516|NCT03054428|16008723|P2|Overall Study|Lost to Follow-up|0
4659517|NCT03054428|16008724|P1|Overall Study|Lost to Follow-up|0
4659518|NCT03054428|16008722|P3|Overall Study|Withdrawal by Subject|3
4659519|NCT03054428|16008723|P2|Overall Study|Withdrawal by Subject|2
4659520|NCT03054428|16008724|P1|Overall Study|Withdrawal by Subject|3
4659521|NCT03054428|16008722|P3|Overall Study|Transitioned to OLE study|73
4659522|NCT03054428|16008723|P2|Overall Study|Transitioned to OLE study|76
4659523|NCT03054428|16008724|P1|Overall Study|Transitioned to OLE study|76
4659524|NCT03054428|16008722|P3|Overall Study|Discont'd to enroll in OLE: not enrolled|0
4659525|NCT03054428|16008723|P2|Overall Study|Discont'd to enroll in OLE: not enrolled|0
4659526|NCT03054428|16008724|P1|Overall Study|Discont'd to enroll in OLE: not enrolled|1
4659527|NCT03054428|16008722|P3|Overall Study|Discontinued to enroll in OLE: enrolled|1
4659613|NCT03053050|16008956|P2|Open-label Phase|Study Terminated by Sponsor|0
4659528|NCT03054428|16008723|P2|Overall Study|Discontinued to enroll in OLE: enrolled|0
4659529|NCT03054428|16008724|P1|Overall Study|Discontinued to enroll in OLE: enrolled|0
4659530|NCT03054428|16008722|P3|Overall Study|Lack of Efficacy|0
4659531|NCT03054428|16008723|P2|Overall Study|Lack of Efficacy|1
4659532|NCT03054428|16008724|P1|Overall Study|Lack of Efficacy|3
4659533|NCT03054428|16008722|P3|Overall Study|Physician Decision|1
4659534|NCT03054428|16008723|P2|Overall Study|Physician Decision|1
4659535|NCT03054428|16008724|P1|Overall Study|Physician Decision|0
4659536|NCT03054064|16008820|P1|Overall Study|Change in Status|1
4659537|NCT03054064|16008820|P1|Overall Study|High Blood Pressure|1
4659538|NCT03054064|16008820|P1|Overall Study|Bladder Issue|1
4659539|NCT03054064|16008820|P1|Overall Study|Investigator Decision|2
4659540|NCT03054064|16008820|P1|Overall Study|Lower Extremity Deep Vein Thrombosis|1
4659541|NCT03053518|16008865|P1|Overall Study|Ineligible|5
4659542|NCT03053518|16008865|P1|Overall Study|Lost to Follow-up|2
4659543|NCT03053518|16008865|P1|Overall Study|Withdrawal by Subject|3
4659544|NCT03053492|16008871|P2|Overall Study|Withdrawal by Subject|5
4659545|NCT03053492|16008872|P1|Overall Study|Withdrawal by Subject|7
4659546|NCT03053492|16008871|P2|Overall Study|Adverse Event|1
4659547|NCT03053492|16008872|P1|Overall Study|Adverse Event|1
4659548|NCT03053427|16008886|P2|Overall Study|Miscellaneous|1
4659549|NCT03053427|16008887|P1|Overall Study|Miscellaneous|0
4659550|NCT03053427|16008886|P2|Overall Study|Withdrawal by Subject|2
4659551|NCT03053427|16008887|P1|Overall Study|Withdrawal by Subject|3
4659552|NCT03053427|16008886|P2|Overall Study|Protocol Deviation|3
4659553|NCT03053427|16008887|P1|Overall Study|Protocol Deviation|3
4659554|NCT03053427|16008886|P2|Overall Study|Worsening of the target disease|1
4659555|NCT03053427|16008887|P1|Overall Study|Worsening of the target disease|0
4659556|NCT03053427|16008886|P2|Overall Study|Lost to Follow-up|2
4659557|NCT03053427|16008887|P1|Overall Study|Lost to Follow-up|2
4659558|NCT03053427|16008886|P2|Overall Study|Lack of Efficacy|3
4659559|NCT03053427|16008887|P1|Overall Study|Lack of Efficacy|1
4659560|NCT03053427|16008886|P2|Overall Study|Adverse Event|4
4659561|NCT03053427|16008887|P1|Overall Study|Adverse Event|4
4659562|NCT03053180|16008909|P1|Overall Study|Failure to Return|1
4659563|NCT03053063|16008921|P4|Open-Label Phase|Investigator's discretion|2
4659564|NCT03053063|16008922|P3|Open-Label Phase|Investigator's discretion|0
4659565|NCT03053063|16008923|P2|Open-Label Phase|Investigator's discretion|0
4659566|NCT03053063|16008924|P1|Open-Label Phase|Investigator's discretion|0
4659567|NCT03053063|16008921|P4|Open-Label Phase|Death|2
4659568|NCT03053063|16008922|P3|Open-Label Phase|Death|0
4659569|NCT03053063|16008923|P2|Open-Label Phase|Death|0
4659570|NCT03053063|16008924|P1|Open-Label Phase|Death|0
4659571|NCT03053063|16008921|P4|Open-Label Phase|Study Terminated by Sponsor|19
4659572|NCT03053063|16008922|P3|Open-Label Phase|Study Terminated by Sponsor|0
4659573|NCT03053063|16008923|P2|Open-Label Phase|Study Terminated by Sponsor|0
4659574|NCT03053063|16008924|P1|Open-Label Phase|Study Terminated by Sponsor|0
4659575|NCT03053063|16008921|P4|Randomized Phase|Entered the Open-Label Phase|0
4659576|NCT03053063|16008922|P3|Randomized Phase|Entered the Open-Label Phase|3
4659577|NCT03053063|16008923|P2|Randomized Phase|Entered the Open-Label Phase|11
4659578|NCT03053063|16008924|P1|Randomized Phase|Entered the Open-Label Phase|9
4659579|NCT03053063|16008921|P4|Randomized Phase|Randomized but Never Treated|0
4659580|NCT03053063|16008922|P3|Randomized Phase|Randomized but Never Treated|2
4659581|NCT03053063|16008923|P2|Randomized Phase|Randomized but Never Treated|3
4659582|NCT03053063|16008924|P1|Randomized Phase|Randomized but Never Treated|1
4659583|NCT03053063|16008921|P4|Randomized Phase|Adverse Event|0
4659584|NCT03053063|16008922|P3|Randomized Phase|Adverse Event|0
4659585|NCT03053063|16008923|P2|Randomized Phase|Adverse Event|1
4659586|NCT03053063|16008924|P1|Randomized Phase|Adverse Event|0
4659587|NCT03053063|16008921|P4|Randomized Phase|Lost to Follow-up|0
4659588|NCT03053063|16008922|P3|Randomized Phase|Lost to Follow-up|1
4659589|NCT03053063|16008923|P2|Randomized Phase|Lost to Follow-up|5
4659590|NCT03053063|16008924|P1|Randomized Phase|Lost to Follow-up|3
4659591|NCT03053063|16008921|P4|Randomized Phase|Investigator's Discretion|0
4659592|NCT03053063|16008922|P3|Randomized Phase|Investigator's Discretion|2
4659593|NCT03053063|16008923|P2|Randomized Phase|Investigator's Discretion|6
4659594|NCT03053063|16008924|P1|Randomized Phase|Investigator's Discretion|8
4659595|NCT03053063|16008921|P4|Randomized Phase|Withdrew consent|0
4659596|NCT03053063|16008922|P3|Randomized Phase|Withdrew consent|5
4659597|NCT03053063|16008923|P2|Randomized Phase|Withdrew consent|11
4659598|NCT03053063|16008924|P1|Randomized Phase|Withdrew consent|8
4659599|NCT03053063|16008921|P4|Randomized Phase|Study Terminated by Sponsor|0
4659600|NCT03053063|16008922|P3|Randomized Phase|Study Terminated by Sponsor|161
4659601|NCT03053063|16008923|P2|Randomized Phase|Study Terminated by Sponsor|317
4659602|NCT03053063|16008924|P1|Randomized Phase|Study Terminated by Sponsor|326
4659603|NCT03053050|16008954|P4|Open-label Phase|Investigator's Discretion|4
4659604|NCT03053050|16008955|P3|Open-label Phase|Investigator's Discretion|0
4659605|NCT03053050|16008956|P2|Open-label Phase|Investigator's Discretion|0
4659606|NCT03053050|16008957|P1|Open-label Phase|Investigator's Discretion|0
4659607|NCT03053050|16008954|P4|Open-label Phase|Withdrew Consent|6
4659608|NCT03053050|16008955|P3|Open-label Phase|Withdrew Consent|0
4659609|NCT03053050|16008956|P2|Open-label Phase|Withdrew Consent|0
4659610|NCT03053050|16008957|P1|Open-label Phase|Withdrew Consent|0
4659611|NCT03053050|16008954|P4|Open-label Phase|Study Terminated by Sponsor|89
4659612|NCT03053050|16008955|P3|Open-label Phase|Study Terminated by Sponsor|0
4659614|NCT03053050|16008957|P1|Open-label Phase|Study Terminated by Sponsor|0
4659615|NCT03053050|16008954|P4|Randomized Phase|Entered the Open-Label Phase|0
4659616|NCT03053050|16008955|P3|Randomized Phase|Entered the Open-Label Phase|18
4659617|NCT03053050|16008956|P2|Randomized Phase|Entered the Open-Label Phase|45
4659618|NCT03053050|16008957|P1|Randomized Phase|Entered the Open-Label Phase|36
4659619|NCT03053050|16008954|P4|Randomized Phase|Randomized but Never Treated|0
4659620|NCT03053050|16008955|P3|Randomized Phase|Randomized but Never Treated|2
4659621|NCT03053050|16008956|P2|Randomized Phase|Randomized but Never Treated|2
4659622|NCT03053050|16008957|P1|Randomized Phase|Randomized but Never Treated|2
4659623|NCT03053050|16008954|P4|Randomized Phase|Adverse Event|0
4659624|NCT03053050|16008955|P3|Randomized Phase|Adverse Event|0
4659625|NCT03053050|16008956|P2|Randomized Phase|Adverse Event|1
4659626|NCT03053050|16008957|P1|Randomized Phase|Adverse Event|0
4659627|NCT03053050|16008954|P4|Randomized Phase|Lost to Follow-up|0
4659628|NCT03053050|16008955|P3|Randomized Phase|Lost to Follow-up|1
4659629|NCT03053050|16008956|P2|Randomized Phase|Lost to Follow-up|1
4659630|NCT03053050|16008957|P1|Randomized Phase|Lost to Follow-up|5
4659631|NCT03053050|16008954|P4|Randomized Phase|Investigator's Discretion|0
4659632|NCT03053050|16008955|P3|Randomized Phase|Investigator's Discretion|3
4659633|NCT03053050|16008956|P2|Randomized Phase|Investigator's Discretion|6
4659634|NCT03053050|16008957|P1|Randomized Phase|Investigator's Discretion|6
4659635|NCT03053050|16008954|P4|Randomized Phase|Withdrew Consent|0
4659636|NCT03053050|16008955|P3|Randomized Phase|Withdrew Consent|9
4659637|NCT03053050|16008956|P2|Randomized Phase|Withdrew Consent|8
4659638|NCT03053050|16008957|P1|Randomized Phase|Withdrew Consent|16
4659639|NCT03053050|16008954|P4|Randomized Phase|Study Terminated by Sponsor|0
4659640|NCT03053050|16008955|P3|Randomized Phase|Study Terminated by Sponsor|128
4659641|NCT03053050|16008956|P2|Randomized Phase|Study Terminated by Sponsor|260
4659642|NCT03053050|16008957|P1|Randomized Phase|Study Terminated by Sponsor|259
4659643|NCT03052764|16009001|P2|Double-Blind Treatment Period|Reason not Specified|1
4659644|NCT03052764|16009002|P1|Double-Blind Treatment Period|Reason not Specified|2
4659645|NCT03052764|16009001|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
4659646|NCT03052764|16009002|P1|Double-Blind Treatment Period|Withdrawal by Subject|3
4659647|NCT03052764|16009001|P2|Double-Blind Treatment Period|Protocol Violation|1
4659648|NCT03052764|16009002|P1|Double-Blind Treatment Period|Protocol Violation|2
4659649|NCT03052764|16009001|P2|Double-Blind Treatment Period|Lack of Efficacy|0
4659650|NCT03052764|16009002|P1|Double-Blind Treatment Period|Lack of Efficacy|1
4659651|NCT03052764|16009001|P2|Double-Blind Treatment Period|Adverse Event|0
4659652|NCT03052764|16009002|P1|Double-Blind Treatment Period|Adverse Event|2
4659653|NCT03052725|16009022|P2|Overall Study|Study terminated by sponsor|144
4659654|NCT03052725|16009023|P1|Overall Study|Study terminated by sponsor|143
4659655|NCT03052725|16009022|P2|Overall Study|Site closure|1
4659656|NCT03052725|16009023|P1|Overall Study|Site closure|0
4659657|NCT03052725|16009022|P2|Overall Study|Pregnancy|1
4659658|NCT03052725|16009023|P1|Overall Study|Pregnancy|0
4659659|NCT03052725|16009022|P2|Overall Study|Withdrawal by Subject|4
4659660|NCT03052725|16009023|P1|Overall Study|Withdrawal by Subject|3
4659661|NCT03052725|16009022|P2|Overall Study|Adverse Event|0
4659662|NCT03052725|16009023|P1|Overall Study|Adverse Event|2
4659663|NCT03052517|16009070|P3|Overall Study|Technical Problems|0
4659664|NCT03052517|16009071|P2|Overall Study|Technical Problems|1
4659665|NCT03052517|16009072|P1|Overall Study|Technical Problems|0
4659666|NCT03052517|16009070|P3|Overall Study|Non-Compliance With Study Treatment|0
4659667|NCT03052517|16009071|P2|Overall Study|Non-Compliance With Study Treatment|2
4659668|NCT03052517|16009072|P1|Overall Study|Non-Compliance With Study Treatment|0
4659669|NCT03052517|16009070|P3|Overall Study|Pregnancy|1
4659670|NCT03052517|16009071|P2|Overall Study|Pregnancy|0
4659671|NCT03052517|16009072|P1|Overall Study|Pregnancy|1
4659672|NCT03052517|16009070|P3|Overall Study|Lost to Follow-up|0
4659673|NCT03052517|16009071|P2|Overall Study|Lost to Follow-up|4
4659674|NCT03052517|16009072|P1|Overall Study|Lost to Follow-up|2
4659675|NCT03052517|16009070|P3|Overall Study|Death|1
4659676|NCT03052517|16009071|P2|Overall Study|Death|0
4659677|NCT03052517|16009072|P1|Overall Study|Death|3
4659678|NCT03052517|16009070|P3|Overall Study|Physician Decision|1
4659679|NCT03052517|16009071|P2|Overall Study|Physician Decision|5
4659680|NCT03052517|16009072|P1|Overall Study|Physician Decision|4
4659681|NCT03052517|16009070|P3|Overall Study|Adverse Event|0
4659682|NCT03052517|16009071|P2|Overall Study|Adverse Event|5
4659683|NCT03052517|16009072|P1|Overall Study|Adverse Event|6
4659684|NCT03052517|16009070|P3|Overall Study|Lack of Efficacy|7
4659685|NCT03052517|16009071|P2|Overall Study|Lack of Efficacy|14
4659686|NCT03052517|16009072|P1|Overall Study|Lack of Efficacy|23
4659687|NCT03052517|16009070|P3|Overall Study|Subject/Guardian Decision|22
4659688|NCT03052517|16009071|P2|Overall Study|Subject/Guardian Decision|45
4659689|NCT03052517|16009072|P1|Overall Study|Subject/Guardian Decision|50
4659690|NCT03052517|16009070|P3|Overall Study|Study Terminated By Sponsor|296
4659691|NCT03052517|16009071|P2|Overall Study|Study Terminated By Sponsor|938
4659692|NCT03052517|16009072|P1|Overall Study|Study Terminated By Sponsor|928
4659693|NCT03052426|16009116|P3|Overall Study|Lost to Follow-up|1
4659694|NCT03052426|16009117|P2|Overall Study|Lost to Follow-up|0
4659695|NCT03052426|16009118|P1|Overall Study|Lost to Follow-up|2
4659696|NCT03052426|16009116|P3|Overall Study|Withdrawal by Subject|0
4659697|NCT03052426|16009117|P2|Overall Study|Withdrawal by Subject|1
4659698|NCT03052426|16009118|P1|Overall Study|Withdrawal by Subject|0
4659699|NCT03052322|16009133|P2|Overall Study|Adverse Event|13
4659700|NCT03052322|16009134|P1|Overall Study|Adverse Event|6
4659701|NCT03052322|16009133|P2|Overall Study|Lost to Follow-up|4
4659702|NCT03052322|16009134|P1|Overall Study|Lost to Follow-up|2
4659703|NCT03052322|16009133|P2|Overall Study|Protocol Violation|0
4659704|NCT03052322|16009134|P1|Overall Study|Protocol Violation|1
4659705|NCT03052322|16009133|P2|Overall Study|Lack of Efficacy|2
4659706|NCT03052322|16009134|P1|Overall Study|Lack of Efficacy|1
4659707|NCT03052322|16009133|P2|Overall Study|Death|2
4659708|NCT03052322|16009134|P1|Overall Study|Death|0
4659709|NCT03052322|16009133|P2|Overall Study|Withdrawal by Subject|9
4659710|NCT03052322|16009134|P1|Overall Study|Withdrawal by Subject|10
4659711|NCT03052322|16009133|P2|Overall Study|Other un-specified|2
4659712|NCT03052322|16009134|P1|Overall Study|Other un-specified|1
4659713|NCT03051607|16009217|P1|Overall Study|Adverse Event|66
4659714|NCT03051217|16009227|P7|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4659715|NCT03051217|16009228|P6|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1
4659716|NCT03051217|16009229|P5|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4659717|NCT03051217|16009230|P4|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4659718|NCT03051217|16009231|P3|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4659719|NCT03051217|16009232|P2|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4659720|NCT03051217|16009233|P1|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0
4659721|NCT03051217|16009227|P7|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4659722|NCT03051217|16009228|P6|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4659723|NCT03051217|16009229|P5|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1
4659724|NCT03051217|16009230|P4|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4659725|NCT03051217|16009231|P3|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4659726|NCT03051217|16009232|P2|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4659727|NCT03051217|16009233|P1|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0
4659728|NCT03051217|16009227|P7|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4659729|NCT03051217|16009228|P6|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4659730|NCT03051217|16009229|P5|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4659731|NCT03051217|16009230|P4|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1
4659732|NCT03051217|16009231|P3|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4659733|NCT03051217|16009232|P2|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4659734|NCT03051217|16009233|P1|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0
4659735|NCT03051217|16009227|P7|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4659736|NCT03051217|16009228|P6|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4659737|NCT03051217|16009229|P5|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4659738|NCT03051217|16009230|P4|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1
4659739|NCT03051217|16009231|P3|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4659740|NCT03051217|16009232|P2|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4659741|NCT03051217|16009233|P1|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0
4659742|NCT03051217|16009227|P7|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
4659743|NCT03051217|16009228|P6|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
4659744|NCT03051217|16009229|P5|Maintenance Period (Week 16 to Week 52)|Adverse Event|2
4659745|NCT03051217|16009230|P4|Maintenance Period (Week 16 to Week 52)|Adverse Event|1
4659746|NCT03051217|16009231|P3|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
4659747|NCT03051217|16009232|P2|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
4659748|NCT03051217|16009233|P1|Maintenance Period (Week 16 to Week 52)|Adverse Event|0
4659749|NCT03051217|16009227|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4659750|NCT03051217|16009228|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4659751|NCT03051217|16009229|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4659752|NCT03051217|16009230|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4659753|NCT03051217|16009231|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4659754|NCT03051217|16009232|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4659755|NCT03051217|16009233|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4659756|NCT03051217|16009227|P7|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4659757|NCT03051217|16009228|P6|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4659758|NCT03051217|16009229|P5|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4659759|NCT03051217|16009230|P4|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4659760|NCT03051217|16009231|P3|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4659761|NCT03051217|16009232|P2|Initial Period (Week 0 to Week 16)|Protocol Violation|1
4659762|NCT03051217|16009233|P1|Initial Period (Week 0 to Week 16)|Protocol Violation|0
4659763|NCT03051217|16009227|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
4659764|NCT03051217|16009228|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
4659765|NCT03051217|16009229|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
4659766|NCT03051217|16009230|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
4659767|NCT03051217|16009231|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
4659768|NCT03051217|16009232|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
4659769|NCT03051217|16009233|P1|Initial Period (Week 0 to Week 16)|Adverse Event|2
4659770|NCT03051165|16009262|P1|Overall Study|Early termination of study|12
4659771|NCT03051165|16009262|P1|Overall Study|Withdrawal by Subject|1
4659772|NCT03051100|16009276|P2|Overall Study|Withdrawal by Subject|0
4659773|NCT03051100|16009277|P1|Overall Study|Withdrawal by Subject|1
4659774|NCT03050398|16009527|P1|Overall Study|Study terminated by sponsor|8
4659775|NCT03050372|16009532|P2|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1
4659776|NCT03050372|16009533|P1|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0
4659777|NCT03050372|16009532|P2|Adaptation Night (Night #1 PSG)|Adverse Event|0
4659778|NCT03050372|16009533|P1|Adaptation Night (Night #1 PSG)|Adverse Event|1
4659779|NCT03050359|16009556|P2|Overall Study|Reason Not Specified|0
4659780|NCT03050359|16009557|P1|Overall Study|Reason Not Specified|1
4659781|NCT03050359|16009556|P2|Overall Study|Pregnancy|0
4659782|NCT03050359|16009557|P1|Overall Study|Pregnancy|1
4659783|NCT03050359|16009556|P2|Overall Study|Voluntary Withdrawal|6
4659784|NCT03050359|16009557|P1|Overall Study|Voluntary Withdrawal|4
4659785|NCT03050359|16009556|P2|Overall Study|Lost to Follow-up|1
4659786|NCT03050359|16009557|P1|Overall Study|Lost to Follow-up|2
4659787|NCT03050359|16009556|P2|Overall Study|Significant Protocol Deviation|3
4659788|NCT03050359|16009557|P1|Overall Study|Significant Protocol Deviation|2
4659789|NCT03050359|16009556|P2|Overall Study|Pretreatment Event/Adverse Event|10
4659790|NCT03050359|16009557|P1|Overall Study|Pretreatment Event/Adverse Event|5
4659791|NCT03050359|16009556|P2|Overall Study|Randomized But Not Treated|0
4659792|NCT03050359|16009557|P1|Overall Study|Randomized But Not Treated|2
4659793|NCT03049852|16009643|P3|Overall Study|Lost to Follow-up|0
4659794|NCT03049852|16009644|P2|Overall Study|Lost to Follow-up|1
4659795|NCT03049852|16009645|P1|Overall Study|Lost to Follow-up|0
4659796|NCT03049748|16009657|P2|Overall Study|Moved out of state (relocation)|1
4659797|NCT03049748|16009658|P1|Overall Study|Moved out of state (relocation)|0
4659798|NCT03049748|16009657|P2|Overall Study|Protocol Violation|2
4659799|NCT03049748|16009658|P1|Overall Study|Protocol Violation|0
4659800|NCT03049748|16009657|P2|Overall Study|Withdrawal by Subject|3
4659801|NCT03049748|16009658|P1|Overall Study|Withdrawal by Subject|0
4659802|NCT03049748|16009657|P2|Overall Study|Death|0
4659803|NCT03049748|16009658|P1|Overall Study|Death|3
4659804|NCT03049748|16009657|P2|Overall Study|Lost to Follow-up|0
4659805|NCT03049748|16009658|P1|Overall Study|Lost to Follow-up|1
4659806|NCT03049488|16009699|P6|Overall Study|Withdrawal by Subject|0
4659807|NCT03049488|16009700|P5|Overall Study|Withdrawal by Subject|1
4659808|NCT03049488|16009701|P4|Overall Study|Withdrawal by Subject|1
4659809|NCT03049488|16009702|P3|Overall Study|Withdrawal by Subject|0
4659810|NCT03049488|16009703|P2|Overall Study|Withdrawal by Subject|0
4659811|NCT03049488|16009704|P1|Overall Study|Withdrawal by Subject|0
4659812|NCT03049488|16009699|P6|Overall Study|Physician Decision|0
4659813|NCT03049488|16009700|P5|Overall Study|Physician Decision|0
4659814|NCT03049488|16009701|P4|Overall Study|Physician Decision|0
4659815|NCT03049488|16009702|P3|Overall Study|Physician Decision|0
4659816|NCT03049488|16009703|P2|Overall Study|Physician Decision|1
4659817|NCT03049488|16009704|P1|Overall Study|Physician Decision|0
4659818|NCT03049488|16009699|P6|Overall Study|Moved from Area|0
4659819|NCT03049488|16009700|P5|Overall Study|Moved from Area|1
4659820|NCT03049488|16009701|P4|Overall Study|Moved from Area|1
4659821|NCT03049488|16009702|P3|Overall Study|Moved from Area|0
4659822|NCT03049488|16009703|P2|Overall Study|Moved from Area|0
4659823|NCT03049488|16009704|P1|Overall Study|Moved from Area|1
4659824|NCT03049488|16009699|P6|Overall Study|Lost to Follow-up|0
4659825|NCT03049488|16009700|P5|Overall Study|Lost to Follow-up|0
4659826|NCT03049488|16009701|P4|Overall Study|Lost to Follow-up|0
4659827|NCT03049488|16009702|P3|Overall Study|Lost to Follow-up|0
4659828|NCT03049488|16009703|P2|Overall Study|Lost to Follow-up|1
4659829|NCT03049488|16009704|P1|Overall Study|Lost to Follow-up|1
4659830|NCT03049280|16009787|P1|Overall Study|Physician Decision|1
4659831|NCT03048500|16009793|P1|Follow up for 3 Years|Death|12
4659832|NCT03048500|16009793|P1|Follow up for 3 Years|Currently in Follow-up|4
4659833|NCT03048500|16009793|P1|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1
4659834|NCT03048500|16009793|P1|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1
4659835|NCT03048500|16009793|P1|Reached 1st Response/Continued Treatment|Death|1
4659836|NCT03048500|16009793|P1|Reached 1st Response/Continued Treatment|Progressive Disease|4
4659837|NCT03048500|16009793|P1|2 Cycles of Treatment|Withdrawal by Subject|1
4659838|NCT03048058|16009816|P2|Overall Study|Withdrawal by Subject|4
4659839|NCT03048058|16009817|P1|Overall Study|Withdrawal by Subject|0
4659840|NCT03048058|16009816|P2|Overall Study|Lost to Follow-up|0
4659841|NCT03048058|16009817|P1|Overall Study|Lost to Follow-up|4
4659842|NCT03047720|16009843|P2|First Intervention (6weeks)|Participant data entry insufficient|0
4659843|NCT03047720|16009844|P1|First Intervention (6weeks)|Participant data entry insufficient|7
4659844|NCT03047551|16009858|P2|Overall Study|Ineligible|1
4659845|NCT03047551|16009859|P1|Overall Study|Ineligible|0
4659846|NCT03047551|16009858|P2|Overall Study|Probe malfunction|1
4659847|NCT03047551|16009859|P1|Overall Study|Probe malfunction|0
4659848|NCT03047551|16009858|P2|Overall Study|Withdrawal by Subject|1
4659849|NCT03047551|16009859|P1|Overall Study|Withdrawal by Subject|0
4659850|NCT03047551|16009858|P2|Overall Study|Physician Decision|0
4659851|NCT03047551|16009859|P1|Overall Study|Physician Decision|1
4659852|NCT03047551|16009858|P2|Overall Study|Did not receive TAS|0
4659853|NCT03047551|16009859|P1|Overall Study|Did not receive TAS|1
4659854|NCT03046446|16009936|P1|Overall Study|Non OA related knee surgery|1
4659855|NCT03046446|16009936|P1|Overall Study|Disease Progression (see caveats)|25
4659934|NCT03044106|16010515|P2|Washout (1 Week)|Withdrawal by Subject|2
4659856|NCT03046446|16009936|P1|Overall Study|Withdrawn by Investigator/Sponsor|3
4659857|NCT03046446|16009936|P1|Overall Study|Withdrawal by Subject|14
4659858|NCT03046446|16009936|P1|Overall Study|Lost to Follow-up|3
4659859|NCT03046446|16009936|P1|Overall Study|Adverse Event|6
4659860|NCT03046446|16009936|P1|Overall Study|Lack of Efficacy|7
4659861|NCT03045887|16009999|P10|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659862|NCT03045887|16010000|P9|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659863|NCT03045887|16010001|P8|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659864|NCT03045887|16010002|P7|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659865|NCT03045887|16010003|P6|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659866|NCT03045887|16010004|P5|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659867|NCT03045887|16010005|P4|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1
4659868|NCT03045887|16010006|P3|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659869|NCT03045887|16010007|P2|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659870|NCT03045887|16010008|P1|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0
4659871|NCT03045887|16009999|P10|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659872|NCT03045887|16010000|P9|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659873|NCT03045887|16010001|P8|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659874|NCT03045887|16010002|P7|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659875|NCT03045887|16010003|P6|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659876|NCT03045887|16010004|P5|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659877|NCT03045887|16010005|P4|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
4659878|NCT03045887|16010006|P3|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1
4659879|NCT03045887|16010007|P2|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659880|NCT03045887|16010008|P1|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0
4659881|NCT03045887|16009999|P10|Part A, Period 2 (1 Day)|Adverse Event|0
4659882|NCT03045887|16010000|P9|Part A, Period 2 (1 Day)|Adverse Event|0
4659883|NCT03045887|16010001|P8|Part A, Period 2 (1 Day)|Adverse Event|0
4659884|NCT03045887|16010002|P7|Part A, Period 2 (1 Day)|Adverse Event|0
4659885|NCT03045887|16010003|P6|Part A, Period 2 (1 Day)|Adverse Event|0
4659886|NCT03045887|16010004|P5|Part A, Period 2 (1 Day)|Adverse Event|0
4659887|NCT03045887|16010005|P4|Part A, Period 2 (1 Day)|Adverse Event|0
4659888|NCT03045887|16010006|P3|Part A, Period 2 (1 Day)|Adverse Event|0
4659889|NCT03045887|16010007|P2|Part A, Period 2 (1 Day)|Adverse Event|0
4659890|NCT03045887|16010008|P1|Part A, Period 2 (1 Day)|Adverse Event|1
4659891|NCT03045887|16009999|P10|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659892|NCT03045887|16010000|P9|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659893|NCT03045887|16010001|P8|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659894|NCT03045887|16010002|P7|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659895|NCT03045887|16010003|P6|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659896|NCT03045887|16010004|P5|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659897|NCT03045887|16010005|P4|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1
4659898|NCT03045887|16010006|P3|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659899|NCT03045887|16010007|P2|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659900|NCT03045887|16010008|P1|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0
4659901|NCT03045887|16009999|P10|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659902|NCT03045887|16010000|P9|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659903|NCT03045887|16010001|P8|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659904|NCT03045887|16010002|P7|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659905|NCT03045887|16010003|P6|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659906|NCT03045887|16010004|P5|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659907|NCT03045887|16010005|P4|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659908|NCT03045887|16010006|P3|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659909|NCT03045887|16010007|P2|Part A,Washout Period 1(4 Weeks)|Physician Decision|0
4659910|NCT03045887|16010008|P1|Part A,Washout Period 1(4 Weeks)|Physician Decision|3
4659911|NCT03045302|16010290|P1|Overall Study|Pre-treatment adverse event|1
4659912|NCT03045081|16010296|P2|Overall Study|Withdrawal by Subject|11
4659913|NCT03045081|16010297|P1|Overall Study|Withdrawal by Subject|6
4659914|NCT03044886|16010316|P3|Overall Study|Lost to Follow-up|12
4659915|NCT03044886|16010317|P2|Overall Study|Lost to Follow-up|10
4659916|NCT03044886|16010318|P1|Overall Study|Lost to Follow-up|15
4659917|NCT03044730|16010359|P1|On Follow-up for 2 Years|Death|17
4659918|NCT03044730|16010359|P1|On Follow-up for 2 Years|Lost to Follow-up|1
4659919|NCT03044730|16010359|P1|On Follow-up for 2 Years|Still in follow-up|7
4659920|NCT03044730|16010359|P1|Cycles 4 and Beyond|Adverse Event|1
4659921|NCT03044730|16010359|P1|Cycles 4 and Beyond|Progressive Disease|9
4659922|NCT03044730|16010359|P1|3 Cycles of Pembro + Capecitab|Adverse Event|1
4659923|NCT03044730|16010359|P1|3 Cycles of Pembro + Capecitab|Death|1
4659924|NCT03044730|16010359|P1|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1
4659925|NCT03044730|16010359|P1|3 Cycles of Pembro + Capecitab|Progressive Disease|1
4659926|NCT03044574|16010379|P2|Overall Study|Lost to Follow-up|45
4659927|NCT03044574|16010380|P1|Overall Study|Lost to Follow-up|37
4659928|NCT03044431|16010406|P1|Overall Study|Lost to Follow-up|59
4659929|NCT03044353|16010419|P3|Overall Study|Adverse Event|0
4659930|NCT03044353|16010420|P2|Overall Study|Adverse Event|1
4659931|NCT03044353|16010421|P1|Overall Study|Adverse Event|0
4659932|NCT03044197|16010504|P2|Overall Study|Withdrawal by Subject|1
4659933|NCT03044197|16010505|P1|Overall Study|Withdrawal by Subject|3
4659935|NCT03044106|16010516|P1|Washout (1 Week)|Withdrawal by Subject|0
4659936|NCT03043651|16010588|P1|Overall Study|Study Terminated by Sponsor|39
4659937|NCT03043651|16010588|P1|Overall Study|Withdrawal by Subject|4
4659938|NCT03043651|16010588|P1|Overall Study|Adverse Event|2
4659939|NCT03043651|16010588|P1|Overall Study|Progressive Disease|2
4659940|NCT03043651|16010588|P1|Overall Study|Death|1
4659941|NCT03043560|16010600|P2|Overall Study|Lost to Follow-up|1
4659942|NCT03043560|16010601|P1|Overall Study|Lost to Follow-up|0
4659943|NCT03043560|16010600|P2|Overall Study|Discontinued Intervention|2
4659944|NCT03043560|16010601|P1|Overall Study|Discontinued Intervention|1
4659945|NCT03043365|16010642|P2|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0
4659946|NCT03043365|16010643|P1|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1
4659947|NCT03043365|16010642|P2|Weeks 0 to Week 8|Lost to Follow-up|0
4659948|NCT03043365|16010643|P1|Weeks 0 to Week 8|Lost to Follow-up|2
4659949|NCT03043365|16010642|P2|Weeks 0 to Week 8|Adverse Event|3
4659950|NCT03043365|16010643|P1|Weeks 0 to Week 8|Adverse Event|1
4659951|NCT03042910|16010697|P1|Overall Study|Enrolled but not treated|1
4659952|NCT03042910|16010697|P1|Overall Study|Withdrawal by Subject|3
4659953|NCT03042910|16010697|P1|Overall Study|Disease Progression|2
4659954|NCT03042910|16010697|P1|Overall Study|Adverse Event|1
4659955|NCT03042559|16010741|P2|Overall Study|drop out|1
4659956|NCT03042559|16010742|P1|Overall Study|drop out|1
4659957|NCT03041792|16010877|P2|Overall Study|Randomized but not treated|1
4659958|NCT03041792|16010878|P1|Overall Study|Randomized but not treated|0
4659959|NCT03041792|16010877|P2|Overall Study|Death in the family|2
4659960|NCT03041792|16010878|P1|Overall Study|Death in the family|0
4659961|NCT03041792|16010877|P2|Overall Study|Adverse Event|0
4659962|NCT03041792|16010878|P1|Overall Study|Adverse Event|4
4659963|NCT03041181|16010951|P2|Overall Study|Disease Progression|2
4659964|NCT03041181|16010952|P1|Overall Study|Disease Progression|1
4659965|NCT03041090|16010968|P2|Overall Study|technical error|3
4659966|NCT03041090|16010969|P1|Overall Study|technical error|0
4659967|NCT03040713|16010979|P1|Overall Study|Positive amyloid scan|3
4659968|NCT03040687|16010987|P3|Overall Study|Withdrawal by Subject|0
4659969|NCT03040687|16010988|P2|Overall Study|Withdrawal by Subject|0
4659970|NCT03040687|16010989|P1|Overall Study|Withdrawal by Subject|1
4659971|NCT03040336|16011058|P2|Overall Study|Withdrawal by Subject|3
4659972|NCT03040336|16011059|P1|Overall Study|Withdrawal by Subject|2
4659973|NCT03040336|16011058|P2|Overall Study|Death|0
4659974|NCT03040336|16011059|P1|Overall Study|Death|1
4659975|NCT03039738|16011172|P2|Overall Study|Incomplete data sets|0
4659976|NCT03039738|16011173|P1|Overall Study|Incomplete data sets|54
4659977|NCT03039699|16011195|P2|Overall Study|Bacterial infection|28
4659978|NCT03039699|16011196|P1|Overall Study|Bacterial infection|12
4659979|NCT03039699|16011195|P2|Overall Study|Lack of data to assess study endpoint|3
4659980|NCT03039699|16011196|P1|Overall Study|Lack of data to assess study endpoint|5
4659981|NCT03039699|16011195|P2|Overall Study|Incorrect inclusion|4
4659982|NCT03039699|16011196|P1|Overall Study|Incorrect inclusion|5
4659983|NCT03039621|16011218|P2|Overall Study|Violation of non-inclusion criteria|2
4659984|NCT03039621|16011219|P1|Overall Study|Violation of non-inclusion criteria|1
4659985|NCT03039621|16011218|P2|Overall Study|Necessity to use drugs forbidden by pro|7
4659986|NCT03039621|16011219|P1|Overall Study|Necessity to use drugs forbidden by pro|4
4659987|NCT03039621|16011218|P2|Overall Study|Non-compliance with protocol requirement|5
4659988|NCT03039621|16011219|P1|Overall Study|Non-compliance with protocol requirement|4
4659989|NCT03039621|16011218|P2|Overall Study|Violation of inclusion criteria|2
4659990|NCT03039621|16011219|P1|Overall Study|Violation of inclusion criteria|3
4659991|NCT03039569|16011243|P2|Overall Study|Lost to Follow-up|4
4659992|NCT03039569|16011244|P1|Overall Study|Lost to Follow-up|5
4659993|NCT03039283|16011289|P1|Overall Study|Protocol Violation|2
4659994|NCT03039192|16011300|P2|Overall Study|Other|2
4659995|NCT03039192|16011301|P1|Overall Study|Other|3
4659996|NCT03039192|16011300|P2|Overall Study|Discontinued from treatment phase|12
4659997|NCT03039192|16011301|P1|Overall Study|Discontinued from treatment phase|19
4659998|NCT03039192|16011300|P2|Overall Study|Withdrawal by Subject|9
4659999|NCT03039192|16011301|P1|Overall Study|Withdrawal by Subject|6
4660000|NCT03039192|16011300|P2|Overall Study|Adverse event, non-fatal|2
4660001|NCT03039192|16011301|P1|Overall Study|Adverse event, non-fatal|0
4660002|NCT03039192|16011300|P2|Overall Study|Adverse event, serious fatal|1
4660003|NCT03039192|16011301|P1|Overall Study|Adverse event, serious fatal|0
4660004|NCT03039192|16011300|P2|Overall Study|Lost to Follow-up|4
4660005|NCT03039192|16011301|P1|Overall Study|Lost to Follow-up|4
4660006|NCT03038126|16011503|P2|Overall Study|Too Ill to Participate|2
4660007|NCT03038126|16011504|P1|Overall Study|Too Ill to Participate|1
4660008|NCT03038126|16011503|P2|Overall Study|Long Term Hospitalization|0
4660009|NCT03038126|16011504|P1|Overall Study|Long Term Hospitalization|2
4660010|NCT03038126|16011503|P2|Overall Study|Lost to Follow-up|1
4660011|NCT03038126|16011504|P1|Overall Study|Lost to Follow-up|0
4660012|NCT03038126|16011503|P2|Overall Study|Withdrawal by Subject|0
4660013|NCT03038126|16011504|P1|Overall Study|Withdrawal by Subject|5
4660014|NCT03038126|16011503|P2|Overall Study|Death|1
4660015|NCT03038126|16011504|P1|Overall Study|Death|1
4660016|NCT03037619|16011546|P2|Overall Study|Lost to Follow-up|1
4660017|NCT03037619|16011547|P1|Overall Study|Lost to Follow-up|0
4660018|NCT03037580|16011561|P2|Overall Study|Death|1
4660019|NCT03037580|16011562|P1|Overall Study|Death|0
4660020|NCT03037580|16011561|P2|Overall Study|Study Terminated by Sponsor|15
4660021|NCT03037580|16011562|P1|Overall Study|Study Terminated by Sponsor|12
4660022|NCT03037580|16011561|P2|Overall Study|Adverse Event|0
4660023|NCT03037580|16011562|P1|Overall Study|Adverse Event|1
4660024|NCT03037580|16011561|P2|Overall Study|Withdrawal by Subject|0
4660025|NCT03037580|16011562|P1|Overall Study|Withdrawal by Subject|3
4660026|NCT03037489|16011587|P2|Overall Study|Withdrawal by Subject|0
4660027|NCT03037489|16011588|P1|Overall Study|Withdrawal by Subject|3
4660028|NCT03037489|16011587|P2|Overall Study|Adverse Event|0
4660029|NCT03037489|16011588|P1|Overall Study|Adverse Event|4
4660030|NCT03037307|16011594|P6|Period 1|Did Not Meet Study Criteria|0
4660031|NCT03037307|16011595|P5|Period 1|Did Not Meet Study Criteria|0
4660032|NCT03037307|16011596|P4|Period 1|Did Not Meet Study Criteria|1
4660033|NCT03037307|16011597|P3|Period 1|Did Not Meet Study Criteria|0
4660034|NCT03037307|16011598|P2|Period 1|Did Not Meet Study Criteria|0
4660035|NCT03037307|16011599|P1|Period 1|Did Not Meet Study Criteria|0
4660036|NCT03036852|16011638|P1|Overall Study|Lost to Follow-up|1
4660037|NCT03036852|16011638|P1|Overall Study|Adverse Event|1
4660038|NCT03036852|16011638|P1|Overall Study|Lack of Efficacy|2
4660039|NCT03036852|16011638|P1|Overall Study|Death|2
4660040|NCT03036839|16011695|P3|Overall Study|Withdrew Consent|1
4660041|NCT03036839|16011696|P2|Overall Study|Withdrew Consent|0
4660042|NCT03036839|16011697|P1|Overall Study|Withdrew Consent|0
4660043|NCT03036839|16011695|P3|Overall Study|Death|3
4660044|NCT03036839|16011696|P2|Overall Study|Death|0
4660045|NCT03036839|16011697|P1|Overall Study|Death|3
4660046|NCT03036839|16011695|P3|Overall Study|Adverse Event|1
4660047|NCT03036839|16011696|P2|Overall Study|Adverse Event|0
4660048|NCT03036839|16011697|P1|Overall Study|Adverse Event|0
4660049|NCT03036124|16011923|P2|Overall Study|Withdrawal by Subject|4
4660050|NCT03036124|16011924|P1|Overall Study|Withdrawal by Subject|5
4660051|NCT03036124|16011923|P2|Overall Study|Lost to Follow-up|2
4660052|NCT03036124|16011924|P1|Overall Study|Lost to Follow-up|0
4660053|NCT03036072|16011942|P2|Overall Study|Physician Decision|1
4660054|NCT03036072|16011943|P1|Overall Study|Physician Decision|0
4660055|NCT03036072|16011942|P2|Overall Study|Withdrawal by Subject|1
4660056|NCT03036072|16011943|P1|Overall Study|Withdrawal by Subject|0
4660057|NCT03036072|16011942|P2|Overall Study|Death|1
4660058|NCT03036072|16011943|P1|Overall Study|Death|0
4660059|NCT03035942|16011963|P3|Overall Study|Adverse Event|5
4660060|NCT03035942|16011964|P2|Overall Study|Adverse Event|4
4660061|NCT03035942|16011965|P1|Overall Study|Adverse Event|8
4660062|NCT03035916|16011994|P3|Overall Study|Puncture failed|0
4660063|NCT03035916|16011995|P2|Overall Study|Puncture failed|2
4660064|NCT03035916|16011996|P1|Overall Study|Puncture failed|0
4660065|NCT03035864|16012045|P2|Follow-up Period|Other|2
4660066|NCT03035864|16012046|P1|Follow-up Period|Other|3
4660067|NCT03035864|16012045|P2|Follow-up Period|Physician Decision|0
4660068|NCT03035864|16012046|P1|Follow-up Period|Physician Decision|1
4660069|NCT03035864|16012045|P2|Follow-up Period|Lost to Follow-up|2
4660070|NCT03035864|16012046|P1|Follow-up Period|Lost to Follow-up|6
4660071|NCT03035864|16012045|P2|Follow-up Period|Adverse Event|0
4660072|NCT03035864|16012046|P1|Follow-up Period|Adverse Event|1
4660073|NCT03035864|16012045|P2|Treatment Period|Other|1
4660074|NCT03035864|16012046|P1|Treatment Period|Other|3
4660075|NCT03035864|16012045|P2|Treatment Period|Adverse Event|0
4660076|NCT03035864|16012046|P1|Treatment Period|Adverse Event|1
4660077|NCT03034967|16012126|P6|Overall Study|Adverse Event, Serious Fatal|1
4660078|NCT03034967|16012127|P5|Overall Study|Adverse Event, Serious Fatal|1
4660079|NCT03034967|16012128|P4|Overall Study|Adverse Event, Serious Fatal|2
4660080|NCT03034967|16012129|P3|Overall Study|Adverse Event, Serious Fatal|1
4660081|NCT03034967|16012130|P2|Overall Study|Adverse Event, Serious Fatal|1
4660082|NCT03034967|16012131|P1|Overall Study|Adverse Event, Serious Fatal|0
4660083|NCT03034967|16012126|P6|Overall Study|Adverse Event, non-fatal|8
4660084|NCT03034967|16012127|P5|Overall Study|Adverse Event, non-fatal|2
4660085|NCT03034967|16012128|P4|Overall Study|Adverse Event, non-fatal|0
4660086|NCT03034967|16012129|P3|Overall Study|Adverse Event, non-fatal|2
4660087|NCT03034967|16012130|P2|Overall Study|Adverse Event, non-fatal|1
4660088|NCT03034967|16012131|P1|Overall Study|Adverse Event, non-fatal|3
4660089|NCT03034967|16012126|P6|Overall Study|Lack of Efficacy|0
4660090|NCT03034967|16012127|P5|Overall Study|Lack of Efficacy|1
4660091|NCT03034967|16012128|P4|Overall Study|Lack of Efficacy|1
4660092|NCT03034967|16012129|P3|Overall Study|Lack of Efficacy|2
4660093|NCT03034967|16012130|P2|Overall Study|Lack of Efficacy|1
4660094|NCT03034967|16012131|P1|Overall Study|Lack of Efficacy|0
4660095|NCT03034967|16012126|P6|Overall Study|Protocol Violation|2
4660096|NCT03034967|16012127|P5|Overall Study|Protocol Violation|0
4660097|NCT03034967|16012128|P4|Overall Study|Protocol Violation|0
4660098|NCT03034967|16012129|P3|Overall Study|Protocol Violation|0
4660099|NCT03034967|16012130|P2|Overall Study|Protocol Violation|0
4660100|NCT03034967|16012131|P1|Overall Study|Protocol Violation|1
4660101|NCT03034967|16012126|P6|Overall Study|Liver function test abnormality|0
4660102|NCT03034967|16012127|P5|Overall Study|Liver function test abnormality|0
4660103|NCT03034967|16012128|P4|Overall Study|Liver function test abnormality|0
4660104|NCT03034967|16012129|P3|Overall Study|Liver function test abnormality|1
4660105|NCT03034967|16012130|P2|Overall Study|Liver function test abnormality|0
4660106|NCT03034967|16012131|P1|Overall Study|Liver function test abnormality|0
4660107|NCT03034967|16012126|P6|Overall Study|Lost to Follow-up|2
4660108|NCT03034967|16012127|P5|Overall Study|Lost to Follow-up|0
4660109|NCT03034967|16012128|P4|Overall Study|Lost to Follow-up|1
4660110|NCT03034967|16012129|P3|Overall Study|Lost to Follow-up|0
4660111|NCT03034967|16012130|P2|Overall Study|Lost to Follow-up|0
4660112|NCT03034967|16012131|P1|Overall Study|Lost to Follow-up|0
4660113|NCT03034967|16012126|P6|Overall Study|Physician Decision|0
4660114|NCT03034967|16012127|P5|Overall Study|Physician Decision|1
4660115|NCT03034967|16012128|P4|Overall Study|Physician Decision|1
4660116|NCT03034967|16012129|P3|Overall Study|Physician Decision|1
4660117|NCT03034967|16012130|P2|Overall Study|Physician Decision|0
4660118|NCT03034967|16012131|P1|Overall Study|Physician Decision|1
4660119|NCT03034967|16012126|P6|Overall Study|Withdrawal by Subject|2
4660120|NCT03034967|16012127|P5|Overall Study|Withdrawal by Subject|9
4660121|NCT03034967|16012128|P4|Overall Study|Withdrawal by Subject|6
4660122|NCT03034967|16012129|P3|Overall Study|Withdrawal by Subject|6
4660123|NCT03034967|16012130|P2|Overall Study|Withdrawal by Subject|2
4660124|NCT03034967|16012131|P1|Overall Study|Withdrawal by Subject|9
4660125|NCT03034954|16012329|P2|Overall Study|Machine malfunction; did not reach 3 mA|0
4660126|NCT03034954|16012330|P1|Overall Study|Machine malfunction; did not reach 3 mA|1
4660127|NCT03034915|16012397|P3|Overall Study|Physician Decision|2
4660128|NCT03034915|16012398|P2|Overall Study|Physician Decision|5
4660129|NCT03034915|16012399|P1|Overall Study|Physician Decision|1
4660130|NCT03034915|16012397|P3|Overall Study|Protocol-defined withdrawal criteria met|29
4660131|NCT03034915|16012398|P2|Overall Study|Protocol-defined withdrawal criteria met|26
4660132|NCT03034915|16012399|P1|Overall Study|Protocol-defined withdrawal criteria met|19
4660133|NCT03034915|16012397|P3|Overall Study|Site closed|4
4660134|NCT03034915|16012398|P2|Overall Study|Site closed|2
4660135|NCT03034915|16012399|P1|Overall Study|Site closed|2
4660136|NCT03034915|16012397|P3|Overall Study|Lack of Efficacy|18
4660137|NCT03034915|16012398|P2|Overall Study|Lack of Efficacy|16
4660138|NCT03034915|16012399|P1|Overall Study|Lack of Efficacy|8
4660139|NCT03034915|16012397|P3|Overall Study|Protocol Deviation|7
4660140|NCT03034915|16012398|P2|Overall Study|Protocol Deviation|14
4660141|NCT03034915|16012399|P1|Overall Study|Protocol Deviation|2
4660142|NCT03034915|16012397|P3|Overall Study|Withdrawal by Subject|41
4660143|NCT03034915|16012398|P2|Overall Study|Withdrawal by Subject|46
4660144|NCT03034915|16012399|P1|Overall Study|Withdrawal by Subject|29
4660145|NCT03034915|16012397|P3|Overall Study|Lost to Follow-up|3
4660146|NCT03034915|16012398|P2|Overall Study|Lost to Follow-up|13
4660147|NCT03034915|16012399|P1|Overall Study|Lost to Follow-up|5
4660148|NCT03034915|16012397|P3|Overall Study|Adverse Event|22
4660149|NCT03034915|16012398|P2|Overall Study|Adverse Event|32
4660150|NCT03034915|16012399|P1|Overall Study|Adverse Event|29
4660151|NCT03034772|16012439|P2|Overall Study|Withdrawal by Subject|1
4660152|NCT03034772|16012440|P1|Overall Study|Withdrawal by Subject|0
4660153|NCT03034772|16012439|P2|Overall Study|Adverse Event|1
4660154|NCT03034772|16012440|P1|Overall Study|Adverse Event|0
4660155|NCT03034577|16012456|P2|Overall Study|Lost to Follow-up|26
4660156|NCT03034577|16012457|P1|Overall Study|Lost to Follow-up|25
4660157|NCT03034577|16012456|P2|Overall Study|Withdrawal by Subject|9
4660158|NCT03034577|16012457|P1|Overall Study|Withdrawal by Subject|6
4660159|NCT03034057|16012473|P1|Overall Study|Medication error without associated AE|1
4660160|NCT03034057|16012473|P1|Overall Study|Adverse Event|22
4660161|NCT03034057|16012473|P1|Overall Study|Lost to Follow-up|19
4660162|NCT03034057|16012473|P1|Overall Study|Not defined|2
4660163|NCT03034057|16012473|P1|Overall Study|Protocol Violation|1
4660164|NCT03034057|16012473|P1|Overall Study|Withdrawal by Subject|10
4660165|NCT03034044|16012479|P1|Overall Study|Enrolled, but not received Xyntha|1
4660166|NCT03033745|16012502|P3|Overall Study|Withdrawal by Subject|0
4660167|NCT03033745|16012503|P2|Overall Study|Withdrawal by Subject|1
4660168|NCT03033745|16012504|P1|Overall Study|Withdrawal by Subject|0
4660169|NCT03033745|16012502|P3|Overall Study|Adverse Event|1
4660170|NCT03033745|16012503|P2|Overall Study|Adverse Event|0
4660171|NCT03033745|16012504|P1|Overall Study|Adverse Event|1
4660172|NCT03033745|16012502|P3|Overall Study|Protocol Violation|1
4660173|NCT03033745|16012503|P2|Overall Study|Protocol Violation|0
4660174|NCT03033745|16012504|P1|Overall Study|Protocol Violation|0
4660175|NCT03032523|16012587|P2|Overall Study|Physician Decision|0
4660176|NCT03032523|16012588|P1|Overall Study|Physician Decision|1
4660177|NCT03032523|16012587|P2|Overall Study|Withdrawal by Subject|2
4660178|NCT03032523|16012588|P1|Overall Study|Withdrawal by Subject|2
4660179|NCT03032510|16012600|P2|Overall Study|Physician Decision|0
4660180|NCT03032510|16012601|P1|Overall Study|Physician Decision|2
4660181|NCT03032510|16012600|P2|Overall Study|Subject noncompliance|2
4660182|NCT03032510|16012601|P1|Overall Study|Subject noncompliance|4
4660183|NCT03032510|16012600|P2|Overall Study|Withdrawal by Subject|7
4660184|NCT03032510|16012601|P1|Overall Study|Withdrawal by Subject|8
4660185|NCT03032510|16012600|P2|Overall Study|Lost to Follow-up|7
4660186|NCT03032510|16012601|P1|Overall Study|Lost to Follow-up|8
4660187|NCT03032510|16012600|P2|Overall Study|Adverse Event|2
4660188|NCT03032510|16012601|P1|Overall Study|Adverse Event|5
4660189|NCT03031899|16012637|P1|Overall Study|lesion disappeared after stopping habit|1
4660190|NCT03031899|16012637|P1|Overall Study|Protocol Violation|1
4660191|NCT03031678|16012654|P1|Overall Study|Study closed prior to completion|1
4660192|NCT03031496|16012663|P2|Period 1|Withdrawal by Subject|2
4660193|NCT03031496|16012664|P1|Period 1|Withdrawal by Subject|0
4660194|NCT03031496|16012663|P2|Period 1|Adverse Event|0
4660195|NCT03031496|16012664|P1|Period 1|Adverse Event|2
4660196|NCT03031431|16012700|P1|Overall Study|Infant removed by maternal request|1
4660197|NCT03029832|16012788|P2|Overall Study|Study Terminated By Sponsor|1
4660198|NCT03029832|16012789|P1|Overall Study|Study Terminated By Sponsor|1
4660199|NCT03029832|16012788|P2|Overall Study|Death due to Disease Progression|0
4660200|NCT03029832|16012789|P1|Overall Study|Death due to Disease Progression|1
4660201|NCT03029832|16012788|P2|Overall Study|Safety Follow-Up Completed|0
4660202|NCT03029832|16012789|P1|Overall Study|Safety Follow-Up Completed|2
4660203|NCT03029819|16012819|P2|Overall Study|Removed due to disruptive behavior|1
4660204|NCT03029819|16012820|P1|Overall Study|Removed due to disruptive behavior|0
4660205|NCT03029819|16012819|P2|Overall Study|Lost to Follow-up|5
4660206|NCT03029819|16012820|P1|Overall Study|Lost to Follow-up|3
4660207|NCT03029780|16012834|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
4660208|NCT03029780|16012835|P1|Overall Study|Adverse Event Unrelated to Study Drug|0
4660209|NCT03029780|16012834|P2|Overall Study|Study Drug Toxicity|5
4660210|NCT03029780|16012835|P1|Overall Study|Study Drug Toxicity|5
4660211|NCT03029780|16012834|P2|Overall Study|Disease Progression|3
4660212|NCT03029780|16012835|P1|Overall Study|Disease Progression|1
4660213|NCT03029650|16012858|P2|Washout (1 Week)|Physician Decision|1
4660214|NCT03029650|16012859|P1|Washout (1 Week)|Physician Decision|0
4660215|NCT03029650|16012858|P2|Washout (1 Week)|Withdrawal by Subject|1
4660216|NCT03029650|16012859|P1|Washout (1 Week)|Withdrawal by Subject|1
4660217|NCT03029234|16012874|P1|Overall Study|Death|61
4660218|NCT03029234|16012874|P1|Overall Study|Withdrawal by Subject|5
4660219|NCT03029234|16012874|P1|Overall Study|Sponsor Decision|1
4660220|NCT03028870|16012997|P4|Overall Study|Administrative|4
4660221|NCT03028870|16012998|P3|Overall Study|Administrative|12
4660222|NCT03028870|16012999|P2|Overall Study|Administrative|5
4660223|NCT03028870|16013000|P1|Overall Study|Administrative|5
4660224|NCT03028870|16012997|P4|Overall Study|Lack of Efficacy|0
4660225|NCT03028870|16012998|P3|Overall Study|Lack of Efficacy|0
4660226|NCT03028870|16012999|P2|Overall Study|Lack of Efficacy|0
4660227|NCT03028870|16013000|P1|Overall Study|Lack of Efficacy|3
4660228|NCT03028870|16012997|P4|Overall Study|Lost to Follow-up|0
4660229|NCT03028870|16012998|P3|Overall Study|Lost to Follow-up|0
4660230|NCT03028870|16012999|P2|Overall Study|Lost to Follow-up|0
4660231|NCT03028870|16013000|P1|Overall Study|Lost to Follow-up|1
4660232|NCT03028870|16012997|P4|Overall Study|Withdrawal by Subject|2
4660233|NCT03028870|16012998|P3|Overall Study|Withdrawal by Subject|1
4660234|NCT03028870|16012999|P2|Overall Study|Withdrawal by Subject|1
4660235|NCT03028870|16013000|P1|Overall Study|Withdrawal by Subject|1
4660236|NCT03028870|16012997|P4|Overall Study|Adverse Event|3
4660237|NCT03028870|16012998|P3|Overall Study|Adverse Event|3
4660238|NCT03028870|16012999|P2|Overall Study|Adverse Event|4
4660239|NCT03028870|16013000|P1|Overall Study|Adverse Event|7
4660240|NCT03028142|16013205|P6|Overall Study|Withdrawal by Subject|0
4660241|NCT03028142|16013206|P5|Overall Study|Withdrawal by Subject|1
4660242|NCT03028142|16013207|P4|Overall Study|Withdrawal by Subject|0
4660243|NCT03028142|16013208|P3|Overall Study|Withdrawal by Subject|0
4660244|NCT03028142|16013209|P2|Overall Study|Withdrawal by Subject|0
4660245|NCT03028142|16013210|P1|Overall Study|Withdrawal by Subject|0
4660246|NCT03028142|16013205|P6|Overall Study|Adverse Event|1
4660247|NCT03028142|16013206|P5|Overall Study|Adverse Event|0
4660248|NCT03028142|16013207|P4|Overall Study|Adverse Event|0
4660249|NCT03028142|16013208|P3|Overall Study|Adverse Event|0
4660250|NCT03028142|16013209|P2|Overall Study|Adverse Event|1
4660251|NCT03028142|16013210|P1|Overall Study|Adverse Event|1
4660252|NCT03028129|16013229|P2|Overall Study|Withdrawal by Subject|45
4660253|NCT03028129|16013230|P1|Overall Study|Withdrawal by Subject|62
4660254|NCT03028129|16013229|P2|Overall Study|Protocol Violation|1
4660255|NCT03028129|16013230|P1|Overall Study|Protocol Violation|1
4660256|NCT03028129|16013229|P2|Overall Study|Physician Decision|1
4660257|NCT03028129|16013230|P1|Overall Study|Physician Decision|0
4660258|NCT03028129|16013229|P2|Overall Study|Lost to Follow-up|38
4660259|NCT03028129|16013230|P1|Overall Study|Lost to Follow-up|50
4660260|NCT03028129|16013229|P2|Overall Study|Adverse Event|2
4660261|NCT03028129|16013230|P1|Overall Study|Adverse Event|13
4660262|NCT03026530|16013326|P2|Overall Study|Protocol Violation|5
4660263|NCT03026530|16013327|P1|Overall Study|Protocol Violation|2
4660264|NCT03026530|16013326|P2|Overall Study|Lost to Follow-up|24
4660265|NCT03026530|16013327|P1|Overall Study|Lost to Follow-up|19
4660266|NCT03026283|16013335|P8|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4660267|NCT03026283|16013336|P7|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4660268|NCT03026283|16013337|P6|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19
4660269|NCT03026283|16013338|P5|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25
4660270|NCT03026283|16013339|P4|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4660271|NCT03026283|16013340|P3|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4660272|NCT03026283|16013341|P2|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4660273|NCT03026283|16013342|P1|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0
4660274|NCT03026283|16013335|P8|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660275|NCT03026283|16013336|P7|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660276|NCT03026283|16013337|P6|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660277|NCT03026283|16013338|P5|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660278|NCT03026283|16013339|P4|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1
4660279|NCT03026283|16013340|P3|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660280|NCT03026283|16013341|P2|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660281|NCT03026283|16013342|P1|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0
4660282|NCT03026283|16013335|P8|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4660283|NCT03026283|16013336|P7|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4660284|NCT03026283|16013337|P6|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7
4660285|NCT03026283|16013338|P5|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4660286|NCT03026283|16013339|P4|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2
4660287|NCT03026283|16013340|P3|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4660288|NCT03026283|16013341|P2|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4660289|NCT03026283|16013342|P1|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0
4660290|NCT03026283|16013335|P8|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4660291|NCT03026283|16013336|P7|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4660292|NCT03026283|16013337|P6|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
4660293|NCT03026283|16013338|P5|Optimal Care/Stress Test/ICA|Lost to Follow-up|2
4660294|NCT03026283|16013339|P4|Optimal Care/Stress Test/ICA|Lost to Follow-up|9
4660295|NCT03026283|16013340|P3|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4660296|NCT03026283|16013341|P2|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4660297|NCT03026283|16013342|P1|Optimal Care/Stress Test/ICA|Lost to Follow-up|0
4660298|NCT03026283|16013335|P8|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4660299|NCT03026283|16013336|P7|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4660300|NCT03026283|16013337|P6|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4660301|NCT03026283|16013338|P5|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11
4660302|NCT03026283|16013339|P4|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8
4660303|NCT03026283|16013340|P3|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4660304|NCT03026283|16013341|P2|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4660305|NCT03026283|16013342|P1|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0
4660306|NCT03026283|16013335|P8|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660307|NCT03026283|16013336|P7|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660308|NCT03026283|16013337|P6|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660309|NCT03026283|16013338|P5|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660310|NCT03026283|16013339|P4|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660311|NCT03026283|16013340|P3|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15
4660312|NCT03026283|16013341|P2|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660313|NCT03026283|16013342|P1|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0
4660314|NCT03026283|16013335|P8|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660315|NCT03026283|16013336|P7|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660316|NCT03026283|16013337|P6|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660317|NCT03026283|16013338|P5|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660318|NCT03026283|16013339|P4|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660319|NCT03026283|16013340|P3|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660320|NCT03026283|16013341|P2|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3
4660321|NCT03026283|16013342|P1|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0
4660322|NCT03026283|16013335|P8|CCTA Diagnosis|Withdrawal by Subject|0
4660323|NCT03026283|16013336|P7|CCTA Diagnosis|Withdrawal by Subject|0
4660324|NCT03026283|16013337|P6|CCTA Diagnosis|Withdrawal by Subject|0
4660325|NCT03026283|16013338|P5|CCTA Diagnosis|Withdrawal by Subject|0
4660326|NCT03026283|16013339|P4|CCTA Diagnosis|Withdrawal by Subject|0
4660327|NCT03026283|16013340|P3|CCTA Diagnosis|Withdrawal by Subject|0
4660328|NCT03026283|16013341|P2|CCTA Diagnosis|Withdrawal by Subject|0
4660329|NCT03026283|16013342|P1|CCTA Diagnosis|Withdrawal by Subject|5
4660330|NCT03026283|16013335|P8|CCTA Diagnosis|CCTA not performed as planned|0
4660331|NCT03026283|16013336|P7|CCTA Diagnosis|CCTA not performed as planned|0
4660332|NCT03026283|16013337|P6|CCTA Diagnosis|CCTA not performed as planned|0
4660333|NCT03026283|16013338|P5|CCTA Diagnosis|CCTA not performed as planned|0
4660334|NCT03026283|16013339|P4|CCTA Diagnosis|CCTA not performed as planned|0
4660335|NCT03026283|16013340|P3|CCTA Diagnosis|CCTA not performed as planned|0
4660336|NCT03026283|16013341|P2|CCTA Diagnosis|CCTA not performed as planned|0
4660337|NCT03026283|16013342|P1|CCTA Diagnosis|CCTA not performed as planned|9
4660338|NCT03026257|16013363|P6|Overall Study|Withdrawal by Subject|0
4660339|NCT03026257|16013364|P5|Overall Study|Withdrawal by Subject|0
4660340|NCT03026257|16013365|P4|Overall Study|Withdrawal by Subject|0
4660341|NCT03026257|16013366|P3|Overall Study|Withdrawal by Subject|0
4660342|NCT03026257|16013367|P2|Overall Study|Withdrawal by Subject|1
4660343|NCT03026257|16013368|P1|Overall Study|Withdrawal by Subject|1
4660344|NCT03026257|16013363|P6|Overall Study|Protocol Violation|0
4660345|NCT03026257|16013364|P5|Overall Study|Protocol Violation|1
4660346|NCT03026257|16013365|P4|Overall Study|Protocol Violation|1
4660347|NCT03026257|16013366|P3|Overall Study|Protocol Violation|0
4660348|NCT03026257|16013367|P2|Overall Study|Protocol Violation|0
4660349|NCT03026257|16013368|P1|Overall Study|Protocol Violation|1
4660350|NCT03026257|16013363|P6|Overall Study|Lost to Follow-up|0
4660351|NCT03026257|16013364|P5|Overall Study|Lost to Follow-up|0
4660352|NCT03026257|16013365|P4|Overall Study|Lost to Follow-up|0
4660353|NCT03026257|16013366|P3|Overall Study|Lost to Follow-up|0
4660354|NCT03026257|16013367|P2|Overall Study|Lost to Follow-up|0
4660355|NCT03026257|16013368|P1|Overall Study|Lost to Follow-up|1
4660356|NCT03026257|16013363|P6|Overall Study|Adverse Event|0
4660357|NCT03026257|16013364|P5|Overall Study|Adverse Event|0
4660358|NCT03026257|16013365|P4|Overall Study|Adverse Event|0
4660359|NCT03026257|16013366|P3|Overall Study|Adverse Event|0
4660360|NCT03026257|16013367|P2|Overall Study|Adverse Event|0
4660361|NCT03026257|16013368|P1|Overall Study|Adverse Event|3
4660362|NCT03026166|16013384|P2|Overall Study|Other|0
4660363|NCT03026166|16013385|P1|Overall Study|Other|1
4660364|NCT03026166|16013384|P2|Overall Study|Study Terminated by Sponsor|3
4660365|NCT03026166|16013385|P1|Overall Study|Study Terminated by Sponsor|3
4660366|NCT03026166|16013384|P2|Overall Study|Lost to Follow-up|0
4660367|NCT03026166|16013385|P1|Overall Study|Lost to Follow-up|1
4660368|NCT03026166|16013384|P2|Overall Study|Withdrawal by Subject|2
4660369|NCT03026166|16013385|P1|Overall Study|Withdrawal by Subject|1
4660370|NCT03026166|16013384|P2|Overall Study|Physician Decision|0
4660371|NCT03026166|16013385|P1|Overall Study|Physician Decision|2
4660372|NCT03026166|16013384|P2|Overall Study|Death|7
4660373|NCT03026166|16013385|P1|Overall Study|Death|22
4660374|NCT03026088|16013401|P1|Overall Study|Study termination|20
4660375|NCT03026075|16013425|P1|Overall Study|Physician Decision|1
4660376|NCT03025217|16013438|P1|Overall Study|Not eligible, poor English|2
4660377|NCT03025217|16013438|P1|Overall Study|Lost to Follow-up|1
4660378|NCT03025217|16013438|P1|Overall Study|Pregnancy|1
4660379|NCT03024970|16013443|P2|Second Intervention|Lost to Follow-up|0
4660380|NCT03024970|16013444|P1|Second Intervention|Lost to Follow-up|1
4660381|NCT03024970|16013443|P2|First Intervention|Adverse Event|0
4660382|NCT03024970|16013444|P1|First Intervention|Adverse Event|1
4660383|NCT03024606|16013522|P2|Overall Study|Withdrawal by Subject|10
4660384|NCT03024606|16013523|P1|Overall Study|Withdrawal by Subject|9
4660385|NCT03023878|16013551|P1|Long Term Follow-Up Period|Death|2
4660386|NCT03023878|16013551|P1|Treatment Period|Adverse Event|1
4660387|NCT03023878|16013551|P1|Treatment Period|Withdrawal by Subject|1
4660388|NCT03023878|16013551|P1|Treatment Period|Disease Progression|1
4660389|NCT03023878|16013551|P1|Between Run-In and Treatment Periods|Protocol-specified criteria|2
4660390|NCT03023878|16013551|P1|Pre-Study Run-In Period|Withdrawal by Subject|5
4660391|NCT03023878|16013551|P1|Pre-Study Run-In Period|Death|1
4660392|NCT03023878|16013551|P1|Pre-Study Run-In Period|Protocol-specified criteria|11
4660393|NCT03023423|16013613|P3|Overall Study|Ongoing|24
4660394|NCT03023423|16013614|P2|Overall Study|Ongoing|32
4660395|NCT03023423|16013615|P1|Overall Study|Ongoing|2
4660396|NCT03023423|16013613|P3|Overall Study|Other|2
4660397|NCT03023423|16013614|P2|Overall Study|Other|2
4660398|NCT03023423|16013615|P1|Overall Study|Other|0
4660399|NCT03023423|16013613|P3|Overall Study|Death|20
4660400|NCT03023423|16013614|P2|Overall Study|Death|12
4660401|NCT03023423|16013615|P1|Overall Study|Death|5
4660402|NCT03023137|16013652|P2|Overall Study|Lost the baby in a car accident|0
4660403|NCT03023137|16013653|P1|Overall Study|Lost the baby in a car accident|1
4660404|NCT03023137|16013652|P2|Overall Study|Protocol Violation|4
4660405|NCT03023137|16013653|P1|Overall Study|Protocol Violation|0
4660406|NCT03023137|16013652|P2|Overall Study|Lost to Follow-up|1
4660407|NCT03023137|16013653|P1|Overall Study|Lost to Follow-up|1
4660408|NCT03023137|16013652|P2|Overall Study|Multiple pregnancy|4
4660409|NCT03023137|16013653|P1|Overall Study|Multiple pregnancy|2
4660410|NCT03022981|16013682|P3|Overall Study|Withdrew Assent By Parent/Guardian|1
4660411|NCT03022981|16013683|P2|Overall Study|Withdrew Assent By Parent/Guardian|0
4660412|NCT03022981|16013684|P1|Overall Study|Withdrew Assent By Parent/Guardian|0
4660413|NCT03022981|16013682|P3|Overall Study|Non-Compliance With Study Drug|2
4660414|NCT03022981|16013683|P2|Overall Study|Non-Compliance With Study Drug|0
4660415|NCT03022981|16013684|P1|Overall Study|Non-Compliance With Study Drug|0
4660416|NCT03022981|16013682|P3|Overall Study|Lost to Follow-up|1
4660417|NCT03022981|16013683|P2|Overall Study|Lost to Follow-up|2
4660418|NCT03022981|16013684|P1|Overall Study|Lost to Follow-up|6
4660419|NCT03022981|16013682|P3|Overall Study|Investigator's Discretion|2
4660420|NCT03022981|16013683|P2|Overall Study|Investigator's Discretion|1
4660421|NCT03022981|16013684|P1|Overall Study|Investigator's Discretion|0
4660422|NCT03022981|16013682|P3|Overall Study|Adverse Event|0
4660423|NCT03022981|16013683|P2|Overall Study|Adverse Event|1
4660424|NCT03022981|16013684|P1|Overall Study|Adverse Event|0
4660425|NCT03022799|16013783|P13|Overall Study|Adverse Event|0
4660426|NCT03022799|16013784|P12|Overall Study|Adverse Event|0
4660427|NCT03022799|16013785|P11|Overall Study|Adverse Event|1
4660428|NCT03022799|16013786|P10|Overall Study|Adverse Event|1
4660429|NCT03022799|16013787|P9|Overall Study|Adverse Event|0
4660430|NCT03022799|16013788|P8|Overall Study|Adverse Event|0
4660431|NCT03022799|16013789|P7|Overall Study|Adverse Event|0
4660432|NCT03022799|16013790|P6|Overall Study|Adverse Event|0
4660433|NCT03022799|16013791|P5|Overall Study|Adverse Event|0
4660434|NCT03022799|16013792|P4|Overall Study|Adverse Event|0
4660435|NCT03022799|16013793|P3|Overall Study|Adverse Event|0
4660436|NCT03022799|16013794|P2|Overall Study|Adverse Event|0
4660437|NCT03022799|16013795|P1|Overall Study|Adverse Event|0
4660438|NCT03022630|16013992|P2|Overall Study|Withdrawal by Subject|5
4660439|NCT03022630|16013993|P1|Overall Study|Withdrawal by Subject|0
4660440|NCT03022630|16013992|P2|Overall Study|Death|7
4660441|NCT03022630|16013993|P1|Overall Study|Death|9
4660442|NCT03022422|16014110|P6|Overall Study|3 subjects consented but not vaccinated|0
4660443|NCT03022422|16014111|P5|Overall Study|3 subjects consented but not vaccinated|0
4660444|NCT03022422|16014112|P4|Overall Study|3 subjects consented but not vaccinated|0
4660445|NCT03022422|16014113|P3|Overall Study|3 subjects consented but not vaccinated|3
4660446|NCT03022422|16014114|P2|Overall Study|3 subjects consented but not vaccinated|0
4660447|NCT03022422|16014115|P1|Overall Study|3 subjects consented but not vaccinated|0
4660448|NCT03022370|16014170|P2|Overall Study|Lost to Follow-up|109
4660449|NCT03022370|16014171|P1|Overall Study|Lost to Follow-up|174
4660450|NCT03022370|16014170|P2|Overall Study|Death|12
4660451|NCT03022370|16014171|P1|Overall Study|Death|6
4660452|NCT03022084|16014247|P2|Overall Study|Lost to Follow-up|3
4660453|NCT03022084|16014248|P1|Overall Study|Lost to Follow-up|2
4660454|NCT03022045|16014256|P2|Overall Study|Withdrawal by Subject|1
4660455|NCT03022045|16014257|P1|Overall Study|Withdrawal by Subject|1
4660456|NCT03022045|16014256|P2|Overall Study|Adverse Event|1
4660457|NCT03022045|16014257|P1|Overall Study|Adverse Event|0
4660458|NCT03021668|16014286|P2|Overall Study|Physician Decision|1
4660459|NCT03021668|16014287|P1|Overall Study|Physician Decision|0
4660460|NCT03021642|16014299|P2|Washout Period (21 Days)|Adverse Event|1
4660461|NCT03021642|16014300|P1|Washout Period (21 Days)|Adverse Event|1
4660462|NCT03021564|16014340|P2|Overall Study|Lost to Follow-up|2
4660463|NCT03021564|16014341|P1|Overall Study|Lost to Follow-up|0
4660464|NCT03021564|16014340|P2|Overall Study|Death|466
4660465|NCT03021564|16014341|P1|Overall Study|Death|84
4660466|NCT03021304|16014385|P1|Overall Study|Lack of Efficacy|1
4660467|NCT03021265|16014390|P1|Overall Study|No visit since the first visit|4
4660468|NCT03021265|16014390|P1|Overall Study|No reason given|2
4660469|NCT03021265|16014390|P1|Overall Study|Lost to Follow-up|67
4660470|NCT03021265|16014390|P1|Overall Study|Improved|17
4660471|NCT03021265|16014390|P1|Overall Study|Lack of Efficacy|3
4660472|NCT03021265|16014390|P1|Overall Study|Adverse Event|29
4660473|NCT03021187|16014400|P4|Overall Study|Lost to Follow-up|4
4660474|NCT03021187|16014401|P3|Overall Study|Lost to Follow-up|1
4660475|NCT03021187|16014402|P2|Overall Study|Lost to Follow-up|3
4660476|NCT03021187|16014403|P1|Overall Study|Lost to Follow-up|10
4660477|NCT03021187|16014400|P4|Overall Study|Withdrawal by Subject|5
4660478|NCT03021187|16014401|P3|Overall Study|Withdrawal by Subject|2
4660479|NCT03021187|16014402|P2|Overall Study|Withdrawal by Subject|6
4660480|NCT03021187|16014403|P1|Overall Study|Withdrawal by Subject|0
4660481|NCT03021187|16014400|P4|Overall Study|Death|0
4660482|NCT03021187|16014401|P3|Overall Study|Death|3
4660483|NCT03021187|16014402|P2|Overall Study|Death|0
4660484|NCT03021187|16014403|P1|Overall Study|Death|0
4660485|NCT03021018|16014559|P3|Overall Study|Fall with subsequent nasal fracture|0
4660486|NCT03021018|16014560|P2|Overall Study|Fall with subsequent nasal fracture|0
4660487|NCT03021018|16014561|P1|Overall Study|Fall with subsequent nasal fracture|1
4660488|NCT03021018|16014559|P3|Overall Study|Adverse Event|0
4660489|NCT03021018|16014560|P2|Overall Study|Adverse Event|0
4660490|NCT03021018|16014561|P1|Overall Study|Adverse Event|1
4660491|NCT03021005|16014592|P2|Overall Study|Lost to Follow-up|26
4660492|NCT03021005|16014593|P1|Overall Study|Lost to Follow-up|39
4660493|NCT03020745|16014607|P10|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660494|NCT03020745|16014608|P9|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2
4660495|NCT03020745|16014609|P8|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660496|NCT03020745|16014610|P7|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660497|NCT03020745|16014611|P6|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660498|NCT03020745|16014612|P5|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660499|NCT03020745|16014613|P4|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660500|NCT03020745|16014614|P3|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660501|NCT03020745|16014615|P2|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660502|NCT03020745|16014616|P1|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0
4660503|NCT03020745|16014607|P10|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660504|NCT03020745|16014608|P9|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
4660505|NCT03020745|16014609|P8|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660506|NCT03020745|16014610|P7|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660507|NCT03020745|16014611|P6|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1
4660508|NCT03020745|16014612|P5|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660509|NCT03020745|16014613|P4|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660510|NCT03020745|16014614|P3|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660511|NCT03020745|16014615|P2|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660512|NCT03020745|16014616|P1|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0
4660513|NCT03020745|16014607|P10|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660514|NCT03020745|16014608|P9|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660515|NCT03020745|16014609|P8|Part 2 (Up to 169 Days)|Withdrawal by Subject|1
4660516|NCT03020745|16014610|P7|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660517|NCT03020745|16014611|P6|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660518|NCT03020745|16014612|P5|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660519|NCT03020745|16014613|P4|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660520|NCT03020745|16014614|P3|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660521|NCT03020745|16014615|P2|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660522|NCT03020745|16014616|P1|Part 2 (Up to 169 Days)|Withdrawal by Subject|0
4660523|NCT03020745|16014607|P10|Part 2 (Up to 169 Days)|Adverse Event|0
4660524|NCT03020745|16014608|P9|Part 2 (Up to 169 Days)|Adverse Event|1
4660525|NCT03020745|16014609|P8|Part 2 (Up to 169 Days)|Adverse Event|0
4660526|NCT03020745|16014610|P7|Part 2 (Up to 169 Days)|Adverse Event|0
4660527|NCT03020745|16014611|P6|Part 2 (Up to 169 Days)|Adverse Event|0
4660528|NCT03020745|16014612|P5|Part 2 (Up to 169 Days)|Adverse Event|0
4660529|NCT03020745|16014613|P4|Part 2 (Up to 169 Days)|Adverse Event|0
4660530|NCT03020745|16014614|P3|Part 2 (Up to 169 Days)|Adverse Event|0
4660531|NCT03020745|16014615|P2|Part 2 (Up to 169 Days)|Adverse Event|0
4660532|NCT03020745|16014616|P1|Part 2 (Up to 169 Days)|Adverse Event|0
4660533|NCT03020576|16014977|P2|Overall Study|Withdrawal by Subject|2
4660534|NCT03020576|16014978|P1|Overall Study|Withdrawal by Subject|1
4660535|NCT03020160|16015033|P2|Overall Study|Continuing to receive emicizumab|41
4660536|NCT03020160|16015034|P1|Overall Study|Continuing to receive emicizumab|7
4660537|NCT03020069|16015093|P2|Overall Study|Lost to Follow-up|1
4660538|NCT03020069|16015094|P1|Overall Study|Lost to Follow-up|0
4660539|NCT03019627|16015140|P2|Overall Study|Other|2
4660540|NCT03019627|16015141|P1|Overall Study|Other|2
4660541|NCT03019627|16015140|P2|Overall Study|not compliance|2
4660542|NCT03019627|16015141|P1|Overall Study|not compliance|2
4660543|NCT03019627|16015140|P2|Overall Study|Lost to Follow-up|1
4660544|NCT03019627|16015141|P1|Overall Study|Lost to Follow-up|2
4660545|NCT03019627|16015140|P2|Overall Study|Unrelated to adverse event|3
4660546|NCT03019627|16015141|P1|Overall Study|Unrelated to adverse event|1
4660547|NCT03019627|16015140|P2|Overall Study|Adverse Event|0
4660548|NCT03019627|16015141|P1|Overall Study|Adverse Event|8
4660549|NCT03019549|16015157|P1|Period 2|Withdrawal by Subject|1
4660550|NCT03019549|16015157|P1|Period 2|Physician Decision|2
4660551|NCT03019549|16015157|P1|Period 2|Adverse Event|2
4660552|NCT03019549|16015157|P1|Washout|DId not meet genotype criteria|11
4660553|NCT03019458|16015170|P2|Overall Study|Death|1
4660554|NCT03019458|16015171|P1|Overall Study|Death|0
4660555|NCT03018938|16015185|P2|Overall Study|Not recorded|2
4660556|NCT03018938|16015186|P1|Overall Study|Not recorded|0
4660557|NCT03018938|16015185|P2|Overall Study|Screen failure-After randomization|2
4660558|NCT03018938|16015186|P1|Overall Study|Screen failure-After randomization|4
4660559|NCT03018938|16015185|P2|Overall Study|Sponsor Decision|1
4660560|NCT03018938|16015186|P1|Overall Study|Sponsor Decision|0
4660561|NCT03018938|16015185|P2|Overall Study|Physician Decision|2
4660562|NCT03018938|16015186|P1|Overall Study|Physician Decision|3
4660563|NCT03018938|16015185|P2|Overall Study|Withdrawal by Subject|45
4660564|NCT03018938|16015186|P1|Overall Study|Withdrawal by Subject|38
4660565|NCT03018938|16015185|P2|Overall Study|Lost to Follow-up|32
4660566|NCT03018938|16015186|P1|Overall Study|Lost to Follow-up|21
4660567|NCT03018938|16015185|P2|Overall Study|Death|1
4660568|NCT03018938|16015186|P1|Overall Study|Death|0
4660569|NCT03018691|16015225|P3|Overall Study|Withdrawal by parent/guardian|1
4660570|NCT03018691|16015226|P2|Overall Study|Withdrawal by parent/guardian|0
4660571|NCT03018691|16015227|P1|Overall Study|Withdrawal by parent/guardian|1
4660572|NCT03018691|16015225|P3|Overall Study|Withdrawal by Subject|1
4660573|NCT03018691|16015226|P2|Overall Study|Withdrawal by Subject|0
4660574|NCT03018691|16015227|P1|Overall Study|Withdrawal by Subject|0
4660575|NCT03018691|16015225|P3|Overall Study|Lack of Efficacy|1
4660576|NCT03018691|16015226|P2|Overall Study|Lack of Efficacy|0
4660577|NCT03018691|16015227|P1|Overall Study|Lack of Efficacy|0
4660578|NCT03018691|16015225|P3|Overall Study|Adverse Event|4
4660579|NCT03018691|16015226|P2|Overall Study|Adverse Event|1
4660580|NCT03018691|16015227|P1|Overall Study|Adverse Event|1
4660581|NCT03018340|16015263|P2|Overall Study|Not further specified|1
4660582|NCT03018340|16015264|P1|Overall Study|Not further specified|0
4660583|NCT03018340|16015263|P2|Overall Study|Protocol Violation|7
4660584|NCT03018340|16015264|P1|Overall Study|Protocol Violation|3
4660585|NCT03018340|16015263|P2|Overall Study|Lost to Follow-up|7
4660586|NCT03018340|16015264|P1|Overall Study|Lost to Follow-up|1
4660587|NCT03018340|16015263|P2|Overall Study|Non-compliance with study drug/procedure|4
4660588|NCT03018340|16015264|P1|Overall Study|Non-compliance with study drug/procedure|3
4660589|NCT03018340|16015263|P2|Overall Study|Lack of Efficacy|1
4660590|NCT03018340|16015264|P1|Overall Study|Lack of Efficacy|0
4660591|NCT03018340|16015263|P2|Overall Study|Withdrawal by Subject|8
4660592|NCT03018340|16015264|P1|Overall Study|Withdrawal by Subject|0
4660593|NCT03018340|16015263|P2|Overall Study|Adverse Event|2
4660594|NCT03018340|16015264|P1|Overall Study|Adverse Event|1
4660595|NCT03018106|16015323|P2|Overall Study|Lost to Follow-up|1
4660596|NCT03018106|16015324|P1|Overall Study|Lost to Follow-up|0
4660597|NCT03018028|16015337|P5|Overall Study|Withdrawal by Subject|0
4660598|NCT03018028|16015338|P4|Overall Study|Withdrawal by Subject|2
4660599|NCT03018028|16015339|P3|Overall Study|Withdrawal by Subject|1
4660600|NCT03018028|16015340|P2|Overall Study|Withdrawal by Subject|0
4660601|NCT03018028|16015341|P1|Overall Study|Withdrawal by Subject|3
4660602|NCT03017846|16015586|P1|Overall Study|Adverse Event|2
4660603|NCT03017846|16015586|P1|Overall Study|Lost to Follow-up|3
4660604|NCT03017612|16015594|P1|Overall Study|Adverse Event|2
4660605|NCT03017235|16015639|P2|Overall Study|Cancer, emergency, allergy, active UTI|2
4660606|NCT03017235|16015640|P1|Overall Study|Cancer, emergency, allergy, active UTI|4
4660607|NCT03017235|16015639|P2|Overall Study|Protocol Violation|1
4660608|NCT03017235|16015640|P1|Overall Study|Protocol Violation|2
4660609|NCT03017235|16015639|P2|Overall Study|Adverse Event|1
4660610|NCT03017235|16015640|P1|Overall Study|Adverse Event|0
4660611|NCT03017235|16015639|P2|Overall Study|Lost to Follow-up|7
4660612|NCT03017235|16015640|P1|Overall Study|Lost to Follow-up|2
4660613|NCT03017235|16015639|P2|Overall Study|Withdrawal by Subject|3
4660614|NCT03017235|16015640|P1|Overall Study|Withdrawal by Subject|4
4660615|NCT03016325|16015706|P5|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4660616|NCT03016325|16015707|P4|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4660617|NCT03016325|16015708|P3|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4660618|NCT03016325|16015709|P2|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1
4660619|NCT03016325|16015710|P1|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0
4660620|NCT03016325|16015706|P5|182-Day Follow-Up Period|Vital status collected via EMR|0
4660621|NCT03016325|16015707|P4|182-Day Follow-Up Period|Vital status collected via EMR|1
4660622|NCT03016325|16015708|P3|182-Day Follow-Up Period|Vital status collected via EMR|0
4660623|NCT03016325|16015709|P2|182-Day Follow-Up Period|Vital status collected via EMR|0
4660624|NCT03016325|16015710|P1|182-Day Follow-Up Period|Vital status collected via EMR|0
4660625|NCT03016325|16015706|P5|182-Day Follow-Up Period|Alive, per civil unit|1
4660626|NCT03016325|16015707|P4|182-Day Follow-Up Period|Alive, per civil unit|0
4660627|NCT03016325|16015708|P3|182-Day Follow-Up Period|Alive, per civil unit|0
4660628|NCT03016325|16015709|P2|182-Day Follow-Up Period|Alive, per civil unit|0
4660629|NCT03016325|16015710|P1|182-Day Follow-Up Period|Alive, per civil unit|0
4660630|NCT03016325|16015706|P5|182-Day Follow-Up Period|Alive, per Family doctor|1
4660631|NCT03016325|16015707|P4|182-Day Follow-Up Period|Alive, per Family doctor|0
4660632|NCT03016325|16015708|P3|182-Day Follow-Up Period|Alive, per Family doctor|0
4660633|NCT03016325|16015709|P2|182-Day Follow-Up Period|Alive, per Family doctor|0
4660634|NCT03016325|16015710|P1|182-Day Follow-Up Period|Alive, per Family doctor|0
4660635|NCT03016325|16015706|P5|182-Day Follow-Up Period|Participant withdrew consent|1
4660636|NCT03016325|16015707|P4|182-Day Follow-Up Period|Participant withdrew consent|0
4660637|NCT03016325|16015708|P3|182-Day Follow-Up Period|Participant withdrew consent|0
4660638|NCT03016325|16015709|P2|182-Day Follow-Up Period|Participant withdrew consent|0
4660639|NCT03016325|16015710|P1|182-Day Follow-Up Period|Participant withdrew consent|0
4660640|NCT03016325|16015706|P5|182-Day Follow-Up Period|Alive, per national insurance system|0
4660641|NCT03016325|16015707|P4|182-Day Follow-Up Period|Alive, per national insurance system|0
4660642|NCT03016325|16015708|P3|182-Day Follow-Up Period|Alive, per national insurance system|0
4660643|NCT03016325|16015709|P2|182-Day Follow-Up Period|Alive, per national insurance system|0
4660644|NCT03016325|16015710|P1|182-Day Follow-Up Period|Alive, per national insurance system|1
4660645|NCT03016325|16015706|P5|182-Day Follow-Up Period|Death|9
4660646|NCT03016325|16015707|P4|182-Day Follow-Up Period|Death|12
4660647|NCT03016325|16015708|P3|182-Day Follow-Up Period|Death|11
4660648|NCT03016325|16015709|P2|182-Day Follow-Up Period|Death|3
4660649|NCT03016325|16015710|P1|182-Day Follow-Up Period|Death|3
4660650|NCT03016325|16015706|P5|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4660651|NCT03016325|16015707|P4|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4660652|NCT03016325|16015708|P3|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4660653|NCT03016325|16015709|P2|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1
4660654|NCT03016325|16015710|P1|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0
4660655|NCT03016325|16015706|P5|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4660656|NCT03016325|16015707|P4|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4660657|NCT03016325|16015708|P3|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1
4660658|NCT03016325|16015709|P2|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4660659|NCT03016325|16015710|P1|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0
4660660|NCT03016325|16015706|P5|32-Day Follow-Up Period|Participant withdrew consent|2
4660661|NCT03016325|16015707|P4|32-Day Follow-Up Period|Participant withdrew consent|0
4660662|NCT03016325|16015708|P3|32-Day Follow-Up Period|Participant withdrew consent|0
4660663|NCT03016325|16015709|P2|32-Day Follow-Up Period|Participant withdrew consent|0
4660664|NCT03016325|16015710|P1|32-Day Follow-Up Period|Participant withdrew consent|0
4660665|NCT03016325|16015706|P5|32-Day Follow-Up Period|Participant refused to visit|2
4660666|NCT03016325|16015707|P4|32-Day Follow-Up Period|Participant refused to visit|0
4660667|NCT03016325|16015708|P3|32-Day Follow-Up Period|Participant refused to visit|2
4660668|NCT03016325|16015709|P2|32-Day Follow-Up Period|Participant refused to visit|1
4660669|NCT03016325|16015710|P1|32-Day Follow-Up Period|Participant refused to visit|0
4660670|NCT03016325|16015706|P5|32-Day Follow-Up Period|Poor/non-compliance|1
4660671|NCT03016325|16015707|P4|32-Day Follow-Up Period|Poor/non-compliance|1
4660672|NCT03016325|16015708|P3|32-Day Follow-Up Period|Poor/non-compliance|0
4660673|NCT03016325|16015709|P2|32-Day Follow-Up Period|Poor/non-compliance|0
4660674|NCT03016325|16015710|P1|32-Day Follow-Up Period|Poor/non-compliance|1
4660675|NCT03016325|16015706|P5|32-Day Follow-Up Period|Lost to Follow-up|0
4660676|NCT03016325|16015707|P4|32-Day Follow-Up Period|Lost to Follow-up|1
4660677|NCT03016325|16015708|P3|32-Day Follow-Up Period|Lost to Follow-up|1
4660678|NCT03016325|16015709|P2|32-Day Follow-Up Period|Lost to Follow-up|0
4660679|NCT03016325|16015710|P1|32-Day Follow-Up Period|Lost to Follow-up|1
4660680|NCT03016325|16015706|P5|32-Day Follow-Up Period|Death|3
4660681|NCT03016325|16015707|P4|32-Day Follow-Up Period|Death|6
4660682|NCT03016325|16015708|P3|32-Day Follow-Up Period|Death|5
4660683|NCT03016325|16015709|P2|32-Day Follow-Up Period|Death|0
4660684|NCT03016325|16015710|P1|32-Day Follow-Up Period|Death|2
4660685|NCT03016325|16015706|P5|Treatment Period|Participant refuses assessments|0
4660686|NCT03016325|16015707|P4|Treatment Period|Participant refuses assessments|0
4660687|NCT03016325|16015708|P3|Treatment Period|Participant refuses assessments|1
4660688|NCT03016325|16015709|P2|Treatment Period|Participant refuses assessments|0
4660689|NCT03016325|16015710|P1|Treatment Period|Participant refuses assessments|0
4660690|NCT03016325|16015706|P5|Treatment Period|Death|2
4660691|NCT03016325|16015707|P4|Treatment Period|Death|0
4660692|NCT03016325|16015708|P3|Treatment Period|Death|0
4660693|NCT03016325|16015709|P2|Treatment Period|Death|0
4660694|NCT03016325|16015710|P1|Treatment Period|Death|0
4660695|NCT03016325|16015706|P5|Treatment Period|Participant withdrew consent|0
4660696|NCT03016325|16015707|P4|Treatment Period|Participant withdrew consent|0
4660697|NCT03016325|16015708|P3|Treatment Period|Participant withdrew consent|0
4660698|NCT03016325|16015709|P2|Treatment Period|Participant withdrew consent|1
4660699|NCT03016325|16015710|P1|Treatment Period|Participant withdrew consent|0
4660700|NCT03016078|16015852|P1|Overall Study|Protocol Violation|1
4660701|NCT03016078|16015852|P1|Overall Study|Protocol Violation|1
4660702|NCT03015220|16015871|P4|Overall Study|Lost to Follow-up|0
4660703|NCT03015220|16015872|P3|Overall Study|Lost to Follow-up|1
4660704|NCT03015220|16015873|P2|Overall Study|Lost to Follow-up|0
4660705|NCT03015220|16015874|P1|Overall Study|Lost to Follow-up|0
4660706|NCT03015220|16015871|P4|Overall Study|Withdrawal by Subject|2
4660707|NCT03015220|16015872|P3|Overall Study|Withdrawal by Subject|2
4660708|NCT03015220|16015873|P2|Overall Study|Withdrawal by Subject|2
4660709|NCT03015220|16015874|P1|Overall Study|Withdrawal by Subject|3
4660710|NCT03015181|16016019|P7|Overall Study|Physician Decision|1
4660711|NCT03015181|16016020|P6|Overall Study|Physician Decision|0
4660712|NCT03015181|16016021|P5|Overall Study|Physician Decision|0
4660713|NCT03015181|16016022|P4|Overall Study|Physician Decision|0
4660714|NCT03015181|16016023|P3|Overall Study|Physician Decision|0
4660715|NCT03015181|16016024|P2|Overall Study|Physician Decision|0
4660716|NCT03015181|16016025|P1|Overall Study|Physician Decision|0
4660717|NCT03015181|16016019|P7|Overall Study|Withdrawal by Subject|0
4660718|NCT03015181|16016020|P6|Overall Study|Withdrawal by Subject|1
4660719|NCT03015181|16016021|P5|Overall Study|Withdrawal by Subject|0
4660720|NCT03015181|16016022|P4|Overall Study|Withdrawal by Subject|0
4660721|NCT03015181|16016023|P3|Overall Study|Withdrawal by Subject|0
4660722|NCT03015181|16016024|P2|Overall Study|Withdrawal by Subject|0
4660723|NCT03015181|16016025|P1|Overall Study|Withdrawal by Subject|0
4660724|NCT03015181|16016019|P7|Overall Study|Enrolled, but product never administered|0
4660725|NCT03015181|16016020|P6|Overall Study|Enrolled, but product never administered|0
4660726|NCT03015181|16016021|P5|Overall Study|Enrolled, but product never administered|0
4660727|NCT03015181|16016022|P4|Overall Study|Enrolled, but product never administered|0
4660728|NCT03015181|16016023|P3|Overall Study|Enrolled, but product never administered|0
4660729|NCT03015181|16016024|P2|Overall Study|Enrolled, but product never administered|0
4660730|NCT03015181|16016025|P1|Overall Study|Enrolled, but product never administered|1
4660731|NCT03014674|16016171|P3|Overall Study|Withdrawal by Subject|0
4660732|NCT03014674|16016172|P2|Overall Study|Withdrawal by Subject|0
4660733|NCT03014674|16016173|P1|Overall Study|Withdrawal by Subject|1
4660734|NCT03014479|16016237|P2|Overall Study|Unacceptable Inability of Site Visit|1
4660735|NCT03014479|16016238|P1|Overall Study|Unacceptable Inability of Site Visit|0
4660736|NCT03014479|16016237|P2|Overall Study|Voluntary Withdrawal|2
4660737|NCT03014479|16016238|P1|Overall Study|Voluntary Withdrawal|0
4660738|NCT03014479|16016237|P2|Overall Study|Adverse Event|1
4660739|NCT03014479|16016238|P1|Overall Study|Adverse Event|0
4660740|NCT03014453|16016284|P1|Overall Study|Refused to take part in|37
4660741|NCT03014453|16016284|P1|Overall Study|Excluded|19
4660742|NCT03014453|16016284|P1|Overall Study|Discontinued GER|3
4660743|NCT03014453|16016284|P1|Overall Study|Lost to Follow-up|12
4660744|NCT03014206|16016288|P1|Overall Study|Registration Violation|12
4660745|NCT03014180|16016292|P1|Overall Study|Protocol Violation|2
4660746|NCT03014011|16016301|P2|Washout|Withdrawal by Subject|0
4660747|NCT03014011|16016302|P1|Washout|Withdrawal by Subject|1
4660748|NCT03014011|16016301|P2|First Intervention|Withdrawal by Subject|0
4660749|NCT03014011|16016302|P1|First Intervention|Withdrawal by Subject|1
4660750|NCT03013985|16016310|P2|Overall Study|Withdrawal by Subject|17
4660751|NCT03013985|16016311|P1|Overall Study|Withdrawal by Subject|14
4660752|NCT03013985|16016310|P2|Overall Study|Protocol Violation|2
4660753|NCT03013985|16016311|P1|Overall Study|Protocol Violation|2
4660754|NCT03012841|16016343|P2|Overall Study|Insurance change|1
4660755|NCT03012841|16016344|P1|Overall Study|Insurance change|0
4660756|NCT03012841|16016343|P2|Overall Study|Study reached n=165 treated subject cap|5
4660757|NCT03012841|16016344|P1|Overall Study|Study reached n=165 treated subject cap|0
4660758|NCT03012841|16016343|P2|Overall Study|No ablation performed|2
4660759|NCT03012841|16016344|P1|Overall Study|No ablation performed|0
4660760|NCT03012841|16016343|P2|Overall Study|Physician Decision|2
4660761|NCT03012841|16016344|P1|Overall Study|Physician Decision|0
4660762|NCT03012841|16016343|P2|Overall Study|Seasonal winter travel|0
4660763|NCT03012841|16016344|P1|Overall Study|Seasonal winter travel|1
4660764|NCT03012841|16016343|P2|Overall Study|Subject relocation|0
4660765|NCT03012841|16016344|P1|Overall Study|Subject relocation|1
4660766|NCT03012841|16016343|P2|Overall Study|Unable to complete 12 month visit|0
4660767|NCT03012841|16016344|P1|Overall Study|Unable to complete 12 month visit|6
4660768|NCT03012841|16016343|P2|Overall Study|Withdrawal by Subject|0
4660769|NCT03012841|16016344|P1|Overall Study|Withdrawal by Subject|6
4660770|NCT03012841|16016343|P2|Overall Study|Lost to Follow-up|1
4660771|NCT03012841|16016344|P1|Overall Study|Lost to Follow-up|6
4660772|NCT03012841|16016343|P2|Overall Study|Protocol Violation|10
4660773|NCT03012841|16016344|P1|Overall Study|Protocol Violation|0
4660774|NCT03012828|16016358|P6|Overall Study|Delay to last visit would delay DBL|1
4660775|NCT03012828|16016359|P5|Overall Study|Delay to last visit would delay DBL|0
4660776|NCT03012828|16016360|P4|Overall Study|Delay to last visit would delay DBL|0
4660777|NCT03012828|16016361|P3|Overall Study|Delay to last visit would delay DBL|0
4660778|NCT03012828|16016362|P2|Overall Study|Delay to last visit would delay DBL|0
4660779|NCT03012828|16016363|P1|Overall Study|Delay to last visit would delay DBL|0
4660780|NCT03012828|16016358|P6|Overall Study|Non-compliance with protocol|0
4660781|NCT03012828|16016359|P5|Overall Study|Non-compliance with protocol|1
4660782|NCT03012828|16016360|P4|Overall Study|Non-compliance with protocol|0
4660783|NCT03012828|16016361|P3|Overall Study|Non-compliance with protocol|0
4660784|NCT03012828|16016362|P2|Overall Study|Non-compliance with protocol|0
4660785|NCT03012828|16016363|P1|Overall Study|Non-compliance with protocol|0
4660786|NCT03012828|16016358|P6|Overall Study|Withdrawal by Subject|1
4660787|NCT03012828|16016359|P5|Overall Study|Withdrawal by Subject|0
4660788|NCT03012828|16016360|P4|Overall Study|Withdrawal by Subject|0
4660789|NCT03012828|16016361|P3|Overall Study|Withdrawal by Subject|1
4660790|NCT03012828|16016362|P2|Overall Study|Withdrawal by Subject|0
4660791|NCT03012828|16016363|P1|Overall Study|Withdrawal by Subject|0
4660792|NCT03012828|16016358|P6|Overall Study|Lost to Follow-up|0
4660793|NCT03012828|16016359|P5|Overall Study|Lost to Follow-up|1
4660794|NCT03012828|16016360|P4|Overall Study|Lost to Follow-up|0
4660795|NCT03012828|16016361|P3|Overall Study|Lost to Follow-up|1
4660796|NCT03012828|16016362|P2|Overall Study|Lost to Follow-up|0
4660797|NCT03012828|16016363|P1|Overall Study|Lost to Follow-up|1
4660798|NCT03012334|16016406|P10|Period 4|Adverse Event|0
4660799|NCT03012334|16016407|P9|Period 4|Adverse Event|1
4660800|NCT03012334|16016408|P8|Period 4|Adverse Event|0
4660801|NCT03012334|16016409|P7|Period 4|Adverse Event|0
4660802|NCT03012334|16016410|P6|Period 4|Adverse Event|0
4660803|NCT03012334|16016411|P5|Period 4|Adverse Event|0
4660804|NCT03012334|16016412|P4|Period 4|Adverse Event|0
4660805|NCT03012334|16016413|P3|Period 4|Adverse Event|0
4660806|NCT03012334|16016414|P2|Period 4|Adverse Event|0
4660807|NCT03012334|16016415|P1|Period 4|Adverse Event|0
4660808|NCT03012334|16016406|P10|Period 4|Non-Compliance|0
4660809|NCT03012334|16016407|P9|Period 4|Non-Compliance|0
4660810|NCT03012334|16016408|P8|Period 4|Non-Compliance|0
4660811|NCT03012334|16016409|P7|Period 4|Non-Compliance|1
4660812|NCT03012334|16016410|P6|Period 4|Non-Compliance|0
4660813|NCT03012334|16016411|P5|Period 4|Non-Compliance|0
4660814|NCT03012334|16016412|P4|Period 4|Non-Compliance|0
4660815|NCT03012334|16016413|P3|Period 4|Non-Compliance|0
4660816|NCT03012334|16016414|P2|Period 4|Non-Compliance|0
4660817|NCT03012334|16016415|P1|Period 4|Non-Compliance|0
4660818|NCT03012334|16016406|P10|Period 2|Protocol Violation|0
4660819|NCT03012334|16016407|P9|Period 2|Protocol Violation|0
4660820|NCT03012334|16016408|P8|Period 2|Protocol Violation|1
4660821|NCT03012334|16016409|P7|Period 2|Protocol Violation|0
4660822|NCT03012334|16016410|P6|Period 2|Protocol Violation|0
4660823|NCT03012334|16016411|P5|Period 2|Protocol Violation|0
4660824|NCT03012334|16016412|P4|Period 2|Protocol Violation|0
4660825|NCT03012334|16016413|P3|Period 2|Protocol Violation|1
4660826|NCT03012334|16016414|P2|Period 2|Protocol Violation|0
4660827|NCT03012334|16016415|P1|Period 2|Protocol Violation|0
4660828|NCT03012334|16016406|P10|Period 2|Withdrawal by Subject|0
4660829|NCT03012334|16016407|P9|Period 2|Withdrawal by Subject|0
4660830|NCT03012334|16016408|P8|Period 2|Withdrawal by Subject|0
4660831|NCT03012334|16016409|P7|Period 2|Withdrawal by Subject|0
4660832|NCT03012334|16016410|P6|Period 2|Withdrawal by Subject|0
4660833|NCT03012334|16016411|P5|Period 2|Withdrawal by Subject|0
4660834|NCT03012334|16016412|P4|Period 2|Withdrawal by Subject|0
4660835|NCT03012334|16016413|P3|Period 2|Withdrawal by Subject|0
4660836|NCT03012334|16016414|P2|Period 2|Withdrawal by Subject|1
4660837|NCT03012334|16016415|P1|Period 2|Withdrawal by Subject|0
4660838|NCT03012334|16016406|P10|Period 1|Withdrawal by Subject|1
4660839|NCT03012334|16016407|P9|Period 1|Withdrawal by Subject|0
4660840|NCT03012334|16016408|P8|Period 1|Withdrawal by Subject|0
4660841|NCT03012334|16016409|P7|Period 1|Withdrawal by Subject|0
4660842|NCT03012334|16016410|P6|Period 1|Withdrawal by Subject|0
4660843|NCT03012334|16016411|P5|Period 1|Withdrawal by Subject|0
4660844|NCT03012334|16016412|P4|Period 1|Withdrawal by Subject|0
4660845|NCT03012334|16016413|P3|Period 1|Withdrawal by Subject|0
4660846|NCT03012334|16016414|P2|Period 1|Withdrawal by Subject|0
4660847|NCT03012334|16016415|P1|Period 1|Withdrawal by Subject|0
4660848|NCT03012061|16016485|P3|Overall Study|Adverse Event|0
4660849|NCT03012061|16016486|P2|Overall Study|Adverse Event|0
4660850|NCT03012061|16016487|P1|Overall Study|Adverse Event|2
4660851|NCT03012061|16016485|P3|Overall Study|Lack of Efficacy|0
4660852|NCT03012061|16016486|P2|Overall Study|Lack of Efficacy|1
4660853|NCT03012061|16016487|P1|Overall Study|Lack of Efficacy|0
4660854|NCT03012061|16016485|P3|Overall Study|Protocol Violation|2
4660855|NCT03012061|16016486|P2|Overall Study|Protocol Violation|0
4660856|NCT03012061|16016487|P1|Overall Study|Protocol Violation|0
4660857|NCT03012061|16016485|P3|Overall Study|Met Protocol Withdrawal Criterion|1
4660858|NCT03012061|16016486|P2|Overall Study|Met Protocol Withdrawal Criterion|0
4660859|NCT03012061|16016487|P1|Overall Study|Met Protocol Withdrawal Criterion|0
4660860|NCT03012061|16016485|P3|Overall Study|Study closed/ Terminated|1
4660861|NCT03012061|16016486|P2|Overall Study|Study closed/ Terminated|0
4660862|NCT03012061|16016487|P1|Overall Study|Study closed/ Terminated|0
4660863|NCT03012061|16016485|P3|Overall Study|Lost to Follow-up|0
4660864|NCT03012061|16016486|P2|Overall Study|Lost to Follow-up|1
4660865|NCT03012061|16016487|P1|Overall Study|Lost to Follow-up|2
4660866|NCT03012061|16016485|P3|Overall Study|Investigator Site Closed|0
4660867|NCT03012061|16016486|P2|Overall Study|Investigator Site Closed|2
4660868|NCT03012061|16016487|P1|Overall Study|Investigator Site Closed|1
4660869|NCT03012061|16016485|P3|Overall Study|Withdrawal by Subject|4
4660870|NCT03012061|16016486|P2|Overall Study|Withdrawal by Subject|5
4660871|NCT03012061|16016487|P1|Overall Study|Withdrawal by Subject|1
4660872|NCT03011840|16016512|P2|Overall Study|Not received PIL in post PIL phase|21
4660873|NCT03011840|16016513|P1|Overall Study|Not received PIL in post PIL phase|0
4660874|NCT03011099|16016523|P2|Overall Study|Withdrawal by Subject|2
4660875|NCT03011099|16016524|P1|Overall Study|Withdrawal by Subject|0
4660876|NCT03011034|16016550|P2|Overall Study|Adverse Event|0
4660877|NCT03011034|16016551|P1|Overall Study|Adverse Event|1
4660878|NCT03010501|16016613|P6|Study Week 3|Withdrawal by Subject|0
4660879|NCT03010501|16016614|P5|Study Week 3|Withdrawal by Subject|0
4660880|NCT03010501|16016615|P4|Study Week 3|Withdrawal by Subject|1
4660881|NCT03010501|16016616|P3|Study Week 3|Withdrawal by Subject|0
4660882|NCT03010501|16016617|P2|Study Week 3|Withdrawal by Subject|0
4660883|NCT03010501|16016618|P1|Study Week 3|Withdrawal by Subject|0
4660884|NCT03010501|16016613|P6|Study Week 1|Withdrawal by Subject|0
4660885|NCT03010501|16016614|P5|Study Week 1|Withdrawal by Subject|0
4660886|NCT03010501|16016615|P4|Study Week 1|Withdrawal by Subject|2
4660887|NCT03010501|16016616|P3|Study Week 1|Withdrawal by Subject|0
4660888|NCT03010501|16016617|P2|Study Week 1|Withdrawal by Subject|1
4660889|NCT03010501|16016618|P1|Study Week 1|Withdrawal by Subject|2
4660890|NCT03010423|16016632|P1|Overall Study|Study termination|8
4660891|NCT03010254|16016645|P2|Overall Study|Other|3
4660892|NCT03010254|16016646|P1|Overall Study|Other|2
4660893|NCT03010254|16016645|P2|Overall Study|Withdrawal by Subject|1
4660894|NCT03010254|16016646|P1|Overall Study|Withdrawal by Subject|1
4660895|NCT03010254|16016645|P2|Overall Study|Lost to Follow-up|0
4660896|NCT03010254|16016646|P1|Overall Study|Lost to Follow-up|4
4660897|NCT03010254|16016645|P2|Overall Study|Adverse Event|1
4660898|NCT03010254|16016646|P1|Overall Study|Adverse Event|0
4660899|NCT03007966|16016788|P2|Overall Study|Did not meeting inclusion/exclusion|0
4660900|NCT03007966|16016789|P1|Overall Study|Did not meeting inclusion/exclusion|1
4660901|NCT03006562|16016852|P2|Overall Study|Lost to Follow-up|1
4660902|NCT03006562|16016853|P1|Overall Study|Lost to Follow-up|0
4660903|NCT03006458|16016944|P2|First Intervention|Unsatisfied Vision|3
4660904|NCT03006458|16016945|P1|First Intervention|Unsatisfied Vision|0
4660905|NCT03006341|16016987|P4|Overall Study|Not linked in the EMR|10685
4660906|NCT03006341|16016988|P3|Overall Study|Not linked in the EMR|30993
4660907|NCT03006341|16016989|P2|Overall Study|Not linked in the EMR|67505
4660908|NCT03006341|16016990|P1|Overall Study|Not linked in the EMR|25069
4660909|NCT03005288|16017034|P2|Overall Study|Physician Decision|1
4660910|NCT03005288|16017035|P1|Overall Study|Physician Decision|0
4660911|NCT03005288|16017034|P2|Overall Study|Protocol deviation|1
4660912|NCT03005288|16017035|P1|Overall Study|Protocol deviation|0
4660913|NCT03005288|16017034|P2|Overall Study|Adverse Event|0
4660914|NCT03005288|16017035|P1|Overall Study|Adverse Event|5
4660915|NCT03005288|16017034|P2|Overall Study|Lost to Follow-up|1
4660916|NCT03005288|16017035|P1|Overall Study|Lost to Follow-up|0
4660917|NCT03005288|16017034|P2|Overall Study|Withdrawal by Subject|5
4660918|NCT03005288|16017035|P1|Overall Study|Withdrawal by Subject|7
4660919|NCT03005067|16017067|P2|Overall Study|Protocol Violation|1
4660920|NCT03005067|16017068|P1|Overall Study|Protocol Violation|0
4660921|NCT03005067|16017067|P2|Overall Study|Other (reason not specified)|1
4660922|NCT03005067|16017068|P1|Overall Study|Other (reason not specified)|3
4660923|NCT03005067|16017067|P2|Overall Study|Adverse Event|3
4660924|NCT03005067|16017068|P1|Overall Study|Adverse Event|4
4660925|NCT03005067|16017067|P2|Overall Study|Withdrawal by Subject|2
4660926|NCT03005067|16017068|P1|Overall Study|Withdrawal by Subject|3
4660927|NCT03004924|16017096|P3|Overall Study|HSV1 Positive|0
4660928|NCT03004924|16017097|P2|Overall Study|HSV1 Positive|0
4660929|NCT03004924|16017098|P1|Overall Study|HSV1 Positive|1
4660930|NCT03004924|16017096|P3|Overall Study|Missed Study Visit|2
4660931|NCT03004924|16017097|P2|Overall Study|Missed Study Visit|0
4660932|NCT03004924|16017098|P1|Overall Study|Missed Study Visit|0
4660933|NCT03004924|16017096|P3|Overall Study|Terminated by Sponsor|1
4660934|NCT03004924|16017097|P2|Overall Study|Terminated by Sponsor|0
4660935|NCT03004924|16017098|P1|Overall Study|Terminated by Sponsor|0
4660936|NCT03004924|16017096|P3|Overall Study|Pregnancy|0
4660937|NCT03004924|16017097|P2|Overall Study|Pregnancy|1
4660938|NCT03004924|16017098|P1|Overall Study|Pregnancy|0
4660939|NCT03004924|16017096|P3|Overall Study|Screen Failure|0
4660940|NCT03004924|16017097|P2|Overall Study|Screen Failure|0
4660941|NCT03004924|16017098|P1|Overall Study|Screen Failure|1
4660942|NCT03004924|16017096|P3|Overall Study|Withdrawal by parent/guardian|2
4660943|NCT03004924|16017097|P2|Overall Study|Withdrawal by parent/guardian|0
4660944|NCT03004924|16017098|P1|Overall Study|Withdrawal by parent/guardian|1
4660945|NCT03004924|16017096|P3|Overall Study|Physician Decision|1
4660946|NCT03004924|16017097|P2|Overall Study|Physician Decision|0
4660947|NCT03004924|16017098|P1|Overall Study|Physician Decision|1
4660948|NCT03004924|16017096|P3|Overall Study|Lack of Efficacy|2
4660949|NCT03004924|16017097|P2|Overall Study|Lack of Efficacy|4
4660950|NCT03004924|16017098|P1|Overall Study|Lack of Efficacy|2
4660951|NCT03004924|16017096|P3|Overall Study|Lost to Follow-up|4
4660952|NCT03004924|16017097|P2|Overall Study|Lost to Follow-up|1
4660953|NCT03004924|16017098|P1|Overall Study|Lost to Follow-up|6
4660954|NCT03004924|16017096|P3|Overall Study|Withdrawal by Subject|5
4660955|NCT03004924|16017097|P2|Overall Study|Withdrawal by Subject|3
4660956|NCT03004924|16017098|P1|Overall Study|Withdrawal by Subject|5
4660957|NCT03004924|16017096|P3|Overall Study|Protocol Violation|1
4660958|NCT03004924|16017097|P2|Overall Study|Protocol Violation|0
4660959|NCT03004924|16017098|P1|Overall Study|Protocol Violation|4
4660960|NCT03004924|16017096|P3|Overall Study|Adverse Event|10
4660961|NCT03004924|16017097|P2|Overall Study|Adverse Event|5
4660962|NCT03004924|16017098|P1|Overall Study|Adverse Event|6
4660963|NCT03004469|16017342|P3|Overall Study|Other unspecified reason|1
4660964|NCT03004469|16017343|P2|Overall Study|Other unspecified reason|4
4660965|NCT03004469|16017344|P1|Overall Study|Other unspecified reason|0
4660966|NCT03004469|16017342|P3|Overall Study|Withdrawal by Subject|10
4660967|NCT03004469|16017343|P2|Overall Study|Withdrawal by Subject|27
4660968|NCT03004469|16017344|P1|Overall Study|Withdrawal by Subject|29
4660969|NCT03004469|16017342|P3|Overall Study|Protocol Violation|1
4660970|NCT03004469|16017343|P2|Overall Study|Protocol Violation|0
4660971|NCT03004469|16017344|P1|Overall Study|Protocol Violation|0
4660972|NCT03004469|16017342|P3|Overall Study|Non-Compliance with Study Drug|0
4660973|NCT03004469|16017343|P2|Overall Study|Non-Compliance with Study Drug|0
4660974|NCT03004469|16017344|P1|Overall Study|Non-Compliance with Study Drug|2
4660975|NCT03004469|16017342|P3|Overall Study|Lost to Follow-up|6
4660976|NCT03004469|16017343|P2|Overall Study|Lost to Follow-up|14
4660977|NCT03004469|16017344|P1|Overall Study|Lost to Follow-up|23
4660978|NCT03004469|16017342|P3|Overall Study|Lack of Efficacy|1
4660979|NCT03004469|16017343|P2|Overall Study|Lack of Efficacy|0
4660980|NCT03004469|16017344|P1|Overall Study|Lack of Efficacy|1
4660981|NCT03004469|16017342|P3|Overall Study|Adverse Event|6
4660982|NCT03004469|16017343|P2|Overall Study|Adverse Event|4
4660983|NCT03004469|16017344|P1|Overall Study|Adverse Event|6
4660984|NCT03003520|16017387|P2|Follow-up|Withdrawal by Subject|0
4660985|NCT03003520|16017388|P1|Follow-up|Withdrawal by Subject|1
4660986|NCT03003520|16017387|P2|Follow-up|Ongoing|2
4660987|NCT03003520|16017388|P1|Follow-up|Ongoing|12
4660988|NCT03003520|16017387|P2|Follow-up|Death|1
4660989|NCT03003520|16017388|P1|Follow-up|Death|1
4660990|NCT03003520|16017387|P2|Consolidation|Withdrawal by Subject|0
4660991|NCT03003520|16017388|P1|Consolidation|Withdrawal by Subject|1
4660992|NCT03003520|16017387|P2|Consolidation|Progressive disease|1
4660993|NCT03003520|16017388|P1|Consolidation|Progressive disease|3
4660994|NCT03003520|16017387|P2|Consolidation|Adverse Event|0
4660995|NCT03003520|16017388|P1|Consolidation|Adverse Event|2
4660996|NCT03003520|16017387|P2|Consolidation|Ongoing|0
4660997|NCT03003520|16017388|P1|Consolidation|Ongoing|18
4660998|NCT03003520|16017387|P2|Induction|Progressive disease|0
4660999|NCT03003520|16017388|P1|Induction|Progressive disease|1
4661000|NCT03003520|16017387|P2|Induction|Withdrawal by Subject|0
4661001|NCT03003520|16017388|P1|Induction|Withdrawal by Subject|3
4661002|NCT03003520|16017387|P2|Induction|Physician Decision|0
4661003|NCT03003520|16017388|P1|Induction|Physician Decision|2
4661004|NCT03003520|16017387|P2|Induction|Palliative care|0
4661005|NCT03003520|16017388|P1|Induction|Palliative care|1
4661006|NCT03003520|16017387|P2|Induction|Death|0
4661007|NCT03003520|16017388|P1|Induction|Death|1
4661008|NCT03003520|16017387|P2|Induction|Adverse Event|0
4661009|NCT03003520|16017388|P1|Induction|Adverse Event|4
4661010|NCT03003520|16017387|P2|Induction|Ongoing|0
4661011|NCT03003520|16017388|P1|Induction|Ongoing|1
4661012|NCT03003494|16017406|P1|Overall Study|Evaluable PF10 questionnaire at visit1|28
4661013|NCT03003390|16017417|P2|Overall Study|Parent refused intervention|0
4661014|NCT03003390|16017418|P1|Overall Study|Parent refused intervention|2
4661015|NCT03003390|16017417|P2|Overall Study|Physician Decision|0
4661016|NCT03003390|16017418|P1|Overall Study|Physician Decision|2
4661017|NCT03003000|16017446|P3|Overall Study|Other than listed|1
4661018|NCT03003000|16017447|P2|Overall Study|Other than listed|1
4661019|NCT03003000|16017448|P1|Overall Study|Other than listed|1
4661020|NCT03003000|16017446|P3|Overall Study|Refused to continue medication|0
4661021|NCT03003000|16017447|P2|Overall Study|Refused to continue medication|0
4661022|NCT03003000|16017448|P1|Overall Study|Refused to continue medication|2
4661023|NCT03003000|16017446|P3|Overall Study|Non-compliant with protocol|1
4661024|NCT03003000|16017447|P2|Overall Study|Non-compliant with protocol|1
4661025|NCT03003000|16017448|P1|Overall Study|Non-compliant with protocol|0
4661026|NCT03003000|16017446|P3|Overall Study|Lack of Efficacy|0
4661027|NCT03003000|16017447|P2|Overall Study|Lack of Efficacy|0
4661028|NCT03003000|16017448|P1|Overall Study|Lack of Efficacy|1
4661029|NCT03003000|16017446|P3|Overall Study|Adverse Event|3
4661030|NCT03003000|16017447|P2|Overall Study|Adverse Event|2
4661031|NCT03003000|16017448|P1|Overall Study|Adverse Event|1
4661032|NCT03002818|16017550|P1|Overall Study|Decision of the investigator|1
4661033|NCT03002623|16017576|P2|Overall Study|Physician Decision|1
4661034|NCT03002623|16017577|P1|Overall Study|Physician Decision|1
4661035|NCT03002623|16017576|P2|Overall Study|Lost to Follow-up|0
4661036|NCT03002623|16017577|P1|Overall Study|Lost to Follow-up|1
4661037|NCT03002610|16017594|P3|Overall Study|Withdrawal by Subject|13
4661038|NCT03002610|16017595|P2|Overall Study|Withdrawal by Subject|25
4661039|NCT03002610|16017596|P1|Overall Study|Withdrawal by Subject|6
4661040|NCT03002194|16017618|P1|Overall Study|Withdrawal by Subject|2
4661041|NCT03002194|16017618|P1|Overall Study|Lack of Efficacy|1
4661042|NCT03002194|16017618|P1|Overall Study|Adverse Event|1
4661043|NCT03002194|16017618|P1|Overall Study|Lost to Follow-up|6
4661044|NCT03002077|16017624|P1|Overall Study|Protocol Violation|21
4661045|NCT03002077|16017624|P1|Overall Study|Pregnancy|4
4661046|NCT03002077|16017624|P1|Overall Study|Lost to Follow-up|21
4661047|NCT03002077|16017624|P1|Overall Study|Withdrawal by Subject|72
4661048|NCT03002077|16017624|P1|Overall Study|Lack of Efficacy|20
4661049|NCT03002077|16017624|P1|Overall Study|Adverse Event|23
4661050|NCT03002077|16017624|P1|Overall Study|Miscellaneous Reasons|10
4661051|NCT03002077|16017624|P1|Overall Study|Site Terminated by Sponsor|5
4661052|NCT03002077|16017624|P1|Overall Study|Study Terminated by Sponsor|257
4661053|NCT03002077|16017624|P1|Overall Study|Non-compliance w/Background ADT|1
4661054|NCT03002077|16017624|P1|Overall Study|Non-compliance with Study Drug|4
4661055|NCT03002038|16017632|P2|Overall Study|Immigration to another region|2
4661056|NCT03002038|16017633|P1|Overall Study|Immigration to another region|0
4661057|NCT03002038|16017632|P2|Overall Study|Withdrawal by Subject|4
4661058|NCT03002038|16017633|P1|Overall Study|Withdrawal by Subject|8
4661059|NCT03002038|16017632|P2|Overall Study|Adverse Event|1
4661060|NCT03002038|16017633|P1|Overall Study|Adverse Event|3
4661061|NCT03001557|16017689|P5|Overall Study|Randomized but not treated|0
4661062|NCT03001557|16017690|P4|Overall Study|Randomized but not treated|0
4661063|NCT03001557|16017691|P3|Overall Study|Randomized but not treated|1
4661064|NCT03001557|16017692|P2|Overall Study|Randomized but not treated|0
4661065|NCT03001557|16017693|P1|Overall Study|Randomized but not treated|0
4661066|NCT03001219|16017992|P2|Extension Period Analysis|Withdrawal by Subject|5
4661067|NCT03001219|16017993|P1|Extension Period Analysis|Withdrawal by Subject|4
4661068|NCT03001219|16017992|P2|Extension Period Analysis|Protocol Deviation|1
4661069|NCT03001219|16017993|P1|Extension Period Analysis|Protocol Deviation|0
4661070|NCT03001219|16017992|P2|Extension Period Analysis|Adverse Event|1
4661071|NCT03001219|16017993|P1|Extension Period Analysis|Adverse Event|1
4661072|NCT03001219|16017992|P2|Extension Period Analysis|Physician Decision|1
4661073|NCT03001219|16017993|P1|Extension Period Analysis|Physician Decision|0
4661074|NCT03001219|16017992|P2|Extension Period Analysis|Participant Non-Compliance|1
4661075|NCT03001219|16017993|P1|Extension Period Analysis|Participant Non-Compliance|0
4661076|NCT03001219|16017992|P2|Extension Period Analysis|Study Termination by Sponsor|36
4661077|NCT03001219|16017993|P1|Extension Period Analysis|Study Termination by Sponsor|0
4661078|NCT03001219|16017992|P2|Proof of Concept|Physician Decision|0
4661079|NCT03001219|16017993|P1|Proof of Concept|Physician Decision|1
4661080|NCT03001219|16017992|P2|Proof of Concept|Adverse Event|1
4661081|NCT03001219|16017993|P1|Proof of Concept|Adverse Event|1
4661082|NCT03001219|16017992|P2|Proof of Concept|Protocol Deviation|1
4661083|NCT03001219|16017993|P1|Proof of Concept|Protocol Deviation|0
4661084|NCT03001219|16017992|P2|Proof of Concept|Withdrawal by Subject|4
4661085|NCT03001219|16017993|P1|Proof of Concept|Withdrawal by Subject|0
4661086|NCT03001219|16017992|P2|Proof of Concept|Study Termination by Sponsor|1
4661087|NCT03001219|16017993|P1|Proof of Concept|Study Termination by Sponsor|0
4661088|NCT03001076|16018054|P2|Overall Study|Lost to Follow-up|2
4661089|NCT03001076|16018055|P1|Overall Study|Lost to Follow-up|0
4661090|NCT03001076|16018054|P2|Overall Study|Sponsor decision|0
4661091|NCT03001076|16018055|P1|Overall Study|Sponsor decision|1
4661092|NCT03001076|16018054|P2|Overall Study|Adverse Event|3
4661093|NCT03001076|16018055|P1|Overall Study|Adverse Event|3
4661094|NCT03001076|16018054|P2|Overall Study|Other|0
4661095|NCT03001076|16018055|P1|Overall Study|Other|1
4661096|NCT03001076|16018054|P2|Overall Study|Withdrawal by patient|0
4661097|NCT03001076|16018055|P1|Overall Study|Withdrawal by patient|2
4661098|NCT03001011|16018089|P2|Overall Study|Other than specified above|8
4661099|NCT03001011|16018090|P1|Overall Study|Other than specified above|3
4661100|NCT03001011|16018089|P2|Overall Study|Chronic kidney disease lead to dialysis|10
4661101|NCT03001011|16018090|P1|Overall Study|Chronic kidney disease lead to dialysis|15
4661102|NCT03001011|16018089|P2|Overall Study|Adverse Event|3
4661103|NCT03001011|16018090|P1|Overall Study|Adverse Event|9
4661104|NCT03000686|16018124|P4|Part 1, Period 1 (1 Day)|Adverse Event|0
4661105|NCT03000686|16018125|P3|Part 1, Period 1 (1 Day)|Adverse Event|0
4661106|NCT03000686|16018126|P2|Part 1, Period 1 (1 Day)|Adverse Event|1
4661107|NCT03000686|16018127|P1|Part 1, Period 1 (1 Day)|Adverse Event|0
4661108|NCT03000452|16018204|P1|Follow-Up Period|Withdrawal by Subject|3
4661109|NCT03000452|16018204|P1|Follow-Up Period|Death|3
4661110|NCT03000452|16018204|P1|Follow-Up Period|Study Terminated by Sponsor|1
4661111|NCT03000452|16018204|P1|Treatment Period|Miscellaneous|2
4661112|NCT03000452|16018204|P1|Treatment Period|Physician Decision|1
4661113|NCT03000452|16018204|P1|Treatment Period|Progressive Disease (PD)|14
4661114|NCT03000452|16018204|P1|Treatment Period|Death|1
4661115|NCT03000075|16018261|P7|Part B|Adverse Event|0
4661116|NCT03000075|16018262|P6|Part B|Adverse Event|0
4661117|NCT03000075|16018263|P5|Part B|Adverse Event|1
4661118|NCT03000075|16018264|P4|Part B|Adverse Event|0
4661119|NCT03000075|16018265|P3|Part B|Adverse Event|0
4661120|NCT03000075|16018266|P2|Part B|Adverse Event|0
4661121|NCT03000075|16018267|P1|Part B|Adverse Event|0
4661122|NCT03000075|16018261|P7|Part B|Not dosed due to AE|1
4661123|NCT03000075|16018262|P6|Part B|Not dosed due to AE|2
4661124|NCT03000075|16018263|P5|Part B|Not dosed due to AE|0
4661125|NCT03000075|16018264|P4|Part B|Not dosed due to AE|0
4661126|NCT03000075|16018265|P3|Part B|Not dosed due to AE|0
4661127|NCT03000075|16018266|P2|Part B|Not dosed due to AE|0
4661128|NCT03000075|16018267|P1|Part B|Not dosed due to AE|0
4661129|NCT03000075|16018261|P7|Part A|Adverse Event|0
4661130|NCT03000075|16018262|P6|Part A|Adverse Event|0
4661131|NCT03000075|16018263|P5|Part A|Adverse Event|0
4661132|NCT03000075|16018264|P4|Part A|Adverse Event|0
4661133|NCT03000075|16018265|P3|Part A|Adverse Event|0
4661134|NCT03000075|16018266|P2|Part A|Adverse Event|0
4661135|NCT03000075|16018267|P1|Part A|Adverse Event|4
4661136|NCT02999672|16018320|P2|Overall Study|Adverse Event|0
4661137|NCT02999672|16018321|P1|Overall Study|Adverse Event|4
4661138|NCT02999672|16018320|P2|Overall Study|Progressive Disease|5
4661139|NCT02999672|16018321|P1|Overall Study|Progressive Disease|9
4661140|NCT02999672|16018320|P2|Overall Study|Study Terminated by Sponsor|1
4661141|NCT02999672|16018321|P1|Overall Study|Study Terminated by Sponsor|0
4661142|NCT02999672|16018320|P2|Overall Study|Death|1
4661143|NCT02999672|16018321|P1|Overall Study|Death|0
4661144|NCT02999633|16018337|P1|Overall Study|Progressive disease|12
4661145|NCT02999633|16018337|P1|Overall Study|Adverse Event|2
4661146|NCT02999178|16018347|P2|Overall Study|Other reason not defined above|13
4661147|NCT02999178|16018348|P1|Overall Study|Other reason not defined above|7
4661148|NCT02999178|16018347|P2|Overall Study|Withdrawal by Subject|21
4661149|NCT02999178|16018348|P1|Overall Study|Withdrawal by Subject|21
4661150|NCT02999178|16018347|P2|Overall Study|Lost to Follow-up|2
4661151|NCT02999178|16018348|P1|Overall Study|Lost to Follow-up|0
4661152|NCT02999178|16018347|P2|Overall Study|Protocol Violation|2
4661153|NCT02999178|16018348|P1|Overall Study|Protocol Violation|1
4661154|NCT02999178|16018347|P2|Overall Study|Adverse Event|62
4661155|NCT02999178|16018348|P1|Overall Study|Adverse Event|85
4661156|NCT02999100|16018398|P6|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4661157|NCT02999100|16018399|P5|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4661158|NCT02999100|16018400|P4|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4661159|NCT02999100|16018401|P3|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1
4661160|NCT02999100|16018402|P2|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4661161|NCT02999100|16018403|P1|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0
4661162|NCT02999100|16018398|P6|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1
4661163|NCT02999100|16018399|P5|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4661164|NCT02999100|16018400|P4|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4661165|NCT02999100|16018401|P3|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4661166|NCT02999100|16018402|P2|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4661167|NCT02999100|16018403|P1|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0
4661168|NCT02999100|16018398|P6|Part 1 (up to 15 Days)|Adverse Event|0
4661169|NCT02999100|16018399|P5|Part 1 (up to 15 Days)|Adverse Event|0
4661170|NCT02999100|16018400|P4|Part 1 (up to 15 Days)|Adverse Event|0
4661171|NCT02999100|16018401|P3|Part 1 (up to 15 Days)|Adverse Event|0
4661172|NCT02999100|16018402|P2|Part 1 (up to 15 Days)|Adverse Event|1
4661173|NCT02999100|16018403|P1|Part 1 (up to 15 Days)|Adverse Event|0
4661174|NCT02998996|16018571|P6|Overall Study|Family reasons|0
4661175|NCT02998996|16018572|P5|Overall Study|Family reasons|1
4661176|NCT02998996|16018573|P4|Overall Study|Family reasons|0
4661177|NCT02998996|16018574|P3|Overall Study|Family reasons|0
4661178|NCT02998996|16018575|P2|Overall Study|Family reasons|0
4661179|NCT02998996|16018576|P1|Overall Study|Family reasons|0
4661180|NCT02998996|16018571|P6|Overall Study|Pregnancy|0
4661181|NCT02998996|16018572|P5|Overall Study|Pregnancy|0
4661182|NCT02998996|16018573|P4|Overall Study|Pregnancy|0
4661183|NCT02998996|16018574|P3|Overall Study|Pregnancy|0
4661184|NCT02998996|16018575|P2|Overall Study|Pregnancy|1
4661185|NCT02998996|16018576|P1|Overall Study|Pregnancy|0
4661186|NCT02998996|16018571|P6|Overall Study|Lost to Follow-up|0
4661187|NCT02998996|16018572|P5|Overall Study|Lost to Follow-up|0
4661188|NCT02998996|16018573|P4|Overall Study|Lost to Follow-up|0
4661189|NCT02998996|16018574|P3|Overall Study|Lost to Follow-up|1
4661190|NCT02998996|16018575|P2|Overall Study|Lost to Follow-up|0
4661191|NCT02998996|16018576|P1|Overall Study|Lost to Follow-up|0
4661192|NCT02998671|16018610|P5|Period 2|Lost to Follow-up|0
4661193|NCT02998671|16018611|P4|Period 2|Lost to Follow-up|1
4661194|NCT02998671|16018612|P3|Period 2|Lost to Follow-up|0
4661195|NCT02998671|16018613|P2|Period 2|Lost to Follow-up|0
4661196|NCT02998671|16018614|P1|Period 2|Lost to Follow-up|0
4661197|NCT02998671|16018610|P5|Period 2|Withdrawal by Subject|0
4661198|NCT02998671|16018611|P4|Period 2|Withdrawal by Subject|0
4661199|NCT02998671|16018612|P3|Period 2|Withdrawal by Subject|0
4661200|NCT02998671|16018613|P2|Period 2|Withdrawal by Subject|1
4661201|NCT02998671|16018614|P1|Period 2|Withdrawal by Subject|0
4661202|NCT02998671|16018610|P5|Period 2|Study Terminated By Sponsor|0
4661203|NCT02998671|16018611|P4|Period 2|Study Terminated By Sponsor|3
4661204|NCT02998671|16018612|P3|Period 2|Study Terminated By Sponsor|1
4661205|NCT02998671|16018613|P2|Period 2|Study Terminated By Sponsor|5
4661206|NCT02998671|16018614|P1|Period 2|Study Terminated By Sponsor|3
4661207|NCT02998671|16018610|P5|Period 2|Adverse Event|0
4661208|NCT02998671|16018611|P4|Period 2|Adverse Event|0
4661209|NCT02998671|16018612|P3|Period 2|Adverse Event|0
4661210|NCT02998671|16018613|P2|Period 2|Adverse Event|1
4661211|NCT02998671|16018614|P1|Period 2|Adverse Event|0
4661212|NCT02998671|16018610|P5|Period 1|Adverse Event|1
4661213|NCT02998671|16018611|P4|Period 1|Adverse Event|0
4661214|NCT02998671|16018612|P3|Period 1|Adverse Event|0
4661215|NCT02998671|16018613|P2|Period 1|Adverse Event|0
4661216|NCT02998671|16018614|P1|Period 1|Adverse Event|0
4661217|NCT02998671|16018610|P5|Period 1|Pregnancy|0
4661218|NCT02998671|16018611|P4|Period 1|Pregnancy|0
4661219|NCT02998671|16018612|P3|Period 1|Pregnancy|0
4661220|NCT02998671|16018613|P2|Period 1|Pregnancy|0
4661221|NCT02998671|16018614|P1|Period 1|Pregnancy|1
4661222|NCT02998671|16018610|P5|Period 1|Withdrawal by Subject|2
4661223|NCT02998671|16018611|P4|Period 1|Withdrawal by Subject|0
4661224|NCT02998671|16018612|P3|Period 1|Withdrawal by Subject|0
4661225|NCT02998671|16018613|P2|Period 1|Withdrawal by Subject|2
4661226|NCT02998671|16018614|P1|Period 1|Withdrawal by Subject|1
4661227|NCT02998671|16018610|P5|Period 1|Study Terminated By Sponsor|1
4661228|NCT02998671|16018611|P4|Period 1|Study Terminated By Sponsor|0
4661229|NCT02998671|16018612|P3|Period 1|Study Terminated By Sponsor|0
4661230|NCT02998671|16018613|P2|Period 1|Study Terminated By Sponsor|1
4661231|NCT02998671|16018614|P1|Period 1|Study Terminated By Sponsor|2
4661232|NCT02998554|16018659|P2|Overall Study|Lack of Efficacy|1
4661233|NCT02998554|16018660|P1|Overall Study|Lack of Efficacy|0
4661234|NCT02998554|16018659|P2|Overall Study|Lost to Follow-up|1
4661235|NCT02998554|16018660|P1|Overall Study|Lost to Follow-up|0
4661236|NCT02998554|16018659|P2|Overall Study|Withdrawal by Subject|6
4661237|NCT02998554|16018660|P1|Overall Study|Withdrawal by Subject|2
4661238|NCT02998554|16018659|P2|Overall Study|Protocol deviation|0
4661239|NCT02998554|16018660|P1|Overall Study|Protocol deviation|1
4661240|NCT02998554|16018659|P2|Overall Study|Adverse Event|3
4661241|NCT02998554|16018660|P1|Overall Study|Adverse Event|8
4661242|NCT02998541|16018691|P3|Overall Study|Withdrawal by Parent/Guardian|1
4661243|NCT02998541|16018692|P2|Overall Study|Withdrawal by Parent/Guardian|0
4661244|NCT02998541|16018693|P1|Overall Study|Withdrawal by Parent/Guardian|0
4661245|NCT02998541|16018691|P3|Overall Study|Physician Decision|3
4661246|NCT02998541|16018692|P2|Overall Study|Physician Decision|0
4661247|NCT02998541|16018693|P1|Overall Study|Physician Decision|0
4661248|NCT02998541|16018691|P3|Overall Study|Lost to Follow-up|1
4661249|NCT02998541|16018692|P2|Overall Study|Lost to Follow-up|3
4661250|NCT02998541|16018693|P1|Overall Study|Lost to Follow-up|0
4661251|NCT02998541|16018691|P3|Overall Study|Withdrawal by Subject|0
4661252|NCT02998541|16018692|P2|Overall Study|Withdrawal by Subject|1
4661253|NCT02998541|16018693|P1|Overall Study|Withdrawal by Subject|3
4661254|NCT02998541|16018691|P3|Overall Study|Protocol Violation|0
4661255|NCT02998541|16018692|P2|Overall Study|Protocol Violation|0
4661256|NCT02998541|16018693|P1|Overall Study|Protocol Violation|1
4661257|NCT02998541|16018691|P3|Overall Study|Adverse Event|1
4661258|NCT02998541|16018692|P2|Overall Study|Adverse Event|5
4661259|NCT02998541|16018693|P1|Overall Study|Adverse Event|4
4661260|NCT02998476|16018748|P2|Overall Study|Death|2
4661261|NCT02998476|16018749|P1|Overall Study|Death|32
4661262|NCT02998476|16018748|P2|Overall Study|Withdrawal by Subject|2
4661263|NCT02998476|16018749|P1|Overall Study|Withdrawal by Subject|1
4661264|NCT02998476|16018748|P2|Overall Study|Disease Progression|0
4661265|NCT02998476|16018749|P1|Overall Study|Disease Progression|1
4661266|NCT02998476|16018748|P2|Overall Study|Ongoing in study|1
4661267|NCT02998476|16018749|P1|Overall Study|Ongoing in study|21
4661268|NCT02998021|16018759|P2|Overall Study|unsafe home|1
4661269|NCT02998021|16018760|P1|Overall Study|unsafe home|0
4661270|NCT02998021|16018759|P2|Overall Study|Withdrawal by Subject|1
4661271|NCT02998021|16018760|P1|Overall Study|Withdrawal by Subject|3
4661272|NCT02997163|16018835|P4|Overall Study|Adverse Event|1
4661273|NCT02997163|16018836|P3|Overall Study|Adverse Event|0
4661274|NCT02997163|16018837|P2|Overall Study|Adverse Event|0
4661275|NCT02997163|16018838|P1|Overall Study|Adverse Event|1
4661276|NCT02996968|16018970|P2|Overall Study|Withdrawal by Subject|0
4661277|NCT02996968|16018971|P1|Overall Study|Withdrawal by Subject|1
4661278|NCT02996682|16018979|P2|Overall Study|Death|3
4661279|NCT02996682|16018980|P1|Overall Study|Death|0
4661280|NCT02996500|16019059|P6|Overall Study|Withdrawal by Subject|0
4661281|NCT02996500|16019060|P5|Overall Study|Withdrawal by Subject|2
4661282|NCT02996500|16019061|P4|Overall Study|Withdrawal by Subject|0
4661283|NCT02996500|16019062|P3|Overall Study|Withdrawal by Subject|3
4661284|NCT02996500|16019063|P2|Overall Study|Withdrawal by Subject|0
4661285|NCT02996500|16019064|P1|Overall Study|Withdrawal by Subject|3
4661286|NCT02996500|16019059|P6|Overall Study|Protocol Violation|0
4661287|NCT02996500|16019060|P5|Overall Study|Protocol Violation|0
4661288|NCT02996500|16019061|P4|Overall Study|Protocol Violation|1
4661289|NCT02996500|16019062|P3|Overall Study|Protocol Violation|0
4661290|NCT02996500|16019063|P2|Overall Study|Protocol Violation|0
4661291|NCT02996500|16019064|P1|Overall Study|Protocol Violation|0
4661292|NCT02996500|16019059|P6|Overall Study|Other|0
4661293|NCT02996500|16019060|P5|Overall Study|Other|0
4661294|NCT02996500|16019061|P4|Overall Study|Other|0
4661295|NCT02996500|16019062|P3|Overall Study|Other|2
4661296|NCT02996500|16019063|P2|Overall Study|Other|0
4661297|NCT02996500|16019064|P1|Overall Study|Other|2
4661298|NCT02996500|16019059|P6|Overall Study|Progressive Disease|0
4661299|NCT02996500|16019060|P5|Overall Study|Progressive Disease|0
4661300|NCT02996500|16019061|P4|Overall Study|Progressive Disease|0
4661301|NCT02996500|16019062|P3|Overall Study|Progressive Disease|0
4661302|NCT02996500|16019063|P2|Overall Study|Progressive Disease|0
4661303|NCT02996500|16019064|P1|Overall Study|Progressive Disease|1
4661304|NCT02996500|16019059|P6|Overall Study|Non-Compliance With Study Drug|1
4661305|NCT02996500|16019060|P5|Overall Study|Non-Compliance With Study Drug|0
4661306|NCT02996500|16019061|P4|Overall Study|Non-Compliance With Study Drug|0
4661307|NCT02996500|16019062|P3|Overall Study|Non-Compliance With Study Drug|0
4661308|NCT02996500|16019063|P2|Overall Study|Non-Compliance With Study Drug|0
4661309|NCT02996500|16019064|P1|Overall Study|Non-Compliance With Study Drug|0
4661310|NCT02996500|16019059|P6|Overall Study|No Longer Meets Eligibility Criteria|0
4661311|NCT02996500|16019060|P5|Overall Study|No Longer Meets Eligibility Criteria|0
4661312|NCT02996500|16019061|P4|Overall Study|No Longer Meets Eligibility Criteria|0
4661313|NCT02996500|16019062|P3|Overall Study|No Longer Meets Eligibility Criteria|1
4661314|NCT02996500|16019063|P2|Overall Study|No Longer Meets Eligibility Criteria|0
4661315|NCT02996500|16019064|P1|Overall Study|No Longer Meets Eligibility Criteria|0
4661316|NCT02996500|16019059|P6|Overall Study|Lost to Follow-up|1
4661317|NCT02996500|16019060|P5|Overall Study|Lost to Follow-up|0
4661318|NCT02996500|16019061|P4|Overall Study|Lost to Follow-up|0
4661319|NCT02996500|16019062|P3|Overall Study|Lost to Follow-up|0
4661320|NCT02996500|16019063|P2|Overall Study|Lost to Follow-up|0
4661321|NCT02996500|16019064|P1|Overall Study|Lost to Follow-up|1
4661322|NCT02996500|16019059|P6|Overall Study|Lack of Efficacy|0
4661323|NCT02996500|16019060|P5|Overall Study|Lack of Efficacy|2
4661324|NCT02996500|16019061|P4|Overall Study|Lack of Efficacy|0
4661325|NCT02996500|16019062|P3|Overall Study|Lack of Efficacy|0
4661326|NCT02996500|16019063|P2|Overall Study|Lack of Efficacy|0
4661327|NCT02996500|16019064|P1|Overall Study|Lack of Efficacy|0
4661328|NCT02996500|16019059|P6|Overall Study|Adverse Event|2
4661329|NCT02996500|16019060|P5|Overall Study|Adverse Event|1
4661330|NCT02996500|16019061|P4|Overall Study|Adverse Event|3
4661331|NCT02996500|16019062|P3|Overall Study|Adverse Event|4
4661332|NCT02996500|16019063|P2|Overall Study|Adverse Event|1
4661333|NCT02996500|16019064|P1|Overall Study|Adverse Event|1
4661334|NCT02996474|16019247|P1|Overall Study|Physician Decision|5
4661335|NCT02996448|16019251|P1|Overall Study|Study terminated due to adverse effects|3
4661336|NCT02996097|16019257|P2|Overall Study|Lost to Follow-up|11
4661337|NCT02996097|16019258|P1|Overall Study|Lost to Follow-up|11
4661338|NCT02995980|16019265|P1|Overall Study|Lost to Follow-up|14
4661339|NCT02994108|16019342|P2|Phase 2 Assessment|Withdrawal by Subject|0
4661340|NCT02994108|16019343|P1|Phase 2 Assessment|Withdrawal by Subject|1
4661341|NCT02994108|16019342|P2|Phase 2 Assessment|Lost to Follow-up|7
4661342|NCT02994108|16019343|P1|Phase 2 Assessment|Lost to Follow-up|8
4661343|NCT02994108|16019342|P2|Phase 1 Assessment|Lost to Follow-up|3
4661344|NCT02994108|16019343|P1|Phase 1 Assessment|Lost to Follow-up|5
4661345|NCT02994108|16019342|P2|Intervention Messages|Withdrawal by Subject|0
4661346|NCT02994108|16019343|P1|Intervention Messages|Withdrawal by Subject|2
4661347|NCT02994056|16019375|P1|Overall Study|Withdrew Consent|1
4661348|NCT02994056|16019375|P1|Overall Study|Death|8
4661349|NCT02993926|16019409|P3|Enantone Treatment Phase|Reason Not Specified|0
4661350|NCT02993926|16019410|P2|Enantone Treatment Phase|Reason Not Specified|0
4661351|NCT02993926|16019411|P1|Enantone Treatment Phase|Reason Not Specified|4
4661352|NCT02993926|16019409|P3|Enantone Treatment Phase|Investigator Judgment|0
4661353|NCT02993926|16019410|P2|Enantone Treatment Phase|Investigator Judgment|0
4661354|NCT02993926|16019411|P1|Enantone Treatment Phase|Investigator Judgment|1
4661355|NCT02993926|16019409|P3|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
4661356|NCT02993926|16019410|P2|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0
4661357|NCT02993926|16019411|P1|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26
4661358|NCT02993926|16019409|P3|Enantone Treatment Phase|Adverse Event|0
4661359|NCT02993926|16019410|P2|Enantone Treatment Phase|Adverse Event|0
4661360|NCT02993926|16019411|P1|Enantone Treatment Phase|Adverse Event|1
4661361|NCT02993783|16019443|P2|Overall Study|Reason not Specified|9
4661362|NCT02993783|16019444|P1|Overall Study|Reason not Specified|6
4661363|NCT02993757|16019476|P2|Overall Study|Voluntary withdraw not due adverse event|8
4661364|NCT02993757|16019477|P1|Overall Study|Voluntary withdraw not due adverse event|8
4661365|NCT02993757|16019476|P2|Overall Study|Lost to Follow-up|0
4661366|NCT02993757|16019477|P1|Overall Study|Lost to Follow-up|1
4661367|NCT02993757|16019476|P2|Overall Study|Non compliance with the protocol|170
4661368|NCT02993757|16019477|P1|Overall Study|Non compliance with the protocol|155
4661369|NCT02993471|16019509|P1|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1
4661370|NCT02993471|16019509|P1|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1
4661371|NCT02993250|16019560|P2|Overall Study|Lost to Follow-up|1
4661372|NCT02993250|16019561|P1|Overall Study|Lost to Follow-up|0
4661373|NCT02992691|16019581|P1|Overall Study|Withdrawal by Subject|1
4661374|NCT02992691|16019581|P1|Overall Study|Adverse Event|2
4661375|NCT02992418|16019600|P2|Overall Study|Lost to Follow-up|22
4661376|NCT02992418|16019601|P1|Overall Study|Lost to Follow-up|27
4661377|NCT02992418|16019600|P2|Overall Study|Non-compliance with the protocol|308
4661378|NCT02992418|16019601|P1|Overall Study|Non-compliance with the protocol|308
4661379|NCT02992418|16019600|P2|Overall Study|Withdrawal by Subject|12
4661380|NCT02992418|16019601|P1|Overall Study|Withdrawal by Subject|11
4661381|NCT02992288|16019641|P6|Overall Study|Withdrawal by Subject|4
4661382|NCT02992288|16019642|P5|Overall Study|Withdrawal by Subject|3
4661383|NCT02992288|16019643|P4|Overall Study|Withdrawal by Subject|5
4661384|NCT02992288|16019644|P3|Overall Study|Withdrawal by Subject|1
4661385|NCT02992288|16019645|P2|Overall Study|Withdrawal by Subject|2
4661386|NCT02992288|16019646|P1|Overall Study|Withdrawal by Subject|4
4661387|NCT02992288|16019641|P6|Overall Study|Protocol Violation|1
4661388|NCT02992288|16019642|P5|Overall Study|Protocol Violation|0
4661389|NCT02992288|16019643|P4|Overall Study|Protocol Violation|0
4661390|NCT02992288|16019644|P3|Overall Study|Protocol Violation|0
4661391|NCT02992288|16019645|P2|Overall Study|Protocol Violation|0
4661392|NCT02992288|16019646|P1|Overall Study|Protocol Violation|0
4661393|NCT02992288|16019641|P6|Overall Study|Lost to Follow-up|0
4661394|NCT02992288|16019642|P5|Overall Study|Lost to Follow-up|0
4661395|NCT02992288|16019643|P4|Overall Study|Lost to Follow-up|1
4661396|NCT02992288|16019644|P3|Overall Study|Lost to Follow-up|0
4661397|NCT02992288|16019645|P2|Overall Study|Lost to Follow-up|0
4661398|NCT02992288|16019646|P1|Overall Study|Lost to Follow-up|0
4661399|NCT02992288|16019641|P6|Overall Study|Death|0
4661400|NCT02992288|16019642|P5|Overall Study|Death|2
4661401|NCT02992288|16019643|P4|Overall Study|Death|1
4661402|NCT02992288|16019644|P3|Overall Study|Death|2
4661403|NCT02992288|16019645|P2|Overall Study|Death|0
4661404|NCT02992288|16019646|P1|Overall Study|Death|2
4661405|NCT02992288|16019641|P6|Overall Study|Physician Decision|1
4661406|NCT02992288|16019642|P5|Overall Study|Physician Decision|0
4661407|NCT02992288|16019643|P4|Overall Study|Physician Decision|0
4661408|NCT02992288|16019644|P3|Overall Study|Physician Decision|1
4661409|NCT02992288|16019645|P2|Overall Study|Physician Decision|0
4661410|NCT02992288|16019646|P1|Overall Study|Physician Decision|3
4661411|NCT02992288|16019641|P6|Overall Study|Non-compliance with study drug|0
4661412|NCT02992288|16019642|P5|Overall Study|Non-compliance with study drug|1
4661413|NCT02992288|16019643|P4|Overall Study|Non-compliance with study drug|0
4661414|NCT02992288|16019644|P3|Overall Study|Non-compliance with study drug|1
4661415|NCT02992288|16019645|P2|Overall Study|Non-compliance with study drug|1
4661416|NCT02992288|16019646|P1|Overall Study|Non-compliance with study drug|0
4661417|NCT02992288|16019641|P6|Overall Study|Adverse Event|7
4661418|NCT02992288|16019642|P5|Overall Study|Adverse Event|2
4661419|NCT02992288|16019643|P4|Overall Study|Adverse Event|2
4661420|NCT02992288|16019644|P3|Overall Study|Adverse Event|2
4661421|NCT02992288|16019645|P2|Overall Study|Adverse Event|2
4661422|NCT02992288|16019646|P1|Overall Study|Adverse Event|8
4661423|NCT02992132|16019731|P3|Overall Study|Physician Decision|1
4661424|NCT02992132|16019732|P2|Overall Study|Physician Decision|0
4661425|NCT02992132|16019733|P1|Overall Study|Physician Decision|0
4661426|NCT02992132|16019731|P3|Overall Study|Withdrawal by Subject|1
4661427|NCT02992132|16019732|P2|Overall Study|Withdrawal by Subject|2
4661428|NCT02992132|16019733|P1|Overall Study|Withdrawal by Subject|0
4661429|NCT02992132|16019731|P3|Overall Study|Caregiver withdrew consent|2
4661430|NCT02992132|16019732|P2|Overall Study|Caregiver withdrew consent|3
4661431|NCT02992132|16019733|P1|Overall Study|Caregiver withdrew consent|2
4661432|NCT02992132|16019731|P3|Overall Study|Protocol Violation|0
4661433|NCT02992132|16019732|P2|Overall Study|Protocol Violation|2
4661434|NCT02992132|16019733|P1|Overall Study|Protocol Violation|2
4661435|NCT02992132|16019731|P3|Overall Study|Progressive disease|0
4661436|NCT02992132|16019732|P2|Overall Study|Progressive disease|0
4661437|NCT02992132|16019733|P1|Overall Study|Progressive disease|1
4661438|NCT02992132|16019731|P3|Overall Study|Non-compliance with study drug|0
4661439|NCT02992132|16019732|P2|Overall Study|Non-compliance with study drug|0
4661440|NCT02992132|16019733|P1|Overall Study|Non-compliance with study drug|2
4661441|NCT02992132|16019731|P3|Overall Study|Lack of Efficacy|0
4661442|NCT02992132|16019732|P2|Overall Study|Lack of Efficacy|0
4661443|NCT02992132|16019733|P1|Overall Study|Lack of Efficacy|2
4661444|NCT02992132|16019731|P3|Overall Study|Adverse Event|3
4661445|NCT02992132|16019732|P2|Overall Study|Adverse Event|1
4661446|NCT02992132|16019733|P1|Overall Study|Adverse Event|4
4661447|NCT02991859|16019846|P17|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661448|NCT02991859|16019847|P16|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661449|NCT02991859|16019848|P15|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661450|NCT02991859|16019849|P14|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661451|NCT02991859|16019850|P13|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661452|NCT02991859|16019851|P12|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661453|NCT02991859|16019852|P11|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661454|NCT02991859|16019853|P10|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661455|NCT02991859|16019854|P9|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1
4661456|NCT02991859|16019855|P8|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661457|NCT02991859|16019856|P7|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661458|NCT02991859|16019857|P6|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661459|NCT02991859|16019858|P5|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661460|NCT02991859|16019859|P4|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661461|NCT02991859|16019860|P3|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661462|NCT02991859|16019861|P2|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661463|NCT02991859|16019862|P1|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0
4661464|NCT02991859|16019846|P17|Wash Out, Up to Day 77|Lost to Follow-up|0
4661465|NCT02991859|16019847|P16|Wash Out, Up to Day 77|Lost to Follow-up|0
4661466|NCT02991859|16019848|P15|Wash Out, Up to Day 77|Lost to Follow-up|0
4661467|NCT02991859|16019849|P14|Wash Out, Up to Day 77|Lost to Follow-up|0
4661468|NCT02991859|16019850|P13|Wash Out, Up to Day 77|Lost to Follow-up|0
4661469|NCT02991859|16019851|P12|Wash Out, Up to Day 77|Lost to Follow-up|0
4661470|NCT02991859|16019852|P11|Wash Out, Up to Day 77|Lost to Follow-up|0
4661471|NCT02991859|16019853|P10|Wash Out, Up to Day 77|Lost to Follow-up|1
4661472|NCT02991859|16019854|P9|Wash Out, Up to Day 77|Lost to Follow-up|0
4661473|NCT02991859|16019855|P8|Wash Out, Up to Day 77|Lost to Follow-up|0
4661474|NCT02991859|16019856|P7|Wash Out, Up to Day 77|Lost to Follow-up|0
4661475|NCT02991859|16019857|P6|Wash Out, Up to Day 77|Lost to Follow-up|0
4661476|NCT02991859|16019858|P5|Wash Out, Up to Day 77|Lost to Follow-up|0
4661477|NCT02991859|16019859|P4|Wash Out, Up to Day 77|Lost to Follow-up|0
4661478|NCT02991859|16019860|P3|Wash Out, Up to Day 77|Lost to Follow-up|0
4661479|NCT02991859|16019861|P2|Wash Out, Up to Day 77|Lost to Follow-up|0
4661480|NCT02991859|16019862|P1|Wash Out, Up to Day 77|Lost to Follow-up|0
4661481|NCT02991859|16019846|P17|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661482|NCT02991859|16019847|P16|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661483|NCT02991859|16019848|P15|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661484|NCT02991859|16019849|P14|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661485|NCT02991859|16019850|P13|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661486|NCT02991859|16019851|P12|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661487|NCT02991859|16019852|P11|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661488|NCT02991859|16019853|P10|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661489|NCT02991859|16019854|P9|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661490|NCT02991859|16019855|P8|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661491|NCT02991859|16019856|P7|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661492|NCT02991859|16019857|P6|Wash Out, Up to Day 77|Withdrawal by Subject|1
4661493|NCT02991859|16019858|P5|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661494|NCT02991859|16019859|P4|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661495|NCT02991859|16019860|P3|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661496|NCT02991859|16019861|P2|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661497|NCT02991859|16019862|P1|Wash Out, Up to Day 77|Withdrawal by Subject|0
4661498|NCT02991859|16019846|P17|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661499|NCT02991859|16019847|P16|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661500|NCT02991859|16019848|P15|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661501|NCT02991859|16019849|P14|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
4661502|NCT02991859|16019850|P13|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1
4661503|NCT02991859|16019851|P12|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661504|NCT02991859|16019852|P11|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661505|NCT02991859|16019853|P10|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661506|NCT02991859|16019854|P9|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661507|NCT02991859|16019855|P8|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661508|NCT02991859|16019856|P7|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661509|NCT02991859|16019857|P6|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661510|NCT02991859|16019858|P5|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661511|NCT02991859|16019859|P4|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661512|NCT02991859|16019860|P3|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661513|NCT02991859|16019861|P2|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661514|NCT02991859|16019862|P1|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0
4661515|NCT02991859|16019846|P17|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661516|NCT02991859|16019847|P16|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661517|NCT02991859|16019848|P15|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661518|NCT02991859|16019849|P14|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661519|NCT02991859|16019850|P13|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661520|NCT02991859|16019851|P12|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661521|NCT02991859|16019852|P11|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661522|NCT02991859|16019853|P10|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661523|NCT02991859|16019854|P9|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661524|NCT02991859|16019855|P8|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661525|NCT02991859|16019856|P7|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661526|NCT02991859|16019857|P6|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661527|NCT02991859|16019858|P5|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
4661528|NCT02991859|16019859|P4|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661529|NCT02991859|16019860|P3|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661530|NCT02991859|16019861|P2|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1
4661531|NCT02991859|16019862|P1|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0
4661532|NCT02991430|16020157|P3|Post-treatment Observation Period|Study Termination|5
4661533|NCT02991430|16020158|P2|Post-treatment Observation Period|Study Termination|6
4661534|NCT02991430|16020159|P1|Post-treatment Observation Period|Study Termination|3
4661535|NCT02991430|16020157|P3|Treatment Period 2|Lost to Follow-up|1
4661536|NCT02991430|16020158|P2|Treatment Period 2|Lost to Follow-up|0
4661537|NCT02991430|16020159|P1|Treatment Period 2|Lost to Follow-up|0
4661538|NCT02991430|16020157|P3|Treatment Period 2|Study Termination|3
4661539|NCT02991430|16020158|P2|Treatment Period 2|Study Termination|3
4661540|NCT02991430|16020159|P1|Treatment Period 2|Study Termination|6
4661541|NCT02991430|16020157|P3|Treatment Period 1|Withdrawal by Subject|0
4661542|NCT02991430|16020158|P2|Treatment Period 1|Withdrawal by Subject|4
4661543|NCT02991430|16020159|P1|Treatment Period 1|Withdrawal by Subject|0
4661544|NCT02991430|16020157|P3|Treatment Period 1|Adverse Event|2
4661545|NCT02991430|16020158|P2|Treatment Period 1|Adverse Event|0
4661546|NCT02991430|16020159|P1|Treatment Period 1|Adverse Event|1
4661547|NCT02991118|16020196|P2|Overall Study|Lost to Follow-up|9
4661548|NCT02991118|16020197|P1|Overall Study|Lost to Follow-up|1
4661549|NCT02991118|16020196|P2|Overall Study|Could not attend study visits|1
4661550|NCT02991118|16020197|P1|Overall Study|Could not attend study visits|0
4661551|NCT02991118|16020196|P2|Overall Study|Withdrawal by Subject|7
4661552|NCT02991118|16020197|P1|Overall Study|Withdrawal by Subject|1
4661553|NCT02991118|16020196|P2|Overall Study|Adverse Event|2
4661554|NCT02991118|16020197|P1|Overall Study|Adverse Event|2
4661555|NCT02991118|16020196|P2|Overall Study|Moved out of the country|1
4661556|NCT02991118|16020197|P1|Overall Study|Moved out of the country|0
4661557|NCT02991118|16020196|P2|Overall Study|Physician Decision|1
4661558|NCT02991118|16020197|P1|Overall Study|Physician Decision|0
4661559|NCT02991118|16020196|P2|Overall Study|Protocol Violation|3
4661560|NCT02991118|16020197|P1|Overall Study|Protocol Violation|0
4661561|NCT02991118|16020196|P2|Overall Study|Death|8
4661562|NCT02991118|16020197|P1|Overall Study|Death|3
4661563|NCT02991040|16020241|P1|Overall Study|Lost to Follow-up|2
4661564|NCT02991040|16020241|P1|Overall Study|Withdrawal by Subject|2
4661565|NCT02990910|16020256|P2|Overall Study|Lack of Efficacy|10
4661566|NCT02990910|16020257|P1|Overall Study|Lack of Efficacy|6
4661567|NCT02990338|16020267|P2|Overall Study|Randomized but not treated|2
4661568|NCT02990338|16020268|P1|Overall Study|Randomized but not treated|4
4661569|NCT02990338|16020267|P2|Overall Study|Other|4
4661570|NCT02990338|16020268|P1|Overall Study|Other|1
4661571|NCT02990338|16020267|P2|Overall Study|Withdrawal by Subject|5
4661572|NCT02990338|16020268|P1|Overall Study|Withdrawal by Subject|6
4661573|NCT02990338|16020267|P2|Overall Study|Poor compliance to protocol|1
4661574|NCT02990338|16020268|P1|Overall Study|Poor compliance to protocol|0
4661575|NCT02990338|16020267|P2|Overall Study|Progressive disease|66
4661576|NCT02990338|16020268|P1|Overall Study|Progressive disease|88
4661577|NCT02990338|16020267|P2|Overall Study|Adverse Event|11
4661578|NCT02990338|16020268|P1|Overall Study|Adverse Event|19
4661579|NCT02990000|16020316|P2|Overall Study|Failed to provide data beyond baseline|34
4661580|NCT02990000|16020317|P1|Overall Study|Failed to provide data beyond baseline|36
4661581|NCT02989805|16020337|P2|Overall Study|invalid consent|4
4661582|NCT02989805|16020338|P1|Overall Study|invalid consent|6
4661583|NCT02989649|16020439|P1|Overall Study|Reason Not Specified|13
4661584|NCT02989649|16020439|P1|Overall Study|Lost For Observation During Study|3
4661585|NCT02989649|16020439|P1|Overall Study|Adverse Event/Adverse Drug Reaction|1
4661586|NCT02989649|16020439|P1|Overall Study|Patient/Investigator's Decision to Stop|403
4661587|NCT02989389|16020475|P10|Period 1|Physician Decision|0
4661588|NCT02989389|16020476|P9|Period 1|Physician Decision|1
4661589|NCT02989389|16020477|P8|Period 1|Physician Decision|0
4661590|NCT02989389|16020478|P7|Period 1|Physician Decision|0
4661591|NCT02989389|16020479|P6|Period 1|Physician Decision|0
4661592|NCT02989389|16020480|P5|Period 1|Physician Decision|0
4661593|NCT02989389|16020481|P4|Period 1|Physician Decision|0
4661594|NCT02989389|16020482|P3|Period 1|Physician Decision|0
4661595|NCT02989389|16020483|P2|Period 1|Physician Decision|0
4661596|NCT02989389|16020484|P1|Period 1|Physician Decision|0
4661597|NCT02989389|16020475|P10|Period 1|Lost to Follow-up|0
4661598|NCT02989389|16020476|P9|Period 1|Lost to Follow-up|0
4661599|NCT02989389|16020477|P8|Period 1|Lost to Follow-up|0
4661600|NCT02989389|16020478|P7|Period 1|Lost to Follow-up|0
4661601|NCT02989389|16020479|P6|Period 1|Lost to Follow-up|0
4661602|NCT02989389|16020480|P5|Period 1|Lost to Follow-up|0
4661603|NCT02989389|16020481|P4|Period 1|Lost to Follow-up|0
4661604|NCT02989389|16020482|P3|Period 1|Lost to Follow-up|0
4661605|NCT02989389|16020483|P2|Period 1|Lost to Follow-up|1
4661606|NCT02989389|16020484|P1|Period 1|Lost to Follow-up|0
4661607|NCT02989168|16020550|P2|Overall Study|Sponsor stopped study.|0
4661608|NCT02989168|16020551|P1|Overall Study|Sponsor stopped study.|1
4661609|NCT02989168|16020550|P2|Overall Study|Adverse Event|2
4661610|NCT02989168|16020551|P1|Overall Study|Adverse Event|1
4661611|NCT02989168|16020550|P2|Overall Study|Physician Decision|1
4661612|NCT02989168|16020551|P1|Overall Study|Physician Decision|0
4661613|NCT02989168|16020550|P2|Overall Study|Withdrawal by Subject|0
4661614|NCT02989168|16020551|P1|Overall Study|Withdrawal by Subject|2
4661615|NCT02988622|16020590|P1|Overall Study|Lost to Follow-up|17
4661616|NCT02988219|16020625|P2|Overall Study|Withdrawal by Subject|2
4661617|NCT02988219|16020626|P1|Overall Study|Withdrawal by Subject|0
4661618|NCT02988219|16020625|P2|Overall Study|Lack of Efficacy|1
4661619|NCT02988219|16020626|P1|Overall Study|Lack of Efficacy|1
4661620|NCT02988115|16020645|P2|Overall Study|Lost to Follow-up|0
4661621|NCT02988115|16020646|P1|Overall Study|Lost to Follow-up|1
4661622|NCT02988115|16020645|P2|Overall Study|Withdrawn by Mistake|0
4661623|NCT02988115|16020646|P1|Overall Study|Withdrawn by Mistake|1
4661624|NCT02988115|16020645|P2|Overall Study|Withdrawal by Subject|1
4661625|NCT02988115|16020646|P1|Overall Study|Withdrawal by Subject|1
4661626|NCT02988115|16020645|P2|Overall Study|Sponsor Decision|2
4661627|NCT02988115|16020646|P1|Overall Study|Sponsor Decision|5
4661628|NCT02988115|16020645|P2|Overall Study|Adverse Event|1
4661629|NCT02988115|16020646|P1|Overall Study|Adverse Event|6
4661630|NCT02987972|16020672|P3|Overall Study|Withdrawal by Subject|21
4661631|NCT02987972|16020673|P2|Overall Study|Withdrawal by Subject|17
4661632|NCT02987972|16020674|P1|Overall Study|Withdrawal by Subject|22
4661633|NCT02987972|16020672|P3|Overall Study|Protocol Violation|5
4661634|NCT02987972|16020673|P2|Overall Study|Protocol Violation|1
4661635|NCT02987972|16020674|P1|Overall Study|Protocol Violation|2
4661636|NCT02987972|16020672|P3|Overall Study|Physician Decision|0
4661637|NCT02987972|16020673|P2|Overall Study|Physician Decision|6
4661638|NCT02987972|16020674|P1|Overall Study|Physician Decision|1
4661639|NCT02987972|16020672|P3|Overall Study|Lost to Follow-up|4
4661640|NCT02987972|16020673|P2|Overall Study|Lost to Follow-up|8
4661641|NCT02987972|16020674|P1|Overall Study|Lost to Follow-up|7
4661642|NCT02987972|16020672|P3|Overall Study|Lack of Efficacy|12
4661643|NCT02987972|16020673|P2|Overall Study|Lack of Efficacy|12
4661644|NCT02987972|16020674|P1|Overall Study|Lack of Efficacy|9
4661645|NCT02987972|16020672|P3|Overall Study|Death|0
4661646|NCT02987972|16020673|P2|Overall Study|Death|0
4661647|NCT02987972|16020674|P1|Overall Study|Death|1
4661648|NCT02987972|16020672|P3|Overall Study|Adverse Event|0
4661649|NCT02987972|16020673|P2|Overall Study|Adverse Event|1
4661650|NCT02987972|16020674|P1|Overall Study|Adverse Event|1
4661651|NCT02987660|16020712|P2|Overall Study|Study terminated by sponsor|10
4661652|NCT02987660|16020713|P1|Overall Study|Study terminated by sponsor|10
4661653|NCT02987543|16020737|P4|Overall Study|Investigator's decision|0
4661654|NCT02987543|16020738|P3|Overall Study|Investigator's decision|0
4661655|NCT02987543|16020739|P2|Overall Study|Investigator's decision|1
4661656|NCT02987543|16020740|P1|Overall Study|Investigator's decision|0
4661657|NCT02987543|16020737|P4|Overall Study|Disease Progression|1
4661658|NCT02987543|16020738|P3|Overall Study|Disease Progression|0
4661659|NCT02987543|16020739|P2|Overall Study|Disease Progression|0
4661660|NCT02987543|16020740|P1|Overall Study|Disease Progression|0
4661661|NCT02987543|16020737|P4|Overall Study|Withdrawal by Subject|7
4661662|NCT02987543|16020738|P3|Overall Study|Withdrawal by Subject|6
4661663|NCT02987543|16020739|P2|Overall Study|Withdrawal by Subject|6
4661664|NCT02987543|16020740|P1|Overall Study|Withdrawal by Subject|17
4661665|NCT02987543|16020737|P4|Overall Study|Screen failure|1
4661666|NCT02987543|16020738|P3|Overall Study|Screen failure|0
4661667|NCT02987543|16020739|P2|Overall Study|Screen failure|0
4661668|NCT02987543|16020740|P1|Overall Study|Screen failure|0
4661669|NCT02987543|16020737|P4|Overall Study|Death|21
4661670|NCT02987543|16020738|P3|Overall Study|Death|42
4661671|NCT02987543|16020739|P2|Overall Study|Death|36
4661672|NCT02987543|16020740|P1|Overall Study|Death|53
4661673|NCT02987543|16020737|P4|Overall Study|Ongoing study at data cut off|18
4661674|NCT02987543|16020738|P3|Overall Study|Ongoing study at data cut off|46
4661675|NCT02987543|16020739|P2|Overall Study|Ongoing study at data cut off|40
4661676|NCT02987543|16020740|P1|Overall Study|Ongoing study at data cut off|92
4661677|NCT02987205|16020770|P1|Overall Study|Withdrawal by Subject|3
4661678|NCT02987205|16020770|P1|Overall Study|Adverse Event|1
4661679|NCT02986854|16020804|P3|Overall Study|Lost to Follow-up|2
4661680|NCT02986854|16020805|P2|Overall Study|Lost to Follow-up|11
4661681|NCT02986854|16020806|P1|Overall Study|Lost to Follow-up|3
4661682|NCT02986854|16020804|P3|Overall Study|Withdrawal by Subject|1
4661683|NCT02986854|16020805|P2|Overall Study|Withdrawal by Subject|1
4661684|NCT02986854|16020806|P1|Overall Study|Withdrawal by Subject|0
4661685|NCT02986373|16020890|P1|Overall Study|Other|24
4661686|NCT02986373|16020890|P1|Overall Study|Withdrawal by Subject|10
4661687|NCT02986373|16020890|P1|Overall Study|Lost to Follow-up|1
4661688|NCT02986373|16020890|P1|Overall Study|Adverse Event|4
4661689|NCT02986139|16020932|P2|Overall Study|Lost to Follow-up|1
4661690|NCT02986139|16020933|P1|Overall Study|Lost to Follow-up|0
4661691|NCT02986139|16020932|P2|Overall Study|Withdrawal by Subject|1
4661692|NCT02986139|16020933|P1|Overall Study|Withdrawal by Subject|0
4661693|NCT02986139|16020932|P2|Overall Study|Sponsor Decision|2
4661694|NCT02986139|16020933|P1|Overall Study|Sponsor Decision|1
4661695|NCT02985996|16020950|P5|Overall Study|Protocol Violation|0
4661696|NCT02985996|16020951|P4|Overall Study|Protocol Violation|0
4661697|NCT02985996|16020952|P3|Overall Study|Protocol Violation|0
4661698|NCT02985996|16020953|P2|Overall Study|Protocol Violation|1
4661699|NCT02985996|16020954|P1|Overall Study|Protocol Violation|0
4661700|NCT02985996|16020950|P5|Overall Study|Withdrawal by Subject|0
4661701|NCT02985996|16020951|P4|Overall Study|Withdrawal by Subject|0
4661702|NCT02985996|16020952|P3|Overall Study|Withdrawal by Subject|1
4661703|NCT02985996|16020953|P2|Overall Study|Withdrawal by Subject|0
4661704|NCT02985996|16020954|P1|Overall Study|Withdrawal by Subject|0
4661705|NCT02985684|16021088|P1|6-Month Closure Success Evaluation|Device Removal|3
4661706|NCT02985684|16021088|P1|6-Month Closure Success Evaluation|Technical Failure (No Device)|5
4661707|NCT02985684|16021088|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|5
4661708|NCT02985398|16021099|P1|Overall Study|Study Burden|9
4661709|NCT02985398|16021099|P1|Overall Study|Withdrawal by Subject|8
4661710|NCT02985398|16021099|P1|Overall Study|Lost to Follow-up|4
4661711|NCT02985398|16021099|P1|Overall Study|Adverse Event|1
4661712|NCT02984995|16021117|P2|Overall Study|Adverse Event|0
4661713|NCT02984995|16021118|P1|Overall Study|Adverse Event|1
4661714|NCT02984995|16021117|P2|Overall Study|Progressive disease|1
4661715|NCT02984995|16021118|P1|Overall Study|Progressive disease|11
4661716|NCT02984995|16021117|P2|Overall Study|Required stem cell transplant|2
4661717|NCT02984995|16021118|P1|Overall Study|Required stem cell transplant|13
4661718|NCT02984982|16021165|P2|Overall Study|Randomized but not treated|1
4661719|NCT02984982|16021166|P1|Overall Study|Randomized but not treated|0
4661720|NCT02984982|16021165|P2|Overall Study|Withdrawal by Subject|0
4661721|NCT02984982|16021166|P1|Overall Study|Withdrawal by Subject|2
4661722|NCT02984982|16021165|P2|Overall Study|Poor Compliance to Protocol|4
4661723|NCT02984982|16021166|P1|Overall Study|Poor Compliance to Protocol|4
4661724|NCT02984982|16021165|P2|Overall Study|Adverse Event|5
4661725|NCT02984982|16021166|P1|Overall Study|Adverse Event|2
4661726|NCT02984943|16021218|P1|Overall Study|Physician Decision|1
4661727|NCT02984943|16021218|P1|Overall Study|Withdrawal by Subject|3
4661728|NCT02984267|16021332|P2|Overall Study|Withdrawal by Subject|1
4661729|NCT02984267|16021333|P1|Overall Study|Withdrawal by Subject|0
4661730|NCT02984267|16021332|P2|Overall Study|Protocol Violation|0
4661731|NCT02984267|16021333|P1|Overall Study|Protocol Violation|1
4661732|NCT02983617|16021378|P2|Overall Study|Still on Study|28
4661733|NCT02983617|16021379|P1|Overall Study|Still on Study|6
4661734|NCT02983617|16021378|P2|Overall Study|Death|1
4661735|NCT02983617|16021379|P1|Overall Study|Death|0
4661736|NCT02983617|16021378|P2|Overall Study|Adverse Event|1
4661737|NCT02983617|16021379|P1|Overall Study|Adverse Event|0
4661738|NCT02983604|16021397|P4|Overall Study|Enrolled but not Treated|0
4661739|NCT02983604|16021398|P3|Overall Study|Enrolled but not Treated|1
4661740|NCT02983604|16021399|P2|Overall Study|Enrolled but not Treated|0
4661741|NCT02983604|16021400|P1|Overall Study|Enrolled but not Treated|0
4661742|NCT02983305|16021449|P2|Overall Study|incomplete data|0
4661743|NCT02983305|16021450|P1|Overall Study|incomplete data|2
4661744|NCT02983227|16021460|P2|Overall Study|Withdrawal by Subject|8
4661745|NCT02983227|16021461|P1|Overall Study|Withdrawal by Subject|19
4661746|NCT02983227|16021460|P2|Overall Study|Physician Decision|1
4661747|NCT02983227|16021461|P1|Overall Study|Physician Decision|3
4661748|NCT02983227|16021460|P2|Overall Study|Multiple Reasons|1
4661749|NCT02983227|16021461|P1|Overall Study|Multiple Reasons|2
4661750|NCT02983227|16021460|P2|Overall Study|Lost to Follow-up|0
4661751|NCT02983227|16021461|P1|Overall Study|Lost to Follow-up|3
4661752|NCT02983227|16021460|P2|Overall Study|Lack of Efficacy|1
4661753|NCT02983227|16021461|P1|Overall Study|Lack of Efficacy|8
4661754|NCT02983227|16021460|P2|Overall Study|Death|0
4661755|NCT02983227|16021461|P1|Overall Study|Death|3
4661756|NCT02983227|16021460|P2|Overall Study|Adverse Event|3
4661757|NCT02983227|16021461|P1|Overall Study|Adverse Event|21
4661758|NCT02982863|16021541|P5|Overall Study|Not eligible patients|492
4661759|NCT02982863|16021542|P4|Overall Study|Not eligible patients|1400
4661760|NCT02982863|16021543|P3|Overall Study|Not eligible patients|1852
4661761|NCT02982863|16021544|P2|Overall Study|Not eligible patients|4261
4661762|NCT02982863|16021545|P1|Overall Study|Not eligible patients|809
4661763|NCT02982720|16021602|P1|Overall Study|Death|1
4661764|NCT02982720|16021602|P1|Overall Study|Adverse Event|3
4661765|NCT02982239|16021612|P2|Overall Study|Lost to Follow-up|2
4661766|NCT02982239|16021613|P1|Overall Study|Lost to Follow-up|3
4661767|NCT02982187|16021629|P8|Overall Study|Withdrawal by Subject|0
4661768|NCT02982187|16021630|P7|Overall Study|Withdrawal by Subject|1
4661769|NCT02982187|16021631|P6|Overall Study|Withdrawal by Subject|0
4661770|NCT02982187|16021632|P5|Overall Study|Withdrawal by Subject|0
4661771|NCT02982187|16021633|P4|Overall Study|Withdrawal by Subject|0
4661772|NCT02982187|16021634|P3|Overall Study|Withdrawal by Subject|0
4661773|NCT02982187|16021635|P2|Overall Study|Withdrawal by Subject|0
4661774|NCT02982187|16021636|P1|Overall Study|Withdrawal by Subject|0
4661775|NCT02982018|16021686|P2|Overall Study|Withdrawal by Subject|1
4661776|NCT02982018|16021687|P1|Overall Study|Withdrawal by Subject|0
4661777|NCT02982018|16021686|P2|Overall Study|Lens Discomfort|0
4661778|NCT02982018|16021687|P1|Overall Study|Lens Discomfort|2
4661779|NCT02982018|16021686|P2|Overall Study|Adverse Event|1
4661780|NCT02982018|16021687|P1|Overall Study|Adverse Event|1
4661781|NCT02982018|16021686|P2|Overall Study|Protocol Violation|1
4661782|NCT02982018|16021687|P1|Overall Study|Protocol Violation|1
4661783|NCT02982018|16021686|P2|Overall Study|Incorrect Lens Dispensed|0
4661784|NCT02982018|16021687|P1|Overall Study|Incorrect Lens Dispensed|1
4661785|NCT02981524|16021701|P1|Overall Study|Withdrawal by Subject|1
4661786|NCT02981524|16021701|P1|Overall Study|Treatment Related Toxicity|1
4661787|NCT02981524|16021701|P1|Overall Study|Death (unrelated)|1
4661788|NCT02981524|16021701|P1|Overall Study|Progressive Disease|14
4661789|NCT02981342|16021713|P4|Overall Study|Lost to Follow-up|0
4661790|NCT02981342|16021714|P3|Overall Study|Lost to Follow-up|0
4661791|NCT02981342|16021715|P2|Overall Study|Lost to Follow-up|1
4661792|NCT02981342|16021716|P1|Overall Study|Lost to Follow-up|0
4661793|NCT02981342|16021713|P4|Overall Study|Randomized, Never Treated|7
4661794|NCT02981342|16021714|P3|Overall Study|Randomized, Never Treated|0
4661795|NCT02981342|16021715|P2|Overall Study|Randomized, Never Treated|1
4661796|NCT02981342|16021716|P1|Overall Study|Randomized, Never Treated|0
4661797|NCT02981342|16021713|P4|Overall Study|Study closed by sponsor|1
4661798|NCT02981342|16021714|P3|Overall Study|Study closed by sponsor|1
4661799|NCT02981342|16021715|P2|Overall Study|Study closed by sponsor|0
4661800|NCT02981342|16021716|P1|Overall Study|Study closed by sponsor|0
4661801|NCT02981342|16021713|P4|Overall Study|Withdrawal by Subject|1
4661802|NCT02981342|16021714|P3|Overall Study|Withdrawal by Subject|3
4661803|NCT02981342|16021715|P2|Overall Study|Withdrawal by Subject|0
4661804|NCT02981342|16021716|P1|Overall Study|Withdrawal by Subject|0
4661805|NCT02981342|16021713|P4|Overall Study|Death|4
4661806|NCT02981342|16021714|P3|Overall Study|Death|9
4661807|NCT02981342|16021715|P2|Overall Study|Death|9
4661808|NCT02981342|16021716|P1|Overall Study|Death|0
4661809|NCT02981342|16021713|P4|Overall Study|Adverse Event|1
4661810|NCT02981342|16021714|P3|Overall Study|Adverse Event|0
4661811|NCT02981342|16021715|P2|Overall Study|Adverse Event|0
4661812|NCT02981342|16021716|P1|Overall Study|Adverse Event|0
4661813|NCT02980783|16021774|P1|Overall Study|Lost to Follow-up|1
4661814|NCT02980601|16021787|P2|Overall Study|Failed to sign consent|0
4661815|NCT02980601|16021788|P1|Overall Study|Failed to sign consent|2
4661816|NCT02980601|16021787|P2|Overall Study|Graft loss|0
4661817|NCT02980601|16021788|P1|Overall Study|Graft loss|1
4661818|NCT02980601|16021787|P2|Overall Study|Death|1
4661819|NCT02980601|16021788|P1|Overall Study|Death|0
4661820|NCT02980601|16021787|P2|Overall Study|Lost to Follow-up|2
4661821|NCT02980601|16021788|P1|Overall Study|Lost to Follow-up|2
4661822|NCT02980523|16021881|P5|Overall Study|Did not receive intervention|0
4661823|NCT02980523|16021882|P4|Overall Study|Did not receive intervention|1
4661824|NCT02980523|16021883|P3|Overall Study|Did not receive intervention|0
4661825|NCT02980523|16021884|P2|Overall Study|Did not receive intervention|0
4661826|NCT02980523|16021885|P1|Overall Study|Did not receive intervention|0
4661827|NCT02980523|16021881|P5|Overall Study|Lack of Efficacy|8
4661828|NCT02980523|16021882|P4|Overall Study|Lack of Efficacy|5
4661829|NCT02980523|16021883|P3|Overall Study|Lack of Efficacy|4
4661830|NCT02980523|16021884|P2|Overall Study|Lack of Efficacy|4
4661831|NCT02980523|16021885|P1|Overall Study|Lack of Efficacy|1
4661832|NCT02980523|16021881|P5|Overall Study|Excluded from analysis|1
4661833|NCT02980523|16021882|P4|Overall Study|Excluded from analysis|1
4661834|NCT02980523|16021883|P3|Overall Study|Excluded from analysis|1
4661835|NCT02980523|16021884|P2|Overall Study|Excluded from analysis|3
4661836|NCT02980523|16021885|P1|Overall Study|Excluded from analysis|1
4661837|NCT02980523|16021881|P5|Overall Study|Lost to Follow-up|1
4661838|NCT02980523|16021882|P4|Overall Study|Lost to Follow-up|2
4661839|NCT02980523|16021883|P3|Overall Study|Lost to Follow-up|1
4661840|NCT02980523|16021884|P2|Overall Study|Lost to Follow-up|4
4661841|NCT02980523|16021885|P1|Overall Study|Lost to Follow-up|1
4661842|NCT02980224|16021929|P2|Overall Study|Withdrawal by Subject|2
4661843|NCT02980224|16021930|P1|Overall Study|Withdrawal by Subject|0
4661844|NCT02980224|16021929|P2|Overall Study|Adverse Event|1
4661845|NCT02980224|16021930|P1|Overall Study|Adverse Event|4
4661846|NCT02980133|16021948|P4|Overall Study|Withdrawal by Subject|0
4661847|NCT02980133|16021949|P3|Overall Study|Withdrawal by Subject|1
4661848|NCT02980133|16021950|P2|Overall Study|Withdrawal by Subject|0
4661849|NCT02980133|16021951|P1|Overall Study|Withdrawal by Subject|0
4661850|NCT02980133|16021948|P4|Overall Study|Withdrawal by parent/guardian|1
4661851|NCT02980133|16021949|P3|Overall Study|Withdrawal by parent/guardian|3
4661852|NCT02980133|16021950|P2|Overall Study|Withdrawal by parent/guardian|3
4661853|NCT02980133|16021951|P1|Overall Study|Withdrawal by parent/guardian|6
4661854|NCT02980133|16021948|P4|Overall Study|Protocol Violation|0
4661855|NCT02980133|16021949|P3|Overall Study|Protocol Violation|0
4661856|NCT02980133|16021950|P2|Overall Study|Protocol Violation|1
4661857|NCT02980133|16021951|P1|Overall Study|Protocol Violation|0
4661858|NCT02980133|16021948|P4|Overall Study|Lost to Follow-up|3
4661859|NCT02980133|16021949|P3|Overall Study|Lost to Follow-up|1
4661860|NCT02980133|16021950|P2|Overall Study|Lost to Follow-up|0
4661861|NCT02980133|16021951|P1|Overall Study|Lost to Follow-up|0
4661862|NCT02980133|16021948|P4|Overall Study|Other than specified|2
4661863|NCT02980133|16021949|P3|Overall Study|Other than specified|2
4661864|NCT02980133|16021950|P2|Overall Study|Other than specified|1
4661865|NCT02980133|16021951|P1|Overall Study|Other than specified|1
4661866|NCT02980107|16021989|P2|Overall Study|Withdrawal by Subject|62
4661867|NCT02980107|16021990|P1|Overall Study|Withdrawal by Subject|51
4661868|NCT02980042|16022004|P2|Overall Study|Insurance issues/treatment plan changes|0
4661869|NCT02980042|16022005|P1|Overall Study|Insurance issues/treatment plan changes|2
4661870|NCT02980042|16022004|P2|Overall Study|Lost to Follow-up|0
4661871|NCT02980042|16022005|P1|Overall Study|Lost to Follow-up|5
4661872|NCT02979639|16022037|P1|Overall Study|Adverse Event|2
4661873|NCT02979639|16022037|P1|Overall Study|Withdrawal by Subject|3
4661874|NCT02979639|16022037|P1|Overall Study|Lost to Follow-up|8
4661875|NCT02979639|16022037|P1|Overall Study|Withdrawal based on medical judgement|1
4661876|NCT02979613|16022069|P2|Open-Label Extension (OLE) Phase|Investigator's Discretion|1
4661877|NCT02979613|16022070|P1|Open-Label Extension (OLE) Phase|Investigator's Discretion|0
4661878|NCT02979613|16022069|P2|Open-Label Extension (OLE) Phase|Death|1
4661879|NCT02979613|16022070|P1|Open-Label Extension (OLE) Phase|Death|0
4661880|NCT02979613|16022069|P2|Open-Label Extension (OLE) Phase|Adverse Event|0
4661881|NCT02979613|16022070|P1|Open-Label Extension (OLE) Phase|Adverse Event|1
4661882|NCT02979613|16022069|P2|Open-Label Extension (OLE) Phase|Withdrew Consent|4
4661883|NCT02979613|16022070|P1|Open-Label Extension (OLE) Phase|Withdrew Consent|2
4661884|NCT02979613|16022069|P2|Double-Blind Phase|Randomized but Never Treated|0
4661885|NCT02979613|16022070|P1|Double-Blind Phase|Randomized but Never Treated|2
4661886|NCT02979613|16022069|P2|Double-Blind Phase|Protocol Violation|1
4661887|NCT02979613|16022070|P1|Double-Blind Phase|Protocol Violation|1
4661888|NCT02979613|16022069|P2|Double-Blind Phase|Lost to Follow-up|1
4661889|NCT02979613|16022070|P1|Double-Blind Phase|Lost to Follow-up|1
4661890|NCT02979613|16022069|P2|Double-Blind Phase|Adverse Event|0
4661891|NCT02979613|16022070|P1|Double-Blind Phase|Adverse Event|2
4661892|NCT02979613|16022069|P2|Double-Blind Phase|Pregnancy|2
4661893|NCT02979613|16022070|P1|Double-Blind Phase|Pregnancy|2
4661894|NCT02979613|16022069|P2|Double-Blind Phase|Withdrew Consent|4
4661895|NCT02979613|16022070|P1|Double-Blind Phase|Withdrew Consent|2
4661896|NCT02979535|16022130|P2|Overall Study|Lost to Follow-up|1
4661897|NCT02979535|16022131|P1|Overall Study|Lost to Follow-up|6
4661898|NCT02979535|16022130|P2|Overall Study|Consent withdrawn by participant|18
4661899|NCT02979535|16022131|P1|Overall Study|Consent withdrawn by participant|11
4661900|NCT02979535|16022130|P2|Overall Study|Non compliance with the protocol|82
4661901|NCT02979535|16022131|P1|Overall Study|Non compliance with the protocol|78
4661902|NCT02979431|16022194|P4|Overall Study|Subject left country after Day14|0
4661903|NCT02979431|16022195|P3|Overall Study|Subject left country after Day14|0
4661904|NCT02979431|16022196|P2|Overall Study|Subject left country after Day14|0
4661905|NCT02979431|16022197|P1|Overall Study|Subject left country after Day14|1
4661906|NCT02979431|16022194|P4|Overall Study|Adverse Event|0
4661907|NCT02979431|16022195|P3|Overall Study|Adverse Event|1
4661908|NCT02979431|16022196|P2|Overall Study|Adverse Event|0
4661909|NCT02979431|16022197|P1|Overall Study|Adverse Event|0
4661910|NCT02979431|16022194|P4|Overall Study|Randomized but received no study drug|0
4661911|NCT02979431|16022195|P3|Overall Study|Randomized but received no study drug|0
4661912|NCT02979431|16022196|P2|Overall Study|Randomized but received no study drug|1
4661913|NCT02979431|16022197|P1|Overall Study|Randomized but received no study drug|1
4661914|NCT02979431|16022194|P4|Overall Study|Parent/guardian withdrew consent|1
4661915|NCT02979431|16022195|P3|Overall Study|Parent/guardian withdrew consent|1
4661916|NCT02979431|16022196|P2|Overall Study|Parent/guardian withdrew consent|1
4661917|NCT02979431|16022197|P1|Overall Study|Parent/guardian withdrew consent|2
4661918|NCT02979249|16022275|P1|Overall Study|Withdrawal by Subject|4
4661919|NCT02979249|16022275|P1|Overall Study|Lost to Follow-up|2
4661920|NCT02979197|16022283|P3|Overall Study|Subject unable to commit to study dates|0
4661921|NCT02979197|16022284|P2|Overall Study|Subject unable to commit to study dates|1
4661922|NCT02979197|16022285|P1|Overall Study|Subject unable to commit to study dates|0
4661923|NCT02979197|16022283|P3|Overall Study|Protocol Violation|0
4661924|NCT02979197|16022284|P2|Overall Study|Protocol Violation|1
4661925|NCT02979197|16022285|P1|Overall Study|Protocol Violation|0
4661926|NCT02979197|16022283|P3|Overall Study|Adverse Event|0
4661927|NCT02979197|16022284|P2|Overall Study|Adverse Event|2
4661928|NCT02979197|16022285|P1|Overall Study|Adverse Event|4
4661929|NCT02978833|16022328|P2|Overall Study|Study terminated|1
4661930|NCT02978833|16022329|P1|Overall Study|Study terminated|1
4661931|NCT02978417|16022358|P2|Overall Study|Lost to Follow-up|2
4661932|NCT02978417|16022359|P1|Overall Study|Lost to Follow-up|2
4661933|NCT02977572|16022414|P2|Overall Study|Exclusion criterion|2
4661934|NCT02977572|16022415|P1|Overall Study|Exclusion criterion|2
4661935|NCT02977507|16022437|P2|Overall Study|Lost to Follow-up|0
4661936|NCT02977507|16022438|P1|Overall Study|Lost to Follow-up|1
4661937|NCT02977507|16022437|P2|Overall Study|Protocol Deviation|0
4661938|NCT02977507|16022438|P1|Overall Study|Protocol Deviation|1
4661939|NCT02976519|16022468|P7|Treatment Period 2 (Part 2 Only)|Adverse Event|1
4661940|NCT02976519|16022469|P6|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4661941|NCT02976519|16022470|P5|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4661942|NCT02976519|16022471|P4|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4661943|NCT02976519|16022472|P3|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4661944|NCT02976519|16022473|P2|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4661945|NCT02976519|16022474|P1|Treatment Period 2 (Part 2 Only)|Adverse Event|0
4661946|NCT02976519|16022468|P7|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1
4661947|NCT02976519|16022469|P6|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4661948|NCT02976519|16022470|P5|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4661949|NCT02976519|16022471|P4|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4661950|NCT02976519|16022472|P3|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4661951|NCT02976519|16022473|P2|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4661952|NCT02976519|16022474|P1|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0
4661953|NCT02976519|16022468|P7|Wash-out Period (Part 2 Only)|Reason not listed|1
4661954|NCT02976519|16022469|P6|Wash-out Period (Part 2 Only)|Reason not listed|0
4661955|NCT02976519|16022470|P5|Wash-out Period (Part 2 Only)|Reason not listed|0
4661956|NCT02976519|16022471|P4|Wash-out Period (Part 2 Only)|Reason not listed|0
4661957|NCT02976519|16022472|P3|Wash-out Period (Part 2 Only)|Reason not listed|0
4661958|NCT02976519|16022473|P2|Wash-out Period (Part 2 Only)|Reason not listed|0
4661959|NCT02976519|16022474|P1|Wash-out Period (Part 2 Only)|Reason not listed|0
4661960|NCT02976519|16022468|P7|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4661961|NCT02976519|16022469|P6|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4661962|NCT02976519|16022470|P5|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4661963|NCT02976519|16022471|P4|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1
4661964|NCT02976519|16022472|P3|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4661965|NCT02976519|16022473|P2|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4661966|NCT02976519|16022474|P1|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0
4661967|NCT02976519|16022468|P7|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4661968|NCT02976519|16022469|P6|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4661969|NCT02976519|16022470|P5|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4661970|NCT02976519|16022471|P4|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4661971|NCT02976519|16022472|P3|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4661972|NCT02976519|16022473|P2|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1
4661973|NCT02976519|16022474|P1|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0
4661974|NCT02976103|16022505|P2|Overall Study|Lost to Follow-up|8
4661975|NCT02976103|16022506|P1|Overall Study|Lost to Follow-up|12
4661976|NCT02976103|16022505|P2|Overall Study|Withdrawal by Subject|0
4661977|NCT02976103|16022506|P1|Overall Study|Withdrawal by Subject|1
4661978|NCT02975700|16022598|P1|Overall Study|Failed screening criteria|2
4661979|NCT02975700|16022598|P1|Overall Study|Progressive disease|3
4661980|NCT02975700|16022598|P1|Overall Study|Adverse Event|1
4661981|NCT02975206|16022632|P3|Overall Study|Other (e.g., lost to follow up)|6
4661982|NCT02975206|16022633|P2|Overall Study|Other (e.g., lost to follow up)|6
4661983|NCT02975206|16022634|P1|Overall Study|Other (e.g., lost to follow up)|13
4661984|NCT02975206|16022632|P3|Overall Study|Withdrawal by Subject|11
4661985|NCT02975206|16022633|P2|Overall Study|Withdrawal by Subject|11
4661986|NCT02975206|16022634|P1|Overall Study|Withdrawal by Subject|14
4661987|NCT02974868|16022651|P4|Cross-Over Extension (COE) Period|Withdrawal by Subject|0
4661988|NCT02974868|16022652|P3|Cross-Over Extension (COE) Period|Withdrawal by Subject|3
4661989|NCT02974868|16022653|P2|Cross-Over Extension (COE) Period|Withdrawal by Subject|1
4661990|NCT02974868|16022654|P1|Cross-Over Extension (COE) Period|Withdrawal by Subject|2
4661991|NCT02974868|16022651|P4|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6
4661992|NCT02974868|16022652|P3|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11
4661993|NCT02974868|16022653|P2|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1
4661994|NCT02974868|16022654|P1|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2
4661995|NCT02974868|16022651|P4|Initial 24-Week Treatment Period (TP)|others|8
4661996|NCT02974868|16022652|P3|Initial 24-Week Treatment Period (TP)|others|1
4661997|NCT02974868|16022653|P2|Initial 24-Week Treatment Period (TP)|others|8
4661998|NCT02974868|16022654|P1|Initial 24-Week Treatment Period (TP)|others|3
4661999|NCT02974868|16022651|P4|Initial 24-Week Treatment Period (TP)|Adverse Event|4
4662000|NCT02974868|16022652|P3|Initial 24-Week Treatment Period (TP)|Adverse Event|2
4662001|NCT02974868|16022653|P2|Initial 24-Week Treatment Period (TP)|Adverse Event|1
4662002|NCT02974868|16022654|P1|Initial 24-Week Treatment Period (TP)|Adverse Event|1
4662003|NCT02974855|16022776|P4|Overall Study|Adverse Event|1
4662004|NCT02974855|16022777|P3|Overall Study|Adverse Event|0
4662005|NCT02974855|16022778|P2|Overall Study|Adverse Event|1
4662006|NCT02974855|16022779|P1|Overall Study|Adverse Event|0
4662007|NCT02974842|16022965|P1|Overall Study|Screen failures|4
4662008|NCT02974842|16022965|P1|Overall Study|Withdrawal by Subject|4
4662009|NCT02974634|16022984|P2|Overall Study|Death|11
4662010|NCT02974634|16022985|P1|Overall Study|Death|8
4662011|NCT02974634|16022984|P2|Overall Study|intervention technology related issues|0
4662012|NCT02974634|16022985|P1|Overall Study|intervention technology related issues|5
4662013|NCT02974634|16022984|P2|Overall Study|Noncompliance|7
4662014|NCT02974634|16022985|P1|Overall Study|Noncompliance|3
4662015|NCT02974634|16022984|P2|Overall Study|Advanced disease|3
4662016|NCT02974634|16022985|P1|Overall Study|Advanced disease|12
4662017|NCT02974543|16022995|P2|Overall Study|Withdrawal by Subject|0
4662018|NCT02974543|16022996|P1|Overall Study|Withdrawal by Subject|1
4662019|NCT02974153|16023030|P3|Overall Study|Other|7
4662020|NCT02974153|16023031|P2|Overall Study|Other|8
4662021|NCT02974153|16023032|P1|Overall Study|Other|14
4662022|NCT02974153|16023030|P3|Overall Study|Study Burden|3
4662023|NCT02974153|16023031|P2|Overall Study|Study Burden|7
4662024|NCT02974153|16023032|P1|Overall Study|Study Burden|8
4662025|NCT02974153|16023030|P3|Overall Study|Withdrawal by Subject|11
4662026|NCT02974153|16023031|P2|Overall Study|Withdrawal by Subject|16
4662027|NCT02974153|16023032|P1|Overall Study|Withdrawal by Subject|9
4662028|NCT02974153|16023030|P3|Overall Study|Physician Decision|1
4662029|NCT02974153|16023031|P2|Overall Study|Physician Decision|2
4662030|NCT02974153|16023032|P1|Overall Study|Physician Decision|0
4662031|NCT02974153|16023030|P3|Overall Study|Lost to Follow-up|17
4662032|NCT02974153|16023031|P2|Overall Study|Lost to Follow-up|10
4662033|NCT02974153|16023032|P1|Overall Study|Lost to Follow-up|9
4662034|NCT02974153|16023030|P3|Overall Study|Lack of Efficacy|10
4662035|NCT02974153|16023031|P2|Overall Study|Lack of Efficacy|5
4662036|NCT02974153|16023032|P1|Overall Study|Lack of Efficacy|6
4662037|NCT02974153|16023030|P3|Overall Study|Adverse Event|1
4662038|NCT02974153|16023031|P2|Overall Study|Adverse Event|0
4662039|NCT02974153|16023032|P1|Overall Study|Adverse Event|6
4662040|NCT02974140|16023118|P1|Overall Study|Study Terminated by Sponsor|36
4662041|NCT02974140|16023118|P1|Overall Study|Lost to Follow-up|1
4662042|NCT02974140|16023118|P1|Overall Study|Adverse Event|2
4662043|NCT02974114|16023134|P3|Overall Study|Other (Not specified)|2
4662044|NCT02974114|16023135|P2|Overall Study|Other (Not specified)|1
4662045|NCT02974114|16023136|P1|Overall Study|Other (Not specified)|0
4662046|NCT02974088|16023179|P2|Overall Study|Adverse Event|1
4662047|NCT02974088|16023180|P1|Overall Study|Adverse Event|0
4662048|NCT02974088|16023179|P2|Overall Study|Lost to Follow-up|2
4662049|NCT02974088|16023180|P1|Overall Study|Lost to Follow-up|0
4662050|NCT02973802|16023186|P1|Overall Study|Withdrawal by Subject|1
4662051|NCT02973802|16023186|P1|Overall Study|Lost to Follow-up|1
4662052|NCT02973477|16023213|P2|Second Intervention|Lost to Follow-up|0
4662053|NCT02973477|16023214|P1|Second Intervention|Lost to Follow-up|1
4662054|NCT02973477|16023213|P2|Washout|Withdrawal by Subject|0
4662055|NCT02973477|16023214|P1|Washout|Withdrawal by Subject|1
4662056|NCT02973477|16023213|P2|First Intervention|Lost to Follow-up|2
4662057|NCT02973477|16023214|P1|First Intervention|Lost to Follow-up|0
4662058|NCT02973100|16023231|P4|Overall Study|Failed to attend Safety followup period|0
4662059|NCT02973100|16023232|P3|Overall Study|Failed to attend Safety followup period|1
4662060|NCT02973100|16023233|P2|Overall Study|Failed to attend Safety followup period|0
4662061|NCT02973100|16023234|P1|Overall Study|Failed to attend Safety followup period|0
4662062|NCT02973100|16023231|P4|Overall Study|Notification of change in address|1
4662063|NCT02973100|16023232|P3|Overall Study|Notification of change in address|0
4662064|NCT02973100|16023233|P2|Overall Study|Notification of change in address|0
4662065|NCT02973100|16023234|P1|Overall Study|Notification of change in address|0
4662066|NCT02973100|16023231|P4|Overall Study|Withdrawal by Subject|4
4662067|NCT02973100|16023232|P3|Overall Study|Withdrawal by Subject|1
4662068|NCT02973100|16023233|P2|Overall Study|Withdrawal by Subject|5
4662069|NCT02973100|16023234|P1|Overall Study|Withdrawal by Subject|3
4662070|NCT02973100|16023231|P4|Overall Study|Lost to Follow-up|0
4662071|NCT02973100|16023232|P3|Overall Study|Lost to Follow-up|1
4662072|NCT02973100|16023233|P2|Overall Study|Lost to Follow-up|1
4662073|NCT02973100|16023234|P1|Overall Study|Lost to Follow-up|3
4662074|NCT02973100|16023231|P4|Overall Study|Adverse Event|2
4662075|NCT02973100|16023232|P3|Overall Study|Adverse Event|1
4662076|NCT02973100|16023233|P2|Overall Study|Adverse Event|2
4662077|NCT02973100|16023234|P1|Overall Study|Adverse Event|1
4662078|NCT02973048|16023272|P2|Overall Study|Withdrawal by Subject|3
4662079|NCT02973048|16023273|P1|Overall Study|Withdrawal by Subject|0
4662080|NCT02973048|16023272|P2|Overall Study|Epidural catheter insertion failure|0
4662081|NCT02973048|16023273|P1|Overall Study|Epidural catheter insertion failure|1
4662082|NCT02972658|16023325|P4|Overall Study|Sponsor Decision|119
4662083|NCT02972658|16023326|P3|Overall Study|Sponsor Decision|72
4662084|NCT02972658|16023327|P2|Overall Study|Sponsor Decision|127
4662085|NCT02972658|16023328|P1|Overall Study|Sponsor Decision|70
4662086|NCT02972658|16023325|P4|Overall Study|Withdrawal due to Caregiver Circumstance|0
4662087|NCT02972658|16023326|P3|Overall Study|Withdrawal due to Caregiver Circumstance|1
4662088|NCT02972658|16023327|P2|Overall Study|Withdrawal due to Caregiver Circumstance|1
4662089|NCT02972658|16023328|P1|Overall Study|Withdrawal due to Caregiver Circumstance|1
4662090|NCT02972658|16023325|P4|Overall Study|Withdrawal by Subject|6
4662091|NCT02972658|16023326|P3|Overall Study|Withdrawal by Subject|1
4662092|NCT02972658|16023327|P2|Overall Study|Withdrawal by Subject|4
4662093|NCT02972658|16023328|P1|Overall Study|Withdrawal by Subject|4
4662094|NCT02972658|16023325|P4|Overall Study|Progressive Disease|1
4662095|NCT02972658|16023326|P3|Overall Study|Progressive Disease|0
4662096|NCT02972658|16023327|P2|Overall Study|Progressive Disease|1
4662097|NCT02972658|16023328|P1|Overall Study|Progressive Disease|0
4662098|NCT02972658|16023325|P4|Overall Study|Lost to Follow-up|2
4662099|NCT02972658|16023326|P3|Overall Study|Lost to Follow-up|1
4662100|NCT02972658|16023327|P2|Overall Study|Lost to Follow-up|1
4662101|NCT02972658|16023328|P1|Overall Study|Lost to Follow-up|0
4662102|NCT02972658|16023325|P4|Overall Study|Death|1
4662103|NCT02972658|16023326|P3|Overall Study|Death|0
4662104|NCT02972658|16023327|P2|Overall Study|Death|0
4662105|NCT02972658|16023328|P1|Overall Study|Death|0
4662106|NCT02972658|16023325|P4|Overall Study|Other-determined by Investigator|0
4662107|NCT02972658|16023326|P3|Overall Study|Other-determined by Investigator|0
4662108|NCT02972658|16023327|P2|Overall Study|Other-determined by Investigator|1
4662109|NCT02972658|16023328|P1|Overall Study|Other-determined by Investigator|1
4662110|NCT02972658|16023325|P4|Overall Study|Adverse Event|2
4662111|NCT02972658|16023326|P3|Overall Study|Adverse Event|0
4662112|NCT02972658|16023327|P2|Overall Study|Adverse Event|3
4662113|NCT02972658|16023328|P1|Overall Study|Adverse Event|0
4662114|NCT02972632|16023358|P1|Overall Study|Voluntary Withdrawal|10
4662115|NCT02972632|16023358|P1|Overall Study|Lost to Follow-up|4
4662116|NCT02972632|16023358|P1|Overall Study|Pretreatment Event/Adverse Event|3
4662117|NCT02972515|16023388|P1|Overall Study|Lost to Follow-up|78
4662118|NCT02972502|16023397|P2|Overall Study|Withdrawal by Subject|1
4662119|NCT02972502|16023398|P1|Overall Study|Withdrawal by Subject|1
4662120|NCT02972502|16023397|P2|Overall Study|Lost to Follow-up|1
4662121|NCT02972502|16023398|P1|Overall Study|Lost to Follow-up|3
4662122|NCT02972359|16023408|P1|Overall Study|Missing|1
4662123|NCT02972359|16023408|P1|Overall Study|Other reasons|5
4662124|NCT02972359|16023408|P1|Overall Study|Lost to Follow-up|26
4662125|NCT02972359|16023408|P1|Overall Study|Protocol Violation|1
4662126|NCT02972359|16023408|P1|Overall Study|Withdrawal by Subject|30
4662127|NCT02972359|16023408|P1|Overall Study|Death|1
4662128|NCT02972359|16023408|P1|Overall Study|Adverse Event|4
4662129|NCT02972359|16023408|P1|Overall Study|Lack of Efficacy|1
4662130|NCT02972359|16023408|P1|Overall Study|Incl. criteria not met/Exclusion met|2
4662131|NCT02972242|16023421|P2|Overall Study|Withdrawal by Subject|0
4662132|NCT02972242|16023422|P1|Overall Study|Withdrawal by Subject|1
4662133|NCT02971670|16023479|P4|Overall Study|Withdrawal by Subject|2
4662134|NCT02971670|16023480|P3|Overall Study|Withdrawal by Subject|1
4662135|NCT02971670|16023481|P2|Overall Study|Withdrawal by Subject|1
4662136|NCT02971670|16023482|P1|Overall Study|Withdrawal by Subject|4
4662137|NCT02971605|16023521|P1|Overall Study|Withdrawal by Subject|1
4662138|NCT02971202|16023635|P3|Overall Study|screen fail after consent|1
4662139|NCT02971202|16023636|P2|Overall Study|screen fail after consent|0
4662140|NCT02971202|16023637|P1|Overall Study|screen fail after consent|1
4662141|NCT02971202|16023635|P3|Overall Study|Pregnancy|0
4662142|NCT02971202|16023636|P2|Overall Study|Pregnancy|0
4662143|NCT02971202|16023637|P1|Overall Study|Pregnancy|1
4662144|NCT02971163|16023653|P2|Overall Study|Lost to Follow-up|2
4662145|NCT02971163|16023654|P1|Overall Study|Lost to Follow-up|4
4662146|NCT02971007|16023677|P3|Overall Study|Patient discontinued study drug|0
4662147|NCT02971007|16023678|P2|Overall Study|Patient discontinued study drug|1
4662148|NCT02971007|16023679|P1|Overall Study|Patient discontinued study drug|0
4662149|NCT02971007|16023677|P3|Overall Study|Patient had yeast at Day 5 visit|0
4662237|NCT02969018|16024047|P5|Overall Study|Protocol Violation|0
4662150|NCT02971007|16023678|P2|Overall Study|Patient had yeast at Day 5 visit|0
4662151|NCT02971007|16023679|P1|Overall Study|Patient had yeast at Day 5 visit|1
4662152|NCT02971007|16023677|P3|Overall Study|Withdrawal by Subject|0
4662153|NCT02971007|16023678|P2|Overall Study|Withdrawal by Subject|1
4662154|NCT02971007|16023679|P1|Overall Study|Withdrawal by Subject|0
4662155|NCT02971007|16023677|P3|Overall Study|Lost to Follow-up|1
4662156|NCT02971007|16023678|P2|Overall Study|Lost to Follow-up|1
4662157|NCT02971007|16023679|P1|Overall Study|Lost to Follow-up|0
4662158|NCT02971007|16023677|P3|Overall Study|Adverse Event|0
4662159|NCT02971007|16023678|P2|Overall Study|Adverse Event|0
4662160|NCT02971007|16023679|P1|Overall Study|Adverse Event|1
4662161|NCT02970669|16023711|P2|Open-label Period|Physician Decision|0
4662162|NCT02970669|16023712|P1|Open-label Period|Physician Decision|1
4662163|NCT02970669|16023711|P2|Open-label Period|Adverse Event|0
4662164|NCT02970669|16023712|P1|Open-label Period|Adverse Event|1
4662165|NCT02970669|16023711|P2|Open-label Period|Withdrawal by Subject|2
4662166|NCT02970669|16023712|P1|Open-label Period|Withdrawal by Subject|2
4662167|NCT02970669|16023711|P2|Double-blind Period|Withdrawal by Subject|2
4662168|NCT02970669|16023712|P1|Double-blind Period|Withdrawal by Subject|2
4662169|NCT02970669|16023711|P2|Double-blind Period|Physician Decision|2
4662170|NCT02970669|16023712|P1|Double-blind Period|Physician Decision|0
4662171|NCT02970669|16023711|P2|Double-blind Period|Study terminated by sponsor|2
4662172|NCT02970669|16023712|P1|Double-blind Period|Study terminated by sponsor|1
4662173|NCT02970669|16023711|P2|Double-blind Period|Death|0
4662174|NCT02970669|16023712|P1|Double-blind Period|Death|1
4662175|NCT02970669|16023711|P2|Double-blind Period|Adverse Event|0
4662176|NCT02970669|16023712|P1|Double-blind Period|Adverse Event|4
4662177|NCT02970292|16023763|P2|Overall Study|Other|0
4662178|NCT02970292|16023764|P1|Overall Study|Other|1
4662179|NCT02970292|16023763|P2|Overall Study|Protocol Violation|0
4662180|NCT02970292|16023764|P1|Overall Study|Protocol Violation|2
4662181|NCT02970292|16023763|P2|Overall Study|Lost to Follow-up|0
4662182|NCT02970292|16023764|P1|Overall Study|Lost to Follow-up|1
4662183|NCT02970292|16023763|P2|Overall Study|Lack of Efficacy|0
4662184|NCT02970292|16023764|P1|Overall Study|Lack of Efficacy|1
4662185|NCT02970292|16023763|P2|Overall Study|Adverse Event|0
4662186|NCT02970292|16023764|P1|Overall Study|Adverse Event|5
4662187|NCT02970292|16023763|P2|Overall Study|Noncompliance with study drug|2
4662188|NCT02970292|16023764|P1|Overall Study|Noncompliance with study drug|2
4662189|NCT02970292|16023763|P2|Overall Study|Withdrawal by Subject|5
4662190|NCT02970292|16023764|P1|Overall Study|Withdrawal by Subject|11
4662191|NCT02970292|16023763|P2|Overall Study|Physician Decision|1
4662192|NCT02970292|16023764|P1|Overall Study|Physician Decision|1
4662193|NCT02969863|16023830|P6|Overall Study|Physician Decision|0
4662194|NCT02969863|16023831|P5|Overall Study|Physician Decision|0
4662195|NCT02969863|16023832|P4|Overall Study|Physician Decision|0
4662196|NCT02969863|16023833|P3|Overall Study|Physician Decision|0
4662197|NCT02969863|16023834|P2|Overall Study|Physician Decision|0
4662198|NCT02969863|16023835|P1|Overall Study|Physician Decision|1
4662199|NCT02969655|16023851|P2|Overall Study|Adverse Event|8
4662200|NCT02969655|16023852|P1|Overall Study|Adverse Event|10
4662201|NCT02969655|16023851|P2|Overall Study|Protocol-specified withdrawal criteria|2
4662202|NCT02969655|16023852|P1|Overall Study|Protocol-specified withdrawal criteria|4
4662203|NCT02969655|16023851|P2|Overall Study|Physician Decision|3
4662204|NCT02969655|16023852|P1|Overall Study|Physician Decision|4
4662205|NCT02969655|16023851|P2|Overall Study|Withdrawal by Subject|2
4662206|NCT02969655|16023852|P1|Overall Study|Withdrawal by Subject|3
4662207|NCT02969590|16023887|P3|Screening Period|Hormones not suppressed post Lupron|0
4662208|NCT02969590|16023888|P2|Screening Period|Hormones not suppressed post Lupron|0
4662209|NCT02969590|16023889|P1|Screening Period|Hormones not suppressed post Lupron|1
4662210|NCT02969408|16023920|P1|Overall Study|Other than specified|1
4662211|NCT02969408|16023920|P1|Overall Study|Protocol Violation|1
4662212|NCT02969408|16023920|P1|Overall Study|Lost to Follow-up|4
4662213|NCT02969408|16023920|P1|Overall Study|Withdrawal by Subject|8
4662214|NCT02969408|16023920|P1|Overall Study|Adverse Event|2
4662215|NCT02969356|16023928|P1|Overall Study|Personal reasons|5
4662216|NCT02969356|16023928|P1|Overall Study|Did not need to be reinjected|6
4662217|NCT02969356|16023928|P1|Overall Study|Lost to Follow-up|3
4662218|NCT02969356|16023928|P1|Overall Study|Consent withdrawn|2
4662219|NCT02969356|16023928|P1|Overall Study|Adverse Event|7
4662220|NCT02969187|16023971|P2|Overall Study|Physician Decision|13
4662221|NCT02969187|16023972|P1|Overall Study|Physician Decision|12
4662222|NCT02969044|16023984|P2|Overall Study|Adverse Event|0
4662223|NCT02969044|16023985|P1|Overall Study|Adverse Event|3
4662224|NCT02969044|16023984|P2|Overall Study|Withdrawal by Subject|6
4662225|NCT02969044|16023985|P1|Overall Study|Withdrawal by Subject|2
4662226|NCT02969018|16024044|P8|Overall Study|Withdrawal by Subject|3
4662227|NCT02969018|16024045|P7|Overall Study|Withdrawal by Subject|4
4662228|NCT02969018|16024046|P6|Overall Study|Withdrawal by Subject|4
4662229|NCT02969018|16024047|P5|Overall Study|Withdrawal by Subject|0
4662230|NCT02969018|16024048|P4|Overall Study|Withdrawal by Subject|1
4662231|NCT02969018|16024049|P3|Overall Study|Withdrawal by Subject|2
4662232|NCT02969018|16024050|P2|Overall Study|Withdrawal by Subject|1
4662233|NCT02969018|16024051|P1|Overall Study|Withdrawal by Subject|0
4662234|NCT02969018|16024044|P8|Overall Study|Protocol Violation|0
4662235|NCT02969018|16024045|P7|Overall Study|Protocol Violation|0
4662236|NCT02969018|16024046|P6|Overall Study|Protocol Violation|0
4662238|NCT02969018|16024048|P4|Overall Study|Protocol Violation|1
4662239|NCT02969018|16024049|P3|Overall Study|Protocol Violation|1
4662240|NCT02969018|16024050|P2|Overall Study|Protocol Violation|0
4662241|NCT02969018|16024051|P1|Overall Study|Protocol Violation|0
4662242|NCT02969018|16024044|P8|Overall Study|Pregnancy|0
4662243|NCT02969018|16024045|P7|Overall Study|Pregnancy|0
4662244|NCT02969018|16024046|P6|Overall Study|Pregnancy|1
4662245|NCT02969018|16024047|P5|Overall Study|Pregnancy|0
4662246|NCT02969018|16024048|P4|Overall Study|Pregnancy|0
4662247|NCT02969018|16024049|P3|Overall Study|Pregnancy|0
4662248|NCT02969018|16024050|P2|Overall Study|Pregnancy|0
4662249|NCT02969018|16024051|P1|Overall Study|Pregnancy|0
4662250|NCT02969018|16024044|P8|Overall Study|Other|2
4662251|NCT02969018|16024045|P7|Overall Study|Other|0
4662252|NCT02969018|16024046|P6|Overall Study|Other|0
4662253|NCT02969018|16024047|P5|Overall Study|Other|0
4662254|NCT02969018|16024048|P4|Overall Study|Other|1
4662255|NCT02969018|16024049|P3|Overall Study|Other|0
4662256|NCT02969018|16024050|P2|Overall Study|Other|0
4662257|NCT02969018|16024051|P1|Overall Study|Other|0
4662258|NCT02969018|16024044|P8|Overall Study|Non-Compliance With Study Drug|0
4662259|NCT02969018|16024045|P7|Overall Study|Non-Compliance With Study Drug|0
4662260|NCT02969018|16024046|P6|Overall Study|Non-Compliance With Study Drug|0
4662261|NCT02969018|16024047|P5|Overall Study|Non-Compliance With Study Drug|0
4662262|NCT02969018|16024048|P4|Overall Study|Non-Compliance With Study Drug|0
4662263|NCT02969018|16024049|P3|Overall Study|Non-Compliance With Study Drug|0
4662264|NCT02969018|16024050|P2|Overall Study|Non-Compliance With Study Drug|0
4662265|NCT02969018|16024051|P1|Overall Study|Non-Compliance With Study Drug|1
4662266|NCT02969018|16024044|P8|Overall Study|No Longer Meets Eligibility Criteria|0
4662267|NCT02969018|16024045|P7|Overall Study|No Longer Meets Eligibility Criteria|1
4662268|NCT02969018|16024046|P6|Overall Study|No Longer Meets Eligibility Criteria|0
4662269|NCT02969018|16024047|P5|Overall Study|No Longer Meets Eligibility Criteria|0
4662270|NCT02969018|16024048|P4|Overall Study|No Longer Meets Eligibility Criteria|0
4662271|NCT02969018|16024049|P3|Overall Study|No Longer Meets Eligibility Criteria|0
4662272|NCT02969018|16024050|P2|Overall Study|No Longer Meets Eligibility Criteria|0
4662273|NCT02969018|16024051|P1|Overall Study|No Longer Meets Eligibility Criteria|0
4662274|NCT02969018|16024044|P8|Overall Study|Lost to Follow-up|1
4662275|NCT02969018|16024045|P7|Overall Study|Lost to Follow-up|0
4662276|NCT02969018|16024046|P6|Overall Study|Lost to Follow-up|1
4662277|NCT02969018|16024047|P5|Overall Study|Lost to Follow-up|1
4662278|NCT02969018|16024048|P4|Overall Study|Lost to Follow-up|0
4662279|NCT02969018|16024049|P3|Overall Study|Lost to Follow-up|2
4662280|NCT02969018|16024050|P2|Overall Study|Lost to Follow-up|2
4662281|NCT02969018|16024051|P1|Overall Study|Lost to Follow-up|1
4662282|NCT02969018|16024044|P8|Overall Study|Lack of Efficacy|1
4662283|NCT02969018|16024045|P7|Overall Study|Lack of Efficacy|1
4662284|NCT02969018|16024046|P6|Overall Study|Lack of Efficacy|1
4662285|NCT02969018|16024047|P5|Overall Study|Lack of Efficacy|1
4662286|NCT02969018|16024048|P4|Overall Study|Lack of Efficacy|0
4662287|NCT02969018|16024049|P3|Overall Study|Lack of Efficacy|0
4662288|NCT02969018|16024050|P2|Overall Study|Lack of Efficacy|1
4662289|NCT02969018|16024051|P1|Overall Study|Lack of Efficacy|0
4662290|NCT02969018|16024044|P8|Overall Study|Adverse Event|0
4662291|NCT02969018|16024045|P7|Overall Study|Adverse Event|2
4662292|NCT02969018|16024046|P6|Overall Study|Adverse Event|1
4662293|NCT02969018|16024047|P5|Overall Study|Adverse Event|0
4662294|NCT02969018|16024048|P4|Overall Study|Adverse Event|2
4662295|NCT02969018|16024049|P3|Overall Study|Adverse Event|1
4662296|NCT02969018|16024050|P2|Overall Study|Adverse Event|4
4662297|NCT02969018|16024051|P1|Overall Study|Adverse Event|2
4662298|NCT02968979|16024191|P1|Overall Study|Withdrawal by Subject|1
4662299|NCT02968979|16024191|P1|Overall Study|Protocol Violation|7
4662300|NCT02968576|16024316|P2|Overall Study|Pregnancy|1
4662301|NCT02968576|16024317|P1|Overall Study|Pregnancy|0
4662302|NCT02968563|16024324|P2|Overall Study|Still on Study|17
4662303|NCT02968563|16024325|P1|Overall Study|Still on Study|0
4662304|NCT02968563|16024324|P2|Overall Study|Death|1
4662305|NCT02968563|16024325|P1|Overall Study|Death|1
4662306|NCT02968563|16024324|P2|Overall Study|Adverse Event|5
4662307|NCT02968563|16024325|P1|Overall Study|Adverse Event|0
4662308|NCT02968173|16024403|P1|Overall Study|Withdrawal by Subject|1
4662309|NCT02967055|16024656|P1|Overall Study|Stopped due to drug cost|1
4662310|NCT02967055|16024656|P1|Overall Study|Stopped due to side effects|3
4662311|NCT02967055|16024656|P1|Overall Study|Lost to Follow-up|2
4662312|NCT02967055|16024656|P1|Overall Study|Screen fail|3
4662313|NCT02967055|16024656|P1|Overall Study|Excluded|40
4662314|NCT02966795|16024677|P2|Overall Study|Patient Left the Country|1
4662315|NCT02966795|16024678|P1|Overall Study|Patient Left the Country|0
4662316|NCT02966509|16024689|P2|End of Life Utilization and Cost 15month|Patient Still Alive|48
4662317|NCT02966509|16024690|P1|End of Life Utilization and Cost 15month|Patient Still Alive|45
4662318|NCT02966509|16024689|P2|End of Life Utilization and Cost 6 Month|Patient Still Alive|75
4662319|NCT02966509|16024690|P1|End of Life Utilization and Cost 6 Month|Patient Still Alive|69
4662320|NCT02966509|16024689|P2|6 Month Satisfaction Survey|Refused to Answer|11
4662321|NCT02966509|16024690|P1|6 Month Satisfaction Survey|Refused to Answer|8
4662322|NCT02966509|16024689|P2|6 Month Satisfaction Survey|Lost to Follow-up|1
4662323|NCT02966509|16024690|P1|6 Month Satisfaction Survey|Lost to Follow-up|1
4662324|NCT02966509|16024689|P2|6 Month Satisfaction Survey|Withdrawal by Subject|3
4662325|NCT02966509|16024690|P1|6 Month Satisfaction Survey|Withdrawal by Subject|2
4662326|NCT02966509|16024689|P2|6 Month Satisfaction Survey|Death|33
4662327|NCT02966509|16024690|P1|6 Month Satisfaction Survey|Death|36
4662328|NCT02966509|16024689|P2|6 Month Satisfaction Decision Survey|Refused to Answer|2
4662329|NCT02966509|16024690|P1|6 Month Satisfaction Decision Survey|Refused to Answer|0
4662330|NCT02966509|16024689|P2|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
4662331|NCT02966509|16024690|P1|6 Month Satisfaction Decision Survey|Lost to Follow-up|1
4662332|NCT02966509|16024689|P2|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3
4662333|NCT02966509|16024690|P1|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2
4662334|NCT02966509|16024689|P2|6 Month Satisfaction Decision Survey|Death|25
4662335|NCT02966509|16024690|P1|6 Month Satisfaction Decision Survey|Death|22
4662336|NCT02966509|16024689|P2|Baseline Satisfaction Survey|Refused to Answer|2
4662337|NCT02966509|16024690|P1|Baseline Satisfaction Survey|Refused to Answer|1
4662338|NCT02966509|16024689|P2|Baseline Satisfaction Survey|Lost to Follow-up|1
4662339|NCT02966509|16024690|P1|Baseline Satisfaction Survey|Lost to Follow-up|1
4662340|NCT02966509|16024689|P2|Baseline Satisfaction Survey|Death|1
4662341|NCT02966509|16024690|P1|Baseline Satisfaction Survey|Death|0
4662342|NCT02966509|16024689|P2|Baseline Satisfaction Survey|Withdrawal by Subject|3
4662343|NCT02966509|16024690|P1|Baseline Satisfaction Survey|Withdrawal by Subject|2
4662344|NCT02966353|16024714|P1|Overall Study|Protocol deviation|2
4662345|NCT02966353|16024714|P1|Overall Study|Progressive disease|2
4662346|NCT02966353|16024714|P1|Overall Study|Physician Decision|3
4662347|NCT02966353|16024714|P1|Overall Study|Death|4
4662348|NCT02966353|16024714|P1|Overall Study|Adverse Event|4
4662349|NCT02966353|16024714|P1|Overall Study|Withdrawal by Subject|7
4662350|NCT02966340|16024723|P2|Overall Study|startle non-responder|1
4662351|NCT02966340|16024724|P1|Overall Study|startle non-responder|1
4662352|NCT02966340|16024723|P2|Overall Study|data acquisition error|0
4662353|NCT02966340|16024724|P1|Overall Study|data acquisition error|1
4662354|NCT02966340|16024723|P2|Overall Study|Withdrawal by Subject|0
4662355|NCT02966340|16024724|P1|Overall Study|Withdrawal by Subject|1
4662356|NCT02966340|16024723|P2|Overall Study|Lost to Follow-up|1
4662357|NCT02966340|16024724|P1|Overall Study|Lost to Follow-up|0
4662358|NCT02966340|16024723|P2|Overall Study|Adverse Event|1
4662359|NCT02966340|16024724|P1|Overall Study|Adverse Event|0
4662360|NCT02966223|16024767|P1|Overall Study|Lost to Follow-up|1
4662361|NCT02966223|16024767|P1|Overall Study|Withdrawal by Subject|11
4662362|NCT02966223|16024767|P1|Overall Study|Physician Decision|3
4662363|NCT02966015|16024775|P2|Inclusion Visit|did not answer questionnaire|3
4662364|NCT02966015|16024776|P1|Inclusion Visit|did not answer questionnaire|8
4662365|NCT02966002|16024782|P1|Overall Study|Lost to Follow-up|1
4662366|NCT02966002|16024782|P1|Overall Study|Adverse Event|1
4662367|NCT02966002|16024782|P1|Overall Study|Withdrawal by Subject|2
4662368|NCT02965846|16024797|P3|Overall Study|Participants not randomized|33
4662369|NCT02965846|16024798|P2|Overall Study|Participants not randomized|0
4662370|NCT02965846|16024799|P1|Overall Study|Participants not randomized|0
4662371|NCT02965846|16024797|P3|Overall Study|Study Terminated By Sponsor|0
4662372|NCT02965846|16024798|P2|Overall Study|Study Terminated By Sponsor|4
4662373|NCT02965846|16024799|P1|Overall Study|Study Terminated By Sponsor|4
4662374|NCT02965846|16024797|P3|Overall Study|Withdrawal by Subject|0
4662375|NCT02965846|16024798|P2|Overall Study|Withdrawal by Subject|1
4662376|NCT02965846|16024799|P1|Overall Study|Withdrawal by Subject|0
4662377|NCT02965846|16024797|P3|Overall Study|Lost to Follow-up|0
4662378|NCT02965846|16024798|P2|Overall Study|Lost to Follow-up|0
4662379|NCT02965846|16024799|P1|Overall Study|Lost to Follow-up|1
4662380|NCT02965833|16024807|P2|Period 2, Second 30 Days of Wear|Protocol Violation|0
4662381|NCT02965833|16024808|P1|Period 2, Second 30 Days of Wear|Protocol Violation|2
4662382|NCT02965833|16024807|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
4662383|NCT02965833|16024808|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
4662384|NCT02965833|16024807|P2|Period 1, First 30 Days of Wear|Protocol Violation|0
4662385|NCT02965833|16024808|P1|Period 1, First 30 Days of Wear|Protocol Violation|1
4662386|NCT02965833|16024807|P2|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4662387|NCT02965833|16024808|P1|Period 1, First 30 Days of Wear|Lost to Follow-up|1
4662388|NCT02965833|16024807|P2|Period 1, First 30 Days of Wear|Adverse Event|1
4662389|NCT02965833|16024808|P1|Period 1, First 30 Days of Wear|Adverse Event|0
4662390|NCT02965820|16024814|P2|Period 2, Second 30 Days|Adverse Event|1
4662391|NCT02965820|16024815|P1|Period 2, Second 30 Days|Adverse Event|1
4662392|NCT02965599|16024854|P2|Overall Study|Protocol-defined stop criteria reached|0
4662393|NCT02965599|16024855|P1|Overall Study|Protocol-defined stop criteria reached|1
4662394|NCT02965456|16024934|P2|Overall Study|Participant ran out of study drug|1
4662395|NCT02965456|16024935|P1|Overall Study|Participant ran out of study drug|0
4662396|NCT02965456|16024934|P2|Overall Study|Protocol Violation|1
4662397|NCT02965456|16024935|P1|Overall Study|Protocol Violation|0
4662398|NCT02965456|16024934|P2|Overall Study|Pregnancy|0
4662399|NCT02965456|16024935|P1|Overall Study|Pregnancy|1
4662400|NCT02965456|16024934|P2|Overall Study|Physician Decision|1
4662401|NCT02965456|16024935|P1|Overall Study|Physician Decision|0
4662402|NCT02965456|16024934|P2|Overall Study|Lack of Efficacy|0
4662403|NCT02965456|16024935|P1|Overall Study|Lack of Efficacy|1
4662404|NCT02965456|16024934|P2|Overall Study|Worsening Condition|2
4662405|NCT02965456|16024935|P1|Overall Study|Worsening Condition|0
4662406|NCT02965456|16024934|P2|Overall Study|Noncompliance with Study Drug|1
4662407|NCT02965456|16024935|P1|Overall Study|Noncompliance with Study Drug|1
4662408|NCT02965456|16024934|P2|Overall Study|Adverse Event|0
4662409|NCT02965456|16024935|P1|Overall Study|Adverse Event|3
4662410|NCT02965456|16024934|P2|Overall Study|Withdrawal by Parent or Guardian|6
4662411|NCT02965456|16024935|P1|Overall Study|Withdrawal by Parent or Guardian|3
4662412|NCT02965456|16024934|P2|Overall Study|Subject Request|13
4662413|NCT02965456|16024935|P1|Overall Study|Subject Request|22
4662414|NCT02965456|16024934|P2|Overall Study|Lost to Follow-up|18
4662415|NCT02965456|16024935|P1|Overall Study|Lost to Follow-up|40
4662416|NCT02964338|16025026|P3|Overall Study|Did not meet criteria|0
4662417|NCT02964338|16025027|P2|Overall Study|Did not meet criteria|0
4662418|NCT02964338|16025028|P1|Overall Study|Did not meet criteria|1
4662419|NCT02964338|16025026|P3|Overall Study|Non-compliant with e-diary|0
4662420|NCT02964338|16025027|P2|Overall Study|Non-compliant with e-diary|1
4662421|NCT02964338|16025028|P1|Overall Study|Non-compliant with e-diary|0
4662422|NCT02964338|16025026|P3|Overall Study|Adverse Event|1
4662423|NCT02964338|16025027|P2|Overall Study|Adverse Event|1
4662424|NCT02964338|16025028|P1|Overall Study|Adverse Event|2
4662425|NCT02964338|16025026|P3|Overall Study|Withdrawal by Subject|1
4662426|NCT02964338|16025027|P2|Overall Study|Withdrawal by Subject|3
4662427|NCT02964338|16025028|P1|Overall Study|Withdrawal by Subject|1
4662428|NCT02964338|16025026|P3|Overall Study|Protocol Violation|0
4662429|NCT02964338|16025027|P2|Overall Study|Protocol Violation|1
4662430|NCT02964338|16025028|P1|Overall Study|Protocol Violation|0
4662431|NCT02964338|16025026|P3|Overall Study|Lost to Follow-up|3
4662432|NCT02964338|16025027|P2|Overall Study|Lost to Follow-up|0
4662433|NCT02964338|16025028|P1|Overall Study|Lost to Follow-up|1
4662434|NCT02964338|16025026|P3|Overall Study|Lack of Efficacy|0
4662435|NCT02964338|16025027|P2|Overall Study|Lack of Efficacy|3
4662436|NCT02964338|16025028|P1|Overall Study|Lack of Efficacy|0
4662437|NCT02964338|16025026|P3|Overall Study|Sponsor terminated study for futility|14
4662438|NCT02964338|16025027|P2|Overall Study|Sponsor terminated study for futility|15
4662439|NCT02964338|16025028|P1|Overall Study|Sponsor terminated study for futility|12
4662440|NCT02964312|16025072|P1|Overall Study|Death|1
4662441|NCT02964312|16025072|P1|Overall Study|Did not consent to long-term FU|14
4662442|NCT02964312|16025072|P1|Overall Study|Lack of Efficacy|10
4662443|NCT02964312|16025072|P1|Overall Study|Withdrawal by Subject|11
4662444|NCT02964312|16025072|P1|Overall Study|Lost to Follow-up|28
4662445|NCT02964247|16025083|P2|Overall Study|Withdrawal by Subject|2
4662446|NCT02964247|16025084|P1|Overall Study|Withdrawal by Subject|1
4662447|NCT02964247|16025083|P2|Overall Study|Lost to Follow-up|0
4662448|NCT02964247|16025084|P1|Overall Study|Lost to Follow-up|2
4662449|NCT02964234|16025142|P2|Overall Study|Lost to Follow-up|13
4662450|NCT02964234|16025143|P1|Overall Study|Lost to Follow-up|22
4662451|NCT02963935|16025172|P2|Overall Study|Unclassified|22
4662452|NCT02963935|16025173|P1|Overall Study|Unclassified|13
4662453|NCT02963935|16025172|P2|Overall Study|Lost to Follow-up|6
4662454|NCT02963935|16025173|P1|Overall Study|Lost to Follow-up|1
4662455|NCT02963935|16025172|P2|Overall Study|Lack of Efficacy|2
4662456|NCT02963935|16025173|P1|Overall Study|Lack of Efficacy|0
4662457|NCT02963935|16025172|P2|Overall Study|Protocol Violation|1
4662458|NCT02963935|16025173|P1|Overall Study|Protocol Violation|2
4662459|NCT02963935|16025172|P2|Overall Study|Adverse Event|6
4662460|NCT02963935|16025173|P1|Overall Study|Adverse Event|12
4662461|NCT02963922|16025281|P2|Overall Study|Other|14
4662462|NCT02963922|16025282|P1|Overall Study|Other|8
4662463|NCT02963922|16025281|P2|Overall Study|Lost to Follow-up|3
4662464|NCT02963922|16025282|P1|Overall Study|Lost to Follow-up|2
4662465|NCT02963922|16025281|P2|Overall Study|Lack of Efficacy|1
4662466|NCT02963922|16025282|P1|Overall Study|Lack of Efficacy|1
4662467|NCT02963922|16025281|P2|Overall Study|Protocol deviation|6
4662468|NCT02963922|16025282|P1|Overall Study|Protocol deviation|6
4662469|NCT02963922|16025281|P2|Overall Study|Adverse Event|6
4662470|NCT02963922|16025282|P1|Overall Study|Adverse Event|15
4662471|NCT02963701|16025380|P2|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0
4662472|NCT02963701|16025381|P1|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1
4662473|NCT02963311|16025436|P1|Overall Study|Screen Failure|4
4662474|NCT02963311|16025436|P1|Overall Study|Withdrawal by Subject|1
4662475|NCT02962960|16025463|P3|Overall Study|Protocol Violation|0
4662476|NCT02962960|16025464|P2|Overall Study|Protocol Violation|0
4662477|NCT02962960|16025465|P1|Overall Study|Protocol Violation|1
4662478|NCT02962960|16025463|P3|Overall Study|Adverse Event|0
4662479|NCT02962960|16025464|P2|Overall Study|Adverse Event|1
4662480|NCT02962960|16025465|P1|Overall Study|Adverse Event|1
4662481|NCT02962960|16025463|P3|Overall Study|Withdrawal by Subject|0
4662482|NCT02962960|16025464|P2|Overall Study|Withdrawal by Subject|1
4662483|NCT02962960|16025465|P1|Overall Study|Withdrawal by Subject|1
4662484|NCT02962908|16025549|P4|Overall Study|Physician Decision|0
4662485|NCT02962908|16025550|P3|Overall Study|Physician Decision|0
4662486|NCT02962908|16025551|P2|Overall Study|Physician Decision|1
4662487|NCT02962908|16025552|P1|Overall Study|Physician Decision|0
4662488|NCT02962908|16025549|P4|Overall Study|Protocol Violation|0
4662489|NCT02962908|16025550|P3|Overall Study|Protocol Violation|0
4662490|NCT02962908|16025551|P2|Overall Study|Protocol Violation|1
4662491|NCT02962908|16025552|P1|Overall Study|Protocol Violation|0
4662492|NCT02962908|16025549|P4|Overall Study|Withdrawal by Subject|2
4662493|NCT02962908|16025550|P3|Overall Study|Withdrawal by Subject|0
4662494|NCT02962908|16025551|P2|Overall Study|Withdrawal by Subject|3
4662495|NCT02962908|16025552|P1|Overall Study|Withdrawal by Subject|0
4662496|NCT02962908|16025549|P4|Overall Study|Lost to Follow-up|1
4662497|NCT02962908|16025550|P3|Overall Study|Lost to Follow-up|0
4662498|NCT02962908|16025551|P2|Overall Study|Lost to Follow-up|3
4662499|NCT02962908|16025552|P1|Overall Study|Lost to Follow-up|0
4662500|NCT02962882|16025616|P1|Overall Study|Transfer from ICU|32
4662501|NCT02962882|16025616|P1|Overall Study|Withdrawal by Subject|2
4662502|NCT02962882|16025616|P1|Overall Study|Adverse Event|2
4662503|NCT02962648|16025652|P1|Overall Study|Subject had problems with transportation|2
4662504|NCT02962648|16025652|P1|Overall Study|Physician Decision|1
4662505|NCT02962648|16025652|P1|Overall Study|Lost to Follow-up|3
4662506|NCT02962648|16025652|P1|Overall Study|Withdrawal by Subject|3
4662507|NCT02962284|16025690|P2|Overall Study|Withdrawal by Subject|0
4662508|NCT02962284|16025691|P1|Overall Study|Withdrawal by Subject|1
4662509|NCT02962284|16025690|P2|Overall Study|Progressive disease|3
4662510|NCT02962284|16025691|P1|Overall Study|Progressive disease|2
4662511|NCT02962284|16025690|P2|Overall Study|Death|0
4662512|NCT02962284|16025691|P1|Overall Study|Death|2
4662513|NCT02961920|16025722|P2|Overall Study|did not achive stydy protocol schedule|1
4662514|NCT02961920|16025723|P1|Overall Study|did not achive stydy protocol schedule|1
4662515|NCT02961790|16025733|P4|Overall Study|without post baseline data|1
4662516|NCT02961790|16025734|P3|Overall Study|without post baseline data|4
4662517|NCT02961790|16025735|P2|Overall Study|without post baseline data|6
4662518|NCT02961790|16025736|P1|Overall Study|without post baseline data|7
4662519|NCT02961790|16025733|P4|Overall Study|without baseline data|0
4662520|NCT02961790|16025734|P3|Overall Study|without baseline data|1
4662521|NCT02961790|16025735|P2|Overall Study|without baseline data|0
4662522|NCT02961790|16025736|P1|Overall Study|without baseline data|4
4662523|NCT02961790|16025733|P4|Overall Study|Canceled|4
4662524|NCT02961790|16025734|P3|Overall Study|Canceled|1
4662525|NCT02961790|16025735|P2|Overall Study|Canceled|5
4662526|NCT02961790|16025736|P1|Overall Study|Canceled|4
4662527|NCT02961764|16025759|P2|Overall Study|Withdrawal by Subject|0
4662528|NCT02961764|16025760|P1|Overall Study|Withdrawal by Subject|2
4662529|NCT02961764|16025759|P2|Overall Study|Lost to Follow-up|24
4662530|NCT02961764|16025760|P1|Overall Study|Lost to Follow-up|35
4662531|NCT02961764|16025759|P2|Overall Study|Death|0
4662532|NCT02961764|16025760|P1|Overall Study|Death|2
4662533|NCT02961764|16025759|P2|Overall Study|Protocol Violation|1
4662534|NCT02961764|16025760|P1|Overall Study|Protocol Violation|0
4662535|NCT02961751|16025834|P1|Overall Study|Protocol Violation|1
4662536|NCT02961751|16025834|P1|Overall Study|Not Eligible at Enrollment|1
4662537|NCT02961751|16025834|P1|Overall Study|Physician Decision|2
4662538|NCT02961751|16025834|P1|Overall Study|Lost to Follow-up|11
4662539|NCT02961244|16025847|P2|Overall Study|İnadequate data|2
4662540|NCT02961244|16025848|P1|Overall Study|İnadequate data|0
4662541|NCT02961244|16025847|P2|Overall Study|Lost to Follow-up|2
4662542|NCT02961244|16025848|P1|Overall Study|Lost to Follow-up|0
4662543|NCT02961244|16025847|P2|Overall Study|Surgery plan change after study approval|2
4662544|NCT02961244|16025848|P1|Overall Study|Surgery plan change after study approval|0
4662545|NCT02961244|16025847|P2|Overall Study|Withdrawal by Subject|2
4662546|NCT02961244|16025848|P1|Overall Study|Withdrawal by Subject|1
4662547|NCT02961244|16025847|P2|Overall Study|Protocol Violation|1
4662548|NCT02961244|16025848|P1|Overall Study|Protocol Violation|0
4662549|NCT02960893|16025901|P2|Extension Phase (48-week)|Sponsors Decision|0
4662550|NCT02960893|16025902|P1|Extension Phase (48-week)|Sponsors Decision|1
4662551|NCT02960893|16025901|P2|Extension Phase (48-week)|Lost to Follow-up|1
4662552|NCT02960893|16025902|P1|Extension Phase (48-week)|Lost to Follow-up|1
4662553|NCT02960893|16025901|P2|Extension Phase (48-week)|Other Reason|1
4662554|NCT02960893|16025902|P1|Extension Phase (48-week)|Other Reason|2
4662555|NCT02960893|16025901|P2|Extension Phase (48-week)|Withdrawal by Subject|8
4662556|NCT02960893|16025902|P1|Extension Phase (48-week)|Withdrawal by Subject|8
4662557|NCT02960893|16025901|P2|Extension Phase (48-week)|Adverse Event|3
4662558|NCT02960893|16025902|P1|Extension Phase (48-week)|Adverse Event|2
4662559|NCT02960893|16025901|P2|Randomization Phase (8-week)|Reason Not Specified|1
4662560|NCT02960893|16025902|P1|Randomization Phase (8-week)|Reason Not Specified|0
4662561|NCT02960893|16025901|P2|Randomization Phase (8-week)|Withdrawal by Subject|1
4662562|NCT02960893|16025902|P1|Randomization Phase (8-week)|Withdrawal by Subject|2
4662563|NCT02960893|16025901|P2|Randomization Phase (8-week)|Adverse Event|0
4662564|NCT02960893|16025902|P1|Randomization Phase (8-week)|Adverse Event|5
4662565|NCT02960854|16025920|P2|Overall Study|Death|6
4662566|NCT02960854|16025921|P1|Overall Study|Death|4
4662567|NCT02960854|16025920|P2|Overall Study|Subject Withdrew Consent|1
4662568|NCT02960854|16025921|P1|Overall Study|Subject Withdrew Consent|0
4662569|NCT02960854|16025920|P2|Overall Study|Subject No Longer Meets Study Criteria|0
4662570|NCT02960854|16025921|P1|Overall Study|Subject No Longer Meets Study Criteria|1
4662571|NCT02960854|16025920|P2|Overall Study|Not Disclosed|2
4662572|NCT02960854|16025921|P1|Overall Study|Not Disclosed|2
4662573|NCT02960217|16025960|P2|Open-Label Extension Phase|Other, Not Specified|1
4662574|NCT02960217|16025961|P1|Open-Label Extension Phase|Other, Not Specified|0
4662575|NCT02960217|16025960|P2|Open-Label Extension Phase|Lack of Efficacy|1
4662576|NCT02960217|16025961|P1|Open-Label Extension Phase|Lack of Efficacy|1
4662577|NCT02960217|16025960|P2|Open-Label Extension Phase|Sponsor Decision|11
4662578|NCT02960217|16025961|P1|Open-Label Extension Phase|Sponsor Decision|18
4662579|NCT02960217|16025960|P2|Open-Label Extension Phase|Adverse Event|0
4662580|NCT02960217|16025961|P1|Open-Label Extension Phase|Adverse Event|1
4662581|NCT02960217|16025960|P2|Maintenance Phase: Treatment Period 2|Other, Not Specified|1
4662582|NCT02960217|16025961|P1|Maintenance Phase: Treatment Period 2|Other, Not Specified|0
4662583|NCT02960217|16025960|P2|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0
4662584|NCT02960217|16025961|P1|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1
4662585|NCT02960217|16025960|P2|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1
4662586|NCT02960217|16025961|P1|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0
4662587|NCT02960217|16025960|P2|Maintenance Phase: Treatment Period 2|Adverse Event|1
4662588|NCT02960217|16025961|P1|Maintenance Phase: Treatment Period 2|Adverse Event|0
4662589|NCT02960217|16025960|P2|Maintenance Phase: Treatment Period 1|Adverse Event|0
4662590|NCT02960217|16025961|P1|Maintenance Phase: Treatment Period 1|Adverse Event|1
4662591|NCT02959983|16026040|P2|Overall Study|Withdrawal by Subject|12
4662592|NCT02959983|16026041|P1|Overall Study|Withdrawal by Subject|7
4662593|NCT02959983|16026040|P2|Overall Study|Adverse Event|1
4662594|NCT02959983|16026041|P1|Overall Study|Adverse Event|5
4662595|NCT02959983|16026040|P2|Overall Study|Physician Decision|0
4662596|NCT02959983|16026041|P1|Overall Study|Physician Decision|1
4662597|NCT02959983|16026040|P2|Overall Study|Other|1
4662598|NCT02959983|16026041|P1|Overall Study|Other|1
4662599|NCT02959983|16026040|P2|Overall Study|Lost to Follow-up|9
4662600|NCT02959983|16026041|P1|Overall Study|Lost to Follow-up|12
4662601|NCT02959983|16026040|P2|Overall Study|Lack of Efficacy|1
4662602|NCT02959983|16026041|P1|Overall Study|Lack of Efficacy|0
4662603|NCT02959983|16026040|P2|Overall Study|Protocol Violation|1
4662604|NCT02959983|16026041|P1|Overall Study|Protocol Violation|0
4662605|NCT02959970|16026055|P2|Overall Study|Lost to Follow-up|5
4662606|NCT02959970|16026056|P1|Overall Study|Lost to Follow-up|1
4662607|NCT02959970|16026055|P2|Overall Study|Withdrawal by Subject|2
4662608|NCT02959970|16026056|P1|Overall Study|Withdrawal by Subject|0
4662609|NCT02959970|16026055|P2|Overall Study|Adverse Event|0
4662610|NCT02959970|16026056|P1|Overall Study|Adverse Event|1
4662611|NCT02959892|16026090|P2|Overall Study|Study termination|1
4662612|NCT02959892|16026091|P1|Overall Study|Study termination|0
4662613|NCT02959892|16026090|P2|Overall Study|PET tracer synthesis failure|0
4662614|NCT02959892|16026091|P1|Overall Study|PET tracer synthesis failure|1
4662615|NCT02959866|16026099|P1|Overall Study|Withdrawal by Subject|1
4662616|NCT02959814|16026188|P1|Overall Study|Excluded by FFR core-lab|24
4662617|NCT02959814|16026188|P1|Overall Study|In-procedure QFR not computed|6
4662618|NCT02959814|16026188|P1|Overall Study|FFR not measured|2
4662619|NCT02959814|16026188|P1|Overall Study|Protocol Violation|7
4662620|NCT02959814|16026188|P1|Overall Study|Excluded based on anatomical criteria|2
4662621|NCT02959814|16026188|P1|Overall Study|Excluded based on diagnostic angiography|16
4662622|NCT02959437|16026211|P4|Overall Study|Participants Ongoing in Study|0
4662623|NCT02959437|16026212|P3|Overall Study|Participants Ongoing in Study|0
4662624|NCT02959437|16026213|P2|Overall Study|Participants Ongoing in Study|0
4662625|NCT02959437|16026214|P1|Overall Study|Participants Ongoing in Study|7
4662626|NCT02959437|16026211|P4|Overall Study|Other Unspecified|0
4662627|NCT02959437|16026212|P3|Overall Study|Other Unspecified|0
4662628|NCT02959437|16026213|P2|Overall Study|Other Unspecified|0
4662629|NCT02959437|16026214|P1|Overall Study|Other Unspecified|2
4662630|NCT02959437|16026211|P4|Overall Study|Study Terminated by Sponsor|0
4662631|NCT02959437|16026212|P3|Overall Study|Study Terminated by Sponsor|0
4662632|NCT02959437|16026213|P2|Overall Study|Study Terminated by Sponsor|0
4662633|NCT02959437|16026214|P1|Overall Study|Study Terminated by Sponsor|2
4662634|NCT02959437|16026211|P4|Overall Study|Progressive Disease|0
4662635|NCT02959437|16026212|P3|Overall Study|Progressive Disease|0
4662636|NCT02959437|16026213|P2|Overall Study|Progressive Disease|1
4662637|NCT02959437|16026214|P1|Overall Study|Progressive Disease|8
4662638|NCT02959437|16026211|P4|Overall Study|Withdrawal by Subject|0
4662639|NCT02959437|16026212|P3|Overall Study|Withdrawal by Subject|0
4662640|NCT02959437|16026213|P2|Overall Study|Withdrawal by Subject|3
4662641|NCT02959437|16026214|P1|Overall Study|Withdrawal by Subject|10
4662642|NCT02959437|16026211|P4|Overall Study|Lost to Follow-up|0
4662643|NCT02959437|16026212|P3|Overall Study|Lost to Follow-up|0
4662644|NCT02959437|16026213|P2|Overall Study|Lost to Follow-up|1
4662645|NCT02959437|16026214|P1|Overall Study|Lost to Follow-up|2
4662646|NCT02959437|16026211|P4|Overall Study|Death|0
4662647|NCT02959437|16026212|P3|Overall Study|Death|0
4662648|NCT02959437|16026213|P2|Overall Study|Death|3
4662649|NCT02959437|16026214|P1|Overall Study|Death|31
4662650|NCT02959190|16026247|P4|Post Treatment Follow Up|Withdrawal by Subject|0
4662651|NCT02959190|16026248|P3|Post Treatment Follow Up|Withdrawal by Subject|1
4662652|NCT02959190|16026249|P2|Post Treatment Follow Up|Withdrawal by Subject|0
4662653|NCT02959190|16026250|P1|Post Treatment Follow Up|Withdrawal by Subject|2
4662654|NCT02959190|16026247|P4|Post Treatment Follow Up|Adverse Event|0
4662655|NCT02959190|16026248|P3|Post Treatment Follow Up|Adverse Event|0
4662656|NCT02959190|16026249|P2|Post Treatment Follow Up|Adverse Event|1
4662657|NCT02959190|16026250|P1|Post Treatment Follow Up|Adverse Event|1
4662658|NCT02959190|16026247|P4|Open Label|Protocol Violation|2
4662659|NCT02959190|16026248|P3|Open Label|Protocol Violation|0
4662660|NCT02959190|16026249|P2|Open Label|Protocol Violation|0
4662661|NCT02959190|16026250|P1|Open Label|Protocol Violation|0
4662662|NCT02959190|16026247|P4|Open Label|Physician Decision|0
4662663|NCT02959190|16026248|P3|Open Label|Physician Decision|1
4662664|NCT02959190|16026249|P2|Open Label|Physician Decision|0
4662665|NCT02959190|16026250|P1|Open Label|Physician Decision|0
4662666|NCT02959190|16026247|P4|Open Label|Withdrawal by Subject|0
4662667|NCT02959190|16026248|P3|Open Label|Withdrawal by Subject|0
4662668|NCT02959190|16026249|P2|Open Label|Withdrawal by Subject|8
4662669|NCT02959190|16026250|P1|Open Label|Withdrawal by Subject|2
4662670|NCT02959190|16026247|P4|Open Label|Pregnancy|0
4662671|NCT02959190|16026248|P3|Open Label|Pregnancy|0
4662672|NCT02959190|16026249|P2|Open Label|Pregnancy|1
4662673|NCT02959190|16026250|P1|Open Label|Pregnancy|0
4662674|NCT02959190|16026247|P4|Open Label|Adverse Event|4
4662675|NCT02959190|16026248|P3|Open Label|Adverse Event|3
4662676|NCT02959190|16026249|P2|Open Label|Adverse Event|7
4662677|NCT02959190|16026250|P1|Open Label|Adverse Event|5
4662678|NCT02959177|16026343|P3|Follow-up Post Treatment Phase|Withdrawal by Subject|2
4662679|NCT02959177|16026344|P2|Follow-up Post Treatment Phase|Withdrawal by Subject|0
4662680|NCT02959177|16026345|P1|Follow-up Post Treatment Phase|Withdrawal by Subject|0
4662681|NCT02959177|16026343|P3|Follow-up Post Treatment Phase|Adverse Event|0
4662682|NCT02959177|16026344|P2|Follow-up Post Treatment Phase|Adverse Event|1
4662683|NCT02959177|16026345|P1|Follow-up Post Treatment Phase|Adverse Event|0
4662684|NCT02959177|16026343|P3|Follow-up Post Treatment Phase|Lost to Follow-up|0
4662685|NCT02959177|16026344|P2|Follow-up Post Treatment Phase|Lost to Follow-up|0
4662686|NCT02959177|16026345|P1|Follow-up Post Treatment Phase|Lost to Follow-up|1
4662687|NCT02959177|16026343|P3|Double-Blind Treatment Phase|Withdrawal by Subject|5
4662688|NCT02959177|16026344|P2|Double-Blind Treatment Phase|Withdrawal by Subject|0
4662689|NCT02959177|16026345|P1|Double-Blind Treatment Phase|Withdrawal by Subject|5
4662690|NCT02959177|16026343|P3|Double-Blind Treatment Phase|Protocol Violation|0
4662691|NCT02959177|16026344|P2|Double-Blind Treatment Phase|Protocol Violation|1
4662692|NCT02959177|16026345|P1|Double-Blind Treatment Phase|Protocol Violation|0
4662693|NCT02959177|16026343|P3|Double-Blind Treatment Phase|Physician Decision|0
4662694|NCT02959177|16026344|P2|Double-Blind Treatment Phase|Physician Decision|0
4662695|NCT02959177|16026345|P1|Double-Blind Treatment Phase|Physician Decision|1
4662696|NCT02959177|16026343|P3|Double-Blind Treatment Phase|Adverse Event|0
4662697|NCT02959177|16026344|P2|Double-Blind Treatment Phase|Adverse Event|2
4662698|NCT02959177|16026345|P1|Double-Blind Treatment Phase|Adverse Event|5
4662699|NCT02959138|16026400|P3|Overall Study|Enrolled but Never Treated|0
4662700|NCT02959138|16026401|P2|Overall Study|Enrolled but Never Treated|1
4662701|NCT02959138|16026402|P1|Overall Study|Enrolled but Never Treated|0
4662702|NCT02958553|16026543|P1|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2
4662703|NCT02958553|16026543|P1|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1
4662704|NCT02958267|16026577|P2|Follow-up Visits|Additional treatment pursued|1
4662705|NCT02958267|16026578|P1|Follow-up Visits|Additional treatment pursued|2
4662706|NCT02958267|16026577|P2|Enrollment to Actual Treatment Complete|Physician Decision|0
4662707|NCT02958267|16026578|P1|Enrollment to Actual Treatment Complete|Physician Decision|1
4662708|NCT02958267|16026577|P2|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0
4662709|NCT02958267|16026578|P1|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1
4662710|NCT02957942|16026590|P2|Overall Study|Practicing experiment protocol|6
4662711|NCT02957942|16026591|P1|Overall Study|Practicing experiment protocol|0
4662712|NCT02957942|16026590|P2|Overall Study|Withdrawal by Subject|1
4662713|NCT02957942|16026591|P1|Overall Study|Withdrawal by Subject|0
4662714|NCT02957747|16026607|P2|Overall Study|Lost to Follow-up|5
4662715|NCT02957747|16026608|P1|Overall Study|Lost to Follow-up|10
4662716|NCT02957747|16026607|P2|Overall Study|Withdrawal by Subject|3
4662717|NCT02957747|16026608|P1|Overall Study|Withdrawal by Subject|0
4662718|NCT02957331|16026636|P2|Overall Study|Protocol Violation|0
4662719|NCT02957331|16026637|P1|Overall Study|Protocol Violation|1
4662720|NCT02956967|16026656|P1|Overall Study|Termination of Nivestim administration|29
4662721|NCT02956967|16026656|P1|Overall Study|Missing|1
4662722|NCT02956967|16026656|P1|Overall Study|Lost to Follow-up|5
4662723|NCT02956967|16026656|P1|Overall Study|Reason non-related to neutropenia|10
4662724|NCT02956967|16026656|P1|Overall Study|Adverse Event|3
4662725|NCT02956837|16026683|P4|Overall Study|Lost to Follow-up|0
4662726|NCT02956837|16026684|P3|Overall Study|Lost to Follow-up|2
4662727|NCT02956837|16026685|P2|Overall Study|Lost to Follow-up|1
4662728|NCT02956837|16026686|P1|Overall Study|Lost to Follow-up|0
4662729|NCT02956837|16026683|P4|Overall Study|Withdrawal by Subject|3
4662730|NCT02956837|16026684|P3|Overall Study|Withdrawal by Subject|0
4662731|NCT02956837|16026685|P2|Overall Study|Withdrawal by Subject|1
4662732|NCT02956837|16026686|P1|Overall Study|Withdrawal by Subject|0
4662733|NCT02956837|16026683|P4|Overall Study|Serious Adverse Events|0
4662734|NCT02956837|16026684|P3|Overall Study|Serious Adverse Events|0
4662735|NCT02956837|16026685|P2|Overall Study|Serious Adverse Events|1
4662736|NCT02956837|16026686|P1|Overall Study|Serious Adverse Events|0
4662737|NCT02956629|16026821|P6|Overall Study|Withdrawal by Subject|0
4662738|NCT02956629|16026822|P5|Overall Study|Withdrawal by Subject|0
4662739|NCT02956629|16026823|P4|Overall Study|Withdrawal by Subject|0
4662740|NCT02956629|16026824|P3|Overall Study|Withdrawal by Subject|0
4662741|NCT02956629|16026825|P2|Overall Study|Withdrawal by Subject|1
4662742|NCT02956629|16026826|P1|Overall Study|Withdrawal by Subject|3
4662743|NCT02956629|16026821|P6|Overall Study|Lost to Follow-up|1
4662744|NCT02956629|16026822|P5|Overall Study|Lost to Follow-up|0
4662745|NCT02956629|16026823|P4|Overall Study|Lost to Follow-up|1
4662746|NCT02956629|16026824|P3|Overall Study|Lost to Follow-up|3
4662747|NCT02956629|16026825|P2|Overall Study|Lost to Follow-up|5
4662748|NCT02956629|16026826|P1|Overall Study|Lost to Follow-up|2
4662749|NCT02956629|16026821|P6|Overall Study|Adverse Event|0
4662750|NCT02956629|16026822|P5|Overall Study|Adverse Event|0
4662751|NCT02956629|16026823|P4|Overall Study|Adverse Event|0
4662752|NCT02956629|16026824|P3|Overall Study|Adverse Event|1
4662753|NCT02956629|16026825|P2|Overall Study|Adverse Event|0
4662754|NCT02956629|16026826|P1|Overall Study|Adverse Event|0
4662755|NCT02956460|16026905|P2|Lens 1|Lost to Follow-up|0
4662756|NCT02956460|16026906|P1|Lens 1|Lost to Follow-up|1
4662757|NCT02956278|16026935|P3|Overall Study|Withdrawal by Subject|0
4662758|NCT02956278|16026936|P2|Overall Study|Withdrawal by Subject|2
4662759|NCT02956278|16026937|P1|Overall Study|Withdrawal by Subject|6
4662760|NCT02956057|16027008|P6|Overall Study|Lost to Follow-up|0
4662761|NCT02956057|16027009|P5|Overall Study|Lost to Follow-up|1
4662762|NCT02956057|16027010|P4|Overall Study|Lost to Follow-up|1
4662763|NCT02956057|16027011|P3|Overall Study|Lost to Follow-up|1
4662764|NCT02956057|16027012|P2|Overall Study|Lost to Follow-up|2
4662765|NCT02956057|16027013|P1|Overall Study|Lost to Follow-up|0
4662766|NCT02956057|16027008|P6|Overall Study|Discontinued intervention|17
4662767|NCT02956057|16027009|P5|Overall Study|Discontinued intervention|4
4662768|NCT02956057|16027010|P4|Overall Study|Discontinued intervention|14
4662769|NCT02956057|16027011|P3|Overall Study|Discontinued intervention|7
4662770|NCT02956057|16027012|P2|Overall Study|Discontinued intervention|10
4662771|NCT02956057|16027013|P1|Overall Study|Discontinued intervention|14
4662772|NCT02956005|16027033|P1|Overall Study|Physician Decision|12
4662773|NCT02956005|16027033|P1|Overall Study|Withdrawal by Subject|3
4662774|NCT02956005|16027033|P1|Overall Study|Not eligible|1
4662775|NCT02955797|16027042|P4|Overall Study|Lost to Follow-up|0
4662776|NCT02955797|16027043|P3|Overall Study|Lost to Follow-up|0
4662777|NCT02955797|16027044|P2|Overall Study|Lost to Follow-up|1
4662778|NCT02955797|16027045|P1|Overall Study|Lost to Follow-up|0
4662779|NCT02955797|16027042|P4|Overall Study|Withdrawal by Subject|1
4662780|NCT02955797|16027043|P3|Overall Study|Withdrawal by Subject|0
4662781|NCT02955797|16027044|P2|Overall Study|Withdrawal by Subject|2
4662782|NCT02955797|16027045|P1|Overall Study|Withdrawal by Subject|2
4662783|NCT02955797|16027042|P4|Overall Study|Protocol Violation|1
4662784|NCT02955797|16027043|P3|Overall Study|Protocol Violation|0
4662785|NCT02955797|16027044|P2|Overall Study|Protocol Violation|0
4662786|NCT02955797|16027045|P1|Overall Study|Protocol Violation|1
4662787|NCT02955212|16027063|P2|Overall Study|Other|2
4662788|NCT02955212|16027064|P1|Overall Study|Other|3
4662789|NCT02955212|16027063|P2|Overall Study|Lost to Follow-up|0
4662790|NCT02955212|16027064|P1|Overall Study|Lost to Follow-up|1
4662791|NCT02955212|16027063|P2|Overall Study|Withdrawal by Subject|3
4662792|NCT02955212|16027064|P1|Overall Study|Withdrawal by Subject|8
4662793|NCT02955212|16027063|P2|Overall Study|Adverse Event|7
4662794|NCT02955212|16027064|P1|Overall Study|Adverse Event|4
4662795|NCT02954952|16027098|P3|Overall Study|No data collected|0
4662796|NCT02954952|16027099|P2|Overall Study|No data collected|1
4662797|NCT02954952|16027100|P1|Overall Study|No data collected|0
4662798|NCT02954952|16027098|P3|Overall Study|Withdrawal by Subject|0
4662799|NCT02954952|16027099|P2|Overall Study|Withdrawal by Subject|0
4662800|NCT02954952|16027100|P1|Overall Study|Withdrawal by Subject|1
4662801|NCT02954887|16027108|P1|Overall Study|Other|1
4662802|NCT02954887|16027108|P1|Overall Study|Lack of Efficacy|3
4662803|NCT02954887|16027108|P1|Overall Study|Withdrawal by Subject|3
4662804|NCT02954848|16027137|P2|Overall Study|Withdrawal by Participant|1
4662805|NCT02954848|16027138|P1|Overall Study|Withdrawal by Participant|0
4662806|NCT02954848|16027137|P2|Overall Study|Adverse Event|3
4662807|NCT02954848|16027138|P1|Overall Study|Adverse Event|2
4662808|NCT02954848|16027137|P2|Overall Study|Randomized but Not Treated|1
4662809|NCT02954848|16027138|P1|Overall Study|Randomized but Not Treated|0
4662810|NCT02954653|16027198|P9|Overall Study|Treatment failure and consent withdrawal|0
4662811|NCT02954653|16027199|P8|Overall Study|Treatment failure and consent withdrawal|0
4662812|NCT02954653|16027200|P7|Overall Study|Treatment failure and consent withdrawal|0
4662813|NCT02954653|16027201|P6|Overall Study|Treatment failure and consent withdrawal|0
4662814|NCT02954653|16027202|P5|Overall Study|Treatment failure and consent withdrawal|0
4662815|NCT02954653|16027203|P4|Overall Study|Treatment failure and consent withdrawal|0
4662816|NCT02954653|16027204|P3|Overall Study|Treatment failure and consent withdrawal|0
4662817|NCT02954653|16027205|P2|Overall Study|Treatment failure and consent withdrawal|1
4662818|NCT02954653|16027206|P1|Overall Study|Treatment failure and consent withdrawal|0
4662819|NCT02954653|16027198|P9|Overall Study|Started another anti-cancer therapy|0
4662820|NCT02954653|16027199|P8|Overall Study|Started another anti-cancer therapy|0
4662821|NCT02954653|16027200|P7|Overall Study|Started another anti-cancer therapy|0
4662822|NCT02954653|16027201|P6|Overall Study|Started another anti-cancer therapy|0
4662823|NCT02954653|16027202|P5|Overall Study|Started another anti-cancer therapy|0
4662824|NCT02954653|16027203|P4|Overall Study|Started another anti-cancer therapy|0
4662825|NCT02954653|16027204|P3|Overall Study|Started another anti-cancer therapy|0
4662826|NCT02954653|16027205|P2|Overall Study|Started another anti-cancer therapy|1
4662827|NCT02954653|16027206|P1|Overall Study|Started another anti-cancer therapy|0
4662828|NCT02954653|16027198|P9|Overall Study|Randomized but did not receive treatment|0
4662829|NCT02954653|16027199|P8|Overall Study|Randomized but did not receive treatment|0
4662830|NCT02954653|16027200|P7|Overall Study|Randomized but did not receive treatment|0
4662831|NCT02954653|16027201|P6|Overall Study|Randomized but did not receive treatment|0
4662832|NCT02954653|16027202|P5|Overall Study|Randomized but did not receive treatment|0
4662833|NCT02954653|16027203|P4|Overall Study|Randomized but did not receive treatment|0
4662834|NCT02954653|16027204|P3|Overall Study|Randomized but did not receive treatment|0
4662835|NCT02954653|16027205|P2|Overall Study|Randomized but did not receive treatment|0
4662836|NCT02954653|16027206|P1|Overall Study|Randomized but did not receive treatment|1
4662837|NCT02954653|16027198|P9|Overall Study|Death|0
4662838|NCT02954653|16027199|P8|Overall Study|Death|0
4662839|NCT02954653|16027200|P7|Overall Study|Death|0
4662840|NCT02954653|16027201|P6|Overall Study|Death|0
4662841|NCT02954653|16027202|P5|Overall Study|Death|0
4662842|NCT02954653|16027203|P4|Overall Study|Death|0
4662843|NCT02954653|16027204|P3|Overall Study|Death|0
4662844|NCT02954653|16027205|P2|Overall Study|Death|1
4662845|NCT02954653|16027206|P1|Overall Study|Death|3
4662846|NCT02954601|16027325|P4|First Intervention (Five Days)|Withdrawal by Subject|0
4662847|NCT02954601|16027326|P3|First Intervention (Five Days)|Withdrawal by Subject|1
4662848|NCT02954601|16027327|P2|First Intervention (Five Days)|Withdrawal by Subject|0
4662849|NCT02954601|16027328|P1|First Intervention (Five Days)|Withdrawal by Subject|0
4662850|NCT02954575|16027350|P1|Overall Study|Adverse Event|1
4662851|NCT02954575|16027350|P1|Overall Study|Withdrawal by Subject|2
4662852|NCT02954354|16027370|P3|Overall Study|Miscellaneous|1
4662853|NCT02954354|16027371|P2|Overall Study|Miscellaneous|2
4662854|NCT02954354|16027372|P1|Overall Study|Miscellaneous|2
4662855|NCT02954354|16027370|P3|Overall Study|Lost to Follow-up|0
4662856|NCT02954354|16027371|P2|Overall Study|Lost to Follow-up|5
4662857|NCT02954354|16027372|P1|Overall Study|Lost to Follow-up|12
4662858|NCT02954354|16027370|P3|Overall Study|Withdrawal by Subject|11
4662859|NCT02954354|16027371|P2|Overall Study|Withdrawal by Subject|9
4662860|NCT02954354|16027372|P1|Overall Study|Withdrawal by Subject|17
4662861|NCT02954354|16027370|P3|Overall Study|Lack of Efficacy|0
4662862|NCT02954354|16027371|P2|Overall Study|Lack of Efficacy|2
4662863|NCT02954354|16027372|P1|Overall Study|Lack of Efficacy|0
4662864|NCT02954354|16027370|P3|Overall Study|Failure to Meet Eligibility Criteria|0
4662865|NCT02954354|16027371|P2|Overall Study|Failure to Meet Eligibility Criteria|0
4662866|NCT02954354|16027372|P1|Overall Study|Failure to Meet Eligibility Criteria|1
4662867|NCT02954354|16027370|P3|Overall Study|Adverse Event|4
4662868|NCT02954354|16027371|P2|Overall Study|Adverse Event|2
4662869|NCT02954354|16027372|P1|Overall Study|Adverse Event|2
4662870|NCT02954159|16027473|P2|Overall Study|Withdrawal by Subject|1
4662871|NCT02954159|16027474|P1|Overall Study|Withdrawal by Subject|0
4662872|NCT02954159|16027473|P2|Overall Study|Study ended prematurely due to low enrol|0
4662873|NCT02954159|16027474|P1|Overall Study|Study ended prematurely due to low enrol|1
4662874|NCT02953938|16027488|P2|Overall Study|Withdrawal by Subject|1
4662875|NCT02953938|16027489|P1|Overall Study|Withdrawal by Subject|1
4662876|NCT02953938|16027488|P2|Overall Study|Adverse Event|1
4662877|NCT02953938|16027489|P1|Overall Study|Adverse Event|0
4662878|NCT02953821|16027520|P2|Overall Study|Refused follow-up visit|1
4662879|NCT02953821|16027521|P1|Overall Study|Refused follow-up visit|2
4662880|NCT02953821|16027520|P2|Overall Study|No improvement|1
4662881|NCT02953821|16027521|P1|Overall Study|No improvement|0
4662882|NCT02953821|16027520|P2|Overall Study|Out of state for indeterminate time|1
4662883|NCT02953821|16027521|P1|Overall Study|Out of state for indeterminate time|0
4662884|NCT02953821|16027520|P2|Overall Study|Lack of Efficacy|0
4662885|NCT02953821|16027521|P1|Overall Study|Lack of Efficacy|1
4662886|NCT02953821|16027520|P2|Overall Study|Change of address|1
4662887|NCT02953821|16027521|P1|Overall Study|Change of address|0
4662888|NCT02953821|16027520|P2|Overall Study|Withdrawal by Subject|3
4662889|NCT02953821|16027521|P1|Overall Study|Withdrawal by Subject|3
4662890|NCT02953821|16027520|P2|Overall Study|Physician Decision|1
4662891|NCT02953821|16027521|P1|Overall Study|Physician Decision|1
4662892|NCT02953821|16027520|P2|Overall Study|Lost to Follow-up|0
4662893|NCT02953821|16027521|P1|Overall Study|Lost to Follow-up|2
4662894|NCT02953821|16027520|P2|Overall Study|Progressive Disease|1
4662895|NCT02953821|16027521|P1|Overall Study|Progressive Disease|5
4662896|NCT02953821|16027520|P2|Overall Study|Death|0
4662897|NCT02953821|16027521|P1|Overall Study|Death|1
4662898|NCT02953821|16027520|P2|Overall Study|Adverse Event|4
4662899|NCT02953821|16027521|P1|Overall Study|Adverse Event|0
4662900|NCT02953678|16027539|P1|Overall Study|Reason unspecified|2
4662901|NCT02953678|16027539|P1|Overall Study|Withdrawal by Subject|3
4662902|NCT02953678|16027539|P1|Overall Study|Relapse of Underlying Malignancy|2
4662903|NCT02953678|16027539|P1|Overall Study|Progressive Disease of GVHD|6
4662904|NCT02953678|16027539|P1|Overall Study|Physician Decision|20
4662905|NCT02953678|16027539|P1|Overall Study|Death|7
4662906|NCT02953678|16027539|P1|Overall Study|Adverse Event|20
4662907|NCT02953314|16027587|P2|Overall Study|Withdrawal of consent (not due to AE)|2
4662908|NCT02953314|16027588|P1|Overall Study|Withdrawal of consent (not due to AE)|0
4662909|NCT02953314|16027587|P2|Overall Study|Adverse Event|1
4662910|NCT02953314|16027588|P1|Overall Study|Adverse Event|0
4662911|NCT02952898|16027614|P3|Overall Study|Non-compliance with study drug|2
4662912|NCT02952898|16027615|P2|Overall Study|Non-compliance with study drug|1
4662913|NCT02952898|16027616|P1|Overall Study|Non-compliance with study drug|1
4662914|NCT02952898|16027614|P3|Overall Study|Lost to Follow-up|2
4662915|NCT02952898|16027615|P2|Overall Study|Lost to Follow-up|2
4662916|NCT02952898|16027616|P1|Overall Study|Lost to Follow-up|3
4662917|NCT02952898|16027614|P3|Overall Study|Adverse Event|3
4662918|NCT02952898|16027615|P2|Overall Study|Adverse Event|8
4662919|NCT02952898|16027616|P1|Overall Study|Adverse Event|8
4662920|NCT02952898|16027614|P3|Overall Study|Withdrawal by Subject|8
4662921|NCT02952898|16027615|P2|Overall Study|Withdrawal by Subject|8
4662922|NCT02952898|16027616|P1|Overall Study|Withdrawal by Subject|10
4662923|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Not treated|1
4662924|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Not treated|0
4662925|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Not treated|0
4662926|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Other than specified|2
4662927|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Other than specified|6
4662928|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Other than specified|0
4662929|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Withdrawal of consent|8
4662930|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Withdrawal of consent|6
4662931|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Withdrawal of consent|0
4662932|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2
4662933|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6
4662934|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0
4662935|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Subject choice|7
4662936|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Subject choice|10
4662937|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Subject choice|0
4662938|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Lost to Follow-up|6
4662939|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Lost to Follow-up|4
4662940|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Lost to Follow-up|0
4662941|NCT02952820|16027740|P3|Active Treatment Period (6 Months)|Adverse Event|5
4662942|NCT02952820|16027741|P2|Active Treatment Period (6 Months)|Adverse Event|6
4662943|NCT02952820|16027742|P1|Active Treatment Period (6 Months)|Adverse Event|0
4662944|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Not treated|4
4662945|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Not treated|4
4662946|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Not treated|4
4662947|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21
4662948|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11
4662949|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13
4662950|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Other than specified|13
4662951|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Other than specified|14
4662952|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Other than specified|0
4662953|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11
4662954|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12
4662955|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17
4662956|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Subject choice|17
4662957|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Subject choice|12
4662958|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Subject choice|15
4662959|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6
4662960|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
4662961|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7
4662962|NCT02952820|16027740|P3|Placebo-Controlled Treatment (6 Months)|Adverse Event|16
4662963|NCT02952820|16027741|P2|Placebo-Controlled Treatment (6 Months)|Adverse Event|9
4662964|NCT02952820|16027742|P1|Placebo-Controlled Treatment (6 Months)|Adverse Event|8
4662965|NCT02952313|16027802|P1|Long-term Follow-up|Death|1
4662966|NCT02952313|16027802|P1|Long-term Follow-up|Physician Decision|1
4662967|NCT02952313|16027802|P1|Long-term Follow-up|Withdrawal by Subject|5
4662968|NCT02952313|16027802|P1|Long-term Follow-up|Lack of Efficacy|6
4662969|NCT02952313|16027802|P1|Long-term Follow-up|Did not reconsent for long-term FU|7
4662970|NCT02952313|16027802|P1|Long-term Follow-up|Lost to Follow-up|12
4662971|NCT02952313|16027802|P1|Primary Endpoint|Missed visit|1
4662972|NCT02952313|16027802|P1|Primary Endpoint|Lack of Efficacy|1
4662973|NCT02952313|16027802|P1|Primary Endpoint|Withdrawal by Subject|1
4662974|NCT02952313|16027802|P1|Primary Endpoint|Lost to Follow-up|4
4662975|NCT02952261|16027813|P2|Overall Study|Protocol Violation|0
4662976|NCT02952261|16027814|P1|Overall Study|Protocol Violation|1
4662977|NCT02952261|16027813|P2|Overall Study|Withdrawal by Subject|5
4662978|NCT02952261|16027814|P1|Overall Study|Withdrawal by Subject|4
4662979|NCT02951988|16027829|P4|Double-Blind Treatment Period|Miscellaneous Reasons|0
4662980|NCT02951988|16027830|P3|Double-Blind Treatment Period|Miscellaneous Reasons|1
4662981|NCT02951988|16027831|P2|Double-Blind Treatment Period|Miscellaneous Reasons|2
4662982|NCT02951988|16027832|P1|Double-Blind Treatment Period|Miscellaneous Reasons|0
4662983|NCT02951988|16027829|P4|Double-Blind Treatment Period|Adverse Event|6
4662984|NCT02951988|16027830|P3|Double-Blind Treatment Period|Adverse Event|3
4662985|NCT02951988|16027831|P2|Double-Blind Treatment Period|Adverse Event|8
4662986|NCT02951988|16027832|P1|Double-Blind Treatment Period|Adverse Event|0
4662987|NCT02951988|16027829|P4|Double-Blind Treatment Period|Withdrawal by Subject|28
4662988|NCT02951988|16027830|P3|Double-Blind Treatment Period|Withdrawal by Subject|22
4662989|NCT02951988|16027831|P2|Double-Blind Treatment Period|Withdrawal by Subject|23
4662990|NCT02951988|16027832|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
4662991|NCT02951988|16027829|P4|Double-Blind Treatment Period|Lost to Follow-up|3
4662992|NCT02951988|16027830|P3|Double-Blind Treatment Period|Lost to Follow-up|12
4662993|NCT02951988|16027831|P2|Double-Blind Treatment Period|Lost to Follow-up|4
4662994|NCT02951988|16027832|P1|Double-Blind Treatment Period|Lost to Follow-up|0
4662995|NCT02951988|16027829|P4|Double-Blind Treatment Period|Pregnancy|0
4662996|NCT02951988|16027830|P3|Double-Blind Treatment Period|Pregnancy|1
4662997|NCT02951988|16027831|P2|Double-Blind Treatment Period|Pregnancy|1
4662998|NCT02951988|16027832|P1|Double-Blind Treatment Period|Pregnancy|0
4662999|NCT02951988|16027829|P4|Double-Blind Treatment Period|Protocol Violation|8
4663000|NCT02951988|16027830|P3|Double-Blind Treatment Period|Protocol Violation|4
4663001|NCT02951988|16027831|P2|Double-Blind Treatment Period|Protocol Violation|4
4663002|NCT02951988|16027832|P1|Double-Blind Treatment Period|Protocol Violation|0
4663003|NCT02951988|16027829|P4|Double-Blind Treatment Period|Non-compliance with study drug|0
4663004|NCT02951988|16027830|P3|Double-Blind Treatment Period|Non-compliance with study drug|3
4663005|NCT02951988|16027831|P2|Double-Blind Treatment Period|Non-compliance with study drug|1
4663006|NCT02951988|16027832|P1|Double-Blind Treatment Period|Non-compliance with study drug|0
4663007|NCT02951988|16027829|P4|Double-Blind Treatment Period|Study terminated by sponsor|69
4663008|NCT02951988|16027830|P3|Double-Blind Treatment Period|Study terminated by sponsor|54
4663009|NCT02951988|16027831|P2|Double-Blind Treatment Period|Study terminated by sponsor|58
4663010|NCT02951988|16027832|P1|Double-Blind Treatment Period|Study terminated by sponsor|0
4663011|NCT02951988|16027829|P4|Double-Blind Treatment Period|Site terminated by sponsor|1
4663012|NCT02951988|16027830|P3|Double-Blind Treatment Period|Site terminated by sponsor|1
4663013|NCT02951988|16027831|P2|Double-Blind Treatment Period|Site terminated by sponsor|0
4663014|NCT02951988|16027832|P1|Double-Blind Treatment Period|Site terminated by sponsor|0
4663015|NCT02951988|16027829|P4|Open-Label Treatment Period|Adverse Event|0
4663016|NCT02951988|16027830|P3|Open-Label Treatment Period|Adverse Event|0
4663017|NCT02951988|16027831|P2|Open-Label Treatment Period|Adverse Event|0
4663018|NCT02951988|16027832|P1|Open-Label Treatment Period|Adverse Event|45
4663019|NCT02951988|16027829|P4|Open-Label Treatment Period|Lack of Efficacy|0
4663020|NCT02951988|16027830|P3|Open-Label Treatment Period|Lack of Efficacy|0
4663021|NCT02951988|16027831|P2|Open-Label Treatment Period|Lack of Efficacy|0
4663022|NCT02951988|16027832|P1|Open-Label Treatment Period|Lack of Efficacy|49
4663023|NCT02951988|16027829|P4|Open-Label Treatment Period|Withdrawal by Subject|0
4663024|NCT02951988|16027830|P3|Open-Label Treatment Period|Withdrawal by Subject|0
4663025|NCT02951988|16027831|P2|Open-Label Treatment Period|Withdrawal by Subject|0
4663026|NCT02951988|16027832|P1|Open-Label Treatment Period|Withdrawal by Subject|78
4663027|NCT02951988|16027829|P4|Open-Label Treatment Period|Lost to Follow-up|0
4663028|NCT02951988|16027830|P3|Open-Label Treatment Period|Lost to Follow-up|0
4663029|NCT02951988|16027831|P2|Open-Label Treatment Period|Lost to Follow-up|0
4663030|NCT02951988|16027832|P1|Open-Label Treatment Period|Lost to Follow-up|28
4663031|NCT02951988|16027829|P4|Open-Label Treatment Period|Pregnancy|0
4663032|NCT02951988|16027830|P3|Open-Label Treatment Period|Pregnancy|0
4663033|NCT02951988|16027831|P2|Open-Label Treatment Period|Pregnancy|0
4663034|NCT02951988|16027832|P1|Open-Label Treatment Period|Pregnancy|2
4663035|NCT02951988|16027829|P4|Open-Label Treatment Period|Protocol Violation|0
4663036|NCT02951988|16027830|P3|Open-Label Treatment Period|Protocol Violation|0
4663037|NCT02951988|16027831|P2|Open-Label Treatment Period|Protocol Violation|0
4663038|NCT02951988|16027832|P1|Open-Label Treatment Period|Protocol Violation|22
4663039|NCT02951988|16027829|P4|Open-Label Treatment Period|Non-compliance with study drug|0
4663040|NCT02951988|16027830|P3|Open-Label Treatment Period|Non-compliance with study drug|0
4663041|NCT02951988|16027831|P2|Open-Label Treatment Period|Non-compliance with study drug|0
4663042|NCT02951988|16027832|P1|Open-Label Treatment Period|Non-compliance with study drug|5
4663043|NCT02951988|16027829|P4|Open-Label Treatment Period|Non-compliance with background ADT|0
4663044|NCT02951988|16027830|P3|Open-Label Treatment Period|Non-compliance with background ADT|0
4663045|NCT02951988|16027831|P2|Open-Label Treatment Period|Non-compliance with background ADT|0
4663046|NCT02951988|16027832|P1|Open-Label Treatment Period|Non-compliance with background ADT|2
4663047|NCT02951988|16027829|P4|Open-Label Treatment Period|Study terminated by sponsor|0
4663048|NCT02951988|16027830|P3|Open-Label Treatment Period|Study terminated by sponsor|0
4663049|NCT02951988|16027831|P2|Open-Label Treatment Period|Study terminated by sponsor|0
4663050|NCT02951988|16027832|P1|Open-Label Treatment Period|Study terminated by sponsor|9
4663051|NCT02951988|16027829|P4|Open-Label Treatment Period|Miscellaneous Reasons|0
4663052|NCT02951988|16027830|P3|Open-Label Treatment Period|Miscellaneous Reasons|0
4663053|NCT02951988|16027831|P2|Open-Label Treatment Period|Miscellaneous Reasons|0
4663054|NCT02951988|16027832|P1|Open-Label Treatment Period|Miscellaneous Reasons|8
4663055|NCT02951819|16027865|P2|Overall Study|Ongoing|11
4663056|NCT02951819|16027866|P1|Overall Study|Ongoing|83
4663057|NCT02951819|16027865|P2|Overall Study|Other|0
4663058|NCT02951819|16027866|P1|Overall Study|Other|1
4663059|NCT02951819|16027865|P2|Overall Study|Progressive Disease|0
4663060|NCT02951819|16027866|P1|Overall Study|Progressive Disease|1
4663061|NCT02951819|16027865|P2|Overall Study|Withdrawal by Subject|0
4663062|NCT02951819|16027866|P1|Overall Study|Withdrawal by Subject|1
4663063|NCT02951819|16027865|P2|Overall Study|Death|3
4663064|NCT02951819|16027866|P1|Overall Study|Death|1
4663065|NCT02951780|16027897|P9|Period 2|Scheduling Conflicts|0
4663066|NCT02951780|16027898|P8|Period 2|Scheduling Conflicts|1
4663067|NCT02951780|16027899|P7|Period 2|Scheduling Conflicts|0
4663068|NCT02951780|16027900|P6|Period 2|Scheduling Conflicts|0
4663069|NCT02951780|16027901|P5|Period 2|Scheduling Conflicts|0
4663070|NCT02951780|16027902|P4|Period 2|Scheduling Conflicts|0
4663071|NCT02951780|16027903|P3|Period 2|Scheduling Conflicts|0
4663072|NCT02951780|16027904|P2|Period 2|Scheduling Conflicts|0
4663073|NCT02951780|16027905|P1|Period 2|Scheduling Conflicts|0
4663074|NCT02951780|16027897|P9|Period 1|Scheduling Conflicts|0
4663075|NCT02951780|16027898|P8|Period 1|Scheduling Conflicts|1
4663076|NCT02951780|16027899|P7|Period 1|Scheduling Conflicts|0
4663077|NCT02951780|16027900|P6|Period 1|Scheduling Conflicts|0
4663078|NCT02951780|16027901|P5|Period 1|Scheduling Conflicts|0
4663079|NCT02951780|16027902|P4|Period 1|Scheduling Conflicts|0
4663080|NCT02951780|16027903|P3|Period 1|Scheduling Conflicts|0
4663081|NCT02951780|16027904|P2|Period 1|Scheduling Conflicts|0
4663082|NCT02951780|16027905|P1|Period 1|Scheduling Conflicts|0
4663083|NCT02951780|16027897|P9|Period 1|Adverse Event|0
4663084|NCT02951780|16027898|P8|Period 1|Adverse Event|0
4663085|NCT02951780|16027899|P7|Period 1|Adverse Event|0
4663086|NCT02951780|16027900|P6|Period 1|Adverse Event|0
4663087|NCT02951780|16027901|P5|Period 1|Adverse Event|0
4663088|NCT02951780|16027902|P4|Period 1|Adverse Event|1
4663089|NCT02951780|16027903|P3|Period 1|Adverse Event|0
4663090|NCT02951780|16027904|P2|Period 1|Adverse Event|0
4663091|NCT02951780|16027905|P1|Period 1|Adverse Event|0
4663092|NCT02951767|16027970|P1|Overall Study|Lost to Follow-up|1
4663093|NCT02951767|16027970|P1|Overall Study|Death|59
4663094|NCT02951767|16027970|P1|Overall Study|Withdrawal by Subject|5
4663095|NCT02951767|16027970|P1|Overall Study|Ongoing at data cutoff 04 July 2016|54
4663096|NCT02951533|16028002|P3|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
4663097|NCT02951533|16028003|P2|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0
4663098|NCT02951533|16028004|P1|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2
4663099|NCT02951533|16028002|P3|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
4663100|NCT02951533|16028003|P2|Part III (Week 64 Through Week 100)|Lost to Follow-up|0
4663101|NCT02951533|16028004|P1|Part III (Week 64 Through Week 100)|Lost to Follow-up|1
4663102|NCT02951533|16028002|P3|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
4663103|NCT02951533|16028003|P2|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0
4663104|NCT02951533|16028004|P1|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1
4663105|NCT02951533|16028002|P3|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0
4663106|NCT02951533|16028003|P2|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2
4663107|NCT02951533|16028004|P1|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1
4663108|NCT02951533|16028002|P3|Part IIb (Week 32 Through Week 56)|Adverse Event|0
4663109|NCT02951533|16028003|P2|Part IIb (Week 32 Through Week 56)|Adverse Event|2
4663110|NCT02951533|16028004|P1|Part IIb (Week 32 Through Week 56)|Adverse Event|0
4663111|NCT02951533|16028002|P3|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
4663112|NCT02951533|16028003|P2|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0
4663113|NCT02951533|16028004|P1|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1
4663114|NCT02951533|16028002|P3|Part IIa (Week 24 Through Week 32)|Adverse Event|0
4663115|NCT02951533|16028003|P2|Part IIa (Week 24 Through Week 32)|Adverse Event|1
4663116|NCT02951533|16028004|P1|Part IIa (Week 24 Through Week 32)|Adverse Event|0
4663117|NCT02951533|16028002|P3|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
4663118|NCT02951533|16028003|P2|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1
4663119|NCT02951533|16028004|P1|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0
4663120|NCT02951533|16028002|P3|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0
4663121|NCT02951533|16028003|P2|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4
4663122|NCT02951533|16028004|P1|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2
4663123|NCT02951533|16028002|P3|Part I (Week 0 Through Week 24)|Lost to Follow-up|0
4663124|NCT02951533|16028003|P2|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
4663125|NCT02951533|16028004|P1|Part I (Week 0 Through Week 24)|Lost to Follow-up|2
4663126|NCT02951533|16028002|P3|Part I (Week 0 Through Week 24)|Adverse Event|0
4663127|NCT02951533|16028003|P2|Part I (Week 0 Through Week 24)|Adverse Event|16
4663128|NCT02951533|16028004|P1|Part I (Week 0 Through Week 24)|Adverse Event|0
4663129|NCT02951052|16028341|P2|Overall Study|Ongoing|0
4663130|NCT02951052|16028342|P1|Overall Study|Ongoing|1
4663131|NCT02951052|16028341|P2|Overall Study|Lack of Efficacy|4
4663132|NCT02951052|16028342|P1|Overall Study|Lack of Efficacy|3
4663133|NCT02951052|16028341|P2|Overall Study|Protocol Violation|3
4663134|NCT02951052|16028342|P1|Overall Study|Protocol Violation|5
4663135|NCT02951052|16028341|P2|Overall Study|Protocol-specified withdrawal criterion|0
4663136|NCT02951052|16028342|P1|Overall Study|Protocol-specified withdrawal criterion|1
4663137|NCT02951052|16028341|P2|Overall Study|Lost to Follow-up|1
4663138|NCT02951052|16028342|P1|Overall Study|Lost to Follow-up|1
4663139|NCT02951052|16028341|P2|Overall Study|Physician Decision|0
4663140|NCT02951052|16028342|P1|Overall Study|Physician Decision|2
4663141|NCT02951052|16028341|P2|Overall Study|Withdrawal by Subject|5
4663142|NCT02951052|16028342|P1|Overall Study|Withdrawal by Subject|1
4663143|NCT02951052|16028341|P2|Overall Study|Adverse Event|5
4663144|NCT02951052|16028342|P1|Overall Study|Adverse Event|13
4663145|NCT02950831|16028510|P1|Overall Study|stimulation trail failure|5
4663146|NCT02950831|16028510|P1|Overall Study|Withdrawal by Subject|3
4663147|NCT02950831|16028510|P1|Overall Study|Lost to Follow-up|1
4663148|NCT02950545|16028552|P6|Session 3 (70 Minutes)|Withdrawal by Subject|1
4663149|NCT02950545|16028553|P5|Session 3 (70 Minutes)|Withdrawal by Subject|0
4663150|NCT02950545|16028554|P4|Session 3 (70 Minutes)|Withdrawal by Subject|0
4663151|NCT02950545|16028555|P3|Session 3 (70 Minutes)|Withdrawal by Subject|0
4663152|NCT02950545|16028556|P2|Session 3 (70 Minutes)|Withdrawal by Subject|0
4663153|NCT02950545|16028557|P1|Session 3 (70 Minutes)|Withdrawal by Subject|0
4663154|NCT02950545|16028552|P6|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4663155|NCT02950545|16028553|P5|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4663156|NCT02950545|16028554|P4|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4663157|NCT02950545|16028555|P3|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4663158|NCT02950545|16028556|P2|Washout 2 (5 Minutes)|Withdrawal by Subject|0
4663159|NCT02950545|16028557|P1|Washout 2 (5 Minutes)|Withdrawal by Subject|1
4663160|NCT02950545|16028552|P6|Session 2 (70 Minutes)|Withdrawal by Subject|0
4663161|NCT02950545|16028553|P5|Session 2 (70 Minutes)|Withdrawal by Subject|1
4663162|NCT02950545|16028554|P4|Session 2 (70 Minutes)|Withdrawal by Subject|0
4663163|NCT02950545|16028555|P3|Session 2 (70 Minutes)|Withdrawal by Subject|0
4663164|NCT02950545|16028556|P2|Session 2 (70 Minutes)|Withdrawal by Subject|0
4663165|NCT02950545|16028557|P1|Session 2 (70 Minutes)|Withdrawal by Subject|0
4663166|NCT02950545|16028552|P6|Washout 1 (5 Minutes)|Withdrawal by Subject|1
4663167|NCT02950545|16028553|P5|Washout 1 (5 Minutes)|Withdrawal by Subject|0
4663168|NCT02950545|16028554|P4|Washout 1 (5 Minutes)|Withdrawal by Subject|1
4663169|NCT02950545|16028555|P3|Washout 1 (5 Minutes)|Withdrawal by Subject|0
4663170|NCT02950545|16028556|P2|Washout 1 (5 Minutes)|Withdrawal by Subject|0
4663171|NCT02950545|16028557|P1|Washout 1 (5 Minutes)|Withdrawal by Subject|1
4663172|NCT02950545|16028552|P6|Session 1 (70 Minutes)|Withdrawal by Subject|1
4663173|NCT02950545|16028553|P5|Session 1 (70 Minutes)|Withdrawal by Subject|0
4663174|NCT02950545|16028554|P4|Session 1 (70 Minutes)|Withdrawal by Subject|0
4663175|NCT02950545|16028555|P3|Session 1 (70 Minutes)|Withdrawal by Subject|0
4663176|NCT02950545|16028556|P2|Session 1 (70 Minutes)|Withdrawal by Subject|0
4663177|NCT02950545|16028557|P1|Session 1 (70 Minutes)|Withdrawal by Subject|0
4663178|NCT02950480|16028566|P2|Overall Study|Withdrawal by Subject|0
4663179|NCT02950480|16028567|P1|Overall Study|Withdrawal by Subject|1
4663180|NCT02949947|16028600|P2|Overall Study|Insurance change|0
4663181|NCT02949947|16028601|P1|Overall Study|Insurance change|1
4663182|NCT02949947|16028600|P2|Overall Study|Non Compliance|1
4663183|NCT02949947|16028601|P1|Overall Study|Non Compliance|0
4663184|NCT02949908|16028634|P1|Overall Study|Study termination|2
4663185|NCT02949271|16028698|P2|Overall Study|Outside the window for cervical dilation|3
4663186|NCT02949271|16028699|P1|Overall Study|Outside the window for cervical dilation|2
4663187|NCT02949271|16028698|P2|Overall Study|Delivered prior to intervention|9
4663188|NCT02949271|16028699|P1|Overall Study|Delivered prior to intervention|7
4663189|NCT02949271|16028698|P2|Overall Study|Withdrawal by Subject|0
4663190|NCT02949271|16028699|P1|Overall Study|Withdrawal by Subject|1
4663191|NCT02949271|16028698|P2|Overall Study|Protocol Violation|3
4663192|NCT02949271|16028699|P1|Overall Study|Protocol Violation|6
4663193|NCT02949271|16028698|P2|Overall Study|Physician Decision|5
4663194|NCT02949271|16028699|P1|Overall Study|Physician Decision|5
4663195|NCT02949271|16028698|P2|Overall Study|Lost to Follow-up|6
4663196|NCT02949271|16028699|P1|Overall Study|Lost to Follow-up|3
4663197|NCT02949271|16028698|P2|Overall Study|Lack of Efficacy|4
4663198|NCT02949271|16028699|P1|Overall Study|Lack of Efficacy|5
4663199|NCT02949219|16028725|P1|Overall Study|Withdrawal by Subject|1
4663200|NCT02949128|16028739|P1|Extension Period|Withdrawal by Subject|1
4663201|NCT02949128|16028739|P1|Extension Period|Physician Decision|1
4663202|NCT02949128|16028739|P1|Initial Evaluation Period|Protocol Violation|1
4663203|NCT02949128|16028739|P1|Initial Evaluation Period|Physician Decision|1
4663204|NCT02949128|16028739|P1|Initial Evaluation Period|Death|2
4663205|NCT02949128|16028739|P1|Initial Evaluation Period|Adverse Event|3
4663206|NCT02949128|16028739|P1|Initial Evaluation Period|Failed to Meet Eligibility Criteria|2
4663207|NCT02949011|16028756|P3|Overall Study|Miscellaneous|6
4663208|NCT02949011|16028757|P2|Overall Study|Miscellaneous|4
4663209|NCT02949011|16028758|P1|Overall Study|Miscellaneous|2
4663210|NCT02949011|16028756|P3|Overall Study|Death|1
4663211|NCT02949011|16028757|P2|Overall Study|Death|0
4663212|NCT02949011|16028758|P1|Overall Study|Death|0
4663213|NCT02949011|16028756|P3|Overall Study|Lost to Follow-up|5
4663214|NCT02949011|16028757|P2|Overall Study|Lost to Follow-up|5
4663215|NCT02949011|16028758|P1|Overall Study|Lost to Follow-up|7
4663216|NCT02949011|16028756|P3|Overall Study|Withdrawal by Subject|21
4663217|NCT02949011|16028757|P2|Overall Study|Withdrawal by Subject|13
4663218|NCT02949011|16028758|P1|Overall Study|Withdrawal by Subject|13
4663219|NCT02949011|16028756|P3|Overall Study|Lack of Efficacy|0
4663220|NCT02949011|16028757|P2|Overall Study|Lack of Efficacy|2
4663221|NCT02949011|16028758|P1|Overall Study|Lack of Efficacy|0
4663222|NCT02949011|16028756|P3|Overall Study|Protocol Deviation|3
4663223|NCT02949011|16028757|P2|Overall Study|Protocol Deviation|3
4663224|NCT02949011|16028758|P1|Overall Study|Protocol Deviation|5
4663225|NCT02949011|16028756|P3|Overall Study|Failed Inclusion/Exclusion Criteria|3
4663226|NCT02949011|16028757|P2|Overall Study|Failed Inclusion/Exclusion Criteria|0
4663227|NCT02949011|16028758|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
4663228|NCT02949011|16028756|P3|Overall Study|Adverse Event|3
4663229|NCT02949011|16028757|P2|Overall Study|Adverse Event|7
4663230|NCT02949011|16028758|P1|Overall Study|Adverse Event|6
4663231|NCT02948634|16028828|P2|Overall Study|Lack of efficacy and study suspended|2
4663232|NCT02948634|16028829|P1|Overall Study|Lack of efficacy and study suspended|10
4663233|NCT02948582|16028839|P6|Washout Period 4|Adverse Event|0
4663234|NCT02948582|16028840|P5|Washout Period 4|Adverse Event|0
4663235|NCT02948582|16028841|P4|Washout Period 4|Adverse Event|0
4663236|NCT02948582|16028842|P3|Washout Period 4|Adverse Event|1
4663237|NCT02948582|16028843|P2|Washout Period 4|Adverse Event|0
4663238|NCT02948582|16028844|P1|Washout Period 4|Adverse Event|1
4663239|NCT02948582|16028839|P6|Washout Period 2|personal reasons|0
4663240|NCT02948582|16028840|P5|Washout Period 2|personal reasons|0
4663241|NCT02948582|16028841|P4|Washout Period 2|personal reasons|1
4663242|NCT02948582|16028842|P3|Washout Period 2|personal reasons|0
4663243|NCT02948582|16028843|P2|Washout Period 2|personal reasons|0
4663244|NCT02948582|16028844|P1|Washout Period 2|personal reasons|0
4663245|NCT02948582|16028839|P6|Washout Period 2|Adverse Event|0
4663246|NCT02948582|16028840|P5|Washout Period 2|Adverse Event|0
4663247|NCT02948582|16028841|P4|Washout Period 2|Adverse Event|0
4663248|NCT02948582|16028842|P3|Washout Period 2|Adverse Event|0
4663249|NCT02948582|16028843|P2|Washout Period 2|Adverse Event|1
4663250|NCT02948582|16028844|P1|Washout Period 2|Adverse Event|0
4663251|NCT02948582|16028839|P6|Washout Period 1|Protocol Violation|1
4663252|NCT02948582|16028840|P5|Washout Period 1|Protocol Violation|0
4663253|NCT02948582|16028841|P4|Washout Period 1|Protocol Violation|0
4663254|NCT02948582|16028842|P3|Washout Period 1|Protocol Violation|0
4663255|NCT02948582|16028843|P2|Washout Period 1|Protocol Violation|0
4663256|NCT02948582|16028844|P1|Washout Period 1|Protocol Violation|0
4663257|NCT02948582|16028839|P6|Washout Period 1|Adverse Event|0
4663258|NCT02948582|16028840|P5|Washout Period 1|Adverse Event|0
4663259|NCT02948582|16028841|P4|Washout Period 1|Adverse Event|0
4663260|NCT02948582|16028842|P3|Washout Period 1|Adverse Event|0
4663261|NCT02948582|16028843|P2|Washout Period 1|Adverse Event|2
4663262|NCT02948582|16028844|P1|Washout Period 1|Adverse Event|0
4663263|NCT02947100|16028966|P1|Overall Study|did not meet inclusion criteria|1
4663264|NCT02947100|16028966|P1|Overall Study|study terminated early|3
4663265|NCT02947022|16028974|P1|Overall Study|Study Stopped|1
4663266|NCT02946580|16028995|P2|Overall Study|Did not undergo posterior spinal fusion|1
4663267|NCT02946580|16028996|P1|Overall Study|Did not undergo posterior spinal fusion|0
4663268|NCT02946580|16028995|P2|Overall Study|Adverse Event|2
4663269|NCT02946580|16028996|P1|Overall Study|Adverse Event|0
4663270|NCT02946580|16028995|P2|Overall Study|Withdrawal by Subject|2
4663271|NCT02946580|16028996|P1|Overall Study|Withdrawal by Subject|1
4663272|NCT02946515|16029014|P2|Overall Study|Lost to Follow-up|1
4663273|NCT02946515|16029015|P1|Overall Study|Lost to Follow-up|2
4663274|NCT02946463|16029028|P2|Primary Evaluation Period|Withdrawal by Subject|1
4663275|NCT02946463|16029029|P1|Primary Evaluation Period|Withdrawal by Subject|0
4663276|NCT02946463|16029028|P2|Primary Evaluation Period|Physician Decision|1
4663277|NCT02946463|16029029|P1|Primary Evaluation Period|Physician Decision|0
4663278|NCT02946385|16029051|P6|Overall Study|Lost to Follow-up|1
4663279|NCT02946385|16029052|P5|Overall Study|Lost to Follow-up|2
4663280|NCT02946385|16029053|P4|Overall Study|Lost to Follow-up|0
4663281|NCT02946385|16029054|P3|Overall Study|Lost to Follow-up|3
4663282|NCT02946385|16029055|P2|Overall Study|Lost to Follow-up|0
4663283|NCT02946385|16029056|P1|Overall Study|Lost to Follow-up|0
4663284|NCT02945657|16029159|P1|Overall Study|Withdrawal by Parent/Guardian|3
4663285|NCT02945657|16029159|P1|Overall Study|Adverse Event|1
4663286|NCT02945410|16029182|P6|Washout 1 (14 Days)|Withdrawal by Subject|0
4663287|NCT02945410|16029183|P5|Washout 1 (14 Days)|Withdrawal by Subject|1
4663288|NCT02945410|16029184|P4|Washout 1 (14 Days)|Withdrawal by Subject|0
4663289|NCT02945410|16029185|P3|Washout 1 (14 Days)|Withdrawal by Subject|2
4663290|NCT02945410|16029186|P2|Washout 1 (14 Days)|Withdrawal by Subject|0
4663291|NCT02945410|16029187|P1|Washout 1 (14 Days)|Withdrawal by Subject|0
4663292|NCT02945410|16029182|P6|Intervention 1 (5 Days)|Adverse Event|1
4663293|NCT02945410|16029183|P5|Intervention 1 (5 Days)|Adverse Event|0
4663294|NCT02945410|16029184|P4|Intervention 1 (5 Days)|Adverse Event|0
4663295|NCT02945410|16029185|P3|Intervention 1 (5 Days)|Adverse Event|0
4663296|NCT02945410|16029186|P2|Intervention 1 (5 Days)|Adverse Event|0
4663297|NCT02945410|16029187|P1|Intervention 1 (5 Days)|Adverse Event|1
4663298|NCT02945410|16029182|P6|Intervention 1 (5 Days)|Withdrawal by Subject|0
4663299|NCT02945410|16029183|P5|Intervention 1 (5 Days)|Withdrawal by Subject|0
4663300|NCT02945410|16029184|P4|Intervention 1 (5 Days)|Withdrawal by Subject|0
4663301|NCT02945410|16029185|P3|Intervention 1 (5 Days)|Withdrawal by Subject|0
4663302|NCT02945410|16029186|P2|Intervention 1 (5 Days)|Withdrawal by Subject|3
4663303|NCT02945410|16029187|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
4663304|NCT02945254|16029218|P2|Overall Study|Withdrawal by Subject|0
4663305|NCT02945254|16029219|P1|Overall Study|Withdrawal by Subject|1
4663306|NCT02945254|16029218|P2|Overall Study|Lost to Follow-up|0
4663307|NCT02945254|16029219|P1|Overall Study|Lost to Follow-up|1
4663308|NCT02945046|16029235|P3|Overall Study|Other than specified|7
4663309|NCT02945046|16029236|P2|Overall Study|Other than specified|4
4663310|NCT02945046|16029237|P1|Overall Study|Other than specified|5
4663311|NCT02945046|16029235|P3|Overall Study|Lack of Efficacy|1
4663312|NCT02945046|16029236|P2|Overall Study|Lack of Efficacy|2
4663313|NCT02945046|16029237|P1|Overall Study|Lack of Efficacy|1
4663314|NCT02945046|16029235|P3|Overall Study|Lost to Follow-up|0
4663315|NCT02945046|16029236|P2|Overall Study|Lost to Follow-up|1
4663316|NCT02945046|16029237|P1|Overall Study|Lost to Follow-up|1
4663317|NCT02945046|16029235|P3|Overall Study|Protocol Violation|2
4663318|NCT02945046|16029236|P2|Overall Study|Protocol Violation|3
4663319|NCT02945046|16029237|P1|Overall Study|Protocol Violation|2
4663320|NCT02945046|16029235|P3|Overall Study|Withdrawal by Subject|3
4663321|NCT02945046|16029236|P2|Overall Study|Withdrawal by Subject|3
4663322|NCT02945046|16029237|P1|Overall Study|Withdrawal by Subject|3
4663323|NCT02945046|16029235|P3|Overall Study|Adverse Event|2
4663324|NCT02945046|16029236|P2|Overall Study|Adverse Event|0
4663325|NCT02945046|16029237|P1|Overall Study|Adverse Event|1
4663326|NCT02944968|16029290|P1|Overall Study|Subject didn't meet eligibility criteria|2
4663327|NCT02944968|16029290|P1|Overall Study|Subject excluded before study procedure|1
4663328|NCT02944656|16029297|P2|Overall Study|Lost to Follow-up|10
4663329|NCT02944656|16029298|P1|Overall Study|Lost to Follow-up|7
4663330|NCT02944656|16029297|P2|Overall Study|No longer eligible|0
4663331|NCT02944656|16029298|P1|Overall Study|No longer eligible|3
4663332|NCT02944513|16029334|P2|Overall Study|Withdrawal by Subject|1
4663333|NCT02944513|16029335|P1|Overall Study|Withdrawal by Subject|4
4663334|NCT02944448|16029360|P2|Overall Study|Abnormal laboratory values|0
4663335|NCT02944448|16029361|P1|Overall Study|Abnormal laboratory values|1
4663336|NCT02944448|16029360|P2|Overall Study|Noncompliant with dosing|0
4663337|NCT02944448|16029361|P1|Overall Study|Noncompliant with dosing|1
4663338|NCT02944448|16029360|P2|Overall Study|Sponsor did not supply drug in time|1
4663339|NCT02944448|16029361|P1|Overall Study|Sponsor did not supply drug in time|0
4663340|NCT02944448|16029360|P2|Overall Study|Withdrawal by Subject|4
4663341|NCT02944448|16029361|P1|Overall Study|Withdrawal by Subject|14
4663342|NCT02944448|16029360|P2|Overall Study|Protocol Violation|7
4663343|NCT02944448|16029361|P1|Overall Study|Protocol Violation|25
4663344|NCT02944448|16029360|P2|Overall Study|Lost to Follow-up|1
4663345|NCT02944448|16029361|P1|Overall Study|Lost to Follow-up|3
4663346|NCT02944448|16029360|P2|Overall Study|Lack of Efficacy|5
4663347|NCT02944448|16029361|P1|Overall Study|Lack of Efficacy|8
4663348|NCT02944448|16029360|P2|Overall Study|Adverse Event|6
4663349|NCT02944448|16029361|P1|Overall Study|Adverse Event|37
4663350|NCT02944383|16029388|P3|Overall Study|Withdrawal by Subject|0
4663351|NCT02944383|16029389|P2|Overall Study|Withdrawal by Subject|0
4663352|NCT02944383|16029390|P1|Overall Study|Withdrawal by Subject|1
4663353|NCT02944383|16029388|P3|Overall Study|Lost to Follow-up|1
4663354|NCT02944383|16029389|P2|Overall Study|Lost to Follow-up|0
4663355|NCT02944383|16029390|P1|Overall Study|Lost to Follow-up|0
4663356|NCT02943668|16029551|P1|Overall Study|Disease Progression|1
4663357|NCT02943577|16029562|P2|Overall Study|Pregnancy|0
4663358|NCT02943577|16029563|P1|Overall Study|Pregnancy|1
4663359|NCT02943577|16029562|P2|Overall Study|Withdrawal by Subject|1
4663360|NCT02943577|16029563|P1|Overall Study|Withdrawal by Subject|1
4663361|NCT02943577|16029562|P2|Overall Study|Lost to Follow-up|1
4663362|NCT02943577|16029563|P1|Overall Study|Lost to Follow-up|0
4663363|NCT02943577|16029562|P2|Overall Study|Adverse Event|2
4663364|NCT02943577|16029563|P1|Overall Study|Adverse Event|3
4663365|NCT02943577|16029562|P2|Overall Study|Protocol Violation|1
4663366|NCT02943577|16029563|P1|Overall Study|Protocol Violation|0
4663367|NCT02943564|16029578|P3|Overall Study|Lack of Efficacy|0
4663368|NCT02943564|16029579|P2|Overall Study|Lack of Efficacy|1
4663369|NCT02943564|16029580|P1|Overall Study|Lack of Efficacy|0
4663370|NCT02943564|16029578|P3|Overall Study|Adverse Event|1
4663371|NCT02943564|16029579|P2|Overall Study|Adverse Event|2
4663372|NCT02943564|16029580|P1|Overall Study|Adverse Event|1
4663373|NCT02943564|16029578|P3|Overall Study|Withdrawal by Subject|2
4663374|NCT02943564|16029579|P2|Overall Study|Withdrawal by Subject|5
4663375|NCT02943564|16029580|P1|Overall Study|Withdrawal by Subject|6
4663376|NCT02943564|16029578|P3|Overall Study|Lost to Follow-up|0
4663377|NCT02943564|16029579|P2|Overall Study|Lost to Follow-up|0
4663378|NCT02943564|16029580|P1|Overall Study|Lost to Follow-up|1
4663379|NCT02943564|16029578|P3|Overall Study|Protocol Violation|2
4663380|NCT02943564|16029579|P2|Overall Study|Protocol Violation|2
4663381|NCT02943564|16029580|P1|Overall Study|Protocol Violation|2
4663382|NCT02943564|16029578|P3|Overall Study|Pregnancy|1
4663383|NCT02943564|16029579|P2|Overall Study|Pregnancy|1
4663384|NCT02943564|16029580|P1|Overall Study|Pregnancy|0
4663385|NCT02943564|16029578|P3|Overall Study|Non-compliance with study drug|0
4663386|NCT02943564|16029579|P2|Overall Study|Non-compliance with study drug|1
4663387|NCT02943564|16029580|P1|Overall Study|Non-compliance with study drug|0
4663388|NCT02943564|16029578|P3|Overall Study|Site terminated by sponsor|0
4663389|NCT02943564|16029579|P2|Overall Study|Site terminated by sponsor|1
4663390|NCT02943564|16029580|P1|Overall Study|Site terminated by sponsor|0
4663391|NCT02943564|16029578|P3|Overall Study|Miscellaneous Reasons|3
4663392|NCT02943564|16029579|P2|Overall Study|Miscellaneous Reasons|0
4663393|NCT02943564|16029580|P1|Overall Study|Miscellaneous Reasons|0
4663394|NCT02943460|16029603|P3|Open Label Extension (OLE)|Still in Open Label Extension Phase|8
4663395|NCT02943460|16029604|P2|Open Label Extension (OLE)|Still in Open Label Extension Phase|14
4663396|NCT02943460|16029605|P1|Open Label Extension (OLE)|Still in Open Label Extension Phase|18
4663397|NCT02943460|16029603|P3|Open Label Extension (OLE)|Investigator's Discretion|0
4663398|NCT02943460|16029604|P2|Open Label Extension (OLE)|Investigator's Discretion|1
4663399|NCT02943460|16029605|P1|Open Label Extension (OLE)|Investigator's Discretion|0
4663400|NCT02943460|16029603|P3|Open Label Extension (OLE)|Withdrew Consent|0
4663401|NCT02943460|16029604|P2|Open Label Extension (OLE)|Withdrew Consent|1
4663402|NCT02943460|16029605|P1|Open Label Extension (OLE)|Withdrew Consent|1
4663403|NCT02943460|16029603|P3|Open Label Extension (OLE)|Adverse Event|1
4663404|NCT02943460|16029604|P2|Open Label Extension (OLE)|Adverse Event|2
4663405|NCT02943460|16029605|P1|Open Label Extension (OLE)|Adverse Event|0
4663406|NCT02943460|16029603|P3|Blinded Study|Withdrew Consent|0
4663407|NCT02943460|16029604|P2|Blinded Study|Withdrew Consent|1
4663408|NCT02943460|16029605|P1|Blinded Study|Withdrew Consent|0
4663409|NCT02943460|16029603|P3|Blinded Study|Adverse Event|0
4663410|NCT02943460|16029604|P2|Blinded Study|Adverse Event|0
4663411|NCT02943460|16029605|P1|Blinded Study|Adverse Event|3
4663412|NCT02943447|16029623|P3|Open-Label Extension Phase|Lost to Follow-up|0
4663413|NCT02943447|16029624|P2|Open-Label Extension Phase|Lost to Follow-up|1
4663414|NCT02943447|16029625|P1|Open-Label Extension Phase|Lost to Follow-up|0
4663415|NCT02943447|16029623|P3|Open-Label Extension Phase|Withdrew consent|1
4663416|NCT02943447|16029624|P2|Open-Label Extension Phase|Withdrew consent|1
4663417|NCT02943447|16029625|P1|Open-Label Extension Phase|Withdrew consent|1
4663418|NCT02943447|16029623|P3|Open-Label Extension Phase|Lack of Efficacy|0
4663419|NCT02943447|16029624|P2|Open-Label Extension Phase|Lack of Efficacy|4
4663420|NCT02943447|16029625|P1|Open-Label Extension Phase|Lack of Efficacy|3
4663421|NCT02943447|16029623|P3|Open-Label Extension Phase|Adverse Event|3
4663422|NCT02943447|16029624|P2|Open-Label Extension Phase|Adverse Event|7
4663423|NCT02943447|16029625|P1|Open-Label Extension Phase|Adverse Event|4
4663424|NCT02943447|16029623|P3|Open-Label Extension Phase|Study terminated by sponsor|6
4663425|NCT02943447|16029624|P2|Open-Label Extension Phase|Study terminated by sponsor|12
4663426|NCT02943447|16029625|P1|Open-Label Extension Phase|Study terminated by sponsor|10
4663427|NCT02943447|16029623|P3|Blinded Study Phase|Investigator's discretion|0
4663428|NCT02943447|16029624|P2|Blinded Study Phase|Investigator's discretion|0
4663429|NCT02943447|16029625|P1|Blinded Study Phase|Investigator's discretion|1
4663430|NCT02943447|16029623|P3|Blinded Study Phase|Adverse Event|0
4663431|NCT02943447|16029624|P2|Blinded Study Phase|Adverse Event|0
4663432|NCT02943447|16029625|P1|Blinded Study Phase|Adverse Event|3
4663433|NCT02943447|16029623|P3|Blinded Study Phase|Withdrew Consent|1
4663434|NCT02943447|16029624|P2|Blinded Study Phase|Withdrew Consent|2
4663435|NCT02943447|16029625|P1|Blinded Study Phase|Withdrew Consent|1
4663436|NCT02943096|16029694|P2|Overall Study|Lack of Efficacy|1
4663437|NCT02943096|16029695|P1|Overall Study|Lack of Efficacy|0
4663438|NCT02942771|16029714|P5|Overall Study|Withdrawal by Subject|2
4663439|NCT02942771|16029715|P4|Overall Study|Withdrawal by Subject|0
4663440|NCT02942771|16029716|P3|Overall Study|Withdrawal by Subject|0
4663441|NCT02942771|16029717|P2|Overall Study|Withdrawal by Subject|0
4663442|NCT02942771|16029718|P1|Overall Study|Withdrawal by Subject|1
4663443|NCT02942771|16029714|P5|Overall Study|Lost to Follow-up|0
4663444|NCT02942771|16029715|P4|Overall Study|Lost to Follow-up|0
4663445|NCT02942771|16029716|P3|Overall Study|Lost to Follow-up|0
4663446|NCT02942771|16029717|P2|Overall Study|Lost to Follow-up|0
4663447|NCT02942771|16029718|P1|Overall Study|Lost to Follow-up|1
4663448|NCT02942771|16029714|P5|Overall Study|Adverse Event|2
4663449|NCT02942771|16029715|P4|Overall Study|Adverse Event|0
4663450|NCT02942771|16029716|P3|Overall Study|Adverse Event|0
4663451|NCT02942771|16029717|P2|Overall Study|Adverse Event|0
4663452|NCT02942771|16029718|P1|Overall Study|Adverse Event|1
4663453|NCT02942576|16029771|P2|Overall Study|Other|8
4663454|NCT02942576|16029772|P1|Overall Study|Other|10
4663455|NCT02942576|16029771|P2|Overall Study|Physician Decision|4
4663456|NCT02942576|16029772|P1|Overall Study|Physician Decision|1
4663457|NCT02942576|16029771|P2|Overall Study|Withdrawal by Subject|5
4663458|NCT02942576|16029772|P1|Overall Study|Withdrawal by Subject|7
4663459|NCT02942576|16029771|P2|Overall Study|Adverse Event|6
4663460|NCT02942576|16029772|P1|Overall Study|Adverse Event|28
4663461|NCT02942017|16029786|P2|Overall Study|Randomized but not dosed|3
4663462|NCT02942017|16029787|P1|Overall Study|Randomized but not dosed|1
4663463|NCT02942017|16029786|P2|Overall Study|Lost to Follow-up|1
4663464|NCT02942017|16029787|P1|Overall Study|Lost to Follow-up|1
4663465|NCT02942017|16029786|P2|Overall Study|Withdrawal by Subject|1
4663466|NCT02942017|16029787|P1|Overall Study|Withdrawal by Subject|0
4663467|NCT02942017|16029786|P2|Overall Study|Adverse Event|1
4663468|NCT02942017|16029787|P1|Overall Study|Adverse Event|0
4663469|NCT02942004|16029818|P3|Overall Study|Randomized but not dosed|4
4663470|NCT02942004|16029819|P2|Overall Study|Randomized but not dosed|9
4663471|NCT02942004|16029820|P1|Overall Study|Randomized but not dosed|3
4663472|NCT02942004|16029818|P3|Overall Study|Lost to Follow-up|2
4663473|NCT02942004|16029819|P2|Overall Study|Lost to Follow-up|1
4663474|NCT02942004|16029820|P1|Overall Study|Lost to Follow-up|1
4663475|NCT02942004|16029818|P3|Overall Study|Withdrawal by Subject|3
4663476|NCT02942004|16029819|P2|Overall Study|Withdrawal by Subject|2
4663477|NCT02942004|16029820|P1|Overall Study|Withdrawal by Subject|0
4663478|NCT02940886|16029934|P2|Overall Study|Enrolment error|1
4663479|NCT02940886|16029935|P1|Overall Study|Enrolment error|0
4663480|NCT02940886|16029934|P2|Overall Study|No treatment|2
4663481|NCT02940886|16029935|P1|Overall Study|No treatment|7
4663482|NCT02940886|16029934|P2|Overall Study|Sponsor decision|1
4663483|NCT02940886|16029935|P1|Overall Study|Sponsor decision|0
4663484|NCT02940886|16029934|P2|Overall Study|Physician Decision|4
4663485|NCT02940886|16029935|P1|Overall Study|Physician Decision|9
4663486|NCT02940886|16029934|P2|Overall Study|Lost to Follow-up|21
4663487|NCT02940886|16029935|P1|Overall Study|Lost to Follow-up|49
4663488|NCT02940886|16029934|P2|Overall Study|Lack of Efficacy|0
4663489|NCT02940886|16029935|P1|Overall Study|Lack of Efficacy|1
4663490|NCT02940886|16029934|P2|Overall Study|Death|0
4663491|NCT02940886|16029935|P1|Overall Study|Death|1
4663492|NCT02940886|16029934|P2|Overall Study|Withdrawal by Subject|20
4663493|NCT02940886|16029935|P1|Overall Study|Withdrawal by Subject|28
4663494|NCT02940886|16029934|P2|Overall Study|Protocol Violation|2
4663495|NCT02940886|16029935|P1|Overall Study|Protocol Violation|0
4663496|NCT02940886|16029934|P2|Overall Study|Adverse Event|3
4663497|NCT02940886|16029935|P1|Overall Study|Adverse Event|7
4663498|NCT02940860|16029981|P2|Overall Study|Not treated|2
4663499|NCT02940860|16029982|P1|Overall Study|Not treated|2
4663500|NCT02940860|16029981|P2|Overall Study|Moved, poor venous access, transport|4
4663501|NCT02940860|16029982|P1|Overall Study|Moved, poor venous access, transport|6
4663502|NCT02940860|16029981|P2|Overall Study|Death|2
4663503|NCT02940860|16029982|P1|Overall Study|Death|3
4663504|NCT02940860|16029981|P2|Overall Study|Protocol Violation|2
4663505|NCT02940860|16029982|P1|Overall Study|Protocol Violation|0
4663506|NCT02940860|16029981|P2|Overall Study|Sponsor Decision|1
4663507|NCT02940860|16029982|P1|Overall Study|Sponsor Decision|0
4663508|NCT02940860|16029981|P2|Overall Study|Physician Decision|3
4663509|NCT02940860|16029982|P1|Overall Study|Physician Decision|5
4663510|NCT02940860|16029981|P2|Overall Study|Lost to Follow-up|7
4663511|NCT02940860|16029982|P1|Overall Study|Lost to Follow-up|13
4663512|NCT02940860|16029981|P2|Overall Study|Withdrawal by Subject|9
4663513|NCT02940860|16029982|P1|Overall Study|Withdrawal by Subject|19
4663514|NCT02940860|16029981|P2|Overall Study|Serious AE|3
4663515|NCT02940860|16029982|P1|Overall Study|Serious AE|7
4663516|NCT02940860|16029981|P2|Overall Study|Non-serious AE|2
4663517|NCT02940860|16029982|P1|Overall Study|Non-serious AE|1
4663518|NCT02940691|16030026|P1|Overall Study|Incarceration|1
4663519|NCT02940691|16030026|P1|Overall Study|Lost to Follow-up|5
4663520|NCT02940626|16030035|P2|Overall Study|Prohibited Concomitant Medication|1
4663521|NCT02940626|16030036|P1|Overall Study|Prohibited Concomitant Medication|0
4663522|NCT02940626|16030035|P2|Overall Study|Transfer to Hospice Care|0
4663523|NCT02940626|16030036|P1|Overall Study|Transfer to Hospice Care|1
4663524|NCT02940626|16030035|P2|Overall Study|Withdrawal by Subject|0
4663525|NCT02940626|16030036|P1|Overall Study|Withdrawal by Subject|1
4663526|NCT02940626|16030035|P2|Overall Study|Lost to Follow-up|2
4663527|NCT02940626|16030036|P1|Overall Study|Lost to Follow-up|5
4663528|NCT02940626|16030035|P2|Overall Study|Death|32
4663529|NCT02940626|16030036|P1|Overall Study|Death|40
4663530|NCT02940574|16030058|P2|1-year Follow-up|Lost to Follow-up|4
4663531|NCT02940574|16030059|P1|1-year Follow-up|Lost to Follow-up|3
4663532|NCT02940574|16030058|P2|From Study Start to 1-month Follow-up|Withdrawal by Subject|0
4663533|NCT02940574|16030059|P1|From Study Start to 1-month Follow-up|Withdrawal by Subject|1
4663534|NCT02940522|16030097|P2|Overall Study|Withdrawal by Subject|0
4663535|NCT02940522|16030098|P1|Overall Study|Withdrawal by Subject|1
4663536|NCT02940522|16030097|P2|Overall Study|Lost to Follow-up|2
4663537|NCT02940522|16030098|P1|Overall Study|Lost to Follow-up|1
4663538|NCT02939950|16030189|P2|Overall Study|Ineligible at Baseline|8
4663539|NCT02939950|16030190|P1|Overall Study|Ineligible at Baseline|2
4663540|NCT02939950|16030189|P2|Overall Study|Randomized, not dispensed|0
4663541|NCT02939950|16030190|P1|Overall Study|Randomized, not dispensed|1
4663542|NCT02939950|16030189|P2|Overall Study|Adverse Event|3
4663543|NCT02939950|16030190|P1|Overall Study|Adverse Event|7
4663544|NCT02939950|16030189|P2|Overall Study|Withdrawal by Subject|28
4663545|NCT02939950|16030190|P1|Overall Study|Withdrawal by Subject|12
4663546|NCT02939950|16030189|P2|Overall Study|Pregnancy|7
4663547|NCT02939950|16030190|P1|Overall Study|Pregnancy|6
4663548|NCT02939950|16030189|P2|Overall Study|Physician Decision|0
4663549|NCT02939950|16030190|P1|Overall Study|Physician Decision|2
4663550|NCT02939950|16030189|P2|Overall Study|Protocol Violation|3
4663551|NCT02939950|16030190|P1|Overall Study|Protocol Violation|6
4663552|NCT02939950|16030189|P2|Overall Study|Unacceptable lens movement|0
4663553|NCT02939950|16030190|P1|Overall Study|Unacceptable lens movement|2
4663554|NCT02939950|16030189|P2|Overall Study|Study related symptoms|8
4663555|NCT02939950|16030190|P1|Overall Study|Study related symptoms|8
4663556|NCT02939950|16030189|P2|Overall Study|Participant Relocated|3
4663557|NCT02939950|16030190|P1|Overall Study|Participant Relocated|5
4663558|NCT02939950|16030189|P2|Overall Study|Military orders|0
4663559|NCT02939950|16030190|P1|Overall Study|Military orders|1
4663560|NCT02939950|16030189|P2|Overall Study|Unacceptable distance lens visual acuity|1
4663561|NCT02939950|16030190|P1|Overall Study|Unacceptable distance lens visual acuity|1
4663562|NCT02939950|16030189|P2|Overall Study|Lack of motivation|2
4663563|NCT02939950|16030190|P1|Overall Study|Lack of motivation|0
4663564|NCT02939950|16030189|P2|Overall Study|Chalazion upper lid|1
4663565|NCT02939950|16030190|P1|Overall Study|Chalazion upper lid|0
4663566|NCT02939950|16030189|P2|Overall Study|Positive slit lamp findings|1
4663567|NCT02939950|16030190|P1|Overall Study|Positive slit lamp findings|0
4663568|NCT02939950|16030189|P2|Overall Study|Lost to Follow-up|16
4663569|NCT02939950|16030190|P1|Overall Study|Lost to Follow-up|13
4663570|NCT02939937|16030200|P2|Overall Study|Lost to Follow-up|3
4663571|NCT02939937|16030201|P1|Overall Study|Lost to Follow-up|1
4663572|NCT02939937|16030200|P2|Overall Study|Adverse Event|0
4663573|NCT02939937|16030201|P1|Overall Study|Adverse Event|5
4663574|NCT02939716|16030215|P6|Overall Study|scanner failure|1
4663575|NCT02939716|16030216|P5|Overall Study|scanner failure|1
4663576|NCT02939716|16030217|P4|Overall Study|scanner failure|1
4663577|NCT02939716|16030218|P3|Overall Study|scanner failure|0
4663578|NCT02939716|16030219|P2|Overall Study|scanner failure|0
4663579|NCT02939716|16030220|P1|Overall Study|scanner failure|0
4663580|NCT02939599|16030245|P2|Overall Study|Study Terminated By Sponsor|2
4663581|NCT02939599|16030246|P1|Overall Study|Study Terminated By Sponsor|2
4663582|NCT02939599|16030245|P2|Overall Study|Adverse Event|0
4663583|NCT02939599|16030246|P1|Overall Study|Adverse Event|1
4663584|NCT02939560|16030260|P1|Overall Study|Protocol Violation|1
4663585|NCT02939560|16030260|P1|Overall Study|Withdrawal by Subject|2
4663586|NCT02939131|16030318|P2|Overall Study|not willing to adhere to protocol|0
4663587|NCT02939131|16030319|P1|Overall Study|not willing to adhere to protocol|2
4663588|NCT02939131|16030318|P2|Overall Study|Other|1
4663589|NCT02939131|16030319|P1|Overall Study|Other|0
4663590|NCT02939131|16030318|P2|Overall Study|severe debilitation|0
4663591|NCT02939131|16030319|P1|Overall Study|severe debilitation|1
4663592|NCT02939131|16030318|P2|Overall Study|Lost to Follow-up|4
4663593|NCT02939131|16030319|P1|Overall Study|Lost to Follow-up|2
4663594|NCT02939131|16030318|P2|Overall Study|Unable to get to clinic|4
4663595|NCT02939131|16030319|P1|Overall Study|Unable to get to clinic|6
4663596|NCT02939079|16030337|P2|Overall Study|relapse during the study|1
4663597|NCT02939079|16030338|P1|Overall Study|relapse during the study|1
4663598|NCT02939079|16030337|P2|Overall Study|Withdrawal by Subject|1
4663599|NCT02939079|16030338|P1|Overall Study|Withdrawal by Subject|0
4663600|NCT02939079|16030337|P2|Overall Study|Protocol Violation|0
4663601|NCT02939079|16030338|P1|Overall Study|Protocol Violation|1
4663602|NCT02939079|16030337|P2|Overall Study|Lost to Follow-up|2
4663603|NCT02939079|16030338|P1|Overall Study|Lost to Follow-up|0
4663604|NCT02939079|16030337|P2|Overall Study|Adverse Event|1
4663605|NCT02939079|16030338|P1|Overall Study|Adverse Event|2
4663606|NCT02939014|16030368|P2|Overall Study|In Overall Survival Follow-up|4
4663607|NCT02939014|16030369|P1|Overall Study|In Overall Survival Follow-up|22
4663608|NCT02939014|16030368|P2|Overall Study|In Progression-Free Survival Follow-up|2
4663609|NCT02939014|16030369|P1|Overall Study|In Progression-Free Survival Follow-up|5
4663610|NCT02939014|16030368|P2|Overall Study|Death|3
4663611|NCT02939014|16030369|P1|Overall Study|Death|3
4663612|NCT02938585|16030413|P4|Overall Study|Withdrawal by Subject|5
4663613|NCT02938585|16030414|P3|Overall Study|Withdrawal by Subject|0
4663614|NCT02938585|16030415|P2|Overall Study|Withdrawal by Subject|0
4663615|NCT02938585|16030416|P1|Overall Study|Withdrawal by Subject|0
4663616|NCT02938585|16030413|P4|Overall Study|Withdrawal by parent or guardian|0
4663617|NCT02938585|16030414|P3|Overall Study|Withdrawal by parent or guardian|0
4663618|NCT02938585|16030415|P2|Overall Study|Withdrawal by parent or guardian|1
4663619|NCT02938585|16030416|P1|Overall Study|Withdrawal by parent or guardian|0
4663620|NCT02938520|16030580|P2|Overall Study|Adverse Event|4
4663621|NCT02938520|16030581|P1|Overall Study|Adverse Event|9
4663622|NCT02938520|16030580|P2|Overall Study|Lack of Efficacy|3
4663623|NCT02938520|16030581|P1|Overall Study|Lack of Efficacy|5
4663624|NCT02938520|16030580|P2|Overall Study|Protocol Violation|1
4663625|NCT02938520|16030581|P1|Overall Study|Protocol Violation|0
4663626|NCT02938520|16030580|P2|Overall Study|Withdrawal by Subject|7
4663627|NCT02938520|16030581|P1|Overall Study|Withdrawal by Subject|7
4663628|NCT02938520|16030580|P2|Overall Study|Lost to Follow-up|2
4663629|NCT02938520|16030581|P1|Overall Study|Lost to Follow-up|2
4663630|NCT02938520|16030580|P2|Overall Study|Physician Decision|5
4663631|NCT02938520|16030581|P1|Overall Study|Physician Decision|2
4663632|NCT02938520|16030580|P2|Overall Study|On-going at the time of analysis|261
4663633|NCT02938520|16030581|P1|Overall Study|On-going at the time of analysis|258
4663634|NCT02937870|16030748|P1|Overall Study|Protocol Deviation|2
4663635|NCT02937870|16030748|P1|Overall Study|Adverse Event|1
4663636|NCT02937740|16030779|P2|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1
4663637|NCT02937740|16030780|P1|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0
4663638|NCT02937740|16030779|P2|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1
4663639|NCT02937740|16030780|P1|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0
4663640|NCT02937740|16030779|P2|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0
4663641|NCT02937740|16030780|P1|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1
4663642|NCT02937740|16030779|P2|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7
4663643|NCT02937740|16030780|P1|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2
4663644|NCT02937740|16030779|P2|BID for 90 Days, 22 mg/Day|Adverse Event|10
4663645|NCT02937740|16030780|P1|BID for 90 Days, 22 mg/Day|Adverse Event|0
4663646|NCT02937740|16030779|P2|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14
4663647|NCT02937740|16030780|P1|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3
4663648|NCT02937701|16030796|P5|Week 22 to Week 50|Other|1
4663649|NCT02937701|16030797|P4|Week 22 to Week 50|Other|0
4663650|NCT02937701|16030798|P3|Week 22 to Week 50|Other|0
4663651|NCT02937701|16030799|P2|Week 22 to Week 50|Other|0
4663652|NCT02937701|16030800|P1|Week 22 to Week 50|Other|0
4663653|NCT02937701|16030796|P5|Week 22 to Week 50|Physician Decision|1
4663654|NCT02937701|16030797|P4|Week 22 to Week 50|Physician Decision|0
4663655|NCT02937701|16030798|P3|Week 22 to Week 50|Physician Decision|2
4663656|NCT02937701|16030799|P2|Week 22 to Week 50|Physician Decision|0
4663657|NCT02937701|16030800|P1|Week 22 to Week 50|Physician Decision|0
4663658|NCT02937701|16030796|P5|Week 22 to Week 50|Lost to Follow-up|1
4663659|NCT02937701|16030797|P4|Week 22 to Week 50|Lost to Follow-up|0
4663660|NCT02937701|16030798|P3|Week 22 to Week 50|Lost to Follow-up|2
4663661|NCT02937701|16030799|P2|Week 22 to Week 50|Lost to Follow-up|0
4663662|NCT02937701|16030800|P1|Week 22 to Week 50|Lost to Follow-up|0
4663663|NCT02937701|16030796|P5|Week 22 to Week 50|Withdrawal by Subject|1
4663664|NCT02937701|16030797|P4|Week 22 to Week 50|Withdrawal by Subject|2
4663665|NCT02937701|16030798|P3|Week 22 to Week 50|Withdrawal by Subject|8
4663666|NCT02937701|16030799|P2|Week 22 to Week 50|Withdrawal by Subject|0
4663667|NCT02937701|16030800|P1|Week 22 to Week 50|Withdrawal by Subject|0
4663668|NCT02937701|16030796|P5|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2
4663669|NCT02937701|16030797|P4|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3
4663670|NCT02937701|16030798|P3|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10
4663671|NCT02937701|16030799|P2|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
4663672|NCT02937701|16030800|P1|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0
4663673|NCT02937701|16030796|P5|Week 22 to Week 50|Adverse Event|3
4663674|NCT02937701|16030797|P4|Week 22 to Week 50|Adverse Event|3
4663675|NCT02937701|16030798|P3|Week 22 to Week 50|Adverse Event|10
4663676|NCT02937701|16030799|P2|Week 22 to Week 50|Adverse Event|0
4663677|NCT02937701|16030800|P1|Week 22 to Week 50|Adverse Event|0
4663678|NCT02937701|16030796|P5|Day 1 to Week 22|Other|0
4663679|NCT02937701|16030797|P4|Day 1 to Week 22|Other|0
4663680|NCT02937701|16030798|P3|Day 1 to Week 22|Other|0
4663681|NCT02937701|16030799|P2|Day 1 to Week 22|Other|0
4663682|NCT02937701|16030800|P1|Day 1 to Week 22|Other|1
4663683|NCT02937701|16030796|P5|Day 1 to Week 22|Physician Decision|0
4663684|NCT02937701|16030797|P4|Day 1 to Week 22|Physician Decision|0
4663685|NCT02937701|16030798|P3|Day 1 to Week 22|Physician Decision|0
4663686|NCT02937701|16030799|P2|Day 1 to Week 22|Physician Decision|0
4663687|NCT02937701|16030800|P1|Day 1 to Week 22|Physician Decision|2
4663688|NCT02937701|16030796|P5|Day 1 to Week 22|Lost to Follow-up|0
4663689|NCT02937701|16030797|P4|Day 1 to Week 22|Lost to Follow-up|0
4663690|NCT02937701|16030798|P3|Day 1 to Week 22|Lost to Follow-up|0
4663691|NCT02937701|16030799|P2|Day 1 to Week 22|Lost to Follow-up|1
4663692|NCT02937701|16030800|P1|Day 1 to Week 22|Lost to Follow-up|1
4663693|NCT02937701|16030796|P5|Day 1 to Week 22|Protocol Violation|0
4663694|NCT02937701|16030797|P4|Day 1 to Week 22|Protocol Violation|0
4663695|NCT02937701|16030798|P3|Day 1 to Week 22|Protocol Violation|0
4663696|NCT02937701|16030799|P2|Day 1 to Week 22|Protocol Violation|1
4663697|NCT02937701|16030800|P1|Day 1 to Week 22|Protocol Violation|1
4663698|NCT02937701|16030796|P5|Day 1 to Week 22|Death|0
4663699|NCT02937701|16030797|P4|Day 1 to Week 22|Death|0
4663700|NCT02937701|16030798|P3|Day 1 to Week 22|Death|0
4663701|NCT02937701|16030799|P2|Day 1 to Week 22|Death|1
4663702|NCT02937701|16030800|P1|Day 1 to Week 22|Death|1
4663703|NCT02937701|16030796|P5|Day 1 to Week 22|Withdrawal by Subject|0
4663704|NCT02937701|16030797|P4|Day 1 to Week 22|Withdrawal by Subject|0
4663705|NCT02937701|16030798|P3|Day 1 to Week 22|Withdrawal by Subject|0
4663706|NCT02937701|16030799|P2|Day 1 to Week 22|Withdrawal by Subject|6
4663707|NCT02937701|16030800|P1|Day 1 to Week 22|Withdrawal by Subject|6
4663708|NCT02937701|16030796|P5|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
4663709|NCT02937701|16030797|P4|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
4663710|NCT02937701|16030798|P3|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0
4663711|NCT02937701|16030799|P2|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9
4663712|NCT02937701|16030800|P1|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5
4663713|NCT02937701|16030796|P5|Day 1 to Week 22|Protocol Specified Criteria|0
4663714|NCT02937701|16030797|P4|Day 1 to Week 22|Protocol Specified Criteria|0
4663715|NCT02937701|16030798|P3|Day 1 to Week 22|Protocol Specified Criteria|0
4663716|NCT02937701|16030799|P2|Day 1 to Week 22|Protocol Specified Criteria|7
4663717|NCT02937701|16030800|P1|Day 1 to Week 22|Protocol Specified Criteria|7
4663718|NCT02937701|16030796|P5|Day 1 to Week 22|Adverse Event|0
4663719|NCT02937701|16030797|P4|Day 1 to Week 22|Adverse Event|0
4663720|NCT02937701|16030798|P3|Day 1 to Week 22|Adverse Event|0
4663721|NCT02937701|16030799|P2|Day 1 to Week 22|Adverse Event|14
4663722|NCT02937701|16030800|P1|Day 1 to Week 22|Adverse Event|11
4663723|NCT02937636|16030831|P2|Overall Study|Other (Not specified)|2
4663724|NCT02937636|16030832|P1|Overall Study|Other (Not specified)|3
4663725|NCT02937584|16030859|P2|Washout|Adverse Event|1
4663726|NCT02937584|16030860|P1|Washout|Adverse Event|0
4663727|NCT02937584|16030859|P2|Period 1|Adverse Event|2
4663728|NCT02937584|16030860|P1|Period 1|Adverse Event|1
4663729|NCT02936869|16030923|P2|Overall Study|Protocol Violation|0
4663730|NCT02936869|16030924|P1|Overall Study|Protocol Violation|1
4663731|NCT02936869|16030923|P2|Overall Study|Legal Case|1
4663732|NCT02936869|16030924|P1|Overall Study|Legal Case|0
4663733|NCT02936869|16030923|P2|Overall Study|Death|1
4663734|NCT02936869|16030924|P1|Overall Study|Death|0
4663735|NCT02936869|16030923|P2|Overall Study|Lost to Follow-up|3
4663736|NCT02936869|16030924|P1|Overall Study|Lost to Follow-up|1
4663737|NCT02935894|16030955|P1|Overall Study|Subject dismissed|1
4663738|NCT02935842|16030970|P4|Testing and Therapy Period 3|Withdrawal by Subject|0
4663739|NCT02935842|16030971|P3|Testing and Therapy Period 3|Withdrawal by Subject|3
4663740|NCT02935842|16030972|P2|Testing and Therapy Period 3|Withdrawal by Subject|0
4663741|NCT02935842|16030973|P1|Testing and Therapy Period 3|Withdrawal by Subject|0
4663742|NCT02935842|16030970|P4|Testing and Therapy Period 3|Lost to Follow-up|1
4663743|NCT02935842|16030971|P3|Testing and Therapy Period 3|Lost to Follow-up|0
4663744|NCT02935842|16030972|P2|Testing and Therapy Period 3|Lost to Follow-up|0
4663745|NCT02935842|16030973|P1|Testing and Therapy Period 3|Lost to Follow-up|0
4663746|NCT02935842|16030970|P4|Testing and Therapy Period 3|Accident prior to treatment|0
4663747|NCT02935842|16030971|P3|Testing and Therapy Period 3|Accident prior to treatment|0
4663748|NCT02935842|16030972|P2|Testing and Therapy Period 3|Accident prior to treatment|2
4663749|NCT02935842|16030973|P1|Testing and Therapy Period 3|Accident prior to treatment|2
4663750|NCT02935842|16030970|P4|Testing and Therapy Period 3|Required other therapy (dysphagia)|0
4663751|NCT02935842|16030971|P3|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
4663752|NCT02935842|16030972|P2|Testing and Therapy Period 3|Required other therapy (dysphagia)|2
4663839|NCT02932306|16031597|P2|Overall Study|Lost to Follow-up|40
4663753|NCT02935842|16030973|P1|Testing and Therapy Period 3|Required other therapy (dysphagia)|1
4663754|NCT02935842|16030970|P4|Testing and Therapy Period 2|Withdrawal by Subject|0
4663755|NCT02935842|16030971|P3|Testing and Therapy Period 2|Withdrawal by Subject|0
4663756|NCT02935842|16030972|P2|Testing and Therapy Period 2|Withdrawal by Subject|0
4663757|NCT02935842|16030973|P1|Testing and Therapy Period 2|Withdrawal by Subject|2
4663758|NCT02935673|16031025|P3|Overall Study|Withdrawal by Subject|0
4663759|NCT02935673|16031026|P2|Overall Study|Withdrawal by Subject|2
4663760|NCT02935673|16031027|P1|Overall Study|Withdrawal by Subject|1
4663761|NCT02935673|16031025|P3|Overall Study|Adverse Event|0
4663762|NCT02935673|16031026|P2|Overall Study|Adverse Event|1
4663763|NCT02935673|16031027|P1|Overall Study|Adverse Event|0
4663764|NCT02935192|16031172|P2|Overall Study|Withdrawal by Subject|4
4663765|NCT02935192|16031173|P1|Overall Study|Withdrawal by Subject|8
4663766|NCT02934178|16031290|P2|Received Vaccination 3|Withdrawal by Subject|0
4663767|NCT02934178|16031291|P1|Received Vaccination 3|Withdrawal by Subject|1
4663768|NCT02934178|16031290|P2|Received Vaccination 2|Death|1
4663769|NCT02934178|16031291|P1|Received Vaccination 2|Death|0
4663770|NCT02933528|16031431|P1|Overall Study|Lost to Follow-up|2
4663771|NCT02933060|16031459|P2|Overall Study|Withdrawal by Subject|1
4663772|NCT02933060|16031460|P1|Overall Study|Withdrawal by Subject|0
4663773|NCT02932943|16031501|P2|Overall Study|Withdrawal by Subject|3
4663774|NCT02932943|16031502|P1|Overall Study|Withdrawal by Subject|3
4663775|NCT02932943|16031501|P2|Overall Study|Adverse Event|2
4663776|NCT02932943|16031502|P1|Overall Study|Adverse Event|2
4663777|NCT02932943|16031501|P2|Overall Study|Lost to Follow-up|2
4663778|NCT02932943|16031502|P1|Overall Study|Lost to Follow-up|0
4663779|NCT02932904|16031518|P4|Overall Study|Randomized But Not Treated|2
4663780|NCT02932904|16031519|P3|Overall Study|Randomized But Not Treated|0
4663781|NCT02932904|16031520|P2|Overall Study|Randomized But Not Treated|1
4663782|NCT02932904|16031521|P1|Overall Study|Randomized But Not Treated|1
4663783|NCT02932904|16031518|P4|Overall Study|Pretreatment Event/Adverse Event|3
4663784|NCT02932904|16031519|P3|Overall Study|Pretreatment Event/Adverse Event|1
4663785|NCT02932904|16031520|P2|Overall Study|Pretreatment Event/Adverse Event|5
4663786|NCT02932904|16031521|P1|Overall Study|Pretreatment Event/Adverse Event|3
4663787|NCT02932904|16031518|P4|Overall Study|Significant Protocol Deviation|1
4663788|NCT02932904|16031519|P3|Overall Study|Significant Protocol Deviation|6
4663789|NCT02932904|16031520|P2|Overall Study|Significant Protocol Deviation|3
4663790|NCT02932904|16031521|P1|Overall Study|Significant Protocol Deviation|2
4663791|NCT02932904|16031518|P4|Overall Study|Lost to Follow-up|0
4663792|NCT02932904|16031519|P3|Overall Study|Lost to Follow-up|6
4663793|NCT02932904|16031520|P2|Overall Study|Lost to Follow-up|3
4663794|NCT02932904|16031521|P1|Overall Study|Lost to Follow-up|5
4663795|NCT02932904|16031518|P4|Overall Study|Voluntary Withdrawal|2
4663796|NCT02932904|16031519|P3|Overall Study|Voluntary Withdrawal|4
4663797|NCT02932904|16031520|P2|Overall Study|Voluntary Withdrawal|1
4663798|NCT02932904|16031521|P1|Overall Study|Voluntary Withdrawal|2
4663799|NCT02932904|16031518|P4|Overall Study|Study Termination|0
4663800|NCT02932904|16031519|P3|Overall Study|Study Termination|0
4663801|NCT02932904|16031520|P2|Overall Study|Study Termination|1
4663802|NCT02932904|16031521|P1|Overall Study|Study Termination|0
4663803|NCT02932904|16031518|P4|Overall Study|Pregnancy|0
4663804|NCT02932904|16031519|P3|Overall Study|Pregnancy|1
4663805|NCT02932904|16031520|P2|Overall Study|Pregnancy|1
4663806|NCT02932904|16031521|P1|Overall Study|Pregnancy|0
4663807|NCT02932904|16031518|P4|Overall Study|Noncompliance with Study Drug|4
4663808|NCT02932904|16031519|P3|Overall Study|Noncompliance with Study Drug|3
4663809|NCT02932904|16031520|P2|Overall Study|Noncompliance with Study Drug|3
4663810|NCT02932904|16031521|P1|Overall Study|Noncompliance with Study Drug|2
4663811|NCT02932904|16031518|P4|Overall Study|Reason not Specified|2
4663812|NCT02932904|16031519|P3|Overall Study|Reason not Specified|2
4663813|NCT02932904|16031520|P2|Overall Study|Reason not Specified|0
4663814|NCT02932904|16031521|P1|Overall Study|Reason not Specified|1
4663815|NCT02932891|16031556|P1|Overall Study|HPA Suppress|2
4663816|NCT02932891|16031556|P1|Overall Study|Lost to Follow-up|2
4663817|NCT02932878|16031562|P2|Overall Study|Due to Lab Results|1
4663818|NCT02932878|16031563|P1|Overall Study|Due to Lab Results|2
4663819|NCT02932462|16031584|P2|Overall Study|Progressive Disease|0
4663820|NCT02932462|16031585|P1|Overall Study|Progressive Disease|1
4663821|NCT02932462|16031584|P2|Overall Study|Non-Compliance With Study Drug|1
4663822|NCT02932462|16031585|P1|Overall Study|Non-Compliance With Study Drug|0
4663823|NCT02932462|16031584|P2|Overall Study|Withdrawal by Subject|4
4663824|NCT02932462|16031585|P1|Overall Study|Withdrawal by Subject|1
4663825|NCT02932462|16031584|P2|Overall Study|Protocol Violation|5
4663826|NCT02932462|16031585|P1|Overall Study|Protocol Violation|0
4663827|NCT02932462|16031584|P2|Overall Study|Lost to Follow-up|1
4663828|NCT02932462|16031585|P1|Overall Study|Lost to Follow-up|4
4663829|NCT02932462|16031584|P2|Overall Study|Adverse Event|2
4663830|NCT02932462|16031585|P1|Overall Study|Adverse Event|1
4663831|NCT02932306|16031597|P2|Overall Study|Withdrew due to burning,itching,stinging|0
4663832|NCT02932306|16031598|P1|Overall Study|Withdrew due to burning,itching,stinging|1
4663833|NCT02932306|16031597|P2|Overall Study|Worsening condition|0
4663834|NCT02932306|16031598|P1|Overall Study|Worsening condition|2
4663835|NCT02932306|16031597|P2|Overall Study|Lack of Efficacy|2
4663836|NCT02932306|16031598|P1|Overall Study|Lack of Efficacy|0
4663837|NCT02932306|16031597|P2|Overall Study|Withdrawal by Parent or Guardian|8
4663838|NCT02932306|16031598|P1|Overall Study|Withdrawal by Parent or Guardian|6
4663840|NCT02932306|16031598|P1|Overall Study|Lost to Follow-up|36
4663841|NCT02932306|16031597|P2|Overall Study|Noncompliance with Study Drug|1
4663842|NCT02932306|16031598|P1|Overall Study|Noncompliance with Study Drug|1
4663843|NCT02932306|16031597|P2|Overall Study|Protocol Violation|1
4663844|NCT02932306|16031598|P1|Overall Study|Protocol Violation|1
4663845|NCT02932306|16031597|P2|Overall Study|Pregnancy|0
4663846|NCT02932306|16031598|P1|Overall Study|Pregnancy|2
4663847|NCT02932306|16031597|P2|Overall Study|Adverse Event|0
4663848|NCT02932306|16031598|P1|Overall Study|Adverse Event|3
4663849|NCT02932306|16031597|P2|Overall Study|Withdrawal by Subject|25
4663850|NCT02932306|16031598|P1|Overall Study|Withdrawal by Subject|16
4663851|NCT02932267|16031612|P1|Overall Study|Pregnancy|1
4663852|NCT02932267|16031612|P1|Overall Study|Lost to Follow-up|4
4663853|NCT02932267|16031612|P1|Overall Study|Withdrawal by Subject|3
4663854|NCT02932228|16031618|P2|Overall Study|not eligible upon chart review|5
4663855|NCT02932228|16031619|P1|Overall Study|not eligible upon chart review|2
4663856|NCT02932228|16031618|P2|Overall Study|Death|23
4663857|NCT02932228|16031619|P1|Overall Study|Death|8
4663858|NCT02931396|16031640|P2|Overall Study|Withdrawal by Subject|0
4663859|NCT02931396|16031641|P1|Overall Study|Withdrawal by Subject|2
4663860|NCT02931396|16031640|P2|Overall Study|Lost to Follow-up|0
4663861|NCT02931396|16031641|P1|Overall Study|Lost to Follow-up|3
4663862|NCT02930837|16031678|P1|Overall Study|Withdrawal by Subject|1
4663863|NCT02930837|16031678|P1|Overall Study|Lost to Follow-up|5
4663864|NCT02930837|16031678|P1|Overall Study|Adverse Event|6
4663865|NCT02930226|16031974|P6|Overall Study|Technical Problems: Leak in plasma bag|0
4663866|NCT02930226|16031975|P5|Overall Study|Technical Problems: Leak in plasma bag|1
4663867|NCT02930226|16031976|P4|Overall Study|Technical Problems: Leak in plasma bag|0
4663868|NCT02930226|16031977|P3|Overall Study|Technical Problems: Leak in plasma bag|0
4663869|NCT02930226|16031978|P2|Overall Study|Technical Problems: Leak in plasma bag|0
4663870|NCT02930226|16031979|P1|Overall Study|Technical Problems: Leak in plasma bag|0
4663871|NCT02930005|16032033|P2|Overall Study|Lost to Follow-up|5
4663872|NCT02930005|16032034|P1|Overall Study|Lost to Follow-up|1
4663873|NCT02929498|16032074|P3|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
4663874|NCT02929498|16032075|P2|Part 1: Dose Confirmation (Upto 2 Years)|Death|0
4663875|NCT02929498|16032076|P1|Part 1: Dose Confirmation (Upto 2 Years)|Death|2
4663876|NCT02929498|16032074|P3|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
4663877|NCT02929498|16032075|P2|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0
4663878|NCT02929498|16032076|P1|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3
4663879|NCT02929407|16032170|P1|Overall Study|Adverse Event|1
4663880|NCT02928770|16032185|P1|Overall Study|Withdrawal by Subject|2
4663881|NCT02928224|16032225|P4|Overall Study|not listed|0
4663882|NCT02928224|16032226|P3|Overall Study|not listed|1
4663883|NCT02928224|16032227|P2|Overall Study|not listed|3
4663884|NCT02928224|16032228|P1|Overall Study|not listed|0
4663885|NCT02928224|16032225|P4|Overall Study|Physician Decision|2
4663886|NCT02928224|16032226|P3|Overall Study|Physician Decision|4
4663887|NCT02928224|16032227|P2|Overall Study|Physician Decision|2
4663888|NCT02928224|16032228|P1|Overall Study|Physician Decision|0
4663889|NCT02928224|16032225|P4|Overall Study|Patient Decision to Discontinue Drug|4
4663890|NCT02928224|16032226|P3|Overall Study|Patient Decision to Discontinue Drug|2
4663891|NCT02928224|16032227|P2|Overall Study|Patient Decision to Discontinue Drug|2
4663892|NCT02928224|16032228|P1|Overall Study|Patient Decision to Discontinue Drug|0
4663893|NCT02928224|16032225|P4|Overall Study|Dose Interruptions>28|4
4663894|NCT02928224|16032226|P3|Overall Study|Dose Interruptions>28|2
4663895|NCT02928224|16032227|P2|Overall Study|Dose Interruptions>28|2
4663896|NCT02928224|16032228|P1|Overall Study|Dose Interruptions>28|1
4663897|NCT02928224|16032225|P4|Overall Study|Withdrawal by Subject|9
4663898|NCT02928224|16032226|P3|Overall Study|Withdrawal by Subject|3
4663899|NCT02928224|16032227|P2|Overall Study|Withdrawal by Subject|4
4663900|NCT02928224|16032228|P1|Overall Study|Withdrawal by Subject|1
4663901|NCT02928224|16032225|P4|Overall Study|Death|11
4663902|NCT02928224|16032226|P3|Overall Study|Death|5
4663903|NCT02928224|16032227|P2|Overall Study|Death|7
4663904|NCT02928224|16032228|P1|Overall Study|Death|1
4663905|NCT02928224|16032225|P4|Overall Study|Changes in Patient's Condition|13
4663906|NCT02928224|16032226|P3|Overall Study|Changes in Patient's Condition|9
4663907|NCT02928224|16032227|P2|Overall Study|Changes in Patient's Condition|9
4663908|NCT02928224|16032228|P1|Overall Study|Changes in Patient's Condition|3
4663909|NCT02928224|16032225|P4|Overall Study|Adverse Event|10
4663910|NCT02928224|16032226|P3|Overall Study|Adverse Event|11
4663911|NCT02928224|16032227|P2|Overall Study|Adverse Event|11
4663912|NCT02928224|16032228|P1|Overall Study|Adverse Event|2
4663913|NCT02928224|16032225|P4|Overall Study|Progressive Disease|103
4663914|NCT02928224|16032226|P3|Overall Study|Progressive Disease|101
4663915|NCT02928224|16032227|P2|Overall Study|Progressive Disease|104
4663916|NCT02928224|16032228|P1|Overall Study|Progressive Disease|23
4663917|NCT02928224|16032225|P4|Overall Study|Treatment Ongoing|37
4663918|NCT02928224|16032226|P3|Overall Study|Treatment Ongoing|78
4663919|NCT02928224|16032227|P2|Overall Study|Treatment Ongoing|78
4663920|NCT02928224|16032228|P1|Overall Study|Treatment Ongoing|6
4663921|NCT02928224|16032225|P4|Overall Study|Randomized, Not Treated|28
4663922|NCT02928224|16032226|P3|Overall Study|Randomized, Not Treated|4
4663923|NCT02928224|16032227|P2|Overall Study|Randomized, Not Treated|2
4663924|NCT02928224|16032228|P1|Overall Study|Randomized, Not Treated|0
4663925|NCT02928029|16032332|P2|Overall Study|AE not related to clinical progression|1
4663926|NCT02928029|16032333|P1|Overall Study|AE not related to clinical progression|1
4663927|NCT02928029|16032332|P2|Overall Study|Clinical progression|2
4663928|NCT02928029|16032333|P1|Overall Study|Clinical progression|1
4663929|NCT02928029|16032332|P2|Overall Study|Radiological progression|0
4663930|NCT02928029|16032333|P1|Overall Study|Radiological progression|1
4663931|NCT02928029|16032332|P2|Overall Study|Withdrawal by Subject|1
4663932|NCT02928029|16032333|P1|Overall Study|Withdrawal by Subject|0
4663933|NCT02927938|16032347|P4|Overall Study|Early Study Termination|3
4663934|NCT02927938|16032348|P3|Overall Study|Early Study Termination|4
4663935|NCT02927938|16032349|P2|Overall Study|Early Study Termination|5
4663936|NCT02927938|16032350|P1|Overall Study|Early Study Termination|1
4663937|NCT02927938|16032347|P4|Overall Study|Death|4
4663938|NCT02927938|16032348|P3|Overall Study|Death|0
4663939|NCT02927938|16032349|P2|Overall Study|Death|1
4663940|NCT02927938|16032350|P1|Overall Study|Death|0
4663941|NCT02927795|16032358|P1|Overall Study|Not Treated|4
4663942|NCT02927795|16032358|P1|Overall Study|Non-evaluable PF10 quest. at visit 2|19
4663943|NCT02927431|16032405|P3|Overall Study|Withdrawal by Subject|1
4663944|NCT02927431|16032406|P2|Overall Study|Withdrawal by Subject|0
4663945|NCT02927431|16032407|P1|Overall Study|Withdrawal by Subject|0
4663946|NCT02927366|16032485|P2|Overall Study|Patient schedule|0
4663947|NCT02927366|16032486|P1|Overall Study|Patient schedule|1
4663948|NCT02927366|16032485|P2|Overall Study|Adverse Event|0
4663949|NCT02927366|16032486|P1|Overall Study|Adverse Event|1
4663950|NCT02927171|16032541|P2|Overall Study|Lost to Follow-up|1
4663951|NCT02927171|16032542|P1|Overall Study|Lost to Follow-up|0
4663952|NCT02926833|16032556|P4|Overall Study|Adverse Event|0
4663953|NCT02926833|16032557|P3|Overall Study|Adverse Event|1
4663954|NCT02926833|16032558|P2|Overall Study|Adverse Event|0
4663955|NCT02926833|16032559|P1|Overall Study|Adverse Event|0
4663956|NCT02926833|16032556|P4|Overall Study|Still on study|14
4663957|NCT02926833|16032557|P3|Overall Study|Still on study|5
4663958|NCT02926833|16032558|P2|Overall Study|Still on study|3
4663959|NCT02926833|16032559|P1|Overall Study|Still on study|2
4663960|NCT02926833|16032556|P4|Overall Study|Death|7
4663961|NCT02926833|16032557|P3|Overall Study|Death|1
4663962|NCT02926833|16032558|P2|Overall Study|Death|1
4663963|NCT02926833|16032559|P1|Overall Study|Death|1
4663964|NCT02926833|16032556|P4|Overall Study|Full Consent Withdrawal|2
4663965|NCT02926833|16032557|P3|Overall Study|Full Consent Withdrawal|0
4663966|NCT02926833|16032558|P2|Overall Study|Full Consent Withdrawal|0
4663967|NCT02926833|16032559|P1|Overall Study|Full Consent Withdrawal|0
4663968|NCT02926638|16032615|P2|Overall Study|Not protocol specified|0
4663969|NCT02926638|16032616|P1|Overall Study|Not protocol specified|1
4663970|NCT02926638|16032615|P2|Overall Study|Ineligible|0
4663971|NCT02926638|16032616|P1|Overall Study|Ineligible|1
4663972|NCT02926638|16032615|P2|Overall Study|Progression|5
4663973|NCT02926638|16032616|P1|Overall Study|Progression|2
4663974|NCT02926573|16032630|P2|Overall Study|Delirium|1
4663975|NCT02926573|16032631|P1|Overall Study|Delirium|0
4663976|NCT02926573|16032630|P2|Overall Study|Return to operating room|2
4663977|NCT02926573|16032631|P1|Overall Study|Return to operating room|0
4663978|NCT02926573|16032630|P2|Overall Study|Withdrawal by Subject|2
4663979|NCT02926573|16032631|P1|Overall Study|Withdrawal by Subject|0
4663980|NCT02926573|16032630|P2|Overall Study|Change to outpatient status|1
4663981|NCT02926573|16032631|P1|Overall Study|Change to outpatient status|5
4663982|NCT02926573|16032630|P2|Overall Study|Change in surgery plan|1
4663983|NCT02926573|16032631|P1|Overall Study|Change in surgery plan|3
4663984|NCT02926573|16032630|P2|Overall Study|Remain intubated|2
4663985|NCT02926573|16032631|P1|Overall Study|Remain intubated|2
4663986|NCT02926573|16032630|P2|Overall Study|Nausea|0
4663987|NCT02926573|16032631|P1|Overall Study|Nausea|1
4663988|NCT02926209|16032649|P2|Study Cohort|Poor Bowel Preparation|0
4663989|NCT02926209|16032650|P1|Study Cohort|Poor Bowel Preparation|1
4663990|NCT02925923|16032663|P2|Overall Study|blood samples hemolyzed|2
4663991|NCT02925923|16032664|P1|Overall Study|blood samples hemolyzed|0
4663992|NCT02925741|16032721|P2|Overall Study|Withdrawal by Subject|0
4663993|NCT02925741|16032722|P1|Overall Study|Withdrawal by Subject|11
4663994|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Adverse Event|1
4663995|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Adverse Event|0
4663996|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Adverse Event|0
4663997|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Adverse Event|0
4663998|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Non-Compliance|2
4663999|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
4664000|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
4664001|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
4664002|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Pregnancy|2
4664003|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Pregnancy|1
4664004|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Pregnancy|0
4664005|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Pregnancy|1
4664006|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6
4664007|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
4664008|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2
4664009|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1
4664010|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Other|6
4664011|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Other|3
4664012|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Other|4
4664013|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Other|1
4664014|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|10
4664015|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|9
4664016|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4664017|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4664018|NCT02925494|16032755|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|23
4664019|NCT02925494|16032756|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
4664020|NCT02925494|16032757|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
4664021|NCT02925494|16032758|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
4664022|NCT02925403|16032786|P2|Overall Study|Lost to Follow-up|1
4664023|NCT02925403|16032787|P1|Overall Study|Lost to Follow-up|0
4664024|NCT02925312|16032801|P2|Overall Study|Adverse Event|0
4664025|NCT02925312|16032802|P1|Overall Study|Adverse Event|2
4664026|NCT02925312|16032801|P2|Overall Study|Lost to Follow-up|0
4664027|NCT02925312|16032802|P1|Overall Study|Lost to Follow-up|25
4664028|NCT02925117|16032818|P12|Period 2 (Weeks 16 - 88)|Other|0
4664029|NCT02925117|16032819|P11|Period 2 (Weeks 16 - 88)|Other|3
4664030|NCT02925117|16032820|P10|Period 2 (Weeks 16 - 88)|Other|4
4664031|NCT02925117|16032821|P9|Period 2 (Weeks 16 - 88)|Other|3
4664032|NCT02925117|16032822|P8|Period 2 (Weeks 16 - 88)|Other|1
4664033|NCT02925117|16032823|P7|Period 2 (Weeks 16 - 88)|Other|1
4664034|NCT02925117|16032824|P6|Period 2 (Weeks 16 - 88)|Other|1
4664035|NCT02925117|16032825|P5|Period 2 (Weeks 16 - 88)|Other|1
4664036|NCT02925117|16032826|P4|Period 2 (Weeks 16 - 88)|Other|0
4664037|NCT02925117|16032827|P3|Period 2 (Weeks 16 - 88)|Other|0
4664038|NCT02925117|16032828|P2|Period 2 (Weeks 16 - 88)|Other|0
4664039|NCT02925117|16032829|P1|Period 2 (Weeks 16 - 88)|Other|0
4664040|NCT02925117|16032818|P12|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4664041|NCT02925117|16032819|P11|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4664042|NCT02925117|16032820|P10|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4664043|NCT02925117|16032821|P9|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4664044|NCT02925117|16032822|P8|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4664045|NCT02925117|16032823|P7|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4664046|NCT02925117|16032824|P6|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2
4664047|NCT02925117|16032825|P5|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1
4664048|NCT02925117|16032826|P4|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4664049|NCT02925117|16032827|P3|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4664050|NCT02925117|16032828|P2|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4664051|NCT02925117|16032829|P1|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0
4664052|NCT02925117|16032818|P12|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4664053|NCT02925117|16032819|P11|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4664054|NCT02925117|16032820|P10|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4664055|NCT02925117|16032821|P9|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2
4664056|NCT02925117|16032822|P8|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3
4664057|NCT02925117|16032823|P7|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4
4664058|NCT02925117|16032824|P6|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1
4664059|NCT02925117|16032825|P5|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4664060|NCT02925117|16032826|P4|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4664061|NCT02925117|16032827|P3|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4664062|NCT02925117|16032828|P2|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4664063|NCT02925117|16032829|P1|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0
4664064|NCT02925117|16032818|P12|Period 2 (Weeks 16 - 88)|Adverse Event|2
4664065|NCT02925117|16032819|P11|Period 2 (Weeks 16 - 88)|Adverse Event|3
4664066|NCT02925117|16032820|P10|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664067|NCT02925117|16032821|P9|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664068|NCT02925117|16032822|P8|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664069|NCT02925117|16032823|P7|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664070|NCT02925117|16032824|P6|Period 2 (Weeks 16 - 88)|Adverse Event|1
4664071|NCT02925117|16032825|P5|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664072|NCT02925117|16032826|P4|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664073|NCT02925117|16032827|P3|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664074|NCT02925117|16032828|P2|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664075|NCT02925117|16032829|P1|Period 2 (Weeks 16 - 88)|Adverse Event|0
4664076|NCT02925117|16032818|P12|Period 1 (Weeks 0 - 16)|Other|0
4664077|NCT02925117|16032819|P11|Period 1 (Weeks 0 - 16)|Other|0
4664078|NCT02925117|16032820|P10|Period 1 (Weeks 0 - 16)|Other|0
4664079|NCT02925117|16032821|P9|Period 1 (Weeks 0 - 16)|Other|0
4664080|NCT02925117|16032822|P8|Period 1 (Weeks 0 - 16)|Other|0
4664081|NCT02925117|16032823|P7|Period 1 (Weeks 0 - 16)|Other|0
4664082|NCT02925117|16032824|P6|Period 1 (Weeks 0 - 16)|Other|0
4664083|NCT02925117|16032825|P5|Period 1 (Weeks 0 - 16)|Other|0
4664084|NCT02925117|16032826|P4|Period 1 (Weeks 0 - 16)|Other|1
4664085|NCT02925117|16032827|P3|Period 1 (Weeks 0 - 16)|Other|1
4664086|NCT02925117|16032828|P2|Period 1 (Weeks 0 - 16)|Other|4
4664087|NCT02925117|16032829|P1|Period 1 (Weeks 0 - 16)|Other|5
4664088|NCT02925117|16032818|P12|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664089|NCT02925117|16032819|P11|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664090|NCT02925117|16032820|P10|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664091|NCT02925117|16032821|P9|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664092|NCT02925117|16032822|P8|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664093|NCT02925117|16032823|P7|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664094|NCT02925117|16032824|P6|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664095|NCT02925117|16032825|P5|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664096|NCT02925117|16032826|P4|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664097|NCT02925117|16032827|P3|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0
4664098|NCT02925117|16032828|P2|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1
4664099|NCT02925117|16032829|P1|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2
4664100|NCT02925117|16032818|P12|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664101|NCT02925117|16032819|P11|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664102|NCT02925117|16032820|P10|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664103|NCT02925117|16032821|P9|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664104|NCT02925117|16032822|P8|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664105|NCT02925117|16032823|P7|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664106|NCT02925117|16032824|P6|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664107|NCT02925117|16032825|P5|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664108|NCT02925117|16032826|P4|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0
4664109|NCT02925117|16032827|P3|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
4664110|NCT02925117|16032828|P2|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3
4664111|NCT02925117|16032829|P1|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10
4664112|NCT02925117|16032818|P12|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664113|NCT02925117|16032819|P11|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664114|NCT02925117|16032820|P10|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664115|NCT02925117|16032821|P9|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664116|NCT02925117|16032822|P8|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664117|NCT02925117|16032823|P7|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664118|NCT02925117|16032824|P6|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664119|NCT02925117|16032825|P5|Period 1 (Weeks 0 - 16)|Adverse Event|0
4664120|NCT02925117|16032826|P4|Period 1 (Weeks 0 - 16)|Adverse Event|2
4664121|NCT02925117|16032827|P3|Period 1 (Weeks 0 - 16)|Adverse Event|1
4664122|NCT02925117|16032828|P2|Period 1 (Weeks 0 - 16)|Adverse Event|3
4664123|NCT02925117|16032829|P1|Period 1 (Weeks 0 - 16)|Adverse Event|1
4664124|NCT02924883|16032940|P2|Overall Study|Ongoing in Study|115
4664125|NCT02924883|16032941|P1|Overall Study|Ongoing in Study|56
4664126|NCT02924883|16032940|P2|Overall Study|Death|13
4664127|NCT02924883|16032941|P1|Overall Study|Death|8
4664128|NCT02924883|16032940|P2|Overall Study|Protocol Violation|1
4664129|NCT02924883|16032941|P1|Overall Study|Protocol Violation|0
4664130|NCT02924883|16032940|P2|Overall Study|Withdrawal by Subject|4
4664131|NCT02924883|16032941|P1|Overall Study|Withdrawal by Subject|5
4664132|NCT02924688|16032966|P6|Overall Study|Withdrawal by Subject|14
4664133|NCT02924688|16032967|P5|Overall Study|Withdrawal by Subject|13
4664134|NCT02924688|16032968|P4|Overall Study|Withdrawal by Subject|12
4664135|NCT02924688|16032969|P3|Overall Study|Withdrawal by Subject|9
4664136|NCT02924688|16032970|P2|Overall Study|Withdrawal by Subject|13
4664137|NCT02924688|16032971|P1|Overall Study|Withdrawal by Subject|14
4664138|NCT02924688|16032966|P6|Overall Study|Physician Decision|1
4664139|NCT02924688|16032967|P5|Overall Study|Physician Decision|1
4664140|NCT02924688|16032968|P4|Overall Study|Physician Decision|1
4664141|NCT02924688|16032969|P3|Overall Study|Physician Decision|0
4664142|NCT02924688|16032970|P2|Overall Study|Physician Decision|1
4664143|NCT02924688|16032971|P1|Overall Study|Physician Decision|2
4664144|NCT02924688|16032966|P6|Overall Study|Lost to Follow-up|4
4664145|NCT02924688|16032967|P5|Overall Study|Lost to Follow-up|2
4664146|NCT02924688|16032968|P4|Overall Study|Lost to Follow-up|4
4664147|NCT02924688|16032969|P3|Overall Study|Lost to Follow-up|2
4664148|NCT02924688|16032970|P2|Overall Study|Lost to Follow-up|4
4664149|NCT02924688|16032971|P1|Overall Study|Lost to Follow-up|2
4664150|NCT02924688|16032966|P6|Overall Study|Protocol defined withdrawal criteria met|0
4664151|NCT02924688|16032967|P5|Overall Study|Protocol defined withdrawal criteria met|1
4664152|NCT02924688|16032968|P4|Overall Study|Protocol defined withdrawal criteria met|1
4664153|NCT02924688|16032969|P3|Overall Study|Protocol defined withdrawal criteria met|1
4664154|NCT02924688|16032970|P2|Overall Study|Protocol defined withdrawal criteria met|0
4664155|NCT02924688|16032971|P1|Overall Study|Protocol defined withdrawal criteria met|1
4664156|NCT02924688|16032966|P6|Overall Study|Protocol Violation|2
4664157|NCT02924688|16032967|P5|Overall Study|Protocol Violation|2
4664158|NCT02924688|16032968|P4|Overall Study|Protocol Violation|6
4664159|NCT02924688|16032969|P3|Overall Study|Protocol Violation|5
4664160|NCT02924688|16032970|P2|Overall Study|Protocol Violation|7
4664161|NCT02924688|16032971|P1|Overall Study|Protocol Violation|3
4664162|NCT02924688|16032966|P6|Overall Study|Lack of Efficacy|1
4664163|NCT02924688|16032967|P5|Overall Study|Lack of Efficacy|1
4664164|NCT02924688|16032968|P4|Overall Study|Lack of Efficacy|2
4664165|NCT02924688|16032969|P3|Overall Study|Lack of Efficacy|4
4664166|NCT02924688|16032970|P2|Overall Study|Lack of Efficacy|3
4664167|NCT02924688|16032971|P1|Overall Study|Lack of Efficacy|2
4664168|NCT02924688|16032966|P6|Overall Study|Adverse Event|2
4664169|NCT02924688|16032967|P5|Overall Study|Adverse Event|3
4664170|NCT02924688|16032968|P4|Overall Study|Adverse Event|2
4664171|NCT02924688|16032969|P3|Overall Study|Adverse Event|2
4664172|NCT02924688|16032970|P2|Overall Study|Adverse Event|3
4664173|NCT02924688|16032971|P1|Overall Study|Adverse Event|9
4664174|NCT02924428|16033041|P2|Overall Study|Pregnancy|1
4664175|NCT02924428|16033042|P1|Overall Study|Pregnancy|0
4664176|NCT02924428|16033041|P2|Overall Study|Lost to Follow-up|4
4664177|NCT02924428|16033042|P1|Overall Study|Lost to Follow-up|2
4664178|NCT02924428|16033041|P2|Overall Study|Physician Decision|0
4664179|NCT02924428|16033042|P1|Overall Study|Physician Decision|1
4664180|NCT02924428|16033041|P2|Overall Study|Adverse Event|0
4664181|NCT02924428|16033042|P1|Overall Study|Adverse Event|1
4664182|NCT02924051|16033077|P2|Overall Study|Withdrawal by Subject|9
4664183|NCT02924051|16033078|P1|Overall Study|Withdrawal by Subject|1
4664184|NCT02923921|16033090|P2|Overall Study|Unknown, Not Collected|6
4664185|NCT02923921|16033091|P1|Overall Study|Unknown, Not Collected|7
4664186|NCT02923921|16033090|P2|Overall Study|Withdrawal by Subject|13
4664187|NCT02923921|16033091|P1|Overall Study|Withdrawal by Subject|6
4664188|NCT02923921|16033090|P2|Overall Study|Lost to Follow-up|0
4664189|NCT02923921|16033091|P1|Overall Study|Lost to Follow-up|1
4664190|NCT02923921|16033090|P2|Overall Study|Sponsor Decision|38
4664191|NCT02923921|16033091|P1|Overall Study|Sponsor Decision|39
4664192|NCT02923830|16033124|P2|Overall Study|Physician Decision|15
4664193|NCT02923830|16033125|P1|Overall Study|Physician Decision|13
4664194|NCT02923427|16033145|P2|Overall Study|can not replace LMA|0
4664195|NCT02923427|16033146|P1|Overall Study|can not replace LMA|1
4664196|NCT02923427|16033145|P2|Overall Study|destaturation|0
4664197|NCT02923427|16033146|P1|Overall Study|destaturation|1
4664198|NCT02923427|16033145|P2|Overall Study|convert to laparatomy|2
4664199|NCT02923427|16033146|P1|Overall Study|convert to laparatomy|2
4664200|NCT02923349|16033173|P7|Overall Study|Death|0
4664201|NCT02923349|16033174|P6|Overall Study|Death|3
4664202|NCT02923349|16033175|P5|Overall Study|Death|2
4664203|NCT02923349|16033176|P4|Overall Study|Death|4
4664204|NCT02923349|16033177|P3|Overall Study|Death|2
4664205|NCT02923349|16033178|P2|Overall Study|Death|0
4664206|NCT02923349|16033179|P1|Overall Study|Death|1
4664207|NCT02923349|16033173|P7|Overall Study|Lost to Follow-up|0
4664208|NCT02923349|16033174|P6|Overall Study|Lost to Follow-up|1
4664209|NCT02923349|16033175|P5|Overall Study|Lost to Follow-up|1
4664210|NCT02923349|16033176|P4|Overall Study|Lost to Follow-up|0
4664211|NCT02923349|16033177|P3|Overall Study|Lost to Follow-up|3
4664212|NCT02923349|16033178|P2|Overall Study|Lost to Follow-up|0
4664213|NCT02923349|16033179|P1|Overall Study|Lost to Follow-up|0
4664214|NCT02923349|16033173|P7|Overall Study|Physician Decision|2
4664215|NCT02923349|16033174|P6|Overall Study|Physician Decision|0
4664216|NCT02923349|16033175|P5|Overall Study|Physician Decision|1
4664217|NCT02923349|16033176|P4|Overall Study|Physician Decision|1
4664218|NCT02923349|16033177|P3|Overall Study|Physician Decision|0
4664219|NCT02923349|16033178|P2|Overall Study|Physician Decision|0
4664220|NCT02923349|16033179|P1|Overall Study|Physician Decision|0
4664221|NCT02923349|16033173|P7|Overall Study|Withdrawal by Subject|0
4664222|NCT02923349|16033174|P6|Overall Study|Withdrawal by Subject|3
4664223|NCT02923349|16033175|P5|Overall Study|Withdrawal by Subject|12
4664224|NCT02923349|16033176|P4|Overall Study|Withdrawal by Subject|10
4664225|NCT02923349|16033177|P3|Overall Study|Withdrawal by Subject|8
4664226|NCT02923349|16033178|P2|Overall Study|Withdrawal by Subject|2
4664227|NCT02923349|16033179|P1|Overall Study|Withdrawal by Subject|2
4664228|NCT02923349|16033173|P7|Overall Study|Other|1
4664229|NCT02923349|16033174|P6|Overall Study|Other|0
4664230|NCT02923349|16033175|P5|Overall Study|Other|3
4664231|NCT02923349|16033176|P4|Overall Study|Other|1
4664232|NCT02923349|16033177|P3|Overall Study|Other|4
4664233|NCT02923349|16033178|P2|Overall Study|Other|2
4664234|NCT02923349|16033179|P1|Overall Study|Other|1
4664235|NCT02923245|16033264|P2|Overall Study|ultrasound order was cancelled|1
4664236|NCT02923245|16033265|P1|Overall Study|ultrasound order was cancelled|2
4664237|NCT02923115|16033288|P6|Overall Study|Randomized, but not dosed|0
4664238|NCT02923115|16033289|P5|Overall Study|Randomized, but not dosed|5
4664239|NCT02923115|16033290|P4|Overall Study|Randomized, but not dosed|1
4664240|NCT02923115|16033291|P3|Overall Study|Randomized, but not dosed|3
4664241|NCT02923115|16033292|P2|Overall Study|Randomized, but not dosed|0
4664242|NCT02923115|16033293|P1|Overall Study|Randomized, but not dosed|0
4664243|NCT02923115|16033288|P6|Overall Study|Withdrawal by Subject|0
4664244|NCT02923115|16033289|P5|Overall Study|Withdrawal by Subject|0
4664245|NCT02923115|16033290|P4|Overall Study|Withdrawal by Subject|0
4664246|NCT02923115|16033291|P3|Overall Study|Withdrawal by Subject|0
4664247|NCT02923115|16033292|P2|Overall Study|Withdrawal by Subject|1
4664248|NCT02923115|16033293|P1|Overall Study|Withdrawal by Subject|0
4664249|NCT02923115|16033288|P6|Overall Study|Lost to Follow-up|0
4664250|NCT02923115|16033289|P5|Overall Study|Lost to Follow-up|0
4664251|NCT02923115|16033290|P4|Overall Study|Lost to Follow-up|1
4664252|NCT02923115|16033291|P3|Overall Study|Lost to Follow-up|0
4664253|NCT02923115|16033292|P2|Overall Study|Lost to Follow-up|0
4664254|NCT02923115|16033293|P1|Overall Study|Lost to Follow-up|0
4664255|NCT02922153|16033410|P2|Overall Study|Physician Decision|1
4664256|NCT02922153|16033411|P1|Overall Study|Physician Decision|1
4664257|NCT02922153|16033410|P2|Overall Study|Lost to Follow-up|0
4664258|NCT02922153|16033411|P1|Overall Study|Lost to Follow-up|1
4664259|NCT02922153|16033410|P2|Overall Study|Death|1
4664260|NCT02922153|16033411|P1|Overall Study|Death|8
4664261|NCT02921425|16033479|P1|Overall Study|Protocol Violation|9
4664262|NCT02921087|16033551|P2|Overall Study|Withdrawal by Subject|1
4664263|NCT02921087|16033552|P1|Overall Study|Withdrawal by Subject|0
4664264|NCT02920983|16033581|P6|Dispense 3|Unacceptable Lens Fit|0
4664265|NCT02920983|16033582|P5|Dispense 3|Unacceptable Lens Fit|1
4664266|NCT02920983|16033583|P4|Dispense 3|Unacceptable Lens Fit|0
4664267|NCT02920983|16033584|P3|Dispense 3|Unacceptable Lens Fit|0
4664268|NCT02920983|16033585|P2|Dispense 3|Unacceptable Lens Fit|1
4664269|NCT02920983|16033586|P1|Dispense 3|Unacceptable Lens Fit|1
4664270|NCT02920983|16033581|P6|Dispense 2|Unscceptable lens fit|0
4664271|NCT02920983|16033582|P5|Dispense 2|Unscceptable lens fit|1
4664272|NCT02920983|16033583|P4|Dispense 2|Unscceptable lens fit|0
4664273|NCT02920983|16033584|P3|Dispense 2|Unscceptable lens fit|0
4664274|NCT02920983|16033585|P2|Dispense 2|Unscceptable lens fit|0
4664275|NCT02920983|16033586|P1|Dispense 2|Unscceptable lens fit|1
4664276|NCT02920983|16033581|P6|Dispense 1|Unacceptable Lens Fit|0
4664277|NCT02920983|16033582|P5|Dispense 1|Unacceptable Lens Fit|1
4664278|NCT02920983|16033583|P4|Dispense 1|Unacceptable Lens Fit|0
4664279|NCT02920983|16033584|P3|Dispense 1|Unacceptable Lens Fit|0
4664280|NCT02920983|16033585|P2|Dispense 1|Unacceptable Lens Fit|0
4664281|NCT02920983|16033586|P1|Dispense 1|Unacceptable Lens Fit|0
4664282|NCT02920970|16033615|P2|Second Intervention|Poor Lens Fit|0
4664283|NCT02920970|16033616|P1|Second Intervention|Poor Lens Fit|1
4664284|NCT02920970|16033615|P2|First Intervention|Adverse Event|1
4664285|NCT02920970|16033616|P1|First Intervention|Adverse Event|0
4664286|NCT02920970|16033615|P2|First Intervention|Protocol Violation|1
4664287|NCT02920970|16033616|P1|First Intervention|Protocol Violation|0
4664288|NCT02920957|16033642|P2|Second Intervention: 1 Month|Lost to Follow-up|1
4664289|NCT02920957|16033643|P1|Second Intervention: 1 Month|Lost to Follow-up|0
4664290|NCT02920957|16033642|P2|First Intervention : 1 Month|Adverse Event|0
4664291|NCT02920957|16033643|P1|First Intervention : 1 Month|Adverse Event|1
4664292|NCT02920957|16033642|P2|First Intervention : 1 Month|Lost to Follow-up|0
4664293|NCT02920957|16033643|P1|First Intervention : 1 Month|Lost to Follow-up|1
4664294|NCT02920957|16033642|P2|First Intervention : 1 Month|Withdrawal by Subject|0
4664295|NCT02920957|16033643|P1|First Intervention : 1 Month|Withdrawal by Subject|2
4664296|NCT02920450|16033732|P4|Overall Study|Withdrawal by Subject|0
4664297|NCT02920450|16033733|P3|Overall Study|Withdrawal by Subject|0
4664298|NCT02920450|16033734|P2|Overall Study|Withdrawal by Subject|0
4664299|NCT02920450|16033735|P1|Overall Study|Withdrawal by Subject|1
4664300|NCT02920450|16033732|P4|Overall Study|Death|0
4664301|NCT02920450|16033733|P3|Overall Study|Death|0
4664302|NCT02920450|16033734|P2|Overall Study|Death|0
4664303|NCT02920450|16033735|P1|Overall Study|Death|1
4664304|NCT02920242|16033746|P3|Overall Study|Did not meet inc./exc. criteria|0
4664305|NCT02920242|16033747|P2|Overall Study|Did not meet inc./exc. criteria|0
4664306|NCT02920242|16033748|P1|Overall Study|Did not meet inc./exc. criteria|1
4664307|NCT02920242|16033746|P3|Overall Study|Withdrawal by Subject|1
4664308|NCT02920242|16033747|P2|Overall Study|Withdrawal by Subject|0
4664309|NCT02920242|16033748|P1|Overall Study|Withdrawal by Subject|1
4664310|NCT02920177|16033776|P2|Overall Study|Lost to Follow-up|1
4664311|NCT02920177|16033777|P1|Overall Study|Lost to Follow-up|0
4664312|NCT02920177|16033776|P2|Overall Study|Physician Decision|0
4664313|NCT02920177|16033777|P1|Overall Study|Physician Decision|1
4664314|NCT02920177|16033776|P2|Overall Study|Withdrawal by Subject|1
4664315|NCT02920177|16033777|P1|Overall Study|Withdrawal by Subject|1
4664316|NCT02919995|16033797|P6|Overall Study|Adverse Event|1
4664317|NCT02919995|16033798|P5|Overall Study|Adverse Event|0
4664318|NCT02919995|16033799|P4|Overall Study|Adverse Event|0
4664319|NCT02919995|16033800|P3|Overall Study|Adverse Event|0
4664320|NCT02919995|16033801|P2|Overall Study|Adverse Event|0
4664321|NCT02919995|16033802|P1|Overall Study|Adverse Event|0
4664322|NCT02919761|16033865|P3|Part 2: Double-blind|Discontinued exclusion 16|2
4664323|NCT02919761|16033866|P2|Part 2: Double-blind|Discontinued exclusion 16|0
4664324|NCT02919761|16033867|P1|Part 2: Double-blind|Discontinued exclusion 16|0
4664325|NCT02919761|16033865|P3|Part 2: Double-blind|Did not meet LDA at Week 20|1
4664326|NCT02919761|16033866|P2|Part 2: Double-blind|Did not meet LDA at Week 20|0
4664327|NCT02919761|16033867|P1|Part 2: Double-blind|Did not meet LDA at Week 20|0
4664328|NCT02919761|16033865|P3|Part 2: Double-blind|Did not meet LDA at Week 16|1
4664329|NCT02919761|16033866|P2|Part 2: Double-blind|Did not meet LDA at Week 16|0
4664330|NCT02919761|16033867|P1|Part 2: Double-blind|Did not meet LDA at Week 16|0
4664331|NCT02919761|16033865|P3|Part 2: Double-blind|Worsening of disease activity|10
4664332|NCT02919761|16033866|P2|Part 2: Double-blind|Worsening of disease activity|4
4664333|NCT02919761|16033867|P1|Part 2: Double-blind|Worsening of disease activity|0
4664334|NCT02919761|16033865|P3|Part 2: Double-blind|Met withdrawal criteria|2
4664335|NCT02919761|16033866|P2|Part 2: Double-blind|Met withdrawal criteria|1
4664336|NCT02919761|16033867|P1|Part 2: Double-blind|Met withdrawal criteria|0
4664337|NCT02919761|16033865|P3|Part 2: Double-blind|Lost to Follow-up|3
4664338|NCT02919761|16033866|P2|Part 2: Double-blind|Lost to Follow-up|0
4664339|NCT02919761|16033867|P1|Part 2: Double-blind|Lost to Follow-up|0
4664340|NCT02919761|16033865|P3|Part 2: Double-blind|Adverse Event|0
4664341|NCT02919761|16033866|P2|Part 2: Double-blind|Adverse Event|1
4664342|NCT02919761|16033867|P1|Part 2: Double-blind|Adverse Event|0
4664343|NCT02919761|16033865|P3|Part 2: Double-blind|Withdrawal by Subject|2
4664344|NCT02919761|16033866|P2|Part 2: Double-blind|Withdrawal by Subject|0
4664345|NCT02919761|16033867|P1|Part 2: Double-blind|Withdrawal by Subject|0
4664346|NCT02919761|16033865|P3|Part 1: Open Label|Termination by Sponsor|0
4664347|NCT02919761|16033866|P2|Part 1: Open Label|Termination by Sponsor|0
4664348|NCT02919761|16033867|P1|Part 1: Open Label|Termination by Sponsor|1
4664349|NCT02919761|16033865|P3|Part 1: Open Label|did not meet inclusion criteria 8|0
4664350|NCT02919761|16033866|P2|Part 1: Open Label|did not meet inclusion criteria 8|0
4664351|NCT02919761|16033867|P1|Part 1: Open Label|did not meet inclusion criteria 8|1
4664352|NCT02919761|16033865|P3|Part 1: Open Label|Dose Greater Than 20mg/Week|0
4664353|NCT02919761|16033866|P2|Part 1: Open Label|Dose Greater Than 20mg/Week|0
4664354|NCT02919761|16033867|P1|Part 1: Open Label|Dose Greater Than 20mg/Week|1
4664355|NCT02919761|16033865|P3|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
4664356|NCT02919761|16033866|P2|Part 1: Open Label|Did Not Achieve Lda At Week 12|0
4664357|NCT02919761|16033867|P1|Part 1: Open Label|Did Not Achieve Lda At Week 12|2
4664358|NCT02919761|16033865|P3|Part 1: Open Label|Met withdrawal criteria|0
4664359|NCT02919761|16033866|P2|Part 1: Open Label|Met withdrawal criteria|0
4664360|NCT02919761|16033867|P1|Part 1: Open Label|Met withdrawal criteria|5
4664361|NCT02919761|16033865|P3|Part 1: Open Label|Lost to Follow-up|0
4664362|NCT02919761|16033866|P2|Part 1: Open Label|Lost to Follow-up|0
4664363|NCT02919761|16033867|P1|Part 1: Open Label|Lost to Follow-up|1
4664364|NCT02919761|16033865|P3|Part 1: Open Label|Adverse Event|0
4664365|NCT02919761|16033866|P2|Part 1: Open Label|Adverse Event|0
4664366|NCT02919761|16033867|P1|Part 1: Open Label|Adverse Event|1
4664367|NCT02919761|16033865|P3|Part 1: Open Label|Withdrawal by Subject|0
4664368|NCT02919761|16033866|P2|Part 1: Open Label|Withdrawal by Subject|0
4664369|NCT02919761|16033867|P1|Part 1: Open Label|Withdrawal by Subject|12
4664370|NCT02919696|16033895|P2|Overall Study|Never Treated|1
4664371|NCT02919696|16033896|P1|Overall Study|Never Treated|0
4664372|NCT02919696|16033895|P2|Overall Study|Sponsor Decision|1
4664373|NCT02919696|16033896|P1|Overall Study|Sponsor Decision|1
4664374|NCT02919696|16033895|P2|Overall Study|Withdrawal by Subject|1
4664375|NCT02919696|16033896|P1|Overall Study|Withdrawal by Subject|2
4664376|NCT02919696|16033895|P2|Overall Study|Adverse Event|2
4664377|NCT02919696|16033896|P1|Overall Study|Adverse Event|1
4664378|NCT02919683|16033918|P2|Post-Surgery Follow-Up|Patient is still completing follow-ups|0
4664379|NCT02919683|16033919|P1|Post-Surgery Follow-Up|Patient is still completing follow-ups|1
4664380|NCT02919683|16033918|P2|Post-Surgery Follow-Up|Death|2
4664381|NCT02919683|16033919|P1|Post-Surgery Follow-Up|Death|2
4664382|NCT02919618|16033932|P1|Overall Study|Death|1
4664383|NCT02919267|16033962|P4|Overall Study|Protocol Violation|4
4664384|NCT02919267|16033963|P3|Overall Study|Protocol Violation|3
4664385|NCT02919267|16033964|P2|Overall Study|Protocol Violation|3
4664386|NCT02919267|16033965|P1|Overall Study|Protocol Violation|0
4664387|NCT02918552|16034105|P2|Overall Study|Lost to Follow-up|1
4664388|NCT02918552|16034106|P1|Overall Study|Lost to Follow-up|0
4664389|NCT02918552|16034105|P2|Overall Study|Withdrawal by Subject|1
4664390|NCT02918552|16034106|P1|Overall Study|Withdrawal by Subject|0
4664391|NCT02918552|16034105|P2|Overall Study|Failed Pharmacokinetics|0
4664392|NCT02918552|16034106|P1|Overall Study|Failed Pharmacokinetics|1
4664393|NCT02918318|16034182|P5|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1
4664394|NCT02918318|16034183|P4|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4664395|NCT02918318|16034184|P3|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4664396|NCT02918318|16034185|P2|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4664397|NCT02918318|16034186|P1|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0
4664398|NCT02918318|16034182|P5|Open Label Treatment Phase: 4 Weeks|Adverse Event|1
4664399|NCT02918318|16034183|P4|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4664400|NCT02918318|16034184|P3|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4664401|NCT02918318|16034185|P2|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4664402|NCT02918318|16034186|P1|Open Label Treatment Phase: 4 Weeks|Adverse Event|0
4664403|NCT02918318|16034182|P5|Posttreatment Phase: Up to 24 Weeks|Other|0
4664404|NCT02918318|16034183|P4|Posttreatment Phase: Up to 24 Weeks|Other|1
4664405|NCT02918318|16034184|P3|Posttreatment Phase: Up to 24 Weeks|Other|1
4664406|NCT02918318|16034185|P2|Posttreatment Phase: Up to 24 Weeks|Other|3
4664407|NCT02918318|16034186|P1|Posttreatment Phase: Up to 24 Weeks|Other|0
4664408|NCT02918318|16034182|P5|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
4664409|NCT02918318|16034183|P4|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
4664410|NCT02918318|16034184|P3|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
4664411|NCT02918318|16034185|P2|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0
4664412|NCT02918318|16034186|P1|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1
4664413|NCT02918318|16034182|P5|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
4664414|NCT02918318|16034183|P4|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
4664415|NCT02918318|16034184|P3|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
4664416|NCT02918318|16034185|P2|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0
4664417|NCT02918318|16034186|P1|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1
4664418|NCT02918318|16034182|P5|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4664419|NCT02918318|16034183|P4|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2
4664420|NCT02918318|16034184|P3|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4664421|NCT02918318|16034185|P2|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4664422|NCT02918318|16034186|P1|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0
4664423|NCT02918318|16034182|P5|Double-blind Induction Phase: 4 Weeks|Other|0
4664424|NCT02918318|16034183|P4|Double-blind Induction Phase: 4 Weeks|Other|1
4664425|NCT02918318|16034184|P3|Double-blind Induction Phase: 4 Weeks|Other|0
4664426|NCT02918318|16034185|P2|Double-blind Induction Phase: 4 Weeks|Other|2
4664427|NCT02918318|16034186|P1|Double-blind Induction Phase: 4 Weeks|Other|0
4664428|NCT02918318|16034182|P5|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4664429|NCT02918318|16034183|P4|Double-blind Induction Phase: 4 Weeks|Non-compliance|1
4664430|NCT02918318|16034184|P3|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4664431|NCT02918318|16034185|P2|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4664432|NCT02918318|16034186|P1|Double-blind Induction Phase: 4 Weeks|Non-compliance|0
4664433|NCT02918318|16034182|P5|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
4664434|NCT02918318|16034183|P4|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
4664435|NCT02918318|16034184|P3|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0
4664436|NCT02918318|16034185|P2|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
4664437|NCT02918318|16034186|P1|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1
4664438|NCT02918318|16034182|P5|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4664439|NCT02918318|16034183|P4|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1
4664440|NCT02918318|16034184|P3|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4664441|NCT02918318|16034185|P2|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4664442|NCT02918318|16034186|P1|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0
4664443|NCT02918318|16034182|P5|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4664444|NCT02918318|16034183|P4|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2
4664445|NCT02918318|16034184|P3|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4664446|NCT02918318|16034185|P2|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4664447|NCT02918318|16034186|P1|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0
4664448|NCT02918318|16034182|P5|Double-blind Induction Phase: 4 Weeks|Adverse Event|0
4664449|NCT02918318|16034183|P4|Double-blind Induction Phase: 4 Weeks|Adverse Event|3
4664450|NCT02918318|16034184|P3|Double-blind Induction Phase: 4 Weeks|Adverse Event|2
4664451|NCT02918318|16034185|P2|Double-blind Induction Phase: 4 Weeks|Adverse Event|4
4664452|NCT02918318|16034186|P1|Double-blind Induction Phase: 4 Weeks|Adverse Event|1
4664453|NCT02918279|16034247|P2|Overall Study|Other|1
4664454|NCT02918279|16034248|P1|Overall Study|Other|3
4664455|NCT02918279|16034247|P2|Overall Study|Withdrawal by parent/guardian|1
4664456|NCT02918279|16034248|P1|Overall Study|Withdrawal by parent/guardian|2
4664457|NCT02918279|16034247|P2|Overall Study|Withdrawal by Subject|15
4664458|NCT02918279|16034248|P1|Overall Study|Withdrawal by Subject|5
4664459|NCT02918279|16034247|P2|Overall Study|Lost to Follow-up|6
4664460|NCT02918279|16034248|P1|Overall Study|Lost to Follow-up|3
4664461|NCT02918266|16034384|P11|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664462|NCT02918266|16034385|P10|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664463|NCT02918266|16034386|P9|Part 2: Intervention Period 1 (2 Days)|Study termination|2
4664464|NCT02918266|16034387|P8|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664465|NCT02918266|16034388|P7|Part 2: Intervention Period 1 (2 Days)|Study termination|2
4664466|NCT02918266|16034389|P6|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664467|NCT02918266|16034390|P5|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664468|NCT02918266|16034391|P4|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664469|NCT02918266|16034392|P3|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664470|NCT02918266|16034393|P2|Part 2: Intervention Period 1 (2 Days)|Study termination|1
4664471|NCT02918266|16034394|P1|Part 2: Intervention Period 1 (2 Days)|Study termination|0
4664472|NCT02918071|16034499|P1|Overall Study|Lost to Follow-up|1
4664473|NCT02918071|16034499|P1|Overall Study|Withdrawal by Subject|2
4664474|NCT02917941|16034509|P1|Survival Follow-up Period|Withdrawal by Subject|4
4664475|NCT02917941|16034509|P1|Survival Follow-up Period|Lost to Follow-up|1
4664476|NCT02917941|16034509|P1|Treatment Period|Reason not Specified|2
4664477|NCT02917941|16034509|P1|Treatment Period|Progressive Disease|11
4664478|NCT02917941|16034509|P1|Treatment Period|Adverse Event|11
4664479|NCT02917265|16034562|P2|Overall Study|Withdrawal by Subject|0
4664480|NCT02917265|16034563|P1|Overall Study|Withdrawal by Subject|1
4664481|NCT02917265|16034562|P2|Overall Study|Physician Decision|0
4664482|NCT02917265|16034563|P1|Overall Study|Physician Decision|1
4664483|NCT02916927|16034579|P2|Overall Study|Withdrawal before first time point|0
4664484|NCT02916927|16034580|P1|Overall Study|Withdrawal before first time point|1
4664485|NCT02916927|16034579|P2|Overall Study|At radiology for 45 & 60 min time points|1
4664486|NCT02916927|16034580|P1|Overall Study|At radiology for 45 & 60 min time points|0
4664487|NCT02916927|16034579|P2|Overall Study|Discharged prior to study drug receipt|2
4664488|NCT02916927|16034580|P1|Overall Study|Discharged prior to study drug receipt|0
4664489|NCT02916433|16034639|P2|Overall Study|Physician Decision|0
4664490|NCT02916433|16034640|P1|Overall Study|Physician Decision|1
4664491|NCT02916433|16034639|P2|Overall Study|Withdrawal by Subject|0
4664492|NCT02916433|16034640|P1|Overall Study|Withdrawal by Subject|1
4664493|NCT02915978|16034663|P3|Overall Study|Adverse Event|0
4664494|NCT02915978|16034664|P2|Overall Study|Adverse Event|1
4664495|NCT02915978|16034665|P1|Overall Study|Adverse Event|2
4664496|NCT02915874|16034717|P2|Overall Study|Started New Anxiety Medication|1
4664497|NCT02915874|16034718|P1|Overall Study|Started New Anxiety Medication|0
4664498|NCT02915874|16034717|P2|Overall Study|Withdrawal by Subject|1
4664499|NCT02915874|16034718|P1|Overall Study|Withdrawal by Subject|1
4664500|NCT02915874|16034717|P2|Overall Study|Lost to Follow-up|4
4664501|NCT02915874|16034718|P1|Overall Study|Lost to Follow-up|5
4664502|NCT02915835|16034738|P2|Overall Study|Withdrawal by Subject|1
4664503|NCT02915835|16034739|P1|Overall Study|Withdrawal by Subject|0
4664504|NCT02915835|16034738|P2|Overall Study|Physician Decision|0
4664505|NCT02915835|16034739|P1|Overall Study|Physician Decision|1
4664506|NCT02915783|16034863|P1|Overall Study|Ongoing: In Survival Follow Up|8
4664507|NCT02915783|16034863|P1|Overall Study|Ongoing: Receiving Treatment|6
4664508|NCT02915302|16034945|P2|Overall Study|Other|0
4664509|NCT02915302|16034946|P1|Overall Study|Other|1
4664510|NCT02915302|16034945|P2|Overall Study|Withdrawal by Subject|29
4664511|NCT02915302|16034946|P1|Overall Study|Withdrawal by Subject|22
4664512|NCT02915302|16034945|P2|Overall Study|Lost to Follow-up|22
4664513|NCT02915302|16034946|P1|Overall Study|Lost to Follow-up|19
4664514|NCT02915302|16034945|P2|Overall Study|Protocol Violation|27
4664515|NCT02915302|16034946|P1|Overall Study|Protocol Violation|20
4664516|NCT02915302|16034945|P2|Overall Study|Adverse Event|0
4664517|NCT02915302|16034946|P1|Overall Study|Adverse Event|3
4664518|NCT02915159|16034958|P2|Overall Study|Lack of Efficacy|3
4664519|NCT02915159|16034959|P1|Overall Study|Lack of Efficacy|0
4664520|NCT02915159|16034958|P2|Overall Study|Adverse Event|2
4664521|NCT02915159|16034959|P1|Overall Study|Adverse Event|2
4664522|NCT02915159|16034958|P2|Overall Study|Request to discontinue treatment|2
4664523|NCT02915159|16034959|P1|Overall Study|Request to discontinue treatment|1
4664524|NCT02915159|16034958|P2|Overall Study|Participant withdrew consent|1
4664525|NCT02915159|16034959|P1|Overall Study|Participant withdrew consent|5
4664526|NCT02915159|16034958|P2|Overall Study|poor/non-compliance|0
4664527|NCT02915159|16034959|P1|Overall Study|poor/non-compliance|1
4664528|NCT02915159|16034958|P2|Overall Study|Participant no longer meets criteria|0
4664529|NCT02915159|16034959|P1|Overall Study|Participant no longer meets criteria|2
4664530|NCT02915016|16035098|P8|Overall Study|Participant unable to adhere|1
4664531|NCT02915016|16035099|P7|Overall Study|Participant unable to adhere|0
4664532|NCT02915016|16035100|P6|Overall Study|Participant unable to adhere|0
4664533|NCT02915016|16035101|P5|Overall Study|Participant unable to adhere|0
4664534|NCT02915016|16035102|P4|Overall Study|Participant unable to adhere|0
4664535|NCT02915016|16035103|P3|Overall Study|Participant unable to adhere|0
4664536|NCT02915016|16035104|P2|Overall Study|Participant unable to adhere|0
4664537|NCT02915016|16035105|P1|Overall Study|Participant unable to adhere|0
4664538|NCT02915016|16035098|P8|Overall Study|HIV infection|0
4664539|NCT02915016|16035099|P7|Overall Study|HIV infection|0
4664540|NCT02915016|16035100|P6|Overall Study|HIV infection|0
4664541|NCT02915016|16035101|P5|Overall Study|HIV infection|1
4664542|NCT02915016|16035102|P4|Overall Study|HIV infection|0
4664543|NCT02915016|16035103|P3|Overall Study|HIV infection|1
4664544|NCT02915016|16035104|P2|Overall Study|HIV infection|1
4664545|NCT02915016|16035105|P1|Overall Study|HIV infection|1
4664546|NCT02915016|16035098|P8|Overall Study|Elected not to continue|0
4664547|NCT02915016|16035099|P7|Overall Study|Elected not to continue|1
4664548|NCT02915016|16035100|P6|Overall Study|Elected not to continue|0
4664549|NCT02915016|16035101|P5|Overall Study|Elected not to continue|0
4664550|NCT02915016|16035102|P4|Overall Study|Elected not to continue|1
4664551|NCT02915016|16035103|P3|Overall Study|Elected not to continue|0
4664552|NCT02915016|16035104|P2|Overall Study|Elected not to continue|0
4664553|NCT02915016|16035105|P1|Overall Study|Elected not to continue|0
4664554|NCT02915016|16035098|P8|Overall Study|Withdrawal by Subject|1
4664555|NCT02915016|16035099|P7|Overall Study|Withdrawal by Subject|1
4664556|NCT02915016|16035100|P6|Overall Study|Withdrawal by Subject|3
4664557|NCT02915016|16035101|P5|Overall Study|Withdrawal by Subject|1
4664558|NCT02915016|16035102|P4|Overall Study|Withdrawal by Subject|0
4664559|NCT02915016|16035103|P3|Overall Study|Withdrawal by Subject|1
4664560|NCT02915016|16035104|P2|Overall Study|Withdrawal by Subject|0
4664561|NCT02915016|16035105|P1|Overall Study|Withdrawal by Subject|2
4664562|NCT02915016|16035098|P8|Overall Study|Physician Decision|0
4664563|NCT02915016|16035099|P7|Overall Study|Physician Decision|2
4664564|NCT02915016|16035100|P6|Overall Study|Physician Decision|1
4664565|NCT02915016|16035101|P5|Overall Study|Physician Decision|0
4664566|NCT02915016|16035102|P4|Overall Study|Physician Decision|0
4664567|NCT02915016|16035103|P3|Overall Study|Physician Decision|1
4664568|NCT02915016|16035104|P2|Overall Study|Physician Decision|0
4664569|NCT02915016|16035105|P1|Overall Study|Physician Decision|0
4664570|NCT02915016|16035098|P8|Overall Study|Lost to Follow-up|2
4664571|NCT02915016|16035099|P7|Overall Study|Lost to Follow-up|8
4664572|NCT02915016|16035100|P6|Overall Study|Lost to Follow-up|2
4664573|NCT02915016|16035101|P5|Overall Study|Lost to Follow-up|5
4664574|NCT02915016|16035102|P4|Overall Study|Lost to Follow-up|3
4664575|NCT02915016|16035103|P3|Overall Study|Lost to Follow-up|5
4664576|NCT02915016|16035104|P2|Overall Study|Lost to Follow-up|2
4664577|NCT02915016|16035105|P1|Overall Study|Lost to Follow-up|4
4664578|NCT02914548|16035318|P3|Overall Study|>40% of body surface area|1
4664579|NCT02914548|16035319|P2|Overall Study|>40% of body surface area|1
4664580|NCT02914548|16035320|P1|Overall Study|>40% of body surface area|0
4664581|NCT02914548|16035318|P3|Overall Study|Withdrawal by Subject|4
4664582|NCT02914548|16035319|P2|Overall Study|Withdrawal by Subject|4
4664583|NCT02914548|16035320|P1|Overall Study|Withdrawal by Subject|3
4664584|NCT02914548|16035318|P3|Overall Study|Protocol Violation|0
4664585|NCT02914548|16035319|P2|Overall Study|Protocol Violation|0
4664586|NCT02914548|16035320|P1|Overall Study|Protocol Violation|1
4664587|NCT02914548|16035318|P3|Overall Study|Physician Decision|0
4664588|NCT02914548|16035319|P2|Overall Study|Physician Decision|2
4664589|NCT02914548|16035320|P1|Overall Study|Physician Decision|2
4664590|NCT02914548|16035318|P3|Overall Study|Adverse Event|15
4664591|NCT02914548|16035319|P2|Overall Study|Adverse Event|7
4664592|NCT02914548|16035320|P1|Overall Study|Adverse Event|15
4664593|NCT02914457|16035351|P1|Overall Study|Protocol Violation|1
4664594|NCT02914457|16035351|P1|Overall Study|ECG acquisition error due to sweating|1
4664595|NCT02914457|16035351|P1|Overall Study|Electrical instability of patient|1
4664596|NCT02914457|16035351|P1|Overall Study|No veins available for lead placement|1
4664597|NCT02914457|16035351|P1|Overall Study|Physician Decision|1
4664598|NCT02914457|16035351|P1|Overall Study|Withdrawal by Subject|1
4664599|NCT02914275|16035361|P2|Overall Study|Excluded due to invalid informed consent|0
4664600|NCT02914275|16035362|P1|Overall Study|Excluded due to invalid informed consent|3
4664601|NCT02914275|16035361|P2|Overall Study|Other|1
4664602|NCT02914275|16035362|P1|Overall Study|Other|4
4664603|NCT02914275|16035361|P2|Overall Study|Physician Decision|1
4664604|NCT02914275|16035362|P1|Overall Study|Physician Decision|3
4664605|NCT02914275|16035361|P2|Overall Study|Protocol Violation|1
4664606|NCT02914275|16035362|P1|Overall Study|Protocol Violation|1
4664607|NCT02914275|16035361|P2|Overall Study|Withdrawal by Subject|10
4664608|NCT02914275|16035362|P1|Overall Study|Withdrawal by Subject|26
4664609|NCT02914275|16035361|P2|Overall Study|Lost to Follow-up|29
4664610|NCT02914275|16035362|P1|Overall Study|Lost to Follow-up|84
4664611|NCT02914236|16035394|P1|Overall Study|Lost to Follow-up|1
4664612|NCT02914184|16035440|P4|Overall Study|Migrated/moved from the study area|1
4664613|NCT02914184|16035441|P3|Overall Study|Migrated/moved from the study area|2
4664614|NCT02914184|16035442|P2|Overall Study|Migrated/moved from the study area|1
4664615|NCT02914184|16035443|P1|Overall Study|Migrated/moved from the study area|2
4664616|NCT02914184|16035440|P4|Overall Study|Other|0
4664617|NCT02914184|16035441|P3|Overall Study|Other|0
4664618|NCT02914184|16035442|P2|Overall Study|Other|0
4664619|NCT02914184|16035443|P1|Overall Study|Other|1
4664620|NCT02914184|16035440|P4|Overall Study|Withdrawal by Subject|3
4664621|NCT02914184|16035441|P3|Overall Study|Withdrawal by Subject|7
4664622|NCT02914184|16035442|P2|Overall Study|Withdrawal by Subject|2
4664623|NCT02914184|16035443|P1|Overall Study|Withdrawal by Subject|4
4664624|NCT02914184|16035440|P4|Overall Study|Lost to Follow-up|7
4664625|NCT02914184|16035441|P3|Overall Study|Lost to Follow-up|8
4664626|NCT02914184|16035442|P2|Overall Study|Lost to Follow-up|10
4664627|NCT02914184|16035443|P1|Overall Study|Lost to Follow-up|7
4664628|NCT02913326|16035500|P2|Overall Study|Adverse Event|0
4664629|NCT02913326|16035501|P1|Overall Study|Adverse Event|1
4664630|NCT02913326|16035500|P2|Overall Study|Lost to Follow-up|1
4664631|NCT02913326|16035501|P1|Overall Study|Lost to Follow-up|0
4664632|NCT02913326|16035500|P2|Overall Study|Reason not listed|1
4664633|NCT02913326|16035501|P1|Overall Study|Reason not listed|0
4664634|NCT02913105|16035537|P3|Overall Study|Withdrawal by Subject|1
4664635|NCT02913105|16035538|P2|Overall Study|Withdrawal by Subject|3
4664636|NCT02913105|16035539|P1|Overall Study|Withdrawal by Subject|0
4664637|NCT02913105|16035537|P3|Overall Study|Physician Decision|0
4664638|NCT02913105|16035538|P2|Overall Study|Physician Decision|1
4664639|NCT02913105|16035539|P1|Overall Study|Physician Decision|1
4664640|NCT02913105|16035537|P3|Overall Study|Reason Not Specified|1
4664641|NCT02913105|16035538|P2|Overall Study|Reason Not Specified|1
4664642|NCT02913105|16035539|P1|Overall Study|Reason Not Specified|3
4664643|NCT02913105|16035537|P3|Overall Study|Non-Compliance With Study Drug|1
4664644|NCT02913105|16035538|P2|Overall Study|Non-Compliance With Study Drug|0
4664645|NCT02913105|16035539|P1|Overall Study|Non-Compliance With Study Drug|0
4664646|NCT02913105|16035537|P3|Overall Study|Adverse Event|4
4664647|NCT02913105|16035538|P2|Overall Study|Adverse Event|0
4664648|NCT02913105|16035539|P1|Overall Study|Adverse Event|11
4664649|NCT02912650|16035592|P4|Overall Study|Adverse Event|0
4664650|NCT02912650|16035593|P3|Overall Study|Adverse Event|1
4664651|NCT02912650|16035594|P2|Overall Study|Adverse Event|0
4664652|NCT02912650|16035595|P1|Overall Study|Adverse Event|0
4664653|NCT02912650|16035592|P4|Overall Study|Withdrawal by Subject|5
4664654|NCT02912650|16035593|P3|Overall Study|Withdrawal by Subject|1
4664655|NCT02912650|16035594|P2|Overall Study|Withdrawal by Subject|0
4664656|NCT02912650|16035595|P1|Overall Study|Withdrawal by Subject|1
4664657|NCT02912468|16035679|P2|Overall Study|Randomized and not treated|1
4664658|NCT02912468|16035680|P1|Overall Study|Randomized and not treated|0
4664659|NCT02912468|16035679|P2|Overall Study|Withdrawal by Subject|2
4664660|NCT02912468|16035680|P1|Overall Study|Withdrawal by Subject|6
4664661|NCT02912468|16035679|P2|Overall Study|Adverse Event|2
4664662|NCT02912468|16035680|P1|Overall Study|Adverse Event|3
4664663|NCT02912455|16035759|P2|Overall Study|Lost to Follow-up|1
4664664|NCT02912455|16035760|P1|Overall Study|Lost to Follow-up|2
4664665|NCT02912455|16035759|P2|Overall Study|Lack of Efficacy|1
4664666|NCT02912455|16035760|P1|Overall Study|Lack of Efficacy|0
4664667|NCT02912455|16035759|P2|Overall Study|Withdrawal by Subject|1
4664668|NCT02912455|16035760|P1|Overall Study|Withdrawal by Subject|0
4664669|NCT02911948|16035855|P2|Overall Study|Unclassified|3
4664670|NCT02911948|16035856|P1|Overall Study|Unclassified|0
4664671|NCT02911948|16035855|P2|Overall Study|Lack of Efficacy|1
4664672|NCT02911948|16035856|P1|Overall Study|Lack of Efficacy|0
4664673|NCT02911948|16035855|P2|Overall Study|Withdrawal by Subject|2
4664674|NCT02911948|16035856|P1|Overall Study|Withdrawal by Subject|0
4664675|NCT02911948|16035855|P2|Overall Study|Protocol Violation|1
4664676|NCT02911948|16035856|P1|Overall Study|Protocol Violation|0
4664677|NCT02911688|16036118|P2|Washout|Withdrawal by Subject|1
4664678|NCT02911688|16036119|P1|Washout|Withdrawal by Subject|0
4664679|NCT02911688|16036118|P2|Washout|Lost to Follow-up|1
4664680|NCT02911688|16036119|P1|Washout|Lost to Follow-up|1
4664681|NCT02911519|16036143|P2|Overall Study|Death|2
4664682|NCT02911519|16036144|P1|Overall Study|Death|0
4664683|NCT02911519|16036143|P2|Overall Study|Lost to Follow-up|2
4664684|NCT02911519|16036144|P1|Overall Study|Lost to Follow-up|2
4664685|NCT02910739|16036176|P4|Overall Study|Adverse Event|0
4664686|NCT02910739|16036177|P3|Overall Study|Adverse Event|0
4664687|NCT02910739|16036178|P2|Overall Study|Adverse Event|0
4664688|NCT02910739|16036179|P1|Overall Study|Adverse Event|1
4664689|NCT02910713|16036205|P1|Overall Study|Investigator Discretion|1
4664690|NCT02910713|16036205|P1|Overall Study|Enrollment cap|7
4664691|NCT02910713|16036205|P1|Overall Study|Received Neither Application|18
4664692|NCT02910713|16036205|P1|Overall Study|Received One Application|10
4664693|NCT02910713|16036205|P1|Overall Study|Subject Choice|4
4664694|NCT02910713|16036205|P1|Overall Study|Protocol Violation|2
4664695|NCT02910167|16036221|P1|Overall Study|Lost to Follow-up|18
4664696|NCT02910167|16036221|P1|Overall Study|Adverse Event|1
4664697|NCT02910089|16036246|P2|Overall Study|Lost insurance eligibility|16
4664698|NCT02910089|16036247|P1|Overall Study|Lost insurance eligibility|22
4664699|NCT02910011|16036259|P1|Overall Study|Physician Decision|2
4664700|NCT02909907|16036368|P2|Overall Study|Withdrawal by Subject|1
4664701|NCT02909907|16036369|P1|Overall Study|Withdrawal by Subject|0
4664702|NCT02909504|16036410|P1|Overall Study|Lost to Follow-up|1
4664703|NCT02909504|16036410|P1|Overall Study|Subject moved|1
4664704|NCT02909504|16036410|P1|Overall Study|Pregnancy|1
4664705|NCT02909504|16036410|P1|Overall Study|Withdrawal by Subject|4
4664706|NCT02909504|16036410|P1|Overall Study|Lack of Efficacy|3
4664707|NCT02909504|16036410|P1|Overall Study|Adverse Event|2
4664708|NCT02909153|16036447|P5|Overall Study|Withdrawal by Subject|0
4664709|NCT02909153|16036448|P4|Overall Study|Withdrawal by Subject|0
4664710|NCT02909153|16036449|P3|Overall Study|Withdrawal by Subject|0
4664711|NCT02909153|16036450|P2|Overall Study|Withdrawal by Subject|1
4664712|NCT02909153|16036451|P1|Overall Study|Withdrawal by Subject|0
4664713|NCT02909101|16036541|P2|Overall Study|Lost to Follow-up|1
4664714|NCT02909101|16036542|P1|Overall Study|Lost to Follow-up|1
4664715|NCT02908880|16036560|P1|Overall Study|Death|5
4664716|NCT02908880|16036560|P1|Overall Study|Withdrawal by Subject|17
4664717|NCT02908880|16036560|P1|Overall Study|Explantation of the device|1
4664718|NCT02908880|16036560|P1|Overall Study|Lost to Follow-up|4
4664719|NCT02908529|16036609|P2|Overall Study|Lost to Follow-up|2
4664720|NCT02908529|16036610|P1|Overall Study|Lost to Follow-up|0
4664721|NCT02908516|16036620|P2|Overall Study|Study Terminated|3
4664722|NCT02908516|16036621|P1|Overall Study|Study Terminated|3
4664723|NCT02908464|16036637|P2|Overall Study|Found ineligible after randomization|2
4664724|NCT02908464|16036638|P1|Overall Study|Found ineligible after randomization|0
4664725|NCT02908464|16036637|P2|Overall Study|Withdrawal by Subject|1
4664726|NCT02908464|16036638|P1|Overall Study|Withdrawal by Subject|2
4664727|NCT02908347|16036659|P2|Overall Study|Lost to Follow-up|0
4664728|NCT02908347|16036660|P1|Overall Study|Lost to Follow-up|1
4664729|NCT02908347|16036659|P2|Overall Study|Adverse Event|1
4664730|NCT02908347|16036660|P1|Overall Study|Adverse Event|0
4664731|NCT02908100|16036756|P3|Overall Study|Randomised in Error|0
4664732|NCT02908100|16036757|P2|Overall Study|Randomised in Error|0
4664733|NCT02908100|16036758|P1|Overall Study|Randomised in Error|1
4664734|NCT02908100|16036756|P3|Overall Study|Withdrawal by Subject|5
4664735|NCT02908100|16036757|P2|Overall Study|Withdrawal by Subject|7
4664736|NCT02908100|16036758|P1|Overall Study|Withdrawal by Subject|8
4664737|NCT02908100|16036756|P3|Overall Study|Pregnancy|0
4664738|NCT02908100|16036757|P2|Overall Study|Pregnancy|2
4664739|NCT02908100|16036758|P1|Overall Study|Pregnancy|1
4664740|NCT02908100|16036756|P3|Overall Study|Physician Decision|0
4664741|NCT02908100|16036757|P2|Overall Study|Physician Decision|1
4664742|NCT02908100|16036758|P1|Overall Study|Physician Decision|0
4664743|NCT02908100|16036756|P3|Overall Study|Non-Compliance With Contraceptive Method|0
4664744|NCT02908100|16036757|P2|Overall Study|Non-Compliance With Contraceptive Method|0
4664745|NCT02908100|16036758|P1|Overall Study|Non-Compliance With Contraceptive Method|1
4664746|NCT02908100|16036756|P3|Overall Study|Non-Compliance With Study Drug|2
4664747|NCT02908100|16036757|P2|Overall Study|Non-Compliance With Study Drug|1
4664748|NCT02908100|16036758|P1|Overall Study|Non-Compliance With Study Drug|1
4664749|NCT02908100|16036756|P3|Overall Study|Lost to Follow-up|2
4664750|NCT02908100|16036757|P2|Overall Study|Lost to Follow-up|1
4664751|NCT02908100|16036758|P1|Overall Study|Lost to Follow-up|0
4664752|NCT02908100|16036756|P3|Overall Study|Lack of Efficacy|3
4664753|NCT02908100|16036757|P2|Overall Study|Lack of Efficacy|3
4664754|NCT02908100|16036758|P1|Overall Study|Lack of Efficacy|2
4664755|NCT02908100|16036756|P3|Overall Study|Death|0
4664756|NCT02908100|16036757|P2|Overall Study|Death|0
4664757|NCT02908100|16036758|P1|Overall Study|Death|2
4664758|NCT02908100|16036756|P3|Overall Study|Adverse Event|9
4664759|NCT02908100|16036757|P2|Overall Study|Adverse Event|6
4664760|NCT02908100|16036758|P1|Overall Study|Adverse Event|7
4664761|NCT02907892|16036794|P2|Overall Study|Lost to Follow-up|40
4664762|NCT02907892|16036795|P1|Overall Study|Lost to Follow-up|27
4664763|NCT02907619|16036815|P3|Overall Study|Other|0
4664764|NCT02907619|16036816|P2|Overall Study|Other|1
4664765|NCT02907619|16036817|P1|Overall Study|Other|0
4664766|NCT02907619|16036815|P3|Overall Study|Withdrawal by Subject|0
4664767|NCT02907619|16036816|P2|Overall Study|Withdrawal by Subject|1
4664768|NCT02907619|16036817|P1|Overall Study|Withdrawal by Subject|1
4664769|NCT02907619|16036815|P3|Overall Study|Death|1
4664770|NCT02907619|16036816|P2|Overall Study|Death|0
4664771|NCT02907619|16036817|P1|Overall Study|Death|0
4664772|NCT02907619|16036815|P3|Overall Study|Study terminated by sponsor|19
4664773|NCT02907619|16036816|P2|Overall Study|Study terminated by sponsor|18
4664774|NCT02907619|16036817|P1|Overall Study|Study terminated by sponsor|18
4664775|NCT02907463|16037033|P1|Overall Study|Missing Exit Form|1
4664776|NCT02907463|16037033|P1|Overall Study|Device Explanted|1
4664777|NCT02907463|16037033|P1|Overall Study|Not Implanted with Study Device|2
4664778|NCT02907463|16037033|P1|Overall Study|MIS Approach was not used|2
4664779|NCT02907463|16037033|P1|Overall Study|Withdrawal by Subject|4
4664780|NCT02907463|16037033|P1|Overall Study|Death|10
4664781|NCT02907463|16037033|P1|Overall Study|Lost to Follow-up|17
4664782|NCT02907216|16037115|P2|Overall Study|Withdrawal by Subject|0
4664783|NCT02907216|16037116|P1|Overall Study|Withdrawal by Subject|1
4664784|NCT02907216|16037115|P2|Overall Study|No benefit to be obtained by continuing|1
4664785|NCT02907216|16037116|P1|Overall Study|No benefit to be obtained by continuing|0
4664786|NCT02906930|16037168|P4|Overall Study|Other|2
4664787|NCT02906930|16037169|P3|Overall Study|Other|1
4664788|NCT02906930|16037170|P2|Overall Study|Other|2
4664789|NCT02906930|16037171|P1|Overall Study|Other|1
4664790|NCT02906930|16037168|P4|Overall Study|Death|0
4664791|NCT02906930|16037169|P3|Overall Study|Death|1
4664792|NCT02906930|16037170|P2|Overall Study|Death|0
4664793|NCT02906930|16037171|P1|Overall Study|Death|0
4664794|NCT02906930|16037168|P4|Overall Study|Lost to Follow-up|2
4664795|NCT02906930|16037169|P3|Overall Study|Lost to Follow-up|5
4664796|NCT02906930|16037170|P2|Overall Study|Lost to Follow-up|7
4664797|NCT02906930|16037171|P1|Overall Study|Lost to Follow-up|5
4664798|NCT02906930|16037168|P4|Overall Study|Withdrawal by Subject|4
4664799|NCT02906930|16037169|P3|Overall Study|Withdrawal by Subject|5
4664800|NCT02906930|16037170|P2|Overall Study|Withdrawal by Subject|5
4664801|NCT02906930|16037171|P1|Overall Study|Withdrawal by Subject|0
4664802|NCT02906917|16037364|P2|Intensification Period (Week 26-38)|Withdrawal by Subject|2
4664803|NCT02906917|16037365|P1|Intensification Period (Week 26-38)|Withdrawal by Subject|3
4664804|NCT02906917|16037364|P2|Intensification Period (Week 26-38)|Lost to Follow-up|1
4664805|NCT02906917|16037365|P1|Intensification Period (Week 26-38)|Lost to Follow-up|3
4664806|NCT02906917|16037364|P2|Intensification Period (Week 26-38)|Adverse Event|2
4664807|NCT02906917|16037365|P1|Intensification Period (Week 26-38)|Adverse Event|0
4664808|NCT02906917|16037364|P2|Intensification Period (Week 26-38)|Unclassified|2
4664809|NCT02906917|16037365|P1|Intensification Period (Week 26-38)|Unclassified|3
4664810|NCT02906917|16037364|P2|Initiation Period (Week 0-26)|Withdrawal by Subject|4
4664811|NCT02906917|16037365|P1|Initiation Period (Week 0-26)|Withdrawal by Subject|3
4664812|NCT02906917|16037364|P2|Initiation Period (Week 0-26)|Lost to Follow-up|4
4664813|NCT02906917|16037365|P1|Initiation Period (Week 0-26)|Lost to Follow-up|1
4664814|NCT02906917|16037364|P2|Initiation Period (Week 0-26)|Adverse Event|0
4664815|NCT02906917|16037365|P1|Initiation Period (Week 0-26)|Adverse Event|1
4664816|NCT02906917|16037364|P2|Initiation Period (Week 0-26)|Unclassified|3
4664817|NCT02906917|16037365|P1|Initiation Period (Week 0-26)|Unclassified|1
4664818|NCT02906709|16037426|P2|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0
4664819|NCT02906709|16037427|P1|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2
4664820|NCT02906709|16037426|P2|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0
4664821|NCT02906709|16037427|P1|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3
4664822|NCT02906709|16037426|P2|Phase A (Week 0 to Week 16)|Death|1
4664823|NCT02906709|16037427|P1|Phase A (Week 0 to Week 16)|Death|0
4664824|NCT02906709|16037426|P2|Phase A (Week 0 to Week 16)|Adverse Event|2
4664825|NCT02906709|16037427|P1|Phase A (Week 0 to Week 16)|Adverse Event|1
4664826|NCT02906670|16037481|P10|Cohort 5P, QW|Radiological Progression|0
4664827|NCT02906670|16037482|P9|Cohort 5P, QW|Radiological Progression|0
4664828|NCT02906670|16037483|P8|Cohort 5P, QW|Radiological Progression|0
4664829|NCT02906670|16037484|P7|Cohort 5P, QW|Radiological Progression|0
4664830|NCT02906670|16037485|P6|Cohort 5P, QW|Radiological Progression|0
4664831|NCT02906670|16037486|P5|Cohort 5P, QW|Radiological Progression|3
4664832|NCT02906670|16037487|P4|Cohort 5P, QW|Radiological Progression|0
4664833|NCT02906670|16037488|P3|Cohort 5P, QW|Radiological Progression|0
4664834|NCT02906670|16037489|P2|Cohort 5P, QW|Radiological Progression|0
4664835|NCT02906670|16037490|P1|Cohort 5P, QW|Radiological Progression|0
4664836|NCT02906670|16037481|P10|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1
4664837|NCT02906670|16037482|P9|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664838|NCT02906670|16037483|P8|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664839|NCT02906670|16037484|P7|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664840|NCT02906670|16037485|P6|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664841|NCT02906670|16037486|P5|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664842|NCT02906670|16037487|P4|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664843|NCT02906670|16037488|P3|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664844|NCT02906670|16037489|P2|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664845|NCT02906670|16037490|P1|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0
4664846|NCT02906670|16037481|P10|Cohort 7P, Q2W|Physician Decision|1
4664847|NCT02906670|16037482|P9|Cohort 7P, Q2W|Physician Decision|0
4664848|NCT02906670|16037483|P8|Cohort 7P, Q2W|Physician Decision|0
4664849|NCT02906670|16037484|P7|Cohort 7P, Q2W|Physician Decision|0
4664850|NCT02906670|16037485|P6|Cohort 7P, Q2W|Physician Decision|0
4664851|NCT02906670|16037486|P5|Cohort 7P, Q2W|Physician Decision|0
4664852|NCT02906670|16037487|P4|Cohort 7P, Q2W|Physician Decision|0
4664853|NCT02906670|16037488|P3|Cohort 7P, Q2W|Physician Decision|0
4664854|NCT02906670|16037489|P2|Cohort 7P, Q2W|Physician Decision|0
4664855|NCT02906670|16037490|P1|Cohort 7P, Q2W|Physician Decision|0
4664856|NCT02906670|16037481|P10|Cohort 7P, Q2W|Adverse Event|1
4664857|NCT02906670|16037482|P9|Cohort 7P, Q2W|Adverse Event|0
4664858|NCT02906670|16037483|P8|Cohort 7P, Q2W|Adverse Event|0
4664859|NCT02906670|16037484|P7|Cohort 7P, Q2W|Adverse Event|0
4664860|NCT02906670|16037485|P6|Cohort 7P, Q2W|Adverse Event|0
4664861|NCT02906670|16037486|P5|Cohort 7P, Q2W|Adverse Event|0
4664862|NCT02906670|16037487|P4|Cohort 7P, Q2W|Adverse Event|0
4664863|NCT02906670|16037488|P3|Cohort 7P, Q2W|Adverse Event|0
4664864|NCT02906670|16037489|P2|Cohort 7P, Q2W|Adverse Event|0
4664865|NCT02906670|16037490|P1|Cohort 7P, Q2W|Adverse Event|0
4664866|NCT02906670|16037481|P10|Cohort 4P, QW|Radiological Progression|0
4664867|NCT02906670|16037482|P9|Cohort 4P, QW|Radiological Progression|0
4664868|NCT02906670|16037483|P8|Cohort 4P, QW|Radiological Progression|0
4664869|NCT02906670|16037484|P7|Cohort 4P, QW|Radiological Progression|0
4664870|NCT02906670|16037485|P6|Cohort 4P, QW|Radiological Progression|0
4664871|NCT02906670|16037486|P5|Cohort 4P, QW|Radiological Progression|0
4664872|NCT02906670|16037487|P4|Cohort 4P, QW|Radiological Progression|3
4664873|NCT02906670|16037488|P3|Cohort 4P, QW|Radiological Progression|0
4664874|NCT02906670|16037489|P2|Cohort 4P, QW|Radiological Progression|0
4664875|NCT02906670|16037490|P1|Cohort 4P, QW|Radiological Progression|0
4664876|NCT02906670|16037481|P10|Cohort 6P, Q2W|Clinical Progression|0
4664877|NCT02906670|16037482|P9|Cohort 6P, Q2W|Clinical Progression|3
4664878|NCT02906670|16037483|P8|Cohort 6P, Q2W|Clinical Progression|0
4664879|NCT02906670|16037484|P7|Cohort 6P, Q2W|Clinical Progression|0
4664880|NCT02906670|16037485|P6|Cohort 6P, Q2W|Clinical Progression|0
4664881|NCT02906670|16037486|P5|Cohort 6P, Q2W|Clinical Progression|0
4664882|NCT02906670|16037487|P4|Cohort 6P, Q2W|Clinical Progression|0
4664883|NCT02906670|16037488|P3|Cohort 6P, Q2W|Clinical Progression|0
4664884|NCT02906670|16037489|P2|Cohort 6P, Q2W|Clinical Progression|0
4664885|NCT02906670|16037490|P1|Cohort 6P, Q2W|Clinical Progression|0
4664886|NCT02906670|16037481|P10|Cohort 6P, Q2W|Radiological Progression|0
4664887|NCT02906670|16037482|P9|Cohort 6P, Q2W|Radiological Progression|1
4664888|NCT02906670|16037483|P8|Cohort 6P, Q2W|Radiological Progression|0
4664889|NCT02906670|16037484|P7|Cohort 6P, Q2W|Radiological Progression|0
4664890|NCT02906670|16037485|P6|Cohort 6P, Q2W|Radiological Progression|0
4664891|NCT02906670|16037486|P5|Cohort 6P, Q2W|Radiological Progression|0
4664892|NCT02906670|16037487|P4|Cohort 6P, Q2W|Radiological Progression|0
4664893|NCT02906670|16037488|P3|Cohort 6P, Q2W|Radiological Progression|0
4664894|NCT02906670|16037489|P2|Cohort 6P, Q2W|Radiological Progression|0
4664895|NCT02906670|16037490|P1|Cohort 6P, Q2W|Radiological Progression|0
4664896|NCT02906670|16037481|P10|Cohort 5P, Q2W|Adverse Event|0
4664897|NCT02906670|16037482|P9|Cohort 5P, Q2W|Adverse Event|0
4664898|NCT02906670|16037483|P8|Cohort 5P, Q2W|Adverse Event|1
4664899|NCT02906670|16037484|P7|Cohort 5P, Q2W|Adverse Event|0
4664900|NCT02906670|16037485|P6|Cohort 5P, Q2W|Adverse Event|0
4664901|NCT02906670|16037486|P5|Cohort 5P, Q2W|Adverse Event|0
4664902|NCT02906670|16037487|P4|Cohort 5P, Q2W|Adverse Event|0
4664903|NCT02906670|16037488|P3|Cohort 5P, Q2W|Adverse Event|0
4664904|NCT02906670|16037489|P2|Cohort 5P, Q2W|Adverse Event|0
4664905|NCT02906670|16037490|P1|Cohort 5P, Q2W|Adverse Event|0
4664906|NCT02906670|16037481|P10|Cohort 5P, Q2W|Radiological Progression|0
4664907|NCT02906670|16037482|P9|Cohort 5P, Q2W|Radiological Progression|0
4664908|NCT02906670|16037483|P8|Cohort 5P, Q2W|Radiological Progression|2
4664909|NCT02906670|16037484|P7|Cohort 5P, Q2W|Radiological Progression|0
4664910|NCT02906670|16037485|P6|Cohort 5P, Q2W|Radiological Progression|0
4664911|NCT02906670|16037486|P5|Cohort 5P, Q2W|Radiological Progression|0
4664912|NCT02906670|16037487|P4|Cohort 5P, Q2W|Radiological Progression|0
4664913|NCT02906670|16037488|P3|Cohort 5P, Q2W|Radiological Progression|0
4664914|NCT02906670|16037489|P2|Cohort 5P, Q2W|Radiological Progression|0
4664915|NCT02906670|16037490|P1|Cohort 5P, Q2W|Radiological Progression|0
4664916|NCT02906670|16037481|P10|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664917|NCT02906670|16037482|P9|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664918|NCT02906670|16037483|P8|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664919|NCT02906670|16037484|P7|Cohort 5, Q2W|Lack of Clinical Benefit|1
4664920|NCT02906670|16037485|P6|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664921|NCT02906670|16037486|P5|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664922|NCT02906670|16037487|P4|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664923|NCT02906670|16037488|P3|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664924|NCT02906670|16037489|P2|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664925|NCT02906670|16037490|P1|Cohort 5, Q2W|Lack of Clinical Benefit|0
4664926|NCT02906670|16037481|P10|Cohort 5, Q2W|Adverse Event|0
4664927|NCT02906670|16037482|P9|Cohort 5, Q2W|Adverse Event|0
4664928|NCT02906670|16037483|P8|Cohort 5, Q2W|Adverse Event|0
4664929|NCT02906670|16037484|P7|Cohort 5, Q2W|Adverse Event|1
4664930|NCT02906670|16037485|P6|Cohort 5, Q2W|Adverse Event|0
4664931|NCT02906670|16037486|P5|Cohort 5, Q2W|Adverse Event|0
4664932|NCT02906670|16037487|P4|Cohort 5, Q2W|Adverse Event|0
4664933|NCT02906670|16037488|P3|Cohort 5, Q2W|Adverse Event|0
4664934|NCT02906670|16037489|P2|Cohort 5, Q2W|Adverse Event|0
4664935|NCT02906670|16037490|P1|Cohort 5, Q2W|Adverse Event|0
4664936|NCT02906670|16037481|P10|Cohort 5, Q2W|Clinical Progression|0
4664937|NCT02906670|16037482|P9|Cohort 5, Q2W|Clinical Progression|0
4664938|NCT02906670|16037483|P8|Cohort 5, Q2W|Clinical Progression|0
4664939|NCT02906670|16037484|P7|Cohort 5, Q2W|Clinical Progression|1
4664940|NCT02906670|16037485|P6|Cohort 5, Q2W|Clinical Progression|0
4664941|NCT02906670|16037486|P5|Cohort 5, Q2W|Clinical Progression|0
4664942|NCT02906670|16037487|P4|Cohort 5, Q2W|Clinical Progression|0
4664943|NCT02906670|16037488|P3|Cohort 5, Q2W|Clinical Progression|0
4664944|NCT02906670|16037489|P2|Cohort 5, Q2W|Clinical Progression|0
4664945|NCT02906670|16037490|P1|Cohort 5, Q2W|Clinical Progression|0
4664946|NCT02906670|16037481|P10|Cohort 5, Q2W|Radiological Progression|0
4664947|NCT02906670|16037482|P9|Cohort 5, Q2W|Radiological Progression|0
4664948|NCT02906670|16037483|P8|Cohort 5, Q2W|Radiological Progression|0
4664949|NCT02906670|16037484|P7|Cohort 5, Q2W|Radiological Progression|4
4664950|NCT02906670|16037485|P6|Cohort 5, Q2W|Radiological Progression|0
4664951|NCT02906670|16037486|P5|Cohort 5, Q2W|Radiological Progression|0
4664952|NCT02906670|16037487|P4|Cohort 5, Q2W|Radiological Progression|0
4664953|NCT02906670|16037488|P3|Cohort 5, Q2W|Radiological Progression|0
4664954|NCT02906670|16037489|P2|Cohort 5, Q2W|Radiological Progression|0
4664955|NCT02906670|16037490|P1|Cohort 5, Q2W|Radiological Progression|0
4664956|NCT02906670|16037481|P10|Cohort 4, Q2W|Clinical Progression|0
4664957|NCT02906670|16037482|P9|Cohort 4, Q2W|Clinical Progression|0
4664958|NCT02906670|16037483|P8|Cohort 4, Q2W|Clinical Progression|0
4664959|NCT02906670|16037484|P7|Cohort 4, Q2W|Clinical Progression|0
4664960|NCT02906670|16037485|P6|Cohort 4, Q2W|Clinical Progression|2
4664961|NCT02906670|16037486|P5|Cohort 4, Q2W|Clinical Progression|0
4664962|NCT02906670|16037487|P4|Cohort 4, Q2W|Clinical Progression|0
4664963|NCT02906670|16037488|P3|Cohort 4, Q2W|Clinical Progression|0
4664964|NCT02906670|16037489|P2|Cohort 4, Q2W|Clinical Progression|0
4664965|NCT02906670|16037490|P1|Cohort 4, Q2W|Clinical Progression|0
4664966|NCT02906670|16037481|P10|Cohort 4, Q2W|Radiological Progression|0
4664967|NCT02906670|16037482|P9|Cohort 4, Q2W|Radiological Progression|0
4664968|NCT02906670|16037483|P8|Cohort 4, Q2W|Radiological Progression|0
4664969|NCT02906670|16037484|P7|Cohort 4, Q2W|Radiological Progression|0
4664970|NCT02906670|16037485|P6|Cohort 4, Q2W|Radiological Progression|1
4664971|NCT02906670|16037486|P5|Cohort 4, Q2W|Radiological Progression|0
4664972|NCT02906670|16037487|P4|Cohort 4, Q2W|Radiological Progression|0
4664973|NCT02906670|16037488|P3|Cohort 4, Q2W|Radiological Progression|0
4664974|NCT02906670|16037489|P2|Cohort 4, Q2W|Radiological Progression|0
4664975|NCT02906670|16037490|P1|Cohort 4, Q2W|Radiological Progression|0
4664976|NCT02906670|16037481|P10|Cohort 3, QW|Lack of Clinical Benefit|0
4664977|NCT02906670|16037482|P9|Cohort 3, QW|Lack of Clinical Benefit|0
4664978|NCT02906670|16037483|P8|Cohort 3, QW|Lack of Clinical Benefit|0
4664979|NCT02906670|16037484|P7|Cohort 3, QW|Lack of Clinical Benefit|0
4664980|NCT02906670|16037485|P6|Cohort 3, QW|Lack of Clinical Benefit|0
4664981|NCT02906670|16037486|P5|Cohort 3, QW|Lack of Clinical Benefit|0
4664982|NCT02906670|16037487|P4|Cohort 3, QW|Lack of Clinical Benefit|0
4664983|NCT02906670|16037488|P3|Cohort 3, QW|Lack of Clinical Benefit|2
4664984|NCT02906670|16037489|P2|Cohort 3, QW|Lack of Clinical Benefit|0
4664985|NCT02906670|16037490|P1|Cohort 3, QW|Lack of Clinical Benefit|0
4664986|NCT02906670|16037481|P10|Cohort 3, QW|Radiological Progression|0
4664987|NCT02906670|16037482|P9|Cohort 3, QW|Radiological Progression|0
4664988|NCT02906670|16037483|P8|Cohort 3, QW|Radiological Progression|0
4664989|NCT02906670|16037484|P7|Cohort 3, QW|Radiological Progression|0
4664990|NCT02906670|16037485|P6|Cohort 3, QW|Radiological Progression|0
4664991|NCT02906670|16037486|P5|Cohort 3, QW|Radiological Progression|0
4664992|NCT02906670|16037487|P4|Cohort 3, QW|Radiological Progression|0
4664993|NCT02906670|16037488|P3|Cohort 3, QW|Radiological Progression|2
4664994|NCT02906670|16037489|P2|Cohort 3, QW|Radiological Progression|0
4664995|NCT02906670|16037490|P1|Cohort 3, QW|Radiological Progression|0
4664996|NCT02906670|16037481|P10|Cohort 2, QW|Radiological Progression|0
4664997|NCT02906670|16037482|P9|Cohort 2, QW|Radiological Progression|0
4664998|NCT02906670|16037483|P8|Cohort 2, QW|Radiological Progression|0
4664999|NCT02906670|16037484|P7|Cohort 2, QW|Radiological Progression|0
4665000|NCT02906670|16037485|P6|Cohort 2, QW|Radiological Progression|0
4665001|NCT02906670|16037486|P5|Cohort 2, QW|Radiological Progression|0
4665002|NCT02906670|16037487|P4|Cohort 2, QW|Radiological Progression|0
4665003|NCT02906670|16037488|P3|Cohort 2, QW|Radiological Progression|0
4665004|NCT02906670|16037489|P2|Cohort 2, QW|Radiological Progression|1
4665005|NCT02906670|16037490|P1|Cohort 2, QW|Radiological Progression|0
4665006|NCT02906670|16037481|P10|Cohort 1, QW|Radiological Progression|0
4665007|NCT02906670|16037482|P9|Cohort 1, QW|Radiological Progression|0
4665008|NCT02906670|16037483|P8|Cohort 1, QW|Radiological Progression|0
4665009|NCT02906670|16037484|P7|Cohort 1, QW|Radiological Progression|0
4665010|NCT02906670|16037485|P6|Cohort 1, QW|Radiological Progression|0
4665011|NCT02906670|16037486|P5|Cohort 1, QW|Radiological Progression|0
4665012|NCT02906670|16037487|P4|Cohort 1, QW|Radiological Progression|0
4665013|NCT02906670|16037488|P3|Cohort 1, QW|Radiological Progression|0
4665014|NCT02906670|16037489|P2|Cohort 1, QW|Radiological Progression|0
4665015|NCT02906670|16037490|P1|Cohort 1, QW|Radiological Progression|1
4665016|NCT02906644|16037607|P2|Weeks 3 to 14|Lost to Follow-up|4
4665017|NCT02906644|16037608|P1|Weeks 3 to 14|Lost to Follow-up|3
4665018|NCT02906644|16037607|P2|Weeks 3 to 14|Withdrawal by Subject|7
4665019|NCT02906644|16037608|P1|Weeks 3 to 14|Withdrawal by Subject|13
4665020|NCT02906644|16037607|P2|First 2 Weeks|Physician Decision|1
4665021|NCT02906644|16037608|P1|First 2 Weeks|Physician Decision|1
4665022|NCT02906644|16037607|P2|First 2 Weeks|Withdrawal by Subject|2
4665023|NCT02906644|16037608|P1|First 2 Weeks|Withdrawal by Subject|0
4665024|NCT02906579|16037624|P1|Overall Study|Physician Decision|1
4665025|NCT02906579|16037624|P1|Overall Study|Adverse Event|1
4665026|NCT02906358|16037828|P2|Overall Study|Lost to Follow-up|15
4665027|NCT02906358|16037829|P1|Overall Study|Lost to Follow-up|12
4665028|NCT02906358|16037828|P2|Overall Study|Withdrawal by Subject|7
4665029|NCT02906358|16037829|P1|Overall Study|Withdrawal by Subject|10
4665030|NCT02905825|16037863|P1|Overall Study|Device Malfunction|1
4665031|NCT02905825|16037863|P1|Overall Study|Protocol Violation|11
4665032|NCT02905331|16037871|P3|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
4665033|NCT02905331|16037872|P2|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2
4665034|NCT02905331|16037873|P1|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0
4665035|NCT02905331|16037871|P3|Active Treatment and Follow up (wk16-40)|Other|0
4665036|NCT02905331|16037872|P2|Active Treatment and Follow up (wk16-40)|Other|6
4665037|NCT02905331|16037873|P1|Active Treatment and Follow up (wk16-40)|Other|0
4665038|NCT02905331|16037871|P3|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
4665039|NCT02905331|16037872|P2|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1
4665040|NCT02905331|16037873|P1|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0
4665041|NCT02905331|16037871|P3|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
4665042|NCT02905331|16037872|P2|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0
4665043|NCT02905331|16037873|P1|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2
4665044|NCT02905331|16037871|P3|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
4665045|NCT02905331|16037872|P2|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0
4665046|NCT02905331|16037873|P1|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1
4665047|NCT02905266|16037901|P2|Maintenance Phase Part 2|Not Reported|17
4665048|NCT02905266|16037902|P1|Maintenance Phase Part 2|Not Reported|10
4665049|NCT02905266|16037901|P2|Maintenance Phase Part 2|Maximum Clinical Benefit|1
4665050|NCT02905266|16037902|P1|Maintenance Phase Part 2|Maximum Clinical Benefit|0
4665051|NCT02905266|16037901|P2|Maintenance Phase Part 2|Study Drug Toxicity|2
4665052|NCT02905266|16037902|P1|Maintenance Phase Part 2|Study Drug Toxicity|1
4665053|NCT02905266|16037901|P2|Maintenance Phase Part 2|Disease Progression|2
4665054|NCT02905266|16037902|P1|Maintenance Phase Part 2|Disease Progression|8
4665055|NCT02905266|16037901|P2|Treatment Period Part 1|Maximum Clinical Benefit|1
4665056|NCT02905266|16037902|P1|Treatment Period Part 1|Maximum Clinical Benefit|0
4665057|NCT02905266|16037901|P2|Treatment Period Part 1|Study Drug Toxicity|15
4665058|NCT02905266|16037902|P1|Treatment Period Part 1|Study Drug Toxicity|22
4665059|NCT02905266|16037901|P2|Treatment Period Part 1|Disease Progression|7
4665060|NCT02905266|16037902|P1|Treatment Period Part 1|Disease Progression|6
4665061|NCT02905266|16037901|P2|Treatment Period Part 1|Subject Withdrew Consent|0
4665062|NCT02905266|16037902|P1|Treatment Period Part 1|Subject Withdrew Consent|1
4665063|NCT02905149|16037924|P2|Overall Study|Lost to Follow-up|0
4665064|NCT02905149|16037925|P1|Overall Study|Lost to Follow-up|2
4665065|NCT02904902|16037950|P1|Overall Study|Withdrawal by Subject|1
4665066|NCT02904265|16037963|P2|Overall Study|Physician Decision|2
4665067|NCT02904265|16037964|P1|Overall Study|Physician Decision|1
4665068|NCT02904096|16037972|P2|Overall Study|Sponsor instructed|0
4665069|NCT02904096|16037973|P1|Overall Study|Sponsor instructed|1
4665070|NCT02904096|16037972|P2|Overall Study|Non-compliant|1
4665071|NCT02904096|16037973|P1|Overall Study|Non-compliant|3
4665072|NCT02904096|16037972|P2|Overall Study|Lost to Follow-up|17
4665073|NCT02904096|16037973|P1|Overall Study|Lost to Follow-up|10
4665074|NCT02904096|16037972|P2|Overall Study|Withdrawal by Subject|3
4665075|NCT02904096|16037973|P1|Overall Study|Withdrawal by Subject|4
4665076|NCT02904096|16037972|P2|Overall Study|Adverse Event|0
4665077|NCT02904096|16037973|P1|Overall Study|Adverse Event|1
4665078|NCT02903966|16037999|P2|Part B (Day 44 to 112)|Withdrawal by Subject|1
4665079|NCT02903966|16038000|P1|Part B (Day 44 to 112)|Withdrawal by Subject|0
4665080|NCT02903966|16037999|P2|Part B (Day 44 to 112)|Lack of Efficacy|1
4665081|NCT02903966|16038000|P1|Part B (Day 44 to 112)|Lack of Efficacy|0
4665082|NCT02903966|16037999|P2|Part A (Day 1 to 43)|Adverse Event|0
4665083|NCT02903966|16038000|P1|Part A (Day 1 to 43)|Adverse Event|1
4665084|NCT02903420|16038082|P1|Overall Study|Death|3
4665085|NCT02903238|16038134|P1|Overall Study|Lost to Follow-up|4
4665086|NCT02903030|16038160|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
4665087|NCT02903030|16038161|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
4665088|NCT02902965|16038179|P1|Overall Study|Withdrawal by Subject|10
4665089|NCT02902809|16038197|P1|Overall Study|Discontinuation of asthma program|28
4665090|NCT02901054|16038278|P1|Overall Study|Withdrawal by Subject|3
4665091|NCT02901054|16038278|P1|Overall Study|Physician Decision|1
4665092|NCT02900378|16038293|P2|Randomization (Visit 2)|Withdrawal of Informed Consent|2
4665093|NCT02900378|16038294|P1|Randomization (Visit 2)|Withdrawal of Informed Consent|0
4665094|NCT02900378|16038293|P2|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3
4665095|NCT02900378|16038294|P1|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5
4665096|NCT02900378|16038293|P2|Randomization (Visit 2)|Protocol Deviation|7
4665097|NCT02900378|16038294|P1|Randomization (Visit 2)|Protocol Deviation|1
4665098|NCT02900378|16038293|P2|Randomization (Visit 2)|Non-compliance with Study Drug|1
4665099|NCT02900378|16038294|P1|Randomization (Visit 2)|Non-compliance with Study Drug|1
4665100|NCT02900378|16038293|P2|Randomization (Visit 2)|Lost to Follow-up|0
4665101|NCT02900378|16038294|P1|Randomization (Visit 2)|Lost to Follow-up|1
4665102|NCT02900378|16038293|P2|Randomization (Visit 2)|Death|4
4665103|NCT02900378|16038294|P1|Randomization (Visit 2)|Death|1
4665104|NCT02900378|16038293|P2|Randomization (Visit 2)|Adverse Event|11
4665105|NCT02900378|16038294|P1|Randomization (Visit 2)|Adverse Event|14
4665106|NCT02900170|16038338|P1|Overall Study|Lost to Follow-up|8
4665107|NCT02900092|16038342|P1|Overall Study|Adverse Event|1
4665108|NCT02899988|16038350|P11|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
4665109|NCT02899988|16038351|P10|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4665110|NCT02899988|16038352|P9|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
4665111|NCT02899988|16038353|P8|Maintenance Period (88 Weeks)|Withdrawal by Subject|2
4665112|NCT02899988|16038354|P7|Maintenance Period (88 Weeks)|Withdrawal by Subject|3
4665113|NCT02899988|16038355|P6|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4665114|NCT02899988|16038356|P5|Maintenance Period (88 Weeks)|Withdrawal by Subject|1
4665115|NCT02899988|16038357|P4|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4665116|NCT02899988|16038358|P3|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4665117|NCT02899988|16038359|P2|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4665118|NCT02899988|16038360|P1|Maintenance Period (88 Weeks)|Withdrawal by Subject|0
4665119|NCT02899988|16038350|P11|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665120|NCT02899988|16038351|P10|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665121|NCT02899988|16038352|P9|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665122|NCT02899988|16038353|P8|Maintenance Period (88 Weeks)|Lost to Follow-up|1
4665123|NCT02899988|16038354|P7|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665124|NCT02899988|16038355|P6|Maintenance Period (88 Weeks)|Lost to Follow-up|1
4665125|NCT02899988|16038356|P5|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665126|NCT02899988|16038357|P4|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665127|NCT02899988|16038358|P3|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665128|NCT02899988|16038359|P2|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665129|NCT02899988|16038360|P1|Maintenance Period (88 Weeks)|Lost to Follow-up|0
4665130|NCT02899988|16038350|P11|Maintenance Period (88 Weeks)|Adverse Event|1
4665131|NCT02899988|16038351|P10|Maintenance Period (88 Weeks)|Adverse Event|2
4665132|NCT02899988|16038352|P9|Maintenance Period (88 Weeks)|Adverse Event|2
4665133|NCT02899988|16038353|P8|Maintenance Period (88 Weeks)|Adverse Event|2
4665134|NCT02899988|16038354|P7|Maintenance Period (88 Weeks)|Adverse Event|1
4665135|NCT02899988|16038355|P6|Maintenance Period (88 Weeks)|Adverse Event|2
4665136|NCT02899988|16038356|P5|Maintenance Period (88 Weeks)|Adverse Event|1
4665137|NCT02899988|16038357|P4|Maintenance Period (88 Weeks)|Adverse Event|0
4665138|NCT02899988|16038358|P3|Maintenance Period (88 Weeks)|Adverse Event|0
4665139|NCT02899988|16038359|P2|Maintenance Period (88 Weeks)|Adverse Event|0
4665140|NCT02899988|16038360|P1|Maintenance Period (88 Weeks)|Adverse Event|0
4665141|NCT02899988|16038350|P11|Induction Period (16 Weeks)|Physician Decision|0
4665142|NCT02899988|16038351|P10|Induction Period (16 Weeks)|Physician Decision|0
4665143|NCT02899988|16038352|P9|Induction Period (16 Weeks)|Physician Decision|0
4665144|NCT02899988|16038353|P8|Induction Period (16 Weeks)|Physician Decision|0
4665145|NCT02899988|16038354|P7|Induction Period (16 Weeks)|Physician Decision|0
4665146|NCT02899988|16038355|P6|Induction Period (16 Weeks)|Physician Decision|0
4665147|NCT02899988|16038356|P5|Induction Period (16 Weeks)|Physician Decision|0
4665148|NCT02899988|16038357|P4|Induction Period (16 Weeks)|Physician Decision|0
4665149|NCT02899988|16038358|P3|Induction Period (16 Weeks)|Physician Decision|0
4665150|NCT02899988|16038359|P2|Induction Period (16 Weeks)|Physician Decision|1
4665151|NCT02899988|16038360|P1|Induction Period (16 Weeks)|Physician Decision|0
4665152|NCT02899988|16038350|P11|Induction Period (16 Weeks)|Adverse Event|0
4665153|NCT02899988|16038351|P10|Induction Period (16 Weeks)|Adverse Event|0
4665154|NCT02899988|16038352|P9|Induction Period (16 Weeks)|Adverse Event|0
4665155|NCT02899988|16038353|P8|Induction Period (16 Weeks)|Adverse Event|0
4665156|NCT02899988|16038354|P7|Induction Period (16 Weeks)|Adverse Event|0
4665157|NCT02899988|16038355|P6|Induction Period (16 Weeks)|Adverse Event|0
4665158|NCT02899988|16038356|P5|Induction Period (16 Weeks)|Adverse Event|0
4665159|NCT02899988|16038357|P4|Induction Period (16 Weeks)|Adverse Event|2
4665160|NCT02899988|16038358|P3|Induction Period (16 Weeks)|Adverse Event|0
4665161|NCT02899988|16038359|P2|Induction Period (16 Weeks)|Adverse Event|0
4665162|NCT02899988|16038360|P1|Induction Period (16 Weeks)|Adverse Event|0
4665163|NCT02899988|16038350|P11|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665164|NCT02899988|16038351|P10|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665165|NCT02899988|16038352|P9|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665166|NCT02899988|16038353|P8|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665167|NCT02899988|16038354|P7|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665168|NCT02899988|16038355|P6|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665169|NCT02899988|16038356|P5|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665170|NCT02899988|16038357|P4|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665171|NCT02899988|16038358|P3|Induction Period (16 Weeks)|Withdrawal by Subject|0
4665172|NCT02899988|16038359|P2|Induction Period (16 Weeks)|Withdrawal by Subject|1
4665173|NCT02899988|16038360|P1|Induction Period (16 Weeks)|Withdrawal by Subject|2
4665174|NCT02899962|16038419|P3|Maintenance Phase|Withdrawal by Subject|36
4665175|NCT02899962|16038420|P2|Maintenance Phase|Withdrawal by Subject|30
4665176|NCT02899962|16038421|P1|Maintenance Phase|Withdrawal by Subject|0
4665177|NCT02899962|16038419|P3|Maintenance Phase|Not clear/almost clear after rescue med|70
4665178|NCT02899962|16038420|P2|Maintenance Phase|Not clear/almost clear after rescue med|65
4665179|NCT02899962|16038421|P1|Maintenance Phase|Not clear/almost clear after rescue med|0
4665180|NCT02899962|16038419|P3|Maintenance Phase|Not achieve treatment success after Wk 4|2
4665181|NCT02899962|16038420|P2|Maintenance Phase|Not achieve treatment success after Wk 4|3
4665182|NCT02899962|16038421|P1|Maintenance Phase|Not achieve treatment success after Wk 4|0
4665183|NCT02899962|16038419|P3|Maintenance Phase|Other reasons|13
4665184|NCT02899962|16038420|P2|Maintenance Phase|Other reasons|9
4665185|NCT02899962|16038421|P1|Maintenance Phase|Other reasons|0
4665186|NCT02899962|16038419|P3|Maintenance Phase|Lost to Follow-up|14
4665187|NCT02899962|16038420|P2|Maintenance Phase|Lost to Follow-up|12
4665188|NCT02899962|16038421|P1|Maintenance Phase|Lost to Follow-up|0
4665189|NCT02899962|16038419|P3|Maintenance Phase|Lack of Efficacy|16
4665190|NCT02899962|16038420|P2|Maintenance Phase|Lack of Efficacy|20
4665191|NCT02899962|16038421|P1|Maintenance Phase|Lack of Efficacy|0
4665192|NCT02899962|16038419|P3|Maintenance Phase|Death|1
4665193|NCT02899962|16038420|P2|Maintenance Phase|Death|0
4665194|NCT02899962|16038421|P1|Maintenance Phase|Death|0
4665195|NCT02899962|16038419|P3|Maintenance Phase|Adverse Event|1
4665196|NCT02899962|16038420|P2|Maintenance Phase|Adverse Event|2
4665197|NCT02899962|16038421|P1|Maintenance Phase|Adverse Event|0
4665198|NCT02899962|16038419|P3|Open-label Phase|Withdrawal by Subject|0
4665199|NCT02899962|16038420|P2|Open-label Phase|Withdrawal by Subject|0
4665200|NCT02899962|16038421|P1|Open-label Phase|Withdrawal by Subject|7
4665201|NCT02899962|16038419|P3|Open-label Phase|Other reasons|0
4665202|NCT02899962|16038420|P2|Open-label Phase|Other reasons|0
4665203|NCT02899962|16038421|P1|Open-label Phase|Other reasons|9
4665204|NCT02899962|16038419|P3|Open-label Phase|Lost to Follow-up|0
4665205|NCT02899962|16038420|P2|Open-label Phase|Lost to Follow-up|0
4665206|NCT02899962|16038421|P1|Open-label Phase|Lost to Follow-up|9
4665207|NCT02899962|16038419|P3|Open-label Phase|Adverse Event|0
4665208|NCT02899962|16038420|P2|Open-label Phase|Adverse Event|0
4665209|NCT02899962|16038421|P1|Open-label Phase|Adverse Event|2
4665210|NCT02899377|16038446|P2|Overall Study|Adverse Event|0
4665211|NCT02899377|16038447|P1|Overall Study|Adverse Event|1
4665212|NCT02899338|16038480|P2|Overall Study|Withdrawal by Subject|0
4665213|NCT02899338|16038481|P1|Overall Study|Withdrawal by Subject|2
4665214|NCT02899338|16038480|P2|Overall Study|Adverse Event|2
4665215|NCT02899338|16038481|P1|Overall Study|Adverse Event|1
4665216|NCT02899156|16038495|P2|Overall Study|Physician Decision|1
4665217|NCT02899156|16038496|P1|Overall Study|Physician Decision|0
4665218|NCT02899156|16038495|P2|Overall Study|Death|0
4665219|NCT02899156|16038496|P1|Overall Study|Death|1
4665220|NCT02898662|16038538|P2|Overall Study|Other|1
4665221|NCT02898662|16038539|P1|Overall Study|Other|0
4665222|NCT02898662|16038538|P2|Overall Study|Subject decision|0
4665223|NCT02898662|16038539|P1|Overall Study|Subject decision|1
4665224|NCT02898662|16038538|P2|Overall Study|Randomized in error|1
4665225|NCT02898662|16038539|P1|Overall Study|Randomized in error|0
4665226|NCT02898662|16038538|P2|Overall Study|Technical issue|1
4665227|NCT02898662|16038539|P1|Overall Study|Technical issue|0
4665228|NCT02898662|16038538|P2|Overall Study|Withdrawal by Subject|1
4665229|NCT02898662|16038539|P1|Overall Study|Withdrawal by Subject|4
4665230|NCT02898662|16038538|P2|Overall Study|Loss of asthma control|24
4665231|NCT02898662|16038539|P1|Overall Study|Loss of asthma control|23
4665232|NCT02898662|16038538|P2|Overall Study|Adverse Event|0
4665233|NCT02898662|16038539|P1|Overall Study|Adverse Event|1
4665234|NCT02898597|16038563|P2|Overall Study|Death|1
4665235|NCT02898597|16038564|P1|Overall Study|Death|0
4665236|NCT02898597|16038563|P2|Overall Study|Lost to Follow-up|9
4665237|NCT02898597|16038564|P1|Overall Study|Lost to Follow-up|0
4665238|NCT02898597|16038563|P2|Overall Study|Protocol Violation|2
4665239|NCT02898597|16038564|P1|Overall Study|Protocol Violation|4
4665240|NCT02898454|16038573|P3|Overall Study|Did Not Met Eligibility Criteria|0
4665241|NCT02898454|16038574|P2|Overall Study|Did Not Met Eligibility Criteria|0
4665242|NCT02898454|16038575|P1|Overall Study|Did Not Met Eligibility Criteria|1
4665243|NCT02898454|16038573|P3|Overall Study|Lost to Follow-up|0
4665244|NCT02898454|16038574|P2|Overall Study|Lost to Follow-up|0
4665245|NCT02898454|16038575|P1|Overall Study|Lost to Follow-up|1
4665246|NCT02898454|16038573|P3|Overall Study|Withdrawal by Subject|3
4665247|NCT02898454|16038574|P2|Overall Study|Withdrawal by Subject|3
4665248|NCT02898454|16038575|P1|Overall Study|Withdrawal by Subject|6
4665249|NCT02898454|16038573|P3|Overall Study|Lack of Efficacy|0
4665250|NCT02898454|16038574|P2|Overall Study|Lack of Efficacy|1
4665251|NCT02898454|16038575|P1|Overall Study|Lack of Efficacy|4
4665252|NCT02898454|16038573|P3|Overall Study|Protocol Violation|1
4665253|NCT02898454|16038574|P2|Overall Study|Protocol Violation|0
4665254|NCT02898454|16038575|P1|Overall Study|Protocol Violation|1
4665255|NCT02898454|16038573|P3|Overall Study|Adverse Event|2
4665256|NCT02898454|16038574|P2|Overall Study|Adverse Event|1
4665257|NCT02898454|16038575|P1|Overall Study|Adverse Event|4
4665258|NCT02898116|16038688|P1|Overall Study|Progressive disease|1
4665259|NCT02898116|16038688|P1|Overall Study|Adverse Event|1
4665260|NCT02897349|16038696|P2|Overall Study|Other than listed above|1
4665261|NCT02897349|16038697|P1|Overall Study|Other than listed above|0
4665262|NCT02897349|16038696|P2|Overall Study|Adverse Event|3
4665263|NCT02897349|16038697|P1|Overall Study|Adverse Event|3
4665264|NCT02897349|16038696|P2|Overall Study|Lost to Follow-up|2
4665265|NCT02897349|16038697|P1|Overall Study|Lost to Follow-up|2
4665266|NCT02897115|16038739|P2|Overall Study|Early termination of study by sponsor|8
4665267|NCT02897115|16038740|P1|Overall Study|Early termination of study by sponsor|11
4665268|NCT02896855|16038817|P2|Overall Study|Withdrawal by Subject|1
4665269|NCT02896855|16038818|P1|Overall Study|Withdrawal by Subject|1
4665270|NCT02896855|16038817|P2|Overall Study|Lost to Follow-up|0
4665271|NCT02896855|16038818|P1|Overall Study|Lost to Follow-up|5
4665272|NCT02896855|16038817|P2|Overall Study|Death|12
4665273|NCT02896855|16038818|P1|Overall Study|Death|13
4665274|NCT02896855|16038817|P2|Overall Study|In Follow-Up|49
4665275|NCT02896855|16038818|P1|Overall Study|In Follow-Up|61
4665276|NCT02896855|16038817|P2|Overall Study|On Study Treatment|60
4665277|NCT02896855|16038818|P1|Overall Study|On Study Treatment|41
4665278|NCT02896361|16038899|P3|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
4665279|NCT02896361|16038900|P2|Third Intervention (2 Weeks)|emergenge of several new painful regions|1
4665280|NCT02896361|16038901|P1|Third Intervention (2 Weeks)|emergenge of several new painful regions|0
4665281|NCT02896361|16038899|P3|Third Intervention (2 Weeks)|Protocol Violation|0
4665282|NCT02896361|16038900|P2|Third Intervention (2 Weeks)|Protocol Violation|0
4665283|NCT02896361|16038901|P1|Third Intervention (2 Weeks)|Protocol Violation|1
4665284|NCT02896296|16038919|P1|Overall Study|Relocation|1
4665285|NCT02896296|16038919|P1|Overall Study|Incarceration|1
4665286|NCT02896296|16038919|P1|Overall Study|Site closing|7
4665287|NCT02896296|16038919|P1|Overall Study|Withdrawal by Subject|10
4665288|NCT02896296|16038919|P1|Overall Study|Physician Decision|2
4665289|NCT02896296|16038919|P1|Overall Study|Pregnancy|1
4665290|NCT02896296|16038919|P1|Overall Study|Lost to Follow-up|19
4665291|NCT02896296|16038919|P1|Overall Study|Adverse Event|1
4665292|NCT02895347|16038927|P2|Overall Study|Withdrawal by Subject|1
4665293|NCT02895347|16038928|P1|Overall Study|Withdrawal by Subject|3
4665294|NCT02895295|16038940|P3|Overall Study|Survey Non-response|92
4665295|NCT02895295|16038941|P2|Overall Study|Survey Non-response|94
4665296|NCT02895295|16038942|P1|Overall Study|Survey Non-response|71
4665297|NCT02894840|16038976|P4|Overall Study|Lost to Follow-up|0
4665298|NCT02894840|16038977|P3|Overall Study|Lost to Follow-up|3
4665299|NCT02894840|16038978|P2|Overall Study|Lost to Follow-up|0
4665300|NCT02894840|16038979|P1|Overall Study|Lost to Follow-up|1
4665301|NCT02892734|16039251|P1|Follow up for 2 Years|Study closed early|1
4665302|NCT02892734|16039251|P1|Follow up for 2 Years|Death|2
4665303|NCT02892734|16039251|P1|Treatment on Study|Progressive Disease|2
4665304|NCT02892513|16039261|P2|Overall Study|Withdrawal by Subject|1
4665305|NCT02892513|16039262|P1|Overall Study|Withdrawal by Subject|0
4665306|NCT02892448|16039271|P3|Overall Study|Screening failure|1
4665307|NCT02892448|16039272|P2|Overall Study|Screening failure|2
4665308|NCT02892448|16039273|P1|Overall Study|Screening failure|2
4665309|NCT02892422|16039293|P1|Overall Study|Investigator decision|1
4665310|NCT02892422|16039293|P1|Overall Study|patient decision|7
4665311|NCT02892422|16039293|P1|Overall Study|patient legally incapable|1
4665312|NCT02892422|16039293|P1|Overall Study|non-compliance|10
4665313|NCT02892422|16039293|P1|Overall Study|moving elsewhere|4
4665314|NCT02892422|16039293|P1|Overall Study|exclusion criteria met|3
4665315|NCT02892422|16039293|P1|Overall Study|withdrawal of consent|13
4665316|NCT02892422|16039293|P1|Overall Study|sponsor information 16159A results|21
4665317|NCT02892422|16039293|P1|Overall Study|Lost to Follow-up|5
4665318|NCT02892422|16039293|P1|Overall Study|Withdrawal by Subject|56
4665319|NCT02892422|16039293|P1|Overall Study|Protocol Violation|4
4665320|NCT02892422|16039293|P1|Overall Study|Non-compliance with study drug|11
4665321|NCT02892422|16039293|P1|Overall Study|Lack of Efficacy|32
4665322|NCT02892422|16039293|P1|Overall Study|Adverse Event|38
4665323|NCT02892422|16039293|P1|Overall Study|Enrolled not treated|4
4665324|NCT02892409|16039299|P2|Overall Study|Withdrawal by Subject|1
4665325|NCT02892409|16039300|P1|Overall Study|Withdrawal by Subject|2
4665326|NCT02892409|16039299|P2|Overall Study|Adverse Event|0
4665327|NCT02892409|16039300|P1|Overall Study|Adverse Event|1
4665328|NCT02892344|16039322|P2|Overall Study|Technical problems|1
4665329|NCT02892344|16039323|P1|Overall Study|Technical problems|0
4665330|NCT02892344|16039322|P2|Overall Study|Subject/guardian decision|4
4665331|NCT02892344|16039323|P1|Overall Study|Subject/guardian decision|0
4665332|NCT02892344|16039322|P2|Overall Study|Physician Decision|2
4665333|NCT02892344|16039323|P1|Overall Study|Physician Decision|0
4665334|NCT02892344|16039322|P2|Overall Study|Non-compliance with study treatment|1
4665335|NCT02892344|16039323|P1|Overall Study|Non-compliance with study treatment|0
4665336|NCT02892344|16039322|P2|Overall Study|Lost to Follow-up|1
4665337|NCT02892344|16039323|P1|Overall Study|Lost to Follow-up|0
4665338|NCT02892344|16039322|P2|Overall Study|Adverse Event|8
4665339|NCT02892344|16039323|P1|Overall Study|Adverse Event|1
4665340|NCT02892344|16039322|P2|Overall Study|Protocol deviation|4
4665341|NCT02892344|16039323|P1|Overall Study|Protocol deviation|3
4665342|NCT02892019|16039372|P2|Overall Study|Adverse Event|1
4665343|NCT02892019|16039373|P1|Overall Study|Adverse Event|1
4665344|NCT02892019|16039372|P2|Overall Study|Withdrawal by Subject|1
4665345|NCT02892019|16039373|P1|Overall Study|Withdrawal by Subject|0
4665346|NCT02892019|16039372|P2|Overall Study|randomized but not treated|1
4665347|NCT02892019|16039373|P1|Overall Study|randomized but not treated|0
4665348|NCT02891200|16039413|P2|Overall Study|Withdrawal by Subject|4
4665349|NCT02891200|16039414|P1|Overall Study|Withdrawal by Subject|1
4665350|NCT02891200|16039413|P2|Overall Study|Death|9
4665351|NCT02891200|16039414|P1|Overall Study|Death|10
4665352|NCT02891200|16039413|P2|Overall Study|Lost to Follow-up|36
4665353|NCT02891200|16039414|P1|Overall Study|Lost to Follow-up|31
4665354|NCT02891174|16039442|P2|Second Intervention (24 Hours)|Protocol Violation|1
4665355|NCT02891174|16039443|P1|Second Intervention (24 Hours)|Protocol Violation|0
4665356|NCT02891174|16039442|P2|Second Intervention (24 Hours)|Withdrew after receiving study drug|1
4665357|NCT02891174|16039443|P1|Second Intervention (24 Hours)|Withdrew after receiving study drug|2
4665358|NCT02891174|16039442|P2|Second Intervention (24 Hours)|Discharged during second intervention|5
4665359|NCT02891174|16039443|P1|Second Intervention (24 Hours)|Discharged during second intervention|3
4665360|NCT02891174|16039442|P2|Second Intervention (24 Hours)|No blood pressure after cross-over|0
4665361|NCT02891174|16039443|P1|Second Intervention (24 Hours)|No blood pressure after cross-over|1
4665362|NCT02891174|16039442|P2|First Intervention (24 Hours)|Withdrew after receiving study drug|6
4665363|NCT02891174|16039443|P1|First Intervention (24 Hours)|Withdrew after receiving study drug|2
4665364|NCT02891174|16039442|P2|First Intervention (24 Hours)|Discharged prior to cross-over|2
4665365|NCT02891174|16039443|P1|First Intervention (24 Hours)|Discharged prior to cross-over|0
4665366|NCT02891174|16039442|P2|First Intervention (24 Hours)|Declined any study medication|5
4665367|NCT02891174|16039443|P1|First Intervention (24 Hours)|Declined any study medication|1
4665368|NCT02891070|16039457|P2|Overall Study|Death|0
4665369|NCT02891070|16039458|P1|Overall Study|Death|3
4665370|NCT02891070|16039457|P2|Overall Study|Withdrawal by Subject|2
4665371|NCT02891070|16039458|P1|Overall Study|Withdrawal by Subject|1
4665372|NCT02891070|16039457|P2|Overall Study|Protocol Violation|1
4665373|NCT02891070|16039458|P1|Overall Study|Protocol Violation|0
4665374|NCT02891070|16039457|P2|Overall Study|Other|0
4665375|NCT02891070|16039458|P1|Overall Study|Other|1
4665376|NCT02891070|16039457|P2|Overall Study|Lost to Follow-up|4
4665377|NCT02891070|16039458|P1|Overall Study|Lost to Follow-up|4
4665378|NCT02891070|16039457|P2|Overall Study|Physician Decision|1
4665379|NCT02891070|16039458|P1|Overall Study|Physician Decision|0
4665380|NCT02891070|16039457|P2|Overall Study|Adverse Event|0
4665381|NCT02891070|16039458|P1|Overall Study|Adverse Event|1
4665382|NCT02890992|16039484|P8|130 Weeks Open-Label Extension Period|Other than specified|0
4665383|NCT02890992|16039485|P7|130 Weeks Open-Label Extension Period|Other than specified|0
4665384|NCT02890992|16039486|P6|130 Weeks Open-Label Extension Period|Other than specified|0
4665385|NCT02890992|16039487|P5|130 Weeks Open-Label Extension Period|Other than specified|0
4665386|NCT02890992|16039488|P4|130 Weeks Open-Label Extension Period|Other than specified|0
4665387|NCT02890992|16039489|P3|130 Weeks Open-Label Extension Period|Other than specified|0
4665388|NCT02890992|16039490|P2|130 Weeks Open-Label Extension Period|Other than specified|2
4665389|NCT02890992|16039491|P1|130 Weeks Open-Label Extension Period|Other than specified|0
4665390|NCT02890992|16039484|P8|130 Weeks Open-Label Extension Period|Included but not treated|1
4665391|NCT02890992|16039485|P7|130 Weeks Open-Label Extension Period|Included but not treated|1
4665392|NCT02890992|16039486|P6|130 Weeks Open-Label Extension Period|Included but not treated|0
4665393|NCT02890992|16039487|P5|130 Weeks Open-Label Extension Period|Included but not treated|0
4665394|NCT02890992|16039488|P4|130 Weeks Open-Label Extension Period|Included but not treated|0
4665395|NCT02890992|16039489|P3|130 Weeks Open-Label Extension Period|Included but not treated|0
4665396|NCT02890992|16039490|P2|130 Weeks Open-Label Extension Period|Included but not treated|0
4665397|NCT02890992|16039491|P1|130 Weeks Open-Label Extension Period|Included but not treated|0
4665398|NCT02890992|16039484|P8|130 Weeks Open-Label Extension Period|Adverse Event|0
4665399|NCT02890992|16039485|P7|130 Weeks Open-Label Extension Period|Adverse Event|0
4665400|NCT02890992|16039486|P6|130 Weeks Open-Label Extension Period|Adverse Event|0
4665401|NCT02890992|16039487|P5|130 Weeks Open-Label Extension Period|Adverse Event|0
4665402|NCT02890992|16039488|P4|130 Weeks Open-Label Extension Period|Adverse Event|0
4665403|NCT02890992|16039489|P3|130 Weeks Open-Label Extension Period|Adverse Event|0
4665404|NCT02890992|16039490|P2|130 Weeks Open-Label Extension Period|Adverse Event|1
4665405|NCT02890992|16039491|P1|130 Weeks Open-Label Extension Period|Adverse Event|0
4665406|NCT02890355|16039688|P2|Overall Study|Not protocol specified|4
4665407|NCT02890355|16039689|P1|Overall Study|Not protocol specified|3
4665408|NCT02890355|16039688|P2|Overall Study|Progression/relapse|39
4665409|NCT02890355|16039689|P1|Overall Study|Progression/relapse|46
4665410|NCT02890355|16039688|P2|Overall Study|Refusal unrelated to adverse event|10
4665411|NCT02890355|16039689|P1|Overall Study|Refusal unrelated to adverse event|5
4665412|NCT02890355|16039688|P2|Overall Study|Adverse Event|5
4665413|NCT02890355|16039689|P1|Overall Study|Adverse Event|5
4665414|NCT02889900|16039709|P1|Overall Study|Not treated|2
4665415|NCT02889900|16039709|P1|Overall Study|Withdrawal by Subject|7
4665416|NCT02889900|16039709|P1|Overall Study|Other|5
4665417|NCT02889900|16039709|P1|Overall Study|Condition under investigation worsened|32
4665418|NCT02889900|16039709|P1|Overall Study|Adverse Event|11
4665419|NCT02889861|16039721|P1|Overall Study|Ongoing in Survival Follow-up|2
4665420|NCT02888756|16039754|P3|Analytical Treatment Interruption|Physician Decision|5
4665421|NCT02888756|16039755|P2|Analytical Treatment Interruption|Physician Decision|6
4665422|NCT02888756|16039756|P1|Analytical Treatment Interruption|Physician Decision|10
4665423|NCT02888171|16039799|P2|Overall Study|Adverse Event|1
4665424|NCT02888171|16039800|P1|Overall Study|Adverse Event|0
4665425|NCT02888171|16039799|P2|Overall Study|Withdrawal by Subject|2
4665426|NCT02888171|16039800|P1|Overall Study|Withdrawal by Subject|3
4665427|NCT02888171|16039799|P2|Overall Study|Lost to Follow-up|1
4665428|NCT02888171|16039800|P1|Overall Study|Lost to Follow-up|2
4665429|NCT02888080|16039829|P2|Overall Study|Adverse Event|1
4665430|NCT02888080|16039830|P1|Overall Study|Adverse Event|0
4665431|NCT02888080|16039829|P2|Overall Study|Lack of Efficacy|1
4665432|NCT02888080|16039830|P1|Overall Study|Lack of Efficacy|0
4665433|NCT02888080|16039829|P2|Overall Study|New Therapy for study indication|0
4665434|NCT02888080|16039830|P1|Overall Study|New Therapy for study indication|1
4665435|NCT02888080|16039829|P2|Overall Study|Subject / Guardian decision|3
4665436|NCT02888080|16039830|P1|Overall Study|Subject / Guardian decision|1
4665437|NCT02887989|16039856|P2|Overall Study|Death|0
4665438|NCT02887989|16039857|P1|Overall Study|Death|1
4665439|NCT02887989|16039856|P2|Overall Study|Withdrawal by Subject|11
4665440|NCT02887989|16039857|P1|Overall Study|Withdrawal by Subject|8
4665441|NCT02887521|16039869|P2|Overall Study|Withdrawal by Subject|3
4665442|NCT02887521|16039870|P1|Overall Study|Withdrawal by Subject|0
4665443|NCT02887183|16039933|P1|Overall Study|Withdrawal by Subject|35
4665444|NCT02887183|16039933|P1|Overall Study|Physician Decision|10
4665445|NCT02887183|16039933|P1|Overall Study|Lost to Follow-up|13
4665446|NCT02887183|16039933|P1|Overall Study|Technical Problems|2
4665447|NCT02887183|16039933|P1|Overall Study|Protocol Violation|6
4665448|NCT02887183|16039933|P1|Overall Study|Pregnancy|1
4665449|NCT02887183|16039933|P1|Overall Study|Death|30
4665450|NCT02887183|16039933|P1|Overall Study|Adverse Event|44
4665451|NCT02886715|16039960|P3|Overall Study|missing|2
4665452|NCT02886715|16039961|P2|Overall Study|missing|2
4665453|NCT02886715|16039962|P1|Overall Study|missing|7
4665454|NCT02886715|16039960|P3|Overall Study|Withdrawal by Subject|5
4665455|NCT02886715|16039961|P2|Overall Study|Withdrawal by Subject|18
4665456|NCT02886715|16039962|P1|Overall Study|Withdrawal by Subject|20
4665457|NCT02886715|16039960|P3|Overall Study|Protocol Violation|1
4665458|NCT02886715|16039961|P2|Overall Study|Protocol Violation|2
4665459|NCT02886715|16039962|P1|Overall Study|Protocol Violation|3
4665460|NCT02886715|16039960|P3|Overall Study|Pregnancy|1
4665461|NCT02886715|16039961|P2|Overall Study|Pregnancy|1
4665462|NCT02886715|16039962|P1|Overall Study|Pregnancy|1
4665463|NCT02886715|16039960|P3|Overall Study|Lost to Follow-up|10
4665464|NCT02886715|16039961|P2|Overall Study|Lost to Follow-up|26
4665465|NCT02886715|16039962|P1|Overall Study|Lost to Follow-up|29
4665466|NCT02886715|16039960|P3|Overall Study|Lack of Efficacy|1
4665467|NCT02886715|16039961|P2|Overall Study|Lack of Efficacy|2
4665468|NCT02886715|16039962|P1|Overall Study|Lack of Efficacy|0
4665469|NCT02886715|16039960|P3|Overall Study|Adverse Event|0
4665470|NCT02886715|16039961|P2|Overall Study|Adverse Event|2
4665471|NCT02886715|16039962|P1|Overall Study|Adverse Event|4
4665472|NCT02886715|16039960|P3|Overall Study|Non-Compliance With Study Drug|0
4665473|NCT02886715|16039961|P2|Overall Study|Non-Compliance With Study Drug|2
4665474|NCT02886715|16039962|P1|Overall Study|Non-Compliance With Study Drug|0
4665475|NCT02886702|16039979|P3|Overall Study|Administrative Reasons|1
4665476|NCT02886702|16039980|P2|Overall Study|Administrative Reasons|0
4665477|NCT02886702|16039981|P1|Overall Study|Administrative Reasons|0
4665478|NCT02886702|16039979|P3|Overall Study|Adverse Event|3
4665479|NCT02886702|16039980|P2|Overall Study|Adverse Event|9
4665480|NCT02886702|16039981|P1|Overall Study|Adverse Event|4
4665481|NCT02886702|16039979|P3|Overall Study|Lack of Efficacy|5
4665482|NCT02886702|16039980|P2|Overall Study|Lack of Efficacy|4
4665483|NCT02886702|16039981|P1|Overall Study|Lack of Efficacy|3
4665484|NCT02886702|16039979|P3|Overall Study|Lost to Follow-up|8
4665485|NCT02886702|16039980|P2|Overall Study|Lost to Follow-up|13
4665486|NCT02886702|16039981|P1|Overall Study|Lost to Follow-up|11
4665487|NCT02886702|16039979|P3|Overall Study|Non-Compliance With Study Drug|4
4665488|NCT02886702|16039980|P2|Overall Study|Non-Compliance With Study Drug|1
4665489|NCT02886702|16039981|P1|Overall Study|Non-Compliance With Study Drug|0
4665490|NCT02886702|16039979|P3|Overall Study|Protocol Violation|1
4665491|NCT02886702|16039980|P2|Overall Study|Protocol Violation|2
4665492|NCT02886702|16039981|P1|Overall Study|Protocol Violation|2
4665493|NCT02886702|16039979|P3|Overall Study|Significant Worsening of Condition|0
4665494|NCT02886702|16039980|P2|Overall Study|Significant Worsening of Condition|1
4665495|NCT02886702|16039981|P1|Overall Study|Significant Worsening of Condition|0
4665496|NCT02886702|16039979|P3|Overall Study|Withdrawal by Subject|22
4665497|NCT02886702|16039980|P2|Overall Study|Withdrawal by Subject|18
4665498|NCT02886702|16039981|P1|Overall Study|Withdrawal by Subject|24
4665499|NCT02886702|16039979|P3|Overall Study|Other|9
4665500|NCT02886702|16039980|P2|Overall Study|Other|3
4665501|NCT02886702|16039981|P1|Overall Study|Other|4
4665502|NCT02886624|16039995|P1|48-week Post Treatment Follow-up|Lost to Follow-up|1
4665503|NCT02886624|16039995|P1|12-week Post Treatment Follow-up|Death|1
4665504|NCT02886338|16040004|P1|Overall Study|Withdrawal by Subject|1
4665505|NCT02885181|16040193|P4|Overall Study|Withdrawal by Subject|1
4665506|NCT02885181|16040194|P3|Overall Study|Withdrawal by Subject|0
4665507|NCT02885181|16040195|P2|Overall Study|Withdrawal by Subject|0
4665508|NCT02885181|16040196|P1|Overall Study|Withdrawal by Subject|0
4665509|NCT02885181|16040193|P4|Overall Study|Adverse Event|1
4665510|NCT02885181|16040194|P3|Overall Study|Adverse Event|0
4665511|NCT02885181|16040195|P2|Overall Study|Adverse Event|0
4665512|NCT02885181|16040196|P1|Overall Study|Adverse Event|0
4665513|NCT02885181|16040193|P4|Overall Study|Investigator's Discretion|1
4665514|NCT02885181|16040194|P3|Overall Study|Investigator's Discretion|0
4665515|NCT02885181|16040195|P2|Overall Study|Investigator's Discretion|1
4665516|NCT02885181|16040196|P1|Overall Study|Investigator's Discretion|0
4665517|NCT02884089|16040308|P4|Follow-up Visit|Withdrawal by Subject|1
4665518|NCT02884089|16040309|P3|Follow-up Visit|Withdrawal by Subject|0
4665519|NCT02884089|16040310|P2|Follow-up Visit|Withdrawal by Subject|0
4665520|NCT02884089|16040311|P1|Follow-up Visit|Withdrawal by Subject|1
4665521|NCT02884089|16040308|P4|Period 4|Lost to Follow-up|0
4665522|NCT02884089|16040309|P3|Period 4|Lost to Follow-up|0
4665523|NCT02884089|16040310|P2|Period 4|Lost to Follow-up|0
4665524|NCT02884089|16040311|P1|Period 4|Lost to Follow-up|1
4665525|NCT02884089|16040308|P4|Period 4|Withdrawal by Subject|0
4665526|NCT02884089|16040309|P3|Period 4|Withdrawal by Subject|0
4665527|NCT02884089|16040310|P2|Period 4|Withdrawal by Subject|1
4665528|NCT02884089|16040311|P1|Period 4|Withdrawal by Subject|0
4665529|NCT02884089|16040308|P4|Washout Period 3|Lost to Follow-up|1
4665530|NCT02884089|16040309|P3|Washout Period 3|Lost to Follow-up|0
4665531|NCT02884089|16040310|P2|Washout Period 3|Lost to Follow-up|0
4665532|NCT02884089|16040311|P1|Washout Period 3|Lost to Follow-up|0
4665533|NCT02884089|16040308|P4|Washout Period 3|Withdrawal by Subject|0
4665534|NCT02884089|16040309|P3|Washout Period 3|Withdrawal by Subject|1
4665535|NCT02884089|16040310|P2|Washout Period 3|Withdrawal by Subject|0
4665536|NCT02884089|16040311|P1|Washout Period 3|Withdrawal by Subject|0
4665537|NCT02884089|16040308|P4|Period 3|Withdrawal by Subject|0
4665538|NCT02884089|16040309|P3|Period 3|Withdrawal by Subject|1
4665539|NCT02884089|16040310|P2|Period 3|Withdrawal by Subject|0
4665540|NCT02884089|16040311|P1|Period 3|Withdrawal by Subject|0
4665541|NCT02884089|16040308|P4|Period 2|Adverse Event|0
4665542|NCT02884089|16040309|P3|Period 2|Adverse Event|0
4665543|NCT02884089|16040310|P2|Period 2|Adverse Event|0
4665544|NCT02884089|16040311|P1|Period 2|Adverse Event|1
4665545|NCT02884089|16040308|P4|Washout Period 1|Withdrawal by Subject|0
4665546|NCT02884089|16040309|P3|Washout Period 1|Withdrawal by Subject|0
4665547|NCT02884089|16040310|P2|Washout Period 1|Withdrawal by Subject|1
4665548|NCT02884089|16040311|P1|Washout Period 1|Withdrawal by Subject|0
4665549|NCT02884089|16040308|P4|Washout Period 1|Lost to Follow-up|1
4665550|NCT02884089|16040309|P3|Washout Period 1|Lost to Follow-up|0
4665551|NCT02884089|16040310|P2|Washout Period 1|Lost to Follow-up|1
4665552|NCT02884089|16040311|P1|Washout Period 1|Lost to Follow-up|0
4665553|NCT02884089|16040308|P4|Period 1|Dosing error|0
4665554|NCT02884089|16040309|P3|Period 1|Dosing error|0
4665555|NCT02884089|16040310|P2|Period 1|Dosing error|2
4665556|NCT02884089|16040311|P1|Period 1|Dosing error|2
4665557|NCT02883452|16040331|P6|Overall Study|Other|1
4665558|NCT02883452|16040332|P5|Overall Study|Other|0
4665559|NCT02883452|16040333|P4|Overall Study|Other|0
4665560|NCT02883452|16040334|P3|Overall Study|Other|0
4665561|NCT02883452|16040335|P2|Overall Study|Other|0
4665562|NCT02883452|16040336|P1|Overall Study|Other|0
4665563|NCT02883452|16040331|P6|Overall Study|Death|0
4665564|NCT02883452|16040332|P5|Overall Study|Death|0
4665565|NCT02883452|16040333|P4|Overall Study|Death|0
4665566|NCT02883452|16040334|P3|Overall Study|Death|1
4665567|NCT02883452|16040335|P2|Overall Study|Death|0
4665568|NCT02883452|16040336|P1|Overall Study|Death|1
4665569|NCT02883452|16040331|P6|Overall Study|Physician Decision|1
4665570|NCT02883452|16040332|P5|Overall Study|Physician Decision|4
4665571|NCT02883452|16040333|P4|Overall Study|Physician Decision|0
4665572|NCT02883452|16040334|P3|Overall Study|Physician Decision|0
4665573|NCT02883452|16040335|P2|Overall Study|Physician Decision|0
4665574|NCT02883452|16040336|P1|Overall Study|Physician Decision|0
4665575|NCT02883452|16040331|P6|Overall Study|Adverse Event|3
4665576|NCT02883452|16040332|P5|Overall Study|Adverse Event|1
4665577|NCT02883452|16040333|P4|Overall Study|Adverse Event|1
4665578|NCT02883452|16040334|P3|Overall Study|Adverse Event|1
4665579|NCT02883452|16040335|P2|Overall Study|Adverse Event|1
4665580|NCT02883452|16040336|P1|Overall Study|Adverse Event|2
4665581|NCT02883452|16040331|P6|Overall Study|Disease progression|5
4665582|NCT02883452|16040332|P5|Overall Study|Disease progression|4
4665583|NCT02883452|16040333|P4|Overall Study|Disease progression|1
4665584|NCT02883452|16040334|P3|Overall Study|Disease progression|0
4665585|NCT02883452|16040335|P2|Overall Study|Disease progression|0
4665586|NCT02883452|16040336|P1|Overall Study|Disease progression|1
4665587|NCT02883452|16040331|P6|Overall Study|Withdrawal by Subject|5
4665588|NCT02883452|16040332|P5|Overall Study|Withdrawal by Subject|2
4665589|NCT02883452|16040333|P4|Overall Study|Withdrawal by Subject|0
4665590|NCT02883452|16040334|P3|Overall Study|Withdrawal by Subject|3
4665591|NCT02883452|16040335|P2|Overall Study|Withdrawal by Subject|1
4665592|NCT02883452|16040336|P1|Overall Study|Withdrawal by Subject|1
4665593|NCT02883244|16040364|P2|Overall Study|Lost to Follow-up|1
4665594|NCT02883244|16040365|P1|Overall Study|Lost to Follow-up|0
4665595|NCT02882854|16040383|P2|Overall Study|Physician Decision|1
4665596|NCT02882854|16040384|P1|Overall Study|Physician Decision|0
4665597|NCT02882854|16040383|P2|Overall Study|Lost to Follow-up|2
4665598|NCT02882854|16040384|P1|Overall Study|Lost to Follow-up|1
4665599|NCT02882152|16040421|P2|Overall Study|Lost to Follow-up|0
4665600|NCT02882152|16040422|P1|Overall Study|Lost to Follow-up|1
4665601|NCT02881957|16040432|P2|Overall Study|Protocol Violation|0
4665602|NCT02881957|16040433|P1|Overall Study|Protocol Violation|1
4665603|NCT02881957|16040432|P2|Overall Study|Withdrawal by Subject|1
4665604|NCT02881957|16040433|P1|Overall Study|Withdrawal by Subject|2
4665605|NCT02881957|16040432|P2|Overall Study|Discharged within 48 hours|1
4665606|NCT02881957|16040433|P1|Overall Study|Discharged within 48 hours|0
4665607|NCT02881957|16040432|P2|Overall Study|Concurrent trial enrollment|1
4665608|NCT02881957|16040433|P1|Overall Study|Concurrent trial enrollment|0
4665609|NCT02881957|16040432|P2|Overall Study|Comfort care|1
4665610|NCT02881957|16040433|P1|Overall Study|Comfort care|0
4665611|NCT02881567|16040519|P1|Overall Study|Reason not Specified|3
4665612|NCT02881567|16040519|P1|Overall Study|Study terminated by sponsor|9
4665613|NCT02881567|16040519|P1|Overall Study|Investigator decision|1
4665614|NCT02881567|16040519|P1|Overall Study|Consent withdrawn|1
4665615|NCT02881567|16040519|P1|Overall Study|Lost to Follow-up|3
4665616|NCT02881567|16040519|P1|Overall Study|Adverse Event|1
4665617|NCT02881047|16040535|P1|Overall Study|Withdrawal by Subject|1
4665618|NCT02881047|16040535|P1|Overall Study|Adverse Event|1
4665619|NCT02880865|16040587|P2|Overall Study|Physician Decision|1
4665620|NCT02880865|16040588|P1|Overall Study|Physician Decision|0
4665621|NCT02880865|16040587|P2|Overall Study|Withdrawal by Subject|2
4665622|NCT02880865|16040588|P1|Overall Study|Withdrawal by Subject|0
4665623|NCT02880865|16040587|P2|Overall Study|Adverse Event|0
4665624|NCT02880865|16040588|P1|Overall Study|Adverse Event|1
4665625|NCT02880761|16040671|P2|Overall Study|Lost to Follow-up|4
4665626|NCT02880761|16040672|P1|Overall Study|Lost to Follow-up|3
4665627|NCT02880761|16040671|P2|Overall Study|Protocol Violation|3
4665628|NCT02880761|16040672|P1|Overall Study|Protocol Violation|4
4665629|NCT02880761|16040671|P2|Overall Study|Withdrawal by Subject|6
4665630|NCT02880761|16040672|P1|Overall Study|Withdrawal by Subject|3
4665631|NCT02880761|16040671|P2|Overall Study|Death|8
4665632|NCT02880761|16040672|P1|Overall Study|Death|6
4665633|NCT02878590|16040900|P1|Overall Study|Withdrawal by Subject|2
4665634|NCT02878330|16040938|P2|Overall Study|Other|7
4665635|NCT02878330|16040939|P1|Overall Study|Other|4
4665636|NCT02878330|16040938|P2|Overall Study|Withdrawal by Subject|21
4665637|NCT02878330|16040939|P1|Overall Study|Withdrawal by Subject|11
4665638|NCT02878330|16040938|P2|Overall Study|Lost to Follow-up|26
4665639|NCT02878330|16040939|P1|Overall Study|Lost to Follow-up|11
4665640|NCT02878330|16040938|P2|Overall Study|Death|2
4665641|NCT02878330|16040939|P1|Overall Study|Death|3
4665642|NCT02878213|16040955|P1|Overall Study|Adverse Event|1
4665643|NCT02878213|16040955|P1|Overall Study|Withdrawal by Subject|2
4665644|NCT02877927|16040962|P2|Overall Study|Missed EOT/PTE Visit|6
4665645|NCT02877927|16040963|P1|Overall Study|Missed EOT/PTE Visit|5
4665646|NCT02877927|16040962|P2|Overall Study|Physician Decision|1
4665647|NCT02877927|16040963|P1|Overall Study|Physician Decision|0
4665648|NCT02877927|16040962|P2|Overall Study|Withdrawal by Subject|12
4665649|NCT02877927|16040963|P1|Overall Study|Withdrawal by Subject|11
4665650|NCT02877927|16040962|P2|Overall Study|Lost to Follow-up|38
4665651|NCT02877927|16040963|P1|Overall Study|Lost to Follow-up|37
4665652|NCT02877927|16040962|P2|Overall Study|Adverse Event|0
4665653|NCT02877927|16040963|P1|Overall Study|Adverse Event|1
4665654|NCT02877680|16040994|P2|Overall Study|Lost to Follow-up|1
4665655|NCT02877680|16040995|P1|Overall Study|Lost to Follow-up|1
4665656|NCT02877082|16041053|P1|Overall Study|Trial was closed early|5
4665657|NCT02877004|16041064|P3|Overall Study|Pregnancy|1
4665658|NCT02877004|16041065|P2|Overall Study|Pregnancy|0
4665659|NCT02877004|16041066|P1|Overall Study|Pregnancy|0
4665660|NCT02876601|16041150|P4|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
4665661|NCT02876601|16041151|P3|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1
4665662|NCT02876601|16041152|P2|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
4665663|NCT02876601|16041153|P1|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0
4665664|NCT02875977|16041251|P2|Overall Study|Lost to Follow-up|29
4665665|NCT02875977|16041252|P1|Overall Study|Lost to Follow-up|42
4665666|NCT02875834|16041270|P4|Randomized Treatment Phase|(Not collected)|9
4665667|NCT02875834|16041271|P3|Randomized Treatment Phase|(Not collected)|10
4665668|NCT02875834|16041272|P2|Randomized Treatment Phase|(Not collected)|9
4665669|NCT02875834|16041273|P1|Randomized Treatment Phase|(Not collected)|0
4665670|NCT02875834|16041270|P4|Randomized Treatment Phase|Protocol Violation|0
4665671|NCT02875834|16041271|P3|Randomized Treatment Phase|Protocol Violation|0
4665672|NCT02875834|16041272|P2|Randomized Treatment Phase|Protocol Violation|2
4665673|NCT02875834|16041273|P1|Randomized Treatment Phase|Protocol Violation|0
4665674|NCT02875834|16041270|P4|Randomized Treatment Phase|Withdrawal by Subject|0
4665675|NCT02875834|16041271|P3|Randomized Treatment Phase|Withdrawal by Subject|1
4665676|NCT02875834|16041272|P2|Randomized Treatment Phase|Withdrawal by Subject|3
4665677|NCT02875834|16041273|P1|Randomized Treatment Phase|Withdrawal by Subject|0
4665678|NCT02875834|16041270|P4|Open-label Phase|(Not collected)|0
4665679|NCT02875834|16041271|P3|Open-label Phase|(Not collected)|0
4665680|NCT02875834|16041272|P2|Open-label Phase|(Not collected)|0
4665681|NCT02875834|16041273|P1|Open-label Phase|(Not collected)|4
4665682|NCT02875834|16041270|P4|Open-label Phase|Withdrawal by Subject|0
4665683|NCT02875834|16041271|P3|Open-label Phase|Withdrawal by Subject|0
4665684|NCT02875834|16041272|P2|Open-label Phase|Withdrawal by Subject|0
4665685|NCT02875834|16041273|P1|Open-label Phase|Withdrawal by Subject|3
4665686|NCT02875613|16041331|P1|Overall Study|Withdrawal by Subject|1
4665687|NCT02875366|16041337|P2|Overall Study|Noncompliance|1
4665688|NCT02875366|16041338|P1|Overall Study|Noncompliance|0
4665689|NCT02875366|16041337|P2|Overall Study|Adverse Event|2
4665690|NCT02875366|16041338|P1|Overall Study|Adverse Event|0
4665691|NCT02875340|16041390|P1|Overall Study|Adverse Event|1
4665692|NCT02875340|16041390|P1|Overall Study|Physician Decision|3
4665693|NCT02875340|16041390|P1|Overall Study|Withdrawal by Subject|2
4665694|NCT02875340|16041390|P1|Overall Study|Death|2
4665695|NCT02875067|16041412|P1|Overall Study|Withdrawal by Termination of Study|5
4665696|NCT02875067|16041412|P1|Overall Study|Withdrawal by Subject|1
4665697|NCT02875028|16041427|P2|Washout Period|Withdrawal by Subject|1
4665698|NCT02875028|16041428|P1|Washout Period|Withdrawal by Subject|0
4665699|NCT02874924|16041459|P3|Overall Study|Withdrawal by Subject|0
4665700|NCT02874924|16041460|P2|Overall Study|Withdrawal by Subject|0
4665701|NCT02874924|16041461|P1|Overall Study|Withdrawal by Subject|1
4665702|NCT02874924|16041459|P3|Overall Study|Adverse Event|0
4665703|NCT02874924|16041460|P2|Overall Study|Adverse Event|0
4665704|NCT02874924|16041461|P1|Overall Study|Adverse Event|2
4665705|NCT02874794|16041494|P2|Overall Study|Death|1
4665706|NCT02874794|16041495|P1|Overall Study|Death|2
4665707|NCT02874794|16041494|P2|Overall Study|Withdrawal by Subject|8
4665708|NCT02874794|16041495|P1|Overall Study|Withdrawal by Subject|2
4665709|NCT02874794|16041494|P2|Overall Study|Physician Decision|2
4665710|NCT02874794|16041495|P1|Overall Study|Physician Decision|3
4665711|NCT02874742|16041527|P3|Overall Study|Ongoing|15
4665712|NCT02874742|16041528|P2|Overall Study|Ongoing|98
4665713|NCT02874742|16041529|P1|Overall Study|Ongoing|87
4665714|NCT02874742|16041527|P3|Overall Study|Other|0
4665715|NCT02874742|16041528|P2|Overall Study|Other|1
4665716|NCT02874742|16041529|P1|Overall Study|Other|3
4665717|NCT02874742|16041527|P3|Overall Study|Withdrawal by Subject|0
4665718|NCT02874742|16041528|P2|Overall Study|Withdrawal by Subject|4
4665719|NCT02874742|16041529|P1|Overall Study|Withdrawal by Subject|8
4665720|NCT02874742|16041527|P3|Overall Study|Lost to Follow-up|0
4665721|NCT02874742|16041528|P2|Overall Study|Lost to Follow-up|0
4665722|NCT02874742|16041529|P1|Overall Study|Lost to Follow-up|2
4665723|NCT02874742|16041527|P3|Overall Study|Death|1
4665724|NCT02874742|16041528|P2|Overall Study|Death|1
4665725|NCT02874742|16041529|P1|Overall Study|Death|3
4665726|NCT02874534|16041583|P2|Overall Study|Ongoing in study|1
4665727|NCT02874534|16041584|P1|Overall Study|Ongoing in study|1
4665728|NCT02874534|16041583|P2|Overall Study|Lost to Follow-up|2
4665729|NCT02874534|16041584|P1|Overall Study|Lost to Follow-up|2
4665730|NCT02874534|16041583|P2|Overall Study|Withdrawal by Subject|8
4665731|NCT02874534|16041584|P1|Overall Study|Withdrawal by Subject|5
4665732|NCT02873754|16041606|P1|Overall Study|Couldn't complete study procedures|1
4665733|NCT02873754|16041606|P1|Overall Study|Lost to Follow-up|5
4665734|NCT02873702|16041623|P4|Maintenance Period (up to Month 6)|Withdrawal by Subject|1
4665735|NCT02873702|16041624|P3|Maintenance Period (up to Month 6)|Withdrawal by Subject|2
4665736|NCT02873702|16041625|P2|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
4665737|NCT02873702|16041626|P1|Maintenance Period (up to Month 6)|Withdrawal by Subject|0
4665738|NCT02873702|16041623|P4|Maintenance Period (up to Month 6)|Relapse of EE|1
4665739|NCT02873702|16041624|P3|Maintenance Period (up to Month 6)|Relapse of EE|4
4665740|NCT02873702|16041625|P2|Maintenance Period (up to Month 6)|Relapse of EE|0
4665741|NCT02873702|16041626|P1|Maintenance Period (up to Month 6)|Relapse of EE|0
4665742|NCT02873702|16041623|P4|Maintenance Period (up to Month 6)|Adverse Event|0
4665743|NCT02873702|16041624|P3|Maintenance Period (up to Month 6)|Adverse Event|1
4665744|NCT02873702|16041625|P2|Maintenance Period (up to Month 6)|Adverse Event|0
4665745|NCT02873702|16041626|P1|Maintenance Period (up to Month 6)|Adverse Event|0
4665746|NCT02873702|16041623|P4|Healing Period (up to Week 8)|Withdrawal by Subject|0
4665747|NCT02873702|16041624|P3|Healing Period (up to Week 8)|Withdrawal by Subject|0
4665748|NCT02873702|16041625|P2|Healing Period (up to Week 8)|Withdrawal by Subject|1
4665749|NCT02873702|16041626|P1|Healing Period (up to Week 8)|Withdrawal by Subject|0
4665750|NCT02873702|16041623|P4|Healing Period (up to Week 8)|Adverse Event|0
4665751|NCT02873702|16041624|P3|Healing Period (up to Week 8)|Adverse Event|0
4665752|NCT02873702|16041625|P2|Healing Period (up to Week 8)|Adverse Event|0
4665753|NCT02873702|16041626|P1|Healing Period (up to Week 8)|Adverse Event|1
4665754|NCT02873689|16041638|P2|Overall Study|Randomized but not Treated|1
4665755|NCT02873689|16041639|P1|Overall Study|Randomized but not Treated|1
4665756|NCT02873689|16041638|P2|Overall Study|Adverse Event|2
4665757|NCT02873689|16041639|P1|Overall Study|Adverse Event|2
4665758|NCT02873689|16041638|P2|Overall Study|Protocol Violation|0
4665759|NCT02873689|16041639|P1|Overall Study|Protocol Violation|1
4665760|NCT02873689|16041638|P2|Overall Study|Withdrawal by Subject|2
4665761|NCT02873689|16041639|P1|Overall Study|Withdrawal by Subject|2
4665762|NCT02873689|16041638|P2|Overall Study|Lack of Efficacy|0
4665763|NCT02873689|16041639|P1|Overall Study|Lack of Efficacy|1
4665764|NCT02873429|16041680|P2|16 Weeks|Lost to Follow-up|0
4665765|NCT02873429|16041681|P1|16 Weeks|Lost to Follow-up|3
4665766|NCT02873429|16041680|P2|16 Weeks|Completed 6-8 week, missed 16 week|2
4665767|NCT02873429|16041681|P1|16 Weeks|Completed 6-8 week, missed 16 week|2
4665768|NCT02873429|16041680|P2|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1
4665769|NCT02873429|16041681|P1|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10
4665770|NCT02873377|16041693|P2|Period Title 3: 6 Months Follow up|Lost to Follow-up|23
4665771|NCT02873377|16041694|P1|Period Title 3: 6 Months Follow up|Lost to Follow-up|15
4665772|NCT02873377|16041693|P2|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
4665773|NCT02873377|16041694|P1|Period Title 2: 3 Months Follow up|Lost to Follow-up|22
4665774|NCT02873221|16041952|P3|Safety Follow-up Period|Withdrawal of Consent|8
4665775|NCT02873221|16041953|P2|Safety Follow-up Period|Withdrawal of Consent|10
4665776|NCT02873221|16041954|P1|Safety Follow-up Period|Withdrawal of Consent|4
4665777|NCT02873221|16041952|P3|Safety Follow-up Period|Lost to Follow-up|5
4665778|NCT02873221|16041953|P2|Safety Follow-up Period|Lost to Follow-up|5
4665779|NCT02873221|16041954|P1|Safety Follow-up Period|Lost to Follow-up|3
4665780|NCT02873221|16041952|P3|Safety Follow-up Period|Protocol Violation|1
4665781|NCT02873221|16041953|P2|Safety Follow-up Period|Protocol Violation|0
4665782|NCT02873221|16041954|P1|Safety Follow-up Period|Protocol Violation|0
4665783|NCT02873221|16041952|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
4665784|NCT02873221|16041953|P2|Safety Follow-up Period|Other Miscellaneous Reasons|2
4665785|NCT02873221|16041954|P1|Safety Follow-up Period|Other Miscellaneous Reasons|0
4665786|NCT02873221|16041952|P3|Treatment Period|Lost to Follow-up|26
4665787|NCT02873221|16041953|P2|Treatment Period|Lost to Follow-up|30
4665788|NCT02873221|16041954|P1|Treatment Period|Lost to Follow-up|26
4665789|NCT02873221|16041952|P3|Treatment Period|Adverse Event|11
4665790|NCT02873221|16041953|P2|Treatment Period|Adverse Event|9
4665791|NCT02873221|16041954|P1|Treatment Period|Adverse Event|4
4665792|NCT02873221|16041952|P3|Treatment Period|Lack of Efficacy|12
4665793|NCT02873221|16041953|P2|Treatment Period|Lack of Efficacy|17
4665794|NCT02873221|16041954|P1|Treatment Period|Lack of Efficacy|0
4665795|NCT02873221|16041952|P3|Treatment Period|Withdrawal of Consent|41
4665796|NCT02873221|16041953|P2|Treatment Period|Withdrawal of Consent|51
4665797|NCT02873221|16041954|P1|Treatment Period|Withdrawal of Consent|52
4665798|NCT02873221|16041952|P3|Treatment Period|Lack of Qualifying Event|1
4665799|NCT02873221|16041953|P2|Treatment Period|Lack of Qualifying Event|3
4665800|NCT02873221|16041954|P1|Treatment Period|Lack of Qualifying Event|0
4665801|NCT02873221|16041952|P3|Treatment Period|Pregnancy|3
4665802|NCT02873221|16041953|P2|Treatment Period|Pregnancy|6
4665803|NCT02873221|16041954|P1|Treatment Period|Pregnancy|4
4665804|NCT02873221|16041952|P3|Treatment Period|Protocol Violation|8
4665805|NCT02873221|16041953|P2|Treatment Period|Protocol Violation|5
4665806|NCT02873221|16041954|P1|Treatment Period|Protocol Violation|2
4665807|NCT02873221|16041952|P3|Treatment Period|Non-Compliance with Study Drug|2
4665808|NCT02873221|16041953|P2|Treatment Period|Non-Compliance with Study Drug|3
4665809|NCT02873221|16041954|P1|Treatment Period|Non-Compliance with Study Drug|0
4665810|NCT02873221|16041952|P3|Treatment Period|Other Miscellaneous Reasons|1
4665811|NCT02873221|16041953|P2|Treatment Period|Other Miscellaneous Reasons|2
4665812|NCT02873221|16041954|P1|Treatment Period|Other Miscellaneous Reasons|0
4665813|NCT02873195|16041976|P2|Overall Study|Ineligible|0
4665814|NCT02873195|16041977|P1|Overall Study|Ineligible|5
4665815|NCT02872935|16042006|P2|Overall Study|Other|1
4665816|NCT02872935|16042007|P1|Overall Study|Other|0
4665817|NCT02872311|16042035|P5|Overall Study|Protocol Violation|0
4665818|NCT02872311|16042036|P4|Overall Study|Protocol Violation|0
4665819|NCT02872311|16042037|P3|Overall Study|Protocol Violation|1
4665820|NCT02872311|16042038|P2|Overall Study|Protocol Violation|2
4665821|NCT02872311|16042039|P1|Overall Study|Protocol Violation|0
4665822|NCT02872311|16042035|P5|Overall Study|Lost to Follow-up|0
4665823|NCT02872311|16042036|P4|Overall Study|Lost to Follow-up|0
4665824|NCT02872311|16042037|P3|Overall Study|Lost to Follow-up|0
4665825|NCT02872311|16042038|P2|Overall Study|Lost to Follow-up|0
4665826|NCT02872311|16042039|P1|Overall Study|Lost to Follow-up|2
4665827|NCT02872311|16042035|P5|Overall Study|Death|0
4665828|NCT02872311|16042036|P4|Overall Study|Death|0
4665829|NCT02872311|16042037|P3|Overall Study|Death|0
4665830|NCT02872311|16042038|P2|Overall Study|Death|0
4665831|NCT02872311|16042039|P1|Overall Study|Death|2
4665832|NCT02872285|16042100|P2|Overall Study|Discontinued due to back surgery|0
4665833|NCT02872285|16042101|P1|Overall Study|Discontinued due to back surgery|1
4665834|NCT02872285|16042100|P2|Overall Study|Lost to Follow-up|2
4665835|NCT02872285|16042101|P1|Overall Study|Lost to Follow-up|2
4665836|NCT02872285|16042100|P2|Overall Study|Withdrawal by Subject|0
4665837|NCT02872285|16042101|P1|Overall Study|Withdrawal by Subject|2
4665838|NCT02872012|16042147|P5|Overall Study|Withdrawal by Subject|0
4665839|NCT02872012|16042148|P4|Overall Study|Withdrawal by Subject|0
4665840|NCT02872012|16042149|P3|Overall Study|Withdrawal by Subject|0
4665841|NCT02872012|16042150|P2|Overall Study|Withdrawal by Subject|0
4665842|NCT02872012|16042151|P1|Overall Study|Withdrawal by Subject|1
4665843|NCT02871739|16042169|P4|Overall Study|Lost to Follow-up|2
4665844|NCT02871739|16042170|P3|Overall Study|Lost to Follow-up|0
4665845|NCT02871739|16042171|P2|Overall Study|Lost to Follow-up|2
4665846|NCT02871739|16042172|P1|Overall Study|Lost to Follow-up|3
4665847|NCT02871635|16042184|P2|Overall Study|Secondary lack of efficacy|1
4665848|NCT02871635|16042185|P1|Overall Study|Secondary lack of efficacy|2
4665849|NCT02871635|16042184|P2|Overall Study|Adverse Event|4
4665850|NCT02871635|16042185|P1|Overall Study|Adverse Event|4
4665851|NCT02871635|16042184|P2|Overall Study|Withdrawal by Subject|4
4665852|NCT02871635|16042185|P1|Overall Study|Withdrawal by Subject|3
4665853|NCT02871635|16042184|P2|Overall Study|Physician Decision|1
4665854|NCT02871635|16042185|P1|Overall Study|Physician Decision|1
4665855|NCT02871635|16042184|P2|Overall Study|Pregnancy|2
4665856|NCT02871635|16042185|P1|Overall Study|Pregnancy|0
4665857|NCT02871635|16042184|P2|Overall Study|Lost to Follow-up|2
4665858|NCT02871635|16042185|P1|Overall Study|Lost to Follow-up|1
4665859|NCT02871635|16042184|P2|Overall Study|Protocol Violation|1
4665860|NCT02871635|16042185|P1|Overall Study|Protocol Violation|3
4665861|NCT02871635|16042184|P2|Overall Study|Primary lack of efficacy|4
4665862|NCT02871635|16042185|P1|Overall Study|Primary lack of efficacy|4
4665863|NCT02871375|16042275|P2|Period 1, First 14 Days of Wear|Inclusion criteria not met|1
4665864|NCT02871375|16042276|P1|Period 1, First 14 Days of Wear|Inclusion criteria not met|0
4665865|NCT02870933|16042322|P2|Overall Study|Withdrawal by Subject|1
4665866|NCT02870933|16042323|P1|Overall Study|Withdrawal by Subject|0
4665867|NCT02870933|16042322|P2|Overall Study|Death|1
4665868|NCT02870933|16042323|P1|Overall Study|Death|2
4665869|NCT02869893|16042396|P1|Overall Study|participant fear of MRI scanner|2
4665870|NCT02869893|16042396|P1|Overall Study|participant aversion to IV|5
4665871|NCT02869438|16042426|P2|Overall Study|Withdrawal by Subject|2
4665872|NCT02869438|16042427|P1|Overall Study|Withdrawal by Subject|1
4665873|NCT02869438|16042426|P2|Overall Study|Adverse Event|0
4665874|NCT02869438|16042427|P1|Overall Study|Adverse Event|1
4665875|NCT02869438|16042426|P2|Overall Study|Lost to Follow-up|0
4665876|NCT02869438|16042427|P1|Overall Study|Lost to Follow-up|1
4665877|NCT02868892|16042475|P1|Overall Study|Investigator left site and no follow-up|6
4665878|NCT02868554|16042484|P3|Overall Study|Lost to Follow-up|1
4665879|NCT02868554|16042485|P2|Overall Study|Lost to Follow-up|0
4665880|NCT02868554|16042486|P1|Overall Study|Lost to Follow-up|3
4665881|NCT02868281|16042511|P2|Overall Study|Long journey/moving away|1
4665882|NCT02868281|16042512|P1|Overall Study|Long journey/moving away|1
4665883|NCT02868281|16042511|P2|Overall Study|Inclusion/exclusion criteria violation|2
4665884|NCT02868281|16042512|P1|Overall Study|Inclusion/exclusion criteria violation|3
4665885|NCT02868281|16042511|P2|Overall Study|Had protocol-defined asthma exacerbation|8
4665886|NCT02868281|16042512|P1|Overall Study|Had protocol-defined asthma exacerbation|8
4665887|NCT02868281|16042511|P2|Overall Study|Physician Decision|0
4665888|NCT02868281|16042512|P1|Overall Study|Physician Decision|2
4665889|NCT02868281|16042511|P2|Overall Study|Withdrawal by Subject|15
4665890|NCT02868281|16042512|P1|Overall Study|Withdrawal by Subject|11
4665891|NCT02868281|16042511|P2|Overall Study|Lost to Follow-up|6
4665892|NCT02868281|16042512|P1|Overall Study|Lost to Follow-up|3
4665893|NCT02868281|16042511|P2|Overall Study|Protocol Violation|10
4665894|NCT02868281|16042512|P1|Overall Study|Protocol Violation|13
4665895|NCT02868281|16042511|P2|Overall Study|Adverse Event|2
4665896|NCT02868281|16042512|P1|Overall Study|Adverse Event|2
4665897|NCT02868216|16042546|P2|Overall Study|Withdrawal by Subject|5
4665898|NCT02868216|16042547|P1|Overall Study|Withdrawal by Subject|7
4665899|NCT02868216|16042546|P2|Overall Study|coronary artery bypass|0
4665900|NCT02868216|16042547|P1|Overall Study|coronary artery bypass|1
4665901|NCT02868216|16042546|P2|Overall Study|Death|1
4665902|NCT02868216|16042547|P1|Overall Study|Death|0
4665903|NCT02867995|16042555|P2|Overall Study|Lost to Follow-up|2
4665904|NCT02867995|16042556|P1|Overall Study|Lost to Follow-up|0
4665905|NCT02867995|16042555|P2|Overall Study|Withdrawal by Subject|1
4665906|NCT02867995|16042556|P1|Overall Study|Withdrawal by Subject|0
4665907|NCT02867709|16042575|P3|Safety Follow-up Period|Protocol Violation|1
4665908|NCT02867709|16042576|P2|Safety Follow-up Period|Protocol Violation|1
4665909|NCT02867709|16042577|P1|Safety Follow-up Period|Protocol Violation|0
4665910|NCT02867709|16042575|P3|Safety Follow-up Period|Pregnancy|0
4665911|NCT02867709|16042576|P2|Safety Follow-up Period|Pregnancy|1
4665912|NCT02867709|16042577|P1|Safety Follow-up Period|Pregnancy|0
4665913|NCT02867709|16042575|P3|Safety Follow-up Period|Lost to Follow-up|7
4665914|NCT02867709|16042576|P2|Safety Follow-up Period|Lost to Follow-up|5
4665915|NCT02867709|16042577|P1|Safety Follow-up Period|Lost to Follow-up|10
4665916|NCT02867709|16042575|P3|Safety Follow-up Period|Withdrawal of Consent|6
4665917|NCT02867709|16042576|P2|Safety Follow-up Period|Withdrawal of Consent|8
4665918|NCT02867709|16042577|P1|Safety Follow-up Period|Withdrawal of Consent|1
4665919|NCT02867709|16042575|P3|Treatment Period|Protocol Violation|3
4665920|NCT02867709|16042576|P2|Treatment Period|Protocol Violation|2
4665921|NCT02867709|16042577|P1|Treatment Period|Protocol Violation|3
4665922|NCT02867709|16042575|P3|Treatment Period|Lack of Qualifying Event|42
4665923|NCT02867709|16042576|P2|Treatment Period|Lack of Qualifying Event|55
4665924|NCT02867709|16042577|P1|Treatment Period|Lack of Qualifying Event|42
4665925|NCT02867709|16042575|P3|Treatment Period|Lost to Follow-up|20
4665926|NCT02867709|16042576|P2|Treatment Period|Lost to Follow-up|20
4665927|NCT02867709|16042577|P1|Treatment Period|Lost to Follow-up|17
4665928|NCT02867709|16042575|P3|Treatment Period|Withdrawal of Consent|8
4665929|NCT02867709|16042576|P2|Treatment Period|Withdrawal of Consent|9
4665930|NCT02867709|16042577|P1|Treatment Period|Withdrawal of Consent|7
4665931|NCT02867709|16042575|P3|Treatment Period|Adverse Event|2
4665932|NCT02867709|16042576|P2|Treatment Period|Adverse Event|1
4665933|NCT02867709|16042577|P1|Treatment Period|Adverse Event|1
4665934|NCT02866942|16042684|P1|Overall Study|Invalid consent|1
4665935|NCT02866695|16042689|P1|Overall Study|Lost to Follow-up|1
4665936|NCT02866695|16042689|P1|Overall Study|Adverse Event|1
4665937|NCT02866175|16042706|P2|Overall Study|Did not receive treatment|15
4665938|NCT02866175|16042707|P1|Overall Study|Did not receive treatment|5
4665939|NCT02866175|16042706|P2|Overall Study|Physician Decision|15
4665940|NCT02866175|16042707|P1|Overall Study|Physician Decision|3
4665941|NCT02866175|16042706|P2|Overall Study|Lack of Efficacy|1
4665942|NCT02866175|16042707|P1|Overall Study|Lack of Efficacy|0
4665943|NCT02866175|16042706|P2|Overall Study|Lost to Follow-up|0
4665944|NCT02866175|16042707|P1|Overall Study|Lost to Follow-up|2
4665945|NCT02866175|16042706|P2|Overall Study|Progressive disease|1
4665946|NCT02866175|16042707|P1|Overall Study|Progressive disease|1
4665947|NCT02866175|16042706|P2|Overall Study|Other|14
4665948|NCT02866175|16042707|P1|Overall Study|Other|7
4665949|NCT02866175|16042706|P2|Overall Study|Death|23
4665950|NCT02866175|16042707|P1|Overall Study|Death|30
4665951|NCT02866175|16042706|P2|Overall Study|Withdrawal by Subject|52
4665952|NCT02866175|16042707|P1|Overall Study|Withdrawal by Subject|31
4665953|NCT02866175|16042706|P2|Overall Study|Adverse Event|54
4665954|NCT02866175|16042707|P1|Overall Study|Adverse Event|56
4665955|NCT02865915|16042727|P2|Overall Study|Dosing group discontinued|5
4665956|NCT02865915|16042728|P1|Overall Study|Dosing group discontinued|0
4665957|NCT02865915|16042727|P2|Overall Study|Study terminated by sponsor|18
4665958|NCT02865915|16042728|P1|Overall Study|Study terminated by sponsor|23
4665959|NCT02865915|16042727|P2|Overall Study|Protocol Violation|1
4665960|NCT02865915|16042728|P1|Overall Study|Protocol Violation|0
4665961|NCT02865915|16042727|P2|Overall Study|Lost to Follow-up|1
4665962|NCT02865915|16042728|P1|Overall Study|Lost to Follow-up|0
4665963|NCT02865915|16042727|P2|Overall Study|Adverse Event|4
4665964|NCT02865915|16042728|P1|Overall Study|Adverse Event|0
4665965|NCT02865915|16042727|P2|Overall Study|Withdrawal by Subject|1
4665966|NCT02865915|16042728|P1|Overall Study|Withdrawal by Subject|1
4665967|NCT02865915|16042727|P2|Overall Study|Pregnancy|0
4665968|NCT02865915|16042728|P1|Overall Study|Pregnancy|1
4665969|NCT02865499|16042771|P1|Baseline|Withdrawal by Subject|1
4665970|NCT02865499|16042771|P1|Baseline|Adverse Event|1
4665971|NCT02865395|16042778|P3|Overall Study|Physician Decision|7
4665972|NCT02865395|16042779|P2|Overall Study|Physician Decision|10
4665973|NCT02865395|16042780|P1|Overall Study|Physician Decision|6
4665974|NCT02865083|16042806|P2|Overall Study|Early Termination|1
4665975|NCT02865083|16042807|P1|Overall Study|Early Termination|3
4665976|NCT02864394|16042868|P2|Overall Study|Ongoing In Study|53
4665977|NCT02864394|16042869|P1|Overall Study|Ongoing In Study|77
4665978|NCT02864394|16042868|P2|Overall Study|Withdrawal by Subject|9
4665979|NCT02864394|16042869|P1|Overall Study|Withdrawal by Subject|1
4665980|NCT02864394|16042868|P2|Overall Study|Death|150
4665981|NCT02864394|16042869|P1|Overall Study|Death|135
4665982|NCT02864381|16042895|P2|Overall Study|Protocol Violation|1
4665983|NCT02864381|16042896|P1|Overall Study|Protocol Violation|0
4665984|NCT02864381|16042895|P2|Overall Study|Investigator's Discretion|0
4665985|NCT02864381|16042896|P1|Overall Study|Investigator's Discretion|1
4665986|NCT02864381|16042895|P2|Overall Study|Lost to Follow-up|1
4665987|NCT02864381|16042896|P1|Overall Study|Lost to Follow-up|1
4665988|NCT02864381|16042895|P2|Overall Study|Reason Unknown|3
4665989|NCT02864381|16042896|P1|Overall Study|Reason Unknown|7
4665990|NCT02864381|16042895|P2|Overall Study|Withdrew Consent|6
4665991|NCT02864381|16042896|P1|Overall Study|Withdrew Consent|5
4665992|NCT02864381|16042895|P2|Overall Study|Death|61
4665993|NCT02864381|16042896|P1|Overall Study|Death|58
4665994|NCT02864342|16042914|P2|Overall Study|Adverse Event|0
4665995|NCT02864342|16042915|P1|Overall Study|Adverse Event|1
4665996|NCT02864342|16042914|P2|Overall Study|Lost Device|0
4665997|NCT02864342|16042915|P1|Overall Study|Lost Device|1
4665998|NCT02864342|16042914|P2|Overall Study|Lost to Follow-up|5
4665999|NCT02864342|16042915|P1|Overall Study|Lost to Follow-up|1
4666000|NCT02864342|16042914|P2|Overall Study|Did Not Start Treatment with Symbicort|1
4666001|NCT02864342|16042915|P1|Overall Study|Did Not Start Treatment with Symbicort|0
4666002|NCT02864342|16042914|P2|Overall Study|Death|1
4666003|NCT02864342|16042915|P1|Overall Study|Death|0
4666004|NCT02864342|16042914|P2|Overall Study|Device Technology Issue|7
4666005|NCT02864342|16042915|P1|Overall Study|Device Technology Issue|6
4666006|NCT02864342|16042914|P2|Overall Study|Withdrawal by Subject|2
4666007|NCT02864342|16042915|P1|Overall Study|Withdrawal by Subject|4
4666008|NCT02864342|16042914|P2|Overall Study|Eligibility Criteria Deviation|3
4666009|NCT02864342|16042915|P1|Overall Study|Eligibility Criteria Deviation|2
4666010|NCT02864316|16042932|P2|Overall Study|Adverse Event|1
4666011|NCT02864316|16042933|P1|Overall Study|Adverse Event|0
4666012|NCT02864316|16042932|P2|Overall Study|Progressive Disease|1
4666013|NCT02864316|16042933|P1|Overall Study|Progressive Disease|2
4666014|NCT02863575|16042971|P3|Overall Study|Adverse Event|0
4666015|NCT02863575|16042972|P2|Overall Study|Adverse Event|1
4666016|NCT02863575|16042973|P1|Overall Study|Adverse Event|0
4666017|NCT02863575|16042971|P3|Overall Study|Withdrawal by Subject|1
4666018|NCT02863575|16042972|P2|Overall Study|Withdrawal by Subject|1
4666019|NCT02863575|16042973|P1|Overall Study|Withdrawal by Subject|0
4666020|NCT02863575|16042971|P3|Overall Study|Participants Unable To Swallow Capsule|0
4666021|NCT02863575|16042972|P2|Overall Study|Participants Unable To Swallow Capsule|0
4666022|NCT02863575|16042973|P1|Overall Study|Participants Unable To Swallow Capsule|1
4666023|NCT02863419|16043025|P3|Overall Study|Died|1
4666024|NCT02863419|16043026|P2|Overall Study|Died|4
4666025|NCT02863419|16043027|P1|Overall Study|Died|3
4666026|NCT02863419|16043025|P3|Overall Study|Withdrawal by Subject|3
4666027|NCT02863419|16043026|P2|Overall Study|Withdrawal by Subject|5
4666028|NCT02863419|16043027|P1|Overall Study|Withdrawal by Subject|5
4666029|NCT02863419|16043025|P3|Overall Study|Lost to Follow-up|4
4666030|NCT02863419|16043026|P2|Overall Study|Lost to Follow-up|1
4666031|NCT02863419|16043027|P1|Overall Study|Lost to Follow-up|0
4666032|NCT02863328|16043144|P2|Overall Study|Died|1
4666033|NCT02863328|16043145|P1|Overall Study|Died|0
4666034|NCT02863328|16043144|P2|Overall Study|Withdrawal by Subject|12
4666035|NCT02863328|16043145|P1|Overall Study|Withdrawal by Subject|7
4666036|NCT02863328|16043144|P2|Overall Study|Lost to Follow-up|10
4666037|NCT02863328|16043145|P1|Overall Study|Lost to Follow-up|4
4666038|NCT02862730|16043300|P7|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4666039|NCT02862730|16043301|P6|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4666040|NCT02862730|16043302|P5|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4666041|NCT02862730|16043303|P4|Third Intervention (84 Hours)|diagnosis of gastroparesis|1
4666042|NCT02862730|16043304|P3|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4666043|NCT02862730|16043305|P2|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4666044|NCT02862730|16043306|P1|Third Intervention (84 Hours)|diagnosis of gastroparesis|0
4666045|NCT02862730|16043300|P7|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4666046|NCT02862730|16043301|P6|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4666047|NCT02862730|16043302|P5|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
4666048|NCT02862730|16043303|P4|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4666049|NCT02862730|16043304|P3|Third Rest Period (7-45 Days)|Withdrawal by Subject|1
4666050|NCT02862730|16043305|P2|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4666051|NCT02862730|16043306|P1|Third Rest Period (7-45 Days)|Withdrawal by Subject|0
4666052|NCT02862730|16043300|P7|Second Intervention (84 Hours)|Withdrawal by Subject|0
4666053|NCT02862730|16043301|P6|Second Intervention (84 Hours)|Withdrawal by Subject|0
4666054|NCT02862730|16043302|P5|Second Intervention (84 Hours)|Withdrawal by Subject|0
4666055|NCT02862730|16043303|P4|Second Intervention (84 Hours)|Withdrawal by Subject|0
4666056|NCT02862730|16043304|P3|Second Intervention (84 Hours)|Withdrawal by Subject|0
4666057|NCT02862730|16043305|P2|Second Intervention (84 Hours)|Withdrawal by Subject|0
4666058|NCT02862730|16043306|P1|Second Intervention (84 Hours)|Withdrawal by Subject|1
4666059|NCT02862730|16043300|P7|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4666060|NCT02862730|16043301|P6|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4666061|NCT02862730|16043302|P5|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4666062|NCT02862730|16043303|P4|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4666063|NCT02862730|16043304|P3|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1
4666064|NCT02862730|16043305|P2|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4666065|NCT02862730|16043306|P1|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0
4666066|NCT02862600|16043361|P1|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7
4666067|NCT02862600|16043361|P1|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1
4666068|NCT02862600|16043361|P1|Period 1--Perhexiline-low Target Range|Protocol Violation|3
4666069|NCT02862600|16043361|P1|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9
4666070|NCT02862574|16043371|P3|Open-Label Treatment Period|Study Terminated by Sponsor|1
4666071|NCT02862574|16043372|P2|Open-Label Treatment Period|Study Terminated by Sponsor|3
4666072|NCT02862574|16043373|P1|Open-Label Treatment Period|Study Terminated by Sponsor|2
4666073|NCT02862574|16043371|P3|Double-Blind Treatment Period|Study Terminated by Sponsor|4
4666074|NCT02862574|16043372|P2|Double-Blind Treatment Period|Study Terminated by Sponsor|1
4666075|NCT02862574|16043373|P1|Double-Blind Treatment Period|Study Terminated by Sponsor|3
4666076|NCT02862574|16043371|P3|Double-Blind Treatment Period|Adverse Event|0
4666077|NCT02862574|16043372|P2|Double-Blind Treatment Period|Adverse Event|1
4666078|NCT02862574|16043373|P1|Double-Blind Treatment Period|Adverse Event|0
4666079|NCT02862548|16043393|P2|Open-Label Extension Phase|Still on Study|24
4666080|NCT02862548|16043394|P1|Open-Label Extension Phase|Still on Study|26
4666081|NCT02862548|16043393|P2|Open-Label Phase|Death|1
4666082|NCT02862548|16043394|P1|Open-Label Phase|Death|0
4666083|NCT02862106|16043424|P2|Overall Study|Subjects moved to other city|0
4666084|NCT02862106|16043425|P1|Overall Study|Subjects moved to other city|1
4666085|NCT02862106|16043424|P2|Overall Study|Withdrawal by Subject|0
4666086|NCT02862106|16043425|P1|Overall Study|Withdrawal by Subject|2
4666087|NCT02862106|16043424|P2|Overall Study|Lost to Follow-up|5
4666088|NCT02862106|16043425|P1|Overall Study|Lost to Follow-up|15
4666089|NCT02862106|16043424|P2|Overall Study|Protocol Violation|1
4666090|NCT02862106|16043425|P1|Overall Study|Protocol Violation|16
4666091|NCT02862106|16043424|P2|Overall Study|Adverse Event|0
4666092|NCT02862106|16043425|P1|Overall Study|Adverse Event|4
4666093|NCT02861807|16043510|P2|Overall Study|Withdrawal by Subject|8
4666094|NCT02861807|16043511|P1|Overall Study|Withdrawal by Subject|5
4666095|NCT02861807|16043510|P2|Overall Study|Lost to Follow-up|6
4666096|NCT02861807|16043511|P1|Overall Study|Lost to Follow-up|7
4666097|NCT02861664|16043527|P2|Overall Study|Withdrawal of Consent|1
4666098|NCT02861664|16043528|P1|Overall Study|Withdrawal of Consent|0
4666099|NCT02861534|16043540|P2|Overall Study|Withdrawal by Subject|18
4666100|NCT02861534|16043541|P1|Overall Study|Withdrawal by Subject|15
4666101|NCT02861534|16043540|P2|Overall Study|Site Terminated by Sponsor|3
4666102|NCT02861534|16043541|P1|Overall Study|Site Terminated by Sponsor|4
4666103|NCT02861534|16043540|P2|Overall Study|Lost to Follow-up|14
4666104|NCT02861534|16043541|P1|Overall Study|Lost to Follow-up|14
4666105|NCT02861534|16043540|P2|Overall Study|Death|552
4666106|NCT02861534|16043541|P1|Overall Study|Death|541
4666107|NCT02860169|16043629|P1|Part C|Other (Screening failure)|1
4666108|NCT02860169|16043629|P1|Part B|Withdrawal by Subject|1
4666109|NCT02860169|16043629|P1|Part B|Other (Screening failure)|10
4666110|NCT02860169|16043629|P1|Part A|Other (did not completed consent)|1
4666111|NCT02860169|16043629|P1|Part A|Other (Survey not completed)|3
4666112|NCT02860169|16043629|P1|Part A|Other (Screening failure)|6
4666113|NCT02860169|16043629|P1|Part A|Withdrawal by Subject|1
4666114|NCT02859454|16043658|P1|Overall Study|PI discretion/off study prior to trtmt|1
4666115|NCT02859246|16043714|P1|Overall Study|Withdrawal by Subject|1
4666116|NCT02859246|16043714|P1|Overall Study|Adverse Event|1
4666117|NCT02859246|16043714|P1|Overall Study|Screen fails|3
4666118|NCT02858726|16043723|P4|Overall Study|Noncompliance|0
4666119|NCT02858726|16043724|P3|Overall Study|Noncompliance|0
4666120|NCT02858726|16043725|P2|Overall Study|Noncompliance|1
4666121|NCT02858726|16043726|P1|Overall Study|Noncompliance|0
4666122|NCT02858726|16043723|P4|Overall Study|Withdrawal by Subject|0
4666123|NCT02858726|16043724|P3|Overall Study|Withdrawal by Subject|1
4666124|NCT02858726|16043725|P2|Overall Study|Withdrawal by Subject|2
4666125|NCT02858726|16043726|P1|Overall Study|Withdrawal by Subject|1
4666126|NCT02858726|16043723|P4|Overall Study|Study Terminated by Sponsor|1
4666127|NCT02858726|16043724|P3|Overall Study|Study Terminated by Sponsor|0
4666128|NCT02858726|16043725|P2|Overall Study|Study Terminated by Sponsor|0
4666129|NCT02858726|16043726|P1|Overall Study|Study Terminated by Sponsor|0
4666130|NCT02858726|16043723|P4|Overall Study|Protocol Violation|1
4666131|NCT02858726|16043724|P3|Overall Study|Protocol Violation|0
4666132|NCT02858726|16043725|P2|Overall Study|Protocol Violation|0
4666133|NCT02858726|16043726|P1|Overall Study|Protocol Violation|0
4666134|NCT02858726|16043723|P4|Overall Study|Physician Decision|0
4666135|NCT02858726|16043724|P3|Overall Study|Physician Decision|1
4666136|NCT02858726|16043725|P2|Overall Study|Physician Decision|0
4666137|NCT02858726|16043726|P1|Overall Study|Physician Decision|0
4666138|NCT02858726|16043723|P4|Overall Study|Adverse Event|1
4666139|NCT02858726|16043724|P3|Overall Study|Adverse Event|9
4666140|NCT02858726|16043725|P2|Overall Study|Adverse Event|4
4666141|NCT02858726|16043726|P1|Overall Study|Adverse Event|4
4666142|NCT02858492|16043757|P4|Overall Study|Protocol defined stopping criteria|1
4666143|NCT02858492|16043758|P3|Overall Study|Protocol defined stopping criteria|0
4666144|NCT02858492|16043759|P2|Overall Study|Protocol defined stopping criteria|0
4666145|NCT02858492|16043760|P1|Overall Study|Protocol defined stopping criteria|0
4666146|NCT02858492|16043757|P4|Overall Study|Lack of Efficacy|1
4666147|NCT02858492|16043758|P3|Overall Study|Lack of Efficacy|0
4666148|NCT02858492|16043759|P2|Overall Study|Lack of Efficacy|0
4666149|NCT02858492|16043760|P1|Overall Study|Lack of Efficacy|0
4666150|NCT02858492|16043757|P4|Overall Study|Adverse Event|3
4666151|NCT02858492|16043758|P3|Overall Study|Adverse Event|0
4666152|NCT02858492|16043759|P2|Overall Study|Adverse Event|0
4666153|NCT02858492|16043760|P1|Overall Study|Adverse Event|0
4666154|NCT02858492|16043757|P4|Overall Study|Withdrawal by Subject|1
4666155|NCT02858492|16043758|P3|Overall Study|Withdrawal by Subject|0
4666156|NCT02858492|16043759|P2|Overall Study|Withdrawal by Subject|1
4666157|NCT02858492|16043760|P1|Overall Study|Withdrawal by Subject|0
4666158|NCT02858440|16043936|P1|Overall Study|Migrated/moved from study area|4
4666159|NCT02858440|16043936|P1|Overall Study|Consent withdrawal|3
4666160|NCT02858440|16043936|P1|Overall Study|Protocol Violation|2
4666161|NCT02858440|16043936|P1|Overall Study|Lost to Follow-up|3
4666162|NCT02858401|16043969|P7|Overall Study|Lost to Follow-up|0
4666163|NCT02858401|16043970|P6|Overall Study|Lost to Follow-up|0
4666164|NCT02858401|16043971|P5|Overall Study|Lost to Follow-up|0
4666165|NCT02858401|16043972|P4|Overall Study|Lost to Follow-up|0
4666166|NCT02858401|16043973|P3|Overall Study|Lost to Follow-up|0
4666167|NCT02858401|16043974|P2|Overall Study|Lost to Follow-up|1
4666168|NCT02858401|16043975|P1|Overall Study|Lost to Follow-up|0
4666169|NCT02858401|16043969|P7|Overall Study|Withdrew Consent|0
4666170|NCT02858401|16043970|P6|Overall Study|Withdrew Consent|1
4666171|NCT02858401|16043971|P5|Overall Study|Withdrew Consent|0
4666172|NCT02858401|16043972|P4|Overall Study|Withdrew Consent|0
4666173|NCT02858401|16043973|P3|Overall Study|Withdrew Consent|0
4666174|NCT02858401|16043974|P2|Overall Study|Withdrew Consent|0
4666175|NCT02858401|16043975|P1|Overall Study|Withdrew Consent|0
4666176|NCT02858362|16044386|P3|Overall Study|Lost to Follow-up|0
4666177|NCT02858362|16044387|P2|Overall Study|Lost to Follow-up|0
4666178|NCT02858362|16044388|P1|Overall Study|Lost to Follow-up|1
4666179|NCT02858362|16044386|P3|Overall Study|Early Study Termination|3
4666180|NCT02858362|16044387|P2|Overall Study|Early Study Termination|0
4666181|NCT02858362|16044388|P1|Overall Study|Early Study Termination|0
4666182|NCT02858362|16044386|P3|Overall Study|Withdrawal by Subject|0
4666183|NCT02858362|16044387|P2|Overall Study|Withdrawal by Subject|0
4666184|NCT02858362|16044388|P1|Overall Study|Withdrawal by Subject|1
4666185|NCT02858362|16044386|P3|Overall Study|Protocol Violation|0
4666186|NCT02858362|16044387|P2|Overall Study|Protocol Violation|1
4666187|NCT02858362|16044388|P1|Overall Study|Protocol Violation|0
4666188|NCT02858180|16044429|P2|Overall Study|Lost to Follow-up|2
4666189|NCT02858180|16044430|P1|Overall Study|Lost to Follow-up|0
4666190|NCT02857816|16044451|P1|Overall Study|Lost to Follow-up|1
4666191|NCT02857816|16044451|P1|Overall Study|Withdrawal by Subject|4
4666192|NCT02857816|16044451|P1|Overall Study|Screen Failure|33
4666193|NCT02857426|16044459|P2|Follow-up|other reason|0
4666194|NCT02857426|16044460|P1|Follow-up|other reason|1
4666195|NCT02857426|16044459|P2|Follow-up|Participant withdrew consent|4
4666196|NCT02857426|16044460|P1|Follow-up|Participant withdrew consent|3
4666197|NCT02857426|16044459|P2|Follow-up|Death|2
4666198|NCT02857426|16044460|P1|Follow-up|Death|6
4666199|NCT02857426|16044459|P2|Treatment|Maximum clinical benefit|0
4666200|NCT02857426|16044460|P1|Treatment|Maximum clinical benefit|1
4666201|NCT02857426|16044459|P2|Treatment|Participant withdrew consent|1
4666202|NCT02857426|16044460|P1|Treatment|Participant withdrew consent|1
4666203|NCT02857426|16044459|P2|Treatment|Adverse event unrelated to study drug|2
4666204|NCT02857426|16044460|P1|Treatment|Adverse event unrelated to study drug|6
4666205|NCT02857426|16044459|P2|Treatment|Death|0
4666206|NCT02857426|16044460|P1|Treatment|Death|1
4666207|NCT02857426|16044459|P2|Treatment|Study drug toxicity|1
4666208|NCT02857426|16044460|P1|Treatment|Study drug toxicity|4
4666209|NCT02857426|16044459|P2|Treatment|Disease progression|13
4666210|NCT02857426|16044460|P1|Treatment|Disease progression|33
4666211|NCT02857283|16044476|P2|First Exposure|Withdrawal by Subject|0
4666212|NCT02857283|16044477|P1|First Exposure|Withdrawal by Subject|1
4666213|NCT02856880|16044511|P1|Overall Study|Withdrawal of consent|1
4666214|NCT02856555|16044555|P3|Overall Study|Randomized but Never Treated|0
4666215|NCT02856555|16044556|P2|Overall Study|Randomized but Never Treated|1
4666216|NCT02856555|16044557|P1|Overall Study|Randomized but Never Treated|0
4666217|NCT02856555|16044555|P3|Overall Study|Withdrawal by Subject|0
4666218|NCT02856555|16044556|P2|Overall Study|Withdrawal by Subject|0
4666219|NCT02856555|16044557|P1|Overall Study|Withdrawal by Subject|3
4666220|NCT02856555|16044555|P3|Overall Study|Lost to Follow-up|0
4666221|NCT02856555|16044556|P2|Overall Study|Lost to Follow-up|3
4666222|NCT02856555|16044557|P1|Overall Study|Lost to Follow-up|1
4666223|NCT02856555|16044555|P3|Overall Study|Adverse Event|0
4666224|NCT02856555|16044556|P2|Overall Study|Adverse Event|0
4666225|NCT02856555|16044557|P1|Overall Study|Adverse Event|1
4666226|NCT02856282|16044565|P1|Overall Study|Withdrawal by Subject|1
4666227|NCT02855541|16044597|P1|Overall Study|Withdrawal by Subject|2
4666228|NCT02855541|16044597|P1|Overall Study|Change in health status|2
4666229|NCT02855411|16044617|P1|Overall Study|Does not meet entrance criteria|14
4666230|NCT02855411|16044617|P1|Overall Study|Study terminated by sponsor|21
4666231|NCT02855359|16044639|P4|Overall Study|Study Termination by Sponsor|0
4666232|NCT02855359|16044640|P3|Overall Study|Study Termination by Sponsor|0
4666233|NCT02855359|16044641|P2|Overall Study|Study Termination by Sponsor|11
4666234|NCT02855359|16044642|P1|Overall Study|Study Termination by Sponsor|9
4666235|NCT02855359|16044639|P4|Overall Study|Death|0
4666236|NCT02855359|16044640|P3|Overall Study|Death|0
4666237|NCT02855359|16044641|P2|Overall Study|Death|2
4666238|NCT02855359|16044642|P1|Overall Study|Death|2
4666239|NCT02854800|16044688|P3|Overall Study|Withdrawal by Subject|3
4666240|NCT02854800|16044689|P2|Overall Study|Withdrawal by Subject|2
4666241|NCT02854800|16044690|P1|Overall Study|Withdrawal by Subject|4
4666242|NCT02854800|16044688|P3|Overall Study|Protocol Violation|3
4666243|NCT02854800|16044689|P2|Overall Study|Protocol Violation|11
4666244|NCT02854800|16044690|P1|Overall Study|Protocol Violation|16
4666245|NCT02854631|16044730|P2|Overall Study|Lost to Follow-up|2
4666246|NCT02854631|16044731|P1|Overall Study|Lost to Follow-up|4
4666247|NCT02854631|16044730|P2|Overall Study|Subjects Randomized but Never Treated|0
4666248|NCT02854631|16044731|P1|Overall Study|Subjects Randomized but Never Treated|2
4666249|NCT02854631|16044730|P2|Overall Study|Protocol Violation|1
4666250|NCT02854631|16044731|P1|Overall Study|Protocol Violation|0
4666251|NCT02854631|16044730|P2|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0
4666252|NCT02854631|16044731|P1|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2
4666253|NCT02854631|16044730|P2|Overall Study|Death|8
4666254|NCT02854631|16044731|P1|Overall Study|Death|12
4666255|NCT02854631|16044730|P2|Overall Study|Investigator's Discretion|0
4666256|NCT02854631|16044731|P1|Overall Study|Investigator's Discretion|2
4666257|NCT02854631|16044730|P2|Overall Study|Withdrew Consent|2
4666258|NCT02854631|16044731|P1|Overall Study|Withdrew Consent|3
4666259|NCT02854631|16044730|P2|Overall Study|Adverse Event|2
4666260|NCT02854631|16044731|P1|Overall Study|Adverse Event|1
4666261|NCT02854605|16044792|P3|Overall Study|Protocol Violation|1
4666262|NCT02854605|16044793|P2|Overall Study|Protocol Violation|0
4666263|NCT02854605|16044794|P1|Overall Study|Protocol Violation|0
4666264|NCT02854605|16044792|P3|Overall Study|Investigator's Discretion|0
4666265|NCT02854605|16044793|P2|Overall Study|Investigator's Discretion|0
4666266|NCT02854605|16044794|P1|Overall Study|Investigator's Discretion|1
4666267|NCT02854605|16044792|P3|Overall Study|Withdrew Consent|1
4666268|NCT02854605|16044793|P2|Overall Study|Withdrew Consent|0
4666269|NCT02854605|16044794|P1|Overall Study|Withdrew Consent|1
4666270|NCT02854605|16044792|P3|Overall Study|Lost to Follow-up|0
4666271|NCT02854605|16044793|P2|Overall Study|Lost to Follow-up|2
4666272|NCT02854605|16044794|P1|Overall Study|Lost to Follow-up|0
4666273|NCT02854605|16044792|P3|Overall Study|Adverse Event|2
4666274|NCT02854605|16044793|P2|Overall Study|Adverse Event|5
4666275|NCT02854605|16044794|P1|Overall Study|Adverse Event|1
4666276|NCT02854527|16044824|P10|Overall Study|Lost to Follow-up|0
4666277|NCT02854527|16044825|P9|Overall Study|Lost to Follow-up|0
4666278|NCT02854527|16044826|P8|Overall Study|Lost to Follow-up|0
4666279|NCT02854527|16044827|P7|Overall Study|Lost to Follow-up|0
4666280|NCT02854527|16044828|P6|Overall Study|Lost to Follow-up|0
4666281|NCT02854527|16044829|P5|Overall Study|Lost to Follow-up|0
4666282|NCT02854527|16044830|P4|Overall Study|Lost to Follow-up|1
4666283|NCT02854527|16044831|P3|Overall Study|Lost to Follow-up|0
4666284|NCT02854527|16044832|P2|Overall Study|Lost to Follow-up|0
4666285|NCT02854527|16044833|P1|Overall Study|Lost to Follow-up|0
4666286|NCT02854527|16044824|P10|Overall Study|Adverse Event|0
4666287|NCT02854527|16044825|P9|Overall Study|Adverse Event|0
4666288|NCT02854527|16044826|P8|Overall Study|Adverse Event|0
4666289|NCT02854527|16044827|P7|Overall Study|Adverse Event|0
4666290|NCT02854527|16044828|P6|Overall Study|Adverse Event|0
4666291|NCT02854527|16044829|P5|Overall Study|Adverse Event|1
4666292|NCT02854527|16044830|P4|Overall Study|Adverse Event|0
4666293|NCT02854527|16044831|P3|Overall Study|Adverse Event|0
4666294|NCT02854527|16044832|P2|Overall Study|Adverse Event|0
4666295|NCT02854527|16044833|P1|Overall Study|Adverse Event|0
4666296|NCT02853929|16044891|P2|Overall Study|Subjects enrolled but not vaccinated|4
4666297|NCT02853929|16044892|P1|Overall Study|Subjects enrolled but not vaccinated|7
4666298|NCT02853929|16044891|P2|Overall Study|Withdrawal by Subject|0
4666299|NCT02853929|16044892|P1|Overall Study|Withdrawal by Subject|1
4666300|NCT02853929|16044891|P2|Overall Study|Lost to Follow-up|0
4666301|NCT02853929|16044892|P1|Overall Study|Lost to Follow-up|3
4666302|NCT02853435|16044933|P6|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4666303|NCT02853435|16044934|P5|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1
4666304|NCT02853435|16044935|P4|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4666305|NCT02853435|16044936|P3|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4666306|NCT02853435|16044937|P2|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4666307|NCT02853435|16044938|P1|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0
4666308|NCT02853331|16045248|P2|Overall Study|Ongoing in study|325
4666309|NCT02853331|16045249|P1|Overall Study|Ongoing in study|368
4666310|NCT02853331|16045248|P2|Overall Study|Withdrawal by Subject|9
4666311|NCT02853331|16045249|P1|Overall Study|Withdrawal by Subject|5
4666312|NCT02853331|16045248|P2|Overall Study|Death|95
4666313|NCT02853331|16045249|P1|Overall Study|Death|59
4666314|NCT02853123|16045281|P2|Washout Period|Adverse Event|0
4666315|NCT02853123|16045282|P1|Washout Period|Adverse Event|1
4666316|NCT02853123|16045281|P2|Washout Period|Worsening of COPD|3
4666317|NCT02853123|16045282|P1|Washout Period|Worsening of COPD|0
4666318|NCT02853123|16045281|P2|Treatment Period 1|Adverse Event|3
4666319|NCT02853123|16045282|P1|Treatment Period 1|Adverse Event|0
4666320|NCT02852434|16045305|P2|Overall Study|Unsuccessful Dilator Procedure|0
4666321|NCT02852434|16045306|P1|Overall Study|Unsuccessful Dilator Procedure|2
4666322|NCT02852434|16045305|P2|Overall Study|Withdrawal by Subject|1
4666323|NCT02852434|16045306|P1|Overall Study|Withdrawal by Subject|0
4666324|NCT02852265|16045322|P2|3-month Follow-up|Lost to Follow-up|1
4666325|NCT02852265|16045323|P1|3-month Follow-up|Lost to Follow-up|1
4666326|NCT02851069|16045356|P1|Overall Study|Other|3
4666327|NCT02851069|16045356|P1|Overall Study|Failure to Return|3
4666328|NCT02850978|16045378|P1|Overall Study|Reason not listed|88
4666329|NCT02850978|16045378|P1|Overall Study|Lost to Follow-up|121
4666330|NCT02850978|16045378|P1|Overall Study|Improvement in condition|34
4666331|NCT02850978|16045378|P1|Overall Study|Lack of Efficacy|40
4666332|NCT02850978|16045378|P1|Overall Study|Adverse Event|81
4666333|NCT02850978|16045378|P1|Overall Study|No visit since the first visit|35
4666334|NCT02850978|16045378|P1|Overall Study|Uncollectable CRF|27
4666335|NCT02850965|16045385|P2|Overall Study|Randomized but not treated|1
4666336|NCT02850965|16045386|P1|Overall Study|Randomized but not treated|0
4666337|NCT02850965|16045385|P2|Overall Study|Physician Decision|1
4666338|NCT02850965|16045386|P1|Overall Study|Physician Decision|0
4666339|NCT02850965|16045385|P2|Overall Study|Withdrawal by Subject|4
4666340|NCT02850965|16045386|P1|Overall Study|Withdrawal by Subject|3
4666341|NCT02850965|16045385|P2|Overall Study|Adverse Event|2
4666342|NCT02850965|16045386|P1|Overall Study|Adverse Event|3
4666343|NCT02850965|16045385|P2|Overall Study|Lack of Efficacy|8
4666344|NCT02850965|16045386|P1|Overall Study|Lack of Efficacy|4
4666345|NCT02850965|16045385|P2|Overall Study|Lost to Follow-up|3
4666346|NCT02850965|16045386|P1|Overall Study|Lost to Follow-up|5
4666347|NCT02850965|16045385|P2|Overall Study|Protocol Violation|2
4666348|NCT02850965|16045386|P1|Overall Study|Protocol Violation|0
4666349|NCT02850965|16045385|P2|Overall Study|Other than listed|4
4666350|NCT02850965|16045386|P1|Overall Study|Other than listed|3
4666351|NCT02850276|16045402|P1|Overall Study|Lost to Follow-up|2
4666352|NCT02850276|16045402|P1|Overall Study|Physician Decision|2
4666353|NCT02850276|16045402|P1|Overall Study|Withdrawal by Subject|14
4666354|NCT02850276|16045402|P1|Overall Study|screen failure|43
4666355|NCT02849990|16045429|P1|Overall Study|Withdrawal by Subject|1
4666356|NCT02849990|16045429|P1|Overall Study|Adverse Event|1
4666357|NCT02849704|16045454|P2|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0
4666358|NCT02849704|16045455|P1|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1
4666359|NCT02849704|16045454|P2|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0
4666360|NCT02849704|16045455|P1|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1
4666361|NCT02849704|16045454|P2|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0
4666362|NCT02849704|16045455|P1|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1
4666363|NCT02849678|16045470|P2|Overall Study|Protocol Violation|6
4666364|NCT02849678|16045471|P1|Overall Study|Protocol Violation|3
4666365|NCT02849626|16045491|P2|Extension Phase A (up to 29 Weeks)|Non-specified|0
4666366|NCT02849626|16045492|P1|Extension Phase A (up to 29 Weeks)|Non-specified|1
4666367|NCT02849626|16045491|P2|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|1
4666368|NCT02849626|16045492|P1|Extension Phase A (up to 29 Weeks)|Inadequate therapeutic effect|3
4666369|NCT02849626|16045491|P2|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0
4666370|NCT02849626|16045492|P1|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4
4666371|NCT02849626|16045491|P2|Extension Phase A (up to 29 Weeks)|Adverse Event|2
4666372|NCT02849626|16045492|P1|Extension Phase A (up to 29 Weeks)|Adverse Event|3
4666373|NCT02849626|16045491|P2|Core Phase (up to 23 Weeks)|Non-specified|0
4666374|NCT02849626|16045492|P1|Core Phase (up to 23 Weeks)|Non-specified|3
4666375|NCT02849626|16045491|P2|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2
4666376|NCT02849626|16045492|P1|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6
4666377|NCT02849626|16045491|P2|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2
4666378|NCT02849626|16045492|P1|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7
4666379|NCT02849626|16045491|P2|Core Phase (up to 23 Weeks)|Adverse Event|3
4666380|NCT02849626|16045492|P1|Core Phase (up to 23 Weeks)|Adverse Event|11
4666381|NCT02849509|16045555|P3|Overall Study|No inform. on termination of Pradaxa/VKA|1
4666382|NCT02849509|16045556|P2|Overall Study|No inform. on termination of Pradaxa/VKA|10
4666383|NCT02849509|16045557|P1|Overall Study|No inform. on termination of Pradaxa/VKA|6
4666384|NCT02849509|16045555|P3|Overall Study|Other, reason not specified|25
4666385|NCT02849509|16045556|P2|Overall Study|Other, reason not specified|29
4666386|NCT02849509|16045557|P1|Overall Study|Other, reason not specified|14
4666387|NCT02849509|16045555|P3|Overall Study|Lost to Follow-up|36
4666388|NCT02849509|16045556|P2|Overall Study|Lost to Follow-up|67
4666389|NCT02849509|16045557|P1|Overall Study|Lost to Follow-up|27
4666390|NCT02849509|16045555|P3|Overall Study|Withdrawal by Subject|12
4666391|NCT02849509|16045556|P2|Overall Study|Withdrawal by Subject|17
4666392|NCT02849509|16045557|P1|Overall Study|Withdrawal by Subject|6
4666393|NCT02849509|16045555|P3|Overall Study|Other adverse event|8
4666394|NCT02849509|16045556|P2|Overall Study|Other adverse event|41
4666395|NCT02849509|16045557|P1|Overall Study|Other adverse event|36
4666478|NCT02848326|16045973|P5|Treatment Period|Withdrawal of Consent|9
4666396|NCT02849509|16045555|P3|Overall Study|Worsening of other pre-existing disease|2
4666397|NCT02849509|16045556|P2|Overall Study|Worsening of other pre-existing disease|1
4666398|NCT02849509|16045557|P1|Overall Study|Worsening of other pre-existing disease|0
4666399|NCT02849509|16045555|P3|Overall Study|Worsening of disease under study|1
4666400|NCT02849509|16045556|P2|Overall Study|Worsening of disease under study|1
4666401|NCT02849509|16045557|P1|Overall Study|Worsening of disease under study|1
4666402|NCT02849080|16045764|P4|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
4666403|NCT02849080|16045765|P3|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
4666404|NCT02849080|16045766|P2|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0
4666405|NCT02849080|16045767|P1|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1
4666406|NCT02849080|16045764|P4|Extension Phase: 53 - 104 Weeks|Other|0
4666407|NCT02849080|16045765|P3|Extension Phase: 53 - 104 Weeks|Other|1
4666408|NCT02849080|16045766|P2|Extension Phase: 53 - 104 Weeks|Other|0
4666409|NCT02849080|16045767|P1|Extension Phase: 53 - 104 Weeks|Other|0
4666410|NCT02849080|16045764|P4|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
4666411|NCT02849080|16045765|P3|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
4666412|NCT02849080|16045766|P2|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0
4666413|NCT02849080|16045767|P1|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2
4666414|NCT02849080|16045764|P4|Main Phase: 0 - 52 Weeks|Death|0
4666415|NCT02849080|16045765|P3|Main Phase: 0 - 52 Weeks|Death|0
4666416|NCT02849080|16045766|P2|Main Phase: 0 - 52 Weeks|Death|2
4666417|NCT02849080|16045767|P1|Main Phase: 0 - 52 Weeks|Death|0
4666418|NCT02849080|16045764|P4|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
4666419|NCT02849080|16045765|P3|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0
4666420|NCT02849080|16045766|P2|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1
4666421|NCT02849080|16045767|P1|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5
4666422|NCT02849080|16045764|P4|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
4666423|NCT02849080|16045765|P3|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0
4666424|NCT02849080|16045766|P2|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4
4666425|NCT02849080|16045767|P1|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7
4666426|NCT02848729|16045894|P2|Overall Study|Emesis|11
4666427|NCT02848729|16045895|P1|Overall Study|Emesis|15
4666428|NCT02848729|16045894|P2|Overall Study|Withdrawal by Subject|0
4666429|NCT02848729|16045895|P1|Overall Study|Withdrawal by Subject|1
4666430|NCT02848664|16045912|P1|Overall Study|no assistance for device training|1
4666431|NCT02848664|16045912|P1|Overall Study|Adverse Event|1
4666432|NCT02848664|16045912|P1|Overall Study|Withdrawal by Subject|2
4666433|NCT02848651|16045920|P1|Overall Study|Withdrawal by Subject|14
4666434|NCT02848651|16045920|P1|Overall Study|Physician Decision|4
4666435|NCT02848651|16045920|P1|Overall Study|Symptomatic Deterioration|1
4666436|NCT02848651|16045920|P1|Overall Study|Non-Compliance|1
4666437|NCT02848651|16045920|P1|Overall Study|Lost to Follow-up|1
4666438|NCT02848651|16045920|P1|Overall Study|Death|85
4666439|NCT02848599|16045949|P2|Overall Study|Protocol Violation|9
4666440|NCT02848599|16045950|P1|Overall Study|Protocol Violation|7
4666441|NCT02848326|16045972|P6|Safety Follow-up Period|Lost to Follow-up|3
4666442|NCT02848326|16045973|P5|Safety Follow-up Period|Lost to Follow-up|1
4666443|NCT02848326|16045974|P4|Safety Follow-up Period|Lost to Follow-up|0
4666444|NCT02848326|16045975|P3|Safety Follow-up Period|Lost to Follow-up|2
4666445|NCT02848326|16045976|P2|Safety Follow-up Period|Lost to Follow-up|0
4666446|NCT02848326|16045977|P1|Safety Follow-up Period|Lost to Follow-up|4
4666447|NCT02848326|16045972|P6|Safety Follow-up Period|Withdrawal of Consent|2
4666448|NCT02848326|16045973|P5|Safety Follow-up Period|Withdrawal of Consent|0
4666449|NCT02848326|16045974|P4|Safety Follow-up Period|Withdrawal of Consent|0
4666450|NCT02848326|16045975|P3|Safety Follow-up Period|Withdrawal of Consent|1
4666451|NCT02848326|16045976|P2|Safety Follow-up Period|Withdrawal of Consent|1
4666452|NCT02848326|16045977|P1|Safety Follow-up Period|Withdrawal of Consent|0
4666453|NCT02848326|16045972|P6|Treatment Period|Non-compliance with Study Drug|0
4666454|NCT02848326|16045973|P5|Treatment Period|Non-compliance with Study Drug|0
4666455|NCT02848326|16045974|P4|Treatment Period|Non-compliance with Study Drug|1
4666456|NCT02848326|16045975|P3|Treatment Period|Non-compliance with Study Drug|0
4666457|NCT02848326|16045976|P2|Treatment Period|Non-compliance with Study Drug|0
4666458|NCT02848326|16045977|P1|Treatment Period|Non-compliance with Study Drug|4
4666459|NCT02848326|16045972|P6|Treatment Period|Protocol Violation|3
4666460|NCT02848326|16045973|P5|Treatment Period|Protocol Violation|3
4666461|NCT02848326|16045974|P4|Treatment Period|Protocol Violation|2
4666462|NCT02848326|16045975|P3|Treatment Period|Protocol Violation|4
4666463|NCT02848326|16045976|P2|Treatment Period|Protocol Violation|3
4666464|NCT02848326|16045977|P1|Treatment Period|Protocol Violation|4
4666465|NCT02848326|16045972|P6|Treatment Period|Pregnancy|1
4666466|NCT02848326|16045973|P5|Treatment Period|Pregnancy|0
4666467|NCT02848326|16045974|P4|Treatment Period|Pregnancy|1
4666468|NCT02848326|16045975|P3|Treatment Period|Pregnancy|1
4666469|NCT02848326|16045976|P2|Treatment Period|Pregnancy|0
4666470|NCT02848326|16045977|P1|Treatment Period|Pregnancy|0
4666471|NCT02848326|16045972|P6|Treatment Period|Lost to Follow-up|3
4666472|NCT02848326|16045973|P5|Treatment Period|Lost to Follow-up|2
4666473|NCT02848326|16045974|P4|Treatment Period|Lost to Follow-up|7
4666474|NCT02848326|16045975|P3|Treatment Period|Lost to Follow-up|11
4666475|NCT02848326|16045976|P2|Treatment Period|Lost to Follow-up|1
4666476|NCT02848326|16045977|P1|Treatment Period|Lost to Follow-up|5
4666477|NCT02848326|16045972|P6|Treatment Period|Withdrawal of Consent|6
4666479|NCT02848326|16045974|P4|Treatment Period|Withdrawal of Consent|6
4666480|NCT02848326|16045975|P3|Treatment Period|Withdrawal of Consent|9
4666481|NCT02848326|16045976|P2|Treatment Period|Withdrawal of Consent|6
4666482|NCT02848326|16045977|P1|Treatment Period|Withdrawal of Consent|20
4666483|NCT02848326|16045972|P6|Treatment Period|Adverse Event|7
4666484|NCT02848326|16045973|P5|Treatment Period|Adverse Event|5
4666485|NCT02848326|16045974|P4|Treatment Period|Adverse Event|6
4666486|NCT02848326|16045975|P3|Treatment Period|Adverse Event|11
4666487|NCT02848326|16045976|P2|Treatment Period|Adverse Event|4
4666488|NCT02848326|16045977|P1|Treatment Period|Adverse Event|5
4666489|NCT02848313|16046011|P2|Overall Study|Lost to follow up|0
4666490|NCT02848313|16046012|P1|Overall Study|Lost to follow up|1
4666491|NCT02848313|16046011|P2|Overall Study|Withdrawal by Subject|1
4666492|NCT02848313|16046012|P1|Overall Study|Withdrawal by Subject|1
4666493|NCT02848313|16046011|P2|Overall Study|Lack of Efficacy|1
4666494|NCT02848313|16046012|P1|Overall Study|Lack of Efficacy|0
4666495|NCT02848313|16046011|P2|Overall Study|Adverse Event|2
4666496|NCT02848313|16046012|P1|Overall Study|Adverse Event|1
4666497|NCT02847858|16046059|P2|Overall Study|Lost to Follow-up|269
4666498|NCT02847858|16046060|P1|Overall Study|Lost to Follow-up|401
4666499|NCT02847650|16046086|P2|Overall Study|Withdrawal by Subject|1
4666500|NCT02847650|16046087|P1|Overall Study|Withdrawal by Subject|1
4666501|NCT02847650|16046086|P2|Overall Study|Protocol Violation|1
4666502|NCT02847650|16046087|P1|Overall Study|Protocol Violation|0
4666503|NCT02847650|16046086|P2|Overall Study|Lost to Follow-up|0
4666504|NCT02847650|16046087|P1|Overall Study|Lost to Follow-up|1
4666505|NCT02847650|16046086|P2|Overall Study|Adverse Event|4
4666506|NCT02847650|16046087|P1|Overall Study|Adverse Event|2
4666507|NCT02847637|16046111|P4|Overall Study|First emicizumab dose delayed|0
4666508|NCT02847637|16046112|P3|Overall Study|First emicizumab dose delayed|0
4666509|NCT02847637|16046113|P2|Overall Study|First emicizumab dose delayed|0
4666510|NCT02847637|16046114|P1|Overall Study|First emicizumab dose delayed|1
4666511|NCT02847637|16046111|P4|Overall Study|Ongoing treatment with emicizumab|63
4666512|NCT02847637|16046112|P3|Overall Study|Ongoing treatment with emicizumab|34
4666513|NCT02847637|16046113|P2|Overall Study|Ongoing treatment with emicizumab|35
4666514|NCT02847637|16046114|P1|Overall Study|Ongoing treatment with emicizumab|16
4666515|NCT02847637|16046111|P4|Overall Study|Withdrew from treatment due to AE|0
4666516|NCT02847637|16046112|P3|Overall Study|Withdrew from treatment due to AE|1
4666517|NCT02847637|16046113|P2|Overall Study|Withdrew from treatment due to AE|0
4666518|NCT02847637|16046114|P1|Overall Study|Withdrew from treatment due to AE|0
4666519|NCT02847494|16046228|P2|Overall Study|Lost to Follow-up|5
4666520|NCT02847494|16046229|P1|Overall Study|Lost to Follow-up|8
4666521|NCT02847260|16046239|P1|Overall Study|Physician Decision|1
4666522|NCT02847260|16046239|P1|Overall Study|Clinical Deterioration|1
4666523|NCT02847260|16046239|P1|Overall Study|Withdrawal by Subject|2
4666524|NCT02847260|16046239|P1|Overall Study|Adverse Event|3
4666525|NCT02847182|16046253|P2|Overall Study|Withdrawal by Subject|1
4666526|NCT02847182|16046254|P1|Overall Study|Withdrawal by Subject|0
4666527|NCT02846779|16046378|P3|Overall Study|Less than 31 days of follow-up|52
4666528|NCT02846779|16046379|P2|Overall Study|Less than 31 days of follow-up|45
4666529|NCT02846779|16046380|P1|Overall Study|Less than 31 days of follow-up|56
4666530|NCT02846779|16046378|P3|Overall Study|Lost Enrollment|86
4666531|NCT02846779|16046379|P2|Overall Study|Lost Enrollment|82
4666532|NCT02846779|16046380|P1|Overall Study|Lost Enrollment|83
4666533|NCT02846558|16046436|P4|Overall Study|Lost to Follow-up|0
4666534|NCT02846558|16046437|P3|Overall Study|Lost to Follow-up|0
4666535|NCT02846558|16046438|P2|Overall Study|Lost to Follow-up|0
4666536|NCT02846558|16046439|P1|Overall Study|Lost to Follow-up|2
4666537|NCT02846558|16046436|P4|Overall Study|Withdrawal by Subject|2
4666538|NCT02846558|16046437|P3|Overall Study|Withdrawal by Subject|2
4666539|NCT02846558|16046438|P2|Overall Study|Withdrawal by Subject|4
4666540|NCT02846558|16046439|P1|Overall Study|Withdrawal by Subject|5
4666541|NCT02846558|16046436|P4|Overall Study|Adverse Event|0
4666542|NCT02846558|16046437|P3|Overall Study|Adverse Event|0
4666543|NCT02846558|16046438|P2|Overall Study|Adverse Event|0
4666544|NCT02846558|16046439|P1|Overall Study|Adverse Event|1
4666545|NCT02846324|16046479|P4|Overall Study|Withdrawal by Subject|0
4666546|NCT02846324|16046480|P3|Overall Study|Withdrawal by Subject|4
4666547|NCT02846324|16046481|P2|Overall Study|Withdrawal by Subject|0
4666548|NCT02846324|16046482|P1|Overall Study|Withdrawal by Subject|1
4666549|NCT02846324|16046479|P4|Overall Study|Other|0
4666550|NCT02846324|16046480|P3|Overall Study|Other|0
4666551|NCT02846324|16046481|P2|Overall Study|Other|0
4666552|NCT02846324|16046482|P1|Overall Study|Other|1
4666553|NCT02845375|16046576|P3|Overall Study|upper airway obstruction|1
4666554|NCT02845375|16046577|P2|Overall Study|upper airway obstruction|2
4666555|NCT02845375|16046578|P1|Overall Study|upper airway obstruction|1
4666556|NCT02845336|16046591|P2|Overall Study|Inability to get medication|0
4666557|NCT02845336|16046592|P1|Overall Study|Inability to get medication|2
4666558|NCT02845336|16046591|P2|Overall Study|Lost to Follow-up|1
4666559|NCT02845336|16046592|P1|Overall Study|Lost to Follow-up|3
4666560|NCT02844946|16046634|P2|Overall Study|Lost to Follow-up|0
4666561|NCT02844946|16046635|P1|Overall Study|Lost to Follow-up|7
4666562|NCT02844920|16046653|P1|Overall Study|Lost to Follow-up|2
4666563|NCT02844543|16046671|P1|Overall Study|Did not meet eligibility criteria|1
4666564|NCT02844543|16046671|P1|Overall Study|Withdrawal by Subject|4
4666565|NCT02843659|16046681|P3|Overall Study|Adverse Event|0
4666566|NCT02843659|16046682|P2|Overall Study|Adverse Event|1
4666567|NCT02843659|16046683|P1|Overall Study|Adverse Event|0
4666568|NCT02843659|16046681|P3|Overall Study|Administrative Reason by Sponsor|4
4666569|NCT02843659|16046682|P2|Overall Study|Administrative Reason by Sponsor|5
4666570|NCT02843659|16046683|P1|Overall Study|Administrative Reason by Sponsor|4
4666571|NCT02843659|16046681|P3|Overall Study|Subject Withdrew Consent|1
4666572|NCT02843659|16046682|P2|Overall Study|Subject Withdrew Consent|0
4666573|NCT02843659|16046683|P1|Overall Study|Subject Withdrew Consent|0
4666574|NCT02843178|16046752|P4|Overall Study|Withdrawal by Subject|1
4666575|NCT02843178|16046753|P3|Overall Study|Withdrawal by Subject|1
4666576|NCT02843178|16046754|P2|Overall Study|Withdrawal by Subject|0
4666577|NCT02843178|16046755|P1|Overall Study|Withdrawal by Subject|0
4666578|NCT02843178|16046752|P4|Overall Study|Lost to Follow-up|3
4666579|NCT02843178|16046753|P3|Overall Study|Lost to Follow-up|6
4666580|NCT02843178|16046754|P2|Overall Study|Lost to Follow-up|8
4666581|NCT02843178|16046755|P1|Overall Study|Lost to Follow-up|8
4666582|NCT02842866|16046795|P2|Overall Study|Withdrawal by Subject|0
4666583|NCT02842866|16046796|P1|Overall Study|Withdrawal by Subject|1
4666584|NCT02842866|16046795|P2|Overall Study|Lost to Follow-up|0
4666585|NCT02842866|16046796|P1|Overall Study|Lost to Follow-up|2
4666586|NCT02842866|16046795|P2|Overall Study|Protocol Violation|2
4666587|NCT02842866|16046796|P1|Overall Study|Protocol Violation|4
4666588|NCT02842866|16046795|P2|Overall Study|Serious Adverse Event|1
4666589|NCT02842866|16046796|P1|Overall Study|Serious Adverse Event|0
4666590|NCT02842853|16046808|P4|Overall Study|Lost to Follow-up|11
4666591|NCT02842853|16046809|P3|Overall Study|Lost to Follow-up|10
4666592|NCT02842853|16046810|P2|Overall Study|Lost to Follow-up|13
4666593|NCT02842853|16046811|P1|Overall Study|Lost to Follow-up|9
4666594|NCT02842853|16046808|P4|Overall Study|Withdrawal by Subject|8
4666595|NCT02842853|16046809|P3|Overall Study|Withdrawal by Subject|9
4666596|NCT02842853|16046810|P2|Overall Study|Withdrawal by Subject|13
4666597|NCT02842853|16046811|P1|Overall Study|Withdrawal by Subject|11
4666598|NCT02842853|16046808|P4|Overall Study|Subject met exclusion criteria|0
4666599|NCT02842853|16046809|P3|Overall Study|Subject met exclusion criteria|0
4666600|NCT02842853|16046810|P2|Overall Study|Subject met exclusion criteria|1
4666601|NCT02842853|16046811|P1|Overall Study|Subject met exclusion criteria|0
4666602|NCT02842853|16046808|P4|Overall Study|Non-compliance with the protocol|5
4666603|NCT02842853|16046809|P3|Overall Study|Non-compliance with the protocol|2
4666604|NCT02842853|16046810|P2|Overall Study|Non-compliance with the protocol|7
4666605|NCT02842853|16046811|P1|Overall Study|Non-compliance with the protocol|3
4666606|NCT02842736|16046831|P1|Overall Study|Diary or safety evaluation not available|1
4666607|NCT02842736|16046831|P1|Overall Study|Intervention for menstrual bleeding|4
4666608|NCT02842736|16046831|P1|Overall Study|Lost to Follow-up|7
4666609|NCT02842151|16046861|P1|Overall Study|Subject moved too far away|1
4666610|NCT02842151|16046861|P1|Overall Study|Adverse Event|1
4666611|NCT02842086|16046869|P2|Overall Study|HIV-1 Infection|6
4666612|NCT02842086|16046870|P1|Overall Study|HIV-1 Infection|5
4666613|NCT02842086|16046869|P2|Overall Study|Lost to Follow-up|236
4666614|NCT02842086|16046870|P1|Overall Study|Lost to Follow-up|274
4666615|NCT02842086|16046869|P2|Overall Study|Withdrew Consent|194
4666616|NCT02842086|16046870|P1|Overall Study|Withdrew Consent|205
4666617|NCT02842086|16046869|P2|Overall Study|Protocol Violation|4
4666618|NCT02842086|16046870|P1|Overall Study|Protocol Violation|8
4666619|NCT02842086|16046869|P2|Overall Study|Non-Compliance with Study Drug|8
4666620|NCT02842086|16046870|P1|Overall Study|Non-Compliance with Study Drug|9
4666621|NCT02842086|16046869|P2|Overall Study|Investigator's Discretion|13
4666622|NCT02842086|16046870|P1|Overall Study|Investigator's Discretion|9
4666623|NCT02842086|16046869|P2|Overall Study|Death|3
4666624|NCT02842086|16046870|P1|Overall Study|Death|3
4666625|NCT02842086|16046869|P2|Overall Study|Adverse Event|20
4666626|NCT02842086|16046870|P1|Overall Study|Adverse Event|18
4666627|NCT02842086|16046869|P2|Overall Study|Still in Double-Blind Phase|3
4666628|NCT02842086|16046870|P1|Overall Study|Still in Double-Blind Phase|7
4666629|NCT02842086|16046869|P2|Overall Study|Randomized but Never Treated|6
4666630|NCT02842086|16046870|P1|Overall Study|Randomized but Never Treated|6
4666631|NCT02842073|16046906|P1|Overall Study|Withdrawal by Subject|1
4666632|NCT02841787|16046932|P3|Overall Study|Withdrawal by Subject|0
4666633|NCT02841787|16046933|P2|Overall Study|Withdrawal by Subject|4
4666634|NCT02841787|16046934|P1|Overall Study|Withdrawal by Subject|1
4666635|NCT02841787|16046932|P3|Overall Study|Symptoms dropped below threshold|0
4666636|NCT02841787|16046933|P2|Overall Study|Symptoms dropped below threshold|0
4666637|NCT02841787|16046934|P1|Overall Study|Symptoms dropped below threshold|1
4666638|NCT02841787|16046932|P3|Overall Study|Lost to Follow-up|0
4666639|NCT02841787|16046933|P2|Overall Study|Lost to Follow-up|0
4666640|NCT02841787|16046934|P1|Overall Study|Lost to Follow-up|1
4666641|NCT02841709|16046948|P5|5th Intervention|Adverse Event|2
4666642|NCT02841709|16046949|P4|5th Intervention|Adverse Event|0
4666643|NCT02841709|16046950|P3|5th Intervention|Adverse Event|0
4666644|NCT02841709|16046951|P2|5th Intervention|Adverse Event|0
4666645|NCT02841709|16046952|P1|5th Intervention|Adverse Event|2
4666646|NCT02840721|16047082|P1|Follow-Up|Withdrawal of Consent|2
4666647|NCT02840721|16047082|P1|Follow-Up|Withdrawal by Subject|4
4666648|NCT02840721|16047082|P1|Follow-Up|Lack of Efficacy|1
4666649|NCT02840721|16047082|P1|Treatment Period|Adverse Event|1
4666650|NCT02840461|16047104|P3|Overall Study|Worsening of Symptom & Kit Error|2
4666651|NCT02840461|16047105|P2|Overall Study|Worsening of Symptom & Kit Error|0
4666652|NCT02840461|16047106|P1|Overall Study|Worsening of Symptom & Kit Error|0
4666653|NCT02840461|16047104|P3|Overall Study|Withdrawal by Subject|2
4666654|NCT02840461|16047105|P2|Overall Study|Withdrawal by Subject|6
4666655|NCT02840461|16047106|P1|Overall Study|Withdrawal by Subject|10
4666656|NCT02840461|16047104|P3|Overall Study|Protocol Violation|1
4666657|NCT02840461|16047105|P2|Overall Study|Protocol Violation|3
4666658|NCT02840461|16047106|P1|Overall Study|Protocol Violation|2
4666659|NCT02840461|16047104|P3|Overall Study|Non-Comliance with Dosing Requirements|0
4666660|NCT02840461|16047105|P2|Overall Study|Non-Comliance with Dosing Requirements|1
4666661|NCT02840461|16047106|P1|Overall Study|Non-Comliance with Dosing Requirements|0
4666662|NCT02840461|16047104|P3|Overall Study|Lost to Follow-up|6
4666663|NCT02840461|16047105|P2|Overall Study|Lost to Follow-up|7
4666664|NCT02840461|16047106|P1|Overall Study|Lost to Follow-up|10
4666665|NCT02840461|16047104|P3|Overall Study|Adverse Event|3
4666666|NCT02840461|16047105|P2|Overall Study|Adverse Event|5
4666667|NCT02840461|16047106|P1|Overall Study|Adverse Event|1
4666668|NCT02840253|16047117|P1|Overall Study|Unsuccessful block|4
4666669|NCT02839876|16047202|P2|Overall Study|Protocol Violation|11
4666670|NCT02839876|16047203|P1|Overall Study|Protocol Violation|10
4666671|NCT02839798|16047265|P1|Overall Study|Withdrawal by Subject|2
4666672|NCT02839746|16047311|P1|Overall Study|Not met selection criteria|12
4666673|NCT02839681|16047325|P1|Overall Study|Death|2
4666674|NCT02839330|16047338|P4|Overall Study|Other reason, not specified|6
4666675|NCT02839330|16047339|P3|Overall Study|Other reason, not specified|3
4666676|NCT02839330|16047340|P2|Overall Study|Other reason, not specified|3
4666677|NCT02839330|16047341|P1|Overall Study|Other reason, not specified|4
4666678|NCT02839330|16047338|P4|Overall Study|Protocol Violation|3
4666679|NCT02839330|16047339|P3|Overall Study|Protocol Violation|2
4666680|NCT02839330|16047340|P2|Overall Study|Protocol Violation|2
4666681|NCT02839330|16047341|P1|Overall Study|Protocol Violation|1
4666682|NCT02839330|16047338|P4|Overall Study|Administrative Reason|1
4666683|NCT02839330|16047339|P3|Overall Study|Administrative Reason|0
4666684|NCT02839330|16047340|P2|Overall Study|Administrative Reason|0
4666685|NCT02839330|16047341|P1|Overall Study|Administrative Reason|0
4666686|NCT02839330|16047338|P4|Overall Study|Lost to Follow-up|25
4666687|NCT02839330|16047339|P3|Overall Study|Lost to Follow-up|29
4666688|NCT02839330|16047340|P2|Overall Study|Lost to Follow-up|27
4666689|NCT02839330|16047341|P1|Overall Study|Lost to Follow-up|22
4666690|NCT02839330|16047338|P4|Overall Study|Withdrawal by Subject|13
4666691|NCT02839330|16047339|P3|Overall Study|Withdrawal by Subject|11
4666692|NCT02839330|16047340|P2|Overall Study|Withdrawal by Subject|19
4666693|NCT02839330|16047341|P1|Overall Study|Withdrawal by Subject|27
4666694|NCT02839330|16047338|P4|Overall Study|Death|1
4666695|NCT02839330|16047339|P3|Overall Study|Death|1
4666696|NCT02839330|16047340|P2|Overall Study|Death|6
4666697|NCT02839330|16047341|P1|Overall Study|Death|4
4666698|NCT02839330|16047338|P4|Overall Study|Adverse Event|2
4666699|NCT02839330|16047339|P3|Overall Study|Adverse Event|2
4666700|NCT02839330|16047340|P2|Overall Study|Adverse Event|1
4666701|NCT02839330|16047341|P1|Overall Study|Adverse Event|0
4666702|NCT02839200|16047376|P6|Overall Study|Randomized in error|0
4666703|NCT02839200|16047377|P5|Overall Study|Randomized in error|0
4666704|NCT02839200|16047378|P4|Overall Study|Randomized in error|0
4666705|NCT02839200|16047379|P3|Overall Study|Randomized in error|0
4666706|NCT02839200|16047380|P2|Overall Study|Randomized in error|1
4666707|NCT02839200|16047381|P1|Overall Study|Randomized in error|0
4666708|NCT02839200|16047376|P6|Overall Study|Adverse Event|0
4666709|NCT02839200|16047377|P5|Overall Study|Adverse Event|1
4666710|NCT02839200|16047378|P4|Overall Study|Adverse Event|0
4666711|NCT02839200|16047379|P3|Overall Study|Adverse Event|0
4666712|NCT02839200|16047380|P2|Overall Study|Adverse Event|0
4666713|NCT02839200|16047381|P1|Overall Study|Adverse Event|0
4666714|NCT02839200|16047376|P6|Overall Study|Lost to Follow-up|0
4666715|NCT02839200|16047377|P5|Overall Study|Lost to Follow-up|1
4666716|NCT02839200|16047378|P4|Overall Study|Lost to Follow-up|0
4666717|NCT02839200|16047379|P3|Overall Study|Lost to Follow-up|0
4666718|NCT02839200|16047380|P2|Overall Study|Lost to Follow-up|0
4666719|NCT02839200|16047381|P1|Overall Study|Lost to Follow-up|2
4666720|NCT02839200|16047376|P6|Overall Study|Withdrawal by Subject|1
4666721|NCT02839200|16047377|P5|Overall Study|Withdrawal by Subject|0
4666722|NCT02839200|16047378|P4|Overall Study|Withdrawal by Subject|0
4666723|NCT02839200|16047379|P3|Overall Study|Withdrawal by Subject|1
4666724|NCT02839200|16047380|P2|Overall Study|Withdrawal by Subject|0
4666725|NCT02839200|16047381|P1|Overall Study|Withdrawal by Subject|2
4666726|NCT02838901|16047415|P2|Overall Study|Lost to Follow-up|1
4666727|NCT02838901|16047416|P1|Overall Study|Lost to Follow-up|1
4666728|NCT02838901|16047415|P2|Overall Study|Withdrawal by Subject|1
4666729|NCT02838901|16047416|P1|Overall Study|Withdrawal by Subject|1
4666730|NCT02838420|16047446|P2|Overall Study|Death|13
4666731|NCT02838420|16047447|P1|Overall Study|Death|8
4666732|NCT02838420|16047446|P2|Overall Study|Withdrawal by Subject|4
4666733|NCT02838420|16047447|P1|Overall Study|Withdrawal by Subject|3
4666734|NCT02838420|16047446|P2|Overall Study|Lost to Follow-up|0
4666735|NCT02838420|16047447|P1|Overall Study|Lost to Follow-up|1
4666736|NCT02838420|16047446|P2|Overall Study|Ongoing in Study|45
4666737|NCT02838420|16047447|P1|Overall Study|Ongoing in Study|113
4666738|NCT02838134|16047510|P2|Overall Study|logistic problems|1
4666739|NCT02838134|16047511|P1|Overall Study|logistic problems|1
4666740|NCT02838134|16047510|P2|Overall Study|Lost to Follow-up|2
4666741|NCT02838134|16047511|P1|Overall Study|Lost to Follow-up|1
4666742|NCT02838017|16047543|P2|Overall Study|Lost to Follow-up|11
4666743|NCT02838017|16047544|P1|Overall Study|Lost to Follow-up|14
4666744|NCT02837952|16047562|P2|Overall Study|Medication Error|0
4666745|NCT02837952|16047563|P1|Overall Study|Medication Error|1
4666746|NCT02837952|16047562|P2|Overall Study|Withdrawal by Subject|5
4666747|NCT02837952|16047563|P1|Overall Study|Withdrawal by Subject|4
4666748|NCT02837952|16047562|P2|Overall Study|Adverse Event|1
4666749|NCT02837952|16047563|P1|Overall Study|Adverse Event|0
4666750|NCT02837029|16047616|P3|2 Year Follow-up|Still in follow-up|0
4666751|NCT02837029|16047617|P2|2 Year Follow-up|Still in follow-up|1
4666752|NCT02837029|16047618|P1|2 Year Follow-up|Still in follow-up|0
4666753|NCT02837029|16047616|P3|2 Year Follow-up|Death|0
4666754|NCT02837029|16047617|P2|2 Year Follow-up|Death|6
4666755|NCT02837029|16047618|P1|2 Year Follow-up|Death|6
4666756|NCT02837029|16047616|P3|Cycle 2 and Beyond|Adverse Event|0
4666757|NCT02837029|16047617|P2|Cycle 2 and Beyond|Adverse Event|0
4666758|NCT02837029|16047618|P1|Cycle 2 and Beyond|Adverse Event|1
4666759|NCT02837029|16047616|P3|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
4666760|NCT02837029|16047617|P2|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1
4666761|NCT02837029|16047618|P1|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0
4666762|NCT02837029|16047616|P3|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
4666763|NCT02837029|16047617|P2|Cycle 1 (DLT Monitoring Period)|Adverse Event|2
4666764|NCT02837029|16047618|P1|Cycle 1 (DLT Monitoring Period)|Adverse Event|0
4666765|NCT02837029|16047616|P3|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
4666766|NCT02837029|16047617|P2|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0
4666767|NCT02837029|16047618|P1|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2
4666768|NCT02837029|16047616|P3|Screening|Failed to meet screening requirements.|0
4666769|NCT02837029|16047617|P2|Screening|Failed to meet screening requirements.|3
4666770|NCT02837029|16047618|P1|Screening|Failed to meet screening requirements.|7
4666771|NCT02836652|16047627|P2|Overall Study|Not on treatment regimen post-op day 15|3
4666772|NCT02836652|16047628|P1|Overall Study|Not on treatment regimen post-op day 15|3
4666773|NCT02836652|16047627|P2|Overall Study|Withdrawn|9
4666774|NCT02836652|16047628|P1|Overall Study|Withdrawn|9
4666775|NCT02836652|16047627|P2|Overall Study|Transplant/Explant|4
4666776|NCT02836652|16047628|P1|Overall Study|Transplant/Explant|3
4666777|NCT02836652|16047627|P2|Overall Study|Death|3
4666778|NCT02836652|16047628|P1|Overall Study|Death|3
4666779|NCT02836613|16047642|P2|Overall Study|Withdrawal by Subject|2
4666780|NCT02836613|16047643|P1|Overall Study|Withdrawal by Subject|0
4666781|NCT02836613|16047642|P2|Overall Study|Lost to Follow-up|1
4666782|NCT02836613|16047643|P1|Overall Study|Lost to Follow-up|0
4666783|NCT02836613|16047642|P2|Overall Study|Accidental drowning|0
4666784|NCT02836613|16047643|P1|Overall Study|Accidental drowning|1
4666785|NCT02836496|16047657|P2|Overall Study|Withdrawal by Subject|1
4666786|NCT02836496|16047658|P1|Overall Study|Withdrawal by Subject|0
4666787|NCT02836496|16047657|P2|Overall Study|Adverse Event|1
4666788|NCT02836496|16047658|P1|Overall Study|Adverse Event|2
4666789|NCT02836249|16047674|P2|Overall Study|Still on Study|55
4666790|NCT02836249|16047675|P1|Overall Study|Still on Study|121
4666791|NCT02836249|16047674|P2|Overall Study|Lost to Follow-up|1
4666792|NCT02836249|16047675|P1|Overall Study|Lost to Follow-up|0
4666793|NCT02836249|16047674|P2|Overall Study|Withdrew Consent|1
4666794|NCT02836249|16047675|P1|Overall Study|Withdrew Consent|0
4666795|NCT02836249|16047674|P2|Overall Study|Pregnancy|0
4666796|NCT02836249|16047675|P1|Overall Study|Pregnancy|2
4666797|NCT02836249|16047674|P2|Overall Study|Randomized but Never Treated|1
4666798|NCT02836249|16047675|P1|Overall Study|Randomized but Never Treated|0
4666799|NCT02836236|16047693|P2|Overall Study|Still on Study|49
4666800|NCT02836236|16047694|P1|Overall Study|Still on Study|101
4666801|NCT02836236|16047693|P2|Overall Study|Investigator's Discretion|0
4666802|NCT02836236|16047694|P1|Overall Study|Investigator's Discretion|1
4666803|NCT02836236|16047693|P2|Overall Study|Adverse Event|1
4666804|NCT02836236|16047694|P1|Overall Study|Adverse Event|0
4666805|NCT02836236|16047693|P2|Overall Study|Withdrew Consent|0
4666806|NCT02836236|16047694|P1|Overall Study|Withdrew Consent|2
4666807|NCT02836236|16047693|P2|Overall Study|Randomized but Never Treated|0
4666808|NCT02836236|16047694|P1|Overall Study|Randomized but Never Treated|1
4666809|NCT02835820|16047710|P2|Overall Study|Baseline Screen Failure|3
4666810|NCT02835820|16047711|P1|Overall Study|Baseline Screen Failure|0
4666811|NCT02835690|16047758|P3|Overall Study|Not Treated|0
4666812|NCT02835690|16047759|P2|Overall Study|Not Treated|2
4666813|NCT02835690|16047760|P1|Overall Study|Not Treated|0
4666814|NCT02835690|16047758|P3|Overall Study|Ongoing in Study (Follow-up)|9
4666815|NCT02835690|16047759|P2|Overall Study|Ongoing in Study (Follow-up)|7
4666816|NCT02835690|16047760|P1|Overall Study|Ongoing in Study (Follow-up)|10
4666817|NCT02835690|16047758|P3|Overall Study|Death|6
4666818|NCT02835690|16047759|P2|Overall Study|Death|6
4666819|NCT02835690|16047760|P1|Overall Study|Death|4
4666820|NCT02835495|16047823|P2|Overall Study|Declined in-person follow-up visit|2
4666821|NCT02835495|16047824|P1|Overall Study|Declined in-person follow-up visit|4
4666822|NCT02835495|16047823|P2|Overall Study|Cancer diagnosis prior intervention|0
4666823|NCT02835495|16047824|P1|Overall Study|Cancer diagnosis prior intervention|1
4666824|NCT02835339|16047850|P2|Overall Study|Did not receive allocated intervention|16
4666825|NCT02835339|16047851|P1|Overall Study|Did not receive allocated intervention|13
4666826|NCT02835092|16047873|P3|Overall Study|Lost to Follow-up|0
4666827|NCT02835092|16047874|P2|Overall Study|Lost to Follow-up|2
4666828|NCT02835092|16047875|P1|Overall Study|Lost to Follow-up|0
4666829|NCT02835092|16047873|P3|Overall Study|Withdrawal by Subject|3
4666830|NCT02835092|16047874|P2|Overall Study|Withdrawal by Subject|6
4666831|NCT02835092|16047875|P1|Overall Study|Withdrawal by Subject|3
4666832|NCT02834819|16047885|P2|Overall Study|Did not complete 7 day follow up call.|0
4666833|NCT02834819|16047886|P1|Overall Study|Did not complete 7 day follow up call.|5
4666834|NCT02834247|16047945|P4|Dose Expansion Phase|Withdrawal by Subject|1
4666835|NCT02834247|16047946|P3|Dose Expansion Phase|Withdrawal by Subject|0
4666836|NCT02834247|16047947|P2|Dose Expansion Phase|Withdrawal by Subject|0
4666837|NCT02834247|16047948|P1|Dose Expansion Phase|Withdrawal by Subject|0
4666838|NCT02834247|16047945|P4|Dose Expansion Phase|Lost to Follow-up|1
4666839|NCT02834247|16047946|P3|Dose Expansion Phase|Lost to Follow-up|0
4666840|NCT02834247|16047947|P2|Dose Expansion Phase|Lost to Follow-up|0
4666841|NCT02834247|16047948|P1|Dose Expansion Phase|Lost to Follow-up|0
4666842|NCT02834247|16047945|P4|Dose Expansion Phase|Death|8
4666843|NCT02834247|16047946|P3|Dose Expansion Phase|Death|0
4666844|NCT02834247|16047947|P2|Dose Expansion Phase|Death|0
4666845|NCT02834247|16047948|P1|Dose Expansion Phase|Death|0
4666846|NCT02834247|16047945|P4|Dose Expansion Phase|Study Terminated by Sponsor|7
4666847|NCT02834247|16047946|P3|Dose Expansion Phase|Study Terminated by Sponsor|0
4666848|NCT02834247|16047947|P2|Dose Expansion Phase|Study Terminated by Sponsor|0
4666849|NCT02834247|16047948|P1|Dose Expansion Phase|Study Terminated by Sponsor|0
4666850|NCT02834247|16047945|P4|Dose Escalation Phase|Withdrawal by Subject|0
4666851|NCT02834247|16047946|P3|Dose Escalation Phase|Withdrawal by Subject|0
4666852|NCT02834247|16047947|P2|Dose Escalation Phase|Withdrawal by Subject|2
4666853|NCT02834247|16047948|P1|Dose Escalation Phase|Withdrawal by Subject|2
4666854|NCT02834247|16047945|P4|Dose Escalation Phase|Lost to Follow-up|0
4666855|NCT02834247|16047946|P3|Dose Escalation Phase|Lost to Follow-up|0
4666856|NCT02834247|16047947|P2|Dose Escalation Phase|Lost to Follow-up|1
4666857|NCT02834247|16047948|P1|Dose Escalation Phase|Lost to Follow-up|0
4666858|NCT02834247|16047945|P4|Dose Escalation Phase|Death|0
4666859|NCT02834247|16047946|P3|Dose Escalation Phase|Death|5
4666860|NCT02834247|16047947|P2|Dose Escalation Phase|Death|6
4666861|NCT02834247|16047948|P1|Dose Escalation Phase|Death|5
4666862|NCT02834247|16047945|P4|Dose Escalation Phase|Study Terminated by Sponsor|0
4666863|NCT02834247|16047946|P3|Dose Escalation Phase|Study Terminated by Sponsor|0
4666864|NCT02834247|16047947|P2|Dose Escalation Phase|Study Terminated by Sponsor|2
4666865|NCT02834247|16047948|P1|Dose Escalation Phase|Study Terminated by Sponsor|1
4666866|NCT02833974|16047977|P2|Overall Study|Adverse Event|3
4666867|NCT02833974|16047978|P1|Overall Study|Adverse Event|0
4666868|NCT02833974|16047977|P2|Overall Study|Lost to Follow-up|0
4666869|NCT02833974|16047978|P1|Overall Study|Lost to Follow-up|1
4666870|NCT02833948|16048004|P2|Overall Study|scans could not be evaluated|2
4666871|NCT02833948|16048005|P1|Overall Study|scans could not be evaluated|5
4666872|NCT02833948|16048004|P2|Overall Study|were not scanned|13
4666873|NCT02833948|16048005|P1|Overall Study|were not scanned|8
4666874|NCT02833948|16048004|P2|Overall Study|Death|3
4666875|NCT02833948|16048005|P1|Overall Study|Death|2
4666876|NCT02833844|16048064|P2|Overall Study|Protocol Violation|4
4666877|NCT02833844|16048065|P1|Overall Study|Protocol Violation|0
4666878|NCT02833844|16048064|P2|Overall Study|Withdrawal by Subject|3
4666879|NCT02833844|16048065|P1|Overall Study|Withdrawal by Subject|2
4666880|NCT02833350|16048107|P7|Overall Study|Withdrawal by Subject|2
4666881|NCT02833350|16048108|P6|Overall Study|Withdrawal by Subject|0
4666882|NCT02833350|16048109|P5|Overall Study|Withdrawal by Subject|2
4666883|NCT02833350|16048110|P4|Overall Study|Withdrawal by Subject|0
4666884|NCT02833350|16048111|P3|Overall Study|Withdrawal by Subject|2
4666885|NCT02833350|16048112|P2|Overall Study|Withdrawal by Subject|3
4666886|NCT02833350|16048113|P1|Overall Study|Withdrawal by Subject|3
4666887|NCT02833350|16048107|P7|Overall Study|Lost to Follow-up|1
4666888|NCT02833350|16048108|P6|Overall Study|Lost to Follow-up|0
4666889|NCT02833350|16048109|P5|Overall Study|Lost to Follow-up|0
4666890|NCT02833350|16048110|P4|Overall Study|Lost to Follow-up|0
4666891|NCT02833350|16048111|P3|Overall Study|Lost to Follow-up|0
4666892|NCT02833350|16048112|P2|Overall Study|Lost to Follow-up|1
4666893|NCT02833350|16048113|P1|Overall Study|Lost to Follow-up|0
4666894|NCT02833350|16048107|P7|Overall Study|Lack of Efficacy|1
4666895|NCT02833350|16048108|P6|Overall Study|Lack of Efficacy|1
4666896|NCT02833350|16048109|P5|Overall Study|Lack of Efficacy|0
4666897|NCT02833350|16048110|P4|Overall Study|Lack of Efficacy|4
4666898|NCT02833350|16048111|P3|Overall Study|Lack of Efficacy|1
4666899|NCT02833350|16048112|P2|Overall Study|Lack of Efficacy|2
4666900|NCT02833350|16048113|P1|Overall Study|Lack of Efficacy|0
4666901|NCT02833350|16048107|P7|Overall Study|Death|0
4666902|NCT02833350|16048108|P6|Overall Study|Death|0
4666903|NCT02833350|16048109|P5|Overall Study|Death|0
4666904|NCT02833350|16048110|P4|Overall Study|Death|0
4666905|NCT02833350|16048111|P3|Overall Study|Death|1
4666906|NCT02833350|16048112|P2|Overall Study|Death|0
4666907|NCT02833350|16048113|P1|Overall Study|Death|0
4666908|NCT02833350|16048107|P7|Overall Study|Adverse Event|1
4666909|NCT02833350|16048108|P6|Overall Study|Adverse Event|0
4666910|NCT02833350|16048109|P5|Overall Study|Adverse Event|1
4666911|NCT02833350|16048110|P4|Overall Study|Adverse Event|4
4666912|NCT02833350|16048111|P3|Overall Study|Adverse Event|4
4666913|NCT02833350|16048112|P2|Overall Study|Adverse Event|3
4666914|NCT02833350|16048113|P1|Overall Study|Adverse Event|0
4666915|NCT02833077|16048320|P2|Overall Study|Protocol Deviation|1
4666916|NCT02833077|16048321|P1|Overall Study|Protocol Deviation|0
4666917|NCT02833077|16048320|P2|Overall Study|Personal Reasons|4
4666918|NCT02833077|16048321|P1|Overall Study|Personal Reasons|6
4666919|NCT02833077|16048320|P2|Overall Study|Lost to Follow-up|1
4666920|NCT02833077|16048321|P1|Overall Study|Lost to Follow-up|10
4666921|NCT02833077|16048320|P2|Overall Study|Adverse Event|2
4666922|NCT02833077|16048321|P1|Overall Study|Adverse Event|1
4666923|NCT02832375|16048344|P2|Overall Study|Withdrawal of Consent|0
4666924|NCT02832375|16048345|P1|Overall Study|Withdrawal of Consent|1
4666925|NCT02832375|16048344|P2|Overall Study|Lost to Follow-up|0
4666926|NCT02832375|16048345|P1|Overall Study|Lost to Follow-up|1
4666927|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
4666928|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Randomized but not Treated|3
4666929|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Randomized but not Treated|0
4666930|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Protocol Violation|2
4666931|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Protocol Violation|5
4666932|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Protocol Violation|0
4666933|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1
4666934|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6
4666935|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0
4666936|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Other|5
4666937|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Other|2
4666938|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Other|0
4666939|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2
4666940|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5
4666941|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0
4666942|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Screen Failure|0
4666943|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Screen Failure|1
4666944|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Screen Failure|0
4666945|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
4666946|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Lost to Follow-up|1
4666947|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Lost to Follow-up|0
4666948|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Death|2
4666949|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Death|0
4666950|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Death|0
4666951|NCT02831855|16048393|P3|Double Blind Phase (24 Weeks)|Adverse Event|6
4666952|NCT02831855|16048394|P2|Double Blind Phase (24 Weeks)|Adverse Event|6
4666953|NCT02831855|16048395|P1|Double Blind Phase (24 Weeks)|Adverse Event|0
4666954|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Other|0
4666955|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Other|0
4666956|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Other|4
4666957|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
4666958|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Withdrawal by Subject|0
4666959|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Withdrawal by Subject|6
4666960|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Protocol Violation|0
4666961|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Protocol Violation|0
4666962|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Protocol Violation|5
4666963|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
4666964|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0
4666965|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2
4666966|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
4666967|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0
4666968|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7
4666969|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Lost to Follow-up|0
4666970|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Lost to Follow-up|0
4666971|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Lost to Follow-up|8
4666972|NCT02831855|16048393|P3|Open Label Phase (24 Weeks)|Adverse Event|0
4666973|NCT02831855|16048394|P2|Open Label Phase (24 Weeks)|Adverse Event|0
4666974|NCT02831855|16048395|P1|Open Label Phase (24 Weeks)|Adverse Event|39
4666975|NCT02831764|16048456|P2|Overall Study|Ongoing at the time of the analysis|335
4666976|NCT02831764|16048457|P1|Overall Study|Ongoing at the time of the analysis|330
4666977|NCT02831764|16048456|P2|Overall Study|Protocol Violation|2
4666978|NCT02831764|16048457|P1|Overall Study|Protocol Violation|5
4666979|NCT02831764|16048456|P2|Overall Study|Lack of Efficacy|2
4666980|NCT02831764|16048457|P1|Overall Study|Lack of Efficacy|2
4666981|NCT02831764|16048456|P2|Overall Study|Adverse Event|5
4666982|NCT02831764|16048457|P1|Overall Study|Adverse Event|8
4666983|NCT02831764|16048456|P2|Overall Study|Lost to Follow-up|5
4666984|NCT02831764|16048457|P1|Overall Study|Lost to Follow-up|6
4666985|NCT02831764|16048456|P2|Overall Study|Physician Decision|2
4666986|NCT02831764|16048457|P1|Overall Study|Physician Decision|2
4666987|NCT02831764|16048456|P2|Overall Study|Withdrawal by Subject|6
4666988|NCT02831764|16048457|P1|Overall Study|Withdrawal by Subject|7
4666989|NCT02831764|16048456|P2|Overall Study|Protocol specific withdrawal criteria|2
4666990|NCT02831764|16048457|P1|Overall Study|Protocol specific withdrawal criteria|0
4666991|NCT02831673|16048521|P2|Overall Study|Ongoing at Week 48 primary analysis.|330
4666992|NCT02831673|16048522|P1|Overall Study|Ongoing at Week 48 primary analysis.|320
4666993|NCT02831673|16048521|P2|Overall Study|Withdrawal by Subject|4
4666994|NCT02831673|16048522|P1|Overall Study|Withdrawal by Subject|6
4666995|NCT02831673|16048521|P2|Overall Study|Physician Decision|3
4666996|NCT02831673|16048522|P1|Overall Study|Physician Decision|6
4666997|NCT02831673|16048521|P2|Overall Study|Lost to Follow-up|6
4666998|NCT02831673|16048522|P1|Overall Study|Lost to Follow-up|9
4666999|NCT02831673|16048521|P2|Overall Study|Protocol Withdrawal Criterion Met|6
4667000|NCT02831673|16048522|P1|Overall Study|Protocol Withdrawal Criterion Met|1
4667001|NCT02831673|16048521|P2|Overall Study|Protocol Violation|4
4667002|NCT02831673|16048522|P1|Overall Study|Protocol Violation|5
4667003|NCT02831673|16048521|P2|Overall Study|Lack of Efficacy|1
4667004|NCT02831673|16048522|P1|Overall Study|Lack of Efficacy|3
4667005|NCT02831673|16048521|P2|Overall Study|Adverse Event|4
4667006|NCT02831673|16048522|P1|Overall Study|Adverse Event|6
4667007|NCT02831387|16048595|P2|Overall Study|Discontinued due to stock recovery|1
4667008|NCT02831387|16048596|P1|Overall Study|Discontinued due to stock recovery|0
4667009|NCT02831387|16048595|P2|Overall Study|Withdrawal by Subject|1
4667010|NCT02831387|16048596|P1|Overall Study|Withdrawal by Subject|1
4667011|NCT02830893|16048616|P2|Overall Study|Discharged to SNF, no transportation.|1
4667012|NCT02830893|16048617|P1|Overall Study|Discharged to SNF, no transportation.|0
4667013|NCT02830893|16048616|P2|Overall Study|Lost to Follow-up|2
4667014|NCT02830893|16048617|P1|Overall Study|Lost to Follow-up|0
4667015|NCT02830893|16048616|P2|Overall Study|Relocation to out of the country|0
4667016|NCT02830893|16048617|P1|Overall Study|Relocation to out of the country|1
4667017|NCT02830880|16048629|P1|Overall Study|Physician Decision|1
4667018|NCT02830880|16048629|P1|Overall Study|Death|1
4667019|NCT02830880|16048629|P1|Overall Study|Adverse reaction to chemotherapy|1
4667020|NCT02830087|16048648|P6|Overall Study|No study staff to follow-up patients|3
4667021|NCT02830087|16048649|P5|Overall Study|No study staff to follow-up patients|3
4667022|NCT02830087|16048650|P4|Overall Study|No study staff to follow-up patients|3
4667023|NCT02830087|16048651|P3|Overall Study|No study staff to follow-up patients|4
4667024|NCT02830087|16048652|P2|Overall Study|No study staff to follow-up patients|4
4667025|NCT02830087|16048653|P1|Overall Study|No study staff to follow-up patients|4
4667026|NCT02829996|16048720|P5|Overall Study|Withdrawal by Subject|0
4667027|NCT02829996|16048721|P4|Overall Study|Withdrawal by Subject|0
4667028|NCT02829996|16048722|P3|Overall Study|Withdrawal by Subject|0
4667029|NCT02829996|16048723|P2|Overall Study|Withdrawal by Subject|0
4667030|NCT02829996|16048724|P1|Overall Study|Withdrawal by Subject|1
4667031|NCT02829944|16048749|P2|Overall Study|Staff unavailable|1
4667032|NCT02829944|16048750|P1|Overall Study|Staff unavailable|0
4667033|NCT02829944|16048749|P2|Overall Study|Catheter broke|1
4667034|NCT02829944|16048750|P1|Overall Study|Catheter broke|0
4667035|NCT02829944|16048749|P2|Overall Study|Catheter Displacement|0
4667036|NCT02829944|16048750|P1|Overall Study|Catheter Displacement|1
4667037|NCT02829944|16048749|P2|Overall Study|Withdrawal by Subject|1
4667038|NCT02829944|16048750|P1|Overall Study|Withdrawal by Subject|2
4667039|NCT02829944|16048749|P2|Overall Study|Inadequate Neuraxial Block|1
4667040|NCT02829944|16048750|P1|Overall Study|Inadequate Neuraxial Block|1
4667041|NCT02829944|16048749|P2|Overall Study|Screen Failure|2
4667042|NCT02829944|16048750|P1|Overall Study|Screen Failure|2
4667043|NCT02829944|16048749|P2|Overall Study|Physician Decision|1
4667044|NCT02829944|16048750|P1|Overall Study|Physician Decision|0
4667045|NCT02829918|16048800|P1|Overall Study|Progression|1
4667046|NCT02829918|16048800|P1|Overall Study|Adverse Event|1
4667047|NCT02829918|16048800|P1|Overall Study|Withdrawal by Subject|4
4667048|NCT02829918|16048800|P1|Overall Study|Death|2
4667049|NCT02829775|16048805|P1|Overall Study|Disease remission|1
4667050|NCT02829775|16048805|P1|Overall Study|Withdrawal by Subject|3
4667051|NCT02829775|16048805|P1|Overall Study|Death|1
4667052|NCT02829138|16048887|P2|Overall Study|Withdrawal by Subject|0
4667053|NCT02829138|16048888|P1|Overall Study|Withdrawal by Subject|1
4667054|NCT02828644|16048917|P2|Overall Study|Lost to Follow-up|22
4667055|NCT02828644|16048918|P1|Overall Study|Lost to Follow-up|23
4667056|NCT02828436|16048925|P2|Period 2|Lost to Follow-up|0
4667057|NCT02828436|16048926|P1|Period 2|Lost to Follow-up|1
4667058|NCT02828436|16048925|P2|Period 2|Did Not Meet Inclusion Criteria|0
4667059|NCT02828436|16048926|P1|Period 2|Did Not Meet Inclusion Criteria|3
4667060|NCT02828436|16048925|P2|Period 2|Withdrawal by Subject|0
4667061|NCT02828436|16048926|P1|Period 2|Withdrawal by Subject|4
4667062|NCT02828436|16048925|P2|Period 1|Lost to Follow-up|1
4667063|NCT02828436|16048926|P1|Period 1|Lost to Follow-up|0
4667064|NCT02828436|16048925|P2|Period 1|Did Not Meet Inclusion Criteria|3
4667065|NCT02828436|16048926|P1|Period 1|Did Not Meet Inclusion Criteria|0
4667066|NCT02828241|16048934|P2|Overall Study|Protocol Violation|0
4667067|NCT02828241|16048935|P1|Overall Study|Protocol Violation|1
4667068|NCT02828241|16048934|P2|Overall Study|Adverse Event|2
4667069|NCT02828241|16048935|P1|Overall Study|Adverse Event|7
4667070|NCT02828124|16048962|P4|Overall Study|Subject Withdrew Consent|1
4667071|NCT02828124|16048963|P3|Overall Study|Subject Withdrew Consent|0
4667072|NCT02828124|16048964|P2|Overall Study|Subject Withdrew Consent|0
4667073|NCT02828124|16048965|P1|Overall Study|Subject Withdrew Consent|0
4667074|NCT02828124|16048962|P4|Overall Study|AE Unrelated to Study Drug|1
4667075|NCT02828124|16048963|P3|Overall Study|AE Unrelated to Study Drug|0
4667076|NCT02828124|16048964|P2|Overall Study|AE Unrelated to Study Drug|0
4667077|NCT02828124|16048965|P1|Overall Study|AE Unrelated to Study Drug|0
4667078|NCT02828124|16048962|P4|Overall Study|Disease Progression|4
4667079|NCT02828124|16048963|P3|Overall Study|Disease Progression|1
4667080|NCT02828124|16048964|P2|Overall Study|Disease Progression|2
4667081|NCT02828124|16048965|P1|Overall Study|Disease Progression|1
4667082|NCT02828111|16049080|P5|Overall Study|Lost to Follow-up|1
4667083|NCT02828111|16049081|P4|Overall Study|Lost to Follow-up|1
4667084|NCT02828111|16049082|P3|Overall Study|Lost to Follow-up|0
4667085|NCT02828111|16049083|P2|Overall Study|Lost to Follow-up|0
4667086|NCT02828111|16049084|P1|Overall Study|Lost to Follow-up|0
4667087|NCT02828111|16049080|P5|Overall Study|Withdrawal by Subject|0
4667088|NCT02828111|16049081|P4|Overall Study|Withdrawal by Subject|0
4667089|NCT02828111|16049082|P3|Overall Study|Withdrawal by Subject|2
4667090|NCT02828111|16049083|P2|Overall Study|Withdrawal by Subject|0
4667091|NCT02828111|16049084|P1|Overall Study|Withdrawal by Subject|0
4667092|NCT02828020|16049145|P3|Safety Follow-up Period|Other Miscellaneous Reasons|0
4667093|NCT02828020|16049146|P2|Safety Follow-up Period|Other Miscellaneous Reasons|0
4667094|NCT02828020|16049147|P1|Safety Follow-up Period|Other Miscellaneous Reasons|1
4667095|NCT02828020|16049145|P3|Safety Follow-up Period|Protocol Violation|1
4667096|NCT02828020|16049146|P2|Safety Follow-up Period|Protocol Violation|2
4667097|NCT02828020|16049147|P1|Safety Follow-up Period|Protocol Violation|0
4667098|NCT02828020|16049145|P3|Safety Follow-up Period|Lost to Follow-up|11
4667099|NCT02828020|16049146|P2|Safety Follow-up Period|Lost to Follow-up|8
4667100|NCT02828020|16049147|P1|Safety Follow-up Period|Lost to Follow-up|9
4667101|NCT02828020|16049145|P3|Safety Follow-up Period|Withdrawal of Consent|7
4667102|NCT02828020|16049146|P2|Safety Follow-up Period|Withdrawal of Consent|8
4667103|NCT02828020|16049147|P1|Safety Follow-up Period|Withdrawal of Consent|10
4667104|NCT02828020|16049145|P3|Treatment Period|Other Miscellaneous Reasons|0
4667105|NCT02828020|16049146|P2|Treatment Period|Other Miscellaneous Reasons|1
4667106|NCT02828020|16049147|P1|Treatment Period|Other Miscellaneous Reasons|0
4667107|NCT02828020|16049145|P3|Treatment Period|Protocol Violation|7
4667108|NCT02828020|16049146|P2|Treatment Period|Protocol Violation|4
4667109|NCT02828020|16049147|P1|Treatment Period|Protocol Violation|2
4667110|NCT02828020|16049145|P3|Treatment Period|Pregnancy|0
4667111|NCT02828020|16049146|P2|Treatment Period|Pregnancy|2
4667112|NCT02828020|16049147|P1|Treatment Period|Pregnancy|0
4667113|NCT02828020|16049145|P3|Treatment Period|Lack of Qualifying Event|43
4667114|NCT02828020|16049146|P2|Treatment Period|Lack of Qualifying Event|53
4667115|NCT02828020|16049147|P1|Treatment Period|Lack of Qualifying Event|44
4667116|NCT02828020|16049145|P3|Treatment Period|Lost to Follow-up|18
4667117|NCT02828020|16049146|P2|Treatment Period|Lost to Follow-up|24
4667118|NCT02828020|16049147|P1|Treatment Period|Lost to Follow-up|21
4667119|NCT02828020|16049145|P3|Treatment Period|Withdrawal of Consent|9
4667120|NCT02828020|16049146|P2|Treatment Period|Withdrawal of Consent|14
4667121|NCT02828020|16049147|P1|Treatment Period|Withdrawal of Consent|10
4667122|NCT02828020|16049145|P3|Treatment Period|Adverse Event|1
4667123|NCT02828020|16049146|P2|Treatment Period|Adverse Event|1
4667124|NCT02828020|16049147|P1|Treatment Period|Adverse Event|3
4667125|NCT02827708|16049178|P2|Overall Study|Death|2
4667126|NCT02827708|16049179|P1|Overall Study|Death|1
4667127|NCT02827708|16049178|P2|Overall Study|Withdrawal by Subject|2
4667128|NCT02827708|16049179|P1|Overall Study|Withdrawal by Subject|1
4667129|NCT02827708|16049178|P2|Overall Study|Lost to Follow-up|1
4667130|NCT02827708|16049179|P1|Overall Study|Lost to Follow-up|3
4667131|NCT02827500|16049258|P2|Overall Study|Other|1
4667132|NCT02827500|16049259|P1|Overall Study|Other|5
4667133|NCT02827500|16049258|P2|Overall Study|Missing primary endpoint data|1
4667134|NCT02827500|16049259|P1|Overall Study|Missing primary endpoint data|3
4667135|NCT02827500|16049258|P2|Overall Study|Withdrawal by Subject|1
4667136|NCT02827500|16049259|P1|Overall Study|Withdrawal by Subject|3
4667137|NCT02827500|16049258|P2|Overall Study|Lost to Follow-up|1
4667138|NCT02827500|16049259|P1|Overall Study|Lost to Follow-up|1
4667139|NCT02827500|16049258|P2|Overall Study|Death|3
4667140|NCT02827500|16049259|P1|Overall Study|Death|7
4667141|NCT02826798|16049280|P5|Overall Study|Withdrawal by Subject|0
4667142|NCT02826798|16049281|P4|Overall Study|Withdrawal by Subject|1
4667143|NCT02826798|16049282|P3|Overall Study|Withdrawal by Subject|0
4667144|NCT02826798|16049283|P2|Overall Study|Withdrawal by Subject|1
4667145|NCT02826798|16049284|P1|Overall Study|Withdrawal by Subject|0
4667146|NCT02826603|16049346|P2|Overall Study|New therapy for study indication|1
4667147|NCT02826603|16049347|P1|Overall Study|New therapy for study indication|0
4667148|NCT02826603|16049346|P2|Overall Study|Death|0
4667149|NCT02826603|16049347|P1|Overall Study|Death|2
4667150|NCT02826603|16049346|P2|Overall Study|Withdrawal by Subject|19
4667151|NCT02826603|16049347|P1|Overall Study|Withdrawal by Subject|20
4667152|NCT02826603|16049346|P2|Overall Study|Protocol Violation|3
4667153|NCT02826603|16049347|P1|Overall Study|Protocol Violation|3
4667154|NCT02826603|16049346|P2|Overall Study|Pregnancy|2
4667155|NCT02826603|16049347|P1|Overall Study|Pregnancy|1
4667156|NCT02826603|16049346|P2|Overall Study|Physician Decision|7
4667157|NCT02826603|16049347|P1|Overall Study|Physician Decision|1
4667158|NCT02826603|16049346|P2|Overall Study|Noncompliance with treatment|2
4667159|NCT02826603|16049347|P1|Overall Study|Noncompliance with treatment|0
4667160|NCT02826603|16049346|P2|Overall Study|Lost to Follow-up|12
4667161|NCT02826603|16049347|P1|Overall Study|Lost to Follow-up|13
4667162|NCT02826603|16049346|P2|Overall Study|Lack of Efficacy|9
4667163|NCT02826603|16049347|P1|Overall Study|Lack of Efficacy|4
4667164|NCT02826603|16049346|P2|Overall Study|Adverse Event|9
4667165|NCT02826603|16049347|P1|Overall Study|Adverse Event|17
4667166|NCT02826421|16049387|P4|Overall Study|Reason not given|0
4667167|NCT02826421|16049388|P3|Overall Study|Reason not given|1
4667168|NCT02826421|16049389|P2|Overall Study|Reason not given|0
4667169|NCT02826421|16049390|P1|Overall Study|Reason not given|1
4667170|NCT02826421|16049387|P4|Overall Study|Withdrawal by Subject|1
4667171|NCT02826421|16049388|P3|Overall Study|Withdrawal by Subject|1
4667172|NCT02826421|16049389|P2|Overall Study|Withdrawal by Subject|3
4667173|NCT02826421|16049390|P1|Overall Study|Withdrawal by Subject|1
4667174|NCT02826421|16049387|P4|Overall Study|Adverse Event|1
4667175|NCT02826421|16049388|P3|Overall Study|Adverse Event|0
4667176|NCT02826421|16049389|P2|Overall Study|Adverse Event|0
4667177|NCT02826421|16049390|P1|Overall Study|Adverse Event|1
4667178|NCT02825992|16049402|P1|Overall Study|Procedure terminated|2
4667179|NCT02825992|16049402|P1|Overall Study|Lost to Follow-up|2
4667180|NCT02825992|16049402|P1|Overall Study|Withdrawal by Subject|4
4667181|NCT02825550|16049423|P1|Overall Study|Physician Decision|1
4667182|NCT02825251|16049431|P2|Overall Study|Unclassified|0
4667183|NCT02825251|16049432|P1|Overall Study|Unclassified|2
4667184|NCT02825251|16049431|P2|Overall Study|Withdrawal by Subject|4
4667185|NCT02825251|16049432|P1|Overall Study|Withdrawal by Subject|1
4667186|NCT02825251|16049431|P2|Overall Study|Lost to Follow-up|1
4667187|NCT02825251|16049432|P1|Overall Study|Lost to Follow-up|0
4667188|NCT02825251|16049431|P2|Overall Study|Adverse Event|1
4667189|NCT02825251|16049432|P1|Overall Study|Adverse Event|0
4667190|NCT02825043|16049618|P1|Overall Study|Lost to Follow-up|4
4667191|NCT02824562|16049640|P2|Overall Study|Death|1
4667192|NCT02824562|16049641|P1|Overall Study|Death|0
4667193|NCT02824562|16049640|P2|Overall Study|Lost to Follow-up|4
4667194|NCT02824562|16049641|P1|Overall Study|Lost to Follow-up|3
4667195|NCT02824432|16049650|P2|Overall Study|Major Protocol Deviation|0
4667196|NCT02824432|16049651|P1|Overall Study|Major Protocol Deviation|1
4667197|NCT02824224|16049727|P2|Overall Study|Did not show up for allocation visit|0
4667198|NCT02824224|16049728|P1|Overall Study|Did not show up for allocation visit|2
4667199|NCT02824224|16049727|P2|Overall Study|Discontinued, IUS expulsion|1
4667200|NCT02824224|16049728|P1|Overall Study|Discontinued, IUS expulsion|0
4667201|NCT02824198|16049748|P2|Overall Study|Withdrawal by Subject|0
4667202|NCT02824198|16049749|P1|Overall Study|Withdrawal by Subject|5
4667203|NCT02824198|16049748|P2|Overall Study|Lost to Follow-up|2
4667204|NCT02824198|16049749|P1|Overall Study|Lost to Follow-up|5
4667205|NCT02824198|16049748|P2|Overall Study|Non-compliance with the protocol|1
4667206|NCT02824198|16049749|P1|Overall Study|Non-compliance with the protocol|5
4667207|NCT02823964|16049779|P1|Overall Study|Withdrawal by Subject|1
4667208|NCT02823964|16049779|P1|Overall Study|Lack of Efficacy|1
4667209|NCT02823964|16049779|P1|Overall Study|Physician Decision|1
4667210|NCT02823964|16049779|P1|Overall Study|Adverse Event|2
4667211|NCT02823470|16049793|P2|Overall Study|Study terminated by sponsor|15
4667212|NCT02823470|16049794|P1|Overall Study|Study terminated by sponsor|8
4667213|NCT02823470|16049793|P2|Overall Study|Adverse Event|0
4667214|NCT02823470|16049794|P1|Overall Study|Adverse Event|1
4667215|NCT02822794|16049862|P2|Overall Study|Withdrew Consent|0
4667216|NCT02822794|16049863|P1|Overall Study|Withdrew Consent|1
4667217|NCT02822235|16049964|P2|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1
4667218|NCT02822235|16049965|P1|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6
4667219|NCT02822235|16049964|P2|Prospective Phase (Day 1 up to Month 12)|Death|0
4667220|NCT02822235|16049965|P1|Prospective Phase (Day 1 up to Month 12)|Death|1
4667221|NCT02822235|16049964|P2|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0
4667222|NCT02822235|16049965|P1|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4
4667223|NCT02822235|16049964|P2|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1
4667224|NCT02822235|16049965|P1|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0
4667225|NCT02822235|16049964|P2|Cross-sectional Phase (Day 1)|Reason Not Specified|0
4667226|NCT02822235|16049965|P1|Cross-sectional Phase (Day 1)|Reason Not Specified|2
4667227|NCT02822235|16049964|P2|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107
4667228|NCT02822235|16049965|P1|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144
4667229|NCT02822222|16050020|P2|Overall Study|Protocol requirement SBP<110 mmHg|0
4667230|NCT02822222|16050021|P1|Overall Study|Protocol requirement SBP<110 mmHg|1
4667231|NCT02821962|16050071|P2|Overall Study|Lost to Follow-up|0
4667232|NCT02821962|16050072|P1|Overall Study|Lost to Follow-up|2
4667233|NCT02821910|16050116|P6|Overall Study|Other than specified|0
4667234|NCT02821910|16050117|P5|Overall Study|Other than specified|0
4667235|NCT02821910|16050118|P4|Overall Study|Other than specified|0
4667236|NCT02821910|16050119|P3|Overall Study|Other than specified|1
4667237|NCT02821910|16050120|P2|Overall Study|Other than specified|0
4667238|NCT02821910|16050121|P1|Overall Study|Other than specified|1
4667239|NCT02821910|16050116|P6|Overall Study|Withdrawal by Subject|1
4667240|NCT02821910|16050117|P5|Overall Study|Withdrawal by Subject|0
4667241|NCT02821910|16050118|P4|Overall Study|Withdrawal by Subject|0
4667242|NCT02821910|16050119|P3|Overall Study|Withdrawal by Subject|1
4667243|NCT02821910|16050120|P2|Overall Study|Withdrawal by Subject|0
4667244|NCT02821910|16050121|P1|Overall Study|Withdrawal by Subject|0
4667245|NCT02821819|16050183|P1|Overall Study|Protocol Violation|1
4667246|NCT02821715|16050188|P6|Overall Study|Protocol Violation|0
4667247|NCT02821715|16050189|P5|Overall Study|Protocol Violation|0
4667248|NCT02821715|16050190|P4|Overall Study|Protocol Violation|0
4667249|NCT02821715|16050191|P3|Overall Study|Protocol Violation|0
4667250|NCT02821715|16050192|P2|Overall Study|Protocol Violation|0
4667251|NCT02821715|16050193|P1|Overall Study|Protocol Violation|1
4667252|NCT02821000|16050280|P1|Overall Study|Ongoing in Study|58
4667253|NCT02821000|16050280|P1|Overall Study|Withdrawal by Subject|1
4667254|NCT02821000|16050280|P1|Overall Study|Death|44
4667255|NCT02820844|16050318|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1
4667256|NCT02820844|16050319|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667257|NCT02820844|16050320|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667258|NCT02820844|16050321|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667259|NCT02820844|16050322|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667260|NCT02820844|16050323|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667261|NCT02820844|16050318|P6|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4667262|NCT02820844|16050319|P5|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2
4667263|NCT02820844|16050320|P4|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4667264|NCT02820844|16050321|P3|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4667265|NCT02820844|16050322|P2|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4667266|NCT02820844|16050323|P1|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0
4667267|NCT02820844|16050318|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667268|NCT02820844|16050319|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667269|NCT02820844|16050320|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2
4667270|NCT02820844|16050321|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7
4667271|NCT02820844|16050322|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667272|NCT02820844|16050323|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0
4667273|NCT02820844|16050318|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4667274|NCT02820844|16050319|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4667275|NCT02820844|16050320|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4667276|NCT02820844|16050321|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1
4667277|NCT02820844|16050322|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4667278|NCT02820844|16050323|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0
4667279|NCT02820844|16050318|P6|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4667280|NCT02820844|16050319|P5|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4667281|NCT02820844|16050320|P4|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2
4667282|NCT02820844|16050321|P3|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1
4667283|NCT02820844|16050322|P2|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4667284|NCT02820844|16050323|P1|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0
4667285|NCT02820844|16050318|P6|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4667286|NCT02820844|16050319|P5|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4667287|NCT02820844|16050320|P4|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4667288|NCT02820844|16050321|P3|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4667289|NCT02820844|16050322|P2|Double-blinded (Up to 48 Weeks)|Investigator discretion|0
4667290|NCT02820844|16050323|P1|Double-blinded (Up to 48 Weeks)|Investigator discretion|1
4667291|NCT02820844|16050318|P6|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4667292|NCT02820844|16050319|P5|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4667293|NCT02820844|16050320|P4|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4667294|NCT02820844|16050321|P3|Double-blinded (Up to 48 Weeks)|Adverse Event|0
4667295|NCT02820844|16050322|P2|Double-blinded (Up to 48 Weeks)|Adverse Event|1
4667296|NCT02820844|16050323|P1|Double-blinded (Up to 48 Weeks)|Adverse Event|2
4667297|NCT02820844|16050318|P6|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4667298|NCT02820844|16050319|P5|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4667299|NCT02820844|16050320|P4|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4667300|NCT02820844|16050321|P3|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4667301|NCT02820844|16050322|P2|Double-blinded (Up to 48 Weeks)|Protocol Violation|3
4667302|NCT02820844|16050323|P1|Double-blinded (Up to 48 Weeks)|Protocol Violation|0
4667303|NCT02820844|16050318|P6|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4667304|NCT02820844|16050319|P5|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4667305|NCT02820844|16050320|P4|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4667306|NCT02820844|16050321|P3|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0
4667307|NCT02820844|16050322|P2|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2
4667308|NCT02820844|16050323|P1|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1
4667309|NCT02820844|16050318|P6|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4667310|NCT02820844|16050319|P5|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4667311|NCT02820844|16050320|P4|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4667312|NCT02820844|16050321|P3|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0
4667313|NCT02820844|16050322|P2|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3
4667314|NCT02820844|16050323|P1|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1
4667315|NCT02820597|16050537|P1|Overall Study|Lost to Follow-up|12
4667316|NCT02820038|16050588|P4|Overall Study|Withdrawal by Subject|13
4667317|NCT02820038|16050589|P3|Overall Study|Withdrawal by Subject|3
4667318|NCT02820038|16050590|P2|Overall Study|Withdrawal by Subject|14
4667319|NCT02820038|16050591|P1|Overall Study|Withdrawal by Subject|3
4667320|NCT02820038|16050588|P4|Overall Study|Lost to Follow-up|9
4667321|NCT02820038|16050589|P3|Overall Study|Lost to Follow-up|2
4667322|NCT02820038|16050590|P2|Overall Study|Lost to Follow-up|11
4667323|NCT02820038|16050591|P1|Overall Study|Lost to Follow-up|7
4667324|NCT02819804|16050718|P1|Complete Cycle 1 (28 Days)|Progressive disease/no response|1
4667325|NCT02819726|16050725|P4|Part B (All Participants)|Protocol non-compliance|0
4667326|NCT02819726|16050726|P3|Part B (All Participants)|Protocol non-compliance|1
4667327|NCT02819726|16050727|P2|Part B (All Participants)|Protocol non-compliance|0
4667328|NCT02819726|16050728|P1|Part B (All Participants)|Protocol non-compliance|0
4667329|NCT02819726|16050725|P4|Part B (All Participants)|Withdrawal by Subject|0
4667330|NCT02819726|16050726|P3|Part B (All Participants)|Withdrawal by Subject|1
4667331|NCT02819726|16050727|P2|Part B (All Participants)|Withdrawal by Subject|1
4667332|NCT02819726|16050728|P1|Part B (All Participants)|Withdrawal by Subject|2
4667333|NCT02819726|16050725|P4|Part B (All Participants)|Lost to Follow-up|2
4667334|NCT02819726|16050726|P3|Part B (All Participants)|Lost to Follow-up|2
4667335|NCT02819726|16050727|P2|Part B (All Participants)|Lost to Follow-up|1
4667336|NCT02819726|16050728|P1|Part B (All Participants)|Lost to Follow-up|1
4667337|NCT02819726|16050725|P4|Part A (All Participants)|Protocol non-compliance|0
4667338|NCT02819726|16050726|P3|Part A (All Participants)|Protocol non-compliance|5
4667339|NCT02819726|16050727|P2|Part A (All Participants)|Protocol non-compliance|4
4667340|NCT02819726|16050728|P1|Part A (All Participants)|Protocol non-compliance|3
4667341|NCT02819726|16050725|P4|Part A (All Participants)|Withdrawal by Subject|0
4667342|NCT02819726|16050726|P3|Part A (All Participants)|Withdrawal by Subject|6
4667343|NCT02819726|16050727|P2|Part A (All Participants)|Withdrawal by Subject|5
4667344|NCT02819726|16050728|P1|Part A (All Participants)|Withdrawal by Subject|3
4667345|NCT02819726|16050725|P4|Part A (All Participants)|Lost to Follow-up|0
4667346|NCT02819726|16050726|P3|Part A (All Participants)|Lost to Follow-up|0
4667347|NCT02819726|16050727|P2|Part A (All Participants)|Lost to Follow-up|1
4667348|NCT02819726|16050728|P1|Part A (All Participants)|Lost to Follow-up|0
4667349|NCT02819310|16050855|P1|Overall Study|Protocol Violation|30
4667350|NCT02819310|16050855|P1|Overall Study|Physician Decision|8
4667351|NCT02819310|16050855|P1|Overall Study|Lack of Efficacy|5
4667352|NCT02819310|16050855|P1|Overall Study|Adverse Event|13
4667353|NCT02819310|16050855|P1|Overall Study|Lost to Follow-up|16
4667354|NCT02819310|16050855|P1|Overall Study|Withdrawal by Subject|37
4667355|NCT02819297|16050861|P2|Overall Study|Protocol Violation|2
4667356|NCT02819297|16050862|P1|Overall Study|Protocol Violation|1
4667357|NCT02819297|16050861|P2|Overall Study|Lack of Efficacy|8
4667358|NCT02819297|16050862|P1|Overall Study|Lack of Efficacy|5
4667359|NCT02819297|16050861|P2|Overall Study|Physician Decision|5
4667360|NCT02819297|16050862|P1|Overall Study|Physician Decision|5
4667361|NCT02819297|16050861|P2|Overall Study|Adverse Event|10
4667362|NCT02819297|16050862|P1|Overall Study|Adverse Event|12
4667363|NCT02819297|16050861|P2|Overall Study|Lost to Follow-up|14
4667364|NCT02819297|16050862|P1|Overall Study|Lost to Follow-up|12
4667365|NCT02819297|16050861|P2|Overall Study|Withdrawal by Subject|13
4667366|NCT02819297|16050862|P1|Overall Study|Withdrawal by Subject|25
4667367|NCT02818998|16050901|P3|Overall Study|Physician Decision|0
4667368|NCT02818998|16050902|P2|Overall Study|Physician Decision|0
4667369|NCT02818998|16050903|P1|Overall Study|Physician Decision|1
4667370|NCT02818998|16050901|P3|Overall Study|Withdrawal by Subject|6
4667371|NCT02818998|16050902|P2|Overall Study|Withdrawal by Subject|6
4667372|NCT02818998|16050903|P1|Overall Study|Withdrawal by Subject|7
4667373|NCT02818998|16050901|P3|Overall Study|Death|8
4667374|NCT02818998|16050902|P2|Overall Study|Death|6
4667375|NCT02818998|16050903|P1|Overall Study|Death|3
4667376|NCT02818998|16050901|P3|Overall Study|Withdrawal by sponsor|1
4667377|NCT02818998|16050902|P2|Overall Study|Withdrawal by sponsor|1
4667378|NCT02818998|16050903|P1|Overall Study|Withdrawal by sponsor|0
4667379|NCT02818998|16050901|P3|Overall Study|Lost to Follow-up|2
4667380|NCT02818998|16050902|P2|Overall Study|Lost to Follow-up|1
4667381|NCT02818998|16050903|P1|Overall Study|Lost to Follow-up|4
4667382|NCT02818998|16050901|P3|Overall Study|Adverse Event|1
4667383|NCT02818998|16050902|P2|Overall Study|Adverse Event|2
4667384|NCT02818998|16050903|P1|Overall Study|Adverse Event|3
4667385|NCT02818920|16050936|P1|Overall Study|Refused Further Treatment|1
4667386|NCT02818920|16050936|P1|Overall Study|Developed Other Disease|1
4667387|NCT02818920|16050936|P1|Overall Study|Adverse Event|3
4667388|NCT02818920|16050936|P1|Overall Study|Went Off Study Prior to Adjuvant Therapy|8
4667389|NCT02818920|16050936|P1|Overall Study|Progressed After Neoadjuvant Therapy|1
4667390|NCT02818920|16050936|P1|Overall Study|Unresectable|4
4667391|NCT02818777|16050940|P1|Overall Study|Adverse Event|3
4667392|NCT02818036|16051007|P2|Overall Study|Withdrawal by Subject|0
4667393|NCT02818036|16051008|P1|Overall Study|Withdrawal by Subject|1
4667394|NCT02818036|16051007|P2|Overall Study|head did not fit in fMRI scanner headres|0
4667395|NCT02818036|16051008|P1|Overall Study|head did not fit in fMRI scanner headres|1
4667396|NCT02817841|16051016|P1|Overall Study|Protocol Violation|94
4667397|NCT02817841|16051016|P1|Overall Study|Other reasons|53
4667398|NCT02817841|16051016|P1|Overall Study|Pregnancy wish|17
4667399|NCT02817841|16051016|P1|Overall Study|Pregnancy|32
4667400|NCT02817841|16051016|P1|Overall Study|Adverse event related to bleeding|51
4667401|NCT02817841|16051016|P1|Overall Study|Adverse event not related to bleeding|131
4667402|NCT02817841|16051016|P1|Overall Study|Withdrawal by Subject|183
4667403|NCT02817841|16051016|P1|Overall Study|Lost to Follow-up|287
4667404|NCT02817828|16051043|P1|Overall Study|Other|26
4667405|NCT02817828|16051043|P1|Overall Study|Withdrawal by Subject|78
4667406|NCT02817828|16051043|P1|Overall Study|Pregnancy wish|15
4667407|NCT02817828|16051043|P1|Overall Study|Pregnancy|7
4667408|NCT02817828|16051043|P1|Overall Study|Protocol Violation|11
4667409|NCT02817828|16051043|P1|Overall Study|Adverse event related to bleeding|53
4667410|NCT02817828|16051043|P1|Overall Study|Adverse event not related to bleeding|104
4667411|NCT02817828|16051043|P1|Overall Study|Lost to Follow-up|41
4667412|NCT02817594|16051078|P1|Overall Study|Did Not Receive Treatment|1
4667413|NCT02817594|16051078|P1|Overall Study|Other|1
4667414|NCT02817594|16051078|P1|Overall Study|Withdrawal by Subject|1
4667415|NCT02817555|16051099|P2|Overall Study|changed to Peritoneal Dialysis|1
4667416|NCT02817555|16051100|P1|Overall Study|changed to Peritoneal Dialysis|0
4667417|NCT02817555|16051099|P2|Overall Study|transplant|1
4667418|NCT02817555|16051100|P1|Overall Study|transplant|1
4667419|NCT02817555|16051099|P2|Overall Study|moved away|0
4667420|NCT02817555|16051100|P1|Overall Study|moved away|1
4667421|NCT02817555|16051099|P2|Overall Study|Death|3
4667422|NCT02817555|16051100|P1|Overall Study|Death|1
4667423|NCT02817516|16051120|P4|Overall Study|Other|0
4667424|NCT02817516|16051121|P3|Overall Study|Other|1
4667425|NCT02817516|16051122|P2|Overall Study|Other|0
4667426|NCT02817516|16051123|P1|Overall Study|Other|0
4667427|NCT02817087|16051160|P2|Overall Study|Withdrawal by Subject|0
4667428|NCT02817087|16051161|P1|Overall Study|Withdrawal by Subject|2
4667429|NCT02816398|16051232|P1|Overall Study|Lost to Follow-up|1
4667430|NCT02816398|16051232|P1|Overall Study|Lack of Efficacy|8
4667431|NCT02816398|16051232|P1|Overall Study|Death|5
4667432|NCT02816138|16051290|P1|Overall Study|Adverse Event|1
4667433|NCT02815735|16051336|P2|Second Intervention (4 Weeks)|Protocol Violation|0
4667434|NCT02815735|16051337|P1|Second Intervention (4 Weeks)|Protocol Violation|1
4667435|NCT02815735|16051336|P2|First Intervention (4 Weeks)|Poor fitting characteristics|1
4667436|NCT02815735|16051337|P1|First Intervention (4 Weeks)|Poor fitting characteristics|0
4667437|NCT02815735|16051336|P2|First Intervention (4 Weeks)|Lost to Follow-up|0
4667438|NCT02815735|16051337|P1|First Intervention (4 Weeks)|Lost to Follow-up|1
4667439|NCT02815735|16051336|P2|First Intervention (4 Weeks)|Discomfort|0
4667440|NCT02815735|16051337|P1|First Intervention (4 Weeks)|Discomfort|1
4667441|NCT02815670|16051391|P1|Overall Study|Prematurely discontinued of the trial|1
4667442|NCT02815397|16051423|P1|Overall Study|Physician Decision|2
4667443|NCT02815293|16051433|P3|Overall Study|Adverse Event|0
4667444|NCT02815293|16051434|P2|Overall Study|Adverse Event|1
4667445|NCT02815293|16051435|P1|Overall Study|Adverse Event|0
4667446|NCT02815293|16051433|P3|Overall Study|Participants not randomized|18
4667447|NCT02815293|16051434|P2|Overall Study|Participants not randomized|0
4667448|NCT02815293|16051435|P1|Overall Study|Participants not randomized|0
4667449|NCT02815293|16051433|P3|Overall Study|Study termination by sponsor|0
4667450|NCT02815293|16051434|P2|Overall Study|Study termination by sponsor|7
4667451|NCT02815293|16051435|P1|Overall Study|Study termination by sponsor|10
4667452|NCT02815267|16051445|P2|Open-Label Phase|Other|5
4667453|NCT02815267|16051446|P1|Open-Label Phase|Other|2
4667454|NCT02815267|16051445|P2|Open-Label Phase|Administrative|12
4667455|NCT02815267|16051446|P1|Open-Label Phase|Administrative|21
4667456|NCT02815267|16051445|P2|Open-Label Phase|Protocol Violation|1
4667457|NCT02815267|16051446|P1|Open-Label Phase|Protocol Violation|0
4667458|NCT02815267|16051445|P2|Open-Label Phase|Withdrawal by Subject|13
4667459|NCT02815267|16051446|P1|Open-Label Phase|Withdrawal by Subject|24
4667460|NCT02815267|16051445|P2|Open-Label Phase|Lost to Follow-up|9
4667461|NCT02815267|16051446|P1|Open-Label Phase|Lost to Follow-up|23
4667462|NCT02815267|16051445|P2|Open-Label Phase|Adverse Event|1
4667463|NCT02815267|16051446|P1|Open-Label Phase|Adverse Event|1
4667464|NCT02815267|16051445|P2|Double-Blind Phase|Received a disallowed medication|1
4667465|NCT02815267|16051446|P1|Double-Blind Phase|Received a disallowed medication|1
4667466|NCT02815267|16051445|P2|Double-Blind Phase|Site withdrawal|6
4667467|NCT02815267|16051446|P1|Double-Blind Phase|Site withdrawal|1
4667468|NCT02815267|16051445|P2|Double-Blind Phase|Protocol Violation|2
4667469|NCT02815267|16051446|P1|Double-Blind Phase|Protocol Violation|3
4667470|NCT02815267|16051445|P2|Double-Blind Phase|Withdrawal by Subject|10
4667471|NCT02815267|16051446|P1|Double-Blind Phase|Withdrawal by Subject|11
4667472|NCT02815267|16051445|P2|Double-Blind Phase|Lost to Follow-up|9
4667473|NCT02815267|16051446|P1|Double-Blind Phase|Lost to Follow-up|17
4667474|NCT02815267|16051445|P2|Double-Blind Phase|Adverse Event|3
4667475|NCT02815267|16051446|P1|Double-Blind Phase|Adverse Event|0
4667476|NCT02814643|16051586|P2|Overall Study|Withdrawal by Subject|2
4667477|NCT02814643|16051587|P1|Overall Study|Withdrawal by Subject|1
4667478|NCT02814643|16051586|P2|Overall Study|Lost to Follow-up|1
4667479|NCT02814643|16051587|P1|Overall Study|Lost to Follow-up|0
4667480|NCT02814565|16051611|P2|Overall Study|Subject decision, caused by AE Influenza|1
4667481|NCT02814565|16051612|P1|Overall Study|Subject decision, caused by AE Influenza|1
4667482|NCT02814565|16051611|P2|Overall Study|Lack of Efficacy|1
4667483|NCT02814565|16051612|P1|Overall Study|Lack of Efficacy|0
4667484|NCT02813694|16051682|P2|Overall Study|Patient hospitalized|0
4667485|NCT02813694|16051683|P1|Overall Study|Patient hospitalized|1
4667486|NCT02813694|16051682|P2|Overall Study|Randomized- did not receive study drug|0
4667487|NCT02813694|16051683|P1|Overall Study|Randomized- did not receive study drug|2
4667488|NCT02813694|16051682|P2|Overall Study|Death|3
4667489|NCT02813694|16051683|P1|Overall Study|Death|3
4667490|NCT02813694|16051682|P2|Overall Study|Lost to Follow-up|1
4667491|NCT02813694|16051683|P1|Overall Study|Lost to Follow-up|1
4667492|NCT02813694|16051682|P2|Overall Study|Withdrawal by Subject|9
4667493|NCT02813694|16051683|P1|Overall Study|Withdrawal by Subject|10
4667494|NCT02813694|16051682|P2|Overall Study|Physician Decision|1
4667495|NCT02813694|16051683|P1|Overall Study|Physician Decision|0
4667496|NCT02813681|16051696|P3|Overall Study|Lost to Follow-up|0
4667497|NCT02813681|16051697|P2|Overall Study|Lost to Follow-up|1
4667498|NCT02813681|16051698|P1|Overall Study|Lost to Follow-up|0
4667499|NCT02813681|16051696|P3|Overall Study|Physician Decision|0
4667500|NCT02813681|16051697|P2|Overall Study|Physician Decision|5
4667501|NCT02813681|16051698|P1|Overall Study|Physician Decision|5
4667502|NCT02813577|16051719|P1|Overall Study|Study terminated|4
4667503|NCT02812186|16051796|P2|Period 1|nonevaluable data sets|6
4667504|NCT02812186|16051797|P1|Period 1|nonevaluable data sets|6
4667505|NCT02812186|16051796|P2|Period 1|Post randomization screen failure|9
4667506|NCT02812186|16051797|P1|Period 1|Post randomization screen failure|5
4667507|NCT02811159|16051861|P1|Treatment Course 1|Lost to Follow-up|1
4667508|NCT02810457|16051900|P2|Overall Study|Physician Decision|1
4667509|NCT02810457|16051901|P1|Overall Study|Physician Decision|0
4667510|NCT02810457|16051900|P2|Overall Study|Miscalculated PD|0
4667511|NCT02810457|16051901|P1|Overall Study|Miscalculated PD|1
4667512|NCT02810457|16051900|P2|Overall Study|Patient ineligibility|0
4667513|NCT02810457|16051901|P1|Overall Study|Patient ineligibility|3
4667514|NCT02810457|16051900|P2|Overall Study|Investigator decision|2
4667515|NCT02810457|16051901|P1|Overall Study|Investigator decision|3
4667516|NCT02810457|16051900|P2|Overall Study|Clinical progression|16
4667517|NCT02810457|16051901|P1|Overall Study|Clinical progression|15
4667518|NCT02810457|16051900|P2|Overall Study|Ongoing at data cutoff and discontinued|2
4667519|NCT02810457|16051901|P1|Overall Study|Ongoing at data cutoff and discontinued|3
4667520|NCT02810457|16051900|P2|Overall Study|Death|28
4667521|NCT02810457|16051901|P1|Overall Study|Death|39
4667522|NCT02810457|16051900|P2|Overall Study|Patient lost to follow-up|2
4667523|NCT02810457|16051901|P1|Overall Study|Patient lost to follow-up|2
4667524|NCT02810457|16051900|P2|Overall Study|Patient decision|35
4667525|NCT02810457|16051901|P1|Overall Study|Patient decision|31
4667526|NCT02810457|16051900|P2|Overall Study|Adverse Event|43
4667527|NCT02810457|16051901|P1|Overall Study|Adverse Event|37
4667528|NCT02810457|16051900|P2|Overall Study|Objective PD assessed by RECIST v1.1|199
4667529|NCT02810457|16051901|P1|Overall Study|Objective PD assessed by RECIST v1.1|191
4667530|NCT02810457|16051900|P2|Overall Study|Randomised but no treatment received|1
4667531|NCT02810457|16051901|P1|Overall Study|Randomised but no treatment received|2
4667532|NCT02809976|16051930|P1|Overall Study|Withdrawal by Subject|1
4667533|NCT02809976|16051930|P1|Overall Study|Lost to Follow-up|1
4667534|NCT02809833|16051968|P1|Overall Study|Missing Information|52
4667535|NCT02809833|16051968|P1|Overall Study|Other|5
4667536|NCT02809833|16051968|P1|Overall Study|Adverse Event (AE)|24
4667537|NCT02809833|16051968|P1|Overall Study|Lost to Follow-up|35
4667538|NCT02809833|16051968|P1|Overall Study|Withdrawal by Subject|34
4667539|NCT02809833|16051968|P1|Overall Study|Noncompliance|1
4667540|NCT02809833|16051968|P1|Overall Study|Remission/Treatment No Longer Needed|3
4667541|NCT02809833|16051968|P1|Overall Study|Lack of Efficacy|89
4667542|NCT02809833|16051968|P1|Overall Study|Intolerance|54
4667543|NCT02809833|16051968|P1|Overall Study|Death|3
4667544|NCT02809118|16052089|P3|Overall Study|Withdrawal by Subject|1
4667545|NCT02809118|16052090|P2|Overall Study|Withdrawal by Subject|1
4667546|NCT02809118|16052091|P1|Overall Study|Withdrawal by Subject|0
4667547|NCT02809053|16052104|P2|Overall Study|Disease Progression|1
4667548|NCT02809053|16052105|P1|Overall Study|Disease Progression|2
4667549|NCT02809053|16052104|P2|Overall Study|Withdrawal by Subject|3
4667550|NCT02809053|16052105|P1|Overall Study|Withdrawal by Subject|2
4667551|NCT02809053|16052104|P2|Overall Study|Lost to Follow-up|1
4667552|NCT02809053|16052105|P1|Overall Study|Lost to Follow-up|3
4667553|NCT02809053|16052104|P2|Overall Study|Death|1
4667554|NCT02809053|16052105|P1|Overall Study|Death|0
4667555|NCT02808975|16052151|P2|Overall Study|Other, not specified|1
4667556|NCT02808975|16052152|P1|Overall Study|Other, not specified|5
4667557|NCT02808975|16052151|P2|Overall Study|Planned HS surgery performed prior Wk 13|0
4667558|NCT02808975|16052152|P1|Overall Study|Planned HS surgery performed prior Wk 13|1
4667559|NCT02808975|16052151|P2|Overall Study|Lost to Follow-up|6
4667560|NCT02808975|16052152|P1|Overall Study|Lost to Follow-up|4
4667561|NCT02808975|16052151|P2|Overall Study|Withdrew consent|8
4667562|NCT02808975|16052152|P1|Overall Study|Withdrew consent|9
4667563|NCT02808975|16052151|P2|Overall Study|Adverse Event|4
4667564|NCT02808975|16052152|P1|Overall Study|Adverse Event|3
4667565|NCT02808338|16052179|P1|Overnight In-lab Polysomonography|Reason not given|1
4667566|NCT02808338|16052179|P1|Overnight In-lab Polysomonography|Withdrawal by Subject|1
4667567|NCT02808338|16052179|P1|Screening|Screen Failure|10
4667568|NCT02808312|16052194|P4|Overall Study|Enrolled but Never Treated|1
4667569|NCT02808312|16052195|P3|Overall Study|Enrolled but Never Treated|0
4667570|NCT02808312|16052196|P2|Overall Study|Enrolled but Never Treated|0
4667571|NCT02808312|16052197|P1|Overall Study|Enrolled but Never Treated|0
4667572|NCT02807948|16052354|P2|Overall Study|Physician Decision|0
4667573|NCT02807948|16052355|P1|Overall Study|Physician Decision|1
4667574|NCT02807402|16052360|P1|Overall Study|Other|2
4667575|NCT02807402|16052360|P1|Overall Study|Death|3
4667576|NCT02807402|16052360|P1|Overall Study|Failure to Return|1
4667577|NCT02807376|16052398|P2|Overall Study|Lost to Follow-up|1
4667578|NCT02807376|16052399|P1|Overall Study|Lost to Follow-up|0
4667579|NCT02807376|16052398|P2|Overall Study|Intra-operative exclusion criteria|0
4667580|NCT02807376|16052399|P1|Overall Study|Intra-operative exclusion criteria|3
4667581|NCT02807259|16052409|P2|Endline (3 Months)|migration, refusal, not available|87
4667582|NCT02807259|16052410|P1|Endline (3 Months)|migration, refusal, not available|35
4667583|NCT02807259|16052409|P2|Midline (3 Months)|migration, refusal, not available|34
4667584|NCT02807259|16052410|P1|Midline (3 Months)|migration, refusal, not available|30
4667585|NCT02807259|16052409|P2|Baseline (3 Months)|migration, refusal, not available|112
4667586|NCT02807259|16052410|P1|Baseline (3 Months)|migration, refusal, not available|77
4667587|NCT02806986|16052428|P1|Treatment Stage 2|Withdrawal by Subject|2
4667588|NCT02806986|16052428|P1|Treatment Stage 2|Adverse Event|3
4667589|NCT02806986|16052428|P1|Treatment Stage 1|Adverse Event|1
4667590|NCT02806973|16052448|P4|Period 3|Adverse Event|0
4667591|NCT02806973|16052449|P3|Period 3|Adverse Event|1
4667592|NCT02806973|16052450|P2|Period 3|Adverse Event|0
4667593|NCT02806973|16052451|P1|Period 3|Adverse Event|0
4667594|NCT02806973|16052448|P4|Period 3|Withdrawal by Subject|3
4667595|NCT02806973|16052449|P3|Period 3|Withdrawal by Subject|0
4667596|NCT02806973|16052450|P2|Period 3|Withdrawal by Subject|0
4667597|NCT02806973|16052451|P1|Period 3|Withdrawal by Subject|0
4667598|NCT02806973|16052448|P4|Period 1|Adverse Event|1
4667599|NCT02806973|16052449|P3|Period 1|Adverse Event|0
4667600|NCT02806973|16052450|P2|Period 1|Adverse Event|0
4667601|NCT02806973|16052451|P1|Period 1|Adverse Event|0
4667602|NCT02806973|16052448|P4|Period 1|Withdrawal by Subject|1
4667603|NCT02806973|16052449|P3|Period 1|Withdrawal by Subject|1
4667604|NCT02806973|16052450|P2|Period 1|Withdrawal by Subject|2
4667605|NCT02806973|16052451|P1|Period 1|Withdrawal by Subject|0
4667606|NCT02806960|16052485|P4|Period 1|Study Terminated (withdrawn by sponsor)|3
4667607|NCT02806960|16052486|P3|Period 1|Study Terminated (withdrawn by sponsor)|3
4667608|NCT02806960|16052487|P2|Period 1|Study Terminated (withdrawn by sponsor)|3
4667609|NCT02806960|16052488|P1|Period 1|Study Terminated (withdrawn by sponsor)|3
4667610|NCT02806947|16052524|P2|Overall Study|Withdrawal by Subject|1
4667611|NCT02806947|16052525|P1|Overall Study|Withdrawal by Subject|5
4667612|NCT02806726|16052607|P1|Overall Study|Lost to Follow-up|1
4667613|NCT02806713|16052616|P2|Overall Study|cancelled surgery|2
4667614|NCT02806713|16052617|P1|Overall Study|cancelled surgery|1
4667615|NCT02806713|16052616|P2|Overall Study|Urethral injury during procedure|0
4667616|NCT02806713|16052617|P1|Overall Study|Urethral injury during procedure|1
4667617|NCT02806505|16052636|P2|Overall Study|Insufficient therapeutic response|4
4667618|NCT02806505|16052637|P1|Overall Study|Insufficient therapeutic response|2
4667619|NCT02806505|16052636|P2|Overall Study|Failure to return|1
4667620|NCT02806505|16052637|P1|Overall Study|Failure to return|0
4667621|NCT02806505|16052636|P2|Overall Study|Did not cooperate/refused treatment|3
4667622|NCT02806505|16052637|P1|Overall Study|Did not cooperate/refused treatment|3
4667623|NCT02806505|16052636|P2|Overall Study|Death|0
4667624|NCT02806505|16052637|P1|Overall Study|Death|4
4667625|NCT02806505|16052636|P2|Overall Study|Adverse event/intercurrent illness|3
4667626|NCT02806505|16052637|P1|Overall Study|Adverse event/intercurrent illness|1
4667627|NCT02806414|16052647|P1|Overall Study|Lost to Follow-up|2
4667628|NCT02806232|16052661|P9|Overall Study|Withdrawal by Subject|0
4667629|NCT02806232|16052662|P8|Overall Study|Withdrawal by Subject|0
4667630|NCT02806232|16052663|P7|Overall Study|Withdrawal by Subject|0
4667631|NCT02806232|16052664|P6|Overall Study|Withdrawal by Subject|1
4667632|NCT02806232|16052665|P5|Overall Study|Withdrawal by Subject|2
4667633|NCT02806232|16052666|P4|Overall Study|Withdrawal by Subject|0
4667634|NCT02806232|16052667|P3|Overall Study|Withdrawal by Subject|0
4667635|NCT02806232|16052668|P2|Overall Study|Withdrawal by Subject|2
4667636|NCT02806232|16052669|P1|Overall Study|Withdrawal by Subject|0
4667637|NCT02806232|16052661|P9|Overall Study|Lost to Follow-up|0
4667638|NCT02806232|16052662|P8|Overall Study|Lost to Follow-up|0
4667639|NCT02806232|16052663|P7|Overall Study|Lost to Follow-up|0
4667640|NCT02806232|16052664|P6|Overall Study|Lost to Follow-up|1
4667641|NCT02806232|16052665|P5|Overall Study|Lost to Follow-up|0
4667642|NCT02806232|16052666|P4|Overall Study|Lost to Follow-up|0
4667643|NCT02806232|16052667|P3|Overall Study|Lost to Follow-up|1
4667644|NCT02806232|16052668|P2|Overall Study|Lost to Follow-up|2
4667645|NCT02806232|16052669|P1|Overall Study|Lost to Follow-up|1
4667646|NCT02806024|16052709|P2|Overall Study|DVT during antepartum admission|1
4667647|NCT02806024|16052710|P1|Overall Study|DVT during antepartum admission|0
4667648|NCT02806024|16052709|P2|Overall Study|Night Delivery|1
4667649|NCT02806024|16052710|P1|Overall Study|Night Delivery|1
4667650|NCT02805907|16052720|P2|Overall Study|Lost to Follow-up|3
4667651|NCT02805907|16052721|P1|Overall Study|Lost to Follow-up|3
4667652|NCT02805790|16052735|P2|Second Intervention (4 Weeks)|Physician Decision|1
4667653|NCT02805790|16052736|P1|Second Intervention (4 Weeks)|Physician Decision|0
4667654|NCT02804750|16052771|P2|Period 4|Adverse Event|5
4667655|NCT02804750|16052772|P1|Period 4|Adverse Event|0
4667656|NCT02804750|16052771|P2|Period 3|Adverse Event|2
4667657|NCT02804750|16052772|P1|Period 3|Adverse Event|0
4667658|NCT02804750|16052771|P2|Period 2|Adverse Event|0
4667659|NCT02804750|16052772|P1|Period 2|Adverse Event|1
4667660|NCT02804750|16052771|P2|Period 1|Withdrawal by Subject|1
4667661|NCT02804750|16052772|P1|Period 1|Withdrawal by Subject|0
4667662|NCT02804750|16052771|P2|Period 1|Adverse Event|2
4667663|NCT02804750|16052772|P1|Period 1|Adverse Event|0
4667664|NCT02804399|16052799|P2|Period 2|Adverse Event|1
4667665|NCT02804399|16052800|P1|Period 2|Adverse Event|0
4667666|NCT02803580|16052872|P1|Overall Study|Inclusion in clinical trial|1
4667667|NCT02803580|16052872|P1|Overall Study|Withdrawal by Subject|3
4667668|NCT02803580|16052872|P1|Overall Study|Lost to Follow-up|19
4667669|NCT02803580|16052872|P1|Overall Study|Death|13
4667670|NCT02803138|16052911|P1|Overall Study|Other, not specified|28
4667671|NCT02803138|16052911|P1|Overall Study|Death|1
4667672|NCT02803138|16052911|P1|Overall Study|Withdrawn consent|1
4667673|NCT02803138|16052911|P1|Overall Study|Insufficient virological response|2
4667674|NCT02803138|16052911|P1|Overall Study|Failure to return|38
4667675|NCT02802878|16052927|P2|Overall Study|Protocol Violation|0
4667676|NCT02802878|16052928|P1|Overall Study|Protocol Violation|1
4667677|NCT02802878|16052927|P2|Overall Study|Withdrawal by Subject|3
4667678|NCT02802878|16052928|P1|Overall Study|Withdrawal by Subject|3
4667679|NCT02802865|16052944|P2|Overall Study|Ineliegible due to tuberculosis|1
4667680|NCT02802865|16052945|P1|Overall Study|Ineliegible due to tuberculosis|0
4667681|NCT02802865|16052944|P2|Overall Study|Pregnancy|1
4667682|NCT02802865|16052945|P1|Overall Study|Pregnancy|1
4667683|NCT02802592|16052967|P1|Overall Study|Study terminated due to loss of funding|4
4667684|NCT02802345|16053144|P2|Overall Study|Other than listed|5
4667685|NCT02802345|16053145|P1|Overall Study|Other than listed|1
4667686|NCT02802345|16053144|P2|Overall Study|Protocol Violation|1
4667687|NCT02802345|16053145|P1|Overall Study|Protocol Violation|0
4667688|NCT02802345|16053144|P2|Overall Study|Withdrawal by Subject|3
4667689|NCT02802345|16053145|P1|Overall Study|Withdrawal by Subject|3
4667690|NCT02802345|16053144|P2|Overall Study|Adverse Event|20
4667691|NCT02802345|16053145|P1|Overall Study|Adverse Event|28
4667692|NCT02802345|16053144|P2|Overall Study|Not Treated|1
4667693|NCT02802345|16053145|P1|Overall Study|Not Treated|0
4667694|NCT02802319|16053161|P2|Overall Study|Lost to Follow-up|4
4667695|NCT02802319|16053162|P1|Overall Study|Lost to Follow-up|0
4667696|NCT02802319|16053161|P2|Overall Study|Physician Decision|1
4667697|NCT02802319|16053162|P1|Overall Study|Physician Decision|2
4667698|NCT02801877|16053325|P4|Overall Study|Never Started Treatment|0
4667699|NCT02801877|16053326|P3|Overall Study|Never Started Treatment|4
4667700|NCT02801877|16053327|P2|Overall Study|Never Started Treatment|0
4667701|NCT02801877|16053328|P1|Overall Study|Never Started Treatment|2
4667702|NCT02801877|16053325|P4|Overall Study|Lost to Follow-up|0
4667703|NCT02801877|16053326|P3|Overall Study|Lost to Follow-up|2
4667704|NCT02801877|16053327|P2|Overall Study|Lost to Follow-up|1
4667705|NCT02801877|16053328|P1|Overall Study|Lost to Follow-up|1
4667706|NCT02801617|16053348|P2|Overall Study|Protocol Violation|6
4667707|NCT02801617|16053349|P1|Overall Study|Protocol Violation|2
4667708|NCT02801578|16053367|P1|Overall Study|Adverse Event|2
4667709|NCT02801396|16053371|P6|Period 1|Withdrawal by Subject|0
4667710|NCT02801396|16053372|P5|Period 1|Withdrawal by Subject|1
4667711|NCT02801396|16053373|P4|Period 1|Withdrawal by Subject|0
4667712|NCT02801396|16053374|P3|Period 1|Withdrawal by Subject|0
4667713|NCT02801396|16053375|P2|Period 1|Withdrawal by Subject|0
4667714|NCT02801396|16053376|P1|Period 1|Withdrawal by Subject|0
4667715|NCT02800928|16053421|P2|Overall Study|Protocol Violation|1
4667716|NCT02800928|16053422|P1|Overall Study|Protocol Violation|1
4667717|NCT02800928|16053421|P2|Overall Study|Withdrawal by Subject|1
4667718|NCT02800928|16053422|P1|Overall Study|Withdrawal by Subject|1
4667719|NCT02800642|16053430|P1|Overall Study|Lost to Follow-up|1
4667720|NCT02800642|16053430|P1|Overall Study|Withdrawal by Subject|3
4667721|NCT02800642|16053430|P1|Overall Study|Adverse Event|6
4667722|NCT02800642|16053430|P1|Overall Study|Physician Decision|2
4667723|NCT02800642|16053430|P1|Overall Study|Other|10
4667724|NCT02800642|16053430|P1|Overall Study|Death|3
4667725|NCT02799784|16053461|P2|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1
4667726|NCT02799784|16053462|P1|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0
4667727|NCT02799784|16053461|P2|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1
4667728|NCT02799784|16053462|P1|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0
4667729|NCT02799784|16053461|P2|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0
4667730|NCT02799784|16053462|P1|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1
4667731|NCT02799784|16053461|P2|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1
4667732|NCT02799784|16053462|P1|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0
4667733|NCT02799784|16053461|P2|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0
4667734|NCT02799784|16053462|P1|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5
4667735|NCT02799784|16053461|P2|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
4667736|NCT02799784|16053462|P1|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1
4667737|NCT02799472|16053470|P2|Overall Study|Lost to Follow-up|1
4667738|NCT02799472|16053471|P1|Overall Study|Lost to Follow-up|0
4667739|NCT02799472|16053470|P2|Overall Study|Lack of Efficacy|0
4667740|NCT02799472|16053471|P1|Overall Study|Lack of Efficacy|2
4667741|NCT02799472|16053470|P2|Overall Study|Withdrawal by Subject|4
4667742|NCT02799472|16053471|P1|Overall Study|Withdrawal by Subject|2
4667743|NCT02799381|16053531|P2|Overall Study|Participant did not take any study drug|0
4667744|NCT02799381|16053532|P1|Overall Study|Participant did not take any study drug|1
4667745|NCT02799381|16053531|P2|Overall Study|Adverse Event|1
4667746|NCT02799381|16053532|P1|Overall Study|Adverse Event|0
4667747|NCT02799381|16053531|P2|Overall Study|Withdrew consent|2
4667748|NCT02799381|16053532|P1|Overall Study|Withdrew consent|3
4667749|NCT02799082|16053552|P2|Overall Study|Protocol Violation|1
4667750|NCT02799082|16053553|P1|Overall Study|Protocol Violation|0
4667751|NCT02799082|16053552|P2|Overall Study|Refused second PDT or withdraw consent|3
4667752|NCT02799082|16053553|P1|Overall Study|Refused second PDT or withdraw consent|4
4667753|NCT02799069|16053590|P3|Overall Study|Protocol Violation|2
4667754|NCT02799069|16053591|P2|Overall Study|Protocol Violation|0
4667755|NCT02799069|16053592|P1|Overall Study|Protocol Violation|1
4667756|NCT02799069|16053590|P3|Overall Study|Withdrawal by Subject|3
4667757|NCT02799069|16053591|P2|Overall Study|Withdrawal by Subject|4
4667758|NCT02799069|16053592|P1|Overall Study|Withdrawal by Subject|4
4667759|NCT02799069|16053590|P3|Overall Study|Lost to Follow-up|0
4667760|NCT02799069|16053591|P2|Overall Study|Lost to Follow-up|1
4667761|NCT02799069|16053592|P1|Overall Study|Lost to Follow-up|1
4667762|NCT02799069|16053590|P3|Overall Study|Lack of Efficacy|0
4667763|NCT02799069|16053591|P2|Overall Study|Lack of Efficacy|0
4667764|NCT02799069|16053592|P1|Overall Study|Lack of Efficacy|2
4667765|NCT02799069|16053590|P3|Overall Study|Adverse Event|2
4667766|NCT02799069|16053591|P2|Overall Study|Adverse Event|2
4667767|NCT02799069|16053592|P1|Overall Study|Adverse Event|0
4667768|NCT02798861|16053930|P1|Overall Study|Withdrawal by Subject|1
4667769|NCT02798861|16053930|P1|Overall Study|Lost to Follow-up|22
4667770|NCT02798835|16053938|P3|Overall Study|Protocol Violation|3
4667771|NCT02798835|16053939|P2|Overall Study|Protocol Violation|0
4667772|NCT02798835|16053940|P1|Overall Study|Protocol Violation|0
4667773|NCT02798315|16054006|P1|Overall Study|Failure to return|1
4667774|NCT02797678|16054040|P4|Second Intervention (5 Nights)|study/device use non-compliance|0
4667775|NCT02797678|16054041|P3|Second Intervention (5 Nights)|study/device use non-compliance|1
4667776|NCT02797678|16054042|P2|Second Intervention (5 Nights)|study/device use non-compliance|0
4667777|NCT02797678|16054043|P1|Second Intervention (5 Nights)|study/device use non-compliance|0
4667778|NCT02797678|16054040|P4|First Intervention (5 Nights)|study/device use non-compliance|0
4667779|NCT02797678|16054041|P3|First Intervention (5 Nights)|study/device use non-compliance|0
4667780|NCT02797678|16054042|P2|First Intervention (5 Nights)|study/device use non-compliance|1
4667781|NCT02797678|16054043|P1|First Intervention (5 Nights)|study/device use non-compliance|0
4667782|NCT02797678|16054040|P4|Screening Phase|Meeting Inclusion/Exclusion criteria|0
4667783|NCT02797678|16054041|P3|Screening Phase|Meeting Inclusion/Exclusion criteria|0
4667784|NCT02797678|16054042|P2|Screening Phase|Meeting Inclusion/Exclusion criteria|0
4667785|NCT02797678|16054043|P1|Screening Phase|Meeting Inclusion/Exclusion criteria|25
4667786|NCT02797522|16054078|P11|Overall Study|Study Terminated by Sponsor|1
4667787|NCT02797522|16054079|P10|Overall Study|Study Terminated by Sponsor|4
4667788|NCT02797522|16054080|P9|Overall Study|Study Terminated by Sponsor|2
4667789|NCT02797522|16054081|P8|Overall Study|Study Terminated by Sponsor|4
4667790|NCT02797522|16054082|P7|Overall Study|Study Terminated by Sponsor|0
4667791|NCT02797522|16054083|P6|Overall Study|Study Terminated by Sponsor|0
4667792|NCT02797522|16054084|P5|Overall Study|Study Terminated by Sponsor|0
4667793|NCT02797522|16054085|P4|Overall Study|Study Terminated by Sponsor|0
4667794|NCT02797522|16054086|P3|Overall Study|Study Terminated by Sponsor|0
4667795|NCT02797522|16054087|P2|Overall Study|Study Terminated by Sponsor|0
4667796|NCT02797522|16054088|P1|Overall Study|Study Terminated by Sponsor|0
4667797|NCT02797132|16054194|P1|Part B (24 Weeks)|Adverse Event|3
4667798|NCT02797132|16054194|P1|Part A (15 Days)|Adverse Event|1
4667799|NCT02797080|16054246|P1|Overall Study|Withdrawal by Subject|1
4667800|NCT02797080|16054246|P1|Overall Study|Lost to Follow-up|1
4667801|NCT02796963|16054288|P4|Overall Study|Lost to Follow-up|72
4667802|NCT02796963|16054289|P3|Overall Study|Lost to Follow-up|69
4667803|NCT02796963|16054290|P2|Overall Study|Lost to Follow-up|76
4667804|NCT02796963|16054291|P1|Overall Study|Lost to Follow-up|89
4667805|NCT02796677|16054361|P4|Overall Study|Reason not mentioned|5
4667806|NCT02796677|16054362|P3|Overall Study|Reason not mentioned|0
4667807|NCT02796677|16054363|P2|Overall Study|Reason not mentioned|3
4667808|NCT02796677|16054364|P1|Overall Study|Reason not mentioned|2
4667809|NCT02796677|16054361|P4|Overall Study|Progressive disease|18
4667810|NCT02796677|16054362|P3|Overall Study|Progressive disease|13
4667811|NCT02796677|16054363|P2|Overall Study|Progressive disease|15
4667812|NCT02796677|16054364|P1|Overall Study|Progressive disease|6
4667813|NCT02796677|16054361|P4|Overall Study|Withdrawal by Subject|7
4667814|NCT02796677|16054362|P3|Overall Study|Withdrawal by Subject|6
4667815|NCT02796677|16054363|P2|Overall Study|Withdrawal by Subject|14
4667816|NCT02796677|16054364|P1|Overall Study|Withdrawal by Subject|4
4667817|NCT02796677|16054361|P4|Overall Study|Lack of Efficacy|20
4667818|NCT02796677|16054362|P3|Overall Study|Lack of Efficacy|14
4667819|NCT02796677|16054363|P2|Overall Study|Lack of Efficacy|9
4667820|NCT02796677|16054364|P1|Overall Study|Lack of Efficacy|7
4667821|NCT02796677|16054361|P4|Overall Study|Lost to Follow-up|2
4667822|NCT02796677|16054362|P3|Overall Study|Lost to Follow-up|2
4667823|NCT02796677|16054363|P2|Overall Study|Lost to Follow-up|5
4667824|NCT02796677|16054364|P1|Overall Study|Lost to Follow-up|1
4667825|NCT02796677|16054361|P4|Overall Study|Protocol Violation|8
4667826|NCT02796677|16054362|P3|Overall Study|Protocol Violation|4
4667827|NCT02796677|16054363|P2|Overall Study|Protocol Violation|5
4667828|NCT02796677|16054364|P1|Overall Study|Protocol Violation|7
4667829|NCT02796677|16054361|P4|Overall Study|Adverse Event|14
4667830|NCT02796677|16054362|P3|Overall Study|Adverse Event|14
4667831|NCT02796677|16054363|P2|Overall Study|Adverse Event|22
4667832|NCT02796677|16054364|P1|Overall Study|Adverse Event|11
4667833|NCT02796651|16054388|P1|Overall Study|Other|10
4667834|NCT02796651|16054388|P1|Overall Study|Lack of Efficacy|1
4667835|NCT02796651|16054388|P1|Overall Study|Protocol Violation|4
4667836|NCT02796651|16054388|P1|Overall Study|Withdrawal by Subject|4
4667837|NCT02796651|16054388|P1|Overall Study|Lost to Follow-up|1
4667838|NCT02796651|16054388|P1|Overall Study|Adverse Event|6
4667839|NCT02795832|16054484|P6|Overall Study|Adverse Event|3
4667840|NCT02795832|16054485|P5|Overall Study|Adverse Event|0
4667841|NCT02795832|16054486|P4|Overall Study|Adverse Event|0
4667842|NCT02795832|16054487|P3|Overall Study|Adverse Event|0
4667843|NCT02795832|16054488|P2|Overall Study|Adverse Event|0
4667844|NCT02795832|16054489|P1|Overall Study|Adverse Event|0
4667845|NCT02795767|16054567|P3|Overall Study|Lack of Efficacy|1
4667846|NCT02795767|16054568|P2|Overall Study|Lack of Efficacy|0
4667847|NCT02795767|16054569|P1|Overall Study|Lack of Efficacy|0
4667848|NCT02795767|16054567|P3|Overall Study|Ongoing Study Treatment|9
4667849|NCT02795767|16054568|P2|Overall Study|Ongoing Study Treatment|10
4667850|NCT02795767|16054569|P1|Overall Study|Ongoing Study Treatment|66
4667851|NCT02795767|16054567|P3|Overall Study|Received Commercial Emicizumab|0
4667852|NCT02795767|16054568|P2|Overall Study|Received Commercial Emicizumab|0
4667853|NCT02795767|16054569|P1|Overall Study|Received Commercial Emicizumab|2
4667854|NCT02794974|16054690|P2|Overall Study|Physician Decision|1
4667855|NCT02794974|16054691|P1|Overall Study|Physician Decision|0
4667856|NCT02794870|16054707|P2|Overall Study|Withdrawal by Subject|0
4667857|NCT02794870|16054708|P1|Overall Study|Withdrawal by Subject|2
4667858|NCT02794480|16054778|P4|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
4667859|NCT02794480|16054779|P3|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4667860|NCT02794480|16054780|P2|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4667861|NCT02794480|16054781|P1|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1
4667862|NCT02794480|16054778|P4|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4667863|NCT02794480|16054779|P3|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4667864|NCT02794480|16054780|P2|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2
4667865|NCT02794480|16054781|P1|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4667866|NCT02794480|16054778|P4|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2
4667867|NCT02794480|16054779|P3|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
4667868|NCT02794480|16054780|P2|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
4667869|NCT02794480|16054781|P1|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0
4667870|NCT02794480|16054778|P4|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
4667871|NCT02794480|16054779|P3|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1
4667872|NCT02794480|16054780|P2|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
4667873|NCT02794480|16054781|P1|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0
4667874|NCT02794480|16054778|P4|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
4667875|NCT02794480|16054779|P3|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1
4667876|NCT02794480|16054780|P2|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
4667877|NCT02794480|16054781|P1|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0
4667878|NCT02794246|16054824|P1|Overall Study|Physician Decision|4
4667879|NCT02794246|16054824|P1|Overall Study|Withdrawal by Subject|2
4667880|NCT02794103|16054836|P1|Overall Study|Loss to follow up due to high sedation|3
4667881|NCT02793947|16054847|P2|Overall Study|Physician Decision|5
4667882|NCT02793947|16054848|P1|Overall Study|Physician Decision|1
4667883|NCT02793947|16054847|P2|Overall Study|Death|0
4667884|NCT02793947|16054848|P1|Overall Study|Death|1
4667885|NCT02793232|16054903|P9|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667886|NCT02793232|16054904|P8|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667887|NCT02793232|16054905|P7|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
4667888|NCT02793232|16054906|P6|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667889|NCT02793232|16054907|P5|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1
4667890|NCT02793232|16054908|P4|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667891|NCT02793232|16054909|P3|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667892|NCT02793232|16054910|P2|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667893|NCT02793232|16054911|P1|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0
4667894|NCT02792829|16055172|P8|Treatment Period 2|Use of proscribed medications|1
4667895|NCT02792829|16055173|P7|Treatment Period 2|Use of proscribed medications|0
4667896|NCT02792829|16055174|P6|Treatment Period 2|Use of proscribed medications|0
4667897|NCT02792829|16055175|P5|Treatment Period 2|Use of proscribed medications|0
4667898|NCT02792829|16055176|P4|Treatment Period 2|Use of proscribed medications|0
4667899|NCT02792829|16055177|P3|Treatment Period 2|Use of proscribed medications|0
4667900|NCT02792829|16055178|P2|Treatment Period 2|Use of proscribed medications|0
4667901|NCT02792829|16055179|P1|Treatment Period 2|Use of proscribed medications|0
4667902|NCT02792829|16055172|P8|Treatment Period 2|Adverse Event|1
4667903|NCT02792829|16055173|P7|Treatment Period 2|Adverse Event|1
4667904|NCT02792829|16055174|P6|Treatment Period 2|Adverse Event|0
4667905|NCT02792829|16055175|P5|Treatment Period 2|Adverse Event|1
4667906|NCT02792829|16055176|P4|Treatment Period 2|Adverse Event|0
4667907|NCT02792829|16055177|P3|Treatment Period 2|Adverse Event|0
4667908|NCT02792829|16055178|P2|Treatment Period 2|Adverse Event|0
4667909|NCT02792829|16055179|P1|Treatment Period 2|Adverse Event|0
4667910|NCT02792829|16055172|P8|Treatment Period 2|Non compliance with alcohol prohibition|0
4667911|NCT02792829|16055173|P7|Treatment Period 2|Non compliance with alcohol prohibition|0
4667912|NCT02792829|16055174|P6|Treatment Period 2|Non compliance with alcohol prohibition|0
4667913|NCT02792829|16055175|P5|Treatment Period 2|Non compliance with alcohol prohibition|0
4667914|NCT02792829|16055176|P4|Treatment Period 2|Non compliance with alcohol prohibition|0
4667915|NCT02792829|16055177|P3|Treatment Period 2|Non compliance with alcohol prohibition|0
4667916|NCT02792829|16055178|P2|Treatment Period 2|Non compliance with alcohol prohibition|1
4667917|NCT02792829|16055179|P1|Treatment Period 2|Non compliance with alcohol prohibition|0
4667918|NCT02792777|16055287|P2|Overall Study|Participant interviewed twice|0
4667919|NCT02792777|16055288|P1|Overall Study|Participant interviewed twice|1
4667920|NCT02792777|16055287|P2|Overall Study|Later determined to be ineligible|0
4667921|NCT02792777|16055288|P1|Overall Study|Later determined to be ineligible|2
4667922|NCT02792777|16055287|P2|Overall Study|Recording malfunction|0
4667923|NCT02792777|16055288|P1|Overall Study|Recording malfunction|2
4667924|NCT02792777|16055287|P2|Overall Study|Withdrawal by Subject|0
4667925|NCT02792777|16055288|P1|Overall Study|Withdrawal by Subject|2
4667926|NCT02792699|16055304|P3|Overall Study|Other|0
4667927|NCT02792699|16055305|P2|Overall Study|Other|0
4667928|NCT02792699|16055306|P1|Overall Study|Other|1
4667929|NCT02792699|16055304|P3|Overall Study|Dissatisfaction with Treatment Efficacy|1
4667930|NCT02792699|16055305|P2|Overall Study|Dissatisfaction with Treatment Efficacy|3
4667931|NCT02792699|16055306|P1|Overall Study|Dissatisfaction with Treatment Efficacy|1
4667932|NCT02792699|16055304|P3|Overall Study|Physician Decision|0
4667933|NCT02792699|16055305|P2|Overall Study|Physician Decision|0
4667934|NCT02792699|16055306|P1|Overall Study|Physician Decision|2
4667935|NCT02792699|16055304|P3|Overall Study|Lost to Follow-up|2
4667936|NCT02792699|16055305|P2|Overall Study|Lost to Follow-up|1
4667937|NCT02792699|16055306|P1|Overall Study|Lost to Follow-up|0
4667938|NCT02792699|16055304|P3|Overall Study|Withdrawal by Subject|3
4667939|NCT02792699|16055305|P2|Overall Study|Withdrawal by Subject|4
4667940|NCT02792699|16055306|P1|Overall Study|Withdrawal by Subject|4
4667941|NCT02792699|16055304|P3|Overall Study|Adverse Event|4
4667942|NCT02792699|16055305|P2|Overall Study|Adverse Event|2
4667943|NCT02792699|16055306|P1|Overall Study|Adverse Event|1
4667944|NCT02792517|16055387|P1|Overall Study|Lost to Follow-up|3
4667945|NCT02792517|16055387|P1|Overall Study|Decision by Sponsor|7
4667946|NCT02792517|16055387|P1|Overall Study|Withdrawal by Subject|10
4667947|NCT02792231|16055403|P2|Overall Study|Ongoing at interim data cutoff|1
4667948|NCT02792231|16055404|P1|Overall Study|Ongoing at interim data cutoff|1
4667949|NCT02792231|16055403|P2|Overall Study|Technical problems|1
4667950|NCT02792231|16055404|P1|Overall Study|Technical problems|0
4667951|NCT02792231|16055403|P2|Overall Study|Protocol deviation|0
4667952|NCT02792231|16055404|P1|Overall Study|Protocol deviation|2
4667953|NCT02792231|16055403|P2|Overall Study|Non-compliance with study treatment|1
4667954|NCT02792231|16055404|P1|Overall Study|Non-compliance with study treatment|2
4667955|NCT02792231|16055403|P2|Overall Study|Pregnancy|3
4667956|NCT02792231|16055404|P1|Overall Study|Pregnancy|1
4667957|NCT02792231|16055403|P2|Overall Study|Lost to Follow-up|5
4667958|NCT02792231|16055404|P1|Overall Study|Lost to Follow-up|9
4667959|NCT02792231|16055403|P2|Overall Study|Lack of Efficacy|9
4667960|NCT02792231|16055404|P1|Overall Study|Lack of Efficacy|7
4667961|NCT02792231|16055403|P2|Overall Study|Physician Decision|11
4667962|NCT02792231|16055404|P1|Overall Study|Physician Decision|14
4667963|NCT02792231|16055403|P2|Overall Study|Adverse Event|13
4667964|NCT02792231|16055404|P1|Overall Study|Adverse Event|16
4667965|NCT02792231|16055403|P2|Overall Study|Patient/guardian decision|41
4667966|NCT02792231|16055404|P1|Overall Study|Patient/guardian decision|32
4667967|NCT02792218|16055426|P2|Overall Study|Ongoing at interim cutoff|5
4667968|NCT02792218|16055427|P1|Overall Study|Ongoing at interim cutoff|1
4667969|NCT02792218|16055426|P2|Overall Study|Pregnancy|0
4667970|NCT02792218|16055427|P1|Overall Study|Pregnancy|1
4667971|NCT02792218|16055426|P2|Overall Study|Non-compliance with study treatment|1
4667972|NCT02792218|16055427|P1|Overall Study|Non-compliance with study treatment|0
4667973|NCT02792218|16055426|P2|Overall Study|New therapy for study indication|1
4667974|NCT02792218|16055427|P1|Overall Study|New therapy for study indication|0
4667975|NCT02792218|16055426|P2|Overall Study|Protocol deviation|2
4667976|NCT02792218|16055427|P1|Overall Study|Protocol deviation|3
4667977|NCT02792218|16055426|P2|Overall Study|Physician Decision|4
4667978|NCT02792218|16055427|P1|Overall Study|Physician Decision|3
4667979|NCT02792218|16055426|P2|Overall Study|Lack of Efficacy|12
4667980|NCT02792218|16055427|P1|Overall Study|Lack of Efficacy|1
4667981|NCT02792218|16055426|P2|Overall Study|Lost to Follow-up|5
4667982|NCT02792218|16055427|P1|Overall Study|Lost to Follow-up|10
4667983|NCT02792218|16055426|P2|Overall Study|Adverse Event|14
4667984|NCT02792218|16055427|P1|Overall Study|Adverse Event|14
4667985|NCT02792218|16055426|P2|Overall Study|Patient/guardian decision|42
4667986|NCT02792218|16055427|P1|Overall Study|Patient/guardian decision|16
4667987|NCT02792062|16055453|P6|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4667988|NCT02792062|16055454|P5|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4667989|NCT02792062|16055455|P4|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4667990|NCT02792062|16055456|P3|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4667991|NCT02792062|16055457|P2|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0
4667992|NCT02792062|16055458|P1|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1
4667993|NCT02791763|16055527|P3|Overall Study|Adverse Event|7
4667994|NCT02791763|16055528|P2|Overall Study|Adverse Event|13
4667995|NCT02791763|16055529|P1|Overall Study|Adverse Event|12
4667996|NCT02791763|16055527|P3|Overall Study|Met hemoglobin stopping criteria|0
4667997|NCT02791763|16055528|P2|Overall Study|Met hemoglobin stopping criteria|0
4667998|NCT02791763|16055529|P1|Overall Study|Met hemoglobin stopping criteria|1
4667999|NCT02791763|16055527|P3|Overall Study|Participant had renal transplant|0
4668000|NCT02791763|16055528|P2|Overall Study|Participant had renal transplant|0
4668001|NCT02791763|16055529|P1|Overall Study|Participant had renal transplant|3
4668002|NCT02791763|16055527|P3|Overall Study|Cancer event|0
4668003|NCT02791763|16055528|P2|Overall Study|Cancer event|3
4668004|NCT02791763|16055529|P1|Overall Study|Cancer event|1
4668005|NCT02791763|16055527|P3|Overall Study|Needs maintenance/changes in dialysis|5
4668006|NCT02791763|16055528|P2|Overall Study|Needs maintenance/changes in dialysis|19
4668007|NCT02791763|16055529|P1|Overall Study|Needs maintenance/changes in dialysis|16
4668008|NCT02791763|16055527|P3|Overall Study|Physician Decision|0
4668009|NCT02791763|16055528|P2|Overall Study|Physician Decision|1
4668010|NCT02791763|16055529|P1|Overall Study|Physician Decision|0
4668011|NCT02791763|16055527|P3|Overall Study|Withdrawal by Subject|0
4668012|NCT02791763|16055528|P2|Overall Study|Withdrawal by Subject|1
4668013|NCT02791763|16055529|P1|Overall Study|Withdrawal by Subject|5
4668014|NCT02791763|16055527|P3|Overall Study|Protocol Violation|1
4668015|NCT02791763|16055528|P2|Overall Study|Protocol Violation|0
4668016|NCT02791763|16055529|P1|Overall Study|Protocol Violation|0
4668017|NCT02791659|16055648|P2|Overall Study|Protocol Violation|1
4668018|NCT02791659|16055649|P1|Overall Study|Protocol Violation|0
4668019|NCT02791516|16055657|P2|Overall Study|Withdrawal by Subject|1
4668020|NCT02791516|16055658|P1|Overall Study|Withdrawal by Subject|1
4668021|NCT02791490|16055670|P2|Overall Study|Withdrawal by Subject|6
4668022|NCT02791490|16055671|P1|Overall Study|Withdrawal by Subject|2
4668023|NCT02791490|16055670|P2|Overall Study|Lost to Follow-up|2
4668024|NCT02791490|16055671|P1|Overall Study|Lost to Follow-up|1
4668025|NCT02791438|16055691|P2|Treatment Period|Withdrawal by Parent/Guardian|0
4668026|NCT02791438|16055692|P1|Treatment Period|Withdrawal by Parent/Guardian|2
4668027|NCT02791438|16055691|P2|Treatment Period|Withdrawal by Subject|1
4668028|NCT02791438|16055692|P1|Treatment Period|Withdrawal by Subject|0
4668029|NCT02791438|16055691|P2|Treatment Period|Adverse Event|0
4668030|NCT02791438|16055692|P1|Treatment Period|Adverse Event|1
4668031|NCT02791269|16055733|P2|Overall Study|Lost to Follow-up|1
4668032|NCT02791269|16055734|P1|Overall Study|Lost to Follow-up|0
4668033|NCT02790606|16055812|P1|Overall Study|Withdrawal by Subject|1
4668034|NCT02790606|16055812|P1|Overall Study|Physician Decision|3
4668035|NCT02790606|16055812|P1|Overall Study|Lost to Follow-up|4
4668036|NCT02790606|16055812|P1|Overall Study|Death|27
4668037|NCT02790073|16055844|P1|Overall Study|Withdrawal by Subject|1
4668038|NCT02790073|16055844|P1|Overall Study|Withdrawal from HD|1
4668039|NCT02790073|16055844|P1|Overall Study|Death|1
4668040|NCT02788747|16055866|P3|Overall Study|Adverse Event|0
4668041|NCT02788747|16055867|P2|Overall Study|Adverse Event|0
4668042|NCT02788747|16055868|P1|Overall Study|Adverse Event|1
4668043|NCT02788656|16055938|P2|Overall Study|Withdrawal by Subject|0
4668044|NCT02788656|16055939|P1|Overall Study|Withdrawal by Subject|1
4668045|NCT02788474|16055961|P2|Open Label Treatment Period|Non-compliance|0
4668046|NCT02788474|16055962|P1|Open Label Treatment Period|Non-compliance|1
4668047|NCT02788474|16055961|P2|Open Label Treatment Period|Patient's refusal|3
4668048|NCT02788474|16055962|P1|Open Label Treatment Period|Patient's refusal|1
4668049|NCT02788474|16055961|P2|Open Label Treatment Period|Other than reason specified|0
4668050|NCT02788474|16055962|P1|Open Label Treatment Period|Other than reason specified|1
4668051|NCT02788474|16055961|P2|Open Label Treatment Period|Adverse Event|9
4668052|NCT02788474|16055962|P1|Open Label Treatment Period|Adverse Event|29
4668053|NCT02788474|16055961|P2|Double Blind Treatment Period|Adverse Event|4
4668054|NCT02788474|16055962|P1|Double Blind Treatment Period|Adverse Event|6
4668055|NCT02788474|16055961|P2|Double Blind Treatment Period|Patient's refusal|0
4668056|NCT02788474|16055962|P1|Double Blind Treatment Period|Patient's refusal|3
4668057|NCT02788474|16055961|P2|Double Blind Treatment Period|Not treated|0
4668058|NCT02788474|16055962|P1|Double Blind Treatment Period|Not treated|1
4668059|NCT02788357|16055977|P2|Overall Study|Lost to Follow-up|0
4668060|NCT02788357|16055978|P1|Overall Study|Lost to Follow-up|3
4668061|NCT02788279|16055993|P3|Overall Study|Sponsor decision|11
4668062|NCT02788279|16055994|P2|Overall Study|Sponsor decision|29
4668063|NCT02788279|16055995|P1|Overall Study|Sponsor decision|18
4668064|NCT02788279|16055993|P3|Overall Study|Lost to Follow-up|2
4668065|NCT02788279|16055994|P2|Overall Study|Lost to Follow-up|3
4668066|NCT02788279|16055995|P1|Overall Study|Lost to Follow-up|0
4668067|NCT02788279|16055993|P3|Overall Study|Withdrawal by Subject|5
4668068|NCT02788279|16055994|P2|Overall Study|Withdrawal by Subject|15
4668069|NCT02788279|16055995|P1|Overall Study|Withdrawal by Subject|10
4668070|NCT02788279|16055993|P3|Overall Study|Death|72
4668071|NCT02788279|16055994|P2|Overall Study|Death|136
4668072|NCT02788279|16055995|P1|Overall Study|Death|62
4668073|NCT02788175|16056055|P1|Overall Study|Ineligible prior to study agent|6
4668074|NCT02788175|16056055|P1|Overall Study|Withdrawal by Subject|4
4668075|NCT02788175|16056055|P1|Overall Study|Protocol Violation|3
4668076|NCT02787863|16056077|P8|Overall Study|Withdrawal by Subject|0
4668077|NCT02787863|16056078|P7|Overall Study|Withdrawal by Subject|0
4668078|NCT02787863|16056079|P6|Overall Study|Withdrawal by Subject|0
4668079|NCT02787863|16056080|P5|Overall Study|Withdrawal by Subject|0
4668080|NCT02787863|16056081|P4|Overall Study|Withdrawal by Subject|0
4668081|NCT02787863|16056082|P3|Overall Study|Withdrawal by Subject|1
4668082|NCT02787863|16056083|P2|Overall Study|Withdrawal by Subject|1
4668083|NCT02787863|16056084|P1|Overall Study|Withdrawal by Subject|0
4668084|NCT02787863|16056077|P8|Overall Study|Death|0
4668085|NCT02787863|16056078|P7|Overall Study|Death|0
4668086|NCT02787863|16056079|P6|Overall Study|Death|0
4668087|NCT02787863|16056080|P5|Overall Study|Death|0
4668088|NCT02787863|16056081|P4|Overall Study|Death|0
4668089|NCT02787863|16056082|P3|Overall Study|Death|1
4668090|NCT02787863|16056083|P2|Overall Study|Death|0
4668091|NCT02787863|16056084|P1|Overall Study|Death|1
4668092|NCT02787551|16056178|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0
4668093|NCT02787551|16056179|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5
4668094|NCT02787551|16056178|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0
4668095|NCT02787551|16056179|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3
4668096|NCT02787551|16056178|P2|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0
4668097|NCT02787551|16056179|P1|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1
4668098|NCT02787551|16056178|P2|Core Period: 26 Weeks|Other than specified|1
4668099|NCT02787551|16056179|P1|Core Period: 26 Weeks|Other than specified|3
4668100|NCT02787551|16056178|P2|Core Period: 26 Weeks|Randomized but not treated|1
4668101|NCT02787551|16056179|P1|Core Period: 26 Weeks|Randomized but not treated|2
4668102|NCT02787551|16056178|P2|Core Period: 26 Weeks|Withdrawal by Subject|9
4668103|NCT02787551|16056179|P1|Core Period: 26 Weeks|Withdrawal by Subject|9
4668104|NCT02787551|16056178|P2|Core Period: 26 Weeks|Poor compliance to protocol|0
4668105|NCT02787551|16056179|P1|Core Period: 26 Weeks|Poor compliance to protocol|2
4668106|NCT02787551|16056178|P2|Core Period: 26 Weeks|Lack of Efficacy|0
4668107|NCT02787551|16056179|P1|Core Period: 26 Weeks|Lack of Efficacy|1
4668108|NCT02787551|16056178|P2|Core Period: 26 Weeks|Adverse Event|0
4668109|NCT02787551|16056179|P1|Core Period: 26 Weeks|Adverse Event|10
4668110|NCT02787304|16056215|P4|Overall Study|Study terminated by sponsor|32
4668111|NCT02787304|16056216|P3|Overall Study|Study terminated by sponsor|31
4668112|NCT02787304|16056217|P2|Overall Study|Study terminated by sponsor|31
4668113|NCT02787304|16056218|P1|Overall Study|Study terminated by sponsor|25
4668114|NCT02787304|16056215|P4|Overall Study|Physician Decision|0
4668115|NCT02787304|16056216|P3|Overall Study|Physician Decision|1
4668116|NCT02787304|16056217|P2|Overall Study|Physician Decision|0
4668117|NCT02787304|16056218|P1|Overall Study|Physician Decision|0
4668118|NCT02787304|16056215|P4|Overall Study|Noncompliance with study drug|0
4668119|NCT02787304|16056216|P3|Overall Study|Noncompliance with study drug|1
4668120|NCT02787304|16056217|P2|Overall Study|Noncompliance with study drug|0
4668121|NCT02787304|16056218|P1|Overall Study|Noncompliance with study drug|0
4668122|NCT02787304|16056215|P4|Overall Study|Lost to Follow-up|1
4668123|NCT02787304|16056216|P3|Overall Study|Lost to Follow-up|0
4668124|NCT02787304|16056217|P2|Overall Study|Lost to Follow-up|0
4668125|NCT02787304|16056218|P1|Overall Study|Lost to Follow-up|1
4668126|NCT02787304|16056215|P4|Overall Study|Withdrawal by Subject|0
4668127|NCT02787304|16056216|P3|Overall Study|Withdrawal by Subject|0
4668128|NCT02787304|16056217|P2|Overall Study|Withdrawal by Subject|4
4668129|NCT02787304|16056218|P1|Overall Study|Withdrawal by Subject|1
4668130|NCT02787304|16056215|P4|Overall Study|Adverse Event|1
4668131|NCT02787304|16056216|P3|Overall Study|Adverse Event|8
4668132|NCT02787304|16056217|P2|Overall Study|Adverse Event|3
4668133|NCT02787304|16056218|P1|Overall Study|Adverse Event|9
4668134|NCT02787083|16056272|P2|Overall Study|Withdrawal by Subject|2
4668135|NCT02787083|16056273|P1|Overall Study|Withdrawal by Subject|2
4668136|NCT02787083|16056272|P2|Overall Study|Adverse Event|0
4668137|NCT02787083|16056273|P1|Overall Study|Adverse Event|1
4668138|NCT02786953|16056298|P2|Overall Study|Physician Decision|1
4668139|NCT02786953|16056299|P1|Overall Study|Physician Decision|0
4668140|NCT02786953|16056298|P2|Overall Study|Withdrawal by Subject|0
4668141|NCT02786953|16056299|P1|Overall Study|Withdrawal by Subject|3
4668142|NCT02786927|16056321|P1|Overall Study|Protocol Violation|4
4668143|NCT02786927|16056321|P1|Overall Study|Adverse Event|1
4668144|NCT02786901|16056331|P3|Overall Study|Randomized in error|1
4668145|NCT02786901|16056332|P2|Overall Study|Randomized in error|0
4668146|NCT02786901|16056333|P1|Overall Study|Randomized in error|2
4668147|NCT02786901|16056331|P3|Overall Study|Disallowed medication|0
4668148|NCT02786901|16056332|P2|Overall Study|Disallowed medication|1
4668149|NCT02786901|16056333|P1|Overall Study|Disallowed medication|1
4668150|NCT02786901|16056331|P3|Overall Study|Subject Request/Lost to Follow up|5
4668151|NCT02786901|16056332|P2|Overall Study|Subject Request/Lost to Follow up|5
4668152|NCT02786901|16056333|P1|Overall Study|Subject Request/Lost to Follow up|1
4668153|NCT02786901|16056331|P3|Overall Study|Rescue Therapy Use|33
4668154|NCT02786901|16056332|P2|Overall Study|Rescue Therapy Use|49
4668155|NCT02786901|16056333|P1|Overall Study|Rescue Therapy Use|71
4668156|NCT02786901|16056331|P3|Overall Study|Physician Decision|0
4668157|NCT02786901|16056332|P2|Overall Study|Physician Decision|0
4668158|NCT02786901|16056333|P1|Overall Study|Physician Decision|1
4668159|NCT02786901|16056331|P3|Overall Study|Adverse Event|2
4668160|NCT02786901|16056332|P2|Overall Study|Adverse Event|1
4668161|NCT02786901|16056333|P1|Overall Study|Adverse Event|1
4668162|NCT02786004|16056391|P2|Overall Study|Withdrawal by Subject|1
4668163|NCT02786004|16056392|P1|Overall Study|Withdrawal by Subject|0
4668164|NCT02785913|16056400|P1|Overall Study|Not protocol specified|1
4668165|NCT02785913|16056400|P1|Overall Study|Progression|18
4668166|NCT02785913|16056400|P1|Overall Study|Death|2
4668167|NCT02785913|16056400|P1|Overall Study|Adverse Event|5
4668168|NCT02785900|16056411|P2|Overall Study|Physician Decision|2
4668169|NCT02785900|16056412|P1|Overall Study|Physician Decision|3
4668170|NCT02785900|16056411|P2|Overall Study|Withdrawal by Subject|8
4668171|NCT02785900|16056412|P1|Overall Study|Withdrawal by Subject|4
4668172|NCT02785900|16056411|P2|Overall Study|Death|32
4668173|NCT02785900|16056412|P1|Overall Study|Death|46
4668174|NCT02785900|16056411|P2|Overall Study|Study Termination by Sponsor|81
4668175|NCT02785900|16056412|P1|Overall Study|Study Termination by Sponsor|64
4668176|NCT02785770|16056436|P4|Intervention Period 3 (1 Day)|Adverse Event|1
4668177|NCT02785770|16056437|P3|Intervention Period 3 (1 Day)|Adverse Event|0
4668178|NCT02785770|16056438|P2|Intervention Period 3 (1 Day)|Adverse Event|0
4668179|NCT02785770|16056439|P1|Intervention Period 3 (1 Day)|Adverse Event|0
4668180|NCT02785770|16056436|P4|Intervention Period 2 (1 Day)|Family related obligations|0
4668181|NCT02785770|16056437|P3|Intervention Period 2 (1 Day)|Family related obligations|1
4668182|NCT02785770|16056438|P2|Intervention Period 2 (1 Day)|Family related obligations|0
4668183|NCT02785770|16056439|P1|Intervention Period 2 (1 Day)|Family related obligations|0
4668184|NCT02785770|16056436|P4|Intervention Period 2 (1 Day)|Adverse Event|0
4668185|NCT02785770|16056437|P3|Intervention Period 2 (1 Day)|Adverse Event|0
4668186|NCT02785770|16056438|P2|Intervention Period 2 (1 Day)|Adverse Event|1
4668187|NCT02785770|16056439|P1|Intervention Period 2 (1 Day)|Adverse Event|0
4668188|NCT02785588|16056506|P1|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1
4668189|NCT02785588|16056506|P1|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1
4668190|NCT02785458|16056522|P2|3 Months|Completed Evaluation at 1 Month|89
4668191|NCT02785458|16056523|P1|3 Months|Completed Evaluation at 1 Month|100
4668192|NCT02785458|16056522|P2|3 Months|Lost to Follow-up|21
4668193|NCT02785458|16056523|P1|3 Months|Lost to Follow-up|25
4668194|NCT02785458|16056522|P2|3 Months|Withdrawal by Subject|1
4668195|NCT02785458|16056523|P1|3 Months|Withdrawal by Subject|3
4668196|NCT02785458|16056522|P2|1 Month|Partial Interview|4
4668197|NCT02785458|16056523|P1|1 Month|Partial Interview|0
4668198|NCT02785458|16056522|P2|1 Month|Completed Evaluation by Baseline|39
4668199|NCT02785458|16056523|P1|1 Month|Completed Evaluation by Baseline|42
4668200|NCT02785458|16056522|P2|1 Month|Deemed Ineligible|0
4668201|NCT02785458|16056523|P1|1 Month|Deemed Ineligible|1
4668202|NCT02785458|16056522|P2|1 Month|Lost to Follow-up|31
4668203|NCT02785458|16056523|P1|1 Month|Lost to Follow-up|38
4668204|NCT02785458|16056522|P2|1 Month|Withdrawal by Subject|1
4668205|NCT02785458|16056523|P1|1 Month|Withdrawal by Subject|2
4668206|NCT02784834|16056710|P1|Overall Study|Lack of Efficacy|1
4668207|NCT02784704|16056716|P2|Overall Study|Subject Non Compliance|0
4668208|NCT02784704|16056717|P1|Overall Study|Subject Non Compliance|2
4668209|NCT02784704|16056716|P2|Overall Study|Withdrawal by Subject|3
4668210|NCT02784704|16056717|P1|Overall Study|Withdrawal by Subject|1
4668211|NCT02784704|16056716|P2|Overall Study|Lost to Follow-up|4
4668212|NCT02784704|16056717|P1|Overall Study|Lost to Follow-up|6
4668213|NCT02784704|16056716|P2|Overall Study|Adverse Event|2
4668214|NCT02784704|16056717|P1|Overall Study|Adverse Event|4
4668215|NCT02784106|16056838|P4|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
4668216|NCT02784106|16056839|P3|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1
4668217|NCT02784106|16056840|P2|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
4668218|NCT02784106|16056841|P1|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0
4668219|NCT02784106|16056838|P4|Open-Label Extension Period (26 Weeks)|Adverse Event|1
4668220|NCT02784106|16056839|P3|Open-Label Extension Period (26 Weeks)|Adverse Event|2
4668221|NCT02784106|16056840|P2|Open-Label Extension Period (26 Weeks)|Adverse Event|0
4668222|NCT02784106|16056841|P1|Open-Label Extension Period (26 Weeks)|Adverse Event|0
4668223|NCT02784106|16056838|P4|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4668224|NCT02784106|16056839|P3|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4668225|NCT02784106|16056840|P2|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4668226|NCT02784106|16056841|P1|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1
4668227|NCT02784106|16056838|P4|Double-Blind Treatment Period (12 Weeks)|Other|0
4668228|NCT02784106|16056839|P3|Double-Blind Treatment Period (12 Weeks)|Other|0
4668229|NCT02784106|16056840|P2|Double-Blind Treatment Period (12 Weeks)|Other|0
4668230|NCT02784106|16056841|P1|Double-Blind Treatment Period (12 Weeks)|Other|2
4668231|NCT02784106|16056838|P4|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4668232|NCT02784106|16056839|P3|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4668233|NCT02784106|16056840|P2|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1
4668234|NCT02784106|16056841|P1|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2
4668235|NCT02784106|16056838|P4|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
4668236|NCT02784106|16056839|P3|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0
4668237|NCT02784106|16056840|P2|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5
4668238|NCT02784106|16056841|P1|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3
4668239|NCT02783768|16056942|P2|Overall Study|Lost to Follow-up|0
4668240|NCT02783768|16056943|P1|Overall Study|Lost to Follow-up|1
4668241|NCT02783729|16056965|P4|Overall Study|Lost to Follow-up|0
4668242|NCT02783729|16056966|P3|Overall Study|Lost to Follow-up|1
4668243|NCT02783729|16056967|P2|Overall Study|Lost to Follow-up|1
4668244|NCT02783729|16056968|P1|Overall Study|Lost to Follow-up|2
4668245|NCT02783729|16056965|P4|Overall Study|Participant's choice|1
4668246|NCT02783729|16056966|P3|Overall Study|Participant's choice|2
4668247|NCT02783729|16056967|P2|Overall Study|Participant's choice|1
4668248|NCT02783729|16056968|P1|Overall Study|Participant's choice|2
4668249|NCT02783729|16056965|P4|Overall Study|Withdrawal by Subject|2
4668250|NCT02783729|16056966|P3|Overall Study|Withdrawal by Subject|1
4668251|NCT02783729|16056967|P2|Overall Study|Withdrawal by Subject|3
4668252|NCT02783729|16056968|P1|Overall Study|Withdrawal by Subject|2
4668253|NCT02783729|16056965|P4|Overall Study|Other|3
4668254|NCT02783729|16056966|P3|Overall Study|Other|2
4668255|NCT02783729|16056967|P2|Overall Study|Other|6
4668256|NCT02783729|16056968|P1|Overall Study|Other|1
4668257|NCT02783729|16056965|P4|Overall Study|Adverse Event|3
4668258|NCT02783729|16056966|P3|Overall Study|Adverse Event|2
4668259|NCT02783729|16056967|P2|Overall Study|Adverse Event|6
4668260|NCT02783729|16056968|P1|Overall Study|Adverse Event|2
4668261|NCT02783729|16056965|P4|Overall Study|Lack of Efficacy|0
4668262|NCT02783729|16056966|P3|Overall Study|Lack of Efficacy|0
4668263|NCT02783729|16056967|P2|Overall Study|Lack of Efficacy|0
4668264|NCT02783729|16056968|P1|Overall Study|Lack of Efficacy|1
4668265|NCT02783599|16057034|P1|Overall Study|Death|1
4668266|NCT02783599|16057034|P1|Overall Study|Physician Decision|2
4668267|NCT02783599|16057034|P1|Overall Study|Adverse Event|4
4668268|NCT02783599|16057034|P1|Overall Study|Surgical Resection|10
4668269|NCT02783599|16057034|P1|Overall Study|Progressive disease|23
4668270|NCT02783573|16057050|P3|Delayed-Start Period|Sponsor Decision|12
4668271|NCT02783573|16057051|P2|Delayed-Start Period|Sponsor Decision|17
4668272|NCT02783573|16057052|P1|Delayed-Start Period|Sponsor Decision|0
4668273|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Sponsor Decision|492
4668274|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Sponsor Decision|512
4668275|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Sponsor Decision|494
4668276|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9
4668277|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
4668278|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3
4668279|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Withdrawal by Subject|23
4668280|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Withdrawal by Subject|20
4668281|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Withdrawal by Subject|15
4668282|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Protocol Violation|0
4668283|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Protocol Violation|2
4668284|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Protocol Violation|1
4668285|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Physician Decision|3
4668286|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Physician Decision|1
4668287|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Physician Decision|3
4668288|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Other-determined by Investigator|2
4668289|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Other-determined by Investigator|1
4668290|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Other-determined by Investigator|0
4668291|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Non-Compliance|0
4668292|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Non-Compliance|1
4668293|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Non-Compliance|0
4668294|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Lost to Follow-up|1
4668295|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Lost to Follow-up|3
4668296|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Lost to Follow-up|3
4668297|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Lack of Efficacy|2
4668298|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Lack of Efficacy|0
4668299|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Lack of Efficacy|0
4668300|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Death|3
4668301|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Death|2
4668302|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Death|4
4668303|NCT02783573|16057050|P3|Placebo-Controlled Treatment Period|Adverse Event|13
4668304|NCT02783573|16057051|P2|Placebo-Controlled Treatment Period|Adverse Event|17
4668305|NCT02783573|16057052|P1|Placebo-Controlled Treatment Period|Adverse Event|13
4668306|NCT02783170|16057117|P2|Overall Study|Randomized but not Vaccinated|0
4668307|NCT02783170|16057118|P1|Overall Study|Randomized but not Vaccinated|1
4668308|NCT02783066|16057159|P1|Overall Study|Withdrawal by Subject|13
4668309|NCT02782923|16057190|P1|Overall Study|Lost to Follow-up|15
4668310|NCT02782676|16057196|P2|Overall Study|Lost to Follow-up|1
4668311|NCT02782676|16057197|P1|Overall Study|Lost to Follow-up|0
4668312|NCT02782377|16057225|P1|Overall Study|Physician Decision|5
4668313|NCT02782325|16057240|P3|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4
4668314|NCT02782325|16057241|P2|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
4668315|NCT02782325|16057242|P1|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0
4668316|NCT02782325|16057240|P3|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0
4668317|NCT02782325|16057241|P2|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2
4668318|NCT02782325|16057242|P1|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4
4668319|NCT02782169|16057270|P2|Overall Study|Lost to Follow-up|2
4668320|NCT02782169|16057271|P1|Overall Study|Lost to Follow-up|1
4668321|NCT02781844|16057289|P8|Treatment Period 1|Adverse Event|0
4668322|NCT02781844|16057290|P7|Treatment Period 1|Adverse Event|0
4668323|NCT02781844|16057291|P6|Treatment Period 1|Adverse Event|1
4668324|NCT02781844|16057292|P5|Treatment Period 1|Adverse Event|0
4668325|NCT02781844|16057293|P4|Treatment Period 1|Adverse Event|0
4668326|NCT02781844|16057294|P3|Treatment Period 1|Adverse Event|0
4668327|NCT02781844|16057295|P2|Treatment Period 1|Adverse Event|0
4668328|NCT02781844|16057296|P1|Treatment Period 1|Adverse Event|0
4668329|NCT02781818|16057429|P3|Overall Study|Lost to Follow-up|1
4668330|NCT02781818|16057430|P2|Overall Study|Lost to Follow-up|2
4668331|NCT02781818|16057431|P1|Overall Study|Lost to Follow-up|4
4668332|NCT02781558|16057497|P2|Overall Study|Adverse Event|0
4668333|NCT02781558|16057498|P1|Overall Study|Adverse Event|1
4668334|NCT02781558|16057497|P2|Overall Study|Lost to Follow-up|2
4668335|NCT02781558|16057498|P1|Overall Study|Lost to Follow-up|2
4668336|NCT02781324|16057585|P2|Overall Study|Physician Decision|2
4668337|NCT02781324|16057586|P1|Overall Study|Physician Decision|1
4668338|NCT02781324|16057585|P2|Overall Study|Withdrawal by Subject|0
4668339|NCT02781324|16057586|P1|Overall Study|Withdrawal by Subject|1
4668340|NCT02781311|16057615|P3|Overall Study|Non-Compliance with Study Drug|0
4668341|NCT02781311|16057616|P2|Overall Study|Non-Compliance with Study Drug|0
4668342|NCT02781311|16057617|P1|Overall Study|Non-Compliance with Study Drug|2
4668343|NCT02781311|16057615|P3|Overall Study|Lost to Follow-up|1
4668344|NCT02781311|16057616|P2|Overall Study|Lost to Follow-up|8
4668345|NCT02781311|16057617|P1|Overall Study|Lost to Follow-up|11
4668346|NCT02781311|16057615|P3|Overall Study|Withdrawal of Consent|2
4668347|NCT02781311|16057616|P2|Overall Study|Withdrawal of Consent|12
4668348|NCT02781311|16057617|P1|Overall Study|Withdrawal of Consent|11
4668349|NCT02781311|16057615|P3|Overall Study|Adverse Event|1
4668350|NCT02781311|16057616|P2|Overall Study|Adverse Event|6
4668351|NCT02781311|16057617|P1|Overall Study|Adverse Event|2
4668352|NCT02780856|16057644|P1|Overall Study|Lost to Follow-up|1
4668353|NCT02780700|16057663|P1|Overall Study|Progressive disease|1
4668354|NCT02780687|16057673|P2|Overall Study|progressive disease|6
4668355|NCT02780687|16057674|P1|Overall Study|progressive disease|29
4668356|NCT02780687|16057673|P2|Overall Study|Switched to commercial program (in CTP)|0
4668357|NCT02780687|16057674|P1|Overall Study|Switched to commercial program (in CTP)|2
4668358|NCT02780687|16057673|P2|Overall Study|Withdrawal by Subject|1
4668359|NCT02780687|16057674|P1|Overall Study|Withdrawal by Subject|2
4668360|NCT02780687|16057673|P2|Overall Study|Adverse Event|1
4668361|NCT02780687|16057674|P1|Overall Study|Adverse Event|1
4668362|NCT02780388|16057746|P5|Overall Study|Withdrawal by Subject|0
4668363|NCT02780388|16057747|P4|Overall Study|Withdrawal by Subject|0
4668364|NCT02780388|16057748|P3|Overall Study|Withdrawal by Subject|0
4668365|NCT02780388|16057749|P2|Overall Study|Withdrawal by Subject|1
4668366|NCT02780388|16057750|P1|Overall Study|Withdrawal by Subject|1
4668367|NCT02780388|16057746|P5|Overall Study|Lost to Follow-up|0
4668368|NCT02780388|16057747|P4|Overall Study|Lost to Follow-up|0
4668369|NCT02780388|16057748|P3|Overall Study|Lost to Follow-up|0
4668370|NCT02780388|16057749|P2|Overall Study|Lost to Follow-up|1
4668371|NCT02780388|16057750|P1|Overall Study|Lost to Follow-up|0
4668372|NCT02780167|16057816|P5|Overall Study|Other|2
4668373|NCT02780167|16057817|P4|Overall Study|Other|1
4668374|NCT02780167|16057818|P3|Overall Study|Other|3
4668375|NCT02780167|16057819|P2|Overall Study|Other|0
4668376|NCT02780167|16057820|P1|Overall Study|Other|0
4668377|NCT02780167|16057816|P5|Overall Study|Withdrawal by Subject|4
4668378|NCT02780167|16057817|P4|Overall Study|Withdrawal by Subject|3
4668379|NCT02780167|16057818|P3|Overall Study|Withdrawal by Subject|4
4668380|NCT02780167|16057819|P2|Overall Study|Withdrawal by Subject|4
4668381|NCT02780167|16057820|P1|Overall Study|Withdrawal by Subject|6
4668382|NCT02780167|16057816|P5|Overall Study|Protocol Violation|2
4668383|NCT02780167|16057817|P4|Overall Study|Protocol Violation|1
4668384|NCT02780167|16057818|P3|Overall Study|Protocol Violation|1
4668385|NCT02780167|16057819|P2|Overall Study|Protocol Violation|5
4668386|NCT02780167|16057820|P1|Overall Study|Protocol Violation|5
4668387|NCT02780167|16057816|P5|Overall Study|No longer meets eligibility criteria|1
4668388|NCT02780167|16057817|P4|Overall Study|No longer meets eligibility criteria|1
4668389|NCT02780167|16057818|P3|Overall Study|No longer meets eligibility criteria|0
4668390|NCT02780167|16057819|P2|Overall Study|No longer meets eligibility criteria|0
4668391|NCT02780167|16057820|P1|Overall Study|No longer meets eligibility criteria|0
4668392|NCT02780167|16057816|P5|Overall Study|Does not meet entrance criteria|0
4668393|NCT02780167|16057817|P4|Overall Study|Does not meet entrance criteria|0
4668394|NCT02780167|16057818|P3|Overall Study|Does not meet entrance criteria|1
4668395|NCT02780167|16057819|P2|Overall Study|Does not meet entrance criteria|0
4668396|NCT02780167|16057820|P1|Overall Study|Does not meet entrance criteria|0
4668397|NCT02780167|16057816|P5|Overall Study|Lost to Follow-up|0
4668398|NCT02780167|16057817|P4|Overall Study|Lost to Follow-up|0
4668399|NCT02780167|16057818|P3|Overall Study|Lost to Follow-up|1
4668400|NCT02780167|16057819|P2|Overall Study|Lost to Follow-up|0
4668401|NCT02780167|16057820|P1|Overall Study|Lost to Follow-up|2
4668402|NCT02780167|16057816|P5|Overall Study|Lack of Efficacy|0
4668403|NCT02780167|16057817|P4|Overall Study|Lack of Efficacy|1
4668404|NCT02780167|16057818|P3|Overall Study|Lack of Efficacy|6
4668405|NCT02780167|16057819|P2|Overall Study|Lack of Efficacy|5
4668406|NCT02780167|16057820|P1|Overall Study|Lack of Efficacy|6
4668407|NCT02780167|16057816|P5|Overall Study|Adverse Event|8
4668408|NCT02780167|16057817|P4|Overall Study|Adverse Event|12
4668409|NCT02780167|16057818|P3|Overall Study|Adverse Event|8
4668410|NCT02780167|16057819|P2|Overall Study|Adverse Event|8
4668411|NCT02780167|16057820|P1|Overall Study|Adverse Event|9
4668412|NCT02779075|16058005|P2|Overall Study|IV lost during 2nd study|0
4668413|NCT02779075|16058006|P1|Overall Study|IV lost during 2nd study|1
4668414|NCT02779075|16058005|P2|Overall Study|Withdrawal by Subject|3
4668415|NCT02779075|16058006|P1|Overall Study|Withdrawal by Subject|1
4668416|NCT02778867|16058069|P4|Phase 2|Adverse Event|1
4668417|NCT02778867|16058070|P3|Phase 2|Adverse Event|0
4668418|NCT02778867|16058071|P2|Phase 2|Adverse Event|0
4668419|NCT02778867|16058072|P1|Phase 2|Adverse Event|0
4668420|NCT02778867|16058069|P4|Phase 2|Physician Decision|1
4668421|NCT02778867|16058070|P3|Phase 2|Physician Decision|0
4668422|NCT02778867|16058071|P2|Phase 2|Physician Decision|0
4668423|NCT02778867|16058072|P1|Phase 2|Physician Decision|0
4668424|NCT02778867|16058069|P4|Phase 2|Withdrawal by Subject|0
4668425|NCT02778867|16058070|P3|Phase 2|Withdrawal by Subject|1
4668426|NCT02778867|16058071|P2|Phase 2|Withdrawal by Subject|0
4668427|NCT02778867|16058072|P1|Phase 2|Withdrawal by Subject|0
4668428|NCT02778867|16058069|P4|Phase 1|Withdrawal by Subject|0
4668429|NCT02778867|16058070|P3|Phase 1|Withdrawal by Subject|0
4668430|NCT02778867|16058071|P2|Phase 1|Withdrawal by Subject|3
4668431|NCT02778867|16058072|P1|Phase 1|Withdrawal by Subject|2
4668432|NCT02778555|16058093|P3|Overall Study|Withdrawal by Subject|107
4668433|NCT02778555|16058094|P2|Overall Study|Withdrawal by Subject|32
4668434|NCT02778555|16058095|P1|Overall Study|Withdrawal by Subject|55
4668435|NCT02778100|16058151|P2|Period 1 (Common Cold)|Withdrawal by Subject|0
4668436|NCT02778100|16058152|P1|Period 1 (Common Cold)|Withdrawal by Subject|1
4668437|NCT02778074|16058183|P2|Overall Study|Lost to Follow-up|10
4668438|NCT02778074|16058184|P1|Overall Study|Lost to Follow-up|7
4668439|NCT02777918|16058216|P2|Overall Study|Withdrawal by Subject|1
4668440|NCT02777918|16058217|P1|Overall Study|Withdrawal by Subject|1
4668441|NCT02777918|16058216|P2|Overall Study|Too busy / stressed|1
4668442|NCT02777918|16058217|P1|Overall Study|Too busy / stressed|1
4668443|NCT02777918|16058216|P2|Overall Study|Medical reasons|2
4668444|NCT02777918|16058217|P1|Overall Study|Medical reasons|1
4668445|NCT02777827|16058235|P6|Washout Between Periods 3 and 4|Protocol Violation|0
4668446|NCT02777827|16058236|P5|Washout Between Periods 3 and 4|Protocol Violation|0
4668447|NCT02777827|16058237|P4|Washout Between Periods 3 and 4|Protocol Violation|0
4668448|NCT02777827|16058238|P3|Washout Between Periods 3 and 4|Protocol Violation|1
4668449|NCT02777827|16058239|P2|Washout Between Periods 3 and 4|Protocol Violation|0
4668450|NCT02777827|16058240|P1|Washout Between Periods 3 and 4|Protocol Violation|0
4668451|NCT02777242|16058443|P1|Overall Study|Withdrawal by Subject|1
4668452|NCT02777242|16058443|P1|Overall Study|Sponsor's request|1
4668453|NCT02777242|16058443|P1|Overall Study|Multiple|1
4668454|NCT02777242|16058443|P1|Overall Study|Lost to Follow-up|1
4668455|NCT02777242|16058443|P1|Overall Study|Other|2
4668456|NCT02777125|16058449|P2|Overall Study|Protocol Violation|12
4668457|NCT02777125|16058450|P1|Overall Study|Protocol Violation|8
4668458|NCT02777125|16058449|P2|Overall Study|Assent form violation|23
4668459|NCT02777125|16058450|P1|Overall Study|Assent form violation|21
4668460|NCT02777125|16058449|P2|Overall Study|Consent form violation|12
4668461|NCT02777125|16058450|P1|Overall Study|Consent form violation|14
4668462|NCT02777086|16058466|P2|Overall Study|Lost to Follow-up|99
4668463|NCT02777086|16058467|P1|Overall Study|Lost to Follow-up|96
4668464|NCT02776683|16058510|P2|Post-switch Period|Other than listed|15
4668465|NCT02776683|16058511|P1|Post-switch Period|Other than listed|0
4668466|NCT02776683|16058510|P2|Post-switch Period|Progressive disease|20
4668467|NCT02776683|16058511|P1|Post-switch Period|Progressive disease|0
4668468|NCT02776683|16058510|P2|Post-switch Period|Physician Decision|3
4668469|NCT02776683|16058511|P1|Post-switch Period|Physician Decision|0
4668470|NCT02776683|16058510|P2|Post-switch Period|Withdrawal by Subject|2
4668471|NCT02776683|16058511|P1|Post-switch Period|Withdrawal by Subject|0
4668472|NCT02776683|16058510|P2|Post-switch Period|Adverse Event|3
4668473|NCT02776683|16058511|P1|Post-switch Period|Adverse Event|0
4668474|NCT02776683|16058510|P2|Pre-switch Period|Other than listed|0
4668475|NCT02776683|16058511|P1|Pre-switch Period|Other than listed|3
4668476|NCT02776683|16058510|P2|Pre-switch Period|Progressive disease|0
4668477|NCT02776683|16058511|P1|Pre-switch Period|Progressive disease|39
4668478|NCT02776683|16058510|P2|Pre-switch Period|Physician Decision|0
4668479|NCT02776683|16058511|P1|Pre-switch Period|Physician Decision|7
4668480|NCT02776683|16058510|P2|Pre-switch Period|Withdrawal by Subject|0
4668481|NCT02776683|16058511|P1|Pre-switch Period|Withdrawal by Subject|9
4668482|NCT02776683|16058510|P2|Pre-switch Period|Adverse Event|0
4668483|NCT02776683|16058511|P1|Pre-switch Period|Adverse Event|21
4668484|NCT02776683|16058510|P2|Pre-switch Period|Protocol Violation|0
4668485|NCT02776683|16058511|P1|Pre-switch Period|Protocol Violation|1
4668486|NCT02776670|16058522|P2|Overall Study|Other - Reason not given|1
4668487|NCT02776670|16058523|P1|Overall Study|Other - Reason not given|0
4668488|NCT02776670|16058522|P2|Overall Study|Withdrawal by Subject|1
4668489|NCT02776670|16058523|P1|Overall Study|Withdrawal by Subject|0
4668490|NCT02776670|16058522|P2|Overall Study|Protocol Violation|2
4668491|NCT02776670|16058523|P1|Overall Study|Protocol Violation|0
4668492|NCT02776670|16058522|P2|Overall Study|Adverse Event|2
4668493|NCT02776670|16058523|P1|Overall Study|Adverse Event|0
4668494|NCT02776553|16058580|P2|Overall Study|Protocol Violation|1
4668495|NCT02776553|16058581|P1|Overall Study|Protocol Violation|0
4668496|NCT02776553|16058580|P2|Overall Study|had other surgery|0
4668497|NCT02776553|16058581|P1|Overall Study|had other surgery|1
4668498|NCT02776553|16058580|P2|Overall Study|got liver transplant|2
4668499|NCT02776553|16058581|P1|Overall Study|got liver transplant|1
4668500|NCT02776553|16058580|P2|Overall Study|Lost to Follow-up|0
4668501|NCT02776553|16058581|P1|Overall Study|Lost to Follow-up|1
4668502|NCT02776033|16058594|P3|Overall Study|Adverse Event|0
4668503|NCT02776033|16058595|P2|Overall Study|Adverse Event|2
4668504|NCT02776033|16058596|P1|Overall Study|Adverse Event|1
4668505|NCT02776033|16058594|P3|Overall Study|Lost to Follow-up|0
4668506|NCT02776033|16058595|P2|Overall Study|Lost to Follow-up|0
4668507|NCT02776033|16058596|P1|Overall Study|Lost to Follow-up|1
4668508|NCT02776033|16058594|P3|Overall Study|Physician Decision|0
4668509|NCT02776033|16058595|P2|Overall Study|Physician Decision|0
4668510|NCT02776033|16058596|P1|Overall Study|Physician Decision|2
4668511|NCT02776033|16058594|P3|Overall Study|Withdrawal by Subject|2
4668512|NCT02776033|16058595|P2|Overall Study|Withdrawal by Subject|0
4668513|NCT02776033|16058596|P1|Overall Study|Withdrawal by Subject|0
4668514|NCT02775916|16058661|P2|Overall Study|Subject/Guardian Decision|0
4668515|NCT02775916|16058662|P1|Overall Study|Subject/Guardian Decision|2
4668516|NCT02775916|16058661|P2|Overall Study|Adverse Event|0
4668517|NCT02775916|16058662|P1|Overall Study|Adverse Event|1
4668518|NCT02775903|16058684|P4|Overall Study|Other-Miscellaneous|5
4668519|NCT02775903|16058685|P3|Overall Study|Other-Miscellaneous|4
4668520|NCT02775903|16058686|P2|Overall Study|Other-Miscellaneous|3
4668521|NCT02775903|16058687|P1|Overall Study|Other-Miscellaneous|4
4668522|NCT02775903|16058684|P4|Overall Study|Lost to Follow-up|1
4668523|NCT02775903|16058685|P3|Overall Study|Lost to Follow-up|1
4668524|NCT02775903|16058686|P2|Overall Study|Lost to Follow-up|0
4668525|NCT02775903|16058687|P1|Overall Study|Lost to Follow-up|0
4668526|NCT02775903|16058684|P4|Overall Study|Adverse Event|1
4668527|NCT02775903|16058685|P3|Overall Study|Adverse Event|1
4668528|NCT02775903|16058686|P2|Overall Study|Adverse Event|0
4668529|NCT02775903|16058687|P1|Overall Study|Adverse Event|0
4668530|NCT02775903|16058684|P4|Overall Study|Withdrawal by Subject|4
4668531|NCT02775903|16058685|P3|Overall Study|Withdrawal by Subject|5
4668532|NCT02775903|16058686|P2|Overall Study|Withdrawal by Subject|5
4668533|NCT02775903|16058687|P1|Overall Study|Withdrawal by Subject|5
4668534|NCT02775903|16058684|P4|Overall Study|Death|35
4668535|NCT02775903|16058685|P3|Overall Study|Death|38
4668536|NCT02775903|16058686|P2|Overall Study|Death|18
4668537|NCT02775903|16058687|P1|Overall Study|Death|19
4668538|NCT02775903|16058684|P4|Overall Study|Ongoing|19
4668539|NCT02775903|16058685|P3|Overall Study|Ongoing|15
4668540|NCT02775903|16058686|P2|Overall Study|Ongoing|15
4668541|NCT02775903|16058687|P1|Overall Study|Ongoing|14
4668542|NCT02775864|16058739|P4|Overall Study|Medicaid eligibility discontinued|890
4668543|NCT02775864|16058740|P3|Overall Study|Medicaid eligibility discontinued|720
4668544|NCT02775864|16058741|P2|Overall Study|Medicaid eligibility discontinued|2019
4668545|NCT02775864|16058742|P1|Overall Study|Medicaid eligibility discontinued|1478
4668546|NCT02775864|16058739|P4|Overall Study|Data ended end of 2010|1194
4668547|NCT02775864|16058740|P3|Overall Study|Data ended end of 2010|1140
4668548|NCT02775864|16058741|P2|Overall Study|Data ended end of 2010|2880
4668549|NCT02775864|16058742|P1|Overall Study|Data ended end of 2010|1764
4668550|NCT02775435|16058775|P2|Overall Study|Not Treated|1
4668551|NCT02775435|16058776|P1|Overall Study|Not Treated|0
4668552|NCT02775435|16058775|P2|Overall Study|Ongoing in Study|72
4668553|NCT02775435|16058776|P1|Overall Study|Ongoing in Study|121
4668554|NCT02775435|16058775|P2|Overall Study|Clinical Progression|26
4668555|NCT02775435|16058776|P1|Overall Study|Clinical Progression|13
4668556|NCT02775435|16058775|P2|Overall Study|Progressive Disease|140
4668557|NCT02775435|16058776|P1|Overall Study|Progressive Disease|86
4668558|NCT02775435|16058775|P2|Overall Study|Withdrawal by Subject|9
4668559|NCT02775435|16058776|P1|Overall Study|Withdrawal by Subject|5
4668560|NCT02775435|16058775|P2|Overall Study|Physician Decision|6
4668561|NCT02775435|16058776|P1|Overall Study|Physician Decision|5
4668562|NCT02775435|16058775|P2|Overall Study|Lost to Follow-up|2
4668563|NCT02775435|16058776|P1|Overall Study|Lost to Follow-up|0
4668564|NCT02775435|16058775|P2|Overall Study|Adverse Event|25
4668565|NCT02775435|16058776|P1|Overall Study|Adverse Event|48
4668566|NCT02775344|16058794|P2|Overall Study|No ovarian cyst identified|2
4668567|NCT02775344|16058795|P1|Overall Study|No ovarian cyst identified|3
4668568|NCT02774681|16058928|P1|Follow-Up for 3 Years|Withdrawal by Subject|1
4668569|NCT02774681|16058928|P1|Follow-Up for 3 Years|Death|11
4668570|NCT02774681|16058928|P1|Treatment on Study|Progressive Disease|7
4668571|NCT02774278|16058992|P1|Overall Study|Protocol Violation|2
4668572|NCT02774278|16058992|P1|Overall Study|Withdrawal by Subject|3
4668573|NCT02774278|16058992|P1|Overall Study|Administrative reasons|6
4668574|NCT02774278|16058992|P1|Overall Study|Refused treatment/did not cooperate|9
4668575|NCT02774278|16058992|P1|Overall Study|Adverse event/intercurrent illness|16
4668576|NCT02774278|16058992|P1|Overall Study|Death|29
4668577|NCT02774278|16058992|P1|Overall Study|Lack of Efficacy|199
4668578|NCT02773537|16059167|P3|Overall Study|Lost to Follow-up|4
4668579|NCT02773537|16059168|P2|Overall Study|Lost to Follow-up|1
4668580|NCT02773537|16059169|P1|Overall Study|Lost to Follow-up|0
4668581|NCT02773446|16059204|P6|First Admission|Lost to Follow-up|0
4668582|NCT02773446|16059205|P5|First Admission|Lost to Follow-up|0
4668583|NCT02773446|16059206|P4|First Admission|Lost to Follow-up|0
4668584|NCT02773446|16059207|P3|First Admission|Lost to Follow-up|0
4668585|NCT02773446|16059208|P2|First Admission|Lost to Follow-up|0
4668586|NCT02773446|16059209|P1|First Admission|Lost to Follow-up|1
4668587|NCT02773446|16059204|P6|First Admission|Withdrawal by Subject|0
4668588|NCT02773446|16059205|P5|First Admission|Withdrawal by Subject|0
4668589|NCT02773446|16059206|P4|First Admission|Withdrawal by Subject|1
4668590|NCT02773446|16059207|P3|First Admission|Withdrawal by Subject|0
4668591|NCT02773446|16059208|P2|First Admission|Withdrawal by Subject|0
4668592|NCT02773446|16059209|P1|First Admission|Withdrawal by Subject|0
4668593|NCT02773368|16059250|P2|Overall Study|Missing|1
4668594|NCT02773368|16059251|P1|Overall Study|Missing|0
4668595|NCT02773368|16059250|P2|Overall Study|Unclassified|1
4668596|NCT02773368|16059251|P1|Overall Study|Unclassified|1
4668597|NCT02773368|16059250|P2|Overall Study|Withdrawal by Subject|1
4668598|NCT02773368|16059251|P1|Overall Study|Withdrawal by Subject|5
4668599|NCT02773368|16059250|P2|Overall Study|Lost to Follow-up|1
4668600|NCT02773368|16059251|P1|Overall Study|Lost to Follow-up|4
4668601|NCT02772809|16059321|P1|Overall Study|not completed some tasks|6
4668602|NCT02772757|16059333|P3|Overall Study|Physician Decision|3
4668603|NCT02772757|16059334|P2|Overall Study|Physician Decision|3
4668604|NCT02772757|16059335|P1|Overall Study|Physician Decision|0
4668605|NCT02772757|16059333|P3|Overall Study|Protocol Violation|1
4668606|NCT02772757|16059334|P2|Overall Study|Protocol Violation|0
4668607|NCT02772757|16059335|P1|Overall Study|Protocol Violation|0
4668608|NCT02772757|16059333|P3|Overall Study|Withdrawal by Subject|1
4668609|NCT02772757|16059334|P2|Overall Study|Withdrawal by Subject|0
4668610|NCT02772757|16059335|P1|Overall Study|Withdrawal by Subject|1
4668611|NCT02771522|16059418|P1|Overall Study|No white spot lesions|3
4668612|NCT02771522|16059418|P1|Overall Study|Withdrawal by Subject|2
4668613|NCT02771522|16059418|P1|Overall Study|Lost to Follow-up|3
4668614|NCT02771366|16059429|P2|Period 2 (Crossover)|Withdrawal by Subject|0
4668615|NCT02771366|16059430|P1|Period 2 (Crossover)|Withdrawal by Subject|2
4668616|NCT02771366|16059429|P2|Period 1|Withdrawal by Subject|2
4668617|NCT02771366|16059430|P1|Period 1|Withdrawal by Subject|0
4668618|NCT02771275|16059456|P1|Overall Study|On Study|11
4668619|NCT02771275|16059456|P1|Overall Study|Reoperation|2
4668620|NCT02771145|16059464|P1|Overall Study|Lost to Follow-up|1
4668621|NCT02771145|16059464|P1|Overall Study|Adverse Event|3
4668622|NCT02770612|16059598|P1|Overall Study|Met exclusion criteria (postop LOS>7d)|1
4668623|NCT02770547|16059604|P2|Overall Study|Adverse Event|1
4668624|NCT02770547|16059605|P1|Overall Study|Adverse Event|0
4668625|NCT02770547|16059604|P2|Overall Study|Patient non-compliant|0
4668626|NCT02770547|16059605|P1|Overall Study|Patient non-compliant|1
4668627|NCT02770248|16059678|P2|Overall Study|Randomized in error, prior to treatment|1
4668628|NCT02770248|16059679|P1|Overall Study|Randomized in error, prior to treatment|0
4668629|NCT02770248|16059678|P2|Overall Study|Adverse Event|1
4668630|NCT02770248|16059679|P1|Overall Study|Adverse Event|0
4668631|NCT02769858|16059697|P1|Overall Study|Withdrawal by Subject|2
4668632|NCT02769624|16059708|P2|Overall Study|Lost to Follow-up|1
4668633|NCT02769624|16059709|P1|Overall Study|Lost to Follow-up|0
4668634|NCT02769312|16059738|P2|Follow-up|Lost to Follow-up|1
4668635|NCT02769312|16059739|P1|Follow-up|Lost to Follow-up|1
4668636|NCT02769312|16059738|P2|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1
4668637|NCT02769312|16059739|P1|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0
4668638|NCT02769312|16059738|P2|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0
4668639|NCT02769312|16059739|P1|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1
4668640|NCT02769312|16059738|P2|Double-Blind (0-2 Weeks)|Adverse Event|0
4668641|NCT02769312|16059739|P1|Double-Blind (0-2 Weeks)|Adverse Event|1
4668642|NCT02769312|16059738|P2|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
4668643|NCT02769312|16059739|P1|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1
4668644|NCT02769247|16059756|P4|Overall Study|Physician Decision|0
4668645|NCT02769247|16059757|P3|Overall Study|Physician Decision|0
4668646|NCT02769247|16059758|P2|Overall Study|Physician Decision|0
4668647|NCT02769247|16059759|P1|Overall Study|Physician Decision|1
4668648|NCT02769247|16059756|P4|Overall Study|Protocol Violation|0
4668649|NCT02769247|16059757|P3|Overall Study|Protocol Violation|1
4668650|NCT02769247|16059758|P2|Overall Study|Protocol Violation|0
4668651|NCT02769247|16059759|P1|Overall Study|Protocol Violation|0
4668652|NCT02769247|16059756|P4|Overall Study|Withdrawal by Subject|1
4668653|NCT02769247|16059757|P3|Overall Study|Withdrawal by Subject|0
4668654|NCT02769247|16059758|P2|Overall Study|Withdrawal by Subject|0
4668655|NCT02769247|16059759|P1|Overall Study|Withdrawal by Subject|1
4668656|NCT02769065|16059827|P30|Overall Study|Pre-treatment Event/Adverse Event|0
4668657|NCT02769065|16059828|P29|Overall Study|Pre-treatment Event/Adverse Event|0
4668658|NCT02769065|16059829|P28|Overall Study|Pre-treatment Event/Adverse Event|0
4668659|NCT02769065|16059830|P27|Overall Study|Pre-treatment Event/Adverse Event|0
4668660|NCT02769065|16059831|P26|Overall Study|Pre-treatment Event/Adverse Event|0
4668661|NCT02769065|16059832|P25|Overall Study|Pre-treatment Event/Adverse Event|0
4668662|NCT02769065|16059833|P24|Overall Study|Pre-treatment Event/Adverse Event|0
4668663|NCT02769065|16059834|P23|Overall Study|Pre-treatment Event/Adverse Event|0
4668664|NCT02769065|16059835|P22|Overall Study|Pre-treatment Event/Adverse Event|0
4668665|NCT02769065|16059836|P21|Overall Study|Pre-treatment Event/Adverse Event|0
4668666|NCT02769065|16059837|P20|Overall Study|Pre-treatment Event/Adverse Event|0
4668667|NCT02769065|16059838|P19|Overall Study|Pre-treatment Event/Adverse Event|0
4668668|NCT02769065|16059839|P18|Overall Study|Pre-treatment Event/Adverse Event|0
4668669|NCT02769065|16059840|P17|Overall Study|Pre-treatment Event/Adverse Event|0
4668670|NCT02769065|16059841|P16|Overall Study|Pre-treatment Event/Adverse Event|0
4668671|NCT02769065|16059842|P15|Overall Study|Pre-treatment Event/Adverse Event|0
4668672|NCT02769065|16059843|P14|Overall Study|Pre-treatment Event/Adverse Event|0
4668673|NCT02769065|16059844|P13|Overall Study|Pre-treatment Event/Adverse Event|0
4668674|NCT02769065|16059845|P12|Overall Study|Pre-treatment Event/Adverse Event|0
4668675|NCT02769065|16059846|P11|Overall Study|Pre-treatment Event/Adverse Event|1
4668676|NCT02769065|16059847|P10|Overall Study|Pre-treatment Event/Adverse Event|0
4668677|NCT02769065|16059848|P9|Overall Study|Pre-treatment Event/Adverse Event|0
4668678|NCT02769065|16059849|P8|Overall Study|Pre-treatment Event/Adverse Event|0
4668679|NCT02769065|16059850|P7|Overall Study|Pre-treatment Event/Adverse Event|0
4668680|NCT02769065|16059851|P6|Overall Study|Pre-treatment Event/Adverse Event|0
4668681|NCT02769065|16059852|P5|Overall Study|Pre-treatment Event/Adverse Event|0
4668682|NCT02769065|16059853|P4|Overall Study|Pre-treatment Event/Adverse Event|0
4668683|NCT02769065|16059854|P3|Overall Study|Pre-treatment Event/Adverse Event|0
4668684|NCT02769065|16059855|P2|Overall Study|Pre-treatment Event/Adverse Event|0
4668685|NCT02769065|16059856|P1|Overall Study|Pre-treatment Event/Adverse Event|0
4668686|NCT02769065|16059827|P30|Overall Study|Reason Not Specified|0
4668687|NCT02769065|16059828|P29|Overall Study|Reason Not Specified|0
4668688|NCT02769065|16059829|P28|Overall Study|Reason Not Specified|0
4668689|NCT02769065|16059830|P27|Overall Study|Reason Not Specified|0
4668690|NCT02769065|16059831|P26|Overall Study|Reason Not Specified|0
4668691|NCT02769065|16059832|P25|Overall Study|Reason Not Specified|0
4668692|NCT02769065|16059833|P24|Overall Study|Reason Not Specified|0
4668693|NCT02769065|16059834|P23|Overall Study|Reason Not Specified|0
4668694|NCT02769065|16059835|P22|Overall Study|Reason Not Specified|0
4668695|NCT02769065|16059836|P21|Overall Study|Reason Not Specified|0
4668696|NCT02769065|16059837|P20|Overall Study|Reason Not Specified|0
4668697|NCT02769065|16059838|P19|Overall Study|Reason Not Specified|0
4668698|NCT02769065|16059839|P18|Overall Study|Reason Not Specified|0
4668699|NCT02769065|16059840|P17|Overall Study|Reason Not Specified|0
4668700|NCT02769065|16059841|P16|Overall Study|Reason Not Specified|0
4668701|NCT02769065|16059842|P15|Overall Study|Reason Not Specified|0
4668702|NCT02769065|16059843|P14|Overall Study|Reason Not Specified|0
4668703|NCT02769065|16059844|P13|Overall Study|Reason Not Specified|0
4668704|NCT02769065|16059845|P12|Overall Study|Reason Not Specified|0
4668705|NCT02769065|16059846|P11|Overall Study|Reason Not Specified|0
4668706|NCT02769065|16059847|P10|Overall Study|Reason Not Specified|0
4668707|NCT02769065|16059848|P9|Overall Study|Reason Not Specified|0
4668708|NCT02769065|16059849|P8|Overall Study|Reason Not Specified|0
4668709|NCT02769065|16059850|P7|Overall Study|Reason Not Specified|1
4668710|NCT02769065|16059851|P6|Overall Study|Reason Not Specified|0
4668711|NCT02769065|16059852|P5|Overall Study|Reason Not Specified|0
4668712|NCT02769065|16059853|P4|Overall Study|Reason Not Specified|0
4668713|NCT02769065|16059854|P3|Overall Study|Reason Not Specified|0
4668714|NCT02769065|16059855|P2|Overall Study|Reason Not Specified|0
4668715|NCT02769065|16059856|P1|Overall Study|Reason Not Specified|0
4668716|NCT02769065|16059827|P30|Overall Study|Voluntary Withdrawal|0
4668717|NCT02769065|16059828|P29|Overall Study|Voluntary Withdrawal|0
4668718|NCT02769065|16059829|P28|Overall Study|Voluntary Withdrawal|0
4668719|NCT02769065|16059830|P27|Overall Study|Voluntary Withdrawal|0
4668720|NCT02769065|16059831|P26|Overall Study|Voluntary Withdrawal|0
4668721|NCT02769065|16059832|P25|Overall Study|Voluntary Withdrawal|0
4668722|NCT02769065|16059833|P24|Overall Study|Voluntary Withdrawal|0
4668723|NCT02769065|16059834|P23|Overall Study|Voluntary Withdrawal|0
4668724|NCT02769065|16059835|P22|Overall Study|Voluntary Withdrawal|0
4668725|NCT02769065|16059836|P21|Overall Study|Voluntary Withdrawal|0
4668726|NCT02769065|16059837|P20|Overall Study|Voluntary Withdrawal|0
4668727|NCT02769065|16059838|P19|Overall Study|Voluntary Withdrawal|0
4668728|NCT02769065|16059839|P18|Overall Study|Voluntary Withdrawal|0
4668729|NCT02769065|16059840|P17|Overall Study|Voluntary Withdrawal|0
4668730|NCT02769065|16059841|P16|Overall Study|Voluntary Withdrawal|0
4668731|NCT02769065|16059842|P15|Overall Study|Voluntary Withdrawal|0
4668732|NCT02769065|16059843|P14|Overall Study|Voluntary Withdrawal|0
4668733|NCT02769065|16059844|P13|Overall Study|Voluntary Withdrawal|0
4668734|NCT02769065|16059845|P12|Overall Study|Voluntary Withdrawal|0
4668735|NCT02769065|16059846|P11|Overall Study|Voluntary Withdrawal|0
4668736|NCT02769065|16059847|P10|Overall Study|Voluntary Withdrawal|0
4668737|NCT02769065|16059848|P9|Overall Study|Voluntary Withdrawal|0
4668738|NCT02769065|16059849|P8|Overall Study|Voluntary Withdrawal|0
4668739|NCT02769065|16059850|P7|Overall Study|Voluntary Withdrawal|0
4668740|NCT02769065|16059851|P6|Overall Study|Voluntary Withdrawal|0
4668741|NCT02769065|16059852|P5|Overall Study|Voluntary Withdrawal|0
4668742|NCT02769065|16059853|P4|Overall Study|Voluntary Withdrawal|0
4668743|NCT02769065|16059854|P3|Overall Study|Voluntary Withdrawal|0
4668744|NCT02769065|16059855|P2|Overall Study|Voluntary Withdrawal|0
4668745|NCT02769065|16059856|P1|Overall Study|Voluntary Withdrawal|1
4668746|NCT02768870|16060266|P1|Overall Study|On Study|19
4668747|NCT02768870|16060266|P1|Overall Study|Reoperation|4
4668748|NCT02768870|16060266|P1|Overall Study|Death|1
4668749|NCT02768870|16060266|P1|Overall Study|Not Implanted with Device|2
4668750|NCT02768298|16060310|P2|Overall Study|Withdrawal of informed consent|1
4668751|NCT02768298|16060311|P1|Overall Study|Withdrawal of informed consent|0
4668752|NCT02768298|16060310|P2|Overall Study|Subject/guardian decision|0
4668753|NCT02768298|16060311|P1|Overall Study|Subject/guardian decision|1
4668754|NCT02768298|16060310|P2|Overall Study|Non-compliance with study treatment|1
4668755|NCT02768298|16060311|P1|Overall Study|Non-compliance with study treatment|0
4668756|NCT02768298|16060310|P2|Overall Study|Death|1
4668757|NCT02768298|16060311|P1|Overall Study|Death|2
4668758|NCT02768298|16060310|P2|Overall Study|Adverse Event|4
4668759|NCT02768298|16060311|P1|Overall Study|Adverse Event|1
4668760|NCT02768194|16060325|P6|Period 3|Other (Reason not specified)|0
4668761|NCT02768194|16060326|P5|Period 3|Other (Reason not specified)|0
4668762|NCT02768194|16060327|P4|Period 3|Other (Reason not specified)|0
4668763|NCT02768194|16060328|P3|Period 3|Other (Reason not specified)|0
4668764|NCT02768194|16060329|P2|Period 3|Other (Reason not specified)|1
4668765|NCT02768194|16060330|P1|Period 3|Other (Reason not specified)|0
4668766|NCT02768194|16060325|P6|Period 2|Other (Reason not specified)|0
4668767|NCT02768194|16060326|P5|Period 2|Other (Reason not specified)|0
4668768|NCT02768194|16060327|P4|Period 2|Other (Reason not specified)|0
4668769|NCT02768194|16060328|P3|Period 2|Other (Reason not specified)|0
4668770|NCT02768194|16060329|P2|Period 2|Other (Reason not specified)|0
4668771|NCT02768194|16060330|P1|Period 2|Other (Reason not specified)|1
4668772|NCT02768194|16060325|P6|Period 1|Adverse Event|0
4668773|NCT02768194|16060326|P5|Period 1|Adverse Event|0
4668774|NCT02768194|16060327|P4|Period 1|Adverse Event|1
4668775|NCT02768194|16060328|P3|Period 1|Adverse Event|0
4668776|NCT02768194|16060329|P2|Period 1|Adverse Event|0
4668777|NCT02768194|16060330|P1|Period 1|Adverse Event|0
4668778|NCT02768103|16060352|P1|Overall Study|1 participant did not fit in the fMRI|1
4668779|NCT02767765|16060413|P1|Overall Study|Withdrawal by Subject|1
4668780|NCT02767765|16060413|P1|Overall Study|Non-Compliance|1
4668781|NCT02767765|16060413|P1|Overall Study|Investigator decision|1
4668782|NCT02767765|16060413|P1|Overall Study|Lost to Follow-up|2
4668783|NCT02767765|16060413|P1|Overall Study|Insufficient response|1
4668784|NCT02767765|16060413|P1|Overall Study|Death|1
4668785|NCT02767765|16060413|P1|Overall Study|Adverse Event|4
4668786|NCT02766777|16060539|P1|Overall Study|Withdrawal by Subject|4
4668787|NCT02766777|16060539|P1|Overall Study|Protocol Violation|1
4668788|NCT02766777|16060539|P1|Overall Study|Non-Compliance With Study Drug|1
4668789|NCT02766777|16060539|P1|Overall Study|Lost to Follow-up|16
4668790|NCT02766777|16060539|P1|Overall Study|Adverse Event|12
4668791|NCT02766608|16060564|P5|Overall Study|Administrative Reasons|0
4668792|NCT02766608|16060565|P4|Overall Study|Administrative Reasons|0
4668793|NCT02766608|16060566|P3|Overall Study|Administrative Reasons|1
4668794|NCT02766608|16060567|P2|Overall Study|Administrative Reasons|1
4668795|NCT02766608|16060568|P1|Overall Study|Administrative Reasons|3
4668796|NCT02766608|16060564|P5|Overall Study|Protocol Violation|1
4668797|NCT02766608|16060565|P4|Overall Study|Protocol Violation|0
4668798|NCT02766608|16060566|P3|Overall Study|Protocol Violation|4
4668799|NCT02766608|16060567|P2|Overall Study|Protocol Violation|4
4668800|NCT02766608|16060568|P1|Overall Study|Protocol Violation|0
4668801|NCT02766608|16060564|P5|Overall Study|Protocol disc criteria|0
4668802|NCT02766608|16060565|P4|Overall Study|Protocol disc criteria|0
4668803|NCT02766608|16060566|P3|Overall Study|Protocol disc criteria|4
4668804|NCT02766608|16060567|P2|Overall Study|Protocol disc criteria|3
4668805|NCT02766608|16060568|P1|Overall Study|Protocol disc criteria|3
4668806|NCT02766608|16060564|P5|Overall Study|Physician Decision|2
4668807|NCT02766608|16060565|P4|Overall Study|Physician Decision|1
4668808|NCT02766608|16060566|P3|Overall Study|Physician Decision|3
4668809|NCT02766608|16060567|P2|Overall Study|Physician Decision|2
4668810|NCT02766608|16060568|P1|Overall Study|Physician Decision|3
4668811|NCT02766608|16060564|P5|Overall Study|Lost to Follow-up|2
4668812|NCT02766608|16060565|P4|Overall Study|Lost to Follow-up|2
4668813|NCT02766608|16060566|P3|Overall Study|Lost to Follow-up|5
4668814|NCT02766608|16060567|P2|Overall Study|Lost to Follow-up|3
4668815|NCT02766608|16060568|P1|Overall Study|Lost to Follow-up|6
4668816|NCT02766608|16060564|P5|Overall Study|Lack of Efficacy|2
4668817|NCT02766608|16060565|P4|Overall Study|Lack of Efficacy|8
4668818|NCT02766608|16060566|P3|Overall Study|Lack of Efficacy|32
4668819|NCT02766608|16060567|P2|Overall Study|Lack of Efficacy|15
4668820|NCT02766608|16060568|P1|Overall Study|Lack of Efficacy|16
4668821|NCT02766608|16060564|P5|Overall Study|Withdrawal by Subject|10
4668822|NCT02766608|16060565|P4|Overall Study|Withdrawal by Subject|13
4668823|NCT02766608|16060566|P3|Overall Study|Withdrawal by Subject|24
4668824|NCT02766608|16060567|P2|Overall Study|Withdrawal by Subject|20
4668825|NCT02766608|16060568|P1|Overall Study|Withdrawal by Subject|21
4668826|NCT02766608|16060564|P5|Overall Study|Adverse Event|12
4668827|NCT02766608|16060565|P4|Overall Study|Adverse Event|13
4668828|NCT02766608|16060566|P3|Overall Study|Adverse Event|17
4668829|NCT02766608|16060567|P2|Overall Study|Adverse Event|22
4668830|NCT02766608|16060568|P1|Overall Study|Adverse Event|27
4668831|NCT02766400|16060660|P2|Overall Study|Withdrawal by Subject|0
4668832|NCT02766400|16060661|P1|Overall Study|Withdrawal by Subject|1
4668833|NCT02766400|16060660|P2|Overall Study|Death|2
4668834|NCT02766400|16060661|P1|Overall Study|Death|1
4668835|NCT02766283|16060676|P1|Overall Study|Lost to Follow-up|27
4668836|NCT02766088|16060709|P1|Overall Study|Death|1
4668837|NCT02766088|16060709|P1|Overall Study|Other|1
4668838|NCT02766088|16060709|P1|Overall Study|Lost to Follow-up|5
4668839|NCT02766088|16060709|P1|Overall Study|Migrated/moved from the study area|1
4668840|NCT02766088|16060709|P1|Overall Study|Sponsor study termination|498
4668841|NCT02766023|16060724|P2|Overall Study|Not Eligible at Enrollment|1
4668842|NCT02766023|16060725|P1|Overall Study|Not Eligible at Enrollment|0
4668843|NCT02766023|16060724|P2|Overall Study|Physician Decision|0
4668844|NCT02766023|16060725|P1|Overall Study|Physician Decision|1
4668845|NCT02766023|16060724|P2|Overall Study|Withdrawal by Subject|5
4668846|NCT02766023|16060725|P1|Overall Study|Withdrawal by Subject|4
4668847|NCT02766023|16060724|P2|Overall Study|Adverse Event|0
4668848|NCT02766023|16060725|P1|Overall Study|Adverse Event|1
4668849|NCT02766023|16060724|P2|Overall Study|Pregnancy|0
4668850|NCT02766023|16060725|P1|Overall Study|Pregnancy|1
4668851|NCT02766023|16060724|P2|Overall Study|Lost to Follow-up|11
4668852|NCT02766023|16060725|P1|Overall Study|Lost to Follow-up|23
4668853|NCT02765490|16060775|P2|Overall Study|Death|1
4668854|NCT02765490|16060776|P1|Overall Study|Death|0
4668855|NCT02765490|16060775|P2|Overall Study|Other|1
4668856|NCT02765490|16060776|P1|Overall Study|Other|0
4668857|NCT02765490|16060775|P2|Overall Study|Lost to Follow-up|1
4668858|NCT02765490|16060776|P1|Overall Study|Lost to Follow-up|1
4668859|NCT02765100|16060809|P2|Overall Study|Lost to Follow-up|1
4668860|NCT02765100|16060810|P1|Overall Study|Lost to Follow-up|0
4668861|NCT02765100|16060809|P2|Overall Study|subject found ineligible after baseline|1
4668862|NCT02765100|16060810|P1|Overall Study|subject found ineligible after baseline|1
4668863|NCT02764775|16060831|P1|Overall Study|Withdrawal by Subject|3
4668864|NCT02764775|16060831|P1|Overall Study|Lost to Follow-up|2
4668865|NCT02764775|16060831|P1|Overall Study|Death|1
4668866|NCT02764697|16060835|P1|Overall Study|Lack of Efficacy|3
4668867|NCT02764229|16060840|P1|Overall Study|Study Stopped by Sponsor|69
4668868|NCT02764229|16060840|P1|Overall Study|Lack of Efficacy|1
4668869|NCT02764229|16060840|P1|Overall Study|Lost to Follow-up|3
4668870|NCT02764229|16060840|P1|Overall Study|Physician Decision|5
4668871|NCT02764229|16060840|P1|Overall Study|Adverse Event|9
4668872|NCT02764229|16060840|P1|Overall Study|Withdrawal by Subject|15
4668873|NCT02764190|16060846|P2|Overall Study|Lost to Follow-up|13
4668874|NCT02764190|16060847|P1|Overall Study|Lost to Follow-up|17
4668875|NCT02764151|16060901|P4|Overall Study|Other|2
4668876|NCT02764151|16060902|P3|Overall Study|Other|0
4668877|NCT02764151|16060903|P2|Overall Study|Other|0
4668878|NCT02764151|16060904|P1|Overall Study|Other|0
4668879|NCT02764151|16060901|P4|Overall Study|Subject refused further follow-up|1
4668880|NCT02764151|16060902|P3|Overall Study|Subject refused further follow-up|0
4668881|NCT02764151|16060903|P2|Overall Study|Subject refused further follow-up|0
4668882|NCT02764151|16060904|P1|Overall Study|Subject refused further follow-up|0
4668883|NCT02763644|16061043|P2|Overall Study|Adverse Event|1
4668884|NCT02763644|16061044|P1|Overall Study|Adverse Event|1
4668885|NCT02763644|16061043|P2|Overall Study|Death|1
4668886|NCT02763644|16061044|P1|Overall Study|Death|1
4668887|NCT02763644|16061043|P2|Overall Study|Patient/guardian decision|0
4668888|NCT02763644|16061044|P1|Overall Study|Patient/guardian decision|1
4668889|NCT02763579|16061064|P2|Overall Study|On-going in study|60
4668890|NCT02763579|16061065|P1|Overall Study|On-going in study|77
4668891|NCT02763579|16061064|P2|Overall Study|Physician Decision|0
4668892|NCT02763579|16061065|P1|Overall Study|Physician Decision|2
4668893|NCT02763579|16061064|P2|Overall Study|Withdrawal by Subject|9
4668894|NCT02763579|16061065|P1|Overall Study|Withdrawal by Subject|18
4668895|NCT02763579|16061064|P2|Overall Study|Lost to Follow-up|1
4668896|NCT02763579|16061065|P1|Overall Study|Lost to Follow-up|3
4668897|NCT02763579|16061064|P2|Overall Study|Death|132
4668898|NCT02763579|16061065|P1|Overall Study|Death|101
4668899|NCT02763566|16061077|P4|Overall Study|Withdrawal by Subject|0
4668900|NCT02763566|16061078|P3|Overall Study|Withdrawal by Subject|0
4668901|NCT02763566|16061079|P2|Overall Study|Withdrawal by Subject|1
4668902|NCT02763566|16061080|P1|Overall Study|Withdrawal by Subject|3
4668903|NCT02763566|16061077|P4|Overall Study|On study treatment at study conclusion|13
4668904|NCT02763566|16061078|P3|Overall Study|On study treatment at study conclusion|54
4668905|NCT02763566|16061079|P2|Overall Study|On study treatment at study conclusion|34
4668906|NCT02763566|16061080|P1|Overall Study|On study treatment at study conclusion|114
4668907|NCT02763566|16061077|P4|Overall Study|Lost to Follow-up|1
4668908|NCT02763566|16061078|P3|Overall Study|Lost to Follow-up|0
4668909|NCT02763566|16061079|P2|Overall Study|Lost to Follow-up|4
4668910|NCT02763566|16061080|P1|Overall Study|Lost to Follow-up|1
4668911|NCT02763254|16061108|P1|Overall Study|Adverse Event|1
4668912|NCT02763215|16061113|P1|Overall Study|Lost to Follow-up|1
4668913|NCT02763215|16061113|P1|Overall Study|Death|1
4668914|NCT02763215|16061113|P1|Overall Study|Visit outside visit-window|1
4668915|NCT02763215|16061113|P1|Overall Study|Missed visit|1
4668916|NCT02763215|16061113|P1|Overall Study|Participants withdrew from study|3
4668917|NCT02763189|16061136|P2|Overall Study|Device failure|2
4668918|NCT02763189|16061137|P1|Overall Study|Device failure|0
4668919|NCT02763046|16061155|P3|Overall Study|Subject/guardian decision|4
4668920|NCT02763046|16061156|P2|Overall Study|Subject/guardian decision|0
4668921|NCT02763046|16061157|P1|Overall Study|Subject/guardian decision|2
4668922|NCT02763046|16061155|P3|Overall Study|Physician Decision|1
4668923|NCT02763046|16061156|P2|Overall Study|Physician Decision|0
4668924|NCT02763046|16061157|P1|Overall Study|Physician Decision|1
4668925|NCT02763046|16061155|P3|Overall Study|Lack of Efficacy|3
4668926|NCT02763046|16061156|P2|Overall Study|Lack of Efficacy|1
4668927|NCT02763046|16061157|P1|Overall Study|Lack of Efficacy|1
4668928|NCT02763046|16061155|P3|Overall Study|Adverse Event|0
4668929|NCT02763046|16061156|P2|Overall Study|Adverse Event|4
4668930|NCT02763046|16061157|P1|Overall Study|Adverse Event|5
4668931|NCT02762578|16061273|P2|Overall Study|Unclassified|0
4668932|NCT02762578|16061274|P1|Overall Study|Unclassified|6
4668933|NCT02762578|16061273|P2|Overall Study|Withdrawal by Subject|2
4668934|NCT02762578|16061274|P1|Overall Study|Withdrawal by Subject|4
4668935|NCT02762578|16061273|P2|Overall Study|Protocol Violation|2
4668936|NCT02762578|16061274|P1|Overall Study|Protocol Violation|4
4668937|NCT02762578|16061273|P2|Overall Study|Adverse Event|6
4668938|NCT02762578|16061274|P1|Overall Study|Adverse Event|1
4668939|NCT02762500|16061376|P2|Overall Study|Adverse Event|2
4668940|NCT02762500|16061377|P1|Overall Study|Adverse Event|0
4668941|NCT02762500|16061376|P2|Overall Study|Withdrawal by Subject|1
4668942|NCT02762500|16061377|P1|Overall Study|Withdrawal by Subject|1
4668943|NCT02762500|16061376|P2|Overall Study|Lack of Efficacy|0
4668944|NCT02762500|16061377|P1|Overall Study|Lack of Efficacy|1
4668945|NCT02762370|16061397|P2|Overall Study|Protocol Violation|0
4668946|NCT02762370|16061398|P1|Overall Study|Protocol Violation|1
4668947|NCT02762084|16061438|P3|Overall Study|Adverse Event|1
4668948|NCT02762084|16061439|P2|Overall Study|Adverse Event|0
4668949|NCT02762084|16061440|P1|Overall Study|Adverse Event|0
4668950|NCT02762084|16061438|P3|Overall Study|Withdrawal by Subject|0
4668951|NCT02762084|16061439|P2|Overall Study|Withdrawal by Subject|0
4668952|NCT02762084|16061440|P1|Overall Study|Withdrawal by Subject|1
4668953|NCT02761980|16061501|P4|Overall Study|Other|0
4668954|NCT02761980|16061502|P3|Overall Study|Other|1
4668955|NCT02761980|16061503|P2|Overall Study|Other|0
4668956|NCT02761980|16061504|P1|Overall Study|Other|0
4668957|NCT02761980|16061501|P4|Overall Study|Withdrawal by Subject|0
4668958|NCT02761980|16061502|P3|Overall Study|Withdrawal by Subject|0
4668959|NCT02761980|16061503|P2|Overall Study|Withdrawal by Subject|1
4668960|NCT02761980|16061504|P1|Overall Study|Withdrawal by Subject|0
4668961|NCT02761980|16061501|P4|Overall Study|Adverse Event|6
4668962|NCT02761980|16061502|P3|Overall Study|Adverse Event|5
4668963|NCT02761980|16061503|P2|Overall Study|Adverse Event|6
4668964|NCT02761980|16061504|P1|Overall Study|Adverse Event|4
4668965|NCT02761733|16061551|P4|Overall Study|Cognitive Impairment|0
4668966|NCT02761733|16061552|P3|Overall Study|Cognitive Impairment|1
4668967|NCT02761733|16061553|P2|Overall Study|Cognitive Impairment|0
4668968|NCT02761733|16061554|P1|Overall Study|Cognitive Impairment|5
4668969|NCT02761733|16061551|P4|Overall Study|Discharged from Study Site|11
4668970|NCT02761733|16061552|P3|Overall Study|Discharged from Study Site|25
4668971|NCT02761733|16061553|P2|Overall Study|Discharged from Study Site|9
4668972|NCT02761733|16061554|P1|Overall Study|Discharged from Study Site|10
4668973|NCT02761733|16061551|P4|Overall Study|Withdrawal by Subject|0
4668974|NCT02761733|16061552|P3|Overall Study|Withdrawal by Subject|0
4668975|NCT02761733|16061553|P2|Overall Study|Withdrawal by Subject|0
4668976|NCT02761733|16061554|P1|Overall Study|Withdrawal by Subject|2
4668977|NCT02761733|16061551|P4|Overall Study|Physician Decision|0
4668978|NCT02761733|16061552|P3|Overall Study|Physician Decision|0
4668979|NCT02761733|16061553|P2|Overall Study|Physician Decision|0
4668980|NCT02761733|16061554|P1|Overall Study|Physician Decision|4
4668981|NCT02761733|16061551|P4|Overall Study|Lost to Follow-up|3
4668982|NCT02761733|16061552|P3|Overall Study|Lost to Follow-up|0
4668983|NCT02761733|16061553|P2|Overall Study|Lost to Follow-up|7
4668984|NCT02761733|16061554|P1|Overall Study|Lost to Follow-up|6
4668985|NCT02761733|16061551|P4|Overall Study|Death|1
4668986|NCT02761733|16061552|P3|Overall Study|Death|1
4668987|NCT02761733|16061553|P2|Overall Study|Death|5
4668988|NCT02761733|16061554|P1|Overall Study|Death|3
4668989|NCT02761642|16061584|P1|Overall Study|Reason Unspecified|21
4668990|NCT02761642|16061584|P1|Overall Study|Physician Decision|1
4668991|NCT02761642|16061584|P1|Overall Study|Lack of Efficacy|20
4668992|NCT02761642|16061584|P1|Overall Study|Death|3
4668993|NCT02761642|16061584|P1|Overall Study|Non-compliant|7
4668994|NCT02761642|16061584|P1|Overall Study|Withdrawal by Subject|2
4668995|NCT02761642|16061584|P1|Overall Study|Adverse Event|13
4668996|NCT02761642|16061584|P1|Overall Study|Did not Receive Study Treatment|3
4668997|NCT02761629|16061597|P2|Overall Study|Randomized But Not Treated|4
4668998|NCT02761629|16061598|P1|Overall Study|Randomized But Not Treated|8
4668999|NCT02761629|16061597|P2|Overall Study|Lost to Follow-up|1
4669000|NCT02761629|16061598|P1|Overall Study|Lost to Follow-up|4
4669001|NCT02761629|16061597|P2|Overall Study|Other|2
4669002|NCT02761629|16061598|P1|Overall Study|Other|0
4669003|NCT02761629|16061597|P2|Overall Study|Withdrawal by Subject|3
4669004|NCT02761629|16061598|P1|Overall Study|Withdrawal by Subject|0
4669005|NCT02761629|16061597|P2|Overall Study|Protocol Violation|2
4669006|NCT02761629|16061598|P1|Overall Study|Protocol Violation|2
4669007|NCT02761629|16061597|P2|Overall Study|Did not Cooperate/Refused Treatment|4
4669008|NCT02761629|16061598|P1|Overall Study|Did not Cooperate/Refused Treatment|2
4669009|NCT02761629|16061597|P2|Overall Study|Failure to Return|4
4669010|NCT02761629|16061598|P1|Overall Study|Failure to Return|2
4669011|NCT02761629|16061597|P2|Overall Study|Insufficient Therapeutic Response|7
4669012|NCT02761629|16061598|P1|Overall Study|Insufficient Therapeutic Response|2
4669013|NCT02761629|16061597|P2|Overall Study|Adverse Event/Intercurrent Illness|5
4669014|NCT02761629|16061598|P1|Overall Study|Adverse Event/Intercurrent Illness|7
4669015|NCT02760927|16061645|P1|Overall Study|Tube Slippage from Device|1
4669016|NCT02760810|16061662|P1|Overall Study|Protocol Violation|1
4669017|NCT02760654|16061670|P2|Overall Study|Withdrawal by Subject|3
4669018|NCT02760654|16061671|P1|Overall Study|Withdrawal by Subject|4
4669019|NCT02760654|16061670|P2|Overall Study|Lost to Follow-up|3
4669020|NCT02760654|16061671|P1|Overall Study|Lost to Follow-up|3
4669021|NCT02760602|16061697|P2|Overall Study|Terminated by sponsor|13
4669022|NCT02760602|16061698|P1|Overall Study|Terminated by sponsor|12
4669023|NCT02760602|16061697|P2|Overall Study|Withdrawal by Subject|0
4669024|NCT02760602|16061698|P1|Overall Study|Withdrawal by Subject|1
4669025|NCT02760368|16061739|P3|Overall Study|Withdrawal by Sponsor|1
4669026|NCT02760368|16061740|P2|Overall Study|Withdrawal by Sponsor|0
4669027|NCT02760368|16061741|P1|Overall Study|Withdrawal by Sponsor|0
4669028|NCT02760368|16061739|P3|Overall Study|Death|0
4669029|NCT02760368|16061740|P2|Overall Study|Death|0
4669030|NCT02760368|16061741|P1|Overall Study|Death|1
4669031|NCT02760368|16061739|P3|Overall Study|Screen Failure|1
4669032|NCT02760368|16061740|P2|Overall Study|Screen Failure|0
4669033|NCT02760368|16061741|P1|Overall Study|Screen Failure|0
4669034|NCT02760368|16061739|P3|Overall Study|Withdrawal by Subject|9
4669035|NCT02760368|16061740|P2|Overall Study|Withdrawal by Subject|8
4669036|NCT02760368|16061741|P1|Overall Study|Withdrawal by Subject|12
4669037|NCT02760069|16061923|P3|Overall Study|Withdrawal by Subject|1
4669038|NCT02760069|16061924|P2|Overall Study|Withdrawal by Subject|1
4669039|NCT02760069|16061925|P1|Overall Study|Withdrawal by Subject|0
4669040|NCT02759939|16061951|P4|Overall Study|Lost to Follow-up|650
4669041|NCT02759939|16061952|P3|Overall Study|Lost to Follow-up|783
4669042|NCT02759939|16061953|P2|Overall Study|Lost to Follow-up|791
4669043|NCT02759939|16061954|P1|Overall Study|Lost to Follow-up|735
4669044|NCT02759939|16061951|P4|Overall Study|Ineligible for T2 and T3|391
4669045|NCT02759939|16061952|P3|Overall Study|Ineligible for T2 and T3|366
4669046|NCT02759939|16061953|P2|Overall Study|Ineligible for T2 and T3|179
4669047|NCT02759939|16061954|P1|Overall Study|Ineligible for T2 and T3|310
4669048|NCT02759939|16061951|P4|Overall Study|Missing data on first outcome assessed|2
4669049|NCT02759939|16061952|P3|Overall Study|Missing data on first outcome assessed|5
4669050|NCT02759939|16061953|P2|Overall Study|Missing data on first outcome assessed|2
4669051|NCT02759939|16061954|P1|Overall Study|Missing data on first outcome assessed|11
4669052|NCT02759692|16061964|P2|Period 2|Test article no longer available|1
4669053|NCT02759692|16061965|P1|Period 2|Test article no longer available|0
4669054|NCT02759692|16061964|P2|Period 2|Lost to Follow-up|0
4669055|NCT02759692|16061965|P1|Period 2|Lost to Follow-up|1
4669056|NCT02759692|16061964|P2|Period 1|Miss-Randomized|1
4669057|NCT02759692|16061965|P1|Period 1|Miss-Randomized|1
4669058|NCT02759692|16061964|P2|Period 1|No longer meets eligibility criteria.|0
4669059|NCT02759692|16061965|P1|Period 1|No longer meets eligibility criteria.|1
4669060|NCT02759692|16061964|P2|Period 1|Test article no longer available|1
4669061|NCT02759692|16061965|P1|Period 1|Test article no longer available|1
4669062|NCT02759562|16061983|P2|Open-Label Treatment Period|Study Terminated by Sponsor|2
4669063|NCT02759562|16061984|P1|Open-Label Treatment Period|Study Terminated by Sponsor|1
4669064|NCT02759562|16061983|P2|Open-Label Treatment Period|Withdrew Consent|0
4669065|NCT02759562|16061984|P1|Open-Label Treatment Period|Withdrew Consent|1
4669066|NCT02759471|16061997|P1|Overall Study|discomfort|2
4669067|NCT02759315|16062053|P5|Overall Study|Study terminated prior to completion|1
4669068|NCT02759315|16062054|P4|Overall Study|Study terminated prior to completion|0
4669069|NCT02759315|16062055|P3|Overall Study|Study terminated prior to completion|5
4669070|NCT02759315|16062056|P2|Overall Study|Study terminated prior to completion|0
4669071|NCT02759315|16062057|P1|Overall Study|Study terminated prior to completion|2
4669072|NCT02759315|16062053|P5|Overall Study|Protocol Violation|0
4669073|NCT02759315|16062054|P4|Overall Study|Protocol Violation|0
4669074|NCT02759315|16062055|P3|Overall Study|Protocol Violation|0
4669075|NCT02759315|16062056|P2|Overall Study|Protocol Violation|1
4669076|NCT02759315|16062057|P1|Overall Study|Protocol Violation|0
4669077|NCT02759315|16062053|P5|Overall Study|Lost to Follow-up|0
4669078|NCT02759315|16062054|P4|Overall Study|Lost to Follow-up|0
4669079|NCT02759315|16062055|P3|Overall Study|Lost to Follow-up|4
4669080|NCT02759315|16062056|P2|Overall Study|Lost to Follow-up|0
4669081|NCT02759315|16062057|P1|Overall Study|Lost to Follow-up|2
4669082|NCT02759315|16062053|P5|Overall Study|Death|0
4669083|NCT02759315|16062054|P4|Overall Study|Death|0
4669084|NCT02759315|16062055|P3|Overall Study|Death|1
4669085|NCT02759315|16062056|P2|Overall Study|Death|0
4669086|NCT02759315|16062057|P1|Overall Study|Death|0
4669087|NCT02759315|16062053|P5|Overall Study|Adverse Event|0
4669088|NCT02759315|16062054|P4|Overall Study|Adverse Event|1
4669089|NCT02759315|16062055|P3|Overall Study|Adverse Event|0
4669090|NCT02759315|16062056|P2|Overall Study|Adverse Event|0
4669091|NCT02759315|16062057|P1|Overall Study|Adverse Event|0
4669092|NCT02759016|16062103|P2|Overall Study|Other not defined above|1
4669093|NCT02759016|16062104|P1|Overall Study|Other not defined above|2
4669094|NCT02759016|16062103|P2|Overall Study|SD, PR-MRDpos or PR-L|2
4669095|NCT02759016|16062104|P1|Overall Study|SD, PR-MRDpos or PR-L|0
4669096|NCT02759016|16062103|P2|Overall Study|Progressive disease|0
4669097|NCT02759016|16062104|P1|Overall Study|Progressive disease|1
4669098|NCT02759016|16062103|P2|Overall Study|Not treated with BI 836826|0
4669099|NCT02759016|16062104|P1|Overall Study|Not treated with BI 836826|1
4669100|NCT02758613|16062133|P4|Treatment|Withdrawal by Subject|0
4669101|NCT02758613|16062134|P3|Treatment|Withdrawal by Subject|1
4669102|NCT02758613|16062135|P2|Treatment|Withdrawal by Subject|0
4669103|NCT02758613|16062136|P1|Treatment|Withdrawal by Subject|1
4669104|NCT02758613|16062133|P4|Treatment|Physician and Sponsor Decision|0
4669105|NCT02758613|16062134|P3|Treatment|Physician and Sponsor Decision|0
4669106|NCT02758613|16062135|P2|Treatment|Physician and Sponsor Decision|0
4669107|NCT02758613|16062136|P1|Treatment|Physician and Sponsor Decision|1
4669108|NCT02758301|16062154|P2|Overall Study|Protocol Violation|1
4669109|NCT02758301|16062155|P1|Overall Study|Protocol Violation|0
4669110|NCT02758301|16062154|P2|Overall Study|Lost to Follow-up|0
4669111|NCT02758301|16062155|P1|Overall Study|Lost to Follow-up|7
4669112|NCT02758301|16062154|P2|Overall Study|Withdrawal by Subject|6
4669113|NCT02758301|16062155|P1|Overall Study|Withdrawal by Subject|5
4669114|NCT02758301|16062154|P2|Overall Study|Physician Decision|1
4669115|NCT02758301|16062155|P1|Overall Study|Physician Decision|10
4669116|NCT02758301|16062154|P2|Overall Study|Death|0
4669117|NCT02758301|16062155|P1|Overall Study|Death|12
4669118|NCT02758171|16062174|P2|Wash-out|Other reason|0
4669119|NCT02758171|16062175|P1|Wash-out|Other reason|1
4669120|NCT02758171|16062174|P2|Wash-out|Withdrawal by Subject|0
4669121|NCT02758171|16062175|P1|Wash-out|Withdrawal by Subject|1
4669122|NCT02757963|16062229|P1|Overall Study|Withdrawal by Subject|34
4669123|NCT02757963|16062229|P1|Overall Study|Physician Decision|1
4669124|NCT02757963|16062229|P1|Overall Study|Lost to Follow-up|5
4669125|NCT02757963|16062229|P1|Overall Study|Reached Stopping Criteria|1054
4669126|NCT02757963|16062229|P1|Overall Study|Adverse Event|3
4669127|NCT02757768|16062269|P2|Overall Study|Miscellaneous|2
4669128|NCT02757768|16062270|P1|Overall Study|Miscellaneous|4
4669129|NCT02757768|16062269|P2|Overall Study|Withdrawal by Subject|9
4669130|NCT02757768|16062270|P1|Overall Study|Withdrawal by Subject|16
4669131|NCT02757768|16062269|P2|Overall Study|Protocol Deviation|9
4669132|NCT02757768|16062270|P1|Overall Study|Protocol Deviation|2
4669133|NCT02757768|16062269|P2|Overall Study|Lost to Follow-up|0
4669134|NCT02757768|16062270|P1|Overall Study|Lost to Follow-up|1
4669135|NCT02757768|16062269|P2|Overall Study|Lack of Efficacy|1
4669136|NCT02757768|16062270|P1|Overall Study|Lack of Efficacy|2
4669137|NCT02757768|16062269|P2|Overall Study|Adverse Event|3
4669138|NCT02757768|16062270|P1|Overall Study|Adverse Event|5
4669139|NCT02757768|16062269|P2|Overall Study|Randomized Never Received Study Drug|4
4669140|NCT02757768|16062270|P1|Overall Study|Randomized Never Received Study Drug|3
4669141|NCT02757625|16062320|P4|Overall Study|Adverse Event|0
4669142|NCT02757625|16062321|P3|Overall Study|Adverse Event|1
4669143|NCT02757625|16062322|P2|Overall Study|Adverse Event|0
4669144|NCT02757625|16062323|P1|Overall Study|Adverse Event|0
4669145|NCT02757625|16062320|P4|Overall Study|Investigator's discretion|0
4669146|NCT02757625|16062321|P3|Overall Study|Investigator's discretion|1
4669147|NCT02757625|16062322|P2|Overall Study|Investigator's discretion|0
4669148|NCT02757625|16062323|P1|Overall Study|Investigator's discretion|0
4669149|NCT02757521|16062482|P2|Overall Study|Adverse Event|0
4669150|NCT02757521|16062483|P1|Overall Study|Adverse Event|1
4669151|NCT02757430|16062489|P1|Overall Study|No procedure performed|2
4669152|NCT02757430|16062489|P1|Overall Study|No informed consent|1
4669153|NCT02757430|16062489|P1|Overall Study|Inclusion/Exclusion criteria not met|3
4669154|NCT02757430|16062489|P1|Overall Study|Physician Decision|6
4669155|NCT02757352|16062508|P10|Follow-Up Period|Withdrawal by Subject|2
4669156|NCT02757352|16062509|P9|Follow-Up Period|Withdrawal by Subject|6
4669157|NCT02757352|16062510|P8|Follow-Up Period|Withdrawal by Subject|1
4669158|NCT02757352|16062511|P7|Follow-Up Period|Withdrawal by Subject|0
4669159|NCT02757352|16062512|P6|Follow-Up Period|Withdrawal by Subject|0
4669160|NCT02757352|16062513|P5|Follow-Up Period|Withdrawal by Subject|0
4669161|NCT02757352|16062514|P4|Follow-Up Period|Withdrawal by Subject|0
4669162|NCT02757352|16062515|P3|Follow-Up Period|Withdrawal by Subject|0
4669163|NCT02757352|16062516|P2|Follow-Up Period|Withdrawal by Subject|0
4669164|NCT02757352|16062517|P1|Follow-Up Period|Withdrawal by Subject|0
4669165|NCT02757352|16062508|P10|Follow-Up Period|Lack of Efficacy|1
4669166|NCT02757352|16062509|P9|Follow-Up Period|Lack of Efficacy|1
4669167|NCT02757352|16062510|P8|Follow-Up Period|Lack of Efficacy|0
4669168|NCT02757352|16062511|P7|Follow-Up Period|Lack of Efficacy|0
4669169|NCT02757352|16062512|P6|Follow-Up Period|Lack of Efficacy|0
4669170|NCT02757352|16062513|P5|Follow-Up Period|Lack of Efficacy|0
4669171|NCT02757352|16062514|P4|Follow-Up Period|Lack of Efficacy|0
4669172|NCT02757352|16062515|P3|Follow-Up Period|Lack of Efficacy|0
4669173|NCT02757352|16062516|P2|Follow-Up Period|Lack of Efficacy|0
4669174|NCT02757352|16062517|P1|Follow-Up Period|Lack of Efficacy|0
4669175|NCT02757352|16062508|P10|Follow-Up Period|Lost to Follow-up|0
4669176|NCT02757352|16062509|P9|Follow-Up Period|Lost to Follow-up|1
4669177|NCT02757352|16062510|P8|Follow-Up Period|Lost to Follow-up|0
4669178|NCT02757352|16062511|P7|Follow-Up Period|Lost to Follow-up|0
4669179|NCT02757352|16062512|P6|Follow-Up Period|Lost to Follow-up|0
4669180|NCT02757352|16062513|P5|Follow-Up Period|Lost to Follow-up|0
4669181|NCT02757352|16062514|P4|Follow-Up Period|Lost to Follow-up|0
4669182|NCT02757352|16062515|P3|Follow-Up Period|Lost to Follow-up|0
4669183|NCT02757352|16062516|P2|Follow-Up Period|Lost to Follow-up|0
4669184|NCT02757352|16062517|P1|Follow-Up Period|Lost to Follow-up|0
4669185|NCT02757352|16062508|P10|Follow-Up Period|Adverse Event|0
4669186|NCT02757352|16062509|P9|Follow-Up Period|Adverse Event|2
4669187|NCT02757352|16062510|P8|Follow-Up Period|Adverse Event|0
4669188|NCT02757352|16062511|P7|Follow-Up Period|Adverse Event|1
4669189|NCT02757352|16062512|P6|Follow-Up Period|Adverse Event|0
4669190|NCT02757352|16062513|P5|Follow-Up Period|Adverse Event|0
4669191|NCT02757352|16062514|P4|Follow-Up Period|Adverse Event|0
4669192|NCT02757352|16062515|P3|Follow-Up Period|Adverse Event|0
4669193|NCT02757352|16062516|P2|Follow-Up Period|Adverse Event|0
4669194|NCT02757352|16062517|P1|Follow-Up Period|Adverse Event|0
4669195|NCT02757352|16062508|P10|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669196|NCT02757352|16062509|P9|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669197|NCT02757352|16062510|P8|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669198|NCT02757352|16062511|P7|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669199|NCT02757352|16062512|P6|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
4669200|NCT02757352|16062513|P5|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1
4669201|NCT02757352|16062514|P4|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2
4669202|NCT02757352|16062515|P3|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669203|NCT02757352|16062516|P2|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669204|NCT02757352|16062517|P1|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669205|NCT02757352|16062508|P10|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669206|NCT02757352|16062509|P9|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669207|NCT02757352|16062510|P8|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669208|NCT02757352|16062511|P7|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669209|NCT02757352|16062512|P6|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1
4669210|NCT02757352|16062513|P5|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669211|NCT02757352|16062514|P4|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669212|NCT02757352|16062515|P3|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669213|NCT02757352|16062516|P2|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669214|NCT02757352|16062517|P1|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0
4669215|NCT02757352|16062508|P10|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669216|NCT02757352|16062509|P9|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669217|NCT02757352|16062510|P8|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669218|NCT02757352|16062511|P7|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669219|NCT02757352|16062512|P6|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669220|NCT02757352|16062513|P5|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1
4669221|NCT02757352|16062514|P4|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669222|NCT02757352|16062515|P3|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669223|NCT02757352|16062516|P2|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669224|NCT02757352|16062517|P1|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0
4669225|NCT02757352|16062508|P10|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669226|NCT02757352|16062509|P9|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669227|NCT02757352|16062510|P8|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669228|NCT02757352|16062511|P7|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669229|NCT02757352|16062512|P6|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4
4669230|NCT02757352|16062513|P5|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1
4669231|NCT02757352|16062514|P4|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2
4669232|NCT02757352|16062515|P3|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669233|NCT02757352|16062516|P2|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669234|NCT02757352|16062517|P1|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0
4669235|NCT02757352|16062508|P10|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669236|NCT02757352|16062509|P9|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669237|NCT02757352|16062510|P8|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669238|NCT02757352|16062511|P7|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669239|NCT02757352|16062512|P6|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1
4669240|NCT02757352|16062513|P5|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669241|NCT02757352|16062514|P4|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3
4669242|NCT02757352|16062515|P3|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669243|NCT02757352|16062516|P2|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669244|NCT02757352|16062517|P1|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0
4669245|NCT02757352|16062508|P10|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669246|NCT02757352|16062509|P9|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669247|NCT02757352|16062510|P8|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669248|NCT02757352|16062511|P7|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669249|NCT02757352|16062512|P6|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669250|NCT02757352|16062513|P5|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669251|NCT02757352|16062514|P4|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0
4669252|NCT02757352|16062515|P3|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42
4669253|NCT02757352|16062516|P2|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40
4669254|NCT02757352|16062517|P1|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62
4669255|NCT02757352|16062508|P10|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669256|NCT02757352|16062509|P9|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669257|NCT02757352|16062510|P8|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669258|NCT02757352|16062511|P7|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669259|NCT02757352|16062512|P6|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669260|NCT02757352|16062513|P5|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669261|NCT02757352|16062514|P4|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0
4669262|NCT02757352|16062515|P3|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4
4669263|NCT02757352|16062516|P2|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
4669264|NCT02757352|16062517|P1|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1
4669265|NCT02757352|16062508|P10|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669266|NCT02757352|16062509|P9|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669267|NCT02757352|16062510|P8|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669268|NCT02757352|16062511|P7|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669269|NCT02757352|16062512|P6|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669270|NCT02757352|16062513|P5|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669271|NCT02757352|16062514|P4|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669272|NCT02757352|16062515|P3|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669273|NCT02757352|16062516|P2|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1
4669274|NCT02757352|16062517|P1|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0
4669275|NCT02757352|16062508|P10|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669276|NCT02757352|16062509|P9|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669277|NCT02757352|16062510|P8|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669278|NCT02757352|16062511|P7|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669279|NCT02757352|16062512|P6|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669280|NCT02757352|16062513|P5|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669281|NCT02757352|16062514|P4|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669282|NCT02757352|16062515|P3|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669283|NCT02757352|16062516|P2|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1
4669284|NCT02757352|16062517|P1|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0
4669285|NCT02757352|16062508|P10|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669286|NCT02757352|16062509|P9|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669287|NCT02757352|16062510|P8|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669288|NCT02757352|16062511|P7|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669289|NCT02757352|16062512|P6|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669290|NCT02757352|16062513|P5|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669291|NCT02757352|16062514|P4|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0
4669292|NCT02757352|16062515|P3|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2
4669293|NCT02757352|16062516|P2|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1
4669294|NCT02757352|16062517|P1|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6
4669295|NCT02757352|16062508|P10|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669296|NCT02757352|16062509|P9|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669297|NCT02757352|16062510|P8|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669298|NCT02757352|16062511|P7|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669299|NCT02757352|16062512|P6|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669300|NCT02757352|16062513|P5|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669301|NCT02757352|16062514|P4|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669302|NCT02757352|16062515|P3|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1
4669303|NCT02757352|16062516|P2|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669304|NCT02757352|16062517|P1|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0
4669305|NCT02757352|16062508|P10|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669306|NCT02757352|16062509|P9|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669307|NCT02757352|16062510|P8|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669308|NCT02757352|16062511|P7|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669309|NCT02757352|16062512|P6|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669310|NCT02757352|16062513|P5|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669311|NCT02757352|16062514|P4|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669312|NCT02757352|16062515|P3|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1
4669313|NCT02757352|16062516|P2|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0
4669314|NCT02757352|16062517|P1|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2
4669315|NCT02756832|16062673|P1|Overall Study|Protocol Deviation|10
4669316|NCT02756832|16062673|P1|Overall Study|Reason not Specified|9
4669317|NCT02756832|16062673|P1|Overall Study|Sponsor Decision/Regulatory Requirement|1
4669318|NCT02756832|16062673|P1|Overall Study|Insufficient Efficacy|2
4669319|NCT02756832|16062673|P1|Overall Study|Patient's Unwillingness|12
4669320|NCT02756832|16062673|P1|Overall Study|Lost for Observation|13
4669321|NCT02756832|16062673|P1|Overall Study|Lost for Observation after Baseline|6
4669322|NCT02756819|16062687|P1|Overall Study|Reason not Specified|9
4669323|NCT02756819|16062687|P1|Overall Study|Adverse Event|2
4669324|NCT02756819|16062687|P1|Overall Study|Insufficient efficacy|2
4669325|NCT02756819|16062687|P1|Overall Study|Patient's unwillingness|16
4669326|NCT02756819|16062687|P1|Overall Study|Lost for observation|23
4669327|NCT02756650|16062786|P1|Overall Study|Adverse Event|1
4669328|NCT02756650|16062786|P1|Overall Study|Physician Decision|1
4669329|NCT02756637|16062809|P2|Overall Study|Did not complete curative therapy|0
4669330|NCT02756637|16062810|P1|Overall Study|Did not complete curative therapy|33
4669331|NCT02756637|16062809|P2|Overall Study|No available NLR value|44
4669332|NCT02756637|16062810|P1|Overall Study|No available NLR value|44
4669333|NCT02756637|16062809|P2|Overall Study|Not eligible for initial SWOG study|10
4669334|NCT02756637|16062810|P1|Overall Study|Not eligible for initial SWOG study|10
4669335|NCT02756611|16062831|P1|Overall Study|Active on Study|205
4669336|NCT02756611|16062831|P1|Overall Study|Missing|2
4669337|NCT02756611|16062831|P1|Overall Study|Other|7
4669338|NCT02756611|16062831|P1|Overall Study|Lost to Follow-up|2
4669339|NCT02756611|16062831|P1|Overall Study|Withdrawal by Subject|1
4669340|NCT02756611|16062831|P1|Overall Study|Death|39
4669341|NCT02756338|16062853|P1|Overall Study|Device Replaced with Pacemaker|4
4669342|NCT02756338|16062853|P1|Overall Study|Withdrawn by Investigator|1
4669343|NCT02756182|16062862|P1|Overall Study|StudyTechnical Difficulties|4
4669344|NCT02756078|16062877|P2|Period 2|Withdrawal by Subject|1
4669345|NCT02756078|16062878|P1|Period 2|Withdrawal by Subject|3
4669346|NCT02756078|16062877|P2|Period 2|Unsatisfactory Lens Fitting|1
4669347|NCT02756078|16062878|P1|Period 2|Unsatisfactory Lens Fitting|0
4669348|NCT02756078|16062877|P2|Period 2|Adverse Event|5
4669349|NCT02756078|16062878|P1|Period 2|Adverse Event|3
4669350|NCT02756078|16062877|P2|Period 1|Lens Discomfort|2
4669351|NCT02756078|16062878|P1|Period 1|Lens Discomfort|2
4669352|NCT02756078|16062877|P2|Period 1|Withdrawal by Subject|6
4669353|NCT02756078|16062878|P1|Period 1|Withdrawal by Subject|6
4669354|NCT02756078|16062877|P2|Period 1|Adverse Event|10
4669355|NCT02756078|16062878|P1|Period 1|Adverse Event|1
4669356|NCT02756078|16062877|P2|Period 1|Protocol Violation|1
4669357|NCT02756078|16062878|P1|Period 1|Protocol Violation|0
4669358|NCT02756078|16062877|P2|Period 1|Lost to Follow-up|2
4669359|NCT02756078|16062878|P1|Period 1|Lost to Follow-up|0
4669360|NCT02756078|16062877|P2|Period 1|Unsatisfactory Lens Fitting|1
4669361|NCT02756078|16062878|P1|Period 1|Unsatisfactory Lens Fitting|0
4669362|NCT02756013|16062896|P1|Overall Study|Hypersensitivity|1
4669363|NCT02756013|16062896|P1|Overall Study|Adverse Event|1
4669364|NCT02755831|16062908|P2|Overall Study|Lost to Follow-up|3
4669365|NCT02755831|16062909|P1|Overall Study|Lost to Follow-up|3
4669366|NCT02755818|16062925|P4|Overall Study|withdrawal by PI|1
4669367|NCT02755818|16062926|P3|Overall Study|withdrawal by PI|1
4669368|NCT02755818|16062927|P2|Overall Study|withdrawal by PI|0
4669369|NCT02755818|16062928|P1|Overall Study|withdrawal by PI|0
4669370|NCT02755818|16062925|P4|Overall Study|Withdrawal by Subject|2
4669371|NCT02755818|16062926|P3|Overall Study|Withdrawal by Subject|0
4669372|NCT02755818|16062927|P2|Overall Study|Withdrawal by Subject|0
4669373|NCT02755818|16062928|P1|Overall Study|Withdrawal by Subject|0
4669374|NCT02755805|16062964|P2|Overall Study|Withdrawal by Subject|2
4669375|NCT02755805|16062965|P1|Overall Study|Withdrawal by Subject|0
4669376|NCT02755805|16062964|P2|Overall Study|Refused assessments|0
4669377|NCT02755805|16062965|P1|Overall Study|Refused assessments|1
4669378|NCT02755805|16062964|P2|Overall Study|Lost to Follow-up|2
4669379|NCT02755805|16062965|P1|Overall Study|Lost to Follow-up|1
4669380|NCT02755649|16062980|P3|Overall Study|Undecided|0
4669381|NCT02755649|16062981|P2|Overall Study|Undecided|0
4669382|NCT02755649|16062982|P1|Overall Study|Undecided|1
4669383|NCT02755649|16062980|P3|Overall Study|Withdrawal by Subject|0
4669384|NCT02755649|16062981|P2|Overall Study|Withdrawal by Subject|1
4669385|NCT02755649|16062982|P1|Overall Study|Withdrawal by Subject|0
4669386|NCT02755649|16062980|P3|Overall Study|Physician Decision|2
4669387|NCT02755649|16062981|P2|Overall Study|Physician Decision|0
4669388|NCT02755649|16062982|P1|Overall Study|Physician Decision|0
4669389|NCT02755649|16062980|P3|Overall Study|Did Not Complete Follow-up Visits|0
4669390|NCT02755649|16062981|P2|Overall Study|Did Not Complete Follow-up Visits|0
4669391|NCT02755649|16062982|P1|Overall Study|Did Not Complete Follow-up Visits|1
4669392|NCT02755649|16062980|P3|Overall Study|Transitioned into OLE study|100
4669393|NCT02755649|16062981|P2|Overall Study|Transitioned into OLE study|98
4669394|NCT02755649|16062982|P1|Overall Study|Transitioned into OLE study|99
4669395|NCT02755116|16063057|P2|Overall Study|surgery converted to open, pt admitted|1
4669396|NCT02755116|16063058|P1|Overall Study|surgery converted to open, pt admitted|3
4669397|NCT02755090|16063074|P2|Overall Study|equipment malfunction|0
4669398|NCT02755090|16063075|P1|Overall Study|equipment malfunction|1
4669399|NCT02754492|16063127|P4|Overall Study|Venous access issues not resulting in AE|4
4669400|NCT02754492|16063128|P3|Overall Study|Venous access issues not resulting in AE|0
4669401|NCT02754492|16063129|P2|Overall Study|Venous access issues not resulting in AE|0
4669402|NCT02754492|16063130|P1|Overall Study|Venous access issues not resulting in AE|0
4669403|NCT02754492|16063127|P4|Overall Study|Adverse Event|13
4669404|NCT02754492|16063128|P3|Overall Study|Adverse Event|0
4669405|NCT02754492|16063129|P2|Overall Study|Adverse Event|0
4669406|NCT02754492|16063130|P1|Overall Study|Adverse Event|0
4669407|NCT02754492|16063127|P4|Overall Study|Equipment malfuntion|5
4669408|NCT02754492|16063128|P3|Overall Study|Equipment malfuntion|2
4669409|NCT02754492|16063129|P2|Overall Study|Equipment malfuntion|0
4669410|NCT02754492|16063130|P1|Overall Study|Equipment malfuntion|0
4669411|NCT02754492|16063127|P4|Overall Study|Withdrawal by Subject|0
4669412|NCT02754492|16063128|P3|Overall Study|Withdrawal by Subject|0
4669413|NCT02754492|16063129|P2|Overall Study|Withdrawal by Subject|0
4669414|NCT02754492|16063130|P1|Overall Study|Withdrawal by Subject|2
4669415|NCT02754492|16063127|P4|Overall Study|Protocol Violation|1
4669416|NCT02754492|16063128|P3|Overall Study|Protocol Violation|0
4669417|NCT02754492|16063129|P2|Overall Study|Protocol Violation|2
4669418|NCT02754492|16063130|P1|Overall Study|Protocol Violation|2
4669419|NCT02754440|16063146|P4|Overall Study|Subject issues not resulting in AE|12
4669420|NCT02754440|16063147|P3|Overall Study|Subject issues not resulting in AE|0
4669421|NCT02754440|16063148|P2|Overall Study|Subject issues not resulting in AE|0
4669422|NCT02754440|16063149|P1|Overall Study|Subject issues not resulting in AE|0
4669423|NCT02754440|16063146|P4|Overall Study|Equipment failure|7
4669424|NCT02754440|16063147|P3|Overall Study|Equipment failure|5
4669425|NCT02754440|16063148|P2|Overall Study|Equipment failure|5
4669426|NCT02754440|16063149|P1|Overall Study|Equipment failure|0
4669427|NCT02754440|16063146|P4|Overall Study|Withdrawal by Subject|1
4669428|NCT02754440|16063147|P3|Overall Study|Withdrawal by Subject|0
4669429|NCT02754440|16063148|P2|Overall Study|Withdrawal by Subject|0
4669430|NCT02754440|16063149|P1|Overall Study|Withdrawal by Subject|0
4669431|NCT02754440|16063146|P4|Overall Study|Adverse Event|9
4669432|NCT02754440|16063147|P3|Overall Study|Adverse Event|0
4669433|NCT02754440|16063148|P2|Overall Study|Adverse Event|1
4669434|NCT02754440|16063149|P1|Overall Study|Adverse Event|3
4669435|NCT02754440|16063146|P4|Overall Study|Protocol Violation|6
4669436|NCT02754440|16063147|P3|Overall Study|Protocol Violation|2
4669437|NCT02754440|16063148|P2|Overall Study|Protocol Violation|2
4669438|NCT02754440|16063149|P1|Overall Study|Protocol Violation|3
4669439|NCT02753946|16063201|P2|Overall Study|Physician Decision|2
4669440|NCT02753946|16063202|P1|Overall Study|Physician Decision|0
4669441|NCT02753946|16063201|P2|Overall Study|Lack of Efficacy|0
4669442|NCT02753946|16063202|P1|Overall Study|Lack of Efficacy|1
4669443|NCT02753946|16063201|P2|Overall Study|Withdrawal by Subject|1
4669444|NCT02753946|16063202|P1|Overall Study|Withdrawal by Subject|6
4669445|NCT02753946|16063201|P2|Overall Study|Adverse Event|6
4669446|NCT02753946|16063202|P1|Overall Study|Adverse Event|7
4669447|NCT02753595|16063303|P2|Overall Study|Sponsor termination|2
4669448|NCT02753595|16063304|P1|Overall Study|Sponsor termination|2
4669449|NCT02753075|16063348|P3|Overall Study|Physician Decision|0
4669450|NCT02753075|16063349|P2|Overall Study|Physician Decision|1
4669451|NCT02753075|16063350|P1|Overall Study|Physician Decision|3
4669452|NCT02753075|16063348|P3|Overall Study|Withdrawal of Consent|3
4669453|NCT02753075|16063349|P2|Overall Study|Withdrawal of Consent|1
4669454|NCT02753075|16063350|P1|Overall Study|Withdrawal of Consent|1
4669455|NCT02753075|16063348|P3|Overall Study|Lost to Follow-up|0
4669456|NCT02753075|16063349|P2|Overall Study|Lost to Follow-up|0
4669457|NCT02753075|16063350|P1|Overall Study|Lost to Follow-up|2
4669458|NCT02753075|16063348|P3|Overall Study|Adverse Event|0
4669459|NCT02753075|16063349|P2|Overall Study|Adverse Event|1
4669460|NCT02753075|16063350|P1|Overall Study|Adverse Event|2
4669461|NCT02752958|16063375|P1|Overall Study|Other (Reason not specified)|2
4669462|NCT02752958|16063375|P1|Overall Study|Withdrawal by Subject|2
4669463|NCT02752958|16063375|P1|Overall Study|Protocol Violation|1
4669464|NCT02752958|16063375|P1|Overall Study|Lost to Follow-up|1
4669465|NCT02752958|16063375|P1|Overall Study|Adverse Event|3
4669466|NCT02752906|16063446|P2|Overall Study|Lost to Follow-up|2
4669467|NCT02752906|16063447|P1|Overall Study|Lost to Follow-up|3
4669468|NCT02752906|16063446|P2|Overall Study|Withdrawal by Subject|2
4669469|NCT02752906|16063447|P1|Overall Study|Withdrawal by Subject|2
4669470|NCT02752906|16063446|P2|Overall Study|Protocol Violation|1
4669471|NCT02752906|16063447|P1|Overall Study|Protocol Violation|2
4669472|NCT02752802|16063472|P2|Overall Study|Contrast Volume Not Collected|0
4669473|NCT02752802|16063473|P1|Overall Study|Contrast Volume Not Collected|1
4669474|NCT02752776|16063485|P3|Overall Study|Withdrawal by Subject|2
4669475|NCT02752776|16063486|P2|Overall Study|Withdrawal by Subject|4
4669476|NCT02752776|16063487|P1|Overall Study|Withdrawal by Subject|3
4669477|NCT02752776|16063485|P3|Overall Study|Death|1
4669478|NCT02752776|16063486|P2|Overall Study|Death|0
4669479|NCT02752776|16063487|P1|Overall Study|Death|0
4669480|NCT02752776|16063485|P3|Overall Study|Subject/guardian decision|4
4669481|NCT02752776|16063486|P2|Overall Study|Subject/guardian decision|6
4669482|NCT02752776|16063487|P1|Overall Study|Subject/guardian decision|8
4669483|NCT02752776|16063485|P3|Overall Study|Protocol Violation|6
4669484|NCT02752776|16063486|P2|Overall Study|Protocol Violation|13
4669485|NCT02752776|16063487|P1|Overall Study|Protocol Violation|10
4669486|NCT02752776|16063485|P3|Overall Study|Pregnancy|3
4669487|NCT02752776|16063486|P2|Overall Study|Pregnancy|6
4669488|NCT02752776|16063487|P1|Overall Study|Pregnancy|1
4669489|NCT02752776|16063485|P3|Overall Study|Physician Decision|2
4669490|NCT02752776|16063486|P2|Overall Study|Physician Decision|6
4669491|NCT02752776|16063487|P1|Overall Study|Physician Decision|2
4669492|NCT02752776|16063485|P3|Overall Study|Non-compliance with study treatment|1
4669493|NCT02752776|16063486|P2|Overall Study|Non-compliance with study treatment|0
4669494|NCT02752776|16063487|P1|Overall Study|Non-compliance with study treatment|0
4669495|NCT02752776|16063485|P3|Overall Study|Lost to Follow-up|4
4669496|NCT02752776|16063486|P2|Overall Study|Lost to Follow-up|12
4669497|NCT02752776|16063487|P1|Overall Study|Lost to Follow-up|11
4669498|NCT02752776|16063485|P3|Overall Study|Lack of Efficacy|14
4669499|NCT02752776|16063486|P2|Overall Study|Lack of Efficacy|6
4669500|NCT02752776|16063487|P1|Overall Study|Lack of Efficacy|2
4669501|NCT02752776|16063485|P3|Overall Study|Adverse Event|11
4669502|NCT02752776|16063486|P2|Overall Study|Adverse Event|23
4669503|NCT02752776|16063487|P1|Overall Study|Adverse Event|15
4669504|NCT02752633|16063533|P1|Overall Study|Withdrawal by Subject|1
4669505|NCT02752087|16063571|P2|Washout|Physician Decision|0
4669506|NCT02752087|16063572|P1|Washout|Physician Decision|1
4669507|NCT02752074|16063582|P2|Overall Study|Withdrawal by Subject|10
4669508|NCT02752074|16063583|P1|Overall Study|Withdrawal by Subject|9
4669509|NCT02752074|16063582|P2|Overall Study|Death|129
4669510|NCT02752074|16063583|P1|Overall Study|Death|146
4669511|NCT02752074|16063582|P2|Overall Study|Lost to Follow-up|4
4669512|NCT02752074|16063583|P1|Overall Study|Lost to Follow-up|1
4669513|NCT02752048|16063608|P3|Overall Study|Withdrawal by Subject|3
4669514|NCT02752048|16063609|P2|Overall Study|Withdrawal by Subject|0
4669515|NCT02752048|16063610|P1|Overall Study|Withdrawal by Subject|0
4669516|NCT02751983|16063629|P2|Three-Month Follow-Up Assessments|Lost to Follow-up|16
4669517|NCT02751983|16063630|P1|Three-Month Follow-Up Assessments|Lost to Follow-up|12
4669518|NCT02751983|16063629|P2|One-Month Follow-Up Assessments|Lost to Follow-up|12
4669519|NCT02751983|16063630|P1|One-Month Follow-Up Assessments|Lost to Follow-up|14
4669520|NCT02751983|16063629|P2|Post-Treatment Assessment|Lost to Follow-up|0
4669521|NCT02751983|16063630|P1|Post-Treatment Assessment|Lost to Follow-up|5
4669522|NCT02751983|16063629|P2|Treatment|Discharged prior to beginning ACT|0
4669523|NCT02751983|16063630|P1|Treatment|Discharged prior to beginning ACT|2
4669524|NCT02751983|16063629|P2|Treatment|Stopped ACT, but Remained in study|0
4669525|NCT02751983|16063630|P1|Treatment|Stopped ACT, but Remained in study|2
4669526|NCT02751931|16063651|P2|Overall Study|Other: Miscelleneous|8
4669527|NCT02751931|16063652|P1|Overall Study|Other: Miscelleneous|10
4669528|NCT02751931|16063651|P2|Overall Study|Adverse Event|0
4669529|NCT02751931|16063652|P1|Overall Study|Adverse Event|3
4669530|NCT02751450|16063742|P2|Overall Study|Adverse Event|0
4669531|NCT02751450|16063743|P1|Overall Study|Adverse Event|1
4669532|NCT02751424|16063764|P9|Part 2|Adverse Event|0
4669533|NCT02751424|16063765|P8|Part 2|Adverse Event|5
4669534|NCT02751424|16063766|P7|Part 2|Adverse Event|0
4669535|NCT02751424|16063767|P6|Part 2|Adverse Event|0
4669536|NCT02751424|16063768|P5|Part 2|Adverse Event|0
4669537|NCT02751424|16063769|P4|Part 2|Adverse Event|0
4669538|NCT02751424|16063770|P3|Part 2|Adverse Event|0
4669539|NCT02751424|16063771|P2|Part 2|Adverse Event|0
4669540|NCT02751424|16063772|P1|Part 2|Adverse Event|0
4669541|NCT02751320|16063928|P1|Overall Study|Withdrawal by Subject|1
4669542|NCT02751320|16063928|P1|Overall Study|Adverse Event|2
4669543|NCT02750943|16063966|P2|Overall Study|Withdrawal by Subject|7
4669544|NCT02750943|16063967|P1|Overall Study|Withdrawal by Subject|5
4669545|NCT02750943|16063966|P2|Overall Study|Lost to Follow-up|2
4669546|NCT02750943|16063967|P1|Overall Study|Lost to Follow-up|1
4669547|NCT02750930|16063981|P1|Overall Study|Study closed/terminated|8
4669548|NCT02750813|16063993|P2|Period 1, First 14 Days of Wear|Reason not given|1
4669549|NCT02750813|16063994|P1|Period 1, First 14 Days of Wear|Reason not given|0
4669550|NCT02750813|16063993|P2|Period 1, First 14 Days of Wear|Withdrawal by Subject|0
4669551|NCT02750813|16063994|P1|Period 1, First 14 Days of Wear|Withdrawal by Subject|1
4669552|NCT02750800|16064009|P1|Overall Study|Other, not specified|3
4669553|NCT02750800|16064009|P1|Overall Study|Patient request|12
4669554|NCT02750800|16064009|P1|Overall Study|Investigator decision|53
4669555|NCT02750800|16064009|P1|Overall Study|Lost to Follow-up|12
4669556|NCT02750800|16064009|P1|Overall Study|Adverse Event|18
4669557|NCT02750761|16064114|P6|Overall Study|Lost to Follow-up|0
4669558|NCT02750761|16064115|P5|Overall Study|Lost to Follow-up|0
4669559|NCT02750761|16064116|P4|Overall Study|Lost to Follow-up|0
4669560|NCT02750761|16064117|P3|Overall Study|Lost to Follow-up|1
4669561|NCT02750761|16064118|P2|Overall Study|Lost to Follow-up|0
4669562|NCT02750761|16064119|P1|Overall Study|Lost to Follow-up|0
4669563|NCT02750709|16064215|P6|Treatment Period 1|Adverse Event|1
4669564|NCT02750709|16064216|P5|Treatment Period 1|Adverse Event|0
4669565|NCT02750709|16064217|P4|Treatment Period 1|Adverse Event|0
4669566|NCT02750709|16064218|P3|Treatment Period 1|Adverse Event|0
4669567|NCT02750709|16064219|P2|Treatment Period 1|Adverse Event|0
4669568|NCT02750709|16064220|P1|Treatment Period 1|Adverse Event|0
4669569|NCT02750618|16064246|P1|Overall Study|Withdrawal by Subject|1
4669570|NCT02750592|16064262|P1|Overall Study|Lack of Efficacy|2
4669571|NCT02750592|16064262|P1|Overall Study|Adverse Event|3
4669572|NCT02750501|16064281|P1|Overall Study|Non-compliant use of PERT|1
4669573|NCT02750501|16064281|P1|Overall Study|G-tube came out|1
4669574|NCT02750501|16064281|P1|Overall Study|Protocol Violation|1
4669575|NCT02750501|16064281|P1|Overall Study|Physician Decision|1
4669576|NCT02750501|16064281|P1|Overall Study|Adverse Event|4
4669577|NCT02750410|16064295|P2|Open-Label Extension Period|Withdrawal by Subject|2
4669578|NCT02750410|16064296|P1|Open-Label Extension Period|Withdrawal by Subject|1
4669579|NCT02750410|16064295|P2|Open-Label Extension Period|Protocol Violation|1
4669580|NCT02750410|16064296|P1|Open-Label Extension Period|Protocol Violation|0
4669581|NCT02750410|16064295|P2|Open-Label Extension Period|Adverse Event|3
4669582|NCT02750410|16064296|P1|Open-Label Extension Period|Adverse Event|5
4669583|NCT02750410|16064295|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
4669584|NCT02750410|16064296|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
4669585|NCT02750410|16064295|P2|Double-Blind Treatment Period|Adverse Event|2
4669586|NCT02750410|16064296|P1|Double-Blind Treatment Period|Adverse Event|2
4669587|NCT02750345|16064314|P6|Intervention 1|Adverse Event|0
4669588|NCT02750345|16064315|P5|Intervention 1|Adverse Event|1
4669589|NCT02750345|16064316|P4|Intervention 1|Adverse Event|0
4669590|NCT02750345|16064317|P3|Intervention 1|Adverse Event|0
4669591|NCT02750345|16064318|P2|Intervention 1|Adverse Event|0
4669592|NCT02750345|16064319|P1|Intervention 1|Adverse Event|0
4669593|NCT02750332|16064345|P2|Treatment Period 1|Withdrawal by Subject|1
4669594|NCT02750332|16064346|P1|Treatment Period 1|Withdrawal by Subject|0
4669595|NCT02750306|16064366|P2|Overall Study|Protocol Violation|0
4669596|NCT02750306|16064367|P1|Overall Study|Protocol Violation|1
4669597|NCT02750306|16064366|P2|Overall Study|Withdrawal by Subject|2
4669598|NCT02750306|16064367|P1|Overall Study|Withdrawal by Subject|5
4669599|NCT02749799|16064426|P1|Overall Study|Withdrawal by Subject|1
4669600|NCT02749799|16064426|P1|Overall Study|Protocol Violation|1
4669601|NCT02749799|16064426|P1|Overall Study|Lost to Follow-up|4
4669602|NCT02749799|16064426|P1|Overall Study|Adverse Event|2
4669603|NCT02749370|16064432|P1|Overall Study|Lost to Follow-up|3
4669604|NCT02749370|16064432|P1|Overall Study|Withdrawal by Subject|11
4669605|NCT02748863|16064482|P5|Treatment Period 2|Pregnancy|1
4669606|NCT02748863|16064483|P4|Treatment Period 2|Pregnancy|0
4669607|NCT02748863|16064484|P3|Treatment Period 2|Pregnancy|0
4669608|NCT02748863|16064485|P2|Treatment Period 2|Pregnancy|0
4669609|NCT02748863|16064486|P1|Treatment Period 2|Pregnancy|0
4669610|NCT02748863|16064482|P5|Treatment Period 2|Lack of Efficacy|0
4669611|NCT02748863|16064483|P4|Treatment Period 2|Lack of Efficacy|0
4669612|NCT02748863|16064484|P3|Treatment Period 2|Lack of Efficacy|0
4669613|NCT02748863|16064485|P2|Treatment Period 2|Lack of Efficacy|1
4669614|NCT02748863|16064486|P1|Treatment Period 2|Lack of Efficacy|0
4669615|NCT02748863|16064482|P5|Treatment Period 2|Adverse Event|0
4669616|NCT02748863|16064483|P4|Treatment Period 2|Adverse Event|2
4669617|NCT02748863|16064484|P3|Treatment Period 2|Adverse Event|0
4669618|NCT02748863|16064485|P2|Treatment Period 2|Adverse Event|2
4669619|NCT02748863|16064486|P1|Treatment Period 2|Adverse Event|3
4669620|NCT02748863|16064482|P5|Treatment Period 2|Lost to Follow-up|0
4669621|NCT02748863|16064483|P4|Treatment Period 2|Lost to Follow-up|0
4669622|NCT02748863|16064484|P3|Treatment Period 2|Lost to Follow-up|0
4669623|NCT02748863|16064485|P2|Treatment Period 2|Lost to Follow-up|0
4669624|NCT02748863|16064486|P1|Treatment Period 2|Lost to Follow-up|2
4669625|NCT02748863|16064482|P5|Treatment Period 1|Withdrawal by Subject|0
4669626|NCT02748863|16064483|P4|Treatment Period 1|Withdrawal by Subject|0
4669627|NCT02748863|16064484|P3|Treatment Period 1|Withdrawal by Subject|1
4669628|NCT02748863|16064485|P2|Treatment Period 1|Withdrawal by Subject|1
4669629|NCT02748863|16064486|P1|Treatment Period 1|Withdrawal by Subject|0
4669630|NCT02748863|16064482|P5|Treatment Period 1|Lack of Efficacy|0
4669631|NCT02748863|16064483|P4|Treatment Period 1|Lack of Efficacy|0
4669632|NCT02748863|16064484|P3|Treatment Period 1|Lack of Efficacy|1
4669633|NCT02748863|16064485|P2|Treatment Period 1|Lack of Efficacy|0
4669634|NCT02748863|16064486|P1|Treatment Period 1|Lack of Efficacy|0
4669635|NCT02748863|16064482|P5|Treatment Period 1|Adverse Event|0
4669636|NCT02748863|16064483|P4|Treatment Period 1|Adverse Event|0
4669637|NCT02748863|16064484|P3|Treatment Period 1|Adverse Event|0
4669638|NCT02748863|16064485|P2|Treatment Period 1|Adverse Event|1
4669639|NCT02748863|16064486|P1|Treatment Period 1|Adverse Event|0
4669640|NCT02748512|16064570|P2|Overall Study|Lost to Follow-up|1
4669641|NCT02748512|16064571|P1|Overall Study|Lost to Follow-up|1
4669642|NCT02748356|16064579|P1|Overall Study|Withdrawal by Subject|1
4669643|NCT02748317|16064584|P1|Overall Study|Death|1
4669644|NCT02748317|16064584|P1|Overall Study|Lost to Follow-up|8
4669645|NCT02748317|16064584|P1|Overall Study|Withdrawal by Subject|14
4669646|NCT02748213|16064591|P2|Overall Study|Other|29
4669647|NCT02748213|16064592|P1|Overall Study|Other|30
4669648|NCT02748213|16064591|P2|Overall Study|Failure to Return|0
4669649|NCT02748213|16064592|P1|Overall Study|Failure to Return|1
4669650|NCT02748213|16064591|P2|Overall Study|Refused Treatment*|6
4669651|NCT02748213|16064592|P1|Overall Study|Refused Treatment*|6
4669652|NCT02748213|16064591|P2|Overall Study|Protocol Violation|4
4669653|NCT02748213|16064592|P1|Overall Study|Protocol Violation|6
4669654|NCT02748213|16064591|P2|Overall Study|Violation of Selection Criteria|0
4669655|NCT02748213|16064592|P1|Overall Study|Violation of Selection Criteria|2
4669656|NCT02748213|16064591|P2|Overall Study|Insufficient Therapeutic Response|57
4669657|NCT02748213|16064592|P1|Overall Study|Insufficient Therapeutic Response|56
4669658|NCT02748213|16064591|P2|Overall Study|Death|3
4669659|NCT02748213|16064592|P1|Overall Study|Death|5
4669660|NCT02748213|16064591|P2|Overall Study|Adverse Event or Intercurrent Illness|11
4669661|NCT02748213|16064592|P1|Overall Study|Adverse Event or Intercurrent Illness|5
4669662|NCT02748213|16064591|P2|Overall Study|Abnormal Laboratory Test|0
4669663|NCT02748213|16064592|P1|Overall Study|Abnormal Laboratory Test|1
4669664|NCT02748213|16064591|P2|Overall Study|Withdrawal Prior to Treatment|2
4669665|NCT02748213|16064592|P1|Overall Study|Withdrawal Prior to Treatment|1
4669666|NCT02748057|16064621|P2|Overall Study|Withdrawal by Subject|0
4669667|NCT02748057|16064622|P1|Overall Study|Withdrawal by Subject|1
4669668|NCT02748057|16064621|P2|Overall Study|Participant Moved|0
4669669|NCT02748057|16064622|P1|Overall Study|Participant Moved|1
4669670|NCT02748057|16064621|P2|Overall Study|Protocol Violation|1
4669671|NCT02748057|16064622|P1|Overall Study|Protocol Violation|2
4669672|NCT02748057|16064621|P2|Overall Study|Physician Decision|1
4669673|NCT02748057|16064622|P1|Overall Study|Physician Decision|0
4669674|NCT02748057|16064621|P2|Overall Study|Adverse Event|0
4669675|NCT02748057|16064622|P1|Overall Study|Adverse Event|1
4669676|NCT02747108|16064700|P2|Overall Study|Protocol Violation|0
4669677|NCT02747108|16064701|P1|Overall Study|Protocol Violation|2
4669678|NCT02747108|16064700|P2|Overall Study|Withdrawal by Subject|0
4669679|NCT02747108|16064701|P1|Overall Study|Withdrawal by Subject|1
4669680|NCT02747108|16064700|P2|Overall Study|Death|2
4669681|NCT02747108|16064701|P1|Overall Study|Death|2
4669682|NCT02747043|16064743|P2|Overall Study|Disease progression|0
4669683|NCT02747043|16064744|P1|Overall Study|Disease progression|4
4669684|NCT02747043|16064743|P2|Overall Study|Protocol Violation|1
4669685|NCT02747043|16064744|P1|Overall Study|Protocol Violation|0
4669686|NCT02747043|16064743|P2|Overall Study|Physician Decision|1
4669687|NCT02747043|16064744|P1|Overall Study|Physician Decision|1
4669688|NCT02747043|16064743|P2|Overall Study|Withdrawal by Subject|1
4669689|NCT02747043|16064744|P1|Overall Study|Withdrawal by Subject|1
4669690|NCT02747043|16064743|P2|Overall Study|Adverse Event|1
4669691|NCT02747043|16064744|P1|Overall Study|Adverse Event|3
4669692|NCT02747043|16064743|P2|Overall Study|Other|1
4669693|NCT02747043|16064744|P1|Overall Study|Other|1
4669694|NCT02747004|16064773|P3|Overall Study|on study treatment/follow-up|41
4669695|NCT02747004|16064774|P2|Overall Study|on study treatment/follow-up|42
4669696|NCT02747004|16064775|P1|Overall Study|on study treatment/follow-up|48
4669697|NCT02747004|16064773|P3|Overall Study|Lost to Follow-up|2
4669698|NCT02747004|16064774|P2|Overall Study|Lost to Follow-up|2
4669699|NCT02747004|16064775|P1|Overall Study|Lost to Follow-up|1
4669700|NCT02747004|16064773|P3|Overall Study|Withdrawal by Subject|4
4669701|NCT02747004|16064774|P2|Overall Study|Withdrawal by Subject|5
4669702|NCT02747004|16064775|P1|Overall Study|Withdrawal by Subject|8
4669703|NCT02746705|16064834|P2|Overall Study|outlier scores deemed not valid|1
4669704|NCT02746705|16064835|P1|Overall Study|outlier scores deemed not valid|0
4669705|NCT02746705|16064834|P2|Overall Study|Lost to Follow-up|0
4669706|NCT02746705|16064835|P1|Overall Study|Lost to Follow-up|1
4669707|NCT02746705|16064834|P2|Overall Study|Physician Decision|1
4669708|NCT02746705|16064835|P1|Overall Study|Physician Decision|1
4669709|NCT02746679|16064849|P2|Overall Study|Lost to Follow-up|6
4669710|NCT02746679|16064850|P1|Overall Study|Lost to Follow-up|4
4669711|NCT02746627|16064883|P3|Overall Study|Withdrawal by Subject|1
4669712|NCT02746627|16064884|P2|Overall Study|Withdrawal by Subject|1
4669713|NCT02746627|16064885|P1|Overall Study|Withdrawal by Subject|1
4669714|NCT02746575|16064908|P1|Overall Study|Unknown history of CVA|1
4669715|NCT02746575|16064908|P1|Overall Study|PI unavailable|1
4669716|NCT02746575|16064908|P1|Overall Study|typ of surgery|1
4669717|NCT02746575|16064908|P1|Overall Study|type of surgery|1
4669718|NCT02746575|16064908|P1|Overall Study|put on beta-blocker|3
4669719|NCT02746575|16064908|P1|Overall Study|Study paused|8
4669720|NCT02746575|16064908|P1|Overall Study|Bradycardia/hypotension|9
4669721|NCT02746575|16064908|P1|Overall Study|Withdrawal by Subject|3
4669722|NCT02746575|16064908|P1|Overall Study|Received epidural|10
4669723|NCT02746575|16064908|P1|Overall Study|Surgery cancelled or time chaned|13
4669724|NCT02745535|16064971|P1|Overall Study|Lost to Follow-up|2
4669725|NCT02745535|16064971|P1|Overall Study|Adverse Event|3
4669726|NCT02745535|16064971|P1|Overall Study|Death|1
4669727|NCT02745392|16064983|P4|Overall Study|Lost to Follow-up|0
4669728|NCT02745392|16064984|P3|Overall Study|Lost to Follow-up|0
4669729|NCT02745392|16064985|P2|Overall Study|Lost to Follow-up|1
4669730|NCT02745392|16064986|P1|Overall Study|Lost to Follow-up|0
4669731|NCT02745145|16065012|P3|Overall Study|Study Termination|7
4669732|NCT02745145|16065013|P2|Overall Study|Study Termination|3
4669733|NCT02745145|16065014|P1|Overall Study|Study Termination|8
4669734|NCT02745145|16065012|P3|Overall Study|Withdrew consent|1
4669735|NCT02745145|16065013|P2|Overall Study|Withdrew consent|1
4669736|NCT02745145|16065014|P1|Overall Study|Withdrew consent|1
4669737|NCT02745145|16065012|P3|Overall Study|Progressive disease|1
4669738|NCT02745145|16065013|P2|Overall Study|Progressive disease|0
4669739|NCT02745145|16065014|P1|Overall Study|Progressive disease|0
4669740|NCT02745145|16065012|P3|Overall Study|Death|0
4669741|NCT02745145|16065013|P2|Overall Study|Death|1
4669742|NCT02745145|16065014|P1|Overall Study|Death|0
4669743|NCT02745145|16065012|P3|Overall Study|Adverse Event|0
4669744|NCT02745145|16065013|P2|Overall Study|Adverse Event|0
4669745|NCT02745145|16065014|P1|Overall Study|Adverse Event|1
4669746|NCT02745119|16065053|P4|Overall Study|Reason Not Specified|1
4669747|NCT02745119|16065054|P3|Overall Study|Reason Not Specified|0
4669748|NCT02745119|16065055|P2|Overall Study|Reason Not Specified|2
4669749|NCT02745119|16065056|P1|Overall Study|Reason Not Specified|0
4669750|NCT02745119|16065053|P4|Overall Study|Physician Decision|2
4669751|NCT02745119|16065054|P3|Overall Study|Physician Decision|2
4669752|NCT02745119|16065055|P2|Overall Study|Physician Decision|2
4669753|NCT02745119|16065056|P1|Overall Study|Physician Decision|0
4669754|NCT02745119|16065053|P4|Overall Study|Study Terminated by Sponsor|251
4669755|NCT02745119|16065054|P3|Overall Study|Study Terminated by Sponsor|135
4669756|NCT02745119|16065055|P2|Overall Study|Study Terminated by Sponsor|252
4669757|NCT02745119|16065056|P1|Overall Study|Study Terminated by Sponsor|134
4669758|NCT02745119|16065053|P4|Overall Study|Withdrawal by Subject|14
4669759|NCT02745119|16065054|P3|Overall Study|Withdrawal by Subject|8
4669760|NCT02745119|16065055|P2|Overall Study|Withdrawal by Subject|15
4669761|NCT02745119|16065056|P1|Overall Study|Withdrawal by Subject|7
4669762|NCT02745119|16065053|P4|Overall Study|Protocol Deviation|1
4669763|NCT02745119|16065054|P3|Overall Study|Protocol Deviation|0
4669764|NCT02745119|16065055|P2|Overall Study|Protocol Deviation|0
4669765|NCT02745119|16065056|P1|Overall Study|Protocol Deviation|0
4669766|NCT02745119|16065053|P4|Overall Study|Lost to Follow-up|1
4669767|NCT02745119|16065054|P3|Overall Study|Lost to Follow-up|0
4669768|NCT02745119|16065055|P2|Overall Study|Lost to Follow-up|0
4669769|NCT02745119|16065056|P1|Overall Study|Lost to Follow-up|0
4669770|NCT02745119|16065053|P4|Overall Study|Death|4
4669771|NCT02745119|16065054|P3|Overall Study|Death|0
4669772|NCT02745119|16065055|P2|Overall Study|Death|3
4669773|NCT02745119|16065056|P1|Overall Study|Death|3
4669774|NCT02745119|16065053|P4|Overall Study|Adverse Event|3
4669775|NCT02745119|16065054|P3|Overall Study|Adverse Event|1
4669776|NCT02745119|16065055|P2|Overall Study|Adverse Event|0
4669777|NCT02745119|16065056|P1|Overall Study|Adverse Event|1
4669778|NCT02744898|16065078|P1|Overall Study|Toxicity|1
4669779|NCT02744898|16065078|P1|Overall Study|Physician Decision|1
4669780|NCT02744898|16065078|P1|Overall Study|Progressive Disease|2
4669781|NCT02744755|16065092|P2|Study Period 2|Lack of Efficacy|2
4669782|NCT02744755|16065093|P1|Study Period 2|Lack of Efficacy|3
4669783|NCT02744755|16065092|P2|Study Period 2|Withdrawal by Subject|2
4669784|NCT02744755|16065093|P1|Study Period 2|Withdrawal by Subject|2
4669785|NCT02744755|16065092|P2|Study Period 2|Lost to Follow-up|2
4669786|NCT02744755|16065093|P1|Study Period 2|Lost to Follow-up|0
4669787|NCT02744755|16065092|P2|Study Period 2|not defined|2
4669788|NCT02744755|16065093|P1|Study Period 2|not defined|3
4669789|NCT02744755|16065092|P2|Study Period 2|Protocol Violation|0
4669790|NCT02744755|16065093|P1|Study Period 2|Protocol Violation|1
4669791|NCT02744755|16065092|P2|Study Period 2|Adverse Event|0
4669792|NCT02744755|16065093|P1|Study Period 2|Adverse Event|5
4669793|NCT02744755|16065092|P2|Study Period 1|Withdrawal by Subject|4
4669794|NCT02744755|16065093|P1|Study Period 1|Withdrawal by Subject|8
4669795|NCT02744755|16065092|P2|Study Period 1|Lack of Efficacy|0
4669796|NCT02744755|16065093|P1|Study Period 1|Lack of Efficacy|1
4669797|NCT02744755|16065092|P2|Study Period 1|Lost to Follow-up|1
4669798|NCT02744755|16065093|P1|Study Period 1|Lost to Follow-up|1
4669799|NCT02744755|16065092|P2|Study Period 1|Adverse Event|1
4669800|NCT02744755|16065093|P1|Study Period 1|Adverse Event|1
4669801|NCT02744755|16065092|P2|Study Period 1|Pregnancy|0
4669802|NCT02744755|16065093|P1|Study Period 1|Pregnancy|1
4669803|NCT02744755|16065092|P2|Study Period 1|not defined|1
4669804|NCT02744755|16065093|P1|Study Period 1|not defined|0
4669805|NCT02744755|16065092|P2|Study Period 1|Protocol Violation|1
4669806|NCT02744755|16065093|P1|Study Period 1|Protocol Violation|2
4669807|NCT02744391|16065153|P1|Overall Study|Withdrawal by Subject|3
4669808|NCT02744391|16065153|P1|Overall Study|Physician Decision|2
4669809|NCT02744391|16065153|P1|Overall Study|Lost to Follow-up|9
4669810|NCT02744066|16065194|P2|Overall Study|Discharged from NICU prior to completion|4
4669811|NCT02744066|16065195|P1|Overall Study|Discharged from NICU prior to completion|0
4669812|NCT02744066|16065194|P2|Overall Study|Withdrawal by parent|1
4669813|NCT02744066|16065195|P1|Overall Study|Withdrawal by parent|0
4669814|NCT02743962|16065205|P2|Overall Study|Atrophic vaginitis diagnosed|0
4669815|NCT02743962|16065206|P1|Overall Study|Atrophic vaginitis diagnosed|1
4669816|NCT02743949|16065228|P3|Overall Study|Voluntary Withdrawal|0
4669817|NCT02743949|16065229|P2|Overall Study|Voluntary Withdrawal|1
4669818|NCT02743949|16065230|P1|Overall Study|Voluntary Withdrawal|2
4669819|NCT02743949|16065228|P3|Overall Study|Significant Protocol Deviation|1
4669820|NCT02743949|16065229|P2|Overall Study|Significant Protocol Deviation|0
4669821|NCT02743949|16065230|P1|Overall Study|Significant Protocol Deviation|2
4669822|NCT02743949|16065228|P3|Overall Study|Adverse Event|2
4669823|NCT02743949|16065229|P2|Overall Study|Adverse Event|0
4669824|NCT02743949|16065230|P1|Overall Study|Adverse Event|0
4669825|NCT02743780|16065257|P5|Part 3 (7 Days)|Adverse Event|0
4669826|NCT02743780|16065258|P4|Part 3 (7 Days)|Adverse Event|0
4669827|NCT02743780|16065259|P3|Part 3 (7 Days)|Adverse Event|1
4669828|NCT02743780|16065260|P2|Part 3 (7 Days)|Adverse Event|0
4669829|NCT02743780|16065261|P1|Part 3 (7 Days)|Adverse Event|0
4669830|NCT02743221|16065380|P2|Overall Study|Patient not eligible, not treated|1
4669831|NCT02743221|16065381|P1|Overall Study|Patient not eligible, not treated|0
4669832|NCT02743221|16065380|P2|Overall Study|Physician Decision|5
4669833|NCT02743221|16065381|P1|Overall Study|Physician Decision|2
4669834|NCT02743221|16065380|P2|Overall Study|non medical reason|2
4669835|NCT02743221|16065381|P1|Overall Study|non medical reason|8
4669836|NCT02743221|16065380|P2|Overall Study|Adverse Event|14
4669837|NCT02743221|16065381|P1|Overall Study|Adverse Event|17
4669838|NCT02743221|16065380|P2|Overall Study|Progressive disease|38
4669839|NCT02743221|16065381|P1|Overall Study|Progressive disease|29
4669840|NCT02743117|16065397|P2|Overall Study|Other|0
4669841|NCT02743117|16065398|P1|Overall Study|Other|1
4669842|NCT02743117|16065397|P2|Overall Study|Lost to Follow-up|1
4669843|NCT02743117|16065398|P1|Overall Study|Lost to Follow-up|0
4669844|NCT02742818|16065423|P2|Overall Study|Protocol Violation|1
4669845|NCT02742818|16065424|P1|Overall Study|Protocol Violation|0
4669846|NCT02742818|16065423|P2|Overall Study|Adverse Event|1
4669847|NCT02742818|16065424|P1|Overall Study|Adverse Event|0
4669848|NCT02742766|16065457|P19|Part 2 (Up to 22 Days)|Physician Decision|0
4669849|NCT02742766|16065458|P18|Part 2 (Up to 22 Days)|Physician Decision|0
4669850|NCT02742766|16065459|P17|Part 2 (Up to 22 Days)|Physician Decision|0
4669851|NCT02742766|16065460|P16|Part 2 (Up to 22 Days)|Physician Decision|1
4669852|NCT02742766|16065461|P15|Part 2 (Up to 22 Days)|Physician Decision|0
4669853|NCT02742766|16065462|P14|Part 2 (Up to 22 Days)|Physician Decision|5
4669854|NCT02742766|16065463|P13|Part 2 (Up to 22 Days)|Physician Decision|2
4669855|NCT02742766|16065464|P12|Part 2 (Up to 22 Days)|Physician Decision|0
4669856|NCT02742766|16065465|P11|Part 2 (Up to 22 Days)|Physician Decision|0
4669857|NCT02742766|16065466|P10|Part 2 (Up to 22 Days)|Physician Decision|0
4669858|NCT02742766|16065467|P9|Part 2 (Up to 22 Days)|Physician Decision|0
4669859|NCT02742766|16065468|P8|Part 2 (Up to 22 Days)|Physician Decision|0
4669860|NCT02742766|16065469|P7|Part 2 (Up to 22 Days)|Physician Decision|0
4669861|NCT02742766|16065470|P6|Part 2 (Up to 22 Days)|Physician Decision|0
4669862|NCT02742766|16065471|P5|Part 2 (Up to 22 Days)|Physician Decision|0
4669863|NCT02742766|16065472|P4|Part 2 (Up to 22 Days)|Physician Decision|0
4669864|NCT02742766|16065473|P3|Part 2 (Up to 22 Days)|Physician Decision|0
4669865|NCT02742766|16065474|P2|Part 2 (Up to 22 Days)|Physician Decision|0
4669866|NCT02742766|16065475|P1|Part 2 (Up to 22 Days)|Physician Decision|0
4669867|NCT02742766|16065457|P19|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669868|NCT02742766|16065458|P18|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669869|NCT02742766|16065459|P17|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669870|NCT02742766|16065460|P16|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669871|NCT02742766|16065461|P15|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669872|NCT02742766|16065462|P14|Part 2 (Up to 22 Days)|Withdrawal by Subject|1
4669873|NCT02742766|16065463|P13|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669874|NCT02742766|16065464|P12|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669875|NCT02742766|16065465|P11|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669876|NCT02742766|16065466|P10|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669877|NCT02742766|16065467|P9|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669878|NCT02742766|16065468|P8|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669879|NCT02742766|16065469|P7|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669880|NCT02742766|16065470|P6|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669881|NCT02742766|16065471|P5|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669882|NCT02742766|16065472|P4|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669883|NCT02742766|16065473|P3|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669884|NCT02742766|16065474|P2|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669885|NCT02742766|16065475|P1|Part 2 (Up to 22 Days)|Withdrawal by Subject|0
4669886|NCT02742649|16065735|P5|Open-Label Period|Lost to Follow-up|1
4669887|NCT02742649|16065736|P4|Open-Label Period|Lost to Follow-up|0
4669888|NCT02742649|16065737|P3|Open-Label Period|Lost to Follow-up|0
4669889|NCT02742649|16065738|P2|Open-Label Period|Lost to Follow-up|0
4669890|NCT02742649|16065739|P1|Open-Label Period|Lost to Follow-up|0
4669891|NCT02742649|16065735|P5|Double-Blind Treatment Period|Adverse Event|0
4669892|NCT02742649|16065736|P4|Double-Blind Treatment Period|Adverse Event|0
4669893|NCT02742649|16065737|P3|Double-Blind Treatment Period|Adverse Event|0
4669894|NCT02742649|16065738|P2|Double-Blind Treatment Period|Adverse Event|1
4669895|NCT02742649|16065739|P1|Double-Blind Treatment Period|Adverse Event|0
4669896|NCT02742649|16065735|P5|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4669897|NCT02742649|16065736|P4|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4669898|NCT02742649|16065737|P3|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4669899|NCT02742649|16065738|P2|Pre-Randomization Washout Period|Washout/Randomization Failure|0
4669900|NCT02742649|16065739|P1|Pre-Randomization Washout Period|Washout/Randomization Failure|5
4669901|NCT02742519|16065778|P3|Part 2 Open Label Period (32 Weeks)|Other|1
4669902|NCT02742519|16065779|P2|Part 2 Open Label Period (32 Weeks)|Other|0
4669903|NCT02742519|16065780|P1|Part 2 Open Label Period (32 Weeks)|Other|0
4669904|NCT02742519|16065778|P3|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9
4669905|NCT02742519|16065779|P2|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
4669906|NCT02742519|16065780|P1|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0
4669907|NCT02742519|16065778|P3|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0
4669908|NCT02742519|16065779|P2|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
4669909|NCT02742519|16065780|P1|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1
4669910|NCT02742441|16065800|P2|Overall Study|Adverse Event|2
4669911|NCT02742441|16065801|P1|Overall Study|Adverse Event|0
4669912|NCT02742441|16065800|P2|Overall Study|Withdrawal by Subject|2
4669913|NCT02742441|16065801|P1|Overall Study|Withdrawal by Subject|2
4669914|NCT02742441|16065800|P2|Overall Study|Lost to Follow-up|4
4669915|NCT02742441|16065801|P1|Overall Study|Lost to Follow-up|4
4669916|NCT02742103|16065848|P2|Overall Study|Withdrawal by Subject|2
4669917|NCT02742103|16065849|P1|Overall Study|Withdrawal by Subject|5
4669918|NCT02742103|16065848|P2|Overall Study|Moved to another town|1
4669919|NCT02742103|16065849|P1|Overall Study|Moved to another town|0
4669920|NCT02742103|16065848|P2|Overall Study|Adverse Event|0
4669921|NCT02742103|16065849|P1|Overall Study|Adverse Event|1
4669922|NCT02742103|16065848|P2|Overall Study|Death|2
4669923|NCT02742103|16065849|P1|Overall Study|Death|2
4669924|NCT02742103|16065848|P2|Overall Study|Protocol Violation|0
4669925|NCT02742103|16065849|P1|Overall Study|Protocol Violation|1
4669926|NCT02741713|16065895|P2|Overall Study|Surgery type changed intra-operatively|1
4669927|NCT02741713|16065896|P1|Overall Study|Surgery type changed intra-operatively|2
4669928|NCT02741635|16065936|P1|Overall Study|Withdrawal by Subject|1
4669929|NCT02741596|16065944|P2|Overall Study|Subject withdrawn-to commercial product|63
4669930|NCT02741596|16065945|P1|Overall Study|Subject withdrawn-to commercial product|54
4669931|NCT02741596|16065944|P2|Overall Study|Subject withdrawn-Other|4
4669932|NCT02741596|16065945|P1|Overall Study|Subject withdrawn-Other|17
4669933|NCT02741596|16065944|P2|Overall Study|Other (Unspecified)|3
4669934|NCT02741596|16065945|P1|Overall Study|Other (Unspecified)|0
4669935|NCT02741596|16065944|P2|Overall Study|Pregnancy|1
4669936|NCT02741596|16065945|P1|Overall Study|Pregnancy|3
4669937|NCT02741596|16065944|P2|Overall Study|Physician Decision|1
4669938|NCT02741596|16065945|P1|Overall Study|Physician Decision|2
4669939|NCT02741596|16065944|P2|Overall Study|Lost to Follow-up|1
4669940|NCT02741596|16065945|P1|Overall Study|Lost to Follow-up|1
4669941|NCT02741596|16065944|P2|Overall Study|Adverse Event|5
4669942|NCT02741596|16065945|P1|Overall Study|Adverse Event|1
4669943|NCT02741518|16065963|P2|Overall Study|Withdrawal by Subject|1
4669944|NCT02741518|16065964|P1|Overall Study|Withdrawal by Subject|1
4669945|NCT02741310|16065974|P2|Overall Study|Sponsor Decision|2
4669946|NCT02741310|16065975|P1|Overall Study|Sponsor Decision|2
4669947|NCT02741271|16066020|P2|Overall Study|Withdrawal by Parent/Guardian|2
4669948|NCT02741271|16066021|P1|Overall Study|Withdrawal by Parent/Guardian|0
4669949|NCT02741271|16066020|P2|Overall Study|Lost to Follow-up|0
4669950|NCT02741271|16066021|P1|Overall Study|Lost to Follow-up|2
4669951|NCT02741245|16066054|P5|Overall Study|Withdrawal by Subject|0
4669952|NCT02741245|16066055|P4|Overall Study|Withdrawal by Subject|1
4669953|NCT02741245|16066056|P3|Overall Study|Withdrawal by Subject|0
4669954|NCT02741245|16066057|P2|Overall Study|Withdrawal by Subject|0
4669955|NCT02741245|16066058|P1|Overall Study|Withdrawal by Subject|0
4669956|NCT02741245|16066054|P5|Overall Study|Protocol Violation|0
4669957|NCT02741245|16066055|P4|Overall Study|Protocol Violation|1
4669958|NCT02741245|16066056|P3|Overall Study|Protocol Violation|0
4669959|NCT02741245|16066057|P2|Overall Study|Protocol Violation|1
4669960|NCT02741245|16066058|P1|Overall Study|Protocol Violation|0
4669961|NCT02741245|16066054|P5|Overall Study|Adverse Event|2
4669962|NCT02741245|16066055|P4|Overall Study|Adverse Event|2
4669963|NCT02741245|16066056|P3|Overall Study|Adverse Event|0
4669964|NCT02741245|16066057|P2|Overall Study|Adverse Event|0
4669965|NCT02741245|16066058|P1|Overall Study|Adverse Event|0
4669966|NCT02741076|16066164|P4|Overall Study|No additional information available|1
4669967|NCT02741076|16066165|P3|Overall Study|No additional information available|1
4669968|NCT02741076|16066166|P2|Overall Study|No additional information available|0
4669969|NCT02741076|16066167|P1|Overall Study|No additional information available|0
4669970|NCT02741076|16066164|P4|Overall Study|Sponsor Request|1
4669971|NCT02741076|16066165|P3|Overall Study|Sponsor Request|0
4669972|NCT02741076|16066166|P2|Overall Study|Sponsor Request|3
4669973|NCT02741076|16066167|P1|Overall Study|Sponsor Request|2
4669974|NCT02741076|16066164|P4|Overall Study|Withdrawal by Subject|0
4669975|NCT02741076|16066165|P3|Overall Study|Withdrawal by Subject|0
4669976|NCT02741076|16066166|P2|Overall Study|Withdrawal by Subject|1
4669977|NCT02741076|16066167|P1|Overall Study|Withdrawal by Subject|0
4669978|NCT02741076|16066164|P4|Overall Study|Lack of Efficacy|0
4669979|NCT02741076|16066165|P3|Overall Study|Lack of Efficacy|0
4669980|NCT02741076|16066166|P2|Overall Study|Lack of Efficacy|0
4669981|NCT02741076|16066167|P1|Overall Study|Lack of Efficacy|1
4669982|NCT02741076|16066164|P4|Overall Study|Adverse Event|0
4669983|NCT02741076|16066165|P3|Overall Study|Adverse Event|1
4669984|NCT02741076|16066166|P2|Overall Study|Adverse Event|1
4669985|NCT02741076|16066167|P1|Overall Study|Adverse Event|0
4669986|NCT02740049|16066292|P1|Overall Study|Isolated cells did not grow sufficiently|1
4669987|NCT02739997|16066298|P1|Overall Study|Withdrawal by Subject|1
4669988|NCT02739997|16066298|P1|Overall Study|Death|1
4669989|NCT02739984|16066312|P2|Overall Study|Lost to Follow-up|0
4669990|NCT02739984|16066313|P1|Overall Study|Lost to Follow-up|3
4669991|NCT02739984|16066312|P2|Overall Study|Death|1
4669992|NCT02739984|16066313|P1|Overall Study|Death|0
4669993|NCT02739984|16066312|P2|Overall Study|Withdrawal by Subject|1
4669994|NCT02739984|16066313|P1|Overall Study|Withdrawal by Subject|1
4669995|NCT02739984|16066312|P2|Overall Study|Sponsor Decision|0
4669996|NCT02739984|16066313|P1|Overall Study|Sponsor Decision|1
4669997|NCT02739828|16066361|P1|Overall Study|Lost to Follow-up|4
4669998|NCT02739828|16066361|P1|Overall Study|Adverse Event|1
4669999|NCT02739594|16066421|P2|Overall Study|Other|2
4670000|NCT02739594|16066422|P1|Overall Study|Other|6
4670001|NCT02739594|16066421|P2|Overall Study|Elevated Serum Creatinine|1
4670002|NCT02739594|16066422|P1|Overall Study|Elevated Serum Creatinine|0
4670003|NCT02739594|16066421|P2|Overall Study|Lost to Follow-up|1
4670004|NCT02739594|16066422|P1|Overall Study|Lost to Follow-up|0
4670005|NCT02739594|16066421|P2|Overall Study|Withdrawal by Subject|1
4670006|NCT02739594|16066422|P1|Overall Study|Withdrawal by Subject|1
4670007|NCT02739594|16066421|P2|Overall Study|Administrative Reasons|3
4670008|NCT02739594|16066422|P1|Overall Study|Administrative Reasons|1
4670009|NCT02739594|16066421|P2|Overall Study|Renal Insufficiency|6
4670010|NCT02739594|16066422|P1|Overall Study|Renal Insufficiency|4
4670011|NCT02739594|16066421|P2|Overall Study|Death|2
4670012|NCT02739594|16066422|P1|Overall Study|Death|4
4670013|NCT02739594|16066421|P2|Overall Study|Protocol Violation|6
4670014|NCT02739594|16066422|P1|Overall Study|Protocol Violation|5
4670015|NCT02739594|16066421|P2|Overall Study|Violation of Eligibility Criteria|2
4670016|NCT02739594|16066422|P1|Overall Study|Violation of Eligibility Criteria|1
4670017|NCT02739594|16066421|P2|Overall Study|Undesired Event|4
4670018|NCT02739594|16066422|P1|Overall Study|Undesired Event|3
4670019|NCT02739360|16066452|P1|Overall Study|Study terminated by Sponsor|2
4670020|NCT02739360|16066452|P1|Overall Study|Adverse Event|1
4670021|NCT02739321|16066458|P2|Overall Study|Withdrawal by Subject|2
4670022|NCT02739321|16066459|P1|Overall Study|Withdrawal by Subject|1
4670023|NCT02739321|16066458|P2|Overall Study|Lost to Follow-up|1
4670024|NCT02739321|16066459|P1|Overall Study|Lost to Follow-up|1
4670025|NCT02739321|16066458|P2|Overall Study|Lack of Efficacy|1
4670026|NCT02739321|16066459|P1|Overall Study|Lack of Efficacy|1
4670027|NCT02739269|16066505|P2|Overall Study|Withdrawal by Subject|2
4670028|NCT02739269|16066506|P1|Overall Study|Withdrawal by Subject|0
4670029|NCT02739269|16066505|P2|Overall Study|Cycle cancellation|2
4670030|NCT02739269|16066506|P1|Overall Study|Cycle cancellation|2
4670031|NCT02739269|16066505|P2|Overall Study|Protocol Violation|0
4670032|NCT02739269|16066506|P1|Overall Study|Protocol Violation|5
4670033|NCT02738879|16066533|P2|Overall Study|Withdrawal by Subject|7
4670034|NCT02738879|16066534|P1|Overall Study|Withdrawal by Subject|5
4670035|NCT02738879|16066533|P2|Overall Study|Site Discontinued Study Participation|0
4670036|NCT02738879|16066534|P1|Overall Study|Site Discontinued Study Participation|1
4670037|NCT02738879|16066533|P2|Overall Study|Screen Failure|2
4670038|NCT02738879|16066534|P1|Overall Study|Screen Failure|1
4670039|NCT02738879|16066533|P2|Overall Study|Pregnancy|1
4670040|NCT02738879|16066534|P1|Overall Study|Pregnancy|0
4670041|NCT02738879|16066533|P2|Overall Study|Physician Decision|4
4670042|NCT02738879|16066534|P1|Overall Study|Physician Decision|3
4670043|NCT02738879|16066533|P2|Overall Study|Protocol Violation|3
4670044|NCT02738879|16066534|P1|Overall Study|Protocol Violation|1
4670045|NCT02738879|16066533|P2|Overall Study|Lost to Follow-up|5
4670046|NCT02738879|16066534|P1|Overall Study|Lost to Follow-up|1
4670047|NCT02738879|16066533|P2|Overall Study|Death|2
4670048|NCT02738879|16066534|P1|Overall Study|Death|0
4670049|NCT02738879|16066533|P2|Overall Study|Adverse Event|1
4670050|NCT02738879|16066534|P1|Overall Study|Adverse Event|1
4670051|NCT02738580|16066586|P2|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1
4670052|NCT02738580|16066587|P1|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0
4670053|NCT02738580|16066586|P2|Overall Study|Withdrawal by Subject|1
4670054|NCT02738580|16066587|P1|Overall Study|Withdrawal by Subject|0
4670055|NCT02738580|16066586|P2|Overall Study|Lack of Efficacy|2
4670056|NCT02738580|16066587|P1|Overall Study|Lack of Efficacy|3
4670057|NCT02738580|16066586|P2|Overall Study|Adverse Event|0
4670058|NCT02738580|16066587|P1|Overall Study|Adverse Event|1
4670059|NCT02738333|16066598|P3|Overall Study|Lost to Follow-up|0
4670060|NCT02738333|16066599|P2|Overall Study|Lost to Follow-up|0
4670061|NCT02738333|16066600|P1|Overall Study|Lost to Follow-up|1
4670062|NCT02738333|16066598|P3|Overall Study|Death|0
4670063|NCT02738333|16066599|P2|Overall Study|Death|0
4670064|NCT02738333|16066600|P1|Overall Study|Death|1
4670065|NCT02738203|16066689|P2|Overall Study|Protocol Violation|1
4670066|NCT02738203|16066690|P1|Overall Study|Protocol Violation|0
4670067|NCT02738203|16066689|P2|Overall Study|Failed IUD Insertion|2
4670068|NCT02738203|16066690|P1|Overall Study|Failed IUD Insertion|2
4670069|NCT02738151|16066706|P2|Overall Study|Other than specified above|21
4670070|NCT02738151|16066707|P1|Overall Study|Other than specified above|11
4670071|NCT02738151|16066706|P2|Overall Study|Poor Compliance to Protocol|3
4670072|NCT02738151|16066707|P1|Overall Study|Poor Compliance to Protocol|4
4670073|NCT02738151|16066706|P2|Overall Study|Hypoglycemia|1
4670074|NCT02738151|16066707|P1|Overall Study|Hypoglycemia|0
4670075|NCT02738151|16066706|P2|Overall Study|Adverse Event|5
4670076|NCT02738151|16066707|P1|Overall Study|Adverse Event|4
4670077|NCT02738151|16066706|P2|Overall Study|Randomized but not treated|1
4670078|NCT02738151|16066707|P1|Overall Study|Randomized but not treated|4
4670079|NCT02738138|16066751|P2|Overall Study|Other - not further specified|0
4670080|NCT02738138|16066752|P1|Overall Study|Other - not further specified|1
4670081|NCT02738138|16066751|P2|Overall Study|Lost to Follow-up|0
4670082|NCT02738138|16066752|P1|Overall Study|Lost to Follow-up|2
4670083|NCT02738138|16066751|P2|Overall Study|Adverse Event|1
4670084|NCT02738138|16066752|P1|Overall Study|Adverse Event|0
4670085|NCT02738008|16066789|P3|Overall Study|Adverse Event|2
4670086|NCT02738008|16066790|P2|Overall Study|Adverse Event|1
4670087|NCT02738008|16066791|P1|Overall Study|Adverse Event|0
4670088|NCT02738008|16066789|P3|Overall Study|Study Terminated by Sponsor|3
4670089|NCT02738008|16066790|P2|Overall Study|Study Terminated by Sponsor|5
4670090|NCT02738008|16066791|P1|Overall Study|Study Terminated by Sponsor|1
4670091|NCT02737852|16066829|P1|Overall Study|Withdrawal by Subject|2
4670092|NCT02737722|16066838|P4|Overall Study|Physician Decision|0
4670093|NCT02737722|16066839|P3|Overall Study|Physician Decision|1
4670094|NCT02737722|16066840|P2|Overall Study|Physician Decision|0
4670095|NCT02737722|16066841|P1|Overall Study|Physician Decision|0
4670096|NCT02737618|16066892|P1|Overall Study|Withdrawal by Subject|9
4670097|NCT02737592|16066897|P1|Overall Study|Withdrawal by Subject|1
4670098|NCT02737358|16066918|P2|Overall Study|Lost to Follow-up|3
4670099|NCT02737358|16066919|P1|Overall Study|Lost to Follow-up|2
4670100|NCT02737358|16066918|P2|Overall Study|Withdrawal by Subject|12
4670101|NCT02737358|16066919|P1|Overall Study|Withdrawal by Subject|7
4670102|NCT02736890|16067026|P2|Crossover Next 12 Weeks|Withdrawal by Subject|0
4670103|NCT02736890|16067027|P1|Crossover Next 12 Weeks|Withdrawal by Subject|1
4670104|NCT02736890|16067026|P2|Crossover Next 12 Weeks|Lost to Follow-up|2
4670105|NCT02736890|16067027|P1|Crossover Next 12 Weeks|Lost to Follow-up|1
4670106|NCT02736825|16067049|P2|Overall Study|Early Termination|1
4670107|NCT02736825|16067050|P1|Overall Study|Early Termination|0
4670108|NCT02736825|16067049|P2|Overall Study|Lost to Follow-up|11
4670109|NCT02736825|16067050|P1|Overall Study|Lost to Follow-up|10
4670110|NCT02736721|16067090|P1|Overall Study|Other|5
4670111|NCT02736721|16067090|P1|Overall Study|Lost to Follow-up|3
4670112|NCT02736721|16067090|P1|Overall Study|Adverse Event|8
4670113|NCT02736578|16067101|P2|Overall Study|Adverse Event|0
4670114|NCT02736578|16067102|P1|Overall Study|Adverse Event|1
4670115|NCT02736188|16067120|P1|Overall Study|Other|6
4670116|NCT02736188|16067120|P1|Overall Study|Withdrawal by Subject|1
4670117|NCT02736188|16067120|P1|Overall Study|Adverse Event|1
4670118|NCT02736188|16067120|P1|Overall Study|Discontinuation of Study by Sponsor|134
4670119|NCT02735980|16067158|P3|Overall Study|Withdrawal by Subject|0
4670120|NCT02735980|16067159|P2|Overall Study|Withdrawal by Subject|2
4670121|NCT02735980|16067160|P1|Overall Study|Withdrawal by Subject|1
4670122|NCT02735980|16067158|P3|Overall Study|Screen failure|0
4670123|NCT02735980|16067159|P2|Overall Study|Screen failure|0
4670124|NCT02735980|16067160|P1|Overall Study|Screen failure|1
4670125|NCT02735980|16067158|P3|Overall Study|Physician Decision|0
4670126|NCT02735980|16067159|P2|Overall Study|Physician Decision|1
4670127|NCT02735980|16067160|P1|Overall Study|Physician Decision|3
4670128|NCT02735980|16067158|P3|Overall Study|Death|0
4670129|NCT02735980|16067159|P2|Overall Study|Death|4
4670130|NCT02735980|16067160|P1|Overall Study|Death|5
4670131|NCT02735980|16067158|P3|Overall Study|Adverse Event|1
4670132|NCT02735980|16067159|P2|Overall Study|Adverse Event|4
4670133|NCT02735980|16067160|P1|Overall Study|Adverse Event|0
4670134|NCT02735915|16067189|P1|Overall Study|Withdrawal by Subject|1
4670135|NCT02735915|16067189|P1|Overall Study|Withdrawal following SAE|2
4670136|NCT02735915|16067189|P1|Overall Study|Not vaccinated but subject ID assigned|8
4670137|NCT02735421|16067221|P1|Overall Study|Pregnancy|1
4670138|NCT02735421|16067221|P1|Overall Study|Inadequate compliance to treatment|1
4670139|NCT02735421|16067221|P1|Overall Study|Lost to Follow-up|3
4670140|NCT02735421|16067221|P1|Overall Study|Withdrawal by Subject|6
4670141|NCT02735421|16067221|P1|Overall Study|Adverse Event|2
4670142|NCT02735200|16067251|P2|Overall Study|Withdrawal by Subject|0
4670143|NCT02735200|16067252|P1|Overall Study|Withdrawal by Subject|8
4670144|NCT02735200|16067251|P2|Overall Study|Lost to Follow-up|5
4670145|NCT02735200|16067252|P1|Overall Study|Lost to Follow-up|0
4670146|NCT02735096|16067295|P1|Overall Study|No symptoms in clinic/personal leave|1
4670147|NCT02735044|16067304|P2|Overall Study|Other, not specified above|11
4670148|NCT02735044|16067305|P1|Overall Study|Other, not specified above|5
4670149|NCT02735044|16067304|P2|Overall Study|Randomized and not treated|2
4670150|NCT02735044|16067305|P1|Overall Study|Randomized and not treated|0
4670151|NCT02735044|16067304|P2|Overall Study|Poor compliance to protocol|7
4670152|NCT02735044|16067305|P1|Overall Study|Poor compliance to protocol|7
4670153|NCT02735044|16067304|P2|Overall Study|Lack of Efficacy|0
4670154|NCT02735044|16067305|P1|Overall Study|Lack of Efficacy|1
4670155|NCT02735044|16067304|P2|Overall Study|Adverse Event|3
4670156|NCT02735044|16067305|P1|Overall Study|Adverse Event|3
4670157|NCT02734810|16067373|P2|Overall Study|Lack of Efficacy|0
4670158|NCT02734810|16067374|P1|Overall Study|Lack of Efficacy|1
4670159|NCT02734810|16067373|P2|Overall Study|Adverse Event|0
4670160|NCT02734810|16067374|P1|Overall Study|Adverse Event|1
4670161|NCT02734693|16067383|P3|Overall Study|Withdrawal by Subject|0
4670162|NCT02734693|16067384|P2|Overall Study|Withdrawal by Subject|0
4670163|NCT02734693|16067385|P1|Overall Study|Withdrawal by Subject|1
4670164|NCT02734693|16067383|P3|Overall Study|Protocol Violation|0
4670165|NCT02734693|16067384|P2|Overall Study|Protocol Violation|0
4670166|NCT02734693|16067385|P1|Overall Study|Protocol Violation|1
4670167|NCT02734693|16067383|P3|Overall Study|Lost to Follow-up|0
4670168|NCT02734693|16067384|P2|Overall Study|Lost to Follow-up|0
4670169|NCT02734693|16067385|P1|Overall Study|Lost to Follow-up|2
4670170|NCT02734693|16067383|P3|Overall Study|Lack of Efficacy|0
4670171|NCT02734693|16067384|P2|Overall Study|Lack of Efficacy|0
4670172|NCT02734693|16067385|P1|Overall Study|Lack of Efficacy|1
4670173|NCT02734693|16067383|P3|Overall Study|Adverse Event|3
4670174|NCT02734693|16067384|P2|Overall Study|Adverse Event|3
4670175|NCT02734693|16067385|P1|Overall Study|Adverse Event|1
4670176|NCT02734433|16067426|P2|Overall Study|Withdrawal by Subject|2
4670177|NCT02734433|16067427|P1|Overall Study|Withdrawal by Subject|1
4670178|NCT02734433|16067426|P2|Overall Study|Clinical progression|1
4670179|NCT02734433|16067427|P1|Overall Study|Clinical progression|0
4670180|NCT02734433|16067426|P2|Overall Study|Disease progression|5
4670181|NCT02734433|16067427|P1|Overall Study|Disease progression|1
4670182|NCT02734212|16067503|P2|Overall Study|Lost to Follow-up|10
4670183|NCT02734212|16067504|P1|Overall Study|Lost to Follow-up|5
4670184|NCT02733991|16067525|P2|Overall Study|Withdrawal by Subject|5
4670185|NCT02733991|16067526|P1|Overall Study|Withdrawal by Subject|0
4670186|NCT02733991|16067525|P2|Overall Study|Adverse Event|0
4670187|NCT02733991|16067526|P1|Overall Study|Adverse Event|1
4670188|NCT02733367|16067566|P1|Overall Study|Withdrawal by Subject|6
4670189|NCT02733042|16067592|P19|Follow-up Period|Withdrawal by Subject|0
4670190|NCT02733042|16067593|P18|Follow-up Period|Withdrawal by Subject|0
4670191|NCT02733042|16067594|P17|Follow-up Period|Withdrawal by Subject|0
4670192|NCT02733042|16067595|P16|Follow-up Period|Withdrawal by Subject|1
4670193|NCT02733042|16067596|P15|Follow-up Period|Withdrawal by Subject|0
4670194|NCT02733042|16067597|P14|Follow-up Period|Withdrawal by Subject|0
4670195|NCT02733042|16067598|P13|Follow-up Period|Withdrawal by Subject|0
4670196|NCT02733042|16067599|P12|Follow-up Period|Withdrawal by Subject|0
4670197|NCT02733042|16067600|P11|Follow-up Period|Withdrawal by Subject|1
4670198|NCT02733042|16067601|P10|Follow-up Period|Withdrawal by Subject|0
4670199|NCT02733042|16067602|P9|Follow-up Period|Withdrawal by Subject|1
4670200|NCT02733042|16067603|P8|Follow-up Period|Withdrawal by Subject|0
4670201|NCT02733042|16067604|P7|Follow-up Period|Withdrawal by Subject|0
4670202|NCT02733042|16067605|P6|Follow-up Period|Withdrawal by Subject|0
4670203|NCT02733042|16067606|P5|Follow-up Period|Withdrawal by Subject|0
4670204|NCT02733042|16067607|P4|Follow-up Period|Withdrawal by Subject|0
4670205|NCT02733042|16067608|P3|Follow-up Period|Withdrawal by Subject|0
4670206|NCT02733042|16067609|P2|Follow-up Period|Withdrawal by Subject|0
4670207|NCT02733042|16067610|P1|Follow-up Period|Withdrawal by Subject|0
4670208|NCT02733042|16067592|P19|Follow-up Period|Other|0
4670209|NCT02733042|16067593|P18|Follow-up Period|Other|0
4670210|NCT02733042|16067594|P17|Follow-up Period|Other|0
4670211|NCT02733042|16067595|P16|Follow-up Period|Other|0
4670212|NCT02733042|16067596|P15|Follow-up Period|Other|0
4670213|NCT02733042|16067597|P14|Follow-up Period|Other|0
4670214|NCT02733042|16067598|P13|Follow-up Period|Other|0
4670215|NCT02733042|16067599|P12|Follow-up Period|Other|0
4670216|NCT02733042|16067600|P11|Follow-up Period|Other|0
4670217|NCT02733042|16067601|P10|Follow-up Period|Other|0
4670218|NCT02733042|16067602|P9|Follow-up Period|Other|0
4670219|NCT02733042|16067603|P8|Follow-up Period|Other|0
4670220|NCT02733042|16067604|P7|Follow-up Period|Other|0
4670221|NCT02733042|16067605|P6|Follow-up Period|Other|0
4670222|NCT02733042|16067606|P5|Follow-up Period|Other|0
4670223|NCT02733042|16067607|P4|Follow-up Period|Other|1
4670224|NCT02733042|16067608|P3|Follow-up Period|Other|0
4670225|NCT02733042|16067609|P2|Follow-up Period|Other|0
4670226|NCT02733042|16067610|P1|Follow-up Period|Other|0
4670227|NCT02733042|16067592|P19|Follow-up Period|Death|2
4670228|NCT02733042|16067593|P18|Follow-up Period|Death|1
4670229|NCT02733042|16067594|P17|Follow-up Period|Death|0
4670230|NCT02733042|16067595|P16|Follow-up Period|Death|4
4670231|NCT02733042|16067596|P15|Follow-up Period|Death|1
4670232|NCT02733042|16067597|P14|Follow-up Period|Death|1
4670233|NCT02733042|16067598|P13|Follow-up Period|Death|8
4670234|NCT02733042|16067599|P12|Follow-up Period|Death|0
4670235|NCT02733042|16067600|P11|Follow-up Period|Death|0
4670236|NCT02733042|16067601|P10|Follow-up Period|Death|0
4670237|NCT02733042|16067602|P9|Follow-up Period|Death|3
4670238|NCT02733042|16067603|P8|Follow-up Period|Death|3
4670239|NCT02733042|16067604|P7|Follow-up Period|Death|0
4670240|NCT02733042|16067605|P6|Follow-up Period|Death|2
4670241|NCT02733042|16067606|P5|Follow-up Period|Death|1
4670242|NCT02733042|16067607|P4|Follow-up Period|Death|0
4670243|NCT02733042|16067608|P3|Follow-up Period|Death|2
4670244|NCT02733042|16067609|P2|Follow-up Period|Death|1
4670245|NCT02733042|16067610|P1|Follow-up Period|Death|1
4670246|NCT02733042|16067592|P19|Follow-up Period|Ongoing on Follow-up|0
4670247|NCT02733042|16067593|P18|Follow-up Period|Ongoing on Follow-up|1
4670248|NCT02733042|16067594|P17|Follow-up Period|Ongoing on Follow-up|0
4670249|NCT02733042|16067595|P16|Follow-up Period|Ongoing on Follow-up|0
4670250|NCT02733042|16067596|P15|Follow-up Period|Ongoing on Follow-up|0
4670251|NCT02733042|16067597|P14|Follow-up Period|Ongoing on Follow-up|3
4670252|NCT02733042|16067598|P13|Follow-up Period|Ongoing on Follow-up|1
4670253|NCT02733042|16067599|P12|Follow-up Period|Ongoing on Follow-up|9
4670254|NCT02733042|16067600|P11|Follow-up Period|Ongoing on Follow-up|4
4670255|NCT02733042|16067601|P10|Follow-up Period|Ongoing on Follow-up|2
4670256|NCT02733042|16067602|P9|Follow-up Period|Ongoing on Follow-up|0
4670257|NCT02733042|16067603|P8|Follow-up Period|Ongoing on Follow-up|1
4670258|NCT02733042|16067604|P7|Follow-up Period|Ongoing on Follow-up|0
4670259|NCT02733042|16067605|P6|Follow-up Period|Ongoing on Follow-up|0
4670260|NCT02733042|16067606|P5|Follow-up Period|Ongoing on Follow-up|0
4670261|NCT02733042|16067607|P4|Follow-up Period|Ongoing on Follow-up|2
4670262|NCT02733042|16067608|P3|Follow-up Period|Ongoing on Follow-up|4
4670263|NCT02733042|16067609|P2|Follow-up Period|Ongoing on Follow-up|2
4670264|NCT02733042|16067610|P1|Follow-up Period|Ongoing on Follow-up|2
4670265|NCT02733042|16067592|P19|Treatment Period|Death|0
4670266|NCT02733042|16067593|P18|Treatment Period|Death|0
4670267|NCT02733042|16067594|P17|Treatment Period|Death|0
4670268|NCT02733042|16067595|P16|Treatment Period|Death|2
4670269|NCT02733042|16067596|P15|Treatment Period|Death|1
4670270|NCT02733042|16067597|P14|Treatment Period|Death|0
4670271|NCT02733042|16067598|P13|Treatment Period|Death|0
4670272|NCT02733042|16067599|P12|Treatment Period|Death|0
4670273|NCT02733042|16067600|P11|Treatment Period|Death|1
4670274|NCT02733042|16067601|P10|Treatment Period|Death|0
4670275|NCT02733042|16067602|P9|Treatment Period|Death|1
4670276|NCT02733042|16067603|P8|Treatment Period|Death|0
4670277|NCT02733042|16067604|P7|Treatment Period|Death|1
4670278|NCT02733042|16067605|P6|Treatment Period|Death|0
4670279|NCT02733042|16067606|P5|Treatment Period|Death|0
4670280|NCT02733042|16067607|P4|Treatment Period|Death|0
4670281|NCT02733042|16067608|P3|Treatment Period|Death|0
4670282|NCT02733042|16067609|P2|Treatment Period|Death|0
4670283|NCT02733042|16067610|P1|Treatment Period|Death|0
4670284|NCT02733042|16067592|P19|Treatment Period|Ongoing on Assigned Treatment|1
4670285|NCT02733042|16067593|P18|Treatment Period|Ongoing on Assigned Treatment|0
4670286|NCT02733042|16067594|P17|Treatment Period|Ongoing on Assigned Treatment|0
4670287|NCT02733042|16067595|P16|Treatment Period|Ongoing on Assigned Treatment|0
4670288|NCT02733042|16067596|P15|Treatment Period|Ongoing on Assigned Treatment|0
4670289|NCT02733042|16067597|P14|Treatment Period|Ongoing on Assigned Treatment|0
4670290|NCT02733042|16067598|P13|Treatment Period|Ongoing on Assigned Treatment|0
4670291|NCT02733042|16067599|P12|Treatment Period|Ongoing on Assigned Treatment|0
4670292|NCT02733042|16067600|P11|Treatment Period|Ongoing on Assigned Treatment|4
4670293|NCT02733042|16067601|P10|Treatment Period|Ongoing on Assigned Treatment|8
4670294|NCT02733042|16067602|P9|Treatment Period|Ongoing on Assigned Treatment|0
4670295|NCT02733042|16067603|P8|Treatment Period|Ongoing on Assigned Treatment|0
4670296|NCT02733042|16067604|P7|Treatment Period|Ongoing on Assigned Treatment|0
4670297|NCT02733042|16067605|P6|Treatment Period|Ongoing on Assigned Treatment|0
4670298|NCT02733042|16067606|P5|Treatment Period|Ongoing on Assigned Treatment|3
4670299|NCT02733042|16067607|P4|Treatment Period|Ongoing on Assigned Treatment|0
4670300|NCT02733042|16067608|P3|Treatment Period|Ongoing on Assigned Treatment|0
4670301|NCT02733042|16067609|P2|Treatment Period|Ongoing on Assigned Treatment|0
4670302|NCT02733042|16067610|P1|Treatment Period|Ongoing on Assigned Treatment|0
4670303|NCT02733042|16067592|P19|Treatment Period|Other|0
4670304|NCT02733042|16067593|P18|Treatment Period|Other|1
4670305|NCT02733042|16067594|P17|Treatment Period|Other|0
4670306|NCT02733042|16067595|P16|Treatment Period|Other|1
4670307|NCT02733042|16067596|P15|Treatment Period|Other|0
4670308|NCT02733042|16067597|P14|Treatment Period|Other|0
4670309|NCT02733042|16067598|P13|Treatment Period|Other|0
4670310|NCT02733042|16067599|P12|Treatment Period|Other|0
4670311|NCT02733042|16067600|P11|Treatment Period|Other|1
4670312|NCT02733042|16067601|P10|Treatment Period|Other|1
4670313|NCT02733042|16067602|P9|Treatment Period|Other|0
4670314|NCT02733042|16067603|P8|Treatment Period|Other|0
4670315|NCT02733042|16067604|P7|Treatment Period|Other|0
4670316|NCT02733042|16067605|P6|Treatment Period|Other|0
4670317|NCT02733042|16067606|P5|Treatment Period|Other|0
4670318|NCT02733042|16067607|P4|Treatment Period|Other|0
4670319|NCT02733042|16067608|P3|Treatment Period|Other|1
4670320|NCT02733042|16067609|P2|Treatment Period|Other|0
4670321|NCT02733042|16067610|P1|Treatment Period|Other|0
4670322|NCT02733042|16067592|P19|Treatment Period|Withdrawal by Subject|0
4670323|NCT02733042|16067593|P18|Treatment Period|Withdrawal by Subject|0
4670324|NCT02733042|16067594|P17|Treatment Period|Withdrawal by Subject|0
4670325|NCT02733042|16067595|P16|Treatment Period|Withdrawal by Subject|0
4670326|NCT02733042|16067596|P15|Treatment Period|Withdrawal by Subject|0
4670327|NCT02733042|16067597|P14|Treatment Period|Withdrawal by Subject|1
4670328|NCT02733042|16067598|P13|Treatment Period|Withdrawal by Subject|1
4670329|NCT02733042|16067599|P12|Treatment Period|Withdrawal by Subject|2
4670330|NCT02733042|16067600|P11|Treatment Period|Withdrawal by Subject|0
4670331|NCT02733042|16067601|P10|Treatment Period|Withdrawal by Subject|1
4670332|NCT02733042|16067602|P9|Treatment Period|Withdrawal by Subject|1
4670333|NCT02733042|16067603|P8|Treatment Period|Withdrawal by Subject|0
4670334|NCT02733042|16067604|P7|Treatment Period|Withdrawal by Subject|0
4670335|NCT02733042|16067605|P6|Treatment Period|Withdrawal by Subject|0
4670336|NCT02733042|16067606|P5|Treatment Period|Withdrawal by Subject|0
4670337|NCT02733042|16067607|P4|Treatment Period|Withdrawal by Subject|1
4670338|NCT02733042|16067608|P3|Treatment Period|Withdrawal by Subject|2
4670339|NCT02733042|16067609|P2|Treatment Period|Withdrawal by Subject|1
4670340|NCT02733042|16067610|P1|Treatment Period|Withdrawal by Subject|0
4670341|NCT02733042|16067592|P19|Treatment Period|Progressive Disease|4
4670342|NCT02733042|16067593|P18|Treatment Period|Progressive Disease|3
4670343|NCT02733042|16067594|P17|Treatment Period|Progressive Disease|2
4670344|NCT02733042|16067595|P16|Treatment Period|Progressive Disease|7
4670345|NCT02733042|16067596|P15|Treatment Period|Progressive Disease|4
4670346|NCT02733042|16067597|P14|Treatment Period|Progressive Disease|1
4670347|NCT02733042|16067598|P13|Treatment Period|Progressive Disease|8
4670348|NCT02733042|16067599|P12|Treatment Period|Progressive Disease|2
4670349|NCT02733042|16067600|P11|Treatment Period|Progressive Disease|2
4670350|NCT02733042|16067601|P10|Treatment Period|Progressive Disease|0
4670351|NCT02733042|16067602|P9|Treatment Period|Progressive Disease|3
4670352|NCT02733042|16067603|P8|Treatment Period|Progressive Disease|3
4670353|NCT02733042|16067604|P7|Treatment Period|Progressive Disease|0
4670354|NCT02733042|16067605|P6|Treatment Period|Progressive Disease|3
4670355|NCT02733042|16067606|P5|Treatment Period|Progressive Disease|1
4670356|NCT02733042|16067607|P4|Treatment Period|Progressive Disease|1
4670357|NCT02733042|16067608|P3|Treatment Period|Progressive Disease|3
4670358|NCT02733042|16067609|P2|Treatment Period|Progressive Disease|1
4670359|NCT02733042|16067610|P1|Treatment Period|Progressive Disease|2
4670360|NCT02733042|16067592|P19|Treatment Period|Adverse Event|0
4670361|NCT02733042|16067593|P18|Treatment Period|Adverse Event|1
4670362|NCT02733042|16067594|P17|Treatment Period|Adverse Event|0
4670363|NCT02733042|16067595|P16|Treatment Period|Adverse Event|0
4670364|NCT02733042|16067596|P15|Treatment Period|Adverse Event|0
4670365|NCT02733042|16067597|P14|Treatment Period|Adverse Event|2
4670366|NCT02733042|16067598|P13|Treatment Period|Adverse Event|0
4670367|NCT02733042|16067599|P12|Treatment Period|Adverse Event|2
4670368|NCT02733042|16067600|P11|Treatment Period|Adverse Event|2
4670369|NCT02733042|16067601|P10|Treatment Period|Adverse Event|0
4670370|NCT02733042|16067602|P9|Treatment Period|Adverse Event|0
4670371|NCT02733042|16067603|P8|Treatment Period|Adverse Event|0
4670372|NCT02733042|16067604|P7|Treatment Period|Adverse Event|0
4670373|NCT02733042|16067605|P6|Treatment Period|Adverse Event|0
4670374|NCT02733042|16067606|P5|Treatment Period|Adverse Event|0
4670375|NCT02733042|16067607|P4|Treatment Period|Adverse Event|1
4670376|NCT02733042|16067608|P3|Treatment Period|Adverse Event|1
4670377|NCT02733042|16067609|P2|Treatment Period|Adverse Event|0
4670378|NCT02733042|16067610|P1|Treatment Period|Adverse Event|1
4670379|NCT02732951|16067815|P2|Overall Study|Protocol Violation|1
4670380|NCT02732951|16067816|P1|Overall Study|Protocol Violation|0
4670381|NCT02732951|16067815|P2|Overall Study|Adverse Event|4
4670382|NCT02732951|16067816|P1|Overall Study|Adverse Event|4
4670383|NCT02732951|16067815|P2|Overall Study|Lost to Follow-up|1
4670384|NCT02732951|16067816|P1|Overall Study|Lost to Follow-up|0
4670385|NCT02732951|16067815|P2|Overall Study|Other than listed|0
4670386|NCT02732951|16067816|P1|Overall Study|Other than listed|1
4670387|NCT02732938|16067826|P3|Overall Study|Study terminated by sponsor|0
4670388|NCT02732938|16067827|P2|Overall Study|Study terminated by sponsor|6
4670389|NCT02732938|16067828|P1|Overall Study|Study terminated by sponsor|3
4670390|NCT02732938|16067826|P3|Overall Study|Refused further follow-up|0
4670391|NCT02732938|16067827|P2|Overall Study|Refused further follow-up|0
4670392|NCT02732938|16067828|P1|Overall Study|Refused further follow-up|1
4670393|NCT02732938|16067826|P3|Overall Study|Randomized but did not receive treatment|0
4670394|NCT02732938|16067827|P2|Overall Study|Randomized but did not receive treatment|1
4670395|NCT02732938|16067828|P1|Overall Study|Randomized but did not receive treatment|0
4670396|NCT02732938|16067826|P3|Overall Study|Death|0
4670397|NCT02732938|16067827|P2|Overall Study|Death|11
4670398|NCT02732938|16067828|P1|Overall Study|Death|0
4670399|NCT02732912|16067874|P2|Overall Study|No outcome; discharged or refused|9
4670400|NCT02732912|16067875|P1|Overall Study|No outcome; discharged or refused|6
4670401|NCT02732912|16067874|P2|Overall Study|Incomplete completion of questionnaire|3
4670402|NCT02732912|16067875|P1|Overall Study|Incomplete completion of questionnaire|2
4670403|NCT02732912|16067874|P2|Overall Study|Discharged before night|6
4670404|NCT02732912|16067875|P1|Overall Study|Discharged before night|2
4670405|NCT02732639|16067900|P1|Overall Study|Lost to Follow-up|1
4670406|NCT02732561|16067926|P2|Overall Study|Withdrawal by Subject|0
4670407|NCT02732561|16067927|P1|Overall Study|Withdrawal by Subject|1
4670408|NCT02732561|16067926|P2|Overall Study|Lost to Follow-up|1
4670409|NCT02732561|16067927|P1|Overall Study|Lost to Follow-up|1
4670410|NCT02732327|16067953|P2|Overall Study|Protocol Violation|1
4670411|NCT02732327|16067954|P1|Overall Study|Protocol Violation|0
4670412|NCT02732210|16067962|P2|Overall Study|Missing|8
4670413|NCT02732210|16067963|P1|Overall Study|Missing|0
4670414|NCT02732210|16067962|P2|Overall Study|Other|103
4670415|NCT02732210|16067963|P1|Overall Study|Other|35
4670416|NCT02732210|16067962|P2|Overall Study|Death|15
4670417|NCT02732210|16067963|P1|Overall Study|Death|4
4670418|NCT02732210|16067962|P2|Overall Study|Lost to Follow-up|57
4670419|NCT02732210|16067963|P1|Overall Study|Lost to Follow-up|5
4670420|NCT02732210|16067962|P2|Overall Study|Withdrawal by Subject|87
4670421|NCT02732210|16067963|P1|Overall Study|Withdrawal by Subject|28
4670422|NCT02732210|16067962|P2|Overall Study|Study Ended|13
4670423|NCT02732210|16067963|P1|Overall Study|Study Ended|13
4670424|NCT02732210|16067962|P2|Overall Study|Site Closed|11
4670425|NCT02732210|16067963|P1|Overall Study|Site Closed|0
4670426|NCT02731755|16068142|P2|First Intervention|Withdrawal by Subject|2
4670427|NCT02731755|16068143|P1|First Intervention|Withdrawal by Subject|0
4670428|NCT02731742|16068167|P4|Overall Study|Study Terminated by Sponsor|1
4670429|NCT02731742|16068168|P3|Overall Study|Study Terminated by Sponsor|1
4670430|NCT02731742|16068169|P2|Overall Study|Study Terminated by Sponsor|1
4670431|NCT02731742|16068170|P1|Overall Study|Study Terminated by Sponsor|2
4670432|NCT02731742|16068167|P4|Overall Study|Physician Decision|1
4670433|NCT02731742|16068168|P3|Overall Study|Physician Decision|0
4670434|NCT02731742|16068169|P2|Overall Study|Physician Decision|0
4670435|NCT02731742|16068170|P1|Overall Study|Physician Decision|0
4670436|NCT02731742|16068167|P4|Overall Study|Death|0
4670437|NCT02731742|16068168|P3|Overall Study|Death|5
4670438|NCT02731742|16068169|P2|Overall Study|Death|2
4670439|NCT02731742|16068170|P1|Overall Study|Death|1
4670440|NCT02731690|16068188|P1|Overall Study|Discontinuation of Study by Sponsor|26
4670441|NCT02731690|16068188|P1|Overall Study|Withdrawal by Subject|3
4670442|NCT02731690|16068188|P1|Overall Study|Adverse Event|1
4670443|NCT02731638|16068208|P2|Overall Study|Lost to Follow-up|9
4670444|NCT02731638|16068209|P1|Overall Study|Lost to Follow-up|6
4670445|NCT02731157|16068452|P1|First Rejuvenated RCE|Withdrawal by Subject|1
4670446|NCT02731131|16068470|P2|Overall Study|Refused Therapy|1
4670447|NCT02731131|16068471|P1|Overall Study|Refused Therapy|0
4670448|NCT02731131|16068470|P2|Overall Study|Psychiatric Disorder|1
4670449|NCT02731131|16068471|P1|Overall Study|Psychiatric Disorder|0
4670450|NCT02730871|16068506|P2|Overall Study|Adverse Event|0
4670451|NCT02730871|16068507|P1|Overall Study|Adverse Event|6
4670452|NCT02730819|16068521|P1|Overall Study|Lost to Follow-up|9
4670453|NCT02730728|16068530|P3|Overall Study|Lack of Efficacy|1
4670454|NCT02730728|16068531|P2|Overall Study|Lack of Efficacy|1
4670455|NCT02730728|16068532|P1|Overall Study|Lack of Efficacy|0
4670456|NCT02730728|16068530|P3|Overall Study|Withdrawal by Subject|0
4670457|NCT02730728|16068531|P2|Overall Study|Withdrawal by Subject|1
4670458|NCT02730728|16068532|P1|Overall Study|Withdrawal by Subject|0
4670459|NCT02730598|16068561|P2|Overall Study|Unrelated Injury affecting outcomes.|0
4670460|NCT02730598|16068562|P1|Overall Study|Unrelated Injury affecting outcomes.|1
4670461|NCT02730598|16068561|P2|Overall Study|Protocol Violation|1
4670462|NCT02730598|16068562|P1|Overall Study|Protocol Violation|0
4670463|NCT02730598|16068561|P2|Overall Study|Withdrawal by Subject|3
4670464|NCT02730598|16068562|P1|Overall Study|Withdrawal by Subject|3
4670465|NCT02730455|16068585|P3|Overall Study|Other|0
4670466|NCT02730455|16068586|P2|Overall Study|Other|2
4670467|NCT02730455|16068587|P1|Overall Study|Other|2
4670468|NCT02730455|16068585|P3|Overall Study|Other|2
4670469|NCT02730455|16068586|P2|Overall Study|Other|1
4670470|NCT02730455|16068587|P1|Overall Study|Other|1
4670471|NCT02730455|16068585|P3|Overall Study|Lost to Follow-up|4
4670472|NCT02730455|16068586|P2|Overall Study|Lost to Follow-up|1
4670473|NCT02730455|16068587|P1|Overall Study|Lost to Follow-up|3
4670474|NCT02730455|16068585|P3|Overall Study|Consent withdrawn|1
4670475|NCT02730455|16068586|P2|Overall Study|Consent withdrawn|4
4670476|NCT02730455|16068587|P1|Overall Study|Consent withdrawn|2
4670477|NCT02730455|16068585|P3|Overall Study|Death|4
4670478|NCT02730455|16068586|P2|Overall Study|Death|6
4670479|NCT02730455|16068587|P1|Overall Study|Death|5
4670480|NCT02730377|16068637|P2|Overall Study|Lost to Follow-up|21
4670481|NCT02730377|16068638|P1|Overall Study|Lost to Follow-up|25
4670482|NCT02730377|16068637|P2|Overall Study|Withdrawal by Subject|42
4670483|NCT02730377|16068638|P1|Overall Study|Withdrawal by Subject|45
4670484|NCT02730377|16068637|P2|Overall Study|Pregnancy|1
4670485|NCT02730377|16068638|P1|Overall Study|Pregnancy|0
4670486|NCT02730377|16068637|P2|Overall Study|Lack of Efficacy|13
4670487|NCT02730377|16068638|P1|Overall Study|Lack of Efficacy|4
4670488|NCT02730377|16068637|P2|Overall Study|Protocol Violation|30
4670489|NCT02730377|16068638|P1|Overall Study|Protocol Violation|23
4670490|NCT02730377|16068637|P2|Overall Study|Adverse Event|41
4670491|NCT02730377|16068638|P1|Overall Study|Adverse Event|79
4670492|NCT02730377|16068637|P2|Overall Study|Inadequate glycaemic control|473
4670493|NCT02730377|16068638|P1|Overall Study|Inadequate glycaemic control|368
4670494|NCT02730377|16068637|P2|Overall Study|Death|8
4670495|NCT02730377|16068638|P1|Overall Study|Death|1
4670496|NCT02730377|16068637|P2|Overall Study|Other|4
4670497|NCT02730377|16068638|P1|Overall Study|Other|5
4670498|NCT02730351|16068688|P2|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0
4670499|NCT02730351|16068689|P1|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1
4670500|NCT02730351|16068688|P2|Treatment Period 2 (2 Weeks)|Adverse Event|0
4670501|NCT02730351|16068689|P1|Treatment Period 2 (2 Weeks)|Adverse Event|1
4670502|NCT02730351|16068688|P2|Wash-out Period (2 Weeks)|Withdrawal by Subject|0
4670503|NCT02730351|16068689|P1|Wash-out Period (2 Weeks)|Withdrawal by Subject|1
4670504|NCT02730351|16068688|P2|Wash-out Period (2 Weeks)|Protocol Violation|1
4670505|NCT02730351|16068689|P1|Wash-out Period (2 Weeks)|Protocol Violation|0
4670506|NCT02730351|16068688|P2|Treatment Period 1 (2 Weeks)|Adverse Event|0
4670507|NCT02730351|16068689|P1|Treatment Period 1 (2 Weeks)|Adverse Event|1
4670508|NCT02730208|16068712|P2|Overall Study|Withdrawal of consent (not due to AE)|1
4670509|NCT02730208|16068713|P1|Overall Study|Withdrawal of consent (not due to AE)|0
4670510|NCT02730195|16068721|P1|Overall Study|Withdrawal by Subject|1
4670511|NCT02729909|16068735|P2|Overall Study|Voluntary Withdrawal|0
4670512|NCT02729909|16068736|P1|Overall Study|Voluntary Withdrawal|1
4670513|NCT02729909|16068735|P2|Overall Study|Significant Protocol Deviation|2
4670514|NCT02729909|16068736|P1|Overall Study|Significant Protocol Deviation|0
4670515|NCT02729909|16068735|P2|Overall Study|Lack of Efficacy|2
4670516|NCT02729909|16068736|P1|Overall Study|Lack of Efficacy|0
4670517|NCT02729909|16068735|P2|Overall Study|Lost to Follow-up|1
4670518|NCT02729909|16068736|P1|Overall Study|Lost to Follow-up|0
4670519|NCT02729896|16068755|P3|Overall Study|Progressive Disease|1
4670520|NCT02729896|16068756|P2|Overall Study|Progressive Disease|0
4670521|NCT02729896|16068757|P1|Overall Study|Progressive Disease|0
4670522|NCT02729896|16068755|P3|Overall Study|Physician Decision|5
4670523|NCT02729896|16068756|P2|Overall Study|Physician Decision|0
4670524|NCT02729896|16068757|P1|Overall Study|Physician Decision|0
4670525|NCT02729896|16068755|P3|Overall Study|Death|10
4670526|NCT02729896|16068756|P2|Overall Study|Death|2
4670527|NCT02729896|16068757|P1|Overall Study|Death|0
4670528|NCT02729831|16068778|P4|6 Month Follow-up|Death|1
4670529|NCT02729831|16068779|P3|6 Month Follow-up|Death|0
4670530|NCT02729831|16068780|P2|6 Month Follow-up|Death|3
4670531|NCT02729831|16068781|P1|6 Month Follow-up|Death|1
4670532|NCT02729831|16068778|P4|6 Month Follow-up|Lost to Follow-up|42
4670533|NCT02729831|16068779|P3|6 Month Follow-up|Lost to Follow-up|48
4670534|NCT02729831|16068780|P2|6 Month Follow-up|Lost to Follow-up|51
4670535|NCT02729831|16068781|P1|6 Month Follow-up|Lost to Follow-up|54
4670536|NCT02729831|16068778|P4|1 Week Post-visit|Lost to Follow-up|36
4670537|NCT02729831|16068779|P3|1 Week Post-visit|Lost to Follow-up|38
4670538|NCT02729831|16068780|P2|1 Week Post-visit|Lost to Follow-up|40
4670539|NCT02729831|16068781|P1|1 Week Post-visit|Lost to Follow-up|43
4670540|NCT02729831|16068778|P4|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17
4670541|NCT02729831|16068779|P3|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18
4670542|NCT02729831|16068780|P2|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23
4670543|NCT02729831|16068781|P1|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38
4670544|NCT02729753|16068809|P2|Overall Study|Device Malfunction. No units in stock.|1
4670545|NCT02729753|16068810|P1|Overall Study|Device Malfunction. No units in stock.|0
4670546|NCT02729545|16068824|P2|Overall Study|Withdrawal by Subject|3
4670547|NCT02729545|16068825|P1|Overall Study|Withdrawal by Subject|2
4670548|NCT02729545|16068824|P2|Overall Study|Lost to Follow-up|1
4670549|NCT02729545|16068825|P1|Overall Study|Lost to Follow-up|0
4670550|NCT02729545|16068824|P2|Overall Study|Pregnancy|1
4670551|NCT02729545|16068825|P1|Overall Study|Pregnancy|1
4670552|NCT02729194|16068847|P1|Overall Study|Withdrawal by Subject|3
4670553|NCT02729051|16068859|P2|Overall Study|Withdrawal by Subject|17
4670554|NCT02729051|16068860|P1|Overall Study|Withdrawal by Subject|6
4670555|NCT02729051|16068859|P2|Overall Study|Physician Decision|1
4670556|NCT02729051|16068860|P1|Overall Study|Physician Decision|1
4670557|NCT02729051|16068859|P2|Overall Study|Lost to Follow-up|2
4670558|NCT02729051|16068860|P1|Overall Study|Lost to Follow-up|1
4670559|NCT02729051|16068859|P2|Overall Study|Lack of Efficacy|1
4670560|NCT02729051|16068860|P1|Overall Study|Lack of Efficacy|1
4670561|NCT02729051|16068859|P2|Overall Study|Adverse Event|11
4670562|NCT02729051|16068860|P1|Overall Study|Adverse Event|21
4670563|NCT02729025|16069004|P2|Overall Study|Sponsor Decision|1
4670564|NCT02729025|16069005|P1|Overall Study|Sponsor Decision|0
4670565|NCT02728895|16069019|P2|Overall Study|Withdrawal by Subject|3
4670566|NCT02728895|16069020|P1|Overall Study|Withdrawal by Subject|0
4670567|NCT02728895|16069019|P2|Overall Study|Other|2
4670568|NCT02728895|16069020|P1|Overall Study|Other|1
4670569|NCT02728830|16069040|P1|Overall Study|Language Barrier|1
4670570|NCT02728830|16069040|P1|Overall Study|Contraindicated Illness|1
4670571|NCT02728830|16069040|P1|Overall Study|Exclusionary Lab Values|1
4670572|NCT02728830|16069040|P1|Overall Study|Lost to Follow-up|1
4670573|NCT02728830|16069040|P1|Overall Study|Withdrawal by Subject|2
4670574|NCT02728830|16069040|P1|Overall Study|Physician Decision|3
4670575|NCT02728830|16069040|P1|Overall Study|Exclusionary Pathology|6
4670576|NCT02728830|16069040|P1|Overall Study|Exclusionary Surgery|9
4670577|NCT02728206|16069055|P1|Overall Study|Death|1
4670578|NCT02728089|16069063|P1|Overall Study|Withdrawal by Subject|1
4670579|NCT02728089|16069063|P1|Overall Study|Physician Decision|2
4670580|NCT02727777|16069151|P3|Overall Study|Progressive disease|0
4670581|NCT02727777|16069152|P2|Overall Study|Progressive disease|0
4670582|NCT02727777|16069153|P1|Overall Study|Progressive disease|2
4670583|NCT02727777|16069151|P3|Overall Study|Screen Failure|0
4670584|NCT02727777|16069152|P2|Overall Study|Screen Failure|0
4670585|NCT02727777|16069153|P1|Overall Study|Screen Failure|2
4670586|NCT02727660|16069174|P3|Overall Study|Administrative Reasons|4
4670587|NCT02727660|16069175|P2|Overall Study|Administrative Reasons|3
4670588|NCT02727660|16069176|P1|Overall Study|Administrative Reasons|2
4670589|NCT02727660|16069174|P3|Overall Study|Protocol Specified Disc. Criteria|2
4670590|NCT02727660|16069175|P2|Overall Study|Protocol Specified Disc. Criteria|5
4670591|NCT02727660|16069176|P1|Overall Study|Protocol Specified Disc. Criteria|5
4670592|NCT02727660|16069174|P3|Overall Study|Protocol Violation|5
4670593|NCT02727660|16069175|P2|Overall Study|Protocol Violation|5
4670594|NCT02727660|16069176|P1|Overall Study|Protocol Violation|7
4670595|NCT02727660|16069174|P3|Overall Study|Lost to Follow-up|8
4670596|NCT02727660|16069175|P2|Overall Study|Lost to Follow-up|9
4670597|NCT02727660|16069176|P1|Overall Study|Lost to Follow-up|5
4670598|NCT02727660|16069174|P3|Overall Study|Physician Decision|14
4670599|NCT02727660|16069175|P2|Overall Study|Physician Decision|8
4670600|NCT02727660|16069176|P1|Overall Study|Physician Decision|3
4670601|NCT02727660|16069174|P3|Overall Study|Withdrawal by Subject|30
4670602|NCT02727660|16069175|P2|Overall Study|Withdrawal by Subject|25
4670603|NCT02727660|16069176|P1|Overall Study|Withdrawal by Subject|26
4670604|NCT02727660|16069174|P3|Overall Study|Adverse Event|32
4670605|NCT02727660|16069175|P2|Overall Study|Adverse Event|21
4670606|NCT02727660|16069176|P1|Overall Study|Adverse Event|28
4670607|NCT02727660|16069174|P3|Overall Study|Lack of Efficacy|70
4670608|NCT02727660|16069175|P2|Overall Study|Lack of Efficacy|40
4670609|NCT02727660|16069176|P1|Overall Study|Lack of Efficacy|40
4670610|NCT02727322|16069195|P2|Overall Study|Protocol Violation|0
4670611|NCT02727322|16069196|P1|Overall Study|Protocol Violation|1
4670612|NCT02727322|16069195|P2|Overall Study|Withdrawal by Subject|1
4670613|NCT02727322|16069196|P1|Overall Study|Withdrawal by Subject|1
4670614|NCT02726945|16069222|P3|Overall Study|Elected to have total knee replacement|0
4670615|NCT02726945|16069223|P2|Overall Study|Elected to have total knee replacement|1
4670616|NCT02726945|16069224|P1|Overall Study|Elected to have total knee replacement|0
4670617|NCT02726945|16069222|P3|Overall Study|Withdrawal by Subject|1
4670618|NCT02726945|16069223|P2|Overall Study|Withdrawal by Subject|0
4670619|NCT02726945|16069224|P1|Overall Study|Withdrawal by Subject|0
4670620|NCT02726399|16069358|P1|Overall Study|Progression of disease|4
4670621|NCT02726399|16069358|P1|Overall Study|Adverse Event|2
4670622|NCT02726399|16069358|P1|Overall Study|Participant Non-Compliance|1
4670623|NCT02726113|16069375|P2|Genomic Analysis|Insurance non-coverage for surgery|1
4670624|NCT02726113|16069376|P1|Genomic Analysis|Insurance non-coverage for surgery|1
4670625|NCT02726113|16069375|P2|Genomic Analysis|Withdrawal by Subject|1
4670626|NCT02726113|16069376|P1|Genomic Analysis|Withdrawal by Subject|2
4670627|NCT02726113|16069375|P2|Genomic Analysis|Protocol Violation|0
4670628|NCT02726113|16069376|P1|Genomic Analysis|Protocol Violation|1
4670629|NCT02726113|16069375|P2|Total Enrollment|Insurance non-coverage for surgery|1
4670630|NCT02726113|16069376|P1|Total Enrollment|Insurance non-coverage for surgery|1
4670631|NCT02726113|16069375|P2|Total Enrollment|Withdrawal by Subject|1
4670632|NCT02726113|16069376|P1|Total Enrollment|Withdrawal by Subject|2
4670633|NCT02726113|16069375|P2|Total Enrollment|Protocol Violation|0
4670634|NCT02726113|16069376|P1|Total Enrollment|Protocol Violation|1
4670635|NCT02726113|16069375|P2|Total Enrollment|Physician Decision|1
4670636|NCT02726113|16069376|P1|Total Enrollment|Physician Decision|0
4670637|NCT02726074|16069383|P1|Overall Study|Others|3
4670638|NCT02726074|16069383|P1|Overall Study|Lost to Follow-up|2
4670639|NCT02726074|16069383|P1|Overall Study|Protocol Violation|3
4670640|NCT02726074|16069383|P1|Overall Study|Adverse Event|14
4670641|NCT02726074|16069383|P1|Overall Study|Withdrawal by Subject|4
4670642|NCT02726022|16069395|P1|Overall Study|Treatment Failure and Poor Compliance|1
4670643|NCT02726022|16069395|P1|Overall Study|Poor Compliance|13
4670644|NCT02726022|16069395|P1|Overall Study|Treatment Failure|8
4670645|NCT02726022|16069395|P1|Overall Study|Adverse Event|14
4670646|NCT02725866|16069404|P1|Overall Study|Other, not specified|4
4670647|NCT02725866|16069404|P1|Overall Study|Insufficient virological response|1
4670648|NCT02725866|16069404|P1|Overall Study|Withdrew consent|3
4670649|NCT02725866|16069404|P1|Overall Study|Failure to return|6
4670650|NCT02725788|16069428|P2|Overall Study|Protocol Violation|1
4670651|NCT02725788|16069429|P1|Overall Study|Protocol Violation|0
4670652|NCT02725788|16069428|P2|Overall Study|Lost to Follow-up|1
4670653|NCT02725788|16069429|P1|Overall Study|Lost to Follow-up|1
4670654|NCT02725710|16069437|P2|Overall Study|Lost to Follow-up|0
4670655|NCT02725710|16069438|P1|Overall Study|Lost to Follow-up|1
4670656|NCT02725671|16069466|P1|Overall Study|Lost to Follow-up|1
4670657|NCT02725515|16069481|P2|Overall Study|Lack of Response|1
4670658|NCT02725515|16069482|P1|Overall Study|Lack of Response|0
4670659|NCT02725515|16069481|P2|Overall Study|Completed Study Under Original Protocol|1
4670660|NCT02725515|16069482|P1|Overall Study|Completed Study Under Original Protocol|0
4670661|NCT02725515|16069481|P2|Overall Study|No Documented Disease Improvement|1
4670662|NCT02725515|16069482|P1|Overall Study|No Documented Disease Improvement|0
4670663|NCT02725515|16069481|P2|Overall Study|Adverse Event|2
4670664|NCT02725515|16069482|P1|Overall Study|Adverse Event|7
4670665|NCT02725515|16069481|P2|Overall Study|Lost to Follow-up|1
4670666|NCT02725515|16069482|P1|Overall Study|Lost to Follow-up|1
4670667|NCT02725515|16069481|P2|Overall Study|Non-Compliance With Study Drug|3
4670668|NCT02725515|16069482|P1|Overall Study|Non-Compliance With Study Drug|0
4670669|NCT02725515|16069481|P2|Overall Study|Withdrawal by Subject|1
4670670|NCT02725515|16069482|P1|Overall Study|Withdrawal by Subject|2
4670671|NCT02725515|16069481|P2|Overall Study|Loss of Improvement per Protocol|25
4670672|NCT02725515|16069482|P1|Overall Study|Loss of Improvement per Protocol|14
4670673|NCT02725515|16069481|P2|Overall Study|Refused infusion (no study treatment)|0
4670674|NCT02725515|16069482|P1|Overall Study|Refused infusion (no study treatment)|1
4670675|NCT02725476|16069494|P2|Overall Study|Adverse Event|1
4670676|NCT02725476|16069495|P1|Overall Study|Adverse Event|1
4670677|NCT02725476|16069494|P2|Overall Study|Physician Decision|0
4670678|NCT02725476|16069495|P1|Overall Study|Physician Decision|2
4670679|NCT02725411|16069506|P3|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
4670680|NCT02725411|16069507|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|3
4670681|NCT02725411|16069508|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
4670682|NCT02725411|16069506|P3|Follow-up Period (24 Weeks)|Other|2
4670683|NCT02725411|16069507|P2|Follow-up Period (24 Weeks)|Other|4
4670684|NCT02725411|16069508|P1|Follow-up Period (24 Weeks)|Other|1
4670685|NCT02725411|16069506|P3|Follow-up Period (24 Weeks)|Lost to Follow-up|0
4670686|NCT02725411|16069507|P2|Follow-up Period (24 Weeks)|Lost to Follow-up|1
4670687|NCT02725411|16069508|P1|Follow-up Period (24 Weeks)|Lost to Follow-up|1
4670688|NCT02725411|16069506|P3|Follow-up Period (24 Weeks)|Lack of Efficacy|0
4670689|NCT02725411|16069507|P2|Follow-up Period (24 Weeks)|Lack of Efficacy|2
4670690|NCT02725411|16069508|P1|Follow-up Period (24 Weeks)|Lack of Efficacy|0
4670691|NCT02725411|16069506|P3|Follow-up Period (24 Weeks)|Adverse Event|0
4670692|NCT02725411|16069507|P2|Follow-up Period (24 Weeks)|Adverse Event|1
4670693|NCT02725411|16069508|P1|Follow-up Period (24 Weeks)|Adverse Event|1
4670694|NCT02725411|16069506|P3|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
4670695|NCT02725411|16069507|P2|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35
4670696|NCT02725411|16069508|P1|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25
4670697|NCT02725411|16069506|P3|Treatment Period (56 Weeks)|Withdrawal by Subject|4
4670698|NCT02725411|16069507|P2|Treatment Period (56 Weeks)|Withdrawal by Subject|1
4670699|NCT02725411|16069508|P1|Treatment Period (56 Weeks)|Withdrawal by Subject|0
4670700|NCT02725411|16069506|P3|Treatment Period (56 Weeks)|Other|5
4670701|NCT02725411|16069507|P2|Treatment Period (56 Weeks)|Other|4
4670702|NCT02725411|16069508|P1|Treatment Period (56 Weeks)|Other|1
4670703|NCT02725411|16069506|P3|Treatment Period (56 Weeks)|Lost to Follow-up|0
4670704|NCT02725411|16069507|P2|Treatment Period (56 Weeks)|Lost to Follow-up|1
4670705|NCT02725411|16069508|P1|Treatment Period (56 Weeks)|Lost to Follow-up|0
4670706|NCT02725411|16069506|P3|Treatment Period (56 Weeks)|Lack of Efficacy|1
4670707|NCT02725411|16069507|P2|Treatment Period (56 Weeks)|Lack of Efficacy|4
4670708|NCT02725411|16069508|P1|Treatment Period (56 Weeks)|Lack of Efficacy|1
4670709|NCT02725411|16069506|P3|Treatment Period (56 Weeks)|Adverse Event|4
4670710|NCT02725411|16069507|P2|Treatment Period (56 Weeks)|Adverse Event|5
4670711|NCT02725411|16069508|P1|Treatment Period (56 Weeks)|Adverse Event|3
4670712|NCT02725268|16069724|P4|Overall Study|Ongoing|0
4670713|NCT02725268|16069725|P3|Overall Study|Ongoing|0
4670714|NCT02725268|16069726|P2|Overall Study|Ongoing|3
4670715|NCT02725268|16069727|P1|Overall Study|Ongoing|3
4670716|NCT02725268|16069724|P4|Overall Study|Reason not Specified|0
4670717|NCT02725268|16069725|P3|Overall Study|Reason not Specified|0
4670718|NCT02725268|16069726|P2|Overall Study|Reason not Specified|1
4670719|NCT02725268|16069727|P1|Overall Study|Reason not Specified|1
4670720|NCT02725268|16069724|P4|Overall Study|Withdrawal by Subject|1
4670721|NCT02725268|16069725|P3|Overall Study|Withdrawal by Subject|8
4670722|NCT02725268|16069726|P2|Overall Study|Withdrawal by Subject|4
4670723|NCT02725268|16069727|P1|Overall Study|Withdrawal by Subject|8
4670724|NCT02725268|16069724|P4|Overall Study|Lost to Follow-up|0
4670725|NCT02725268|16069725|P3|Overall Study|Lost to Follow-up|0
4670726|NCT02725268|16069726|P2|Overall Study|Lost to Follow-up|3
4670727|NCT02725268|16069727|P1|Overall Study|Lost to Follow-up|2
4670728|NCT02725268|16069724|P4|Overall Study|Death|16
4670729|NCT02725268|16069725|P3|Overall Study|Death|29
4670730|NCT02725268|16069726|P2|Overall Study|Death|48
4670731|NCT02725268|16069727|P1|Overall Study|Death|45
4670732|NCT02725008|16069763|P2|Overall Study|Admitted to hospital|1
4670733|NCT02725008|16069764|P1|Overall Study|Admitted to hospital|0
4670734|NCT02725008|16069763|P2|Overall Study|Withdrawal by Subject|2
4670735|NCT02725008|16069764|P1|Overall Study|Withdrawal by Subject|2
4670736|NCT02725008|16069763|P2|Overall Study|Lost to Follow-up|9
4670737|NCT02725008|16069764|P1|Overall Study|Lost to Follow-up|7
4670738|NCT02724644|16069817|P2|Overall Study|Administrative|0
4670739|NCT02724644|16069818|P1|Overall Study|Administrative|1
4670740|NCT02724644|16069817|P2|Overall Study|Withdrawal by Subject|1
4670741|NCT02724644|16069818|P1|Overall Study|Withdrawal by Subject|7
4670742|NCT02724644|16069817|P2|Overall Study|Lost to Follow-up|2
4670743|NCT02724644|16069818|P1|Overall Study|Lost to Follow-up|6
4670744|NCT02724644|16069817|P2|Overall Study|Adverse Event|1
4670745|NCT02724644|16069818|P1|Overall Study|Adverse Event|7
4670746|NCT02724111|16069852|P2|Overall Study|Protocol Violation|5
4670747|NCT02724111|16069853|P1|Overall Study|Protocol Violation|2
4670748|NCT02723786|16069886|P1|Overall Study|Lost to Follow-up|1
4670749|NCT02723630|16069914|P6|Intervention Period 3|consumption of restricted item|0
4670750|NCT02723630|16069915|P5|Intervention Period 3|consumption of restricted item|0
4670751|NCT02723630|16069916|P4|Intervention Period 3|consumption of restricted item|0
4670752|NCT02723630|16069917|P3|Intervention Period 3|consumption of restricted item|0
4670753|NCT02723630|16069918|P2|Intervention Period 3|consumption of restricted item|1
4670754|NCT02723630|16069919|P1|Intervention Period 3|consumption of restricted item|0
4670755|NCT02723630|16069914|P6|Intervention Period 1|Adverse Event|0
4670756|NCT02723630|16069915|P5|Intervention Period 1|Adverse Event|0
4670757|NCT02723630|16069916|P4|Intervention Period 1|Adverse Event|0
4670758|NCT02723630|16069917|P3|Intervention Period 1|Adverse Event|0
4670759|NCT02723630|16069918|P2|Intervention Period 1|Adverse Event|0
4670760|NCT02723630|16069919|P1|Intervention Period 1|Adverse Event|1
4670761|NCT02723591|16069950|P2|Overall Study|Miscellaneous|6
4670762|NCT02723591|16069951|P1|Overall Study|Miscellaneous|5
4670763|NCT02723591|16069950|P2|Overall Study|Randomized but Never Received StudyDrug|12
4670764|NCT02723591|16069951|P1|Overall Study|Randomized but Never Received StudyDrug|12
4670765|NCT02723591|16069950|P2|Overall Study|Withdrawal by Subject|8
4670766|NCT02723591|16069951|P1|Overall Study|Withdrawal by Subject|4
4670767|NCT02723591|16069950|P2|Overall Study|Protocol Violation|23
4670768|NCT02723591|16069951|P1|Overall Study|Protocol Violation|20
4670769|NCT02723591|16069950|P2|Overall Study|Lost to Follow-up|7
4670770|NCT02723591|16069951|P1|Overall Study|Lost to Follow-up|1
4670771|NCT02723591|16069950|P2|Overall Study|Lack of Efficacy|3
4670772|NCT02723591|16069951|P1|Overall Study|Lack of Efficacy|4
4670773|NCT02723591|16069950|P2|Overall Study|Death|2
4670774|NCT02723591|16069951|P1|Overall Study|Death|2
4670775|NCT02723591|16069950|P2|Overall Study|Adverse Event|40
4670776|NCT02723591|16069951|P1|Overall Study|Adverse Event|48
4670777|NCT02723344|16070079|P2|Overall Study|Lost to Follow-up|4
4670778|NCT02723344|16070080|P1|Overall Study|Lost to Follow-up|0
4670779|NCT02723201|16070103|P3|Second Intervention Period|Adverse Event|0
4670780|NCT02723201|16070104|P2|Second Intervention Period|Adverse Event|0
4670781|NCT02723201|16070105|P1|Second Intervention Period|Adverse Event|1
4670782|NCT02723201|16070103|P3|Second Intervention Period|Protocol Violation|0
4670783|NCT02723201|16070104|P2|Second Intervention Period|Protocol Violation|0
4670784|NCT02723201|16070105|P1|Second Intervention Period|Protocol Violation|1
4670785|NCT02723188|16070164|P3|Overall Study|Withdrawal by Subject|0
4670786|NCT02723188|16070165|P2|Overall Study|Withdrawal by Subject|0
4670787|NCT02723188|16070166|P1|Overall Study|Withdrawal by Subject|1
4670788|NCT02723175|16070179|P2|Overall Study|Lost to 3 Month Follow Up|1
4670789|NCT02723175|16070180|P1|Overall Study|Lost to 3 Month Follow Up|1
4670790|NCT02723175|16070179|P2|Overall Study|Lost to 1 Month Follow Up|2
4670791|NCT02723175|16070180|P1|Overall Study|Lost to 1 Month Follow Up|3
4670792|NCT02723084|16070222|P2|Overall Study|Lost to Follow-up|0
4670793|NCT02723084|16070223|P1|Overall Study|Lost to Follow-up|3
4670794|NCT02723084|16070222|P2|Overall Study|Withdrawal by Subject|1
4670795|NCT02723084|16070223|P1|Overall Study|Withdrawal by Subject|1
4670796|NCT02722967|16070237|P3|Overall Study|Non-adherence of the patch to the skin|2
4670797|NCT02722967|16070238|P2|Overall Study|Non-adherence of the patch to the skin|0
4670798|NCT02722967|16070239|P1|Overall Study|Non-adherence of the patch to the skin|0
4670799|NCT02722967|16070237|P3|Overall Study|Physician Decision|0
4670800|NCT02722967|16070238|P2|Overall Study|Physician Decision|0
4670801|NCT02722967|16070239|P1|Overall Study|Physician Decision|1
4670802|NCT02722967|16070237|P3|Overall Study|Withdrawal by Subject|1
4670803|NCT02722967|16070238|P2|Overall Study|Withdrawal by Subject|0
4670804|NCT02722967|16070239|P1|Overall Study|Withdrawal by Subject|1
4670805|NCT02722967|16070237|P3|Overall Study|Non-compliance with patch wearing|1
4670806|NCT02722967|16070238|P2|Overall Study|Non-compliance with patch wearing|1
4670807|NCT02722967|16070239|P1|Overall Study|Non-compliance with patch wearing|2
4670808|NCT02722967|16070237|P3|Overall Study|Lost to Follow-up|0
4670809|NCT02722967|16070238|P2|Overall Study|Lost to Follow-up|1
4670810|NCT02722967|16070239|P1|Overall Study|Lost to Follow-up|0
4670811|NCT02722967|16070237|P3|Overall Study|Adverse Event|0
4670812|NCT02722967|16070238|P2|Overall Study|Adverse Event|0
4670813|NCT02722967|16070239|P1|Overall Study|Adverse Event|1
4670814|NCT02722928|16070249|P2|Overall Study|Required Intraoperative MRI|7
4670815|NCT02722928|16070250|P1|Overall Study|Required Intraoperative MRI|5
4670816|NCT02722928|16070249|P2|Overall Study|Standard CT was not as required per prot|13
4670817|NCT02722928|16070250|P1|Overall Study|Standard CT was not as required per prot|5
4670818|NCT02722304|16070380|P5|Overall Study|Other|1
4670819|NCT02722304|16070381|P4|Overall Study|Other|1
4670820|NCT02722304|16070382|P3|Overall Study|Other|0
4670821|NCT02722304|16070383|P2|Overall Study|Other|0
4670822|NCT02722304|16070384|P1|Overall Study|Other|0
4670823|NCT02722304|16070380|P5|Overall Study|Study Terminated by Sponsor|1
4670824|NCT02722304|16070381|P4|Overall Study|Study Terminated by Sponsor|1
4670825|NCT02722304|16070382|P3|Overall Study|Study Terminated by Sponsor|2
4670826|NCT02722304|16070383|P2|Overall Study|Study Terminated by Sponsor|0
4670827|NCT02722304|16070384|P1|Overall Study|Study Terminated by Sponsor|1
4670828|NCT02722278|16070436|P2|Overall Study|Site closure not study related|1
4670829|NCT02722278|16070437|P1|Overall Study|Site closure not study related|0
4670830|NCT02722278|16070436|P2|Overall Study|Subject declined after tx assignment|1
4670831|NCT02722278|16070437|P1|Overall Study|Subject declined after tx assignment|0
4670832|NCT02722278|16070436|P2|Overall Study|High PSA pre-study/ not eligible|1
4670833|NCT02722278|16070437|P1|Overall Study|High PSA pre-study/ not eligible|0
4670834|NCT02722278|16070436|P2|Overall Study|Protocol Violation|0
4670835|NCT02722278|16070437|P1|Overall Study|Protocol Violation|1
4670836|NCT02722278|16070436|P2|Overall Study|Lost to Follow-up|0
4670837|NCT02722278|16070437|P1|Overall Study|Lost to Follow-up|2
4670838|NCT02722278|16070436|P2|Overall Study|Adverse Event|1
4670839|NCT02722278|16070437|P1|Overall Study|Adverse Event|4
4670840|NCT02722278|16070436|P2|Overall Study|Withdrawal by Subject|3
4670841|NCT02722278|16070437|P1|Overall Study|Withdrawal by Subject|5
4670842|NCT02722148|16070461|P1|Overall Study|Non compliant with treatment regimen|3
4670843|NCT02722148|16070461|P1|Overall Study|Lost to Follow-up|2
4670844|NCT02722044|16070468|P1|Overall Study|Did Not Meet Criteria at Week 14|1
4670845|NCT02722044|16070468|P1|Overall Study|Withdrawal by Subject|1
4670846|NCT02722044|16070468|P1|Overall Study|Physician Decision|1
4670847|NCT02722044|16070468|P1|Overall Study|Adverse Event|2
4670848|NCT02721966|16070498|P5|Overall Study|Did not continue to period 2|5
4670849|NCT02721966|16070499|P4|Overall Study|Did not continue to period 2|0
4670850|NCT02721966|16070500|P3|Overall Study|Did not continue to period 2|0
4670851|NCT02721966|16070501|P2|Overall Study|Did not continue to period 2|12
4670852|NCT02721966|16070502|P1|Overall Study|Did not continue to period 2|5
4670853|NCT02721966|16070498|P5|Overall Study|Pregnancy|0
4670854|NCT02721966|16070499|P4|Overall Study|Pregnancy|0
4670855|NCT02721966|16070500|P3|Overall Study|Pregnancy|0
4670856|NCT02721966|16070501|P2|Overall Study|Pregnancy|0
4670857|NCT02721966|16070502|P1|Overall Study|Pregnancy|1
4670858|NCT02721966|16070498|P5|Overall Study|Physician Decision|0
4670859|NCT02721966|16070499|P4|Overall Study|Physician Decision|0
4670860|NCT02721966|16070500|P3|Overall Study|Physician Decision|0
4670861|NCT02721966|16070501|P2|Overall Study|Physician Decision|1
4670862|NCT02721966|16070502|P1|Overall Study|Physician Decision|1
4670863|NCT02721966|16070498|P5|Overall Study|Lost to Follow-up|0
4670864|NCT02721966|16070499|P4|Overall Study|Lost to Follow-up|0
4670865|NCT02721966|16070500|P3|Overall Study|Lost to Follow-up|3
4670866|NCT02721966|16070501|P2|Overall Study|Lost to Follow-up|0
4670867|NCT02721966|16070502|P1|Overall Study|Lost to Follow-up|0
4670868|NCT02721966|16070498|P5|Overall Study|Lack of Efficacy|0
4670869|NCT02721966|16070499|P4|Overall Study|Lack of Efficacy|0
4670870|NCT02721966|16070500|P3|Overall Study|Lack of Efficacy|0
4670871|NCT02721966|16070501|P2|Overall Study|Lack of Efficacy|4
4670872|NCT02721966|16070502|P1|Overall Study|Lack of Efficacy|7
4670873|NCT02721966|16070498|P5|Overall Study|Death|0
4670874|NCT02721966|16070499|P4|Overall Study|Death|0
4670875|NCT02721966|16070500|P3|Overall Study|Death|0
4670876|NCT02721966|16070501|P2|Overall Study|Death|0
4670877|NCT02721966|16070502|P1|Overall Study|Death|1
4670878|NCT02721966|16070498|P5|Overall Study|Adverse Event|0
4670879|NCT02721966|16070499|P4|Overall Study|Adverse Event|0
4670880|NCT02721966|16070500|P3|Overall Study|Adverse Event|3
4670881|NCT02721966|16070501|P2|Overall Study|Adverse Event|4
4670882|NCT02721966|16070502|P1|Overall Study|Adverse Event|4
4670883|NCT02721966|16070498|P5|Overall Study|Withdrawal by Subject|0
4670884|NCT02721966|16070499|P4|Overall Study|Withdrawal by Subject|7
4670885|NCT02721966|16070500|P3|Overall Study|Withdrawal by Subject|3
4670886|NCT02721966|16070501|P2|Overall Study|Withdrawal by Subject|2
4670887|NCT02721966|16070502|P1|Overall Study|Withdrawal by Subject|9
4670888|NCT02721966|16070498|P5|Overall Study|Protocol Violation|0
4670889|NCT02721966|16070499|P4|Overall Study|Protocol Violation|0
4670890|NCT02721966|16070500|P3|Overall Study|Protocol Violation|0
4670891|NCT02721966|16070501|P2|Overall Study|Protocol Violation|0
4670892|NCT02721966|16070502|P1|Overall Study|Protocol Violation|1
4670893|NCT02721875|16070542|P2|Overall Study|Progressive disease/relapse|0
4670894|NCT02721875|16070543|P1|Overall Study|Progressive disease/relapse|1
4670895|NCT02721147|16070594|P3|Overall Study|Lost to Follow-up|0
4670896|NCT02721147|16070595|P2|Overall Study|Lost to Follow-up|0
4670897|NCT02721147|16070596|P1|Overall Study|Lost to Follow-up|2
4670898|NCT02720757|16070640|P1|Overall Study|General exclusion|3
4670899|NCT02720757|16070640|P1|Overall Study|Missing|3
4670900|NCT02720757|16070640|P1|Overall Study|Patients wish to withdraw|2
4670901|NCT02720757|16070640|P1|Overall Study|Informed consent withdrawal|1
4670902|NCT02720757|16070640|P1|Overall Study|Loss of contact|4
4670903|NCT02720757|16070640|P1|Overall Study|Other reason|5
4670904|NCT02720536|16070654|P1|Overall Study|PR- unwilling to comply with procedures|1
4670905|NCT02720536|16070654|P1|Overall Study|PR - abnormal lab value(s)|1
4670906|NCT02720536|16070654|P1|Overall Study|PR - adverse event|1
4670907|NCT02720536|16070654|P1|Overall Study|PR - death|1
4670908|NCT02720536|16070654|P1|Overall Study|PR - unsatisfactory therapeutic effect|2
4670909|NCT02720536|16070654|P1|Overall Study|PR - pregnancy|2
4670910|NCT02720536|16070654|P1|Overall Study|Primary reason (PR) - subject withdrawal|11
4670911|NCT02720523|16070689|P7|Period 2: Long-term Extension Period|Other|3
4670912|NCT02720523|16070690|P6|Period 2: Long-term Extension Period|Other|0
4670913|NCT02720523|16070691|P5|Period 2: Long-term Extension Period|Other|2
4670914|NCT02720523|16070692|P4|Period 2: Long-term Extension Period|Other|0
4670915|NCT02720523|16070693|P3|Period 2: Long-term Extension Period|Other|0
4670916|NCT02720523|16070694|P2|Period 2: Long-term Extension Period|Other|0
4670917|NCT02720523|16070695|P1|Period 2: Long-term Extension Period|Other|0
4670918|NCT02720523|16070689|P7|Period 2: Long-term Extension Period|Withdrawal by Subject|1
4670919|NCT02720523|16070690|P6|Period 2: Long-term Extension Period|Withdrawal by Subject|1
4670920|NCT02720523|16070691|P5|Period 2: Long-term Extension Period|Withdrawal by Subject|2
4670921|NCT02720523|16070692|P4|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4670922|NCT02720523|16070693|P3|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4670923|NCT02720523|16070694|P2|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4670924|NCT02720523|16070695|P1|Period 2: Long-term Extension Period|Withdrawal by Subject|0
4670925|NCT02720523|16070689|P7|Period 2: Long-term Extension Period|Adverse Event|11
4670926|NCT02720523|16070690|P6|Period 2: Long-term Extension Period|Adverse Event|7
4670927|NCT02720523|16070691|P5|Period 2: Long-term Extension Period|Adverse Event|4
4670928|NCT02720523|16070692|P4|Period 2: Long-term Extension Period|Adverse Event|0
4670929|NCT02720523|16070693|P3|Period 2: Long-term Extension Period|Adverse Event|0
4670930|NCT02720523|16070694|P2|Period 2: Long-term Extension Period|Adverse Event|0
4670931|NCT02720523|16070695|P1|Period 2: Long-term Extension Period|Adverse Event|0
4670932|NCT02720523|16070689|P7|Period 2: Long-term Extension Period|Ongoing|45
4670933|NCT02720523|16070690|P6|Period 2: Long-term Extension Period|Ongoing|54
4670934|NCT02720523|16070691|P5|Period 2: Long-term Extension Period|Ongoing|57
4670935|NCT02720523|16070692|P4|Period 2: Long-term Extension Period|Ongoing|0
4670936|NCT02720523|16070693|P3|Period 2: Long-term Extension Period|Ongoing|0
4670937|NCT02720523|16070694|P2|Period 2: Long-term Extension Period|Ongoing|0
4670938|NCT02720523|16070695|P1|Period 2: Long-term Extension Period|Ongoing|0
4670939|NCT02720523|16070689|P7|Period 1: Placebo-controlled Period|Other|0
4670940|NCT02720523|16070690|P6|Period 1: Placebo-controlled Period|Other|0
4670941|NCT02720523|16070691|P5|Period 1: Placebo-controlled Period|Other|0
4670942|NCT02720523|16070692|P4|Period 1: Placebo-controlled Period|Other|1
4670943|NCT02720523|16070693|P3|Period 1: Placebo-controlled Period|Other|1
4670944|NCT02720523|16070694|P2|Period 1: Placebo-controlled Period|Other|0
4670945|NCT02720523|16070695|P1|Period 1: Placebo-controlled Period|Other|0
4670946|NCT02720523|16070689|P7|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4670947|NCT02720523|16070690|P6|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4670948|NCT02720523|16070691|P5|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4670949|NCT02720523|16070692|P4|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4670950|NCT02720523|16070693|P3|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4670951|NCT02720523|16070694|P2|Period 1: Placebo-controlled Period|Lack of Efficacy|0
4670952|NCT02720523|16070695|P1|Period 1: Placebo-controlled Period|Lack of Efficacy|1
4670953|NCT02720523|16070689|P7|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4670954|NCT02720523|16070690|P6|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4670955|NCT02720523|16070691|P5|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4670956|NCT02720523|16070692|P4|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4670957|NCT02720523|16070693|P3|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4670958|NCT02720523|16070694|P2|Period 1: Placebo-controlled Period|Withdrawal by Subject|0
4670959|NCT02720523|16070695|P1|Period 1: Placebo-controlled Period|Withdrawal by Subject|1
4670960|NCT02720523|16070689|P7|Period 1: Placebo-controlled Period|Adverse Event|0
4670961|NCT02720523|16070690|P6|Period 1: Placebo-controlled Period|Adverse Event|0
4670962|NCT02720523|16070691|P5|Period 1: Placebo-controlled Period|Adverse Event|0
4670963|NCT02720523|16070692|P4|Period 1: Placebo-controlled Period|Adverse Event|5
4670964|NCT02720523|16070693|P3|Period 1: Placebo-controlled Period|Adverse Event|1
4670965|NCT02720523|16070694|P2|Period 1: Placebo-controlled Period|Adverse Event|0
4670966|NCT02720523|16070695|P1|Period 1: Placebo-controlled Period|Adverse Event|0
4670967|NCT02720510|16070754|P2|Overall Study|Physician Decision|2
4670968|NCT02720510|16070755|P1|Overall Study|Physician Decision|1
4670969|NCT02720510|16070754|P2|Overall Study|Adverse Event|1
4670970|NCT02720510|16070755|P1|Overall Study|Adverse Event|0
4670971|NCT02720510|16070754|P2|Overall Study|Study Terminated by the sponsor|0
4670972|NCT02720510|16070755|P1|Overall Study|Study Terminated by the sponsor|2
4670973|NCT02720484|16070773|P1|Follow Up for 2 Years|Lost to Follow-up|2
4670974|NCT02720484|16070773|P1|Follow Up for 2 Years|Death|3
4670975|NCT02720484|16070773|P1|Follow Up for 2 Years|Withdrawal by Subject|1
4670976|NCT02720484|16070773|P1|Treatment on Study|Progressive Disease|4
4670977|NCT02720484|16070773|P1|Treatment on Study|Withdrawal by Subject|1
4670978|NCT02720484|16070773|P1|Treatment on Study|Adverse Event|1
4670979|NCT02720198|16070805|P2|Overall Study|Withdrawal by Subject|1
4670980|NCT02720198|16070806|P1|Overall Study|Withdrawal by Subject|0
4670981|NCT02720081|16070841|P2|Overall Study|Protocol Violation|1
4670982|NCT02720081|16070842|P1|Overall Study|Protocol Violation|4
4670983|NCT02720081|16070841|P2|Overall Study|Adverse Event|3
4670984|NCT02720081|16070842|P1|Overall Study|Adverse Event|0
4670985|NCT02720042|16070898|P1|Overall Study|unable due to non-study-related illness|3
4670986|NCT02720042|16070898|P1|Overall Study|Phasix Mesh explanted|1
4670987|NCT02720042|16070898|P1|Overall Study|Physician Decision|3
4670988|NCT02720042|16070898|P1|Overall Study|Withdrawal by Subject|1
4670989|NCT02720042|16070898|P1|Overall Study|Lost to Follow-up|4
4670990|NCT02720042|16070898|P1|Overall Study|Death|3
4670991|NCT02719743|16070939|P5|Overall Study|Lost to Follow-up|0
4670992|NCT02719743|16070940|P4|Overall Study|Lost to Follow-up|0
4670993|NCT02719743|16070941|P3|Overall Study|Lost to Follow-up|0
4670994|NCT02719743|16070942|P2|Overall Study|Lost to Follow-up|1
4670995|NCT02719743|16070943|P1|Overall Study|Lost to Follow-up|1
4670996|NCT02719743|16070939|P5|Overall Study|Migrated/moved from study area|2
4670997|NCT02719743|16070940|P4|Overall Study|Migrated/moved from study area|0
4670998|NCT02719743|16070941|P3|Overall Study|Migrated/moved from study area|0
4670999|NCT02719743|16070942|P2|Overall Study|Migrated/moved from study area|0
4671000|NCT02719743|16070943|P1|Overall Study|Migrated/moved from study area|0
4671001|NCT02719743|16070939|P5|Overall Study|Consent withdrawal|0
4671002|NCT02719743|16070940|P4|Overall Study|Consent withdrawal|1
4671003|NCT02719743|16070941|P3|Overall Study|Consent withdrawal|0
4671004|NCT02719743|16070942|P2|Overall Study|Consent withdrawal|2
4671005|NCT02719743|16070943|P1|Overall Study|Consent withdrawal|0
4671006|NCT02719522|16071084|P1|Overall Study|Lost to Follow-up|5
4671007|NCT02719522|16071084|P1|Overall Study|Death|2
4671008|NCT02719522|16071084|P1|Overall Study|Implant Failure|4
4671009|NCT02719353|16071126|P2|First Intervention|Physician Decision|1
4671010|NCT02719353|16071127|P1|First Intervention|Physician Decision|0
4671011|NCT02719171|16071166|P5|Overall Study|Other|0
4671012|NCT02719171|16071167|P4|Overall Study|Other|1
4671013|NCT02719171|16071168|P3|Overall Study|Other|0
4671014|NCT02719171|16071169|P2|Overall Study|Other|0
4671015|NCT02719171|16071170|P1|Overall Study|Other|0
4671016|NCT02719171|16071166|P5|Overall Study|Subject Withdrawal|0
4671017|NCT02719171|16071167|P4|Overall Study|Subject Withdrawal|1
4671018|NCT02719171|16071168|P3|Overall Study|Subject Withdrawal|2
4671019|NCT02719171|16071169|P2|Overall Study|Subject Withdrawal|2
4671020|NCT02719171|16071170|P1|Overall Study|Subject Withdrawal|0
4671021|NCT02719171|16071166|P5|Overall Study|Lost to Follow-up|0
4671022|NCT02719171|16071167|P4|Overall Study|Lost to Follow-up|0
4671023|NCT02719171|16071168|P3|Overall Study|Lost to Follow-up|1
4671024|NCT02719171|16071169|P2|Overall Study|Lost to Follow-up|0
4671025|NCT02719171|16071170|P1|Overall Study|Lost to Follow-up|0
4671026|NCT02719171|16071166|P5|Overall Study|Adverse Event|2
4671027|NCT02719171|16071167|P4|Overall Study|Adverse Event|0
4671028|NCT02719171|16071168|P3|Overall Study|Adverse Event|0
4671029|NCT02719171|16071169|P2|Overall Study|Adverse Event|2
4671030|NCT02719171|16071170|P1|Overall Study|Adverse Event|1
4671031|NCT02719028|16071287|P4|Overall Study|Protocol Violation|1
4671032|NCT02719028|16071288|P3|Overall Study|Protocol Violation|0
4671033|NCT02719028|16071289|P2|Overall Study|Protocol Violation|0
4671034|NCT02719028|16071290|P1|Overall Study|Protocol Violation|0
4671035|NCT02719028|16071287|P4|Overall Study|Use of prohibited medication|0
4671036|NCT02719028|16071288|P3|Overall Study|Use of prohibited medication|1
4671037|NCT02719028|16071289|P2|Overall Study|Use of prohibited medication|0
4671038|NCT02719028|16071290|P1|Overall Study|Use of prohibited medication|0
4671039|NCT02719028|16071287|P4|Overall Study|Physician Decision|1
4671040|NCT02719028|16071288|P3|Overall Study|Physician Decision|1
4671041|NCT02719028|16071289|P2|Overall Study|Physician Decision|1
4671042|NCT02719028|16071290|P1|Overall Study|Physician Decision|0
4671043|NCT02719028|16071287|P4|Overall Study|Adverse Event|8
4671044|NCT02719028|16071288|P3|Overall Study|Adverse Event|4
4671045|NCT02719028|16071289|P2|Overall Study|Adverse Event|1
4671046|NCT02719028|16071290|P1|Overall Study|Adverse Event|2
4671047|NCT02718898|16071314|P7|Post Treatment Follow-up Period|Withdrawal by Subject|3
4671048|NCT02718898|16071315|P6|Post Treatment Follow-up Period|Withdrawal by Subject|5
4671049|NCT02718898|16071316|P5|Post Treatment Follow-up Period|Withdrawal by Subject|0
4671050|NCT02718898|16071317|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
4671051|NCT02718898|16071318|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
4671052|NCT02718898|16071319|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
4671053|NCT02718898|16071320|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
4671054|NCT02718898|16071314|P7|Post Treatment Follow-up Period|Lost to Follow-up|1
4671055|NCT02718898|16071315|P6|Post Treatment Follow-up Period|Lost to Follow-up|5
4671056|NCT02718898|16071316|P5|Post Treatment Follow-up Period|Lost to Follow-up|1
4671057|NCT02718898|16071317|P4|Post Treatment Follow-up Period|Lost to Follow-up|0
4671058|NCT02718898|16071318|P3|Post Treatment Follow-up Period|Lost to Follow-up|0
4671059|NCT02718898|16071319|P2|Post Treatment Follow-up Period|Lost to Follow-up|0
4671060|NCT02718898|16071320|P1|Post Treatment Follow-up Period|Lost to Follow-up|0
4671061|NCT02718898|16071314|P7|Post Treatment Follow-up Period|Adverse Event|1
4671062|NCT02718898|16071315|P6|Post Treatment Follow-up Period|Adverse Event|1
4671063|NCT02718898|16071316|P5|Post Treatment Follow-up Period|Adverse Event|0
4671064|NCT02718898|16071317|P4|Post Treatment Follow-up Period|Adverse Event|0
4671065|NCT02718898|16071318|P3|Post Treatment Follow-up Period|Adverse Event|0
4671066|NCT02718898|16071319|P2|Post Treatment Follow-up Period|Adverse Event|0
4671067|NCT02718898|16071320|P1|Post Treatment Follow-up Period|Adverse Event|0
4671068|NCT02718898|16071314|P7|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4671069|NCT02718898|16071315|P6|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4671070|NCT02718898|16071316|P5|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4671071|NCT02718898|16071317|P4|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1
4671072|NCT02718898|16071318|P3|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4671073|NCT02718898|16071319|P2|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4671074|NCT02718898|16071320|P1|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0
4671075|NCT02718898|16071314|P7|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4671076|NCT02718898|16071315|P6|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4671077|NCT02718898|16071316|P5|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4671078|NCT02718898|16071317|P4|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1
4671079|NCT02718898|16071318|P3|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4671080|NCT02718898|16071319|P2|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4671081|NCT02718898|16071320|P1|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0
4671082|NCT02718898|16071314|P7|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4671083|NCT02718898|16071315|P6|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4671084|NCT02718898|16071316|P5|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4671085|NCT02718898|16071317|P4|Open Label Treatment Period (OLTP)|Lack of Efficacy|2
4671086|NCT02718898|16071318|P3|Open Label Treatment Period (OLTP)|Lack of Efficacy|1
4671087|NCT02718898|16071319|P2|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4671088|NCT02718898|16071320|P1|Open Label Treatment Period (OLTP)|Lack of Efficacy|0
4671089|NCT02718898|16071314|P7|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4671090|NCT02718898|16071315|P6|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4671091|NCT02718898|16071316|P5|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4671092|NCT02718898|16071317|P4|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3
4671093|NCT02718898|16071318|P3|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1
4671094|NCT02718898|16071319|P2|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4671095|NCT02718898|16071320|P1|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0
4671096|NCT02718898|16071314|P7|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4671097|NCT02718898|16071315|P6|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4671098|NCT02718898|16071316|P5|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4671099|NCT02718898|16071317|P4|Open Label Treatment Period (OLTP)|Lost to Follow-up|2
4671100|NCT02718898|16071318|P3|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4671101|NCT02718898|16071319|P2|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4671102|NCT02718898|16071320|P1|Open Label Treatment Period (OLTP)|Lost to Follow-up|0
4671103|NCT02718898|16071314|P7|Open Label Treatment Period (OLTP)|Adverse Event|0
4671104|NCT02718898|16071315|P6|Open Label Treatment Period (OLTP)|Adverse Event|0
4671105|NCT02718898|16071316|P5|Open Label Treatment Period (OLTP)|Adverse Event|0
4671106|NCT02718898|16071317|P4|Open Label Treatment Period (OLTP)|Adverse Event|1
4671107|NCT02718898|16071318|P3|Open Label Treatment Period (OLTP)|Adverse Event|1
4671108|NCT02718898|16071319|P2|Open Label Treatment Period (OLTP)|Adverse Event|0
4671109|NCT02718898|16071320|P1|Open Label Treatment Period (OLTP)|Adverse Event|0
4671110|NCT02718898|16071314|P7|Blinded Treatment Period|Lost to Follow-up|0
4671111|NCT02718898|16071315|P6|Blinded Treatment Period|Lost to Follow-up|0
4671112|NCT02718898|16071316|P5|Blinded Treatment Period|Lost to Follow-up|0
4671113|NCT02718898|16071317|P4|Blinded Treatment Period|Lost to Follow-up|0
4671114|NCT02718898|16071318|P3|Blinded Treatment Period|Lost to Follow-up|0
4671115|NCT02718898|16071319|P2|Blinded Treatment Period|Lost to Follow-up|0
4671116|NCT02718898|16071320|P1|Blinded Treatment Period|Lost to Follow-up|2
4671117|NCT02718898|16071314|P7|Blinded Treatment Period|Lack of Efficacy|0
4671118|NCT02718898|16071315|P6|Blinded Treatment Period|Lack of Efficacy|0
4671119|NCT02718898|16071316|P5|Blinded Treatment Period|Lack of Efficacy|0
4671120|NCT02718898|16071317|P4|Blinded Treatment Period|Lack of Efficacy|0
4671121|NCT02718898|16071318|P3|Blinded Treatment Period|Lack of Efficacy|0
4671122|NCT02718898|16071319|P2|Blinded Treatment Period|Lack of Efficacy|0
4671123|NCT02718898|16071320|P1|Blinded Treatment Period|Lack of Efficacy|1
4671124|NCT02718898|16071314|P7|Blinded Treatment Period|Physician Decision|0
4671125|NCT02718898|16071315|P6|Blinded Treatment Period|Physician Decision|0
4671126|NCT02718898|16071316|P5|Blinded Treatment Period|Physician Decision|0
4671127|NCT02718898|16071317|P4|Blinded Treatment Period|Physician Decision|0
4671128|NCT02718898|16071318|P3|Blinded Treatment Period|Physician Decision|0
4671129|NCT02718898|16071319|P2|Blinded Treatment Period|Physician Decision|0
4671130|NCT02718898|16071320|P1|Blinded Treatment Period|Physician Decision|1
4671131|NCT02718898|16071314|P7|Blinded Treatment Period|Adverse Event|0
4671132|NCT02718898|16071315|P6|Blinded Treatment Period|Adverse Event|0
4671133|NCT02718898|16071316|P5|Blinded Treatment Period|Adverse Event|0
4671134|NCT02718898|16071317|P4|Blinded Treatment Period|Adverse Event|0
4671135|NCT02718898|16071318|P3|Blinded Treatment Period|Adverse Event|0
4671136|NCT02718898|16071319|P2|Blinded Treatment Period|Adverse Event|1
4671137|NCT02718898|16071320|P1|Blinded Treatment Period|Adverse Event|5
4671138|NCT02718625|16071355|P2|Overall Study|Termination of Study by Sponsor|1
4671139|NCT02718625|16071356|P1|Overall Study|Termination of Study by Sponsor|0
4671140|NCT02718625|16071355|P2|Overall Study|Adverse Event|1
4671141|NCT02718625|16071356|P1|Overall Study|Adverse Event|0
4671142|NCT02718417|16071375|P3|Long-term Follow-up Phase|Other|0
4671143|NCT02718417|16071376|P2|Long-term Follow-up Phase|Other|2
4671144|NCT02718417|16071377|P1|Long-term Follow-up Phase|Other|0
4671145|NCT02718417|16071375|P3|Long-term Follow-up Phase|Withdrawal by Subject|9
4671146|NCT02718417|16071376|P2|Long-term Follow-up Phase|Withdrawal by Subject|9
4671147|NCT02718417|16071377|P1|Long-term Follow-up Phase|Withdrawal by Subject|6
4671148|NCT02718417|16071375|P3|Long-term Follow-up Phase|Study terminated by sponsor|112
4671149|NCT02718417|16071376|P2|Long-term Follow-up Phase|Study terminated by sponsor|80
4671150|NCT02718417|16071377|P1|Long-term Follow-up Phase|Study terminated by sponsor|105
4671151|NCT02718417|16071375|P3|Long-term Follow-up Phase|Lost to Follow-up|3
4671152|NCT02718417|16071376|P2|Long-term Follow-up Phase|Lost to Follow-up|4
4671153|NCT02718417|16071377|P1|Long-term Follow-up Phase|Lost to Follow-up|8
4671154|NCT02718417|16071375|P3|Long-term Follow-up Phase|Death leading to discontinuation|11
4671155|NCT02718417|16071376|P2|Long-term Follow-up Phase|Death leading to discontinuation|17
4671156|NCT02718417|16071377|P1|Long-term Follow-up Phase|Death leading to discontinuation|20
4671157|NCT02718417|16071375|P3|Follow-up Phase|Death leading to discontinuation|3
4671158|NCT02718417|16071376|P2|Follow-up Phase|Death leading to discontinuation|7
4671159|NCT02718417|16071377|P1|Follow-up Phase|Death leading to discontinuation|7
4671160|NCT02718417|16071375|P3|Follow-up Phase|Lost to Follow-up|0
4671161|NCT02718417|16071376|P2|Follow-up Phase|Lost to Follow-up|3
4671162|NCT02718417|16071377|P1|Follow-up Phase|Lost to Follow-up|2
4671163|NCT02718417|16071375|P3|Follow-up Phase|Study terminated by sponsor|6
4671164|NCT02718417|16071376|P2|Follow-up Phase|Study terminated by sponsor|138
4671165|NCT02718417|16071377|P1|Follow-up Phase|Study terminated by sponsor|100
4671166|NCT02718417|16071375|P3|Follow-up Phase|Withdrawal by Subject|5
4671167|NCT02718417|16071376|P2|Follow-up Phase|Withdrawal by Subject|17
4671168|NCT02718417|16071377|P1|Follow-up Phase|Withdrawal by Subject|19
4671169|NCT02718417|16071375|P3|Follow-up Phase|Other|4
4671170|NCT02718417|16071376|P2|Follow-up Phase|Other|6
4671171|NCT02718417|16071377|P1|Follow-up Phase|Other|4
4671172|NCT02718417|16071375|P3|Follow-up Phase|Adverse Event|1
4671173|NCT02718417|16071376|P2|Follow-up Phase|Adverse Event|1
4671174|NCT02718417|16071377|P1|Follow-up Phase|Adverse Event|3
4671175|NCT02718417|16071375|P3|Observation Phase (OP)|Other|7
4671176|NCT02718417|16071376|P2|Observation Phase (OP)|Other|0
4671177|NCT02718417|16071377|P1|Observation Phase (OP)|Other|0
4671178|NCT02718417|16071375|P3|Observation Phase (OP)|Global deterioration of health status|1
4671179|NCT02718417|16071376|P2|Observation Phase (OP)|Global deterioration of health status|0
4671180|NCT02718417|16071377|P1|Observation Phase (OP)|Global deterioration of health status|0
4671181|NCT02718417|16071375|P3|Observation Phase (OP)|Withdrawal by Subject|34
4671182|NCT02718417|16071376|P2|Observation Phase (OP)|Withdrawal by Subject|0
4671183|NCT02718417|16071377|P1|Observation Phase (OP)|Withdrawal by Subject|0
4671184|NCT02718417|16071375|P3|Observation Phase (OP)|Study terminated by sponsor|135
4671185|NCT02718417|16071376|P2|Observation Phase (OP)|Study terminated by sponsor|0
4671186|NCT02718417|16071377|P1|Observation Phase (OP)|Study terminated by sponsor|0
4671187|NCT02718417|16071375|P3|Observation Phase (OP)|Progressive disease|92
4671188|NCT02718417|16071376|P2|Observation Phase (OP)|Progressive disease|0
4671189|NCT02718417|16071377|P1|Observation Phase (OP)|Progressive disease|0
4671190|NCT02718417|16071375|P3|Observation Phase (OP)|Physician Decision|9
4671191|NCT02718417|16071376|P2|Observation Phase (OP)|Physician Decision|0
4671192|NCT02718417|16071377|P1|Observation Phase (OP)|Physician Decision|0
4671193|NCT02718417|16071375|P3|Observation Phase (OP)|Lost to Follow-up|1
4671194|NCT02718417|16071376|P2|Observation Phase (OP)|Lost to Follow-up|0
4671195|NCT02718417|16071377|P1|Observation Phase (OP)|Lost to Follow-up|0
4671196|NCT02718417|16071375|P3|Observation Phase (OP)|Death leading to discontinuation|2
4671197|NCT02718417|16071376|P2|Observation Phase (OP)|Death leading to discontinuation|0
4671198|NCT02718417|16071377|P1|Observation Phase (OP)|Death leading to discontinuation|0
4671199|NCT02718417|16071375|P3|Observation Phase (OP)|Adverse Event|1
4671200|NCT02718417|16071376|P2|Observation Phase (OP)|Adverse Event|0
4671201|NCT02718417|16071377|P1|Observation Phase (OP)|Adverse Event|0
4671202|NCT02718417|16071375|P3|Maintenance Phase (MP)|Study terminated by sponsor|0
4671203|NCT02718417|16071376|P2|Maintenance Phase (MP)|Study terminated by sponsor|140
4671204|NCT02718417|16071377|P1|Maintenance Phase (MP)|Study terminated by sponsor|114
4671205|NCT02718417|16071375|P3|Maintenance Phase (MP)|Withdrawal by Subject|0
4671206|NCT02718417|16071376|P2|Maintenance Phase (MP)|Withdrawal by Subject|20
4671207|NCT02718417|16071377|P1|Maintenance Phase (MP)|Withdrawal by Subject|17
4671208|NCT02718417|16071375|P3|Maintenance Phase (MP)|Other|0
4671209|NCT02718417|16071376|P2|Maintenance Phase (MP)|Other|1
4671210|NCT02718417|16071377|P1|Maintenance Phase (MP)|Other|2
4671211|NCT02718417|16071375|P3|Maintenance Phase (MP)|Progressive disease|0
4671212|NCT02718417|16071376|P2|Maintenance Phase (MP)|Progressive disease|88
4671213|NCT02718417|16071377|P1|Maintenance Phase (MP)|Progressive disease|100
4671214|NCT02718417|16071375|P3|Maintenance Phase (MP)|Physician's decision|0
4671215|NCT02718417|16071376|P2|Maintenance Phase (MP)|Physician's decision|7
4671216|NCT02718417|16071377|P1|Maintenance Phase (MP)|Physician's decision|6
4671217|NCT02718417|16071375|P3|Maintenance Phase (MP)|No longer met eligibility criteria|0
4671218|NCT02718417|16071376|P2|Maintenance Phase (MP)|No longer met eligibility criteria|1
4671219|NCT02718417|16071377|P1|Maintenance Phase (MP)|No longer met eligibility criteria|0
4671220|NCT02718417|16071375|P3|Maintenance Phase (MP)|Global deterioration of health status|0
4671221|NCT02718417|16071376|P2|Maintenance Phase (MP)|Global deterioration of health status|3
4671222|NCT02718417|16071377|P1|Maintenance Phase (MP)|Global deterioration of health status|5
4671223|NCT02718417|16071375|P3|Maintenance Phase (MP)|Death leading to discontinuation|0
4671224|NCT02718417|16071376|P2|Maintenance Phase (MP)|Death leading to discontinuation|1
4671225|NCT02718417|16071377|P1|Maintenance Phase (MP)|Death leading to discontinuation|1
4671226|NCT02718417|16071375|P3|Maintenance Phase (MP)|Adverse Event|0
4671227|NCT02718417|16071376|P2|Maintenance Phase (MP)|Adverse Event|26
4671228|NCT02718417|16071377|P1|Maintenance Phase (MP)|Adverse Event|21
4671229|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Other|1
4671230|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Other|0
4671231|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Other|2
4671232|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Withdrawal by Subject|15
4671233|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Withdrawal by Subject|8
4671234|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Withdrawal by Subject|13
4671235|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Progressive disease|10
4671236|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Progressive disease|7
4671237|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Progressive disease|11
4671238|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Physician's decision|4
4671239|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Physician's decision|0
4671240|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Physician's decision|5
4671241|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|No longer met eligibility criteria|1
4671242|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|No longer met eligibility criteria|2
4671243|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|No longer met eligibility criteria|4
4671244|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Global deterioration of health status|1
4671245|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Global deterioration of health status|2
4671246|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Global deterioration of health status|3
4671247|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Death leading to discontinuation|1
4671248|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Death leading to discontinuation|4
4671249|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Death leading to discontinuation|5
4671250|NCT02718417|16071375|P3|Chemotherapy Phase (CP)|Adverse Event|13
4671251|NCT02718417|16071376|P2|Chemotherapy Phase (CP)|Adverse Event|14
4671252|NCT02718417|16071377|P1|Chemotherapy Phase (CP)|Adverse Event|9
4671253|NCT02718326|16071483|P3|Overall Study|Pregnancy|0
4671254|NCT02718326|16071484|P2|Overall Study|Pregnancy|0
4671255|NCT02718326|16071485|P1|Overall Study|Pregnancy|1
4671256|NCT02718326|16071483|P3|Overall Study|Protocol Deviation|0
4671257|NCT02718326|16071484|P2|Overall Study|Protocol Deviation|0
4671258|NCT02718326|16071485|P1|Overall Study|Protocol Deviation|1
4671259|NCT02718326|16071483|P3|Overall Study|Lost to Follow-up|14
4671260|NCT02718326|16071484|P2|Overall Study|Lost to Follow-up|5
4671261|NCT02718326|16071485|P1|Overall Study|Lost to Follow-up|18
4671262|NCT02718326|16071483|P3|Overall Study|Withdrawal by Subject|6
4671263|NCT02718326|16071484|P2|Overall Study|Withdrawal by Subject|9
4671264|NCT02718326|16071485|P1|Overall Study|Withdrawal by Subject|4
4671265|NCT02718326|16071483|P3|Overall Study|Death|2
4671266|NCT02718326|16071484|P2|Overall Study|Death|1
4671267|NCT02718326|16071485|P1|Overall Study|Death|8
4671268|NCT02718326|16071483|P3|Overall Study|Adverse Event|0
4671269|NCT02718326|16071484|P2|Overall Study|Adverse Event|9
4671270|NCT02718326|16071485|P1|Overall Study|Adverse Event|4
4671271|NCT02717754|16071606|P6|Overall Study|Incorrect Infusion Duration|20
4671272|NCT02717754|16071607|P5|Overall Study|Incorrect Infusion Duration|20
4671273|NCT02717754|16071608|P4|Overall Study|Incorrect Infusion Duration|10
4671274|NCT02717754|16071609|P3|Overall Study|Incorrect Infusion Duration|0
4671275|NCT02717754|16071610|P2|Overall Study|Incorrect Infusion Duration|0
4671276|NCT02717754|16071611|P1|Overall Study|Incorrect Infusion Duration|0
4671277|NCT02717494|16071642|P3|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4
4671278|NCT02717494|16071643|P2|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
4671279|NCT02717494|16071644|P1|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0
4671280|NCT02717494|16071642|P3|First Intervention (Step 1)|Death|1
4671281|NCT02717494|16071643|P2|First Intervention (Step 1)|Death|0
4671282|NCT02717494|16071644|P1|First Intervention (Step 1)|Death|0
4671283|NCT02717494|16071642|P3|First Intervention (Step 1)|Withdrawal by Subject|1
4671284|NCT02717494|16071643|P2|First Intervention (Step 1)|Withdrawal by Subject|0
4671285|NCT02717494|16071644|P1|First Intervention (Step 1)|Withdrawal by Subject|2
4671286|NCT02717494|16071642|P3|First Intervention (Step 1)|Lost to Follow-up|3
4671287|NCT02717494|16071643|P2|First Intervention (Step 1)|Lost to Follow-up|7
4671288|NCT02717494|16071644|P1|First Intervention (Step 1)|Lost to Follow-up|4
4671289|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Patient missed required visits|1
4671290|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Patient missed required visits|1
4671291|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Patient missed required visits|0
4671292|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Patient missed required visits|0
4671293|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Patient missed required visits|0
4671294|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4671295|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4671296|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Psychosocial issues|1
4671297|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4671298|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Psychosocial issues|0
4671299|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1
4671300|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4671301|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4671302|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4671303|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0
4671304|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Change of residence|1
4671305|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Change of residence|1
4671306|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Change of residence|0
4671307|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Change of residence|0
4671308|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Change of residence|0
4671309|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Family circumstances|1
4671310|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Family circumstances|0
4671311|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Family circumstances|0
4671312|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Family circumstances|0
4671313|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Family circumstances|0
4671314|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Investigator decision|1
4671315|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Investigator decision|1
4671316|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Investigator decision|0
4671317|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Investigator decision|0
4671318|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Investigator decision|0
4671319|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Patient decision|2
4671320|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Patient decision|2
4671321|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Patient decision|0
4671322|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Patient decision|0
4671323|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Patient decision|0
4671324|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4671325|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4671326|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Enrolled but not treated|1
4671327|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4671328|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Enrolled but not treated|0
4671329|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Lost to Follow-up|2
4671330|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Lost to Follow-up|3
4671331|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
4671332|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
4671333|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Lost to Follow-up|0
4671334|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8
4671335|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13
4671336|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14
4671337|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
4671338|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0
4671339|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Protocol Violation|1
4671340|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Protocol Violation|0
4671341|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Protocol Violation|1
4671342|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Protocol Violation|0
4671343|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Protocol Violation|0
4671344|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2
4671345|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3
4671346|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4
4671347|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
4671348|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0
4671349|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Lack of Efficacy|2
4671350|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Lack of Efficacy|9
4671351|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Lack of Efficacy|6
4671352|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
4671353|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Lack of Efficacy|0
4671354|NCT02717195|16071706|P5|Double-blind Treatment (DBT) Period|Adverse Event|8
4671355|NCT02717195|16071707|P4|Double-blind Treatment (DBT) Period|Adverse Event|11
4671356|NCT02717195|16071708|P3|Double-blind Treatment (DBT) Period|Adverse Event|10
4671357|NCT02717195|16071709|P2|Double-blind Treatment (DBT) Period|Adverse Event|0
4671358|NCT02717195|16071710|P1|Double-blind Treatment (DBT) Period|Adverse Event|0
4671359|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4671360|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4671361|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4671362|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Noncompliance with protocol|0
4671363|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Noncompliance with protocol|1
4671364|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4671365|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4671366|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4671367|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Patient fraud with payment|0
4671368|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Patient fraud with payment|1
4671369|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Sponsor requested|0
4671370|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Sponsor requested|0
4671371|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Sponsor requested|0
4671372|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Sponsor requested|1
4671373|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Sponsor requested|0
4671374|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Duplicate subject|0
4671375|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Duplicate subject|0
4671376|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Duplicate subject|0
4671377|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Duplicate subject|0
4671378|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Duplicate subject|1
4671379|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4671380|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4671381|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4671382|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1
4671383|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0
4671384|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4671385|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4671386|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4671538|NCT02714218|16072357|P1|Overall Study|Complete Response|1
4671387|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0
4671388|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1
4671389|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4671390|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4671391|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4671392|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1
4671393|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0
4671394|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Investigator decision|0
4671395|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Investigator decision|0
4671396|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Investigator decision|0
4671397|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Investigator decision|1
4671398|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Investigator decision|2
4671399|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4671400|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4671401|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4671402|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1
4671403|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0
4671404|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Change of place of residence|0
4671405|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Change of place of residence|0
4671406|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Change of place of residence|0
4671407|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Change of place of residence|0
4671408|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Change of place of residence|1
4671409|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4671410|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4671411|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4671412|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Low level of drug in the blood|0
4671413|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Low level of drug in the blood|1
4671414|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Patient decision|0
4671415|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Patient decision|0
4671416|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Patient decision|0
4671417|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Patient decision|2
4671418|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Patient decision|5
4671419|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Technical error|0
4671420|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Technical error|0
4671421|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Technical error|0
4671422|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Technical error|0
4671423|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Technical error|1
4671424|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4671425|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4671426|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4671427|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Lack of results for blood levels|0
4671428|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Lack of results for blood levels|1
4671429|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Enrolled but not treated|0
4671430|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Enrolled but not treated|0
4671431|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Enrolled but not treated|0
4671432|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Enrolled but not treated|3
4671433|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Enrolled but not treated|3
4671434|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
4671435|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
4671436|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0
4671437|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75
4671438|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189
4671439|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Lost to Follow-up|0
4671440|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Lost to Follow-up|0
4671441|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Lost to Follow-up|0
4671442|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Lost to Follow-up|4
4671443|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Lost to Follow-up|9
4671444|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4671445|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4671446|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Withdrawal by Subject|0
4671447|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Withdrawal by Subject|12
4671448|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Withdrawal by Subject|43
4671449|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Protocol Violation|0
4671450|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Protocol Violation|0
4671451|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Protocol Violation|0
4671452|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Protocol Violation|1
4671453|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Protocol Violation|3
4671454|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
4671455|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
4671456|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Non-compliance with IMP|0
4671457|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Non-compliance with IMP|1
4671458|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Non-compliance with IMP|7
4671459|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4671460|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4671461|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Lack of Efficacy|0
4671462|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Lack of Efficacy|1
4671463|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Lack of Efficacy|2
4671464|NCT02717195|16071706|P5|Prospective Confirmation (PC) Period|Adverse Event|0
4671465|NCT02717195|16071707|P4|Prospective Confirmation (PC) Period|Adverse Event|0
4671466|NCT02717195|16071708|P3|Prospective Confirmation (PC) Period|Adverse Event|0
4671467|NCT02717195|16071709|P2|Prospective Confirmation (PC) Period|Adverse Event|7
4671468|NCT02717195|16071710|P1|Prospective Confirmation (PC) Period|Adverse Event|19
4671469|NCT02717130|16071741|P1|Overall Study|Study Closure|4
4671470|NCT02717130|16071741|P1|Overall Study|Physician Decision|1
4671471|NCT02717130|16071741|P1|Overall Study|Adverse Event|1
4671472|NCT02717130|16071741|P1|Overall Study|Withdrawal by Subject|1
4671473|NCT02716987|16071751|P6|Overall Study|Withdrawal by Subject|1
4671474|NCT02716987|16071752|P5|Overall Study|Withdrawal by Subject|1
4671475|NCT02716987|16071753|P4|Overall Study|Withdrawal by Subject|0
4671476|NCT02716987|16071754|P3|Overall Study|Withdrawal by Subject|0
4671477|NCT02716987|16071755|P2|Overall Study|Withdrawal by Subject|0
4671478|NCT02716987|16071756|P1|Overall Study|Withdrawal by Subject|0
4671479|NCT02716987|16071751|P6|Overall Study|Ligand synthesis failure|0
4671480|NCT02716987|16071752|P5|Overall Study|Ligand synthesis failure|0
4671481|NCT02716987|16071753|P4|Overall Study|Ligand synthesis failure|0
4671482|NCT02716987|16071754|P3|Overall Study|Ligand synthesis failure|1
4671483|NCT02716987|16071755|P2|Overall Study|Ligand synthesis failure|0
4671484|NCT02716987|16071756|P1|Overall Study|Ligand synthesis failure|0
4671485|NCT02716896|16071822|P2|Overall Study|Physician Decision|1
4671486|NCT02716896|16071823|P1|Overall Study|Physician Decision|0
4671487|NCT02716805|16071874|P4|Overall Study|Progressive disease|0
4671488|NCT02716805|16071875|P3|Overall Study|Progressive disease|0
4671489|NCT02716805|16071876|P2|Overall Study|Progressive disease|0
4671490|NCT02716805|16071877|P1|Overall Study|Progressive disease|2
4671491|NCT02716779|16071885|P3|Combination Therapy|Adverse Event|1
4671492|NCT02716779|16071886|P2|Combination Therapy|Adverse Event|2
4671493|NCT02716779|16071887|P1|Combination Therapy|Adverse Event|0
4671494|NCT02716779|16071885|P3|Monotherapy|Adverse Event|1
4671495|NCT02716779|16071886|P2|Monotherapy|Adverse Event|1
4671496|NCT02716779|16071887|P1|Monotherapy|Adverse Event|0
4671497|NCT02716584|16071987|P2|Overall Study|Lost to Follow-up|5
4671498|NCT02716584|16071988|P1|Overall Study|Lost to Follow-up|8
4671499|NCT02716298|16072044|P2|First Intervention (1 Month)|Lens discomfort|1
4671500|NCT02716298|16072045|P1|First Intervention (1 Month)|Lens discomfort|1
4671501|NCT02716194|16072063|P3|Period 1 - ADVATE|Withdrawal by Subject|0
4671502|NCT02716194|16072064|P2|Period 1 - ADVATE|Withdrawal by Subject|1
4671503|NCT02716194|16072065|P1|Period 1 - ADVATE|Withdrawal by Subject|1
4671504|NCT02715804|16072145|P2|Overall Study|Other than specified|3
4671505|NCT02715804|16072146|P1|Overall Study|Other than specified|2
4671506|NCT02715804|16072145|P2|Overall Study|Withdrawal by Subject|4
4671507|NCT02715804|16072146|P1|Overall Study|Withdrawal by Subject|5
4671508|NCT02715804|16072145|P2|Overall Study|Death|106
4671509|NCT02715804|16072146|P1|Overall Study|Death|222
4671510|NCT02715765|16072169|P3|Overall Study|Study Termination|0
4671511|NCT02715765|16072170|P2|Overall Study|Study Termination|0
4671512|NCT02715765|16072171|P1|Overall Study|Study Termination|3
4671513|NCT02715726|16072184|P2|Overall Study|Randomized but not treated|2
4671514|NCT02715726|16072185|P1|Overall Study|Randomized but not treated|1
4671515|NCT02715726|16072184|P2|Overall Study|Other than specified above|15
4671516|NCT02715726|16072185|P1|Overall Study|Other than specified above|11
4671517|NCT02715726|16072184|P2|Overall Study|Participant moved|3
4671518|NCT02715726|16072185|P1|Overall Study|Participant moved|1
4671519|NCT02715726|16072184|P2|Overall Study|Death|1
4671520|NCT02715726|16072185|P1|Overall Study|Death|2
4671521|NCT02715726|16072184|P2|Overall Study|Protocol Violation|0
4671522|NCT02715726|16072185|P1|Overall Study|Protocol Violation|1
4671523|NCT02715726|16072184|P2|Overall Study|Adverse Event|6
4671524|NCT02715726|16072185|P1|Overall Study|Adverse Event|2
4671525|NCT02714868|16072265|P2|Overall Study|PI withdraw did not meet inclusion|0
4671526|NCT02714868|16072266|P1|Overall Study|PI withdraw did not meet inclusion|1
4671527|NCT02714868|16072265|P2|Overall Study|PI withdrawal safety risk self/others|0
4671528|NCT02714868|16072266|P1|Overall Study|PI withdrawal safety risk self/others|1
4671529|NCT02714868|16072265|P2|Overall Study|Withdrawal by Subject|0
4671530|NCT02714868|16072266|P1|Overall Study|Withdrawal by Subject|3
4671531|NCT02714426|16072293|P2|Overall Study|Withdrawal by Subject|2
4671532|NCT02714426|16072294|P1|Overall Study|Withdrawal by Subject|2
4671533|NCT02714218|16072355|P3|Overall Study|Stop treatment, but will do follow up|0
4671534|NCT02714218|16072356|P2|Overall Study|Stop treatment, but will do follow up|1
4671535|NCT02714218|16072357|P1|Overall Study|Stop treatment, but will do follow up|0
4671536|NCT02714218|16072355|P3|Overall Study|Complete Response|0
4671537|NCT02714218|16072356|P2|Overall Study|Complete Response|0
4671539|NCT02714218|16072355|P3|Overall Study|Dose Delayed > 6 weeks|0
4671540|NCT02714218|16072356|P2|Overall Study|Dose Delayed > 6 weeks|0
4671541|NCT02714218|16072357|P1|Overall Study|Dose Delayed > 6 weeks|1
4671542|NCT02714218|16072355|P3|Overall Study|Completed|0
4671543|NCT02714218|16072356|P2|Overall Study|Completed|0
4671544|NCT02714218|16072357|P1|Overall Study|Completed|2
4671545|NCT02714218|16072355|P3|Overall Study|Not Reported|0
4671546|NCT02714218|16072356|P2|Overall Study|Not Reported|5
4671547|NCT02714218|16072357|P1|Overall Study|Not Reported|9
4671548|NCT02714218|16072355|P3|Overall Study|Medical Decision|0
4671549|NCT02714218|16072356|P2|Overall Study|Medical Decision|1
4671550|NCT02714218|16072357|P1|Overall Study|Medical Decision|0
4671551|NCT02714218|16072355|P3|Overall Study|Maximum Clinical Benefit|0
4671552|NCT02714218|16072356|P2|Overall Study|Maximum Clinical Benefit|2
4671553|NCT02714218|16072357|P1|Overall Study|Maximum Clinical Benefit|2
4671554|NCT02714218|16072355|P3|Overall Study|Participant Withdrew Consent|0
4671555|NCT02714218|16072356|P2|Overall Study|Participant Withdrew Consent|3
4671556|NCT02714218|16072357|P1|Overall Study|Participant Withdrew Consent|2
4671557|NCT02714218|16072355|P3|Overall Study|Request to Discontinue Treatment|1
4671558|NCT02714218|16072356|P2|Overall Study|Request to Discontinue Treatment|5
4671559|NCT02714218|16072357|P1|Overall Study|Request to Discontinue Treatment|1
4671560|NCT02714218|16072355|P3|Overall Study|Study Drug Toxicity|4
4671561|NCT02714218|16072356|P2|Overall Study|Study Drug Toxicity|69
4671562|NCT02714218|16072357|P1|Overall Study|Study Drug Toxicity|46
4671563|NCT02714218|16072355|P3|Overall Study|Adverse Event Unrelated to Study Drug|0
4671564|NCT02714218|16072356|P2|Overall Study|Adverse Event Unrelated to Study Drug|6
4671565|NCT02714218|16072357|P1|Overall Study|Adverse Event Unrelated to Study Drug|10
4671566|NCT02714218|16072355|P3|Overall Study|Disease Progression|14
4671567|NCT02714218|16072356|P2|Overall Study|Disease Progression|51
4671568|NCT02714218|16072357|P1|Overall Study|Disease Progression|56
4671569|NCT02714062|16072407|P3|Overall Study|Protocol Violation|0
4671570|NCT02714062|16072408|P2|Overall Study|Protocol Violation|1
4671571|NCT02714062|16072409|P1|Overall Study|Protocol Violation|0
4671572|NCT02714062|16072407|P3|Overall Study|Withdrawal by Subject|1
4671573|NCT02714062|16072408|P2|Overall Study|Withdrawal by Subject|0
4671574|NCT02714062|16072409|P1|Overall Study|Withdrawal by Subject|1
4671575|NCT02714062|16072407|P3|Overall Study|Adverse Event|2
4671576|NCT02714062|16072408|P2|Overall Study|Adverse Event|0
4671577|NCT02714062|16072409|P1|Overall Study|Adverse Event|0
4671578|NCT02713867|16072455|P2|Treatment Period|Disease Progression|78
4671579|NCT02713867|16072456|P1|Treatment Period|Disease Progression|79
4671580|NCT02713867|16072455|P2|Treatment Period|Study Drug Toxicity|20
4671581|NCT02713867|16072456|P1|Treatment Period|Study Drug Toxicity|16
4671582|NCT02713867|16072455|P2|Treatment Period|Death|3
4671583|NCT02713867|16072456|P1|Treatment Period|Death|7
4671584|NCT02713867|16072455|P2|Treatment Period|AE unrelated to Study Drug|9
4671585|NCT02713867|16072456|P1|Treatment Period|AE unrelated to Study Drug|8
4671586|NCT02713867|16072455|P2|Treatment Period|Requested to Discontinue|7
4671587|NCT02713867|16072456|P1|Treatment Period|Requested to Discontinue|8
4671588|NCT02713867|16072455|P2|Treatment Period|Withdrew consent|6
4671589|NCT02713867|16072456|P1|Treatment Period|Withdrew consent|1
4671590|NCT02713867|16072455|P2|Treatment Period|Maximum Clinical Benefit|4
4671591|NCT02713867|16072456|P1|Treatment Period|Maximum Clinical Benefit|3
4671592|NCT02713867|16072455|P2|Treatment Period|Poor/Non Compliance|0
4671593|NCT02713867|16072456|P1|Treatment Period|Poor/Non Compliance|1
4671594|NCT02713867|16072455|P2|Treatment Period|No longer meets study criteria|1
4671595|NCT02713867|16072456|P1|Treatment Period|No longer meets study criteria|2
4671596|NCT02713867|16072455|P2|Treatment Period|Administrative reason by sponsor|4
4671597|NCT02713867|16072456|P1|Treatment Period|Administrative reason by sponsor|9
4671598|NCT02713867|16072455|P2|Treatment Period|Other Reasons|18
4671599|NCT02713867|16072456|P1|Treatment Period|Other Reasons|12
4671600|NCT02713867|16072455|P2|Treatment Period|Not Reported|0
4671601|NCT02713867|16072456|P1|Treatment Period|Not Reported|1
4671602|NCT02713867|16072455|P2|Randomization|Participant Withdrew consent|2
4671603|NCT02713867|16072456|P1|Randomization|Participant Withdrew consent|0
4671604|NCT02713867|16072455|P2|Randomization|Other Reason|1
4671605|NCT02713867|16072456|P1|Randomization|Other Reason|2
4671606|NCT02713828|16072494|P2|Overall Study|study terminated but patient allowed to|0
4671607|NCT02713828|16072495|P1|Overall Study|study terminated but patient allowed to|2
4671608|NCT02713828|16072494|P2|Overall Study|Withdrawal by Subject|0
4671609|NCT02713828|16072495|P1|Overall Study|Withdrawal by Subject|1
4671610|NCT02713828|16072494|P2|Overall Study|Death|0
4671611|NCT02713828|16072495|P1|Overall Study|Death|2
4671612|NCT02713789|16072507|P3|Overall Study|Lost to Follow-up|1
4671613|NCT02713789|16072508|P2|Overall Study|Lost to Follow-up|1
4671614|NCT02713789|16072509|P1|Overall Study|Lost to Follow-up|0
4671615|NCT02713594|16072572|P2|Overall Study|Lost to Follow-up|374
4671616|NCT02713594|16072573|P1|Overall Study|Lost to Follow-up|358
4671617|NCT02713594|16072572|P2|Overall Study|Withdrawal by Subject|22
4671618|NCT02713594|16072573|P1|Overall Study|Withdrawal by Subject|32
4671619|NCT02713542|16072585|P2|Overall Study|Withdrawal by Subject|1
4671620|NCT02713542|16072586|P1|Overall Study|Withdrawal by Subject|4
4671621|NCT02713542|16072585|P2|Overall Study|Use of prohibited medication|5
4671622|NCT02713542|16072586|P1|Overall Study|Use of prohibited medication|14
4671623|NCT02713529|16072599|P7|Overall Study|Death|3
4671624|NCT02713529|16072600|P6|Overall Study|Death|13
4671625|NCT02713529|16072601|P5|Overall Study|Death|3
4671626|NCT02713529|16072602|P4|Overall Study|Death|27
4671627|NCT02713529|16072603|P3|Overall Study|Death|26
4671628|NCT02713529|16072604|P2|Overall Study|Death|3
4671629|NCT02713529|16072605|P1|Overall Study|Death|3
4671630|NCT02713529|16072599|P7|Overall Study|Lost to Follow-up|0
4671631|NCT02713529|16072600|P6|Overall Study|Lost to Follow-up|0
4671632|NCT02713529|16072601|P5|Overall Study|Lost to Follow-up|0
4671633|NCT02713529|16072602|P4|Overall Study|Lost to Follow-up|0
4671634|NCT02713529|16072603|P3|Overall Study|Lost to Follow-up|1
4671635|NCT02713529|16072604|P2|Overall Study|Lost to Follow-up|0
4671636|NCT02713529|16072605|P1|Overall Study|Lost to Follow-up|1
4671637|NCT02713529|16072599|P7|Overall Study|Withdrawal by Subject|1
4671638|NCT02713529|16072600|P6|Overall Study|Withdrawal by Subject|1
4671639|NCT02713529|16072601|P5|Overall Study|Withdrawal by Subject|0
4671640|NCT02713529|16072602|P4|Overall Study|Withdrawal by Subject|2
4671641|NCT02713529|16072603|P3|Overall Study|Withdrawal by Subject|4
4671642|NCT02713529|16072604|P2|Overall Study|Withdrawal by Subject|1
4671643|NCT02713529|16072605|P1|Overall Study|Withdrawal by Subject|3
4671644|NCT02713243|16072698|P2|Overall Study|Protocol deviation|1
4671645|NCT02713243|16072699|P1|Overall Study|Protocol deviation|0
4671646|NCT02713243|16072698|P2|Overall Study|Administrative problems|1
4671647|NCT02713243|16072699|P1|Overall Study|Administrative problems|0
4671648|NCT02713243|16072698|P2|Overall Study|Abnormal laboratory value(s)#|0
4671649|NCT02713243|16072699|P1|Overall Study|Abnormal laboratory value(s)#|1
4671650|NCT02713204|16072717|P8|From Week 12 up to Week 36|Participant Re-located|0
4671651|NCT02713204|16072718|P7|From Week 12 up to Week 36|Participant Re-located|0
4671652|NCT02713204|16072719|P6|From Week 12 up to Week 36|Participant Re-located|0
4671653|NCT02713204|16072720|P5|From Week 12 up to Week 36|Participant Re-located|1
4671654|NCT02713204|16072721|P4|From Week 12 up to Week 36|Participant Re-located|0
4671655|NCT02713204|16072722|P3|From Week 12 up to Week 36|Participant Re-located|0
4671656|NCT02713204|16072723|P2|From Week 12 up to Week 36|Participant Re-located|0
4671657|NCT02713204|16072724|P1|From Week 12 up to Week 36|Participant Re-located|0
4671658|NCT02713204|16072717|P8|From Week 12 up to Week 36|Lost to Follow-up|0
4671659|NCT02713204|16072718|P7|From Week 12 up to Week 36|Lost to Follow-up|0
4671660|NCT02713204|16072719|P6|From Week 12 up to Week 36|Lost to Follow-up|0
4671661|NCT02713204|16072720|P5|From Week 12 up to Week 36|Lost to Follow-up|0
4671662|NCT02713204|16072721|P4|From Week 12 up to Week 36|Lost to Follow-up|2
4671663|NCT02713204|16072722|P3|From Week 12 up to Week 36|Lost to Follow-up|0
4671664|NCT02713204|16072723|P2|From Week 12 up to Week 36|Lost to Follow-up|0
4671665|NCT02713204|16072724|P1|From Week 12 up to Week 36|Lost to Follow-up|0
4671666|NCT02713204|16072717|P8|From Week 12 up to Week 36|Death|3
4671667|NCT02713204|16072718|P7|From Week 12 up to Week 36|Death|0
4671668|NCT02713204|16072719|P6|From Week 12 up to Week 36|Death|1
4671669|NCT02713204|16072720|P5|From Week 12 up to Week 36|Death|0
4671670|NCT02713204|16072721|P4|From Week 12 up to Week 36|Death|1
4671671|NCT02713204|16072722|P3|From Week 12 up to Week 36|Death|0
4671672|NCT02713204|16072723|P2|From Week 12 up to Week 36|Death|0
4671673|NCT02713204|16072724|P1|From Week 12 up to Week 36|Death|0
4671674|NCT02713204|16072717|P8|From Week 12 up to Week 36|Adverse Event|1
4671675|NCT02713204|16072718|P7|From Week 12 up to Week 36|Adverse Event|2
4671676|NCT02713204|16072719|P6|From Week 12 up to Week 36|Adverse Event|0
4671677|NCT02713204|16072720|P5|From Week 12 up to Week 36|Adverse Event|1
4671678|NCT02713204|16072721|P4|From Week 12 up to Week 36|Adverse Event|1
4671679|NCT02713204|16072722|P3|From Week 12 up to Week 36|Adverse Event|0
4671680|NCT02713204|16072723|P2|From Week 12 up to Week 36|Adverse Event|0
4671681|NCT02713204|16072724|P1|From Week 12 up to Week 36|Adverse Event|1
4671682|NCT02713204|16072717|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671683|NCT02713204|16072718|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671684|NCT02713204|16072719|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671685|NCT02713204|16072720|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671686|NCT02713204|16072721|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671687|NCT02713204|16072722|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671688|NCT02713204|16072723|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
4671689|NCT02713204|16072724|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671690|NCT02713204|16072717|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671691|NCT02713204|16072718|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671692|NCT02713204|16072719|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671693|NCT02713204|16072720|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671694|NCT02713204|16072721|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671695|NCT02713204|16072722|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
4671696|NCT02713204|16072723|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671697|NCT02713204|16072724|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671698|NCT02713204|16072717|P8|Baseline (Day 1) up to Week 12|Adverse Event|0
4671699|NCT02713204|16072718|P7|Baseline (Day 1) up to Week 12|Adverse Event|0
4671700|NCT02713204|16072719|P6|Baseline (Day 1) up to Week 12|Adverse Event|0
4671701|NCT02713204|16072720|P5|Baseline (Day 1) up to Week 12|Adverse Event|0
4671702|NCT02713204|16072721|P4|Baseline (Day 1) up to Week 12|Adverse Event|0
4671703|NCT02713204|16072722|P3|Baseline (Day 1) up to Week 12|Adverse Event|1
4671704|NCT02713204|16072723|P2|Baseline (Day 1) up to Week 12|Adverse Event|0
4671705|NCT02713204|16072724|P1|Baseline (Day 1) up to Week 12|Adverse Event|1
4671706|NCT02712996|16072783|P2|Second Intervention (Study Days 43-84)|Adverse Event|1
4671707|NCT02712996|16072784|P1|Second Intervention (Study Days 43-84)|Adverse Event|0
4671708|NCT02712983|16072843|P9|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4671709|NCT02712983|16072844|P8|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
4671710|NCT02712983|16072845|P7|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
4671711|NCT02712983|16072846|P6|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1
4671712|NCT02712983|16072847|P5|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2
4671713|NCT02712983|16072848|P4|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4671714|NCT02712983|16072849|P3|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4671715|NCT02712983|16072850|P2|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4671716|NCT02712983|16072851|P1|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0
4671717|NCT02712983|16072843|P9|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671718|NCT02712983|16072844|P8|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671719|NCT02712983|16072845|P7|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671720|NCT02712983|16072846|P6|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671721|NCT02712983|16072847|P5|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671722|NCT02712983|16072848|P4|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1
4671723|NCT02712983|16072849|P3|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671724|NCT02712983|16072850|P2|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671725|NCT02712983|16072851|P1|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0
4671726|NCT02712983|16072843|P9|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4671727|NCT02712983|16072844|P8|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
4671728|NCT02712983|16072845|P7|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
4671729|NCT02712983|16072846|P6|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4671730|NCT02712983|16072847|P5|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4671731|NCT02712983|16072848|P4|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4671732|NCT02712983|16072849|P3|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4671733|NCT02712983|16072850|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1
4671734|NCT02712983|16072851|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4671735|NCT02712983|16072843|P9|Treatment Phase|Subject Decision|0
4671736|NCT02712983|16072844|P8|Treatment Phase|Subject Decision|2
4671737|NCT02712983|16072845|P7|Treatment Phase|Subject Decision|1
4671738|NCT02712983|16072846|P6|Treatment Phase|Subject Decision|0
4671739|NCT02712983|16072847|P5|Treatment Phase|Subject Decision|1
4671740|NCT02712983|16072848|P4|Treatment Phase|Subject Decision|2
4671741|NCT02712983|16072849|P3|Treatment Phase|Subject Decision|0
4671742|NCT02712983|16072850|P2|Treatment Phase|Subject Decision|0
4671743|NCT02712983|16072851|P1|Treatment Phase|Subject Decision|2
4671744|NCT02712983|16072843|P9|Treatment Phase|Physician Decision|1
4671745|NCT02712983|16072844|P8|Treatment Phase|Physician Decision|1
4671746|NCT02712983|16072845|P7|Treatment Phase|Physician Decision|0
4671747|NCT02712983|16072846|P6|Treatment Phase|Physician Decision|0
4671748|NCT02712983|16072847|P5|Treatment Phase|Physician Decision|0
4671749|NCT02712983|16072848|P4|Treatment Phase|Physician Decision|0
4671750|NCT02712983|16072849|P3|Treatment Phase|Physician Decision|0
4671751|NCT02712983|16072850|P2|Treatment Phase|Physician Decision|0
4671752|NCT02712983|16072851|P1|Treatment Phase|Physician Decision|0
4671753|NCT02712983|16072843|P9|Treatment Phase|Technical Problems|0
4671754|NCT02712983|16072844|P8|Treatment Phase|Technical Problems|0
4671755|NCT02712983|16072845|P7|Treatment Phase|Technical Problems|1
4671756|NCT02712983|16072846|P6|Treatment Phase|Technical Problems|0
4671757|NCT02712983|16072847|P5|Treatment Phase|Technical Problems|0
4671758|NCT02712983|16072848|P4|Treatment Phase|Technical Problems|0
4671759|NCT02712983|16072849|P3|Treatment Phase|Technical Problems|0
4671760|NCT02712983|16072850|P2|Treatment Phase|Technical Problems|0
4671761|NCT02712983|16072851|P1|Treatment Phase|Technical Problems|0
4671762|NCT02712983|16072843|P9|Treatment Phase|Protocol Deviation|0
4671763|NCT02712983|16072844|P8|Treatment Phase|Protocol Deviation|0
4671764|NCT02712983|16072845|P7|Treatment Phase|Protocol Deviation|1
4671765|NCT02712983|16072846|P6|Treatment Phase|Protocol Deviation|0
4671766|NCT02712983|16072847|P5|Treatment Phase|Protocol Deviation|0
4671767|NCT02712983|16072848|P4|Treatment Phase|Protocol Deviation|2
4671768|NCT02712983|16072849|P3|Treatment Phase|Protocol Deviation|0
4671769|NCT02712983|16072850|P2|Treatment Phase|Protocol Deviation|0
4671770|NCT02712983|16072851|P1|Treatment Phase|Protocol Deviation|0
4671771|NCT02712983|16072843|P9|Treatment Phase|Adverse Event|1
4671772|NCT02712983|16072844|P8|Treatment Phase|Adverse Event|6
4671773|NCT02712983|16072845|P7|Treatment Phase|Adverse Event|6
4671774|NCT02712983|16072846|P6|Treatment Phase|Adverse Event|0
4671775|NCT02712983|16072847|P5|Treatment Phase|Adverse Event|3
4671776|NCT02712983|16072848|P4|Treatment Phase|Adverse Event|4
4671777|NCT02712983|16072849|P3|Treatment Phase|Adverse Event|1
4671778|NCT02712983|16072850|P2|Treatment Phase|Adverse Event|1
4671779|NCT02712983|16072851|P1|Treatment Phase|Adverse Event|3
4671780|NCT02712788|16073083|P2|Overall Study|Protocol Violation|0
4671781|NCT02712788|16073084|P1|Overall Study|Protocol Violation|1
4671782|NCT02712788|16073083|P2|Overall Study|Physician Decision|0
4671783|NCT02712788|16073084|P1|Overall Study|Physician Decision|1
4671784|NCT02712554|16073094|P2|Part B: Treatment Phase|Other|1
4671785|NCT02712554|16073095|P1|Part B: Treatment Phase|Other|0
4671786|NCT02712554|16073094|P2|Part B: Treatment Phase|Withdrawal by Subject|1
4671787|NCT02712554|16073095|P1|Part B: Treatment Phase|Withdrawal by Subject|0
4671788|NCT02712554|16073094|P2|Part B: Treatment Phase|Adverse Event|1
4671789|NCT02712554|16073095|P1|Part B: Treatment Phase|Adverse Event|0
4671790|NCT02712554|16073094|P2|Part B: Qualification Phase|Adverse Event|1
4671791|NCT02712554|16073095|P1|Part B: Qualification Phase|Adverse Event|0
4671792|NCT02712554|16073094|P2|Part B: Qualification Phase|Withdrawal by Subject|3
4671793|NCT02712554|16073095|P1|Part B: Qualification Phase|Withdrawal by Subject|0
4671794|NCT02712554|16073094|P2|Part B: Qualification Phase|Sponsor Decision|4
4671795|NCT02712554|16073095|P1|Part B: Qualification Phase|Sponsor Decision|0
4671796|NCT02712554|16073094|P2|Part B: Qualification Phase|Drug Discrimination Failure|13
4671797|NCT02712554|16073095|P1|Part B: Qualification Phase|Drug Discrimination Failure|0
4671798|NCT02712333|16073240|P2|First Period|Withdrawal by Subject|2
4671799|NCT02712333|16073241|P1|First Period|Withdrawal by Subject|3
4671800|NCT02712320|16073259|P1|Overall Study|Treating with the prohibited medications|2
4671801|NCT02712320|16073259|P1|Overall Study|Transferred to another facility|1
4671802|NCT02712320|16073259|P1|Overall Study|Withdrawal by Subject|1
4671803|NCT02712320|16073259|P1|Overall Study|Lost to Follow-up|1
4671804|NCT02712008|16073302|P8|From Week 12 up to Week 36|Withdrawal by Subject|2
4671805|NCT02712008|16073303|P7|From Week 12 up to Week 36|Withdrawal by Subject|3
4671806|NCT02712008|16073304|P6|From Week 12 up to Week 36|Withdrawal by Subject|0
4671807|NCT02712008|16073305|P5|From Week 12 up to Week 36|Withdrawal by Subject|0
4671808|NCT02712008|16073306|P4|From Week 12 up to Week 36|Withdrawal by Subject|0
4671809|NCT02712008|16073307|P3|From Week 12 up to Week 36|Withdrawal by Subject|0
4671810|NCT02712008|16073308|P2|From Week 12 up to Week 36|Withdrawal by Subject|0
4671811|NCT02712008|16073309|P1|From Week 12 up to Week 36|Withdrawal by Subject|0
4671812|NCT02712008|16073302|P8|From Week 12 up to Week 36|Physician Decision|0
4671813|NCT02712008|16073303|P7|From Week 12 up to Week 36|Physician Decision|0
4671814|NCT02712008|16073304|P6|From Week 12 up to Week 36|Physician Decision|0
4671815|NCT02712008|16073305|P5|From Week 12 up to Week 36|Physician Decision|1
4671816|NCT02712008|16073306|P4|From Week 12 up to Week 36|Physician Decision|1
4671817|NCT02712008|16073307|P3|From Week 12 up to Week 36|Physician Decision|0
4671818|NCT02712008|16073308|P2|From Week 12 up to Week 36|Physician Decision|0
4671819|NCT02712008|16073309|P1|From Week 12 up to Week 36|Physician Decision|0
4671820|NCT02712008|16073302|P8|From Week 12 up to Week 36|Lost to Follow-up|0
4671821|NCT02712008|16073303|P7|From Week 12 up to Week 36|Lost to Follow-up|1
4671822|NCT02712008|16073304|P6|From Week 12 up to Week 36|Lost to Follow-up|0
4671823|NCT02712008|16073305|P5|From Week 12 up to Week 36|Lost to Follow-up|0
4671824|NCT02712008|16073306|P4|From Week 12 up to Week 36|Lost to Follow-up|1
4671825|NCT02712008|16073307|P3|From Week 12 up to Week 36|Lost to Follow-up|0
4671826|NCT02712008|16073308|P2|From Week 12 up to Week 36|Lost to Follow-up|0
4671827|NCT02712008|16073309|P1|From Week 12 up to Week 36|Lost to Follow-up|0
4671828|NCT02712008|16073302|P8|From Week 12 up to Week 36|Death|0
4671829|NCT02712008|16073303|P7|From Week 12 up to Week 36|Death|1
4671830|NCT02712008|16073304|P6|From Week 12 up to Week 36|Death|0
4671831|NCT02712008|16073305|P5|From Week 12 up to Week 36|Death|0
4671832|NCT02712008|16073306|P4|From Week 12 up to Week 36|Death|0
4671833|NCT02712008|16073307|P3|From Week 12 up to Week 36|Death|0
4671834|NCT02712008|16073308|P2|From Week 12 up to Week 36|Death|0
4671835|NCT02712008|16073309|P1|From Week 12 up to Week 36|Death|1
4671836|NCT02712008|16073302|P8|From Week 12 up to Week 36|Adverse Event|2
4671837|NCT02712008|16073303|P7|From Week 12 up to Week 36|Adverse Event|0
4671838|NCT02712008|16073304|P6|From Week 12 up to Week 36|Adverse Event|0
4671839|NCT02712008|16073305|P5|From Week 12 up to Week 36|Adverse Event|1
4671840|NCT02712008|16073306|P4|From Week 12 up to Week 36|Adverse Event|0
4671841|NCT02712008|16073307|P3|From Week 12 up to Week 36|Adverse Event|0
4671842|NCT02712008|16073308|P2|From Week 12 up to Week 36|Adverse Event|0
4671843|NCT02712008|16073309|P1|From Week 12 up to Week 36|Adverse Event|0
4671844|NCT02712008|16073302|P8|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671845|NCT02712008|16073303|P7|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671846|NCT02712008|16073304|P6|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671847|NCT02712008|16073305|P5|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671848|NCT02712008|16073306|P4|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671849|NCT02712008|16073307|P3|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671850|NCT02712008|16073308|P2|Baseline (Day 1) up to Week 12|Other Unspecified|1
4671851|NCT02712008|16073309|P1|Baseline (Day 1) up to Week 12|Other Unspecified|0
4671852|NCT02712008|16073302|P8|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671853|NCT02712008|16073303|P7|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671854|NCT02712008|16073304|P6|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671855|NCT02712008|16073305|P5|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671856|NCT02712008|16073306|P4|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671857|NCT02712008|16073307|P3|Baseline (Day 1) up to Week 12|Protocol Violation|1
4671858|NCT02712008|16073308|P2|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671859|NCT02712008|16073309|P1|Baseline (Day 1) up to Week 12|Protocol Violation|0
4671860|NCT02712008|16073302|P8|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671861|NCT02712008|16073303|P7|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671862|NCT02712008|16073304|P6|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671863|NCT02712008|16073305|P5|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671864|NCT02712008|16073306|P4|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4671865|NCT02712008|16073307|P3|Baseline (Day 1) up to Week 12|Lost to Follow-up|2
4671866|NCT02712008|16073308|P2|Baseline (Day 1) up to Week 12|Lost to Follow-up|0
4673824|NCT02684357|16081274|P4|Part A|Other|0
4671867|NCT02712008|16073309|P1|Baseline (Day 1) up to Week 12|Lost to Follow-up|1
4671868|NCT02712008|16073302|P8|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671869|NCT02712008|16073303|P7|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671870|NCT02712008|16073304|P6|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671871|NCT02712008|16073305|P5|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671872|NCT02712008|16073306|P4|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671873|NCT02712008|16073307|P3|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1
4671874|NCT02712008|16073308|P2|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2
4671875|NCT02712008|16073309|P1|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0
4671876|NCT02712008|16073302|P8|Baseline (Day 1) up to Week 12|Death|0
4671877|NCT02712008|16073303|P7|Baseline (Day 1) up to Week 12|Death|0
4671878|NCT02712008|16073304|P6|Baseline (Day 1) up to Week 12|Death|0
4671879|NCT02712008|16073305|P5|Baseline (Day 1) up to Week 12|Death|0
4671880|NCT02712008|16073306|P4|Baseline (Day 1) up to Week 12|Death|0
4671881|NCT02712008|16073307|P3|Baseline (Day 1) up to Week 12|Death|0
4671882|NCT02712008|16073308|P2|Baseline (Day 1) up to Week 12|Death|0
4671883|NCT02712008|16073309|P1|Baseline (Day 1) up to Week 12|Death|3
4671884|NCT02711995|16073341|P1|Washout (90 Days)|Conflicting medication|1
4671885|NCT02711800|16073380|P1|Overall Study|Withdrawal by Subject|1
4671886|NCT02711800|16073380|P1|Overall Study|Lost to Follow-up|1
4671887|NCT02711345|16073399|P10|Overall Study|Death|0
4671888|NCT02711345|16073400|P9|Overall Study|Death|0
4671889|NCT02711345|16073401|P8|Overall Study|Death|1
4671890|NCT02711345|16073402|P7|Overall Study|Death|0
4671891|NCT02711345|16073403|P6|Overall Study|Death|0
4671892|NCT02711345|16073404|P5|Overall Study|Death|0
4671893|NCT02711345|16073405|P4|Overall Study|Death|0
4671894|NCT02711345|16073406|P3|Overall Study|Death|0
4671895|NCT02711345|16073407|P2|Overall Study|Death|0
4671896|NCT02711345|16073408|P1|Overall Study|Death|1
4671897|NCT02711345|16073399|P10|Overall Study|Subject/guardian decision|4
4671898|NCT02711345|16073400|P9|Overall Study|Subject/guardian decision|0
4671899|NCT02711345|16073401|P8|Overall Study|Subject/guardian decision|1
4671900|NCT02711345|16073402|P7|Overall Study|Subject/guardian decision|3
4671901|NCT02711345|16073403|P6|Overall Study|Subject/guardian decision|2
4671902|NCT02711345|16073404|P5|Overall Study|Subject/guardian decision|0
4671903|NCT02711345|16073405|P4|Overall Study|Subject/guardian decision|0
4671904|NCT02711345|16073406|P3|Overall Study|Subject/guardian decision|0
4671905|NCT02711345|16073407|P2|Overall Study|Subject/guardian decision|0
4671906|NCT02711345|16073408|P1|Overall Study|Subject/guardian decision|0
4671907|NCT02711345|16073399|P10|Overall Study|Progressive disease|6
4671908|NCT02711345|16073400|P9|Overall Study|Progressive disease|5
4671909|NCT02711345|16073401|P8|Overall Study|Progressive disease|4
4671910|NCT02711345|16073402|P7|Overall Study|Progressive disease|8
4671911|NCT02711345|16073403|P6|Overall Study|Progressive disease|2
4671912|NCT02711345|16073404|P5|Overall Study|Progressive disease|7
4671913|NCT02711345|16073405|P4|Overall Study|Progressive disease|3
4671914|NCT02711345|16073406|P3|Overall Study|Progressive disease|5
4671915|NCT02711345|16073407|P2|Overall Study|Progressive disease|3
4671916|NCT02711345|16073408|P1|Overall Study|Progressive disease|1
4671917|NCT02711345|16073399|P10|Overall Study|Physician Decision|0
4671918|NCT02711345|16073400|P9|Overall Study|Physician Decision|1
4671919|NCT02711345|16073401|P8|Overall Study|Physician Decision|0
4671920|NCT02711345|16073402|P7|Overall Study|Physician Decision|0
4671921|NCT02711345|16073403|P6|Overall Study|Physician Decision|0
4671922|NCT02711345|16073404|P5|Overall Study|Physician Decision|0
4671923|NCT02711345|16073405|P4|Overall Study|Physician Decision|0
4671924|NCT02711345|16073406|P3|Overall Study|Physician Decision|1
4671925|NCT02711345|16073407|P2|Overall Study|Physician Decision|0
4671926|NCT02711345|16073408|P1|Overall Study|Physician Decision|0
4671927|NCT02711345|16073399|P10|Overall Study|Adverse Event|2
4671928|NCT02711345|16073400|P9|Overall Study|Adverse Event|0
4671929|NCT02711345|16073401|P8|Overall Study|Adverse Event|0
4671930|NCT02711345|16073402|P7|Overall Study|Adverse Event|1
4671931|NCT02711345|16073403|P6|Overall Study|Adverse Event|2
4671932|NCT02711345|16073404|P5|Overall Study|Adverse Event|1
4671933|NCT02711345|16073405|P4|Overall Study|Adverse Event|1
4671934|NCT02711345|16073406|P3|Overall Study|Adverse Event|0
4671935|NCT02711345|16073407|P2|Overall Study|Adverse Event|0
4671936|NCT02711345|16073408|P1|Overall Study|Adverse Event|0
4671937|NCT02711306|16073594|P2|Overall Study|Withdrawal by Subject|2
4671938|NCT02711306|16073595|P1|Overall Study|Withdrawal by Subject|2
4671939|NCT02710422|16073788|P2|Overall Study|Termination of study|9
4671940|NCT02710422|16073789|P1|Overall Study|Termination of study|9
4671941|NCT02710292|16073805|P2|Period 1, First 10 Days of Wear|Withdrawal by Subject|2
4671942|NCT02710292|16073806|P1|Period 1, First 10 Days of Wear|Withdrawal by Subject|1
4671943|NCT02710292|16073805|P2|Period 1, First 10 Days of Wear|Adverse Event|1
4671944|NCT02710292|16073806|P1|Period 1, First 10 Days of Wear|Adverse Event|0
4671945|NCT02710214|16073815|P2|Overall Study|Death|1
4671946|NCT02710214|16073816|P1|Overall Study|Death|0
4671947|NCT02710214|16073815|P2|Overall Study|Lack of Efficacy|1
4671948|NCT02710214|16073816|P1|Overall Study|Lack of Efficacy|0
4671949|NCT02710214|16073815|P2|Overall Study|Lost to Follow-up|0
4671950|NCT02710214|16073816|P1|Overall Study|Lost to Follow-up|1
4671951|NCT02710136|16073850|P2|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0
4671952|NCT02710136|16073851|P1|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1
4671953|NCT02710071|16073876|P2|Second Intervention (6 Weeks).|Withdrawal by Subject|2
4671954|NCT02710071|16073877|P1|Second Intervention (6 Weeks).|Withdrawal by Subject|1
4671955|NCT02710071|16073876|P2|First Intervention (6 Weeks).|Withdrawal by Subject|4
4671956|NCT02710071|16073877|P1|First Intervention (6 Weeks).|Withdrawal by Subject|3
4671957|NCT02710045|16073887|P3|Overall Study|Poor Attendance|0
4671958|NCT02710045|16073888|P2|Overall Study|Poor Attendance|1
4671959|NCT02710045|16073889|P1|Overall Study|Poor Attendance|0
4671960|NCT02710045|16073887|P3|Overall Study|Physician Decision|1
4671961|NCT02710045|16073888|P2|Overall Study|Physician Decision|0
4671962|NCT02710045|16073889|P1|Overall Study|Physician Decision|0
4671963|NCT02710045|16073887|P3|Overall Study|Lost to Follow-up|7
4671964|NCT02710045|16073888|P2|Overall Study|Lost to Follow-up|6
4671965|NCT02710045|16073889|P1|Overall Study|Lost to Follow-up|3
4671966|NCT02710045|16073887|P3|Overall Study|Protocol Violation|3
4671967|NCT02710045|16073888|P2|Overall Study|Protocol Violation|2
4671968|NCT02710045|16073889|P1|Overall Study|Protocol Violation|1
4671969|NCT02710045|16073887|P3|Overall Study|Withdrawal by Subject|2
4671970|NCT02710045|16073888|P2|Overall Study|Withdrawal by Subject|6
4671971|NCT02710045|16073889|P1|Overall Study|Withdrawal by Subject|6
4671972|NCT02710045|16073887|P3|Overall Study|Death|0
4671973|NCT02710045|16073888|P2|Overall Study|Death|2
4671974|NCT02710045|16073889|P1|Overall Study|Death|1
4671975|NCT02709889|16073923|P4|Overall Study|Other, Not Specified|6
4671976|NCT02709889|16073924|P3|Overall Study|Other, Not Specified|1
4671977|NCT02709889|16073925|P2|Overall Study|Other, Not Specified|1
4671978|NCT02709889|16073926|P1|Overall Study|Other, Not Specified|0
4671979|NCT02709889|16073923|P4|Overall Study|Study Terminated by Sponsor|17
4671980|NCT02709889|16073924|P3|Overall Study|Study Terminated by Sponsor|2
4671981|NCT02709889|16073925|P2|Overall Study|Study Terminated by Sponsor|6
4671982|NCT02709889|16073926|P1|Overall Study|Study Terminated by Sponsor|4
4671983|NCT02709889|16073923|P4|Overall Study|Lost to Follow-up|4
4671984|NCT02709889|16073924|P3|Overall Study|Lost to Follow-up|0
4671985|NCT02709889|16073925|P2|Overall Study|Lost to Follow-up|0
4671986|NCT02709889|16073926|P1|Overall Study|Lost to Follow-up|2
4671987|NCT02709889|16073923|P4|Overall Study|Physician Decision|5
4671988|NCT02709889|16073924|P3|Overall Study|Physician Decision|3
4671989|NCT02709889|16073925|P2|Overall Study|Physician Decision|2
4671990|NCT02709889|16073926|P1|Overall Study|Physician Decision|1
4671991|NCT02709889|16073923|P4|Overall Study|Death|44
4671992|NCT02709889|16073924|P3|Overall Study|Death|4
4671993|NCT02709889|16073925|P2|Overall Study|Death|38
4671994|NCT02709889|16073926|P1|Overall Study|Death|25
4671995|NCT02709889|16073923|P4|Overall Study|Withdrawal by Subject|12
4671996|NCT02709889|16073924|P3|Overall Study|Withdrawal by Subject|2
4671997|NCT02709889|16073925|P2|Overall Study|Withdrawal by Subject|10
4671998|NCT02709889|16073926|P1|Overall Study|Withdrawal by Subject|11
4671999|NCT02709785|16074007|P3|Overall Study|Withdrawal by Subject|1
4672000|NCT02709785|16074008|P2|Overall Study|Withdrawal by Subject|2
4672001|NCT02709785|16074009|P1|Overall Study|Withdrawal by Subject|1
4672002|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
4672003|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
4672004|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2
4672005|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4
4672006|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0
4672007|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4672008|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4672009|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|enrolled not treated|1
4672010|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4672011|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|enrolled not treated|0
4672012|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1
4672013|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
4672014|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
4672015|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2
4672016|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0
4672017|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Adverse Event|2
4672018|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Adverse Event|5
4672019|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Adverse Event|8
4672020|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Adverse Event|4
4672021|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Adverse Event|0
4672022|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2
4672023|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1
4672024|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
4672025|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3
4672026|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0
4672027|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
4672028|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
4672029|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4
4672030|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1
4672031|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0
4672032|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Other|7
4673825|NCT02684357|16081275|P3|Part A|Other|0
4672033|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Other|6
4672034|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Other|5
4672035|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Other|6
4672036|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Other|0
4672037|NCT02709746|16074034|P5|Phase B (Double-blind Treatment Period)|Protocol Violation|2
4672038|NCT02709746|16074035|P4|Phase B (Double-blind Treatment Period)|Protocol Violation|0
4672039|NCT02709746|16074036|P3|Phase B (Double-blind Treatment Period)|Protocol Violation|0
4672040|NCT02709746|16074037|P2|Phase B (Double-blind Treatment Period)|Protocol Violation|1
4672041|NCT02709746|16074038|P1|Phase B (Double-blind Treatment Period)|Protocol Violation|0
4672042|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4672043|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4672044|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4672045|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0
4672046|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103
4672047|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4672048|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4672049|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4672050|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0
4672051|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7
4672052|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4672053|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4672054|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4672055|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Enrolled not treated|0
4672056|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Enrolled not treated|7
4672057|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4672058|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4672059|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4672060|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0
4672061|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12
4672062|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Adverse Event|0
4672063|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Adverse Event|0
4672064|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Adverse Event|0
4672065|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Adverse Event|0
4672066|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Adverse Event|2
4672067|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4672068|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4672069|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4672070|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0
4672071|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7
4672072|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4672073|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4672074|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4672075|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0
4672076|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12
4672077|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Not sepcified|0
4672078|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Not sepcified|0
4672079|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Not sepcified|0
4672080|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Not sepcified|0
4672081|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Not sepcified|14
4672082|NCT02709746|16074034|P5|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4672083|NCT02709746|16074035|P4|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4672084|NCT02709746|16074036|P3|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4672085|NCT02709746|16074037|P2|Phase A (Single-blind Treatment Period)|Protocol Violation|0
4672086|NCT02709746|16074038|P1|Phase A (Single-blind Treatment Period)|Protocol Violation|4
4672087|NCT02709577|16074160|P4|Overall Study|Withdrawal by Subject|0
4672088|NCT02709577|16074161|P3|Overall Study|Withdrawal by Subject|2
4672089|NCT02709577|16074162|P2|Overall Study|Withdrawal by Subject|3
4672090|NCT02709577|16074163|P1|Overall Study|Withdrawal by Subject|2
4672091|NCT02709577|16074160|P4|Overall Study|procedural complication|0
4672092|NCT02709577|16074161|P3|Overall Study|procedural complication|0
4672093|NCT02709577|16074162|P2|Overall Study|procedural complication|1
4672094|NCT02709577|16074163|P1|Overall Study|procedural complication|0
4672095|NCT02709577|16074160|P4|Overall Study|non-accommodating anatomy|0
4672096|NCT02709577|16074161|P3|Overall Study|non-accommodating anatomy|0
4672097|NCT02709577|16074162|P2|Overall Study|non-accommodating anatomy|1
4672098|NCT02709577|16074163|P1|Overall Study|non-accommodating anatomy|0
4672099|NCT02709538|16074178|P3|Overall Study|Other|5
4672100|NCT02709538|16074179|P2|Overall Study|Other|7
4672101|NCT02709538|16074180|P1|Overall Study|Other|16
4672102|NCT02709538|16074178|P3|Overall Study|Withdrawal by Parent or Legal Guardian|0
4672103|NCT02709538|16074179|P2|Overall Study|Withdrawal by Parent or Legal Guardian|0
4672104|NCT02709538|16074180|P1|Overall Study|Withdrawal by Parent or Legal Guardian|1
4672105|NCT02709538|16074178|P3|Overall Study|Protocol deviation|4
4672106|NCT02709538|16074179|P2|Overall Study|Protocol deviation|4
4672107|NCT02709538|16074180|P1|Overall Study|Protocol deviation|10
4672108|NCT02709538|16074178|P3|Overall Study|Non-compliance with study drug|0
4672109|NCT02709538|16074179|P2|Overall Study|Non-compliance with study drug|0
4672110|NCT02709538|16074180|P1|Overall Study|Non-compliance with study drug|2
4672111|NCT02709538|16074178|P3|Overall Study|Non-compliance with study procedures|0
4672112|NCT02709538|16074179|P2|Overall Study|Non-compliance with study procedures|0
4672113|NCT02709538|16074180|P1|Overall Study|Non-compliance with study procedures|5
4672114|NCT02709538|16074178|P3|Overall Study|Withdrawal by Subject|4
4672115|NCT02709538|16074179|P2|Overall Study|Withdrawal by Subject|7
4672116|NCT02709538|16074180|P1|Overall Study|Withdrawal by Subject|40
4672117|NCT02709538|16074178|P3|Overall Study|Physician Decision|0
4672118|NCT02709538|16074179|P2|Overall Study|Physician Decision|0
4672119|NCT02709538|16074180|P1|Overall Study|Physician Decision|1
4672120|NCT02709538|16074178|P3|Overall Study|Lost to Follow-up|4
4672121|NCT02709538|16074179|P2|Overall Study|Lost to Follow-up|8
4672122|NCT02709538|16074180|P1|Overall Study|Lost to Follow-up|24
4672123|NCT02709538|16074178|P3|Overall Study|Lack of Efficacy|0
4672124|NCT02709538|16074179|P2|Overall Study|Lack of Efficacy|0
4672125|NCT02709538|16074180|P1|Overall Study|Lack of Efficacy|1
4672126|NCT02709538|16074178|P3|Overall Study|Adverse Event|3
4672127|NCT02709538|16074179|P2|Overall Study|Adverse Event|2
4672128|NCT02709538|16074180|P1|Overall Study|Adverse Event|13
4672129|NCT02709486|16074191|P3|Overall Study|Withdrawal by Subject|32
4672130|NCT02709486|16074192|P2|Overall Study|Withdrawal by Subject|22
4672131|NCT02709486|16074193|P1|Overall Study|Withdrawal by Subject|32
4672132|NCT02709486|16074191|P3|Overall Study|Other|3
4672133|NCT02709486|16074192|P2|Overall Study|Other|2
4672134|NCT02709486|16074193|P1|Overall Study|Other|0
4672135|NCT02709486|16074191|P3|Overall Study|Lost to Follow-up|2
4672136|NCT02709486|16074192|P2|Overall Study|Lost to Follow-up|2
4672137|NCT02709486|16074193|P1|Overall Study|Lost to Follow-up|3
4672138|NCT02709486|16074191|P3|Overall Study|Insufficient clinical response|3
4672139|NCT02709486|16074192|P2|Overall Study|Insufficient clinical response|3
4672140|NCT02709486|16074193|P1|Overall Study|Insufficient clinical response|7
4672141|NCT02709486|16074191|P3|Overall Study|Death|2
4672142|NCT02709486|16074192|P2|Overall Study|Death|0
4672143|NCT02709486|16074193|P1|Overall Study|Death|0
4672144|NCT02709486|16074191|P3|Overall Study|Adverse Event|3
4672145|NCT02709486|16074192|P2|Overall Study|Adverse Event|5
4672146|NCT02709486|16074193|P1|Overall Study|Adverse Event|2
4672147|NCT02709369|16074384|P1|Overall Study|Did not received intervention|2
4672148|NCT02709369|16074384|P1|Overall Study|Withdrawal by Subject|10
4672149|NCT02709369|16074384|P1|Overall Study|Lost to Follow-up|15
4672150|NCT02709330|16074418|P2|Overall Study|Withdrawal by Subject|0
4672151|NCT02709330|16074419|P1|Overall Study|Withdrawal by Subject|4
4672152|NCT02709330|16074418|P2|Overall Study|Physician Decision|0
4672153|NCT02709330|16074419|P1|Overall Study|Physician Decision|2
4672154|NCT02709330|16074418|P2|Overall Study|Lost to Follow-up|0
4672155|NCT02709330|16074419|P1|Overall Study|Lost to Follow-up|2
4672156|NCT02709330|16074418|P2|Overall Study|Death|0
4672157|NCT02709330|16074419|P1|Overall Study|Death|5
4672158|NCT02709096|16074433|P2|Overall Study|non-compliance|1
4672159|NCT02709096|16074434|P1|Overall Study|non-compliance|1
4672160|NCT02709083|16074440|P1|Overall Study|Original PI left institution|7
4672161|NCT02709005|16074453|P2|Overall Study|Withdrawal by Subject|0
4672162|NCT02709005|16074454|P1|Overall Study|Withdrawal by Subject|3
4672163|NCT02709005|16074453|P2|Overall Study|Lost to Follow-up|1
4672164|NCT02709005|16074454|P1|Overall Study|Lost to Follow-up|1
4672165|NCT02708524|16074523|P4|Overall Study|Subject lost study lens|0
4672166|NCT02708524|16074524|P3|Overall Study|Subject lost study lens|0
4672167|NCT02708524|16074525|P2|Overall Study|Subject lost study lens|0
4672168|NCT02708524|16074526|P1|Overall Study|Subject lost study lens|1
4672169|NCT02708524|16074523|P4|Overall Study|Did not wear lens at final visit|0
4672170|NCT02708524|16074524|P3|Overall Study|Did not wear lens at final visit|0
4672171|NCT02708524|16074525|P2|Overall Study|Did not wear lens at final visit|1
4672172|NCT02708524|16074526|P1|Overall Study|Did not wear lens at final visit|0
4672173|NCT02708524|16074523|P4|Overall Study|Dispensed incorrect study lens|0
4672174|NCT02708524|16074524|P3|Overall Study|Dispensed incorrect study lens|1
4672175|NCT02708524|16074525|P2|Overall Study|Dispensed incorrect study lens|1
4672176|NCT02708524|16074526|P1|Overall Study|Dispensed incorrect study lens|0
4672177|NCT02708524|16074523|P4|Overall Study|Withdrawal by Subject|0
4672178|NCT02708524|16074524|P3|Overall Study|Withdrawal by Subject|0
4672179|NCT02708524|16074525|P2|Overall Study|Withdrawal by Subject|1
4672180|NCT02708524|16074526|P1|Overall Study|Withdrawal by Subject|1
4672181|NCT02708524|16074523|P4|Overall Study|Protocol Violation|0
4672182|NCT02708524|16074524|P3|Overall Study|Protocol Violation|0
4672183|NCT02708524|16074525|P2|Overall Study|Protocol Violation|1
4672184|NCT02708524|16074526|P1|Overall Study|Protocol Violation|0
4672185|NCT02708524|16074523|P4|Overall Study|Lost to Follow-up|0
4672186|NCT02708524|16074524|P3|Overall Study|Lost to Follow-up|1
4672187|NCT02708524|16074525|P2|Overall Study|Lost to Follow-up|1
4672188|NCT02708524|16074526|P1|Overall Study|Lost to Follow-up|1
4672189|NCT02708524|16074523|P4|Overall Study|Lens Discomfort|0
4672190|NCT02708524|16074524|P3|Overall Study|Lens Discomfort|1
4672191|NCT02708524|16074525|P2|Overall Study|Lens Discomfort|0
4672192|NCT02708524|16074526|P1|Overall Study|Lens Discomfort|1
4672193|NCT02708524|16074523|P4|Overall Study|Adverse Event|0
4672194|NCT02708524|16074524|P3|Overall Study|Adverse Event|0
4672195|NCT02708524|16074525|P2|Overall Study|Adverse Event|1
4672196|NCT02708524|16074526|P1|Overall Study|Adverse Event|0
4672197|NCT02708498|16074580|P8|Overall Study|Unknown reason, missing data|0
4672198|NCT02708498|16074581|P7|Overall Study|Unknown reason, missing data|0
4672199|NCT02708498|16074582|P6|Overall Study|Unknown reason, missing data|132
4672200|NCT02708498|16074583|P5|Overall Study|Unknown reason, missing data|195
4672201|NCT02708498|16074584|P4|Overall Study|Unknown reason, missing data|51
4672202|NCT02708498|16074585|P3|Overall Study|Unknown reason, missing data|62
4672203|NCT02708498|16074586|P2|Overall Study|Unknown reason, missing data|0
4672204|NCT02708498|16074587|P1|Overall Study|Unknown reason, missing data|0
4672205|NCT02708498|16074580|P8|Overall Study|Death|0
4672206|NCT02708498|16074581|P7|Overall Study|Death|0
4672207|NCT02708498|16074582|P6|Overall Study|Death|0
4672208|NCT02708498|16074583|P5|Overall Study|Death|1
4672209|NCT02708498|16074584|P4|Overall Study|Death|0
4672210|NCT02708498|16074585|P3|Overall Study|Death|0
4672211|NCT02708498|16074586|P2|Overall Study|Death|19
4672212|NCT02708498|16074587|P1|Overall Study|Death|20
4672213|NCT02708485|16074615|P2|Overall Study|Withdrawal by Subject|2
4672214|NCT02708485|16074616|P1|Overall Study|Withdrawal by Subject|3
4672215|NCT02708355|16074636|P3|Overall Study|Adverse Event|0
4672216|NCT02708355|16074637|P2|Overall Study|Adverse Event|0
4672217|NCT02708355|16074638|P1|Overall Study|Adverse Event|1
4672218|NCT02708277|16074662|P2|Overall Study|Lost to Follow-up|4
4672219|NCT02708277|16074663|P1|Overall Study|Lost to Follow-up|7
4672220|NCT02708121|16074715|P2|Overall Study|Withdrawal by Subject|4
4672221|NCT02708121|16074716|P1|Overall Study|Withdrawal by Subject|0
4672222|NCT02708121|16074715|P2|Overall Study|Withdrawn by Study Team|1
4672223|NCT02708121|16074716|P1|Overall Study|Withdrawn by Study Team|1
4672224|NCT02708095|16074728|P3|Overall Study|Withdrawal by Subject|4
4672225|NCT02708095|16074729|P2|Overall Study|Withdrawal by Subject|3
4672226|NCT02708095|16074730|P1|Overall Study|Withdrawal by Subject|5
4672227|NCT02708095|16074728|P3|Overall Study|Protocol Violation|1
4672228|NCT02708095|16074729|P2|Overall Study|Protocol Violation|0
4672229|NCT02708095|16074730|P1|Overall Study|Protocol Violation|0
4672230|NCT02708095|16074728|P3|Overall Study|Physician Decision|2
4672231|NCT02708095|16074729|P2|Overall Study|Physician Decision|3
4672232|NCT02708095|16074730|P1|Overall Study|Physician Decision|2
4672233|NCT02708095|16074728|P3|Overall Study|Lost to Follow-up|0
4672234|NCT02708095|16074729|P2|Overall Study|Lost to Follow-up|0
4672235|NCT02708095|16074730|P1|Overall Study|Lost to Follow-up|2
4672236|NCT02708095|16074728|P3|Overall Study|Lack of Efficacy|0
4672237|NCT02708095|16074729|P2|Overall Study|Lack of Efficacy|3
4672238|NCT02708095|16074730|P1|Overall Study|Lack of Efficacy|9
4672239|NCT02708095|16074728|P3|Overall Study|Adverse Event|11
4672240|NCT02708095|16074729|P2|Overall Study|Adverse Event|10
4672241|NCT02708095|16074730|P1|Overall Study|Adverse Event|4
4672242|NCT02707991|16074753|P2|Overall Study|Became ineligible|1
4672243|NCT02707991|16074754|P1|Overall Study|Became ineligible|0
4672244|NCT02707991|16074753|P2|Overall Study|Protocol Violation|0
4672245|NCT02707991|16074754|P1|Overall Study|Protocol Violation|1
4672246|NCT02707965|16074771|P16|Overall Study|Protocol deviation|0
4672247|NCT02707965|16074772|P15|Overall Study|Protocol deviation|0
4672248|NCT02707965|16074773|P14|Overall Study|Protocol deviation|0
4672249|NCT02707965|16074774|P13|Overall Study|Protocol deviation|0
4672250|NCT02707965|16074775|P12|Overall Study|Protocol deviation|0
4672251|NCT02707965|16074776|P11|Overall Study|Protocol deviation|0
4672252|NCT02707965|16074777|P10|Overall Study|Protocol deviation|0
4672253|NCT02707965|16074778|P9|Overall Study|Protocol deviation|0
4672254|NCT02707965|16074779|P8|Overall Study|Protocol deviation|1
4672255|NCT02707965|16074780|P7|Overall Study|Protocol deviation|0
4672256|NCT02707965|16074781|P6|Overall Study|Protocol deviation|0
4672257|NCT02707965|16074782|P5|Overall Study|Protocol deviation|0
4672258|NCT02707965|16074783|P4|Overall Study|Protocol deviation|0
4672259|NCT02707965|16074784|P3|Overall Study|Protocol deviation|0
4672260|NCT02707965|16074785|P2|Overall Study|Protocol deviation|1
4672261|NCT02707965|16074786|P1|Overall Study|Protocol deviation|1
4672262|NCT02707965|16074771|P16|Overall Study|PI decisions|0
4672263|NCT02707965|16074772|P15|Overall Study|PI decisions|2
4672264|NCT02707965|16074773|P14|Overall Study|PI decisions|0
4672265|NCT02707965|16074774|P13|Overall Study|PI decisions|0
4672266|NCT02707965|16074775|P12|Overall Study|PI decisions|0
4672267|NCT02707965|16074776|P11|Overall Study|PI decisions|0
4672268|NCT02707965|16074777|P10|Overall Study|PI decisions|0
4672269|NCT02707965|16074778|P9|Overall Study|PI decisions|0
4672270|NCT02707965|16074779|P8|Overall Study|PI decisions|0
4672271|NCT02707965|16074780|P7|Overall Study|PI decisions|0
4672272|NCT02707965|16074781|P6|Overall Study|PI decisions|0
4672273|NCT02707965|16074782|P5|Overall Study|PI decisions|0
4672274|NCT02707965|16074783|P4|Overall Study|PI decisions|0
4672275|NCT02707965|16074784|P3|Overall Study|PI decisions|0
4672276|NCT02707965|16074785|P2|Overall Study|PI decisions|0
4672277|NCT02707965|16074786|P1|Overall Study|PI decisions|0
4672278|NCT02707965|16074771|P16|Overall Study|Withdrawal by Subject|0
4672279|NCT02707965|16074772|P15|Overall Study|Withdrawal by Subject|0
4672280|NCT02707965|16074773|P14|Overall Study|Withdrawal by Subject|0
4672281|NCT02707965|16074774|P13|Overall Study|Withdrawal by Subject|0
4672282|NCT02707965|16074775|P12|Overall Study|Withdrawal by Subject|0
4672283|NCT02707965|16074776|P11|Overall Study|Withdrawal by Subject|0
4672284|NCT02707965|16074777|P10|Overall Study|Withdrawal by Subject|0
4672285|NCT02707965|16074778|P9|Overall Study|Withdrawal by Subject|0
4672286|NCT02707965|16074779|P8|Overall Study|Withdrawal by Subject|2
4672287|NCT02707965|16074780|P7|Overall Study|Withdrawal by Subject|0
4672288|NCT02707965|16074781|P6|Overall Study|Withdrawal by Subject|0
4672289|NCT02707965|16074782|P5|Overall Study|Withdrawal by Subject|0
4672290|NCT02707965|16074783|P4|Overall Study|Withdrawal by Subject|0
4672291|NCT02707965|16074784|P3|Overall Study|Withdrawal by Subject|1
4672292|NCT02707965|16074785|P2|Overall Study|Withdrawal by Subject|0
4672293|NCT02707965|16074786|P1|Overall Study|Withdrawal by Subject|0
4672294|NCT02707952|16074838|P4|Overall Study|Withdrawal by Subject|0
4672295|NCT02707952|16074839|P3|Overall Study|Withdrawal by Subject|2
4672296|NCT02707952|16074840|P2|Overall Study|Withdrawal by Subject|1
4672297|NCT02707952|16074841|P1|Overall Study|Withdrawal by Subject|0
4672298|NCT02707952|16074838|P4|Overall Study|Lost to Follow-up|0
4672299|NCT02707952|16074839|P3|Overall Study|Lost to Follow-up|0
4672300|NCT02707952|16074840|P2|Overall Study|Lost to Follow-up|0
4672301|NCT02707952|16074841|P1|Overall Study|Lost to Follow-up|1
4672302|NCT02707952|16074838|P4|Overall Study|Adverse Event|0
4672303|NCT02707952|16074839|P3|Overall Study|Adverse Event|0
4672304|NCT02707952|16074840|P2|Overall Study|Adverse Event|0
4672305|NCT02707952|16074841|P1|Overall Study|Adverse Event|1
4672306|NCT02707640|16074862|P2|Overall Study|Sponsor Discretion|0
4672307|NCT02707640|16074863|P1|Overall Study|Sponsor Discretion|1
4672308|NCT02707640|16074862|P2|Overall Study|Participant's Personal Decision|2
4672309|NCT02707640|16074863|P1|Overall Study|Participant's Personal Decision|1
4672310|NCT02707640|16074862|P2|Overall Study|Withdrawal by Subject|1
4672311|NCT02707640|16074863|P1|Overall Study|Withdrawal by Subject|0
4672312|NCT02707640|16074862|P2|Overall Study|Physician Decision|0
4672313|NCT02707640|16074863|P1|Overall Study|Physician Decision|2
4672314|NCT02707640|16074862|P2|Overall Study|Death|2
4672315|NCT02707640|16074863|P1|Overall Study|Death|1
4672316|NCT02707640|16074862|P2|Overall Study|Adverse Event|2
4672317|NCT02707640|16074863|P1|Overall Study|Adverse Event|4
4672318|NCT02707601|16074883|P2|Overall Study|Participants Randomized but Not Treated|0
4672319|NCT02707601|16074884|P1|Overall Study|Participants Randomized but Not Treated|2
4672320|NCT02707601|16074883|P2|Overall Study|Lost to Follow-up|1
4672321|NCT02707601|16074884|P1|Overall Study|Lost to Follow-up|1
4672322|NCT02707601|16074883|P2|Overall Study|Withdrew Consent|1
4672323|NCT02707601|16074884|P1|Overall Study|Withdrew Consent|0
4672324|NCT02707601|16074883|P2|Overall Study|Investigator's Discretion|0
4672325|NCT02707601|16074884|P1|Overall Study|Investigator's Discretion|1
4672326|NCT02707601|16074883|P2|Overall Study|Lack of Efficacy|1
4672327|NCT02707601|16074884|P1|Overall Study|Lack of Efficacy|0
4672328|NCT02707601|16074883|P2|Overall Study|Death|1
4672329|NCT02707601|16074884|P1|Overall Study|Death|0
4672330|NCT02706951|16074973|P3|Overall Study|Other|0
4672331|NCT02706951|16074974|P2|Overall Study|Other|1
4672332|NCT02706951|16074975|P1|Overall Study|Other|2
4672333|NCT02706951|16074973|P3|Overall Study|Lost to Follow-up|1
4672334|NCT02706951|16074974|P2|Overall Study|Lost to Follow-up|4
4672335|NCT02706951|16074975|P1|Overall Study|Lost to Follow-up|0
4672336|NCT02706951|16074973|P3|Overall Study|Withdrawal by Subject|6
4672337|NCT02706951|16074974|P2|Overall Study|Withdrawal by Subject|6
4672338|NCT02706951|16074975|P1|Overall Study|Withdrawal by Subject|11
4672339|NCT02706951|16074973|P3|Overall Study|Adverse Event|3
4672340|NCT02706951|16074974|P2|Overall Study|Adverse Event|5
4672341|NCT02706951|16074975|P1|Overall Study|Adverse Event|1
4672342|NCT02706938|16075009|P2|Second Period, 6 Weeks|Withdrawal by Subject|3
4672343|NCT02706938|16075010|P1|Second Period, 6 Weeks|Withdrawal by Subject|0
4672344|NCT02706938|16075009|P2|Second Period, 6 Weeks|Adverse Event|7
4672345|NCT02706938|16075010|P1|Second Period, 6 Weeks|Adverse Event|0
4672346|NCT02706938|16075009|P2|First Period, 6 Weeks|Withdrawal by Subject|0
4672347|NCT02706938|16075010|P1|First Period, 6 Weeks|Withdrawal by Subject|1
4672348|NCT02706938|16075009|P2|First Period, 6 Weeks|Lost to Follow-up|2
4672349|NCT02706938|16075010|P1|First Period, 6 Weeks|Lost to Follow-up|2
4672350|NCT02706938|16075009|P2|First Period, 6 Weeks|Adverse Event|0
4672351|NCT02706938|16075010|P1|First Period, 6 Weeks|Adverse Event|8
4672352|NCT02706899|16075074|P2|Overall Study|Study Termination by Sponsor|6
4672353|NCT02706899|16075075|P1|Overall Study|Study Termination by Sponsor|4
4672354|NCT02706899|16075074|P2|Overall Study|Death|0
4672355|NCT02706899|16075075|P1|Overall Study|Death|8
4672356|NCT02706899|16075074|P2|Overall Study|Withdrawal by Subject|0
4672357|NCT02706899|16075075|P1|Overall Study|Withdrawal by Subject|1
4672358|NCT02706886|16075106|P9|Part A: SAD Period|Withdrawal by Subject|0
4672359|NCT02706886|16075107|P8|Part A: SAD Period|Withdrawal by Subject|0
4672360|NCT02706886|16075108|P7|Part A: SAD Period|Withdrawal by Subject|0
4672361|NCT02706886|16075109|P6|Part A: SAD Period|Withdrawal by Subject|0
4672362|NCT02706886|16075110|P5|Part A: SAD Period|Withdrawal by Subject|0
4672363|NCT02706886|16075111|P4|Part A: SAD Period|Withdrawal by Subject|2
4672364|NCT02706886|16075112|P3|Part A: SAD Period|Withdrawal by Subject|0
4672365|NCT02706886|16075113|P2|Part A: SAD Period|Withdrawal by Subject|0
4672366|NCT02706886|16075114|P1|Part A: SAD Period|Withdrawal by Subject|0
4672367|NCT02706873|16075231|P4|Overall Study|Ongoing|1
4672368|NCT02706873|16075232|P3|Overall Study|Ongoing|0
4672369|NCT02706873|16075233|P2|Overall Study|Ongoing|0
4672370|NCT02706873|16075234|P1|Overall Study|Ongoing|0
4672371|NCT02706873|16075231|P4|Overall Study|Not Dosed|1
4672372|NCT02706873|16075232|P3|Overall Study|Not Dosed|0
4672373|NCT02706873|16075233|P2|Overall Study|Not Dosed|0
4672374|NCT02706873|16075234|P1|Overall Study|Not Dosed|1
4672375|NCT02706873|16075231|P4|Overall Study|Other|3
4672376|NCT02706873|16075232|P3|Overall Study|Other|2
4672377|NCT02706873|16075233|P2|Overall Study|Other|1
4672378|NCT02706873|16075234|P1|Overall Study|Other|5
4672379|NCT02706873|16075231|P4|Overall Study|Lack of Efficacy|3
4672380|NCT02706873|16075232|P3|Overall Study|Lack of Efficacy|0
4672381|NCT02706873|16075233|P2|Overall Study|Lack of Efficacy|0
4672382|NCT02706873|16075234|P1|Overall Study|Lack of Efficacy|10
4672383|NCT02706873|16075231|P4|Overall Study|Lost to Follow-up|2
4672384|NCT02706873|16075232|P3|Overall Study|Lost to Follow-up|4
4672385|NCT02706873|16075233|P2|Overall Study|Lost to Follow-up|0
4672386|NCT02706873|16075234|P1|Overall Study|Lost to Follow-up|3
4672387|NCT02706873|16075231|P4|Overall Study|Withdrawal by Subject|11
4672388|NCT02706873|16075232|P3|Overall Study|Withdrawal by Subject|8
4672389|NCT02706873|16075233|P2|Overall Study|Withdrawal by Subject|0
4672390|NCT02706873|16075234|P1|Overall Study|Withdrawal by Subject|15
4672391|NCT02706873|16075231|P4|Overall Study|Adverse Event|12
4672392|NCT02706873|16075232|P3|Overall Study|Adverse Event|13
4672393|NCT02706873|16075233|P2|Overall Study|Adverse Event|3
4672394|NCT02706873|16075234|P1|Overall Study|Adverse Event|13
4672395|NCT02706847|16075334|P4|Week 12 to Week 24|Other|4
4672396|NCT02706847|16075335|P3|Week 12 to Week 24|Other|1
4672397|NCT02706847|16075336|P2|Week 12 to Week 24|Other|0
4672398|NCT02706847|16075337|P1|Week 12 to Week 24|Other|1
4672399|NCT02706847|16075334|P4|Week 12 to Week 24|Lost to Follow-up|1
4672400|NCT02706847|16075335|P3|Week 12 to Week 24|Lost to Follow-up|0
4672401|NCT02706847|16075336|P2|Week 12 to Week 24|Lost to Follow-up|0
4672402|NCT02706847|16075337|P1|Week 12 to Week 24|Lost to Follow-up|0
4672403|NCT02706847|16075334|P4|Week 12 to Week 24|Withdrawal by Subject|4
4672404|NCT02706847|16075335|P3|Week 12 to Week 24|Withdrawal by Subject|1
4672405|NCT02706847|16075336|P2|Week 12 to Week 24|Withdrawal by Subject|0
4672406|NCT02706847|16075337|P1|Week 12 to Week 24|Withdrawal by Subject|1
4672407|NCT02706847|16075334|P4|Week 12 to Week 24|Adverse Event|5
4672408|NCT02706847|16075335|P3|Week 12 to Week 24|Adverse Event|2
4672409|NCT02706847|16075336|P2|Week 12 to Week 24|Adverse Event|2
4672410|NCT02706847|16075337|P1|Week 12 to Week 24|Adverse Event|1
4672411|NCT02706847|16075334|P4|Day 1 to Week 12|Randomized in Error|0
4672412|NCT02706847|16075335|P3|Day 1 to Week 12|Randomized in Error|1
4672413|NCT02706847|16075336|P2|Day 1 to Week 12|Randomized in Error|0
4672414|NCT02706847|16075337|P1|Day 1 to Week 12|Randomized in Error|0
4672415|NCT02706847|16075334|P4|Day 1 to Week 12|Other|2
4672416|NCT02706847|16075335|P3|Day 1 to Week 12|Other|2
4672417|NCT02706847|16075336|P2|Day 1 to Week 12|Other|4
4672418|NCT02706847|16075337|P1|Day 1 to Week 12|Other|4
4672419|NCT02706847|16075334|P4|Day 1 to Week 12|Lost to Follow-up|0
4672420|NCT02706847|16075335|P3|Day 1 to Week 12|Lost to Follow-up|0
4672421|NCT02706847|16075336|P2|Day 1 to Week 12|Lost to Follow-up|1
4672422|NCT02706847|16075337|P1|Day 1 to Week 12|Lost to Follow-up|2
4672423|NCT02706847|16075334|P4|Day 1 to Week 12|Withdrawal by Subject|2
4672424|NCT02706847|16075335|P3|Day 1 to Week 12|Withdrawal by Subject|4
4672425|NCT02706847|16075336|P2|Day 1 to Week 12|Withdrawal by Subject|1
4672426|NCT02706847|16075337|P1|Day 1 to Week 12|Withdrawal by Subject|2
4672427|NCT02706847|16075334|P4|Day 1 to Week 12|Adverse Event|12
4672428|NCT02706847|16075335|P3|Day 1 to Week 12|Adverse Event|1
4672429|NCT02706847|16075336|P2|Day 1 to Week 12|Adverse Event|2
4672430|NCT02706847|16075337|P1|Day 1 to Week 12|Adverse Event|2
4672431|NCT02706834|16075379|P11|Overall Study|Other Reason Not Specified|0
4672432|NCT02706834|16075380|P10|Overall Study|Other Reason Not Specified|0
4672433|NCT02706834|16075381|P9|Overall Study|Other Reason Not Specified|0
4672434|NCT02706834|16075382|P8|Overall Study|Other Reason Not Specified|0
4672435|NCT02706834|16075383|P7|Overall Study|Other Reason Not Specified|0
4672436|NCT02706834|16075384|P6|Overall Study|Other Reason Not Specified|0
4672437|NCT02706834|16075385|P5|Overall Study|Other Reason Not Specified|1
4672438|NCT02706834|16075386|P4|Overall Study|Other Reason Not Specified|0
4672439|NCT02706834|16075387|P3|Overall Study|Other Reason Not Specified|0
4672440|NCT02706834|16075388|P2|Overall Study|Other Reason Not Specified|0
4672441|NCT02706834|16075389|P1|Overall Study|Other Reason Not Specified|1
4672442|NCT02706834|16075379|P11|Overall Study|Voluntary Withdrawal|0
4672443|NCT02706834|16075380|P10|Overall Study|Voluntary Withdrawal|1
4672444|NCT02706834|16075381|P9|Overall Study|Voluntary Withdrawal|0
4672445|NCT02706834|16075382|P8|Overall Study|Voluntary Withdrawal|0
4672446|NCT02706834|16075383|P7|Overall Study|Voluntary Withdrawal|0
4672447|NCT02706834|16075384|P6|Overall Study|Voluntary Withdrawal|0
4672448|NCT02706834|16075385|P5|Overall Study|Voluntary Withdrawal|0
4672449|NCT02706834|16075386|P4|Overall Study|Voluntary Withdrawal|0
4672450|NCT02706834|16075387|P3|Overall Study|Voluntary Withdrawal|0
4672451|NCT02706834|16075388|P2|Overall Study|Voluntary Withdrawal|0
4672452|NCT02706834|16075389|P1|Overall Study|Voluntary Withdrawal|1
4672453|NCT02706834|16075379|P11|Overall Study|Lost to Follow-up|0
4672454|NCT02706834|16075380|P10|Overall Study|Lost to Follow-up|0
4672455|NCT02706834|16075381|P9|Overall Study|Lost to Follow-up|0
4672456|NCT02706834|16075382|P8|Overall Study|Lost to Follow-up|0
4672457|NCT02706834|16075383|P7|Overall Study|Lost to Follow-up|0
4672458|NCT02706834|16075384|P6|Overall Study|Lost to Follow-up|0
4672459|NCT02706834|16075385|P5|Overall Study|Lost to Follow-up|0
4672460|NCT02706834|16075386|P4|Overall Study|Lost to Follow-up|0
4672461|NCT02706834|16075387|P3|Overall Study|Lost to Follow-up|1
4672462|NCT02706834|16075388|P2|Overall Study|Lost to Follow-up|0
4672463|NCT02706834|16075389|P1|Overall Study|Lost to Follow-up|0
4672464|NCT02706834|16075379|P11|Overall Study|Pretreatment Event/Adverse Event|1
4672465|NCT02706834|16075380|P10|Overall Study|Pretreatment Event/Adverse Event|0
4672466|NCT02706834|16075381|P9|Overall Study|Pretreatment Event/Adverse Event|0
4672467|NCT02706834|16075382|P8|Overall Study|Pretreatment Event/Adverse Event|0
4672468|NCT02706834|16075383|P7|Overall Study|Pretreatment Event/Adverse Event|0
4672469|NCT02706834|16075384|P6|Overall Study|Pretreatment Event/Adverse Event|0
4672470|NCT02706834|16075385|P5|Overall Study|Pretreatment Event/Adverse Event|0
4672471|NCT02706834|16075386|P4|Overall Study|Pretreatment Event/Adverse Event|0
4672472|NCT02706834|16075387|P3|Overall Study|Pretreatment Event/Adverse Event|0
4672473|NCT02706834|16075388|P2|Overall Study|Pretreatment Event/Adverse Event|1
4672474|NCT02706834|16075389|P1|Overall Study|Pretreatment Event/Adverse Event|0
4672475|NCT02706717|16075533|P2|Overall Study|Death|1
4672476|NCT02706717|16075534|P1|Overall Study|Death|0
4672477|NCT02706717|16075533|P2|Overall Study|Physician Decision|1
4672478|NCT02706717|16075534|P1|Overall Study|Physician Decision|0
4672479|NCT02706717|16075533|P2|Overall Study|Lost to Follow-up|1
4672480|NCT02706717|16075534|P1|Overall Study|Lost to Follow-up|0
4672481|NCT02706717|16075533|P2|Overall Study|Withdrawal by Subject|8
4672482|NCT02706717|16075534|P1|Overall Study|Withdrawal by Subject|1
4672483|NCT02706691|16075598|P1|Overall Study|Adverse Event|1
4672484|NCT02706483|16075605|P1|Overall Study|Subject moved|1
4672485|NCT02706483|16075605|P1|Overall Study|Site closure|4
4672486|NCT02706483|16075605|P1|Overall Study|Non-compliance with visits|6
4672487|NCT02706483|16075605|P1|Overall Study|Withdrawal by Subject|136
4672488|NCT02706483|16075605|P1|Overall Study|Protocol Violation|18
4672489|NCT02706483|16075605|P1|Overall Study|Pregnancy|6
4672490|NCT02706483|16075605|P1|Overall Study|Physician Decision|6
4672491|NCT02706483|16075605|P1|Overall Study|Non-compliance with study drug|15
4672492|NCT02706483|16075605|P1|Overall Study|Lost to Follow-up|101
4672493|NCT02706483|16075605|P1|Overall Study|Lack of Efficacy|39
4672494|NCT02706483|16075605|P1|Overall Study|Death|1
4672495|NCT02706483|16075605|P1|Overall Study|Adverse Event|97
4672496|NCT02706327|16075612|P3|Overall Study|Lost to Follow-up|2
4672497|NCT02706327|16075613|P2|Overall Study|Lost to Follow-up|1
4672498|NCT02706327|16075614|P1|Overall Study|Lost to Follow-up|1
4672499|NCT02705716|16075666|P2|Overall Study|Withdrawal of Consent|1
4672500|NCT02705716|16075667|P1|Overall Study|Withdrawal of Consent|1
4672501|NCT02705716|16075666|P2|Overall Study|Protocol Violation|0
4672502|NCT02705716|16075667|P1|Overall Study|Protocol Violation|3
4672503|NCT02705716|16075666|P2|Overall Study|Adverse Event|1
4672504|NCT02705716|16075667|P1|Overall Study|Adverse Event|0
4672505|NCT02705625|16075680|P3|Overall Study|Overdosing|1
4672506|NCT02705625|16075681|P2|Overall Study|Overdosing|0
4672507|NCT02705625|16075682|P1|Overall Study|Overdosing|0
4672508|NCT02705625|16075680|P3|Overall Study|Non-compliance|1
4672509|NCT02705625|16075681|P2|Overall Study|Non-compliance|1
4672510|NCT02705625|16075682|P1|Overall Study|Non-compliance|0
4672511|NCT02705625|16075680|P3|Overall Study|Lost to Follow-up|1
4672512|NCT02705625|16075681|P2|Overall Study|Lost to Follow-up|0
4672513|NCT02705625|16075682|P1|Overall Study|Lost to Follow-up|0
4672514|NCT02705625|16075680|P3|Overall Study|Withdrawal by Subject|5
4672515|NCT02705625|16075681|P2|Overall Study|Withdrawal by Subject|4
4672516|NCT02705625|16075682|P1|Overall Study|Withdrawal by Subject|1
4672517|NCT02705625|16075680|P3|Overall Study|Death|1
4672518|NCT02705625|16075681|P2|Overall Study|Death|0
4672519|NCT02705625|16075682|P1|Overall Study|Death|0
4672520|NCT02705625|16075680|P3|Overall Study|Adverse Event|2
4672521|NCT02705625|16075681|P2|Overall Study|Adverse Event|5
4672522|NCT02705625|16075682|P1|Overall Study|Adverse Event|6
4672523|NCT02705625|16075680|P3|Overall Study|Protocol Violation|0
4672524|NCT02705625|16075681|P2|Overall Study|Protocol Violation|0
4672525|NCT02705625|16075682|P1|Overall Study|Protocol Violation|1
4672526|NCT02705586|16075711|P1|Overall Study|Vacation/Planned Absence|1
4672527|NCT02705586|16075711|P1|Overall Study|Transportation Difficulties|5
4672528|NCT02705586|16075711|P1|Overall Study|Health Issues|2
4672529|NCT02705105|16075749|P2|Follow-Up|Discontinued per Amendment 3|2
4672530|NCT02705105|16075750|P1|Follow-Up|Discontinued per Amendment 3|0
4672531|NCT02705105|16075749|P2|Follow-Up|Study Terminated|26
4672532|NCT02705105|16075750|P1|Follow-Up|Study Terminated|0
4672533|NCT02705105|16075749|P2|Follow-Up|Withdrawal by Subject|14
4672534|NCT02705105|16075750|P1|Follow-Up|Withdrawal by Subject|1
4672535|NCT02705105|16075749|P2|Follow-Up|Death|68
4672536|NCT02705105|16075750|P1|Follow-Up|Death|3
4672537|NCT02705105|16075749|P2|Treatment|Ongoing w/ Treatment at time of data cut|2
4672538|NCT02705105|16075750|P1|Treatment|Ongoing w/ Treatment at time of data cut|0
4672539|NCT02705105|16075749|P2|Treatment|Physician Decision|3
4672540|NCT02705105|16075750|P1|Treatment|Physician Decision|0
4672541|NCT02705105|16075749|P2|Treatment|Clinical Disease Progression|32
4672542|NCT02705105|16075750|P1|Treatment|Clinical Disease Progression|0
4672543|NCT02705105|16075749|P2|Treatment|Adverse Event|17
4672544|NCT02705105|16075750|P1|Treatment|Adverse Event|0
4672545|NCT02705105|16075749|P2|Treatment|Withdrawal by Subject|5
4672546|NCT02705105|16075750|P1|Treatment|Withdrawal by Subject|3
4672547|NCT02705105|16075749|P2|Treatment|Objective Disease Progression|50
4672548|NCT02705105|16075750|P1|Treatment|Objective Disease Progression|1
4672549|NCT02704689|16075813|P1|Overall Study|Study device not implanted|2
4673826|NCT02684357|16081276|P2|Part A|Other|1
4672550|NCT02704689|16075813|P1|Overall Study|Physician Decision|1
4672551|NCT02704143|16075830|P1|Overall Study|disease progression|10
4672552|NCT02704091|16075855|P2|Overall Study|Other|8
4672553|NCT02704091|16075856|P1|Overall Study|Other|2
4672554|NCT02704091|16075855|P2|Overall Study|Lost to Follow-up|5
4672555|NCT02704091|16075856|P1|Overall Study|Lost to Follow-up|13
4672556|NCT02704091|16075855|P2|Overall Study|Consent withdrawn|4
4672557|NCT02704091|16075856|P1|Overall Study|Consent withdrawn|4
4672558|NCT02704091|16075855|P2|Overall Study|Protocol Violation|3
4672559|NCT02704091|16075856|P1|Overall Study|Protocol Violation|5
4672560|NCT02704091|16075855|P2|Overall Study|Adverse Event|3
4672561|NCT02704091|16075856|P1|Overall Study|Adverse Event|4
4672562|NCT02703636|16075916|P1|Overall Study|Withdrawal by Subject|1
4672563|NCT02703636|16075916|P1|Overall Study|Study stopped by sponsor|1
4672564|NCT02703636|16075916|P1|Overall Study|Adverse Event|14
4672565|NCT02703532|16075931|P4|Overall Study|Lost to Follow-up|0
4672566|NCT02703532|16075932|P3|Overall Study|Lost to Follow-up|2
4672567|NCT02703532|16075933|P2|Overall Study|Lost to Follow-up|0
4672568|NCT02703532|16075934|P1|Overall Study|Lost to Follow-up|2
4672569|NCT02703532|16075931|P4|Overall Study|Withdrawal by Subject|1
4672570|NCT02703532|16075932|P3|Overall Study|Withdrawal by Subject|0
4672571|NCT02703532|16075933|P2|Overall Study|Withdrawal by Subject|1
4672572|NCT02703532|16075934|P1|Overall Study|Withdrawal by Subject|0
4672573|NCT02703454|16075996|P2|Overall Study|Study discontinuation|8
4672574|NCT02703454|16075997|P1|Overall Study|Study discontinuation|5
4672575|NCT02703454|16075996|P2|Overall Study|Lost to Follow-up|2
4672576|NCT02703454|16075997|P1|Overall Study|Lost to Follow-up|1
4672577|NCT02703454|16075996|P2|Overall Study|Withdrawal by Subject|3
4672578|NCT02703454|16075997|P1|Overall Study|Withdrawal by Subject|4
4672579|NCT02703454|16075996|P2|Overall Study|Not treated|3
4672580|NCT02703454|16075997|P1|Overall Study|Not treated|1
4672581|NCT02703337|16076032|P8|Period One (Part A)|Withdrawal by Subject|0
4672582|NCT02703337|16076033|P7|Period One (Part A)|Withdrawal by Subject|0
4672583|NCT02703337|16076034|P6|Period One (Part A)|Withdrawal by Subject|0
4672584|NCT02703337|16076035|P5|Period One (Part A)|Withdrawal by Subject|1
4672585|NCT02703337|16076036|P4|Period One (Part A)|Withdrawal by Subject|0
4672586|NCT02703337|16076037|P3|Period One (Part A)|Withdrawal by Subject|0
4672587|NCT02703337|16076038|P2|Period One (Part A)|Withdrawal by Subject|0
4672588|NCT02703337|16076039|P1|Period One (Part A)|Withdrawal by Subject|0
4672589|NCT02703324|16076059|P6|Period Two|Withdrawal by Subject|0
4672590|NCT02703324|16076060|P5|Period Two|Withdrawal by Subject|0
4672591|NCT02703324|16076061|P4|Period Two|Withdrawal by Subject|0
4672592|NCT02703324|16076062|P3|Period Two|Withdrawal by Subject|1
4672593|NCT02703324|16076063|P2|Period Two|Withdrawal by Subject|0
4672594|NCT02703324|16076064|P1|Period Two|Withdrawal by Subject|0
4672595|NCT02703259|16076075|P2|2 Weeks Postoperative Assessment|Lost to Follow-up|10
4672596|NCT02703259|16076076|P1|2 Weeks Postoperative Assessment|Lost to Follow-up|10
4672597|NCT02703259|16076075|P2|24 Hours Postoperative Assessment|excluded from analysis per protocol|2
4672598|NCT02703259|16076076|P1|24 Hours Postoperative Assessment|excluded from analysis per protocol|1
4672599|NCT02703259|16076075|P2|24 Hours Postoperative Assessment|Lost to Follow-up|4
4672600|NCT02703259|16076076|P1|24 Hours Postoperative Assessment|Lost to Follow-up|1
4672601|NCT02702609|16076124|P2|Overall Study|Physician Decision|0
4672602|NCT02702609|16076125|P1|Overall Study|Physician Decision|1
4672603|NCT02702609|16076124|P2|Overall Study|Lost to Follow-up|4
4672604|NCT02702609|16076125|P1|Overall Study|Lost to Follow-up|8
4672605|NCT02702401|16076143|P2|Overall Study|Ongoing in study|34
4672606|NCT02702401|16076144|P1|Overall Study|Ongoing in study|94
4672607|NCT02702401|16076143|P2|Overall Study|Withdrawal by Subject|0
4672608|NCT02702401|16076144|P1|Overall Study|Withdrawal by Subject|4
4672609|NCT02702401|16076143|P2|Overall Study|Death|101
4672610|NCT02702401|16076144|P1|Overall Study|Death|180
4672611|NCT02702193|16076166|P2|12 Month Follow up|Lost to Follow-up|18
4672612|NCT02702193|16076167|P1|12 Month Follow up|Lost to Follow-up|16
4672613|NCT02702193|16076166|P2|12 Month Follow up|Withdrawal by Subject|0
4672614|NCT02702193|16076167|P1|12 Month Follow up|Withdrawal by Subject|1
4672615|NCT02702193|16076166|P2|8 Month Follow up|Lost to Follow-up|18
4672616|NCT02702193|16076167|P1|8 Month Follow up|Lost to Follow-up|14
4672617|NCT02702193|16076166|P2|8 Month Follow up|Withdrawal by Subject|0
4672618|NCT02702193|16076167|P1|8 Month Follow up|Withdrawal by Subject|1
4672619|NCT02702193|16076166|P2|4 Month Follow up|Lost to Follow-up|18
4672620|NCT02702193|16076167|P1|4 Month Follow up|Lost to Follow-up|17
4672621|NCT02702193|16076166|P2|4 Month Follow up|Withdrawal by Subject|0
4672622|NCT02702193|16076167|P1|4 Month Follow up|Withdrawal by Subject|1
4672623|NCT02702193|16076166|P2|Baseline Assessment/Randomization|Withdrawal by Subject|0
4672624|NCT02702193|16076167|P1|Baseline Assessment/Randomization|Withdrawal by Subject|1
4672625|NCT02702011|16076195|P4|Overall Study|Withdrawal by Subject|0
4672626|NCT02702011|16076196|P3|Overall Study|Withdrawal by Subject|0
4672627|NCT02702011|16076197|P2|Overall Study|Withdrawal by Subject|1
4672628|NCT02702011|16076198|P1|Overall Study|Withdrawal by Subject|0
4672629|NCT02701985|16076210|P2|Overall Study|Adverse Event|5
4672630|NCT02701985|16076211|P1|Overall Study|Adverse Event|0
4672631|NCT02701985|16076210|P2|Overall Study|Death|0
4672632|NCT02701985|16076211|P1|Overall Study|Death|1
4672633|NCT02701985|16076210|P2|Overall Study|Lost to Follow-up|0
4672634|NCT02701985|16076211|P1|Overall Study|Lost to Follow-up|1
4672635|NCT02701985|16076210|P2|Overall Study|Withdrawal by Subject|1
4672636|NCT02701985|16076211|P1|Overall Study|Withdrawal by Subject|1
4672637|NCT02701764|16076254|P2|Overall Study|Lost to Follow-up|1
4672638|NCT02701764|16076255|P1|Overall Study|Lost to Follow-up|0
4672639|NCT02701634|16076314|P2|Overall Study|Randomized but not treated|0
4672640|NCT02701634|16076315|P1|Overall Study|Randomized but not treated|1
4672641|NCT02701634|16076314|P2|Overall Study|Withdrew Consent|7
4672642|NCT02701634|16076315|P1|Overall Study|Withdrew Consent|6
4672643|NCT02701634|16076314|P2|Overall Study|Study terminated by Sponsor|17
4672644|NCT02701634|16076315|P1|Overall Study|Study terminated by Sponsor|15
4672645|NCT02701634|16076314|P2|Overall Study|Investigator's Discretion|4
4672646|NCT02701634|16076315|P1|Overall Study|Investigator's Discretion|7
4672647|NCT02701634|16076314|P2|Overall Study|Death|0
4672648|NCT02701634|16076315|P1|Overall Study|Death|1
4672649|NCT02701634|16076314|P2|Overall Study|Adverse Event|3
4672650|NCT02701634|16076315|P1|Overall Study|Adverse Event|2
4672651|NCT02701361|16076385|P3|Overall Study|incarceration|1
4672652|NCT02701361|16076386|P2|Overall Study|incarceration|0
4672653|NCT02701361|16076387|P1|Overall Study|incarceration|0
4672654|NCT02701361|16076385|P3|Overall Study|timed out in rehab center|0
4672655|NCT02701361|16076386|P2|Overall Study|timed out in rehab center|1
4672656|NCT02701361|16076387|P1|Overall Study|timed out in rehab center|0
4672657|NCT02701361|16076385|P3|Overall Study|Withdrawal by Subject|0
4672658|NCT02701361|16076386|P2|Overall Study|Withdrawal by Subject|0
4672659|NCT02701361|16076387|P1|Overall Study|Withdrawal by Subject|4
4672660|NCT02701361|16076385|P3|Overall Study|Lost to Follow-up|1
4672661|NCT02701361|16076386|P2|Overall Study|Lost to Follow-up|2
4672662|NCT02701361|16076387|P1|Overall Study|Lost to Follow-up|5
4672663|NCT02701296|16076428|P2|Overall Study|Incomplete Data|2
4672664|NCT02701296|16076429|P1|Overall Study|Incomplete Data|0
4672665|NCT02700997|16076681|P1|Overall Study|No CT measurement - pelvic calcification|1
4672666|NCT02700997|16076681|P1|Overall Study|Did not undergo CT imaging|1
4672667|NCT02700984|16076687|P2|Overall Study|Reason not specified|2
4672668|NCT02700984|16076688|P1|Overall Study|Reason not specified|3
4672669|NCT02700984|16076687|P2|Overall Study|Withdrawal by Subject|9
4672670|NCT02700984|16076688|P1|Overall Study|Withdrawal by Subject|8
4672671|NCT02700984|16076687|P2|Overall Study|Physician Decision|1
4672672|NCT02700984|16076688|P1|Overall Study|Physician Decision|0
4672673|NCT02700984|16076687|P2|Overall Study|Lost to Follow-up|1
4672674|NCT02700984|16076688|P1|Overall Study|Lost to Follow-up|2
4672675|NCT02700984|16076687|P2|Overall Study|Death|1
4672676|NCT02700984|16076688|P1|Overall Study|Death|2
4672677|NCT02700815|16076741|P4|Overall Study|Withdrawal by Subject|0
4672678|NCT02700815|16076742|P3|Overall Study|Withdrawal by Subject|1
4672679|NCT02700815|16076743|P2|Overall Study|Withdrawal by Subject|0
4672680|NCT02700815|16076744|P1|Overall Study|Withdrawal by Subject|0
4672681|NCT02700815|16076741|P4|Overall Study|Refusal to continue medication|1
4672682|NCT02700815|16076742|P3|Overall Study|Refusal to continue medication|0
4672683|NCT02700815|16076743|P2|Overall Study|Refusal to continue medication|1
4672684|NCT02700815|16076744|P1|Overall Study|Refusal to continue medication|0
4672685|NCT02700815|16076741|P4|Overall Study|Lost to Follow-up|1
4672686|NCT02700815|16076742|P3|Overall Study|Lost to Follow-up|0
4672687|NCT02700815|16076743|P2|Overall Study|Lost to Follow-up|0
4672688|NCT02700815|16076744|P1|Overall Study|Lost to Follow-up|1
4672689|NCT02700815|16076741|P4|Overall Study|Lack of Efficacy|2
4672690|NCT02700815|16076742|P3|Overall Study|Lack of Efficacy|1
4672691|NCT02700815|16076743|P2|Overall Study|Lack of Efficacy|0
4672692|NCT02700815|16076744|P1|Overall Study|Lack of Efficacy|0
4672693|NCT02700815|16076741|P4|Overall Study|Adverse Event|3
4672694|NCT02700815|16076742|P3|Overall Study|Adverse Event|2
4672695|NCT02700815|16076743|P2|Overall Study|Adverse Event|6
4672696|NCT02700815|16076744|P1|Overall Study|Adverse Event|0
4672697|NCT02700412|16076782|P1|Overall Study|Withdrawal by Subject|2
4672698|NCT02700412|16076782|P1|Overall Study|Protocol Violation|5
4672699|NCT02700412|16076782|P1|Overall Study|Lack of Efficacy|19
4672700|NCT02700412|16076782|P1|Overall Study|Death|1
4672701|NCT02700412|16076782|P1|Overall Study|Adverse Event|6
4672702|NCT02699996|16076833|P2|Overall Study|Withdrawal by Subject|2
4672703|NCT02699996|16076834|P1|Overall Study|Withdrawal by Subject|5
4672704|NCT02699983|16076852|P2|Overall Study|Withdrawal by Subject|0
4672705|NCT02699983|16076853|P1|Overall Study|Withdrawal by Subject|1
4672706|NCT02699892|16076918|P1|Overall Study|Other|36
4672707|NCT02699866|16076923|P1|Overall Study|Adverse Event|3
4672708|NCT02699866|16076923|P1|Overall Study|Physician Decision|2
4672709|NCT02699866|16076923|P1|Overall Study|Withdrawal by Subject|3
4672710|NCT02699684|16076931|P2|Period 2, Second 30 Days of Wear|Adverse Event|0
4672711|NCT02699684|16076932|P1|Period 2, Second 30 Days of Wear|Adverse Event|1
4672712|NCT02699593|16076949|P2|Period 2|Torn Contact Lens|0
4672713|NCT02699593|16076950|P1|Period 2|Torn Contact Lens|1
4672714|NCT02699593|16076949|P2|Period 2|Lost Contact Lens|1
4672715|NCT02699593|16076950|P1|Period 2|Lost Contact Lens|0
4672716|NCT02699593|16076949|P2|Period 2|Adverse Event|1
4672717|NCT02699593|16076950|P1|Period 2|Adverse Event|1
4672718|NCT02699593|16076949|P2|Period 1|Adverse Event|1
4672719|NCT02699593|16076950|P1|Period 1|Adverse Event|1
4672720|NCT02699593|16076949|P2|Period 1|Withdrawal by Subject|1
4672721|NCT02699593|16076950|P1|Period 1|Withdrawal by Subject|0
4672722|NCT02699593|16076949|P2|Period 1|Protocol Violation|1
4672723|NCT02699593|16076950|P1|Period 1|Protocol Violation|0
4672724|NCT02699593|16076949|P2|Period 1|Torn Contact Len|3
4672725|NCT02699593|16076950|P1|Period 1|Torn Contact Len|4
4673827|NCT02684357|16081277|P1|Part A|Other|0
4672726|NCT02699593|16076949|P2|Period 1|Unsatisfactory Visual Response|1
4672727|NCT02699593|16076950|P1|Period 1|Unsatisfactory Visual Response|0
4672728|NCT02699450|16076961|P3|Overall Study|Adverse Event|0
4672729|NCT02699450|16076962|P2|Overall Study|Adverse Event|0
4672730|NCT02699450|16076963|P1|Overall Study|Adverse Event|1
4672731|NCT02699450|16076961|P3|Overall Study|Withdrawal by Subject|2
4672732|NCT02699450|16076962|P2|Overall Study|Withdrawal by Subject|1
4672733|NCT02699450|16076963|P1|Overall Study|Withdrawal by Subject|3
4672734|NCT02699450|16076961|P3|Overall Study|Physician Decision|0
4672735|NCT02699450|16076962|P2|Overall Study|Physician Decision|0
4672736|NCT02699450|16076963|P1|Overall Study|Physician Decision|2
4672737|NCT02699450|16076961|P3|Overall Study|Lost to Follow-up|5
4672738|NCT02699450|16076962|P2|Overall Study|Lost to Follow-up|0
4672739|NCT02699450|16076963|P1|Overall Study|Lost to Follow-up|3
4672740|NCT02699450|16076961|P3|Overall Study|Protocol Violation|5
4672741|NCT02699450|16076962|P2|Overall Study|Protocol Violation|3
4672742|NCT02699450|16076963|P1|Overall Study|Protocol Violation|4
4672743|NCT02699450|16076961|P3|Overall Study|Met Criteria for Study Exit|1
4672744|NCT02699450|16076962|P2|Overall Study|Met Criteria for Study Exit|0
4672745|NCT02699450|16076963|P1|Overall Study|Met Criteria for Study Exit|0
4672746|NCT02699450|16076961|P3|Overall Study|Death|2
4672747|NCT02699450|16076962|P2|Overall Study|Death|1
4672748|NCT02699450|16076963|P1|Overall Study|Death|2
4672749|NCT02699099|16077101|P3|Overall Study|Withdrawal by Subject|2
4672750|NCT02699099|16077102|P2|Overall Study|Withdrawal by Subject|1
4672751|NCT02699099|16077103|P1|Overall Study|Withdrawal by Subject|6
4672752|NCT02699099|16077101|P3|Overall Study|Lost to Follow-up|0
4672753|NCT02699099|16077102|P2|Overall Study|Lost to Follow-up|1
4672754|NCT02699099|16077103|P1|Overall Study|Lost to Follow-up|0
4672755|NCT02699099|16077101|P3|Overall Study|Adverse Event|1
4672756|NCT02699099|16077102|P2|Overall Study|Adverse Event|0
4672757|NCT02699099|16077103|P1|Overall Study|Adverse Event|1
4672758|NCT02698865|16077179|P2|Overall Study|Lost to Follow-up|2
4672759|NCT02698865|16077180|P1|Overall Study|Lost to Follow-up|4
4672760|NCT02698865|16077179|P2|Overall Study|Physician Decision|4
4672761|NCT02698865|16077180|P1|Overall Study|Physician Decision|0
4672762|NCT02698865|16077179|P2|Overall Study|Withdrawal by Subject|16
4672763|NCT02698865|16077180|P1|Overall Study|Withdrawal by Subject|20
4672764|NCT02698865|16077179|P2|Overall Study|Other|11
4672765|NCT02698865|16077180|P1|Overall Study|Other|11
4672766|NCT02698475|16077218|P1|Overall Study|Protocol Violation|1
4672767|NCT02698475|16077218|P1|Overall Study|Withdrawal by Subject|3
4672768|NCT02698475|16077218|P1|Overall Study|Lack of Efficacy|1
4672769|NCT02698436|16077235|P2|Overall Study|Non-compliance with study regimen|0
4672770|NCT02698436|16077236|P1|Overall Study|Non-compliance with study regimen|1
4672771|NCT02698436|16077235|P2|Overall Study|Lost to Follow-up|4
4672772|NCT02698436|16077236|P1|Overall Study|Lost to Follow-up|2
4672773|NCT02698436|16077235|P2|Overall Study|Withdrawal by Subject|3
4672774|NCT02698436|16077236|P1|Overall Study|Withdrawal by Subject|3
4672775|NCT02698436|16077235|P2|Overall Study|Adverse Event|0
4672776|NCT02698436|16077236|P1|Overall Study|Adverse Event|1
4672777|NCT02698423|16077276|P2|Overall Study|Lost to Follow-up|24
4672778|NCT02698423|16077277|P1|Overall Study|Lost to Follow-up|19
4672779|NCT02698410|16077285|P1|Overall Study|Other|1
4672780|NCT02698410|16077285|P1|Overall Study|Withdrawal by Subject|1
4672781|NCT02698410|16077285|P1|Overall Study|Adverse Event|2
4672782|NCT02698371|16077304|P1|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2
4672783|NCT02698371|16077304|P1|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3
4672784|NCT02698371|16077304|P1|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3
4672785|NCT02698371|16077304|P1|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3
4672786|NCT02698371|16077304|P1|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3
4672787|NCT02698371|16077304|P1|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3
4672788|NCT02698371|16077304|P1|All Participants Flow|Lost to Follow-up|3
4672789|NCT02698241|16077426|P1|Overall Study|Death|2
4672790|NCT02698241|16077426|P1|Overall Study|geographic and licensing issue|1
4672791|NCT02698241|16077426|P1|Overall Study|Subject on inodrip not safe to continue|6
4672792|NCT02698241|16077426|P1|Overall Study|Lost to Follow-up|3
4672793|NCT02698241|16077426|P1|Overall Study|Subject underwent system modification|2
4672794|NCT02698241|16077426|P1|Overall Study|Physician Decision|2
4672795|NCT02698241|16077426|P1|Overall Study|Withdrawal by Subject|7
4672796|NCT02698241|16077426|P1|Overall Study|Screening not met|7
4672797|NCT02698241|16077426|P1|Overall Study|Inclusion/exclusion criteria not met|4
4672798|NCT02698189|16077433|P2|Overall Study|Still ongoing in the study|1
4672799|NCT02698189|16077434|P1|Overall Study|Still ongoing in the study|0
4672800|NCT02698189|16077433|P2|Overall Study|Progressive disease|5
4672801|NCT02698189|16077434|P1|Overall Study|Progressive disease|3
4672802|NCT02698176|16077464|P4|Overall Study|Clinical progression|0
4672803|NCT02698176|16077465|P3|Overall Study|Clinical progression|0
4672804|NCT02698176|16077466|P2|Overall Study|Clinical progression|0
4672805|NCT02698176|16077467|P1|Overall Study|Clinical progression|3
4672806|NCT02698176|16077464|P4|Overall Study|Adverse Event|0
4672807|NCT02698176|16077465|P3|Overall Study|Adverse Event|0
4672808|NCT02698176|16077466|P2|Overall Study|Adverse Event|0
4672809|NCT02698176|16077467|P1|Overall Study|Adverse Event|2
4672810|NCT02698176|16077464|P4|Overall Study|Progressive disease|0
4672811|NCT02698176|16077465|P3|Overall Study|Progressive disease|1
4672812|NCT02698176|16077466|P2|Overall Study|Progressive disease|3
4672813|NCT02698176|16077467|P1|Overall Study|Progressive disease|4
4672814|NCT02697773|16077524|P3|Overall Study|Randomized but not treated|0
4672815|NCT02697773|16077525|P2|Overall Study|Randomized but not treated|1
4672816|NCT02697773|16077526|P1|Overall Study|Randomized but not treated|1
4672817|NCT02697773|16077524|P3|Overall Study|Withdrawal by Subject|13
4672818|NCT02697773|16077525|P2|Overall Study|Withdrawal by Subject|13
4672819|NCT02697773|16077526|P1|Overall Study|Withdrawal by Subject|10
4672820|NCT02697773|16077524|P3|Overall Study|Protocol Violation|0
4672821|NCT02697773|16077525|P2|Overall Study|Protocol Violation|1
4672822|NCT02697773|16077526|P1|Overall Study|Protocol Violation|1
4672823|NCT02697773|16077524|P3|Overall Study|Other|10
4672824|NCT02697773|16077525|P2|Overall Study|Other|11
4672825|NCT02697773|16077526|P1|Overall Study|Other|15
4672826|NCT02697773|16077524|P3|Overall Study|Lost to Follow-up|7
4672827|NCT02697773|16077525|P2|Overall Study|Lost to Follow-up|5
4672828|NCT02697773|16077526|P1|Overall Study|Lost to Follow-up|5
4672829|NCT02697773|16077524|P3|Overall Study|Lack of Efficacy|6
4672830|NCT02697773|16077525|P2|Overall Study|Lack of Efficacy|6
4672831|NCT02697773|16077526|P1|Overall Study|Lack of Efficacy|4
4672832|NCT02697773|16077524|P3|Overall Study|Death|2
4672833|NCT02697773|16077525|P2|Overall Study|Death|0
4672834|NCT02697773|16077526|P1|Overall Study|Death|0
4672835|NCT02697773|16077524|P3|Overall Study|Adverse Event|2
4672836|NCT02697773|16077525|P2|Overall Study|Adverse Event|1
4672837|NCT02697773|16077526|P1|Overall Study|Adverse Event|2
4672838|NCT02697435|16077707|P2|Overall Study|Physician Decision|4
4672839|NCT02697435|16077708|P1|Overall Study|Physician Decision|0
4672840|NCT02697435|16077707|P2|Overall Study|Withdrawal by Subject|0
4672841|NCT02697435|16077708|P1|Overall Study|Withdrawal by Subject|1
4672842|NCT02696850|16077816|P2|Overall Study|Lost to Follow-up|5
4672843|NCT02696850|16077817|P1|Overall Study|Lost to Follow-up|8
4672844|NCT02696850|16077816|P2|Overall Study|Withdrawal by Subject|3
4672845|NCT02696850|16077817|P1|Overall Study|Withdrawal by Subject|3
4672846|NCT02696798|16077830|P3|Post-treatment Follow-up Period|No progressive improvement|0
4672847|NCT02696798|16077831|P2|Post-treatment Follow-up Period|No progressive improvement|1
4672848|NCT02696798|16077832|P1|Post-treatment Follow-up Period|No progressive improvement|0
4672849|NCT02696798|16077830|P3|Post-treatment Follow-up Period|Physician Decision|0
4672850|NCT02696798|16077831|P2|Post-treatment Follow-up Period|Physician Decision|2
4672851|NCT02696798|16077832|P1|Post-treatment Follow-up Period|Physician Decision|0
4672852|NCT02696798|16077830|P3|Post-treatment Follow-up Period|Withdrawal by Subject|12
4672853|NCT02696798|16077831|P2|Post-treatment Follow-up Period|Withdrawal by Subject|8
4672854|NCT02696798|16077832|P1|Post-treatment Follow-up Period|Withdrawal by Subject|2
4672855|NCT02696798|16077830|P3|Post-treatment Follow-up Period|Lack of Efficacy|0
4672856|NCT02696798|16077831|P2|Post-treatment Follow-up Period|Lack of Efficacy|2
4672857|NCT02696798|16077832|P1|Post-treatment Follow-up Period|Lack of Efficacy|1
4672858|NCT02696798|16077830|P3|Post-treatment Follow-up Period|Lost to Follow-up|1
4672859|NCT02696798|16077831|P2|Post-treatment Follow-up Period|Lost to Follow-up|1
4672860|NCT02696798|16077832|P1|Post-treatment Follow-up Period|Lost to Follow-up|0
4672861|NCT02696798|16077830|P3|Post-treatment Follow-up Period|Adverse Event|6
4672862|NCT02696798|16077831|P2|Post-treatment Follow-up Period|Adverse Event|12
4672863|NCT02696798|16077832|P1|Post-treatment Follow-up Period|Adverse Event|2
4672864|NCT02696798|16077830|P3|Extended Treatment Period|Withdrawal by Subject|3
4672865|NCT02696798|16077831|P2|Extended Treatment Period|Withdrawal by Subject|2
4672866|NCT02696798|16077832|P1|Extended Treatment Period|Withdrawal by Subject|3
4672867|NCT02696798|16077830|P3|Extended Treatment Period|Physician Decision|0
4672868|NCT02696798|16077831|P2|Extended Treatment Period|Physician Decision|1
4672869|NCT02696798|16077832|P1|Extended Treatment Period|Physician Decision|0
4672870|NCT02696798|16077830|P3|Extended Treatment Period|Lost to Follow-up|0
4672871|NCT02696798|16077831|P2|Extended Treatment Period|Lost to Follow-up|0
4672872|NCT02696798|16077832|P1|Extended Treatment Period|Lost to Follow-up|1
4672873|NCT02696798|16077830|P3|Extended Treatment Period|Lack of Efficacy|2
4672874|NCT02696798|16077831|P2|Extended Treatment Period|Lack of Efficacy|2
4672875|NCT02696798|16077832|P1|Extended Treatment Period|Lack of Efficacy|7
4672876|NCT02696798|16077830|P3|Extended Treatment Period|Adverse Event|5
4672877|NCT02696798|16077831|P2|Extended Treatment Period|Adverse Event|4
4672878|NCT02696798|16077832|P1|Extended Treatment Period|Adverse Event|1
4672879|NCT02696798|16077830|P3|Blinded Treatment Dosing Period|Withdrawal by Subject|4
4672880|NCT02696798|16077831|P2|Blinded Treatment Dosing Period|Withdrawal by Subject|3
4672881|NCT02696798|16077832|P1|Blinded Treatment Dosing Period|Withdrawal by Subject|7
4672882|NCT02696798|16077830|P3|Blinded Treatment Dosing Period|Physician Decision|0
4672883|NCT02696798|16077831|P2|Blinded Treatment Dosing Period|Physician Decision|1
4672884|NCT02696798|16077832|P1|Blinded Treatment Dosing Period|Physician Decision|0
4672885|NCT02696798|16077830|P3|Blinded Treatment Dosing Period|Lost to Follow-up|0
4672886|NCT02696798|16077831|P2|Blinded Treatment Dosing Period|Lost to Follow-up|1
4672887|NCT02696798|16077832|P1|Blinded Treatment Dosing Period|Lost to Follow-up|0
4672888|NCT02696798|16077830|P3|Blinded Treatment Dosing Period|Lack of Efficacy|1
4672889|NCT02696798|16077831|P2|Blinded Treatment Dosing Period|Lack of Efficacy|1
4672890|NCT02696798|16077832|P1|Blinded Treatment Dosing Period|Lack of Efficacy|2
4672891|NCT02696798|16077830|P3|Blinded Treatment Dosing Period|Death|1
4672892|NCT02696798|16077831|P2|Blinded Treatment Dosing Period|Death|0
4672893|NCT02696798|16077832|P1|Blinded Treatment Dosing Period|Death|0
4672894|NCT02696798|16077830|P3|Blinded Treatment Dosing Period|Adverse Event|2
4672895|NCT02696798|16077831|P2|Blinded Treatment Dosing Period|Adverse Event|9
4672896|NCT02696798|16077832|P1|Blinded Treatment Dosing Period|Adverse Event|2
4672897|NCT02696785|16077929|P4|Follow-up Period|Withdrawal by Subject|4
4672898|NCT02696785|16077930|P3|Follow-up Period|Withdrawal by Subject|5
4672899|NCT02696785|16077931|P2|Follow-up Period|Withdrawal by Subject|0
4672900|NCT02696785|16077932|P1|Follow-up Period|Withdrawal by Subject|1
4672901|NCT02696785|16077929|P4|Follow-up Period|Lack of Efficacy|1
4672902|NCT02696785|16077930|P3|Follow-up Period|Lack of Efficacy|0
4672903|NCT02696785|16077931|P2|Follow-up Period|Lack of Efficacy|0
4672904|NCT02696785|16077932|P1|Follow-up Period|Lack of Efficacy|0
4672905|NCT02696785|16077929|P4|Follow-up Period|Lost to Follow-up|1
4672906|NCT02696785|16077930|P3|Follow-up Period|Lost to Follow-up|0
4672907|NCT02696785|16077931|P2|Follow-up Period|Lost to Follow-up|0
4672908|NCT02696785|16077932|P1|Follow-up Period|Lost to Follow-up|0
4672909|NCT02696785|16077929|P4|Follow-up Period|Adverse Event|2
4672910|NCT02696785|16077930|P3|Follow-up Period|Adverse Event|8
4672911|NCT02696785|16077931|P2|Follow-up Period|Adverse Event|0
4672912|NCT02696785|16077932|P1|Follow-up Period|Adverse Event|0
4672913|NCT02696785|16077929|P4|Extended Treatment Period|Withdrawal by Subject|5
4672914|NCT02696785|16077930|P3|Extended Treatment Period|Withdrawal by Subject|3
4672915|NCT02696785|16077931|P2|Extended Treatment Period|Withdrawal by Subject|2
4672916|NCT02696785|16077932|P1|Extended Treatment Period|Withdrawal by Subject|1
4672917|NCT02696785|16077929|P4|Extended Treatment Period|Lack of Efficacy|0
4672918|NCT02696785|16077930|P3|Extended Treatment Period|Lack of Efficacy|0
4672919|NCT02696785|16077931|P2|Extended Treatment Period|Lack of Efficacy|1
4672920|NCT02696785|16077932|P1|Extended Treatment Period|Lack of Efficacy|0
4672921|NCT02696785|16077929|P4|Extended Treatment Period|Adverse Event|1
4672922|NCT02696785|16077930|P3|Extended Treatment Period|Adverse Event|2
4672923|NCT02696785|16077931|P2|Extended Treatment Period|Adverse Event|3
4672924|NCT02696785|16077932|P1|Extended Treatment Period|Adverse Event|2
4672925|NCT02696785|16077929|P4|Washout Period|Lack of Efficacy|0
4672926|NCT02696785|16077930|P3|Washout Period|Lack of Efficacy|0
4672927|NCT02696785|16077931|P2|Washout Period|Lack of Efficacy|1
4672928|NCT02696785|16077932|P1|Washout Period|Lack of Efficacy|0
4672929|NCT02696785|16077929|P4|Washout Period|Withdrawal by Subject|0
4672930|NCT02696785|16077930|P3|Washout Period|Withdrawal by Subject|0
4672931|NCT02696785|16077931|P2|Washout Period|Withdrawal by Subject|1
4672932|NCT02696785|16077932|P1|Washout Period|Withdrawal by Subject|0
4672933|NCT02696785|16077929|P4|Blinded Treatment Period|Screen Failure|0
4672934|NCT02696785|16077930|P3|Blinded Treatment Period|Screen Failure|0
4672935|NCT02696785|16077931|P2|Blinded Treatment Period|Screen Failure|0
4672936|NCT02696785|16077932|P1|Blinded Treatment Period|Screen Failure|1
4672937|NCT02696785|16077929|P4|Blinded Treatment Period|Lack of Efficacy|1
4672938|NCT02696785|16077930|P3|Blinded Treatment Period|Lack of Efficacy|0
4672939|NCT02696785|16077931|P2|Blinded Treatment Period|Lack of Efficacy|0
4672940|NCT02696785|16077932|P1|Blinded Treatment Period|Lack of Efficacy|0
4672941|NCT02696785|16077929|P4|Blinded Treatment Period|Withdrawal by Subject|2
4672942|NCT02696785|16077930|P3|Blinded Treatment Period|Withdrawal by Subject|1
4672943|NCT02696785|16077931|P2|Blinded Treatment Period|Withdrawal by Subject|1
4672944|NCT02696785|16077932|P1|Blinded Treatment Period|Withdrawal by Subject|0
4672945|NCT02696785|16077929|P4|Blinded Treatment Period|Adverse Event|0
4672946|NCT02696785|16077930|P3|Blinded Treatment Period|Adverse Event|3
4672947|NCT02696785|16077931|P2|Blinded Treatment Period|Adverse Event|1
4672948|NCT02696785|16077932|P1|Blinded Treatment Period|Adverse Event|0
4672949|NCT02696434|16078052|P2|Overall Study|Physician Decision|1
4672950|NCT02696434|16078053|P1|Overall Study|Physician Decision|0
4672951|NCT02696434|16078052|P2|Overall Study|Withdrawal by Subject|12
4672952|NCT02696434|16078053|P1|Overall Study|Withdrawal by Subject|14
4672953|NCT02696434|16078052|P2|Overall Study|Lost to Follow-up|4
4672954|NCT02696434|16078053|P1|Overall Study|Lost to Follow-up|5
4672955|NCT02696434|16078052|P2|Overall Study|Adverse Event|1
4672956|NCT02696434|16078053|P1|Overall Study|Adverse Event|3
4672957|NCT02696317|16078071|P2|Period 2, 10 Days of Wear|Withdrawal by Subject|0
4672958|NCT02696317|16078072|P1|Period 2, 10 Days of Wear|Withdrawal by Subject|1
4672959|NCT02696317|16078071|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|4
4672960|NCT02696317|16078072|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|2
4672961|NCT02696226|16078116|P4|Overall Study|Study terminated - lack of enrollment|0
4672962|NCT02696226|16078117|P3|Overall Study|Study terminated - lack of enrollment|2
4672963|NCT02696226|16078118|P2|Overall Study|Study terminated - lack of enrollment|0
4672964|NCT02696226|16078119|P1|Overall Study|Study terminated - lack of enrollment|1
4672965|NCT02696031|16078150|P3|Week 52|Withdrawal by Subject|9
4672966|NCT02696031|16078151|P2|Week 52|Withdrawal by Subject|3
4672967|NCT02696031|16078152|P1|Week 52|Withdrawal by Subject|12
4672968|NCT02696031|16078150|P3|Week 52|Protocol Violation|0
4672969|NCT02696031|16078151|P2|Week 52|Protocol Violation|0
4672970|NCT02696031|16078152|P1|Week 52|Protocol Violation|1
4672971|NCT02696031|16078150|P3|Week 52|Pregnancy|0
4672972|NCT02696031|16078151|P2|Week 52|Pregnancy|2
4672973|NCT02696031|16078152|P1|Week 52|Pregnancy|0
4672974|NCT02696031|16078150|P3|Week 52|Physician Decision|2
4672975|NCT02696031|16078151|P2|Week 52|Physician Decision|1
4672976|NCT02696031|16078152|P1|Week 52|Physician Decision|1
4672977|NCT02696031|16078150|P3|Week 52|Lost to Follow-up|1
4672978|NCT02696031|16078151|P2|Week 52|Lost to Follow-up|1
4672979|NCT02696031|16078152|P1|Week 52|Lost to Follow-up|1
4672980|NCT02696031|16078150|P3|Week 52|Lack of Efficacy|11
4672981|NCT02696031|16078151|P2|Week 52|Lack of Efficacy|7
4672982|NCT02696031|16078152|P1|Week 52|Lack of Efficacy|10
4672983|NCT02696031|16078150|P3|Week 52|Adverse Event|3
4672984|NCT02696031|16078151|P2|Week 52|Adverse Event|5
4672985|NCT02696031|16078152|P1|Week 52|Adverse Event|4
4672986|NCT02696031|16078150|P3|Week 24|Withdrawal by Subject|5
4672987|NCT02696031|16078151|P2|Week 24|Withdrawal by Subject|1
4672988|NCT02696031|16078152|P1|Week 24|Withdrawal by Subject|4
4672989|NCT02696031|16078150|P3|Week 24|Protocol Violation|0
4672990|NCT02696031|16078151|P2|Week 24|Protocol Violation|0
4672991|NCT02696031|16078152|P1|Week 24|Protocol Violation|1
4672992|NCT02696031|16078150|P3|Week 24|Physician Decision|1
4672993|NCT02696031|16078151|P2|Week 24|Physician Decision|0
4672994|NCT02696031|16078152|P1|Week 24|Physician Decision|1
4672995|NCT02696031|16078150|P3|Week 24|Lost to Follow-up|1
4672996|NCT02696031|16078151|P2|Week 24|Lost to Follow-up|1
4672997|NCT02696031|16078152|P1|Week 24|Lost to Follow-up|0
4672998|NCT02696031|16078150|P3|Week 24|Lack of Efficacy|2
4672999|NCT02696031|16078151|P2|Week 24|Lack of Efficacy|1
4673000|NCT02696031|16078152|P1|Week 24|Lack of Efficacy|2
4673001|NCT02696031|16078150|P3|Week 24|Adverse Event|2
4673002|NCT02696031|16078151|P2|Week 24|Adverse Event|4
4673003|NCT02696031|16078152|P1|Week 24|Adverse Event|2
4673004|NCT02695719|16078166|P2|Overall Study|Voluntary Withdrawal|0
4673005|NCT02695719|16078167|P1|Overall Study|Voluntary Withdrawal|1
4673006|NCT02695719|16078166|P2|Overall Study|Significant Protocol Deviation|1
4673007|NCT02695719|16078167|P1|Overall Study|Significant Protocol Deviation|0
4673008|NCT02695719|16078166|P2|Overall Study|Pretreatment Event/Adverse Event|9
4673009|NCT02695719|16078167|P1|Overall Study|Pretreatment Event/Adverse Event|2
4673010|NCT02695628|16078185|P1|Overall Study|Withdrawal by Subject|1
4673011|NCT02695537|16078191|P1|Overall Study|Protocol Violation|3
4673012|NCT02695537|16078191|P1|Overall Study|Withdrawal by Subject|4
4673013|NCT02695537|16078191|P1|Overall Study|Lack of Efficacy|28
4673014|NCT02695537|16078191|P1|Overall Study|Adverse Event|3
4673015|NCT02695524|16078201|P2|Overall Study|Death|1
4673016|NCT02695524|16078202|P1|Overall Study|Death|0
4673017|NCT02695524|16078201|P2|Overall Study|Lost to Follow-up|2
4673018|NCT02695524|16078202|P1|Overall Study|Lost to Follow-up|3
4673019|NCT02695420|16078231|P4|Overall Study|Death|0
4673020|NCT02695420|16078232|P3|Overall Study|Death|0
4673021|NCT02695420|16078233|P2|Overall Study|Death|1
4673022|NCT02695420|16078234|P1|Overall Study|Death|0
4673023|NCT02695329|16078256|P2|Overall Study|Poor X-ray quality for measurement|5
4673024|NCT02695329|16078257|P1|Overall Study|Poor X-ray quality for measurement|4
4673025|NCT02695329|16078256|P2|Overall Study|Adverse Event|0
4673026|NCT02695329|16078257|P1|Overall Study|Adverse Event|1
4673027|NCT02694978|16078277|P2|Overall Study|Other-Withdrew prior to dosing|8
4673028|NCT02694978|16078278|P1|Overall Study|Other-Withdrew prior to dosing|9
4673029|NCT02694978|16078277|P2|Overall Study|Other-Personal reasons|3
4673030|NCT02694978|16078278|P1|Overall Study|Other-Personal reasons|3
4673031|NCT02694978|16078277|P2|Overall Study|Other-Protocol noncompliant|1
4673032|NCT02694978|16078278|P1|Overall Study|Other-Protocol noncompliant|2
4673033|NCT02694978|16078277|P2|Overall Study|Other-Unable to be reached|1
4673034|NCT02694978|16078278|P1|Overall Study|Other-Unable to be reached|0
4673035|NCT02694978|16078277|P2|Overall Study|Other-Investigator's decision|0
4673036|NCT02694978|16078278|P1|Overall Study|Other-Investigator's decision|1
4673037|NCT02694978|16078277|P2|Overall Study|Other-Decision of Participant|1
4673038|NCT02694978|16078278|P1|Overall Study|Other-Decision of Participant|6
4673039|NCT02694978|16078277|P2|Overall Study|Death|1
4673040|NCT02694978|16078278|P1|Overall Study|Death|4
4673041|NCT02694978|16078277|P2|Overall Study|Lost to Follow-up|17
4673042|NCT02694978|16078278|P1|Overall Study|Lost to Follow-up|14
4673043|NCT02694978|16078277|P2|Overall Study|Withdrawal by Subject|19
4673044|NCT02694978|16078278|P1|Overall Study|Withdrawal by Subject|22
4673045|NCT02694978|16078277|P2|Overall Study|Adverse Event|9
4673046|NCT02694978|16078278|P1|Overall Study|Adverse Event|10
4673047|NCT02694757|16078299|P1|Overall Study|Lack of Efficacy|3
4673048|NCT02694744|16078305|P2|Overall Study|Taking potassium supplement: exclusion 6|1
4673049|NCT02694744|16078306|P1|Overall Study|Taking potassium supplement: exclusion 6|0
4673050|NCT02694744|16078305|P2|Overall Study|Lost to Follow-up|0
4673051|NCT02694744|16078306|P1|Overall Study|Lost to Follow-up|1
4673052|NCT02694744|16078305|P2|Overall Study|Physician Decision|2
4673053|NCT02694744|16078306|P1|Overall Study|Physician Decision|1
4673054|NCT02694744|16078305|P2|Overall Study|Withdrawal by Subject|1
4673055|NCT02694744|16078306|P1|Overall Study|Withdrawal by Subject|2
4673056|NCT02694744|16078305|P2|Overall Study|Adverse Event|1
4673057|NCT02694744|16078306|P1|Overall Study|Adverse Event|2
4673058|NCT02694718|16078314|P1|Overall Study|Withdrawal by Subject|1
4673059|NCT02694718|16078314|P1|Overall Study|Death|1
4673060|NCT02694562|16078332|P1|Overall Study|Physician Decision|1
4673061|NCT02694562|16078332|P1|Overall Study|Screen Failure|2
4673062|NCT02694562|16078332|P1|Overall Study|Lost to Follow-up|3
4673063|NCT02694562|16078332|P1|Overall Study|Protocol Violation|4
4673064|NCT02694562|16078332|P1|Overall Study|Death|8
4673065|NCT02694549|16078341|P1|Overall Study|screen failures|2
4673066|NCT02694536|16078347|P1|Overall Study|Other|22
4673067|NCT02694536|16078347|P1|Overall Study|Death|8
4673068|NCT02694536|16078347|P1|Overall Study|Withdrawal by Subject|8
4673069|NCT02694536|16078347|P1|Overall Study|Study Drug-Related Adverse Event|1
4673070|NCT02694536|16078347|P1|Overall Study|Lost to Follow-up|1
4673071|NCT02694536|16078347|P1|Overall Study|Progressive Disease|40
4673072|NCT02694523|16078358|P7|Part B|Other|1
4673073|NCT02694523|16078359|P6|Part B|Other|0
4673074|NCT02694523|16078360|P5|Part B|Other|0
4673075|NCT02694523|16078361|P4|Part B|Other|0
4673076|NCT02694523|16078362|P3|Part B|Other|1
4673077|NCT02694523|16078363|P2|Part B|Other|0
4673078|NCT02694523|16078364|P1|Part B|Other|0
4673079|NCT02694523|16078358|P7|Part B|Withdrawal by Subject|0
4673080|NCT02694523|16078359|P6|Part B|Withdrawal by Subject|3
4673081|NCT02694523|16078360|P5|Part B|Withdrawal by Subject|1
4673082|NCT02694523|16078361|P4|Part B|Withdrawal by Subject|0
4673083|NCT02694523|16078362|P3|Part B|Withdrawal by Subject|9
4673084|NCT02694523|16078363|P2|Part B|Withdrawal by Subject|0
4673085|NCT02694523|16078364|P1|Part B|Withdrawal by Subject|0
4673086|NCT02694523|16078358|P7|Part B|Lost to Follow-up|1
4673087|NCT02694523|16078359|P6|Part B|Lost to Follow-up|0
4673088|NCT02694523|16078360|P5|Part B|Lost to Follow-up|2
4673089|NCT02694523|16078361|P4|Part B|Lost to Follow-up|3
4673090|NCT02694523|16078362|P3|Part B|Lost to Follow-up|2
4673091|NCT02694523|16078363|P2|Part B|Lost to Follow-up|0
4673092|NCT02694523|16078364|P1|Part B|Lost to Follow-up|0
4673093|NCT02694523|16078358|P7|Part B|Protocol Violation|0
4673094|NCT02694523|16078359|P6|Part B|Protocol Violation|0
4673095|NCT02694523|16078360|P5|Part B|Protocol Violation|0
4673096|NCT02694523|16078361|P4|Part B|Protocol Violation|0
4673097|NCT02694523|16078362|P3|Part B|Protocol Violation|1
4673098|NCT02694523|16078363|P2|Part B|Protocol Violation|0
4673099|NCT02694523|16078364|P1|Part B|Protocol Violation|0
4673100|NCT02694523|16078358|P7|Part B|Adverse Event|0
4673101|NCT02694523|16078359|P6|Part B|Adverse Event|2
4673102|NCT02694523|16078360|P5|Part B|Adverse Event|1
4673103|NCT02694523|16078361|P4|Part B|Adverse Event|1
4673104|NCT02694523|16078362|P3|Part B|Adverse Event|7
4673105|NCT02694523|16078363|P2|Part B|Adverse Event|0
4673106|NCT02694523|16078364|P1|Part B|Adverse Event|0
4673107|NCT02694523|16078358|P7|Part A|Other|0
4673108|NCT02694523|16078359|P6|Part A|Other|0
4673109|NCT02694523|16078360|P5|Part A|Other|0
4673110|NCT02694523|16078361|P4|Part A|Other|0
4673111|NCT02694523|16078362|P3|Part A|Other|0
4673112|NCT02694523|16078363|P2|Part A|Other|1
4673113|NCT02694523|16078364|P1|Part A|Other|1
4673114|NCT02694523|16078358|P7|Part A|Withdrawal by Subject|0
4673115|NCT02694523|16078359|P6|Part A|Withdrawal by Subject|0
4673116|NCT02694523|16078360|P5|Part A|Withdrawal by Subject|0
4673117|NCT02694523|16078361|P4|Part A|Withdrawal by Subject|0
4673118|NCT02694523|16078362|P3|Part A|Withdrawal by Subject|0
4673119|NCT02694523|16078363|P2|Part A|Withdrawal by Subject|1
4673120|NCT02694523|16078364|P1|Part A|Withdrawal by Subject|3
4673121|NCT02694523|16078358|P7|Part A|Lost to Follow-up|0
4673122|NCT02694523|16078359|P6|Part A|Lost to Follow-up|0
4673123|NCT02694523|16078360|P5|Part A|Lost to Follow-up|0
4673124|NCT02694523|16078361|P4|Part A|Lost to Follow-up|0
4673125|NCT02694523|16078362|P3|Part A|Lost to Follow-up|0
4673126|NCT02694523|16078363|P2|Part A|Lost to Follow-up|2
4673127|NCT02694523|16078364|P1|Part A|Lost to Follow-up|1
4673128|NCT02694523|16078358|P7|Part A|Protocol Violation|0
4673129|NCT02694523|16078359|P6|Part A|Protocol Violation|0
4673130|NCT02694523|16078360|P5|Part A|Protocol Violation|0
4673131|NCT02694523|16078361|P4|Part A|Protocol Violation|0
4673132|NCT02694523|16078362|P3|Part A|Protocol Violation|0
4673133|NCT02694523|16078363|P2|Part A|Protocol Violation|0
4673134|NCT02694523|16078364|P1|Part A|Protocol Violation|1
4673135|NCT02694523|16078358|P7|Part A|Adverse Event|0
4673136|NCT02694523|16078359|P6|Part A|Adverse Event|0
4673137|NCT02694523|16078360|P5|Part A|Adverse Event|0
4673138|NCT02694523|16078361|P4|Part A|Adverse Event|0
4673139|NCT02694523|16078362|P3|Part A|Adverse Event|0
4673140|NCT02694523|16078363|P2|Part A|Adverse Event|3
4673141|NCT02694523|16078364|P1|Part A|Adverse Event|7
4673142|NCT02694328|16078394|P2|Overall Study|Abnormal Laboratory Value|3
4673143|NCT02694328|16078395|P1|Overall Study|Abnormal Laboratory Value|0
4673144|NCT02694328|16078394|P2|Overall Study|Protocol Violation|5
4673145|NCT02694328|16078395|P1|Overall Study|Protocol Violation|6
4673146|NCT02694328|16078394|P2|Overall Study|Pregnancy|1
4673147|NCT02694328|16078395|P1|Overall Study|Pregnancy|1
4673148|NCT02694328|16078394|P2|Overall Study|Lack of Efficacy|2
4673149|NCT02694328|16078395|P1|Overall Study|Lack of Efficacy|1
4673150|NCT02694328|16078394|P2|Overall Study|Incarceration|1
4673151|NCT02694328|16078395|P1|Overall Study|Incarceration|1
4673152|NCT02694328|16078394|P2|Overall Study|Noncompliant with study drug|8
4673153|NCT02694328|16078395|P1|Overall Study|Noncompliant with study drug|11
4673154|NCT02694328|16078394|P2|Overall Study|Lost to Follow-up|22
4673155|NCT02694328|16078395|P1|Overall Study|Lost to Follow-up|26
4673156|NCT02694328|16078394|P2|Overall Study|Withdrawal by Subject|23
4673157|NCT02694328|16078395|P1|Overall Study|Withdrawal by Subject|27
4673158|NCT02694328|16078394|P2|Overall Study|Adverse Event|33
4673159|NCT02694328|16078395|P1|Overall Study|Adverse Event|27
4673160|NCT02693834|16078417|P2|Week 2 Practice|Adverse Event|1
4673161|NCT02693834|16078418|P1|Week 2 Practice|Adverse Event|0
4673162|NCT02693834|16078417|P2|Baseline Measurement|Adverse Event|0
4673163|NCT02693834|16078418|P1|Baseline Measurement|Adverse Event|1
4673164|NCT02693834|16078417|P2|Baseline Measurement|Withdrawal by Subject|0
4673165|NCT02693834|16078418|P1|Baseline Measurement|Withdrawal by Subject|1
4673166|NCT02693743|16078428|P2|Overall Study|Physician Decision|0
4673167|NCT02693743|16078429|P1|Overall Study|Physician Decision|1
4673168|NCT02693691|16078460|P1|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1
4673169|NCT02693691|16078460|P1|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11
4673170|NCT02693691|16078460|P1|Extended Follow-Up (Until Last pt 12M)|Death|12
4673171|NCT02693691|16078460|P1|Primary Endpoint Analysis (First 12M)|Adverse Event|1
4673172|NCT02693691|16078460|P1|Primary Endpoint Analysis (First 12M)|Physician Decision|7
4673173|NCT02693691|16078460|P1|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12
4673174|NCT02693691|16078460|P1|Primary Endpoint Analysis (First 12M)|Death|30
4673175|NCT02693171|16078467|P1|Overall Study|Discontinuation of Study by Sponsor|8
4673176|NCT02693171|16078467|P1|Overall Study|Adverse Event|1
4673177|NCT02693106|16078499|P1|Overall Study|No time|3
4673178|NCT02693002|16078511|P2|Overall Study|Withdrawal by Subject|0
4673179|NCT02693002|16078512|P1|Overall Study|Withdrawal by Subject|1
4673180|NCT02692716|16078535|P2|Overall Study|Withdrawal by Subject|1
4673181|NCT02692716|16078536|P1|Overall Study|Withdrawal by Subject|3
4673182|NCT02692716|16078535|P2|Overall Study|Lost to Follow-up|5
4673183|NCT02692716|16078536|P1|Overall Study|Lost to Follow-up|2
4673184|NCT02692703|16078576|P1|Overall Study|Other|1
4673185|NCT02692703|16078576|P1|Overall Study|Lost to Follow-up|1
4673186|NCT02692560|16078584|P2|Overall Study|Withdrawal by Subject|6
4673187|NCT02692560|16078585|P1|Overall Study|Withdrawal by Subject|0
4673188|NCT02692482|16078625|P2|Overall Study|Withdrawal by Subject|2
4673189|NCT02692482|16078626|P1|Overall Study|Withdrawal by Subject|1
4673190|NCT02692482|16078625|P2|Overall Study|Death|2
4673191|NCT02692482|16078626|P1|Overall Study|Death|2
4673192|NCT02692417|16078640|P2|Overall Study|Adverse Event|0
4673193|NCT02692417|16078641|P1|Overall Study|Adverse Event|1
4673194|NCT02692417|16078640|P2|Overall Study|Withdrawal by Subject|1
4673195|NCT02692417|16078641|P1|Overall Study|Withdrawal by Subject|5
4673196|NCT02692235|16078653|P2|Overall Study|Adverse Event|2
4673197|NCT02692235|16078654|P1|Overall Study|Adverse Event|1
4673198|NCT02692235|16078653|P2|Overall Study|Withdrawal by Subject|1
4673199|NCT02692235|16078654|P1|Overall Study|Withdrawal by Subject|2
4673200|NCT02691936|16078670|P2|Overall Study|Withdrawal by Subject|5
4673201|NCT02691936|16078671|P1|Overall Study|Withdrawal by Subject|2
4673202|NCT02691741|16078693|P2|Overall Study|Withdrawal by Subject|4
4673203|NCT02691741|16078694|P1|Overall Study|Withdrawal by Subject|0
4673204|NCT02691741|16078693|P2|Overall Study|Physician Decision|1
4673205|NCT02691741|16078694|P1|Overall Study|Physician Decision|0
4673206|NCT02691741|16078693|P2|Overall Study|Lost to Follow-up|0
4673207|NCT02691741|16078694|P1|Overall Study|Lost to Follow-up|1
4673208|NCT02691741|16078693|P2|Overall Study|Adverse Event|2
4673209|NCT02691741|16078694|P1|Overall Study|Adverse Event|0
4673210|NCT02691702|16078734|P11|Overall Study|Protocol Violation|0
4673211|NCT02691702|16078735|P10|Overall Study|Protocol Violation|2
4673212|NCT02691702|16078736|P9|Overall Study|Protocol Violation|0
4673213|NCT02691702|16078737|P8|Overall Study|Protocol Violation|0
4673214|NCT02691702|16078738|P7|Overall Study|Protocol Violation|0
4673215|NCT02691702|16078739|P6|Overall Study|Protocol Violation|0
4673216|NCT02691702|16078740|P5|Overall Study|Protocol Violation|0
4673217|NCT02691702|16078741|P4|Overall Study|Protocol Violation|0
4673218|NCT02691702|16078742|P3|Overall Study|Protocol Violation|0
4673219|NCT02691702|16078743|P2|Overall Study|Protocol Violation|0
4673220|NCT02691702|16078744|P1|Overall Study|Protocol Violation|0
4673221|NCT02691702|16078734|P11|Overall Study|Other|0
4673222|NCT02691702|16078735|P10|Overall Study|Other|0
4673223|NCT02691702|16078736|P9|Overall Study|Other|1
4673224|NCT02691702|16078737|P8|Overall Study|Other|0
4673225|NCT02691702|16078738|P7|Overall Study|Other|1
4673226|NCT02691702|16078739|P6|Overall Study|Other|0
4673227|NCT02691702|16078740|P5|Overall Study|Other|0
4673228|NCT02691702|16078741|P4|Overall Study|Other|0
4673229|NCT02691702|16078742|P3|Overall Study|Other|0
4673230|NCT02691702|16078743|P2|Overall Study|Other|0
4673231|NCT02691702|16078744|P1|Overall Study|Other|0
4673232|NCT02691702|16078734|P11|Overall Study|Withdrawal by Subject|0
4673233|NCT02691702|16078735|P10|Overall Study|Withdrawal by Subject|0
4673234|NCT02691702|16078736|P9|Overall Study|Withdrawal by Subject|0
4673235|NCT02691702|16078737|P8|Overall Study|Withdrawal by Subject|0
4673236|NCT02691702|16078738|P7|Overall Study|Withdrawal by Subject|2
4673237|NCT02691702|16078739|P6|Overall Study|Withdrawal by Subject|1
4673238|NCT02691702|16078740|P5|Overall Study|Withdrawal by Subject|0
4673239|NCT02691702|16078741|P4|Overall Study|Withdrawal by Subject|0
4673240|NCT02691702|16078742|P3|Overall Study|Withdrawal by Subject|0
4673241|NCT02691702|16078743|P2|Overall Study|Withdrawal by Subject|1
4673242|NCT02691702|16078744|P1|Overall Study|Withdrawal by Subject|1
4673243|NCT02691702|16078734|P11|Overall Study|Lost to Follow-up|1
4673244|NCT02691702|16078735|P10|Overall Study|Lost to Follow-up|0
4673245|NCT02691702|16078736|P9|Overall Study|Lost to Follow-up|0
4673246|NCT02691702|16078737|P8|Overall Study|Lost to Follow-up|0
4673247|NCT02691702|16078738|P7|Overall Study|Lost to Follow-up|0
4673248|NCT02691702|16078739|P6|Overall Study|Lost to Follow-up|2
4673249|NCT02691702|16078740|P5|Overall Study|Lost to Follow-up|0
4673250|NCT02691702|16078741|P4|Overall Study|Lost to Follow-up|0
4673251|NCT02691702|16078742|P3|Overall Study|Lost to Follow-up|1
4673252|NCT02691702|16078743|P2|Overall Study|Lost to Follow-up|0
4673253|NCT02691702|16078744|P1|Overall Study|Lost to Follow-up|0
4673254|NCT02691702|16078734|P11|Overall Study|Adverse Event|1
4673255|NCT02691702|16078735|P10|Overall Study|Adverse Event|0
4673256|NCT02691702|16078736|P9|Overall Study|Adverse Event|1
4673257|NCT02691702|16078737|P8|Overall Study|Adverse Event|0
4673258|NCT02691702|16078738|P7|Overall Study|Adverse Event|0
4673259|NCT02691702|16078739|P6|Overall Study|Adverse Event|0
4673260|NCT02691702|16078740|P5|Overall Study|Adverse Event|0
4673261|NCT02691702|16078741|P4|Overall Study|Adverse Event|0
4673262|NCT02691702|16078742|P3|Overall Study|Adverse Event|0
4673263|NCT02691702|16078743|P2|Overall Study|Adverse Event|0
4673264|NCT02691702|16078744|P1|Overall Study|Adverse Event|1
4673265|NCT02691572|16079030|P2|Overall Study|Protocol Violation|1
4673266|NCT02691572|16079031|P1|Overall Study|Protocol Violation|0
4673267|NCT02691572|16079030|P2|Overall Study|Withdrawal by Subject|0
4673268|NCT02691572|16079031|P1|Overall Study|Withdrawal by Subject|1
4673269|NCT02691507|16079039|P2|Overall Study|Missed Visit 3|1
4673270|NCT02691507|16079040|P1|Overall Study|Missed Visit 3|0
4673271|NCT02691494|16079173|P3|Post-Treatment Follow-Up Period|Non-Compliance|1
4673272|NCT02691494|16079174|P2|Post-Treatment Follow-Up Period|Non-Compliance|1
4673273|NCT02691494|16079175|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
4673274|NCT02691494|16079173|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3
4673275|NCT02691494|16079174|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
4673276|NCT02691494|16079175|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0
4673277|NCT02691494|16079173|P3|Post-Treatment Follow-Up Period|Other|1
4673278|NCT02691494|16079174|P2|Post-Treatment Follow-Up Period|Other|1
4673279|NCT02691494|16079175|P1|Post-Treatment Follow-Up Period|Other|2
4673280|NCT02691494|16079173|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
4673281|NCT02691494|16079174|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4673282|NCT02691494|16079175|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4673283|NCT02691494|16079173|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|8
4673284|NCT02691494|16079174|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
4673285|NCT02691494|16079175|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
4673286|NCT02691468|16079203|P2|Overall Study|Failure to advance FOB|0
4673287|NCT02691468|16079204|P1|Overall Study|Failure to advance FOB|2
4673288|NCT02691468|16079203|P2|Overall Study|Lost to Follow-up|1
4673289|NCT02691468|16079204|P1|Overall Study|Lost to Follow-up|2
4673290|NCT02691468|16079203|P2|Overall Study|Bronchial blocker use|1
4673291|NCT02691468|16079204|P1|Overall Study|Bronchial blocker use|2
4673292|NCT02691013|16079265|P2|Overall Study|Withdrawal by Subject|0
4673293|NCT02691013|16079266|P1|Overall Study|Withdrawal by Subject|3
4673294|NCT02690974|16079280|P1|Overall Study|Protocol Deviation|1
4673295|NCT02690974|16079280|P1|Overall Study|Protocol-defined stopping criteria|1
4673296|NCT02690974|16079280|P1|Overall Study|Non-compliance with study treatment|1
4673297|NCT02690974|16079280|P1|Overall Study|Physician Decision|2
4673298|NCT02690974|16079280|P1|Overall Study|Withdrawal of Informed Consent|3
4673299|NCT02690974|16079280|P1|Overall Study|Lost to Follow-up|3
4673300|NCT02690974|16079280|P1|Overall Study|Subject/guardian decision|4
4673301|NCT02690974|16079280|P1|Overall Study|Death|9
4673302|NCT02690974|16079280|P1|Overall Study|Adverse Event|16
4673303|NCT02690727|16079321|P2|Overall Study|Adverse Event|2
4673304|NCT02690727|16079322|P1|Overall Study|Adverse Event|2
4673305|NCT02690701|16079334|P2|Treatment Period 2|Protocol Violation|1
4673306|NCT02690701|16079335|P1|Treatment Period 2|Protocol Violation|0
4673307|NCT02690701|16079334|P2|Treatment Period 2|Withdrawal by Subject|2
4673308|NCT02690701|16079335|P1|Treatment Period 2|Withdrawal by Subject|0
4673309|NCT02690701|16079334|P2|Treatment Period 2|Lost to Follow-up|2
4673310|NCT02690701|16079335|P1|Treatment Period 2|Lost to Follow-up|0
4673311|NCT02690701|16079334|P2|Treatment Period 2|Lack of Efficacy|0
4673312|NCT02690701|16079335|P1|Treatment Period 2|Lack of Efficacy|1
4673313|NCT02690701|16079334|P2|Treatment Period 2|Adverse Event|0
4673314|NCT02690701|16079335|P1|Treatment Period 2|Adverse Event|2
4673315|NCT02690701|16079334|P2|Treatment Period 1|Withdrawal by Subject|1
4673316|NCT02690701|16079335|P1|Treatment Period 1|Withdrawal by Subject|0
4673317|NCT02690701|16079334|P2|Treatment Period 1|Adverse Event|2
4673318|NCT02690701|16079335|P1|Treatment Period 1|Adverse Event|2
4673319|NCT02690207|16079400|P1|Overall Study|Other reasons for withdrawal|23
4673320|NCT02690207|16079400|P1|Overall Study|Suspected HZ Episode|1
4673321|NCT02690207|16079400|P1|Overall Study|Migrated/moved from study area|5
4673322|NCT02690207|16079400|P1|Overall Study|Non-serious Adverse Event|18
4673323|NCT02690207|16079400|P1|Overall Study|Serious adverse event|110
4673324|NCT02690207|16079400|P1|Overall Study|Protocol Violation|2
4673325|NCT02690207|16079400|P1|Overall Study|Withdrawal by Subject|46
4673326|NCT02690207|16079400|P1|Overall Study|Lost to Follow-up|48
4673327|NCT02690194|16079410|P3|Overall Study|Withdrawal by Subject|0
4673328|NCT02690194|16079411|P2|Overall Study|Withdrawal by Subject|4
4673329|NCT02690194|16079412|P1|Overall Study|Withdrawal by Subject|1
4673330|NCT02689804|16079619|P2|Overall Study|Withdrawal by Subject|0
4673331|NCT02689804|16079620|P1|Overall Study|Withdrawal by Subject|2
4673332|NCT02689492|16079646|P1|Overall Study|Other than listed|1
4673333|NCT02689492|16079646|P1|Overall Study|Withdrawal/ Physician's Decision|1
4673334|NCT02689492|16079646|P1|Overall Study|Withdrawal/Loss To Follow-Up|1
4673335|NCT02689492|16079646|P1|Overall Study|Physician Decision|2
4673336|NCT02689492|16079646|P1|Overall Study|Death|9
4673337|NCT02689492|16079646|P1|Overall Study|Withdrawal by Subject|11
4673338|NCT02689492|16079646|P1|Overall Study|Lost to Follow-up|61
4673339|NCT02689219|16079662|P2|Overall Study|Disease Progression|6
4673340|NCT02689219|16079663|P1|Overall Study|Disease Progression|10
4673341|NCT02689219|16079662|P2|Overall Study|Death|1
4673342|NCT02689219|16079663|P1|Overall Study|Death|1
4673343|NCT02689206|16079680|P5|Overall Study|Withdrawal by Subject|0
4673344|NCT02689206|16079681|P4|Overall Study|Withdrawal by Subject|0
4673345|NCT02689206|16079682|P3|Overall Study|Withdrawal by Subject|1
4673346|NCT02689206|16079683|P2|Overall Study|Withdrawal by Subject|0
4673347|NCT02689206|16079684|P1|Overall Study|Withdrawal by Subject|1
4673348|NCT02689206|16079680|P5|Overall Study|Physician Decision|0
4673349|NCT02689206|16079681|P4|Overall Study|Physician Decision|0
4673350|NCT02689206|16079682|P3|Overall Study|Physician Decision|0
4673351|NCT02689206|16079683|P2|Overall Study|Physician Decision|0
4673352|NCT02689206|16079684|P1|Overall Study|Physician Decision|1
4673353|NCT02689206|16079680|P5|Overall Study|Other: Reached stopping criteria|4
4673354|NCT02689206|16079681|P4|Overall Study|Other: Reached stopping criteria|3
4673355|NCT02689206|16079682|P3|Overall Study|Other: Reached stopping criteria|2
4673356|NCT02689206|16079683|P2|Overall Study|Other: Reached stopping criteria|1
4673357|NCT02689206|16079684|P1|Overall Study|Other: Reached stopping criteria|0
4673358|NCT02689206|16079680|P5|Overall Study|Protocol Violation|2
4673359|NCT02689206|16079681|P4|Overall Study|Protocol Violation|1
4673360|NCT02689206|16079682|P3|Overall Study|Protocol Violation|0
4673361|NCT02689206|16079683|P2|Overall Study|Protocol Violation|0
4673362|NCT02689206|16079684|P1|Overall Study|Protocol Violation|1
4673363|NCT02689206|16079680|P5|Overall Study|Adverse Event|2
4673364|NCT02689206|16079681|P4|Overall Study|Adverse Event|0
4673365|NCT02689206|16079682|P3|Overall Study|Adverse Event|1
4673366|NCT02689206|16079683|P2|Overall Study|Adverse Event|0
4673367|NCT02689206|16079684|P1|Overall Study|Adverse Event|0
4673368|NCT02688933|16079897|P2|Overall Study|Lost to Follow-up|5
4673369|NCT02688933|16079898|P1|Overall Study|Lost to Follow-up|1
4673370|NCT02688933|16079897|P2|Overall Study|Other than Specified|25
4673371|NCT02688933|16079898|P1|Overall Study|Other than Specified|14
4673372|NCT02688933|16079897|P2|Overall Study|Hypoglycemia|0
4673373|NCT02688933|16079898|P1|Overall Study|Hypoglycemia|2
4673374|NCT02688933|16079897|P2|Overall Study|Poor compliance to protocol|4
4673375|NCT02688933|16079898|P1|Overall Study|Poor compliance to protocol|7
4673376|NCT02688933|16079897|P2|Overall Study|Lack of Efficacy|2
4673377|NCT02688933|16079898|P1|Overall Study|Lack of Efficacy|2
4673378|NCT02688933|16079897|P2|Overall Study|Adverse Event|1
4673379|NCT02688933|16079898|P1|Overall Study|Adverse Event|3
4673380|NCT02688764|16079958|P2|Overall Study|Withdrawal by parent|0
4673381|NCT02688764|16079959|P1|Overall Study|Withdrawal by parent|3
4673382|NCT02688764|16079958|P2|Overall Study|Subject taken off dialysis|0
4673383|NCT02688764|16079959|P1|Overall Study|Subject taken off dialysis|1
4673384|NCT02688764|16079958|P2|Overall Study|Subject moving out|0
4673385|NCT02688764|16079959|P1|Overall Study|Subject moving out|2
4673386|NCT02688764|16079958|P2|Overall Study|Study drug taste/Withd. parent|0
4673387|NCT02688764|16079959|P1|Overall Study|Study drug taste/Withd. parent|1
4673388|NCT02688764|16079958|P2|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0
4673389|NCT02688764|16079959|P1|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1
4673390|NCT02688764|16079958|P2|Overall Study|Phosphorus level outside safe range|1
4673391|NCT02688764|16079959|P1|Overall Study|Phosphorus level outside safe range|0
4673392|NCT02688764|16079958|P2|Overall Study|Non-compl./Withd. subject|2
4673393|NCT02688764|16079959|P1|Overall Study|Non-compl./Withd. subject|0
4673394|NCT02688764|16079958|P2|Overall Study|Non-compl./Ph. decision/Withd. subject|1
4673395|NCT02688764|16079959|P1|Overall Study|Non-compl./Ph. decision/Withd. subject|1
4673396|NCT02688764|16079958|P2|Overall Study|Non-compl./Physician decision|0
4673397|NCT02688764|16079959|P1|Overall Study|Non-compl./Physician decision|2
4673398|NCT02688764|16079958|P2|Overall Study|Non-compliance with study drug|0
4673399|NCT02688764|16079959|P1|Overall Study|Non-compliance with study drug|4
4673400|NCT02688764|16079958|P2|Overall Study|Lack of efficacy/Physician decision|1
4673401|NCT02688764|16079959|P1|Overall Study|Lack of efficacy/Physician decision|0
4673402|NCT02688764|16079958|P2|Overall Study|Lack of Efficacy|2
4673403|NCT02688764|16079959|P1|Overall Study|Lack of Efficacy|3
4673404|NCT02688764|16079958|P2|Overall Study|Kidney transplant|4
4673405|NCT02688764|16079959|P1|Overall Study|Kidney transplant|10
4673406|NCT02688764|16079958|P2|Overall Study|AE/Withd. subject|0
4673407|NCT02688764|16079959|P1|Overall Study|AE/Withd. subject|1
4673408|NCT02688764|16079958|P2|Overall Study|AE/Withd. parent/Withd. subject|1
4673409|NCT02688764|16079959|P1|Overall Study|AE/Withd. parent/Withd. subject|1
4673410|NCT02688764|16079958|P2|Overall Study|AE/Withd. parent|0
4673411|NCT02688764|16079959|P1|Overall Study|AE/Withd. parent|3
4673412|NCT02688764|16079958|P2|Overall Study|AE/Physician decision|0
4673413|NCT02688764|16079959|P1|Overall Study|AE/Physician decision|1
4673414|NCT02688764|16079958|P2|Overall Study|AE/Other|1
4673415|NCT02688764|16079959|P1|Overall Study|AE/Other|0
4673416|NCT02688764|16079958|P2|Overall Study|AE/Non-compl./Withd. parent|1
4673417|NCT02688764|16079959|P1|Overall Study|AE/Non-compl./Withd. parent|0
4673418|NCT02688764|16079958|P2|Overall Study|AE/Non-compl.|0
4673419|NCT02688764|16079959|P1|Overall Study|AE/Non-compl.|1
4673420|NCT02688764|16079958|P2|Overall Study|AE/Lack of efficacy|0
4673421|NCT02688764|16079959|P1|Overall Study|AE/Lack of efficacy|1
4673422|NCT02688764|16079958|P2|Overall Study|AE/Kidney transplant|0
4673423|NCT02688764|16079959|P1|Overall Study|AE/Kidney transplant|1
4673424|NCT02688764|16079958|P2|Overall Study|Adverse Event|3
4673425|NCT02688764|16079959|P1|Overall Study|Adverse Event|3
4673426|NCT02688387|16080026|P22|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673427|NCT02688387|16080027|P21|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673428|NCT02688387|16080028|P20|Part 3B, Washout Period 3 (10 Days)|Study terminated|1
4673429|NCT02688387|16080029|P19|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673430|NCT02688387|16080030|P18|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673431|NCT02688387|16080031|P17|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673432|NCT02688387|16080032|P16|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673433|NCT02688387|16080033|P15|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673434|NCT02688387|16080034|P14|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673435|NCT02688387|16080035|P13|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673436|NCT02688387|16080036|P12|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673437|NCT02688387|16080037|P11|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673438|NCT02688387|16080038|P10|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673439|NCT02688387|16080039|P9|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673440|NCT02688387|16080040|P8|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673441|NCT02688387|16080041|P7|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673442|NCT02688387|16080042|P6|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673443|NCT02688387|16080043|P5|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673444|NCT02688387|16080044|P4|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673445|NCT02688387|16080045|P3|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673446|NCT02688387|16080046|P2|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673447|NCT02688387|16080047|P1|Part 3B, Washout Period 3 (10 Days)|Study terminated|0
4673448|NCT02688387|16080026|P22|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673449|NCT02688387|16080027|P21|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
4673450|NCT02688387|16080028|P20|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673451|NCT02688387|16080029|P19|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1
4673452|NCT02688387|16080030|P18|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673453|NCT02688387|16080031|P17|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673454|NCT02688387|16080032|P16|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673455|NCT02688387|16080033|P15|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673456|NCT02688387|16080034|P14|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673457|NCT02688387|16080035|P13|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673458|NCT02688387|16080036|P12|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673459|NCT02688387|16080037|P11|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673460|NCT02688387|16080038|P10|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673461|NCT02688387|16080039|P9|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673462|NCT02688387|16080040|P8|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673463|NCT02688387|16080041|P7|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673464|NCT02688387|16080042|P6|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673465|NCT02688387|16080043|P5|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673466|NCT02688387|16080044|P4|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673467|NCT02688387|16080045|P3|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673468|NCT02688387|16080046|P2|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673469|NCT02688387|16080047|P1|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0
4673470|NCT02688387|16080026|P22|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673471|NCT02688387|16080027|P21|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1
4673472|NCT02688387|16080028|P20|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673473|NCT02688387|16080029|P19|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673474|NCT02688387|16080030|P18|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673475|NCT02688387|16080031|P17|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673476|NCT02688387|16080032|P16|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673477|NCT02688387|16080033|P15|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673478|NCT02688387|16080034|P14|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673479|NCT02688387|16080035|P13|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673480|NCT02688387|16080036|P12|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673481|NCT02688387|16080037|P11|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673482|NCT02688387|16080038|P10|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673483|NCT02688387|16080039|P9|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673484|NCT02688387|16080040|P8|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673485|NCT02688387|16080041|P7|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673486|NCT02688387|16080042|P6|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673487|NCT02688387|16080043|P5|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673488|NCT02688387|16080044|P4|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673489|NCT02688387|16080045|P3|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673490|NCT02688387|16080046|P2|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673491|NCT02688387|16080047|P1|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0
4673492|NCT02688387|16080026|P22|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673493|NCT02688387|16080027|P21|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673494|NCT02688387|16080028|P20|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673495|NCT02688387|16080029|P19|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673496|NCT02688387|16080030|P18|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673497|NCT02688387|16080031|P17|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673498|NCT02688387|16080032|P16|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673499|NCT02688387|16080033|P15|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1
4673500|NCT02688387|16080034|P14|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673501|NCT02688387|16080035|P13|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673502|NCT02688387|16080036|P12|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673503|NCT02688387|16080037|P11|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673504|NCT02688387|16080038|P10|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673505|NCT02688387|16080039|P9|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673506|NCT02688387|16080040|P8|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673507|NCT02688387|16080041|P7|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673508|NCT02688387|16080042|P6|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673509|NCT02688387|16080043|P5|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673510|NCT02688387|16080044|P4|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673511|NCT02688387|16080045|P3|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673512|NCT02688387|16080046|P2|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673513|NCT02688387|16080047|P1|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673514|NCT02688387|16080026|P22|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673515|NCT02688387|16080027|P21|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673516|NCT02688387|16080028|P20|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673517|NCT02688387|16080029|P19|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673518|NCT02688387|16080030|P18|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673519|NCT02688387|16080031|P17|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673520|NCT02688387|16080032|P16|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673521|NCT02688387|16080033|P15|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673522|NCT02688387|16080034|P14|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673523|NCT02688387|16080035|P13|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673524|NCT02688387|16080036|P12|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673525|NCT02688387|16080037|P11|Part 2, Period 1 (up to 6 Days)|Adverse Event|1
4673526|NCT02688387|16080038|P10|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673527|NCT02688387|16080039|P9|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673528|NCT02688387|16080040|P8|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673529|NCT02688387|16080041|P7|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673530|NCT02688387|16080042|P6|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673531|NCT02688387|16080043|P5|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673532|NCT02688387|16080044|P4|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673533|NCT02688387|16080045|P3|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673534|NCT02688387|16080046|P2|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673535|NCT02688387|16080047|P1|Part 2, Period 1 (up to 6 Days)|Adverse Event|0
4673536|NCT02688387|16080026|P22|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673537|NCT02688387|16080027|P21|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673538|NCT02688387|16080028|P20|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673539|NCT02688387|16080029|P19|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673540|NCT02688387|16080030|P18|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673541|NCT02688387|16080031|P17|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673542|NCT02688387|16080032|P16|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673543|NCT02688387|16080033|P15|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673544|NCT02688387|16080034|P14|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673545|NCT02688387|16080035|P13|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673546|NCT02688387|16080036|P12|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673547|NCT02688387|16080037|P11|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673548|NCT02688387|16080038|P10|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673549|NCT02688387|16080039|P9|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673550|NCT02688387|16080040|P8|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673551|NCT02688387|16080041|P7|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673552|NCT02688387|16080042|P6|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673553|NCT02688387|16080043|P5|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673554|NCT02688387|16080044|P4|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673555|NCT02688387|16080045|P3|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673556|NCT02688387|16080046|P2|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0
4673557|NCT02688387|16080047|P1|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1
4673558|NCT02688387|16080026|P22|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673559|NCT02688387|16080027|P21|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673560|NCT02688387|16080028|P20|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673561|NCT02688387|16080029|P19|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673562|NCT02688387|16080030|P18|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673563|NCT02688387|16080031|P17|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673564|NCT02688387|16080032|P16|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673565|NCT02688387|16080033|P15|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673566|NCT02688387|16080034|P14|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673567|NCT02688387|16080035|P13|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673568|NCT02688387|16080036|P12|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673569|NCT02688387|16080037|P11|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673570|NCT02688387|16080038|P10|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673571|NCT02688387|16080039|P9|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673572|NCT02688387|16080040|P8|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673573|NCT02688387|16080041|P7|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673574|NCT02688387|16080042|P6|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673575|NCT02688387|16080043|P5|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
4673576|NCT02688387|16080044|P4|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673577|NCT02688387|16080045|P3|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1
4673578|NCT02688387|16080046|P2|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673579|NCT02688387|16080047|P1|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0
4673580|NCT02688387|16080026|P22|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673581|NCT02688387|16080027|P21|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673582|NCT02688387|16080028|P20|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673583|NCT02688387|16080029|P19|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673584|NCT02688387|16080030|P18|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673585|NCT02688387|16080031|P17|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673586|NCT02688387|16080032|P16|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673587|NCT02688387|16080033|P15|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673588|NCT02688387|16080034|P14|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673589|NCT02688387|16080035|P13|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673590|NCT02688387|16080036|P12|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673591|NCT02688387|16080037|P11|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673592|NCT02688387|16080038|P10|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673593|NCT02688387|16080039|P9|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673594|NCT02688387|16080040|P8|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673595|NCT02688387|16080041|P7|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673596|NCT02688387|16080042|P6|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673597|NCT02688387|16080043|P5|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673598|NCT02688387|16080044|P4|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673599|NCT02688387|16080045|P3|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673600|NCT02688387|16080046|P2|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1
4673601|NCT02688387|16080047|P1|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0
4673602|NCT02688387|16080026|P22|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673603|NCT02688387|16080027|P21|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673604|NCT02688387|16080028|P20|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673605|NCT02688387|16080029|P19|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673606|NCT02688387|16080030|P18|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673607|NCT02688387|16080031|P17|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673608|NCT02688387|16080032|P16|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673609|NCT02688387|16080033|P15|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673610|NCT02688387|16080034|P14|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673611|NCT02688387|16080035|P13|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673612|NCT02688387|16080036|P12|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673613|NCT02688387|16080037|P11|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673614|NCT02688387|16080038|P10|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673615|NCT02688387|16080039|P9|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673616|NCT02688387|16080040|P8|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673617|NCT02688387|16080041|P7|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673618|NCT02688387|16080042|P6|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673619|NCT02688387|16080043|P5|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673620|NCT02688387|16080044|P4|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1
4673621|NCT02688387|16080045|P3|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673622|NCT02688387|16080046|P2|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673623|NCT02688387|16080047|P1|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0
4673624|NCT02688387|16080026|P22|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673625|NCT02688387|16080027|P21|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673626|NCT02688387|16080028|P20|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673627|NCT02688387|16080029|P19|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673628|NCT02688387|16080030|P18|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673629|NCT02688387|16080031|P17|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673630|NCT02688387|16080032|P16|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673631|NCT02688387|16080033|P15|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673632|NCT02688387|16080034|P14|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673633|NCT02688387|16080035|P13|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673634|NCT02688387|16080036|P12|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673635|NCT02688387|16080037|P11|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673636|NCT02688387|16080038|P10|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673637|NCT02688387|16080039|P9|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673638|NCT02688387|16080040|P8|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673639|NCT02688387|16080041|P7|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673640|NCT02688387|16080042|P6|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673641|NCT02688387|16080043|P5|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673642|NCT02688387|16080044|P4|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673643|NCT02688387|16080045|P3|Part 1, Period 1 (up to 6 Days)|Adverse Event|1
4673644|NCT02688387|16080046|P2|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673645|NCT02688387|16080047|P1|Part 1, Period 1 (up to 6 Days)|Adverse Event|0
4673646|NCT02688192|16080315|P2|Overall Study|Physician Decision|0
4673647|NCT02688192|16080316|P1|Overall Study|Physician Decision|1
4673648|NCT02688192|16080315|P2|Overall Study|Lost to Follow-up|5
4673649|NCT02688192|16080316|P1|Overall Study|Lost to Follow-up|11
4673650|NCT02688153|16080335|P2|Overall Study|Conversion to Commercial Valve|0
4673651|NCT02688153|16080336|P1|Overall Study|Conversion to Commercial Valve|3
4673652|NCT02688153|16080335|P2|Overall Study|Valve Explant|0
4673653|NCT02688153|16080336|P1|Overall Study|Valve Explant|1
4673654|NCT02688153|16080335|P2|Overall Study|Withdrawal by Subject|2
4673655|NCT02688153|16080336|P1|Overall Study|Withdrawal by Subject|4
4673656|NCT02688153|16080335|P2|Overall Study|Death|5
4673657|NCT02688153|16080336|P1|Overall Study|Death|7
4673658|NCT02687919|16080396|P2|Overall Study|Protocol Violation|0
4673659|NCT02687919|16080397|P1|Overall Study|Protocol Violation|2
4673660|NCT02687919|16080396|P2|Overall Study|Withdrawal by Subject|6
4673661|NCT02687919|16080397|P1|Overall Study|Withdrawal by Subject|6
4673662|NCT02687542|16080430|P5|Overall Study|Withdrawal by Subject|4
4673663|NCT02687542|16080431|P4|Overall Study|Withdrawal by Subject|2
4673664|NCT02687542|16080432|P3|Overall Study|Withdrawal by Subject|1
4673665|NCT02687542|16080433|P2|Overall Study|Withdrawal by Subject|1
4673666|NCT02687542|16080434|P1|Overall Study|Withdrawal by Subject|0
4673667|NCT02687542|16080430|P5|Overall Study|Adverse Event|9
4673668|NCT02687542|16080431|P4|Overall Study|Adverse Event|2
4673669|NCT02687542|16080432|P3|Overall Study|Adverse Event|3
4673670|NCT02687542|16080433|P2|Overall Study|Adverse Event|1
4673671|NCT02687542|16080434|P1|Overall Study|Adverse Event|3
4673672|NCT02687542|16080430|P5|Overall Study|Other|5
4673673|NCT02687542|16080431|P4|Overall Study|Other|6
4673674|NCT02687542|16080432|P3|Overall Study|Other|10
4673675|NCT02687542|16080433|P2|Overall Study|Other|9
4673676|NCT02687542|16080434|P1|Overall Study|Other|5
4673677|NCT02687542|16080430|P5|Overall Study|Protocol Violation|0
4673678|NCT02687542|16080431|P4|Overall Study|Protocol Violation|0
4673679|NCT02687542|16080432|P3|Overall Study|Protocol Violation|0
4673680|NCT02687542|16080433|P2|Overall Study|Protocol Violation|1
4673681|NCT02687542|16080434|P1|Overall Study|Protocol Violation|0
4673682|NCT02687542|16080430|P5|Overall Study|Lost to Follow-up|1
4673683|NCT02687542|16080431|P4|Overall Study|Lost to Follow-up|0
4673684|NCT02687542|16080432|P3|Overall Study|Lost to Follow-up|0
4673685|NCT02687542|16080433|P2|Overall Study|Lost to Follow-up|0
4673686|NCT02687542|16080434|P1|Overall Study|Lost to Follow-up|0
4673687|NCT02687542|16080430|P5|Overall Study|Medication error without associated AEs|1
4673688|NCT02687542|16080431|P4|Overall Study|Medication error without associated AEs|0
4673689|NCT02687542|16080432|P3|Overall Study|Medication error without associated AEs|0
4673690|NCT02687542|16080433|P2|Overall Study|Medication error without associated AEs|0
4673691|NCT02687542|16080434|P1|Overall Study|Medication error without associated AEs|0
4673692|NCT02687191|16080563|P6|Overall Study|Withdrawal by Subject|0
4673693|NCT02687191|16080564|P5|Overall Study|Withdrawal by Subject|0
4673694|NCT02687191|16080565|P4|Overall Study|Withdrawal by Subject|1
4673695|NCT02687191|16080566|P3|Overall Study|Withdrawal by Subject|0
4673696|NCT02687191|16080567|P2|Overall Study|Withdrawal by Subject|0
4673697|NCT02687191|16080568|P1|Overall Study|Withdrawal by Subject|0
4673698|NCT02687191|16080563|P6|Overall Study|Death|1
4673699|NCT02687191|16080564|P5|Overall Study|Death|1
4673700|NCT02687191|16080565|P4|Overall Study|Death|0
4673701|NCT02687191|16080566|P3|Overall Study|Death|1
4673702|NCT02687191|16080567|P2|Overall Study|Death|1
4673703|NCT02687191|16080568|P1|Overall Study|Death|0
4673704|NCT02686164|16080732|P1|Overall Study|Clinical progression|1
4673705|NCT02686164|16080732|P1|Overall Study|Withdrawal of consent|1
4673706|NCT02686164|16080732|P1|Overall Study|Adverse Event|1
4673707|NCT02686034|16080769|P2|Open Label Period 3|Lost to Follow-up|1
4673708|NCT02686034|16080770|P1|Open Label Period 3|Lost to Follow-up|0
4673709|NCT02686034|16080769|P2|Randomized Controlled Period 2|Spontaneous reduction in migraines|0
4673710|NCT02686034|16080770|P1|Randomized Controlled Period 2|Spontaneous reduction in migraines|1
4673711|NCT02686034|16080769|P2|Randomized Controlled Period 2|Adverse Event|2
4673712|NCT02686034|16080770|P1|Randomized Controlled Period 2|Adverse Event|0
4673713|NCT02686034|16080769|P2|Randomized Controlled Period 2|Withdrawal by Subject|0
4673714|NCT02686034|16080770|P1|Randomized Controlled Period 2|Withdrawal by Subject|3
4673715|NCT02686034|16080769|P2|Randomized Controlled Period 2|Lost to Follow-up|2
4673716|NCT02686034|16080770|P1|Randomized Controlled Period 2|Lost to Follow-up|1
4673717|NCT02686034|16080769|P2|Run-In Period 1|Lost to Follow-up|4
4673718|NCT02686034|16080770|P1|Run-In Period 1|Lost to Follow-up|4
4673719|NCT02686034|16080769|P2|Run-In Period 1|Withdrawal by Subject|3
4673720|NCT02686034|16080770|P1|Run-In Period 1|Withdrawal by Subject|4
4673721|NCT02686034|16080769|P2|Run-In Period 1|Eligibility|10
4673722|NCT02686034|16080770|P1|Run-In Period 1|Eligibility|12
4673723|NCT02685826|16080820|P3|Overall Study|Full Clinical Hold by FDA|20
4673724|NCT02685826|16080821|P2|Overall Study|Full Clinical Hold by FDA|9
4673725|NCT02685826|16080822|P1|Overall Study|Full Clinical Hold by FDA|19
4673726|NCT02685826|16080820|P3|Overall Study|Withdrawal by Subject|0
4673727|NCT02685826|16080821|P2|Overall Study|Withdrawal by Subject|0
4673728|NCT02685826|16080822|P1|Overall Study|Withdrawal by Subject|2
4673729|NCT02685826|16080820|P3|Overall Study|Progressive Disease|0
4673730|NCT02685826|16080821|P2|Overall Study|Progressive Disease|1
4673731|NCT02685826|16080822|P1|Overall Study|Progressive Disease|2
4673732|NCT02685826|16080820|P3|Overall Study|Adverse Event|1
4673733|NCT02685826|16080821|P2|Overall Study|Adverse Event|0
4673734|NCT02685826|16080822|P1|Overall Study|Adverse Event|2
4673735|NCT02685488|16080916|P2|Overall Study|Withdrawal by Subject|1
4673736|NCT02685488|16080917|P1|Overall Study|Withdrawal by Subject|0
4673737|NCT02685202|16080970|P1|Overall Study|Lost to Follow-up|9
4673738|NCT02685072|16080978|P2|1-Month Follow-Up|Withdrawal by Subject|0
4673739|NCT02685072|16080979|P1|1-Month Follow-Up|Withdrawal by Subject|1
4673740|NCT02685072|16080978|P2|Treatment Period|Withdrawal by Subject|3
4673741|NCT02685072|16080979|P1|Treatment Period|Withdrawal by Subject|1
4673742|NCT02685072|16080978|P2|Treatment Period|Lost to Follow-up|6
4673743|NCT02685072|16080979|P1|Treatment Period|Lost to Follow-up|12
4673744|NCT02685033|16081023|P2|Overall Study|Adverse Event|0
4673745|NCT02685033|16081024|P1|Overall Study|Adverse Event|1
4673746|NCT02685033|16081023|P2|Overall Study|Lost to Follow-up|1
4673747|NCT02685033|16081024|P1|Overall Study|Lost to Follow-up|2
4673748|NCT02685033|16081023|P2|Overall Study|Withdrawal of Consent|1
4673749|NCT02685033|16081024|P1|Overall Study|Withdrawal of Consent|0
4673750|NCT02684981|16081060|P3|Overall Study|Other|17
4673751|NCT02684981|16081061|P2|Overall Study|Other|49
4673752|NCT02684981|16081062|P1|Overall Study|Other|83
4673753|NCT02684981|16081060|P3|Overall Study|Permanently discontinued the treatment|110
4673754|NCT02684981|16081061|P2|Overall Study|Permanently discontinued the treatment|161
4673755|NCT02684981|16081062|P1|Overall Study|Permanently discontinued the treatment|157
4673756|NCT02684370|16081222|P6|Part B|Subject Withdrawal|2
4673757|NCT02684370|16081223|P5|Part B|Subject Withdrawal|1
4673758|NCT02684370|16081224|P4|Part B|Subject Withdrawal|1
4673759|NCT02684370|16081225|P3|Part B|Subject Withdrawal|0
4673760|NCT02684370|16081226|P2|Part B|Subject Withdrawal|0
4673761|NCT02684370|16081227|P1|Part B|Subject Withdrawal|0
4673762|NCT02684370|16081222|P6|Part B|Lost to Follow-up|5
4673763|NCT02684370|16081223|P5|Part B|Lost to Follow-up|2
4673764|NCT02684370|16081224|P4|Part B|Lost to Follow-up|1
4673765|NCT02684370|16081225|P3|Part B|Lost to Follow-up|0
4673766|NCT02684370|16081226|P2|Part B|Lost to Follow-up|0
4673767|NCT02684370|16081227|P1|Part B|Lost to Follow-up|0
4673768|NCT02684370|16081222|P6|Part B|Adverse Event|1
4673769|NCT02684370|16081223|P5|Part B|Adverse Event|2
4673770|NCT02684370|16081224|P4|Part B|Adverse Event|0
4673771|NCT02684370|16081225|P3|Part B|Adverse Event|0
4673772|NCT02684370|16081226|P2|Part B|Adverse Event|0
4673773|NCT02684370|16081227|P1|Part B|Adverse Event|0
4673774|NCT02684370|16081222|P6|Part A|Other|0
4673775|NCT02684370|16081223|P5|Part A|Other|0
4673776|NCT02684370|16081224|P4|Part A|Other|0
4673777|NCT02684370|16081225|P3|Part A|Other|1
4673778|NCT02684370|16081226|P2|Part A|Other|0
4673779|NCT02684370|16081227|P1|Part A|Other|0
4673780|NCT02684370|16081222|P6|Part A|Subject Withdrawal|0
4673781|NCT02684370|16081223|P5|Part A|Subject Withdrawal|0
4673782|NCT02684370|16081224|P4|Part A|Subject Withdrawal|0
4673783|NCT02684370|16081225|P3|Part A|Subject Withdrawal|3
4673784|NCT02684370|16081226|P2|Part A|Subject Withdrawal|0
4673785|NCT02684370|16081227|P1|Part A|Subject Withdrawal|1
4673786|NCT02684370|16081222|P6|Part A|Lost to Follow-up|0
4673787|NCT02684370|16081223|P5|Part A|Lost to Follow-up|0
4673788|NCT02684370|16081224|P4|Part A|Lost to Follow-up|0
4673789|NCT02684370|16081225|P3|Part A|Lost to Follow-up|0
4673790|NCT02684370|16081226|P2|Part A|Lost to Follow-up|1
4673791|NCT02684370|16081227|P1|Part A|Lost to Follow-up|1
4673792|NCT02684370|16081222|P6|Part A|Adverse Event|0
4673793|NCT02684370|16081223|P5|Part A|Adverse Event|0
4673794|NCT02684370|16081224|P4|Part A|Adverse Event|0
4673795|NCT02684370|16081225|P3|Part A|Adverse Event|1
4673796|NCT02684370|16081226|P2|Part A|Adverse Event|0
4673797|NCT02684370|16081227|P1|Part A|Adverse Event|2
4673798|NCT02684357|16081272|P6|Part B|Other|1
4673799|NCT02684357|16081273|P5|Part B|Other|0
4673800|NCT02684357|16081274|P4|Part B|Other|1
4673801|NCT02684357|16081275|P3|Part B|Other|0
4673802|NCT02684357|16081276|P2|Part B|Other|0
4673803|NCT02684357|16081277|P1|Part B|Other|0
4673804|NCT02684357|16081272|P6|Part B|Withdrawal by Subject|4
4673805|NCT02684357|16081273|P5|Part B|Withdrawal by Subject|2
4673806|NCT02684357|16081274|P4|Part B|Withdrawal by Subject|0
4673807|NCT02684357|16081275|P3|Part B|Withdrawal by Subject|0
4673808|NCT02684357|16081276|P2|Part B|Withdrawal by Subject|0
4673809|NCT02684357|16081277|P1|Part B|Withdrawal by Subject|0
4673810|NCT02684357|16081272|P6|Part B|Lost to Follow-up|7
4673811|NCT02684357|16081273|P5|Part B|Lost to Follow-up|1
4673812|NCT02684357|16081274|P4|Part B|Lost to Follow-up|1
4673813|NCT02684357|16081275|P3|Part B|Lost to Follow-up|0
4673814|NCT02684357|16081276|P2|Part B|Lost to Follow-up|0
4673815|NCT02684357|16081277|P1|Part B|Lost to Follow-up|0
4673816|NCT02684357|16081272|P6|Part B|Adverse Event (Other)|1
4673817|NCT02684357|16081273|P5|Part B|Adverse Event (Other)|1
4673818|NCT02684357|16081274|P4|Part B|Adverse Event (Other)|1
4673819|NCT02684357|16081275|P3|Part B|Adverse Event (Other)|0
4673820|NCT02684357|16081276|P2|Part B|Adverse Event (Other)|0
4673821|NCT02684357|16081277|P1|Part B|Adverse Event (Other)|0
4673822|NCT02684357|16081272|P6|Part A|Other|0
4673823|NCT02684357|16081273|P5|Part A|Other|0
4673828|NCT02684357|16081272|P6|Part A|Withdrawal by Subject|0
4673829|NCT02684357|16081273|P5|Part A|Withdrawal by Subject|0
4673830|NCT02684357|16081274|P4|Part A|Withdrawal by Subject|0
4673831|NCT02684357|16081275|P3|Part A|Withdrawal by Subject|0
4673832|NCT02684357|16081276|P2|Part A|Withdrawal by Subject|0
4673833|NCT02684357|16081277|P1|Part A|Withdrawal by Subject|3
4673834|NCT02684357|16081272|P6|Part A|Lost to Follow-up|0
4673835|NCT02684357|16081273|P5|Part A|Lost to Follow-up|0
4673836|NCT02684357|16081274|P4|Part A|Lost to Follow-up|0
4673837|NCT02684357|16081275|P3|Part A|Lost to Follow-up|2
4673838|NCT02684357|16081276|P2|Part A|Lost to Follow-up|2
4673839|NCT02684357|16081277|P1|Part A|Lost to Follow-up|0
4673840|NCT02684357|16081272|P6|Part A|Adverse Event (Worsening of Disease)|0
4673841|NCT02684357|16081273|P5|Part A|Adverse Event (Worsening of Disease)|0
4673842|NCT02684357|16081274|P4|Part A|Adverse Event (Worsening of Disease)|0
4673843|NCT02684357|16081275|P3|Part A|Adverse Event (Worsening of Disease)|0
4673844|NCT02684357|16081276|P2|Part A|Adverse Event (Worsening of Disease)|0
4673845|NCT02684357|16081277|P1|Part A|Adverse Event (Worsening of Disease)|1
4673846|NCT02684344|16081327|P2|Overall Study|Withdrawal by Subject|1
4673847|NCT02684344|16081328|P1|Overall Study|Withdrawal by Subject|0
4673848|NCT02684279|16081334|P1|Overall Study|Physician Decision|1
4673849|NCT02684279|16081334|P1|Overall Study|Site closures|7
4673850|NCT02684279|16081334|P1|Overall Study|family emergency|1
4673851|NCT02684279|16081334|P1|Overall Study|subject to have surgery|1
4673852|NCT02684279|16081334|P1|Overall Study|non compliance with study visits|2
4673853|NCT02684279|16081334|P1|Overall Study|non-compliance with study drug|9
4673854|NCT02684279|16081334|P1|Overall Study|Withdrawal by Subject|92
4673855|NCT02684279|16081334|P1|Overall Study|Pregnancy|8
4673856|NCT02684279|16081334|P1|Overall Study|Protocol Violation|6
4673857|NCT02684279|16081334|P1|Overall Study|Lost to Follow-up|61
4673858|NCT02684279|16081334|P1|Overall Study|Lack of Efficacy|4
4673859|NCT02684279|16081334|P1|Overall Study|Adverse Event|87
4673860|NCT02684097|16081386|P2|Overall Study|Lack of Efficacy|6
4673861|NCT02684097|16081387|P1|Overall Study|Lack of Efficacy|13
4673862|NCT02683889|16081433|P1|Overall Study|Withdrawal by Subject|1
4673863|NCT02683876|16081441|P2|Overall Study|samples damaged during shipping|0
4673864|NCT02683876|16081442|P1|Overall Study|samples damaged during shipping|2
4673865|NCT02683785|16081452|P2|Overall Study|Adverse Event|2
4673866|NCT02683785|16081453|P1|Overall Study|Adverse Event|0
4673867|NCT02683785|16081452|P2|Overall Study|Lost to Follow-up|1
4673868|NCT02683785|16081453|P1|Overall Study|Lost to Follow-up|0
4673869|NCT02683785|16081452|P2|Overall Study|Withdrawal by Subject|1
4673870|NCT02683785|16081453|P1|Overall Study|Withdrawal by Subject|1
4673871|NCT02683746|16081510|P2|Overall Study|Physician Decision|1
4673872|NCT02683746|16081511|P1|Overall Study|Physician Decision|2
4673873|NCT02683746|16081510|P2|Overall Study|Withdrawal by Subject|5
4673874|NCT02683746|16081511|P1|Overall Study|Withdrawal by Subject|6
4673875|NCT02683746|16081510|P2|Overall Study|Lost to Follow-up|6
4673876|NCT02683746|16081511|P1|Overall Study|Lost to Follow-up|5
4673877|NCT02683746|16081510|P2|Overall Study|Adverse Event|2
4673878|NCT02683746|16081511|P1|Overall Study|Adverse Event|3
4673879|NCT02683668|16081554|P3|Period 2|Withdrawal by Subject|0
4673880|NCT02683668|16081555|P2|Period 2|Withdrawal by Subject|1
4673881|NCT02683668|16081556|P1|Period 2|Withdrawal by Subject|0
4673882|NCT02683109|16081663|P2|Overall Study|Adverse Event|0
4673883|NCT02683109|16081664|P1|Overall Study|Adverse Event|1
4673884|NCT02682823|16081685|P5|Overall Study|Adverse Event|0
4673885|NCT02682823|16081686|P4|Overall Study|Adverse Event|1
4673886|NCT02682823|16081687|P3|Overall Study|Adverse Event|0
4673887|NCT02682823|16081688|P2|Overall Study|Adverse Event|0
4673888|NCT02682823|16081689|P1|Overall Study|Adverse Event|0
4673889|NCT02682823|16081685|P5|Overall Study|Protocol Deviation|0
4673890|NCT02682823|16081686|P4|Overall Study|Protocol Deviation|0
4673891|NCT02682823|16081687|P3|Overall Study|Protocol Deviation|0
4673892|NCT02682823|16081688|P2|Overall Study|Protocol Deviation|1
4673893|NCT02682823|16081689|P1|Overall Study|Protocol Deviation|0
4673894|NCT02682823|16081685|P5|Overall Study|Withdrawal by Subject|1
4673895|NCT02682823|16081686|P4|Overall Study|Withdrawal by Subject|0
4673896|NCT02682823|16081687|P3|Overall Study|Withdrawal by Subject|1
4673897|NCT02682823|16081688|P2|Overall Study|Withdrawal by Subject|0
4673898|NCT02682823|16081689|P1|Overall Study|Withdrawal by Subject|0
4673899|NCT02682602|16081725|P2|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0
4673900|NCT02682602|16081726|P1|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3
4673901|NCT02682602|16081725|P2|Pre-operative Diseased & Normal Hips|Unusable images|0
4673902|NCT02682602|16081726|P1|Pre-operative Diseased & Normal Hips|Unusable images|1
4673903|NCT02681510|16081921|P1|Overall Study|Lost to Follow-up|9
4673904|NCT02681510|16081921|P1|Overall Study|Withdrawal by Subject|1
4673905|NCT02681094|16081951|P3|2 - Enrolled Participants Set|No treatment given|1
4673906|NCT02681094|16081952|P2|2 - Enrolled Participants Set|No treatment given|1
4673907|NCT02681094|16081953|P1|2 - Enrolled Participants Set|No treatment given|0
4673908|NCT02681094|16081951|P3|2 - Enrolled Participants Set|Other|7
4673909|NCT02681094|16081952|P2|2 - Enrolled Participants Set|Other|6
4673910|NCT02681094|16081953|P1|2 - Enrolled Participants Set|Other|6
4673911|NCT02681094|16081951|P3|2 - Enrolled Participants Set|Study specific discontinuation criteria|21
4673912|NCT02681094|16081952|P2|2 - Enrolled Participants Set|Study specific discontinuation criteria|15
4673913|NCT02681094|16081953|P1|2 - Enrolled Participants Set|Study specific discontinuation criteria|14
4674081|NCT02679573|16082490|P1|Overall Study|Lack of Efficacy|12
4673914|NCT02681094|16081951|P3|2 - Enrolled Participants Set|Lack of therapeutic response|14
4673915|NCT02681094|16081952|P2|2 - Enrolled Participants Set|Lack of therapeutic response|5
4673916|NCT02681094|16081953|P1|2 - Enrolled Participants Set|Lack of therapeutic response|1
4673917|NCT02681094|16081951|P3|2 - Enrolled Participants Set|Severe non-compliance to protocol|1
4673918|NCT02681094|16081952|P2|2 - Enrolled Participants Set|Severe non-compliance to protocol|0
4673919|NCT02681094|16081953|P1|2 - Enrolled Participants Set|Severe non-compliance to protocol|2
4673920|NCT02681094|16081951|P3|2 - Enrolled Participants Set|Adverse Event|1
4673921|NCT02681094|16081952|P2|2 - Enrolled Participants Set|Adverse Event|4
4673922|NCT02681094|16081953|P1|2 - Enrolled Participants Set|Adverse Event|10
4673923|NCT02681094|16081951|P3|2 - Enrolled Participants Set|Participant decision|9
4673924|NCT02681094|16081952|P2|2 - Enrolled Participants Set|Participant decision|10
4673925|NCT02681094|16081953|P1|2 - Enrolled Participants Set|Participant decision|7
4673926|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|No treatment given|1
4673927|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|No treatment given|1
4673928|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|No treatment given|0
4673929|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|Other|7
4673930|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|Other|6
4673931|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|Other|6
4673932|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20
4673933|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13
4673934|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11
4673935|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14
4673936|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5
4673937|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1
4673938|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1
4673939|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0
4673940|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2
4673941|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|Adverse Event|1
4673942|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|Adverse Event|4
4673943|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|Adverse Event|10
4673944|NCT02681094|16081951|P3|1 -Modified Enrolled Participants Set|Participant decision|9
4673945|NCT02681094|16081952|P2|1 -Modified Enrolled Participants Set|Participant decision|10
4673946|NCT02681094|16081953|P1|1 -Modified Enrolled Participants Set|Participant decision|7
4673947|NCT02680847|16081972|P3|Overall Study|Adverse Event|1
4673948|NCT02680847|16081973|P2|Overall Study|Adverse Event|0
4673949|NCT02680847|16081974|P1|Overall Study|Adverse Event|0
4673950|NCT02680847|16081972|P3|Overall Study|Lack of Efficacy|2
4673951|NCT02680847|16081973|P2|Overall Study|Lack of Efficacy|0
4673952|NCT02680847|16081974|P1|Overall Study|Lack of Efficacy|0
4673953|NCT02680847|16081972|P3|Overall Study|Unwilling to participate in study|0
4673954|NCT02680847|16081973|P2|Overall Study|Unwilling to participate in study|1
4673955|NCT02680847|16081974|P1|Overall Study|Unwilling to participate in study|1
4673956|NCT02680847|16081972|P3|Overall Study|No longer met eligibility criteria|0
4673957|NCT02680847|16081973|P2|Overall Study|No longer met eligibility criteria|2
4673958|NCT02680847|16081974|P1|Overall Study|No longer met eligibility criteria|2
4673959|NCT02680847|16081972|P3|Overall Study|Other|0
4673960|NCT02680847|16081973|P2|Overall Study|Other|0
4673961|NCT02680847|16081974|P1|Overall Study|Other|2
4673962|NCT02680834|16082011|P2|Overall Study|Lost to Follow-up|1
4673963|NCT02680834|16082012|P1|Overall Study|Lost to Follow-up|0
4673964|NCT02680834|16082011|P2|Overall Study|Withdrawal by Subject|0
4673965|NCT02680834|16082012|P1|Overall Study|Withdrawal by Subject|6
4673966|NCT02680834|16082011|P2|Overall Study|Physician Decision|2
4673967|NCT02680834|16082012|P1|Overall Study|Physician Decision|5
4673968|NCT02680756|16082024|P2|Overall Study|None of above or not recorded|2
4673969|NCT02680756|16082025|P1|Overall Study|None of above or not recorded|3
4673970|NCT02680756|16082024|P2|Overall Study|TSAT above 60% or a ferritin above 800 m|0
4673971|NCT02680756|16082025|P1|Overall Study|TSAT above 60% or a ferritin above 800 m|1
4673972|NCT02680756|16082024|P2|Overall Study|Protocol Violation|0
4673973|NCT02680756|16082025|P1|Overall Study|Protocol Violation|1
4673974|NCT02680756|16082024|P2|Overall Study|Death|0
4673975|NCT02680756|16082025|P1|Overall Study|Death|1
4673976|NCT02680756|16082024|P2|Overall Study|Blood transfusion for any reason|1
4673977|NCT02680756|16082025|P1|Overall Study|Blood transfusion for any reason|0
4673978|NCT02680756|16082024|P2|Overall Study|Hb ≤7.5 g/dL|2
4673979|NCT02680756|16082025|P1|Overall Study|Hb ≤7.5 g/dL|0
4673980|NCT02680756|16082024|P2|Overall Study|Physician Decision|1
4673981|NCT02680756|16082025|P1|Overall Study|Physician Decision|4
4673982|NCT02680756|16082024|P2|Overall Study|Withdrawal by Subject|5
4673983|NCT02680756|16082025|P1|Overall Study|Withdrawal by Subject|5
4673984|NCT02680756|16082024|P2|Overall Study|Lost to Follow-up|6
4673985|NCT02680756|16082025|P1|Overall Study|Lost to Follow-up|7
4673986|NCT02680756|16082024|P2|Overall Study|Adverse Event|2
4673987|NCT02680756|16082025|P1|Overall Study|Adverse Event|10
4673988|NCT02680665|16082073|P1|Overall Study|No visit after the first prescription|5
4673989|NCT02680639|16082079|P3|Screening Period|Screen Failure|0
4673990|NCT02680639|16082080|P2|Screening Period|Screen Failure|0
4673991|NCT02680639|16082081|P1|Screening Period|Screen Failure|7
4673992|NCT02680041|16082163|P1|Overall Study|Lost to Follow-up|2
4673993|NCT02680041|16082163|P1|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8
4673994|NCT02680002|16082178|P6|Overall Study|Adverse Event|2
4673995|NCT02680002|16082179|P5|Overall Study|Adverse Event|1
4673996|NCT02680002|16082180|P4|Overall Study|Adverse Event|0
4673997|NCT02680002|16082181|P3|Overall Study|Adverse Event|0
4673998|NCT02680002|16082182|P2|Overall Study|Adverse Event|0
4673999|NCT02680002|16082183|P1|Overall Study|Adverse Event|0
4674000|NCT02680002|16082178|P6|Overall Study|Other|0
4674001|NCT02680002|16082179|P5|Overall Study|Other|1
4674002|NCT02680002|16082180|P4|Overall Study|Other|0
4674003|NCT02680002|16082181|P3|Overall Study|Other|0
4674004|NCT02680002|16082182|P2|Overall Study|Other|1
4674005|NCT02680002|16082183|P1|Overall Study|Other|0
4674006|NCT02680002|16082178|P6|Overall Study|Missed Visit 8 (Day 201)|0
4674007|NCT02680002|16082179|P5|Overall Study|Missed Visit 8 (Day 201)|5
4674008|NCT02680002|16082180|P4|Overall Study|Missed Visit 8 (Day 201)|1
4674009|NCT02680002|16082181|P3|Overall Study|Missed Visit 8 (Day 201)|3
4674010|NCT02680002|16082182|P2|Overall Study|Missed Visit 8 (Day 201)|1
4674011|NCT02680002|16082183|P1|Overall Study|Missed Visit 8 (Day 201)|2
4674012|NCT02680002|16082178|P6|Overall Study|Withdrawal by Subject|2
4674013|NCT02680002|16082179|P5|Overall Study|Withdrawal by Subject|2
4674014|NCT02680002|16082180|P4|Overall Study|Withdrawal by Subject|0
4674015|NCT02680002|16082181|P3|Overall Study|Withdrawal by Subject|1
4674016|NCT02680002|16082182|P2|Overall Study|Withdrawal by Subject|0
4674017|NCT02680002|16082183|P1|Overall Study|Withdrawal by Subject|0
4674018|NCT02680002|16082178|P6|Overall Study|Protocol Violation|2
4674019|NCT02680002|16082179|P5|Overall Study|Protocol Violation|1
4674020|NCT02680002|16082180|P4|Overall Study|Protocol Violation|0
4674021|NCT02680002|16082181|P3|Overall Study|Protocol Violation|1
4674022|NCT02680002|16082182|P2|Overall Study|Protocol Violation|0
4674023|NCT02680002|16082183|P1|Overall Study|Protocol Violation|1
4674024|NCT02680002|16082178|P6|Overall Study|Physician Decision|1
4674025|NCT02680002|16082179|P5|Overall Study|Physician Decision|1
4674026|NCT02680002|16082180|P4|Overall Study|Physician Decision|1
4674027|NCT02680002|16082181|P3|Overall Study|Physician Decision|1
4674028|NCT02680002|16082182|P2|Overall Study|Physician Decision|1
4674029|NCT02680002|16082183|P1|Overall Study|Physician Decision|5
4674030|NCT02680002|16082178|P6|Overall Study|Lost to Follow-up|2
4674031|NCT02680002|16082179|P5|Overall Study|Lost to Follow-up|0
4674032|NCT02680002|16082180|P4|Overall Study|Lost to Follow-up|2
4674033|NCT02680002|16082181|P3|Overall Study|Lost to Follow-up|4
4674034|NCT02680002|16082182|P2|Overall Study|Lost to Follow-up|1
4674035|NCT02680002|16082183|P1|Overall Study|Lost to Follow-up|5
4674036|NCT02679755|16082326|P2|Overall Study|Adverse events not related to study drug|2
4674037|NCT02679755|16082327|P1|Overall Study|Adverse events not related to study drug|1
4674038|NCT02679755|16082326|P2|Overall Study|Adverse Event|4
4674039|NCT02679755|16082327|P1|Overall Study|Adverse Event|1
4674040|NCT02679755|16082326|P2|Overall Study|Withdrawal by participant|3
4674041|NCT02679755|16082327|P1|Overall Study|Withdrawal by participant|6
4674042|NCT02679755|16082326|P2|Overall Study|Not defined|2
4674043|NCT02679755|16082327|P1|Overall Study|Not defined|0
4674044|NCT02679755|16082326|P2|Overall Study|Objective progression or relapse|83
4674045|NCT02679755|16082327|P1|Overall Study|Objective progression or relapse|24
4674046|NCT02679755|16082326|P2|Overall Study|Lost to Follow-up|0
4674047|NCT02679755|16082327|P1|Overall Study|Lost to Follow-up|1
4674048|NCT02679755|16082326|P2|Overall Study|Global deterioration of health status|8
4674049|NCT02679755|16082327|P1|Overall Study|Global deterioration of health status|1
4674050|NCT02679755|16082326|P2|Overall Study|Death|3
4674051|NCT02679755|16082327|P1|Overall Study|Death|0
4674052|NCT02679729|16082369|P9|Overall Study|Participant decision|0
4674053|NCT02679729|16082370|P8|Overall Study|Participant decision|0
4674054|NCT02679729|16082371|P7|Overall Study|Participant decision|1
4674055|NCT02679729|16082372|P6|Overall Study|Participant decision|0
4674056|NCT02679729|16082373|P5|Overall Study|Participant decision|0
4674057|NCT02679729|16082374|P4|Overall Study|Participant decision|0
4674058|NCT02679729|16082375|P3|Overall Study|Participant decision|0
4674059|NCT02679729|16082376|P2|Overall Study|Participant decision|1
4674060|NCT02679729|16082377|P1|Overall Study|Participant decision|0
4674061|NCT02679729|16082369|P9|Overall Study|Lost to Follow-up|0
4674062|NCT02679729|16082370|P8|Overall Study|Lost to Follow-up|0
4674063|NCT02679729|16082371|P7|Overall Study|Lost to Follow-up|0
4674064|NCT02679729|16082372|P6|Overall Study|Lost to Follow-up|0
4674065|NCT02679729|16082373|P5|Overall Study|Lost to Follow-up|1
4674066|NCT02679729|16082374|P4|Overall Study|Lost to Follow-up|0
4674067|NCT02679729|16082375|P3|Overall Study|Lost to Follow-up|0
4674068|NCT02679729|16082376|P2|Overall Study|Lost to Follow-up|1
4674069|NCT02679729|16082377|P1|Overall Study|Lost to Follow-up|0
4674070|NCT02679573|16082489|P2|Overall Study|Lost to Follow-up|3
4674071|NCT02679573|16082490|P1|Overall Study|Lost to Follow-up|0
4674072|NCT02679573|16082489|P2|Overall Study|Physician Decision|4
4674073|NCT02679573|16082490|P1|Overall Study|Physician Decision|2
4674074|NCT02679573|16082489|P2|Overall Study|Death|0
4674075|NCT02679573|16082490|P1|Overall Study|Death|2
4674076|NCT02679573|16082489|P2|Overall Study|Withdrawal by Subject|9
4674077|NCT02679573|16082490|P1|Overall Study|Withdrawal by Subject|2
4674078|NCT02679573|16082489|P2|Overall Study|Could not complete required study visits|2
4674079|NCT02679573|16082490|P1|Overall Study|Could not complete required study visits|6
4674080|NCT02679573|16082489|P2|Overall Study|Lack of Efficacy|15
4674082|NCT02679573|16082489|P2|Overall Study|Adverse Event|6
4674083|NCT02679573|16082490|P1|Overall Study|Adverse Event|13
4674084|NCT02679287|16082514|P2|Period 3|Work/Scheduling Conflict|1
4674085|NCT02679287|16082515|P1|Period 3|Work/Scheduling Conflict|0
4674086|NCT02679287|16082514|P2|Period 2|Disliked Mobile System|0
4674087|NCT02679287|16082515|P1|Period 2|Disliked Mobile System|2
4674088|NCT02679287|16082514|P2|Period 2|Work/Scheduling Conflict|0
4674089|NCT02679287|16082515|P1|Period 2|Work/Scheduling Conflict|1
4674090|NCT02679287|16082514|P2|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1
4674091|NCT02679287|16082515|P1|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0
4674092|NCT02679287|16082514|P2|Period 1: Randomization-Study Session 1|Disliked mobile system|1
4674093|NCT02679287|16082515|P1|Period 1: Randomization-Study Session 1|Disliked mobile system|0
4674094|NCT02679287|16082514|P2|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3
4674095|NCT02679287|16082515|P1|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2
4674096|NCT02679287|16082514|P2|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1
4674097|NCT02679287|16082515|P1|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2
4674098|NCT02679274|16082545|P2|Overall Study|Withdrawal by Subject|0
4674099|NCT02679274|16082546|P1|Overall Study|Withdrawal by Subject|1
4674100|NCT02679235|16082576|P1|Overall Study|Adverse Event|1
4674101|NCT02679235|16082576|P1|Overall Study|Withdrawal by Subject|3
4674102|NCT02679222|16082583|P1|Overall Study|No time for project|1
4674103|NCT02678923|16082613|P2|Overall Study|Did Not Return for Study Visits|0
4674104|NCT02678923|16082614|P1|Overall Study|Did Not Return for Study Visits|1
4674105|NCT02678923|16082613|P2|Overall Study|Lost to Follow-up|0
4674106|NCT02678923|16082614|P1|Overall Study|Lost to Follow-up|1
4674107|NCT02678923|16082613|P2|Overall Study|Withdrawal by Subject|2
4674108|NCT02678923|16082614|P1|Overall Study|Withdrawal by Subject|3
4674109|NCT02678923|16082613|P2|Overall Study|Protocol Deviation (Not Dosed)|3
4674110|NCT02678923|16082614|P1|Overall Study|Protocol Deviation (Not Dosed)|1
4674111|NCT02678676|16082630|P2|Overall Study|Unconfirmed for lost to follow-up|67
4674112|NCT02678676|16082631|P1|Overall Study|Unconfirmed for lost to follow-up|85
4674113|NCT02678676|16082630|P2|Overall Study|Lost to Follow-up|151
4674114|NCT02678676|16082631|P1|Overall Study|Lost to Follow-up|171
4674115|NCT02678676|16082630|P2|Overall Study|Withdrawal by Subject|5
4674116|NCT02678676|16082631|P1|Overall Study|Withdrawal by Subject|13
4674117|NCT02678676|16082630|P2|Overall Study|Death|649
4674118|NCT02678676|16082631|P1|Overall Study|Death|619
4674119|NCT02678416|16082662|P1|Part 2|Withdrawal by Subject|1
4674120|NCT02678416|16082662|P1|Part 2|Adverse Event|2
4674121|NCT02678416|16082662|P1|Part 1|Withdrawal by Subject|1
4674122|NCT02678390|16082682|P2|AE (1 Day)|Withdrawal by Subject|1
4674123|NCT02678390|16082683|P1|AE (1 Day)|Withdrawal by Subject|0
4674124|NCT02678286|16082699|P2|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
4674125|NCT02678286|16082700|P1|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2
4674126|NCT02678286|16082699|P2|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2
4674127|NCT02678286|16082700|P1|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3
4674128|NCT02678286|16082699|P2|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0
4674129|NCT02678286|16082700|P1|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1
4674130|NCT02678286|16082699|P2|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1
4674131|NCT02678286|16082700|P1|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0
4674132|NCT02678286|16082699|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1
4674133|NCT02678286|16082700|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2
4674134|NCT02678000|16082752|P5|PART 2|Withdrawal by Subject|0
4674135|NCT02678000|16082753|P4|PART 2|Withdrawal by Subject|0
4674136|NCT02678000|16082754|P3|PART 2|Withdrawal by Subject|1
4674137|NCT02678000|16082755|P2|PART 2|Withdrawal by Subject|0
4674138|NCT02678000|16082756|P1|PART 2|Withdrawal by Subject|0
4674139|NCT02678000|16082752|P5|PART 2|Adverse Event|0
4674140|NCT02678000|16082753|P4|PART 2|Adverse Event|1
4674141|NCT02678000|16082754|P3|PART 2|Adverse Event|2
4674142|NCT02678000|16082755|P2|PART 2|Adverse Event|0
4674143|NCT02678000|16082756|P1|PART 2|Adverse Event|0
4674144|NCT02677896|16082794|P2|Overall Study|Did not receive study drug|2
4674145|NCT02677896|16082795|P1|Overall Study|Did not receive study drug|2
4674146|NCT02677896|16082794|P2|Overall Study|Miscellaneous|11
4674147|NCT02677896|16082795|P1|Overall Study|Miscellaneous|6
4674148|NCT02677896|16082794|P2|Overall Study|Withdrawal by patient:|30
4674149|NCT02677896|16082795|P1|Overall Study|Withdrawal by patient:|25
4674150|NCT02677896|16082794|P2|Overall Study|Protocol deviation|1
4674151|NCT02677896|16082795|P1|Overall Study|Protocol deviation|2
4674152|NCT02677896|16082794|P2|Overall Study|Progressive disease:|171
4674153|NCT02677896|16082795|P1|Overall Study|Progressive disease:|65
4674154|NCT02677896|16082794|P2|Overall Study|Lost to Follow-up|1
4674155|NCT02677896|16082795|P1|Overall Study|Lost to Follow-up|0
4674156|NCT02677896|16082794|P2|Overall Study|Death|7
4674157|NCT02677896|16082795|P1|Overall Study|Death|9
4674158|NCT02677896|16082794|P2|Overall Study|Adverse Event|21
4674159|NCT02677896|16082795|P1|Overall Study|Adverse Event|28
4674160|NCT02677844|16082823|P7|Period 3|Withdrawal by Subject|0
4674161|NCT02677844|16082824|P6|Period 3|Withdrawal by Subject|0
4674162|NCT02677844|16082825|P5|Period 3|Withdrawal by Subject|0
4674163|NCT02677844|16082826|P4|Period 3|Withdrawal by Subject|1
4674164|NCT02677844|16082827|P3|Period 3|Withdrawal by Subject|0
4674165|NCT02677844|16082828|P2|Period 3|Withdrawal by Subject|0
4674166|NCT02677844|16082829|P1|Period 3|Withdrawal by Subject|0
4674167|NCT02677220|16082967|P1|Overall Study|Adverse Event|1
4674168|NCT02677116|16082982|P9|Overall Study|Withdrawal by Subject|0
4674169|NCT02677116|16082983|P8|Overall Study|Withdrawal by Subject|0
4674170|NCT02677116|16082984|P7|Overall Study|Withdrawal by Subject|0
4674171|NCT02677116|16082985|P6|Overall Study|Withdrawal by Subject|0
4674172|NCT02677116|16082986|P5|Overall Study|Withdrawal by Subject|0
4674173|NCT02677116|16082987|P4|Overall Study|Withdrawal by Subject|0
4674174|NCT02677116|16082988|P3|Overall Study|Withdrawal by Subject|0
4674175|NCT02677116|16082989|P2|Overall Study|Withdrawal by Subject|0
4674176|NCT02677116|16082990|P1|Overall Study|Withdrawal by Subject|1
4674177|NCT02677116|16082982|P9|Overall Study|Withdrawal by parent or guardian|0
4674178|NCT02677116|16082983|P8|Overall Study|Withdrawal by parent or guardian|1
4674179|NCT02677116|16082984|P7|Overall Study|Withdrawal by parent or guardian|2
4674180|NCT02677116|16082985|P6|Overall Study|Withdrawal by parent or guardian|0
4674181|NCT02677116|16082986|P5|Overall Study|Withdrawal by parent or guardian|0
4674182|NCT02677116|16082987|P4|Overall Study|Withdrawal by parent or guardian|1
4674183|NCT02677116|16082988|P3|Overall Study|Withdrawal by parent or guardian|0
4674184|NCT02677116|16082989|P2|Overall Study|Withdrawal by parent or guardian|1
4674185|NCT02677116|16082990|P1|Overall Study|Withdrawal by parent or guardian|2
4674186|NCT02677116|16082982|P9|Overall Study|Physician Decision|2
4674187|NCT02677116|16082983|P8|Overall Study|Physician Decision|1
4674188|NCT02677116|16082984|P7|Overall Study|Physician Decision|1
4674189|NCT02677116|16082985|P6|Overall Study|Physician Decision|3
4674190|NCT02677116|16082986|P5|Overall Study|Physician Decision|1
4674191|NCT02677116|16082987|P4|Overall Study|Physician Decision|2
4674192|NCT02677116|16082988|P3|Overall Study|Physician Decision|3
4674193|NCT02677116|16082989|P2|Overall Study|Physician Decision|2
4674194|NCT02677116|16082990|P1|Overall Study|Physician Decision|0
4674195|NCT02677116|16082982|P9|Overall Study|Adverse Event|0
4674196|NCT02677116|16082983|P8|Overall Study|Adverse Event|0
4674197|NCT02677116|16082984|P7|Overall Study|Adverse Event|1
4674198|NCT02677116|16082985|P6|Overall Study|Adverse Event|1
4674199|NCT02677116|16082986|P5|Overall Study|Adverse Event|0
4674200|NCT02677116|16082987|P4|Overall Study|Adverse Event|0
4674201|NCT02677116|16082988|P3|Overall Study|Adverse Event|0
4674202|NCT02677116|16082989|P2|Overall Study|Adverse Event|1
4674203|NCT02677116|16082990|P1|Overall Study|Adverse Event|0
4674204|NCT02676895|16083063|P3|Overall Study|Withdrawal by Subject|1
4674205|NCT02676895|16083064|P2|Overall Study|Withdrawal by Subject|0
4674206|NCT02676895|16083065|P1|Overall Study|Withdrawal by Subject|0
4674207|NCT02676895|16083063|P3|Overall Study|Lost to Follow-up|1
4674208|NCT02676895|16083064|P2|Overall Study|Lost to Follow-up|0
4674209|NCT02676895|16083065|P1|Overall Study|Lost to Follow-up|0
4674210|NCT02676895|16083063|P3|Overall Study|Adverse Event|1
4674211|NCT02676895|16083064|P2|Overall Study|Adverse Event|3
4674212|NCT02676895|16083065|P1|Overall Study|Adverse Event|0
4674213|NCT02676895|16083063|P3|Overall Study|Protocol Violation|0
4674214|NCT02676895|16083064|P2|Overall Study|Protocol Violation|0
4674215|NCT02676895|16083065|P1|Overall Study|Protocol Violation|1
4674216|NCT02676895|16083063|P3|Overall Study|Administrative reason|0
4674217|NCT02676895|16083064|P2|Overall Study|Administrative reason|0
4674218|NCT02676895|16083065|P1|Overall Study|Administrative reason|1
4674219|NCT02676882|16083108|P2|Overall Study|Withdrawal by Subject|2
4674220|NCT02676882|16083109|P1|Overall Study|Withdrawal by Subject|1
4674221|NCT02676882|16083108|P2|Overall Study|Lost to Follow-up|0
4674222|NCT02676882|16083109|P1|Overall Study|Lost to Follow-up|1
4674223|NCT02676882|16083108|P2|Overall Study|Adverse Event|0
4674224|NCT02676882|16083109|P1|Overall Study|Adverse Event|1
4674225|NCT02676466|16083128|P8|Overall Study|Withdrawal by Subject|1
4674226|NCT02676466|16083129|P7|Overall Study|Withdrawal by Subject|1
4674227|NCT02676466|16083130|P6|Overall Study|Withdrawal by Subject|1
4674228|NCT02676466|16083131|P5|Overall Study|Withdrawal by Subject|3
4674229|NCT02676466|16083132|P4|Overall Study|Withdrawal by Subject|0
4674230|NCT02676466|16083133|P3|Overall Study|Withdrawal by Subject|1
4674231|NCT02676466|16083134|P2|Overall Study|Withdrawal by Subject|3
4674232|NCT02676466|16083135|P1|Overall Study|Withdrawal by Subject|4
4674233|NCT02676466|16083128|P8|Overall Study|Death|0
4674234|NCT02676466|16083129|P7|Overall Study|Death|0
4674235|NCT02676466|16083130|P6|Overall Study|Death|0
4674236|NCT02676466|16083131|P5|Overall Study|Death|0
4674237|NCT02676466|16083132|P4|Overall Study|Death|0
4674238|NCT02676466|16083133|P3|Overall Study|Death|1
4674239|NCT02676466|16083134|P2|Overall Study|Death|2
4674240|NCT02676466|16083135|P1|Overall Study|Death|0
4674241|NCT02675998|16083218|P4|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1
4674242|NCT02675998|16083219|P3|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
4674243|NCT02675998|16083220|P2|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
4674244|NCT02675998|16083221|P1|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0
4674245|NCT02675998|16083218|P4|4-Week Randomized Withdrawal Period|Physician Decision|0
4674246|NCT02675998|16083219|P3|4-Week Randomized Withdrawal Period|Physician Decision|0
4674247|NCT02675998|16083220|P2|4-Week Randomized Withdrawal Period|Physician Decision|0
4674248|NCT02675998|16083221|P1|4-Week Randomized Withdrawal Period|Physician Decision|1
4674249|NCT02675998|16083218|P4|4-Week Randomized Withdrawal Period|Protocol Violation|1
4674250|NCT02675998|16083219|P3|4-Week Randomized Withdrawal Period|Protocol Violation|0
4674251|NCT02675998|16083220|P2|4-Week Randomized Withdrawal Period|Protocol Violation|0
4674252|NCT02675998|16083221|P1|4-Week Randomized Withdrawal Period|Protocol Violation|0
4674253|NCT02675998|16083218|P4|4-Week Randomized Withdrawal Period|Adverse Event|3
4674254|NCT02675998|16083219|P3|4-Week Randomized Withdrawal Period|Adverse Event|1
4674255|NCT02675998|16083220|P2|4-Week Randomized Withdrawal Period|Adverse Event|0
4674256|NCT02675998|16083221|P1|4-Week Randomized Withdrawal Period|Adverse Event|0
4674257|NCT02675998|16083218|P4|4-Week Randomized Withdrawal Period|Lack of Efficacy|3
4674258|NCT02675998|16083219|P3|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
4674259|NCT02675998|16083220|P2|4-Week Randomized Withdrawal Period|Lack of Efficacy|1
4674260|NCT02675998|16083221|P1|4-Week Randomized Withdrawal Period|Lack of Efficacy|0
4674261|NCT02675998|16083218|P4|8-Week Treatment Period|Other|0
4674262|NCT02675998|16083219|P3|8-Week Treatment Period|Other|2
4674263|NCT02675998|16083220|P2|8-Week Treatment Period|Other|1
4674264|NCT02675998|16083221|P1|8-Week Treatment Period|Other|3
4674265|NCT02675998|16083218|P4|8-Week Treatment Period|Protocol Violation|0
4674266|NCT02675998|16083219|P3|8-Week Treatment Period|Protocol Violation|1
4674267|NCT02675998|16083220|P2|8-Week Treatment Period|Protocol Violation|1
4674268|NCT02675998|16083221|P1|8-Week Treatment Period|Protocol Violation|1
4674269|NCT02675998|16083218|P4|8-Week Treatment Period|GI side Effects|0
4674270|NCT02675998|16083219|P3|8-Week Treatment Period|GI side Effects|2
4674271|NCT02675998|16083220|P2|8-Week Treatment Period|GI side Effects|4
4674272|NCT02675998|16083221|P1|8-Week Treatment Period|GI side Effects|1
4674273|NCT02675998|16083218|P4|8-Week Treatment Period|Physician Decision|0
4674274|NCT02675998|16083219|P3|8-Week Treatment Period|Physician Decision|2
4674275|NCT02675998|16083220|P2|8-Week Treatment Period|Physician Decision|0
4674276|NCT02675998|16083221|P1|8-Week Treatment Period|Physician Decision|1
4674277|NCT02675998|16083218|P4|8-Week Treatment Period|Lack of Efficacy|0
4674278|NCT02675998|16083219|P3|8-Week Treatment Period|Lack of Efficacy|3
4674279|NCT02675998|16083220|P2|8-Week Treatment Period|Lack of Efficacy|5
4674280|NCT02675998|16083221|P1|8-Week Treatment Period|Lack of Efficacy|2
4674281|NCT02675998|16083218|P4|8-Week Treatment Period|Withdrawal by Subject|0
4674282|NCT02675998|16083219|P3|8-Week Treatment Period|Withdrawal by Subject|3
4674283|NCT02675998|16083220|P2|8-Week Treatment Period|Withdrawal by Subject|3
4674284|NCT02675998|16083221|P1|8-Week Treatment Period|Withdrawal by Subject|3
4674285|NCT02675998|16083218|P4|8-Week Treatment Period|Adverse Event|0
4674286|NCT02675998|16083219|P3|8-Week Treatment Period|Adverse Event|6
4674287|NCT02675998|16083220|P2|8-Week Treatment Period|Adverse Event|5
4674288|NCT02675998|16083221|P1|8-Week Treatment Period|Adverse Event|6
4674289|NCT02675907|16083237|P2|Study Overall|Lost to Follow-up|2
4674290|NCT02675907|16083238|P1|Study Overall|Lost to Follow-up|0
4674291|NCT02675907|16083237|P2|Study Overall|Withdrawal by Subject|2
4674292|NCT02675907|16083238|P1|Study Overall|Withdrawal by Subject|2
4674293|NCT02675907|16083237|P2|Study Overall|Lack of Efficacy|0
4674294|NCT02675907|16083238|P1|Study Overall|Lack of Efficacy|1
4674295|NCT02675907|16083237|P2|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
4674296|NCT02675907|16083238|P1|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1
4674297|NCT02675907|16083237|P2|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
4674298|NCT02675907|16083238|P1|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4
4674299|NCT02675751|16083283|P1|Overall Study|Lost to Follow-up|16
4674300|NCT02675634|16083287|P6|Test Period 2|Adverse Event|1
4674301|NCT02675634|16083288|P5|Test Period 2|Adverse Event|0
4674302|NCT02675634|16083289|P4|Test Period 2|Adverse Event|0
4674303|NCT02675634|16083290|P3|Test Period 2|Adverse Event|0
4674304|NCT02675634|16083291|P2|Test Period 2|Adverse Event|0
4674305|NCT02675634|16083292|P1|Test Period 2|Adverse Event|0
4674306|NCT02675634|16083287|P6|Test Period 2|Lack of Efficacy|0
4674307|NCT02675634|16083288|P5|Test Period 2|Lack of Efficacy|0
4674308|NCT02675634|16083289|P4|Test Period 2|Lack of Efficacy|0
4674309|NCT02675634|16083290|P3|Test Period 2|Lack of Efficacy|0
4674310|NCT02675634|16083291|P2|Test Period 2|Lack of Efficacy|0
4674311|NCT02675634|16083292|P1|Test Period 2|Lack of Efficacy|1
4674312|NCT02675634|16083287|P6|Test Period 1|Device deficiency that did not lead to A|0
4674313|NCT02675634|16083288|P5|Test Period 1|Device deficiency that did not lead to A|0
4674314|NCT02675634|16083289|P4|Test Period 1|Device deficiency that did not lead to A|0
4674315|NCT02675634|16083290|P3|Test Period 1|Device deficiency that did not lead to A|1
4674316|NCT02675634|16083291|P2|Test Period 1|Device deficiency that did not lead to A|0
4674317|NCT02675634|16083292|P1|Test Period 1|Device deficiency that did not lead to A|0
4674318|NCT02675634|16083287|P6|Test Period 1|Adverse Event|0
4674319|NCT02675634|16083288|P5|Test Period 1|Adverse Event|0
4674320|NCT02675634|16083289|P4|Test Period 1|Adverse Event|1
4674321|NCT02675634|16083290|P3|Test Period 1|Adverse Event|0
4674322|NCT02675634|16083291|P2|Test Period 1|Adverse Event|1
4674323|NCT02675634|16083292|P1|Test Period 1|Adverse Event|0
4674324|NCT02675517|16083309|P1|Overall Study|Evaluable PF-10 questionnaire at visit1|151
4674325|NCT02675517|16083309|P1|Overall Study|No evaluable PF-10 questionnaire at all|8
4674326|NCT02675426|16083321|P3|Overall Study|Other|2
4674327|NCT02675426|16083322|P2|Overall Study|Other|1
4674328|NCT02675426|16083323|P1|Overall Study|Other|3
4674329|NCT02675426|16083321|P3|Overall Study|Lost to Follow-up|2
4674330|NCT02675426|16083322|P2|Overall Study|Lost to Follow-up|0
4674331|NCT02675426|16083323|P1|Overall Study|Lost to Follow-up|1
4674332|NCT02675426|16083321|P3|Overall Study|Withdrawal by Subject|5
4674333|NCT02675426|16083322|P2|Overall Study|Withdrawal by Subject|5
4674334|NCT02675426|16083323|P1|Overall Study|Withdrawal by Subject|3
4674335|NCT02675426|16083321|P3|Overall Study|Adverse Event|9
4674336|NCT02675426|16083322|P2|Overall Study|Adverse Event|2
4674337|NCT02675426|16083323|P1|Overall Study|Adverse Event|6
4674338|NCT02675231|16083367|P3|Overall Study|On study treatment/follow up|23
4674339|NCT02675231|16083368|P2|Overall Study|On study treatment/follow up|31
4674340|NCT02675231|16083369|P1|Overall Study|On study treatment/follow up|23
4674341|NCT02675231|16083367|P3|Overall Study|Lost to Follow-up|2
4674342|NCT02675231|16083368|P2|Overall Study|Lost to Follow-up|2
4674343|NCT02675231|16083369|P1|Overall Study|Lost to Follow-up|2
4674344|NCT02675231|16083367|P3|Overall Study|Withdrawal by Subject|1
4674345|NCT02675231|16083368|P2|Overall Study|Withdrawal by Subject|3
4674346|NCT02675231|16083369|P1|Overall Study|Withdrawal by Subject|1
4674347|NCT02675075|16083405|P2|Overall Study|Lost to Follow-up|0
4674348|NCT02675075|16083406|P1|Overall Study|Lost to Follow-up|3
4674349|NCT02674854|16083418|P3|Overall Study|Subject missed V6.2|0
4674350|NCT02674854|16083419|P2|Overall Study|Subject missed V6.2|0
4674351|NCT02674854|16083420|P1|Overall Study|Subject missed V6.2|1
4674352|NCT02674854|16083418|P3|Overall Study|Death|0
4674353|NCT02674854|16083419|P2|Overall Study|Death|1
4674354|NCT02674854|16083420|P1|Overall Study|Death|0
4674355|NCT02674854|16083418|P3|Overall Study|Protocol Violation|2
4674356|NCT02674854|16083419|P2|Overall Study|Protocol Violation|1
4674357|NCT02674854|16083420|P1|Overall Study|Protocol Violation|1
4674358|NCT02674854|16083418|P3|Overall Study|Disallowed Concurrent Medication|0
4674359|NCT02674854|16083419|P2|Overall Study|Disallowed Concurrent Medication|2
4674360|NCT02674854|16083420|P1|Overall Study|Disallowed Concurrent Medication|2
4674361|NCT02674854|16083418|P3|Overall Study|Lack of Efficacy|0
4674362|NCT02674854|16083419|P2|Overall Study|Lack of Efficacy|3
4674363|NCT02674854|16083420|P1|Overall Study|Lack of Efficacy|0
4674364|NCT02674854|16083418|P3|Overall Study|Lost to Follow-up|2
4674365|NCT02674854|16083419|P2|Overall Study|Lost to Follow-up|0
4674366|NCT02674854|16083420|P1|Overall Study|Lost to Follow-up|1
4674367|NCT02674854|16083418|P3|Overall Study|No-compliant subject|1
4674368|NCT02674854|16083419|P2|Overall Study|No-compliant subject|0
4674369|NCT02674854|16083420|P1|Overall Study|No-compliant subject|1
4674370|NCT02674854|16083418|P3|Overall Study|Withdrawal by Subject|4
4674371|NCT02674854|16083419|P2|Overall Study|Withdrawal by Subject|5
4674372|NCT02674854|16083420|P1|Overall Study|Withdrawal by Subject|1
4674373|NCT02674854|16083418|P3|Overall Study|Adverse Event|5
4674374|NCT02674854|16083419|P2|Overall Study|Adverse Event|15
4674375|NCT02674854|16083420|P1|Overall Study|Adverse Event|17
4674376|NCT02674685|16083428|P1|Overall Study|Protocol Violation|4
4674377|NCT02674633|16083469|P2|Overall Study|Withdrawal by Parent/Guardian|2
4674378|NCT02674633|16083470|P1|Overall Study|Withdrawal by Parent/Guardian|1
4674379|NCT02674633|16083469|P2|Overall Study|Physician Decision|0
4674380|NCT02674633|16083470|P1|Overall Study|Physician Decision|1
4674381|NCT02674633|16083469|P2|Overall Study|Lost to Follow-up|2
4674382|NCT02674633|16083470|P1|Overall Study|Lost to Follow-up|3
4674383|NCT02674568|16083490|P1|Overall Study|Other, Not Specified|20
4674384|NCT02674568|16083490|P1|Overall Study|Lost to Follow-up|9
4674385|NCT02674568|16083490|P1|Overall Study|Physician Decision|2
4674386|NCT02674568|16083490|P1|Overall Study|Death|303
4674387|NCT02674568|16083490|P1|Overall Study|Withdrawal by Subject|5
4674388|NCT02674477|16083515|P2|Overall Study|Protocol Violation|2
4674389|NCT02674477|16083516|P1|Overall Study|Protocol Violation|8
4674390|NCT02674386|16083540|P3|Overall Study|Enrolled but not evaluated|0
4674391|NCT02674386|16083541|P2|Overall Study|Enrolled but not evaluated|4
4674392|NCT02674386|16083542|P1|Overall Study|Enrolled but not evaluated|0
4674393|NCT02674386|16083540|P3|Overall Study|Other|0
4674394|NCT02674386|16083541|P2|Overall Study|Other|1
4674395|NCT02674386|16083542|P1|Overall Study|Other|0
4674396|NCT02674386|16083540|P3|Overall Study|Withdrawal by Subject|0
4674397|NCT02674386|16083541|P2|Overall Study|Withdrawal by Subject|4
4674398|NCT02674386|16083542|P1|Overall Study|Withdrawal by Subject|0
4674399|NCT02674386|16083540|P3|Overall Study|Lost to Follow-up|1
4674400|NCT02674386|16083541|P2|Overall Study|Lost to Follow-up|1
4674401|NCT02674386|16083542|P1|Overall Study|Lost to Follow-up|0
4674402|NCT02674334|16083597|P2|Overall Study|NIRS not recording|0
4674403|NCT02674334|16083598|P1|Overall Study|NIRS not recording|1
4674404|NCT02674334|16083597|P2|Overall Study|participant difficulty breathing|0
4674405|NCT02674334|16083598|P1|Overall Study|participant difficulty breathing|1
4674406|NCT02674334|16083597|P2|Overall Study|Lost to Follow-up|3
4674407|NCT02674334|16083598|P1|Overall Study|Lost to Follow-up|5
4674408|NCT02674204|16083608|P2|Overall Study|Adverse Event|0
4674409|NCT02674204|16083609|P1|Overall Study|Adverse Event|1
4674410|NCT02674061|16083645|P2|Overall Study|Ongoing in Study|20
4674411|NCT02674061|16083646|P1|Overall Study|Ongoing in Study|71
4674412|NCT02674061|16083645|P2|Overall Study|Withdrawal by Subject|2
4674413|NCT02674061|16083646|P1|Overall Study|Withdrawal by Subject|9
4674414|NCT02674061|16083645|P2|Overall Study|Lost to Follow-up|0
4674415|NCT02674061|16083646|P1|Overall Study|Lost to Follow-up|1
4674416|NCT02674061|16083645|P2|Overall Study|Death|69
4674417|NCT02674061|16083646|P1|Overall Study|Death|204
4674418|NCT02673684|16083870|P2|Overall Study|Study not completed d/t loss of funding|8
4674419|NCT02673684|16083871|P1|Overall Study|Study not completed d/t loss of funding|9
4674420|NCT02673619|16083887|P4|Overall Study|Lack of Efficacy|0
4674421|NCT02673619|16083888|P3|Overall Study|Lack of Efficacy|1
4674422|NCT02673619|16083889|P2|Overall Study|Lack of Efficacy|0
4674423|NCT02673619|16083890|P1|Overall Study|Lack of Efficacy|0
4674424|NCT02673619|16083887|P4|Overall Study|Adverse Event|0
4674425|NCT02673619|16083888|P3|Overall Study|Adverse Event|1
4674426|NCT02673619|16083889|P2|Overall Study|Adverse Event|0
4674427|NCT02673619|16083890|P1|Overall Study|Adverse Event|0
4674428|NCT02673619|16083887|P4|Overall Study|Withdrawal by Subject|0
4674429|NCT02673619|16083888|P3|Overall Study|Withdrawal by Subject|1
4674430|NCT02673619|16083889|P2|Overall Study|Withdrawal by Subject|1
4674431|NCT02673619|16083890|P1|Overall Study|Withdrawal by Subject|1
4674432|NCT02673619|16083887|P4|Overall Study|Lost to Follow-up|0
4674433|NCT02673619|16083888|P3|Overall Study|Lost to Follow-up|0
4674434|NCT02673619|16083889|P2|Overall Study|Lost to Follow-up|0
4674435|NCT02673619|16083890|P1|Overall Study|Lost to Follow-up|1
4674436|NCT02673515|16084001|P2|Overall Study|Lack of motivation|1
4674437|NCT02673515|16084002|P1|Overall Study|Lack of motivation|2
4674438|NCT02673489|16084018|P2|Follow Up Period|Unable to return for follow-up|1
4674439|NCT02673489|16084019|P1|Follow Up Period|Unable to return for follow-up|0
4674440|NCT02673489|16084018|P2|Follow Up Period|Unable to return for week 24 follow-up|1
4674441|NCT02673489|16084019|P1|Follow Up Period|Unable to return for week 24 follow-up|0
4674442|NCT02673489|16084018|P2|Treatment Period|Adverse Event|1
4674443|NCT02673489|16084019|P1|Treatment Period|Adverse Event|0
4674444|NCT02673489|16084018|P2|Treatment Period|Participant was incarcerated|1
4674445|NCT02673489|16084019|P1|Treatment Period|Participant was incarcerated|0
4674446|NCT02673489|16084018|P2|Treatment Period|Participant moved to another province|0
4674447|NCT02673489|16084019|P1|Treatment Period|Participant moved to another province|1
4674448|NCT02673489|16084018|P2|Treatment Period|Participant request to discontinue|1
4674449|NCT02673489|16084019|P1|Treatment Period|Participant request to discontinue|1
4674450|NCT02673489|16084018|P2|Treatment Period|Lost to Follow-up|0
4674451|NCT02673489|16084019|P1|Treatment Period|Lost to Follow-up|3
4674452|NCT02672852|16084084|P7|Part B|Other|2
4674453|NCT02672852|16084085|P6|Part B|Other|1
4674454|NCT02672852|16084086|P5|Part B|Other|4
4674455|NCT02672852|16084087|P4|Part B|Other|0
4674456|NCT02672852|16084088|P3|Part B|Other|0
4674457|NCT02672852|16084089|P2|Part B|Other|0
4674458|NCT02672852|16084090|P1|Part B|Other|0
4674459|NCT02672852|16084084|P7|Part B|Withdrawal by Subject|7
4674460|NCT02672852|16084085|P6|Part B|Withdrawal by Subject|0
4674461|NCT02672852|16084086|P5|Part B|Withdrawal by Subject|5
4674462|NCT02672852|16084087|P4|Part B|Withdrawal by Subject|0
4674463|NCT02672852|16084088|P3|Part B|Withdrawal by Subject|0
4674464|NCT02672852|16084089|P2|Part B|Withdrawal by Subject|0
4674465|NCT02672852|16084090|P1|Part B|Withdrawal by Subject|0
4674466|NCT02672852|16084084|P7|Part B|Lost to Follow-up|1
4674467|NCT02672852|16084085|P6|Part B|Lost to Follow-up|4
4674468|NCT02672852|16084086|P5|Part B|Lost to Follow-up|3
4674469|NCT02672852|16084087|P4|Part B|Lost to Follow-up|0
4674470|NCT02672852|16084088|P3|Part B|Lost to Follow-up|0
4674471|NCT02672852|16084089|P2|Part B|Lost to Follow-up|0
4674472|NCT02672852|16084090|P1|Part B|Lost to Follow-up|0
4674473|NCT02672852|16084084|P7|Part B|Other adverse event|1
4674474|NCT02672852|16084085|P6|Part B|Other adverse event|5
4674475|NCT02672852|16084086|P5|Part B|Other adverse event|3
4674476|NCT02672852|16084087|P4|Part B|Other adverse event|0
4674477|NCT02672852|16084088|P3|Part B|Other adverse event|0
4674478|NCT02672852|16084089|P2|Part B|Other adverse event|0
4674479|NCT02672852|16084090|P1|Part B|Other adverse event|0
4674480|NCT02672852|16084084|P7|Part B|Worsening pre-existing condition|0
4674481|NCT02672852|16084085|P6|Part B|Worsening pre-existing condition|1
4674482|NCT02672852|16084086|P5|Part B|Worsening pre-existing condition|0
4674483|NCT02672852|16084087|P4|Part B|Worsening pre-existing condition|0
4674484|NCT02672852|16084088|P3|Part B|Worsening pre-existing condition|0
4674485|NCT02672852|16084089|P2|Part B|Worsening pre-existing condition|0
4674486|NCT02672852|16084090|P1|Part B|Worsening pre-existing condition|0
4674487|NCT02672852|16084084|P7|Part B|Disease worsening|1
4674488|NCT02672852|16084085|P6|Part B|Disease worsening|0
4674489|NCT02672852|16084086|P5|Part B|Disease worsening|1
4674490|NCT02672852|16084087|P4|Part B|Disease worsening|0
4674491|NCT02672852|16084088|P3|Part B|Disease worsening|0
4674492|NCT02672852|16084089|P2|Part B|Disease worsening|0
4674493|NCT02672852|16084090|P1|Part B|Disease worsening|0
4674494|NCT02672852|16084084|P7|Part A2|Not entered in Part B|0
4674495|NCT02672852|16084085|P6|Part A2|Not entered in Part B|0
4674496|NCT02672852|16084086|P5|Part A2|Not entered in Part B|0
4674497|NCT02672852|16084087|P4|Part A2|Not entered in Part B|4
4674498|NCT02672852|16084088|P3|Part A2|Not entered in Part B|0
4674499|NCT02672852|16084089|P2|Part A2|Not entered in Part B|0
4674500|NCT02672852|16084090|P1|Part A2|Not entered in Part B|0
4674501|NCT02672852|16084084|P7|Part A2|Other|0
4674502|NCT02672852|16084085|P6|Part A2|Other|0
4674503|NCT02672852|16084086|P5|Part A2|Other|0
4674504|NCT02672852|16084087|P4|Part A2|Other|0
4674505|NCT02672852|16084088|P3|Part A2|Other|3
4674506|NCT02672852|16084089|P2|Part A2|Other|0
4674507|NCT02672852|16084090|P1|Part A2|Other|0
4674508|NCT02672852|16084084|P7|Part A2|Withdrawal by Subject|0
4674509|NCT02672852|16084085|P6|Part A2|Withdrawal by Subject|0
4674510|NCT02672852|16084086|P5|Part A2|Withdrawal by Subject|0
4674511|NCT02672852|16084087|P4|Part A2|Withdrawal by Subject|0
4674512|NCT02672852|16084088|P3|Part A2|Withdrawal by Subject|1
4674513|NCT02672852|16084089|P2|Part A2|Withdrawal by Subject|0
4674514|NCT02672852|16084090|P1|Part A2|Withdrawal by Subject|0
4674515|NCT02672852|16084084|P7|Part A2|Lost to Follow-up|0
4674516|NCT02672852|16084085|P6|Part A2|Lost to Follow-up|0
4674517|NCT02672852|16084086|P5|Part A2|Lost to Follow-up|0
4674518|NCT02672852|16084087|P4|Part A2|Lost to Follow-up|0
4674519|NCT02672852|16084088|P3|Part A2|Lost to Follow-up|2
4674520|NCT02672852|16084089|P2|Part A2|Lost to Follow-up|0
4674521|NCT02672852|16084090|P1|Part A2|Lost to Follow-up|0
4674522|NCT02672852|16084084|P7|Part A2|Adverse Event|0
4674523|NCT02672852|16084085|P6|Part A2|Adverse Event|0
4674524|NCT02672852|16084086|P5|Part A2|Adverse Event|0
4674525|NCT02672852|16084087|P4|Part A2|Adverse Event|0
4674526|NCT02672852|16084088|P3|Part A2|Adverse Event|3
4674527|NCT02672852|16084089|P2|Part A2|Adverse Event|0
4674528|NCT02672852|16084090|P1|Part A2|Adverse Event|0
4674529|NCT02672852|16084084|P7|Part A2|Disease worsening|0
4674530|NCT02672852|16084085|P6|Part A2|Disease worsening|0
4674531|NCT02672852|16084086|P5|Part A2|Disease worsening|0
4674532|NCT02672852|16084087|P4|Part A2|Disease worsening|0
4674533|NCT02672852|16084088|P3|Part A2|Disease worsening|1
4674534|NCT02672852|16084089|P2|Part A2|Disease worsening|0
4674535|NCT02672852|16084090|P1|Part A2|Disease worsening|0
4674536|NCT02672852|16084084|P7|Part A1|Withdrawal by Subject|0
4674537|NCT02672852|16084085|P6|Part A1|Withdrawal by Subject|0
4674538|NCT02672852|16084086|P5|Part A1|Withdrawal by Subject|0
4674539|NCT02672852|16084087|P4|Part A1|Withdrawal by Subject|0
4674540|NCT02672852|16084088|P3|Part A1|Withdrawal by Subject|0
4674541|NCT02672852|16084089|P2|Part A1|Withdrawal by Subject|1
4674542|NCT02672852|16084090|P1|Part A1|Withdrawal by Subject|1
4674543|NCT02672852|16084084|P7|Part A1|Lost to Follow-up|0
4674544|NCT02672852|16084085|P6|Part A1|Lost to Follow-up|0
4674545|NCT02672852|16084086|P5|Part A1|Lost to Follow-up|0
4674546|NCT02672852|16084087|P4|Part A1|Lost to Follow-up|0
4674547|NCT02672852|16084088|P3|Part A1|Lost to Follow-up|0
4674548|NCT02672852|16084089|P2|Part A1|Lost to Follow-up|2
4674549|NCT02672852|16084090|P1|Part A1|Lost to Follow-up|1
4674550|NCT02672852|16084084|P7|Part A1|Adverse Event|0
4674551|NCT02672852|16084085|P6|Part A1|Adverse Event|0
4674552|NCT02672852|16084086|P5|Part A1|Adverse Event|0
4674553|NCT02672852|16084087|P4|Part A1|Adverse Event|0
4674554|NCT02672852|16084088|P3|Part A1|Adverse Event|0
4674555|NCT02672852|16084089|P2|Part A1|Adverse Event|1
4674556|NCT02672852|16084090|P1|Part A1|Adverse Event|0
4674557|NCT02672852|16084084|P7|Part A1|Disease Worsening|0
4674558|NCT02672852|16084085|P6|Part A1|Disease Worsening|0
4674559|NCT02672852|16084086|P5|Part A1|Disease Worsening|0
4674560|NCT02672852|16084087|P4|Part A1|Disease Worsening|0
4674561|NCT02672852|16084088|P3|Part A1|Disease Worsening|0
4674562|NCT02672852|16084089|P2|Part A1|Disease Worsening|0
4674563|NCT02672852|16084090|P1|Part A1|Disease Worsening|1
4674564|NCT02672553|16084121|P2|Overall Study|Intraoperative screen failure|0
4674565|NCT02672553|16084122|P1|Overall Study|Intraoperative screen failure|2
4674566|NCT02672553|16084121|P2|Overall Study|Withdrawal by Subject|3
4674567|NCT02672553|16084122|P1|Overall Study|Withdrawal by Subject|3
4674568|NCT02672553|16084121|P2|Overall Study|Conversion to Commercial Valve|0
4674569|NCT02672553|16084122|P1|Overall Study|Conversion to Commercial Valve|3
4674570|NCT02672553|16084121|P2|Overall Study|Valve Explant|0
4674571|NCT02672553|16084122|P1|Overall Study|Valve Explant|1
4674572|NCT02672553|16084121|P2|Overall Study|Death|5
4674573|NCT02672553|16084122|P1|Overall Study|Death|3
4674574|NCT02672423|16084194|P10|Period 3|Physician Decision|0
4674575|NCT02672423|16084195|P9|Period 3|Physician Decision|0
4674576|NCT02672423|16084196|P8|Period 3|Physician Decision|0
4674577|NCT02672423|16084197|P7|Period 3|Physician Decision|0
4674578|NCT02672423|16084198|P6|Period 3|Physician Decision|1
4674579|NCT02672423|16084199|P5|Period 3|Physician Decision|0
4674580|NCT02672423|16084200|P4|Period 3|Physician Decision|0
4674581|NCT02672423|16084201|P3|Period 3|Physician Decision|0
4674582|NCT02672423|16084202|P2|Period 3|Physician Decision|0
4674583|NCT02672423|16084203|P1|Period 3|Physician Decision|0
4674584|NCT02672423|16084194|P10|Period 3|Withdrawal by Subject|0
4674585|NCT02672423|16084195|P9|Period 3|Withdrawal by Subject|0
4674586|NCT02672423|16084196|P8|Period 3|Withdrawal by Subject|1
4674587|NCT02672423|16084197|P7|Period 3|Withdrawal by Subject|0
4674588|NCT02672423|16084198|P6|Period 3|Withdrawal by Subject|0
4674589|NCT02672423|16084199|P5|Period 3|Withdrawal by Subject|0
4674590|NCT02672423|16084200|P4|Period 3|Withdrawal by Subject|0
4674591|NCT02672423|16084201|P3|Period 3|Withdrawal by Subject|0
4674592|NCT02672423|16084202|P2|Period 3|Withdrawal by Subject|0
4674593|NCT02672423|16084203|P1|Period 3|Withdrawal by Subject|0
4674594|NCT02672423|16084194|P10|Period 2|Withdrawal by Subject|0
4674595|NCT02672423|16084195|P9|Period 2|Withdrawal by Subject|0
4674596|NCT02672423|16084196|P8|Period 2|Withdrawal by Subject|0
4674597|NCT02672423|16084197|P7|Period 2|Withdrawal by Subject|0
4674598|NCT02672423|16084198|P6|Period 2|Withdrawal by Subject|0
4674599|NCT02672423|16084199|P5|Period 2|Withdrawal by Subject|0
4674600|NCT02672423|16084200|P4|Period 2|Withdrawal by Subject|0
4674601|NCT02672423|16084201|P3|Period 2|Withdrawal by Subject|1
4674602|NCT02672423|16084202|P2|Period 2|Withdrawal by Subject|0
4674603|NCT02672423|16084203|P1|Period 2|Withdrawal by Subject|0
4674604|NCT02672423|16084194|P10|Period 1|Adverse Event|0
4674605|NCT02672423|16084195|P9|Period 1|Adverse Event|0
4674606|NCT02672423|16084196|P8|Period 1|Adverse Event|0
4674607|NCT02672423|16084197|P7|Period 1|Adverse Event|0
4674608|NCT02672423|16084198|P6|Period 1|Adverse Event|0
4674609|NCT02672423|16084199|P5|Period 1|Adverse Event|1
4674610|NCT02672423|16084200|P4|Period 1|Adverse Event|0
4674611|NCT02672423|16084201|P3|Period 1|Adverse Event|0
4674612|NCT02672423|16084202|P2|Period 1|Adverse Event|0
4674613|NCT02672423|16084203|P1|Period 1|Adverse Event|0
4674614|NCT02671760|16084298|P3|Overall Study|Lost to Follow-up|0
4674615|NCT02671760|16084299|P2|Overall Study|Lost to Follow-up|1
4674616|NCT02671760|16084300|P1|Overall Study|Lost to Follow-up|0
4674617|NCT02671500|16084326|P1|Overall Study|Lost to Follow-up|2
4674618|NCT02671500|16084326|P1|Overall Study|Lack of Efficacy|12
4674619|NCT02671461|16084341|P3|Follow-up|Administrative Reason by Sponsor|0
4674620|NCT02671461|16084342|P2|Follow-up|Administrative Reason by Sponsor|1
4674621|NCT02671461|16084343|P1|Follow-up|Administrative Reason by Sponsor|0
4674622|NCT02671461|16084341|P3|Follow-up|Lost to Follow-up|1
4674623|NCT02671461|16084342|P2|Follow-up|Lost to Follow-up|0
4674624|NCT02671461|16084343|P1|Follow-up|Lost to Follow-up|0
4674625|NCT02671461|16084341|P3|Follow-up|Withdrawal by Subject|0
4674626|NCT02671461|16084342|P2|Follow-up|Withdrawal by Subject|0
4674627|NCT02671461|16084343|P1|Follow-up|Withdrawal by Subject|1
4674628|NCT02671461|16084341|P3|Treatment|Randomized, not treated|0
4674629|NCT02671461|16084342|P2|Treatment|Randomized, not treated|0
4674630|NCT02671461|16084343|P1|Treatment|Randomized, not treated|1
4674631|NCT02671461|16084341|P3|Treatment|Administrative Reason by Sponsor|4
4674632|NCT02671461|16084342|P2|Treatment|Administrative Reason by Sponsor|3
4674633|NCT02671461|16084343|P1|Treatment|Administrative Reason by Sponsor|1
4674634|NCT02671461|16084341|P3|Treatment|Adverse Event|1
4674635|NCT02671461|16084342|P2|Treatment|Adverse Event|0
4674636|NCT02671461|16084343|P1|Treatment|Adverse Event|0
4674637|NCT02671422|16084366|P1|Overall Study|Other not defined above|3
4674638|NCT02671422|16084366|P1|Overall Study|Not treated with Vargatef®|3
4674639|NCT02671422|16084366|P1|Overall Study|Adverse Event unrelated to Vargatef®|8
4674640|NCT02671422|16084366|P1|Overall Study|Sponsor decision|5
4674641|NCT02671422|16084366|P1|Overall Study|Worsening of Disease|4
4674642|NCT02671422|16084366|P1|Overall Study|Progressive Disease|156
4674643|NCT02671422|16084366|P1|Overall Study|Withdrawal by Subject|7
4674644|NCT02671422|16084366|P1|Overall Study|Lost to Follow-up|4
4674645|NCT02671422|16084366|P1|Overall Study|Lack of Efficacy|1
4674646|NCT02671422|16084366|P1|Overall Study|Adverse Event|68
4674647|NCT02671422|16084366|P1|Overall Study|Lost to Follow-up|1
4674648|NCT02671266|16084372|P2|Overall Study|Withdrawal by Subject|1
4674649|NCT02671266|16084373|P1|Overall Study|Withdrawal by Subject|1
4674650|NCT02670928|16084396|P2|Overall Study|Miss 3 classes in a row in first 12 wks|0
4674651|NCT02670928|16084397|P1|Overall Study|Miss 3 classes in a row in first 12 wks|2
4674652|NCT02670928|16084396|P2|Overall Study|Lost to Follow-up|0
4674653|NCT02670928|16084397|P1|Overall Study|Lost to Follow-up|1
4674654|NCT02670928|16084396|P2|Overall Study|Withdrawal by Subject|0
4674655|NCT02670928|16084397|P1|Overall Study|Withdrawal by Subject|4
4674656|NCT02670928|16084396|P2|Overall Study|Adverse Event|1
4674657|NCT02670928|16084397|P1|Overall Study|Adverse Event|3
4674658|NCT02670915|16084424|P3|Overall Study|Unclassified|0
4674659|NCT02670915|16084425|P2|Overall Study|Unclassified|3
4674660|NCT02670915|16084426|P1|Overall Study|Unclassified|0
4674661|NCT02670915|16084424|P3|Overall Study|Withdrawal by parent/guardian|1
4674662|NCT02670915|16084425|P2|Overall Study|Withdrawal by parent/guardian|4
4674663|NCT02670915|16084426|P1|Overall Study|Withdrawal by parent/guardian|4
4674664|NCT02670915|16084424|P3|Overall Study|Withdrawal by Subject|4
4674665|NCT02670915|16084425|P2|Overall Study|Withdrawal by Subject|1
4674666|NCT02670915|16084426|P1|Overall Study|Withdrawal by Subject|0
4674667|NCT02670551|16084710|P3|Overall Study|Did Not Receive Treatment|0
4674668|NCT02670551|16084711|P2|Overall Study|Did Not Receive Treatment|3
4674669|NCT02670551|16084712|P1|Overall Study|Did Not Receive Treatment|5
4674670|NCT02670551|16084710|P3|Overall Study|Other Miscellaneous Reasons|3
4674671|NCT02670551|16084711|P2|Overall Study|Other Miscellaneous Reasons|3
4674672|NCT02670551|16084712|P1|Overall Study|Other Miscellaneous Reasons|2
4674673|NCT02670551|16084710|P3|Overall Study|Noncompliance with study drug|2
4674674|NCT02670551|16084711|P2|Overall Study|Noncompliance with study drug|3
4674675|NCT02670551|16084712|P1|Overall Study|Noncompliance with study drug|3
4674676|NCT02670551|16084710|P3|Overall Study|Protocol Violation|0
4674677|NCT02670551|16084711|P2|Overall Study|Protocol Violation|0
4674678|NCT02670551|16084712|P1|Overall Study|Protocol Violation|1
4674679|NCT02670551|16084710|P3|Overall Study|Lost to Follow-up|6
4674680|NCT02670551|16084711|P2|Overall Study|Lost to Follow-up|7
4674681|NCT02670551|16084712|P1|Overall Study|Lost to Follow-up|5
4674682|NCT02670551|16084710|P3|Overall Study|Withdrawal of Consent|8
4674683|NCT02670551|16084711|P2|Overall Study|Withdrawal of Consent|3
4674684|NCT02670551|16084712|P1|Overall Study|Withdrawal of Consent|6
4674685|NCT02670551|16084710|P3|Overall Study|Lack of Efficacy|3
4674686|NCT02670551|16084711|P2|Overall Study|Lack of Efficacy|0
4674687|NCT02670551|16084712|P1|Overall Study|Lack of Efficacy|2
4674688|NCT02670551|16084710|P3|Overall Study|Adverse Event|9
4674689|NCT02670551|16084711|P2|Overall Study|Adverse Event|7
4674690|NCT02670551|16084712|P1|Overall Study|Adverse Event|4
4674691|NCT02670538|16084726|P3|Overall Study|Other Miscellaneous Reasons|2
4674692|NCT02670538|16084727|P2|Overall Study|Other Miscellaneous Reasons|1
4674693|NCT02670538|16084728|P1|Overall Study|Other Miscellaneous Reasons|0
4674694|NCT02670538|16084726|P3|Overall Study|Noncompliance with Study Drug|2
4674695|NCT02670538|16084727|P2|Overall Study|Noncompliance with Study Drug|3
4674696|NCT02670538|16084728|P1|Overall Study|Noncompliance with Study Drug|1
4674697|NCT02670538|16084726|P3|Overall Study|Protocol Violation|1
4674698|NCT02670538|16084727|P2|Overall Study|Protocol Violation|4
4674699|NCT02670538|16084728|P1|Overall Study|Protocol Violation|3
4674700|NCT02670538|16084726|P3|Overall Study|Lack of Efficacy|2
4674701|NCT02670538|16084727|P2|Overall Study|Lack of Efficacy|1
4674702|NCT02670538|16084728|P1|Overall Study|Lack of Efficacy|7
4674703|NCT02670538|16084726|P3|Overall Study|Adverse Event|11
4674704|NCT02670538|16084727|P2|Overall Study|Adverse Event|5
4674705|NCT02670538|16084728|P1|Overall Study|Adverse Event|5
4674706|NCT02670538|16084726|P3|Overall Study|Lost to Follow-up|7
4674707|NCT02670538|16084727|P2|Overall Study|Lost to Follow-up|12
4674708|NCT02670538|16084728|P1|Overall Study|Lost to Follow-up|8
4674709|NCT02670538|16084726|P3|Overall Study|Withdrawal of Consent|5
4674710|NCT02670538|16084727|P2|Overall Study|Withdrawal of Consent|6
4674711|NCT02670538|16084728|P1|Overall Study|Withdrawal of Consent|8
4674712|NCT02670473|16084739|P1|Overall Study|Withdrawal by Subject|1
4674713|NCT02670330|16084798|P2|Overall Study|Lost to Follow-up|2
4674714|NCT02670330|16084799|P1|Overall Study|Lost to Follow-up|3
4674715|NCT02670330|16084798|P2|Overall Study|Withdrawal by Subject|29
4674716|NCT02670330|16084799|P1|Overall Study|Withdrawal by Subject|34
4674717|NCT02670330|16084798|P2|Overall Study|Adverse Event|3
4674718|NCT02670330|16084799|P1|Overall Study|Adverse Event|1
4674719|NCT02670330|16084798|P2|Overall Study|Study Terminated By Sponsor|43
4674720|NCT02670330|16084799|P1|Overall Study|Study Terminated By Sponsor|36
4674721|NCT02670330|16084798|P2|Overall Study|Protocol Deviation|0
4674722|NCT02670330|16084799|P1|Overall Study|Protocol Deviation|1
4674723|NCT02670083|16084811|P2|Overall Study|Non-Compliance With Study Drug|0
4674724|NCT02670083|16084812|P1|Overall Study|Non-Compliance With Study Drug|1
4674725|NCT02670083|16084811|P2|Overall Study|Withdrawal by Subject|31
4674726|NCT02670083|16084812|P1|Overall Study|Withdrawal by Subject|32
4674727|NCT02670083|16084811|P2|Overall Study|Symptomatic Deterioration|2
4674728|NCT02670083|16084812|P1|Overall Study|Symptomatic Deterioration|0
4674729|NCT02670083|16084811|P2|Overall Study|Study Terminated By Sponsor|254
4674730|NCT02670083|16084812|P1|Overall Study|Study Terminated By Sponsor|257
4674731|NCT02670083|16084811|P2|Overall Study|Physician Decision|2
4674732|NCT02670083|16084812|P1|Overall Study|Physician Decision|0
4674733|NCT02670083|16084811|P2|Overall Study|Multiple Reasons|9
4674734|NCT02670083|16084812|P1|Overall Study|Multiple Reasons|9
4674735|NCT02670083|16084811|P2|Overall Study|Lost to Follow-up|2
4674736|NCT02670083|16084812|P1|Overall Study|Lost to Follow-up|2
4674737|NCT02670083|16084811|P2|Overall Study|Death|6
4674738|NCT02670083|16084812|P1|Overall Study|Death|4
4674739|NCT02670083|16084811|P2|Overall Study|Adverse Event|13
4674740|NCT02670083|16084812|P1|Overall Study|Adverse Event|16
4674741|NCT02669940|16084857|P2|Overall Study|Insufficient follow-up data|0
4674742|NCT02669940|16084858|P1|Overall Study|Insufficient follow-up data|1
4674743|NCT02669940|16084857|P2|Overall Study|Failure to return|3
4674744|NCT02669940|16084858|P1|Overall Study|Failure to return|0
4674745|NCT02669862|16084960|P3|Overall Study|Protocol Violation|1
4674746|NCT02669862|16084961|P2|Overall Study|Protocol Violation|0
4674747|NCT02669862|16084962|P1|Overall Study|Protocol Violation|0
4674748|NCT02669862|16084960|P3|Overall Study|moved|0
4674749|NCT02669862|16084961|P2|Overall Study|moved|1
4674750|NCT02669862|16084962|P1|Overall Study|moved|0
4674751|NCT02669862|16084960|P3|Overall Study|Withdrawal by Subject|3
4674752|NCT02669862|16084961|P2|Overall Study|Withdrawal by Subject|2
4674753|NCT02669862|16084962|P1|Overall Study|Withdrawal by Subject|2
4674754|NCT02669862|16084960|P3|Overall Study|Lost to Follow-up|1
4674755|NCT02669862|16084961|P2|Overall Study|Lost to Follow-up|2
4674756|NCT02669862|16084962|P1|Overall Study|Lost to Follow-up|0
4674757|NCT02669849|16084978|P3|Overall Study|Other|2
4674758|NCT02669849|16084979|P2|Overall Study|Other|0
4674759|NCT02669849|16084980|P1|Overall Study|Other|0
4674760|NCT02669849|16084978|P3|Overall Study|Study terminated by sponsor|14
4674761|NCT02669849|16084979|P2|Overall Study|Study terminated by sponsor|1
4674762|NCT02669849|16084980|P1|Overall Study|Study terminated by sponsor|16
4674763|NCT02669849|16084978|P3|Overall Study|Death|2
4674764|NCT02669849|16084979|P2|Overall Study|Death|1
4674765|NCT02669849|16084980|P1|Overall Study|Death|1
4674766|NCT02669849|16084978|P3|Overall Study|Lost to Follow-up|3
4674767|NCT02669849|16084979|P2|Overall Study|Lost to Follow-up|0
4674768|NCT02669849|16084980|P1|Overall Study|Lost to Follow-up|1
4674769|NCT02669849|16084978|P3|Overall Study|Withdrawal of Consent (not due to AE)|3
4674770|NCT02669849|16084979|P2|Overall Study|Withdrawal of Consent (not due to AE)|0
4674771|NCT02669849|16084980|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
4674772|NCT02669758|16085023|P1|Overall Study|Protocol Violation|1
4674773|NCT02669758|16085023|P1|Overall Study|Study noncompliance|1
4674774|NCT02669758|16085023|P1|Overall Study|Pregnancy|1
4674775|NCT02669758|16085023|P1|Overall Study|Lack of Efficacy|5
4674776|NCT02669758|16085023|P1|Overall Study|Non-Compliance with Study Drug|8
4674777|NCT02669758|16085023|P1|Overall Study|Adverse Event|16
4674778|NCT02669758|16085023|P1|Overall Study|Lost to Follow-up|19
4674779|NCT02669758|16085023|P1|Overall Study|Withdrawal by Subject|43
4674780|NCT02669667|16085034|P7|Overall Study|Lost to Follow-up|0
4674781|NCT02669667|16085035|P6|Overall Study|Lost to Follow-up|1
4674782|NCT02669667|16085036|P5|Overall Study|Lost to Follow-up|0
4674783|NCT02669667|16085037|P4|Overall Study|Lost to Follow-up|0
4674784|NCT02669667|16085038|P3|Overall Study|Lost to Follow-up|0
4674785|NCT02669667|16085039|P2|Overall Study|Lost to Follow-up|0
4674786|NCT02669667|16085040|P1|Overall Study|Lost to Follow-up|0
4674787|NCT02669433|16085143|P3|Overall Study|Death|1
4674788|NCT02669433|16085144|P2|Overall Study|Death|1
4674789|NCT02669433|16085145|P1|Overall Study|Death|0
4674790|NCT02669433|16085143|P3|Overall Study|Withdrawal by Caregiver|2
4674791|NCT02669433|16085144|P2|Overall Study|Withdrawal by Caregiver|0
4674792|NCT02669433|16085145|P1|Overall Study|Withdrawal by Caregiver|1
4674793|NCT02669433|16085143|P3|Overall Study|Withdrawal by Subject|0
4674794|NCT02669433|16085144|P2|Overall Study|Withdrawal by Subject|1
4674795|NCT02669433|16085145|P1|Overall Study|Withdrawal by Subject|5
4674796|NCT02669433|16085143|P3|Overall Study|Sponsor Termination|1
4674797|NCT02669433|16085144|P2|Overall Study|Sponsor Termination|0
4674798|NCT02669433|16085145|P1|Overall Study|Sponsor Termination|1
4674799|NCT02669433|16085143|P3|Overall Study|Adverse Event|10
4674800|NCT02669433|16085144|P2|Overall Study|Adverse Event|7
4674801|NCT02669433|16085145|P1|Overall Study|Adverse Event|6
4674802|NCT02669433|16085143|P3|Overall Study|Physician Decision|0
4674803|NCT02669433|16085144|P2|Overall Study|Physician Decision|1
4674804|NCT02669433|16085145|P1|Overall Study|Physician Decision|1
4674805|NCT02669433|16085143|P3|Overall Study|Disease Progression|0
4674806|NCT02669433|16085144|P2|Overall Study|Disease Progression|0
4674807|NCT02669433|16085145|P1|Overall Study|Disease Progression|1
4674808|NCT02669433|16085143|P3|Overall Study|Protocol Violation|1
4674809|NCT02669433|16085144|P2|Overall Study|Protocol Violation|4
4674810|NCT02669433|16085145|P1|Overall Study|Protocol Violation|0
4674811|NCT02669407|16085159|P1|Overall Study|Physician Decision|3
4674812|NCT02669264|16085188|P7|Overall Study|Miscellaneous|2
4674813|NCT02669264|16085189|P6|Overall Study|Miscellaneous|0
4674814|NCT02669264|16085190|P5|Overall Study|Miscellaneous|0
4674815|NCT02669264|16085191|P4|Overall Study|Miscellaneous|0
4674816|NCT02669264|16085192|P3|Overall Study|Miscellaneous|0
4674817|NCT02669264|16085193|P2|Overall Study|Miscellaneous|0
4674818|NCT02669264|16085194|P1|Overall Study|Miscellaneous|0
4674819|NCT02669264|16085188|P7|Overall Study|Lost to Follow-up|0
4674820|NCT02669264|16085189|P6|Overall Study|Lost to Follow-up|0
4674821|NCT02669264|16085190|P5|Overall Study|Lost to Follow-up|1
4674822|NCT02669264|16085191|P4|Overall Study|Lost to Follow-up|0
4674823|NCT02669264|16085192|P3|Overall Study|Lost to Follow-up|0
4674824|NCT02669264|16085193|P2|Overall Study|Lost to Follow-up|0
4674825|NCT02669264|16085194|P1|Overall Study|Lost to Follow-up|0
4674826|NCT02669264|16085188|P7|Overall Study|Withdrawal by Subject|0
4674827|NCT02669264|16085189|P6|Overall Study|Withdrawal by Subject|0
4674828|NCT02669264|16085190|P5|Overall Study|Withdrawal by Subject|1
4674829|NCT02669264|16085191|P4|Overall Study|Withdrawal by Subject|0
4674830|NCT02669264|16085192|P3|Overall Study|Withdrawal by Subject|0
4674831|NCT02669264|16085193|P2|Overall Study|Withdrawal by Subject|1
4674832|NCT02669264|16085194|P1|Overall Study|Withdrawal by Subject|0
4674833|NCT02669264|16085188|P7|Overall Study|Death|3
4674834|NCT02669264|16085189|P6|Overall Study|Death|6
4674835|NCT02669264|16085190|P5|Overall Study|Death|3
4674836|NCT02669264|16085191|P4|Overall Study|Death|3
4674837|NCT02669264|16085192|P3|Overall Study|Death|3
4674838|NCT02669264|16085193|P2|Overall Study|Death|5
4674839|NCT02669264|16085194|P1|Overall Study|Death|5
4674840|NCT02669095|16085340|P2|Overall Study|Visit 5 assessments not completed|1
4674841|NCT02669095|16085341|P1|Overall Study|Visit 5 assessments not completed|0
4674842|NCT02669095|16085340|P2|Overall Study|Torn Lens|1
4674843|NCT02669095|16085341|P1|Overall Study|Torn Lens|0
4674844|NCT02669095|16085340|P2|Overall Study|Unsatisfactory Lens Fitting|1
4674845|NCT02669095|16085341|P1|Overall Study|Unsatisfactory Lens Fitting|0
4674846|NCT02669095|16085340|P2|Overall Study|Adverse Event|0
4674847|NCT02669095|16085341|P1|Overall Study|Adverse Event|1
4674848|NCT02669082|16085349|P1|Overall Study|Adverse Event|1
4674849|NCT02669043|16085361|P1|Overall Study|Didn't meet I/E criteria|4
4674850|NCT02669017|16085374|P9|Overall Study|Miscellaneous|2
4674851|NCT02669017|16085375|P8|Overall Study|Miscellaneous|13
4674852|NCT02669017|16085376|P7|Overall Study|Miscellaneous|1
4674853|NCT02669017|16085377|P6|Overall Study|Miscellaneous|1
4674854|NCT02669017|16085378|P5|Overall Study|Miscellaneous|2
4674855|NCT02669017|16085379|P4|Overall Study|Miscellaneous|0
4674856|NCT02669017|16085380|P3|Overall Study|Miscellaneous|0
4674857|NCT02669017|16085381|P2|Overall Study|Miscellaneous|0
4674858|NCT02669017|16085382|P1|Overall Study|Miscellaneous|0
4674859|NCT02669017|16085374|P9|Overall Study|Lost to Follow-up|1
4674860|NCT02669017|16085375|P8|Overall Study|Lost to Follow-up|0
4674861|NCT02669017|16085376|P7|Overall Study|Lost to Follow-up|0
4674862|NCT02669017|16085377|P6|Overall Study|Lost to Follow-up|0
4674863|NCT02669017|16085378|P5|Overall Study|Lost to Follow-up|0
4674864|NCT02669017|16085379|P4|Overall Study|Lost to Follow-up|0
4674865|NCT02669017|16085380|P3|Overall Study|Lost to Follow-up|0
4674866|NCT02669017|16085381|P2|Overall Study|Lost to Follow-up|0
4674867|NCT02669017|16085382|P1|Overall Study|Lost to Follow-up|0
4674868|NCT02669017|16085374|P9|Overall Study|Withdrawal by Subject|2
4674869|NCT02669017|16085375|P8|Overall Study|Withdrawal by Subject|2
4674870|NCT02669017|16085376|P7|Overall Study|Withdrawal by Subject|0
4674871|NCT02669017|16085377|P6|Overall Study|Withdrawal by Subject|0
4674872|NCT02669017|16085378|P5|Overall Study|Withdrawal by Subject|2
4674873|NCT02669017|16085379|P4|Overall Study|Withdrawal by Subject|1
4674874|NCT02669017|16085380|P3|Overall Study|Withdrawal by Subject|0
4674875|NCT02669017|16085381|P2|Overall Study|Withdrawal by Subject|0
4674876|NCT02669017|16085382|P1|Overall Study|Withdrawal by Subject|0
4674877|NCT02669017|16085374|P9|Overall Study|Death|20
4674878|NCT02669017|16085375|P8|Overall Study|Death|47
4674879|NCT02669017|16085376|P7|Overall Study|Death|10
4674880|NCT02669017|16085377|P6|Overall Study|Death|18
4674881|NCT02669017|16085378|P5|Overall Study|Death|8
4674882|NCT02669017|16085379|P4|Overall Study|Death|3
4674883|NCT02669017|16085380|P3|Overall Study|Death|2
4674884|NCT02669017|16085381|P2|Overall Study|Death|2
4674885|NCT02669017|16085382|P1|Overall Study|Death|1
4674886|NCT02668822|16085527|P2|Overall Study|Study Terminated by Sponsor|9
4674887|NCT02668822|16085528|P1|Overall Study|Study Terminated by Sponsor|7
4674888|NCT02668822|16085527|P2|Overall Study|Protocol Violation|0
4674889|NCT02668822|16085528|P1|Overall Study|Protocol Violation|2
4674890|NCT02668783|16085550|P2|Overall Study|Withdrawal by Subject|0
4674891|NCT02668783|16085551|P1|Overall Study|Withdrawal by Subject|1
4674892|NCT02668783|16085550|P2|Overall Study|Subject moved|0
4674893|NCT02668783|16085551|P1|Overall Study|Subject moved|1
4674894|NCT02668783|16085550|P2|Overall Study|Study terminated by sponsor|10
4674895|NCT02668783|16085551|P1|Overall Study|Study terminated by sponsor|9
4674896|NCT02668783|16085550|P2|Overall Study|Protocol Violation|1
4674897|NCT02668783|16085551|P1|Overall Study|Protocol Violation|2
4674898|NCT02668783|16085550|P2|Overall Study|Pregnancy|1
4674899|NCT02668783|16085551|P1|Overall Study|Pregnancy|0
4674900|NCT02668640|16085571|P1|Overall Study|Other, not specified|1
4674901|NCT02668640|16085571|P1|Overall Study|Lost to Follow-up|13
4674902|NCT02668302|16085623|P2|Overall Study|Withdrawal by Subject|0
4674903|NCT02668302|16085624|P1|Overall Study|Withdrawal by Subject|1
4674904|NCT02667912|16085663|P2|Overall Study|Withdrawal by Subject|0
4674905|NCT02667912|16085664|P1|Overall Study|Withdrawal by Subject|1
4674906|NCT02667912|16085663|P2|Overall Study|Withdrawal by Subject|2
4674907|NCT02667912|16085664|P1|Overall Study|Withdrawal by Subject|1
4674908|NCT02667912|16085663|P2|Overall Study|Death|1
4674909|NCT02667912|16085664|P1|Overall Study|Death|3
4674910|NCT02667626|16085764|P2|Overall Study|Withdrawal by Subject|1
4674911|NCT02667626|16085765|P1|Overall Study|Withdrawal by Subject|0
4674912|NCT02667457|16085781|P2|Overall Study|Other Reason|2
4674913|NCT02667457|16085782|P1|Overall Study|Other Reason|0
4674914|NCT02667457|16085781|P2|Overall Study|Withdrawal by Subject|0
4674915|NCT02667457|16085782|P1|Overall Study|Withdrawal by Subject|1
4674916|NCT02667288|16085806|P1|Overall Study|Withdrawal by Subject|5
4674917|NCT02667288|16085806|P1|Overall Study|Lost to Follow-up|3
4674918|NCT02667288|16085806|P1|Overall Study|Protocol Violation|5
4674919|NCT02667275|16085813|P2|Overall Study|Discontinued early without completing|1
4674920|NCT02667275|16085814|P1|Overall Study|Discontinued early without completing|0
4674921|NCT02667275|16085813|P2|Overall Study|Withdrawal by Subject|5
4674922|NCT02667275|16085814|P1|Overall Study|Withdrawal by Subject|0
4674923|NCT02667275|16085813|P2|Overall Study|Lost to Follow-up|2
4674924|NCT02667275|16085814|P1|Overall Study|Lost to Follow-up|0
4674925|NCT02667275|16085813|P2|Overall Study|Protocol Violation|7
4674926|NCT02667275|16085814|P1|Overall Study|Protocol Violation|11
4674927|NCT02667236|16085824|P2|Overall Study|Withdrawal by Subject|0
4674928|NCT02667236|16085825|P1|Overall Study|Withdrawal by Subject|2
4674929|NCT02667236|16085824|P2|Overall Study|Adverse Event|1
4674930|NCT02667236|16085825|P1|Overall Study|Adverse Event|1
4674931|NCT02666664|16085947|P2|Overall Study|Lost to Follow-up|2
4674932|NCT02666664|16085948|P1|Overall Study|Lost to Follow-up|1
4674933|NCT02666664|16085947|P2|Overall Study|Sponsor decision|1
4674934|NCT02666664|16085948|P1|Overall Study|Sponsor decision|0
4674935|NCT02666664|16085947|P2|Overall Study|Withdrawal by participant|40
4674936|NCT02666664|16085948|P1|Overall Study|Withdrawal by participant|23
4674937|NCT02666664|16085947|P2|Overall Study|Adverse Event|37
4674938|NCT02666664|16085948|P1|Overall Study|Adverse Event|12
4674939|NCT02666664|16085947|P2|Overall Study|Other|1
4674940|NCT02666664|16085948|P1|Overall Study|Other|0
4674941|NCT02666664|16085947|P2|Overall Study|Protocol Violation|2
4674942|NCT02666664|16085948|P1|Overall Study|Protocol Violation|0
4674943|NCT02666664|16085947|P2|Overall Study|Physician Decision|1
4674944|NCT02666664|16085948|P1|Overall Study|Physician Decision|0
4674945|NCT02666430|16086031|P2|Period 3|Lost to Follow-up|0
4674946|NCT02666430|16086032|P1|Period 3|Lost to Follow-up|1
4674947|NCT02666430|16086031|P2|Period 2|Withdrawal by Subject|4
4674948|NCT02666430|16086032|P1|Period 2|Withdrawal by Subject|1
4674949|NCT02666430|16086031|P2|Period 1|Adverse Event|1
4674950|NCT02666430|16086032|P1|Period 1|Adverse Event|0
4674951|NCT02666430|16086031|P2|Period 1|Lost to Follow-up|0
4674952|NCT02666430|16086032|P1|Period 1|Lost to Follow-up|1
4674953|NCT02666222|16086167|P1|Overall Study|Death|2
4674954|NCT02665689|16086203|P2|Overall Study|Lost to Follow-up|1
4674955|NCT02665689|16086204|P1|Overall Study|Lost to Follow-up|0
4674956|NCT02665689|16086203|P2|Overall Study|Trial termination|1
4674957|NCT02665689|16086204|P1|Overall Study|Trial termination|1
4674958|NCT02665689|16086203|P2|Overall Study|Adverse Event|0
4674959|NCT02665689|16086204|P1|Overall Study|Adverse Event|1
4674960|NCT02665455|16086239|P1|Overall Study|Protocol Violation|1
4674961|NCT02665455|16086239|P1|Overall Study|Adverse Event|1
4674962|NCT02665455|16086239|P1|Overall Study|Lost to Follow-up|1
4674963|NCT02665455|16086239|P1|Overall Study|Withdrawal by Subject|6
4674964|NCT02665286|16086283|P3|Overall Study|Lost to Follow-up|1
4674965|NCT02665286|16086284|P2|Overall Study|Lost to Follow-up|2
4674966|NCT02665286|16086285|P1|Overall Study|Lost to Follow-up|3
4674967|NCT02664415|16086436|P2|Overall Study|Adverse Event|0
4674968|NCT02664415|16086437|P1|Overall Study|Adverse Event|1
4674969|NCT02664272|16086483|P1|Overall Study|Fluoroscopic images not made available|2
4674970|NCT02663817|16086504|P1|Overall Study|Screen failure|2
4674971|NCT02663687|16086524|P5|Overall Study|Other|0
4674972|NCT02663687|16086525|P4|Overall Study|Other|0
4674973|NCT02663687|16086526|P3|Overall Study|Other|1
4674974|NCT02663687|16086527|P2|Overall Study|Other|0
4674975|NCT02663687|16086528|P1|Overall Study|Other|1
4674976|NCT02663687|16086524|P5|Overall Study|Adverse Event|0
4674977|NCT02663687|16086525|P4|Overall Study|Adverse Event|0
4674978|NCT02663687|16086526|P3|Overall Study|Adverse Event|0
4674979|NCT02663687|16086527|P2|Overall Study|Adverse Event|0
4674980|NCT02663687|16086528|P1|Overall Study|Adverse Event|1
4674981|NCT02663674|16086582|P2|Overall Study|Other Event (Health Related)|1
4674982|NCT02663674|16086583|P1|Overall Study|Other Event (Health Related)|0
4674983|NCT02663674|16086582|P2|Overall Study|Physician Decision|1
4674984|NCT02663674|16086583|P1|Overall Study|Physician Decision|1
4674985|NCT02663674|16086582|P2|Overall Study|Withdrawal by Subject|4
4674986|NCT02663674|16086583|P1|Overall Study|Withdrawal by Subject|1
4674987|NCT02663674|16086582|P2|Overall Study|Lost to Follow-up|4
4674988|NCT02663674|16086583|P1|Overall Study|Lost to Follow-up|5
4674989|NCT02663453|16086847|P2|Overall Study|Withdrawal by Subject|0
4674990|NCT02663453|16086848|P1|Overall Study|Withdrawal by Subject|1
4674991|NCT02663453|16086847|P2|Overall Study|Death|4
4674992|NCT02663453|16086848|P1|Overall Study|Death|4
4674993|NCT02663128|16086893|P6|Period 2|Physician Decision|0
4674994|NCT02663128|16086894|P5|Period 2|Physician Decision|1
4674995|NCT02663128|16086895|P4|Period 2|Physician Decision|0
4674996|NCT02663128|16086896|P3|Period 2|Physician Decision|0
4674997|NCT02663128|16086897|P2|Period 2|Physician Decision|0
4674998|NCT02663128|16086898|P1|Period 2|Physician Decision|0
4674999|NCT02662764|16086912|P1|Overall Study|Patient discharged prior to 24 hrs|5
4675000|NCT02662764|16086912|P1|Overall Study|Patient changed treatment|1
4675001|NCT02662764|16086912|P1|Overall Study|Device failure|4
4675002|NCT02662764|16086912|P1|Overall Study|Withdrawal by Subject|5
4675003|NCT02662764|16086912|P1|Overall Study|Protocol Violation|1
4675004|NCT02662764|16086912|P1|Overall Study|Lack of Efficacy|8
4675005|NCT02662764|16086912|P1|Overall Study|Adverse Event|6
4675006|NCT02662569|16086980|P4|Overall Study|Lost to Follow-up|0
4675007|NCT02662569|16086981|P3|Overall Study|Lost to Follow-up|0
4675008|NCT02662569|16086982|P2|Overall Study|Lost to Follow-up|0
4675009|NCT02662569|16086983|P1|Overall Study|Lost to Follow-up|1
4675010|NCT02662569|16086980|P4|Overall Study|Withdrawal by Subject|4
4675011|NCT02662569|16086981|P3|Overall Study|Withdrawal by Subject|6
4675012|NCT02662569|16086982|P2|Overall Study|Withdrawal by Subject|1
4675013|NCT02662569|16086983|P1|Overall Study|Withdrawal by Subject|6
4675014|NCT02662556|16087081|P1|Overall Study|Lack of Efficacy|4
4675015|NCT02662556|16087081|P1|Overall Study|Adverse Event|4
4675016|NCT02661815|16087150|P4|Overall Study|Withdrawal by Subject|0
4675017|NCT02661815|16087151|P3|Overall Study|Withdrawal by Subject|0
4675018|NCT02661815|16087152|P2|Overall Study|Withdrawal by Subject|0
4675019|NCT02661815|16087153|P1|Overall Study|Withdrawal by Subject|1
4675020|NCT02661594|16087175|P4|Overall Study|Protocol Violation|0
4675021|NCT02661594|16087176|P3|Overall Study|Protocol Violation|1
4675022|NCT02661594|16087177|P2|Overall Study|Protocol Violation|0
4675023|NCT02661594|16087178|P1|Overall Study|Protocol Violation|1
4675024|NCT02661490|16087193|P5|Overall Study|Reason not Specified|1
4675025|NCT02661490|16087194|P4|Overall Study|Reason not Specified|0
4675026|NCT02661490|16087195|P3|Overall Study|Reason not Specified|0
4675027|NCT02661490|16087196|P2|Overall Study|Reason not Specified|0
4675028|NCT02661490|16087197|P1|Overall Study|Reason not Specified|0
4675029|NCT02661490|16087193|P5|Overall Study|Death|0
4675030|NCT02661490|16087194|P4|Overall Study|Death|1
4675031|NCT02661490|16087195|P3|Overall Study|Death|0
4675032|NCT02661490|16087196|P2|Overall Study|Death|1
4675033|NCT02661490|16087197|P1|Overall Study|Death|1
4675034|NCT02661490|16087193|P5|Overall Study|Withdrawal by Subject|0
4675035|NCT02661490|16087194|P4|Overall Study|Withdrawal by Subject|0
4675036|NCT02661490|16087195|P3|Overall Study|Withdrawal by Subject|2
4675037|NCT02661490|16087196|P2|Overall Study|Withdrawal by Subject|0
4675038|NCT02661490|16087197|P1|Overall Study|Withdrawal by Subject|2
4675039|NCT02661490|16087193|P5|Overall Study|Lost to Follow-up|2
4675040|NCT02661490|16087194|P4|Overall Study|Lost to Follow-up|0
4675041|NCT02661490|16087195|P3|Overall Study|Lost to Follow-up|0
4675042|NCT02661490|16087196|P2|Overall Study|Lost to Follow-up|1
4675043|NCT02661490|16087197|P1|Overall Study|Lost to Follow-up|0
4675044|NCT02661178|16087365|P15|Part 1|Protocol Violation|0
4675045|NCT02661178|16087366|P14|Part 1|Protocol Violation|0
4675046|NCT02661178|16087367|P13|Part 1|Protocol Violation|0
4675047|NCT02661178|16087368|P12|Part 1|Protocol Violation|0
4675048|NCT02661178|16087369|P11|Part 1|Protocol Violation|0
4675049|NCT02661178|16087370|P10|Part 1|Protocol Violation|0
4675050|NCT02661178|16087371|P9|Part 1|Protocol Violation|0
4675051|NCT02661178|16087372|P8|Part 1|Protocol Violation|0
4675052|NCT02661178|16087373|P7|Part 1|Protocol Violation|0
4675053|NCT02661178|16087374|P6|Part 1|Protocol Violation|0
4675054|NCT02661178|16087375|P5|Part 1|Protocol Violation|0
4675055|NCT02661178|16087376|P4|Part 1|Protocol Violation|0
4675056|NCT02661178|16087377|P3|Part 1|Protocol Violation|0
4675057|NCT02661178|16087378|P2|Part 1|Protocol Violation|0
4675058|NCT02661178|16087379|P1|Part 1|Protocol Violation|1
4675059|NCT02661061|16087737|P2|Overall Study|Withdrawal by Subject|1
4675060|NCT02661061|16087738|P1|Overall Study|Withdrawal by Subject|1
4675061|NCT02661061|16087737|P2|Overall Study|Lack of Efficacy|1
4675062|NCT02661061|16087738|P1|Overall Study|Lack of Efficacy|1
4675063|NCT02660983|16087748|P2|Open Label Extension Phase (24 Weeks)|Other|1
4675064|NCT02660983|16087749|P1|Open Label Extension Phase (24 Weeks)|Other|0
4675065|NCT02660983|16087748|P2|Open Label Extension Phase (24 Weeks)|Adverse Event|3
4675066|NCT02660983|16087749|P1|Open Label Extension Phase (24 Weeks)|Adverse Event|1
4675067|NCT02660983|16087748|P2|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4
4675068|NCT02660983|16087749|P1|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1
4675069|NCT02660983|16087748|P2|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
4675070|NCT02660983|16087749|P1|Open Label Extension Phase (24 Weeks)|Protocol Violation|1
4675071|NCT02660983|16087748|P2|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9
4675072|NCT02660983|16087749|P1|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8
4675073|NCT02660983|16087748|P2|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12
4675074|NCT02660983|16087749|P1|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15
4675075|NCT02660983|16087748|P2|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5
4675076|NCT02660983|16087749|P1|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1
4675077|NCT02660827|16087800|P1|2-6 Years Old Age Group|Withdrawal by Subject|1
4675078|NCT02660580|16087834|P5|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
4675079|NCT02660580|16087835|P4|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1
4675080|NCT02660580|16087836|P3|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
4675081|NCT02660580|16087837|P2|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
4675082|NCT02660580|16087838|P1|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0
4675083|NCT02660580|16087834|P5|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
4675084|NCT02660580|16087835|P4|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2
4675085|NCT02660580|16087836|P3|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3
4675086|NCT02660580|16087837|P2|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
4675087|NCT02660580|16087838|P1|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0
4675088|NCT02660580|16087834|P5|Extended Treatment Period(Week 16 to 52)|Adverse Event|4
4675089|NCT02660580|16087835|P4|Extended Treatment Period(Week 16 to 52)|Adverse Event|6
4675090|NCT02660580|16087836|P3|Extended Treatment Period(Week 16 to 52)|Adverse Event|8
4675091|NCT02660580|16087837|P2|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
4675092|NCT02660580|16087838|P1|Extended Treatment Period(Week 16 to 52)|Adverse Event|0
4675093|NCT02660580|16087834|P5|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
4675094|NCT02660580|16087835|P4|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2
4675095|NCT02660580|16087836|P3|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4
4675096|NCT02660580|16087837|P2|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
4675097|NCT02660580|16087838|P1|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0
4675098|NCT02660580|16087834|P5|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
4675099|NCT02660580|16087835|P4|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
4675100|NCT02660580|16087836|P3|Extended Treatment Period(Week 16 to 52)|Other un-specified|1
4675101|NCT02660580|16087837|P2|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
4675102|NCT02660580|16087838|P1|Extended Treatment Period(Week 16 to 52)|Other un-specified|0
4675103|NCT02660580|16087834|P5|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1
4675104|NCT02660580|16087835|P4|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
4675105|NCT02660580|16087836|P3|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2
4675106|NCT02660580|16087837|P2|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
4675107|NCT02660580|16087838|P1|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0
4675108|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
4675109|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
4675110|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0
4675111|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2
4675112|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1
4675113|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
4675114|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
4675115|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0
4675116|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4
4675117|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1
4675118|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Adverse Event|0
4675119|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Adverse Event|0
4675120|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Adverse Event|0
4675121|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Adverse Event|9
4675122|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Adverse Event|2
4675123|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4675124|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4675125|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4675126|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2
4675127|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0
4675128|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4675129|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4675130|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4675131|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Other un-specified|0
4675132|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Other un-specified|1
4675133|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
4675134|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
4675135|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Protocol Violation|0
4675136|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Protocol Violation|1
4675137|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Protocol Violation|3
4675138|NCT02660580|16087834|P5|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
4675139|NCT02660580|16087835|P4|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
4675140|NCT02660580|16087836|P3|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0
4675141|NCT02660580|16087837|P2|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
4675142|NCT02660580|16087838|P1|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1
4675143|NCT02660242|16087953|P1|Glucagon Injection|Lost to Follow-up|1
4675144|NCT02660242|16087953|P1|Glucose Tabs|Lost to Follow-up|1
4675145|NCT02660229|16088009|P2|Overall Study|Withdrawal by Subject|1
4675146|NCT02660229|16088010|P1|Overall Study|Withdrawal by Subject|0
4675147|NCT02660229|16088009|P2|Overall Study|Adverse Event|0
4675148|NCT02660229|16088010|P1|Overall Study|Adverse Event|2
4675149|NCT02659631|16088051|P10|Overall Study|Death (treatment phase)|0
4675150|NCT02659631|16088052|P9|Overall Study|Death (treatment phase)|0
4675151|NCT02659631|16088053|P8|Overall Study|Death (treatment phase)|0
4675152|NCT02659631|16088054|P7|Overall Study|Death (treatment phase)|1
4675153|NCT02659631|16088055|P6|Overall Study|Death (treatment phase)|0
4675154|NCT02659631|16088056|P5|Overall Study|Death (treatment phase)|1
4675155|NCT02659631|16088057|P4|Overall Study|Death (treatment phase)|0
4675156|NCT02659631|16088058|P3|Overall Study|Death (treatment phase)|0
4675157|NCT02659631|16088059|P2|Overall Study|Death (treatment phase)|0
4675158|NCT02659631|16088060|P1|Overall Study|Death (treatment phase)|0
4675159|NCT02659631|16088051|P10|Overall Study|Death (follow-up phase)|0
4675160|NCT02659631|16088052|P9|Overall Study|Death (follow-up phase)|1
4675161|NCT02659631|16088053|P8|Overall Study|Death (follow-up phase)|3
4675162|NCT02659631|16088054|P7|Overall Study|Death (follow-up phase)|0
4675163|NCT02659631|16088055|P6|Overall Study|Death (follow-up phase)|2
4675164|NCT02659631|16088056|P5|Overall Study|Death (follow-up phase)|3
4675165|NCT02659631|16088057|P4|Overall Study|Death (follow-up phase)|1
4675166|NCT02659631|16088058|P3|Overall Study|Death (follow-up phase)|1
4675167|NCT02659631|16088059|P2|Overall Study|Death (follow-up phase)|2
4675168|NCT02659631|16088060|P1|Overall Study|Death (follow-up phase)|1
4675169|NCT02659631|16088051|P10|Overall Study|Participant refused further follow-up|0
4675170|NCT02659631|16088052|P9|Overall Study|Participant refused further follow-up|1
4675171|NCT02659631|16088053|P8|Overall Study|Participant refused further follow-up|0
4675172|NCT02659631|16088054|P7|Overall Study|Participant refused further follow-up|0
4675173|NCT02659631|16088055|P6|Overall Study|Participant refused further follow-up|0
4675174|NCT02659631|16088056|P5|Overall Study|Participant refused further follow-up|0
4675175|NCT02659631|16088057|P4|Overall Study|Participant refused further follow-up|1
4675176|NCT02659631|16088058|P3|Overall Study|Participant refused further follow-up|0
4675177|NCT02659631|16088059|P2|Overall Study|Participant refused further follow-up|0
4675178|NCT02659631|16088060|P1|Overall Study|Participant refused further follow-up|0
4675179|NCT02659631|16088051|P10|Overall Study|Withdrawal prior to treatment|0
4675180|NCT02659631|16088052|P9|Overall Study|Withdrawal prior to treatment|0
4675181|NCT02659631|16088053|P8|Overall Study|Withdrawal prior to treatment|0
4675182|NCT02659631|16088054|P7|Overall Study|Withdrawal prior to treatment|0
4675183|NCT02659631|16088055|P6|Overall Study|Withdrawal prior to treatment|0
4675184|NCT02659631|16088056|P5|Overall Study|Withdrawal prior to treatment|1
4675185|NCT02659631|16088057|P4|Overall Study|Withdrawal prior to treatment|0
4675186|NCT02659631|16088058|P3|Overall Study|Withdrawal prior to treatment|0
4675187|NCT02659631|16088059|P2|Overall Study|Withdrawal prior to treatment|0
4675188|NCT02659631|16088060|P1|Overall Study|Withdrawal prior to treatment|0
4675189|NCT02659631|16088051|P10|Overall Study|Lost to Follow-up|0
4675190|NCT02659631|16088052|P9|Overall Study|Lost to Follow-up|0
4675191|NCT02659631|16088053|P8|Overall Study|Lost to Follow-up|0
4675192|NCT02659631|16088054|P7|Overall Study|Lost to Follow-up|0
4675193|NCT02659631|16088055|P6|Overall Study|Lost to Follow-up|1
4675194|NCT02659631|16088056|P5|Overall Study|Lost to Follow-up|0
4675195|NCT02659631|16088057|P4|Overall Study|Lost to Follow-up|0
4675196|NCT02659631|16088058|P3|Overall Study|Lost to Follow-up|2
4675197|NCT02659631|16088059|P2|Overall Study|Lost to Follow-up|0
4675198|NCT02659631|16088060|P1|Overall Study|Lost to Follow-up|0
4675199|NCT02659540|16088194|P2|Overall Study|Progressive disease|6
4675200|NCT02659540|16088195|P1|Overall Study|Progressive disease|2
4675201|NCT02659540|16088194|P2|Overall Study|Death|0
4675202|NCT02659540|16088195|P1|Overall Study|Death|1
4675203|NCT02659540|16088194|P2|Overall Study|Adverse Event|2
4675204|NCT02659540|16088195|P1|Overall Study|Adverse Event|3
4675205|NCT02659098|16088226|P1|Overall Study|Withdrawal by Subject|7
4675206|NCT02658487|16088284|P1|Overall Study|Refractory AML|1
4675207|NCT02658487|16088284|P1|Overall Study|Treatment Failure, circulating blasts|1
4675208|NCT02658487|16088284|P1|Overall Study|Adverse Event|1
4675209|NCT02658487|16088284|P1|Overall Study|Alternative therapy|1
4675210|NCT02658487|16088284|P1|Overall Study|Disease progression|10
4675211|NCT02658487|16088284|P1|Overall Study|Death|2
4675212|NCT02658149|16088355|P2|Overall Study|Physician Decision|0
4675213|NCT02658149|16088356|P1|Overall Study|Physician Decision|1
4675214|NCT02658084|16088372|P2|Overall Study|Study Termination|0
4675215|NCT02658084|16088373|P1|Overall Study|Study Termination|1
4675216|NCT02658084|16088372|P2|Overall Study|Withdrawal by Subject|0
4675217|NCT02658084|16088373|P1|Overall Study|Withdrawal by Subject|1
4675218|NCT02657889|16088426|P4|Overall Study|Ongoing in Study|19
4675219|NCT02657889|16088427|P3|Overall Study|Ongoing in Study|24
4675220|NCT02657889|16088428|P2|Overall Study|Ongoing in Study|5
4675221|NCT02657889|16088429|P1|Overall Study|Ongoing in Study|0
4675222|NCT02657889|16088426|P4|Overall Study|Withdrawal by Subject|0
4675223|NCT02657889|16088427|P3|Overall Study|Withdrawal by Subject|8
4675224|NCT02657889|16088428|P2|Overall Study|Withdrawal by Subject|0
4675225|NCT02657889|16088429|P1|Overall Study|Withdrawal by Subject|0
4675226|NCT02657889|16088426|P4|Overall Study|Lost to Follow-up|2
4675227|NCT02657889|16088427|P3|Overall Study|Lost to Follow-up|1
4675228|NCT02657889|16088428|P2|Overall Study|Lost to Follow-up|0
4675229|NCT02657889|16088429|P1|Overall Study|Lost to Follow-up|2
4675230|NCT02657889|16088426|P4|Overall Study|Death|34
4675231|NCT02657889|16088427|P3|Overall Study|Death|20
4675232|NCT02657889|16088428|P2|Overall Study|Death|2
4675233|NCT02657889|16088429|P1|Overall Study|Death|5
4675234|NCT02657434|16088470|P2|Overall Study|Protocol Violation|0
4675235|NCT02657434|16088471|P1|Overall Study|Protocol Violation|1
4675236|NCT02657434|16088470|P2|Overall Study|Withdrawal by Subject|16
4675237|NCT02657434|16088471|P1|Overall Study|Withdrawal by Subject|27
4675238|NCT02657434|16088470|P2|Overall Study|Randomization by Error|0
4675239|NCT02657434|16088471|P1|Overall Study|Randomization by Error|2
4675240|NCT02657434|16088470|P2|Overall Study|Lost to Follow-up|2
4675241|NCT02657434|16088471|P1|Overall Study|Lost to Follow-up|2
4675242|NCT02657434|16088470|P2|Overall Study|Death|183
4675243|NCT02657434|16088471|P1|Overall Study|Death|177
4675244|NCT02657434|16088470|P2|Overall Study|On-Going in Study|91
4675245|NCT02657434|16088471|P1|Overall Study|On-Going in Study|77
4675246|NCT02657408|16088501|P2|Overall Study|Adverse Event|7
4675247|NCT02657408|16088502|P1|Overall Study|Adverse Event|3
4675248|NCT02657369|16088526|P1|Overall Study|Study terminated by sponsor|7
4675249|NCT02657369|16088526|P1|Overall Study|Death|27
4675250|NCT02657031|16088557|P2|Overall Study|Adverse Event|2
4675251|NCT02657031|16088558|P1|Overall Study|Adverse Event|1
4675252|NCT02656693|16088590|P3|Overall Study|Bariatric surgery|2
4675253|NCT02656693|16088591|P2|Overall Study|Bariatric surgery|1
4675254|NCT02656693|16088592|P1|Overall Study|Bariatric surgery|0
4675255|NCT02656693|16088590|P3|Overall Study|Pregnancy|1
4675256|NCT02656693|16088591|P2|Overall Study|Pregnancy|1
4675257|NCT02656693|16088592|P1|Overall Study|Pregnancy|1
4675258|NCT02656329|16088675|P2|Overall Study|Other than specified above|6
4675259|NCT02656329|16088676|P1|Overall Study|Other than specified above|5
4675260|NCT02656329|16088675|P2|Overall Study|Study termination by Sponsor|142
4675261|NCT02656329|16088676|P1|Overall Study|Study termination by Sponsor|150
4675262|NCT02656329|16088675|P2|Overall Study|Withdrawal by Subject|6
4675263|NCT02656329|16088676|P1|Overall Study|Withdrawal by Subject|7
4675264|NCT02656329|16088675|P2|Overall Study|Lost to Follow-up|3
4675265|NCT02656329|16088676|P1|Overall Study|Lost to Follow-up|2
4675266|NCT02656290|16088699|P1|Overall Study|Subjects Remain On Study|26
4675267|NCT02656173|16088709|P2|Overall Study|Miscellaneous|0
4675268|NCT02656173|16088710|P1|Overall Study|Miscellaneous|2
4675269|NCT02656173|16088709|P2|Overall Study|Protocol Violation|1
4675270|NCT02656173|16088710|P1|Overall Study|Protocol Violation|0
4675271|NCT02656173|16088709|P2|Overall Study|Withdrawal by Subject|3
4675272|NCT02656173|16088710|P1|Overall Study|Withdrawal by Subject|1
4675273|NCT02656173|16088709|P2|Overall Study|Adverse Event|5
4675274|NCT02656173|16088710|P1|Overall Study|Adverse Event|7
4675275|NCT02656173|16088709|P2|Overall Study|Deviation from the Eligible Criteria|2
4675276|NCT02656173|16088710|P1|Overall Study|Deviation from the Eligible Criteria|3
4675277|NCT02655887|16088782|P1|Overall Study|Missed 12-month follow-up visit|4
4675278|NCT02655887|16088782|P1|Overall Study|Withdrawal by Subject|3
4675279|NCT02655887|16088782|P1|Overall Study|Death|4
4675280|NCT02655887|16088782|P1|Overall Study|Lost to Follow-up|3
4675281|NCT02655679|16088801|P5|Overall Study|Other Miscellaneous Reasons|0
4675282|NCT02655679|16088802|P4|Overall Study|Other Miscellaneous Reasons|0
4675283|NCT02655679|16088803|P3|Overall Study|Other Miscellaneous Reasons|0
4675284|NCT02655679|16088804|P2|Overall Study|Other Miscellaneous Reasons|0
4675285|NCT02655679|16088805|P1|Overall Study|Other Miscellaneous Reasons|1
4675286|NCT02655679|16088801|P5|Overall Study|Lost to Follow-up|0
4675287|NCT02655679|16088802|P4|Overall Study|Lost to Follow-up|1
4675288|NCT02655679|16088803|P3|Overall Study|Lost to Follow-up|1
4675289|NCT02655679|16088804|P2|Overall Study|Lost to Follow-up|1
4675290|NCT02655679|16088805|P1|Overall Study|Lost to Follow-up|0
4675291|NCT02655679|16088801|P5|Overall Study|Inability to Comply with the Protocol|0
4675292|NCT02655679|16088802|P4|Overall Study|Inability to Comply with the Protocol|0
4675293|NCT02655679|16088803|P3|Overall Study|Inability to Comply with the Protocol|0
4675294|NCT02655679|16088804|P2|Overall Study|Inability to Comply with the Protocol|0
4675295|NCT02655679|16088805|P1|Overall Study|Inability to Comply with the Protocol|1
4675296|NCT02655679|16088801|P5|Overall Study|Withdrawal by Subject|1
4675297|NCT02655679|16088802|P4|Overall Study|Withdrawal by Subject|3
4675298|NCT02655679|16088803|P3|Overall Study|Withdrawal by Subject|0
4675299|NCT02655679|16088804|P2|Overall Study|Withdrawal by Subject|1
4675300|NCT02655679|16088805|P1|Overall Study|Withdrawal by Subject|1
4675301|NCT02655679|16088801|P5|Overall Study|Adverse Event|0
4675302|NCT02655679|16088802|P4|Overall Study|Adverse Event|0
4675303|NCT02655679|16088803|P3|Overall Study|Adverse Event|0
4675304|NCT02655679|16088804|P2|Overall Study|Adverse Event|1
4675305|NCT02655679|16088805|P1|Overall Study|Adverse Event|0
4675306|NCT02655666|16088877|P1|Overall Study|Sponsor stopped this clinical research.|12
4675307|NCT02655419|16088931|P2|Overall Study|Other|1
4675308|NCT02655419|16088932|P1|Overall Study|Other|0
4675309|NCT02655419|16088931|P2|Overall Study|Withdrawal by Subject|1
4675310|NCT02655419|16088932|P1|Overall Study|Withdrawal by Subject|4
4675311|NCT02655419|16088931|P2|Overall Study|Enrolled but not treated|5
4675312|NCT02655419|16088932|P1|Overall Study|Enrolled but not treated|1
4675313|NCT02655237|16089052|P2|Overall Study|Randomized but Not Treated|0
4675314|NCT02655237|16089053|P1|Overall Study|Randomized but Not Treated|1
4675315|NCT02655237|16089052|P2|Overall Study|Reduction of Hemoglobin Concentration|0
4675316|NCT02655237|16089053|P1|Overall Study|Reduction of Hemoglobin Concentration|1
4675317|NCT02655237|16089052|P2|Overall Study|Recovery Leading to Surgery|1
4675318|NCT02655237|16089053|P1|Overall Study|Recovery Leading to Surgery|2
4675319|NCT02655237|16089052|P2|Overall Study|Lack of Efficacy|1
4675320|NCT02655237|16089053|P1|Overall Study|Lack of Efficacy|0
4675321|NCT02655237|16089052|P2|Overall Study|Withdrawal by Participant|2
4675322|NCT02655237|16089053|P1|Overall Study|Withdrawal by Participant|1
4675323|NCT02655237|16089052|P2|Overall Study|Protocol Deviation|0
4675324|NCT02655237|16089053|P1|Overall Study|Protocol Deviation|2
4675325|NCT02655237|16089052|P2|Overall Study|Adverse Event|7
4675326|NCT02655237|16089053|P1|Overall Study|Adverse Event|10
4675327|NCT02655224|16089093|P2|Overall Study|Adverse Event|1
4675328|NCT02655224|16089094|P1|Overall Study|Adverse Event|1
4675329|NCT02655016|16089126|P2|Overall Study|Withdrawal by Subject|36
4675330|NCT02655016|16089127|P1|Overall Study|Withdrawal by Subject|18
4675331|NCT02655016|16089126|P2|Overall Study|Lost to Follow-up|1
4675332|NCT02655016|16089127|P1|Overall Study|Lost to Follow-up|1
4675333|NCT02655016|16089126|P2|Overall Study|Death|48
4675334|NCT02655016|16089127|P1|Overall Study|Death|30
4675335|NCT02655016|16089126|P2|Overall Study|Site closed|1
4675336|NCT02655016|16089127|P1|Overall Study|Site closed|0
4675337|NCT02655016|16089126|P2|Overall Study|Disease progression|4
4675338|NCT02655016|16089127|P1|Overall Study|Disease progression|6
4675339|NCT02654717|16089188|P2|Overall Study|Non-permitted medication|0
4675340|NCT02654717|16089189|P1|Overall Study|Non-permitted medication|3
4675341|NCT02654717|16089188|P2|Overall Study|Withdrawal by Subject|1
4675342|NCT02654717|16089189|P1|Overall Study|Withdrawal by Subject|0
4675343|NCT02654717|16089188|P2|Overall Study|Protocol Violation|2
4675344|NCT02654717|16089189|P1|Overall Study|Protocol Violation|1
4675345|NCT02654717|16089188|P2|Overall Study|Adverse Event|2
4675346|NCT02654717|16089189|P1|Overall Study|Adverse Event|2
4675347|NCT02654145|16089240|P1|Overall Study|Withdrawal by Subject|5
4675348|NCT02654145|16089240|P1|Overall Study|Protocol Violation|1
4675349|NCT02654145|16089240|P1|Overall Study|Lack of Efficacy|1
4675350|NCT02654132|16089249|P2|Overall Study|Never treated|2
4675351|NCT02654132|16089250|P1|Overall Study|Never treated|0
4675352|NCT02654132|16089249|P2|Overall Study|Clinical Progression (not protocol)|1
4675353|NCT02654132|16089250|P1|Overall Study|Clinical Progression (not protocol)|0
4675354|NCT02654132|16089249|P2|Overall Study|Inadequate response to therapy|0
4675355|NCT02654132|16089250|P1|Overall Study|Inadequate response to therapy|1
4675356|NCT02654132|16089249|P2|Overall Study|Subject Withdrew Consent|1
4675357|NCT02654132|16089250|P1|Overall Study|Subject Withdrew Consent|2
4675358|NCT02654132|16089249|P2|Overall Study|Not Reported|1
4675359|NCT02654132|16089250|P1|Overall Study|Not Reported|0
4675360|NCT02654132|16089249|P2|Overall Study|Subj Request to Discontinue Treatment|0
4675361|NCT02654132|16089250|P1|Overall Study|Subj Request to Discontinue Treatment|1
4675362|NCT02654132|16089249|P2|Overall Study|Maximum Clinical Benefit|2
4675363|NCT02654132|16089250|P1|Overall Study|Maximum Clinical Benefit|0
4675364|NCT02654132|16089249|P2|Overall Study|Study Drug Toxicity|2
4675365|NCT02654132|16089250|P1|Overall Study|Study Drug Toxicity|1
4675366|NCT02654132|16089249|P2|Overall Study|Switched to another tx|1
4675367|NCT02654132|16089250|P1|Overall Study|Switched to another tx|0
4675368|NCT02654132|16089249|P2|Overall Study|Adverse Event Unrelated to Study Drug|5
4675369|NCT02654132|16089250|P1|Overall Study|Adverse Event Unrelated to Study Drug|5
4675370|NCT02654132|16089249|P2|Overall Study|Disease Progression|31
4675371|NCT02654132|16089250|P1|Overall Study|Disease Progression|26
4675372|NCT02654054|16089261|P3|Post-Treatment Follow-Up Period|Non-Compliance|4
4675373|NCT02654054|16089262|P2|Post-Treatment Follow-Up Period|Non-Compliance|0
4675374|NCT02654054|16089263|P1|Post-Treatment Follow-Up Period|Non-Compliance|0
4675375|NCT02654054|16089261|P3|Post-Treatment Follow-Up Period|Other|4
4675376|NCT02654054|16089262|P2|Post-Treatment Follow-Up Period|Other|0
4675377|NCT02654054|16089263|P1|Post-Treatment Follow-Up Period|Other|1
4675378|NCT02654054|16089261|P3|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
4675379|NCT02654054|16089262|P2|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
4675380|NCT02654054|16089263|P1|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2
4675381|NCT02654054|16089261|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|13
4675382|NCT02654054|16089262|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4675383|NCT02654054|16089263|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4675384|NCT02654054|16089261|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
4675385|NCT02654054|16089262|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
4675386|NCT02654054|16089263|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|2
4675387|NCT02654002|16089298|P9|Overall Study|Withdrew Consent|0
4675388|NCT02654002|16089299|P8|Overall Study|Withdrew Consent|1
4675389|NCT02654002|16089300|P7|Overall Study|Withdrew Consent|0
4675390|NCT02654002|16089301|P6|Overall Study|Withdrew Consent|1
4675391|NCT02654002|16089302|P5|Overall Study|Withdrew Consent|0
4675392|NCT02654002|16089303|P4|Overall Study|Withdrew Consent|0
4675393|NCT02654002|16089304|P3|Overall Study|Withdrew Consent|0
4675394|NCT02654002|16089305|P2|Overall Study|Withdrew Consent|0
4675395|NCT02654002|16089306|P1|Overall Study|Withdrew Consent|0
4675396|NCT02654002|16089298|P9|Overall Study|Adverse Event|0
4675397|NCT02654002|16089299|P8|Overall Study|Adverse Event|0
4675398|NCT02654002|16089300|P7|Overall Study|Adverse Event|1
4675399|NCT02654002|16089301|P6|Overall Study|Adverse Event|0
4675400|NCT02654002|16089302|P5|Overall Study|Adverse Event|0
4675401|NCT02654002|16089303|P4|Overall Study|Adverse Event|0
4675402|NCT02654002|16089304|P3|Overall Study|Adverse Event|0
4675403|NCT02654002|16089305|P2|Overall Study|Adverse Event|0
4675404|NCT02654002|16089306|P1|Overall Study|Adverse Event|0
4675405|NCT02653625|16089480|P1|Overall Study|Suspected Drug Induced Liver Injury|1
4675406|NCT02653625|16089480|P1|Overall Study|Protocol Violation|1
4675407|NCT02653625|16089480|P1|Overall Study|Non-compliance with Study Drug|1
4675408|NCT02653625|16089480|P1|Overall Study|Adverse Event|1
4675409|NCT02653495|16089504|P2|Overall Study|Screening Failure|0
4675410|NCT02653495|16089505|P1|Overall Study|Screening Failure|10
4675411|NCT02653495|16089504|P2|Overall Study|Lost to Follow-up|0
4675412|NCT02653495|16089505|P1|Overall Study|Lost to Follow-up|2
4675413|NCT02653326|16089557|P2|Overall Study|Lost to Follow-up|7
4675414|NCT02653326|16089558|P1|Overall Study|Lost to Follow-up|10
4675415|NCT02653170|16089596|P3|Overall Study|Lost to Follow-up|10
4675416|NCT02653170|16089597|P2|Overall Study|Lost to Follow-up|4
4675417|NCT02653170|16089598|P1|Overall Study|Lost to Follow-up|12
4675418|NCT02653170|16089596|P3|Overall Study|withdrawn by study team|5
4675419|NCT02653170|16089597|P2|Overall Study|withdrawn by study team|4
4675420|NCT02653170|16089598|P1|Overall Study|withdrawn by study team|2
4675421|NCT02653170|16089596|P3|Overall Study|Withdrawal by Subject|3
4675422|NCT02653170|16089597|P2|Overall Study|Withdrawal by Subject|8
4675423|NCT02653170|16089598|P1|Overall Study|Withdrawal by Subject|3
4675424|NCT02652949|16089640|P1|12-Month Follow-up Secondary Endpoint|Death|4
4675425|NCT02652949|16089640|P1|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1
4675426|NCT02652949|16089640|P1|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2
4675427|NCT02652949|16089640|P1|6-Month Follow-up Secondary Endpoint|Death|5
4675428|NCT02652949|16089640|P1|30-Day Follow-up for Secondary Endpoint|Death|1
4675429|NCT02652949|16089640|P1|30-Day Follow-up for Primary Endpoint|Death|1
4675430|NCT02652767|16089675|P1|Overall Study|Withdrawal by Subject|1
4675431|NCT02652767|16089675|P1|Overall Study|Lost to Follow-up|1
4675432|NCT02652767|16089675|P1|Overall Study|Death|2
4675433|NCT02652624|16089703|P2|Extension Phase|Withdrew Consent|1
4675434|NCT02652624|16089704|P1|Extension Phase|Withdrew Consent|0
4675435|NCT02652624|16089703|P2|Extension Phase|Adverse Event|1
4675436|NCT02652624|16089704|P1|Extension Phase|Adverse Event|0
4675437|NCT02652624|16089703|P2|Extension Phase|Pregnancy|1
4675438|NCT02652624|16089704|P1|Extension Phase|Pregnancy|1
4675439|NCT02652624|16089703|P2|Extension Phase|Lost to Follow-up|1
4675440|NCT02652624|16089704|P1|Extension Phase|Lost to Follow-up|3
4675441|NCT02652624|16089703|P2|Randomized Phase|Lost to Follow-up|1
4675442|NCT02652624|16089704|P1|Randomized Phase|Lost to Follow-up|0
4675443|NCT02652624|16089703|P2|Randomized Phase|Death|1
4675444|NCT02652624|16089704|P1|Randomized Phase|Death|0
4675445|NCT02652624|16089703|P2|Randomized Phase|Investigator's Discretion|2
4675446|NCT02652624|16089704|P1|Randomized Phase|Investigator's Discretion|0
4675447|NCT02652624|16089703|P2|Randomized Phase|Pregnancy|1
4675448|NCT02652624|16089704|P1|Randomized Phase|Pregnancy|3
4675449|NCT02652260|16089792|P2|Overall Study|Withdrawal by Subject|1
4675450|NCT02652260|16089793|P1|Overall Study|Withdrawal by Subject|0
4675451|NCT02652260|16089792|P2|Overall Study|Pregnancy|1
4675452|NCT02652260|16089793|P1|Overall Study|Pregnancy|0
4675453|NCT02652156|16089852|P3|Overall Study|Physician Decision|0
4675454|NCT02652156|16089853|P2|Overall Study|Physician Decision|0
4675455|NCT02652156|16089854|P1|Overall Study|Physician Decision|1
4675456|NCT02651922|16089880|P1|Overall Study|due to exclusion criteria|2
4675457|NCT02651688|16089900|P3|Overall Study|Withdrawal by Subject|2
4675458|NCT02651688|16089901|P2|Overall Study|Withdrawal by Subject|0
4675459|NCT02651688|16089902|P1|Overall Study|Withdrawal by Subject|1
4675460|NCT02651688|16089900|P3|Overall Study|Lost to Follow-up|0
4675461|NCT02651688|16089901|P2|Overall Study|Lost to Follow-up|3
4675462|NCT02651688|16089902|P1|Overall Study|Lost to Follow-up|1
4675463|NCT02651688|16089900|P3|Overall Study|Principal Investigator (PI) decision|0
4675464|NCT02651688|16089901|P2|Overall Study|Principal Investigator (PI) decision|2
4675465|NCT02651688|16089902|P1|Overall Study|Principal Investigator (PI) decision|0
4675466|NCT02651688|16089900|P3|Overall Study|Non-compliance|1
4675467|NCT02651688|16089901|P2|Overall Study|Non-compliance|0
4675468|NCT02651688|16089902|P1|Overall Study|Non-compliance|0
4675469|NCT02651467|16089985|P3|Overall Study|Other (Not specified)|2
4675470|NCT02651467|16089986|P2|Overall Study|Other (Not specified)|0
4675471|NCT02651467|16089987|P1|Overall Study|Other (Not specified)|1
4675472|NCT02651467|16089985|P3|Overall Study|Withdrawal by Subject|2
4675473|NCT02651467|16089986|P2|Overall Study|Withdrawal by Subject|0
4675474|NCT02651467|16089987|P1|Overall Study|Withdrawal by Subject|0
4675475|NCT02651220|16090066|P3|Overall Study|Withdrawal by Parent/Guardian|1
4675476|NCT02651220|16090067|P2|Overall Study|Withdrawal by Parent/Guardian|1
4675477|NCT02651220|16090068|P1|Overall Study|Withdrawal by Parent/Guardian|0
4675478|NCT02651220|16090066|P3|Overall Study|Miscellaneous|2
4675479|NCT02651220|16090067|P2|Overall Study|Miscellaneous|1
4675480|NCT02651220|16090068|P1|Overall Study|Miscellaneous|4
4675481|NCT02651220|16090066|P3|Overall Study|Withdrawal by Subject|8
4675482|NCT02651220|16090067|P2|Overall Study|Withdrawal by Subject|6
4675483|NCT02651220|16090068|P1|Overall Study|Withdrawal by Subject|5
4675484|NCT02651220|16090066|P3|Overall Study|Protocol Violation|1
4675485|NCT02651220|16090067|P2|Overall Study|Protocol Violation|0
4675486|NCT02651220|16090068|P1|Overall Study|Protocol Violation|0
4675487|NCT02651220|16090066|P3|Overall Study|Pregnancy|1
4675488|NCT02651220|16090067|P2|Overall Study|Pregnancy|0
4675489|NCT02651220|16090068|P1|Overall Study|Pregnancy|1
4675490|NCT02651220|16090066|P3|Overall Study|Non-Compliance with Study Drug|1
4675491|NCT02651220|16090067|P2|Overall Study|Non-Compliance with Study Drug|0
4675492|NCT02651220|16090068|P1|Overall Study|Non-Compliance with Study Drug|4
4675493|NCT02651220|16090066|P3|Overall Study|Lost to Follow-up|14
4675494|NCT02651220|16090067|P2|Overall Study|Lost to Follow-up|14
4675495|NCT02651220|16090068|P1|Overall Study|Lost to Follow-up|8
4675496|NCT02651220|16090066|P3|Overall Study|Adverse Event|1
4675497|NCT02651220|16090067|P2|Overall Study|Adverse Event|5
4675498|NCT02651220|16090068|P1|Overall Study|Adverse Event|1
4675499|NCT02651194|16090082|P1|Overall Study|Other|2
4675500|NCT02651194|16090082|P1|Overall Study|Lost to Follow-up|3
4675501|NCT02651155|16090090|P2|Overall Study|Voluntary Withdrawal|0
4675502|NCT02651155|16090091|P1|Overall Study|Voluntary Withdrawal|5
4675503|NCT02651155|16090090|P2|Overall Study|Pretreatment Event/Adverse Event|2
4675504|NCT02651155|16090091|P1|Overall Study|Pretreatment Event/Adverse Event|1
4675505|NCT02650921|16090116|P1|Overall Study|Due to Medical Condition|1
4675506|NCT02650921|16090116|P1|Overall Study|Adverse Event|1
4675507|NCT02650921|16090116|P1|Overall Study|Lost to Follow-up|2
4675508|NCT02650921|16090116|P1|Overall Study|Withdrawal by Subject|4
4675509|NCT02650895|16090170|P6|Overall Study|Withdrawal by Subject|0
4675510|NCT02650895|16090171|P5|Overall Study|Withdrawal by Subject|0
4675511|NCT02650895|16090172|P4|Overall Study|Withdrawal by Subject|0
4675512|NCT02650895|16090173|P3|Overall Study|Withdrawal by Subject|0
4675513|NCT02650895|16090174|P2|Overall Study|Withdrawal by Subject|1
4675514|NCT02650895|16090175|P1|Overall Study|Withdrawal by Subject|0
4675515|NCT02650466|16090222|P1|Overall Study|Lost to Follow-up|1
4675516|NCT02650466|16090222|P1|Overall Study|Withdrawal by Subject|5
4675517|NCT02650466|16090222|P1|Overall Study|Physician Decision|1
4675518|NCT02650128|16090352|P1|Overall Study|Death|2
4675519|NCT02649946|16090361|P2|Overall Study|Missed 6-month follow-up visit|4
4675520|NCT02649946|16090362|P1|Overall Study|Missed 6-month follow-up visit|0
4675521|NCT02649946|16090361|P2|Overall Study|Erroneously enrolled|0
4675522|NCT02649946|16090362|P1|Overall Study|Erroneously enrolled|1
4675523|NCT02649946|16090361|P2|Overall Study|Lost to Follow-up|1
4675524|NCT02649946|16090362|P1|Overall Study|Lost to Follow-up|2
4675525|NCT02649946|16090361|P2|Overall Study|Physician Decision|0
4675526|NCT02649946|16090362|P1|Overall Study|Physician Decision|1
4675527|NCT02649946|16090361|P2|Overall Study|Death|9
4675528|NCT02649946|16090362|P1|Overall Study|Death|7
4675529|NCT02649946|16090361|P2|Overall Study|Withdrawal by Subject|1
4675530|NCT02649946|16090362|P1|Overall Study|Withdrawal by Subject|1
4675531|NCT02649894|16090391|P2|Overall Study|Other, not specified|0
4675532|NCT02649894|16090392|P1|Overall Study|Other, not specified|6
4675533|NCT02649894|16090391|P2|Overall Study|Death|7
4675534|NCT02649894|16090392|P1|Overall Study|Death|30
4675535|NCT02649894|16090391|P2|Overall Study|Lost to Follow-up|1
4675536|NCT02649894|16090392|P1|Overall Study|Lost to Follow-up|2
4675537|NCT02649894|16090391|P2|Overall Study|Withdrawal by Subject|2
4675538|NCT02649894|16090392|P1|Overall Study|Withdrawal by Subject|5
4675539|NCT02649894|16090391|P2|Overall Study|Physician Decision|1
4675540|NCT02649894|16090392|P1|Overall Study|Physician Decision|0
4675541|NCT02649894|16090391|P2|Overall Study|Adverse Event|0
4675542|NCT02649894|16090392|P1|Overall Study|Adverse Event|1
4675543|NCT02649634|16090420|P2|Overall Study|Lost to Follow-up|1
4675544|NCT02649634|16090421|P1|Overall Study|Lost to Follow-up|0
4675545|NCT02649634|16090420|P2|Overall Study|Withdrawal by Subject|5
4675546|NCT02649634|16090421|P1|Overall Study|Withdrawal by Subject|3
4675547|NCT02649218|16090538|P1|Overall Study|Withdrawal by Subject|2
4675548|NCT02649218|16090538|P1|Overall Study|Physician Decision|1
4675549|NCT02649218|16090538|P1|Overall Study|Protocol Violation|3
4675550|NCT02649218|16090538|P1|Overall Study|Pregnancy|3
4675551|NCT02649218|16090538|P1|Overall Study|Lack of Efficacy|8
4675552|NCT02649218|16090538|P1|Overall Study|Adverse Event|8
4675553|NCT02648698|16090613|P2|Overall Study|Protocol Violation|5
4675554|NCT02648698|16090614|P1|Overall Study|Protocol Violation|1
4675555|NCT02648438|16090671|P3|Overall Study|Withdrawal by Subject|0
4675556|NCT02648438|16090672|P2|Overall Study|Withdrawal by Subject|1
4675557|NCT02648438|16090673|P1|Overall Study|Withdrawal by Subject|1
4675558|NCT02648438|16090671|P3|Overall Study|Protocol Violation|0
4675559|NCT02648438|16090672|P2|Overall Study|Protocol Violation|0
4675560|NCT02648438|16090673|P1|Overall Study|Protocol Violation|2
4675561|NCT02648438|16090671|P3|Overall Study|Eligibility criteria not fulfilled|0
4675562|NCT02648438|16090672|P2|Overall Study|Eligibility criteria not fulfilled|2
4675563|NCT02648438|16090673|P1|Overall Study|Eligibility criteria not fulfilled|0
4675564|NCT02648217|16090719|P2|Overall Study|Unclassified|0
4675565|NCT02648217|16090720|P1|Overall Study|Unclassified|5
4675566|NCT02648217|16090719|P2|Overall Study|Withdrawal by Subject|3
4675567|NCT02648217|16090720|P1|Overall Study|Withdrawal by Subject|4
4675568|NCT02648217|16090719|P2|Overall Study|Lost to Follow-up|1
4675569|NCT02648217|16090720|P1|Overall Study|Lost to Follow-up|1
4675570|NCT02648217|16090719|P2|Overall Study|Adverse Event|1
4675571|NCT02648217|16090720|P1|Overall Study|Adverse Event|0
4675572|NCT02648204|16090742|P4|Overall Study|Adverse Event|0
4675573|NCT02648204|16090743|P3|Overall Study|Adverse Event|1
4675574|NCT02648204|16090744|P2|Overall Study|Adverse Event|0
4675575|NCT02648204|16090745|P1|Overall Study|Adverse Event|0
4675576|NCT02648204|16090742|P4|Overall Study|Death|2
4675577|NCT02648204|16090743|P3|Overall Study|Death|2
4675578|NCT02648204|16090744|P2|Overall Study|Death|1
4675579|NCT02648204|16090745|P1|Overall Study|Death|1
4675580|NCT02648204|16090742|P4|Overall Study|Missing follow-up information|2
4675581|NCT02648204|16090743|P3|Overall Study|Missing follow-up information|4
4675582|NCT02648204|16090744|P2|Overall Study|Missing follow-up information|4
4675583|NCT02648204|16090745|P1|Overall Study|Missing follow-up information|4
4675584|NCT02648204|16090742|P4|Overall Study|Lost to Follow-up|6
4675585|NCT02648204|16090743|P3|Overall Study|Lost to Follow-up|4
4675586|NCT02648204|16090744|P2|Overall Study|Lost to Follow-up|8
4675587|NCT02648204|16090745|P1|Overall Study|Lost to Follow-up|5
4675588|NCT02648204|16090742|P4|Overall Study|Withdrawal by Subject|6
4675589|NCT02648204|16090743|P3|Overall Study|Withdrawal by Subject|2
4675590|NCT02648204|16090744|P2|Overall Study|Withdrawal by Subject|8
4675591|NCT02648204|16090745|P1|Overall Study|Withdrawal by Subject|12
4675592|NCT02647944|16090883|P2|Overall Study|Adverse Event|0
4675593|NCT02647944|16090884|P1|Overall Study|Adverse Event|2
4675594|NCT02647944|16090883|P2|Overall Study|Withdrawal by Subject|3
4675595|NCT02647944|16090884|P1|Overall Study|Withdrawal by Subject|0
4675596|NCT02647905|16090908|P1|Overall Study|Withdrawal by Subject|2
4675597|NCT02647905|16090908|P1|Overall Study|Lost to Follow-up|1
4675598|NCT02647866|16090918|P5|Overall Study|Subject moved to different country|0
4675599|NCT02647866|16090919|P4|Overall Study|Subject moved to different country|0
4675600|NCT02647866|16090920|P3|Overall Study|Subject moved to different country|0
4675601|NCT02647866|16090921|P2|Overall Study|Subject moved to different country|0
4675602|NCT02647866|16090922|P1|Overall Study|Subject moved to different country|1
4675603|NCT02647866|16090918|P5|Overall Study|Death|0
4675604|NCT02647866|16090919|P4|Overall Study|Death|0
4675605|NCT02647866|16090920|P3|Overall Study|Death|0
4675606|NCT02647866|16090921|P2|Overall Study|Death|1
4675607|NCT02647866|16090922|P1|Overall Study|Death|0
4675608|NCT02647866|16090918|P5|Overall Study|Physician Decision|2
4675609|NCT02647866|16090919|P4|Overall Study|Physician Decision|0
4675610|NCT02647866|16090920|P3|Overall Study|Physician Decision|1
4675611|NCT02647866|16090921|P2|Overall Study|Physician Decision|1
4675612|NCT02647866|16090922|P1|Overall Study|Physician Decision|0
4675613|NCT02647866|16090918|P5|Overall Study|Withdrawal by Subject|4
4675614|NCT02647866|16090919|P4|Overall Study|Withdrawal by Subject|4
4675615|NCT02647866|16090920|P3|Overall Study|Withdrawal by Subject|2
4675616|NCT02647866|16090921|P2|Overall Study|Withdrawal by Subject|1
4675617|NCT02647866|16090922|P1|Overall Study|Withdrawal by Subject|1
4675618|NCT02647866|16090918|P5|Overall Study|Disease Worsening|1
4675619|NCT02647866|16090919|P4|Overall Study|Disease Worsening|0
4675620|NCT02647866|16090920|P3|Overall Study|Disease Worsening|0
4675621|NCT02647866|16090921|P2|Overall Study|Disease Worsening|1
4675622|NCT02647866|16090922|P1|Overall Study|Disease Worsening|3
4675623|NCT02647866|16090918|P5|Overall Study|Adverse Event|1
4675624|NCT02647866|16090919|P4|Overall Study|Adverse Event|2
4675625|NCT02647866|16090920|P3|Overall Study|Adverse Event|2
4675626|NCT02647866|16090921|P2|Overall Study|Adverse Event|0
4675627|NCT02647866|16090922|P1|Overall Study|Adverse Event|0
4675628|NCT02647788|16090999|P2|Overall Study|Felt nauseous with assigned medication|1
4675629|NCT02647788|16091000|P1|Overall Study|Felt nauseous with assigned medication|1
4675630|NCT02647788|16090999|P2|Overall Study|Felt itchy with assigned medication|0
4675631|NCT02647788|16091000|P1|Overall Study|Felt itchy with assigned medication|1
4675632|NCT02647788|16090999|P2|Overall Study|Withdrawal by Subject|0
4675633|NCT02647788|16091000|P1|Overall Study|Withdrawal by Subject|1
4675634|NCT02647788|16090999|P2|Overall Study|Did not want opiate|1
4675635|NCT02647788|16091000|P1|Overall Study|Did not want opiate|0
4675636|NCT02647788|16090999|P2|Overall Study|Lost to Follow-up|11
4675637|NCT02647788|16091000|P1|Overall Study|Lost to Follow-up|13
4675638|NCT02647658|16091012|P2|Overall Study|Consent refusal|24
4675639|NCT02647658|16091013|P1|Overall Study|Consent refusal|15
4675640|NCT02647645|16091041|P2|Overall Study|Lost to Follow-up|1
4675641|NCT02647645|16091042|P1|Overall Study|Lost to Follow-up|2
4675642|NCT02647320|16091064|P5|Overall Study|Disposition Missing Due to Fire at Site|4
4675643|NCT02647320|16091065|P4|Overall Study|Disposition Missing Due to Fire at Site|3
4675644|NCT02647320|16091066|P3|Overall Study|Disposition Missing Due to Fire at Site|4
4675645|NCT02647320|16091067|P2|Overall Study|Disposition Missing Due to Fire at Site|3
4675646|NCT02647320|16091068|P1|Overall Study|Disposition Missing Due to Fire at Site|2
4675647|NCT02647320|16091064|P5|Overall Study|Lack of Efficacy|0
4675648|NCT02647320|16091065|P4|Overall Study|Lack of Efficacy|1
4675649|NCT02647320|16091066|P3|Overall Study|Lack of Efficacy|0
4675650|NCT02647320|16091067|P2|Overall Study|Lack of Efficacy|0
4675651|NCT02647320|16091068|P1|Overall Study|Lack of Efficacy|0
4675652|NCT02647320|16091064|P5|Overall Study|Develop anemia|0
4675653|NCT02647320|16091065|P4|Overall Study|Develop anemia|0
4675654|NCT02647320|16091066|P3|Overall Study|Develop anemia|0
4675655|NCT02647320|16091067|P2|Overall Study|Develop anemia|0
4675656|NCT02647320|16091068|P1|Overall Study|Develop anemia|1
4675657|NCT02647320|16091064|P5|Overall Study|Lost to Follow-up|0
4675658|NCT02647320|16091065|P4|Overall Study|Lost to Follow-up|0
4675659|NCT02647320|16091066|P3|Overall Study|Lost to Follow-up|0
4675660|NCT02647320|16091067|P2|Overall Study|Lost to Follow-up|1
4675661|NCT02647320|16091068|P1|Overall Study|Lost to Follow-up|1
4675662|NCT02647320|16091064|P5|Overall Study|Reason not provided|2
4675663|NCT02647320|16091065|P4|Overall Study|Reason not provided|0
4675664|NCT02647320|16091066|P3|Overall Study|Reason not provided|1
4675665|NCT02647320|16091067|P2|Overall Study|Reason not provided|0
4675666|NCT02647320|16091068|P1|Overall Study|Reason not provided|0
4675667|NCT02647320|16091064|P5|Overall Study|Study terminated by sponsor|2
4675668|NCT02647320|16091065|P4|Overall Study|Study terminated by sponsor|1
4675669|NCT02647320|16091066|P3|Overall Study|Study terminated by sponsor|1
4675670|NCT02647320|16091067|P2|Overall Study|Study terminated by sponsor|1
4675671|NCT02647320|16091068|P1|Overall Study|Study terminated by sponsor|1
4675672|NCT02647320|16091064|P5|Overall Study|Persistent hyperglycemia|1
4675673|NCT02647320|16091065|P4|Overall Study|Persistent hyperglycemia|1
4675674|NCT02647320|16091066|P3|Overall Study|Persistent hyperglycemia|1
4675675|NCT02647320|16091067|P2|Overall Study|Persistent hyperglycemia|1
4675676|NCT02647320|16091068|P1|Overall Study|Persistent hyperglycemia|0
4675677|NCT02647320|16091064|P5|Overall Study|Withdrawal by Subject|7
4675678|NCT02647320|16091065|P4|Overall Study|Withdrawal by Subject|2
4675679|NCT02647320|16091066|P3|Overall Study|Withdrawal by Subject|2
4675680|NCT02647320|16091067|P2|Overall Study|Withdrawal by Subject|4
4675681|NCT02647320|16091068|P1|Overall Study|Withdrawal by Subject|7
4675682|NCT02647320|16091064|P5|Overall Study|Protocol Violation|0
4675683|NCT02647320|16091065|P4|Overall Study|Protocol Violation|0
4675684|NCT02647320|16091066|P3|Overall Study|Protocol Violation|3
4675685|NCT02647320|16091067|P2|Overall Study|Protocol Violation|0
4675686|NCT02647320|16091068|P1|Overall Study|Protocol Violation|0
4675687|NCT02647320|16091064|P5|Overall Study|Adverse Event|1
4675688|NCT02647320|16091065|P4|Overall Study|Adverse Event|2
4675689|NCT02647320|16091066|P3|Overall Study|Adverse Event|3
4675690|NCT02647320|16091067|P2|Overall Study|Adverse Event|1
4675691|NCT02647320|16091068|P1|Overall Study|Adverse Event|0
4675692|NCT02647281|16091159|P9|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1
4675693|NCT02647281|16091160|P8|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675694|NCT02647281|16091161|P7|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675695|NCT02647281|16091162|P6|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675696|NCT02647281|16091163|P5|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675697|NCT02647281|16091164|P4|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675698|NCT02647281|16091165|P3|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675699|NCT02647281|16091166|P2|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675700|NCT02647281|16091167|P1|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0
4675701|NCT02646891|16091355|P10|Overall Study|Death|0
4675702|NCT02646891|16091356|P9|Overall Study|Death|1
4675703|NCT02646891|16091357|P8|Overall Study|Death|1
4675704|NCT02646891|16091358|P7|Overall Study|Death|1
4675705|NCT02646891|16091359|P6|Overall Study|Death|0
4675706|NCT02646891|16091360|P5|Overall Study|Death|0
4675707|NCT02646891|16091361|P4|Overall Study|Death|0
4675708|NCT02646891|16091362|P3|Overall Study|Death|0
4675709|NCT02646891|16091363|P2|Overall Study|Death|0
4675710|NCT02646891|16091364|P1|Overall Study|Death|0
4675711|NCT02646891|16091355|P10|Overall Study|Withdrawal by Subject|3
4675712|NCT02646891|16091356|P9|Overall Study|Withdrawal by Subject|7
4675713|NCT02646891|16091357|P8|Overall Study|Withdrawal by Subject|9
4675714|NCT02646891|16091358|P7|Overall Study|Withdrawal by Subject|5
4675715|NCT02646891|16091359|P6|Overall Study|Withdrawal by Subject|0
4675716|NCT02646891|16091360|P5|Overall Study|Withdrawal by Subject|0
4675717|NCT02646891|16091361|P4|Overall Study|Withdrawal by Subject|0
4675718|NCT02646891|16091362|P3|Overall Study|Withdrawal by Subject|1
4675719|NCT02646891|16091363|P2|Overall Study|Withdrawal by Subject|0
4675720|NCT02646891|16091364|P1|Overall Study|Withdrawal by Subject|2
4675721|NCT02646891|16091355|P10|Overall Study|Protocol Violation|0
4675722|NCT02646891|16091356|P9|Overall Study|Protocol Violation|0
4675723|NCT02646891|16091357|P8|Overall Study|Protocol Violation|1
4675724|NCT02646891|16091358|P7|Overall Study|Protocol Violation|1
4675725|NCT02646891|16091359|P6|Overall Study|Protocol Violation|0
4675726|NCT02646891|16091360|P5|Overall Study|Protocol Violation|0
4675727|NCT02646891|16091361|P4|Overall Study|Protocol Violation|0
4675728|NCT02646891|16091362|P3|Overall Study|Protocol Violation|0
4675729|NCT02646891|16091363|P2|Overall Study|Protocol Violation|0
4675730|NCT02646891|16091364|P1|Overall Study|Protocol Violation|0
4675731|NCT02646891|16091355|P10|Overall Study|Lost to Follow-up|2
4675732|NCT02646891|16091356|P9|Overall Study|Lost to Follow-up|2
4675733|NCT02646891|16091357|P8|Overall Study|Lost to Follow-up|2
4675734|NCT02646891|16091358|P7|Overall Study|Lost to Follow-up|2
4675735|NCT02646891|16091359|P6|Overall Study|Lost to Follow-up|0
4675736|NCT02646891|16091360|P5|Overall Study|Lost to Follow-up|0
4675737|NCT02646891|16091361|P4|Overall Study|Lost to Follow-up|0
4675738|NCT02646891|16091362|P3|Overall Study|Lost to Follow-up|0
4675739|NCT02646891|16091363|P2|Overall Study|Lost to Follow-up|0
4675740|NCT02646891|16091364|P1|Overall Study|Lost to Follow-up|0
4675741|NCT02646891|16091355|P10|Overall Study|Adverse Event|0
4675742|NCT02646891|16091356|P9|Overall Study|Adverse Event|0
4675743|NCT02646891|16091357|P8|Overall Study|Adverse Event|0
4675744|NCT02646891|16091358|P7|Overall Study|Adverse Event|0
4675745|NCT02646891|16091359|P6|Overall Study|Adverse Event|0
4675746|NCT02646891|16091360|P5|Overall Study|Adverse Event|0
4675747|NCT02646891|16091361|P4|Overall Study|Adverse Event|0
4675748|NCT02646891|16091362|P3|Overall Study|Adverse Event|0
4675749|NCT02646891|16091363|P2|Overall Study|Adverse Event|1
4675750|NCT02646891|16091364|P1|Overall Study|Adverse Event|0
4675751|NCT02646566|16091538|P3|Overall Study|Treatment failure|0
4675752|NCT02646566|16091539|P2|Overall Study|Treatment failure|0
4675753|NCT02646566|16091540|P1|Overall Study|Treatment failure|1
4675754|NCT02646566|16091538|P3|Overall Study|Lost to Follow-up|5
4675755|NCT02646566|16091539|P2|Overall Study|Lost to Follow-up|4
4675756|NCT02646566|16091540|P1|Overall Study|Lost to Follow-up|5
4675757|NCT02646124|16091591|P2|Overall Study|Lost to Follow-up|2
4675758|NCT02646124|16091592|P1|Overall Study|Lost to Follow-up|0
4675759|NCT02645409|16091628|P2|Overall Study|Physician Decision|0
4675760|NCT02645409|16091629|P1|Overall Study|Physician Decision|1
4675761|NCT02645409|16091628|P2|Overall Study|Withdrawal by Subject|0
4675762|NCT02645409|16091629|P1|Overall Study|Withdrawal by Subject|3
4675763|NCT02644668|16091816|P3|Overall Study|Withdrawal by Subject|1
4675764|NCT02644668|16091817|P2|Overall Study|Withdrawal by Subject|0
4675765|NCT02644668|16091818|P1|Overall Study|Withdrawal by Subject|0
4675766|NCT02644668|16091816|P3|Overall Study|Protocol Violation|1
4675767|NCT02644668|16091817|P2|Overall Study|Protocol Violation|0
4675768|NCT02644668|16091818|P1|Overall Study|Protocol Violation|0
4675769|NCT02644668|16091816|P3|Overall Study|Adverse Event|1
4675770|NCT02644668|16091817|P2|Overall Study|Adverse Event|0
4675771|NCT02644668|16091818|P1|Overall Study|Adverse Event|2
4675772|NCT02644356|16091857|P1|Overall Study|Withdrawal by Subject|2
4675773|NCT02644122|16091940|P1|Overall Study|Withdrawal by Subject|1
4675774|NCT02644109|16091950|P2|Overall Study|Adverse Event|4
4675775|NCT02644109|16091951|P1|Overall Study|Adverse Event|0
4675776|NCT02644096|16091959|P2|Overall Study|Withdrawal by Subject|25
4675777|NCT02644096|16091960|P1|Overall Study|Withdrawal by Subject|28
4675778|NCT02643693|16092005|P6|Overall Study|Protocol Adherence Issues|1
4675779|NCT02643693|16092006|P5|Overall Study|Protocol Adherence Issues|0
4675780|NCT02643693|16092007|P4|Overall Study|Protocol Adherence Issues|0
4675781|NCT02643693|16092008|P3|Overall Study|Protocol Adherence Issues|1
4675782|NCT02643693|16092009|P2|Overall Study|Protocol Adherence Issues|0
4675783|NCT02643693|16092010|P1|Overall Study|Protocol Adherence Issues|2
4675784|NCT02643693|16092005|P6|Overall Study|Withdrawal by Subject|0
4675785|NCT02643693|16092006|P5|Overall Study|Withdrawal by Subject|0
4675786|NCT02643693|16092007|P4|Overall Study|Withdrawal by Subject|0
4675787|NCT02643693|16092008|P3|Overall Study|Withdrawal by Subject|0
4675788|NCT02643693|16092009|P2|Overall Study|Withdrawal by Subject|1
4675789|NCT02643693|16092010|P1|Overall Study|Withdrawal by Subject|0
4675790|NCT02643693|16092005|P6|Overall Study|Physician Decision|0
4675791|NCT02643693|16092006|P5|Overall Study|Physician Decision|0
4675792|NCT02643693|16092007|P4|Overall Study|Physician Decision|0
4675793|NCT02643693|16092008|P3|Overall Study|Physician Decision|0
4675794|NCT02643693|16092009|P2|Overall Study|Physician Decision|1
4675795|NCT02643693|16092010|P1|Overall Study|Physician Decision|0
4675796|NCT02643628|16092023|P2|Overall Study|Relocated out of state|1
4675797|NCT02643628|16092024|P1|Overall Study|Relocated out of state|0
4675798|NCT02643628|16092023|P2|Overall Study|Withdrawal by Subject|1
4675799|NCT02643628|16092024|P1|Overall Study|Withdrawal by Subject|0
4675800|NCT02643628|16092023|P2|Overall Study|Lost to Follow-up|4
4675801|NCT02643628|16092024|P1|Overall Study|Lost to Follow-up|1
4675802|NCT02643472|16092055|P2|Overall Study|Lost to Follow-up|26
4675803|NCT02643472|16092056|P1|Overall Study|Lost to Follow-up|22
4675804|NCT02643472|16092055|P2|Overall Study|Protocol Violation|1
4675805|NCT02643472|16092056|P1|Overall Study|Protocol Violation|0
4675806|NCT02643472|16092055|P2|Overall Study|Withdrawal by Subject|2
4675807|NCT02643472|16092056|P1|Overall Study|Withdrawal by Subject|3
4675808|NCT02643472|16092055|P2|Overall Study|Death|5
4675809|NCT02643472|16092056|P1|Overall Study|Death|2
4675810|NCT02643394|16092082|P2|Overall Study|Protocol Violation|5
4675811|NCT02643394|16092083|P1|Overall Study|Protocol Violation|4
4675812|NCT02643355|16092093|P2|Overall Study|Protocol Violation|2
4675813|NCT02643355|16092094|P1|Overall Study|Protocol Violation|0
4675814|NCT02643355|16092093|P2|Overall Study|Withdrawal by Subject|3
4675815|NCT02643355|16092094|P1|Overall Study|Withdrawal by Subject|1
4675816|NCT02643251|16092108|P2|Overall Study|PI Decision to terminate patient|0
4675817|NCT02643251|16092109|P1|Overall Study|PI Decision to terminate patient|1
4675818|NCT02643251|16092108|P2|Overall Study|Protocol Violation|0
4675819|NCT02643251|16092109|P1|Overall Study|Protocol Violation|1
4675820|NCT02643251|16092108|P2|Overall Study|Lost to Follow-up|1
4675821|NCT02643251|16092109|P1|Overall Study|Lost to Follow-up|4
4675822|NCT02643251|16092108|P2|Overall Study|Withdrawal by Subject|0
4675823|NCT02643251|16092109|P1|Overall Study|Withdrawal by Subject|2
4675824|NCT02643251|16092108|P2|Overall Study|Adverse Event|1
4675825|NCT02643251|16092109|P1|Overall Study|Adverse Event|3
4675826|NCT02643082|16092141|P2|Period 1|Adverse Event|0
4675827|NCT02643082|16092142|P1|Period 1|Adverse Event|1
4675828|NCT02642965|16092200|P1|Overall Study|Physician Decision|9
4675829|NCT02642965|16092200|P1|Overall Study|Lack of Efficacy|4
4675830|NCT02642679|16092244|P1|Overall Study|Physician Decision|1
4675831|NCT02642679|16092244|P1|Overall Study|Physician Decision|1
4675832|NCT02642679|16092244|P1|Overall Study|Withdrawal by Subject|1
4675833|NCT02642653|16092252|P2|Overall Study|Adverse Event|0
4675834|NCT02642653|16092253|P1|Overall Study|Adverse Event|2
4675835|NCT02642614|16092294|P4|Overall Study|Withdrawal by Subject|0
4675836|NCT02642614|16092295|P3|Overall Study|Withdrawal by Subject|0
4675837|NCT02642614|16092296|P2|Overall Study|Withdrawal by Subject|1
4675838|NCT02642614|16092297|P1|Overall Study|Withdrawal by Subject|1
4675839|NCT02642614|16092294|P4|Overall Study|Lost to Follow-up|0
4675840|NCT02642614|16092295|P3|Overall Study|Lost to Follow-up|0
4675841|NCT02642614|16092296|P2|Overall Study|Lost to Follow-up|0
4675842|NCT02642614|16092297|P1|Overall Study|Lost to Follow-up|1
4675843|NCT02642614|16092294|P4|Overall Study|Adverse Event|2
4675844|NCT02642614|16092295|P3|Overall Study|Adverse Event|2
4675845|NCT02642614|16092296|P2|Overall Study|Adverse Event|1
4675846|NCT02642614|16092297|P1|Overall Study|Adverse Event|1
4675847|NCT02642432|16092364|P1|Overall Study|Other|3
4675848|NCT02642432|16092364|P1|Overall Study|Lost to Follow-up|2
4675849|NCT02642432|16092364|P1|Overall Study|Withdrew Consent|1
4675850|NCT02642432|16092364|P1|Overall Study|Adverse Event|2
4675851|NCT02642159|16092410|P2|Overall Study|Other than specified above|3
4675852|NCT02642159|16092411|P1|Overall Study|Other than specified above|10
4675853|NCT02642159|16092410|P2|Overall Study|Poor compliance to study protocol|0
4675854|NCT02642159|16092411|P1|Overall Study|Poor compliance to study protocol|1
4675855|NCT02642159|16092410|P2|Overall Study|Withdrawal by Subject|1
4675856|NCT02642159|16092411|P1|Overall Study|Withdrawal by Subject|9
4675857|NCT02642159|16092410|P2|Overall Study|Adverse Event|4
4675858|NCT02642159|16092411|P1|Overall Study|Adverse Event|10
4675859|NCT02642159|16092410|P2|Overall Study|Randomized but not treated|0
4675860|NCT02642159|16092411|P1|Overall Study|Randomized but not treated|1
4675861|NCT02641730|16092535|P5|Observational Period (Week 60 - Week 84)|Other|1
4675862|NCT02641730|16092536|P4|Observational Period (Week 60 - Week 84)|Other|0
4675863|NCT02641730|16092537|P3|Observational Period (Week 60 - Week 84)|Other|0
4675864|NCT02641730|16092538|P2|Observational Period (Week 60 - Week 84)|Other|0
4675865|NCT02641730|16092539|P1|Observational Period (Week 60 - Week 84)|Other|0
4675866|NCT02641730|16092535|P5|After Controlled Period (Week 16 - 52)|Other|1
4675867|NCT02641730|16092536|P4|After Controlled Period (Week 16 - 52)|Other|0
4675868|NCT02641730|16092537|P3|After Controlled Period (Week 16 - 52)|Other|1
4675869|NCT02641730|16092538|P2|After Controlled Period (Week 16 - 52)|Other|1
4675870|NCT02641730|16092539|P1|After Controlled Period (Week 16 - 52)|Other|0
4675871|NCT02641730|16092535|P5|After Controlled Period (Week 16 - 52)|Pregnancy|1
4675872|NCT02641730|16092536|P4|After Controlled Period (Week 16 - 52)|Pregnancy|1
4675873|NCT02641730|16092537|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
4675874|NCT02641730|16092538|P2|After Controlled Period (Week 16 - 52)|Pregnancy|0
4675875|NCT02641730|16092539|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
4675876|NCT02641730|16092535|P5|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
4675877|NCT02641730|16092536|P4|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
4675878|NCT02641730|16092537|P3|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
4675879|NCT02641730|16092538|P2|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2
4675880|NCT02641730|16092539|P1|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0
4675881|NCT02641730|16092535|P5|After Controlled Period (Week 16 - 52)|Adverse Event|4
4675882|NCT02641730|16092536|P4|After Controlled Period (Week 16 - 52)|Adverse Event|5
4675883|NCT02641730|16092537|P3|After Controlled Period (Week 16 - 52)|Adverse Event|1
4675884|NCT02641730|16092538|P2|After Controlled Period (Week 16 - 52)|Adverse Event|1
4675885|NCT02641730|16092539|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
4675886|NCT02641730|16092535|P5|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
4675887|NCT02641730|16092536|P4|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1
4675888|NCT02641730|16092537|P3|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4675889|NCT02641730|16092538|P2|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0
4675890|NCT02641730|16092539|P1|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2
4675891|NCT02641587|16092643|P2|Ambulatory Period|Withdrawal by Subject|0
4675892|NCT02641587|16092644|P1|Ambulatory Period|Withdrawal by Subject|1
4675893|NCT02641587|16092643|P2|Confinement Period|Withdrawal by Subject|1
4675894|NCT02641587|16092644|P1|Confinement Period|Withdrawal by Subject|2
4675895|NCT02641587|16092643|P2|Confinement Period|Adverse Event|0
4675896|NCT02641587|16092644|P1|Confinement Period|Adverse Event|1
4675897|NCT02641392|16092765|P3|Overall Study|Death|1
4675898|NCT02641392|16092766|P2|Overall Study|Death|0
4675899|NCT02641392|16092767|P1|Overall Study|Death|0
4675900|NCT02641392|16092765|P3|Overall Study|Miscellaneous|3
4675901|NCT02641392|16092766|P2|Overall Study|Miscellaneous|0
4675902|NCT02641392|16092767|P1|Overall Study|Miscellaneous|0
4675903|NCT02641392|16092765|P3|Overall Study|Lack of Efficacy|101
4675904|NCT02641392|16092766|P2|Overall Study|Lack of Efficacy|0
4675905|NCT02641392|16092767|P1|Overall Study|Lack of Efficacy|0
4675906|NCT02641392|16092765|P3|Overall Study|Study Terminated by Sponsor|144
4675907|NCT02641392|16092766|P2|Overall Study|Study Terminated by Sponsor|12
4675908|NCT02641392|16092767|P1|Overall Study|Study Terminated by Sponsor|4
4675909|NCT02641392|16092765|P3|Overall Study|Adverse Event|25
4675910|NCT02641392|16092766|P2|Overall Study|Adverse Event|1
4675911|NCT02641392|16092767|P1|Overall Study|Adverse Event|0
4675912|NCT02641392|16092765|P3|Overall Study|Withdrawal by Subject|17
4675913|NCT02641392|16092766|P2|Overall Study|Withdrawal by Subject|0
4675914|NCT02641392|16092767|P1|Overall Study|Withdrawal by Subject|0
4675915|NCT02641392|16092765|P3|Overall Study|Lost to Follow-up|2
4675916|NCT02641392|16092766|P2|Overall Study|Lost to Follow-up|0
4675917|NCT02641392|16092767|P1|Overall Study|Lost to Follow-up|0
4675918|NCT02641379|16092786|P11|Overall Study|PCR positive|0
4675919|NCT02641379|16092787|P10|Overall Study|PCR positive|0
4675920|NCT02641379|16092788|P9|Overall Study|PCR positive|0
4675921|NCT02641379|16092789|P8|Overall Study|PCR positive|0
4675922|NCT02641379|16092790|P7|Overall Study|PCR positive|1
4675923|NCT02641379|16092791|P6|Overall Study|PCR positive|0
4675924|NCT02641379|16092792|P5|Overall Study|PCR positive|0
4675925|NCT02641379|16092793|P4|Overall Study|PCR positive|0
4675926|NCT02641379|16092794|P3|Overall Study|PCR positive|0
4675927|NCT02641379|16092795|P2|Overall Study|PCR positive|0
4675928|NCT02641379|16092796|P1|Overall Study|PCR positive|0
4675929|NCT02641379|16092786|P11|Overall Study|Missing PCR result at Week 8|0
4675930|NCT02641379|16092787|P10|Overall Study|Missing PCR result at Week 8|1
4675931|NCT02641379|16092788|P9|Overall Study|Missing PCR result at Week 8|0
4675932|NCT02641379|16092789|P8|Overall Study|Missing PCR result at Week 8|0
4675933|NCT02641379|16092790|P7|Overall Study|Missing PCR result at Week 8|0
4675934|NCT02641379|16092791|P6|Overall Study|Missing PCR result at Week 8|0
4675935|NCT02641379|16092792|P5|Overall Study|Missing PCR result at Week 8|0
4675936|NCT02641379|16092793|P4|Overall Study|Missing PCR result at Week 8|0
4675937|NCT02641379|16092794|P3|Overall Study|Missing PCR result at Week 8|0
4675938|NCT02641379|16092795|P2|Overall Study|Missing PCR result at Week 8|0
4675939|NCT02641379|16092796|P1|Overall Study|Missing PCR result at Week 8|0
4675940|NCT02641379|16092786|P11|Overall Study|Participant treated after Week 24|0
4675941|NCT02641379|16092787|P10|Overall Study|Participant treated after Week 24|0
4675942|NCT02641379|16092788|P9|Overall Study|Participant treated after Week 24|1
4675943|NCT02641379|16092789|P8|Overall Study|Participant treated after Week 24|0
4675944|NCT02641379|16092790|P7|Overall Study|Participant treated after Week 24|0
4675945|NCT02641379|16092791|P6|Overall Study|Participant treated after Week 24|0
4675946|NCT02641379|16092792|P5|Overall Study|Participant treated after Week 24|0
4675947|NCT02641379|16092793|P4|Overall Study|Participant treated after Week 24|0
4675948|NCT02641379|16092794|P3|Overall Study|Participant treated after Week 24|0
4675949|NCT02641379|16092795|P2|Overall Study|Participant treated after Week 24|0
4675950|NCT02641379|16092796|P1|Overall Study|Participant treated after Week 24|0
4675951|NCT02641379|16092786|P11|Overall Study|Participant's PCR high|0
4675952|NCT02641379|16092787|P10|Overall Study|Participant's PCR high|0
4675953|NCT02641379|16092788|P9|Overall Study|Participant's PCR high|0
4675954|NCT02641379|16092789|P8|Overall Study|Participant's PCR high|1
4675955|NCT02641379|16092790|P7|Overall Study|Participant's PCR high|0
4675956|NCT02641379|16092791|P6|Overall Study|Participant's PCR high|0
4675957|NCT02641379|16092792|P5|Overall Study|Participant's PCR high|0
4675958|NCT02641379|16092793|P4|Overall Study|Participant's PCR high|0
4675959|NCT02641379|16092794|P3|Overall Study|Participant's PCR high|0
4675960|NCT02641379|16092795|P2|Overall Study|Participant's PCR high|0
4675961|NCT02641379|16092796|P1|Overall Study|Participant's PCR high|0
4675962|NCT02641379|16092786|P11|Overall Study|Negative PCR result|0
4675963|NCT02641379|16092787|P10|Overall Study|Negative PCR result|1
4675964|NCT02641379|16092788|P9|Overall Study|Negative PCR result|0
4675965|NCT02641379|16092789|P8|Overall Study|Negative PCR result|0
4675966|NCT02641379|16092790|P7|Overall Study|Negative PCR result|0
4675967|NCT02641379|16092791|P6|Overall Study|Negative PCR result|0
4675968|NCT02641379|16092792|P5|Overall Study|Negative PCR result|0
4675969|NCT02641379|16092793|P4|Overall Study|Negative PCR result|0
4675970|NCT02641379|16092794|P3|Overall Study|Negative PCR result|0
4675971|NCT02641379|16092795|P2|Overall Study|Negative PCR result|0
4675972|NCT02641379|16092796|P1|Overall Study|Negative PCR result|0
4675973|NCT02641379|16092786|P11|Overall Study|No 2 Log drop at Week 12|1
4675974|NCT02641379|16092787|P10|Overall Study|No 2 Log drop at Week 12|0
4675975|NCT02641379|16092788|P9|Overall Study|No 2 Log drop at Week 12|0
4675976|NCT02641379|16092789|P8|Overall Study|No 2 Log drop at Week 12|0
4675977|NCT02641379|16092790|P7|Overall Study|No 2 Log drop at Week 12|0
4675978|NCT02641379|16092791|P6|Overall Study|No 2 Log drop at Week 12|0
4675979|NCT02641379|16092792|P5|Overall Study|No 2 Log drop at Week 12|0
4675980|NCT02641379|16092793|P4|Overall Study|No 2 Log drop at Week 12|0
4675981|NCT02641379|16092794|P3|Overall Study|No 2 Log drop at Week 12|0
4675982|NCT02641379|16092795|P2|Overall Study|No 2 Log drop at Week 12|0
4675983|NCT02641379|16092796|P1|Overall Study|No 2 Log drop at Week 12|0
4675984|NCT02641379|16092786|P11|Overall Study|Non-response Week 12|0
4675985|NCT02641379|16092787|P10|Overall Study|Non-response Week 12|0
4675986|NCT02641379|16092788|P9|Overall Study|Non-response Week 12|0
4675987|NCT02641379|16092789|P8|Overall Study|Non-response Week 12|1
4675988|NCT02641379|16092790|P7|Overall Study|Non-response Week 12|0
4675989|NCT02641379|16092791|P6|Overall Study|Non-response Week 12|0
4675990|NCT02641379|16092792|P5|Overall Study|Non-response Week 12|0
4675991|NCT02641379|16092793|P4|Overall Study|Non-response Week 12|0
4675992|NCT02641379|16092794|P3|Overall Study|Non-response Week 12|0
4675993|NCT02641379|16092795|P2|Overall Study|Non-response Week 12|0
4675994|NCT02641379|16092796|P1|Overall Study|Non-response Week 12|0
4675995|NCT02641379|16092786|P11|Overall Study|Participant showed weight reduction|0
4675996|NCT02641379|16092787|P10|Overall Study|Participant showed weight reduction|0
4675997|NCT02641379|16092788|P9|Overall Study|Participant showed weight reduction|0
4675998|NCT02641379|16092789|P8|Overall Study|Participant showed weight reduction|1
4675999|NCT02641379|16092790|P7|Overall Study|Participant showed weight reduction|0
4676000|NCT02641379|16092791|P6|Overall Study|Participant showed weight reduction|0
4676001|NCT02641379|16092792|P5|Overall Study|Participant showed weight reduction|0
4676002|NCT02641379|16092793|P4|Overall Study|Participant showed weight reduction|0
4676003|NCT02641379|16092794|P3|Overall Study|Participant showed weight reduction|0
4676004|NCT02641379|16092795|P2|Overall Study|Participant showed weight reduction|0
4676005|NCT02641379|16092796|P1|Overall Study|Participant showed weight reduction|0
4676006|NCT02641379|16092786|P11|Overall Study|Source data not found|0
4676007|NCT02641379|16092787|P10|Overall Study|Source data not found|0
4676008|NCT02641379|16092788|P9|Overall Study|Source data not found|0
4676009|NCT02641379|16092789|P8|Overall Study|Source data not found|0
4676010|NCT02641379|16092790|P7|Overall Study|Source data not found|0
4676011|NCT02641379|16092791|P6|Overall Study|Source data not found|1
4676012|NCT02641379|16092792|P5|Overall Study|Source data not found|0
4676013|NCT02641379|16092793|P4|Overall Study|Source data not found|0
4676014|NCT02641379|16092794|P3|Overall Study|Source data not found|0
4676015|NCT02641379|16092795|P2|Overall Study|Source data not found|0
4676016|NCT02641379|16092796|P1|Overall Study|Source data not found|0
4676017|NCT02641379|16092786|P11|Overall Study|Lost to Follow-up|0
4676018|NCT02641379|16092787|P10|Overall Study|Lost to Follow-up|0
4676019|NCT02641379|16092788|P9|Overall Study|Lost to Follow-up|1
4676020|NCT02641379|16092789|P8|Overall Study|Lost to Follow-up|0
4676021|NCT02641379|16092790|P7|Overall Study|Lost to Follow-up|0
4676022|NCT02641379|16092791|P6|Overall Study|Lost to Follow-up|0
4676023|NCT02641379|16092792|P5|Overall Study|Lost to Follow-up|0
4676024|NCT02641379|16092793|P4|Overall Study|Lost to Follow-up|0
4676025|NCT02641379|16092794|P3|Overall Study|Lost to Follow-up|0
4676026|NCT02641379|16092795|P2|Overall Study|Lost to Follow-up|0
4676027|NCT02641379|16092796|P1|Overall Study|Lost to Follow-up|0
4676028|NCT02641379|16092786|P11|Overall Study|Participation in sili rescue study|0
4676029|NCT02641379|16092787|P10|Overall Study|Participation in sili rescue study|0
4676030|NCT02641379|16092788|P9|Overall Study|Participation in sili rescue study|0
4676031|NCT02641379|16092789|P8|Overall Study|Participation in sili rescue study|0
4676032|NCT02641379|16092790|P7|Overall Study|Participation in sili rescue study|0
4676033|NCT02641379|16092791|P6|Overall Study|Participation in sili rescue study|1
4676034|NCT02641379|16092792|P5|Overall Study|Participation in sili rescue study|0
4676035|NCT02641379|16092793|P4|Overall Study|Participation in sili rescue study|0
4676036|NCT02641379|16092794|P3|Overall Study|Participation in sili rescue study|0
4676037|NCT02641379|16092795|P2|Overall Study|Participation in sili rescue study|0
4676038|NCT02641379|16092796|P1|Overall Study|Participation in sili rescue study|0
4676039|NCT02641379|16092786|P11|Overall Study|Protocol Violation|0
4676040|NCT02641379|16092787|P10|Overall Study|Protocol Violation|0
4676041|NCT02641379|16092788|P9|Overall Study|Protocol Violation|1
4676042|NCT02641379|16092789|P8|Overall Study|Protocol Violation|0
4676043|NCT02641379|16092790|P7|Overall Study|Protocol Violation|0
4676044|NCT02641379|16092791|P6|Overall Study|Protocol Violation|0
4676045|NCT02641379|16092792|P5|Overall Study|Protocol Violation|2
4676046|NCT02641379|16092793|P4|Overall Study|Protocol Violation|0
4676047|NCT02641379|16092794|P3|Overall Study|Protocol Violation|0
4676048|NCT02641379|16092795|P2|Overall Study|Protocol Violation|0
4676049|NCT02641379|16092796|P1|Overall Study|Protocol Violation|0
4676050|NCT02641379|16092786|P11|Overall Study|Blood could not be drawn|0
4676051|NCT02641379|16092787|P10|Overall Study|Blood could not be drawn|0
4676052|NCT02641379|16092788|P9|Overall Study|Blood could not be drawn|0
4676053|NCT02641379|16092789|P8|Overall Study|Blood could not be drawn|0
4676054|NCT02641379|16092790|P7|Overall Study|Blood could not be drawn|0
4676055|NCT02641379|16092791|P6|Overall Study|Blood could not be drawn|0
4676056|NCT02641379|16092792|P5|Overall Study|Blood could not be drawn|1
4676057|NCT02641379|16092793|P4|Overall Study|Blood could not be drawn|0
4676058|NCT02641379|16092794|P3|Overall Study|Blood could not be drawn|0
4676059|NCT02641379|16092795|P2|Overall Study|Blood could not be drawn|0
4676060|NCT02641379|16092796|P1|Overall Study|Blood could not be drawn|0
4676061|NCT02641379|16092786|P11|Overall Study|Baseline viral load unavailable|0
4676062|NCT02641379|16092787|P10|Overall Study|Baseline viral load unavailable|0
4676063|NCT02641379|16092788|P9|Overall Study|Baseline viral load unavailable|0
4676064|NCT02641379|16092789|P8|Overall Study|Baseline viral load unavailable|0
4676065|NCT02641379|16092790|P7|Overall Study|Baseline viral load unavailable|0
4676066|NCT02641379|16092791|P6|Overall Study|Baseline viral load unavailable|0
4676067|NCT02641379|16092792|P5|Overall Study|Baseline viral load unavailable|0
4676068|NCT02641379|16092793|P4|Overall Study|Baseline viral load unavailable|1
4676069|NCT02641379|16092794|P3|Overall Study|Baseline viral load unavailable|0
4676070|NCT02641379|16092795|P2|Overall Study|Baseline viral load unavailable|0
4676071|NCT02641379|16092796|P1|Overall Study|Baseline viral load unavailable|0
4676072|NCT02641379|16092786|P11|Overall Study|Inclusion criteria not fulfilled|0
4676073|NCT02641379|16092787|P10|Overall Study|Inclusion criteria not fulfilled|0
4676074|NCT02641379|16092788|P9|Overall Study|Inclusion criteria not fulfilled|0
4676075|NCT02641379|16092789|P8|Overall Study|Inclusion criteria not fulfilled|0
4676076|NCT02641379|16092790|P7|Overall Study|Inclusion criteria not fulfilled|0
4676077|NCT02641379|16092791|P6|Overall Study|Inclusion criteria not fulfilled|0
4676078|NCT02641379|16092792|P5|Overall Study|Inclusion criteria not fulfilled|0
4676079|NCT02641379|16092793|P4|Overall Study|Inclusion criteria not fulfilled|1
4676080|NCT02641379|16092794|P3|Overall Study|Inclusion criteria not fulfilled|0
4676081|NCT02641379|16092795|P2|Overall Study|Inclusion criteria not fulfilled|0
4676082|NCT02641379|16092796|P1|Overall Study|Inclusion criteria not fulfilled|0
4676083|NCT02641379|16092786|P11|Overall Study|PCR sample for Week 4 not drawn|0
4676084|NCT02641379|16092787|P10|Overall Study|PCR sample for Week 4 not drawn|0
4676085|NCT02641379|16092788|P9|Overall Study|PCR sample for Week 4 not drawn|0
4676086|NCT02641379|16092789|P8|Overall Study|PCR sample for Week 4 not drawn|0
4676087|NCT02641379|16092790|P7|Overall Study|PCR sample for Week 4 not drawn|0
4676088|NCT02641379|16092791|P6|Overall Study|PCR sample for Week 4 not drawn|0
4676089|NCT02641379|16092792|P5|Overall Study|PCR sample for Week 4 not drawn|0
4676090|NCT02641379|16092793|P4|Overall Study|PCR sample for Week 4 not drawn|1
4676091|NCT02641379|16092794|P3|Overall Study|PCR sample for Week 4 not drawn|0
4676092|NCT02641379|16092795|P2|Overall Study|PCR sample for Week 4 not drawn|0
4676093|NCT02641379|16092796|P1|Overall Study|PCR sample for Week 4 not drawn|0
4676094|NCT02641379|16092786|P11|Overall Study|PCR positive at Week 28|0
4676095|NCT02641379|16092787|P10|Overall Study|PCR positive at Week 28|0
4676096|NCT02641379|16092788|P9|Overall Study|PCR positive at Week 28|0
4676097|NCT02641379|16092789|P8|Overall Study|PCR positive at Week 28|0
4676098|NCT02641379|16092790|P7|Overall Study|PCR positive at Week 28|0
4676099|NCT02641379|16092791|P6|Overall Study|PCR positive at Week 28|0
4676100|NCT02641379|16092792|P5|Overall Study|PCR positive at Week 28|0
4676101|NCT02641379|16092793|P4|Overall Study|PCR positive at Week 28|0
4676102|NCT02641379|16092794|P3|Overall Study|PCR positive at Week 28|1
4676103|NCT02641379|16092795|P2|Overall Study|PCR positive at Week 28|0
4676104|NCT02641379|16092796|P1|Overall Study|PCR positive at Week 28|0
4676105|NCT02641379|16092786|P11|Overall Study|No PCR at baseline|0
4676106|NCT02641379|16092787|P10|Overall Study|No PCR at baseline|0
4676107|NCT02641379|16092788|P9|Overall Study|No PCR at baseline|0
4676108|NCT02641379|16092789|P8|Overall Study|No PCR at baseline|0
4676109|NCT02641379|16092790|P7|Overall Study|No PCR at baseline|0
4676110|NCT02641379|16092791|P6|Overall Study|No PCR at baseline|0
4676111|NCT02641379|16092792|P5|Overall Study|No PCR at baseline|0
4676112|NCT02641379|16092793|P4|Overall Study|No PCR at baseline|0
4676113|NCT02641379|16092794|P3|Overall Study|No PCR at baseline|1
4676114|NCT02641379|16092795|P2|Overall Study|No PCR at baseline|0
4676115|NCT02641379|16092796|P1|Overall Study|No PCR at baseline|0
4676116|NCT02641379|16092786|P11|Overall Study|PCR not performed at Week 12|0
4676117|NCT02641379|16092787|P10|Overall Study|PCR not performed at Week 12|0
4676118|NCT02641379|16092788|P9|Overall Study|PCR not performed at Week 12|0
4676119|NCT02641379|16092789|P8|Overall Study|PCR not performed at Week 12|0
4676120|NCT02641379|16092790|P7|Overall Study|PCR not performed at Week 12|0
4676121|NCT02641379|16092791|P6|Overall Study|PCR not performed at Week 12|0
4676122|NCT02641379|16092792|P5|Overall Study|PCR not performed at Week 12|0
4676123|NCT02641379|16092793|P4|Overall Study|PCR not performed at Week 12|0
4676124|NCT02641379|16092794|P3|Overall Study|PCR not performed at Week 12|1
4676125|NCT02641379|16092795|P2|Overall Study|PCR not performed at Week 12|0
4676126|NCT02641379|16092796|P1|Overall Study|PCR not performed at Week 12|0
4676127|NCT02641379|16092786|P11|Overall Study|PCR positive at Week 48|0
4676128|NCT02641379|16092787|P10|Overall Study|PCR positive at Week 48|0
4676129|NCT02641379|16092788|P9|Overall Study|PCR positive at Week 48|0
4676130|NCT02641379|16092789|P8|Overall Study|PCR positive at Week 48|0
4676131|NCT02641379|16092790|P7|Overall Study|PCR positive at Week 48|0
4676132|NCT02641379|16092791|P6|Overall Study|PCR positive at Week 48|0
4676133|NCT02641379|16092792|P5|Overall Study|PCR positive at Week 48|0
4676134|NCT02641379|16092793|P4|Overall Study|PCR positive at Week 48|0
4676135|NCT02641379|16092794|P3|Overall Study|PCR positive at Week 48|0
4676136|NCT02641379|16092795|P2|Overall Study|PCR positive at Week 48|1
4676137|NCT02641379|16092796|P1|Overall Study|PCR positive at Week 48|0
4676138|NCT02641379|16092786|P11|Overall Study|PCR positive at Week 68|0
4676139|NCT02641379|16092787|P10|Overall Study|PCR positive at Week 68|0
4676140|NCT02641379|16092788|P9|Overall Study|PCR positive at Week 68|0
4676141|NCT02641379|16092789|P8|Overall Study|PCR positive at Week 68|0
4676142|NCT02641379|16092790|P7|Overall Study|PCR positive at Week 68|0
4676143|NCT02641379|16092791|P6|Overall Study|PCR positive at Week 68|0
4676144|NCT02641379|16092792|P5|Overall Study|PCR positive at Week 68|0
4676145|NCT02641379|16092793|P4|Overall Study|PCR positive at Week 68|0
4676146|NCT02641379|16092794|P3|Overall Study|PCR positive at Week 68|0
4676147|NCT02641379|16092795|P2|Overall Study|PCR positive at Week 68|1
4676148|NCT02641379|16092796|P1|Overall Study|PCR positive at Week 68|0
4676149|NCT02641379|16092786|P11|Overall Study|Financial problems|0
4676150|NCT02641379|16092787|P10|Overall Study|Financial problems|0
4676151|NCT02641379|16092788|P9|Overall Study|Financial problems|0
4676152|NCT02641379|16092789|P8|Overall Study|Financial problems|0
4676153|NCT02641379|16092790|P7|Overall Study|Financial problems|0
4676154|NCT02641379|16092791|P6|Overall Study|Financial problems|0
4676155|NCT02641379|16092792|P5|Overall Study|Financial problems|0
4676156|NCT02641379|16092793|P4|Overall Study|Financial problems|0
4676157|NCT02641379|16092794|P3|Overall Study|Financial problems|0
4676158|NCT02641379|16092795|P2|Overall Study|Financial problems|1
4676159|NCT02641379|16092796|P1|Overall Study|Financial problems|0
4676160|NCT02641379|16092786|P11|Overall Study|Therapy stopped due to misunderstanding|0
4676161|NCT02641379|16092787|P10|Overall Study|Therapy stopped due to misunderstanding|0
4676162|NCT02641379|16092788|P9|Overall Study|Therapy stopped due to misunderstanding|0
4676163|NCT02641379|16092789|P8|Overall Study|Therapy stopped due to misunderstanding|0
4676164|NCT02641379|16092790|P7|Overall Study|Therapy stopped due to misunderstanding|0
4676165|NCT02641379|16092791|P6|Overall Study|Therapy stopped due to misunderstanding|0
4676166|NCT02641379|16092792|P5|Overall Study|Therapy stopped due to misunderstanding|0
4676167|NCT02641379|16092793|P4|Overall Study|Therapy stopped due to misunderstanding|0
4676168|NCT02641379|16092794|P3|Overall Study|Therapy stopped due to misunderstanding|0
4676169|NCT02641379|16092795|P2|Overall Study|Therapy stopped due to misunderstanding|0
4676170|NCT02641379|16092796|P1|Overall Study|Therapy stopped due to misunderstanding|1
4676171|NCT02641379|16092786|P11|Overall Study|Participant stopped study/treatment|0
4676172|NCT02641379|16092787|P10|Overall Study|Participant stopped study/treatment|0
4676173|NCT02641379|16092788|P9|Overall Study|Participant stopped study/treatment|1
4676174|NCT02641379|16092789|P8|Overall Study|Participant stopped study/treatment|0
4676175|NCT02641379|16092790|P7|Overall Study|Participant stopped study/treatment|2
4676176|NCT02641379|16092791|P6|Overall Study|Participant stopped study/treatment|1
4676177|NCT02641379|16092792|P5|Overall Study|Participant stopped study/treatment|0
4676178|NCT02641379|16092793|P4|Overall Study|Participant stopped study/treatment|0
4676179|NCT02641379|16092794|P3|Overall Study|Participant stopped study/treatment|1
4676180|NCT02641379|16092795|P2|Overall Study|Participant stopped study/treatment|3
4676181|NCT02641379|16092796|P1|Overall Study|Participant stopped study/treatment|1
4676182|NCT02641379|16092786|P11|Overall Study|Participant showed relapse|0
4676183|NCT02641379|16092787|P10|Overall Study|Participant showed relapse|0
4676184|NCT02641379|16092788|P9|Overall Study|Participant showed relapse|0
4676185|NCT02641379|16092789|P8|Overall Study|Participant showed relapse|0
4676186|NCT02641379|16092790|P7|Overall Study|Participant showed relapse|1
4676187|NCT02641379|16092791|P6|Overall Study|Participant showed relapse|0
4676188|NCT02641379|16092792|P5|Overall Study|Participant showed relapse|0
4676189|NCT02641379|16092793|P4|Overall Study|Participant showed relapse|0
4676190|NCT02641379|16092794|P3|Overall Study|Participant showed relapse|0
4676191|NCT02641379|16092795|P2|Overall Study|Participant showed relapse|0
4676192|NCT02641379|16092796|P1|Overall Study|Participant showed relapse|1
4676193|NCT02641379|16092786|P11|Overall Study|PCR positive at follow up 2|0
4676194|NCT02641379|16092787|P10|Overall Study|PCR positive at follow up 2|0
4676195|NCT02641379|16092788|P9|Overall Study|PCR positive at follow up 2|0
4676196|NCT02641379|16092789|P8|Overall Study|PCR positive at follow up 2|0
4676197|NCT02641379|16092790|P7|Overall Study|PCR positive at follow up 2|0
4676198|NCT02641379|16092791|P6|Overall Study|PCR positive at follow up 2|0
4676199|NCT02641379|16092792|P5|Overall Study|PCR positive at follow up 2|0
4676200|NCT02641379|16092793|P4|Overall Study|PCR positive at follow up 2|0
4676201|NCT02641379|16092794|P3|Overall Study|PCR positive at follow up 2|0
4676202|NCT02641379|16092795|P2|Overall Study|PCR positive at follow up 2|0
4676203|NCT02641379|16092796|P1|Overall Study|PCR positive at follow up 2|1
4676204|NCT02641379|16092786|P11|Overall Study|PCR positive at Week 24|0
4676205|NCT02641379|16092787|P10|Overall Study|PCR positive at Week 24|1
4676206|NCT02641379|16092788|P9|Overall Study|PCR positive at Week 24|0
4676207|NCT02641379|16092789|P8|Overall Study|PCR positive at Week 24|8
4676208|NCT02641379|16092790|P7|Overall Study|PCR positive at Week 24|3
4676209|NCT02641379|16092791|P6|Overall Study|PCR positive at Week 24|6
4676210|NCT02641379|16092792|P5|Overall Study|PCR positive at Week 24|0
4676211|NCT02641379|16092793|P4|Overall Study|PCR positive at Week 24|0
4676212|NCT02641379|16092794|P3|Overall Study|PCR positive at Week 24|62
4676213|NCT02641379|16092795|P2|Overall Study|PCR positive at Week 24|21
4676214|NCT02641379|16092796|P1|Overall Study|PCR positive at Week 24|15
4676215|NCT02641379|16092786|P11|Overall Study|Participant cannot be reached|1
4676216|NCT02641379|16092787|P10|Overall Study|Participant cannot be reached|2
4676217|NCT02641379|16092788|P9|Overall Study|Participant cannot be reached|0
4676218|NCT02641379|16092789|P8|Overall Study|Participant cannot be reached|1
4676219|NCT02641379|16092790|P7|Overall Study|Participant cannot be reached|0
4676220|NCT02641379|16092791|P6|Overall Study|Participant cannot be reached|1
4676221|NCT02641379|16092792|P5|Overall Study|Participant cannot be reached|2
4676222|NCT02641379|16092793|P4|Overall Study|Participant cannot be reached|8
4676223|NCT02641379|16092794|P3|Overall Study|Participant cannot be reached|0
4676224|NCT02641379|16092795|P2|Overall Study|Participant cannot be reached|4
4676225|NCT02641379|16092796|P1|Overall Study|Participant cannot be reached|4
4676226|NCT02641379|16092786|P11|Overall Study|Participant's compliance|1
4676227|NCT02641379|16092787|P10|Overall Study|Participant's compliance|1
4676228|NCT02641379|16092788|P9|Overall Study|Participant's compliance|1
4676229|NCT02641379|16092789|P8|Overall Study|Participant's compliance|0
4676230|NCT02641379|16092790|P7|Overall Study|Participant's compliance|0
4676231|NCT02641379|16092791|P6|Overall Study|Participant's compliance|2
4676232|NCT02641379|16092792|P5|Overall Study|Participant's compliance|0
4676233|NCT02641379|16092793|P4|Overall Study|Participant's compliance|1
4676234|NCT02641379|16092794|P3|Overall Study|Participant's compliance|0
4676235|NCT02641379|16092795|P2|Overall Study|Participant's compliance|1
4676236|NCT02641379|16092796|P1|Overall Study|Participant's compliance|0
4676237|NCT02641379|16092786|P11|Overall Study|Participant unable to attend study visit|0
4676238|NCT02641379|16092787|P10|Overall Study|Participant unable to attend study visit|2
4676239|NCT02641379|16092788|P9|Overall Study|Participant unable to attend study visit|0
4676240|NCT02641379|16092789|P8|Overall Study|Participant unable to attend study visit|1
4676241|NCT02641379|16092790|P7|Overall Study|Participant unable to attend study visit|1
4676242|NCT02641379|16092791|P6|Overall Study|Participant unable to attend study visit|1
4676243|NCT02641379|16092792|P5|Overall Study|Participant unable to attend study visit|5
4676244|NCT02641379|16092793|P4|Overall Study|Participant unable to attend study visit|2
4676245|NCT02641379|16092794|P3|Overall Study|Participant unable to attend study visit|1
4676246|NCT02641379|16092795|P2|Overall Study|Participant unable to attend study visit|10
4676247|NCT02641379|16092796|P1|Overall Study|Participant unable to attend study visit|4
4676248|NCT02641379|16092786|P11|Overall Study|Lack of Efficacy|0
4676249|NCT02641379|16092787|P10|Overall Study|Lack of Efficacy|0
4676250|NCT02641379|16092788|P9|Overall Study|Lack of Efficacy|0
4676251|NCT02641379|16092789|P8|Overall Study|Lack of Efficacy|5
4676252|NCT02641379|16092790|P7|Overall Study|Lack of Efficacy|0
4676253|NCT02641379|16092791|P6|Overall Study|Lack of Efficacy|2
4676254|NCT02641379|16092792|P5|Overall Study|Lack of Efficacy|0
4676255|NCT02641379|16092793|P4|Overall Study|Lack of Efficacy|0
4676256|NCT02641379|16092794|P3|Overall Study|Lack of Efficacy|2
4676257|NCT02641379|16092795|P2|Overall Study|Lack of Efficacy|0
4676258|NCT02641379|16092796|P1|Overall Study|Lack of Efficacy|0
4676259|NCT02641379|16092786|P11|Overall Study|Adverse Event|5
4676260|NCT02641379|16092787|P10|Overall Study|Adverse Event|1
4676261|NCT02641379|16092788|P9|Overall Study|Adverse Event|1
4676262|NCT02641379|16092789|P8|Overall Study|Adverse Event|0
4676263|NCT02641379|16092790|P7|Overall Study|Adverse Event|5
4676264|NCT02641379|16092791|P6|Overall Study|Adverse Event|1
4676265|NCT02641379|16092792|P5|Overall Study|Adverse Event|5
4676266|NCT02641379|16092793|P4|Overall Study|Adverse Event|2
4676267|NCT02641379|16092794|P3|Overall Study|Adverse Event|2
4676268|NCT02641379|16092795|P2|Overall Study|Adverse Event|8
4676269|NCT02641379|16092796|P1|Overall Study|Adverse Event|7
4676270|NCT02641379|16092786|P11|Overall Study|Withdrawal of informed consent|0
4676271|NCT02641379|16092787|P10|Overall Study|Withdrawal of informed consent|0
4676272|NCT02641379|16092788|P9|Overall Study|Withdrawal of informed consent|0
4676273|NCT02641379|16092789|P8|Overall Study|Withdrawal of informed consent|1
4676274|NCT02641379|16092790|P7|Overall Study|Withdrawal of informed consent|0
4676275|NCT02641379|16092791|P6|Overall Study|Withdrawal of informed consent|0
4676276|NCT02641379|16092792|P5|Overall Study|Withdrawal of informed consent|0
4676277|NCT02641379|16092793|P4|Overall Study|Withdrawal of informed consent|0
4676278|NCT02641379|16092794|P3|Overall Study|Withdrawal of informed consent|0
4676279|NCT02641379|16092795|P2|Overall Study|Withdrawal of informed consent|1
4676280|NCT02641379|16092796|P1|Overall Study|Withdrawal of informed consent|0
4676281|NCT02641379|16092786|P11|Overall Study|Exclusion criterion during screening|0
4676282|NCT02641379|16092787|P10|Overall Study|Exclusion criterion during screening|0
4676283|NCT02641379|16092788|P9|Overall Study|Exclusion criterion during screening|0
4676284|NCT02641379|16092789|P8|Overall Study|Exclusion criterion during screening|0
4676285|NCT02641379|16092790|P7|Overall Study|Exclusion criterion during screening|0
4676286|NCT02641379|16092791|P6|Overall Study|Exclusion criterion during screening|0
4676287|NCT02641379|16092792|P5|Overall Study|Exclusion criterion during screening|2
4676288|NCT02641379|16092793|P4|Overall Study|Exclusion criterion during screening|1
4676289|NCT02641379|16092794|P3|Overall Study|Exclusion criterion during screening|0
4676290|NCT02641379|16092795|P2|Overall Study|Exclusion criterion during screening|0
4676291|NCT02641379|16092796|P1|Overall Study|Exclusion criterion during screening|1
4676292|NCT02640755|16092914|P2|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0
4676293|NCT02640755|16092915|P1|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1
4676294|NCT02640755|16092914|P2|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0
4676295|NCT02640755|16092915|P1|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1
4676296|NCT02640755|16092914|P2|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1
4676297|NCT02640755|16092915|P1|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0
4676298|NCT02640677|16092969|P1|Overall Study|Withdrawal by Subject|1
4676299|NCT02640677|16092969|P1|Overall Study|Lost to Follow-up|1
4676300|NCT02640625|16092976|P1|Overall Study|Adverse Event|1
4676301|NCT02640612|16092985|P3|Overall Study|Lack of Efficacy|0
4676302|NCT02640612|16092986|P2|Overall Study|Lack of Efficacy|1
4676303|NCT02640612|16092987|P1|Overall Study|Lack of Efficacy|1
4676304|NCT02640612|16092985|P3|Overall Study|Protocol Violation|0
4676305|NCT02640612|16092986|P2|Overall Study|Protocol Violation|2
4676306|NCT02640612|16092987|P1|Overall Study|Protocol Violation|0
4676307|NCT02640612|16092985|P3|Overall Study|Lost to Follow-up|1
4676308|NCT02640612|16092986|P2|Overall Study|Lost to Follow-up|1
4676309|NCT02640612|16092987|P1|Overall Study|Lost to Follow-up|4
4676310|NCT02640612|16092985|P3|Overall Study|Withdrawal by Subject|3
4676311|NCT02640612|16092986|P2|Overall Study|Withdrawal by Subject|3
4676312|NCT02640612|16092987|P1|Overall Study|Withdrawal by Subject|10
4676313|NCT02640612|16092985|P3|Overall Study|Death|0
4676314|NCT02640612|16092986|P2|Overall Study|Death|0
4676315|NCT02640612|16092987|P1|Overall Study|Death|1
4676316|NCT02640612|16092985|P3|Overall Study|Adverse Event|2
4676317|NCT02640612|16092986|P2|Overall Study|Adverse Event|7
4676318|NCT02640612|16092987|P1|Overall Study|Adverse Event|6
4676319|NCT02640547|16093011|P1|Overall Study|Miscellaneous|3
4676320|NCT02640547|16093011|P1|Overall Study|Death|6
4676321|NCT02640547|16093011|P1|Overall Study|Withdrawal by Subject|1
4676322|NCT02640547|16093011|P1|Overall Study|Failure to Return|1
4676323|NCT02640482|16093088|P2|Overall Study|Lost to Follow-up|0
4676324|NCT02640482|16093089|P1|Overall Study|Lost to Follow-up|3
4676325|NCT02640404|16093101|P2|Overall Study|Withdrawal by Subject|0
4676326|NCT02640404|16093102|P1|Overall Study|Withdrawal by Subject|1
4676327|NCT02640404|16093101|P2|Overall Study|Protocol Violation|0
4676328|NCT02640404|16093102|P1|Overall Study|Protocol Violation|1
4676329|NCT02640235|16093112|P2|Overall Study|Other|2
4676330|NCT02640235|16093113|P1|Overall Study|Other|1
4676331|NCT02640235|16093112|P2|Overall Study|Death|3
4676332|NCT02640235|16093113|P1|Overall Study|Death|2
4676333|NCT02640235|16093112|P2|Overall Study|Lost to Follow-up|3
4676334|NCT02640235|16093113|P1|Overall Study|Lost to Follow-up|4
4676335|NCT02640235|16093112|P2|Overall Study|Withdrawal by Subject|6
4676336|NCT02640235|16093113|P1|Overall Study|Withdrawal by Subject|7
4676337|NCT02640157|16093136|P3|Overall Study|Randomized in error; did not receive Tx|0
4676338|NCT02640157|16093137|P2|Overall Study|Randomized in error; did not receive Tx|1
4676339|NCT02640157|16093138|P1|Overall Study|Randomized in error; did not receive Tx|0
4676340|NCT02640157|16093136|P3|Overall Study|Lost to Follow-up|7
4676341|NCT02640157|16093137|P2|Overall Study|Lost to Follow-up|2
4676342|NCT02640157|16093138|P1|Overall Study|Lost to Follow-up|9
4676343|NCT02640157|16093136|P3|Overall Study|Withdrew consent|2
4676344|NCT02640157|16093137|P2|Overall Study|Withdrew consent|0
4676345|NCT02640157|16093138|P1|Overall Study|Withdrew consent|2
4676346|NCT02640157|16093136|P3|Overall Study|Adverse Event|1
4676347|NCT02640157|16093137|P2|Overall Study|Adverse Event|2
4676348|NCT02640157|16093138|P1|Overall Study|Adverse Event|2
4676349|NCT02640053|16093157|P2|Overall Study|Chemo regimen changed after 1st Rx|1
4676350|NCT02640053|16093158|P1|Overall Study|Chemo regimen changed after 1st Rx|0
4676351|NCT02640053|16093157|P2|Overall Study|Alternative Therapy|1
4676352|NCT02640053|16093158|P1|Overall Study|Alternative Therapy|1
4676353|NCT02640053|16093157|P2|Overall Study|Adverse Event|1
4676354|NCT02640053|16093158|P1|Overall Study|Adverse Event|1
4676355|NCT02640053|16093157|P2|Overall Study|Withdrawal by Subject|1
4676356|NCT02640053|16093158|P1|Overall Study|Withdrawal by Subject|2
4676357|NCT02639559|16093265|P2|Overall Study|Issues with vascular acess|0
4676358|NCT02639559|16093266|P1|Overall Study|Issues with vascular acess|1
4676359|NCT02639559|16093265|P2|Overall Study|Mobilization failure|3
4676360|NCT02639559|16093266|P1|Overall Study|Mobilization failure|0
4676361|NCT02639338|16093702|P2|Overall Study|Randomized but Not Treated|1
4676362|NCT02639338|16093703|P1|Overall Study|Randomized but Not Treated|0
4676363|NCT02639338|16093702|P2|Overall Study|Death|0
4676364|NCT02639338|16093703|P1|Overall Study|Death|1
4676365|NCT02639338|16093702|P2|Overall Study|Withdrew Consent|2
4676366|NCT02639338|16093703|P1|Overall Study|Withdrew Consent|1
4676367|NCT02639338|16093702|P2|Overall Study|Lost to Follow-up|2
4676368|NCT02639338|16093703|P1|Overall Study|Lost to Follow-up|2
4676369|NCT02639247|16093748|P2|Overall Study|Protocol Violation|0
4676370|NCT02639247|16093749|P1|Overall Study|Protocol Violation|1
4676371|NCT02639247|16093748|P2|Overall Study|Withdrew Consent|1
4676372|NCT02639247|16093749|P1|Overall Study|Withdrew Consent|0
4676373|NCT02639247|16093748|P2|Overall Study|Death|0
4676374|NCT02639247|16093749|P1|Overall Study|Death|2
4676375|NCT02639247|16093748|P2|Overall Study|Lost to Follow-up|1
4676376|NCT02639247|16093749|P1|Overall Study|Lost to Follow-up|2
4676377|NCT02639182|16093767|P2|Overall Study|Participants Still on Study|24
4676378|NCT02639182|16093768|P1|Overall Study|Participants Still on Study|25
4676379|NCT02639182|16093767|P2|Overall Study|Withdrew consent|0
4676380|NCT02639182|16093768|P1|Overall Study|Withdrew consent|6
4676381|NCT02639182|16093767|P2|Overall Study|Lost to Follow-up|1
4676382|NCT02639182|16093768|P1|Overall Study|Lost to Follow-up|1
4676383|NCT02639182|16093767|P2|Overall Study|Death|41
4676384|NCT02639182|16093768|P1|Overall Study|Death|35
4676385|NCT02639052|16093801|P1|Overall Study|Lost to Follow-up|1
4676386|NCT02638948|16093838|P4|Overall Study|Other than specified above|1
4676387|NCT02638948|16093839|P3|Overall Study|Other than specified above|1
4676388|NCT02638948|16093840|P2|Overall Study|Other than specified above|1
4676389|NCT02638948|16093841|P1|Overall Study|Other than specified above|4
4676390|NCT02638948|16093838|P4|Overall Study|Participant no longer met study criteria|0
4676391|NCT02638948|16093839|P3|Overall Study|Participant no longer met study criteria|0
4676392|NCT02638948|16093840|P2|Overall Study|Participant no longer met study criteria|1
4676393|NCT02638948|16093841|P1|Overall Study|Participant no longer met study criteria|0
4676394|NCT02638948|16093838|P4|Overall Study|Poor/Non-Compliance|0
4676395|NCT02638948|16093839|P3|Overall Study|Poor/Non-Compliance|1
4676396|NCT02638948|16093840|P2|Overall Study|Poor/Non-Compliance|2
4676397|NCT02638948|16093841|P1|Overall Study|Poor/Non-Compliance|0
4676398|NCT02638948|16093838|P4|Overall Study|Lost to Follow-up|1
4676399|NCT02638948|16093839|P3|Overall Study|Lost to Follow-up|1
4676400|NCT02638948|16093840|P2|Overall Study|Lost to Follow-up|0
4676401|NCT02638948|16093841|P1|Overall Study|Lost to Follow-up|0
4676402|NCT02638948|16093838|P4|Overall Study|Lack of Efficacy|0
4676403|NCT02638948|16093839|P3|Overall Study|Lack of Efficacy|0
4676404|NCT02638948|16093840|P2|Overall Study|Lack of Efficacy|1
4676405|NCT02638948|16093841|P1|Overall Study|Lack of Efficacy|1
4676406|NCT02638948|16093838|P4|Overall Study|Adverse Event|1
4676407|NCT02638948|16093839|P3|Overall Study|Adverse Event|1
4676408|NCT02638948|16093840|P2|Overall Study|Adverse Event|0
4676409|NCT02638948|16093841|P1|Overall Study|Adverse Event|0
4676410|NCT02638948|16093838|P4|Overall Study|Administrative Reason by Sponsor|4
4676411|NCT02638948|16093839|P3|Overall Study|Administrative Reason by Sponsor|0
4676412|NCT02638948|16093840|P2|Overall Study|Administrative Reason by Sponsor|1
4676413|NCT02638948|16093841|P1|Overall Study|Administrative Reason by Sponsor|0
4676414|NCT02638948|16093838|P4|Overall Study|Withdrawal by Subject|1
4676415|NCT02638948|16093839|P3|Overall Study|Withdrawal by Subject|3
4676416|NCT02638948|16093840|P2|Overall Study|Withdrawal by Subject|5
4676417|NCT02638948|16093841|P1|Overall Study|Withdrawal by Subject|4
4676418|NCT02638623|16093928|P2|Overall Study|Not given intervention|0
4676419|NCT02638623|16093929|P1|Overall Study|Not given intervention|2
4676420|NCT02638623|16093928|P2|Overall Study|Surgery timing|6
4676421|NCT02638623|16093929|P1|Overall Study|Surgery timing|5
4676422|NCT02638493|16093959|P3|Overall Study|Inability to provide semen samples|0
4676423|NCT02638493|16093960|P2|Overall Study|Inability to provide semen samples|0
4676424|NCT02638493|16093961|P1|Overall Study|Inability to provide semen samples|2
4676425|NCT02638337|16093992|P2|Overall Study|Other - Miscellaneous|3
4676426|NCT02638337|16093993|P1|Overall Study|Other - Miscellaneous|4
4676427|NCT02638337|16093992|P2|Overall Study|Lost to Follow-up|7
4676428|NCT02638337|16093993|P1|Overall Study|Lost to Follow-up|7
4676429|NCT02638337|16093992|P2|Overall Study|Withdrawal by Subject|16
4676430|NCT02638337|16093993|P1|Overall Study|Withdrawal by Subject|13
4676431|NCT02638337|16093992|P2|Overall Study|Protocol Violation|0
4676432|NCT02638337|16093993|P1|Overall Study|Protocol Violation|3
4676433|NCT02638337|16093992|P2|Overall Study|Adverse Event|10
4676434|NCT02638337|16093993|P1|Overall Study|Adverse Event|6
4676435|NCT02638259|16094077|P2|Treatment Period 2|Withdrawal by Subject|7
4676436|NCT02638259|16094078|P1|Treatment Period 2|Withdrawal by Subject|1
4676437|NCT02638259|16094077|P2|Treatment Period 2|Adverse Event|4
4676438|NCT02638259|16094078|P1|Treatment Period 2|Adverse Event|5
4676439|NCT02638259|16094077|P2|Treatment Period 1|Withdrawn per sponsor decision|2
4676440|NCT02638259|16094078|P1|Treatment Period 1|Withdrawn per sponsor decision|0
4676441|NCT02638259|16094077|P2|Treatment Period 1|Withdrawal by Subject|6
4676442|NCT02638259|16094078|P1|Treatment Period 1|Withdrawal by Subject|4
4676443|NCT02638259|16094077|P2|Treatment Period 1|Protocol Violation|3
4676444|NCT02638259|16094078|P1|Treatment Period 1|Protocol Violation|0
4676445|NCT02638259|16094077|P2|Treatment Period 1|Lack of Efficacy|1
4676446|NCT02638259|16094078|P1|Treatment Period 1|Lack of Efficacy|0
4676447|NCT02638259|16094077|P2|Treatment Period 1|Death|1
4676448|NCT02638259|16094078|P1|Treatment Period 1|Death|0
4676449|NCT02638259|16094077|P2|Treatment Period 1|Adverse Event|5
4676450|NCT02638259|16094078|P1|Treatment Period 1|Adverse Event|1
4676451|NCT02638129|16094170|P2|Overall Study|Study terminated|30
4676452|NCT02638129|16094171|P1|Overall Study|Study terminated|28
4676453|NCT02638103|16094187|P4|Overall Study|Other than specified|4
4676454|NCT02638103|16094188|P3|Overall Study|Other than specified|2
4676455|NCT02638103|16094189|P2|Overall Study|Other than specified|4
4676456|NCT02638103|16094190|P1|Overall Study|Other than specified|5
4676457|NCT02638103|16094187|P4|Overall Study|Lack of Efficacy|22
4676458|NCT02638103|16094188|P3|Overall Study|Lack of Efficacy|12
4676459|NCT02638103|16094189|P2|Overall Study|Lack of Efficacy|10
4676460|NCT02638103|16094190|P1|Overall Study|Lack of Efficacy|14
4676461|NCT02638103|16094187|P4|Overall Study|Lost to Follow-up|37
4676462|NCT02638103|16094188|P3|Overall Study|Lost to Follow-up|20
4676463|NCT02638103|16094189|P2|Overall Study|Lost to Follow-up|33
4676464|NCT02638103|16094190|P1|Overall Study|Lost to Follow-up|26
4676465|NCT02638103|16094187|P4|Overall Study|Non-compliance to Study Procedures|1
4676466|NCT02638103|16094188|P3|Overall Study|Non-compliance to Study Procedures|1
4676467|NCT02638103|16094189|P2|Overall Study|Non-compliance to Study Procedures|1
4676468|NCT02638103|16094190|P1|Overall Study|Non-compliance to Study Procedures|2
4676469|NCT02638103|16094187|P4|Overall Study|Pregnancy|1
4676470|NCT02638103|16094188|P3|Overall Study|Pregnancy|0
4676471|NCT02638103|16094189|P2|Overall Study|Pregnancy|3
4676472|NCT02638103|16094190|P1|Overall Study|Pregnancy|2
4676473|NCT02638103|16094187|P4|Overall Study|Protocol Violation|4
4676474|NCT02638103|16094188|P3|Overall Study|Protocol Violation|1
4676475|NCT02638103|16094189|P2|Overall Study|Protocol Violation|2
4676476|NCT02638103|16094190|P1|Overall Study|Protocol Violation|1
4676477|NCT02638103|16094187|P4|Overall Study|Withdrawal by Subject|61
4676478|NCT02638103|16094188|P3|Overall Study|Withdrawal by Subject|30
4676479|NCT02638103|16094189|P2|Overall Study|Withdrawal by Subject|53
4676480|NCT02638103|16094190|P1|Overall Study|Withdrawal by Subject|43
4676481|NCT02638103|16094187|P4|Overall Study|Adverse Event|12
4676482|NCT02638103|16094188|P3|Overall Study|Adverse Event|19
4676483|NCT02638103|16094189|P2|Overall Study|Adverse Event|12
4676484|NCT02638103|16094190|P1|Overall Study|Adverse Event|13
4676485|NCT02638012|16094277|P1|Overall Study|Lost to Follow-up|1
4676486|NCT02637856|16094322|P2|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3
4676487|NCT02637856|16094323|P1|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0
4676488|NCT02637856|16094322|P2|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1
4676489|NCT02637856|16094323|P1|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0
4676490|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Site Closing|0
4676491|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Site Closing|6
4676492|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Pregnancy Attempts|0
4676493|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Pregnancy Attempts|2
4676494|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Incarceration|0
4676495|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Incarceration|1
4676496|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Failed Drug Test|0
4676497|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Failed Drug Test|1
4676498|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0
4676499|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164
4676500|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Protocol Deviation|0
4676501|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Protocol Deviation|2
4676502|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Withdrawal by Subject|0
4676503|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Withdrawal by Subject|20
4676504|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Pregnancy|0
4676505|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Pregnancy|7
4676506|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Physician Decision|0
4676507|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Physician Decision|2
4676508|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Lost to Follow-up|0
4676509|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Lost to Follow-up|5
4676510|NCT02637856|16094322|P2|Main Study (Baseline to Week 100)|Adverse Event|0
4676511|NCT02637856|16094323|P1|Main Study (Baseline to Week 100)|Adverse Event|9
4676512|NCT02637557|16094453|P4|Overall Study|Withdrawal by Subject|2
4676513|NCT02637557|16094454|P3|Overall Study|Withdrawal by Subject|4
4676514|NCT02637557|16094455|P2|Overall Study|Withdrawal by Subject|3
4676515|NCT02637557|16094456|P1|Overall Study|Withdrawal by Subject|1
4676516|NCT02637557|16094453|P4|Overall Study|Protocol Violation|1
4676517|NCT02637557|16094454|P3|Overall Study|Protocol Violation|2
4676518|NCT02637557|16094455|P2|Overall Study|Protocol Violation|0
4676519|NCT02637557|16094456|P1|Overall Study|Protocol Violation|2
4676520|NCT02637557|16094453|P4|Overall Study|Physician Decision|0
4676521|NCT02637557|16094454|P3|Overall Study|Physician Decision|0
4676522|NCT02637557|16094455|P2|Overall Study|Physician Decision|0
4676523|NCT02637557|16094456|P1|Overall Study|Physician Decision|1
4676524|NCT02637557|16094453|P4|Overall Study|Lost to Follow-up|1
4676525|NCT02637557|16094454|P3|Overall Study|Lost to Follow-up|0
4676526|NCT02637557|16094455|P2|Overall Study|Lost to Follow-up|1
4676527|NCT02637557|16094456|P1|Overall Study|Lost to Follow-up|1
4676528|NCT02637557|16094453|P4|Overall Study|Adverse Event|3
4676529|NCT02637557|16094454|P3|Overall Study|Adverse Event|3
4676530|NCT02637557|16094455|P2|Overall Study|Adverse Event|1
4676531|NCT02637557|16094456|P1|Overall Study|Adverse Event|3
4676532|NCT02637323|16094548|P2|Overall Study|Protocol Violation|1
4676533|NCT02637323|16094549|P1|Overall Study|Protocol Violation|0
4676534|NCT02637323|16094548|P2|Overall Study|Lost to Follow-up|0
4676535|NCT02637323|16094549|P1|Overall Study|Lost to Follow-up|2
4676536|NCT02637141|16094560|P3|Overall Study|Withdrawal by Subject|1
4676537|NCT02637141|16094561|P2|Overall Study|Withdrawal by Subject|1
4676538|NCT02637141|16094562|P1|Overall Study|Withdrawal by Subject|1
4676539|NCT02637141|16094560|P3|Overall Study|Adverse Event|0
4676540|NCT02637141|16094561|P2|Overall Study|Adverse Event|1
4676541|NCT02637141|16094562|P1|Overall Study|Adverse Event|1
4676542|NCT02637063|16094597|P3|Overall Study|Withdrawal by Subject|3
4676543|NCT02637063|16094598|P2|Overall Study|Withdrawal by Subject|2
4676544|NCT02637063|16094599|P1|Overall Study|Withdrawal by Subject|2
4676545|NCT02637063|16094597|P3|Overall Study|Lost to Follow-up|3
4676546|NCT02637063|16094598|P2|Overall Study|Lost to Follow-up|2
4676547|NCT02637063|16094599|P1|Overall Study|Lost to Follow-up|3
4676548|NCT02637037|16094627|P2|Overall Study|Adverse Event|0
4676549|NCT02637037|16094628|P1|Overall Study|Adverse Event|1
4676550|NCT02637037|16094627|P2|Overall Study|Withdrawal by Subject|1
4676551|NCT02637037|16094628|P1|Overall Study|Withdrawal by Subject|2
4676552|NCT02637037|16094627|P2|Overall Study|Positive drug screen at admission|0
4676553|NCT02637037|16094628|P1|Overall Study|Positive drug screen at admission|1
4676554|NCT02636907|16094694|P1|Extension Phase|Lack of Efficacy|1
4676555|NCT02636907|16094694|P1|Extension Phase|Lost to Follow-up|2
4676556|NCT02636907|16094694|P1|Extension Phase|Physician Decision|1
4676557|NCT02636907|16094694|P1|Extension Phase|Withdrawal by Subject|4
4676558|NCT02636907|16094694|P1|Extension Phase|Adverse Event|2
4676559|NCT02636907|16094694|P1|Autoinjector Assessment Period|Withdrawal by Subject|2
4676560|NCT02636907|16094694|P1|Autoinjector Assessment Period|Adverse Event|2
4676561|NCT02636608|16094711|P1|Overall Study|Did Not Receive Treatment|1
4676562|NCT02636608|16094711|P1|Overall Study|Other|2
4676563|NCT02636608|16094711|P1|Overall Study|Death|3
4676564|NCT02636608|16094711|P1|Overall Study|Insufficient Virological Response|1
4676565|NCT02636608|16094711|P1|Overall Study|Failure to Return|4
4676566|NCT02636595|16094739|P1|Overall Study|Other|1
4676567|NCT02636595|16094739|P1|Overall Study|Lost to Follow-up|1
4676568|NCT02636361|16094745|P5|Period 4|Physician Decision|0
4676569|NCT02636361|16094746|P4|Period 4|Physician Decision|1
4676570|NCT02636361|16094747|P3|Period 4|Physician Decision|0
4676571|NCT02636361|16094748|P2|Period 4|Physician Decision|0
4676572|NCT02636361|16094749|P1|Period 4|Physician Decision|0
4676573|NCT02636283|16094768|P2|Overall Study|Trial Terminated Prematurely|3
4676574|NCT02636283|16094769|P1|Overall Study|Trial Terminated Prematurely|0
4676575|NCT02636283|16094768|P2|Overall Study|Adverse Event|0
4676576|NCT02636283|16094769|P1|Overall Study|Adverse Event|2
4676577|NCT02635984|16094797|P2|Overall Study|Study Arm Closed|0
4676578|NCT02635984|16094798|P1|Overall Study|Study Arm Closed|1
4676579|NCT02635984|16094797|P2|Overall Study|Lost to Follow-up|4
4676580|NCT02635984|16094798|P1|Overall Study|Lost to Follow-up|2
4676581|NCT02635646|16094830|P2|Overall Study|Pregnancy|1
4676582|NCT02635646|16094831|P1|Overall Study|Pregnancy|1
4676583|NCT02635646|16094830|P2|Overall Study|Lost to Follow-up|25
4676584|NCT02635646|16094831|P1|Overall Study|Lost to Follow-up|24
4676585|NCT02635347|16094867|P2|Overall Study|Failed screening|7
4676586|NCT02635347|16094868|P1|Overall Study|Failed screening|20
4676587|NCT02635204|16094899|P2|Overall Study|Lost to Follow-up|1
4676588|NCT02635204|16094900|P1|Overall Study|Lost to Follow-up|1
4676589|NCT02635204|16094899|P2|Overall Study|Adverse Event|0
4676590|NCT02635204|16094900|P1|Overall Study|Adverse Event|1
4676591|NCT02634983|16094910|P2|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0
4676592|NCT02634983|16094911|P1|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2
4676593|NCT02634801|16094970|P3|Follow-up Period|Adverse Event|0
4676594|NCT02634801|16094971|P2|Follow-up Period|Adverse Event|5
4676595|NCT02634801|16094972|P1|Follow-up Period|Adverse Event|1
4676596|NCT02634801|16094970|P3|Follow-up Period|Withdrawal by Subject|5
4676597|NCT02634801|16094971|P2|Follow-up Period|Withdrawal by Subject|2
4676598|NCT02634801|16094972|P1|Follow-up Period|Withdrawal by Subject|1
4676599|NCT02634801|16094970|P3|Follow-up Period|Physician Decision|1
4676600|NCT02634801|16094971|P2|Follow-up Period|Physician Decision|0
4676601|NCT02634801|16094972|P1|Follow-up Period|Physician Decision|0
4676602|NCT02634801|16094970|P3|Follow-up Period|Lost to Follow-up|2
4676603|NCT02634801|16094971|P2|Follow-up Period|Lost to Follow-up|1
4676604|NCT02634801|16094972|P1|Follow-up Period|Lost to Follow-up|3
4676605|NCT02634801|16094970|P3|Extension Period (Weeks 24 to 36)|Missing|0
4676606|NCT02634801|16094971|P2|Extension Period (Weeks 24 to 36)|Missing|0
4676607|NCT02634801|16094972|P1|Extension Period (Weeks 24 to 36)|Missing|1
4676608|NCT02634801|16094970|P3|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
4676609|NCT02634801|16094971|P2|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
4676610|NCT02634801|16094972|P1|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1
4676611|NCT02634801|16094970|P3|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
4676612|NCT02634801|16094971|P2|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0
4676613|NCT02634801|16094972|P1|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1
4676614|NCT02634801|16094970|P3|Extension Period (Weeks 24 to 36)|Adverse Event|1
4676615|NCT02634801|16094971|P2|Extension Period (Weeks 24 to 36)|Adverse Event|0
4676616|NCT02634801|16094972|P1|Extension Period (Weeks 24 to 36)|Adverse Event|0
4676617|NCT02634801|16094970|P3|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3
4676618|NCT02634801|16094971|P2|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8
4676619|NCT02634801|16094972|P1|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0
4676620|NCT02634801|16094970|P3|Treatment Period (Weeks 0 to 24)|Protocol Violation|1
4676621|NCT02634801|16094971|P2|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
4676622|NCT02634801|16094972|P1|Treatment Period (Weeks 0 to 24)|Protocol Violation|0
4676623|NCT02634801|16094970|P3|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
4676624|NCT02634801|16094971|P2|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1
4676625|NCT02634801|16094972|P1|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2
4676626|NCT02634801|16094970|P3|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
4676627|NCT02634801|16094971|P2|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2
4676628|NCT02634801|16094972|P1|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0
4676629|NCT02634801|16094970|P3|Treatment Period (Weeks 0 to 24)|Adverse Event|0
4676630|NCT02634801|16094971|P2|Treatment Period (Weeks 0 to 24)|Adverse Event|20
4676631|NCT02634801|16094972|P1|Treatment Period (Weeks 0 to 24)|Adverse Event|2
4676632|NCT02634788|16095072|P4|Overall Study|Withdrawal by Subject|0
4676633|NCT02634788|16095073|P3|Overall Study|Withdrawal by Subject|1
4676634|NCT02634788|16095074|P2|Overall Study|Withdrawal by Subject|1
4676635|NCT02634788|16095075|P1|Overall Study|Withdrawal by Subject|0
4676636|NCT02634788|16095072|P4|Overall Study|Lost to Follow-up|0
4676637|NCT02634788|16095073|P3|Overall Study|Lost to Follow-up|0
4676638|NCT02634788|16095074|P2|Overall Study|Lost to Follow-up|1
4676639|NCT02634788|16095075|P1|Overall Study|Lost to Follow-up|0
4676640|NCT02634788|16095072|P4|Overall Study|Lack of Efficacy|4
4676641|NCT02634788|16095073|P3|Overall Study|Lack of Efficacy|1
4676642|NCT02634788|16095074|P2|Overall Study|Lack of Efficacy|0
4676643|NCT02634788|16095075|P1|Overall Study|Lack of Efficacy|4
4676644|NCT02634788|16095072|P4|Overall Study|Adverse Event|1
4676645|NCT02634788|16095073|P3|Overall Study|Adverse Event|3
4676646|NCT02634788|16095074|P2|Overall Study|Adverse Event|8
4676647|NCT02634788|16095075|P1|Overall Study|Adverse Event|0
4676648|NCT02634606|16095141|P1|Overall Study|unable to obtain the drug at start|13
4676649|NCT02634580|16095153|P4|Overall Study|Subject Request|1
4676650|NCT02634580|16095154|P3|Overall Study|Subject Request|1
4676651|NCT02634580|16095155|P2|Overall Study|Subject Request|0
4676652|NCT02634580|16095156|P1|Overall Study|Subject Request|1
4676653|NCT02634346|16095213|P3|Overall Study|Protocol Violation|0
4676654|NCT02634346|16095214|P2|Overall Study|Protocol Violation|1
4676655|NCT02634346|16095215|P1|Overall Study|Protocol Violation|0
4676656|NCT02634346|16095213|P3|Overall Study|Lost to Follow-up|0
4676657|NCT02634346|16095214|P2|Overall Study|Lost to Follow-up|0
4676658|NCT02634346|16095215|P1|Overall Study|Lost to Follow-up|1
4676659|NCT02634346|16095213|P3|Overall Study|Lack of Efficacy|8
4676660|NCT02634346|16095214|P2|Overall Study|Lack of Efficacy|2
4676661|NCT02634346|16095215|P1|Overall Study|Lack of Efficacy|1
4676662|NCT02634346|16095213|P3|Overall Study|Adverse Event|7
4676663|NCT02634346|16095214|P2|Overall Study|Adverse Event|2
4676664|NCT02634346|16095215|P1|Overall Study|Adverse Event|2
4676665|NCT02634346|16095213|P3|Overall Study|Withdrawal by Subject|8
4676666|NCT02634346|16095214|P2|Overall Study|Withdrawal by Subject|9
4676667|NCT02634346|16095215|P1|Overall Study|Withdrawal by Subject|8
4676668|NCT02634320|16095229|P1|Overall Study|Lack of Efficacy|2
4676669|NCT02634320|16095229|P1|Overall Study|Withdrawal by Subject|5
4676670|NCT02634320|16095229|P1|Overall Study|Protocol Violation|1
4676671|NCT02634320|16095229|P1|Overall Study|Out of window for study visits|1
4676672|NCT02634320|16095229|P1|Overall Study|Moved out of area|2
4676673|NCT02634320|16095229|P1|Overall Study|Lost to Follow-up|3
4676674|NCT02634320|16095229|P1|Overall Study|Adverse Event|2
4676675|NCT02634151|16095265|P2|Overall Study|Other|1
4676676|NCT02634151|16095266|P1|Overall Study|Other|0
4676677|NCT02634151|16095265|P2|Overall Study|Non-Compliance|1
4676678|NCT02634151|16095266|P1|Overall Study|Non-Compliance|0
4676679|NCT02634151|16095265|P2|Overall Study|Withdrawal by Subject|0
4676680|NCT02634151|16095266|P1|Overall Study|Withdrawal by Subject|1
4676681|NCT02633800|16095468|P2|Overall Study|Patient Request|1
4676682|NCT02633800|16095469|P1|Overall Study|Patient Request|1
4676683|NCT02633800|16095468|P2|Overall Study|Withdrawal by Subject|3
4676684|NCT02633800|16095469|P1|Overall Study|Withdrawal by Subject|0
4676685|NCT02633800|16095468|P2|Overall Study|Adverse event, non-fatal|2
4676686|NCT02633800|16095469|P1|Overall Study|Adverse event, non-fatal|7
4676687|NCT02633800|16095468|P2|Overall Study|Study terminated by sponsor|5
4676688|NCT02633800|16095469|P1|Overall Study|Study terminated by sponsor|6
4676689|NCT02633800|16095468|P2|Overall Study|Clinical progression|6
4676690|NCT02633800|16095469|P1|Overall Study|Clinical progression|3
4676691|NCT02633800|16095468|P2|Overall Study|Radiologic(al) progression|23
4676692|NCT02633800|16095469|P1|Overall Study|Radiologic(al) progression|23
4676693|NCT02633800|16095468|P2|Overall Study|Reason not provided|0
4676694|NCT02633800|16095469|P1|Overall Study|Reason not provided|1
4676695|NCT02633800|16095468|P2|Overall Study|Death|3
4676696|NCT02633800|16095469|P1|Overall Study|Death|3
4676697|NCT02633787|16095479|P1|Overall Study|Withdrawal by Subject|1
4676698|NCT02633501|16095500|P6|Overall Study|Lost to Follow-up|0
4676699|NCT02633501|16095501|P5|Overall Study|Lost to Follow-up|2
4676700|NCT02633501|16095502|P4|Overall Study|Lost to Follow-up|1
4676701|NCT02633501|16095503|P3|Overall Study|Lost to Follow-up|0
4676702|NCT02633501|16095504|P2|Overall Study|Lost to Follow-up|0
4676703|NCT02633501|16095505|P1|Overall Study|Lost to Follow-up|0
4676704|NCT02633501|16095500|P6|Overall Study|Various other reasons|11
4676705|NCT02633501|16095501|P5|Overall Study|Various other reasons|7
4676706|NCT02633501|16095502|P4|Overall Study|Various other reasons|1
4676707|NCT02633501|16095503|P3|Overall Study|Various other reasons|4
4676708|NCT02633501|16095504|P2|Overall Study|Various other reasons|2
4676709|NCT02633501|16095505|P1|Overall Study|Various other reasons|0
4676710|NCT02633501|16095500|P6|Overall Study|Withdrawal by Subject|3
4676711|NCT02633501|16095501|P5|Overall Study|Withdrawal by Subject|1
4676712|NCT02633501|16095502|P4|Overall Study|Withdrawal by Subject|2
4676713|NCT02633501|16095503|P3|Overall Study|Withdrawal by Subject|2
4676714|NCT02633501|16095504|P2|Overall Study|Withdrawal by Subject|1
4676715|NCT02633501|16095505|P1|Overall Study|Withdrawal by Subject|2
4676716|NCT02633501|16095500|P6|Overall Study|Adverse Event|1
4676717|NCT02633501|16095501|P5|Overall Study|Adverse Event|1
4676718|NCT02633501|16095502|P4|Overall Study|Adverse Event|0
4676719|NCT02633501|16095503|P3|Overall Study|Adverse Event|1
4676720|NCT02633501|16095504|P2|Overall Study|Adverse Event|0
4676721|NCT02633501|16095505|P1|Overall Study|Adverse Event|0
4676722|NCT02633215|16095567|P2|Overall Study|Lost to Follow-up|3
4676723|NCT02633215|16095568|P1|Overall Study|Lost to Follow-up|2
4676724|NCT02633020|16095580|P2|Overall Study|Adverse Event|0
4676725|NCT02633020|16095581|P1|Overall Study|Adverse Event|1
4676726|NCT02632838|16095605|P2|Overall Study|Lost to Follow-up|2
4676727|NCT02632838|16095606|P1|Overall Study|Lost to Follow-up|0
4676728|NCT02632838|16095605|P2|Overall Study|Withdrawal by Subject|0
4676729|NCT02632838|16095606|P1|Overall Study|Withdrawal by Subject|3
4676730|NCT02632786|16095643|P2|Overall Study|Withdrawal by Subject|0
4676731|NCT02632786|16095644|P1|Overall Study|Withdrawal by Subject|1
4676732|NCT02632786|16095643|P2|Overall Study|Physician Decision|4
4676733|NCT02632786|16095644|P1|Overall Study|Physician Decision|5
4676734|NCT02632786|16095643|P2|Overall Study|Death|2
4676735|NCT02632786|16095644|P1|Overall Study|Death|3
4676736|NCT02632786|16095643|P2|Overall Study|Adverse Event|1
4676737|NCT02632786|16095644|P1|Overall Study|Adverse Event|2
4676738|NCT02632747|16095664|P2|Wash-out Period|Adverse Event|0
4676739|NCT02632747|16095665|P1|Wash-out Period|Adverse Event|1
4676740|NCT02632110|16095865|P10|Overall Study|Withdrawal by Subject|1
4676741|NCT02632110|16095866|P9|Overall Study|Withdrawal by Subject|1
4676742|NCT02632110|16095867|P8|Overall Study|Withdrawal by Subject|3
4676743|NCT02632110|16095868|P7|Overall Study|Withdrawal by Subject|3
4676744|NCT02632110|16095869|P6|Overall Study|Withdrawal by Subject|1
4676745|NCT02632110|16095870|P5|Overall Study|Withdrawal by Subject|1
4676746|NCT02632110|16095871|P4|Overall Study|Withdrawal by Subject|0
4676747|NCT02632110|16095872|P3|Overall Study|Withdrawal by Subject|0
4676748|NCT02632110|16095873|P2|Overall Study|Withdrawal by Subject|1
4676749|NCT02632110|16095874|P1|Overall Study|Withdrawal by Subject|1
4676750|NCT02631876|16096364|P2|Overall Study|Other than specified|4
4676751|NCT02631876|16096365|P1|Overall Study|Other than specified|4
4676752|NCT02631876|16096364|P2|Overall Study|Withdrawal by Subject|9
4676753|NCT02631876|16096365|P1|Overall Study|Withdrawal by Subject|16
4676754|NCT02631876|16096364|P2|Overall Study|Lost to Follow-up|0
4676755|NCT02631876|16096365|P1|Overall Study|Lost to Follow-up|2
4676756|NCT02631876|16096364|P2|Overall Study|Investigator's discretion|0
4676757|NCT02631876|16096365|P1|Overall Study|Investigator's discretion|1
4676758|NCT02631876|16096364|P2|Overall Study|Death|50
4676759|NCT02631876|16096365|P1|Overall Study|Death|96
4676760|NCT02631746|16096441|P1|Overall Study|Lack of Efficacy|3
4676761|NCT02631577|16096454|P2|Overall Study|Withdrawal by Subject|1
4676762|NCT02631577|16096455|P1|Overall Study|Withdrawal by Subject|0
4676763|NCT02631577|16096454|P2|Overall Study|Death|3
4676764|NCT02631577|16096455|P1|Overall Study|Death|1
4676765|NCT02631551|16096473|P4|Overall Study|Other, specific reasons not collected|2
4676766|NCT02631551|16096474|P3|Overall Study|Other, specific reasons not collected|2
4676767|NCT02631551|16096475|P2|Overall Study|Other, specific reasons not collected|7
4676768|NCT02631551|16096476|P1|Overall Study|Other, specific reasons not collected|5
4676769|NCT02631551|16096473|P4|Overall Study|Non-compliance with study drug|0
4676770|NCT02631551|16096474|P3|Overall Study|Non-compliance with study drug|0
4676771|NCT02631551|16096475|P2|Overall Study|Non-compliance with study drug|0
4676772|NCT02631551|16096476|P1|Overall Study|Non-compliance with study drug|1
4676773|NCT02631551|16096473|P4|Overall Study|Non-compliance with study procedures|1
4676774|NCT02631551|16096474|P3|Overall Study|Non-compliance with study procedures|1
4676775|NCT02631551|16096475|P2|Overall Study|Non-compliance with study procedures|0
4676776|NCT02631551|16096476|P1|Overall Study|Non-compliance with study procedures|0
4676777|NCT02631551|16096473|P4|Overall Study|Protocol deviation|0
4676778|NCT02631551|16096474|P3|Overall Study|Protocol deviation|3
4676779|NCT02631551|16096475|P2|Overall Study|Protocol deviation|6
4676780|NCT02631551|16096476|P1|Overall Study|Protocol deviation|3
4676781|NCT02631551|16096473|P4|Overall Study|Withdrawal by Subject|5
4676782|NCT02631551|16096474|P3|Overall Study|Withdrawal by Subject|0
4676783|NCT02631551|16096475|P2|Overall Study|Withdrawal by Subject|2
4676784|NCT02631551|16096476|P1|Overall Study|Withdrawal by Subject|2
4676785|NCT02631551|16096473|P4|Overall Study|Lost to Follow-up|3
4676786|NCT02631551|16096474|P3|Overall Study|Lost to Follow-up|0
4676787|NCT02631551|16096475|P2|Overall Study|Lost to Follow-up|2
4676788|NCT02631551|16096476|P1|Overall Study|Lost to Follow-up|1
4676789|NCT02631551|16096473|P4|Overall Study|Lack of Efficacy|0
4676790|NCT02631551|16096474|P3|Overall Study|Lack of Efficacy|1
4676791|NCT02631551|16096475|P2|Overall Study|Lack of Efficacy|0
4676792|NCT02631551|16096476|P1|Overall Study|Lack of Efficacy|0
4676793|NCT02631551|16096473|P4|Overall Study|Adverse Event|0
4676794|NCT02631551|16096474|P3|Overall Study|Adverse Event|4
4676795|NCT02631551|16096475|P2|Overall Study|Adverse Event|2
4676796|NCT02631551|16096476|P1|Overall Study|Adverse Event|1
4676797|NCT02631070|16096497|P2|Overall Study|Miscellaneous|10
4676798|NCT02631070|16096498|P1|Overall Study|Miscellaneous|4
4676799|NCT02631070|16096497|P2|Overall Study|Progressive Disease|2
4676800|NCT02631070|16096498|P1|Overall Study|Progressive Disease|6
4676801|NCT02631070|16096497|P2|Overall Study|Protocol Violation|0
4676802|NCT02631070|16096498|P1|Overall Study|Protocol Violation|2
4676803|NCT02631070|16096497|P2|Overall Study|Withdrawal by Subject|10
4676804|NCT02631070|16096498|P1|Overall Study|Withdrawal by Subject|17
4676805|NCT02631070|16096497|P2|Overall Study|Lack of Efficacy|50
4676806|NCT02631070|16096498|P1|Overall Study|Lack of Efficacy|68
4676807|NCT02631070|16096497|P2|Overall Study|Adverse Event|4
4676808|NCT02631070|16096498|P1|Overall Study|Adverse Event|15
4676809|NCT02630966|16096592|P2|Overall Study|Lack of Efficacy|2
4676810|NCT02630966|16096593|P1|Overall Study|Lack of Efficacy|0
4676811|NCT02630966|16096592|P2|Overall Study|Voluntary Withdrawal|1
4676812|NCT02630966|16096593|P1|Overall Study|Voluntary Withdrawal|1
4676813|NCT02630966|16096592|P2|Overall Study|Significant Protocol Deviation|2
4676814|NCT02630966|16096593|P1|Overall Study|Significant Protocol Deviation|0
4676815|NCT02630966|16096592|P2|Overall Study|Adverse Event|3
4676816|NCT02630966|16096593|P1|Overall Study|Adverse Event|1
4676817|NCT02630706|16096621|P3|Overall Study|Withdrawal by Subject|7
4676818|NCT02630706|16096622|P2|Overall Study|Withdrawal by Subject|5
4676819|NCT02630706|16096623|P1|Overall Study|Withdrawal by Subject|4
4676820|NCT02630706|16096621|P3|Overall Study|Pregnancy|0
4676821|NCT02630706|16096622|P2|Overall Study|Pregnancy|1
4676822|NCT02630706|16096623|P1|Overall Study|Pregnancy|0
4676823|NCT02630706|16096621|P3|Overall Study|Physician Decision|0
4676824|NCT02630706|16096622|P2|Overall Study|Physician Decision|1
4676825|NCT02630706|16096623|P1|Overall Study|Physician Decision|1
4676826|NCT02630706|16096621|P3|Overall Study|Lost to Follow-up|2
4676827|NCT02630706|16096622|P2|Overall Study|Lost to Follow-up|1
4676828|NCT02630706|16096623|P1|Overall Study|Lost to Follow-up|0
4676829|NCT02630706|16096621|P3|Overall Study|Adverse Event|1
4676830|NCT02630706|16096622|P2|Overall Study|Adverse Event|1
4676831|NCT02630706|16096623|P1|Overall Study|Adverse Event|2
4676832|NCT02630693|16096732|P2|Overall Study|No receive treatment|1
4676833|NCT02630693|16096733|P1|Overall Study|No receive treatment|0
4676834|NCT02630563|16096745|P1|Overall Study|Administrative|1
4676835|NCT02630472|16096756|P2|Overall Study|Physician Decision|0
4676836|NCT02630472|16096757|P1|Overall Study|Physician Decision|10
4676837|NCT02630459|16096775|P4|Overall Study|Subject missed week 24 assessment|0
4676838|NCT02630459|16096776|P3|Overall Study|Subject missed week 24 assessment|0
4676839|NCT02630459|16096777|P2|Overall Study|Subject missed week 24 assessment|0
4676840|NCT02630459|16096778|P1|Overall Study|Subject missed week 24 assessment|1
4676841|NCT02630459|16096775|P4|Overall Study|Withdrawal by Subject|1
4676842|NCT02630459|16096776|P3|Overall Study|Withdrawal by Subject|4
4676843|NCT02630459|16096777|P2|Overall Study|Withdrawal by Subject|1
4676844|NCT02630459|16096778|P1|Overall Study|Withdrawal by Subject|2
4676845|NCT02630459|16096775|P4|Overall Study|Sponsor decision|0
4676846|NCT02630459|16096776|P3|Overall Study|Sponsor decision|1
4676847|NCT02630459|16096777|P2|Overall Study|Sponsor decision|0
4676848|NCT02630459|16096778|P1|Overall Study|Sponsor decision|0
4676849|NCT02630459|16096775|P4|Overall Study|Protocol-specified criteria|2
4676850|NCT02630459|16096776|P3|Overall Study|Protocol-specified criteria|0
4676851|NCT02630459|16096777|P2|Overall Study|Protocol-specified criteria|1
4676852|NCT02630459|16096778|P1|Overall Study|Protocol-specified criteria|0
4676853|NCT02630251|16096800|P4|Overall Study|Physician Decision|0
4676854|NCT02630251|16096801|P3|Overall Study|Physician Decision|1
4676855|NCT02630251|16096802|P2|Overall Study|Physician Decision|0
4676856|NCT02630251|16096803|P1|Overall Study|Physician Decision|0
4676857|NCT02630186|16096917|P1|Overall Study|Withdrawal by Subject|1
4676858|NCT02629965|16096933|P2|Period 2|Adverse Event|0
4676859|NCT02629965|16096934|P1|Period 2|Adverse Event|1
4676860|NCT02629965|16096933|P2|Period 1|Other than listed above|2
4676861|NCT02629965|16096934|P1|Period 1|Other than listed above|1
4676862|NCT02629965|16096933|P2|Period 1|Unexpected worsening of disease|0
4676863|NCT02629965|16096934|P1|Period 1|Unexpected worsening of disease|2
4676864|NCT02629965|16096933|P2|Period 1|Adverse Event|0
4676865|NCT02629965|16096934|P1|Period 1|Adverse Event|1
4676866|NCT02629861|16096973|P3|Overall Study|Pregnancy|0
4676867|NCT02629861|16096974|P2|Overall Study|Pregnancy|1
4676868|NCT02629861|16096975|P1|Overall Study|Pregnancy|2
4676869|NCT02629861|16096973|P3|Overall Study|Other|0
4676870|NCT02629861|16096974|P2|Overall Study|Other|1
4676871|NCT02629861|16096975|P1|Overall Study|Other|1
4676872|NCT02629861|16096973|P3|Overall Study|Lost to Follow-up|4
4676873|NCT02629861|16096974|P2|Overall Study|Lost to Follow-up|9
4676874|NCT02629861|16096975|P1|Overall Study|Lost to Follow-up|12
4676875|NCT02629861|16096973|P3|Overall Study|Protocol Violation|7
4676876|NCT02629861|16096974|P2|Overall Study|Protocol Violation|3
4676877|NCT02629861|16096975|P1|Overall Study|Protocol Violation|2
4676878|NCT02629861|16096973|P3|Overall Study|Withdrawal by Subject|13
4676879|NCT02629861|16096974|P2|Overall Study|Withdrawal by Subject|8
4676880|NCT02629861|16096975|P1|Overall Study|Withdrawal by Subject|5
4676881|NCT02629861|16096973|P3|Overall Study|Adverse Event|4
4676882|NCT02629861|16096974|P2|Overall Study|Adverse Event|5
4676883|NCT02629861|16096975|P1|Overall Study|Adverse Event|7
4676884|NCT02629822|16097022|P1|Extension Study|Extension Period is Ongoing|6
4676885|NCT02629822|16097022|P1|Base Study|Non-Compliance With Study Drug|1
4676886|NCT02629822|16097022|P1|Base Study|Lost to Follow-up|2
4676887|NCT02629159|16097064|P3|Overall Study|Other|8
4676888|NCT02629159|16097065|P2|Overall Study|Other|4
4676889|NCT02629159|16097066|P1|Overall Study|Other|6
4676890|NCT02629159|16097064|P3|Overall Study|Lack of Efficacy|1
4676891|NCT02629159|16097065|P2|Overall Study|Lack of Efficacy|0
4676892|NCT02629159|16097066|P1|Overall Study|Lack of Efficacy|4
4676893|NCT02629159|16097064|P3|Overall Study|Lost to Follow-up|5
4676894|NCT02629159|16097065|P2|Overall Study|Lost to Follow-up|4
4676895|NCT02629159|16097066|P1|Overall Study|Lost to Follow-up|7
4676896|NCT02629159|16097064|P3|Overall Study|Withdrawal by Subject|15
4676897|NCT02629159|16097065|P2|Overall Study|Withdrawal by Subject|11
4676898|NCT02629159|16097066|P1|Overall Study|Withdrawal by Subject|22
4676899|NCT02629159|16097064|P3|Overall Study|Adverse Event|22
4676900|NCT02629159|16097065|P2|Overall Study|Adverse Event|20
4676901|NCT02629159|16097066|P1|Overall Study|Adverse Event|17
4676902|NCT02629133|16097118|P2|Overall Study|Withdrawal by Subject|1
4676903|NCT02629133|16097119|P1|Overall Study|Withdrawal by Subject|1
4676904|NCT02629133|16097118|P2|Overall Study|Lost to Follow-up|1
4676905|NCT02629133|16097119|P1|Overall Study|Lost to Follow-up|3
4676906|NCT02628938|16097162|P3|Overall Study|Failure to comply with the instructions|3
4676907|NCT02628938|16097163|P2|Overall Study|Failure to comply with the instructions|0
4676908|NCT02628938|16097164|P1|Overall Study|Failure to comply with the instructions|3
4676909|NCT02628938|16097162|P3|Overall Study|Did not attend the follow up recall|1
4676910|NCT02628938|16097163|P2|Overall Study|Did not attend the follow up recall|2
4676911|NCT02628938|16097164|P1|Overall Study|Did not attend the follow up recall|2
4676912|NCT02628873|16097180|P2|Second Test (1 Hour)|Physician Decision|0
4676913|NCT02628873|16097181|P1|Second Test (1 Hour)|Physician Decision|1
4676914|NCT02628873|16097180|P2|Break (1 Hour)|Withdrawal by Subject|1
4676915|NCT02628873|16097181|P1|Break (1 Hour)|Withdrawal by Subject|0
4676916|NCT02628769|16097191|P2|Second Intervention|Physician Decision|1
4676917|NCT02628769|16097192|P1|Second Intervention|Physician Decision|0
4676918|NCT02628769|16097191|P2|Second Intervention|Adverse Event|0
4676919|NCT02628769|16097192|P1|Second Intervention|Adverse Event|2
4676920|NCT02628769|16097191|P2|First Intervention|Withdrawal by Subject|1
4676921|NCT02628769|16097192|P1|First Intervention|Withdrawal by Subject|0
4676922|NCT02628769|16097191|P2|First Intervention|Adverse Event|0
4676923|NCT02628769|16097192|P1|First Intervention|Adverse Event|1
4676924|NCT02628743|16097230|P1|Overall Study|Physician Decision|2
4676925|NCT02628743|16097230|P1|Overall Study|Study Terminated by Sponsor|76
4676926|NCT02628743|16097230|P1|Overall Study|Withdrawal by Subject|50
4676927|NCT02628743|16097230|P1|Overall Study|Other|3
4676928|NCT02628600|16097256|P2|Overall Study|Other not specified|0
4676929|NCT02628600|16097257|P1|Overall Study|Other not specified|1
4676930|NCT02628600|16097256|P2|Overall Study|Physician Decision|2
4676931|NCT02628600|16097257|P1|Overall Study|Physician Decision|2
4676932|NCT02628600|16097256|P2|Overall Study|Lost to Follow-up|0
4676933|NCT02628600|16097257|P1|Overall Study|Lost to Follow-up|1
4676934|NCT02628600|16097256|P2|Overall Study|Withdrawal by Subject|8
4676935|NCT02628600|16097257|P1|Overall Study|Withdrawal by Subject|13
4676936|NCT02628600|16097256|P2|Overall Study|Lack of Efficacy|0
4676937|NCT02628600|16097257|P1|Overall Study|Lack of Efficacy|2
4676938|NCT02628600|16097256|P2|Overall Study|Protocol Violation|1
4676939|NCT02628600|16097257|P1|Overall Study|Protocol Violation|0
4676940|NCT02628600|16097256|P2|Overall Study|Adverse Event|20
4676941|NCT02628600|16097257|P1|Overall Study|Adverse Event|3
4676942|NCT02628600|16097256|P2|Overall Study|Death|1
4676943|NCT02628600|16097257|P1|Overall Study|Death|2
4676944|NCT02628418|16097271|P2|Overall Study|Lost to Follow-up|2
4676945|NCT02628418|16097272|P1|Overall Study|Lost to Follow-up|1
4676946|NCT02628028|16097363|P8|Long-term Extension (LTE) Period|Other|3
4676947|NCT02628028|16097364|P7|Long-term Extension (LTE) Period|Other|4
4676948|NCT02628028|16097365|P6|Long-term Extension (LTE) Period|Other|3
4676949|NCT02628028|16097366|P5|Long-term Extension (LTE) Period|Other|0
4676950|NCT02628028|16097367|P4|Long-term Extension (LTE) Period|Other|0
4676951|NCT02628028|16097368|P3|Long-term Extension (LTE) Period|Other|0
4676952|NCT02628028|16097369|P2|Long-term Extension (LTE) Period|Other|0
4676953|NCT02628028|16097370|P1|Long-term Extension (LTE) Period|Other|0
4676954|NCT02628028|16097363|P8|Long-term Extension (LTE) Period|Withdrawal by Subject|3
4676955|NCT02628028|16097364|P7|Long-term Extension (LTE) Period|Withdrawal by Subject|3
4676956|NCT02628028|16097365|P6|Long-term Extension (LTE) Period|Withdrawal by Subject|2
4676957|NCT02628028|16097366|P5|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4676958|NCT02628028|16097367|P4|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4676959|NCT02628028|16097368|P3|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4676960|NCT02628028|16097369|P2|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4676961|NCT02628028|16097370|P1|Long-term Extension (LTE) Period|Withdrawal by Subject|0
4676962|NCT02628028|16097363|P8|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
4676963|NCT02628028|16097364|P7|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51
4676964|NCT02628028|16097365|P6|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52
4676965|NCT02628028|16097366|P5|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4676966|NCT02628028|16097367|P4|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4676967|NCT02628028|16097368|P3|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4676968|NCT02628028|16097369|P2|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4676969|NCT02628028|16097370|P1|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0
4676970|NCT02628028|16097363|P8|Long-term Extension (LTE) Period|Lack of Efficacy|1
4676971|NCT02628028|16097364|P7|Long-term Extension (LTE) Period|Lack of Efficacy|0
4676972|NCT02628028|16097365|P6|Long-term Extension (LTE) Period|Lack of Efficacy|2
4676973|NCT02628028|16097366|P5|Long-term Extension (LTE) Period|Lack of Efficacy|0
4676974|NCT02628028|16097367|P4|Long-term Extension (LTE) Period|Lack of Efficacy|0
4676975|NCT02628028|16097368|P3|Long-term Extension (LTE) Period|Lack of Efficacy|0
4676976|NCT02628028|16097369|P2|Long-term Extension (LTE) Period|Lack of Efficacy|0
4676977|NCT02628028|16097370|P1|Long-term Extension (LTE) Period|Lack of Efficacy|0
4676978|NCT02628028|16097363|P8|Long-term Extension (LTE) Period|Adverse Event|3
4676979|NCT02628028|16097364|P7|Long-term Extension (LTE) Period|Adverse Event|0
4676980|NCT02628028|16097365|P6|Long-term Extension (LTE) Period|Adverse Event|1
4676981|NCT02628028|16097366|P5|Long-term Extension (LTE) Period|Adverse Event|0
4676982|NCT02628028|16097367|P4|Long-term Extension (LTE) Period|Adverse Event|0
4676983|NCT02628028|16097368|P3|Long-term Extension (LTE) Period|Adverse Event|0
4676984|NCT02628028|16097369|P2|Long-term Extension (LTE) Period|Adverse Event|0
4676985|NCT02628028|16097370|P1|Long-term Extension (LTE) Period|Adverse Event|0
4676986|NCT02628028|16097363|P8|Dosing Period|Other|4
4676987|NCT02628028|16097364|P7|Dosing Period|Other|2
4676988|NCT02628028|16097365|P6|Dosing Period|Other|1
4676989|NCT02628028|16097366|P5|Dosing Period|Other|2
4676990|NCT02628028|16097367|P4|Dosing Period|Other|0
4676991|NCT02628028|16097368|P3|Dosing Period|Other|0
4676992|NCT02628028|16097369|P2|Dosing Period|Other|0
4676993|NCT02628028|16097370|P1|Dosing Period|Other|0
4676994|NCT02628028|16097363|P8|Dosing Period|Lost to Follow-up|0
4676995|NCT02628028|16097364|P7|Dosing Period|Lost to Follow-up|1
4676996|NCT02628028|16097365|P6|Dosing Period|Lost to Follow-up|0
4676997|NCT02628028|16097366|P5|Dosing Period|Lost to Follow-up|0
4676998|NCT02628028|16097367|P4|Dosing Period|Lost to Follow-up|0
4676999|NCT02628028|16097368|P3|Dosing Period|Lost to Follow-up|0
4677000|NCT02628028|16097369|P2|Dosing Period|Lost to Follow-up|0
4677001|NCT02628028|16097370|P1|Dosing Period|Lost to Follow-up|0
4677002|NCT02628028|16097363|P8|Dosing Period|Site Terminated by Sponsor|0
4677003|NCT02628028|16097364|P7|Dosing Period|Site Terminated by Sponsor|1
4677004|NCT02628028|16097365|P6|Dosing Period|Site Terminated by Sponsor|1
4677005|NCT02628028|16097366|P5|Dosing Period|Site Terminated by Sponsor|0
4677006|NCT02628028|16097367|P4|Dosing Period|Site Terminated by Sponsor|0
4677007|NCT02628028|16097368|P3|Dosing Period|Site Terminated by Sponsor|0
4677008|NCT02628028|16097369|P2|Dosing Period|Site Terminated by Sponsor|0
4677009|NCT02628028|16097370|P1|Dosing Period|Site Terminated by Sponsor|0
4677010|NCT02628028|16097363|P8|Dosing Period|Physician Decision|0
4677011|NCT02628028|16097364|P7|Dosing Period|Physician Decision|0
4677012|NCT02628028|16097365|P6|Dosing Period|Physician Decision|1
4677013|NCT02628028|16097366|P5|Dosing Period|Physician Decision|0
4677014|NCT02628028|16097367|P4|Dosing Period|Physician Decision|0
4677015|NCT02628028|16097368|P3|Dosing Period|Physician Decision|0
4677016|NCT02628028|16097369|P2|Dosing Period|Physician Decision|0
4677017|NCT02628028|16097370|P1|Dosing Period|Physician Decision|0
4677018|NCT02628028|16097363|P8|Dosing Period|Study Terminated by Sponsor|7
4677019|NCT02628028|16097364|P7|Dosing Period|Study Terminated by Sponsor|7
4677020|NCT02628028|16097365|P6|Dosing Period|Study Terminated by Sponsor|6
4677021|NCT02628028|16097366|P5|Dosing Period|Study Terminated by Sponsor|7
4677022|NCT02628028|16097367|P4|Dosing Period|Study Terminated by Sponsor|0
4677023|NCT02628028|16097368|P3|Dosing Period|Study Terminated by Sponsor|0
4677024|NCT02628028|16097369|P2|Dosing Period|Study Terminated by Sponsor|0
4677025|NCT02628028|16097370|P1|Dosing Period|Study Terminated by Sponsor|0
4677026|NCT02628028|16097363|P8|Dosing Period|Lack of Efficacy|0
4677027|NCT02628028|16097364|P7|Dosing Period|Lack of Efficacy|1
4677028|NCT02628028|16097365|P6|Dosing Period|Lack of Efficacy|0
4677029|NCT02628028|16097366|P5|Dosing Period|Lack of Efficacy|3
4677030|NCT02628028|16097367|P4|Dosing Period|Lack of Efficacy|0
4677031|NCT02628028|16097368|P3|Dosing Period|Lack of Efficacy|0
4677032|NCT02628028|16097369|P2|Dosing Period|Lack of Efficacy|0
4677033|NCT02628028|16097370|P1|Dosing Period|Lack of Efficacy|0
4677034|NCT02628028|16097363|P8|Dosing Period|Death|1
4677035|NCT02628028|16097364|P7|Dosing Period|Death|0
4677036|NCT02628028|16097365|P6|Dosing Period|Death|0
4677037|NCT02628028|16097366|P5|Dosing Period|Death|0
4677038|NCT02628028|16097367|P4|Dosing Period|Death|0
4677039|NCT02628028|16097368|P3|Dosing Period|Death|0
4677040|NCT02628028|16097369|P2|Dosing Period|Death|0
4677041|NCT02628028|16097370|P1|Dosing Period|Death|0
4677042|NCT02628028|16097363|P8|Dosing Period|Adverse Event|2
4677043|NCT02628028|16097364|P7|Dosing Period|Adverse Event|3
4677044|NCT02628028|16097365|P6|Dosing Period|Adverse Event|1
4677045|NCT02628028|16097366|P5|Dosing Period|Adverse Event|2
4677046|NCT02628028|16097367|P4|Dosing Period|Adverse Event|0
4677047|NCT02628028|16097368|P3|Dosing Period|Adverse Event|0
4677048|NCT02628028|16097369|P2|Dosing Period|Adverse Event|0
4677049|NCT02628028|16097370|P1|Dosing Period|Adverse Event|0
4677050|NCT02628028|16097363|P8|Dosing Period|Withdrawal by Subject|1
4677051|NCT02628028|16097364|P7|Dosing Period|Withdrawal by Subject|1
4677052|NCT02628028|16097365|P6|Dosing Period|Withdrawal by Subject|4
4677053|NCT02628028|16097366|P5|Dosing Period|Withdrawal by Subject|2
4677054|NCT02628028|16097367|P4|Dosing Period|Withdrawal by Subject|0
4677055|NCT02628028|16097368|P3|Dosing Period|Withdrawal by Subject|1
4677056|NCT02628028|16097369|P2|Dosing Period|Withdrawal by Subject|0
4677057|NCT02628028|16097370|P1|Dosing Period|Withdrawal by Subject|0
4677058|NCT02627144|16097455|P1|Overall Study|Other|17
4677059|NCT02627144|16097455|P1|Overall Study|Enrolled, not treated|6
4677060|NCT02627144|16097455|P1|Overall Study|Lost to Follow-up|8
4677061|NCT02627144|16097455|P1|Overall Study|Administrative reasons|65
4677062|NCT02627144|16097455|P1|Overall Study|Refusal of treatment / poor cooperation|38
4677063|NCT02627144|16097455|P1|Overall Study|Death from other cause|8
4677064|NCT02627144|16097455|P1|Overall Study|Death from cancer|20
4677065|NCT02627144|16097455|P1|Overall Study|Cancer progression|171
4677066|NCT02627144|16097455|P1|Overall Study|Serious adverse event|32
4677067|NCT02626819|16097496|P2|Overall Study|Diagnosed w/ catastrophic illness|1
4677068|NCT02626819|16097497|P1|Overall Study|Diagnosed w/ catastrophic illness|0
4677069|NCT02626819|16097496|P2|Overall Study|Withdrawal by Subject|0
4677070|NCT02626819|16097497|P1|Overall Study|Withdrawal by Subject|1
4677071|NCT02626819|16097496|P2|Overall Study|Lost to Follow-up|2
4677072|NCT02626819|16097497|P1|Overall Study|Lost to Follow-up|3
4677073|NCT02626780|16097517|P1|Overall Study|Withdrawal by Subject|3
4677074|NCT02626520|16097550|P2|Overall Study|Study terminated|1
4677075|NCT02626520|16097551|P1|Overall Study|Study terminated|0
4677076|NCT02626520|16097550|P2|Overall Study|Did not start protocol therapy|2
4677077|NCT02626520|16097551|P1|Overall Study|Did not start protocol therapy|0
4677078|NCT02626520|16097550|P2|Overall Study|Lack of Efficacy|2
4677079|NCT02626520|16097551|P1|Overall Study|Lack of Efficacy|0
4677080|NCT02626520|16097550|P2|Overall Study|Adverse Event|4
4677081|NCT02626520|16097551|P1|Overall Study|Adverse Event|0
4677082|NCT02626520|16097550|P2|Overall Study|Physician Decision|1
4677083|NCT02626520|16097551|P1|Overall Study|Physician Decision|1
4677084|NCT02626182|16097563|P2|Overall Study|Adverse Event|0
4677085|NCT02626182|16097564|P1|Overall Study|Adverse Event|2
4677086|NCT02626026|16097580|P6|Overall Study|Randomized but Never Treated|0
4677087|NCT02626026|16097581|P5|Overall Study|Randomized but Never Treated|1
4677088|NCT02626026|16097582|P4|Overall Study|Randomized but Never Treated|0
4677089|NCT02626026|16097583|P3|Overall Study|Randomized but Never Treated|0
4677090|NCT02626026|16097584|P2|Overall Study|Randomized but Never Treated|0
4677091|NCT02626026|16097585|P1|Overall Study|Randomized but Never Treated|0
4677092|NCT02626000|16097663|P1|Overall Study|Death|23
4677093|NCT02626000|16097663|P1|Overall Study|Continuing Study|13
4677094|NCT02625974|16097677|P2|Overall Study|Protocol Violation|1
4677095|NCT02625974|16097678|P1|Overall Study|Protocol Violation|0
4677096|NCT02625974|16097677|P2|Overall Study|non-compliance with study drug|2
4677097|NCT02625974|16097678|P1|Overall Study|non-compliance with study drug|0
4677098|NCT02625974|16097677|P2|Overall Study|positive parasitemia|0
4677099|NCT02625974|16097678|P1|Overall Study|positive parasitemia|1
4677100|NCT02625974|16097677|P2|Overall Study|Withdrawal by Subject|1
4677101|NCT02625974|16097678|P1|Overall Study|Withdrawal by Subject|3
4677102|NCT02625974|16097677|P2|Overall Study|Adverse Event|2
4677103|NCT02625974|16097678|P1|Overall Study|Adverse Event|12
4677104|NCT02625922|16097788|P2|Overall Study|Systolic blood pressure < 125 mmHg|1
4677105|NCT02625922|16097789|P1|Overall Study|Systolic blood pressure < 125 mmHg|1
4677106|NCT02625922|16097788|P2|Overall Study|Non-availability of IMP|1
4677107|NCT02625922|16097789|P1|Overall Study|Non-availability of IMP|1
4677108|NCT02625623|16097808|P2|Overall Study|Off-Treatment, but follow up ongoing|24
4677109|NCT02625623|16097809|P1|Overall Study|Off-Treatment, but follow up ongoing|30
4677110|NCT02625623|16097808|P2|Overall Study|Still on Treatment|10
4677111|NCT02625623|16097809|P1|Overall Study|Still on Treatment|10
4677112|NCT02625623|16097808|P2|Overall Study|Participants randomized but not treated|1
4677113|NCT02625623|16097809|P1|Overall Study|Participants randomized but not treated|9
4677114|NCT02625324|16097872|P1|12-Month Follow-up Secondary Endpoint|Death|4
4677115|NCT02625324|16097872|P1|6-Month Follow-up Subject Accountability|Lost to Follow-up|1
4677116|NCT02625324|16097872|P1|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2
4677117|NCT02625324|16097872|P1|6-Month Follow-up Subject Accountability|Death|5
4677118|NCT02625324|16097872|P1|30-Day Follow-up for Secondary Endpoint|Death|1
4677119|NCT02625324|16097872|P1|30-Day Follow-up for Primary Endpoint|Death|1
4677120|NCT02625259|16097897|P5|First Intervention (Day 1)|Withdrawal by Subject|0
4677121|NCT02625259|16097898|P4|First Intervention (Day 1)|Withdrawal by Subject|1
4677122|NCT02625259|16097899|P3|First Intervention (Day 1)|Withdrawal by Subject|0
4677123|NCT02625259|16097900|P2|First Intervention (Day 1)|Withdrawal by Subject|0
4677124|NCT02625259|16097901|P1|First Intervention (Day 1)|Withdrawal by Subject|0
4677125|NCT02625259|16097897|P5|First Intervention (Day 1)|Adverse Event|0
4677126|NCT02625259|16097898|P4|First Intervention (Day 1)|Adverse Event|0
4677127|NCT02625259|16097899|P3|First Intervention (Day 1)|Adverse Event|0
4677128|NCT02625259|16097900|P2|First Intervention (Day 1)|Adverse Event|1
4677129|NCT02625259|16097901|P1|First Intervention (Day 1)|Adverse Event|2
4677130|NCT02625259|16097897|P5|First Intervention (Day 1)|Other|0
4677131|NCT02625259|16097898|P4|First Intervention (Day 1)|Other|0
4677132|NCT02625259|16097899|P3|First Intervention (Day 1)|Other|1
4677133|NCT02625259|16097900|P2|First Intervention (Day 1)|Other|0
4677134|NCT02625259|16097901|P1|First Intervention (Day 1)|Other|0
4677135|NCT02625233|16097938|P2|Overall Study|Adverse Event|0
4677136|NCT02625233|16097939|P1|Overall Study|Adverse Event|2
4677137|NCT02625220|16097947|P1|Overall Study|Study discontinued at site|2
4677138|NCT02625220|16097947|P1|Overall Study|Protocol Violation|1
4677139|NCT02625220|16097947|P1|Overall Study|Lost to Follow-up|2
4677140|NCT02625220|16097947|P1|Overall Study|Adverse Event|2
4677141|NCT02624986|16098075|P8|Overall Study|Withdrawal by Subject|1
4677142|NCT02624986|16098076|P7|Overall Study|Withdrawal by Subject|0
4677143|NCT02624986|16098077|P6|Overall Study|Withdrawal by Subject|0
4677144|NCT02624986|16098078|P5|Overall Study|Withdrawal by Subject|0
4677145|NCT02624986|16098079|P4|Overall Study|Withdrawal by Subject|0
4677146|NCT02624986|16098080|P3|Overall Study|Withdrawal by Subject|0
4677147|NCT02624986|16098081|P2|Overall Study|Withdrawal by Subject|0
4677148|NCT02624986|16098082|P1|Overall Study|Withdrawal by Subject|0
4677149|NCT02624986|16098075|P8|Overall Study|Protocol Violation|0
4677150|NCT02624986|16098076|P7|Overall Study|Protocol Violation|0
4677151|NCT02624986|16098077|P6|Overall Study|Protocol Violation|0
4677152|NCT02624986|16098078|P5|Overall Study|Protocol Violation|0
4677153|NCT02624986|16098079|P4|Overall Study|Protocol Violation|0
4677154|NCT02624986|16098080|P3|Overall Study|Protocol Violation|0
4677155|NCT02624986|16098081|P2|Overall Study|Protocol Violation|0
4677156|NCT02624986|16098082|P1|Overall Study|Protocol Violation|1
4677157|NCT02624986|16098075|P8|Overall Study|Progressive Disease|0
4677158|NCT02624986|16098076|P7|Overall Study|Progressive Disease|0
4677159|NCT02624986|16098077|P6|Overall Study|Progressive Disease|0
4677160|NCT02624986|16098078|P5|Overall Study|Progressive Disease|0
4677161|NCT02624986|16098079|P4|Overall Study|Progressive Disease|0
4677162|NCT02624986|16098080|P3|Overall Study|Progressive Disease|0
4677163|NCT02624986|16098081|P2|Overall Study|Progressive Disease|1
4677164|NCT02624986|16098082|P1|Overall Study|Progressive Disease|0
4677165|NCT02624986|16098075|P8|Overall Study|Study Terminated by Sponsor|3
4677166|NCT02624986|16098076|P7|Overall Study|Study Terminated by Sponsor|4
4677167|NCT02624986|16098077|P6|Overall Study|Study Terminated by Sponsor|2
4677168|NCT02624986|16098078|P5|Overall Study|Study Terminated by Sponsor|2
4677169|NCT02624986|16098079|P4|Overall Study|Study Terminated by Sponsor|1
4677170|NCT02624986|16098080|P3|Overall Study|Study Terminated by Sponsor|0
4677171|NCT02624986|16098081|P2|Overall Study|Study Terminated by Sponsor|1
4677172|NCT02624986|16098082|P1|Overall Study|Study Terminated by Sponsor|1
4677173|NCT02624986|16098075|P8|Overall Study|Death|1
4677174|NCT02624986|16098076|P7|Overall Study|Death|0
4677175|NCT02624986|16098077|P6|Overall Study|Death|0
4677176|NCT02624986|16098078|P5|Overall Study|Death|2
4677177|NCT02624986|16098079|P4|Overall Study|Death|2
4677178|NCT02624986|16098080|P3|Overall Study|Death|2
4677179|NCT02624986|16098081|P2|Overall Study|Death|1
4677180|NCT02624986|16098082|P1|Overall Study|Death|0
4677181|NCT02624791|16098272|P6|Overall Study|Withdrawal by Subject|0
4677182|NCT02624791|16098273|P5|Overall Study|Withdrawal by Subject|0
4677183|NCT02624791|16098274|P4|Overall Study|Withdrawal by Subject|0
4677184|NCT02624791|16098275|P3|Overall Study|Withdrawal by Subject|0
4677185|NCT02624791|16098276|P2|Overall Study|Withdrawal by Subject|0
4677186|NCT02624791|16098277|P1|Overall Study|Withdrawal by Subject|2
4677187|NCT02624713|16098284|P2|Overall Study|Lost to Follow-up|0
4677188|NCT02624713|16098285|P1|Overall Study|Lost to Follow-up|14
4677189|NCT02624687|16098309|P2|Overall Study|medical leave from work|1
4677190|NCT02624687|16098310|P1|Overall Study|medical leave from work|0
4677191|NCT02624687|16098309|P2|Overall Study|Withdrawal by Subject|1
4677192|NCT02624687|16098310|P1|Overall Study|Withdrawal by Subject|1
4677193|NCT02624492|16098341|P3|Overall Study|Progressive disease|3
4677194|NCT02624492|16098342|P2|Overall Study|Progressive disease|2
4677195|NCT02624492|16098343|P1|Overall Study|Progressive disease|0
4677196|NCT02624492|16098341|P3|Overall Study|Adverse Event|2
4677197|NCT02624492|16098342|P2|Overall Study|Adverse Event|2
4677198|NCT02624492|16098343|P1|Overall Study|Adverse Event|2
4677199|NCT02624284|16098378|P3|Overall Study|Adverse Event|1
4677200|NCT02624284|16098379|P2|Overall Study|Adverse Event|0
4677201|NCT02624284|16098380|P1|Overall Study|Adverse Event|0
4677202|NCT02624284|16098378|P3|Overall Study|Revealed exclusionary condition|0
4677203|NCT02624284|16098379|P2|Overall Study|Revealed exclusionary condition|2
4677204|NCT02624284|16098380|P1|Overall Study|Revealed exclusionary condition|2
4677205|NCT02624284|16098378|P3|Overall Study|Protocol Violation|7
4677206|NCT02624284|16098379|P2|Overall Study|Protocol Violation|10
4677207|NCT02624284|16098380|P1|Overall Study|Protocol Violation|9
4677208|NCT02624284|16098378|P3|Overall Study|Withdrawal by Subject|3
4677209|NCT02624284|16098379|P2|Overall Study|Withdrawal by Subject|6
4677210|NCT02624284|16098380|P1|Overall Study|Withdrawal by Subject|3
4677211|NCT02624050|16098399|P2|Overall Study|Protocol Violation|0
4677212|NCT02624050|16098400|P1|Overall Study|Protocol Violation|2
4677213|NCT02624050|16098399|P2|Overall Study|Physician Decision|0
4677214|NCT02624050|16098400|P1|Overall Study|Physician Decision|4
4677215|NCT02623959|16098428|P2|Overall Study|Progression|1
4677216|NCT02623959|16098429|P1|Overall Study|Progression|0
4677217|NCT02623725|16098509|P2|Overall Study|Withdrawal by Subject|1
4677218|NCT02623725|16098510|P1|Overall Study|Withdrawal by Subject|7
4677219|NCT02623725|16098509|P2|Overall Study|Serious adverse event|2
4677220|NCT02623725|16098510|P1|Overall Study|Serious adverse event|0
4677221|NCT02623725|16098509|P2|Overall Study|Non compliance with protocol|3
4677222|NCT02623725|16098510|P1|Overall Study|Non compliance with protocol|9
4677223|NCT02623361|16098544|P2|Overall Study|Withdrawal by Subject|1
4677224|NCT02623361|16098545|P1|Overall Study|Withdrawal by Subject|0
4677225|NCT02623361|16098544|P2|Overall Study|Protocol Violation|1
4677226|NCT02623361|16098545|P1|Overall Study|Protocol Violation|0
4677227|NCT02623335|16098584|P2|Overall Study|Protocol Violation|1
4677228|NCT02623335|16098585|P1|Overall Study|Protocol Violation|2
4677229|NCT02623335|16098584|P2|Overall Study|Withdrawal by Subject|5
4677230|NCT02623335|16098585|P1|Overall Study|Withdrawal by Subject|2
4677231|NCT02623335|16098584|P2|Overall Study|Lost to Follow-up|23
4677232|NCT02623335|16098585|P1|Overall Study|Lost to Follow-up|15
4677233|NCT02623335|16098584|P2|Overall Study|Death|7
4677234|NCT02623335|16098585|P1|Overall Study|Death|8
4677235|NCT02623322|16098612|P3|Overall Study|Lost to Follow-up|0
4677236|NCT02623322|16098613|P2|Overall Study|Lost to Follow-up|1
4677237|NCT02623322|16098614|P1|Overall Study|Lost to Follow-up|2
4677238|NCT02623218|16098652|P5|Overall Study|Lost to Follow-up|0
4677239|NCT02623218|16098653|P4|Overall Study|Lost to Follow-up|0
4677240|NCT02623218|16098654|P3|Overall Study|Lost to Follow-up|0
4677241|NCT02623218|16098655|P2|Overall Study|Lost to Follow-up|1
4677242|NCT02623218|16098656|P1|Overall Study|Lost to Follow-up|0
4677243|NCT02622828|16098678|P1|Overall Study|participant withdrew|3
4677244|NCT02622724|16098685|P2|Overall Study|Early termination of study|43
4677245|NCT02622724|16098686|P1|Overall Study|Early termination of study|38
4677246|NCT02622724|16098685|P2|Overall Study|Lost to Follow-UP, withdrawal of consent|7
4677247|NCT02622724|16098686|P1|Overall Study|Lost to Follow-UP, withdrawal of consent|4
4677248|NCT02622724|16098685|P2|Overall Study|Death|53
4677249|NCT02622724|16098686|P1|Overall Study|Death|51
4677250|NCT02622568|16098764|P2|Overall Study|Lost to Follow-up|5
4677251|NCT02622568|16098765|P1|Overall Study|Lost to Follow-up|5
4677252|NCT02622321|16098775|P4|Overall Study|Withdrawal by Subject|0
4677253|NCT02622321|16098776|P3|Overall Study|Withdrawal by Subject|0
4677254|NCT02622321|16098777|P2|Overall Study|Withdrawal by Subject|0
4677255|NCT02622321|16098778|P1|Overall Study|Withdrawal by Subject|1
4677256|NCT02622321|16098775|P4|Overall Study|Ongoing treatment with emicizumab|7
4677257|NCT02622321|16098776|P3|Overall Study|Ongoing treatment with emicizumab|49
4677258|NCT02622321|16098777|P2|Overall Study|Ongoing treatment with emicizumab|13
4677259|NCT02622321|16098778|P1|Overall Study|Ongoing treatment with emicizumab|31
4677260|NCT02622321|16098775|P4|Overall Study|Ongoing in safety follow-up|0
4677261|NCT02622321|16098776|P3|Overall Study|Ongoing in safety follow-up|0
4677262|NCT02622321|16098777|P2|Overall Study|Ongoing in safety follow-up|0
4677263|NCT02622321|16098778|P1|Overall Study|Ongoing in safety follow-up|3
4677264|NCT02622321|16098775|P4|Overall Study|Ongoing treatment with no emicizumab|0
4677265|NCT02622321|16098776|P3|Overall Study|Ongoing treatment with no emicizumab|0
4677266|NCT02622321|16098777|P2|Overall Study|Ongoing treatment with no emicizumab|5
4677267|NCT02622321|16098778|P1|Overall Study|Ongoing treatment with no emicizumab|0
4677268|NCT02622113|16098849|P2|Overall Study|Stopping Criteria|3
4677269|NCT02622113|16098850|P1|Overall Study|Stopping Criteria|1
4677270|NCT02622113|16098849|P2|Overall Study|Withdrawal by Subject|2
4677271|NCT02622113|16098850|P1|Overall Study|Withdrawal by Subject|0
4677272|NCT02622113|16098849|P2|Overall Study|Physician Decision|1
4677273|NCT02622113|16098850|P1|Overall Study|Physician Decision|0
4677274|NCT02622113|16098849|P2|Overall Study|Adverse Event|4
4677275|NCT02622113|16098850|P1|Overall Study|Adverse Event|4
4677276|NCT02622074|16098868|P6|Overall Study|Withdrawal by Subject|0
4677277|NCT02622074|16098869|P5|Overall Study|Withdrawal by Subject|0
4677278|NCT02622074|16098870|P4|Overall Study|Withdrawal by Subject|0
4677279|NCT02622074|16098871|P3|Overall Study|Withdrawal by Subject|0
4677280|NCT02622074|16098872|P2|Overall Study|Withdrawal by Subject|1
4677281|NCT02622074|16098873|P1|Overall Study|Withdrawal by Subject|0
4677282|NCT02622074|16098868|P6|Overall Study|Death|0
4677283|NCT02622074|16098869|P5|Overall Study|Death|1
4677284|NCT02622074|16098870|P4|Overall Study|Death|1
4677285|NCT02622074|16098871|P3|Overall Study|Death|0
4677286|NCT02622074|16098872|P2|Overall Study|Death|0
4677287|NCT02622074|16098873|P1|Overall Study|Death|4
4677288|NCT02621931|16098977|P3|Overall Study|Other|3
4677289|NCT02621931|16098978|P2|Overall Study|Other|1
4677290|NCT02621931|16098979|P1|Overall Study|Other|1
4677291|NCT02621931|16098977|P3|Overall Study|Lack of Efficacy|1
4677292|NCT02621931|16098978|P2|Overall Study|Lack of Efficacy|0
4677293|NCT02621931|16098979|P1|Overall Study|Lack of Efficacy|0
4677294|NCT02621931|16098977|P3|Overall Study|Lost to Follow-up|10
4677295|NCT02621931|16098978|P2|Overall Study|Lost to Follow-up|7
4677296|NCT02621931|16098979|P1|Overall Study|Lost to Follow-up|8
4677297|NCT02621931|16098977|P3|Overall Study|Noncompliance to study procedures|2
4677298|NCT02621931|16098978|P2|Overall Study|Noncompliance to study procedures|1
4677299|NCT02621931|16098979|P1|Overall Study|Noncompliance to study procedures|0
4677300|NCT02621931|16098977|P3|Overall Study|Pregnancy|0
4677301|NCT02621931|16098978|P2|Overall Study|Pregnancy|0
4677302|NCT02621931|16098979|P1|Overall Study|Pregnancy|2
4677303|NCT02621931|16098977|P3|Overall Study|Protocol Violation|2
4677304|NCT02621931|16098978|P2|Overall Study|Protocol Violation|2
4677305|NCT02621931|16098979|P1|Overall Study|Protocol Violation|2
4677306|NCT02621931|16098977|P3|Overall Study|Withdrawal by Subject|11
4677307|NCT02621931|16098978|P2|Overall Study|Withdrawal by Subject|10
4677308|NCT02621931|16098979|P1|Overall Study|Withdrawal by Subject|12
4677309|NCT02621931|16098977|P3|Overall Study|Adverse Event|7
4677310|NCT02621931|16098978|P2|Overall Study|Adverse Event|5
4677311|NCT02621931|16098979|P1|Overall Study|Adverse Event|8
4677312|NCT02621931|16098977|P3|Overall Study|Death|0
4677313|NCT02621931|16098978|P2|Overall Study|Death|1
4677314|NCT02621931|16098979|P1|Overall Study|Death|0
4677315|NCT02621606|16099061|P3|Overall Study|Withdrawal by Subject|0
4677316|NCT02621606|16099062|P2|Overall Study|Withdrawal by Subject|1
4677317|NCT02621606|16099063|P1|Overall Study|Withdrawal by Subject|0
4677318|NCT02621424|16099091|P2|Overall Study|Withdrawal by Subject|2
4677319|NCT02621424|16099092|P1|Overall Study|Withdrawal by Subject|1
4677320|NCT02621073|16099100|P2|Overall Study|Physician Decision|2
4677321|NCT02621073|16099101|P1|Overall Study|Physician Decision|3
4677322|NCT02621073|16099100|P2|Overall Study|Lost to Follow-up|1
4677323|NCT02621073|16099101|P1|Overall Study|Lost to Follow-up|0
4677324|NCT02621047|16099163|P3|Overall Study|Adverse Event|1
4677325|NCT02621047|16099164|P2|Overall Study|Adverse Event|0
4677326|NCT02621047|16099165|P1|Overall Study|Adverse Event|0
4677327|NCT02621034|16099281|P3|Overall Study|Lost to Follow-up|5
4677328|NCT02621034|16099282|P2|Overall Study|Lost to Follow-up|2
4677329|NCT02621034|16099283|P1|Overall Study|Lost to Follow-up|3
4677330|NCT02620787|16099317|P2|Overall Study|Eligibility Criteria Not Met|0
4677331|NCT02620787|16099318|P1|Overall Study|Eligibility Criteria Not Met|1
4677332|NCT02620787|16099317|P2|Overall Study|Adverse Event|0
4677333|NCT02620787|16099318|P1|Overall Study|Adverse Event|1
4677334|NCT02620384|16099360|P2|Overall Study|Drug shortage prevented 2nd dose|1
4677335|NCT02620384|16099361|P1|Overall Study|Drug shortage prevented 2nd dose|0
4677336|NCT02620384|16099360|P2|Overall Study|Discharged prior to 2nd dose|5
4677337|NCT02620384|16099361|P1|Overall Study|Discharged prior to 2nd dose|2
4677338|NCT02620384|16099360|P2|Overall Study|Adverse Event|1
4677339|NCT02620384|16099361|P1|Overall Study|Adverse Event|2
4677340|NCT02620020|16099393|P4|Overall Study|Death|0
4677341|NCT02620020|16099394|P3|Overall Study|Death|0
4677342|NCT02620020|16099395|P2|Overall Study|Death|1
4677343|NCT02620020|16099396|P1|Overall Study|Death|0
4677344|NCT02620020|16099393|P4|Overall Study|Withdrawal by Subject|12
4677345|NCT02620020|16099394|P3|Overall Study|Withdrawal by Subject|17
4677346|NCT02620020|16099395|P2|Overall Study|Withdrawal by Subject|16
4677347|NCT02620020|16099396|P1|Overall Study|Withdrawal by Subject|20
4677348|NCT02620020|16099393|P4|Overall Study|Protocol Violation|1
4677349|NCT02620020|16099394|P3|Overall Study|Protocol Violation|1
4677350|NCT02620020|16099395|P2|Overall Study|Protocol Violation|2
4677351|NCT02620020|16099396|P1|Overall Study|Protocol Violation|5
4677352|NCT02620020|16099393|P4|Overall Study|Physician Decision|4
4677353|NCT02620020|16099394|P3|Overall Study|Physician Decision|3
4677354|NCT02620020|16099395|P2|Overall Study|Physician Decision|4
4677355|NCT02620020|16099396|P1|Overall Study|Physician Decision|7
4677356|NCT02620020|16099393|P4|Overall Study|Lost to Follow-up|4
4677357|NCT02620020|16099394|P3|Overall Study|Lost to Follow-up|1
4677358|NCT02620020|16099395|P2|Overall Study|Lost to Follow-up|8
4677359|NCT02620020|16099396|P1|Overall Study|Lost to Follow-up|4
4677360|NCT02620020|16099393|P4|Overall Study|Adverse Event|5
4677361|NCT02620020|16099394|P3|Overall Study|Adverse Event|3
4677362|NCT02620020|16099395|P2|Overall Study|Adverse Event|4
4677363|NCT02620020|16099396|P1|Overall Study|Adverse Event|8
4677364|NCT02619812|16099422|P4|Overall Study|Withdrawal by Subject|2
4677365|NCT02619812|16099423|P3|Overall Study|Withdrawal by Subject|1
4677366|NCT02619812|16099424|P2|Overall Study|Withdrawal by Subject|0
4677367|NCT02619812|16099425|P1|Overall Study|Withdrawal by Subject|0
4677368|NCT02619617|16099458|P2|Period 2 SOM230 - 2nd Attack|Physician Decision|3
4677369|NCT02619617|16099459|P1|Period 2 SOM230 - 2nd Attack|Physician Decision|0
4677370|NCT02619617|16099458|P2|Period 2 SOM230 - 2nd Attack|Protocol Violation|1
4677371|NCT02619617|16099459|P1|Period 2 SOM230 - 2nd Attack|Protocol Violation|0
4677372|NCT02619175|16099555|P2|Overall Study|foot pain|0
4677373|NCT02619175|16099556|P1|Overall Study|foot pain|1
4677374|NCT02619175|16099555|P2|Overall Study|Withdrawal by Subject|0
4677375|NCT02619175|16099556|P1|Overall Study|Withdrawal by Subject|1
4677376|NCT02618928|16099570|P1|Overall Study|Treatment Never Started|7
4677377|NCT02618928|16099570|P1|Overall Study|Missing|6
4677378|NCT02618928|16099570|P1|Overall Study|Other|11
4677379|NCT02618928|16099570|P1|Overall Study|Death|3
4677380|NCT02618928|16099570|P1|Overall Study|Withdrawal by Subject|2
4677381|NCT02618928|16099570|P1|Overall Study|Insufficient Virological Response|1
4677382|NCT02618928|16099570|P1|Overall Study|Failure to Return|28
4677383|NCT02618759|16099665|P2|Overall Study|Other Reasons|4
4677384|NCT02618759|16099666|P1|Overall Study|Other Reasons|1
4677385|NCT02618759|16099665|P2|Overall Study|Withdrawal by Subject|0
4677386|NCT02618759|16099666|P1|Overall Study|Withdrawal by Subject|1
4677387|NCT02618759|16099665|P2|Overall Study|Lost to Follow-up|1
4677388|NCT02618759|16099666|P1|Overall Study|Lost to Follow-up|0
4677389|NCT02617628|16099854|P2|Overall Study|Withdr, Transfers-other prisons, dropout|61
4677390|NCT02617628|16099855|P1|Overall Study|Withdr, Transfers-other prisons, dropout|62
4677391|NCT02616900|16099863|P1|Overall Study|Incomplete data|6
4677392|NCT02616900|16099863|P1|Overall Study|Withdrawal by Subject|3
4677393|NCT02616900|16099863|P1|Overall Study|Protocol Violation|5
4677394|NCT02616900|16099863|P1|Overall Study|Lost to Follow-up|2
4677395|NCT02616900|16099863|P1|Overall Study|Lack of Efficacy|7
4677396|NCT02616783|16099871|P2|Overall Study|Withdrew Consent|1
4677397|NCT02616783|16099872|P1|Overall Study|Withdrew Consent|1
4677398|NCT02616783|16099871|P2|Overall Study|Protocol Violation|1
4677399|NCT02616783|16099872|P1|Overall Study|Protocol Violation|1
4677400|NCT02616783|16099871|P2|Overall Study|Non-Compliance with Study Drug|0
4677401|NCT02616783|16099872|P1|Overall Study|Non-Compliance with Study Drug|1
4677402|NCT02616783|16099871|P2|Overall Study|Death|0
4677403|NCT02616783|16099872|P1|Overall Study|Death|1
4677404|NCT02616783|16099871|P2|Overall Study|Adverse Event|0
4677405|NCT02616783|16099872|P1|Overall Study|Adverse Event|1
4677406|NCT02616783|16099871|P2|Overall Study|Randomized but Not Treated|0
4677407|NCT02616783|16099872|P1|Overall Study|Randomized but Not Treated|1
4677408|NCT02616614|16099895|P3|Overall Study|Other|1
4677409|NCT02616614|16099896|P2|Overall Study|Other|2
4677410|NCT02616614|16099897|P1|Overall Study|Other|1
4677411|NCT02616614|16099895|P3|Overall Study|Pregnancy|1
4677412|NCT02616614|16099896|P2|Overall Study|Pregnancy|0
4677413|NCT02616614|16099897|P1|Overall Study|Pregnancy|2
4677414|NCT02616614|16099895|P3|Overall Study|Lost to Follow-up|13
4677415|NCT02616614|16099896|P2|Overall Study|Lost to Follow-up|28
4677416|NCT02616614|16099897|P1|Overall Study|Lost to Follow-up|31
4677417|NCT02616614|16099895|P3|Overall Study|More than 3 applications missed|1
4677418|NCT02616614|16099896|P2|Overall Study|More than 3 applications missed|8
4677419|NCT02616614|16099897|P1|Overall Study|More than 3 applications missed|6
4677420|NCT02616614|16099895|P3|Overall Study|Prohibited Medication|5
4677421|NCT02616614|16099896|P2|Overall Study|Prohibited Medication|9
4677422|NCT02616614|16099897|P1|Overall Study|Prohibited Medication|12
4677423|NCT02616614|16099895|P3|Overall Study|Protocol Violation|1
4677424|NCT02616614|16099896|P2|Overall Study|Protocol Violation|3
4677425|NCT02616614|16099897|P1|Overall Study|Protocol Violation|0
4677426|NCT02616614|16099895|P3|Overall Study|Adverse Event|1
4677427|NCT02616614|16099896|P2|Overall Study|Adverse Event|4
4677428|NCT02616614|16099897|P1|Overall Study|Adverse Event|1
4677429|NCT02616614|16099895|P3|Overall Study|Physician Decision|0
4677430|NCT02616614|16099896|P2|Overall Study|Physician Decision|1
4677431|NCT02616614|16099897|P1|Overall Study|Physician Decision|2
4677432|NCT02616614|16099895|P3|Overall Study|Withdrawal by Subject|6
4677433|NCT02616614|16099896|P2|Overall Study|Withdrawal by Subject|5
4677434|NCT02616614|16099897|P1|Overall Study|Withdrawal by Subject|10
4677435|NCT02616601|16099914|P3|Overall Study|Non-Compliance with Test Article|1
4677436|NCT02616601|16099915|P2|Overall Study|Non-Compliance with Test Article|0
4677437|NCT02616601|16099916|P1|Overall Study|Non-Compliance with Test Article|1
4677438|NCT02616601|16099914|P3|Overall Study|Lost to Follow-up|1
4677439|NCT02616601|16099915|P2|Overall Study|Lost to Follow-up|0
4677440|NCT02616601|16099916|P1|Overall Study|Lost to Follow-up|1
4677441|NCT02616601|16099914|P3|Overall Study|Death|0
4677442|NCT02616601|16099915|P2|Overall Study|Death|0
4677443|NCT02616601|16099916|P1|Overall Study|Death|1
4677444|NCT02616601|16099914|P3|Overall Study|Adverse Event|2
4677445|NCT02616601|16099915|P2|Overall Study|Adverse Event|0
4677446|NCT02616601|16099916|P1|Overall Study|Adverse Event|2
4677447|NCT02616601|16099914|P3|Overall Study|Withdrawal by Subject|3
4677448|NCT02616601|16099915|P2|Overall Study|Withdrawal by Subject|4
4677449|NCT02616601|16099916|P1|Overall Study|Withdrawal by Subject|4
4677450|NCT02616380|16099943|P1|Overall Study|Other|2
4677451|NCT02616380|16099943|P1|Overall Study|Lost to Follow-up|1
4677452|NCT02616146|16099967|P2|Overall Study|Physician Decision|1
4677453|NCT02616146|16099968|P1|Overall Study|Physician Decision|2
4677454|NCT02616146|16099967|P2|Overall Study|Withdrawal by Subject|24
4677455|NCT02616146|16099968|P1|Overall Study|Withdrawal by Subject|30
4677456|NCT02616146|16099967|P2|Overall Study|Participant moved|3
4677457|NCT02616146|16099968|P1|Overall Study|Participant moved|4
4677458|NCT02616146|16099967|P2|Overall Study|Study terminated by sponsor|432
4677459|NCT02616146|16099968|P1|Overall Study|Study terminated by sponsor|1372
4677460|NCT02616146|16099967|P2|Overall Study|Protocol Violation|3
4677461|NCT02616146|16099968|P1|Overall Study|Protocol Violation|6
4677462|NCT02616146|16099967|P2|Overall Study|Pregnancy wish|0
4677463|NCT02616146|16099968|P1|Overall Study|Pregnancy wish|3
4677464|NCT02616146|16099967|P2|Overall Study|Pregnancy|2
4677465|NCT02616146|16099968|P1|Overall Study|Pregnancy|2
4677466|NCT02616146|16099967|P2|Overall Study|Non-compliance with study drug|2
4677467|NCT02616146|16099968|P1|Overall Study|Non-compliance with study drug|4
4677468|NCT02616146|16099967|P2|Overall Study|Non-compliance with study protocol|0
4677469|NCT02616146|16099968|P1|Overall Study|Non-compliance with study protocol|2
4677470|NCT02616146|16099967|P2|Overall Study|Lost to Follow-up|13
4677471|NCT02616146|16099968|P1|Overall Study|Lost to Follow-up|23
4677472|NCT02616146|16099967|P2|Overall Study|Adverse Event|24
4677473|NCT02616146|16099968|P1|Overall Study|Adverse Event|64
4677474|NCT02616029|16099984|P2|Overall Study|Enrolled and Never Treated|1
4677475|NCT02616029|16099985|P1|Overall Study|Enrolled and Never Treated|1
4677476|NCT02616029|16099984|P2|Overall Study|Withdrew Consent|0
4677477|NCT02616029|16099985|P1|Overall Study|Withdrew Consent|1
4677478|NCT02616029|16099984|P2|Overall Study|Protocol Violation|0
4677479|NCT02616029|16099985|P1|Overall Study|Protocol Violation|1
4677480|NCT02616029|16099984|P2|Overall Study|Death|1
4677481|NCT02616029|16099985|P1|Overall Study|Death|0
4677482|NCT02616029|16099984|P2|Overall Study|Adverse Event|0
4677483|NCT02616029|16099985|P1|Overall Study|Adverse Event|1
4677484|NCT02615990|16100056|P2|Overall Study|study terminated|1
4677485|NCT02615990|16100057|P1|Overall Study|study terminated|1
4677486|NCT02615509|16100154|P1|Overall Study|Withdrawal by Subject|8
4677487|NCT02615509|16100154|P1|Overall Study|Death|4
4677488|NCT02615509|16100154|P1|Overall Study|Lost to Follow-up|134
4677489|NCT02615470|16100164|P2|Overall Study|Lost to Follow-up|32
4677490|NCT02615470|16100165|P1|Overall Study|Lost to Follow-up|21
4677491|NCT02615249|16100175|P1|Overall Study|Withdrawal by Subject|1
4677492|NCT02615145|16100216|P4|Overall Study|Other, Not Specified|0
4677493|NCT02615145|16100217|P3|Overall Study|Other, Not Specified|0
4677494|NCT02615145|16100218|P2|Overall Study|Other, Not Specified|2
4677495|NCT02615145|16100219|P1|Overall Study|Other, Not Specified|5
4677496|NCT02615145|16100216|P4|Overall Study|Death|0
4677497|NCT02615145|16100217|P3|Overall Study|Death|0
4677498|NCT02615145|16100218|P2|Overall Study|Death|3
4677499|NCT02615145|16100219|P1|Overall Study|Death|2
4677500|NCT02615145|16100216|P4|Overall Study|Failure to Return|0
4677501|NCT02615145|16100217|P3|Overall Study|Failure to Return|7
4677502|NCT02615145|16100218|P2|Overall Study|Failure to Return|10
4677503|NCT02615145|16100219|P1|Overall Study|Failure to Return|20
4677504|NCT02615145|16100216|P4|Overall Study|Did Not Start Treatment|1
4677505|NCT02615145|16100217|P3|Overall Study|Did Not Start Treatment|1
4677506|NCT02615145|16100218|P2|Overall Study|Did Not Start Treatment|0
4677507|NCT02615145|16100219|P1|Overall Study|Did Not Start Treatment|0
4677508|NCT02614898|16100306|P2|Overall Study|Missing|1
4677509|NCT02614898|16100307|P1|Overall Study|Missing|0
4677510|NCT02614898|16100306|P2|Overall Study|Other-Additional Information Unavailable|11
4677511|NCT02614898|16100307|P1|Overall Study|Other-Additional Information Unavailable|0
4677512|NCT02614898|16100306|P2|Overall Study|Withdrawal by Parent/Guardian|1
4677513|NCT02614898|16100307|P1|Overall Study|Withdrawal by Parent/Guardian|1
4677514|NCT02614898|16100306|P2|Overall Study|Withdrawal by Subject|2
4677515|NCT02614898|16100307|P1|Overall Study|Withdrawal by Subject|0
4677516|NCT02614898|16100306|P2|Overall Study|Study Terminated by Sponsor|0
4677517|NCT02614898|16100307|P1|Overall Study|Study Terminated by Sponsor|3
4677518|NCT02614898|16100306|P2|Overall Study|Physician Decision|8
4677519|NCT02614898|16100307|P1|Overall Study|Physician Decision|1
4677520|NCT02614898|16100306|P2|Overall Study|Lost to Follow-up|2
4677521|NCT02614898|16100307|P1|Overall Study|Lost to Follow-up|0
4677522|NCT02614898|16100306|P2|Overall Study|Participated until study termination|26
4677523|NCT02614898|16100307|P1|Overall Study|Participated until study termination|10
4677524|NCT02614794|16100319|P2|Overall Study|Physician Decision|1
4677525|NCT02614794|16100320|P1|Overall Study|Physician Decision|0
4677526|NCT02614794|16100319|P2|Overall Study|Lost to Follow-up|0
4677527|NCT02614794|16100320|P1|Overall Study|Lost to Follow-up|2
4677528|NCT02614794|16100319|P2|Overall Study|Withdrawal by Subject|5
4677529|NCT02614794|16100320|P1|Overall Study|Withdrawal by Subject|16
4677530|NCT02614794|16100319|P2|Overall Study|Death|84
4677531|NCT02614794|16100320|P1|Overall Study|Death|126
4677532|NCT02614794|16100319|P2|Overall Study|In long term follow up|85
4677533|NCT02614794|16100320|P1|Overall Study|In long term follow up|148
4677534|NCT02614794|16100319|P2|Overall Study|On treatment|27
4677535|NCT02614794|16100320|P1|Overall Study|On treatment|118
4677536|NCT02614729|16100354|P2|Overall Study|Withdrawal by Subject|0
4677537|NCT02614729|16100355|P1|Overall Study|Withdrawal by Subject|1
4677538|NCT02614703|16100375|P2|Overall Study|Withdrawal by Subject|1
4677539|NCT02614703|16100376|P1|Overall Study|Withdrawal by Subject|7
4677540|NCT02614560|16100420|P2|Overall Study|Death|2
4677541|NCT02614560|16100421|P1|Overall Study|Death|6
4677542|NCT02614287|16100469|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|3
4677543|NCT02614287|16100470|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|6
4677544|NCT02614287|16100469|P2|Post Treatment Follow-up Phase|Lost to Follow-up|2
4677545|NCT02614287|16100470|P1|Post Treatment Follow-up Phase|Lost to Follow-up|2
4677546|NCT02614287|16100469|P2|Post Treatment Follow-up Phase|Adverse Event|0
4677547|NCT02614287|16100470|P1|Post Treatment Follow-up Phase|Adverse Event|1
4677548|NCT02614287|16100469|P2|Open Label (OL) Treatment Phase|Withdrawal by Subject|7
4677549|NCT02614287|16100470|P1|Open Label (OL) Treatment Phase|Withdrawal by Subject|10
4677550|NCT02614287|16100469|P2|Open Label (OL) Treatment Phase|Physician Decision|0
4677551|NCT02614287|16100470|P1|Open Label (OL) Treatment Phase|Physician Decision|1
4677552|NCT02614287|16100469|P2|Open Label (OL) Treatment Phase|Lost to Follow-up|4
4677553|NCT02614287|16100470|P1|Open Label (OL) Treatment Phase|Lost to Follow-up|7
4677554|NCT02614287|16100469|P2|Open Label (OL) Treatment Phase|Lack of Efficacy|5
4677555|NCT02614287|16100470|P1|Open Label (OL) Treatment Phase|Lack of Efficacy|13
4677556|NCT02614287|16100469|P2|Open Label (OL) Treatment Phase|Adverse Event|6
4677557|NCT02614287|16100470|P1|Open Label (OL) Treatment Phase|Adverse Event|7
4677558|NCT02614261|16100516|P3|Overall Study|Withdrawal by Subject|7
4677559|NCT02614261|16100517|P2|Overall Study|Withdrawal by Subject|4
4677560|NCT02614261|16100518|P1|Overall Study|Withdrawal by Subject|19
4677561|NCT02614261|16100516|P3|Overall Study|Protocol Violation|0
4677562|NCT02614261|16100517|P2|Overall Study|Protocol Violation|1
4677563|NCT02614261|16100518|P1|Overall Study|Protocol Violation|6
4677564|NCT02614261|16100516|P3|Overall Study|Pregnancy|0
4677565|NCT02614261|16100517|P2|Overall Study|Pregnancy|2
4677566|NCT02614261|16100518|P1|Overall Study|Pregnancy|2
4677567|NCT02614261|16100516|P3|Overall Study|Physician Decision|1
4677568|NCT02614261|16100517|P2|Overall Study|Physician Decision|1
4677569|NCT02614261|16100518|P1|Overall Study|Physician Decision|2
4677570|NCT02614261|16100516|P3|Overall Study|Lost to Follow-up|1
4677571|NCT02614261|16100517|P2|Overall Study|Lost to Follow-up|4
4677572|NCT02614261|16100518|P1|Overall Study|Lost to Follow-up|10
4677573|NCT02614261|16100516|P3|Overall Study|Lack of Efficacy|0
4677574|NCT02614261|16100517|P2|Overall Study|Lack of Efficacy|0
4677575|NCT02614261|16100518|P1|Overall Study|Lack of Efficacy|4
4677576|NCT02614261|16100516|P3|Overall Study|Adverse Event|2
4677577|NCT02614261|16100517|P2|Overall Study|Adverse Event|3
4677578|NCT02614261|16100518|P1|Overall Study|Adverse Event|6
4677579|NCT02614196|16100584|P6|Post Treatment Follow-up Phase|Withdrawal by Subject|0
4677580|NCT02614196|16100585|P5|Post Treatment Follow-up Phase|Withdrawal by Subject|0
4677581|NCT02614196|16100586|P4|Post Treatment Follow-up Phase|Withdrawal by Subject|1
4677582|NCT02614196|16100587|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
4677583|NCT02614196|16100588|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
4677584|NCT02614196|16100589|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|10
4677585|NCT02614196|16100584|P6|Post Treatment Follow-up Phase|Protocol Violation|0
4677586|NCT02614196|16100585|P5|Post Treatment Follow-up Phase|Protocol Violation|1
4677587|NCT02614196|16100586|P4|Post Treatment Follow-up Phase|Protocol Violation|0
4677588|NCT02614196|16100587|P3|Post Treatment Follow-up Phase|Protocol Violation|0
4677589|NCT02614196|16100588|P2|Post Treatment Follow-up Phase|Protocol Violation|1
4677590|NCT02614196|16100589|P1|Post Treatment Follow-up Phase|Protocol Violation|0
4677591|NCT02614196|16100584|P6|Post Treatment Follow-up Phase|Pregnancy|0
4677592|NCT02614196|16100585|P5|Post Treatment Follow-up Phase|Pregnancy|0
4677593|NCT02614196|16100586|P4|Post Treatment Follow-up Phase|Pregnancy|0
4677594|NCT02614196|16100587|P3|Post Treatment Follow-up Phase|Pregnancy|0
4677595|NCT02614196|16100588|P2|Post Treatment Follow-up Phase|Pregnancy|0
4677596|NCT02614196|16100589|P1|Post Treatment Follow-up Phase|Pregnancy|2
4677597|NCT02614196|16100584|P6|Post Treatment Follow-up Phase|Lost to Follow-up|0
4677598|NCT02614196|16100585|P5|Post Treatment Follow-up Phase|Lost to Follow-up|1
4677599|NCT02614196|16100586|P4|Post Treatment Follow-up Phase|Lost to Follow-up|0
4677600|NCT02614196|16100587|P3|Post Treatment Follow-up Phase|Lost to Follow-up|3
4677601|NCT02614196|16100588|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
4677602|NCT02614196|16100589|P1|Post Treatment Follow-up Phase|Lost to Follow-up|8
4677603|NCT02614196|16100584|P6|Double Blind Treatment Phase|Did not receive study drug|0
4677604|NCT02614196|16100585|P5|Double Blind Treatment Phase|Did not receive study drug|0
4677605|NCT02614196|16100586|P4|Double Blind Treatment Phase|Did not receive study drug|0
4677606|NCT02614196|16100587|P3|Double Blind Treatment Phase|Did not receive study drug|3
4677607|NCT02614196|16100588|P2|Double Blind Treatment Phase|Did not receive study drug|2
4677608|NCT02614196|16100589|P1|Double Blind Treatment Phase|Did not receive study drug|2
4677609|NCT02614196|16100584|P6|Double Blind Treatment Phase|Withdrawal by Subject|0
4677610|NCT02614196|16100585|P5|Double Blind Treatment Phase|Withdrawal by Subject|0
4677611|NCT02614196|16100586|P4|Double Blind Treatment Phase|Withdrawal by Subject|4
4677612|NCT02614196|16100587|P3|Double Blind Treatment Phase|Withdrawal by Subject|14
4677613|NCT02614196|16100588|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
4677614|NCT02614196|16100589|P1|Double Blind Treatment Phase|Withdrawal by Subject|39
4677615|NCT02614196|16100584|P6|Double Blind Treatment Phase|Terminated by sponsor|0
4677616|NCT02614196|16100585|P5|Double Blind Treatment Phase|Terminated by sponsor|0
4677617|NCT02614196|16100586|P4|Double Blind Treatment Phase|Terminated by sponsor|0
4677618|NCT02614196|16100587|P3|Double Blind Treatment Phase|Terminated by sponsor|0
4677619|NCT02614196|16100588|P2|Double Blind Treatment Phase|Terminated by sponsor|0
4677620|NCT02614196|16100589|P1|Double Blind Treatment Phase|Terminated by sponsor|1
4677621|NCT02614196|16100584|P6|Double Blind Treatment Phase|Protocol Violation|0
4677622|NCT02614196|16100585|P5|Double Blind Treatment Phase|Protocol Violation|1
4677623|NCT02614196|16100586|P4|Double Blind Treatment Phase|Protocol Violation|0
4677624|NCT02614196|16100587|P3|Double Blind Treatment Phase|Protocol Violation|1
4677625|NCT02614196|16100588|P2|Double Blind Treatment Phase|Protocol Violation|2
4677626|NCT02614196|16100589|P1|Double Blind Treatment Phase|Protocol Violation|5
4677627|NCT02614196|16100584|P6|Double Blind Treatment Phase|Pregnancy|0
4677628|NCT02614196|16100585|P5|Double Blind Treatment Phase|Pregnancy|0
4677629|NCT02614196|16100586|P4|Double Blind Treatment Phase|Pregnancy|0
4677630|NCT02614196|16100587|P3|Double Blind Treatment Phase|Pregnancy|0
4677631|NCT02614196|16100588|P2|Double Blind Treatment Phase|Pregnancy|2
4677632|NCT02614196|16100589|P1|Double Blind Treatment Phase|Pregnancy|1
4677633|NCT02614196|16100584|P6|Double Blind Treatment Phase|Physician Decision|0
4677634|NCT02614196|16100585|P5|Double Blind Treatment Phase|Physician Decision|0
4677635|NCT02614196|16100586|P4|Double Blind Treatment Phase|Physician Decision|0
4677636|NCT02614196|16100587|P3|Double Blind Treatment Phase|Physician Decision|2
4677637|NCT02614196|16100588|P2|Double Blind Treatment Phase|Physician Decision|0
4677638|NCT02614196|16100589|P1|Double Blind Treatment Phase|Physician Decision|4
4677639|NCT02614196|16100584|P6|Double Blind Treatment Phase|Lost to Follow-up|0
4677640|NCT02614196|16100585|P5|Double Blind Treatment Phase|Lost to Follow-up|0
4677641|NCT02614196|16100586|P4|Double Blind Treatment Phase|Lost to Follow-up|0
4677642|NCT02614196|16100587|P3|Double Blind Treatment Phase|Lost to Follow-up|1
4677643|NCT02614196|16100588|P2|Double Blind Treatment Phase|Lost to Follow-up|7
4677644|NCT02614196|16100589|P1|Double Blind Treatment Phase|Lost to Follow-up|10
4677645|NCT02614196|16100584|P6|Double Blind Treatment Phase|Lack of Efficacy|0
4677646|NCT02614196|16100585|P5|Double Blind Treatment Phase|Lack of Efficacy|0
4677647|NCT02614196|16100586|P4|Double Blind Treatment Phase|Lack of Efficacy|0
4677648|NCT02614196|16100587|P3|Double Blind Treatment Phase|Lack of Efficacy|1
4677649|NCT02614196|16100588|P2|Double Blind Treatment Phase|Lack of Efficacy|1
4677650|NCT02614196|16100589|P1|Double Blind Treatment Phase|Lack of Efficacy|6
4677651|NCT02614196|16100584|P6|Double Blind Treatment Phase|Adverse Event|0
4677652|NCT02614196|16100585|P5|Double Blind Treatment Phase|Adverse Event|0
4677653|NCT02614196|16100586|P4|Double Blind Treatment Phase|Adverse Event|0
4677654|NCT02614196|16100587|P3|Double Blind Treatment Phase|Adverse Event|9
4677655|NCT02614196|16100588|P2|Double Blind Treatment Phase|Adverse Event|5
4677656|NCT02614196|16100589|P1|Double Blind Treatment Phase|Adverse Event|8
4677657|NCT02614183|16100635|P3|Post Treatment Follow-up Phase|Withdrawal by Subject|5
4677658|NCT02614183|16100636|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|2
4677659|NCT02614183|16100637|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|7
4677660|NCT02614183|16100635|P3|Post Treatment Follow-up Phase|Protocol Violation|0
4677661|NCT02614183|16100636|P2|Post Treatment Follow-up Phase|Protocol Violation|0
4677662|NCT02614183|16100637|P1|Post Treatment Follow-up Phase|Protocol Violation|1
4677663|NCT02614183|16100635|P3|Post Treatment Follow-up Phase|Physician Decision|2
4677664|NCT02614183|16100636|P2|Post Treatment Follow-up Phase|Physician Decision|1
4677665|NCT02614183|16100637|P1|Post Treatment Follow-up Phase|Physician Decision|5
4677666|NCT02614183|16100635|P3|Post Treatment Follow-up Phase|Lost to Follow-up|5
4677667|NCT02614183|16100636|P2|Post Treatment Follow-up Phase|Lost to Follow-up|3
4677668|NCT02614183|16100637|P1|Post Treatment Follow-up Phase|Lost to Follow-up|5
4677669|NCT02614183|16100635|P3|Double Blind Treatment Phase|Did not receive study drug|2
4677670|NCT02614183|16100636|P2|Double Blind Treatment Phase|Did not receive study drug|1
4677671|NCT02614183|16100637|P1|Double Blind Treatment Phase|Did not receive study drug|1
4677672|NCT02614183|16100635|P3|Double Blind Treatment Phase|Withdrawal by Subject|16
4677673|NCT02614183|16100636|P2|Double Blind Treatment Phase|Withdrawal by Subject|11
4677674|NCT02614183|16100637|P1|Double Blind Treatment Phase|Withdrawal by Subject|33
4677675|NCT02614183|16100635|P3|Double Blind Treatment Phase|Protocol Violation|2
4677676|NCT02614183|16100636|P2|Double Blind Treatment Phase|Protocol Violation|2
4677677|NCT02614183|16100637|P1|Double Blind Treatment Phase|Protocol Violation|2
4677678|NCT02614183|16100635|P3|Double Blind Treatment Phase|Pregnancy|3
4677679|NCT02614183|16100636|P2|Double Blind Treatment Phase|Pregnancy|1
4677680|NCT02614183|16100637|P1|Double Blind Treatment Phase|Pregnancy|2
4677681|NCT02614183|16100635|P3|Double Blind Treatment Phase|Physician Decision|2
4677682|NCT02614183|16100636|P2|Double Blind Treatment Phase|Physician Decision|3
4677683|NCT02614183|16100637|P1|Double Blind Treatment Phase|Physician Decision|7
4677684|NCT02614183|16100635|P3|Double Blind Treatment Phase|Lost to Follow-up|5
4677685|NCT02614183|16100636|P2|Double Blind Treatment Phase|Lost to Follow-up|9
4677686|NCT02614183|16100637|P1|Double Blind Treatment Phase|Lost to Follow-up|18
4677687|NCT02614183|16100635|P3|Double Blind Treatment Phase|Lack of Efficacy|2
4677688|NCT02614183|16100636|P2|Double Blind Treatment Phase|Lack of Efficacy|1
4677689|NCT02614183|16100637|P1|Double Blind Treatment Phase|Lack of Efficacy|10
4677690|NCT02614183|16100635|P3|Double Blind Treatment Phase|Adverse Event|7
4677691|NCT02614183|16100636|P2|Double Blind Treatment Phase|Adverse Event|9
4677692|NCT02614183|16100637|P1|Double Blind Treatment Phase|Adverse Event|10
4677693|NCT02614131|16100681|P7|Overall Study|Adverse Event|1
4677694|NCT02614131|16100682|P6|Overall Study|Adverse Event|0
4677695|NCT02614131|16100683|P5|Overall Study|Adverse Event|0
4677696|NCT02614131|16100684|P4|Overall Study|Adverse Event|0
4677697|NCT02614131|16100685|P3|Overall Study|Adverse Event|0
4677698|NCT02614131|16100686|P2|Overall Study|Adverse Event|0
4677699|NCT02614131|16100687|P1|Overall Study|Adverse Event|0
4677700|NCT02614131|16100681|P7|Overall Study|Withdrawal by Subject|0
4677701|NCT02614131|16100682|P6|Overall Study|Withdrawal by Subject|0
4677702|NCT02614131|16100683|P5|Overall Study|Withdrawal by Subject|0
4677703|NCT02614131|16100684|P4|Overall Study|Withdrawal by Subject|0
4677704|NCT02614131|16100685|P3|Overall Study|Withdrawal by Subject|0
4677705|NCT02614131|16100686|P2|Overall Study|Withdrawal by Subject|0
4677706|NCT02614131|16100687|P1|Overall Study|Withdrawal by Subject|1
4677707|NCT02614079|16100718|P1|Overall Study|Withdrawal by Subject|1
4677708|NCT02613910|16100722|P1|Overall Study|Termination of study|1
4677709|NCT02613871|16100808|P1|Overall Study|Withdrew Consent|1
4677710|NCT02613871|16100808|P1|Overall Study|Death|2
4677711|NCT02613572|16100830|P3|Phase II: Double-Blind Rand Plac Control|Death|0
4677712|NCT02613572|16100831|P2|Phase II: Double-Blind Rand Plac Control|Death|1
4677713|NCT02613572|16100832|P1|Phase II: Double-Blind Rand Plac Control|Death|0
4677714|NCT02613572|16100830|P3|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
4677715|NCT02613572|16100831|P2|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0
4677716|NCT02613572|16100832|P1|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1
4677717|NCT02613507|16100854|P2|Overall Study|Randomized but not Treated|10
4677718|NCT02613507|16100855|P1|Overall Study|Randomized but not Treated|1
4677719|NCT02613507|16100854|P2|Overall Study|Subject no Longer Meets Study Criteria|0
4677720|NCT02613507|16100855|P1|Overall Study|Subject no Longer Meets Study Criteria|1
4677721|NCT02613507|16100854|P2|Overall Study|Brain Radiotherapy Activity Limited|0
4677722|NCT02613507|16100855|P1|Overall Study|Brain Radiotherapy Activity Limited|1
4677723|NCT02613507|16100854|P2|Overall Study|Maximum Clinical Benefit|10
4677724|NCT02613507|16100855|P1|Overall Study|Maximum Clinical Benefit|4
4677725|NCT02613507|16100854|P2|Overall Study|Lost to Follow-up|0
4677726|NCT02613507|16100855|P1|Overall Study|Lost to Follow-up|1
4677727|NCT02613507|16100854|P2|Overall Study|Participant Withdrew Consent|2
4677728|NCT02613507|16100855|P1|Overall Study|Participant Withdrew Consent|0
4677729|NCT02613507|16100854|P2|Overall Study|Request to Discontinue Study Treatment|17
4677730|NCT02613507|16100855|P1|Overall Study|Request to Discontinue Study Treatment|8
4677731|NCT02613507|16100854|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
4677732|NCT02613507|16100855|P1|Overall Study|Adverse Event Unrelated to Study Drug|17
4677733|NCT02613507|16100854|P2|Overall Study|Death|0
4677734|NCT02613507|16100855|P1|Overall Study|Death|3
4677735|NCT02613507|16100854|P2|Overall Study|Study Drug Toxicity|14
4677736|NCT02613507|16100855|P1|Overall Study|Study Drug Toxicity|15
4677737|NCT02613507|16100854|P2|Overall Study|Disease Progression|109
4677738|NCT02613507|16100855|P1|Overall Study|Disease Progression|237
4677739|NCT02613481|16100871|P1|Overall Study|Withdrawal by Subject|2
4677740|NCT02613481|16100871|P1|Overall Study|Lost to Follow-up|7
4677741|NCT02613403|16100882|P5|Overall Study|Withdrawal by Subject|0
4677742|NCT02613403|16100883|P4|Overall Study|Withdrawal by Subject|0
4677743|NCT02613403|16100884|P3|Overall Study|Withdrawal by Subject|0
4677744|NCT02613403|16100885|P2|Overall Study|Withdrawal by Subject|0
4677745|NCT02613403|16100886|P1|Overall Study|Withdrawal by Subject|2
4677746|NCT02613403|16100882|P5|Overall Study|Lost to Follow-up|0
4677747|NCT02613403|16100883|P4|Overall Study|Lost to Follow-up|0
4677748|NCT02613403|16100884|P3|Overall Study|Lost to Follow-up|0
4677749|NCT02613403|16100885|P2|Overall Study|Lost to Follow-up|1
4677750|NCT02613403|16100886|P1|Overall Study|Lost to Follow-up|0
4677751|NCT02613221|16100938|P1|Overall Study|Enrolled but Not Treated|1
4677752|NCT02613221|16100938|P1|Overall Study|Delayed Treatment|1
4677753|NCT02613221|16100938|P1|Overall Study|Voluntary Discontinuation|1
4677754|NCT02613221|16100938|P1|Overall Study|Adverse Event|2
4677755|NCT02613221|16100938|P1|Overall Study|Lack of efficacy (exacerbation)|50
4677756|NCT02613208|16100950|P1|Overall Study|Death|37
4677757|NCT02613208|16100950|P1|Overall Study|Lost to Follow-up|5
4677758|NCT02613208|16100950|P1|Overall Study|Physician Decision|2
4677759|NCT02613208|16100950|P1|Overall Study|Change of address|2
4677760|NCT02613208|16100950|P1|Overall Study|Withdrawal by Subject|1
4677761|NCT02613182|16100964|P1|Overall Study|Withdrawal by Subject|6
4677762|NCT02613182|16100964|P1|Overall Study|Study Terminated by Sponsor|21
4677763|NCT02613182|16100964|P1|Overall Study|Physician Decision|1
4677764|NCT02613182|16100964|P1|Overall Study|Death|6
4677765|NCT02612909|16100986|P5|Phase 3|Withdrawal by Subject|0
4677766|NCT02612909|16100987|P4|Phase 3|Withdrawal by Subject|1
4677767|NCT02612909|16100988|P3|Phase 3|Withdrawal by Subject|0
4677768|NCT02612909|16100989|P2|Phase 3|Withdrawal by Subject|0
4677769|NCT02612909|16100990|P1|Phase 3|Withdrawal by Subject|0
4677770|NCT02612909|16100986|P5|Phase 2|Pregnancy|0
4677771|NCT02612909|16100987|P4|Phase 2|Pregnancy|0
4677772|NCT02612909|16100988|P3|Phase 2|Pregnancy|1
4677773|NCT02612909|16100989|P2|Phase 2|Pregnancy|0
4677774|NCT02612909|16100990|P1|Phase 2|Pregnancy|0
4677775|NCT02612909|16100986|P5|Phase 2|Withdrawal by Subject|0
4677776|NCT02612909|16100987|P4|Phase 2|Withdrawal by Subject|0
4677777|NCT02612909|16100988|P3|Phase 2|Withdrawal by Subject|0
4677778|NCT02612909|16100989|P2|Phase 2|Withdrawal by Subject|5
4677779|NCT02612909|16100990|P1|Phase 2|Withdrawal by Subject|2
4677780|NCT02612779|16101073|P2|Overall Study|Subsequent therapy|0
4677781|NCT02612779|16101074|P1|Overall Study|Subsequent therapy|3
4677782|NCT02612779|16101073|P2|Overall Study|Principal Investigator decision|0
4677783|NCT02612779|16101074|P1|Overall Study|Principal Investigator decision|2
4677784|NCT02612779|16101073|P2|Overall Study|Maximum clinical benefit|1
4677785|NCT02612779|16101074|P1|Overall Study|Maximum clinical benefit|10
4677786|NCT02612779|16101073|P2|Overall Study|Lost to Follow-up|0
4677787|NCT02612779|16101074|P1|Overall Study|Lost to Follow-up|1
4677788|NCT02612779|16101073|P2|Overall Study|Participant withdrew consent|0
4677789|NCT02612779|16101074|P1|Overall Study|Participant withdrew consent|4
4677790|NCT02612779|16101073|P2|Overall Study|Adverse event unrelated to study drug|0
4677791|NCT02612779|16101074|P1|Overall Study|Adverse event unrelated to study drug|5
4677792|NCT02612779|16101073|P2|Overall Study|Death|0
4677793|NCT02612779|16101074|P1|Overall Study|Death|1
4677794|NCT02612779|16101073|P2|Overall Study|Study drug toxicity|0
4677795|NCT02612779|16101074|P1|Overall Study|Study drug toxicity|9
4677796|NCT02612779|16101073|P2|Overall Study|Disease progression|2
4677797|NCT02612779|16101074|P1|Overall Study|Disease progression|29
4677798|NCT02612779|16101073|P2|Overall Study|No longer meet study criteria|1
4677799|NCT02612779|16101074|P1|Overall Study|No longer meet study criteria|0
4677800|NCT02612779|16101073|P2|Overall Study|Administrative reason by sponsor|1
4677801|NCT02612779|16101074|P1|Overall Study|Administrative reason by sponsor|0
4677802|NCT02612727|16101086|P2|Overall Study|Direct hyperbilirubinemia|2
4677803|NCT02612727|16101087|P1|Overall Study|Direct hyperbilirubinemia|0
4677804|NCT02612727|16101086|P2|Overall Study|Needed treatment incompatible with PT|1
4677805|NCT02612727|16101087|P1|Overall Study|Needed treatment incompatible with PT|1
4677806|NCT02612727|16101086|P2|Overall Study|Parent request|1
4677807|NCT02612727|16101087|P1|Overall Study|Parent request|4
4677808|NCT02612623|16101146|P4|Overall Study|Adverse Event|0
4677809|NCT02612623|16101147|P3|Overall Study|Adverse Event|1
4677810|NCT02612623|16101148|P2|Overall Study|Adverse Event|0
4677811|NCT02612623|16101149|P1|Overall Study|Adverse Event|1
4677812|NCT02612623|16101146|P4|Overall Study|Withdrawal by Subject|0
4677813|NCT02612623|16101147|P3|Overall Study|Withdrawal by Subject|0
4677814|NCT02612623|16101148|P2|Overall Study|Withdrawal by Subject|1
4677815|NCT02612623|16101149|P1|Overall Study|Withdrawal by Subject|0
4677816|NCT02612610|16101163|P4|Overall Study|Cough Improvement|0
4677817|NCT02612610|16101164|P3|Overall Study|Cough Improvement|1
4677818|NCT02612610|16101165|P2|Overall Study|Cough Improvement|0
4677819|NCT02612610|16101166|P1|Overall Study|Cough Improvement|0
4677820|NCT02612610|16101163|P4|Overall Study|Noncompliance|0
4677821|NCT02612610|16101164|P3|Overall Study|Noncompliance|0
4677822|NCT02612610|16101165|P2|Overall Study|Noncompliance|0
4677823|NCT02612610|16101166|P1|Overall Study|Noncompliance|1
4677824|NCT02612610|16101163|P4|Overall Study|Physician Decision|0
4677825|NCT02612610|16101164|P3|Overall Study|Physician Decision|0
4677826|NCT02612610|16101165|P2|Overall Study|Physician Decision|1
4677827|NCT02612610|16101166|P1|Overall Study|Physician Decision|0
4677828|NCT02612610|16101163|P4|Overall Study|Lack of Efficacy|1
4677829|NCT02612610|16101164|P3|Overall Study|Lack of Efficacy|0
4677830|NCT02612610|16101165|P2|Overall Study|Lack of Efficacy|2
4677831|NCT02612610|16101166|P1|Overall Study|Lack of Efficacy|1
4677832|NCT02612610|16101163|P4|Overall Study|Protocol Violation|0
4677833|NCT02612610|16101164|P3|Overall Study|Protocol Violation|1
4677834|NCT02612610|16101165|P2|Overall Study|Protocol Violation|1
4677835|NCT02612610|16101166|P1|Overall Study|Protocol Violation|0
4677836|NCT02612610|16101163|P4|Overall Study|Lost to Follow-up|0
4677837|NCT02612610|16101164|P3|Overall Study|Lost to Follow-up|0
4677838|NCT02612610|16101165|P2|Overall Study|Lost to Follow-up|1
4677839|NCT02612610|16101166|P1|Overall Study|Lost to Follow-up|0
4677840|NCT02612610|16101163|P4|Overall Study|Adverse Event|10
4677841|NCT02612610|16101164|P3|Overall Study|Adverse Event|3
4677842|NCT02612610|16101165|P2|Overall Study|Adverse Event|2
4677843|NCT02612610|16101166|P1|Overall Study|Adverse Event|2
4677844|NCT02612610|16101163|P4|Overall Study|Withdrawal by Subject|2
4677845|NCT02612610|16101164|P3|Overall Study|Withdrawal by Subject|0
4677846|NCT02612610|16101165|P2|Overall Study|Withdrawal by Subject|1
4677847|NCT02612610|16101166|P1|Overall Study|Withdrawal by Subject|1
4677848|NCT02612428|16101410|P2|VTL-308E|Lost to Follow-up|0
4677849|NCT02612428|16101411|P1|VTL-308E|Lost to Follow-up|2
4677850|NCT02612428|16101410|P2|VTL-308E|Death|7
4677851|NCT02612428|16101411|P1|VTL-308E|Death|9
4677852|NCT02612428|16101410|P2|VTL-308|Withdrawal by Subject|1
4677853|NCT02612428|16101411|P1|VTL-308|Withdrawal by Subject|0
4677854|NCT02612428|16101410|P2|VTL-308|Death|16
4677855|NCT02612428|16101411|P1|VTL-308|Death|14
4677856|NCT02612285|16101421|P1|Overall Study|Withdrawal by Subject|1
4677857|NCT02612155|16101427|P2|Overall Study|Lost to Follow-up|2
4677858|NCT02612155|16101428|P1|Overall Study|Lost to Follow-up|2
4677859|NCT02612155|16101427|P2|Overall Study|Death|1
4677860|NCT02612155|16101428|P1|Overall Study|Death|1
4677861|NCT02612077|16101448|P1|Overall Study|Unknown reason|2
4677862|NCT02612077|16101448|P1|Overall Study|Disease Progression|3
4677863|NCT02612077|16101448|P1|Overall Study|Enrollment in a Clinical Trial|1
4677864|NCT02612077|16101448|P1|Overall Study|Moved or Changed Medical Team|23
4677865|NCT02612077|16101448|P1|Overall Study|Death|377
4677866|NCT02612077|16101448|P1|Overall Study|Lost to Follow-up|20
4677867|NCT02612077|16101448|P1|Overall Study|Protocol Violation|28
4677868|NCT02612077|16101448|P1|Overall Study|Withdrawal by Subject|9
4677869|NCT02612077|16101448|P1|Overall Study|Adverse Event|3
4677870|NCT02612064|16101460|P2|Overall Study|Other|2
4677871|NCT02612064|16101461|P1|Overall Study|Other|0
4677872|NCT02612064|16101460|P2|Overall Study|Withdrawal by Subject|1
4677873|NCT02612064|16101461|P1|Overall Study|Withdrawal by Subject|1
4677874|NCT02611830|16101475|P4|Maintenance Phase|Reason not specified|0
4677875|NCT02611830|16101476|P3|Maintenance Phase|Reason not specified|4
4677876|NCT02611830|16101477|P2|Maintenance Phase|Reason not specified|1
4677877|NCT02611830|16101478|P1|Maintenance Phase|Reason not specified|0
4677878|NCT02611830|16101475|P4|Maintenance Phase|Pregnancy|0
4677879|NCT02611830|16101476|P3|Maintenance Phase|Pregnancy|1
4677880|NCT02611830|16101477|P2|Maintenance Phase|Pregnancy|0
4677881|NCT02611830|16101478|P1|Maintenance Phase|Pregnancy|0
4677882|NCT02611830|16101475|P4|Maintenance Phase|Voluntary Withdrawal|5
4677883|NCT02611830|16101476|P3|Maintenance Phase|Voluntary Withdrawal|2
4677884|NCT02611830|16101477|P2|Maintenance Phase|Voluntary Withdrawal|1
4677885|NCT02611830|16101478|P1|Maintenance Phase|Voluntary Withdrawal|0
4677886|NCT02611830|16101475|P4|Maintenance Phase|Lost to Follow-up|1
4677887|NCT02611830|16101476|P3|Maintenance Phase|Lost to Follow-up|0
4677888|NCT02611830|16101477|P2|Maintenance Phase|Lost to Follow-up|0
4677889|NCT02611830|16101478|P1|Maintenance Phase|Lost to Follow-up|0
4677890|NCT02611830|16101475|P4|Maintenance Phase|Significant Protocol Deviation|1
4677891|NCT02611830|16101476|P3|Maintenance Phase|Significant Protocol Deviation|1
4677892|NCT02611830|16101477|P2|Maintenance Phase|Significant Protocol Deviation|0
4677893|NCT02611830|16101478|P1|Maintenance Phase|Significant Protocol Deviation|0
4677894|NCT02611830|16101475|P4|Maintenance Phase|Pretreatment Event/Adverse Event|2
4677895|NCT02611830|16101476|P3|Maintenance Phase|Pretreatment Event/Adverse Event|5
4677896|NCT02611830|16101477|P2|Maintenance Phase|Pretreatment Event/Adverse Event|5
4677897|NCT02611830|16101478|P1|Maintenance Phase|Pretreatment Event/Adverse Event|0
4677898|NCT02611830|16101475|P4|Maintenance Phase|Lack of Efficacy|6
4677899|NCT02611830|16101476|P3|Maintenance Phase|Lack of Efficacy|18
4677900|NCT02611830|16101477|P2|Maintenance Phase|Lack of Efficacy|29
4677901|NCT02611830|16101478|P1|Maintenance Phase|Lack of Efficacy|0
4677902|NCT02611830|16101475|P4|OL Induction Phase|Reason not specified|0
4677903|NCT02611830|16101476|P3|OL Induction Phase|Reason not specified|0
4677904|NCT02611830|16101477|P2|OL Induction Phase|Reason not specified|0
4677905|NCT02611830|16101478|P1|OL Induction Phase|Reason not specified|3
4677906|NCT02611830|16101475|P4|OL Induction Phase|Lack of Efficacy|0
4677907|NCT02611830|16101476|P3|OL Induction Phase|Lack of Efficacy|0
4677908|NCT02611830|16101477|P2|OL Induction Phase|Lack of Efficacy|0
4677909|NCT02611830|16101478|P1|OL Induction Phase|Lack of Efficacy|9
4677910|NCT02611830|16101475|P4|OL Induction Phase|Voluntary Withdrawal|0
4677911|NCT02611830|16101476|P3|OL Induction Phase|Voluntary Withdrawal|0
4677912|NCT02611830|16101477|P2|OL Induction Phase|Voluntary Withdrawal|0
4677913|NCT02611830|16101478|P1|OL Induction Phase|Voluntary Withdrawal|5
4677914|NCT02611830|16101475|P4|OL Induction Phase|Significant Protocol Deviation|0
4677915|NCT02611830|16101476|P3|OL Induction Phase|Significant Protocol Deviation|0
4677916|NCT02611830|16101477|P2|OL Induction Phase|Significant Protocol Deviation|0
4677917|NCT02611830|16101478|P1|OL Induction Phase|Significant Protocol Deviation|4
4677918|NCT02611830|16101475|P4|OL Induction Phase|Pretreatment Event/Adverse Event|0
4677919|NCT02611830|16101476|P3|OL Induction Phase|Pretreatment Event/Adverse Event|0
4677920|NCT02611830|16101477|P2|OL Induction Phase|Pretreatment Event/Adverse Event|0
4677921|NCT02611830|16101478|P1|OL Induction Phase|Pretreatment Event/Adverse Event|9
4677922|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Lost to Follow-up|1
4677923|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Lost to Follow-up|0
4677924|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Lost to Follow-up|0
4677925|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Withdrawal by Subject|14
4677926|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Withdrawal by Subject|5
4677927|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Withdrawal by Subject|0
4677928|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Pregnancy|1
4677929|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Pregnancy|0
4677930|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Pregnancy|0
4677931|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Lack of Efficacy|78
4677932|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Lack of Efficacy|43
4677933|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Lack of Efficacy|0
4677934|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Reason not Specified|2
4677935|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Reason not Specified|1
4677936|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Reason not Specified|0
4677937|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Randomized but not Treated|0
4677938|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Randomized but not Treated|1
4677939|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Randomized but not Treated|0
4677940|NCT02611817|16101502|P3|Double-blind Maintenance Phase|Adverse Event|11
4677941|NCT02611817|16101503|P2|Double-blind Maintenance Phase|Adverse Event|12
4677942|NCT02611817|16101504|P1|Double-blind Maintenance Phase|Adverse Event|0
4677943|NCT02611817|16101502|P3|Open-label Induction Phase|Adverse Event|0
4677944|NCT02611817|16101503|P2|Open-label Induction Phase|Adverse Event|0
4677945|NCT02611817|16101504|P1|Open-label Induction Phase|Adverse Event|16
4677946|NCT02611817|16101502|P3|Open-label Induction Phase|Protocol Violation|0
4677947|NCT02611817|16101503|P2|Open-label Induction Phase|Protocol Violation|0
4677948|NCT02611817|16101504|P1|Open-label Induction Phase|Protocol Violation|5
4677949|NCT02611817|16101502|P3|Open-label Induction Phase|Lost to Follow-up|0
4677950|NCT02611817|16101503|P2|Open-label Induction Phase|Lost to Follow-up|0
4677951|NCT02611817|16101504|P1|Open-label Induction Phase|Lost to Follow-up|2
4677952|NCT02611817|16101502|P3|Open-label Induction Phase|Withdrawal by Subject|0
4677953|NCT02611817|16101503|P2|Open-label Induction Phase|Withdrawal by Subject|0
4677954|NCT02611817|16101504|P1|Open-label Induction Phase|Withdrawal by Subject|9
4677955|NCT02611817|16101502|P3|Open-label Induction Phase|Pregnancy|0
4677956|NCT02611817|16101503|P2|Open-label Induction Phase|Pregnancy|0
4677957|NCT02611817|16101504|P1|Open-label Induction Phase|Pregnancy|1
4677958|NCT02611817|16101502|P3|Open-label Induction Phase|Lack of Efficacy|0
4677959|NCT02611817|16101503|P2|Open-label Induction Phase|Lack of Efficacy|0
4677960|NCT02611817|16101504|P1|Open-label Induction Phase|Lack of Efficacy|8
4677961|NCT02611817|16101502|P3|Open-label Induction Phase|Reason not Specified|0
4677962|NCT02611817|16101503|P2|Open-label Induction Phase|Reason not Specified|0
4677963|NCT02611817|16101504|P1|Open-label Induction Phase|Reason not Specified|9
4677964|NCT02611752|16101528|P2|Overall Study|Adverse Event|1
4677965|NCT02611752|16101529|P1|Overall Study|Adverse Event|0
4677966|NCT02611479|16101561|P1|Data Cleaning|No baseline function or pain metrics|2
4677967|NCT02611479|16101561|P1|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18
4677968|NCT02611479|16101561|P1|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2
4677969|NCT02611479|16101561|P1|Baseline Enrollment|Exited study|13
4677970|NCT02610842|16101693|P1|Overall Study|Lost to Follow-up|5
4677971|NCT02610816|16101702|P4|Phase 2|Pregnancy|1
4677972|NCT02610816|16101703|P3|Phase 2|Pregnancy|0
4677973|NCT02610816|16101704|P2|Phase 2|Pregnancy|0
4677974|NCT02610816|16101705|P1|Phase 2|Pregnancy|0
4677975|NCT02610816|16101702|P4|Phase 2|Physician Decision|2
4677976|NCT02610816|16101703|P3|Phase 2|Physician Decision|0
4677977|NCT02610816|16101704|P2|Phase 2|Physician Decision|0
4677978|NCT02610816|16101705|P1|Phase 2|Physician Decision|0
4677979|NCT02610816|16101702|P4|Phase 2|Lost to Follow-up|0
4677980|NCT02610816|16101703|P3|Phase 2|Lost to Follow-up|2
4677981|NCT02610816|16101704|P2|Phase 2|Lost to Follow-up|0
4677982|NCT02610816|16101705|P1|Phase 2|Lost to Follow-up|0
4677983|NCT02610816|16101702|P4|Phase 2|Withdrawal by Subject|3
4677984|NCT02610816|16101703|P3|Phase 2|Withdrawal by Subject|9
4677985|NCT02610816|16101704|P2|Phase 2|Withdrawal by Subject|0
4677986|NCT02610816|16101705|P1|Phase 2|Withdrawal by Subject|0
4677987|NCT02610816|16101702|P4|Phase 1|Physician Decision|0
4677988|NCT02610816|16101703|P3|Phase 1|Physician Decision|0
4677989|NCT02610816|16101704|P2|Phase 1|Physician Decision|1
4677990|NCT02610816|16101705|P1|Phase 1|Physician Decision|0
4677991|NCT02610816|16101702|P4|Phase 1|Lost to Follow-up|0
4677992|NCT02610816|16101703|P3|Phase 1|Lost to Follow-up|0
4677993|NCT02610816|16101704|P2|Phase 1|Lost to Follow-up|1
4677994|NCT02610816|16101705|P1|Phase 1|Lost to Follow-up|2
4677995|NCT02610816|16101702|P4|Phase 1|Withdrawal by Subject|0
4677996|NCT02610816|16101703|P3|Phase 1|Withdrawal by Subject|0
4677997|NCT02610816|16101704|P2|Phase 1|Withdrawal by Subject|6
4677998|NCT02610816|16101705|P1|Phase 1|Withdrawal by Subject|2
4677999|NCT02610777|16101728|P2|Overall Study|Ongoing on Treatment|7
4678000|NCT02610777|16101729|P1|Overall Study|Ongoing on Treatment|6
4678001|NCT02610777|16101728|P2|Overall Study|Other|1
4678002|NCT02610777|16101729|P1|Overall Study|Other|0
4678003|NCT02610777|16101728|P2|Overall Study|Withdrawal by Subject|2
4678004|NCT02610777|16101729|P1|Overall Study|Withdrawal by Subject|1
4678005|NCT02610777|16101728|P2|Overall Study|Ongoing in Follow-up|12
4678006|NCT02610777|16101729|P1|Overall Study|Ongoing in Follow-up|14
4678007|NCT02610725|16101735|P1|Overall Study|self-reported contraindication|9
4678008|NCT02610725|16101735|P1|Overall Study|Lost to Follow-up|197
4678009|NCT02610231|16101750|P1|Overall Study|Other|3
4678010|NCT02610231|16101750|P1|Overall Study|Non Compliance|2
4678011|NCT02610231|16101750|P1|Overall Study|Physician Decision|1
4678012|NCT02610231|16101750|P1|Overall Study|Surgery|2
4678013|NCT02610231|16101750|P1|Overall Study|Death|5
4678014|NCT02610231|16101750|P1|Overall Study|Adverse Event|20
4678015|NCT02610231|16101750|P1|Overall Study|Withdrawal by Subject|27
4678016|NCT02610192|16101757|P1|Overall Study|Physician Decision|1
4678017|NCT02610192|16101757|P1|Overall Study|Received other treatment|8
4678018|NCT02610140|16101772|P2|Long-term Follow-up|Ongoing but not completed|17
4678019|NCT02610140|16101773|P1|Long-term Follow-up|Ongoing but not completed|30
4678020|NCT02610140|16101772|P2|Long-term Follow-up|Lost to Follow-up|2
4678021|NCT02610140|16101773|P1|Long-term Follow-up|Lost to Follow-up|1
4678022|NCT02610140|16101772|P2|Long-term Follow-up|Withdrawal by Subject|3
4678023|NCT02610140|16101773|P1|Long-term Follow-up|Withdrawal by Subject|6
4678024|NCT02610140|16101772|P2|Long-term Follow-up|Death|44
4678025|NCT02610140|16101773|P1|Long-term Follow-up|Death|86
4678026|NCT02610140|16101772|P2|Active Follow-up|Ongoing but not completed|1
4678027|NCT02610140|16101773|P1|Active Follow-up|Ongoing but not completed|4
4678028|NCT02610140|16101772|P2|Active Follow-up|Deterioration of general conditions|0
4678029|NCT02610140|16101773|P1|Active Follow-up|Deterioration of general conditions|1
4678030|NCT02610140|16101772|P2|Active Follow-up|Progressive disease - clinical|2
4678031|NCT02610140|16101773|P1|Active Follow-up|Progressive disease - clinical|1
4678032|NCT02610140|16101772|P2|Active Follow-up|Withdrawal by Subject|0
4678033|NCT02610140|16101773|P1|Active Follow-up|Withdrawal by Subject|4
4678034|NCT02610140|16101772|P2|Active Follow-up|Death|1
4678035|NCT02610140|16101773|P1|Active Follow-up|Death|8
4678036|NCT02610140|16101772|P2|Active Follow-up|Progressive disease - radiological|22
4678037|NCT02610140|16101773|P1|Active Follow-up|Progressive disease - radiological|30
4678038|NCT02610140|16101772|P2|Safety Follow-up|Withdrawal by Subject|12
4678039|NCT02610140|16101773|P1|Safety Follow-up|Withdrawal by Subject|12
4678040|NCT02610140|16101772|P2|Safety Follow-up|Deterioration of general conditions|5
4678041|NCT02610140|16101773|P1|Safety Follow-up|Deterioration of general conditions|15
4678042|NCT02610140|16101772|P2|Safety Follow-up|Death|2
4678043|NCT02610140|16101773|P1|Safety Follow-up|Death|12
4678044|NCT02610140|16101772|P2|Safety Follow-up|No follow-up|3
4678045|NCT02610140|16101773|P1|Safety Follow-up|No follow-up|5
4678046|NCT02610140|16101772|P2|Safety Follow-up|Lost to Follow-up|0
4678047|NCT02610140|16101773|P1|Safety Follow-up|Lost to Follow-up|1
4678048|NCT02610140|16101772|P2|Safety Follow-up|Other|2
4678049|NCT02610140|16101773|P1|Safety Follow-up|Other|0
4678050|NCT02610140|16101772|P2|Randomization and Treatment Period|Not treated|10
4678051|NCT02610140|16101773|P1|Randomization and Treatment Period|Not treated|3
4678052|NCT02610140|16101772|P2|Randomization and Treatment Period|Ongoing but not completed|2
4678053|NCT02610140|16101773|P1|Randomization and Treatment Period|Ongoing but not completed|9
4678054|NCT02610140|16101772|P2|Randomization and Treatment Period|Progressive disease - clinical|5
4678055|NCT02610140|16101773|P1|Randomization and Treatment Period|Progressive disease - clinical|12
4678056|NCT02610140|16101772|P2|Randomization and Treatment Period|Adverse Event|13
4678057|NCT02610140|16101773|P1|Randomization and Treatment Period|Adverse Event|44
4678058|NCT02610140|16101772|P2|Randomization and Treatment Period|Withdrawal by Subject|12
4678059|NCT02610140|16101773|P1|Randomization and Treatment Period|Withdrawal by Subject|12
4678060|NCT02610140|16101772|P2|Randomization and Treatment Period|Death|1
4678061|NCT02610140|16101773|P1|Randomization and Treatment Period|Death|7
4678062|NCT02610140|16101772|P2|Randomization and Treatment Period|Lack of Efficacy|0
4678063|NCT02610140|16101773|P1|Randomization and Treatment Period|Lack of Efficacy|1
4678064|NCT02610140|16101772|P2|Randomization and Treatment Period|Physician Decision|1
4678065|NCT02610140|16101773|P1|Randomization and Treatment Period|Physician Decision|0
4678066|NCT02610140|16101772|P2|Randomization and Treatment Period|Protocol Violation|0
4678067|NCT02610140|16101773|P1|Randomization and Treatment Period|Protocol Violation|1
4678068|NCT02610140|16101772|P2|Randomization and Treatment Period|Progressive disease - radiological|23
4678069|NCT02610140|16101773|P1|Randomization and Treatment Period|Progressive disease - radiological|54
4678070|NCT02610140|16101772|P2|Randomization and Treatment Period|Radiological progression|15
4678071|NCT02610140|16101773|P1|Randomization and Treatment Period|Radiological progression|23
4678072|NCT02609984|16101803|P2|Overall Study|Disease Progression|0
4678073|NCT02609984|16101804|P1|Overall Study|Disease Progression|2
4678074|NCT02609984|16101803|P2|Overall Study|Withdrawal by Subject|1
4678075|NCT02609984|16101804|P1|Overall Study|Withdrawal by Subject|0
4678076|NCT02609984|16101803|P2|Overall Study|Lost to Follow-up|2
4678077|NCT02609984|16101804|P1|Overall Study|Lost to Follow-up|1
4678078|NCT02609984|16101803|P2|Overall Study|Participation Discontinued by Sponsor|10
4678079|NCT02609984|16101804|P1|Overall Study|Participation Discontinued by Sponsor|12
4678080|NCT02609984|16101803|P2|Overall Study|Death|26
4678081|NCT02609984|16101804|P1|Overall Study|Death|29
4678082|NCT02609672|16101846|P2|Overall Study|Lost to Follow-up|1
4678083|NCT02609672|16101847|P1|Overall Study|Lost to Follow-up|3
4678084|NCT02609659|16101881|P1|Overall Study|Other|1
4678085|NCT02609659|16101881|P1|Overall Study|Lost to Follow-up|6
4678086|NCT02609659|16101881|P1|Overall Study|Adverse Event|1
4678087|NCT02609633|16101891|P2|Overall Study|Reason not Specified|1
4678088|NCT02609633|16101892|P1|Overall Study|Reason not Specified|2
4678089|NCT02609633|16101891|P2|Overall Study|Non-Compliant with Study Procedures|0
4678090|NCT02609633|16101892|P1|Overall Study|Non-Compliant with Study Procedures|2
4678091|NCT02609633|16101891|P2|Overall Study|Protocol Deviation|0
4678092|NCT02609633|16101892|P1|Overall Study|Protocol Deviation|1
4678093|NCT02609633|16101891|P2|Overall Study|Consent Withdrawn|1
4678094|NCT02609633|16101892|P1|Overall Study|Consent Withdrawn|0
4678095|NCT02609607|16101919|P2|Overall Study|Lost to Follow-up|1
4678096|NCT02609607|16101920|P1|Overall Study|Lost to Follow-up|0
4678097|NCT02609399|16101944|P2|Influenza Season 2016-2017|Found ineligible after randomization|0
4678098|NCT02609399|16101945|P1|Influenza Season 2016-2017|Found ineligible after randomization|1
4678099|NCT02609399|16101944|P2|Influenza Season 2016-2017|Lost to Follow-up|5
4678100|NCT02609399|16101945|P1|Influenza Season 2016-2017|Lost to Follow-up|8
4678101|NCT02609399|16101944|P2|Influenza Season 2015-2016|Lost to Follow-up|2
4678102|NCT02609399|16101945|P1|Influenza Season 2015-2016|Lost to Follow-up|3
4678103|NCT02609178|16101975|P6|First Crown|Withdrawal by Subject|0
4678104|NCT02609178|16101976|P5|First Crown|Withdrawal by Subject|0
4678105|NCT02609178|16101977|P4|First Crown|Withdrawal by Subject|1
4678106|NCT02609178|16101978|P3|First Crown|Withdrawal by Subject|1
4678107|NCT02609178|16101979|P2|First Crown|Withdrawal by Subject|0
4678108|NCT02609178|16101980|P1|First Crown|Withdrawal by Subject|0
4678109|NCT02608892|16102042|P2|Overall Study|Lost to Follow-up|0
4678110|NCT02608892|16102043|P1|Overall Study|Lost to Follow-up|1
4678111|NCT02608879|16102055|P3|Overall Study|Did not meet continuation criteria|3
4678112|NCT02608879|16102056|P2|Overall Study|Did not meet continuation criteria|0
4678113|NCT02608879|16102057|P1|Overall Study|Did not meet continuation criteria|0
4678114|NCT02608879|16102055|P3|Overall Study|Lost to Follow-up|0
4678115|NCT02608879|16102056|P2|Overall Study|Lost to Follow-up|0
4678116|NCT02608879|16102057|P1|Overall Study|Lost to Follow-up|1
4678117|NCT02608684|16102076|P1|Overall Study|Withdrawal by Subject|1
4678118|NCT02608684|16102076|P1|Overall Study|Physician Decision|2
4678119|NCT02608099|16102163|P2|Overall Study|Ablation procedure not initiated|2
4678120|NCT02608099|16102164|P1|Overall Study|Ablation procedure not initiated|3
4678121|NCT02607956|16102202|P2|Overall Study|Lost to Follow-up|15
4678122|NCT02607956|16102203|P1|Overall Study|Lost to Follow-up|18
4678123|NCT02607956|16102202|P2|Overall Study|Withdrew Consent|16
4678124|NCT02607956|16102203|P1|Overall Study|Withdrew Consent|16
4678125|NCT02607956|16102202|P2|Overall Study|Protocol Violation|1
4678126|NCT02607956|16102203|P1|Overall Study|Protocol Violation|3
4678127|NCT02607956|16102202|P2|Overall Study|Non-Compliance with Study Drug|3
4678128|NCT02607956|16102203|P1|Overall Study|Non-Compliance with Study Drug|0
4678129|NCT02607956|16102202|P2|Overall Study|Investigator's Discretion|2
4678130|NCT02607956|16102203|P1|Overall Study|Investigator's Discretion|7
4678131|NCT02607956|16102202|P2|Overall Study|Death|4
4678132|NCT02607956|16102203|P1|Overall Study|Death|4
4678133|NCT02607956|16102202|P2|Overall Study|Adverse Event|3
4678134|NCT02607956|16102203|P1|Overall Study|Adverse Event|4
4678135|NCT02607956|16102202|P2|Overall Study|Still on Study|281
4678136|NCT02607956|16102203|P1|Overall Study|Still on Study|268
4678137|NCT02607956|16102202|P2|Overall Study|Randomized and Never Treated|5
4678138|NCT02607956|16102203|P1|Overall Study|Randomized and Never Treated|7
4678139|NCT02607930|16102233|P2|Overall Study|Lost to Follow-up|16
4678140|NCT02607930|16102234|P1|Overall Study|Lost to Follow-up|24
4678141|NCT02607930|16102233|P2|Overall Study|Withdrew Consent|15
4678142|NCT02607930|16102234|P1|Overall Study|Withdrew Consent|14
4678143|NCT02607930|16102233|P2|Overall Study|Protocol Violation|3
4678144|NCT02607930|16102234|P1|Overall Study|Protocol Violation|2
4678145|NCT02607930|16102233|P2|Overall Study|Non-Compliance with Study Drug|5
4678146|NCT02607930|16102234|P1|Overall Study|Non-Compliance with Study Drug|3
4678147|NCT02607930|16102233|P2|Overall Study|Investigator's Discretion|2
4678148|NCT02607930|16102234|P1|Overall Study|Investigator's Discretion|6
4678149|NCT02607930|16102233|P2|Overall Study|Death|1
4678150|NCT02607930|16102234|P1|Overall Study|Death|2
4678151|NCT02607930|16102233|P2|Overall Study|Adverse Event|4
4678152|NCT02607930|16102234|P1|Overall Study|Adverse Event|0
4678153|NCT02607930|16102233|P2|Overall Study|Still in Study|269
4678154|NCT02607930|16102234|P1|Overall Study|Still in Study|263
4678155|NCT02607930|16102233|P2|Overall Study|Randomized and Never Treated|0
4678156|NCT02607930|16102234|P1|Overall Study|Randomized and Never Treated|2
4678157|NCT02607865|16102278|P4|Overall Study|Unclassified|0
4678158|NCT02607865|16102279|P3|Overall Study|Unclassified|2
4678159|NCT02607865|16102280|P2|Overall Study|Unclassified|1
4678160|NCT02607865|16102281|P1|Overall Study|Unclassified|1
4678161|NCT02607865|16102278|P4|Overall Study|Death|3
4678162|NCT02607865|16102279|P3|Overall Study|Death|1
4678163|NCT02607865|16102280|P2|Overall Study|Death|4
4678164|NCT02607865|16102281|P1|Overall Study|Death|5
4678165|NCT02607865|16102278|P4|Overall Study|Withdrawal by Subject|8
4678166|NCT02607865|16102279|P3|Overall Study|Withdrawal by Subject|17
4678167|NCT02607865|16102280|P2|Overall Study|Withdrawal by Subject|18
4678168|NCT02607865|16102281|P1|Overall Study|Withdrawal by Subject|18
4678169|NCT02607865|16102278|P4|Overall Study|Lost to Follow-up|5
4678170|NCT02607865|16102279|P3|Overall Study|Lost to Follow-up|7
4678171|NCT02607865|16102280|P2|Overall Study|Lost to Follow-up|7
4678172|NCT02607865|16102281|P1|Overall Study|Lost to Follow-up|9
4678173|NCT02607800|16102455|P2|Overall Study|Randomized/Enrolled but Not Treated|1
4678174|NCT02607800|16102456|P1|Overall Study|Randomized/Enrolled but Not Treated|1
4678175|NCT02607800|16102455|P2|Overall Study|Withdrew Consent|0
4678176|NCT02607800|16102456|P1|Overall Study|Withdrew Consent|2
4678177|NCT02607800|16102455|P2|Overall Study|Lost to Follow-up|10
4678178|NCT02607800|16102456|P1|Overall Study|Lost to Follow-up|7
4678179|NCT02607735|16102474|P3|Deferred Treatment Substudy|Withdrew Consent|1
4678180|NCT02607735|16102475|P2|Deferred Treatment Substudy|Withdrew Consent|0
4678181|NCT02607735|16102476|P1|Deferred Treatment Substudy|Withdrew Consent|0
4678182|NCT02607735|16102474|P3|Deferred Treatment Substudy|Lost to Follow-up|4
4678183|NCT02607735|16102475|P2|Deferred Treatment Substudy|Lost to Follow-up|0
4678184|NCT02607735|16102476|P1|Deferred Treatment Substudy|Lost to Follow-up|0
4678185|NCT02607735|16102474|P3|Primary Study|Withdrew Consent|0
4678186|NCT02607735|16102475|P2|Primary Study|Withdrew Consent|0
4678187|NCT02607735|16102476|P1|Primary Study|Withdrew Consent|2
4678188|NCT02607735|16102474|P3|Primary Study|Lost to Follow-up|0
4678189|NCT02607735|16102475|P2|Primary Study|Lost to Follow-up|0
4678190|NCT02607735|16102476|P1|Primary Study|Lost to Follow-up|4
4678191|NCT02607735|16102474|P3|Primary Study|Randomized but Never Treated|0
4678192|NCT02607735|16102475|P2|Primary Study|Randomized but Never Treated|0
4678193|NCT02607735|16102476|P1|Primary Study|Randomized but Never Treated|1
4678194|NCT02607306|16102510|P3|Overall Study|Protocol Violation|1
4678195|NCT02607306|16102511|P2|Overall Study|Protocol Violation|2
4678196|NCT02607306|16102512|P1|Overall Study|Protocol Violation|4
4678197|NCT02607306|16102510|P3|Overall Study|Lack of Efficacy|1
4678198|NCT02607306|16102511|P2|Overall Study|Lack of Efficacy|1
4678199|NCT02607306|16102512|P1|Overall Study|Lack of Efficacy|0
4678200|NCT02607306|16102510|P3|Overall Study|Withdrawal by Subject|2
4678201|NCT02607306|16102511|P2|Overall Study|Withdrawal by Subject|10
4678202|NCT02607306|16102512|P1|Overall Study|Withdrawal by Subject|8
4678203|NCT02607306|16102510|P3|Overall Study|Unclassified|0
4678204|NCT02607306|16102511|P2|Overall Study|Unclassified|4
4678205|NCT02607306|16102512|P1|Overall Study|Unclassified|1
4678206|NCT02607306|16102510|P3|Overall Study|Adverse Event|6
4678207|NCT02607306|16102511|P2|Overall Study|Adverse Event|6
4678208|NCT02607306|16102512|P1|Overall Study|Adverse Event|8
4678209|NCT02607280|16102634|P2|Overall Study|Decrease in CrCl <15|1
4678210|NCT02607280|16102635|P1|Overall Study|Decrease in CrCl <15|0
4678211|NCT02607280|16102634|P2|Overall Study|Adverse Event|0
4678212|NCT02607280|16102635|P1|Overall Study|Adverse Event|4
4678213|NCT02606877|16102680|P2|Overall Study|Other than listed above|0
4678214|NCT02606877|16102681|P1|Overall Study|Other than listed above|1
4678215|NCT02606877|16102680|P2|Overall Study|Non-compliance with protocol|1
4678216|NCT02606877|16102681|P1|Overall Study|Non-compliance with protocol|0
4678217|NCT02606877|16102680|P2|Overall Study|Adverse Event|0
4678218|NCT02606877|16102681|P1|Overall Study|Adverse Event|3
4678219|NCT02606643|16102720|P2|Overall Study|did not meet inclusion criteria|3
4678220|NCT02606643|16102721|P1|Overall Study|did not meet inclusion criteria|1
4678221|NCT02606279|16102779|P2|Overall Study|Lost to Follow-up|1
4678222|NCT02606279|16102780|P1|Overall Study|Lost to Follow-up|0
4678223|NCT02606253|16102795|P3|Overall Study|Physician Decision|0
4678224|NCT02606253|16102796|P2|Overall Study|Physician Decision|1
4678225|NCT02606253|16102797|P1|Overall Study|Physician Decision|1
4678226|NCT02606253|16102795|P3|Overall Study|Protocol Violation|0
4678227|NCT02606253|16102796|P2|Overall Study|Protocol Violation|1
4678228|NCT02606253|16102797|P1|Overall Study|Protocol Violation|2
4678229|NCT02606253|16102795|P3|Overall Study|Adverse Event|0
4678230|NCT02606253|16102796|P2|Overall Study|Adverse Event|0
4678231|NCT02606253|16102797|P1|Overall Study|Adverse Event|2
4678232|NCT02605954|16102899|P2|Overall Study|Randomized but not treated|1
4678233|NCT02605954|16102900|P1|Overall Study|Randomized but not treated|0
4678234|NCT02605954|16102899|P2|Overall Study|Lost to Follow-up|0
4678235|NCT02605954|16102900|P1|Overall Study|Lost to Follow-up|3
4678236|NCT02605954|16102899|P2|Overall Study|Withdrew Consent|2
4678237|NCT02605954|16102900|P1|Overall Study|Withdrew Consent|2
4678238|NCT02605954|16102899|P2|Overall Study|Non-Compliance with Study Drug|0
4678239|NCT02605954|16102900|P1|Overall Study|Non-Compliance with Study Drug|1
4678240|NCT02605954|16102899|P2|Overall Study|Investigator's Discretion|0
4678241|NCT02605954|16102900|P1|Overall Study|Investigator's Discretion|1
4678242|NCT02605954|16102899|P2|Overall Study|Adverse Event|1
4678243|NCT02605954|16102900|P1|Overall Study|Adverse Event|5
4678244|NCT02605928|16102917|P1|Overall Study|Lack of Efficacy|5
4678245|NCT02605928|16102917|P1|Overall Study|Model tuning phase|28
4678246|NCT02605837|16102960|P2|Overall Study|Physician Decision|1
4678247|NCT02605837|16102961|P1|Overall Study|Physician Decision|0
4678248|NCT02605837|16102960|P2|Overall Study|Withdrawal by Subject|8
4678249|NCT02605837|16102961|P1|Overall Study|Withdrawal by Subject|8
4678250|NCT02605837|16102960|P2|Overall Study|Non-Compliance with Study Drug|1
4678251|NCT02605837|16102961|P1|Overall Study|Non-Compliance with Study Drug|0
4678252|NCT02605837|16102960|P2|Overall Study|Adverse Event|1
4678253|NCT02605837|16102961|P1|Overall Study|Adverse Event|3
4678254|NCT02605824|16103000|P2|Overall Study|Physician Decision|0
4678255|NCT02605824|16103001|P1|Overall Study|Physician Decision|1
4678256|NCT02605642|16103011|P2|Overall Study|Lack of response|11
4678257|NCT02605642|16103012|P1|Overall Study|Lack of response|24
4678258|NCT02605642|16103011|P2|Overall Study|Withdrawal by Subject|2
4678259|NCT02605642|16103012|P1|Overall Study|Withdrawal by Subject|23
4678260|NCT02605642|16103011|P2|Overall Study|Adverse Event|2
4678261|NCT02605642|16103012|P1|Overall Study|Adverse Event|14
4678262|NCT02605642|16103011|P2|Overall Study|Lost to Follow-up|1
4678263|NCT02605642|16103012|P1|Overall Study|Lost to Follow-up|12
4678264|NCT02605642|16103011|P2|Overall Study|Physician Decision|0
4678265|NCT02605642|16103012|P1|Overall Study|Physician Decision|10
4678266|NCT02605642|16103011|P2|Overall Study|Participant non-compliance|4
4678267|NCT02605642|16103012|P1|Overall Study|Participant non-compliance|2
4678268|NCT02605642|16103011|P2|Overall Study|Other|1
4678269|NCT02605642|16103012|P1|Overall Study|Other|11
4678270|NCT02605447|16103054|P1|Overall Study|Not disclosed|1
4678271|NCT02605447|16103054|P1|Overall Study|Withdrawal by Subject|10
4678272|NCT02605447|16103054|P1|Overall Study|Lost to Follow-up|24
4678273|NCT02605447|16103054|P1|Overall Study|Physician Decision|1
4678274|NCT02605447|16103054|P1|Overall Study|Death|66
4678275|NCT02605174|16103165|P7|Overall Study|Randomization Failure|30
4678276|NCT02605174|16103166|P6|Overall Study|Randomization Failure|11
4678277|NCT02605174|16103167|P5|Overall Study|Randomization Failure|16
4678278|NCT02605174|16103168|P4|Overall Study|Randomization Failure|7
4678279|NCT02605174|16103169|P3|Overall Study|Randomization Failure|20
4678280|NCT02605174|16103170|P2|Overall Study|Randomization Failure|6
4678281|NCT02605174|16103171|P1|Overall Study|Randomization Failure|22
4678282|NCT02605174|16103165|P7|Overall Study|Physician Decision|3
4678283|NCT02605174|16103166|P6|Overall Study|Physician Decision|0
4678284|NCT02605174|16103167|P5|Overall Study|Physician Decision|0
4678285|NCT02605174|16103168|P4|Overall Study|Physician Decision|0
4678286|NCT02605174|16103169|P3|Overall Study|Physician Decision|0
4678287|NCT02605174|16103170|P2|Overall Study|Physician Decision|0
4678288|NCT02605174|16103171|P1|Overall Study|Physician Decision|2
4678289|NCT02605174|16103165|P7|Overall Study|Withdrawal by Subject|15
4678290|NCT02605174|16103166|P6|Overall Study|Withdrawal by Subject|4
4678291|NCT02605174|16103167|P5|Overall Study|Withdrawal by Subject|6
4678292|NCT02605174|16103168|P4|Overall Study|Withdrawal by Subject|11
4678293|NCT02605174|16103169|P3|Overall Study|Withdrawal by Subject|14
4678294|NCT02605174|16103170|P2|Overall Study|Withdrawal by Subject|6
4678295|NCT02605174|16103171|P1|Overall Study|Withdrawal by Subject|9
4678296|NCT02605174|16103165|P7|Overall Study|Pregnancy|0
4678297|NCT02605174|16103166|P6|Overall Study|Pregnancy|0
4678298|NCT02605174|16103167|P5|Overall Study|Pregnancy|0
4678299|NCT02605174|16103168|P4|Overall Study|Pregnancy|2
4678300|NCT02605174|16103169|P3|Overall Study|Pregnancy|0
4678301|NCT02605174|16103170|P2|Overall Study|Pregnancy|0
4678302|NCT02605174|16103171|P1|Overall Study|Pregnancy|1
4678303|NCT02605174|16103165|P7|Overall Study|Protocol Violation|12
4678304|NCT02605174|16103166|P6|Overall Study|Protocol Violation|7
4678305|NCT02605174|16103167|P5|Overall Study|Protocol Violation|7
4678306|NCT02605174|16103168|P4|Overall Study|Protocol Violation|6
4678307|NCT02605174|16103169|P3|Overall Study|Protocol Violation|14
4678308|NCT02605174|16103170|P2|Overall Study|Protocol Violation|4
4678309|NCT02605174|16103171|P1|Overall Study|Protocol Violation|10
4678310|NCT02605174|16103165|P7|Overall Study|Lost to Follow-up|29
4678311|NCT02605174|16103166|P6|Overall Study|Lost to Follow-up|10
4678312|NCT02605174|16103167|P5|Overall Study|Lost to Follow-up|20
4678313|NCT02605174|16103168|P4|Overall Study|Lost to Follow-up|10
4678314|NCT02605174|16103169|P3|Overall Study|Lost to Follow-up|27
4678315|NCT02605174|16103170|P2|Overall Study|Lost to Follow-up|7
4678316|NCT02605174|16103171|P1|Overall Study|Lost to Follow-up|20
4678317|NCT02605174|16103165|P7|Overall Study|Adverse Event|0
4678318|NCT02605174|16103166|P6|Overall Study|Adverse Event|0
4678319|NCT02605174|16103167|P5|Overall Study|Adverse Event|4
4678320|NCT02605174|16103168|P4|Overall Study|Adverse Event|0
4678321|NCT02605174|16103169|P3|Overall Study|Adverse Event|1
4678322|NCT02605174|16103170|P2|Overall Study|Adverse Event|0
4678323|NCT02605174|16103171|P1|Overall Study|Adverse Event|0
4678324|NCT02605122|16103233|P2|Overall Study|Lost to Follow-up|1
4678325|NCT02605122|16103234|P1|Overall Study|Lost to Follow-up|1
4678326|NCT02605122|16103233|P2|Overall Study|Withdrawal by Subject|1
4678327|NCT02605122|16103234|P1|Overall Study|Withdrawal by Subject|4
4678328|NCT02604589|16103257|P3|Overall Study|catheter dislodgement|1
4678329|NCT02604589|16103258|P2|Overall Study|catheter dislodgement|0
4678330|NCT02604589|16103259|P1|Overall Study|catheter dislodgement|0
4678331|NCT02604550|16103287|P2|Overall Study|Incomplete data using paper journal|19
4678332|NCT02604550|16103288|P1|Overall Study|Incomplete data using paper journal|18
4678333|NCT02604550|16103287|P2|Overall Study|Withdrawal by Subject|1
4678334|NCT02604550|16103288|P1|Overall Study|Withdrawal by Subject|0
4678335|NCT02604550|16103287|P2|Overall Study|Lost to Follow-up|6
4678336|NCT02604550|16103288|P1|Overall Study|Lost to Follow-up|7
4678337|NCT02604433|16103314|P2|Post Treatment Follow-up Period|Follow-up is ongoing|24
4678338|NCT02604433|16103315|P1|Post Treatment Follow-up Period|Follow-up is ongoing|42
4678339|NCT02604433|16103314|P2|Double-blind Treatment Period|Study is ongoing|74
4678340|NCT02604433|16103315|P1|Double-blind Treatment Period|Study is ongoing|156
4678341|NCT02604433|16103314|P2|Double-blind Treatment Period|D/C TRT: protocol violation|0
4678342|NCT02604433|16103315|P1|Double-blind Treatment Period|D/C TRT: protocol violation|1
4678343|NCT02604433|16103314|P2|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
4678344|NCT02604433|16103315|P1|Double-blind Treatment Period|D/C TRT: other, e.g. moved, personal|3
4678345|NCT02604433|16103314|P2|Double-blind Treatment Period|D/C TRT: lack of efficacy|8
4678346|NCT02604433|16103315|P1|Double-blind Treatment Period|D/C TRT: lack of efficacy|2
4678347|NCT02604433|16103314|P2|Double-blind Treatment Period|D/C TRT: adverse event|1
4678348|NCT02604433|16103315|P1|Double-blind Treatment Period|D/C TRT: adverse event|10
4678349|NCT02604433|16103314|P2|Double-blind Treatment Period|D/C TRT: withdrawal by subject|12
4678350|NCT02604433|16103315|P1|Double-blind Treatment Period|D/C TRT: withdrawal by subject|26
4678351|NCT02604433|16103314|P2|Double-blind Treatment Period|Death|1
4678352|NCT02604433|16103315|P1|Double-blind Treatment Period|Death|1
4678353|NCT02604433|16103314|P2|Double-blind Treatment Period|Personal reasons or moved|1
4678354|NCT02604433|16103315|P1|Double-blind Treatment Period|Personal reasons or moved|2
4678355|NCT02604433|16103314|P2|Double-blind Treatment Period|Adverse Event|0
4678356|NCT02604433|16103315|P1|Double-blind Treatment Period|Adverse Event|4
4678357|NCT02604433|16103314|P2|Double-blind Treatment Period|Withdrawal by Subject|6
4678358|NCT02604433|16103315|P1|Double-blind Treatment Period|Withdrawal by Subject|13
4678359|NCT02604407|16103384|P3|Overall Study|Other|4
4678360|NCT02604407|16103385|P2|Overall Study|Other|1
4678361|NCT02604407|16103386|P1|Overall Study|Other|3
4678362|NCT02604407|16103384|P3|Overall Study|Lack of Efficacy|0
4678363|NCT02604407|16103385|P2|Overall Study|Lack of Efficacy|0
4678364|NCT02604407|16103386|P1|Overall Study|Lack of Efficacy|1
4678365|NCT02604407|16103384|P3|Overall Study|Lost to Follow-up|2
4678366|NCT02604407|16103385|P2|Overall Study|Lost to Follow-up|1
4678367|NCT02604407|16103386|P1|Overall Study|Lost to Follow-up|2
4678368|NCT02604407|16103384|P3|Overall Study|Withdrawal by Subject|5
4678369|NCT02604407|16103385|P2|Overall Study|Withdrawal by Subject|3
4678370|NCT02604407|16103386|P1|Overall Study|Withdrawal by Subject|3
4678371|NCT02604407|16103384|P3|Overall Study|Protocol Violation|0
4678372|NCT02604407|16103385|P2|Overall Study|Protocol Violation|0
4678373|NCT02604407|16103386|P1|Overall Study|Protocol Violation|2
4678374|NCT02604407|16103384|P3|Overall Study|Adverse Event|5
4678375|NCT02604407|16103385|P2|Overall Study|Adverse Event|7
4678376|NCT02604407|16103386|P1|Overall Study|Adverse Event|0
4678377|NCT02604342|16103399|P2|Overall Study|Physician Decision|0
4678378|NCT02604342|16103400|P1|Overall Study|Physician Decision|2
4678379|NCT02604342|16103399|P2|Overall Study|Lost to Follow-up|1
4678380|NCT02604342|16103400|P1|Overall Study|Lost to Follow-up|1
4678381|NCT02604342|16103399|P2|Overall Study|Study Termination by Sponsor|0
4678382|NCT02604342|16103400|P1|Overall Study|Study Termination by Sponsor|1
4678383|NCT02604342|16103399|P2|Overall Study|Other|0
4678384|NCT02604342|16103400|P1|Overall Study|Other|1
4678385|NCT02604342|16103399|P2|Overall Study|Withdrawal by Subject|6
4678386|NCT02604342|16103400|P1|Overall Study|Withdrawal by Subject|5
4678387|NCT02604342|16103399|P2|Overall Study|Progression of disease|0
4678388|NCT02604342|16103400|P1|Overall Study|Progression of disease|1
4678389|NCT02604342|16103399|P2|Overall Study|Death|16
4678390|NCT02604342|16103400|P1|Overall Study|Death|32
4678391|NCT02604264|16103452|P2|Intervention|Didn't use CVC for at least 21 days|242
4678392|NCT02604264|16103453|P1|Intervention|Didn't use CVC for at least 21 days|200
4678393|NCT02604212|16103463|P4|Overall Study|Withdrawal by Subject|0
4678394|NCT02604212|16103464|P3|Overall Study|Withdrawal by Subject|1
4678395|NCT02604212|16103465|P2|Overall Study|Withdrawal by Subject|0
4678396|NCT02604212|16103466|P1|Overall Study|Withdrawal by Subject|0
4678397|NCT02604212|16103463|P4|Overall Study|Study Terminated by Sponsor|3
4678398|NCT02604212|16103464|P3|Overall Study|Study Terminated by Sponsor|3
4678399|NCT02604212|16103465|P2|Overall Study|Study Terminated by Sponsor|1
4678400|NCT02604212|16103466|P1|Overall Study|Study Terminated by Sponsor|2
4678401|NCT02604199|16103534|P4|Overall Study|Withdrawal by Subject|0
4678402|NCT02604199|16103535|P3|Overall Study|Withdrawal by Subject|0
4678403|NCT02604199|16103536|P2|Overall Study|Withdrawal by Subject|1
4678404|NCT02604199|16103537|P1|Overall Study|Withdrawal by Subject|0
4678405|NCT02604199|16103534|P4|Overall Study|Study terminated by sponsor|2
4678406|NCT02604199|16103535|P3|Overall Study|Study terminated by sponsor|0
4678407|NCT02604199|16103536|P2|Overall Study|Study terminated by sponsor|2
4678408|NCT02604199|16103537|P1|Overall Study|Study terminated by sponsor|0
4678409|NCT02604199|16103534|P4|Overall Study|Pregnancy|1
4678410|NCT02604199|16103535|P3|Overall Study|Pregnancy|0
4678411|NCT02604199|16103536|P2|Overall Study|Pregnancy|0
4678412|NCT02604199|16103537|P1|Overall Study|Pregnancy|0
4678413|NCT02604160|16103606|P2|Overall Study|Physician Decision|1
4678414|NCT02604160|16103607|P1|Overall Study|Physician Decision|0
4678415|NCT02604160|16103606|P2|Overall Study|Protocol Violation|1
4678416|NCT02604160|16103607|P1|Overall Study|Protocol Violation|0
4678417|NCT02604017|16103621|P2|Overall Study|Other|0
4678418|NCT02604017|16103622|P1|Overall Study|Other|1
4678419|NCT02604017|16103621|P2|Overall Study|Lost to Follow-up|6
4678420|NCT02604017|16103622|P1|Overall Study|Lost to Follow-up|5
4678421|NCT02604017|16103621|P2|Overall Study|Withdrew Consent|2
4678422|NCT02604017|16103622|P1|Overall Study|Withdrew Consent|0
4678423|NCT02603952|16103651|P4|Overall Study|Received oseltamivir by error|1
4678424|NCT02603952|16103652|P3|Overall Study|Received oseltamivir by error|0
4678425|NCT02603952|16103653|P2|Overall Study|Received oseltamivir by error|0
4678426|NCT02603952|16103654|P1|Overall Study|Received oseltamivir by error|0
4678427|NCT02603952|16103651|P4|Overall Study|Withdrawal by Subject|0
4678428|NCT02603952|16103652|P3|Overall Study|Withdrawal by Subject|0
4678429|NCT02603952|16103653|P2|Overall Study|Withdrawal by Subject|0
4678430|NCT02603952|16103654|P1|Overall Study|Withdrawal by Subject|1
4678431|NCT02603887|16103702|P1|Overall Study|Disease progression|1
4678432|NCT02603887|16103702|P1|Overall Study|Adverse Event|4
4678433|NCT02603887|16103702|P1|Overall Study|FDA Guidance|1
4678434|NCT02603809|16103715|P6|Overall Study|Lack of Efficacy|1
4678435|NCT02603809|16103716|P5|Overall Study|Lack of Efficacy|0
4678436|NCT02603809|16103717|P4|Overall Study|Lack of Efficacy|0
4678437|NCT02603809|16103718|P3|Overall Study|Lack of Efficacy|0
4678438|NCT02603809|16103719|P2|Overall Study|Lack of Efficacy|1
4678439|NCT02603809|16103720|P1|Overall Study|Lack of Efficacy|0
4678440|NCT02603809|16103715|P6|Overall Study|Adverse Event|1
4678441|NCT02603809|16103716|P5|Overall Study|Adverse Event|1
4678442|NCT02603809|16103717|P4|Overall Study|Adverse Event|2
4678443|NCT02603809|16103718|P3|Overall Study|Adverse Event|2
4678444|NCT02603809|16103719|P2|Overall Study|Adverse Event|0
4678445|NCT02603809|16103720|P1|Overall Study|Adverse Event|3
4678446|NCT02603809|16103715|P6|Overall Study|Physician Decision|1
4678447|NCT02603809|16103716|P5|Overall Study|Physician Decision|2
4678448|NCT02603809|16103717|P4|Overall Study|Physician Decision|1
4678449|NCT02603809|16103718|P3|Overall Study|Physician Decision|0
4678450|NCT02603809|16103719|P2|Overall Study|Physician Decision|0
4678451|NCT02603809|16103720|P1|Overall Study|Physician Decision|0
4678452|NCT02603809|16103715|P6|Overall Study|Pre-specified discontinuation criteria|1
4678453|NCT02603809|16103716|P5|Overall Study|Pre-specified discontinuation criteria|3
4678454|NCT02603809|16103717|P4|Overall Study|Pre-specified discontinuation criteria|2
4678455|NCT02603809|16103718|P3|Overall Study|Pre-specified discontinuation criteria|2
4678456|NCT02603809|16103719|P2|Overall Study|Pre-specified discontinuation criteria|3
4678457|NCT02603809|16103720|P1|Overall Study|Pre-specified discontinuation criteria|3
4678458|NCT02603809|16103715|P6|Overall Study|Lost to Follow-up|2
4678459|NCT02603809|16103716|P5|Overall Study|Lost to Follow-up|2
4678460|NCT02603809|16103717|P4|Overall Study|Lost to Follow-up|4
4678461|NCT02603809|16103718|P3|Overall Study|Lost to Follow-up|1
4678462|NCT02603809|16103719|P2|Overall Study|Lost to Follow-up|3
4678463|NCT02603809|16103720|P1|Overall Study|Lost to Follow-up|2
4678464|NCT02603809|16103715|P6|Overall Study|Withdrawal by Subject|4
4678465|NCT02603809|16103716|P5|Overall Study|Withdrawal by Subject|3
4678466|NCT02603809|16103717|P4|Overall Study|Withdrawal by Subject|3
4678467|NCT02603809|16103718|P3|Overall Study|Withdrawal by Subject|2
4678468|NCT02603809|16103719|P2|Overall Study|Withdrawal by Subject|1
4678469|NCT02603809|16103720|P1|Overall Study|Withdrawal by Subject|4
4678470|NCT02603419|16103786|P6|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1
4678471|NCT02603419|16103787|P5|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4678472|NCT02603419|16103788|P4|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4678473|NCT02603419|16103789|P3|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4678474|NCT02603419|16103790|P2|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4678475|NCT02603419|16103791|P1|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0
4678476|NCT02603419|16103786|P6|Expansion Phase:Maximum Exposure:48Weeks|Death|1
4678477|NCT02603419|16103787|P5|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4678478|NCT02603419|16103788|P4|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4678479|NCT02603419|16103789|P3|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4678480|NCT02603419|16103790|P2|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4678481|NCT02603419|16103791|P1|Expansion Phase:Maximum Exposure:48Weeks|Death|0
4678482|NCT02603419|16103786|P6|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1
4678483|NCT02603419|16103787|P5|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4678484|NCT02603419|16103788|P4|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4678485|NCT02603419|16103789|P3|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4678486|NCT02603419|16103790|P2|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4678487|NCT02603419|16103791|P1|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0
4678488|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4678489|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4678490|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2
4678491|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4678492|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4678493|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0
4678494|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
4678495|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
4678496|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|Other|0
4678497|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
4678498|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|Other|1
4678499|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|Other|2
4678500|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4678501|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4678502|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4678503|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4678504|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1
4678505|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0
4678506|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4678507|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1
4678508|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4678509|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4678510|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4678511|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0
4678512|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
4678513|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1
4678514|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
4678515|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3
4678516|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0
4678517|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2
4678518|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0
4678519|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3
4678520|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
4678521|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
4678522|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4
4678523|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2
4678524|NCT02603419|16103786|P6|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4678525|NCT02603419|16103787|P5|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4678526|NCT02603419|16103788|P4|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4678527|NCT02603419|16103789|P3|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4678528|NCT02603419|16103790|P2|Lead-in Phase:Maximum Exposure:123Weeks|Death|1
4678529|NCT02603419|16103791|P1|Lead-in Phase:Maximum Exposure:123Weeks|Death|0
4678530|NCT02603393|16103978|P2|Overall Study|Sponsor decision|0
4678531|NCT02603393|16103979|P1|Overall Study|Sponsor decision|1
4678532|NCT02603393|16103978|P2|Overall Study|Non-compliance with study treatment|0
4678533|NCT02603393|16103979|P1|Overall Study|Non-compliance with study treatment|1
4678534|NCT02603393|16103978|P2|Overall Study|Lost to Follow-up|2
4678535|NCT02603393|16103979|P1|Overall Study|Lost to Follow-up|1
4678536|NCT02603393|16103978|P2|Overall Study|Protocol deviation|3
4678537|NCT02603393|16103979|P1|Overall Study|Protocol deviation|2
4678538|NCT02603393|16103978|P2|Overall Study|Physician Decision|3
4678539|NCT02603393|16103979|P1|Overall Study|Physician Decision|3
4678540|NCT02603393|16103978|P2|Overall Study|Death|4
4678541|NCT02603393|16103979|P1|Overall Study|Death|3
4678542|NCT02603393|16103978|P2|Overall Study|Lack of Efficacy|2
4678543|NCT02603393|16103979|P1|Overall Study|Lack of Efficacy|7
4678544|NCT02603393|16103978|P2|Overall Study|Technical problems|7
4678545|NCT02603393|16103979|P1|Overall Study|Technical problems|4
4678546|NCT02603393|16103978|P2|Overall Study|Adverse Event|15
4678547|NCT02603393|16103979|P1|Overall Study|Adverse Event|17
4678548|NCT02603393|16103978|P2|Overall Study|Patient/guardian decision|18
4678549|NCT02603393|16103979|P1|Overall Study|Patient/guardian decision|32
4678550|NCT02603172|16104018|P8|Part A (Approximately 16 Weeks)|Adverse Event|0
4678551|NCT02603172|16104019|P7|Part A (Approximately 16 Weeks)|Adverse Event|0
4678552|NCT02603172|16104020|P6|Part A (Approximately 16 Weeks)|Adverse Event|0
4678553|NCT02603172|16104021|P5|Part A (Approximately 16 Weeks)|Adverse Event|0
4678554|NCT02603172|16104022|P4|Part A (Approximately 16 Weeks)|Adverse Event|0
4678555|NCT02603172|16104023|P3|Part A (Approximately 16 Weeks)|Adverse Event|1
4678556|NCT02603172|16104024|P2|Part A (Approximately 16 Weeks)|Adverse Event|0
4678557|NCT02603172|16104025|P1|Part A (Approximately 16 Weeks)|Adverse Event|0
4678558|NCT02603120|16104153|P2|Overall Study|Lost to Follow-up|2
4678559|NCT02603120|16104154|P1|Overall Study|Lost to Follow-up|2
4678560|NCT02603120|16104153|P2|Overall Study|Withdrew Consent|7
4678561|NCT02603120|16104154|P1|Overall Study|Withdrew Consent|3
4678562|NCT02603120|16104153|P2|Overall Study|Pregnancy|1
4678563|NCT02603120|16104154|P1|Overall Study|Pregnancy|0
4678564|NCT02603120|16104153|P2|Overall Study|Death|0
4678565|NCT02603120|16104154|P1|Overall Study|Death|2
4678566|NCT02603120|16104153|P2|Overall Study|Adverse Event|2
4678567|NCT02603120|16104154|P1|Overall Study|Adverse Event|3
4678568|NCT02603120|16104153|P2|Overall Study|Still in Study|269
4678569|NCT02603120|16104154|P1|Overall Study|Still in Study|272
4678570|NCT02603120|16104153|P2|Overall Study|Randomized but Never Treated|2
4678571|NCT02603120|16104154|P1|Overall Study|Randomized but Never Treated|2
4678572|NCT02603107|16104174|P2|Optional Extension Phase|Still in Study|213
4678573|NCT02603107|16104175|P1|Optional Extension Phase|Still in Study|241
4678574|NCT02603107|16104174|P2|Randomized Phase|Lost to Follow-up|3
4678575|NCT02603107|16104175|P1|Randomized Phase|Lost to Follow-up|0
4678576|NCT02603107|16104174|P2|Randomized Phase|Withdrew Consent|14
4678577|NCT02603107|16104175|P1|Randomized Phase|Withdrew Consent|8
4678578|NCT02603107|16104174|P2|Randomized Phase|Protocol Violation|0
4678579|NCT02603107|16104175|P1|Randomized Phase|Protocol Violation|1
4678580|NCT02603107|16104174|P2|Randomized Phase|Non-Compliance with Study Drug|1
4678581|NCT02603107|16104175|P1|Randomized Phase|Non-Compliance with Study Drug|1
4678582|NCT02603107|16104174|P2|Randomized Phase|Investigator's Discretion|1
4678583|NCT02603107|16104175|P1|Randomized Phase|Investigator's Discretion|0
4678584|NCT02603107|16104174|P2|Randomized Phase|Death|1
4678585|NCT02603107|16104175|P1|Randomized Phase|Death|1
4678586|NCT02603107|16104174|P2|Randomized Phase|Adverse Event|0
4678587|NCT02603107|16104175|P1|Randomized Phase|Adverse Event|2
4678588|NCT02603107|16104174|P2|Randomized Phase|Still in Study|27
4678589|NCT02603107|16104175|P1|Randomized Phase|Still in Study|32
4678590|NCT02603107|16104174|P2|Randomized Phase|Randomized and Never Treated|1
4678591|NCT02603107|16104175|P1|Randomized Phase|Randomized and Never Treated|0
4678592|NCT02602080|16104238|P3|Overall Study|Protocol Violation|3
4678593|NCT02602080|16104239|P2|Overall Study|Protocol Violation|1
4678594|NCT02602080|16104240|P1|Overall Study|Protocol Violation|6
4678595|NCT02601820|16104283|P1|1-Yr Post-Treatment (T5)|Missing T5 Record|88
4678596|NCT02601820|16104283|P1|12 Weeks Post-Treatment (T4)|Missing T4 record|3
4678597|NCT02601820|16104283|P1|Late On-Treatment (T3)|missing T3 Record|49
4678598|NCT02601820|16104283|P1|Early On-Treatment (T2)|Missing T2 Record|51
4678599|NCT02601625|16104312|P4|Overall Study|Lost to Follow-up|1
4678600|NCT02601625|16104313|P3|Overall Study|Lost to Follow-up|1
4678601|NCT02601625|16104314|P2|Overall Study|Lost to Follow-up|0
4678602|NCT02601625|16104315|P1|Overall Study|Lost to Follow-up|0
4678603|NCT02601573|16104368|P5|Overall Study|Withdrawal by Subject|0
4678604|NCT02601573|16104369|P4|Overall Study|Withdrawal by Subject|1
4678605|NCT02601573|16104370|P3|Overall Study|Withdrawal by Subject|0
4678606|NCT02601573|16104371|P2|Overall Study|Withdrawal by Subject|1
4678607|NCT02601573|16104372|P1|Overall Study|Withdrawal by Subject|0
4678608|NCT02601573|16104368|P5|Overall Study|Lost to Follow-up|2
4678609|NCT02601573|16104369|P4|Overall Study|Lost to Follow-up|0
4678610|NCT02601573|16104370|P3|Overall Study|Lost to Follow-up|1
4678611|NCT02601573|16104371|P2|Overall Study|Lost to Follow-up|3
4678612|NCT02601573|16104372|P1|Overall Study|Lost to Follow-up|0
4678613|NCT02601560|16104407|P8|Overall Study|Other|0
4678614|NCT02601560|16104408|P7|Overall Study|Other|1
4678615|NCT02601560|16104409|P6|Overall Study|Other|0
4678616|NCT02601560|16104410|P5|Overall Study|Other|0
4678617|NCT02601560|16104411|P4|Overall Study|Other|0
4678618|NCT02601560|16104412|P3|Overall Study|Other|0
4678619|NCT02601560|16104413|P2|Overall Study|Other|0
4678620|NCT02601560|16104414|P1|Overall Study|Other|0
4678621|NCT02601469|16104598|P2|Overall Study|Enrolled in Error|0
4678622|NCT02601469|16104599|P1|Overall Study|Enrolled in Error|1
4678623|NCT02601313|16104608|P3|Overall Study|Enrolled, did not initiate AC|0
4678624|NCT02601313|16104609|P2|Overall Study|Enrolled, did not initiate AC|0
4678625|NCT02601313|16104610|P1|Overall Study|Enrolled, did not initiate AC|4
4678626|NCT02601313|16104608|P3|Overall Study|Still on study|10
4678627|NCT02601313|16104609|P2|Overall Study|Still on study|52
4678628|NCT02601313|16104610|P1|Overall Study|Still on study|0
4678629|NCT02601313|16104608|P3|Overall Study|Enrolled, did not initiate KTE-X19|1
4678630|NCT02601313|16104609|P2|Overall Study|Enrolled, did not initiate KTE-X19|1
4678631|NCT02601313|16104610|P1|Overall Study|Enrolled, did not initiate KTE-X19|0
4678632|NCT02601313|16104608|P3|Overall Study|Enrolled, did not initiate CTE/KTE-X19|2
4678633|NCT02601313|16104609|P2|Overall Study|Enrolled, did not initiate CTE/KTE-X19|5
4678634|NCT02601313|16104610|P1|Overall Study|Enrolled, did not initiate CTE/KTE-X19|0
4678635|NCT02601313|16104608|P3|Overall Study|Death|4
4678636|NCT02601313|16104609|P2|Overall Study|Death|16
4678637|NCT02601313|16104610|P1|Overall Study|Death|2
4678638|NCT02601300|16104629|P1|Extension Phase|Lack of Efficacy|10
4678639|NCT02601300|16104629|P1|Extension Phase|Adverse Event|4
4678640|NCT02601300|16104629|P1|Extension Phase|Withdrawal by Subject|3
4678641|NCT02601300|16104629|P1|Induction Phase|Protocol Violation|1
4678642|NCT02601300|16104629|P1|Induction Phase|Lack of Efficacy|2
4678643|NCT02601209|16104649|P9|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4678644|NCT02601209|16104650|P8|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4678645|NCT02601209|16104651|P7|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
4678646|NCT02601209|16104652|P6|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2
4678647|NCT02601209|16104653|P5|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1
4678648|NCT02601209|16104654|P4|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4678649|NCT02601209|16104655|P3|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4678650|NCT02601209|16104656|P2|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4678651|NCT02601209|16104657|P1|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0
4678652|NCT02601209|16104649|P9|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4678653|NCT02601209|16104650|P8|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4678654|NCT02601209|16104651|P7|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4678655|NCT02601209|16104652|P6|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4678656|NCT02601209|16104653|P5|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4678657|NCT02601209|16104654|P4|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0
4678658|NCT02601209|16104655|P3|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
4678659|NCT02601209|16104656|P2|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
4678660|NCT02601209|16104657|P1|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1
4678661|NCT02600923|16104704|P1|Overall Study|Not treated|1
4678662|NCT02600923|16104704|P1|Overall Study|Study terminated by Sponsor|53
4678663|NCT02600923|16104704|P1|Overall Study|Objective progression or relapse|50
4678664|NCT02600923|16104704|P1|Overall Study|Withdrawal by Subject|5
4678665|NCT02600923|16104704|P1|Overall Study|Lost to Follow-up|1
4678666|NCT02600923|16104704|P1|Overall Study|Insufficient clinical response|6
4678667|NCT02600923|16104704|P1|Overall Study|Global deterioration of health status|2
4678668|NCT02600923|16104704|P1|Overall Study|Adverse Event|3
4678669|NCT02600923|16104704|P1|Overall Study|Death|10
4678670|NCT02600871|16104714|P2|Overall Study|Lost to Follow-up|10
4678671|NCT02600871|16104715|P1|Overall Study|Lost to Follow-up|13
4678672|NCT02600845|16104725|P1|Overall Study|Consent Withdrawal|5
4678673|NCT02600845|16104725|P1|Overall Study|Non-compliance with Study Procedures|10
4678674|NCT02600845|16104725|P1|Overall Study|Reason Not Specified|3
4678675|NCT02600819|16104740|P2|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|7
4678676|NCT02600819|16104741|P1|Open-Label Extension (OLE) (B/F/TAF)|Still on B/F/TAF Study Drug|0
4678677|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|0
4678678|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Still on E/C/F/TAF Study Drug|3
4678679|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Lost to Follow-up|0
4678680|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Lost to Follow-up|2
4678681|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Withdrew Consent|0
4678682|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Withdrew Consent|5
4678683|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|0
4678684|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Non-Compliance with Study Drug|1
4678685|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Investigator's Discretion|0
4678686|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Investigator's Discretion|4
4678687|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Death|0
4678688|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Death|2
4678689|NCT02600819|16104740|P2|Main Study (E/C/F/TAF)|Adverse Event|0
4678690|NCT02600819|16104741|P1|Main Study (E/C/F/TAF)|Adverse Event|2
4678691|NCT02600559|16104813|P1|Overall Study|Lost to Follow-up|20
4678692|NCT02600559|16104813|P1|Overall Study|Withdrawal by Subject|3
4678693|NCT02600351|16104854|P4|Overall Study|Randomized but Not Treated|3
4678694|NCT02600351|16104855|P3|Overall Study|Randomized but Not Treated|1
4678695|NCT02600351|16104856|P2|Overall Study|Randomized but Not Treated|0
4678696|NCT02600351|16104857|P1|Overall Study|Randomized but Not Treated|1
4678697|NCT02600351|16104854|P4|Overall Study|Lost to Follow-up|0
4678698|NCT02600351|16104855|P3|Overall Study|Lost to Follow-up|0
4678699|NCT02600351|16104856|P2|Overall Study|Lost to Follow-up|0
4678700|NCT02600351|16104857|P1|Overall Study|Lost to Follow-up|1
4678701|NCT02600351|16104854|P4|Overall Study|Lack of Efficacy|2
4678702|NCT02600351|16104855|P3|Overall Study|Lack of Efficacy|5
4678703|NCT02600351|16104856|P2|Overall Study|Lack of Efficacy|0
4678704|NCT02600351|16104857|P1|Overall Study|Lack of Efficacy|3
4678705|NCT02599961|16104892|P1|Overall Study|Other, Not Specified|3
4678706|NCT02599961|16104892|P1|Overall Study|Discontinuation of Study by Sponsor|9
4678707|NCT02599961|16104892|P1|Overall Study|Subject Non-Compliance|2
4678708|NCT02599961|16104892|P1|Overall Study|Withdrawal by Subject|1
4678709|NCT02599129|16104966|P2|Overall Study|Withdrawal by Subject|1
4678710|NCT02599129|16104967|P1|Overall Study|Withdrawal by Subject|2
4678711|NCT02599129|16104966|P2|Overall Study|Lost to Follow-up|0
4678712|NCT02599129|16104967|P1|Overall Study|Lost to Follow-up|1
4678713|NCT02599129|16104966|P2|Overall Study|Lack of Efficacy|2
4678714|NCT02599129|16104967|P1|Overall Study|Lack of Efficacy|2
4678715|NCT02598934|16104983|P2|Overall Study|Protocol Violation|2
4678716|NCT02598934|16104984|P1|Overall Study|Protocol Violation|1
4678717|NCT02598934|16104983|P2|Overall Study|Administrative|1
4678718|NCT02598934|16104984|P1|Overall Study|Administrative|2
4678719|NCT02598934|16104983|P2|Overall Study|Withdrawal by Subject|3
4678720|NCT02598934|16104984|P1|Overall Study|Withdrawal by Subject|2
4678721|NCT02598934|16104983|P2|Overall Study|Failure to Return|3
4678722|NCT02598934|16104984|P1|Overall Study|Failure to Return|3
4678723|NCT02598934|16104983|P2|Overall Study|Adverse Event|13
4678724|NCT02598934|16104984|P1|Overall Study|Adverse Event|11
4678725|NCT02598622|16104996|P2|Overall Study|Physician Decision|0
4678726|NCT02598622|16104997|P1|Overall Study|Physician Decision|3
4678727|NCT02598622|16104996|P2|Overall Study|Withdrawal by Subject|0
4678728|NCT02598622|16104997|P1|Overall Study|Withdrawal by Subject|3
4678729|NCT02598297|16105026|P2|Overall Study|Followed for survival|0
4678730|NCT02598297|16105027|P1|Overall Study|Followed for survival|1
4678731|NCT02598297|16105026|P2|Overall Study|Subject/guardian decision|0
4678732|NCT02598297|16105027|P1|Overall Study|Subject/guardian decision|1
4678733|NCT02598297|16105026|P2|Overall Study|Physician Decision|0
4678734|NCT02598297|16105027|P1|Overall Study|Physician Decision|1
4678735|NCT02598297|16105026|P2|Overall Study|Adverse Event|1
4678736|NCT02598297|16105027|P1|Overall Study|Adverse Event|1
4678737|NCT02598297|16105026|P2|Overall Study|Study terminated by Sponsor|23
4678738|NCT02598297|16105027|P1|Overall Study|Study terminated by Sponsor|21
4678739|NCT02598193|16105053|P1|Overall Study|Does not want to take Nintedanib|1
4678740|NCT02598193|16105053|P1|Overall Study|Listed in active lung transplant list|1
4678741|NCT02598193|16105053|P1|Overall Study|Withdrawal by Subject|1
4678742|NCT02598193|16105053|P1|Overall Study|Adverse Event|13
4678743|NCT02598128|16105061|P4|Period A: Days -7 to -1|Adverse Event|0
4678744|NCT02598128|16105062|P3|Period A: Days -7 to -1|Adverse Event|0
4678745|NCT02598128|16105063|P2|Period A: Days -7 to -1|Adverse Event|0
4678746|NCT02598128|16105064|P1|Period A: Days -7 to -1|Adverse Event|1
4678747|NCT02598076|16105107|P2|Overall Study|Lost to Follow-up|3
4678748|NCT02598076|16105108|P1|Overall Study|Lost to Follow-up|2
4678749|NCT02597946|16105122|P1|Overall Study|Other than above|1
4678750|NCT02597946|16105122|P1|Overall Study|Progressive disease|16
4678751|NCT02597946|16105122|P1|Overall Study|Withdrawal by Subject|1
4678752|NCT02597933|16105133|P2|Overall Study|Other than stated above|14
4678753|NCT02597933|16105134|P1|Overall Study|Other than stated above|7
4678754|NCT02597933|16105133|P2|Overall Study|Not treated|2
4678755|NCT02597933|16105134|P1|Overall Study|Not treated|2
4678756|NCT02597933|16105133|P2|Overall Study|Adverse Event|28
4678757|NCT02597933|16105134|P1|Overall Study|Adverse Event|20
4678758|NCT02597933|16105133|P2|Overall Study|Protocol Violation|2
4678759|NCT02597933|16105134|P1|Overall Study|Protocol Violation|2
4678760|NCT02597933|16105133|P2|Overall Study|Withdrawal by Subject|5
4678761|NCT02597933|16105134|P1|Overall Study|Withdrawal by Subject|7
4678762|NCT02597920|16105165|P3|Overall Study|Other|0
4678763|NCT02597920|16105166|P2|Overall Study|Other|0
4678764|NCT02597920|16105167|P1|Overall Study|Other|1
4678765|NCT02597920|16105165|P3|Overall Study|Other than specified|5
4678766|NCT02597920|16105166|P2|Overall Study|Other than specified|31
4678767|NCT02597920|16105167|P1|Overall Study|Other than specified|10
4678768|NCT02597920|16105165|P3|Overall Study|Refuse to continue in the study|1
4678769|NCT02597920|16105166|P2|Overall Study|Refuse to continue in the study|13
4678770|NCT02597920|16105167|P1|Overall Study|Refuse to continue in the study|3
4678771|NCT02597920|16105165|P3|Overall Study|Lost to Follow-up|0
4678772|NCT02597920|16105166|P2|Overall Study|Lost to Follow-up|9
4678773|NCT02597920|16105167|P1|Overall Study|Lost to Follow-up|7
4678774|NCT02597920|16105165|P3|Overall Study|Other adverse event|0
4678775|NCT02597920|16105166|P2|Overall Study|Other adverse event|30
4678776|NCT02597920|16105167|P1|Overall Study|Other adverse event|20
4678777|NCT02597920|16105165|P3|Overall Study|Worsening of other pre-existing disease|0
4678778|NCT02597920|16105166|P2|Overall Study|Worsening of other pre-existing disease|1
4678779|NCT02597920|16105167|P1|Overall Study|Worsening of other pre-existing disease|0
4678780|NCT02597855|16105201|P2|Overall Study|Lost to Follow-up|1
4678781|NCT02597855|16105202|P1|Overall Study|Lost to Follow-up|2
4678782|NCT02597452|16105305|P1|Overall Study|testing incomplete|30
4678783|NCT02597062|16105417|P1|Overall Study|Ineligible|1
4678784|NCT02597049|16105426|P3|Overall Study|Noncompliant with Study Visits|0
4678785|NCT02597049|16105427|P2|Overall Study|Noncompliant with Study Visits|0
4678786|NCT02597049|16105428|P1|Overall Study|Noncompliant with Study Visits|1
4678787|NCT02597049|16105426|P3|Overall Study|Death|0
4678788|NCT02597049|16105427|P2|Overall Study|Death|0
4678789|NCT02597049|16105428|P1|Overall Study|Death|2
4678790|NCT02597049|16105426|P3|Overall Study|Adverse Event|0
4678791|NCT02597049|16105427|P2|Overall Study|Adverse Event|0
4678792|NCT02597049|16105428|P1|Overall Study|Adverse Event|2
4678793|NCT02597049|16105426|P3|Overall Study|Withdrawal by Subject|1
4678794|NCT02597049|16105427|P2|Overall Study|Withdrawal by Subject|2
4678795|NCT02597049|16105428|P1|Overall Study|Withdrawal by Subject|2
4678796|NCT02597049|16105426|P3|Overall Study|Lost to Follow-up|2
4678797|NCT02597049|16105427|P2|Overall Study|Lost to Follow-up|3
4678798|NCT02597049|16105428|P1|Overall Study|Lost to Follow-up|0
4678799|NCT02596971|16105469|P3|Overall Study|Death|0
4678800|NCT02596971|16105470|P2|Overall Study|Death|0
4678801|NCT02596971|16105471|P1|Overall Study|Death|2
4678802|NCT02596971|16105469|P3|Overall Study|In Follow-up|15
4678803|NCT02596971|16105470|P2|Overall Study|In Follow-up|0
4678804|NCT02596971|16105471|P1|Overall Study|In Follow-up|4
4678805|NCT02596971|16105469|P3|Overall Study|Ongoing|24
4678806|NCT02596971|16105470|P2|Overall Study|Ongoing|6
4678807|NCT02596971|16105471|P1|Overall Study|Ongoing|36
4678808|NCT02596971|16105469|P3|Overall Study|Withdrawal by Subject|2
4678809|NCT02596971|16105470|P2|Overall Study|Withdrawal by Subject|0
4678810|NCT02596971|16105471|P1|Overall Study|Withdrawal by Subject|0
4678811|NCT02596971|16105469|P3|Overall Study|Physician Decision|1
4678812|NCT02596971|16105470|P2|Overall Study|Physician Decision|0
4678813|NCT02596971|16105471|P1|Overall Study|Physician Decision|0
4678814|NCT02596971|16105469|P3|Overall Study|Disease Progression|0
4678815|NCT02596971|16105470|P2|Overall Study|Disease Progression|1
4678816|NCT02596971|16105471|P1|Overall Study|Disease Progression|0
4678817|NCT02596958|16105500|P1|Overall Study|Excluded Due to Second Line Treatment|9
4678818|NCT02596958|16105500|P1|Overall Study|Missing|32
4678819|NCT02596958|16105500|P1|Overall Study|Lost to Follow-up|33
4678820|NCT02596958|16105500|P1|Overall Study|Administrative Reasons/Other|231
4678821|NCT02596958|16105500|P1|Overall Study|Refusal of Treatment/Poor Cooperation|61
4678822|NCT02596958|16105500|P1|Overall Study|Death From Other Cause|33
4678823|NCT02596958|16105500|P1|Overall Study|Death From Cancer|112
4678824|NCT02596958|16105500|P1|Overall Study|Cancer Progression|441
4678825|NCT02596958|16105500|P1|Overall Study|Serious Adverse Drug Reactions|44
4678826|NCT02596945|16105512|P1|Overall Study|Missing|1
4678827|NCT02596945|16105512|P1|Overall Study|Withdrawal by Subject|1
4678828|NCT02596945|16105512|P1|Overall Study|Other Erythropoietin stimulating agent|4
4678829|NCT02596945|16105512|P1|Overall Study|Change to hemodialysis|15
4678830|NCT02596945|16105512|P1|Overall Study|Other|32
4678831|NCT02596945|16105512|P1|Overall Study|No documentation of study drug dosing|3
4678832|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Early Escape|70
4678833|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Early Escape|69
4678834|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Early Escape|76
4678835|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Early Escape|66
4678836|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2
4678837|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
4678838|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
4678839|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0
4678840|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Death|0
4678841|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Death|1
4678842|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Death|0
4678843|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Death|0
4678844|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2
4678845|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1
4678846|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
4678847|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0
4678848|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
4678849|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
4678850|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1
4678851|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0
4678852|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
4678853|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0
4678854|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2
4678855|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1
4678856|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5
4678857|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13
4678858|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4
4678859|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10
4678860|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13
4678861|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
4678862|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14
4678863|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15
4678864|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Pregnancy|1
4678865|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
4678866|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
4678867|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Pregnancy|0
4678868|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Adverse Event|12
4678869|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
4678870|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Adverse Event|15
4678871|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Adverse Event|11
4678872|NCT02596893|16105522|P4|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58
4678873|NCT02596893|16105523|P3|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48
4678874|NCT02596893|16105524|P2|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56
4678875|NCT02596893|16105525|P1|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61
4678876|NCT02596854|16105584|P1|Overall Study|Withdrawn|8
4678877|NCT02596711|16105606|P3|Overall Study|Lost to Follow-up|3
4678878|NCT02596711|16105607|P2|Overall Study|Lost to Follow-up|2
4678879|NCT02596711|16105608|P1|Overall Study|Lost to Follow-up|1
4678880|NCT02596620|16105624|P2|Overall Study|Lost to Follow-up|1
4678881|NCT02596620|16105625|P1|Overall Study|Lost to Follow-up|1
4678882|NCT02596230|16105663|P5|Objective 2, One Year|Other|0
4678883|NCT02596230|16105664|P4|Objective 2, One Year|Other|0
4678884|NCT02596230|16105665|P3|Objective 2, One Year|Other|2
4678885|NCT02596230|16105666|P2|Objective 2, One Year|Other|3
4678886|NCT02596230|16105667|P1|Objective 2, One Year|Other|0
4678887|NCT02596230|16105663|P5|Objective 2, One Year|Death|30
4678888|NCT02596230|16105664|P4|Objective 2, One Year|Death|21
4678889|NCT02596230|16105665|P3|Objective 2, One Year|Death|41
4678890|NCT02596230|16105666|P2|Objective 2, One Year|Death|12
4678891|NCT02596230|16105667|P1|Objective 2, One Year|Death|0
4678892|NCT02596230|16105663|P5|Objective 2, One Year|Adverse drug reaction|0
4678893|NCT02596230|16105664|P4|Objective 2, One Year|Adverse drug reaction|0
4678894|NCT02596230|16105665|P3|Objective 2, One Year|Adverse drug reaction|0
4678895|NCT02596230|16105666|P2|Objective 2, One Year|Adverse drug reaction|1
4678896|NCT02596230|16105667|P1|Objective 2, One Year|Adverse drug reaction|0
4678897|NCT02596230|16105663|P5|Objective 2, One Year|Withdrawal by Subject|2
4678898|NCT02596230|16105664|P4|Objective 2, One Year|Withdrawal by Subject|5
4678899|NCT02596230|16105665|P3|Objective 2, One Year|Withdrawal by Subject|14
4678900|NCT02596230|16105666|P2|Objective 2, One Year|Withdrawal by Subject|11
4678901|NCT02596230|16105667|P1|Objective 2, One Year|Withdrawal by Subject|0
4678902|NCT02596230|16105663|P5|Objective 2, One Year|Lost to Follow-up|46
4678903|NCT02596230|16105664|P4|Objective 2, One Year|Lost to Follow-up|32
4678904|NCT02596230|16105665|P3|Objective 2, One Year|Lost to Follow-up|41
4678905|NCT02596230|16105666|P2|Objective 2, One Year|Lost to Follow-up|41
4678906|NCT02596230|16105667|P1|Objective 2, One Year|Lost to Follow-up|0
4678907|NCT02596230|16105663|P5|Screening Period for Objective 2|Participants not participating in obj 2|0
4678908|NCT02596230|16105664|P4|Screening Period for Objective 2|Participants not participating in obj 2|846
4678909|NCT02596230|16105665|P3|Screening Period for Objective 2|Participants not participating in obj 2|0
4678910|NCT02596230|16105666|P2|Screening Period for Objective 2|Participants not participating in obj 2|228
4678911|NCT02596230|16105667|P1|Screening Period for Objective 2|Participants not participating in obj 2|3714
4678912|NCT02596035|16105691|P3|Overall Study|Other Reasons|0
4678913|NCT02596035|16105692|P2|Overall Study|Other Reasons|4
4678914|NCT02596035|16105693|P1|Overall Study|Other Reasons|3
4678915|NCT02596035|16105691|P3|Overall Study|Poor/Non-Compliance|0
4678916|NCT02596035|16105692|P2|Overall Study|Poor/Non-Compliance|1
4678917|NCT02596035|16105693|P1|Overall Study|Poor/Non-Compliance|0
4678918|NCT02596035|16105691|P3|Overall Study|Withdrawal by Subject|0
4678919|NCT02596035|16105692|P2|Overall Study|Withdrawal by Subject|2
4678920|NCT02596035|16105693|P1|Overall Study|Withdrawal by Subject|4
4678921|NCT02596035|16105691|P3|Overall Study|Adverse Event|0
4678922|NCT02596035|16105692|P2|Overall Study|Adverse Event|2
4678923|NCT02596035|16105693|P1|Overall Study|Adverse Event|6
4678924|NCT02596035|16105691|P3|Overall Study|Study Drug Toxicity|0
4678925|NCT02596035|16105692|P2|Overall Study|Study Drug Toxicity|3
4678926|NCT02596035|16105693|P1|Overall Study|Study Drug Toxicity|11
4678927|NCT02596035|16105691|P3|Overall Study|Disease Progression|1
4678928|NCT02596035|16105692|P2|Overall Study|Disease Progression|32
4678929|NCT02596035|16105693|P1|Overall Study|Disease Progression|62
4678930|NCT02596009|16105729|P6|Overall Study|Administrative problems|0
4678931|NCT02596009|16105730|P5|Overall Study|Administrative problems|0
4678932|NCT02596009|16105731|P4|Overall Study|Administrative problems|0
4678933|NCT02596009|16105732|P3|Overall Study|Administrative problems|0
4678934|NCT02596009|16105733|P2|Overall Study|Administrative problems|1
4678935|NCT02596009|16105734|P1|Overall Study|Administrative problems|0
4678936|NCT02595970|16105751|P1|Overall Study|Lack of Efficacy|7
4678937|NCT02595970|16105751|P1|Overall Study|Adverse Event|5
4678938|NCT02595970|16105751|P1|Overall Study|Protocol Violation|4
4678939|NCT02595970|16105751|P1|Overall Study|Physician Decision|2
4678940|NCT02595970|16105751|P1|Overall Study|Withdrawal by Subject|2
4678941|NCT02595723|16105768|P3|First Washout (21 Days)|Lost to Follow-up|0
4678942|NCT02595723|16105769|P2|First Washout (21 Days)|Lost to Follow-up|0
4678943|NCT02595723|16105770|P1|First Washout (21 Days)|Lost to Follow-up|1
4678944|NCT02595723|16105768|P3|First Washout (21 Days)|Withdrawal by Subject|0
4678945|NCT02595723|16105769|P2|First Washout (21 Days)|Withdrawal by Subject|0
4678946|NCT02595723|16105770|P1|First Washout (21 Days)|Withdrawal by Subject|1
4678947|NCT02595502|16105823|P2|Period 3|Received Incorrect Treatment at period 3|1
4678948|NCT02595502|16105824|P1|Period 3|Received Incorrect Treatment at period 3|0
4678949|NCT02595502|16105823|P2|Period 3|Lost to Follow-up|0
4678950|NCT02595502|16105824|P1|Period 3|Lost to Follow-up|1
4678951|NCT02595502|16105823|P2|Period 3|Protocol Violation|1
4678952|NCT02595502|16105824|P1|Period 3|Protocol Violation|0
4678953|NCT02595502|16105823|P2|Period 2|Received incorrect lens at Period 1|1
4678954|NCT02595502|16105824|P1|Period 2|Received incorrect lens at Period 1|0
4678955|NCT02595502|16105823|P2|Period 2|Adverse Event|1
4678956|NCT02595502|16105824|P1|Period 2|Adverse Event|1
4678957|NCT02595502|16105823|P2|Period 1|Lost to Follow-up|1
4678958|NCT02595502|16105824|P1|Period 1|Lost to Follow-up|0
4678959|NCT02595502|16105823|P2|Period 1|Withdrawal by Subject|0
4678960|NCT02595502|16105824|P1|Period 1|Withdrawal by Subject|1
4678961|NCT02595502|16105823|P2|Period 1|Adverse Event|1
4678962|NCT02595502|16105824|P1|Period 1|Adverse Event|0
4678963|NCT02595450|16105830|P1|Overall Study|Enrolled, but not treated|8
4678964|NCT02595450|16105830|P1|Overall Study|Unspecified (only completed 1 cycle)|73
4678965|NCT02595437|16105836|P1|Triferic Via IV|Withdrawal by Subject|1
4678966|NCT02595372|16105854|P1|Overall Study|Disease Progression|1
4678967|NCT02595372|16105854|P1|Overall Study|Physician Decision|2
4678968|NCT02595372|16105854|P1|Overall Study|Adverse Event|6
4678969|NCT02595073|16105865|P2|Overall Study|Protocol Violation|0
4678970|NCT02595073|16105866|P1|Overall Study|Protocol Violation|2
4678971|NCT02595073|16105865|P2|Overall Study|Progressive Disease|1
4678972|NCT02595073|16105866|P1|Overall Study|Progressive Disease|0
4678973|NCT02595008|16105876|P2|Overall Study|Enrolled In Error|0
4678974|NCT02595008|16105877|P1|Overall Study|Enrolled In Error|1
4678975|NCT02594163|16105915|P2|Follow-up Period|Physician Decision|1
4678976|NCT02594163|16105916|P1|Follow-up Period|Physician Decision|0
4678977|NCT02594163|16105915|P2|Follow-up Period|Progressive Disease|0
4678978|NCT02594163|16105916|P1|Follow-up Period|Progressive Disease|2
4678979|NCT02594163|16105915|P2|Follow-up Period|Adverse Event|1
4678980|NCT02594163|16105916|P1|Follow-up Period|Adverse Event|0
4678981|NCT02594163|16105915|P2|Follow-up Period|Death|5
4678982|NCT02594163|16105916|P1|Follow-up Period|Death|2
4678983|NCT02594163|16105915|P2|Follow-up Period|Lost to Follow-up|0
4678984|NCT02594163|16105916|P1|Follow-up Period|Lost to Follow-up|1
4678985|NCT02594163|16105915|P2|Follow-up Period|Study Termination by Sponsor|4
4678986|NCT02594163|16105916|P1|Follow-up Period|Study Termination by Sponsor|6
4678987|NCT02594163|16105915|P2|Follow-up Period|Withdrawal by Subject|1
4678988|NCT02594163|16105916|P1|Follow-up Period|Withdrawal by Subject|0
4678989|NCT02594163|16105915|P2|Treatment Period|Other, Non-AE|0
4678990|NCT02594163|16105916|P1|Treatment Period|Other, Non-AE|1
4678991|NCT02594163|16105915|P2|Treatment Period|Study termination by sponsor|1
4678992|NCT02594163|16105916|P1|Treatment Period|Study termination by sponsor|2
4678993|NCT02594163|16105915|P2|Treatment Period|Physician Decision|3
4678994|NCT02594163|16105916|P1|Treatment Period|Physician Decision|1
4678995|NCT02594163|16105915|P2|Treatment Period|Adverse Event|5
4678996|NCT02594163|16105916|P1|Treatment Period|Adverse Event|1
4678997|NCT02594163|16105915|P2|Treatment Period|Progressive disease|3
4678998|NCT02594163|16105916|P1|Treatment Period|Progressive disease|2
4678999|NCT02594098|16105947|P2|Overall Study|Other|1
4679000|NCT02594098|16105948|P1|Overall Study|Other|0
4679001|NCT02594098|16105947|P2|Overall Study|Seek alternative treatment|1
4679002|NCT02594098|16105948|P1|Overall Study|Seek alternative treatment|2
4679003|NCT02594098|16105947|P2|Overall Study|Terminated participation|2
4679004|NCT02594098|16105948|P1|Overall Study|Terminated participation|6
4679005|NCT02594098|16105947|P2|Overall Study|Withdrawal by Subject|3
4679006|NCT02594098|16105948|P1|Overall Study|Withdrawal by Subject|1
4679007|NCT02594098|16105947|P2|Overall Study|Lack of Efficacy|6
4679008|NCT02594098|16105948|P1|Overall Study|Lack of Efficacy|17
4679009|NCT02593864|16106017|P1|Overall Study|Lost to Follow-up|3
4679010|NCT02593864|16106017|P1|Overall Study|Withdrawal by Subject|3
4679011|NCT02593825|16106024|P2|Intervention|Lost to Follow-up|12
4679012|NCT02593825|16106025|P1|Intervention|Lost to Follow-up|10
4679013|NCT02593773|16106037|P1|Overall Study|Death|1
4679014|NCT02593773|16106037|P1|Overall Study|Study Terminated by Sponsor|31
4679015|NCT02593773|16106037|P1|Overall Study|Voluntary Withdrawal|3
4679016|NCT02593305|16106069|P3|Post 1|Comparison only group. No intervention.|10
4679017|NCT02593305|16106070|P2|Post 1|Comparison only group. No intervention.|0
4679018|NCT02593305|16106071|P1|Post 1|Comparison only group. No intervention.|0
4679019|NCT02593149|16106086|P2|Intervention|Didn't use CVC for at least 21 day|115
4679020|NCT02593149|16106087|P1|Intervention|Didn't use CVC for at least 21 day|116
4679021|NCT02593149|16106086|P2|Run-In|Didn't use CVC for at least 21 days|38
4679022|NCT02593149|16106087|P1|Run-In|Didn't use CVC for at least 21 days|36
4679023|NCT02593097|16106095|P2|Second Intervention (12 Weeks)|Withdrawal by Subject|0
4679024|NCT02593097|16106096|P1|Second Intervention (12 Weeks)|Withdrawal by Subject|1
4679025|NCT02593097|16106095|P2|Second Intervention (12 Weeks)|Lack of Efficacy|0
4679026|NCT02593097|16106096|P1|Second Intervention (12 Weeks)|Lack of Efficacy|1
4679027|NCT02593097|16106095|P2|Second Intervention (12 Weeks)|Lost to Follow-up|1
4679028|NCT02593097|16106096|P1|Second Intervention (12 Weeks)|Lost to Follow-up|1
4679029|NCT02593097|16106095|P2|First Intervention (12 Weeks)|Withdrawal by Subject|2
4679030|NCT02593097|16106096|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
4679031|NCT02593097|16106095|P2|First Intervention (12 Weeks)|Lost to Follow-up|2
4679032|NCT02593097|16106096|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
4679033|NCT02592876|16106117|P2|Overall Study|Death|9
4679034|NCT02592876|16106118|P1|Overall Study|Death|6
4679035|NCT02592876|16106117|P2|Overall Study|Lost to Follow-up|1
4679036|NCT02592876|16106118|P1|Overall Study|Lost to Follow-up|0
4679037|NCT02592876|16106117|P2|Overall Study|Study Termination by Sponsor|27
4679038|NCT02592876|16106118|P1|Overall Study|Study Termination by Sponsor|32
4679039|NCT02592876|16106117|P2|Overall Study|Withdrawal by Subject|3
4679040|NCT02592876|16106118|P1|Overall Study|Withdrawal by Subject|3
4679041|NCT02592447|16106189|P2|Overall Study|Withdrawal by Subject|1
4679042|NCT02592447|16106190|P1|Overall Study|Withdrawal by Subject|0
4679043|NCT02592447|16106189|P2|Overall Study|Ineligible after randomization|0
4679044|NCT02592447|16106190|P1|Overall Study|Ineligible after randomization|1
4679045|NCT02592447|16106189|P2|Overall Study|Lost to Follow-up|0
4679046|NCT02592447|16106190|P1|Overall Study|Lost to Follow-up|1
4679047|NCT02592434|16106198|P3|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
4679048|NCT02592434|16106199|P2|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1
4679049|NCT02592434|16106200|P1|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0
4679050|NCT02592434|16106198|P3|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
4679051|NCT02592434|16106199|P2|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1
4679052|NCT02592434|16106200|P1|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0
4679053|NCT02592434|16106198|P3|Double Blind Phase (26 Weeks)|Protocol Deviation|1
4679054|NCT02592434|16106199|P2|Double Blind Phase (26 Weeks)|Protocol Deviation|0
4679055|NCT02592434|16106200|P1|Double Blind Phase (26 Weeks)|Protocol Deviation|0
4679056|NCT02592434|16106198|P3|Double Blind Phase (26 Weeks)|Other|0
4679057|NCT02592434|16106199|P2|Double Blind Phase (26 Weeks)|Other|1
4679058|NCT02592434|16106200|P1|Double Blind Phase (26 Weeks)|Other|0
4679059|NCT02592434|16106198|P3|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44
4679060|NCT02592434|16106199|P2|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22
4679061|NCT02592434|16106200|P1|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0
4679062|NCT02592434|16106198|P3|Double Blind Phase (26 Weeks)|Adverse Event|2
4679063|NCT02592434|16106199|P2|Double Blind Phase (26 Weeks)|Adverse Event|2
4679064|NCT02592434|16106200|P1|Double Blind Phase (26 Weeks)|Adverse Event|0
4679065|NCT02592434|16106198|P3|Open-Label Phase (18 Weeks)|Protocol Deviation|0
4679066|NCT02592434|16106199|P2|Open-Label Phase (18 Weeks)|Protocol Deviation|0
4679067|NCT02592434|16106200|P1|Open-Label Phase (18 Weeks)|Protocol Deviation|4
4679068|NCT02592434|16106198|P3|Open-Label Phase (18 Weeks)|Other|0
4679069|NCT02592434|16106199|P2|Open-Label Phase (18 Weeks)|Other|0
4679070|NCT02592434|16106200|P1|Open-Label Phase (18 Weeks)|Other|3
4679071|NCT02592434|16106198|P3|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
4679072|NCT02592434|16106199|P2|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0
4679073|NCT02592434|16106200|P1|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21
4679074|NCT02592434|16106198|P3|Open-Label Phase (18 Weeks)|Adverse Event|0
4679075|NCT02592434|16106199|P2|Open-Label Phase (18 Weeks)|Adverse Event|0
4679076|NCT02592434|16106200|P1|Open-Label Phase (18 Weeks)|Adverse Event|12
4679077|NCT02592018|16106331|P1|Overall Study|Lost to Follow-up|1
4679078|NCT02592018|16106331|P1|Overall Study|Adverse Event|1
4679079|NCT02591290|16106378|P1|Overall Study|Withdrawal by Subject|2
4679080|NCT02591238|16106388|P4|Overall Study|personal circumstances|0
4679081|NCT02591238|16106389|P3|Overall Study|personal circumstances|0
4679082|NCT02591238|16106390|P2|Overall Study|personal circumstances|1
4679083|NCT02591238|16106391|P1|Overall Study|personal circumstances|0
4679084|NCT02591238|16106388|P4|Overall Study|personal circumstances|1
4679085|NCT02591238|16106389|P3|Overall Study|personal circumstances|0
4679086|NCT02591238|16106390|P2|Overall Study|personal circumstances|0
4679087|NCT02591238|16106391|P1|Overall Study|personal circumstances|0
4679088|NCT02591238|16106388|P4|Overall Study|influenza|1
4679089|NCT02591238|16106389|P3|Overall Study|influenza|0
4679090|NCT02591238|16106390|P2|Overall Study|influenza|0
4679091|NCT02591238|16106391|P1|Overall Study|influenza|0
4679092|NCT02591238|16106388|P4|Overall Study|Withdrawal by Subject|1
4679093|NCT02591238|16106389|P3|Overall Study|Withdrawal by Subject|0
4679094|NCT02591238|16106390|P2|Overall Study|Withdrawal by Subject|0
4679095|NCT02591238|16106391|P1|Overall Study|Withdrawal by Subject|0
4679096|NCT02591238|16106388|P4|Overall Study|Pregnancy|0
4679097|NCT02591238|16106389|P3|Overall Study|Pregnancy|0
4679098|NCT02591238|16106390|P2|Overall Study|Pregnancy|0
4679099|NCT02591238|16106391|P1|Overall Study|Pregnancy|1
4679100|NCT02590939|16106427|P2|Overall Study|Failed the nociceptive test|1
4679101|NCT02590939|16106428|P1|Overall Study|Failed the nociceptive test|2
4679102|NCT02590939|16106427|P2|Overall Study|Withdrawal by Subject|1
4679103|NCT02590939|16106428|P1|Overall Study|Withdrawal by Subject|3
4679104|NCT02590588|16106448|P1|Overall Study|Adverse Event|1
4679105|NCT02590562|16106456|P1|Overall Study|Did Not Meet the Inclusion Criteria|6
4679106|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679107|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1
4679108|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679109|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679110|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679111|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679112|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679113|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679114|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0
4679115|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679116|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1
4679117|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679118|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679119|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679120|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679266|NCT02590432|16106522|P2|Open-label Treatment Period|Lack of Efficacy|5
4679121|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679122|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679123|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0
4679124|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Protocol Violation|1
4679125|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679126|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679127|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679128|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679129|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679130|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679131|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679132|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Protocol Violation|0
4679133|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1
4679134|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679135|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679136|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679137|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679138|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679139|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679140|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679141|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0
4679142|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1
4679143|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3
4679144|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679145|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679146|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679147|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679148|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679149|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679150|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0
4679151|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679152|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1
4679153|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679154|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679155|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679156|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679157|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679158|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679159|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0
4679160|NCT02590432|16106515|P9|Dose-reduced Open Label Treatment Period|Adverse Event|15
4679161|NCT02590432|16106516|P8|Dose-reduced Open Label Treatment Period|Adverse Event|12
4679162|NCT02590432|16106517|P7|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679163|NCT02590432|16106518|P6|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679164|NCT02590432|16106519|P5|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679165|NCT02590432|16106520|P4|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679166|NCT02590432|16106521|P3|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679167|NCT02590432|16106522|P2|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679168|NCT02590432|16106523|P1|Dose-reduced Open Label Treatment Period|Adverse Event|0
4679169|NCT02590432|16106515|P9|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679170|NCT02590432|16106516|P8|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679171|NCT02590432|16106517|P7|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679172|NCT02590432|16106518|P6|Double-blind Treatment Period|Non-compliance with Study Drug|1
4679173|NCT02590432|16106519|P5|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679174|NCT02590432|16106520|P4|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679175|NCT02590432|16106521|P3|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679176|NCT02590432|16106522|P2|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679177|NCT02590432|16106523|P1|Double-blind Treatment Period|Non-compliance with Study Drug|0
4679178|NCT02590432|16106515|P9|Double-blind Treatment Period|Lost to Follow-up|0
4679179|NCT02590432|16106516|P8|Double-blind Treatment Period|Lost to Follow-up|0
4679180|NCT02590432|16106517|P7|Double-blind Treatment Period|Lost to Follow-up|0
4679181|NCT02590432|16106518|P6|Double-blind Treatment Period|Lost to Follow-up|2
4679182|NCT02590432|16106519|P5|Double-blind Treatment Period|Lost to Follow-up|0
4679183|NCT02590432|16106520|P4|Double-blind Treatment Period|Lost to Follow-up|0
4679184|NCT02590432|16106521|P3|Double-blind Treatment Period|Lost to Follow-up|1
4679185|NCT02590432|16106522|P2|Double-blind Treatment Period|Lost to Follow-up|0
4679186|NCT02590432|16106523|P1|Double-blind Treatment Period|Lost to Follow-up|0
4679187|NCT02590432|16106515|P9|Double-blind Treatment Period|Withdrawal of Consent|0
4679188|NCT02590432|16106516|P8|Double-blind Treatment Period|Withdrawal of Consent|0
4679189|NCT02590432|16106517|P7|Double-blind Treatment Period|Withdrawal of Consent|1
4679190|NCT02590432|16106518|P6|Double-blind Treatment Period|Withdrawal of Consent|1
4679191|NCT02590432|16106519|P5|Double-blind Treatment Period|Withdrawal of Consent|3
4679192|NCT02590432|16106520|P4|Double-blind Treatment Period|Withdrawal of Consent|3
4679193|NCT02590432|16106521|P3|Double-blind Treatment Period|Withdrawal of Consent|1
4679194|NCT02590432|16106522|P2|Double-blind Treatment Period|Withdrawal of Consent|0
4679195|NCT02590432|16106523|P1|Double-blind Treatment Period|Withdrawal of Consent|0
4679196|NCT02590432|16106515|P9|Double-blind Treatment Period|Lack of Efficacy|0
4679197|NCT02590432|16106516|P8|Double-blind Treatment Period|Lack of Efficacy|0
4679198|NCT02590432|16106517|P7|Double-blind Treatment Period|Lack of Efficacy|0
4679199|NCT02590432|16106518|P6|Double-blind Treatment Period|Lack of Efficacy|0
4679200|NCT02590432|16106519|P5|Double-blind Treatment Period|Lack of Efficacy|0
4679201|NCT02590432|16106520|P4|Double-blind Treatment Period|Lack of Efficacy|0
4679202|NCT02590432|16106521|P3|Double-blind Treatment Period|Lack of Efficacy|1
4679203|NCT02590432|16106522|P2|Double-blind Treatment Period|Lack of Efficacy|0
4679204|NCT02590432|16106523|P1|Double-blind Treatment Period|Lack of Efficacy|0
4679205|NCT02590432|16106515|P9|Double-blind Treatment Period|Adverse Event|0
4679206|NCT02590432|16106516|P8|Double-blind Treatment Period|Adverse Event|0
4679207|NCT02590432|16106517|P7|Double-blind Treatment Period|Adverse Event|20
4679208|NCT02590432|16106518|P6|Double-blind Treatment Period|Adverse Event|22
4679209|NCT02590432|16106519|P5|Double-blind Treatment Period|Adverse Event|6
4679210|NCT02590432|16106520|P4|Double-blind Treatment Period|Adverse Event|12
4679211|NCT02590432|16106521|P3|Double-blind Treatment Period|Adverse Event|14
4679212|NCT02590432|16106522|P2|Double-blind Treatment Period|Adverse Event|0
4679213|NCT02590432|16106523|P1|Double-blind Treatment Period|Adverse Event|0
4679214|NCT02590432|16106515|P9|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679215|NCT02590432|16106516|P8|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679216|NCT02590432|16106517|P7|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679217|NCT02590432|16106518|P6|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679218|NCT02590432|16106519|P5|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679219|NCT02590432|16106520|P4|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679220|NCT02590432|16106521|P3|Open-label Treatment Period|Other Miscellaneous Reasons|0
4679221|NCT02590432|16106522|P2|Open-label Treatment Period|Other Miscellaneous Reasons|6
4679222|NCT02590432|16106523|P1|Open-label Treatment Period|Other Miscellaneous Reasons|10
4679223|NCT02590432|16106515|P9|Open-label Treatment Period|Non-compliance with Study Drug|0
4679224|NCT02590432|16106516|P8|Open-label Treatment Period|Non-compliance with Study Drug|0
4679225|NCT02590432|16106517|P7|Open-label Treatment Period|Non-compliance with Study Drug|0
4679226|NCT02590432|16106518|P6|Open-label Treatment Period|Non-compliance with Study Drug|0
4679227|NCT02590432|16106519|P5|Open-label Treatment Period|Non-compliance with Study Drug|0
4679228|NCT02590432|16106520|P4|Open-label Treatment Period|Non-compliance with Study Drug|0
4679229|NCT02590432|16106521|P3|Open-label Treatment Period|Non-compliance with Study Drug|0
4679230|NCT02590432|16106522|P2|Open-label Treatment Period|Non-compliance with Study Drug|1
4679231|NCT02590432|16106523|P1|Open-label Treatment Period|Non-compliance with Study Drug|7
4679232|NCT02590432|16106515|P9|Open-label Treatment Period|Protocol Violation|0
4679233|NCT02590432|16106516|P8|Open-label Treatment Period|Protocol Violation|0
4679234|NCT02590432|16106517|P7|Open-label Treatment Period|Protocol Violation|0
4679235|NCT02590432|16106518|P6|Open-label Treatment Period|Protocol Violation|0
4679236|NCT02590432|16106519|P5|Open-label Treatment Period|Protocol Violation|0
4679237|NCT02590432|16106520|P4|Open-label Treatment Period|Protocol Violation|0
4679238|NCT02590432|16106521|P3|Open-label Treatment Period|Protocol Violation|0
4679239|NCT02590432|16106522|P2|Open-label Treatment Period|Protocol Violation|4
4679240|NCT02590432|16106523|P1|Open-label Treatment Period|Protocol Violation|10
4679241|NCT02590432|16106515|P9|Open-label Treatment Period|Lost to Follow-up|0
4679242|NCT02590432|16106516|P8|Open-label Treatment Period|Lost to Follow-up|0
4679243|NCT02590432|16106517|P7|Open-label Treatment Period|Lost to Follow-up|0
4679244|NCT02590432|16106518|P6|Open-label Treatment Period|Lost to Follow-up|0
4679245|NCT02590432|16106519|P5|Open-label Treatment Period|Lost to Follow-up|0
4679246|NCT02590432|16106520|P4|Open-label Treatment Period|Lost to Follow-up|0
4679247|NCT02590432|16106521|P3|Open-label Treatment Period|Lost to Follow-up|0
4679248|NCT02590432|16106522|P2|Open-label Treatment Period|Lost to Follow-up|29
4679249|NCT02590432|16106523|P1|Open-label Treatment Period|Lost to Follow-up|51
4679250|NCT02590432|16106515|P9|Open-label Treatment Period|Withdrawal of Consent|0
4679251|NCT02590432|16106516|P8|Open-label Treatment Period|Withdrawal of Consent|0
4679252|NCT02590432|16106517|P7|Open-label Treatment Period|Withdrawal of Consent|0
4679253|NCT02590432|16106518|P6|Open-label Treatment Period|Withdrawal of Consent|0
4679254|NCT02590432|16106519|P5|Open-label Treatment Period|Withdrawal of Consent|0
4679255|NCT02590432|16106520|P4|Open-label Treatment Period|Withdrawal of Consent|0
4679256|NCT02590432|16106521|P3|Open-label Treatment Period|Withdrawal of Consent|0
4679257|NCT02590432|16106522|P2|Open-label Treatment Period|Withdrawal of Consent|28
4679258|NCT02590432|16106523|P1|Open-label Treatment Period|Withdrawal of Consent|43
4679259|NCT02590432|16106515|P9|Open-label Treatment Period|Lack of Efficacy|0
4679260|NCT02590432|16106516|P8|Open-label Treatment Period|Lack of Efficacy|0
4679261|NCT02590432|16106517|P7|Open-label Treatment Period|Lack of Efficacy|0
4679262|NCT02590432|16106518|P6|Open-label Treatment Period|Lack of Efficacy|0
4679263|NCT02590432|16106519|P5|Open-label Treatment Period|Lack of Efficacy|0
4679264|NCT02590432|16106520|P4|Open-label Treatment Period|Lack of Efficacy|0
4679265|NCT02590432|16106521|P3|Open-label Treatment Period|Lack of Efficacy|0
4679267|NCT02590432|16106523|P1|Open-label Treatment Period|Lack of Efficacy|14
4679268|NCT02590432|16106515|P9|Open-label Treatment Period|Adverse Event|0
4679269|NCT02590432|16106516|P8|Open-label Treatment Period|Adverse Event|0
4679270|NCT02590432|16106517|P7|Open-label Treatment Period|Adverse Event|0
4679271|NCT02590432|16106518|P6|Open-label Treatment Period|Adverse Event|0
4679272|NCT02590432|16106519|P5|Open-label Treatment Period|Adverse Event|0
4679273|NCT02590432|16106520|P4|Open-label Treatment Period|Adverse Event|0
4679274|NCT02590432|16106521|P3|Open-label Treatment Period|Adverse Event|0
4679275|NCT02590432|16106522|P2|Open-label Treatment Period|Adverse Event|79
4679276|NCT02590432|16106523|P1|Open-label Treatment Period|Adverse Event|97
4679277|NCT02590406|16106559|P2|Overall Study|Saturometer malfunction|1
4679278|NCT02590406|16106560|P1|Overall Study|Saturometer malfunction|0
4679279|NCT02590406|16106559|P2|Overall Study|Adverse Event|0
4679280|NCT02590406|16106560|P1|Overall Study|Adverse Event|1
4679281|NCT02590354|16106574|P1|Phase 2 - Treatment Interruption|Lost to Follow-up|2
4679282|NCT02590354|16106574|P1|Phase 1|Lost to Follow-up|1
4679283|NCT02590354|16106574|P1|Phase 1|Subject does not want to participate|20
4679284|NCT02590354|16106574|P1|Phase 1|Detectable level of HIV DNA or caRNA|75
4679285|NCT02590354|16106574|P1|Phase 1|Confirmed neutrophil count <1200/µl|1
4679286|NCT02590354|16106574|P1|Phase 1|Active hepatitis B or C infection|1
4679287|NCT02590003|16106601|P2|Overall Study|Death|2
4679288|NCT02590003|16106602|P1|Overall Study|Death|1
4679289|NCT02589665|16106639|P10|Maintenance Extension Period|Non-responder|1
4679290|NCT02589665|16106640|P9|Maintenance Extension Period|Non-responder|0
4679291|NCT02589665|16106641|P8|Maintenance Extension Period|Non-responder|0
4679292|NCT02589665|16106642|P7|Maintenance Extension Period|Non-responder|0
4679293|NCT02589665|16106643|P6|Maintenance Extension Period|Non-responder|0
4679294|NCT02589665|16106644|P5|Maintenance Extension Period|Non-responder|0
4679295|NCT02589665|16106645|P4|Maintenance Extension Period|Non-responder|0
4679296|NCT02589665|16106646|P3|Maintenance Extension Period|Non-responder|0
4679297|NCT02589665|16106647|P2|Maintenance Extension Period|Non-responder|0
4679298|NCT02589665|16106648|P1|Maintenance Extension Period|Non-responder|0
4679299|NCT02589665|16106639|P10|Maintenance Extension Period|Adverse Event|2
4679300|NCT02589665|16106640|P9|Maintenance Extension Period|Adverse Event|0
4679301|NCT02589665|16106641|P8|Maintenance Extension Period|Adverse Event|0
4679302|NCT02589665|16106642|P7|Maintenance Extension Period|Adverse Event|0
4679303|NCT02589665|16106643|P6|Maintenance Extension Period|Adverse Event|0
4679304|NCT02589665|16106644|P5|Maintenance Extension Period|Adverse Event|0
4679305|NCT02589665|16106645|P4|Maintenance Extension Period|Adverse Event|0
4679306|NCT02589665|16106646|P3|Maintenance Extension Period|Adverse Event|0
4679307|NCT02589665|16106647|P2|Maintenance Extension Period|Adverse Event|0
4679308|NCT02589665|16106648|P1|Maintenance Extension Period|Adverse Event|0
4679309|NCT02589665|16106639|P10|Maintenance Extension Period|Lack of Efficacy|4
4679310|NCT02589665|16106640|P9|Maintenance Extension Period|Lack of Efficacy|0
4679311|NCT02589665|16106641|P8|Maintenance Extension Period|Lack of Efficacy|0
4679312|NCT02589665|16106642|P7|Maintenance Extension Period|Lack of Efficacy|0
4679313|NCT02589665|16106643|P6|Maintenance Extension Period|Lack of Efficacy|0
4679314|NCT02589665|16106644|P5|Maintenance Extension Period|Lack of Efficacy|0
4679315|NCT02589665|16106645|P4|Maintenance Extension Period|Lack of Efficacy|0
4679316|NCT02589665|16106646|P3|Maintenance Extension Period|Lack of Efficacy|0
4679317|NCT02589665|16106647|P2|Maintenance Extension Period|Lack of Efficacy|0
4679318|NCT02589665|16106648|P1|Maintenance Extension Period|Lack of Efficacy|0
4679319|NCT02589665|16106639|P10|Maintenance Extension Period|Withdrawal by Subject|4
4679320|NCT02589665|16106640|P9|Maintenance Extension Period|Withdrawal by Subject|0
4679321|NCT02589665|16106641|P8|Maintenance Extension Period|Withdrawal by Subject|0
4679322|NCT02589665|16106642|P7|Maintenance Extension Period|Withdrawal by Subject|0
4679323|NCT02589665|16106643|P6|Maintenance Extension Period|Withdrawal by Subject|0
4679324|NCT02589665|16106644|P5|Maintenance Extension Period|Withdrawal by Subject|0
4679325|NCT02589665|16106645|P4|Maintenance Extension Period|Withdrawal by Subject|0
4679326|NCT02589665|16106646|P3|Maintenance Extension Period|Withdrawal by Subject|0
4679327|NCT02589665|16106647|P2|Maintenance Extension Period|Withdrawal by Subject|0
4679328|NCT02589665|16106648|P1|Maintenance Extension Period|Withdrawal by Subject|0
4679329|NCT02589665|16106639|P10|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57
4679330|NCT02589665|16106640|P9|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679331|NCT02589665|16106641|P8|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679332|NCT02589665|16106642|P7|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679333|NCT02589665|16106643|P6|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679334|NCT02589665|16106644|P5|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679335|NCT02589665|16106645|P4|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679336|NCT02589665|16106646|P3|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679337|NCT02589665|16106647|P2|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679338|NCT02589665|16106648|P1|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0
4679339|NCT02589665|16106639|P10|Induction Extension Period|Reason Not Collected|0
4679340|NCT02589665|16106640|P9|Induction Extension Period|Reason Not Collected|1
4679341|NCT02589665|16106641|P8|Induction Extension Period|Reason Not Collected|0
4679342|NCT02589665|16106642|P7|Induction Extension Period|Reason Not Collected|0
4679343|NCT02589665|16106643|P6|Induction Extension Period|Reason Not Collected|0
4679344|NCT02589665|16106644|P5|Induction Extension Period|Reason Not Collected|0
4679345|NCT02589665|16106645|P4|Induction Extension Period|Reason Not Collected|0
4679346|NCT02589665|16106646|P3|Induction Extension Period|Reason Not Collected|0
4679347|NCT02589665|16106647|P2|Induction Extension Period|Reason Not Collected|0
4679348|NCT02589665|16106648|P1|Induction Extension Period|Reason Not Collected|0
4679349|NCT02589665|16106639|P10|Induction Extension Period|Physician Decision|0
4679350|NCT02589665|16106640|P9|Induction Extension Period|Physician Decision|1
4679351|NCT02589665|16106641|P8|Induction Extension Period|Physician Decision|0
4679352|NCT02589665|16106642|P7|Induction Extension Period|Physician Decision|0
4679353|NCT02589665|16106643|P6|Induction Extension Period|Physician Decision|0
4679354|NCT02589665|16106644|P5|Induction Extension Period|Physician Decision|0
4679355|NCT02589665|16106645|P4|Induction Extension Period|Physician Decision|0
4679356|NCT02589665|16106646|P3|Induction Extension Period|Physician Decision|0
4679357|NCT02589665|16106647|P2|Induction Extension Period|Physician Decision|0
4679358|NCT02589665|16106648|P1|Induction Extension Period|Physician Decision|0
4679359|NCT02589665|16106639|P10|Induction Extension Period|Withdrawal by Subject|0
4679360|NCT02589665|16106640|P9|Induction Extension Period|Withdrawal by Subject|3
4679361|NCT02589665|16106641|P8|Induction Extension Period|Withdrawal by Subject|2
4679362|NCT02589665|16106642|P7|Induction Extension Period|Withdrawal by Subject|0
4679363|NCT02589665|16106643|P6|Induction Extension Period|Withdrawal by Subject|0
4679364|NCT02589665|16106644|P5|Induction Extension Period|Withdrawal by Subject|0
4679365|NCT02589665|16106645|P4|Induction Extension Period|Withdrawal by Subject|0
4679366|NCT02589665|16106646|P3|Induction Extension Period|Withdrawal by Subject|0
4679367|NCT02589665|16106647|P2|Induction Extension Period|Withdrawal by Subject|0
4679368|NCT02589665|16106648|P1|Induction Extension Period|Withdrawal by Subject|0
4679369|NCT02589665|16106639|P10|Induction Extension Period|Lack of Efficacy|0
4679370|NCT02589665|16106640|P9|Induction Extension Period|Lack of Efficacy|3
4679371|NCT02589665|16106641|P8|Induction Extension Period|Lack of Efficacy|0
4679372|NCT02589665|16106642|P7|Induction Extension Period|Lack of Efficacy|0
4679373|NCT02589665|16106643|P6|Induction Extension Period|Lack of Efficacy|0
4679374|NCT02589665|16106644|P5|Induction Extension Period|Lack of Efficacy|0
4679375|NCT02589665|16106645|P4|Induction Extension Period|Lack of Efficacy|0
4679376|NCT02589665|16106646|P3|Induction Extension Period|Lack of Efficacy|0
4679377|NCT02589665|16106647|P2|Induction Extension Period|Lack of Efficacy|0
4679378|NCT02589665|16106648|P1|Induction Extension Period|Lack of Efficacy|0
4679379|NCT02589665|16106639|P10|Induction Extension Period|Adverse Event|0
4679380|NCT02589665|16106640|P9|Induction Extension Period|Adverse Event|4
4679381|NCT02589665|16106641|P8|Induction Extension Period|Adverse Event|0
4679382|NCT02589665|16106642|P7|Induction Extension Period|Adverse Event|0
4679383|NCT02589665|16106643|P6|Induction Extension Period|Adverse Event|0
4679384|NCT02589665|16106644|P5|Induction Extension Period|Adverse Event|0
4679385|NCT02589665|16106645|P4|Induction Extension Period|Adverse Event|0
4679386|NCT02589665|16106646|P3|Induction Extension Period|Adverse Event|0
4679387|NCT02589665|16106647|P2|Induction Extension Period|Adverse Event|0
4679388|NCT02589665|16106648|P1|Induction Extension Period|Adverse Event|0
4679389|NCT02589665|16106639|P10|Maintenance Period|Reason Not Collected|0
4679390|NCT02589665|16106640|P9|Maintenance Period|Reason Not Collected|0
4679391|NCT02589665|16106641|P8|Maintenance Period|Reason Not Collected|0
4679392|NCT02589665|16106642|P7|Maintenance Period|Reason Not Collected|1
4679393|NCT02589665|16106643|P6|Maintenance Period|Reason Not Collected|1
4679394|NCT02589665|16106644|P5|Maintenance Period|Reason Not Collected|0
4679395|NCT02589665|16106645|P4|Maintenance Period|Reason Not Collected|0
4679396|NCT02589665|16106646|P3|Maintenance Period|Reason Not Collected|0
4679397|NCT02589665|16106647|P2|Maintenance Period|Reason Not Collected|0
4679398|NCT02589665|16106648|P1|Maintenance Period|Reason Not Collected|0
4679399|NCT02589665|16106639|P10|Maintenance Period|Physician Decision|0
4679400|NCT02589665|16106640|P9|Maintenance Period|Physician Decision|0
4679401|NCT02589665|16106641|P8|Maintenance Period|Physician Decision|0
4679402|NCT02589665|16106642|P7|Maintenance Period|Physician Decision|0
4679403|NCT02589665|16106643|P6|Maintenance Period|Physician Decision|1
4679404|NCT02589665|16106644|P5|Maintenance Period|Physician Decision|0
4679405|NCT02589665|16106645|P4|Maintenance Period|Physician Decision|0
4679406|NCT02589665|16106646|P3|Maintenance Period|Physician Decision|0
4679407|NCT02589665|16106647|P2|Maintenance Period|Physician Decision|0
4679408|NCT02589665|16106648|P1|Maintenance Period|Physician Decision|0
4679409|NCT02589665|16106639|P10|Maintenance Period|Lost to Follow-up|0
4679410|NCT02589665|16106640|P9|Maintenance Period|Lost to Follow-up|0
4679411|NCT02589665|16106641|P8|Maintenance Period|Lost to Follow-up|0
4679412|NCT02589665|16106642|P7|Maintenance Period|Lost to Follow-up|0
4679413|NCT02589665|16106643|P6|Maintenance Period|Lost to Follow-up|1
4679414|NCT02589665|16106644|P5|Maintenance Period|Lost to Follow-up|0
4679415|NCT02589665|16106645|P4|Maintenance Period|Lost to Follow-up|0
4679416|NCT02589665|16106646|P3|Maintenance Period|Lost to Follow-up|0
4679417|NCT02589665|16106647|P2|Maintenance Period|Lost to Follow-up|0
4679418|NCT02589665|16106648|P1|Maintenance Period|Lost to Follow-up|0
4679419|NCT02589665|16106639|P10|Maintenance Period|Adverse Event|0
4679420|NCT02589665|16106640|P9|Maintenance Period|Adverse Event|0
4679421|NCT02589665|16106641|P8|Maintenance Period|Adverse Event|0
4679422|NCT02589665|16106642|P7|Maintenance Period|Adverse Event|2
4679423|NCT02589665|16106643|P6|Maintenance Period|Adverse Event|0
4679424|NCT02589665|16106644|P5|Maintenance Period|Adverse Event|0
4679425|NCT02589665|16106645|P4|Maintenance Period|Adverse Event|0
4679426|NCT02589665|16106646|P3|Maintenance Period|Adverse Event|0
4679427|NCT02589665|16106647|P2|Maintenance Period|Adverse Event|0
4679428|NCT02589665|16106648|P1|Maintenance Period|Adverse Event|0
4679429|NCT02589665|16106639|P10|Maintenance Period|Lack of Efficacy|0
4679430|NCT02589665|16106640|P9|Maintenance Period|Lack of Efficacy|0
4679431|NCT02589665|16106641|P8|Maintenance Period|Lack of Efficacy|0
4679432|NCT02589665|16106642|P7|Maintenance Period|Lack of Efficacy|0
4679433|NCT02589665|16106643|P6|Maintenance Period|Lack of Efficacy|1
4679434|NCT02589665|16106644|P5|Maintenance Period|Lack of Efficacy|2
4679435|NCT02589665|16106645|P4|Maintenance Period|Lack of Efficacy|0
4679436|NCT02589665|16106646|P3|Maintenance Period|Lack of Efficacy|0
4679437|NCT02589665|16106647|P2|Maintenance Period|Lack of Efficacy|0
4679438|NCT02589665|16106648|P1|Maintenance Period|Lack of Efficacy|0
4679439|NCT02589665|16106639|P10|Maintenance Period|Withdrawal by Subject|0
4679440|NCT02589665|16106640|P9|Maintenance Period|Withdrawal by Subject|0
4679441|NCT02589665|16106641|P8|Maintenance Period|Withdrawal by Subject|0
4679442|NCT02589665|16106642|P7|Maintenance Period|Withdrawal by Subject|4
4679443|NCT02589665|16106643|P6|Maintenance Period|Withdrawal by Subject|2
4679444|NCT02589665|16106644|P5|Maintenance Period|Withdrawal by Subject|4
4679445|NCT02589665|16106645|P4|Maintenance Period|Withdrawal by Subject|0
4679446|NCT02589665|16106646|P3|Maintenance Period|Withdrawal by Subject|0
4679447|NCT02589665|16106647|P2|Maintenance Period|Withdrawal by Subject|0
4679448|NCT02589665|16106648|P1|Maintenance Period|Withdrawal by Subject|0
4679449|NCT02589665|16106639|P10|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679450|NCT02589665|16106640|P9|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679451|NCT02589665|16106641|P8|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679452|NCT02589665|16106642|P7|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39
4679453|NCT02589665|16106643|P6|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41
4679454|NCT02589665|16106644|P5|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7
4679455|NCT02589665|16106645|P4|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679456|NCT02589665|16106646|P3|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679457|NCT02589665|16106647|P2|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679458|NCT02589665|16106648|P1|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0
4679459|NCT02589665|16106639|P10|Induction Period|Protocol Violation|0
4679460|NCT02589665|16106640|P9|Induction Period|Protocol Violation|0
4679461|NCT02589665|16106641|P8|Induction Period|Protocol Violation|0
4679462|NCT02589665|16106642|P7|Induction Period|Protocol Violation|0
4679463|NCT02589665|16106643|P6|Induction Period|Protocol Violation|0
4679464|NCT02589665|16106644|P5|Induction Period|Protocol Violation|0
4679465|NCT02589665|16106645|P4|Induction Period|Protocol Violation|0
4679466|NCT02589665|16106646|P3|Induction Period|Protocol Violation|0
4679467|NCT02589665|16106647|P2|Induction Period|Protocol Violation|1
4679468|NCT02589665|16106648|P1|Induction Period|Protocol Violation|0
4679469|NCT02589665|16106639|P10|Induction Period|Withdrawal by Subject|0
4679470|NCT02589665|16106640|P9|Induction Period|Withdrawal by Subject|0
4679471|NCT02589665|16106641|P8|Induction Period|Withdrawal by Subject|0
4679472|NCT02589665|16106642|P7|Induction Period|Withdrawal by Subject|0
4679473|NCT02589665|16106643|P6|Induction Period|Withdrawal by Subject|0
4679474|NCT02589665|16106644|P5|Induction Period|Withdrawal by Subject|0
4679475|NCT02589665|16106645|P4|Induction Period|Withdrawal by Subject|1
4679476|NCT02589665|16106646|P3|Induction Period|Withdrawal by Subject|0
4679477|NCT02589665|16106647|P2|Induction Period|Withdrawal by Subject|1
4679478|NCT02589665|16106648|P1|Induction Period|Withdrawal by Subject|0
4679479|NCT02589665|16106639|P10|Induction Period|Adverse Event|0
4679480|NCT02589665|16106640|P9|Induction Period|Adverse Event|0
4679481|NCT02589665|16106641|P8|Induction Period|Adverse Event|0
4679482|NCT02589665|16106642|P7|Induction Period|Adverse Event|0
4679483|NCT02589665|16106643|P6|Induction Period|Adverse Event|0
4679484|NCT02589665|16106644|P5|Induction Period|Adverse Event|0
4679485|NCT02589665|16106645|P4|Induction Period|Adverse Event|2
4679486|NCT02589665|16106646|P3|Induction Period|Adverse Event|2
4679487|NCT02589665|16106647|P2|Induction Period|Adverse Event|0
4679488|NCT02589665|16106648|P1|Induction Period|Adverse Event|3
4679489|NCT02589665|16106639|P10|Induction Period|Did not receive drug|0
4679490|NCT02589665|16106640|P9|Induction Period|Did not receive drug|0
4679491|NCT02589665|16106641|P8|Induction Period|Did not receive drug|0
4679492|NCT02589665|16106642|P7|Induction Period|Did not receive drug|0
4679493|NCT02589665|16106643|P6|Induction Period|Did not receive drug|0
4679494|NCT02589665|16106644|P5|Induction Period|Did not receive drug|0
4679495|NCT02589665|16106645|P4|Induction Period|Did not receive drug|1
4679496|NCT02589665|16106646|P3|Induction Period|Did not receive drug|0
4679497|NCT02589665|16106647|P2|Induction Period|Did not receive drug|0
4679498|NCT02589665|16106648|P1|Induction Period|Did not receive drug|0
4679499|NCT02589639|16106713|P3|Overall Study|Not Treated|0
4679500|NCT02589639|16106714|P2|Overall Study|Not Treated|3
4679501|NCT02589639|16106715|P1|Overall Study|Not Treated|0
4679502|NCT02589639|16106713|P3|Overall Study|Other reason than specified above|1
4679503|NCT02589639|16106714|P2|Overall Study|Other reason than specified above|2
4679504|NCT02589639|16106715|P1|Overall Study|Other reason than specified above|1
4679505|NCT02589639|16106713|P3|Overall Study|Adverse Event|3
4679506|NCT02589639|16106714|P2|Overall Study|Adverse Event|5
4679507|NCT02589639|16106715|P1|Overall Study|Adverse Event|4
4679508|NCT02589639|16106713|P3|Overall Study|Patient withdrawal, not due to AE|0
4679509|NCT02589639|16106714|P2|Overall Study|Patient withdrawal, not due to AE|0
4679510|NCT02589639|16106715|P1|Overall Study|Patient withdrawal, not due to AE|3
4679511|NCT02589639|16106713|P3|Overall Study|Protocol Violation|0
4679512|NCT02589639|16106714|P2|Overall Study|Protocol Violation|0
4679513|NCT02589639|16106715|P1|Overall Study|Protocol Violation|1
4679514|NCT02589639|16106713|P3|Overall Study|Lost to Follow-up|0
4679515|NCT02589639|16106714|P2|Overall Study|Lost to Follow-up|0
4679516|NCT02589639|16106715|P1|Overall Study|Lost to Follow-up|1
4679517|NCT02589626|16106728|P2|Overall Study|Adverse Event|1
4679518|NCT02589626|16106729|P1|Overall Study|Adverse Event|1
4679519|NCT02589626|16106728|P2|Overall Study|Withdrawal by Subject|1
4679520|NCT02589626|16106729|P1|Overall Study|Withdrawal by Subject|1
4679521|NCT02589626|16106728|P2|Overall Study|Other than the reason specified|0
4679522|NCT02589626|16106729|P1|Overall Study|Other than the reason specified|1
4679523|NCT02589405|16106737|P1|Overall Study|Withdrawal by Subject|1
4679524|NCT02589405|16106737|P1|Overall Study|Adverse Event|3
4679525|NCT02588339|16106875|P1|Overall Study|GVHD Progression prior to treatment|2
4679526|NCT02588339|16106875|P1|Overall Study|Withdrawal by Subject|1
4679527|NCT02588261|16106887|P2|Overall Study|Lost to Follow-up|0
4679528|NCT02588261|16106888|P1|Overall Study|Lost to Follow-up|1
4679529|NCT02588261|16106887|P2|Overall Study|Adverse Event|24
4679530|NCT02588261|16106888|P1|Overall Study|Adverse Event|29
4679531|NCT02588261|16106887|P2|Overall Study|Progressive Disease|82
4679532|NCT02588261|16106888|P1|Overall Study|Progressive Disease|61
4679533|NCT02588261|16106887|P2|Overall Study|Miscellaneous|4
4679534|NCT02588261|16106888|P1|Overall Study|Miscellaneous|5
4679535|NCT02588261|16106887|P2|Overall Study|Noncompliance with Study Drug|1
4679536|NCT02588261|16106888|P1|Overall Study|Noncompliance with Study Drug|0
4679537|NCT02588261|16106887|P2|Overall Study|Withdrawal by Subject|8
4679538|NCT02588261|16106888|P1|Overall Study|Withdrawal by Subject|12
4679539|NCT02588261|16106887|P2|Overall Study|Death|2
4679540|NCT02588261|16106888|P1|Overall Study|Death|1
4679541|NCT02588261|16106887|P2|Overall Study|Protocol Deviation|0
4679542|NCT02588261|16106888|P1|Overall Study|Protocol Deviation|1
4679543|NCT02588261|16106887|P2|Overall Study|Study Terminated by Sponsor|142
4679544|NCT02588261|16106888|P1|Overall Study|Study Terminated by Sponsor|157
4679545|NCT02588092|16106924|P10|Overall Study|Sponsor Decision|1
4679546|NCT02588092|16106925|P9|Overall Study|Sponsor Decision|1
4679547|NCT02588092|16106926|P8|Overall Study|Sponsor Decision|0
4679548|NCT02588092|16106927|P7|Overall Study|Sponsor Decision|0
4679549|NCT02588092|16106928|P6|Overall Study|Sponsor Decision|0
4679550|NCT02588092|16106929|P5|Overall Study|Sponsor Decision|0
4679551|NCT02588092|16106930|P4|Overall Study|Sponsor Decision|0
4679552|NCT02588092|16106931|P3|Overall Study|Sponsor Decision|0
4679553|NCT02588092|16106932|P2|Overall Study|Sponsor Decision|0
4679554|NCT02588092|16106933|P1|Overall Study|Sponsor Decision|0
4679555|NCT02588092|16106924|P10|Overall Study|Started Another Treatment|0
4679556|NCT02588092|16106925|P9|Overall Study|Started Another Treatment|0
4679557|NCT02588092|16106926|P8|Overall Study|Started Another Treatment|1
4679558|NCT02588092|16106927|P7|Overall Study|Started Another Treatment|0
4679559|NCT02588092|16106928|P6|Overall Study|Started Another Treatment|0
4679560|NCT02588092|16106929|P5|Overall Study|Started Another Treatment|1
4679561|NCT02588092|16106930|P4|Overall Study|Started Another Treatment|0
4679562|NCT02588092|16106931|P3|Overall Study|Started Another Treatment|0
4679563|NCT02588092|16106932|P2|Overall Study|Started Another Treatment|0
4679564|NCT02588092|16106933|P1|Overall Study|Started Another Treatment|0
4679565|NCT02588092|16106924|P10|Overall Study|Withdrawal by Subject|0
4679566|NCT02588092|16106925|P9|Overall Study|Withdrawal by Subject|0
4679567|NCT02588092|16106926|P8|Overall Study|Withdrawal by Subject|2
4679568|NCT02588092|16106927|P7|Overall Study|Withdrawal by Subject|1
4679569|NCT02588092|16106928|P6|Overall Study|Withdrawal by Subject|1
4679570|NCT02588092|16106929|P5|Overall Study|Withdrawal by Subject|0
4679571|NCT02588092|16106930|P4|Overall Study|Withdrawal by Subject|0
4679572|NCT02588092|16106931|P3|Overall Study|Withdrawal by Subject|0
4679573|NCT02588092|16106932|P2|Overall Study|Withdrawal by Subject|0
4679574|NCT02588092|16106933|P1|Overall Study|Withdrawal by Subject|0
4679575|NCT02588092|16106924|P10|Overall Study|Death|2
4679576|NCT02588092|16106925|P9|Overall Study|Death|5
4679577|NCT02588092|16106926|P8|Overall Study|Death|1
4679578|NCT02588092|16106927|P7|Overall Study|Death|2
4679579|NCT02588092|16106928|P6|Overall Study|Death|2
4679580|NCT02588092|16106929|P5|Overall Study|Death|2
4679581|NCT02588092|16106930|P4|Overall Study|Death|3
4679582|NCT02588092|16106931|P3|Overall Study|Death|3
4679583|NCT02588092|16106932|P2|Overall Study|Death|3
4679584|NCT02588092|16106933|P1|Overall Study|Death|4
4679585|NCT02587819|16107127|P1|Overall Study|Lost to Follow-up|1
4679586|NCT02587819|16107127|P1|Overall Study|Adverse Event|1
4679587|NCT02587520|16107163|P18|Overall Study|Lost to Follow-up|0
4679588|NCT02587520|16107164|P17|Overall Study|Lost to Follow-up|0
4679589|NCT02587520|16107165|P16|Overall Study|Lost to Follow-up|0
4679590|NCT02587520|16107166|P15|Overall Study|Lost to Follow-up|0
4679591|NCT02587520|16107167|P14|Overall Study|Lost to Follow-up|0
4679592|NCT02587520|16107168|P13|Overall Study|Lost to Follow-up|0
4679593|NCT02587520|16107169|P12|Overall Study|Lost to Follow-up|1
4679594|NCT02587520|16107170|P11|Overall Study|Lost to Follow-up|2
4679595|NCT02587520|16107171|P10|Overall Study|Lost to Follow-up|2
4679596|NCT02587520|16107172|P9|Overall Study|Lost to Follow-up|0
4679597|NCT02587520|16107173|P8|Overall Study|Lost to Follow-up|1
4679598|NCT02587520|16107174|P7|Overall Study|Lost to Follow-up|1
4679599|NCT02587520|16107175|P6|Overall Study|Lost to Follow-up|1
4679600|NCT02587520|16107176|P5|Overall Study|Lost to Follow-up|0
4679601|NCT02587520|16107177|P4|Overall Study|Lost to Follow-up|2
4679602|NCT02587520|16107178|P3|Overall Study|Lost to Follow-up|0
4679603|NCT02587520|16107179|P2|Overall Study|Lost to Follow-up|2
4679604|NCT02587520|16107180|P1|Overall Study|Lost to Follow-up|0
4679605|NCT02587520|16107163|P18|Overall Study|Withdrawal by Subject|0
4679606|NCT02587520|16107164|P17|Overall Study|Withdrawal by Subject|0
4679607|NCT02587520|16107165|P16|Overall Study|Withdrawal by Subject|0
4679608|NCT02587520|16107166|P15|Overall Study|Withdrawal by Subject|0
4679609|NCT02587520|16107167|P14|Overall Study|Withdrawal by Subject|1
4679610|NCT02587520|16107168|P13|Overall Study|Withdrawal by Subject|0
4679611|NCT02587520|16107169|P12|Overall Study|Withdrawal by Subject|0
4679612|NCT02587520|16107170|P11|Overall Study|Withdrawal by Subject|0
4679613|NCT02587520|16107171|P10|Overall Study|Withdrawal by Subject|0
4679614|NCT02587520|16107172|P9|Overall Study|Withdrawal by Subject|0
4679615|NCT02587520|16107173|P8|Overall Study|Withdrawal by Subject|0
4679616|NCT02587520|16107174|P7|Overall Study|Withdrawal by Subject|1
4679617|NCT02587520|16107175|P6|Overall Study|Withdrawal by Subject|1
4679618|NCT02587520|16107176|P5|Overall Study|Withdrawal by Subject|0
4679619|NCT02587520|16107177|P4|Overall Study|Withdrawal by Subject|1
4679620|NCT02587520|16107178|P3|Overall Study|Withdrawal by Subject|1
4679621|NCT02587520|16107179|P2|Overall Study|Withdrawal by Subject|0
4679622|NCT02587520|16107180|P1|Overall Study|Withdrawal by Subject|0
4679623|NCT02587520|16107163|P18|Overall Study|Adverse Event|0
4679624|NCT02587520|16107164|P17|Overall Study|Adverse Event|0
4679625|NCT02587520|16107165|P16|Overall Study|Adverse Event|0
4679626|NCT02587520|16107166|P15|Overall Study|Adverse Event|0
4679627|NCT02587520|16107167|P14|Overall Study|Adverse Event|0
4679628|NCT02587520|16107168|P13|Overall Study|Adverse Event|0
4679629|NCT02587520|16107169|P12|Overall Study|Adverse Event|1
4679630|NCT02587520|16107170|P11|Overall Study|Adverse Event|0
4679631|NCT02587520|16107171|P10|Overall Study|Adverse Event|0
4679632|NCT02587520|16107172|P9|Overall Study|Adverse Event|0
4679633|NCT02587520|16107173|P8|Overall Study|Adverse Event|0
4679634|NCT02587520|16107174|P7|Overall Study|Adverse Event|0
4679635|NCT02587520|16107175|P6|Overall Study|Adverse Event|0
4679636|NCT02587520|16107176|P5|Overall Study|Adverse Event|0
4679637|NCT02587520|16107177|P4|Overall Study|Adverse Event|0
4679638|NCT02587520|16107178|P3|Overall Study|Adverse Event|0
4679639|NCT02587520|16107179|P2|Overall Study|Adverse Event|0
4679640|NCT02587520|16107180|P1|Overall Study|Adverse Event|0
4679641|NCT02587520|16107163|P18|Overall Study|Protocol Violation|0
4679642|NCT02587520|16107164|P17|Overall Study|Protocol Violation|0
4679643|NCT02587520|16107165|P16|Overall Study|Protocol Violation|0
4679644|NCT02587520|16107166|P15|Overall Study|Protocol Violation|0
4679645|NCT02587520|16107167|P14|Overall Study|Protocol Violation|0
4679646|NCT02587520|16107168|P13|Overall Study|Protocol Violation|0
4679647|NCT02587520|16107169|P12|Overall Study|Protocol Violation|2
4679648|NCT02587520|16107170|P11|Overall Study|Protocol Violation|1
4679649|NCT02587520|16107171|P10|Overall Study|Protocol Violation|3
4679650|NCT02587520|16107172|P9|Overall Study|Protocol Violation|3
4679651|NCT02587520|16107173|P8|Overall Study|Protocol Violation|1
4679652|NCT02587520|16107174|P7|Overall Study|Protocol Violation|1
4679653|NCT02587520|16107175|P6|Overall Study|Protocol Violation|1
4679654|NCT02587520|16107176|P5|Overall Study|Protocol Violation|0
4679655|NCT02587520|16107177|P4|Overall Study|Protocol Violation|2
4679656|NCT02587520|16107178|P3|Overall Study|Protocol Violation|0
4679657|NCT02587520|16107179|P2|Overall Study|Protocol Violation|0
4679658|NCT02587520|16107180|P1|Overall Study|Protocol Violation|2
4679659|NCT02587234|16107220|P2|Overall Study|Lost to Follow-up|2
4679660|NCT02587234|16107221|P1|Overall Study|Lost to Follow-up|0
4679661|NCT02587234|16107220|P2|Overall Study|Withdrawal by Subject|1
4679662|NCT02587234|16107221|P1|Overall Study|Withdrawal by Subject|1
4679663|NCT02587221|16107233|P2|Overall Study|Other Reason or Unspecified|1
4679664|NCT02587221|16107234|P1|Overall Study|Other Reason or Unspecified|2
4679665|NCT02587221|16107233|P2|Overall Study|Protocol Violation|5
4679666|NCT02587221|16107234|P1|Overall Study|Protocol Violation|6
4679667|NCT02587221|16107233|P2|Overall Study|Lost to Follow-up|19
4679668|NCT02587221|16107234|P1|Overall Study|Lost to Follow-up|21
4679669|NCT02587221|16107233|P2|Overall Study|Withdrawal by Subject|61
4679670|NCT02587221|16107234|P1|Overall Study|Withdrawal by Subject|66
4679671|NCT02587221|16107233|P2|Overall Study|Death|34
4679672|NCT02587221|16107234|P1|Overall Study|Death|33
4679673|NCT02587221|16107233|P2|Overall Study|Adverse Event|3
4679674|NCT02587221|16107234|P1|Overall Study|Adverse Event|3
4679675|NCT02587143|16107280|P2|Overall Study|Adverse Event|0
4679676|NCT02587143|16107281|P1|Overall Study|Adverse Event|1
4679677|NCT02587065|16107298|P1|Overall Study|Reason not Specified|3
4679678|NCT02587065|16107298|P1|Overall Study|Discontinuation of Study Medication|2
4679679|NCT02587065|16107298|P1|Overall Study|Non-adherence to the Protocol|3
4679680|NCT02587065|16107298|P1|Overall Study|Withdrawal of Informed Consent (IC)|5
4679681|NCT02587065|16107298|P1|Overall Study|Adverse Event|14
4679682|NCT02586805|16107363|P4|Overall Study|Physician Decision|0
4679683|NCT02586805|16107364|P3|Overall Study|Physician Decision|0
4679684|NCT02586805|16107365|P2|Overall Study|Physician Decision|0
4679685|NCT02586805|16107366|P1|Overall Study|Physician Decision|1
4679686|NCT02586805|16107363|P4|Overall Study|Lost to Follow-up|0
4679687|NCT02586805|16107364|P3|Overall Study|Lost to Follow-up|1
4679688|NCT02586805|16107365|P2|Overall Study|Lost to Follow-up|0
4679689|NCT02586805|16107366|P1|Overall Study|Lost to Follow-up|0
4679690|NCT02586805|16107363|P4|Overall Study|Adverse Event|0
4679691|NCT02586805|16107364|P3|Overall Study|Adverse Event|1
4679692|NCT02586805|16107365|P2|Overall Study|Adverse Event|0
4679693|NCT02586805|16107366|P1|Overall Study|Adverse Event|2
4679694|NCT02586805|16107363|P4|Overall Study|Withdrawal by Subject|2
4679695|NCT02586805|16107364|P3|Overall Study|Withdrawal by Subject|1
4679696|NCT02586805|16107365|P2|Overall Study|Withdrawal by Subject|1
4679697|NCT02586805|16107366|P1|Overall Study|Withdrawal by Subject|3
4679698|NCT02586506|16107394|P1|Overall Study|Other Reason|2
4679699|NCT02586506|16107394|P1|Overall Study|Lost to Follow-up|1
4679700|NCT02586506|16107394|P1|Overall Study|Protocol Violation|6
4679701|NCT02586493|16107400|P1|Overall Study|Withdrawal by Subject|1
4679702|NCT02586493|16107400|P1|Overall Study|Lost to Follow-up|1
4679703|NCT02586493|16107400|P1|Overall Study|Protocol Violation|6
4679704|NCT02586493|16107400|P1|Overall Study|Adverse Event|4
4679705|NCT02586415|16107408|P2|Overall Study|Lost to Follow-up|2
4679706|NCT02586415|16107409|P1|Overall Study|Lost to Follow-up|1
4679707|NCT02586415|16107408|P2|Overall Study|Death|23
4679708|NCT02586415|16107409|P1|Overall Study|Death|13
4679709|NCT02586233|16107426|P7|Overall Study|Death|0
4679710|NCT02586233|16107427|P6|Overall Study|Death|0
4679711|NCT02586233|16107428|P5|Overall Study|Death|2
4679712|NCT02586233|16107429|P4|Overall Study|Death|0
4679713|NCT02586233|16107430|P3|Overall Study|Death|0
4679714|NCT02586233|16107431|P2|Overall Study|Death|1
4679715|NCT02586233|16107432|P1|Overall Study|Death|0
4679716|NCT02586233|16107426|P7|Overall Study|Randomized but did not receive treatment|2
4679717|NCT02586233|16107427|P6|Overall Study|Randomized but did not receive treatment|2
4679718|NCT02586233|16107428|P5|Overall Study|Randomized but did not receive treatment|0
4679719|NCT02586233|16107429|P4|Overall Study|Randomized but did not receive treatment|0
4679720|NCT02586233|16107430|P3|Overall Study|Randomized but did not receive treatment|0
4679721|NCT02586233|16107431|P2|Overall Study|Randomized but did not receive treatment|1
4679722|NCT02586233|16107432|P1|Overall Study|Randomized but did not receive treatment|0
4679723|NCT02586077|16107491|P1|Overall Study|Lost to Follow-up|3
4679724|NCT02586077|16107491|P1|Overall Study|Physician Decision|4
4679725|NCT02586077|16107491|P1|Overall Study|Withdrawal by Subject|1
4679726|NCT02586025|16107501|P2|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|35
4679727|NCT02586025|16107502|P1|Treatment-Free Follow-Up|Remain in Treatment-Free Follow-Up|56
4679728|NCT02586025|16107501|P2|Adjuvant Treatment|Recurrent Disease|4
4679729|NCT02586025|16107502|P1|Adjuvant Treatment|Recurrent Disease|1
4679730|NCT02586025|16107501|P2|Adjuvant Treatment|Physician Decision|1
4679731|NCT02586025|16107502|P1|Adjuvant Treatment|Physician Decision|0
4679732|NCT02586025|16107501|P2|Adjuvant Treatment|Withdrawal by Subject|3
4679733|NCT02586025|16107502|P1|Adjuvant Treatment|Withdrawal by Subject|5
4679734|NCT02586025|16107501|P2|Adjuvant Treatment|Remain in Adjuvant Treatment|61
4679735|NCT02586025|16107502|P1|Adjuvant Treatment|Remain in Adjuvant Treatment|133
4679736|NCT02586025|16107501|P2|Neoadjuvant Treatment|Progressive Disease|3
4679737|NCT02586025|16107502|P1|Neoadjuvant Treatment|Progressive Disease|2
4679738|NCT02586025|16107501|P2|Neoadjuvant Treatment|Physician Decision|1
4679739|NCT02586025|16107502|P1|Neoadjuvant Treatment|Physician Decision|2
4679740|NCT02586025|16107501|P2|Neoadjuvant Treatment|Withdrawal by Subject|3
4679741|NCT02586025|16107502|P1|Neoadjuvant Treatment|Withdrawal by Subject|4
4679742|NCT02586025|16107501|P2|Neoadjuvant Treatment|Adverse Event|0
4679743|NCT02586025|16107502|P1|Neoadjuvant Treatment|Adverse Event|1
4679744|NCT02586025|16107501|P2|Neoadjuvant Treatment|Death|0
4679745|NCT02586025|16107502|P1|Neoadjuvant Treatment|Death|1
4679746|NCT02586025|16107501|P2|Neoadjuvant Treatment|Did Not Receive Study Drug|0
4679747|NCT02586025|16107502|P1|Neoadjuvant Treatment|Did Not Receive Study Drug|1
4679748|NCT02586012|16107538|P6|Overall Study|study terminated|0
4679749|NCT02586012|16107539|P5|Overall Study|study terminated|1
4679750|NCT02586012|16107540|P4|Overall Study|study terminated|1
4679751|NCT02586012|16107541|P3|Overall Study|study terminated|1
4679752|NCT02586012|16107542|P2|Overall Study|study terminated|2
4679753|NCT02586012|16107543|P1|Overall Study|study terminated|0
4679754|NCT02586012|16107538|P6|Overall Study|Protocol Violation|1
4679755|NCT02586012|16107539|P5|Overall Study|Protocol Violation|0
4679756|NCT02586012|16107540|P4|Overall Study|Protocol Violation|0
4679757|NCT02586012|16107541|P3|Overall Study|Protocol Violation|0
4679758|NCT02586012|16107542|P2|Overall Study|Protocol Violation|0
4679759|NCT02586012|16107543|P1|Overall Study|Protocol Violation|0
4679760|NCT02586012|16107538|P6|Overall Study|Withdrawal by Subject|2
4679761|NCT02586012|16107539|P5|Overall Study|Withdrawal by Subject|0
4679762|NCT02586012|16107540|P4|Overall Study|Withdrawal by Subject|1
4679763|NCT02586012|16107541|P3|Overall Study|Withdrawal by Subject|0
4679764|NCT02586012|16107542|P2|Overall Study|Withdrawal by Subject|1
4679765|NCT02586012|16107543|P1|Overall Study|Withdrawal by Subject|1
4679766|NCT02585999|16107554|P1|Overall Study|Protocol Violation|1
4679767|NCT02585999|16107554|P1|Overall Study|Lost to Follow-up|1
4679768|NCT02585960|16107562|P3|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
4679769|NCT02585960|16107563|P2|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1
4679770|NCT02585960|16107564|P1|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0
4679771|NCT02585960|16107562|P3|Prophylactic Treatment Period|Major protocol deviation|0
4679772|NCT02585960|16107563|P2|Prophylactic Treatment Period|Major protocol deviation|4
4679773|NCT02585960|16107564|P1|Prophylactic Treatment Period|Major protocol deviation|0
4679774|NCT02585960|16107562|P3|PK/Safety Assessment Period|Screen Failure|1
4679775|NCT02585960|16107563|P2|PK/Safety Assessment Period|Screen Failure|0
4679776|NCT02585960|16107564|P1|PK/Safety Assessment Period|Screen Failure|0
4679777|NCT02585960|16107562|P3|PK/Safety Assessment Period|Withdrawn by sponsor|0
4679778|NCT02585960|16107563|P2|PK/Safety Assessment Period|Withdrawn by sponsor|1
4679779|NCT02585960|16107564|P1|PK/Safety Assessment Period|Withdrawn by sponsor|0
4679780|NCT02585960|16107562|P3|PK/Safety Assessment Period|Other|0
4679781|NCT02585960|16107563|P2|PK/Safety Assessment Period|Other|4
4679782|NCT02585960|16107564|P1|PK/Safety Assessment Period|Other|4
4679783|NCT02585960|16107562|P3|PK/Safety Assessment Period|Non-compliance to study procedures|0
4679784|NCT02585960|16107563|P2|PK/Safety Assessment Period|Non-compliance to study procedures|2
4679785|NCT02585960|16107564|P1|PK/Safety Assessment Period|Non-compliance to study procedures|0
4679786|NCT02585960|16107562|P3|PK/Safety Assessment Period|Withdrawal by Subject|5
4679787|NCT02585960|16107563|P2|PK/Safety Assessment Period|Withdrawal by Subject|2
4679788|NCT02585960|16107564|P1|PK/Safety Assessment Period|Withdrawal by Subject|1
4679789|NCT02585960|16107562|P3|PK/Safety Assessment Period|Physician Decision|0
4679790|NCT02585960|16107563|P2|PK/Safety Assessment Period|Physician Decision|1
4679791|NCT02585960|16107564|P1|PK/Safety Assessment Period|Physician Decision|0
4679792|NCT02585934|16107634|P2|Overall Study|Another Reason|5
4679793|NCT02585934|16107635|P1|Overall Study|Another Reason|10
4679794|NCT02585934|16107634|P2|Overall Study|Sponsor Termination|2
4679795|NCT02585934|16107635|P1|Overall Study|Sponsor Termination|1
4679796|NCT02585934|16107634|P2|Overall Study|Caregiver Withdrew Consent|7
4679797|NCT02585934|16107635|P1|Overall Study|Caregiver Withdrew Consent|7
4679798|NCT02585934|16107634|P2|Overall Study|Death|0
4679799|NCT02585934|16107635|P1|Overall Study|Death|2
4679800|NCT02585934|16107634|P2|Overall Study|Lack of Efficacy|1
4679801|NCT02585934|16107635|P1|Overall Study|Lack of Efficacy|2
4679802|NCT02585934|16107634|P2|Overall Study|Withdrawal by Subject|21
4679803|NCT02585934|16107635|P1|Overall Study|Withdrawal by Subject|7
4679804|NCT02585934|16107634|P2|Overall Study|Physician Decision|2
4679805|NCT02585934|16107635|P1|Overall Study|Physician Decision|3
4679806|NCT02585934|16107634|P2|Overall Study|Adverse Event|22
4679807|NCT02585934|16107635|P1|Overall Study|Adverse Event|21
4679808|NCT02585934|16107634|P2|Overall Study|Protocol Violation|11
4679809|NCT02585934|16107635|P1|Overall Study|Protocol Violation|14
4679810|NCT02585934|16107634|P2|Overall Study|Lost to Follow-up|2
4679811|NCT02585934|16107635|P1|Overall Study|Lost to Follow-up|2
4679812|NCT02585830|16107691|P1|Overall Study|Withdrawal by Subject|3
4679813|NCT02585778|16107700|P2|Overall Study|Other than specified above|2
4679814|NCT02585778|16107701|P1|Overall Study|Other than specified above|6
4679815|NCT02585778|16107700|P2|Overall Study|Randomized but not treated|2
4679816|NCT02585778|16107701|P1|Overall Study|Randomized but not treated|1
4679817|NCT02585778|16107700|P2|Overall Study|Death|1
4679818|NCT02585778|16107701|P1|Overall Study|Death|0
4679819|NCT02585778|16107700|P2|Overall Study|Poor compliance to study protocol|2
4679820|NCT02585778|16107701|P1|Overall Study|Poor compliance to study protocol|0
4679821|NCT02585778|16107700|P2|Overall Study|Participant did not wish to continue|4
4679822|NCT02585778|16107701|P1|Overall Study|Participant did not wish to continue|9
4679823|NCT02585778|16107700|P2|Overall Study|Adverse Event|4
4679824|NCT02585778|16107701|P1|Overall Study|Adverse Event|17
4679825|NCT02585713|16107817|P2|Overall Study|Other|1
4679826|NCT02585713|16107818|P1|Overall Study|Other|3
4679827|NCT02585713|16107817|P2|Overall Study|Withdrew prior to treatment|7
4679828|NCT02585713|16107818|P1|Overall Study|Withdrew prior to treatment|2
4679829|NCT02584959|16107881|P3|Period 2|Withdrawn from study|2
4679830|NCT02584959|16107882|P2|Period 2|Withdrawn from study|1
4679831|NCT02584959|16107883|P1|Period 2|Withdrawn from study|6
4679832|NCT02584959|16107881|P3|Period 1|Withdrawn from study|0
4679833|NCT02584959|16107882|P2|Period 1|Withdrawn from study|4
4679834|NCT02584959|16107883|P1|Period 1|Withdrawn from study|3
4679835|NCT02584855|16107938|P6|Post Treatment Follow-up Period|Protocol Violation|0
4679836|NCT02584855|16107939|P5|Post Treatment Follow-up Period|Protocol Violation|1
4679837|NCT02584855|16107940|P4|Post Treatment Follow-up Period|Protocol Violation|0
4679838|NCT02584855|16107941|P3|Post Treatment Follow-up Period|Protocol Violation|0
4679839|NCT02584855|16107942|P2|Post Treatment Follow-up Period|Protocol Violation|0
4679840|NCT02584855|16107943|P1|Post Treatment Follow-up Period|Protocol Violation|0
4679841|NCT02584855|16107938|P6|Post Treatment Follow-up Period|Withdrawal by Subject|0
4679842|NCT02584855|16107939|P5|Post Treatment Follow-up Period|Withdrawal by Subject|7
4679843|NCT02584855|16107940|P4|Post Treatment Follow-up Period|Withdrawal by Subject|0
4679844|NCT02584855|16107941|P3|Post Treatment Follow-up Period|Withdrawal by Subject|0
4679845|NCT02584855|16107942|P2|Post Treatment Follow-up Period|Withdrawal by Subject|0
4679846|NCT02584855|16107943|P1|Post Treatment Follow-up Period|Withdrawal by Subject|0
4679847|NCT02584855|16107938|P6|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4679848|NCT02584855|16107939|P5|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4679849|NCT02584855|16107940|P4|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4679850|NCT02584855|16107941|P3|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4679851|NCT02584855|16107942|P2|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1
4679852|NCT02584855|16107943|P1|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0
4679934|NCT02584504|16108097|P1|Open-label Treatment|Physician Decision|0
4679853|NCT02584855|16107938|P6|Double-Blind Withdrawal Period|Lack of Efficacy|0
4679854|NCT02584855|16107939|P5|Double-Blind Withdrawal Period|Lack of Efficacy|0
4679855|NCT02584855|16107940|P4|Double-Blind Withdrawal Period|Lack of Efficacy|0
4679856|NCT02584855|16107941|P3|Double-Blind Withdrawal Period|Lack of Efficacy|0
4679857|NCT02584855|16107942|P2|Double-Blind Withdrawal Period|Lack of Efficacy|10
4679858|NCT02584855|16107943|P1|Double-Blind Withdrawal Period|Lack of Efficacy|0
4679859|NCT02584855|16107938|P6|Double-Blind Withdrawal Period|Adverse Event|0
4679860|NCT02584855|16107939|P5|Double-Blind Withdrawal Period|Adverse Event|0
4679861|NCT02584855|16107940|P4|Double-Blind Withdrawal Period|Adverse Event|1
4679862|NCT02584855|16107941|P3|Double-Blind Withdrawal Period|Adverse Event|0
4679863|NCT02584855|16107942|P2|Double-Blind Withdrawal Period|Adverse Event|4
4679864|NCT02584855|16107943|P1|Double-Blind Withdrawal Period|Adverse Event|0
4679865|NCT02584855|16107938|P6|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4679866|NCT02584855|16107939|P5|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4679867|NCT02584855|16107940|P4|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4679868|NCT02584855|16107941|P3|Double-Blind Withdrawal Period|Withdrawal by Subject|2
4679869|NCT02584855|16107942|P2|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4679870|NCT02584855|16107943|P1|Double-Blind Withdrawal Period|Withdrawal by Subject|0
4679871|NCT02584855|16107938|P6|Open-Label Treatment Period|Sponsor Decision|0
4679872|NCT02584855|16107939|P5|Open-Label Treatment Period|Sponsor Decision|0
4679873|NCT02584855|16107940|P4|Open-Label Treatment Period|Sponsor Decision|0
4679874|NCT02584855|16107941|P3|Open-Label Treatment Period|Sponsor Decision|0
4679875|NCT02584855|16107942|P2|Open-Label Treatment Period|Sponsor Decision|0
4679876|NCT02584855|16107943|P1|Open-Label Treatment Period|Sponsor Decision|1
4679877|NCT02584855|16107938|P6|Open-Label Treatment Period|No PI Available|0
4679878|NCT02584855|16107939|P5|Open-Label Treatment Period|No PI Available|0
4679879|NCT02584855|16107940|P4|Open-Label Treatment Period|No PI Available|0
4679880|NCT02584855|16107941|P3|Open-Label Treatment Period|No PI Available|0
4679881|NCT02584855|16107942|P2|Open-Label Treatment Period|No PI Available|0
4679882|NCT02584855|16107943|P1|Open-Label Treatment Period|No PI Available|2
4679883|NCT02584855|16107938|P6|Open-Label Treatment Period|Protocol Violation|0
4679884|NCT02584855|16107939|P5|Open-Label Treatment Period|Protocol Violation|0
4679885|NCT02584855|16107940|P4|Open-Label Treatment Period|Protocol Violation|0
4679886|NCT02584855|16107941|P3|Open-Label Treatment Period|Protocol Violation|0
4679887|NCT02584855|16107942|P2|Open-Label Treatment Period|Protocol Violation|0
4679888|NCT02584855|16107943|P1|Open-Label Treatment Period|Protocol Violation|1
4679889|NCT02584855|16107938|P6|Open-Label Treatment Period|Lost to Follow-up|0
4679890|NCT02584855|16107939|P5|Open-Label Treatment Period|Lost to Follow-up|0
4679891|NCT02584855|16107940|P4|Open-Label Treatment Period|Lost to Follow-up|0
4679892|NCT02584855|16107941|P3|Open-Label Treatment Period|Lost to Follow-up|0
4679893|NCT02584855|16107942|P2|Open-Label Treatment Period|Lost to Follow-up|0
4679894|NCT02584855|16107943|P1|Open-Label Treatment Period|Lost to Follow-up|1
4679895|NCT02584855|16107938|P6|Open-Label Treatment Period|Death|0
4679896|NCT02584855|16107939|P5|Open-Label Treatment Period|Death|0
4679897|NCT02584855|16107940|P4|Open-Label Treatment Period|Death|0
4679898|NCT02584855|16107941|P3|Open-Label Treatment Period|Death|0
4679899|NCT02584855|16107942|P2|Open-Label Treatment Period|Death|0
4679900|NCT02584855|16107943|P1|Open-Label Treatment Period|Death|2
4679901|NCT02584855|16107938|P6|Open-Label Treatment Period|Adverse Event|0
4679902|NCT02584855|16107939|P5|Open-Label Treatment Period|Adverse Event|0
4679903|NCT02584855|16107940|P4|Open-Label Treatment Period|Adverse Event|0
4679904|NCT02584855|16107941|P3|Open-Label Treatment Period|Adverse Event|0
4679905|NCT02584855|16107942|P2|Open-Label Treatment Period|Adverse Event|0
4679906|NCT02584855|16107943|P1|Open-Label Treatment Period|Adverse Event|14
4679907|NCT02584855|16107938|P6|Open-Label Treatment Period|Withdrawal by Subject|0
4679908|NCT02584855|16107939|P5|Open-Label Treatment Period|Withdrawal by Subject|0
4679909|NCT02584855|16107940|P4|Open-Label Treatment Period|Withdrawal by Subject|0
4679910|NCT02584855|16107941|P3|Open-Label Treatment Period|Withdrawal by Subject|0
4679911|NCT02584855|16107942|P2|Open-Label Treatment Period|Withdrawal by Subject|0
4679912|NCT02584855|16107943|P1|Open-Label Treatment Period|Withdrawal by Subject|21
4679913|NCT02584855|16107938|P6|Open-Label Treatment Period|Lack of Efficacy|0
4679914|NCT02584855|16107939|P5|Open-Label Treatment Period|Lack of Efficacy|0
4679915|NCT02584855|16107940|P4|Open-Label Treatment Period|Lack of Efficacy|0
4679916|NCT02584855|16107941|P3|Open-Label Treatment Period|Lack of Efficacy|0
4679917|NCT02584855|16107942|P2|Open-Label Treatment Period|Lack of Efficacy|0
4679918|NCT02584855|16107943|P1|Open-Label Treatment Period|Lack of Efficacy|61
4679919|NCT02584660|16108075|P2|Overall Study|Other|1
4679920|NCT02584660|16108076|P1|Overall Study|Other|0
4679921|NCT02584660|16108075|P2|Overall Study|Withdrawal by Subject|2
4679922|NCT02584660|16108076|P1|Overall Study|Withdrawal by Subject|0
4679923|NCT02584660|16108075|P2|Overall Study|Protocol Violation|1
4679924|NCT02584660|16108076|P1|Overall Study|Protocol Violation|0
4679925|NCT02584660|16108075|P2|Overall Study|Lost to Follow-up|4
4679926|NCT02584660|16108076|P1|Overall Study|Lost to Follow-up|3
4679927|NCT02584660|16108075|P2|Overall Study|Adverse Event|0
4679928|NCT02584660|16108076|P1|Overall Study|Adverse Event|4
4679929|NCT02584504|16108095|P3|Open-label Treatment|Entered but not treated|1
4679930|NCT02584504|16108096|P2|Open-label Treatment|Entered but not treated|1
4679931|NCT02584504|16108097|P1|Open-label Treatment|Entered but not treated|0
4679932|NCT02584504|16108095|P3|Open-label Treatment|Physician Decision|0
4679933|NCT02584504|16108096|P2|Open-label Treatment|Physician Decision|1
4679935|NCT02584504|16108095|P3|Open-label Treatment|Adverse Event|3
4679936|NCT02584504|16108096|P2|Open-label Treatment|Adverse Event|2
4679937|NCT02584504|16108097|P1|Open-label Treatment|Adverse Event|2
4679938|NCT02584504|16108095|P3|Open-label Treatment|Participant withdrew consent|4
4679939|NCT02584504|16108096|P2|Open-label Treatment|Participant withdrew consent|0
4679940|NCT02584504|16108097|P1|Open-label Treatment|Participant withdrew consent|0
4679941|NCT02584504|16108095|P3|Double-blind Treatment|Family Matter|0
4679942|NCT02584504|16108096|P2|Double-blind Treatment|Family Matter|1
4679943|NCT02584504|16108097|P1|Double-blind Treatment|Family Matter|0
4679944|NCT02584504|16108095|P3|Double-blind Treatment|Adverse Event|0
4679945|NCT02584504|16108096|P2|Double-blind Treatment|Adverse Event|1
4679946|NCT02584504|16108097|P1|Double-blind Treatment|Adverse Event|0
4679947|NCT02584504|16108095|P3|Double-blind Treatment|Participant withdrew consent|1
4679948|NCT02584504|16108096|P2|Double-blind Treatment|Participant withdrew consent|0
4679949|NCT02584504|16108097|P1|Double-blind Treatment|Participant withdrew consent|0
4679950|NCT02584452|16108153|P2|Overall Study|Lost to Follow-up|1
4679951|NCT02584452|16108154|P1|Overall Study|Lost to Follow-up|1
4679952|NCT02584452|16108153|P2|Overall Study|Physician Decision|1
4679953|NCT02584452|16108154|P1|Overall Study|Physician Decision|1
4679954|NCT02583477|16108191|P2|Overall Study|Study terminated|2
4679955|NCT02583477|16108192|P1|Overall Study|Study terminated|2
4679956|NCT02583477|16108191|P2|Overall Study|Death|16
4679957|NCT02583477|16108192|P1|Overall Study|Death|1
4679958|NCT02583477|16108191|P2|Overall Study|Adverse Event|2
4679959|NCT02583477|16108192|P1|Overall Study|Adverse Event|0
4679960|NCT02583425|16108212|P1|Treatment Period|Adverse Event|1
4679961|NCT02583425|16108212|P1|Baseline|Did not meet continued criteria|5
4679962|NCT02583425|16108212|P1|Screening|Did not meet entry criteria|12
4679963|NCT02583269|16108222|P5|Overall Study|Patient hospitalized prior to start|0
4679964|NCT02583269|16108223|P4|Overall Study|Patient hospitalized prior to start|0
4679965|NCT02583269|16108224|P3|Overall Study|Patient hospitalized prior to start|0
4679966|NCT02583269|16108225|P2|Overall Study|Patient hospitalized prior to start|0
4679967|NCT02583269|16108226|P1|Overall Study|Patient hospitalized prior to start|1
4679968|NCT02583256|16108255|P4|Overall Study|Administrative/Other|2
4679969|NCT02583256|16108256|P3|Overall Study|Administrative/Other|1
4679970|NCT02583256|16108257|P2|Overall Study|Administrative/Other|0
4679971|NCT02583256|16108258|P1|Overall Study|Administrative/Other|2
4679972|NCT02583256|16108255|P4|Overall Study|Lost to Follow-up|1
4679973|NCT02583256|16108256|P3|Overall Study|Lost to Follow-up|0
4679974|NCT02583256|16108257|P2|Overall Study|Lost to Follow-up|1
4679975|NCT02583256|16108258|P1|Overall Study|Lost to Follow-up|1
4679976|NCT02583256|16108255|P4|Overall Study|Withdrawal by Subject|0
4679977|NCT02583256|16108256|P3|Overall Study|Withdrawal by Subject|1
4679978|NCT02583256|16108257|P2|Overall Study|Withdrawal by Subject|1
4679979|NCT02583256|16108258|P1|Overall Study|Withdrawal by Subject|0
4679980|NCT02583048|16108355|P3|Overall Study|Failed to meet eligibility criterion|1
4679981|NCT02583048|16108356|P2|Overall Study|Failed to meet eligibility criterion|0
4679982|NCT02583048|16108357|P1|Overall Study|Failed to meet eligibility criterion|0
4679983|NCT02583048|16108355|P3|Overall Study|Withdrawal by Subject|0
4679984|NCT02583048|16108356|P2|Overall Study|Withdrawal by Subject|1
4679985|NCT02583048|16108357|P1|Overall Study|Withdrawal by Subject|0
4679986|NCT02582983|16108392|P1|Overall Study|Adverse Event|1
4679987|NCT02582983|16108392|P1|Overall Study|Withdrawal by Subject|2
4679988|NCT02582983|16108392|P1|Overall Study|Death|3
4679989|NCT02582814|16108455|P2|Overall Study|Adverse Event|4
4679990|NCT02582814|16108456|P1|Overall Study|Adverse Event|4
4679991|NCT02582814|16108455|P2|Overall Study|Withdrawal by Subject|3
4679992|NCT02582814|16108456|P1|Overall Study|Withdrawal by Subject|4
4679993|NCT02582814|16108455|P2|Overall Study|Study-specific withdrawal criteria|0
4679994|NCT02582814|16108456|P1|Overall Study|Study-specific withdrawal criteria|1
4679995|NCT02582749|16108496|P2|Overall Study|Withdrawal by Subject|1
4679996|NCT02582749|16108497|P1|Overall Study|Withdrawal by Subject|0
4679997|NCT02582749|16108496|P2|Overall Study|Study terminated by funder|10
4679998|NCT02582749|16108497|P1|Overall Study|Study terminated by funder|5
4679999|NCT02582684|16108527|P1|Overall Study|Found to be ineligible after enrollment|2
4680000|NCT02582684|16108527|P1|Overall Study|Subject withdrew consent|1
4680001|NCT02582684|16108527|P1|Overall Study|Subject not able to get to clinic|10
4680002|NCT02582684|16108527|P1|Overall Study|Unable to contact subject/parent|4
4680003|NCT02582671|16108546|P1|Overall Study|Other, not specified|1
4680004|NCT02582671|16108546|P1|Overall Study|Failure to return|1
4680005|NCT02582658|16108558|P1|Overall Study|Not further specified|11
4680006|NCT02582658|16108558|P1|Overall Study|Death|1
4680007|NCT02582658|16108558|P1|Overall Study|Withdrawn Consent|1
4680008|NCT02582658|16108558|P1|Overall Study|Insufficient Virological Response|2
4680009|NCT02582658|16108558|P1|Overall Study|Failure to Return|10
4680010|NCT02582632|16108576|P1|Overall Study|Other|1
4680011|NCT02582515|16108591|P2|Overall Study|Withdrawal by Subject|1
4680012|NCT02582515|16108592|P1|Overall Study|Withdrawal by Subject|0
4680013|NCT02582255|16108600|P2|Overall Study|Protocol Violation|3
4680014|NCT02582255|16108601|P1|Overall Study|Protocol Violation|0
4680015|NCT02582242|16108614|P2|Overall Study|Unclassified|1
4680016|NCT02582242|16108615|P1|Overall Study|Unclassified|2
4680017|NCT02582242|16108614|P2|Overall Study|Withdrawal by Subject|11
4680018|NCT02582242|16108615|P1|Overall Study|Withdrawal by Subject|11
4680019|NCT02582242|16108614|P2|Overall Study|Lost to Follow-up|1
4680020|NCT02582242|16108615|P1|Overall Study|Lost to Follow-up|0
4680021|NCT02582242|16108614|P2|Overall Study|Protocol Violation|1
4680022|NCT02582242|16108615|P1|Overall Study|Protocol Violation|3
4680023|NCT02582242|16108614|P2|Overall Study|Adverse Event|3
4680024|NCT02582242|16108615|P1|Overall Study|Adverse Event|4
4680025|NCT02581995|16108679|P1|Overall Study|Death|4
4680026|NCT02581995|16108679|P1|Overall Study|Physician Decision|1
4680027|NCT02581995|16108679|P1|Overall Study|Withdrawal by participant|12
4680028|NCT02581995|16108679|P1|Overall Study|Lost to Follow-up|5
4680029|NCT02581995|16108679|P1|Overall Study|Adverse Event|6
4680030|NCT02581995|16108679|P1|Overall Study|Unspecified other|3
4680031|NCT02581930|16108693|P1|Overall Study|patient declined further treatment|1
4680032|NCT02581930|16108693|P1|Overall Study|Withdrawal by Subject|1
4680033|NCT02581891|16108701|P2|Overall Study|Discontinued during followup|0
4680034|NCT02581891|16108702|P1|Overall Study|Discontinued during followup|1
4680035|NCT02581891|16108701|P2|Overall Study|Other Reasons|1
4680036|NCT02581891|16108702|P1|Overall Study|Other Reasons|3
4680037|NCT02581891|16108701|P2|Overall Study|Withdrawal by Subject|5
4680038|NCT02581891|16108702|P1|Overall Study|Withdrawal by Subject|4
4680039|NCT02581891|16108701|P2|Overall Study|Physician Decision|1
4680040|NCT02581891|16108702|P1|Overall Study|Physician Decision|0
4680041|NCT02581891|16108701|P2|Overall Study|Lost to Follow-up|2
4680042|NCT02581891|16108702|P1|Overall Study|Lost to Follow-up|1
4680043|NCT02581891|16108701|P2|Overall Study|Death|4
4680044|NCT02581891|16108702|P1|Overall Study|Death|3
4680045|NCT02581891|16108701|P2|Overall Study|Adverse Event|6
4680046|NCT02581891|16108702|P1|Overall Study|Adverse Event|4
4680047|NCT02581488|16108765|P2|Overall Study|Protocol Violation|4
4680048|NCT02581488|16108766|P1|Overall Study|Protocol Violation|0
4680049|NCT02581488|16108765|P2|Overall Study|Non-Compliance|0
4680050|NCT02581488|16108766|P1|Overall Study|Non-Compliance|1
4680051|NCT02581488|16108765|P2|Overall Study|Withdrawal by Subject|0
4680052|NCT02581488|16108766|P1|Overall Study|Withdrawal by Subject|1
4680053|NCT02581488|16108765|P2|Overall Study|Lost to Follow-up|0
4680054|NCT02581488|16108766|P1|Overall Study|Lost to Follow-up|1
4680055|NCT02581488|16108765|P2|Overall Study|Adverse Event|7
4680056|NCT02581488|16108766|P1|Overall Study|Adverse Event|6
4680057|NCT02581410|16108797|P2|End of Study Phase|Other-transfer of subject not completed|1
4680058|NCT02581410|16108798|P1|End of Study Phase|Other-transfer of subject not completed|0
4680059|NCT02581410|16108797|P2|End of Study Phase|Lost to Follow-up|2
4680060|NCT02581410|16108798|P1|End of Study Phase|Lost to Follow-up|0
4680061|NCT02581410|16108797|P2|End of Study Phase|Migrated/moved from study area|3
4680062|NCT02581410|16108798|P1|End of Study Phase|Migrated/moved from study area|0
4680063|NCT02581410|16108797|P2|End of Study Phase|Withdrawal by Subject|2
4680064|NCT02581410|16108798|P1|End of Study Phase|Withdrawal by Subject|1
4680065|NCT02581410|16108797|P2|End of Study Phase|Adverse Event|3
4680066|NCT02581410|16108798|P1|End of Study Phase|Adverse Event|4
4680067|NCT02581410|16108797|P2|Vaccination Phase|Migrated/moved from study area|1
4680068|NCT02581410|16108798|P1|Vaccination Phase|Migrated/moved from study area|0
4680069|NCT02581410|16108797|P2|Vaccination Phase|Withdrawal by Subject|1
4680070|NCT02581410|16108798|P1|Vaccination Phase|Withdrawal by Subject|0
4680071|NCT02581410|16108797|P2|Vaccination Phase|Adverse Event|1
4680072|NCT02581410|16108798|P1|Vaccination Phase|Adverse Event|2
4680073|NCT02581345|16108828|P4|Part 2: Week 17 to Week 47|Unspecified Reason|1
4680074|NCT02581345|16108829|P3|Part 2: Week 17 to Week 47|Unspecified Reason|1
4680075|NCT02581345|16108830|P2|Part 2: Week 17 to Week 47|Unspecified Reason|0
4680076|NCT02581345|16108831|P1|Part 2: Week 17 to Week 47|Unspecified Reason|2
4680077|NCT02581345|16108828|P4|Part 2: Week 17 to Week 47|Lost to Follow-up|1
4680078|NCT02581345|16108829|P3|Part 2: Week 17 to Week 47|Lost to Follow-up|0
4680079|NCT02581345|16108830|P2|Part 2: Week 17 to Week 47|Lost to Follow-up|0
4680080|NCT02581345|16108831|P1|Part 2: Week 17 to Week 47|Lost to Follow-up|2
4680081|NCT02581345|16108828|P4|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2
4680082|NCT02581345|16108829|P3|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3
4680083|NCT02581345|16108830|P2|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0
4680084|NCT02581345|16108831|P1|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8
4680085|NCT02581345|16108828|P4|Part 2: Week 17 to Week 47|Withdrawal by Subject|5
4680086|NCT02581345|16108829|P3|Part 2: Week 17 to Week 47|Withdrawal by Subject|7
4680087|NCT02581345|16108830|P2|Part 2: Week 17 to Week 47|Withdrawal by Subject|0
4680088|NCT02581345|16108831|P1|Part 2: Week 17 to Week 47|Withdrawal by Subject|9
4680089|NCT02581345|16108828|P4|Part 2: Week 17 to Week 47|Physician Decision|1
4680090|NCT02581345|16108829|P3|Part 2: Week 17 to Week 47|Physician Decision|2
4680091|NCT02581345|16108830|P2|Part 2: Week 17 to Week 47|Physician Decision|0
4680092|NCT02581345|16108831|P1|Part 2: Week 17 to Week 47|Physician Decision|3
4680093|NCT02581345|16108828|P4|Part 2: Week 17 to Week 47|Adverse Event|2
4680094|NCT02581345|16108829|P3|Part 2: Week 17 to Week 47|Adverse Event|2
4680095|NCT02581345|16108830|P2|Part 2: Week 17 to Week 47|Adverse Event|0
4680096|NCT02581345|16108831|P1|Part 2: Week 17 to Week 47|Adverse Event|5
4680097|NCT02581345|16108828|P4|Part 1: up to Week 16|Did Not Receive Treatment|0
4680098|NCT02581345|16108829|P3|Part 1: up to Week 16|Did Not Receive Treatment|0
4680099|NCT02581345|16108830|P2|Part 1: up to Week 16|Did Not Receive Treatment|1
4680100|NCT02581345|16108831|P1|Part 1: up to Week 16|Did Not Receive Treatment|1
4680101|NCT02581345|16108828|P4|Part 1: up to Week 16|Unspecified Reason|0
4680102|NCT02581345|16108829|P3|Part 1: up to Week 16|Unspecified Reason|0
4680103|NCT02581345|16108830|P2|Part 1: up to Week 16|Unspecified Reason|3
4680104|NCT02581345|16108831|P1|Part 1: up to Week 16|Unspecified Reason|3
4680105|NCT02581345|16108828|P4|Part 1: up to Week 16|Lost to Follow-up|0
4680106|NCT02581345|16108829|P3|Part 1: up to Week 16|Lost to Follow-up|0
4680107|NCT02581345|16108830|P2|Part 1: up to Week 16|Lost to Follow-up|0
4680108|NCT02581345|16108831|P1|Part 1: up to Week 16|Lost to Follow-up|2
4680109|NCT02581345|16108828|P4|Part 1: up to Week 16|Withdrawal by Subject|0
4680110|NCT02581345|16108829|P3|Part 1: up to Week 16|Withdrawal by Subject|0
4680111|NCT02581345|16108830|P2|Part 1: up to Week 16|Withdrawal by Subject|7
4680112|NCT02581345|16108831|P1|Part 1: up to Week 16|Withdrawal by Subject|4
4680113|NCT02581345|16108828|P4|Part 1: up to Week 16|Physician Decision|0
4680114|NCT02581345|16108829|P3|Part 1: up to Week 16|Physician Decision|0
4680115|NCT02581345|16108830|P2|Part 1: up to Week 16|Physician Decision|4
4680116|NCT02581345|16108831|P1|Part 1: up to Week 16|Physician Decision|2
4680117|NCT02581345|16108828|P4|Part 1: up to Week 16|Adverse Event|0
4680118|NCT02581345|16108829|P3|Part 1: up to Week 16|Adverse Event|0
4680119|NCT02581345|16108830|P2|Part 1: up to Week 16|Adverse Event|8
4680120|NCT02581345|16108831|P1|Part 1: up to Week 16|Adverse Event|3
4680121|NCT02581202|16108933|P1|Overall Study|Pregnancy|3
4680122|NCT02581202|16108933|P1|Overall Study|Lost to Follow-up|5
4680123|NCT02581202|16108933|P1|Overall Study|Withdrawal by Subject|4
4680124|NCT02581202|16108933|P1|Overall Study|Lack of Efficacy|2
4680125|NCT02581189|16108972|P1|Overall Study|Other, not specified|7
4680126|NCT02581189|16108972|P1|Overall Study|Insufficient virological response|2
4680127|NCT02581189|16108972|P1|Overall Study|Death|3
4680128|NCT02581189|16108972|P1|Overall Study|Withdrew consent|5
4680129|NCT02581189|16108972|P1|Overall Study|Failure to return|36
4680130|NCT02581163|16108986|P1|Overall Study|Other, not specified|9
4680131|NCT02581163|16108986|P1|Overall Study|Death|1
4680132|NCT02581163|16108986|P1|Overall Study|Withdrew consent|1
4680133|NCT02581163|16108986|P1|Overall Study|Insufficient virological response|3
4680134|NCT02581163|16108986|P1|Overall Study|Failure to return|15
4680135|NCT02580877|16109020|P2|Overall Study|Adverse Event|1
4680136|NCT02580877|16109021|P1|Overall Study|Adverse Event|0
4680137|NCT02580877|16109020|P2|Overall Study|Withdrawal by Subject|3
4680138|NCT02580877|16109021|P1|Overall Study|Withdrawal by Subject|1
4680139|NCT02580591|16109055|P4|Overall Study|Other than specified|2
4680140|NCT02580591|16109056|P3|Overall Study|Other than specified|5
4680141|NCT02580591|16109057|P2|Overall Study|Other than specified|2
4680142|NCT02580591|16109058|P1|Overall Study|Other than specified|3
4680143|NCT02580591|16109055|P4|Overall Study|Not treated|0
4680144|NCT02580591|16109056|P3|Overall Study|Not treated|0
4680145|NCT02580591|16109057|P2|Overall Study|Not treated|1
4680146|NCT02580591|16109058|P1|Overall Study|Not treated|1
4680147|NCT02580591|16109055|P4|Overall Study|Withdrawal by Subject|3
4680148|NCT02580591|16109056|P3|Overall Study|Withdrawal by Subject|2
4680149|NCT02580591|16109057|P2|Overall Study|Withdrawal by Subject|1
4680150|NCT02580591|16109058|P1|Overall Study|Withdrawal by Subject|6
4680151|NCT02580591|16109055|P4|Overall Study|Lost to Follow-up|1
4680152|NCT02580591|16109056|P3|Overall Study|Lost to Follow-up|3
4680153|NCT02580591|16109057|P2|Overall Study|Lost to Follow-up|3
4680154|NCT02580591|16109058|P1|Overall Study|Lost to Follow-up|5
4680155|NCT02580591|16109055|P4|Overall Study|Protocol Violation|1
4680156|NCT02580591|16109056|P3|Overall Study|Protocol Violation|1
4680157|NCT02580591|16109057|P2|Overall Study|Protocol Violation|2
4680158|NCT02580591|16109058|P1|Overall Study|Protocol Violation|3
4680159|NCT02580591|16109055|P4|Overall Study|Adverse Event|5
4680160|NCT02580591|16109056|P3|Overall Study|Adverse Event|2
4680161|NCT02580591|16109057|P2|Overall Study|Adverse Event|1
4680162|NCT02580591|16109058|P1|Overall Study|Adverse Event|0
4680163|NCT02580357|16109091|P3|Overall Study|Protocol Violation|0
4680164|NCT02580357|16109092|P2|Overall Study|Protocol Violation|0
4680165|NCT02580357|16109093|P1|Overall Study|Protocol Violation|1
4680166|NCT02580357|16109091|P3|Overall Study|Lost to Follow-up|0
4680167|NCT02580357|16109092|P2|Overall Study|Lost to Follow-up|0
4680168|NCT02580357|16109093|P1|Overall Study|Lost to Follow-up|2
4680169|NCT02580240|16109110|P2|Overall Study|Physician Decision|0
4680170|NCT02580240|16109111|P1|Overall Study|Physician Decision|2
4680171|NCT02580058|16109149|P3|Overall Study|Withdrawal by Subject|36
4680172|NCT02580058|16109150|P2|Overall Study|Withdrawal by Subject|26
4680173|NCT02580058|16109151|P1|Overall Study|Withdrawal by Subject|24
4680174|NCT02580058|16109149|P3|Overall Study|Ongoing|46
4680175|NCT02580058|16109150|P2|Overall Study|Ongoing|55
4680176|NCT02580058|16109151|P1|Overall Study|Ongoing|51
4680177|NCT02580058|16109149|P3|Overall Study|Lost to Follow-up|4
4680178|NCT02580058|16109150|P2|Overall Study|Lost to Follow-up|5
4680179|NCT02580058|16109151|P1|Overall Study|Lost to Follow-up|4
4680180|NCT02579928|16109218|P2|Overall Study|Withdrawal by Subject|0
4680181|NCT02579928|16109219|P1|Overall Study|Withdrawal by Subject|1
4680182|NCT02579863|16109259|P2|Overall Study|Withdrawal by Subject|19
4680183|NCT02579863|16109260|P1|Overall Study|Withdrawal by Subject|17
4680184|NCT02579863|16109259|P2|Overall Study|Study Terminated at Selected Sites|3
4680185|NCT02579863|16109260|P1|Overall Study|Study Terminated at Selected Sites|3
4680186|NCT02579863|16109259|P2|Overall Study|Screen Failure|2
4680187|NCT02579863|16109260|P1|Overall Study|Screen Failure|1
4680188|NCT02579863|16109259|P2|Overall Study|Physician Decision|2
4680189|NCT02579863|16109260|P1|Overall Study|Physician Decision|0
4680190|NCT02579863|16109259|P2|Overall Study|Lost to Follow-up|1
4680191|NCT02579863|16109260|P1|Overall Study|Lost to Follow-up|2
4680192|NCT02579863|16109259|P2|Overall Study|Death|3
4680193|NCT02579863|16109260|P1|Overall Study|Death|11
4680194|NCT02579863|16109259|P2|Overall Study|Adverse Event|12
4680195|NCT02579863|16109260|P1|Overall Study|Adverse Event|17
4680196|NCT02579863|16109259|P2|Overall Study|Ongoing in Trial|112
4680197|NCT02579863|16109260|P1|Overall Study|Ongoing in Trial|105
4680198|NCT02579772|16109287|P2|Overall Study|flu-like illness, orthopedic trauma|1
4680199|NCT02579772|16109288|P1|Overall Study|flu-like illness, orthopedic trauma|1
4680200|NCT02579772|16109287|P2|Overall Study|Usage of additional antioxidants|0
4680201|NCT02579772|16109288|P1|Overall Study|Usage of additional antioxidants|1
4680202|NCT02579772|16109287|P2|Overall Study|Withdrawal by Subject|1
4680203|NCT02579772|16109288|P1|Overall Study|Withdrawal by Subject|0
4680204|NCT02579759|16109309|P3|Overall Study|Lost to Follow-up|2
4680205|NCT02579759|16109310|P2|Overall Study|Lost to Follow-up|2
4680206|NCT02579759|16109311|P1|Overall Study|Lost to Follow-up|2
4680207|NCT02579759|16109309|P3|Overall Study|Withdrawal by Subject|5
4680208|NCT02579759|16109310|P2|Overall Study|Withdrawal by Subject|3
4680209|NCT02579759|16109311|P1|Overall Study|Withdrawal by Subject|3
4680210|NCT02579759|16109309|P3|Overall Study|Adverse Event|1
4680211|NCT02579759|16109310|P2|Overall Study|Adverse Event|3
4680212|NCT02579759|16109311|P1|Overall Study|Adverse Event|4
4680213|NCT02579759|16109309|P3|Overall Study|Inclusion/exclusion criteria|1
4680214|NCT02579759|16109310|P2|Overall Study|Inclusion/exclusion criteria|0
4680215|NCT02579759|16109311|P1|Overall Study|Inclusion/exclusion criteria|0
4680216|NCT02579759|16109309|P3|Overall Study|Pregnancy|0
4680217|NCT02579759|16109310|P2|Overall Study|Pregnancy|1
4680218|NCT02579759|16109311|P1|Overall Study|Pregnancy|0
4680219|NCT02579759|16109309|P3|Overall Study|Non compliance|0
4680220|NCT02579759|16109310|P2|Overall Study|Non compliance|1
4680221|NCT02579759|16109311|P1|Overall Study|Non compliance|0
4680222|NCT02579759|16109309|P3|Overall Study|Sponsor stopped Dose 2|0
4680223|NCT02579759|16109310|P2|Overall Study|Sponsor stopped Dose 2|41
4680224|NCT02579759|16109311|P1|Overall Study|Sponsor stopped Dose 2|0
4680225|NCT02579759|16109309|P3|Overall Study|BfArM hold|12
4680226|NCT02579759|16109310|P2|Overall Study|BfArM hold|12
4680227|NCT02579759|16109311|P1|Overall Study|BfArM hold|13
4680228|NCT02579759|16109309|P3|Overall Study|Other (Sponsor stopped Dose 2)|0
4680229|NCT02579759|16109310|P2|Overall Study|Other (Sponsor stopped Dose 2)|1
4680230|NCT02579759|16109311|P1|Overall Study|Other (Sponsor stopped Dose 2)|0
4680231|NCT02579759|16109309|P3|Overall Study|Protocol Violation|0
4680232|NCT02579759|16109310|P2|Overall Study|Protocol Violation|0
4680233|NCT02579759|16109311|P1|Overall Study|Protocol Violation|2
4680234|NCT02579629|16109358|P3|Overall Study|Screen Failure|2
4680235|NCT02579629|16109359|P2|Overall Study|Screen Failure|0
4680236|NCT02579629|16109360|P1|Overall Study|Screen Failure|2
4680237|NCT02579629|16109358|P3|Overall Study|Withdrawal by Subject|0
4680238|NCT02579629|16109359|P2|Overall Study|Withdrawal by Subject|1
4680239|NCT02579629|16109360|P1|Overall Study|Withdrawal by Subject|0
4680240|NCT02579603|16109409|P2|Overall Study|Other than stated|0
4680241|NCT02579603|16109410|P1|Overall Study|Other than stated|1
4680242|NCT02579603|16109409|P2|Overall Study|Adverse Event|2
4680243|NCT02579603|16109410|P1|Overall Study|Adverse Event|2
4680244|NCT02579603|16109409|P2|Overall Study|Not treated|0
4680245|NCT02579603|16109410|P1|Overall Study|Not treated|1
4680246|NCT02579382|16109440|P4|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
4680247|NCT02579382|16109441|P3|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
4680248|NCT02579382|16109442|P2|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1
4680249|NCT02579382|16109443|P1|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0
4680250|NCT02579382|16109440|P4|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
4680251|NCT02579382|16109441|P3|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
4680252|NCT02579382|16109442|P2|Optional Treatment Extension Phase(OTEP)|Pregnancy|1
4680253|NCT02579382|16109443|P1|Optional Treatment Extension Phase(OTEP)|Pregnancy|0
4680254|NCT02579382|16109440|P4|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
4680255|NCT02579382|16109441|P3|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
4680256|NCT02579382|16109442|P2|Optional Treatment Extension Phase(OTEP)|Adverse Event|1
4680257|NCT02579382|16109443|P1|Optional Treatment Extension Phase(OTEP)|Adverse Event|0
4680258|NCT02579382|16109440|P4|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
4680259|NCT02579382|16109441|P3|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
4680260|NCT02579382|16109442|P2|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1
4680261|NCT02579382|16109443|P1|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0
4680262|NCT02579382|16109440|P4|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
4680263|NCT02579382|16109441|P3|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2
4680264|NCT02579382|16109442|P2|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0
4680265|NCT02579382|16109443|P1|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1
4680266|NCT02579382|16109440|P4|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4
4680267|NCT02579382|16109441|P3|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1
4680268|NCT02579382|16109442|P2|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3
4680269|NCT02579382|16109443|P1|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0
4680270|NCT02579382|16109440|P4|Main Study Phase|Lack of Efficacy|1
4680271|NCT02579382|16109441|P3|Main Study Phase|Lack of Efficacy|0
4680272|NCT02579382|16109442|P2|Main Study Phase|Lack of Efficacy|0
4680273|NCT02579382|16109443|P1|Main Study Phase|Lack of Efficacy|0
4680274|NCT02579382|16109440|P4|Main Study Phase|Withdrew Consent|2
4680275|NCT02579382|16109441|P3|Main Study Phase|Withdrew Consent|0
4680276|NCT02579382|16109442|P2|Main Study Phase|Withdrew Consent|0
4680277|NCT02579382|16109443|P1|Main Study Phase|Withdrew Consent|0
4680278|NCT02579382|16109440|P4|Main Study Phase|Lost to Follow-up|0
4680279|NCT02579382|16109441|P3|Main Study Phase|Lost to Follow-up|2
4680280|NCT02579382|16109442|P2|Main Study Phase|Lost to Follow-up|0
4680281|NCT02579382|16109443|P1|Main Study Phase|Lost to Follow-up|0
4680282|NCT02578992|16109565|P2|Overall Study|equipment not available or malfunction|3
4680283|NCT02578992|16109566|P1|Overall Study|equipment not available or malfunction|3
4680284|NCT02578940|16109578|P1|Overall Study|Lost to Follow-up|1
4680285|NCT02578940|16109578|P1|Overall Study|Screening failure|5
4680286|NCT02578862|16109587|P2|Overall Study|Unplanned unilateral procedure|1
4680287|NCT02578862|16109588|P1|Overall Study|Unplanned unilateral procedure|0
4680288|NCT02578862|16109587|P2|Overall Study|Withdrawal by Subject|1
4680289|NCT02578862|16109588|P1|Overall Study|Withdrawal by Subject|0
4680290|NCT02578706|16109626|P3|Overall Study|Physician Decision|0
4680291|NCT02578706|16109627|P2|Overall Study|Physician Decision|1
4680292|NCT02578706|16109628|P1|Overall Study|Physician Decision|0
4680293|NCT02578706|16109626|P3|Overall Study|Lost to Follow-up|0
4680294|NCT02578706|16109627|P2|Overall Study|Lost to Follow-up|4
4680295|NCT02578706|16109628|P1|Overall Study|Lost to Follow-up|0
4680296|NCT02578706|16109626|P3|Overall Study|Withdrawal by Subject|0
4680297|NCT02578706|16109627|P2|Overall Study|Withdrawal by Subject|0
4680298|NCT02578706|16109628|P1|Overall Study|Withdrawal by Subject|1
4680299|NCT02578680|16109707|P2|Overall Study|Ongoing in Study|96
4680300|NCT02578680|16109708|P1|Overall Study|Ongoing in Study|276
4680301|NCT02578680|16109707|P2|Overall Study|Withdrawal by Subject|5
4680302|NCT02578680|16109708|P1|Overall Study|Withdrawal by Subject|8
4680303|NCT02578680|16109707|P2|Overall Study|Withdrawal by Parent/Guardian|0
4680304|NCT02578680|16109708|P1|Overall Study|Withdrawal by Parent/Guardian|1
4680305|NCT02578680|16109707|P2|Overall Study|Protocol Violation|1
4680306|NCT02578680|16109708|P1|Overall Study|Protocol Violation|1
4680307|NCT02578680|16109707|P2|Overall Study|Death|104
4680308|NCT02578680|16109708|P1|Overall Study|Death|124
4680309|NCT02578316|16109724|P1|Extension Phase|Progression of disease|6
4680310|NCT02578186|16109757|P2|Period 1 (First of Crossover)|Withdrawal by Subject|1
4680311|NCT02578186|16109758|P1|Period 1 (First of Crossover)|Withdrawal by Subject|1
4680312|NCT02578186|16109757|P2|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
4680313|NCT02578186|16109758|P1|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4
4680314|NCT02577887|16109847|P1|Overall Study|Withdrawal by Subject|80
4680315|NCT02577887|16109847|P1|Overall Study|Protocol Violation|125
4680316|NCT02577887|16109847|P1|Overall Study|Death|93
4680317|NCT02577718|16109873|P1|Overall Study|Withdrawal by Subject|2
4680318|NCT02577718|16109873|P1|Overall Study|Death|6
4680319|NCT02577354|16109915|P2|Overall Study|Adverse Event|5
4680320|NCT02577354|16109916|P1|Overall Study|Adverse Event|4
4680321|NCT02577354|16109915|P2|Overall Study|Missed Visit|3
4680322|NCT02577354|16109916|P1|Overall Study|Missed Visit|4
4680323|NCT02577354|16109915|P2|Overall Study|Lost to Follow-up|1
4680324|NCT02577354|16109916|P1|Overall Study|Lost to Follow-up|3
4680325|NCT02577354|16109915|P2|Overall Study|Lack of Efficacy|4
4680326|NCT02577354|16109916|P1|Overall Study|Lack of Efficacy|4
4680327|NCT02577315|16109976|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
4680328|NCT02577315|16109977|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4680329|NCT02577146|16109993|P1|Overall Study|Screen Failure|17
4680330|NCT02577146|16109993|P1|Overall Study|Physician Decision|3
4680331|NCT02577146|16109993|P1|Overall Study|Lost to Follow-up|8
4680332|NCT02577107|16110000|P2|Overall Study|Protocol deviation|1
4680333|NCT02577107|16110001|P1|Overall Study|Protocol deviation|0
4680334|NCT02577029|16110068|P8|Overall Study|Sponsor Termination of the Study|12
4680335|NCT02577029|16110069|P7|Overall Study|Sponsor Termination of the Study|12
4680336|NCT02577029|16110070|P6|Overall Study|Sponsor Termination of the Study|12
4680337|NCT02577029|16110071|P5|Overall Study|Sponsor Termination of the Study|10
4680338|NCT02577029|16110072|P4|Overall Study|Sponsor Termination of the Study|12
4680339|NCT02577029|16110073|P3|Overall Study|Sponsor Termination of the Study|5
4680340|NCT02577029|16110074|P2|Overall Study|Sponsor Termination of the Study|2
4680341|NCT02577029|16110075|P1|Overall Study|Sponsor Termination of the Study|9
4680342|NCT02577029|16110068|P8|Overall Study|Withdrawal by Subject|0
4680343|NCT02577029|16110069|P7|Overall Study|Withdrawal by Subject|0
4680344|NCT02577029|16110070|P6|Overall Study|Withdrawal by Subject|1
4680345|NCT02577029|16110071|P5|Overall Study|Withdrawal by Subject|0
4680346|NCT02577029|16110072|P4|Overall Study|Withdrawal by Subject|0
4680347|NCT02577029|16110073|P3|Overall Study|Withdrawal by Subject|0
4680348|NCT02577029|16110074|P2|Overall Study|Withdrawal by Subject|0
4680349|NCT02577029|16110075|P1|Overall Study|Withdrawal by Subject|0
4680350|NCT02577029|16110068|P8|Overall Study|Adverse Event|0
4680351|NCT02577029|16110069|P7|Overall Study|Adverse Event|0
4680352|NCT02577029|16110070|P6|Overall Study|Adverse Event|0
4680353|NCT02577029|16110071|P5|Overall Study|Adverse Event|1
4680354|NCT02577029|16110072|P4|Overall Study|Adverse Event|0
4680355|NCT02577029|16110073|P3|Overall Study|Adverse Event|2
4680356|NCT02577029|16110074|P2|Overall Study|Adverse Event|0
4680357|NCT02577029|16110075|P1|Overall Study|Adverse Event|1
4680358|NCT02577016|16110183|P2|Overall Study|Physician Decision|1
4680359|NCT02577016|16110184|P1|Overall Study|Physician Decision|0
4680360|NCT02577016|16110183|P2|Overall Study|Adverse Event|1
4680361|NCT02577016|16110184|P1|Overall Study|Adverse Event|2
4680362|NCT02577003|16110202|P2|Overall Study|Withdrawal by Subject|1
4680363|NCT02577003|16110203|P1|Overall Study|Withdrawal by Subject|0
4680364|NCT02577003|16110202|P2|Overall Study|Adverse Event|4
4680365|NCT02577003|16110203|P1|Overall Study|Adverse Event|2
4680366|NCT02576990|16110223|P2|Overall Study|Clinical Progression|4
4680367|NCT02576990|16110224|P1|Overall Study|Clinical Progression|13
4680368|NCT02576990|16110223|P2|Overall Study|Did not receive study treatment|1
4680369|NCT02576990|16110224|P1|Overall Study|Did not receive study treatment|3
4680370|NCT02576990|16110223|P2|Overall Study|Withdrawal by Subject|2
4680371|NCT02576990|16110224|P1|Overall Study|Withdrawal by Subject|0
4680372|NCT02576990|16110223|P2|Overall Study|Complete Response|0
4680373|NCT02576990|16110224|P1|Overall Study|Complete Response|1
4680374|NCT02576990|16110223|P2|Overall Study|Adverse Event|4
4680375|NCT02576990|16110224|P1|Overall Study|Adverse Event|6
4680376|NCT02576990|16110223|P2|Overall Study|Progressive Disease|12
4680377|NCT02576990|16110224|P1|Overall Study|Progressive Disease|17
4680378|NCT02576990|16110223|P2|Overall Study|Physician Decision|1
4680379|NCT02576990|16110224|P1|Overall Study|Physician Decision|3
4680380|NCT02576977|16110252|P2|Overall Study|Ongoing in trial|77
4680381|NCT02576977|16110253|P1|Overall Study|Ongoing in trial|53
4680382|NCT02576977|16110252|P2|Overall Study|Withdrawal by Subject|9
4680383|NCT02576977|16110253|P1|Overall Study|Withdrawal by Subject|9
4680384|NCT02576977|16110252|P2|Overall Study|Study Terminated at Selected Sites|2
4680385|NCT02576977|16110253|P1|Overall Study|Study Terminated at Selected Sites|3
4680386|NCT02576977|16110252|P2|Overall Study|Screen failure|0
4680387|NCT02576977|16110253|P1|Overall Study|Screen failure|1
4680388|NCT02576977|16110252|P2|Overall Study|Death|35
4680389|NCT02576977|16110253|P1|Overall Study|Death|47
4680390|NCT02576977|16110252|P2|Overall Study|Adverse Event|2
4680391|NCT02576977|16110253|P1|Overall Study|Adverse Event|13
4680392|NCT02576951|16110275|P4|Overall Study|Protocol Violation|1
4680393|NCT02576951|16110276|P3|Overall Study|Protocol Violation|0
4680394|NCT02576951|16110277|P2|Overall Study|Protocol Violation|0
4680395|NCT02576951|16110278|P1|Overall Study|Protocol Violation|0
4680396|NCT02576951|16110275|P4|Overall Study|Withdrawal by Subject|2
4680397|NCT02576951|16110276|P3|Overall Study|Withdrawal by Subject|0
4680398|NCT02576951|16110277|P2|Overall Study|Withdrawal by Subject|0
4680399|NCT02576951|16110278|P1|Overall Study|Withdrawal by Subject|1
4680400|NCT02576951|16110275|P4|Overall Study|Lost to Follow-up|2
4680401|NCT02576951|16110276|P3|Overall Study|Lost to Follow-up|2
4680402|NCT02576951|16110277|P2|Overall Study|Lost to Follow-up|0
4680403|NCT02576951|16110278|P1|Overall Study|Lost to Follow-up|0
4680404|NCT02576938|16110302|P3|Overall Study|Met Exclusion Criteria|0
4680405|NCT02576938|16110303|P2|Overall Study|Met Exclusion Criteria|1
4680406|NCT02576938|16110304|P1|Overall Study|Met Exclusion Criteria|0
4680407|NCT02576938|16110302|P3|Overall Study|Physician Decision|0
4680408|NCT02576938|16110303|P2|Overall Study|Physician Decision|1
4680409|NCT02576938|16110304|P1|Overall Study|Physician Decision|0
4680410|NCT02576938|16110302|P3|Overall Study|Lost to Follow-up|1
4680411|NCT02576938|16110303|P2|Overall Study|Lost to Follow-up|0
4680412|NCT02576938|16110304|P1|Overall Study|Lost to Follow-up|2
4680413|NCT02576938|16110302|P3|Overall Study|Lack of Efficacy|0
4680414|NCT02576938|16110303|P2|Overall Study|Lack of Efficacy|4
4680415|NCT02576938|16110304|P1|Overall Study|Lack of Efficacy|9
4680416|NCT02576938|16110302|P3|Overall Study|Withdrawal by Subject|4
4680417|NCT02576938|16110303|P2|Overall Study|Withdrawal by Subject|2
4680418|NCT02576938|16110304|P1|Overall Study|Withdrawal by Subject|3
4680419|NCT02576938|16110302|P3|Overall Study|Protocol Violation|1
4680420|NCT02576938|16110303|P2|Overall Study|Protocol Violation|1
4680421|NCT02576938|16110304|P1|Overall Study|Protocol Violation|1
4680422|NCT02576938|16110302|P3|Overall Study|Adverse Event|6
4680423|NCT02576938|16110303|P2|Overall Study|Adverse Event|3
4680424|NCT02576938|16110304|P1|Overall Study|Adverse Event|5
4680425|NCT02576678|16110350|P3|Overall Study|Miscellaneous|0
4680426|NCT02576678|16110351|P2|Overall Study|Miscellaneous|0
4680427|NCT02576678|16110352|P1|Overall Study|Miscellaneous|2
4680428|NCT02576678|16110350|P3|Overall Study|Lost to Follow-up|1
4680429|NCT02576678|16110351|P2|Overall Study|Lost to Follow-up|0
4680430|NCT02576678|16110352|P1|Overall Study|Lost to Follow-up|0
4680431|NCT02576678|16110350|P3|Overall Study|Withdrawal by Subject|2
4680432|NCT02576678|16110351|P2|Overall Study|Withdrawal by Subject|1
4680433|NCT02576678|16110352|P1|Overall Study|Withdrawal by Subject|3
4680434|NCT02576678|16110350|P3|Overall Study|Adverse Event|2
4680435|NCT02576678|16110351|P2|Overall Study|Adverse Event|0
4680436|NCT02576678|16110352|P1|Overall Study|Adverse Event|0
4680437|NCT02576652|16110384|P1|Overall Study|Withdrawal by Subject|2
4680438|NCT02576639|16110396|P5|Overall Study|Physician Decision|1
4680439|NCT02576639|16110397|P4|Overall Study|Physician Decision|0
4680440|NCT02576639|16110398|P3|Overall Study|Physician Decision|0
4680441|NCT02576639|16110399|P2|Overall Study|Physician Decision|0
4680442|NCT02576639|16110400|P1|Overall Study|Physician Decision|0
4680443|NCT02576639|16110396|P5|Overall Study|Adverse Event|2
4680444|NCT02576639|16110397|P4|Overall Study|Adverse Event|1
4680445|NCT02576639|16110398|P3|Overall Study|Adverse Event|1
4680446|NCT02576639|16110399|P2|Overall Study|Adverse Event|0
4680447|NCT02576639|16110400|P1|Overall Study|Adverse Event|1
4680448|NCT02576639|16110396|P5|Overall Study|Withdrawal by Subject|1
4680449|NCT02576639|16110397|P4|Overall Study|Withdrawal by Subject|0
4680450|NCT02576639|16110398|P3|Overall Study|Withdrawal by Subject|1
4680451|NCT02576639|16110399|P2|Overall Study|Withdrawal by Subject|2
4680452|NCT02576639|16110400|P1|Overall Study|Withdrawal by Subject|1
4680453|NCT02576587|16110459|P2|Follow up Period (Case Only)|Controls not eligible for followup|155
4680454|NCT02576587|16110460|P1|Follow up Period (Case Only)|Controls not eligible for followup|0
4680455|NCT02576587|16110459|P2|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0
4680456|NCT02576587|16110460|P1|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92
4680457|NCT02576587|16110459|P2|Follow up Period (Case Only)|Withdrawal by Subject|0
4680458|NCT02576587|16110460|P1|Follow up Period (Case Only)|Withdrawal by Subject|25
4680459|NCT02576587|16110459|P2|Baseline|Equipment failure|1
4680460|NCT02576587|16110460|P1|Baseline|Equipment failure|0
4680461|NCT02576535|16110478|P1|Overall Study|Withdrawal by Subject|2
4680462|NCT02576509|16110489|P2|Follow-up Period|Other reason|2
4680463|NCT02576509|16110490|P1|Follow-up Period|Other reason|1
4680464|NCT02576509|16110489|P2|Follow-up Period|Lost to Follow-up|1
4680465|NCT02576509|16110490|P1|Follow-up Period|Lost to Follow-up|0
4680466|NCT02576509|16110489|P2|Follow-up Period|Participant withdrew consent|14
4680467|NCT02576509|16110490|P1|Follow-up Period|Participant withdrew consent|7
4680468|NCT02576509|16110489|P2|Follow-up Period|Death|35
4680469|NCT02576509|16110490|P1|Follow-up Period|Death|41
4680470|NCT02576509|16110489|P2|Treatment Period|Other reason|7
4680471|NCT02576509|16110490|P1|Treatment Period|Other reason|2
4680472|NCT02576509|16110489|P2|Treatment Period|Participant no longer meets criteria|0
4680473|NCT02576509|16110490|P1|Treatment Period|Participant no longer meets criteria|1
4680474|NCT02576509|16110489|P2|Treatment Period|Poor/non-compliance|1
4680475|NCT02576509|16110490|P1|Treatment Period|Poor/non-compliance|0
4680476|NCT02576509|16110489|P2|Treatment Period|Maximum clinical benefit|0
4680477|NCT02576509|16110490|P1|Treatment Period|Maximum clinical benefit|1
4680478|NCT02576509|16110489|P2|Treatment Period|Lost to Follow-up|1
4680479|NCT02576509|16110490|P1|Treatment Period|Lost to Follow-up|0
4680480|NCT02576509|16110489|P2|Treatment Period|Participant withdrew consent|7
4680481|NCT02576509|16110490|P1|Treatment Period|Participant withdrew consent|2
4680482|NCT02576509|16110489|P2|Treatment Period|Participant request to stop treatment|17
4680483|NCT02576509|16110490|P1|Treatment Period|Participant request to stop treatment|8
4680484|NCT02576509|16110489|P2|Treatment Period|Adverse event unrelated to study drug|40
4680485|NCT02576509|16110490|P1|Treatment Period|Adverse event unrelated to study drug|37
4680486|NCT02576509|16110489|P2|Treatment Period|Death|1
4680487|NCT02576509|16110490|P1|Treatment Period|Death|1
4680488|NCT02576509|16110489|P2|Treatment Period|Study drug toxicity|41
4680489|NCT02576509|16110490|P1|Treatment Period|Study drug toxicity|32
4680490|NCT02576509|16110489|P2|Treatment Period|Disease progression|240
4680491|NCT02576509|16110490|P1|Treatment Period|Disease progression|245
4680492|NCT02576509|16110489|P2|Pre-Treatment Period|Participant no longer meets criteria|2
4680493|NCT02576509|16110490|P1|Pre-Treatment Period|Participant no longer meets criteria|3
4680494|NCT02576509|16110489|P2|Pre-Treatment Period|Participant withdrew consent|5
4680495|NCT02576509|16110490|P1|Pre-Treatment Period|Participant withdrew consent|1
4680496|NCT02576509|16110489|P2|Pre-Treatment Period|Participant request to stop therapy|2
4680497|NCT02576509|16110490|P1|Pre-Treatment Period|Participant request to stop therapy|0
4680498|NCT02576145|16110519|P2|Overall Study|Tetanus Titers Decreased|1
4680499|NCT02576145|16110520|P1|Overall Study|Tetanus Titers Decreased|0
4680500|NCT02576145|16110519|P2|Overall Study|Acute rejection|0
4680501|NCT02576145|16110520|P1|Overall Study|Acute rejection|1
4680502|NCT02576145|16110519|P2|Overall Study|Withdrawal by Subject|0
4680503|NCT02576145|16110520|P1|Overall Study|Withdrawal by Subject|1
4680504|NCT02576145|16110519|P2|Overall Study|Adverse Event|0
4680505|NCT02576145|16110520|P1|Overall Study|Adverse Event|1
4680506|NCT02576067|16110558|P2|Overall Study|Physician Decision|0
4680507|NCT02576067|16110559|P1|Overall Study|Physician Decision|4
4680508|NCT02576067|16110558|P2|Overall Study|screen failure/ re-enrolled|25
4680509|NCT02576067|16110559|P1|Overall Study|screen failure/ re-enrolled|0
4680510|NCT02576067|16110558|P2|Overall Study|not randomized, failed run-in|0
4680511|NCT02576067|16110559|P1|Overall Study|not randomized, failed run-in|7
4680512|NCT02576067|16110558|P2|Overall Study|study closure of main CIRT trial)|8
4680513|NCT02576067|16110559|P1|Overall Study|study closure of main CIRT trial)|0
4680514|NCT02576067|16110558|P2|Overall Study|Withdrawal by Subject|2
4680515|NCT02576067|16110559|P1|Overall Study|Withdrawal by Subject|11
4680516|NCT02576067|16110558|P2|Overall Study|Lost to Follow-up|0
4680517|NCT02576067|16110559|P1|Overall Study|Lost to Follow-up|11
4680518|NCT02576067|16110558|P2|Overall Study|Lack of Efficacy|0
4680519|NCT02576067|16110559|P1|Overall Study|Lack of Efficacy|1
4680520|NCT02576067|16110558|P2|Overall Study|Death|1
4680521|NCT02576067|16110559|P1|Overall Study|Death|0
4680522|NCT02576054|16110569|P1|Overall Study|Withdrawal by Subject|1
4680523|NCT02575950|16110590|P4|Overall Study|Lost to Follow-up|3
4680524|NCT02575950|16110591|P3|Overall Study|Lost to Follow-up|0
4680525|NCT02575950|16110592|P2|Overall Study|Lost to Follow-up|1
4680526|NCT02575950|16110593|P1|Overall Study|Lost to Follow-up|0
4680527|NCT02575950|16110590|P4|Overall Study|Withdrawal by Subject|2
4680528|NCT02575950|16110591|P3|Overall Study|Withdrawal by Subject|0
4680529|NCT02575950|16110592|P2|Overall Study|Withdrawal by Subject|0
4680530|NCT02575950|16110593|P1|Overall Study|Withdrawal by Subject|0
4680531|NCT02575911|16110622|P1|Overall Study|Lost to Follow-up|1
4680532|NCT02575833|16110642|P2|Overall Study|Lost to Follow-up|0
4680533|NCT02575833|16110643|P1|Overall Study|Lost to Follow-up|1
4680534|NCT02575833|16110642|P2|Overall Study|Withdrawal by Subject|1
4680535|NCT02575833|16110643|P1|Overall Study|Withdrawal by Subject|0
4680536|NCT02575807|16110658|P5|Overall Study|Withdrawal by Subject|2
4680537|NCT02575807|16110659|P4|Overall Study|Withdrawal by Subject|1
4680538|NCT02575807|16110660|P3|Overall Study|Withdrawal by Subject|1
4680539|NCT02575807|16110661|P2|Overall Study|Withdrawal by Subject|0
4680540|NCT02575807|16110662|P1|Overall Study|Withdrawal by Subject|0
4680541|NCT02575807|16110658|P5|Overall Study|Subject ineligible - medical implant|0
4680542|NCT02575807|16110659|P4|Overall Study|Subject ineligible - medical implant|1
4680543|NCT02575807|16110660|P3|Overall Study|Subject ineligible - medical implant|0
4680544|NCT02575807|16110661|P2|Overall Study|Subject ineligible - medical implant|0
4680545|NCT02575807|16110662|P1|Overall Study|Subject ineligible - medical implant|0
4680546|NCT02575807|16110658|P5|Overall Study|Terminated due to physician decision|0
4680547|NCT02575807|16110659|P4|Overall Study|Terminated due to physician decision|0
4680548|NCT02575807|16110660|P3|Overall Study|Terminated due to physician decision|1
4680549|NCT02575807|16110661|P2|Overall Study|Terminated due to physician decision|0
4680550|NCT02575807|16110662|P1|Overall Study|Terminated due to physician decision|0
4680551|NCT02575807|16110658|P5|Overall Study|Terminated due to FDA clinical hold|0
4680552|NCT02575807|16110659|P4|Overall Study|Terminated due to FDA clinical hold|0
4680553|NCT02575807|16110660|P3|Overall Study|Terminated due to FDA clinical hold|0
4680554|NCT02575807|16110661|P2|Overall Study|Terminated due to FDA clinical hold|0
4680555|NCT02575807|16110662|P1|Overall Study|Terminated due to FDA clinical hold|1
4680556|NCT02575807|16110658|P5|Overall Study|Study terminated by Sponsor|1
4680557|NCT02575807|16110659|P4|Overall Study|Study terminated by Sponsor|0
4680558|NCT02575807|16110660|P3|Overall Study|Study terminated by Sponsor|7
4680559|NCT02575807|16110661|P2|Overall Study|Study terminated by Sponsor|1
4680560|NCT02575807|16110662|P1|Overall Study|Study terminated by Sponsor|0
4680561|NCT02575807|16110658|P5|Overall Study|Death|1
4680562|NCT02575807|16110659|P4|Overall Study|Death|0
4680563|NCT02575807|16110660|P3|Overall Study|Death|7
4680564|NCT02575807|16110661|P2|Overall Study|Death|3
4680565|NCT02575807|16110662|P1|Overall Study|Death|8
4680566|NCT02575365|16110702|P1|Overall Study|Lost to Follow-up|4
4680567|NCT02575079|16110722|P2|Overall Study|Withdrawal by Subject|0
4680568|NCT02575079|16110723|P1|Overall Study|Withdrawal by Subject|3
4680569|NCT02575079|16110722|P2|Overall Study|Death|0
4680570|NCT02575079|16110723|P1|Overall Study|Death|3
4680571|NCT02574845|16110748|P6|Overall Study|Adverse Event|1
4680572|NCT02574845|16110749|P5|Overall Study|Adverse Event|0
4680573|NCT02574845|16110750|P4|Overall Study|Adverse Event|0
4680574|NCT02574845|16110751|P3|Overall Study|Adverse Event|0
4680575|NCT02574845|16110752|P2|Overall Study|Adverse Event|1
4680576|NCT02574845|16110753|P1|Overall Study|Adverse Event|0
4680577|NCT02574845|16110748|P6|Overall Study|Consent withdrawn further participation|0
4680578|NCT02574845|16110749|P5|Overall Study|Consent withdrawn further participation|1
4680579|NCT02574845|16110750|P4|Overall Study|Consent withdrawn further participation|0
4680580|NCT02574845|16110751|P3|Overall Study|Consent withdrawn further participation|0
4680581|NCT02574845|16110752|P2|Overall Study|Consent withdrawn further participation|0
4680582|NCT02574845|16110753|P1|Overall Study|Consent withdrawn further participation|0
4680583|NCT02574637|16110788|P10|Open-label (OL) Period|Study Terminated By Sponsor|0
4680584|NCT02574637|16110789|P9|Open-label (OL) Period|Study Terminated By Sponsor|1
4680585|NCT02574637|16110790|P8|Open-label (OL) Period|Study Terminated By Sponsor|1
4680586|NCT02574637|16110791|P7|Open-label (OL) Period|Study Terminated By Sponsor|2
4680587|NCT02574637|16110792|P6|Open-label (OL) Period|Study Terminated By Sponsor|1
4680588|NCT02574637|16110793|P5|Open-label (OL) Period|Study Terminated By Sponsor|0
4680589|NCT02574637|16110794|P4|Open-label (OL) Period|Study Terminated By Sponsor|0
4680590|NCT02574637|16110795|P3|Open-label (OL) Period|Study Terminated By Sponsor|0
4680591|NCT02574637|16110796|P2|Open-label (OL) Period|Study Terminated By Sponsor|0
4680592|NCT02574637|16110797|P1|Open-label (OL) Period|Study Terminated By Sponsor|0
4680593|NCT02574637|16110788|P10|Open-label (OL) Period|Withdrawal by Subject|1
4680594|NCT02574637|16110789|P9|Open-label (OL) Period|Withdrawal by Subject|0
4680595|NCT02574637|16110790|P8|Open-label (OL) Period|Withdrawal by Subject|0
4680596|NCT02574637|16110791|P7|Open-label (OL) Period|Withdrawal by Subject|0
4680597|NCT02574637|16110792|P6|Open-label (OL) Period|Withdrawal by Subject|1
4680598|NCT02574637|16110793|P5|Open-label (OL) Period|Withdrawal by Subject|0
4680599|NCT02574637|16110794|P4|Open-label (OL) Period|Withdrawal by Subject|0
4680600|NCT02574637|16110795|P3|Open-label (OL) Period|Withdrawal by Subject|0
4680601|NCT02574637|16110796|P2|Open-label (OL) Period|Withdrawal by Subject|0
4680602|NCT02574637|16110797|P1|Open-label (OL) Period|Withdrawal by Subject|0
4680603|NCT02574637|16110788|P10|Open-label (OL) Period|Adverse Event|0
4680604|NCT02574637|16110789|P9|Open-label (OL) Period|Adverse Event|1
4680605|NCT02574637|16110790|P8|Open-label (OL) Period|Adverse Event|0
4680606|NCT02574637|16110791|P7|Open-label (OL) Period|Adverse Event|0
4680607|NCT02574637|16110792|P6|Open-label (OL) Period|Adverse Event|0
4680608|NCT02574637|16110793|P5|Open-label (OL) Period|Adverse Event|0
4680609|NCT02574637|16110794|P4|Open-label (OL) Period|Adverse Event|0
4680610|NCT02574637|16110795|P3|Open-label (OL) Period|Adverse Event|0
4680611|NCT02574637|16110796|P2|Open-label (OL) Period|Adverse Event|0
4680612|NCT02574637|16110797|P1|Open-label (OL) Period|Adverse Event|0
4680613|NCT02574637|16110788|P10|Double-blind Period|Reason Not Specified|0
4680614|NCT02574637|16110789|P9|Double-blind Period|Reason Not Specified|0
4680615|NCT02574637|16110790|P8|Double-blind Period|Reason Not Specified|0
4680616|NCT02574637|16110791|P7|Double-blind Period|Reason Not Specified|0
4680617|NCT02574637|16110792|P6|Double-blind Period|Reason Not Specified|0
4680618|NCT02574637|16110793|P5|Double-blind Period|Reason Not Specified|0
4680619|NCT02574637|16110794|P4|Double-blind Period|Reason Not Specified|1
4680620|NCT02574637|16110795|P3|Double-blind Period|Reason Not Specified|0
4680621|NCT02574637|16110796|P2|Double-blind Period|Reason Not Specified|0
4680622|NCT02574637|16110797|P1|Double-blind Period|Reason Not Specified|0
4680623|NCT02574637|16110788|P10|Double-blind Period|Study Terminated By Sponsor|0
4680624|NCT02574637|16110789|P9|Double-blind Period|Study Terminated By Sponsor|0
4680625|NCT02574637|16110790|P8|Double-blind Period|Study Terminated By Sponsor|0
4680626|NCT02574637|16110791|P7|Double-blind Period|Study Terminated By Sponsor|0
4680627|NCT02574637|16110792|P6|Double-blind Period|Study Terminated By Sponsor|0
4680628|NCT02574637|16110793|P5|Double-blind Period|Study Terminated By Sponsor|2
4680629|NCT02574637|16110794|P4|Double-blind Period|Study Terminated By Sponsor|2
4680630|NCT02574637|16110795|P3|Double-blind Period|Study Terminated By Sponsor|5
4680631|NCT02574637|16110796|P2|Double-blind Period|Study Terminated By Sponsor|1
4680632|NCT02574637|16110797|P1|Double-blind Period|Study Terminated By Sponsor|1
4680633|NCT02574637|16110788|P10|Double-blind Period|Non-Compliance With Study Drug|0
4680634|NCT02574637|16110789|P9|Double-blind Period|Non-Compliance With Study Drug|0
4680635|NCT02574637|16110790|P8|Double-blind Period|Non-Compliance With Study Drug|0
4680636|NCT02574637|16110791|P7|Double-blind Period|Non-Compliance With Study Drug|0
4680637|NCT02574637|16110792|P6|Double-blind Period|Non-Compliance With Study Drug|0
4680638|NCT02574637|16110793|P5|Double-blind Period|Non-Compliance With Study Drug|0
4680639|NCT02574637|16110794|P4|Double-blind Period|Non-Compliance With Study Drug|1
4680640|NCT02574637|16110795|P3|Double-blind Period|Non-Compliance With Study Drug|0
4680641|NCT02574637|16110796|P2|Double-blind Period|Non-Compliance With Study Drug|0
4680642|NCT02574637|16110797|P1|Double-blind Period|Non-Compliance With Study Drug|0
4680643|NCT02574637|16110788|P10|Double-blind Period|Protocol Deviation|0
4680644|NCT02574637|16110789|P9|Double-blind Period|Protocol Deviation|0
4680645|NCT02574637|16110790|P8|Double-blind Period|Protocol Deviation|0
4680646|NCT02574637|16110791|P7|Double-blind Period|Protocol Deviation|0
4680647|NCT02574637|16110792|P6|Double-blind Period|Protocol Deviation|0
4680648|NCT02574637|16110793|P5|Double-blind Period|Protocol Deviation|0
4680649|NCT02574637|16110794|P4|Double-blind Period|Protocol Deviation|0
4680650|NCT02574637|16110795|P3|Double-blind Period|Protocol Deviation|0
4680651|NCT02574637|16110796|P2|Double-blind Period|Protocol Deviation|0
4680652|NCT02574637|16110797|P1|Double-blind Period|Protocol Deviation|1
4680653|NCT02574637|16110788|P10|Double-blind Period|Lack of Efficacy|0
4680654|NCT02574637|16110789|P9|Double-blind Period|Lack of Efficacy|0
4680655|NCT02574637|16110790|P8|Double-blind Period|Lack of Efficacy|0
4680656|NCT02574637|16110791|P7|Double-blind Period|Lack of Efficacy|0
4680657|NCT02574637|16110792|P6|Double-blind Period|Lack of Efficacy|0
4680658|NCT02574637|16110793|P5|Double-blind Period|Lack of Efficacy|0
4680659|NCT02574637|16110794|P4|Double-blind Period|Lack of Efficacy|0
4680660|NCT02574637|16110795|P3|Double-blind Period|Lack of Efficacy|2
4680661|NCT02574637|16110796|P2|Double-blind Period|Lack of Efficacy|0
4680662|NCT02574637|16110797|P1|Double-blind Period|Lack of Efficacy|0
4680663|NCT02574637|16110788|P10|Double-blind Period|Adverse Event|0
4680664|NCT02574637|16110789|P9|Double-blind Period|Adverse Event|0
4680665|NCT02574637|16110790|P8|Double-blind Period|Adverse Event|0
4680666|NCT02574637|16110791|P7|Double-blind Period|Adverse Event|0
4680667|NCT02574637|16110792|P6|Double-blind Period|Adverse Event|0
4680668|NCT02574637|16110793|P5|Double-blind Period|Adverse Event|0
4680669|NCT02574637|16110794|P4|Double-blind Period|Adverse Event|0
4680670|NCT02574637|16110795|P3|Double-blind Period|Adverse Event|0
4680671|NCT02574637|16110796|P2|Double-blind Period|Adverse Event|0
4680672|NCT02574637|16110797|P1|Double-blind Period|Adverse Event|1
4680673|NCT02574481|16110897|P4|Overall Study|Death|0
4680674|NCT02574481|16110898|P3|Overall Study|Death|0
4680675|NCT02574481|16110899|P2|Overall Study|Death|6
4680676|NCT02574481|16110900|P1|Overall Study|Death|6
4680677|NCT02574481|16110897|P4|Overall Study|Other|0
4680678|NCT02574481|16110898|P3|Overall Study|Other|0
4680679|NCT02574481|16110899|P2|Overall Study|Other|0
4680680|NCT02574481|16110900|P1|Overall Study|Other|1
4680681|NCT02574481|16110897|P4|Overall Study|Visit Missed|0
4680682|NCT02574481|16110898|P3|Overall Study|Visit Missed|2
4680683|NCT02574481|16110899|P2|Overall Study|Visit Missed|4
4680684|NCT02574481|16110900|P1|Overall Study|Visit Missed|12
4680685|NCT02574481|16110897|P4|Overall Study|Adverse Event|0
4680686|NCT02574481|16110898|P3|Overall Study|Adverse Event|0
4680687|NCT02574481|16110899|P2|Overall Study|Adverse Event|0
4680688|NCT02574481|16110900|P1|Overall Study|Adverse Event|2
4680689|NCT02574481|16110897|P4|Overall Study|Withdrawal by Subject|0
4680690|NCT02574481|16110898|P3|Overall Study|Withdrawal by Subject|1
4680691|NCT02574481|16110899|P2|Overall Study|Withdrawal by Subject|4
4680692|NCT02574481|16110900|P1|Overall Study|Withdrawal by Subject|6
4680693|NCT02574312|16110940|P2|3 Months Follow-up|Withdrawal by Subject|0
4680694|NCT02574312|16110941|P1|3 Months Follow-up|Withdrawal by Subject|1
4680695|NCT02574260|16110957|P1|Overall Study|Disease Progression|1
4680696|NCT02574247|16110966|P3|Overall Study|Did not meet inclusion criteria|5
4680697|NCT02574247|16110967|P2|Overall Study|Did not meet inclusion criteria|3
4680698|NCT02574247|16110968|P1|Overall Study|Did not meet inclusion criteria|4
4680699|NCT02574247|16110966|P3|Overall Study|Withdrawal by Subject|0
4680700|NCT02574247|16110967|P2|Overall Study|Withdrawal by Subject|0
4680701|NCT02574247|16110968|P1|Overall Study|Withdrawal by Subject|1
4680702|NCT02573948|16110980|P1|Longitudinal Cohort|Incarcerated|25
4680703|NCT02573948|16110980|P1|Longitudinal Cohort|Lost to Follow-up|22
4680704|NCT02573948|16110980|P1|Longitudinal Cohort|Death|9
4680705|NCT02573870|16110990|P2|Overall Study|Other: Fail to Meet Visit|2
4680706|NCT02573870|16110991|P1|Overall Study|Other: Fail to Meet Visit|0
4680707|NCT02573870|16110990|P2|Overall Study|Lost to Follow-up|1
4680708|NCT02573870|16110991|P1|Overall Study|Lost to Follow-up|0
4680709|NCT02573870|16110990|P2|Overall Study|Other: Reached defined stopping criteria|1
4680710|NCT02573870|16110991|P1|Overall Study|Other: Reached defined stopping criteria|0
4680711|NCT02573870|16110990|P2|Overall Study|Lack of Efficacy|1
4680712|NCT02573870|16110991|P1|Overall Study|Lack of Efficacy|0
4680713|NCT02573870|16110990|P2|Overall Study|Adverse Event|2
4680714|NCT02573870|16110991|P1|Overall Study|Adverse Event|0
4680715|NCT02573467|16111039|P4|Post-treatment Follow up Epoch|Technical problems|0
4680716|NCT02573467|16111040|P3|Post-treatment Follow up Epoch|Technical problems|1
4680717|NCT02573467|16111041|P2|Post-treatment Follow up Epoch|Technical problems|0
4680718|NCT02573467|16111042|P1|Post-treatment Follow up Epoch|Technical problems|0
4680719|NCT02573467|16111039|P4|Post-treatment Follow up Epoch|Withdrawal by Subject|2
4680720|NCT02573467|16111040|P3|Post-treatment Follow up Epoch|Withdrawal by Subject|9
4680721|NCT02573467|16111041|P2|Post-treatment Follow up Epoch|Withdrawal by Subject|4
4680722|NCT02573467|16111042|P1|Post-treatment Follow up Epoch|Withdrawal by Subject|5
4680723|NCT02573467|16111039|P4|Post-treatment Follow up Epoch|Death|1
4680724|NCT02573467|16111040|P3|Post-treatment Follow up Epoch|Death|0
4680725|NCT02573467|16111041|P2|Post-treatment Follow up Epoch|Death|1
4680726|NCT02573467|16111042|P1|Post-treatment Follow up Epoch|Death|1
4680727|NCT02573467|16111039|P4|Double-blind Treatment Epoch|Study Terminated by sponsor|55
4680728|NCT02573467|16111040|P3|Double-blind Treatment Epoch|Study Terminated by sponsor|48
4680729|NCT02573467|16111041|P2|Double-blind Treatment Epoch|Study Terminated by sponsor|51
4680730|NCT02573467|16111042|P1|Double-blind Treatment Epoch|Study Terminated by sponsor|50
4680731|NCT02573467|16111039|P4|Double-blind Treatment Epoch|Withdrawal by Subject|0
4680732|NCT02573467|16111040|P3|Double-blind Treatment Epoch|Withdrawal by Subject|1
4680733|NCT02573467|16111041|P2|Double-blind Treatment Epoch|Withdrawal by Subject|1
4680734|NCT02573467|16111042|P1|Double-blind Treatment Epoch|Withdrawal by Subject|2
4680735|NCT02573467|16111039|P4|Double-blind Treatment Epoch|Adverse Event|0
4680736|NCT02573467|16111040|P3|Double-blind Treatment Epoch|Adverse Event|1
4680737|NCT02573467|16111041|P2|Double-blind Treatment Epoch|Adverse Event|0
4680738|NCT02573467|16111042|P1|Double-blind Treatment Epoch|Adverse Event|1
4680739|NCT02573467|16111039|P4|Double-blind Treatment Epoch|Lack of Efficacy|0
4680740|NCT02573467|16111040|P3|Double-blind Treatment Epoch|Lack of Efficacy|1
4680741|NCT02573467|16111041|P2|Double-blind Treatment Epoch|Lack of Efficacy|0
4680742|NCT02573467|16111042|P1|Double-blind Treatment Epoch|Lack of Efficacy|0
4680743|NCT02573311|16111106|P2|Disposition for Part 2|Other than specified above|3
4680744|NCT02573311|16111107|P1|Disposition for Part 2|Other than specified above|13
4680745|NCT02573311|16111106|P2|Disposition for Part 2|Investigator decision|1
4680746|NCT02573311|16111107|P1|Disposition for Part 2|Investigator decision|0
4680747|NCT02573311|16111106|P2|Disposition for Part 2|Withdrawal by Subject|3
4680748|NCT02573311|16111107|P1|Disposition for Part 2|Withdrawal by Subject|60
4680749|NCT02573311|16111106|P2|Disposition for Part 2|Lost to Follow-up|7
4680750|NCT02573311|16111107|P1|Disposition for Part 2|Lost to Follow-up|76
4680751|NCT02573311|16111106|P2|Disposition for Part 2|Adverse Event|5
4680752|NCT02573311|16111107|P1|Disposition for Part 2|Adverse Event|36
4680753|NCT02573311|16111106|P2|Disposition for Part 2|Physician Decision|7
4680754|NCT02573311|16111107|P1|Disposition for Part 2|Physician Decision|25
4680755|NCT02573311|16111106|P2|Disposition for Part 1|Withdrawal by Subject|3
4680756|NCT02573311|16111107|P1|Disposition for Part 1|Withdrawal by Subject|7
4680757|NCT02573155|16111176|P2|Washout Between Treatment Period 4 and 5|Adverse Event|1
4680758|NCT02573155|16111177|P1|Washout Between Treatment Period 4 and 5|Adverse Event|0
4680759|NCT02573155|16111176|P2|Washout Between Treatment Period 3 and 4|Adverse Event|1
4680760|NCT02573155|16111177|P1|Washout Between Treatment Period 3 and 4|Adverse Event|0
4680761|NCT02573155|16111176|P2|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1
4680762|NCT02573155|16111177|P1|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0
4680763|NCT02573155|16111176|P2|Washout Between Treatment Period 2 and 3|Adverse Event|2
4680764|NCT02573155|16111177|P1|Washout Between Treatment Period 2 and 3|Adverse Event|0
4680765|NCT02573155|16111176|P2|Washout Between Treatment Period 2 and 3|Sponsor's decision|0
4680766|NCT02573155|16111177|P1|Washout Between Treatment Period 2 and 3|Sponsor's decision|1
4680767|NCT02573155|16111176|P2|Washout Between Treatment Period 1 and 2|Adverse Event|3
4680768|NCT02573155|16111177|P1|Washout Between Treatment Period 1 and 2|Adverse Event|0
4680769|NCT02573155|16111176|P2|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1
4680770|NCT02573155|16111177|P1|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0
4680771|NCT02573155|16111176|P2|Washout Between Treatment Period 1 and 2|Physician Decision|1
4680772|NCT02573155|16111177|P1|Washout Between Treatment Period 1 and 2|Physician Decision|0
4680773|NCT02573012|16111325|P2|Overall Study|Physician Decision|2
4680774|NCT02573012|16111326|P1|Overall Study|Physician Decision|1
4680775|NCT02573012|16111325|P2|Overall Study|Study Ended per Protocol|0
4680776|NCT02573012|16111326|P1|Overall Study|Study Ended per Protocol|1
4680777|NCT02573012|16111325|P2|Overall Study|Withdrawal by Subject|2
4680778|NCT02573012|16111326|P1|Overall Study|Withdrawal by Subject|2
4680779|NCT02573012|16111325|P2|Overall Study|Non-compliance|2
4680780|NCT02573012|16111326|P1|Overall Study|Non-compliance|1
4680781|NCT02573012|16111325|P2|Overall Study|Lack of Efficacy|4
4680782|NCT02573012|16111326|P1|Overall Study|Lack of Efficacy|5
4680783|NCT02573012|16111325|P2|Overall Study|Adverse Event|5
4680784|NCT02573012|16111326|P1|Overall Study|Adverse Event|5
4680785|NCT02572817|16111378|P2|Overall Study|Lost to Follow-up|3
4680786|NCT02572817|16111379|P1|Overall Study|Lost to Follow-up|3
4680787|NCT02572817|16111378|P2|Overall Study|Death|3
4680788|NCT02572817|16111379|P1|Overall Study|Death|6
4680789|NCT02572401|16111487|P4|Overall Study|Death|1
4680790|NCT02572401|16111488|P3|Overall Study|Death|0
4680791|NCT02572401|16111489|P2|Overall Study|Death|0
4680792|NCT02572401|16111490|P1|Overall Study|Death|0
4680793|NCT02572401|16111487|P4|Overall Study|Lost to Follow-up|9
4680794|NCT02572401|16111488|P3|Overall Study|Lost to Follow-up|9
4680795|NCT02572401|16111489|P2|Overall Study|Lost to Follow-up|8
4680796|NCT02572401|16111490|P1|Overall Study|Lost to Follow-up|5
4680797|NCT02572388|16111520|P4|Overall Study|Withdrawal by Subject|2
4680798|NCT02572388|16111521|P3|Overall Study|Withdrawal by Subject|2
4680799|NCT02572388|16111522|P2|Overall Study|Withdrawal by Subject|1
4680800|NCT02572388|16111523|P1|Overall Study|Withdrawal by Subject|1
4680801|NCT02572167|16111548|P3|Overall Study|Did not meet inclusion criteria|1
4680802|NCT02572167|16111549|P2|Overall Study|Did not meet inclusion criteria|0
4680803|NCT02572167|16111550|P1|Overall Study|Did not meet inclusion criteria|0
4680804|NCT02572167|16111548|P3|Overall Study|Death|1
4680805|NCT02572167|16111549|P2|Overall Study|Death|3
4680806|NCT02572167|16111550|P1|Overall Study|Death|0
4680807|NCT02572167|16111548|P3|Overall Study|Lost to Follow-up|1
4680808|NCT02572167|16111549|P2|Overall Study|Lost to Follow-up|2
4680809|NCT02572167|16111550|P1|Overall Study|Lost to Follow-up|0
4680810|NCT02572167|16111548|P3|Overall Study|Withdrawal by Subject|1
4680811|NCT02572167|16111549|P2|Overall Study|Withdrawal by Subject|3
4680812|NCT02572167|16111550|P1|Overall Study|Withdrawal by Subject|0
4680813|NCT02572167|16111548|P3|Overall Study|In follow up|27
4680814|NCT02572167|16111549|P2|Overall Study|In follow up|48
4680815|NCT02572167|16111550|P1|Overall Study|In follow up|6
4680816|NCT02572076|16111564|P1|Overall Study|Protocol Violation|1
4680817|NCT02571972|16111568|P1|Overall Study|Withdrawal by Subject|2
4680818|NCT02571972|16111568|P1|Overall Study|Protocol Violation|2
4680819|NCT02571777|16111580|P5|Overall Study|Pregnancy|0
4680820|NCT02571777|16111581|P4|Overall Study|Pregnancy|2
4680821|NCT02571777|16111582|P3|Overall Study|Pregnancy|0
4680822|NCT02571777|16111583|P2|Overall Study|Pregnancy|0
4680823|NCT02571777|16111584|P1|Overall Study|Pregnancy|0
4680824|NCT02571777|16111580|P5|Overall Study|Physician Decision|4
4680825|NCT02571777|16111581|P4|Overall Study|Physician Decision|2
4680826|NCT02571777|16111582|P3|Overall Study|Physician Decision|5
4680827|NCT02571777|16111583|P2|Overall Study|Physician Decision|7
4680828|NCT02571777|16111584|P1|Overall Study|Physician Decision|1
4680829|NCT02571777|16111580|P5|Overall Study|Lost to Follow-up|1
4680830|NCT02571777|16111581|P4|Overall Study|Lost to Follow-up|0
4680831|NCT02571777|16111582|P3|Overall Study|Lost to Follow-up|2
4680832|NCT02571777|16111583|P2|Overall Study|Lost to Follow-up|1
4680833|NCT02571777|16111584|P1|Overall Study|Lost to Follow-up|1
4680834|NCT02571777|16111580|P5|Overall Study|Death|0
4680835|NCT02571777|16111581|P4|Overall Study|Death|0
4680836|NCT02571777|16111582|P3|Overall Study|Death|4
4680837|NCT02571777|16111583|P2|Overall Study|Death|1
4680838|NCT02571777|16111584|P1|Overall Study|Death|1
4680839|NCT02571777|16111580|P5|Overall Study|Protocol Deviation|4
4680840|NCT02571777|16111581|P4|Overall Study|Protocol Deviation|8
4680841|NCT02571777|16111582|P3|Overall Study|Protocol Deviation|4
4680842|NCT02571777|16111583|P2|Overall Study|Protocol Deviation|3
4680843|NCT02571777|16111584|P1|Overall Study|Protocol Deviation|2
4680844|NCT02571777|16111580|P5|Overall Study|Subject/guardian decision|27
4680845|NCT02571777|16111581|P4|Overall Study|Subject/guardian decision|25
4680846|NCT02571777|16111582|P3|Overall Study|Subject/guardian decision|26
4680847|NCT02571777|16111583|P2|Overall Study|Subject/guardian decision|26
4680848|NCT02571777|16111584|P1|Overall Study|Subject/guardian decision|34
4680849|NCT02571452|16111721|P2|Overall Study 6-Month Follow-up|Protocol Violation|0
4680850|NCT02571452|16111722|P1|Overall Study 6-Month Follow-up|Protocol Violation|1
4680851|NCT02571452|16111721|P2|Overall Study 6-Month Follow-up|Lost to Follow-up|0
4680852|NCT02571452|16111722|P1|Overall Study 6-Month Follow-up|Lost to Follow-up|4
4680853|NCT02571452|16111721|P2|Overall Study Treatment|Protocol Violation|1
4680854|NCT02571452|16111722|P1|Overall Study Treatment|Protocol Violation|0
4680855|NCT02571244|16111763|P2|Overall Study|Unable to reach out post discharge|0
4680856|NCT02571244|16111764|P1|Overall Study|Unable to reach out post discharge|3
4680857|NCT02571244|16111763|P2|Overall Study|Lost to Follow-up|1
4680858|NCT02571244|16111764|P1|Overall Study|Lost to Follow-up|0
4680859|NCT02571075|16111822|P2|Overall Study|Lost to Follow-up|24
4680860|NCT02571075|16111823|P1|Overall Study|Lost to Follow-up|20
4680861|NCT02571049|16111837|P2|Randomization|Adverse Event|1
4680862|NCT02571049|16111838|P1|Randomization|Adverse Event|0
4680863|NCT02571049|16111837|P2|Randomization|No migraine attack|1
4680864|NCT02571049|16111838|P1|Randomization|No migraine attack|0
4680865|NCT02571049|16111837|P2|Screening|Did not meet entry criteria|2
4680866|NCT02571049|16111838|P1|Screening|Did not meet entry criteria|2
4680867|NCT02570750|16111846|P2|Overall Study|Adverse Event|1
4680868|NCT02570750|16111847|P1|Overall Study|Adverse Event|2
4680869|NCT02570750|16111846|P2|Overall Study|Lost to Follow-up|2
4680870|NCT02570750|16111847|P1|Overall Study|Lost to Follow-up|2
4680871|NCT02570750|16111846|P2|Overall Study|Withdrawal by Subject|0
4680872|NCT02570750|16111847|P1|Overall Study|Withdrawal by Subject|5
4680873|NCT02570750|16111846|P2|Overall Study|Protocol deviation|2
4680874|NCT02570750|16111847|P1|Overall Study|Protocol deviation|4
4680875|NCT02570750|16111846|P2|Overall Study|Inclusion/exclusion criteria deviation|0
4680876|NCT02570750|16111847|P1|Overall Study|Inclusion/exclusion criteria deviation|1
4680877|NCT02570711|16111865|P2|Overall Study|Early Termination of Study by Sponsor|2
4680878|NCT02570711|16111866|P1|Overall Study|Early Termination of Study by Sponsor|0
4680879|NCT02570711|16111865|P2|Overall Study|Death|0
4680880|NCT02570711|16111866|P1|Overall Study|Death|1
4680881|NCT02570165|16111954|P7|Overall Study|Withdrawal Request by GSK|0
4680882|NCT02570165|16111955|P6|Overall Study|Withdrawal Request by GSK|0
4680883|NCT02570165|16111956|P5|Overall Study|Withdrawal Request by GSK|0
4680884|NCT02570165|16111957|P4|Overall Study|Withdrawal Request by GSK|0
4680885|NCT02570165|16111958|P3|Overall Study|Withdrawal Request by GSK|2
4680886|NCT02570165|16111959|P2|Overall Study|Withdrawal Request by GSK|0
4680887|NCT02570165|16111960|P1|Overall Study|Withdrawal Request by GSK|0
4680888|NCT02570165|16111954|P7|Overall Study|Par. did not Meet Continuation Criteria|0
4680889|NCT02570165|16111955|P6|Overall Study|Par. did not Meet Continuation Criteria|1
4680890|NCT02570165|16111956|P5|Overall Study|Par. did not Meet Continuation Criteria|0
4680891|NCT02570165|16111957|P4|Overall Study|Par. did not Meet Continuation Criteria|0
4680892|NCT02570165|16111958|P3|Overall Study|Par. did not Meet Continuation Criteria|0
4680893|NCT02570165|16111959|P2|Overall Study|Par. did not Meet Continuation Criteria|0
4680894|NCT02570165|16111960|P1|Overall Study|Par. did not Meet Continuation Criteria|0
4680895|NCT02570165|16111954|P7|Overall Study|Withdrawal by Subject|0
4680896|NCT02570165|16111955|P6|Overall Study|Withdrawal by Subject|0
4680897|NCT02570165|16111956|P5|Overall Study|Withdrawal by Subject|1
4680898|NCT02570165|16111957|P4|Overall Study|Withdrawal by Subject|2
4680899|NCT02570165|16111958|P3|Overall Study|Withdrawal by Subject|0
4680900|NCT02570165|16111959|P2|Overall Study|Withdrawal by Subject|0
4680901|NCT02570165|16111960|P1|Overall Study|Withdrawal by Subject|0
4680902|NCT02570165|16111954|P7|Overall Study|Physician Decision|0
4680903|NCT02570165|16111955|P6|Overall Study|Physician Decision|0
4680904|NCT02570165|16111956|P5|Overall Study|Physician Decision|0
4680905|NCT02570165|16111957|P4|Overall Study|Physician Decision|0
4680906|NCT02570165|16111958|P3|Overall Study|Physician Decision|0
4680907|NCT02570165|16111959|P2|Overall Study|Physician Decision|1
4680908|NCT02570165|16111960|P1|Overall Study|Physician Decision|0
4680909|NCT02570165|16111954|P7|Overall Study|Lost to Follow-up|0
4680910|NCT02570165|16111955|P6|Overall Study|Lost to Follow-up|0
4680911|NCT02570165|16111956|P5|Overall Study|Lost to Follow-up|0
4680912|NCT02570165|16111957|P4|Overall Study|Lost to Follow-up|1
4680913|NCT02570165|16111958|P3|Overall Study|Lost to Follow-up|1
4680914|NCT02570165|16111959|P2|Overall Study|Lost to Follow-up|0
4680915|NCT02570165|16111960|P1|Overall Study|Lost to Follow-up|0
4680916|NCT02570165|16111954|P7|Overall Study|Par. Reached Stopping Criteria|0
4680917|NCT02570165|16111955|P6|Overall Study|Par. Reached Stopping Criteria|1
4680918|NCT02570165|16111956|P5|Overall Study|Par. Reached Stopping Criteria|1
4680919|NCT02570165|16111957|P4|Overall Study|Par. Reached Stopping Criteria|2
4680920|NCT02570165|16111958|P3|Overall Study|Par. Reached Stopping Criteria|0
4680921|NCT02570165|16111959|P2|Overall Study|Par. Reached Stopping Criteria|1
4680922|NCT02570165|16111960|P1|Overall Study|Par. Reached Stopping Criteria|1
4680923|NCT02570165|16111954|P7|Overall Study|Lack of Efficacy|0
4680924|NCT02570165|16111955|P6|Overall Study|Lack of Efficacy|0
4680925|NCT02570165|16111956|P5|Overall Study|Lack of Efficacy|4
4680926|NCT02570165|16111957|P4|Overall Study|Lack of Efficacy|0
4680927|NCT02570165|16111958|P3|Overall Study|Lack of Efficacy|0
4680928|NCT02570165|16111959|P2|Overall Study|Lack of Efficacy|1
4680929|NCT02570165|16111960|P1|Overall Study|Lack of Efficacy|0
4680930|NCT02570165|16111954|P7|Overall Study|Adverse Event|0
4680931|NCT02570165|16111955|P6|Overall Study|Adverse Event|0
4680932|NCT02570165|16111956|P5|Overall Study|Adverse Event|0
4680933|NCT02570165|16111957|P4|Overall Study|Adverse Event|0
4680934|NCT02570165|16111958|P3|Overall Study|Adverse Event|2
4680935|NCT02570165|16111959|P2|Overall Study|Adverse Event|0
4680936|NCT02570165|16111960|P1|Overall Study|Adverse Event|1
4680937|NCT02570152|16111983|P1|Overall Study|Migrated/moved from study area|13
4680938|NCT02570152|16111983|P1|Overall Study|Protocol Violation|2
4680939|NCT02570126|16112014|P2|Overall Study|Withdrawal by Subject|7
4680940|NCT02570126|16112015|P1|Overall Study|Withdrawal by Subject|3
4680941|NCT02570126|16112014|P2|Overall Study|Protocol Violation|1
4680942|NCT02570126|16112015|P1|Overall Study|Protocol Violation|0
4680943|NCT02570126|16112014|P2|Overall Study|Violation Of Procedures GSK|1
4680944|NCT02570126|16112015|P1|Overall Study|Violation Of Procedures GSK|0
4680945|NCT02570126|16112014|P2|Overall Study|Unable To Arrange Visit 3|0
4680946|NCT02570126|16112015|P1|Overall Study|Unable To Arrange Visit 3|1
4680947|NCT02570126|16112014|P2|Overall Study|Lost to Follow-up|0
4680948|NCT02570126|16112015|P1|Overall Study|Lost to Follow-up|2
4680949|NCT02570074|16112041|P2|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0
4680950|NCT02570074|16112042|P1|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1
4680951|NCT02569996|16112111|P1|Overall Study|Unknown reason|1
4680952|NCT02569996|16112111|P1|Overall Study|Complete remission|7
4680953|NCT02569996|16112111|P1|Overall Study|Lost to Follow-up|5
4680954|NCT02569996|16112111|P1|Overall Study|Withdrawal by Subject|5
4680955|NCT02569996|16112111|P1|Overall Study|Non-compliance|9
4680956|NCT02569996|16112111|P1|Overall Study|New anti-lymphoma treatment|1
4680957|NCT02569996|16112111|P1|Overall Study|Progression of the disease|18
4680958|NCT02569996|16112111|P1|Overall Study|Physician Decision|3
4680959|NCT02569996|16112111|P1|Overall Study|Adverse Event|6
4680960|NCT02569957|16112123|P2|Overall Study|Withdrawal by Subject|1
4680961|NCT02569957|16112124|P1|Overall Study|Withdrawal by Subject|0
4680962|NCT02569853|16112156|P2|Overall Study|Physician Decision|1
4680963|NCT02569853|16112157|P1|Overall Study|Physician Decision|1
4680964|NCT02569853|16112156|P2|Overall Study|Did not experience migraine attack|7
4680965|NCT02569853|16112157|P1|Overall Study|Did not experience migraine attack|10
4680966|NCT02569853|16112156|P2|Overall Study|Protocol Violation|1
4680967|NCT02569853|16112157|P1|Overall Study|Protocol Violation|1
4680968|NCT02569853|16112156|P2|Overall Study|Lost to Follow-up|3
4680969|NCT02569853|16112157|P1|Overall Study|Lost to Follow-up|3
4680970|NCT02569853|16112156|P2|Overall Study|Withdrawal by Subject|2
4680971|NCT02569853|16112157|P1|Overall Study|Withdrawal by Subject|3
4680972|NCT02569853|16112156|P2|Overall Study|Adverse Event|0
4680973|NCT02569853|16112157|P1|Overall Study|Adverse Event|2
4680974|NCT02569710|16112175|P10|Overall Study|Withdrawal by Subject|0
4680975|NCT02569710|16112176|P9|Overall Study|Withdrawal by Subject|0
4680976|NCT02569710|16112177|P8|Overall Study|Withdrawal by Subject|0
4680977|NCT02569710|16112178|P7|Overall Study|Withdrawal by Subject|0
4680978|NCT02569710|16112179|P6|Overall Study|Withdrawal by Subject|1
4680979|NCT02569710|16112180|P5|Overall Study|Withdrawal by Subject|0
4680980|NCT02569710|16112181|P4|Overall Study|Withdrawal by Subject|0
4680981|NCT02569710|16112182|P3|Overall Study|Withdrawal by Subject|0
4680982|NCT02569710|16112183|P2|Overall Study|Withdrawal by Subject|0
4680983|NCT02569710|16112184|P1|Overall Study|Withdrawal by Subject|0
4680984|NCT02569710|16112175|P10|Overall Study|Virologic failure|0
4680985|NCT02569710|16112176|P9|Overall Study|Virologic failure|0
4680986|NCT02569710|16112177|P8|Overall Study|Virologic failure|0
4680987|NCT02569710|16112178|P7|Overall Study|Virologic failure|1
4680988|NCT02569710|16112179|P6|Overall Study|Virologic failure|0
4680989|NCT02569710|16112180|P5|Overall Study|Virologic failure|1
4680990|NCT02569710|16112181|P4|Overall Study|Virologic failure|0
4680991|NCT02569710|16112182|P3|Overall Study|Virologic failure|0
4680992|NCT02569710|16112183|P2|Overall Study|Virologic failure|0
4680993|NCT02569710|16112184|P1|Overall Study|Virologic failure|0
4680994|NCT02569710|16112175|P10|Overall Study|Lost to Follow-up|0
4680995|NCT02569710|16112176|P9|Overall Study|Lost to Follow-up|1
4680996|NCT02569710|16112177|P8|Overall Study|Lost to Follow-up|0
4680997|NCT02569710|16112178|P7|Overall Study|Lost to Follow-up|1
4680998|NCT02569710|16112179|P6|Overall Study|Lost to Follow-up|0
4680999|NCT02569710|16112180|P5|Overall Study|Lost to Follow-up|0
4681000|NCT02569710|16112181|P4|Overall Study|Lost to Follow-up|0
4681001|NCT02569710|16112182|P3|Overall Study|Lost to Follow-up|0
4681002|NCT02569710|16112183|P2|Overall Study|Lost to Follow-up|0
4681003|NCT02569710|16112184|P1|Overall Study|Lost to Follow-up|0
4681004|NCT02569710|16112175|P10|Overall Study|Adverse Event|0
4681005|NCT02569710|16112176|P9|Overall Study|Adverse Event|0
4681006|NCT02569710|16112177|P8|Overall Study|Adverse Event|0
4681007|NCT02569710|16112178|P7|Overall Study|Adverse Event|0
4681008|NCT02569710|16112179|P6|Overall Study|Adverse Event|0
4681009|NCT02569710|16112180|P5|Overall Study|Adverse Event|0
4681010|NCT02569710|16112181|P4|Overall Study|Adverse Event|0
4681011|NCT02569710|16112182|P3|Overall Study|Adverse Event|0
4681012|NCT02569710|16112183|P2|Overall Study|Adverse Event|0
4681013|NCT02569710|16112184|P1|Overall Study|Adverse Event|1
4681014|NCT02569437|16112524|P2|Overall Study|Lost to Follow-up|14
4681015|NCT02569437|16112525|P1|Overall Study|Lost to Follow-up|12
4681016|NCT02569398|16112555|P3|Overall Study|Other|13
4681017|NCT02569398|16112556|P2|Overall Study|Other|14
4681018|NCT02569398|16112557|P1|Overall Study|Other|12
4681019|NCT02569398|16112555|P3|Overall Study|Study terminated by sponsor|134
4681020|NCT02569398|16112556|P2|Overall Study|Study terminated by sponsor|131
4681021|NCT02569398|16112557|P1|Overall Study|Study terminated by sponsor|130
4681022|NCT02569398|16112555|P3|Overall Study|Withdrawal by Subject|30
4681023|NCT02569398|16112556|P2|Overall Study|Withdrawal by Subject|43
4681024|NCT02569398|16112557|P1|Overall Study|Withdrawal by Subject|43
4681025|NCT02569398|16112555|P3|Overall Study|Adverse Event|6
4681026|NCT02569398|16112556|P2|Overall Study|Adverse Event|1
4681027|NCT02569398|16112557|P1|Overall Study|Adverse Event|0
4681028|NCT02568683|16112632|P2|Overall Study|Study Terminated By Sponsor|2
4681029|NCT02568683|16112633|P1|Overall Study|Study Terminated By Sponsor|5
4681030|NCT02568683|16112632|P2|Overall Study|Withdrew Consent|0
4681031|NCT02568683|16112633|P1|Overall Study|Withdrew Consent|1
4681032|NCT02568683|16112632|P2|Overall Study|Death|2
4681033|NCT02568683|16112633|P1|Overall Study|Death|0
4681034|NCT02568475|16112662|P2|Overall Study|Transferred to another facility|0
4681035|NCT02568475|16112663|P1|Overall Study|Transferred to another facility|1
4681036|NCT02568475|16112662|P2|Overall Study|Short-term: Discharge location unknown|0
4681037|NCT02568475|16112663|P1|Overall Study|Short-term: Discharge location unknown|4
4681038|NCT02568475|16112662|P2|Overall Study|Discharged home|4
4681039|NCT02568475|16112663|P1|Overall Study|Discharged home|4
4681040|NCT02568475|16112662|P2|Overall Study|Withdrawal by Subject|0
4681041|NCT02568475|16112663|P1|Overall Study|Withdrawal by Subject|2
4681042|NCT02568475|16112662|P2|Overall Study|Lost to Follow-up|39
4681043|NCT02568475|16112663|P1|Overall Study|Lost to Follow-up|40
4681044|NCT02568397|16112677|P2|Period 2|Physician Decision|1
4681045|NCT02568397|16112678|P1|Period 2|Physician Decision|0
4681046|NCT02568397|16112677|P2|Period 2|Withdrawal by Subject|1
4681047|NCT02568397|16112678|P1|Period 2|Withdrawal by Subject|0
4681048|NCT02568384|16112702|P1|Overall Study|Mobile devices incompatible with App|2
4681049|NCT02568254|16112716|P6|Period 3|Unstatisfactory Lens fitting|0
4681050|NCT02568254|16112717|P5|Period 3|Unstatisfactory Lens fitting|1
4681051|NCT02568254|16112718|P4|Period 3|Unstatisfactory Lens fitting|0
4681052|NCT02568254|16112719|P3|Period 3|Unstatisfactory Lens fitting|0
4681053|NCT02568254|16112720|P2|Period 3|Unstatisfactory Lens fitting|0
4681054|NCT02568254|16112721|P1|Period 3|Unstatisfactory Lens fitting|0
4681055|NCT02568254|16112716|P6|Period 2|Adverse Event|0
4681056|NCT02568254|16112717|P5|Period 2|Adverse Event|0
4681057|NCT02568254|16112718|P4|Period 2|Adverse Event|0
4681058|NCT02568254|16112719|P3|Period 2|Adverse Event|1
4681059|NCT02568254|16112720|P2|Period 2|Adverse Event|0
4681060|NCT02568254|16112721|P1|Period 2|Adverse Event|0
4681061|NCT02568046|16112731|P2|Overall Study|Other Events|1
4681062|NCT02568046|16112732|P1|Overall Study|Other Events|0
4681063|NCT02568046|16112731|P2|Overall Study|Withdrawal by Subject|1
4681064|NCT02568046|16112732|P1|Overall Study|Withdrawal by Subject|2
4681065|NCT02568046|16112731|P2|Overall Study|Progressive Disease|0
4681066|NCT02568046|16112732|P1|Overall Study|Progressive Disease|1
4681067|NCT02568046|16112731|P2|Overall Study|Death|0
4681068|NCT02568046|16112732|P1|Overall Study|Death|2
4681069|NCT02568046|16112731|P2|Overall Study|Adverse Event|1
4681070|NCT02568046|16112732|P1|Overall Study|Adverse Event|0
4681071|NCT02567708|16112795|P2|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3
4681072|NCT02567708|16112796|P1|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0
4681073|NCT02567708|16112795|P2|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0
4681074|NCT02567708|16112796|P1|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2
4681075|NCT02567708|16112795|P2|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1
4681076|NCT02567708|16112796|P1|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0
4681077|NCT02567708|16112795|P2|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2
4681078|NCT02567708|16112796|P1|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0
4681079|NCT02567656|16112841|P6|Overall Study|Premature discontinuation due to PD|0
4681080|NCT02567656|16112842|P5|Overall Study|Premature discontinuation due to PD|0
4681081|NCT02567656|16112843|P4|Overall Study|Premature discontinuation due to PD|0
4681082|NCT02567656|16112844|P3|Overall Study|Premature discontinuation due to PD|2
4681083|NCT02567656|16112845|P2|Overall Study|Premature discontinuation due to PD|1
4681084|NCT02567656|16112846|P1|Overall Study|Premature discontinuation due to PD|1
4681085|NCT02567552|16112878|P2|Overall Study|Adverse Event|1
4681086|NCT02567552|16112879|P1|Overall Study|Adverse Event|0
4681087|NCT02567188|16112909|P1|Overall Study|Protocol Violation|5
4681088|NCT02567188|16112909|P1|Overall Study|Started Hemodialysis|2
4681089|NCT02567188|16112909|P1|Overall Study|Moved and Changed Clinic|1
4681090|NCT02567188|16112909|P1|Overall Study|Refused Treatment/ Did not Cooperate|1
4681091|NCT02567188|16112909|P1|Overall Study|Withdrawal by Subject|1
4681092|NCT02567188|16112909|P1|Overall Study|Adverse Event|1
4681093|NCT02567188|16112909|P1|Overall Study|Lost to Follow-up|5
4681094|NCT02567188|16112909|P1|Overall Study|Terminated Mircera Treatment|9
4681095|NCT02567188|16112909|P1|Overall Study|Death|10
4681096|NCT02566889|16112940|P2|Overall Study|Other|2
4681097|NCT02566889|16112941|P1|Overall Study|Other|6
4681098|NCT02566889|16112940|P2|Overall Study|Adverse Event|2
4681099|NCT02566889|16112941|P1|Overall Study|Adverse Event|4
4681100|NCT02566889|16112940|P2|Overall Study|Withdrawal by Subject|1
4681101|NCT02566889|16112941|P1|Overall Study|Withdrawal by Subject|3
4681102|NCT02566785|16112959|P2|Overall Study|Worsening condition|1
4681103|NCT02566785|16112960|P1|Overall Study|Worsening condition|1
4681104|NCT02566785|16112959|P2|Overall Study|Lost to Follow-up|2
4681105|NCT02566785|16112960|P1|Overall Study|Lost to Follow-up|0
4681106|NCT02566759|16112987|P17|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1
4681107|NCT02566759|16112988|P16|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681108|NCT02566759|16112989|P15|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681109|NCT02566759|16112990|P14|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681110|NCT02566759|16112991|P13|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681111|NCT02566759|16112992|P12|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681112|NCT02566759|16112993|P11|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681113|NCT02566759|16112994|P10|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681114|NCT02566759|16112995|P9|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681115|NCT02566759|16112996|P8|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681116|NCT02566759|16112997|P7|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681117|NCT02566759|16112998|P6|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681118|NCT02566759|16112999|P5|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681119|NCT02566759|16113000|P4|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681120|NCT02566759|16113001|P3|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681121|NCT02566759|16113002|P2|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681122|NCT02566759|16113003|P1|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0
4681123|NCT02566759|16112987|P17|All Parts|Other|0
4681124|NCT02566759|16112988|P16|All Parts|Other|0
4681125|NCT02566759|16112989|P15|All Parts|Other|0
4681126|NCT02566759|16112990|P14|All Parts|Other|2
4681127|NCT02566759|16112991|P13|All Parts|Other|0
4681128|NCT02566759|16112992|P12|All Parts|Other|0
4681129|NCT02566759|16112993|P11|All Parts|Other|0
4681130|NCT02566759|16112994|P10|All Parts|Other|0
4681131|NCT02566759|16112995|P9|All Parts|Other|0
4681132|NCT02566759|16112996|P8|All Parts|Other|0
4681133|NCT02566759|16112997|P7|All Parts|Other|0
4681134|NCT02566759|16112998|P6|All Parts|Other|0
4681135|NCT02566759|16112999|P5|All Parts|Other|0
4681136|NCT02566759|16113000|P4|All Parts|Other|0
4681137|NCT02566759|16113001|P3|All Parts|Other|0
4681138|NCT02566759|16113002|P2|All Parts|Other|0
4681139|NCT02566759|16113003|P1|All Parts|Other|0
4681140|NCT02566759|16112987|P17|All Parts|Adverse Event|0
4681141|NCT02566759|16112988|P16|All Parts|Adverse Event|0
4681142|NCT02566759|16112989|P15|All Parts|Adverse Event|0
4681143|NCT02566759|16112990|P14|All Parts|Adverse Event|3
4681144|NCT02566759|16112991|P13|All Parts|Adverse Event|1
4681145|NCT02566759|16112992|P12|All Parts|Adverse Event|0
4681146|NCT02566759|16112993|P11|All Parts|Adverse Event|0
4681147|NCT02566759|16112994|P10|All Parts|Adverse Event|0
4681148|NCT02566759|16112995|P9|All Parts|Adverse Event|0
4681149|NCT02566759|16112996|P8|All Parts|Adverse Event|0
4681150|NCT02566759|16112997|P7|All Parts|Adverse Event|0
4681151|NCT02566759|16112998|P6|All Parts|Adverse Event|0
4681152|NCT02566759|16112999|P5|All Parts|Adverse Event|0
4681153|NCT02566759|16113000|P4|All Parts|Adverse Event|0
4681154|NCT02566759|16113001|P3|All Parts|Adverse Event|0
4681155|NCT02566759|16113002|P2|All Parts|Adverse Event|0
4681156|NCT02566759|16113003|P1|All Parts|Adverse Event|0
4681157|NCT02566759|16112987|P17|All Parts|Withdrawal by Subject|0
4681158|NCT02566759|16112988|P16|All Parts|Withdrawal by Subject|0
4681159|NCT02566759|16112989|P15|All Parts|Withdrawal by Subject|0
4681160|NCT02566759|16112990|P14|All Parts|Withdrawal by Subject|0
4681161|NCT02566759|16112991|P13|All Parts|Withdrawal by Subject|0
4681162|NCT02566759|16112992|P12|All Parts|Withdrawal by Subject|0
4681163|NCT02566759|16112993|P11|All Parts|Withdrawal by Subject|0
4681164|NCT02566759|16112994|P10|All Parts|Withdrawal by Subject|0
4681165|NCT02566759|16112995|P9|All Parts|Withdrawal by Subject|0
4681166|NCT02566759|16112996|P8|All Parts|Withdrawal by Subject|0
4681167|NCT02566759|16112997|P7|All Parts|Withdrawal by Subject|0
4681168|NCT02566759|16112998|P6|All Parts|Withdrawal by Subject|0
4681169|NCT02566759|16112999|P5|All Parts|Withdrawal by Subject|0
4681170|NCT02566759|16113000|P4|All Parts|Withdrawal by Subject|0
4681171|NCT02566759|16113001|P3|All Parts|Withdrawal by Subject|0
4681172|NCT02566759|16113002|P2|All Parts|Withdrawal by Subject|1
4681173|NCT02566759|16113003|P1|All Parts|Withdrawal by Subject|0
4681174|NCT02566577|16113165|P2|Overall Study|Physical limitation|0
4681175|NCT02566577|16113166|P1|Overall Study|Physical limitation|1
4681176|NCT02566577|16113165|P2|Overall Study|Equipment failure|1
4681177|NCT02566577|16113166|P1|Overall Study|Equipment failure|1
4681178|NCT02566577|16113165|P2|Overall Study|Withdrawal by Subject|1
4681179|NCT02566577|16113166|P1|Overall Study|Withdrawal by Subject|1
4681180|NCT02566109|16113246|P1|Overall Study|Withdrawal by Subject|1
4681181|NCT02566031|16113310|P2|Overall Study|Lost to Follow-up|1
4681182|NCT02566031|16113311|P1|Overall Study|Lost to Follow-up|1
4681183|NCT02566031|16113310|P2|Overall Study|Adverse Event|1
4681184|NCT02566031|16113311|P1|Overall Study|Adverse Event|3
4681185|NCT02566031|16113310|P2|Overall Study|Protocol deviation|3
4681186|NCT02566031|16113311|P1|Overall Study|Protocol deviation|2
4681187|NCT02566031|16113310|P2|Overall Study|Patient/guardian decision|7
4681188|NCT02566031|16113311|P1|Overall Study|Patient/guardian decision|14
4681189|NCT02566005|16113328|P2|Overall Study|labor after randomization|4
4681190|NCT02566005|16113329|P1|Overall Study|labor after randomization|0
4681191|NCT02566005|16113328|P2|Overall Study|did not receive foley|1
4681192|NCT02566005|16113329|P1|Overall Study|did not receive foley|0
4681193|NCT02566005|16113328|P2|Overall Study|received foley|0
4681194|NCT02566005|16113329|P1|Overall Study|received foley|8
4681195|NCT02566005|16113328|P2|Overall Study|vaginal bleeding|1
4681196|NCT02566005|16113329|P1|Overall Study|vaginal bleeding|0
4681197|NCT02565914|16113357|P1|Overall Study|Enrolled, but did not receive study drug|2
4681198|NCT02565914|16113357|P1|Overall Study|Other|18
4681199|NCT02565914|16113357|P1|Overall Study|Commercial drug available|5
4681200|NCT02565914|16113357|P1|Overall Study|Parent study termination by sponsor|1
4681201|NCT02565914|16113357|P1|Overall Study|Physician Decision|6
4681202|NCT02565914|16113357|P1|Overall Study|Other noncompliance|6
4681203|NCT02565914|16113357|P1|Overall Study|Death (not treatment emergent)|1
4681204|NCT02565914|16113357|P1|Overall Study|Lost to Follow-up|12
4681205|NCT02565914|16113357|P1|Overall Study|Withdrawal of consent (not due to AE)|25
4681206|NCT02565914|16113357|P1|Overall Study|Adverse Event|17
4681207|NCT02565810|16113391|P1|Overall Study|Withdrawal by Subject|1
4681208|NCT02565784|16113400|P1|Second Treatment|Withdrawal by Subject|2
4681209|NCT02565784|16113400|P1|First Treatment|Withdrawal by Subject|1
4681210|NCT02565784|16113400|P1|First Treatment|Adverse Event|1
4681211|NCT02565706|16113412|P4|Overall Study|Lost to Follow-up|74
4681212|NCT02565706|16113413|P3|Overall Study|Lost to Follow-up|82
4681213|NCT02565706|16113414|P2|Overall Study|Lost to Follow-up|75
4681214|NCT02565706|16113415|P1|Overall Study|Lost to Follow-up|72
4681215|NCT02565706|16113412|P4|Overall Study|Withdrawal by Subject|11
4681216|NCT02565706|16113413|P3|Overall Study|Withdrawal by Subject|7
4681217|NCT02565706|16113414|P2|Overall Study|Withdrawal by Subject|7
4681218|NCT02565706|16113415|P1|Overall Study|Withdrawal by Subject|5
4681219|NCT02565615|16113521|P5|Overall Study|Untreated|567
4681220|NCT02565615|16113522|P4|Overall Study|Untreated|0
4681221|NCT02565615|16113523|P3|Overall Study|Untreated|0
4681222|NCT02565615|16113524|P2|Overall Study|Untreated|0
4681223|NCT02565615|16113525|P1|Overall Study|Untreated|0
4681224|NCT02565615|16113521|P5|Overall Study|Adverse Event|9
4681225|NCT02565615|16113522|P4|Overall Study|Adverse Event|0
4681226|NCT02565615|16113523|P3|Overall Study|Adverse Event|0
4681227|NCT02565615|16113524|P2|Overall Study|Adverse Event|1
4681228|NCT02565615|16113525|P1|Overall Study|Adverse Event|1
4681229|NCT02565615|16113521|P5|Overall Study|Reason not defined|62
4681230|NCT02565615|16113522|P4|Overall Study|Reason not defined|1
4681231|NCT02565615|16113523|P3|Overall Study|Reason not defined|0
4681232|NCT02565615|16113524|P2|Overall Study|Reason not defined|2
4681233|NCT02565615|16113525|P1|Overall Study|Reason not defined|0
4681234|NCT02565615|16113521|P5|Overall Study|Not meeting eligibility criteria|25
4681235|NCT02565615|16113522|P4|Overall Study|Not meeting eligibility criteria|0
4681236|NCT02565615|16113523|P3|Overall Study|Not meeting eligibility criteria|0
4681237|NCT02565615|16113524|P2|Overall Study|Not meeting eligibility criteria|7
4681238|NCT02565615|16113525|P1|Overall Study|Not meeting eligibility criteria|0
4681239|NCT02565615|16113521|P5|Overall Study|Lost to Follow-up|765
4681240|NCT02565615|16113522|P4|Overall Study|Lost to Follow-up|1
4681241|NCT02565615|16113523|P3|Overall Study|Lost to Follow-up|0
4681242|NCT02565615|16113524|P2|Overall Study|Lost to Follow-up|4
4681243|NCT02565615|16113525|P1|Overall Study|Lost to Follow-up|0
4681244|NCT02565615|16113521|P5|Overall Study|Not willing to participate in study|169
4681245|NCT02565615|16113522|P4|Overall Study|Not willing to participate in study|1
4681246|NCT02565615|16113523|P3|Overall Study|Not willing to participate in study|0
4681247|NCT02565615|16113524|P2|Overall Study|Not willing to participate in study|21
4681248|NCT02565615|16113525|P1|Overall Study|Not willing to participate in study|2
4681249|NCT02565615|16113521|P5|Overall Study|Death|4
4681250|NCT02565615|16113522|P4|Overall Study|Death|0
4681251|NCT02565615|16113523|P3|Overall Study|Death|0
4681252|NCT02565615|16113524|P2|Overall Study|Death|1
4681253|NCT02565615|16113525|P1|Overall Study|Death|0
4681254|NCT02565576|16113639|P2|Overall Study|Adverse Event|0
4681255|NCT02565576|16113640|P1|Overall Study|Adverse Event|1
4681256|NCT02565576|16113639|P2|Overall Study|Death|2
4681257|NCT02565576|16113640|P1|Overall Study|Death|0
4681258|NCT02565576|16113639|P2|Overall Study|Lost to Follow-up|0
4681259|NCT02565576|16113640|P1|Overall Study|Lost to Follow-up|1
4681260|NCT02565576|16113639|P2|Overall Study|subject / guardian decision|3
4681261|NCT02565576|16113640|P1|Overall Study|subject / guardian decision|1
4681262|NCT02565576|16113639|P2|Overall Study|abnormal lab value|0
4681263|NCT02565576|16113640|P1|Overall Study|abnormal lab value|2
4681264|NCT02565381|16113683|P3|Overall Study|Lost to Follow-up|1
4681265|NCT02565381|16113684|P2|Overall Study|Lost to Follow-up|0
4681266|NCT02565381|16113685|P1|Overall Study|Lost to Follow-up|1
4681267|NCT02565186|16113725|P2|Overall Study|Did Not Receive Study Drug|86
4681268|NCT02565186|16113726|P1|Overall Study|Did Not Receive Study Drug|55
4681269|NCT02565186|16113725|P2|Overall Study|Missing|0
4681270|NCT02565186|16113726|P1|Overall Study|Missing|1
4681271|NCT02565186|16113725|P2|Overall Study|Sponsor Request|9
4681272|NCT02565186|16113726|P1|Overall Study|Sponsor Request|5
4681273|NCT02565186|16113725|P2|Overall Study|Physician Decision|16
4681274|NCT02565186|16113726|P1|Overall Study|Physician Decision|18
4681275|NCT02565186|16113725|P2|Overall Study|Withdrawal by Subject|214
4681276|NCT02565186|16113726|P1|Overall Study|Withdrawal by Subject|229
4681277|NCT02565186|16113725|P2|Overall Study|Non-Compliance|55
4681278|NCT02565186|16113726|P1|Overall Study|Non-Compliance|57
4681279|NCT02565186|16113725|P2|Overall Study|Lost to Follow-up|93
4681280|NCT02565186|16113726|P1|Overall Study|Lost to Follow-up|102
4681281|NCT02565186|16113725|P2|Overall Study|Adverse Event|148
4681282|NCT02565186|16113726|P1|Overall Study|Adverse Event|113
4681283|NCT02565147|16113740|P2|Overall Study|Death|1
4681284|NCT02565147|16113741|P1|Overall Study|Death|1
4681285|NCT02565147|16113740|P2|Overall Study|Lost to Follow-up|1
4681286|NCT02565147|16113741|P1|Overall Study|Lost to Follow-up|0
4681287|NCT02565147|16113740|P2|Overall Study|Withdrawal by Subject|1
4681288|NCT02565147|16113741|P1|Overall Study|Withdrawal by Subject|5
4681289|NCT02565108|16113765|P2|Overall Study|Withdrew Consent|0
4681290|NCT02565108|16113766|P1|Overall Study|Withdrew Consent|1
4681291|NCT02565108|16113765|P2|Overall Study|Adverse Event|0
4681292|NCT02565108|16113766|P1|Overall Study|Adverse Event|1
4681293|NCT02564952|16113782|P1|Overall Study|Participant Met Withdrawal Criteria|1
4681294|NCT02564952|16113782|P1|Overall Study|Low Efficacy|1
4681295|NCT02564952|16113782|P1|Overall Study|Withdrawal by Subject|1
4681296|NCT02564952|16113782|P1|Overall Study|Participant Withdrawn by Investigator|1
4681297|NCT02564952|16113782|P1|Overall Study|Lost to Follow-up|1
4681298|NCT02564952|16113782|P1|Overall Study|Adverse Event|6
4681299|NCT02564887|16113827|P2|Overall Study|Lost to Follow-up|0
4681300|NCT02564887|16113828|P1|Overall Study|Lost to Follow-up|6
4681301|NCT02564718|16113846|P2|Overall Study|Withdrew from treatment|1
4681302|NCT02564718|16113847|P1|Overall Study|Withdrew from treatment|0
4681303|NCT02564263|16113935|P2|Overall Study|Ongoing in Study|25
4681304|NCT02564263|16113936|P1|Overall Study|Ongoing in Study|42
4681305|NCT02564263|16113935|P2|Overall Study|Withdrawal by Subject|18
4681306|NCT02564263|16113936|P1|Overall Study|Withdrawal by Subject|5
4681307|NCT02564263|16113935|P2|Overall Study|Death|242
4681308|NCT02564263|16113936|P1|Overall Study|Death|236
4681309|NCT02564263|16113935|P2|Overall Study|Adverse Event|29
4681310|NCT02564263|16113936|P1|Overall Study|Adverse Event|31
4681311|NCT02564211|16113958|P1|Overall Study|Adverse Event|4
4681312|NCT02564120|16113969|P1|Overall Study|Other medical condition|24
4681313|NCT02564120|16113969|P1|Overall Study|Withdrawal by Subject|204
4681314|NCT02564120|16113969|P1|Overall Study|Death|58
4681315|NCT02564120|16113969|P1|Overall Study|Did not return release forms|160
4681316|NCT02564055|16114017|P6|Overall Study|Withdrawal by Subject|10
4681317|NCT02564055|16114018|P5|Overall Study|Withdrawal by Subject|10
4681318|NCT02564055|16114019|P4|Overall Study|Withdrawal by Subject|3
4681319|NCT02564055|16114020|P3|Overall Study|Withdrawal by Subject|3
4681320|NCT02564055|16114021|P2|Overall Study|Withdrawal by Subject|4
4681321|NCT02564055|16114022|P1|Overall Study|Withdrawal by Subject|4
4681322|NCT02564055|16114017|P6|Overall Study|Physician Decision|0
4681323|NCT02564055|16114018|P5|Overall Study|Physician Decision|0
4681324|NCT02564055|16114019|P4|Overall Study|Physician Decision|0
4681325|NCT02564055|16114020|P3|Overall Study|Physician Decision|1
4681326|NCT02564055|16114021|P2|Overall Study|Physician Decision|0
4681327|NCT02564055|16114022|P1|Overall Study|Physician Decision|0
4681328|NCT02564055|16114017|P6|Overall Study|Lost to Follow-up|0
4681329|NCT02564055|16114018|P5|Overall Study|Lost to Follow-up|1
4681330|NCT02564055|16114019|P4|Overall Study|Lost to Follow-up|2
4681331|NCT02564055|16114020|P3|Overall Study|Lost to Follow-up|4
4681332|NCT02564055|16114021|P2|Overall Study|Lost to Follow-up|1
4681333|NCT02564055|16114022|P1|Overall Study|Lost to Follow-up|0
4681334|NCT02564055|16114017|P6|Overall Study|Reached stopping criteria|1
4681335|NCT02564055|16114018|P5|Overall Study|Reached stopping criteria|0
4681336|NCT02564055|16114019|P4|Overall Study|Reached stopping criteria|0
4681337|NCT02564055|16114020|P3|Overall Study|Reached stopping criteria|0
4681338|NCT02564055|16114021|P2|Overall Study|Reached stopping criteria|0
4681339|NCT02564055|16114022|P1|Overall Study|Reached stopping criteria|0
4681340|NCT02564055|16114017|P6|Overall Study|Protocol Violation|0
4681341|NCT02564055|16114018|P5|Overall Study|Protocol Violation|0
4681342|NCT02564055|16114019|P4|Overall Study|Protocol Violation|0
4681343|NCT02564055|16114020|P3|Overall Study|Protocol Violation|0
4681344|NCT02564055|16114021|P2|Overall Study|Protocol Violation|0
4681345|NCT02564055|16114022|P1|Overall Study|Protocol Violation|1
4681346|NCT02564055|16114017|P6|Overall Study|Adverse Event|1
4681347|NCT02564055|16114018|P5|Overall Study|Adverse Event|4
4681348|NCT02564055|16114019|P4|Overall Study|Adverse Event|1
4681349|NCT02564055|16114020|P3|Overall Study|Adverse Event|4
4681350|NCT02564055|16114021|P2|Overall Study|Adverse Event|0
4681351|NCT02564055|16114022|P1|Overall Study|Adverse Event|1
4681352|NCT02564042|16114276|P6|Overall Study|Withdrawal by Subject|12
4681353|NCT02564042|16114277|P5|Overall Study|Withdrawal by Subject|10
4681354|NCT02564042|16114278|P4|Overall Study|Withdrawal by Subject|2
4681355|NCT02564042|16114279|P3|Overall Study|Withdrawal by Subject|2
4681356|NCT02564042|16114280|P2|Overall Study|Withdrawal by Subject|3
4681357|NCT02564042|16114281|P1|Overall Study|Withdrawal by Subject|5
4681358|NCT02564042|16114276|P6|Overall Study|Physician Decision|0
4681359|NCT02564042|16114277|P5|Overall Study|Physician Decision|0
4681360|NCT02564042|16114278|P4|Overall Study|Physician Decision|1
4681361|NCT02564042|16114279|P3|Overall Study|Physician Decision|0
4681362|NCT02564042|16114280|P2|Overall Study|Physician Decision|0
4681363|NCT02564042|16114281|P1|Overall Study|Physician Decision|1
4681364|NCT02564042|16114276|P6|Overall Study|Lost to Follow-up|1
4681365|NCT02564042|16114277|P5|Overall Study|Lost to Follow-up|1
4681366|NCT02564042|16114278|P4|Overall Study|Lost to Follow-up|0
4681367|NCT02564042|16114279|P3|Overall Study|Lost to Follow-up|1
4681368|NCT02564042|16114280|P2|Overall Study|Lost to Follow-up|1
4681369|NCT02564042|16114281|P1|Overall Study|Lost to Follow-up|1
4681370|NCT02564042|16114276|P6|Overall Study|Adverse Event|1
4681371|NCT02564042|16114277|P5|Overall Study|Adverse Event|0
4681372|NCT02564042|16114278|P4|Overall Study|Adverse Event|0
4681373|NCT02564042|16114279|P3|Overall Study|Adverse Event|3
4681374|NCT02564042|16114280|P2|Overall Study|Adverse Event|4
4681375|NCT02564042|16114281|P1|Overall Study|Adverse Event|4
4681376|NCT02563899|16114576|P4|Overall Study|Withdrawal by Subject|0
4681377|NCT02563899|16114577|P3|Overall Study|Withdrawal by Subject|1
4681378|NCT02563899|16114578|P2|Overall Study|Withdrawal by Subject|0
4681379|NCT02563899|16114579|P1|Overall Study|Withdrawal by Subject|0
4681380|NCT02563899|16114576|P4|Overall Study|Protocol Violation|0
4681381|NCT02563899|16114577|P3|Overall Study|Protocol Violation|0
4681382|NCT02563899|16114578|P2|Overall Study|Protocol Violation|0
4681383|NCT02563899|16114579|P1|Overall Study|Protocol Violation|1
4681384|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4681385|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1
4681386|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4681387|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4681388|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4681389|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0
4681390|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1
4681391|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4681392|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4681393|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4681394|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4681395|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0
4681396|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2
4681397|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4681398|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4681399|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4681400|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4681401|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0
4681402|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2
4681403|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4681404|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4681405|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4681406|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4681407|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0
4681408|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1
4681409|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2
4681410|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4681411|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4681412|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4681413|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0
4681414|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4681415|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6
4681416|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4681417|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4681418|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4681419|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0
4681420|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3
4681421|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15
4681422|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4681423|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4681424|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4681425|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0
4681426|NCT02563548|16114655|P6|Dose Expansion (Up to 60 Weeks)|Adverse Event|8
4681427|NCT02563548|16114656|P5|Dose Expansion (Up to 60 Weeks)|Adverse Event|1
4681428|NCT02563548|16114657|P4|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4681429|NCT02563548|16114658|P3|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4681430|NCT02563548|16114659|P2|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4681431|NCT02563548|16114660|P1|Dose Expansion (Up to 60 Weeks)|Adverse Event|0
4681432|NCT02563548|16114655|P6|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4681433|NCT02563548|16114656|P5|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4681434|NCT02563548|16114657|P4|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1
4681435|NCT02563548|16114658|P3|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2
4681436|NCT02563548|16114659|P2|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4681437|NCT02563548|16114660|P1|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0
4681438|NCT02563548|16114655|P6|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4681439|NCT02563548|16114656|P5|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4681440|NCT02563548|16114657|P4|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4681441|NCT02563548|16114658|P3|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3
4681442|NCT02563548|16114659|P2|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4681443|NCT02563548|16114660|P1|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0
4681444|NCT02563548|16114655|P6|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
4681445|NCT02563548|16114656|P5|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
4681446|NCT02563548|16114657|P4|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0
4681447|NCT02563548|16114658|P3|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
4681448|NCT02563548|16114659|P2|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2
4681449|NCT02563548|16114660|P1|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1
4681450|NCT02563548|16114655|P6|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4681451|NCT02563548|16114656|P5|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4681452|NCT02563548|16114657|P4|Dose Escalation (Up to 46 Weeks)|Adverse Event|1
4681453|NCT02563548|16114658|P3|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4681454|NCT02563548|16114659|P2|Dose Escalation (Up to 46 Weeks)|Adverse Event|0
4681455|NCT02563548|16114660|P1|Dose Escalation (Up to 46 Weeks)|Adverse Event|2
4681456|NCT02563106|16114724|P2|Overall Study|Other reason - not specified|1
4681457|NCT02563106|16114725|P1|Overall Study|Other reason - not specified|2
4681458|NCT02563106|16114724|P2|Overall Study|Physician Decision|1
4681459|NCT02563106|16114725|P1|Overall Study|Physician Decision|3
4681460|NCT02563106|16114724|P2|Overall Study|Lost to Follow-up|2
4681461|NCT02563106|16114725|P1|Overall Study|Lost to Follow-up|3
4681462|NCT02563106|16114724|P2|Overall Study|Use of non-permitted concurrent therapy|2
4681463|NCT02563106|16114725|P1|Overall Study|Use of non-permitted concurrent therapy|1
4681464|NCT02563106|16114724|P2|Overall Study|Protocol Violation|0
4681465|NCT02563106|16114725|P1|Overall Study|Protocol Violation|1
4681466|NCT02563106|16114724|P2|Overall Study|Adverse Event|15
4681467|NCT02563106|16114725|P1|Overall Study|Adverse Event|17
4681468|NCT02563106|16114724|P2|Overall Study|Withdrawal by Subject|8
4681469|NCT02563106|16114725|P1|Overall Study|Withdrawal by Subject|7
4681470|NCT02563028|16114764|P1|Overall Study|Unable to elicit VEP post induction|1
4681471|NCT02563028|16114764|P1|Overall Study|Lack of equipment|1
4681472|NCT02562482|16114853|P2|Overall Study|Illness/Injury unrelated to product|1
4681473|NCT02562482|16114854|P1|Overall Study|Illness/Injury unrelated to product|0
4681474|NCT02562482|16114853|P2|Overall Study|Physician Decision|3
4681475|NCT02562482|16114854|P1|Overall Study|Physician Decision|1
4681476|NCT02562482|16114853|P2|Overall Study|Withdrawal by Subject|3
4681477|NCT02562482|16114854|P1|Overall Study|Withdrawal by Subject|5
4681478|NCT02562482|16114853|P2|Overall Study|Moved from area|3
4681479|NCT02562482|16114854|P1|Overall Study|Moved from area|2
4681480|NCT02562482|16114853|P2|Overall Study|Lost to Follow-up|6
4681481|NCT02562482|16114854|P1|Overall Study|Lost to Follow-up|9
4681482|NCT02562482|16114853|P2|Overall Study|Enrolled, but did not receive product|0
4681483|NCT02562482|16114854|P1|Overall Study|Enrolled, but did not receive product|4
4681484|NCT02561832|16114889|P2|Overall Study|Disease progression|3
4681485|NCT02561832|16114890|P1|Overall Study|Disease progression|3
4681486|NCT02561832|16114889|P2|Overall Study|Adverse Event|0
4681487|NCT02561832|16114890|P1|Overall Study|Adverse Event|3
4681488|NCT02561832|16114889|P2|Overall Study|Withdrawal by Subject|1
4681489|NCT02561832|16114890|P1|Overall Study|Withdrawal by Subject|1
4681490|NCT02561806|16114898|P2|Post-Treatment Follow-up|Withdrawal by Subject|0
4681491|NCT02561806|16114899|P1|Post-Treatment Follow-up|Withdrawal by Subject|1
4681492|NCT02561806|16114898|P2|Post-Treatment Follow-up|Lost to Follow-up|1
4681493|NCT02561806|16114899|P1|Post-Treatment Follow-up|Lost to Follow-up|1
4681494|NCT02561806|16114898|P2|Maintenance Period|Site staff became unblinded|1
4681495|NCT02561806|16114899|P1|Maintenance Period|Site staff became unblinded|0
4681496|NCT02561806|16114898|P2|Maintenance Period|Withdrawal by Subject|3
4681497|NCT02561806|16114899|P1|Maintenance Period|Withdrawal by Subject|5
4681498|NCT02561806|16114898|P2|Maintenance Period|Protocol Violation|0
4681499|NCT02561806|16114899|P1|Maintenance Period|Protocol Violation|1
4681500|NCT02561806|16114898|P2|Maintenance Period|Lost to Follow-up|2
4681501|NCT02561806|16114899|P1|Maintenance Period|Lost to Follow-up|2
4681502|NCT02561806|16114898|P2|Maintenance Period|Lack of Efficacy|1
4681503|NCT02561806|16114899|P1|Maintenance Period|Lack of Efficacy|3
4681504|NCT02561806|16114898|P2|Maintenance Period|Adverse Event|1
4681505|NCT02561806|16114899|P1|Maintenance Period|Adverse Event|2
4681506|NCT02561806|16114898|P2|Induction Period|Randomized but not treated|1
4681507|NCT02561806|16114899|P1|Induction Period|Randomized but not treated|0
4681508|NCT02561806|16114898|P2|Induction Period|Site staff became unblinded|0
4681509|NCT02561806|16114899|P1|Induction Period|Site staff became unblinded|1
4681510|NCT02561806|16114898|P2|Induction Period|Withdrawal by Subject|2
4681511|NCT02561806|16114899|P1|Induction Period|Withdrawal by Subject|0
4681512|NCT02561806|16114898|P2|Induction Period|Lack of Efficacy|0
4681513|NCT02561806|16114899|P1|Induction Period|Lack of Efficacy|1
4681514|NCT02561806|16114898|P2|Induction Period|Adverse Event|2
4681515|NCT02561806|16114899|P1|Induction Period|Adverse Event|0
4681516|NCT02561572|16115003|P2|Overall Study|Protocol Violation|1
4681517|NCT02561572|16115004|P1|Overall Study|Protocol Violation|0
4681518|NCT02561572|16115003|P2|Overall Study|Inadequate time before surgery|1
4681519|NCT02561572|16115004|P1|Overall Study|Inadequate time before surgery|2
4681520|NCT02561195|16115062|P6|Overall Study|Randomized but not treated|0
4681521|NCT02561195|16115063|P5|Overall Study|Randomized but not treated|0
4681522|NCT02561195|16115064|P4|Overall Study|Randomized but not treated|0
4681523|NCT02561195|16115065|P3|Overall Study|Randomized but not treated|0
4681524|NCT02561195|16115066|P2|Overall Study|Randomized but not treated|0
4681525|NCT02561195|16115067|P1|Overall Study|Randomized but not treated|1
4681526|NCT02561195|16115062|P6|Overall Study|Withdrawal by Subject|0
4681527|NCT02561195|16115063|P5|Overall Study|Withdrawal by Subject|6
4681528|NCT02561195|16115064|P4|Overall Study|Withdrawal by Subject|2
4681529|NCT02561195|16115065|P3|Overall Study|Withdrawal by Subject|4
4681530|NCT02561195|16115066|P2|Overall Study|Withdrawal by Subject|4
4681531|NCT02561195|16115067|P1|Overall Study|Withdrawal by Subject|3
4681532|NCT02561195|16115062|P6|Overall Study|Death|0
4681533|NCT02561195|16115063|P5|Overall Study|Death|0
4681534|NCT02561195|16115064|P4|Overall Study|Death|2
4681535|NCT02561195|16115065|P3|Overall Study|Death|0
4681536|NCT02561195|16115066|P2|Overall Study|Death|1
4681537|NCT02561195|16115067|P1|Overall Study|Death|2
4681538|NCT02561195|16115062|P6|Overall Study|Protocol Violation|2
4681539|NCT02561195|16115063|P5|Overall Study|Protocol Violation|5
4681540|NCT02561195|16115064|P4|Overall Study|Protocol Violation|2
4681541|NCT02561195|16115065|P3|Overall Study|Protocol Violation|1
4681542|NCT02561195|16115066|P2|Overall Study|Protocol Violation|0
4681543|NCT02561195|16115067|P1|Overall Study|Protocol Violation|1
4681544|NCT02561195|16115062|P6|Overall Study|Other|1
4681545|NCT02561195|16115063|P5|Overall Study|Other|5
4681546|NCT02561195|16115064|P4|Overall Study|Other|7
4681547|NCT02561195|16115065|P3|Overall Study|Other|1
4681548|NCT02561195|16115066|P2|Overall Study|Other|3
4681549|NCT02561195|16115067|P1|Overall Study|Other|7
4681550|NCT02561195|16115062|P6|Overall Study|No longer willing to participate|3
4681551|NCT02561195|16115063|P5|Overall Study|No longer willing to participate|1
4681552|NCT02561195|16115064|P4|Overall Study|No longer willing to participate|4
4681553|NCT02561195|16115065|P3|Overall Study|No longer willing to participate|0
4681554|NCT02561195|16115066|P2|Overall Study|No longer willing to participate|4
4681555|NCT02561195|16115067|P1|Overall Study|No longer willing to participate|2
4681556|NCT02561195|16115062|P6|Overall Study|No longer meets eligibility criteria|1
4681557|NCT02561195|16115063|P5|Overall Study|No longer meets eligibility criteria|4
4681558|NCT02561195|16115064|P4|Overall Study|No longer meets eligibility criteria|4
4681559|NCT02561195|16115065|P3|Overall Study|No longer meets eligibility criteria|0
4681560|NCT02561195|16115066|P2|Overall Study|No longer meets eligibility criteria|1
4681561|NCT02561195|16115067|P1|Overall Study|No longer meets eligibility criteria|0
4681562|NCT02561195|16115062|P6|Overall Study|Lost to Follow-up|3
4681563|NCT02561195|16115063|P5|Overall Study|Lost to Follow-up|3
4681564|NCT02561195|16115064|P4|Overall Study|Lost to Follow-up|2
4681565|NCT02561195|16115065|P3|Overall Study|Lost to Follow-up|0
4681566|NCT02561195|16115066|P2|Overall Study|Lost to Follow-up|4
4681567|NCT02561195|16115067|P1|Overall Study|Lost to Follow-up|3
4681568|NCT02561195|16115062|P6|Overall Study|Adverse Event|0
4681569|NCT02561195|16115063|P5|Overall Study|Adverse Event|4
4681570|NCT02561195|16115064|P4|Overall Study|Adverse Event|3
4681571|NCT02561195|16115065|P3|Overall Study|Adverse Event|0
4681572|NCT02561195|16115066|P2|Overall Study|Adverse Event|5
4681573|NCT02561195|16115067|P1|Overall Study|Adverse Event|4
4681574|NCT02561156|16115228|P13|Part 2|Adverse Event|0
4681575|NCT02561156|16115229|P12|Part 2|Adverse Event|1
4681576|NCT02561156|16115230|P11|Part 2|Adverse Event|0
4681577|NCT02561156|16115231|P10|Part 2|Adverse Event|0
4681578|NCT02561156|16115232|P9|Part 2|Adverse Event|0
4681579|NCT02561156|16115233|P8|Part 2|Adverse Event|0
4681580|NCT02561156|16115234|P7|Part 2|Adverse Event|0
4681581|NCT02561156|16115235|P6|Part 2|Adverse Event|0
4681582|NCT02561156|16115236|P5|Part 2|Adverse Event|0
4681583|NCT02561156|16115237|P4|Part 2|Adverse Event|0
4681584|NCT02561156|16115238|P3|Part 2|Adverse Event|0
4681585|NCT02561156|16115239|P2|Part 2|Adverse Event|0
4681586|NCT02561156|16115240|P1|Part 2|Adverse Event|0
4681587|NCT02561078|16115412|P2|Overall Study|Withdrawal by Subject|10
4681588|NCT02561078|16115413|P1|Overall Study|Withdrawal by Subject|13
4681589|NCT02561078|16115412|P2|Overall Study|Physician Decision|3
4681590|NCT02561078|16115413|P1|Overall Study|Physician Decision|2
4681591|NCT02561078|16115412|P2|Overall Study|Non-Compliance with Study Drug|3
4681592|NCT02561078|16115413|P1|Overall Study|Non-Compliance with Study Drug|6
4681593|NCT02561078|16115412|P2|Overall Study|Lost to Follow-up|6
4681594|NCT02561078|16115413|P1|Overall Study|Lost to Follow-up|2
4681595|NCT02561078|16115412|P2|Overall Study|Death|1
4681596|NCT02561078|16115413|P1|Overall Study|Death|2
4681597|NCT02561078|16115412|P2|Overall Study|Adverse Event|2
4681598|NCT02561078|16115413|P1|Overall Study|Adverse Event|5
4681599|NCT02560558|16115538|P2|Overall Study|Withdrawal by Subject|0
4681600|NCT02560558|16115539|P1|Overall Study|Withdrawal by Subject|3
4681601|NCT02560558|16115538|P2|Overall Study|Protocol Violation|0
4681602|NCT02560558|16115539|P1|Overall Study|Protocol Violation|3
4681603|NCT02560558|16115538|P2|Overall Study|Lost to Follow-up|4
4681604|NCT02560558|16115539|P1|Overall Study|Lost to Follow-up|0
4681605|NCT02560558|16115538|P2|Overall Study|Death|2
4681606|NCT02560558|16115539|P1|Overall Study|Death|0
4681607|NCT02560558|16115538|P2|Overall Study|Adverse Event|0
4681608|NCT02560558|16115539|P1|Overall Study|Adverse Event|1
4681609|NCT02560389|16115591|P3|Overall Study|Tested positive for illicit substance|0
4681610|NCT02560389|16115592|P2|Overall Study|Tested positive for illicit substance|1
4681611|NCT02560389|16115593|P1|Overall Study|Tested positive for illicit substance|0
4681612|NCT02560389|16115591|P3|Overall Study|Lost to Follow-up|2
4681613|NCT02560389|16115592|P2|Overall Study|Lost to Follow-up|2
4681614|NCT02560389|16115593|P1|Overall Study|Lost to Follow-up|1
4681615|NCT02560025|16115691|P1|Overall Study|Ineligible after consent/ registration|3
4681616|NCT02560012|16115700|P1|Overall Study|Study Terminated|2
4681617|NCT02559895|16115708|P4|Overall Study|Other|3
4681618|NCT02559895|16115709|P3|Overall Study|Other|3
4681619|NCT02559895|16115710|P2|Overall Study|Other|5
4681620|NCT02559895|16115711|P1|Overall Study|Other|1
4681621|NCT02559895|16115708|P4|Overall Study|Study Burden|22
4681622|NCT02559895|16115709|P3|Overall Study|Study Burden|12
4681623|NCT02559895|16115710|P2|Overall Study|Study Burden|16
4681624|NCT02559895|16115711|P1|Overall Study|Study Burden|10
4681625|NCT02559895|16115708|P4|Overall Study|Withdrawal by Subject|9
4681626|NCT02559895|16115709|P3|Overall Study|Withdrawal by Subject|20
4681627|NCT02559895|16115710|P2|Overall Study|Withdrawal by Subject|9
4681628|NCT02559895|16115711|P1|Overall Study|Withdrawal by Subject|16
4681629|NCT02559895|16115708|P4|Overall Study|Physician Decision|0
4681630|NCT02559895|16115709|P3|Overall Study|Physician Decision|3
4681631|NCT02559895|16115710|P2|Overall Study|Physician Decision|1
4681632|NCT02559895|16115711|P1|Overall Study|Physician Decision|1
4681633|NCT02559895|16115708|P4|Overall Study|Lost to Follow-up|17
4681634|NCT02559895|16115709|P3|Overall Study|Lost to Follow-up|12
4681635|NCT02559895|16115710|P2|Overall Study|Lost to Follow-up|16
4681636|NCT02559895|16115711|P1|Overall Study|Lost to Follow-up|22
4681637|NCT02559895|16115708|P4|Overall Study|Lack of Efficacy|8
4681638|NCT02559895|16115709|P3|Overall Study|Lack of Efficacy|2
4681639|NCT02559895|16115710|P2|Overall Study|Lack of Efficacy|3
4681640|NCT02559895|16115711|P1|Overall Study|Lack of Efficacy|2
4681641|NCT02559895|16115708|P4|Overall Study|Adverse Event|1
4681642|NCT02559895|16115709|P3|Overall Study|Adverse Event|2
4681643|NCT02559895|16115710|P2|Overall Study|Adverse Event|3
4681644|NCT02559895|16115711|P1|Overall Study|Adverse Event|3
4681645|NCT02559713|16115801|P1|Overall Study|Pretreatment Event/ Adverse Event|1
4681646|NCT02559687|16115811|P1|Overall Study|Ongoing Follow-Up|14
4681647|NCT02559687|16115811|P1|Overall Study|Withdrawal by Subject|4
4681648|NCT02559687|16115811|P1|Overall Study|Death|103
4681649|NCT02559622|16115824|P4|Overall Study|Patient/guardian decision|1
4681650|NCT02559622|16115825|P3|Overall Study|Patient/guardian decision|0
4681651|NCT02559622|16115826|P2|Overall Study|Patient/guardian decision|2
4681652|NCT02559622|16115827|P1|Overall Study|Patient/guardian decision|1
4681653|NCT02559622|16115824|P4|Overall Study|Adverse Event|2
4681654|NCT02559622|16115825|P3|Overall Study|Adverse Event|2
4681655|NCT02559622|16115826|P2|Overall Study|Adverse Event|2
4681656|NCT02559622|16115827|P1|Overall Study|Adverse Event|0
4681657|NCT02559622|16115824|P4|Overall Study|Progressive disease|0
4681658|NCT02559622|16115825|P3|Overall Study|Progressive disease|0
4681659|NCT02559622|16115826|P2|Overall Study|Progressive disease|1
4681660|NCT02559622|16115827|P1|Overall Study|Progressive disease|0
4681661|NCT02559570|16115911|P5|Overall Study|Other Miscellaneous Reasons|0
4681662|NCT02559570|16115912|P4|Overall Study|Other Miscellaneous Reasons|0
4681663|NCT02559570|16115913|P3|Overall Study|Other Miscellaneous Reasons|1
4681664|NCT02559570|16115914|P2|Overall Study|Other Miscellaneous Reasons|0
4681665|NCT02559570|16115915|P1|Overall Study|Other Miscellaneous Reasons|0
4681666|NCT02559570|16115911|P5|Overall Study|Protocol Violation|1
4681667|NCT02559570|16115912|P4|Overall Study|Protocol Violation|0
4681668|NCT02559570|16115913|P3|Overall Study|Protocol Violation|0
4681669|NCT02559570|16115914|P2|Overall Study|Protocol Violation|0
4681670|NCT02559570|16115915|P1|Overall Study|Protocol Violation|1
4681671|NCT02559570|16115911|P5|Overall Study|Lost to Follow-up|0
4681672|NCT02559570|16115912|P4|Overall Study|Lost to Follow-up|0
4681673|NCT02559570|16115913|P3|Overall Study|Lost to Follow-up|0
4681674|NCT02559570|16115914|P2|Overall Study|Lost to Follow-up|0
4681675|NCT02559570|16115915|P1|Overall Study|Lost to Follow-up|1
4681676|NCT02559570|16115911|P5|Overall Study|Withdrawal of Consent|1
4681677|NCT02559570|16115912|P4|Overall Study|Withdrawal of Consent|2
4681678|NCT02559570|16115913|P3|Overall Study|Withdrawal of Consent|1
4681679|NCT02559570|16115914|P2|Overall Study|Withdrawal of Consent|0
4681680|NCT02559570|16115915|P1|Overall Study|Withdrawal of Consent|0
4681681|NCT02559570|16115911|P5|Overall Study|Adverse Event|0
4681682|NCT02559570|16115912|P4|Overall Study|Adverse Event|1
4681683|NCT02559570|16115913|P3|Overall Study|Adverse Event|0
4681684|NCT02559570|16115914|P2|Overall Study|Adverse Event|2
4681685|NCT02559570|16115915|P1|Overall Study|Adverse Event|0
4681686|NCT02559414|16115953|P3|Overall Study|Other|1
4681687|NCT02559414|16115954|P2|Overall Study|Other|1
4681688|NCT02559414|16115955|P1|Overall Study|Other|0
4681689|NCT02559414|16115953|P3|Overall Study|Withdrawal by Subject|1
4681690|NCT02559414|16115954|P2|Overall Study|Withdrawal by Subject|0
4681691|NCT02559414|16115955|P1|Overall Study|Withdrawal by Subject|1
4681692|NCT02559414|16115953|P3|Overall Study|Lost to Follow-up|0
4681693|NCT02559414|16115954|P2|Overall Study|Lost to Follow-up|1
4681694|NCT02559414|16115955|P1|Overall Study|Lost to Follow-up|0
4681695|NCT02559310|16115995|P2|Overall Study|Randomized but not treated|2
4681696|NCT02559310|16115996|P1|Overall Study|Randomized but not treated|3
4681697|NCT02559310|16115995|P2|Overall Study|Sponsor Decision|1
4681698|NCT02559310|16115996|P1|Overall Study|Sponsor Decision|0
4681699|NCT02559310|16115995|P2|Overall Study|Withdrawal by Subject|9
4681700|NCT02559310|16115996|P1|Overall Study|Withdrawal by Subject|13
4681701|NCT02559310|16115995|P2|Overall Study|Physician Decision|1
4681702|NCT02559310|16115996|P1|Overall Study|Physician Decision|2
4681703|NCT02559310|16115995|P2|Overall Study|Lost to Follow-up|3
4681704|NCT02559310|16115996|P1|Overall Study|Lost to Follow-up|5
4681705|NCT02559310|16115995|P2|Overall Study|Death|3
4681706|NCT02559310|16115996|P1|Overall Study|Death|4
4681707|NCT02559206|16116014|P8|Overall Study|Other Not Specified|0
4681708|NCT02559206|16116015|P7|Overall Study|Other Not Specified|0
4681709|NCT02559206|16116016|P6|Overall Study|Other Not Specified|0
4681710|NCT02559206|16116017|P5|Overall Study|Other Not Specified|0
4681711|NCT02559206|16116018|P4|Overall Study|Other Not Specified|1
4681712|NCT02559206|16116019|P3|Overall Study|Other Not Specified|0
4681713|NCT02559206|16116020|P2|Overall Study|Other Not Specified|0
4681714|NCT02559206|16116021|P1|Overall Study|Other Not Specified|0
4681715|NCT02559206|16116014|P8|Overall Study|Lack of Efficacy|3
4681716|NCT02559206|16116015|P7|Overall Study|Lack of Efficacy|3
4681717|NCT02559206|16116016|P6|Overall Study|Lack of Efficacy|3
4681718|NCT02559206|16116017|P5|Overall Study|Lack of Efficacy|2
4681719|NCT02559206|16116018|P4|Overall Study|Lack of Efficacy|2
4681720|NCT02559206|16116019|P3|Overall Study|Lack of Efficacy|3
4681721|NCT02559206|16116020|P2|Overall Study|Lack of Efficacy|0
4681722|NCT02559206|16116021|P1|Overall Study|Lack of Efficacy|1
4681723|NCT02559206|16116014|P8|Overall Study|Lost to Follow-up|4
4681724|NCT02559206|16116015|P7|Overall Study|Lost to Follow-up|1
4681725|NCT02559206|16116016|P6|Overall Study|Lost to Follow-up|5
4681726|NCT02559206|16116017|P5|Overall Study|Lost to Follow-up|2
4681727|NCT02559206|16116018|P4|Overall Study|Lost to Follow-up|3
4681728|NCT02559206|16116019|P3|Overall Study|Lost to Follow-up|3
4681729|NCT02559206|16116020|P2|Overall Study|Lost to Follow-up|5
4681730|NCT02559206|16116021|P1|Overall Study|Lost to Follow-up|3
4681731|NCT02559206|16116014|P8|Overall Study|Withdrawal by Subject|2
4681732|NCT02559206|16116015|P7|Overall Study|Withdrawal by Subject|1
4681733|NCT02559206|16116016|P6|Overall Study|Withdrawal by Subject|4
4681734|NCT02559206|16116017|P5|Overall Study|Withdrawal by Subject|5
4681735|NCT02559206|16116018|P4|Overall Study|Withdrawal by Subject|3
4681736|NCT02559206|16116019|P3|Overall Study|Withdrawal by Subject|1
4681737|NCT02559206|16116020|P2|Overall Study|Withdrawal by Subject|3
4681738|NCT02559206|16116021|P1|Overall Study|Withdrawal by Subject|3
4681739|NCT02559206|16116014|P8|Overall Study|Protocol Violation|0
4681740|NCT02559206|16116015|P7|Overall Study|Protocol Violation|0
4681741|NCT02559206|16116016|P6|Overall Study|Protocol Violation|2
4681742|NCT02559206|16116017|P5|Overall Study|Protocol Violation|0
4681743|NCT02559206|16116018|P4|Overall Study|Protocol Violation|0
4681744|NCT02559206|16116019|P3|Overall Study|Protocol Violation|1
4681745|NCT02559206|16116020|P2|Overall Study|Protocol Violation|0
4681746|NCT02559206|16116021|P1|Overall Study|Protocol Violation|1
4681747|NCT02559206|16116014|P8|Overall Study|Adverse Event|0
4681748|NCT02559206|16116015|P7|Overall Study|Adverse Event|1
4681749|NCT02559206|16116016|P6|Overall Study|Adverse Event|0
4681750|NCT02559206|16116017|P5|Overall Study|Adverse Event|3
4681751|NCT02559206|16116018|P4|Overall Study|Adverse Event|5
4681752|NCT02559206|16116019|P3|Overall Study|Adverse Event|1
4681753|NCT02559206|16116020|P2|Overall Study|Adverse Event|4
4681754|NCT02559206|16116021|P1|Overall Study|Adverse Event|0
4681755|NCT02558894|16116063|P2|Overall Study|Closure of Part A|1
4681756|NCT02558894|16116064|P1|Overall Study|Closure of Part A|2
4681757|NCT02558894|16116063|P2|Overall Study|Withdrawal by Subject|1
4681758|NCT02558894|16116064|P1|Overall Study|Withdrawal by Subject|2
4681759|NCT02558894|16116063|P2|Overall Study|Death; any cause, entire study duration|31
4681760|NCT02558894|16116064|P1|Overall Study|Death; any cause, entire study duration|28
4681761|NCT02558790|16116125|P1|Overall Study|Screen Fail|3
4681762|NCT02558790|16116125|P1|Overall Study|Withdrawal by Subject|1
4681763|NCT02558790|16116125|P1|Overall Study|Physician Decision|1
4681764|NCT02558790|16116125|P1|Overall Study|Lost to Follow-up|2
4681765|NCT02558400|16116132|P3|Overall Study|Ineligible for the study|0
4681766|NCT02558400|16116133|P2|Overall Study|Ineligible for the study|2
4681767|NCT02558400|16116134|P1|Overall Study|Ineligible for the study|0
4681768|NCT02558400|16116132|P3|Overall Study|Death|0
4681769|NCT02558400|16116133|P2|Overall Study|Death|1
4681770|NCT02558400|16116134|P1|Overall Study|Death|0
4681771|NCT02558400|16116132|P3|Overall Study|Protocol Violation|8
4681772|NCT02558400|16116133|P2|Overall Study|Protocol Violation|3
4681773|NCT02558400|16116134|P1|Overall Study|Protocol Violation|6
4681774|NCT02558400|16116132|P3|Overall Study|Physician Decision|0
4681775|NCT02558400|16116133|P2|Overall Study|Physician Decision|2
4681776|NCT02558400|16116134|P1|Overall Study|Physician Decision|2
4681777|NCT02558400|16116132|P3|Overall Study|Disallowed Concurrent Medication|5
4681778|NCT02558400|16116133|P2|Overall Study|Disallowed Concurrent Medication|7
4681779|NCT02558400|16116134|P1|Overall Study|Disallowed Concurrent Medication|6
4681780|NCT02558400|16116132|P3|Overall Study|Lack of Efficacy|1
4681781|NCT02558400|16116133|P2|Overall Study|Lack of Efficacy|13
4681782|NCT02558400|16116134|P1|Overall Study|Lack of Efficacy|0
4681783|NCT02558400|16116132|P3|Overall Study|Lost to Follow-up|4
4681784|NCT02558400|16116133|P2|Overall Study|Lost to Follow-up|5
4681785|NCT02558400|16116134|P1|Overall Study|Lost to Follow-up|5
4681786|NCT02558400|16116132|P3|Overall Study|Non-Compliant|3
4681787|NCT02558400|16116133|P2|Overall Study|Non-Compliant|1
4681788|NCT02558400|16116134|P1|Overall Study|Non-Compliant|0
4681789|NCT02558400|16116132|P3|Overall Study|Withdrawal by Subject|8
4681790|NCT02558400|16116133|P2|Overall Study|Withdrawal by Subject|9
4681791|NCT02558400|16116134|P1|Overall Study|Withdrawal by Subject|13
4681792|NCT02558400|16116132|P3|Overall Study|Adverse Event|4
4681793|NCT02558400|16116133|P2|Overall Study|Adverse Event|53
4681794|NCT02558400|16116134|P1|Overall Study|Adverse Event|47
4681795|NCT02558231|16116158|P2|Overall Study|Ongoing|104
4681796|NCT02558231|16116159|P1|Overall Study|Ongoing|109
4681797|NCT02558231|16116158|P2|Overall Study|Sponsor Decision|1
4681798|NCT02558231|16116159|P1|Overall Study|Sponsor Decision|0
4681799|NCT02558231|16116158|P2|Overall Study|Physician Decision|5
4681800|NCT02558231|16116159|P1|Overall Study|Physician Decision|6
4681801|NCT02558231|16116158|P2|Overall Study|Withdrawal by Subject|3
4681802|NCT02558231|16116159|P1|Overall Study|Withdrawal by Subject|4
4681803|NCT02558231|16116158|P2|Overall Study|Lost to Follow-up|2
4681804|NCT02558231|16116159|P1|Overall Study|Lost to Follow-up|2
4681805|NCT02558231|16116158|P2|Overall Study|Death|9
4681806|NCT02558231|16116159|P1|Overall Study|Death|2
4681807|NCT02557646|16116250|P1|Overall Study|Other|14
4681808|NCT02557646|16116250|P1|Overall Study|Lost to Follow-up|17
4681809|NCT02557646|16116250|P1|Overall Study|Withdrawal by Subject|18
4681810|NCT02557646|16116250|P1|Overall Study|Lack of Efficacy|186
4681811|NCT02557646|16116250|P1|Overall Study|Death|1
4681812|NCT02557646|16116250|P1|Overall Study|Adverse Event|40
4681813|NCT02557516|16116277|P4|Overall Study|Sponsor decision|8
4681814|NCT02557516|16116278|P3|Overall Study|Sponsor decision|2
4681815|NCT02557516|16116279|P2|Overall Study|Sponsor decision|1
4681816|NCT02557516|16116280|P1|Overall Study|Sponsor decision|0
4681817|NCT02557516|16116277|P4|Overall Study|Physician Decision|0
4681818|NCT02557516|16116278|P3|Overall Study|Physician Decision|0
4681819|NCT02557516|16116279|P2|Overall Study|Physician Decision|2
4681820|NCT02557516|16116280|P1|Overall Study|Physician Decision|0
4681821|NCT02557516|16116277|P4|Overall Study|Disease progression|0
4681822|NCT02557516|16116278|P3|Overall Study|Disease progression|0
4681823|NCT02557516|16116279|P2|Overall Study|Disease progression|2
4681824|NCT02557516|16116280|P1|Overall Study|Disease progression|0
4681825|NCT02557516|16116277|P4|Overall Study|Adverse Event|1
4681826|NCT02557516|16116278|P3|Overall Study|Adverse Event|2
4681827|NCT02557516|16116279|P2|Overall Study|Adverse Event|0
4681828|NCT02557516|16116280|P1|Overall Study|Adverse Event|1
4681829|NCT02557399|16116301|P2|Overall Study|Withdrawal by Subject|1
4681830|NCT02557399|16116302|P1|Overall Study|Withdrawal by Subject|1
4681831|NCT02557399|16116301|P2|Overall Study|Protocol-defined stopping criteria|1
4681832|NCT02557399|16116302|P1|Overall Study|Protocol-defined stopping criteria|0
4681833|NCT02557399|16116301|P2|Overall Study|Protocol Violation|1
4681834|NCT02557399|16116302|P1|Overall Study|Protocol Violation|0
4681835|NCT02557399|16116301|P2|Overall Study|Adverse Event|5
4681836|NCT02557399|16116302|P1|Overall Study|Adverse Event|6
4681837|NCT02557100|16116337|P3|Cumulative Abatacept Period|Request to Discontinue|1
4681838|NCT02557100|16116338|P2|Cumulative Abatacept Period|Request to Discontinue|0
4681839|NCT02557100|16116339|P1|Cumulative Abatacept Period|Request to Discontinue|0
4681840|NCT02557100|16116337|P3|Cumulative Abatacept Period|Lost to Follow-up|2
4681841|NCT02557100|16116338|P2|Cumulative Abatacept Period|Lost to Follow-up|0
4681842|NCT02557100|16116339|P1|Cumulative Abatacept Period|Lost to Follow-up|0
4681843|NCT02557100|16116337|P3|Cumulative Abatacept Period|Other Reasons|1
4681844|NCT02557100|16116338|P2|Cumulative Abatacept Period|Other Reasons|0
4681845|NCT02557100|16116339|P1|Cumulative Abatacept Period|Other Reasons|0
4681846|NCT02557100|16116337|P3|Transition to Open Label|Entered Cumulative Abatacept Period|0
4681847|NCT02557100|16116338|P2|Transition to Open Label|Entered Cumulative Abatacept Period|36
4681848|NCT02557100|16116339|P1|Transition to Open Label|Entered Cumulative Abatacept Period|40
4681849|NCT02557100|16116337|P3|Single Blind Treatment Period|Adverse Event|0
4681850|NCT02557100|16116338|P2|Single Blind Treatment Period|Adverse Event|1
4681851|NCT02557100|16116339|P1|Single Blind Treatment Period|Adverse Event|0
4681852|NCT02557100|16116337|P3|Single Blind Treatment Period|Request to Discontinue|0
4681853|NCT02557100|16116338|P2|Single Blind Treatment Period|Request to Discontinue|1
4681854|NCT02557100|16116339|P1|Single Blind Treatment Period|Request to Discontinue|0
4681855|NCT02557100|16116337|P3|Single Blind Treatment Period|Death|0
4681856|NCT02557100|16116338|P2|Single Blind Treatment Period|Death|1
4681857|NCT02557100|16116339|P1|Single Blind Treatment Period|Death|0
4681858|NCT02557100|16116337|P3|Single Blind Treatment Period|Lost to Follow-up|0
4681859|NCT02557100|16116338|P2|Single Blind Treatment Period|Lost to Follow-up|1
4681860|NCT02557100|16116339|P1|Single Blind Treatment Period|Lost to Follow-up|0
4681861|NCT02556918|16116392|P2|Overall Study|Withdrawal by Subject|4
4681862|NCT02556918|16116393|P1|Overall Study|Withdrawal by Subject|4
4681863|NCT02556918|16116392|P2|Overall Study|Protocol Violation|6
4681864|NCT02556918|16116393|P1|Overall Study|Protocol Violation|5
4681865|NCT02556801|16116453|P4|Overall Study|Personal reasons patient|1
4681866|NCT02556801|16116454|P3|Overall Study|Personal reasons patient|0
4681867|NCT02556801|16116455|P2|Overall Study|Personal reasons patient|0
4681868|NCT02556801|16116456|P1|Overall Study|Personal reasons patient|0
4681869|NCT02556801|16116453|P4|Overall Study|Pregnancy|0
4681870|NCT02556801|16116454|P3|Overall Study|Pregnancy|0
4681871|NCT02556801|16116455|P2|Overall Study|Pregnancy|1
4681872|NCT02556801|16116456|P1|Overall Study|Pregnancy|0
4681873|NCT02556801|16116453|P4|Overall Study|Adverse Event|3
4681874|NCT02556801|16116454|P3|Overall Study|Adverse Event|0
4681875|NCT02556801|16116455|P2|Overall Study|Adverse Event|2
4681876|NCT02556801|16116456|P1|Overall Study|Adverse Event|0
4681877|NCT02556801|16116453|P4|Overall Study|Protocol Violation|1
4681878|NCT02556801|16116454|P3|Overall Study|Protocol Violation|1
4681879|NCT02556801|16116455|P2|Overall Study|Protocol Violation|3
4681880|NCT02556801|16116456|P1|Overall Study|Protocol Violation|0
4681881|NCT02556801|16116453|P4|Overall Study|Withdrawal by Subject|0
4681882|NCT02556801|16116454|P3|Overall Study|Withdrawal by Subject|1
4681883|NCT02556801|16116455|P2|Overall Study|Withdrawal by Subject|1
4681884|NCT02556801|16116456|P1|Overall Study|Withdrawal by Subject|1
4681885|NCT02556801|16116453|P4|Overall Study|Lost to Follow-up|0
4681886|NCT02556801|16116454|P3|Overall Study|Lost to Follow-up|2
4681887|NCT02556801|16116455|P2|Overall Study|Lost to Follow-up|0
4681888|NCT02556801|16116456|P1|Overall Study|Lost to Follow-up|1
4681889|NCT02556632|16116518|P3|Overall Study|Treatment or Change Delay|1
4681890|NCT02556632|16116519|P2|Overall Study|Treatment or Change Delay|0
4681891|NCT02556632|16116520|P1|Overall Study|Treatment or Change Delay|0
4681892|NCT02556632|16116518|P3|Overall Study|Disliked Study Procedures|1
4681893|NCT02556632|16116519|P2|Overall Study|Disliked Study Procedures|0
4681894|NCT02556632|16116520|P1|Overall Study|Disliked Study Procedures|0
4681895|NCT02556632|16116518|P3|Overall Study|Ineligible|0
4681896|NCT02556632|16116519|P2|Overall Study|Ineligible|1
4681897|NCT02556632|16116520|P1|Overall Study|Ineligible|0
4681898|NCT02556632|16116518|P3|Overall Study|Did Not Start RT|0
4681899|NCT02556632|16116519|P2|Overall Study|Did Not Start RT|1
4681900|NCT02556632|16116520|P1|Overall Study|Did Not Start RT|0
4681901|NCT02556632|16116518|P3|Overall Study|Possibly Related Adverse Event|1
4681902|NCT02556632|16116519|P2|Overall Study|Possibly Related Adverse Event|0
4681903|NCT02556632|16116520|P1|Overall Study|Possibly Related Adverse Event|0
4681904|NCT02556632|16116518|P3|Overall Study|Related Adverse Event|0
4681905|NCT02556632|16116519|P2|Overall Study|Related Adverse Event|1
4681906|NCT02556632|16116520|P1|Overall Study|Related Adverse Event|0
4681907|NCT02556632|16116518|P3|Overall Study|Unrelated Adverse Event|3
4681908|NCT02556632|16116519|P2|Overall Study|Unrelated Adverse Event|0
4681909|NCT02556632|16116520|P1|Overall Study|Unrelated Adverse Event|1
4681910|NCT02556632|16116518|P3|Overall Study|Withdrew (Unrelated Medical)|0
4681911|NCT02556632|16116519|P2|Overall Study|Withdrew (Unrelated Medical)|0
4681912|NCT02556632|16116520|P1|Overall Study|Withdrew (Unrelated Medical)|1
4681913|NCT02556632|16116518|P3|Overall Study|Changed Mind|0
4681914|NCT02556632|16116519|P2|Overall Study|Changed Mind|1
4681915|NCT02556632|16116520|P1|Overall Study|Changed Mind|0
4681916|NCT02556632|16116518|P3|Overall Study|Personal Issues|1
4681917|NCT02556632|16116519|P2|Overall Study|Personal Issues|1
4681918|NCT02556632|16116520|P1|Overall Study|Personal Issues|0
4681919|NCT02556632|16116518|P3|Overall Study|No Reason|1
4681920|NCT02556632|16116519|P2|Overall Study|No Reason|0
4681921|NCT02556632|16116520|P1|Overall Study|No Reason|1
4681922|NCT02556632|16116518|P3|Overall Study|Disliked Intervention|1
4681923|NCT02556632|16116519|P2|Overall Study|Disliked Intervention|1
4681924|NCT02556632|16116520|P1|Overall Study|Disliked Intervention|1
4681925|NCT02556632|16116518|P3|Overall Study|Lost to Follow-up|0
4681926|NCT02556632|16116519|P2|Overall Study|Lost to Follow-up|0
4681927|NCT02556632|16116520|P1|Overall Study|Lost to Follow-up|1
4681928|NCT02556307|16116560|P1|Overall Study|Enrolled but not treated|2
4681929|NCT02556307|16116560|P1|Overall Study|Change to triple therapy|4
4681930|NCT02556307|16116560|P1|Overall Study|Lost to Follow-up|36
4681931|NCT02556307|16116560|P1|Overall Study|Premature treatment interruption|11
4681932|NCT02556255|16116570|P1|Overall Study|Lost to Follow-up|4
4681933|NCT02556203|16116585|P2|Overall Study|Adverse Event|0
4681934|NCT02556203|16116586|P1|Overall Study|Adverse Event|1
4681935|NCT02556203|16116585|P2|Overall Study|Lost to Follow-up|5
4681936|NCT02556203|16116586|P1|Overall Study|Lost to Follow-up|5
4681937|NCT02556203|16116585|P2|Overall Study|Withdrawal by Subject|21
4681938|NCT02556203|16116586|P1|Overall Study|Withdrawal by Subject|21
4681939|NCT02556177|16116608|P2|Overall Study|Subjects did not complete all 4 visits|61
4681940|NCT02556177|16116609|P1|Overall Study|Subjects did not complete all 4 visits|283
4681941|NCT02556138|16116617|P1|Overall Study|Withdrawal by Subject|1
4681942|NCT02555878|16116653|P2|Overall Study|Other|17
4681943|NCT02555878|16116654|P1|Overall Study|Other|17
4681944|NCT02555878|16116653|P2|Overall Study|Physician Decision|13
4681945|NCT02555878|16116654|P1|Overall Study|Physician Decision|12
4681946|NCT02555878|16116653|P2|Overall Study|Protocol Violation|2
4681947|NCT02555878|16116654|P1|Overall Study|Protocol Violation|1
4681948|NCT02555878|16116653|P2|Overall Study|Death|59
4681949|NCT02555878|16116654|P1|Overall Study|Death|74
4681950|NCT02555878|16116653|P2|Overall Study|Adverse Event|8
4681951|NCT02555878|16116654|P1|Overall Study|Adverse Event|12
4681952|NCT02555878|16116653|P2|Overall Study|Withdrawal by Subject|48
4681953|NCT02555878|16116654|P1|Overall Study|Withdrawal by Subject|48
4681954|NCT02555878|16116653|P2|Overall Study|Lost to Follow-up|3
4681955|NCT02555878|16116654|P1|Overall Study|Lost to Follow-up|2
4681956|NCT02555722|16116686|P2|Month 2|Lost to Follow-up|0
4681957|NCT02555722|16116687|P1|Month 2|Lost to Follow-up|1
4681958|NCT02555722|16116686|P2|Month 2|Withdrawal by Subject|0
4681959|NCT02555722|16116687|P1|Month 2|Withdrawal by Subject|3
4681960|NCT02555722|16116686|P2|Month 1|Lens Discomfort|0
4681961|NCT02555722|16116687|P1|Month 1|Lens Discomfort|1
4681962|NCT02555722|16116686|P2|Week 2|Withdrawal by Subject|0
4681963|NCT02555722|16116687|P1|Week 2|Withdrawal by Subject|1
4681964|NCT02555722|16116686|P2|Week 2|Adverse Event|1
4681965|NCT02555722|16116687|P1|Week 2|Adverse Event|0
4681966|NCT02555683|16116872|P3|Overall Study|Death post Treatment/safety period|0
4681967|NCT02555683|16116873|P2|Overall Study|Death post Treatment/safety period|1
4681968|NCT02555683|16116874|P1|Overall Study|Death post Treatment/safety period|0
4681969|NCT02555683|16116872|P3|Overall Study|Subject/guardian decision|22
4681970|NCT02555683|16116873|P2|Overall Study|Subject/guardian decision|12
4681971|NCT02555683|16116874|P1|Overall Study|Subject/guardian decision|12
4681972|NCT02555683|16116872|P3|Overall Study|Adverse Event|1
4681973|NCT02555683|16116873|P2|Overall Study|Adverse Event|0
4681974|NCT02555683|16116874|P1|Overall Study|Adverse Event|1
4681975|NCT02555683|16116872|P3|Overall Study|Death|2
4681976|NCT02555683|16116873|P2|Overall Study|Death|1
4681977|NCT02555683|16116874|P1|Overall Study|Death|0
4681978|NCT02555683|16116872|P3|Overall Study|Lack of Efficacy|0
4681979|NCT02555683|16116873|P2|Overall Study|Lack of Efficacy|0
4681980|NCT02555683|16116874|P1|Overall Study|Lack of Efficacy|2
4681981|NCT02555683|16116872|P3|Overall Study|Protocol deviation|0
4681982|NCT02555683|16116873|P2|Overall Study|Protocol deviation|1
4681983|NCT02555683|16116874|P1|Overall Study|Protocol deviation|0
4681984|NCT02555683|16116872|P3|Overall Study|Technical Problems|0
4681985|NCT02555683|16116873|P2|Overall Study|Technical Problems|1
4681986|NCT02555683|16116874|P1|Overall Study|Technical Problems|1
4681987|NCT02555683|16116872|P3|Overall Study|Lost to Follow-up|2
4681988|NCT02555683|16116873|P2|Overall Study|Lost to Follow-up|1
4681989|NCT02555683|16116874|P1|Overall Study|Lost to Follow-up|2
4681990|NCT02555683|16116872|P3|Overall Study|Physician Decision|2
4681991|NCT02555683|16116873|P2|Overall Study|Physician Decision|0
4681992|NCT02555683|16116874|P1|Overall Study|Physician Decision|1
4681993|NCT02555657|16116905|P2|Overall Study|Status Not Recorded|31
4681994|NCT02555657|16116906|P1|Overall Study|Status Not Recorded|44
4681995|NCT02555657|16116905|P2|Overall Study|Withdrawal by Subject|32
4681996|NCT02555657|16116906|P1|Overall Study|Withdrawal by Subject|11
4681997|NCT02555657|16116905|P2|Overall Study|Death|247
4681998|NCT02555657|16116906|P1|Overall Study|Death|257
4681999|NCT02555618|16116953|P2|Overall Study|Sponsor's Circumstances|0
4682000|NCT02555618|16116954|P1|Overall Study|Sponsor's Circumstances|1
4682001|NCT02555371|16116996|P5|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4682002|NCT02555371|16116997|P4|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1
4682003|NCT02555371|16116998|P3|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4682004|NCT02555371|16116999|P2|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4682005|NCT02555371|16117000|P1|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0
4682006|NCT02555371|16116996|P5|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1
4682007|NCT02555371|16116997|P4|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4682008|NCT02555371|16116998|P3|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4682009|NCT02555371|16116999|P2|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4682010|NCT02555371|16117000|P1|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0
4682011|NCT02555371|16116996|P5|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2
4682012|NCT02555371|16116997|P4|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4682013|NCT02555371|16116998|P3|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4682014|NCT02555371|16116999|P2|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4682015|NCT02555371|16117000|P1|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0
4682016|NCT02555371|16116996|P5|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4682017|NCT02555371|16116997|P4|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2
4682018|NCT02555371|16116998|P3|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4682019|NCT02555371|16116999|P2|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4682020|NCT02555371|16117000|P1|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0
4682021|NCT02555371|16116996|P5|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4682022|NCT02555371|16116997|P4|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1
4682023|NCT02555371|16116998|P3|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4682024|NCT02555371|16116999|P2|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4682025|NCT02555371|16117000|P1|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0
4682026|NCT02555371|16116996|P5|Part C (DB Period: Up to 52W)|Adverse Event|0
4682027|NCT02555371|16116997|P4|Part C (DB Period: Up to 52W)|Adverse Event|0
4682028|NCT02555371|16116998|P3|Part C (DB Period: Up to 52W)|Adverse Event|1
4682029|NCT02555371|16116999|P2|Part C (DB Period: Up to 52W)|Adverse Event|2
4682030|NCT02555371|16117000|P1|Part C (DB Period: Up to 52W)|Adverse Event|0
4682031|NCT02555371|16116996|P5|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4682032|NCT02555371|16116997|P4|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4682033|NCT02555371|16116998|P3|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4682034|NCT02555371|16116999|P2|Part C (DB Period: Up to 52W)|Lack of Efficacy|1
4682035|NCT02555371|16117000|P1|Part C (DB Period: Up to 52W)|Lack of Efficacy|0
4682036|NCT02555371|16116996|P5|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
4682037|NCT02555371|16116997|P4|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
4682038|NCT02555371|16116998|P3|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
4682039|NCT02555371|16116999|P2|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2
4682040|NCT02555371|16117000|P1|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0
4682041|NCT02555371|16116996|P5|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
4682042|NCT02555371|16116997|P4|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
4682043|NCT02555371|16116998|P3|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45
4682044|NCT02555371|16116999|P2|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84
4682045|NCT02555371|16117000|P1|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0
4682046|NCT02555371|16116996|P5|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4682047|NCT02555371|16116997|P4|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4682048|NCT02555371|16116998|P3|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4682049|NCT02555371|16116999|P2|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0
4682050|NCT02555371|16117000|P1|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2
4682051|NCT02555371|16116996|P5|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4682052|NCT02555371|16116997|P4|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4682053|NCT02555371|16116998|P3|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4682054|NCT02555371|16116999|P2|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0
4682055|NCT02555371|16117000|P1|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1
4682056|NCT02555371|16116996|P5|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4682057|NCT02555371|16116997|P4|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4682058|NCT02555371|16116998|P3|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4682059|NCT02555371|16116999|P2|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0
4682060|NCT02555371|16117000|P1|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5
4682061|NCT02555371|16116996|P5|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4682062|NCT02555371|16116997|P4|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4682063|NCT02555371|16116998|P3|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4682064|NCT02555371|16116999|P2|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0
4682065|NCT02555371|16117000|P1|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2
4682066|NCT02555371|16116996|P5|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4682244|NCT02553772|16117632|P2|Overall Study|Lack of Efficacy|0
4682067|NCT02555371|16116997|P4|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4682068|NCT02555371|16116998|P3|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4682069|NCT02555371|16116999|P2|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0
4682070|NCT02555371|16117000|P1|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1
4682071|NCT02555215|16117051|P1|Overall Study|Investigator Decision|2
4682072|NCT02555215|16117051|P1|Overall Study|Other|1
4682073|NCT02554981|16117083|P1|Overall Study|Other Miscellaneous Reasons|3
4682074|NCT02554981|16117083|P1|Overall Study|Administrative Reasons|1
4682075|NCT02554981|16117083|P1|Overall Study|Adverse Event|1
4682076|NCT02554929|16117109|P2|Overall Study|Withdrawal by Subject|8
4682077|NCT02554929|16117110|P1|Overall Study|Withdrawal by Subject|2
4682078|NCT02554929|16117109|P2|Overall Study|Lost to Follow-up|4
4682079|NCT02554929|16117110|P1|Overall Study|Lost to Follow-up|4
4682080|NCT02554890|16117128|P2|Open-label|Withdrawal by Subject|1
4682081|NCT02554890|16117129|P1|Open-label|Withdrawal by Subject|0
4682082|NCT02554890|16117128|P2|Open-label|Technical problems|1
4682083|NCT02554890|16117129|P1|Open-label|Technical problems|0
4682084|NCT02554890|16117128|P2|Open-label|Lost to Follow-up|7
4682085|NCT02554890|16117129|P1|Open-label|Lost to Follow-up|0
4682086|NCT02554890|16117128|P2|Open-label|Subject/Guardian decision|11
4682087|NCT02554890|16117129|P1|Open-label|Subject/Guardian decision|0
4682088|NCT02554890|16117128|P2|Open-label|Physician Decision|1
4682089|NCT02554890|16117129|P1|Open-label|Physician Decision|0
4682090|NCT02554890|16117128|P2|Open-label|Death|1
4682091|NCT02554890|16117129|P1|Open-label|Death|0
4682092|NCT02554890|16117128|P2|Open-label|Adverse Event|30
4682093|NCT02554890|16117129|P1|Open-label|Adverse Event|0
4682094|NCT02554890|16117128|P2|Double-blind|Noncompliance with study treatment|5
4682095|NCT02554890|16117129|P1|Double-blind|Noncompliance with study treatment|6
4682096|NCT02554890|16117128|P2|Double-blind|Withdrawal by Subject|6
4682097|NCT02554890|16117129|P1|Double-blind|Withdrawal by Subject|5
4682098|NCT02554890|16117128|P2|Double-blind|Technical problems|0
4682099|NCT02554890|16117129|P1|Double-blind|Technical problems|1
4682100|NCT02554890|16117128|P2|Double-blind|Lost to Follow-up|5
4682101|NCT02554890|16117129|P1|Double-blind|Lost to Follow-up|7
4682102|NCT02554890|16117128|P2|Double-blind|Subject/Guardian decision|16
4682103|NCT02554890|16117129|P1|Double-blind|Subject/Guardian decision|21
4682104|NCT02554890|16117128|P2|Double-blind|Physician Decision|3
4682105|NCT02554890|16117129|P1|Double-blind|Physician Decision|4
4682106|NCT02554890|16117128|P2|Double-blind|Protocol Violation|1
4682107|NCT02554890|16117129|P1|Double-blind|Protocol Violation|1
4682108|NCT02554890|16117128|P2|Double-blind|Death|4
4682109|NCT02554890|16117129|P1|Double-blind|Death|6
4682110|NCT02554890|16117128|P2|Double-blind|Adverse Event|51
4682111|NCT02554890|16117129|P1|Double-blind|Adverse Event|45
4682112|NCT02554877|16117157|P4|Overall Study|No longer willing to participate|0
4682113|NCT02554877|16117158|P3|Overall Study|No longer willing to participate|2
4682114|NCT02554877|16117159|P2|Overall Study|No longer willing to participate|2
4682115|NCT02554877|16117160|P1|Overall Study|No longer willing to participate|0
4682116|NCT02554877|16117157|P4|Overall Study|Insufficient clinical response|0
4682117|NCT02554877|16117158|P3|Overall Study|Insufficient clinical response|0
4682118|NCT02554877|16117159|P2|Overall Study|Insufficient clinical response|0
4682119|NCT02554877|16117160|P1|Overall Study|Insufficient clinical response|4
4682120|NCT02554877|16117157|P4|Overall Study|Other|3
4682121|NCT02554877|16117158|P3|Overall Study|Other|0
4682122|NCT02554877|16117159|P2|Overall Study|Other|3
4682123|NCT02554877|16117160|P1|Overall Study|Other|1
4682124|NCT02554877|16117157|P4|Overall Study|Protocol Violation|0
4682125|NCT02554877|16117158|P3|Overall Study|Protocol Violation|1
4682126|NCT02554877|16117159|P2|Overall Study|Protocol Violation|1
4682127|NCT02554877|16117160|P1|Overall Study|Protocol Violation|3
4682128|NCT02554877|16117157|P4|Overall Study|No longer met eligibility criteria|1
4682129|NCT02554877|16117158|P3|Overall Study|No longer met eligibility criteria|1
4682130|NCT02554877|16117159|P2|Overall Study|No longer met eligibility criteria|0
4682131|NCT02554877|16117160|P1|Overall Study|No longer met eligibility criteria|1
4682132|NCT02554877|16117157|P4|Overall Study|Did not meet entrance criteria|0
4682133|NCT02554877|16117158|P3|Overall Study|Did not meet entrance criteria|1
4682134|NCT02554877|16117159|P2|Overall Study|Did not meet entrance criteria|0
4682135|NCT02554877|16117160|P1|Overall Study|Did not meet entrance criteria|0
4682136|NCT02554877|16117157|P4|Overall Study|Lost to Follow-up|2
4682137|NCT02554877|16117158|P3|Overall Study|Lost to Follow-up|1
4682138|NCT02554877|16117159|P2|Overall Study|Lost to Follow-up|1
4682139|NCT02554877|16117160|P1|Overall Study|Lost to Follow-up|1
4682140|NCT02554877|16117157|P4|Overall Study|Adverse Event|1
4682141|NCT02554877|16117158|P3|Overall Study|Adverse Event|0
4682142|NCT02554877|16117159|P2|Overall Study|Adverse Event|0
4682143|NCT02554877|16117160|P1|Overall Study|Adverse Event|2
4682144|NCT02554786|16117248|P5|Overall Study|Pregnancy|1
4682145|NCT02554786|16117249|P4|Overall Study|Pregnancy|1
4682146|NCT02554786|16117250|P3|Overall Study|Pregnancy|0
4682147|NCT02554786|16117251|P2|Overall Study|Pregnancy|0
4682148|NCT02554786|16117252|P1|Overall Study|Pregnancy|0
4682149|NCT02554786|16117248|P5|Overall Study|Physician Decision|1
4682150|NCT02554786|16117249|P4|Overall Study|Physician Decision|1
4682151|NCT02554786|16117250|P3|Overall Study|Physician Decision|4
4682152|NCT02554786|16117251|P2|Overall Study|Physician Decision|1
4682153|NCT02554786|16117252|P1|Overall Study|Physician Decision|0
4682154|NCT02554786|16117248|P5|Overall Study|Non-compliance with study treatment|1
4682155|NCT02554786|16117249|P4|Overall Study|Non-compliance with study treatment|0
4682156|NCT02554786|16117250|P3|Overall Study|Non-compliance with study treatment|1
4682157|NCT02554786|16117251|P2|Overall Study|Non-compliance with study treatment|1
4682158|NCT02554786|16117252|P1|Overall Study|Non-compliance with study treatment|0
4682159|NCT02554786|16117248|P5|Overall Study|Death|0
4682160|NCT02554786|16117249|P4|Overall Study|Death|1
4682161|NCT02554786|16117250|P3|Overall Study|Death|0
4682162|NCT02554786|16117251|P2|Overall Study|Death|0
4682163|NCT02554786|16117252|P1|Overall Study|Death|0
4682164|NCT02554786|16117248|P5|Overall Study|Adverse Event|2
4682165|NCT02554786|16117249|P4|Overall Study|Adverse Event|0
4682166|NCT02554786|16117250|P3|Overall Study|Adverse Event|0
4682167|NCT02554786|16117251|P2|Overall Study|Adverse Event|0
4682168|NCT02554786|16117252|P1|Overall Study|Adverse Event|0
4682169|NCT02554786|16117248|P5|Overall Study|Technical problems|1
4682170|NCT02554786|16117249|P4|Overall Study|Technical problems|2
4682171|NCT02554786|16117250|P3|Overall Study|Technical problems|0
4682172|NCT02554786|16117251|P2|Overall Study|Technical problems|1
4682173|NCT02554786|16117252|P1|Overall Study|Technical problems|1
4682174|NCT02554786|16117248|P5|Overall Study|Protocol deviation|2
4682175|NCT02554786|16117249|P4|Overall Study|Protocol deviation|4
4682176|NCT02554786|16117250|P3|Overall Study|Protocol deviation|3
4682177|NCT02554786|16117251|P2|Overall Study|Protocol deviation|3
4682178|NCT02554786|16117252|P1|Overall Study|Protocol deviation|1
4682179|NCT02554786|16117248|P5|Overall Study|Lost to Follow-up|2
4682180|NCT02554786|16117249|P4|Overall Study|Lost to Follow-up|2
4682181|NCT02554786|16117250|P3|Overall Study|Lost to Follow-up|4
4682182|NCT02554786|16117251|P2|Overall Study|Lost to Follow-up|3
4682183|NCT02554786|16117252|P1|Overall Study|Lost to Follow-up|4
4682184|NCT02554786|16117248|P5|Overall Study|Subject/guardian decision|20
4682185|NCT02554786|16117249|P4|Overall Study|Subject/guardian decision|30
4682186|NCT02554786|16117250|P3|Overall Study|Subject/guardian decision|18
4682187|NCT02554786|16117251|P2|Overall Study|Subject/guardian decision|17
4682188|NCT02554786|16117252|P1|Overall Study|Subject/guardian decision|29
4682189|NCT02554682|16117414|P10|Overall Study|Physician Decision|0
4682190|NCT02554682|16117415|P9|Overall Study|Physician Decision|0
4682191|NCT02554682|16117416|P8|Overall Study|Physician Decision|0
4682192|NCT02554682|16117417|P7|Overall Study|Physician Decision|0
4682193|NCT02554682|16117418|P6|Overall Study|Physician Decision|0
4682194|NCT02554682|16117419|P5|Overall Study|Physician Decision|0
4682195|NCT02554682|16117420|P4|Overall Study|Physician Decision|0
4682196|NCT02554682|16117421|P3|Overall Study|Physician Decision|0
4682197|NCT02554682|16117422|P2|Overall Study|Physician Decision|2
4682198|NCT02554682|16117423|P1|Overall Study|Physician Decision|2
4682199|NCT02554682|16117414|P10|Overall Study|Withdrawal by Subject|0
4682200|NCT02554682|16117415|P9|Overall Study|Withdrawal by Subject|0
4682201|NCT02554682|16117416|P8|Overall Study|Withdrawal by Subject|0
4682202|NCT02554682|16117417|P7|Overall Study|Withdrawal by Subject|0
4682203|NCT02554682|16117418|P6|Overall Study|Withdrawal by Subject|0
4682204|NCT02554682|16117419|P5|Overall Study|Withdrawal by Subject|0
4682205|NCT02554682|16117420|P4|Overall Study|Withdrawal by Subject|0
4682206|NCT02554682|16117421|P3|Overall Study|Withdrawal by Subject|0
4682207|NCT02554682|16117422|P2|Overall Study|Withdrawal by Subject|1
4682208|NCT02554682|16117423|P1|Overall Study|Withdrawal by Subject|2
4682209|NCT02554682|16117414|P10|Overall Study|Lost to Follow-up|2
4682210|NCT02554682|16117415|P9|Overall Study|Lost to Follow-up|2
4682211|NCT02554682|16117416|P8|Overall Study|Lost to Follow-up|6
4682212|NCT02554682|16117417|P7|Overall Study|Lost to Follow-up|6
4682213|NCT02554682|16117418|P6|Overall Study|Lost to Follow-up|1
4682214|NCT02554682|16117419|P5|Overall Study|Lost to Follow-up|2
4682215|NCT02554682|16117420|P4|Overall Study|Lost to Follow-up|3
4682216|NCT02554682|16117421|P3|Overall Study|Lost to Follow-up|4
4682217|NCT02554682|16117422|P2|Overall Study|Lost to Follow-up|9
4682218|NCT02554682|16117423|P1|Overall Study|Lost to Follow-up|11
4682219|NCT02554656|16117472|P1|Overall Study|Protocol Violation|3
4682220|NCT02554279|16117517|P2|Overall Study|Other reason|6
4682221|NCT02554279|16117518|P1|Overall Study|Other reason|19
4682222|NCT02554279|16117517|P2|Overall Study|Protocol Violation|1
4682223|NCT02554279|16117518|P1|Overall Study|Protocol Violation|2
4682224|NCT02554279|16117517|P2|Overall Study|Withdrawal by Subject|4
4682225|NCT02554279|16117518|P1|Overall Study|Withdrawal by Subject|6
4682226|NCT02554279|16117517|P2|Overall Study|Lost to Follow-up|2
4682227|NCT02554279|16117518|P1|Overall Study|Lost to Follow-up|3
4682228|NCT02554279|16117517|P2|Overall Study|Adverse Event|5
4682229|NCT02554279|16117518|P1|Overall Study|Adverse Event|2
4682230|NCT02554019|16117553|P3|Overall Study|Adverse Event|0
4682231|NCT02554019|16117554|P2|Overall Study|Adverse Event|0
4682232|NCT02554019|16117555|P1|Overall Study|Adverse Event|1
4682233|NCT02554019|16117553|P3|Overall Study|Withdrawal by Subject|2
4682234|NCT02554019|16117554|P2|Overall Study|Withdrawal by Subject|0
4682235|NCT02554019|16117555|P1|Overall Study|Withdrawal by Subject|1
4682236|NCT02553928|16117577|P2|Overall Study|Administrative reason(s)|1
4682237|NCT02553928|16117578|P1|Overall Study|Administrative reason(s)|0
4682238|NCT02553928|16117577|P2|Overall Study|Lost to Follow-up|1
4682239|NCT02553928|16117578|P1|Overall Study|Lost to Follow-up|0
4682240|NCT02553928|16117577|P2|Overall Study|Adverse Event|1
4682241|NCT02553928|16117578|P1|Overall Study|Adverse Event|2
4682242|NCT02553772|16117632|P2|Overall Study|Other Miscellaneous Reasons|1
4682243|NCT02553772|16117633|P1|Overall Study|Other Miscellaneous Reasons|0
4682245|NCT02553772|16117633|P1|Overall Study|Lack of Efficacy|1
4682246|NCT02553772|16117632|P2|Overall Study|Withdrawal of Consent|1
4682247|NCT02553772|16117633|P1|Overall Study|Withdrawal of Consent|1
4682248|NCT02553772|16117632|P2|Overall Study|Lost to Follow-up|1
4682249|NCT02553772|16117633|P1|Overall Study|Lost to Follow-up|2
4682250|NCT02553772|16117632|P2|Overall Study|Adverse Event|3
4682251|NCT02553772|16117633|P1|Overall Study|Adverse Event|2
4682252|NCT02553629|16117678|P2|Overall Study|Logistic reasons|6
4682253|NCT02553629|16117679|P1|Overall Study|Logistic reasons|3
4682254|NCT02553538|16117695|P2|Overall Study|Died or Left Network|56
4682255|NCT02553538|16117696|P1|Overall Study|Died or Left Network|54
4682256|NCT02553538|16117695|P2|Overall Study|Could Not Reach by Telephone|0
4682257|NCT02553538|16117696|P1|Overall Study|Could Not Reach by Telephone|133
4682258|NCT02553499|16117730|P14|Overall Study|Withdrawal by Subject|0
4682259|NCT02553499|16117731|P13|Overall Study|Withdrawal by Subject|0
4682260|NCT02553499|16117732|P12|Overall Study|Withdrawal by Subject|0
4682261|NCT02553499|16117733|P11|Overall Study|Withdrawal by Subject|1
4682262|NCT02553499|16117734|P10|Overall Study|Withdrawal by Subject|0
4682263|NCT02553499|16117735|P9|Overall Study|Withdrawal by Subject|1
4682264|NCT02553499|16117736|P8|Overall Study|Withdrawal by Subject|1
4682265|NCT02553499|16117737|P7|Overall Study|Withdrawal by Subject|0
4682266|NCT02553499|16117738|P6|Overall Study|Withdrawal by Subject|0
4682267|NCT02553499|16117739|P5|Overall Study|Withdrawal by Subject|0
4682268|NCT02553499|16117740|P4|Overall Study|Withdrawal by Subject|0
4682269|NCT02553499|16117741|P3|Overall Study|Withdrawal by Subject|0
4682270|NCT02553499|16117742|P2|Overall Study|Withdrawal by Subject|0
4682271|NCT02553499|16117743|P1|Overall Study|Withdrawal by Subject|2
4682272|NCT02553499|16117730|P14|Overall Study|Study Terminated by Sponsor|0
4682273|NCT02553499|16117731|P13|Overall Study|Study Terminated by Sponsor|0
4682274|NCT02553499|16117732|P12|Overall Study|Study Terminated by Sponsor|0
4682275|NCT02553499|16117733|P11|Overall Study|Study Terminated by Sponsor|0
4682276|NCT02553499|16117734|P10|Overall Study|Study Terminated by Sponsor|0
4682277|NCT02553499|16117735|P9|Overall Study|Study Terminated by Sponsor|1
4682278|NCT02553499|16117736|P8|Overall Study|Study Terminated by Sponsor|0
4682279|NCT02553499|16117737|P7|Overall Study|Study Terminated by Sponsor|0
4682280|NCT02553499|16117738|P6|Overall Study|Study Terminated by Sponsor|0
4682281|NCT02553499|16117739|P5|Overall Study|Study Terminated by Sponsor|0
4682282|NCT02553499|16117740|P4|Overall Study|Study Terminated by Sponsor|0
4682283|NCT02553499|16117741|P3|Overall Study|Study Terminated by Sponsor|0
4682284|NCT02553499|16117742|P2|Overall Study|Study Terminated by Sponsor|0
4682285|NCT02553499|16117743|P1|Overall Study|Study Terminated by Sponsor|0
4682286|NCT02553499|16117730|P14|Overall Study|Progressive Disease|1
4682287|NCT02553499|16117731|P13|Overall Study|Progressive Disease|2
4682288|NCT02553499|16117732|P12|Overall Study|Progressive Disease|0
4682289|NCT02553499|16117733|P11|Overall Study|Progressive Disease|0
4682290|NCT02553499|16117734|P10|Overall Study|Progressive Disease|1
4682291|NCT02553499|16117735|P9|Overall Study|Progressive Disease|0
4682292|NCT02553499|16117736|P8|Overall Study|Progressive Disease|0
4682293|NCT02553499|16117737|P7|Overall Study|Progressive Disease|1
4682294|NCT02553499|16117738|P6|Overall Study|Progressive Disease|1
4682295|NCT02553499|16117739|P5|Overall Study|Progressive Disease|1
4682296|NCT02553499|16117740|P4|Overall Study|Progressive Disease|2
4682297|NCT02553499|16117741|P3|Overall Study|Progressive Disease|0
4682298|NCT02553499|16117742|P2|Overall Study|Progressive Disease|0
4682299|NCT02553499|16117743|P1|Overall Study|Progressive Disease|0
4682300|NCT02553499|16117730|P14|Overall Study|Physician Decision|0
4682301|NCT02553499|16117731|P13|Overall Study|Physician Decision|1
4682302|NCT02553499|16117732|P12|Overall Study|Physician Decision|3
4682303|NCT02553499|16117733|P11|Overall Study|Physician Decision|1
4682304|NCT02553499|16117734|P10|Overall Study|Physician Decision|2
4682305|NCT02553499|16117735|P9|Overall Study|Physician Decision|1
4682306|NCT02553499|16117736|P8|Overall Study|Physician Decision|1
4682307|NCT02553499|16117737|P7|Overall Study|Physician Decision|0
4682308|NCT02553499|16117738|P6|Overall Study|Physician Decision|0
4682309|NCT02553499|16117739|P5|Overall Study|Physician Decision|1
4682310|NCT02553499|16117740|P4|Overall Study|Physician Decision|0
4682311|NCT02553499|16117741|P3|Overall Study|Physician Decision|1
4682312|NCT02553499|16117742|P2|Overall Study|Physician Decision|1
4682313|NCT02553499|16117743|P1|Overall Study|Physician Decision|0
4682314|NCT02553499|16117730|P14|Overall Study|Lost to Follow-up|0
4682315|NCT02553499|16117731|P13|Overall Study|Lost to Follow-up|0
4682316|NCT02553499|16117732|P12|Overall Study|Lost to Follow-up|0
4682317|NCT02553499|16117733|P11|Overall Study|Lost to Follow-up|0
4682318|NCT02553499|16117734|P10|Overall Study|Lost to Follow-up|0
4682319|NCT02553499|16117735|P9|Overall Study|Lost to Follow-up|0
4682320|NCT02553499|16117736|P8|Overall Study|Lost to Follow-up|0
4682321|NCT02553499|16117737|P7|Overall Study|Lost to Follow-up|1
4682322|NCT02553499|16117738|P6|Overall Study|Lost to Follow-up|0
4682323|NCT02553499|16117739|P5|Overall Study|Lost to Follow-up|0
4682324|NCT02553499|16117740|P4|Overall Study|Lost to Follow-up|0
4682325|NCT02553499|16117741|P3|Overall Study|Lost to Follow-up|0
4682326|NCT02553499|16117742|P2|Overall Study|Lost to Follow-up|0
4682327|NCT02553499|16117743|P1|Overall Study|Lost to Follow-up|0
4682328|NCT02553499|16117730|P14|Overall Study|Death|0
4682329|NCT02553499|16117731|P13|Overall Study|Death|0
4682330|NCT02553499|16117732|P12|Overall Study|Death|0
4682331|NCT02553499|16117733|P11|Overall Study|Death|1
4682332|NCT02553499|16117734|P10|Overall Study|Death|0
4682333|NCT02553499|16117735|P9|Overall Study|Death|0
4682334|NCT02553499|16117736|P8|Overall Study|Death|0
4682335|NCT02553499|16117737|P7|Overall Study|Death|0
4682336|NCT02553499|16117738|P6|Overall Study|Death|2
4682337|NCT02553499|16117739|P5|Overall Study|Death|1
4682338|NCT02553499|16117740|P4|Overall Study|Death|0
4682339|NCT02553499|16117741|P3|Overall Study|Death|1
4682340|NCT02553499|16117742|P2|Overall Study|Death|1
4682341|NCT02553499|16117743|P1|Overall Study|Death|0
4682342|NCT02553499|16117730|P14|Overall Study|Adverse Event|1
4682343|NCT02553499|16117731|P13|Overall Study|Adverse Event|0
4682344|NCT02553499|16117732|P12|Overall Study|Adverse Event|0
4682345|NCT02553499|16117733|P11|Overall Study|Adverse Event|0
4682346|NCT02553499|16117734|P10|Overall Study|Adverse Event|0
4682347|NCT02553499|16117735|P9|Overall Study|Adverse Event|0
4682348|NCT02553499|16117736|P8|Overall Study|Adverse Event|1
4682349|NCT02553499|16117737|P7|Overall Study|Adverse Event|1
4682350|NCT02553499|16117738|P6|Overall Study|Adverse Event|0
4682351|NCT02553499|16117739|P5|Overall Study|Adverse Event|0
4682352|NCT02553499|16117740|P4|Overall Study|Adverse Event|0
4682353|NCT02553499|16117741|P3|Overall Study|Adverse Event|0
4682354|NCT02553499|16117742|P2|Overall Study|Adverse Event|0
4682355|NCT02553499|16117743|P1|Overall Study|Adverse Event|0
4682356|NCT02553421|16117845|P2|Overall Study|Improper Device Placement|0
4682357|NCT02553421|16117846|P1|Overall Study|Improper Device Placement|3
4682358|NCT02553421|16117845|P2|Overall Study|Incomplete or Insufficient Data Collecte|0
4682359|NCT02553421|16117846|P1|Overall Study|Incomplete or Insufficient Data Collecte|5
4682360|NCT02553421|16117845|P2|Overall Study|Lost to Follow-up|1
4682361|NCT02553421|16117846|P1|Overall Study|Lost to Follow-up|21
4682362|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1
4682363|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0
4682364|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Protocol Violation|1
4682365|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Protocol Violation|0
4682366|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
4682367|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1
4682368|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Lost to Follow-up|1
4682369|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Lost to Follow-up|0
4682370|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Withdrawal by Subject|5
4682371|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Withdrawal by Subject|4
4682372|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Adverse Event|5
4682373|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Adverse Event|6
4682374|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Death|3
4682375|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Death|1
4682376|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Non-compliance with study drug|1
4682377|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Non-compliance with study drug|0
4682378|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Physician Decision|4
4682379|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Physician Decision|2
4682380|NCT02553317|16117856|P2|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1
4682381|NCT02553317|16117857|P1|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0
4682382|NCT02552966|16117887|P1|Overall Study|Withdrawal by Subject|3
4682383|NCT02552966|16117887|P1|Overall Study|Lost to Follow-up|2
4682384|NCT02552732|16117913|P1|Overall Study|Withdrawal by Subject|6
4682385|NCT02552732|16117913|P1|Overall Study|Day 1 SpO2 > 96%|1
4682386|NCT02552732|16117913|P1|Overall Study|Physician Decision|1
4682387|NCT02552732|16117913|P1|Overall Study|Lost to Follow-up|2
4682388|NCT02552355|16117949|P4|Overall Study|Withdrawal by Subject|1
4682389|NCT02552355|16117950|P3|Overall Study|Withdrawal by Subject|0
4682390|NCT02552355|16117951|P2|Overall Study|Withdrawal by Subject|0
4682391|NCT02552355|16117952|P1|Overall Study|Withdrawal by Subject|0
4682392|NCT02552355|16117949|P4|Overall Study|Adverse Event|0
4682393|NCT02552355|16117950|P3|Overall Study|Adverse Event|2
4682394|NCT02552355|16117951|P2|Overall Study|Adverse Event|2
4682395|NCT02552355|16117952|P1|Overall Study|Adverse Event|0
4682396|NCT02552303|16117998|P4|Follow-Up|ineligible|0
4682397|NCT02552303|16117999|P3|Follow-Up|ineligible|0
4682398|NCT02552303|16118000|P2|Follow-Up|ineligible|2
4682399|NCT02552303|16118001|P1|Follow-Up|ineligible|0
4682400|NCT02552303|16117998|P4|Follow-Up|Lost to Follow-up|0
4682401|NCT02552303|16117999|P3|Follow-Up|Lost to Follow-up|1
4682402|NCT02552303|16118000|P2|Follow-Up|Lost to Follow-up|0
4682403|NCT02552303|16118001|P1|Follow-Up|Lost to Follow-up|0
4682404|NCT02552303|16117998|P4|Allocation|ineligible|0
4682405|NCT02552303|16117999|P3|Allocation|ineligible|0
4682406|NCT02552303|16118000|P2|Allocation|ineligible|1
4682407|NCT02552303|16118001|P1|Allocation|ineligible|1
4682408|NCT02552303|16117998|P4|Allocation|Withdrawal by Subject|1
4682409|NCT02552303|16117999|P3|Allocation|Withdrawal by Subject|1
4682410|NCT02552303|16118000|P2|Allocation|Withdrawal by Subject|1
4682411|NCT02552303|16118001|P1|Allocation|Withdrawal by Subject|2
4682412|NCT02552238|16118015|P1|Overall Study|Adverse Event|2
4682413|NCT02552212|16118028|P2|Overall Study|Missing/Unspecified|0
4682414|NCT02552212|16118029|P1|Overall Study|Missing/Unspecified|1
4682415|NCT02552212|16118028|P2|Overall Study|Not eligible|1
4682416|NCT02552212|16118029|P1|Overall Study|Not eligible|0
4682417|NCT02552212|16118028|P2|Overall Study|As per suggestion|1
4682418|NCT02552212|16118029|P1|Overall Study|As per suggestion|0
4682419|NCT02552212|16118028|P2|Overall Study|Patient's decision|1
4682420|NCT02552212|16118029|P1|Overall Study|Patient's decision|0
4682421|NCT02552212|16118028|P2|Overall Study|Study non-compliance|1
4682422|NCT02552212|16118029|P1|Overall Study|Study non-compliance|1
4682423|NCT02552212|16118028|P2|Overall Study|Withdrawal by Subject|7
4682424|NCT02552212|16118029|P1|Overall Study|Withdrawal by Subject|3
4682425|NCT02552212|16118028|P2|Overall Study|Lost to Follow-up|0
4682426|NCT02552212|16118029|P1|Overall Study|Lost to Follow-up|1
4682427|NCT02552212|16118028|P2|Overall Study|Protocol Violation|1
4682428|NCT02552212|16118029|P1|Overall Study|Protocol Violation|1
4682429|NCT02552212|16118028|P2|Overall Study|Lack of Efficacy|2
4682430|NCT02552212|16118029|P1|Overall Study|Lack of Efficacy|2
4682431|NCT02552212|16118028|P2|Overall Study|Adverse Event|3
4682432|NCT02552212|16118029|P1|Overall Study|Adverse Event|6
4682433|NCT02552147|16118103|P2|Second Intervention (7 Days)|Protocol Violation|0
4682434|NCT02552147|16118104|P1|Second Intervention (7 Days)|Protocol Violation|2
4682435|NCT02552147|16118103|P2|First Intervention (7 Days)|Protocol Violation|0
4682436|NCT02552147|16118104|P1|First Intervention (7 Days)|Protocol Violation|1
4682437|NCT02552121|16118138|P8|Part 2: Cohort Expansion|Death|0
4682438|NCT02552121|16118139|P7|Part 2: Cohort Expansion|Death|0
4682439|NCT02552121|16118140|P6|Part 2: Cohort Expansion|Death|0
4682440|NCT02552121|16118141|P5|Part 2: Cohort Expansion|Death|0
4682441|NCT02552121|16118142|P4|Part 2: Cohort Expansion|Death|0
4682442|NCT02552121|16118143|P3|Part 2: Cohort Expansion|Death|1
4682443|NCT02552121|16118144|P2|Part 2: Cohort Expansion|Death|0
4682444|NCT02552121|16118145|P1|Part 2: Cohort Expansion|Death|0
4682445|NCT02552121|16118138|P8|Part 2: Cohort Expansion|Adverse Event|0
4682446|NCT02552121|16118139|P7|Part 2: Cohort Expansion|Adverse Event|0
4682447|NCT02552121|16118140|P6|Part 2: Cohort Expansion|Adverse Event|0
4682448|NCT02552121|16118141|P5|Part 2: Cohort Expansion|Adverse Event|0
4682449|NCT02552121|16118142|P4|Part 2: Cohort Expansion|Adverse Event|1
4682450|NCT02552121|16118143|P3|Part 2: Cohort Expansion|Adverse Event|6
4682451|NCT02552121|16118144|P2|Part 2: Cohort Expansion|Adverse Event|0
4682452|NCT02552121|16118145|P1|Part 2: Cohort Expansion|Adverse Event|0
4682453|NCT02552121|16118138|P8|Part 2: Cohort Expansion|Disease Progression|3
4682454|NCT02552121|16118139|P7|Part 2: Cohort Expansion|Disease Progression|0
4682455|NCT02552121|16118140|P6|Part 2: Cohort Expansion|Disease Progression|4
4682456|NCT02552121|16118141|P5|Part 2: Cohort Expansion|Disease Progression|1
4682457|NCT02552121|16118142|P4|Part 2: Cohort Expansion|Disease Progression|2
4682458|NCT02552121|16118143|P3|Part 2: Cohort Expansion|Disease Progression|3
4682459|NCT02552121|16118144|P2|Part 2: Cohort Expansion|Disease Progression|0
4682460|NCT02552121|16118145|P1|Part 2: Cohort Expansion|Disease Progression|0
4682461|NCT02552121|16118138|P8|Part 2: Cohort Expansion|Patient Choice|0
4682462|NCT02552121|16118139|P7|Part 2: Cohort Expansion|Patient Choice|1
4682463|NCT02552121|16118140|P6|Part 2: Cohort Expansion|Patient Choice|0
4682464|NCT02552121|16118141|P5|Part 2: Cohort Expansion|Patient Choice|0
4682465|NCT02552121|16118142|P4|Part 2: Cohort Expansion|Patient Choice|0
4682466|NCT02552121|16118143|P3|Part 2: Cohort Expansion|Patient Choice|1
4682467|NCT02552121|16118144|P2|Part 2: Cohort Expansion|Patient Choice|0
4682468|NCT02552121|16118145|P1|Part 2: Cohort Expansion|Patient Choice|0
4682469|NCT02552121|16118138|P8|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682470|NCT02552121|16118139|P7|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682471|NCT02552121|16118140|P6|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682472|NCT02552121|16118141|P5|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682473|NCT02552121|16118142|P4|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682474|NCT02552121|16118143|P3|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682475|NCT02552121|16118144|P2|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1
4682476|NCT02552121|16118145|P1|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0
4682477|NCT02552121|16118138|P8|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682478|NCT02552121|16118139|P7|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682479|NCT02552121|16118140|P6|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682480|NCT02552121|16118141|P5|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682481|NCT02552121|16118142|P4|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682482|NCT02552121|16118143|P3|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682483|NCT02552121|16118144|P2|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2
4682484|NCT02552121|16118145|P1|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0
4682485|NCT02552121|16118138|P8|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682486|NCT02552121|16118139|P7|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682487|NCT02552121|16118140|P6|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682488|NCT02552121|16118141|P5|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682489|NCT02552121|16118142|P4|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682490|NCT02552121|16118143|P3|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682491|NCT02552121|16118144|P2|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2
4682492|NCT02552121|16118145|P1|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0
4682493|NCT02552121|16118138|P8|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682494|NCT02552121|16118139|P7|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682495|NCT02552121|16118140|P6|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682496|NCT02552121|16118141|P5|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682497|NCT02552121|16118142|P4|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682498|NCT02552121|16118143|P3|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682499|NCT02552121|16118144|P2|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1
4682500|NCT02552121|16118145|P1|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0
4682501|NCT02552121|16118138|P8|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682502|NCT02552121|16118139|P7|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682503|NCT02552121|16118140|P6|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682504|NCT02552121|16118141|P5|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682505|NCT02552121|16118142|P4|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682506|NCT02552121|16118143|P3|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682507|NCT02552121|16118144|P2|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0
4682508|NCT02552121|16118145|P1|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1
4682509|NCT02552121|16118138|P8|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682510|NCT02552121|16118139|P7|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682511|NCT02552121|16118140|P6|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682512|NCT02552121|16118141|P5|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682513|NCT02552121|16118142|P4|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682514|NCT02552121|16118143|P3|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682515|NCT02552121|16118144|P2|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0
4682516|NCT02552121|16118145|P1|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2
4682517|NCT02551874|16118406|P2|Overall Study|Did not enter long-term study|25
4682518|NCT02551874|16118407|P1|Overall Study|Did not enter long-term study|18
4682519|NCT02551874|16118406|P2|Overall Study|Did not receive randomized treatment|7
4682520|NCT02551874|16118407|P1|Overall Study|Did not receive randomized treatment|0
4682521|NCT02551874|16118406|P2|Overall Study|Reason not reported|4
4682522|NCT02551874|16118407|P1|Overall Study|Reason not reported|10
4682523|NCT02551874|16118406|P2|Overall Study|Pregnancy|1
4682524|NCT02551874|16118407|P1|Overall Study|Pregnancy|0
4682525|NCT02551874|16118406|P2|Overall Study|Lost to Follow-up|2
4682526|NCT02551874|16118407|P1|Overall Study|Lost to Follow-up|0
4682527|NCT02551731|16118476|P1|Overall Study|Withdrawal by Subject|2
4682528|NCT02551692|16118496|P3|Overall Study|Withdrawal by Subject|1
4682529|NCT02551692|16118497|P2|Overall Study|Withdrawal by Subject|0
4682530|NCT02551692|16118498|P1|Overall Study|Withdrawal by Subject|1
4682531|NCT02551692|16118496|P3|Overall Study|Lost to Follow-up|4
4682532|NCT02551692|16118497|P2|Overall Study|Lost to Follow-up|1
4682533|NCT02551692|16118498|P1|Overall Study|Lost to Follow-up|0
4682534|NCT02551666|16118514|P2|Overall Study|Withdrawal by Subject|3
4682535|NCT02551666|16118515|P1|Overall Study|Withdrawal by Subject|1
4682536|NCT02551055|16118605|P8|Overall Study|Reason not specified|0
4682537|NCT02551055|16118606|P7|Overall Study|Reason not specified|1
4682538|NCT02551055|16118607|P6|Overall Study|Reason not specified|0
4682539|NCT02551055|16118608|P5|Overall Study|Reason not specified|1
4682540|NCT02551055|16118609|P4|Overall Study|Reason not specified|0
4682541|NCT02551055|16118610|P3|Overall Study|Reason not specified|0
4682542|NCT02551055|16118611|P2|Overall Study|Reason not specified|0
4682543|NCT02551055|16118612|P1|Overall Study|Reason not specified|0
4682544|NCT02551055|16118605|P8|Overall Study|Withdrawal by Subject|0
4682545|NCT02551055|16118606|P7|Overall Study|Withdrawal by Subject|0
4682546|NCT02551055|16118607|P6|Overall Study|Withdrawal by Subject|0
4682547|NCT02551055|16118608|P5|Overall Study|Withdrawal by Subject|2
4682548|NCT02551055|16118609|P4|Overall Study|Withdrawal by Subject|1
4682549|NCT02551055|16118610|P3|Overall Study|Withdrawal by Subject|0
4682550|NCT02551055|16118611|P2|Overall Study|Withdrawal by Subject|1
4682551|NCT02551055|16118612|P1|Overall Study|Withdrawal by Subject|1
4682552|NCT02551055|16118605|P8|Overall Study|Study Terminated by Sponsor|0
4682553|NCT02551055|16118606|P7|Overall Study|Study Terminated by Sponsor|0
4682554|NCT02551055|16118607|P6|Overall Study|Study Terminated by Sponsor|0
4682555|NCT02551055|16118608|P5|Overall Study|Study Terminated by Sponsor|2
4682556|NCT02551055|16118609|P4|Overall Study|Study Terminated by Sponsor|2
4682557|NCT02551055|16118610|P3|Overall Study|Study Terminated by Sponsor|0
4682558|NCT02551055|16118611|P2|Overall Study|Study Terminated by Sponsor|1
4682559|NCT02551055|16118612|P1|Overall Study|Study Terminated by Sponsor|1
4682560|NCT02551055|16118605|P8|Overall Study|Death|0
4682561|NCT02551055|16118606|P7|Overall Study|Death|2
4682562|NCT02551055|16118607|P6|Overall Study|Death|1
4682563|NCT02551055|16118608|P5|Overall Study|Death|2
4682564|NCT02551055|16118609|P4|Overall Study|Death|2
4682565|NCT02551055|16118610|P3|Overall Study|Death|2
4682566|NCT02551055|16118611|P2|Overall Study|Death|4
4682567|NCT02551055|16118612|P1|Overall Study|Death|2
4682568|NCT02550873|16118687|P3|Open Label Extension|Study ongoing|111
4682569|NCT02550873|16118688|P2|Open Label Extension|Study ongoing|0
4682570|NCT02550873|16118689|P1|Open Label Extension|Study ongoing|0
4682571|NCT02550873|16118687|P3|Randomized Double Blind|Disease progression|0
4682572|NCT02550873|16118688|P2|Randomized Double Blind|Disease progression|1
4682573|NCT02550873|16118689|P1|Randomized Double Blind|Disease progression|1
4682574|NCT02550873|16118687|P3|Randomized Double Blind|Adverse Event|0
4682575|NCT02550873|16118688|P2|Randomized Double Blind|Adverse Event|1
4682576|NCT02550873|16118689|P1|Randomized Double Blind|Adverse Event|3
4682577|NCT02550795|16118770|P3|Overall Study|Physician Decision|0
4682578|NCT02550795|16118771|P2|Overall Study|Physician Decision|1
4682579|NCT02550795|16118772|P1|Overall Study|Physician Decision|0
4682580|NCT02550652|16118788|P2|Overall Study|Ongoing in study|56
4682581|NCT02550652|16118789|P1|Overall Study|Ongoing in study|59
4682582|NCT02550652|16118788|P2|Overall Study|Withdrawal by Subject|4
4682583|NCT02550652|16118789|P1|Overall Study|Withdrawal by Subject|3
4682584|NCT02550652|16118788|P2|Overall Study|Lack of Efficacy|0
4682585|NCT02550652|16118789|P1|Overall Study|Lack of Efficacy|1
4682586|NCT02550652|16118788|P2|Overall Study|Death|2
4682587|NCT02550652|16118789|P1|Overall Study|Death|0
4682588|NCT02550288|16118836|P5|Overall Study|Withdrawal by Subject|0
4682589|NCT02550288|16118837|P4|Overall Study|Withdrawal by Subject|1
4682590|NCT02550288|16118838|P3|Overall Study|Withdrawal by Subject|0
4682591|NCT02550288|16118839|P2|Overall Study|Withdrawal by Subject|0
4682592|NCT02550288|16118840|P1|Overall Study|Withdrawal by Subject|0
4682593|NCT02550288|16118836|P5|Overall Study|Participant moved|0
4682594|NCT02550288|16118837|P4|Overall Study|Participant moved|1
4682595|NCT02550288|16118838|P3|Overall Study|Participant moved|0
4682596|NCT02550288|16118839|P2|Overall Study|Participant moved|0
4682597|NCT02550288|16118840|P1|Overall Study|Participant moved|0
4682598|NCT02550288|16118836|P5|Overall Study|Protocol Violation|3
4682599|NCT02550288|16118837|P4|Overall Study|Protocol Violation|0
4682600|NCT02550288|16118838|P3|Overall Study|Protocol Violation|1
4682601|NCT02550288|16118839|P2|Overall Study|Protocol Violation|2
4682602|NCT02550288|16118840|P1|Overall Study|Protocol Violation|2
4682603|NCT02550288|16118836|P5|Overall Study|Physician Decision|0
4682604|NCT02550288|16118837|P4|Overall Study|Physician Decision|1
4682605|NCT02550288|16118838|P3|Overall Study|Physician Decision|0
4682606|NCT02550288|16118839|P2|Overall Study|Physician Decision|0
4682607|NCT02550288|16118840|P1|Overall Study|Physician Decision|0
4682608|NCT02550288|16118836|P5|Overall Study|Adverse Event|0
4682609|NCT02550288|16118837|P4|Overall Study|Adverse Event|0
4682610|NCT02550288|16118838|P3|Overall Study|Adverse Event|0
4682611|NCT02550288|16118839|P2|Overall Study|Adverse Event|1
4682612|NCT02550288|16118840|P1|Overall Study|Adverse Event|0
4682613|NCT02550106|16118996|P1|Overall Study|Withdrawal by Subject|2
4682614|NCT02550106|16118996|P1|Overall Study|Protocol Violation|6
4682615|NCT02550106|16118996|P1|Overall Study|Lack of Efficacy|3
4682616|NCT02550106|16118996|P1|Overall Study|Adverse Event|1
4682617|NCT02549859|16119020|P1|Long-term 60 Hz DBS|Study Closed|1
4682618|NCT02549573|16119106|P2|Overall Study|Protocol Violation|1
4682619|NCT02549573|16119107|P1|Overall Study|Protocol Violation|0
4682620|NCT02549573|16119106|P2|Overall Study|Withdrawal by Subject|2
4682621|NCT02549573|16119107|P1|Overall Study|Withdrawal by Subject|0
4682622|NCT02549352|16119161|P2|12-month Follow-up|Other|3
4682623|NCT02549352|16119162|P1|12-month Follow-up|Other|1
4682624|NCT02549352|16119161|P2|12-month Follow-up|Protocol Violation|1
4682625|NCT02549352|16119162|P1|12-month Follow-up|Protocol Violation|0
4682626|NCT02549352|16119161|P2|12-month Follow-up|Death|1
4682627|NCT02549352|16119162|P1|12-month Follow-up|Death|0
4682628|NCT02549352|16119161|P2|12-month Follow-up|Lost to Follow-up|2
4682629|NCT02549352|16119162|P1|12-month Follow-up|Lost to Follow-up|3
4682630|NCT02549352|16119161|P2|12-month Follow-up|Withdrawal by Subject|5
4682631|NCT02549352|16119162|P1|12-month Follow-up|Withdrawal by Subject|4
4682632|NCT02549352|16119161|P2|3-day Treatment and 8-week Follow-up|Other|2
4682633|NCT02549352|16119162|P1|3-day Treatment and 8-week Follow-up|Other|0
4682634|NCT02549352|16119161|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
4682635|NCT02549352|16119162|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
4682636|NCT02549352|16119161|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
4682637|NCT02549352|16119162|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
4682638|NCT02549339|16119178|P2|12-month Follow-up|Other|3
4682639|NCT02549339|16119179|P1|12-month Follow-up|Other|0
4682640|NCT02549339|16119178|P2|12-month Follow-up|Lost to Follow-up|3
4682641|NCT02549339|16119179|P1|12-month Follow-up|Lost to Follow-up|1
4682642|NCT02549339|16119178|P2|12-month Follow-up|Withdrawal by Subject|3
4682643|NCT02549339|16119179|P1|12-month Follow-up|Withdrawal by Subject|8
4682644|NCT02549339|16119178|P2|12-month Follow-up|Lack of Efficacy|2
4682645|NCT02549339|16119179|P1|12-month Follow-up|Lack of Efficacy|0
4682646|NCT02549339|16119178|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2
4682647|NCT02549339|16119179|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
4682648|NCT02549339|16119178|P2|3-day Treatment and 8-week Follow-up|Other|0
4682649|NCT02549339|16119179|P1|3-day Treatment and 8-week Follow-up|Other|1
4682650|NCT02549339|16119178|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3
4682651|NCT02549339|16119179|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1
4682652|NCT02549339|16119178|P2|3-day Treatment and 8-week Follow-up|Protocol Violation|0
4682653|NCT02549339|16119179|P1|3-day Treatment and 8-week Follow-up|Protocol Violation|2
4682654|NCT02549287|16119195|P2|Overall Study|Withdrawal by Subject|6
4682655|NCT02549287|16119196|P1|Overall Study|Withdrawal by Subject|15
4682656|NCT02549287|16119195|P2|Overall Study|Lost to Follow-up|26
4682657|NCT02549287|16119196|P1|Overall Study|Lost to Follow-up|65
4682658|NCT02549196|16119230|P4|Overall Study|Withdrawal by Subject|0
4682659|NCT02549196|16119231|P3|Overall Study|Withdrawal by Subject|1
4682660|NCT02549196|16119232|P2|Overall Study|Withdrawal by Subject|0
4682661|NCT02549196|16119233|P1|Overall Study|Withdrawal by Subject|1
4682662|NCT02549196|16119230|P4|Overall Study|Protocol Violation|1
4682663|NCT02549196|16119231|P3|Overall Study|Protocol Violation|0
4682664|NCT02549196|16119232|P2|Overall Study|Protocol Violation|0
4682665|NCT02549196|16119233|P1|Overall Study|Protocol Violation|0
4682666|NCT02549027|16119289|P6|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4682667|NCT02549027|16119290|P5|Period 5 - MK-6096 or Placebo|Protocol Violation|2
4682668|NCT02549027|16119291|P4|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4682669|NCT02549027|16119292|P3|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4682670|NCT02549027|16119293|P2|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4682671|NCT02549027|16119294|P1|Period 5 - MK-6096 or Placebo|Protocol Violation|0
4682672|NCT02549027|16119289|P6|Washout After Period 4|Withdrawal by Subject|0
4682673|NCT02549027|16119290|P5|Washout After Period 4|Withdrawal by Subject|0
4682674|NCT02549027|16119291|P4|Washout After Period 4|Withdrawal by Subject|1
4682675|NCT02549027|16119292|P3|Washout After Period 4|Withdrawal by Subject|1
4682676|NCT02549027|16119293|P2|Washout After Period 4|Withdrawal by Subject|1
4682677|NCT02549027|16119294|P1|Washout After Period 4|Withdrawal by Subject|0
4682678|NCT02548962|16119424|P2|Overall Study|Withdrawal by Subject|0
4682679|NCT02548962|16119425|P1|Overall Study|Withdrawal by Subject|1
4682680|NCT02548650|16119477|P2|Double Therapy|Withdrawal by Subject|1
4682681|NCT02548650|16119478|P1|Double Therapy|Withdrawal by Subject|0
4682682|NCT02548650|16119477|P2|Double Therapy|Adverse Event|1
4682683|NCT02548650|16119478|P1|Double Therapy|Adverse Event|1
4682684|NCT02548650|16119477|P2|Triple Therapy|Withdrawal by Subject|4
4682685|NCT02548650|16119478|P1|Triple Therapy|Withdrawal by Subject|0
4682686|NCT02548650|16119477|P2|Triple Therapy|Adverse Event|0
4682687|NCT02548650|16119478|P1|Triple Therapy|Adverse Event|1
4682688|NCT02548585|16119493|P7|Overall Study|Randomized but not treated|0
4682689|NCT02548585|16119494|P6|Overall Study|Randomized but not treated|1
4682690|NCT02548585|16119495|P5|Overall Study|Randomized but not treated|0
4682691|NCT02548585|16119496|P4|Overall Study|Randomized but not treated|0
4682692|NCT02548585|16119497|P3|Overall Study|Randomized but not treated|0
4682693|NCT02548585|16119498|P2|Overall Study|Randomized but not treated|0
4682694|NCT02548585|16119499|P1|Overall Study|Randomized but not treated|0
4682695|NCT02548585|16119493|P7|Overall Study|Other|1
4682696|NCT02548585|16119494|P6|Overall Study|Other|0
4682697|NCT02548585|16119495|P5|Overall Study|Other|3
4682698|NCT02548585|16119496|P4|Overall Study|Other|2
4682699|NCT02548585|16119497|P3|Overall Study|Other|0
4682700|NCT02548585|16119498|P2|Overall Study|Other|0
4682701|NCT02548585|16119499|P1|Overall Study|Other|1
4682702|NCT02548585|16119493|P7|Overall Study|Lost to Follow-up|0
4682703|NCT02548585|16119494|P6|Overall Study|Lost to Follow-up|0
4682704|NCT02548585|16119495|P5|Overall Study|Lost to Follow-up|0
4682705|NCT02548585|16119496|P4|Overall Study|Lost to Follow-up|0
4682706|NCT02548585|16119497|P3|Overall Study|Lost to Follow-up|0
4682707|NCT02548585|16119498|P2|Overall Study|Lost to Follow-up|0
4682708|NCT02548585|16119499|P1|Overall Study|Lost to Follow-up|1
4682709|NCT02548585|16119493|P7|Overall Study|Withdrawal by Subject|0
4682710|NCT02548585|16119494|P6|Overall Study|Withdrawal by Subject|1
4682711|NCT02548585|16119495|P5|Overall Study|Withdrawal by Subject|0
4682712|NCT02548585|16119496|P4|Overall Study|Withdrawal by Subject|0
4682713|NCT02548585|16119497|P3|Overall Study|Withdrawal by Subject|0
4682714|NCT02548585|16119498|P2|Overall Study|Withdrawal by Subject|0
4682715|NCT02548585|16119499|P1|Overall Study|Withdrawal by Subject|0
4682716|NCT02548455|16119717|P1|Overall Study|Visit not completed|173
4682717|NCT02548455|16119717|P1|Overall Study|Lost to Follow-up|14
4682718|NCT02548455|16119717|P1|Overall Study|Death|26
4682719|NCT02548455|16119717|P1|Overall Study|Withdrawal by Subject|27
4682720|NCT02548156|16119778|P6|Washout Period 1|Lost to Follow-up|0
4682721|NCT02548156|16119779|P5|Washout Period 1|Lost to Follow-up|1
4682722|NCT02548156|16119780|P4|Washout Period 1|Lost to Follow-up|0
4682723|NCT02548156|16119781|P3|Washout Period 1|Lost to Follow-up|0
4682724|NCT02548156|16119782|P2|Washout Period 1|Lost to Follow-up|0
4682725|NCT02548156|16119783|P1|Washout Period 1|Lost to Follow-up|0
4682726|NCT02548143|16119802|P2|Overall Study|Withdrawal by Subject|1
4682727|NCT02548143|16119803|P1|Overall Study|Withdrawal by Subject|0
4682728|NCT02548143|16119802|P2|Overall Study|Adverse Event|0
4682729|NCT02548143|16119803|P1|Overall Study|Adverse Event|1
4682730|NCT02548078|16119815|P2|Overall Study|Lost to Follow-up|3
4682731|NCT02548078|16119816|P1|Overall Study|Lost to Follow-up|1
4682732|NCT02548078|16119815|P2|Overall Study|Moved from study area|3
4682733|NCT02548078|16119816|P1|Overall Study|Moved from study area|3
4682734|NCT02548078|16119815|P2|Overall Study|Serious adverse event/Adverse event|0
4682735|NCT02548078|16119816|P1|Overall Study|Serious adverse event/Adverse event|1
4682736|NCT02547987|16120004|P1|Overall Study|Adverse Event|2
4682737|NCT02547987|16120004|P1|Overall Study|Withdrawal by Subject|1
4682738|NCT02547974|16120012|P4|Overall Study|Withdrawal by Subject|0
4682739|NCT02547974|16120013|P3|Overall Study|Withdrawal by Subject|0
4682740|NCT02547974|16120014|P2|Overall Study|Withdrawal by Subject|0
4682741|NCT02547974|16120015|P1|Overall Study|Withdrawal by Subject|1
4682742|NCT02547935|16120102|P3|Overall Study|Death|0
4682743|NCT02547935|16120103|P2|Overall Study|Death|1
4682744|NCT02547935|16120104|P1|Overall Study|Death|1
4682745|NCT02547935|16120102|P3|Overall Study|Lost to Follow-up|1
4682746|NCT02547935|16120103|P2|Overall Study|Lost to Follow-up|2
4682747|NCT02547935|16120104|P1|Overall Study|Lost to Follow-up|0
4682748|NCT02547935|16120102|P3|Overall Study|Physician Decision|0
4682749|NCT02547935|16120103|P2|Overall Study|Physician Decision|1
4682750|NCT02547935|16120104|P1|Overall Study|Physician Decision|0
4682751|NCT02547935|16120102|P3|Overall Study|Screen Failure|0
4682752|NCT02547935|16120103|P2|Overall Study|Screen Failure|0
4682753|NCT02547935|16120104|P1|Overall Study|Screen Failure|2
4682754|NCT02547935|16120102|P3|Overall Study|Withdrawal by Subject|4
4682755|NCT02547935|16120103|P2|Overall Study|Withdrawal by Subject|3
4682756|NCT02547935|16120104|P1|Overall Study|Withdrawal by Subject|2
4682757|NCT02547935|16120102|P3|Overall Study|Other|0
4682758|NCT02547935|16120103|P2|Overall Study|Other|1
4682759|NCT02547935|16120104|P1|Overall Study|Other|0
4682760|NCT02547766|16120142|P1|Overall Study|Withdrawal by Subject|1
4682761|NCT02547649|16120162|P3|Overall Study|Withdrawal by Subject|2
4682762|NCT02547649|16120163|P2|Overall Study|Withdrawal by Subject|4
4682763|NCT02547649|16120164|P1|Overall Study|Withdrawal by Subject|0
4682764|NCT02547649|16120162|P3|Overall Study|Not vaccinated|1
4682765|NCT02547649|16120163|P2|Overall Study|Not vaccinated|0
4682766|NCT02547649|16120164|P1|Overall Study|Not vaccinated|0
4682767|NCT02547649|16120162|P3|Overall Study|Lost to Follow-up|1
4682768|NCT02547649|16120163|P2|Overall Study|Lost to Follow-up|1
4682769|NCT02547649|16120164|P1|Overall Study|Lost to Follow-up|3
4682770|NCT02547454|16120229|P1|Overall Study|No data|11
4682771|NCT02547454|16120229|P1|Overall Study|Other|39
4682772|NCT02547454|16120229|P1|Overall Study|Lost to Follow-up|26
4682773|NCT02547454|16120229|P1|Overall Study|Death|38
4682774|NCT02547454|16120229|P1|Overall Study|Due to no further need to treat|4
4682775|NCT02547454|16120229|P1|Overall Study|Due to transplantation|1
4682776|NCT02547454|16120229|P1|Overall Study|Due to hemodialysis|53
4682777|NCT02547363|16120259|P2|12-month Follow-up|Other|0
4682778|NCT02547363|16120260|P1|12-month Follow-up|Other|1
4682779|NCT02547363|16120259|P2|12-month Follow-up|Lack of Efficacy|1
4682780|NCT02547363|16120260|P1|12-month Follow-up|Lack of Efficacy|1
4682781|NCT02547363|16120259|P2|12-month Follow-up|Lost to Follow-up|1
4682782|NCT02547363|16120260|P1|12-month Follow-up|Lost to Follow-up|4
4682783|NCT02547363|16120259|P2|12-month Follow-up|Withdrawal by Subject|3
4682784|NCT02547363|16120260|P1|12-month Follow-up|Withdrawal by Subject|4
4682785|NCT02547363|16120259|P2|3-day Treatment and 8-week Follow-up|Other|1
4682786|NCT02547363|16120260|P1|3-day Treatment and 8-week Follow-up|Other|1
4682787|NCT02547363|16120259|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
4682788|NCT02547363|16120260|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
4682789|NCT02547363|16120259|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8
4682790|NCT02547363|16120260|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2
4682791|NCT02547363|16120259|P2|3-day Treatment and 8-week Follow-up|Adverse Event|1
4682792|NCT02547363|16120260|P1|3-day Treatment and 8-week Follow-up|Adverse Event|0
4682793|NCT02547233|16120276|P2|12-month Follow-up|Other|1
4682794|NCT02547233|16120277|P1|12-month Follow-up|Other|0
4682795|NCT02547233|16120276|P2|12-month Follow-up|Protocol Violation|1
4682796|NCT02547233|16120277|P1|12-month Follow-up|Protocol Violation|0
4682797|NCT02547233|16120276|P2|12-month Follow-up|Lack of Efficacy|2
4682798|NCT02547233|16120277|P1|12-month Follow-up|Lack of Efficacy|1
4682799|NCT02547233|16120276|P2|12-month Follow-up|Lost to Follow-up|3
4682800|NCT02547233|16120277|P1|12-month Follow-up|Lost to Follow-up|3
4682801|NCT02547233|16120276|P2|12-month Follow-up|Withdrawal by Subject|10
4682802|NCT02547233|16120277|P1|12-month Follow-up|Withdrawal by Subject|10
4682803|NCT02547233|16120276|P2|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1
4682804|NCT02547233|16120277|P1|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0
4682805|NCT02547233|16120276|P2|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9
4682806|NCT02547233|16120277|P1|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0
4682807|NCT02547233|16120276|P2|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0
4682808|NCT02547233|16120277|P1|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1
4682809|NCT02547233|16120276|P2|3-day Treatment and 8-week Follow-up|Adverse Event|0
4682810|NCT02547233|16120277|P1|3-day Treatment and 8-week Follow-up|Adverse Event|1
4682811|NCT02547220|16120293|P2|Overall Study|Study terminated by sponsor|20
4682812|NCT02547220|16120294|P1|Overall Study|Study terminated by sponsor|18
4682813|NCT02547220|16120293|P2|Overall Study|Withdrawal by Subject|0
4682814|NCT02547220|16120294|P1|Overall Study|Withdrawal by Subject|1
4682815|NCT02547129|16120330|P2|Overall Study|Difficulty with ongoing infection|0
4682816|NCT02547129|16120331|P1|Overall Study|Difficulty with ongoing infection|1
4682817|NCT02547038|16120374|P2|Overall Study|Lost to Follow-up|2
4682818|NCT02547038|16120375|P1|Overall Study|Lost to Follow-up|3
4682819|NCT02546986|16120392|P2|Survival Follow-Up Phase|Lost to Follow-up|2
4682820|NCT02546986|16120393|P1|Survival Follow-Up Phase|Lost to Follow-up|2
4682821|NCT02546986|16120392|P2|Survival Follow-Up Phase|Alive|16
4682822|NCT02546986|16120393|P1|Survival Follow-Up Phase|Alive|13
4682823|NCT02546986|16120392|P2|Survival Follow-Up Phase|Death|12
4682824|NCT02546986|16120393|P1|Survival Follow-Up Phase|Death|18
4682825|NCT02546986|16120392|P2|Survival Follow-Up Phase|Missing Status|5
4682826|NCT02546986|16120393|P1|Survival Follow-Up Phase|Missing Status|3
4682827|NCT02546986|16120392|P2|Treatment Period|Miscellaneous|9
4682828|NCT02546986|16120393|P1|Treatment Period|Miscellaneous|7
4682829|NCT02546986|16120392|P2|Treatment Period|Study Terminated by Sponsor|1
4682830|NCT02546986|16120393|P1|Treatment Period|Study Terminated by Sponsor|0
4682831|NCT02546986|16120392|P2|Treatment Period|Non-compliance with Study Drug|1
4682832|NCT02546986|16120393|P1|Treatment Period|Non-compliance with Study Drug|0
4682833|NCT02546986|16120392|P2|Treatment Period|Withdrawal by Subject|1
4682834|NCT02546986|16120393|P1|Treatment Period|Withdrawal by Subject|1
4682835|NCT02546986|16120392|P2|Treatment Period|Protocol Violation|0
4682836|NCT02546986|16120393|P1|Treatment Period|Protocol Violation|1
4682837|NCT02546986|16120392|P2|Treatment Period|Physician Decision|2
4682838|NCT02546986|16120393|P1|Treatment Period|Physician Decision|1
4682839|NCT02546986|16120392|P2|Treatment Period|Death|4
4682840|NCT02546986|16120393|P1|Treatment Period|Death|3
4682841|NCT02546986|16120392|P2|Treatment Period|Symptomatic Deterioration|3
4682842|NCT02546986|16120393|P1|Treatment Period|Symptomatic Deterioration|4
4682843|NCT02546986|16120392|P2|Treatment Period|Adverse Event|6
4682844|NCT02546986|16120393|P1|Treatment Period|Adverse Event|14
4682845|NCT02546986|16120392|P2|Treatment Period|Progressive Disease|22
4682846|NCT02546986|16120393|P1|Treatment Period|Progressive Disease|20
4682847|NCT02546765|16120420|P4|Overall Study|Withdrawal by Subject|0
4682848|NCT02546765|16120421|P3|Overall Study|Withdrawal by Subject|0
4682849|NCT02546765|16120422|P2|Overall Study|Withdrawal by Subject|1
4682850|NCT02546765|16120423|P1|Overall Study|Withdrawal by Subject|0
4682851|NCT02546609|16120464|P3|Overall Study|travel or work schedule restriction|2
4682852|NCT02546609|16120465|P2|Overall Study|travel or work schedule restriction|0
4682853|NCT02546609|16120466|P1|Overall Study|travel or work schedule restriction|0
4682854|NCT02546609|16120464|P3|Overall Study|Lost to Follow-up|1
4682855|NCT02546609|16120465|P2|Overall Study|Lost to Follow-up|3
4682856|NCT02546609|16120466|P1|Overall Study|Lost to Follow-up|2
4682857|NCT02546609|16120464|P3|Overall Study|Protocol Violation|1
4682858|NCT02546609|16120465|P2|Overall Study|Protocol Violation|1
4682859|NCT02546609|16120466|P1|Overall Study|Protocol Violation|0
4682860|NCT02546609|16120464|P3|Overall Study|Adverse Event|1
4682861|NCT02546609|16120465|P2|Overall Study|Adverse Event|6
4682862|NCT02546609|16120466|P1|Overall Study|Adverse Event|0
4682863|NCT02546609|16120464|P3|Overall Study|Withdrawal by Subject|2
4682864|NCT02546609|16120465|P2|Overall Study|Withdrawal by Subject|1
4682865|NCT02546609|16120466|P1|Overall Study|Withdrawal by Subject|0
4682866|NCT02546544|16120546|P1|Overall Study|Withdrawal by Subject|1
4682867|NCT02546544|16120546|P1|Overall Study|Adverse Event|1
4682868|NCT02546544|16120546|P1|Overall Study|Disease Progression|14
4682869|NCT02546362|16120587|P1|12-week Treatment Period|Change in medication|1
4682870|NCT02546362|16120587|P1|12-week Treatment Period|Lost to Follow-up|2
4682871|NCT02546362|16120587|P1|12-week Treatment Period|Withdrawal by Subject|6
4682872|NCT02546362|16120587|P1|4-week Treatment Period|Change in medication|2
4682873|NCT02546362|16120587|P1|4-week Treatment Period|Lost to Follow-up|1
4682874|NCT02546323|16120608|P2|Overall Study|Met Withdrawal Criteria|14
4682875|NCT02546323|16120609|P1|Overall Study|Met Withdrawal Criteria|2
4682876|NCT02546323|16120608|P2|Overall Study|Non-compliance with Study Drug|2
4682877|NCT02546323|16120609|P1|Overall Study|Non-compliance with Study Drug|2
4682878|NCT02546323|16120608|P2|Overall Study|Lost to Follow-up|3
4682879|NCT02546323|16120609|P1|Overall Study|Lost to Follow-up|2
4682880|NCT02546323|16120608|P2|Overall Study|Patient Specific Reasons|2
4682881|NCT02546323|16120609|P1|Overall Study|Patient Specific Reasons|1
4682882|NCT02546323|16120608|P2|Overall Study|Adverse Event|11
4682883|NCT02546323|16120609|P1|Overall Study|Adverse Event|17
4682884|NCT02546323|16120608|P2|Overall Study|Eligibility Criteria not Fulfilled|1
4682885|NCT02546323|16120609|P1|Overall Study|Eligibility Criteria not Fulfilled|0
4682886|NCT02546323|16120608|P2|Overall Study|Withdrawal by Subject|33
4682887|NCT02546323|16120609|P1|Overall Study|Withdrawal by Subject|36
4682888|NCT02546193|16120629|P4|Overall Study|Not eligible at time of induction|0
4682889|NCT02546193|16120630|P3|Overall Study|Not eligible at time of induction|1
4682890|NCT02546193|16120631|P2|Overall Study|Not eligible at time of induction|6
4682891|NCT02546193|16120632|P1|Overall Study|Not eligible at time of induction|4
4682892|NCT02546193|16120629|P4|Overall Study|Withdrawal by Subject|0
4682893|NCT02546193|16120630|P3|Overall Study|Withdrawal by Subject|1
4682894|NCT02546193|16120631|P2|Overall Study|Withdrawal by Subject|0
4682895|NCT02546193|16120632|P1|Overall Study|Withdrawal by Subject|2
4682896|NCT02545933|16120669|P3|Overall Study|Protocol Violation|1
4682897|NCT02545933|16120670|P2|Overall Study|Protocol Violation|0
4682898|NCT02545933|16120671|P1|Overall Study|Protocol Violation|1
4682899|NCT02545933|16120669|P3|Overall Study|Withdrawal by Subject|3
4682900|NCT02545933|16120670|P2|Overall Study|Withdrawal by Subject|3
4682901|NCT02545933|16120671|P1|Overall Study|Withdrawal by Subject|2
4682902|NCT02545933|16120669|P3|Overall Study|Adverse Event|0
4682903|NCT02545933|16120670|P2|Overall Study|Adverse Event|0
4682904|NCT02545933|16120671|P1|Overall Study|Adverse Event|3
4682905|NCT02545868|16120682|P3|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|34
4682906|NCT02545868|16120683|P2|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|35
4682907|NCT02545868|16120684|P1|Optional Ocrelizumab Ext (OOE) Period|OOE period ongoing|33
4682908|NCT02545543|16120767|P2|Overall Study|Enrolment of subject at >1 study site|1
4682909|NCT02545543|16120768|P1|Overall Study|Enrolment of subject at >1 study site|1
4682910|NCT02545543|16120767|P2|Overall Study|Noncomplaince|0
4682911|NCT02545543|16120768|P1|Overall Study|Noncomplaince|1
4682912|NCT02545543|16120767|P2|Overall Study|Withdrawal by Subject|8
4682913|NCT02545543|16120768|P1|Overall Study|Withdrawal by Subject|9
4682914|NCT02545543|16120767|P2|Overall Study|Physician Decision|0
4682915|NCT02545543|16120768|P1|Overall Study|Physician Decision|3
4682916|NCT02545543|16120767|P2|Overall Study|Lost to Follow-up|25
4682917|NCT02545543|16120768|P1|Overall Study|Lost to Follow-up|67
4682918|NCT02545504|16120794|P2|Overall Study|Lost to Follow-up|2
4682919|NCT02545504|16120795|P1|Overall Study|Lost to Follow-up|2
4682920|NCT02545504|16120794|P2|Overall Study|Investigator's discretion|1
4682921|NCT02545504|16120795|P1|Overall Study|Investigator's discretion|3
4682922|NCT02545504|16120794|P2|Overall Study|Withdrew consent|11
4682923|NCT02545504|16120795|P1|Overall Study|Withdrew consent|9
4682924|NCT02545504|16120794|P2|Overall Study|Unknown reason|32
4682925|NCT02545504|16120795|P1|Overall Study|Unknown reason|30
4682926|NCT02545504|16120794|P2|Overall Study|Death|168
4682927|NCT02545504|16120795|P1|Overall Study|Death|174
4682928|NCT02545322|16120809|P1|Overall Study|Withdrawal by Subject|3
4682929|NCT02545270|16120817|P3|Overall Study|Videos being too similar to other|2
4682930|NCT02545270|16120818|P2|Overall Study|Videos being too similar to other|0
4682931|NCT02545270|16120819|P1|Overall Study|Videos being too similar to other|0
4682932|NCT02545270|16120817|P3|Overall Study|technical difficulties|0
4682933|NCT02545270|16120818|P2|Overall Study|technical difficulties|1
4682934|NCT02545270|16120819|P1|Overall Study|technical difficulties|0
4682935|NCT02545075|16120848|P2|Treatment|Completed treatment|12
4682936|NCT02545075|16120849|P1|Treatment|Completed treatment|40
4682937|NCT02545075|16120848|P2|Treatment|Participant drug toxicity|0
4682938|NCT02545075|16120849|P1|Treatment|Participant drug toxicity|1
4682939|NCT02545075|16120848|P2|Treatment|Death|0
4682940|NCT02545075|16120849|P1|Treatment|Death|1
4682941|NCT02545075|16120848|P2|Treatment|Adverse event not related to study drug|0
4682942|NCT02545075|16120849|P1|Treatment|Adverse event not related to study drug|1
4682943|NCT02545075|16120848|P2|Treatment|Withdrawal by Subject|0
4682944|NCT02545075|16120849|P1|Treatment|Withdrawal by Subject|1
4682945|NCT02545075|16120848|P2|Treatment|Participant dicontinued study treatment|9
4682946|NCT02545075|16120849|P1|Treatment|Participant dicontinued study treatment|7
4682947|NCT02545075|16120848|P2|Treatment|Disease progression|32
4682948|NCT02545075|16120849|P1|Treatment|Disease progression|71
4682949|NCT02545075|16120848|P2|Randomization|Withdrawal by Subject|6
4682950|NCT02545075|16120849|P1|Randomization|Withdrawal by Subject|0
4682951|NCT02545075|16120848|P2|Randomization|Lost to Follow-up|1
4682952|NCT02545075|16120849|P1|Randomization|Lost to Follow-up|0
4682953|NCT02544763|16120885|P3|Overall Study|Difficulties taking IMP|0
4682954|NCT02544763|16120886|P2|Overall Study|Difficulties taking IMP|0
4682955|NCT02544763|16120887|P1|Overall Study|Difficulties taking IMP|1
4682956|NCT02544763|16120885|P3|Overall Study|Physician Decision|0
4682957|NCT02544763|16120886|P2|Overall Study|Physician Decision|1
4682958|NCT02544763|16120887|P1|Overall Study|Physician Decision|0
4682959|NCT02544763|16120885|P3|Overall Study|Met withdrawal criteria|0
4682960|NCT02544763|16120886|P2|Overall Study|Met withdrawal criteria|2
4682961|NCT02544763|16120887|P1|Overall Study|Met withdrawal criteria|0
4682962|NCT02544763|16120885|P3|Overall Study|Withdrawn by parent/guardian|1
4682963|NCT02544763|16120886|P2|Overall Study|Withdrawn by parent/guardian|1
4682964|NCT02544763|16120887|P1|Overall Study|Withdrawn by parent/guardian|1
4682965|NCT02544763|16120885|P3|Overall Study|Adverse Event|0
4682966|NCT02544763|16120886|P2|Overall Study|Adverse Event|8
4682967|NCT02544763|16120887|P1|Overall Study|Adverse Event|8
4682968|NCT02544633|16120911|P4|Survival Follow-up Period|Study Terminated by Sponsor|3
4682969|NCT02544633|16120912|P3|Survival Follow-up Period|Study Terminated by Sponsor|2
4682970|NCT02544633|16120913|P2|Survival Follow-up Period|Study Terminated by Sponsor|4
4682971|NCT02544633|16120914|P1|Survival Follow-up Period|Study Terminated by Sponsor|12
4682972|NCT02544633|16120911|P4|Survival Follow-up Period|Withdrawal by Subject|0
4682973|NCT02544633|16120912|P3|Survival Follow-up Period|Withdrawal by Subject|1
4682974|NCT02544633|16120913|P2|Survival Follow-up Period|Withdrawal by Subject|0
4682975|NCT02544633|16120914|P1|Survival Follow-up Period|Withdrawal by Subject|4
4682976|NCT02544633|16120911|P4|Survival Follow-up Period|Lost to Follow-up|0
4682977|NCT02544633|16120912|P3|Survival Follow-up Period|Lost to Follow-up|1
4682978|NCT02544633|16120913|P2|Survival Follow-up Period|Lost to Follow-up|1
4682979|NCT02544633|16120914|P1|Survival Follow-up Period|Lost to Follow-up|0
4682980|NCT02544633|16120911|P4|Survival Follow-up Period|Death|9
4682981|NCT02544633|16120912|P3|Survival Follow-up Period|Death|3
4682982|NCT02544633|16120913|P2|Survival Follow-up Period|Death|14
4682983|NCT02544633|16120914|P1|Survival Follow-up Period|Death|12
4682984|NCT02544633|16120911|P4|Treatment Period|Clinical Disease Progression|1
4682985|NCT02544633|16120912|P3|Treatment Period|Clinical Disease Progression|0
4682986|NCT02544633|16120913|P2|Treatment Period|Clinical Disease Progression|0
4682987|NCT02544633|16120914|P1|Treatment Period|Clinical Disease Progression|0
4682988|NCT02544633|16120911|P4|Treatment Period|Non-compliance|0
4682989|NCT02544633|16120912|P3|Treatment Period|Non-compliance|1
4682990|NCT02544633|16120913|P2|Treatment Period|Non-compliance|0
4682991|NCT02544633|16120914|P1|Treatment Period|Non-compliance|0
4682992|NCT02544633|16120911|P4|Treatment Period|Death|0
4682993|NCT02544633|16120912|P3|Treatment Period|Death|1
4682994|NCT02544633|16120913|P2|Treatment Period|Death|0
4682995|NCT02544633|16120914|P1|Treatment Period|Death|0
4682996|NCT02544633|16120911|P4|Treatment Period|Lost to Follow-up|0
4682997|NCT02544633|16120912|P3|Treatment Period|Lost to Follow-up|0
4682998|NCT02544633|16120913|P2|Treatment Period|Lost to Follow-up|1
4682999|NCT02544633|16120914|P1|Treatment Period|Lost to Follow-up|0
4683000|NCT02544633|16120911|P4|Treatment Period|Withdrawal by Subject|0
4683001|NCT02544633|16120912|P3|Treatment Period|Withdrawal by Subject|0
4683002|NCT02544633|16120913|P2|Treatment Period|Withdrawal by Subject|0
4683003|NCT02544633|16120914|P1|Treatment Period|Withdrawal by Subject|1
4683004|NCT02544633|16120911|P4|Treatment Period|Global Deterioration of Health|1
4683005|NCT02544633|16120912|P3|Treatment Period|Global Deterioration of Health|0
4683006|NCT02544633|16120913|P2|Treatment Period|Global Deterioration of Health|3
4683007|NCT02544633|16120914|P1|Treatment Period|Global Deterioration of Health|3
4683008|NCT02544633|16120911|P4|Treatment Period|Lack of Efficacy|5
4683009|NCT02544633|16120912|P3|Treatment Period|Lack of Efficacy|5
4683010|NCT02544633|16120913|P2|Treatment Period|Lack of Efficacy|11
4683011|NCT02544633|16120914|P1|Treatment Period|Lack of Efficacy|17
4683012|NCT02544633|16120911|P4|Treatment Period|Adverse Event|5
4683013|NCT02544633|16120912|P3|Treatment Period|Adverse Event|0
4683014|NCT02544633|16120913|P2|Treatment Period|Adverse Event|4
4683015|NCT02544633|16120914|P1|Treatment Period|Adverse Event|7
4683016|NCT02544633|16120911|P4|Treatment Period|Patient Still on Treatment/Study|0
4683017|NCT02544633|16120912|P3|Treatment Period|Patient Still on Treatment/Study|1
4683018|NCT02544633|16120913|P2|Treatment Period|Patient Still on Treatment/Study|1
4683019|NCT02544633|16120914|P1|Treatment Period|Patient Still on Treatment/Study|0
4683020|NCT02544451|16120998|P3|Overall Study|Other|0
4683021|NCT02544451|16120999|P2|Overall Study|Other|4
4683022|NCT02544451|16121000|P1|Overall Study|Other|4
4683023|NCT02544451|16120998|P3|Overall Study|Physician Decision|0
4683024|NCT02544451|16120999|P2|Overall Study|Physician Decision|0
4683025|NCT02544451|16121000|P1|Overall Study|Physician Decision|4
4683026|NCT02544451|16120998|P3|Overall Study|Lost to Follow-up|0
4683027|NCT02544451|16120999|P2|Overall Study|Lost to Follow-up|0
4683028|NCT02544451|16121000|P1|Overall Study|Lost to Follow-up|2
4683029|NCT02544451|16120998|P3|Overall Study|Withdrawal of consent (not due to AE)|1
4683030|NCT02544451|16120999|P2|Overall Study|Withdrawal of consent (not due to AE)|2
4683031|NCT02544451|16121000|P1|Overall Study|Withdrawal of consent (not due to AE)|3
4683032|NCT02544451|16120998|P3|Overall Study|Adverse Event|0
4683033|NCT02544451|16120999|P2|Overall Study|Adverse Event|6
4683034|NCT02544451|16121000|P1|Overall Study|Adverse Event|1
4683035|NCT02544152|16121045|P2|Overall Study|Other|0
4683036|NCT02544152|16121046|P1|Overall Study|Other|1
4683037|NCT02544152|16121045|P2|Overall Study|Withdrawal by Subject|3
4683038|NCT02544152|16121046|P1|Overall Study|Withdrawal by Subject|0
4683039|NCT02544152|16121045|P2|Overall Study|Adverse Event|4
4683040|NCT02544152|16121046|P1|Overall Study|Adverse Event|0
4683041|NCT02544074|16121089|P21|Overall Study|Tablet error|0
4683042|NCT02544074|16121090|P20|Overall Study|Tablet error|0
4683043|NCT02544074|16121091|P19|Overall Study|Tablet error|0
4683044|NCT02544074|16121092|P18|Overall Study|Tablet error|0
4683045|NCT02544074|16121093|P17|Overall Study|Tablet error|0
4683046|NCT02544074|16121094|P16|Overall Study|Tablet error|0
4683047|NCT02544074|16121095|P15|Overall Study|Tablet error|0
4683048|NCT02544074|16121096|P14|Overall Study|Tablet error|0
4683049|NCT02544074|16121097|P13|Overall Study|Tablet error|0
4683050|NCT02544074|16121098|P12|Overall Study|Tablet error|0
4683051|NCT02544074|16121099|P11|Overall Study|Tablet error|0
4683052|NCT02544074|16121100|P10|Overall Study|Tablet error|1
4683053|NCT02544074|16121101|P9|Overall Study|Tablet error|0
4683054|NCT02544074|16121102|P8|Overall Study|Tablet error|0
4683055|NCT02544074|16121103|P7|Overall Study|Tablet error|0
4683056|NCT02544074|16121104|P6|Overall Study|Tablet error|1
4683057|NCT02544074|16121105|P5|Overall Study|Tablet error|0
4683058|NCT02544074|16121106|P4|Overall Study|Tablet error|0
4683059|NCT02544074|16121107|P3|Overall Study|Tablet error|0
4683060|NCT02544074|16121108|P2|Overall Study|Tablet error|0
4683061|NCT02544074|16121109|P1|Overall Study|Tablet error|0
4683062|NCT02544074|16121089|P21|Overall Study|Withdrawal by Subject|0
4683063|NCT02544074|16121090|P20|Overall Study|Withdrawal by Subject|0
4683064|NCT02544074|16121091|P19|Overall Study|Withdrawal by Subject|0
4683065|NCT02544074|16121092|P18|Overall Study|Withdrawal by Subject|0
4683066|NCT02544074|16121093|P17|Overall Study|Withdrawal by Subject|0
4683067|NCT02544074|16121094|P16|Overall Study|Withdrawal by Subject|0
4683068|NCT02544074|16121095|P15|Overall Study|Withdrawal by Subject|0
4683069|NCT02544074|16121096|P14|Overall Study|Withdrawal by Subject|0
4683070|NCT02544074|16121097|P13|Overall Study|Withdrawal by Subject|0
4683071|NCT02544074|16121098|P12|Overall Study|Withdrawal by Subject|0
4683072|NCT02544074|16121099|P11|Overall Study|Withdrawal by Subject|0
4683073|NCT02544074|16121100|P10|Overall Study|Withdrawal by Subject|0
4683074|NCT02544074|16121101|P9|Overall Study|Withdrawal by Subject|0
4683075|NCT02544074|16121102|P8|Overall Study|Withdrawal by Subject|0
4683076|NCT02544074|16121103|P7|Overall Study|Withdrawal by Subject|0
4683077|NCT02544074|16121104|P6|Overall Study|Withdrawal by Subject|0
4683078|NCT02544074|16121105|P5|Overall Study|Withdrawal by Subject|0
4683079|NCT02544074|16121106|P4|Overall Study|Withdrawal by Subject|0
4683080|NCT02544074|16121107|P3|Overall Study|Withdrawal by Subject|0
4683081|NCT02544074|16121108|P2|Overall Study|Withdrawal by Subject|1
4683082|NCT02544074|16121109|P1|Overall Study|Withdrawal by Subject|0
4683083|NCT02543918|16121145|P2|Overall Study|Adverse Event|1
4683084|NCT02543918|16121146|P1|Overall Study|Adverse Event|1
4683085|NCT02543918|16121145|P2|Overall Study|Withdrawal by Subject|1
4683086|NCT02543918|16121146|P1|Overall Study|Withdrawal by Subject|1
4683087|NCT02543918|16121145|P2|Overall Study|Lost to Follow-up|1
4683088|NCT02543918|16121146|P1|Overall Study|Lost to Follow-up|1
4683089|NCT02543918|16121145|P2|Overall Study|Never treated|1
4683090|NCT02543918|16121146|P1|Overall Study|Never treated|0
4683091|NCT02543892|16121160|P8|Had Immunology Data|Withdrawal by Subject|0
4683092|NCT02543892|16121161|P7|Had Immunology Data|Withdrawal by Subject|1
4683093|NCT02543892|16121162|P6|Had Immunology Data|Withdrawal by Subject|0
4683094|NCT02543892|16121163|P5|Had Immunology Data|Withdrawal by Subject|0
4683095|NCT02543892|16121164|P4|Had Immunology Data|Withdrawal by Subject|0
4683096|NCT02543892|16121165|P3|Had Immunology Data|Withdrawal by Subject|0
4683097|NCT02543892|16121166|P2|Had Immunology Data|Withdrawal by Subject|0
4683098|NCT02543892|16121167|P1|Had Immunology Data|Withdrawal by Subject|0
4683099|NCT02543892|16121160|P8|Received Vaccination 2|Adverse Event|0
4683100|NCT02543892|16121161|P7|Received Vaccination 2|Adverse Event|0
4683101|NCT02543892|16121162|P6|Received Vaccination 2|Adverse Event|0
4683102|NCT02543892|16121163|P5|Received Vaccination 2|Adverse Event|0
4683103|NCT02543892|16121164|P4|Received Vaccination 2|Adverse Event|0
4683104|NCT02543892|16121165|P3|Received Vaccination 2|Adverse Event|0
4683105|NCT02543892|16121166|P2|Received Vaccination 2|Adverse Event|1
4683106|NCT02543892|16121167|P1|Received Vaccination 2|Adverse Event|0
4683107|NCT02543892|16121160|P8|Received Vaccination 2|Physician Decision|0
4683108|NCT02543892|16121161|P7|Received Vaccination 2|Physician Decision|0
4683109|NCT02543892|16121162|P6|Received Vaccination 2|Physician Decision|1
4683110|NCT02543892|16121163|P5|Received Vaccination 2|Physician Decision|0
4683111|NCT02543892|16121164|P4|Received Vaccination 2|Physician Decision|0
4683112|NCT02543892|16121165|P3|Received Vaccination 2|Physician Decision|0
4683113|NCT02543892|16121166|P2|Received Vaccination 2|Physician Decision|0
4683114|NCT02543892|16121167|P1|Received Vaccination 2|Physician Decision|0
4683115|NCT02543892|16121160|P8|Received Vaccination 2|Withdrawal by Subject|1
4683116|NCT02543892|16121161|P7|Received Vaccination 2|Withdrawal by Subject|0
4683117|NCT02543892|16121162|P6|Received Vaccination 2|Withdrawal by Subject|0
4683118|NCT02543892|16121163|P5|Received Vaccination 2|Withdrawal by Subject|0
4683119|NCT02543892|16121164|P4|Received Vaccination 2|Withdrawal by Subject|0
4683120|NCT02543892|16121165|P3|Received Vaccination 2|Withdrawal by Subject|0
4683121|NCT02543892|16121166|P2|Received Vaccination 2|Withdrawal by Subject|0
4683122|NCT02543892|16121167|P1|Received Vaccination 2|Withdrawal by Subject|1
4683123|NCT02543801|16121234|P4|Overall Study|Protocol Violation|0
4683124|NCT02543801|16121235|P3|Overall Study|Protocol Violation|0
4683125|NCT02543801|16121236|P2|Overall Study|Protocol Violation|2
4683126|NCT02543801|16121237|P1|Overall Study|Protocol Violation|1
4683127|NCT02543658|16121257|P2|Overall Study|Lack of Efficacy|4
4683128|NCT02543658|16121258|P1|Overall Study|Lack of Efficacy|0
4683129|NCT02543528|16121295|P5|Extended Wear Period|Withdrawal by Subject|0
4683130|NCT02543528|16121296|P4|Extended Wear Period|Withdrawal by Subject|5
4683131|NCT02543528|16121297|P3|Extended Wear Period|Withdrawal by Subject|4
4683132|NCT02543528|16121298|P2|Extended Wear Period|Withdrawal by Subject|9
4683133|NCT02543528|16121299|P1|Extended Wear Period|Withdrawal by Subject|10
4683134|NCT02543528|16121295|P5|Extended Wear Period|Lost to Follow-up|0
4683135|NCT02543528|16121296|P4|Extended Wear Period|Lost to Follow-up|1
4683136|NCT02543528|16121297|P3|Extended Wear Period|Lost to Follow-up|2
4683137|NCT02543528|16121298|P2|Extended Wear Period|Lost to Follow-up|1
4683138|NCT02543528|16121299|P1|Extended Wear Period|Lost to Follow-up|0
4683139|NCT02543528|16121295|P5|Extended Wear Period|Unsatisfactory Lens Fitting|0
4683140|NCT02543528|16121296|P4|Extended Wear Period|Unsatisfactory Lens Fitting|0
4683141|NCT02543528|16121297|P3|Extended Wear Period|Unsatisfactory Lens Fitting|0
4683142|NCT02543528|16121298|P2|Extended Wear Period|Unsatisfactory Lens Fitting|0
4683143|NCT02543528|16121299|P1|Extended Wear Period|Unsatisfactory Lens Fitting|1
4683144|NCT02543528|16121295|P5|Extended Wear Period|Missed too many scheduled visits|0
4683145|NCT02543528|16121296|P4|Extended Wear Period|Missed too many scheduled visits|3
4683146|NCT02543528|16121297|P3|Extended Wear Period|Missed too many scheduled visits|1
4683147|NCT02543528|16121298|P2|Extended Wear Period|Missed too many scheduled visits|0
4683148|NCT02543528|16121299|P1|Extended Wear Period|Missed too many scheduled visits|0
4683149|NCT02543528|16121295|P5|Extended Wear Period|Adverse Event|0
4683150|NCT02543528|16121296|P4|Extended Wear Period|Adverse Event|3
4683151|NCT02543528|16121297|P3|Extended Wear Period|Adverse Event|16
4683152|NCT02543528|16121298|P2|Extended Wear Period|Adverse Event|11
4683153|NCT02543528|16121299|P1|Extended Wear Period|Adverse Event|17
4683154|NCT02543528|16121295|P5|Adaptation Period|Adverse Event|2
4683155|NCT02543528|16121296|P4|Adaptation Period|Adverse Event|0
4683156|NCT02543528|16121297|P3|Adaptation Period|Adverse Event|0
4683157|NCT02543528|16121298|P2|Adaptation Period|Adverse Event|0
4683158|NCT02543528|16121299|P1|Adaptation Period|Adverse Event|0
4683159|NCT02543528|16121295|P5|Adaptation Period|Lost to Follow-up|14
4683160|NCT02543528|16121296|P4|Adaptation Period|Lost to Follow-up|0
4683161|NCT02543528|16121297|P3|Adaptation Period|Lost to Follow-up|0
4683162|NCT02543528|16121298|P2|Adaptation Period|Lost to Follow-up|0
4683163|NCT02543528|16121299|P1|Adaptation Period|Lost to Follow-up|0
4683164|NCT02543528|16121295|P5|Adaptation Period|Lens Handling Difficultes|8
4683165|NCT02543528|16121296|P4|Adaptation Period|Lens Handling Difficultes|0
4683166|NCT02543528|16121297|P3|Adaptation Period|Lens Handling Difficultes|0
4683167|NCT02543528|16121298|P2|Adaptation Period|Lens Handling Difficultes|0
4683168|NCT02543528|16121299|P1|Adaptation Period|Lens Handling Difficultes|0
4683169|NCT02543528|16121295|P5|Adaptation Period|Unsatisfactory Lens Fitting|2
4683170|NCT02543528|16121296|P4|Adaptation Period|Unsatisfactory Lens Fitting|0
4683171|NCT02543528|16121297|P3|Adaptation Period|Unsatisfactory Lens Fitting|0
4683172|NCT02543528|16121298|P2|Adaptation Period|Unsatisfactory Lens Fitting|0
4683173|NCT02543528|16121299|P1|Adaptation Period|Unsatisfactory Lens Fitting|0
4683174|NCT02543346|16121332|P4|Second Priming Visit|Adverse Event|0
4683175|NCT02543346|16121333|P3|Second Priming Visit|Adverse Event|0
4683176|NCT02543346|16121334|P2|Second Priming Visit|Adverse Event|0
4683177|NCT02543346|16121335|P1|Second Priming Visit|Adverse Event|1
4683178|NCT02543346|16121332|P4|Second Priming Visit|Withdrawal by Subject|2
4683179|NCT02543346|16121333|P3|Second Priming Visit|Withdrawal by Subject|2
4683180|NCT02543346|16121334|P2|Second Priming Visit|Withdrawal by Subject|2
4683181|NCT02543346|16121335|P1|Second Priming Visit|Withdrawal by Subject|0
4683182|NCT02543294|16121361|P1|Overall Study|Withdrawal by Subject|7
4683183|NCT02543294|16121361|P1|Overall Study|Physician Decision|2
4683184|NCT02543294|16121361|P1|Overall Study|Lost to Follow-up|3
4683185|NCT02542943|16121369|P3|Overall Study|Withdrawal by Subject|0
4683186|NCT02542943|16121370|P2|Overall Study|Withdrawal by Subject|1
4683187|NCT02542943|16121371|P1|Overall Study|Withdrawal by Subject|0
4683188|NCT02542943|16121369|P3|Overall Study|Lost to Follow-up|0
4683189|NCT02542943|16121370|P2|Overall Study|Lost to Follow-up|0
4683190|NCT02542943|16121371|P1|Overall Study|Lost to Follow-up|1
4683191|NCT02542865|16121398|P2|Overall Study|Withdrawal by Subject|0
4683192|NCT02542865|16121399|P1|Overall Study|Withdrawal by Subject|16
4683193|NCT02542865|16121398|P2|Overall Study|Identified as screen failure|0
4683194|NCT02542865|16121399|P1|Overall Study|Identified as screen failure|1
4683195|NCT02542631|16121462|P2|Overall Study|Used Prohibited Medication|1
4683196|NCT02542631|16121463|P1|Overall Study|Used Prohibited Medication|2
4683197|NCT02542631|16121462|P2|Overall Study|Other|1
4683198|NCT02542631|16121463|P1|Overall Study|Other|2
4683199|NCT02542631|16121462|P2|Overall Study|Death|2
4683200|NCT02542631|16121463|P1|Overall Study|Death|1
4683201|NCT02542631|16121462|P2|Overall Study|Lost to Follow-up|5
4683202|NCT02542631|16121463|P1|Overall Study|Lost to Follow-up|6
4683203|NCT02542631|16121462|P2|Overall Study|Physician Decision|4
4683204|NCT02542631|16121463|P1|Overall Study|Physician Decision|6
4683205|NCT02542631|16121462|P2|Overall Study|Protocol Violation|1
4683206|NCT02542631|16121463|P1|Overall Study|Protocol Violation|1
4683207|NCT02542631|16121462|P2|Overall Study|Withdrawal by Subject|16
4683208|NCT02542631|16121463|P1|Overall Study|Withdrawal by Subject|11
4683209|NCT02542631|16121462|P2|Overall Study|Sponsor Termination|0
4683210|NCT02542631|16121463|P1|Overall Study|Sponsor Termination|1
4683211|NCT02542631|16121462|P2|Overall Study|Adverse Event|1
4683212|NCT02542631|16121463|P1|Overall Study|Adverse Event|1
4683213|NCT02542605|16121485|P3|Part B: Randomization Phase|Withdrawal by Subject|1
4683214|NCT02542605|16121486|P2|Part B: Randomization Phase|Withdrawal by Subject|0
4683215|NCT02542605|16121487|P1|Part B: Randomization Phase|Withdrawal by Subject|0
4683216|NCT02542605|16121485|P3|Part B: Challenge Phase|Sponsor decision|0
4683217|NCT02542605|16121486|P2|Part B: Challenge Phase|Sponsor decision|0
4683218|NCT02542605|16121487|P1|Part B: Challenge Phase|Sponsor decision|1
4683219|NCT02542267|16121575|P1|Overall Study|Other|5
4683220|NCT02542267|16121575|P1|Overall Study|Surgical Bypass of All Study Devices|12
4683221|NCT02542267|16121575|P1|Overall Study|Death|12
4683222|NCT02542267|16121575|P1|Overall Study|Lost to Follow-up|4
4683223|NCT02542267|16121575|P1|Overall Study|Physician Decision|5
4683224|NCT02542267|16121575|P1|Overall Study|Withdrawal by Subject|8
4683225|NCT02542267|16121575|P1|Overall Study|Ongoing|31
4683226|NCT02542072|16121583|P2|Second Intervention (1 Month)|Lens discomfort|0
4683227|NCT02542072|16121584|P1|Second Intervention (1 Month)|Lens discomfort|1
4683228|NCT02542072|16121583|P2|Second Intervention (1 Month)|Lost to Follow-up|0
4683229|NCT02542072|16121584|P1|Second Intervention (1 Month)|Lost to Follow-up|1
4683230|NCT02542072|16121583|P2|First Intervention (1 Month)|Protocol Violation|0
4683231|NCT02542072|16121584|P1|First Intervention (1 Month)|Protocol Violation|1
4683232|NCT02542072|16121583|P2|First Intervention (1 Month)|Lens discomfort|2
4683233|NCT02542072|16121584|P1|First Intervention (1 Month)|Lens discomfort|1
4683234|NCT02542072|16121583|P2|First Intervention (1 Month)|Lost to Follow-up|0
4683235|NCT02542072|16121584|P1|First Intervention (1 Month)|Lost to Follow-up|2
4683236|NCT02542072|16121583|P2|First Intervention (1 Month)|Adverse Event|1
4683237|NCT02542072|16121584|P1|First Intervention (1 Month)|Adverse Event|1
4683238|NCT02541903|16121708|P1|Overall Study|Death|1
4683239|NCT02541669|16121739|P5|Double-Blinded Treatment Period|Withdrawal by Subject|1
4683240|NCT02541669|16121740|P4|Double-Blinded Treatment Period|Withdrawal by Subject|0
4683241|NCT02541669|16121741|P3|Double-Blinded Treatment Period|Withdrawal by Subject|1
4683242|NCT02541669|16121742|P2|Double-Blinded Treatment Period|Withdrawal by Subject|0
4683243|NCT02541669|16121743|P1|Double-Blinded Treatment Period|Withdrawal by Subject|0
4683244|NCT02541604|16121790|P12|Overall Study|Medical condition may jeopardize safety|0
4683245|NCT02541604|16121791|P11|Overall Study|Medical condition may jeopardize safety|0
4683246|NCT02541604|16121792|P10|Overall Study|Medical condition may jeopardize safety|0
4683247|NCT02541604|16121793|P9|Overall Study|Medical condition may jeopardize safety|0
4683248|NCT02541604|16121794|P8|Overall Study|Medical condition may jeopardize safety|1
4683249|NCT02541604|16121795|P7|Overall Study|Medical condition may jeopardize safety|0
4683250|NCT02541604|16121796|P6|Overall Study|Medical condition may jeopardize safety|0
4683251|NCT02541604|16121797|P5|Overall Study|Medical condition may jeopardize safety|0
4683252|NCT02541604|16121798|P4|Overall Study|Medical condition may jeopardize safety|0
4683253|NCT02541604|16121799|P3|Overall Study|Medical condition may jeopardize safety|0
4683254|NCT02541604|16121800|P2|Overall Study|Medical condition may jeopardize safety|0
4683255|NCT02541604|16121801|P1|Overall Study|Medical condition may jeopardize safety|0
4683256|NCT02541604|16121790|P12|Overall Study|Study Terminated by Sponsor|0
4683257|NCT02541604|16121791|P11|Overall Study|Study Terminated by Sponsor|0
4683258|NCT02541604|16121792|P10|Overall Study|Study Terminated by Sponsor|0
4683259|NCT02541604|16121793|P9|Overall Study|Study Terminated by Sponsor|0
4683260|NCT02541604|16121794|P8|Overall Study|Study Terminated by Sponsor|0
4683261|NCT02541604|16121795|P7|Overall Study|Study Terminated by Sponsor|0
4683262|NCT02541604|16121796|P6|Overall Study|Study Terminated by Sponsor|0
4683263|NCT02541604|16121797|P5|Overall Study|Study Terminated by Sponsor|0
4683264|NCT02541604|16121798|P4|Overall Study|Study Terminated by Sponsor|1
4683265|NCT02541604|16121799|P3|Overall Study|Study Terminated by Sponsor|2
4683266|NCT02541604|16121800|P2|Overall Study|Study Terminated by Sponsor|4
4683267|NCT02541604|16121801|P1|Overall Study|Study Terminated by Sponsor|1
4683268|NCT02541604|16121790|P12|Overall Study|Withdrawal by Subject|0
4683269|NCT02541604|16121791|P11|Overall Study|Withdrawal by Subject|0
4683270|NCT02541604|16121792|P10|Overall Study|Withdrawal by Subject|0
4683271|NCT02541604|16121793|P9|Overall Study|Withdrawal by Subject|1
4683272|NCT02541604|16121794|P8|Overall Study|Withdrawal by Subject|0
4683273|NCT02541604|16121795|P7|Overall Study|Withdrawal by Subject|0
4683274|NCT02541604|16121796|P6|Overall Study|Withdrawal by Subject|1
4683275|NCT02541604|16121797|P5|Overall Study|Withdrawal by Subject|1
4683276|NCT02541604|16121798|P4|Overall Study|Withdrawal by Subject|0
4683277|NCT02541604|16121799|P3|Overall Study|Withdrawal by Subject|1
4683278|NCT02541604|16121800|P2|Overall Study|Withdrawal by Subject|0
4683279|NCT02541604|16121801|P1|Overall Study|Withdrawal by Subject|2
4683280|NCT02541604|16121790|P12|Overall Study|Lost to Follow-up|0
4683281|NCT02541604|16121791|P11|Overall Study|Lost to Follow-up|0
4683282|NCT02541604|16121792|P10|Overall Study|Lost to Follow-up|0
4683283|NCT02541604|16121793|P9|Overall Study|Lost to Follow-up|0
4683284|NCT02541604|16121794|P8|Overall Study|Lost to Follow-up|0
4683285|NCT02541604|16121795|P7|Overall Study|Lost to Follow-up|1
4683286|NCT02541604|16121796|P6|Overall Study|Lost to Follow-up|1
4683287|NCT02541604|16121797|P5|Overall Study|Lost to Follow-up|0
4683288|NCT02541604|16121798|P4|Overall Study|Lost to Follow-up|0
4683289|NCT02541604|16121799|P3|Overall Study|Lost to Follow-up|1
4683290|NCT02541604|16121800|P2|Overall Study|Lost to Follow-up|0
4683291|NCT02541604|16121801|P1|Overall Study|Lost to Follow-up|2
4683292|NCT02541604|16121790|P12|Overall Study|Death|3
4683293|NCT02541604|16121791|P11|Overall Study|Death|2
4683294|NCT02541604|16121792|P10|Overall Study|Death|4
4683295|NCT02541604|16121793|P9|Overall Study|Death|3
4683296|NCT02541604|16121794|P8|Overall Study|Death|9
4683297|NCT02541604|16121795|P7|Overall Study|Death|9
4683298|NCT02541604|16121796|P6|Overall Study|Death|8
4683299|NCT02541604|16121797|P5|Overall Study|Death|9
4683300|NCT02541604|16121798|P4|Overall Study|Death|2
4683301|NCT02541604|16121799|P3|Overall Study|Death|7
4683302|NCT02541604|16121800|P2|Overall Study|Death|5
4683303|NCT02541604|16121801|P1|Overall Study|Death|6
4683304|NCT02540850|16121920|P3|Overall Study|Lost to Follow-up|34
4683305|NCT02540850|16121921|P2|Overall Study|Lost to Follow-up|66
4683306|NCT02540850|16121922|P1|Overall Study|Lost to Follow-up|69
4683307|NCT02540668|16121963|P2|Period 2 - LY3314814 and Warfarin|Physician Decision|1
4683308|NCT02540668|16121964|P1|Period 2 - LY3314814 and Warfarin|Physician Decision|0
4683309|NCT02540538|16121995|P3|Overall Study|Pregnancy|0
4683310|NCT02540538|16121996|P2|Overall Study|Pregnancy|1
4683311|NCT02540538|16121997|P1|Overall Study|Pregnancy|0
4683312|NCT02540356|16122065|P2|Overall Study|Terminated due to disease progression|0
4683313|NCT02540356|16122066|P1|Overall Study|Terminated due to disease progression|1
4683314|NCT02540291|16122101|P4|Overall Study|Other|0
4683315|NCT02540291|16122102|P3|Overall Study|Other|1
4683316|NCT02540291|16122103|P2|Overall Study|Other|0
4683317|NCT02540291|16122104|P1|Overall Study|Other|0
4683318|NCT02540291|16122101|P4|Overall Study|Study Terminated By Sponsor|0
4683319|NCT02540291|16122102|P3|Overall Study|Study Terminated By Sponsor|0
4683320|NCT02540291|16122103|P2|Overall Study|Study Terminated By Sponsor|0
4683321|NCT02540291|16122104|P1|Overall Study|Study Terminated By Sponsor|1
4683322|NCT02540291|16122101|P4|Overall Study|Withdrawal Of Consent|0
4683323|NCT02540291|16122102|P3|Overall Study|Withdrawal Of Consent|0
4683324|NCT02540291|16122103|P2|Overall Study|Withdrawal Of Consent|1
4683325|NCT02540291|16122104|P1|Overall Study|Withdrawal Of Consent|0
4683326|NCT02540291|16122101|P4|Overall Study|Lost to Follow-up|0
4683327|NCT02540291|16122102|P3|Overall Study|Lost to Follow-up|1
4683328|NCT02540291|16122103|P2|Overall Study|Lost to Follow-up|0
4683329|NCT02540291|16122104|P1|Overall Study|Lost to Follow-up|0
4683330|NCT02540291|16122101|P4|Overall Study|Death|7
4683331|NCT02540291|16122102|P3|Overall Study|Death|5
4683332|NCT02540291|16122103|P2|Overall Study|Death|7
4683333|NCT02540291|16122104|P1|Overall Study|Death|7
4683334|NCT02540265|16122139|P3|Overall Study|Lost to Follow-up|1
4683335|NCT02540265|16122140|P2|Overall Study|Lost to Follow-up|0
4683336|NCT02540265|16122141|P1|Overall Study|Lost to Follow-up|0
4683337|NCT02540213|16122196|P1|Overall Study|Enrolled but not treated|2
4683338|NCT02540213|16122196|P1|Overall Study|Consent withdrawn|7
4683339|NCT02540213|16122196|P1|Overall Study|Lack of Efficacy|6
4683340|NCT02540213|16122196|P1|Overall Study|Kidney transplant|3
4683341|NCT02540213|16122196|P1|Overall Study|Administrative reasons|3
4683342|NCT02540213|16122196|P1|Overall Study|Death/adverse event|18
4683343|NCT02540083|16122250|P1|Overall Study|Withdrawal by Subject|16
4683344|NCT02539797|16122291|P3|Overall Study|Lost to Follow-up|0
4683345|NCT02539797|16122292|P2|Overall Study|Lost to Follow-up|1
4683346|NCT02539797|16122293|P1|Overall Study|Lost to Follow-up|0
4683347|NCT02539368|16122345|P5|Overall Study|Missing|0
4683348|NCT02539368|16122346|P4|Overall Study|Missing|0
4683349|NCT02539368|16122347|P3|Overall Study|Missing|0
4683350|NCT02539368|16122348|P2|Overall Study|Missing|3
4683351|NCT02539368|16122349|P1|Overall Study|Missing|10
4683352|NCT02539368|16122345|P5|Overall Study|Other|3
4683353|NCT02539368|16122346|P4|Overall Study|Other|1
4683354|NCT02539368|16122347|P3|Overall Study|Other|24
4683355|NCT02539368|16122348|P2|Overall Study|Other|18
4683356|NCT02539368|16122349|P1|Overall Study|Other|145
4683357|NCT02539368|16122345|P5|Overall Study|Participant Non-compliant|0
4683358|NCT02539368|16122346|P4|Overall Study|Participant Non-compliant|1
4683359|NCT02539368|16122347|P3|Overall Study|Participant Non-compliant|1
4683360|NCT02539368|16122348|P2|Overall Study|Participant Non-compliant|2
4683361|NCT02539368|16122349|P1|Overall Study|Participant Non-compliant|13
4683362|NCT02539368|16122345|P5|Overall Study|Adverse Event|3
4683363|NCT02539368|16122346|P4|Overall Study|Adverse Event|0
4683364|NCT02539368|16122347|P3|Overall Study|Adverse Event|9
4683365|NCT02539368|16122348|P2|Overall Study|Adverse Event|5
4683366|NCT02539368|16122349|P1|Overall Study|Adverse Event|44
4683367|NCT02539368|16122345|P5|Overall Study|Lost to Follow-up|3
4683368|NCT02539368|16122346|P4|Overall Study|Lost to Follow-up|4
4683369|NCT02539368|16122347|P3|Overall Study|Lost to Follow-up|16
4683370|NCT02539368|16122348|P2|Overall Study|Lost to Follow-up|21
4683371|NCT02539368|16122349|P1|Overall Study|Lost to Follow-up|96
4683372|NCT02539368|16122345|P5|Overall Study|Physician Decision|2
4683373|NCT02539368|16122346|P4|Overall Study|Physician Decision|0
4683374|NCT02539368|16122347|P3|Overall Study|Physician Decision|7
4683375|NCT02539368|16122348|P2|Overall Study|Physician Decision|15
4683376|NCT02539368|16122349|P1|Overall Study|Physician Decision|49
4683377|NCT02539368|16122345|P5|Overall Study|Withdrawal by Subject|3
4683378|NCT02539368|16122346|P4|Overall Study|Withdrawal by Subject|1
4683379|NCT02539368|16122347|P3|Overall Study|Withdrawal by Subject|9
4683380|NCT02539368|16122348|P2|Overall Study|Withdrawal by Subject|35
4683381|NCT02539368|16122349|P1|Overall Study|Withdrawal by Subject|44
4683382|NCT02539368|16122345|P5|Overall Study|Death|0
4683383|NCT02539368|16122346|P4|Overall Study|Death|0
4683384|NCT02539368|16122347|P3|Overall Study|Death|1
4683385|NCT02539368|16122348|P2|Overall Study|Death|2
4683386|NCT02539368|16122349|P1|Overall Study|Death|4
4683387|NCT02539225|16122482|P2|Part B|Physician Decision|9
4683388|NCT02539225|16122483|P1|Part B|Physician Decision|0
4683389|NCT02539225|16122482|P2|Part B|Withdrawal by Subject|3
4683390|NCT02539225|16122483|P1|Part B|Withdrawal by Subject|0
4683391|NCT02539225|16122482|P2|Part B|Adverse Event|4
4683392|NCT02539225|16122483|P1|Part B|Adverse Event|4
4683393|NCT02539225|16122482|P2|Pre Treatment for Part B|Physician Decision|0
4683394|NCT02539225|16122483|P1|Pre Treatment for Part B|Physician Decision|2
4683395|NCT02539225|16122482|P2|Pre Treatment for Part B|Withdrawal by Subject|0
4683396|NCT02539225|16122483|P1|Pre Treatment for Part B|Withdrawal by Subject|1
4683397|NCT02539225|16122482|P2|Pre Treatment for Part B|Adverse Event|1
4683398|NCT02539225|16122483|P1|Pre Treatment for Part B|Adverse Event|1
4683399|NCT02539225|16122482|P2|Pre Treatment for Part B|Progressive disease|1
4683400|NCT02539225|16122483|P1|Pre Treatment for Part B|Progressive disease|1
4683401|NCT02539225|16122482|P2|Part A|Did Not Receive study Drug|1
4683402|NCT02539225|16122483|P1|Part A|Did Not Receive study Drug|1
4683403|NCT02539225|16122482|P2|Part A|Physician Decision|7
4683404|NCT02539225|16122483|P1|Part A|Physician Decision|4
4683405|NCT02539225|16122482|P2|Part A|Withdrawal by Subject|4
4683406|NCT02539225|16122483|P1|Part A|Withdrawal by Subject|2
4683407|NCT02539225|16122482|P2|Part A|Adverse Event|4
4683408|NCT02539225|16122483|P1|Part A|Adverse Event|13
4683409|NCT02539134|16122510|P6|Overall Study|Lost to Follow-up|0
4683410|NCT02539134|16122511|P5|Overall Study|Lost to Follow-up|0
4683411|NCT02539134|16122512|P4|Overall Study|Lost to Follow-up|0
4683412|NCT02539134|16122513|P3|Overall Study|Lost to Follow-up|0
4683413|NCT02539134|16122514|P2|Overall Study|Lost to Follow-up|0
4683414|NCT02539134|16122515|P1|Overall Study|Lost to Follow-up|1
4683415|NCT02538965|16122584|P1|Follow-Up Period|Withdrawal by Parent|4
4683416|NCT02538965|16122584|P1|Follow-Up Period|Other = Death due to disease progression|13
4683417|NCT02538965|16122584|P1|Treatment Period|Physician Decision|2
4683418|NCT02538965|16122584|P1|Treatment Period|Disease Progression|1
4683419|NCT02538965|16122584|P1|Treatment Period|Treatment Failure|9
4683420|NCT02538965|16122584|P1|Treatment Period|Withdrawal by Parent/Guardian|2
4683421|NCT02538965|16122584|P1|Treatment Period|Adverse Event|2
4683422|NCT02538965|16122584|P1|Treatment Period|Other = Death due to disease progression|1
4683423|NCT02538666|16122630|P3|Overall Study|Withdrew Consent|1
4683424|NCT02538666|16122631|P2|Overall Study|Withdrew Consent|1
4683425|NCT02538666|16122632|P1|Overall Study|Withdrew Consent|0
4683426|NCT02538666|16122630|P3|Overall Study|no longer meets study criteria|0
4683427|NCT02538666|16122631|P2|Overall Study|no longer meets study criteria|0
4683428|NCT02538666|16122632|P1|Overall Study|no longer meets study criteria|1
4683429|NCT02538666|16122630|P3|Overall Study|Disease progression|0
4683430|NCT02538666|16122631|P2|Overall Study|Disease progression|0
4683431|NCT02538666|16122632|P1|Overall Study|Disease progression|1
4683432|NCT02538471|16122675|P1|Overall Study|Progression of disease|2
4683433|NCT02538107|16122711|P1|Overall Study|Not recorded|7
4683434|NCT02538107|16122711|P1|Overall Study|Other|7
4683435|NCT02538107|16122711|P1|Overall Study|Surgery|1
4683436|NCT02538107|16122711|P1|Overall Study|Adverse Event|4
4683437|NCT02538107|16122711|P1|Overall Study|Administrative reason|5
4683438|NCT02538107|16122711|P1|Overall Study|Death|4
4683439|NCT02538107|16122711|P1|Overall Study|Withdrawal by Subject|17
4683440|NCT02538107|16122711|P1|Overall Study|No further treatment necessary|18
4683441|NCT02538107|16122711|P1|Overall Study|Administration of other ESA|11
4683442|NCT02538107|16122711|P1|Overall Study|Necessity of dialysis|20
4683443|NCT02538107|16122711|P1|Overall Study|Missing|5
4683444|NCT02538107|16122711|P1|Overall Study|Did not receive any Mircera dose|11
4683445|NCT02538094|16122731|P2|Washout (4 Weeks)|Withdrawal by Subject|1
4683446|NCT02538094|16122732|P1|Washout (4 Weeks)|Withdrawal by Subject|0
4683447|NCT02538094|16122731|P2|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1
4683448|NCT02538094|16122732|P1|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0
4683449|NCT02538029|16122762|P3|Overall Study|unable to complete cognitive assessments|1
4683450|NCT02538029|16122763|P2|Overall Study|unable to complete cognitive assessments|0
4683451|NCT02538029|16122764|P1|Overall Study|unable to complete cognitive assessments|1
4683452|NCT02537574|16122855|P3|Overall Study|Noncompliance with Protocol|1
4683453|NCT02537574|16122856|P2|Overall Study|Noncompliance with Protocol|0
4683454|NCT02537574|16122857|P1|Overall Study|Noncompliance with Protocol|0
4683455|NCT02537574|16122855|P3|Overall Study|Subject did not want last Vivitrol Injec|1
4683456|NCT02537574|16122856|P2|Overall Study|Subject did not want last Vivitrol Injec|0
4683457|NCT02537574|16122857|P1|Overall Study|Subject did not want last Vivitrol Injec|0
4683458|NCT02537574|16122855|P3|Overall Study|Transportation Issues|1
4683459|NCT02537574|16122856|P2|Overall Study|Transportation Issues|0
4683460|NCT02537574|16122857|P1|Overall Study|Transportation Issues|0
4683461|NCT02537574|16122855|P3|Overall Study|Failed Naloxone Challenge|0
4683462|NCT02537574|16122856|P2|Overall Study|Failed Naloxone Challenge|1
4683463|NCT02537574|16122857|P1|Overall Study|Failed Naloxone Challenge|0
4683464|NCT02537574|16122855|P3|Overall Study|Incarceration|0
4683465|NCT02537574|16122856|P2|Overall Study|Incarceration|1
4683466|NCT02537574|16122857|P1|Overall Study|Incarceration|0
4683467|NCT02537574|16122855|P3|Overall Study|Patient not Stable|0
4683468|NCT02537574|16122856|P2|Overall Study|Patient not Stable|1
4683469|NCT02537574|16122857|P1|Overall Study|Patient not Stable|0
4683470|NCT02537574|16122855|P3|Overall Study|Duplicate Patient|0
4683471|NCT02537574|16122856|P2|Overall Study|Duplicate Patient|0
4683472|NCT02537574|16122857|P1|Overall Study|Duplicate Patient|1
4683473|NCT02537574|16122855|P3|Overall Study|Lack of Efficacy|15
4683474|NCT02537574|16122856|P2|Overall Study|Lack of Efficacy|16
4683475|NCT02537574|16122857|P1|Overall Study|Lack of Efficacy|14
4683476|NCT02537574|16122855|P3|Overall Study|Withdrawal by Subject|29
4683477|NCT02537574|16122856|P2|Overall Study|Withdrawal by Subject|27
4683478|NCT02537574|16122857|P1|Overall Study|Withdrawal by Subject|37
4683479|NCT02537574|16122855|P3|Overall Study|Protocol Violation|3
4683480|NCT02537574|16122856|P2|Overall Study|Protocol Violation|2
4683481|NCT02537574|16122857|P1|Overall Study|Protocol Violation|4
4683482|NCT02537574|16122855|P3|Overall Study|Physician Decision|0
4683483|NCT02537574|16122856|P2|Overall Study|Physician Decision|0
4683484|NCT02537574|16122857|P1|Overall Study|Physician Decision|2
4683485|NCT02537574|16122855|P3|Overall Study|Noncompliance with study drug|1
4683486|NCT02537574|16122856|P2|Overall Study|Noncompliance with study drug|1
4683487|NCT02537574|16122857|P1|Overall Study|Noncompliance with study drug|0
4683488|NCT02537574|16122855|P3|Overall Study|Lost to Follow-up|55
4683489|NCT02537574|16122856|P2|Overall Study|Lost to Follow-up|51
4683490|NCT02537574|16122857|P1|Overall Study|Lost to Follow-up|40
4683491|NCT02537574|16122855|P3|Overall Study|Adverse Event|2
4683492|NCT02537574|16122856|P2|Overall Study|Adverse Event|3
4683493|NCT02537574|16122857|P1|Overall Study|Adverse Event|1
4683494|NCT02537522|16122883|P4|Phase II - Period 1 Bilateral|Adverse Event|1
4683495|NCT02537522|16122884|P3|Phase II - Period 1 Bilateral|Adverse Event|0
4683496|NCT02537522|16122885|P2|Phase II - Period 1 Bilateral|Adverse Event|0
4683497|NCT02537522|16122886|P1|Phase II - Period 1 Bilateral|Adverse Event|0
4683498|NCT02537522|16122883|P4|Phase I - Contralateral|unsatisfactory lens fitting|0
4683499|NCT02537522|16122884|P3|Phase I - Contralateral|unsatisfactory lens fitting|0
4683500|NCT02537522|16122885|P2|Phase I - Contralateral|unsatisfactory lens fitting|1
4683501|NCT02537522|16122886|P1|Phase I - Contralateral|unsatisfactory lens fitting|0
4683502|NCT02537522|16122883|P4|Phase I - Contralateral|incorrect randomization|0
4683503|NCT02537522|16122884|P3|Phase I - Contralateral|incorrect randomization|0
4683504|NCT02537522|16122885|P2|Phase I - Contralateral|incorrect randomization|1
4683505|NCT02537522|16122886|P1|Phase I - Contralateral|incorrect randomization|0
4683506|NCT02537522|16122883|P4|Phase I - Contralateral|Withdrawal by Subject|0
4683507|NCT02537522|16122884|P3|Phase I - Contralateral|Withdrawal by Subject|0
4683508|NCT02537522|16122885|P2|Phase I - Contralateral|Withdrawal by Subject|1
4683509|NCT02537522|16122886|P1|Phase I - Contralateral|Withdrawal by Subject|0
4683510|NCT02537522|16122883|P4|Phase I - Contralateral|Subject no longer eligible|0
4683511|NCT02537522|16122884|P3|Phase I - Contralateral|Subject no longer eligible|0
4683512|NCT02537522|16122885|P2|Phase I - Contralateral|Subject no longer eligible|7
4683513|NCT02537522|16122886|P1|Phase I - Contralateral|Subject no longer eligible|15
4683514|NCT02537431|16122903|P1|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1
4683515|NCT02537015|16122932|P1|Overall Study|Other Miscellaneous Reasons|1
4683516|NCT02537015|16122932|P1|Overall Study|Withdrawal by Subject|2
4683517|NCT02537015|16122932|P1|Overall Study|Adverse Event|3
4683518|NCT02536976|16122938|P2|Overall Study|Physician Decision|1
4683519|NCT02536976|16122939|P1|Overall Study|Physician Decision|0
4683520|NCT02536963|16122949|P1|Overall Study|Withdrawal by Subject|18
4683521|NCT02536833|16122957|P4|Overall Study|Withdrawal by Subject|11
4683522|NCT02536833|16122958|P3|Overall Study|Withdrawal by Subject|5
4683523|NCT02536833|16122959|P2|Overall Study|Withdrawal by Subject|3
4683524|NCT02536833|16122960|P1|Overall Study|Withdrawal by Subject|4
4683525|NCT02536833|16122957|P4|Overall Study|Subject Non-Compliance|0
4683526|NCT02536833|16122958|P3|Overall Study|Subject Non-Compliance|1
4683527|NCT02536833|16122959|P2|Overall Study|Subject Non-Compliance|1
4683528|NCT02536833|16122960|P1|Overall Study|Subject Non-Compliance|0
4683529|NCT02536833|16122957|P4|Overall Study|Site Terminated by Sponsor|2
4683530|NCT02536833|16122958|P3|Overall Study|Site Terminated by Sponsor|2
4683531|NCT02536833|16122959|P2|Overall Study|Site Terminated by Sponsor|2
4683532|NCT02536833|16122960|P1|Overall Study|Site Terminated by Sponsor|2
4683533|NCT02536833|16122957|P4|Overall Study|Physician Decision|1
4683534|NCT02536833|16122958|P3|Overall Study|Physician Decision|0
4683535|NCT02536833|16122959|P2|Overall Study|Physician Decision|0
4683536|NCT02536833|16122960|P1|Overall Study|Physician Decision|0
4683537|NCT02536833|16122957|P4|Overall Study|Lost to Follow-up|2
4683538|NCT02536833|16122958|P3|Overall Study|Lost to Follow-up|2
4683539|NCT02536833|16122959|P2|Overall Study|Lost to Follow-up|1
4683540|NCT02536833|16122960|P1|Overall Study|Lost to Follow-up|2
4683541|NCT02536833|16122957|P4|Overall Study|Adverse Event|1
4683542|NCT02536833|16122958|P3|Overall Study|Adverse Event|4
4683543|NCT02536833|16122959|P2|Overall Study|Adverse Event|3
4683544|NCT02536833|16122960|P1|Overall Study|Adverse Event|1
4683545|NCT02536833|16122957|P4|Overall Study|Discontinued Before Treatment|2
4683546|NCT02536833|16122958|P3|Overall Study|Discontinued Before Treatment|1
4683547|NCT02536833|16122959|P2|Overall Study|Discontinued Before Treatment|0
4683548|NCT02536833|16122960|P1|Overall Study|Discontinued Before Treatment|0
4683549|NCT02536781|16123021|P2|Overall Study|Lost to Follow-up|0
4683550|NCT02536781|16123022|P1|Overall Study|Lost to Follow-up|2
4683551|NCT02536664|16123032|P2|Overall Study|Missing|20
4683552|NCT02536664|16123033|P1|Overall Study|Missing|53
4683553|NCT02536664|16123032|P2|Overall Study|Other|24
4683554|NCT02536664|16123033|P1|Overall Study|Other|18
4683555|NCT02536664|16123032|P2|Overall Study|Withdrawal by Subject|5
4683556|NCT02536664|16123033|P1|Overall Study|Withdrawal by Subject|8
4683557|NCT02536664|16123032|P2|Overall Study|Intolerability|6
4683558|NCT02536664|16123033|P1|Overall Study|Intolerability|8
4683559|NCT02536664|16123032|P2|Overall Study|Death due to other reason|2
4683560|NCT02536664|16123033|P1|Overall Study|Death due to other reason|3
4683561|NCT02536664|16123032|P2|Overall Study|Death due to lymphoma|1
4683562|NCT02536664|16123033|P1|Overall Study|Death due to lymphoma|2
4683563|NCT02536664|16123032|P2|Overall Study|Progression|18
4683564|NCT02536664|16123033|P1|Overall Study|Progression|13
4683565|NCT02536664|16123032|P2|Overall Study|Inadequate completion of documentation|4
4683566|NCT02536664|16123033|P1|Overall Study|Inadequate completion of documentation|2
4683567|NCT02536378|16123053|P2|Overall Study|Patient refused further follow up|2
4683568|NCT02536378|16123054|P1|Overall Study|Patient refused further follow up|6
4683569|NCT02536378|16123053|P2|Overall Study|Death|2
4683570|NCT02536378|16123054|P1|Overall Study|Death|1
4683571|NCT02536378|16123053|P2|Overall Study|Withdrawal by Subject|1
4683572|NCT02536378|16123054|P1|Overall Study|Withdrawal by Subject|0
4683573|NCT02536378|16123053|P2|Overall Study|Physician Decision|2
4683574|NCT02536378|16123054|P1|Overall Study|Physician Decision|0
4683575|NCT02536339|16123068|P1|Overall Study|Death|20
4683576|NCT02536339|16123068|P1|Overall Study|Withdrawal by Subject|3
4683577|NCT02536339|16123068|P1|Overall Study|Lost to Follow-up|2
4683578|NCT02536339|16123068|P1|Overall Study|Treatment Ongoing|2
4683579|NCT02536339|16123068|P1|Overall Study|In Survival Follow-Up|4
4683580|NCT02536313|16123094|P2|Overall Study|Lack of Efficacy|1
4683581|NCT02536313|16123095|P1|Overall Study|Lack of Efficacy|0
4683582|NCT02535741|16123164|P1|Overall Study|Missing data|6
4683583|NCT02535741|16123164|P1|Overall Study|Exclusion criteria: Bilateral implant|4
4683584|NCT02535741|16123164|P1|Overall Study|Lost to Follow-up|10
4683585|NCT02535741|16123164|P1|Overall Study|Withdrawal by Subject|9
4683586|NCT02535741|16123164|P1|Overall Study|Adverse Event|3
4683587|NCT02535715|16123172|P3|Overall Study|Withdrawal by Subject|1
4683588|NCT02535715|16123173|P2|Overall Study|Withdrawal by Subject|0
4683589|NCT02535715|16123174|P1|Overall Study|Withdrawal by Subject|0
4683590|NCT02535416|16123237|P9|Overall Study|Family bereavement overseas|0
4683591|NCT02535416|16123238|P8|Overall Study|Family bereavement overseas|0
4683592|NCT02535416|16123239|P7|Overall Study|Family bereavement overseas|0
4683593|NCT02535416|16123240|P6|Overall Study|Family bereavement overseas|0
4683594|NCT02535416|16123241|P5|Overall Study|Family bereavement overseas|0
4683595|NCT02535416|16123242|P4|Overall Study|Family bereavement overseas|0
4683596|NCT02535416|16123243|P3|Overall Study|Family bereavement overseas|0
4683597|NCT02535416|16123244|P2|Overall Study|Family bereavement overseas|0
4683598|NCT02535416|16123245|P1|Overall Study|Family bereavement overseas|1
4683599|NCT02535364|16123297|P1|12-Month Follow-up Period|Subject transferred to hospice|1
4683600|NCT02535364|16123297|P1|12-Month Follow-up Period|Subject received alternative therapy|2
4683601|NCT02535364|16123297|P1|12-Month Follow-up Period|Underwent stem cell transplant|5
4683602|NCT02535364|16123297|P1|12-Month Follow-up Period|Death|5
4683603|NCT02535364|16123297|P1|12-Month Follow-up Period|Disease progression|22
4683604|NCT02535364|16123297|P1|Study Treatment|Study placed on clinical hold by FDA|1
4683605|NCT02535364|16123297|P1|Study Treatment|Death|1
4683606|NCT02535364|16123297|P1|Part B Screening|Change in diagnosis, no longer eligible|2
4683607|NCT02535364|16123297|P1|Part B Screening|Adverse Event|1
4683608|NCT02535364|16123297|P1|Part B Screening|Withdrawal by Subject|1
4683609|NCT02535364|16123297|P1|Part B Screening|Physician Decision|1
4683610|NCT02535364|16123297|P1|Part B Screening|Death|2
4683611|NCT02535364|16123297|P1|Part B Screening|Unable to manufacture JCAR015|3
4683612|NCT02535364|16123297|P1|Part B Screening|Study placed on clinical hold by FDA|7
4683613|NCT02535364|16123297|P1|Part A Screening Through Leukapheresis|Disease progression|1
4683614|NCT02535364|16123297|P1|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2
4683615|NCT02535364|16123297|P1|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22
4683616|NCT02535000|16123381|P2|Overall Study|Cancellation of surgery.|2
4683617|NCT02535000|16123382|P1|Overall Study|Cancellation of surgery.|1
4683618|NCT02534935|16123393|P3|Overall Study|Lost to Follow-up|1
4683619|NCT02534935|16123394|P2|Overall Study|Lost to Follow-up|1
4683620|NCT02534935|16123395|P1|Overall Study|Lost to Follow-up|0
4683621|NCT02534935|16123393|P3|Overall Study|Adverse Event|0
4683622|NCT02534935|16123394|P2|Overall Study|Adverse Event|2
4683623|NCT02534935|16123395|P1|Overall Study|Adverse Event|0
4683624|NCT02534935|16123393|P3|Overall Study|No longer meets the eligibility criteria|0
4683625|NCT02534935|16123394|P2|Overall Study|No longer meets the eligibility criteria|3
4683626|NCT02534935|16123395|P1|Overall Study|No longer meets the eligibility criteria|0
4683627|NCT02534935|16123393|P3|Overall Study|Withdrawal by Subject|3
4683628|NCT02534935|16123394|P2|Overall Study|Withdrawal by Subject|3
4683629|NCT02534935|16123395|P1|Overall Study|Withdrawal by Subject|0
4683630|NCT02534935|16123393|P3|Overall Study|No longer willing to participate|1
4683631|NCT02534935|16123394|P2|Overall Study|No longer willing to participate|1
4683632|NCT02534935|16123395|P1|Overall Study|No longer willing to participate|0
4683633|NCT02534896|16123556|P3|Overall Study|Insufficient therapeutic response|0
4683634|NCT02534896|16123557|P2|Overall Study|Insufficient therapeutic response|0
4683635|NCT02534896|16123558|P1|Overall Study|Insufficient therapeutic response|2
4683636|NCT02534896|16123556|P3|Overall Study|Adverse Event|1
4683637|NCT02534896|16123557|P2|Overall Study|Adverse Event|1
4683638|NCT02534896|16123558|P1|Overall Study|Adverse Event|2
4683639|NCT02534883|16123577|P2|Overall Study|Early Termination|3
4683640|NCT02534883|16123578|P1|Overall Study|Early Termination|8
4683641|NCT02534493|16123594|P1|Overall Study|Withdrawal by Subject|1
4683642|NCT02534493|16123594|P1|Overall Study|Lost to Follow-up|1
4683643|NCT02534350|16123605|P2|Overall Study|Withdrew Consent|0
4683644|NCT02534350|16123606|P1|Overall Study|Withdrew Consent|2
4683645|NCT02534350|16123605|P2|Overall Study|Protocol Violation|0
4683646|NCT02534350|16123606|P1|Overall Study|Protocol Violation|1
4683647|NCT02534350|16123605|P2|Overall Study|Randomized But Not Treated|0
4683648|NCT02534350|16123606|P1|Overall Study|Randomized But Not Treated|1
4683649|NCT02534324|16123620|P2|Overall Study|Adverse Event|0
4683650|NCT02534324|16123621|P1|Overall Study|Adverse Event|1
4683651|NCT02534324|16123620|P2|Overall Study|Lost to Follow-up|7
4683652|NCT02534324|16123621|P1|Overall Study|Lost to Follow-up|20
4683653|NCT02534324|16123620|P2|Overall Study|Protocol Violation|1
4683654|NCT02534324|16123621|P1|Overall Study|Protocol Violation|4
4683655|NCT02533999|16123686|P2|Overall Study|Randomized but intervention not received|1
4683656|NCT02533999|16123687|P1|Overall Study|Randomized but intervention not received|0
4683657|NCT02533999|16123686|P2|Overall Study|Adverse Event|1
4683658|NCT02533999|16123687|P1|Overall Study|Adverse Event|0
4683659|NCT02533999|16123686|P2|Overall Study|Protocol Violation|0
4683660|NCT02533999|16123687|P1|Overall Study|Protocol Violation|3
4683661|NCT02533999|16123686|P2|Overall Study|Lost to Follow-up|5
4683662|NCT02533999|16123687|P1|Overall Study|Lost to Follow-up|3
4683663|NCT02533570|16123738|P3|Overall Study|Adverse Event|1
4683664|NCT02533570|16123739|P2|Overall Study|Adverse Event|1
4683665|NCT02533570|16123740|P1|Overall Study|Adverse Event|0
4683666|NCT02533531|16123751|P1|Overall Study|Device did not turn on|1
4683667|NCT02533453|16123814|P1|Overall Study|Withdrawal by Subject|2
4683668|NCT02533453|16123814|P1|Overall Study|Protocol Violation|1
4683669|NCT02533453|16123814|P1|Overall Study|Adverse Event|6
4683670|NCT02533401|16123873|P1|Overall Study|Violation of Selection Criteria|1
4683671|NCT02533401|16123873|P1|Overall Study|Lost to Follow-up|1
4683672|NCT02533401|16123873|P1|Overall Study|Insufficient Response/Progressed Disease|1
4683673|NCT02533401|16123873|P1|Overall Study|Death|5
4683674|NCT02533401|16123873|P1|Overall Study|Adverse Event/Intercurrent Disease|3
4683675|NCT02533375|16123881|P1|Overall Study|Adverse Event|2
4683676|NCT02533375|16123881|P1|Overall Study|Lack of Efficacy|3
4683677|NCT02533258|16123913|P1|Overall Study|Lack of Efficacy|2
4683678|NCT02533258|16123913|P1|Overall Study|Progression of pleural effusion|1
4683679|NCT02533258|16123913|P1|Overall Study|Economic factor|1
4683680|NCT02533258|16123913|P1|Overall Study|Other|1
4683681|NCT02533258|16123913|P1|Overall Study|Death|2
4683682|NCT02533258|16123913|P1|Overall Study|Adverse Event|1
4683683|NCT02532972|16124054|P1|Overall Study|Withdrawal by Subject|1
4683684|NCT02532855|16124071|P2|Overall Study|Withdrawal by Subject|8
4683685|NCT02532855|16124072|P1|Overall Study|Withdrawal by Subject|4
4683686|NCT02532855|16124071|P2|Overall Study|Lost to Follow-up|3
4683687|NCT02532855|16124072|P1|Overall Study|Lost to Follow-up|4
4683688|NCT02532764|16124106|P10|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
4683689|NCT02532764|16124107|P9|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
4683690|NCT02532764|16124108|P8|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1
4683691|NCT02532764|16124109|P7|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683692|NCT02532764|16124110|P6|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683693|NCT02532764|16124111|P5|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683694|NCT02532764|16124112|P4|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683695|NCT02532764|16124113|P3|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683696|NCT02532764|16124114|P2|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683697|NCT02532764|16124115|P1|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0
4683698|NCT02532647|16124266|P3|Overall Study|Did not receive trial medication|1
4683699|NCT02532647|16124267|P2|Overall Study|Did not receive trial medication|0
4683700|NCT02532647|16124268|P1|Overall Study|Did not receive trial medication|1
4683701|NCT02532543|16124286|P4|Overall Study|Lost to Follow-up|0
4683702|NCT02532543|16124287|P3|Overall Study|Lost to Follow-up|1
4683703|NCT02532543|16124288|P2|Overall Study|Lost to Follow-up|0
4683704|NCT02532543|16124289|P1|Overall Study|Lost to Follow-up|0
4683705|NCT02532517|16124323|P1|Overall Study|Death|4
4683706|NCT02532517|16124323|P1|Overall Study|Withdrawal by Subject|4
4683707|NCT02532517|16124323|P1|Overall Study|Lost to Follow-up|4
4683708|NCT02532517|16124323|P1|Overall Study|Failed Angiographic eligibility|1
4683709|NCT02532517|16124323|P1|Overall Study|Did not complete 24-Month visit|4
4683710|NCT02532465|16124343|P2|Overall Study|Lack of Efficacy|1
4683711|NCT02532465|16124344|P1|Overall Study|Lack of Efficacy|0
4683712|NCT02532465|16124343|P2|Overall Study|Protocol Violation|0
4683713|NCT02532465|16124344|P1|Overall Study|Protocol Violation|1
4683714|NCT02532374|16124354|P1|Overall Study|Physician Decision|1
4683715|NCT02532374|16124354|P1|Overall Study|Withdrawal by Subject|1
4683716|NCT02532283|16124380|P2|Overall Study|Withdrawal by Subject|3
4683717|NCT02532283|16124381|P1|Overall Study|Withdrawal by Subject|8
4683718|NCT02532283|16124380|P2|Overall Study|Lost to Follow-up|1
4683719|NCT02532283|16124381|P1|Overall Study|Lost to Follow-up|0
4683720|NCT02532283|16124380|P2|Overall Study|Death|0
4683721|NCT02532283|16124381|P1|Overall Study|Death|1
4683722|NCT02532283|16124380|P2|Overall Study|Adverse Event|1
4683723|NCT02532283|16124381|P1|Overall Study|Adverse Event|0
4683724|NCT02532179|16124423|P1|Overall Study|Subject received depot steroid injection|1
4683725|NCT02532179|16124423|P1|Overall Study|Pregnancy|1
4683726|NCT02532179|16124423|P1|Overall Study|Lost to Follow-up|1
4683727|NCT02531802|16124493|P21|Received Vaccination 2|Withdrawal by Subject|0
4683728|NCT02531802|16124494|P20|Received Vaccination 2|Withdrawal by Subject|1
4683729|NCT02531802|16124495|P19|Received Vaccination 2|Withdrawal by Subject|1
4683730|NCT02531802|16124496|P18|Received Vaccination 2|Withdrawal by Subject|1
4683731|NCT02531802|16124497|P17|Received Vaccination 2|Withdrawal by Subject|0
4683732|NCT02531802|16124498|P16|Received Vaccination 2|Withdrawal by Subject|0
4683733|NCT02531802|16124499|P15|Received Vaccination 2|Withdrawal by Subject|1
4683734|NCT02531802|16124500|P14|Received Vaccination 2|Withdrawal by Subject|1
4683735|NCT02531802|16124501|P13|Received Vaccination 2|Withdrawal by Subject|1
4683736|NCT02531802|16124502|P12|Received Vaccination 2|Withdrawal by Subject|0
4683737|NCT02531802|16124503|P11|Received Vaccination 2|Withdrawal by Subject|1
4683738|NCT02531802|16124504|P10|Received Vaccination 2|Withdrawal by Subject|0
4683739|NCT02531802|16124505|P9|Received Vaccination 2|Withdrawal by Subject|0
4683740|NCT02531802|16124506|P8|Received Vaccination 2|Withdrawal by Subject|0
4683741|NCT02531802|16124507|P7|Received Vaccination 2|Withdrawal by Subject|0
4683742|NCT02531802|16124508|P6|Received Vaccination 2|Withdrawal by Subject|0
4683743|NCT02531802|16124509|P5|Received Vaccination 2|Withdrawal by Subject|0
4683744|NCT02531802|16124510|P4|Received Vaccination 2|Withdrawal by Subject|0
4683745|NCT02531802|16124511|P3|Received Vaccination 2|Withdrawal by Subject|0
4683746|NCT02531802|16124512|P2|Received Vaccination 2|Withdrawal by Subject|0
4683747|NCT02531802|16124513|P1|Received Vaccination 2|Withdrawal by Subject|0
4683748|NCT02531802|16124493|P21|Received Vaccination 2|Adverse Event|1
4683749|NCT02531802|16124494|P20|Received Vaccination 2|Adverse Event|0
4683750|NCT02531802|16124495|P19|Received Vaccination 2|Adverse Event|1
4683751|NCT02531802|16124496|P18|Received Vaccination 2|Adverse Event|2
4683752|NCT02531802|16124497|P17|Received Vaccination 2|Adverse Event|0
4683753|NCT02531802|16124498|P16|Received Vaccination 2|Adverse Event|0
4683754|NCT02531802|16124499|P15|Received Vaccination 2|Adverse Event|0
4683755|NCT02531802|16124500|P14|Received Vaccination 2|Adverse Event|0
4683756|NCT02531802|16124501|P13|Received Vaccination 2|Adverse Event|0
4683757|NCT02531802|16124502|P12|Received Vaccination 2|Adverse Event|0
4683758|NCT02531802|16124503|P11|Received Vaccination 2|Adverse Event|0
4683759|NCT02531802|16124504|P10|Received Vaccination 2|Adverse Event|0
4683760|NCT02531802|16124505|P9|Received Vaccination 2|Adverse Event|0
4683761|NCT02531802|16124506|P8|Received Vaccination 2|Adverse Event|0
4683762|NCT02531802|16124507|P7|Received Vaccination 2|Adverse Event|0
4683763|NCT02531802|16124508|P6|Received Vaccination 2|Adverse Event|2
4683764|NCT02531802|16124509|P5|Received Vaccination 2|Adverse Event|0
4683765|NCT02531802|16124510|P4|Received Vaccination 2|Adverse Event|0
4683766|NCT02531802|16124511|P3|Received Vaccination 2|Adverse Event|0
4683767|NCT02531802|16124512|P2|Received Vaccination 2|Adverse Event|0
4683768|NCT02531802|16124513|P1|Received Vaccination 2|Adverse Event|0
4683769|NCT02531802|16124493|P21|Received Vaccination 2|Physician Decision|0
4683770|NCT02531802|16124494|P20|Received Vaccination 2|Physician Decision|0
4683771|NCT02531802|16124495|P19|Received Vaccination 2|Physician Decision|0
4683772|NCT02531802|16124496|P18|Received Vaccination 2|Physician Decision|1
4683773|NCT02531802|16124497|P17|Received Vaccination 2|Physician Decision|0
4683774|NCT02531802|16124498|P16|Received Vaccination 2|Physician Decision|0
4683775|NCT02531802|16124499|P15|Received Vaccination 2|Physician Decision|0
4683776|NCT02531802|16124500|P14|Received Vaccination 2|Physician Decision|1
4683777|NCT02531802|16124501|P13|Received Vaccination 2|Physician Decision|0
4683778|NCT02531802|16124502|P12|Received Vaccination 2|Physician Decision|0
4683779|NCT02531802|16124503|P11|Received Vaccination 2|Physician Decision|0
4683780|NCT02531802|16124504|P10|Received Vaccination 2|Physician Decision|2
4683781|NCT02531802|16124505|P9|Received Vaccination 2|Physician Decision|0
4683782|NCT02531802|16124506|P8|Received Vaccination 2|Physician Decision|0
4683783|NCT02531802|16124507|P7|Received Vaccination 2|Physician Decision|0
4683784|NCT02531802|16124508|P6|Received Vaccination 2|Physician Decision|1
4683785|NCT02531802|16124509|P5|Received Vaccination 2|Physician Decision|0
4683786|NCT02531802|16124510|P4|Received Vaccination 2|Physician Decision|0
4683787|NCT02531802|16124511|P3|Received Vaccination 2|Physician Decision|0
4683788|NCT02531802|16124512|P2|Received Vaccination 2|Physician Decision|0
4683789|NCT02531802|16124513|P1|Received Vaccination 2|Physician Decision|0
4683790|NCT02531802|16124493|P21|Received Vaccination 2|Medication interfering with study taken|0
4683791|NCT02531802|16124494|P20|Received Vaccination 2|Medication interfering with study taken|0
4683792|NCT02531802|16124495|P19|Received Vaccination 2|Medication interfering with study taken|1
4683793|NCT02531802|16124496|P18|Received Vaccination 2|Medication interfering with study taken|0
4683794|NCT02531802|16124497|P17|Received Vaccination 2|Medication interfering with study taken|0
4683795|NCT02531802|16124498|P16|Received Vaccination 2|Medication interfering with study taken|0
4683796|NCT02531802|16124499|P15|Received Vaccination 2|Medication interfering with study taken|0
4683797|NCT02531802|16124500|P14|Received Vaccination 2|Medication interfering with study taken|0
4683798|NCT02531802|16124501|P13|Received Vaccination 2|Medication interfering with study taken|1
4683799|NCT02531802|16124502|P12|Received Vaccination 2|Medication interfering with study taken|0
4683800|NCT02531802|16124503|P11|Received Vaccination 2|Medication interfering with study taken|1
4683801|NCT02531802|16124504|P10|Received Vaccination 2|Medication interfering with study taken|1
4683802|NCT02531802|16124505|P9|Received Vaccination 2|Medication interfering with study taken|0
4683803|NCT02531802|16124506|P8|Received Vaccination 2|Medication interfering with study taken|0
4683804|NCT02531802|16124507|P7|Received Vaccination 2|Medication interfering with study taken|0
4683805|NCT02531802|16124508|P6|Received Vaccination 2|Medication interfering with study taken|0
4683806|NCT02531802|16124509|P5|Received Vaccination 2|Medication interfering with study taken|0
4683807|NCT02531802|16124510|P4|Received Vaccination 2|Medication interfering with study taken|0
4683808|NCT02531802|16124511|P3|Received Vaccination 2|Medication interfering with study taken|1
4683809|NCT02531802|16124512|P2|Received Vaccination 2|Medication interfering with study taken|0
4683810|NCT02531802|16124513|P1|Received Vaccination 2|Medication interfering with study taken|0
4683811|NCT02531698|16124945|P2|Overall Study|Lost to Follow-up|0
4683812|NCT02531698|16124946|P1|Overall Study|Lost to Follow-up|1
4683813|NCT02531698|16124945|P2|Overall Study|Protocol Violation|0
4683814|NCT02531698|16124946|P1|Overall Study|Protocol Violation|2
4683815|NCT02531698|16124945|P2|Overall Study|Withdrawal by Subject|1
4683816|NCT02531698|16124946|P1|Overall Study|Withdrawal by Subject|6
4683817|NCT02531698|16124945|P2|Overall Study|Adverse Event|1
4683818|NCT02531698|16124946|P1|Overall Study|Adverse Event|2
4683819|NCT02531646|16125193|P3|Overall Study|equip. image processing issue|0
4683820|NCT02531646|16125194|P2|Overall Study|equip. image processing issue|1
4683821|NCT02531646|16125195|P1|Overall Study|equip. image processing issue|5
4683822|NCT02531633|16125214|P10|Part B (104 Weeks)|Lost to Follow-up|0
4683823|NCT02531633|16125215|P9|Part B (104 Weeks)|Lost to Follow-up|0
4683824|NCT02531633|16125216|P8|Part B (104 Weeks)|Lost to Follow-up|1
4683825|NCT02531633|16125217|P7|Part B (104 Weeks)|Lost to Follow-up|0
4683826|NCT02531633|16125218|P6|Part B (104 Weeks)|Lost to Follow-up|0
4683827|NCT02531633|16125219|P5|Part B (104 Weeks)|Lost to Follow-up|0
4683828|NCT02531633|16125220|P4|Part B (104 Weeks)|Lost to Follow-up|0
4683829|NCT02531633|16125221|P3|Part B (104 Weeks)|Lost to Follow-up|0
4683830|NCT02531633|16125222|P2|Part B (104 Weeks)|Lost to Follow-up|0
4683831|NCT02531633|16125223|P1|Part B (104 Weeks)|Lost to Follow-up|0
4683832|NCT02531633|16125214|P10|Part B (104 Weeks)|Sponsor request|4
4683833|NCT02531633|16125215|P9|Part B (104 Weeks)|Sponsor request|5
4683834|NCT02531633|16125216|P8|Part B (104 Weeks)|Sponsor request|3
4683835|NCT02531633|16125217|P7|Part B (104 Weeks)|Sponsor request|5
4683836|NCT02531633|16125218|P6|Part B (104 Weeks)|Sponsor request|8
4683837|NCT02531633|16125219|P5|Part B (104 Weeks)|Sponsor request|0
4683838|NCT02531633|16125220|P4|Part B (104 Weeks)|Sponsor request|0
4683839|NCT02531633|16125221|P3|Part B (104 Weeks)|Sponsor request|0
4683840|NCT02531633|16125222|P2|Part B (104 Weeks)|Sponsor request|0
4683841|NCT02531633|16125223|P1|Part B (104 Weeks)|Sponsor request|0
4683842|NCT02531633|16125214|P10|Part A (52 Weeks)|Other|0
4683843|NCT02531633|16125215|P9|Part A (52 Weeks)|Other|0
4683844|NCT02531633|16125216|P8|Part A (52 Weeks)|Other|0
4683845|NCT02531633|16125217|P7|Part A (52 Weeks)|Other|0
4683846|NCT02531633|16125218|P6|Part A (52 Weeks)|Other|0
4683847|NCT02531633|16125219|P5|Part A (52 Weeks)|Other|0
4683848|NCT02531633|16125220|P4|Part A (52 Weeks)|Other|0
4683849|NCT02531633|16125221|P3|Part A (52 Weeks)|Other|0
4683850|NCT02531633|16125222|P2|Part A (52 Weeks)|Other|0
4683851|NCT02531633|16125223|P1|Part A (52 Weeks)|Other|2
4683852|NCT02531633|16125214|P10|Part A (52 Weeks)|Withdrawal by Subject|0
4683853|NCT02531633|16125215|P9|Part A (52 Weeks)|Withdrawal by Subject|0
4683854|NCT02531633|16125216|P8|Part A (52 Weeks)|Withdrawal by Subject|0
4683855|NCT02531633|16125217|P7|Part A (52 Weeks)|Withdrawal by Subject|0
4683856|NCT02531633|16125218|P6|Part A (52 Weeks)|Withdrawal by Subject|0
4683857|NCT02531633|16125219|P5|Part A (52 Weeks)|Withdrawal by Subject|3
4683858|NCT02531633|16125220|P4|Part A (52 Weeks)|Withdrawal by Subject|3
4683859|NCT02531633|16125221|P3|Part A (52 Weeks)|Withdrawal by Subject|1
4683860|NCT02531633|16125222|P2|Part A (52 Weeks)|Withdrawal by Subject|6
4683861|NCT02531633|16125223|P1|Part A (52 Weeks)|Withdrawal by Subject|6
4683862|NCT02531633|16125214|P10|Part A (52 Weeks)|Physician Decision|0
4683863|NCT02531633|16125215|P9|Part A (52 Weeks)|Physician Decision|0
4683864|NCT02531633|16125216|P8|Part A (52 Weeks)|Physician Decision|0
4683865|NCT02531633|16125217|P7|Part A (52 Weeks)|Physician Decision|0
4683866|NCT02531633|16125218|P6|Part A (52 Weeks)|Physician Decision|0
4683867|NCT02531633|16125219|P5|Part A (52 Weeks)|Physician Decision|0
4683868|NCT02531633|16125220|P4|Part A (52 Weeks)|Physician Decision|1
4683869|NCT02531633|16125221|P3|Part A (52 Weeks)|Physician Decision|3
4683870|NCT02531633|16125222|P2|Part A (52 Weeks)|Physician Decision|4
4683871|NCT02531633|16125223|P1|Part A (52 Weeks)|Physician Decision|1
4683872|NCT02531633|16125214|P10|Part A (52 Weeks)|Lost to Follow-up|0
4683873|NCT02531633|16125215|P9|Part A (52 Weeks)|Lost to Follow-up|0
4683874|NCT02531633|16125216|P8|Part A (52 Weeks)|Lost to Follow-up|0
4683875|NCT02531633|16125217|P7|Part A (52 Weeks)|Lost to Follow-up|0
4683876|NCT02531633|16125218|P6|Part A (52 Weeks)|Lost to Follow-up|0
4683877|NCT02531633|16125219|P5|Part A (52 Weeks)|Lost to Follow-up|1
4683878|NCT02531633|16125220|P4|Part A (52 Weeks)|Lost to Follow-up|0
4683879|NCT02531633|16125221|P3|Part A (52 Weeks)|Lost to Follow-up|0
4683880|NCT02531633|16125222|P2|Part A (52 Weeks)|Lost to Follow-up|0
4683881|NCT02531633|16125223|P1|Part A (52 Weeks)|Lost to Follow-up|0
4683882|NCT02531633|16125214|P10|Part A (52 Weeks)|Protocol Violation|0
4683883|NCT02531633|16125215|P9|Part A (52 Weeks)|Protocol Violation|0
4683884|NCT02531633|16125216|P8|Part A (52 Weeks)|Protocol Violation|0
4683885|NCT02531633|16125217|P7|Part A (52 Weeks)|Protocol Violation|0
4683886|NCT02531633|16125218|P6|Part A (52 Weeks)|Protocol Violation|0
4683887|NCT02531633|16125219|P5|Part A (52 Weeks)|Protocol Violation|0
4683888|NCT02531633|16125220|P4|Part A (52 Weeks)|Protocol Violation|0
4683889|NCT02531633|16125221|P3|Part A (52 Weeks)|Protocol Violation|0
4683890|NCT02531633|16125222|P2|Part A (52 Weeks)|Protocol Violation|0
4683891|NCT02531633|16125223|P1|Part A (52 Weeks)|Protocol Violation|1
4683892|NCT02531633|16125214|P10|Part A (52 Weeks)|Sponsor request|0
4683893|NCT02531633|16125215|P9|Part A (52 Weeks)|Sponsor request|0
4683894|NCT02531633|16125216|P8|Part A (52 Weeks)|Sponsor request|0
4683895|NCT02531633|16125217|P7|Part A (52 Weeks)|Sponsor request|0
4683896|NCT02531633|16125218|P6|Part A (52 Weeks)|Sponsor request|0
4683897|NCT02531633|16125219|P5|Part A (52 Weeks)|Sponsor request|19
4683898|NCT02531633|16125220|P4|Part A (52 Weeks)|Sponsor request|18
4683899|NCT02531633|16125221|P3|Part A (52 Weeks)|Sponsor request|18
4683900|NCT02531633|16125222|P2|Part A (52 Weeks)|Sponsor request|24
4683901|NCT02531633|16125223|P1|Part A (52 Weeks)|Sponsor request|24
4683902|NCT02531438|16125702|P2|Overall Study|Randomized with Exclusion Criteria|0
4683903|NCT02531438|16125703|P1|Overall Study|Randomized with Exclusion Criteria|1
4683904|NCT02531438|16125702|P2|Overall Study|Missed EOT/PTE Visit|2
4683905|NCT02531438|16125703|P1|Overall Study|Missed EOT/PTE Visit|5
4683906|NCT02531438|16125702|P2|Overall Study|Randomized, but Not Treated|0
4683907|NCT02531438|16125703|P1|Overall Study|Randomized, but Not Treated|4
4683908|NCT02531438|16125702|P2|Overall Study|Death|3
4683909|NCT02531438|16125703|P1|Overall Study|Death|6
4683910|NCT02531438|16125702|P2|Overall Study|Physician Decision|1
4683911|NCT02531438|16125703|P1|Overall Study|Physician Decision|0
4683912|NCT02531438|16125702|P2|Overall Study|Withdrawal by Subject|8
4683913|NCT02531438|16125703|P1|Overall Study|Withdrawal by Subject|7
4683914|NCT02531438|16125702|P2|Overall Study|Lost to Follow-up|3
4683915|NCT02531438|16125703|P1|Overall Study|Lost to Follow-up|0
4683916|NCT02531438|16125702|P2|Overall Study|Adverse Event|9
4683917|NCT02531438|16125703|P1|Overall Study|Adverse Event|7
4683918|NCT02531373|16125722|P9|Overall Study|Withdrawal by Subject|0
4683919|NCT02531373|16125723|P8|Overall Study|Withdrawal by Subject|0
4683920|NCT02531373|16125724|P7|Overall Study|Withdrawal by Subject|0
4683921|NCT02531373|16125725|P6|Overall Study|Withdrawal by Subject|0
4683922|NCT02531373|16125726|P5|Overall Study|Withdrawal by Subject|3
4683923|NCT02531373|16125727|P4|Overall Study|Withdrawal by Subject|0
4683924|NCT02531373|16125728|P3|Overall Study|Withdrawal by Subject|0
4683925|NCT02531373|16125729|P2|Overall Study|Withdrawal by Subject|0
4683926|NCT02531373|16125730|P1|Overall Study|Withdrawal by Subject|0
4683927|NCT02531373|16125722|P9|Overall Study|Withdrawal by Parent/Guardian|3
4683928|NCT02531373|16125723|P8|Overall Study|Withdrawal by Parent/Guardian|1
4683929|NCT02531373|16125724|P7|Overall Study|Withdrawal by Parent/Guardian|4
4683930|NCT02531373|16125725|P6|Overall Study|Withdrawal by Parent/Guardian|3
4683931|NCT02531373|16125726|P5|Overall Study|Withdrawal by Parent/Guardian|0
4683932|NCT02531373|16125727|P4|Overall Study|Withdrawal by Parent/Guardian|0
4683933|NCT02531373|16125728|P3|Overall Study|Withdrawal by Parent/Guardian|0
4683934|NCT02531373|16125729|P2|Overall Study|Withdrawal by Parent/Guardian|0
4683935|NCT02531373|16125730|P1|Overall Study|Withdrawal by Parent/Guardian|0
4683936|NCT02531373|16125722|P9|Overall Study|Protocol Violation|1
4683937|NCT02531373|16125723|P8|Overall Study|Protocol Violation|0
4683938|NCT02531373|16125724|P7|Overall Study|Protocol Violation|1
4683939|NCT02531373|16125725|P6|Overall Study|Protocol Violation|1
4683940|NCT02531373|16125726|P5|Overall Study|Protocol Violation|0
4683941|NCT02531373|16125727|P4|Overall Study|Protocol Violation|0
4683942|NCT02531373|16125728|P3|Overall Study|Protocol Violation|0
4683943|NCT02531373|16125729|P2|Overall Study|Protocol Violation|0
4683944|NCT02531373|16125730|P1|Overall Study|Protocol Violation|0
4683945|NCT02531373|16125722|P9|Overall Study|Physician Decision|0
4683946|NCT02531373|16125723|P8|Overall Study|Physician Decision|0
4683947|NCT02531373|16125724|P7|Overall Study|Physician Decision|0
4683948|NCT02531373|16125725|P6|Overall Study|Physician Decision|1
4683949|NCT02531373|16125726|P5|Overall Study|Physician Decision|2
4683950|NCT02531373|16125727|P4|Overall Study|Physician Decision|0
4683951|NCT02531373|16125728|P3|Overall Study|Physician Decision|0
4683952|NCT02531373|16125729|P2|Overall Study|Physician Decision|0
4683953|NCT02531373|16125730|P1|Overall Study|Physician Decision|0
4683954|NCT02531373|16125722|P9|Overall Study|Lost to Follow-up|0
4683955|NCT02531373|16125723|P8|Overall Study|Lost to Follow-up|0
4683956|NCT02531373|16125724|P7|Overall Study|Lost to Follow-up|2
4683957|NCT02531373|16125725|P6|Overall Study|Lost to Follow-up|2
4683958|NCT02531373|16125726|P5|Overall Study|Lost to Follow-up|0
4683959|NCT02531373|16125727|P4|Overall Study|Lost to Follow-up|0
4683960|NCT02531373|16125728|P3|Overall Study|Lost to Follow-up|0
4683961|NCT02531373|16125729|P2|Overall Study|Lost to Follow-up|0
4683962|NCT02531373|16125730|P1|Overall Study|Lost to Follow-up|0
4683963|NCT02531373|16125722|P9|Overall Study|Lack of Efficacy|5
4683964|NCT02531373|16125723|P8|Overall Study|Lack of Efficacy|8
4683965|NCT02531373|16125724|P7|Overall Study|Lack of Efficacy|4
4683966|NCT02531373|16125725|P6|Overall Study|Lack of Efficacy|2
4683967|NCT02531373|16125726|P5|Overall Study|Lack of Efficacy|3
4683968|NCT02531373|16125727|P4|Overall Study|Lack of Efficacy|0
4683969|NCT02531373|16125728|P3|Overall Study|Lack of Efficacy|0
4683970|NCT02531373|16125729|P2|Overall Study|Lack of Efficacy|0
4683971|NCT02531373|16125730|P1|Overall Study|Lack of Efficacy|0
4683972|NCT02531113|16125802|P1|Extension Period: Week 12 up to Week 160|Pregnancy|1
4683973|NCT02531113|16125802|P1|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11
4683974|NCT02531113|16125802|P1|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19
4683975|NCT02531113|16125802|P1|Extension Period: Week 12 up to Week 160|Adverse Event|5
4683976|NCT02531113|16125802|P1|Extension Period: Week 12 up to Week 160|Physician Decision|2
4683977|NCT02531113|16125802|P1|Induction Period: Week 0 to 12|Withdrawal by Subject|3
4683978|NCT02531113|16125802|P1|Induction Period: Week 0 to 12|Lack of Efficacy|4
4683979|NCT02531113|16125802|P1|Induction Period: Week 0 to 12|Adverse Event|4
4683980|NCT02531035|16125834|P2|Overall Study|Randomized, not treated|1
4683981|NCT02531035|16125835|P1|Overall Study|Randomized, not treated|2
4683982|NCT02531035|16125834|P2|Overall Study|Lost to Follow-up|10
4683983|NCT02531035|16125835|P1|Overall Study|Lost to Follow-up|8
4683984|NCT02531035|16125834|P2|Overall Study|Withdrawal by Subject|32
4683985|NCT02531035|16125835|P1|Overall Study|Withdrawal by Subject|42
4683986|NCT02531035|16125834|P2|Overall Study|Other|2
4683987|NCT02531035|16125835|P1|Overall Study|Other|3
4683988|NCT02531035|16125834|P2|Overall Study|Adverse Event|45
4683989|NCT02531035|16125835|P1|Overall Study|Adverse Event|16
4683990|NCT02531035|16125834|P2|Overall Study|Physician Decision|0
4683991|NCT02531035|16125835|P1|Overall Study|Physician Decision|1
4683992|NCT02531035|16125834|P2|Overall Study|Noncompliance with study drug|3
4683993|NCT02531035|16125835|P1|Overall Study|Noncompliance with study drug|8
4683994|NCT02531035|16125834|P2|Overall Study|Protocol Violation|1
4683995|NCT02531035|16125835|P1|Overall Study|Protocol Violation|1
4683996|NCT02531035|16125834|P2|Overall Study|Death|1
4683997|NCT02531035|16125835|P1|Overall Study|Death|0
4683998|NCT02530970|16125860|P1|Overall Study|Relocation|3
4683999|NCT02530970|16125860|P1|Overall Study|Change in Provider|5
4684000|NCT02530970|16125860|P1|Overall Study|Explant|2
4684001|NCT02530970|16125860|P1|Overall Study|Insurance|2
4684002|NCT02530970|16125860|P1|Overall Study|Hospitalization|1
4684003|NCT02530970|16125860|P1|Overall Study|Death|6
4684004|NCT02530970|16125860|P1|Overall Study|Withdrawal by Subject|14
4684005|NCT02530970|16125860|P1|Overall Study|Physician Decision|5
4684006|NCT02530970|16125860|P1|Overall Study|Lost to Follow-up|88
4684007|NCT02530970|16125860|P1|Overall Study|Adverse Event|8
4684008|NCT02530671|16125867|P2|Overall Study|Withdrawal by Subject|0
4684009|NCT02530671|16125868|P1|Overall Study|Withdrawal by Subject|1
4684010|NCT02530671|16125867|P2|Overall Study|Lost to Follow-up|0
4684011|NCT02530671|16125868|P1|Overall Study|Lost to Follow-up|2
4684012|NCT02530385|16125956|P2|Overall Study|Withdrawal by Subject|1
4684013|NCT02530385|16125957|P1|Overall Study|Withdrawal by Subject|0
4684014|NCT02530242|16126009|P2|Overall Study|excluded due to asthma and oxcarbazepine|1
4684015|NCT02530242|16126010|P1|Overall Study|excluded due to asthma and oxcarbazepine|0
4684016|NCT02530125|16126029|P1|Followed for Survival for 2 Years|Early termination of study|3
4684017|NCT02530125|16126029|P1|Completed Treatment|Early termination of study|1
4684018|NCT02529995|16126043|P2|Part B|Discontinued Study|5
4684019|NCT02529995|16126044|P1|Part B|Discontinued Study|6
4684020|NCT02529995|16126043|P2|Part B|Ongoing Study at Data Cut-off|7
4684021|NCT02529995|16126044|P1|Part B|Ongoing Study at Data Cut-off|0
4684022|NCT02529995|16126043|P2|Part A|Discontinued Study|0
4684023|NCT02529995|16126044|P1|Part A|Discontinued Study|1
4684024|NCT02529995|16126043|P2|Part A|Ongoing Study at Data Cut-off|16
4684025|NCT02529995|16126044|P1|Part A|Ongoing Study at Data Cut-off|14
4684026|NCT02529553|16126087|P9|Overall Study|Withdrawal by Subject|0
4684027|NCT02529553|16126088|P8|Overall Study|Withdrawal by Subject|1
4684028|NCT02529553|16126089|P7|Overall Study|Withdrawal by Subject|0
4684029|NCT02529553|16126090|P6|Overall Study|Withdrawal by Subject|1
4684030|NCT02529553|16126091|P5|Overall Study|Withdrawal by Subject|0
4684031|NCT02529553|16126092|P4|Overall Study|Withdrawal by Subject|0
4684032|NCT02529553|16126093|P3|Overall Study|Withdrawal by Subject|0
4684033|NCT02529553|16126094|P2|Overall Study|Withdrawal by Subject|0
4684034|NCT02529553|16126095|P1|Overall Study|Withdrawal by Subject|0
4684035|NCT02529553|16126087|P9|Overall Study|Physician Decision|0
4684036|NCT02529553|16126088|P8|Overall Study|Physician Decision|0
4684037|NCT02529553|16126089|P7|Overall Study|Physician Decision|0
4684038|NCT02529553|16126090|P6|Overall Study|Physician Decision|0
4684039|NCT02529553|16126091|P5|Overall Study|Physician Decision|1
4684040|NCT02529553|16126092|P4|Overall Study|Physician Decision|0
4684041|NCT02529553|16126093|P3|Overall Study|Physician Decision|0
4684042|NCT02529553|16126094|P2|Overall Study|Physician Decision|1
4684043|NCT02529553|16126095|P1|Overall Study|Physician Decision|0
4684044|NCT02529553|16126087|P9|Overall Study|Progressive Disease|3
4684045|NCT02529553|16126088|P8|Overall Study|Progressive Disease|5
4684046|NCT02529553|16126089|P7|Overall Study|Progressive Disease|3
4684047|NCT02529553|16126090|P6|Overall Study|Progressive Disease|3
4684048|NCT02529553|16126091|P5|Overall Study|Progressive Disease|2
4684049|NCT02529553|16126092|P4|Overall Study|Progressive Disease|3
4684050|NCT02529553|16126093|P3|Overall Study|Progressive Disease|1
4684051|NCT02529553|16126094|P2|Overall Study|Progressive Disease|0
4684052|NCT02529553|16126095|P1|Overall Study|Progressive Disease|1
4684053|NCT02529488|16126134|P1|Overall Study|Death|3
4684054|NCT02529488|16126134|P1|Overall Study|Adverse Event|1
4684055|NCT02529137|16126142|P1|Overall Study|Discontinuation for different reasons|8
4684056|NCT02528643|16126179|P2|Overall Study|No End of Study Information Available|0
4684057|NCT02528643|16126180|P1|Overall Study|No End of Study Information Available|1
4684058|NCT02528643|16126179|P2|Overall Study|Miscellaneous|1
4684059|NCT02528643|16126180|P1|Overall Study|Miscellaneous|0
4684060|NCT02528643|16126179|P2|Overall Study|Withdrawal by Subject|7
4684061|NCT02528643|16126180|P1|Overall Study|Withdrawal by Subject|0
4684062|NCT02528643|16126179|P2|Overall Study|Lost to Follow-up|1
4684063|NCT02528643|16126180|P1|Overall Study|Lost to Follow-up|0
4684064|NCT02528643|16126179|P2|Overall Study|Death|76
4684065|NCT02528643|16126180|P1|Overall Study|Death|38
4684066|NCT02528331|16126222|P1|Overall Study|Withdrawal by Subject|2
4684067|NCT02528305|16126290|P1|Overall Study|Physician Decision|1
4684068|NCT02528305|16126290|P1|Overall Study|Adverse Event|1
4684069|NCT02528305|16126290|P1|Overall Study|Withdrawal by Subject|1
4684070|NCT02528253|16126337|P5|Overall Study|Withdrawn Due to Pregnancy|1
4684071|NCT02528253|16126338|P4|Overall Study|Withdrawn Due to Pregnancy|0
4684072|NCT02528253|16126339|P3|Overall Study|Withdrawn Due to Pregnancy|0
4684073|NCT02528253|16126340|P2|Overall Study|Withdrawn Due to Pregnancy|1
4684074|NCT02528253|16126341|P1|Overall Study|Withdrawn Due to Pregnancy|0
4684075|NCT02528253|16126337|P5|Overall Study|Protocol Violation|4
4684076|NCT02528253|16126338|P4|Overall Study|Protocol Violation|0
4684077|NCT02528253|16126339|P3|Overall Study|Protocol Violation|4
4684078|NCT02528253|16126340|P2|Overall Study|Protocol Violation|2
4684079|NCT02528253|16126341|P1|Overall Study|Protocol Violation|1
4684080|NCT02528253|16126337|P5|Overall Study|Withdrawal by Subject|73
4684081|NCT02528253|16126338|P4|Overall Study|Withdrawal by Subject|48
4684082|NCT02528253|16126339|P3|Overall Study|Withdrawal by Subject|29
4684083|NCT02528253|16126340|P2|Overall Study|Withdrawal by Subject|20
4684084|NCT02528253|16126341|P1|Overall Study|Withdrawal by Subject|25
4684085|NCT02528253|16126337|P5|Overall Study|Other|76
4684086|NCT02528253|16126338|P4|Overall Study|Other|52
4684087|NCT02528253|16126339|P3|Overall Study|Other|58
4684088|NCT02528253|16126340|P2|Overall Study|Other|22
4684089|NCT02528253|16126341|P1|Overall Study|Other|21
4684090|NCT02528253|16126337|P5|Overall Study|Lost to Follow-up|34
4684091|NCT02528253|16126338|P4|Overall Study|Lost to Follow-up|16
4684092|NCT02528253|16126339|P3|Overall Study|Lost to Follow-up|31
4684093|NCT02528253|16126340|P2|Overall Study|Lost to Follow-up|9
4684094|NCT02528253|16126341|P1|Overall Study|Lost to Follow-up|16
4684095|NCT02528253|16126337|P5|Overall Study|Insufficient clinical response|16
4684096|NCT02528253|16126338|P4|Overall Study|Insufficient clinical response|12
4684097|NCT02528253|16126339|P3|Overall Study|Insufficient clinical response|13
4684098|NCT02528253|16126340|P2|Overall Study|Insufficient clinical response|10
4684099|NCT02528253|16126341|P1|Overall Study|Insufficient clinical response|7
4684100|NCT02528253|16126337|P5|Overall Study|Death|1
4684101|NCT02528253|16126338|P4|Overall Study|Death|0
4684102|NCT02528253|16126339|P3|Overall Study|Death|1
4684103|NCT02528253|16126340|P2|Overall Study|Death|2
4684104|NCT02528253|16126341|P1|Overall Study|Death|2
4684105|NCT02528253|16126337|P5|Overall Study|Adverse Event|18
4684106|NCT02528253|16126338|P4|Overall Study|Adverse Event|8
4684107|NCT02528253|16126339|P3|Overall Study|Adverse Event|4
4684108|NCT02528253|16126340|P2|Overall Study|Adverse Event|4
4684109|NCT02528253|16126341|P1|Overall Study|Adverse Event|3
4684110|NCT02528214|16126634|P2|Overall Study|Other than specified above|1
4684111|NCT02528214|16126635|P1|Overall Study|Other than specified above|0
4684112|NCT02528214|16126634|P2|Overall Study|Adverse Event|1
4684113|NCT02528214|16126635|P1|Overall Study|Adverse Event|0
4684114|NCT02528214|16126634|P2|Overall Study|Protocol Violation|1
4684115|NCT02528214|16126635|P1|Overall Study|Protocol Violation|0
4684116|NCT02528188|16126670|P3|Overall Study|Randomized but not treated|12
4684117|NCT02528188|16126671|P2|Overall Study|Randomized but not treated|7
4684118|NCT02528188|16126672|P1|Overall Study|Randomized but not treated|6
4684119|NCT02528188|16126670|P3|Overall Study|Other|74
4684120|NCT02528188|16126671|P2|Overall Study|Other|91
4684121|NCT02528188|16126672|P1|Overall Study|Other|89
4684122|NCT02528188|16126670|P3|Overall Study|Death|0
4684123|NCT02528188|16126671|P2|Overall Study|Death|4
4684124|NCT02528188|16126672|P1|Overall Study|Death|4
4684125|NCT02528188|16126670|P3|Overall Study|Lost to Follow-up|31
4684126|NCT02528188|16126671|P2|Overall Study|Lost to Follow-up|21
4684127|NCT02528188|16126672|P1|Overall Study|Lost to Follow-up|25
4684128|NCT02528188|16126670|P3|Overall Study|Withdrawal by Subject|100
4684129|NCT02528188|16126671|P2|Overall Study|Withdrawal by Subject|104
4684130|NCT02528188|16126672|P1|Overall Study|Withdrawal by Subject|97
4684131|NCT02528188|16126670|P3|Overall Study|Lack of Efficacy|22
4684132|NCT02528188|16126671|P2|Overall Study|Lack of Efficacy|21
4684133|NCT02528188|16126672|P1|Overall Study|Lack of Efficacy|19
4684134|NCT02528188|16126670|P3|Overall Study|Protocol Violation|4
4684135|NCT02528188|16126671|P2|Overall Study|Protocol Violation|6
4684136|NCT02528188|16126672|P1|Overall Study|Protocol Violation|4
4684137|NCT02528188|16126670|P3|Overall Study|Adverse Event|8
4684138|NCT02528188|16126671|P2|Overall Study|Adverse Event|22
4684139|NCT02528188|16126672|P1|Overall Study|Adverse Event|23
4684140|NCT02527434|16126947|P3|Overall Study|Site closure|0
4684141|NCT02527434|16126948|P2|Overall Study|Site closure|0
4684142|NCT02527434|16126949|P1|Overall Study|Site closure|1
4684143|NCT02527434|16126947|P3|Overall Study|Reason Not Specified|0
4684144|NCT02527434|16126948|P2|Overall Study|Reason Not Specified|0
4684145|NCT02527434|16126949|P1|Overall Study|Reason Not Specified|1
4684146|NCT02527434|16126947|P3|Overall Study|Withdrawal by Subject|3
4684147|NCT02527434|16126948|P2|Overall Study|Withdrawal by Subject|3
4684148|NCT02527434|16126949|P1|Overall Study|Withdrawal by Subject|5
4684149|NCT02527434|16126947|P3|Overall Study|Death|17
4684150|NCT02527434|16126948|P2|Overall Study|Death|6
4684151|NCT02527434|16126949|P1|Overall Study|Death|19
4684152|NCT02527434|16126947|P3|Overall Study|Lost to Follow-up|0
4684153|NCT02527434|16126948|P2|Overall Study|Lost to Follow-up|2
4684154|NCT02527434|16126949|P1|Overall Study|Lost to Follow-up|2
4684155|NCT02527161|16127007|P1|Overall Study|Lost to Follow-up|6
4684156|NCT02527161|16127007|P1|Overall Study|Adverse Event|1
4684157|NCT02527161|16127007|P1|Overall Study|Physician Decision|1
4684158|NCT02527161|16127007|P1|Overall Study|Only Recruited to Part A|27
4684159|NCT02527161|16127007|P1|Overall Study|Consent violation|4
4684160|NCT02527161|16127007|P1|Overall Study|MRI contraindication|6
4684161|NCT02527161|16127007|P1|Overall Study|Delay in or unfit for surgery|16
4684162|NCT02527161|16127007|P1|Overall Study|Withdrawal by Subject|19
4684163|NCT02527161|16127007|P1|Overall Study|Failed MRI|52
4684164|NCT02527148|16127026|P2|Overall Study|Did not receive study intervention|0
4684165|NCT02527148|16127027|P1|Overall Study|Did not receive study intervention|1
4684166|NCT02526693|16127057|P2|Overall Study|Physician Decision|1
4684167|NCT02526693|16127058|P1|Overall Study|Physician Decision|3
4684168|NCT02526550|16127103|P1|Overall Study|Lost to Follow-up|1
4684169|NCT02526524|16127115|P6|Overall Study|Sponsor Decision|0
4684170|NCT02526524|16127116|P5|Overall Study|Sponsor Decision|0
4684171|NCT02526524|16127117|P4|Overall Study|Sponsor Decision|0
4684172|NCT02526524|16127118|P3|Overall Study|Sponsor Decision|0
4684173|NCT02526524|16127119|P2|Overall Study|Sponsor Decision|0
4684174|NCT02526524|16127120|P1|Overall Study|Sponsor Decision|1
4684175|NCT02526524|16127115|P6|Overall Study|Physician Decision|0
4684176|NCT02526524|16127116|P5|Overall Study|Physician Decision|1
4684177|NCT02526524|16127117|P4|Overall Study|Physician Decision|0
4684178|NCT02526524|16127118|P3|Overall Study|Physician Decision|0
4684179|NCT02526524|16127119|P2|Overall Study|Physician Decision|0
4684180|NCT02526524|16127120|P1|Overall Study|Physician Decision|0
4684181|NCT02526524|16127115|P6|Overall Study|Loss of Glucose Control|0
4684182|NCT02526524|16127116|P5|Overall Study|Loss of Glucose Control|2
4684183|NCT02526524|16127117|P4|Overall Study|Loss of Glucose Control|0
4684184|NCT02526524|16127118|P3|Overall Study|Loss of Glucose Control|3
4684185|NCT02526524|16127119|P2|Overall Study|Loss of Glucose Control|0
4684186|NCT02526524|16127120|P1|Overall Study|Loss of Glucose Control|0
4684187|NCT02526524|16127115|P6|Overall Study|Protocol Violation|3
4684188|NCT02526524|16127116|P5|Overall Study|Protocol Violation|4
4684189|NCT02526524|16127117|P4|Overall Study|Protocol Violation|3
4684190|NCT02526524|16127118|P3|Overall Study|Protocol Violation|5
4684191|NCT02526524|16127119|P2|Overall Study|Protocol Violation|1
4684192|NCT02526524|16127120|P1|Overall Study|Protocol Violation|3
4684193|NCT02526524|16127115|P6|Overall Study|Lost to Follow-up|5
4684194|NCT02526524|16127116|P5|Overall Study|Lost to Follow-up|2
4684195|NCT02526524|16127117|P4|Overall Study|Lost to Follow-up|1
4684196|NCT02526524|16127118|P3|Overall Study|Lost to Follow-up|8
4684197|NCT02526524|16127119|P2|Overall Study|Lost to Follow-up|3
4684198|NCT02526524|16127120|P1|Overall Study|Lost to Follow-up|2
4684199|NCT02526524|16127115|P6|Overall Study|Adverse Event|8
4684200|NCT02526524|16127116|P5|Overall Study|Adverse Event|6
4684201|NCT02526524|16127117|P4|Overall Study|Adverse Event|2
4684202|NCT02526524|16127118|P3|Overall Study|Adverse Event|4
4684203|NCT02526524|16127119|P2|Overall Study|Adverse Event|2
4684204|NCT02526524|16127120|P1|Overall Study|Adverse Event|3
4684205|NCT02526524|16127115|P6|Overall Study|Withdrawal by Subject|5
4684206|NCT02526524|16127116|P5|Overall Study|Withdrawal by Subject|9
4684207|NCT02526524|16127117|P4|Overall Study|Withdrawal by Subject|1
4684208|NCT02526524|16127118|P3|Overall Study|Withdrawal by Subject|6
4684209|NCT02526524|16127119|P2|Overall Study|Withdrawal by Subject|3
4684210|NCT02526524|16127120|P1|Overall Study|Withdrawal by Subject|3
4684211|NCT02526290|16127134|P1|Overall Study|Physician Decision|1
4684212|NCT02526290|16127134|P1|Overall Study|Withdrawal by Subject|4
4684213|NCT02526290|16127134|P1|Overall Study|Adverse Event|3
4684214|NCT02526212|16127168|P2|Overall Study|Death|1
4684215|NCT02526212|16127169|P1|Overall Study|Death|0
4684216|NCT02526212|16127168|P2|Overall Study|Lost to Follow-up|0
4684217|NCT02526212|16127169|P1|Overall Study|Lost to Follow-up|1
4684218|NCT02526212|16127168|P2|Overall Study|Incarceration|0
4684219|NCT02526212|16127169|P1|Overall Study|Incarceration|1
4684220|NCT02525874|16127183|P1|Overall Study|New lesions in Brain|1
4684221|NCT02525874|16127183|P1|Overall Study|Alternative Treatment for MS|2
4684222|NCT02525874|16127183|P1|Overall Study|Disease relapse|4
4684223|NCT02525874|16127183|P1|Overall Study|Disease progression, defined by protocol|2
4684224|NCT02525874|16127183|P1|Overall Study|Lost to Follow-up|7
4684225|NCT02525874|16127183|P1|Overall Study|Adverse Event|17
4684226|NCT02525874|16127183|P1|Overall Study|Non-compliance with study drug|3
4684227|NCT02525874|16127183|P1|Overall Study|Consent withdrawn|22
4684228|NCT02525874|16127183|P1|Overall Study|Investigator Decision|1
4684229|NCT02525874|16127183|P1|Overall Study|Other|1
4684230|NCT02525744|16127196|P4|Period 5|Physician Decision|0
4684231|NCT02525744|16127197|P3|Period 5|Physician Decision|0
4684232|NCT02525744|16127198|P2|Period 5|Physician Decision|0
4684233|NCT02525744|16127199|P1|Period 5|Physician Decision|1
4684234|NCT02525744|16127196|P4|Period 4|Withdrawal by Subject|0
4684235|NCT02525744|16127197|P3|Period 4|Withdrawal by Subject|0
4684236|NCT02525744|16127198|P2|Period 4|Withdrawal by Subject|0
4684237|NCT02525744|16127199|P1|Period 4|Withdrawal by Subject|1
4684238|NCT02525744|16127196|P4|Period 3|Adverse Event|0
4684239|NCT02525744|16127197|P3|Period 3|Adverse Event|0
4684240|NCT02525744|16127198|P2|Period 3|Adverse Event|1
4684241|NCT02525744|16127199|P1|Period 3|Adverse Event|0
4684242|NCT02525744|16127196|P4|Period 1|Physician Decision|0
4684243|NCT02525744|16127197|P3|Period 1|Physician Decision|1
4684244|NCT02525744|16127198|P2|Period 1|Physician Decision|0
4684245|NCT02525744|16127199|P1|Period 1|Physician Decision|0
4684246|NCT02525627|16127235|P2|Overall Study|Site terminated|10
4684247|NCT02525627|16127236|P1|Overall Study|Site terminated|11
4684248|NCT02525627|16127235|P2|Overall Study|Death|0
4684249|NCT02525627|16127236|P1|Overall Study|Death|1
4684250|NCT02525627|16127235|P2|Overall Study|Withdrawal by Subject|2
4684251|NCT02525627|16127236|P1|Overall Study|Withdrawal by Subject|1
4684252|NCT02525627|16127235|P2|Overall Study|Revision|1
4684253|NCT02525627|16127236|P1|Overall Study|Revision|1
4684254|NCT02525588|16127248|P2|Overall Study|Adverse Event|1
4684255|NCT02525588|16127249|P1|Overall Study|Adverse Event|0
4684256|NCT02525588|16127248|P2|Overall Study|Withdrawal by Subject|1
4684257|NCT02525588|16127249|P1|Overall Study|Withdrawal by Subject|1
4684258|NCT02525588|16127248|P2|Overall Study|Lost to Follow-up|0
4684259|NCT02525588|16127249|P1|Overall Study|Lost to Follow-up|2
4684260|NCT02525588|16127248|P2|Overall Study|Death|1
4684261|NCT02525588|16127249|P1|Overall Study|Death|3
4684262|NCT02525094|16127361|P2|Overall Study|Not Treated|1
4684263|NCT02525094|16127362|P1|Overall Study|Not Treated|1
4684264|NCT02525094|16127361|P2|Overall Study|Withdrawal by Subject|6
4684265|NCT02525094|16127362|P1|Overall Study|Withdrawal by Subject|5
4684266|NCT02525094|16127361|P2|Overall Study|Lost to Follow-up|1
4684267|NCT02525094|16127362|P1|Overall Study|Lost to Follow-up|2
4684268|NCT02524847|16127425|P1|Overall Study|Reason not Specified|1
4684269|NCT02524847|16127425|P1|Overall Study|Death|1
4684270|NCT02524847|16127425|P1|Overall Study|Condition no Longer Requires Treatment|4
4684271|NCT02524847|16127425|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
4684272|NCT02524847|16127425|P1|Overall Study|Adverse Event|4
4684273|NCT02524665|16127437|P1|Overall Study|Lost to Follow-up|1
4684274|NCT02524288|16127488|P1|Overall Study|Physician Decision|2
4684275|NCT02524288|16127488|P1|Overall Study|Pregnancy|22
4684276|NCT02524288|16127488|P1|Overall Study|Withdrawal by Subject|76
4684277|NCT02524288|16127488|P1|Overall Study|Subject Moved|32
4684278|NCT02524288|16127488|P1|Overall Study|Study Terminated By Sponsor|1417
4684279|NCT02524288|16127488|P1|Overall Study|Site Discontinued Study Participation|1
4684280|NCT02524288|16127488|P1|Overall Study|Screen Failure|2
4684281|NCT02524288|16127488|P1|Overall Study|Protocol Violation|6
4684282|NCT02524288|16127488|P1|Overall Study|Pregnancy Wish|6
4684283|NCT02524288|16127488|P1|Overall Study|Non-Compliance With Study Drug|14
4684284|NCT02524288|16127488|P1|Overall Study|Non-Compliance With Protocol|32
4684285|NCT02524288|16127488|P1|Overall Study|Lost to Follow-up|216
4684286|NCT02524288|16127488|P1|Overall Study|Adverse Event|115
4684287|NCT02524158|16127498|P2|6-month Assessment|Lost to Follow-up|20
4684288|NCT02524158|16127499|P1|6-month Assessment|Lost to Follow-up|21
4684289|NCT02524158|16127498|P2|6-month Assessment|Withdrawal by Subject|1
4684290|NCT02524158|16127499|P1|6-month Assessment|Withdrawal by Subject|1
4684291|NCT02524158|16127498|P2|12-weeks Assessment|Lost to Follow-up|12
4684292|NCT02524158|16127499|P1|12-weeks Assessment|Lost to Follow-up|18
4684293|NCT02524158|16127498|P2|12-weeks Assessment|Withdrawal by Subject|1
4684294|NCT02524158|16127499|P1|12-weeks Assessment|Withdrawal by Subject|1
4684295|NCT02524145|16127541|P3|Overall Study|Withdrawal by Subject|3
4684296|NCT02524145|16127542|P2|Overall Study|Withdrawal by Subject|2
4684297|NCT02524145|16127543|P1|Overall Study|Withdrawal by Subject|2
4684298|NCT02522884|16127640|P1|Overall Study|Missed 12-month Follow-up|9
4684299|NCT02522884|16127640|P1|Overall Study|Death|3
4684300|NCT02522884|16127640|P1|Overall Study|Withdrawal by Subject|6
4684301|NCT02522728|16127672|P2|Overall Study|Did not receive randomized study device|1
4684302|NCT02522728|16127673|P1|Overall Study|Did not receive randomized study device|0
4684303|NCT02522728|16127672|P2|Overall Study|Adverse Event|1
4684304|NCT02522728|16127673|P1|Overall Study|Adverse Event|2
4684305|NCT02522728|16127672|P2|Overall Study|Death|3
4684306|NCT02522728|16127673|P1|Overall Study|Death|4
4684307|NCT02522728|16127672|P2|Overall Study|Withdrawal by Subject|6
4684308|NCT02522728|16127673|P1|Overall Study|Withdrawal by Subject|6
4684309|NCT02522624|16127689|P2|Overall Study|Technical failure|0
4684310|NCT02522624|16127690|P1|Overall Study|Technical failure|1
4684311|NCT02522481|16127706|P1|Overall Study|Not dosed|1
4684312|NCT02522481|16127706|P1|Overall Study|discontinued|1
4684313|NCT02522403|16127736|P2|Overall Study|Withdrawal by Subject|4
4684314|NCT02522403|16127737|P1|Overall Study|Withdrawal by Subject|2
4684315|NCT02522403|16127736|P2|Overall Study|Lost to Follow-up|2
4684316|NCT02522403|16127737|P1|Overall Study|Lost to Follow-up|2
4684317|NCT02522377|16127749|P2|Overall Study|Remission Achieved|0
4684318|NCT02522377|16127750|P1|Overall Study|Remission Achieved|3
4684319|NCT02522377|16127749|P2|Overall Study|Withdrawal by Subject|0
4684320|NCT02522377|16127750|P1|Overall Study|Withdrawal by Subject|1
4684321|NCT02522325|16127766|P2|Overall Study|Adverse Event|1
4684322|NCT02522325|16127767|P1|Overall Study|Adverse Event|0
4684323|NCT02522299|16127775|P2|Overall Study|Withdrawal by Subject|0
4684324|NCT02522299|16127776|P1|Overall Study|Withdrawal by Subject|2
4684325|NCT02522299|16127775|P2|Overall Study|Physician Decision|1
4684326|NCT02522299|16127776|P1|Overall Study|Physician Decision|0
4684327|NCT02522299|16127775|P2|Overall Study|Adverse Event|0
4684328|NCT02522299|16127776|P1|Overall Study|Adverse Event|2
4684329|NCT02522286|16127859|P4|Overall Study|Withdrawal by Subject|3
4684330|NCT02522286|16127860|P3|Overall Study|Withdrawal by Subject|0
4684331|NCT02522286|16127861|P2|Overall Study|Withdrawal by Subject|0
4684332|NCT02522286|16127862|P1|Overall Study|Withdrawal by Subject|3
4684333|NCT02521948|16127898|P1|Overall Study|Did not attend one or both follow-ups|6
4684334|NCT02521948|16127898|P1|Overall Study|Lost to Follow-up|1
4684335|NCT02521948|16127898|P1|Overall Study|Death|4
4684336|NCT02521948|16127898|P1|Overall Study|Adverse Event|2
4684337|NCT02521792|16127907|P1|Overall Study|Study Terminated|6
4684338|NCT02521376|16127957|P4|Overall Study|Enrolled, But Not Treated|0
4684339|NCT02521376|16127958|P3|Overall Study|Enrolled, But Not Treated|0
4684340|NCT02521376|16127959|P2|Overall Study|Enrolled, But Not Treated|0
4684341|NCT02521376|16127960|P1|Overall Study|Enrolled, But Not Treated|1
4684342|NCT02520726|16128014|P2|Overall Study|Lost to Follow-up|2
4684343|NCT02520726|16128015|P1|Overall Study|Lost to Follow-up|3
4684344|NCT02520531|16128025|P2|Overall Study|Not study device|0
4684345|NCT02520531|16128026|P1|Overall Study|Not study device|1
4684346|NCT02520531|16128025|P2|Overall Study|Withdrawal by Subject|0
4684347|NCT02520531|16128026|P1|Overall Study|Withdrawal by Subject|1
4684348|NCT02520531|16128025|P2|Overall Study|Meet exclusion criterion|1
4684349|NCT02520531|16128026|P1|Overall Study|Meet exclusion criterion|0
4684350|NCT02520531|16128025|P2|Overall Study|Lost to Follow-up|1
4684351|NCT02520531|16128026|P1|Overall Study|Lost to Follow-up|1
4684352|NCT02520531|16128025|P2|Overall Study|Death|2
4684353|NCT02520531|16128026|P1|Overall Study|Death|1
4684354|NCT02520531|16128025|P2|Overall Study|Revision of study device components|2
4684355|NCT02520531|16128026|P1|Overall Study|Revision of study device components|2
4684356|NCT02520388|16128111|P2|Overall Study|Other (reason not defined)|4
4684357|NCT02520388|16128112|P1|Overall Study|Other (reason not defined)|4
4684358|NCT02520388|16128111|P2|Overall Study|Lost to Follow-up|2
4684359|NCT02520388|16128112|P1|Overall Study|Lost to Follow-up|3
4684360|NCT02520388|16128111|P2|Overall Study|Adverse Event|4
4684361|NCT02520388|16128112|P1|Overall Study|Adverse Event|1
4684362|NCT02520388|16128111|P2|Overall Study|Subject or parent/guardian request|6
4684363|NCT02520388|16128112|P1|Overall Study|Subject or parent/guardian request|0
4684364|NCT02520388|16128111|P2|Overall Study|Physician Decision|0
4684365|NCT02520388|16128112|P1|Overall Study|Physician Decision|1
4684366|NCT02520310|16128120|P1|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2
4684367|NCT02520310|16128120|P1|AT 3 Year Clinical Follow-up|Death|2
4684368|NCT02520310|16128120|P1|At 1 Year Clinical Follow-up|Withdrawal by Subject|1
4684369|NCT02520310|16128120|P1|At 6 Months Clinical Follow-up|Death|1
4684370|NCT02520284|16128301|P3|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
4684371|NCT02520284|16128302|P2|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1
4684372|NCT02520284|16128303|P1|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2
4684373|NCT02520284|16128301|P3|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3
4684374|NCT02520284|16128302|P2|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1
4684375|NCT02520284|16128303|P1|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2
4684376|NCT02520284|16128301|P3|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2
4684377|NCT02520284|16128302|P2|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4
4684378|NCT02520284|16128303|P1|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3
4684379|NCT02520284|16128301|P3|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28
4684380|NCT02520284|16128302|P2|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29
4684381|NCT02520284|16128303|P1|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25
4684382|NCT02520284|16128301|P3|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
4684383|NCT02520284|16128302|P2|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2
4684384|NCT02520284|16128303|P1|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0
4684385|NCT02520284|16128301|P3|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0
4684386|NCT02520284|16128302|P2|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
4684387|NCT02520284|16128303|P1|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1
4684388|NCT02520284|16128301|P3|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3
4684389|NCT02520284|16128302|P2|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
4684390|NCT02520284|16128303|P1|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2
4684391|NCT02520284|16128301|P3|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15
4684392|NCT02520284|16128302|P2|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11
4684393|NCT02520284|16128303|P1|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17
4684394|NCT02520284|16128301|P3|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1
4684395|NCT02520284|16128302|P2|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
4684396|NCT02520284|16128303|P1|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0
4684397|NCT02520284|16128301|P3|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
4684398|NCT02520284|16128302|P2|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
4684399|NCT02520284|16128303|P1|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1
4684400|NCT02520284|16128301|P3|Blinded Induction Phase: Up to Week 8|Adverse Event|0
4684401|NCT02520284|16128302|P2|Blinded Induction Phase: Up to Week 8|Adverse Event|3
4684402|NCT02520284|16128303|P1|Blinded Induction Phase: Up to Week 8|Adverse Event|1
4684403|NCT02520089|16128337|P2|Overall Study|Lost to Follow-up|4
4684404|NCT02520089|16128338|P1|Overall Study|Lost to Follow-up|3
4684405|NCT02519855|16128348|P2|Overall Study|Lost to Follow-up|3
4684406|NCT02519855|16128349|P1|Overall Study|Lost to Follow-up|3
4684407|NCT02519855|16128348|P2|Overall Study|Adverse Event|1
4684408|NCT02519855|16128349|P1|Overall Study|Adverse Event|0
4684409|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2
4684410|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
4684411|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0
4684412|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1
4684413|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
4684414|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0
4684415|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Completed Chemotherapy|13
4684416|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
4684417|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Completed Chemotherapy|0
4684418|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2
4684419|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
4684420|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0
4684421|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Death|1
4684422|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Death|0
4684423|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Death|0
4684424|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Withdrawal by Subject|1
4684425|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
4684426|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Withdrawal by Subject|0
4684427|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3
4684428|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
4684429|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0
4684430|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Adverse Event|1
4684431|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Adverse Event|0
4684432|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Adverse Event|0
4684433|NCT02519842|16128367|P3|Optional Extension: Cycles 2-6|Physician Decision|5
4684434|NCT02519842|16128368|P2|Optional Extension: Cycles 2-6|Physician Decision|0
4684435|NCT02519842|16128369|P1|Optional Extension: Cycles 2-6|Physician Decision|0
4684436|NCT02519842|16128367|P3|Base Study: Cycle 1|Non-compliance with Study Drug|0
4684437|NCT02519842|16128368|P2|Base Study: Cycle 1|Non-compliance with Study Drug|1
4684438|NCT02519842|16128369|P1|Base Study: Cycle 1|Non-compliance with Study Drug|0
4684439|NCT02519842|16128367|P3|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
4684440|NCT02519842|16128368|P2|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1
4684441|NCT02519842|16128369|P1|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0
4684442|NCT02519842|16128367|P3|Base Study: Cycle 1|Adverse Event|0
4684443|NCT02519842|16128368|P2|Base Study: Cycle 1|Adverse Event|0
4684444|NCT02519842|16128369|P1|Base Study: Cycle 1|Adverse Event|1
4684445|NCT02519842|16128367|P3|Base Study: Cycle 1|Screening Failure|0
4684446|NCT02519842|16128368|P2|Base Study: Cycle 1|Screening Failure|1
4684447|NCT02519842|16128369|P1|Base Study: Cycle 1|Screening Failure|1
4684448|NCT02519712|16128388|P1|Overall Study|Accruals are donors|2
4684449|NCT02519712|16128388|P1|Overall Study|Disease Progression|1
4684450|NCT02519712|16128388|P1|Overall Study|Disease Relapse|1
4684451|NCT02519595|16128417|P3|Overall Study|Protocol Violation|16
4684452|NCT02519595|16128418|P2|Overall Study|Protocol Violation|22
4684453|NCT02519595|16128419|P1|Overall Study|Protocol Violation|8
4684454|NCT02519504|16128444|P2|Overall Study|Did not participate in direct testing|86
4684455|NCT02519504|16128445|P1|Overall Study|Did not participate in direct testing|95
4684456|NCT02519504|16128444|P2|Overall Study|Ineligible for direct testing|12
4684457|NCT02519504|16128445|P1|Overall Study|Ineligible for direct testing|12
4684458|NCT02519504|16128444|P2|Overall Study|Protocol Violation|5
4684459|NCT02519504|16128445|P1|Overall Study|Protocol Violation|6
4684460|NCT02519231|16128544|P2|Overall Study|Withdrawal by Subject|1
4684461|NCT02519231|16128545|P1|Overall Study|Withdrawal by Subject|0
4684462|NCT02519231|16128544|P2|Overall Study|Lost to Follow-up|5
4684463|NCT02519231|16128545|P1|Overall Study|Lost to Follow-up|2
4684464|NCT02518971|16128661|P2|Overall Study|eligibility criteria no longer met|3
4684465|NCT02518971|16128662|P1|Overall Study|eligibility criteria no longer met|6
4684466|NCT02518971|16128661|P2|Overall Study|medication lost in mail|1
4684467|NCT02518971|16128662|P1|Overall Study|medication lost in mail|0
4684468|NCT02518971|16128661|P2|Overall Study|Side effects|0
4684469|NCT02518971|16128662|P1|Overall Study|Side effects|1
4684470|NCT02518971|16128661|P2|Overall Study|Withdrawal by Subject|5
4684471|NCT02518971|16128662|P1|Overall Study|Withdrawal by Subject|4
4684472|NCT02518971|16128661|P2|Overall Study|Protocol Violation|4
4684473|NCT02518971|16128662|P1|Overall Study|Protocol Violation|6
4684474|NCT02518971|16128661|P2|Overall Study|Physician Decision|6
4684475|NCT02518971|16128662|P1|Overall Study|Physician Decision|6
4684476|NCT02518971|16128661|P2|Overall Study|Lost to Follow-up|1
4684477|NCT02518971|16128662|P1|Overall Study|Lost to Follow-up|0
4684478|NCT02518919|16128682|P3|Overall Study|Protocol Violation|2
4684479|NCT02518919|16128683|P2|Overall Study|Protocol Violation|1
4684480|NCT02518919|16128684|P1|Overall Study|Protocol Violation|1
4684481|NCT02518685|16128714|P2|Overall Study|Lost to Follow-up|4
4684482|NCT02518685|16128715|P1|Overall Study|Lost to Follow-up|1
4684483|NCT02518685|16128714|P2|Overall Study|Physician Decision|0
4684484|NCT02518685|16128715|P1|Overall Study|Physician Decision|1
4684485|NCT02518685|16128714|P2|Overall Study|Pregnancy|0
4684486|NCT02518685|16128715|P1|Overall Study|Pregnancy|1
4684487|NCT02518685|16128714|P2|Overall Study|relocation, study fatigue|2
4684488|NCT02518685|16128715|P1|Overall Study|relocation, study fatigue|7
4684489|NCT02518685|16128714|P2|Overall Study|Withdrawal by Subject|3
4684490|NCT02518685|16128715|P1|Overall Study|Withdrawal by Subject|10
4684491|NCT02518685|16128714|P2|Overall Study|Adverse Event|1
4684492|NCT02518685|16128715|P1|Overall Study|Adverse Event|29
4684493|NCT02518620|16128724|P2|Overall Study|Relocation|1
4684494|NCT02518620|16128725|P1|Overall Study|Relocation|2
4684495|NCT02518620|16128724|P2|Overall Study|Pregnancy|0
4684496|NCT02518620|16128725|P1|Overall Study|Pregnancy|1
4684497|NCT02518620|16128724|P2|Overall Study|Pregnancy Wish|0
4684498|NCT02518620|16128725|P1|Overall Study|Pregnancy Wish|3
4684499|NCT02518620|16128724|P2|Overall Study|Death|0
4684500|NCT02518620|16128725|P1|Overall Study|Death|1
4684501|NCT02518620|16128724|P2|Overall Study|Withdrawal by Subject|9
4684502|NCT02518620|16128725|P1|Overall Study|Withdrawal by Subject|17
4684503|NCT02518620|16128724|P2|Overall Study|Lost to Follow-up|1
4684504|NCT02518620|16128725|P1|Overall Study|Lost to Follow-up|1
4684505|NCT02518620|16128724|P2|Overall Study|Sponsor's Decision|3
4684506|NCT02518620|16128725|P1|Overall Study|Sponsor's Decision|0
4684507|NCT02518620|16128724|P2|Overall Study|Physician Decision|1
4684508|NCT02518620|16128725|P1|Overall Study|Physician Decision|1
4684509|NCT02518620|16128724|P2|Overall Study|Non-Compliance with Study Drug|0
4684510|NCT02518620|16128725|P1|Overall Study|Non-Compliance with Study Drug|1
4684511|NCT02518620|16128724|P2|Overall Study|Lack of Efficacy|0
4684512|NCT02518620|16128725|P1|Overall Study|Lack of Efficacy|2
4684513|NCT02518620|16128724|P2|Overall Study|Adverse Event|11
4684514|NCT02518620|16128725|P1|Overall Study|Adverse Event|23
4684515|NCT02518490|16128748|P2|Overall Study|Withdrawal by Subject|1
4684516|NCT02518490|16128749|P1|Overall Study|Withdrawal by Subject|1
4684517|NCT02518464|16128767|P1|Overall Study|Adverse Event|2
4684518|NCT02518113|16128788|P4|Overall Study|Progressive Disease|0
4684519|NCT02518113|16128789|P3|Overall Study|Progressive Disease|3
4684520|NCT02518113|16128790|P2|Overall Study|Progressive Disease|2
4684521|NCT02518113|16128791|P1|Overall Study|Progressive Disease|1
4684522|NCT02518113|16128788|P4|Overall Study|Physician Decision|0
4684523|NCT02518113|16128789|P3|Overall Study|Physician Decision|0
4684524|NCT02518113|16128790|P2|Overall Study|Physician Decision|1
4684525|NCT02518113|16128791|P1|Overall Study|Physician Decision|0
4684526|NCT02518113|16128788|P4|Overall Study|Death|0
4684527|NCT02518113|16128789|P3|Overall Study|Death|0
4684528|NCT02518113|16128790|P2|Overall Study|Death|2
4684529|NCT02518113|16128791|P1|Overall Study|Death|1
4684530|NCT02518113|16128788|P4|Overall Study|Adverse Event|0
4684531|NCT02518113|16128789|P3|Overall Study|Adverse Event|1
4684532|NCT02518113|16128790|P2|Overall Study|Adverse Event|0
4684533|NCT02518113|16128791|P1|Overall Study|Adverse Event|1
4684534|NCT02518048|16128832|P1|Overall Study|Withdrawal by Subject|1
4684535|NCT02517866|16128858|P3|Overall Study|Reason not specified|0
4684536|NCT02517866|16128859|P2|Overall Study|Reason not specified|0
4684537|NCT02517866|16128860|P1|Overall Study|Reason not specified|2
4684538|NCT02517866|16128858|P3|Overall Study|Investigator Decision|0
4684539|NCT02517866|16128859|P2|Overall Study|Investigator Decision|1
4684540|NCT02517866|16128860|P1|Overall Study|Investigator Decision|2
4684541|NCT02517866|16128858|P3|Overall Study|Voluntary Withdrawal|0
4684542|NCT02517866|16128859|P2|Overall Study|Voluntary Withdrawal|2
4684543|NCT02517866|16128860|P1|Overall Study|Voluntary Withdrawal|2
4684544|NCT02517866|16128858|P3|Overall Study|Lost to Follow-up|0
4684545|NCT02517866|16128859|P2|Overall Study|Lost to Follow-up|0
4684546|NCT02517866|16128860|P1|Overall Study|Lost to Follow-up|1
4684547|NCT02517866|16128858|P3|Overall Study|Significant Protocol Deviation|0
4684548|NCT02517866|16128859|P2|Overall Study|Significant Protocol Deviation|1
4684549|NCT02517866|16128860|P1|Overall Study|Significant Protocol Deviation|4
4684550|NCT02517866|16128858|P3|Overall Study|Pretreatment Event/Adverse Event|0
4684551|NCT02517866|16128859|P2|Overall Study|Pretreatment Event/Adverse Event|2
4684552|NCT02517866|16128860|P1|Overall Study|Pretreatment Event/Adverse Event|9
4684553|NCT02517541|16128931|P1|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2
4684554|NCT02517541|16128931|P1|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4
4684555|NCT02517541|16128931|P1|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1
4684556|NCT02517541|16128931|P1|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2
4684557|NCT02517541|16128931|P1|Test Period (SenSura Mio Convex Soft)|Adverse Event|3
4684558|NCT02517541|16128931|P1|Baseline Period (Own Product)|Protocol Violation|1
4684559|NCT02517528|16128937|P1|Overall Study|Withdrawal by Subject|1
4684560|NCT02517515|16128947|P2|Overall Study|Other|0
4684561|NCT02517515|16128948|P1|Overall Study|Other|1
4684562|NCT02517515|16128947|P2|Overall Study|Lost to Follow-up|0
4684563|NCT02517515|16128948|P1|Overall Study|Lost to Follow-up|1
4684564|NCT02517515|16128947|P2|Overall Study|Withdrew Consent|1
4684565|NCT02517515|16128948|P1|Overall Study|Withdrew Consent|0
4684566|NCT02517515|16128947|P2|Overall Study|Adverse Event|1
4684567|NCT02517515|16128948|P1|Overall Study|Adverse Event|0
4684568|NCT02517463|16128965|P2|Overall Study|Lost to Follow-up|2
4684569|NCT02517463|16128966|P1|Overall Study|Lost to Follow-up|5
4684570|NCT02517268|16128978|P2|Overall Study|Withdrawal by Subject|0
4684571|NCT02517268|16128979|P1|Overall Study|Withdrawal by Subject|1
4684572|NCT02516982|16129031|P4|Overall Study|Did not install the app|47
4684573|NCT02516982|16129032|P3|Overall Study|Did not install the app|46
4684574|NCT02516982|16129033|P2|Overall Study|Did not install the app|0
4684575|NCT02516982|16129034|P1|Overall Study|Did not install the app|0
4684576|NCT02516982|16129031|P4|Overall Study|Protocol Violation|1
4684577|NCT02516982|16129032|P3|Overall Study|Protocol Violation|1
4684578|NCT02516982|16129033|P2|Overall Study|Protocol Violation|0
4684579|NCT02516982|16129034|P1|Overall Study|Protocol Violation|0
4684580|NCT02516982|16129031|P4|Overall Study|Withdrawal by Subject|2
4684581|NCT02516982|16129032|P3|Overall Study|Withdrawal by Subject|1
4684582|NCT02516982|16129033|P2|Overall Study|Withdrawal by Subject|0
4684583|NCT02516982|16129034|P1|Overall Study|Withdrawal by Subject|0
4684584|NCT02516982|16129031|P4|Overall Study|Called in to antenatal appointment|0
4684585|NCT02516982|16129032|P3|Overall Study|Called in to antenatal appointment|0
4684586|NCT02516982|16129033|P2|Overall Study|Called in to antenatal appointment|35
4684587|NCT02516982|16129034|P1|Overall Study|Called in to antenatal appointment|32
4684588|NCT02516605|16129061|P5|Overall Study|Withdrawal by Subject|0
4684589|NCT02516605|16129062|P4|Overall Study|Withdrawal by Subject|1
4684590|NCT02516605|16129063|P3|Overall Study|Withdrawal by Subject|0
4684591|NCT02516605|16129064|P2|Overall Study|Withdrawal by Subject|0
4684592|NCT02516605|16129065|P1|Overall Study|Withdrawal by Subject|0
4684593|NCT02516605|16129061|P5|Overall Study|Protocol Violation|1
4684594|NCT02516605|16129062|P4|Overall Study|Protocol Violation|0
4684595|NCT02516605|16129063|P3|Overall Study|Protocol Violation|0
4684596|NCT02516605|16129064|P2|Overall Study|Protocol Violation|0
4684597|NCT02516605|16129065|P1|Overall Study|Protocol Violation|0
4684598|NCT02516592|16129136|P2|Overall Study|Death|1
4684599|NCT02516592|16129137|P1|Overall Study|Death|1
4684600|NCT02516592|16129136|P2|Overall Study|Abnormal test procedure result|0
4684601|NCT02516592|16129137|P1|Overall Study|Abnormal test procedure result|1
4684602|NCT02516592|16129136|P2|Overall Study|Adverse Event|2
4684603|NCT02516592|16129137|P1|Overall Study|Adverse Event|1
4684604|NCT02516592|16129136|P2|Overall Study|Patient/guardian decision|1
4684605|NCT02516592|16129137|P1|Overall Study|Patient/guardian decision|2
4684606|NCT02516592|16129136|P2|Overall Study|Lost to Follow-up|3
4684607|NCT02516592|16129137|P1|Overall Study|Lost to Follow-up|2
4684608|NCT02516592|16129136|P2|Overall Study|Protocol deviation|4
4684609|NCT02516592|16129137|P1|Overall Study|Protocol deviation|4
4684610|NCT02516592|16129136|P2|Overall Study|Patient withdrew consent|2
4684611|NCT02516592|16129137|P1|Overall Study|Patient withdrew consent|5
4684612|NCT02516410|16129159|P2|Overall Study|Withdrawal by Subject|1
4684613|NCT02516410|16129160|P1|Overall Study|Withdrawal by Subject|0
4684614|NCT02516410|16129159|P2|Overall Study|Adverse Event|1
4684615|NCT02516410|16129160|P1|Overall Study|Adverse Event|0
4684616|NCT02516306|16129189|P2|Period 2: Day 8 - 91|Protocol Violation|2
4684617|NCT02516306|16129190|P1|Period 2: Day 8 - 91|Protocol Violation|1
4684618|NCT02516228|16129196|P1|Overall Study|Physician Decision|1
4684619|NCT02516228|16129196|P1|Overall Study|Withdrawal by Subject|1
4684620|NCT02516228|16129196|P1|Overall Study|Lost to Follow-up|1
4684621|NCT02516202|16129207|P3|Overall Study|Stopped Follow-up|1
4684622|NCT02516202|16129208|P2|Overall Study|Stopped Follow-up|0
4684623|NCT02516202|16129209|P1|Overall Study|Stopped Follow-up|0
4684624|NCT02516202|16129207|P3|Overall Study|Lost to Follow-up|1
4684625|NCT02516202|16129208|P2|Overall Study|Lost to Follow-up|1
4684626|NCT02516202|16129209|P1|Overall Study|Lost to Follow-up|1
4684627|NCT02516202|16129207|P3|Overall Study|Withdrawal by Subject|1
4684628|NCT02516202|16129208|P2|Overall Study|Withdrawal by Subject|0
4684629|NCT02516202|16129209|P1|Overall Study|Withdrawal by Subject|1
4684630|NCT02516163|16129235|P1|Overall Study|MRI contraindication exclusion|6
4684631|NCT02516163|16129235|P1|Overall Study|Data not recorded|2
4684632|NCT02516163|16129235|P1|Overall Study|Use of incorrect measurement technique|5
4684633|NCT02516163|16129235|P1|Overall Study|Unfit/delay in surgery|3
4684634|NCT02516163|16129235|P1|Overall Study|Failed MRI/incorrect MRI protocol|11
4684635|NCT02516163|16129235|P1|Overall Study|Withdrawal by Subject|1
4684636|NCT02516098|16129249|P2|Period 2|Withdrawal by Subject|1
4684637|NCT02516098|16129250|P1|Period 2|Withdrawal by Subject|0
4684638|NCT02516098|16129249|P2|Washout After Period 1|Adverse Event|1
4684639|NCT02516098|16129250|P1|Washout After Period 1|Adverse Event|0
4684640|NCT02516098|16129249|P2|Period 1|Protocol Violation|0
4684641|NCT02516098|16129250|P1|Period 1|Protocol Violation|1
4684642|NCT02515994|16129278|P2|Overall Study|Withdrawal by Subject|0
4684643|NCT02515994|16129279|P1|Overall Study|Withdrawal by Subject|2
4684644|NCT02515994|16129278|P2|Overall Study|Adverse Event|1
4684645|NCT02515994|16129279|P1|Overall Study|Adverse Event|3
4684646|NCT02515994|16129278|P2|Overall Study|No Longer Meets Eligibility Criteria|1
4684647|NCT02515994|16129279|P1|Overall Study|No Longer Meets Eligibility Criteria|2
4684648|NCT02515994|16129278|P2|Overall Study|Protocol Violation|5
4684649|NCT02515994|16129279|P1|Overall Study|Protocol Violation|3
4684650|NCT02515942|16129294|P3|Overall Study|Withdrawal by Subject|2
4684651|NCT02515942|16129295|P2|Overall Study|Withdrawal by Subject|3
4684652|NCT02515942|16129296|P1|Overall Study|Withdrawal by Subject|0
4684653|NCT02515942|16129294|P3|Overall Study|Lost to Follow-up|0
4684654|NCT02515942|16129295|P2|Overall Study|Lost to Follow-up|0
4684655|NCT02515942|16129296|P1|Overall Study|Lost to Follow-up|2
4684656|NCT02515942|16129294|P3|Overall Study|Lack of Efficacy|1
4684657|NCT02515942|16129295|P2|Overall Study|Lack of Efficacy|0
4684658|NCT02515942|16129296|P1|Overall Study|Lack of Efficacy|0
4684659|NCT02515942|16129294|P3|Overall Study|Death|1
4684660|NCT02515942|16129295|P2|Overall Study|Death|0
4684661|NCT02515942|16129296|P1|Overall Study|Death|0
4684662|NCT02515942|16129294|P3|Overall Study|Adverse Event|0
4684663|NCT02515942|16129295|P2|Overall Study|Adverse Event|0
4684664|NCT02515942|16129296|P1|Overall Study|Adverse Event|5
4684665|NCT02515669|16129382|P4|48 Week Open-Label Phase|Other|0
4684666|NCT02515669|16129383|P3|48 Week Open-Label Phase|Other|1
4684667|NCT02515669|16129384|P2|48 Week Open-Label Phase|Other|0
4684668|NCT02515669|16129385|P1|48 Week Open-Label Phase|Other|0
4684669|NCT02515331|16129470|P3|Overall Study|Adverse Event|0
4684670|NCT02515331|16129471|P2|Overall Study|Adverse Event|0
4684671|NCT02515331|16129472|P1|Overall Study|Adverse Event|2
4684672|NCT02515331|16129470|P3|Overall Study|Protocol deviation|3
4684673|NCT02515331|16129471|P2|Overall Study|Protocol deviation|0
4684674|NCT02515331|16129472|P1|Overall Study|Protocol deviation|0
4684675|NCT02515331|16129470|P3|Overall Study|Withdrawal by Subject|1
4684676|NCT02515331|16129471|P2|Overall Study|Withdrawal by Subject|0
4684677|NCT02515331|16129472|P1|Overall Study|Withdrawal by Subject|0
4684678|NCT02515279|16129493|P1|Overall Study|Other|22
4684679|NCT02515279|16129493|P1|Overall Study|End-of-treatment visit not attended|17
4684680|NCT02515279|16129493|P1|Overall Study|Withdrawal by Subject|18
4684681|NCT02515279|16129493|P1|Overall Study|Lost to Follow-up|9
4684682|NCT02515279|16129493|P1|Overall Study|Lack of Efficacy|31
4684683|NCT02515279|16129493|P1|Overall Study|Adverse Event|7
4684684|NCT02515097|16129512|P2|Overall Study|Adverse Event|1
4684685|NCT02515097|16129513|P1|Overall Study|Adverse Event|2
4684686|NCT02515097|16129512|P2|Overall Study|Withdrawal by Subject|3
4684687|NCT02515097|16129513|P1|Overall Study|Withdrawal by Subject|1
4684688|NCT02515097|16129512|P2|Overall Study|Lost to Follow-up|2
4684689|NCT02515097|16129513|P1|Overall Study|Lost to Follow-up|4
4684690|NCT02515045|16129534|P3|Overall Study|Lost to Follow-up|1
4684691|NCT02515045|16129535|P2|Overall Study|Lost to Follow-up|1
4684692|NCT02515045|16129536|P1|Overall Study|Lost to Follow-up|0
4684693|NCT02515045|16129534|P3|Overall Study|Adverse Event|3
4684694|NCT02515045|16129535|P2|Overall Study|Adverse Event|3
4684695|NCT02515045|16129536|P1|Overall Study|Adverse Event|0
4684696|NCT02514772|16129573|P2|Overall Study|Withdrawal by Subject|1
4684697|NCT02514772|16129574|P1|Overall Study|Withdrawal by Subject|2
4684698|NCT02514772|16129573|P2|Overall Study|Death|1
4684699|NCT02514772|16129574|P1|Overall Study|Death|0
4684700|NCT02514772|16129573|P2|Overall Study|Adverse Event|0
4684701|NCT02514772|16129574|P1|Overall Study|Adverse Event|1
4684702|NCT02514746|16129588|P2|Overall Study|Other|1
4684703|NCT02514746|16129589|P1|Overall Study|Other|5
4684704|NCT02514746|16129588|P2|Overall Study|Withdrawal by Subject|10
4684705|NCT02514746|16129589|P1|Overall Study|Withdrawal by Subject|12
4684706|NCT02514746|16129588|P2|Overall Study|Physician Decision|2
4684707|NCT02514746|16129589|P1|Overall Study|Physician Decision|4
4684708|NCT02514746|16129588|P2|Overall Study|Chronically Ill|2
4684709|NCT02514746|16129589|P1|Overall Study|Chronically Ill|1
4684710|NCT02514577|16129626|P2|Overall Study|Adverse Event|1
4684711|NCT02514577|16129627|P1|Overall Study|Adverse Event|1
4684712|NCT02514577|16129626|P2|Overall Study|Withdrawal by Subject|6
4684713|NCT02514577|16129627|P1|Overall Study|Withdrawal by Subject|6
4684714|NCT02514577|16129626|P2|Overall Study|Protocol Violation|0
4684715|NCT02514577|16129627|P1|Overall Study|Protocol Violation|1
4684716|NCT02514577|16129626|P2|Overall Study|Lost to Follow-up|6
4684717|NCT02514577|16129627|P1|Overall Study|Lost to Follow-up|6
4684718|NCT02514551|16129637|P2|Overall Study|Participant Never Treated|2
4684719|NCT02514551|16129638|P1|Overall Study|Participant Never Treated|0
4684720|NCT02514551|16129637|P2|Overall Study|Lost to Follow-up|1
4684721|NCT02514551|16129638|P1|Overall Study|Lost to Follow-up|0
4684722|NCT02514473|16129655|P2|Overall Study|Other|1
4684723|NCT02514473|16129656|P1|Overall Study|Other|1
4684724|NCT02514473|16129655|P2|Overall Study|Lost to Follow-up|1
4684725|NCT02514473|16129656|P1|Overall Study|Lost to Follow-up|0
4684726|NCT02514473|16129655|P2|Overall Study|Withdrawal by Subject|1
4684727|NCT02514473|16129656|P1|Overall Study|Withdrawal by Subject|2
4684728|NCT02514473|16129655|P2|Overall Study|Adverse Event|2
4684729|NCT02514473|16129656|P1|Overall Study|Adverse Event|0
4684730|NCT02514174|16129697|P1|Overall Study|Treated off study with Afatinib.|1
4684731|NCT02514174|16129697|P1|Overall Study|Treatment change|1
4684732|NCT02514174|16129697|P1|Overall Study|Progressive disease|11
4684733|NCT02514174|16129697|P1|Overall Study|Study closed by sponsor|9
4684734|NCT02514174|16129697|P1|Overall Study|Adverse Event|2
4684735|NCT02514174|16129697|P1|Overall Study|Patient refused to continue medication|1
4684736|NCT02514122|16129708|P2|Overall Study|Withdrawal by Subject|0
4684737|NCT02514122|16129709|P1|Overall Study|Withdrawal by Subject|2
4684738|NCT02514083|16129717|P1|Overall Study|Adverse Event|1
4684739|NCT02513823|16129761|P1|Overall Study|Physician Decision|1
4684740|NCT02513823|16129761|P1|Overall Study|Lost to Follow-up|4
4684741|NCT02513771|16129768|P2|Overall Study|Not being able to get to clinic|0
4684742|NCT02513771|16129769|P1|Overall Study|Not being able to get to clinic|1
4684743|NCT02513771|16129768|P2|Overall Study|Lost to Follow-up|1
4684744|NCT02513771|16129769|P1|Overall Study|Lost to Follow-up|1
4684745|NCT02513745|16129807|P2|Overall Study|Criteria at time of surgery not met.|3
4684746|NCT02513745|16129808|P1|Overall Study|Criteria at time of surgery not met.|3
4684747|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Labor Reasons|0
4684748|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Labor Reasons|0
4684749|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Labor Reasons|0
4684750|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Labor Reasons|1
4684751|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Labor Reasons|0
4684752|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Labor Reasons|0
4684753|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4684754|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4684755|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4684756|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3
4684757|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4684758|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0
4684759|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Subject move out of town|0
4684760|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Subject move out of town|0
4684761|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Subject move out of town|0
4684762|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Subject move out of town|1
4684763|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Subject move out of town|0
4684764|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Subject move out of town|0
4684765|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Death|0
4684766|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Death|0
4684767|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Death|0
4684768|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Death|1
4684769|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Death|0
4684770|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Death|0
4684771|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Physician Decision|0
4684772|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Physician Decision|0
4684773|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Physician Decision|0
4684774|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Physician Decision|0
4684775|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Physician Decision|0
4684776|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Physician Decision|2
4684777|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Adverse Event|0
4684778|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Adverse Event|0
4684779|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Adverse Event|0
4684780|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Adverse Event|4
4684781|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Adverse Event|1
4684782|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Adverse Event|1
4684783|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Lost to Follow-up|0
4684784|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Lost to Follow-up|0
4684785|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Lost to Follow-up|0
4684786|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Lost to Follow-up|7
4684787|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Lost to Follow-up|2
4684788|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Lost to Follow-up|4
4684789|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
4684790|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
4684791|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0
4684792|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20
4684793|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16
4684794|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12
4684795|NCT02513550|16130062|P6|Post-Treatment Follow-up Period|Withdrawal by Subject|0
4684796|NCT02513550|16130063|P5|Post-Treatment Follow-up Period|Withdrawal by Subject|0
4684797|NCT02513550|16130064|P4|Post-Treatment Follow-up Period|Withdrawal by Subject|0
4684798|NCT02513550|16130065|P3|Post-Treatment Follow-up Period|Withdrawal by Subject|26
4684799|NCT02513550|16130066|P2|Post-Treatment Follow-up Period|Withdrawal by Subject|20
4684800|NCT02513550|16130067|P1|Post-Treatment Follow-up Period|Withdrawal by Subject|12
4684801|NCT02513550|16130062|P6|Double Blind Treatment Period|Death|0
4684802|NCT02513550|16130063|P5|Double Blind Treatment Period|Death|0
4684803|NCT02513550|16130064|P4|Double Blind Treatment Period|Death|0
4684804|NCT02513550|16130065|P3|Double Blind Treatment Period|Death|2
4684805|NCT02513550|16130066|P2|Double Blind Treatment Period|Death|0
4684806|NCT02513550|16130067|P1|Double Blind Treatment Period|Death|1
4684807|NCT02513550|16130062|P6|Double Blind Treatment Period|Due to personal business|0
4684808|NCT02513550|16130063|P5|Double Blind Treatment Period|Due to personal business|0
4684809|NCT02513550|16130064|P4|Double Blind Treatment Period|Due to personal business|0
4684810|NCT02513550|16130065|P3|Double Blind Treatment Period|Due to personal business|1
4684811|NCT02513550|16130066|P2|Double Blind Treatment Period|Due to personal business|0
4684812|NCT02513550|16130067|P1|Double Blind Treatment Period|Due to personal business|2
4684813|NCT02513550|16130062|P6|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4684814|NCT02513550|16130063|P5|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4684815|NCT02513550|16130064|P4|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4684816|NCT02513550|16130065|P3|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1
4684817|NCT02513550|16130066|P2|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4684818|NCT02513550|16130067|P1|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0
4684819|NCT02513550|16130062|P6|Double Blind Treatment Period|Site terminated by sponsor|0
4684820|NCT02513550|16130063|P5|Double Blind Treatment Period|Site terminated by sponsor|0
4684821|NCT02513550|16130064|P4|Double Blind Treatment Period|Site terminated by sponsor|0
4684822|NCT02513550|16130065|P3|Double Blind Treatment Period|Site terminated by sponsor|3
4684823|NCT02513550|16130066|P2|Double Blind Treatment Period|Site terminated by sponsor|1
4684824|NCT02513550|16130067|P1|Double Blind Treatment Period|Site terminated by sponsor|1
4684825|NCT02513550|16130062|P6|Double Blind Treatment Period|Physician Decision|0
4684826|NCT02513550|16130063|P5|Double Blind Treatment Period|Physician Decision|0
4684827|NCT02513550|16130064|P4|Double Blind Treatment Period|Physician Decision|0
4684828|NCT02513550|16130065|P3|Double Blind Treatment Period|Physician Decision|4
4684829|NCT02513550|16130066|P2|Double Blind Treatment Period|Physician Decision|0
4684830|NCT02513550|16130067|P1|Double Blind Treatment Period|Physician Decision|2
4684831|NCT02513550|16130062|P6|Double Blind Treatment Period|Protocol Violation|0
4684832|NCT02513550|16130063|P5|Double Blind Treatment Period|Protocol Violation|0
4684833|NCT02513550|16130064|P4|Double Blind Treatment Period|Protocol Violation|0
4684834|NCT02513550|16130065|P3|Double Blind Treatment Period|Protocol Violation|4
4684835|NCT02513550|16130066|P2|Double Blind Treatment Period|Protocol Violation|1
4684836|NCT02513550|16130067|P1|Double Blind Treatment Period|Protocol Violation|1
4684837|NCT02513550|16130062|P6|Double Blind Treatment Period|Lack of Efficacy|0
4684838|NCT02513550|16130063|P5|Double Blind Treatment Period|Lack of Efficacy|0
4684839|NCT02513550|16130064|P4|Double Blind Treatment Period|Lack of Efficacy|0
4684840|NCT02513550|16130065|P3|Double Blind Treatment Period|Lack of Efficacy|6
4684841|NCT02513550|16130066|P2|Double Blind Treatment Period|Lack of Efficacy|5
4684842|NCT02513550|16130067|P1|Double Blind Treatment Period|Lack of Efficacy|4
4684843|NCT02513550|16130062|P6|Double Blind Treatment Period|Lost to Follow-up|1
4684844|NCT02513550|16130063|P5|Double Blind Treatment Period|Lost to Follow-up|0
4684845|NCT02513550|16130064|P4|Double Blind Treatment Period|Lost to Follow-up|0
4684846|NCT02513550|16130065|P3|Double Blind Treatment Period|Lost to Follow-up|11
4684847|NCT02513550|16130066|P2|Double Blind Treatment Period|Lost to Follow-up|7
4684848|NCT02513550|16130067|P1|Double Blind Treatment Period|Lost to Follow-up|9
4684849|NCT02513550|16130062|P6|Double Blind Treatment Period|Adverse Event|0
4684850|NCT02513550|16130063|P5|Double Blind Treatment Period|Adverse Event|1
4684851|NCT02513550|16130064|P4|Double Blind Treatment Period|Adverse Event|0
4684852|NCT02513550|16130065|P3|Double Blind Treatment Period|Adverse Event|17
4684853|NCT02513550|16130066|P2|Double Blind Treatment Period|Adverse Event|13
4684854|NCT02513550|16130067|P1|Double Blind Treatment Period|Adverse Event|5
4684855|NCT02513550|16130062|P6|Double Blind Treatment Period|Withdrawal by Subject|0
4684856|NCT02513550|16130063|P5|Double Blind Treatment Period|Withdrawal by Subject|0
4684857|NCT02513550|16130064|P4|Double Blind Treatment Period|Withdrawal by Subject|0
4684858|NCT02513550|16130065|P3|Double Blind Treatment Period|Withdrawal by Subject|25
4684859|NCT02513550|16130066|P2|Double Blind Treatment Period|Withdrawal by Subject|11
4684860|NCT02513550|16130067|P1|Double Blind Treatment Period|Withdrawal by Subject|11
4684861|NCT02513472|16130161|P2|Overall Study|Other|3
4684862|NCT02513472|16130162|P1|Overall Study|Other|3
4684863|NCT02513472|16130161|P2|Overall Study|Treatment Completed as per Protocol|1
4684864|NCT02513472|16130162|P1|Overall Study|Treatment Completed as per Protocol|3
4684865|NCT02513472|16130161|P2|Overall Study|Subject Choice|6
4684866|NCT02513472|16130162|P1|Overall Study|Subject Choice|2
4684867|NCT02513472|16130161|P2|Overall Study|Withdrawal by Subject|4
4684868|NCT02513472|16130162|P1|Overall Study|Withdrawal by Subject|0
4684869|NCT02513472|16130161|P2|Overall Study|Adverse Event|11
4684870|NCT02513472|16130162|P1|Overall Study|Adverse Event|7
4684871|NCT02513472|16130161|P2|Overall Study|Clinical Disease Progression|12
4684872|NCT02513472|16130162|P1|Overall Study|Clinical Disease Progression|5
4684873|NCT02513472|16130161|P2|Overall Study|Radiological Disease Progression|56
4684874|NCT02513472|16130162|P1|Overall Study|Radiological Disease Progression|45
4684875|NCT02513459|16130197|P1|Overall Study|Surgery planned-- not done|1
4684876|NCT02513459|16130197|P1|Overall Study|Reproductive plans|1
4684877|NCT02513459|16130197|P1|Overall Study|Lack of response|1
4684878|NCT02513459|16130197|P1|Overall Study|Subject decision|2
4684879|NCT02513459|16130197|P1|Overall Study|Pregnancy|2
4684880|NCT02513459|16130197|P1|Overall Study|Loss of efficacy|2
4684881|NCT02513459|16130197|P1|Overall Study|Withdrew consent|5
4684882|NCT02513459|16130197|P1|Overall Study|Adverse Event|7
4684883|NCT02513160|16130265|P4|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4684884|NCT02513160|16130266|P3|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4684885|NCT02513160|16130267|P2|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1
4684886|NCT02513160|16130268|P1|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0
4684887|NCT02513160|16130265|P4|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4684888|NCT02513160|16130266|P3|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4684889|NCT02513160|16130267|P2|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0
4684890|NCT02513160|16130268|P1|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1
4684891|NCT02513160|16130265|P4|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4684892|NCT02513160|16130266|P3|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4684893|NCT02513160|16130267|P2|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1
4684894|NCT02513160|16130268|P1|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2
4684895|NCT02513160|16130265|P4|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4684896|NCT02513160|16130266|P3|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4684897|NCT02513160|16130267|P2|Treatment Period (Day 0 to Week 6)|Noncompliance|0
4684898|NCT02513160|16130268|P1|Treatment Period (Day 0 to Week 6)|Noncompliance|1
4684899|NCT02513160|16130265|P4|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1
4684900|NCT02513160|16130266|P3|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0
4684901|NCT02513160|16130267|P2|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
4684902|NCT02513160|16130268|P1|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2
4684903|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4684904|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4684905|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0
4684906|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10
4684907|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4684908|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4684909|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0
4684910|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1
4684911|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4684912|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4684913|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0
4684914|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20
4684915|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4684916|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4684917|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|0
4684918|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|4
4684919|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4684920|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4684921|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0
4684922|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6
4684923|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4684924|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4684925|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0
4684926|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214
4684927|NCT02513160|16130265|P4|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4684928|NCT02513160|16130266|P3|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4684929|NCT02513160|16130267|P2|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0
4684930|NCT02513160|16130268|P1|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33
4684931|NCT02513095|16130326|P2|Overall Study|Stampede resulted in transfers out of ER|16
4684932|NCT02513095|16130327|P1|Overall Study|Stampede resulted in transfers out of ER|14
4684933|NCT02512861|16130378|P2|Overall Study|Withdrawal by Subject|1
4684934|NCT02512861|16130379|P1|Overall Study|Withdrawal by Subject|0
4684935|NCT02512861|16130378|P2|Overall Study|Physician Decision|1
4684936|NCT02512861|16130379|P1|Overall Study|Physician Decision|3
4684937|NCT02512861|16130378|P2|Overall Study|Protocol Violation|7
4684938|NCT02512861|16130379|P1|Overall Study|Protocol Violation|3
4684939|NCT02512302|16130657|P10|Period 4|Adverse Event|0
4684940|NCT02512302|16130658|P9|Period 4|Adverse Event|0
4684941|NCT02512302|16130659|P8|Period 4|Adverse Event|0
4684942|NCT02512302|16130660|P7|Period 4|Adverse Event|1
4684943|NCT02512302|16130661|P6|Period 4|Adverse Event|0
4684944|NCT02512302|16130662|P5|Period 4|Adverse Event|0
4684945|NCT02512302|16130663|P4|Period 4|Adverse Event|0
4684946|NCT02512302|16130664|P3|Period 4|Adverse Event|0
4684947|NCT02512302|16130665|P2|Period 4|Adverse Event|0
4684948|NCT02512302|16130666|P1|Period 4|Adverse Event|0
4684949|NCT02512302|16130657|P10|Period 3|Lost to Follow-up|0
4684950|NCT02512302|16130658|P9|Period 3|Lost to Follow-up|0
4684951|NCT02512302|16130659|P8|Period 3|Lost to Follow-up|0
4684952|NCT02512302|16130660|P7|Period 3|Lost to Follow-up|0
4684953|NCT02512302|16130661|P6|Period 3|Lost to Follow-up|0
4684954|NCT02512302|16130662|P5|Period 3|Lost to Follow-up|0
4684955|NCT02512302|16130663|P4|Period 3|Lost to Follow-up|0
4684956|NCT02512302|16130664|P3|Period 3|Lost to Follow-up|1
4684957|NCT02512302|16130665|P2|Period 3|Lost to Follow-up|0
4684958|NCT02512302|16130666|P1|Period 3|Lost to Follow-up|0
4684959|NCT02512302|16130657|P10|Period 2|Adverse Event|1
4684960|NCT02512302|16130658|P9|Period 2|Adverse Event|0
4684961|NCT02512302|16130659|P8|Period 2|Adverse Event|0
4684962|NCT02512302|16130660|P7|Period 2|Adverse Event|0
4684963|NCT02512302|16130661|P6|Period 2|Adverse Event|0
4684964|NCT02512302|16130662|P5|Period 2|Adverse Event|0
4684965|NCT02512302|16130663|P4|Period 2|Adverse Event|0
4684966|NCT02512302|16130664|P3|Period 2|Adverse Event|0
4684967|NCT02512302|16130665|P2|Period 2|Adverse Event|0
4684968|NCT02512302|16130666|P1|Period 2|Adverse Event|0
4684969|NCT02512302|16130657|P10|Period 1|Adverse Event|0
4684970|NCT02512302|16130658|P9|Period 1|Adverse Event|0
4684971|NCT02512302|16130659|P8|Period 1|Adverse Event|0
4684972|NCT02512302|16130660|P7|Period 1|Adverse Event|0
4684973|NCT02512302|16130661|P6|Period 1|Adverse Event|0
4684974|NCT02512302|16130662|P5|Period 1|Adverse Event|0
4684975|NCT02512302|16130663|P4|Period 1|Adverse Event|0
4684976|NCT02512302|16130664|P3|Period 1|Adverse Event|0
4684977|NCT02512302|16130665|P2|Period 1|Adverse Event|1
4684978|NCT02512302|16130666|P1|Period 1|Adverse Event|0
4684979|NCT02512068|16130782|P2|Overall Study|Reason Not Specified|5
4684980|NCT02512068|16130783|P1|Overall Study|Reason Not Specified|3
4684981|NCT02512068|16130782|P2|Overall Study|Lack of Efficacy|1
4684982|NCT02512068|16130783|P1|Overall Study|Lack of Efficacy|0
4684983|NCT02512068|16130782|P2|Overall Study|Voluntary Withdrawal|1
4684984|NCT02512068|16130783|P1|Overall Study|Voluntary Withdrawal|0
4684985|NCT02512068|16130782|P2|Overall Study|Major Protocol Deviation|0
4684986|NCT02512068|16130783|P1|Overall Study|Major Protocol Deviation|1
4684987|NCT02512068|16130782|P2|Overall Study|Pretreatment Event/Adverse Event|6
4684988|NCT02512068|16130783|P1|Overall Study|Pretreatment Event/Adverse Event|8
4684989|NCT02512042|16130809|P2|Overall Study|Other|11
4684990|NCT02512042|16130810|P1|Overall Study|Other|11
4684991|NCT02512042|16130809|P2|Overall Study|Lost to Follow-up|2
4684992|NCT02512042|16130810|P1|Overall Study|Lost to Follow-up|5
4684993|NCT02512042|16130809|P2|Overall Study|Non-compliance with study drug|2
4684994|NCT02512042|16130810|P1|Overall Study|Non-compliance with study drug|1
4684995|NCT02512042|16130809|P2|Overall Study|Withdrawal by Subject|6
4684996|NCT02512042|16130810|P1|Overall Study|Withdrawal by Subject|6
4684997|NCT02512042|16130809|P2|Overall Study|Adverse Event|4
4684998|NCT02512042|16130810|P1|Overall Study|Adverse Event|0
4684999|NCT02511782|16130819|P3|Overall Study|Withdrawal by Subject|0
4685000|NCT02511782|16130820|P2|Overall Study|Withdrawal by Subject|0
4685001|NCT02511782|16130821|P1|Overall Study|Withdrawal by Subject|1
4685002|NCT02511678|16130847|P1|Overall Study|Received Radiation Treatment|1
4685003|NCT02511678|16130847|P1|Overall Study|Protocol Violation|1
4685004|NCT02511678|16130847|P1|Overall Study|Biopsy was Negative|1
4685005|NCT02511678|16130847|P1|Overall Study|Required Radiofrequency Ablation|1
4685006|NCT02511678|16130847|P1|Overall Study|Oncologist Cancelled Study Cryoablation|1
4685007|NCT02511678|16130847|P1|Overall Study|Targeted Therapy to Index Tumor Required|5
4685008|NCT02511678|16130847|P1|Overall Study|Adverse Event|1
4685009|NCT02511678|16130847|P1|Overall Study|Death|19
4685010|NCT02511678|16130847|P1|Overall Study|Lost to Follow-up|4
4685011|NCT02511678|16130847|P1|Overall Study|Withdrawal by Subject|2
4685012|NCT02511431|16130929|P6|Treatment|Lost to Follow-up|1
4685013|NCT02511431|16130930|P5|Treatment|Lost to Follow-up|0
4685014|NCT02511431|16130931|P4|Treatment|Lost to Follow-up|0
4685015|NCT02511431|16130932|P3|Treatment|Lost to Follow-up|1
4685016|NCT02511431|16130933|P2|Treatment|Lost to Follow-up|0
4685017|NCT02511431|16130934|P1|Treatment|Lost to Follow-up|0
4685018|NCT02511184|16130961|P2|Overall Study|Withdrawal by Subject|1
4685019|NCT02511184|16130962|P1|Overall Study|Withdrawal by Subject|0
4685020|NCT02511184|16130961|P2|Overall Study|Study terminated by sponsor|5
4685021|NCT02511184|16130962|P1|Overall Study|Study terminated by sponsor|1
4685022|NCT02511184|16130961|P2|Overall Study|Lost to Follow-up|1
4685023|NCT02511184|16130962|P1|Overall Study|Lost to Follow-up|0
4685024|NCT02511184|16130961|P2|Overall Study|Death|0
4685025|NCT02511184|16130962|P1|Overall Study|Death|1
4685026|NCT02510820|16131012|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4685027|NCT02510820|16131013|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4685028|NCT02510820|16131012|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
4685029|NCT02510820|16131013|P1|First Intervention (4 Weeks)|Withdrawal by Subject|0
4685030|NCT02510664|16131054|P3|Overall Study|Time Constraints|0
4685031|NCT02510664|16131055|P2|Overall Study|Time Constraints|1
4685032|NCT02510664|16131056|P1|Overall Study|Time Constraints|1
4685033|NCT02510664|16131054|P3|Overall Study|Provider Retired/No Time to Reschedule|0
4685034|NCT02510664|16131055|P2|Overall Study|Provider Retired/No Time to Reschedule|10
4685035|NCT02510664|16131056|P1|Overall Study|Provider Retired/No Time to Reschedule|10
4685036|NCT02510664|16131054|P3|Overall Study|Transferred Care|0
4685037|NCT02510664|16131055|P2|Overall Study|Transferred Care|9
4685038|NCT02510664|16131056|P1|Overall Study|Transferred Care|9
4685039|NCT02510014|16131098|P2|Treatment Period|Incarceration, pregnancy, misc|5
4685040|NCT02510014|16131099|P1|Treatment Period|Incarceration, pregnancy, misc|29
4685041|NCT02510014|16131098|P2|Treatment Period|Protocol Violation|4
4685042|NCT02510014|16131099|P1|Treatment Period|Protocol Violation|4
4685043|NCT02510014|16131098|P2|Treatment Period|Withdrawn by the investigator|1
4685044|NCT02510014|16131099|P1|Treatment Period|Withdrawn by the investigator|7
4685045|NCT02510014|16131098|P2|Treatment Period|Withdrawal by Subject|24
4685046|NCT02510014|16131099|P1|Treatment Period|Withdrawal by Subject|67
4685047|NCT02510014|16131098|P2|Treatment Period|Physician Decision|0
4685048|NCT02510014|16131099|P1|Treatment Period|Physician Decision|5
4685049|NCT02510014|16131098|P2|Treatment Period|Lost to Follow-up|19
4685050|NCT02510014|16131099|P1|Treatment Period|Lost to Follow-up|80
4685051|NCT02510014|16131098|P2|Treatment Period|Withdrawal symptoms|0
4685052|NCT02510014|16131099|P1|Treatment Period|Withdrawal symptoms|3
4685053|NCT02510014|16131098|P2|Treatment Period|Adverse Event|4
4685054|NCT02510014|16131099|P1|Treatment Period|Adverse Event|11
4685055|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Other|1
4685056|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Other|19
4685057|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Protocol Violation|0
4685058|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Protocol Violation|2
4685059|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1
4685060|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7
4685061|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3
4685062|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22
4685063|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Physician Decision|1
4685064|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Physician Decision|0
4685065|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3
4685066|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44
4685067|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0
4685068|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1
4685069|NCT02510014|16131098|P2|Run-In Period (Days -14 to Day -1)|Adverse Event|1
4685070|NCT02510014|16131099|P1|Run-In Period (Days -14 to Day -1)|Adverse Event|1
4685071|NCT02509117|16131202|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1
4685072|NCT02509117|16131203|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685073|NCT02509117|16131204|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685074|NCT02509117|16131205|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685075|NCT02509117|16131206|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685076|NCT02509117|16131207|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685077|NCT02509117|16131208|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685078|NCT02509117|16131209|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685079|NCT02509117|16131210|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685080|NCT02509117|16131211|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0
4685081|NCT02509117|16131202|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1
4685082|NCT02509117|16131203|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685083|NCT02509117|16131204|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685084|NCT02509117|16131205|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685085|NCT02509117|16131206|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685086|NCT02509117|16131207|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685087|NCT02509117|16131208|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685088|NCT02509117|16131209|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685089|NCT02509117|16131210|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685090|NCT02509117|16131211|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0
4685091|NCT02509117|16131202|P10|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685092|NCT02509117|16131203|P9|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685093|NCT02509117|16131204|P8|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685094|NCT02509117|16131205|P7|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685095|NCT02509117|16131206|P6|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685096|NCT02509117|16131207|P5|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685097|NCT02509117|16131208|P4|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685098|NCT02509117|16131209|P3|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685099|NCT02509117|16131210|P2|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1
4685100|NCT02509117|16131211|P1|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0
4685101|NCT02509078|16131422|P2|Overall Study|Protocol Violation|1
4685102|NCT02509078|16131423|P1|Overall Study|Protocol Violation|1
4685103|NCT02509026|16131566|P1|Retreatment Period (12 Weeks)|Enrolled but not treated|1
4685104|NCT02509026|16131566|P1|Retreatment Period (12 Weeks)|Withdrawal by Subject|2
4685105|NCT02509026|16131566|P1|Retreatment Period (12 Weeks)|Lost to Follow-up|1
4685106|NCT02509026|16131566|P1|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5
4685107|NCT02509026|16131566|P1|Withdrawal Period (40 Weeks)|Protocol Violation|2
4685108|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Enrolled but not treated|1
4685109|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Withdrawal by Subject|1
4685110|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Protocol Violation|1
4685111|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Other|2
4685112|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Lost to Follow-up|1
4685113|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Lack of Efficacy|6
4685114|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Eligibility Criteria|5
4685115|NCT02509026|16131566|P1|Induction Period (24 Weeks)|Adverse Event|5
4685116|NCT02508935|16131763|P1|Overall Study|Trial terminated by sponsor|5
4685117|NCT02508935|16131763|P1|Overall Study|Physician Decision|1
4685118|NCT02508935|16131763|P1|Overall Study|Protocol Violation|1
4685119|NCT02508935|16131763|P1|Overall Study|Adverse Event|3
4685120|NCT02508935|16131763|P1|Overall Study|Emesis|3
4685121|NCT02508935|16131763|P1|Overall Study|Pain Score <4|1
4685122|NCT02508935|16131763|P1|Overall Study|Withdrawal by Caregiver|8
4685123|NCT02508935|16131763|P1|Overall Study|Withdrawal by Subject|1
4685124|NCT02508701|16131779|P4|Overall Study|Lost to Follow-up|3
4685125|NCT02508701|16131780|P3|Overall Study|Lost to Follow-up|5
4685126|NCT02508701|16131781|P2|Overall Study|Lost to Follow-up|5
4685127|NCT02508701|16131782|P1|Overall Study|Lost to Follow-up|9
4685128|NCT02508194|16131867|P2|Overall Study|Principal Investigator Decision|2
4685129|NCT02508194|16131868|P1|Overall Study|Principal Investigator Decision|1
4685130|NCT02508194|16131867|P2|Overall Study|Error in Randomization|3
4685131|NCT02508194|16131868|P1|Overall Study|Error in Randomization|1
4685132|NCT02508194|16131867|P2|Overall Study|Withdrawal by Subject|18
4685133|NCT02508194|16131868|P1|Overall Study|Withdrawal by Subject|20
4685134|NCT02508194|16131867|P2|Overall Study|Lost to Follow-up|18
4685135|NCT02508194|16131868|P1|Overall Study|Lost to Follow-up|25
4685136|NCT02508194|16131867|P2|Overall Study|Death|3
4685137|NCT02508194|16131868|P1|Overall Study|Death|5
4685138|NCT02508116|16131908|P2|Overall Study|Physician Decision|0
4685139|NCT02508116|16131909|P1|Overall Study|Physician Decision|2
4685140|NCT02508116|16131908|P2|Overall Study|Protocol Violation|2
4685141|NCT02508116|16131909|P1|Overall Study|Protocol Violation|1
4685142|NCT02508116|16131908|P2|Overall Study|Withdrawal by Subject|2
4685143|NCT02508116|16131909|P1|Overall Study|Withdrawal by Subject|3
4685144|NCT02508116|16131908|P2|Overall Study|Lost to Follow-up|3
4685145|NCT02508116|16131909|P1|Overall Study|Lost to Follow-up|2
4685146|NCT02507973|16131936|P1|Overall Study|Adverse Event|1
4685147|NCT02507752|16131942|P1|Overall Study|Participant didn't perform visit Week 24|1
4685148|NCT02507752|16131942|P1|Overall Study|Participant didn't perform visit Week 12|1
4685149|NCT02507752|16131942|P1|Overall Study|Infusion reaction at first infusion|1
4685150|NCT02507752|16131942|P1|Overall Study|Lost to Follow-up|7
4685151|NCT02507752|16131942|P1|Overall Study|Protocol Violation|6
4685152|NCT02507752|16131942|P1|Overall Study|Adverse Event|1
4685153|NCT02507375|16131986|P2|Overall Study|Adverse Event|1
4685154|NCT02507375|16131987|P1|Overall Study|Adverse Event|0
4685155|NCT02507375|16131986|P2|Overall Study|Refused treatment|1
4685156|NCT02507375|16131987|P1|Overall Study|Refused treatment|0
4685157|NCT02507375|16131986|P2|Overall Study|Death|1
4685158|NCT02507375|16131987|P1|Overall Study|Death|0
4685159|NCT02507375|16131986|P2|Overall Study|Progressive Disease|5
4685160|NCT02507375|16131987|P1|Overall Study|Progressive Disease|4
4685161|NCT02507349|16132006|P2|Overall Study|Lost to Follow-up|144
4685162|NCT02507349|16132007|P1|Overall Study|Lost to Follow-up|174
4685163|NCT02507349|16132006|P2|Overall Study|Withdrawal by Subject|1
4685164|NCT02507349|16132007|P1|Overall Study|Withdrawal by Subject|1
4685165|NCT02507349|16132006|P2|Overall Study|Death|16
4685166|NCT02507349|16132007|P1|Overall Study|Death|12
4685167|NCT02507219|16132031|P6|Overall Study|Withdrawal by Subject|0
4685168|NCT02507219|16132032|P5|Overall Study|Withdrawal by Subject|1
4685169|NCT02507219|16132033|P4|Overall Study|Withdrawal by Subject|0
4685170|NCT02507219|16132034|P3|Overall Study|Withdrawal by Subject|0
4685171|NCT02507219|16132035|P2|Overall Study|Withdrawal by Subject|0
4685172|NCT02507219|16132036|P1|Overall Study|Withdrawal by Subject|0
4685173|NCT02507219|16132031|P6|Overall Study|Physician Decision|0
4685174|NCT02507219|16132032|P5|Overall Study|Physician Decision|0
4685175|NCT02507219|16132033|P4|Overall Study|Physician Decision|0
4685176|NCT02507219|16132034|P3|Overall Study|Physician Decision|0
4685177|NCT02507219|16132035|P2|Overall Study|Physician Decision|0
4685178|NCT02507219|16132036|P1|Overall Study|Physician Decision|1
4685179|NCT02506881|16132072|P4|First Intervention (Day 1)|Violation of blood storage conditions|12
4685180|NCT02506881|16132073|P3|First Intervention (Day 1)|Violation of blood storage conditions|12
4685181|NCT02506881|16132074|P2|First Intervention (Day 1)|Violation of blood storage conditions|0
4685182|NCT02506881|16132075|P1|First Intervention (Day 1)|Violation of blood storage conditions|0
4685183|NCT02506881|16132072|P4|First Intervention (Day 1)|Withdrawal by Subject|0
4685184|NCT02506881|16132073|P3|First Intervention (Day 1)|Withdrawal by Subject|0
4685185|NCT02506881|16132074|P2|First Intervention (Day 1)|Withdrawal by Subject|0
4685186|NCT02506881|16132075|P1|First Intervention (Day 1)|Withdrawal by Subject|1
4685187|NCT02506881|16132072|P4|First Intervention (Day 1)|Protocol Violation|0
4685188|NCT02506881|16132073|P3|First Intervention (Day 1)|Protocol Violation|1
4685189|NCT02506881|16132074|P2|First Intervention (Day 1)|Protocol Violation|0
4685190|NCT02506881|16132075|P1|First Intervention (Day 1)|Protocol Violation|0
4685191|NCT02506816|16132148|P1|Overall Study|Adverse Event|3
4685192|NCT02506257|16132274|P4|Overall Study|Protocol Violation|0
4685193|NCT02506257|16132275|P3|Overall Study|Protocol Violation|1
4685194|NCT02506257|16132276|P2|Overall Study|Protocol Violation|0
4685195|NCT02506257|16132277|P1|Overall Study|Protocol Violation|0
4685196|NCT02506257|16132274|P4|Overall Study|Adverse Event|0
4685197|NCT02506257|16132275|P3|Overall Study|Adverse Event|3
4685198|NCT02506257|16132276|P2|Overall Study|Adverse Event|2
4685199|NCT02506257|16132277|P1|Overall Study|Adverse Event|0
4685200|NCT02506101|16132309|P2|Overall Study|No enrollment and staff unavailability|0
4685201|NCT02506101|16132310|P1|Overall Study|No enrollment and staff unavailability|1
4685202|NCT02506101|16132309|P2|Overall Study|Transportation issues|0
4685203|NCT02506101|16132310|P1|Overall Study|Transportation issues|1
4685204|NCT02506036|16132326|P2|First Intervention (4-6 Weeks)|Withdrawal by Subject|1
4685205|NCT02506036|16132327|P1|First Intervention (4-6 Weeks)|Withdrawal by Subject|0
4685206|NCT02506036|16132326|P2|First Intervention (4-6 Weeks)|Lost to Follow-up|1
4685207|NCT02506036|16132327|P1|First Intervention (4-6 Weeks)|Lost to Follow-up|0
4685208|NCT02506036|16132326|P2|First Intervention (4-6 Weeks)|Death|0
4685209|NCT02506036|16132327|P1|First Intervention (4-6 Weeks)|Death|1
4685210|NCT02505945|16132335|P2|Overall Study|Lost to Follow-up|1
4685211|NCT02505945|16132336|P1|Overall Study|Lost to Follow-up|6
4685212|NCT02505945|16132335|P2|Overall Study|Physician Decision|1
4685213|NCT02505945|16132336|P1|Overall Study|Physician Decision|2
4685214|NCT02505945|16132335|P2|Overall Study|Adverse Event|0
4685215|NCT02505945|16132336|P1|Overall Study|Adverse Event|1
4685216|NCT02505945|16132335|P2|Overall Study|Withdrawal by Subject|2
4685217|NCT02505945|16132336|P1|Overall Study|Withdrawal by Subject|13
4685218|NCT02505867|16132357|P2|Overall Study|Lack of Efficacy|6
4685219|NCT02505867|16132358|P1|Overall Study|Lack of Efficacy|6
4685220|NCT02505542|16132364|P4|Part B: Double-Blind Period|Subject did not complete all visits|0
4685221|NCT02505542|16132365|P3|Part B: Double-Blind Period|Subject did not complete all visits|0
4685222|NCT02505542|16132366|P2|Part B: Double-Blind Period|Subject did not complete all visits|1
4685223|NCT02505542|16132367|P1|Part B: Double-Blind Period|Subject did not complete all visits|0
4685224|NCT02505542|16132364|P4|Part B: Double-Blind Period|Miscalculation|0
4685225|NCT02505542|16132365|P3|Part B: Double-Blind Period|Miscalculation|0
4685226|NCT02505542|16132366|P2|Part B: Double-Blind Period|Miscalculation|1
4685227|NCT02505542|16132367|P1|Part B: Double-Blind Period|Miscalculation|0
4685228|NCT02505542|16132364|P4|Part B: Double-Blind Period|Lack of Efficacy|0
4685229|NCT02505542|16132365|P3|Part B: Double-Blind Period|Lack of Efficacy|0
4685230|NCT02505542|16132366|P2|Part B: Double-Blind Period|Lack of Efficacy|1
4685231|NCT02505542|16132367|P1|Part B: Double-Blind Period|Lack of Efficacy|0
4685232|NCT02505542|16132364|P4|Part B: Double-Blind Period|Patient was moved from the country|1
4685233|NCT02505542|16132365|P3|Part B: Double-Blind Period|Patient was moved from the country|0
4685234|NCT02505542|16132366|P2|Part B: Double-Blind Period|Patient was moved from the country|0
4685235|NCT02505542|16132367|P1|Part B: Double-Blind Period|Patient was moved from the country|0
4685236|NCT02505542|16132364|P4|Part B: Double-Blind Period|Week 94 missed|0
4685237|NCT02505542|16132365|P3|Part B: Double-Blind Period|Week 94 missed|1
4685238|NCT02505542|16132366|P2|Part B: Double-Blind Period|Week 94 missed|0
4685239|NCT02505542|16132367|P1|Part B: Double-Blind Period|Week 94 missed|0
4685240|NCT02505542|16132364|P4|Part B: Double-Blind Period|Planning pregnancy|0
4685241|NCT02505542|16132365|P3|Part B: Double-Blind Period|Planning pregnancy|0
4685242|NCT02505542|16132366|P2|Part B: Double-Blind Period|Planning pregnancy|1
4685243|NCT02505542|16132367|P1|Part B: Double-Blind Period|Planning pregnancy|0
4685244|NCT02505542|16132364|P4|Part B: Double-Blind Period|Withdrawal by Subject|2
4685245|NCT02505542|16132365|P3|Part B: Double-Blind Period|Withdrawal by Subject|7
4685246|NCT02505542|16132366|P2|Part B: Double-Blind Period|Withdrawal by Subject|8
4685247|NCT02505542|16132367|P1|Part B: Double-Blind Period|Withdrawal by Subject|0
4685248|NCT02505542|16132364|P4|Part B: Double-Blind Period|Lost to Follow-up|1
4685249|NCT02505542|16132365|P3|Part B: Double-Blind Period|Lost to Follow-up|0
4685250|NCT02505542|16132366|P2|Part B: Double-Blind Period|Lost to Follow-up|0
4685251|NCT02505542|16132367|P1|Part B: Double-Blind Period|Lost to Follow-up|0
4685252|NCT02505542|16132364|P4|Part B: Double-Blind Period|Adverse Event|3
4685253|NCT02505542|16132365|P3|Part B: Double-Blind Period|Adverse Event|1
4685254|NCT02505542|16132366|P2|Part B: Double-Blind Period|Adverse Event|0
4685255|NCT02505542|16132367|P1|Part B: Double-Blind Period|Adverse Event|0
4685256|NCT02505542|16132364|P4|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
4685257|NCT02505542|16132365|P3|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
4685258|NCT02505542|16132366|P2|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0
4685259|NCT02505542|16132367|P1|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341
4685260|NCT02505542|16132364|P4|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
4685261|NCT02505542|16132365|P3|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
4685262|NCT02505542|16132366|P2|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0
4685263|NCT02505542|16132367|P1|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3
4685264|NCT02505542|16132364|P4|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
4685265|NCT02505542|16132365|P3|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
4685266|NCT02505542|16132366|P2|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0
4685267|NCT02505542|16132367|P1|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2
4685268|NCT02505542|16132364|P4|Part A: Open-Label Period|Non-compliance|0
4685269|NCT02505542|16132365|P3|Part A: Open-Label Period|Non-compliance|0
4685270|NCT02505542|16132366|P2|Part A: Open-Label Period|Non-compliance|0
4685271|NCT02505542|16132367|P1|Part A: Open-Label Period|Non-compliance|1
4685272|NCT02505542|16132364|P4|Part A: Open-Label Period|Screening failure (detected too late)|0
4685273|NCT02505542|16132365|P3|Part A: Open-Label Period|Screening failure (detected too late)|0
4685274|NCT02505542|16132366|P2|Part A: Open-Label Period|Screening failure (detected too late)|0
4685275|NCT02505542|16132367|P1|Part A: Open-Label Period|Screening failure (detected too late)|1
4685276|NCT02505542|16132364|P4|Part A: Open-Label Period|Medical monitor decision|0
4685277|NCT02505542|16132365|P3|Part A: Open-Label Period|Medical monitor decision|0
4685278|NCT02505542|16132366|P2|Part A: Open-Label Period|Medical monitor decision|0
4685279|NCT02505542|16132367|P1|Part A: Open-Label Period|Medical monitor decision|1
4685280|NCT02505542|16132364|P4|Part A: Open-Label Period|Sponsor directive|0
4685281|NCT02505542|16132365|P3|Part A: Open-Label Period|Sponsor directive|0
4685282|NCT02505542|16132366|P2|Part A: Open-Label Period|Sponsor directive|0
4685283|NCT02505542|16132367|P1|Part A: Open-Label Period|Sponsor directive|1
4685284|NCT02505542|16132364|P4|Part A: Open-Label Period|Pregnancy|0
4685285|NCT02505542|16132365|P3|Part A: Open-Label Period|Pregnancy|0
4685286|NCT02505542|16132366|P2|Part A: Open-Label Period|Pregnancy|0
4685287|NCT02505542|16132367|P1|Part A: Open-Label Period|Pregnancy|2
4685288|NCT02505542|16132364|P4|Part A: Open-Label Period|Participant did not attend week 48 visit|0
4685289|NCT02505542|16132365|P3|Part A: Open-Label Period|Participant did not attend week 48 visit|0
4685290|NCT02505542|16132366|P2|Part A: Open-Label Period|Participant did not attend week 48 visit|0
4685291|NCT02505542|16132367|P1|Part A: Open-Label Period|Participant did not attend week 48 visit|1
4685292|NCT02505542|16132364|P4|Part A: Open-Label Period|New medical history available|0
4685293|NCT02505542|16132365|P3|Part A: Open-Label Period|New medical history available|0
4685294|NCT02505542|16132366|P2|Part A: Open-Label Period|New medical history available|0
4685295|NCT02505542|16132367|P1|Part A: Open-Label Period|New medical history available|1
4685296|NCT02505542|16132364|P4|Part A: Open-Label Period|Withdrawal by Subject|0
4685297|NCT02505542|16132365|P3|Part A: Open-Label Period|Withdrawal by Subject|0
4685298|NCT02505542|16132366|P2|Part A: Open-Label Period|Withdrawal by Subject|0
4685299|NCT02505542|16132367|P1|Part A: Open-Label Period|Withdrawal by Subject|27
4685300|NCT02505542|16132364|P4|Part A: Open-Label Period|Lost to Follow-up|0
4685301|NCT02505542|16132365|P3|Part A: Open-Label Period|Lost to Follow-up|0
4685302|NCT02505542|16132366|P2|Part A: Open-Label Period|Lost to Follow-up|0
4685303|NCT02505542|16132367|P1|Part A: Open-Label Period|Lost to Follow-up|5
4685304|NCT02505542|16132364|P4|Part A: Open-Label Period|Protocol Violation|0
4685305|NCT02505542|16132365|P3|Part A: Open-Label Period|Protocol Violation|0
4685306|NCT02505542|16132366|P2|Part A: Open-Label Period|Protocol Violation|0
4685307|NCT02505542|16132367|P1|Part A: Open-Label Period|Protocol Violation|1
4685308|NCT02505542|16132364|P4|Part A: Open-Label Period|Lack of Efficacy|0
4685309|NCT02505542|16132365|P3|Part A: Open-Label Period|Lack of Efficacy|0
4685310|NCT02505542|16132366|P2|Part A: Open-Label Period|Lack of Efficacy|0
4685311|NCT02505542|16132367|P1|Part A: Open-Label Period|Lack of Efficacy|5
4685312|NCT02505542|16132364|P4|Part A: Open-Label Period|Adverse Event|0
4685313|NCT02505542|16132365|P3|Part A: Open-Label Period|Adverse Event|0
4685314|NCT02505542|16132366|P2|Part A: Open-Label Period|Adverse Event|0
4685315|NCT02505542|16132367|P1|Part A: Open-Label Period|Adverse Event|31
4685316|NCT02505334|16132475|P2|Extension Treatment Period|Unclassified|0
4685317|NCT02505334|16132476|P1|Extension Treatment Period|Unclassified|3
4685318|NCT02505334|16132475|P2|Extension Treatment Period|Withdrawal by Subject|0
4685319|NCT02505334|16132476|P1|Extension Treatment Period|Withdrawal by Subject|6
4685320|NCT02505334|16132475|P2|Extension Treatment Period|Lack of Efficacy|0
4685321|NCT02505334|16132476|P1|Extension Treatment Period|Lack of Efficacy|4
4685322|NCT02505334|16132475|P2|Extension Treatment Period|Adverse Event|0
4685323|NCT02505334|16132476|P1|Extension Treatment Period|Adverse Event|5
4685324|NCT02505334|16132475|P2|Main Treatment Period|Unclassified|10
4685325|NCT02505334|16132476|P1|Main Treatment Period|Unclassified|4
4685326|NCT02505334|16132475|P2|Main Treatment Period|Withdrawal by Subject|8
4685327|NCT02505334|16132476|P1|Main Treatment Period|Withdrawal by Subject|1
4685328|NCT02505334|16132475|P2|Main Treatment Period|Protocol Violation|1
4685329|NCT02505334|16132476|P1|Main Treatment Period|Protocol Violation|0
4685330|NCT02505334|16132475|P2|Main Treatment Period|Lack of Efficacy|17
4685331|NCT02505334|16132476|P1|Main Treatment Period|Lack of Efficacy|7
4685332|NCT02505334|16132475|P2|Main Treatment Period|Adverse Event|3
4685333|NCT02505334|16132476|P1|Main Treatment Period|Adverse Event|3
4685334|NCT02505217|16132609|P2|Overall Study|Withdrawal by Subject|2
4685335|NCT02505217|16132610|P1|Overall Study|Withdrawal by Subject|1
4685336|NCT02504892|16132629|P1|Overall Study|Adverse event-pneumonitis|2
4685337|NCT02504827|16132636|P1|Overall Study|Could not produce sputum|1
4685338|NCT02504671|16132675|P6|Overall Study|Protocol defined stopping criteria|3
4685339|NCT02504671|16132676|P5|Overall Study|Protocol defined stopping criteria|3
4685340|NCT02504671|16132677|P4|Overall Study|Protocol defined stopping criteria|5
4685341|NCT02504671|16132678|P3|Overall Study|Protocol defined stopping criteria|3
4685342|NCT02504671|16132679|P2|Overall Study|Protocol defined stopping criteria|4
4685343|NCT02504671|16132680|P1|Overall Study|Protocol defined stopping criteria|7
4685344|NCT02504671|16132675|P6|Overall Study|Lost to Follow-up|1
4685345|NCT02504671|16132676|P5|Overall Study|Lost to Follow-up|0
4685346|NCT02504671|16132677|P4|Overall Study|Lost to Follow-up|0
4685347|NCT02504671|16132678|P3|Overall Study|Lost to Follow-up|2
4685348|NCT02504671|16132679|P2|Overall Study|Lost to Follow-up|0
4685349|NCT02504671|16132680|P1|Overall Study|Lost to Follow-up|0
4685350|NCT02504671|16132675|P6|Overall Study|Protocol Violation|1
4685351|NCT02504671|16132676|P5|Overall Study|Protocol Violation|0
4685352|NCT02504671|16132677|P4|Overall Study|Protocol Violation|0
4685353|NCT02504671|16132678|P3|Overall Study|Protocol Violation|0
4685354|NCT02504671|16132679|P2|Overall Study|Protocol Violation|1
4685355|NCT02504671|16132680|P1|Overall Study|Protocol Violation|2
4685356|NCT02504671|16132675|P6|Overall Study|Adverse Event|2
4685357|NCT02504671|16132676|P5|Overall Study|Adverse Event|0
4685358|NCT02504671|16132677|P4|Overall Study|Adverse Event|1
4685359|NCT02504671|16132678|P3|Overall Study|Adverse Event|0
4685360|NCT02504671|16132679|P2|Overall Study|Adverse Event|1
4685361|NCT02504671|16132680|P1|Overall Study|Adverse Event|1
4685362|NCT02504671|16132675|P6|Overall Study|Lack of Efficacy|4
4685363|NCT02504671|16132676|P5|Overall Study|Lack of Efficacy|4
4685364|NCT02504671|16132677|P4|Overall Study|Lack of Efficacy|0
4685365|NCT02504671|16132678|P3|Overall Study|Lack of Efficacy|1
4685366|NCT02504671|16132679|P2|Overall Study|Lack of Efficacy|3
4685367|NCT02504671|16132680|P1|Overall Study|Lack of Efficacy|1
4685368|NCT02504671|16132675|P6|Overall Study|Withdrawal by Subject|3
4685369|NCT02504671|16132676|P5|Overall Study|Withdrawal by Subject|5
4685370|NCT02504671|16132677|P4|Overall Study|Withdrawal by Subject|4
4685371|NCT02504671|16132678|P3|Overall Study|Withdrawal by Subject|4
4685372|NCT02504671|16132679|P2|Overall Study|Withdrawal by Subject|5
4685373|NCT02504671|16132680|P1|Overall Study|Withdrawal by Subject|1
4685374|NCT02504541|16132852|P1|Overall Study|Multiple|5
4685375|NCT02504541|16132852|P1|Overall Study|Other|2
4685376|NCT02504541|16132852|P1|Overall Study|Termination by Sponsor|1
4685377|NCT02504541|16132852|P1|Overall Study|Protocol Violation|2
4685378|NCT02504541|16132852|P1|Overall Study|Met Stopping Criteria|1
4685379|NCT02504541|16132852|P1|Overall Study|Lost to Follow-up|1
4685380|NCT02504541|16132852|P1|Overall Study|Withdrawal by Subject|4
4685381|NCT02504541|16132852|P1|Overall Study|Adverse Event|4
4685382|NCT02504502|16132858|P2|Crossover to Enhanced Report|Lost to Follow-up|0
4685383|NCT02504502|16132859|P1|Crossover to Enhanced Report|Lost to Follow-up|5
4685384|NCT02504502|16132858|P2|Routine Care vs. Enhanced Report|Lost to Follow-up|7
4685385|NCT02504502|16132859|P1|Routine Care vs. Enhanced Report|Lost to Follow-up|4
4685386|NCT02504424|16132865|P1|Overall Study|Withdrawal by Subject|2
4685387|NCT02504320|16132874|P4|Treatment Period 3|Adverse Event|0
4685388|NCT02504320|16132875|P3|Treatment Period 3|Adverse Event|1
4685389|NCT02504320|16132876|P2|Treatment Period 3|Adverse Event|0
4685390|NCT02504320|16132877|P1|Treatment Period 3|Adverse Event|0
4685391|NCT02504320|16132874|P4|Treatment Period 3|Positive Drug Screen|1
4685392|NCT02504320|16132875|P3|Treatment Period 3|Positive Drug Screen|0
4685393|NCT02504320|16132876|P2|Treatment Period 3|Positive Drug Screen|0
4685394|NCT02504320|16132877|P1|Treatment Period 3|Positive Drug Screen|0
4685395|NCT02504320|16132874|P4|Treatment Period 2|Positive Drug Screen|0
4685396|NCT02504320|16132875|P3|Treatment Period 2|Positive Drug Screen|0
4685397|NCT02504320|16132876|P2|Treatment Period 2|Positive Drug Screen|1
4685398|NCT02504320|16132877|P1|Treatment Period 2|Positive Drug Screen|0
4685399|NCT02504320|16132874|P4|Treatment Period 1|Positive Drug Screen|0
4685400|NCT02504320|16132875|P3|Treatment Period 1|Positive Drug Screen|1
4685401|NCT02504320|16132876|P2|Treatment Period 1|Positive Drug Screen|0
4685402|NCT02504320|16132877|P1|Treatment Period 1|Positive Drug Screen|0
4685403|NCT02504294|16132897|P2|Overall Study|Lost to Follow-up|7
4685404|NCT02504294|16132898|P1|Overall Study|Lost to Follow-up|6
4685405|NCT02504294|16132897|P2|Overall Study|Physician Decision|2
4685406|NCT02504294|16132898|P1|Overall Study|Physician Decision|1
4685407|NCT02504294|16132897|P2|Overall Study|Protocol Violation|26
4685408|NCT02504294|16132898|P1|Overall Study|Protocol Violation|27
4685409|NCT02504294|16132897|P2|Overall Study|Withdrawal by Subject|1
4685410|NCT02504294|16132898|P1|Overall Study|Withdrawal by Subject|7
4685411|NCT02504294|16132897|P2|Overall Study|Adverse Event|12
4685412|NCT02504294|16132898|P1|Overall Study|Adverse Event|15
4685413|NCT02504268|16132908|P2|Overall Study|Not Disclosed|0
4685414|NCT02504268|16132909|P1|Overall Study|Not Disclosed|1
4685415|NCT02504268|16132908|P2|Overall Study|Poor/Non-Compliance|2
4685416|NCT02504268|16132909|P1|Overall Study|Poor/Non-Compliance|3
4685417|NCT02504268|16132908|P2|Overall Study|Lack of Efficacy|35
4685418|NCT02504268|16132909|P1|Overall Study|Lack of Efficacy|11
4685419|NCT02504268|16132908|P2|Overall Study|No Longer Meets Study Criteria|3
4685420|NCT02504268|16132909|P1|Overall Study|No Longer Meets Study Criteria|2
4685421|NCT02504268|16132908|P2|Overall Study|Subject Request to Discontinue|3
4685422|NCT02504268|16132909|P1|Overall Study|Subject Request to Discontinue|11
4685423|NCT02504268|16132908|P2|Overall Study|Death|1
4685424|NCT02504268|16132909|P1|Overall Study|Death|1
4685425|NCT02504268|16132908|P2|Overall Study|Lost to Follow-up|6
4685426|NCT02504268|16132909|P1|Overall Study|Lost to Follow-up|3
4685427|NCT02504268|16132908|P2|Overall Study|Pregnancy|0
4685428|NCT02504268|16132909|P1|Overall Study|Pregnancy|2
4685429|NCT02504268|16132908|P2|Overall Study|Withdrawal of Consent|10
4685430|NCT02504268|16132909|P1|Overall Study|Withdrawal of Consent|11
4685431|NCT02504268|16132908|P2|Overall Study|Adverse Event|8
4685432|NCT02504268|16132909|P1|Overall Study|Adverse Event|18
4685433|NCT02503865|16132944|P3|Overall Study|Refused treatment|2
4685434|NCT02503865|16132945|P2|Overall Study|Refused treatment|39
4685435|NCT02503865|16132946|P1|Overall Study|Refused treatment|4
4685436|NCT02503865|16132944|P3|Overall Study|Moved out of area|0
4685437|NCT02503865|16132945|P2|Overall Study|Moved out of area|8
4685438|NCT02503865|16132946|P1|Overall Study|Moved out of area|1
4685439|NCT02503787|16132991|P1|Implant to 3 Month Endpoint|Withdrawal by Subject|1
4685440|NCT02503787|16132991|P1|Implant to 3 Month Endpoint|Adverse Event|2
4685441|NCT02503787|16132991|P1|Successful Trial (≥50% Pain Relief)|Physician Decision|2
4685442|NCT02503787|16132991|P1|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3
4685443|NCT02503787|16132991|P1|Device Trial (HD Programming Trial)|Withdrawal by Subject|1
4685444|NCT02503787|16132991|P1|Device Trial (HD Programming Trial)|Lack of Efficacy|6
4685445|NCT02503787|16132991|P1|Enrollment|Unable to be programmed|1
4685446|NCT02503787|16132991|P1|Enrollment|Inability to implant system|1
4685447|NCT02503787|16132991|P1|Enrollment|Protocol Violation|1
4685448|NCT02503787|16132991|P1|Enrollment|Adverse Event|1
4685449|NCT02503787|16132991|P1|Enrollment|Study closure|1
4685450|NCT02503787|16132991|P1|Enrollment|Lost to Follow-up|1
4685451|NCT02503787|16132991|P1|Enrollment|Insurance issue|2
4685452|NCT02503787|16132991|P1|Enrollment|Physician Decision|2
4685453|NCT02503787|16132991|P1|Enrollment|Inclusion/exclusion criteria not met|4
4685454|NCT02503787|16132991|P1|Enrollment|Withdrawal by Subject|6
4685455|NCT02503540|16133008|P1|Overall Study|Withdrawal by Subject|1
4685456|NCT02503540|16133008|P1|Overall Study|Death|2
4685457|NCT02503501|16133029|P2|Overall Study|Withdrawal by Subject|2
4685458|NCT02503501|16133030|P1|Overall Study|Withdrawal by Subject|0
4685459|NCT02503501|16133029|P2|Overall Study|Protocol Violation|1
4685460|NCT02503501|16133030|P1|Overall Study|Protocol Violation|0
4685461|NCT02503501|16133029|P2|Overall Study|Physician Decision|0
4685462|NCT02503501|16133030|P1|Overall Study|Physician Decision|1
4685463|NCT02503332|16133066|P4|Overall Study|Other|1
4685464|NCT02503332|16133067|P3|Overall Study|Other|1
4685465|NCT02503332|16133068|P2|Overall Study|Other|6
4685466|NCT02503332|16133069|P1|Overall Study|Other|5
4685467|NCT02503332|16133066|P4|Overall Study|Death|0
4685468|NCT02503332|16133067|P3|Overall Study|Death|2
4685469|NCT02503332|16133068|P2|Overall Study|Death|2
4685470|NCT02503332|16133069|P1|Overall Study|Death|0
4685471|NCT02503332|16133066|P4|Overall Study|Subject Request|1
4685472|NCT02503332|16133067|P3|Overall Study|Subject Request|2
4685473|NCT02503332|16133068|P2|Overall Study|Subject Request|5
4685474|NCT02503332|16133069|P1|Overall Study|Subject Request|6
4685475|NCT02503332|16133066|P4|Overall Study|Sponsor's Decision|1
4685476|NCT02503332|16133067|P3|Overall Study|Sponsor's Decision|0
4685477|NCT02503332|16133068|P2|Overall Study|Sponsor's Decision|0
4685478|NCT02503332|16133069|P1|Overall Study|Sponsor's Decision|1
4685479|NCT02503332|16133066|P4|Overall Study|Investigator's Decision|0
4685480|NCT02503332|16133067|P3|Overall Study|Investigator's Decision|0
4685481|NCT02503332|16133068|P2|Overall Study|Investigator's Decision|1
4685482|NCT02503332|16133069|P1|Overall Study|Investigator's Decision|5
4685483|NCT02503332|16133066|P4|Overall Study|Adverse Event|1
4685484|NCT02503332|16133067|P3|Overall Study|Adverse Event|3
4685485|NCT02503332|16133068|P2|Overall Study|Adverse Event|5
4685486|NCT02503332|16133069|P1|Overall Study|Adverse Event|17
4685487|NCT02503215|16133120|P1|Overall Study|Unable to use positive airway pressure|2
4685488|NCT02503215|16133120|P1|Overall Study|Unable to wear compression stockings|1
4685489|NCT02503202|16133131|P5|Extension: Month 6 to 24|Withdrawal by Subject|0
4685490|NCT02503202|16133132|P4|Extension: Month 6 to 24|Withdrawal by Subject|4
4685491|NCT02503202|16133133|P3|Extension: Month 6 to 24|Withdrawal by Subject|2
4685492|NCT02503202|16133134|P2|Extension: Month 6 to 24|Withdrawal by Subject|8
4685493|NCT02503202|16133135|P1|Extension: Month 6 to 24|Withdrawal by Subject|5
4685494|NCT02503202|16133131|P5|Extension: Month 6 to 24|Physician Decision|0
4685495|NCT02503202|16133132|P4|Extension: Month 6 to 24|Physician Decision|3
4685496|NCT02503202|16133133|P3|Extension: Month 6 to 24|Physician Decision|1
4685497|NCT02503202|16133134|P2|Extension: Month 6 to 24|Physician Decision|0
4685498|NCT02503202|16133135|P1|Extension: Month 6 to 24|Physician Decision|1
4685499|NCT02503202|16133131|P5|Extension: Month 6 to 24|Lost to Follow-up|1
4685500|NCT02503202|16133132|P4|Extension: Month 6 to 24|Lost to Follow-up|10
4685501|NCT02503202|16133133|P3|Extension: Month 6 to 24|Lost to Follow-up|6
4685502|NCT02503202|16133134|P2|Extension: Month 6 to 24|Lost to Follow-up|8
4685503|NCT02503202|16133135|P1|Extension: Month 6 to 24|Lost to Follow-up|4
4685504|NCT02503202|16133131|P5|Extension: Month 6 to 24|Death|0
4685505|NCT02503202|16133132|P4|Extension: Month 6 to 24|Death|0
4685506|NCT02503202|16133133|P3|Extension: Month 6 to 24|Death|0
4685507|NCT02503202|16133134|P2|Extension: Month 6 to 24|Death|0
4685508|NCT02503202|16133135|P1|Extension: Month 6 to 24|Death|1
4685509|NCT02503202|16133131|P5|Extension: Month 6 to 24|Protocol Violation|0
4685510|NCT02503202|16133132|P4|Extension: Month 6 to 24|Protocol Violation|1
4685511|NCT02503202|16133133|P3|Extension: Month 6 to 24|Protocol Violation|0
4685512|NCT02503202|16133134|P2|Extension: Month 6 to 24|Protocol Violation|0
4685513|NCT02503202|16133135|P1|Extension: Month 6 to 24|Protocol Violation|0
4685514|NCT02503202|16133131|P5|Base Study: Up to Month 6|Randomized not vaccinated|0
4685515|NCT02503202|16133132|P4|Base Study: Up to Month 6|Randomized not vaccinated|2
4685516|NCT02503202|16133133|P3|Base Study: Up to Month 6|Randomized not vaccinated|1
4685517|NCT02503202|16133134|P2|Base Study: Up to Month 6|Randomized not vaccinated|0
4685518|NCT02503202|16133135|P1|Base Study: Up to Month 6|Randomized not vaccinated|0
4685519|NCT02503202|16133131|P5|Base Study: Up to Month 6|Withdrawal by Subject|1
4685520|NCT02503202|16133132|P4|Base Study: Up to Month 6|Withdrawal by Subject|4
4685521|NCT02503202|16133133|P3|Base Study: Up to Month 6|Withdrawal by Subject|4
4685522|NCT02503202|16133134|P2|Base Study: Up to Month 6|Withdrawal by Subject|3
4685523|NCT02503202|16133135|P1|Base Study: Up to Month 6|Withdrawal by Subject|6
4685524|NCT02503202|16133131|P5|Base Study: Up to Month 6|Physician Decision|1
4685525|NCT02503202|16133132|P4|Base Study: Up to Month 6|Physician Decision|0
4685526|NCT02503202|16133133|P3|Base Study: Up to Month 6|Physician Decision|0
4685527|NCT02503202|16133134|P2|Base Study: Up to Month 6|Physician Decision|0
4685528|NCT02503202|16133135|P1|Base Study: Up to Month 6|Physician Decision|0
4685529|NCT02503202|16133131|P5|Base Study: Up to Month 6|Lost to Follow-up|1
4685530|NCT02503202|16133132|P4|Base Study: Up to Month 6|Lost to Follow-up|5
4685531|NCT02503202|16133133|P3|Base Study: Up to Month 6|Lost to Follow-up|10
4685532|NCT02503202|16133134|P2|Base Study: Up to Month 6|Lost to Follow-up|8
4685533|NCT02503202|16133135|P1|Base Study: Up to Month 6|Lost to Follow-up|11
4685534|NCT02503202|16133131|P5|Base Study: Up to Month 6|Death|0
4685535|NCT02503202|16133132|P4|Base Study: Up to Month 6|Death|0
4685536|NCT02503202|16133133|P3|Base Study: Up to Month 6|Death|0
4685537|NCT02503202|16133134|P2|Base Study: Up to Month 6|Death|1
4685538|NCT02503202|16133135|P1|Base Study: Up to Month 6|Death|1
4685539|NCT02503085|16133177|P4|Period 2: Washout (3 to 7 Days)|Adverse Event|0
4685540|NCT02503085|16133178|P3|Period 2: Washout (3 to 7 Days)|Adverse Event|1
4685541|NCT02503085|16133179|P2|Period 2: Washout (3 to 7 Days)|Adverse Event|0
4685542|NCT02503085|16133180|P1|Period 2: Washout (3 to 7 Days)|Adverse Event|1
4685543|NCT02502864|16133219|P1|Overall Study|Withdrawal by Subject|1
4685544|NCT02502734|16133228|P2|Washout Period|Adverse Event|0
4685545|NCT02502734|16133229|P1|Washout Period|Adverse Event|1
4685546|NCT02502734|16133228|P2|Double-blind Treatment Period 1|Adverse Event|0
4685547|NCT02502734|16133229|P1|Double-blind Treatment Period 1|Adverse Event|1
4685548|NCT02502526|16133240|P3|Overall Study|Enrollment suspension|1
4685549|NCT02502526|16133241|P2|Overall Study|Enrollment suspension|1
4685550|NCT02502526|16133242|P1|Overall Study|Enrollment suspension|4
4685551|NCT02502526|16133240|P3|Overall Study|Disqualified due to cataract grading|1
4685552|NCT02502526|16133241|P2|Overall Study|Disqualified due to cataract grading|0
4685553|NCT02502526|16133242|P1|Overall Study|Disqualified due to cataract grading|0
4685554|NCT02502526|16133240|P3|Overall Study|Withdrawal by Subject|1
4685555|NCT02502526|16133241|P2|Overall Study|Withdrawal by Subject|1
4685556|NCT02502526|16133242|P1|Overall Study|Withdrawal by Subject|0
4685557|NCT02502526|16133240|P3|Overall Study|Lost to Follow-up|3
4685558|NCT02502526|16133241|P2|Overall Study|Lost to Follow-up|2
4685559|NCT02502526|16133242|P1|Overall Study|Lost to Follow-up|2
4685560|NCT02502149|16133339|P5|Intermediate|Discontinued prematurely|0
4685561|NCT02502149|16133340|P4|Intermediate|Discontinued prematurely|0
4685562|NCT02502149|16133341|P3|Intermediate|Discontinued prematurely|0
4685563|NCT02502149|16133342|P2|Intermediate|Discontinued prematurely|0
4685564|NCT02502149|16133343|P1|Intermediate|Discontinued prematurely|1
4685565|NCT02501928|16133478|P6|Overall Study|Withdrawal By Parent/Guardian|0
4685566|NCT02501928|16133479|P5|Overall Study|Withdrawal By Parent/Guardian|1
4685567|NCT02501928|16133480|P4|Overall Study|Withdrawal By Parent/Guardian|0
4685568|NCT02501928|16133481|P3|Overall Study|Withdrawal By Parent/Guardian|0
4685569|NCT02501928|16133482|P2|Overall Study|Withdrawal By Parent/Guardian|0
4685570|NCT02501928|16133483|P1|Overall Study|Withdrawal By Parent/Guardian|0
4685571|NCT02501629|16133709|P2|Overall Study|Subject did not return to site|1
4685572|NCT02501629|16133710|P1|Overall Study|Subject did not return to site|0
4685573|NCT02501629|16133709|P2|Overall Study|Withdrawal by Subject|5
4685574|NCT02501629|16133710|P1|Overall Study|Withdrawal by Subject|3
4685575|NCT02501629|16133709|P2|Overall Study|Early termination by sponsor|0
4685576|NCT02501629|16133710|P1|Overall Study|Early termination by sponsor|1
4685577|NCT02501629|16133709|P2|Overall Study|Withdrawn from study by sponsor|0
4685578|NCT02501629|16133710|P1|Overall Study|Withdrawn from study by sponsor|1
4685579|NCT02501629|16133709|P2|Overall Study|Death|1
4685580|NCT02501629|16133710|P1|Overall Study|Death|0
4685581|NCT02501473|16133756|P8|Overall Study|Reason not specified|0
4685582|NCT02501473|16133757|P7|Overall Study|Reason not specified|0
4685583|NCT02501473|16133758|P6|Overall Study|Reason not specified|0
4685584|NCT02501473|16133759|P5|Overall Study|Reason not specified|0
4685585|NCT02501473|16133760|P4|Overall Study|Reason not specified|1
4685586|NCT02501473|16133761|P3|Overall Study|Reason not specified|1
4685587|NCT02501473|16133762|P2|Overall Study|Reason not specified|0
4685588|NCT02501473|16133763|P1|Overall Study|Reason not specified|0
4685589|NCT02501473|16133756|P8|Overall Study|Lost to Follow-up|0
4685590|NCT02501473|16133757|P7|Overall Study|Lost to Follow-up|0
4685591|NCT02501473|16133758|P6|Overall Study|Lost to Follow-up|1
4685592|NCT02501473|16133759|P5|Overall Study|Lost to Follow-up|0
4685593|NCT02501473|16133760|P4|Overall Study|Lost to Follow-up|0
4685594|NCT02501473|16133761|P3|Overall Study|Lost to Follow-up|1
4685595|NCT02501473|16133762|P2|Overall Study|Lost to Follow-up|0
4685596|NCT02501473|16133763|P1|Overall Study|Lost to Follow-up|1
4685597|NCT02501473|16133756|P8|Overall Study|Death|0
4685598|NCT02501473|16133757|P7|Overall Study|Death|0
4685599|NCT02501473|16133758|P6|Overall Study|Death|1
4685600|NCT02501473|16133759|P5|Overall Study|Death|0
4685601|NCT02501473|16133760|P4|Overall Study|Death|1
4685602|NCT02501473|16133761|P3|Overall Study|Death|1
4685603|NCT02501473|16133762|P2|Overall Study|Death|0
4685604|NCT02501473|16133763|P1|Overall Study|Death|0
4685605|NCT02501473|16133756|P8|Overall Study|Withdrawal by Subject|0
4685606|NCT02501473|16133757|P7|Overall Study|Withdrawal by Subject|0
4685607|NCT02501473|16133758|P6|Overall Study|Withdrawal by Subject|2
4685608|NCT02501473|16133759|P5|Overall Study|Withdrawal by Subject|2
4685609|NCT02501473|16133760|P4|Overall Study|Withdrawal by Subject|3
4685610|NCT02501473|16133761|P3|Overall Study|Withdrawal by Subject|3
4685611|NCT02501473|16133762|P2|Overall Study|Withdrawal by Subject|0
4685612|NCT02501473|16133763|P1|Overall Study|Withdrawal by Subject|0
4685613|NCT02501473|16133756|P8|Overall Study|Study Terminated|0
4685614|NCT02501473|16133757|P7|Overall Study|Study Terminated|1
4685615|NCT02501473|16133758|P6|Overall Study|Study Terminated|10
4685616|NCT02501473|16133759|P5|Overall Study|Study Terminated|2
4685617|NCT02501473|16133760|P4|Overall Study|Study Terminated|9
4685618|NCT02501473|16133761|P3|Overall Study|Study Terminated|7
4685619|NCT02501473|16133762|P2|Overall Study|Study Terminated|3
4685620|NCT02501473|16133763|P1|Overall Study|Study Terminated|2
4685621|NCT02501161|16133858|P2|Overall Study|Other|0
4685622|NCT02501161|16133859|P1|Overall Study|Other|3
4685623|NCT02501161|16133858|P2|Overall Study|Withdrawal by Subject|15
4685624|NCT02501161|16133859|P1|Overall Study|Withdrawal by Subject|10
4685625|NCT02501161|16133858|P2|Overall Study|Lost to Follow-up|4
4685626|NCT02501161|16133859|P1|Overall Study|Lost to Follow-up|7
4685627|NCT02501161|16133858|P2|Overall Study|Adverse Event|6
4685628|NCT02501161|16133859|P1|Overall Study|Adverse Event|2
4685629|NCT02500979|16133983|P2|Period 2|Change in risk|0
4685630|NCT02500979|16133984|P1|Period 2|Change in risk|1
4685631|NCT02500979|16133983|P2|Period 1|Subject decision|0
4685632|NCT02500979|16133984|P1|Period 1|Subject decision|2
4685633|NCT02500979|16133983|P2|Period 1|Adverse Event|0
4685634|NCT02500979|16133984|P1|Period 1|Adverse Event|1
4685635|NCT02500979|16133983|P2|Period 1|Severe non-compliance to protocol|1
4685636|NCT02500979|16133984|P1|Period 1|Severe non-compliance to protocol|0
4685637|NCT02500979|16133983|P2|Period 1|Hyperglycemia|0
4685638|NCT02500979|16133984|P1|Period 1|Hyperglycemia|1
4685639|NCT02500901|16134018|P1|Overall Study|Disease ProgressionDD|2
4685640|NCT02500797|16134046|P8|Overall Study|Withdrawal by Subject|0
4685641|NCT02500797|16134047|P7|Overall Study|Withdrawal by Subject|0
4685642|NCT02500797|16134048|P6|Overall Study|Withdrawal by Subject|0
4685643|NCT02500797|16134049|P5|Overall Study|Withdrawal by Subject|0
4685644|NCT02500797|16134050|P4|Overall Study|Withdrawal by Subject|0
4685645|NCT02500797|16134051|P3|Overall Study|Withdrawal by Subject|0
4685646|NCT02500797|16134052|P2|Overall Study|Withdrawal by Subject|0
4685647|NCT02500797|16134053|P1|Overall Study|Withdrawal by Subject|1
4685648|NCT02500797|16134046|P8|Overall Study|Cancel (rapid disease progression)|0
4685649|NCT02500797|16134047|P7|Overall Study|Cancel (rapid disease progression)|0
4685650|NCT02500797|16134048|P6|Overall Study|Cancel (rapid disease progression)|1
4685651|NCT02500797|16134049|P5|Overall Study|Cancel (rapid disease progression)|1
4685652|NCT02500797|16134050|P4|Overall Study|Cancel (rapid disease progression)|0
4685653|NCT02500797|16134051|P3|Overall Study|Cancel (rapid disease progression)|0
4685654|NCT02500797|16134052|P2|Overall Study|Cancel (rapid disease progression)|0
4685655|NCT02500797|16134053|P1|Overall Study|Cancel (rapid disease progression)|0
4685656|NCT02500758|16134113|P2|Second Intervention (2 Minutes)|Protocol Violation|1
4685657|NCT02500758|16134114|P1|Second Intervention (2 Minutes)|Protocol Violation|1
4685658|NCT02500758|16134113|P2|Second Intervention (2 Minutes)|Lost to Follow-up|1
4685659|NCT02500758|16134114|P1|Second Intervention (2 Minutes)|Lost to Follow-up|0
4685660|NCT02500758|16134113|P2|Second Intervention (2 Minutes)|Withdrawal by Subject|0
4685661|NCT02500758|16134114|P1|Second Intervention (2 Minutes)|Withdrawal by Subject|2
4685662|NCT02500758|16134113|P2|Washout (1 Week)|Lost to Follow-up|2
4685663|NCT02500758|16134114|P1|Washout (1 Week)|Lost to Follow-up|2
4685664|NCT02500758|16134113|P2|First Intervention (2 Minutes)|Withdrawal by Subject|1
4685665|NCT02500758|16134114|P1|First Intervention (2 Minutes)|Withdrawal by Subject|0
4685666|NCT02500732|16134124|P2|Overall Study|Physician Decision|1
4685667|NCT02500732|16134125|P1|Overall Study|Physician Decision|0
4685668|NCT02500706|16134142|P3|Overall Study|Unclassified|1
4685669|NCT02500706|16134143|P2|Overall Study|Unclassified|0
4685670|NCT02500706|16134144|P1|Overall Study|Unclassified|0
4685671|NCT02500706|16134142|P3|Overall Study|Withdrawal by Subject|4
4685672|NCT02500706|16134143|P2|Overall Study|Withdrawal by Subject|6
4685673|NCT02500706|16134144|P1|Overall Study|Withdrawal by Subject|4
4685674|NCT02500706|16134142|P3|Overall Study|Lost to Follow-up|1
4685675|NCT02500706|16134143|P2|Overall Study|Lost to Follow-up|1
4685676|NCT02500706|16134144|P1|Overall Study|Lost to Follow-up|0
4685677|NCT02500706|16134142|P3|Overall Study|Adverse Event|1
4685678|NCT02500706|16134143|P2|Overall Study|Adverse Event|0
4685679|NCT02500706|16134144|P1|Overall Study|Adverse Event|0
4685680|NCT02500641|16134298|P2|Overall Study|Non compliance to study drug|1
4685681|NCT02500641|16134299|P1|Overall Study|Non compliance to study drug|0
4685682|NCT02500641|16134298|P2|Overall Study|Sponsor decision|0
4685683|NCT02500641|16134299|P1|Overall Study|Sponsor decision|1
4685684|NCT02500641|16134298|P2|Overall Study|Lost to Follow-up|0
4685685|NCT02500641|16134299|P1|Overall Study|Lost to Follow-up|1
4685686|NCT02500641|16134298|P2|Overall Study|Protocol Violation|2
4685687|NCT02500641|16134299|P1|Overall Study|Protocol Violation|1
4685688|NCT02500641|16134298|P2|Overall Study|Unable to follow study procedures|2
4685689|NCT02500641|16134299|P1|Overall Study|Unable to follow study procedures|3
4685690|NCT02500641|16134298|P2|Overall Study|Withdrawal by Subject|5
4685691|NCT02500641|16134299|P1|Overall Study|Withdrawal by Subject|4
4685692|NCT02500641|16134298|P2|Overall Study|Adverse Event|2
4685693|NCT02500641|16134299|P1|Overall Study|Adverse Event|0
4685694|NCT02500537|16134320|P2|Overall Study|Withdrawal by Subject|0
4685695|NCT02500537|16134321|P1|Overall Study|Withdrawal by Subject|1
4685696|NCT02500537|16134320|P2|Overall Study|Lost to Follow-up|1
4685697|NCT02500537|16134321|P1|Overall Study|Lost to Follow-up|0
4685698|NCT02500537|16134320|P2|Overall Study|Death|0
4685699|NCT02500537|16134321|P1|Overall Study|Death|2
4685700|NCT02500056|16134390|P2|Overall Study|Death|1
4685701|NCT02500056|16134391|P1|Overall Study|Death|3
4685702|NCT02500056|16134390|P2|Overall Study|Recurrence|0
4685703|NCT02500056|16134391|P1|Overall Study|Recurrence|1
4685704|NCT02500056|16134390|P2|Overall Study|Lost to Follow-up|7
4685705|NCT02500056|16134391|P1|Overall Study|Lost to Follow-up|3
4685706|NCT02499952|16134401|P1|Overall Study|Death|9
4685707|NCT02499952|16134401|P1|Overall Study|Lost to Follow-up|1
4685708|NCT02499900|16134410|P2|Extension Study Period|Other|2
4685709|NCT02499900|16134411|P1|Extension Study Period|Other|0
4685710|NCT02499900|16134410|P2|Extension Study Period|Lost to Follow-up|5
4685711|NCT02499900|16134411|P1|Extension Study Period|Lost to Follow-up|2
4685712|NCT02499900|16134410|P2|Extension Study Period|Pregnancy|2
4685713|NCT02499900|16134411|P1|Extension Study Period|Pregnancy|1
4685714|NCT02499900|16134410|P2|Extension Study Period|Physician Decision|5
4685715|NCT02499900|16134411|P1|Extension Study Period|Physician Decision|2
4685716|NCT02499900|16134410|P2|Extension Study Period|Withdrawal by Subject|2
4685717|NCT02499900|16134411|P1|Extension Study Period|Withdrawal by Subject|5
4685718|NCT02499900|16134410|P2|Extension Study Period|Adverse Event|4
4685719|NCT02499900|16134411|P1|Extension Study Period|Adverse Event|2
4685720|NCT02499900|16134410|P2|Completed Core, Continued Into Extension|Personal motivation|0
4685721|NCT02499900|16134411|P1|Completed Core, Continued Into Extension|Personal motivation|1
4685722|NCT02499900|16134410|P2|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0
4685723|NCT02499900|16134411|P1|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1
4685724|NCT02499900|16134410|P2|Completed Core, Continued Into Extension|Withdrawal by Subject|2
4685725|NCT02499900|16134411|P1|Completed Core, Continued Into Extension|Withdrawal by Subject|0
4685726|NCT02499900|16134410|P2|Completed Core, Continued Into Extension|Physician Decision|0
4685727|NCT02499900|16134411|P1|Completed Core, Continued Into Extension|Physician Decision|1
4685728|NCT02499900|16134410|P2|Core Study Period|Death|1
4685729|NCT02499900|16134411|P1|Core Study Period|Death|0
4685730|NCT02499900|16134410|P2|Core Study Period|Adverse Event|14
4685731|NCT02499900|16134411|P1|Core Study Period|Adverse Event|18
4685732|NCT02499900|16134410|P2|Core Study Period|Withdrawal by Subject|10
4685733|NCT02499900|16134411|P1|Core Study Period|Withdrawal by Subject|11
4685734|NCT02499900|16134410|P2|Core Study Period|Protocol Violation|0
4685735|NCT02499900|16134411|P1|Core Study Period|Protocol Violation|3
4685736|NCT02499900|16134410|P2|Core Study Period|Pregnancy|0
4685737|NCT02499900|16134411|P1|Core Study Period|Pregnancy|1
4685738|NCT02499900|16134410|P2|Core Study Period|Per sponsor request|1
4685739|NCT02499900|16134411|P1|Core Study Period|Per sponsor request|0
4685740|NCT02499900|16134410|P2|Core Study Period|Lost to Follow-up|2
4685741|NCT02499900|16134411|P1|Core Study Period|Lost to Follow-up|1
4685742|NCT02499900|16134410|P2|Core Study Period|Other|4
4685743|NCT02499900|16134411|P1|Core Study Period|Other|1
4685744|NCT02499783|16134442|P3|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2
4685745|NCT02499783|16134443|P2|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
4685746|NCT02499783|16134444|P1|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0
4685747|NCT02499783|16134442|P3|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9
4685748|NCT02499783|16134443|P2|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
4685749|NCT02499783|16134444|P1|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0
4685750|NCT02499783|16134442|P3|Open Label Period: Weeks 8 to 26|Withdrew Consent|2
4685751|NCT02499783|16134443|P2|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
4685752|NCT02499783|16134444|P1|Open Label Period: Weeks 8 to 26|Withdrew Consent|0
4685753|NCT02499783|16134442|P3|Open Label Period: Weeks 8 to 26|Adverse Event|16
4685754|NCT02499783|16134443|P2|Open Label Period: Weeks 8 to 26|Adverse Event|0
4685755|NCT02499783|16134444|P1|Open Label Period: Weeks 8 to 26|Adverse Event|0
4685756|NCT02499783|16134442|P3|DB Period: Weeks 0-8|Other|0
4685757|NCT02499783|16134443|P2|DB Period: Weeks 0-8|Other|1
4685758|NCT02499783|16134444|P1|DB Period: Weeks 0-8|Other|1
4685759|NCT02499783|16134442|P3|DB Period: Weeks 0-8|Withdrew Consent|0
4685760|NCT02499783|16134443|P2|DB Period: Weeks 0-8|Withdrew Consent|0
4685761|NCT02499783|16134444|P1|DB Period: Weeks 0-8|Withdrew Consent|1
4685762|NCT02499783|16134442|P3|DB Period: Weeks 0-8|Adverse Event|0
4685763|NCT02499783|16134443|P2|DB Period: Weeks 0-8|Adverse Event|6
4685764|NCT02499783|16134444|P1|DB Period: Weeks 0-8|Adverse Event|8
4685765|NCT02499783|16134442|P3|DB Period/Placebo-Controlled: Weeks 0-4|Other|0
4685766|NCT02499783|16134443|P2|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
4685767|NCT02499783|16134444|P1|DB Period/Placebo-Controlled: Weeks 0-4|Other|1
4685768|NCT02499783|16134442|P3|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
4685769|NCT02499783|16134443|P2|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0
4685770|NCT02499783|16134444|P1|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1
4685771|NCT02499783|16134442|P3|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0
4685772|NCT02499783|16134443|P2|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4
4685773|NCT02499783|16134444|P1|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2
4685774|NCT02499770|16134493|P2|Overall Study|Randomized but not enrolled|1
4685775|NCT02499770|16134494|P1|Overall Study|Randomized but not enrolled|0
4685776|NCT02499770|16134493|P2|Overall Study|Withdrawn by PI for compassionate reason|1
4685777|NCT02499770|16134494|P1|Overall Study|Withdrawn by PI for compassionate reason|0
4685778|NCT02499770|16134493|P2|Overall Study|Subject declined further treatment|0
4685779|NCT02499770|16134494|P1|Overall Study|Subject declined further treatment|1
4685780|NCT02499770|16134493|P2|Overall Study|Lost to Follow-up|2
4685781|NCT02499770|16134494|P1|Overall Study|Lost to Follow-up|0
4685782|NCT02499770|16134493|P2|Overall Study|Withdrawal by Subject|7
4685783|NCT02499770|16134494|P1|Overall Study|Withdrawal by Subject|0
4685784|NCT02499770|16134493|P2|Overall Study|Study completion|10
4685785|NCT02499770|16134494|P1|Overall Study|Study completion|1
4685786|NCT02499770|16134493|P2|Overall Study|Death|56
4685787|NCT02499770|16134494|P1|Overall Study|Death|17
4685788|NCT02499575|16134614|P2|Overall Study|Protocol Violation|1
4685789|NCT02499575|16134615|P1|Overall Study|Protocol Violation|0
4685790|NCT02499406|16134625|P1|Overall Study|missed 3 treatment sessions|4
4685791|NCT02499263|16134646|P1|Overall Study|Pregnancy|1
4685792|NCT02499263|16134646|P1|Overall Study|Participant's decision|3
4685793|NCT02499263|16134646|P1|Overall Study|Adverse Events/Serious Adverse Events|11
4685794|NCT02499263|16134646|P1|Overall Study|investigator's judgment|12
4685795|NCT02499263|16134646|P1|Overall Study|Lack of Efficacy|22
4685796|NCT02499263|16134646|P1|Overall Study|Participant's withdrawal of consent|4
4685797|NCT02499263|16134646|P1|Overall Study|Lost to Follow-up|9
4685798|NCT02499172|16134683|P4|Overall Study|Lost to Follow-up|0
4685799|NCT02499172|16134684|P3|Overall Study|Lost to Follow-up|0
4685800|NCT02499172|16134685|P2|Overall Study|Lost to Follow-up|64
4685801|NCT02499172|16134686|P1|Overall Study|Lost to Follow-up|65
4685802|NCT02499172|16134683|P4|Overall Study|Financial reason|436
4685803|NCT02499172|16134684|P3|Overall Study|Financial reason|523
4685804|NCT02499172|16134685|P2|Overall Study|Financial reason|0
4685805|NCT02499172|16134686|P1|Overall Study|Financial reason|0
4685806|NCT02499159|16134698|P2|30-Day Follow-Up Phone Call|Other|0
4685807|NCT02499159|16134699|P1|30-Day Follow-Up Phone Call|Other|1
4685808|NCT02499159|16134698|P2|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0
4685809|NCT02499159|16134699|P1|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2
4685810|NCT02499159|16134698|P2|30-Day Follow-Up Phone Call|Lost to Follow-up|1
4685811|NCT02499159|16134699|P1|30-Day Follow-Up Phone Call|Lost to Follow-up|3
4685812|NCT02499159|16134698|P2|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
4685813|NCT02499159|16134699|P1|30-Day Follow-Up Phone Call|Withdrawal by Subject|1
4685814|NCT02499159|16134698|P2|Randomization|Protocol Violation|1
4685815|NCT02499159|16134699|P1|Randomization|Protocol Violation|1
4685816|NCT02499146|16134723|P1|Overall Study|Began other treatment/therapy|13
4685817|NCT02499146|16134723|P1|Overall Study|Ongoing at date of cut-off|9
4685818|NCT02499146|16134723|P1|Overall Study|Other|2
4685819|NCT02499146|16134723|P1|Overall Study|Withdrawal by Subject|1
4685820|NCT02499146|16134723|P1|Overall Study|Lost to Follow-up|1
4685821|NCT02499120|16134763|P2|Overall Study|Ongoing on study|11
4685822|NCT02499120|16134764|P1|Overall Study|Ongoing on study|15
4685823|NCT02499120|16134763|P2|Overall Study|Other|0
4685824|NCT02499120|16134764|P1|Overall Study|Other|1
4685825|NCT02499120|16134763|P2|Overall Study|Withdrawal by Subject|5
4685826|NCT02499120|16134764|P1|Overall Study|Withdrawal by Subject|2
4685827|NCT02499120|16134763|P2|Overall Study|Participant refused further follow-up|0
4685828|NCT02499120|16134764|P1|Overall Study|Participant refused further follow-up|1
4685829|NCT02499120|16134763|P2|Overall Study|Lost to Follow-up|2
4685830|NCT02499120|16134764|P1|Overall Study|Lost to Follow-up|1
4685831|NCT02499120|16134763|P2|Overall Study|Death|42
4685832|NCT02499120|16134764|P1|Overall Study|Death|45
4685833|NCT02499029|16134795|P2|Overall Study|Death|0
4685834|NCT02499029|16134796|P1|Overall Study|Death|1
4685835|NCT02499029|16134795|P2|Overall Study|Physician Decision|1
4685836|NCT02499029|16134796|P1|Overall Study|Physician Decision|2
4685837|NCT02499029|16134795|P2|Overall Study|Lost to Follow-up|2
4685838|NCT02499029|16134796|P1|Overall Study|Lost to Follow-up|2
4685839|NCT02498821|16134823|P2|Overall Study|Screen failure|5
4685840|NCT02498821|16134824|P1|Overall Study|Screen failure|3
4685841|NCT02498678|16134868|P2|Overall Study|interference from the surgical team|2
4685842|NCT02498678|16134869|P1|Overall Study|interference from the surgical team|0
4685843|NCT02498652|16134885|P2|Overall Study|Protocol Violation|1
4685844|NCT02498652|16134886|P1|Overall Study|Protocol Violation|0
4685845|NCT02498418|16135029|P3|Overall Study|Participant taken prohibited medication|1
4685846|NCT02498418|16135030|P2|Overall Study|Participant taken prohibited medication|1
4685847|NCT02498418|16135031|P1|Overall Study|Participant taken prohibited medication|0
4685848|NCT02498418|16135029|P3|Overall Study|Lost to Follow-up|1
4685849|NCT02498418|16135030|P2|Overall Study|Lost to Follow-up|1
4685850|NCT02498418|16135031|P1|Overall Study|Lost to Follow-up|0
4685851|NCT02498418|16135029|P3|Overall Study|Withdrawal by Subject|3
4685852|NCT02498418|16135030|P2|Overall Study|Withdrawal by Subject|0
4685853|NCT02498418|16135031|P1|Overall Study|Withdrawal by Subject|2
4685854|NCT02498418|16135029|P3|Overall Study|Lack of Efficacy|1
4685855|NCT02498418|16135030|P2|Overall Study|Lack of Efficacy|0
4685856|NCT02498418|16135031|P1|Overall Study|Lack of Efficacy|0
4685857|NCT02498236|16135055|P8|Overall Study|Withdrawal by Subject|0
4685858|NCT02498236|16135056|P7|Overall Study|Withdrawal by Subject|0
4685859|NCT02498236|16135057|P6|Overall Study|Withdrawal by Subject|0
4685860|NCT02498236|16135058|P5|Overall Study|Withdrawal by Subject|1
4685861|NCT02498236|16135059|P4|Overall Study|Withdrawal by Subject|0
4685862|NCT02498236|16135060|P3|Overall Study|Withdrawal by Subject|0
4685863|NCT02498236|16135061|P2|Overall Study|Withdrawal by Subject|0
4685864|NCT02498236|16135062|P1|Overall Study|Withdrawal by Subject|0
4685865|NCT02498236|16135055|P8|Overall Study|Equipment failure|0
4685866|NCT02498236|16135056|P7|Overall Study|Equipment failure|1
4685867|NCT02498236|16135057|P6|Overall Study|Equipment failure|0
4685868|NCT02498236|16135058|P5|Overall Study|Equipment failure|0
4685869|NCT02498236|16135059|P4|Overall Study|Equipment failure|0
4685870|NCT02498236|16135060|P3|Overall Study|Equipment failure|0
4685871|NCT02498236|16135061|P2|Overall Study|Equipment failure|0
4685872|NCT02498236|16135062|P1|Overall Study|Equipment failure|0
4685873|NCT02498236|16135055|P8|Overall Study|Did not show for testing|1
4685874|NCT02498236|16135056|P7|Overall Study|Did not show for testing|0
4685875|NCT02498236|16135057|P6|Overall Study|Did not show for testing|0
4685876|NCT02498236|16135058|P5|Overall Study|Did not show for testing|0
4685877|NCT02498236|16135059|P4|Overall Study|Did not show for testing|0
4685878|NCT02498236|16135060|P3|Overall Study|Did not show for testing|0
4685879|NCT02498236|16135061|P2|Overall Study|Did not show for testing|0
4685880|NCT02498236|16135062|P1|Overall Study|Did not show for testing|1
4685881|NCT02498067|16135091|P1|Overall Study|Did not meet inclusion criteria|11
4685882|NCT02498067|16135091|P1|Overall Study|Lost to Follow-up|22
4685883|NCT02497976|16135112|P2|Overall Study|Moved out of area|1
4685884|NCT02497976|16135113|P1|Overall Study|Moved out of area|0
4685885|NCT02497976|16135112|P2|Overall Study|Withdrawal by Subject|0
4685886|NCT02497976|16135113|P1|Overall Study|Withdrawal by Subject|2
4685887|NCT02497781|16135208|P2|Overall Study|Lost to Follow-up|1
4685888|NCT02497781|16135209|P1|Overall Study|Lost to Follow-up|1
4685889|NCT02497781|16135208|P2|Overall Study|Randomised but not treated|1
4685890|NCT02497781|16135209|P1|Overall Study|Randomised but not treated|1
4685891|NCT02497781|16135208|P2|Overall Study|Lack of Efficacy|1
4685892|NCT02497781|16135209|P1|Overall Study|Lack of Efficacy|0
4685893|NCT02497781|16135208|P2|Overall Study|Withdrawal by Subject|0
4685894|NCT02497781|16135209|P1|Overall Study|Withdrawal by Subject|2
4685895|NCT02497755|16135272|P2|Overall Study|Protocol Violation|0
4685896|NCT02497755|16135273|P1|Overall Study|Protocol Violation|1
4685897|NCT02497612|16135290|P4|Overall Study|Not eligible|1
4685898|NCT02497612|16135291|P3|Overall Study|Not eligible|0
4685899|NCT02497612|16135292|P2|Overall Study|Not eligible|0
4685900|NCT02497612|16135293|P1|Overall Study|Not eligible|1
4685901|NCT02497612|16135290|P4|Overall Study|Other unspecified|0
4685902|NCT02497612|16135291|P3|Overall Study|Other unspecified|2
4685903|NCT02497612|16135292|P2|Overall Study|Other unspecified|1
4685904|NCT02497612|16135293|P1|Overall Study|Other unspecified|1
4685905|NCT02497612|16135290|P4|Overall Study|Lost to Follow-up|1
4685906|NCT02497612|16135291|P3|Overall Study|Lost to Follow-up|0
4685907|NCT02497612|16135292|P2|Overall Study|Lost to Follow-up|1
4685908|NCT02497612|16135293|P1|Overall Study|Lost to Follow-up|1
4685909|NCT02497612|16135290|P4|Overall Study|Adverse Event|1
4685910|NCT02497612|16135291|P3|Overall Study|Adverse Event|4
4685911|NCT02497612|16135292|P2|Overall Study|Adverse Event|1
4685912|NCT02497612|16135293|P1|Overall Study|Adverse Event|3
4685913|NCT02497612|16135290|P4|Overall Study|Investigator's judgement|2
4685914|NCT02497612|16135291|P3|Overall Study|Investigator's judgement|0
4685915|NCT02497612|16135292|P2|Overall Study|Investigator's judgement|0
4685916|NCT02497612|16135293|P1|Overall Study|Investigator's judgement|1
4685917|NCT02497612|16135290|P4|Overall Study|Participant's request|1
4685918|NCT02497612|16135291|P3|Overall Study|Participant's request|4
4685919|NCT02497612|16135292|P2|Overall Study|Participant's request|3
4685920|NCT02497612|16135293|P1|Overall Study|Participant's request|2
4685921|NCT02497612|16135290|P4|Overall Study|Met >=1 anti-malarial treatment criteria|41
4685922|NCT02497612|16135291|P3|Overall Study|Met >=1 anti-malarial treatment criteria|39
4685923|NCT02497612|16135292|P2|Overall Study|Met >=1 anti-malarial treatment criteria|51
4685924|NCT02497612|16135293|P1|Overall Study|Met >=1 anti-malarial treatment criteria|57
4685925|NCT02497469|16135421|P2|Overall Study|Reason not Specified|6
4685926|NCT02497469|16135422|P1|Overall Study|Reason not Specified|6
4685927|NCT02497469|16135421|P2|Overall Study|Lack of Efficacy|40
4685928|NCT02497469|16135422|P1|Overall Study|Lack of Efficacy|86
4685929|NCT02497469|16135421|P2|Overall Study|Pregnancy|1
4685930|NCT02497469|16135422|P1|Overall Study|Pregnancy|1
4685931|NCT02497469|16135421|P2|Overall Study|Voluntary Withdrawal|41
4685932|NCT02497469|16135422|P1|Overall Study|Voluntary Withdrawal|39
4685933|NCT02497469|16135421|P2|Overall Study|Lost to Follow-up|4
4685934|NCT02497469|16135422|P1|Overall Study|Lost to Follow-up|14
4685935|NCT02497469|16135421|P2|Overall Study|Significant Protocol Deviation|5
4685936|NCT02497469|16135422|P1|Overall Study|Significant Protocol Deviation|4
4685937|NCT02497469|16135421|P2|Overall Study|Leukopenia or Lymphopenia|0
4685938|NCT02497469|16135422|P1|Overall Study|Leukopenia or Lymphopenia|1
4685939|NCT02497469|16135421|P2|Overall Study|Pretreatment Event/Adverse Event|16
4685940|NCT02497469|16135422|P1|Overall Study|Pretreatment Event/Adverse Event|18
4685941|NCT02497469|16135421|P2|Overall Study|Randomized but not Treated|2
4685942|NCT02497469|16135422|P1|Overall Study|Randomized but not Treated|0
4685943|NCT02497391|16135432|P6|Period 3 (14 Days)|Withdrawal by Subject|0
4685944|NCT02497391|16135433|P5|Period 3 (14 Days)|Withdrawal by Subject|0
4685945|NCT02497391|16135434|P4|Period 3 (14 Days)|Withdrawal by Subject|0
4685946|NCT02497391|16135435|P3|Period 3 (14 Days)|Withdrawal by Subject|1
4685947|NCT02497391|16135436|P2|Period 3 (14 Days)|Withdrawal by Subject|0
4685948|NCT02497391|16135437|P1|Period 3 (14 Days)|Withdrawal by Subject|0
4685949|NCT02497391|16135432|P6|Period 3 (14 Days)|Sponsor Decision|0
4685950|NCT02497391|16135433|P5|Period 3 (14 Days)|Sponsor Decision|1
4685951|NCT02497391|16135434|P4|Period 3 (14 Days)|Sponsor Decision|0
4685952|NCT02497391|16135435|P3|Period 3 (14 Days)|Sponsor Decision|0
4685953|NCT02497391|16135436|P2|Period 3 (14 Days)|Sponsor Decision|0
4685954|NCT02497391|16135437|P1|Period 3 (14 Days)|Sponsor Decision|0
4685955|NCT02497391|16135432|P6|Period 3 (14 Days)|Adverse Event|0
4685956|NCT02497391|16135433|P5|Period 3 (14 Days)|Adverse Event|0
4685957|NCT02497391|16135434|P4|Period 3 (14 Days)|Adverse Event|0
4685958|NCT02497391|16135435|P3|Period 3 (14 Days)|Adverse Event|0
4685959|NCT02497391|16135436|P2|Period 3 (14 Days)|Adverse Event|1
4685960|NCT02497391|16135437|P1|Period 3 (14 Days)|Adverse Event|0
4685961|NCT02497391|16135432|P6|Period 2 (14 Days)|Sponsor Decision|3
4685962|NCT02497391|16135433|P5|Period 2 (14 Days)|Sponsor Decision|2
4685963|NCT02497391|16135434|P4|Period 2 (14 Days)|Sponsor Decision|3
4685964|NCT02497391|16135435|P3|Period 2 (14 Days)|Sponsor Decision|2
4685965|NCT02497391|16135436|P2|Period 2 (14 Days)|Sponsor Decision|1
4685966|NCT02497391|16135437|P1|Period 2 (14 Days)|Sponsor Decision|3
4685967|NCT02497391|16135432|P6|Period 2 (14 Days)|Withdrawal by Subject|0
4685968|NCT02497391|16135433|P5|Period 2 (14 Days)|Withdrawal by Subject|0
4685969|NCT02497391|16135434|P4|Period 2 (14 Days)|Withdrawal by Subject|0
4685970|NCT02497391|16135435|P3|Period 2 (14 Days)|Withdrawal by Subject|1
4685971|NCT02497391|16135436|P2|Period 2 (14 Days)|Withdrawal by Subject|0
4685972|NCT02497391|16135437|P1|Period 2 (14 Days)|Withdrawal by Subject|1
4685973|NCT02497287|16135448|P1|Follow-up Phase (4 Week)|Other|1
4685974|NCT02497287|16135448|P1|Follow-up Phase (4 Week)|Adverse Event|3
4685975|NCT02497287|16135448|P1|Follow-up Phase (4 Week)|Lost to Follow-up|5
4685976|NCT02497287|16135448|P1|Follow-up Phase (4 Week)|Withdrawal by Subject|10
4685977|NCT02497287|16135448|P1|Follow-up Phase (4 Week)|PI Decision|12
4685978|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1
4685979|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Death|2
4685980|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Pregnancy|2
4685981|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3
4685982|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Protocol Violation|3
4685983|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10
4685984|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Other|21
4685985|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25
4685986|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Adverse Event|25
4685987|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30
4685988|NCT02497287|16135448|P1|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331
4685989|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1
4685990|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Protocol Violation|1
4685991|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Lost to Follow-up|5
4685992|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Other|13
4685993|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Lack of Efficacy|21
4685994|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Withdrawal by Subject|22
4685995|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Adverse Event|52
4685996|NCT02497287|16135448|P1|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84
4685997|NCT02496884|16135543|P4|Overall Study|Withdrawal by Subject|0
4685998|NCT02496884|16135544|P3|Overall Study|Withdrawal by Subject|0
4685999|NCT02496884|16135545|P2|Overall Study|Withdrawal by Subject|3
4686000|NCT02496884|16135546|P1|Overall Study|Withdrawal by Subject|0
4686001|NCT02496884|16135543|P4|Overall Study|Counted twice as enrolled|0
4686002|NCT02496884|16135544|P3|Overall Study|Counted twice as enrolled|0
4686003|NCT02496884|16135545|P2|Overall Study|Counted twice as enrolled|0
4686004|NCT02496884|16135546|P1|Overall Study|Counted twice as enrolled|2
4686005|NCT02496767|16135572|P8|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
4686006|NCT02496767|16135573|P7|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
4686007|NCT02496767|16135574|P6|Double-blind, Withdrawal Phase|Withdrawal by Subject|1
4686008|NCT02496767|16135575|P5|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4686009|NCT02496767|16135576|P4|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4686010|NCT02496767|16135577|P3|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4686011|NCT02496767|16135578|P2|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4686012|NCT02496767|16135579|P1|Double-blind, Withdrawal Phase|Withdrawal by Subject|0
4686013|NCT02496767|16135572|P8|Double-blind, Withdrawal Phase|Death|2
4686014|NCT02496767|16135573|P7|Double-blind, Withdrawal Phase|Death|1
4686015|NCT02496767|16135574|P6|Double-blind, Withdrawal Phase|Death|0
4686016|NCT02496767|16135575|P5|Double-blind, Withdrawal Phase|Death|0
4686017|NCT02496767|16135576|P4|Double-blind, Withdrawal Phase|Death|0
4686018|NCT02496767|16135577|P3|Double-blind, Withdrawal Phase|Death|0
4686019|NCT02496767|16135578|P2|Double-blind, Withdrawal Phase|Death|0
4686020|NCT02496767|16135579|P1|Double-blind, Withdrawal Phase|Death|0
4686021|NCT02496767|16135572|P8|Double-blind, Withdrawal Phase|Adverse Event|1
4686022|NCT02496767|16135573|P7|Double-blind, Withdrawal Phase|Adverse Event|2
4686023|NCT02496767|16135574|P6|Double-blind, Withdrawal Phase|Adverse Event|1
4686024|NCT02496767|16135575|P5|Double-blind, Withdrawal Phase|Adverse Event|0
4686025|NCT02496767|16135576|P4|Double-blind, Withdrawal Phase|Adverse Event|0
4686026|NCT02496767|16135577|P3|Double-blind, Withdrawal Phase|Adverse Event|0
4686027|NCT02496767|16135578|P2|Double-blind, Withdrawal Phase|Adverse Event|0
4686028|NCT02496767|16135579|P1|Double-blind, Withdrawal Phase|Adverse Event|0
4686029|NCT02496767|16135572|P8|Double-blind, Withdrawal Phase|Progressive disease|1
4686030|NCT02496767|16135573|P7|Double-blind, Withdrawal Phase|Progressive disease|0
4686031|NCT02496767|16135574|P6|Double-blind, Withdrawal Phase|Progressive disease|4
4686032|NCT02496767|16135575|P5|Double-blind, Withdrawal Phase|Progressive disease|0
4686033|NCT02496767|16135576|P4|Double-blind, Withdrawal Phase|Progressive disease|0
4686034|NCT02496767|16135577|P3|Double-blind, Withdrawal Phase|Progressive disease|0
4686035|NCT02496767|16135578|P2|Double-blind, Withdrawal Phase|Progressive disease|0
4686036|NCT02496767|16135579|P1|Double-blind, Withdrawal Phase|Progressive disease|0
4686037|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686038|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686039|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686040|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686041|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686042|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686043|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Protocol Violation|1
4686044|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Protocol Violation|0
4686045|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4686046|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4686047|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4686048|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1
4686049|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
4686050|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4686051|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
4686052|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4686053|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Physician Decision|0
4686054|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Physician Decision|0
4686055|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Physician Decision|0
4686056|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Physician Decision|0
4686057|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Physician Decision|0
4686058|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Physician Decision|1
4686059|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Physician Decision|4
4686060|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
4686061|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4686062|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4686063|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4686064|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2
4686065|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1
4686066|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3
4686067|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4
4686068|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4686069|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Various|0
4686070|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Various|0
4686071|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Various|0
4686072|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Various|2
4686073|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Various|5
4686074|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Various|4
4686075|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Various|9
4686076|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Various|0
4686077|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Death|0
4686078|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Death|0
4686079|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Death|0
4686080|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Death|4
4686081|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Death|2
4686082|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Death|6
4686083|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Death|10
4686084|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Death|0
4686085|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Progressive disease|0
4686086|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Progressive disease|0
4686087|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Progressive disease|0
4686088|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Progressive disease|14
4686089|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Progressive disease|8
4686090|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Progressive disease|9
4686091|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Progressive disease|13
4686092|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Progressive disease|0
4686093|NCT02496767|16135572|P8|Double-blind, Placebo-controlled Phase|Adverse Event|0
4686094|NCT02496767|16135573|P7|Double-blind, Placebo-controlled Phase|Adverse Event|0
4686095|NCT02496767|16135574|P6|Double-blind, Placebo-controlled Phase|Adverse Event|0
4686096|NCT02496767|16135575|P5|Double-blind, Placebo-controlled Phase|Adverse Event|43
4686097|NCT02496767|16135576|P4|Double-blind, Placebo-controlled Phase|Adverse Event|43
4686098|NCT02496767|16135577|P3|Double-blind, Placebo-controlled Phase|Adverse Event|23
4686099|NCT02496767|16135578|P2|Double-blind, Placebo-controlled Phase|Adverse Event|13
4686100|NCT02496767|16135579|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
4686101|NCT02496767|16135572|P8|Open-label Lead-in Phase|Lost to Follow-up|0
4686102|NCT02496767|16135573|P7|Open-label Lead-in Phase|Lost to Follow-up|0
4686103|NCT02496767|16135574|P6|Open-label Lead-in Phase|Lost to Follow-up|0
4686104|NCT02496767|16135575|P5|Open-label Lead-in Phase|Lost to Follow-up|0
4686105|NCT02496767|16135576|P4|Open-label Lead-in Phase|Lost to Follow-up|0
4686106|NCT02496767|16135577|P3|Open-label Lead-in Phase|Lost to Follow-up|0
4686107|NCT02496767|16135578|P2|Open-label Lead-in Phase|Lost to Follow-up|0
4686108|NCT02496767|16135579|P1|Open-label Lead-in Phase|Lost to Follow-up|1
4686109|NCT02496767|16135572|P8|Open-label Lead-in Phase|Protocol Violation|0
4686110|NCT02496767|16135573|P7|Open-label Lead-in Phase|Protocol Violation|0
4686111|NCT02496767|16135574|P6|Open-label Lead-in Phase|Protocol Violation|0
4686112|NCT02496767|16135575|P5|Open-label Lead-in Phase|Protocol Violation|0
4686113|NCT02496767|16135576|P4|Open-label Lead-in Phase|Protocol Violation|0
4686114|NCT02496767|16135577|P3|Open-label Lead-in Phase|Protocol Violation|0
4686115|NCT02496767|16135578|P2|Open-label Lead-in Phase|Protocol Violation|0
4686116|NCT02496767|16135579|P1|Open-label Lead-in Phase|Protocol Violation|2
4686117|NCT02496767|16135572|P8|Open-label Lead-in Phase|Adverse Event|0
4686118|NCT02496767|16135573|P7|Open-label Lead-in Phase|Adverse Event|0
4686119|NCT02496767|16135574|P6|Open-label Lead-in Phase|Adverse Event|0
4686120|NCT02496767|16135575|P5|Open-label Lead-in Phase|Adverse Event|0
4686121|NCT02496767|16135576|P4|Open-label Lead-in Phase|Adverse Event|0
4686122|NCT02496767|16135577|P3|Open-label Lead-in Phase|Adverse Event|0
4686123|NCT02496767|16135578|P2|Open-label Lead-in Phase|Adverse Event|0
4686124|NCT02496767|16135579|P1|Open-label Lead-in Phase|Adverse Event|176
4686125|NCT02496702|16135619|P2|Overall Study|Only partially tested|2
4686126|NCT02496702|16135620|P1|Overall Study|Only partially tested|0
4686127|NCT02496702|16135619|P2|Overall Study|Lost to Follow-up|6
4686128|NCT02496702|16135620|P1|Overall Study|Lost to Follow-up|8
4686129|NCT02496533|16135642|P2|Overall Study|Late for radiologic testing|2
4686130|NCT02496533|16135643|P1|Overall Study|Late for radiologic testing|0
4686131|NCT02496533|16135642|P2|Overall Study|Patient did not complete all measures|4
4686132|NCT02496533|16135643|P1|Overall Study|Patient did not complete all measures|0
4686133|NCT02496533|16135642|P2|Overall Study|Lack of data on outcome|0
4686134|NCT02496533|16135643|P1|Overall Study|Lack of data on outcome|3
4686135|NCT02496221|16135655|P2|Treatment Period 2 - 4 Days|Physician Decision|0
4686136|NCT02496221|16135656|P1|Treatment Period 2 - 4 Days|Physician Decision|1
4686137|NCT02496221|16135655|P2|Treatment Period 2 - 4 Days|Protocol Violation|0
4686138|NCT02496221|16135656|P1|Treatment Period 2 - 4 Days|Protocol Violation|1
4686139|NCT02496221|16135655|P2|Treatment Period 2 - 4 Days|Adverse Event|1
4686140|NCT02496221|16135656|P1|Treatment Period 2 - 4 Days|Adverse Event|0
4686141|NCT02496091|16135690|P1|Overall Study|Eligibility criteria not fulfilled|2
4686142|NCT02496039|16135699|P1|Overall Study|Protocol Violation|1
4686143|NCT02496039|16135699|P1|Overall Study|Adverse Event|3
4686144|NCT02496000|16135714|P3|Overall Study|undetermined|0
4686145|NCT02496000|16135715|P2|Overall Study|undetermined|1
4686146|NCT02496000|16135716|P1|Overall Study|undetermined|0
4686147|NCT02496000|16135714|P3|Overall Study|Non-compliance or lack of cooperation|0
4686148|NCT02496000|16135715|P2|Overall Study|Non-compliance or lack of cooperation|2
4686149|NCT02496000|16135716|P1|Overall Study|Non-compliance or lack of cooperation|0
4686150|NCT02496000|16135714|P3|Overall Study|Protocol Violation|1
4686151|NCT02496000|16135715|P2|Overall Study|Protocol Violation|0
4686152|NCT02496000|16135716|P1|Overall Study|Protocol Violation|0
4686153|NCT02496000|16135714|P3|Overall Study|Lost to Follow-up|1
4686154|NCT02496000|16135715|P2|Overall Study|Lost to Follow-up|0
4686155|NCT02496000|16135716|P1|Overall Study|Lost to Follow-up|1
4686156|NCT02496000|16135714|P3|Overall Study|Withdrawal by Subject|0
4686157|NCT02496000|16135715|P2|Overall Study|Withdrawal by Subject|2
4686158|NCT02496000|16135716|P1|Overall Study|Withdrawal by Subject|1
4686159|NCT02495948|16135737|P2|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
4686160|NCT02495948|16135738|P1|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1
4686161|NCT02495948|16135737|P2|Period 1, First 30 Days of Wear|Adverse Event|1
4686162|NCT02495948|16135738|P1|Period 1, First 30 Days of Wear|Adverse Event|0
4686163|NCT02495857|16135748|P3|Overall Study|Other|2
4686164|NCT02495857|16135749|P2|Overall Study|Other|3
4686165|NCT02495857|16135750|P1|Overall Study|Other|3
4686166|NCT02495857|16135748|P3|Overall Study|Lost to Follow-up|3
4686167|NCT02495857|16135749|P2|Overall Study|Lost to Follow-up|5
4686168|NCT02495857|16135750|P1|Overall Study|Lost to Follow-up|4
4686169|NCT02495857|16135748|P3|Overall Study|Protocol Violation|2
4686170|NCT02495857|16135749|P2|Overall Study|Protocol Violation|1
4686171|NCT02495857|16135750|P1|Overall Study|Protocol Violation|1
4686172|NCT02495857|16135748|P3|Overall Study|Physician Decision|0
4686173|NCT02495857|16135749|P2|Overall Study|Physician Decision|1
4686174|NCT02495857|16135750|P1|Overall Study|Physician Decision|0
4686175|NCT02495857|16135748|P3|Overall Study|Withdrawal by Subject|10
4686176|NCT02495857|16135749|P2|Overall Study|Withdrawal by Subject|6
4686177|NCT02495857|16135750|P1|Overall Study|Withdrawal by Subject|9
4686178|NCT02495857|16135748|P3|Overall Study|Adverse Event|1
4686179|NCT02495857|16135749|P2|Overall Study|Adverse Event|0
4686180|NCT02495857|16135750|P1|Overall Study|Adverse Event|5
4686181|NCT02495844|16135766|P2|Overall Study|Hepatitis Positivity|1
4686182|NCT02495844|16135767|P1|Overall Study|Hepatitis Positivity|0
4686183|NCT02495844|16135766|P2|Overall Study|AE, non-fatal|1
4686184|NCT02495844|16135767|P1|Overall Study|AE, non-fatal|0
4686185|NCT02495844|16135766|P2|Overall Study|Lack of Efficacy|2
4686186|NCT02495844|16135767|P1|Overall Study|Lack of Efficacy|1
4686187|NCT02495233|16135890|P2|Overall Study|Miscellaneous|1
4686188|NCT02495233|16135891|P1|Overall Study|Miscellaneous|0
4686189|NCT02495168|16135920|P3|Overall Study|Lack of Efficacy|3
4686190|NCT02495168|16135921|P2|Overall Study|Lack of Efficacy|0
4686191|NCT02495168|16135922|P1|Overall Study|Lack of Efficacy|0
4686192|NCT02495168|16135920|P3|Overall Study|Adverse Event|3
4686193|NCT02495168|16135921|P2|Overall Study|Adverse Event|8
4686194|NCT02495168|16135922|P1|Overall Study|Adverse Event|4
4686195|NCT02495168|16135920|P3|Overall Study|Protocol Violation|1
4686196|NCT02495168|16135921|P2|Overall Study|Protocol Violation|10
4686197|NCT02495168|16135922|P1|Overall Study|Protocol Violation|0
4686198|NCT02495168|16135920|P3|Overall Study|Withdrawal by Subject|2
4686199|NCT02495168|16135921|P2|Overall Study|Withdrawal by Subject|4
4686200|NCT02495168|16135922|P1|Overall Study|Withdrawal by Subject|1
4686201|NCT02495168|16135920|P3|Overall Study|Lost to Follow-up|1
4686202|NCT02495168|16135921|P2|Overall Study|Lost to Follow-up|6
4686203|NCT02495168|16135922|P1|Overall Study|Lost to Follow-up|10
4686204|NCT02495168|16135920|P3|Overall Study|Physician Decision|0
4686205|NCT02495168|16135921|P2|Overall Study|Physician Decision|1
4686206|NCT02495168|16135922|P1|Overall Study|Physician Decision|1
4686207|NCT02495168|16135920|P3|Overall Study|Did not Complete Final Visit On Time|2
4686208|NCT02495168|16135921|P2|Overall Study|Did not Complete Final Visit On Time|3
4686209|NCT02495168|16135922|P1|Overall Study|Did not Complete Final Visit On Time|4
4686210|NCT02495168|16135920|P3|Overall Study|Other than Specified|5
4686211|NCT02495168|16135921|P2|Overall Study|Other than Specified|22
4686212|NCT02495168|16135922|P1|Overall Study|Other than Specified|18
4686213|NCT02495025|16135981|P2|Overall Study|Withdrawal by Subject|0
4686214|NCT02495025|16135982|P1|Overall Study|Withdrawal by Subject|5
4686215|NCT02495025|16135981|P2|Overall Study|Lost to Follow-up|14
4686216|NCT02495025|16135982|P1|Overall Study|Lost to Follow-up|21
4686217|NCT02494596|16136034|P3|Overall Study|Refused Treatment|0
4686218|NCT02494596|16136035|P2|Overall Study|Refused Treatment|1
4686219|NCT02494596|16136036|P1|Overall Study|Refused Treatment|0
4686220|NCT02494596|16136034|P3|Overall Study|Adverse Event|0
4686221|NCT02494596|16136035|P2|Overall Study|Adverse Event|1
4686222|NCT02494596|16136036|P1|Overall Study|Adverse Event|0
4686223|NCT02494596|16136034|P3|Overall Study|Insufficient Therapeutic Response|1
4686224|NCT02494596|16136035|P2|Overall Study|Insufficient Therapeutic Response|3
4686225|NCT02494596|16136036|P1|Overall Study|Insufficient Therapeutic Response|3
4686226|NCT02494583|16136064|P3|Overall Study|Ongoing in Study|34
4686227|NCT02494583|16136065|P2|Overall Study|Ongoing in Study|51
4686228|NCT02494583|16136066|P1|Overall Study|Ongoing in Study|56
4686229|NCT02494583|16136064|P3|Overall Study|Withdrawal by Subject|15
4686230|NCT02494583|16136065|P2|Overall Study|Withdrawal by Subject|15
4686231|NCT02494583|16136066|P1|Overall Study|Withdrawal by Subject|3
4686232|NCT02494583|16136064|P3|Overall Study|Protocol Violation|0
4686233|NCT02494583|16136065|P2|Overall Study|Protocol Violation|2
4686234|NCT02494583|16136066|P1|Overall Study|Protocol Violation|1
4686235|NCT02494583|16136064|P3|Overall Study|Lost to Follow-up|0
4686236|NCT02494583|16136065|P2|Overall Study|Lost to Follow-up|0
4686237|NCT02494583|16136066|P1|Overall Study|Lost to Follow-up|1
4686238|NCT02494583|16136064|P3|Overall Study|Death|201
4686239|NCT02494583|16136065|P2|Overall Study|Death|189
4686240|NCT02494583|16136066|P1|Overall Study|Death|195
4686241|NCT02494401|16136164|P2|Overall Study|Withdrawal by Subject|2
4686242|NCT02494401|16136165|P1|Overall Study|Withdrawal by Subject|3
4686243|NCT02494401|16136164|P2|Overall Study|Lost to Follow-up|25
4686244|NCT02494401|16136165|P1|Overall Study|Lost to Follow-up|22
4686245|NCT02494206|16136217|P1|Overall Study|Disease Progression|1
4686246|NCT02494206|16136217|P1|Overall Study|Adverse Event|1
4686247|NCT02493946|16136271|P3|Open Label Period|Site error|1
4686248|NCT02493946|16136272|P2|Open Label Period|Site error|0
4686249|NCT02493946|16136273|P1|Open Label Period|Site error|0
4686250|NCT02493946|16136271|P3|Open Label Period|Pregnancy|3
4686251|NCT02493946|16136272|P2|Open Label Period|Pregnancy|0
4686252|NCT02493946|16136273|P1|Open Label Period|Pregnancy|0
4686253|NCT02493946|16136271|P3|Open Label Period|Investigator decision, non-availability|1
4686254|NCT02493946|16136272|P2|Open Label Period|Investigator decision, non-availability|0
4686255|NCT02493946|16136273|P1|Open Label Period|Investigator decision, non-availability|0
4686256|NCT02493946|16136271|P3|Open Label Period|Investigator decision, non-compliance|2
4686257|NCT02493946|16136272|P2|Open Label Period|Investigator decision, non-compliance|0
4686258|NCT02493946|16136273|P1|Open Label Period|Investigator decision, non-compliance|0
4686259|NCT02493946|16136271|P3|Open Label Period|Lost to Follow-up|1
4686260|NCT02493946|16136272|P2|Open Label Period|Lost to Follow-up|0
4686261|NCT02493946|16136273|P1|Open Label Period|Lost to Follow-up|0
4686262|NCT02493946|16136271|P3|Open Label Period|Adverse Event|4
4686263|NCT02493946|16136272|P2|Open Label Period|Adverse Event|0
4686264|NCT02493946|16136273|P1|Open Label Period|Adverse Event|0
4686265|NCT02493946|16136271|P3|Open Label Period|Withdrawal by Subject|74
4686266|NCT02493946|16136272|P2|Open Label Period|Withdrawal by Subject|0
4686267|NCT02493946|16136273|P1|Open Label Period|Withdrawal by Subject|0
4686268|NCT02493946|16136271|P3|DB Period|Withdrawal by Subject|0
4686269|NCT02493946|16136272|P2|DB Period|Withdrawal by Subject|5
4686270|NCT02493946|16136273|P1|DB Period|Withdrawal by Subject|8
4686271|NCT02493868|16136306|P2|Follow-up Phase|Other|1
4686272|NCT02493868|16136307|P1|Follow-up Phase|Other|2
4686273|NCT02493868|16136306|P2|Follow-up Phase|Investigator Decision|1
4686274|NCT02493868|16136307|P1|Follow-up Phase|Investigator Decision|5
4686275|NCT02493868|16136306|P2|Follow-up Phase|Withdrawal by Subject|0
4686276|NCT02493868|16136307|P1|Follow-up Phase|Withdrawal by Subject|3
4686277|NCT02493868|16136306|P2|Follow-up Phase|Lost to Follow-up|0
4686278|NCT02493868|16136307|P1|Follow-up Phase|Lost to Follow-up|1
4686279|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Other|9
4686280|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Other|4
4686281|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1
4686282|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0
4686283|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Pregnancy|0
4686284|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Pregnancy|1
4686285|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7
4686286|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5
4686287|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Protocol Violation|1
4686288|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Protocol Violation|1
4686289|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0
4686290|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1
4686291|NCT02493868|16136306|P2|Maintenance Phase: DE+TE Participants|Adverse Event|4
4686292|NCT02493868|16136307|P1|Maintenance Phase: DE+TE Participants|Adverse Event|1
4686293|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Other|2
4686294|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Other|10
4686295|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20
4686296|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107
4686297|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5
4686298|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14
4686299|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3
4686300|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8
4686301|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Protocol Violation|1
4686302|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Protocol Violation|4
4686303|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Lack of Efficacy|0
4686304|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Lack of Efficacy|8
4686305|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Lost to Follow-up|1
4686306|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Lost to Follow-up|2
4686307|NCT02493868|16136306|P2|Optimization Phase: DE+TE Participants|Adverse Event|0
4686308|NCT02493868|16136307|P1|Optimization Phase: DE+TE Participants|Adverse Event|5
4686309|NCT02493868|16136306|P2|Induction Phase: DE Participants|Other|0
4686310|NCT02493868|16136307|P1|Induction Phase: DE Participants|Other|8
4686311|NCT02493868|16136306|P2|Induction Phase: DE Participants|Not meet criteria to continue next phase|0
4686312|NCT02493868|16136307|P1|Induction Phase: DE Participants|Not meet criteria to continue next phase|114
4686313|NCT02493868|16136306|P2|Induction Phase: DE Participants|Withdrawal by Subject|0
4686314|NCT02493868|16136307|P1|Induction Phase: DE Participants|Withdrawal by Subject|15
4686315|NCT02493868|16136306|P2|Induction Phase: DE Participants|Protocol Violation|0
4686316|NCT02493868|16136307|P1|Induction Phase: DE Participants|Protocol Violation|2
4686317|NCT02493868|16136306|P2|Induction Phase: DE Participants|Lack of Efficacy|0
4686318|NCT02493868|16136307|P1|Induction Phase: DE Participants|Lack of Efficacy|2
4686319|NCT02493868|16136306|P2|Induction Phase: DE Participants|Lost to Follow-up|0
4686320|NCT02493868|16136307|P1|Induction Phase: DE Participants|Lost to Follow-up|1
4686321|NCT02493868|16136306|P2|Induction Phase: DE Participants|Adverse Event|0
4686322|NCT02493868|16136307|P1|Induction Phase: DE Participants|Adverse Event|22
4686323|NCT02493855|16136356|P3|Overall Study|Withdrawal by Subject|0
4686324|NCT02493855|16136357|P2|Overall Study|Withdrawal by Subject|0
4686325|NCT02493855|16136358|P1|Overall Study|Withdrawal by Subject|1
4686326|NCT02493855|16136356|P3|Overall Study|Adverse Event|0
4686327|NCT02493855|16136357|P2|Overall Study|Adverse Event|1
4686328|NCT02493855|16136358|P1|Overall Study|Adverse Event|0
4686329|NCT02493855|16136356|P3|Overall Study|Non-compliance|0
4686330|NCT02493855|16136357|P2|Overall Study|Non-compliance|0
4686331|NCT02493855|16136358|P1|Overall Study|Non-compliance|1
4686332|NCT02493777|16136368|P2|Overall Study|Lost to Follow-up|1
4686333|NCT02493777|16136369|P1|Overall Study|Lost to Follow-up|0
4686334|NCT02493764|16136379|P2|Overall Study|Withdrawal by Subject|7
4686335|NCT02493764|16136380|P1|Overall Study|Withdrawal by Subject|11
4686336|NCT02493764|16136379|P2|Overall Study|Withdrawal parent/guardian|1
4686337|NCT02493764|16136380|P1|Overall Study|Withdrawal parent/guardian|0
4686338|NCT02493764|16136379|P2|Overall Study|Participant moved|5
4686339|NCT02493764|16136380|P1|Overall Study|Participant moved|17
4686340|NCT02493764|16136379|P2|Overall Study|Physician Decision|1
4686341|NCT02493764|16136380|P1|Overall Study|Physician Decision|1
4686342|NCT02493764|16136379|P2|Overall Study|Protocol Violation|7
4686343|NCT02493764|16136380|P1|Overall Study|Protocol Violation|6
4686344|NCT02493764|16136379|P2|Overall Study|Lost to Follow-up|1
4686345|NCT02493764|16136380|P1|Overall Study|Lost to Follow-up|2
4686346|NCT02493764|16136379|P2|Overall Study|Death|58
4686347|NCT02493764|16136380|P1|Overall Study|Death|44
4686348|NCT02493764|16136379|P2|Overall Study|Adverse Event|2
4686349|NCT02493764|16136380|P1|Overall Study|Adverse Event|2
4686350|NCT02493751|16136430|P2|Overall Study|Ongoing|23
4686351|NCT02493751|16136431|P1|Overall Study|Ongoing|11
4686352|NCT02493751|16136430|P2|Overall Study|Withdrawal by Subject|5
4686353|NCT02493751|16136431|P1|Overall Study|Withdrawal by Subject|2
4686354|NCT02493751|16136430|P2|Overall Study|Lost to Follow-up|1
4686355|NCT02493751|16136431|P1|Overall Study|Lost to Follow-up|0
4686356|NCT02493712|16136439|P3|Overall Study|Lack of Efficacy|3
4686357|NCT02493712|16136440|P2|Overall Study|Lack of Efficacy|5
4686358|NCT02493712|16136441|P1|Overall Study|Lack of Efficacy|0
4686359|NCT02493712|16136439|P3|Overall Study|Physician Decision|0
4686360|NCT02493712|16136440|P2|Overall Study|Physician Decision|1
4686361|NCT02493712|16136441|P1|Overall Study|Physician Decision|0
4686362|NCT02493712|16136439|P3|Overall Study|Lost to Follow-up|0
4686363|NCT02493712|16136440|P2|Overall Study|Lost to Follow-up|0
4686364|NCT02493712|16136441|P1|Overall Study|Lost to Follow-up|1
4686365|NCT02493712|16136439|P3|Overall Study|Protocol Violation|1
4686366|NCT02493712|16136440|P2|Overall Study|Protocol Violation|0
4686367|NCT02493712|16136441|P1|Overall Study|Protocol Violation|0
4686368|NCT02493712|16136439|P3|Overall Study|Withdrawal by Subject|2
4686369|NCT02493712|16136440|P2|Overall Study|Withdrawal by Subject|0
4686370|NCT02493712|16136441|P1|Overall Study|Withdrawal by Subject|1
4686371|NCT02493517|16136478|P2|Overall Study|Missed study visit|1
4686372|NCT02493517|16136479|P1|Overall Study|Missed study visit|0
4686373|NCT02493517|16136478|P2|Overall Study|Adverse Event|2
4686374|NCT02493517|16136479|P1|Overall Study|Adverse Event|0
4686375|NCT02493517|16136478|P2|Overall Study|Withdrawal by Subject|2
4686376|NCT02493517|16136479|P1|Overall Study|Withdrawal by Subject|1
4686377|NCT02493517|16136478|P2|Overall Study|Protocol Violation|2
4686378|NCT02493517|16136479|P1|Overall Study|Protocol Violation|1
4686379|NCT02493127|16136559|P2|Overall Study|Lost to Follow-up|1
4686380|NCT02493127|16136560|P1|Overall Study|Lost to Follow-up|1
4686381|NCT02493062|16136578|P1|Overall Study|Physician Decision|12
4686382|NCT02492984|16136601|P2|Overall Study|Withdrawal by Subject|0
4686383|NCT02492984|16136602|P1|Overall Study|Withdrawal by Subject|1
4686384|NCT02492984|16136601|P2|Overall Study|Protocol Violation|0
4686385|NCT02492984|16136602|P1|Overall Study|Protocol Violation|1
4686386|NCT02492984|16136601|P2|Overall Study|Adverse Event|0
4686387|NCT02492984|16136602|P1|Overall Study|Adverse Event|1
4686388|NCT02492958|16136626|P4|Overall Study|Adverse Event|0
4686389|NCT02492958|16136627|P3|Overall Study|Adverse Event|1
4686390|NCT02492958|16136628|P2|Overall Study|Adverse Event|0
4686391|NCT02492958|16136629|P1|Overall Study|Adverse Event|1
4686392|NCT02492958|16136626|P4|Overall Study|Withdrawal by Subject|0
4686393|NCT02492958|16136627|P3|Overall Study|Withdrawal by Subject|1
4686394|NCT02492958|16136628|P2|Overall Study|Withdrawal by Subject|0
4686395|NCT02492958|16136629|P1|Overall Study|Withdrawal by Subject|0
4686396|NCT02492880|16136715|P1|Overall Study|Protocol Violation|1
4686397|NCT02492880|16136715|P1|Overall Study|Lost to Follow-up|1
4686398|NCT02492841|16136722|P3|Overall Study|Lost to Follow-up|35
4686399|NCT02492841|16136723|P2|Overall Study|Lost to Follow-up|31
4686400|NCT02492841|16136724|P1|Overall Study|Lost to Follow-up|34
4686401|NCT02492763|16136743|P4|Overall Study|Study Terminated by Sponsor|10
4686402|NCT02492763|16136744|P3|Overall Study|Study Terminated by Sponsor|6
4686403|NCT02492763|16136745|P2|Overall Study|Study Terminated by Sponsor|10
4686404|NCT02492763|16136746|P1|Overall Study|Study Terminated by Sponsor|13
4686405|NCT02492763|16136743|P4|Overall Study|Screen Failure|1
4686406|NCT02492763|16136744|P3|Overall Study|Screen Failure|0
4686407|NCT02492763|16136745|P2|Overall Study|Screen Failure|0
4686408|NCT02492763|16136746|P1|Overall Study|Screen Failure|0
4686409|NCT02492763|16136743|P4|Overall Study|Non-Compliance With Study Drug|0
4686410|NCT02492763|16136744|P3|Overall Study|Non-Compliance With Study Drug|0
4686411|NCT02492763|16136745|P2|Overall Study|Non-Compliance With Study Drug|1
4686412|NCT02492763|16136746|P1|Overall Study|Non-Compliance With Study Drug|0
4686413|NCT02492763|16136743|P4|Overall Study|Lost to Follow-up|0
4686414|NCT02492763|16136744|P3|Overall Study|Lost to Follow-up|1
4686415|NCT02492763|16136745|P2|Overall Study|Lost to Follow-up|0
4686416|NCT02492763|16136746|P1|Overall Study|Lost to Follow-up|0
4686417|NCT02492763|16136743|P4|Overall Study|Hyperglycemia Discontinuation Criteria|0
4686418|NCT02492763|16136744|P3|Overall Study|Hyperglycemia Discontinuation Criteria|0
4686419|NCT02492763|16136745|P2|Overall Study|Hyperglycemia Discontinuation Criteria|1
4686420|NCT02492763|16136746|P1|Overall Study|Hyperglycemia Discontinuation Criteria|0
4686421|NCT02492763|16136743|P4|Overall Study|Death|0
4686422|NCT02492763|16136744|P3|Overall Study|Death|1
4686423|NCT02492763|16136745|P2|Overall Study|Death|0
4686424|NCT02492763|16136746|P1|Overall Study|Death|0
4686425|NCT02492763|16136743|P4|Overall Study|Adverse Event|2
4686426|NCT02492763|16136744|P3|Overall Study|Adverse Event|1
4686427|NCT02492763|16136745|P2|Overall Study|Adverse Event|1
4686428|NCT02492763|16136746|P1|Overall Study|Adverse Event|3
4686429|NCT02492763|16136743|P4|Overall Study|Withdrawal by Subject|0
4686430|NCT02492763|16136744|P3|Overall Study|Withdrawal by Subject|1
4686431|NCT02492763|16136745|P2|Overall Study|Withdrawal by Subject|2
4686432|NCT02492763|16136746|P1|Overall Study|Withdrawal by Subject|0
4686433|NCT02492165|16136851|P4|Overall Study|Withdrawal by Subject|0
4686434|NCT02492165|16136852|P3|Overall Study|Withdrawal by Subject|0
4686435|NCT02492165|16136853|P2|Overall Study|Withdrawal by Subject|1
4686436|NCT02492165|16136854|P1|Overall Study|Withdrawal by Subject|0
4686437|NCT02492100|16136876|P1|Overall Study|Death|1
4686438|NCT02491892|16136905|P2|Overall Study|Lost to Follow-up|0
4686439|NCT02491892|16136906|P1|Overall Study|Lost to Follow-up|1
4686440|NCT02491892|16136905|P2|Overall Study|Refused Treatment|0
4686441|NCT02491892|16136906|P1|Overall Study|Refused Treatment|1
4686442|NCT02491892|16136905|P2|Overall Study|Lack of Efficacy|36
4686443|NCT02491892|16136906|P1|Overall Study|Lack of Efficacy|37
4686444|NCT02491892|16136905|P2|Overall Study|Death|1
4686445|NCT02491892|16136906|P1|Overall Study|Death|1
4686446|NCT02491892|16136905|P2|Overall Study|Adverse Event|1
4686447|NCT02491892|16136906|P1|Overall Study|Adverse Event|1
4686448|NCT02491684|16136961|P2|Treatment Phase|Investigator and Sponsor decision|1
4686449|NCT02491684|16136962|P1|Treatment Phase|Investigator and Sponsor decision|0
4686450|NCT02491684|16136961|P2|Treatment Phase|Incorrect randomisation|0
4686451|NCT02491684|16136962|P1|Treatment Phase|Incorrect randomisation|1
4686452|NCT02491684|16136961|P2|Treatment Phase|Adverse Event|2
4686453|NCT02491684|16136962|P1|Treatment Phase|Adverse Event|2
4686454|NCT02491463|16137000|P4|Overall Study|Lost to Follow-up|0
4686455|NCT02491463|16137001|P3|Overall Study|Lost to Follow-up|3
4686456|NCT02491463|16137002|P2|Overall Study|Lost to Follow-up|3
4686457|NCT02491463|16137003|P1|Overall Study|Lost to Follow-up|0
4686458|NCT02491463|16137000|P4|Overall Study|Migrated/moved from study area|1
4686459|NCT02491463|16137001|P3|Overall Study|Migrated/moved from study area|1
4686460|NCT02491463|16137002|P2|Overall Study|Migrated/moved from study area|5
4686461|NCT02491463|16137003|P1|Overall Study|Migrated/moved from study area|1
4686462|NCT02491463|16137000|P4|Overall Study|Withdrawal by Subject|0
4686463|NCT02491463|16137001|P3|Overall Study|Withdrawal by Subject|0
4686464|NCT02491463|16137002|P2|Overall Study|Withdrawal by Subject|2
4686465|NCT02491463|16137003|P1|Overall Study|Withdrawal by Subject|1
4686466|NCT02491411|16137106|P1|Overall Study|Physician Decision|4
4686467|NCT02491073|16137137|P2|Overall Study|screen failure|0
4686468|NCT02491073|16137138|P1|Overall Study|screen failure|1
4686469|NCT02490475|16137190|P4|Period 2: Extension Phase|Adverse Event|0
4686470|NCT02490475|16137191|P3|Period 2: Extension Phase|Adverse Event|1
4686471|NCT02490475|16137192|P2|Period 2: Extension Phase|Adverse Event|0
4686472|NCT02490475|16137193|P1|Period 2: Extension Phase|Adverse Event|0
4686473|NCT02490475|16137190|P4|Period 2: Extension Phase|Refused Treatment|1
4686474|NCT02490475|16137191|P3|Period 2: Extension Phase|Refused Treatment|0
4686475|NCT02490475|16137192|P2|Period 2: Extension Phase|Refused Treatment|0
4686476|NCT02490475|16137193|P1|Period 2: Extension Phase|Refused Treatment|0
4686477|NCT02490475|16137190|P4|Period 2: Extension Phase|Insufficient Therapeutic Response|0
4686478|NCT02490475|16137191|P3|Period 2: Extension Phase|Insufficient Therapeutic Response|2
4686479|NCT02490475|16137192|P2|Period 2: Extension Phase|Insufficient Therapeutic Response|0
4686480|NCT02490475|16137193|P1|Period 2: Extension Phase|Insufficient Therapeutic Response|1
4686481|NCT02490475|16137190|P4|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2
4686482|NCT02490475|16137191|P3|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4
4686483|NCT02490475|16137192|P2|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
4686484|NCT02490475|16137193|P1|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1
4686485|NCT02490475|16137190|P4|Period 1: First 6 Cycles|Refused Treatment|0
4686486|NCT02490475|16137191|P3|Period 1: First 6 Cycles|Refused Treatment|0
4686487|NCT02490475|16137192|P2|Period 1: First 6 Cycles|Refused Treatment|0
4686488|NCT02490475|16137193|P1|Period 1: First 6 Cycles|Refused Treatment|1
4686489|NCT02490475|16137190|P4|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4686490|NCT02490475|16137191|P3|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4686491|NCT02490475|16137192|P2|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0
4686492|NCT02490475|16137193|P1|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2
4686493|NCT02490475|16137190|P4|Period 1: First 6 Cycles|Adverse Event|1
4686494|NCT02490475|16137191|P3|Period 1: First 6 Cycles|Adverse Event|0
4686495|NCT02490475|16137192|P2|Period 1: First 6 Cycles|Adverse Event|1
4686496|NCT02490475|16137193|P1|Period 1: First 6 Cycles|Adverse Event|2
4686497|NCT02490371|16137271|P2|Overall Study|Lost to Follow-up|1
4686498|NCT02490371|16137272|P1|Overall Study|Lost to Follow-up|1
4686499|NCT02489981|16137299|P1|Overall Study|Other than listed|28
4686500|NCT02489981|16137299|P1|Overall Study|Lost to Follow-up|31
4686501|NCT02489981|16137299|P1|Overall Study|Improved|31
4686502|NCT02489981|16137299|P1|Overall Study|Insufficient effectiveness|16
4686503|NCT02489981|16137299|P1|Overall Study|Adverse Event|21
4686504|NCT02489968|16137306|P6|Double-blind Treatment Period|Other than specified above|0
4686505|NCT02489968|16137307|P5|Double-blind Treatment Period|Other than specified above|1
4686506|NCT02489968|16137308|P4|Double-blind Treatment Period|Other than specified above|0
4686507|NCT02489968|16137309|P3|Double-blind Treatment Period|Other than specified above|0
4686508|NCT02489968|16137310|P2|Double-blind Treatment Period|Other than specified above|0
4686509|NCT02489968|16137311|P1|Double-blind Treatment Period|Other than specified above|0
4686510|NCT02489968|16137306|P6|Double-blind Treatment Period|Withdrawal by Subject|2
4686511|NCT02489968|16137307|P5|Double-blind Treatment Period|Withdrawal by Subject|0
4686512|NCT02489968|16137308|P4|Double-blind Treatment Period|Withdrawal by Subject|2
4686513|NCT02489968|16137309|P3|Double-blind Treatment Period|Withdrawal by Subject|0
4686514|NCT02489968|16137310|P2|Double-blind Treatment Period|Withdrawal by Subject|0
4686515|NCT02489968|16137311|P1|Double-blind Treatment Period|Withdrawal by Subject|0
4686516|NCT02489968|16137306|P6|Double-blind Treatment Period|Protocol Violation|1
4686517|NCT02489968|16137307|P5|Double-blind Treatment Period|Protocol Violation|1
4686518|NCT02489968|16137308|P4|Double-blind Treatment Period|Protocol Violation|0
4686519|NCT02489968|16137309|P3|Double-blind Treatment Period|Protocol Violation|0
4686520|NCT02489968|16137310|P2|Double-blind Treatment Period|Protocol Violation|0
4686521|NCT02489968|16137311|P1|Double-blind Treatment Period|Protocol Violation|0
4686522|NCT02489968|16137306|P6|Double-blind Treatment Period|Adverse Event|5
4686523|NCT02489968|16137307|P5|Double-blind Treatment Period|Adverse Event|4
4686524|NCT02489968|16137308|P4|Double-blind Treatment Period|Adverse Event|6
4686525|NCT02489968|16137309|P3|Double-blind Treatment Period|Adverse Event|2
4686526|NCT02489968|16137310|P2|Double-blind Treatment Period|Adverse Event|0
4686527|NCT02489968|16137311|P1|Double-blind Treatment Period|Adverse Event|0
4686528|NCT02489968|16137306|P6|Open-label Treatment Period|Other than specified above|0
4686529|NCT02489968|16137307|P5|Open-label Treatment Period|Other than specified above|0
4686530|NCT02489968|16137308|P4|Open-label Treatment Period|Other than specified above|0
4686531|NCT02489968|16137309|P3|Open-label Treatment Period|Other than specified above|0
4686532|NCT02489968|16137310|P2|Open-label Treatment Period|Other than specified above|189
4686533|NCT02489968|16137311|P1|Open-label Treatment Period|Other than specified above|204
4686534|NCT02489968|16137306|P6|Open-label Treatment Period|Withdrawal by Subject|0
4686535|NCT02489968|16137307|P5|Open-label Treatment Period|Withdrawal by Subject|0
4686536|NCT02489968|16137308|P4|Open-label Treatment Period|Withdrawal by Subject|0
4686537|NCT02489968|16137309|P3|Open-label Treatment Period|Withdrawal by Subject|0
4686538|NCT02489968|16137310|P2|Open-label Treatment Period|Withdrawal by Subject|7
4686539|NCT02489968|16137311|P1|Open-label Treatment Period|Withdrawal by Subject|4
4686540|NCT02489968|16137306|P6|Open-label Treatment Period|Lost to Follow-up|0
4686541|NCT02489968|16137307|P5|Open-label Treatment Period|Lost to Follow-up|0
4686542|NCT02489968|16137308|P4|Open-label Treatment Period|Lost to Follow-up|0
4686543|NCT02489968|16137309|P3|Open-label Treatment Period|Lost to Follow-up|0
4686544|NCT02489968|16137310|P2|Open-label Treatment Period|Lost to Follow-up|3
4686545|NCT02489968|16137311|P1|Open-label Treatment Period|Lost to Follow-up|0
4686546|NCT02489968|16137306|P6|Open-label Treatment Period|Protocol Violation|0
4686547|NCT02489968|16137307|P5|Open-label Treatment Period|Protocol Violation|0
4686548|NCT02489968|16137308|P4|Open-label Treatment Period|Protocol Violation|0
4686549|NCT02489968|16137309|P3|Open-label Treatment Period|Protocol Violation|0
4686550|NCT02489968|16137310|P2|Open-label Treatment Period|Protocol Violation|2
4686551|NCT02489968|16137311|P1|Open-label Treatment Period|Protocol Violation|2
4686552|NCT02489968|16137306|P6|Open-label Treatment Period|Adverse Event|0
4686553|NCT02489968|16137307|P5|Open-label Treatment Period|Adverse Event|0
4686554|NCT02489968|16137308|P4|Open-label Treatment Period|Adverse Event|0
4686555|NCT02489968|16137309|P3|Open-label Treatment Period|Adverse Event|0
4686556|NCT02489968|16137310|P2|Open-label Treatment Period|Adverse Event|7
4686557|NCT02489968|16137311|P1|Open-label Treatment Period|Adverse Event|14
4686558|NCT02489799|16137325|P2|Overall Study|Death|1
4686559|NCT02489799|16137326|P1|Overall Study|Death|0
4686560|NCT02489799|16137325|P2|Overall Study|Withdrawal by Subject|1
4686561|NCT02489799|16137326|P1|Overall Study|Withdrawal by Subject|1
4686562|NCT02489799|16137325|P2|Overall Study|Failure to Maintain Eligibility|6
4686563|NCT02489799|16137326|P1|Overall Study|Failure to Maintain Eligibility|4
4686564|NCT02489799|16137325|P2|Overall Study|Lost to Follow-up|1
4686565|NCT02489799|16137326|P1|Overall Study|Lost to Follow-up|4
4686566|NCT02489773|16137352|P2|Overall Study|Leave the country or the state|1
4686567|NCT02489773|16137353|P1|Overall Study|Leave the country or the state|1
4686568|NCT02489773|16137352|P2|Overall Study|Withdrawal by Subject|0
4686569|NCT02489773|16137353|P1|Overall Study|Withdrawal by Subject|1
4686570|NCT02489773|16137352|P2|Overall Study|Physician Decision|0
4686571|NCT02489773|16137353|P1|Overall Study|Physician Decision|1
4686572|NCT02489773|16137352|P2|Overall Study|Lost to Follow-up|1
4686573|NCT02489773|16137353|P1|Overall Study|Lost to Follow-up|4
4686574|NCT02489500|16137363|P2|Overall Study|Death|1
4686575|NCT02489500|16137364|P1|Overall Study|Death|1
4686576|NCT02489344|16137382|P1|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2
4686577|NCT02489344|16137382|P1|LTS14116 (Extension Study): 31 Months|Adverse Event|1
4686578|NCT02489344|16137382|P1|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1
4686579|NCT02489344|16137382|P1|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1
4686580|NCT02489279|16137424|P2|Overall Study|Lost to Follow-up|10
4686581|NCT02489279|16137425|P1|Overall Study|Lost to Follow-up|12
4686582|NCT02488980|16137466|P3|Overall Study|Protocol Violation|2
4686583|NCT02488980|16137467|P2|Overall Study|Protocol Violation|2
4686584|NCT02488980|16137468|P1|Overall Study|Protocol Violation|2
4686585|NCT02488915|16137485|P1|Overall Study|Withdrawal by Subject|1
4686586|NCT02488915|16137485|P1|Overall Study|Lost to Follow-up|4
4686587|NCT02488915|16137485|P1|Overall Study|Death|21
4686588|NCT02488824|16137503|P2|Overall Study|Adverse Event|1
4686589|NCT02488824|16137504|P1|Overall Study|Adverse Event|1
4686590|NCT02488681|16137518|P1|Overall Study|Implant unsuccessful|7
4686591|NCT02488330|16137522|P1|Overall Study|Study Termination by Sponsor|4
4686592|NCT02488330|16137522|P1|Overall Study|Disease Progression|3
4686593|NCT02488330|16137522|P1|Overall Study|Death|2
4686594|NCT02488330|16137522|P1|Overall Study|Physician Decision|2
4686595|NCT02488330|16137522|P1|Overall Study|Adverse Event|1
4686596|NCT02488239|16137543|P1|Overall Study|Did not undergo implant procedure|1
4686597|NCT02488239|16137543|P1|Overall Study|Consent ineligible|1
4686598|NCT02488239|16137543|P1|Overall Study|Physician Decision|2
4686599|NCT02488239|16137543|P1|Overall Study|Withdrawal by Subject|3
4686600|NCT02488239|16137543|P1|Overall Study|Death|3
4686601|NCT02488005|16137560|P1|Overall Study|Lost to Follow-up|2
4686602|NCT02487979|16137570|P1|Overall Study|Progressive Disease|17
4686603|NCT02487979|16137570|P1|Overall Study|Withdrawal by Subject|2
4686604|NCT02487979|16137570|P1|Overall Study|Physician Decision|2
4686605|NCT02487810|16137582|P2|Overall Study|Withdrawal by Subject|0
4686606|NCT02487810|16137583|P1|Overall Study|Withdrawal by Subject|1
4686607|NCT02487771|16137615|P2|Overall Study|Withdrawal by Subject|5
4686608|NCT02487771|16137616|P1|Overall Study|Withdrawal by Subject|3
4686609|NCT02487771|16137615|P2|Overall Study|Moved out of area|6
4686610|NCT02487771|16137616|P1|Overall Study|Moved out of area|5
4686611|NCT02487771|16137615|P2|Overall Study|Lost to Follow-up|3
4686612|NCT02487771|16137616|P1|Overall Study|Lost to Follow-up|2
4686613|NCT02487498|16137782|P2|Period: Period 2|Physician Decision|0
4686614|NCT02487498|16137783|P1|Period: Period 2|Physician Decision|1
4686615|NCT02487498|16137782|P2|Period: Period 2|Death|1
4686616|NCT02487498|16137783|P1|Period: Period 2|Death|0
4686617|NCT02487498|16137782|P2|Period: Period 2|Lost to Follow-up|1
4686618|NCT02487498|16137783|P1|Period: Period 2|Lost to Follow-up|1
4686619|NCT02487498|16137782|P2|Period: Period 2|Subject/guardian decision|1
4686620|NCT02487498|16137783|P1|Period: Period 2|Subject/guardian decision|2
4686621|NCT02487498|16137782|P2|Period: Period 2|Adverse Event|2
4686622|NCT02487498|16137783|P1|Period: Period 2|Adverse Event|2
4686623|NCT02487498|16137782|P2|Period: Washout|Non-compliance with study treatment|1
4686624|NCT02487498|16137783|P1|Period: Washout|Non-compliance with study treatment|0
4686625|NCT02487498|16137782|P2|Period: Washout|Physician Decision|0
4686626|NCT02487498|16137783|P1|Period: Washout|Physician Decision|1
4686627|NCT02487498|16137782|P2|Period: Washout|Lack of Efficacy|1
4686628|NCT02487498|16137783|P1|Period: Washout|Lack of Efficacy|1
4686629|NCT02487498|16137782|P2|Period: Washout|Subject/guardian decision|5
4686630|NCT02487498|16137783|P1|Period: Washout|Subject/guardian decision|0
4686631|NCT02487498|16137782|P2|Period: Period 1|Protocol deviation|0
4686632|NCT02487498|16137783|P1|Period: Period 1|Protocol deviation|1
4686633|NCT02487498|16137782|P2|Period: Period 1|Physician Decision|1
4686634|NCT02487498|16137783|P1|Period: Period 1|Physician Decision|0
4686635|NCT02487498|16137782|P2|Period: Period 1|Lack of Efficacy|0
4686636|NCT02487498|16137783|P1|Period: Period 1|Lack of Efficacy|1
4686637|NCT02487498|16137782|P2|Period: Period 1|Lost to Follow-up|2
4686638|NCT02487498|16137783|P1|Period: Period 1|Lost to Follow-up|0
4686639|NCT02487498|16137782|P2|Period: Period 1|Subject/guardian decision|4
4686640|NCT02487498|16137783|P1|Period: Period 1|Subject/guardian decision|2
4686641|NCT02487498|16137782|P2|Period: Period 1|Adverse Event|4
4686642|NCT02487498|16137783|P1|Period: Period 1|Adverse Event|2
4686643|NCT02487472|16137827|P1|Overall Study|Other|2
4686644|NCT02487472|16137827|P1|Overall Study|Did not complete telephonic interviews|9
4686645|NCT02487446|16137843|P2|Period 2|Adverse Event|2
4686646|NCT02487446|16137844|P1|Period 2|Adverse Event|6
4686647|NCT02487446|16137843|P2|Period 2|Withdrawal by Subject|1
4686648|NCT02487446|16137844|P1|Period 2|Withdrawal by Subject|1
4686649|NCT02487446|16137843|P2|Period 2|Lost to Follow-up|1
4686650|NCT02487446|16137844|P1|Period 2|Lost to Follow-up|1
4686651|NCT02487446|16137843|P2|Period 2|Protocol deviation|1
4686652|NCT02487446|16137844|P1|Period 2|Protocol deviation|0
4686653|NCT02487446|16137843|P2|Washout|Adverse Event|2
4686654|NCT02487446|16137844|P1|Washout|Adverse Event|2
4686655|NCT02487446|16137843|P2|Washout|Withdrawal by Subject|4
4686656|NCT02487446|16137844|P1|Washout|Withdrawal by Subject|1
4686657|NCT02487446|16137843|P2|Washout|Lost to Follow-up|2
4686658|NCT02487446|16137844|P1|Washout|Lost to Follow-up|0
4686659|NCT02487446|16137843|P2|Period 1|Adverse Event|5
4686660|NCT02487446|16137844|P1|Period 1|Adverse Event|5
4686661|NCT02487446|16137843|P2|Period 1|Withdrawal by Subject|0
4686662|NCT02487446|16137844|P1|Period 1|Withdrawal by Subject|2
4686663|NCT02487446|16137843|P2|Period 1|Lost to Follow-up|0
4686664|NCT02487446|16137844|P1|Period 1|Lost to Follow-up|2
4686665|NCT02487446|16137843|P2|Period 1|Protocol deviation|2
4686666|NCT02487446|16137844|P1|Period 1|Protocol deviation|3
4686667|NCT02487446|16137843|P2|Period 1|Lack of Efficacy|0
4686668|NCT02487446|16137844|P1|Period 1|Lack of Efficacy|1
4686669|NCT02487446|16137843|P2|Period 1|Physician Decision|1
4686670|NCT02487446|16137844|P1|Period 1|Physician Decision|0
4686671|NCT02487199|16137924|P2|Overall Study|Withdrew Consent|1
4686672|NCT02487199|16137925|P1|Overall Study|Withdrew Consent|0
4686673|NCT02487030|16137950|P7|Overall Study|Death|0
4686674|NCT02487030|16137951|P6|Overall Study|Death|0
4686675|NCT02487030|16137952|P5|Overall Study|Death|1
4686676|NCT02487030|16137953|P4|Overall Study|Death|0
4686677|NCT02487030|16137954|P3|Overall Study|Death|0
4686678|NCT02487030|16137955|P2|Overall Study|Death|0
4686679|NCT02487030|16137956|P1|Overall Study|Death|0
4686680|NCT02487030|16137950|P7|Overall Study|Adverse Event|0
4686681|NCT02487030|16137951|P6|Overall Study|Adverse Event|0
4686682|NCT02487030|16137952|P5|Overall Study|Adverse Event|0
4686683|NCT02487030|16137953|P4|Overall Study|Adverse Event|1
4686684|NCT02487030|16137954|P3|Overall Study|Adverse Event|0
4686685|NCT02487030|16137955|P2|Overall Study|Adverse Event|0
4686686|NCT02487030|16137956|P1|Overall Study|Adverse Event|0
4686687|NCT02487030|16137950|P7|Overall Study|Lost to Follow-up|0
4686688|NCT02487030|16137951|P6|Overall Study|Lost to Follow-up|1
4686689|NCT02487030|16137952|P5|Overall Study|Lost to Follow-up|0
4686690|NCT02487030|16137953|P4|Overall Study|Lost to Follow-up|1
4686691|NCT02487030|16137954|P3|Overall Study|Lost to Follow-up|1
4686692|NCT02487030|16137955|P2|Overall Study|Lost to Follow-up|0
4686693|NCT02487030|16137956|P1|Overall Study|Lost to Follow-up|0
4686694|NCT02487030|16137950|P7|Overall Study|Lack of Efficacy|0
4686695|NCT02487030|16137951|P6|Overall Study|Lack of Efficacy|0
4686696|NCT02487030|16137952|P5|Overall Study|Lack of Efficacy|1
4686697|NCT02487030|16137953|P4|Overall Study|Lack of Efficacy|0
4686698|NCT02487030|16137954|P3|Overall Study|Lack of Efficacy|1
4686699|NCT02487030|16137955|P2|Overall Study|Lack of Efficacy|4
4686700|NCT02487030|16137956|P1|Overall Study|Lack of Efficacy|2
4686701|NCT02486952|16137987|P1|Overall Study|Other|2
4686702|NCT02486952|16137987|P1|Overall Study|Lost to Follow-up|26
4686703|NCT02486952|16137987|P1|Overall Study|Lack of Efficacy|3
4686704|NCT02486952|16137987|P1|Overall Study|Death|15
4686705|NCT02486952|16137987|P1|Overall Study|Adverse Event|1
4686706|NCT02486952|16137987|P1|Overall Study|Not Started Induction Therapy|3
4686707|NCT02486796|16138005|P2|Overall Study|Physician Decision|0
4686708|NCT02486796|16138006|P1|Overall Study|Physician Decision|1
4686709|NCT02486796|16138005|P2|Overall Study|Withdrawal by Subject|1
4686710|NCT02486796|16138006|P1|Overall Study|Withdrawal by Subject|1
4686711|NCT02486757|16138018|P1|Overall Study|Lost to Follow-up|1
4686712|NCT02486692|16138024|P2|Overall Study|did not login for randomization|7
4686713|NCT02486692|16138025|P1|Overall Study|did not login for randomization|4
4686714|NCT02486653|16138037|P2|Overall Study|surgery cancelled|1
4686715|NCT02486653|16138038|P1|Overall Study|surgery cancelled|4
4686716|NCT02486653|16138037|P2|Overall Study|Protocol Violation|0
4686717|NCT02486653|16138038|P1|Overall Study|Protocol Violation|1
4686718|NCT02486653|16138037|P2|Overall Study|Withdrawal by Subject|3
4686719|NCT02486653|16138038|P1|Overall Study|Withdrawal by Subject|1
4686720|NCT02486627|16138062|P2|Overall Study|Lost to Follow-up|3
4686721|NCT02486627|16138063|P1|Overall Study|Lost to Follow-up|1
4686722|NCT02486627|16138062|P2|Overall Study|Significant Participant Noncompliance|1
4686723|NCT02486627|16138063|P1|Overall Study|Significant Participant Noncompliance|1
4686724|NCT02486627|16138062|P2|Overall Study|Consent Withdrawn by Participant|3
4686725|NCT02486627|16138063|P1|Overall Study|Consent Withdrawn by Participant|4
4686726|NCT02486627|16138062|P2|Overall Study|Other Unspecified|2
4686727|NCT02486627|16138063|P1|Overall Study|Other Unspecified|0
4686728|NCT02486627|16138062|P2|Overall Study|Death|0
4686729|NCT02486627|16138063|P1|Overall Study|Death|1
4686730|NCT02486588|16138086|P6|Overall Study|Randomized in error- ineligible|746
4686731|NCT02486588|16138087|P5|Overall Study|Randomized in error- ineligible|746
4686732|NCT02486588|16138088|P4|Overall Study|Randomized in error- ineligible|738
4686733|NCT02486588|16138089|P3|Overall Study|Randomized in error- ineligible|755
4686734|NCT02486588|16138090|P2|Overall Study|Randomized in error- ineligible|750
4686735|NCT02486588|16138091|P1|Overall Study|Randomized in error- ineligible|738
4686736|NCT02486302|16138166|P1|Overall Study|Not treated|3
4686737|NCT02486302|16138166|P1|Overall Study|Excluded due to legal reasons|8
4686738|NCT02486302|16138166|P1|Overall Study|Documentation not completed|255
4686739|NCT02486302|16138166|P1|Overall Study|Discontinued prematurely|410
4686740|NCT02485925|16138263|P1|Overall Study|Lost to Follow-up|11
4686741|NCT02485925|16138263|P1|Overall Study|Death|1
4686742|NCT02485925|16138263|P1|Overall Study|Withdrawal by Subject|3
4686743|NCT02485717|16138295|P3|Overall Study|Did Not Meet Exclusion Criteria #12|0
4686744|NCT02485717|16138296|P2|Overall Study|Did Not Meet Exclusion Criteria #12|1
4686745|NCT02485717|16138297|P1|Overall Study|Did Not Meet Exclusion Criteria #12|0
4686746|NCT02485717|16138295|P3|Overall Study|Did Not Meet Exclusion Criteria #2|0
4686747|NCT02485717|16138296|P2|Overall Study|Did Not Meet Exclusion Criteria #2|1
4686748|NCT02485717|16138297|P1|Overall Study|Did Not Meet Exclusion Criteria #2|0
4686749|NCT02485717|16138295|P3|Overall Study|Withdrawal by Subject|1
4686750|NCT02485717|16138296|P2|Overall Study|Withdrawal by Subject|0
4686751|NCT02485717|16138297|P1|Overall Study|Withdrawal by Subject|0
4686752|NCT02485717|16138295|P3|Overall Study|Lost to Follow-up|0
4686753|NCT02485717|16138296|P2|Overall Study|Lost to Follow-up|0
4686754|NCT02485717|16138297|P1|Overall Study|Lost to Follow-up|6
4686755|NCT02485704|16138312|P2|Overall Study|Did Not Meet Inclusion Criteria #2|0
4686756|NCT02485704|16138313|P1|Overall Study|Did Not Meet Inclusion Criteria #2|1
4686757|NCT02485704|16138312|P2|Overall Study|Withdrawal by Subject|3
4686758|NCT02485704|16138313|P1|Overall Study|Withdrawal by Subject|0
4686759|NCT02485704|16138312|P2|Overall Study|Lost to Follow-up|5
4686760|NCT02485704|16138313|P1|Overall Study|Lost to Follow-up|4
4686761|NCT02485483|16138361|P2|Overall Study|Discontinued after baseline|0
4686762|NCT02485483|16138362|P1|Overall Study|Discontinued after baseline|39
4686763|NCT02485483|16138361|P2|Overall Study|Depression at baseline|0
4686764|NCT02485483|16138362|P1|Overall Study|Depression at baseline|15
4686765|NCT02485353|16138377|P1|Overall Study|Disease Progression|1
4686766|NCT02485353|16138377|P1|Overall Study|Death|1
4686767|NCT02485301|16138384|P2|Overall Study|Other|4
4686768|NCT02485301|16138385|P1|Overall Study|Other|3
4686769|NCT02485301|16138384|P2|Overall Study|Lost to Follow-up|17
4686770|NCT02485301|16138385|P1|Overall Study|Lost to Follow-up|17
4686771|NCT02485301|16138384|P2|Overall Study|Migrated/moved from study area|19
4686772|NCT02485301|16138385|P1|Overall Study|Migrated/moved from study area|10
4686773|NCT02485301|16138384|P2|Overall Study|Withdrawal by Subject|7
4686774|NCT02485301|16138385|P1|Overall Study|Withdrawal by Subject|6
4686775|NCT02485301|16138384|P2|Overall Study|Protocol Violation|1
4686776|NCT02485301|16138385|P1|Overall Study|Protocol Violation|0
4686777|NCT02485301|16138384|P2|Overall Study|Serious Adverse Events|1
4686778|NCT02485301|16138385|P1|Overall Study|Serious Adverse Events|2
4686779|NCT02485158|16138435|P1|Overall Study|expected drug side effect|1
4686780|NCT02485158|16138435|P1|Overall Study|Withdrawal by Subject|3
4686781|NCT02484911|16138524|P2|Overall Study|Protocol Violation|1
4686782|NCT02484911|16138525|P1|Overall Study|Protocol Violation|2
4686783|NCT02484911|16138524|P2|Overall Study|Withdrawal by Subject|1
4686784|NCT02484911|16138525|P1|Overall Study|Withdrawal by Subject|2
4686785|NCT02484729|16138615|P10|Overall Study|Failure of IntelliCap Error|1
4686786|NCT02484729|16138616|P9|Overall Study|Failure of IntelliCap Error|0
4686787|NCT02484729|16138617|P8|Overall Study|Failure of IntelliCap Error|0
4686788|NCT02484729|16138618|P7|Overall Study|Failure of IntelliCap Error|0
4686789|NCT02484729|16138619|P6|Overall Study|Failure of IntelliCap Error|0
4686790|NCT02484729|16138620|P5|Overall Study|Failure of IntelliCap Error|0
4686791|NCT02484729|16138621|P4|Overall Study|Failure of IntelliCap Error|0
4686792|NCT02484729|16138622|P3|Overall Study|Failure of IntelliCap Error|0
4686793|NCT02484729|16138623|P2|Overall Study|Failure of IntelliCap Error|0
4686794|NCT02484729|16138624|P1|Overall Study|Failure of IntelliCap Error|0
4686795|NCT02484690|16138825|P5|Overall Study|Lost to Follow-up|0
4686796|NCT02484690|16138826|P4|Overall Study|Lost to Follow-up|0
4686797|NCT02484690|16138827|P3|Overall Study|Lost to Follow-up|1
4686798|NCT02484690|16138828|P2|Overall Study|Lost to Follow-up|0
4686799|NCT02484690|16138829|P1|Overall Study|Lost to Follow-up|0
4686800|NCT02484690|16138825|P5|Overall Study|Physician Decision|0
4686801|NCT02484690|16138826|P4|Overall Study|Physician Decision|0
4686802|NCT02484690|16138827|P3|Overall Study|Physician Decision|1
4686803|NCT02484690|16138828|P2|Overall Study|Physician Decision|0
4686804|NCT02484690|16138829|P1|Overall Study|Physician Decision|2
4686805|NCT02484690|16138825|P5|Overall Study|Withdrawal by Subject|0
4686806|NCT02484690|16138826|P4|Overall Study|Withdrawal by Subject|2
4686807|NCT02484690|16138827|P3|Overall Study|Withdrawal by Subject|1
4686808|NCT02484690|16138828|P2|Overall Study|Withdrawal by Subject|3
4686809|NCT02484690|16138829|P1|Overall Study|Withdrawal by Subject|1
4686810|NCT02484690|16138825|P5|Overall Study|Death|1
4686811|NCT02484690|16138826|P4|Overall Study|Death|0
4686812|NCT02484690|16138827|P3|Overall Study|Death|0
4686813|NCT02484690|16138828|P2|Overall Study|Death|0
4686814|NCT02484690|16138829|P1|Overall Study|Death|0
4686815|NCT02484690|16138825|P5|Overall Study|Adverse Event|5
4686816|NCT02484690|16138826|P4|Overall Study|Adverse Event|0
4686817|NCT02484690|16138827|P3|Overall Study|Adverse Event|0
4686818|NCT02484690|16138828|P2|Overall Study|Adverse Event|3
4686819|NCT02484690|16138829|P1|Overall Study|Adverse Event|1
4686820|NCT02484651|16138973|P2|Overall Study|Time of the procedure less than 90 min.|2
4686821|NCT02484651|16138974|P1|Overall Study|Time of the procedure less than 90 min.|1
4686822|NCT02484651|16138973|P2|Overall Study|BIS monitoring failed.|1
4686823|NCT02484651|16138974|P1|Overall Study|BIS monitoring failed.|1
4686824|NCT02484651|16138973|P2|Overall Study|Patients' data files were corrupted.|1
4686825|NCT02484651|16138974|P1|Overall Study|Patients' data files were corrupted.|1
4686826|NCT02483975|16139008|P2|Overall Study|Physician Decision|0
4686827|NCT02483975|16139009|P1|Overall Study|Physician Decision|2
4686828|NCT02483975|16139008|P2|Overall Study|Lost to Follow-up|1
4686829|NCT02483975|16139009|P1|Overall Study|Lost to Follow-up|0
4686830|NCT02483975|16139008|P2|Overall Study|Adverse Event|1
4686831|NCT02483975|16139009|P1|Overall Study|Adverse Event|0
4686832|NCT02483611|16139047|P3|Overall Study|Protocol Violation|1
4686833|NCT02483611|16139048|P2|Overall Study|Protocol Violation|0
4686834|NCT02483611|16139049|P1|Overall Study|Protocol Violation|0
4686835|NCT02483585|16139146|P2|Open-label Treatment Phase|Lost to Follow-up|5
4686836|NCT02483585|16139147|P1|Open-label Treatment Phase|Lost to Follow-up|3
4686837|NCT02483585|16139146|P2|Open-label Treatment Phase|Withdrawal by Subject|14
4686838|NCT02483585|16139147|P1|Open-label Treatment Phase|Withdrawal by Subject|18
4686839|NCT02483585|16139146|P2|Open-label Treatment Phase|Decision by Sponsor|1
4686840|NCT02483585|16139147|P1|Open-label Treatment Phase|Decision by Sponsor|0
4686841|NCT02483585|16139146|P2|Open-label Treatment Phase|Protocol-specified Criteria|5
4686842|NCT02483585|16139147|P1|Open-label Treatment Phase|Protocol-specified Criteria|6
4686843|NCT02483585|16139146|P2|Double-blind Treatment Phase|Lost to Follow-up|2
4686844|NCT02483585|16139147|P1|Double-blind Treatment Phase|Lost to Follow-up|3
4686845|NCT02483585|16139146|P2|Double-blind Treatment Phase|Withdrawal by Subject|12
4686846|NCT02483585|16139147|P1|Double-blind Treatment Phase|Withdrawal by Subject|12
4686847|NCT02483585|16139146|P2|Double-blind Treatment Phase|Decision by Sponsor|1
4686848|NCT02483585|16139147|P1|Double-blind Treatment Phase|Decision by Sponsor|1
4686849|NCT02483572|16139169|P2|Overall Study|Physician Decision|1
4686850|NCT02483572|16139170|P1|Overall Study|Physician Decision|0
4686851|NCT02483572|16139169|P2|Overall Study|Lost to Follow-up|0
4686852|NCT02483572|16139170|P1|Overall Study|Lost to Follow-up|1
4686853|NCT02483572|16139169|P2|Overall Study|Withdrawal by Subject|0
4686854|NCT02483572|16139170|P1|Overall Study|Withdrawal by Subject|1
4686855|NCT02483533|16139184|P2|Overall Study|Lack of Efficacy|50
4686856|NCT02483533|16139185|P1|Overall Study|Lack of Efficacy|50
4686857|NCT02483416|16139195|P2|Overall Study|Treatment stop|0
4686858|NCT02483416|16139196|P1|Overall Study|Treatment stop|3
4686859|NCT02483416|16139195|P2|Overall Study|Other reason|1
4686860|NCT02483416|16139196|P1|Overall Study|Other reason|0
4686861|NCT02482935|16139251|P2|Period 1|Withdrawal by Subject|0
4686862|NCT02482935|16139252|P1|Period 1|Withdrawal by Subject|1
4686863|NCT02482805|16139280|P3|Overall Study|Lost to Follow-up|0
4686864|NCT02482805|16139281|P2|Overall Study|Lost to Follow-up|4
4686865|NCT02482805|16139282|P1|Overall Study|Lost to Follow-up|4
4686866|NCT02482571|16139401|P1|Overall Study|Withdrawal by Subject|4
4686867|NCT02482571|16139401|P1|Overall Study|Scanner or Respiract failure|3
4686868|NCT02482571|16139401|P1|Overall Study|Adverse Event|1
4686869|NCT02482428|16139413|P5|Overall Study|subject/guardian decision|2
4686870|NCT02482428|16139414|P4|Overall Study|subject/guardian decision|0
4686871|NCT02482428|16139415|P3|Overall Study|subject/guardian decision|0
4686872|NCT02482428|16139416|P2|Overall Study|subject/guardian decision|2
4686873|NCT02482428|16139417|P1|Overall Study|subject/guardian decision|4
4686874|NCT02482428|16139413|P5|Overall Study|protocol deviation|0
4686875|NCT02482428|16139414|P4|Overall Study|protocol deviation|0
4686876|NCT02482428|16139415|P3|Overall Study|protocol deviation|0
4686877|NCT02482428|16139416|P2|Overall Study|protocol deviation|1
4686878|NCT02482428|16139417|P1|Overall Study|protocol deviation|1
4686879|NCT02482428|16139413|P5|Overall Study|Physician Decision|1
4686880|NCT02482428|16139414|P4|Overall Study|Physician Decision|0
4686881|NCT02482428|16139415|P3|Overall Study|Physician Decision|0
4686882|NCT02482428|16139416|P2|Overall Study|Physician Decision|0
4686883|NCT02482428|16139417|P1|Overall Study|Physician Decision|0
4686884|NCT02482428|16139413|P5|Overall Study|Lost to Follow-up|4
4686885|NCT02482428|16139414|P4|Overall Study|Lost to Follow-up|2
4686886|NCT02482428|16139415|P3|Overall Study|Lost to Follow-up|1
4686887|NCT02482428|16139416|P2|Overall Study|Lost to Follow-up|9
4686888|NCT02482428|16139417|P1|Overall Study|Lost to Follow-up|4
4686889|NCT02482298|16139440|P3|Overall Study|Lost to Follow-up|0
4686890|NCT02482298|16139441|P2|Overall Study|Lost to Follow-up|1
4686891|NCT02482298|16139442|P1|Overall Study|Lost to Follow-up|0
4686892|NCT02482298|16139440|P3|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1
4686893|NCT02482298|16139441|P2|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
4686894|NCT02482298|16139442|P1|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0
4686895|NCT02482298|16139440|P3|Overall Study|Did Not Fulfill Randomization Criteria|0
4686896|NCT02482298|16139441|P2|Overall Study|Did Not Fulfill Randomization Criteria|1
4686897|NCT02482298|16139442|P1|Overall Study|Did Not Fulfill Randomization Criteria|0
4686898|NCT02482298|16139440|P3|Overall Study|Withdrawal by Subject|2
4686899|NCT02482298|16139441|P2|Overall Study|Withdrawal by Subject|1
4686900|NCT02482298|16139442|P1|Overall Study|Withdrawal by Subject|2
4686901|NCT02482233|16139464|P2|Overall Study|Lost to Follow-up|1
4686902|NCT02482233|16139465|P1|Overall Study|Lost to Follow-up|1
4686903|NCT02482129|16139501|P2|Overall Study|Criteria not met|0
4686904|NCT02482129|16139502|P1|Overall Study|Criteria not met|1
4686905|NCT02482129|16139501|P2|Overall Study|Withdrawal by Subject|0
4686906|NCT02482129|16139502|P1|Overall Study|Withdrawal by Subject|2
4686907|NCT02482129|16139501|P2|Overall Study|Adverse Event|0
4686908|NCT02482129|16139502|P1|Overall Study|Adverse Event|1
4686909|NCT02482129|16139501|P2|Overall Study|Criteria not met-prior to treatment|0
4686910|NCT02482129|16139502|P1|Overall Study|Criteria not met-prior to treatment|1
4686911|NCT02482129|16139501|P2|Overall Study|Unable to draw blood-prior to treatment|0
4686912|NCT02482129|16139502|P1|Overall Study|Unable to draw blood-prior to treatment|1
4686913|NCT02482129|16139501|P2|Overall Study|Withdrawal by subject-prior to treatment|1
4686914|NCT02482129|16139502|P1|Overall Study|Withdrawal by subject-prior to treatment|0
4686915|NCT02482129|16139501|P2|Overall Study|Adverse Event-prior to treatment|1
4686916|NCT02482129|16139502|P1|Overall Study|Adverse Event-prior to treatment|0
4686917|NCT02481947|16139531|P2|Overall Study|Protocol Violation|5
4686918|NCT02481947|16139532|P1|Overall Study|Protocol Violation|1
4686919|NCT02481947|16139531|P2|Overall Study|Physician Decision|5
4686920|NCT02481947|16139532|P1|Overall Study|Physician Decision|4
4686921|NCT02481947|16139531|P2|Overall Study|Adverse Event|11
4686922|NCT02481947|16139532|P1|Overall Study|Adverse Event|6
4686923|NCT02481947|16139531|P2|Overall Study|Lost to Follow-up|5
4686924|NCT02481947|16139532|P1|Overall Study|Lost to Follow-up|11
4686925|NCT02481947|16139531|P2|Overall Study|Withdrawal by Subject|10
4686926|NCT02481947|16139532|P1|Overall Study|Withdrawal by Subject|24
4686927|NCT02481934|16139538|P1|Overall Study|Death|2
4686928|NCT02481830|16139545|P2|Overall Study|Participant not eligible for trial|1
4686929|NCT02481830|16139546|P1|Overall Study|Participant not eligible for trial|0
4686930|NCT02481830|16139545|P2|Overall Study|Disease Progression|1
4686931|NCT02481830|16139546|P1|Overall Study|Disease Progression|1
4686932|NCT02481830|16139545|P2|Overall Study|Withdrawal by Subject|14
4686933|NCT02481830|16139546|P1|Overall Study|Withdrawal by Subject|0
4686934|NCT02481830|16139545|P2|Overall Study|No longer meets Study Criteria|4
4686935|NCT02481830|16139546|P1|Overall Study|No longer meets Study Criteria|1
4686936|NCT02422615|16139723|P2|Overall Study|Technical problems|1
4686937|NCT02422615|16139724|P1|Overall Study|Technical problems|0
4686938|NCT02422615|16139723|P2|Overall Study|Protocol Violation|1
4686939|NCT02422615|16139724|P1|Overall Study|Protocol Violation|1
4686940|NCT02422615|16139723|P2|Overall Study|Death|0
4686941|NCT02422615|16139724|P1|Overall Study|Death|2
4686942|NCT02422615|16139723|P2|Overall Study|Subject/guardian decision|5
4686943|NCT02422615|16139724|P1|Overall Study|Subject/guardian decision|21
4686944|NCT02422615|16139723|P2|Overall Study|Physician Decision|7
4686945|NCT02422615|16139724|P1|Overall Study|Physician Decision|22
4686946|NCT02422615|16139723|P2|Overall Study|Adverse Event|10
4686947|NCT02422615|16139724|P1|Overall Study|Adverse Event|41
4686948|NCT02422615|16139723|P2|Overall Study|Progressive disease|142
4686949|NCT02422615|16139724|P1|Overall Study|Progressive disease|193
4686950|NCT02481050|16139730|P1|Overall Study|Other|3
4686951|NCT02481050|16139730|P1|Overall Study|Withdrawal by Subject|7
4686952|NCT02481050|16139730|P1|Overall Study|Disease Progression|47
4686953|NCT02481050|16139730|P1|Overall Study|Adverse Event|1
4686954|NCT02480764|16139761|P3|Overall Study|Reason not Specified|0
4686955|NCT02480764|16139762|P2|Overall Study|Reason not Specified|1
4686956|NCT02480764|16139763|P1|Overall Study|Reason not Specified|0
4686957|NCT02480764|16139761|P3|Overall Study|Lack of Efficacy|3
4686958|NCT02480764|16139762|P2|Overall Study|Lack of Efficacy|3
4686959|NCT02480764|16139763|P1|Overall Study|Lack of Efficacy|0
4686960|NCT02480764|16139761|P3|Overall Study|Voluntary Withdrawal|10
4686961|NCT02480764|16139762|P2|Overall Study|Voluntary Withdrawal|5
4686962|NCT02480764|16139763|P1|Overall Study|Voluntary Withdrawal|6
4686963|NCT02480764|16139761|P3|Overall Study|Lost to Follow-up|2
4686964|NCT02480764|16139762|P2|Overall Study|Lost to Follow-up|1
4686965|NCT02480764|16139763|P1|Overall Study|Lost to Follow-up|0
4686966|NCT02480764|16139761|P3|Overall Study|Major Protocol Deviation|3
4686967|NCT02480764|16139762|P2|Overall Study|Major Protocol Deviation|4
4686968|NCT02480764|16139763|P1|Overall Study|Major Protocol Deviation|1
4686969|NCT02480764|16139761|P3|Overall Study|Pretreatment Event/Adverse Event|3
4686970|NCT02480764|16139762|P2|Overall Study|Pretreatment Event/Adverse Event|6
4686971|NCT02480764|16139763|P1|Overall Study|Pretreatment Event/Adverse Event|3
4686972|NCT02480712|16139789|P1|Overall Study|Lack of Efficacy|1
4686973|NCT02480712|16139789|P1|Overall Study|Death|1
4686974|NCT02480712|16139789|P1|Overall Study|Withdrew Consent|3
4686975|NCT02480712|16139789|P1|Overall Study|Lost to Follow-up|5
4686976|NCT02480712|16139789|P1|Overall Study|Enrolled but Never Treated|1
4686977|NCT02480621|16139808|P2|Follow Up|Lost to Follow-up|2
4686978|NCT02480621|16139809|P1|Follow Up|Lost to Follow-up|4
4686979|NCT02480621|16139808|P2|Randomization|Surgeon did not give intervention|1
4686980|NCT02480621|16139809|P1|Randomization|Surgeon did not give intervention|0
4686981|NCT02480621|16139808|P2|Randomization|Withdrawal by Subject|0
4686982|NCT02480621|16139809|P1|Randomization|Withdrawal by Subject|1
4686983|NCT02480153|16139886|P3|Period 3: Week 52 Dosing to Week 78|Death|0
4686984|NCT02480153|16139887|P2|Period 3: Week 52 Dosing to Week 78|Death|1
4686985|NCT02480153|16139888|P1|Period 3: Week 52 Dosing to Week 78|Death|0
4686986|NCT02480153|16139886|P3|Period 3: Week 52 Dosing to Week 78|Adverse Event|1
4686987|NCT02480153|16139887|P2|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
4686988|NCT02480153|16139888|P1|Period 3: Week 52 Dosing to Week 78|Adverse Event|0
4686989|NCT02480153|16139886|P3|Period 3: Week 52 Dosing to Week 78|Other|1
4686990|NCT02480153|16139887|P2|Period 3: Week 52 Dosing to Week 78|Other|0
4686991|NCT02480153|16139888|P1|Period 3: Week 52 Dosing to Week 78|Other|0
4686992|NCT02480153|16139886|P3|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1
4686993|NCT02480153|16139887|P2|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0
4686994|NCT02480153|16139888|P1|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4
4686995|NCT02480153|16139886|P3|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1
4686996|NCT02480153|16139887|P2|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2
4686997|NCT02480153|16139888|P1|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3
4686998|NCT02480153|16139886|P3|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
4686999|NCT02480153|16139887|P2|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1
4687000|NCT02480153|16139888|P1|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0
4687001|NCT02480153|16139886|P3|Period 2: Week 26 to Week 52 Pre-dose|Other|0
4687002|NCT02480153|16139887|P2|Period 2: Week 26 to Week 52 Pre-dose|Other|0
4687003|NCT02480153|16139888|P1|Period 2: Week 26 to Week 52 Pre-dose|Other|2
4687004|NCT02480153|16139886|P3|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3
4687005|NCT02480153|16139887|P2|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7
4687006|NCT02480153|16139888|P1|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6
4687007|NCT02480153|16139886|P3|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1
4687008|NCT02480153|16139887|P2|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3
4687009|NCT02480153|16139888|P1|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8
4687010|NCT02480153|16139886|P3|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
4687011|NCT02480153|16139887|P2|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1
4687012|NCT02480153|16139888|P1|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0
4687013|NCT02480153|16139886|P3|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3
4687014|NCT02480153|16139887|P2|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1
4687015|NCT02480153|16139888|P1|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4
4687016|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
4687017|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2
4687018|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0
4687019|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Death|0
4687020|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Death|1
4687021|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Death|0
4687022|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Other|0
4687023|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Other|1
4687024|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Other|0
4687025|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0
4687026|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8
4687027|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3
4687028|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0
4687029|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2
4687030|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1
4687031|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
4687032|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1
4687033|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0
4687034|NCT02480153|16139886|P3|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
4687035|NCT02480153|16139887|P2|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1
4687036|NCT02480153|16139888|P1|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0
4687037|NCT02480114|16140065|P2|Overall Study|Not eligible|1
4687038|NCT02480114|16140066|P1|Overall Study|Not eligible|0
4687039|NCT02480114|16140065|P2|Overall Study|Improper completion of survey|1
4687040|NCT02480114|16140066|P1|Overall Study|Improper completion of survey|1
4687041|NCT02480114|16140065|P2|Overall Study|Disease progression|0
4687042|NCT02480114|16140066|P1|Overall Study|Disease progression|3
4687043|NCT02480114|16140065|P2|Overall Study|Withdrawal by Subject|4
4687044|NCT02480114|16140066|P1|Overall Study|Withdrawal by Subject|2
4687045|NCT02480114|16140065|P2|Overall Study|Not completing surveys|2
4687046|NCT02480114|16140066|P1|Overall Study|Not completing surveys|3
4687047|NCT02480010|16140078|P2|Overall Study|Refused Treatment|3
4687048|NCT02480010|16140079|P1|Overall Study|Refused Treatment|0
4687049|NCT02480010|16140078|P2|Overall Study|Insufficient therapeutic response|29
4687050|NCT02480010|16140079|P1|Overall Study|Insufficient therapeutic response|31
4687051|NCT02480010|16140078|P2|Overall Study|Death|0
4687052|NCT02480010|16140079|P1|Overall Study|Death|1
4687053|NCT02480010|16140078|P2|Overall Study|Adverse Event|1
4687054|NCT02480010|16140079|P1|Overall Study|Adverse Event|3
4687055|NCT02479880|16140125|P2|Overall Study|Pregnancy|1
4687056|NCT02479880|16140126|P1|Overall Study|Pregnancy|0
4687057|NCT02479880|16140125|P2|Overall Study|Study Terminated by Sponsor|12
4687058|NCT02479880|16140126|P1|Overall Study|Study Terminated by Sponsor|13
4687059|NCT02479802|16140132|P1|Overall Study|Adverse Event|1
4687060|NCT02479802|16140132|P1|Overall Study|Lost to Follow-up|1
4687061|NCT02479412|16140159|P9|Overall Study|Randomization to wrong PK sampling group|0
4687062|NCT02479412|16140160|P8|Overall Study|Randomization to wrong PK sampling group|0
4687063|NCT02479412|16140161|P7|Overall Study|Randomization to wrong PK sampling group|0
4687064|NCT02479412|16140162|P6|Overall Study|Randomization to wrong PK sampling group|0
4687065|NCT02479412|16140163|P5|Overall Study|Randomization to wrong PK sampling group|1
4687066|NCT02479412|16140164|P4|Overall Study|Randomization to wrong PK sampling group|0
4687067|NCT02479412|16140165|P3|Overall Study|Randomization to wrong PK sampling group|0
4687068|NCT02479412|16140166|P2|Overall Study|Randomization to wrong PK sampling group|0
4687069|NCT02479412|16140167|P1|Overall Study|Randomization to wrong PK sampling group|0
4687070|NCT02479412|16140159|P9|Overall Study|Study-specific withdrawal criteria|1
4687071|NCT02479412|16140160|P8|Overall Study|Study-specific withdrawal criteria|1
4687072|NCT02479412|16140161|P7|Overall Study|Study-specific withdrawal criteria|0
4687073|NCT02479412|16140162|P6|Overall Study|Study-specific withdrawal criteria|0
4687074|NCT02479412|16140163|P5|Overall Study|Study-specific withdrawal criteria|0
4687075|NCT02479412|16140164|P4|Overall Study|Study-specific withdrawal criteria|1
4687076|NCT02479412|16140165|P3|Overall Study|Study-specific withdrawal criteria|1
4687077|NCT02479412|16140166|P2|Overall Study|Study-specific withdrawal criteria|0
4687078|NCT02479412|16140167|P1|Overall Study|Study-specific withdrawal criteria|0
4687079|NCT02479412|16140159|P9|Overall Study|Adverse Event|0
4687080|NCT02479412|16140160|P8|Overall Study|Adverse Event|0
4687081|NCT02479412|16140161|P7|Overall Study|Adverse Event|0
4687082|NCT02479412|16140162|P6|Overall Study|Adverse Event|0
4687083|NCT02479412|16140163|P5|Overall Study|Adverse Event|0
4687084|NCT02479412|16140164|P4|Overall Study|Adverse Event|0
4687085|NCT02479412|16140165|P3|Overall Study|Adverse Event|1
4687086|NCT02479412|16140166|P2|Overall Study|Adverse Event|0
4687087|NCT02479412|16140167|P1|Overall Study|Adverse Event|0
4687088|NCT02479139|16140244|P6|Overall Study|Other Miscellaneous Reasons|0
4687089|NCT02479139|16140245|P5|Overall Study|Other Miscellaneous Reasons|1
4687090|NCT02479139|16140246|P4|Overall Study|Other Miscellaneous Reasons|1
4687091|NCT02479139|16140247|P3|Overall Study|Other Miscellaneous Reasons|1
4687092|NCT02479139|16140248|P2|Overall Study|Other Miscellaneous Reasons|0
4687093|NCT02479139|16140249|P1|Overall Study|Other Miscellaneous Reasons|1
4687094|NCT02479139|16140244|P6|Overall Study|Treatment Failure/Lack of Efficacy|0
4687095|NCT02479139|16140245|P5|Overall Study|Treatment Failure/Lack of Efficacy|0
4687096|NCT02479139|16140246|P4|Overall Study|Treatment Failure/Lack of Efficacy|0
4687097|NCT02479139|16140247|P3|Overall Study|Treatment Failure/Lack of Efficacy|1
4687098|NCT02479139|16140248|P2|Overall Study|Treatment Failure/Lack of Efficacy|0
4687099|NCT02479139|16140249|P1|Overall Study|Treatment Failure/Lack of Efficacy|0
4687100|NCT02479139|16140244|P6|Overall Study|Withdrew Consent|1
4687101|NCT02479139|16140245|P5|Overall Study|Withdrew Consent|1
4687102|NCT02479139|16140246|P4|Overall Study|Withdrew Consent|4
4687103|NCT02479139|16140247|P3|Overall Study|Withdrew Consent|1
4687104|NCT02479139|16140248|P2|Overall Study|Withdrew Consent|6
4687105|NCT02479139|16140249|P1|Overall Study|Withdrew Consent|5
4687106|NCT02479139|16140244|P6|Overall Study|Lost to Follow-up|5
4687107|NCT02479139|16140245|P5|Overall Study|Lost to Follow-up|3
4687108|NCT02479139|16140246|P4|Overall Study|Lost to Follow-up|2
4687109|NCT02479139|16140247|P3|Overall Study|Lost to Follow-up|4
4687110|NCT02479139|16140248|P2|Overall Study|Lost to Follow-up|4
4687111|NCT02479139|16140249|P1|Overall Study|Lost to Follow-up|2
4687112|NCT02420691|16140275|P1|Overall Study|Withdrawal by Subject|3
4687113|NCT02420691|16140275|P1|Overall Study|Adverse Event|3
4687114|NCT02478632|16140290|P2|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1
4687115|NCT02478632|16140291|P1|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5
4687116|NCT02478632|16140290|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3
4687117|NCT02478632|16140291|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2
4687118|NCT02478632|16140290|P2|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5
4687119|NCT02478632|16140291|P1|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4
4687120|NCT02478463|16140326|P1|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1
4687121|NCT02478463|16140326|P1|Washout Period (Up to 42 Days)|Lost to Follow-up|1
4687122|NCT02478463|16140326|P1|Treatment Period 1 (Up to Day 29)|Physician Decision|1
4687123|NCT02478398|16140443|P2|Overall Study|Withdrawal By Participant|4
4687124|NCT02478398|16140444|P1|Overall Study|Withdrawal By Participant|10
4687125|NCT02478398|16140443|P2|Overall Study|Withdrawal By Parent/Guardian|6
4687126|NCT02478398|16140444|P1|Overall Study|Withdrawal By Parent/Guardian|9
4687127|NCT02478398|16140443|P2|Overall Study|Protocol Violation|1
4687128|NCT02478398|16140444|P1|Overall Study|Protocol Violation|3
4687129|NCT02478398|16140443|P2|Overall Study|Non-Compliance With Study Drug|1
4687130|NCT02478398|16140444|P1|Overall Study|Non-Compliance With Study Drug|5
4687131|NCT02478398|16140443|P2|Overall Study|Lost to Follow-up|4
4687132|NCT02478398|16140444|P1|Overall Study|Lost to Follow-up|5
4687133|NCT02478398|16140443|P2|Overall Study|Adverse Event|5
4687134|NCT02478398|16140444|P1|Overall Study|Adverse Event|20
4687135|NCT02478372|16140464|P2|Overall Study|Death|2
4687136|NCT02478372|16140465|P1|Overall Study|Death|0
4687137|NCT02478372|16140464|P2|Overall Study|Lost to Follow-up|4
4687138|NCT02478372|16140465|P1|Overall Study|Lost to Follow-up|1
4687139|NCT02478372|16140464|P2|Overall Study|Protocol Violation|8
4687140|NCT02478372|16140465|P1|Overall Study|Protocol Violation|12
4687141|NCT02478359|16140489|P2|Overall Study|Disenrolled from health plan|65
4687142|NCT02478359|16140490|P1|Overall Study|Disenrolled from health plan|106
4687143|NCT02478164|16140562|P1|Overall Study|Withdrawal by Subject|1
4687144|NCT02478164|16140562|P1|Overall Study|Adverse Event|1
4687145|NCT02478164|16140562|P1|Overall Study|Lack of Efficacy|13
4687146|NCT02477670|16140575|P7|Stage 2|Withdrawal by Subject|0
4687147|NCT02477670|16140576|P6|Stage 2|Withdrawal by Subject|0
4687148|NCT02477670|16140577|P5|Stage 2|Withdrawal by Subject|0
4687149|NCT02477670|16140578|P4|Stage 2|Withdrawal by Subject|1
4687150|NCT02477670|16140579|P3|Stage 2|Withdrawal by Subject|0
4687151|NCT02477670|16140580|P2|Stage 2|Withdrawal by Subject|0
4687152|NCT02477670|16140581|P1|Stage 2|Withdrawal by Subject|0
4687153|NCT02477670|16140575|P7|Stage 2|Antipsychotic Medication Changed|0
4687154|NCT02477670|16140576|P6|Stage 2|Antipsychotic Medication Changed|0
4687155|NCT02477670|16140577|P5|Stage 2|Antipsychotic Medication Changed|0
4687156|NCT02477670|16140578|P4|Stage 2|Antipsychotic Medication Changed|0
4687157|NCT02477670|16140579|P3|Stage 2|Antipsychotic Medication Changed|1
4687158|NCT02477670|16140580|P2|Stage 2|Antipsychotic Medication Changed|0
4687159|NCT02477670|16140581|P1|Stage 2|Antipsychotic Medication Changed|0
4687160|NCT02477670|16140575|P7|Stage 2|Adverse Event|0
4687161|NCT02477670|16140576|P6|Stage 2|Adverse Event|0
4687162|NCT02477670|16140577|P5|Stage 2|Adverse Event|0
4687163|NCT02477670|16140578|P4|Stage 2|Adverse Event|0
4687164|NCT02477670|16140579|P3|Stage 2|Adverse Event|1
4687165|NCT02477670|16140580|P2|Stage 2|Adverse Event|0
4687166|NCT02477670|16140581|P1|Stage 2|Adverse Event|0
4687167|NCT02477670|16140575|P7|Stage 1|Non-compliance with Study Drug|0
4687168|NCT02477670|16140576|P6|Stage 1|Non-compliance with Study Drug|0
4687169|NCT02477670|16140577|P5|Stage 1|Non-compliance with Study Drug|0
4687170|NCT02477670|16140578|P4|Stage 1|Non-compliance with Study Drug|0
4687171|NCT02477670|16140579|P3|Stage 1|Non-compliance with Study Drug|0
4687172|NCT02477670|16140580|P2|Stage 1|Non-compliance with Study Drug|2
4687173|NCT02477670|16140581|P1|Stage 1|Non-compliance with Study Drug|1
4687174|NCT02477670|16140575|P7|Stage 1|Withdrawal by Subject|0
4687175|NCT02477670|16140576|P6|Stage 1|Withdrawal by Subject|0
4687176|NCT02477670|16140577|P5|Stage 1|Withdrawal by Subject|0
4687177|NCT02477670|16140578|P4|Stage 1|Withdrawal by Subject|0
4687178|NCT02477670|16140579|P3|Stage 1|Withdrawal by Subject|0
4687179|NCT02477670|16140580|P2|Stage 1|Withdrawal by Subject|2
4687180|NCT02477670|16140581|P1|Stage 1|Withdrawal by Subject|1
4687181|NCT02477670|16140575|P7|Stage 1|Lost to Follow-up|0
4687182|NCT02477670|16140576|P6|Stage 1|Lost to Follow-up|0
4687183|NCT02477670|16140577|P5|Stage 1|Lost to Follow-up|0
4687184|NCT02477670|16140578|P4|Stage 1|Lost to Follow-up|0
4687185|NCT02477670|16140579|P3|Stage 1|Lost to Follow-up|0
4687186|NCT02477670|16140580|P2|Stage 1|Lost to Follow-up|2
4687187|NCT02477670|16140581|P1|Stage 1|Lost to Follow-up|0
4687188|NCT02477670|16140575|P7|Stage 1|Adverse Event|0
4687189|NCT02477670|16140576|P6|Stage 1|Adverse Event|0
4687190|NCT02477670|16140577|P5|Stage 1|Adverse Event|0
4687191|NCT02477670|16140578|P4|Stage 1|Adverse Event|0
4687192|NCT02477670|16140579|P3|Stage 1|Adverse Event|0
4687193|NCT02477670|16140580|P2|Stage 1|Adverse Event|7
4687194|NCT02477670|16140581|P1|Stage 1|Adverse Event|2
4687195|NCT02477618|16140797|P2|Overall Study|Left Study Site for Rehabilitation|1
4687196|NCT02477618|16140798|P1|Overall Study|Left Study Site for Rehabilitation|0
4687197|NCT02477618|16140797|P2|Overall Study|Transferred Away from Study Site|0
4687198|NCT02477618|16140798|P1|Overall Study|Transferred Away from Study Site|1
4687199|NCT02477618|16140797|P2|Overall Study|Adverse Event|1
4687200|NCT02477618|16140798|P1|Overall Study|Adverse Event|1
4687201|NCT02477618|16140797|P2|Overall Study|Died in Double-Blind Treatment Period|11
4687202|NCT02477618|16140798|P1|Overall Study|Died in Double-Blind Treatment Period|11
4687203|NCT02477618|16140797|P2|Overall Study|Completed Visits but Discontinued Drug|1
4687204|NCT02477618|16140798|P1|Overall Study|Completed Visits but Discontinued Drug|2
4687205|NCT02477605|16140822|P2|Overall Study|Administered gas during surgery|1
4687206|NCT02477605|16140823|P1|Overall Study|Administered gas during surgery|0
4687207|NCT02477605|16140822|P2|Overall Study|Withdrawal by Subject|1
4687208|NCT02477605|16140823|P1|Overall Study|Withdrawal by Subject|0
4687209|NCT02477605|16140822|P2|Overall Study|Lost to Follow-up|2
4687210|NCT02477605|16140823|P1|Overall Study|Lost to Follow-up|0
4687211|NCT02477605|16140822|P2|Overall Study|Discontinued prior to treatment|0
4687212|NCT02477605|16140823|P1|Overall Study|Discontinued prior to treatment|1
4687213|NCT02477553|16140839|P2|Overall Study|patient deceased|0
4687214|NCT02477553|16140840|P1|Overall Study|patient deceased|1
4687215|NCT02477553|16140839|P2|Overall Study|MD advised against screening|3
4687216|NCT02477553|16140840|P1|Overall Study|MD advised against screening|1
4687217|NCT02477553|16140839|P2|Overall Study|Elevated risk for CRC|2
4687218|NCT02477553|16140840|P1|Overall Study|Elevated risk for CRC|2
4687219|NCT02477553|16140839|P2|Overall Study|Technical issues with intervention|0
4687220|NCT02477553|16140840|P1|Overall Study|Technical issues with intervention|2
4687221|NCT02477553|16140839|P2|Overall Study|Workup consistent w/CRC|1
4687222|NCT02477553|16140840|P1|Overall Study|Workup consistent w/CRC|1
4687223|NCT02477553|16140839|P2|Overall Study|No MD visit|1
4687224|NCT02477553|16140840|P1|Overall Study|No MD visit|1
4687225|NCT02477553|16140839|P2|Overall Study|Screening up-to-date|13
4687226|NCT02477553|16140840|P1|Overall Study|Screening up-to-date|12
4687227|NCT02477527|16140860|P1|Overall Study|Screen Failure|3
4687228|NCT02477527|16140860|P1|Overall Study|Withdrawal by Subject|1
4687229|NCT02477527|16140860|P1|Overall Study|Lost to Follow-up|2
4687230|NCT02477332|16140895|P6|Overall Study|Withdrawal by Subject|0
4687231|NCT02477332|16140896|P5|Overall Study|Withdrawal by Subject|1
4687232|NCT02477332|16140897|P4|Overall Study|Withdrawal by Subject|2
4687233|NCT02477332|16140898|P3|Overall Study|Withdrawal by Subject|1
4687234|NCT02477332|16140899|P2|Overall Study|Withdrawal by Subject|3
4687235|NCT02477332|16140900|P1|Overall Study|Withdrawal by Subject|0
4687236|NCT02477332|16140895|P6|Overall Study|Physician Decision|1
4687237|NCT02477332|16140896|P5|Overall Study|Physician Decision|0
4687238|NCT02477332|16140897|P4|Overall Study|Physician Decision|3
4687239|NCT02477332|16140898|P3|Overall Study|Physician Decision|1
4687240|NCT02477332|16140899|P2|Overall Study|Physician Decision|0
4687241|NCT02477332|16140900|P1|Overall Study|Physician Decision|0
4687242|NCT02477332|16140895|P6|Overall Study|Lost to Follow-up|0
4687243|NCT02477332|16140896|P5|Overall Study|Lost to Follow-up|0
4687244|NCT02477332|16140897|P4|Overall Study|Lost to Follow-up|0
4687245|NCT02477332|16140898|P3|Overall Study|Lost to Follow-up|2
4687246|NCT02477332|16140899|P2|Overall Study|Lost to Follow-up|0
4687247|NCT02477332|16140900|P1|Overall Study|Lost to Follow-up|0
4687248|NCT02477332|16140895|P6|Overall Study|Technical problems|0
4687249|NCT02477332|16140896|P5|Overall Study|Technical problems|0
4687250|NCT02477332|16140897|P4|Overall Study|Technical problems|0
4687251|NCT02477332|16140898|P3|Overall Study|Technical problems|1
4687252|NCT02477332|16140899|P2|Overall Study|Technical problems|0
4687253|NCT02477332|16140900|P1|Overall Study|Technical problems|0
4687254|NCT02477332|16140895|P6|Overall Study|Protocol Violation|1
4687255|NCT02477332|16140896|P5|Overall Study|Protocol Violation|1
4687256|NCT02477332|16140897|P4|Overall Study|Protocol Violation|3
4687257|NCT02477332|16140898|P3|Overall Study|Protocol Violation|3
4687258|NCT02477332|16140899|P2|Overall Study|Protocol Violation|0
4687259|NCT02477332|16140900|P1|Overall Study|Protocol Violation|2
4687260|NCT02477332|16140895|P6|Overall Study|Pregnancy|0
4687261|NCT02477332|16140896|P5|Overall Study|Pregnancy|0
4687262|NCT02477332|16140897|P4|Overall Study|Pregnancy|1
4687263|NCT02477332|16140898|P3|Overall Study|Pregnancy|0
4687264|NCT02477332|16140899|P2|Overall Study|Pregnancy|0
4687265|NCT02477332|16140900|P1|Overall Study|Pregnancy|0
4687266|NCT02477332|16140895|P6|Overall Study|Non-compliance with study treatment|0
4687267|NCT02477332|16140896|P5|Overall Study|Non-compliance with study treatment|0
4687268|NCT02477332|16140897|P4|Overall Study|Non-compliance with study treatment|0
4687269|NCT02477332|16140898|P3|Overall Study|Non-compliance with study treatment|2
4687270|NCT02477332|16140899|P2|Overall Study|Non-compliance with study treatment|1
4687271|NCT02477332|16140900|P1|Overall Study|Non-compliance with study treatment|0
4687272|NCT02477332|16140895|P6|Overall Study|Lack of Efficacy|1
4687273|NCT02477332|16140896|P5|Overall Study|Lack of Efficacy|1
4687274|NCT02477332|16140897|P4|Overall Study|Lack of Efficacy|2
4687275|NCT02477332|16140898|P3|Overall Study|Lack of Efficacy|1
4687276|NCT02477332|16140899|P2|Overall Study|Lack of Efficacy|2
4687277|NCT02477332|16140900|P1|Overall Study|Lack of Efficacy|1
4687278|NCT02477332|16140895|P6|Overall Study|Adverse Event|2
4687279|NCT02477332|16140896|P5|Overall Study|Adverse Event|1
4687280|NCT02477332|16140897|P4|Overall Study|Adverse Event|2
4687281|NCT02477332|16140898|P3|Overall Study|Adverse Event|1
4687282|NCT02477332|16140899|P2|Overall Study|Adverse Event|1
4687283|NCT02477332|16140900|P1|Overall Study|Adverse Event|0
4687284|NCT02477215|16140992|P3|Fixed Dose Phase|Physician Decision|0
4687285|NCT02477215|16140993|P2|Fixed Dose Phase|Physician Decision|7
4687286|NCT02477215|16140994|P1|Fixed Dose Phase|Physician Decision|0
4687287|NCT02477215|16140992|P3|Dose Escalation Phase|Physician Decision|0
4687288|NCT02477215|16140993|P2|Dose Escalation Phase|Physician Decision|2
4687289|NCT02477215|16140994|P1|Dose Escalation Phase|Physician Decision|1
4687290|NCT02477020|16141010|P2|Overall Study|Lack of Efficacy|5
4687291|NCT02477020|16141011|P1|Overall Study|Lack of Efficacy|14
4687292|NCT02477020|16141010|P2|Overall Study|Reason not Specified|1
4687293|NCT02477020|16141011|P1|Overall Study|Reason not Specified|3
4687294|NCT02477020|16141010|P2|Overall Study|Voluntary Withdrawal|16
4687295|NCT02477020|16141011|P1|Overall Study|Voluntary Withdrawal|7
4687296|NCT02477020|16141010|P2|Overall Study|Pretreatment Event/Adverse Event|6
4687297|NCT02477020|16141011|P1|Overall Study|Pretreatment Event/Adverse Event|6
4687298|NCT02476994|16141041|P2|Overall Study|Based on feedback from FDA|0
4687299|NCT02476994|16141042|P1|Overall Study|Based on feedback from FDA|1
4687300|NCT02476916|16141070|P2|Extension Period|On Treatment|17
4687301|NCT02476916|16141071|P1|Extension Period|On Treatment|12
4687302|NCT02476916|16141070|P2|Extension Period|Prematurely Discontinued Treatment|1
4687303|NCT02476916|16141071|P1|Extension Period|Prematurely Discontinued Treatment|6
4687304|NCT02476916|16141070|P2|Core Period|Withdrawal by Subject|0
4687305|NCT02476916|16141071|P1|Core Period|Withdrawal by Subject|3
4687306|NCT02476916|16141070|P2|Core Period|Investigator decision|1
4687307|NCT02476916|16141071|P1|Core Period|Investigator decision|1
4687308|NCT02476916|16141070|P2|Core Period|Adverse Event|2
4687309|NCT02476916|16141071|P1|Core Period|Adverse Event|2
4687310|NCT02476617|16141156|P1|Overall Study|Lost to Follow-up|1
4687311|NCT02476617|16141156|P1|Overall Study|Adverse Event|1
4687312|NCT02476578|16141162|P2|Overall Study|Lost to Follow-up|13
4687313|NCT02476578|16141163|P1|Overall Study|Lost to Follow-up|6
4687314|NCT02476578|16141162|P2|Overall Study|Died before Email was sent (<9.11.2015)|43
4687315|NCT02476578|16141163|P1|Overall Study|Died before Email was sent (<9.11.2015)|35
4687316|NCT02476422|16141225|P2|Overall Study|Subject/guardian decision|1
4687317|NCT02476422|16141226|P1|Overall Study|Subject/guardian decision|0
4687318|NCT02476201|16141267|P1|Overall Study|Unsuccessful implant|1
4687319|NCT02476201|16141267|P1|Overall Study|Withdrawal by Subject|1
4687320|NCT02476201|16141267|P1|Overall Study|MPP programmed to OFF|2
4687321|NCT02476201|16141267|P1|Overall Study|Lost to Follow-up|2
4687322|NCT02476201|16141267|P1|Overall Study|Death|2
4687323|NCT02476201|16141267|P1|Overall Study|Adverse Event|4
4687324|NCT02476201|16141267|P1|Overall Study|Study echo not performed|5
4687325|NCT02476201|16141267|P1|Overall Study|Unable to program MPP|9
4687326|NCT02476175|16141275|P1|Overall Study|Adverse Event|2
4687327|NCT02476006|16141299|P1|Overall Study|Enrolled but not treated|4
4687328|NCT02476006|16141299|P1|Overall Study|Protocol Violation|1
4687329|NCT02476006|16141299|P1|Overall Study|Excluded from study|1
4687330|NCT02476006|16141299|P1|Overall Study|Switched to commercial drug|4
4687331|NCT02476006|16141299|P1|Overall Study|Study ended treatment not available|4
4687332|NCT02476006|16141299|P1|Overall Study|Physician Decision|5
4687333|NCT02476006|16141299|P1|Overall Study|Lost to Follow-up|5
4687334|NCT02476006|16141299|P1|Overall Study|Sponsor decision|6
4687335|NCT02476006|16141299|P1|Overall Study|Poor compliance to study protocol|3
4687336|NCT02476006|16141299|P1|Overall Study|Adverse Event|41
4687337|NCT02476006|16141299|P1|Overall Study|Participant did not wish to continue|39
4687338|NCT02476006|16141299|P1|Overall Study|Pregnancy|1
4687339|NCT02476006|16141299|P1|Overall Study|Lack of treatment efficacy|2
4687340|NCT02476006|16141299|P1|Overall Study|Death|4
4687341|NCT02475980|16141313|P1|Overall Study|Withdrawal by Subject|1
4687342|NCT02475980|16141313|P1|Overall Study|Lost to Follow-up|4
4687343|NCT02475733|16141339|P2|Overall Study|Physician Decision|0
4687344|NCT02475733|16141340|P1|Overall Study|Physician Decision|1
4687345|NCT02475733|16141339|P2|Overall Study|Withdrawal by Subject|0
4687346|NCT02475733|16141340|P1|Overall Study|Withdrawal by Subject|1
4687347|NCT02475655|16141397|P2|Overall Study|Lost to Follow-up|1
4687348|NCT02475655|16141398|P1|Overall Study|Lost to Follow-up|0
4687349|NCT02475629|16141550|P1|Overall Study|Subject non-compliance|1
4687350|NCT02475629|16141550|P1|Overall Study|Lost to Follow-up|1
4687351|NCT02475629|16141550|P1|Overall Study|Withdrawal by Subject|1
4687352|NCT02475629|16141550|P1|Overall Study|Physician Decision|1
4687353|NCT02475629|16141550|P1|Overall Study|Death|4
4687354|NCT02475629|16141550|P1|Overall Study|Adverse Event|1
4687355|NCT02475564|16141573|P2|Overall Study|Intense Menstrual bleeding|0
4687356|NCT02475564|16141574|P1|Overall Study|Intense Menstrual bleeding|1
4687357|NCT02475564|16141573|P2|Overall Study|Lost to Follow-up|1
4687358|NCT02475564|16141574|P1|Overall Study|Lost to Follow-up|2
4687359|NCT02475564|16141573|P2|Overall Study|Withdrawal by Subject|0
4687360|NCT02475564|16141574|P1|Overall Study|Withdrawal by Subject|1
4687361|NCT02475395|16141586|P2|Overall Study|Protocol Violation|3
4687362|NCT02475395|16141587|P1|Overall Study|Protocol Violation|30
4687363|NCT02475278|16141597|P1|Overall Study|Reason Not Specified|1
4687364|NCT02475278|16141597|P1|Overall Study|Lost to Follow-up|1
4687365|NCT02475265|16141608|P1|Overall Study|Withdrawal by Subject|2
4687366|NCT02475265|16141608|P1|Overall Study|Physician Decision|1
4687367|NCT02474589|16141659|P2|Overall Study|Inability to complete study procedures|1
4687368|NCT02474589|16141660|P1|Overall Study|Inability to complete study procedures|5
4687369|NCT02474589|16141659|P2|Overall Study|Withdrawal by Subject|0
4687370|NCT02474589|16141660|P1|Overall Study|Withdrawal by Subject|4
4687371|NCT02474589|16141659|P2|Overall Study|Protocol Violation|1
4687372|NCT02474589|16141660|P1|Overall Study|Protocol Violation|4
4687373|NCT02474589|16141659|P2|Overall Study|Lost to Follow-up|1
4687374|NCT02474589|16141660|P1|Overall Study|Lost to Follow-up|6
4687375|NCT02474589|16141659|P2|Overall Study|Adverse Event|2
4687376|NCT02474589|16141660|P1|Overall Study|Adverse Event|6
4687377|NCT02474082|16141719|P2|Overall Study|Protocol deviation|1
4687378|NCT02474082|16141720|P1|Overall Study|Protocol deviation|0
4687379|NCT02474082|16141719|P2|Overall Study|Non-compliance with study treatment|2
4687380|NCT02474082|16141720|P1|Overall Study|Non-compliance with study treatment|0
4687381|NCT02474082|16141719|P2|Overall Study|Participant/guardian decision|2
4687382|NCT02474082|16141720|P1|Overall Study|Participant/guardian decision|1
4687383|NCT02474082|16141719|P2|Overall Study|Dose tapering not achieved|4
4687384|NCT02474082|16141720|P1|Overall Study|Dose tapering not achieved|0
4687385|NCT02474082|16141719|P2|Overall Study|Lost to Follow-up|2
4687386|NCT02474082|16141720|P1|Overall Study|Lost to Follow-up|2
4687387|NCT02474082|16141719|P2|Overall Study|Withdrawal of informed consent|11
4687388|NCT02474082|16141720|P1|Overall Study|Withdrawal of informed consent|1
4687389|NCT02474082|16141719|P2|Overall Study|Adverse Event|32
4687390|NCT02474082|16141720|P1|Overall Study|Adverse Event|2
4687391|NCT02474069|16141754|P3|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
4687392|NCT02474069|16141755|P2|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2
4687393|NCT02474069|16141756|P1|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0
4687394|NCT02474069|16141754|P3|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1
4687395|NCT02474069|16141755|P2|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
4687396|NCT02474069|16141756|P1|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0
4687397|NCT02474069|16141754|P3|Comparative Dosing Phase (CDP)|Lost to Follow-up|1
4687398|NCT02474069|16141755|P2|Comparative Dosing Phase (CDP)|Lost to Follow-up|4
4687399|NCT02474069|16141756|P1|Comparative Dosing Phase (CDP)|Lost to Follow-up|0
4687400|NCT02474069|16141754|P3|Comparative Dosing Phase (CDP)|Adverse Event|2
4687401|NCT02474069|16141755|P2|Comparative Dosing Phase (CDP)|Adverse Event|3
4687402|NCT02474069|16141756|P1|Comparative Dosing Phase (CDP)|Adverse Event|0
4687403|NCT02474069|16141754|P3|Selection Phase (SP)|Withdrawal of Informed Consent|0
4687404|NCT02474069|16141755|P2|Selection Phase (SP)|Withdrawal of Informed Consent|0
4687405|NCT02474069|16141756|P1|Selection Phase (SP)|Withdrawal of Informed Consent|3
4687406|NCT02474069|16141754|P3|Selection Phase (SP)|Withdrawal by Subject|0
4687407|NCT02474069|16141755|P2|Selection Phase (SP)|Withdrawal by Subject|0
4687408|NCT02474069|16141756|P1|Selection Phase (SP)|Withdrawal by Subject|3
4687409|NCT02474069|16141754|P3|Selection Phase (SP)|Technical Problem|0
4687410|NCT02474069|16141755|P2|Selection Phase (SP)|Technical Problem|0
4687411|NCT02474069|16141756|P1|Selection Phase (SP)|Technical Problem|1
4687412|NCT02474069|16141754|P3|Selection Phase (SP)|No longer requires treatment|0
4687413|NCT02474069|16141755|P2|Selection Phase (SP)|No longer requires treatment|0
4687414|NCT02474069|16141756|P1|Selection Phase (SP)|No longer requires treatment|1
4687415|NCT02474069|16141754|P3|Selection Phase (SP)|Protocol Violation|0
4687416|NCT02474069|16141755|P2|Selection Phase (SP)|Protocol Violation|0
4687417|NCT02474069|16141756|P1|Selection Phase (SP)|Protocol Violation|1
4687418|NCT02474069|16141754|P3|Selection Phase (SP)|Physician Decision|0
4687419|NCT02474069|16141755|P2|Selection Phase (SP)|Physician Decision|0
4687420|NCT02474069|16141756|P1|Selection Phase (SP)|Physician Decision|1
4687421|NCT02474069|16141754|P3|Selection Phase (SP)|Lost to Follow-up|0
4687422|NCT02474069|16141755|P2|Selection Phase (SP)|Lost to Follow-up|0
4687423|NCT02474069|16141756|P1|Selection Phase (SP)|Lost to Follow-up|4
4687424|NCT02474069|16141754|P3|Selection Phase (SP)|Lack of Efficacy|0
4687425|NCT02474069|16141755|P2|Selection Phase (SP)|Lack of Efficacy|0
4687426|NCT02474069|16141756|P1|Selection Phase (SP)|Lack of Efficacy|1
4687427|NCT02474069|16141754|P3|Selection Phase (SP)|Adverse Event|0
4687428|NCT02474069|16141755|P2|Selection Phase (SP)|Adverse Event|0
4687429|NCT02474069|16141756|P1|Selection Phase (SP)|Adverse Event|8
4687430|NCT02473965|16141789|P2|Overall Study|Physician Decision|2
4687431|NCT02473965|16141790|P1|Overall Study|Physician Decision|0
4687432|NCT02473965|16141789|P2|Overall Study|Withdrawal by Subject|3
4687433|NCT02473965|16141790|P1|Overall Study|Withdrawal by Subject|2
4687434|NCT02473965|16141789|P2|Overall Study|MG worsening|1
4687435|NCT02473965|16141790|P1|Overall Study|MG worsening|4
4687436|NCT02473965|16141789|P2|Overall Study|Adverse Event|4
4687437|NCT02473965|16141790|P1|Overall Study|Adverse Event|6
4687438|NCT02473952|16141802|P2|Overall Study|Withdrawal by Subject|6
4687439|NCT02473952|16141803|P1|Overall Study|Withdrawal by Subject|0
4687440|NCT02473952|16141802|P2|Overall Study|Adverse Event|2
4687441|NCT02473952|16141803|P1|Overall Study|Adverse Event|2
4687442|NCT02473640|16141843|P1|Treatment Period 1|Adverse Event|1
4687443|NCT02473523|16141852|P1|Overall Study|Lost to Follow-up|1
4687444|NCT02473523|16141852|P1|Overall Study|Death|1
4687445|NCT02473510|16141873|P2|Overall Study|Lost to Follow-up|2
4687446|NCT02473510|16141874|P1|Overall Study|Lost to Follow-up|1
4687447|NCT02473471|16141888|P1|Overall Study|Lost to Follow-up|1
4687448|NCT02473471|16141888|P1|Overall Study|poor oral hygiene|2
4687449|NCT02473445|16141919|P1|Overall Study|Sponsor Decision|20
4687450|NCT02473445|16141919|P1|Overall Study|Withdrawal by Subject|2
4687451|NCT02473367|16141925|P1|Period 4|Lost to Follow-up|1
4687452|NCT02473367|16141925|P1|Wait 1|Withdrawal by Subject|1
4687453|NCT02473289|16141945|P2|Overall Study|Other|0
4687454|NCT02473289|16141946|P1|Overall Study|Other|2
4687455|NCT02473289|16141945|P2|Overall Study|Treatment Unblinded + Adverse event|1
4687456|NCT02473289|16141946|P1|Overall Study|Treatment Unblinded + Adverse event|0
4687457|NCT02473289|16141945|P2|Overall Study|Withdrawal of consent|7
4687458|NCT02473289|16141946|P1|Overall Study|Withdrawal of consent|6
4687459|NCT02473289|16141945|P2|Overall Study|Protocol Violation|1
4687460|NCT02473289|16141946|P1|Overall Study|Protocol Violation|0
4687461|NCT02473289|16141945|P2|Overall Study|Lost to Follow-up|1
4687462|NCT02473289|16141946|P1|Overall Study|Lost to Follow-up|1
4687463|NCT02473289|16141945|P2|Overall Study|Adverse Event|3
4687464|NCT02473289|16141946|P1|Overall Study|Adverse Event|2
4687465|NCT02472977|16141971|P3|Overall Study|Subject request to discontinue treatment|0
4687466|NCT02472977|16141972|P2|Overall Study|Subject request to discontinue treatment|1
4687467|NCT02472977|16141973|P1|Overall Study|Subject request to discontinue treatment|0
4687468|NCT02472977|16141971|P3|Overall Study|Study drug toxicity|2
4687469|NCT02472977|16141972|P2|Overall Study|Study drug toxicity|0
4687470|NCT02472977|16141973|P1|Overall Study|Study drug toxicity|2
4687471|NCT02472977|16141971|P3|Overall Study|Withdrawal by Subject|0
4687472|NCT02472977|16141972|P2|Overall Study|Withdrawal by Subject|1
4687473|NCT02472977|16141973|P1|Overall Study|Withdrawal by Subject|0
4687474|NCT02472977|16141971|P3|Overall Study|Disease progression|6
4687475|NCT02472977|16141972|P2|Overall Study|Disease progression|25
4687476|NCT02472977|16141973|P1|Overall Study|Disease progression|4
4687477|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Protocol Violation|1
4687478|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Protocol Violation|3
4687479|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Withdrawal by Subject|1
4687480|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Withdrawal by Subject|3
4687481|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Lost to Follow-up|1
4687482|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Lost to Follow-up|2
4687483|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Physician Decision|1
4687484|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Physician Decision|1
4687485|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Death|1
4687486|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Death|0
4687487|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Disease Progression|56
4687488|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Disease Progression|52
4687489|NCT02472964|16141998|P2|Part 2 (Week 24-week 48)|Adverse Event|2
4687490|NCT02472964|16141999|P1|Part 2 (Week 24-week 48)|Adverse Event|4
4687491|NCT02472964|16141998|P2|Part 1 (up to Week 24)|Other|1
4687492|NCT02472964|16141999|P1|Part 1 (up to Week 24)|Other|2
4687493|NCT02472964|16141998|P2|Part 1 (up to Week 24)|Withdrawal by Subject|2
4687494|NCT02472964|16141999|P1|Part 1 (up to Week 24)|Withdrawal by Subject|7
4687495|NCT02472964|16141998|P2|Part 1 (up to Week 24)|Lost to Follow-up|1
4687496|NCT02472964|16141999|P1|Part 1 (up to Week 24)|Lost to Follow-up|0
4687497|NCT02472964|16141998|P2|Part 1 (up to Week 24)|Physician Decision|1
4687498|NCT02472964|16141999|P1|Part 1 (up to Week 24)|Physician Decision|3
4687499|NCT02472964|16141998|P2|Part 1 (up to Week 24)|Death|6
4687500|NCT02472964|16141999|P1|Part 1 (up to Week 24)|Death|3
4687501|NCT02472964|16141998|P2|Part 1 (up to Week 24)|disease progression|47
4687502|NCT02472964|16141999|P1|Part 1 (up to Week 24)|disease progression|58
4687503|NCT02472964|16141998|P2|Part 1 (up to Week 24)|Adverse Event|4
4687504|NCT02472964|16141999|P1|Part 1 (up to Week 24)|Adverse Event|2
4687505|NCT02472886|16142008|P3|Overall Study|Lack of Efficacy|1
4687506|NCT02472886|16142009|P2|Overall Study|Lack of Efficacy|2
4687507|NCT02472886|16142010|P1|Overall Study|Lack of Efficacy|0
4687508|NCT02472847|16142038|P2|Overall Study|Withdrawal by Subject|5
4687509|NCT02472847|16142039|P1|Overall Study|Withdrawal by Subject|1
4687510|NCT02472795|16142050|P5|Overall Study|Withdrawal by Subject|1
4687511|NCT02472795|16142051|P4|Overall Study|Withdrawal by Subject|0
4687512|NCT02472795|16142052|P3|Overall Study|Withdrawal by Subject|0
4687513|NCT02472795|16142053|P2|Overall Study|Withdrawal by Subject|0
4687514|NCT02472795|16142054|P1|Overall Study|Withdrawal by Subject|0
4687515|NCT02472795|16142050|P5|Overall Study|Adverse Event|2
4687516|NCT02472795|16142051|P4|Overall Study|Adverse Event|0
4687517|NCT02472795|16142052|P3|Overall Study|Adverse Event|0
4687518|NCT02472795|16142053|P2|Overall Study|Adverse Event|1
4687519|NCT02472795|16142054|P1|Overall Study|Adverse Event|0
4687520|NCT02472756|16142086|P1|Maintenance (Approximately 2 Years)|Adverse Event|1
4687521|NCT02472756|16142086|P1|Maintenance (Approximately 2 Years)|Progression Disease|2
4687522|NCT02472756|16142086|P1|Maintenance (Approximately 2 Years)|Lack of Drug|7
4687523|NCT02472756|16142086|P1|Induction (Approximately 6 Months)|Enrolled But Not Treated|1
4687524|NCT02472756|16142086|P1|Induction (Approximately 6 Months)|Adverse Event|1
4687525|NCT02472652|16142107|P1|Overall Study|Lost to Follow-up|1
4687526|NCT02472639|16142114|P2|Overall Study|Physician Decision|3
4687527|NCT02472639|16142115|P1|Overall Study|Physician Decision|4
4687528|NCT02472405|16142171|P1|Overall Study|Adverse Event|1
4687529|NCT02472405|16142171|P1|Overall Study|Lost to Follow-up|9
4687530|NCT02472366|16142179|P2|Overall Study|Lost to Follow-up|0
4687531|NCT02472366|16142180|P1|Overall Study|Lost to Follow-up|1
4687532|NCT02472353|16142196|P2|Overall Study|Study Termination|4
4687533|NCT02472353|16142197|P1|Overall Study|Study Termination|1
4687534|NCT02472353|16142196|P2|Overall Study|Withdrawal by Subject|1
4687535|NCT02472353|16142197|P1|Overall Study|Withdrawal by Subject|2
4687536|NCT02472353|16142196|P2|Overall Study|Lost to Follow-up|1
4687537|NCT02472353|16142197|P1|Overall Study|Lost to Follow-up|1
4687538|NCT02472145|16142234|P3|Overall Study|Other|43
4687539|NCT02472145|16142235|P2|Overall Study|Other|45
4687540|NCT02472145|16142236|P1|Overall Study|Other|0
4687541|NCT02472145|16142234|P3|Overall Study|Sponsor decision|2
4687542|NCT02472145|16142235|P2|Overall Study|Sponsor decision|3
4687543|NCT02472145|16142236|P1|Overall Study|Sponsor decision|0
4687544|NCT02472145|16142234|P3|Overall Study|Withdrawal by Subject|13
4687545|NCT02472145|16142235|P2|Overall Study|Withdrawal by Subject|9
4687546|NCT02472145|16142236|P1|Overall Study|Withdrawal by Subject|0
4687547|NCT02472145|16142234|P3|Overall Study|Lost to Follow-up|0
4687548|NCT02472145|16142235|P2|Overall Study|Lost to Follow-up|1
4687549|NCT02472145|16142236|P1|Overall Study|Lost to Follow-up|0
4687550|NCT02472145|16142234|P3|Overall Study|Death|99
4687551|NCT02472145|16142235|P2|Overall Study|Death|101
4687552|NCT02472145|16142236|P1|Overall Study|Death|10
4687553|NCT02471755|16142257|P2|Overall Study|Lost to Follow-up|1
4687554|NCT02471755|16142258|P1|Overall Study|Lost to Follow-up|0
4687555|NCT02471755|16142257|P2|Overall Study|Withdrawal by Subject|0
4687556|NCT02471755|16142258|P1|Overall Study|Withdrawal by Subject|1
4687557|NCT02471612|16142287|P1|Overall Study|Lost to Follow-up|2
4687558|NCT02471404|16142318|P3|Overall Study|Other reasons not specified|12
4687559|NCT02471404|16142319|P2|Overall Study|Other reasons not specified|7
4687560|NCT02471404|16142320|P1|Overall Study|Other reasons not specified|10
4687561|NCT02471404|16142318|P3|Overall Study|Withdrawal by Subject|5
4687562|NCT02471404|16142319|P2|Overall Study|Withdrawal by Subject|4
4687563|NCT02471404|16142320|P1|Overall Study|Withdrawal by Subject|8
4687564|NCT02471404|16142318|P3|Overall Study|Protocol Violation|0
4687565|NCT02471404|16142319|P2|Overall Study|Protocol Violation|0
4687566|NCT02471404|16142320|P1|Overall Study|Protocol Violation|1
4687567|NCT02471404|16142318|P3|Overall Study|Lost to Follow-up|3
4687568|NCT02471404|16142319|P2|Overall Study|Lost to Follow-up|1
4687569|NCT02471404|16142320|P1|Overall Study|Lost to Follow-up|1
4687570|NCT02471404|16142318|P3|Overall Study|Failure to Meet Randomization Criteria|1
4687571|NCT02471404|16142319|P2|Overall Study|Failure to Meet Randomization Criteria|0
4687572|NCT02471404|16142320|P1|Overall Study|Failure to Meet Randomization Criteria|2
4687573|NCT02471404|16142318|P3|Overall Study|Developed Study Withdrawal Criteria|2
4687574|NCT02471404|16142319|P2|Overall Study|Developed Study Withdrawal Criteria|1
4687575|NCT02471404|16142320|P1|Overall Study|Developed Study Withdrawal Criteria|4
4687576|NCT02471404|16142318|P3|Overall Study|Adverse Event|2
4687577|NCT02471404|16142319|P2|Overall Study|Adverse Event|1
4687578|NCT02471404|16142320|P1|Overall Study|Adverse Event|7
4687579|NCT02471183|16142352|P1|Extended Treatment Period|Lack of Efficacy|1
4687580|NCT02471183|16142352|P1|Main Treatment Period|Withdrawal by Subject|1
4687581|NCT02471183|16142352|P1|Main Treatment Period|Adverse Event|1
4687582|NCT02470806|16142387|P2|Overall Study|Lack of Efficacy|15
4687583|NCT02470806|16142388|P1|Overall Study|Lack of Efficacy|5
4687584|NCT02470806|16142387|P2|Overall Study|Withdrawal by Subject|10
4687585|NCT02470806|16142388|P1|Overall Study|Withdrawal by Subject|3
4687586|NCT02470806|16142387|P2|Overall Study|Physician Decision|3
4687587|NCT02470806|16142388|P1|Overall Study|Physician Decision|0
4687588|NCT02470806|16142387|P2|Overall Study|Protocol Violation|11
4687589|NCT02470806|16142388|P1|Overall Study|Protocol Violation|4
4687590|NCT02470806|16142387|P2|Overall Study|Adverse Event|2
4687591|NCT02470806|16142388|P1|Overall Study|Adverse Event|5
4687592|NCT02470806|16142387|P2|Overall Study|Lost to Follow-up|1
4687593|NCT02470806|16142388|P1|Overall Study|Lost to Follow-up|1
4687594|NCT02470585|16142441|P3|Overall Study|Other|6
4687595|NCT02470585|16142442|P2|Overall Study|Other|4
4687596|NCT02470585|16142443|P1|Overall Study|Other|4
4687597|NCT02470585|16142441|P3|Overall Study|Lost to Follow-up|4
4687598|NCT02470585|16142442|P2|Overall Study|Lost to Follow-up|5
4687599|NCT02470585|16142443|P1|Overall Study|Lost to Follow-up|2
4687600|NCT02470585|16142441|P3|Overall Study|Withdrawal by Subject|29
4687601|NCT02470585|16142442|P2|Overall Study|Withdrawal by Subject|21
4687602|NCT02470585|16142443|P1|Overall Study|Withdrawal by Subject|19
4687603|NCT02470585|16142441|P3|Overall Study|Death|86
4687604|NCT02470585|16142442|P2|Overall Study|Death|87
4687605|NCT02470585|16142443|P1|Overall Study|Death|82
4687606|NCT02470429|16142476|P2|Overall Study|Withdrawal by Subject|0
4687607|NCT02470429|16142477|P1|Overall Study|Withdrawal by Subject|1
4687608|NCT02470429|16142476|P2|Overall Study|Adverse Event|0
4687609|NCT02470429|16142477|P1|Overall Study|Adverse Event|1
4687610|NCT02470403|16142495|P5|Overall Study|Subject/guardian decision|0
4687611|NCT02470403|16142496|P4|Overall Study|Subject/guardian decision|4
4687612|NCT02470403|16142497|P3|Overall Study|Subject/guardian decision|0
4687613|NCT02470403|16142498|P2|Overall Study|Subject/guardian decision|0
4687614|NCT02470403|16142499|P1|Overall Study|Subject/guardian decision|1
4687615|NCT02470403|16142495|P5|Overall Study|Lost to Follow-up|0
4687616|NCT02470403|16142496|P4|Overall Study|Lost to Follow-up|0
4687617|NCT02470403|16142497|P3|Overall Study|Lost to Follow-up|0
4687618|NCT02470403|16142498|P2|Overall Study|Lost to Follow-up|1
4687619|NCT02470403|16142499|P1|Overall Study|Lost to Follow-up|0
4687620|NCT02470403|16142495|P5|Overall Study|Adverse Event|0
4687621|NCT02470403|16142496|P4|Overall Study|Adverse Event|0
4687622|NCT02470403|16142497|P3|Overall Study|Adverse Event|0
4687623|NCT02470403|16142498|P2|Overall Study|Adverse Event|0
4687624|NCT02470403|16142499|P1|Overall Study|Adverse Event|1
4687625|NCT02469961|16142579|P2|Overall Study|Physician Decision|1
4687626|NCT02469961|16142580|P1|Overall Study|Physician Decision|4
4687627|NCT02469896|16142594|P2|Overall Study|Withdrawal by Subject|0
4687628|NCT02469896|16142595|P1|Overall Study|Withdrawal by Subject|2
4687629|NCT02469623|16142665|P1|Overall Study|Death|3
4687630|NCT02469623|16142665|P1|Overall Study|Withdrawal by Subject|2
4687631|NCT02469623|16142665|P1|Overall Study|Lost to Follow-up|4
4687632|NCT02469623|16142665|P1|Overall Study|Not consented for long-term follow-up|4
4687633|NCT02469610|16142672|P2|Overall Study|exclusion criteria|1
4687634|NCT02469610|16142673|P1|Overall Study|exclusion criteria|2
4687635|NCT02469610|16142672|P2|Overall Study|Lost to Follow-up|0
4687636|NCT02469610|16142673|P1|Overall Study|Lost to Follow-up|1
4687637|NCT02469610|16142672|P2|Overall Study|Death|0
4687638|NCT02469610|16142673|P1|Overall Study|Death|1
4687639|NCT02469415|16142700|P1|Overall Study|Investigational agent placed on hold|2
4687640|NCT02469415|16142700|P1|Overall Study|Withdrawal by Subject|1
4687641|NCT02469298|16142708|P4|Overall Study|Withdrawal by Subject|1
4687642|NCT02469298|16142709|P3|Overall Study|Withdrawal by Subject|0
4687643|NCT02469298|16142710|P2|Overall Study|Withdrawal by Subject|0
4687644|NCT02469298|16142711|P1|Overall Study|Withdrawal by Subject|0
4687645|NCT02469298|16142708|P4|Overall Study|Physician Decision|1
4687646|NCT02469298|16142709|P3|Overall Study|Physician Decision|0
4687647|NCT02469298|16142710|P2|Overall Study|Physician Decision|0
4687648|NCT02469298|16142711|P1|Overall Study|Physician Decision|0
4687649|NCT02469298|16142708|P4|Overall Study|Lost to Follow-up|0
4687650|NCT02469298|16142709|P3|Overall Study|Lost to Follow-up|1
4687651|NCT02469298|16142710|P2|Overall Study|Lost to Follow-up|0
4687652|NCT02469298|16142711|P1|Overall Study|Lost to Follow-up|1
4687653|NCT02469298|16142708|P4|Overall Study|Protocol Violation|0
4687654|NCT02469298|16142709|P3|Overall Study|Protocol Violation|1
4687655|NCT02469298|16142710|P2|Overall Study|Protocol Violation|1
4687656|NCT02469298|16142711|P1|Overall Study|Protocol Violation|0
4687657|NCT02469246|16142851|P2|Double-Blind Phase|Lost to Follow-up|5
4687658|NCT02469246|16142852|P1|Double-Blind Phase|Lost to Follow-up|9
4687659|NCT02469246|16142851|P2|Double-Blind Phase|Withdrew Consent|25
4687660|NCT02469246|16142852|P1|Double-Blind Phase|Withdrew Consent|25
4687661|NCT02469246|16142851|P2|Double-Blind Phase|Protocol Violation|1
4687662|NCT02469246|16142852|P1|Double-Blind Phase|Protocol Violation|1
4687663|NCT02469246|16142851|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
4687664|NCT02469246|16142852|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
4687665|NCT02469246|16142851|P2|Double-Blind Phase|Investigator's Discretion|8
4687666|NCT02469246|16142852|P1|Double-Blind Phase|Investigator's Discretion|8
4687667|NCT02469246|16142851|P2|Double-Blind Phase|Lack of Efficacy|1
4687668|NCT02469246|16142852|P1|Double-Blind Phase|Lack of Efficacy|2
4687669|NCT02469246|16142851|P2|Double-Blind Phase|Death|0
4687670|NCT02469246|16142852|P1|Double-Blind Phase|Death|2
4687671|NCT02469246|16142851|P2|Double-Blind Phase|Adverse Event|9
4687672|NCT02469246|16142852|P1|Double-Blind Phase|Adverse Event|12
4687673|NCT02469246|16142851|P2|Double-Blind Phase|Randomized and Never Treated|6
4687674|NCT02469246|16142852|P1|Double-Blind Phase|Randomized and Never Treated|5
4687675|NCT02407236|16142890|P8|Maintenance Study (44 Weeks)|Other|1
4687676|NCT02407236|16142891|P7|Maintenance Study (44 Weeks)|Other|2
4687677|NCT02407236|16142892|P6|Maintenance Study (44 Weeks)|Other|1
4687678|NCT02407236|16142893|P5|Maintenance Study (44 Weeks)|Other|1
4687679|NCT02407236|16142894|P4|Maintenance Study (44 Weeks)|Other|0
4687680|NCT02407236|16142895|P3|Maintenance Study (44 Weeks)|Other|0
4687681|NCT02407236|16142896|P2|Maintenance Study (44 Weeks)|Other|0
4687682|NCT02407236|16142897|P1|Maintenance Study (44 Weeks)|Other|0
4687683|NCT02407236|16142890|P8|Maintenance Study (44 Weeks)|Sponsor decision|0
4687684|NCT02407236|16142891|P7|Maintenance Study (44 Weeks)|Sponsor decision|0
4687685|NCT02407236|16142892|P6|Maintenance Study (44 Weeks)|Sponsor decision|1
4687686|NCT02407236|16142893|P5|Maintenance Study (44 Weeks)|Sponsor decision|0
4687687|NCT02407236|16142894|P4|Maintenance Study (44 Weeks)|Sponsor decision|1
4687688|NCT02407236|16142895|P3|Maintenance Study (44 Weeks)|Sponsor decision|0
4687689|NCT02407236|16142896|P2|Maintenance Study (44 Weeks)|Sponsor decision|0
4687690|NCT02407236|16142897|P1|Maintenance Study (44 Weeks)|Sponsor decision|0
4687691|NCT02407236|16142890|P8|Maintenance Study (44 Weeks)|Withdraw of consent|5
4687692|NCT02407236|16142891|P7|Maintenance Study (44 Weeks)|Withdraw of consent|7
4687693|NCT02407236|16142892|P6|Maintenance Study (44 Weeks)|Withdraw of consent|5
4687694|NCT02407236|16142893|P5|Maintenance Study (44 Weeks)|Withdraw of consent|10
4687695|NCT02407236|16142894|P4|Maintenance Study (44 Weeks)|Withdraw of consent|8
4687696|NCT02407236|16142895|P3|Maintenance Study (44 Weeks)|Withdraw of consent|0
4687697|NCT02407236|16142896|P2|Maintenance Study (44 Weeks)|Withdraw of consent|0
4687698|NCT02407236|16142897|P1|Maintenance Study (44 Weeks)|Withdraw of consent|0
4687699|NCT02407236|16142890|P8|Maintenance Study (44 Weeks)|Death|1
4687700|NCT02407236|16142891|P7|Maintenance Study (44 Weeks)|Death|0
4687701|NCT02407236|16142892|P6|Maintenance Study (44 Weeks)|Death|0
4687702|NCT02407236|16142893|P5|Maintenance Study (44 Weeks)|Death|0
4687703|NCT02407236|16142894|P4|Maintenance Study (44 Weeks)|Death|0
4687704|NCT02407236|16142895|P3|Maintenance Study (44 Weeks)|Death|0
4687705|NCT02407236|16142896|P2|Maintenance Study (44 Weeks)|Death|0
4687706|NCT02407236|16142897|P1|Maintenance Study (44 Weeks)|Death|0
4687707|NCT02407236|16142890|P8|Maintenance Study (44 Weeks)|Lost to Follow-up|1
4687708|NCT02407236|16142891|P7|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4687709|NCT02407236|16142892|P6|Maintenance Study (44 Weeks)|Lost to Follow-up|1
4687710|NCT02407236|16142893|P5|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4687711|NCT02407236|16142894|P4|Maintenance Study (44 Weeks)|Lost to Follow-up|1
4687712|NCT02407236|16142895|P3|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4687713|NCT02407236|16142896|P2|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4687714|NCT02407236|16142897|P1|Maintenance Study (44 Weeks)|Lost to Follow-up|0
4687715|NCT02407236|16142890|P8|Induction Study (8 Weeks)|Other|0
4687716|NCT02407236|16142891|P7|Induction Study (8 Weeks)|Other|0
4687717|NCT02407236|16142892|P6|Induction Study (8 Weeks)|Other|0
4687718|NCT02407236|16142893|P5|Induction Study (8 Weeks)|Other|0
4687719|NCT02407236|16142894|P4|Induction Study (8 Weeks)|Other|0
4687720|NCT02407236|16142895|P3|Induction Study (8 Weeks)|Other|5
4687721|NCT02407236|16142896|P2|Induction Study (8 Weeks)|Other|1
4687722|NCT02407236|16142897|P1|Induction Study (8 Weeks)|Other|2
4687723|NCT02407236|16142890|P8|Induction Study (8 Weeks)|Physician Decision|0
4687724|NCT02407236|16142891|P7|Induction Study (8 Weeks)|Physician Decision|0
4687725|NCT02407236|16142892|P6|Induction Study (8 Weeks)|Physician Decision|0
4687726|NCT02407236|16142893|P5|Induction Study (8 Weeks)|Physician Decision|0
4687727|NCT02407236|16142894|P4|Induction Study (8 Weeks)|Physician Decision|0
4687728|NCT02407236|16142895|P3|Induction Study (8 Weeks)|Physician Decision|0
4687729|NCT02407236|16142896|P2|Induction Study (8 Weeks)|Physician Decision|1
4687730|NCT02407236|16142897|P1|Induction Study (8 Weeks)|Physician Decision|1
4687731|NCT02407236|16142890|P8|Induction Study (8 Weeks)|Lost to Follow-up|0
4687732|NCT02407236|16142891|P7|Induction Study (8 Weeks)|Lost to Follow-up|0
4687733|NCT02407236|16142892|P6|Induction Study (8 Weeks)|Lost to Follow-up|0
4687734|NCT02407236|16142893|P5|Induction Study (8 Weeks)|Lost to Follow-up|0
4687735|NCT02407236|16142894|P4|Induction Study (8 Weeks)|Lost to Follow-up|0
4687736|NCT02407236|16142895|P3|Induction Study (8 Weeks)|Lost to Follow-up|1
4687737|NCT02407236|16142896|P2|Induction Study (8 Weeks)|Lost to Follow-up|0
4687738|NCT02407236|16142897|P1|Induction Study (8 Weeks)|Lost to Follow-up|0
4687739|NCT02407236|16142890|P8|Induction Study (8 Weeks)|Withdrawal by Subject|0
4687740|NCT02407236|16142891|P7|Induction Study (8 Weeks)|Withdrawal by Subject|0
4687741|NCT02407236|16142892|P6|Induction Study (8 Weeks)|Withdrawal by Subject|0
4687742|NCT02407236|16142893|P5|Induction Study (8 Weeks)|Withdrawal by Subject|0
4687743|NCT02407236|16142894|P4|Induction Study (8 Weeks)|Withdrawal by Subject|0
4687744|NCT02407236|16142895|P3|Induction Study (8 Weeks)|Withdrawal by Subject|7
4687745|NCT02407236|16142896|P2|Induction Study (8 Weeks)|Withdrawal by Subject|9
4687746|NCT02407236|16142897|P1|Induction Study (8 Weeks)|Withdrawal by Subject|17
4687747|NCT02407236|16142890|P8|Induction Study (8 Weeks)|Death|0
4687748|NCT02407236|16142891|P7|Induction Study (8 Weeks)|Death|0
4687749|NCT02407236|16142892|P6|Induction Study (8 Weeks)|Death|0
4687750|NCT02407236|16142893|P5|Induction Study (8 Weeks)|Death|0
4687751|NCT02407236|16142894|P4|Induction Study (8 Weeks)|Death|0
4687752|NCT02407236|16142895|P3|Induction Study (8 Weeks)|Death|1
4687753|NCT02407236|16142896|P2|Induction Study (8 Weeks)|Death|0
4687754|NCT02407236|16142897|P1|Induction Study (8 Weeks)|Death|0
4687755|NCT02407236|16142890|P8|Induction Study (8 Weeks)|Adverse Event|0
4687756|NCT02407236|16142891|P7|Induction Study (8 Weeks)|Adverse Event|0
4687757|NCT02407236|16142892|P6|Induction Study (8 Weeks)|Adverse Event|0
4687758|NCT02407236|16142893|P5|Induction Study (8 Weeks)|Adverse Event|0
4687759|NCT02407236|16142894|P4|Induction Study (8 Weeks)|Adverse Event|0
4687760|NCT02407236|16142895|P3|Induction Study (8 Weeks)|Adverse Event|1
4687761|NCT02407236|16142896|P2|Induction Study (8 Weeks)|Adverse Event|0
4687762|NCT02407236|16142897|P1|Induction Study (8 Weeks)|Adverse Event|3
4687763|NCT02469168|16143136|P2|Overall Study|Trial closed|0
4687764|NCT02469168|16143137|P1|Overall Study|Trial closed|1
4687765|NCT02469090|16143157|P3|Period 2: Maintenance Treatment Phase|Death|1
4687766|NCT02469090|16143158|P2|Period 2: Maintenance Treatment Phase|Death|0
4687767|NCT02469090|16143159|P1|Period 2: Maintenance Treatment Phase|Death|0
4687768|NCT02469090|16143157|P3|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
4687769|NCT02469090|16143158|P2|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1
4687770|NCT02469090|16143159|P1|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0
4687771|NCT02469090|16143157|P3|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4
4687772|NCT02469090|16143158|P2|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3
4687773|NCT02469090|16143159|P1|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0
4687774|NCT02469090|16143157|P3|Period 2: Maintenance Treatment Phase|Adverse Event|15
4687775|NCT02469090|16143158|P2|Period 2: Maintenance Treatment Phase|Adverse Event|5
4687776|NCT02469090|16143159|P1|Period 2: Maintenance Treatment Phase|Adverse Event|0
4687777|NCT02469090|16143157|P3|Period 1: Dose Titration Phase|Lack of Efficacy|0
4687778|NCT02469090|16143158|P2|Period 1: Dose Titration Phase|Lack of Efficacy|0
4687779|NCT02469090|16143159|P1|Period 1: Dose Titration Phase|Lack of Efficacy|11
4687780|NCT02469090|16143157|P3|Period 1: Dose Titration Phase|Lost to Follow-up|0
4687781|NCT02469090|16143158|P2|Period 1: Dose Titration Phase|Lost to Follow-up|0
4687782|NCT02469090|16143159|P1|Period 1: Dose Titration Phase|Lost to Follow-up|1
4687783|NCT02469090|16143157|P3|Period 1: Dose Titration Phase|Withdrawal by Subject|0
4687784|NCT02469090|16143158|P2|Period 1: Dose Titration Phase|Withdrawal by Subject|0
4687785|NCT02469090|16143159|P1|Period 1: Dose Titration Phase|Withdrawal by Subject|8
4687786|NCT02469090|16143157|P3|Period 1: Dose Titration Phase|Adverse Event|0
4687787|NCT02469090|16143158|P2|Period 1: Dose Titration Phase|Adverse Event|0
4687788|NCT02469090|16143159|P1|Period 1: Dose Titration Phase|Adverse Event|12
4687789|NCT02469077|16143186|P2|Post Intervention /Followup|Withdrawal by Subject|1
4687790|NCT02469077|16143187|P1|Post Intervention /Followup|Withdrawal by Subject|2
4687791|NCT02469077|16143186|P2|Post Randomization/Intervention Period|Conflicting health issues|1
4687792|NCT02469077|16143187|P1|Post Randomization/Intervention Period|Conflicting health issues|0
4687793|NCT02469077|16143186|P2|Post Randomization/Intervention Period|Relocated|1
4687794|NCT02469077|16143187|P1|Post Randomization/Intervention Period|Relocated|1
4687795|NCT02469077|16143186|P2|Post Randomization/Intervention Period|Scheduling issues|2
4687796|NCT02469077|16143187|P1|Post Randomization/Intervention Period|Scheduling issues|3
4687797|NCT02469064|16143219|P2|Overall Study|Request not to receive intervention.|3
4687798|NCT02469064|16143220|P1|Overall Study|Request not to receive intervention.|1
4687799|NCT02468934|16143228|P1|Overall Study|Screen Failure|3
4687800|NCT02468934|16143228|P1|Overall Study|Withdrawal by Subject|4
4687801|NCT02468674|16143279|P9|Overall Study|Protocol Deviation|1
4687802|NCT02468674|16143280|P8|Overall Study|Protocol Deviation|1
4687803|NCT02468674|16143281|P7|Overall Study|Protocol Deviation|0
4687804|NCT02468674|16143282|P6|Overall Study|Protocol Deviation|0
4687805|NCT02468674|16143283|P5|Overall Study|Protocol Deviation|0
4687806|NCT02468674|16143284|P4|Overall Study|Protocol Deviation|0
4687807|NCT02468674|16143285|P3|Overall Study|Protocol Deviation|0
4687808|NCT02468674|16143286|P2|Overall Study|Protocol Deviation|0
4687809|NCT02468674|16143287|P1|Overall Study|Protocol Deviation|0
4687810|NCT02468674|16143279|P9|Overall Study|Patient/Guardian Decision|1
4687811|NCT02468674|16143280|P8|Overall Study|Patient/Guardian Decision|2
4687812|NCT02468674|16143281|P7|Overall Study|Patient/Guardian Decision|0
4687813|NCT02468674|16143282|P6|Overall Study|Patient/Guardian Decision|0
4687814|NCT02468674|16143283|P5|Overall Study|Patient/Guardian Decision|1
4687815|NCT02468674|16143284|P4|Overall Study|Patient/Guardian Decision|0
4687816|NCT02468674|16143285|P3|Overall Study|Patient/Guardian Decision|0
4687817|NCT02468674|16143286|P2|Overall Study|Patient/Guardian Decision|0
4687818|NCT02468674|16143287|P1|Overall Study|Patient/Guardian Decision|0
4687819|NCT02468674|16143279|P9|Overall Study|Physician Decision|0
4687820|NCT02468674|16143280|P8|Overall Study|Physician Decision|0
4687821|NCT02468674|16143281|P7|Overall Study|Physician Decision|1
4687822|NCT02468674|16143282|P6|Overall Study|Physician Decision|0
4687823|NCT02468674|16143283|P5|Overall Study|Physician Decision|0
4687824|NCT02468674|16143284|P4|Overall Study|Physician Decision|0
4687825|NCT02468674|16143285|P3|Overall Study|Physician Decision|0
4687826|NCT02468674|16143286|P2|Overall Study|Physician Decision|0
4687827|NCT02468674|16143287|P1|Overall Study|Physician Decision|0
4687828|NCT02468674|16143279|P9|Overall Study|Lost to Follow-up|1
4687829|NCT02468674|16143280|P8|Overall Study|Lost to Follow-up|1
4687830|NCT02468674|16143281|P7|Overall Study|Lost to Follow-up|0
4687831|NCT02468674|16143282|P6|Overall Study|Lost to Follow-up|0
4687832|NCT02468674|16143283|P5|Overall Study|Lost to Follow-up|0
4687833|NCT02468674|16143284|P4|Overall Study|Lost to Follow-up|0
4687834|NCT02468674|16143285|P3|Overall Study|Lost to Follow-up|0
4687835|NCT02468674|16143286|P2|Overall Study|Lost to Follow-up|0
4687836|NCT02468674|16143287|P1|Overall Study|Lost to Follow-up|1
4687837|NCT02468674|16143279|P9|Overall Study|Adverse Event|0
4687838|NCT02468674|16143280|P8|Overall Study|Adverse Event|0
4687839|NCT02468674|16143281|P7|Overall Study|Adverse Event|0
4687840|NCT02468674|16143282|P6|Overall Study|Adverse Event|1
4687841|NCT02468674|16143283|P5|Overall Study|Adverse Event|0
4687842|NCT02468674|16143284|P4|Overall Study|Adverse Event|1
4687843|NCT02468674|16143285|P3|Overall Study|Adverse Event|0
4687844|NCT02468674|16143286|P2|Overall Study|Adverse Event|0
4687845|NCT02468674|16143287|P1|Overall Study|Adverse Event|0
4687846|NCT02468648|16143343|P1|Overall Study|Death|1
4687847|NCT02468414|16143410|P2|Overall Study|Screen Failure|0
4687848|NCT02468414|16143411|P1|Overall Study|Screen Failure|1
4687849|NCT02468414|16143410|P2|Overall Study|Poor in-vitro secreting TARGTs|0
4687850|NCT02468414|16143411|P1|Overall Study|Poor in-vitro secreting TARGTs|1
4687851|NCT02468414|16143410|P2|Overall Study|Early Study Termination by Sponsor|0
4687852|NCT02468414|16143411|P1|Overall Study|Early Study Termination by Sponsor|1
4687853|NCT02468193|16143417|P1|Overall Study|Subject/ Guardian decision|2
4687854|NCT02468193|16143417|P1|Overall Study|Adverse Event|4
4687855|NCT02466659|16143739|P2|Overall Study|Lost to Follow-up|2
4687856|NCT02466659|16143740|P1|Overall Study|Lost to Follow-up|5
4687857|NCT02466555|16143794|P1|Overall Study|Lost to Follow-up|2
4687858|NCT02466516|16143806|P5|Overall Study|Lost to Follow-up|0
4687859|NCT02466516|16143807|P4|Overall Study|Lost to Follow-up|0
4687860|NCT02466516|16143808|P3|Overall Study|Lost to Follow-up|1
4687861|NCT02466516|16143809|P2|Overall Study|Lost to Follow-up|0
4687862|NCT02466516|16143810|P1|Overall Study|Lost to Follow-up|2
4687863|NCT02466516|16143806|P5|Overall Study|Withdrew Consent|0
4687864|NCT02466516|16143807|P4|Overall Study|Withdrew Consent|0
4687865|NCT02466516|16143808|P3|Overall Study|Withdrew Consent|0
4687866|NCT02466516|16143809|P2|Overall Study|Withdrew Consent|0
4687867|NCT02466516|16143810|P1|Overall Study|Withdrew Consent|1
4687868|NCT02466516|16143806|P5|Overall Study|Adverse Event|0
4687869|NCT02466516|16143807|P4|Overall Study|Adverse Event|0
4687870|NCT02466516|16143808|P3|Overall Study|Adverse Event|0
4687871|NCT02466516|16143809|P2|Overall Study|Adverse Event|1
4687872|NCT02466516|16143810|P1|Overall Study|Adverse Event|1
4687873|NCT02466425|16143829|P2|Overall Study|Withdrawal by Parent/Guardian|0
4687874|NCT02466425|16143830|P1|Overall Study|Withdrawal by Parent/Guardian|2
4687875|NCT02466425|16143829|P2|Overall Study|Other|3
4687876|NCT02466425|16143830|P1|Overall Study|Other|1
4687877|NCT02466425|16143829|P2|Overall Study|Withdrawal by Subject|1
4687878|NCT02466425|16143830|P1|Overall Study|Withdrawal by Subject|0
4687879|NCT02466425|16143829|P2|Overall Study|Protocol Violation|0
4687880|NCT02466425|16143830|P1|Overall Study|Protocol Violation|1
4687881|NCT02466425|16143829|P2|Overall Study|Lost to Follow-up|0
4687882|NCT02466425|16143830|P1|Overall Study|Lost to Follow-up|3
4687883|NCT02466425|16143829|P2|Overall Study|Lack of Efficacy|1
4687884|NCT02466425|16143830|P1|Overall Study|Lack of Efficacy|4
4687885|NCT02466425|16143829|P2|Overall Study|Adverse Event|11
4687886|NCT02466425|16143830|P1|Overall Study|Adverse Event|3
4687887|NCT02465931|16143868|P2|Overall Study|Withdrawal by Subject|0
4687888|NCT02465931|16143869|P1|Overall Study|Withdrawal by Subject|1
4687889|NCT02465931|16143868|P2|Overall Study|Protocol Violation|0
4687890|NCT02465931|16143869|P1|Overall Study|Protocol Violation|1
4687891|NCT02465931|16143868|P2|Overall Study|Lost to Follow-up|11
4687892|NCT02465931|16143869|P1|Overall Study|Lost to Follow-up|9
4687893|NCT02465866|16143875|P4|Period 3|Withdrawal by Subject|0
4687894|NCT02465866|16143876|P3|Period 3|Withdrawal by Subject|0
4687895|NCT02465866|16143877|P2|Period 3|Withdrawal by Subject|1
4687896|NCT02465866|16143878|P1|Period 3|Withdrawal by Subject|0
4687897|NCT02465528|16143968|P4|Overall Study|Physician Decision|0
4687898|NCT02465528|16143969|P3|Overall Study|Physician Decision|1
4687899|NCT02465528|16143970|P2|Overall Study|Physician Decision|0
4687900|NCT02465528|16143971|P1|Overall Study|Physician Decision|0
4687901|NCT02465528|16143968|P4|Overall Study|Adverse Event|1
4687902|NCT02465528|16143969|P3|Overall Study|Adverse Event|0
4687903|NCT02465528|16143970|P2|Overall Study|Adverse Event|0
4687904|NCT02465528|16143971|P1|Overall Study|Adverse Event|0
4687905|NCT02465528|16143968|P4|Overall Study|Withdrawal by Subject|0
4687906|NCT02465528|16143969|P3|Overall Study|Withdrawal by Subject|2
4687907|NCT02465528|16143970|P2|Overall Study|Withdrawal by Subject|0
4687908|NCT02465528|16143971|P1|Overall Study|Withdrawal by Subject|0
4687909|NCT02465528|16143968|P4|Overall Study|Study terminated by sponsor|0
4687910|NCT02465528|16143969|P3|Overall Study|Study terminated by sponsor|0
4687911|NCT02465528|16143970|P2|Overall Study|Study terminated by sponsor|2
4687912|NCT02465528|16143971|P1|Overall Study|Study terminated by sponsor|1
4687913|NCT02465528|16143968|P4|Overall Study|Progressive disease|4
4687914|NCT02465528|16143969|P3|Overall Study|Progressive disease|9
4687915|NCT02465528|16143970|P2|Overall Study|Progressive disease|2
4687916|NCT02465528|16143971|P1|Overall Study|Progressive disease|0
4687917|NCT02465515|16144004|P2|Overall Study|Lost to Follow-up|51
4687918|NCT02465515|16144005|P1|Overall Study|Lost to Follow-up|68
4687919|NCT02465515|16144004|P2|Overall Study|Physician Decision|12
4687920|NCT02465515|16144005|P1|Overall Study|Physician Decision|8
4687921|NCT02465515|16144004|P2|Overall Study|Withdrawal by Subject|43
4687922|NCT02465515|16144005|P1|Overall Study|Withdrawal by Subject|74
4687923|NCT02465515|16144004|P2|Overall Study|Investigator site closed|5
4687924|NCT02465515|16144005|P1|Overall Study|Investigator site closed|4
4687925|NCT02465489|16144051|P1|Overall Study|Adverse Event|5
4687926|NCT02465463|16144080|P2|Overall Study|Protocol Violation|0
4687927|NCT02465463|16144081|P1|Overall Study|Protocol Violation|1
4687928|NCT02465463|16144080|P2|Overall Study|Death|0
4687929|NCT02465463|16144081|P1|Overall Study|Death|1
4687930|NCT02465463|16144080|P2|Overall Study|Lost to Follow-up|1
4687931|NCT02465463|16144081|P1|Overall Study|Lost to Follow-up|2
4687932|NCT02465437|16144129|P4|Overall Study|Adverse Event|0
4687933|NCT02465437|16144130|P3|Overall Study|Adverse Event|0
4687934|NCT02465437|16144131|P2|Overall Study|Adverse Event|1
4687935|NCT02465437|16144132|P1|Overall Study|Adverse Event|0
4687936|NCT02465437|16144129|P4|Overall Study|Withdrawal by Subject|1
4687937|NCT02465437|16144130|P3|Overall Study|Withdrawal by Subject|0
4687938|NCT02465437|16144131|P2|Overall Study|Withdrawal by Subject|0
4687939|NCT02465437|16144132|P1|Overall Study|Withdrawal by Subject|1
4687940|NCT02465437|16144129|P4|Overall Study|Physician Decision|0
4687941|NCT02465437|16144130|P3|Overall Study|Physician Decision|1
4687942|NCT02465437|16144131|P2|Overall Study|Physician Decision|0
4687943|NCT02465437|16144132|P1|Overall Study|Physician Decision|0
4687944|NCT02465203|16144192|P3|Overall Study|Patient/guardian decision|1
4687945|NCT02465203|16144193|P2|Overall Study|Patient/guardian decision|1
4687946|NCT02465203|16144194|P1|Overall Study|Patient/guardian decision|1
4687947|NCT02465203|16144192|P3|Overall Study|New therapy for study indication|0
4687948|NCT02465203|16144193|P2|Overall Study|New therapy for study indication|0
4687949|NCT02465203|16144194|P1|Overall Study|New therapy for study indication|4
4687950|NCT02465203|16144192|P3|Overall Study|Study terminated by sponsor|11
4687951|NCT02465203|16144193|P2|Overall Study|Study terminated by sponsor|34
4687952|NCT02465203|16144194|P1|Overall Study|Study terminated by sponsor|50
4687953|NCT02465203|16144192|P3|Overall Study|Protocol Violation|1
4687954|NCT02465203|16144193|P2|Overall Study|Protocol Violation|1
4687955|NCT02465203|16144194|P1|Overall Study|Protocol Violation|1
4687956|NCT02464059|16144314|P1|Overall Study|Lost to Follow-up|6
4687957|NCT02463409|16144373|P1|Overall Study|Screen failure|1
4687958|NCT02463409|16144373|P1|Overall Study|Withdrawal by Subject|1
4687959|NCT02463331|16144381|P2|Overall Study|Physician Decision|0
4687960|NCT02463331|16144382|P1|Overall Study|Physician Decision|3
4687961|NCT02463331|16144381|P2|Overall Study|Lack of Efficacy|0
4687962|NCT02463331|16144382|P1|Overall Study|Lack of Efficacy|6
4687963|NCT02463331|16144381|P2|Overall Study|Pregnancy|3
4687964|NCT02463331|16144382|P1|Overall Study|Pregnancy|2
4687965|NCT02463331|16144381|P2|Overall Study|Lost to Follow-up|1
4687966|NCT02463331|16144382|P1|Overall Study|Lost to Follow-up|1
4687967|NCT02463331|16144381|P2|Overall Study|Adverse Event|2
4687968|NCT02463331|16144382|P1|Overall Study|Adverse Event|4
4687969|NCT02463097|16144398|P1|Overall Study|Withdrawal by Subject|1
4687970|NCT02463071|16144407|P3|Overall Study|Lost to Follow-up|1
4687971|NCT02463071|16144408|P2|Overall Study|Lost to Follow-up|0
4687972|NCT02463071|16144409|P1|Overall Study|Lost to Follow-up|0
4687973|NCT02463071|16144407|P3|Overall Study|Protocol Violation|0
4687974|NCT02463071|16144408|P2|Overall Study|Protocol Violation|2
4687975|NCT02463071|16144409|P1|Overall Study|Protocol Violation|0
4687976|NCT02463071|16144407|P3|Overall Study|Reason not specified|4
4687977|NCT02463071|16144408|P2|Overall Study|Reason not specified|9
4687978|NCT02463071|16144409|P1|Overall Study|Reason not specified|7
4687979|NCT02463071|16144407|P3|Overall Study|Eligibility criteria not fulfilled|0
4687980|NCT02463071|16144408|P2|Overall Study|Eligibility criteria not fulfilled|0
4687981|NCT02463071|16144409|P1|Overall Study|Eligibility criteria not fulfilled|1
4687982|NCT02463071|16144407|P3|Overall Study|Death|0
4687983|NCT02463071|16144408|P2|Overall Study|Death|0
4687984|NCT02463071|16144409|P1|Overall Study|Death|1
4687985|NCT02463071|16144407|P3|Overall Study|Adverse Event|1
4687986|NCT02463071|16144408|P2|Overall Study|Adverse Event|5
4687987|NCT02463071|16144409|P1|Overall Study|Adverse Event|3
4687988|NCT02462928|16144469|P3|Overall Study|Reason not Specified|5
4687989|NCT02462928|16144470|P2|Overall Study|Reason not Specified|6
4687990|NCT02462928|16144471|P1|Overall Study|Reason not Specified|4
4687991|NCT02462928|16144469|P3|Overall Study|Protocol Violation|0
4687992|NCT02462928|16144470|P2|Overall Study|Protocol Violation|1
4687993|NCT02462928|16144471|P1|Overall Study|Protocol Violation|0
4687994|NCT02462928|16144469|P3|Overall Study|Withdrawal by Patient|21
4687995|NCT02462928|16144470|P2|Overall Study|Withdrawal by Patient|21
4687996|NCT02462928|16144471|P1|Overall Study|Withdrawal by Patient|31
4687997|NCT02462928|16144469|P3|Overall Study|Lost to Follow-up|1
4687998|NCT02462928|16144470|P2|Overall Study|Lost to Follow-up|4
4687999|NCT02462928|16144471|P1|Overall Study|Lost to Follow-up|4
4688000|NCT02462928|16144469|P3|Overall Study|Lack of Efficacy|3
4688001|NCT02462928|16144470|P2|Overall Study|Lack of Efficacy|8
4688002|NCT02462928|16144471|P1|Overall Study|Lack of Efficacy|3
4688003|NCT02462928|16144469|P3|Overall Study|Adverse Event|25
4688004|NCT02462928|16144470|P2|Overall Study|Adverse Event|51
4688005|NCT02462928|16144471|P1|Overall Study|Adverse Event|47
4688006|NCT02462928|16144469|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|2
4688007|NCT02462928|16144470|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4688008|NCT02462928|16144471|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4688009|NCT02462876|16144491|P1|Overall Study|Ongoing|10
4688010|NCT02462876|16144491|P1|Overall Study|Other|6
4688011|NCT02462876|16144491|P1|Overall Study|Amputation Above the Metatarsals|1
4688012|NCT02462876|16144491|P1|Overall Study|Surgical Bypass|9
4688013|NCT02462876|16144491|P1|Overall Study|Lost to Follow-up|4
4688014|NCT02462876|16144491|P1|Overall Study|Death|3
4688015|NCT02462759|16144501|P3|Part 1: Double Blind|Death|0
4688016|NCT02462759|16144502|P2|Part 1: Double Blind|Death|0
4688017|NCT02462759|16144503|P1|Part 1: Double Blind|Death|1
4688018|NCT02462720|16144551|P2|Part 2|Protocol Violation|1
4688019|NCT02462720|16144552|P1|Part 2|Protocol Violation|0
4688020|NCT02462720|16144551|P2|Part 2|Withdrawal by Subject|0
4688021|NCT02462720|16144552|P1|Part 2|Withdrawal by Subject|1
4688022|NCT02462486|16144565|P3|Overall Study|Reason not Specified|3
4688023|NCT02462486|16144566|P2|Overall Study|Reason not Specified|4
4688024|NCT02462486|16144567|P1|Overall Study|Reason not Specified|3
4688025|NCT02462486|16144565|P3|Overall Study|Protocol Violation|1
4688026|NCT02462486|16144566|P2|Overall Study|Protocol Violation|1
4688027|NCT02462486|16144567|P1|Overall Study|Protocol Violation|3
4688028|NCT02462486|16144565|P3|Overall Study|Withdrawal by Subject|19
4688029|NCT02462486|16144566|P2|Overall Study|Withdrawal by Subject|22
4688030|NCT02462486|16144567|P1|Overall Study|Withdrawal by Subject|25
4688031|NCT02462486|16144565|P3|Overall Study|Lost to Follow-up|2
4688032|NCT02462486|16144566|P2|Overall Study|Lost to Follow-up|4
4688033|NCT02462486|16144567|P1|Overall Study|Lost to Follow-up|3
4688034|NCT02462486|16144565|P3|Overall Study|Lack of Efficacy|3
4688035|NCT02462486|16144566|P2|Overall Study|Lack of Efficacy|12
4688036|NCT02462486|16144567|P1|Overall Study|Lack of Efficacy|6
4688037|NCT02462486|16144565|P3|Overall Study|Adverse Event|21
4688038|NCT02462486|16144566|P2|Overall Study|Adverse Event|48
4688039|NCT02462486|16144567|P1|Overall Study|Adverse Event|53
4688040|NCT02462486|16144565|P3|Overall Study|Screen Failure:Missed Exclusion Criteria|3
4688041|NCT02462486|16144566|P2|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4688042|NCT02462486|16144567|P1|Overall Study|Screen Failure:Missed Exclusion Criteria|1
4688043|NCT02462473|16144587|P1|Overall Study|Other|3
4688044|NCT02462473|16144587|P1|Overall Study|Death|1
4688045|NCT02462083|16144678|P1|Overall Study|Other than specified|45
4688046|NCT02462083|16144678|P1|Overall Study|Worsening condition|16
4688047|NCT02462083|16144678|P1|Overall Study|Adverse Event|33
4688048|NCT02462083|16144678|P1|Overall Study|Protocol Violation|6
4688049|NCT02462083|16144678|P1|Overall Study|Pregnancy|1
4688050|NCT02462083|16144678|P1|Overall Study|Lack of Efficacy|151
4688051|NCT02462083|16144678|P1|Overall Study|Lost to Follow-up|41
4688052|NCT02462083|16144678|P1|Overall Study|Withdrawal by Subject|87
4688053|NCT02462083|16144678|P1|Overall Study|Sponsor request|39
4688054|NCT02462057|16144698|P5|Overall Study|Joined HealthyFood Before Intervention|17
4688055|NCT02462057|16144699|P4|Overall Study|Joined HealthyFood Before Intervention|16
4688056|NCT02462057|16144700|P3|Overall Study|Joined HealthyFood Before Intervention|23
4688057|NCT02462057|16144701|P2|Overall Study|Joined HealthyFood Before Intervention|13
4688058|NCT02462057|16144702|P1|Overall Study|Joined HealthyFood Before Intervention|22
4688059|NCT02462057|16144698|P5|Overall Study|Left Vitality|33
4688060|NCT02462057|16144699|P4|Overall Study|Left Vitality|35
4688061|NCT02462057|16144700|P3|Overall Study|Left Vitality|23
4688062|NCT02462057|16144701|P2|Overall Study|Left Vitality|27
4688063|NCT02462057|16144702|P1|Overall Study|Left Vitality|32
4688064|NCT02461758|16144788|P4|Overall Study|Lost to Follow-up|0
4688065|NCT02461758|16144789|P3|Overall Study|Lost to Follow-up|1
4688066|NCT02461758|16144790|P2|Overall Study|Lost to Follow-up|1
4688067|NCT02461758|16144791|P1|Overall Study|Lost to Follow-up|0
4688068|NCT02461628|16144832|P2|Overall Study|Refused to complete survey|7
4688069|NCT02461628|16144833|P1|Overall Study|Refused to complete survey|4
4688070|NCT02461589|16144857|P10|Overall Study|Withdrawal from trial before exposure|1
4688071|NCT02461589|16144858|P9|Overall Study|Withdrawal from trial before exposure|0
4688072|NCT02461589|16144859|P8|Overall Study|Withdrawal from trial before exposure|0
4688073|NCT02461589|16144860|P7|Overall Study|Withdrawal from trial before exposure|0
4688074|NCT02461589|16144861|P6|Overall Study|Withdrawal from trial before exposure|0
4688075|NCT02461589|16144862|P5|Overall Study|Withdrawal from trial before exposure|0
4688076|NCT02461589|16144863|P4|Overall Study|Withdrawal from trial before exposure|0
4688077|NCT02461589|16144864|P3|Overall Study|Withdrawal from trial before exposure|0
4688078|NCT02461589|16144865|P2|Overall Study|Withdrawal from trial before exposure|0
4688079|NCT02461589|16144866|P1|Overall Study|Withdrawal from trial before exposure|0
4688080|NCT02461589|16144857|P10|Overall Study|Missing follow-up information|0
4688081|NCT02461589|16144858|P9|Overall Study|Missing follow-up information|0
4688082|NCT02461589|16144859|P8|Overall Study|Missing follow-up information|0
4688083|NCT02461589|16144860|P7|Overall Study|Missing follow-up information|1
4688084|NCT02461589|16144861|P6|Overall Study|Missing follow-up information|0
4688085|NCT02461589|16144862|P5|Overall Study|Missing follow-up information|0
4688086|NCT02461589|16144863|P4|Overall Study|Missing follow-up information|0
4688087|NCT02461589|16144864|P3|Overall Study|Missing follow-up information|0
4688088|NCT02461589|16144865|P2|Overall Study|Missing follow-up information|1
4688089|NCT02461589|16144866|P1|Overall Study|Missing follow-up information|1
4688090|NCT02461589|16144857|P10|Overall Study|Unclassified|2
4688091|NCT02461589|16144858|P9|Overall Study|Unclassified|0
4688092|NCT02461589|16144859|P8|Overall Study|Unclassified|0
4688093|NCT02461589|16144860|P7|Overall Study|Unclassified|1
4688094|NCT02461589|16144861|P6|Overall Study|Unclassified|0
4688095|NCT02461589|16144862|P5|Overall Study|Unclassified|0
4688096|NCT02461589|16144863|P4|Overall Study|Unclassified|0
4688097|NCT02461589|16144864|P3|Overall Study|Unclassified|0
4688098|NCT02461589|16144865|P2|Overall Study|Unclassified|0
4688099|NCT02461589|16144866|P1|Overall Study|Unclassified|0
4688100|NCT02461589|16144857|P10|Overall Study|Death|0
4688101|NCT02461589|16144858|P9|Overall Study|Death|0
4688102|NCT02461589|16144859|P8|Overall Study|Death|1
4688103|NCT02461589|16144860|P7|Overall Study|Death|0
4688104|NCT02461589|16144861|P6|Overall Study|Death|0
4688105|NCT02461589|16144862|P5|Overall Study|Death|0
4688106|NCT02461589|16144863|P4|Overall Study|Death|0
4688107|NCT02461589|16144864|P3|Overall Study|Death|0
4688108|NCT02461589|16144865|P2|Overall Study|Death|0
4688109|NCT02461589|16144866|P1|Overall Study|Death|0
4688110|NCT02461589|16144857|P10|Overall Study|Lost to Follow-up|1
4688111|NCT02461589|16144858|P9|Overall Study|Lost to Follow-up|3
4688112|NCT02461589|16144859|P8|Overall Study|Lost to Follow-up|1
4688113|NCT02461589|16144860|P7|Overall Study|Lost to Follow-up|3
4688114|NCT02461589|16144861|P6|Overall Study|Lost to Follow-up|1
4688115|NCT02461589|16144862|P5|Overall Study|Lost to Follow-up|1
4688116|NCT02461589|16144863|P4|Overall Study|Lost to Follow-up|3
4688117|NCT02461589|16144864|P3|Overall Study|Lost to Follow-up|2
4688118|NCT02461589|16144865|P2|Overall Study|Lost to Follow-up|0
4688119|NCT02461589|16144866|P1|Overall Study|Lost to Follow-up|0
4688120|NCT02461589|16144857|P10|Overall Study|Withdrawal by Subject|1
4688121|NCT02461589|16144858|P9|Overall Study|Withdrawal by Subject|3
4688122|NCT02461589|16144859|P8|Overall Study|Withdrawal by Subject|3
4688123|NCT02461589|16144860|P7|Overall Study|Withdrawal by Subject|1
4688124|NCT02461589|16144861|P6|Overall Study|Withdrawal by Subject|2
4688125|NCT02461589|16144862|P5|Overall Study|Withdrawal by Subject|1
4688126|NCT02461589|16144863|P4|Overall Study|Withdrawal by Subject|2
4688127|NCT02461589|16144864|P3|Overall Study|Withdrawal by Subject|3
4688128|NCT02461589|16144865|P2|Overall Study|Withdrawal by Subject|1
4688129|NCT02461589|16144866|P1|Overall Study|Withdrawal by Subject|5
4688130|NCT02461290|16144999|P1|Overall Study|Lost to Follow-up|3
4688131|NCT02461290|16144999|P1|Overall Study|Withdrawn for Inadequate Clinical Stage|7
4688132|NCT02461160|16145019|P13|Overall Study|Lost to Follow-up|0
4688133|NCT02461160|16145020|P12|Overall Study|Lost to Follow-up|0
4688134|NCT02461160|16145021|P11|Overall Study|Lost to Follow-up|0
4688135|NCT02461160|16145022|P10|Overall Study|Lost to Follow-up|0
4688136|NCT02461160|16145023|P9|Overall Study|Lost to Follow-up|0
4688137|NCT02461160|16145024|P8|Overall Study|Lost to Follow-up|1
4688138|NCT02461160|16145025|P7|Overall Study|Lost to Follow-up|0
4688139|NCT02461160|16145026|P6|Overall Study|Lost to Follow-up|0
4688140|NCT02461160|16145027|P5|Overall Study|Lost to Follow-up|0
4688141|NCT02461160|16145028|P4|Overall Study|Lost to Follow-up|0
4688142|NCT02461160|16145029|P3|Overall Study|Lost to Follow-up|0
4688143|NCT02461160|16145030|P2|Overall Study|Lost to Follow-up|0
4688144|NCT02461160|16145031|P1|Overall Study|Lost to Follow-up|0
4688145|NCT02461134|16145242|P1|Overall Study|Adverse Event|1
4688146|NCT02460991|16145250|P2|Overall Study|Withdrawal by Subject|2
4688147|NCT02460991|16145251|P1|Overall Study|Withdrawal by Subject|0
4688148|NCT02460978|16145268|P3|Overall Study|Pregnancy|2
4688149|NCT02460978|16145269|P2|Overall Study|Pregnancy|0
4688150|NCT02460978|16145270|P1|Overall Study|Pregnancy|0
4688151|NCT02460978|16145268|P3|Overall Study|Discontinued due to DKA/hypoglycemia|4
4688152|NCT02460978|16145269|P2|Overall Study|Discontinued due to DKA/hypoglycemia|5
4688153|NCT02460978|16145270|P1|Overall Study|Discontinued due to DKA/hypoglycemia|2
4688154|NCT02460978|16145268|P3|Overall Study|Protocol Violation|1
4688155|NCT02460978|16145269|P2|Overall Study|Protocol Violation|1
4688156|NCT02460978|16145270|P1|Overall Study|Protocol Violation|1
4688157|NCT02460978|16145268|P3|Overall Study|Lost to Follow-up|1
4688158|NCT02460978|16145269|P2|Overall Study|Lost to Follow-up|3
4688159|NCT02460978|16145270|P1|Overall Study|Lost to Follow-up|2
4688160|NCT02460978|16145268|P3|Overall Study|Withdrawal by Subject|14
4688161|NCT02460978|16145269|P2|Overall Study|Withdrawal by Subject|5
4688162|NCT02460978|16145270|P1|Overall Study|Withdrawal by Subject|5
4688163|NCT02460978|16145268|P3|Overall Study|Adverse Event|11
4688164|NCT02460978|16145269|P2|Overall Study|Adverse Event|11
4688165|NCT02460978|16145270|P1|Overall Study|Adverse Event|17
4688166|NCT02460822|16145296|P1|Overall Study|Withdrawal by Subject|1
4688167|NCT02368691|16145305|P1|Overall Study|Physician Decision|4
4688168|NCT02368691|16145305|P1|Overall Study|Lack of Efficacy|15
4688169|NCT02368691|16145305|P1|Overall Study|Death|13
4688170|NCT02460679|16145316|P1|Overall Study|Withdrawal by Subject|4
4688171|NCT02460679|16145316|P1|Overall Study|Investigator Decision|1
4688172|NCT02460575|16145341|P2|Overall Study|Lost to Follow-up|0
4688173|NCT02460575|16145342|P1|Overall Study|Lost to Follow-up|1
4688174|NCT02460562|16145352|P2|Overall Study|Lost to Follow-up|16
4688175|NCT02460562|16145353|P1|Overall Study|Lost to Follow-up|15
4688176|NCT02460380|16145369|P2|Overall Study|Withdrawal by Subject|5
4688177|NCT02460380|16145370|P1|Overall Study|Withdrawal by Subject|10
4688178|NCT02460263|16145390|P1|Transition Period|Death|1
4688179|NCT02460263|16145390|P1|Transition Period|Withdrawal by Subject|1
4688180|NCT02460198|16145403|P2|Overall Study|Ongoing|30
4688181|NCT02460198|16145404|P1|Overall Study|Ongoing|25
4688182|NCT02460198|16145403|P2|Overall Study|Withdrawal by Subject|4
4688183|NCT02460198|16145404|P1|Overall Study|Withdrawal by Subject|2
4688184|NCT02460198|16145403|P2|Overall Study|Lost to Follow-up|1
4688185|NCT02460198|16145404|P1|Overall Study|Lost to Follow-up|1
4688186|NCT02460198|16145403|P2|Overall Study|Death|25
4688187|NCT02460198|16145404|P1|Overall Study|Death|32
4688188|NCT02460198|16145403|P2|Overall Study|Adverse Event|3
4688189|NCT02460198|16145404|P1|Overall Study|Adverse Event|1
4688190|NCT02460159|16145438|P2|Overall Study|Withdrawal by Subject|0
4688191|NCT02460159|16145439|P1|Overall Study|Withdrawal by Subject|2
4688192|NCT02460159|16145438|P2|Overall Study|Adverse Event|1
4688193|NCT02460159|16145439|P1|Overall Study|Adverse Event|4
4688194|NCT02459951|16145467|P1|Overall Study|Unable to meet holding requirement|1
4688195|NCT02459899|16145478|P4|Overall Study|Withdrawal by Subject|0
4688196|NCT02459899|16145479|P3|Overall Study|Withdrawal by Subject|0
4688197|NCT02459899|16145480|P2|Overall Study|Withdrawal by Subject|3
4688198|NCT02459899|16145481|P1|Overall Study|Withdrawal by Subject|1
4688199|NCT02459899|16145478|P4|Overall Study|Non-compliance with the treatment|1
4688200|NCT02459899|16145479|P3|Overall Study|Non-compliance with the treatment|0
4688201|NCT02459899|16145480|P2|Overall Study|Non-compliance with the treatment|0
4688202|NCT02459899|16145481|P1|Overall Study|Non-compliance with the treatment|0
4688203|NCT02459899|16145478|P4|Overall Study|Lost to Follow-up|1
4688204|NCT02459899|16145479|P3|Overall Study|Lost to Follow-up|0
4688205|NCT02459899|16145480|P2|Overall Study|Lost to Follow-up|2
4688206|NCT02459899|16145481|P1|Overall Study|Lost to Follow-up|1
4688207|NCT02459899|16145478|P4|Overall Study|Adverse Event|0
4688208|NCT02459899|16145479|P3|Overall Study|Adverse Event|0
4688209|NCT02459899|16145480|P2|Overall Study|Adverse Event|1
4688210|NCT02459899|16145481|P1|Overall Study|Adverse Event|1
4688211|NCT02459665|16145515|P4|Overall Study|Withdrawal by Subject|2
4688212|NCT02459665|16145516|P3|Overall Study|Withdrawal by Subject|1
4688213|NCT02459665|16145517|P2|Overall Study|Withdrawal by Subject|1
4688214|NCT02459665|16145518|P1|Overall Study|Withdrawal by Subject|0
4688215|NCT02459418|16145549|P2|Overall Study|Abnormal Transvaginal Ultrasound|0
4688216|NCT02459418|16145550|P1|Overall Study|Abnormal Transvaginal Ultrasound|1
4688217|NCT02459418|16145549|P2|Overall Study|Elevated Creatine Kinase|0
4688218|NCT02459418|16145550|P1|Overall Study|Elevated Creatine Kinase|1
4688219|NCT02459418|16145549|P2|Overall Study|Withdrawal by Subject|1
4688220|NCT02459418|16145550|P1|Overall Study|Withdrawal by Subject|1
4688221|NCT02459418|16145549|P2|Overall Study|Adverse Event|1
4688222|NCT02459418|16145550|P1|Overall Study|Adverse Event|0
4688223|NCT02459418|16145549|P2|Overall Study|Endometrial thickness of >5 mm|0
4688224|NCT02459418|16145550|P1|Overall Study|Endometrial thickness of >5 mm|1
4688225|NCT02459418|16145549|P2|Overall Study|Physician Decision|2
4688226|NCT02459418|16145550|P1|Overall Study|Physician Decision|0
4688227|NCT02459418|16145549|P2|Overall Study|Protocol Violation|2
4688228|NCT02459418|16145550|P1|Overall Study|Protocol Violation|0
4688229|NCT02459418|16145549|P2|Overall Study|Exclusion Criteria|0
4688230|NCT02459418|16145550|P1|Overall Study|Exclusion Criteria|4
4688231|NCT02459093|16145616|P2|Overall Study|Lost to Follow-up|7
4688232|NCT02459093|16145617|P1|Overall Study|Lost to Follow-up|6
4688233|NCT02459093|16145616|P2|Overall Study|Protocol Violation|11
4688234|NCT02459093|16145617|P1|Overall Study|Protocol Violation|6
4688235|NCT02366195|16145671|P1|Overall Study|Death|26
4688236|NCT02366195|16145671|P1|Overall Study|Lost to Follow-up|1
4688237|NCT02366195|16145671|P1|Overall Study|Withdrawal by Subject|6
4688238|NCT02366195|16145671|P1|Overall Study|Continuing Study|79
4688239|NCT02458469|16145689|P6|Second Intervention (2 Weeks)|Withdrawal by Subject|1
4688240|NCT02458469|16145690|P5|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4688241|NCT02458469|16145691|P4|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4688242|NCT02458469|16145692|P3|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4688243|NCT02458469|16145693|P2|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4688244|NCT02458469|16145694|P1|Second Intervention (2 Weeks)|Withdrawal by Subject|0
4688245|NCT02458469|16145689|P6|First Intervention (2 Weeks)|Physician Decision|0
4688246|NCT02458469|16145690|P5|First Intervention (2 Weeks)|Physician Decision|0
4688247|NCT02458469|16145691|P4|First Intervention (2 Weeks)|Physician Decision|0
4688248|NCT02458469|16145692|P3|First Intervention (2 Weeks)|Physician Decision|0
4688249|NCT02458469|16145693|P2|First Intervention (2 Weeks)|Physician Decision|0
4688250|NCT02458469|16145694|P1|First Intervention (2 Weeks)|Physician Decision|1
4688251|NCT02458469|16145689|P6|First Intervention (2 Weeks)|Lost to Follow-up|0
4688252|NCT02458469|16145690|P5|First Intervention (2 Weeks)|Lost to Follow-up|0
4688253|NCT02458469|16145691|P4|First Intervention (2 Weeks)|Lost to Follow-up|0
4688254|NCT02458469|16145692|P3|First Intervention (2 Weeks)|Lost to Follow-up|1
4688255|NCT02458469|16145693|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
4688256|NCT02458469|16145694|P1|First Intervention (2 Weeks)|Lost to Follow-up|0
4688257|NCT02458287|16145740|P4|Overall Study|Relocated Out of State|1
4688258|NCT02458287|16145741|P3|Overall Study|Relocated Out of State|0
4688259|NCT02458287|16145742|P2|Overall Study|Relocated Out of State|0
4688260|NCT02458287|16145743|P1|Overall Study|Relocated Out of State|0
4688261|NCT02458287|16145740|P4|Overall Study|Withdrawal by Subject|1
4688262|NCT02458287|16145741|P3|Overall Study|Withdrawal by Subject|2
4688263|NCT02458287|16145742|P2|Overall Study|Withdrawal by Subject|2
4688264|NCT02458287|16145743|P1|Overall Study|Withdrawal by Subject|0
4688265|NCT02458287|16145740|P4|Overall Study|Protocol Violation|0
4688266|NCT02458287|16145741|P3|Overall Study|Protocol Violation|0
4688267|NCT02458287|16145742|P2|Overall Study|Protocol Violation|1
4688268|NCT02458287|16145743|P1|Overall Study|Protocol Violation|0
4688269|NCT02458287|16145740|P4|Overall Study|Lost to Follow-up|0
4688270|NCT02458287|16145741|P3|Overall Study|Lost to Follow-up|1
4688271|NCT02458287|16145742|P2|Overall Study|Lost to Follow-up|1
4688272|NCT02458287|16145743|P1|Overall Study|Lost to Follow-up|0
4688273|NCT02458287|16145740|P4|Overall Study|Adverse Event|1
4688274|NCT02458287|16145741|P3|Overall Study|Adverse Event|0
4688275|NCT02458287|16145742|P2|Overall Study|Adverse Event|0
4688276|NCT02458287|16145743|P1|Overall Study|Adverse Event|0
4688277|NCT02458092|16145801|P2|Overall Study|Withdrawal by Subject|0
4688278|NCT02458092|16145802|P1|Overall Study|Withdrawal by Subject|1
4688279|NCT02457910|16145820|P6|Overall Study|Death|0
4688280|NCT02457910|16145821|P5|Overall Study|Death|0
4688281|NCT02457910|16145822|P4|Overall Study|Death|0
4688282|NCT02457910|16145823|P3|Overall Study|Death|1
4688283|NCT02457910|16145824|P2|Overall Study|Death|0
4688284|NCT02457910|16145825|P1|Overall Study|Death|0
4688285|NCT02457910|16145820|P6|Overall Study|Other complicating illness|1
4688286|NCT02457910|16145821|P5|Overall Study|Other complicating illness|0
4688287|NCT02457910|16145822|P4|Overall Study|Other complicating illness|0
4688288|NCT02457910|16145823|P3|Overall Study|Other complicating illness|0
4688289|NCT02457910|16145824|P2|Overall Study|Other complicating illness|0
4688290|NCT02457910|16145825|P1|Overall Study|Other complicating illness|0
4688291|NCT02457910|16145820|P6|Overall Study|Disease progression|6
4688292|NCT02457910|16145821|P5|Overall Study|Disease progression|4
4688293|NCT02457910|16145822|P4|Overall Study|Disease progression|1
4688294|NCT02457910|16145823|P3|Overall Study|Disease progression|1
4688295|NCT02457910|16145824|P2|Overall Study|Disease progression|3
4688296|NCT02457910|16145825|P1|Overall Study|Disease progression|3
4688297|NCT02457910|16145820|P6|Overall Study|Adverse Event|3
4688298|NCT02457910|16145821|P5|Overall Study|Adverse Event|1
4688299|NCT02457910|16145822|P4|Overall Study|Adverse Event|1
4688300|NCT02457910|16145823|P3|Overall Study|Adverse Event|1
4688301|NCT02457910|16145824|P2|Overall Study|Adverse Event|2
4688302|NCT02457910|16145825|P1|Overall Study|Adverse Event|0
4688303|NCT02457910|16145820|P6|Overall Study|Withdrawal by Subject|1
4688304|NCT02457910|16145821|P5|Overall Study|Withdrawal by Subject|0
4688305|NCT02457910|16145822|P4|Overall Study|Withdrawal by Subject|0
4688306|NCT02457910|16145823|P3|Overall Study|Withdrawal by Subject|0
4688307|NCT02457910|16145824|P2|Overall Study|Withdrawal by Subject|0
4688308|NCT02457910|16145825|P1|Overall Study|Withdrawal by Subject|0
4688309|NCT02457819|16145849|P1|Overall Study|Adverse Event|33
4688310|NCT02457819|16145849|P1|Overall Study|Lack of Efficacy|19
4688311|NCT02457819|16145849|P1|Overall Study|Lost to Follow-up|10
4688312|NCT02457819|16145849|P1|Overall Study|non compliance with study drug|4
4688313|NCT02457819|16145849|P1|Overall Study|Protocol Violation|1
4688314|NCT02457819|16145849|P1|Overall Study|Withdrawal by Subject|24
4688315|NCT02457819|16145849|P1|Overall Study|reason not given|8
4688316|NCT02457793|16145861|P6|Overall Study|Physician Decision|3
4688317|NCT02457793|16145862|P5|Overall Study|Physician Decision|1
4688318|NCT02457793|16145863|P4|Overall Study|Physician Decision|1
4688319|NCT02457793|16145864|P3|Overall Study|Physician Decision|1
4688320|NCT02457793|16145865|P2|Overall Study|Physician Decision|0
4688321|NCT02457793|16145866|P1|Overall Study|Physician Decision|1
4688322|NCT02457793|16145861|P6|Overall Study|Adverse Event|0
4688323|NCT02457793|16145862|P5|Overall Study|Adverse Event|0
4688324|NCT02457793|16145863|P4|Overall Study|Adverse Event|1
4688325|NCT02457793|16145864|P3|Overall Study|Adverse Event|0
4688326|NCT02457793|16145865|P2|Overall Study|Adverse Event|0
4688327|NCT02457793|16145866|P1|Overall Study|Adverse Event|0
4688328|NCT02457793|16145861|P6|Overall Study|Withdrawal by Subject|2
4688329|NCT02457793|16145862|P5|Overall Study|Withdrawal by Subject|2
4688330|NCT02457793|16145863|P4|Overall Study|Withdrawal by Subject|2
4688331|NCT02457793|16145864|P3|Overall Study|Withdrawal by Subject|2
4688332|NCT02457793|16145865|P2|Overall Study|Withdrawal by Subject|4
4688333|NCT02457793|16145866|P1|Overall Study|Withdrawal by Subject|0
4688334|NCT02457793|16145861|P6|Overall Study|Reason not specified|1
4688335|NCT02457793|16145862|P5|Overall Study|Reason not specified|1
4688336|NCT02457793|16145863|P4|Overall Study|Reason not specified|1
4688337|NCT02457793|16145864|P3|Overall Study|Reason not specified|0
4688338|NCT02457793|16145865|P2|Overall Study|Reason not specified|0
4688339|NCT02457793|16145866|P1|Overall Study|Reason not specified|0
4688340|NCT02457637|16146010|P1|Clinic or Telephone Follow-up|Lost to Follow-up|71
4688341|NCT02457611|16146018|P1|Overall Study|Lost to Follow-up|3
4688342|NCT02457546|16146032|P2|Overall Study|Adverse Event|1
4688343|NCT02457546|16146033|P1|Overall Study|Adverse Event|0
4688344|NCT02457546|16146032|P2|Overall Study|Lost to Follow-up|1
4688345|NCT02457546|16146033|P1|Overall Study|Lost to Follow-up|4
4688346|NCT02457546|16146032|P2|Overall Study|Refused to complete study/procedures|1
4688347|NCT02457546|16146033|P1|Overall Study|Refused to complete study/procedures|1
4688348|NCT02457546|16146032|P2|Overall Study|Other reasons|1
4688349|NCT02457546|16146033|P1|Overall Study|Other reasons|4
4688350|NCT02457247|16146088|P4|Period 2|Voluntary Withdrawal|0
4688351|NCT02457247|16146089|P3|Period 2|Voluntary Withdrawal|0
4688352|NCT02457247|16146090|P2|Period 2|Voluntary Withdrawal|1
4688353|NCT02457247|16146091|P1|Period 2|Voluntary Withdrawal|1
4688354|NCT02457247|16146088|P4|Period 2|Lost to Follow-up|0
4688355|NCT02457247|16146089|P3|Period 2|Lost to Follow-up|0
4688356|NCT02457247|16146090|P2|Period 2|Lost to Follow-up|1
4688357|NCT02457247|16146091|P1|Period 2|Lost to Follow-up|0
4688358|NCT02457247|16146088|P4|Period 2|Significant Protocol Deviation|0
4688359|NCT02457247|16146089|P3|Period 2|Significant Protocol Deviation|0
4688360|NCT02457247|16146090|P2|Period 2|Significant Protocol Deviation|0
4688361|NCT02457247|16146091|P1|Period 2|Significant Protocol Deviation|1
4688362|NCT02457247|16146088|P4|Period 2|Pretreatment Event/Adverse Event|0
4688363|NCT02457247|16146089|P3|Period 2|Pretreatment Event/Adverse Event|0
4688364|NCT02457247|16146090|P2|Period 2|Pretreatment Event/Adverse Event|1
4688365|NCT02457247|16146091|P1|Period 2|Pretreatment Event/Adverse Event|0
4688366|NCT02457247|16146088|P4|Period 1|Voluntary Withdrawal|0
4688367|NCT02457247|16146089|P3|Period 1|Voluntary Withdrawal|0
4688368|NCT02457247|16146090|P2|Period 1|Voluntary Withdrawal|0
4688369|NCT02457247|16146091|P1|Period 1|Voluntary Withdrawal|1
4688370|NCT02457247|16146088|P4|Period 1|Significant Protocol Deviation|0
4688371|NCT02457247|16146089|P3|Period 1|Significant Protocol Deviation|0
4688372|NCT02457247|16146090|P2|Period 1|Significant Protocol Deviation|1
4688373|NCT02457247|16146091|P1|Period 1|Significant Protocol Deviation|1
4688374|NCT02457247|16146088|P4|Period 1|Pretreatment Event/Adverse Event|0
4688375|NCT02457247|16146089|P3|Period 1|Pretreatment Event/Adverse Event|0
4688376|NCT02457247|16146090|P2|Period 1|Pretreatment Event/Adverse Event|1
4688377|NCT02457247|16146091|P1|Period 1|Pretreatment Event/Adverse Event|0
4688378|NCT02457195|16146111|P1|Overall Study|Withdrawal by Subject|4
4688379|NCT02457195|16146111|P1|Overall Study|Protocol Violation|2
4688380|NCT02457195|16146111|P1|Overall Study|Adverse Event|3
4688381|NCT02457182|16146117|P2|Overall Study|Lost to Follow-up|0
4688382|NCT02457182|16146118|P1|Overall Study|Lost to Follow-up|1
4688383|NCT02457065|16146136|P2|Overall Study|Lost to Follow-up|11
4688384|NCT02457065|16146137|P1|Overall Study|Lost to Follow-up|9
4688385|NCT02456740|16146159|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
4688386|NCT02456740|16146160|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
4688387|NCT02456740|16146161|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
4688388|NCT02456740|16146162|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4
4688389|NCT02456740|16146163|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2
4688390|NCT02456740|16146164|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3
4688391|NCT02456740|16146165|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4688392|NCT02456740|16146166|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4688393|NCT02456740|16146167|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4688394|NCT02456740|16146159|P9|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688395|NCT02456740|16146160|P8|Active Treatment Phase (Weeks 24 - 52)|Death|1
4688396|NCT02456740|16146161|P7|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688397|NCT02456740|16146162|P6|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688398|NCT02456740|16146163|P5|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688399|NCT02456740|16146164|P4|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688400|NCT02456740|16146165|P3|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688401|NCT02456740|16146166|P2|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688402|NCT02456740|16146167|P1|Active Treatment Phase (Weeks 24 - 52)|Death|0
4688403|NCT02456740|16146159|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
4688404|NCT02456740|16146160|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
4688405|NCT02456740|16146161|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8
4688406|NCT02456740|16146162|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9
4688407|NCT02456740|16146163|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11
4688408|NCT02456740|16146164|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10
4688409|NCT02456740|16146165|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4688410|NCT02456740|16146166|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4688411|NCT02456740|16146167|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4688412|NCT02456740|16146159|P9|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5
4688413|NCT02456740|16146160|P8|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4688414|NCT02456740|16146161|P7|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4688415|NCT02456740|16146162|P6|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4688416|NCT02456740|16146163|P5|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4
4688417|NCT02456740|16146164|P4|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1
4688418|NCT02456740|16146165|P3|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4688419|NCT02456740|16146166|P2|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4688420|NCT02456740|16146167|P1|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0
4688421|NCT02456740|16146159|P9|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4688422|NCT02456740|16146160|P8|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4688423|NCT02456740|16146161|P7|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4688424|NCT02456740|16146162|P6|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4688425|NCT02456740|16146163|P5|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4688426|NCT02456740|16146164|P4|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0
4688427|NCT02456740|16146165|P3|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5
4688428|NCT02456740|16146166|P2|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4
4688429|NCT02456740|16146167|P1|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9
4688430|NCT02456740|16146159|P9|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4688431|NCT02456740|16146160|P8|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4688432|NCT02456740|16146161|P7|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4688433|NCT02456740|16146162|P6|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4688434|NCT02456740|16146163|P5|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4688435|NCT02456740|16146164|P4|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0
4688436|NCT02456740|16146165|P3|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21
4688437|NCT02456740|16146166|P2|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28
4688438|NCT02456740|16146167|P1|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27
4688439|NCT02456740|16146159|P9|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4688440|NCT02456740|16146160|P8|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4688441|NCT02456740|16146161|P7|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4688442|NCT02456740|16146162|P6|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4688443|NCT02456740|16146163|P5|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4688444|NCT02456740|16146164|P4|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0
4688445|NCT02456740|16146165|P3|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
4688446|NCT02456740|16146166|P2|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
4688447|NCT02456740|16146167|P1|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1
4688448|NCT02456727|16146191|P2|Overall Study|Never Initiated Treatment|30
4688449|NCT02456727|16146192|P1|Overall Study|Never Initiated Treatment|43
4688450|NCT02456727|16146191|P2|Overall Study|Withdrawal by Subject|10
4688451|NCT02456727|16146192|P1|Overall Study|Withdrawal by Subject|1
4688452|NCT02456727|16146191|P2|Overall Study|Death|1
4688453|NCT02456727|16146192|P1|Overall Study|Death|2
4688454|NCT02456727|16146191|P2|Overall Study|Lost to Follow-up|65
4688455|NCT02456727|16146192|P1|Overall Study|Lost to Follow-up|63
4688456|NCT02456662|16146274|P2|Overall Study|Lost to Follow-up|1
4688457|NCT02456662|16146275|P1|Overall Study|Lost to Follow-up|2
4688458|NCT02456636|16146284|P3|Overall Study|Lost to Follow-up|50
4688459|NCT02456636|16146285|P2|Overall Study|Lost to Follow-up|44
4688460|NCT02456636|16146286|P1|Overall Study|Lost to Follow-up|50
4688461|NCT02456636|16146284|P3|Overall Study|Withdrawal by Subject|16
4688462|NCT02456636|16146285|P2|Overall Study|Withdrawal by Subject|14
4688463|NCT02456636|16146286|P1|Overall Study|Withdrawal by Subject|13
4688464|NCT02456636|16146284|P3|Overall Study|Physician Decision|4
4688465|NCT02456636|16146285|P2|Overall Study|Physician Decision|5
4688466|NCT02456636|16146286|P1|Overall Study|Physician Decision|4
4688467|NCT02456636|16146284|P3|Overall Study|Pregnancy|5
4688468|NCT02456636|16146285|P2|Overall Study|Pregnancy|3
4688469|NCT02456636|16146286|P1|Overall Study|Pregnancy|1
4688470|NCT02456636|16146284|P3|Overall Study|Death|0
4688471|NCT02456636|16146285|P2|Overall Study|Death|3
4688472|NCT02456636|16146286|P1|Overall Study|Death|0
4688473|NCT02456103|16146336|P1|Overall Study|Withdrawal by Subject|24
4688474|NCT02456103|16146336|P1|Overall Study|Lost to Follow-up|1
4688475|NCT02456103|16146336|P1|Overall Study|Abnormal Laboratory Value|2
4688476|NCT02456103|16146336|P1|Overall Study|Adverse Event|5
4688477|NCT02456103|16146336|P1|Overall Study|Protocol Violation|1
4688478|NCT02456103|16146336|P1|Overall Study|Required prohibited medications|5
4688479|NCT02456103|16146336|P1|Overall Study|Physician Decision|1
4688480|NCT02456103|16146336|P1|Overall Study|Study Closure|207
4688481|NCT02455518|16146349|P4|Overall Study|Protocol Violation|3
4688482|NCT02455518|16146350|P3|Overall Study|Protocol Violation|1
4688483|NCT02455518|16146351|P2|Overall Study|Protocol Violation|1
4688484|NCT02455518|16146352|P1|Overall Study|Protocol Violation|0
4688485|NCT02455388|16146374|P3|Overall Study|Withdrawal by Subject|7
4688486|NCT02455388|16146375|P2|Overall Study|Withdrawal by Subject|0
4688487|NCT02455388|16146376|P1|Overall Study|Withdrawal by Subject|0
4688488|NCT02455388|16146374|P3|Overall Study|Protocol Violation|4
4688489|NCT02455388|16146375|P2|Overall Study|Protocol Violation|0
4688490|NCT02455388|16146376|P1|Overall Study|Protocol Violation|1
4688491|NCT02455336|16146387|P2|Overall Study|Non-responder to treatment|0
4688492|NCT02455336|16146388|P1|Overall Study|Non-responder to treatment|2
4688493|NCT02455336|16146387|P2|Overall Study|Adverse Event|0
4688494|NCT02455336|16146388|P1|Overall Study|Adverse Event|3
4688495|NCT02455336|16146387|P2|Overall Study|Withdrawal by Subject|2
4688496|NCT02455336|16146388|P1|Overall Study|Withdrawal by Subject|0
4688497|NCT02455076|16146403|P5|Outpatient|Lost to Follow-up|12
4688498|NCT02455076|16146404|P4|Outpatient|Lost to Follow-up|1
4688499|NCT02455076|16146405|P3|Outpatient|Lost to Follow-up|0
4688500|NCT02455076|16146406|P2|Outpatient|Lost to Follow-up|0
4688501|NCT02455076|16146407|P1|Outpatient|Lost to Follow-up|0
4688502|NCT02455076|16146403|P5|Outpatient|Adverse Event|0
4688503|NCT02455076|16146404|P4|Outpatient|Adverse Event|5
4688504|NCT02455076|16146405|P3|Outpatient|Adverse Event|0
4688505|NCT02455076|16146406|P2|Outpatient|Adverse Event|0
4688506|NCT02455076|16146407|P1|Outpatient|Adverse Event|0
4688507|NCT02455076|16146403|P5|Inpatient|Adverse Event|0
4688508|NCT02455076|16146404|P4|Inpatient|Adverse Event|0
4688509|NCT02455076|16146405|P3|Inpatient|Adverse Event|0
4688510|NCT02455076|16146406|P2|Inpatient|Adverse Event|0
4688511|NCT02455076|16146407|P1|Inpatient|Adverse Event|3
4688512|NCT02455076|16146403|P5|Inpatient|Discharged <24 h after admission|0
4688513|NCT02455076|16146404|P4|Inpatient|Discharged <24 h after admission|0
4688514|NCT02455076|16146405|P3|Inpatient|Discharged <24 h after admission|0
4688515|NCT02455076|16146406|P2|Inpatient|Discharged <24 h after admission|1
4688516|NCT02455076|16146407|P1|Inpatient|Discharged <24 h after admission|0
4688517|NCT02455076|16146403|P5|Inpatient|Withdrawal by Subject|0
4688518|NCT02455076|16146404|P4|Inpatient|Withdrawal by Subject|0
4688519|NCT02455076|16146405|P3|Inpatient|Withdrawal by Subject|0
4688520|NCT02455076|16146406|P2|Inpatient|Withdrawal by Subject|0
4688521|NCT02455076|16146407|P1|Inpatient|Withdrawal by Subject|1
4688522|NCT02455050|16146493|P4|Treatment Period 2|Lost to Follow-up|1
4688523|NCT02455050|16146494|P3|Treatment Period 2|Lost to Follow-up|2
4688524|NCT02455050|16146495|P2|Treatment Period 2|Lost to Follow-up|0
4688525|NCT02455050|16146496|P1|Treatment Period 2|Lost to Follow-up|1
4688526|NCT02455050|16146493|P4|Treatment Period 1|Lost to Follow-up|2
4688527|NCT02455050|16146494|P3|Treatment Period 1|Lost to Follow-up|1
4688528|NCT02455050|16146495|P2|Treatment Period 1|Lost to Follow-up|1
4688529|NCT02455050|16146496|P1|Treatment Period 1|Lost to Follow-up|1
4688530|NCT02454959|16146560|P1|Overall Study|Adverse Event|2
4688531|NCT02454959|16146560|P1|Overall Study|Withdrawal by Subject|3
4688532|NCT02454959|16146560|P1|Overall Study|Physician Decision|1
4688533|NCT02454959|16146560|P1|Overall Study|Protocol-Specified Criteria|3
4688534|NCT02454933|16146580|P2|Overall Study|Withdrawal by Subject|2
4688535|NCT02454933|16146581|P1|Overall Study|Withdrawal by Subject|0
4688536|NCT02454933|16146580|P2|Overall Study|Adverse Event|1
4688537|NCT02454933|16146581|P1|Overall Study|Adverse Event|1
4688538|NCT02454933|16146580|P2|Overall Study|Progressive disease|5
4688539|NCT02454933|16146581|P1|Overall Study|Progressive disease|7
4688540|NCT02454608|16146595|P3|Open Label Period|Withdrawal by Subject|8
4688541|NCT02454608|16146596|P2|Open Label Period|Withdrawal by Subject|0
4688542|NCT02454608|16146597|P1|Open Label Period|Withdrawal by Subject|0
4688543|NCT02454608|16146595|P3|Open Label Period|Lost to Follow-up|11
4688544|NCT02454608|16146596|P2|Open Label Period|Lost to Follow-up|0
4688545|NCT02454608|16146597|P1|Open Label Period|Lost to Follow-up|0
4688546|NCT02454608|16146595|P3|Double-Blind Period|Lack of Efficacy|0
4688547|NCT02454608|16146596|P2|Double-Blind Period|Lack of Efficacy|2
4688548|NCT02454608|16146597|P1|Double-Blind Period|Lack of Efficacy|0
4688549|NCT02454530|16146620|P2|Overall Study|Lost to Follow-up|4
4688550|NCT02454530|16146621|P1|Overall Study|Lost to Follow-up|4
4688551|NCT02454530|16146620|P2|Overall Study|Death|41
4688552|NCT02454530|16146621|P1|Overall Study|Death|2
4688553|NCT02454530|16146620|P2|Overall Study|Missing information|69
4688554|NCT02454530|16146621|P1|Overall Study|Missing information|56
4688555|NCT02454530|16146620|P2|Overall Study|Other|13
4688556|NCT02454530|16146621|P1|Overall Study|Other|8
4688557|NCT02454478|16146658|P1|Overall Study|Incomplete DLT Evaluation|1
4688558|NCT02454101|16146752|P2|Overall Study|Lost to Follow-up|4
4688559|NCT02454101|16146753|P1|Overall Study|Lost to Follow-up|3
4688560|NCT02454101|16146752|P2|Overall Study|Adverse Event|3
4688561|NCT02454101|16146753|P1|Overall Study|Adverse Event|2
4688562|NCT02453841|16146775|P1|Overall Study|Unable to obtain blood samples|2
4688563|NCT02453841|16146775|P1|Overall Study|Protocol Violation|1
4688564|NCT02453711|16146798|P9|Overall Study|Unclassified|0
4688565|NCT02453711|16146799|P8|Overall Study|Unclassified|0
4688566|NCT02453711|16146800|P7|Overall Study|Unclassified|0
4688567|NCT02453711|16146801|P6|Overall Study|Unclassified|0
4688568|NCT02453711|16146802|P5|Overall Study|Unclassified|0
4688569|NCT02453711|16146803|P4|Overall Study|Unclassified|0
4688570|NCT02453711|16146804|P3|Overall Study|Unclassified|1
4688571|NCT02453711|16146805|P2|Overall Study|Unclassified|0
4688572|NCT02453711|16146806|P1|Overall Study|Unclassified|1
4688573|NCT02453711|16146798|P9|Overall Study|Death|0
4688574|NCT02453711|16146799|P8|Overall Study|Death|0
4688575|NCT02453711|16146800|P7|Overall Study|Death|1
4688576|NCT02453711|16146801|P6|Overall Study|Death|0
4688577|NCT02453711|16146802|P5|Overall Study|Death|0
4688578|NCT02453711|16146803|P4|Overall Study|Death|0
4688579|NCT02453711|16146804|P3|Overall Study|Death|0
4688580|NCT02453711|16146805|P2|Overall Study|Death|0
4688581|NCT02453711|16146806|P1|Overall Study|Death|0
4688582|NCT02453711|16146798|P9|Overall Study|Lost to Follow-up|6
4688583|NCT02453711|16146799|P8|Overall Study|Lost to Follow-up|6
4688584|NCT02453711|16146800|P7|Overall Study|Lost to Follow-up|2
4688585|NCT02453711|16146801|P6|Overall Study|Lost to Follow-up|5
4688586|NCT02453711|16146802|P5|Overall Study|Lost to Follow-up|1
4688587|NCT02453711|16146803|P4|Overall Study|Lost to Follow-up|3
4688588|NCT02453711|16146804|P3|Overall Study|Lost to Follow-up|2
4688589|NCT02453711|16146805|P2|Overall Study|Lost to Follow-up|3
4688590|NCT02453711|16146806|P1|Overall Study|Lost to Follow-up|5
4688591|NCT02453711|16146798|P9|Overall Study|Withdrawal by Subject|7
4688592|NCT02453711|16146799|P8|Overall Study|Withdrawal by Subject|1
4688593|NCT02453711|16146800|P7|Overall Study|Withdrawal by Subject|0
4688594|NCT02453711|16146801|P6|Overall Study|Withdrawal by Subject|1
4688595|NCT02453711|16146802|P5|Overall Study|Withdrawal by Subject|1
4688596|NCT02453711|16146803|P4|Overall Study|Withdrawal by Subject|4
4688597|NCT02453711|16146804|P3|Overall Study|Withdrawal by Subject|6
4688598|NCT02453711|16146805|P2|Overall Study|Withdrawal by Subject|4
4688599|NCT02453711|16146806|P1|Overall Study|Withdrawal by Subject|5
4688600|NCT02453685|16147150|P2|Overall Study|Unclassified|2
4688601|NCT02453685|16147151|P1|Overall Study|Unclassified|4
4688602|NCT02453685|16147150|P2|Overall Study|Withdrawal by Subject|4
4688603|NCT02453685|16147151|P1|Overall Study|Withdrawal by Subject|8
4688604|NCT02453685|16147150|P2|Overall Study|Lost to Follow-up|1
4688605|NCT02453685|16147151|P1|Overall Study|Lost to Follow-up|0
4688606|NCT02453685|16147150|P2|Overall Study|Protocol Violation|4
4688607|NCT02453685|16147151|P1|Overall Study|Protocol Violation|7
4688608|NCT02453685|16147150|P2|Overall Study|Adverse Event|1
4688609|NCT02453685|16147151|P1|Overall Study|Adverse Event|0
4688610|NCT02453555|16147209|P6|Extension Period|Withdrawal by Subject|0
4688611|NCT02453555|16147210|P5|Extension Period|Withdrawal by Subject|0
4688612|NCT02453555|16147211|P4|Extension Period|Withdrawal by Subject|0
4688613|NCT02453555|16147212|P3|Extension Period|Withdrawal by Subject|1
4688614|NCT02453555|16147213|P2|Extension Period|Withdrawal by Subject|0
4688615|NCT02453555|16147214|P1|Extension Period|Withdrawal by Subject|0
4688616|NCT02453555|16147209|P6|Extension Period|Protocol Violation|0
4688617|NCT02453555|16147210|P5|Extension Period|Protocol Violation|0
4688618|NCT02453555|16147211|P4|Extension Period|Protocol Violation|0
4688619|NCT02453555|16147212|P3|Extension Period|Protocol Violation|1
4688620|NCT02453555|16147213|P2|Extension Period|Protocol Violation|0
4688621|NCT02453555|16147214|P1|Extension Period|Protocol Violation|0
4688622|NCT02453555|16147209|P6|Extension Period|Adverse Event|1
4688623|NCT02453555|16147210|P5|Extension Period|Adverse Event|1
4688624|NCT02453555|16147211|P4|Extension Period|Adverse Event|2
4688625|NCT02453555|16147212|P3|Extension Period|Adverse Event|1
4688626|NCT02453555|16147213|P2|Extension Period|Adverse Event|0
4688627|NCT02453555|16147214|P1|Extension Period|Adverse Event|0
4688628|NCT02453555|16147209|P6|24-week Double-blind Treatment Period|Other than specified above|0
4688629|NCT02453555|16147210|P5|24-week Double-blind Treatment Period|Other than specified above|0
4688630|NCT02453555|16147211|P4|24-week Double-blind Treatment Period|Other than specified above|0
4688631|NCT02453555|16147212|P3|24-week Double-blind Treatment Period|Other than specified above|0
4688632|NCT02453555|16147213|P2|24-week Double-blind Treatment Period|Other than specified above|3
4688633|NCT02453555|16147214|P1|24-week Double-blind Treatment Period|Other than specified above|0
4688634|NCT02453555|16147209|P6|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4688635|NCT02453555|16147210|P5|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4688636|NCT02453555|16147211|P4|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4688637|NCT02453555|16147212|P3|24-week Double-blind Treatment Period|Withdrawal by Subject|0
4688638|NCT02453555|16147213|P2|24-week Double-blind Treatment Period|Withdrawal by Subject|4
4688639|NCT02453555|16147214|P1|24-week Double-blind Treatment Period|Withdrawal by Subject|2
4688640|NCT02453555|16147209|P6|24-week Double-blind Treatment Period|Lost to Follow-up|0
4688641|NCT02453555|16147210|P5|24-week Double-blind Treatment Period|Lost to Follow-up|0
4688642|NCT02453555|16147211|P4|24-week Double-blind Treatment Period|Lost to Follow-up|0
4688643|NCT02453555|16147212|P3|24-week Double-blind Treatment Period|Lost to Follow-up|0
4688644|NCT02453555|16147213|P2|24-week Double-blind Treatment Period|Lost to Follow-up|0
4688645|NCT02453555|16147214|P1|24-week Double-blind Treatment Period|Lost to Follow-up|1
4688646|NCT02453555|16147209|P6|24-week Double-blind Treatment Period|Adverse Event|0
4688647|NCT02453555|16147210|P5|24-week Double-blind Treatment Period|Adverse Event|0
4688648|NCT02453555|16147211|P4|24-week Double-blind Treatment Period|Adverse Event|0
4688649|NCT02453555|16147212|P3|24-week Double-blind Treatment Period|Adverse Event|0
4688650|NCT02453555|16147213|P2|24-week Double-blind Treatment Period|Adverse Event|0
4688651|NCT02453555|16147214|P1|24-week Double-blind Treatment Period|Adverse Event|2
4688652|NCT02453386|16147230|P3|Overall Study|Other|1
4688653|NCT02453386|16147231|P2|Overall Study|Other|0
4688654|NCT02453386|16147232|P1|Overall Study|Other|1
4688655|NCT02453386|16147230|P3|Overall Study|Lost to Follow-up|1
4688656|NCT02453386|16147231|P2|Overall Study|Lost to Follow-up|0
4688657|NCT02453386|16147232|P1|Overall Study|Lost to Follow-up|0
4688658|NCT02453386|16147230|P3|Overall Study|Sponsor Terminated by Investigator|2
4688659|NCT02453386|16147231|P2|Overall Study|Sponsor Terminated by Investigator|1
4688660|NCT02453386|16147232|P1|Overall Study|Sponsor Terminated by Investigator|0
4688661|NCT02453386|16147230|P3|Overall Study|Subject Terminated by Sponsor|1
4688662|NCT02453386|16147231|P2|Overall Study|Subject Terminated by Sponsor|1
4688663|NCT02453386|16147232|P1|Overall Study|Subject Terminated by Sponsor|1
4688664|NCT02453386|16147230|P3|Overall Study|Sponsor Terminated Study|11
4688665|NCT02453386|16147231|P2|Overall Study|Sponsor Terminated Study|8
4688666|NCT02453386|16147232|P1|Overall Study|Sponsor Terminated Study|14
4688667|NCT02453386|16147230|P3|Overall Study|Withdrawal by Subject|9
4688668|NCT02453386|16147231|P2|Overall Study|Withdrawal by Subject|9
4688669|NCT02453386|16147232|P1|Overall Study|Withdrawal by Subject|10
4688670|NCT02453386|16147230|P3|Overall Study|Protocol Violation|1
4688671|NCT02453386|16147231|P2|Overall Study|Protocol Violation|0
4688672|NCT02453386|16147232|P1|Overall Study|Protocol Violation|1
4688673|NCT02453386|16147230|P3|Overall Study|Adverse Event|15
4688674|NCT02453386|16147231|P2|Overall Study|Adverse Event|30
4688675|NCT02453386|16147232|P1|Overall Study|Adverse Event|22
4688676|NCT02453321|16147296|P3|Overall Study|Deep Venous Thrombosis|0
4688677|NCT02453321|16147297|P2|Overall Study|Deep Venous Thrombosis|1
4688678|NCT02453321|16147298|P1|Overall Study|Deep Venous Thrombosis|0
4688679|NCT02453321|16147296|P3|Overall Study|Weakness|2
4688680|NCT02453321|16147297|P2|Overall Study|Weakness|1
4688681|NCT02453321|16147298|P1|Overall Study|Weakness|1
4688682|NCT02453282|16147318|P3|Overall Study|Other|1
4688683|NCT02453282|16147319|P2|Overall Study|Other|1
4688684|NCT02453282|16147320|P1|Overall Study|Other|1
4688685|NCT02453282|16147318|P3|Overall Study|Participants ongoing at data cut-off|62
4688686|NCT02453282|16147319|P2|Overall Study|Participants ongoing at data cut-off|84
4688687|NCT02453282|16147320|P1|Overall Study|Participants ongoing at data cut-off|85
4688688|NCT02453282|16147318|P3|Overall Study|Withdrawal by Subject|11
4688689|NCT02453282|16147319|P2|Overall Study|Withdrawal by Subject|10
4688690|NCT02453282|16147320|P1|Overall Study|Withdrawal by Subject|12
4688691|NCT02453282|16147318|P3|Overall Study|Lost to Follow-up|2
4688692|NCT02453282|16147319|P2|Overall Study|Lost to Follow-up|0
4688693|NCT02453282|16147320|P1|Overall Study|Lost to Follow-up|1
4688694|NCT02453282|16147318|P3|Overall Study|Death|296
4688695|NCT02453282|16147319|P2|Overall Study|Death|277
4688696|NCT02453282|16147320|P1|Overall Study|Death|275
4688697|NCT02453256|16147401|P2|Open Label Period|Withdrawal by Subject|1
4688698|NCT02453256|16147402|P1|Open Label Period|Withdrawal by Subject|5
4688699|NCT02453256|16147401|P2|Open Label Period|Other|2
4688700|NCT02453256|16147402|P1|Open Label Period|Other|0
4688701|NCT02453256|16147401|P2|Open Label Period|Lost to Follow-up|0
4688702|NCT02453256|16147402|P1|Open Label Period|Lost to Follow-up|1
4688703|NCT02453256|16147401|P2|Open Label Period|Death|1
4688704|NCT02453256|16147402|P1|Open Label Period|Death|0
4688705|NCT02453256|16147401|P2|Open Label Period|Adverse Event|3
4688706|NCT02453256|16147402|P1|Open Label Period|Adverse Event|1
4688707|NCT02453256|16147401|P2|Double Blind Period|Other|1
4688708|NCT02453256|16147402|P1|Double Blind Period|Other|0
4688709|NCT02453256|16147401|P2|Double Blind Period|Withdrawal by Subject|5
4688710|NCT02453256|16147402|P1|Double Blind Period|Withdrawal by Subject|9
4688711|NCT02453256|16147401|P2|Double Blind Period|Adverse Event|2
4688712|NCT02453256|16147402|P1|Double Blind Period|Adverse Event|3
4688713|NCT02453256|16147401|P2|Double Blind Period|Death|1
4688714|NCT02453256|16147402|P1|Double Blind Period|Death|1
4688715|NCT02453191|16147522|P1|Overall Study|Withdrawal by Subject|1
4688716|NCT02453048|16147539|P5|Overall Study|Lost to Follow-up|0
4688717|NCT02453048|16147540|P4|Overall Study|Lost to Follow-up|0
4688718|NCT02453048|16147541|P3|Overall Study|Lost to Follow-up|2
4688719|NCT02453048|16147542|P2|Overall Study|Lost to Follow-up|1
4688720|NCT02453048|16147543|P1|Overall Study|Lost to Follow-up|0
4688721|NCT02453048|16147539|P5|Overall Study|Only part of initial 6 mo. study|6
4688722|NCT02453048|16147540|P4|Overall Study|Only part of initial 6 mo. study|0
4688723|NCT02453048|16147541|P3|Overall Study|Only part of initial 6 mo. study|0
4688724|NCT02453048|16147542|P2|Overall Study|Only part of initial 6 mo. study|0
4688725|NCT02453048|16147543|P1|Overall Study|Only part of initial 6 mo. study|0
4688726|NCT02452892|16147603|P4|Follow-up|Subject left town on Day 42|0
4688727|NCT02452892|16147604|P3|Follow-up|Subject left town on Day 42|0
4688728|NCT02452892|16147605|P2|Follow-up|Subject left town on Day 42|0
4688729|NCT02452892|16147606|P1|Follow-up|Subject left town on Day 42|1
4688730|NCT02452892|16147603|P4|Follow-up|Withdrawal by Subject|1
4688731|NCT02452892|16147604|P3|Follow-up|Withdrawal by Subject|0
4688732|NCT02452892|16147605|P2|Follow-up|Withdrawal by Subject|0
4688733|NCT02452892|16147606|P1|Follow-up|Withdrawal by Subject|0
4688734|NCT02452892|16147603|P4|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
4688735|NCT02452892|16147604|P3|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
4688736|NCT02452892|16147605|P2|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0
4688737|NCT02452892|16147606|P1|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2
4688738|NCT02452892|16147603|P4|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2
4688739|NCT02452892|16147604|P3|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
4688740|NCT02452892|16147605|P2|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
4688741|NCT02452892|16147606|P1|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0
4688742|NCT02452892|16147603|P4|Week 1 Initial Randommization|Lost to Follow-up|0
4688743|NCT02452892|16147604|P3|Week 1 Initial Randommization|Lost to Follow-up|1
4688744|NCT02452892|16147605|P2|Week 1 Initial Randommization|Lost to Follow-up|0
4688745|NCT02452892|16147606|P1|Week 1 Initial Randommization|Lost to Follow-up|0
4688746|NCT02452892|16147603|P4|Week 1 Initial Randommization|Adverse Event|0
4688747|NCT02452892|16147604|P3|Week 1 Initial Randommization|Adverse Event|0
4688748|NCT02452892|16147605|P2|Week 1 Initial Randommization|Adverse Event|0
4688749|NCT02452892|16147606|P1|Week 1 Initial Randommization|Adverse Event|1
4688750|NCT02452554|16147641|P6|Overall Study|Never Received Treatment|0
4688751|NCT02452554|16147642|P5|Overall Study|Never Received Treatment|0
4688752|NCT02452554|16147643|P4|Overall Study|Never Received Treatment|0
4688753|NCT02452554|16147644|P3|Overall Study|Never Received Treatment|0
4688754|NCT02452554|16147645|P2|Overall Study|Never Received Treatment|0
4688755|NCT02452554|16147646|P1|Overall Study|Never Received Treatment|1
4688756|NCT02452554|16147641|P6|Overall Study|Ineligible|0
4688757|NCT02452554|16147642|P5|Overall Study|Ineligible|0
4688758|NCT02452554|16147643|P4|Overall Study|Ineligible|0
4688759|NCT02452554|16147644|P3|Overall Study|Ineligible|0
4688760|NCT02452554|16147645|P2|Overall Study|Ineligible|1
4688761|NCT02452554|16147646|P1|Overall Study|Ineligible|0
4688762|NCT02452554|16147641|P6|Overall Study|Withdrawal by Subject|1
4688763|NCT02452554|16147642|P5|Overall Study|Withdrawal by Subject|0
4688764|NCT02452554|16147643|P4|Overall Study|Withdrawal by Subject|0
4688765|NCT02452554|16147644|P3|Overall Study|Withdrawal by Subject|2
4688766|NCT02452554|16147645|P2|Overall Study|Withdrawal by Subject|0
4688767|NCT02452554|16147646|P1|Overall Study|Withdrawal by Subject|1
4688768|NCT02452554|16147641|P6|Overall Study|Physician Decision|0
4688769|NCT02452554|16147642|P5|Overall Study|Physician Decision|0
4688770|NCT02452554|16147643|P4|Overall Study|Physician Decision|0
4688771|NCT02452554|16147644|P3|Overall Study|Physician Decision|0
4688772|NCT02452554|16147645|P2|Overall Study|Physician Decision|1
4688773|NCT02452554|16147646|P1|Overall Study|Physician Decision|0
4688774|NCT02452554|16147641|P6|Overall Study|Lack of Efficacy|8
4688775|NCT02452554|16147642|P5|Overall Study|Lack of Efficacy|5
4688776|NCT02452554|16147643|P4|Overall Study|Lack of Efficacy|1
4688777|NCT02452554|16147644|P3|Overall Study|Lack of Efficacy|9
4688778|NCT02452554|16147645|P2|Overall Study|Lack of Efficacy|14
4688779|NCT02452554|16147646|P1|Overall Study|Lack of Efficacy|13
4688780|NCT02452554|16147641|P6|Overall Study|Death|0
4688781|NCT02452554|16147642|P5|Overall Study|Death|0
4688782|NCT02452554|16147643|P4|Overall Study|Death|0
4688783|NCT02452554|16147644|P3|Overall Study|Death|0
4688784|NCT02452554|16147645|P2|Overall Study|Death|1
4688785|NCT02452554|16147646|P1|Overall Study|Death|2
4688786|NCT02452463|16147699|P3|Overall Study|Withdrawal by Subject|0
4688787|NCT02452463|16147700|P2|Overall Study|Withdrawal by Subject|1
4688788|NCT02452463|16147701|P1|Overall Study|Withdrawal by Subject|0
4688789|NCT02452463|16147699|P3|Overall Study|Recommended by DSMB|0
4688790|NCT02452463|16147700|P2|Overall Study|Recommended by DSMB|1
4688791|NCT02452463|16147701|P1|Overall Study|Recommended by DSMB|0
4688792|NCT02452463|16147699|P3|Overall Study|Study Suspended|0
4688793|NCT02452463|16147700|P2|Overall Study|Study Suspended|0
4688794|NCT02452463|16147701|P1|Overall Study|Study Suspended|1
4688795|NCT02452463|16147699|P3|Overall Study|Death|0
4688796|NCT02452463|16147700|P2|Overall Study|Death|0
4688797|NCT02452463|16147701|P1|Overall Study|Death|1
4688798|NCT02452424|16147744|P11|Overall Study|Adverse Event|1
4688799|NCT02452424|16147745|P10|Overall Study|Adverse Event|0
4688800|NCT02452424|16147746|P9|Overall Study|Adverse Event|0
4688801|NCT02452424|16147747|P8|Overall Study|Adverse Event|0
4688802|NCT02452424|16147748|P7|Overall Study|Adverse Event|0
4688803|NCT02452424|16147749|P6|Overall Study|Adverse Event|0
4688804|NCT02452424|16147750|P5|Overall Study|Adverse Event|0
4688805|NCT02452424|16147751|P4|Overall Study|Adverse Event|0
4688806|NCT02452424|16147752|P3|Overall Study|Adverse Event|0
4688807|NCT02452424|16147753|P2|Overall Study|Adverse Event|0
4688808|NCT02452424|16147754|P1|Overall Study|Adverse Event|0
4688809|NCT02452424|16147744|P11|Overall Study|Progressive disease (per RECIST)|0
4688810|NCT02452424|16147745|P10|Overall Study|Progressive disease (per RECIST)|0
4688811|NCT02452424|16147746|P9|Overall Study|Progressive disease (per RECIST)|2
4688812|NCT02452424|16147747|P8|Overall Study|Progressive disease (per RECIST)|0
4688813|NCT02452424|16147748|P7|Overall Study|Progressive disease (per RECIST)|0
4688814|NCT02452424|16147749|P6|Overall Study|Progressive disease (per RECIST)|0
4688815|NCT02452424|16147750|P5|Overall Study|Progressive disease (per RECIST)|0
4688816|NCT02452424|16147751|P4|Overall Study|Progressive disease (per RECIST)|0
4688817|NCT02452424|16147752|P3|Overall Study|Progressive disease (per RECIST)|0
4688818|NCT02452424|16147753|P2|Overall Study|Progressive disease (per RECIST)|0
4688819|NCT02452424|16147754|P1|Overall Study|Progressive disease (per RECIST)|0
4688820|NCT02452424|16147744|P11|Overall Study|Other|1
4688821|NCT02452424|16147745|P10|Overall Study|Other|0
4688822|NCT02452424|16147746|P9|Overall Study|Other|0
4688823|NCT02452424|16147747|P8|Overall Study|Other|3
4688824|NCT02452424|16147748|P7|Overall Study|Other|4
4688825|NCT02452424|16147749|P6|Overall Study|Other|1
4688826|NCT02452424|16147750|P5|Overall Study|Other|0
4688827|NCT02452424|16147751|P4|Overall Study|Other|0
4688828|NCT02452424|16147752|P3|Overall Study|Other|1
4688829|NCT02452424|16147753|P2|Overall Study|Other|0
4688830|NCT02452424|16147754|P1|Overall Study|Other|0
4688831|NCT02452424|16147744|P11|Overall Study|Withdrawal by Subject|0
4688832|NCT02452424|16147745|P10|Overall Study|Withdrawal by Subject|1
4688833|NCT02452424|16147746|P9|Overall Study|Withdrawal by Subject|1
4688834|NCT02452424|16147747|P8|Overall Study|Withdrawal by Subject|0
4688835|NCT02452424|16147748|P7|Overall Study|Withdrawal by Subject|1
4688836|NCT02452424|16147749|P6|Overall Study|Withdrawal by Subject|0
4688837|NCT02452424|16147750|P5|Overall Study|Withdrawal by Subject|0
4688838|NCT02452424|16147751|P4|Overall Study|Withdrawal by Subject|2
4688839|NCT02452424|16147752|P3|Overall Study|Withdrawal by Subject|3
4688840|NCT02452424|16147753|P2|Overall Study|Withdrawal by Subject|0
4688841|NCT02452424|16147754|P1|Overall Study|Withdrawal by Subject|0
4688842|NCT02452424|16147744|P11|Overall Study|Lost to Follow-up|0
4688843|NCT02452424|16147745|P10|Overall Study|Lost to Follow-up|0
4688844|NCT02452424|16147746|P9|Overall Study|Lost to Follow-up|0
4688845|NCT02452424|16147747|P8|Overall Study|Lost to Follow-up|0
4688846|NCT02452424|16147748|P7|Overall Study|Lost to Follow-up|0
4688847|NCT02452424|16147749|P6|Overall Study|Lost to Follow-up|0
4688848|NCT02452424|16147750|P5|Overall Study|Lost to Follow-up|0
4688849|NCT02452424|16147751|P4|Overall Study|Lost to Follow-up|0
4688850|NCT02452424|16147752|P3|Overall Study|Lost to Follow-up|1
4688851|NCT02452424|16147753|P2|Overall Study|Lost to Follow-up|1
4688852|NCT02452424|16147754|P1|Overall Study|Lost to Follow-up|0
4688853|NCT02452424|16147744|P11|Overall Study|Death|0
4688854|NCT02452424|16147745|P10|Overall Study|Death|1
4688855|NCT02452424|16147746|P9|Overall Study|Death|3
4688856|NCT02452424|16147747|P8|Overall Study|Death|1
4688857|NCT02452424|16147748|P7|Overall Study|Death|5
4688858|NCT02452424|16147749|P6|Overall Study|Death|0
4688859|NCT02452424|16147750|P5|Overall Study|Death|2
4688860|NCT02452424|16147751|P4|Overall Study|Death|6
4688861|NCT02452424|16147752|P3|Overall Study|Death|2
4688862|NCT02452424|16147753|P2|Overall Study|Death|2
4688863|NCT02452424|16147754|P1|Overall Study|Death|2
4688864|NCT02452320|16147797|P2|Overall Study|Adverse Event|1
4688865|NCT02452320|16147798|P1|Overall Study|Adverse Event|0
4688866|NCT02452190|16147810|P2|Overall Study|Death|1
4688867|NCT02452190|16147811|P1|Overall Study|Death|0
4688868|NCT02452190|16147810|P2|Overall Study|Participant traveled abroad|0
4688869|NCT02452190|16147811|P1|Overall Study|Participant traveled abroad|1
4688870|NCT02452190|16147810|P2|Overall Study|Noncompliance with study drug|0
4688871|NCT02452190|16147811|P1|Overall Study|Noncompliance with study drug|1
4688872|NCT02452190|16147810|P2|Overall Study|Withdrawal by Subject|11
4688873|NCT02452190|16147811|P1|Overall Study|Withdrawal by Subject|20
4688874|NCT02452190|16147810|P2|Overall Study|Adverse Event|5
4688875|NCT02452190|16147811|P1|Overall Study|Adverse Event|2
4688876|NCT02452190|16147810|P2|Overall Study|Lost to Follow-up|3
4688877|NCT02452190|16147811|P1|Overall Study|Lost to Follow-up|4
4688878|NCT02452190|16147810|P2|Overall Study|Lack of Efficacy|1
4688879|NCT02452190|16147811|P1|Overall Study|Lack of Efficacy|3
4688880|NCT02452190|16147810|P2|Overall Study|Investigator's Decision|0
4688881|NCT02452190|16147811|P1|Overall Study|Investigator's Decision|2
4688882|NCT02452190|16147810|P2|Overall Study|Pregnancy|0
4688883|NCT02452190|16147811|P1|Overall Study|Pregnancy|1
4688884|NCT02452190|16147810|P2|Overall Study|Withdrawal by Sponsor|3
4688885|NCT02452190|16147811|P1|Overall Study|Withdrawal by Sponsor|1
4688886|NCT02452047|16147849|P3|Overall Study|Withdrawal by Subject|0
4688887|NCT02452047|16147850|P2|Overall Study|Withdrawal by Subject|0
4688888|NCT02452047|16147851|P1|Overall Study|Withdrawal by Subject|1
4688889|NCT02452047|16147849|P3|Overall Study|Lost to Follow-up|0
4688890|NCT02452047|16147850|P2|Overall Study|Lost to Follow-up|1
4688891|NCT02452047|16147851|P1|Overall Study|Lost to Follow-up|1
4688892|NCT02452047|16147849|P3|Overall Study|Physician Decision|0
4688893|NCT02452047|16147850|P2|Overall Study|Physician Decision|0
4688894|NCT02452047|16147851|P1|Overall Study|Physician Decision|1
4688895|NCT02452047|16147849|P3|Overall Study|Death|1
4688896|NCT02452047|16147850|P2|Overall Study|Death|3
4688897|NCT02452047|16147851|P1|Overall Study|Death|1
4688898|NCT02452047|16147849|P3|Overall Study|Adverse Event|1
4688899|NCT02452047|16147850|P2|Overall Study|Adverse Event|1
4688900|NCT02452047|16147851|P1|Overall Study|Adverse Event|0
4688901|NCT02452034|16147916|P6|Overall Study|Withdrawn by Parent/Guardian|0
4688902|NCT02452034|16147917|P5|Overall Study|Withdrawn by Parent/Guardian|0
4688903|NCT02452034|16147918|P4|Overall Study|Withdrawn by Parent/Guardian|0
4688904|NCT02452034|16147919|P3|Overall Study|Withdrawn by Parent/Guardian|0
4688905|NCT02452034|16147920|P2|Overall Study|Withdrawn by Parent/Guardian|0
4688906|NCT02452034|16147921|P1|Overall Study|Withdrawn by Parent/Guardian|1
4688907|NCT02452034|16147916|P6|Overall Study|Screen Failure|0
4688908|NCT02452034|16147917|P5|Overall Study|Screen Failure|0
4688909|NCT02452034|16147918|P4|Overall Study|Screen Failure|1
4688910|NCT02452034|16147919|P3|Overall Study|Screen Failure|0
4688911|NCT02452034|16147920|P2|Overall Study|Screen Failure|0
4688912|NCT02452034|16147921|P1|Overall Study|Screen Failure|1
4688913|NCT02452034|16147916|P6|Overall Study|Protocol Violation|1
4688914|NCT02452034|16147917|P5|Overall Study|Protocol Violation|0
4688915|NCT02452034|16147918|P4|Overall Study|Protocol Violation|0
4688916|NCT02452034|16147919|P3|Overall Study|Protocol Violation|0
4688917|NCT02452034|16147920|P2|Overall Study|Protocol Violation|0
4688918|NCT02452034|16147921|P1|Overall Study|Protocol Violation|0
4688919|NCT02452034|16147916|P6|Overall Study|Physician Decision|0
4688920|NCT02452034|16147917|P5|Overall Study|Physician Decision|0
4688921|NCT02452034|16147918|P4|Overall Study|Physician Decision|0
4688922|NCT02452034|16147919|P3|Overall Study|Physician Decision|1
4688923|NCT02452034|16147920|P2|Overall Study|Physician Decision|1
4688924|NCT02452034|16147921|P1|Overall Study|Physician Decision|0
4688925|NCT02452034|16147916|P6|Overall Study|Death|1
4688926|NCT02452034|16147917|P5|Overall Study|Death|1
4688927|NCT02452034|16147918|P4|Overall Study|Death|0
4688928|NCT02452034|16147919|P3|Overall Study|Death|0
4688929|NCT02452034|16147920|P2|Overall Study|Death|0
4688930|NCT02452034|16147921|P1|Overall Study|Death|0
4688931|NCT02452034|16147916|P6|Overall Study|Adverse Event|1
4688932|NCT02452034|16147917|P5|Overall Study|Adverse Event|0
4688933|NCT02452034|16147918|P4|Overall Study|Adverse Event|0
4688934|NCT02452034|16147919|P3|Overall Study|Adverse Event|0
4688935|NCT02452034|16147920|P2|Overall Study|Adverse Event|0
4688936|NCT02452034|16147921|P1|Overall Study|Adverse Event|0
4688937|NCT02451943|16147994|P2|Overall Study|Lost to Follow-up|4
4688938|NCT02451943|16147995|P1|Overall Study|Lost to Follow-up|3
4688939|NCT02451943|16147994|P2|Overall Study|Withdrawal by Subject|16
4688940|NCT02451943|16147995|P1|Overall Study|Withdrawal by Subject|13
4688941|NCT02451943|16147994|P2|Overall Study|On Treatment|4
4688942|NCT02451943|16147995|P1|Overall Study|On Treatment|4
4688943|NCT02451930|16148024|P2|Overall Study|Other|1
4688944|NCT02451930|16148025|P1|Overall Study|Other|0
4688945|NCT02451930|16148024|P2|Overall Study|Withdrawal by Subject|1
4688946|NCT02451930|16148025|P1|Overall Study|Withdrawal by Subject|0
4688947|NCT02451930|16148024|P2|Overall Study|Sponsor Decision|10
4688948|NCT02451930|16148025|P1|Overall Study|Sponsor Decision|2
4688949|NCT02451930|16148024|P2|Overall Study|Lost to Follow-up|3
4688950|NCT02451930|16148025|P1|Overall Study|Lost to Follow-up|0
4688951|NCT02451930|16148024|P2|Overall Study|Death|15
4688952|NCT02451930|16148025|P1|Overall Study|Death|0
4688953|NCT02451917|16148048|P2|First Intervention (24 Weeks)|Adverse Event|2
4688954|NCT02451917|16148049|P1|First Intervention (24 Weeks)|Adverse Event|0
4688955|NCT02451917|16148048|P2|First Intervention (24 Weeks)|Death|1
4688956|NCT02451917|16148049|P1|First Intervention (24 Weeks)|Death|0
4688957|NCT02451917|16148048|P2|First Intervention (24 Weeks)|Lost to Follow-up|0
4688958|NCT02451917|16148049|P1|First Intervention (24 Weeks)|Lost to Follow-up|2
4688959|NCT02451670|16148091|P2|Overall Study|Did not have qualifying follow-up visit.|696
4688960|NCT02451670|16148092|P1|Overall Study|Did not have qualifying follow-up visit.|714
4688961|NCT02451358|16148202|P4|Overall Study|Protocol Violation|0
4688962|NCT02451358|16148203|P3|Overall Study|Protocol Violation|1
4688963|NCT02451358|16148204|P2|Overall Study|Protocol Violation|1
4688964|NCT02451358|16148205|P1|Overall Study|Protocol Violation|0
4688965|NCT02451358|16148202|P4|Overall Study|Withdrawal by Subject|0
4688966|NCT02451358|16148203|P3|Overall Study|Withdrawal by Subject|0
4688967|NCT02451358|16148204|P2|Overall Study|Withdrawal by Subject|1
4688968|NCT02451358|16148205|P1|Overall Study|Withdrawal by Subject|1
4688969|NCT02451137|16148293|P2|Overall Study|Other than specified above|3
4688970|NCT02451137|16148294|P1|Overall Study|Other than specified above|2
4688971|NCT02451137|16148293|P2|Overall Study|Withdrawal by Subject|63
4688972|NCT02451137|16148294|P1|Overall Study|Withdrawal by Subject|40
4688973|NCT02451137|16148293|P2|Overall Study|Sponsor decision|25
4688974|NCT02451137|16148294|P1|Overall Study|Sponsor decision|13
4688975|NCT02451137|16148293|P2|Overall Study|Physician Decision|5
4688976|NCT02451137|16148294|P1|Overall Study|Physician Decision|6
4688977|NCT02451137|16148293|P2|Overall Study|Lost to Follow-up|61
4688978|NCT02451137|16148294|P1|Overall Study|Lost to Follow-up|53
4688979|NCT02451137|16148293|P2|Overall Study|Investigator's decision|19
4688980|NCT02451137|16148294|P1|Overall Study|Investigator's decision|23
4688981|NCT02451137|16148293|P2|Overall Study|Hypoglycemia|1
4688982|NCT02451137|16148294|P1|Overall Study|Hypoglycemia|2
4688983|NCT02451137|16148293|P2|Overall Study|Participant decision:discontinue insulin|43
4688984|NCT02451137|16148294|P1|Overall Study|Participant decision:discontinue insulin|41
4688985|NCT02451137|16148293|P2|Overall Study|Lack of Efficacy|9
4688986|NCT02451137|16148294|P1|Overall Study|Lack of Efficacy|4
4688987|NCT02451137|16148293|P2|Overall Study|Adverse Event|42
4688988|NCT02451137|16148294|P1|Overall Study|Adverse Event|43
4688989|NCT02451137|16148293|P2|Overall Study|Randomized but not treated|27
4688990|NCT02451137|16148294|P1|Overall Study|Randomized but not treated|19
4688991|NCT02451124|16148324|P1|Overall Study|Withdrawal by Subject|1
4688992|NCT02451007|16148335|P1|Overall Study|Disease Progression|2
4688993|NCT02451007|16148335|P1|Overall Study|Adverse Event|1
4688994|NCT02451007|16148335|P1|Overall Study|Withdrawal by Subject|4
4688995|NCT02450552|16148374|P3|Overall Study|Physician Decision|1
4688996|NCT02450552|16148375|P2|Overall Study|Physician Decision|0
4688997|NCT02450552|16148376|P1|Overall Study|Physician Decision|1
4688998|NCT02450552|16148374|P3|Overall Study|Withdrawal by Subject|4
4688999|NCT02450552|16148375|P2|Overall Study|Withdrawal by Subject|0
4689000|NCT02450552|16148376|P1|Overall Study|Withdrawal by Subject|4
4689001|NCT02450539|16148419|P2|Overall Study|On study treatment/follow up|25
4689002|NCT02450539|16148420|P1|Overall Study|On study treatment/follow up|27
4689003|NCT02450539|16148419|P2|Overall Study|Lost to Follow-up|1
4689004|NCT02450539|16148420|P1|Overall Study|Lost to Follow-up|4
4689005|NCT02450539|16148419|P2|Overall Study|Withdrawal by Subject|7
4689006|NCT02450539|16148420|P1|Overall Study|Withdrawal by Subject|19
4689007|NCT02450526|16148444|P5|OL Period (Cycles 2-5)|Protocol Violation|7
4689008|NCT02450526|16148445|P4|OL Period (Cycles 2-5)|Protocol Violation|0
4689009|NCT02450526|16148446|P3|OL Period (Cycles 2-5)|Protocol Violation|0
4689010|NCT02450526|16148447|P2|OL Period (Cycles 2-5)|Protocol Violation|0
4689011|NCT02450526|16148448|P1|OL Period (Cycles 2-5)|Protocol Violation|0
4689012|NCT02450526|16148444|P5|OL Period (Cycles 2-5)|Lack of Efficacy|1
4689013|NCT02450526|16148445|P4|OL Period (Cycles 2-5)|Lack of Efficacy|0
4689014|NCT02450526|16148446|P3|OL Period (Cycles 2-5)|Lack of Efficacy|0
4689015|NCT02450526|16148447|P2|OL Period (Cycles 2-5)|Lack of Efficacy|0
4689016|NCT02450526|16148448|P1|OL Period (Cycles 2-5)|Lack of Efficacy|0
4689017|NCT02450526|16148444|P5|OL Period (Cycles 2-5)|Withdrawal by Subject|31
4689018|NCT02450526|16148445|P4|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4689019|NCT02450526|16148446|P3|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4689020|NCT02450526|16148447|P2|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4689021|NCT02450526|16148448|P1|OL Period (Cycles 2-5)|Withdrawal by Subject|0
4689022|NCT02450526|16148444|P5|OL Period (Cycles 2-5)|Adverse Event|2
4689023|NCT02450526|16148445|P4|OL Period (Cycles 2-5)|Adverse Event|0
4689024|NCT02450526|16148446|P3|OL Period (Cycles 2-5)|Adverse Event|0
4689025|NCT02450526|16148447|P2|OL Period (Cycles 2-5)|Adverse Event|0
4689026|NCT02450526|16148448|P1|OL Period (Cycles 2-5)|Adverse Event|0
4689027|NCT02450526|16148444|P5|DB Period (Cycle 1)|Protocol Violation|0
4689028|NCT02450526|16148445|P4|DB Period (Cycle 1)|Protocol Violation|1
4689029|NCT02450526|16148446|P3|DB Period (Cycle 1)|Protocol Violation|0
4689030|NCT02450526|16148447|P2|DB Period (Cycle 1)|Protocol Violation|0
4689031|NCT02450526|16148448|P1|DB Period (Cycle 1)|Protocol Violation|2
4689032|NCT02450526|16148444|P5|DB Period (Cycle 1)|Lost to Follow-up|0
4689033|NCT02450526|16148445|P4|DB Period (Cycle 1)|Lost to Follow-up|0
4689034|NCT02450526|16148446|P3|DB Period (Cycle 1)|Lost to Follow-up|0
4689035|NCT02450526|16148447|P2|DB Period (Cycle 1)|Lost to Follow-up|0
4689036|NCT02450526|16148448|P1|DB Period (Cycle 1)|Lost to Follow-up|1
4689037|NCT02450526|16148444|P5|DB Period (Cycle 1)|Withdrawal by Subject|0
4689038|NCT02450526|16148445|P4|DB Period (Cycle 1)|Withdrawal by Subject|1
4689039|NCT02450526|16148446|P3|DB Period (Cycle 1)|Withdrawal by Subject|8
4689040|NCT02450526|16148447|P2|DB Period (Cycle 1)|Withdrawal by Subject|3
4689041|NCT02450526|16148448|P1|DB Period (Cycle 1)|Withdrawal by Subject|28
4689042|NCT02450526|16148444|P5|DB Period (Cycle 1)|Adverse Event|0
4689043|NCT02450526|16148445|P4|DB Period (Cycle 1)|Adverse Event|0
4689044|NCT02450526|16148446|P3|DB Period (Cycle 1)|Adverse Event|2
4689045|NCT02450526|16148447|P2|DB Period (Cycle 1)|Adverse Event|0
4689046|NCT02450526|16148448|P1|DB Period (Cycle 1)|Adverse Event|0
4689047|NCT02450487|16148533|P1|Overall Study|Lost to Follow-up|3
4689048|NCT02449915|16148555|P2|Overall Study|Abnormal preop lab|1
4689049|NCT02449915|16148556|P1|Overall Study|Abnormal preop lab|0
4689050|NCT02449915|16148555|P2|Overall Study|Intraoperative surgical findings|1
4689051|NCT02449915|16148556|P1|Overall Study|Intraoperative surgical findings|1
4689052|NCT02449915|16148555|P2|Overall Study|Withdrawal by Subject|2
4689053|NCT02449915|16148556|P1|Overall Study|Withdrawal by Subject|0
4689054|NCT02449915|16148555|P2|Overall Study|Exclusion criteria - drug use|0
4689055|NCT02449915|16148556|P1|Overall Study|Exclusion criteria - drug use|1
4689056|NCT02449902|16148564|P2|Overall Study|Withdrawal by Subject|1
4689057|NCT02449902|16148565|P1|Overall Study|Withdrawal by Subject|0
4689058|NCT02449902|16148564|P2|Overall Study|Adverse Event|1
4689059|NCT02449902|16148565|P1|Overall Study|Adverse Event|0
4689060|NCT02449889|16148592|P3|Overall Study|Protocol Violation|1
4689061|NCT02449889|16148593|P2|Overall Study|Protocol Violation|4
4689062|NCT02449889|16148594|P1|Overall Study|Protocol Violation|0
4689063|NCT02449889|16148592|P3|Overall Study|Adverse Event|0
4689064|NCT02449889|16148593|P2|Overall Study|Adverse Event|2
4689065|NCT02449889|16148594|P1|Overall Study|Adverse Event|1
4689066|NCT02449044|16148728|P1|Overall Study|Sponsor Discontinued Trial|3
4689067|NCT02449044|16148728|P1|Overall Study|Physician Decision|9
4689068|NCT02449044|16148728|P1|Overall Study|Met Withdrawal Criteria|7
4689069|NCT02449044|16148728|P1|Overall Study|Adverse Event|30
4689070|NCT02449044|16148728|P1|Overall Study|Withdrawal by Subject|13
4689071|NCT02449044|16148728|P1|Overall Study|Lost to Follow-up|2
4689072|NCT02449018|16148749|P2|Overall Study|Patient decision|0
4689073|NCT02449018|16148750|P1|Overall Study|Patient decision|2
4689074|NCT02449018|16148749|P2|Overall Study|Protocol deviation|0
4689075|NCT02449018|16148750|P1|Overall Study|Protocol deviation|4
4689076|NCT02449018|16148749|P2|Overall Study|Adverse Event|1
4689077|NCT02449018|16148750|P1|Overall Study|Adverse Event|5
4689078|NCT02449018|16148749|P2|Overall Study|Administrative problems|0
4689079|NCT02449018|16148750|P1|Overall Study|Administrative problems|1
4689080|NCT02449018|16148749|P2|Overall Study|Abnormal laboratory value|1
4689081|NCT02449018|16148750|P1|Overall Study|Abnormal laboratory value|0
4689082|NCT02448875|16148797|P3|Overall Study|Withdrawal by Subject|0
4689083|NCT02448875|16148798|P2|Overall Study|Withdrawal by Subject|0
4689084|NCT02448875|16148799|P1|Overall Study|Withdrawal by Subject|1
4689085|NCT02448875|16148797|P3|Overall Study|Investigator Decision|1
4689086|NCT02448875|16148798|P2|Overall Study|Investigator Decision|0
4689087|NCT02448875|16148799|P1|Overall Study|Investigator Decision|3
4689088|NCT02448875|16148797|P3|Overall Study|Lost to Follow-up|0
4689089|NCT02448875|16148798|P2|Overall Study|Lost to Follow-up|0
4689090|NCT02448875|16148799|P1|Overall Study|Lost to Follow-up|1
4689091|NCT02448875|16148797|P3|Overall Study|Adverse Event|0
4689092|NCT02448875|16148798|P2|Overall Study|Adverse Event|1
4689093|NCT02448875|16148799|P1|Overall Study|Adverse Event|2
4689094|NCT02448810|16148847|P8|Overall Study|Other (unspecified)|0
4689095|NCT02448810|16148848|P7|Overall Study|Other (unspecified)|2
4689096|NCT02448810|16148849|P6|Overall Study|Other (unspecified)|0
4689097|NCT02448810|16148850|P5|Overall Study|Other (unspecified)|0
4689098|NCT02448810|16148851|P4|Overall Study|Other (unspecified)|0
4689099|NCT02448810|16148852|P3|Overall Study|Other (unspecified)|0
4689100|NCT02448810|16148853|P2|Overall Study|Other (unspecified)|0
4689101|NCT02448810|16148854|P1|Overall Study|Other (unspecified)|0
4689102|NCT02448810|16148847|P8|Overall Study|Lost to Follow-up|0
4689103|NCT02448810|16148848|P7|Overall Study|Lost to Follow-up|0
4689104|NCT02448810|16148849|P6|Overall Study|Lost to Follow-up|0
4689105|NCT02448810|16148850|P5|Overall Study|Lost to Follow-up|0
4689106|NCT02448810|16148851|P4|Overall Study|Lost to Follow-up|0
4689107|NCT02448810|16148852|P3|Overall Study|Lost to Follow-up|0
4689108|NCT02448810|16148853|P2|Overall Study|Lost to Follow-up|1
4689109|NCT02448810|16148854|P1|Overall Study|Lost to Follow-up|0
4689110|NCT02448810|16148847|P8|Overall Study|Other (Progressive disease)|5
4689111|NCT02448810|16148848|P7|Overall Study|Other (Progressive disease)|14
4689112|NCT02448810|16148849|P6|Overall Study|Other (Progressive disease)|9
4689113|NCT02448810|16148850|P5|Overall Study|Other (Progressive disease)|23
4689114|NCT02448810|16148851|P4|Overall Study|Other (Progressive disease)|3
4689115|NCT02448810|16148852|P3|Overall Study|Other (Progressive disease)|0
4689116|NCT02448810|16148853|P2|Overall Study|Other (Progressive disease)|2
4689117|NCT02448810|16148854|P1|Overall Study|Other (Progressive disease)|2
4689118|NCT02448810|16148847|P8|Overall Study|Death|0
4689119|NCT02448810|16148848|P7|Overall Study|Death|0
4689120|NCT02448810|16148849|P6|Overall Study|Death|0
4689121|NCT02448810|16148850|P5|Overall Study|Death|1
4689122|NCT02448810|16148851|P4|Overall Study|Death|0
4689123|NCT02448810|16148852|P3|Overall Study|Death|1
4689124|NCT02448810|16148853|P2|Overall Study|Death|0
4689125|NCT02448810|16148854|P1|Overall Study|Death|1
4689126|NCT02448810|16148847|P8|Overall Study|Other (study terminated by sponsor)|1
4689127|NCT02448810|16148848|P7|Overall Study|Other (study terminated by sponsor)|2
4689128|NCT02448810|16148849|P6|Overall Study|Other (study terminated by sponsor)|2
4689129|NCT02448810|16148850|P5|Overall Study|Other (study terminated by sponsor)|4
4689130|NCT02448810|16148851|P4|Overall Study|Other (study terminated by sponsor)|0
4689131|NCT02448810|16148852|P3|Overall Study|Other (study terminated by sponsor)|0
4689132|NCT02448810|16148853|P2|Overall Study|Other (study terminated by sponsor)|0
4689133|NCT02448810|16148854|P1|Overall Study|Other (study terminated by sponsor)|0
4689134|NCT02448810|16148847|P8|Overall Study|Withdrawal by Subject|2
4689135|NCT02448810|16148848|P7|Overall Study|Withdrawal by Subject|0
4689136|NCT02448810|16148849|P6|Overall Study|Withdrawal by Subject|5
4689137|NCT02448810|16148850|P5|Overall Study|Withdrawal by Subject|3
4689138|NCT02448810|16148851|P4|Overall Study|Withdrawal by Subject|0
4689139|NCT02448810|16148852|P3|Overall Study|Withdrawal by Subject|1
4689140|NCT02448810|16148853|P2|Overall Study|Withdrawal by Subject|0
4689141|NCT02448810|16148854|P1|Overall Study|Withdrawal by Subject|0
4689142|NCT02448810|16148847|P8|Overall Study|Adverse Event|0
4689143|NCT02448810|16148848|P7|Overall Study|Adverse Event|0
4689144|NCT02448810|16148849|P6|Overall Study|Adverse Event|0
4689145|NCT02448810|16148850|P5|Overall Study|Adverse Event|0
4689146|NCT02448810|16148851|P4|Overall Study|Adverse Event|0
4689147|NCT02448810|16148852|P3|Overall Study|Adverse Event|1
4689148|NCT02448810|16148853|P2|Overall Study|Adverse Event|0
4689149|NCT02448810|16148854|P1|Overall Study|Adverse Event|0
4689150|NCT02448719|16148931|P11|Overall Study|Withdrawal by Subject|0
4689151|NCT02448719|16148932|P10|Overall Study|Withdrawal by Subject|0
4689152|NCT02448719|16148933|P9|Overall Study|Withdrawal by Subject|0
4689153|NCT02448719|16148934|P8|Overall Study|Withdrawal by Subject|0
4689154|NCT02448719|16148935|P7|Overall Study|Withdrawal by Subject|0
4689155|NCT02448719|16148936|P6|Overall Study|Withdrawal by Subject|0
4689156|NCT02448719|16148937|P5|Overall Study|Withdrawal by Subject|1
4689157|NCT02448719|16148938|P4|Overall Study|Withdrawal by Subject|0
4689158|NCT02448719|16148939|P3|Overall Study|Withdrawal by Subject|0
4689159|NCT02448719|16148940|P2|Overall Study|Withdrawal by Subject|0
4689160|NCT02448719|16148941|P1|Overall Study|Withdrawal by Subject|0
4689161|NCT02448706|16149165|P2|Overall Study|Protocol Violation|1
4689162|NCT02448706|16149166|P1|Overall Study|Protocol Violation|1
4689163|NCT02448706|16149165|P2|Overall Study|Withdrawal by Subject|3
4689164|NCT02448706|16149166|P1|Overall Study|Withdrawal by Subject|4
4689165|NCT02448680|16149180|P2|Overall Study|Withdrawal by Subject|2
4689166|NCT02448680|16149181|P1|Overall Study|Withdrawal by Subject|0
4689167|NCT02448680|16149180|P2|Overall Study|Physician Decision|1
4689168|NCT02448680|16149181|P1|Overall Study|Physician Decision|1
4689169|NCT02448563|16149250|P2|Overall Study|Withdrawal by Subject|1
4689170|NCT02448563|16149251|P1|Overall Study|Withdrawal by Subject|0
4689171|NCT02448563|16149250|P2|Overall Study|Lost to Follow-up|10
4689172|NCT02448563|16149251|P1|Overall Study|Lost to Follow-up|16
4689173|NCT02448537|16149273|P3|Overall Study|Withdrawal by Subject|1
4689174|NCT02448537|16149274|P2|Overall Study|Withdrawal by Subject|1
4689175|NCT02448537|16149275|P1|Overall Study|Withdrawal by Subject|1
4689176|NCT02448043|16149389|P2|Overall Study|Protocol Violation|2
4689177|NCT02448043|16149390|P1|Overall Study|Protocol Violation|1
4689178|NCT02448043|16149389|P2|Overall Study|Withdrawal by Subject|2
4689179|NCT02448043|16149390|P1|Overall Study|Withdrawal by Subject|2
4689180|NCT02447952|16149408|P1|Overall Study|Withdrawal by Subject|4
4689181|NCT02447952|16149408|P1|Overall Study|Physician Decision|1
4689182|NCT02447952|16149408|P1|Overall Study|Adverse Event|2
4689183|NCT02447887|16149465|P1|Overall Study|Study was terminated|3
4689184|NCT02447848|16149478|P1|Overall Study|Withdrawal by Subject|4
4689185|NCT02447848|16149478|P1|Overall Study|Lack of Efficacy|4
4689186|NCT02447848|16149478|P1|Overall Study|Patient discharged|3
4689187|NCT02447458|16149494|P6|Overall Study|Other|0
4689188|NCT02447458|16149495|P5|Overall Study|Other|0
4689189|NCT02447458|16149496|P4|Overall Study|Other|0
4689190|NCT02447458|16149497|P3|Overall Study|Other|1
4689191|NCT02447458|16149498|P2|Overall Study|Other|0
4689192|NCT02447458|16149499|P1|Overall Study|Other|0
4689193|NCT02447432|16149597|P2|Epoch 001|Lost to Follow-up|3
4689194|NCT02447432|16149598|P1|Epoch 001|Lost to Follow-up|1
4689195|NCT02447432|16149597|P2|Epoch 001|Migrated/moved from study area|5
4689196|NCT02447432|16149598|P1|Epoch 001|Migrated/moved from study area|3
4689197|NCT02447432|16149597|P2|Epoch 001|Withdrawal by Subject|4
4689198|NCT02447432|16149598|P1|Epoch 001|Withdrawal by Subject|0
4689199|NCT02447432|16149597|P2|Epoch 001|Adverse Event|1
4689200|NCT02447432|16149598|P1|Epoch 001|Adverse Event|1
4689201|NCT02447328|16149630|P1|Overall Study|Withdrawal by Subject|1
4689202|NCT02447250|16149634|P1|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4
4689203|NCT02447250|16149634|P1|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1
4689204|NCT02447250|16149634|P1|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1
4689205|NCT02447081|16149651|P1|Overall Study|unsuccessful implant procedure|10
4689206|NCT02447081|16149651|P1|Overall Study|Visit not completed|17
4689207|NCT02447081|16149651|P1|Overall Study|Lost to Follow-up|36
4689208|NCT02447081|16149651|P1|Overall Study|Death|161
4689209|NCT02447029|16149667|P2|Overall Study|Withdrawal by Subject|2
4689210|NCT02447029|16149668|P1|Overall Study|Withdrawal by Subject|3
4689211|NCT02446990|16149688|P2|Overall Study|Withdrawal by Subject|199
4689212|NCT02446990|16149689|P1|Overall Study|Withdrawal by Subject|231
4689213|NCT02446990|16149688|P2|Overall Study|Physician Decision|0
4689214|NCT02446990|16149689|P1|Overall Study|Physician Decision|1
4689215|NCT02446990|16149688|P2|Overall Study|Lost to Follow-up|1
4689216|NCT02446990|16149689|P1|Overall Study|Lost to Follow-up|3
4689217|NCT02446990|16149688|P2|Overall Study|Death|458
4689218|NCT02446990|16149689|P1|Overall Study|Death|485
4689219|NCT02446912|16149724|P3|Overall Study|Miscellaneous|4
4689220|NCT02446912|16149725|P2|Overall Study|Miscellaneous|2
4689221|NCT02446912|16149726|P1|Overall Study|Miscellaneous|2
4689222|NCT02446912|16149724|P3|Overall Study|Withdrawal by Subject|15
4689223|NCT02446912|16149725|P2|Overall Study|Withdrawal by Subject|15
4689224|NCT02446912|16149726|P1|Overall Study|Withdrawal by Subject|10
4689225|NCT02446912|16149724|P3|Overall Study|Severe non-compliance to protocol|1
4689226|NCT02446912|16149725|P2|Overall Study|Severe non-compliance to protocol|0
4689227|NCT02446912|16149726|P1|Overall Study|Severe non-compliance to protocol|1
4689228|NCT02446912|16149724|P3|Overall Study|Lost to Follow-up|2
4689229|NCT02446912|16149725|P2|Overall Study|Lost to Follow-up|0
4689230|NCT02446912|16149726|P1|Overall Study|Lost to Follow-up|0
4689231|NCT02446912|16149724|P3|Overall Study|Lack of Efficacy|7
4689232|NCT02446912|16149725|P2|Overall Study|Lack of Efficacy|4
4689233|NCT02446912|16149726|P1|Overall Study|Lack of Efficacy|1
4689234|NCT02446912|16149724|P3|Overall Study|Study-specific withdrawal criteria|0
4689235|NCT02446912|16149725|P2|Overall Study|Study-specific withdrawal criteria|0
4689236|NCT02446912|16149726|P1|Overall Study|Study-specific withdrawal criteria|1
4689237|NCT02446912|16149724|P3|Overall Study|Condition under investigation worsened|1
4689238|NCT02446912|16149725|P2|Overall Study|Condition under investigation worsened|1
4689239|NCT02446912|16149726|P1|Overall Study|Condition under investigation worsened|0
4689240|NCT02446912|16149724|P3|Overall Study|Adverse Event|5
4689241|NCT02446912|16149725|P2|Overall Study|Adverse Event|13
4689242|NCT02446912|16149726|P1|Overall Study|Adverse Event|3
4689243|NCT02446899|16149799|P2|Overall Study|Failure to Meet Randomization Criteria|2
4689244|NCT02446899|16149800|P1|Overall Study|Failure to Meet Randomization Criteria|0
4689245|NCT02446899|16149799|P2|Overall Study|Miscellaneous|4
4689246|NCT02446899|16149800|P1|Overall Study|Miscellaneous|5
4689247|NCT02446899|16149799|P2|Overall Study|Withdrawal by Subject|19
4689248|NCT02446899|16149800|P1|Overall Study|Withdrawal by Subject|11
4689249|NCT02446899|16149799|P2|Overall Study|Severe Non-Compliance to Protocol|1
4689250|NCT02446899|16149800|P1|Overall Study|Severe Non-Compliance to Protocol|0
4689251|NCT02446899|16149799|P2|Overall Study|Lost to Follow-up|3
4689252|NCT02446899|16149800|P1|Overall Study|Lost to Follow-up|1
4689253|NCT02446899|16149799|P2|Overall Study|Lack of Efficacy|8
4689254|NCT02446899|16149800|P1|Overall Study|Lack of Efficacy|2
4689255|NCT02446899|16149799|P2|Overall Study|Study Specific Withdrawal Criteria|0
4689256|NCT02446899|16149800|P1|Overall Study|Study Specific Withdrawal Criteria|1
4689257|NCT02446899|16149799|P2|Overall Study|Condition Under Investigation Worsened|4
4689258|NCT02446899|16149800|P1|Overall Study|Condition Under Investigation Worsened|1
4689259|NCT02446899|16149799|P2|Overall Study|Adverse Event|7
4689260|NCT02446899|16149800|P1|Overall Study|Adverse Event|4
4689261|NCT02446769|16149837|P3|Study Period|Randomized in Error|0
4689262|NCT02446769|16149838|P2|Study Period|Randomized in Error|2
4689263|NCT02446769|16149839|P1|Study Period|Randomized in Error|0
4689264|NCT02446769|16149837|P3|Screening Period|Screen Failure|0
4689265|NCT02446769|16149838|P2|Screening Period|Screen Failure|0
4689266|NCT02446769|16149839|P1|Screening Period|Screen Failure|11
4689267|NCT02446743|16149862|P2|Overall Study|Other|3
4689268|NCT02446743|16149863|P1|Overall Study|Other|2
4689269|NCT02446743|16149862|P2|Overall Study|Adverse Event|1
4689270|NCT02446743|16149863|P1|Overall Study|Adverse Event|1
4689271|NCT02446743|16149862|P2|Overall Study|Lost to Follow-up|0
4689272|NCT02446743|16149863|P1|Overall Study|Lost to Follow-up|1
4689273|NCT02446743|16149862|P2|Overall Study|Withdrawal by Subject|1
4689274|NCT02446743|16149863|P1|Overall Study|Withdrawal by Subject|1
4689275|NCT02446717|16150018|P5|Overall Study|Withdrew consent|0
4689276|NCT02446717|16150019|P4|Overall Study|Withdrew consent|1
4689277|NCT02446717|16150020|P3|Overall Study|Withdrew consent|0
4689278|NCT02446717|16150021|P2|Overall Study|Withdrew consent|0
4689279|NCT02446717|16150022|P1|Overall Study|Withdrew consent|0
4689280|NCT02446717|16150018|P5|Overall Study|Lost to Follow-up|1
4689281|NCT02446717|16150019|P4|Overall Study|Lost to Follow-up|0
4689282|NCT02446717|16150020|P3|Overall Study|Lost to Follow-up|1
4689283|NCT02446717|16150021|P2|Overall Study|Lost to Follow-up|1
4689284|NCT02446717|16150022|P1|Overall Study|Lost to Follow-up|0
4689285|NCT02446717|16150018|P5|Overall Study|Adverse Event|0
4689286|NCT02446717|16150019|P4|Overall Study|Adverse Event|0
4689287|NCT02446717|16150020|P3|Overall Study|Adverse Event|1
4689288|NCT02446717|16150021|P2|Overall Study|Adverse Event|0
4689289|NCT02446717|16150022|P1|Overall Study|Adverse Event|0
4689290|NCT02446691|16150049|P1|Overall Study|Protocol Violation|1
4689291|NCT02446691|16150049|P1|Overall Study|Lost to Follow-up|8
4689292|NCT02446691|16150049|P1|Overall Study|Withdrawal by Subject|2
4689293|NCT02446418|16150119|P2|Overall Study|Protocol defined stopping criteria reach|0
4689294|NCT02446418|16150120|P1|Overall Study|Protocol defined stopping criteria reach|1
4689295|NCT02446418|16150119|P2|Overall Study|Lack of Efficacy|0
4689296|NCT02446418|16150120|P1|Overall Study|Lack of Efficacy|2
4689297|NCT02446418|16150119|P2|Overall Study|Protocol Violation|2
4689298|NCT02446418|16150120|P1|Overall Study|Protocol Violation|1
4689299|NCT02446418|16150119|P2|Overall Study|Lost to Follow-up|2
4689300|NCT02446418|16150120|P1|Overall Study|Lost to Follow-up|2
4689301|NCT02446418|16150119|P2|Overall Study|Withdrawal by Subject|3
4689302|NCT02446418|16150120|P1|Overall Study|Withdrawal by Subject|3
4689303|NCT02446418|16150119|P2|Overall Study|Physician Decision|1
4689304|NCT02446418|16150120|P1|Overall Study|Physician Decision|5
4689305|NCT02446418|16150119|P2|Overall Study|Adverse Event|8
4689306|NCT02446418|16150120|P1|Overall Study|Adverse Event|4
4689307|NCT02446171|16150191|P4|Overall Study|Withdrawal by Subject|0
4689308|NCT02446171|16150192|P3|Overall Study|Withdrawal by Subject|2
4689309|NCT02446171|16150193|P2|Overall Study|Withdrawal by Subject|0
4689310|NCT02446171|16150194|P1|Overall Study|Withdrawal by Subject|0
4689311|NCT02446015|16150265|P2|Overall Study|Withdrawal by Subject|0
4689312|NCT02446015|16150266|P1|Overall Study|Withdrawal by Subject|1
4689313|NCT02446015|16150265|P2|Overall Study|Adverse Event|1
4689314|NCT02446015|16150266|P1|Overall Study|Adverse Event|0
4689315|NCT02445963|16150281|P4|Overall Study|Symptoms post-vaccination|0
4689316|NCT02445963|16150282|P3|Overall Study|Symptoms post-vaccination|1
4689317|NCT02445963|16150283|P2|Overall Study|Symptoms post-vaccination|0
4689318|NCT02445963|16150284|P1|Overall Study|Symptoms post-vaccination|0
4689319|NCT02445963|16150281|P4|Overall Study|Change in employment|0
4689320|NCT02445963|16150282|P3|Overall Study|Change in employment|0
4689321|NCT02445963|16150283|P2|Overall Study|Change in employment|0
4689322|NCT02445963|16150284|P1|Overall Study|Change in employment|1
4689323|NCT02445963|16150281|P4|Overall Study|Lost to Follow-up|0
4689324|NCT02445963|16150282|P3|Overall Study|Lost to Follow-up|0
4689325|NCT02445963|16150283|P2|Overall Study|Lost to Follow-up|0
4689326|NCT02445963|16150284|P1|Overall Study|Lost to Follow-up|1
4689327|NCT02445755|16150405|P1|Overall Study|Screen Failure|5
4689328|NCT02445755|16150405|P1|Overall Study|Protocol Violation|6
4689329|NCT02445755|16150405|P1|Overall Study|Withdrawal by Subject|2
4689330|NCT02445586|16150419|P1|Overall Study|Medical Condition|1
4689331|NCT02445586|16150419|P1|Overall Study|Protocol Violation|1
4689332|NCT02445586|16150419|P1|Overall Study|Disease Progression|10
4689333|NCT02445586|16150419|P1|Overall Study|Withdrawal by Subject|13
4689334|NCT02445586|16150419|P1|Overall Study|Death|14
4689335|NCT02445573|16150459|P2|Overall Study|Lost to Follow-up|1
4689336|NCT02445573|16150460|P1|Overall Study|Lost to Follow-up|0
4689337|NCT02445573|16150459|P2|Overall Study|Withdrawal by Subject|1
4689338|NCT02445573|16150460|P1|Overall Study|Withdrawal by Subject|1
4689339|NCT02444793|16150557|P4|Overall Study|Objective progression or relapse|3
4689340|NCT02444793|16150558|P3|Overall Study|Objective progression or relapse|2
4689341|NCT02444793|16150559|P2|Overall Study|Objective progression or relapse|1
4689342|NCT02444793|16150560|P1|Overall Study|Objective progression or relapse|9
4689343|NCT02444793|16150557|P4|Overall Study|Other|0
4689344|NCT02444793|16150558|P3|Overall Study|Other|2
4689345|NCT02444793|16150559|P2|Overall Study|Other|0
4689346|NCT02444793|16150560|P1|Overall Study|Other|0
4689347|NCT02444793|16150557|P4|Overall Study|Death|0
4689348|NCT02444793|16150558|P3|Overall Study|Death|0
4689349|NCT02444793|16150559|P2|Overall Study|Death|3
4689350|NCT02444793|16150560|P1|Overall Study|Death|0
4689351|NCT02444793|16150557|P4|Overall Study|Lost to Follow-up|0
4689352|NCT02444793|16150558|P3|Overall Study|Lost to Follow-up|0
4689353|NCT02444793|16150559|P2|Overall Study|Lost to Follow-up|2
4689354|NCT02444793|16150560|P1|Overall Study|Lost to Follow-up|2
4689355|NCT02444533|16150719|P2|Overall Study|Only gave post-procedure complications|2
4689356|NCT02444533|16150720|P1|Overall Study|Only gave post-procedure complications|2
4689357|NCT02444533|16150719|P2|Overall Study|Not able to complete forms|2
4689358|NCT02444533|16150720|P1|Overall Study|Not able to complete forms|0
4689359|NCT02444182|16150753|P2|Overall Study|Lost to Follow-up|4
4689360|NCT02444182|16150754|P1|Overall Study|Lost to Follow-up|0
4689361|NCT02444182|16150753|P2|Overall Study|non-compliance|1
4689362|NCT02444182|16150754|P1|Overall Study|non-compliance|2
4689363|NCT02328326|16150775|P2|Overall Study|Lost to Follow-up|4
4689364|NCT02328326|16150776|P1|Overall Study|Lost to Follow-up|10
4689365|NCT02328326|16150775|P2|Overall Study|Death|1
4689366|NCT02328326|16150776|P1|Overall Study|Death|2
4689367|NCT02328326|16150775|P2|Overall Study|Withdrawal by Subject|3
4689368|NCT02328326|16150776|P1|Overall Study|Withdrawal by Subject|10
4689369|NCT02443883|16150788|P4|Overall Study|Randomized, but never treated|0
4689370|NCT02443883|16150789|P3|Overall Study|Randomized, but never treated|0
4689371|NCT02443883|16150790|P2|Overall Study|Randomized, but never treated|0
4689372|NCT02443883|16150791|P1|Overall Study|Randomized, but never treated|1
4689373|NCT02443883|16150788|P4|Overall Study|Withdrawal by Subject|2
4689374|NCT02443883|16150789|P3|Overall Study|Withdrawal by Subject|0
4689375|NCT02443883|16150790|P2|Overall Study|Withdrawal by Subject|0
4689376|NCT02443883|16150791|P1|Overall Study|Withdrawal by Subject|1
4689377|NCT02443883|16150788|P4|Overall Study|Physician Decision|3
4689378|NCT02443883|16150789|P3|Overall Study|Physician Decision|0
4689379|NCT02443883|16150790|P2|Overall Study|Physician Decision|1
4689380|NCT02443883|16150791|P1|Overall Study|Physician Decision|1
4689381|NCT02443883|16150788|P4|Overall Study|Lost to Follow-up|0
4689382|NCT02443883|16150789|P3|Overall Study|Lost to Follow-up|1
4689383|NCT02443883|16150790|P2|Overall Study|Lost to Follow-up|2
4689384|NCT02443883|16150791|P1|Overall Study|Lost to Follow-up|3
4689385|NCT02443883|16150788|P4|Overall Study|Adverse Event|0
4689386|NCT02443883|16150789|P3|Overall Study|Adverse Event|0
4689387|NCT02443883|16150790|P2|Overall Study|Adverse Event|1
4689388|NCT02443883|16150791|P1|Overall Study|Adverse Event|0
4689389|NCT02443805|16150811|P2|Overall Study|Any other reason not above-mentioned|2
4689390|NCT02443805|16150812|P1|Overall Study|Any other reason not above-mentioned|3
4689391|NCT02443805|16150811|P2|Overall Study|Withdrawal by parent/guardian|5
4689392|NCT02443805|16150812|P1|Overall Study|Withdrawal by parent/guardian|3
4689393|NCT02443805|16150811|P2|Overall Study|Non-compliance with study drug|4
4689394|NCT02443805|16150812|P1|Overall Study|Non-compliance with study drug|6
4689395|NCT02443805|16150811|P2|Overall Study|Lack of Efficacy|1
4689396|NCT02443805|16150812|P1|Overall Study|Lack of Efficacy|1
4689397|NCT02443805|16150811|P2|Overall Study|Protocol Violation|4
4689398|NCT02443805|16150812|P1|Overall Study|Protocol Violation|2
4689399|NCT02443805|16150811|P2|Overall Study|Pregnancy|5
4689400|NCT02443805|16150812|P1|Overall Study|Pregnancy|6
4689401|NCT02443805|16150811|P2|Overall Study|Lost to Follow-up|14
4689402|NCT02443805|16150812|P1|Overall Study|Lost to Follow-up|19
4689403|NCT02443805|16150811|P2|Overall Study|Withdrawal by Subject|74
4689404|NCT02443805|16150812|P1|Overall Study|Withdrawal by Subject|73
4689405|NCT02443805|16150811|P2|Overall Study|Adverse Event|18
4689406|NCT02443805|16150812|P1|Overall Study|Adverse Event|100
4689407|NCT02443740|16150843|P11|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689408|NCT02443740|16150844|P10|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689409|NCT02443740|16150845|P9|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689410|NCT02443740|16150846|P8|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689411|NCT02443740|16150847|P7|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689412|NCT02443740|16150848|P6|Intervention Period 1 (3 Days)|Withdrawal by Subject|1
4689413|NCT02443740|16150849|P5|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689414|NCT02443740|16150850|P4|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689415|NCT02443740|16150851|P3|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689416|NCT02443740|16150852|P2|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689417|NCT02443740|16150853|P1|Intervention Period 1 (3 Days)|Withdrawal by Subject|0
4689418|NCT02443740|16150843|P11|Intervention Period 1 (3 Days)|Protocol Violation|0
4689419|NCT02443740|16150844|P10|Intervention Period 1 (3 Days)|Protocol Violation|0
4689420|NCT02443740|16150845|P9|Intervention Period 1 (3 Days)|Protocol Violation|0
4689421|NCT02443740|16150846|P8|Intervention Period 1 (3 Days)|Protocol Violation|0
4689422|NCT02443740|16150847|P7|Intervention Period 1 (3 Days)|Protocol Violation|1
4689423|NCT02443740|16150848|P6|Intervention Period 1 (3 Days)|Protocol Violation|0
4689424|NCT02443740|16150849|P5|Intervention Period 1 (3 Days)|Protocol Violation|0
4689425|NCT02443740|16150850|P4|Intervention Period 1 (3 Days)|Protocol Violation|0
4689426|NCT02443740|16150851|P3|Intervention Period 1 (3 Days)|Protocol Violation|0
4689427|NCT02443740|16150852|P2|Intervention Period 1 (3 Days)|Protocol Violation|0
4689428|NCT02443740|16150853|P1|Intervention Period 1 (3 Days)|Protocol Violation|1
4689429|NCT02443740|16150843|P11|Intervention Period 1 (3 Days)|Adverse Event|0
4689430|NCT02443740|16150844|P10|Intervention Period 1 (3 Days)|Adverse Event|0
4689431|NCT02443740|16150845|P9|Intervention Period 1 (3 Days)|Adverse Event|0
4689432|NCT02443740|16150846|P8|Intervention Period 1 (3 Days)|Adverse Event|0
4689433|NCT02443740|16150847|P7|Intervention Period 1 (3 Days)|Adverse Event|0
4689434|NCT02443740|16150848|P6|Intervention Period 1 (3 Days)|Adverse Event|1
4689435|NCT02443740|16150849|P5|Intervention Period 1 (3 Days)|Adverse Event|0
4689436|NCT02443740|16150850|P4|Intervention Period 1 (3 Days)|Adverse Event|0
4689437|NCT02443740|16150851|P3|Intervention Period 1 (3 Days)|Adverse Event|0
4689438|NCT02443740|16150852|P2|Intervention Period 1 (3 Days)|Adverse Event|0
4689439|NCT02443740|16150853|P1|Intervention Period 1 (3 Days)|Adverse Event|0
4689440|NCT02443688|16151035|P3|Overall Study|Sponsor Request|0
4689441|NCT02443688|16151036|P2|Overall Study|Sponsor Request|1
4689442|NCT02443688|16151037|P1|Overall Study|Sponsor Request|2
4689443|NCT02443688|16151035|P3|Overall Study|Non-compliance with study drug|4
4689444|NCT02443688|16151036|P2|Overall Study|Non-compliance with study drug|2
4689445|NCT02443688|16151037|P1|Overall Study|Non-compliance with study drug|1
4689446|NCT02443688|16151035|P3|Overall Study|Withdrawal by Subject|4
4689447|NCT02443688|16151036|P2|Overall Study|Withdrawal by Subject|3
4689448|NCT02443688|16151037|P1|Overall Study|Withdrawal by Subject|3
4689449|NCT02443688|16151035|P3|Overall Study|Pregnancy|1
4689450|NCT02443688|16151036|P2|Overall Study|Pregnancy|0
4689451|NCT02443688|16151037|P1|Overall Study|Pregnancy|0
4689452|NCT02443688|16151035|P3|Overall Study|Physician Decision|1
4689453|NCT02443688|16151036|P2|Overall Study|Physician Decision|0
4689454|NCT02443688|16151037|P1|Overall Study|Physician Decision|3
4689455|NCT02443688|16151035|P3|Overall Study|Lost to Follow-up|0
4689456|NCT02443688|16151036|P2|Overall Study|Lost to Follow-up|0
4689457|NCT02443688|16151037|P1|Overall Study|Lost to Follow-up|1
4689458|NCT02443688|16151035|P3|Overall Study|Adverse Event|2
4689459|NCT02443688|16151036|P2|Overall Study|Adverse Event|3
4689460|NCT02443688|16151037|P1|Overall Study|Adverse Event|2
4689461|NCT02443402|16151147|P2|Overall Study|Screen Failure|2
4689462|NCT02443402|16151148|P1|Overall Study|Screen Failure|1
4689463|NCT02443402|16151147|P2|Overall Study|Withdrawal by Subject|1
4689464|NCT02443402|16151148|P1|Overall Study|Withdrawal by Subject|3
4689465|NCT02443298|16151210|P2|Overall Study|Withdrawal by Subject|2
4689466|NCT02443298|16151211|P1|Overall Study|Withdrawal by Subject|1
4689467|NCT02443298|16151210|P2|Overall Study|Adverse Event|3
4689468|NCT02443298|16151211|P1|Overall Study|Adverse Event|3
4689469|NCT02443103|16151231|P1|Overall Study|Noncompliance|1
4689470|NCT02443103|16151231|P1|Overall Study|Adverse Event|2
4689471|NCT02442830|16151244|P2|Overall Study|Technical Failure|1
4689472|NCT02442830|16151245|P1|Overall Study|Technical Failure|0
4689473|NCT02442804|16151255|P2|Overall Study|Adverse Event|0
4689474|NCT02442804|16151256|P1|Overall Study|Adverse Event|1
4689475|NCT02442804|16151255|P2|Overall Study|Withdrawal by Subject|1
4689476|NCT02442804|16151256|P1|Overall Study|Withdrawal by Subject|0
4689477|NCT02442622|16151363|P2|Overall Study|Withdrawal by Subject|1
4689478|NCT02442622|16151364|P1|Overall Study|Withdrawal by Subject|3
4689479|NCT02442349|16151374|P1|Overall Study|On-going Study at Data Cut-off|149
4689480|NCT02442349|16151374|P1|Overall Study|Withdrawal by Subject|8
4689481|NCT02442349|16151374|P1|Overall Study|Death|14
4689482|NCT02442310|16151379|P1|Overall Study|Withdrawal by Subject|1
4689483|NCT02442310|16151379|P1|Overall Study|Adverse Event|2
4689484|NCT02442284|16151401|P1|Overall Study|Other|1
4689485|NCT02442284|16151401|P1|Overall Study|Lost to Follow-up|3
4689486|NCT02442284|16151401|P1|Overall Study|Withdrew Consent|2
4689487|NCT02442284|16151401|P1|Overall Study|Adverse Event|1
4689488|NCT02442271|16151408|P1|Overall Study|Other|1
4689489|NCT02442271|16151408|P1|Overall Study|Lost to Follow-up|1
4689490|NCT02442271|16151408|P1|Overall Study|Withdrew Consent|1
4689491|NCT02442271|16151408|P1|Overall Study|Adverse Event|1
4689492|NCT02442206|16151434|P2|Period 2|Adverse Event|0
4689493|NCT02442206|16151435|P1|Period 2|Adverse Event|1
4689494|NCT02442206|16151434|P2|Period 1|COPD exacerbation|1
4689495|NCT02442206|16151435|P1|Period 1|COPD exacerbation|0
4689496|NCT02442206|16151434|P2|Period 1|withdrew consent|1
4689497|NCT02442206|16151435|P1|Period 1|withdrew consent|0
4689498|NCT02442206|16151434|P2|Period 1|Adverse Event|1
4689499|NCT02442206|16151435|P1|Period 1|Adverse Event|1
4689500|NCT02441946|16151467|P3|Extension Period (8 Weeks)|Withdrawal by Subject|0
4689501|NCT02441946|16151468|P2|Extension Period (8 Weeks)|Withdrawal by Subject|0
4689502|NCT02441946|16151469|P1|Extension Period (8 Weeks)|Withdrawal by Subject|1
4689503|NCT02441946|16151467|P3|Extension Period (8 Weeks)|Adverse Event|0
4689504|NCT02441946|16151468|P2|Extension Period (8 Weeks)|Adverse Event|0
4689505|NCT02441946|16151469|P1|Extension Period (8 Weeks)|Adverse Event|1
4689506|NCT02441946|16151467|P3|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
4689507|NCT02441946|16151468|P2|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0
4689508|NCT02441946|16151469|P1|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9
4689509|NCT02441946|16151467|P3|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
4689510|NCT02441946|16151468|P2|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0
4689511|NCT02441946|16151469|P1|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1
4689512|NCT02441946|16151467|P3|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
4689513|NCT02441946|16151468|P2|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0
4689514|NCT02441946|16151469|P1|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1
4689515|NCT02441946|16151467|P3|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
4689516|NCT02441946|16151468|P2|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0
4689517|NCT02441946|16151469|P1|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1
4689518|NCT02441946|16151467|P3|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
4689519|NCT02441946|16151468|P2|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0
4689520|NCT02441946|16151469|P1|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15
4689521|NCT02441946|16151467|P3|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
4689522|NCT02441946|16151468|P2|Cycle 1 Period 1 (2 Weeks)|Never Treated|1
4689523|NCT02441946|16151469|P1|Cycle 1 Period 1 (2 Weeks)|Never Treated|0
4689524|NCT02441946|16151467|P3|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
4689525|NCT02441946|16151468|P2|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3
4689526|NCT02441946|16151469|P1|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0
4689527|NCT02441946|16151467|P3|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
4689528|NCT02441946|16151468|P2|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0
4689529|NCT02441946|16151469|P1|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1
4689530|NCT02441946|16151467|P3|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0
4689531|NCT02441946|16151468|P2|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
4689532|NCT02441946|16151469|P1|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1
4689533|NCT02441517|16151490|P1|Overall Study|Study Terminated by Sponsor|1
4689534|NCT02441517|16151490|P1|Overall Study|Withdrawal by Subject|2
4689535|NCT02441517|16151490|P1|Overall Study|Lost to Follow-up|1
4689536|NCT02441309|16151503|P3|Overall Study|Withdrawal by Subject|1
4689537|NCT02441309|16151504|P2|Overall Study|Withdrawal by Subject|0
4689538|NCT02441309|16151505|P1|Overall Study|Withdrawal by Subject|1
4689539|NCT02441309|16151503|P3|Overall Study|Adverse Event|0
4689540|NCT02441309|16151504|P2|Overall Study|Adverse Event|1
4689541|NCT02441309|16151505|P1|Overall Study|Adverse Event|0
4689542|NCT02441309|16151503|P3|Overall Study|Disease progression|2
4689543|NCT02441309|16151504|P2|Overall Study|Disease progression|1
4689544|NCT02441309|16151505|P1|Overall Study|Disease progression|2
4689545|NCT02441283|16151534|P1|Overall Study|Other, not specified|32
4689546|NCT02441283|16151534|P1|Overall Study|Death|1
4689547|NCT02441283|16151534|P1|Overall Study|Lost to Follow-up|42
4689548|NCT02441283|16151534|P1|Overall Study|Withdrew consent|15
4689549|NCT02441218|16151547|P2|Overall Study|Lost to Follow-up|1
4689550|NCT02441218|16151548|P1|Overall Study|Lost to Follow-up|2
4689551|NCT02441218|16151547|P2|Overall Study|Withdrawal by Subject|58
4689552|NCT02441218|16151548|P1|Overall Study|Withdrawal by Subject|73
4689553|NCT02441218|16151547|P2|Overall Study|Death|553
4689554|NCT02441218|16151548|P1|Overall Study|Death|503
4689555|NCT02441179|16151574|P2|Overall Study|Withdrawal by Subject|1
4689556|NCT02441179|16151575|P1|Overall Study|Withdrawal by Subject|1
4689557|NCT02441114|16151593|P1|Washout2|Withdrawal by Subject|4
4689558|NCT02441036|16151604|P5|Overall Study|No tissue resected|0
4689559|NCT02441036|16151605|P4|Overall Study|No tissue resected|1
4689560|NCT02441036|16151606|P3|Overall Study|No tissue resected|0
4689561|NCT02441036|16151607|P2|Overall Study|No tissue resected|1
4689562|NCT02441036|16151608|P1|Overall Study|No tissue resected|0
4689563|NCT02440789|16151635|P1|Overall Study|Not willing to adhere to reqs|1
4689564|NCT02440789|16151635|P1|Overall Study|Withdrawal by Subject|3
4689565|NCT02440594|16151710|P8|Overall Study|Administratively w/drawn|1
4689566|NCT02440594|16151711|P7|Overall Study|Administratively w/drawn|2
4689567|NCT02440594|16151712|P6|Overall Study|Administratively w/drawn|0
4689568|NCT02440594|16151713|P5|Overall Study|Administratively w/drawn|0
4689569|NCT02440594|16151714|P4|Overall Study|Administratively w/drawn|0
4689570|NCT02440594|16151715|P3|Overall Study|Administratively w/drawn|0
4689571|NCT02440594|16151716|P2|Overall Study|Administratively w/drawn|2
4689572|NCT02440594|16151717|P1|Overall Study|Administratively w/drawn|3
4689573|NCT02440594|16151710|P8|Overall Study|Withdrawal by Subject|7
4689574|NCT02440594|16151711|P7|Overall Study|Withdrawal by Subject|7
4689575|NCT02440594|16151712|P6|Overall Study|Withdrawal by Subject|2
4689576|NCT02440594|16151713|P5|Overall Study|Withdrawal by Subject|2
4689577|NCT02440594|16151714|P4|Overall Study|Withdrawal by Subject|38
4689578|NCT02440594|16151715|P3|Overall Study|Withdrawal by Subject|59
4689579|NCT02440594|16151716|P2|Overall Study|Withdrawal by Subject|67
4689580|NCT02440594|16151717|P1|Overall Study|Withdrawal by Subject|81
4689581|NCT02440594|16151710|P8|Overall Study|Cognitive Impairment/Communication Issue|0
4689582|NCT02440594|16151711|P7|Overall Study|Cognitive Impairment/Communication Issue|0
4689583|NCT02440594|16151712|P6|Overall Study|Cognitive Impairment/Communication Issue|1
4689584|NCT02440594|16151713|P5|Overall Study|Cognitive Impairment/Communication Issue|2
4689585|NCT02440594|16151714|P4|Overall Study|Cognitive Impairment/Communication Issue|4
4689586|NCT02440594|16151715|P3|Overall Study|Cognitive Impairment/Communication Issue|4
4689587|NCT02440594|16151716|P2|Overall Study|Cognitive Impairment/Communication Issue|6
4689588|NCT02440594|16151717|P1|Overall Study|Cognitive Impairment/Communication Issue|14
4689589|NCT02440594|16151710|P8|Overall Study|Lost to Follow-up|48
4689590|NCT02440594|16151711|P7|Overall Study|Lost to Follow-up|28
4689591|NCT02440594|16151712|P6|Overall Study|Lost to Follow-up|4
4689592|NCT02440594|16151713|P5|Overall Study|Lost to Follow-up|5
4689593|NCT02440594|16151714|P4|Overall Study|Lost to Follow-up|47
4689594|NCT02440594|16151715|P3|Overall Study|Lost to Follow-up|54
4689595|NCT02440594|16151716|P2|Overall Study|Lost to Follow-up|33
4689596|NCT02440594|16151717|P1|Overall Study|Lost to Follow-up|34
4689597|NCT02439320|16151834|P3|Overall Study|Randomization Failure|34
4689598|NCT02439320|16151835|P2|Overall Study|Randomization Failure|46
4689599|NCT02439320|16151836|P1|Overall Study|Randomization Failure|35
4689600|NCT02439320|16151834|P3|Overall Study|Sponsor Request|1
4689601|NCT02439320|16151835|P2|Overall Study|Sponsor Request|2
4689602|NCT02439320|16151836|P1|Overall Study|Sponsor Request|0
4689603|NCT02439320|16151834|P3|Overall Study|Physician Decision|0
4689604|NCT02439320|16151835|P2|Overall Study|Physician Decision|1
4689605|NCT02439320|16151836|P1|Overall Study|Physician Decision|2
4689606|NCT02439320|16151834|P3|Overall Study|Withdrawal by Subject|14
4689607|NCT02439320|16151835|P2|Overall Study|Withdrawal by Subject|16
4689608|NCT02439320|16151836|P1|Overall Study|Withdrawal by Subject|12
4689609|NCT02439320|16151834|P3|Overall Study|Pregnancy|1
4689610|NCT02439320|16151835|P2|Overall Study|Pregnancy|1
4689611|NCT02439320|16151836|P1|Overall Study|Pregnancy|0
4689612|NCT02439320|16151834|P3|Overall Study|Noncompliance with Protocol|7
4689613|NCT02439320|16151835|P2|Overall Study|Noncompliance with Protocol|11
4689614|NCT02439320|16151836|P1|Overall Study|Noncompliance with Protocol|10
4689615|NCT02439320|16151834|P3|Overall Study|Death|0
4689616|NCT02439320|16151835|P2|Overall Study|Death|1
4689617|NCT02439320|16151836|P1|Overall Study|Death|0
4689618|NCT02439320|16151834|P3|Overall Study|Lost to Follow-up|42
4689619|NCT02439320|16151835|P2|Overall Study|Lost to Follow-up|34
4689620|NCT02439320|16151836|P1|Overall Study|Lost to Follow-up|37
4689621|NCT02439320|16151834|P3|Overall Study|Adverse Event|0
4689622|NCT02439320|16151835|P2|Overall Study|Adverse Event|2
4689623|NCT02439320|16151836|P1|Overall Study|Adverse Event|0
4689624|NCT02439138|16151916|P1|Overall Study|PI decision to terminate the study|2
4689625|NCT02439138|16151916|P1|Overall Study|Adverse Event|1
4689626|NCT02438826|16151929|P4|Post-Treatment Phase|Withdrawal by Subject|0
4689627|NCT02438826|16151930|P3|Post-Treatment Phase|Withdrawal by Subject|0
4689628|NCT02438826|16151931|P2|Post-Treatment Phase|Withdrawal by Subject|1
4689629|NCT02438826|16151932|P1|Post-Treatment Phase|Withdrawal by Subject|1
4689630|NCT02438826|16151929|P4|Post-Treatment Phase|Physician Decision|0
4689631|NCT02438826|16151930|P3|Post-Treatment Phase|Physician Decision|0
4689632|NCT02438826|16151931|P2|Post-Treatment Phase|Physician Decision|0
4689633|NCT02438826|16151932|P1|Post-Treatment Phase|Physician Decision|1
4689634|NCT02438826|16151929|P4|Post-Treatment Phase|Lack of Efficacy|0
4689635|NCT02438826|16151930|P3|Post-Treatment Phase|Lack of Efficacy|0
4689636|NCT02438826|16151931|P2|Post-Treatment Phase|Lack of Efficacy|0
4689637|NCT02438826|16151932|P1|Post-Treatment Phase|Lack of Efficacy|4
4689638|NCT02438826|16151929|P4|Post-Treatment Phase|Adverse Event|0
4689639|NCT02438826|16151930|P3|Post-Treatment Phase|Adverse Event|0
4689640|NCT02438826|16151931|P2|Post-Treatment Phase|Adverse Event|0
4689641|NCT02438826|16151932|P1|Post-Treatment Phase|Adverse Event|3
4689642|NCT02438826|16151929|P4|Open-Label Treatment Phase|Withdrawal by Subject|0
4689643|NCT02438826|16151930|P3|Open-Label Treatment Phase|Withdrawal by Subject|0
4689644|NCT02438826|16151931|P2|Open-Label Treatment Phase|Withdrawal by Subject|7
4689645|NCT02438826|16151932|P1|Open-Label Treatment Phase|Withdrawal by Subject|6
4689646|NCT02438826|16151929|P4|Open-Label Treatment Phase|Lost to Follow-up|0
4689647|NCT02438826|16151930|P3|Open-Label Treatment Phase|Lost to Follow-up|0
4689648|NCT02438826|16151931|P2|Open-Label Treatment Phase|Lost to Follow-up|2
4689649|NCT02438826|16151932|P1|Open-Label Treatment Phase|Lost to Follow-up|0
4689650|NCT02438826|16151929|P4|Open-Label Treatment Phase|Lack of Efficacy|0
4689651|NCT02438826|16151930|P3|Open-Label Treatment Phase|Lack of Efficacy|0
4689652|NCT02438826|16151931|P2|Open-Label Treatment Phase|Lack of Efficacy|18
4689653|NCT02438826|16151932|P1|Open-Label Treatment Phase|Lack of Efficacy|27
4689654|NCT02438826|16151929|P4|Open-Label Treatment Phase|Adverse Event|0
4689655|NCT02438826|16151930|P3|Open-Label Treatment Phase|Adverse Event|0
4689656|NCT02438826|16151931|P2|Open-Label Treatment Phase|Adverse Event|6
4689657|NCT02438826|16151932|P1|Open-Label Treatment Phase|Adverse Event|11
4689658|NCT02438826|16151929|P4|Double-Blind Treatment Phase|Screen Failure|0
4689659|NCT02438826|16151930|P3|Double-Blind Treatment Phase|Screen Failure|0
4689660|NCT02438826|16151931|P2|Double-Blind Treatment Phase|Screen Failure|0
4689661|NCT02438826|16151932|P1|Double-Blind Treatment Phase|Screen Failure|2
4689662|NCT02438826|16151929|P4|Double-Blind Treatment Phase|Protocol Violation|0
4689663|NCT02438826|16151930|P3|Double-Blind Treatment Phase|Protocol Violation|0
4689664|NCT02438826|16151931|P2|Double-Blind Treatment Phase|Protocol Violation|2
4689665|NCT02438826|16151932|P1|Double-Blind Treatment Phase|Protocol Violation|1
4689666|NCT02438826|16151929|P4|Double-Blind Treatment Phase|Withdrawal by Subject|0
4689667|NCT02438826|16151930|P3|Double-Blind Treatment Phase|Withdrawal by Subject|0
4689668|NCT02438826|16151931|P2|Double-Blind Treatment Phase|Withdrawal by Subject|1
4689669|NCT02438826|16151932|P1|Double-Blind Treatment Phase|Withdrawal by Subject|1
4689670|NCT02438826|16151929|P4|Double-Blind Treatment Phase|Lack of Efficacy|0
4689671|NCT02438826|16151930|P3|Double-Blind Treatment Phase|Lack of Efficacy|0
4689672|NCT02438826|16151931|P2|Double-Blind Treatment Phase|Lack of Efficacy|0
4689673|NCT02438826|16151932|P1|Double-Blind Treatment Phase|Lack of Efficacy|1
4689674|NCT02438826|16151929|P4|Double-Blind Treatment Phase|Adverse Event|0
4689675|NCT02438826|16151930|P3|Double-Blind Treatment Phase|Adverse Event|0
4689676|NCT02438826|16151931|P2|Double-Blind Treatment Phase|Adverse Event|1
4689677|NCT02438826|16151932|P1|Double-Blind Treatment Phase|Adverse Event|1
4689678|NCT02438813|16151966|P1|Overall Study|Patients Not Treated/No EOT Visit|249
4689679|NCT02438813|16151966|P1|Overall Study|Study Ended by Sponsor|80
4689680|NCT02438813|16151966|P1|Overall Study|Patient Lost to Follow-Up|137
4689681|NCT02438813|16151966|P1|Overall Study|Patient Decision|59
4689682|NCT02438787|16152018|P3|Overall Study|Site terminated by sponsor|1
4689683|NCT02438787|16152019|P2|Overall Study|Site terminated by sponsor|0
4689684|NCT02438787|16152020|P1|Overall Study|Site terminated by sponsor|0
4689685|NCT02438787|16152018|P3|Overall Study|Other|0
4689686|NCT02438787|16152019|P2|Overall Study|Other|1
4689687|NCT02438787|16152020|P1|Overall Study|Other|0
4689688|NCT02438787|16152018|P3|Overall Study|Study discontinued by sponsor|69
4689689|NCT02438787|16152019|P2|Overall Study|Study discontinued by sponsor|72
4689690|NCT02438787|16152020|P1|Overall Study|Study discontinued by sponsor|64
4689691|NCT02438787|16152018|P3|Overall Study|Withdrawal by Subject|10
4689692|NCT02438787|16152019|P2|Overall Study|Withdrawal by Subject|7
4689693|NCT02438787|16152020|P1|Overall Study|Withdrawal by Subject|15
4689694|NCT02438787|16152018|P3|Overall Study|Protocol Violation|1
4689695|NCT02438787|16152019|P2|Overall Study|Protocol Violation|0
4689696|NCT02438787|16152020|P1|Overall Study|Protocol Violation|0
4689697|NCT02438787|16152018|P3|Overall Study|Lost to Follow-up|0
4689698|NCT02438787|16152019|P2|Overall Study|Lost to Follow-up|1
4689699|NCT02438787|16152020|P1|Overall Study|Lost to Follow-up|0
4689700|NCT02438787|16152018|P3|Overall Study|Lack of Efficacy|0
4689701|NCT02438787|16152019|P2|Overall Study|Lack of Efficacy|2
4689702|NCT02438787|16152020|P1|Overall Study|Lack of Efficacy|1
4689703|NCT02438787|16152018|P3|Overall Study|Adverse Event|2
4689704|NCT02438787|16152019|P2|Overall Study|Adverse Event|0
4689705|NCT02438787|16152020|P1|Overall Study|Adverse Event|1
4689706|NCT02438384|16152140|P3|Overall Study|Lost to Follow-up|4
4689707|NCT02438384|16152141|P2|Overall Study|Lost to Follow-up|6
4689708|NCT02438384|16152142|P1|Overall Study|Lost to Follow-up|8
4689709|NCT02438280|16152161|P2|Overall Study|Physician Decision|0
4689710|NCT02438280|16152162|P1|Overall Study|Physician Decision|1
4689711|NCT02438137|16152172|P2|Overall Study|Physician Decision|1
4689712|NCT02438137|16152173|P1|Overall Study|Physician Decision|0
4689713|NCT02438137|16152172|P2|Overall Study|Withdrawal by Subject|3
4689714|NCT02438137|16152173|P1|Overall Study|Withdrawal by Subject|4
4689715|NCT02438137|16152172|P2|Overall Study|Adverse Event|0
4689716|NCT02438137|16152173|P1|Overall Study|Adverse Event|1
4689717|NCT02438137|16152172|P2|Overall Study|Lost to Follow-up|2
4689718|NCT02438137|16152173|P1|Overall Study|Lost to Follow-up|3
4689719|NCT02437903|16152181|P1|Overall Study|Lost to Follow-up|3
4689720|NCT02437903|16152181|P1|Overall Study|Withdrawal by Subject|1
4689721|NCT02437903|16152181|P1|Overall Study|Adverse Event|1
4689722|NCT02437890|16152194|P5|Overall Study|Death|0
4689723|NCT02437890|16152195|P4|Overall Study|Death|2
4689724|NCT02437890|16152196|P3|Overall Study|Death|0
4689725|NCT02437890|16152197|P2|Overall Study|Death|0
4689726|NCT02437890|16152198|P1|Overall Study|Death|0
4689727|NCT02437890|16152194|P5|Overall Study|Withdrawal by Subject|5
4689728|NCT02437890|16152195|P4|Overall Study|Withdrawal by Subject|5
4689729|NCT02437890|16152196|P3|Overall Study|Withdrawal by Subject|6
4689730|NCT02437890|16152197|P2|Overall Study|Withdrawal by Subject|2
4689731|NCT02437890|16152198|P1|Overall Study|Withdrawal by Subject|1
4689732|NCT02437890|16152194|P5|Overall Study|Adverse Event|7
4689733|NCT02437890|16152195|P4|Overall Study|Adverse Event|11
4689734|NCT02437890|16152196|P3|Overall Study|Adverse Event|5
4689735|NCT02437890|16152197|P2|Overall Study|Adverse Event|9
4689736|NCT02437890|16152198|P1|Overall Study|Adverse Event|4
4689737|NCT02437890|16152194|P5|Overall Study|Lack of Efficacy|1
4689738|NCT02437890|16152195|P4|Overall Study|Lack of Efficacy|3
4689739|NCT02437890|16152196|P3|Overall Study|Lack of Efficacy|0
4689740|NCT02437890|16152197|P2|Overall Study|Lack of Efficacy|3
4689741|NCT02437890|16152198|P1|Overall Study|Lack of Efficacy|1
4689742|NCT02437890|16152194|P5|Overall Study|Unable to attend visit(s)|0
4689743|NCT02437890|16152195|P4|Overall Study|Unable to attend visit(s)|0
4689744|NCT02437890|16152196|P3|Overall Study|Unable to attend visit(s)|0
4689745|NCT02437890|16152197|P2|Overall Study|Unable to attend visit(s)|0
4689746|NCT02437890|16152198|P1|Overall Study|Unable to attend visit(s)|1
4689747|NCT02437890|16152194|P5|Overall Study|Physician Decision|0
4689748|NCT02437890|16152195|P4|Overall Study|Physician Decision|1
4689749|NCT02437890|16152196|P3|Overall Study|Physician Decision|0
4689750|NCT02437890|16152197|P2|Overall Study|Physician Decision|0
4689751|NCT02437890|16152198|P1|Overall Study|Physician Decision|0
4689752|NCT02437890|16152194|P5|Overall Study|Sponsor's decision|2
4689753|NCT02437890|16152195|P4|Overall Study|Sponsor's decision|0
4689754|NCT02437890|16152196|P3|Overall Study|Sponsor's decision|4
4689755|NCT02437890|16152197|P2|Overall Study|Sponsor's decision|1
4689756|NCT02437890|16152198|P1|Overall Study|Sponsor's decision|1
4689757|NCT02437890|16152194|P5|Overall Study|Non-compliance to study drug|1
4689758|NCT02437890|16152195|P4|Overall Study|Non-compliance to study drug|0
4689759|NCT02437890|16152196|P3|Overall Study|Non-compliance to study drug|0
4689760|NCT02437890|16152197|P2|Overall Study|Non-compliance to study drug|1
4689761|NCT02437890|16152198|P1|Overall Study|Non-compliance to study drug|0
4689762|NCT02437864|16152411|P2|Overall Study|Protocol Violation|0
4689763|NCT02437864|16152412|P1|Overall Study|Protocol Violation|4
4689764|NCT02437513|16152433|P1|Overall Study|Withdrawal by Subject|2
4689765|NCT02437409|16152458|P1|Overall Study|Screening failure|12
4689766|NCT02437409|16152458|P1|Overall Study|Withdrawal by Subject|3
4689767|NCT02437318|16152551|P2|Overall Study|Untreated|1
4689768|NCT02437318|16152552|P1|Overall Study|Untreated|0
4689769|NCT02437318|16152551|P2|Overall Study|Protocol Violation|6
4689770|NCT02437318|16152552|P1|Overall Study|Protocol Violation|5
4689771|NCT02437318|16152551|P2|Overall Study|Death|4
4689772|NCT02437318|16152552|P1|Overall Study|Death|4
4689773|NCT02437318|16152551|P2|Overall Study|Adverse Event|3
4689774|NCT02437318|16152552|P1|Overall Study|Adverse Event|14
4689775|NCT02437318|16152551|P2|Overall Study|Physician Decision|10
4689776|NCT02437318|16152552|P1|Overall Study|Physician Decision|11
4689777|NCT02437318|16152551|P2|Overall Study|Subject/guardian decision|10
4689778|NCT02437318|16152552|P1|Overall Study|Subject/guardian decision|22
4689779|NCT02437318|16152551|P2|Overall Study|Progressive disease|208
4689780|NCT02437318|16152552|P1|Overall Study|Progressive disease|173
4689781|NCT02437305|16152560|P2|Overall Study|Lost to Follow-up|12
4689782|NCT02437305|16152561|P1|Overall Study|Lost to Follow-up|18
4689783|NCT02437188|16152588|P2|Overall Study|Adverse Event|1
4689784|NCT02437188|16152589|P1|Overall Study|Adverse Event|0
4689785|NCT02437188|16152588|P2|Overall Study|Randomized but did not receive surgery|8
4689786|NCT02437188|16152589|P1|Overall Study|Randomized but did not receive surgery|4
4689787|NCT02437162|16152606|P3|Overall Study|Other|1
4689788|NCT02437162|16152607|P2|Overall Study|Other|0
4689789|NCT02437162|16152608|P1|Overall Study|Other|0
4689790|NCT02437162|16152606|P3|Overall Study|Death|0
4689791|NCT02437162|16152607|P2|Overall Study|Death|1
4689792|NCT02437162|16152608|P1|Overall Study|Death|0
4689793|NCT02437162|16152606|P3|Overall Study|Lost to Follow-up|1
4689794|NCT02437162|16152607|P2|Overall Study|Lost to Follow-up|0
4689795|NCT02437162|16152608|P1|Overall Study|Lost to Follow-up|1
4689796|NCT02437162|16152606|P3|Overall Study|Adverse Event|0
4689797|NCT02437162|16152607|P2|Overall Study|Adverse Event|1
4689798|NCT02437162|16152608|P1|Overall Study|Adverse Event|0
4689799|NCT02437162|16152606|P3|Overall Study|Withdrawal by Subject|9
4689800|NCT02437162|16152607|P2|Overall Study|Withdrawal by Subject|7
4689801|NCT02437162|16152608|P1|Overall Study|Withdrawal by Subject|13
4689802|NCT02437162|16152606|P3|Overall Study|Study discontinued by Sponsor|97
4689803|NCT02437162|16152607|P2|Overall Study|Study discontinued by Sponsor|98
4689804|NCT02437162|16152608|P1|Overall Study|Study discontinued by Sponsor|93
4689805|NCT02437162|16152606|P3|Overall Study|Randomized but not treated|1
4689806|NCT02437162|16152607|P2|Overall Study|Randomized but not treated|0
4689807|NCT02437162|16152608|P1|Overall Study|Randomized but not treated|0
4689808|NCT02437162|16152606|P3|Overall Study|Protocol Violation|0
4689809|NCT02437162|16152607|P2|Overall Study|Protocol Violation|1
4689810|NCT02437162|16152608|P1|Overall Study|Protocol Violation|0
4689811|NCT02436915|16152728|P2|Overall Study|Withdrawal by Subject|1
4689812|NCT02436915|16152729|P1|Overall Study|Withdrawal by Subject|0
4689813|NCT02436889|16152751|P2|Overall Study|Does not like/could not tolerate medicat|1
4689814|NCT02436889|16152752|P1|Overall Study|Does not like/could not tolerate medicat|0
4689815|NCT02436889|16152751|P2|Overall Study|No improvement in symptoms|0
4689816|NCT02436889|16152752|P1|Overall Study|No improvement in symptoms|1
4689817|NCT02436811|16152780|P3|Overall Study|Lost to Follow-up|7
4689818|NCT02436811|16152781|P2|Overall Study|Lost to Follow-up|9
4689819|NCT02436811|16152782|P1|Overall Study|Lost to Follow-up|2
4689820|NCT02436759|16152792|P2|Overall Study|Withdrawal by Subject|1
4689821|NCT02436759|16152793|P1|Overall Study|Withdrawal by Subject|0
4689822|NCT02436759|16152792|P2|Overall Study|Protocol Violation|0
4689823|NCT02436759|16152793|P1|Overall Study|Protocol Violation|1
4689824|NCT02436759|16152792|P2|Overall Study|Adverse Event|0
4689825|NCT02436759|16152793|P1|Overall Study|Adverse Event|3
4689826|NCT02436681|16152801|P1|Overall Study|Death|2
4689827|NCT02436681|16152801|P1|Overall Study|Withdrawal by Subject|2
4689828|NCT02436681|16152801|P1|Overall Study|Lost to Follow-up|10
4689829|NCT02436577|16152818|P6|Overall Study|Protocol Deviation|0
4689830|NCT02436577|16152819|P5|Overall Study|Protocol Deviation|0
4689831|NCT02436577|16152820|P4|Overall Study|Protocol Deviation|0
4689832|NCT02436577|16152821|P3|Overall Study|Protocol Deviation|0
4689833|NCT02436577|16152822|P2|Overall Study|Protocol Deviation|1
4689834|NCT02436577|16152823|P1|Overall Study|Protocol Deviation|0
4689835|NCT02436356|16152879|P3|Overall Study|Withdrawal by Subject|0
4689836|NCT02436356|16152880|P2|Overall Study|Withdrawal by Subject|0
4689837|NCT02436356|16152881|P1|Overall Study|Withdrawal by Subject|1
4689838|NCT02436356|16152879|P3|Overall Study|Excluded due to other medical conditions|0
4689839|NCT02436356|16152880|P2|Overall Study|Excluded due to other medical conditions|0
4689840|NCT02436356|16152881|P1|Overall Study|Excluded due to other medical conditions|3
4689841|NCT02436356|16152879|P3|Overall Study|Surgical Approach (Dorsal not volar)|0
4689842|NCT02436356|16152880|P2|Overall Study|Surgical Approach (Dorsal not volar)|0
4689843|NCT02436356|16152881|P1|Overall Study|Surgical Approach (Dorsal not volar)|1
4689844|NCT02436356|16152879|P3|Overall Study|Lost to Follow-up|0
4689845|NCT02436356|16152880|P2|Overall Study|Lost to Follow-up|1
4689846|NCT02436356|16152881|P1|Overall Study|Lost to Follow-up|0
4689847|NCT02436356|16152879|P3|Overall Study|Excluded by MRI Screening|2
4689848|NCT02436356|16152880|P2|Overall Study|Excluded by MRI Screening|0
4689849|NCT02436356|16152881|P1|Overall Study|Excluded by MRI Screening|0
4689850|NCT02436330|16152912|P2|Cohort 6|Withdrawal by Subject|1
4689851|NCT02436330|16152913|P1|Cohort 6|Withdrawal by Subject|1
4689852|NCT02436330|16152912|P2|Cohort 6|Lost to Follow-up|0
4689853|NCT02436330|16152913|P1|Cohort 6|Lost to Follow-up|2
4689854|NCT02436330|16152912|P2|Cohort 5|Withdrawal by Subject|2
4689855|NCT02436330|16152913|P1|Cohort 5|Withdrawal by Subject|3
4689856|NCT02436330|16152912|P2|Cohort 5|Lost to Follow-up|2
4689857|NCT02436330|16152913|P1|Cohort 5|Lost to Follow-up|3
4689858|NCT02436330|16152912|P2|Cohort 4|Withdrawal by Subject|0
4689859|NCT02436330|16152913|P1|Cohort 4|Withdrawal by Subject|1
4689860|NCT02436330|16152912|P2|Cohort 4|Lost to Follow-up|0
4689861|NCT02436330|16152913|P1|Cohort 4|Lost to Follow-up|1
4689862|NCT02436330|16152912|P2|Cohort 3|Withdrawal by Subject|0
4689863|NCT02436330|16152913|P1|Cohort 3|Withdrawal by Subject|4
4689864|NCT02436330|16152912|P2|Cohort 3|Lost to Follow-up|0
4689865|NCT02436330|16152913|P1|Cohort 3|Lost to Follow-up|1
4689866|NCT02436330|16152912|P2|Cohort 2|Withdrawal by Subject|3
4689867|NCT02436330|16152913|P1|Cohort 2|Withdrawal by Subject|2
4689868|NCT02436330|16152912|P2|Cohort 2|Lost to Follow-up|0
4689869|NCT02436330|16152913|P1|Cohort 2|Lost to Follow-up|2
4689870|NCT02436330|16152912|P2|Cohort 1|Withdrawal by Subject|1
4689871|NCT02436330|16152913|P1|Cohort 1|Withdrawal by Subject|0
4689872|NCT02436330|16152912|P2|Cohort 1|Lost to Follow-up|2
4689873|NCT02436330|16152913|P1|Cohort 1|Lost to Follow-up|5
4689874|NCT02436304|16152958|P3|Overall Study|Randomized in error didn't meet I/E crit|1
4689875|NCT02436304|16152959|P2|Overall Study|Randomized in error didn't meet I/E crit|0
4689876|NCT02436304|16152960|P1|Overall Study|Randomized in error didn't meet I/E crit|0
4689877|NCT02436304|16152958|P3|Overall Study|Withdrawal by Subject|0
4689878|NCT02436304|16152959|P2|Overall Study|Withdrawal by Subject|1
4689879|NCT02436304|16152960|P1|Overall Study|Withdrawal by Subject|0
4689880|NCT02436304|16152958|P3|Overall Study|Lost to Follow-up|0
4689881|NCT02436304|16152959|P2|Overall Study|Lost to Follow-up|1
4689882|NCT02436304|16152960|P1|Overall Study|Lost to Follow-up|0
4689883|NCT02436239|16152979|P4|Down-Taper Period|Withdrawal by Subject|2
4689884|NCT02436239|16152980|P3|Down-Taper Period|Withdrawal by Subject|1
4689885|NCT02436239|16152981|P2|Down-Taper Period|Withdrawal by Subject|4
4689886|NCT02436239|16152982|P1|Down-Taper Period|Withdrawal by Subject|4
4689887|NCT02436239|16152979|P4|Open-Lable Treatment Period|Other Reason|0
4689888|NCT02436239|16152980|P3|Open-Lable Treatment Period|Other Reason|0
4689889|NCT02436239|16152981|P2|Open-Lable Treatment Period|Other Reason|1
4689890|NCT02436239|16152982|P1|Open-Lable Treatment Period|Other Reason|1
4689891|NCT02436239|16152979|P4|Open-Lable Treatment Period|Noncompliance with Study Drug|1
4689892|NCT02436239|16152980|P3|Open-Lable Treatment Period|Noncompliance with Study Drug|3
4689893|NCT02436239|16152981|P2|Open-Lable Treatment Period|Noncompliance with Study Drug|6
4689894|NCT02436239|16152982|P1|Open-Lable Treatment Period|Noncompliance with Study Drug|5
4689895|NCT02436239|16152979|P4|Open-Lable Treatment Period|Protocol Violation|0
4689896|NCT02436239|16152980|P3|Open-Lable Treatment Period|Protocol Violation|1
4689897|NCT02436239|16152981|P2|Open-Lable Treatment Period|Protocol Violation|1
4689898|NCT02436239|16152982|P1|Open-Lable Treatment Period|Protocol Violation|0
4689899|NCT02436239|16152979|P4|Open-Lable Treatment Period|Lost to Follow-up|1
4689900|NCT02436239|16152980|P3|Open-Lable Treatment Period|Lost to Follow-up|4
4689901|NCT02436239|16152981|P2|Open-Lable Treatment Period|Lost to Follow-up|2
4689902|NCT02436239|16152982|P1|Open-Lable Treatment Period|Lost to Follow-up|4
4689903|NCT02436239|16152979|P4|Open-Lable Treatment Period|Withdrawal by Subject|0
4689904|NCT02436239|16152980|P3|Open-Lable Treatment Period|Withdrawal by Subject|9
4689905|NCT02436239|16152981|P2|Open-Lable Treatment Period|Withdrawal by Subject|15
4689906|NCT02436239|16152982|P1|Open-Lable Treatment Period|Withdrawal by Subject|10
4689907|NCT02436239|16152979|P4|Open-Lable Treatment Period|Lack of Efficacy|1
4689908|NCT02436239|16152980|P3|Open-Lable Treatment Period|Lack of Efficacy|6
4689909|NCT02436239|16152981|P2|Open-Lable Treatment Period|Lack of Efficacy|6
4689910|NCT02436239|16152982|P1|Open-Lable Treatment Period|Lack of Efficacy|1
4689911|NCT02436239|16152979|P4|Open-Lable Treatment Period|Adverse Event|2
4689912|NCT02436239|16152980|P3|Open-Lable Treatment Period|Adverse Event|4
4689913|NCT02436239|16152981|P2|Open-Lable Treatment Period|Adverse Event|3
4689914|NCT02436239|16152982|P1|Open-Lable Treatment Period|Adverse Event|12
4689915|NCT02436200|16153004|P1|Overall Study|Significant outlier|1
4689916|NCT02436135|16153011|P2|Overall Study|Study Terminated By Sponsor|1
4689917|NCT02436135|16153012|P1|Overall Study|Study Terminated By Sponsor|0
4689918|NCT02436135|16153011|P2|Overall Study|Withdrawal by Participant|0
4689919|NCT02436135|16153012|P1|Overall Study|Withdrawal by Participant|1
4689920|NCT02436135|16153011|P2|Overall Study|Adverse Event|0
4689921|NCT02436135|16153012|P1|Overall Study|Adverse Event|1
4689922|NCT02436135|16153011|P2|Overall Study|Investigator Discretion|2
4689923|NCT02436135|16153012|P1|Overall Study|Investigator Discretion|1
4689924|NCT02436135|16153011|P2|Overall Study|Progressive Disease|1
4689925|NCT02436135|16153012|P1|Overall Study|Progressive Disease|3
4689926|NCT02435966|16153050|P3|Overall Study|Withdrawal by Subject|0
4689927|NCT02435966|16153051|P2|Overall Study|Withdrawal by Subject|1
4689928|NCT02435966|16153052|P1|Overall Study|Withdrawal by Subject|0
4689929|NCT02435914|16153064|P4|Overall Study|Other Miscellaneous Reason|0
4689930|NCT02435914|16153065|P3|Overall Study|Other Miscellaneous Reason|1
4689931|NCT02435914|16153066|P2|Overall Study|Other Miscellaneous Reason|0
4689932|NCT02435914|16153067|P1|Overall Study|Other Miscellaneous Reason|0
4689933|NCT02435914|16153064|P4|Overall Study|Withdrawal by Subject|0
4689934|NCT02435914|16153065|P3|Overall Study|Withdrawal by Subject|0
4689935|NCT02435914|16153066|P2|Overall Study|Withdrawal by Subject|1
4689936|NCT02435914|16153067|P1|Overall Study|Withdrawal by Subject|0
4689937|NCT02435914|16153064|P4|Overall Study|Ocular Adverse Event|0
4689938|NCT02435914|16153065|P3|Overall Study|Ocular Adverse Event|0
4689939|NCT02435914|16153066|P2|Overall Study|Ocular Adverse Event|0
4689940|NCT02435914|16153067|P1|Overall Study|Ocular Adverse Event|1
4689941|NCT02435836|16153089|P1|Overall Study|AE of Worsening Schizophrenia|96
4689942|NCT02435836|16153089|P1|Overall Study|Met Withdrawal Criteria|7
4689943|NCT02435836|16153089|P1|Overall Study|Protocol Violation|6
4689944|NCT02435836|16153089|P1|Overall Study|Noncompliance|27
4689945|NCT02435836|16153089|P1|Overall Study|Sponsor discontinued trial|167
4689946|NCT02435836|16153089|P1|Overall Study|Adverse Event|44
4689947|NCT02435836|16153089|P1|Overall Study|Insufficient Clinical Response|26
4689948|NCT02435836|16153089|P1|Overall Study|Withdrawal by Subject|236
4689949|NCT02435836|16153089|P1|Overall Study|Lack of Efficacy|1
4689950|NCT02435836|16153089|P1|Overall Study|Lost to Follow-up|21
4689951|NCT02435433|16153159|P5|Overall Study|Lost to Follow-up|0
4689952|NCT02435433|16153160|P4|Overall Study|Lost to Follow-up|0
4689953|NCT02435433|16153161|P3|Overall Study|Lost to Follow-up|0
4689954|NCT02435433|16153162|P2|Overall Study|Lost to Follow-up|2
4689955|NCT02435433|16153163|P1|Overall Study|Lost to Follow-up|2
4689956|NCT02435433|16153159|P5|Overall Study|Withdrawal by Subject|0
4689957|NCT02435433|16153160|P4|Overall Study|Withdrawal by Subject|0
4689958|NCT02435433|16153161|P3|Overall Study|Withdrawal by Subject|0
4689959|NCT02435433|16153162|P2|Overall Study|Withdrawal by Subject|3
4689960|NCT02435433|16153163|P1|Overall Study|Withdrawal by Subject|2
4689961|NCT02435433|16153159|P5|Overall Study|On Treatment|0
4689962|NCT02435433|16153160|P4|Overall Study|On Treatment|0
4689963|NCT02435433|16153161|P3|Overall Study|On Treatment|0
4689964|NCT02435433|16153162|P2|Overall Study|On Treatment|0
4689965|NCT02435433|16153163|P1|Overall Study|On Treatment|11
4689966|NCT02435277|16153189|P4|Overall Study|Withdrawal by Subject|0
4689967|NCT02435277|16153190|P3|Overall Study|Withdrawal by Subject|0
4689968|NCT02435277|16153191|P2|Overall Study|Withdrawal by Subject|0
4689969|NCT02435277|16153192|P1|Overall Study|Withdrawal by Subject|1
4689970|NCT02435277|16153189|P4|Overall Study|Adverse Event|0
4689971|NCT02435277|16153190|P3|Overall Study|Adverse Event|0
4689972|NCT02435277|16153191|P2|Overall Study|Adverse Event|1
4689973|NCT02435277|16153192|P1|Overall Study|Adverse Event|1
4689974|NCT02435147|16153206|P1|Overall Study|non-evaluable DXA scan|11
4689975|NCT02435069|16153211|P5|Effectiveness - Second Intervention|Lack of Efficacy|1
4689976|NCT02435069|16153212|P4|Effectiveness - Second Intervention|Lack of Efficacy|0
4689977|NCT02435069|16153213|P3|Effectiveness - Second Intervention|Lack of Efficacy|0
4689978|NCT02435069|16153214|P2|Effectiveness - Second Intervention|Lack of Efficacy|0
4689979|NCT02435069|16153215|P1|Effectiveness - Second Intervention|Lack of Efficacy|0
4689980|NCT02435069|16153211|P5|Dose Response - First Intervention|Adverse Event|0
4689981|NCT02435069|16153212|P4|Dose Response - First Intervention|Adverse Event|0
4689982|NCT02435069|16153213|P3|Dose Response - First Intervention|Adverse Event|1
4689983|NCT02435069|16153214|P2|Dose Response - First Intervention|Adverse Event|1
4689984|NCT02435069|16153215|P1|Dose Response - First Intervention|Adverse Event|0
4689985|NCT02434939|16153237|P2|Overall Study|Adverse Event|1
4689986|NCT02434939|16153238|P1|Overall Study|Adverse Event|0
4689987|NCT02434939|16153237|P2|Overall Study|Withdrawal by Subject|0
4689988|NCT02434939|16153238|P1|Overall Study|Withdrawal by Subject|3
4689989|NCT02434939|16153237|P2|Overall Study|Lack of Efficacy|48
4689990|NCT02434939|16153238|P1|Overall Study|Lack of Efficacy|34
4689991|NCT02434770|16153253|P3|Week 18 to Week|Received Non-study Polio Vaccine|3
4689992|NCT02434770|16153254|P2|Week 18 to Week|Received Non-study Polio Vaccine|6
4689993|NCT02434770|16153255|P1|Week 18 to Week|Received Non-study Polio Vaccine|6
4689994|NCT02434770|16153253|P3|Week 18 to Week|Withdrawal by Subject|2
4689995|NCT02434770|16153254|P2|Week 18 to Week|Withdrawal by Subject|0
4689996|NCT02434770|16153255|P1|Week 18 to Week|Withdrawal by Subject|0
4689997|NCT02434770|16153253|P3|Week 18 to Week|Lost to Follow-up|1
4689998|NCT02434770|16153254|P2|Week 18 to Week|Lost to Follow-up|2
4689999|NCT02434770|16153255|P1|Week 18 to Week|Lost to Follow-up|2
4690000|NCT02434770|16153253|P3|Week 1 to Week 18|Death|0
4690001|NCT02434770|16153254|P2|Week 1 to Week 18|Death|0
4690002|NCT02434770|16153255|P1|Week 1 to Week 18|Death|1
4690003|NCT02434770|16153253|P3|Week 1 to Week 18|Relocated Out of Study Area|1
4690004|NCT02434770|16153254|P2|Week 1 to Week 18|Relocated Out of Study Area|0
4690005|NCT02434770|16153255|P1|Week 1 to Week 18|Relocated Out of Study Area|0
4690006|NCT02434770|16153253|P3|Week 1 to Week 18|Received Non-study Polio Vaccine|9
4690007|NCT02434770|16153254|P2|Week 1 to Week 18|Received Non-study Polio Vaccine|10
4690008|NCT02434770|16153255|P1|Week 1 to Week 18|Received Non-study Polio Vaccine|8
4690009|NCT02434770|16153253|P3|Week 1 to Week 18|Withdrawal by Subject|5
4690010|NCT02434770|16153254|P2|Week 1 to Week 18|Withdrawal by Subject|12
4690011|NCT02434770|16153255|P1|Week 1 to Week 18|Withdrawal by Subject|6
4690012|NCT02434770|16153253|P3|Week 1 to Week 18|Lost to Follow-up|2
4690013|NCT02434770|16153254|P2|Week 1 to Week 18|Lost to Follow-up|0
4690014|NCT02434770|16153255|P1|Week 1 to Week 18|Lost to Follow-up|0
4690015|NCT02434471|16153405|P1|Overall Study|Physician Decision|9
4690016|NCT02282020|16153414|P2|Overall Study|Withdrew Consent Prior to Dosing|12
4690017|NCT02282020|16153415|P1|Overall Study|Withdrew Consent Prior to Dosing|0
4690018|NCT02282020|16153414|P2|Overall Study|Developed Discontinuation Criteria|3
4690019|NCT02282020|16153415|P1|Overall Study|Developed Discontinuation Criteria|1
4690020|NCT02282020|16153414|P2|Overall Study|Severe Non-compliance to Protocol|0
4690021|NCT02282020|16153415|P1|Overall Study|Severe Non-compliance to Protocol|1
4690022|NCT02282020|16153414|P2|Overall Study|Miscellaneous|17
4690023|NCT02282020|16153415|P1|Overall Study|Miscellaneous|4
4690024|NCT02282020|16153414|P2|Overall Study|Withdrawal by Subject|10
4690025|NCT02282020|16153415|P1|Overall Study|Withdrawal by Subject|5
4690026|NCT02282020|16153414|P2|Overall Study|Adverse Event|15
4690027|NCT02282020|16153415|P1|Overall Study|Adverse Event|13
4690028|NCT02282020|16153414|P2|Overall Study|Objective Disease Progression|30
4690029|NCT02282020|16153415|P1|Overall Study|Objective Disease Progression|111
4690030|NCT02434328|16153462|P2|Overall Study|Other|1
4690031|NCT02434328|16153463|P1|Overall Study|Other|4
4690032|NCT02434328|16153462|P2|Overall Study|Lost to Follow-up|6
4690033|NCT02434328|16153463|P1|Overall Study|Lost to Follow-up|1
4690034|NCT02434328|16153462|P2|Overall Study|Death|7
4690035|NCT02434328|16153463|P1|Overall Study|Death|4
4690036|NCT02434328|16153462|P2|Overall Study|Withdrawal by Subject|21
4690037|NCT02434328|16153463|P1|Overall Study|Withdrawal by Subject|12
4690038|NCT02434328|16153462|P2|Overall Study|Physician Decision|1
4690039|NCT02434328|16153463|P1|Overall Study|Physician Decision|0
4690040|NCT02434328|16153462|P2|Overall Study|Lack of Efficacy|2
4690041|NCT02434328|16153463|P1|Overall Study|Lack of Efficacy|0
4690042|NCT02434328|16153462|P2|Overall Study|Adverse Event|4
4690043|NCT02434328|16153463|P1|Overall Study|Adverse Event|9
4690044|NCT02433834|16153538|P1|Overall Study|Physician Decision|1
4690045|NCT02433834|16153538|P1|Overall Study|Adverse Event|6
4690046|NCT02433834|16153538|P1|Overall Study|Withdrawal by Subject|14
4690047|NCT02433834|16153538|P1|Overall Study|Lost to Follow-up|6
4690048|NCT02433834|16153538|P1|Overall Study|Protocol Violation|3
4690049|NCT02433834|16153538|P1|Overall Study|Protocol-specified criteria|7
4690050|NCT02433678|16153598|P2|Overall Study|Lost to Follow-up|2
4690051|NCT02433678|16153599|P1|Overall Study|Lost to Follow-up|1
4690052|NCT02433483|16153692|P1|Overall Study|Other antineoplastic therapy/HSCT|1
4690053|NCT02433483|16153692|P1|Overall Study|Unacceptable toxicity|1
4690054|NCT02433340|16153719|P4|Overall Study|Other|0
4690055|NCT02433340|16153720|P3|Overall Study|Other|0
4690056|NCT02433340|16153721|P2|Overall Study|Other|1
4690057|NCT02433340|16153722|P1|Overall Study|Other|0
4690058|NCT02433340|16153719|P4|Overall Study|Required Alternative/Prohibited Therapy|0
4690059|NCT02433340|16153720|P3|Overall Study|Required Alternative/Prohibited Therapy|0
4690060|NCT02433340|16153721|P2|Overall Study|Required Alternative/Prohibited Therapy|0
4690061|NCT02433340|16153722|P1|Overall Study|Required Alternative/Prohibited Therapy|1
4690062|NCT02433340|16153719|P4|Overall Study|Lost to Follow-up|0
4690063|NCT02433340|16153720|P3|Overall Study|Lost to Follow-up|0
4690064|NCT02433340|16153721|P2|Overall Study|Lost to Follow-up|1
4690065|NCT02433340|16153722|P1|Overall Study|Lost to Follow-up|0
4690066|NCT02433340|16153719|P4|Overall Study|Withdrawal by Subject|2
4690067|NCT02433340|16153720|P3|Overall Study|Withdrawal by Subject|1
4690068|NCT02433340|16153721|P2|Overall Study|Withdrawal by Subject|0
4690069|NCT02433340|16153722|P1|Overall Study|Withdrawal by Subject|1
4690070|NCT02433340|16153719|P4|Overall Study|Adverse Event|0
4690071|NCT02433340|16153720|P3|Overall Study|Adverse Event|1
4690072|NCT02433340|16153721|P2|Overall Study|Adverse Event|0
4690073|NCT02433340|16153722|P1|Overall Study|Adverse Event|0
4690074|NCT02433288|16154616|P2|Overall Study|Death|3
4690075|NCT02433288|16154617|P1|Overall Study|Death|0
4690076|NCT02433288|16154616|P2|Overall Study|Lost to Follow-up|14
4690077|NCT02433288|16154617|P1|Overall Study|Lost to Follow-up|2
4690078|NCT02433288|16154616|P2|Overall Study|Withdrawal by Subject|99
4690079|NCT02433288|16154617|P1|Overall Study|Withdrawal by Subject|101
4690080|NCT02433288|16154616|P2|Overall Study|Eligibility criteria not fullfilled|3
4690081|NCT02433288|16154617|P1|Overall Study|Eligibility criteria not fullfilled|7
4690082|NCT02433288|16154616|P2|Overall Study|Severe non-compliance to protocol|7
4690083|NCT02433288|16154617|P1|Overall Study|Severe non-compliance to protocol|13
4690084|NCT02433080|16154662|P2|Overall Study|Withdrawal by Subject|2
4690085|NCT02433080|16154663|P1|Overall Study|Withdrawal by Subject|0
4690086|NCT02433080|16154662|P2|Overall Study|Lost to Follow-up|2
4690087|NCT02433080|16154663|P1|Overall Study|Lost to Follow-up|1
4690088|NCT02432274|16154783|P8|Overall Study|Ongoing|7
4690089|NCT02432274|16154784|P7|Overall Study|Ongoing|0
4690090|NCT02432274|16154785|P6|Overall Study|Ongoing|0
4690091|NCT02432274|16154786|P5|Overall Study|Ongoing|3
4690092|NCT02432274|16154787|P4|Overall Study|Ongoing|1
4690093|NCT02432274|16154788|P3|Overall Study|Ongoing|1
4690094|NCT02432274|16154789|P2|Overall Study|Ongoing|0
4690095|NCT02432274|16154790|P1|Overall Study|Ongoing|0
4690096|NCT02432274|16154783|P8|Overall Study|Other than specified|1
4690097|NCT02432274|16154784|P7|Overall Study|Other than specified|0
4690098|NCT02432274|16154785|P6|Overall Study|Other than specified|1
4690099|NCT02432274|16154786|P5|Overall Study|Other than specified|0
4690100|NCT02432274|16154787|P4|Overall Study|Other than specified|0
4690101|NCT02432274|16154788|P3|Overall Study|Other than specified|0
4690102|NCT02432274|16154789|P2|Overall Study|Other than specified|1
4690103|NCT02432274|16154790|P1|Overall Study|Other than specified|0
4690104|NCT02432274|16154783|P8|Overall Study|Participant Choice|0
4690105|NCT02432274|16154784|P7|Overall Study|Participant Choice|1
4690106|NCT02432274|16154785|P6|Overall Study|Participant Choice|0
4690107|NCT02432274|16154786|P5|Overall Study|Participant Choice|0
4690108|NCT02432274|16154787|P4|Overall Study|Participant Choice|0
4690109|NCT02432274|16154788|P3|Overall Study|Participant Choice|1
4690110|NCT02432274|16154789|P2|Overall Study|Participant Choice|0
4690111|NCT02432274|16154790|P1|Overall Study|Participant Choice|0
4690112|NCT02432274|16154783|P8|Overall Study|Withdrawal by Subject|2
4690113|NCT02432274|16154784|P7|Overall Study|Withdrawal by Subject|1
4690114|NCT02432274|16154785|P6|Overall Study|Withdrawal by Subject|0
4690115|NCT02432274|16154786|P5|Overall Study|Withdrawal by Subject|2
4690116|NCT02432274|16154787|P4|Overall Study|Withdrawal by Subject|0
4690117|NCT02432274|16154788|P3|Overall Study|Withdrawal by Subject|0
4690118|NCT02432274|16154789|P2|Overall Study|Withdrawal by Subject|0
4690119|NCT02432274|16154790|P1|Overall Study|Withdrawal by Subject|0
4690120|NCT02432274|16154783|P8|Overall Study|Adverse Event|0
4690121|NCT02432274|16154784|P7|Overall Study|Adverse Event|2
4690122|NCT02432274|16154785|P6|Overall Study|Adverse Event|0
4690123|NCT02432274|16154786|P5|Overall Study|Adverse Event|1
4690124|NCT02432274|16154787|P4|Overall Study|Adverse Event|0
4690125|NCT02432274|16154788|P3|Overall Study|Adverse Event|1
4690126|NCT02432274|16154789|P2|Overall Study|Adverse Event|0
4690127|NCT02432274|16154790|P1|Overall Study|Adverse Event|0
4690128|NCT02432274|16154783|P8|Overall Study|Clinical Disease Progression|1
4690129|NCT02432274|16154784|P7|Overall Study|Clinical Disease Progression|0
4690130|NCT02432274|16154785|P6|Overall Study|Clinical Disease Progression|0
4690131|NCT02432274|16154786|P5|Overall Study|Clinical Disease Progression|1
4690132|NCT02432274|16154787|P4|Overall Study|Clinical Disease Progression|0
4690133|NCT02432274|16154788|P3|Overall Study|Clinical Disease Progression|1
4690134|NCT02432274|16154789|P2|Overall Study|Clinical Disease Progression|4
4690135|NCT02432274|16154790|P1|Overall Study|Clinical Disease Progression|0
4690136|NCT02432274|16154783|P8|Overall Study|Radiological Disease Progression|9
4690137|NCT02432274|16154784|P7|Overall Study|Radiological Disease Progression|11
4690138|NCT02432274|16154785|P6|Overall Study|Radiological Disease Progression|6
4690139|NCT02432274|16154786|P5|Overall Study|Radiological Disease Progression|24
4690140|NCT02432274|16154787|P4|Overall Study|Radiological Disease Progression|0
4690141|NCT02432274|16154788|P3|Overall Study|Radiological Disease Progression|7
4690142|NCT02432274|16154789|P2|Overall Study|Radiological Disease Progression|4
4690143|NCT02432274|16154790|P1|Overall Study|Radiological Disease Progression|3
4690144|NCT02432196|16154903|P1|Overall Study|On Study|20
4690145|NCT02432196|16154903|P1|Overall Study|Reoperation|3
4690146|NCT02432196|16154903|P1|Overall Study|Death|2
4690147|NCT02432196|16154903|P1|Overall Study|Not Implanted with Device|1
4690148|NCT02432144|16154911|P1|Overall Study|Participant Non-Compliance|1
4690149|NCT02432105|16154919|P3|Overall Study|Randomized in error|2
4690150|NCT02432105|16154920|P2|Overall Study|Randomized in error|0
4690151|NCT02432105|16154921|P1|Overall Study|Randomized in error|0
4690152|NCT02432105|16154919|P3|Overall Study|Culture positive for yeast|0
4690153|NCT02432105|16154920|P2|Overall Study|Culture positive for yeast|1
4690154|NCT02432105|16154921|P1|Overall Study|Culture positive for yeast|0
4690155|NCT02432105|16154919|P3|Overall Study|Withdrawal by Subject|1
4690156|NCT02432105|16154920|P2|Overall Study|Withdrawal by Subject|0
4690157|NCT02432105|16154921|P1|Overall Study|Withdrawal by Subject|1
4690158|NCT02432105|16154919|P3|Overall Study|Lost to Follow-up|0
4690159|NCT02432105|16154920|P2|Overall Study|Lost to Follow-up|1
4690160|NCT02432105|16154921|P1|Overall Study|Lost to Follow-up|1
4690161|NCT02432040|16154938|P2|Overall Study|Physician Decision|1
4690162|NCT02432040|16154939|P1|Overall Study|Physician Decision|1
4690163|NCT02432040|16154938|P2|Overall Study|Lost to Follow-up|5
4690164|NCT02432040|16154939|P1|Overall Study|Lost to Follow-up|4
4690165|NCT02432040|16154938|P2|Overall Study|Lack of Efficacy|0
4690166|NCT02432040|16154939|P1|Overall Study|Lack of Efficacy|3
4690167|NCT02431806|16154963|P4|Double-blind Treatment Period|Reason Not Specified|2
4690168|NCT02431806|16154964|P3|Double-blind Treatment Period|Reason Not Specified|5
4690169|NCT02431806|16154965|P2|Double-blind Treatment Period|Reason Not Specified|1
4690170|NCT02431806|16154966|P1|Double-blind Treatment Period|Reason Not Specified|0
4690171|NCT02431806|16154963|P4|Double-blind Treatment Period|Investigational Product Non-compliance|1
4690172|NCT02431806|16154964|P3|Double-blind Treatment Period|Investigational Product Non-compliance|3
4690173|NCT02431806|16154965|P2|Double-blind Treatment Period|Investigational Product Non-compliance|0
4690174|NCT02431806|16154966|P1|Double-blind Treatment Period|Investigational Product Non-compliance|1
4690175|NCT02431806|16154963|P4|Double-blind Treatment Period|Lost to Follow-up|8
4690176|NCT02431806|16154964|P3|Double-blind Treatment Period|Lost to Follow-up|5
4690177|NCT02431806|16154965|P2|Double-blind Treatment Period|Lost to Follow-up|4
4690178|NCT02431806|16154966|P1|Double-blind Treatment Period|Lost to Follow-up|7
4690179|NCT02431806|16154963|P4|Double-blind Treatment Period|Withdrawal of Consent|5
4690180|NCT02431806|16154964|P3|Double-blind Treatment Period|Withdrawal of Consent|5
4690181|NCT02431806|16154965|P2|Double-blind Treatment Period|Withdrawal of Consent|7
4690182|NCT02431806|16154966|P1|Double-blind Treatment Period|Withdrawal of Consent|10
4690183|NCT02431806|16154963|P4|Double-blind Treatment Period|Lack of Efficacy|2
4690184|NCT02431806|16154964|P3|Double-blind Treatment Period|Lack of Efficacy|2
4690185|NCT02431806|16154965|P2|Double-blind Treatment Period|Lack of Efficacy|0
4690186|NCT02431806|16154966|P1|Double-blind Treatment Period|Lack of Efficacy|2
4690187|NCT02431806|16154963|P4|Double-blind Treatment Period|Adverse Event|7
4690188|NCT02431806|16154964|P3|Double-blind Treatment Period|Adverse Event|11
4690189|NCT02431806|16154965|P2|Double-blind Treatment Period|Adverse Event|7
4690190|NCT02431806|16154966|P1|Double-blind Treatment Period|Adverse Event|4
4690191|NCT02431806|16154963|P4|Double-blind Treatment Period|Did not Receive Treatment|1
4690192|NCT02431806|16154964|P3|Double-blind Treatment Period|Did not Receive Treatment|1
4690193|NCT02431806|16154965|P2|Double-blind Treatment Period|Did not Receive Treatment|2
4690194|NCT02431806|16154966|P1|Double-blind Treatment Period|Did not Receive Treatment|1
4690195|NCT02431793|16154983|P3|Overall Study|Lost to Follow-up|104
4690196|NCT02431793|16154984|P2|Overall Study|Lost to Follow-up|122
4690197|NCT02431793|16154985|P1|Overall Study|Lost to Follow-up|101
4690198|NCT02431793|16154983|P3|Overall Study|Withdrawal by Subject|5
4690199|NCT02431793|16154984|P2|Overall Study|Withdrawal by Subject|5
4690200|NCT02431793|16154985|P1|Overall Study|Withdrawal by Subject|7
4690201|NCT02431793|16154983|P3|Overall Study|Ineligible doe to not filling Rx|8
4690202|NCT02431793|16154984|P2|Overall Study|Ineligible doe to not filling Rx|7
4690203|NCT02431793|16154985|P1|Overall Study|Ineligible doe to not filling Rx|11
4690204|NCT02431676|16155033|P3|Overall Study|no lab obtained|2
4690205|NCT02431676|16155034|P2|Overall Study|no lab obtained|1
4690206|NCT02431676|16155035|P1|Overall Study|no lab obtained|0
4690207|NCT02431559|16155111|P4|Overall Study|Physician Decision|1
4690208|NCT02431559|16155112|P3|Overall Study|Physician Decision|0
4690209|NCT02431559|16155113|P2|Overall Study|Physician Decision|0
4690210|NCT02431559|16155114|P1|Overall Study|Physician Decision|0
4690211|NCT02431559|16155111|P4|Overall Study|Withdrawal by Subject|4
4690212|NCT02431559|16155112|P3|Overall Study|Withdrawal by Subject|0
4690213|NCT02431559|16155113|P2|Overall Study|Withdrawal by Subject|1
4690214|NCT02431559|16155114|P1|Overall Study|Withdrawal by Subject|0
4690215|NCT02431559|16155111|P4|Overall Study|Progressive disease|22
4690216|NCT02431559|16155112|P3|Overall Study|Progressive disease|4
4690217|NCT02431559|16155113|P2|Overall Study|Progressive disease|1
4690218|NCT02431559|16155114|P1|Overall Study|Progressive disease|2
4690219|NCT02431559|16155111|P4|Overall Study|Adverse Event|4
4690220|NCT02431559|16155112|P3|Overall Study|Adverse Event|0
4690221|NCT02431559|16155113|P2|Overall Study|Adverse Event|1
4690222|NCT02431559|16155114|P1|Overall Study|Adverse Event|0
4690223|NCT02431533|16155138|P2|Overall Study|Developed Exclusionary criteria|0
4690224|NCT02431533|16155139|P1|Overall Study|Developed Exclusionary criteria|1
4690225|NCT02431533|16155138|P2|Overall Study|Withdrawal by Subject|3
4690226|NCT02431533|16155139|P1|Overall Study|Withdrawal by Subject|1
4690227|NCT02431468|16155244|P3|Overall Study|noncompliance, investigator termination,|2
4690228|NCT02431468|16155245|P2|Overall Study|noncompliance, investigator termination,|2
4690229|NCT02431468|16155246|P1|Overall Study|noncompliance, investigator termination,|2
4690230|NCT02431468|16155244|P3|Overall Study|Withdrawal by Subject|2
4690231|NCT02431468|16155245|P2|Overall Study|Withdrawal by Subject|12
4690232|NCT02431468|16155246|P1|Overall Study|Withdrawal by Subject|4
4690233|NCT02431468|16155244|P3|Overall Study|Adverse Event|5
4690234|NCT02431468|16155245|P2|Overall Study|Adverse Event|4
4690235|NCT02431468|16155246|P1|Overall Study|Adverse Event|2
4690236|NCT02431260|16155337|P14|Overall Study|Other Unspecified|0
4690237|NCT02431260|16155338|P13|Overall Study|Other Unspecified|1
4690238|NCT02431260|16155339|P12|Overall Study|Other Unspecified|1
4690239|NCT02431260|16155340|P11|Overall Study|Other Unspecified|0
4690240|NCT02431260|16155341|P10|Overall Study|Other Unspecified|0
4690241|NCT02431260|16155342|P9|Overall Study|Other Unspecified|0
4690242|NCT02431260|16155343|P8|Overall Study|Other Unspecified|0
4690243|NCT02431260|16155344|P7|Overall Study|Other Unspecified|0
4690244|NCT02431260|16155345|P6|Overall Study|Other Unspecified|0
4690245|NCT02431260|16155346|P5|Overall Study|Other Unspecified|0
4690246|NCT02431260|16155347|P4|Overall Study|Other Unspecified|0
4690247|NCT02431260|16155348|P3|Overall Study|Other Unspecified|0
4690248|NCT02431260|16155349|P2|Overall Study|Other Unspecified|0
4690249|NCT02431260|16155350|P1|Overall Study|Other Unspecified|0
4690250|NCT02431260|16155337|P14|Overall Study|Physician Decision|0
4690251|NCT02431260|16155338|P13|Overall Study|Physician Decision|0
4690252|NCT02431260|16155339|P12|Overall Study|Physician Decision|0
4690253|NCT02431260|16155340|P11|Overall Study|Physician Decision|0
4690254|NCT02431260|16155341|P10|Overall Study|Physician Decision|0
4690255|NCT02431260|16155342|P9|Overall Study|Physician Decision|0
4690256|NCT02431260|16155343|P8|Overall Study|Physician Decision|0
4690257|NCT02431260|16155344|P7|Overall Study|Physician Decision|0
4690258|NCT02431260|16155345|P6|Overall Study|Physician Decision|1
4690259|NCT02431260|16155346|P5|Overall Study|Physician Decision|0
4690260|NCT02431260|16155347|P4|Overall Study|Physician Decision|0
4690261|NCT02431260|16155348|P3|Overall Study|Physician Decision|0
4690262|NCT02431260|16155349|P2|Overall Study|Physician Decision|0
4690263|NCT02431260|16155350|P1|Overall Study|Physician Decision|0
4690264|NCT02431260|16155337|P14|Overall Study|Study Terminated by the Sponsor|0
4690265|NCT02431260|16155338|P13|Overall Study|Study Terminated by the Sponsor|4
4690266|NCT02431260|16155339|P12|Overall Study|Study Terminated by the Sponsor|0
4690267|NCT02431260|16155340|P11|Overall Study|Study Terminated by the Sponsor|1
4690268|NCT02431260|16155341|P10|Overall Study|Study Terminated by the Sponsor|1
4690269|NCT02431260|16155342|P9|Overall Study|Study Terminated by the Sponsor|1
4690270|NCT02431260|16155343|P8|Overall Study|Study Terminated by the Sponsor|2
4690271|NCT02431260|16155344|P7|Overall Study|Study Terminated by the Sponsor|1
4690272|NCT02431260|16155345|P6|Overall Study|Study Terminated by the Sponsor|0
4690273|NCT02431260|16155346|P5|Overall Study|Study Terminated by the Sponsor|1
4690274|NCT02431260|16155347|P4|Overall Study|Study Terminated by the Sponsor|1
4690275|NCT02431260|16155348|P3|Overall Study|Study Terminated by the Sponsor|2
4690276|NCT02431260|16155349|P2|Overall Study|Study Terminated by the Sponsor|0
4690277|NCT02431260|16155350|P1|Overall Study|Study Terminated by the Sponsor|0
4690278|NCT02431260|16155337|P14|Overall Study|Lost to Follow-up|0
4690279|NCT02431260|16155338|P13|Overall Study|Lost to Follow-up|0
4690280|NCT02431260|16155339|P12|Overall Study|Lost to Follow-up|0
4690281|NCT02431260|16155340|P11|Overall Study|Lost to Follow-up|0
4690282|NCT02431260|16155341|P10|Overall Study|Lost to Follow-up|0
4690283|NCT02431260|16155342|P9|Overall Study|Lost to Follow-up|0
4690284|NCT02431260|16155343|P8|Overall Study|Lost to Follow-up|0
4690285|NCT02431260|16155344|P7|Overall Study|Lost to Follow-up|0
4690286|NCT02431260|16155345|P6|Overall Study|Lost to Follow-up|1
4690287|NCT02431260|16155346|P5|Overall Study|Lost to Follow-up|0
4690288|NCT02431260|16155347|P4|Overall Study|Lost to Follow-up|0
4690289|NCT02431260|16155348|P3|Overall Study|Lost to Follow-up|0
4690290|NCT02431260|16155349|P2|Overall Study|Lost to Follow-up|0
4690291|NCT02431260|16155350|P1|Overall Study|Lost to Follow-up|0
4690292|NCT02431260|16155337|P14|Overall Study|Death|1
4690293|NCT02431260|16155338|P13|Overall Study|Death|5
4690294|NCT02431260|16155339|P12|Overall Study|Death|2
4690295|NCT02431260|16155340|P11|Overall Study|Death|3
4690296|NCT02431260|16155341|P10|Overall Study|Death|6
4690297|NCT02431260|16155342|P9|Overall Study|Death|6
4690298|NCT02431260|16155343|P8|Overall Study|Death|1
4690299|NCT02431260|16155344|P7|Overall Study|Death|3
4690300|NCT02431260|16155345|P6|Overall Study|Death|2
4690301|NCT02431260|16155346|P5|Overall Study|Death|2
4690302|NCT02431260|16155347|P4|Overall Study|Death|4
4690303|NCT02431260|16155348|P3|Overall Study|Death|3
4690304|NCT02431260|16155349|P2|Overall Study|Death|4
4690305|NCT02431260|16155350|P1|Overall Study|Death|4
4690306|NCT02431260|16155337|P14|Overall Study|Subject Decision|0
4690307|NCT02431260|16155338|P13|Overall Study|Subject Decision|0
4690308|NCT02431260|16155339|P12|Overall Study|Subject Decision|1
4690309|NCT02431260|16155340|P11|Overall Study|Subject Decision|0
4690310|NCT02431260|16155341|P10|Overall Study|Subject Decision|1
4690311|NCT02431260|16155342|P9|Overall Study|Subject Decision|1
4690312|NCT02431260|16155343|P8|Overall Study|Subject Decision|0
4690313|NCT02431260|16155344|P7|Overall Study|Subject Decision|0
4690314|NCT02431260|16155345|P6|Overall Study|Subject Decision|0
4690315|NCT02431260|16155346|P5|Overall Study|Subject Decision|0
4690316|NCT02431260|16155347|P4|Overall Study|Subject Decision|0
4690317|NCT02431260|16155348|P3|Overall Study|Subject Decision|1
4690318|NCT02431260|16155349|P2|Overall Study|Subject Decision|1
4690319|NCT02431260|16155350|P1|Overall Study|Subject Decision|0
4690320|NCT02431247|16155443|P2|Overall Study|Non-compliance with study drug|0
4690321|NCT02431247|16155444|P1|Overall Study|Non-compliance with study drug|1
4690322|NCT02431247|16155443|P2|Overall Study|Ongoing|336
4690323|NCT02431247|16155444|P1|Overall Study|Ongoing|339
4690324|NCT02431247|16155443|P2|Overall Study|Other|1
4690325|NCT02431247|16155444|P1|Overall Study|Other|2
4690326|NCT02431247|16155443|P2|Overall Study|Withdrawal by Subject|6
4690327|NCT02431247|16155444|P1|Overall Study|Withdrawal by Subject|4
4690328|NCT02431247|16155443|P2|Overall Study|Physician Decision|0
4690329|NCT02431247|16155444|P1|Overall Study|Physician Decision|3
4690330|NCT02431247|16155443|P2|Overall Study|Adverse Event|15
4690331|NCT02431247|16155444|P1|Overall Study|Adverse Event|8
4690332|NCT02431247|16155443|P2|Overall Study|Lost to Follow-up|5
4690333|NCT02431247|16155444|P1|Overall Study|Lost to Follow-up|5
4690334|NCT02430870|16155537|P8|Part 2|Other Reason Not Specified|1
4690335|NCT02430870|16155538|P7|Part 2|Other Reason Not Specified|0
4690336|NCT02430870|16155539|P6|Part 2|Other Reason Not Specified|0
4690337|NCT02430870|16155540|P5|Part 2|Other Reason Not Specified|0
4690338|NCT02430870|16155541|P4|Part 2|Other Reason Not Specified|0
4690339|NCT02430870|16155542|P3|Part 2|Other Reason Not Specified|0
4690340|NCT02430870|16155543|P2|Part 2|Other Reason Not Specified|0
4690341|NCT02430870|16155544|P1|Part 2|Other Reason Not Specified|0
4690342|NCT02430870|16155537|P8|Part 2|Voluntary Withdrawal|0
4690343|NCT02430870|16155538|P7|Part 2|Voluntary Withdrawal|1
4690344|NCT02430870|16155539|P6|Part 2|Voluntary Withdrawal|0
4690345|NCT02430870|16155540|P5|Part 2|Voluntary Withdrawal|0
4690346|NCT02430870|16155541|P4|Part 2|Voluntary Withdrawal|0
4690347|NCT02430870|16155542|P3|Part 2|Voluntary Withdrawal|0
4690348|NCT02430870|16155543|P2|Part 2|Voluntary Withdrawal|0
4690349|NCT02430870|16155544|P1|Part 2|Voluntary Withdrawal|0
4690350|NCT02430532|16155631|P2|Overall Study|Adverse Event|1
4690351|NCT02430532|16155632|P1|Overall Study|Adverse Event|0
4690352|NCT02430532|16155631|P2|Overall Study|Consent Withdrawn|2
4690353|NCT02430532|16155632|P1|Overall Study|Consent Withdrawn|0
4690354|NCT02430532|16155631|P2|Overall Study|Sponsor Decision to Stop Study Early|25
4690355|NCT02430532|16155632|P1|Overall Study|Sponsor Decision to Stop Study Early|30
4690356|NCT02430311|16155673|P2|Part B|Death|0
4690357|NCT02430311|16155674|P1|Part B|Death|1
4690358|NCT02430311|16155673|P2|Part B|Adverse Event|0
4690359|NCT02430311|16155674|P1|Part B|Adverse Event|1
4690360|NCT02430311|16155673|P2|Part B|Withdrawal by Subject|2
4690361|NCT02430311|16155674|P1|Part B|Withdrawal by Subject|2
4690362|NCT02430311|16155673|P2|Part B|Meet study-specific withdrawal criteria|6
4690363|NCT02430311|16155674|P1|Part B|Meet study-specific withdrawal criteria|6
4690364|NCT02430311|16155673|P2|Part A|Withdrawal by Subject|0
4690365|NCT02430311|16155674|P1|Part A|Withdrawal by Subject|1
4690366|NCT02430311|16155673|P2|Part A|Adverse Event|1
4690367|NCT02430311|16155674|P1|Part A|Adverse Event|0
4690368|NCT02429856|16155728|P2|Overall Study|Withdrawal by Subject|1
4690369|NCT02429856|16155729|P1|Overall Study|Withdrawal by Subject|1
4690370|NCT02429856|16155728|P2|Overall Study|Lost to Follow-up|5
4690371|NCT02429856|16155729|P1|Overall Study|Lost to Follow-up|6
4690372|NCT02429856|16155728|P2|Overall Study|Death|13
4690373|NCT02429856|16155729|P1|Overall Study|Death|12
4690374|NCT02429791|16155747|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5
4690375|NCT02429791|16155748|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7
4690376|NCT02429791|16155747|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
4690377|NCT02429791|16155748|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
4690378|NCT02429791|16155747|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1
4690379|NCT02429791|16155748|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0
4690380|NCT02429791|16155747|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
4690381|NCT02429791|16155748|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4
4690382|NCT02429791|16155747|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4
4690383|NCT02429791|16155748|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
4690384|NCT02429791|16155747|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12
4690385|NCT02429791|16155748|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11
4690386|NCT02429791|16155747|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
4690387|NCT02429791|16155748|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3
4690388|NCT02429791|16155747|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|4
4690389|NCT02429791|16155748|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|1
4690390|NCT02429791|16155747|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2
4690391|NCT02429791|16155748|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
4690392|NCT02429791|16155747|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
4690393|NCT02429791|16155748|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
4690394|NCT02429791|16155747|P2|Early Switch Phase (Up to Week 52)|Physician Decision|2
4690395|NCT02429791|16155748|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
4690396|NCT02429791|16155747|P2|Early Switch Phase (Up to Week 52)|Adverse Event|2
4690397|NCT02429791|16155748|P1|Early Switch Phase (Up to Week 52)|Adverse Event|6
4690398|NCT02429778|16155836|P2|Overall Study|Withdrawal by Subject|0
4690399|NCT02429778|16155837|P1|Overall Study|Withdrawal by Subject|5
4690400|NCT02429778|16155836|P2|Overall Study|Lost to Follow-up|0
4690401|NCT02429778|16155837|P1|Overall Study|Lost to Follow-up|2
4690402|NCT02429427|16155868|P2|Overall Study|Other|41
4690403|NCT02429427|16155869|P1|Overall Study|Other|62
4690404|NCT02429427|16155868|P2|Overall Study|Withdrawal by Subject|34
4690405|NCT02429427|16155869|P1|Overall Study|Withdrawal by Subject|64
4690406|NCT02429427|16155868|P2|Overall Study|Lost to Follow-up|6
4690407|NCT02429427|16155869|P1|Overall Study|Lost to Follow-up|15
4690408|NCT02429427|16155868|P2|Overall Study|Protocol Violation|6
4690409|NCT02429427|16155869|P1|Overall Study|Protocol Violation|10
4690410|NCT02429427|16155868|P2|Overall Study|Adverse Event|92
4690411|NCT02429427|16155869|P1|Overall Study|Adverse Event|220
4690412|NCT02429310|16155883|P2|Overall Study|Protocol Violation|1
4690413|NCT02429310|16155884|P1|Overall Study|Protocol Violation|1
4690414|NCT02429310|16155883|P2|Overall Study|Lost to Follow-up|2
4690415|NCT02429310|16155884|P1|Overall Study|Lost to Follow-up|1
4690416|NCT02429258|16155894|P2|Overall Study|Protocol Violation|1
4690417|NCT02429258|16155895|P1|Overall Study|Protocol Violation|0
4690418|NCT02429258|16155894|P2|Overall Study|Withdrawal by Subject|0
4690419|NCT02429258|16155895|P1|Overall Study|Withdrawal by Subject|2
4690420|NCT02428855|16155949|P1|Overall Study|Withdrawal by Subject|2
4690421|NCT02428699|16155956|P2|Washout Period 1|Screen Failure|2
4690422|NCT02428699|16155957|P1|Washout Period 1|Screen Failure|1
4690423|NCT02428608|16155985|P1|Overall Study|various|16
4690424|NCT02428608|16155985|P1|Overall Study|Death|1
4690425|NCT02428608|16155985|P1|Overall Study|moved away|10
4690426|NCT02428608|16155985|P1|Overall Study|scheduling conflicts|15
4690427|NCT02428608|16155985|P1|Overall Study|Withdrawal by Subject|2
4690428|NCT02428608|16155985|P1|Overall Study|Lost to Follow-up|37
4690429|NCT02428608|16155985|P1|Overall Study|Pregnancy|2
4690430|NCT02428413|16156017|P2|Overall Study|Nurse Refusal|0
4690431|NCT02428413|16156018|P1|Overall Study|Nurse Refusal|1
4690432|NCT02428413|16156017|P2|Overall Study|Missed Cases|2
4690433|NCT02428413|16156018|P1|Overall Study|Missed Cases|1
4690434|NCT02428413|16156017|P2|Overall Study|Case Cancelled|0
4690435|NCT02428413|16156018|P1|Overall Study|Case Cancelled|2
4690436|NCT02428413|16156017|P2|Overall Study|Protocol Violation|2
4690437|NCT02428413|16156018|P1|Overall Study|Protocol Violation|1
4690438|NCT02428413|16156017|P2|Overall Study|Device to measure WAG malfunctioned|5
4690439|NCT02428413|16156018|P1|Overall Study|Device to measure WAG malfunctioned|3
4690440|NCT02428296|16156053|P1|Overall Study|Withdrawal by Subject|2
4690441|NCT02428296|16156053|P1|Overall Study|Adverse Event|7
4690442|NCT02428231|16156065|P2|Overall Study|Adverse Event|0
4690443|NCT02428231|16156066|P1|Overall Study|Adverse Event|3
4690444|NCT02428231|16156065|P2|Overall Study|Required Symptomatic Therapy|1
4690445|NCT02428231|16156066|P1|Overall Study|Required Symptomatic Therapy|0
4690446|NCT02428231|16156065|P2|Overall Study|Other|16
4690447|NCT02428231|16156066|P1|Overall Study|Other|10
4690448|NCT02427984|16156098|P3|Overall Study|Lost to Follow-up|18
4690449|NCT02427984|16156099|P2|Overall Study|Lost to Follow-up|5
4690450|NCT02427984|16156100|P1|Overall Study|Lost to Follow-up|13
4690451|NCT02427958|16156114|P1|Overall Study|Lack of Efficacy|1
4690452|NCT02427958|16156114|P1|Overall Study|Withdrawal by Subject|14
4690453|NCT02427958|16156114|P1|Overall Study|Lost to Follow-up|6
4690454|NCT02427958|16156114|P1|Overall Study|Pretreatment Event (PTE) or AE|3
4690455|NCT02427646|16156207|P2|Overall Study|Bothersome hand weakness|4
4690456|NCT02427646|16156208|P1|Overall Study|Bothersome hand weakness|2
4690457|NCT02427646|16156207|P2|Overall Study|Protocol Violation|3
4690458|NCT02427646|16156208|P1|Overall Study|Protocol Violation|3
4690459|NCT02427646|16156207|P2|Overall Study|Physician Decision|4
4690460|NCT02427646|16156208|P1|Overall Study|Physician Decision|1
4690461|NCT02427646|16156207|P2|Overall Study|Lack of Efficacy|3
4690462|NCT02427646|16156208|P1|Overall Study|Lack of Efficacy|2
4690463|NCT02427607|16156216|P1|Overall Study|Withdrawal by Subject|1
4690464|NCT02427477|16156222|P2|Period 1|Adverse Event|0
4690465|NCT02427477|16156223|P1|Period 1|Adverse Event|1
4690466|NCT02427399|16156236|P5|Overall Study|Protocol Violation|15
4690467|NCT02427399|16156237|P4|Overall Study|Protocol Violation|18
4690468|NCT02427399|16156238|P3|Overall Study|Protocol Violation|12
4690469|NCT02427399|16156239|P2|Overall Study|Protocol Violation|16
4690470|NCT02427399|16156240|P1|Overall Study|Protocol Violation|14
4690471|NCT02427100|16156264|P2|Overall Study|Lost to Follow-up|2
4690472|NCT02427100|16156265|P1|Overall Study|Lost to Follow-up|0
4690473|NCT02426918|16156276|P3|Overall Study|Other|9
4690474|NCT02426918|16156277|P2|Overall Study|Other|11
4690475|NCT02426918|16156278|P1|Overall Study|Other|9
4690476|NCT02426918|16156276|P3|Overall Study|Withdrawal by Subject|4
4690477|NCT02426918|16156277|P2|Overall Study|Withdrawal by Subject|5
4690478|NCT02426918|16156278|P1|Overall Study|Withdrawal by Subject|5
4690479|NCT02426918|16156276|P3|Overall Study|Physician Decision|1
4690480|NCT02426918|16156277|P2|Overall Study|Physician Decision|1
4690481|NCT02426918|16156278|P1|Overall Study|Physician Decision|1
4690482|NCT02426918|16156276|P3|Overall Study|Adverse Event|0
4690483|NCT02426918|16156277|P2|Overall Study|Adverse Event|2
4690484|NCT02426918|16156278|P1|Overall Study|Adverse Event|2
4690485|NCT02426658|16156313|P1|Overall Study|Patient expired before treatment|2
4690486|NCT02426658|16156313|P1|Overall Study|Withdrawal by Subject|1
4690487|NCT02426580|16156320|P2|Overall Study|Allergic to egg white|0
4690488|NCT02426580|16156321|P1|Overall Study|Allergic to egg white|1
4690489|NCT02426580|16156320|P2|Overall Study|Kidney transplant|0
4690490|NCT02426580|16156321|P1|Overall Study|Kidney transplant|3
4690491|NCT02426580|16156320|P2|Overall Study|transfer to hemodialysis|5
4690492|NCT02426580|16156321|P1|Overall Study|transfer to hemodialysis|5
4690493|NCT02426580|16156320|P2|Overall Study|Lost to Follow-up|9
4690494|NCT02426580|16156321|P1|Overall Study|Lost to Follow-up|0
4690495|NCT02426580|16156320|P2|Overall Study|Death|2
4690496|NCT02426580|16156321|P1|Overall Study|Death|2
4690497|NCT02255422|16156334|P7|Overall Study|Lost to Follow-up|0
4690498|NCT02255422|16156335|P6|Overall Study|Lost to Follow-up|0
4690499|NCT02255422|16156336|P5|Overall Study|Lost to Follow-up|0
4690500|NCT02255422|16156337|P4|Overall Study|Lost to Follow-up|0
4690501|NCT02255422|16156338|P3|Overall Study|Lost to Follow-up|1
4690502|NCT02255422|16156339|P2|Overall Study|Lost to Follow-up|0
4690503|NCT02255422|16156340|P1|Overall Study|Lost to Follow-up|0
4690504|NCT02255422|16156334|P7|Overall Study|Withdrawal by Subject|2
4690505|NCT02255422|16156335|P6|Overall Study|Withdrawal by Subject|0
4690506|NCT02255422|16156336|P5|Overall Study|Withdrawal by Subject|0
4690507|NCT02255422|16156337|P4|Overall Study|Withdrawal by Subject|0
4690508|NCT02255422|16156338|P3|Overall Study|Withdrawal by Subject|0
4690509|NCT02255422|16156339|P2|Overall Study|Withdrawal by Subject|0
4690510|NCT02255422|16156340|P1|Overall Study|Withdrawal by Subject|0
4690511|NCT02426541|16156365|P2|Overall Study|Protocol Violation|0
4690512|NCT02426541|16156366|P1|Overall Study|Protocol Violation|1
4690513|NCT02426138|16156378|P2|First Intervention (12 Weeks)|Withdrawal by Subject|1
4690514|NCT02426138|16156379|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
4690515|NCT02426125|16156419|P2|Overall Study|Withdrawal by Subject|16
4690516|NCT02426125|16156420|P1|Overall Study|Withdrawal by Subject|16
4690517|NCT02426125|16156419|P2|Overall Study|Protocol Violation|0
4690518|NCT02426125|16156420|P1|Overall Study|Protocol Violation|1
4690519|NCT02426125|16156419|P2|Overall Study|Lost to Follow-up|10
4690520|NCT02426125|16156420|P1|Overall Study|Lost to Follow-up|12
4690521|NCT02425826|16156451|P3|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1
4690522|NCT02425826|16156452|P2|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
4690523|NCT02425826|16156453|P1|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0
4690524|NCT02425826|16156451|P3|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1
4690525|NCT02425826|16156452|P2|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0
4690526|NCT02425826|16156453|P1|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8
4690527|NCT02425826|16156451|P3|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4
4690528|NCT02425826|16156452|P2|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0
4690529|NCT02425826|16156453|P1|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12
4690530|NCT02425826|16156451|P3|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6
4690531|NCT02425826|16156452|P2|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0
4690532|NCT02425826|16156453|P1|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8
4690533|NCT02425826|16156451|P3|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2
4690534|NCT02425826|16156452|P2|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0
4690535|NCT02425826|16156453|P1|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7
4690536|NCT02425826|16156451|P3|Placebo-controlled Phase (Week 0 - 16)|Other|0
4690537|NCT02425826|16156452|P2|Placebo-controlled Phase (Week 0 - 16)|Other|1
4690538|NCT02425826|16156453|P1|Placebo-controlled Phase (Week 0 - 16)|Other|3
4690539|NCT02425826|16156451|P3|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0
4690540|NCT02425826|16156452|P2|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4
4690541|NCT02425826|16156453|P1|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10
4690542|NCT02425826|16156451|P3|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0
4690543|NCT02425826|16156452|P2|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1
4690544|NCT02425826|16156453|P1|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9
4690545|NCT02425826|16156451|P3|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
4690546|NCT02425826|16156452|P2|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1
4690547|NCT02425826|16156453|P1|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0
4690548|NCT02425826|16156451|P3|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0
4690549|NCT02425826|16156452|P2|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2
4690550|NCT02425826|16156453|P1|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5
4690551|NCT02425111|16156507|P1|Part B: Treatment Extension Period|Lack of Efficacy|7
4690552|NCT02425111|16156507|P1|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3
4690553|NCT02425111|16156507|P1|Part A: Treatment Period|Lost to Follow-up|2
4690554|NCT02425111|16156507|P1|Part A: Treatment Period|Voluntary Withdrawal|4
4690555|NCT02425111|16156507|P1|Part A: Treatment Period|Lack of Efficacy|15
4690556|NCT02425111|16156507|P1|Part A: Treatment Period|Pretreatment Event/Adverse Event|2
4690557|NCT02425098|16156528|P2|Overall Study|Reason not Specified|1
4690558|NCT02425098|16156529|P1|Overall Study|Reason not Specified|0
4690559|NCT02425098|16156528|P2|Overall Study|Pregnancy|0
4690560|NCT02425098|16156529|P1|Overall Study|Pregnancy|2
4690561|NCT02425098|16156528|P2|Overall Study|Withdrawal by Subject|8
4690562|NCT02425098|16156529|P1|Overall Study|Withdrawal by Subject|4
4690563|NCT02425098|16156528|P2|Overall Study|Lost to Follow-up|7
4690564|NCT02425098|16156529|P1|Overall Study|Lost to Follow-up|7
4690565|NCT02424734|16156681|P3|Overall Study|Treatment stopped to be discharged home|0
4690566|NCT02424734|16156682|P2|Overall Study|Treatment stopped to be discharged home|2
4690567|NCT02424734|16156683|P1|Overall Study|Treatment stopped to be discharged home|2
4690568|NCT02424630|16156702|P2|Overall Study|Open procedure|1
4690569|NCT02424630|16156703|P1|Overall Study|Open procedure|0
4690570|NCT02424630|16156702|P2|Overall Study|No rotator cuff tear|2
4690571|NCT02424630|16156703|P1|Overall Study|No rotator cuff tear|1
4690572|NCT02424591|16156713|P2|Overall Study|Protocol Violation|3
4690573|NCT02424591|16156714|P1|Overall Study|Protocol Violation|2
4690574|NCT02424578|16156726|P2|Overall Study|Withdrawal by Subject|1
4690575|NCT02424578|16156727|P1|Overall Study|Withdrawal by Subject|0
4690576|NCT02424565|16156733|P2|Period 1 (D0)|Protocol Violation|1
4690577|NCT02424565|16156734|P1|Period 1 (D0)|Protocol Violation|0
4690578|NCT02424539|16156743|P3|Overall Study|Other: Reached stopping criteria|6
4690579|NCT02424539|16156744|P2|Overall Study|Other: Reached stopping criteria|7
4690580|NCT02424539|16156745|P1|Overall Study|Other: Reached stopping criteria|11
4690581|NCT02424539|16156743|P3|Overall Study|Withdrawal by Subject|0
4690582|NCT02424539|16156744|P2|Overall Study|Withdrawal by Subject|1
4690583|NCT02424539|16156745|P1|Overall Study|Withdrawal by Subject|3
4690584|NCT02424539|16156743|P3|Overall Study|Physician Decision|1
4690585|NCT02424539|16156744|P2|Overall Study|Physician Decision|0
4690586|NCT02424539|16156745|P1|Overall Study|Physician Decision|0
4690587|NCT02424539|16156743|P3|Overall Study|Adverse Event|1
4690588|NCT02424539|16156744|P2|Overall Study|Adverse Event|0
4690589|NCT02424539|16156745|P1|Overall Study|Adverse Event|0
4690590|NCT02424383|16156828|P1|Overall Study|Ineligible for Major Protocol Deviation|39
4690591|NCT02424383|16156828|P1|Overall Study|Other|7
4690592|NCT02424383|16156828|P1|Overall Study|Lost to Follow-up|81
4690593|NCT02424383|16156828|P1|Overall Study|Investigator's decision|44
4690594|NCT02424383|16156828|P1|Overall Study|Sponsor's decision|3
4690595|NCT02424383|16156828|P1|Overall Study|Death|170
4690596|NCT02424383|16156828|P1|Overall Study|Withdrawal by Subject|32
4690597|NCT02424344|16156852|P2|Overall Study|Adverse Event|8
4690598|NCT02424344|16156853|P1|Overall Study|Adverse Event|4
4690599|NCT02424344|16156852|P2|Overall Study|Lost to Follow-up|0
4690600|NCT02424344|16156853|P1|Overall Study|Lost to Follow-up|1
4690601|NCT02424344|16156852|P2|Overall Study|Withdrawal by Subject|1
4690602|NCT02424344|16156853|P1|Overall Study|Withdrawal by Subject|2
4690603|NCT02424344|16156852|P2|Overall Study|Lack of Efficacy|1
4690604|NCT02424344|16156853|P1|Overall Study|Lack of Efficacy|0
4690605|NCT02424149|16156871|P2|Overall Study|Withdrawal by Subject|1
4690606|NCT02424149|16156872|P1|Overall Study|Withdrawal by Subject|0
4690607|NCT02424149|16156871|P2|Overall Study|surgery cancelled|0
4690608|NCT02424149|16156872|P1|Overall Study|surgery cancelled|2
4690609|NCT02424097|16156888|P2|Overall Study|Lost to Follow-up|2
4690610|NCT02424097|16156889|P1|Overall Study|Lost to Follow-up|1
4690611|NCT02423798|16156944|P1|Overall Study|Withdrawal by Subject|3
4690612|NCT02423291|16157010|P1|Overall Study|Adverse Event|1
4690613|NCT02423291|16157010|P1|Overall Study|Lack of Efficacy|14
4690614|NCT02423109|16157040|P2|Lens 1|Adverse Event|0
4690615|NCT02423109|16157041|P1|Lens 1|Adverse Event|1
4690616|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0
4690617|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3
4690618|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0
4690619|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1
4690620|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6
4690621|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2
4690622|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
4690623|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2
4690624|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3
4690625|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5
4690626|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6
4690627|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10
4690628|NCT02422797|16157074|P2|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1
4690629|NCT02422797|16157075|P1|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0
4690630|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7
4690631|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2
4690632|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
4690633|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1
4690634|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Protocol Violation|3
4690635|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Protocol Violation|0
4690636|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
4690637|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1
4690638|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2
4690639|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1
4690640|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Physician Decision|1
4690641|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Physician Decision|0
4690642|NCT02422797|16157074|P2|Early Switch Phase (Up to Week 52)|Adverse Event|1
4690643|NCT02422797|16157075|P1|Early Switch Phase (Up to Week 52)|Adverse Event|11
4690644|NCT02422303|16157172|P2|Overall Study|Lost to Follow-up|1
4690645|NCT02422303|16157173|P1|Overall Study|Lost to Follow-up|1
4690646|NCT02422264|16157188|P2|Overall Study|Subject vaccinated outside of the study|1
4690647|NCT02422264|16157189|P1|Overall Study|Subject vaccinated outside of the study|0
4690648|NCT02422264|16157188|P2|Overall Study|Migrated/moved from study area|1
4690649|NCT02422264|16157189|P1|Overall Study|Migrated/moved from study area|3
4690650|NCT02422264|16157188|P2|Overall Study|Withdrawal by Subject|2
4690651|NCT02422264|16157189|P1|Overall Study|Withdrawal by Subject|1
4690652|NCT02422264|16157188|P2|Overall Study|Serious Adverse Event|0
4690653|NCT02422264|16157189|P1|Overall Study|Serious Adverse Event|1
4690654|NCT02422186|16157235|P2|Follow-up Phase (2 Weeks)|Other|0
4690655|NCT02422186|16157236|P1|Follow-up Phase (2 Weeks)|Other|3
4690656|NCT02422186|16157235|P2|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0
4690657|NCT02422186|16157236|P1|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1
4690658|NCT02422186|16157235|P2|Double-blind Induction Phase (4 Weeks)|Other|0
4690659|NCT02422186|16157236|P1|Double-blind Induction Phase (4 Weeks)|Other|1
4690660|NCT02422186|16157235|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
4690661|NCT02422186|16157236|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|4
4690662|NCT02422186|16157235|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
4690663|NCT02422186|16157236|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3
4690664|NCT02422186|16157235|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2
4690665|NCT02422186|16157236|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
4690666|NCT02422186|16157235|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
4690667|NCT02422186|16157236|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0
4690668|NCT02422186|16157235|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
4690669|NCT02422186|16157236|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
4690670|NCT02421952|16157258|P1|Overall Study|Surgery cancelled|1
4690671|NCT02421952|16157258|P1|Overall Study|Subject uncooperative for baseline test|2
4690672|NCT02421952|16157258|P1|Overall Study|Failed seriation task|13
4690673|NCT02421952|16157258|P1|Overall Study|Diary Not Returned|93
4690674|NCT02421939|16157267|P2|Overall Study|Protocol deviation|1
4690675|NCT02421939|16157268|P1|Overall Study|Protocol deviation|1
4690676|NCT02421939|16157267|P2|Overall Study|Miscellaneous|5
4690677|NCT02421939|16157268|P1|Overall Study|Miscellaneous|4
4690678|NCT02421939|16157267|P2|Overall Study|Completed 1 or 2 chemo cycles with CRs|19
4690679|NCT02421939|16157268|P1|Overall Study|Completed 1 or 2 chemo cycles with CRs|0
4690680|NCT02421939|16157267|P2|Overall Study|Physician Decision|11
4690681|NCT02421939|16157268|P1|Overall Study|Physician Decision|11
4690682|NCT02421939|16157267|P2|Overall Study|Withdrawal by Subject|24
4690683|NCT02421939|16157268|P1|Overall Study|Withdrawal by Subject|5
4690684|NCT02421939|16157267|P2|Overall Study|Adverse Event|5
4690685|NCT02421939|16157268|P1|Overall Study|Adverse Event|28
4690686|NCT02421939|16157267|P2|Overall Study|Disease relapse|2
4690687|NCT02421939|16157268|P1|Overall Study|Disease relapse|33
4690688|NCT02421939|16157267|P2|Overall Study|Death|10
4690689|NCT02421939|16157268|P1|Overall Study|Death|36
4690690|NCT02421939|16157267|P2|Overall Study|Lack of Efficacy|31
4690691|NCT02421939|16157268|P1|Overall Study|Lack of Efficacy|21
4690692|NCT02421939|16157267|P2|Overall Study|Progressive disease|16
4690693|NCT02421939|16157268|P1|Overall Study|Progressive disease|70
4690694|NCT02220855|16157294|P1|Overall Study|Withdrawal by Subject|1
4690695|NCT02220855|16157294|P1|Overall Study|Disease Progression|5
4690696|NCT02220855|16157294|P1|Overall Study|Adverse Event|8
4690697|NCT02421887|16157304|P2|Overall Study|Adverse Event|0
4690698|NCT02421887|16157305|P1|Overall Study|Adverse Event|2
4690699|NCT02421887|16157304|P2|Overall Study|Physician Decision|4
4690700|NCT02421887|16157305|P1|Overall Study|Physician Decision|2
4690701|NCT02421887|16157304|P2|Overall Study|Withdrawal by Subject|5
4690702|NCT02421887|16157305|P1|Overall Study|Withdrawal by Subject|8
4690703|NCT02421887|16157304|P2|Overall Study|Lost to Follow-up|0
4690704|NCT02421887|16157305|P1|Overall Study|Lost to Follow-up|5
4690705|NCT02421666|16157331|P2|12-month Follow-up|Withdrawal by Subject|11
4690706|NCT02421666|16157332|P1|12-month Follow-up|Withdrawal by Subject|6
4690707|NCT02421666|16157331|P2|12-month Follow-up|Lost to Follow-up|5
4690708|NCT02421666|16157332|P1|12-month Follow-up|Lost to Follow-up|5
4690709|NCT02421666|16157331|P2|6-month Follow-up|Withdrawal by Subject|6
4690710|NCT02421666|16157332|P1|6-month Follow-up|Withdrawal by Subject|5
4690711|NCT02421666|16157331|P2|6-month Follow-up|Lost to Follow-up|7
4690712|NCT02421666|16157332|P1|6-month Follow-up|Lost to Follow-up|8
4690713|NCT02421588|16157340|P2|Overall Study|Not treated|8
4690714|NCT02421588|16157341|P1|Overall Study|Not treated|2
4690715|NCT02421588|16157340|P2|Overall Study|Withdrawal by Subject|16
4690716|NCT02421588|16157341|P1|Overall Study|Withdrawal by Subject|14
4690717|NCT02421588|16157340|P2|Overall Study|Treatment-related AE|14
4690718|NCT02421588|16157341|P1|Overall Study|Treatment-related AE|10
4690719|NCT02421588|16157340|P2|Overall Study|Symptomatic deterioration|19
4690720|NCT02421588|16157341|P1|Overall Study|Symptomatic deterioration|13
4690721|NCT02421588|16157340|P2|Overall Study|Other reason not specified|1
4690722|NCT02421588|16157341|P1|Overall Study|Other reason not specified|3
4690723|NCT02421588|16157340|P2|Overall Study|Physician Decision|17
4690724|NCT02421588|16157341|P1|Overall Study|Physician Decision|8
4690725|NCT02421588|16157340|P2|Overall Study|Death|3
4690726|NCT02421588|16157341|P1|Overall Study|Death|11
4690727|NCT02421588|16157340|P2|Overall Study|Progressive disease|135
4690728|NCT02421588|16157341|P1|Overall Study|Progressive disease|152
4690729|NCT02421588|16157340|P2|Overall Study|Non-treatment-related AE|8
4690730|NCT02421588|16157341|P1|Overall Study|Non-treatment-related AE|8
4690731|NCT02421510|16157364|P3|Overall Study|Lost to Follow-up|0
4690732|NCT02421510|16157365|P2|Overall Study|Lost to Follow-up|1
4690733|NCT02421510|16157366|P1|Overall Study|Lost to Follow-up|1
4690734|NCT02421510|16157364|P3|Overall Study|Withdrawal by Subject|12
4690735|NCT02421510|16157365|P2|Overall Study|Withdrawal by Subject|18
4690736|NCT02421510|16157366|P1|Overall Study|Withdrawal by Subject|14
4690737|NCT02421510|16157364|P3|Overall Study|Pregnancy|0
4690738|NCT02421510|16157365|P2|Overall Study|Pregnancy|1
4690739|NCT02421510|16157366|P1|Overall Study|Pregnancy|1
4690740|NCT02421510|16157364|P3|Overall Study|Adverse Event|18
4690741|NCT02421510|16157365|P2|Overall Study|Adverse Event|10
4690742|NCT02421510|16157366|P1|Overall Study|Adverse Event|9
4690743|NCT02421510|16157364|P3|Overall Study|Physician Decision|3
4690744|NCT02421510|16157365|P2|Overall Study|Physician Decision|1
4690745|NCT02421510|16157366|P1|Overall Study|Physician Decision|1
4690746|NCT02421510|16157364|P3|Overall Study|Noncompliance with study drug|0
4690747|NCT02421510|16157365|P2|Overall Study|Noncompliance with study drug|0
4690748|NCT02421510|16157366|P1|Overall Study|Noncompliance with study drug|1
4690749|NCT02421510|16157364|P3|Overall Study|Death|0
4690750|NCT02421510|16157365|P2|Overall Study|Death|0
4690751|NCT02421510|16157366|P1|Overall Study|Death|1
4690752|NCT02421510|16157364|P3|Overall Study|Protocol Violation|0
4690753|NCT02421510|16157365|P2|Overall Study|Protocol Violation|2
4690754|NCT02421510|16157366|P1|Overall Study|Protocol Violation|1
4690755|NCT02421510|16157364|P3|Overall Study|Other|3
4690756|NCT02421510|16157365|P2|Overall Study|Other|2
4690757|NCT02421510|16157366|P1|Overall Study|Other|4
4690758|NCT02421419|16157398|P3|Overall Study|Physician Decision|1
4690759|NCT02421419|16157399|P2|Overall Study|Physician Decision|0
4690760|NCT02421419|16157400|P1|Overall Study|Physician Decision|0
4690761|NCT02421172|16157470|P5|Period 2|Patient/guardian decision|1
4690762|NCT02421172|16157471|P4|Period 2|Patient/guardian decision|2
4690763|NCT02421172|16157472|P3|Period 2|Patient/guardian decision|3
4690764|NCT02421172|16157473|P2|Period 2|Patient/guardian decision|0
4690765|NCT02421172|16157474|P1|Period 2|Patient/guardian decision|0
4690766|NCT02421172|16157470|P5|Period 2|Lost to Follow-up|0
4690767|NCT02421172|16157471|P4|Period 2|Lost to Follow-up|1
4690768|NCT02421172|16157472|P3|Period 2|Lost to Follow-up|0
4690769|NCT02421172|16157473|P2|Period 2|Lost to Follow-up|0
4690770|NCT02421172|16157474|P1|Period 2|Lost to Follow-up|0
4690771|NCT02421172|16157470|P5|Period 2|Adverse Event|0
4690772|NCT02421172|16157471|P4|Period 2|Adverse Event|0
4690773|NCT02421172|16157472|P3|Period 2|Adverse Event|4
4690774|NCT02421172|16157473|P2|Period 2|Adverse Event|0
4690775|NCT02421172|16157474|P1|Period 2|Adverse Event|0
4690776|NCT02421172|16157470|P5|Period 1|Patient/guardian decision|0
4690777|NCT02421172|16157471|P4|Period 1|Patient/guardian decision|0
4690778|NCT02421172|16157472|P3|Period 1|Patient/guardian decision|0
4690779|NCT02421172|16157473|P2|Period 1|Patient/guardian decision|1
4690780|NCT02421172|16157474|P1|Period 1|Patient/guardian decision|0
4690781|NCT02421172|16157470|P5|Period 1|Lost to Follow-up|0
4690782|NCT02421172|16157471|P4|Period 1|Lost to Follow-up|0
4690783|NCT02421172|16157472|P3|Period 1|Lost to Follow-up|0
4690784|NCT02421172|16157473|P2|Period 1|Lost to Follow-up|1
4690785|NCT02421172|16157474|P1|Period 1|Lost to Follow-up|3
4690786|NCT02421172|16157470|P5|Period 1|Adverse Event|0
4690787|NCT02421172|16157471|P4|Period 1|Adverse Event|0
4690788|NCT02421172|16157472|P3|Period 1|Adverse Event|0
4690789|NCT02421172|16157473|P2|Period 1|Adverse Event|0
4690790|NCT02421172|16157474|P1|Period 1|Adverse Event|1
4690791|NCT02421120|16157518|P1|Overall Study|Adverse Event|1
4690792|NCT02420821|16157573|P2|Overall Study|Death|116
4690793|NCT02420821|16157574|P1|Overall Study|Death|129
4690794|NCT02420821|16157573|P2|Overall Study|Withdrawal by Subject|17
4690795|NCT02420821|16157574|P1|Overall Study|Withdrawal by Subject|31
4690796|NCT02420821|16157573|P2|Overall Study|Physician Decision|2
4690797|NCT02420821|16157574|P1|Overall Study|Physician Decision|5
4690798|NCT02420821|16157573|P2|Overall Study|Non-compliance|2
4690799|NCT02420821|16157574|P1|Overall Study|Non-compliance|1
4690800|NCT02420821|16157573|P2|Overall Study|Lost to Follow-up|0
4690801|NCT02420821|16157574|P1|Overall Study|Lost to Follow-up|2
4690802|NCT02420379|16157644|P2|Overall Study|Transitioned to commercial drug|0
4690803|NCT02420379|16157645|P1|Overall Study|Transitioned to commercial drug|1
4690804|NCT02420379|16157644|P2|Overall Study|Unable to complete due to schooling|1
4690805|NCT02420379|16157645|P1|Overall Study|Unable to complete due to schooling|0
4690806|NCT02420379|16157644|P2|Overall Study|Withdrawal by Subject|3
4690807|NCT02420379|16157645|P1|Overall Study|Withdrawal by Subject|0
4690808|NCT02420353|16157663|P2|Overall Study|Withdrawal by Subject|1
4690809|NCT02420353|16157664|P1|Overall Study|Withdrawal by Subject|0
4690810|NCT02420327|16157756|P1|Overall Study|Protocol Violation|1
4690811|NCT02420327|16157756|P1|Overall Study|Lost to Follow-up|1
4690812|NCT02420327|16157756|P1|Overall Study|Withdrawal by Subject|6
4690813|NCT02420327|16157756|P1|Overall Study|Pregnancy|1
4690814|NCT02420327|16157756|P1|Overall Study|Adverse Event|7
4690815|NCT02420262|16157792|P2|Overall Study|Unclassified|1
4690816|NCT02420262|16157793|P1|Overall Study|Unclassified|0
4690817|NCT02420262|16157792|P2|Overall Study|Withdrawal by Subject|4
4690818|NCT02420262|16157793|P1|Overall Study|Withdrawal by Subject|1
4690819|NCT02420262|16157792|P2|Overall Study|Adverse Event|0
4690820|NCT02420262|16157793|P1|Overall Study|Adverse Event|1
4690821|NCT02420093|16157819|P2|Overall Study|Withdrawal by Subject|1
4690822|NCT02420093|16157820|P1|Overall Study|Withdrawal by Subject|1
4690823|NCT02419937|16157882|P2|Overall Study|Lost to Follow-up|0
4690824|NCT02419937|16157883|P1|Overall Study|Lost to Follow-up|1
4690825|NCT02419807|16157896|P1|Overall Study|Protocol Violation|5
4690826|NCT02419807|16157896|P1|Overall Study|Physician Decision|1
4690827|NCT02419807|16157896|P1|Overall Study|Withdrawal by Subject|4
4690828|NCT02419755|16157902|P2|Overall Study|Withdrawal by Subject|0
4690829|NCT02419755|16157903|P1|Overall Study|Withdrawal by Subject|1
4690830|NCT02419755|16157902|P2|Overall Study|Ineligible|0
4690831|NCT02419755|16157903|P1|Overall Study|Ineligible|1
4690832|NCT02419755|16157902|P2|Overall Study|Relapse|1
4690833|NCT02419755|16157903|P1|Overall Study|Relapse|0
4690834|NCT02419755|16157902|P2|Overall Study|Death|3
4690835|NCT02419755|16157903|P1|Overall Study|Death|1
4690836|NCT02419612|16157929|P2|Long-term Treatment Period|Withdrawal by Subject|2
4690837|NCT02419612|16157930|P1|Long-term Treatment Period|Withdrawal by Subject|8
4690838|NCT02419612|16157929|P2|Long-term Treatment Period|Subject Decision|4
4690839|NCT02419612|16157930|P1|Long-term Treatment Period|Subject Decision|2
4690840|NCT02419612|16157929|P2|Long-term Treatment Period|Other|4
4690841|NCT02419612|16157930|P1|Long-term Treatment Period|Other|4
4690842|NCT02419612|16157929|P2|Long-term Treatment Period|Adverse Event|5
4690843|NCT02419612|16157930|P1|Long-term Treatment Period|Adverse Event|0
4690844|NCT02419612|16157929|P2|Long-term Treatment Period|Death|1
4690845|NCT02419612|16157930|P1|Long-term Treatment Period|Death|0
4690846|NCT02419612|16157929|P2|Long-term Treatment Period|Lack of Efficacy|1
4690847|NCT02419612|16157930|P1|Long-term Treatment Period|Lack of Efficacy|1
4690848|NCT02419612|16157929|P2|Long-term Treatment Period|Lost to Follow-up|4
4690849|NCT02419612|16157930|P1|Long-term Treatment Period|Lost to Follow-up|6
4690850|NCT02419612|16157929|P2|Long-term Treatment Period|Non-compliance with Study Drug|1
4690851|NCT02419612|16157930|P1|Long-term Treatment Period|Non-compliance with Study Drug|1
4690852|NCT02419612|16157929|P2|Short-term Treatment Period|Subject moved out of state|1
4690853|NCT02419612|16157930|P1|Short-term Treatment Period|Subject moved out of state|0
4690854|NCT02419612|16157929|P2|Short-term Treatment Period|Worsening of liver function|1
4690855|NCT02419612|16157930|P1|Short-term Treatment Period|Worsening of liver function|0
4690856|NCT02419612|16157929|P2|Short-term Treatment Period|Non-compliance with Study Drug|2
4690857|NCT02419612|16157930|P1|Short-term Treatment Period|Non-compliance with Study Drug|0
4690858|NCT02419612|16157929|P2|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
4690859|NCT02419612|16157930|P1|Short-term Treatment Period|Subject Request To Discontinue Treatment|1
4690860|NCT02419612|16157929|P2|Short-term Treatment Period|Withdrawal by Subject|9
4690861|NCT02419612|16157930|P1|Short-term Treatment Period|Withdrawal by Subject|9
4690862|NCT02419612|16157929|P2|Short-term Treatment Period|Lost to Follow-up|6
4690863|NCT02419612|16157930|P1|Short-term Treatment Period|Lost to Follow-up|6
4690864|NCT02419612|16157929|P2|Short-term Treatment Period|Death|2
4690865|NCT02419612|16157930|P1|Short-term Treatment Period|Death|0
4690866|NCT02419612|16157929|P2|Short-term Treatment Period|Adverse Event|1
4690867|NCT02419612|16157930|P1|Short-term Treatment Period|Adverse Event|1
4690868|NCT02419573|16157952|P2|Overall Study|Withdrawal by Subject|0
4690869|NCT02419573|16157953|P1|Overall Study|Withdrawal by Subject|1
4690870|NCT02419573|16157952|P2|Overall Study|Lost to Follow-up|0
4690871|NCT02419573|16157953|P1|Overall Study|Lost to Follow-up|3
4690872|NCT02419508|16157983|P2|Overall Study|Other - Reason not specified|1
4690873|NCT02419508|16157984|P1|Overall Study|Other - Reason not specified|0
4690874|NCT02419508|16157983|P2|Overall Study|Withdrawal by Subject|0
4690875|NCT02419508|16157984|P1|Overall Study|Withdrawal by Subject|1
4690876|NCT02419508|16157983|P2|Overall Study|Adverse Event|3
4690877|NCT02419508|16157984|P1|Overall Study|Adverse Event|9
4690878|NCT02419469|16158002|P1|Overall Study|Withdrawal by Subject|1
4690879|NCT02419313|16158006|P2|Second Intervention|Lost to Follow-up|0
4690880|NCT02419313|16158007|P1|Second Intervention|Lost to Follow-up|1
4690881|NCT02419313|16158006|P2|First Intervention|Lost to Follow-up|0
4690882|NCT02419313|16158007|P1|First Intervention|Lost to Follow-up|2
4690883|NCT02419001|16158019|P2|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0
4690884|NCT02419001|16158020|P1|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1
4690885|NCT02418910|16158030|P1|Overall Study|Withdrawal by Subject|4
4690886|NCT02418910|16158030|P1|Overall Study|Lost to Follow-up|3
4690887|NCT02418819|16158038|P4|Overall Study|No longer willing to participate|1
4690888|NCT02418819|16158039|P3|Overall Study|No longer willing to participate|2
4690889|NCT02418819|16158040|P2|Overall Study|No longer willing to participate|0
4690890|NCT02418819|16158041|P1|Overall Study|No longer willing to participate|0
4690891|NCT02418819|16158038|P4|Overall Study|No longer meets eligibility criteria|0
4690892|NCT02418819|16158039|P3|Overall Study|No longer meets eligibility criteria|1
4690893|NCT02418819|16158040|P2|Overall Study|No longer meets eligibility criteria|0
4690894|NCT02418819|16158041|P1|Overall Study|No longer meets eligibility criteria|0
4690895|NCT02418819|16158038|P4|Overall Study|Lost to Follow-up|0
4690896|NCT02418819|16158039|P3|Overall Study|Lost to Follow-up|0
4690897|NCT02418819|16158040|P2|Overall Study|Lost to Follow-up|0
4690898|NCT02418819|16158041|P1|Overall Study|Lost to Follow-up|1
4690899|NCT02418819|16158038|P4|Overall Study|Adverse Event|0
4690900|NCT02418819|16158039|P3|Overall Study|Adverse Event|1
4690901|NCT02418819|16158040|P2|Overall Study|Adverse Event|0
4690902|NCT02418819|16158041|P1|Overall Study|Adverse Event|0
4690903|NCT02418754|16158084|P5|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
4690904|NCT02418754|16158085|P4|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
4690905|NCT02418754|16158086|P3|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
4690906|NCT02418754|16158087|P2|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1
4690907|NCT02418754|16158088|P1|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0
4690908|NCT02418754|16158084|P5|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
4690909|NCT02418754|16158085|P4|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
4690910|NCT02418754|16158086|P3|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1
4690911|NCT02418754|16158087|P2|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2
4690912|NCT02418754|16158088|P1|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0
4690913|NCT02418754|16158084|P5|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0
4690914|NCT02418754|16158085|P4|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1
4690915|NCT02418754|16158086|P3|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
4690916|NCT02418754|16158087|P2|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4
4690917|NCT02418754|16158088|P1|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3
4690918|NCT02418754|16158084|P5|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24
4690919|NCT02418754|16158085|P4|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21
4690920|NCT02418754|16158086|P3|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
4690921|NCT02418754|16158087|P2|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28
4690922|NCT02418754|16158088|P1|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26
4690923|NCT02418754|16158084|P5|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4690924|NCT02418754|16158085|P4|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4690925|NCT02418754|16158086|P3|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4690926|NCT02418754|16158087|P2|Period 2 (Day 1 to Week 52/End of Study)|Death|0
4690927|NCT02418754|16158088|P1|Period 2 (Day 1 to Week 52/End of Study)|Death|1
4690928|NCT02418754|16158084|P5|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
4690929|NCT02418754|16158085|P4|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2
4690930|NCT02418754|16158086|P3|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6
4690931|NCT02418754|16158087|P2|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7
4690932|NCT02418754|16158088|P1|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3
4690933|NCT02418754|16158084|P5|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4690934|NCT02418754|16158085|P4|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4690935|NCT02418754|16158086|P3|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1
4690936|NCT02418754|16158087|P2|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4690937|NCT02418754|16158088|P1|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0
4690938|NCT02418754|16158084|P5|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
4690939|NCT02418754|16158085|P4|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
4690940|NCT02418754|16158086|P3|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1
4690941|NCT02418754|16158087|P2|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2
4690942|NCT02418754|16158088|P1|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0
4690943|NCT02418754|16158084|P5|Period 1 (Day 1 to Week 12)|Physician Decision|0
4690944|NCT02418754|16158085|P4|Period 1 (Day 1 to Week 12)|Physician Decision|0
4690945|NCT02418754|16158086|P3|Period 1 (Day 1 to Week 12)|Physician Decision|0
4690946|NCT02418754|16158087|P2|Period 1 (Day 1 to Week 12)|Physician Decision|0
4690947|NCT02418754|16158088|P1|Period 1 (Day 1 to Week 12)|Physician Decision|1
4690948|NCT02418754|16158084|P5|Period 1 (Day 1 to Week 12)|Death|0
4690949|NCT02418754|16158085|P4|Period 1 (Day 1 to Week 12)|Death|0
4690950|NCT02418754|16158086|P3|Period 1 (Day 1 to Week 12)|Death|0
4690951|NCT02418754|16158087|P2|Period 1 (Day 1 to Week 12)|Death|0
4690952|NCT02418754|16158088|P1|Period 1 (Day 1 to Week 12)|Death|1
4690953|NCT02418754|16158084|P5|Period 1 (Day 1 to Week 12)|Adverse Event|0
4690954|NCT02418754|16158085|P4|Period 1 (Day 1 to Week 12)|Adverse Event|0
4690955|NCT02418754|16158086|P3|Period 1 (Day 1 to Week 12)|Adverse Event|0
4690956|NCT02418754|16158087|P2|Period 1 (Day 1 to Week 12)|Adverse Event|2
4690957|NCT02418754|16158088|P1|Period 1 (Day 1 to Week 12)|Adverse Event|0
4690958|NCT02418585|16158137|P2|Follow-up Phase (24 Weeks)|Other|2
4690959|NCT02418585|16158138|P1|Follow-up Phase (24 Weeks)|Other|3
4690960|NCT02418585|16158137|P2|Follow-up Phase (24 Weeks)|Investigator Decision|17
4690961|NCT02418585|16158138|P1|Follow-up Phase (24 Weeks)|Investigator Decision|6
4690962|NCT02418585|16158137|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
4690963|NCT02418585|16158138|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6
4690964|NCT02418585|16158137|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
4690965|NCT02418585|16158138|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|3
4690966|NCT02418585|16158137|P2|Double Blind (DB) Phase (4 Weeks)|Other|1
4690967|NCT02418585|16158138|P1|Double Blind (DB) Phase (4 Weeks)|Other|0
4690968|NCT02418585|16158137|P2|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1
4690969|NCT02418585|16158138|P1|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9
4690970|NCT02418585|16158137|P2|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0
4690971|NCT02418585|16158138|P1|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2
4690972|NCT02418585|16158137|P2|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7
4690973|NCT02418585|16158138|P1|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4
4690974|NCT02418585|16158137|P2|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
4690975|NCT02418585|16158138|P1|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2
4690976|NCT02418585|16158137|P2|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
4690977|NCT02418585|16158138|P1|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1
4690978|NCT02418468|16158217|P2|Overall Study|Withdrawal of informed consent|1
4690979|NCT02418468|16158218|P1|Overall Study|Withdrawal of informed consent|1
4690980|NCT02418468|16158217|P2|Overall Study|Adverse Event|0
4690981|NCT02418468|16158218|P1|Overall Study|Adverse Event|1
4690982|NCT02418455|16158224|P1|Continuation Period|Sponsor Decision|7
4690983|NCT02418455|16158224|P1|48-Week Treatment Period|Other- Not Specified|1
4690984|NCT02418182|16158267|P2|Overall Study|Lost to Follow-up|2
4690985|NCT02418182|16158268|P1|Overall Study|Lost to Follow-up|0
4690986|NCT02418182|16158267|P2|Overall Study|Unable to re-consent|15
4690987|NCT02418182|16158268|P1|Overall Study|Unable to re-consent|18
4690988|NCT02418156|16158280|P1|Overall Study|Subject refused to return|1
4690989|NCT02418156|16158280|P1|Overall Study|Withdrawal by Subject|1
4690990|NCT02418156|16158280|P1|Overall Study|Physician Decision|1
4690991|NCT02418156|16158280|P1|Overall Study|Death|2
4690992|NCT02418156|16158280|P1|Overall Study|Lost to Follow-up|12
4690993|NCT02418000|16158322|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3
4690994|NCT02418000|16158323|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4690995|NCT02418000|16158324|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4690996|NCT02418000|16158325|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4690997|NCT02418000|16158326|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0
4690998|NCT02418000|16158322|P5|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1
4690999|NCT02418000|16158323|P4|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4691000|NCT02418000|16158324|P3|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4691001|NCT02418000|16158325|P2|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4691002|NCT02418000|16158326|P1|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0
4691003|NCT02418000|16158322|P5|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691004|NCT02418000|16158323|P4|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3
4691005|NCT02418000|16158324|P3|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691006|NCT02418000|16158325|P2|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691007|NCT02418000|16158326|P1|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691008|NCT02418000|16158322|P5|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691009|NCT02418000|16158323|P4|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691010|NCT02418000|16158324|P3|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3
4691011|NCT02418000|16158325|P2|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691012|NCT02418000|16158326|P1|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0
4691013|NCT02418000|16158322|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4691014|NCT02418000|16158323|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4691015|NCT02418000|16158324|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4691016|NCT02418000|16158325|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9
4691017|NCT02418000|16158326|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0
4691018|NCT02418000|16158322|P5|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4691019|NCT02418000|16158323|P4|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4691020|NCT02418000|16158324|P3|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4691021|NCT02418000|16158325|P2|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1
4691022|NCT02418000|16158326|P1|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0
4691023|NCT02418000|16158322|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4691024|NCT02418000|16158323|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4691025|NCT02418000|16158324|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4691026|NCT02418000|16158325|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0
4691027|NCT02418000|16158326|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1
4691028|NCT02418000|16158322|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4691029|NCT02418000|16158323|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4691030|NCT02418000|16158324|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4691031|NCT02418000|16158325|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0
4691032|NCT02418000|16158326|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4
4691033|NCT02418000|16158322|P5|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4691034|NCT02418000|16158323|P4|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4691035|NCT02418000|16158324|P3|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4691036|NCT02418000|16158325|P2|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0
4691037|NCT02418000|16158326|P1|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2
4691038|NCT02417961|16158444|P1|Overall Study|Withdrawal by Subject|2
4691039|NCT02417961|16158444|P1|Overall Study|Lost to Follow-up|1
4691040|NCT02417961|16158444|P1|Overall Study|Adverse Event|1
4691041|NCT02417935|16158456|P2|Treatment Period|Physician Decision|1
4691042|NCT02417935|16158457|P1|Treatment Period|Physician Decision|3
4691043|NCT02417935|16158456|P2|Treatment Period|Withdrawal by Subject|3
4691044|NCT02417935|16158457|P1|Treatment Period|Withdrawal by Subject|3
4691045|NCT02417935|16158456|P2|Treatment Period|Protocol Violation|1
4691046|NCT02417935|16158457|P1|Treatment Period|Protocol Violation|2
4691047|NCT02417935|16158456|P2|Treatment Period|Entry Criteria not met|1
4691048|NCT02417935|16158457|P1|Treatment Period|Entry Criteria not met|0
4691049|NCT02417935|16158456|P2|Treatment Period|Lost to Follow-up|0
4691050|NCT02417935|16158457|P1|Treatment Period|Lost to Follow-up|1
4691051|NCT02417935|16158456|P2|Treatment Period|Adverse Event|10
4691052|NCT02417935|16158457|P1|Treatment Period|Adverse Event|12
4691053|NCT02417753|16158515|P1|Overall Study|Death|1
4691054|NCT02417441|16158535|P2|Overall Study|Inconclusive due to missing data|19
4691055|NCT02417441|16158536|P1|Overall Study|Inconclusive due to missing data|52
4691056|NCT02417246|16158604|P2|Phase 2 1st Generic Administered|Physician Decision|0
4691057|NCT02417246|16158605|P1|Phase 2 1st Generic Administered|Physician Decision|1
4691058|NCT02417246|16158604|P2|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3
4691059|NCT02417246|16158605|P1|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2
4691060|NCT02417246|16158604|P2|Phase 1 Brand Name Metoprolol ER|Physician Decision|0
4691061|NCT02417246|16158605|P1|Phase 1 Brand Name Metoprolol ER|Physician Decision|1
4691062|NCT02417246|16158604|P2|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
4691063|NCT02417246|16158605|P1|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1
4691064|NCT02417233|16158628|P3|Overall Study|Mentally unstable|0
4691065|NCT02417233|16158629|P2|Overall Study|Mentally unstable|1
4691066|NCT02417233|16158630|P1|Overall Study|Mentally unstable|0
4691067|NCT02417233|16158628|P3|Overall Study|Relocation out of study area|1
4691068|NCT02417233|16158629|P2|Overall Study|Relocation out of study area|0
4691069|NCT02417233|16158630|P1|Overall Study|Relocation out of study area|1
4691070|NCT02417233|16158628|P3|Overall Study|Withdrawal by Subject|8
4691071|NCT02417233|16158629|P2|Overall Study|Withdrawal by Subject|1
4691072|NCT02417233|16158630|P1|Overall Study|Withdrawal by Subject|2
4691073|NCT02417233|16158628|P3|Overall Study|Protocol Violation|2
4691074|NCT02417233|16158629|P2|Overall Study|Protocol Violation|0
4691075|NCT02417233|16158630|P1|Overall Study|Protocol Violation|2
4691076|NCT02417233|16158628|P3|Overall Study|Lost to Follow-up|34
4691077|NCT02417233|16158629|P2|Overall Study|Lost to Follow-up|39
4691078|NCT02417233|16158630|P1|Overall Study|Lost to Follow-up|27
4691079|NCT02417233|16158628|P3|Overall Study|Death|14
4691080|NCT02417233|16158629|P2|Overall Study|Death|10
4691081|NCT02417233|16158630|P1|Overall Study|Death|4
4691082|NCT02417064|16158667|P3|Follow-up Phase (24 Weeks)|Other|3
4691083|NCT02417064|16158668|P2|Follow-up Phase (24 Weeks)|Other|2
4691084|NCT02417064|16158669|P1|Follow-up Phase (24 Weeks)|Other|2
4691085|NCT02417064|16158667|P3|Follow-up Phase (24 Weeks)|PI Decision|44
4691086|NCT02417064|16158668|P2|Follow-up Phase (24 Weeks)|PI Decision|29
4691087|NCT02417064|16158669|P1|Follow-up Phase (24 Weeks)|PI Decision|34
4691088|NCT02417064|16158667|P3|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2
4691089|NCT02417064|16158668|P2|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9
4691090|NCT02417064|16158669|P1|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3
4691091|NCT02417064|16158667|P3|Follow-up Phase (24 Weeks)|Protocol Violation|1
4691092|NCT02417064|16158668|P2|Follow-up Phase (24 Weeks)|Protocol Violation|0
4691093|NCT02417064|16158669|P1|Follow-up Phase (24 Weeks)|Protocol Violation|0
4691094|NCT02417064|16158667|P3|Follow-up Phase (24 Weeks)|Lost to Follow-up|1
4691095|NCT02417064|16158668|P2|Follow-up Phase (24 Weeks)|Lost to Follow-up|2
4691096|NCT02417064|16158669|P1|Follow-up Phase (24 Weeks)|Lost to Follow-up|0
4691097|NCT02417064|16158667|P3|Double-blind Induction Phase (4 Weeks)|Other|2
4691098|NCT02417064|16158668|P2|Double-blind Induction Phase (4 Weeks)|Other|4
4691099|NCT02417064|16158669|P1|Double-blind Induction Phase (4 Weeks)|Other|1
4691100|NCT02417064|16158667|P3|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
4691101|NCT02417064|16158668|P2|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5
4691102|NCT02417064|16158669|P1|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1
4691103|NCT02417064|16158667|P3|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
4691104|NCT02417064|16158668|P2|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1
4691105|NCT02417064|16158669|P1|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2
4691106|NCT02417064|16158667|P3|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
4691107|NCT02417064|16158668|P2|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1
4691108|NCT02417064|16158669|P1|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0
4691109|NCT02417064|16158667|P3|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0
4691110|NCT02417064|16158668|P2|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
4691111|NCT02417064|16158669|P1|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1
4691112|NCT02417064|16158667|P3|Double-blind Induction Phase (4 Weeks)|Adverse Event|2
4691113|NCT02417064|16158668|P2|Double-blind Induction Phase (4 Weeks)|Adverse Event|7
4691114|NCT02417064|16158669|P1|Double-blind Induction Phase (4 Weeks)|Adverse Event|1
4691115|NCT02416934|16158740|P2|Overall Study|re-operation|0
4691116|NCT02416934|16158741|P1|Overall Study|re-operation|1
4691117|NCT02416934|16158740|P2|Overall Study|surgery started late|1
4691118|NCT02416934|16158741|P1|Overall Study|surgery started late|0
4691119|NCT02416934|16158740|P2|Overall Study|Protocol Violation|1
4691120|NCT02416934|16158741|P1|Overall Study|Protocol Violation|0
4691121|NCT02416934|16158740|P2|Overall Study|recruited during continuing renewal proc|1
4691122|NCT02416934|16158741|P1|Overall Study|recruited during continuing renewal proc|0
4691123|NCT02416934|16158740|P2|Overall Study|Withdrawal by Subject|0
4691124|NCT02416934|16158741|P1|Overall Study|Withdrawal by Subject|1
4691125|NCT02416934|16158740|P2|Overall Study|Lost to Follow-up|2
4691126|NCT02416934|16158741|P1|Overall Study|Lost to Follow-up|0
4691127|NCT02416934|16158740|P2|Overall Study|given steroids|2
4691128|NCT02416934|16158741|P1|Overall Study|given steroids|1
4691129|NCT02416908|16158756|P4|Dose Escalation Phase|Withdrawal by Subject|0
4691130|NCT02416908|16158757|P3|Dose Escalation Phase|Withdrawal by Subject|1
4691131|NCT02416908|16158758|P2|Dose Escalation Phase|Withdrawal by Subject|0
4691132|NCT02416908|16158759|P1|Dose Escalation Phase|Withdrawal by Subject|0
4691133|NCT02416908|16158756|P4|Dose Escalation Phase|Adverse Event|0
4691134|NCT02416908|16158757|P3|Dose Escalation Phase|Adverse Event|3
4691135|NCT02416908|16158758|P2|Dose Escalation Phase|Adverse Event|0
4691136|NCT02416908|16158759|P1|Dose Escalation Phase|Adverse Event|0
4691137|NCT02416791|16158777|P3|6 Months|Lost to Follow-up|1
4691138|NCT02416791|16158778|P2|6 Months|Lost to Follow-up|0
4691139|NCT02416791|16158779|P1|6 Months|Lost to Follow-up|0
4691140|NCT02416180|16158877|P1|Overall Study|Withdrawal by Subject|1
4691141|NCT02415959|16158938|P5|Overall Study|Protocol Violation|0
4691142|NCT02415959|16158939|P4|Overall Study|Protocol Violation|1
4691143|NCT02415959|16158940|P3|Overall Study|Protocol Violation|0
4691144|NCT02415959|16158941|P2|Overall Study|Protocol Violation|0
4691145|NCT02415959|16158942|P1|Overall Study|Protocol Violation|0
4691146|NCT02415959|16158938|P5|Overall Study|Adverse Event|0
4691147|NCT02415959|16158939|P4|Overall Study|Adverse Event|0
4691148|NCT02415959|16158940|P3|Overall Study|Adverse Event|0
4691149|NCT02415959|16158941|P2|Overall Study|Adverse Event|1
4691150|NCT02415959|16158942|P1|Overall Study|Adverse Event|0
4691151|NCT02415595|16159388|P4|Overall Study|Other|0
4691152|NCT02415595|16159389|P3|Overall Study|Other|1
4691153|NCT02415595|16159390|P2|Overall Study|Other|1
4691154|NCT02415595|16159391|P1|Overall Study|Other|0
4691155|NCT02415595|16159388|P4|Overall Study|Withdrawal by Subject|3
4691156|NCT02415595|16159389|P3|Overall Study|Withdrawal by Subject|1
4691157|NCT02415595|16159390|P2|Overall Study|Withdrawal by Subject|0
4691158|NCT02415595|16159391|P1|Overall Study|Withdrawal by Subject|4
4691159|NCT02415595|16159388|P4|Overall Study|Reached stopping criteria|0
4691160|NCT02415595|16159389|P3|Overall Study|Reached stopping criteria|1
4691161|NCT02415595|16159390|P2|Overall Study|Reached stopping criteria|1
4691162|NCT02415595|16159391|P1|Overall Study|Reached stopping criteria|0
4691163|NCT02415595|16159388|P4|Overall Study|Poor/Non-compliance|0
4691164|NCT02415595|16159389|P3|Overall Study|Poor/Non-compliance|1
4691165|NCT02415595|16159390|P2|Overall Study|Poor/Non-compliance|0
4691166|NCT02415595|16159391|P1|Overall Study|Poor/Non-compliance|1
4691167|NCT02415595|16159388|P4|Overall Study|Lost to Follow-up|1
4691168|NCT02415595|16159389|P3|Overall Study|Lost to Follow-up|1
4691169|NCT02415595|16159390|P2|Overall Study|Lost to Follow-up|3
4691170|NCT02415595|16159391|P1|Overall Study|Lost to Follow-up|1
4691171|NCT02415595|16159388|P4|Overall Study|Lack of Efficacy|0
4691172|NCT02415595|16159389|P3|Overall Study|Lack of Efficacy|0
4691173|NCT02415595|16159390|P2|Overall Study|Lack of Efficacy|4
4691174|NCT02415595|16159391|P1|Overall Study|Lack of Efficacy|4
4691175|NCT02415595|16159388|P4|Overall Study|Adverse Event|10
4691176|NCT02415595|16159389|P3|Overall Study|Adverse Event|5
4691177|NCT02415595|16159390|P2|Overall Study|Adverse Event|3
4691178|NCT02415595|16159391|P1|Overall Study|Adverse Event|1
4691179|NCT02415595|16159388|P4|Overall Study|Administrative reason by sponsor|39
4691180|NCT02415595|16159389|P3|Overall Study|Administrative reason by sponsor|41
4691181|NCT02415595|16159390|P2|Overall Study|Administrative reason by sponsor|40
4691182|NCT02415595|16159391|P1|Overall Study|Administrative reason by sponsor|39
4691183|NCT02415400|16159533|P4|Overall Study|Site closure; participant won't transfer|1
4691184|NCT02415400|16159534|P3|Overall Study|Site closure; participant won't transfer|0
4691185|NCT02415400|16159535|P2|Overall Study|Site closure; participant won't transfer|0
4691186|NCT02415400|16159536|P1|Overall Study|Site closure; participant won't transfer|0
4691187|NCT02415400|16159533|P4|Overall Study|Investigator decision|1
4691188|NCT02415400|16159534|P3|Overall Study|Investigator decision|1
4691189|NCT02415400|16159535|P2|Overall Study|Investigator decision|0
4691190|NCT02415400|16159536|P1|Overall Study|Investigator decision|0
4691191|NCT02415400|16159533|P4|Overall Study|Participant in jail|0
4691192|NCT02415400|16159534|P3|Overall Study|Participant in jail|1
4691193|NCT02415400|16159535|P2|Overall Study|Participant in jail|0
4691194|NCT02415400|16159536|P1|Overall Study|Participant in jail|0
4691195|NCT02415400|16159533|P4|Overall Study|Poor treatment monitoring|0
4691196|NCT02415400|16159534|P3|Overall Study|Poor treatment monitoring|1
4691197|NCT02415400|16159535|P2|Overall Study|Poor treatment monitoring|0
4691198|NCT02415400|16159536|P1|Overall Study|Poor treatment monitoring|0
4691199|NCT02415400|16159533|P4|Overall Study|State regulations prevent participation|0
4691200|NCT02415400|16159534|P3|Overall Study|State regulations prevent participation|1
4691201|NCT02415400|16159535|P2|Overall Study|State regulations prevent participation|0
4691202|NCT02415400|16159536|P1|Overall Study|State regulations prevent participation|0
4691203|NCT02415400|16159533|P4|Overall Study|Coagulation values cannot be set|0
4691204|NCT02415400|16159534|P3|Overall Study|Coagulation values cannot be set|1
4691205|NCT02415400|16159535|P2|Overall Study|Coagulation values cannot be set|0
4691206|NCT02415400|16159536|P1|Overall Study|Coagulation values cannot be set|0
4691207|NCT02415400|16159533|P4|Overall Study|Stroke and stroke rehabilitation|0
4691208|NCT02415400|16159534|P3|Overall Study|Stroke and stroke rehabilitation|1
4691209|NCT02415400|16159535|P2|Overall Study|Stroke and stroke rehabilitation|0
4691210|NCT02415400|16159536|P1|Overall Study|Stroke and stroke rehabilitation|0
4691211|NCT02415400|16159533|P4|Overall Study|No study drug on site|0
4691212|NCT02415400|16159534|P3|Overall Study|No study drug on site|0
4691213|NCT02415400|16159535|P2|Overall Study|No study drug on site|1
4691214|NCT02415400|16159536|P1|Overall Study|No study drug on site|0
4691215|NCT02415400|16159533|P4|Overall Study|Randomized in error|0
4691216|NCT02415400|16159534|P3|Overall Study|Randomized in error|0
4691217|NCT02415400|16159535|P2|Overall Study|Randomized in error|0
4691218|NCT02415400|16159536|P1|Overall Study|Randomized in error|2
4691219|NCT02415400|16159533|P4|Overall Study|Participant wanted home visits|0
4691220|NCT02415400|16159534|P3|Overall Study|Participant wanted home visits|0
4691221|NCT02415400|16159535|P2|Overall Study|Participant wanted home visits|0
4691222|NCT02415400|16159536|P1|Overall Study|Participant wanted home visits|1
4691223|NCT02415400|16159533|P4|Overall Study|Participant doesn't answer phone|0
4691224|NCT02415400|16159534|P3|Overall Study|Participant doesn't answer phone|0
4691225|NCT02415400|16159535|P2|Overall Study|Participant doesn't answer phone|0
4691226|NCT02415400|16159536|P1|Overall Study|Participant doesn't answer phone|1
4691227|NCT02415400|16159533|P4|Overall Study|Participant no longer meets criteria|1
4691228|NCT02415400|16159534|P3|Overall Study|Participant no longer meets criteria|0
4691229|NCT02415400|16159535|P2|Overall Study|Participant no longer meets criteria|0
4691230|NCT02415400|16159536|P1|Overall Study|Participant no longer meets criteria|2
4691231|NCT02415400|16159533|P4|Overall Study|Poor/Non-Compliance|4
4691232|NCT02415400|16159534|P3|Overall Study|Poor/Non-Compliance|3
4691233|NCT02415400|16159535|P2|Overall Study|Poor/Non-Compliance|1
4691234|NCT02415400|16159536|P1|Overall Study|Poor/Non-Compliance|0
4691235|NCT02415400|16159533|P4|Overall Study|Lost to Follow-up|5
4691236|NCT02415400|16159534|P3|Overall Study|Lost to Follow-up|2
4691237|NCT02415400|16159535|P2|Overall Study|Lost to Follow-up|3
4691238|NCT02415400|16159536|P1|Overall Study|Lost to Follow-up|3
4691239|NCT02415400|16159533|P4|Overall Study|Death|42
4691240|NCT02415400|16159534|P3|Overall Study|Death|35
4691241|NCT02415400|16159535|P2|Overall Study|Death|41
4691242|NCT02415400|16159536|P1|Overall Study|Death|39
4691243|NCT02415400|16159533|P4|Overall Study|Participant withdrew consent|21
4691244|NCT02415400|16159534|P3|Overall Study|Participant withdrew consent|30
4691245|NCT02415400|16159535|P2|Overall Study|Participant withdrew consent|12
4691246|NCT02415400|16159536|P1|Overall Study|Participant withdrew consent|14
4691247|NCT02415400|16159533|P4|Overall Study|Participant request to stop therapy|6
4691248|NCT02415400|16159534|P3|Overall Study|Participant request to stop therapy|8
4691249|NCT02415400|16159535|P2|Overall Study|Participant request to stop therapy|3
4691250|NCT02415400|16159536|P1|Overall Study|Participant request to stop therapy|4
4691251|NCT02415400|16159533|P4|Overall Study|Adverse Event|2
4691252|NCT02415400|16159534|P3|Overall Study|Adverse Event|1
4691253|NCT02415400|16159535|P2|Overall Study|Adverse Event|1
4691254|NCT02415400|16159536|P1|Overall Study|Adverse Event|0
4691255|NCT02415127|16159604|P2|Overall Study|Adverse Event|0
4691256|NCT02415127|16159605|P1|Overall Study|Adverse Event|1
4691257|NCT02414958|16159622|P3|Overall Study|Other than specified|5
4691258|NCT02414958|16159623|P2|Overall Study|Other than specified|4
4691259|NCT02414958|16159624|P1|Overall Study|Other than specified|4
4691260|NCT02414958|16159622|P3|Overall Study|Withdrawal by Subject|5
4691261|NCT02414958|16159623|P2|Overall Study|Withdrawal by Subject|3
4691262|NCT02414958|16159624|P1|Overall Study|Withdrawal by Subject|5
4691263|NCT02414958|16159622|P3|Overall Study|Lost to Follow-up|0
4691264|NCT02414958|16159623|P2|Overall Study|Lost to Follow-up|4
4691265|NCT02414958|16159624|P1|Overall Study|Lost to Follow-up|7
4691266|NCT02414958|16159622|P3|Overall Study|Protocol Violation|1
4691267|NCT02414958|16159623|P2|Overall Study|Protocol Violation|3
4691268|NCT02414958|16159624|P1|Overall Study|Protocol Violation|10
4691269|NCT02414958|16159622|P3|Overall Study|Adverse Event|3
4691270|NCT02414958|16159623|P2|Overall Study|Adverse Event|6
4691271|NCT02414958|16159624|P1|Overall Study|Adverse Event|6
4691272|NCT02414854|16159657|P4|Overall Study|Other than specified above|37
4691273|NCT02414854|16159658|P3|Overall Study|Other than specified above|17
4691274|NCT02414854|16159659|P2|Overall Study|Other than specified above|37
4691275|NCT02414854|16159660|P1|Overall Study|Other than specified above|12
4691276|NCT02414854|16159657|P4|Overall Study|Poor compliance to protocol|2
4691277|NCT02414854|16159658|P3|Overall Study|Poor compliance to protocol|2
4691278|NCT02414854|16159659|P2|Overall Study|Poor compliance to protocol|1
4691279|NCT02414854|16159660|P1|Overall Study|Poor compliance to protocol|1
4691280|NCT02414854|16159657|P4|Overall Study|Adverse Event|12
4691281|NCT02414854|16159658|P3|Overall Study|Adverse Event|1
4691282|NCT02414854|16159659|P2|Overall Study|Adverse Event|7
4691283|NCT02414854|16159660|P1|Overall Study|Adverse Event|9
4691284|NCT02414841|16159824|P2|Overall Study|Randomized But Not Treated|4
4691285|NCT02414841|16159825|P1|Overall Study|Randomized But Not Treated|6
4691286|NCT02414841|16159824|P2|Overall Study|Received a Kidney Transplant|4
4691287|NCT02414841|16159825|P1|Overall Study|Received a Kidney Transplant|13
4691288|NCT02414841|16159824|P2|Overall Study|Death|14
4691289|NCT02414841|16159825|P1|Overall Study|Death|17
4691290|NCT02414841|16159824|P2|Overall Study|Lost to Follow-up|6
4691291|NCT02414841|16159825|P1|Overall Study|Lost to Follow-up|13
4691292|NCT02414841|16159824|P2|Overall Study|Withdrawal by Subject|5
4691293|NCT02414841|16159825|P1|Overall Study|Withdrawal by Subject|7
4691294|NCT02414828|16159837|P4|Overall Study|Lost to Follow-up|2
4691295|NCT02414828|16159838|P3|Overall Study|Lost to Follow-up|1
4691296|NCT02414828|16159839|P2|Overall Study|Lost to Follow-up|1
4691297|NCT02414828|16159840|P1|Overall Study|Lost to Follow-up|0
4691298|NCT02414152|16159933|P1|Overall Study|Lack of Efficacy|1
4691299|NCT02414152|16159933|P1|Overall Study|Withdrawal by Subject|1
4691300|NCT02413996|16159939|P2|Overall Study|not comfortable with the intervention|2
4691301|NCT02413996|16159940|P1|Overall Study|not comfortable with the intervention|9
4691302|NCT02413593|16159985|P1|Overall Study|Adverse Event|1
4691303|NCT02413593|16159985|P1|Overall Study|Lost to Follow-up|3
4691304|NCT02413489|16160004|P3|Overall Study|Study Terminated By Sponsor|1
4691305|NCT02413489|16160005|P2|Overall Study|Study Terminated By Sponsor|13
4691306|NCT02413489|16160006|P1|Overall Study|Study Terminated By Sponsor|2
4691307|NCT02413489|16160004|P3|Overall Study|Withdrawal by Subject|0
4691308|NCT02413489|16160005|P2|Overall Study|Withdrawal by Subject|0
4691309|NCT02413489|16160006|P1|Overall Study|Withdrawal by Subject|2
4691310|NCT02413489|16160004|P3|Overall Study|Death|4
4691311|NCT02413489|16160005|P2|Overall Study|Death|3
4691312|NCT02413489|16160006|P1|Overall Study|Death|11
4691313|NCT02413398|16160047|P2|Overall Study|Other Eligibility criteria|2
4691314|NCT02413398|16160048|P1|Overall Study|Other Eligibility criteria|1
4691315|NCT02413398|16160047|P2|Overall Study|Withdrawal by Subject|1
4691316|NCT02413398|16160048|P1|Overall Study|Withdrawal by Subject|1
4691317|NCT02413398|16160047|P2|Overall Study|Lost to Follow-up|4
4691318|NCT02413398|16160048|P1|Overall Study|Lost to Follow-up|2
4691319|NCT02413372|16160063|P3|Follow-up|Subject unable to return for visit|1
4691320|NCT02413372|16160064|P2|Follow-up|Subject unable to return for visit|0
4691321|NCT02413372|16160065|P1|Follow-up|Subject unable to return for visit|0
4691322|NCT02413372|16160063|P3|Follow-up|Subject Withdrew Consent|1
4691323|NCT02413372|16160064|P2|Follow-up|Subject Withdrew Consent|0
4691324|NCT02413372|16160065|P1|Follow-up|Subject Withdrew Consent|1
4691325|NCT02413372|16160063|P3|Follow-up|Lost to Follow-up|0
4691326|NCT02413372|16160064|P2|Follow-up|Lost to Follow-up|1
4691327|NCT02413372|16160065|P1|Follow-up|Lost to Follow-up|1
4691328|NCT02413372|16160063|P3|Treatment|Withdrawal by Subject|0
4691329|NCT02413372|16160064|P2|Treatment|Withdrawal by Subject|0
4691330|NCT02413372|16160065|P1|Treatment|Withdrawal by Subject|1
4691331|NCT02413372|16160063|P3|Treatment|Lost to Follow-up|1
4691332|NCT02413372|16160064|P2|Treatment|Lost to Follow-up|2
4691333|NCT02413372|16160065|P1|Treatment|Lost to Follow-up|0
4691334|NCT02413346|16160114|P2|Overall Study|Other Miscellaneous Reasons|3
4691335|NCT02413346|16160115|P1|Overall Study|Other Miscellaneous Reasons|4
4691336|NCT02413346|16160114|P2|Overall Study|Protocol Violation|0
4691337|NCT02413346|16160115|P1|Overall Study|Protocol Violation|2
4691338|NCT02413346|16160114|P2|Overall Study|Lost to Follow-up|21
4691339|NCT02413346|16160115|P1|Overall Study|Lost to Follow-up|17
4691340|NCT02413346|16160114|P2|Overall Study|Withdrawal by Subject|40
4691341|NCT02413346|16160115|P1|Overall Study|Withdrawal by Subject|30
4691342|NCT02413346|16160114|P2|Overall Study|Adverse Event|6
4691343|NCT02413346|16160115|P1|Overall Study|Adverse Event|6
4691344|NCT02413333|16160125|P2|Period 2|Protocol Deviation|0
4691345|NCT02413333|16160126|P1|Period 2|Protocol Deviation|1
4691346|NCT02413333|16160125|P2|Period 1|Reason Not Specified|1
4691347|NCT02413333|16160126|P1|Period 1|Reason Not Specified|0
4691348|NCT02413333|16160125|P2|Period 1|Adverse Event|0
4691349|NCT02413333|16160126|P1|Period 1|Adverse Event|1
4691350|NCT02413294|16160134|P1|Overall Study|Withdrawal by Subject|1
4691351|NCT02413255|16160169|P17|Overall Study|Voluntary Withdrawal|0
4691352|NCT02413255|16160170|P16|Overall Study|Voluntary Withdrawal|0
4691353|NCT02413255|16160171|P15|Overall Study|Voluntary Withdrawal|1
4691354|NCT02413255|16160172|P14|Overall Study|Voluntary Withdrawal|0
4691355|NCT02413255|16160173|P13|Overall Study|Voluntary Withdrawal|0
4691356|NCT02413255|16160174|P12|Overall Study|Voluntary Withdrawal|0
4691357|NCT02413255|16160175|P11|Overall Study|Voluntary Withdrawal|0
4691358|NCT02413255|16160176|P10|Overall Study|Voluntary Withdrawal|0
4691359|NCT02413255|16160177|P9|Overall Study|Voluntary Withdrawal|0
4691360|NCT02413255|16160178|P8|Overall Study|Voluntary Withdrawal|0
4691361|NCT02413255|16160179|P7|Overall Study|Voluntary Withdrawal|0
4691362|NCT02413255|16160180|P6|Overall Study|Voluntary Withdrawal|0
4691363|NCT02413255|16160181|P5|Overall Study|Voluntary Withdrawal|0
4691364|NCT02413255|16160182|P4|Overall Study|Voluntary Withdrawal|0
4691365|NCT02413255|16160183|P3|Overall Study|Voluntary Withdrawal|0
4691366|NCT02413255|16160184|P2|Overall Study|Voluntary Withdrawal|0
4691367|NCT02413255|16160185|P1|Overall Study|Voluntary Withdrawal|0
4691368|NCT02413229|16160541|P8|Overall Study|Progressive Disease|1
4691369|NCT02413229|16160542|P7|Overall Study|Progressive Disease|0
4691370|NCT02413229|16160543|P6|Overall Study|Progressive Disease|0
4691371|NCT02413229|16160544|P5|Overall Study|Progressive Disease|0
4691372|NCT02413229|16160545|P4|Overall Study|Progressive Disease|0
4691373|NCT02413229|16160546|P3|Overall Study|Progressive Disease|0
4691374|NCT02413229|16160547|P2|Overall Study|Progressive Disease|0
4691375|NCT02413229|16160548|P1|Overall Study|Progressive Disease|0
4691376|NCT02413229|16160541|P8|Overall Study|Withdrawal by Subject|2
4691377|NCT02413229|16160542|P7|Overall Study|Withdrawal by Subject|0
4691378|NCT02413229|16160543|P6|Overall Study|Withdrawal by Subject|0
4691379|NCT02413229|16160544|P5|Overall Study|Withdrawal by Subject|1
4691380|NCT02413229|16160545|P4|Overall Study|Withdrawal by Subject|0
4691381|NCT02413229|16160546|P3|Overall Study|Withdrawal by Subject|0
4691382|NCT02413229|16160547|P2|Overall Study|Withdrawal by Subject|1
4691383|NCT02413229|16160548|P1|Overall Study|Withdrawal by Subject|1
4691384|NCT02413229|16160541|P8|Overall Study|Lost to Follow-up|0
4691385|NCT02413229|16160542|P7|Overall Study|Lost to Follow-up|0
4691386|NCT02413229|16160543|P6|Overall Study|Lost to Follow-up|0
4691387|NCT02413229|16160544|P5|Overall Study|Lost to Follow-up|2
4691388|NCT02413229|16160545|P4|Overall Study|Lost to Follow-up|0
4691389|NCT02413229|16160546|P3|Overall Study|Lost to Follow-up|1
4691390|NCT02413229|16160547|P2|Overall Study|Lost to Follow-up|0
4691391|NCT02413229|16160548|P1|Overall Study|Lost to Follow-up|0
4691392|NCT02413229|16160541|P8|Overall Study|Adverse Event|1
4691393|NCT02413229|16160542|P7|Overall Study|Adverse Event|0
4691394|NCT02413229|16160543|P6|Overall Study|Adverse Event|0
4691395|NCT02413229|16160544|P5|Overall Study|Adverse Event|0
4691396|NCT02413229|16160545|P4|Overall Study|Adverse Event|1
4691397|NCT02413229|16160546|P3|Overall Study|Adverse Event|0
4691398|NCT02413229|16160547|P2|Overall Study|Adverse Event|0
4691399|NCT02413229|16160548|P1|Overall Study|Adverse Event|0
4691400|NCT02412878|16160687|P2|Overall Study|Lost to Follow-up|3
4691401|NCT02412878|16160688|P1|Overall Study|Lost to Follow-up|2
4691402|NCT02412878|16160687|P2|Overall Study|Withdrawal by Subject|10
4691403|NCT02412878|16160688|P1|Overall Study|Withdrawal by Subject|19
4691404|NCT02412852|16160706|P4|Overall Study|Physician Decision|1
4691405|NCT02412852|16160707|P3|Overall Study|Physician Decision|0
4691406|NCT02412852|16160708|P2|Overall Study|Physician Decision|0
4691407|NCT02412852|16160709|P1|Overall Study|Physician Decision|0
4691408|NCT02412852|16160706|P4|Overall Study|Withdrawal by Subject|0
4691409|NCT02412852|16160707|P3|Overall Study|Withdrawal by Subject|0
4691410|NCT02412852|16160708|P2|Overall Study|Withdrawal by Subject|1
4691411|NCT02412852|16160709|P1|Overall Study|Withdrawal by Subject|0
4691412|NCT02412761|16160735|P6|First Intervention (2 Weeks)|Withdrawal by Subject|1
4691413|NCT02412761|16160736|P5|First Intervention (2 Weeks)|Withdrawal by Subject|0
4691414|NCT02412761|16160737|P4|First Intervention (2 Weeks)|Withdrawal by Subject|0
4691415|NCT02412761|16160738|P3|First Intervention (2 Weeks)|Withdrawal by Subject|1
4691416|NCT02412761|16160739|P2|First Intervention (2 Weeks)|Withdrawal by Subject|1
4691417|NCT02412761|16160740|P1|First Intervention (2 Weeks)|Withdrawal by Subject|0
4691418|NCT02412722|16160754|P6|Overall Study|Reason not Specified|6
4691419|NCT02412722|16160755|P5|Overall Study|Reason not Specified|2
4691420|NCT02412722|16160756|P4|Overall Study|Reason not Specified|1
4691421|NCT02412722|16160757|P3|Overall Study|Reason not Specified|2
4691422|NCT02412722|16160758|P2|Overall Study|Reason not Specified|0
4691423|NCT02412722|16160759|P1|Overall Study|Reason not Specified|3
4691424|NCT02412722|16160754|P6|Overall Study|Received drug in run-in and discontinued|0
4691425|NCT02412722|16160755|P5|Overall Study|Received drug in run-in and discontinued|0
4691426|NCT02412722|16160756|P4|Overall Study|Received drug in run-in and discontinued|0
4691427|NCT02412722|16160757|P3|Overall Study|Received drug in run-in and discontinued|0
4691428|NCT02412722|16160758|P2|Overall Study|Received drug in run-in and discontinued|2
4691429|NCT02412722|16160759|P1|Overall Study|Received drug in run-in and discontinued|0
4691430|NCT02412722|16160754|P6|Overall Study|Lost to Follow-up|0
4691431|NCT02412722|16160755|P5|Overall Study|Lost to Follow-up|1
4691432|NCT02412722|16160756|P4|Overall Study|Lost to Follow-up|0
4691433|NCT02412722|16160757|P3|Overall Study|Lost to Follow-up|0
4691434|NCT02412722|16160758|P2|Overall Study|Lost to Follow-up|0
4691435|NCT02412722|16160759|P1|Overall Study|Lost to Follow-up|0
4691436|NCT02412722|16160754|P6|Overall Study|Withdrawal by Subject|1
4691437|NCT02412722|16160755|P5|Overall Study|Withdrawal by Subject|1
4691438|NCT02412722|16160756|P4|Overall Study|Withdrawal by Subject|2
4691439|NCT02412722|16160757|P3|Overall Study|Withdrawal by Subject|1
4691440|NCT02412722|16160758|P2|Overall Study|Withdrawal by Subject|0
4691441|NCT02412722|16160759|P1|Overall Study|Withdrawal by Subject|2
4691442|NCT02412722|16160754|P6|Overall Study|Progressive Disease|3
4691443|NCT02412722|16160755|P5|Overall Study|Progressive Disease|3
4691444|NCT02412722|16160756|P4|Overall Study|Progressive Disease|9
4691445|NCT02412722|16160757|P3|Overall Study|Progressive Disease|4
4691446|NCT02412722|16160758|P2|Overall Study|Progressive Disease|4
4691447|NCT02412722|16160759|P1|Overall Study|Progressive Disease|6
4691448|NCT02412722|16160754|P6|Overall Study|Adverse Event|3
4691449|NCT02412722|16160755|P5|Overall Study|Adverse Event|0
4691450|NCT02412722|16160756|P4|Overall Study|Adverse Event|3
4691451|NCT02412722|16160757|P3|Overall Study|Adverse Event|0
4691452|NCT02412722|16160758|P2|Overall Study|Adverse Event|2
4691453|NCT02412722|16160759|P1|Overall Study|Adverse Event|0
4691454|NCT02412657|16160830|P3|Overall Study|Protocol Violation|3
4691455|NCT02412657|16160831|P2|Overall Study|Protocol Violation|2
4691456|NCT02412657|16160832|P1|Overall Study|Protocol Violation|0
4691457|NCT02412657|16160830|P3|Overall Study|Lost to Follow-up|0
4691458|NCT02412657|16160831|P2|Overall Study|Lost to Follow-up|0
4691459|NCT02412657|16160832|P1|Overall Study|Lost to Follow-up|1
4691460|NCT02412488|16160876|P1|Overall Study|Reveal LINQ explant|1
4691461|NCT02412488|16160876|P1|Overall Study|No Reveal LINQ Insertion Attempt|1
4691462|NCT02412488|16160876|P1|Overall Study|Physician Decision|1
4691463|NCT02412488|16160876|P1|Overall Study|Withdrawal by Subject|5
4691464|NCT02412488|16160876|P1|Overall Study|Lost to Follow-up|10
4691465|NCT02412436|16160880|P1|Overall Study|Not Willing to Adhere to Requirements|1
4691466|NCT02412436|16160880|P1|Overall Study|Death|1
4691467|NCT02412436|16160880|P1|Overall Study|Unable to get to clinic|3
4691468|NCT02412436|16160880|P1|Overall Study|Lost to Follow-up|6
4691469|NCT02412436|16160880|P1|Overall Study|Protocol-mandated Discontinuation|7
4691470|NCT02412371|16160900|P6|Overall Study|Other|3
4691471|NCT02412371|16160901|P5|Overall Study|Other|1
4691472|NCT02412371|16160902|P4|Overall Study|Other|0
4691473|NCT02412371|16160903|P3|Overall Study|Other|0
4691474|NCT02412371|16160904|P2|Overall Study|Other|1
4691475|NCT02412371|16160905|P1|Overall Study|Other|2
4691476|NCT02412371|16160900|P6|Overall Study|Death|2
4691477|NCT02412371|16160901|P5|Overall Study|Death|5
4691478|NCT02412371|16160902|P4|Overall Study|Death|3
4691479|NCT02412371|16160903|P3|Overall Study|Death|1
4691480|NCT02412371|16160904|P2|Overall Study|Death|2
4691481|NCT02412371|16160905|P1|Overall Study|Death|4
4691482|NCT02412371|16160900|P6|Overall Study|Sponsor Discontinued Study|0
4691483|NCT02412371|16160901|P5|Overall Study|Sponsor Discontinued Study|5
4691484|NCT02412371|16160902|P4|Overall Study|Sponsor Discontinued Study|4
4691485|NCT02412371|16160903|P3|Overall Study|Sponsor Discontinued Study|6
4691486|NCT02412371|16160904|P2|Overall Study|Sponsor Discontinued Study|4
4691487|NCT02412371|16160905|P1|Overall Study|Sponsor Discontinued Study|1
4691488|NCT02412371|16160900|P6|Overall Study|Withdrawal by Subject|0
4691489|NCT02412371|16160901|P5|Overall Study|Withdrawal by Subject|1
4691490|NCT02412371|16160902|P4|Overall Study|Withdrawal by Subject|1
4691491|NCT02412371|16160903|P3|Overall Study|Withdrawal by Subject|0
4691492|NCT02412371|16160904|P2|Overall Study|Withdrawal by Subject|2
4691493|NCT02412371|16160905|P1|Overall Study|Withdrawal by Subject|0
4691494|NCT02412306|16160933|P5|Overall Study|Death|2
4691495|NCT02412306|16160934|P4|Overall Study|Death|0
4691496|NCT02412306|16160935|P3|Overall Study|Death|15
4691497|NCT02412306|16160936|P2|Overall Study|Death|7
4691498|NCT02412306|16160937|P1|Overall Study|Death|5
4691499|NCT02412306|16160933|P5|Overall Study|Withdrawal by Subject|0
4691500|NCT02412306|16160934|P4|Overall Study|Withdrawal by Subject|0
4691501|NCT02412306|16160935|P3|Overall Study|Withdrawal by Subject|1
4691502|NCT02412306|16160936|P2|Overall Study|Withdrawal by Subject|0
4691503|NCT02412306|16160937|P1|Overall Study|Withdrawal by Subject|0
4691504|NCT02412306|16160933|P5|Overall Study|Lost to Follow-up|0
4691505|NCT02412306|16160934|P4|Overall Study|Lost to Follow-up|0
4691506|NCT02412306|16160935|P3|Overall Study|Lost to Follow-up|0
4691507|NCT02412306|16160936|P2|Overall Study|Lost to Follow-up|1
4691508|NCT02412306|16160937|P1|Overall Study|Lost to Follow-up|0
4691509|NCT02412111|16160999|P3|Active Comparator Period (8 Weeks)|Other|2
4691510|NCT02412111|16161000|P2|Active Comparator Period (8 Weeks)|Other|0
4691511|NCT02412111|16161001|P1|Active Comparator Period (8 Weeks)|Other|0
4691512|NCT02412111|16160999|P3|Active Comparator Period (8 Weeks)|Other non-compliance|0
4691513|NCT02412111|16161000|P2|Active Comparator Period (8 Weeks)|Other non-compliance|1
4691514|NCT02412111|16161001|P1|Active Comparator Period (8 Weeks)|Other non-compliance|0
4691515|NCT02412111|16160999|P3|Active Comparator Period (8 Weeks)|Lost to Follow-up|1
4691516|NCT02412111|16161000|P2|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
4691517|NCT02412111|16161001|P1|Active Comparator Period (8 Weeks)|Lost to Follow-up|0
4691518|NCT02412111|16160999|P3|Active Comparator Period (8 Weeks)|Participants refused further dosing|1
4691519|NCT02412111|16161000|P2|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
4691520|NCT02412111|16161001|P1|Active Comparator Period (8 Weeks)|Participants refused further dosing|0
4691521|NCT02412111|16160999|P3|Active Comparator Period (8 Weeks)|Adverse Event|2
4691522|NCT02412111|16161000|P2|Active Comparator Period (8 Weeks)|Adverse Event|0
4691523|NCT02412111|16161001|P1|Active Comparator Period (8 Weeks)|Adverse Event|0
4691524|NCT02412111|16160999|P3|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
4691525|NCT02412111|16161000|P2|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0
4691526|NCT02412111|16161001|P1|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2
4691527|NCT02412111|16160999|P3|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
4691528|NCT02412111|16161000|P2|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0
4691529|NCT02412111|16161001|P1|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1
4691530|NCT02411747|16161084|P2|Overall Study|Protocol Violation|4
4691531|NCT02411747|16161085|P1|Overall Study|Protocol Violation|2
4691532|NCT02411747|16161084|P2|Overall Study|Withdrawal by Subject|0
4691533|NCT02411747|16161085|P1|Overall Study|Withdrawal by Subject|1
4691534|NCT02411591|16161101|P3|Overall Study|Physician Decision|1
4691535|NCT02411591|16161102|P2|Overall Study|Physician Decision|3
4691536|NCT02411591|16161103|P1|Overall Study|Physician Decision|0
4691537|NCT02411591|16161101|P3|Overall Study|Withdrawal by Subject|0
4691538|NCT02411591|16161102|P2|Overall Study|Withdrawal by Subject|3
4691539|NCT02411591|16161103|P1|Overall Study|Withdrawal by Subject|0
4691540|NCT02411591|16161101|P3|Overall Study|Adverse Event|2
4691541|NCT02411591|16161102|P2|Overall Study|Adverse Event|4
4691542|NCT02411591|16161103|P1|Overall Study|Adverse Event|0
4691543|NCT02411578|16161135|P2|Crossover Trial Phase|Pregnancy|1
4691544|NCT02411578|16161136|P1|Crossover Trial Phase|Pregnancy|0
4691545|NCT02411539|16161193|P2|Overall Study|Confounding medical condition|1
4691546|NCT02411539|16161194|P1|Overall Study|Confounding medical condition|0
4691547|NCT02411539|16161193|P2|Overall Study|Lost to Follow-up|0
4691548|NCT02411539|16161194|P1|Overall Study|Lost to Follow-up|2
4691549|NCT02411448|16161285|P3|Overall Study|Alive on study treatment|43
4691550|NCT02411448|16161286|P2|Overall Study|Alive on study treatment|64
4691551|NCT02411448|16161287|P1|Overall Study|Alive on study treatment|3
4691552|NCT02411448|16161285|P3|Overall Study|Did not receive study treatment|0
4691553|NCT02411448|16161286|P2|Overall Study|Did not receive study treatment|3
4691554|NCT02411448|16161287|P1|Overall Study|Did not receive study treatment|0
4691555|NCT02411448|16161285|P3|Overall Study|Other|0
4691556|NCT02411448|16161286|P2|Overall Study|Other|2
4691557|NCT02411448|16161287|P1|Overall Study|Other|0
4691558|NCT02411448|16161285|P3|Overall Study|Withdrawal by Subject|9
4691559|NCT02411448|16161286|P2|Overall Study|Withdrawal by Subject|14
4691560|NCT02411448|16161287|P1|Overall Study|Withdrawal by Subject|1
4691561|NCT02411396|16161316|P1|Overall Study|Death|10
4691562|NCT02411396|16161316|P1|Overall Study|Lost to Follow-up|31
4691563|NCT02411292|16161329|P1|Overall Study|Lost to Follow-up|3
4691564|NCT02411292|16161329|P1|Overall Study|Death|2
4691565|NCT02411292|16161329|P1|Overall Study|Discharged before 3rd enoxaparin dose|16
4691566|NCT02411201|16161335|P1|Overall Study|Age group completed|2
4691567|NCT02411201|16161335|P1|Overall Study|Withdrawal by Subject|2
4691568|NCT02411201|16161335|P1|Overall Study|Adverse Event|2
4691569|NCT02411110|16161348|P2|Treatment Period 2|Personal Reasons|2
4691570|NCT02411110|16161349|P1|Treatment Period 2|Personal Reasons|0
4691571|NCT02411110|16161348|P2|Treatment Period 2|Lost to Follow-up|2
4691572|NCT02411110|16161349|P1|Treatment Period 2|Lost to Follow-up|0
4691573|NCT02411110|16161348|P2|Treatment Period 2|Adverse Event|0
4691574|NCT02411110|16161349|P1|Treatment Period 2|Adverse Event|1
4691575|NCT02411110|16161348|P2|Treatment Period 1|Other Miscellaneous Reasons|0
4691576|NCT02411110|16161349|P1|Treatment Period 1|Other Miscellaneous Reasons|2
4691577|NCT02411110|16161348|P2|Treatment Period 1|Personal Reasons|5
4691578|NCT02411110|16161349|P1|Treatment Period 1|Personal Reasons|2
4691579|NCT02411110|16161348|P2|Treatment Period 1|Lost to Follow-up|0
4691580|NCT02411110|16161349|P1|Treatment Period 1|Lost to Follow-up|1
4691581|NCT02411110|16161348|P2|Treatment Period 1|Adverse Event|2
4691582|NCT02411110|16161349|P1|Treatment Period 1|Adverse Event|4
4691583|NCT02411084|16161359|P2|Overall Study|Other reasons|5
4691584|NCT02411084|16161360|P1|Overall Study|Other reasons|0
4691585|NCT02411084|16161359|P2|Overall Study|Adverse Event|1
4691586|NCT02411084|16161360|P1|Overall Study|Adverse Event|2
4691587|NCT02411084|16161359|P2|Overall Study|Death|4
4691588|NCT02411084|16161360|P1|Overall Study|Death|5
4691589|NCT02411084|16161359|P2|Overall Study|Lack of Efficacy|3
4691590|NCT02411084|16161360|P1|Overall Study|Lack of Efficacy|6
4691591|NCT02410824|16161392|P2|First Intervention (One Week)|Headache|1
4691592|NCT02410824|16161393|P1|First Intervention (One Week)|Headache|0
4691593|NCT02410629|16161438|P2|Overall Study|Subject underwent heart surgery|1
4691594|NCT02410629|16161439|P1|Overall Study|Subject underwent heart surgery|0
4691595|NCT02410629|16161438|P2|Overall Study|Subject moved back to home country|1
4691596|NCT02410629|16161439|P1|Overall Study|Subject moved back to home country|0
4691597|NCT02410629|16161438|P2|Overall Study|Subject returned to work|0
4691598|NCT02410629|16161439|P1|Overall Study|Subject returned to work|1
4691599|NCT02410629|16161438|P2|Overall Study|Family cannot commit to the study|1
4691600|NCT02410629|16161439|P1|Overall Study|Family cannot commit to the study|2
4691601|NCT02410551|16161455|P1|Overall Study|FDA Clinical hold-patients taken off|2
4691602|NCT02410551|16161455|P1|Overall Study|Withdrawal by Subject|1
4691603|NCT02410551|16161455|P1|Overall Study|Adverse Event|1
4691604|NCT02410343|16161473|P2|Extension Period (12 Months)|Early termination of study by sponsor|1
4691605|NCT02410343|16161474|P1|Extension Period (12 Months)|Early termination of study by sponsor|0
4691606|NCT02410343|16161473|P2|Extension Period (12 Months)|Adverse Event|0
4691607|NCT02410343|16161474|P1|Extension Period (12 Months)|Adverse Event|1
4691608|NCT02410343|16161473|P2|Core Period (24 Weeks)|Early termination of study by sponsor|7
4691609|NCT02410343|16161474|P1|Core Period (24 Weeks)|Early termination of study by sponsor|4
4691610|NCT02410343|16161473|P2|Core Period (24 Weeks)|Adverse Event|0
4691611|NCT02410343|16161474|P1|Core Period (24 Weeks)|Adverse Event|1
4691612|NCT02410278|16161520|P3|Study Treatment Period|GSRS Threshold Not Met|0
4691613|NCT02410278|16161521|P2|Study Treatment Period|GSRS Threshold Not Met|1
4691614|NCT02410278|16161522|P1|Study Treatment Period|GSRS Threshold Not Met|0
4691615|NCT02410278|16161520|P3|Study Treatment Period|Other|0
4691616|NCT02410278|16161521|P2|Study Treatment Period|Other|3
4691617|NCT02410278|16161522|P1|Study Treatment Period|Other|0
4691618|NCT02410278|16161520|P3|Study Treatment Period|Withdrawal by Subject|0
4691619|NCT02410278|16161521|P2|Study Treatment Period|Withdrawal by Subject|1
4691620|NCT02410278|16161522|P1|Study Treatment Period|Withdrawal by Subject|0
4691621|NCT02410278|16161520|P3|Study Treatment Period|Physician Decision|1
4691622|NCT02410278|16161521|P2|Study Treatment Period|Physician Decision|0
4691623|NCT02410278|16161522|P1|Study Treatment Period|Physician Decision|0
4691624|NCT02410278|16161520|P3|Study Treatment Period|Adverse Event|3
4691625|NCT02410278|16161521|P2|Study Treatment Period|Adverse Event|6
4691626|NCT02410278|16161522|P1|Study Treatment Period|Adverse Event|0
4691627|NCT02410278|16161520|P3|Run-in Period|Pregnancy|0
4691628|NCT02410278|16161521|P2|Run-in Period|Pregnancy|0
4691629|NCT02410278|16161522|P1|Run-in Period|Pregnancy|1
4691630|NCT02410278|16161520|P3|Run-in Period|Withdrawal by Subject|0
4691631|NCT02410278|16161521|P2|Run-in Period|Withdrawal by Subject|0
4691632|NCT02410278|16161522|P1|Run-in Period|Withdrawal by Subject|1
4691633|NCT02410278|16161520|P3|Run-in Period|Lost to Follow-up|0
4691634|NCT02410278|16161521|P2|Run-in Period|Lost to Follow-up|0
4691635|NCT02410278|16161522|P1|Run-in Period|Lost to Follow-up|1
4691636|NCT02410278|16161520|P3|Run-in Period|GSRS Threshold Not Met|0
4691637|NCT02410278|16161521|P2|Run-in Period|GSRS Threshold Not Met|0
4691638|NCT02410278|16161522|P1|Run-in Period|GSRS Threshold Not Met|30
4691639|NCT02410278|16161520|P3|Run-in Period|Adverse Event|0
4691640|NCT02410278|16161521|P2|Run-in Period|Adverse Event|0
4691641|NCT02410278|16161522|P1|Run-in Period|Adverse Event|5
4691642|NCT02410252|16161547|P1|Overall Study|Physician Decision|2
4691643|NCT02410252|16161547|P1|Overall Study|Withdrawal by Subject|4
4691644|NCT02410200|16161560|P1|Overall Study|Adverse Event|2
4691645|NCT02409732|16161630|P1|Overall Study|Lost to Follow-up|2
4691646|NCT02409732|16161630|P1|Overall Study|Withdrawal by Subject|4
4691647|NCT02409719|16161640|P2|Overall Study|Lost to Follow-up|3
4691648|NCT02409719|16161641|P1|Overall Study|Lost to Follow-up|3
4691649|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4691650|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4691651|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3
4691652|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4691653|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0
4691654|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
4691655|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
4691656|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1
4691657|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
4691812|NCT02170727|16162413|P2|Overall Study|Withdrawal by Subject|0
4691658|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0
4691659|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
4691660|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2
4691661|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5
4691662|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4
4691663|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0
4691664|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
4691665|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
4691666|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4
4691667|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5
4691668|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0
4691669|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2
4691670|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1
4691671|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4
4691672|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7
4691673|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0
4691674|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4691675|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2
4691676|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4691677|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4691678|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0
4691679|NCT02409667|16161651|P5|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
4691680|NCT02409667|16161652|P4|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3
4691681|NCT02409667|16161653|P3|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4
4691682|NCT02409667|16161654|P2|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7
4691683|NCT02409667|16161655|P1|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0
4691684|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4691685|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4691686|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4691687|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Adverse Event|0
4691688|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Adverse Event|25
4691689|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4691690|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4691691|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4691692|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0
4691693|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48
4691694|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4691695|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4691696|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4691697|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0
4691698|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6
4691699|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4691700|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4691701|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4691702|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0
4691703|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5
4691704|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4691705|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4691706|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4691707|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Physician Decision|0
4691708|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Physician Decision|4
4691709|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4691710|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4691711|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4691712|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Pregnancy|0
4691713|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Pregnancy|1
4691714|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4691715|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4691716|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4691717|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Protocol deviation|0
4691718|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Protocol deviation|20
4691719|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4691720|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4691721|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4691722|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0
4691723|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6
4691724|NCT02409667|16161651|P5|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4691725|NCT02409667|16161652|P4|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4691726|NCT02409667|16161653|P3|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4691727|NCT02409667|16161654|P2|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0
4691728|NCT02409667|16161655|P1|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6
4691729|NCT02409355|16161717|P2|Overall Study|Study terminated by Sponsor|3
4691730|NCT02409355|16161718|P1|Overall Study|Study terminated by Sponsor|2
4691731|NCT02409355|16161717|P2|Overall Study|Death|1
4691732|NCT02409355|16161718|P1|Overall Study|Death|1
4691733|NCT02409355|16161717|P2|Overall Study|Withdrawal by Subject|0
4691734|NCT02409355|16161718|P1|Overall Study|Withdrawal by Subject|1
4691735|NCT02408523|16161841|P2|Overall Study|Did not satisfy extension conditions|1
4691736|NCT02408523|16161842|P1|Overall Study|Did not satisfy extension conditions|0
4691737|NCT02408523|16161841|P2|Overall Study|Sponsor request|0
4691738|NCT02408523|16161842|P1|Overall Study|Sponsor request|1
4691739|NCT02408523|16161841|P2|Overall Study|Withdrawal by Subject|1
4691740|NCT02408523|16161842|P1|Overall Study|Withdrawal by Subject|3
4691741|NCT02408523|16161841|P2|Overall Study|Lost to Follow-up|3
4691742|NCT02408523|16161842|P1|Overall Study|Lost to Follow-up|2
4691743|NCT02408523|16161841|P2|Overall Study|Protocol Violation|2
4691744|NCT02408523|16161842|P1|Overall Study|Protocol Violation|1
4691745|NCT02408523|16161841|P2|Overall Study|Lack of Efficacy|1
4691746|NCT02408523|16161842|P1|Overall Study|Lack of Efficacy|0
4691747|NCT02408523|16161841|P2|Overall Study|Adverse Event|10
4691748|NCT02408523|16161842|P1|Overall Study|Adverse Event|4
4691749|NCT02408484|16161862|P1|Overall Study|Not treated during study period|1
4691750|NCT02408484|16161862|P1|Overall Study|Withdrawal by Subject|3
4691751|NCT02408068|16161965|P6|Treatment 3 (1.5 Days)|Adverse Event|0
4691752|NCT02408068|16161966|P5|Treatment 3 (1.5 Days)|Adverse Event|0
4691753|NCT02408068|16161967|P4|Treatment 3 (1.5 Days)|Adverse Event|0
4691754|NCT02408068|16161968|P3|Treatment 3 (1.5 Days)|Adverse Event|1
4691755|NCT02408068|16161969|P2|Treatment 3 (1.5 Days)|Adverse Event|0
4691756|NCT02408068|16161970|P1|Treatment 3 (1.5 Days)|Adverse Event|0
4691757|NCT02407704|16162042|P4|Overall Study|Withdrawal by Subject|0
4691758|NCT02407704|16162043|P3|Overall Study|Withdrawal by Subject|1
4691759|NCT02407704|16162044|P2|Overall Study|Withdrawal by Subject|0
4691760|NCT02407704|16162045|P1|Overall Study|Withdrawal by Subject|0
4691761|NCT02407704|16162042|P4|Overall Study|Protocol Violation|1
4691762|NCT02407704|16162043|P3|Overall Study|Protocol Violation|0
4691763|NCT02407704|16162044|P2|Overall Study|Protocol Violation|0
4691764|NCT02407704|16162045|P1|Overall Study|Protocol Violation|0
4691765|NCT02407704|16162042|P4|Overall Study|Lost to Follow-up|2
4691766|NCT02407704|16162043|P3|Overall Study|Lost to Follow-up|0
4691767|NCT02407704|16162044|P2|Overall Study|Lost to Follow-up|0
4691768|NCT02407704|16162045|P1|Overall Study|Lost to Follow-up|0
4691769|NCT02407249|16162088|P1|Overall Study|Not treated|13
4691770|NCT02407249|16162088|P1|Overall Study|Did not complete 12-month follow-up|13
4691771|NCT02407223|16162099|P3|Overall Study|Other|25
4691772|NCT02407223|16162100|P2|Overall Study|Other|27
4691773|NCT02407223|16162101|P1|Overall Study|Other|29
4691774|NCT02407223|16162099|P3|Overall Study|Subject Refused Further Study Treatment|0
4691775|NCT02407223|16162100|P2|Overall Study|Subject Refused Further Study Treatment|1
4691776|NCT02407223|16162101|P1|Overall Study|Subject Refused Further Study Treatment|0
4691777|NCT02407223|16162099|P3|Overall Study|Study Terminated by Sponsor|86
4691778|NCT02407223|16162100|P2|Overall Study|Study Terminated by Sponsor|80
4691779|NCT02407223|16162101|P1|Overall Study|Study Terminated by Sponsor|77
4691780|NCT02407223|16162099|P3|Overall Study|Withdrawal by Subject|4
4691781|NCT02407223|16162100|P2|Overall Study|Withdrawal by Subject|4
4691782|NCT02407223|16162101|P1|Overall Study|Withdrawal by Subject|2
4691783|NCT02407223|16162099|P3|Overall Study|Lost to Follow-up|2
4691784|NCT02407223|16162100|P2|Overall Study|Lost to Follow-up|0
4691785|NCT02407223|16162101|P1|Overall Study|Lost to Follow-up|1
4691786|NCT02407223|16162099|P3|Overall Study|Lack of Efficacy|4
4691787|NCT02407223|16162100|P2|Overall Study|Lack of Efficacy|6
4691788|NCT02407223|16162101|P1|Overall Study|Lack of Efficacy|6
4691789|NCT02407223|16162099|P3|Overall Study|Adverse Event|1
4691790|NCT02407223|16162100|P2|Overall Study|Adverse Event|0
4691791|NCT02407223|16162101|P1|Overall Study|Adverse Event|1
4691792|NCT02406677|16162238|P2|Overall Study|Withdrawal by Subject|0
4691793|NCT02406677|16162239|P1|Overall Study|Withdrawal by Subject|1
4691794|NCT02406677|16162238|P2|Overall Study|Discharged on prasugrel|587
4691795|NCT02406677|16162239|P1|Overall Study|Discharged on prasugrel|283
4691796|NCT02406677|16162238|P2|Overall Study|Discharged without P2Y12|3
4691797|NCT02406677|16162239|P1|Overall Study|Discharged without P2Y12|1
4691798|NCT02406677|16162238|P2|Overall Study|Death|8
4691799|NCT02406677|16162239|P1|Overall Study|Death|16
4691800|NCT02406612|16162253|P2|Overall Study|Guidewire Failure|1
4691801|NCT02406612|16162254|P1|Overall Study|Guidewire Failure|0
4691802|NCT02406612|16162253|P2|Overall Study|Intra-procedural Exclusion|3
4691803|NCT02406612|16162254|P1|Overall Study|Intra-procedural Exclusion|1
4691804|NCT02406612|16162253|P2|Overall Study|Screening Failure|0
4691805|NCT02406612|16162254|P1|Overall Study|Screening Failure|3
4691806|NCT02406586|16162269|P3|Overall Study|Withdrawal by Subject|0
4691807|NCT02406586|16162270|P2|Overall Study|Withdrawal by Subject|0
4691808|NCT02406586|16162271|P1|Overall Study|Withdrawal by Subject|1
4691809|NCT02406586|16162269|P3|Overall Study|Lost to Follow-up|2
4691810|NCT02406586|16162270|P2|Overall Study|Lost to Follow-up|4
4691811|NCT02406586|16162271|P1|Overall Study|Lost to Follow-up|0
4691813|NCT02170727|16162414|P1|Overall Study|Withdrawal by Subject|2
4691814|NCT02170727|16162413|P2|Overall Study|Lost to Follow-up|0
4691815|NCT02170727|16162414|P1|Overall Study|Lost to Follow-up|1
4691816|NCT02406261|16162442|P2|Period 2|Withdrawal by Subject|1
4691817|NCT02406261|16162443|P1|Period 2|Withdrawal by Subject|0
4691818|NCT02406261|16162442|P2|Period 2|Protocol Violation|1
4691819|NCT02406261|16162443|P1|Period 2|Protocol Violation|0
4691820|NCT02406261|16162442|P2|Period 2|Physician Decision|1
4691821|NCT02406261|16162443|P1|Period 2|Physician Decision|0
4691822|NCT02406261|16162442|P2|Period 1|Adverse Event|0
4691823|NCT02406261|16162443|P1|Period 1|Adverse Event|1
4691824|NCT02406261|16162442|P2|Period 1|Lost to Follow-up|0
4691825|NCT02406261|16162443|P1|Period 1|Lost to Follow-up|2
4691826|NCT02406248|16162455|P1|Overall Study|Withdrawal by Subject|2
4691827|NCT02406248|16162455|P1|Overall Study|Death|7
4691828|NCT02406027|16162466|P7|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4691829|NCT02406027|16162467|P6|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4691830|NCT02406027|16162468|P5|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1
4691831|NCT02406027|16162469|P4|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4691832|NCT02406027|16162470|P3|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4691833|NCT02406027|16162471|P2|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4691834|NCT02406027|16162472|P1|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0
4691835|NCT02406027|16162466|P7|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4691836|NCT02406027|16162467|P6|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1
4691837|NCT02406027|16162468|P5|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4691838|NCT02406027|16162469|P4|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4691839|NCT02406027|16162470|P3|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4691840|NCT02406027|16162471|P2|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4691841|NCT02406027|16162472|P1|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0
4691842|NCT02406027|16162466|P7|Open-label Phase (Period 2)|Study Terminated by Sponsor|19
4691843|NCT02406027|16162467|P6|Open-label Phase (Period 2)|Study Terminated by Sponsor|24
4691844|NCT02406027|16162468|P5|Open-label Phase (Period 2)|Study Terminated by Sponsor|7
4691845|NCT02406027|16162469|P4|Open-label Phase (Period 2)|Study Terminated by Sponsor|11
4691846|NCT02406027|16162470|P3|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
4691847|NCT02406027|16162471|P2|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
4691848|NCT02406027|16162472|P1|Open-label Phase (Period 2)|Study Terminated by Sponsor|0
4691849|NCT02406027|16162466|P7|Open-label Phase (Period 2)|Withdrawal by Subject|2
4691850|NCT02406027|16162467|P6|Open-label Phase (Period 2)|Withdrawal by Subject|0
4691851|NCT02406027|16162468|P5|Open-label Phase (Period 2)|Withdrawal by Subject|4
4691852|NCT02406027|16162469|P4|Open-label Phase (Period 2)|Withdrawal by Subject|2
4691853|NCT02406027|16162470|P3|Open-label Phase (Period 2)|Withdrawal by Subject|0
4691854|NCT02406027|16162471|P2|Open-label Phase (Period 2)|Withdrawal by Subject|0
4691855|NCT02406027|16162472|P1|Open-label Phase (Period 2)|Withdrawal by Subject|0
4691856|NCT02406027|16162466|P7|Open-label Phase (Period 2)|Physician Decision|1
4691857|NCT02406027|16162467|P6|Open-label Phase (Period 2)|Physician Decision|1
4691858|NCT02406027|16162468|P5|Open-label Phase (Period 2)|Physician Decision|0
4691859|NCT02406027|16162469|P4|Open-label Phase (Period 2)|Physician Decision|0
4691860|NCT02406027|16162470|P3|Open-label Phase (Period 2)|Physician Decision|0
4691861|NCT02406027|16162471|P2|Open-label Phase (Period 2)|Physician Decision|0
4691862|NCT02406027|16162472|P1|Open-label Phase (Period 2)|Physician Decision|0
4691863|NCT02406027|16162466|P7|Open-label Phase (Period 2)|Adverse Event|0
4691864|NCT02406027|16162467|P6|Open-label Phase (Period 2)|Adverse Event|0
4691865|NCT02406027|16162468|P5|Open-label Phase (Period 2)|Adverse Event|2
4691866|NCT02406027|16162469|P4|Open-label Phase (Period 2)|Adverse Event|2
4691867|NCT02406027|16162470|P3|Open-label Phase (Period 2)|Adverse Event|0
4691868|NCT02406027|16162471|P2|Open-label Phase (Period 2)|Adverse Event|0
4691869|NCT02406027|16162472|P1|Open-label Phase (Period 2)|Adverse Event|0
4691870|NCT02406027|16162466|P7|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4691871|NCT02406027|16162467|P6|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4691872|NCT02406027|16162468|P5|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4691873|NCT02406027|16162469|P4|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4691874|NCT02406027|16162470|P3|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
4691875|NCT02406027|16162471|P2|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0
4691876|NCT02406027|16162472|P1|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1
4691877|NCT02406027|16162466|P7|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4691878|NCT02406027|16162467|P6|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4691879|NCT02406027|16162468|P5|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4691880|NCT02406027|16162469|P4|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0
4691881|NCT02406027|16162470|P3|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
4691882|NCT02406027|16162471|P2|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1
4691883|NCT02406027|16162472|P1|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2
4691884|NCT02406027|16162466|P7|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4691885|NCT02406027|16162467|P6|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4691886|NCT02406027|16162468|P5|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4691887|NCT02406027|16162469|P4|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4691888|NCT02406027|16162470|P3|Double-blind Treatment Phase (Period 1)|Physician Decision|1
4691889|NCT02406027|16162471|P2|Double-blind Treatment Phase (Period 1)|Physician Decision|0
4691890|NCT02406027|16162472|P1|Double-blind Treatment Phase (Period 1)|Physician Decision|3
4691891|NCT02406027|16162466|P7|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4691892|NCT02406027|16162467|P6|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4691893|NCT02406027|16162468|P5|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4691894|NCT02406027|16162469|P4|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4691895|NCT02406027|16162470|P3|Double-blind Treatment Phase (Period 1)|Adverse Event|1
4691896|NCT02406027|16162471|P2|Double-blind Treatment Phase (Period 1)|Adverse Event|2
4691897|NCT02406027|16162472|P1|Double-blind Treatment Phase (Period 1)|Adverse Event|0
4691898|NCT02405962|16162502|P2|Overall Study|A participant has moved to another place|1
4691899|NCT02405962|16162503|P1|Overall Study|A participant has moved to another place|0
4691900|NCT02405962|16162502|P2|Overall Study|Lost to Follow-up|4
4691901|NCT02405962|16162503|P1|Overall Study|Lost to Follow-up|1
4691902|NCT02405780|16162541|P4|Period II|Non-compliance with study procedures|4
4691903|NCT02405780|16162542|P3|Period II|Non-compliance with study procedures|7
4691904|NCT02405780|16162543|P2|Period II|Non-compliance with study procedures|2
4691905|NCT02405780|16162544|P1|Period II|Non-compliance with study procedures|5
4691906|NCT02405780|16162541|P4|Period II|Withdrawal by Subject|3
4691907|NCT02405780|16162542|P3|Period II|Withdrawal by Subject|0
4691908|NCT02405780|16162543|P2|Period II|Withdrawal by Subject|4
4691909|NCT02405780|16162544|P1|Period II|Withdrawal by Subject|7
4691910|NCT02405780|16162541|P4|Period II|Pregnancy|0
4691911|NCT02405780|16162542|P3|Period II|Pregnancy|1
4691912|NCT02405780|16162543|P2|Period II|Pregnancy|0
4691913|NCT02405780|16162544|P1|Period II|Pregnancy|0
4691914|NCT02405780|16162541|P4|Period II|Medical reason|0
4691915|NCT02405780|16162542|P3|Period II|Medical reason|0
4691916|NCT02405780|16162543|P2|Period II|Medical reason|1
4691917|NCT02405780|16162544|P1|Period II|Medical reason|0
4691918|NCT02405780|16162541|P4|Period II|Adverse Event|11
4691919|NCT02405780|16162542|P3|Period II|Adverse Event|4
4691920|NCT02405780|16162543|P2|Period II|Adverse Event|5
4691921|NCT02405780|16162544|P1|Period II|Adverse Event|3
4691922|NCT02405780|16162541|P4|Period I|Non-compliance with study procedures|11
4691923|NCT02405780|16162542|P3|Period I|Non-compliance with study procedures|8
4691924|NCT02405780|16162543|P2|Period I|Non-compliance with study procedures|6
4691925|NCT02405780|16162544|P1|Period I|Non-compliance with study procedures|8
4691926|NCT02405780|16162541|P4|Period I|Withdrawal by Subject|4
4691927|NCT02405780|16162542|P3|Period I|Withdrawal by Subject|3
4691928|NCT02405780|16162543|P2|Period I|Withdrawal by Subject|1
4691929|NCT02405780|16162544|P1|Period I|Withdrawal by Subject|9
4691930|NCT02405780|16162541|P4|Period I|Screening Failure|0
4691931|NCT02405780|16162542|P3|Period I|Screening Failure|1
4691932|NCT02405780|16162543|P2|Period I|Screening Failure|0
4691933|NCT02405780|16162544|P1|Period I|Screening Failure|1
4691934|NCT02405780|16162541|P4|Period I|Medical reasons|1
4691935|NCT02405780|16162542|P3|Period I|Medical reasons|0
4691936|NCT02405780|16162543|P2|Period I|Medical reasons|1
4691937|NCT02405780|16162544|P1|Period I|Medical reasons|1
4691938|NCT02405780|16162541|P4|Period I|Adverse Event|7
4691939|NCT02405780|16162542|P3|Period I|Adverse Event|3
4691940|NCT02405780|16162543|P2|Period I|Adverse Event|0
4691941|NCT02405780|16162544|P1|Period I|Adverse Event|8
4691942|NCT02405442|16162607|P4|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
4691943|NCT02405442|16162608|P3|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
4691944|NCT02405442|16162609|P2|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0
4691945|NCT02405442|16162610|P1|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1
4691946|NCT02405442|16162607|P4|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
4691947|NCT02405442|16162608|P3|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
4691948|NCT02405442|16162609|P2|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1
4691949|NCT02405442|16162610|P1|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0
4691950|NCT02405442|16162607|P4|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
4691951|NCT02405442|16162608|P3|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
4691952|NCT02405442|16162609|P2|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1
4691953|NCT02405442|16162610|P1|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2
4691954|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
4691955|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
4691956|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Lost to Follow-up|1
4691957|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Lost to Follow-up|0
4691958|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
4691959|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
4691960|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Lack of Efficacy|1
4691961|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Lack of Efficacy|0
4691962|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Withdrew Consent|1
4691963|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Withdrew Consent|1
4691964|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Withdrew Consent|2
4691965|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Withdrew Consent|1
4691966|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2
4691967|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3
4691968|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1
4691969|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0
4691970|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Adverse Event|6
4691971|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Adverse Event|2
4691972|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Adverse Event|1
4691973|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Adverse Event|6
4691974|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Investigator's Discretion|2
4691975|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
4691976|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Investigator's Discretion|11
4691977|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Investigator's Discretion|14
4691978|NCT02405442|16162607|P4|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13
4691979|NCT02405442|16162608|P3|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
4691980|NCT02405442|16162609|P2|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28
4691981|NCT02405442|16162610|P1|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27
4691982|NCT02405442|16162607|P4|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
4691983|NCT02405442|16162608|P3|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
4691984|NCT02405442|16162609|P2|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1
4691985|NCT02405442|16162610|P1|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0
4691986|NCT02405442|16162607|P4|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
4691987|NCT02405442|16162608|P3|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0
4691988|NCT02405442|16162609|P2|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
4691989|NCT02405442|16162610|P1|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1
4691990|NCT02405442|16162607|P4|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
4691991|NCT02405442|16162608|P3|Double-Blind Phase (up to Week 8)|Withdrew Consent|2
4691992|NCT02405442|16162609|P2|Double-Blind Phase (up to Week 8)|Withdrew Consent|1
4691993|NCT02405442|16162610|P1|Double-Blind Phase (up to Week 8)|Withdrew Consent|0
4691994|NCT02405442|16162607|P4|Double-Blind Phase (up to Week 8)|Adverse Event|1
4691995|NCT02405442|16162608|P3|Double-Blind Phase (up to Week 8)|Adverse Event|4
4691996|NCT02405442|16162609|P2|Double-Blind Phase (up to Week 8)|Adverse Event|2
4691997|NCT02405442|16162610|P1|Double-Blind Phase (up to Week 8)|Adverse Event|0
4691998|NCT02405091|16162664|P3|Overall Study|Physician Decision|0
4691999|NCT02405091|16162665|P2|Overall Study|Physician Decision|2
4692000|NCT02405091|16162666|P1|Overall Study|Physician Decision|2
4692001|NCT02405091|16162664|P3|Overall Study|Lost to Follow-up|0
4692002|NCT02405091|16162665|P2|Overall Study|Lost to Follow-up|6
4692003|NCT02405091|16162666|P1|Overall Study|Lost to Follow-up|5
4692004|NCT02405091|16162664|P3|Overall Study|Death|0
4692005|NCT02405091|16162665|P2|Overall Study|Death|1
4692006|NCT02405091|16162666|P1|Overall Study|Death|0
4692007|NCT02405091|16162664|P3|Overall Study|Withdrawal by Subject|0
4692008|NCT02405091|16162665|P2|Overall Study|Withdrawal by Subject|8
4692009|NCT02405091|16162666|P1|Overall Study|Withdrawal by Subject|4
4692010|NCT02405091|16162664|P3|Overall Study|Noncompliance|2
4692011|NCT02405091|16162665|P2|Overall Study|Noncompliance|6
4692012|NCT02405091|16162666|P1|Overall Study|Noncompliance|1
4692013|NCT02405091|16162664|P3|Overall Study|Protocol Violation|0
4692014|NCT02405091|16162665|P2|Overall Study|Protocol Violation|0
4692015|NCT02405091|16162666|P1|Overall Study|Protocol Violation|1
4692016|NCT02405091|16162664|P3|Overall Study|Adverse Event|0
4692017|NCT02405091|16162665|P2|Overall Study|Adverse Event|10
4692018|NCT02405091|16162666|P1|Overall Study|Adverse Event|16
4692019|NCT02404649|16162725|P2|Overall Study|Adverse Event|2
4692020|NCT02404649|16162726|P1|Overall Study|Adverse Event|1
4692021|NCT02404545|16162745|P2|Overall Study|Sponsor Termination|6
4692022|NCT02404545|16162746|P1|Overall Study|Sponsor Termination|6
4692023|NCT02404493|16162765|P2|Overall Study|Adverse Event|1
4692024|NCT02404493|16162766|P1|Overall Study|Adverse Event|1
4692025|NCT02404389|16163011|P5|Overall Study|Subject/guardian decision|1
4692026|NCT02404389|16163012|P4|Overall Study|Subject/guardian decision|1
4692027|NCT02404389|16163013|P3|Overall Study|Subject/guardian decision|0
4692028|NCT02404389|16163014|P2|Overall Study|Subject/guardian decision|0
4692029|NCT02404389|16163015|P1|Overall Study|Subject/guardian decision|1
4692030|NCT02404389|16163011|P5|Overall Study|Adverse Event|2
4692031|NCT02404389|16163012|P4|Overall Study|Adverse Event|0
4692032|NCT02404389|16163013|P3|Overall Study|Adverse Event|1
4692033|NCT02404389|16163014|P2|Overall Study|Adverse Event|0
4692034|NCT02404389|16163015|P1|Overall Study|Adverse Event|1
4692035|NCT02404350|16163055|P4|Overall Study|Due to Technical problems|1
4692036|NCT02404350|16163056|P3|Overall Study|Due to Technical problems|0
4692037|NCT02404350|16163057|P2|Overall Study|Due to Technical problems|0
4692038|NCT02404350|16163058|P1|Overall Study|Due to Technical problems|0
4692039|NCT02404350|16163055|P4|Overall Study|Due to Non-compliance with treatment|1
4692040|NCT02404350|16163056|P3|Overall Study|Due to Non-compliance with treatment|0
4692041|NCT02404350|16163057|P2|Overall Study|Due to Non-compliance with treatment|0
4692042|NCT02404350|16163058|P1|Overall Study|Due to Non-compliance with treatment|0
4692043|NCT02404350|16163055|P4|Overall Study|Withdrawal by Subject|19
4692044|NCT02404350|16163056|P3|Overall Study|Withdrawal by Subject|3
4692045|NCT02404350|16163057|P2|Overall Study|Withdrawal by Subject|3
4692046|NCT02404350|16163058|P1|Overall Study|Withdrawal by Subject|7
4692047|NCT02404350|16163055|P4|Overall Study|Pregnancy|1
4692048|NCT02404350|16163056|P3|Overall Study|Pregnancy|0
4692049|NCT02404350|16163057|P2|Overall Study|Pregnancy|0
4692050|NCT02404350|16163058|P1|Overall Study|Pregnancy|0
4692051|NCT02404350|16163055|P4|Overall Study|Physician Decision|2
4692052|NCT02404350|16163056|P3|Overall Study|Physician Decision|0
4692053|NCT02404350|16163057|P2|Overall Study|Physician Decision|0
4692054|NCT02404350|16163058|P1|Overall Study|Physician Decision|1
4692055|NCT02404350|16163055|P4|Overall Study|Lost to Follow-up|1
4692056|NCT02404350|16163056|P3|Overall Study|Lost to Follow-up|0
4692057|NCT02404350|16163057|P2|Overall Study|Lost to Follow-up|0
4692058|NCT02404350|16163058|P1|Overall Study|Lost to Follow-up|2
4692059|NCT02404350|16163055|P4|Overall Study|Lack of Efficacy|3
4692060|NCT02404350|16163056|P3|Overall Study|Lack of Efficacy|0
4692061|NCT02404350|16163057|P2|Overall Study|Lack of Efficacy|1
4692062|NCT02404350|16163058|P1|Overall Study|Lack of Efficacy|3
4692063|NCT02404350|16163055|P4|Overall Study|Adverse Event|9
4692064|NCT02404350|16163056|P3|Overall Study|Adverse Event|3
4692065|NCT02404350|16163057|P2|Overall Study|Adverse Event|2
4692066|NCT02404350|16163058|P1|Overall Study|Adverse Event|2
4692067|NCT02404311|16163106|P5|Part A: Month 0-18|Participant unable to adhere|0
4692068|NCT02404311|16163107|P4|Part A: Month 0-18|Participant unable to adhere|0
4692069|NCT02404311|16163108|P3|Part A: Month 0-18|Participant unable to adhere|0
4692070|NCT02404311|16163109|P2|Part A: Month 0-18|Participant unable to adhere|0
4692071|NCT02404311|16163110|P1|Part A: Month 0-18|Participant unable to adhere|7
4692072|NCT02404311|16163106|P5|Part A: Month 0-18|HIV Infection|0
4692073|NCT02404311|16163107|P4|Part A: Month 0-18|HIV Infection|0
4692074|NCT02404311|16163108|P3|Part A: Month 0-18|HIV Infection|0
4692075|NCT02404311|16163109|P2|Part A: Month 0-18|HIV Infection|2
4692076|NCT02404311|16163110|P1|Part A: Month 0-18|HIV Infection|6
4692077|NCT02404311|16163106|P5|Part A: Month 0-18|Withdrawal by Subject|0
4692078|NCT02404311|16163107|P4|Part A: Month 0-18|Withdrawal by Subject|0
4692079|NCT02404311|16163108|P3|Part A: Month 0-18|Withdrawal by Subject|0
4692080|NCT02404311|16163109|P2|Part A: Month 0-18|Withdrawal by Subject|2
4692081|NCT02404311|16163110|P1|Part A: Month 0-18|Withdrawal by Subject|6
4692082|NCT02404311|16163106|P5|Part A: Month 0-18|Lost to Follow-up|0
4692083|NCT02404311|16163107|P4|Part A: Month 0-18|Lost to Follow-up|0
4692084|NCT02404311|16163108|P3|Part A: Month 0-18|Lost to Follow-up|0
4692085|NCT02404311|16163109|P2|Part A: Month 0-18|Lost to Follow-up|2
4692086|NCT02404311|16163110|P1|Part A: Month 0-18|Lost to Follow-up|4
4692087|NCT02404311|16163106|P5|Part A: Month 0-18|Physician Decision|0
4692088|NCT02404311|16163107|P4|Part A: Month 0-18|Physician Decision|0
4692089|NCT02404311|16163108|P3|Part A: Month 0-18|Physician Decision|0
4692090|NCT02404311|16163109|P2|Part A: Month 0-18|Physician Decision|0
4692091|NCT02404311|16163110|P1|Part A: Month 0-18|Physician Decision|1
4692092|NCT02404311|16163106|P5|Part A: Month 0-18|Death|0
4692093|NCT02404311|16163107|P4|Part A: Month 0-18|Death|0
4692094|NCT02404311|16163108|P3|Part A: Month 0-18|Death|0
4692095|NCT02404311|16163109|P2|Part A: Month 0-18|Death|0
4692096|NCT02404311|16163110|P1|Part A: Month 0-18|Death|2
4692097|NCT02404220|16163251|P4|Overall Study|Enrolled but Never Treated|0
4692098|NCT02404220|16163252|P3|Overall Study|Enrolled but Never Treated|0
4692099|NCT02404220|16163253|P2|Overall Study|Enrolled but Never Treated|2
4692100|NCT02404220|16163254|P1|Overall Study|Enrolled but Never Treated|0
4692101|NCT02404220|16163251|P4|Overall Study|Withdrawal by Subject|0
4692102|NCT02404220|16163252|P3|Overall Study|Withdrawal by Subject|0
4692103|NCT02404220|16163253|P2|Overall Study|Withdrawal by Subject|1
4692104|NCT02404220|16163254|P1|Overall Study|Withdrawal by Subject|0
4692105|NCT02404220|16163251|P4|Overall Study|Study Terminated by Sponsor|1
4692106|NCT02404220|16163252|P3|Overall Study|Study Terminated by Sponsor|2
4692107|NCT02404220|16163253|P2|Overall Study|Study Terminated by Sponsor|0
4692108|NCT02404220|16163254|P1|Overall Study|Study Terminated by Sponsor|0
4692109|NCT02404220|16163251|P4|Overall Study|Progressive Disease|1
4692110|NCT02404220|16163252|P3|Overall Study|Progressive Disease|1
4692111|NCT02404220|16163253|P2|Overall Study|Progressive Disease|0
4692112|NCT02404220|16163254|P1|Overall Study|Progressive Disease|0
4692113|NCT02404220|16163251|P4|Overall Study|Death|8
4692114|NCT02404220|16163252|P3|Overall Study|Death|3
4692115|NCT02404220|16163253|P2|Overall Study|Death|5
4692116|NCT02404220|16163254|P1|Overall Study|Death|5
4692117|NCT02404220|16163251|P4|Overall Study|Adverse Event|0
4692118|NCT02404220|16163252|P3|Overall Study|Adverse Event|1
4692119|NCT02404220|16163253|P2|Overall Study|Adverse Event|0
4692120|NCT02404220|16163254|P1|Overall Study|Adverse Event|0
4692121|NCT02404103|16163290|P2|Overall Study|Lost to Follow-up|3
4692122|NCT02404103|16163291|P1|Overall Study|Lost to Follow-up|3
4692123|NCT02404103|16163290|P2|Overall Study|Adverse Event|0
4692124|NCT02404103|16163291|P1|Overall Study|Adverse Event|1
4692125|NCT02404025|16163311|P1|Overall Study|Lack of Efficacy|3
4692126|NCT02404025|16163311|P1|Overall Study|Adverse Event|1
4692127|NCT02403817|16163393|P2|Overall Study|Withdrawal by Subject|0
4692128|NCT02403817|16163394|P1|Overall Study|Withdrawal by Subject|5
4692129|NCT02403674|16163425|P2|Overall Study|Protocol Violation|2
4692130|NCT02403674|16163426|P1|Overall Study|Protocol Violation|4
4692131|NCT02403674|16163425|P2|Overall Study|Pregnancy|1
4692132|NCT02403674|16163426|P1|Overall Study|Pregnancy|1
4692133|NCT02403674|16163425|P2|Overall Study|Not treated with study drug|2
4692134|NCT02403674|16163426|P1|Overall Study|Not treated with study drug|4
4692135|NCT02403674|16163425|P2|Overall Study|Physician Decision|2
4692136|NCT02403674|16163426|P1|Overall Study|Physician Decision|2
4692137|NCT02403674|16163425|P2|Overall Study|Withdrawal by Subject|11
4692138|NCT02403674|16163426|P1|Overall Study|Withdrawal by Subject|8
4692139|NCT02403674|16163425|P2|Overall Study|Noncompliance with study drug|2
4692140|NCT02403674|16163426|P1|Overall Study|Noncompliance with study drug|1
4692141|NCT02403674|16163425|P2|Overall Study|Lost to Follow-up|7
4692142|NCT02403674|16163426|P1|Overall Study|Lost to Follow-up|6
4692143|NCT02403674|16163425|P2|Overall Study|Lack of Efficacy|10
4692144|NCT02403674|16163426|P1|Overall Study|Lack of Efficacy|18
4692145|NCT02403674|16163425|P2|Overall Study|Death|3
4692146|NCT02403674|16163426|P1|Overall Study|Death|1
4692147|NCT02403674|16163425|P2|Overall Study|Adverse Event|23
4692148|NCT02403674|16163426|P1|Overall Study|Adverse Event|10
4692149|NCT02403635|16163465|P1|Overall Study|Not eligible|9
4692150|NCT02403271|16163542|P2|Period 2|Other varied reasons|10
4692151|NCT02403271|16163543|P1|Period 2|Other varied reasons|0
4692152|NCT02403271|16163542|P2|Period 2|Study Terminated by Sponsor|14
4692153|NCT02403271|16163543|P1|Period 2|Study Terminated by Sponsor|0
4692154|NCT02403271|16163542|P2|Period 2|Lost to Follow-up|2
4692155|NCT02403271|16163543|P1|Period 2|Lost to Follow-up|0
4692156|NCT02403271|16163542|P2|Period 2|Death|84
4692157|NCT02403271|16163543|P1|Period 2|Death|0
4692158|NCT02403271|16163542|P2|Period 2|Withdrawal by Subject|14
4692159|NCT02403271|16163543|P1|Period 2|Withdrawal by Subject|0
4692160|NCT02403271|16163542|P2|Period 1|Other varied reasons|0
4692161|NCT02403271|16163543|P1|Period 1|Other varied reasons|1
4692162|NCT02403206|16163557|P2|Overall Study|Reason not given|4
4692163|NCT02403206|16163558|P1|Overall Study|Reason not given|2
4692164|NCT02403206|16163557|P2|Overall Study|Withdrawal by Subject|3
4692165|NCT02403206|16163558|P1|Overall Study|Withdrawal by Subject|3
4692166|NCT02403206|16163557|P2|Overall Study|Physician Decision|0
4692167|NCT02403206|16163558|P1|Overall Study|Physician Decision|2
4692168|NCT02403206|16163557|P2|Overall Study|Lost to Follow-up|3
4692169|NCT02403206|16163558|P1|Overall Study|Lost to Follow-up|4
4692170|NCT02403180|16163569|P2|Period 2 (5 Days)|Withdrawal by Subject|1
4692171|NCT02403180|16163570|P1|Period 2 (5 Days)|Withdrawal by Subject|0
4692172|NCT02403180|16163569|P2|Pre-Treatment Period|Withdrawal by subject prior to treatment|1
4692173|NCT02403180|16163570|P1|Pre-Treatment Period|Withdrawal by subject prior to treatment|0
4692174|NCT02402933|16163599|P1|Overall Study|Discontinued; Site Termination|10
4692175|NCT02402933|16163599|P1|Overall Study|Withdrawal by Subject|4
4692176|NCT02402322|16163643|P3|Follow-up|Withdrawal by Subject|24
4692177|NCT02402322|16163644|P2|Follow-up|Withdrawal by Subject|3
4692178|NCT02402322|16163645|P1|Follow-up|Withdrawal by Subject|6
4692179|NCT02402322|16163643|P3|Pretreatment|Withdrawal by Subject|1
4692180|NCT02402322|16163644|P2|Pretreatment|Withdrawal by Subject|1
4692181|NCT02402322|16163645|P1|Pretreatment|Withdrawal by Subject|3
4692182|NCT02134353|16163694|P2|Overall Study|Other - Patient's Choice|1
4692183|NCT02134353|16163695|P1|Overall Study|Other - Patient's Choice|0
4692184|NCT02134353|16163694|P2|Overall Study|Relocation|0
4692185|NCT02134353|16163695|P1|Overall Study|Relocation|1
4692186|NCT02134353|16163694|P2|Overall Study|Pregnancy|1
4692187|NCT02134353|16163695|P1|Overall Study|Pregnancy|0
4692188|NCT02134353|16163694|P2|Overall Study|Death|1
4692189|NCT02134353|16163695|P1|Overall Study|Death|0
4692190|NCT02134353|16163694|P2|Overall Study|Withdrawal by Subject|13
4692191|NCT02134353|16163695|P1|Overall Study|Withdrawal by Subject|12
4692192|NCT02134353|16163694|P2|Overall Study|Lack of Efficacy|1
4692193|NCT02134353|16163695|P1|Overall Study|Lack of Efficacy|2
4692194|NCT02134353|16163694|P2|Overall Study|Lost to Follow-up|1
4692195|NCT02134353|16163695|P1|Overall Study|Lost to Follow-up|1
4692196|NCT02134353|16163694|P2|Overall Study|Adverse Event|6
4692197|NCT02134353|16163695|P1|Overall Study|Adverse Event|10
4692198|NCT02402218|16163722|P3|Overall Study|Withdrawal by Subject|1
4692199|NCT02402218|16163723|P2|Overall Study|Withdrawal by Subject|1
4692200|NCT02402218|16163724|P1|Overall Study|Withdrawal by Subject|1
4692201|NCT02402218|16163722|P3|Overall Study|Adverse Event|1
4692202|NCT02402218|16163723|P2|Overall Study|Adverse Event|2
4692203|NCT02402218|16163724|P1|Overall Study|Adverse Event|0
4692204|NCT02402218|16163722|P3|Overall Study|Reinfection|1
4692205|NCT02402218|16163723|P2|Overall Study|Reinfection|0
4692206|NCT02402218|16163724|P1|Overall Study|Reinfection|0
4692207|NCT02402218|16163722|P3|Overall Study|Death|0
4692208|NCT02402218|16163723|P2|Overall Study|Death|0
4692209|NCT02402218|16163724|P1|Overall Study|Death|1
4692210|NCT02402218|16163722|P3|Overall Study|Lack of Efficacy|1
4692211|NCT02402218|16163723|P2|Overall Study|Lack of Efficacy|1
4692212|NCT02402218|16163724|P1|Overall Study|Lack of Efficacy|0
4692213|NCT02402218|16163722|P3|Overall Study|Did not pickup study medication|13
4692214|NCT02402218|16163723|P2|Overall Study|Did not pickup study medication|9
4692215|NCT02402218|16163724|P1|Overall Study|Did not pickup study medication|12
4692216|NCT02402166|16163747|P1|Overall Study|Lost to Follow-up|1
4692217|NCT02402166|16163747|P1|Overall Study|Withdrawal by Subject|2
4692218|NCT02402166|16163747|P1|Overall Study|Adverse Event|2
4692219|NCT02401867|16163814|P1|Analysis|Cervical assay could not be conducted|9
4692220|NCT02401867|16163814|P1|Specimen Collection|Didn't receive 1 or more tests|10
4692221|NCT02401672|16163821|P2|Overall Study|Withdrawal by Subject|3
4692222|NCT02401672|16163822|P1|Overall Study|Withdrawal by Subject|1
4692223|NCT02401529|16163864|P2|Overall Study|Protocol Violation|0
4692224|NCT02401529|16163865|P1|Overall Study|Protocol Violation|5
4692225|NCT02401529|16163864|P2|Overall Study|Physician Decision|6
4692226|NCT02401529|16163865|P1|Overall Study|Physician Decision|2
4692227|NCT02401529|16163864|P2|Overall Study|Lost to Follow-up|1
4692228|NCT02401529|16163865|P1|Overall Study|Lost to Follow-up|2
4692229|NCT02401412|16163932|P2|Overall Study|Improper Enrollment per In/Ex Criteria|6
4692230|NCT02401412|16163933|P1|Overall Study|Improper Enrollment per In/Ex Criteria|10
4692231|NCT02401412|16163932|P2|Overall Study|Subject withdrawal prior to intervention|1
4692232|NCT02401412|16163933|P1|Overall Study|Subject withdrawal prior to intervention|0
4692233|NCT02401412|16163932|P2|Overall Study|Withdrawal by Subject|4
4692234|NCT02401412|16163933|P1|Overall Study|Withdrawal by Subject|4
4692235|NCT02401412|16163932|P2|Overall Study|Discontinued Intervention|21
4692236|NCT02401412|16163933|P1|Overall Study|Discontinued Intervention|15
4692237|NCT02401412|16163932|P2|Overall Study|Lost to Follow-up|0
4692238|NCT02401412|16163933|P1|Overall Study|Lost to Follow-up|1
4692239|NCT02401256|16163941|P1|Overall Study|Withdrawal by Subject|12
4692240|NCT02401256|16163941|P1|Overall Study|Adverse Event|5
4692241|NCT02401230|16163950|P3|Overall Study|Lost to Follow-up|3
4692242|NCT02401230|16163951|P2|Overall Study|Lost to Follow-up|3
4692243|NCT02401230|16163952|P1|Overall Study|Lost to Follow-up|1
4692244|NCT02401230|16163950|P3|Overall Study|Withdrawal by Subject|1
4692245|NCT02401230|16163951|P2|Overall Study|Withdrawal by Subject|1
4692246|NCT02401230|16163952|P1|Overall Study|Withdrawal by Subject|2
4692247|NCT02401230|16163950|P3|Overall Study|Adverse Event|0
4692248|NCT02401230|16163951|P2|Overall Study|Adverse Event|2
4692249|NCT02401230|16163952|P1|Overall Study|Adverse Event|3
4692250|NCT02400905|16164031|P1|Overall Study|Subject refused visit|1
4692251|NCT02400905|16164031|P1|Overall Study|Death|3
4692252|NCT02400905|16164031|P1|Overall Study|Withdrawal by Subject|5
4692253|NCT02400905|16164031|P1|Overall Study|Lost to Follow-up|6
4692254|NCT02400905|16164031|P1|Overall Study|Ongoing Follow-up|256
4692255|NCT02400749|16164041|P2|Week 17 - 32|Adverse Event|1
4692256|NCT02400749|16164042|P1|Week 17 - 32|Adverse Event|2
4692257|NCT02400749|16164041|P2|Week 17 - 32|Withdrawal by Subject|2
4692258|NCT02400749|16164042|P1|Week 17 - 32|Withdrawal by Subject|3
4692259|NCT02400749|16164041|P2|Week 0 -16|Protocol Violation|0
4692260|NCT02400749|16164042|P1|Week 0 -16|Protocol Violation|1
4692261|NCT02400749|16164041|P2|Week 0 -16|Lost to Follow-up|0
4692262|NCT02400749|16164042|P1|Week 0 -16|Lost to Follow-up|2
4692263|NCT02400749|16164041|P2|Week 0 -16|Adverse Event|1
4692264|NCT02400749|16164042|P1|Week 0 -16|Adverse Event|3
4692265|NCT02400749|16164041|P2|Week 0 -16|Withdrawal by Subject|5
4692266|NCT02400749|16164042|P1|Week 0 -16|Withdrawal by Subject|5
4692267|NCT02400580|16164069|P2|Overall Study|Adverse Event|0
4692268|NCT02400580|16164070|P1|Overall Study|Adverse Event|1
4692269|NCT02400580|16164069|P2|Overall Study|Withdrawal by Subject|1
4692270|NCT02400580|16164070|P1|Overall Study|Withdrawal by Subject|1
4692271|NCT02400346|16164097|P1|Overall Study|Lost to Follow-up|1
4692272|NCT02400346|16164097|P1|Overall Study|Administrative or other reason(s)|2
4692273|NCT02400346|16164097|P1|Overall Study|Withdrawal by Subject|7
4692274|NCT02400346|16164097|P1|Overall Study|Non-compliance with IMP|1
4692275|NCT02400346|16164097|P1|Overall Study|Lack of Efficacy|9
4692276|NCT02400346|16164097|P1|Overall Study|Adverse Event|24
4692277|NCT02400333|16164105|P4|Overall Study|Protocol Violation|1
4692278|NCT02400333|16164106|P3|Overall Study|Protocol Violation|2
4692279|NCT02400333|16164107|P2|Overall Study|Protocol Violation|0
4692280|NCT02400333|16164108|P1|Overall Study|Protocol Violation|1
4692281|NCT02400333|16164105|P4|Overall Study|Withdrawal by Subject|1
4692282|NCT02400333|16164106|P3|Overall Study|Withdrawal by Subject|0
4692283|NCT02400333|16164107|P2|Overall Study|Withdrawal by Subject|1
4692284|NCT02400333|16164108|P1|Overall Study|Withdrawal by Subject|0
4692285|NCT02400307|16164168|P2|Overall Study|Enrolled and Never Dosed|0
4692286|NCT02400307|16164169|P1|Overall Study|Enrolled and Never Dosed|1
4692287|NCT02399254|16164223|P1|Overall Study|Physician Decision|2
4692288|NCT02399163|16164230|P1|Overall Study|Withdrawal by Participant|5
4692289|NCT02399163|16164230|P1|Overall Study|Protocol Deviation|2
4692290|NCT02399163|16164230|P1|Overall Study|Adverse Event|2
4692291|NCT02398227|16164300|P2|Overall Study|Removed from treatment and dropped out|0
4692292|NCT02398227|16164301|P1|Overall Study|Removed from treatment and dropped out|1
4692293|NCT02398227|16164300|P2|Overall Study|Withdrawal by Subject|6
4692294|NCT02398227|16164301|P1|Overall Study|Withdrawal by Subject|5
4692295|NCT02398227|16164300|P2|Overall Study|Lost to Follow-up|12
4692296|NCT02398227|16164301|P1|Overall Study|Lost to Follow-up|21
4692297|NCT02398188|16164311|P2|Overall Study|Withdrawal by Subject|16
4692298|NCT02398188|16164312|P1|Overall Study|Withdrawal by Subject|7
4692299|NCT02398188|16164311|P2|Overall Study|Pregnancy|0
4692300|NCT02398188|16164312|P1|Overall Study|Pregnancy|1
4692301|NCT02398188|16164311|P2|Overall Study|Sponsor Decision|1
4692302|NCT02398188|16164312|P1|Overall Study|Sponsor Decision|2
4692303|NCT02398188|16164311|P2|Overall Study|Protocol Violation|10
4692304|NCT02398188|16164312|P1|Overall Study|Protocol Violation|6
4692305|NCT02398188|16164311|P2|Overall Study|Non-compliance|4
4692306|NCT02398188|16164312|P1|Overall Study|Non-compliance|4
4692307|NCT02398188|16164311|P2|Overall Study|Lost to Follow-up|0
4692308|NCT02398188|16164312|P1|Overall Study|Lost to Follow-up|5
4692309|NCT02398188|16164311|P2|Overall Study|Adverse Event|3
4692310|NCT02398188|16164312|P1|Overall Study|Adverse Event|2
4692311|NCT02397915|16164330|P4|Period 1|Physician Decision|0
4692312|NCT02397915|16164331|P3|Period 1|Physician Decision|0
4692313|NCT02397915|16164332|P2|Period 1|Physician Decision|0
4692314|NCT02397915|16164333|P1|Period 1|Physician Decision|1
4692315|NCT02397915|16164330|P4|Period 1|Protocol Violation|0
4692316|NCT02397915|16164331|P3|Period 1|Protocol Violation|0
4692317|NCT02397915|16164332|P2|Period 1|Protocol Violation|1
4692318|NCT02397915|16164333|P1|Period 1|Protocol Violation|0
4692319|NCT02397837|16164385|P2|Overall Study|Physician Decision|1
4692320|NCT02397837|16164386|P1|Overall Study|Physician Decision|1
4692321|NCT02397837|16164385|P2|Overall Study|Withdrawal by Subject|5
4692322|NCT02397837|16164386|P1|Overall Study|Withdrawal by Subject|6
4692323|NCT02397694|16164481|P2|Open Label Extension Phase|Lost to Follow-up|0
4692324|NCT02397694|16164482|P1|Open Label Extension Phase|Lost to Follow-up|4
4692325|NCT02397694|16164481|P2|Open Label Extension Phase|Withdrew Consent|1
4692326|NCT02397694|16164482|P1|Open Label Extension Phase|Withdrew Consent|3
4692327|NCT02397694|16164481|P2|Open Label Extension Phase|Protocol Violation|0
4692328|NCT02397694|16164482|P1|Open Label Extension Phase|Protocol Violation|1
4692329|NCT02397694|16164481|P2|Double-Blinded Phase|Lost to Follow-up|1
4692330|NCT02397694|16164482|P1|Double-Blinded Phase|Lost to Follow-up|1
4692331|NCT02397694|16164481|P2|Double-Blinded Phase|Withdrawal by Subject|0
4692332|NCT02397694|16164482|P1|Double-Blinded Phase|Withdrawal by Subject|1
4692333|NCT02397694|16164481|P2|Double-Blinded Phase|Non-compliance with study drug|2
4692334|NCT02397694|16164482|P1|Double-Blinded Phase|Non-compliance with study drug|0
4692335|NCT02397694|16164481|P2|Double-Blinded Phase|Adverse Event|0
4692336|NCT02397694|16164482|P1|Double-Blinded Phase|Adverse Event|1
4692337|NCT02397655|16164520|P1|Overall Study|data not completed|1301
4692338|NCT02397473|16164531|P2|Post Treatment Follow-up Phase|Withdrawal by Subject|1
4692339|NCT02397473|16164532|P1|Post Treatment Follow-up Phase|Withdrawal by Subject|0
4692340|NCT02397473|16164531|P2|Post Treatment Follow-up Phase|Protocol Violation|0
4692341|NCT02397473|16164532|P1|Post Treatment Follow-up Phase|Protocol Violation|1
4692342|NCT02397473|16164531|P2|Post Treatment Follow-up Phase|Lost to Follow-up|0
4692343|NCT02397473|16164532|P1|Post Treatment Follow-up Phase|Lost to Follow-up|1
4692344|NCT02397473|16164531|P2|Post Treatment Follow-up Phase|Lack of Efficacy|1
4692345|NCT02397473|16164532|P1|Post Treatment Follow-up Phase|Lack of Efficacy|1
4692346|NCT02397473|16164531|P2|Treatment Phase|Protocol Violation(did not receive drug)|3
4692347|NCT02397473|16164532|P1|Treatment Phase|Protocol Violation(did not receive drug)|0
4692348|NCT02397473|16164531|P2|Treatment Phase|Withdrawal by Subject|1
4692349|NCT02397473|16164532|P1|Treatment Phase|Withdrawal by Subject|2
4692350|NCT02397473|16164531|P2|Treatment Phase|Lost to Follow-up|0
4692351|NCT02397473|16164532|P1|Treatment Phase|Lost to Follow-up|1
4692352|NCT02397473|16164531|P2|Treatment Phase|Lack of Efficacy|1
4692353|NCT02397473|16164532|P1|Treatment Phase|Lack of Efficacy|8
4692354|NCT02397473|16164531|P2|Treatment Phase|Adverse Event|2
4692355|NCT02397473|16164532|P1|Treatment Phase|Adverse Event|1
4692356|NCT02397447|16164562|P2|Overall Study|Lost to Follow-up|2
4692357|NCT02397447|16164563|P1|Overall Study|Lost to Follow-up|2
4692358|NCT02397096|16164640|P2|Study Extensions|Ongoing|202
4692359|NCT02397096|16164641|P1|Study Extensions|Ongoing|399
4692360|NCT02397096|16164640|P2|Week 24 to Week 48|Lost to Follow-up|0
4692361|NCT02397096|16164641|P1|Week 24 to Week 48|Lost to Follow-up|2
4692362|NCT02397096|16164640|P2|Week 24 to Week 48|Withdrawal by Subject|2
4692363|NCT02397096|16164641|P1|Week 24 to Week 48|Withdrawal by Subject|5
4692364|NCT02397096|16164640|P2|Week 24 to Week 48|Physician Decision|1
4692365|NCT02397096|16164641|P1|Week 24 to Week 48|Physician Decision|2
4692366|NCT02397096|16164640|P2|Week 24 to Week 48|Non-Compliance With Study Drug|1
4692367|NCT02397096|16164641|P1|Week 24 to Week 48|Non-Compliance With Study Drug|0
4692368|NCT02397096|16164640|P2|Week 24 to Week 48|Lack of Efficacy|1
4692369|NCT02397096|16164641|P1|Week 24 to Week 48|Lack of Efficacy|5
4692370|NCT02397096|16164640|P2|Week 24 to Week 48|Adverse Event|2
4692371|NCT02397096|16164641|P1|Week 24 to Week 48|Adverse Event|6
4692372|NCT02397096|16164640|P2|Day 1 to Week 24|Withdrawal by Subject|1
4692373|NCT02397096|16164641|P1|Day 1 to Week 24|Withdrawal by Subject|6
4692374|NCT02397096|16164640|P2|Day 1 to Week 24|Protocol Violation|4
4692375|NCT02397096|16164641|P1|Day 1 to Week 24|Protocol Violation|1
4692376|NCT02397096|16164640|P2|Day 1 to Week 24|Physician Decision|3
4692377|NCT02397096|16164641|P1|Day 1 to Week 24|Physician Decision|2
4692378|NCT02397096|16164640|P2|Day 1 to Week 24|Lost to Follow-up|4
4692379|NCT02397096|16164641|P1|Day 1 to Week 24|Lost to Follow-up|3
4692380|NCT02397096|16164640|P2|Day 1 to Week 24|Lack of Efficacy|1
4692381|NCT02397096|16164641|P1|Day 1 to Week 24|Lack of Efficacy|0
4692382|NCT02397096|16164640|P2|Day 1 to Week 24|Death|0
4692383|NCT02397096|16164641|P1|Day 1 to Week 24|Death|1
4692384|NCT02397096|16164640|P2|Day 1 to Week 24|Adverse Event|1
4692385|NCT02397096|16164641|P1|Day 1 to Week 24|Adverse Event|7
4692386|NCT02396953|16164674|P3|Overall Study|Personal Reasons|0
4692387|NCT02396953|16164675|P2|Overall Study|Personal Reasons|1
4692388|NCT02396953|16164676|P1|Overall Study|Personal Reasons|1
4692389|NCT02396953|16164674|P3|Overall Study|Insulin like Growth Factor-1 increased|2
4692390|NCT02396953|16164675|P2|Overall Study|Insulin like Growth Factor-1 increased|2
4692391|NCT02396953|16164676|P1|Overall Study|Insulin like Growth Factor-1 increased|3
4692392|NCT02396953|16164674|P3|Overall Study|Withdrawal by Subject|1
4692393|NCT02396953|16164675|P2|Overall Study|Withdrawal by Subject|0
4692394|NCT02396953|16164676|P1|Overall Study|Withdrawal by Subject|0
4692395|NCT02396537|16164751|P2|Overall Study|Protocol Violation|1
4692396|NCT02396537|16164752|P1|Overall Study|Protocol Violation|0
4692397|NCT02396420|16164764|P1|Overall Study|Death|1
4692398|NCT02396381|16164788|P2|Overall Study|Randomization/Screening Error|1
4692399|NCT02396381|16164789|P1|Overall Study|Randomization/Screening Error|3
4692400|NCT02396381|16164788|P2|Overall Study|Possible conflict of interest|0
4692401|NCT02396381|16164789|P1|Overall Study|Possible conflict of interest|1
4692402|NCT02396381|16164788|P2|Overall Study|Could not complete visit|0
4692403|NCT02396381|16164789|P1|Overall Study|Could not complete visit|1
4692404|NCT02396381|16164788|P2|Overall Study|Moved out of town/state|3
4692405|NCT02396381|16164789|P1|Overall Study|Moved out of town/state|1
4692406|NCT02396381|16164788|P2|Overall Study|Non-compliance with study procedures|0
4692407|NCT02396381|16164789|P1|Overall Study|Non-compliance with study procedures|1
4692408|NCT02396381|16164788|P2|Overall Study|Pregnancy|0
4692409|NCT02396381|16164789|P1|Overall Study|Pregnancy|2
4692410|NCT02396381|16164788|P2|Overall Study|Physician Decision|5
4692411|NCT02396381|16164789|P1|Overall Study|Physician Decision|5
4692412|NCT02396381|16164788|P2|Overall Study|Site terminated by sponsor|8
4692413|NCT02396381|16164789|P1|Overall Study|Site terminated by sponsor|7
4692414|NCT02396381|16164788|P2|Overall Study|Protocol Violation|0
4692415|NCT02396381|16164789|P1|Overall Study|Protocol Violation|1
4692416|NCT02396381|16164788|P2|Overall Study|Lost to Follow-up|31
4692417|NCT02396381|16164789|P1|Overall Study|Lost to Follow-up|49
4692418|NCT02396381|16164788|P2|Overall Study|Withdrawal by Subject|24
4692419|NCT02396381|16164789|P1|Overall Study|Withdrawal by Subject|33
4692420|NCT02396381|16164788|P2|Overall Study|Adverse Event|2
4692421|NCT02396381|16164789|P1|Overall Study|Adverse Event|3
4692422|NCT02396316|16164828|P2|Overall Study|Treatment unblinded|1
4692423|NCT02396316|16164829|P1|Overall Study|Treatment unblinded|0
4692424|NCT02396316|16164828|P2|Overall Study|Protocol Violation|1
4692425|NCT02396316|16164829|P1|Overall Study|Protocol Violation|0
4692426|NCT02396316|16164828|P2|Overall Study|Progressive disease|3
4692427|NCT02396316|16164829|P1|Overall Study|Progressive disease|6
4692428|NCT02396316|16164828|P2|Overall Study|Physician Decision|0
4692429|NCT02396316|16164829|P1|Overall Study|Physician Decision|1
4692430|NCT02396212|16164848|P1|Overall Study|Lack of Efficacy|2
4692431|NCT02396212|16164848|P1|Overall Study|Adverse Event|1
4692432|NCT02395822|16165001|P1|Overall Study|Death|1
4692433|NCT02395822|16165001|P1|Overall Study|Withdrawal by Subject|1
4692434|NCT02395666|16165022|P2|Overall Study|Withdrawal by Subject|1
4692435|NCT02395666|16165023|P1|Overall Study|Withdrawal by Subject|2
4692436|NCT02395666|16165022|P2|Overall Study|Lost to Follow-up|0
4692437|NCT02395666|16165023|P1|Overall Study|Lost to Follow-up|1
4692438|NCT02395666|16165022|P2|Overall Study|Physician Decision|0
4692439|NCT02395666|16165023|P1|Overall Study|Physician Decision|3
4692440|NCT02395653|16165037|P1|Overall Study|Lost to Follow-up|1
4692441|NCT02395653|16165037|P1|Overall Study|Withdrawal by Subject|1
4692442|NCT02395653|16165037|P1|Overall Study|Inclusion Criteria Not Met at Screening|3
4692443|NCT02395653|16165037|P1|Overall Study|Investigator Decision at Screening|1
4692444|NCT02395653|16165037|P1|Overall Study|SSEC Application But With 0 Dose|1
4692445|NCT02395653|16165037|P1|Overall Study|Consent Withdrawn at Screening|1
4692446|NCT02395653|16165037|P1|Overall Study|Exclusion Criteria Met at Screening|4
4692447|NCT02395627|16165047|P3|Overall Study|Did not receive pembrolizumab|0
4692448|NCT02395627|16165048|P2|Overall Study|Did not receive pembrolizumab|1
4692449|NCT02395627|16165049|P1|Overall Study|Did not receive pembrolizumab|3
4692450|NCT02395627|16165047|P3|Overall Study|Withdrawal by Subject|0
4692451|NCT02395627|16165048|P2|Overall Study|Withdrawal by Subject|2
4692452|NCT02395627|16165049|P1|Overall Study|Withdrawal by Subject|0
4692453|NCT02395536|16165077|P2|Overall Study|Insurance issue|1
4692454|NCT02395536|16165078|P1|Overall Study|Insurance issue|0
4692455|NCT02395536|16165077|P2|Overall Study|Inclusion/Excusion Criteria Violation|2
4692456|NCT02395536|16165078|P1|Overall Study|Inclusion/Excusion Criteria Violation|1
4692457|NCT02395536|16165077|P2|Overall Study|Withdrawal by Subject|17
4692458|NCT02395536|16165078|P1|Overall Study|Withdrawal by Subject|9
4692459|NCT02395536|16165077|P2|Overall Study|Physician Decision|6
4692460|NCT02395536|16165078|P1|Overall Study|Physician Decision|4
4692461|NCT02395536|16165077|P2|Overall Study|Death|0
4692462|NCT02395536|16165078|P1|Overall Study|Death|2
4692463|NCT02395536|16165077|P2|Overall Study|Lost to Follow-up|4
4692464|NCT02395536|16165078|P1|Overall Study|Lost to Follow-up|4
4692465|NCT02395471|16165086|P2|Overall Study|Subject not eligible|0
4692466|NCT02395471|16165087|P1|Overall Study|Subject not eligible|1
4692467|NCT02395471|16165086|P2|Overall Study|Patient did not return for procedure|1
4692468|NCT02395471|16165087|P1|Overall Study|Patient did not return for procedure|0
4692469|NCT02395471|16165086|P2|Overall Study|Failure to swollow sponge twice|0
4692470|NCT02395471|16165087|P1|Overall Study|Failure to swollow sponge twice|1
4692471|NCT02395471|16165086|P2|Overall Study|Protocol Violation|1
4692472|NCT02395471|16165087|P1|Overall Study|Protocol Violation|0
4692473|NCT02395471|16165086|P2|Overall Study|Physician Decision|0
4692474|NCT02395471|16165087|P1|Overall Study|Physician Decision|1
4692475|NCT02395471|16165086|P2|Overall Study|Withdrawal by Subject|1
4692476|NCT02395471|16165087|P1|Overall Study|Withdrawal by Subject|2
4692477|NCT02395471|16165086|P2|Overall Study|Lost to Follow-up|0
4692478|NCT02395471|16165087|P1|Overall Study|Lost to Follow-up|2
4692479|NCT02395302|16165102|P1|Overall Study|Physician Decision|2
4692480|NCT02395302|16165102|P1|Overall Study|Withdrawal by Subject|2
4692481|NCT02395302|16165102|P1|Overall Study|Run In Failure|7
4692482|NCT02395302|16165102|P1|Overall Study|Screen Failure|3
4692483|NCT02395172|16165122|P2|Overall Study|Participants randomized but not treated|31
4692484|NCT02395172|16165123|P1|Overall Study|Participants randomized but not treated|3
4692485|NCT02395133|16165162|P4|Overall Study|Other than specified above|4
4692486|NCT02395133|16165163|P3|Overall Study|Other than specified above|2
4692487|NCT02395133|16165164|P2|Overall Study|Other than specified above|2
4692488|NCT02395133|16165165|P1|Overall Study|Other than specified above|5
4692489|NCT02395133|16165162|P4|Overall Study|Sponsor decision|1
4692490|NCT02395133|16165163|P3|Overall Study|Sponsor decision|0
4692491|NCT02395133|16165164|P2|Overall Study|Sponsor decision|0
4692492|NCT02395133|16165165|P1|Overall Study|Sponsor decision|2
4692493|NCT02395133|16165162|P4|Overall Study|Consent withdrawn with personal reason|3
4692494|NCT02395133|16165163|P3|Overall Study|Consent withdrawn with personal reason|0
4692495|NCT02395133|16165164|P2|Overall Study|Consent withdrawn with personal reason|1
4692496|NCT02395133|16165165|P1|Overall Study|Consent withdrawn with personal reason|0
4692497|NCT02395133|16165162|P4|Overall Study|Consent withdrawn with no reason given|2
4692498|NCT02395133|16165163|P3|Overall Study|Consent withdrawn with no reason given|0
4692499|NCT02395133|16165164|P2|Overall Study|Consent withdrawn with no reason given|3
4692500|NCT02395133|16165165|P1|Overall Study|Consent withdrawn with no reason given|1
4692501|NCT02395133|16165162|P4|Overall Study|Pregnancy|0
4692502|NCT02395133|16165163|P3|Overall Study|Pregnancy|3
4692503|NCT02395133|16165164|P2|Overall Study|Pregnancy|0
4692504|NCT02395133|16165165|P1|Overall Study|Pregnancy|0
4692505|NCT02395133|16165162|P4|Overall Study|Lost to Follow-up|0
4692506|NCT02395133|16165163|P3|Overall Study|Lost to Follow-up|1
4692507|NCT02395133|16165164|P2|Overall Study|Lost to Follow-up|1
4692508|NCT02395133|16165165|P1|Overall Study|Lost to Follow-up|0
4692509|NCT02395133|16165162|P4|Overall Study|Protocol Violation|3
4692510|NCT02395133|16165163|P3|Overall Study|Protocol Violation|0
4692511|NCT02395133|16165164|P2|Overall Study|Protocol Violation|1
4692512|NCT02395133|16165165|P1|Overall Study|Protocol Violation|1
4692513|NCT02395133|16165162|P4|Overall Study|Lack of Efficacy|1
4692514|NCT02395133|16165163|P3|Overall Study|Lack of Efficacy|1
4692515|NCT02395133|16165164|P2|Overall Study|Lack of Efficacy|0
4692516|NCT02395133|16165165|P1|Overall Study|Lack of Efficacy|1
4692517|NCT02395133|16165162|P4|Overall Study|Adverse Event|0
4692518|NCT02395133|16165163|P3|Overall Study|Adverse Event|3
4692519|NCT02395133|16165164|P2|Overall Study|Adverse Event|1
4692520|NCT02395133|16165165|P1|Overall Study|Adverse Event|4
4692521|NCT02395055|16165253|P2|Overall Study|Withdrawal by Subject|3
4692522|NCT02395055|16165254|P1|Overall Study|Withdrawal by Subject|7
4692523|NCT02395042|16165267|P3|Treatment 2 Period|Lack of Efficacy|0
4692524|NCT02395042|16165268|P2|Treatment 2 Period|Lack of Efficacy|1
4692525|NCT02395042|16165269|P1|Treatment 2 Period|Lack of Efficacy|1
4692526|NCT02395042|16165267|P3|Treatment 1 Period|Other Miscellaneous Reasons|1
4692527|NCT02395042|16165268|P2|Treatment 1 Period|Other Miscellaneous Reasons|2
4692528|NCT02395042|16165269|P1|Treatment 1 Period|Other Miscellaneous Reasons|0
4692529|NCT02395042|16165267|P3|Treatment 1 Period|Lost to Follow-up|0
4692530|NCT02395042|16165268|P2|Treatment 1 Period|Lost to Follow-up|0
4692531|NCT02395042|16165269|P1|Treatment 1 Period|Lost to Follow-up|1
4692532|NCT02395042|16165267|P3|Treatment 1 Period|Lack of Efficacy|0
4692533|NCT02395042|16165268|P2|Treatment 1 Period|Lack of Efficacy|1
4692534|NCT02395042|16165269|P1|Treatment 1 Period|Lack of Efficacy|1
4692535|NCT02395042|16165267|P3|Treatment 1 Period|Adverse Event|1
4692536|NCT02395042|16165268|P2|Treatment 1 Period|Adverse Event|3
4692537|NCT02395042|16165269|P1|Treatment 1 Period|Adverse Event|1
4692538|NCT02394925|16165307|P1|Overall Study|Unsatisfactory Visual Response|5
4692539|NCT02394925|16165307|P1|Overall Study|No longer meet eligibility criteria|1
4692540|NCT02394925|16165307|P1|Overall Study|Protocol Violation|5
4692541|NCT02394925|16165307|P1|Overall Study|Lost to Follow-up|9
4692542|NCT02394925|16165307|P1|Overall Study|Lens handling difficulities|5
4692543|NCT02394925|16165307|P1|Overall Study|Lens Discomfort|3
4692544|NCT02394925|16165307|P1|Overall Study|Adverse Event|1
4692545|NCT02394808|16165372|P2|Period 2|Lost to Follow-up|0
4692546|NCT02394808|16165373|P1|Period 2|Lost to Follow-up|1
4692547|NCT02394808|16165372|P2|Period 1|Unsatisfactory lens fitting|1
4692548|NCT02394808|16165373|P1|Period 1|Unsatisfactory lens fitting|0
4692549|NCT02394756|16165381|P6|Period 2|Unsatisfactory Visual Response|0
4692550|NCT02394756|16165382|P5|Period 2|Unsatisfactory Visual Response|1
4692551|NCT02394756|16165383|P4|Period 2|Unsatisfactory Visual Response|0
4692552|NCT02394756|16165384|P3|Period 2|Unsatisfactory Visual Response|0
4692553|NCT02394756|16165385|P2|Period 2|Unsatisfactory Visual Response|0
4692554|NCT02394756|16165386|P1|Period 2|Unsatisfactory Visual Response|0
4692555|NCT02394756|16165381|P6|Period 1|Withdrawal by Subject|0
4692556|NCT02394756|16165382|P5|Period 1|Withdrawal by Subject|0
4692557|NCT02394756|16165383|P4|Period 1|Withdrawal by Subject|1
4692558|NCT02394756|16165384|P3|Period 1|Withdrawal by Subject|1
4692559|NCT02394756|16165385|P2|Period 1|Withdrawal by Subject|1
4692560|NCT02394756|16165386|P1|Period 1|Withdrawal by Subject|0
4692561|NCT02394756|16165381|P6|Period 1|Lens Discomfort|1
4692562|NCT02394756|16165382|P5|Period 1|Lens Discomfort|0
4692563|NCT02394756|16165383|P4|Period 1|Lens Discomfort|0
4692564|NCT02394756|16165384|P3|Period 1|Lens Discomfort|0
4692565|NCT02394756|16165385|P2|Period 1|Lens Discomfort|0
4692566|NCT02394756|16165386|P1|Period 1|Lens Discomfort|0
4692567|NCT02394730|16165399|P2|Overall Study|Withdrawal by Subject|1
4692568|NCT02394730|16165400|P1|Overall Study|Withdrawal by Subject|0
4692569|NCT02394730|16165399|P2|Overall Study|Lost to Follow-up|0
4692570|NCT02394730|16165400|P1|Overall Study|Lost to Follow-up|1
4692571|NCT02394665|16165437|P3|Overall Study|Physician Decision|0
4692572|NCT02394665|16165438|P2|Overall Study|Physician Decision|0
4692573|NCT02394665|16165439|P1|Overall Study|Physician Decision|1
4692574|NCT02394600|16165461|P2|Overall Study|Protocol Violation|0
4692575|NCT02394600|16165462|P1|Overall Study|Protocol Violation|1
4692576|NCT02394600|16165461|P2|Overall Study|Withdrawal by Subject|1
4692577|NCT02394600|16165462|P1|Overall Study|Withdrawal by Subject|0
4692578|NCT02394600|16165461|P2|Overall Study|Lost to Follow-up|1
4692579|NCT02394600|16165462|P1|Overall Study|Lost to Follow-up|0
4692580|NCT02394600|16165461|P2|Overall Study|Adverse Event|0
4692581|NCT02394600|16165462|P1|Overall Study|Adverse Event|3
4692582|NCT02394561|16165472|P2|Extension Phase|Lack of Efficacy|3
4692583|NCT02394561|16165473|P1|Extension Phase|Lack of Efficacy|3
4692584|NCT02394561|16165472|P2|Extension Phase|Withdrawal by Subject|5
4692585|NCT02394561|16165473|P1|Extension Phase|Withdrawal by Subject|0
4692586|NCT02394561|16165472|P2|Extension Phase|Physician Decision|2
4692587|NCT02394561|16165473|P1|Extension Phase|Physician Decision|0
4692588|NCT02394561|16165472|P2|Extension Phase|Lost to Follow-up|0
4692589|NCT02394561|16165473|P1|Extension Phase|Lost to Follow-up|1
4692590|NCT02394561|16165472|P2|Extension Phase|Protocol Violation|0
4692591|NCT02394561|16165473|P1|Extension Phase|Protocol Violation|1
4692592|NCT02394561|16165472|P2|Extension Phase|Death|1
4692593|NCT02394561|16165473|P1|Extension Phase|Death|0
4692594|NCT02394561|16165472|P2|Extension Phase|Adverse Event|1
4692595|NCT02394561|16165473|P1|Extension Phase|Adverse Event|6
4692596|NCT02394561|16165472|P2|CORE Phase|Lack of Efficacy|6
4692597|NCT02394561|16165473|P1|CORE Phase|Lack of Efficacy|1
4692598|NCT02394561|16165472|P2|CORE Phase|Withdrawal by Subject|2
4692599|NCT02394561|16165473|P1|CORE Phase|Withdrawal by Subject|2
4692600|NCT02394561|16165472|P2|CORE Phase|Physician Decision|1
4692601|NCT02394561|16165473|P1|CORE Phase|Physician Decision|1
4692602|NCT02394561|16165472|P2|CORE Phase|Lost to Follow-up|0
4692603|NCT02394561|16165473|P1|CORE Phase|Lost to Follow-up|1
4692604|NCT02394561|16165472|P2|CORE Phase|Pregnancy|0
4692605|NCT02394561|16165473|P1|CORE Phase|Pregnancy|1
4692606|NCT02394561|16165472|P2|CORE Phase|Death|1
4692607|NCT02394561|16165473|P1|CORE Phase|Death|0
4692608|NCT02394561|16165472|P2|CORE Phase|Adverse Event|9
4692609|NCT02394561|16165473|P1|CORE Phase|Adverse Event|7
4692610|NCT02394340|16165520|P1|Overall Study|Adverse Event|1
4692611|NCT02394340|16165520|P1|Overall Study|Failed drug screen test|1
4692612|NCT02393950|16165527|P2|Overall Study|Withdrawal by Subject|1
4692613|NCT02393950|16165528|P1|Overall Study|Withdrawal by Subject|0
4692614|NCT02393950|16165527|P2|Overall Study|Adverse Event|0
4692615|NCT02393950|16165528|P1|Overall Study|Adverse Event|1
4692616|NCT02393859|16165595|P2|Overall Study|Continuing Study|43
4692617|NCT02393859|16165596|P1|Overall Study|Continuing Study|32
4692618|NCT02393859|16165595|P2|Overall Study|Death|8
4692619|NCT02393859|16165596|P1|Overall Study|Death|16
4692620|NCT02393859|16165595|P2|Overall Study|Withdrawal by Subject|2
4692621|NCT02393859|16165596|P1|Overall Study|Withdrawal by Subject|5
4692622|NCT02393859|16165595|P2|Overall Study|Decision by Sponsor|1
4692623|NCT02393859|16165596|P1|Overall Study|Decision by Sponsor|1
4692624|NCT02393755|16165621|P2|Overall Study|Physician Decision|2
4692625|NCT02393755|16165622|P1|Overall Study|Physician Decision|0
4692626|NCT02393755|16165621|P2|Overall Study|Adverse Event|2
4692627|NCT02393755|16165622|P1|Overall Study|Adverse Event|0
4692628|NCT02393755|16165621|P2|Overall Study|Withdrawal by Subject|3
4692629|NCT02393755|16165622|P1|Overall Study|Withdrawal by Subject|0
4692630|NCT02393547|16165641|P1|Overall Study|Lost to Follow-up|1
4692631|NCT02393547|16165641|P1|Overall Study|Withdrawal by Subject|3
4692632|NCT02393547|16165641|P1|Overall Study|Adverse Event|2
4692633|NCT02393209|16165732|P4|Overall Study|Lost to Follow-up|0
4692634|NCT02393209|16165733|P3|Overall Study|Lost to Follow-up|0
4692635|NCT02393209|16165734|P2|Overall Study|Lost to Follow-up|1
4692636|NCT02393209|16165735|P1|Overall Study|Lost to Follow-up|0
4692637|NCT02393209|16165732|P4|Overall Study|Patient Seen by Another Oncologist|0
4692638|NCT02393209|16165733|P3|Overall Study|Patient Seen by Another Oncologist|0
4692639|NCT02393209|16165734|P2|Overall Study|Patient Seen by Another Oncologist|1
4692640|NCT02393209|16165735|P1|Overall Study|Patient Seen by Another Oncologist|0
4692641|NCT02393209|16165732|P4|Overall Study|Death from Legionella Infection|0
4692642|NCT02393209|16165733|P3|Overall Study|Death from Legionella Infection|0
4692643|NCT02393209|16165734|P2|Overall Study|Death from Legionella Infection|1
4692644|NCT02393209|16165735|P1|Overall Study|Death from Legionella Infection|0
4692645|NCT02393209|16165732|P4|Overall Study|Death due to Disease Progression|0
4692646|NCT02393209|16165733|P3|Overall Study|Death due to Disease Progression|0
4692647|NCT02393209|16165734|P2|Overall Study|Death due to Disease Progression|2
4692648|NCT02393209|16165735|P1|Overall Study|Death due to Disease Progression|2
4692649|NCT02393209|16165732|P4|Overall Study|Death|0
4692650|NCT02393209|16165733|P3|Overall Study|Death|0
4692651|NCT02393209|16165734|P2|Overall Study|Death|2
4692652|NCT02393209|16165735|P1|Overall Study|Death|2
4692653|NCT02393209|16165732|P4|Overall Study|Withdrawal by Patient|0
4692654|NCT02393209|16165733|P3|Overall Study|Withdrawal by Patient|0
4692655|NCT02393209|16165734|P2|Overall Study|Withdrawal by Patient|0
4692656|NCT02393209|16165735|P1|Overall Study|Withdrawal by Patient|1
4692657|NCT02393209|16165732|P4|Overall Study|Study Terminated by Sponsor|0
4692658|NCT02393209|16165733|P3|Overall Study|Study Terminated by Sponsor|0
4692659|NCT02393209|16165734|P2|Overall Study|Study Terminated by Sponsor|1
4692660|NCT02393209|16165735|P1|Overall Study|Study Terminated by Sponsor|1
4692661|NCT02392624|16165824|P3|Overall Study|Other|1
4692662|NCT02392624|16165825|P2|Overall Study|Other|1
4692663|NCT02392624|16165826|P1|Overall Study|Other|49
4692664|NCT02392624|16165824|P3|Overall Study|Sponsor/Investigator Decision|0
4692665|NCT02392624|16165825|P2|Overall Study|Sponsor/Investigator Decision|1
4692666|NCT02392624|16165826|P1|Overall Study|Sponsor/Investigator Decision|2
4692667|NCT02392624|16165824|P3|Overall Study|Protocol Violation|1
4692668|NCT02392624|16165825|P2|Overall Study|Protocol Violation|0
4692669|NCT02392624|16165826|P1|Overall Study|Protocol Violation|0
4692670|NCT02392624|16165824|P3|Overall Study|Pregnancy|0
4692671|NCT02392624|16165825|P2|Overall Study|Pregnancy|0
4692672|NCT02392624|16165826|P1|Overall Study|Pregnancy|1
4692673|NCT02392624|16165824|P3|Overall Study|Adverse Event|2
4692674|NCT02392624|16165825|P2|Overall Study|Adverse Event|1
4692675|NCT02392624|16165826|P1|Overall Study|Adverse Event|4
4692676|NCT02392624|16165824|P3|Overall Study|Withdrawal by Subject|9
4692677|NCT02392624|16165825|P2|Overall Study|Withdrawal by Subject|12
4692678|NCT02392624|16165826|P1|Overall Study|Withdrawal by Subject|15
4692679|NCT02392559|16165841|P2|Overall Study|Withdrawal by Subject|1
4692680|NCT02392559|16165842|P1|Overall Study|Withdrawal by Subject|0
4692681|NCT02392507|16165873|P1|Maintenance Regimen|On Study Treatment at Study Conclusion|11
4692682|NCT02392507|16165873|P1|Maintenance Regimen|Death|1
4692683|NCT02392507|16165873|P1|Induction Regimen|Withdrawal by Subject|2
4692684|NCT02392507|16165873|P1|Induction Regimen|Physician Decision|1
4692685|NCT02392507|16165873|P1|Induction Regimen|On Study Treatment at Study Conclusion|11
4692686|NCT02392507|16165873|P1|Induction Regimen|Death|3
4692687|NCT02392481|16165912|P4|Overall Study|Withdrawal by Subject|0
4692688|NCT02392481|16165913|P3|Overall Study|Withdrawal by Subject|1
4692689|NCT02392481|16165914|P2|Overall Study|Withdrawal by Subject|0
4692690|NCT02392481|16165915|P1|Overall Study|Withdrawal by Subject|0
4692691|NCT02392481|16165912|P4|Overall Study|Adverse Event|2
4692692|NCT02392481|16165913|P3|Overall Study|Adverse Event|1
4692693|NCT02392481|16165914|P2|Overall Study|Adverse Event|0
4692694|NCT02392481|16165915|P1|Overall Study|Adverse Event|0
4692695|NCT02392403|16165937|P1|Overall Study|Withdrawal by Subject|1
4692696|NCT02392403|16165937|P1|Overall Study|Death|1
4692697|NCT02392403|16165937|P1|Overall Study|Adverse Event|1
4692698|NCT02392377|16165951|P2|Overall Study|Withdrawal by Subject|1
4692699|NCT02392377|16165952|P1|Overall Study|Withdrawal by Subject|0
4692700|NCT02392247|16166044|P1|Overall Study|Surgery cancelled; no data|1
4692701|NCT02392247|16166044|P1|Overall Study|Withdrawal by Subject|1
4692702|NCT02392234|16166055|P6|Treatment Period 2 (8 Weeks)|Adverse Event|0
4692703|NCT02392234|16166056|P5|Treatment Period 2 (8 Weeks)|Adverse Event|0
4692704|NCT02392234|16166057|P4|Treatment Period 2 (8 Weeks)|Adverse Event|0
4692705|NCT02392234|16166058|P3|Treatment Period 2 (8 Weeks)|Adverse Event|0
4692706|NCT02392234|16166059|P2|Treatment Period 2 (8 Weeks)|Adverse Event|0
4692707|NCT02392234|16166060|P1|Treatment Period 2 (8 Weeks)|Adverse Event|1
4692708|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4692709|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
4692710|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4692711|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Randomized but not treated|1
4692712|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4692713|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Randomized but not treated|0
4692714|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Other|0
4692715|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Other|0
4692716|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Other|0
4692717|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Other|0
4692718|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Other|0
4692719|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Other|1
4692720|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Noncompliance|1
4692721|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Noncompliance|0
4692722|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Noncompliance|0
4692723|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Noncompliance|0
4692724|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Noncompliance|0
4692725|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Noncompliance|0
4692726|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Pregnancy|0
4692727|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Pregnancy|0
4692728|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Pregnancy|1
4692729|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Pregnancy|0
4692730|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Pregnancy|0
4692731|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Pregnancy|1
4692732|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
4692733|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4692734|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4692735|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4692736|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4692737|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4692738|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4692739|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2
4692740|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4692741|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4692742|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4692743|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0
4692744|NCT02392234|16166055|P6|Treatment Period 1 (8 Weeks)|Adverse Event|1
4692745|NCT02392234|16166056|P5|Treatment Period 1 (8 Weeks)|Adverse Event|1
4692746|NCT02392234|16166057|P4|Treatment Period 1 (8 Weeks)|Adverse Event|0
4692747|NCT02392234|16166058|P3|Treatment Period 1 (8 Weeks)|Adverse Event|1
4692748|NCT02392234|16166059|P2|Treatment Period 1 (8 Weeks)|Adverse Event|0
4692749|NCT02392234|16166060|P1|Treatment Period 1 (8 Weeks)|Adverse Event|1
4692750|NCT02392104|16166092|P1|Overall Study|INRs drawn by visiting nurse services|1
4692751|NCT02392104|16166092|P1|Overall Study|admitted to skilled nursing facility|3
4692752|NCT02392104|16166092|P1|Overall Study|INR goal range changed|1
4692753|NCT02392104|16166092|P1|Overall Study|transferred care to another doctor|2
4692754|NCT02392104|16166092|P1|Overall Study|bleeding event|1
4692755|NCT02392104|16166092|P1|Overall Study|discontinuation of warfarin|3
4692756|NCT02392000|16166103|P1|Overall Study|Lost to Follow-up|8
4692757|NCT02392000|16166103|P1|Overall Study|Withdrawal by Subject|1
4692758|NCT02392000|16166103|P1|Overall Study|Greater than mild sleep apnea exclusion|18
4692759|NCT02391961|16166126|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4692760|NCT02391961|16166127|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4692761|NCT02391961|16166126|P2|Washout (2 Weeks)|Withdrawal by Subject|1
4692762|NCT02391961|16166127|P1|Washout (2 Weeks)|Withdrawal by Subject|1
4692763|NCT02391961|16166126|P2|First Intervention (4 Weeks)|Adverse Event|0
4692764|NCT02391961|16166127|P1|First Intervention (4 Weeks)|Adverse Event|2
4692765|NCT02391948|16166150|P5|24-month Assessment|Not able to schedule visit in timeframe|8
4692766|NCT02391948|16166151|P4|24-month Assessment|Not able to schedule visit in timeframe|9
4692767|NCT02391948|16166152|P3|24-month Assessment|Not able to schedule visit in timeframe|2
4692768|NCT02391948|16166153|P2|24-month Assessment|Not able to schedule visit in timeframe|5
4692769|NCT02391948|16166154|P1|24-month Assessment|Not able to schedule visit in timeframe|8
4692770|NCT02391948|16166150|P5|24-month Assessment|Medical issue/illness|0
4692771|NCT02391948|16166151|P4|24-month Assessment|Medical issue/illness|0
4692772|NCT02391948|16166152|P3|24-month Assessment|Medical issue/illness|1
4692773|NCT02391948|16166153|P2|24-month Assessment|Medical issue/illness|0
4692774|NCT02391948|16166154|P1|24-month Assessment|Medical issue/illness|0
4692775|NCT02391948|16166150|P5|24-month Assessment|Lost to Follow-up|0
4692776|NCT02391948|16166151|P4|24-month Assessment|Lost to Follow-up|0
4692777|NCT02391948|16166152|P3|24-month Assessment|Lost to Follow-up|0
4692778|NCT02391948|16166153|P2|24-month Assessment|Lost to Follow-up|4
4692779|NCT02391948|16166154|P1|24-month Assessment|Lost to Follow-up|5
4692780|NCT02391948|16166150|P5|24-month Assessment|Withdrawal by Subject|1
4692781|NCT02391948|16166151|P4|24-month Assessment|Withdrawal by Subject|0
4692782|NCT02391948|16166152|P3|24-month Assessment|Withdrawal by Subject|0
4692783|NCT02391948|16166153|P2|24-month Assessment|Withdrawal by Subject|1
4692784|NCT02391948|16166154|P1|24-month Assessment|Withdrawal by Subject|1
4692785|NCT02391948|16166150|P5|24-month Assessment|Death|1
4692786|NCT02391948|16166151|P4|24-month Assessment|Death|0
4692787|NCT02391948|16166152|P3|24-month Assessment|Death|0
4692788|NCT02391948|16166153|P2|24-month Assessment|Death|0
4692789|NCT02391948|16166154|P1|24-month Assessment|Death|0
4692790|NCT02391948|16166150|P5|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
4692791|NCT02391948|16166151|P4|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31
4692792|NCT02391948|16166152|P3|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22
4692793|NCT02391948|16166153|P2|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41
4692794|NCT02391948|16166154|P1|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66
4692795|NCT02391948|16166150|P5|18-month Assessment|Not able to schedule visit in timeframe|4
4692796|NCT02391948|16166151|P4|18-month Assessment|Not able to schedule visit in timeframe|1
4692797|NCT02391948|16166152|P3|18-month Assessment|Not able to schedule visit in timeframe|2
4692798|NCT02391948|16166153|P2|18-month Assessment|Not able to schedule visit in timeframe|3
4692799|NCT02391948|16166154|P1|18-month Assessment|Not able to schedule visit in timeframe|3
4692800|NCT02391948|16166150|P5|18-month Assessment|Lost to Follow-up|3
4692801|NCT02391948|16166151|P4|18-month Assessment|Lost to Follow-up|2
4692802|NCT02391948|16166152|P3|18-month Assessment|Lost to Follow-up|2
4692803|NCT02391948|16166153|P2|18-month Assessment|Lost to Follow-up|6
4692804|NCT02391948|16166154|P1|18-month Assessment|Lost to Follow-up|2
4692805|NCT02391948|16166150|P5|18-month Assessment|Withdrawal by Subject|0
4692806|NCT02391948|16166151|P4|18-month Assessment|Withdrawal by Subject|1
4692807|NCT02391948|16166152|P3|18-month Assessment|Withdrawal by Subject|0
4692808|NCT02391948|16166153|P2|18-month Assessment|Withdrawal by Subject|0
4692809|NCT02391948|16166154|P1|18-month Assessment|Withdrawal by Subject|1
4692810|NCT02391948|16166150|P5|18-month Assessment|Death|1
4692811|NCT02391948|16166151|P4|18-month Assessment|Death|1
4692812|NCT02391948|16166152|P3|18-month Assessment|Death|0
4692813|NCT02391948|16166153|P2|18-month Assessment|Death|0
4692814|NCT02391948|16166154|P1|18-month Assessment|Death|0
4692815|NCT02391948|16166150|P5|12-month Assessment|Not able to schedule visit in timeframe|1
4692816|NCT02391948|16166151|P4|12-month Assessment|Not able to schedule visit in timeframe|2
4692817|NCT02391948|16166152|P3|12-month Assessment|Not able to schedule visit in timeframe|0
4692818|NCT02391948|16166153|P2|12-month Assessment|Not able to schedule visit in timeframe|4
4692819|NCT02391948|16166154|P1|12-month Assessment|Not able to schedule visit in timeframe|2
4692820|NCT02391948|16166150|P5|12-month Assessment|Medical issue/illness|0
4692821|NCT02391948|16166151|P4|12-month Assessment|Medical issue/illness|1
4692822|NCT02391948|16166152|P3|12-month Assessment|Medical issue/illness|0
4692823|NCT02391948|16166153|P2|12-month Assessment|Medical issue/illness|1
4692824|NCT02391948|16166154|P1|12-month Assessment|Medical issue/illness|0
4692825|NCT02391948|16166150|P5|12-month Assessment|Lost to Follow-up|5
4692826|NCT02391948|16166151|P4|12-month Assessment|Lost to Follow-up|4
4692827|NCT02391948|16166152|P3|12-month Assessment|Lost to Follow-up|4
4692828|NCT02391948|16166153|P2|12-month Assessment|Lost to Follow-up|4
4692829|NCT02391948|16166154|P1|12-month Assessment|Lost to Follow-up|5
4692830|NCT02391948|16166150|P5|12-month Assessment|Withdrawal by Subject|0
4692831|NCT02391948|16166151|P4|12-month Assessment|Withdrawal by Subject|1
4692832|NCT02391948|16166152|P3|12-month Assessment|Withdrawal by Subject|0
4692833|NCT02391948|16166153|P2|12-month Assessment|Withdrawal by Subject|0
4692834|NCT02391948|16166154|P1|12-month Assessment|Withdrawal by Subject|1
4692835|NCT02391948|16166150|P5|12-month Assessment|Death|0
4692836|NCT02391948|16166151|P4|12-month Assessment|Death|1
4692837|NCT02391948|16166152|P3|12-month Assessment|Death|0
4692838|NCT02391948|16166153|P2|12-month Assessment|Death|0
4692839|NCT02391948|16166154|P1|12-month Assessment|Death|0
4692840|NCT02391948|16166150|P5|6-month Assessment|In 2-visit study (6-month N/A)|24
4692841|NCT02391948|16166151|P4|6-month Assessment|In 2-visit study (6-month N/A)|35
4692842|NCT02391948|16166152|P3|6-month Assessment|In 2-visit study (6-month N/A)|24
4692843|NCT02391948|16166153|P2|6-month Assessment|In 2-visit study (6-month N/A)|42
4692844|NCT02391948|16166154|P1|6-month Assessment|In 2-visit study (6-month N/A)|68
4692845|NCT02391948|16166150|P5|6-month Assessment|Not able to schedule visit in timeframe|0
4692846|NCT02391948|16166151|P4|6-month Assessment|Not able to schedule visit in timeframe|5
4692847|NCT02391948|16166152|P3|6-month Assessment|Not able to schedule visit in timeframe|4
4692848|NCT02391948|16166153|P2|6-month Assessment|Not able to schedule visit in timeframe|8
4692849|NCT02391948|16166154|P1|6-month Assessment|Not able to schedule visit in timeframe|6
4692850|NCT02391948|16166150|P5|6-month Assessment|Medical issue/illness|0
4692851|NCT02391948|16166151|P4|6-month Assessment|Medical issue/illness|0
4692852|NCT02391948|16166152|P3|6-month Assessment|Medical issue/illness|0
4692853|NCT02391948|16166153|P2|6-month Assessment|Medical issue/illness|1
4692854|NCT02391948|16166154|P1|6-month Assessment|Medical issue/illness|1
4692855|NCT02391948|16166150|P5|6-month Assessment|Lost to Follow-up|1
4692856|NCT02391948|16166151|P4|6-month Assessment|Lost to Follow-up|3
4692857|NCT02391948|16166152|P3|6-month Assessment|Lost to Follow-up|2
4692858|NCT02391948|16166153|P2|6-month Assessment|Lost to Follow-up|5
4692859|NCT02391948|16166154|P1|6-month Assessment|Lost to Follow-up|4
4692860|NCT02391948|16166150|P5|6-month Assessment|Withdrawal by Subject|0
4692861|NCT02391948|16166151|P4|6-month Assessment|Withdrawal by Subject|2
4692862|NCT02391948|16166152|P3|6-month Assessment|Withdrawal by Subject|1
4692863|NCT02391948|16166153|P2|6-month Assessment|Withdrawal by Subject|0
4692864|NCT02391948|16166154|P1|6-month Assessment|Withdrawal by Subject|0
4692865|NCT02391948|16166150|P5|6-month Assessment|Death|1
4692866|NCT02391948|16166151|P4|6-month Assessment|Death|0
4692867|NCT02391948|16166152|P3|6-month Assessment|Death|0
4692868|NCT02391948|16166153|P2|6-month Assessment|Death|0
4692869|NCT02391948|16166154|P1|6-month Assessment|Death|0
4692870|NCT02391584|16166278|P2|12 Month (End of Study)|Lost to Follow-up|0
4692871|NCT02391584|16166279|P1|12 Month (End of Study)|Lost to Follow-up|2
4692872|NCT02391584|16166278|P2|6 Month|Withdrawal by Subject|0
4692873|NCT02391584|16166279|P1|6 Month|Withdrawal by Subject|1
4692874|NCT02391584|16166278|P2|3 Month|Lost to Follow-up|0
4692875|NCT02391584|16166279|P1|3 Month|Lost to Follow-up|1
4692876|NCT02391584|16166278|P2|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0
4692877|NCT02391584|16166279|P1|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1
4692878|NCT02391584|16166278|P2|Primary Endpoint (6-weeks)|Lost to Follow-up|2
4692879|NCT02391584|16166279|P1|Primary Endpoint (6-weeks)|Lost to Follow-up|1
4692880|NCT02391545|16166296|P2|Overall Study|Other Reasons|4
4692881|NCT02391545|16166297|P1|Overall Study|Other Reasons|6
4692882|NCT02391545|16166296|P2|Overall Study|Withdrawal by Subject|1
4692883|NCT02391545|16166297|P1|Overall Study|Withdrawal by Subject|0
4692884|NCT02391545|16166296|P2|Overall Study|Termination of study by sponsor|20
4692885|NCT02391545|16166297|P1|Overall Study|Termination of study by sponsor|20
4692886|NCT02391545|16166296|P2|Overall Study|Lost to Follow-up|1
4692887|NCT02391545|16166297|P1|Overall Study|Lost to Follow-up|0
4692888|NCT02391545|16166296|P2|Overall Study|Death|2
4692889|NCT02391545|16166297|P1|Overall Study|Death|0
4692890|NCT02391363|16166317|P2|Overall Study|Withdrawal by Subject|3
4692891|NCT02391363|16166318|P1|Overall Study|Withdrawal by Subject|6
4692892|NCT02391363|16166317|P2|Overall Study|Lost to Follow-up|5
4692893|NCT02391363|16166318|P1|Overall Study|Lost to Follow-up|5
4692894|NCT02391311|16166384|P2|Overall Study|deemed ineligible after baseline|1
4692895|NCT02391311|16166385|P1|Overall Study|deemed ineligible after baseline|1
4692896|NCT02391311|16166384|P2|Overall Study|Lost to Follow-up|1
4692897|NCT02391311|16166385|P1|Overall Study|Lost to Follow-up|2
4692898|NCT02391116|16166393|P1|Survival Follow-up|Switching to Other Therapy|1
4692899|NCT02391116|16166393|P1|Survival Follow-up|Withdrawal by Subject|3
4692900|NCT02391116|16166393|P1|Active Follow-up|Switching to Other Therapy|2
4692901|NCT02391116|16166393|P1|Active Follow-up|Withdrawal by Subject|1
4692902|NCT02391116|16166393|P1|Safety Follow-up|Deterioration of General Conditions|3
4692903|NCT02391116|16166393|P1|Safety Follow-up|No Follow Up|1
4692904|NCT02391116|16166393|P1|Safety Follow-up|Switching to Other Therapy|4
4692905|NCT02391116|16166393|P1|Safety Follow-up|Withdrawal by Subject|4
4692906|NCT02391116|16166393|P1|Safety Follow-up|Adverse Event|1
4692907|NCT02391116|16166393|P1|Treatment|AE with Clinical PD|3
4692908|NCT02391116|16166393|P1|Treatment|Adverse Event (AE) Without Clinical PD|9
4692909|NCT02391116|16166393|P1|Treatment|Protocol Violation|1
4692910|NCT02391116|16166393|P1|Treatment|Withdrawal by Subject|1
4692911|NCT02391038|16166447|P3|Overall Study|Progressive disease|6
4692912|NCT02391038|16166448|P2|Overall Study|Progressive disease|3
4692913|NCT02391038|16166449|P1|Overall Study|Progressive disease|3
4692914|NCT02390557|16166616|P3|Wave 2|Survey non-respondent|23
4692915|NCT02390557|16166617|P2|Wave 2|Survey non-respondent|41
4692916|NCT02390557|16166618|P1|Wave 2|Survey non-respondent|72
4692917|NCT02390362|16166628|P2|Overall Study|Withdrawal by Subject|1
4692918|NCT02390362|16166629|P1|Overall Study|Withdrawal by Subject|0
4692919|NCT02390219|16166637|P1|Overall Study|Other|2
4692920|NCT02390219|16166637|P1|Overall Study|Lost to Follow-up|2
4692921|NCT02390219|16166637|P1|Overall Study|Withdrawal by Subject|1
4692922|NCT02390219|16166637|P1|Overall Study|Adverse Event|6
4692923|NCT02390219|16166637|P1|Overall Study|Physician Decision|1
4692924|NCT02390219|16166637|P1|Overall Study|Death|1
4692925|NCT02390167|16166647|P1|Overall Study|Lost to Follow-up|1
4692926|NCT02390076|16166669|P3|Overall Study|Lost to Follow-up|4
4692927|NCT02390076|16166670|P2|Overall Study|Lost to Follow-up|1
4692928|NCT02390076|16166671|P1|Overall Study|Lost to Follow-up|2
4692929|NCT02389894|16166700|P3|Overall Study|Lost to Follow-up|1
4692930|NCT02389894|16166701|P2|Overall Study|Lost to Follow-up|1
4692931|NCT02389894|16166702|P1|Overall Study|Lost to Follow-up|2
4692932|NCT02389894|16166700|P3|Overall Study|Withdrawal by Subject|5
4692933|NCT02389894|16166701|P2|Overall Study|Withdrawal by Subject|4
4692934|NCT02389894|16166702|P1|Overall Study|Withdrawal by Subject|2
4692935|NCT02389894|16166700|P3|Overall Study|Death|3
4692936|NCT02389894|16166701|P2|Overall Study|Death|5
4692937|NCT02389894|16166702|P1|Overall Study|Death|4
4692938|NCT02389829|16166834|P2|Overall Study|Lost to Follow-up|1
4692939|NCT02389829|16166835|P1|Overall Study|Lost to Follow-up|0
4692940|NCT02389816|16166850|P3|Overall Study|Reason not Specified|0
4692941|NCT02389816|16166851|P2|Overall Study|Reason not Specified|2
4692942|NCT02389816|16166852|P1|Overall Study|Reason not Specified|0
4692943|NCT02389816|16166850|P3|Overall Study|Non Compliance with Study Drug|1
4692944|NCT02389816|16166851|P2|Overall Study|Non Compliance with Study Drug|1
4692945|NCT02389816|16166852|P1|Overall Study|Non Compliance with Study Drug|1
4692946|NCT02389816|16166850|P3|Overall Study|Lack of Efficacy|0
4692947|NCT02389816|16166851|P2|Overall Study|Lack of Efficacy|0
4692948|NCT02389816|16166852|P1|Overall Study|Lack of Efficacy|1
4692949|NCT02389816|16166850|P3|Overall Study|Withdrawal of Consent|4
4692950|NCT02389816|16166851|P2|Overall Study|Withdrawal of Consent|4
4692951|NCT02389816|16166852|P1|Overall Study|Withdrawal of Consent|6
4692952|NCT02389816|16166850|P3|Overall Study|Lost to Follow-up|0
4692953|NCT02389816|16166851|P2|Overall Study|Lost to Follow-up|0
4692954|NCT02389816|16166852|P1|Overall Study|Lost to Follow-up|1
4692955|NCT02389816|16166850|P3|Overall Study|Major Protocol Deviation|0
4692956|NCT02389816|16166851|P2|Overall Study|Major Protocol Deviation|0
4692957|NCT02389816|16166852|P1|Overall Study|Major Protocol Deviation|1
4692958|NCT02389816|16166850|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|7
4692959|NCT02389816|16166851|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|6
4692960|NCT02389816|16166852|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|4
4692961|NCT02389816|16166850|P3|Overall Study|Randomized but Not Treated|0
4692962|NCT02389816|16166851|P2|Overall Study|Randomized but Not Treated|0
4692963|NCT02389816|16166852|P1|Overall Study|Randomized but Not Treated|1
4692964|NCT02389764|16166884|P1|Overall Study|Lack of Efficacy|9
4692965|NCT02389621|16166919|P2|Posttreatment Period|Other - Miscellaneous|0
4692966|NCT02389621|16166920|P1|Posttreatment Period|Other - Miscellaneous|2
4692967|NCT02389621|16166919|P2|Posttreatment Period|Lost to Follow-up|1
4692968|NCT02389621|16166920|P1|Posttreatment Period|Lost to Follow-up|1
4692969|NCT02389621|16166919|P2|Posttreatment Period|Withdrawal by Subject|2
4692970|NCT02389621|16166920|P1|Posttreatment Period|Withdrawal by Subject|3
4692971|NCT02389621|16166919|P2|Posttreatment Period|Adverse Event|1
4692972|NCT02389621|16166920|P1|Posttreatment Period|Adverse Event|3
4692973|NCT02389621|16166919|P2|Treatment Period|Withdrawal by Subject|1
4692974|NCT02389621|16166920|P1|Treatment Period|Withdrawal by Subject|1
4692975|NCT02389452|16166950|P1|Overall Study|Enrolled but Not Eligible for Study|6
4692976|NCT02389452|16166950|P1|Overall Study|Withdrawal by Subject|5
4692977|NCT02389452|16166950|P1|Overall Study|Adverse Event|1
4692978|NCT02389452|16166950|P1|Overall Study|Lost to Follow-up|13
4692979|NCT02388997|16167062|P2|Overall Study|Tested positive for virus during run-in|1
4692980|NCT02388997|16167063|P1|Overall Study|Tested positive for virus during run-in|0
4692981|NCT02388997|16167062|P2|Overall Study|Lung function exclusion criteria|2
4692982|NCT02388997|16167063|P1|Overall Study|Lung function exclusion criteria|0
4692983|NCT02388997|16167062|P2|Overall Study|Withdrawal by Subject|1
4692984|NCT02388997|16167063|P1|Overall Study|Withdrawal by Subject|2
4692985|NCT02388997|16167062|P2|Overall Study|Adverse Event|2
4692986|NCT02388997|16167063|P1|Overall Study|Adverse Event|1
4692987|NCT02388932|16167081|P1|Overall Study|Death|1
4692988|NCT02388776|16167102|P1|Overall Study|Lost to Follow-up|1
4692989|NCT02388776|16167102|P1|Overall Study|Death|1
4692990|NCT02388763|16167107|P2|Period 1, 10 Days of Wear|Withdrawal by Subject|1
4692991|NCT02388763|16167108|P1|Period 1, 10 Days of Wear|Withdrawal by Subject|1
4692992|NCT02388763|16167107|P2|Habitual, 10 Days of Wear|Withdrawal by Subject|1
4692993|NCT02388763|16167108|P1|Habitual, 10 Days of Wear|Withdrawal by Subject|1
4692994|NCT02388737|16167122|P3|Overall Study|Reason Not Specified|4
4692995|NCT02388737|16167123|P2|Overall Study|Reason Not Specified|5
4692996|NCT02388737|16167124|P1|Overall Study|Reason Not Specified|5
4692997|NCT02388737|16167122|P3|Overall Study|Lack of Efficacy|3
4692998|NCT02388737|16167123|P2|Overall Study|Lack of Efficacy|0
4692999|NCT02388737|16167124|P1|Overall Study|Lack of Efficacy|3
4693000|NCT02388737|16167122|P3|Overall Study|Voluntary Withdrawal|17
4693001|NCT02388737|16167123|P2|Overall Study|Voluntary Withdrawal|18
4693002|NCT02388737|16167124|P1|Overall Study|Voluntary Withdrawal|10
4693003|NCT02388737|16167122|P3|Overall Study|Lost to Follow-up|4
4693004|NCT02388737|16167123|P2|Overall Study|Lost to Follow-up|1
4693005|NCT02388737|16167124|P1|Overall Study|Lost to Follow-up|5
4693006|NCT02388737|16167122|P3|Overall Study|Major Protocol Deviation|22
4693007|NCT02388737|16167123|P2|Overall Study|Major Protocol Deviation|25
4693008|NCT02388737|16167124|P1|Overall Study|Major Protocol Deviation|18
4693009|NCT02388737|16167122|P3|Overall Study|Pretreatment Event/Adverse Event|12
4693010|NCT02388737|16167123|P2|Overall Study|Pretreatment Event/Adverse Event|11
4693011|NCT02388737|16167124|P1|Overall Study|Pretreatment Event/Adverse Event|13
4693012|NCT02388724|16167158|P2|Overall Study|Randomized but not Treated|2
4693013|NCT02388724|16167159|P1|Overall Study|Randomized but not Treated|0
4693014|NCT02388724|16167158|P2|Overall Study|Voluntary Withdrawal|5
4693015|NCT02388724|16167159|P1|Overall Study|Voluntary Withdrawal|6
4693016|NCT02388724|16167158|P2|Overall Study|Pretreatment Event/Adverse Event|2
4693017|NCT02388724|16167159|P1|Overall Study|Pretreatment Event/Adverse Event|3
4693018|NCT02388724|16167158|P2|Overall Study|Major Protocol Deviation|3
4693019|NCT02388724|16167159|P1|Overall Study|Major Protocol Deviation|3
4693020|NCT02388724|16167158|P2|Overall Study|Reason not Specified|1
4693021|NCT02388724|16167159|P1|Overall Study|Reason not Specified|0
4693022|NCT02388347|16167205|P5|Overall Study|Withdrawal by Subject|0
4693023|NCT02388347|16167206|P4|Overall Study|Withdrawal by Subject|0
4693024|NCT02388347|16167207|P3|Overall Study|Withdrawal by Subject|1
4693025|NCT02388347|16167208|P2|Overall Study|Withdrawal by Subject|0
4693026|NCT02388347|16167209|P1|Overall Study|Withdrawal by Subject|0
4693027|NCT02388295|16167288|P3|Treatment Weeks 3 to 12|Adverse Event|0
4693028|NCT02388295|16167289|P2|Treatment Weeks 3 to 12|Adverse Event|1
4693029|NCT02388295|16167290|P1|Treatment Weeks 3 to 12|Adverse Event|1
4693030|NCT02388295|16167288|P3|Dose Escalation Week 2|Determined not eligible|1
4693031|NCT02388295|16167289|P2|Dose Escalation Week 2|Determined not eligible|1
4693032|NCT02388295|16167290|P1|Dose Escalation Week 2|Determined not eligible|1
4693033|NCT02388295|16167288|P3|Dose Escalation Week 2|Protocol Violation|0
4693034|NCT02388295|16167289|P2|Dose Escalation Week 2|Protocol Violation|1
4693035|NCT02388295|16167290|P1|Dose Escalation Week 2|Protocol Violation|0
4693036|NCT02388295|16167288|P3|Dose Escalation Week 1|Determined not eligible|1
4693037|NCT02388295|16167289|P2|Dose Escalation Week 1|Determined not eligible|1
4693038|NCT02388295|16167290|P1|Dose Escalation Week 1|Determined not eligible|1
4693039|NCT02388295|16167288|P3|Dose Escalation Week 1|Adverse Event|1
4693040|NCT02388295|16167289|P2|Dose Escalation Week 1|Adverse Event|2
4693041|NCT02388295|16167290|P1|Dose Escalation Week 1|Adverse Event|1
4693042|NCT02388269|16167308|P3|Overall Study|Screen Failure|10
4693043|NCT02388269|16167309|P2|Overall Study|Screen Failure|0
4693044|NCT02388269|16167310|P1|Overall Study|Screen Failure|0
4693045|NCT02388269|16167308|P3|Overall Study|Protocol Violation|0
4693046|NCT02388269|16167309|P2|Overall Study|Protocol Violation|0
4693047|NCT02388269|16167310|P1|Overall Study|Protocol Violation|2
4693048|NCT02388269|16167308|P3|Overall Study|no diary data|0
4693049|NCT02388269|16167309|P2|Overall Study|no diary data|0
4693050|NCT02388269|16167310|P1|Overall Study|no diary data|3
4693051|NCT02388269|16167308|P3|Overall Study|less than 50% stimulations|0
4693052|NCT02388269|16167309|P2|Overall Study|less than 50% stimulations|0
4693053|NCT02388269|16167310|P1|Overall Study|less than 50% stimulations|1
4693054|NCT02388269|16167308|P3|Overall Study|Withdrawal by Subject|0
4693055|NCT02388269|16167309|P2|Overall Study|Withdrawal by Subject|2
4693056|NCT02388269|16167310|P1|Overall Study|Withdrawal by Subject|1
4693057|NCT02388269|16167308|P3|Overall Study|Adverse Event|0
4693058|NCT02388269|16167309|P2|Overall Study|Adverse Event|0
4693059|NCT02388269|16167310|P1|Overall Study|Adverse Event|2
4693060|NCT02388191|16167342|P2|Overall Study|Patient did not receive IUD|0
4693061|NCT02388191|16167343|P1|Overall Study|Patient did not receive IUD|1
4693062|NCT02388165|16167359|P2|Overall Study|Did not meet entrance criteria|2
4693063|NCT02388165|16167360|P1|Overall Study|Did not meet entrance criteria|5
4693064|NCT02388165|16167359|P2|Overall Study|Adverse Event|5
4693065|NCT02388165|16167360|P1|Overall Study|Adverse Event|3
4693066|NCT02388165|16167359|P2|Overall Study|Death|10
4693067|NCT02388165|16167360|P1|Overall Study|Death|13
4693068|NCT02388165|16167359|P2|Overall Study|Lost to Follow-up|20
4693069|NCT02388165|16167360|P1|Overall Study|Lost to Follow-up|19
4693070|NCT02388165|16167359|P2|Overall Study|Withdrawal of consent|32
4693071|NCT02388165|16167360|P1|Overall Study|Withdrawal of consent|31
4693072|NCT02388165|16167359|P2|Overall Study|No longer meet eligibility criteria|43
4693073|NCT02388165|16167360|P1|Overall Study|No longer meet eligibility criteria|40
4693074|NCT02388165|16167359|P2|Overall Study|Other|13
4693075|NCT02388165|16167360|P1|Overall Study|Other|11
4693076|NCT02388165|16167359|P2|Overall Study|Study terminated by sponsor|5
4693077|NCT02388165|16167360|P1|Overall Study|Study terminated by sponsor|5
4693078|NCT02388074|16167390|P1|Overall Study|Sample Not Returned|1
4693079|NCT02388074|16167390|P1|Overall Study|Lost in Transit|2
4693080|NCT02387996|16167394|P1|Overall Study|Poor/Non-Compliance|1
4693081|NCT02387996|16167394|P1|Overall Study|Lost to Follow-up|1
4693082|NCT02387996|16167394|P1|Overall Study|Subject Withdrew Consent|1
4693083|NCT02387996|16167394|P1|Overall Study|Subject Request to Discontinue Treatment|9
4693084|NCT02387996|16167394|P1|Overall Study|Adverse Event Unrelated to Study Drug|34
4693085|NCT02387996|16167394|P1|Overall Study|Study Drug Toxicity|14
4693086|NCT02387996|16167394|P1|Overall Study|Disease Progression|144
4693087|NCT02387983|16167405|P1|Overall Study|Withdrawal by Subject|2
4693088|NCT02387983|16167405|P1|Overall Study|Protocol Violation|1
4693089|NCT02387983|16167405|P1|Overall Study|Adverse Event|4
4693090|NCT02387970|16167419|P2|Overall Study|Did not complete 1-year follow up|2
4693091|NCT02387970|16167420|P1|Overall Study|Did not complete 1-year follow up|1
4693092|NCT02387957|16167441|P3|Overall Study|The study was discontinued|20
4693093|NCT02387957|16167442|P2|Overall Study|The study was discontinued|21
4693094|NCT02387957|16167443|P1|Overall Study|The study was discontinued|21
4693095|NCT02387762|16167514|P2|Overall Study|Withdrawal by Subject|0
4693096|NCT02387762|16167515|P1|Overall Study|Withdrawal by Subject|1
4693097|NCT02387580|16167547|P6|Overall Study|Withdrawal by Subject|0
4693098|NCT02387580|16167548|P5|Overall Study|Withdrawal by Subject|0
4693099|NCT02387580|16167549|P4|Overall Study|Withdrawal by Subject|1
4693100|NCT02387580|16167550|P3|Overall Study|Withdrawal by Subject|0
4693101|NCT02387580|16167551|P2|Overall Study|Withdrawal by Subject|0
4693102|NCT02387580|16167552|P1|Overall Study|Withdrawal by Subject|0
4693103|NCT02387372|16167645|P2|Overall Study|Not Treated|0
4693104|NCT02387372|16167646|P1|Overall Study|Not Treated|1
4693105|NCT02387164|16167736|P2|Overall Study|Diagnosed|2
4693106|NCT02387164|16167737|P1|Overall Study|Diagnosed|1
4693107|NCT02387164|16167736|P2|Overall Study|Lost to Follow-up|0
4693108|NCT02387164|16167737|P1|Overall Study|Lost to Follow-up|2
4693109|NCT02386345|16167781|P1|Overall Study|Did not complete 12-month follow-up|72
4693110|NCT02386345|16167781|P1|Overall Study|Repeat Procedure|10
4693111|NCT02386345|16167781|P1|Overall Study|Adverse Event|5
4693112|NCT02386345|16167781|P1|Overall Study|Lost to Follow-up|1
4693113|NCT02386345|16167781|P1|Overall Study|Not treated|14
4693114|NCT02386189|16167791|P2|Overall Study|Death|0
4693115|NCT02386189|16167792|P1|Overall Study|Death|1
4693116|NCT02386189|16167791|P2|Overall Study|Withdrawal by Subject|0
4693117|NCT02386189|16167792|P1|Overall Study|Withdrawal by Subject|1
4693118|NCT02386189|16167791|P2|Overall Study|Lost to Follow-up|3
4693119|NCT02386189|16167792|P1|Overall Study|Lost to Follow-up|2
4693120|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
4693121|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
4693122|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0
4693123|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8
4693124|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5
4693125|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Other|0
4693126|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Other|0
4693127|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Other|0
4693128|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Other|0
4693129|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Other|1
4693130|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Withdrawal by Subject|0
4693131|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Withdrawal by Subject|0
4693132|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Withdrawal by Subject|0
4693133|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Withdrawal by Subject|1
4693134|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Withdrawal by Subject|3
4693135|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4693136|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4693137|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4693138|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2
4693139|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0
4693140|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Lost to Follow-up|0
4693141|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Lost to Follow-up|0
4693142|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Lost to Follow-up|0
4693143|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Lost to Follow-up|2
4693144|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Lost to Follow-up|2
4693145|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Adverse Event|0
4693146|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Adverse Event|0
4693147|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Adverse Event|0
4693148|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Adverse Event|1
4693149|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Adverse Event|2
4693150|NCT02386098|16167815|P5|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
4693151|NCT02386098|16167816|P4|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
4693152|NCT02386098|16167817|P3|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0
4693153|NCT02386098|16167818|P2|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29
4693154|NCT02386098|16167819|P1|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30
4693155|NCT02385799|16167898|P2|Overall Study|Withdrawal by Subject|4
4693156|NCT02385799|16167899|P1|Overall Study|Withdrawal by Subject|0
4693157|NCT02385799|16167898|P2|Overall Study|Adverse Event|2
4693158|NCT02385799|16167899|P1|Overall Study|Adverse Event|4
4693159|NCT02385799|16167898|P2|Overall Study|Lost to Follow-up|2
4693160|NCT02385799|16167899|P1|Overall Study|Lost to Follow-up|1
4693161|NCT02385708|16167940|P2|Overall Study|Protocol Violation|1
4693162|NCT02385708|16167941|P1|Overall Study|Protocol Violation|1
4693163|NCT02385708|16167940|P2|Overall Study|Investigator decision|7
4693164|NCT02385708|16167941|P1|Overall Study|Investigator decision|5
4693165|NCT02385708|16167940|P2|Overall Study|Withdrawn - surgery canceled|5
4693166|NCT02385708|16167941|P1|Overall Study|Withdrawn - surgery canceled|2
4693167|NCT02385708|16167940|P2|Overall Study|Withdrawal by Subject|2
4693168|NCT02385708|16167941|P1|Overall Study|Withdrawal by Subject|0
4693169|NCT02385669|16167947|P1|Overall Study|Adverse Event|2
4693170|NCT02385526|16167955|P3|Overall Study|Protocol Violation|0
4693171|NCT02385526|16167956|P2|Overall Study|Protocol Violation|0
4693172|NCT02385526|16167957|P1|Overall Study|Protocol Violation|1
4693173|NCT02385526|16167955|P3|Overall Study|Physician Decision|0
4693174|NCT02385526|16167956|P2|Overall Study|Physician Decision|0
4693175|NCT02385526|16167957|P1|Overall Study|Physician Decision|1
4693176|NCT02385526|16167955|P3|Overall Study|Lost to Follow-up|0
4693177|NCT02385526|16167956|P2|Overall Study|Lost to Follow-up|1
4693178|NCT02385526|16167957|P1|Overall Study|Lost to Follow-up|0
4693179|NCT02385526|16167955|P3|Overall Study|Withdrawal by Subject|0
4693180|NCT02385526|16167956|P2|Overall Study|Withdrawal by Subject|2
4693181|NCT02385526|16167957|P1|Overall Study|Withdrawal by Subject|0
4693182|NCT02385084|16167984|P6|Period 2|Protocol Violation|0
4693183|NCT02385084|16167985|P5|Period 2|Protocol Violation|0
4693184|NCT02385084|16167986|P4|Period 2|Protocol Violation|0
4693185|NCT02385084|16167987|P3|Period 2|Protocol Violation|1
4693186|NCT02385084|16167988|P2|Period 2|Protocol Violation|0
4693187|NCT02385084|16167989|P1|Period 2|Protocol Violation|0
4693188|NCT02384993|16168002|P2|Overall Study|Adverse Event|1
4693189|NCT02384993|16168003|P1|Overall Study|Adverse Event|0
4693190|NCT02384941|16168029|P3|Overall Study|Other than specified above|1
4693191|NCT02384941|16168030|P2|Overall Study|Other than specified above|0
4693192|NCT02384941|16168031|P1|Overall Study|Other than specified above|4
4693193|NCT02384941|16168029|P3|Overall Study|Pregnancy|1
4693194|NCT02384941|16168030|P2|Overall Study|Pregnancy|0
4693195|NCT02384941|16168031|P1|Overall Study|Pregnancy|0
4693196|NCT02384941|16168029|P3|Overall Study|Withdrawal by Subject|20
4693197|NCT02384941|16168030|P2|Overall Study|Withdrawal by Subject|19
4693198|NCT02384941|16168031|P1|Overall Study|Withdrawal by Subject|26
4693199|NCT02384941|16168029|P3|Overall Study|Protocol Violation|0
4693200|NCT02384941|16168030|P2|Overall Study|Protocol Violation|0
4693201|NCT02384941|16168031|P1|Overall Study|Protocol Violation|3
4693202|NCT02384941|16168029|P3|Overall Study|Physician Decision|0
4693203|NCT02384941|16168030|P2|Overall Study|Physician Decision|1
4693204|NCT02384941|16168031|P1|Overall Study|Physician Decision|1
4693205|NCT02384941|16168029|P3|Overall Study|Non-Compliance With Study Drug|1
4693206|NCT02384941|16168030|P2|Overall Study|Non-Compliance With Study Drug|0
4693207|NCT02384941|16168031|P1|Overall Study|Non-Compliance With Study Drug|2
4693208|NCT02384941|16168029|P3|Overall Study|Lost to Follow-up|1
4693209|NCT02384941|16168030|P2|Overall Study|Lost to Follow-up|2
4693210|NCT02384941|16168031|P1|Overall Study|Lost to Follow-up|3
4693211|NCT02384941|16168029|P3|Overall Study|Adverse Event|17
4693212|NCT02384941|16168030|P2|Overall Study|Adverse Event|13
4693213|NCT02384941|16168031|P1|Overall Study|Adverse Event|11
4693214|NCT02384538|16168062|P2|Overall Study|Other|3
4693215|NCT02384538|16168063|P1|Overall Study|Other|1
4693216|NCT02384538|16168062|P2|Overall Study|Withdrew Consent|4
4693217|NCT02384538|16168063|P1|Overall Study|Withdrew Consent|0
4693218|NCT02384538|16168062|P2|Overall Study|Lack of Efficacy|4
4693219|NCT02384538|16168063|P1|Overall Study|Lack of Efficacy|4
4693220|NCT02384538|16168062|P2|Overall Study|Adverse Event|4
4693221|NCT02384538|16168063|P1|Overall Study|Adverse Event|1
4693222|NCT02384460|16168083|P2|Overall Study|Non-compliance|0
4693223|NCT02384460|16168084|P1|Overall Study|Non-compliance|1
4693224|NCT02384460|16168083|P2|Overall Study|Elective medical treatment|0
4693225|NCT02384460|16168084|P1|Overall Study|Elective medical treatment|1
4693226|NCT02384460|16168083|P2|Overall Study|Withdrawal by Subject|3
4693227|NCT02384460|16168084|P1|Overall Study|Withdrawal by Subject|0
4693228|NCT02384460|16168083|P2|Overall Study|Adverse Event|2
4693229|NCT02384460|16168084|P1|Overall Study|Adverse Event|5
4693230|NCT02384460|16168083|P2|Overall Study|Returned to previous therapeutic regimen|1
4693231|NCT02384460|16168084|P1|Overall Study|Returned to previous therapeutic regimen|0
4693232|NCT02384460|16168083|P2|Overall Study|Protocol Violation|1
4693233|NCT02384460|16168084|P1|Overall Study|Protocol Violation|0
4693234|NCT02384382|16168102|P1|Overall Study|Disease progression|16
4693235|NCT02384382|16168102|P1|Overall Study|Adverse Event|1
4693236|NCT02384382|16168102|P1|Overall Study|Death|1
4693237|NCT02384382|16168102|P1|Overall Study|Transitioned to study-NCT02960022|5
4693238|NCT02058095|16168109|P2|Overall Study|Adverse Event|0
4693239|NCT02058095|16168110|P1|Overall Study|Adverse Event|1
4693240|NCT02383966|16168187|P2|Overall Study|Randomized, but not treated|3
4693241|NCT02383966|16168188|P1|Overall Study|Randomized, but not treated|1
4693242|NCT02383966|16168187|P2|Overall Study|Ongoing at clinical cut-off date|4
4693243|NCT02383966|16168188|P1|Overall Study|Ongoing at clinical cut-off date|25
4693244|NCT02383940|16168208|P2|Overall Study|Other than specified above|0
4693245|NCT02383940|16168209|P1|Overall Study|Other than specified above|1
4693246|NCT02383940|16168208|P2|Overall Study|Randomized but not treated|0
4693247|NCT02383940|16168209|P1|Overall Study|Randomized but not treated|2
4693248|NCT02383940|16168208|P2|Overall Study|Withdrawal by Subject|1
4693249|NCT02383940|16168209|P1|Overall Study|Withdrawal by Subject|1
4693250|NCT02383940|16168208|P2|Overall Study|Physician Decision|0
4693251|NCT02383940|16168209|P1|Overall Study|Physician Decision|2
4693252|NCT02383940|16168208|P2|Overall Study|Lost to Follow-up|2
4693253|NCT02383940|16168209|P1|Overall Study|Lost to Follow-up|2
4693254|NCT02383940|16168208|P2|Overall Study|Adverse Event|0
4693255|NCT02383940|16168209|P1|Overall Study|Adverse Event|1
4693256|NCT02383862|16168225|P2|3 Month Follow up|Lost to Follow-up|21
4693257|NCT02383862|16168226|P1|3 Month Follow up|Lost to Follow-up|23
4693258|NCT02383758|16168259|P2|Overall Study|Withdrawal by Subject|2
4693259|NCT02383758|16168260|P1|Overall Study|Withdrawal by Subject|0
4693260|NCT02383589|16168288|P2|Overall Study|Non-compliance with study drug|1
4693261|NCT02383589|16168289|P1|Overall Study|Non-compliance with study drug|0
4693262|NCT02383589|16168288|P2|Overall Study|Withdrawal by Subject|5
4693263|NCT02383589|16168289|P1|Overall Study|Withdrawal by Subject|0
4693264|NCT02383589|16168288|P2|Overall Study|Lost to Follow-up|1
4693265|NCT02383589|16168289|P1|Overall Study|Lost to Follow-up|0
4693266|NCT02383589|16168288|P2|Overall Study|Adverse Event|3
4693267|NCT02383589|16168289|P1|Overall Study|Adverse Event|1
4693268|NCT02383576|16168312|P2|Overall Study|Administrative/Other|4
4693269|NCT02383576|16168313|P1|Overall Study|Administrative/Other|2
4693270|NCT02383576|16168312|P2|Overall Study|Investigator's Decision|1
4693271|NCT02383576|16168313|P1|Overall Study|Investigator's Decision|0
4693272|NCT02383576|16168312|P2|Overall Study|Withdrew Consent|6
4693273|NCT02383576|16168313|P1|Overall Study|Withdrew Consent|1
4693274|NCT02383576|16168312|P2|Overall Study|Lost to Follow-up|1
4693275|NCT02383576|16168313|P1|Overall Study|Lost to Follow-up|7
4693276|NCT02383576|16168312|P2|Overall Study|Death|33
4693277|NCT02383576|16168313|P1|Overall Study|Death|53
4693278|NCT02383472|16168329|P2|Overall Study|Withdrawal by Subject|1
4693279|NCT02383472|16168330|P1|Overall Study|Withdrawal by Subject|1
4693280|NCT02383433|16168344|P1|Overall Study|Disease progression|2
4693281|NCT02383355|16168363|P2|Overall Study|Adverse Event|0
4693282|NCT02383355|16168364|P1|Overall Study|Adverse Event|2
4693283|NCT02383056|16168380|P2|Overall Study|Lost to Follow-up|2
4693284|NCT02383056|16168381|P1|Overall Study|Lost to Follow-up|0
4693285|NCT02383056|16168380|P2|Overall Study|Adverse Event|0
4693286|NCT02383056|16168381|P1|Overall Study|Adverse Event|1
4693287|NCT02382991|16168407|P2|Overall Study|Withdrawal by Subject|1
4693288|NCT02382991|16168408|P1|Overall Study|Withdrawal by Subject|0
4693289|NCT02382991|16168407|P2|Overall Study|Lost to Follow-up|0
4693290|NCT02382991|16168408|P1|Overall Study|Lost to Follow-up|1
4693291|NCT02382991|16168407|P2|Overall Study|Adverse Event|2
4693292|NCT02382991|16168408|P1|Overall Study|Adverse Event|1
4693293|NCT02382939|16168420|P2|Overall Study|Withdrawal by Subject|2
4693294|NCT02382939|16168421|P1|Overall Study|Withdrawal by Subject|2
4693295|NCT02382939|16168420|P2|Overall Study|Adverse Event|1
4693296|NCT02382939|16168421|P1|Overall Study|Adverse Event|1
4693297|NCT02382796|16168504|P1|Overall Study|Commercial dacomitinib became available|3
4693298|NCT02382796|16168504|P1|Overall Study|Objective progression or relapse|3
4693299|NCT02382796|16168504|P1|Overall Study|Global deterioration of health status|1
4693300|NCT02382640|16168554|P4|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
4693301|NCT02382640|16168555|P3|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
4693302|NCT02382640|16168556|P2|Intervention Period 4 (3 Days)|Laboratory Abnormality|0
4693303|NCT02382640|16168557|P1|Intervention Period 4 (3 Days)|Laboratory Abnormality|1
4693304|NCT02382276|16168598|P3|Overall Study|Physician Decision|2
4693305|NCT02382276|16168599|P2|Overall Study|Physician Decision|0
4693306|NCT02382276|16168600|P1|Overall Study|Physician Decision|0
4693307|NCT02382276|16168598|P3|Overall Study|Adverse Event|32
4693308|NCT02382276|16168599|P2|Overall Study|Adverse Event|2
4693309|NCT02382276|16168600|P1|Overall Study|Adverse Event|7
4693310|NCT02382276|16168598|P3|Overall Study|Withdrawal by Subject|5
4693311|NCT02382276|16168599|P2|Overall Study|Withdrawal by Subject|8
4693312|NCT02382276|16168600|P1|Overall Study|Withdrawal by Subject|4
4693313|NCT02382133|16168612|P1|Overall Study|pressure injury both sites|1
4693314|NCT02382133|16168612|P1|Overall Study|arterial catheter loss|4
4693315|NCT02382133|16168612|P1|Overall Study|Physician Decision|2
4693316|NCT02382133|16168612|P1|Overall Study|transfer out of ICU|4
4693317|NCT02382133|16168612|P1|Overall Study|Death|22
4693318|NCT02382016|16168619|P2|OL Extension Period|Withdrawal by Subject|0
4693319|NCT02382016|16168620|P1|OL Extension Period|Withdrawal by Subject|1
4693320|NCT02382016|16168619|P2|OL Extension Period|Death|0
4693321|NCT02382016|16168620|P1|OL Extension Period|Death|2
4693322|NCT02382016|16168619|P2|OL Extension Period|Physician Decision|0
4693323|NCT02382016|16168620|P1|OL Extension Period|Physician Decision|3
4693324|NCT02382016|16168619|P2|Open-label (OL) Treatment Period|Death|0
4693325|NCT02382016|16168620|P1|Open-label (OL) Treatment Period|Death|4
4693326|NCT02382016|16168619|P2|Open-label (OL) Treatment Period|Withdrawal by Subject|0
4693327|NCT02382016|16168620|P1|Open-label (OL) Treatment Period|Withdrawal by Subject|2
4693328|NCT02382016|16168619|P2|Open-label (OL) Treatment Period|Physician Decision|0
4693329|NCT02382016|16168620|P1|Open-label (OL) Treatment Period|Physician Decision|3
4693330|NCT02382016|16168619|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|1
4693331|NCT02382016|16168620|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|0
4693332|NCT02382016|16168619|P2|Double-blind (DB) Treatment Period|Lack of Efficacy|0
4693333|NCT02382016|16168620|P1|Double-blind (DB) Treatment Period|Lack of Efficacy|1
4693334|NCT02382016|16168619|P2|Double-blind (DB) Treatment Period|Physician Decision|0
4693335|NCT02382016|16168620|P1|Double-blind (DB) Treatment Period|Physician Decision|3
4693336|NCT02381795|16168644|P1|Overall Study|Study Terminated|2
4693337|NCT02381795|16168644|P1|Overall Study|Withdrawal by Subject|1
4693338|NCT02381652|16168659|P3|Overall Study|Withdrawal by Subject|1
4693339|NCT02381652|16168660|P2|Overall Study|Withdrawal by Subject|0
4693340|NCT02381652|16168661|P1|Overall Study|Withdrawal by Subject|0
4693341|NCT02043548|16168670|P2|Overall Study|Adverse Event|1
4693342|NCT02043548|16168671|P1|Overall Study|Adverse Event|0
4693343|NCT02043548|16168670|P2|Overall Study|Lack of Efficacy|0
4693344|NCT02043548|16168671|P1|Overall Study|Lack of Efficacy|1
4693345|NCT02380859|16168783|P2|Overall Study|Withdrawal by Subject|0
4693346|NCT02380859|16168784|P1|Overall Study|Withdrawal by Subject|2
4693347|NCT02380742|16168820|P2|Overall Study|Withdrawal by Subject|0
4693348|NCT02380742|16168821|P1|Overall Study|Withdrawal by Subject|1
4693349|NCT02380690|16168835|P2|Overall Study|Withdrawal by Subject|8
4693350|NCT02380690|16168836|P1|Overall Study|Withdrawal by Subject|20
4693351|NCT02380690|16168835|P2|Overall Study|Lost to Follow-up|4
4693352|NCT02380690|16168836|P1|Overall Study|Lost to Follow-up|14
4693353|NCT02380677|16168884|P12|Overall Study|Other|0
4693354|NCT02380677|16168885|P11|Overall Study|Other|0
4693355|NCT02380677|16168886|P10|Overall Study|Other|0
4693356|NCT02380677|16168887|P9|Overall Study|Other|0
4693357|NCT02380677|16168888|P8|Overall Study|Other|0
4693358|NCT02380677|16168889|P7|Overall Study|Other|0
4693359|NCT02380677|16168890|P6|Overall Study|Other|1
4693360|NCT02380677|16168891|P5|Overall Study|Other|1
4693361|NCT02380677|16168892|P4|Overall Study|Other|1
4693362|NCT02380677|16168893|P3|Overall Study|Other|0
4693363|NCT02380677|16168894|P2|Overall Study|Other|0
4693364|NCT02380677|16168895|P1|Overall Study|Other|0
4693365|NCT02380677|16168884|P12|Overall Study|Withdrawal by Subject|3
4693366|NCT02380677|16168885|P11|Overall Study|Withdrawal by Subject|0
4693367|NCT02380677|16168886|P10|Overall Study|Withdrawal by Subject|1
4693368|NCT02380677|16168887|P9|Overall Study|Withdrawal by Subject|0
4693369|NCT02380677|16168888|P8|Overall Study|Withdrawal by Subject|0
4693370|NCT02380677|16168889|P7|Overall Study|Withdrawal by Subject|0
4693371|NCT02380677|16168890|P6|Overall Study|Withdrawal by Subject|0
4693372|NCT02380677|16168891|P5|Overall Study|Withdrawal by Subject|0
4693373|NCT02380677|16168892|P4|Overall Study|Withdrawal by Subject|0
4693374|NCT02380677|16168893|P3|Overall Study|Withdrawal by Subject|0
4693375|NCT02380677|16168894|P2|Overall Study|Withdrawal by Subject|0
4693376|NCT02380677|16168895|P1|Overall Study|Withdrawal by Subject|0
4693377|NCT02380677|16168884|P12|Overall Study|Lack of Efficacy|1
4693378|NCT02380677|16168885|P11|Overall Study|Lack of Efficacy|2
4693379|NCT02380677|16168886|P10|Overall Study|Lack of Efficacy|0
4693380|NCT02380677|16168887|P9|Overall Study|Lack of Efficacy|2
4693381|NCT02380677|16168888|P8|Overall Study|Lack of Efficacy|2
4693382|NCT02380677|16168889|P7|Overall Study|Lack of Efficacy|1
4693383|NCT02380677|16168890|P6|Overall Study|Lack of Efficacy|1
4693384|NCT02380677|16168891|P5|Overall Study|Lack of Efficacy|4
4693385|NCT02380677|16168892|P4|Overall Study|Lack of Efficacy|0
4693386|NCT02380677|16168893|P3|Overall Study|Lack of Efficacy|2
4693387|NCT02380677|16168894|P2|Overall Study|Lack of Efficacy|1
4693388|NCT02380677|16168895|P1|Overall Study|Lack of Efficacy|0
4693389|NCT02380677|16168884|P12|Overall Study|Physician Decision|0
4693390|NCT02380677|16168885|P11|Overall Study|Physician Decision|0
4693391|NCT02380677|16168886|P10|Overall Study|Physician Decision|0
4693392|NCT02380677|16168887|P9|Overall Study|Physician Decision|0
4693393|NCT02380677|16168888|P8|Overall Study|Physician Decision|0
4693394|NCT02380677|16168889|P7|Overall Study|Physician Decision|0
4693395|NCT02380677|16168890|P6|Overall Study|Physician Decision|0
4693396|NCT02380677|16168891|P5|Overall Study|Physician Decision|0
4693397|NCT02380677|16168892|P4|Overall Study|Physician Decision|1
4693398|NCT02380677|16168893|P3|Overall Study|Physician Decision|1
4693399|NCT02380677|16168894|P2|Overall Study|Physician Decision|0
4693400|NCT02380677|16168895|P1|Overall Study|Physician Decision|1
4693401|NCT02380677|16168884|P12|Overall Study|Adverse Event|1
4693402|NCT02380677|16168885|P11|Overall Study|Adverse Event|2
4693403|NCT02380677|16168886|P10|Overall Study|Adverse Event|1
4693404|NCT02380677|16168887|P9|Overall Study|Adverse Event|2
4693405|NCT02380677|16168888|P8|Overall Study|Adverse Event|2
4693406|NCT02380677|16168889|P7|Overall Study|Adverse Event|2
4693407|NCT02380677|16168890|P6|Overall Study|Adverse Event|4
4693408|NCT02380677|16168891|P5|Overall Study|Adverse Event|1
4693409|NCT02380677|16168892|P4|Overall Study|Adverse Event|1
4693410|NCT02380677|16168893|P3|Overall Study|Adverse Event|0
4693411|NCT02380677|16168894|P2|Overall Study|Adverse Event|0
4693412|NCT02380677|16168895|P1|Overall Study|Adverse Event|0
4693413|NCT02380287|16168951|P8|Overall Study|Adverse Event|0
4693414|NCT02380287|16168952|P7|Overall Study|Adverse Event|0
4693415|NCT02380287|16168953|P6|Overall Study|Adverse Event|0
4693416|NCT02380287|16168954|P5|Overall Study|Adverse Event|0
4693417|NCT02380287|16168955|P4|Overall Study|Adverse Event|0
4693418|NCT02380287|16168956|P3|Overall Study|Adverse Event|1
4693419|NCT02380287|16168957|P2|Overall Study|Adverse Event|0
4693420|NCT02380287|16168958|P1|Overall Study|Adverse Event|0
4693421|NCT02380248|16168974|P1|Overall Study|Withdrawal by Subject|3
4693422|NCT02380248|16168974|P1|Overall Study|Lost to Follow-up|11
4693423|NCT02379923|16168990|P1|Overall Study|Death|5
4693424|NCT02379728|16169019|P4|Overall Study|Protocol Violation|0
4693425|NCT02379728|16169020|P3|Overall Study|Protocol Violation|2
4693426|NCT02379728|16169021|P2|Overall Study|Protocol Violation|0
4693427|NCT02379728|16169022|P1|Overall Study|Protocol Violation|0
4693428|NCT02379728|16169019|P4|Overall Study|Withdrawal by Subject|3
4693429|NCT02379728|16169020|P3|Overall Study|Withdrawal by Subject|5
4693430|NCT02379728|16169021|P2|Overall Study|Withdrawal by Subject|0
4693431|NCT02379728|16169022|P1|Overall Study|Withdrawal by Subject|5
4693432|NCT02379728|16169019|P4|Overall Study|Lost to Follow-up|0
4693433|NCT02379728|16169020|P3|Overall Study|Lost to Follow-up|3
4693434|NCT02379728|16169021|P2|Overall Study|Lost to Follow-up|0
4693435|NCT02379728|16169022|P1|Overall Study|Lost to Follow-up|1
4693436|NCT02379637|16169078|P2|Overall Study|Withdrawal by Subject|0
4693437|NCT02379637|16169079|P1|Overall Study|Withdrawal by Subject|1
4693438|NCT02379637|16169078|P2|Overall Study|Adverse Event|0
4693439|NCT02379637|16169079|P1|Overall Study|Adverse Event|1
4693440|NCT02379637|16169078|P2|Overall Study|Protocol Violation|1
4693441|NCT02379637|16169079|P1|Overall Study|Protocol Violation|0
4693442|NCT02379390|16169118|P2|Overall Study|Study Termination|1
4693443|NCT02379390|16169119|P1|Overall Study|Study Termination|0
4693444|NCT02379390|16169118|P2|Overall Study|Investigator's decision|0
4693445|NCT02379390|16169119|P1|Overall Study|Investigator's decision|1
4693446|NCT02379390|16169118|P2|Overall Study|Adverse Event|1
4693447|NCT02379390|16169119|P1|Overall Study|Adverse Event|1
4693448|NCT02379221|16169147|P1|Overall Study|Lost to Follow-up|1
4693449|NCT02379091|16169183|P4|Overall Study|Lack of Efficacy|0
4693450|NCT02379091|16169184|P3|Overall Study|Lack of Efficacy|0
4693451|NCT02379091|16169185|P2|Overall Study|Lack of Efficacy|0
4693452|NCT02379091|16169186|P1|Overall Study|Lack of Efficacy|3
4693453|NCT02379091|16169183|P4|Overall Study|Study Termination|8
4693454|NCT02379091|16169184|P3|Overall Study|Study Termination|5
4693455|NCT02379091|16169185|P2|Overall Study|Study Termination|2
4693456|NCT02379091|16169186|P1|Overall Study|Study Termination|7
4693457|NCT02379091|16169183|P4|Overall Study|Voluntary Withdrawal|4
4693458|NCT02379091|16169184|P3|Overall Study|Voluntary Withdrawal|2
4693459|NCT02379091|16169185|P2|Overall Study|Voluntary Withdrawal|5
4693460|NCT02379091|16169186|P1|Overall Study|Voluntary Withdrawal|2
4693461|NCT02379091|16169183|P4|Overall Study|Lost to Follow-up|1
4693462|NCT02379091|16169184|P3|Overall Study|Lost to Follow-up|0
4693463|NCT02379091|16169185|P2|Overall Study|Lost to Follow-up|0
4693464|NCT02379091|16169186|P1|Overall Study|Lost to Follow-up|0
4693465|NCT02379091|16169183|P4|Overall Study|Principal Investigator Discretion|0
4693466|NCT02379091|16169184|P3|Overall Study|Principal Investigator Discretion|0
4693467|NCT02379091|16169185|P2|Overall Study|Principal Investigator Discretion|1
4693468|NCT02379091|16169186|P1|Overall Study|Principal Investigator Discretion|0
4693469|NCT02379091|16169183|P4|Overall Study|Pretreatment Event/Adverse Event|1
4693470|NCT02379091|16169184|P3|Overall Study|Pretreatment Event/Adverse Event|0
4693471|NCT02379091|16169185|P2|Overall Study|Pretreatment Event/Adverse Event|2
4693472|NCT02379091|16169186|P1|Overall Study|Pretreatment Event/Adverse Event|0
4693473|NCT02379052|16169224|P2|Overall Study|Subject was Incarcerated|1
4693474|NCT02379052|16169225|P1|Overall Study|Subject was Incarcerated|0
4693475|NCT02379052|16169224|P2|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0
4693476|NCT02379052|16169225|P1|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1
4693477|NCT02379052|16169224|P2|Overall Study|Lost to Follow-up|1
4693478|NCT02379052|16169225|P1|Overall Study|Lost to Follow-up|2
4693479|NCT02379052|16169224|P2|Overall Study|Withdrawal by Subject|0
4693480|NCT02379052|16169225|P1|Overall Study|Withdrawal by Subject|2
4693481|NCT02379052|16169224|P2|Overall Study|Physician Decision|1
4693482|NCT02379052|16169225|P1|Overall Study|Physician Decision|1
4693483|NCT02379052|16169224|P2|Overall Study|Adverse Event|1
4693484|NCT02379052|16169225|P1|Overall Study|Adverse Event|0
4693485|NCT02379052|16169224|P2|Overall Study|Protocol Violation|1
4693486|NCT02379052|16169225|P1|Overall Study|Protocol Violation|0
4693487|NCT02378961|16169267|P4|Overall Study|Death|0
4693488|NCT02378961|16169268|P3|Overall Study|Death|1
4693489|NCT02378961|16169269|P2|Overall Study|Death|0
4693490|NCT02378961|16169270|P1|Overall Study|Death|0
4693491|NCT02378961|16169267|P4|Overall Study|Lack of Efficacy|1
4693492|NCT02378961|16169268|P3|Overall Study|Lack of Efficacy|0
4693493|NCT02378961|16169269|P2|Overall Study|Lack of Efficacy|2
4693494|NCT02378961|16169270|P1|Overall Study|Lack of Efficacy|4
4693495|NCT02378935|16169307|P7|Overall Study|Death|0
4693496|NCT02378935|16169308|P6|Overall Study|Death|0
4693497|NCT02378935|16169309|P5|Overall Study|Death|0
4693498|NCT02378935|16169310|P4|Overall Study|Death|0
4693499|NCT02378935|16169311|P3|Overall Study|Death|1
4693500|NCT02378935|16169312|P2|Overall Study|Death|0
4693501|NCT02378935|16169313|P1|Overall Study|Death|0
4693502|NCT02378935|16169307|P7|Overall Study|Lack of Efficacy|0
4693503|NCT02378935|16169308|P6|Overall Study|Lack of Efficacy|0
4693504|NCT02378935|16169309|P5|Overall Study|Lack of Efficacy|0
4693505|NCT02378935|16169310|P4|Overall Study|Lack of Efficacy|6
4693506|NCT02378935|16169311|P3|Overall Study|Lack of Efficacy|2
4693507|NCT02378935|16169312|P2|Overall Study|Lack of Efficacy|0
4693508|NCT02378935|16169313|P1|Overall Study|Lack of Efficacy|10
4693509|NCT02378883|16169364|P1|12 Months Follow-Up|Death|2
4693510|NCT02378883|16169364|P1|12 Months Follow-Up|Lost to Follow-up|3
4693511|NCT02378883|16169364|P1|30 Day Follow-Up|Death|1
4693512|NCT02378883|16169364|P1|30 Day Follow-Up|Missed Visit|2
4693513|NCT02378883|16169364|P1|30 Day Follow-Up|Physician Decision|2
4693514|NCT02378883|16169364|P1|30 Day Follow-Up|Withdrawal by Subject|1
4693515|NCT02378883|16169364|P1|Enrollment|Attempt to use Apollo was not performed|3
4693516|NCT02378883|16169364|P1|Enrollment|Subject did not meet Inclusion criteria|6
4693517|NCT02378662|16169430|P2|Overall Study|Early Discontinuation|0
4693518|NCT02378662|16169431|P1|Overall Study|Early Discontinuation|2
4693519|NCT02378506|16169437|P1|Overall Study|Randomized But Not Treated|1
4693520|NCT02378506|16169437|P1|Overall Study|Adverse Event|14
4693521|NCT02378506|16169437|P1|Overall Study|Death|1
4693522|NCT02378506|16169437|P1|Overall Study|Protocol Violation|2
4693523|NCT02378506|16169437|P1|Overall Study|Withdrawal by Subject|4
4693524|NCT02378506|16169437|P1|Overall Study|Lack of Efficacy|3
4693525|NCT02378480|16169456|P2|Overall Study|Lost to Follow-up|18
4693526|NCT02378480|16169457|P1|Overall Study|Lost to Follow-up|10
4693527|NCT02378480|16169456|P2|Overall Study|Withdrawal by Subject|4
4693528|NCT02378480|16169457|P1|Overall Study|Withdrawal by Subject|9
4693529|NCT02378480|16169456|P2|Overall Study|Missed EOT/PTE Visit|2
4693530|NCT02378480|16169457|P1|Overall Study|Missed EOT/PTE Visit|1
4693531|NCT02378480|16169456|P2|Overall Study|Adverse Event|1
4693532|NCT02378480|16169457|P1|Overall Study|Adverse Event|0
4693533|NCT02378480|16169456|P2|Overall Study|Randomized, but Not Treated|4
4693534|NCT02378480|16169457|P1|Overall Study|Randomized, but Not Treated|6
4693535|NCT02378480|16169456|P2|Overall Study|Death|2
4693536|NCT02378480|16169457|P1|Overall Study|Death|1
4693537|NCT02378480|16169456|P2|Overall Study|Physician Decision|1
4693538|NCT02378480|16169457|P1|Overall Study|Physician Decision|1
4693539|NCT02378220|16169484|P2|Overall Study|Death|1
4693540|NCT02378220|16169485|P1|Overall Study|Death|6
4693541|NCT02377921|16169583|P2|Overall Study|Subject non-compliance|1
4693542|NCT02377921|16169584|P1|Overall Study|Subject non-compliance|1
4693543|NCT02377817|16169608|P2|Overall Study|Unrelated injury prevented lateral sleep|0
4693544|NCT02377817|16169609|P1|Overall Study|Unrelated injury prevented lateral sleep|1
4693545|NCT02377817|16169608|P2|Overall Study|Transportation/childcare barriers.|0
4693546|NCT02377817|16169609|P1|Overall Study|Transportation/childcare barriers.|2
4693547|NCT02377466|16169673|P2|Overall Study|Other: Randomized and not treated|2
4693548|NCT02377466|16169674|P1|Overall Study|Other: Randomized and not treated|0
4693549|NCT02377427|16169805|P5|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4693550|NCT02377427|16169806|P4|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4693551|NCT02377427|16169807|P3|Part B (From Week 20 and up to Week 80)|Protocol Violation|1
4693552|NCT02377427|16169808|P2|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4693553|NCT02377427|16169809|P1|Part B (From Week 20 and up to Week 80)|Protocol Violation|0
4693554|NCT02377427|16169805|P5|Part A (Up to Week 20)|Withdrawal by Subject|0
4693555|NCT02377427|16169806|P4|Part A (Up to Week 20)|Withdrawal by Subject|0
4693556|NCT02377427|16169807|P3|Part A (Up to Week 20)|Withdrawal by Subject|0
4693557|NCT02377427|16169808|P2|Part A (Up to Week 20)|Withdrawal by Subject|0
4693558|NCT02377427|16169809|P1|Part A (Up to Week 20)|Withdrawal by Subject|2
4693559|NCT02377427|16169805|P5|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4693560|NCT02377427|16169806|P4|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4693561|NCT02377427|16169807|P3|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4693562|NCT02377427|16169808|P2|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0
4693563|NCT02377427|16169809|P1|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1
4693564|NCT02377427|16169805|P5|Part A (Up to Week 20)|Physician Decision|0
4693565|NCT02377427|16169806|P4|Part A (Up to Week 20)|Physician Decision|0
4693566|NCT02377427|16169807|P3|Part A (Up to Week 20)|Physician Decision|0
4693567|NCT02377427|16169808|P2|Part A (Up to Week 20)|Physician Decision|0
4693568|NCT02377427|16169809|P1|Part A (Up to Week 20)|Physician Decision|1
4693569|NCT02377362|16169882|P13|Part B Overall|Withdrawal by Subject|0
4693570|NCT02377362|16169883|P12|Part B Overall|Withdrawal by Subject|1
4693571|NCT02377362|16169884|P11|Part B Overall|Withdrawal by Subject|0
4693572|NCT02377362|16169885|P10|Part B Overall|Withdrawal by Subject|0
4693573|NCT02377362|16169886|P9|Part B Overall|Withdrawal by Subject|0
4693574|NCT02377362|16169887|P8|Part B Overall|Withdrawal by Subject|0
4693575|NCT02377362|16169888|P7|Part B Overall|Withdrawal by Subject|1
4693576|NCT02377362|16169889|P6|Part B Overall|Withdrawal by Subject|0
4693577|NCT02377362|16169890|P5|Part B Overall|Withdrawal by Subject|0
4693578|NCT02377362|16169891|P4|Part B Overall|Withdrawal by Subject|0
4693579|NCT02377362|16169892|P3|Part B Overall|Withdrawal by Subject|0
4693580|NCT02377362|16169893|P2|Part B Overall|Withdrawal by Subject|0
4693581|NCT02377362|16169894|P1|Part B Overall|Withdrawal by Subject|0
4693582|NCT02377362|16169882|P13|Part B Overall|Adverse Event|0
4693583|NCT02377362|16169883|P12|Part B Overall|Adverse Event|0
4693584|NCT02377362|16169884|P11|Part B Overall|Adverse Event|0
4693585|NCT02377362|16169885|P10|Part B Overall|Adverse Event|0
4693586|NCT02377362|16169886|P9|Part B Overall|Adverse Event|0
4693587|NCT02377362|16169887|P8|Part B Overall|Adverse Event|1
4693588|NCT02377362|16169888|P7|Part B Overall|Adverse Event|1
4693589|NCT02377362|16169889|P6|Part B Overall|Adverse Event|0
4693590|NCT02377362|16169890|P5|Part B Overall|Adverse Event|0
4693591|NCT02377362|16169891|P4|Part B Overall|Adverse Event|0
4693592|NCT02377362|16169892|P3|Part B Overall|Adverse Event|0
4693593|NCT02377362|16169893|P2|Part B Overall|Adverse Event|0
4693594|NCT02377362|16169894|P1|Part B Overall|Adverse Event|0
4693595|NCT02377362|16169882|P13|Part B Overall|Protocol Violation|0
4693596|NCT02377362|16169883|P12|Part B Overall|Protocol Violation|0
4693597|NCT02377362|16169884|P11|Part B Overall|Protocol Violation|0
4693598|NCT02377362|16169885|P10|Part B Overall|Protocol Violation|1
4693599|NCT02377362|16169886|P9|Part B Overall|Protocol Violation|0
4693600|NCT02377362|16169887|P8|Part B Overall|Protocol Violation|0
4693601|NCT02377362|16169888|P7|Part B Overall|Protocol Violation|0
4693602|NCT02377362|16169889|P6|Part B Overall|Protocol Violation|0
4693603|NCT02377362|16169890|P5|Part B Overall|Protocol Violation|0
4693604|NCT02377362|16169891|P4|Part B Overall|Protocol Violation|0
4693605|NCT02377362|16169892|P3|Part B Overall|Protocol Violation|0
4693606|NCT02377362|16169893|P2|Part B Overall|Protocol Violation|0
4693607|NCT02377362|16169894|P1|Part B Overall|Protocol Violation|0
4693608|NCT02377362|16169882|P13|Part A Third Treatment|Highest dose level 1200 not used|0
4693609|NCT02377362|16169883|P12|Part A Third Treatment|Highest dose level 1200 not used|0
4693610|NCT02377362|16169884|P11|Part A Third Treatment|Highest dose level 1200 not used|0
4693611|NCT02377362|16169885|P10|Part A Third Treatment|Highest dose level 1200 not used|0
4693612|NCT02377362|16169886|P9|Part A Third Treatment|Highest dose level 1200 not used|0
4693613|NCT02377362|16169887|P8|Part A Third Treatment|Highest dose level 1200 not used|0
4693614|NCT02377362|16169888|P7|Part A Third Treatment|Highest dose level 1200 not used|0
4693615|NCT02377362|16169889|P6|Part A Third Treatment|Highest dose level 1200 not used|4
4693616|NCT02377362|16169890|P5|Part A Third Treatment|Highest dose level 1200 not used|3
4693617|NCT02377362|16169891|P4|Part A Third Treatment|Highest dose level 1200 not used|4
4693618|NCT02377362|16169892|P3|Part A Third Treatment|Highest dose level 1200 not used|0
4693619|NCT02377362|16169893|P2|Part A Third Treatment|Highest dose level 1200 not used|0
4693620|NCT02377362|16169894|P1|Part A Third Treatment|Highest dose level 1200 not used|0
4693621|NCT02377362|16169882|P13|Part A Second Treatment|Protocol Violation|0
4693622|NCT02377362|16169883|P12|Part A Second Treatment|Protocol Violation|0
4693623|NCT02377362|16169884|P11|Part A Second Treatment|Protocol Violation|0
4693624|NCT02377362|16169885|P10|Part A Second Treatment|Protocol Violation|0
4693625|NCT02377362|16169886|P9|Part A Second Treatment|Protocol Violation|0
4693626|NCT02377362|16169887|P8|Part A Second Treatment|Protocol Violation|0
4693627|NCT02377362|16169888|P7|Part A Second Treatment|Protocol Violation|0
4693628|NCT02377362|16169889|P6|Part A Second Treatment|Protocol Violation|0
4693629|NCT02377362|16169890|P5|Part A Second Treatment|Protocol Violation|1
4693630|NCT02377362|16169891|P4|Part A Second Treatment|Protocol Violation|0
4693631|NCT02377362|16169892|P3|Part A Second Treatment|Protocol Violation|0
4693632|NCT02377362|16169893|P2|Part A Second Treatment|Protocol Violation|0
4693633|NCT02377362|16169894|P1|Part A Second Treatment|Protocol Violation|0
4693634|NCT02377349|16170103|P2|Overall Study|Other|1
4693635|NCT02377349|16170104|P1|Overall Study|Other|0
4693636|NCT02377349|16170103|P2|Overall Study|Lost to follow-up (complete vaccination)|5
4693637|NCT02377349|16170104|P1|Overall Study|Lost to follow-up (complete vaccination)|6
4693638|NCT02377349|16170103|P2|Overall Study|Lost to follow-up (partial vaccination)|0
4693639|NCT02377349|16170104|P1|Overall Study|Lost to follow-up (partial vaccination)|1
4693640|NCT02377349|16170103|P2|Overall Study|Withdrawal by Subject|3
4693641|NCT02377349|16170104|P1|Overall Study|Withdrawal by Subject|5
4693642|NCT02377349|16170103|P2|Overall Study|Protocol Violation|2
4693643|NCT02377349|16170104|P1|Overall Study|Protocol Violation|3
4693644|NCT02377349|16170103|P2|Overall Study|Serious Adverse Event|0
4693645|NCT02377349|16170104|P1|Overall Study|Serious Adverse Event|1
4693646|NCT02377063|16170142|P1|Overall Study|Non-compliance|5
4693647|NCT02376790|16170160|P3|Overall Study|Lost to Follow-up|12
4693648|NCT02376790|16170161|P2|Overall Study|Lost to Follow-up|10
4693649|NCT02376790|16170162|P1|Overall Study|Lost to Follow-up|15
4693650|NCT02376790|16170160|P3|Overall Study|Decision by Sponsor|4
4693651|NCT02376790|16170161|P2|Overall Study|Decision by Sponsor|1
4693652|NCT02376790|16170162|P1|Overall Study|Decision by Sponsor|2
4693653|NCT02376790|16170160|P3|Overall Study|Withdrawal by Subject|37
4693654|NCT02376790|16170161|P2|Overall Study|Withdrawal by Subject|36
4693655|NCT02376790|16170162|P1|Overall Study|Withdrawal by Subject|43
4693656|NCT02376166|16170353|P1|Overall Study|Discontinued metformin early|2
4693657|NCT02376166|16170353|P1|Overall Study|Adverse Event|1
4693658|NCT02375971|16170381|P3|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0
4693659|NCT02375971|16170382|P2|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
4693660|NCT02375971|16170383|P1|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1
4693661|NCT02375971|16170381|P3|Follow-Up Phase (up to Day 169)|Death|4
4693662|NCT02375971|16170382|P2|Follow-Up Phase (up to Day 169)|Death|4
4693663|NCT02375971|16170383|P1|Follow-Up Phase (up to Day 169)|Death|4
4693664|NCT02375971|16170381|P3|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
4693665|NCT02375971|16170382|P2|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0
4693666|NCT02375971|16170383|P1|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1
4693667|NCT02375971|16170381|P3|Follow-Up Phase (up to Day 169)|Adverse Event|0
4693668|NCT02375971|16170382|P2|Follow-Up Phase (up to Day 169)|Adverse Event|0
4693669|NCT02375971|16170383|P1|Follow-Up Phase (up to Day 169)|Adverse Event|1
4693670|NCT02375971|16170381|P3|Treatment (Day 1 - Baseline)|Adverse Event|1
4693671|NCT02375971|16170382|P2|Treatment (Day 1 - Baseline)|Adverse Event|0
4693672|NCT02375971|16170383|P1|Treatment (Day 1 - Baseline)|Adverse Event|0
4693673|NCT02375971|16170381|P3|Treatment (Day 1 - Baseline)|Lost to Follow-up|1
4693674|NCT02375971|16170382|P2|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
4693675|NCT02375971|16170383|P1|Treatment (Day 1 - Baseline)|Lost to Follow-up|0
4693676|NCT02375971|16170381|P3|Treatment (Day 1 - Baseline)|Physician Decision|1
4693677|NCT02375971|16170382|P2|Treatment (Day 1 - Baseline)|Physician Decision|1
4693678|NCT02375971|16170383|P1|Treatment (Day 1 - Baseline)|Physician Decision|1
4693679|NCT02375971|16170381|P3|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2
4693680|NCT02375971|16170382|P2|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
4693681|NCT02375971|16170383|P1|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0
4693682|NCT02375724|16170425|P2|Overall Study|Adverse Event|4
4693683|NCT02375724|16170426|P1|Overall Study|Adverse Event|2
4693684|NCT02375724|16170425|P2|Overall Study|Protocol Violation|0
4693685|NCT02375724|16170426|P1|Overall Study|Protocol Violation|1
4693686|NCT02375724|16170425|P2|Overall Study|Lost to Follow-up|0
4693687|NCT02375724|16170426|P1|Overall Study|Lost to Follow-up|1
4693688|NCT02375724|16170425|P2|Overall Study|Withdrawal by Subject|1
4693689|NCT02375724|16170426|P1|Overall Study|Withdrawal by Subject|1
4693690|NCT02375724|16170425|P2|Overall Study|Lack of Efficacy|1
4693691|NCT02375724|16170426|P1|Overall Study|Lack of Efficacy|1
4693692|NCT02375698|16170438|P2|Overall Study|Physician Decision|0
4693693|NCT02375698|16170439|P1|Overall Study|Physician Decision|2
4693694|NCT02375698|16170438|P2|Overall Study|Withdrawal by Subject|2
4693695|NCT02375698|16170439|P1|Overall Study|Withdrawal by Subject|0
4693696|NCT02375373|16170447|P1|Overall Study|Withdrawal by Subject|11
4693697|NCT02375347|16170451|P1|Overall Study|Protocol Violation|1
4693698|NCT02374957|16170457|P2|Overall Study|Patient did not complete forms correctly|0
4693699|NCT02374957|16170458|P1|Overall Study|Patient did not complete forms correctly|1
4693700|NCT02374671|16170487|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
4693701|NCT02374671|16170488|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
4693702|NCT02374671|16170489|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
4693703|NCT02374671|16170487|P3|Implantation- Nonrandomized & Randomized|Adverse Event|1
4693704|NCT02374671|16170488|P2|Implantation- Nonrandomized & Randomized|Adverse Event|0
4693705|NCT02374671|16170489|P1|Implantation- Nonrandomized & Randomized|Adverse Event|7
4693706|NCT02374671|16170487|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2
4693707|NCT02374671|16170488|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
4693708|NCT02374671|16170489|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17
4693709|NCT02374671|16170487|P3|Observation (Deferred Implantation)|Adverse Event|1
4693710|NCT02374671|16170488|P2|Observation (Deferred Implantation)|Adverse Event|0
4693711|NCT02374671|16170489|P1|Observation (Deferred Implantation)|Adverse Event|0
4693712|NCT02374671|16170487|P3|Observation (Deferred Implantation)|Withdrawal by Subject|4
4693713|NCT02374671|16170488|P2|Observation (Deferred Implantation)|Withdrawal by Subject|0
4693714|NCT02374671|16170489|P1|Observation (Deferred Implantation)|Withdrawal by Subject|0
4693715|NCT02374593|16170497|P2|Overall Study|non-compliant|0
4693716|NCT02374593|16170498|P1|Overall Study|non-compliant|2
4693717|NCT02374463|16170510|P2|Overall Study|Withdrawal by Subject|3
4693718|NCT02374463|16170511|P1|Overall Study|Withdrawal by Subject|3
4693719|NCT02374346|16170560|P1|Overall Study|operated or discharged during weekend|48
4693720|NCT02374307|16170568|P2|6-months Follow-up|Withdrawal by Subject|3
4693721|NCT02374307|16170569|P1|6-months Follow-up|Withdrawal by Subject|0
4693722|NCT02374307|16170568|P2|6-months Follow-up|Death|1
4693723|NCT02374307|16170569|P1|6-months Follow-up|Death|2
4693724|NCT02374307|16170568|P2|6-months Follow-up|Lost to Follow-up|2
4693725|NCT02374307|16170569|P1|6-months Follow-up|Lost to Follow-up|1
4693726|NCT02374307|16170568|P2|3-months Follow-up|Missed first follow-up|1
4693727|NCT02374307|16170569|P1|3-months Follow-up|Missed first follow-up|5
4693728|NCT02374307|16170568|P2|3-months Follow-up|Death|2
4693729|NCT02374307|16170569|P1|3-months Follow-up|Death|1
4693730|NCT02374307|16170568|P2|3-months Follow-up|Withdrawal by Subject|4
4693731|NCT02374307|16170569|P1|3-months Follow-up|Withdrawal by Subject|1
4693732|NCT02374307|16170568|P2|3-months Follow-up|Lost to Follow-up|2
4693733|NCT02374307|16170569|P1|3-months Follow-up|Lost to Follow-up|1
4693734|NCT02374255|16170600|P4|Overall Study|Withdrawal by Subject|0
4693735|NCT02374255|16170601|P3|Overall Study|Withdrawal by Subject|0
4693736|NCT02374255|16170602|P2|Overall Study|Withdrawal by Subject|0
4693737|NCT02374255|16170603|P1|Overall Study|Withdrawal by Subject|2
4693738|NCT02374099|16170704|P2|Overall Study|Study Terminated by Sponsor|4
4693739|NCT02374099|16170705|P1|Overall Study|Study Terminated by Sponsor|3
4693740|NCT02374099|16170704|P2|Overall Study|Randomized, but not treated|1
4693741|NCT02374099|16170705|P1|Overall Study|Randomized, but not treated|2
4693742|NCT02374099|16170704|P2|Overall Study|Miscellaneous|3
4693743|NCT02374099|16170705|P1|Overall Study|Miscellaneous|2
4693744|NCT02374099|16170704|P2|Overall Study|Withdrawal by Subject|1
4693745|NCT02374099|16170705|P1|Overall Study|Withdrawal by Subject|5
4693746|NCT02374099|16170704|P2|Overall Study|Progressive Disease|40
4693747|NCT02374099|16170705|P1|Overall Study|Progressive Disease|35
4693748|NCT02374099|16170704|P2|Overall Study|Adverse Event|0
4693749|NCT02374099|16170705|P1|Overall Study|Adverse Event|1
4693750|NCT01987596|16170796|P2|Overall Study|Progressive Disease; missing all period|1
4693751|NCT01987596|16170797|P1|Overall Study|Progressive Disease; missing all period|0
4693752|NCT01987596|16170796|P2|Overall Study|Physician Decision|0
4693753|NCT01987596|16170797|P1|Overall Study|Physician Decision|1
4693754|NCT02373202|16170828|P4|Overall Study|Other|0
4693755|NCT02373202|16170829|P3|Overall Study|Other|0
4693756|NCT02373202|16170830|P2|Overall Study|Other|1
4693757|NCT02373202|16170831|P1|Overall Study|Other|0
4693758|NCT02373202|16170828|P4|Overall Study|Lack of Efficacy|0
4693759|NCT02373202|16170829|P3|Overall Study|Lack of Efficacy|1
4693760|NCT02373202|16170830|P2|Overall Study|Lack of Efficacy|0
4693761|NCT02373202|16170831|P1|Overall Study|Lack of Efficacy|0
4693762|NCT02373202|16170828|P4|Overall Study|Adverse Event|1
4693763|NCT02373202|16170829|P3|Overall Study|Adverse Event|2
4693764|NCT02373202|16170830|P2|Overall Study|Adverse Event|5
4693765|NCT02373202|16170831|P1|Overall Study|Adverse Event|2
4693766|NCT02373098|16170906|P2|Overall Study|Adverse Event|0
4693767|NCT02373098|16170907|P1|Overall Study|Adverse Event|3
4693768|NCT02373098|16170906|P2|Overall Study|Withdrawal by Subject|0
4693769|NCT02373098|16170907|P1|Overall Study|Withdrawal by Subject|5
4693770|NCT02373098|16170906|P2|Overall Study|Protocol Violation|0
4693771|NCT02373098|16170907|P1|Overall Study|Protocol Violation|3
4693772|NCT02373098|16170906|P2|Overall Study|Lost to Follow-up|0
4693773|NCT02373098|16170907|P1|Overall Study|Lost to Follow-up|1
4693774|NCT02372799|16170935|P3|Down-taper Period|Lost to Follow-up|2
4693775|NCT02372799|16170936|P2|Down-taper Period|Lost to Follow-up|2
4693776|NCT02372799|16170937|P1|Down-taper Period|Lost to Follow-up|1
4693777|NCT02372799|16170935|P3|Treatment Period|Miscellaneous Reasons|0
4693778|NCT02372799|16170936|P2|Treatment Period|Miscellaneous Reasons|1
4693779|NCT02372799|16170937|P1|Treatment Period|Miscellaneous Reasons|1
4693780|NCT02372799|16170935|P3|Treatment Period|Non-compliance with study drug|4
4693781|NCT02372799|16170936|P2|Treatment Period|Non-compliance with study drug|4
4693782|NCT02372799|16170937|P1|Treatment Period|Non-compliance with study drug|4
4693783|NCT02372799|16170935|P3|Treatment Period|Protocol Violation|0
4693784|NCT02372799|16170936|P2|Treatment Period|Protocol Violation|0
4693785|NCT02372799|16170937|P1|Treatment Period|Protocol Violation|3
4693786|NCT02372799|16170935|P3|Treatment Period|Lost to Follow-up|3
4693787|NCT02372799|16170936|P2|Treatment Period|Lost to Follow-up|5
4693788|NCT02372799|16170937|P1|Treatment Period|Lost to Follow-up|11
4693789|NCT02372799|16170935|P3|Treatment Period|Withdrawal by Subject|2
4693790|NCT02372799|16170936|P2|Treatment Period|Withdrawal by Subject|10
4693791|NCT02372799|16170937|P1|Treatment Period|Withdrawal by Subject|10
4693792|NCT02372799|16170935|P3|Treatment Period|Insufficient therapeutic response|0
4693793|NCT02372799|16170936|P2|Treatment Period|Insufficient therapeutic response|2
4693794|NCT02372799|16170937|P1|Treatment Period|Insufficient therapeutic response|2
4693795|NCT02372799|16170935|P3|Treatment Period|Adverse Event|6
4693796|NCT02372799|16170936|P2|Treatment Period|Adverse Event|10
4693797|NCT02372799|16170937|P1|Treatment Period|Adverse Event|3
4693798|NCT02372396|16170966|P2|Overall Study|Lost to Follow-up|9
4693799|NCT02372396|16170967|P1|Overall Study|Lost to Follow-up|7
4693800|NCT02372253|16170991|P2|Overall Study|Non Compliance|0
4693801|NCT02372253|16170992|P1|Overall Study|Non Compliance|2
4693802|NCT02372071|16171037|P1|Overall Study|Protocol Violation|18
4693803|NCT02372058|16171042|P1|Overall Study|Withdrawal by Subject|3
4693804|NCT02371980|16171048|P5|Double-blind Period|Missing|0
4693805|NCT02371980|16171049|P4|Double-blind Period|Missing|0
4693806|NCT02371980|16171050|P3|Double-blind Period|Missing|0
4693807|NCT02371980|16171051|P2|Double-blind Period|Missing|1
4693808|NCT02371980|16171052|P1|Double-blind Period|Missing|0
4693809|NCT02371980|16171048|P5|Double-blind Period|Reason not Specified|1
4693810|NCT02371980|16171049|P4|Double-blind Period|Reason not Specified|2
4693811|NCT02371980|16171050|P3|Double-blind Period|Reason not Specified|3
4693812|NCT02371980|16171051|P2|Double-blind Period|Reason not Specified|3
4693813|NCT02371980|16171052|P1|Double-blind Period|Reason not Specified|0
4693814|NCT02371980|16171048|P5|Double-blind Period|Relapse|26
4693815|NCT02371980|16171049|P4|Double-blind Period|Relapse|25
4693816|NCT02371980|16171050|P3|Double-blind Period|Relapse|25
4693817|NCT02371980|16171051|P2|Double-blind Period|Relapse|50
4693818|NCT02371980|16171052|P1|Double-blind Period|Relapse|0
4693819|NCT02371980|16171048|P5|Double-blind Period|Voluntary Withdrawal|11
4693820|NCT02371980|16171049|P4|Double-blind Period|Voluntary Withdrawal|9
4693821|NCT02371980|16171050|P3|Double-blind Period|Voluntary Withdrawal|8
4693822|NCT02371980|16171051|P2|Double-blind Period|Voluntary Withdrawal|12
4693823|NCT02371980|16171052|P1|Double-blind Period|Voluntary Withdrawal|0
4693824|NCT02371980|16171048|P5|Double-blind Period|Lost to Follow-up|5
4693825|NCT02371980|16171049|P4|Double-blind Period|Lost to Follow-up|6
4693826|NCT02371980|16171050|P3|Double-blind Period|Lost to Follow-up|8
4693827|NCT02371980|16171051|P2|Double-blind Period|Lost to Follow-up|8
4693828|NCT02371980|16171052|P1|Double-blind Period|Lost to Follow-up|0
4693829|NCT02371980|16171048|P5|Double-blind Period|Noncompliance with Study Drug|3
4693830|NCT02371980|16171049|P4|Double-blind Period|Noncompliance with Study Drug|2
4693831|NCT02371980|16171050|P3|Double-blind Period|Noncompliance with Study Drug|2
4693832|NCT02371980|16171051|P2|Double-blind Period|Noncompliance with Study Drug|1
4693833|NCT02371980|16171052|P1|Double-blind Period|Noncompliance with Study Drug|0
4693834|NCT02371980|16171048|P5|Double-blind Period|Significant Protocol Deviation|3
4693835|NCT02371980|16171049|P4|Double-blind Period|Significant Protocol Deviation|3
4693836|NCT02371980|16171050|P3|Double-blind Period|Significant Protocol Deviation|7
4693837|NCT02371980|16171051|P2|Double-blind Period|Significant Protocol Deviation|2
4693838|NCT02371980|16171052|P1|Double-blind Period|Significant Protocol Deviation|0
4693839|NCT02371980|16171048|P5|Double-blind Period|Pretreatment Event/Adverse Event|9
4693840|NCT02371980|16171049|P4|Double-blind Period|Pretreatment Event/Adverse Event|2
4693841|NCT02371980|16171050|P3|Double-blind Period|Pretreatment Event/Adverse Event|3
4693842|NCT02371980|16171051|P2|Double-blind Period|Pretreatment Event/Adverse Event|4
4693843|NCT02371980|16171052|P1|Double-blind Period|Pretreatment Event/Adverse Event|0
4693844|NCT02371980|16171048|P5|Open-label Period|Reason not Specified|0
4693845|NCT02371980|16171049|P4|Open-label Period|Reason not Specified|0
4693846|NCT02371980|16171050|P3|Open-label Period|Reason not Specified|0
4693847|NCT02371980|16171051|P2|Open-label Period|Reason not Specified|0
4693848|NCT02371980|16171052|P1|Open-label Period|Reason not Specified|9
4693849|NCT02371980|16171048|P5|Open-label Period|Did not Meet Randomization Criteria|0
4693850|NCT02371980|16171049|P4|Open-label Period|Did not Meet Randomization Criteria|0
4693851|NCT02371980|16171050|P3|Open-label Period|Did not Meet Randomization Criteria|0
4693852|NCT02371980|16171051|P2|Open-label Period|Did not Meet Randomization Criteria|0
4693853|NCT02371980|16171052|P1|Open-label Period|Did not Meet Randomization Criteria|162
4693854|NCT02371980|16171048|P5|Open-label Period|Lack of Efficacy|0
4693855|NCT02371980|16171049|P4|Open-label Period|Lack of Efficacy|0
4693856|NCT02371980|16171050|P3|Open-label Period|Lack of Efficacy|0
4693857|NCT02371980|16171051|P2|Open-label Period|Lack of Efficacy|0
4693858|NCT02371980|16171052|P1|Open-label Period|Lack of Efficacy|116
4693859|NCT02371980|16171048|P5|Open-label Period|Pregnancy|0
4693860|NCT02371980|16171049|P4|Open-label Period|Pregnancy|0
4693861|NCT02371980|16171050|P3|Open-label Period|Pregnancy|0
4693862|NCT02371980|16171051|P2|Open-label Period|Pregnancy|0
4693863|NCT02371980|16171052|P1|Open-label Period|Pregnancy|1
4693864|NCT02371980|16171048|P5|Open-label Period|Voluntary Withdrawal|0
4693865|NCT02371980|16171049|P4|Open-label Period|Voluntary Withdrawal|0
4693866|NCT02371980|16171050|P3|Open-label Period|Voluntary Withdrawal|0
4693867|NCT02371980|16171051|P2|Open-label Period|Voluntary Withdrawal|0
4693868|NCT02371980|16171052|P1|Open-label Period|Voluntary Withdrawal|91
4693869|NCT02371980|16171048|P5|Open-label Period|Lost to Follow-up|0
4693870|NCT02371980|16171049|P4|Open-label Period|Lost to Follow-up|0
4693871|NCT02371980|16171050|P3|Open-label Period|Lost to Follow-up|0
4693872|NCT02371980|16171051|P2|Open-label Period|Lost to Follow-up|0
4693873|NCT02371980|16171052|P1|Open-label Period|Lost to Follow-up|55
4693874|NCT02371980|16171048|P5|Open-label Period|Noncompliance with Study Drug|0
4693875|NCT02371980|16171049|P4|Open-label Period|Noncompliance with Study Drug|0
4693876|NCT02371980|16171050|P3|Open-label Period|Noncompliance with Study Drug|0
4693877|NCT02371980|16171051|P2|Open-label Period|Noncompliance with Study Drug|0
4693878|NCT02371980|16171052|P1|Open-label Period|Noncompliance with Study Drug|10
4693879|NCT02371980|16171048|P5|Open-label Period|Significant Protocol Deviation|0
4693880|NCT02371980|16171049|P4|Open-label Period|Significant Protocol Deviation|0
4693881|NCT02371980|16171050|P3|Open-label Period|Significant Protocol Deviation|0
4693882|NCT02371980|16171051|P2|Open-label Period|Significant Protocol Deviation|0
4693883|NCT02371980|16171052|P1|Open-label Period|Significant Protocol Deviation|19
4693884|NCT02371980|16171048|P5|Open-label Period|Pretreatment Event/Adverse Event|0
4693885|NCT02371980|16171049|P4|Open-label Period|Pretreatment Event/Adverse Event|0
4693886|NCT02371980|16171050|P3|Open-label Period|Pretreatment Event/Adverse Event|0
4693887|NCT02371980|16171051|P2|Open-label Period|Pretreatment Event/Adverse Event|0
4693888|NCT02371980|16171052|P1|Open-label Period|Pretreatment Event/Adverse Event|63
4693889|NCT02371759|16171112|P8|Overall Study|Withdrawal by Subject|1
4693890|NCT02371759|16171113|P7|Overall Study|Withdrawal by Subject|0
4693891|NCT02371759|16171114|P6|Overall Study|Withdrawal by Subject|0
4693892|NCT02371759|16171115|P5|Overall Study|Withdrawal by Subject|0
4693893|NCT02371759|16171116|P4|Overall Study|Withdrawal by Subject|0
4693894|NCT02371759|16171117|P3|Overall Study|Withdrawal by Subject|0
4693895|NCT02371759|16171118|P2|Overall Study|Withdrawal by Subject|0
4693896|NCT02371759|16171119|P1|Overall Study|Withdrawal by Subject|0
4693897|NCT02371759|16171112|P8|Overall Study|Protocol Violation|3
4693898|NCT02371759|16171113|P7|Overall Study|Protocol Violation|0
4693899|NCT02371759|16171114|P6|Overall Study|Protocol Violation|1
4693900|NCT02371759|16171115|P5|Overall Study|Protocol Violation|3
4693901|NCT02371759|16171116|P4|Overall Study|Protocol Violation|0
4693902|NCT02371759|16171117|P3|Overall Study|Protocol Violation|1
4693903|NCT02371759|16171118|P2|Overall Study|Protocol Violation|1
4693904|NCT02371759|16171119|P1|Overall Study|Protocol Violation|3
4693905|NCT02371746|16171336|P7|Overall Study|Consent withdrawn|1
4693906|NCT02371746|16171337|P6|Overall Study|Consent withdrawn|0
4693907|NCT02371746|16171338|P5|Overall Study|Consent withdrawn|0
4693908|NCT02371746|16171339|P4|Overall Study|Consent withdrawn|0
4693909|NCT02371746|16171340|P3|Overall Study|Consent withdrawn|0
4693910|NCT02371746|16171341|P2|Overall Study|Consent withdrawn|0
4693911|NCT02371746|16171342|P1|Overall Study|Consent withdrawn|0
4693912|NCT02371629|16171385|P2|Overall Study|Protocol deviation|1
4693913|NCT02371629|16171386|P1|Overall Study|Protocol deviation|0
4693914|NCT02371629|16171385|P2|Overall Study|Lack of Efficacy|2
4693915|NCT02371629|16171386|P1|Overall Study|Lack of Efficacy|0
4693916|NCT02371629|16171385|P2|Overall Study|Noncompliance with study treatment|0
4693917|NCT02371629|16171386|P1|Overall Study|Noncompliance with study treatment|1
4693918|NCT02371629|16171385|P2|Overall Study|Death|1
4693919|NCT02371629|16171386|P1|Overall Study|Death|1
4693920|NCT02371629|16171385|P2|Overall Study|Physician Decision|3
4693921|NCT02371629|16171386|P1|Overall Study|Physician Decision|2
4693922|NCT02371629|16171385|P2|Overall Study|Adverse Event|8
4693923|NCT02371629|16171386|P1|Overall Study|Adverse Event|8
4693924|NCT02371629|16171385|P2|Overall Study|Patient decision|10
4693925|NCT02371629|16171386|P1|Overall Study|Patient decision|14
4693926|NCT02371616|16171422|P2|Overall Study|Other (Not specified)|5
4693927|NCT02371616|16171423|P1|Overall Study|Other (Not specified)|1
4693928|NCT02371616|16171422|P2|Overall Study|Withdrawal of Consent|0
4693929|NCT02371616|16171423|P1|Overall Study|Withdrawal of Consent|1
4693930|NCT02371616|16171422|P2|Overall Study|Adverse Event|1
4693931|NCT02371616|16171423|P1|Overall Study|Adverse Event|0
4693932|NCT02371616|16171422|P2|Overall Study|Protocol Violation|1
4693933|NCT02371616|16171423|P1|Overall Study|Protocol Violation|2
4693934|NCT02371369|16171441|P2|Part 2|Death|1
4693935|NCT02371369|16171442|P1|Part 2|Death|0
4693936|NCT02371369|16171441|P2|Part 2|Physician Decision|0
4693937|NCT02371369|16171442|P1|Part 2|Physician Decision|1
4693938|NCT02371369|16171441|P2|Part 2|Withdrawal by Subject|1
4693939|NCT02371369|16171442|P1|Part 2|Withdrawal by Subject|5
4693940|NCT02371369|16171441|P2|Part 2|Adverse Event|2
4693941|NCT02371369|16171442|P1|Part 2|Adverse Event|3
4693942|NCT02371369|16171441|P2|Part 1|Protocol Violation|1
4693943|NCT02371369|16171442|P1|Part 1|Protocol Violation|0
4693944|NCT02371369|16171441|P2|Part 1|Disease progression|1
4693945|NCT02371369|16171442|P1|Part 1|Disease progression|0
4693946|NCT02371369|16171441|P2|Part 1|Withdrawal by Subject|6
4693947|NCT02371369|16171442|P1|Part 1|Withdrawal by Subject|1
4693948|NCT02371369|16171441|P2|Part 1|Adverse Event|0
4693949|NCT02371369|16171442|P1|Part 1|Adverse Event|8
4693950|NCT02371369|16171441|P2|Part 1|Physician Decision|3
4693951|NCT02371369|16171442|P1|Part 1|Physician Decision|0
4693952|NCT02370914|16171533|P1|Overall Study|Protocol Violation|2
4693953|NCT02370888|16171541|P1|Overall Study|did not meet chimerism criteria|6
4693954|NCT02370888|16171541|P1|Overall Study|disease progression|2
4693955|NCT02370784|16171551|P2|Overall Study|Patient started prohibited medication|1
4693956|NCT02370784|16171552|P1|Overall Study|Patient started prohibited medication|0
4693957|NCT02370667|16171567|P3|Overall Study|Lost to Follow-up|0
4693958|NCT02370667|16171568|P2|Overall Study|Lost to Follow-up|1
4693959|NCT02370667|16171569|P1|Overall Study|Lost to Follow-up|0
4693960|NCT02370641|16171633|P2|Overall Study|dropped study|2
4693961|NCT02370641|16171634|P1|Overall Study|dropped study|4
4693962|NCT02370615|16171642|P2|Overall Study|Adverse Event|0
4693963|NCT02370615|16171643|P1|Overall Study|Adverse Event|1
4693964|NCT02370602|16171686|P6|Overall Study|Pretreatment Event/Adverse Event|0
4693965|NCT02370602|16171687|P5|Overall Study|Pretreatment Event/Adverse Event|0
4693966|NCT02370602|16171688|P4|Overall Study|Pretreatment Event/Adverse Event|0
4693967|NCT02370602|16171689|P3|Overall Study|Pretreatment Event/Adverse Event|0
4693968|NCT02370602|16171690|P2|Overall Study|Pretreatment Event/Adverse Event|0
4693969|NCT02370602|16171691|P1|Overall Study|Pretreatment Event/Adverse Event|1
4693970|NCT02370537|16171785|P3|Part B|Withdrawal by Subject|0
4693971|NCT02370537|16171786|P2|Part B|Withdrawal by Subject|1
4693972|NCT02370537|16171787|P1|Part B|Withdrawal by Subject|0
4693973|NCT02370537|16171785|P3|Part B|Not randomised to receive treatment|259
4693974|NCT02370537|16171786|P2|Part B|Not randomised to receive treatment|2
4693975|NCT02370537|16171787|P1|Part B|Not randomised to receive treatment|1
4693976|NCT02370537|16171785|P3|Part A (Open-label Recruitment)|Adverse Event|1
4693977|NCT02370537|16171786|P2|Part A (Open-label Recruitment)|Adverse Event|0
4693978|NCT02370537|16171787|P1|Part A (Open-label Recruitment)|Adverse Event|0
4693979|NCT02370537|16171785|P3|Part A (Open-label Recruitment)|Withdrawal by Subject|0
4693980|NCT02370537|16171786|P2|Part A (Open-label Recruitment)|Withdrawal by Subject|1
4693981|NCT02370537|16171787|P1|Part A (Open-label Recruitment)|Withdrawal by Subject|0
4693982|NCT02370498|16171836|P2|Overall Study|Ongoing In Trial|33
4693983|NCT02370498|16171837|P1|Overall Study|Ongoing In Trial|56
4693984|NCT02370498|16171836|P2|Overall Study|Withdrawal by Subject|11
4693985|NCT02370498|16171837|P1|Overall Study|Withdrawal by Subject|6
4693986|NCT02370498|16171836|P2|Overall Study|Protocol Violation|2
4693987|NCT02370498|16171837|P1|Overall Study|Protocol Violation|1
4693988|NCT02370498|16171836|P2|Overall Study|Lost to Follow-up|0
4693989|NCT02370498|16171837|P1|Overall Study|Lost to Follow-up|1
4693990|NCT02370498|16171836|P2|Overall Study|Death|242
4693991|NCT02370498|16171837|P1|Overall Study|Death|222
4693992|NCT02370498|16171836|P2|Overall Study|Adverse Event|8
4693993|NCT02370498|16171837|P1|Overall Study|Adverse Event|10
4693994|NCT02370420|16171891|P2|Overall Study|Lost to Follow-up|9
4693995|NCT02370420|16171892|P1|Overall Study|Lost to Follow-up|11
4693996|NCT02370420|16171891|P2|Overall Study|Physician Decision|3
4693997|NCT02370420|16171892|P1|Overall Study|Physician Decision|3
4693998|NCT02370394|16171929|P2|Overall Study|Withdrawal by Subject|1
4693999|NCT02370394|16171930|P1|Overall Study|Withdrawal by Subject|0
4694000|NCT02370394|16171929|P2|Overall Study|Lost to Follow-up|1
4694001|NCT02370394|16171930|P1|Overall Study|Lost to Follow-up|2
4694002|NCT02370368|16171946|P2|Overall Study|Withdrawal by Subject|4
4694003|NCT02370368|16171947|P1|Overall Study|Withdrawal by Subject|5
4694004|NCT02370368|16171946|P2|Overall Study|Adverse Event|2
4694005|NCT02370368|16171947|P1|Overall Study|Adverse Event|1
4694006|NCT02370251|16171957|P1|Overall Study|Death|4
4694007|NCT02370251|16171957|P1|Overall Study|Received less than 8 days of Omegaven|7
4694008|NCT02370160|16171963|P3|Overall Study|Death|1
4694009|NCT02370160|16171964|P2|Overall Study|Death|4
4694010|NCT02370160|16171965|P1|Overall Study|Death|3
4694011|NCT02370121|16171989|P2|Overall Study|Lost to Follow-up|1
4694012|NCT02370121|16171990|P1|Overall Study|Lost to Follow-up|1
4694013|NCT02370095|16172030|P2|Overall Study|Withdrawal by Subject|1
4694014|NCT02370095|16172031|P1|Overall Study|Withdrawal by Subject|0
4694015|NCT02370043|16172061|P6|Overall Study|Withdrawal by Subject|1
4694016|NCT02370043|16172062|P5|Overall Study|Withdrawal by Subject|1
4694017|NCT02370043|16172063|P4|Overall Study|Withdrawal by Subject|0
4694018|NCT02370043|16172064|P3|Overall Study|Withdrawal by Subject|0
4694019|NCT02370043|16172065|P2|Overall Study|Withdrawal by Subject|0
4694020|NCT02370043|16172066|P1|Overall Study|Withdrawal by Subject|0
4694021|NCT02369874|16172207|P3|Overall Study|Participant Ongoing|32
4694022|NCT02369874|16172208|P2|Overall Study|Participant Ongoing|45
4694023|NCT02369874|16172209|P1|Overall Study|Participant Ongoing|34
4694024|NCT02369874|16172207|P3|Overall Study|Miscellaneous|0
4694025|NCT02369874|16172208|P2|Overall Study|Miscellaneous|1
4694026|NCT02369874|16172209|P1|Overall Study|Miscellaneous|1
4694027|NCT02369874|16172207|P3|Overall Study|Withdrawal by Subject|27
4694028|NCT02369874|16172208|P2|Overall Study|Withdrawal by Subject|9
4694029|NCT02369874|16172209|P1|Overall Study|Withdrawal by Subject|7
4694030|NCT02369874|16172207|P3|Overall Study|Lost to Follow-up|2
4694031|NCT02369874|16172208|P2|Overall Study|Lost to Follow-up|2
4694032|NCT02369874|16172209|P1|Overall Study|Lost to Follow-up|2
4694033|NCT02369848|16172256|P1|Overall Study|Lost to Follow-up|1
4694034|NCT02369848|16172256|P1|Overall Study|Withdrawal by Subject|2
4694035|NCT02369848|16172256|P1|Overall Study|Death|1
4694036|NCT01949662|16172333|P2|Overall Study|Ineligible|1
4694037|NCT01949662|16172334|P1|Overall Study|Ineligible|0
4694038|NCT01949662|16172333|P2|Overall Study|Dropped out|3
4694039|NCT01949662|16172334|P1|Overall Study|Dropped out|1
4694040|NCT01949662|16172333|P2|Overall Study|Discharged before an agitation event|3
4694041|NCT01949662|16172334|P1|Overall Study|Discharged before an agitation event|8
4694042|NCT01949662|16172333|P2|Overall Study|Death|7
4694043|NCT01949662|16172334|P1|Overall Study|Death|9
4694044|NCT02369510|16172364|P3|Overall Study|Epidural Activation|5
4694045|NCT02369510|16172365|P2|Overall Study|Epidural Activation|1
4694046|NCT02369510|16172366|P1|Overall Study|Epidural Activation|1
4694047|NCT02369510|16172364|P3|Overall Study|Spilled Medication|1
4694048|NCT02369510|16172365|P2|Overall Study|Spilled Medication|2
4694049|NCT02369510|16172366|P1|Overall Study|Spilled Medication|1
4694050|NCT02369341|16172405|P2|Overall Study|Migrated/moved from study area|0
4694051|NCT02369341|16172406|P1|Overall Study|Migrated/moved from study area|1
4694052|NCT02368886|16172582|P4|Overall Study|Ineligible|1
4694053|NCT02368886|16172583|P3|Overall Study|Ineligible|0
4694054|NCT02368886|16172584|P2|Overall Study|Ineligible|0
4694055|NCT02368886|16172585|P1|Overall Study|Ineligible|0
4694056|NCT02368886|16172582|P4|Overall Study|Cancel|3
4694057|NCT02368886|16172583|P3|Overall Study|Cancel|1
4694058|NCT02368886|16172584|P2|Overall Study|Cancel|1
4694059|NCT02368886|16172585|P1|Overall Study|Cancel|1
4694060|NCT02368314|16172637|P2|Overall Study|Adverse Event|2
4694061|NCT02368314|16172638|P1|Overall Study|Adverse Event|1
4694062|NCT02368314|16172637|P2|Overall Study|Withdrawal by Subject|1
4694063|NCT02368314|16172638|P1|Overall Study|Withdrawal by Subject|2
4694064|NCT02368210|16172650|P2|Overall Study|Adverse Event|1
4694065|NCT02368210|16172651|P1|Overall Study|Adverse Event|0
4694066|NCT02368210|16172650|P2|Overall Study|Withdrawal by Subject|0
4694067|NCT02368210|16172651|P1|Overall Study|Withdrawal by Subject|1
4694068|NCT02367911|16172678|P2|Overall Study|Lost to Follow-up|2
4694069|NCT02367911|16172679|P1|Overall Study|Lost to Follow-up|2
4694070|NCT02367911|16172678|P2|Overall Study|Withdrawal by Subject|2
4694071|NCT02367911|16172679|P1|Overall Study|Withdrawal by Subject|3
4694072|NCT02367885|16172690|P3|Overall Study|Withdrawal by Subject|0
4694073|NCT02367885|16172691|P2|Overall Study|Withdrawal by Subject|0
4694074|NCT02367885|16172692|P1|Overall Study|Withdrawal by Subject|1
4694075|NCT02367885|16172690|P3|Overall Study|Lost to Follow-up|0
4694076|NCT02367885|16172691|P2|Overall Study|Lost to Follow-up|0
4694077|NCT02367885|16172692|P1|Overall Study|Lost to Follow-up|1
4694078|NCT02367833|16172935|P3|Overall Study|Withdrawal by Subject|0
4694079|NCT02367833|16172936|P2|Overall Study|Withdrawal by Subject|1
4694080|NCT02367833|16172937|P1|Overall Study|Withdrawal by Subject|1
4694081|NCT02367794|16172976|P3|Overall Study|Hypercalcemia prior to C1D1|1
4694082|NCT02367794|16172977|P2|Overall Study|Hypercalcemia prior to C1D1|0
4694083|NCT02367794|16172978|P1|Overall Study|Hypercalcemia prior to C1D1|0
4694084|NCT02367794|16172976|P3|Overall Study|Patient unable to receive carboplatin|1
4694085|NCT02367794|16172977|P2|Overall Study|Patient unable to receive carboplatin|0
4694086|NCT02367794|16172978|P1|Overall Study|Patient unable to receive carboplatin|0
4694087|NCT02367794|16172976|P3|Overall Study|Randomized in error|1
4694088|NCT02367794|16172977|P2|Overall Study|Randomized in error|0
4694089|NCT02367794|16172978|P1|Overall Study|Randomized in error|0
4694090|NCT02367794|16172976|P3|Overall Study|Brain metastasis|0
4694091|NCT02367794|16172977|P2|Overall Study|Brain metastasis|0
4694092|NCT02367794|16172978|P1|Overall Study|Brain metastasis|1
4694093|NCT02367794|16172976|P3|Overall Study|Withdrawal by Subject|14
4694094|NCT02367794|16172977|P2|Overall Study|Withdrawal by Subject|12
4694095|NCT02367794|16172978|P1|Overall Study|Withdrawal by Subject|25
4694096|NCT02367794|16172976|P3|Overall Study|Protocol Violation|1
4694097|NCT02367794|16172977|P2|Overall Study|Protocol Violation|0
4694098|NCT02367794|16172978|P1|Overall Study|Protocol Violation|1
4694099|NCT02367794|16172976|P3|Overall Study|Physician Decision|1
4694100|NCT02367794|16172977|P2|Overall Study|Physician Decision|3
4694101|NCT02367794|16172978|P1|Overall Study|Physician Decision|0
4694102|NCT02367794|16172976|P3|Overall Study|Lost to Follow-up|1
4694103|NCT02367794|16172977|P2|Overall Study|Lost to Follow-up|2
4694104|NCT02367794|16172978|P1|Overall Study|Lost to Follow-up|1
4694105|NCT02367794|16172976|P3|Overall Study|Death|229
4694106|NCT02367794|16172977|P2|Overall Study|Death|223
4694107|NCT02367794|16172978|P1|Overall Study|Death|230
4694108|NCT02367781|16172991|P2|Overall Study|Administrative-Change Facility|0
4694109|NCT02367781|16172992|P1|Overall Study|Administrative-Change Facility|1
4694110|NCT02367781|16172991|P2|Overall Study|Death Prior First Dose|0
4694111|NCT02367781|16172992|P1|Overall Study|Death Prior First Dose|1
4694112|NCT02367781|16172991|P2|Overall Study|Prolonged Hospitalization|0
4694113|NCT02367781|16172992|P1|Overall Study|Prolonged Hospitalization|1
4694114|NCT02367781|16172991|P2|Overall Study|On-going in study|88
4694115|NCT02367781|16172992|P1|Overall Study|On-going in study|214
4694116|NCT02367781|16172991|P2|Overall Study|Death|136
4694117|NCT02367781|16172992|P1|Overall Study|Death|240
4694118|NCT02367781|16172991|P2|Overall Study|Lost to Follow-up|1
4694119|NCT02367781|16172992|P1|Overall Study|Lost to Follow-up|0
4694120|NCT02367781|16172991|P2|Overall Study|Non-Compliance|0
4694121|NCT02367781|16172992|P1|Overall Study|Non-Compliance|1
4694122|NCT02367781|16172991|P2|Overall Study|Randomized in Error|4
4694123|NCT02367781|16172992|P1|Overall Study|Randomized in Error|5
4694124|NCT02367781|16172991|P2|Overall Study|Physician Decision|0
4694125|NCT02367781|16172992|P1|Overall Study|Physician Decision|1
4694126|NCT02367781|16172991|P2|Overall Study|Protocol Violation|1
4694127|NCT02367781|16172992|P1|Overall Study|Protocol Violation|0
4694128|NCT02367781|16172991|P2|Overall Study|Withdrawal by Subject|10
4694129|NCT02367781|16172992|P1|Overall Study|Withdrawal by Subject|19
4694130|NCT02367729|16173002|P2|Overall Study|Withdrawal by Subject|5
4694131|NCT02367729|16173003|P1|Overall Study|Withdrawal by Subject|0
4694132|NCT02367729|16173002|P2|Overall Study|Adverse Event|2
4694133|NCT02367729|16173003|P1|Overall Study|Adverse Event|1
4694134|NCT02367729|16173002|P2|Overall Study|Organic disorder diagnosed|1
4694135|NCT02367729|16173003|P1|Overall Study|Organic disorder diagnosed|2
4694136|NCT02367521|16173036|P2|Overall Study|unable to find transportation|0
4694137|NCT02367521|16173037|P1|Overall Study|unable to find transportation|2
4694138|NCT02367521|16173036|P2|Overall Study|severe headache after intervention|0
4694139|NCT02367521|16173037|P1|Overall Study|severe headache after intervention|2
4694140|NCT02367352|16173115|P3|Overall Study|Adverse Event|0
4694141|NCT02367352|16173116|P2|Overall Study|Adverse Event|0
4694142|NCT02367352|16173117|P1|Overall Study|Adverse Event|1
4694143|NCT02367352|16173115|P3|Overall Study|Participant Received Alternative Therapy|0
4694144|NCT02367352|16173116|P2|Overall Study|Participant Received Alternative Therapy|0
4694145|NCT02367352|16173117|P1|Overall Study|Participant Received Alternative Therapy|1
4694146|NCT02367352|16173115|P3|Overall Study|Progressive disease|0
4694147|NCT02367352|16173116|P2|Overall Study|Progressive disease|0
4694148|NCT02367352|16173117|P1|Overall Study|Progressive disease|7
4694149|NCT02367131|16173167|P1|Overall Study|Other than stated above|20
4694150|NCT02367131|16173167|P1|Overall Study|No change/progressive disease|78
4694151|NCT02367131|16173167|P1|Overall Study|Improvement/remission|2
4694152|NCT02367131|16173167|P1|Overall Study|Request by patient|54
4694153|NCT02367131|16173167|P1|Overall Study|No visit since the first visit|4
4694154|NCT02367131|16173167|P1|Overall Study|Adverse Event|64
4694155|NCT02366936|16173428|P1|Overall Study|Physician Decision|2
4694156|NCT02366936|16173428|P1|Overall Study|Lost to Follow-up|4
4694157|NCT02366936|16173428|P1|Overall Study|Withdrawal by Subject|2
4694158|NCT02366923|16173433|P1|Overall Study|High Astigmatism|3
4694159|NCT02366923|16173433|P1|Overall Study|Positive Slit Lamp Findings|2
4694160|NCT02366923|16173433|P1|Overall Study|Withdrawal by Subject|1
4694161|NCT02366910|16173446|P1|Overall Study|Screen Failure|3
4694162|NCT02366910|16173446|P1|Overall Study|Withdrawal by Subject|2
4694163|NCT02366767|16173494|P2|Overall Study|left for home after 1 day at camp|0
4694164|NCT02366767|16173495|P1|Overall Study|left for home after 1 day at camp|1
4694165|NCT02366689|16173508|P3|Overall Study|Pregnancy|1
4694166|NCT02366689|16173509|P2|Overall Study|Pregnancy|1
4694167|NCT02366689|16173510|P1|Overall Study|Pregnancy|0
4694168|NCT02366689|16173508|P3|Overall Study|Lost to Follow-up|0
4694169|NCT02366689|16173509|P2|Overall Study|Lost to Follow-up|2
4694170|NCT02366689|16173510|P1|Overall Study|Lost to Follow-up|3
4694171|NCT02366689|16173508|P3|Overall Study|Withdrawal by Subject|1
4694172|NCT02366689|16173509|P2|Overall Study|Withdrawal by Subject|0
4694173|NCT02366689|16173510|P1|Overall Study|Withdrawal by Subject|1
4694174|NCT02366637|16173562|P2|Second Intervention Period|Study Terminated by Sponsor|1
4694175|NCT02366637|16173563|P1|Second Intervention Period|Study Terminated by Sponsor|1
4694176|NCT02366637|16173562|P2|First Intervention Period|Study Terminated by Sponsor|4
4694177|NCT02366637|16173563|P1|First Intervention Period|Study Terminated by Sponsor|6
4694178|NCT02366637|16173562|P2|First Intervention Period|Adverse Event|1
4694179|NCT02366637|16173563|P1|First Intervention Period|Adverse Event|0
4694180|NCT02366468|16173589|P2|Overall Study|Other|2
4694181|NCT02366468|16173590|P1|Overall Study|Other|0
4694182|NCT02366468|16173589|P2|Overall Study|Death|2
4694183|NCT02366468|16173590|P1|Overall Study|Death|1
4694184|NCT02366468|16173589|P2|Overall Study|Lost to Follow-up|0
4694185|NCT02366468|16173590|P1|Overall Study|Lost to Follow-up|2
4694186|NCT02366468|16173589|P2|Overall Study|Withdrawal by Subject|5
4694187|NCT02366468|16173590|P1|Overall Study|Withdrawal by Subject|1
4694188|NCT02366468|16173589|P2|Overall Study|Adverse Event|0
4694189|NCT02366468|16173590|P1|Overall Study|Adverse Event|2
4694190|NCT02366143|16173624|P3|Overall Study|Ineligible|0
4694191|NCT02366143|16173625|P2|Overall Study|Ineligible|0
4694192|NCT02366143|16173626|P1|Overall Study|Ineligible|1
4694193|NCT02366143|16173624|P3|Overall Study|PI Move and Site Closure|1
4694194|NCT02366143|16173625|P2|Overall Study|PI Move and Site Closure|1
4694195|NCT02366143|16173626|P1|Overall Study|PI Move and Site Closure|0
4694196|NCT02366143|16173624|P3|Overall Study|Randomization Error|1
4694197|NCT02366143|16173625|P2|Overall Study|Randomization Error|0
4694198|NCT02366143|16173626|P1|Overall Study|Randomization Error|0
4694199|NCT02366143|16173624|P3|Overall Study|Increased Microscopic RBCS on Urinalysis|0
4694200|NCT02366143|16173625|P2|Overall Study|Increased Microscopic RBCS on Urinalysis|0
4694201|NCT02366143|16173626|P1|Overall Study|Increased Microscopic RBCS on Urinalysis|1
4694202|NCT02366143|16173624|P3|Overall Study|On-Going in Study|79
4694203|NCT02366143|16173625|P2|Overall Study|On-Going in Study|101
4694204|NCT02366143|16173626|P1|Overall Study|On-Going in Study|107
4694205|NCT02366143|16173624|P3|Overall Study|Withdrawal by Subject|16
4694206|NCT02366143|16173625|P2|Overall Study|Withdrawal by Subject|21
4694207|NCT02366143|16173626|P1|Overall Study|Withdrawal by Subject|15
4694208|NCT02366143|16173624|P3|Overall Study|Protocol Violation|0
4694209|NCT02366143|16173625|P2|Overall Study|Protocol Violation|2
4694210|NCT02366143|16173626|P1|Overall Study|Protocol Violation|0
4694211|NCT02366143|16173624|P3|Overall Study|Physician Decision|1
4694212|NCT02366143|16173625|P2|Overall Study|Physician Decision|1
4694213|NCT02366143|16173626|P1|Overall Study|Physician Decision|2
4694214|NCT02366143|16173624|P3|Overall Study|Lost to Follow-up|1
4694215|NCT02366143|16173625|P2|Overall Study|Lost to Follow-up|1
4694216|NCT02366143|16173626|P1|Overall Study|Lost to Follow-up|2
4694217|NCT02366143|16173624|P3|Overall Study|Death|301
4694218|NCT02366143|16173625|P2|Overall Study|Death|275
4694219|NCT02366143|16173626|P1|Overall Study|Death|272
4694220|NCT02365636|16173730|P3|Overall Study|Other|0
4694221|NCT02365636|16173731|P2|Overall Study|Other|0
4694222|NCT02365636|16173732|P1|Overall Study|Other|2
4694223|NCT02365636|16173730|P3|Overall Study|Lost to Follow-up|1
4694224|NCT02365636|16173731|P2|Overall Study|Lost to Follow-up|0
4694225|NCT02365636|16173732|P1|Overall Study|Lost to Follow-up|0
4694226|NCT02365636|16173730|P3|Overall Study|Protocol Violation|0
4694227|NCT02365636|16173731|P2|Overall Study|Protocol Violation|4
4694228|NCT02365636|16173732|P1|Overall Study|Protocol Violation|1
4694229|NCT02365636|16173730|P3|Overall Study|Adverse Event|2
4694230|NCT02365636|16173731|P2|Overall Study|Adverse Event|3
4694231|NCT02365636|16173732|P1|Overall Study|Adverse Event|3
4694232|NCT02365584|16173778|P2|Overall Study|Disease Progression|12
4694233|NCT02365584|16173779|P1|Overall Study|Disease Progression|9
4694234|NCT02365584|16173778|P2|Overall Study|Withdrawal by Subject|0
4694235|NCT02365584|16173779|P1|Overall Study|Withdrawal by Subject|1
4694236|NCT02365584|16173778|P2|Overall Study|Adverse Event|2
4694237|NCT02365584|16173779|P1|Overall Study|Adverse Event|2
4694238|NCT02365558|16173803|P2|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1
4694239|NCT02365558|16173804|P1|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0
4694240|NCT02365558|16173803|P2|Period 1 (Day 1 Through Day 7)|Adverse Event|0
4694241|NCT02365558|16173804|P1|Period 1 (Day 1 Through Day 7)|Adverse Event|1
4694242|NCT02365519|16173817|P3|Randomized and Treated|Withdrawal by Subject|1
4694243|NCT02365519|16173818|P2|Randomized and Treated|Withdrawal by Subject|1
4694244|NCT02365519|16173819|P1|Randomized and Treated|Withdrawal by Subject|0
4694245|NCT02365519|16173817|P3|Randomized and Treated|Adverse Event|0
4694246|NCT02365519|16173818|P2|Randomized and Treated|Adverse Event|1
4694247|NCT02365519|16173819|P1|Randomized and Treated|Adverse Event|0
4694248|NCT02365298|16173840|P2|Period 2|Protocol Violation|1
4694249|NCT02365298|16173841|P1|Period 2|Protocol Violation|0
4694250|NCT02365298|16173840|P2|Period 2|Test Article longer available|1
4694251|NCT02365298|16173841|P1|Period 2|Test Article longer available|0
4694252|NCT02365298|16173840|P2|Period 2|Discontinued at request of Sponsor|0
4694253|NCT02365298|16173841|P1|Period 2|Discontinued at request of Sponsor|1
4694254|NCT02365298|16173840|P2|Period 2|incorrect Rx dispensed|0
4694255|NCT02365298|16173841|P1|Period 2|incorrect Rx dispensed|1
4694256|NCT02365285|16173861|P4|Overall Study|Adverse Event|2
4694257|NCT02365285|16173862|P3|Overall Study|Adverse Event|0
4694258|NCT02365285|16173863|P2|Overall Study|Adverse Event|0
4694259|NCT02365285|16173864|P1|Overall Study|Adverse Event|0
4694260|NCT02365285|16173861|P4|Overall Study|Physician Decision|0
4694261|NCT02365285|16173862|P3|Overall Study|Physician Decision|1
4694262|NCT02365285|16173863|P2|Overall Study|Physician Decision|1
4694263|NCT02365285|16173864|P1|Overall Study|Physician Decision|0
4694264|NCT02365233|16173881|P3|Overall Study|IRB withheld the data|2
4694265|NCT02365233|16173882|P2|Overall Study|IRB withheld the data|2
4694266|NCT02365233|16173883|P1|Overall Study|IRB withheld the data|1
4694267|NCT02365207|16173891|P1|Overall Study|Physician Decision|1
4694268|NCT02365207|16173891|P1|Overall Study|Withdrawal by Subject|1
4694269|NCT02364999|16173897|P2|Overall Study|Randomized but did not receive treatment|3
4694270|NCT02364999|16173898|P1|Overall Study|Randomized but did not receive treatment|2
4694271|NCT02364999|16173897|P2|Overall Study|Other|1
4694272|NCT02364999|16173898|P1|Overall Study|Other|0
4694273|NCT02364999|16173897|P2|Overall Study|Withdrawal by Subject|14
4694274|NCT02364999|16173898|P1|Overall Study|Withdrawal by Subject|14
4694275|NCT02364999|16173897|P2|Overall Study|Protocol Violation|2
4694276|NCT02364999|16173898|P1|Overall Study|Protocol Violation|3
4694277|NCT02364999|16173897|P2|Overall Study|Lost to Follow-up|15
4694278|NCT02364999|16173898|P1|Overall Study|Lost to Follow-up|10
4694279|NCT02364999|16173897|P2|Overall Study|Death|138
4694280|NCT02364999|16173898|P1|Overall Study|Death|136
4694281|NCT02364947|16173924|P3|Overall Study|Death|0
4694282|NCT02364947|16173925|P2|Overall Study|Death|1
4694283|NCT02364947|16173926|P1|Overall Study|Death|0
4694284|NCT02364947|16173924|P3|Overall Study|Physician Decision|5
4694285|NCT02364947|16173925|P2|Overall Study|Physician Decision|2
4694286|NCT02364947|16173926|P1|Overall Study|Physician Decision|3
4694287|NCT02364947|16173924|P3|Overall Study|Protocol Violation|1
4694288|NCT02364947|16173925|P2|Overall Study|Protocol Violation|1
4694289|NCT02364947|16173926|P1|Overall Study|Protocol Violation|1
4694290|NCT02364947|16173924|P3|Overall Study|Adverse Event|11
4694291|NCT02364947|16173925|P2|Overall Study|Adverse Event|33
4694292|NCT02364947|16173926|P1|Overall Study|Adverse Event|45
4694293|NCT02364947|16173924|P3|Overall Study|Withdrawal by Subject|9
4694294|NCT02364947|16173925|P2|Overall Study|Withdrawal by Subject|8
4694295|NCT02364947|16173926|P1|Overall Study|Withdrawal by Subject|10
4694296|NCT02364388|16174095|P1|Overall Study|No Biopsy|2
4694297|NCT02364388|16174095|P1|Overall Study|No OA/US data|2
4694298|NCT02364388|16174095|P1|Overall Study|Technical Failure|3
4694299|NCT02364388|16174095|P1|Overall Study|Protocol Violation|1
4694300|NCT02364336|16174102|P2|Overall Study|Adverse Event|1
4694301|NCT02364336|16174103|P1|Overall Study|Adverse Event|0
4694302|NCT02364180|16174116|P1|Overall Study|Screen Fail|1
4694303|NCT01905657|16174123|P3|Overall Study|Excluded from Efficacy Analysis|0
4694304|NCT01905657|16174124|P2|Overall Study|Excluded from Efficacy Analysis|0
4694305|NCT01905657|16174125|P1|Overall Study|Excluded from Efficacy Analysis|1
4694306|NCT01905657|16174123|P3|Overall Study|Continuing in Study|11
4694307|NCT01905657|16174124|P2|Overall Study|Continuing in Study|74
4694308|NCT01905657|16174125|P1|Overall Study|Continuing in Study|74
4694309|NCT01905657|16174123|P3|Overall Study|Withdrawal by Subject|45
4694310|NCT01905657|16174124|P2|Overall Study|Withdrawal by Subject|10
4694311|NCT01905657|16174125|P1|Overall Study|Withdrawal by Subject|5
4694312|NCT01905657|16174123|P3|Overall Study|Protocol Violation|1
4694313|NCT01905657|16174124|P2|Overall Study|Protocol Violation|1
4694314|NCT01905657|16174125|P1|Overall Study|Protocol Violation|2
4694315|NCT01905657|16174123|P3|Overall Study|Progressive Disease|89
4694316|NCT01905657|16174124|P2|Overall Study|Progressive Disease|126
4694317|NCT01905657|16174125|P1|Overall Study|Progressive Disease|124
4694318|NCT01905657|16174123|P3|Overall Study|Physician Decision|113
4694319|NCT01905657|16174124|P2|Overall Study|Physician Decision|74
4694320|NCT01905657|16174125|P1|Overall Study|Physician Decision|82
4694321|NCT01905657|16174123|P3|Overall Study|Other|1
4694322|NCT01905657|16174124|P2|Overall Study|Other|7
4694323|NCT01905657|16174125|P1|Overall Study|Other|3
4694324|NCT01905657|16174123|P3|Overall Study|Death|21
4694325|NCT01905657|16174124|P2|Overall Study|Death|21
4694326|NCT01905657|16174125|P1|Overall Study|Death|21
4694327|NCT01905657|16174123|P3|Overall Study|Adverse Event|47
4694328|NCT01905657|16174124|P2|Overall Study|Adverse Event|32
4694329|NCT01905657|16174125|P1|Overall Study|Adverse Event|33
4694330|NCT01905657|16174123|P3|Overall Study|Not Treated|0
4694331|NCT01905657|16174124|P2|Overall Study|Not Treated|1
4694332|NCT01905657|16174125|P1|Overall Study|Not Treated|0
4694333|NCT02364037|16174157|P2|Overall Study|Lost to Follow-up|49
4694334|NCT02364037|16174158|P1|Overall Study|Lost to Follow-up|37
4694335|NCT02364037|16174157|P2|Overall Study|Withdrawal by Subject|4
4694336|NCT02364037|16174158|P1|Overall Study|Withdrawal by Subject|7
4694337|NCT02363959|16174178|P2|Overall Study|Medical instability|0
4694338|NCT02363959|16174179|P1|Overall Study|Medical instability|1
4694339|NCT02363946|16174208|P13|Overall Study|Lost to Follow-up|0
4694340|NCT02363946|16174209|P12|Overall Study|Lost to Follow-up|0
4694341|NCT02363946|16174210|P11|Overall Study|Lost to Follow-up|0
4694342|NCT02363946|16174211|P10|Overall Study|Lost to Follow-up|0
4694343|NCT02363946|16174212|P9|Overall Study|Lost to Follow-up|0
4694344|NCT02363946|16174213|P8|Overall Study|Lost to Follow-up|1
4694345|NCT02363946|16174214|P7|Overall Study|Lost to Follow-up|0
4694346|NCT02363946|16174215|P6|Overall Study|Lost to Follow-up|0
4694347|NCT02363946|16174216|P5|Overall Study|Lost to Follow-up|0
4694348|NCT02363946|16174217|P4|Overall Study|Lost to Follow-up|0
4694349|NCT02363946|16174218|P3|Overall Study|Lost to Follow-up|0
4694350|NCT02363946|16174219|P2|Overall Study|Lost to Follow-up|0
4694351|NCT02363946|16174220|P1|Overall Study|Lost to Follow-up|0
4694352|NCT02363478|16174449|P1|Overall Study|Adverse Event|4
4694353|NCT02363478|16174449|P1|Overall Study|Lost to Follow-up|4
4694354|NCT02363439|16174456|P1|Overall Study|Lack of Efficacy|4
4694355|NCT02363322|16174462|P2|Overall Study|Lost to Follow-up|0
4694356|NCT02363322|16174463|P1|Overall Study|Lost to Follow-up|1
4694357|NCT02363283|16174473|P1|Overall Study|Not eligible due to transaminitis|1
4694358|NCT02363283|16174473|P1|Overall Study|Withdrawal by Subject|1
4694359|NCT01901874|16174490|P1|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6
4694360|NCT01901874|16174490|P1|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2
4694361|NCT01901874|16174490|P1|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5
4694362|NCT01901874|16174490|P1|1-Year (365-Day) MAE Evaluation|Death|7
4694363|NCT01901874|16174490|P1|30-Day MAE Evaluation|Insufficient Follow-up|1
4694364|NCT01901874|16174490|P1|Screening Committee Retrospective Review|Protocol Violation|47
4694365|NCT02362789|16174505|P3|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2
4694366|NCT02362789|16174506|P2|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1
4694367|NCT02362789|16174507|P1|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0
4694368|NCT02362789|16174505|P3|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4
4694369|NCT02362789|16174506|P2|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1
4694370|NCT02362789|16174507|P1|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0
4694371|NCT02362789|16174505|P3|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6
4694372|NCT02362789|16174506|P2|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2
4694373|NCT02362789|16174507|P1|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0
4694374|NCT02362789|16174505|P3|Run-in Phase (Week 0 to 16)|Adverse Event|0
4694375|NCT02362789|16174506|P2|Run-in Phase (Week 0 to 16)|Adverse Event|0
4694376|NCT02362789|16174507|P1|Run-in Phase (Week 0 to 16)|Adverse Event|1
4694377|NCT02362789|16174505|P3|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
4694378|NCT02362789|16174506|P2|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0
4694379|NCT02362789|16174507|P1|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1
4694380|NCT02362724|16174516|P2|Overall Study|Adverse Event|0
4694381|NCT02362724|16174517|P1|Overall Study|Adverse Event|3
4694382|NCT02362724|16174516|P2|Overall Study|Withdrawal by Subject|1
4694383|NCT02362724|16174517|P1|Overall Study|Withdrawal by Subject|3
4694384|NCT02362646|16174576|P2|Overall Study|received transplant|14
4694385|NCT02362646|16174577|P1|Overall Study|received transplant|21
4694386|NCT02362646|16174576|P2|Overall Study|Withdrawal by Subject|2
4694387|NCT02362646|16174577|P1|Overall Study|Withdrawal by Subject|2
4694388|NCT02362646|16174576|P2|Overall Study|Death|8
4694389|NCT02362646|16174577|P1|Overall Study|Death|15
4694390|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|67
4694391|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|160
4694392|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Ongoing at the time of analysis|55
4694393|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
4694394|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|1
4694395|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Progression of disease|0
4694396|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
4694397|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|2
4694398|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|No longer meets study criteria|0
4694399|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
4694400|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|1
4694401|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Pregnancy|0
4694402|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|5
4694403|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|8
4694404|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Non-compliance with study drug|3
4694405|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|1
4694406|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
4694407|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Lost to Follow-up|3
4694408|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|1
4694409|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|5
4694410|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Withdrawal by Subject|0
4694411|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Death|12
4694412|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Death|5
4694413|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Death|1
4694414|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|5
4694415|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|4
4694416|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Adverse Event|3
4694417|NCT02362503|16174609|P3|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|6
4694418|NCT02362503|16174610|P2|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|9
4694419|NCT02362503|16174611|P1|Open Label Period-Up to Atleast 96 Weeks|Lack of Efficacy|3
4694420|NCT02362503|16174609|P3|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
4694421|NCT02362503|16174610|P2|Double-blind Period-Up to 8 Days|No longer meets study criteria|1
4694422|NCT02362503|16174611|P1|Double-blind Period-Up to 8 Days|No longer meets study criteria|0
4694423|NCT02362503|16174609|P3|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
4694424|NCT02362503|16174610|P2|Double-blind Period-Up to 8 Days|Lost to Follow-up|1
4694425|NCT02362503|16174611|P1|Double-blind Period-Up to 8 Days|Lost to Follow-up|0
4694426|NCT02362503|16174609|P3|Double-blind Period-Up to 8 Days|Death|0
4694427|NCT02362503|16174610|P2|Double-blind Period-Up to 8 Days|Death|1
4694428|NCT02362503|16174611|P1|Double-blind Period-Up to 8 Days|Death|1
4694429|NCT02362503|16174609|P3|Double-blind Period-Up to 8 Days|Adverse Event|0
4694430|NCT02362503|16174610|P2|Double-blind Period-Up to 8 Days|Adverse Event|2
4694431|NCT02362503|16174611|P1|Double-blind Period-Up to 8 Days|Adverse Event|0
4694432|NCT02362425|16174640|P4|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
4694433|NCT02362425|16174641|P3|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1
4694434|NCT02362425|16174642|P2|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
4694435|NCT02362425|16174643|P1|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0
4694436|NCT02362425|16174640|P4|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1
4694437|NCT02362425|16174641|P3|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
4694438|NCT02362425|16174642|P2|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
4694439|NCT02362425|16174643|P1|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0
4694440|NCT02362425|16174640|P4|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2
4694441|NCT02362425|16174641|P3|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
4694442|NCT02362425|16174642|P2|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
4694443|NCT02362425|16174643|P1|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0
4694444|NCT02362425|16174640|P4|Phase 1 (up to 6 Months)|Study closure|0
4694445|NCT02362425|16174641|P3|Phase 1 (up to 6 Months)|Study closure|0
4694446|NCT02362425|16174642|P2|Phase 1 (up to 6 Months)|Study closure|0
4694447|NCT02362425|16174643|P1|Phase 1 (up to 6 Months)|Study closure|9
4694448|NCT02362425|16174640|P4|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
4694449|NCT02362425|16174641|P3|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
4694450|NCT02362425|16174642|P2|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0
4694451|NCT02362425|16174643|P1|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3
4694452|NCT02362425|16174640|P4|Phase 1 (up to 6 Months)|Screening failure|0
4694453|NCT02362425|16174641|P3|Phase 1 (up to 6 Months)|Screening failure|0
4694454|NCT02362425|16174642|P2|Phase 1 (up to 6 Months)|Screening failure|0
4694455|NCT02362425|16174643|P1|Phase 1 (up to 6 Months)|Screening failure|1
4694456|NCT02362425|16174640|P4|Phase 1 (up to 6 Months)|Medicinal contraindication|0
4694457|NCT02362425|16174641|P3|Phase 1 (up to 6 Months)|Medicinal contraindication|0
4694458|NCT02362425|16174642|P2|Phase 1 (up to 6 Months)|Medicinal contraindication|0
4694459|NCT02362425|16174643|P1|Phase 1 (up to 6 Months)|Medicinal contraindication|1
4694460|NCT02362425|16174640|P4|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
4694461|NCT02362425|16174641|P3|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
4694462|NCT02362425|16174642|P2|Phase 1 (up to 6 Months)|Withdrawal by Subject|0
4694463|NCT02362425|16174643|P1|Phase 1 (up to 6 Months)|Withdrawal by Subject|2
4694464|NCT02362412|16174761|P2|Treatment Period III|Lost to Follow-up|1
4694465|NCT02362412|16174762|P1|Treatment Period III|Lost to Follow-up|0
4694466|NCT02362360|16174796|P2|Period 1|Withdrawal by Subject|1
4694467|NCT02362360|16174797|P1|Period 1|Withdrawal by Subject|2
4694468|NCT02362360|16174796|P2|Period 1|Lack of Efficacy|0
4694469|NCT02362360|16174797|P1|Period 1|Lack of Efficacy|1
4694470|NCT02362282|16174814|P2|Overall Study|Withdrawal by Subject|0
4694471|NCT02362282|16174815|P1|Overall Study|Withdrawal by Subject|1
4694472|NCT02361762|16174837|P2|Overall Study|Lost to Follow-up|1
4694473|NCT02361762|16174838|P1|Overall Study|Lost to Follow-up|0
4694474|NCT02361762|16174837|P2|Overall Study|Withdrawal by Subject|1
4694475|NCT02361762|16174838|P1|Overall Study|Withdrawal by Subject|0
4694476|NCT02361580|16174889|P2|Overall Study|Lost to Follow-up|3
4694477|NCT02361580|16174890|P1|Overall Study|Lost to Follow-up|6
4694478|NCT02361216|16174919|P2|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2
4694479|NCT02361216|16174920|P1|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0
4694480|NCT02361216|16174919|P2|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
4694481|NCT02361216|16174920|P1|3 Day Treatment and 8 Week Follow/up|Trial site closed|3
4694482|NCT02361216|16174919|P2|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11
4694483|NCT02361216|16174920|P1|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6
4694484|NCT02361216|16174919|P2|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0
4694485|NCT02361216|16174920|P1|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1
4694486|NCT02361216|16174919|P2|3 Day Treatment and 8 Week Follow/up|Adverse Event|2
4694487|NCT02361216|16174920|P1|3 Day Treatment and 8 Week Follow/up|Adverse Event|1
4694488|NCT02361216|16174919|P2|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1
4694489|NCT02361216|16174920|P1|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0
4694490|NCT02360995|16174935|P3|Overall Study|Withdrawal by Subject|0
4694491|NCT02360995|16174936|P2|Overall Study|Withdrawal by Subject|1
4694492|NCT02360995|16174937|P1|Overall Study|Withdrawal by Subject|0
4694493|NCT02360995|16174935|P3|Overall Study|Lost to Follow-up|2
4694494|NCT02360995|16174936|P2|Overall Study|Lost to Follow-up|0
4694495|NCT02360995|16174937|P1|Overall Study|Lost to Follow-up|2
4694496|NCT02360475|16175001|P4|Overall Study|Migrated/moved from study area|1
4694497|NCT02360475|16175002|P3|Overall Study|Migrated/moved from study area|0
4694498|NCT02360475|16175003|P2|Overall Study|Migrated/moved from study area|0
4694499|NCT02360475|16175004|P1|Overall Study|Migrated/moved from study area|0
4694500|NCT02360475|16175001|P4|Overall Study|Withdrawal by Subject|0
4694501|NCT02360475|16175002|P3|Overall Study|Withdrawal by Subject|2
4694502|NCT02360475|16175003|P2|Overall Study|Withdrawal by Subject|1
4694503|NCT02360475|16175004|P1|Overall Study|Withdrawal by Subject|0
4694504|NCT02360475|16175001|P4|Overall Study|Lost to Follow-up|4
4694505|NCT02360475|16175002|P3|Overall Study|Lost to Follow-up|6
4694506|NCT02360475|16175003|P2|Overall Study|Lost to Follow-up|12
4694507|NCT02360475|16175004|P1|Overall Study|Lost to Follow-up|4
4694508|NCT02360397|16175062|P1|Overall Study|Adverse Event|1
4694509|NCT02360397|16175062|P1|Overall Study|Incomplete screening|3
4694510|NCT02360293|16175071|P2|Overall Study|Excluded|0
4694511|NCT02360293|16175072|P1|Overall Study|Excluded|1
4694512|NCT02360293|16175071|P2|Overall Study|Withdrawal by Subject|1
4694513|NCT02360293|16175072|P1|Overall Study|Withdrawal by Subject|2
4694514|NCT02360293|16175071|P2|Overall Study|Lost to Follow-up|95
4694515|NCT02360293|16175072|P1|Overall Study|Lost to Follow-up|73
4694516|NCT02360280|16175086|P2|Overall Study|Lost to Follow-up|0
4694517|NCT02360280|16175087|P1|Overall Study|Lost to Follow-up|1
4694518|NCT02360280|16175086|P2|Overall Study|Adverse Event|1
4694519|NCT02360280|16175087|P1|Overall Study|Adverse Event|0
4694520|NCT02360280|16175086|P2|Overall Study|Withdrawal by Subject|0
4694521|NCT02360280|16175087|P1|Overall Study|Withdrawal by Subject|2
4694522|NCT02360228|16175102|P3|Overall Study|Unstable symptoms during screening|1
4694523|NCT02360228|16175103|P2|Overall Study|Unstable symptoms during screening|0
4694524|NCT02360228|16175104|P1|Overall Study|Unstable symptoms during screening|0
4694525|NCT02360228|16175102|P3|Overall Study|Self-discontinued medication|0
4694526|NCT02360228|16175103|P2|Overall Study|Self-discontinued medication|1
4694527|NCT02360228|16175104|P1|Overall Study|Self-discontinued medication|0
4694528|NCT02360228|16175102|P3|Overall Study|Withdrawal by Subject|0
4694529|NCT02360228|16175103|P2|Overall Study|Withdrawal by Subject|0
4694530|NCT02360228|16175104|P1|Overall Study|Withdrawal by Subject|1
4694531|NCT02360111|16175199|P1|Overall Study|Death|2
4694532|NCT02360098|16175209|P1|Overall Study|Physician Decision|7
4694533|NCT02359903|16175277|P2|Overall Study|Adverse Event|2
4694534|NCT02359903|16175278|P1|Overall Study|Adverse Event|0
4694535|NCT02359890|16175286|P1|Overall Study|Never treated with study catheter|6
4694536|NCT02359890|16175286|P1|Overall Study|Not meeting eligibility|4
4694537|NCT02359877|16175297|P4|Overall Study|Adverse Event|1
4694538|NCT02359877|16175298|P3|Overall Study|Adverse Event|0
4694539|NCT02359877|16175299|P2|Overall Study|Adverse Event|0
4694540|NCT02359877|16175300|P1|Overall Study|Adverse Event|0
4694541|NCT02359877|16175297|P4|Overall Study|Withdrawal by Subject|2
4694542|NCT02359877|16175298|P3|Overall Study|Withdrawal by Subject|0
4694543|NCT02359877|16175299|P2|Overall Study|Withdrawal by Subject|0
4694544|NCT02359877|16175300|P1|Overall Study|Withdrawal by Subject|1
4694545|NCT02359851|16175350|P1|Overall Study|Disease progression|1
4694546|NCT02359851|16175350|P1|Overall Study|Death|1
4694547|NCT02359552|16175360|P2|Overall Study|Lost to Follow-up|4
4694548|NCT02359552|16175361|P1|Overall Study|Lost to Follow-up|3
4694549|NCT02359435|16175383|P2|Overall Study|Lost to Follow-up|4
4694550|NCT02359435|16175384|P1|Overall Study|Lost to Follow-up|4
4694551|NCT02359045|16175444|P2|Overall Study|Adverse Event|1
4694552|NCT02359045|16175445|P1|Overall Study|Adverse Event|0
4694553|NCT02359045|16175444|P2|Overall Study|Lost to Follow-up|1
4694554|NCT02359045|16175445|P1|Overall Study|Lost to Follow-up|1
4694555|NCT02359045|16175444|P2|Overall Study|Eligibility criteria not fulfilled|1
4694556|NCT02359045|16175445|P1|Overall Study|Eligibility criteria not fulfilled|3
4694557|NCT02358863|16175753|P1|Overall Study|Physician Decision|3
4694558|NCT02358668|16175760|P3|Overall Study|Withdrawal by Subject|0
4694559|NCT02358668|16175761|P2|Overall Study|Withdrawal by Subject|1
4694560|NCT02358668|16175762|P1|Overall Study|Withdrawal by Subject|0
4694561|NCT02358668|16175760|P3|Overall Study|Adverse Event|0
4694562|NCT02358668|16175761|P2|Overall Study|Adverse Event|0
4694563|NCT02358668|16175762|P1|Overall Study|Adverse Event|2
4694564|NCT02358473|16175911|P1|Overall Study|Physician Decision|2
4694565|NCT02358473|16175911|P1|Overall Study|Withdrawal by Subject|2
4694566|NCT02358473|16175911|P1|Overall Study|Adverse Event|3
4694567|NCT02358473|16175911|P1|Overall Study|Disease Progession|6
4694568|NCT01877655|16175922|P2|Overall Study|Randomized but Never Received Drug|5
4694569|NCT01877655|16175923|P1|Overall Study|Randomized but Never Received Drug|8
4694570|NCT01877655|16175922|P2|Overall Study|Miscellaneous|4
4694571|NCT01877655|16175923|P1|Overall Study|Miscellaneous|4
4694572|NCT01877655|16175922|P2|Overall Study|Physician Decision|10
4694573|NCT01877655|16175923|P1|Overall Study|Physician Decision|11
4694574|NCT01877655|16175922|P2|Overall Study|Withdrawal by Subject|26
4694575|NCT01877655|16175923|P1|Overall Study|Withdrawal by Subject|18
4694576|NCT01877655|16175922|P2|Overall Study|Death|52
4694577|NCT01877655|16175923|P1|Overall Study|Death|57
4694578|NCT02358369|16175942|P5|Treatment Period C|Adverse Event|7
4694579|NCT02358369|16175943|P4|Treatment Period C|Adverse Event|0
4694580|NCT02358369|16175944|P3|Treatment Period C|Adverse Event|0
4694581|NCT02358369|16175945|P2|Treatment Period C|Adverse Event|0
4694582|NCT02358369|16175946|P1|Treatment Period C|Adverse Event|0
4694583|NCT02358369|16175942|P5|Treatment Period A/B|Withdrawal by Subject|0
4694584|NCT02358369|16175943|P4|Treatment Period A/B|Withdrawal by Subject|2
4694585|NCT02358369|16175944|P3|Treatment Period A/B|Withdrawal by Subject|0
4694586|NCT02358369|16175945|P2|Treatment Period A/B|Withdrawal by Subject|2
4694587|NCT02358369|16175946|P1|Treatment Period A/B|Withdrawal by Subject|0
4694588|NCT02358369|16175942|P5|Treatment Period A/B|Death|0
4694589|NCT02358369|16175943|P4|Treatment Period A/B|Death|0
4694590|NCT02358369|16175944|P3|Treatment Period A/B|Death|1
4694591|NCT02358369|16175945|P2|Treatment Period A/B|Death|0
4694592|NCT02358369|16175946|P1|Treatment Period A/B|Death|0
4694593|NCT02358369|16175942|P5|Treatment Period A/B|Adverse Event|0
4694594|NCT02358369|16175943|P4|Treatment Period A/B|Adverse Event|2
4694595|NCT02358369|16175944|P3|Treatment Period A/B|Adverse Event|1
4694596|NCT02358369|16175945|P2|Treatment Period A/B|Adverse Event|0
4694597|NCT02358369|16175946|P1|Treatment Period A/B|Adverse Event|0
4694598|NCT02358369|16175942|P5|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4694599|NCT02358369|16175943|P4|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4694600|NCT02358369|16175944|P3|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4694601|NCT02358369|16175945|P2|Pre-Randomization Washout Period|Not Qualified for Randomization|0
4694602|NCT02358369|16175946|P1|Pre-Randomization Washout Period|Not Qualified for Randomization|35
4694603|NCT02358343|16175992|P5|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4694604|NCT02358343|16175993|P4|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4694605|NCT02358343|16175994|P3|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1
4694606|NCT02358343|16175995|P2|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4694607|NCT02358343|16175996|P1|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0
4694608|NCT02358343|16175992|P5|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
4694609|NCT02358343|16175993|P4|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
4694610|NCT02358343|16175994|P3|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2
4694611|NCT02358343|16175995|P2|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
4694612|NCT02358343|16175996|P1|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0
4694613|NCT02358343|16175992|P5|Comparative Efficacy Trial / Observation|Death|0
4694614|NCT02358343|16175993|P4|Comparative Efficacy Trial / Observation|Death|0
4694615|NCT02358343|16175994|P3|Comparative Efficacy Trial / Observation|Death|2
4694616|NCT02358343|16175995|P2|Comparative Efficacy Trial / Observation|Death|0
4694617|NCT02358343|16175996|P1|Comparative Efficacy Trial / Observation|Death|0
4694618|NCT02358343|16175992|P5|Screening Intervention|Determined Ineligible|0
4694619|NCT02358343|16175993|P4|Screening Intervention|Determined Ineligible|0
4694620|NCT02358343|16175994|P3|Screening Intervention|Determined Ineligible|0
4694621|NCT02358343|16175995|P2|Screening Intervention|Determined Ineligible|6
4694622|NCT02358343|16175996|P1|Screening Intervention|Determined Ineligible|5
4694623|NCT02358343|16175992|P5|Screening Intervention|Withdrawal by Subject|0
4694624|NCT02358343|16175993|P4|Screening Intervention|Withdrawal by Subject|0
4694625|NCT02358343|16175994|P3|Screening Intervention|Withdrawal by Subject|0
4694626|NCT02358343|16175995|P2|Screening Intervention|Withdrawal by Subject|0
4694627|NCT02358343|16175996|P1|Screening Intervention|Withdrawal by Subject|1
4694628|NCT02358343|16175992|P5|Screening Intervention|Death|0
4694629|NCT02358343|16175993|P4|Screening Intervention|Death|0
4694630|NCT02358343|16175994|P3|Screening Intervention|Death|0
4694631|NCT02358343|16175995|P2|Screening Intervention|Death|2
4694632|NCT02358343|16175996|P1|Screening Intervention|Death|0
4694633|NCT02358044|16176052|P2|Overall Study|Withdrawal by Subject|4
4694634|NCT02358044|16176053|P1|Overall Study|Withdrawal by Subject|0
4694635|NCT02358044|16176052|P2|Overall Study|Physician Decision|1
4694636|NCT02358044|16176053|P1|Overall Study|Physician Decision|0
4694637|NCT02358044|16176052|P2|Overall Study|Lost to Follow-up|1
4694638|NCT02358044|16176053|P1|Overall Study|Lost to Follow-up|2
4694639|NCT02358044|16176052|P2|Overall Study|Adverse Event|1
4694640|NCT02358044|16176053|P1|Overall Study|Adverse Event|0
4694641|NCT02358031|16176072|P3|Overall Study|Ongoing in Study|33
4694642|NCT02358031|16176073|P2|Overall Study|Ongoing in Study|64
4694643|NCT02358031|16176074|P1|Overall Study|Ongoing in Study|61
4694644|NCT02358031|16176072|P3|Overall Study|Withdrawal by Subject|17
4694645|NCT02358031|16176073|P2|Overall Study|Withdrawal by Subject|12
4694646|NCT02358031|16176074|P1|Overall Study|Withdrawal by Subject|14
4694647|NCT02358031|16176072|P3|Overall Study|Lost to Follow-up|1
4694648|NCT02358031|16176073|P2|Overall Study|Lost to Follow-up|1
4694649|NCT02358031|16176074|P1|Overall Study|Lost to Follow-up|0
4694650|NCT02358031|16176072|P3|Overall Study|Death|249
4694651|NCT02358031|16176073|P2|Overall Study|Death|204
4694652|NCT02358031|16176074|P1|Overall Study|Death|226
4694653|NCT02357940|16176201|P2|Overall Study|Investigator's judgement|1
4694654|NCT02357940|16176202|P1|Overall Study|Investigator's judgement|0
4694655|NCT02357940|16176201|P2|Overall Study|Adverse Event|1
4694656|NCT02357940|16176202|P1|Overall Study|Adverse Event|0
4694657|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7
4694658|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6
4694659|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17
4694660|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0
4694661|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Physician Decision|1
4694662|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Physician Decision|1
4694663|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Physician Decision|0
4694664|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Physician Decision|0
4694665|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3
4694666|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
4694667|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1
4694668|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0
4694669|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
4694670|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
4694671|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2
4694672|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0
4694673|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3
4694674|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
4694675|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1
4694676|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0
4694677|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
4694678|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Protocol Violation|5
4694679|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Protocol Violation|2
4694680|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Protocol Violation|0
4694681|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Adverse Event|2
4694682|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Adverse Event|10
4694683|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Adverse Event|6
4694684|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Adverse Event|0
4694685|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18
4694686|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5
4694687|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3
4694688|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0
4694689|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18
4694690|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21
4694691|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20
4694692|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0
4694693|NCT02357901|16176329|P4|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12
4694694|NCT02357901|16176330|P3|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23
4694695|NCT02357901|16176331|P2|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26
4694696|NCT02357901|16176332|P1|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0
4694697|NCT02357901|16176329|P4|Run-In Period (Days -14 to Day -1)|Run-In failures|0
4694698|NCT02357901|16176330|P3|Run-In Period (Days -14 to Day -1)|Run-In failures|0
4694699|NCT02357901|16176331|P2|Run-In Period (Days -14 to Day -1)|Run-In failures|0
4694700|NCT02357901|16176332|P1|Run-In Period (Days -14 to Day -1)|Run-In failures|161
4694701|NCT02357810|16176382|P1|Follow-up at Treatment Discontinuation|Still in Follow-up|11
4694702|NCT02357810|16176382|P1|Follow-up at Treatment Discontinuation|Lost to Follow-up|3
4694703|NCT02357810|16176382|P1|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4
4694704|NCT02357810|16176382|P1|12 Week Response and Further Treatment|Wound Complications|1
4694705|NCT02357810|16176382|P1|12 Week Response and Further Treatment|Progressive Disease|15
4694706|NCT02357810|16176382|P1|12 Week Response and Further Treatment|Withdrawal by Subject|1
4694707|NCT02357810|16176382|P1|12 Week Response and Further Treatment|Adverse Event|5
4694708|NCT02357810|16176382|P1|Reached 12 Weeks Response|Other|1
4694709|NCT02357810|16176382|P1|Reached 12 Weeks Response|Physician Decision|1
4694710|NCT02357810|16176382|P1|Reached 12 Weeks Response|Death|1
4694711|NCT02357810|16176382|P1|Reached 12 Weeks Response|Protocol Violation|1
4694712|NCT02357810|16176382|P1|Reached 12 Weeks Response|Withdrawal by Subject|8
4694713|NCT02357810|16176382|P1|Reached 12 Weeks Response|Progressive Disease|39
4694714|NCT02357810|16176382|P1|Reached 12 Weeks Response|Adverse Event|5
4694715|NCT02357810|16176382|P1|Registered and Started Treatment|Found not to be eligible for the study|26
4694716|NCT02357810|16176382|P1|Registered and Started Treatment|Withdrawal by Subject|1
4694717|NCT02357576|16176432|P2|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0
4694718|NCT02357576|16176433|P1|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2
4694719|NCT02357576|16176432|P2|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4
4694720|NCT02357576|16176433|P1|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1
4694721|NCT02357576|16176432|P2|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0
4694722|NCT02357576|16176433|P1|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1
4694723|NCT02357576|16176432|P2|Neurodevelopmental Outcome Follow Up|Scheduling error|1
4694724|NCT02357576|16176433|P1|Neurodevelopmental Outcome Follow Up|Scheduling error|1
4694725|NCT02357576|16176432|P2|Treatment Period|Physician Decision|1
4694726|NCT02357576|16176433|P1|Treatment Period|Physician Decision|0
4694727|NCT02357576|16176432|P2|Treatment Period|Withdrawal by Subject|1
4694728|NCT02357576|16176433|P1|Treatment Period|Withdrawal by Subject|0
4694729|NCT02357459|16176474|P3|Overall Study|Job Commitments|1
4694730|NCT02357459|16176475|P2|Overall Study|Job Commitments|0
4694731|NCT02357459|16176476|P1|Overall Study|Job Commitments|0
4694732|NCT02357459|16176474|P3|Overall Study|Pre-planned Knee surgery|2
4694733|NCT02357459|16176475|P2|Overall Study|Pre-planned Knee surgery|0
4694734|NCT02357459|16176476|P1|Overall Study|Pre-planned Knee surgery|0
4694735|NCT02357459|16176474|P3|Overall Study|Incarceration|1
4694736|NCT02357459|16176475|P2|Overall Study|Incarceration|0
4694737|NCT02357459|16176476|P1|Overall Study|Incarceration|0
4694738|NCT02357459|16176474|P3|Overall Study|Instruction from PCP|0
4694739|NCT02357459|16176475|P2|Overall Study|Instruction from PCP|0
4694740|NCT02357459|16176476|P1|Overall Study|Instruction from PCP|1
4694741|NCT02357459|16176474|P3|Overall Study|Patient Relocated|0
4694742|NCT02357459|16176475|P2|Overall Study|Patient Relocated|0
4694743|NCT02357459|16176476|P1|Overall Study|Patient Relocated|2
4694744|NCT02357459|16176474|P3|Overall Study|Lack of Efficacy|4
4694745|NCT02357459|16176475|P2|Overall Study|Lack of Efficacy|4
4694746|NCT02357459|16176476|P1|Overall Study|Lack of Efficacy|7
4694747|NCT02357459|16176474|P3|Overall Study|Lost to Follow-up|0
4694748|NCT02357459|16176475|P2|Overall Study|Lost to Follow-up|3
4694749|NCT02357459|16176476|P1|Overall Study|Lost to Follow-up|1
4694750|NCT02357459|16176474|P3|Overall Study|Protocol Violation|0
4694751|NCT02357459|16176475|P2|Overall Study|Protocol Violation|1
4694752|NCT02357459|16176476|P1|Overall Study|Protocol Violation|1
4694753|NCT02357459|16176474|P3|Overall Study|Physician Decision|0
4694754|NCT02357459|16176475|P2|Overall Study|Physician Decision|2
4694755|NCT02357459|16176476|P1|Overall Study|Physician Decision|0
4694756|NCT02357459|16176474|P3|Overall Study|Withdrawal by Subject|3
4694757|NCT02357459|16176475|P2|Overall Study|Withdrawal by Subject|3
4694758|NCT02357459|16176476|P1|Overall Study|Withdrawal by Subject|5
4694759|NCT02357459|16176474|P3|Overall Study|Adverse Event|1
4694760|NCT02357459|16176475|P2|Overall Study|Adverse Event|1
4694761|NCT02357459|16176476|P1|Overall Study|Adverse Event|0
4694762|NCT02357420|16176522|P4|Overall Study|Lost to Follow-up|3
4694763|NCT02357420|16176523|P3|Overall Study|Lost to Follow-up|2
4694764|NCT02357420|16176524|P2|Overall Study|Lost to Follow-up|0
4694765|NCT02357420|16176525|P1|Overall Study|Lost to Follow-up|3
4694766|NCT02357420|16176522|P4|Overall Study|Withdrawn Consent|6
4694767|NCT02357420|16176523|P3|Overall Study|Withdrawn Consent|6
4694768|NCT02357420|16176524|P2|Overall Study|Withdrawn Consent|8
4694769|NCT02357420|16176525|P1|Overall Study|Withdrawn Consent|4
4694770|NCT02357420|16176522|P4|Overall Study|Protocol Non-compliance|1
4694771|NCT02357420|16176523|P3|Overall Study|Protocol Non-compliance|0
4694772|NCT02357420|16176524|P2|Overall Study|Protocol Non-compliance|0
4694773|NCT02357420|16176525|P1|Overall Study|Protocol Non-compliance|0
4694774|NCT02357420|16176522|P4|Overall Study|Prohibited Medication|0
4694775|NCT02357420|16176523|P3|Overall Study|Prohibited Medication|0
4694776|NCT02357420|16176524|P2|Overall Study|Prohibited Medication|1
4694777|NCT02357420|16176525|P1|Overall Study|Prohibited Medication|1
4694778|NCT02357420|16176522|P4|Overall Study|Investigator Decision|0
4694779|NCT02357420|16176523|P3|Overall Study|Investigator Decision|0
4694780|NCT02357420|16176524|P2|Overall Study|Investigator Decision|0
4694781|NCT02357420|16176525|P1|Overall Study|Investigator Decision|1
4694782|NCT02357420|16176522|P4|Overall Study|Adverse Event|9
4694783|NCT02357420|16176523|P3|Overall Study|Adverse Event|8
4694784|NCT02357420|16176524|P2|Overall Study|Adverse Event|3
4694785|NCT02357420|16176525|P1|Overall Study|Adverse Event|3
4694786|NCT02357342|16176586|P2|First 6 Months|Death|0
4694787|NCT02357342|16176587|P1|First 6 Months|Death|2
4694788|NCT02357147|16176635|P2|Maintenance Treatment Phase|Not Treated|0
4694789|NCT02357147|16176636|P1|Maintenance Treatment Phase|Not Treated|1
4694790|NCT02357147|16176635|P2|Maintenance Treatment Phase|Sponsor Decision|15
4694791|NCT02357147|16176636|P1|Maintenance Treatment Phase|Sponsor Decision|0
4694792|NCT02357147|16176635|P2|Maintenance Treatment Phase|Adverse Event|3
4694793|NCT02357147|16176636|P1|Maintenance Treatment Phase|Adverse Event|0
4694794|NCT02357147|16176635|P2|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0
4694795|NCT02357147|16176636|P1|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10
4694796|NCT02357147|16176635|P2|Maintenance Treatment Phase|Withdrawal by Subject|1
4694797|NCT02357147|16176636|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
4694798|NCT02357147|16176635|P2|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10
4694799|NCT02357147|16176636|P1|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15
4694800|NCT02357147|16176635|P2|Combination Treatment Phase|Not treated|2
4694801|NCT02357147|16176636|P1|Combination Treatment Phase|Not treated|0
4694802|NCT02357147|16176635|P2|Combination Treatment Phase|Other|0
4694803|NCT02357147|16176636|P1|Combination Treatment Phase|Other|1
4694804|NCT02357147|16176635|P2|Combination Treatment Phase|Sponsor Decision|12
4694805|NCT02357147|16176636|P1|Combination Treatment Phase|Sponsor Decision|0
4694806|NCT02357147|16176635|P2|Combination Treatment Phase|Death|1
4694807|NCT02357147|16176636|P1|Combination Treatment Phase|Death|1
4694808|NCT02357147|16176635|P2|Combination Treatment Phase|Adverse Event|4
4694809|NCT02357147|16176636|P1|Combination Treatment Phase|Adverse Event|12
4694810|NCT02357147|16176635|P2|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1
4694811|NCT02357147|16176636|P1|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4
4694812|NCT02357147|16176635|P2|Combination Treatment Phase|Withdrawal by Subject|2
4694813|NCT02357147|16176636|P1|Combination Treatment Phase|Withdrawal by Subject|4
4694814|NCT02357147|16176635|P2|Combination Treatment Phase|Investigator Discretion|1
4694815|NCT02357147|16176636|P1|Combination Treatment Phase|Investigator Discretion|1
4694816|NCT02357147|16176635|P2|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1
4694817|NCT02357147|16176636|P1|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0
4694818|NCT02357147|16176635|P2|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
4694819|NCT02357147|16176636|P1|Combination Treatment Phase|Progressive Disease (Radiographic test)|3
4694820|NCT02356887|16176667|P1|Overall Study|poor compliance|2
4694821|NCT02356783|16176684|P2|Overall Study|Lost to Follow-up|3
4694822|NCT02356783|16176685|P1|Overall Study|Lost to Follow-up|1
4694823|NCT02356588|16176695|P2|Overall Study|Protocol Violation|1
4694824|NCT02356588|16176696|P1|Overall Study|Protocol Violation|0
4694825|NCT02356588|16176695|P2|Overall Study|Withdrawal by Subject|0
4694826|NCT02356588|16176696|P1|Overall Study|Withdrawal by Subject|1
4694827|NCT02356588|16176695|P2|Overall Study|Adverse Event|2
4694828|NCT02356588|16176696|P1|Overall Study|Adverse Event|0
4694829|NCT02356588|16176695|P2|Overall Study|Lack of Efficacy|10
4694830|NCT02356588|16176696|P1|Overall Study|Lack of Efficacy|4
4694831|NCT02356562|16176813|P2|Overall Study|site closure|0
4694832|NCT02356562|16176814|P1|Overall Study|site closure|1
4694833|NCT02356562|16176813|P2|Overall Study|Re-entered treatment in a previous study|0
4694834|NCT02356562|16176814|P1|Overall Study|Re-entered treatment in a previous study|1
4694835|NCT02356562|16176813|P2|Overall Study|Withdrawal by Subject|1
4694836|NCT02356562|16176814|P1|Overall Study|Withdrawal by Subject|0
4694837|NCT02356211|16176843|P2|Overall Study|ineligible|8
4694838|NCT02356211|16176844|P1|Overall Study|ineligible|1
4694839|NCT02356211|16176843|P2|Overall Study|Withdrawal by Subject|2
4694840|NCT02356211|16176844|P1|Overall Study|Withdrawal by Subject|2
4694841|NCT02355743|16176903|P1|Overall Study|Lost to Follow-up|1
4694842|NCT02355743|16176903|P1|Overall Study|Withdrawal by Subject|1
4694843|NCT02355691|16176911|P2|Overall Study|Loss of Research Personnel|9
4694844|NCT02355691|16176912|P1|Overall Study|Loss of Research Personnel|7
4694845|NCT02355665|16176922|P2|Overall Study|Compliance, PI decision, move, eligible|3
4694927|NCT02354222|16177779|P2|Overall Study|Withdrawal by Subject|3
4694846|NCT02355665|16176923|P1|Overall Study|Compliance, PI decision, move, eligible|6
4694847|NCT02355665|16176922|P2|Overall Study|Death|2
4694848|NCT02355665|16176923|P1|Overall Study|Death|4
4694849|NCT02355665|16176922|P2|Overall Study|Lost to Follow-up|103
4694850|NCT02355665|16176923|P1|Overall Study|Lost to Follow-up|131
4694851|NCT02355665|16176922|P2|Overall Study|Withdrawal by Subject|100
4694852|NCT02355665|16176923|P1|Overall Study|Withdrawal by Subject|90
4694853|NCT02355665|16176922|P2|Overall Study|Protocol Violation|0
4694854|NCT02355665|16176923|P1|Overall Study|Protocol Violation|2
4694855|NCT02355665|16176922|P2|Overall Study|Adverse Event|24
4694856|NCT02355665|16176923|P1|Overall Study|Adverse Event|16
4694857|NCT02355028|16177381|P2|Overall Study|Deemed ineligible after randomization|4
4694858|NCT02355028|16177382|P1|Overall Study|Deemed ineligible after randomization|8
4694859|NCT02355028|16177381|P2|Overall Study|Withdrawal by Subject|1
4694860|NCT02355028|16177382|P1|Overall Study|Withdrawal by Subject|1
4694861|NCT02355028|16177381|P2|Overall Study|Adverse Event|0
4694862|NCT02355028|16177382|P1|Overall Study|Adverse Event|2
4694863|NCT02354976|16177418|P3|Overall Study|Adverse Event|2
4694864|NCT02354976|16177419|P2|Overall Study|Adverse Event|0
4694865|NCT02354976|16177420|P1|Overall Study|Adverse Event|1
4694866|NCT02354976|16177418|P3|Overall Study|Study-specifc withdrawal criteria|0
4694867|NCT02354976|16177419|P2|Overall Study|Study-specifc withdrawal criteria|1
4694868|NCT02354976|16177420|P1|Overall Study|Study-specifc withdrawal criteria|0
4694869|NCT02354976|16177418|P3|Overall Study|Other - reason not specified|1
4694870|NCT02354976|16177419|P2|Overall Study|Other - reason not specified|0
4694871|NCT02354976|16177420|P1|Overall Study|Other - reason not specified|1
4694872|NCT02354690|16177483|P1|Overall Study|Physician Decision|1
4694873|NCT02354599|16177497|P6|Overall Study|Withdrawal by Subject|0
4694874|NCT02354599|16177498|P5|Overall Study|Withdrawal by Subject|0
4694875|NCT02354599|16177499|P4|Overall Study|Withdrawal by Subject|0
4694876|NCT02354599|16177500|P3|Overall Study|Withdrawal by Subject|0
4694877|NCT02354599|16177501|P2|Overall Study|Withdrawal by Subject|1
4694878|NCT02354599|16177502|P1|Overall Study|Withdrawal by Subject|1
4694879|NCT02354599|16177497|P6|Overall Study|Pretreatment Event/Adverse Event|1
4694880|NCT02354599|16177498|P5|Overall Study|Pretreatment Event/Adverse Event|0
4694881|NCT02354599|16177499|P4|Overall Study|Pretreatment Event/Adverse Event|0
4694882|NCT02354599|16177500|P3|Overall Study|Pretreatment Event/Adverse Event|0
4694883|NCT02354599|16177501|P2|Overall Study|Pretreatment Event/Adverse Event|0
4694884|NCT02354599|16177502|P1|Overall Study|Pretreatment Event/Adverse Event|0
4694885|NCT02354586|16177572|P1|Overall Study|Disease progression|116
4694886|NCT02354586|16177572|P1|Overall Study|Lost to Follow-up|6
4694887|NCT02354586|16177572|P1|Overall Study|Withdrawal by Subject|51
4694888|NCT02354586|16177572|P1|Overall Study|Death|168
4694889|NCT02354508|16177591|P3|Period 3: Post-treatment Follow up Phase|Physician Decision|1
4694890|NCT02354508|16177592|P2|Period 3: Post-treatment Follow up Phase|Physician Decision|0
4694891|NCT02354508|16177593|P1|Period 3: Post-treatment Follow up Phase|Physician Decision|3
4694892|NCT02354508|16177591|P3|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
4694893|NCT02354508|16177592|P2|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1
4694894|NCT02354508|16177593|P1|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0
4694895|NCT02354508|16177591|P3|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
4694896|NCT02354508|16177592|P2|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2
4694897|NCT02354508|16177593|P1|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1
4694898|NCT02354508|16177591|P3|Period 2: Extension Phase|Physician Decision|1
4694899|NCT02354508|16177592|P2|Period 2: Extension Phase|Physician Decision|0
4694900|NCT02354508|16177593|P1|Period 2: Extension Phase|Physician Decision|5
4694901|NCT02354508|16177591|P3|Period 2: Extension Phase|Withdrawal by Subject|0
4694902|NCT02354508|16177592|P2|Period 2: Extension Phase|Withdrawal by Subject|1
4694903|NCT02354508|16177593|P1|Period 2: Extension Phase|Withdrawal by Subject|0
4694904|NCT02354508|16177591|P3|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2
4694905|NCT02354508|16177592|P2|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3
4694906|NCT02354508|16177593|P1|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1
4694907|NCT02354508|16177591|P3|Period 1: Core Phase|Withdrawal by Subject|2
4694908|NCT02354508|16177592|P2|Period 1: Core Phase|Withdrawal by Subject|1
4694909|NCT02354508|16177593|P1|Period 1: Core Phase|Withdrawal by Subject|0
4694910|NCT02354508|16177591|P3|Period 1: Core Phase|Unsatisfactory therapeutic effect|2
4694911|NCT02354508|16177592|P2|Period 1: Core Phase|Unsatisfactory therapeutic effect|0
4694912|NCT02354508|16177593|P1|Period 1: Core Phase|Unsatisfactory therapeutic effect|1
4694913|NCT02354508|16177591|P3|Period 1: Core Phase|Adverse Event|2
4694914|NCT02354508|16177592|P2|Period 1: Core Phase|Adverse Event|1
4694915|NCT02354508|16177593|P1|Period 1: Core Phase|Adverse Event|1
4694916|NCT02354417|16177695|P1|Overall Study|Physician Decision|1
4694917|NCT02354235|16177762|P2|Overall Study|Conflict with the stopping criteria|1
4694918|NCT02354235|16177763|P1|Overall Study|Conflict with the stopping criteria|0
4694919|NCT02354235|16177762|P2|Overall Study|Withdrawal by Subject|3
4694920|NCT02354235|16177763|P1|Overall Study|Withdrawal by Subject|1
4694921|NCT02354235|16177762|P2|Overall Study|Physician Decision|1
4694922|NCT02354235|16177763|P1|Overall Study|Physician Decision|0
4694923|NCT02354235|16177762|P2|Overall Study|Adverse Event|2
4694924|NCT02354235|16177763|P1|Overall Study|Adverse Event|2
4694925|NCT02354222|16177779|P2|Overall Study|Conflict with the stopping criteria|4
4694926|NCT02354222|16177780|P1|Overall Study|Conflict with the stopping criteria|0
4694928|NCT02354222|16177780|P1|Overall Study|Withdrawal by Subject|2
4694929|NCT02354222|16177779|P2|Overall Study|Pregnancy|0
4694930|NCT02354222|16177780|P1|Overall Study|Pregnancy|1
4694931|NCT02354222|16177779|P2|Overall Study|Physician Decision|1
4694932|NCT02354222|16177780|P1|Overall Study|Physician Decision|1
4694933|NCT02354222|16177779|P2|Overall Study|Adverse Event|3
4694934|NCT02354222|16177780|P1|Overall Study|Adverse Event|0
4694935|NCT02353871|16177811|P2|Overall Study|Lost to Follow-up|0
4694936|NCT02353871|16177812|P1|Overall Study|Lost to Follow-up|2
4694937|NCT02353871|16177811|P2|Overall Study|Consent withdrawn|8
4694938|NCT02353871|16177812|P1|Overall Study|Consent withdrawn|1
4694939|NCT02353871|16177811|P2|Overall Study|Protocol deviation|1
4694940|NCT02353871|16177812|P1|Overall Study|Protocol deviation|0
4694941|NCT02353572|16177905|P1|Overall Study|Study terminated|2
4694942|NCT02353572|16177905|P1|Overall Study|Withdrawal by Subject|1
4694943|NCT01844765|16177911|P2|Overall Study|Untreated|0
4694944|NCT01844765|16177912|P1|Overall Study|Untreated|1
4694945|NCT01844765|16177911|P2|Overall Study|Protocol Violation|0
4694946|NCT01844765|16177912|P1|Overall Study|Protocol Violation|1
4694947|NCT01844765|16177911|P2|Overall Study|Disease progression|0
4694948|NCT01844765|16177912|P1|Overall Study|Disease progression|1
4694949|NCT01844765|16177911|P2|Overall Study|Administrative problems|1
4694950|NCT01844765|16177912|P1|Overall Study|Administrative problems|1
4694951|NCT01844765|16177911|P2|Overall Study|Withdrawal by Subject|1
4694952|NCT01844765|16177912|P1|Overall Study|Withdrawal by Subject|0
4694953|NCT01844765|16177911|P2|Overall Study|Adverse Event|4
4694954|NCT01844765|16177912|P1|Overall Study|Adverse Event|5
4694955|NCT02353468|16177930|P1|Overall Study|Study terminated|3
4694956|NCT02353442|16177936|P2|Overall Study|Withdrawal by Subject|4
4694957|NCT02353442|16177937|P1|Overall Study|Withdrawal by Subject|3
4694958|NCT02353169|16177992|P4|Overall Study|Pre-op medication|0
4694959|NCT02353169|16177993|P3|Overall Study|Pre-op medication|1
4694960|NCT02353169|16177994|P2|Overall Study|Pre-op medication|0
4694961|NCT02353169|16177995|P1|Overall Study|Pre-op medication|0
4694962|NCT02353169|16177992|P4|Overall Study|ECG data error|2
4694963|NCT02353169|16177993|P3|Overall Study|ECG data error|2
4694964|NCT02353169|16177994|P2|Overall Study|ECG data error|3
4694965|NCT02353169|16177995|P1|Overall Study|ECG data error|0
4694966|NCT02353169|16177992|P4|Overall Study|Inhalational induction|0
4694967|NCT02353169|16177993|P3|Overall Study|Inhalational induction|0
4694968|NCT02353169|16177994|P2|Overall Study|Inhalational induction|2
4694969|NCT02353169|16177995|P1|Overall Study|Inhalational induction|0
4694970|NCT02353169|16177992|P4|Overall Study|OR team declined|0
4694971|NCT02353169|16177993|P3|Overall Study|OR team declined|0
4694972|NCT02353169|16177994|P2|Overall Study|OR team declined|0
4694973|NCT02353169|16177995|P1|Overall Study|OR team declined|2
4694974|NCT02353169|16177992|P4|Overall Study|QTc > 450 msec|1
4694975|NCT02353169|16177993|P3|Overall Study|QTc > 450 msec|1
4694976|NCT02353169|16177994|P2|Overall Study|QTc > 450 msec|1
4694977|NCT02353169|16177995|P1|Overall Study|QTc > 450 msec|1
4694978|NCT02352948|16178087|P6|Overall Study|Other|0
4694979|NCT02352948|16178088|P5|Overall Study|Other|0
4694980|NCT02352948|16178089|P4|Overall Study|Other|0
4694981|NCT02352948|16178090|P3|Overall Study|Other|2
4694982|NCT02352948|16178091|P2|Overall Study|Other|0
4694983|NCT02352948|16178092|P1|Overall Study|Other|0
4694984|NCT02352948|16178087|P6|Overall Study|Eligibility criteria not fulfilled|0
4694985|NCT02352948|16178088|P5|Overall Study|Eligibility criteria not fulfilled|0
4694986|NCT02352948|16178089|P4|Overall Study|Eligibility criteria not fulfilled|1
4694987|NCT02352948|16178090|P3|Overall Study|Eligibility criteria not fulfilled|0
4694988|NCT02352948|16178091|P2|Overall Study|Eligibility criteria not fulfilled|1
4694989|NCT02352948|16178092|P1|Overall Study|Eligibility criteria not fulfilled|0
4694990|NCT02352948|16178087|P6|Overall Study|Withdrawal by Subject|4
4694991|NCT02352948|16178088|P5|Overall Study|Withdrawal by Subject|9
4694992|NCT02352948|16178089|P4|Overall Study|Withdrawal by Subject|23
4694993|NCT02352948|16178090|P3|Overall Study|Withdrawal by Subject|11
4694994|NCT02352948|16178091|P2|Overall Study|Withdrawal by Subject|10
4694995|NCT02352948|16178092|P1|Overall Study|Withdrawal by Subject|1
4694996|NCT02352948|16178087|P6|Overall Study|Lost to Follow-up|1
4694997|NCT02352948|16178088|P5|Overall Study|Lost to Follow-up|2
4694998|NCT02352948|16178089|P4|Overall Study|Lost to Follow-up|1
4694999|NCT02352948|16178090|P3|Overall Study|Lost to Follow-up|2
4695000|NCT02352948|16178091|P2|Overall Study|Lost to Follow-up|0
4695001|NCT02352948|16178092|P1|Overall Study|Lost to Follow-up|1
4695002|NCT02352948|16178087|P6|Overall Study|Death|44
4695003|NCT02352948|16178088|P5|Overall Study|Death|77
4695004|NCT02352948|16178089|P4|Overall Study|Death|74
4695005|NCT02352948|16178090|P3|Overall Study|Death|114
4695006|NCT02352948|16178091|P2|Overall Study|Death|48
4695007|NCT02352948|16178092|P1|Overall Study|Death|47
4695008|NCT02352779|16178217|P3|Overall Study|No Reason|1
4695009|NCT02352779|16178218|P2|Overall Study|No Reason|0
4695010|NCT02352779|16178219|P1|Overall Study|No Reason|0
4695011|NCT02352779|16178217|P3|Overall Study|Other Medical Reason|1
4695012|NCT02352779|16178218|P2|Overall Study|Other Medical Reason|0
4695013|NCT02352779|16178219|P1|Overall Study|Other Medical Reason|0
4695014|NCT02352779|16178217|P3|Overall Study|Absence of Symptoms|0
4695015|NCT02352779|16178218|P2|Overall Study|Absence of Symptoms|0
4695016|NCT02352779|16178219|P1|Overall Study|Absence of Symptoms|1
4695017|NCT02352779|16178217|P3|Overall Study|Study Related Symptoms|0
4695018|NCT02352779|16178218|P2|Overall Study|Study Related Symptoms|0
4695019|NCT02352779|16178219|P1|Overall Study|Study Related Symptoms|1
4695020|NCT02352779|16178217|P3|Overall Study|Changed Mind|0
4695021|NCT02352779|16178218|P2|Overall Study|Changed Mind|0
4695022|NCT02352779|16178219|P1|Overall Study|Changed Mind|1
4695023|NCT02352779|16178217|P3|Overall Study|Disliked Intervention|0
4695024|NCT02352779|16178218|P2|Overall Study|Disliked Intervention|0
4695025|NCT02352779|16178219|P1|Overall Study|Disliked Intervention|1
4695026|NCT02352779|16178217|P3|Overall Study|Feeling Overwhelmed|0
4695027|NCT02352779|16178218|P2|Overall Study|Feeling Overwhelmed|0
4695028|NCT02352779|16178219|P1|Overall Study|Feeling Overwhelmed|1
4695029|NCT02352779|16178217|P3|Overall Study|Too Many Forms|0
4695030|NCT02352779|16178218|P2|Overall Study|Too Many Forms|0
4695031|NCT02352779|16178219|P1|Overall Study|Too Many Forms|2
4695032|NCT02352779|16178217|P3|Overall Study|Personal Issues|0
4695033|NCT02352779|16178218|P2|Overall Study|Personal Issues|1
4695034|NCT02352779|16178219|P1|Overall Study|Personal Issues|1
4695035|NCT02352493|16178245|P18|Overall Study|Lost to Follow-up|0
4695036|NCT02352493|16178246|P17|Overall Study|Lost to Follow-up|0
4695037|NCT02352493|16178247|P16|Overall Study|Lost to Follow-up|0
4695038|NCT02352493|16178248|P15|Overall Study|Lost to Follow-up|0
4695039|NCT02352493|16178249|P14|Overall Study|Lost to Follow-up|2
4695040|NCT02352493|16178250|P13|Overall Study|Lost to Follow-up|1
4695041|NCT02352493|16178251|P12|Overall Study|Lost to Follow-up|0
4695042|NCT02352493|16178252|P11|Overall Study|Lost to Follow-up|0
4695043|NCT02352493|16178253|P10|Overall Study|Lost to Follow-up|1
4695044|NCT02352493|16178254|P9|Overall Study|Lost to Follow-up|0
4695045|NCT02352493|16178255|P8|Overall Study|Lost to Follow-up|0
4695046|NCT02352493|16178256|P7|Overall Study|Lost to Follow-up|0
4695047|NCT02352493|16178257|P6|Overall Study|Lost to Follow-up|0
4695048|NCT02352493|16178258|P5|Overall Study|Lost to Follow-up|0
4695049|NCT02352493|16178259|P4|Overall Study|Lost to Follow-up|0
4695050|NCT02352493|16178260|P3|Overall Study|Lost to Follow-up|0
4695051|NCT02352493|16178261|P2|Overall Study|Lost to Follow-up|0
4695052|NCT02352493|16178262|P1|Overall Study|Lost to Follow-up|0
4695053|NCT02352493|16178245|P18|Overall Study|Withdrawal by Subject|0
4695054|NCT02352493|16178246|P17|Overall Study|Withdrawal by Subject|0
4695055|NCT02352493|16178247|P16|Overall Study|Withdrawal by Subject|0
4695056|NCT02352493|16178248|P15|Overall Study|Withdrawal by Subject|1
4695057|NCT02352493|16178249|P14|Overall Study|Withdrawal by Subject|0
4695058|NCT02352493|16178250|P13|Overall Study|Withdrawal by Subject|0
4695059|NCT02352493|16178251|P12|Overall Study|Withdrawal by Subject|0
4695060|NCT02352493|16178252|P11|Overall Study|Withdrawal by Subject|0
4695061|NCT02352493|16178253|P10|Overall Study|Withdrawal by Subject|0
4695062|NCT02352493|16178254|P9|Overall Study|Withdrawal by Subject|1
4695063|NCT02352493|16178255|P8|Overall Study|Withdrawal by Subject|0
4695064|NCT02352493|16178256|P7|Overall Study|Withdrawal by Subject|0
4695065|NCT02352493|16178257|P6|Overall Study|Withdrawal by Subject|0
4695066|NCT02352493|16178258|P5|Overall Study|Withdrawal by Subject|0
4695067|NCT02352493|16178259|P4|Overall Study|Withdrawal by Subject|0
4695068|NCT02352493|16178260|P3|Overall Study|Withdrawal by Subject|0
4695069|NCT02352493|16178261|P2|Overall Study|Withdrawal by Subject|0
4695070|NCT02352493|16178262|P1|Overall Study|Withdrawal by Subject|0
4695071|NCT02352493|16178245|P18|Overall Study|Pregnancy|0
4695072|NCT02352493|16178246|P17|Overall Study|Pregnancy|0
4695073|NCT02352493|16178247|P16|Overall Study|Pregnancy|0
4695074|NCT02352493|16178248|P15|Overall Study|Pregnancy|0
4695075|NCT02352493|16178249|P14|Overall Study|Pregnancy|0
4695076|NCT02352493|16178250|P13|Overall Study|Pregnancy|0
4695077|NCT02352493|16178251|P12|Overall Study|Pregnancy|0
4695078|NCT02352493|16178252|P11|Overall Study|Pregnancy|0
4695079|NCT02352493|16178253|P10|Overall Study|Pregnancy|0
4695080|NCT02352493|16178254|P9|Overall Study|Pregnancy|1
4695081|NCT02352493|16178255|P8|Overall Study|Pregnancy|0
4695082|NCT02352493|16178256|P7|Overall Study|Pregnancy|1
4695083|NCT02352493|16178257|P6|Overall Study|Pregnancy|0
4695084|NCT02352493|16178258|P5|Overall Study|Pregnancy|0
4695085|NCT02352493|16178259|P4|Overall Study|Pregnancy|0
4695086|NCT02352493|16178260|P3|Overall Study|Pregnancy|0
4695087|NCT02352493|16178261|P2|Overall Study|Pregnancy|0
4695088|NCT02352493|16178262|P1|Overall Study|Pregnancy|0
4695089|NCT02351960|16178495|P2|Overall Study|Significant Protocol Deviation|5
4695090|NCT02351960|16178496|P1|Overall Study|Significant Protocol Deviation|0
4695091|NCT02351960|16178495|P2|Overall Study|Voluntary Withdrawal|4
4695092|NCT02351960|16178496|P1|Overall Study|Voluntary Withdrawal|5
4695093|NCT02351960|16178495|P2|Overall Study|Pretreatment Event/Adverse Event|3
4695094|NCT02351960|16178496|P1|Overall Study|Pretreatment Event/Adverse Event|6
4695095|NCT02351934|16178517|P2|Follow-Up|2 ERAS Components Noncompliant|4
4695096|NCT02351934|16178518|P1|Follow-Up|2 ERAS Components Noncompliant|0
4695097|NCT02351934|16178517|P2|Follow-Up|1 ERAS Component Noncompliant|6
4695098|NCT02351934|16178518|P1|Follow-Up|1 ERAS Component Noncompliant|0
4695099|NCT02351934|16178517|P2|Follow-Up|No documentation|0
4695100|NCT02351934|16178518|P1|Follow-Up|No documentation|2
4695101|NCT02351934|16178517|P2|Follow-Up|Hypotension|0
4695102|NCT02351934|16178518|P1|Follow-Up|Hypotension|3
4695103|NCT02351934|16178517|P2|Follow-Up|Early dismissal|0
4695104|NCT02351934|16178518|P1|Follow-Up|Early dismissal|3
4695105|NCT02351934|16178517|P2|Follow-Up|Acute Kidney Injury|0
4695106|NCT02351934|16178518|P1|Follow-Up|Acute Kidney Injury|1
4695107|NCT02351934|16178517|P2|Follow-Up|POD weight<pre-op weight|0
4695108|NCT02351934|16178518|P1|Follow-Up|POD weight<pre-op weight|3
4695109|NCT02351934|16178517|P2|Allocation|Acute Kidney Injury on Post Op Day 1|0
4695110|NCT02351934|16178518|P1|Allocation|Acute Kidney Injury on Post Op Day 1|1
4695111|NCT02351934|16178517|P2|Allocation|Hypotension preventing administration|0
4695112|NCT02351934|16178518|P1|Allocation|Hypotension preventing administration|2
4695113|NCT02351934|16178517|P2|Allocation|POD weight<pre-op weight|0
4695114|NCT02351934|16178518|P1|Allocation|POD weight<pre-op weight|3
4695115|NCT02351817|16178534|P2|Period 2|Protocol Violation|0
4695116|NCT02351817|16178535|P1|Period 2|Protocol Violation|1
4695117|NCT02351817|16178534|P2|Period 2|Adverse Event|2
4695118|NCT02351817|16178535|P1|Period 2|Adverse Event|0
4695119|NCT02351817|16178534|P2|Period 1|Lack of Efficacy|1
4695120|NCT02351817|16178535|P1|Period 1|Lack of Efficacy|0
4695121|NCT02351817|16178534|P2|Period 1|Adverse Event|2
4695122|NCT02351817|16178535|P1|Period 1|Adverse Event|1
4695123|NCT02351167|16178596|P3|Overall Study|Withdrawal by Subject|21
4695124|NCT02351167|16178597|P2|Overall Study|Withdrawal by Subject|18
4695125|NCT02351167|16178598|P1|Overall Study|Withdrawal by Subject|19
4695126|NCT02350478|16178777|P2|Overall Study|Lost to Follow-up|1
4695127|NCT02350478|16178778|P1|Overall Study|Lost to Follow-up|5
4695128|NCT02350309|16178800|P6|Treatment Period 4 (2 Days)|Death in the Family|1
4695129|NCT02350309|16178801|P5|Treatment Period 4 (2 Days)|Death in the Family|0
4695130|NCT02350309|16178802|P4|Treatment Period 4 (2 Days)|Death in the Family|0
4695131|NCT02350309|16178803|P3|Treatment Period 4 (2 Days)|Death in the Family|0
4695132|NCT02350309|16178804|P2|Treatment Period 4 (2 Days)|Death in the Family|0
4695133|NCT02350309|16178805|P1|Treatment Period 4 (2 Days)|Death in the Family|0
4695134|NCT02350309|16178800|P6|Treatment Period 1 (2 Days)|Physician Decision|0
4695135|NCT02350309|16178801|P5|Treatment Period 1 (2 Days)|Physician Decision|0
4695136|NCT02350309|16178802|P4|Treatment Period 1 (2 Days)|Physician Decision|0
4695137|NCT02350309|16178803|P3|Treatment Period 1 (2 Days)|Physician Decision|1
4695138|NCT02350309|16178804|P2|Treatment Period 1 (2 Days)|Physician Decision|0
4695139|NCT02350309|16178805|P1|Treatment Period 1 (2 Days)|Physician Decision|0
4695140|NCT02350127|16178846|P2|8-Month Assessment|Withdrawal by Subject|8
4695141|NCT02350127|16178847|P1|8-Month Assessment|Withdrawal by Subject|5
4695142|NCT02350127|16178846|P2|8-Month Assessment|Death|1
4695143|NCT02350127|16178847|P1|8-Month Assessment|Death|1
4695144|NCT02350127|16178846|P2|4-Month Assessment|Death|0
4695145|NCT02350127|16178847|P1|4-Month Assessment|Death|1
4695146|NCT02350127|16178846|P2|4-Month Assessment|Withdrawal by Subject|9
4695147|NCT02350127|16178847|P1|4-Month Assessment|Withdrawal by Subject|10
4695148|NCT02349789|16178886|P1|Overall Study|Withdrawal by Subject|2
4695149|NCT02349711|16178897|P2|Overall Study|Lost to Follow-up|1
4695150|NCT02349711|16178898|P1|Overall Study|Lost to Follow-up|1
4695151|NCT02349711|16178897|P2|Overall Study|Withdrawal by Subject|1
4695152|NCT02349711|16178898|P1|Overall Study|Withdrawal by Subject|2
4695153|NCT02349542|16178931|P1|Overall Study|Withdrawal by Subject|5
4695154|NCT02349451|16178955|P4|Overall Study|Withdrawal by Subject|1
4695155|NCT02349451|16178956|P3|Overall Study|Withdrawal by Subject|2
4695156|NCT02349451|16178957|P2|Overall Study|Withdrawal by Subject|1
4695157|NCT02349451|16178958|P1|Overall Study|Withdrawal by Subject|0
4695158|NCT02349425|16179009|P4|Period 2|Adverse Event|0
4695159|NCT02349425|16179010|P3|Period 2|Adverse Event|1
4695160|NCT02349425|16179011|P2|Period 2|Adverse Event|1
4695161|NCT02349425|16179012|P1|Period 2|Adverse Event|0
4695162|NCT02349425|16179009|P4|Period 1|Adverse Event|0
4695163|NCT02349425|16179010|P3|Period 1|Adverse Event|0
4695164|NCT02349425|16179011|P2|Period 1|Adverse Event|1
4695165|NCT02349425|16179012|P1|Period 1|Adverse Event|1
4695166|NCT02349412|16179186|P2|Overall Study|Withdrawal by Subject|7
4695167|NCT02349412|16179187|P1|Overall Study|Withdrawal by Subject|7
4695168|NCT02349360|16179203|P2|Overall Study|Withdrawal by Subject|1
4695169|NCT02349360|16179204|P1|Overall Study|Withdrawal by Subject|0
4695170|NCT02349295|16179215|P14|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695171|NCT02349295|16179216|P13|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695172|NCT02349295|16179217|P12|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4
4695173|NCT02349295|16179218|P11|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695174|NCT02349295|16179219|P10|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695175|NCT02349295|16179220|P9|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695176|NCT02349295|16179221|P8|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695177|NCT02349295|16179222|P7|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695178|NCT02349295|16179223|P6|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695179|NCT02349295|16179224|P5|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695180|NCT02349295|16179225|P4|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695181|NCT02349295|16179226|P3|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695182|NCT02349295|16179227|P2|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695183|NCT02349295|16179228|P1|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0
4695184|NCT02349295|16179215|P14|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695185|NCT02349295|16179216|P13|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695186|NCT02349295|16179217|P12|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2
4695187|NCT02349295|16179218|P11|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695188|NCT02349295|16179219|P10|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695189|NCT02349295|16179220|P9|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695190|NCT02349295|16179221|P8|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695191|NCT02349295|16179222|P7|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695192|NCT02349295|16179223|P6|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695193|NCT02349295|16179224|P5|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695194|NCT02349295|16179225|P4|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695195|NCT02349295|16179226|P3|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695196|NCT02349295|16179227|P2|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695197|NCT02349295|16179228|P1|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0
4695198|NCT02349295|16179215|P14|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695199|NCT02349295|16179216|P13|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
4695200|NCT02349295|16179217|P12|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1
4695201|NCT02349295|16179218|P11|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695202|NCT02349295|16179219|P10|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695203|NCT02349295|16179220|P9|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695204|NCT02349295|16179221|P8|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695205|NCT02349295|16179222|P7|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695206|NCT02349295|16179223|P6|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695207|NCT02349295|16179224|P5|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695208|NCT02349295|16179225|P4|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695209|NCT02349295|16179226|P3|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695210|NCT02349295|16179227|P2|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695211|NCT02349295|16179228|P1|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0
4695212|NCT02349295|16179215|P14|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695213|NCT02349295|16179216|P13|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2
4695214|NCT02349295|16179217|P12|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1
4695215|NCT02349295|16179218|P11|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695216|NCT02349295|16179219|P10|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695217|NCT02349295|16179220|P9|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695218|NCT02349295|16179221|P8|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695219|NCT02349295|16179222|P7|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695220|NCT02349295|16179223|P6|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695221|NCT02349295|16179224|P5|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695222|NCT02349295|16179225|P4|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695223|NCT02349295|16179226|P3|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695224|NCT02349295|16179227|P2|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695225|NCT02349295|16179228|P1|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0
4695226|NCT02349295|16179215|P14|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
4695227|NCT02349295|16179216|P13|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5
4695228|NCT02349295|16179217|P12|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1
4695229|NCT02349295|16179218|P11|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695230|NCT02349295|16179219|P10|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695231|NCT02349295|16179220|P9|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695232|NCT02349295|16179221|P8|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695233|NCT02349295|16179222|P7|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695234|NCT02349295|16179223|P6|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695235|NCT02349295|16179224|P5|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695236|NCT02349295|16179225|P4|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695237|NCT02349295|16179226|P3|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695238|NCT02349295|16179227|P2|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695239|NCT02349295|16179228|P1|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0
4695240|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695241|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695242|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695243|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695244|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695245|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Physician Decision|2
4695246|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Physician Decision|2
4695247|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695248|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695249|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695250|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695251|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695252|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695253|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Physician Decision|0
4695254|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695255|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695256|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695257|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695258|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695259|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
4695260|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2
4695261|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695262|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695263|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695264|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695265|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695266|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695267|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0
4695268|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695269|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695270|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695271|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3
4695272|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1
4695273|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2
4695274|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4
4695275|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695276|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695277|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695278|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695279|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695280|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695281|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0
4695282|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Death|0
4695283|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Death|0
4695284|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Death|0
4695285|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Death|0
4695286|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Death|1
4695287|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Death|1
4695288|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Death|1
4695289|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Death|0
4695290|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Death|0
4695291|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Death|0
4695292|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Death|0
4695293|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Death|0
4695294|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Death|0
4695295|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Death|0
4695296|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695297|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695298|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695299|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695300|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3
4695301|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695302|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2
4695303|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695304|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695305|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695306|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695307|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695308|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695309|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0
4695310|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695311|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695312|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695313|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Adverse Event|2
4695314|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Adverse Event|2
4695315|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Adverse Event|9
4695316|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Adverse Event|9
4695317|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695318|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695319|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695320|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695321|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695322|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695323|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Adverse Event|0
4695324|NCT02349295|16179215|P14|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695325|NCT02349295|16179216|P13|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695326|NCT02349295|16179217|P12|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695327|NCT02349295|16179218|P11|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18
4695328|NCT02349295|16179219|P10|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19
4695329|NCT02349295|16179220|P9|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25
4695330|NCT02349295|16179221|P8|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32
4695331|NCT02349295|16179222|P7|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695332|NCT02349295|16179223|P6|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695333|NCT02349295|16179224|P5|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695334|NCT02349295|16179225|P4|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695335|NCT02349295|16179226|P3|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695336|NCT02349295|16179227|P2|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695337|NCT02349295|16179228|P1|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0
4695338|NCT02349295|16179215|P14|IR (Week 16-24)|Lack of Efficacy|0
4695339|NCT02349295|16179216|P13|IR (Week 16-24)|Lack of Efficacy|0
4695340|NCT02349295|16179217|P12|IR (Week 16-24)|Lack of Efficacy|0
4695341|NCT02349295|16179218|P11|IR (Week 16-24)|Lack of Efficacy|0
4695342|NCT02349295|16179219|P10|IR (Week 16-24)|Lack of Efficacy|0
4695343|NCT02349295|16179220|P9|IR (Week 16-24)|Lack of Efficacy|0
4695344|NCT02349295|16179221|P8|IR (Week 16-24)|Lack of Efficacy|0
4695345|NCT02349295|16179222|P7|IR (Week 16-24)|Lack of Efficacy|0
4695346|NCT02349295|16179223|P6|IR (Week 16-24)|Lack of Efficacy|0
4695347|NCT02349295|16179224|P5|IR (Week 16-24)|Lack of Efficacy|0
4695348|NCT02349295|16179225|P4|IR (Week 16-24)|Lack of Efficacy|1
4695349|NCT02349295|16179226|P3|IR (Week 16-24)|Lack of Efficacy|0
4695350|NCT02349295|16179227|P2|IR (Week 16-24)|Lack of Efficacy|0
4695351|NCT02349295|16179228|P1|IR (Week 16-24)|Lack of Efficacy|0
4695352|NCT02349295|16179215|P14|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695353|NCT02349295|16179216|P13|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695354|NCT02349295|16179217|P12|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695355|NCT02349295|16179218|P11|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695356|NCT02349295|16179219|P10|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695357|NCT02349295|16179220|P9|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695358|NCT02349295|16179221|P8|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695359|NCT02349295|16179222|P7|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695360|NCT02349295|16179223|P6|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695361|NCT02349295|16179224|P5|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695362|NCT02349295|16179225|P4|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695363|NCT02349295|16179226|P3|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
4695364|NCT02349295|16179227|P2|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1
4695365|NCT02349295|16179228|P1|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0
4695366|NCT02349295|16179215|P14|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695367|NCT02349295|16179216|P13|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695368|NCT02349295|16179217|P12|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695369|NCT02349295|16179218|P11|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695370|NCT02349295|16179219|P10|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695371|NCT02349295|16179220|P9|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695372|NCT02349295|16179221|P8|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695373|NCT02349295|16179222|P7|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695374|NCT02349295|16179223|P6|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695375|NCT02349295|16179224|P5|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695376|NCT02349295|16179225|P4|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0
4695377|NCT02349295|16179226|P3|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2
4695378|NCT02349295|16179227|P2|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
4695379|NCT02349295|16179228|P1|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1
4695380|NCT02349295|16179215|P14|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695381|NCT02349295|16179216|P13|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695382|NCT02349295|16179217|P12|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695383|NCT02349295|16179218|P11|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695384|NCT02349295|16179219|P10|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695385|NCT02349295|16179220|P9|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695386|NCT02349295|16179221|P8|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695387|NCT02349295|16179222|P7|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695388|NCT02349295|16179223|P6|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695389|NCT02349295|16179224|P5|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695390|NCT02349295|16179225|P4|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0
4695391|NCT02349295|16179226|P3|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7
4695392|NCT02349295|16179227|P2|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
4695393|NCT02349295|16179228|P1|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2
4695394|NCT02349295|16179215|P14|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695395|NCT02349295|16179216|P13|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695396|NCT02349295|16179217|P12|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695397|NCT02349295|16179218|P11|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695398|NCT02349295|16179219|P10|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695399|NCT02349295|16179220|P9|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695400|NCT02349295|16179221|P8|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695401|NCT02349295|16179222|P7|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695402|NCT02349295|16179223|P6|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695403|NCT02349295|16179224|P5|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695404|NCT02349295|16179225|P4|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0
4695405|NCT02349295|16179226|P3|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9
4695406|NCT02349295|16179227|P2|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2
4695407|NCT02349295|16179228|P1|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4
4695408|NCT02349295|16179215|P14|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695409|NCT02349295|16179216|P13|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695410|NCT02349295|16179217|P12|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695411|NCT02349295|16179218|P11|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695412|NCT02349295|16179219|P10|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695413|NCT02349295|16179220|P9|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695414|NCT02349295|16179221|P8|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695415|NCT02349295|16179222|P7|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695416|NCT02349295|16179223|P6|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695417|NCT02349295|16179224|P5|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695418|NCT02349295|16179225|P4|Double Blind Treatment (Week 0-24)|Adverse Event|0
4695419|NCT02349295|16179226|P3|Double Blind Treatment (Week 0-24)|Adverse Event|5
4695420|NCT02349295|16179227|P2|Double Blind Treatment (Week 0-24)|Adverse Event|5
4695421|NCT02349295|16179228|P1|Double Blind Treatment (Week 0-24)|Adverse Event|7
4695422|NCT02349061|16179368|P3|Study Extension (Week 56 to Week 120)|Physician Decision|1
4695423|NCT02349061|16179369|P2|Study Extension (Week 56 to Week 120)|Physician Decision|0
4695424|NCT02349061|16179370|P1|Study Extension (Week 56 to Week 120)|Physician Decision|0
4695425|NCT02349061|16179368|P3|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1
4695426|NCT02349061|16179369|P2|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2
4695427|NCT02349061|16179370|P1|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0
4695428|NCT02349061|16179368|P3|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1
4695429|NCT02349061|16179369|P2|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
4695430|NCT02349061|16179370|P1|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0
4695431|NCT02349061|16179368|P3|Study Extension (Week 56 to Week 120)|Adverse Event|0
4695432|NCT02349061|16179369|P2|Study Extension (Week 56 to Week 120)|Adverse Event|3
4695433|NCT02349061|16179370|P1|Study Extension (Week 56 to Week 120)|Adverse Event|0
4695434|NCT02349061|16179368|P3|Main Study: Week 24 to 56|Physician Decision|1
4695435|NCT02349061|16179369|P2|Main Study: Week 24 to 56|Physician Decision|0
4695436|NCT02349061|16179370|P1|Main Study: Week 24 to 56|Physician Decision|0
4695437|NCT02349061|16179368|P3|Main Study: Week 24 to 56|Withdrawal by Subject|1
4695438|NCT02349061|16179369|P2|Main Study: Week 24 to 56|Withdrawal by Subject|0
4695439|NCT02349061|16179370|P1|Main Study: Week 24 to 56|Withdrawal by Subject|0
4695440|NCT02349061|16179368|P3|Main Study: Week 24 to 56|Lack of Efficacy|0
4695441|NCT02349061|16179369|P2|Main Study: Week 24 to 56|Lack of Efficacy|1
4695442|NCT02349061|16179370|P1|Main Study: Week 24 to 56|Lack of Efficacy|0
4695443|NCT02349061|16179368|P3|Main Study: Week 24 to 56|Adverse Event|1
4695444|NCT02349061|16179369|P2|Main Study: Week 24 to 56|Adverse Event|2
4695445|NCT02349061|16179370|P1|Main Study: Week 24 to 56|Adverse Event|0
4695446|NCT02349061|16179368|P3|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
4695447|NCT02349061|16179369|P2|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0
4695448|NCT02349061|16179370|P1|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2
4695449|NCT02349061|16179368|P3|Main Study: PCP (Up to Week 24)|Other|0
4695450|NCT02349061|16179369|P2|Main Study: PCP (Up to Week 24)|Other|1
4695451|NCT02349061|16179370|P1|Main Study: PCP (Up to Week 24)|Other|1
4695452|NCT02349061|16179368|P3|Main Study: PCP (Up to Week 24)|Physician Decision|0
4695453|NCT02349061|16179369|P2|Main Study: PCP (Up to Week 24)|Physician Decision|0
4695454|NCT02349061|16179370|P1|Main Study: PCP (Up to Week 24)|Physician Decision|1
4695455|NCT02349061|16179368|P3|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
4695456|NCT02349061|16179369|P2|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0
4695457|NCT02349061|16179370|P1|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1
4695458|NCT02349061|16179368|P3|Main Study: PCP (Up to Week 24)|Adverse Event|0
4695459|NCT02349061|16179369|P2|Main Study: PCP (Up to Week 24)|Adverse Event|3
4695460|NCT02349061|16179370|P1|Main Study: PCP (Up to Week 24)|Adverse Event|4
4695461|NCT02349048|16179390|P2|Overall Study|Lost to Follow-up|0
4695462|NCT02349048|16179391|P1|Overall Study|Lost to Follow-up|1
4695463|NCT02349048|16179390|P2|Overall Study|Withdrawal by Subject|0
4695464|NCT02349048|16179391|P1|Overall Study|Withdrawal by Subject|4
4695465|NCT02348840|16179452|P4|Overall Study|Withdrawal by Subject|0
4695466|NCT02348840|16179453|P3|Overall Study|Withdrawal by Subject|0
4695467|NCT02348840|16179454|P2|Overall Study|Withdrawal by Subject|1
4695468|NCT02348840|16179455|P1|Overall Study|Withdrawal by Subject|2
4695469|NCT02348723|16179469|P2|Overall Study|Adverse Event|1
4695470|NCT02348723|16179470|P1|Overall Study|Adverse Event|3
4695471|NCT02348723|16179469|P2|Overall Study|Reason other than specified|1
4695472|NCT02348723|16179470|P1|Overall Study|Reason other than specified|1
4695473|NCT02348723|16179469|P2|Overall Study|Consent withdrawn|3
4695474|NCT02348723|16179470|P1|Overall Study|Consent withdrawn|1
4695475|NCT02348723|16179469|P2|Overall Study|Lost to Follow-up|1
4695476|NCT02348723|16179470|P1|Overall Study|Lost to Follow-up|1
4695477|NCT02348723|16179469|P2|Overall Study|Non-compliant with Protocol|0
4695478|NCT02348723|16179470|P1|Overall Study|Non-compliant with Protocol|1
4695479|NCT02348723|16179469|P2|Overall Study|No ablation|20
4695480|NCT02348723|16179470|P1|Overall Study|No ablation|21
4695481|NCT02348008|16179696|P3|Overall Study|Symptomatic Deterioration|0
4695482|NCT02348008|16179697|P2|Overall Study|Symptomatic Deterioration|1
4695483|NCT02348008|16179698|P1|Overall Study|Symptomatic Deterioration|0
4695484|NCT02348008|16179696|P3|Overall Study|Withdrawal by Subject|0
4695485|NCT02348008|16179697|P2|Overall Study|Withdrawal by Subject|1
4695486|NCT02348008|16179698|P1|Overall Study|Withdrawal by Subject|0
4695487|NCT02348008|16179696|P3|Overall Study|Disease Progression|16
4695488|NCT02348008|16179697|P2|Overall Study|Disease Progression|5
4695489|NCT02348008|16179698|P1|Overall Study|Disease Progression|1
4695490|NCT02348008|16179696|P3|Overall Study|Adverse Event|3
4695491|NCT02348008|16179697|P2|Overall Study|Adverse Event|3
4695492|NCT02348008|16179698|P1|Overall Study|Adverse Event|2
4695493|NCT02347943|16179714|P3|Overall Study|Study was cancelled|45
4695494|NCT02347943|16179715|P2|Overall Study|Study was cancelled|67
4695495|NCT02347943|16179716|P1|Overall Study|Study was cancelled|140
4695496|NCT02347813|16179726|P2|First Intervention, 24 Weeks|Adverse Event|1
4695497|NCT02347813|16179727|P1|First Intervention, 24 Weeks|Adverse Event|1
4695498|NCT02347813|16179726|P2|First Intervention, 24 Weeks|Withdrawal by Subject|1
4695499|NCT02347813|16179727|P1|First Intervention, 24 Weeks|Withdrawal by Subject|1
4695500|NCT02347787|16179737|P2|9 Month Follow-Up|Withdrawal by Subject|12
4695501|NCT02347787|16179738|P1|9 Month Follow-Up|Withdrawal by Subject|9
4695502|NCT02347787|16179737|P2|9 Month Follow-Up|Lost to Follow-up|59
4695503|NCT02347787|16179738|P1|9 Month Follow-Up|Lost to Follow-up|52
4695504|NCT02347787|16179737|P2|6 Month Follow-Up|Withdrawal by Subject|9
4695505|NCT02347787|16179738|P1|6 Month Follow-Up|Withdrawal by Subject|3
4695506|NCT02347787|16179737|P2|6 Month Follow-Up|Lost to Follow-up|47
4695507|NCT02347787|16179738|P1|6 Month Follow-Up|Lost to Follow-up|63
4695508|NCT02347774|16179800|P3|On Study Treatment|ranomized in error|1
4695509|NCT02347774|16179801|P2|On Study Treatment|ranomized in error|0
4695510|NCT02347774|16179802|P1|On Study Treatment|ranomized in error|0
4695511|NCT02347774|16179800|P3|On Study Treatment|Met Prolonged QT criteria|0
4695512|NCT02347774|16179801|P2|On Study Treatment|Met Prolonged QT criteria|0
4695513|NCT02347774|16179802|P1|On Study Treatment|Met Prolonged QT criteria|1
4695514|NCT02347774|16179800|P3|On Study Treatment|Lost to Follow-up|1
4695515|NCT02347774|16179801|P2|On Study Treatment|Lost to Follow-up|6
4695516|NCT02347774|16179802|P1|On Study Treatment|Lost to Follow-up|2
4695517|NCT02347774|16179800|P3|On Study Treatment|withdrew consent|12
4695518|NCT02347774|16179801|P2|On Study Treatment|withdrew consent|8
4695519|NCT02347774|16179802|P1|On Study Treatment|withdrew consent|9
4695520|NCT02347774|16179800|P3|On Study Treatment|Protocol Violation|1
4695521|NCT02347774|16179801|P2|On Study Treatment|Protocol Violation|0
4695522|NCT02347774|16179802|P1|On Study Treatment|Protocol Violation|0
4695523|NCT02347774|16179800|P3|On Study Treatment|non-complicance with study medication|0
4695524|NCT02347774|16179801|P2|On Study Treatment|non-complicance with study medication|2
4695525|NCT02347774|16179802|P1|On Study Treatment|non-complicance with study medication|0
4695526|NCT02347774|16179800|P3|On Study Treatment|Lack of Efficacy|2
4695527|NCT02347774|16179801|P2|On Study Treatment|Lack of Efficacy|0
4695528|NCT02347774|16179802|P1|On Study Treatment|Lack of Efficacy|3
4695529|NCT02347774|16179800|P3|On Study Treatment|Adverse Event|19
4695530|NCT02347774|16179801|P2|On Study Treatment|Adverse Event|15
4695531|NCT02347774|16179802|P1|On Study Treatment|Adverse Event|9
4695532|NCT02347774|16179800|P3|Study Participation|randomized in error|1
4695533|NCT02347774|16179801|P2|Study Participation|randomized in error|0
4695534|NCT02347774|16179802|P1|Study Participation|randomized in error|0
4695535|NCT02347774|16179800|P3|Study Participation|incarceration|0
4695536|NCT02347774|16179801|P2|Study Participation|incarceration|0
4695537|NCT02347774|16179802|P1|Study Participation|incarceration|1
4695538|NCT02347774|16179800|P3|Study Participation|non-compliance with study drug|0
4695539|NCT02347774|16179801|P2|Study Participation|non-compliance with study drug|1
4695540|NCT02347774|16179802|P1|Study Participation|non-compliance with study drug|0
4695541|NCT02347774|16179800|P3|Study Participation|Met Prolonged QT criteria|0
4695542|NCT02347774|16179801|P2|Study Participation|Met Prolonged QT criteria|0
4695543|NCT02347774|16179802|P1|Study Participation|Met Prolonged QT criteria|1
4695544|NCT02347774|16179800|P3|Study Participation|withdrew consent|1
4695545|NCT02347774|16179801|P2|Study Participation|withdrew consent|1
4695546|NCT02347774|16179802|P1|Study Participation|withdrew consent|1
4695547|NCT02347774|16179800|P3|Study Participation|Adverse Event|6
4695548|NCT02347774|16179801|P2|Study Participation|Adverse Event|4
4695549|NCT02347774|16179802|P1|Study Participation|Adverse Event|1
4695550|NCT02347774|16179800|P3|Study Participation|Withdrawal by Subject|15
4695551|NCT02347774|16179801|P2|Study Participation|Withdrawal by Subject|9
4695552|NCT02347774|16179802|P1|Study Participation|Withdrawal by Subject|8
4695553|NCT02347774|16179800|P3|Study Participation|Lost to Follow-up|2
4695554|NCT02347774|16179801|P2|Study Participation|Lost to Follow-up|6
4695555|NCT02347774|16179802|P1|Study Participation|Lost to Follow-up|3
4695556|NCT02347761|16179858|P3|On Study Treatment|Adverse Event|20
4695557|NCT02347761|16179859|P2|On Study Treatment|Adverse Event|8
4695558|NCT02347761|16179860|P1|On Study Treatment|Adverse Event|10
4695559|NCT02347761|16179858|P3|On Study Treatment|durg not working|1
4695560|NCT02347761|16179859|P2|On Study Treatment|durg not working|1
4695561|NCT02347761|16179860|P1|On Study Treatment|durg not working|0
4695562|NCT02347761|16179858|P3|On Study Treatment|investigator discretion|0
4695563|NCT02347761|16179859|P2|On Study Treatment|investigator discretion|0
4695564|NCT02347761|16179860|P1|On Study Treatment|investigator discretion|2
4695565|NCT02347761|16179858|P3|On Study Treatment|Lost to Follow-up|1
4695566|NCT02347761|16179859|P2|On Study Treatment|Lost to Follow-up|1
4695567|NCT02347761|16179860|P1|On Study Treatment|Lost to Follow-up|2
4695568|NCT02347761|16179858|P3|On Study Treatment|dissastisfaction with device|4
4695569|NCT02347761|16179859|P2|On Study Treatment|dissastisfaction with device|1
4695570|NCT02347761|16179860|P1|On Study Treatment|dissastisfaction with device|2
4695571|NCT02347761|16179858|P3|On Study Treatment|move/travel|5
4695572|NCT02347761|16179859|P2|On Study Treatment|move/travel|6
4695573|NCT02347761|16179860|P1|On Study Treatment|move/travel|2
4695574|NCT02347761|16179858|P3|On Study Treatment|Withdrawal by Subject|5
4695575|NCT02347761|16179859|P2|On Study Treatment|Withdrawal by Subject|3
4695576|NCT02347761|16179860|P1|On Study Treatment|Withdrawal by Subject|7
4695577|NCT02347761|16179858|P3|On Study Treatment|non-compliance with study medication|2
4695578|NCT02347761|16179859|P2|On Study Treatment|non-compliance with study medication|0
4695579|NCT02347761|16179860|P1|On Study Treatment|non-compliance with study medication|0
4695580|NCT02347761|16179858|P3|On Study Treatment|Lack of Efficacy|4
4695581|NCT02347761|16179859|P2|On Study Treatment|Lack of Efficacy|3
4695582|NCT02347761|16179860|P1|On Study Treatment|Lack of Efficacy|2
4695583|NCT02347761|16179858|P3|All Collected|moved/travel|0
4695584|NCT02347761|16179859|P2|All Collected|moved/travel|1
4695585|NCT02347761|16179860|P1|All Collected|moved/travel|0
4695586|NCT02347761|16179858|P3|All Collected|exacerbation of COPD|1
4695587|NCT02347761|16179859|P2|All Collected|exacerbation of COPD|0
4695588|NCT02347761|16179860|P1|All Collected|exacerbation of COPD|0
4695589|NCT02347761|16179858|P3|All Collected|instillation site pain|1
4695590|NCT02347761|16179859|P2|All Collected|instillation site pain|0
4695591|NCT02347761|16179860|P1|All Collected|instillation site pain|0
4695592|NCT02347761|16179858|P3|All Collected|invetigator disretion|0
4695593|NCT02347761|16179859|P2|All Collected|invetigator disretion|0
4695594|NCT02347761|16179860|P1|All Collected|invetigator disretion|2
4695595|NCT02347761|16179858|P3|All Collected|Withdrawal by Subject|22
4695596|NCT02347761|16179859|P2|All Collected|Withdrawal by Subject|11
4695597|NCT02347761|16179860|P1|All Collected|Withdrawal by Subject|11
4695598|NCT02347761|16179858|P3|All Collected|Lost to Follow-up|3
4695599|NCT02347761|16179859|P2|All Collected|Lost to Follow-up|2
4695600|NCT02347761|16179860|P1|All Collected|Lost to Follow-up|3
4695601|NCT02347761|16179858|P3|All Collected|Death|0
4695602|NCT02347761|16179859|P2|All Collected|Death|0
4695603|NCT02347761|16179860|P1|All Collected|Death|1
4695604|NCT02347657|16179921|P2|Overall Study|Other|3
4695605|NCT02347657|16179922|P1|Overall Study|Other|3
4695606|NCT02347657|16179921|P2|Overall Study|Randomized but not treated|0
4695607|NCT02347657|16179922|P1|Overall Study|Randomized but not treated|1
4695608|NCT02347657|16179921|P2|Overall Study|Withdrawal by Subject|7
4695609|NCT02347657|16179922|P1|Overall Study|Withdrawal by Subject|6
4695610|NCT02347657|16179921|P2|Overall Study|Adverse Event|4
4695611|NCT02347657|16179922|P1|Overall Study|Adverse Event|8
4695612|NCT02347657|16179921|P2|Overall Study|Physician Decision|1
4695613|NCT02347657|16179922|P1|Overall Study|Physician Decision|0
4695614|NCT02347332|16180000|P2|Overall Study|Switch Post-Trial program|1
4695615|NCT02347332|16180001|P1|Overall Study|Switch Post-Trial program|0
4695616|NCT02347332|16180000|P2|Overall Study|Protocol requirement|1
4695617|NCT02347332|16180001|P1|Overall Study|Protocol requirement|1
4695618|NCT02347332|16180000|P2|Overall Study|Withdrawal by Subject|14
4695619|NCT02347332|16180001|P1|Overall Study|Withdrawal by Subject|20
4695620|NCT02347332|16180000|P2|Overall Study|Physician Decision|3
4695621|NCT02347332|16180001|P1|Overall Study|Physician Decision|4
4695622|NCT02347332|16180000|P2|Overall Study|Lost to Follow-up|1
4695623|NCT02347332|16180001|P1|Overall Study|Lost to Follow-up|2
4695624|NCT02347332|16180000|P2|Overall Study|Protocol Violation|1
4695625|NCT02347332|16180001|P1|Overall Study|Protocol Violation|1
4695626|NCT02347332|16180000|P2|Overall Study|Death (Unknown, Various reasons)|6
4695627|NCT02347332|16180001|P1|Overall Study|Death (Unknown, Various reasons)|6
4695628|NCT02347332|16180000|P2|Overall Study|Adverse Event|41
4695629|NCT02347332|16180001|P1|Overall Study|Adverse Event|50
4695630|NCT02347332|16180000|P2|Overall Study|Progressive disease|159
4695631|NCT02347332|16180001|P1|Overall Study|Progressive disease|141
4695632|NCT02347332|16180000|P2|Overall Study|Not treated|2
4695633|NCT02347332|16180001|P1|Overall Study|Not treated|5
4695634|NCT02347189|16180015|P1|Overall Study|No primary outcome data available|2
4695635|NCT02347189|16180015|P1|Overall Study|No implant attempted of study device|9
4695636|NCT02347176|16180034|P4|Overall Study|Other|0
4695637|NCT02347176|16180035|P3|Overall Study|Other|2
4695638|NCT02347176|16180036|P2|Overall Study|Other|2
4695639|NCT02347176|16180037|P1|Overall Study|Other|1
4695640|NCT02347176|16180034|P4|Overall Study|Withdrawal by Subject|3
4695641|NCT02347176|16180035|P3|Overall Study|Withdrawal by Subject|5
4695642|NCT02347176|16180036|P2|Overall Study|Withdrawal by Subject|5
4695643|NCT02347176|16180037|P1|Overall Study|Withdrawal by Subject|9
4695644|NCT02347176|16180034|P4|Overall Study|Lost to Follow-up|1
4695645|NCT02347176|16180035|P3|Overall Study|Lost to Follow-up|1
4695646|NCT02347176|16180036|P2|Overall Study|Lost to Follow-up|3
4695647|NCT02347176|16180037|P1|Overall Study|Lost to Follow-up|2
4695648|NCT02347098|16180122|P2|Overall Study|no visit due to illness|1
4695649|NCT02347098|16180123|P1|Overall Study|no visit due to illness|2
4695650|NCT02347098|16180122|P2|Overall Study|Refuse Follow-up Visit|5
4695651|NCT02347098|16180123|P1|Overall Study|Refuse Follow-up Visit|1
4695652|NCT02347098|16180122|P2|Overall Study|Lost to Follow-up|2
4695653|NCT02347098|16180123|P1|Overall Study|Lost to Follow-up|2
4695654|NCT02347098|16180122|P2|Overall Study|Withdrawal by Subject|0
4695655|NCT02347098|16180123|P1|Overall Study|Withdrawal by Subject|1
4695656|NCT02347098|16180122|P2|Overall Study|Death|0
4695657|NCT02347098|16180123|P1|Overall Study|Death|1
4695658|NCT02347085|16180135|P1|Overall Study|Protocol Criteria|2
4695659|NCT02347085|16180135|P1|Overall Study|Lost to Follow-up|1
4695660|NCT02347085|16180135|P1|Overall Study|Withdrawal by Subject|4
4695661|NCT02347085|16180135|P1|Overall Study|Lack of Efficacy|1
4695662|NCT02347085|16180135|P1|Overall Study|Adverse Event|2
4695663|NCT02347072|16180157|P1|Overall Study|Disc due to Protocol-specified Criteria|6
4695664|NCT02347072|16180157|P1|Overall Study|Protocol Violation|1
4695665|NCT02347072|16180157|P1|Overall Study|Lost to Follow-up|2
4695666|NCT02347072|16180157|P1|Overall Study|Physician Decision|1
4695667|NCT02347072|16180157|P1|Overall Study|Withdrawal by Subject|6
4695668|NCT02347072|16180157|P1|Overall Study|Adverse Event|2
4695669|NCT02346877|16180191|P2|Overall Study|Missing|0
4695670|NCT02346877|16180192|P1|Overall Study|Missing|5
4695671|NCT02346877|16180191|P2|Overall Study|Sponsor Decision|0
4695672|NCT02346877|16180192|P1|Overall Study|Sponsor Decision|12
4695673|NCT02346877|16180191|P2|Overall Study|Administrative Decision|0
4695674|NCT02346877|16180192|P1|Overall Study|Administrative Decision|1
4695675|NCT02346877|16180191|P2|Overall Study|Adverse Event|0
4695676|NCT02346877|16180192|P1|Overall Study|Adverse Event|1
4695677|NCT02346721|16180202|P1|Overall Study|Lack of Efficacy|1
4695678|NCT02346721|16180202|P1|Overall Study|Withdrew Consent|3
4695679|NCT02346370|16180241|P3|Overall Study|Physician Decision|0
4695680|NCT02346370|16180242|P2|Overall Study|Physician Decision|1
4695681|NCT02346370|16180243|P1|Overall Study|Physician Decision|0
4695682|NCT02346370|16180241|P3|Overall Study|Radiologic progression|1
4695683|NCT02346370|16180242|P2|Overall Study|Radiologic progression|0
4695684|NCT02346370|16180243|P1|Overall Study|Radiologic progression|0
4695685|NCT02346370|16180241|P3|Overall Study|Sponsor discontinued study|2
4695686|NCT02346370|16180242|P2|Overall Study|Sponsor discontinued study|0
4695687|NCT02346370|16180243|P1|Overall Study|Sponsor discontinued study|5
4695688|NCT02346370|16180241|P3|Overall Study|Death|1
4695689|NCT02346370|16180242|P2|Overall Study|Death|3
4695690|NCT02346370|16180243|P1|Overall Study|Death|1
4695691|NCT02346370|16180241|P3|Overall Study|Withdrawal of consent|0
4695692|NCT02346370|16180242|P2|Overall Study|Withdrawal of consent|0
4695693|NCT02346370|16180243|P1|Overall Study|Withdrawal of consent|1
4695694|NCT02346370|16180241|P3|Overall Study|Not treated|0
4695695|NCT02346370|16180242|P2|Overall Study|Not treated|0
4695696|NCT02346370|16180243|P1|Overall Study|Not treated|1
4695697|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695698|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695699|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695700|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695701|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695702|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1
4695703|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695704|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695705|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695706|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695707|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695708|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695709|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695710|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695711|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695712|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695713|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695714|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695715|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695716|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695717|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695718|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695719|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695720|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0
4695721|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3
4695722|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
4695723|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4
4695724|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695725|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695726|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2
4695727|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695728|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695729|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695730|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695731|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695732|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695733|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695734|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695735|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695736|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695737|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695738|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695739|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695740|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695741|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695742|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695743|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695744|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0
4695745|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4695746|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4695747|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10
4695748|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695749|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4695750|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4
4695751|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695752|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695753|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695754|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695755|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695756|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695757|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695758|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695759|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695760|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695761|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695762|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695763|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695764|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695765|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695766|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695767|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695768|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4695769|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
4695770|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
4695771|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1
4695772|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695773|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3
4695774|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
4695775|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2
4695776|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695777|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695778|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695779|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695780|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695781|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695782|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695783|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695784|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695785|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695786|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695787|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695788|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695789|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695790|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695791|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695792|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0
4695793|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695794|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695795|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1
4695796|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695797|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695798|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695799|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695800|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695801|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695802|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695803|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695804|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695805|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695806|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695807|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695808|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695809|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695810|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695811|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695812|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695813|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695814|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695815|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695816|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0
4695817|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695818|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695819|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
4695820|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695821|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695822|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1
4695823|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695824|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695825|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695826|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695827|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695828|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695829|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695830|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695831|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695832|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695833|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695834|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695835|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695836|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695837|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695838|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695839|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695840|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0
4695841|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|Death|0
4695842|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|Death|0
4695843|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|Death|1
4695844|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|Death|0
4695845|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|Death|1
4695846|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|Death|1
4695847|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|Death|0
4695848|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|Death|0
4695849|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|Death|0
4695850|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|Death|0
4695851|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|Death|0
4695852|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|Death|0
4695853|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|Death|0
4695854|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|Death|0
4695855|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|Death|0
4695856|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|Death|0
4695857|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|Death|0
4695858|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|Death|0
4695859|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|Death|0
4695860|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|Death|0
4695861|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|Death|0
4695862|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|Death|0
4695863|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|Death|0
4695864|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|Death|0
4695865|NCT02346240|16180292|P24|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
4695866|NCT02346240|16180293|P23|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
4695867|NCT02346240|16180294|P22|Open-Label Period (Week 48 to Week 144)|Adverse Event|13
4695868|NCT02346240|16180295|P21|Open-Label Period (Week 48 to Week 144)|Adverse Event|3
4695869|NCT02346240|16180296|P20|Open-Label Period (Week 48 to Week 144)|Adverse Event|2
4695870|NCT02346240|16180297|P19|Open-Label Period (Week 48 to Week 144)|Adverse Event|6
4695871|NCT02346240|16180298|P18|Open-Label Period (Week 48 to Week 144)|Adverse Event|1
4695872|NCT02346240|16180299|P17|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695873|NCT02346240|16180300|P16|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695874|NCT02346240|16180301|P15|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695875|NCT02346240|16180302|P14|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695876|NCT02346240|16180303|P13|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695877|NCT02346240|16180304|P12|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695878|NCT02346240|16180305|P11|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695879|NCT02346240|16180306|P10|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695880|NCT02346240|16180307|P9|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695881|NCT02346240|16180308|P8|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695882|NCT02346240|16180309|P7|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695883|NCT02346240|16180310|P6|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695884|NCT02346240|16180311|P5|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695885|NCT02346240|16180312|P4|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695886|NCT02346240|16180313|P3|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695887|NCT02346240|16180314|P2|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695888|NCT02346240|16180315|P1|Open-Label Period (Week 48 to Week 144)|Adverse Event|0
4695889|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695890|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695891|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695892|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695893|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695894|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695895|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695896|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695897|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695898|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1
4695899|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695900|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695901|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695902|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695903|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695904|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695905|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695906|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695907|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695908|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695909|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695910|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695911|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695912|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0
4695913|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695914|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695915|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695916|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695917|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695918|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695919|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695920|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695921|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695922|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1
4695923|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695924|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695925|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695926|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695927|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695928|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695929|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695930|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695931|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695932|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695933|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695934|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695935|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695936|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0
4695937|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695938|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695939|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695940|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695941|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695942|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695943|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695944|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695945|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695946|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1
4695947|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695948|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695949|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695950|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695951|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695952|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695953|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695954|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695955|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695956|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695957|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695958|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695959|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695960|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0
4695961|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695962|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695963|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695964|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695965|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695966|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695967|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695968|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695969|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695970|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695971|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695972|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695973|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695974|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1
4695975|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695976|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695977|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695978|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695979|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695980|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695981|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695982|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695983|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695984|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0
4695985|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695986|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695987|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695988|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695989|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695990|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695991|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695992|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695993|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695994|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695995|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695996|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695997|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695998|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4695999|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1
4696000|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696001|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696002|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696003|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696004|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696005|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696006|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696007|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696008|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0
4696009|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696010|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696011|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696012|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696013|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696014|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696015|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696016|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696017|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696018|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4696019|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4696020|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696021|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4696022|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696023|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696024|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1
4696025|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696026|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696027|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696028|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696029|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696030|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696031|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696032|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0
4696033|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696034|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696035|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696036|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696037|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696038|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696039|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696040|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696041|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696042|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696043|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696044|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696045|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696046|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696047|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696048|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696049|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696050|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Moved out of state|1
4696051|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696052|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696053|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696054|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696055|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696056|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Moved out of state|0
4696057|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696058|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696059|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696060|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696061|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696062|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696063|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696064|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4
4696065|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8
4696066|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
4696067|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3
4696068|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696069|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696070|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696071|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696072|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696073|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696074|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696075|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696076|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696077|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696078|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696079|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696080|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4696081|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696082|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696083|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696084|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696085|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696086|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696087|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696088|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4696089|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
4696090|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5
4696091|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
4696092|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696093|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2
4696094|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4696095|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696096|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4696097|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4696098|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4696099|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4696100|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696101|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696102|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696103|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696104|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4696105|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696106|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696107|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696108|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696109|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696110|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696111|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696112|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696113|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696114|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
4696115|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696116|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696117|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696118|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696119|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696120|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696121|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696122|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696123|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696124|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696125|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696126|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696127|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696128|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4696129|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696130|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696131|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696132|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696133|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696134|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696135|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696136|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696137|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3
4696138|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696139|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4696140|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696141|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696142|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696143|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696144|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696145|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696146|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696147|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696148|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696149|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696150|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696151|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696152|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4696153|NCT02346240|16180292|P24|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696154|NCT02346240|16180293|P23|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696155|NCT02346240|16180294|P22|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696156|NCT02346240|16180295|P21|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696157|NCT02346240|16180296|P20|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696158|NCT02346240|16180297|P19|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696159|NCT02346240|16180298|P18|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696160|NCT02346240|16180299|P17|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4696161|NCT02346240|16180300|P16|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4696162|NCT02346240|16180301|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
4696163|NCT02346240|16180302|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4696164|NCT02346240|16180303|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696165|NCT02346240|16180304|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696166|NCT02346240|16180305|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696167|NCT02346240|16180306|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696168|NCT02346240|16180307|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4696169|NCT02346240|16180308|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4696170|NCT02346240|16180309|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696171|NCT02346240|16180310|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696172|NCT02346240|16180311|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696173|NCT02346240|16180312|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696174|NCT02346240|16180313|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696175|NCT02346240|16180314|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696176|NCT02346240|16180315|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4696177|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696178|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696179|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696180|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696181|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696182|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696183|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696184|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696185|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696186|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696187|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696188|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696189|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696190|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696191|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696192|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696193|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696194|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696195|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696196|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696197|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696198|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1
4696199|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696200|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0
4696201|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Non-compliance|0
4696202|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Non-compliance|0
4696203|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Non-compliance|0
4696204|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Non-compliance|0
4696205|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Non-compliance|0
4696206|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Non-compliance|0
4696207|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Non-compliance|0
4696208|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Non-compliance|0
4696209|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Non-compliance|0
4696210|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Non-compliance|0
4696211|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Non-compliance|0
4696212|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Non-compliance|0
4696213|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Non-compliance|0
4696214|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Non-compliance|0
4696215|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Non-compliance|0
4696216|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Non-compliance|0
4696217|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Non-compliance|0
4696218|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Non-compliance|0
4696219|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Non-compliance|0
4696220|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Non-compliance|0
4696221|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Non-compliance|1
4696222|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Non-compliance|0
4696223|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Non-compliance|1
4696224|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Non-compliance|0
4696225|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696226|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696227|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696228|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696229|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696230|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696231|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696232|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696233|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696234|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696235|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696236|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696237|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696238|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696239|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696240|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696241|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696242|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696243|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696244|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0
4696245|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
4696246|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3
4696247|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2
4696248|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1
4696249|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696250|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696251|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696252|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696253|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696254|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696255|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696256|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696257|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696258|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696259|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696260|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696261|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696262|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696263|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696264|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696265|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696266|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696267|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696268|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Lost to Follow-up|0
4696269|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Lost to Follow-up|3
4696270|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
4696271|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Lost to Follow-up|2
4696272|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Lost to Follow-up|1
4696273|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696274|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696275|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696276|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696277|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696278|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696279|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696280|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696281|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696282|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696283|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696284|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696285|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696286|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696287|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696288|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696289|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696290|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696291|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696292|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696293|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696294|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696295|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Protocol Violation|1
4696296|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Protocol Violation|0
4696297|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696298|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696299|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696300|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696301|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696302|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696303|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696304|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696305|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696306|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696307|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696308|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696309|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696310|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696311|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696312|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696313|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696314|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696315|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696316|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696317|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696318|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696319|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Lack of Efficacy|1
4696320|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Lack of Efficacy|0
4696321|NCT02346240|16180292|P24|Initial Period (Baseline to Week 16)|Adverse Event|0
4696322|NCT02346240|16180293|P23|Initial Period (Baseline to Week 16)|Adverse Event|0
4696323|NCT02346240|16180294|P22|Initial Period (Baseline to Week 16)|Adverse Event|0
4696324|NCT02346240|16180295|P21|Initial Period (Baseline to Week 16)|Adverse Event|0
4696325|NCT02346240|16180296|P20|Initial Period (Baseline to Week 16)|Adverse Event|0
4696326|NCT02346240|16180297|P19|Initial Period (Baseline to Week 16)|Adverse Event|0
4696327|NCT02346240|16180298|P18|Initial Period (Baseline to Week 16)|Adverse Event|0
4696328|NCT02346240|16180299|P17|Initial Period (Baseline to Week 16)|Adverse Event|0
4696329|NCT02346240|16180300|P16|Initial Period (Baseline to Week 16)|Adverse Event|0
4696330|NCT02346240|16180301|P15|Initial Period (Baseline to Week 16)|Adverse Event|0
4696331|NCT02346240|16180302|P14|Initial Period (Baseline to Week 16)|Adverse Event|0
4696332|NCT02346240|16180303|P13|Initial Period (Baseline to Week 16)|Adverse Event|0
4696333|NCT02346240|16180304|P12|Initial Period (Baseline to Week 16)|Adverse Event|0
4696334|NCT02346240|16180305|P11|Initial Period (Baseline to Week 16)|Adverse Event|0
4696335|NCT02346240|16180306|P10|Initial Period (Baseline to Week 16)|Adverse Event|0
4696336|NCT02346240|16180307|P9|Initial Period (Baseline to Week 16)|Adverse Event|0
4696337|NCT02346240|16180308|P8|Initial Period (Baseline to Week 16)|Adverse Event|0
4696338|NCT02346240|16180309|P7|Initial Period (Baseline to Week 16)|Adverse Event|0
4696339|NCT02346240|16180310|P6|Initial Period (Baseline to Week 16)|Adverse Event|0
4696340|NCT02346240|16180311|P5|Initial Period (Baseline to Week 16)|Adverse Event|0
4696341|NCT02346240|16180312|P4|Initial Period (Baseline to Week 16)|Adverse Event|1
4696427|NCT02345161|16180701|P2|Overall Study|Adverse Event|19
4696342|NCT02346240|16180313|P3|Initial Period (Baseline to Week 16)|Adverse Event|1
4696343|NCT02346240|16180314|P2|Initial Period (Baseline to Week 16)|Adverse Event|4
4696344|NCT02346240|16180315|P1|Initial Period (Baseline to Week 16)|Adverse Event|0
4696345|NCT01835223|16180354|P2|Overall Study|Became Inelligible|0
4696346|NCT01835223|16180355|P1|Overall Study|Became Inelligible|4
4696347|NCT01835223|16180354|P2|Overall Study|Disease progression|1
4696348|NCT01835223|16180355|P1|Overall Study|Disease progression|2
4696349|NCT01835223|16180354|P2|Overall Study|Withdrawal by Subject|0
4696350|NCT01835223|16180355|P1|Overall Study|Withdrawal by Subject|2
4696351|NCT01835223|16180354|P2|Overall Study|Adverse Event|0
4696352|NCT01835223|16180355|P1|Overall Study|Adverse Event|1
4696353|NCT02346136|16180375|P2|Overall Study|Study termination|18
4696354|NCT02346136|16180376|P1|Overall Study|Study termination|14
4696355|NCT02346136|16180375|P2|Overall Study|Death|0
4696356|NCT02346136|16180376|P1|Overall Study|Death|1
4696357|NCT02346136|16180375|P2|Overall Study|Withdrawal by Subject|5
4696358|NCT02346136|16180376|P1|Overall Study|Withdrawal by Subject|7
4696359|NCT02345889|16180412|P4|Overall Study|Cecum not intubated|0
4696360|NCT02345889|16180413|P3|Overall Study|Cecum not intubated|0
4696361|NCT02345889|16180414|P2|Overall Study|Cecum not intubated|0
4696362|NCT02345889|16180415|P1|Overall Study|Cecum not intubated|1
4696363|NCT02345889|16180412|P4|Overall Study|Ulcerative Colitis identified|0
4696364|NCT02345889|16180413|P3|Overall Study|Ulcerative Colitis identified|0
4696365|NCT02345889|16180414|P2|Overall Study|Ulcerative Colitis identified|0
4696366|NCT02345889|16180415|P1|Overall Study|Ulcerative Colitis identified|1
4696367|NCT02345889|16180412|P4|Overall Study|Recognized ineligible post-randomization|1
4696368|NCT02345889|16180413|P3|Overall Study|Recognized ineligible post-randomization|2
4696369|NCT02345889|16180414|P2|Overall Study|Recognized ineligible post-randomization|0
4696370|NCT02345889|16180415|P1|Overall Study|Recognized ineligible post-randomization|1
4696371|NCT02345889|16180412|P4|Overall Study|Polyposis identified during procedure|1
4696372|NCT02345889|16180413|P3|Overall Study|Polyposis identified during procedure|0
4696373|NCT02345889|16180414|P2|Overall Study|Polyposis identified during procedure|1
4696374|NCT02345889|16180415|P1|Overall Study|Polyposis identified during procedure|1
4696375|NCT02345889|16180412|P4|Overall Study|Inadequate Bowel Prep|14
4696376|NCT02345889|16180413|P3|Overall Study|Inadequate Bowel Prep|18
4696377|NCT02345889|16180414|P2|Overall Study|Inadequate Bowel Prep|16
4696378|NCT02345889|16180415|P1|Overall Study|Inadequate Bowel Prep|17
4696379|NCT02345811|16180481|P2|First Intervention|Withdrawal by Subject|1
4696380|NCT02345811|16180482|P1|First Intervention|Withdrawal by Subject|1
4696381|NCT02345512|16180533|P1|Overall Study|Withdrawal by Subject|1
4696382|NCT02345512|16180533|P1|Overall Study|Adverse Event|1
4696383|NCT02345330|16180627|P1|Overall Study|Progressive Disease|2
4696384|NCT02345330|16180627|P1|Overall Study|Death|1
4696385|NCT02345252|16180639|P2|Double-Blind Phase|Randomized but Never Treated|2
4696386|NCT02345252|16180640|P1|Double-Blind Phase|Randomized but Never Treated|0
4696387|NCT02345252|16180639|P2|Double-Blind Phase|Lost to Follow-up|10
4696388|NCT02345252|16180640|P1|Double-Blind Phase|Lost to Follow-up|8
4696389|NCT02345252|16180639|P2|Double-Blind Phase|Withdrew Consent|23
4696390|NCT02345252|16180640|P1|Double-Blind Phase|Withdrew Consent|21
4696391|NCT02345252|16180639|P2|Double-Blind Phase|Protocol Violation|1
4696392|NCT02345252|16180640|P1|Double-Blind Phase|Protocol Violation|2
4696393|NCT02345252|16180639|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
4696394|NCT02345252|16180640|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
4696395|NCT02345252|16180639|P2|Double-Blind Phase|Investigator's Discretion|6
4696396|NCT02345252|16180640|P1|Double-Blind Phase|Investigator's Discretion|4
4696397|NCT02345252|16180639|P2|Double-Blind Phase|Lack of Efficacy|0
4696398|NCT02345252|16180640|P1|Double-Blind Phase|Lack of Efficacy|1
4696399|NCT02345252|16180639|P2|Double-Blind Phase|Death|2
4696400|NCT02345252|16180640|P1|Double-Blind Phase|Death|1
4696401|NCT02345252|16180639|P2|Double-Blind Phase|Adverse Event|3
4696402|NCT02345252|16180640|P1|Double-Blind Phase|Adverse Event|2
4696403|NCT02345226|16180668|P2|Open-Label Extension Phase|Lost to Follow-up|1
4696404|NCT02345226|16180669|P1|Open-Label Extension Phase|Lost to Follow-up|0
4696405|NCT02345226|16180668|P2|Double-Blind Phase|Randomized but Never Treated|4
4696406|NCT02345226|16180669|P1|Double-Blind Phase|Randomized but Never Treated|2
4696407|NCT02345226|16180668|P2|Double-Blind Phase|Lost to Follow-up|16
4696408|NCT02345226|16180669|P1|Double-Blind Phase|Lost to Follow-up|12
4696409|NCT02345226|16180668|P2|Double-Blind Phase|Withdrew Consent|39
4696410|NCT02345226|16180669|P1|Double-Blind Phase|Withdrew Consent|41
4696411|NCT02345226|16180668|P2|Double-Blind Phase|Non-Compliance with Study Drug|2
4696412|NCT02345226|16180669|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
4696413|NCT02345226|16180668|P2|Double-Blind Phase|Investigator's Discretion|3
4696414|NCT02345226|16180669|P1|Double-Blind Phase|Investigator's Discretion|4
4696415|NCT02345226|16180668|P2|Double-Blind Phase|Lack of Efficacy|0
4696416|NCT02345226|16180669|P1|Double-Blind Phase|Lack of Efficacy|1
4696417|NCT02345226|16180668|P2|Double-Blind Phase|Pregnancy|1
4696418|NCT02345226|16180669|P1|Double-Blind Phase|Pregnancy|0
4696419|NCT02345226|16180668|P2|Double-Blind Phase|Death|0
4696420|NCT02345226|16180669|P1|Double-Blind Phase|Death|3
4696421|NCT02345226|16180668|P2|Double-Blind Phase|Adverse Event|6
4696422|NCT02345226|16180669|P1|Double-Blind Phase|Adverse Event|5
4696423|NCT02345161|16180701|P2|Overall Study|Lost to Follow-up|1
4696424|NCT02345161|16180702|P1|Overall Study|Lost to Follow-up|0
4696425|NCT02345161|16180701|P2|Overall Study|Physician Decision|4
4696426|NCT02345161|16180702|P1|Overall Study|Physician Decision|4
4696428|NCT02345161|16180702|P1|Overall Study|Adverse Event|16
4696429|NCT02345161|16180701|P2|Overall Study|Withdrawal by Subject|33
4696430|NCT02345161|16180702|P1|Overall Study|Withdrawal by Subject|25
4696431|NCT02345070|16180807|P3|Overall Study|Other than specified above|7
4696432|NCT02345070|16180808|P2|Overall Study|Other than specified above|3
4696433|NCT02345070|16180809|P1|Overall Study|Other than specified above|6
4696434|NCT02345070|16180807|P3|Overall Study|Poor compliance to protocol|0
4696435|NCT02345070|16180808|P2|Overall Study|Poor compliance to protocol|0
4696436|NCT02345070|16180809|P1|Overall Study|Poor compliance to protocol|2
4696437|NCT02345070|16180807|P3|Overall Study|Adverse Event|16
4696438|NCT02345070|16180808|P2|Overall Study|Adverse Event|8
4696439|NCT02345070|16180809|P1|Overall Study|Adverse Event|12
4696440|NCT01824290|16180842|P2|Overall Study|Investigator Reported Clinical Worsening|1
4696441|NCT01824290|16180843|P1|Overall Study|Investigator Reported Clinical Worsening|1
4696442|NCT01824290|16180842|P2|Overall Study|Parent/Caregiver Decision|1
4696443|NCT01824290|16180843|P1|Overall Study|Parent/Caregiver Decision|1
4696444|NCT01824290|16180842|P2|Overall Study|Entry Criteria Not Met|0
4696445|NCT01824290|16180843|P1|Overall Study|Entry Criteria Not Met|1
4696446|NCT02344745|16180857|P2|Overall Study|Data collection sheets were lost|0
4696447|NCT02344745|16180858|P1|Overall Study|Data collection sheets were lost|2
4696448|NCT02344576|16180887|P4|6-Month Follow-Up|Lost to Follow-up|6
4696449|NCT02344576|16180888|P3|6-Month Follow-Up|Lost to Follow-up|13
4696450|NCT02344576|16180889|P2|6-Month Follow-Up|Lost to Follow-up|5
4696451|NCT02344576|16180890|P1|6-Month Follow-Up|Lost to Follow-up|4
4696452|NCT02344576|16180887|P4|6-Month Follow-Up|Withdrawal by Subject|2
4696453|NCT02344576|16180888|P3|6-Month Follow-Up|Withdrawal by Subject|1
4696454|NCT02344576|16180889|P2|6-Month Follow-Up|Withdrawal by Subject|0
4696455|NCT02344576|16180890|P1|6-Month Follow-Up|Withdrawal by Subject|1
4696456|NCT02344576|16180887|P4|6-Month Follow-Up|Death|0
4696457|NCT02344576|16180888|P3|6-Month Follow-Up|Death|0
4696458|NCT02344576|16180889|P2|6-Month Follow-Up|Death|14
4696459|NCT02344576|16180890|P1|6-Month Follow-Up|Death|14
4696460|NCT02344576|16180887|P4|1-Month Follow-Up|Lost to Follow-up|3
4696461|NCT02344576|16180888|P3|1-Month Follow-Up|Lost to Follow-up|11
4696462|NCT02344576|16180889|P2|1-Month Follow-Up|Lost to Follow-up|5
4696463|NCT02344576|16180890|P1|1-Month Follow-Up|Lost to Follow-up|2
4696464|NCT02344576|16180887|P4|1-Month Follow-Up|Withdrawal by Subject|10
4696465|NCT02344576|16180888|P3|1-Month Follow-Up|Withdrawal by Subject|8
4696466|NCT02344576|16180889|P2|1-Month Follow-Up|Withdrawal by Subject|14
4696467|NCT02344576|16180890|P1|1-Month Follow-Up|Withdrawal by Subject|3
4696468|NCT02344576|16180887|P4|1-Month Follow-Up|Death|0
4696469|NCT02344576|16180888|P3|1-Month Follow-Up|Death|0
4696470|NCT02344576|16180889|P2|1-Month Follow-Up|Death|8
4696471|NCT02344576|16180890|P1|1-Month Follow-Up|Death|13
4696472|NCT02344576|16180887|P4|Enrollment|Agreed to Medical Record Review Only|0
4696473|NCT02344576|16180888|P3|Enrollment|Agreed to Medical Record Review Only|0
4696474|NCT02344576|16180889|P2|Enrollment|Agreed to Medical Record Review Only|8
4696475|NCT02344576|16180890|P1|Enrollment|Agreed to Medical Record Review Only|7
4696476|NCT02344342|16180953|P4|Overall Study|Industry partner dropped out|10
4696477|NCT02344342|16180954|P3|Overall Study|Industry partner dropped out|14
4696478|NCT02344342|16180955|P2|Overall Study|Industry partner dropped out|9
4696479|NCT02344342|16180956|P1|Overall Study|Industry partner dropped out|11
4696480|NCT02344173|16181022|P1|12-month Visit|Lost to Follow-up|58
4696481|NCT02344173|16181022|P1|12-month Visit|Withdrawal by Subject|30
4696482|NCT02344173|16181022|P1|12-month Visit|Death|8
4696483|NCT02344173|16181022|P1|Procedure|Ablation Procedure Not Performed|7
4696484|NCT02344004|16181030|P2|Overall Study|Protocol Violation|0
4696485|NCT02344004|16181031|P1|Overall Study|Protocol Violation|1
4696486|NCT02344004|16181030|P2|Overall Study|Other Not Specified|0
4696487|NCT02344004|16181031|P1|Overall Study|Other Not Specified|12
4696488|NCT02344004|16181030|P2|Overall Study|Rescue Medication|0
4696489|NCT02344004|16181031|P1|Overall Study|Rescue Medication|2
4696490|NCT02344004|16181030|P2|Overall Study|Withdrawal by Subject|5
4696491|NCT02344004|16181031|P1|Overall Study|Withdrawal by Subject|22
4696492|NCT02344004|16181030|P2|Overall Study|Physician Decision|1
4696493|NCT02344004|16181031|P1|Overall Study|Physician Decision|4
4696494|NCT02344004|16181030|P2|Overall Study|Death|7
4696495|NCT02344004|16181031|P1|Overall Study|Death|9
4696496|NCT02344004|16181030|P2|Overall Study|Adverse Event|1
4696497|NCT02344004|16181031|P1|Overall Study|Adverse Event|11
4696498|NCT02343939|16181058|P9|Overall Study|Never Treated With ENTO|0
4696499|NCT02343939|16181059|P8|Overall Study|Never Treated With ENTO|2
4696500|NCT02343939|16181060|P7|Overall Study|Never Treated With ENTO|1
4696501|NCT02343939|16181061|P6|Overall Study|Never Treated With ENTO|0
4696502|NCT02343939|16181062|P5|Overall Study|Never Treated With ENTO|0
4696503|NCT02343939|16181063|P4|Overall Study|Never Treated With ENTO|0
4696504|NCT02343939|16181064|P3|Overall Study|Never Treated With ENTO|0
4696505|NCT02343939|16181065|P2|Overall Study|Never Treated With ENTO|0
4696506|NCT02343939|16181066|P1|Overall Study|Never Treated With ENTO|0
4696507|NCT02343939|16181058|P9|Overall Study|Adverse Event|0
4696508|NCT02343939|16181059|P8|Overall Study|Adverse Event|0
4696509|NCT02343939|16181060|P7|Overall Study|Adverse Event|0
4696510|NCT02343939|16181061|P6|Overall Study|Adverse Event|1
4696511|NCT02343939|16181062|P5|Overall Study|Adverse Event|0
4696512|NCT02343939|16181063|P4|Overall Study|Adverse Event|0
4696513|NCT02343939|16181064|P3|Overall Study|Adverse Event|0
4696514|NCT02343939|16181065|P2|Overall Study|Adverse Event|0
4696515|NCT02343939|16181066|P1|Overall Study|Adverse Event|0
4696516|NCT02343939|16181058|P9|Overall Study|Investigator's discretion|0
4696517|NCT02343939|16181059|P8|Overall Study|Investigator's discretion|0
4696518|NCT02343939|16181060|P7|Overall Study|Investigator's discretion|1
4696519|NCT02343939|16181061|P6|Overall Study|Investigator's discretion|0
4696520|NCT02343939|16181062|P5|Overall Study|Investigator's discretion|0
4696521|NCT02343939|16181063|P4|Overall Study|Investigator's discretion|1
4696522|NCT02343939|16181064|P3|Overall Study|Investigator's discretion|0
4696523|NCT02343939|16181065|P2|Overall Study|Investigator's discretion|0
4696524|NCT02343939|16181066|P1|Overall Study|Investigator's discretion|0
4696525|NCT02343939|16181058|P9|Overall Study|Treatment failure|0
4696526|NCT02343939|16181059|P8|Overall Study|Treatment failure|1
4696527|NCT02343939|16181060|P7|Overall Study|Treatment failure|2
4696528|NCT02343939|16181061|P6|Overall Study|Treatment failure|0
4696529|NCT02343939|16181062|P5|Overall Study|Treatment failure|0
4696530|NCT02343939|16181063|P4|Overall Study|Treatment failure|0
4696531|NCT02343939|16181064|P3|Overall Study|Treatment failure|0
4696532|NCT02343939|16181065|P2|Overall Study|Treatment failure|0
4696533|NCT02343939|16181066|P1|Overall Study|Treatment failure|0
4696534|NCT02343939|16181058|P9|Overall Study|Withdrew consent|6
4696535|NCT02343939|16181059|P8|Overall Study|Withdrew consent|8
4696536|NCT02343939|16181060|P7|Overall Study|Withdrew consent|0
4696537|NCT02343939|16181061|P6|Overall Study|Withdrew consent|0
4696538|NCT02343939|16181062|P5|Overall Study|Withdrew consent|2
4696539|NCT02343939|16181063|P4|Overall Study|Withdrew consent|2
4696540|NCT02343939|16181064|P3|Overall Study|Withdrew consent|1
4696541|NCT02343939|16181065|P2|Overall Study|Withdrew consent|6
4696542|NCT02343939|16181066|P1|Overall Study|Withdrew consent|3
4696543|NCT02343939|16181058|P9|Overall Study|Study terminated by sponsor|0
4696544|NCT02343939|16181059|P8|Overall Study|Study terminated by sponsor|4
4696545|NCT02343939|16181060|P7|Overall Study|Study terminated by sponsor|3
4696546|NCT02343939|16181061|P6|Overall Study|Study terminated by sponsor|5
4696547|NCT02343939|16181062|P5|Overall Study|Study terminated by sponsor|1
4696548|NCT02343939|16181063|P4|Overall Study|Study terminated by sponsor|1
4696549|NCT02343939|16181064|P3|Overall Study|Study terminated by sponsor|0
4696550|NCT02343939|16181065|P2|Overall Study|Study terminated by sponsor|27
4696551|NCT02343939|16181066|P1|Overall Study|Study terminated by sponsor|0
4696552|NCT02343939|16181058|P9|Overall Study|Death|1
4696553|NCT02343939|16181059|P8|Overall Study|Death|22
4696554|NCT02343939|16181060|P7|Overall Study|Death|8
4696555|NCT02343939|16181061|P6|Overall Study|Death|11
4696556|NCT02343939|16181062|P5|Overall Study|Death|5
4696557|NCT02343939|16181063|P4|Overall Study|Death|2
4696558|NCT02343939|16181064|P3|Overall Study|Death|4
4696559|NCT02343939|16181065|P2|Overall Study|Death|15
4696560|NCT02343939|16181066|P1|Overall Study|Death|0
4696561|NCT01818492|16181176|P1|Overall Study|Additional therapy when not allowed PP|4
4696562|NCT01818492|16181176|P1|Overall Study|Withdrawal by Subject|1
4696563|NCT01818492|16181176|P1|Overall Study|Death|3
4696564|NCT01818492|16181176|P1|Overall Study|Adverse Event|2
4696565|NCT02343458|16181223|P4|Overall Study|Protocol Specified Criteria|8
4696566|NCT02343458|16181224|P3|Overall Study|Protocol Specified Criteria|14
4696567|NCT02343458|16181225|P2|Overall Study|Protocol Specified Criteria|13
4696568|NCT02343458|16181226|P1|Overall Study|Protocol Specified Criteria|17
4696569|NCT02343458|16181223|P4|Overall Study|Protocol Violation|2
4696570|NCT02343458|16181224|P3|Overall Study|Protocol Violation|2
4696571|NCT02343458|16181225|P2|Overall Study|Protocol Violation|5
4696572|NCT02343458|16181226|P1|Overall Study|Protocol Violation|2
4696573|NCT02343458|16181223|P4|Overall Study|Lost to Follow-up|1
4696574|NCT02343458|16181224|P3|Overall Study|Lost to Follow-up|3
4696575|NCT02343458|16181225|P2|Overall Study|Lost to Follow-up|5
4696576|NCT02343458|16181226|P1|Overall Study|Lost to Follow-up|5
4696577|NCT02343458|16181223|P4|Overall Study|Physician Decision|2
4696578|NCT02343458|16181224|P3|Overall Study|Physician Decision|2
4696579|NCT02343458|16181225|P2|Overall Study|Physician Decision|4
4696580|NCT02343458|16181226|P1|Overall Study|Physician Decision|1
4696581|NCT02343458|16181223|P4|Overall Study|Withdrawal by Subject|14
4696582|NCT02343458|16181224|P3|Overall Study|Withdrawal by Subject|23
4696583|NCT02343458|16181225|P2|Overall Study|Withdrawal by Subject|17
4696584|NCT02343458|16181226|P1|Overall Study|Withdrawal by Subject|18
4696585|NCT02343458|16181223|P4|Overall Study|Lack of Efficacy|8
4696586|NCT02343458|16181224|P3|Overall Study|Lack of Efficacy|4
4696587|NCT02343458|16181225|P2|Overall Study|Lack of Efficacy|8
4696588|NCT02343458|16181226|P1|Overall Study|Lack of Efficacy|3
4696589|NCT02343458|16181223|P4|Overall Study|Adverse Event|3
4696590|NCT02343458|16181224|P3|Overall Study|Adverse Event|15
4696591|NCT02343458|16181225|P2|Overall Study|Adverse Event|14
4696592|NCT02343458|16181226|P1|Overall Study|Adverse Event|15
4696593|NCT02343406|16181305|P5|Overall Study|Other, not specified|0
4696594|NCT02343406|16181306|P4|Overall Study|Other, not specified|4
4696595|NCT02343406|16181307|P3|Overall Study|Other, not specified|1
4696596|NCT02343406|16181308|P2|Overall Study|Other, not specified|1
4696597|NCT02343406|16181309|P1|Overall Study|Other, not specified|2
4696598|NCT02343406|16181305|P5|Overall Study|Other primary malignancy|0
4696599|NCT02343406|16181306|P4|Overall Study|Other primary malignancy|0
4696600|NCT02343406|16181307|P3|Overall Study|Other primary malignancy|0
4696601|NCT02343406|16181308|P2|Overall Study|Other primary malignancy|1
4696602|NCT02343406|16181309|P1|Overall Study|Other primary malignancy|0
4696603|NCT02343406|16181305|P5|Overall Study|Start of a new anti-cancer treatment|0
4696604|NCT02343406|16181306|P4|Overall Study|Start of a new anti-cancer treatment|1
4696605|NCT02343406|16181307|P3|Overall Study|Start of a new anti-cancer treatment|0
4696606|NCT02343406|16181308|P2|Overall Study|Start of a new anti-cancer treatment|1
4696607|NCT02343406|16181309|P1|Overall Study|Start of a new anti-cancer treatment|0
4696608|NCT02343406|16181305|P5|Overall Study|Death|0
4696609|NCT02343406|16181306|P4|Overall Study|Death|0
4696610|NCT02343406|16181307|P3|Overall Study|Death|0
4696611|NCT02343406|16181308|P2|Overall Study|Death|1
4696612|NCT02343406|16181309|P1|Overall Study|Death|2
4696613|NCT02343406|16181305|P5|Overall Study|Withdrawal by Subject|0
4696614|NCT02343406|16181306|P4|Overall Study|Withdrawal by Subject|3
4696615|NCT02343406|16181307|P3|Overall Study|Withdrawal by Subject|8
4696616|NCT02343406|16181308|P2|Overall Study|Withdrawal by Subject|4
4696617|NCT02343406|16181309|P1|Overall Study|Withdrawal by Subject|6
4696618|NCT02343406|16181305|P5|Overall Study|Adverse Event|0
4696619|NCT02343406|16181306|P4|Overall Study|Adverse Event|3
4696620|NCT02343406|16181307|P3|Overall Study|Adverse Event|6
4696621|NCT02343406|16181308|P2|Overall Study|Adverse Event|8
4696622|NCT02343406|16181309|P1|Overall Study|Adverse Event|6
4696623|NCT02343406|16181305|P5|Overall Study|Progressive disease|5
4696624|NCT02343406|16181306|P4|Overall Study|Progressive disease|15
4696625|NCT02343406|16181307|P3|Overall Study|Progressive disease|43
4696626|NCT02343406|16181308|P2|Overall Study|Progressive disease|70
4696627|NCT02343406|16181309|P1|Overall Study|Progressive disease|72
4696628|NCT02343263|16181377|P3|Overall Study|Physician Decision|1
4696629|NCT02343263|16181378|P2|Overall Study|Physician Decision|3
4696630|NCT02343263|16181379|P1|Overall Study|Physician Decision|5
4696631|NCT02343159|16181408|P3|Overall Study|Enrollment Error|0
4696632|NCT02343159|16181409|P2|Overall Study|Enrollment Error|0
4696633|NCT02343159|16181410|P1|Overall Study|Enrollment Error|1
4696634|NCT02343159|16181408|P3|Overall Study|Sponsor Decision|0
4696635|NCT02343159|16181409|P2|Overall Study|Sponsor Decision|1
4696636|NCT02343159|16181410|P1|Overall Study|Sponsor Decision|0
4696637|NCT02343159|16181408|P3|Overall Study|Adverse Event|2
4696638|NCT02343159|16181409|P2|Overall Study|Adverse Event|4
4696639|NCT02343159|16181410|P1|Overall Study|Adverse Event|4
4696640|NCT02343159|16181408|P3|Overall Study|Lost to Follow-up|2
4696641|NCT02343159|16181409|P2|Overall Study|Lost to Follow-up|2
4696642|NCT02343159|16181410|P1|Overall Study|Lost to Follow-up|0
4696643|NCT02343159|16181408|P3|Overall Study|Withdrawal by Subject|2
4696644|NCT02343159|16181409|P2|Overall Study|Withdrawal by Subject|0
4696645|NCT02343159|16181410|P1|Overall Study|Withdrawal by Subject|3
4696646|NCT02343159|16181408|P3|Overall Study|Physician Decision|1
4696647|NCT02343159|16181409|P2|Overall Study|Physician Decision|0
4696648|NCT02343159|16181410|P1|Overall Study|Physician Decision|2
4696649|NCT02343159|16181408|P3|Overall Study|Early Study Termination|23
4696650|NCT02343159|16181409|P2|Overall Study|Early Study Termination|19
4696651|NCT02343159|16181410|P1|Overall Study|Early Study Termination|16
4696652|NCT02343003|16181454|P2|Overall Study|terminated by sponsor|0
4696653|NCT02343003|16181455|P1|Overall Study|terminated by sponsor|2
4696654|NCT02343003|16181454|P2|Overall Study|exclusion criteria met|1
4696655|NCT02343003|16181455|P1|Overall Study|exclusion criteria met|1
4696656|NCT02343003|16181454|P2|Overall Study|Death|1
4696657|NCT02343003|16181455|P1|Overall Study|Death|0
4696658|NCT02343003|16181454|P2|Overall Study|Protocol Violation|0
4696659|NCT02343003|16181455|P1|Overall Study|Protocol Violation|1
4696660|NCT02343003|16181454|P2|Overall Study|Lost to Follow-up|1
4696661|NCT02343003|16181455|P1|Overall Study|Lost to Follow-up|5
4696662|NCT02343003|16181454|P2|Overall Study|Withdrawal by Subject|4
4696663|NCT02343003|16181455|P1|Overall Study|Withdrawal by Subject|9
4696664|NCT02342886|16181476|P5|Overall Study|Protocol Violation|0
4696665|NCT02342886|16181477|P4|Overall Study|Protocol Violation|2
4696666|NCT02342886|16181478|P3|Overall Study|Protocol Violation|0
4696667|NCT02342886|16181479|P2|Overall Study|Protocol Violation|0
4696668|NCT02342886|16181480|P1|Overall Study|Protocol Violation|0
4696669|NCT02342886|16181476|P5|Overall Study|Late exclusion: pyrazinamide resistance|0
4696670|NCT02342886|16181477|P4|Overall Study|Late exclusion: pyrazinamide resistance|0
4696671|NCT02342886|16181478|P3|Overall Study|Late exclusion: pyrazinamide resistance|1
4696672|NCT02342886|16181479|P2|Overall Study|Late exclusion: pyrazinamide resistance|0
4696673|NCT02342886|16181480|P1|Overall Study|Late exclusion: pyrazinamide resistance|0
4696674|NCT02342886|16181476|P5|Overall Study|Pregnancy|0
4696675|NCT02342886|16181477|P4|Overall Study|Pregnancy|0
4696676|NCT02342886|16181478|P3|Overall Study|Pregnancy|2
4696677|NCT02342886|16181479|P2|Overall Study|Pregnancy|0
4696678|NCT02342886|16181480|P1|Overall Study|Pregnancy|0
4696679|NCT02342886|16181476|P5|Overall Study|Investigator/sponsor decision|1
4696680|NCT02342886|16181477|P4|Overall Study|Investigator/sponsor decision|3
4696681|NCT02342886|16181478|P3|Overall Study|Investigator/sponsor decision|0
4696682|NCT02342886|16181479|P2|Overall Study|Investigator/sponsor decision|2
4696683|NCT02342886|16181480|P1|Overall Study|Investigator/sponsor decision|0
4696684|NCT02342886|16181476|P5|Overall Study|Withdrawal by Subject|0
4696685|NCT02342886|16181477|P4|Overall Study|Withdrawal by Subject|1
4696686|NCT02342886|16181478|P3|Overall Study|Withdrawal by Subject|0
4696687|NCT02342886|16181479|P2|Overall Study|Withdrawal by Subject|1
4696688|NCT02342886|16181480|P1|Overall Study|Withdrawal by Subject|0
4696689|NCT02342886|16181476|P5|Overall Study|Death|1
4696690|NCT02342886|16181477|P4|Overall Study|Death|0
4696691|NCT02342886|16181478|P3|Overall Study|Death|1
4696692|NCT02342886|16181479|P2|Overall Study|Death|2
4696693|NCT02342886|16181480|P1|Overall Study|Death|1
4696694|NCT02342886|16181476|P5|Overall Study|Lost to Follow-up|0
4696695|NCT02342886|16181477|P4|Overall Study|Lost to Follow-up|0
4696696|NCT02342886|16181478|P3|Overall Study|Lost to Follow-up|0
4696697|NCT02342886|16181479|P2|Overall Study|Lost to Follow-up|0
4696698|NCT02342886|16181480|P1|Overall Study|Lost to Follow-up|1
4696699|NCT02342886|16181476|P5|Overall Study|Adverse event/specific toxicity|1
4696700|NCT02342886|16181477|P4|Overall Study|Adverse event/specific toxicity|2
4696701|NCT02342886|16181478|P3|Overall Study|Adverse event/specific toxicity|11
4696702|NCT02342886|16181479|P2|Overall Study|Adverse event/specific toxicity|3
4696703|NCT02342886|16181480|P1|Overall Study|Adverse event/specific toxicity|4
4696704|NCT02342886|16181476|P5|Overall Study|Late exclusion: rifampicin resistance|0
4696705|NCT02342886|16181477|P4|Overall Study|Late exclusion: rifampicin resistance|0
4696706|NCT02342886|16181478|P3|Overall Study|Late exclusion: rifampicin resistance|0
4696707|NCT02342886|16181479|P2|Overall Study|Late exclusion: rifampicin resistance|0
4696708|NCT02342886|16181480|P1|Overall Study|Late exclusion: rifampicin resistance|1
4696709|NCT02342886|16181476|P5|Overall Study|Treatment non-compliance|0
4696710|NCT02342886|16181477|P4|Overall Study|Treatment non-compliance|1
4696711|NCT02342886|16181478|P3|Overall Study|Treatment non-compliance|0
4696712|NCT02342886|16181479|P2|Overall Study|Treatment non-compliance|0
4696713|NCT02342886|16181480|P1|Overall Study|Treatment non-compliance|1
4696714|NCT02342743|16181497|P1|Treatment Period|Change in prophylactic medication|1
4696715|NCT02342743|16181497|P1|Treatment Period|Lost to Follow-up|8
4696716|NCT02342743|16181497|P1|Treatment Period|Withdrawal by Subject|2
4696717|NCT02342743|16181497|P1|Baseline Period|Screening failure regarding baseline|7
4696718|NCT02342743|16181497|P1|Baseline Period|Change in prophylactic medication|3
4696719|NCT02342743|16181497|P1|Baseline Period|Lost to Follow-up|2
4696720|NCT02342743|16181497|P1|Baseline Period|Withdrawal by Subject|3
4696721|NCT02342704|16181510|P2|Overall Study|Adverse Event|3
4696722|NCT02342704|16181511|P1|Overall Study|Adverse Event|1
4696723|NCT02342704|16181510|P2|Overall Study|Lost to Follow-up|1
4696724|NCT02342704|16181511|P1|Overall Study|Lost to Follow-up|2
4696725|NCT02342704|16181510|P2|Overall Study|Withdrawal by Subject|0
4696726|NCT02342704|16181511|P1|Overall Study|Withdrawal by Subject|1
4696727|NCT02342704|16181510|P2|Overall Study|Other|1
4696728|NCT02342704|16181511|P1|Overall Study|Other|0
4696729|NCT02342704|16181510|P2|Overall Study|Sponsor Termination|43
4696730|NCT02342704|16181511|P1|Overall Study|Sponsor Termination|49
4696731|NCT02342704|16181510|P2|Overall Study|Physician Decision|3
4696732|NCT02342704|16181511|P1|Overall Study|Physician Decision|0
4696733|NCT02342678|16181539|P2|Overall Study|Illness/medical reason|1
4696734|NCT02342678|16181540|P1|Overall Study|Illness/medical reason|1
4696735|NCT02342678|16181539|P2|Overall Study|Family illness/emergency|1
4696736|NCT02342678|16181540|P1|Overall Study|Family illness/emergency|0
4696737|NCT02342678|16181539|P2|Overall Study|Too busy to complete study|2
4696738|NCT02342678|16181540|P1|Overall Study|Too busy to complete study|0
4696739|NCT02342678|16181539|P2|Overall Study|Lost to Follow-up|1
4696740|NCT02342678|16181540|P1|Overall Study|Lost to Follow-up|0
4696741|NCT02342548|16181571|P3|Overall Study|Other|1
4696742|NCT02342548|16181572|P2|Overall Study|Other|1
4696743|NCT02342548|16181573|P1|Overall Study|Other|1
4696744|NCT02342548|16181571|P3|Overall Study|Withdrawal by Subject|4
4696745|NCT02342548|16181572|P2|Overall Study|Withdrawal by Subject|3
4696746|NCT02342548|16181573|P1|Overall Study|Withdrawal by Subject|1
4696747|NCT02342548|16181571|P3|Overall Study|Protocol Violation|0
4696748|NCT02342548|16181572|P2|Overall Study|Protocol Violation|1
4696749|NCT02342548|16181573|P1|Overall Study|Protocol Violation|0
4696750|NCT02342548|16181571|P3|Overall Study|Study terminated by sponsor|25
4696751|NCT02342548|16181572|P2|Overall Study|Study terminated by sponsor|39
4696752|NCT02342548|16181573|P1|Overall Study|Study terminated by sponsor|20
4696753|NCT02342548|16181571|P3|Overall Study|Lost to Follow-up|0
4696754|NCT02342548|16181572|P2|Overall Study|Lost to Follow-up|1
4696755|NCT02342548|16181573|P1|Overall Study|Lost to Follow-up|0
4696756|NCT02342548|16181571|P3|Overall Study|Adverse Event|13
4696757|NCT02342548|16181572|P2|Overall Study|Adverse Event|17
4696758|NCT02342548|16181573|P1|Overall Study|Adverse Event|12
4696759|NCT02342418|16181617|P2|Overall Study|Adverse Event|1
4696760|NCT02342418|16181618|P1|Overall Study|Adverse Event|0
4696761|NCT02342288|16181797|P2|Overall Study|coordinator not available|2
4696762|NCT02342288|16181798|P1|Overall Study|coordinator not available|0
4696763|NCT02342288|16181797|P2|Overall Study|subject cannot tolerate numbing drops|1
4696764|NCT02342288|16181798|P1|Overall Study|subject cannot tolerate numbing drops|0
4696765|NCT02342288|16181797|P2|Overall Study|coordinator contaminated with blood|1
4696766|NCT02342288|16181798|P1|Overall Study|coordinator contaminated with blood|0
4696767|NCT02342288|16181797|P2|Overall Study|Withdrawal by Subject|0
4696768|NCT02342288|16181798|P1|Overall Study|Withdrawal by Subject|1
4696769|NCT02342288|16181797|P2|Overall Study|anesthesia leak in system|0
4696770|NCT02342288|16181798|P1|Overall Study|anesthesia leak in system|1
4696771|NCT02342288|16181797|P2|Overall Study|no protocol anesthesiologist available|2
4696772|NCT02342288|16181798|P1|Overall Study|no protocol anesthesiologist available|3
4696773|NCT02342223|16181804|P1|Overall Study|Lost to Follow-up|1
4696774|NCT02342171|16181824|P2|Overall Study|Missing age data|1
4696775|NCT02342171|16181825|P1|Overall Study|Missing age data|0
4696776|NCT02342171|16181824|P2|Overall Study|Unknown outcome|1
4696777|NCT02342171|16181825|P1|Overall Study|Unknown outcome|0
4696778|NCT02342171|16181824|P2|Overall Study|Missing cycle treshold value|0
4696779|NCT02342171|16181825|P1|Overall Study|Missing cycle treshold value|1
4696780|NCT02342171|16181824|P2|Overall Study|Received favipiravir|0
4696781|NCT02342171|16181825|P1|Overall Study|Received favipiravir|10
4696782|NCT02342171|16181824|P2|Overall Study|Death|87
4696783|NCT02342171|16181825|P1|Overall Study|Death|4
4696784|NCT02341482|16182091|P1|Overall Study|Adverse Event|1
4696785|NCT02341456|16182120|P3|Overall Study|Physician Decision|0
4696786|NCT02341456|16182121|P2|Overall Study|Physician Decision|0
4696787|NCT02341456|16182122|P1|Overall Study|Physician Decision|1
4696788|NCT02341456|16182120|P3|Overall Study|Moved to local access programme.|1
4696789|NCT02341456|16182121|P2|Overall Study|Moved to local access programme.|1
4696790|NCT02341456|16182122|P1|Overall Study|Moved to local access programme.|0
4696791|NCT02341456|16182120|P3|Overall Study|Withdrawal by Subject|1
4696792|NCT02341456|16182121|P2|Overall Study|Withdrawal by Subject|1
4696793|NCT02341456|16182122|P1|Overall Study|Withdrawal by Subject|0
4696794|NCT02341456|16182120|P3|Overall Study|Death|1
4696795|NCT02341456|16182121|P2|Overall Study|Death|1
4696796|NCT02341456|16182122|P1|Overall Study|Death|1
4696797|NCT02341456|16182120|P3|Overall Study|Disease progression|1
4696798|NCT02341456|16182121|P2|Overall Study|Disease progression|3
4696799|NCT02341456|16182122|P1|Overall Study|Disease progression|2
4696800|NCT02341417|16182247|P3|Overall Study|Death|1
4696801|NCT02341417|16182248|P2|Overall Study|Death|0
4696802|NCT02341417|16182249|P1|Overall Study|Death|0
4696803|NCT02341417|16182247|P3|Overall Study|Decision by sponsor|0
4696804|NCT02341417|16182248|P2|Overall Study|Decision by sponsor|0
4696805|NCT02341417|16182249|P1|Overall Study|Decision by sponsor|2
4696806|NCT02341417|16182247|P3|Overall Study|Withdrawal by Subject|0
4696807|NCT02341417|16182248|P2|Overall Study|Withdrawal by Subject|2
4696808|NCT02341417|16182249|P1|Overall Study|Withdrawal by Subject|0
4696809|NCT02340975|16182314|P6|Overall Study|Other|6
4696810|NCT02340975|16182315|P5|Overall Study|Other|0
4696811|NCT02340975|16182316|P4|Overall Study|Other|2
4696812|NCT02340975|16182317|P3|Overall Study|Other|0
4696813|NCT02340975|16182318|P2|Overall Study|Other|4
4696814|NCT02340975|16182319|P1|Overall Study|Other|0
4696815|NCT02340975|16182314|P6|Overall Study|Withdrawal by Subject|0
4696816|NCT02340975|16182315|P5|Overall Study|Withdrawal by Subject|2
4696817|NCT02340975|16182316|P4|Overall Study|Withdrawal by Subject|3
4696818|NCT02340975|16182317|P3|Overall Study|Withdrawal by Subject|3
4696819|NCT02340975|16182318|P2|Overall Study|Withdrawal by Subject|0
4696820|NCT02340975|16182319|P1|Overall Study|Withdrawal by Subject|0
4696821|NCT02340975|16182314|P6|Overall Study|Lost to Follow-up|0
4696822|NCT02340975|16182315|P5|Overall Study|Lost to Follow-up|2
4696823|NCT02340975|16182316|P4|Overall Study|Lost to Follow-up|0
4696824|NCT02340975|16182317|P3|Overall Study|Lost to Follow-up|0
4696825|NCT02340975|16182318|P2|Overall Study|Lost to Follow-up|0
4696826|NCT02340975|16182319|P1|Overall Study|Lost to Follow-up|0
4696827|NCT02340975|16182314|P6|Overall Study|Death|13
4696828|NCT02340975|16182315|P5|Overall Study|Death|21
4696829|NCT02340975|16182316|P4|Overall Study|Death|7
4696830|NCT02340975|16182317|P3|Overall Study|Death|21
4696831|NCT02340975|16182318|P2|Overall Study|Death|23
4696832|NCT02340975|16182319|P1|Overall Study|Death|6
4696833|NCT02340962|16182433|P2|Overall Study|Lost to Follow-up|0
4696834|NCT02340962|16182434|P1|Overall Study|Lost to Follow-up|1
4696835|NCT02340819|16182454|P1|Overall Study|Discontinued with other reason|1
4696836|NCT02340819|16182454|P1|Overall Study|Withdrawal by Subject|2
4696837|NCT02340819|16182454|P1|Overall Study|Adverse Event|1
4696838|NCT02340806|16182483|P2|Overall Study|re-dose < 90 min of CSE|3
4696839|NCT02340806|16182484|P1|Overall Study|re-dose < 90 min of CSE|1
4696840|NCT02340806|16182483|P2|Overall Study|history of chronic pain medication|0
4696841|NCT02340806|16182484|P1|Overall Study|history of chronic pain medication|1
4696842|NCT02340806|16182483|P2|Overall Study|epidural catheter replaced|1
4696843|NCT02340806|16182484|P1|Overall Study|epidural catheter replaced|2
4696844|NCT02340806|16182483|P2|Overall Study|Protocol Violation|0
4696845|NCT02340806|16182484|P1|Overall Study|Protocol Violation|2
4696846|NCT02340780|16182510|P1|Overall Study|Ineligible|1
4696847|NCT02340663|16182578|P2|Overall Study|Withdrawal by Subject|1
4696848|NCT02340663|16182579|P1|Overall Study|Withdrawal by Subject|3
4696849|NCT02340663|16182578|P2|Overall Study|Protocol Violation|0
4696850|NCT02340663|16182579|P1|Overall Study|Protocol Violation|1
4696851|NCT02340663|16182578|P2|Overall Study|Lost to Follow-up|0
4696852|NCT02340663|16182579|P1|Overall Study|Lost to Follow-up|1
4696853|NCT02340520|16182635|P1|Overall Study|Withdrawal by Subject|1
4696854|NCT02340520|16182635|P1|Overall Study|Patient did not take drug as specified|1
4696855|NCT02340520|16182635|P1|Overall Study|Lost to Follow-up|1
4696856|NCT02340221|16182687|P2|Overall Study|Continued on study|290
4696857|NCT02340221|16182688|P1|Overall Study|Continued on study|140
4696858|NCT02340221|16182687|P2|Overall Study|Reason Not Specified|1
4696859|NCT02340221|16182688|P1|Overall Study|Reason Not Specified|0
4696860|NCT02340221|16182687|P2|Overall Study|Lost to Follow-up|3
4696861|NCT02340221|16182688|P1|Overall Study|Lost to Follow-up|2
4696862|NCT02340221|16182687|P2|Overall Study|Withdrawal by Participant|22
4696863|NCT02340221|16182688|P1|Overall Study|Withdrawal by Participant|14
4696864|NCT02340221|16182687|P2|Overall Study|Death|101
4696865|NCT02340221|16182688|P1|Overall Study|Death|58
4696866|NCT02340078|16182722|P1|Overall Study|Protocol Violation|1
4696867|NCT01802632|16182733|P6|Overall Study|Other (not specified)|1
4696868|NCT01802632|16182734|P5|Overall Study|Other (not specified)|0
4696869|NCT01802632|16182735|P4|Overall Study|Other (not specified)|1
4696870|NCT01802632|16182736|P3|Overall Study|Other (not specified)|7
4696871|NCT01802632|16182737|P2|Overall Study|Other (not specified)|0
4696872|NCT01802632|16182738|P1|Overall Study|Other (not specified)|0
4696873|NCT01802632|16182733|P6|Overall Study|Ongoing Study at Data Cut-off|22
4696874|NCT01802632|16182734|P5|Overall Study|Ongoing Study at Data Cut-off|6
4696875|NCT01802632|16182735|P4|Overall Study|Ongoing Study at Data Cut-off|50
4696876|NCT01802632|16182736|P3|Overall Study|Ongoing Study at Data Cut-off|115
4696877|NCT01802632|16182737|P2|Overall Study|Ongoing Study at Data Cut-off|16
4696878|NCT01802632|16182738|P1|Overall Study|Ongoing Study at Data Cut-off|168
4696879|NCT01802632|16182733|P6|Overall Study|Objective Disease Progression|4
4696880|NCT01802632|16182734|P5|Overall Study|Objective Disease Progression|4
4696881|NCT01802632|16182735|P4|Overall Study|Objective Disease Progression|6
4696882|NCT01802632|16182736|P3|Overall Study|Objective Disease Progression|104
4696883|NCT01802632|16182737|P2|Overall Study|Objective Disease Progression|12
4696884|NCT01802632|16182738|P1|Overall Study|Objective Disease Progression|1
4696885|NCT01802632|16182733|P6|Overall Study|Withdrawal by Subject|1
4696886|NCT01802632|16182734|P5|Overall Study|Withdrawal by Subject|0
4696887|NCT01802632|16182735|P4|Overall Study|Withdrawal by Subject|3
4696888|NCT01802632|16182736|P3|Overall Study|Withdrawal by Subject|7
4696889|NCT01802632|16182737|P2|Overall Study|Withdrawal by Subject|2
4696890|NCT01802632|16182738|P1|Overall Study|Withdrawal by Subject|4
4696891|NCT01802632|16182733|P6|Overall Study|Death|0
4696892|NCT01802632|16182734|P5|Overall Study|Death|2
4696893|NCT01802632|16182735|P4|Overall Study|Death|0
4696894|NCT01802632|16182736|P3|Overall Study|Death|38
4696895|NCT01802632|16182737|P2|Overall Study|Death|1
4696896|NCT01802632|16182738|P1|Overall Study|Death|28
4696897|NCT02340000|16182754|P2|Time Period 2|Lost to Follow-up|8
4696898|NCT02340000|16182755|P1|Time Period 2|Lost to Follow-up|10
4696899|NCT02340000|16182754|P2|Time Period 2|Withdrawal by Subject|7
4696900|NCT02340000|16182755|P1|Time Period 2|Withdrawal by Subject|9
4696901|NCT02340000|16182754|P2|Time Period 1|Lost to Follow-up|7
4696902|NCT02340000|16182755|P1|Time Period 1|Lost to Follow-up|6
4696903|NCT02340000|16182754|P2|Time Period 1|Withdrawal by Subject|8
4696904|NCT02340000|16182755|P1|Time Period 1|Withdrawal by Subject|6
4696905|NCT02339909|16182785|P3|Overall Study|Became ineligible after randomisation|71
4696906|NCT02339909|16182786|P2|Overall Study|Became ineligible after randomisation|63
4696907|NCT02339909|16182787|P1|Overall Study|Became ineligible after randomisation|89
4696908|NCT02339584|16182825|P2|Overall Study|Withdrawal by Subject|4
4696909|NCT02339584|16182826|P1|Overall Study|Withdrawal by Subject|2
4696910|NCT02339584|16182825|P2|Overall Study|Protocol Violation|1
4696911|NCT02339584|16182826|P1|Overall Study|Protocol Violation|1
4696912|NCT02339584|16182825|P2|Overall Study|Physician Decision|2
4696913|NCT02339584|16182826|P1|Overall Study|Physician Decision|1
4696914|NCT02339584|16182825|P2|Overall Study|Lack of Efficacy|1
4696915|NCT02339584|16182826|P1|Overall Study|Lack of Efficacy|0
4696916|NCT02339584|16182825|P2|Overall Study|Adverse Event|7
4696917|NCT02339584|16182826|P1|Overall Study|Adverse Event|11
4696918|NCT02339506|16182846|P2|Washout (Period 2)|Withdrawal by Subject|0
4696919|NCT02339506|16182847|P1|Washout (Period 2)|Withdrawal by Subject|2
4696920|NCT02339506|16182846|P2|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1
4696921|NCT02339506|16182847|P1|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0
4696922|NCT02339285|16182876|P3|Overall Study|Protocol Deviation|0
4696923|NCT02339285|16182877|P2|Overall Study|Protocol Deviation|1
4696924|NCT02339285|16182878|P1|Overall Study|Protocol Deviation|0
4696925|NCT02339285|16182876|P3|Overall Study|Lost to Follow-up|1
4696926|NCT02339285|16182877|P2|Overall Study|Lost to Follow-up|1
4696927|NCT02339285|16182878|P1|Overall Study|Lost to Follow-up|1
4696928|NCT02339285|16182876|P3|Overall Study|Withdrawal by Subject|1
4696929|NCT02339285|16182877|P2|Overall Study|Withdrawal by Subject|1
4696930|NCT02339285|16182878|P1|Overall Study|Withdrawal by Subject|0
4696931|NCT02339155|16182924|P2|Overall Study|Withdrawal by Subject|4
4696932|NCT02339155|16182925|P1|Overall Study|Withdrawal by Subject|4
4696933|NCT02339155|16182924|P2|Overall Study|Physician Decision|1
4696934|NCT02339155|16182925|P1|Overall Study|Physician Decision|2
4696935|NCT02339155|16182924|P2|Overall Study|Lost to Follow-up|9
4696936|NCT02339155|16182925|P1|Overall Study|Lost to Follow-up|8
4696937|NCT02339155|16182924|P2|Overall Study|Death|1
4696938|NCT02339155|16182925|P1|Overall Study|Death|1
4696939|NCT02339155|16182924|P2|Overall Study|Adverse Event|6
4696940|NCT02339155|16182925|P1|Overall Study|Adverse Event|0
4696941|NCT02338882|16183131|P2|Overall Study|Lost to Follow-up|3
4696942|NCT02338882|16183132|P1|Overall Study|Lost to Follow-up|6
4696943|NCT02338882|16183131|P2|Overall Study|Death|0
4696944|NCT02338882|16183132|P1|Overall Study|Death|1
4696945|NCT02338843|16183170|P2|Overall Study|Discontinued prior to randomizat|0
4696946|NCT02338843|16183171|P1|Overall Study|Discontinued prior to randomizat|1
4696947|NCT02338843|16183170|P2|Overall Study|Subject Recovered|2
4696948|NCT02338843|16183171|P1|Overall Study|Subject Recovered|0
4696949|NCT02338843|16183170|P2|Overall Study|Withdrawal by Subject|2
4696950|NCT02338843|16183171|P1|Overall Study|Withdrawal by Subject|0
4696951|NCT02338843|16183170|P2|Overall Study|Physician Decision|0
4696952|NCT02338843|16183171|P1|Overall Study|Physician Decision|1
4696953|NCT02338843|16183170|P2|Overall Study|Death|53
4696954|NCT02338843|16183171|P1|Overall Study|Death|40
4696955|NCT02338843|16183170|P2|Overall Study|Adverse Event|1
4696956|NCT02338843|16183171|P1|Overall Study|Adverse Event|2
4696957|NCT02338492|16183199|P1|Overall Study|Reason not captured above|6
4696958|NCT02338492|16183199|P1|Overall Study|Lost to Follow-up|4
4696959|NCT02338492|16183199|P1|Overall Study|Adverse Event|3
4696960|NCT02338492|16183199|P1|Overall Study|Death|32
4696961|NCT02338362|16183215|P2|Overall Study|Withdrawal by Subject|1
4696962|NCT02338362|16183216|P1|Overall Study|Withdrawal by Subject|1
4696963|NCT02338193|16183246|P3|Overall Study|intolerant of side effects|0
4696964|NCT02338193|16183247|P2|Overall Study|intolerant of side effects|0
4696965|NCT02338193|16183248|P1|Overall Study|intolerant of side effects|1
4696966|NCT02338193|16183246|P3|Overall Study|moved out of state|0
4696967|NCT02338193|16183247|P2|Overall Study|moved out of state|1
4696968|NCT02338193|16183248|P1|Overall Study|moved out of state|0
4696969|NCT02338193|16183246|P3|Overall Study|Noncompliant with visits|7
4696970|NCT02338193|16183247|P2|Overall Study|Noncompliant with visits|2
4696971|NCT02338193|16183248|P1|Overall Study|Noncompliant with visits|2
4696972|NCT02338193|16183246|P3|Overall Study|Pregnancy|1
4696973|NCT02338193|16183247|P2|Overall Study|Pregnancy|1
4696974|NCT02338193|16183248|P1|Overall Study|Pregnancy|0
4696975|NCT02338193|16183246|P3|Overall Study|Withdrawal by Subject|2
4696976|NCT02338193|16183247|P2|Overall Study|Withdrawal by Subject|0
4696977|NCT02338193|16183248|P1|Overall Study|Withdrawal by Subject|0
4696978|NCT02338154|16183301|P1|Overall Study|Missing Exit Reason on Exit Form|1
4696979|NCT02338154|16183301|P1|Overall Study|Patients Without Exit Form|47
4696980|NCT02338154|16183301|P1|Overall Study|Other Reason|3
4696981|NCT02338154|16183301|P1|Overall Study|Lost to Follow-up|8
4696982|NCT02338154|16183301|P1|Overall Study|Withdrawal by Subject or by Investigator|10
4696983|NCT02338154|16183301|P1|Overall Study|Valve Explant|11
4696984|NCT02338154|16183301|P1|Overall Study|Valve Implant Failure|17
4696985|NCT02338154|16183301|P1|Overall Study|Death|46
4696986|NCT02337946|16183425|P3|Protocol Treatment 2 Period|Reason not specified|4
4696987|NCT02337946|16183426|P2|Protocol Treatment 2 Period|Reason not specified|4
4696988|NCT02337946|16183427|P1|Protocol Treatment 2 Period|Reason not specified|0
4696989|NCT02337946|16183425|P3|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7
4696990|NCT02337946|16183426|P2|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5
4696991|NCT02337946|16183427|P1|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0
4696992|NCT02337946|16183425|P3|Protocol Treatment 2 Period|Death During Protocol Treatment|0
4696993|NCT02337946|16183426|P2|Protocol Treatment 2 Period|Death During Protocol Treatment|1
4696994|NCT02337946|16183427|P1|Protocol Treatment 2 Period|Death During Protocol Treatment|0
4696995|NCT02337946|16183425|P3|Protocol Treatment 2 Period|Lack of Efficacy|29
4696996|NCT02337946|16183426|P2|Protocol Treatment 2 Period|Lack of Efficacy|29
4696997|NCT02337946|16183427|P1|Protocol Treatment 2 Period|Lack of Efficacy|0
4696998|NCT02337946|16183425|P3|Protocol Treatment 2 Period|Voluntary Withdrawal|1
4696999|NCT02337946|16183426|P2|Protocol Treatment 2 Period|Voluntary Withdrawal|3
4697000|NCT02337946|16183427|P1|Protocol Treatment 2 Period|Voluntary Withdrawal|0
4697001|NCT02337946|16183425|P3|Protocol Treatment 2 Period|Adverse Event|9
4697002|NCT02337946|16183426|P2|Protocol Treatment 2 Period|Adverse Event|9
4697003|NCT02337946|16183427|P1|Protocol Treatment 2 Period|Adverse Event|0
4697004|NCT02337946|16183425|P3|In-between Period|Without Informed Consent|0
4697005|NCT02337946|16183426|P2|In-between Period|Without Informed Consent|0
4697006|NCT02337946|16183427|P1|In-between Period|Without Informed Consent|1
4697007|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Reason not specified|0
4697008|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Reason not specified|0
4697009|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Reason not specified|8
4697010|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
4697011|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0
4697012|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1
4697013|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
4697014|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0
4697015|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9
4697016|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Death During Protocol Treatment|0
4697017|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Death During Protocol Treatment|0
4697018|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Death During Protocol Treatment|3
4697019|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Lack of Efficacy|0
4697020|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Lack of Efficacy|0
4697021|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Lack of Efficacy|15
4697022|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Voluntary Withdrawal|0
4697023|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Voluntary Withdrawal|0
4697024|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Voluntary Withdrawal|6
4697025|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Major Protocol Deviation|0
4697026|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Major Protocol Deviation|0
4697027|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Major Protocol Deviation|1
4697028|NCT02337946|16183425|P3|Protocol Treatment 1 Period|Adverse Event|0
4697029|NCT02337946|16183426|P2|Protocol Treatment 1 Period|Adverse Event|0
4697030|NCT02337946|16183427|P1|Protocol Treatment 1 Period|Adverse Event|7
4697031|NCT02337907|16183488|P6|Overall Study|Adverse Event|0
4697032|NCT02337907|16183489|P5|Overall Study|Adverse Event|4
4697033|NCT02337907|16183490|P4|Overall Study|Adverse Event|1
4697034|NCT02337907|16183491|P3|Overall Study|Adverse Event|1
4697035|NCT02337907|16183492|P2|Overall Study|Adverse Event|1
4697036|NCT02337907|16183493|P1|Overall Study|Adverse Event|1
4697037|NCT02337907|16183488|P6|Overall Study|Lost to Follow-up|1
4697038|NCT02337907|16183489|P5|Overall Study|Lost to Follow-up|0
4697039|NCT02337907|16183490|P4|Overall Study|Lost to Follow-up|0
4697040|NCT02337907|16183491|P3|Overall Study|Lost to Follow-up|0
4697041|NCT02337907|16183492|P2|Overall Study|Lost to Follow-up|0
4697042|NCT02337907|16183493|P1|Overall Study|Lost to Follow-up|0
4697043|NCT02337907|16183488|P6|Overall Study|Withdrawal by Subject|0
4697044|NCT02337907|16183489|P5|Overall Study|Withdrawal by Subject|5
4697045|NCT02337907|16183490|P4|Overall Study|Withdrawal by Subject|2
4697046|NCT02337907|16183491|P3|Overall Study|Withdrawal by Subject|0
4697047|NCT02337907|16183492|P2|Overall Study|Withdrawal by Subject|3
4697048|NCT02337907|16183493|P1|Overall Study|Withdrawal by Subject|2
4697049|NCT02337907|16183488|P6|Overall Study|Other than listed|0
4697050|NCT02337907|16183489|P5|Overall Study|Other than listed|1
4697051|NCT02337907|16183490|P4|Overall Study|Other than listed|1
4697052|NCT02337907|16183491|P3|Overall Study|Other than listed|0
4697053|NCT02337907|16183492|P2|Overall Study|Other than listed|0
4697054|NCT02337907|16183493|P1|Overall Study|Other than listed|1
4697055|NCT02337764|16183528|P1|Overall Study|Lack of Efficacy|2
4697056|NCT02337764|16183528|P1|Overall Study|Voluntary Withdrawal|12
4697057|NCT02337764|16183528|P1|Overall Study|Pretreatment Event/Adverse Event|46
4697058|NCT02337751|16183541|P2|Overall Study|Investigator's Judgement|0
4697059|NCT02337751|16183542|P1|Overall Study|Investigator's Judgement|1
4697060|NCT02337751|16183541|P2|Overall Study|Lack of Efficacy|5
4697061|NCT02337751|16183542|P1|Overall Study|Lack of Efficacy|2
4697062|NCT02337751|16183541|P2|Overall Study|Voluntary Withdrawal|8
4697063|NCT02337751|16183542|P1|Overall Study|Voluntary Withdrawal|6
4697064|NCT02337751|16183541|P2|Overall Study|Pretreatment Event/Adverse Event|3
4697065|NCT02337751|16183542|P1|Overall Study|Pretreatment Event/Adverse Event|2
4697066|NCT02337738|16183561|P3|Overall Study|Investigator's Judgment|3
4697067|NCT02337738|16183562|P2|Overall Study|Investigator's Judgment|1
4697068|NCT02337738|16183563|P1|Overall Study|Investigator's Judgment|1
4697069|NCT02337738|16183561|P3|Overall Study|Lack of Efficacy|0
4697070|NCT02337738|16183562|P2|Overall Study|Lack of Efficacy|4
4697071|NCT02337738|16183563|P1|Overall Study|Lack of Efficacy|2
4697072|NCT02337738|16183561|P3|Overall Study|Voluntary Withdrawal|2
4697073|NCT02337738|16183562|P2|Overall Study|Voluntary Withdrawal|5
4697074|NCT02337738|16183563|P1|Overall Study|Voluntary Withdrawal|10
4697075|NCT02337738|16183561|P3|Overall Study|Major Protocol Deviation (in-Treatment)|0
4697076|NCT02337738|16183562|P2|Overall Study|Major Protocol Deviation (in-Treatment)|1
4697077|NCT02337738|16183563|P1|Overall Study|Major Protocol Deviation (in-Treatment)|0
4697078|NCT02337738|16183561|P3|Overall Study|Pretreatment Event/Adverse Event|21
4697079|NCT02337738|16183562|P2|Overall Study|Pretreatment Event/Adverse Event|18
4697080|NCT02337738|16183563|P1|Overall Study|Pretreatment Event/Adverse Event|9
4697081|NCT02337738|16183561|P3|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
4697082|NCT02337738|16183562|P2|Overall Study|Major Protocol Deviation (Pre-Treatment)|1
4697083|NCT02337738|16183563|P1|Overall Study|Major Protocol Deviation (Pre-Treatment)|0
4697084|NCT02337725|16183603|P2|Overall Study|Lack of Efficacy|0
4697085|NCT02337725|16183604|P1|Overall Study|Lack of Efficacy|4
4697086|NCT02337725|16183603|P2|Overall Study|Voluntary Withdrawal|3
4697087|NCT02337725|16183604|P1|Overall Study|Voluntary Withdrawal|14
4697088|NCT02337725|16183603|P2|Overall Study|Major Protocol Deviation|1
4697089|NCT02337725|16183604|P1|Overall Study|Major Protocol Deviation|0
4697090|NCT02337725|16183603|P2|Overall Study|Pretreatment Event/AE in Treatment|3
4697091|NCT02337725|16183604|P1|Overall Study|Pretreatment Event/AE in Treatment|8
4697092|NCT02337725|16183603|P2|Overall Study|Pretreatment Event/AE before Treatment|1
4697093|NCT02337725|16183604|P1|Overall Study|Pretreatment Event/AE before Treatment|0
4697094|NCT02337491|16183628|P2|Overall Study|On Treatment|0
4697095|NCT02337491|16183629|P1|Overall Study|On Treatment|2
4697096|NCT02337491|16183628|P2|Overall Study|Progressive Disease|28
4697097|NCT02337491|16183629|P1|Overall Study|Progressive Disease|44
4697098|NCT02337491|16183628|P2|Overall Study|Withdrawal by Subject|0
4697099|NCT02337491|16183629|P1|Overall Study|Withdrawal by Subject|3
4697100|NCT02337491|16183628|P2|Overall Study|Adverse Event|1
4697101|NCT02337491|16183629|P1|Overall Study|Adverse Event|0
4697102|NCT02337491|16183628|P2|Overall Study|Death|1
4697103|NCT02337491|16183629|P1|Overall Study|Death|1
4697104|NCT02337478|16183643|P1|Overall Study|Lack of Efficacy|5
4697105|NCT02337387|16183653|P4|Overall Study|Sponsor Decision to Terminate Study|3
4697106|NCT02337387|16183654|P3|Overall Study|Sponsor Decision to Terminate Study|3
4697107|NCT02337387|16183655|P2|Overall Study|Sponsor Decision to Terminate Study|7
4697108|NCT02337387|16183656|P1|Overall Study|Sponsor Decision to Terminate Study|14
4697109|NCT02337387|16183653|P4|Overall Study|Adverse Event|0
4697110|NCT02337387|16183654|P3|Overall Study|Adverse Event|0
4697111|NCT02337387|16183655|P2|Overall Study|Adverse Event|1
4697112|NCT02337387|16183656|P1|Overall Study|Adverse Event|0
4697113|NCT02337361|16183674|P2|6-month Follow-up|Lost to Follow-up|4
4697114|NCT02337361|16183675|P1|6-month Follow-up|Lost to Follow-up|2
4697115|NCT02337361|16183674|P2|3-month Follow-up|Lost to Follow-up|14
4697116|NCT02337361|16183675|P1|3-month Follow-up|Lost to Follow-up|19
4697117|NCT02336815|16183738|P2|Overall Study|Other|5
4697118|NCT02336815|16183739|P1|Overall Study|Other|1
4697119|NCT02336815|16183738|P2|Overall Study|Lost to Follow-up|3
4697120|NCT02336815|16183739|P1|Overall Study|Lost to Follow-up|1
4697121|NCT02336815|16183738|P2|Overall Study|Withdrawal by Subject|2
4697122|NCT02336815|16183739|P1|Overall Study|Withdrawal by Subject|3
4697123|NCT02336815|16183738|P2|Overall Study|Physician Decision|4
4697124|NCT02336815|16183739|P1|Overall Study|Physician Decision|11
4697125|NCT02336815|16183738|P2|Overall Study|Adverse Event|39
4697126|NCT02336815|16183739|P1|Overall Study|Adverse Event|18
4697127|NCT02336815|16183738|P2|Overall Study|Disease Progression|70
4697128|NCT02336815|16183739|P1|Overall Study|Disease Progression|45
4697129|NCT02336607|16183778|P4|Overall Study|Withdrawal by Subject|20
4697130|NCT02336607|16183779|P3|Overall Study|Withdrawal by Subject|0
4697131|NCT02336607|16183780|P2|Overall Study|Withdrawal by Subject|2
4697132|NCT02336607|16183781|P1|Overall Study|Withdrawal by Subject|0
4697133|NCT02336607|16183778|P4|Overall Study|Adverse Event|26
4697134|NCT02336607|16183779|P3|Overall Study|Adverse Event|2
4697135|NCT02336607|16183780|P2|Overall Study|Adverse Event|2
4697136|NCT02336607|16183781|P1|Overall Study|Adverse Event|0
4697137|NCT02336607|16183778|P4|Overall Study|Protocol Violation|3
4697138|NCT02336607|16183779|P3|Overall Study|Protocol Violation|1
4697139|NCT02336607|16183780|P2|Overall Study|Protocol Violation|1
4697140|NCT02336607|16183781|P1|Overall Study|Protocol Violation|0
4697141|NCT02336607|16183778|P4|Overall Study|Lost to Follow-up|21
4697142|NCT02336607|16183779|P3|Overall Study|Lost to Follow-up|0
4697143|NCT02336607|16183780|P2|Overall Study|Lost to Follow-up|1
4697144|NCT02336607|16183781|P1|Overall Study|Lost to Follow-up|2
4697145|NCT02336607|16183778|P4|Overall Study|Lack of Efficacy|2
4697146|NCT02336607|16183779|P3|Overall Study|Lack of Efficacy|0
4697147|NCT02336607|16183780|P2|Overall Study|Lack of Efficacy|0
4697148|NCT02336607|16183781|P1|Overall Study|Lack of Efficacy|1
4697149|NCT02336607|16183778|P4|Overall Study|Physician Decision|15
4697150|NCT02336607|16183779|P3|Overall Study|Physician Decision|3
4697151|NCT02336607|16183780|P2|Overall Study|Physician Decision|4
4697152|NCT02336607|16183781|P1|Overall Study|Physician Decision|1
4697153|NCT02336555|16183884|P2|Treatment Period 2 (28 Days)|Adverse Event|1
4697154|NCT02336555|16183885|P1|Treatment Period 2 (28 Days)|Adverse Event|0
4697155|NCT02336555|16183884|P2|Treatment Period 1 (28 Days)|Physician Decision|0
4697156|NCT02336555|16183885|P1|Treatment Period 1 (28 Days)|Physician Decision|2
4697157|NCT02336555|16183884|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4697158|NCT02336555|16183885|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4697159|NCT02336451|16183898|P5|Overall Study|Patient/guardian decision|1
4697160|NCT02336451|16183899|P4|Overall Study|Patient/guardian decision|2
4697161|NCT02336451|16183900|P3|Overall Study|Patient/guardian decision|0
4697162|NCT02336451|16183901|P2|Overall Study|Patient/guardian decision|4
4697163|NCT02336451|16183902|P1|Overall Study|Patient/guardian decision|2
4697164|NCT02336451|16183898|P5|Overall Study|Protocol Violation|0
4697165|NCT02336451|16183899|P4|Overall Study|Protocol Violation|0
4697166|NCT02336451|16183900|P3|Overall Study|Protocol Violation|0
4697167|NCT02336451|16183901|P2|Overall Study|Protocol Violation|0
4697168|NCT02336451|16183902|P1|Overall Study|Protocol Violation|1
4697169|NCT02336451|16183898|P5|Overall Study|Progressive disease|4
4697170|NCT02336451|16183899|P4|Overall Study|Progressive disease|14
4697171|NCT02336451|16183900|P3|Overall Study|Progressive disease|2
4697172|NCT02336451|16183901|P2|Overall Study|Progressive disease|26
4697173|NCT02336451|16183902|P1|Overall Study|Progressive disease|23
4697174|NCT02336451|16183898|P5|Overall Study|Physician Decision|3
4697175|NCT02336451|16183899|P4|Overall Study|Physician Decision|16
4697176|NCT02336451|16183900|P3|Overall Study|Physician Decision|7
4697177|NCT02336451|16183901|P2|Overall Study|Physician Decision|6
4697178|NCT02336451|16183902|P1|Overall Study|Physician Decision|9
4697179|NCT02336451|16183898|P5|Overall Study|Death|6
4697180|NCT02336451|16183899|P4|Overall Study|Death|6
4697181|NCT02336451|16183900|P3|Overall Study|Death|3
4697182|NCT02336451|16183901|P2|Overall Study|Death|2
4697183|NCT02336451|16183902|P1|Overall Study|Death|6
4697184|NCT02336451|16183898|P5|Overall Study|Adverse Event|4
4697185|NCT02336451|16183899|P4|Overall Study|Adverse Event|6
4697186|NCT02336451|16183900|P3|Overall Study|Adverse Event|0
4697187|NCT02336451|16183901|P2|Overall Study|Adverse Event|2
4697188|NCT02336451|16183902|P1|Overall Study|Adverse Event|1
4697189|NCT02336425|16184059|P4|Overall Study|Study terminated.|3
4697190|NCT02336425|16184060|P3|Overall Study|Study terminated.|3
4697191|NCT02336425|16184061|P2|Overall Study|Study terminated.|2
4697192|NCT02336425|16184062|P1|Overall Study|Study terminated.|2
4697193|NCT02336373|16184112|P1|Overall Study|Physician Decision|14
4697194|NCT02336373|16184112|P1|Overall Study|Protocol closed early|4
4697195|NCT02336282|16184131|P1|Overall Study|Not enough time to complete sessions|2
4697196|NCT02336282|16184131|P1|Overall Study|Lost to Follow-up|1
4697197|NCT02336282|16184131|P1|Overall Study|Uncomfortable with technology|1
4697198|NCT02336282|16184131|P1|Overall Study|Unrelated illness|1
4697199|NCT02336178|16184155|P1|Overall Study|Other|1
4697200|NCT02336178|16184155|P1|Overall Study|Withdrawal by Subject|1
4697201|NCT02336178|16184155|P1|Overall Study|Protocol Violation|1
4697202|NCT02336178|16184155|P1|Overall Study|Lost to Follow-up|1
4697203|NCT02336165|16184246|P5|Overall Study|Other|0
4697204|NCT02336165|16184247|P4|Overall Study|Other|1
4697205|NCT02336165|16184248|P3|Overall Study|Other|0
4697206|NCT02336165|16184249|P2|Overall Study|Other|0
4697207|NCT02336165|16184250|P1|Overall Study|Other|1
4697208|NCT02336165|16184246|P5|Overall Study|Non-compliance|0
4697209|NCT02336165|16184247|P4|Overall Study|Non-compliance|1
4697210|NCT02336165|16184248|P3|Overall Study|Non-compliance|0
4697211|NCT02336165|16184249|P2|Overall Study|Non-compliance|0
4697212|NCT02336165|16184250|P1|Overall Study|Non-compliance|1
4697213|NCT02336165|16184246|P5|Overall Study|Progressive disease|19
4697214|NCT02336165|16184247|P4|Overall Study|Progressive disease|24
4697215|NCT02336165|16184248|P3|Overall Study|Progressive disease|27
4697216|NCT02336165|16184249|P2|Overall Study|Progressive disease|22
4697217|NCT02336165|16184250|P1|Overall Study|Progressive disease|23
4697218|NCT02336165|16184246|P5|Overall Study|Adverse Event|1
4697219|NCT02336165|16184247|P4|Overall Study|Adverse Event|4
4697220|NCT02336165|16184248|P3|Overall Study|Adverse Event|2
4697221|NCT02336165|16184249|P2|Overall Study|Adverse Event|1
4697222|NCT02336165|16184250|P1|Overall Study|Adverse Event|4
4697223|NCT02336165|16184246|P5|Overall Study|Withdrawal by Subject|1
4697224|NCT02336165|16184247|P4|Overall Study|Withdrawal by Subject|0
4697225|NCT02336165|16184248|P3|Overall Study|Withdrawal by Subject|1
4697226|NCT02336165|16184249|P2|Overall Study|Withdrawal by Subject|0
4697227|NCT02336165|16184250|P1|Overall Study|Withdrawal by Subject|0
4697228|NCT02336165|16184246|P5|Overall Study|Physician Decision|0
4697229|NCT02336165|16184247|P4|Overall Study|Physician Decision|1
4697230|NCT02336165|16184248|P3|Overall Study|Physician Decision|1
4697231|NCT02336165|16184249|P2|Overall Study|Physician Decision|2
4697232|NCT02336165|16184250|P1|Overall Study|Physician Decision|2
4697233|NCT02336165|16184246|P5|Overall Study|Death|1
4697234|NCT02336165|16184247|P4|Overall Study|Death|0
4697235|NCT02336165|16184248|P3|Overall Study|Death|0
4697236|NCT02336165|16184249|P2|Overall Study|Death|0
4697237|NCT02336165|16184250|P1|Overall Study|Death|3
4697238|NCT02336074|16184284|P2|Overall Study|Adverse Event|2
4697239|NCT02336074|16184285|P1|Overall Study|Adverse Event|0
4697240|NCT02335489|16184330|P1|Overall Study|Lack of Efficacy|1
4697241|NCT02335489|16184330|P1|Overall Study|Physician Decision|2
4697242|NCT02335489|16184330|P1|Overall Study|Withdrawal by Subject|2
4697243|NCT02335489|16184330|P1|Overall Study|Lost to Follow-up|1
4697244|NCT02335489|16184330|P1|Overall Study|Sponsor terminated study|4
4697245|NCT02335450|16184357|P1|Overall Study|Pregnancy|1
4697246|NCT02335424|16184361|P1|Overall Study|Not treated|4
4697247|NCT02335424|16184361|P1|Overall Study|Physician Decision|3
4697248|NCT02335424|16184361|P1|Overall Study|Lost to Follow-up|2
4697249|NCT02335424|16184361|P1|Overall Study|Death|239
4697250|NCT02335424|16184361|P1|Overall Study|Adverse Event|25
4697251|NCT02335424|16184361|P1|Overall Study|Ongoing In Study|89
4697252|NCT02335424|16184361|P1|Overall Study|Withdrawal by Subject|12
4697253|NCT02335346|16184394|P1|Overall Study|Withdrawal by Subject|1
4697254|NCT02335346|16184394|P1|Overall Study|Adverse Event|11
4697255|NCT02334748|16184716|P1|Overall Study|Lack of Efficacy|4
4697256|NCT02334748|16184716|P1|Overall Study|Patient no longer required study drug|2
4697257|NCT02334748|16184716|P1|Overall Study|Inclusion in the CACZ8852306 study|1
4697258|NCT02334748|16184716|P1|Overall Study|Adverse Event|1
4697259|NCT02334423|16184747|P2|Overall Study|Protocol Violation|3
4697260|NCT02334423|16184748|P1|Overall Study|Protocol Violation|10
4697261|NCT02334384|16184762|P2|Overall Study|Lost to Follow-up|1
4697262|NCT02334384|16184763|P1|Overall Study|Lost to Follow-up|1
4697263|NCT02334306|16184775|P2|Double-blind Period|Withdrawal by Subject|1
4697264|NCT02334306|16184776|P1|Double-blind Period|Withdrawal by Subject|1
4697265|NCT02334306|16184775|P2|Double-blind Period|Adverse Event|1
4697266|NCT02334306|16184776|P1|Double-blind Period|Adverse Event|0
4697267|NCT02334215|16184814|P3|Overall Study|Incarcerated|7
4697268|NCT02334215|16184815|P2|Overall Study|Incarcerated|0
4697269|NCT02334215|16184816|P1|Overall Study|Incarcerated|0
4697270|NCT02334215|16184814|P3|Overall Study|Not released from incarceration on time|3
4697271|NCT02334215|16184815|P2|Overall Study|Not released from incarceration on time|3
4697272|NCT02334215|16184816|P1|Overall Study|Not released from incarceration on time|3
4697273|NCT02334215|16184814|P3|Overall Study|Withdrawal by Subject|1
4697274|NCT02334215|16184815|P2|Overall Study|Withdrawal by Subject|2
4697275|NCT02334215|16184816|P1|Overall Study|Withdrawal by Subject|2
4697276|NCT02334215|16184814|P3|Overall Study|Lost to Follow-up|4
4697277|NCT02334215|16184815|P2|Overall Study|Lost to Follow-up|0
4697278|NCT02334215|16184816|P1|Overall Study|Lost to Follow-up|1
4697279|NCT02334215|16184814|P3|Overall Study|Death|0
4697280|NCT02334215|16184815|P2|Overall Study|Death|1
4697281|NCT02334215|16184816|P1|Overall Study|Death|1
4697282|NCT02333630|16184896|P2|Overall Study|Lost to Follow-up|2
4697283|NCT02333630|16184897|P1|Overall Study|Lost to Follow-up|5
4697284|NCT02333487|16184912|P3|Overall Study|Adverse Event|0
4697285|NCT02333487|16184913|P2|Overall Study|Adverse Event|2
4697286|NCT02333487|16184914|P1|Overall Study|Adverse Event|0
4697287|NCT02333383|16184925|P1|Overall Study|Transfer to another hospital|2
4697288|NCT02333383|16184925|P1|Overall Study|Withdrawal by Subject|3
4697289|NCT02333383|16184925|P1|Overall Study|Lost to Follow-up|15
4697290|NCT02333383|16184925|P1|Overall Study|Adalimumab discontinuation|21
4697291|NCT02333331|16184939|P4|Overall Study|Patient/Guardian Decision|1
4697292|NCT02333331|16184940|P3|Overall Study|Patient/Guardian Decision|9
4697293|NCT02333331|16184941|P2|Overall Study|Patient/Guardian Decision|2
4697294|NCT02333331|16184942|P1|Overall Study|Patient/Guardian Decision|1
4697295|NCT02333331|16184939|P4|Overall Study|Protocol Deviation|1
4697296|NCT02333331|16184940|P3|Overall Study|Protocol Deviation|2
4697297|NCT02333331|16184941|P2|Overall Study|Protocol Deviation|3
4697298|NCT02333331|16184942|P1|Overall Study|Protocol Deviation|0
4697299|NCT02333331|16184939|P4|Overall Study|Physician Decision|0
4697300|NCT02333331|16184940|P3|Overall Study|Physician Decision|0
4697301|NCT02333331|16184941|P2|Overall Study|Physician Decision|1
4697302|NCT02333331|16184942|P1|Overall Study|Physician Decision|0
4697303|NCT02333331|16184939|P4|Overall Study|Lost to Follow-up|0
4697304|NCT02333331|16184940|P3|Overall Study|Lost to Follow-up|1
4697305|NCT02333331|16184941|P2|Overall Study|Lost to Follow-up|0
4697306|NCT02333331|16184942|P1|Overall Study|Lost to Follow-up|0
4697307|NCT02333331|16184939|P4|Overall Study|Death|0
4697308|NCT02333331|16184940|P3|Overall Study|Death|2
4697309|NCT02333331|16184941|P2|Overall Study|Death|0
4697310|NCT02333331|16184942|P1|Overall Study|Death|0
4697311|NCT02333331|16184939|P4|Overall Study|Adverse Event|1
4697312|NCT02333331|16184940|P3|Overall Study|Adverse Event|4
4697313|NCT02333331|16184941|P2|Overall Study|Adverse Event|0
4697314|NCT02333331|16184942|P1|Overall Study|Adverse Event|1
4697315|NCT02332889|16184986|P1|Overall Study|Physician Decision|1
4697316|NCT02332876|16184992|P2|Overall Study|Lost to Follow-up|1
4697317|NCT02332876|16184993|P1|Overall Study|Lost to Follow-up|1
4697318|NCT02332824|16185005|P6|Overall Study|Transfer|0
4697319|NCT02332824|16185006|P5|Overall Study|Transfer|0
4697320|NCT02332824|16185007|P4|Overall Study|Transfer|1
4697321|NCT02332824|16185008|P3|Overall Study|Transfer|1
4697322|NCT02332824|16185009|P2|Overall Study|Transfer|0
4697323|NCT02332824|16185010|P1|Overall Study|Transfer|0
4697324|NCT02332824|16185005|P6|Overall Study|Inconvenient schedule|0
4697325|NCT02332824|16185006|P5|Overall Study|Inconvenient schedule|0
4697326|NCT02332824|16185007|P4|Overall Study|Inconvenient schedule|0
4697327|NCT02332824|16185008|P3|Overall Study|Inconvenient schedule|0
4697328|NCT02332824|16185009|P2|Overall Study|Inconvenient schedule|1
4697329|NCT02332824|16185010|P1|Overall Study|Inconvenient schedule|1
4697330|NCT02332824|16185005|P6|Overall Study|Voluntary Withdrawal|0
4697331|NCT02332824|16185006|P5|Overall Study|Voluntary Withdrawal|0
4697332|NCT02332824|16185007|P4|Overall Study|Voluntary Withdrawal|0
4697333|NCT02332824|16185008|P3|Overall Study|Voluntary Withdrawal|0
4697334|NCT02332824|16185009|P2|Overall Study|Voluntary Withdrawal|0
4697335|NCT02332824|16185010|P1|Overall Study|Voluntary Withdrawal|1
4697336|NCT02332824|16185005|P6|Overall Study|Pretreatment Event/Adverse Event|1
4697337|NCT02332824|16185006|P5|Overall Study|Pretreatment Event/Adverse Event|4
4697338|NCT02332824|16185007|P4|Overall Study|Pretreatment Event/Adverse Event|1
4697339|NCT02332824|16185008|P3|Overall Study|Pretreatment Event/Adverse Event|1
4697340|NCT02332824|16185009|P2|Overall Study|Pretreatment Event/Adverse Event|0
4697341|NCT02332824|16185010|P1|Overall Study|Pretreatment Event/Adverse Event|4
4697342|NCT02332798|16185051|P3|Overall Study|Abnormal Laboratory Findings|0
4697343|NCT02332798|16185052|P2|Overall Study|Abnormal Laboratory Findings|0
4697344|NCT02332798|16185053|P1|Overall Study|Abnormal Laboratory Findings|1
4697345|NCT02332798|16185051|P3|Overall Study|Positive Urine Drug Test|0
4697346|NCT02332798|16185052|P2|Overall Study|Positive Urine Drug Test|1
4697347|NCT02332798|16185053|P1|Overall Study|Positive Urine Drug Test|0
4697348|NCT02332798|16185051|P3|Overall Study|Unwilling to Participate in Study|1
4697349|NCT02332798|16185052|P2|Overall Study|Unwilling to Participate in Study|1
4697350|NCT02332798|16185053|P1|Overall Study|Unwilling to Participate in Study|0
4697351|NCT02332720|16185126|P23|Part A and Part B|Withdrawal by Subject|0
4697352|NCT02332720|16185127|P22|Part A and Part B|Withdrawal by Subject|0
4697353|NCT02332720|16185128|P21|Part A and Part B|Withdrawal by Subject|0
4697354|NCT02332720|16185129|P20|Part A and Part B|Withdrawal by Subject|1
4697355|NCT02332720|16185130|P19|Part A and Part B|Withdrawal by Subject|0
4697356|NCT02332720|16185131|P18|Part A and Part B|Withdrawal by Subject|0
4697357|NCT02332720|16185132|P17|Part A and Part B|Withdrawal by Subject|0
4697358|NCT02332720|16185133|P16|Part A and Part B|Withdrawal by Subject|0
4697359|NCT02332720|16185134|P15|Part A and Part B|Withdrawal by Subject|0
4697360|NCT02332720|16185135|P14|Part A and Part B|Withdrawal by Subject|0
4697361|NCT02332720|16185136|P13|Part A and Part B|Withdrawal by Subject|0
4697362|NCT02332720|16185137|P12|Part A and Part B|Withdrawal by Subject|0
4697363|NCT02332720|16185138|P11|Part A and Part B|Withdrawal by Subject|0
4697364|NCT02332720|16185139|P10|Part A and Part B|Withdrawal by Subject|0
4697365|NCT02332720|16185140|P9|Part A and Part B|Withdrawal by Subject|0
4697366|NCT02332720|16185141|P8|Part A and Part B|Withdrawal by Subject|0
4697367|NCT02332720|16185142|P7|Part A and Part B|Withdrawal by Subject|0
4697368|NCT02332720|16185143|P6|Part A and Part B|Withdrawal by Subject|1
4697369|NCT02332720|16185144|P5|Part A and Part B|Withdrawal by Subject|0
4697370|NCT02332720|16185145|P4|Part A and Part B|Withdrawal by Subject|0
4697371|NCT02332720|16185146|P3|Part A and Part B|Withdrawal by Subject|0
4697372|NCT02332720|16185147|P2|Part A and Part B|Withdrawal by Subject|0
4697373|NCT02332720|16185148|P1|Part A and Part B|Withdrawal by Subject|0
4697374|NCT02332720|16185126|P23|Part A and Part B|Physician Decision|0
4697375|NCT02332720|16185127|P22|Part A and Part B|Physician Decision|0
4697376|NCT02332720|16185128|P21|Part A and Part B|Physician Decision|0
4697377|NCT02332720|16185129|P20|Part A and Part B|Physician Decision|0
4697378|NCT02332720|16185130|P19|Part A and Part B|Physician Decision|1
4697379|NCT02332720|16185131|P18|Part A and Part B|Physician Decision|0
4697380|NCT02332720|16185132|P17|Part A and Part B|Physician Decision|0
4697381|NCT02332720|16185133|P16|Part A and Part B|Physician Decision|0
4697382|NCT02332720|16185134|P15|Part A and Part B|Physician Decision|0
4697383|NCT02332720|16185135|P14|Part A and Part B|Physician Decision|0
4697384|NCT02332720|16185136|P13|Part A and Part B|Physician Decision|0
4697385|NCT02332720|16185137|P12|Part A and Part B|Physician Decision|0
4697386|NCT02332720|16185138|P11|Part A and Part B|Physician Decision|0
4697387|NCT02332720|16185139|P10|Part A and Part B|Physician Decision|0
4697388|NCT02332720|16185140|P9|Part A and Part B|Physician Decision|0
4697389|NCT02332720|16185141|P8|Part A and Part B|Physician Decision|0
4697390|NCT02332720|16185142|P7|Part A and Part B|Physician Decision|0
4697391|NCT02332720|16185143|P6|Part A and Part B|Physician Decision|0
4697392|NCT02332720|16185144|P5|Part A and Part B|Physician Decision|0
4697393|NCT02332720|16185145|P4|Part A and Part B|Physician Decision|0
4697394|NCT02332720|16185146|P3|Part A and Part B|Physician Decision|0
4697395|NCT02332720|16185147|P2|Part A and Part B|Physician Decision|0
4697396|NCT02332720|16185148|P1|Part A and Part B|Physician Decision|0
4697397|NCT02332720|16185126|P23|Part A and Part B|Adverse Event|0
4697398|NCT02332720|16185127|P22|Part A and Part B|Adverse Event|0
4697399|NCT02332720|16185128|P21|Part A and Part B|Adverse Event|0
4697400|NCT02332720|16185129|P20|Part A and Part B|Adverse Event|0
4697401|NCT02332720|16185130|P19|Part A and Part B|Adverse Event|0
4697402|NCT02332720|16185131|P18|Part A and Part B|Adverse Event|1
4697403|NCT02332720|16185132|P17|Part A and Part B|Adverse Event|0
4697404|NCT02332720|16185133|P16|Part A and Part B|Adverse Event|0
4697405|NCT02332720|16185134|P15|Part A and Part B|Adverse Event|0
4697406|NCT02332720|16185135|P14|Part A and Part B|Adverse Event|0
4697407|NCT02332720|16185136|P13|Part A and Part B|Adverse Event|0
4697408|NCT02332720|16185137|P12|Part A and Part B|Adverse Event|0
4697409|NCT02332720|16185138|P11|Part A and Part B|Adverse Event|0
4697410|NCT02332720|16185139|P10|Part A and Part B|Adverse Event|0
4697411|NCT02332720|16185140|P9|Part A and Part B|Adverse Event|0
4697412|NCT02332720|16185141|P8|Part A and Part B|Adverse Event|0
4697413|NCT02332720|16185142|P7|Part A and Part B|Adverse Event|0
4697414|NCT02332720|16185143|P6|Part A and Part B|Adverse Event|0
4697415|NCT02332720|16185144|P5|Part A and Part B|Adverse Event|0
4697416|NCT02332720|16185145|P4|Part A and Part B|Adverse Event|0
4697417|NCT02332720|16185146|P3|Part A and Part B|Adverse Event|0
4697418|NCT02332720|16185147|P2|Part A and Part B|Adverse Event|0
4697419|NCT02332720|16185148|P1|Part A and Part B|Adverse Event|0
4697420|NCT02332720|16185126|P23|Part A and Part B|Lost to Follow-up|0
4697421|NCT02332720|16185127|P22|Part A and Part B|Lost to Follow-up|0
4697422|NCT02332720|16185128|P21|Part A and Part B|Lost to Follow-up|0
4697423|NCT02332720|16185129|P20|Part A and Part B|Lost to Follow-up|0
4697424|NCT02332720|16185130|P19|Part A and Part B|Lost to Follow-up|0
4697425|NCT02332720|16185131|P18|Part A and Part B|Lost to Follow-up|0
4697426|NCT02332720|16185132|P17|Part A and Part B|Lost to Follow-up|0
4697427|NCT02332720|16185133|P16|Part A and Part B|Lost to Follow-up|1
4697428|NCT02332720|16185134|P15|Part A and Part B|Lost to Follow-up|0
4697429|NCT02332720|16185135|P14|Part A and Part B|Lost to Follow-up|0
4697430|NCT02332720|16185136|P13|Part A and Part B|Lost to Follow-up|0
4697431|NCT02332720|16185137|P12|Part A and Part B|Lost to Follow-up|0
4697432|NCT02332720|16185138|P11|Part A and Part B|Lost to Follow-up|0
4697433|NCT02332720|16185139|P10|Part A and Part B|Lost to Follow-up|0
4697434|NCT02332720|16185140|P9|Part A and Part B|Lost to Follow-up|0
4697435|NCT02332720|16185141|P8|Part A and Part B|Lost to Follow-up|1
4697436|NCT02332720|16185142|P7|Part A and Part B|Lost to Follow-up|1
4697437|NCT02332720|16185143|P6|Part A and Part B|Lost to Follow-up|2
4697438|NCT02332720|16185144|P5|Part A and Part B|Lost to Follow-up|0
4697439|NCT02332720|16185145|P4|Part A and Part B|Lost to Follow-up|0
4697440|NCT02332720|16185146|P3|Part A and Part B|Lost to Follow-up|0
4697441|NCT02332720|16185147|P2|Part A and Part B|Lost to Follow-up|0
4697442|NCT02332720|16185148|P1|Part A and Part B|Lost to Follow-up|1
4697443|NCT02332707|16185284|P18|Overall Study|Withdrawal by Subject|0
4697444|NCT02332707|16185285|P17|Overall Study|Withdrawal by Subject|0
4697445|NCT02332707|16185286|P16|Overall Study|Withdrawal by Subject|0
4697446|NCT02332707|16185287|P15|Overall Study|Withdrawal by Subject|0
4697447|NCT02332707|16185288|P14|Overall Study|Withdrawal by Subject|0
4697448|NCT02332707|16185289|P13|Overall Study|Withdrawal by Subject|0
4697449|NCT02332707|16185290|P12|Overall Study|Withdrawal by Subject|0
4697450|NCT02332707|16185291|P11|Overall Study|Withdrawal by Subject|0
4697451|NCT02332707|16185292|P10|Overall Study|Withdrawal by Subject|3
4697452|NCT02332707|16185293|P9|Overall Study|Withdrawal by Subject|0
4697453|NCT02332707|16185294|P8|Overall Study|Withdrawal by Subject|0
4697454|NCT02332707|16185295|P7|Overall Study|Withdrawal by Subject|0
4697455|NCT02332707|16185296|P6|Overall Study|Withdrawal by Subject|0
4697456|NCT02332707|16185297|P5|Overall Study|Withdrawal by Subject|0
4697457|NCT02332707|16185298|P4|Overall Study|Withdrawal by Subject|0
4697458|NCT02332707|16185299|P3|Overall Study|Withdrawal by Subject|1
4697459|NCT02332707|16185300|P2|Overall Study|Withdrawal by Subject|0
4697460|NCT02332707|16185301|P1|Overall Study|Withdrawal by Subject|0
4697461|NCT02332707|16185284|P18|Overall Study|Physician Decision|0
4697462|NCT02332707|16185285|P17|Overall Study|Physician Decision|0
4697463|NCT02332707|16185286|P16|Overall Study|Physician Decision|0
4697464|NCT02332707|16185287|P15|Overall Study|Physician Decision|0
4697465|NCT02332707|16185288|P14|Overall Study|Physician Decision|0
4697466|NCT02332707|16185289|P13|Overall Study|Physician Decision|1
4697467|NCT02332707|16185290|P12|Overall Study|Physician Decision|0
4697468|NCT02332707|16185291|P11|Overall Study|Physician Decision|0
4697469|NCT02332707|16185292|P10|Overall Study|Physician Decision|0
4697470|NCT02332707|16185293|P9|Overall Study|Physician Decision|0
4697471|NCT02332707|16185294|P8|Overall Study|Physician Decision|0
4697472|NCT02332707|16185295|P7|Overall Study|Physician Decision|0
4697473|NCT02332707|16185296|P6|Overall Study|Physician Decision|0
4697474|NCT02332707|16185297|P5|Overall Study|Physician Decision|0
4697475|NCT02332707|16185298|P4|Overall Study|Physician Decision|1
4697476|NCT02332707|16185299|P3|Overall Study|Physician Decision|0
4697477|NCT02332707|16185300|P2|Overall Study|Physician Decision|0
4697478|NCT02332707|16185301|P1|Overall Study|Physician Decision|0
4697479|NCT02332707|16185284|P18|Overall Study|Lost to Follow-up|0
4697480|NCT02332707|16185285|P17|Overall Study|Lost to Follow-up|0
4697481|NCT02332707|16185286|P16|Overall Study|Lost to Follow-up|0
4697482|NCT02332707|16185287|P15|Overall Study|Lost to Follow-up|0
4697483|NCT02332707|16185288|P14|Overall Study|Lost to Follow-up|0
4697484|NCT02332707|16185289|P13|Overall Study|Lost to Follow-up|3
4697485|NCT02332707|16185290|P12|Overall Study|Lost to Follow-up|0
4697486|NCT02332707|16185291|P11|Overall Study|Lost to Follow-up|2
4697487|NCT02332707|16185292|P10|Overall Study|Lost to Follow-up|0
4697488|NCT02332707|16185293|P9|Overall Study|Lost to Follow-up|0
4697489|NCT02332707|16185294|P8|Overall Study|Lost to Follow-up|0
4697490|NCT02332707|16185295|P7|Overall Study|Lost to Follow-up|0
4697491|NCT02332707|16185296|P6|Overall Study|Lost to Follow-up|1
4697492|NCT02332707|16185297|P5|Overall Study|Lost to Follow-up|0
4697493|NCT02332707|16185298|P4|Overall Study|Lost to Follow-up|0
4697494|NCT02332707|16185299|P3|Overall Study|Lost to Follow-up|0
4697495|NCT02332707|16185300|P2|Overall Study|Lost to Follow-up|0
4697496|NCT02332707|16185301|P1|Overall Study|Lost to Follow-up|0
4697497|NCT02332707|16185284|P18|Overall Study|Adverse Event|0
4697498|NCT02332707|16185285|P17|Overall Study|Adverse Event|0
4697499|NCT02332707|16185286|P16|Overall Study|Adverse Event|0
4697500|NCT02332707|16185287|P15|Overall Study|Adverse Event|0
4697501|NCT02332707|16185288|P14|Overall Study|Adverse Event|0
4697502|NCT02332707|16185289|P13|Overall Study|Adverse Event|1
4697503|NCT02332707|16185290|P12|Overall Study|Adverse Event|0
4697504|NCT02332707|16185291|P11|Overall Study|Adverse Event|0
4697505|NCT02332707|16185292|P10|Overall Study|Adverse Event|0
4697506|NCT02332707|16185293|P9|Overall Study|Adverse Event|0
4697507|NCT02332707|16185294|P8|Overall Study|Adverse Event|0
4697508|NCT02332707|16185295|P7|Overall Study|Adverse Event|0
4697509|NCT02332707|16185296|P6|Overall Study|Adverse Event|0
4697510|NCT02332707|16185297|P5|Overall Study|Adverse Event|0
4697511|NCT02332707|16185298|P4|Overall Study|Adverse Event|0
4697512|NCT02332707|16185299|P3|Overall Study|Adverse Event|0
4697513|NCT02332707|16185300|P2|Overall Study|Adverse Event|0
4697514|NCT02332707|16185301|P1|Overall Study|Adverse Event|0
4697515|NCT02332590|16185395|P2|Overall Study|Other than specified above|5
4697516|NCT02332590|16185396|P1|Overall Study|Other than specified above|6
4697517|NCT02332590|16185395|P2|Overall Study|Randomized but not treated|0
4697518|NCT02332590|16185396|P1|Overall Study|Randomized but not treated|1
4697519|NCT02332590|16185395|P2|Overall Study|Poor compliance to protocol|1
4697520|NCT02332590|16185396|P1|Overall Study|Poor compliance to protocol|3
4697521|NCT02332590|16185395|P2|Overall Study|Lack of Efficacy|2
4697522|NCT02332590|16185396|P1|Overall Study|Lack of Efficacy|4
4697523|NCT02332590|16185395|P2|Overall Study|Adverse Event|11
4697524|NCT02332590|16185396|P1|Overall Study|Adverse Event|15
4697525|NCT02332239|16185460|P2|Overall Study|Lost to Follow-up|6
4697526|NCT02332239|16185461|P1|Overall Study|Lost to Follow-up|4
4697527|NCT02331680|16185497|P3|Overall Study|Protocol Violation|3
4697528|NCT02331680|16185498|P2|Overall Study|Protocol Violation|0
4697529|NCT02331680|16185499|P1|Overall Study|Protocol Violation|0
4697530|NCT02331680|16185497|P3|Overall Study|Non-compliance with study drug|1
4697531|NCT02331680|16185498|P2|Overall Study|Non-compliance with study drug|0
4697532|NCT02331680|16185499|P1|Overall Study|Non-compliance with study drug|0
4697533|NCT02331680|16185497|P3|Overall Study|Met withdrawal criteria|5
4697534|NCT02331680|16185498|P2|Overall Study|Met withdrawal criteria|2
4697535|NCT02331680|16185499|P1|Overall Study|Met withdrawal criteria|2
4697536|NCT02331680|16185497|P3|Overall Study|Withdrawal by Subject|2
4697537|NCT02331680|16185498|P2|Overall Study|Withdrawal by Subject|1
4697538|NCT02331680|16185499|P1|Overall Study|Withdrawal by Subject|0
4697539|NCT02331680|16185497|P3|Overall Study|Physician Decision|2
4697540|NCT02331680|16185498|P2|Overall Study|Physician Decision|1
4697541|NCT02331680|16185499|P1|Overall Study|Physician Decision|1
4697542|NCT02331680|16185497|P3|Overall Study|Adverse Event|2
4697543|NCT02331680|16185498|P2|Overall Study|Adverse Event|0
4697544|NCT02331680|16185499|P1|Overall Study|Adverse Event|3
4697545|NCT02331446|16185529|P4|Overall Study|Lost before baseline analysis|0
4697546|NCT02331446|16185530|P3|Overall Study|Lost before baseline analysis|1
4697547|NCT02331446|16185531|P2|Overall Study|Lost before baseline analysis|1
4697548|NCT02331446|16185532|P1|Overall Study|Lost before baseline analysis|0
4697549|NCT02331446|16185529|P4|Overall Study|Physician Decision|1
4697550|NCT02331446|16185530|P3|Overall Study|Physician Decision|0
4697551|NCT02331446|16185531|P2|Overall Study|Physician Decision|1
4697552|NCT02331446|16185532|P1|Overall Study|Physician Decision|0
4697553|NCT02331446|16185529|P4|Overall Study|Disease|1
4697554|NCT02331446|16185530|P3|Overall Study|Disease|2
4697555|NCT02331446|16185531|P2|Overall Study|Disease|2
4697556|NCT02331446|16185532|P1|Overall Study|Disease|0
4697557|NCT02331446|16185529|P4|Overall Study|Personal Problem|0
4697558|NCT02331446|16185530|P3|Overall Study|Personal Problem|0
4697559|NCT02331446|16185531|P2|Overall Study|Personal Problem|0
4697560|NCT02331446|16185532|P1|Overall Study|Personal Problem|2
4697561|NCT02331446|16185529|P4|Overall Study|Lost to Follow-up|1
4697562|NCT02331446|16185530|P3|Overall Study|Lost to Follow-up|0
4697563|NCT02331446|16185531|P2|Overall Study|Lost to Follow-up|1
4697564|NCT02331446|16185532|P1|Overall Study|Lost to Follow-up|2
4697565|NCT02331394|16185608|P1|Overall Study|Disease progression|1
4697566|NCT02331368|16185619|P1|Overall Study|Withdrawal by Subject|3
4697567|NCT02330549|16185744|P2|Overall Study|Failure to meet randomization criteria|0
4697568|NCT02330549|16185745|P1|Overall Study|Failure to meet randomization criteria|1
4697569|NCT02330549|16185744|P2|Overall Study|Subject withdrew consent|1
4697570|NCT02330549|16185745|P1|Overall Study|Subject withdrew consent|2
4697571|NCT02330549|16185744|P2|Overall Study|Adverse Event|0
4697572|NCT02330549|16185745|P1|Overall Study|Adverse Event|1
4697573|NCT02330081|16185961|P1|Overall Study|Protocol Violation|6
4697574|NCT02330081|16185961|P1|Overall Study|Donation did not meet criteria|1
4697575|NCT02330081|16185961|P1|Overall Study|Adverse Event|1
4697576|NCT02330055|16185982|P2|Overall Study|participant did not sleep|1
4697577|NCT02330055|16185983|P1|Overall Study|participant did not sleep|0
4697578|NCT02330055|16185982|P2|Overall Study|data for less than 60 minutes|3
4697579|NCT02330055|16185983|P1|Overall Study|data for less than 60 minutes|3
4697580|NCT02330055|16185982|P2|Overall Study|participant forgot to wear device|5
4697581|NCT02330055|16185983|P1|Overall Study|participant forgot to wear device|5
4697582|NCT02330055|16185982|P2|Overall Study|technical issues|0
4697583|NCT02330055|16185983|P1|Overall Study|technical issues|2
4697584|NCT02329743|16186029|P3|Overall Study|Other|3
4697585|NCT02329743|16186030|P2|Overall Study|Other|2
4697586|NCT02329743|16186031|P1|Overall Study|Other|0
4697587|NCT02329743|16186029|P3|Overall Study|Withdrawal by Subject|1
4697588|NCT02329743|16186030|P2|Overall Study|Withdrawal by Subject|4
4697589|NCT02329743|16186031|P1|Overall Study|Withdrawal by Subject|4
4697590|NCT02329743|16186029|P3|Overall Study|Lost to Follow-up|1
4697591|NCT02329743|16186030|P2|Overall Study|Lost to Follow-up|0
4697592|NCT02329743|16186031|P1|Overall Study|Lost to Follow-up|1
4697593|NCT02329743|16186029|P3|Overall Study|Adverse Event|3
4697594|NCT02329743|16186030|P2|Overall Study|Adverse Event|1
4697595|NCT02329743|16186031|P1|Overall Study|Adverse Event|1
4697596|NCT02329730|16186046|P12|Overall Study|Withdrawal by Subject|0
4697597|NCT02329730|16186047|P11|Overall Study|Withdrawal by Subject|0
4697598|NCT02329730|16186048|P10|Overall Study|Withdrawal by Subject|1
4697599|NCT02329730|16186049|P9|Overall Study|Withdrawal by Subject|1
4697600|NCT02329730|16186050|P8|Overall Study|Withdrawal by Subject|1
4697601|NCT02329730|16186051|P7|Overall Study|Withdrawal by Subject|1
4697602|NCT02329730|16186052|P6|Overall Study|Withdrawal by Subject|0
4697603|NCT02329730|16186053|P5|Overall Study|Withdrawal by Subject|1
4697604|NCT02329730|16186054|P4|Overall Study|Withdrawal by Subject|0
4697605|NCT02329730|16186055|P3|Overall Study|Withdrawal by Subject|0
4697606|NCT02329730|16186056|P2|Overall Study|Withdrawal by Subject|0
4697607|NCT02329730|16186057|P1|Overall Study|Withdrawal by Subject|0
4697608|NCT02329730|16186046|P12|Overall Study|Protocol Violation|0
4697609|NCT02329730|16186047|P11|Overall Study|Protocol Violation|0
4697610|NCT02329730|16186048|P10|Overall Study|Protocol Violation|0
4697611|NCT02329730|16186049|P9|Overall Study|Protocol Violation|0
4697612|NCT02329730|16186050|P8|Overall Study|Protocol Violation|0
4697613|NCT02329730|16186051|P7|Overall Study|Protocol Violation|0
4697614|NCT02329730|16186052|P6|Overall Study|Protocol Violation|2
4697615|NCT02329730|16186053|P5|Overall Study|Protocol Violation|2
4697616|NCT02329730|16186054|P4|Overall Study|Protocol Violation|0
4697617|NCT02329730|16186055|P3|Overall Study|Protocol Violation|0
4697618|NCT02329730|16186056|P2|Overall Study|Protocol Violation|0
4697619|NCT02329730|16186057|P1|Overall Study|Protocol Violation|0
4697620|NCT02329431|16186168|P2|Overall Study|Lost to Follow-up|13
4697621|NCT02329431|16186169|P1|Overall Study|Lost to Follow-up|20
4697622|NCT02329223|16186188|P3|Overall Study|Adverse Event|0
4697623|NCT02329223|16186189|P2|Overall Study|Adverse Event|1
4697624|NCT02329223|16186190|P1|Overall Study|Adverse Event|0
4697625|NCT02329223|16186188|P3|Overall Study|Physician Decision|1
4697626|NCT02329223|16186189|P2|Overall Study|Physician Decision|0
4697627|NCT02329223|16186190|P1|Overall Study|Physician Decision|0
4697628|NCT02329223|16186188|P3|Overall Study|Withdrawal by Subject|5
4697629|NCT02329223|16186189|P2|Overall Study|Withdrawal by Subject|2
4697630|NCT02329223|16186190|P1|Overall Study|Withdrawal by Subject|1
4697631|NCT02328937|16186240|P6|Period 2|Adverse Event|0
4697632|NCT02328937|16186241|P5|Period 2|Adverse Event|0
4697633|NCT02328937|16186242|P4|Period 2|Adverse Event|0
4697634|NCT02328937|16186243|P3|Period 2|Adverse Event|1
4697635|NCT02328937|16186244|P2|Period 2|Adverse Event|0
4697636|NCT02328937|16186245|P1|Period 2|Adverse Event|0
4697637|NCT02328937|16186240|P6|Period 1|Lost to Follow-up|0
4697638|NCT02328937|16186241|P5|Period 1|Lost to Follow-up|0
4697639|NCT02328937|16186242|P4|Period 1|Lost to Follow-up|1
4697640|NCT02328937|16186243|P3|Period 1|Lost to Follow-up|0
4697641|NCT02328937|16186244|P2|Period 1|Lost to Follow-up|0
4697642|NCT02328937|16186245|P1|Period 1|Lost to Follow-up|0
4697643|NCT01701674|16186263|P1|Overall Study|Unable to safely complete treatment|1
4697644|NCT02328547|16186272|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
4697645|NCT02328547|16186273|P1|First Intervention (12 Weeks)|Withdrawal by Subject|2
4697646|NCT02328547|16186272|P2|First Intervention (12 Weeks)|Lost to Follow-up|0
4697647|NCT02328547|16186273|P1|First Intervention (12 Weeks)|Lost to Follow-up|1
4697648|NCT02328105|16186348|P1|Overall Study|Still On Study in Follow-Up|4
4697649|NCT02328105|16186348|P1|Overall Study|Withdrawal by Subject|1
4697650|NCT02328105|16186348|P1|Overall Study|Death|6
4697651|NCT02328040|16186353|P2|First Intervention (2 Days)|Withdrawal by Subject|1
4697652|NCT02328040|16186354|P1|First Intervention (2 Days)|Withdrawal by Subject|1
4697653|NCT02328027|16186364|P2|Overall Study|Withdrawal by Subject|1
4697654|NCT02328027|16186365|P1|Overall Study|Withdrawal by Subject|0
4697655|NCT02327325|16186469|P3|Overall Study|Excluded by Study Team|1
4697656|NCT02327325|16186470|P2|Overall Study|Excluded by Study Team|0
4697657|NCT02327325|16186471|P1|Overall Study|Excluded by Study Team|0
4697658|NCT02327325|16186469|P3|Overall Study|Withdrawal by Subject|4
4697659|NCT02327325|16186470|P2|Overall Study|Withdrawal by Subject|4
4697660|NCT02327325|16186471|P1|Overall Study|Withdrawal by Subject|1
4697661|NCT02327260|16186494|P3|Overall Study|cognitive concerns|0
4697662|NCT02327260|16186495|P2|Overall Study|cognitive concerns|0
4697663|NCT02327260|16186496|P1|Overall Study|cognitive concerns|1
4697664|NCT02327260|16186494|P3|Overall Study|non-adherence to protocol|0
4697665|NCT02327260|16186495|P2|Overall Study|non-adherence to protocol|0
4697666|NCT02327260|16186496|P1|Overall Study|non-adherence to protocol|2
4697667|NCT02327260|16186494|P3|Overall Study|invalid phone number|0
4697668|NCT02327260|16186495|P2|Overall Study|invalid phone number|1
4697669|NCT02327260|16186496|P1|Overall Study|invalid phone number|1
4697670|NCT02327260|16186494|P3|Overall Study|Lost to Follow-up|2
4697671|NCT02327260|16186495|P2|Overall Study|Lost to Follow-up|3
4697672|NCT02327260|16186496|P1|Overall Study|Lost to Follow-up|2
4697673|NCT02327169|16186543|P15|Overall Study|Lost to Follow-up|0
4697674|NCT02327169|16186544|P14|Overall Study|Lost to Follow-up|0
4697675|NCT02327169|16186545|P13|Overall Study|Lost to Follow-up|0
4697676|NCT02327169|16186546|P12|Overall Study|Lost to Follow-up|0
4697677|NCT02327169|16186547|P11|Overall Study|Lost to Follow-up|0
4697678|NCT02327169|16186548|P10|Overall Study|Lost to Follow-up|0
4697679|NCT02327169|16186549|P9|Overall Study|Lost to Follow-up|0
4697680|NCT02327169|16186550|P8|Overall Study|Lost to Follow-up|0
4697681|NCT02327169|16186551|P7|Overall Study|Lost to Follow-up|0
4697682|NCT02327169|16186552|P6|Overall Study|Lost to Follow-up|0
4697683|NCT02327169|16186553|P5|Overall Study|Lost to Follow-up|1
4697684|NCT02327169|16186554|P4|Overall Study|Lost to Follow-up|0
4697685|NCT02327169|16186555|P3|Overall Study|Lost to Follow-up|0
4697686|NCT02327169|16186556|P2|Overall Study|Lost to Follow-up|0
4697687|NCT02327169|16186557|P1|Overall Study|Lost to Follow-up|0
4697688|NCT02327169|16186543|P15|Overall Study|Withdrawal by Subject|3
4697689|NCT02327169|16186544|P14|Overall Study|Withdrawal by Subject|0
4697690|NCT02327169|16186545|P13|Overall Study|Withdrawal by Subject|0
4697691|NCT02327169|16186546|P12|Overall Study|Withdrawal by Subject|0
4697692|NCT02327169|16186547|P11|Overall Study|Withdrawal by Subject|0
4697693|NCT02327169|16186548|P10|Overall Study|Withdrawal by Subject|0
4697694|NCT02327169|16186549|P9|Overall Study|Withdrawal by Subject|0
4697695|NCT02327169|16186550|P8|Overall Study|Withdrawal by Subject|1
4697696|NCT02327169|16186551|P7|Overall Study|Withdrawal by Subject|0
4697697|NCT02327169|16186552|P6|Overall Study|Withdrawal by Subject|0
4697698|NCT02327169|16186553|P5|Overall Study|Withdrawal by Subject|1
4697699|NCT02327169|16186554|P4|Overall Study|Withdrawal by Subject|0
4697700|NCT02327169|16186555|P3|Overall Study|Withdrawal by Subject|0
4697701|NCT02327169|16186556|P2|Overall Study|Withdrawal by Subject|0
4697702|NCT02327169|16186557|P1|Overall Study|Withdrawal by Subject|1
4697703|NCT02327169|16186543|P15|Overall Study|Reason Not Specified|2
4697704|NCT02327169|16186544|P14|Overall Study|Reason Not Specified|0
4697705|NCT02327169|16186545|P13|Overall Study|Reason Not Specified|0
4697706|NCT02327169|16186546|P12|Overall Study|Reason Not Specified|1
4697707|NCT02327169|16186547|P11|Overall Study|Reason Not Specified|2
4697708|NCT02327169|16186548|P10|Overall Study|Reason Not Specified|1
4697709|NCT02327169|16186549|P9|Overall Study|Reason Not Specified|0
4697710|NCT02327169|16186550|P8|Overall Study|Reason Not Specified|0
4697711|NCT02327169|16186551|P7|Overall Study|Reason Not Specified|0
4697712|NCT02327169|16186552|P6|Overall Study|Reason Not Specified|0
4697713|NCT02327169|16186553|P5|Overall Study|Reason Not Specified|0
4697714|NCT02327169|16186554|P4|Overall Study|Reason Not Specified|0
4697715|NCT02327169|16186555|P3|Overall Study|Reason Not Specified|1
4697716|NCT02327169|16186556|P2|Overall Study|Reason Not Specified|0
4697717|NCT02327169|16186557|P1|Overall Study|Reason Not Specified|0
4697718|NCT02327169|16186543|P15|Overall Study|Symptomatic Deterioration|1
4697719|NCT02327169|16186544|P14|Overall Study|Symptomatic Deterioration|2
4697720|NCT02327169|16186545|P13|Overall Study|Symptomatic Deterioration|0
4697721|NCT02327169|16186546|P12|Overall Study|Symptomatic Deterioration|0
4697722|NCT02327169|16186547|P11|Overall Study|Symptomatic Deterioration|0
4697723|NCT02327169|16186548|P10|Overall Study|Symptomatic Deterioration|1
4697724|NCT02327169|16186549|P9|Overall Study|Symptomatic Deterioration|2
4697725|NCT02327169|16186550|P8|Overall Study|Symptomatic Deterioration|0
4697726|NCT02327169|16186551|P7|Overall Study|Symptomatic Deterioration|0
4697727|NCT02327169|16186552|P6|Overall Study|Symptomatic Deterioration|1
4697728|NCT02327169|16186553|P5|Overall Study|Symptomatic Deterioration|1
4697729|NCT02327169|16186554|P4|Overall Study|Symptomatic Deterioration|0
4697730|NCT02327169|16186555|P3|Overall Study|Symptomatic Deterioration|1
4697731|NCT02327169|16186556|P2|Overall Study|Symptomatic Deterioration|0
4697732|NCT02327169|16186557|P1|Overall Study|Symptomatic Deterioration|0
4697733|NCT02327169|16186543|P15|Overall Study|Adverse Event|1
4697734|NCT02327169|16186544|P14|Overall Study|Adverse Event|2
4697735|NCT02327169|16186545|P13|Overall Study|Adverse Event|0
4697736|NCT02327169|16186546|P12|Overall Study|Adverse Event|3
4697737|NCT02327169|16186547|P11|Overall Study|Adverse Event|0
4697738|NCT02327169|16186548|P10|Overall Study|Adverse Event|2
4697739|NCT02327169|16186549|P9|Overall Study|Adverse Event|0
4697740|NCT02327169|16186550|P8|Overall Study|Adverse Event|0
4697741|NCT02327169|16186551|P7|Overall Study|Adverse Event|0
4697742|NCT02327169|16186552|P6|Overall Study|Adverse Event|0
4697743|NCT02327169|16186553|P5|Overall Study|Adverse Event|1
4697744|NCT02327169|16186554|P4|Overall Study|Adverse Event|0
4697745|NCT02327169|16186555|P3|Overall Study|Adverse Event|1
4697746|NCT02327169|16186556|P2|Overall Study|Adverse Event|0
4697747|NCT02327169|16186557|P1|Overall Study|Adverse Event|2
4697748|NCT02327169|16186543|P15|Overall Study|Progressive Disease|3
4697749|NCT02327169|16186544|P14|Overall Study|Progressive Disease|3
4697750|NCT02327169|16186545|P13|Overall Study|Progressive Disease|1
4697751|NCT02327169|16186546|P12|Overall Study|Progressive Disease|3
4697752|NCT02327169|16186547|P11|Overall Study|Progressive Disease|4
4697753|NCT02327169|16186548|P10|Overall Study|Progressive Disease|4
4697754|NCT02327169|16186549|P9|Overall Study|Progressive Disease|4
4697755|NCT02327169|16186550|P8|Overall Study|Progressive Disease|3
4697756|NCT02327169|16186551|P7|Overall Study|Progressive Disease|3
4697757|NCT02327169|16186552|P6|Overall Study|Progressive Disease|3
4697758|NCT02327169|16186553|P5|Overall Study|Progressive Disease|4
4697759|NCT02327169|16186554|P4|Overall Study|Progressive Disease|3
4697760|NCT02327169|16186555|P3|Overall Study|Progressive Disease|4
4697761|NCT02327169|16186556|P2|Overall Study|Progressive Disease|3
4697762|NCT02327169|16186557|P1|Overall Study|Progressive Disease|1
4697763|NCT02327130|16186787|P1|Overall Study|Met exclusion criteria|3
4697764|NCT02327130|16186787|P1|Overall Study|Incorrectly place ventilator adaptor|1
4697765|NCT02327130|16186787|P1|Overall Study|Unable to provide breath sample|1
4697766|NCT02327130|16186787|P1|Overall Study|Physician Decision|2
4697767|NCT02327130|16186787|P1|Overall Study|Discharged in less than 5 days|5
4697768|NCT02327013|16186806|P5|Overall Study|Withdrawal before treatment|0
4697769|NCT02327013|16186807|P4|Overall Study|Withdrawal before treatment|0
4697770|NCT02327013|16186808|P3|Overall Study|Withdrawal before treatment|5
4697771|NCT02327013|16186809|P2|Overall Study|Withdrawal before treatment|1
4697772|NCT02327013|16186810|P1|Overall Study|Withdrawal before treatment|2
4697773|NCT02327013|16186806|P5|Overall Study|Protocol Violation|1
4697774|NCT02327013|16186807|P4|Overall Study|Protocol Violation|0
4697775|NCT02327013|16186808|P3|Overall Study|Protocol Violation|3
4697776|NCT02327013|16186809|P2|Overall Study|Protocol Violation|0
4697777|NCT02327013|16186810|P1|Overall Study|Protocol Violation|0
4697778|NCT02327013|16186806|P5|Overall Study|Administrative or other reason(s)|1
4697779|NCT02327013|16186807|P4|Overall Study|Administrative or other reason(s)|1
4697780|NCT02327013|16186808|P3|Overall Study|Administrative or other reason(s)|11
4697781|NCT02327013|16186809|P2|Overall Study|Administrative or other reason(s)|5
4697782|NCT02327013|16186810|P1|Overall Study|Administrative or other reason(s)|1
4697783|NCT02327013|16186806|P5|Overall Study|Lost to Follow-up|0
4697784|NCT02327013|16186807|P4|Overall Study|Lost to Follow-up|0
4697785|NCT02327013|16186808|P3|Overall Study|Lost to Follow-up|5
4697786|NCT02327013|16186809|P2|Overall Study|Lost to Follow-up|4
4697787|NCT02327013|16186810|P1|Overall Study|Lost to Follow-up|2
4697788|NCT02327013|16186806|P5|Overall Study|Withdrawal of Consent|0
4697789|NCT02327013|16186807|P4|Overall Study|Withdrawal of Consent|0
4697790|NCT02327013|16186808|P3|Overall Study|Withdrawal of Consent|3
4697791|NCT02327013|16186809|P2|Overall Study|Withdrawal of Consent|0
4697792|NCT02327013|16186810|P1|Overall Study|Withdrawal of Consent|1
4697793|NCT02327013|16186806|P5|Overall Study|Non-compliance with IMP|0
4697794|NCT02327013|16186807|P4|Overall Study|Non-compliance with IMP|0
4697795|NCT02327013|16186808|P3|Overall Study|Non-compliance with IMP|7
4697796|NCT02327013|16186809|P2|Overall Study|Non-compliance with IMP|2
4697797|NCT02327013|16186810|P1|Overall Study|Non-compliance with IMP|1
4697798|NCT02327013|16186806|P5|Overall Study|Lack of Efficacy|1
4697799|NCT02327013|16186807|P4|Overall Study|Lack of Efficacy|0
4697800|NCT02327013|16186808|P3|Overall Study|Lack of Efficacy|5
4697801|NCT02327013|16186809|P2|Overall Study|Lack of Efficacy|0
4697802|NCT02327013|16186810|P1|Overall Study|Lack of Efficacy|2
4697803|NCT02327013|16186806|P5|Overall Study|Adverse Event|1
4697804|NCT02327013|16186807|P4|Overall Study|Adverse Event|0
4697805|NCT02327013|16186808|P3|Overall Study|Adverse Event|3
4697806|NCT02327013|16186809|P2|Overall Study|Adverse Event|4
4697807|NCT02327013|16186810|P1|Overall Study|Adverse Event|4
4697808|NCT02326597|16186998|P2|Overall Study|Lost to Follow-up|32
4697809|NCT02326597|16186999|P1|Overall Study|Lost to Follow-up|42
4697810|NCT01686152|16187020|P3|Overall Study|Lost to Follow-up|5
4697811|NCT01686152|16187021|P2|Overall Study|Lost to Follow-up|6
4697812|NCT01686152|16187022|P1|Overall Study|Lost to Follow-up|7
4697813|NCT01686152|16187020|P3|Overall Study|IP Non-compliance|0
4697814|NCT01686152|16187021|P2|Overall Study|IP Non-compliance|5
4697815|NCT01686152|16187022|P1|Overall Study|IP Non-compliance|5
4697816|NCT01686152|16187020|P3|Overall Study|Lack of Efficacy|1
4697817|NCT01686152|16187021|P2|Overall Study|Lack of Efficacy|0
4697818|NCT01686152|16187022|P1|Overall Study|Lack of Efficacy|0
4697819|NCT01686152|16187020|P3|Overall Study|Adverse Event|0
4697820|NCT01686152|16187021|P2|Overall Study|Adverse Event|11
4697821|NCT01686152|16187022|P1|Overall Study|Adverse Event|12
4697822|NCT01686152|16187020|P3|Overall Study|Protocol Violation|0
4697823|NCT01686152|16187021|P2|Overall Study|Protocol Violation|1
4697824|NCT01686152|16187022|P1|Overall Study|Protocol Violation|6
4697825|NCT01686152|16187020|P3|Overall Study|Drug Code Unblinded|0
4697826|NCT01686152|16187021|P2|Overall Study|Drug Code Unblinded|1
4697827|NCT01686152|16187022|P1|Overall Study|Drug Code Unblinded|0
4697828|NCT01686152|16187020|P3|Overall Study|Withdrawal by Subject|3
4697829|NCT01686152|16187021|P2|Overall Study|Withdrawal by Subject|11
4697830|NCT01686152|16187022|P1|Overall Study|Withdrawal by Subject|11
4697831|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
4697832|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
4697833|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6
4697834|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697835|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697836|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697837|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697838|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697839|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697840|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697841|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697842|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697843|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697844|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4697845|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
4697846|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7
4697847|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2
4697848|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697849|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697850|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697851|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697852|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697853|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697854|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697855|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697856|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697857|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697858|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4697859|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1
4697860|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
4697861|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7
4697862|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697863|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697864|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697865|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697866|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697867|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697868|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697869|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697870|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697871|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697872|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4697873|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|2
4697874|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697875|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697876|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697877|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697878|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697879|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697880|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697881|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697882|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697883|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697884|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697885|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697886|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4697887|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697888|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4697889|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4697890|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697891|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697892|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697893|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697894|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697895|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697896|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697897|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697898|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697899|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697900|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4697901|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697902|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
4697903|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|3
4697904|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697905|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697906|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697907|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697908|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697909|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697910|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697911|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697912|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697913|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697914|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4697915|NCT02326298|16187058|P14|Open-label Period (Week 48 to Week 144)|Death|0
4697916|NCT02326298|16187059|P13|Open-label Period (Week 48 to Week 144)|Death|0
4697917|NCT02326298|16187060|P12|Open-label Period (Week 48 to Week 144)|Death|1
4697918|NCT02326298|16187061|P11|Open-label Period (Week 48 to Week 144)|Death|0
4697919|NCT02326298|16187062|P10|Open-label Period (Week 48 to Week 144)|Death|0
4697920|NCT02326298|16187063|P9|Open-label Period (Week 48 to Week 144)|Death|0
4697921|NCT02326298|16187064|P8|Open-label Period (Week 48 to Week 144)|Death|0
4697922|NCT02326298|16187065|P7|Open-label Period (Week 48 to Week 144)|Death|0
4697923|NCT02326298|16187066|P6|Open-label Period (Week 48 to Week 144)|Death|0
4697924|NCT02326298|16187067|P5|Open-label Period (Week 48 to Week 144)|Death|0
4697925|NCT02326298|16187068|P4|Open-label Period (Week 48 to Week 144)|Death|0
4697926|NCT02326298|16187069|P3|Open-label Period (Week 48 to Week 144)|Death|0
4697927|NCT02326298|16187070|P2|Open-label Period (Week 48 to Week 144)|Death|0
4697928|NCT02326298|16187071|P1|Open-label Period (Week 48 to Week 144)|Death|0
4697929|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697930|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697931|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697932|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697933|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697934|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697935|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697936|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697937|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2
4697938|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697939|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697940|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697941|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697942|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0
4697943|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697944|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697945|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697946|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697947|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697948|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697949|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4697950|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697951|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697952|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697953|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697954|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697955|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697956|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4697957|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697958|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697959|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697960|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697961|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697962|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697963|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
4697964|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1
4697965|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697966|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697967|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697968|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697969|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697970|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4697971|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697972|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697973|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697974|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697975|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697976|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697977|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1
4697978|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697979|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697980|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697981|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697982|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697983|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697984|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0
4697985|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697986|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697987|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697988|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697989|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697990|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697991|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697992|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
4697993|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697994|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697995|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697996|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697997|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697998|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4697999|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698000|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698001|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698002|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698003|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698004|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698005|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698006|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698007|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1
4698008|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698009|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698010|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698011|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698012|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0
4698013|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698014|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698015|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698016|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698017|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698018|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4
4698019|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698020|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2
4698021|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1
4698022|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698023|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698024|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698025|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698026|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0
4698027|NCT02326298|16187058|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698028|NCT02326298|16187059|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698029|NCT02326298|16187060|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698030|NCT02326298|16187061|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698031|NCT02326298|16187062|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698032|NCT02326298|16187063|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698033|NCT02326298|16187064|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698034|NCT02326298|16187065|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
4698035|NCT02326298|16187066|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698036|NCT02326298|16187067|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698037|NCT02326298|16187068|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698038|NCT02326298|16187069|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698039|NCT02326298|16187070|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698040|NCT02326298|16187071|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698041|NCT02326298|16187058|P14|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698042|NCT02326298|16187059|P13|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698043|NCT02326298|16187060|P12|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698044|NCT02326298|16187061|P11|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698045|NCT02326298|16187062|P10|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698046|NCT02326298|16187063|P9|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698047|NCT02326298|16187064|P8|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698048|NCT02326298|16187065|P7|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698049|NCT02326298|16187066|P6|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698050|NCT02326298|16187067|P5|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698051|NCT02326298|16187068|P4|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698052|NCT02326298|16187069|P3|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2
4698053|NCT02326298|16187070|P2|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698054|NCT02326298|16187071|P1|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0
4698055|NCT02326298|16187058|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698056|NCT02326298|16187059|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698057|NCT02326298|16187060|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698058|NCT02326298|16187061|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698059|NCT02326298|16187062|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698060|NCT02326298|16187063|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698061|NCT02326298|16187064|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698062|NCT02326298|16187065|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698063|NCT02326298|16187066|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698064|NCT02326298|16187067|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698065|NCT02326298|16187068|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698066|NCT02326298|16187069|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698067|NCT02326298|16187070|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
4698068|NCT02326298|16187071|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
4698069|NCT02326298|16187058|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698070|NCT02326298|16187059|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698071|NCT02326298|16187060|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698072|NCT02326298|16187061|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698073|NCT02326298|16187062|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698074|NCT02326298|16187063|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698075|NCT02326298|16187064|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698076|NCT02326298|16187065|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698077|NCT02326298|16187066|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698078|NCT02326298|16187067|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698079|NCT02326298|16187068|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698080|NCT02326298|16187069|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698081|NCT02326298|16187070|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
4698082|NCT02326298|16187071|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
4698083|NCT02326298|16187058|P14|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698084|NCT02326298|16187059|P13|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698085|NCT02326298|16187060|P12|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698086|NCT02326298|16187061|P11|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698087|NCT02326298|16187062|P10|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698088|NCT02326298|16187063|P9|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698089|NCT02326298|16187064|P8|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698090|NCT02326298|16187065|P7|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698091|NCT02326298|16187066|P6|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698092|NCT02326298|16187067|P5|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698093|NCT02326298|16187068|P4|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698094|NCT02326298|16187069|P3|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698095|NCT02326298|16187070|P2|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0
4698096|NCT02326298|16187071|P1|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1
4698097|NCT02326298|16187058|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698098|NCT02326298|16187059|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698099|NCT02326298|16187060|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698100|NCT02326298|16187061|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698101|NCT02326298|16187062|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698102|NCT02326298|16187063|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698103|NCT02326298|16187064|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698104|NCT02326298|16187065|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698105|NCT02326298|16187066|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698106|NCT02326298|16187067|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698107|NCT02326298|16187068|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698108|NCT02326298|16187069|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
4698109|NCT02326298|16187070|P2|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698110|NCT02326298|16187071|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698111|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698112|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698113|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Pregnancy|1
4698114|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698115|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698116|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698117|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698118|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698119|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698120|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698121|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698122|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698123|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698124|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698125|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Pregnancy|0
4698126|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698127|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698128|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698129|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1
4698130|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698131|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698132|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698133|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698134|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698135|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698136|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698137|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698138|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698139|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698140|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0
4698141|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
4698142|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698143|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3
4698144|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1
4698145|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698146|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698147|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698148|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698149|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698150|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698151|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698152|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698153|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698154|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698155|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0
4698156|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2
4698157|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698158|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698159|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4
4698160|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698161|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698162|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698163|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698164|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698165|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698166|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698167|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698168|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698169|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698170|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0
4698171|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3
4698172|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698173|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2
4698174|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698175|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1
4698176|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698177|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698178|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698179|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698180|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698181|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698182|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698183|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698184|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698185|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0
4698186|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698187|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698188|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698189|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Protocol Violation|1
4698190|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698191|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698192|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698193|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698194|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698195|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698196|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698197|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698198|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698199|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698200|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Protocol Violation|0
4698201|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698202|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698203|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4698204|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698205|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1
4698206|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698207|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698208|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698209|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698210|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698211|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698212|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698213|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698214|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698215|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0
4698216|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Adverse Event|1
4698217|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698218|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Adverse Event|3
4698219|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Adverse Event|8
4698220|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Adverse Event|1
4698221|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698222|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698223|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698224|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698225|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698226|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698227|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698228|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698229|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698230|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Adverse Event|0
4698231|NCT02326272|16187094|P15|Open-label Period (Week 48 to Week 144)|Death|0
4698232|NCT02326272|16187095|P14|Open-label Period (Week 48 to Week 144)|Death|0
4698233|NCT02326272|16187096|P13|Open-label Period (Week 48 to Week 144)|Death|1
4698234|NCT02326272|16187097|P12|Open-label Period (Week 48 to Week 144)|Death|0
4698235|NCT02326272|16187098|P11|Open-label Period (Week 48 to Week 144)|Death|0
4698236|NCT02326272|16187099|P10|Open-label Period (Week 48 to Week 144)|Death|0
4698237|NCT02326272|16187100|P9|Open-label Period (Week 48 to Week 144)|Death|0
4698238|NCT02326272|16187101|P8|Open-label Period (Week 48 to Week 144)|Death|0
4698239|NCT02326272|16187102|P7|Open-label Period (Week 48 to Week 144)|Death|0
4698240|NCT02326272|16187103|P6|Open-label Period (Week 48 to Week 144)|Death|0
4698241|NCT02326272|16187104|P5|Open-label Period (Week 48 to Week 144)|Death|0
4698242|NCT02326272|16187105|P4|Open-label Period (Week 48 to Week 144)|Death|0
4698243|NCT02326272|16187106|P3|Open-label Period (Week 48 to Week 144)|Death|0
4698244|NCT02326272|16187107|P2|Open-label Period (Week 48 to Week 144)|Death|0
4698245|NCT02326272|16187108|P1|Open-label Period (Week 48 to Week 144)|Death|0
4698246|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698247|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698248|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698249|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698250|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698251|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698252|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698253|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698254|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1
4698255|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698256|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698257|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698258|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698259|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698260|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0
4698261|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698262|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698263|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698264|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698265|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698266|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698267|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698268|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698269|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698270|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1
4698271|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698272|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698273|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698274|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698275|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0
4698276|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698277|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698278|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698279|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698280|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698281|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698282|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
4698283|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
4698284|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1
4698285|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2
4698286|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698287|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698288|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698289|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698290|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0
4698291|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698292|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698293|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698294|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698295|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698296|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698297|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Non-compliance|1
4698298|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698299|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698300|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698301|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698302|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698303|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698304|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698305|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Non-compliance|0
4698306|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698307|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698308|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698309|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698310|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698311|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698312|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698313|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698314|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Pregnancy|1
4698315|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698316|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698317|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698318|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698319|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698320|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Pregnancy|0
4698321|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698322|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698323|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698324|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698325|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698326|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698327|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698328|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1
4698329|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698330|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698331|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698332|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698333|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698334|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698335|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0
4698336|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698337|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698338|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698339|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698340|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698341|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698342|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698343|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698344|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698345|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3
4698346|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698347|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1
4698348|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698349|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698350|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0
4698351|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698352|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698353|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698354|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698355|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698356|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698357|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698358|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
4698359|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698360|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2
4698361|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698362|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698363|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698364|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698365|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0
4698366|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698367|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698368|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698369|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698370|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698371|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4698372|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4698373|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698374|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1
4698375|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2
4698376|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698377|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698378|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698379|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698380|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0
4698381|NCT02326272|16187094|P15|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698382|NCT02326272|16187095|P14|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698383|NCT02326272|16187096|P13|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698384|NCT02326272|16187097|P12|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698385|NCT02326272|16187098|P11|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698386|NCT02326272|16187099|P10|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698387|NCT02326272|16187100|P9|Maintenance Period (Week 16 to Week 48)|Adverse Event|1
4698388|NCT02326272|16187101|P8|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4698389|NCT02326272|16187102|P7|Maintenance Period (Week 16 to Week 48)|Adverse Event|4
4698390|NCT02326272|16187103|P6|Maintenance Period (Week 16 to Week 48)|Adverse Event|3
4698391|NCT02326272|16187104|P5|Maintenance Period (Week 16 to Week 48)|Adverse Event|2
4698392|NCT02326272|16187105|P4|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698393|NCT02326272|16187106|P3|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698394|NCT02326272|16187107|P2|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698395|NCT02326272|16187108|P1|Maintenance Period (Week 16 to Week 48)|Adverse Event|0
4698396|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698397|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698398|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698399|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698400|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698401|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698402|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698403|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698404|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698405|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698406|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698407|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698408|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1
4698409|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698410|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0
4698411|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698412|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698413|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698414|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698415|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698416|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698417|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698418|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698419|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698420|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698421|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698422|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698423|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1
4698424|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698425|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0
4698426|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698427|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698428|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698429|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698430|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698431|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698432|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698433|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698434|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698435|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698436|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698437|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698438|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Missed two doses|1
4698439|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698440|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Missed two doses|0
4698441|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698442|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698443|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698444|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698445|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698446|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698447|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698448|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698449|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698450|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698451|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698452|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698453|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Moved from the study area|1
4698454|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698455|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Moved from the study area|0
4698456|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698457|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698458|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698459|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698460|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698461|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698462|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698463|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698464|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698465|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698466|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698467|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0
4698468|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1
4698469|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2
4698470|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3
4698471|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698472|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698473|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698474|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698475|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698476|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698477|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698478|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698479|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698480|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698481|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698482|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698483|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0
4698484|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2
4698485|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1
4698486|NCT02326272|16187094|P15|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698487|NCT02326272|16187095|P14|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698488|NCT02326272|16187096|P13|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698489|NCT02326272|16187097|P12|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698490|NCT02326272|16187098|P11|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698491|NCT02326272|16187099|P10|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698492|NCT02326272|16187100|P9|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698493|NCT02326272|16187101|P8|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698494|NCT02326272|16187102|P7|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698495|NCT02326272|16187103|P6|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698496|NCT02326272|16187104|P5|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698497|NCT02326272|16187105|P4|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698498|NCT02326272|16187106|P3|Initial Period (Week 0 to Week 16)|Adverse Event|1
4698499|NCT02326272|16187107|P2|Initial Period (Week 0 to Week 16)|Adverse Event|3
4698500|NCT02326272|16187108|P1|Initial Period (Week 0 to Week 16)|Adverse Event|0
4698501|NCT02326220|16187145|P3|Open-label Treatment Period|Lost to Follow-up|1
4698502|NCT02326220|16187146|P2|Open-label Treatment Period|Lost to Follow-up|0
4698503|NCT02326220|16187147|P1|Open-label Treatment Period|Lost to Follow-up|0
4698504|NCT02326220|16187145|P3|Open-label Treatment Period|Withdrawal by Subject|1
4698505|NCT02326220|16187146|P2|Open-label Treatment Period|Withdrawal by Subject|0
4698506|NCT02326220|16187147|P1|Open-label Treatment Period|Withdrawal by Subject|0
4698507|NCT02326220|16187145|P3|Double-blind Treatment Period|Withdrawal by Subject|0
4698508|NCT02326220|16187146|P2|Double-blind Treatment Period|Withdrawal by Subject|1
4698509|NCT02326220|16187147|P1|Double-blind Treatment Period|Withdrawal by Subject|0
4698510|NCT02326220|16187145|P3|Double-blind Treatment Period|Protocol Violation|0
4698511|NCT02326220|16187146|P2|Double-blind Treatment Period|Protocol Violation|1
4698512|NCT02326220|16187147|P1|Double-blind Treatment Period|Protocol Violation|0
4698513|NCT02326220|16187145|P3|Double-blind Treatment Period|Adverse Event|0
4698514|NCT02326220|16187146|P2|Double-blind Treatment Period|Adverse Event|2
4698515|NCT02326220|16187147|P1|Double-blind Treatment Period|Adverse Event|1
4698516|NCT02326025|16187200|P2|Overall Study|Protocol Violation|1
4698517|NCT02326025|16187201|P1|Overall Study|Protocol Violation|0
4698518|NCT02326025|16187200|P2|Overall Study|Withdrawal by Subject|2
4698519|NCT02326025|16187201|P1|Overall Study|Withdrawal by Subject|0
4698520|NCT02326025|16187200|P2|Overall Study|Physician and Participant Decision|0
4698521|NCT02326025|16187201|P1|Overall Study|Physician and Participant Decision|1
4698522|NCT02326025|16187200|P2|Overall Study|Physician Decision|2
4698523|NCT02326025|16187201|P1|Overall Study|Physician Decision|1
4698524|NCT02326025|16187200|P2|Overall Study|Adverse Event|0
4698525|NCT02326025|16187201|P1|Overall Study|Adverse Event|3
4698526|NCT02325791|16187248|P4|Overall Study|Withdrawal by Subject|16
4698527|NCT02325791|16187249|P3|Overall Study|Withdrawal by Subject|8
4698528|NCT02325791|16187250|P2|Overall Study|Withdrawal by Subject|5
4698529|NCT02325791|16187251|P1|Overall Study|Withdrawal by Subject|0
4698530|NCT02325791|16187248|P4|Overall Study|Protocol Violation|0
4698531|NCT02325791|16187249|P3|Overall Study|Protocol Violation|1
4698532|NCT02325791|16187250|P2|Overall Study|Protocol Violation|0
4698533|NCT02325791|16187251|P1|Overall Study|Protocol Violation|0
4698534|NCT02325791|16187248|P4|Overall Study|Physician Decision|0
4698535|NCT02325791|16187249|P3|Overall Study|Physician Decision|1
4698536|NCT02325791|16187250|P2|Overall Study|Physician Decision|1
4698537|NCT02325791|16187251|P1|Overall Study|Physician Decision|0
4698538|NCT02325791|16187248|P4|Overall Study|Lost to Follow-up|9
4698539|NCT02325791|16187249|P3|Overall Study|Lost to Follow-up|14
4698540|NCT02325791|16187250|P2|Overall Study|Lost to Follow-up|15
4698541|NCT02325791|16187251|P1|Overall Study|Lost to Follow-up|0
4698542|NCT02325791|16187248|P4|Overall Study|Death|1
4698543|NCT02325791|16187249|P3|Overall Study|Death|0
4698544|NCT02325791|16187250|P2|Overall Study|Death|3
4698545|NCT02325791|16187251|P1|Overall Study|Death|0
4698546|NCT02325791|16187248|P4|Overall Study|Adverse Event|0
4698547|NCT02325791|16187249|P3|Overall Study|Adverse Event|1
4698548|NCT02325791|16187250|P2|Overall Study|Adverse Event|1
4698549|NCT02325791|16187251|P1|Overall Study|Adverse Event|0
4698550|NCT02325713|16187286|P16|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698551|NCT02325713|16187287|P15|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698552|NCT02325713|16187288|P14|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698553|NCT02325713|16187289|P13|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698554|NCT02325713|16187290|P12|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698555|NCT02325713|16187291|P11|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698556|NCT02325713|16187292|P10|Intervention Period 3 (2 Days)|Withdrawal by Subject|1
4698557|NCT02325713|16187293|P9|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698558|NCT02325713|16187294|P8|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698559|NCT02325713|16187295|P7|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698560|NCT02325713|16187296|P6|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698561|NCT02325713|16187297|P5|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698562|NCT02325713|16187298|P4|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698563|NCT02325713|16187299|P3|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698564|NCT02325713|16187300|P2|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698565|NCT02325713|16187301|P1|Intervention Period 3 (2 Days)|Withdrawal by Subject|0
4698566|NCT02325713|16187286|P16|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698567|NCT02325713|16187287|P15|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698568|NCT02325713|16187288|P14|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698569|NCT02325713|16187289|P13|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698570|NCT02325713|16187290|P12|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698571|NCT02325713|16187291|P11|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698572|NCT02325713|16187292|P10|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698573|NCT02325713|16187293|P9|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698574|NCT02325713|16187294|P8|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698575|NCT02325713|16187295|P7|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698576|NCT02325713|16187296|P6|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698577|NCT02325713|16187297|P5|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698578|NCT02325713|16187298|P4|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698579|NCT02325713|16187299|P3|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698580|NCT02325713|16187300|P2|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0
4698581|NCT02325713|16187301|P1|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1
4698582|NCT02325713|16187286|P16|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698583|NCT02325713|16187287|P15|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698584|NCT02325713|16187288|P14|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698585|NCT02325713|16187289|P13|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698586|NCT02325713|16187290|P12|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698587|NCT02325713|16187291|P11|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1
4698588|NCT02325713|16187292|P10|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698589|NCT02325713|16187293|P9|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698590|NCT02325713|16187294|P8|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698591|NCT02325713|16187295|P7|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698592|NCT02325713|16187296|P6|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698593|NCT02325713|16187297|P5|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698594|NCT02325713|16187298|P4|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698595|NCT02325713|16187299|P3|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698596|NCT02325713|16187300|P2|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698597|NCT02325713|16187301|P1|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0
4698598|NCT02325518|16187415|P2|Overall Study|Withdrawal by Subject|1
4698599|NCT02325518|16187416|P1|Overall Study|Withdrawal by Subject|0
4698600|NCT02325518|16187415|P2|Overall Study|Physician Decision|1
4698601|NCT02325518|16187416|P1|Overall Study|Physician Decision|0
4698602|NCT02325518|16187415|P2|Overall Study|Adverse Event|1
4698603|NCT02325518|16187416|P1|Overall Study|Adverse Event|4
4698604|NCT02325401|16187425|P3|Overall Study|Withdrawal by Subject|1
4698605|NCT02325401|16187426|P2|Overall Study|Withdrawal by Subject|1
4698606|NCT02325401|16187427|P1|Overall Study|Withdrawal by Subject|0
4698607|NCT02325219|16187450|P5|After Controlled Period (Week 16 - 52)|Pregnancy|0
4698608|NCT02325219|16187451|P4|After Controlled Period (Week 16 - 52)|Pregnancy|0
4698609|NCT02325219|16187452|P3|After Controlled Period (Week 16 - 52)|Pregnancy|0
4698610|NCT02325219|16187453|P2|After Controlled Period (Week 16 - 52)|Pregnancy|1
4698611|NCT02325219|16187454|P1|After Controlled Period (Week 16 - 52)|Pregnancy|0
4698612|NCT02325219|16187450|P5|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4698613|NCT02325219|16187451|P4|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4698614|NCT02325219|16187452|P3|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4698615|NCT02325219|16187453|P2|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2
4698616|NCT02325219|16187454|P1|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0
4698617|NCT02325219|16187450|P5|After Controlled Period (Week 16 - 52)|Adverse Event|1
4698618|NCT02325219|16187451|P4|After Controlled Period (Week 16 - 52)|Adverse Event|0
4698619|NCT02325219|16187452|P3|After Controlled Period (Week 16 - 52)|Adverse Event|0
4698620|NCT02325219|16187453|P2|After Controlled Period (Week 16 - 52)|Adverse Event|0
4698621|NCT02325219|16187454|P1|After Controlled Period (Week 16 - 52)|Adverse Event|0
4698622|NCT02325219|16187450|P5|Controlled Period (Week 0 - 16)|Other|0
4698623|NCT02325219|16187451|P4|Controlled Period (Week 0 - 16)|Other|0
4698624|NCT02325219|16187452|P3|Controlled Period (Week 0 - 16)|Other|1
4698625|NCT02325219|16187453|P2|Controlled Period (Week 0 - 16)|Other|0
4698626|NCT02325219|16187454|P1|Controlled Period (Week 0 - 16)|Other|0
4698627|NCT02325219|16187450|P5|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4698628|NCT02325219|16187451|P4|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4698629|NCT02325219|16187452|P3|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0
4698630|NCT02325219|16187453|P2|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1
4698631|NCT02325219|16187454|P1|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6
4698632|NCT02325219|16187450|P5|Controlled Period (Week 0 - 16)|Adverse Event|0
4698633|NCT02325219|16187451|P4|Controlled Period (Week 0 - 16)|Adverse Event|0
4698634|NCT02325219|16187452|P3|Controlled Period (Week 0 - 16)|Adverse Event|0
4698635|NCT02325219|16187453|P2|Controlled Period (Week 0 - 16)|Adverse Event|1
4698636|NCT02325219|16187454|P1|Controlled Period (Week 0 - 16)|Adverse Event|6
4698637|NCT02324842|16187646|P3|Overall Study|Lost to Follow-up|2
4698638|NCT02324842|16187647|P2|Overall Study|Lost to Follow-up|1
4698639|NCT02324842|16187648|P1|Overall Study|Lost to Follow-up|1
4698640|NCT02324699|16187682|P1|Overall Study|study terminated|1
4698641|NCT02324569|16187802|P2|Overall Study|Inconvenient Schedule|0
4698642|NCT02324569|16187803|P1|Overall Study|Inconvenient Schedule|2
4698643|NCT02324569|16187802|P2|Overall Study|Change Insulin Dosage Exceeding Criteria|2
4698644|NCT02324569|16187803|P1|Overall Study|Change Insulin Dosage Exceeding Criteria|0
4698645|NCT02324569|16187802|P2|Overall Study|Lack of Efficacy|3
4698646|NCT02324569|16187803|P1|Overall Study|Lack of Efficacy|2
4698647|NCT02324569|16187802|P2|Overall Study|Voluntary Withdrawal|6
4698648|NCT02324569|16187803|P1|Overall Study|Voluntary Withdrawal|3
4698649|NCT02324569|16187802|P2|Overall Study|Pretreatment Event/Adverse Event|10
4698650|NCT02324569|16187803|P1|Overall Study|Pretreatment Event/Adverse Event|9
4698651|NCT02324465|16187861|P2|Overall Study|device failure|1
4698652|NCT02324465|16187862|P1|Overall Study|device failure|0
4698653|NCT02324361|16187876|P2|Overall Study|Lost to Follow-up|2
4698654|NCT02324361|16187877|P1|Overall Study|Lost to Follow-up|5
4698655|NCT02324270|16187907|P3|Overall Study|Non Compliance with Study Drug|0
4698656|NCT02324270|16187908|P2|Overall Study|Non Compliance with Study Drug|2
4698657|NCT02324270|16187909|P1|Overall Study|Non Compliance with Study Drug|1
4698658|NCT02324270|16187907|P3|Overall Study|Protocol Violation|1
4698659|NCT02324270|16187908|P2|Overall Study|Protocol Violation|1
4698660|NCT02324270|16187909|P1|Overall Study|Protocol Violation|0
4698661|NCT02324270|16187907|P3|Overall Study|Lost to Follow-up|4
4698662|NCT02324270|16187908|P2|Overall Study|Lost to Follow-up|3
4698663|NCT02324270|16187909|P1|Overall Study|Lost to Follow-up|4
4698664|NCT02324270|16187907|P3|Overall Study|Withdrawal by Subject|0
4698665|NCT02324270|16187908|P2|Overall Study|Withdrawal by Subject|1
4698666|NCT02324270|16187909|P1|Overall Study|Withdrawal by Subject|0
4698667|NCT02324205|16187919|P1|Overall Study|Withdrawal by Subject|37
4698668|NCT02324153|16187931|P2|Overall Study|Developed delirium preoperatively|0
4698747|NCT02322866|16188129|P1|Overall Study|Protocol Violation|1
4698669|NCT02324153|16187932|P1|Overall Study|Developed delirium preoperatively|1
4698670|NCT02324153|16187931|P2|Overall Study|Surgery postponed after randomization|0
4698671|NCT02324153|16187932|P1|Overall Study|Surgery postponed after randomization|3
4698672|NCT02324153|16187931|P2|Overall Study|Withdrawal by Subject|1
4698673|NCT02324153|16187932|P1|Overall Study|Withdrawal by Subject|4
4698674|NCT02324049|16187963|P1|Part C|Study terminated|11
4698675|NCT02323646|16187976|P3|Treatment Course 2|Non-compliance|1
4698676|NCT02323646|16187977|P2|Treatment Course 2|Non-compliance|1
4698677|NCT02323646|16187978|P1|Treatment Course 2|Non-compliance|0
4698678|NCT02323646|16187976|P3|Treatment Course 2|Lost to Follow-up|1
4698679|NCT02323646|16187977|P2|Treatment Course 2|Lost to Follow-up|0
4698680|NCT02323646|16187978|P1|Treatment Course 2|Lost to Follow-up|0
4698681|NCT02323646|16187976|P3|Treatment Course 2|Adverse Event|1
4698682|NCT02323646|16187977|P2|Treatment Course 2|Adverse Event|0
4698683|NCT02323646|16187978|P1|Treatment Course 2|Adverse Event|1
4698684|NCT02323646|16187976|P3|Treatment Course 1|Withdrawal by Subject|0
4698685|NCT02323646|16187977|P2|Treatment Course 1|Withdrawal by Subject|2
4698686|NCT02323646|16187978|P1|Treatment Course 1|Withdrawal by Subject|0
4698687|NCT02323646|16187976|P3|Treatment Course 1|Lost to Follow-up|2
4698688|NCT02323646|16187977|P2|Treatment Course 1|Lost to Follow-up|0
4698689|NCT02323646|16187978|P1|Treatment Course 1|Lost to Follow-up|1
4698690|NCT02323646|16187976|P3|Treatment Course 1|Heavy Bleeding|0
4698691|NCT02323646|16187977|P2|Treatment Course 1|Heavy Bleeding|1
4698692|NCT02323646|16187978|P1|Treatment Course 1|Heavy Bleeding|1
4698693|NCT02323646|16187976|P3|Treatment Course 1|Adverse Event|1
4698694|NCT02323646|16187977|P2|Treatment Course 1|Adverse Event|0
4698695|NCT02323646|16187978|P1|Treatment Course 1|Adverse Event|1
4698696|NCT02323204|16188026|P4|6-month Follow-up Survey Completion|Withdrawal by Subject|1
4698697|NCT02323204|16188027|P3|6-month Follow-up Survey Completion|Withdrawal by Subject|3
4698698|NCT02323204|16188028|P2|6-month Follow-up Survey Completion|Withdrawal by Subject|0
4698699|NCT02323204|16188029|P1|6-month Follow-up Survey Completion|Withdrawal by Subject|0
4698700|NCT02323204|16188026|P4|6-month Follow-up Survey Completion|Lost to Follow-up|43
4698701|NCT02323204|16188027|P3|6-month Follow-up Survey Completion|Lost to Follow-up|38
4698702|NCT02323204|16188028|P2|6-month Follow-up Survey Completion|Lost to Follow-up|50
4698703|NCT02323204|16188029|P1|6-month Follow-up Survey Completion|Lost to Follow-up|49
4698704|NCT02323204|16188026|P4|3-month Follow-up Survey Completion|Withdrawal by Subject|2
4698705|NCT02323204|16188027|P3|3-month Follow-up Survey Completion|Withdrawal by Subject|0
4698706|NCT02323204|16188028|P2|3-month Follow-up Survey Completion|Withdrawal by Subject|2
4698707|NCT02323204|16188029|P1|3-month Follow-up Survey Completion|Withdrawal by Subject|0
4698708|NCT02323204|16188026|P4|3-month Follow-up Survey Completion|Lost to Follow-up|42
4698709|NCT02323204|16188027|P3|3-month Follow-up Survey Completion|Lost to Follow-up|41
4698710|NCT02323204|16188028|P2|3-month Follow-up Survey Completion|Lost to Follow-up|45
4698711|NCT02323204|16188029|P1|3-month Follow-up Survey Completion|Lost to Follow-up|54
4698712|NCT02323204|16188026|P4|6-week Follow-up Intervention Booster|Withdrawal by Subject|2
4698713|NCT02323204|16188027|P3|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
4698714|NCT02323204|16188028|P2|6-week Follow-up Intervention Booster|Withdrawal by Subject|8
4698715|NCT02323204|16188029|P1|6-week Follow-up Intervention Booster|Withdrawal by Subject|0
4698716|NCT02323204|16188026|P4|6-week Follow-up Intervention Booster|Lost to Follow-up|34
4698717|NCT02323204|16188027|P3|6-week Follow-up Intervention Booster|Lost to Follow-up|0
4698718|NCT02323204|16188028|P2|6-week Follow-up Intervention Booster|Lost to Follow-up|35
4698719|NCT02323204|16188029|P1|6-week Follow-up Intervention Booster|Lost to Follow-up|0
4698720|NCT02323204|16188026|P4|6-week Follow-up Survey Completion|Withdrawal by Subject|2
4698721|NCT02323204|16188027|P3|6-week Follow-up Survey Completion|Withdrawal by Subject|3
4698722|NCT02323204|16188028|P2|6-week Follow-up Survey Completion|Withdrawal by Subject|8
4698723|NCT02323204|16188029|P1|6-week Follow-up Survey Completion|Withdrawal by Subject|12
4698724|NCT02323204|16188026|P4|6-week Follow-up Survey Completion|Lost to Follow-up|35
4698725|NCT02323204|16188027|P3|6-week Follow-up Survey Completion|Lost to Follow-up|39
4698726|NCT02323204|16188028|P2|6-week Follow-up Survey Completion|Lost to Follow-up|28
4698727|NCT02323204|16188029|P1|6-week Follow-up Survey Completion|Lost to Follow-up|29
4698728|NCT02323204|16188026|P4|Baseline Survey Completion|Withdrawal by Subject|3
4698729|NCT02323204|16188027|P3|Baseline Survey Completion|Withdrawal by Subject|5
4698730|NCT02323204|16188028|P2|Baseline Survey Completion|Withdrawal by Subject|9
4698731|NCT02323204|16188029|P1|Baseline Survey Completion|Withdrawal by Subject|10
4698732|NCT02322892|16188102|P2|Overall Study|Protocol Violation|0
4698733|NCT02322892|16188103|P1|Overall Study|Protocol Violation|1
4698734|NCT02322892|16188102|P2|Overall Study|Met exclusion criteria|1
4698735|NCT02322892|16188103|P1|Overall Study|Met exclusion criteria|0
4698736|NCT02322892|16188102|P2|Overall Study|Surgery cancelled|2
4698737|NCT02322892|16188103|P1|Overall Study|Surgery cancelled|1
4698738|NCT02322879|16188119|P2|First Intervention|Physician Decision|0
4698739|NCT02322879|16188120|P1|First Intervention|Physician Decision|1
4698740|NCT02322866|16188128|P2|Overall Study|Other Miscellaneous Reasons|6
4698741|NCT02322866|16188129|P1|Overall Study|Other Miscellaneous Reasons|6
4698742|NCT02322866|16188128|P2|Overall Study|Lack of Efficacy|1
4698743|NCT02322866|16188129|P1|Overall Study|Lack of Efficacy|3
4698744|NCT02322866|16188128|P2|Overall Study|Noncompliance with Treatment|4
4698745|NCT02322866|16188129|P1|Overall Study|Noncompliance with Treatment|3
4698746|NCT02322866|16188128|P2|Overall Study|Protocol Violation|0
4698748|NCT02322866|16188128|P2|Overall Study|Lost to Follow-up|39
4698749|NCT02322866|16188129|P1|Overall Study|Lost to Follow-up|36
4698750|NCT02322866|16188128|P2|Overall Study|Withdrawal of Consent|25
4698751|NCT02322866|16188129|P1|Overall Study|Withdrawal of Consent|16
4698752|NCT02322866|16188128|P2|Overall Study|Adverse Event|11
4698753|NCT02322866|16188129|P1|Overall Study|Adverse Event|6
4698754|NCT02322814|16188156|P5|Overall Study|Withdrawal by Subject|3
4698755|NCT02322814|16188157|P4|Overall Study|Withdrawal by Subject|1
4698756|NCT02322814|16188158|P3|Overall Study|Withdrawal by Subject|2
4698757|NCT02322814|16188159|P2|Overall Study|Withdrawal by Subject|4
4698758|NCT02322814|16188160|P1|Overall Study|Withdrawal by Subject|5
4698759|NCT02322814|16188156|P5|Overall Study|Death|6
4698760|NCT02322814|16188157|P4|Overall Study|Death|10
4698761|NCT02322814|16188158|P3|Overall Study|Death|30
4698762|NCT02322814|16188159|P2|Overall Study|Death|22
4698763|NCT02322814|16188160|P1|Overall Study|Death|7
4698764|NCT02322814|16188156|P5|Overall Study|Protocol Violation|0
4698765|NCT02322814|16188157|P4|Overall Study|Protocol Violation|0
4698766|NCT02322814|16188158|P3|Overall Study|Protocol Violation|0
4698767|NCT02322814|16188159|P2|Overall Study|Protocol Violation|0
4698768|NCT02322814|16188160|P1|Overall Study|Protocol Violation|1
4698769|NCT02322814|16188156|P5|Overall Study|Other|0
4698770|NCT02322814|16188157|P4|Overall Study|Other|0
4698771|NCT02322814|16188158|P3|Overall Study|Other|0
4698772|NCT02322814|16188159|P2|Overall Study|Other|0
4698773|NCT02322814|16188160|P1|Overall Study|Other|2
4698774|NCT02322814|16188156|P5|Overall Study|Lost to Follow-up|0
4698775|NCT02322814|16188157|P4|Overall Study|Lost to Follow-up|0
4698776|NCT02322814|16188158|P3|Overall Study|Lost to Follow-up|1
4698777|NCT02322814|16188159|P2|Overall Study|Lost to Follow-up|2
4698778|NCT02322814|16188160|P1|Overall Study|Lost to Follow-up|1
4698779|NCT02322814|16188156|P5|Overall Study|Progressive Disease|0
4698780|NCT02322814|16188157|P4|Overall Study|Progressive Disease|1
4698781|NCT02322814|16188158|P3|Overall Study|Progressive Disease|0
4698782|NCT02322814|16188159|P2|Overall Study|Progressive Disease|2
4698783|NCT02322814|16188160|P1|Overall Study|Progressive Disease|0
4698784|NCT02322814|16188156|P5|Overall Study|Ongoing Study|22
4698785|NCT02322814|16188157|P4|Overall Study|Ongoing Study|20
4698786|NCT02322814|16188158|P3|Overall Study|Ongoing Study|14
4698787|NCT02322814|16188159|P2|Overall Study|Ongoing Study|13
4698788|NCT02322814|16188160|P1|Overall Study|Ongoing Study|0
4698789|NCT02322775|16188186|P2|Overall Study|Not willing to perform all FU visits|1
4698790|NCT02322775|16188187|P1|Overall Study|Not willing to perform all FU visits|0
4698791|NCT02322775|16188186|P2|Overall Study|Withdrawal by Subject|4
4698792|NCT02322775|16188187|P1|Overall Study|Withdrawal by Subject|3
4698793|NCT02322775|16188186|P2|Overall Study|Protocol Violation|0
4698794|NCT02322775|16188187|P1|Overall Study|Protocol Violation|1
4698795|NCT02322775|16188186|P2|Overall Study|Lost to Follow-up|1
4698796|NCT02322775|16188187|P1|Overall Study|Lost to Follow-up|0
4698797|NCT02322775|16188186|P2|Overall Study|Adverse Event|0
4698798|NCT02322775|16188187|P1|Overall Study|Adverse Event|1
4698799|NCT02322749|16188213|P6|Period 3|Withdrawal by Subject|0
4698800|NCT02322749|16188214|P5|Period 3|Withdrawal by Subject|0
4698801|NCT02322749|16188215|P4|Period 3|Withdrawal by Subject|0
4698802|NCT02322749|16188216|P3|Period 3|Withdrawal by Subject|1
4698803|NCT02322749|16188217|P2|Period 3|Withdrawal by Subject|0
4698804|NCT02322749|16188218|P1|Period 3|Withdrawal by Subject|0
4698805|NCT02322749|16188213|P6|Period 2|Withdrawal by Subject|0
4698806|NCT02322749|16188214|P5|Period 2|Withdrawal by Subject|0
4698807|NCT02322749|16188215|P4|Period 2|Withdrawal by Subject|1
4698808|NCT02322749|16188216|P3|Period 2|Withdrawal by Subject|0
4698809|NCT02322749|16188217|P2|Period 2|Withdrawal by Subject|0
4698810|NCT02322749|16188218|P1|Period 2|Withdrawal by Subject|0
4698811|NCT02322749|16188213|P6|Period 2|Adverse Event|0
4698812|NCT02322749|16188214|P5|Period 2|Adverse Event|0
4698813|NCT02322749|16188215|P4|Period 2|Adverse Event|1
4698814|NCT02322749|16188216|P3|Period 2|Adverse Event|0
4698815|NCT02322749|16188217|P2|Period 2|Adverse Event|0
4698816|NCT02322749|16188218|P1|Period 2|Adverse Event|0
4698817|NCT02322710|16188243|P2|Overall Study|Protocol Violation|25
4698818|NCT02322710|16188244|P1|Overall Study|Protocol Violation|20
4698819|NCT02322710|16188243|P2|Overall Study|No efficacy assessment post-baseline|1
4698820|NCT02322710|16188244|P1|Overall Study|No efficacy assessment post-baseline|0
4698821|NCT02322411|16188257|P2|Overall Study|Withdrawal by Subject|0
4698822|NCT02322411|16188258|P1|Overall Study|Withdrawal by Subject|1
4698823|NCT02322411|16188257|P2|Overall Study|Lost to Follow-up|7
4698824|NCT02322411|16188258|P1|Overall Study|Lost to Follow-up|4
4698825|NCT02322281|16188327|P3|Overall Study|Miscellaneous|4
4698826|NCT02322281|16188328|P2|Overall Study|Miscellaneous|0
4698827|NCT02322281|16188329|P1|Overall Study|Miscellaneous|0
4698828|NCT02322281|16188327|P3|Overall Study|Missing|1
4698829|NCT02322281|16188328|P2|Overall Study|Missing|0
4698830|NCT02322281|16188329|P1|Overall Study|Missing|0
4698831|NCT02322281|16188327|P3|Overall Study|Study Terminated by Sponsor|0
4698832|NCT02322281|16188328|P2|Overall Study|Study Terminated by Sponsor|0
4698833|NCT02322281|16188329|P1|Overall Study|Study Terminated by Sponsor|2
4698834|NCT02322281|16188327|P3|Overall Study|Physician Decision|5
4698835|NCT02322281|16188328|P2|Overall Study|Physician Decision|0
4698836|NCT02322281|16188329|P1|Overall Study|Physician Decision|2
4698837|NCT02322281|16188327|P3|Overall Study|Withdrawal by Subject|6
4698838|NCT02322281|16188328|P2|Overall Study|Withdrawal by Subject|1
4698839|NCT02322281|16188329|P1|Overall Study|Withdrawal by Subject|1
4698840|NCT02322281|16188327|P3|Overall Study|Death|3
4698841|NCT02322281|16188328|P2|Overall Study|Death|3
4698842|NCT02322281|16188329|P1|Overall Study|Death|3
4698843|NCT02322281|16188327|P3|Overall Study|Adverse Event|6
4698844|NCT02322281|16188328|P2|Overall Study|Adverse Event|4
4698845|NCT02322281|16188329|P1|Overall Study|Adverse Event|3
4698846|NCT02322281|16188327|P3|Overall Study|Progressive Disease|49
4698847|NCT02322281|16188328|P2|Overall Study|Progressive Disease|14
4698848|NCT02322281|16188329|P1|Overall Study|Progressive Disease|42
4698849|NCT02322229|16188377|P1|Overall Study|Physician Decision|2
4698850|NCT02322216|16188389|P2|Overall Study|Withdrawal by Subject|4
4698851|NCT02322216|16188390|P1|Overall Study|Withdrawal by Subject|1
4698852|NCT02322216|16188389|P2|Overall Study|Adverse Event|0
4698853|NCT02322216|16188390|P1|Overall Study|Adverse Event|1
4698854|NCT02322190|16188397|P2|Overall Study|Death on study|0
4698855|NCT02322190|16188398|P1|Overall Study|Death on study|1
4698856|NCT02321930|16188406|P1|Overall Study|Lost to Follow-up|1
4698857|NCT01668654|16188414|P1|Overall Study|Withdrawal by Subject|1
4698858|NCT01668654|16188414|P1|Overall Study|Study Closed/Terminated|3
4698859|NCT02321800|16188456|P2|Overall Study|Other, Miscellaneous|1
4698860|NCT02321800|16188457|P1|Overall Study|Other, Miscellaneous|3
4698861|NCT02321800|16188456|P2|Overall Study|Adverse Event|3
4698862|NCT02321800|16188457|P1|Overall Study|Adverse Event|2
4698863|NCT02321800|16188456|P2|Overall Study|Lost to Follow-up|4
4698864|NCT02321800|16188457|P1|Overall Study|Lost to Follow-up|10
4698865|NCT02321800|16188456|P2|Overall Study|Protocol Violation|0
4698866|NCT02321800|16188457|P1|Overall Study|Protocol Violation|1
4698867|NCT02321800|16188456|P2|Overall Study|Death|0
4698868|NCT02321800|16188457|P1|Overall Study|Death|1
4698869|NCT02321800|16188456|P2|Overall Study|Withdrawal by Subject|3
4698870|NCT02321800|16188457|P1|Overall Study|Withdrawal by Subject|3
4698871|NCT02321462|16188546|P2|Overall Study|Subject withdrawn before any treatment|1
4698872|NCT02321462|16188547|P1|Overall Study|Subject withdrawn before any treatment|1
4698873|NCT02321462|16188546|P2|Overall Study|Withdrawal by Subject|2
4698874|NCT02321462|16188547|P1|Overall Study|Withdrawal by Subject|5
4698875|NCT02321436|16188569|P2|Overall Study|Lost to Follow-up|1
4698876|NCT02321436|16188570|P1|Overall Study|Lost to Follow-up|0
4698877|NCT02321436|16188569|P2|Overall Study|Withdrawal by Subject|0
4698878|NCT02321436|16188570|P1|Overall Study|Withdrawal by Subject|1
4698879|NCT02321319|16188586|P1|Overall Study|Product discontinued|5
4698880|NCT02321098|16188618|P3|Additional 15 Months Treatment|Withdrawal by Subject|1
4698881|NCT02321098|16188619|P2|Additional 15 Months Treatment|Withdrawal by Subject|0
4698882|NCT02321098|16188620|P1|Additional 15 Months Treatment|Withdrawal by Subject|0
4698883|NCT02321098|16188618|P3|Additional 15 Months Treatment|Lost to Follow-up|1
4698884|NCT02321098|16188619|P2|Additional 15 Months Treatment|Lost to Follow-up|0
4698885|NCT02321098|16188620|P1|Additional 15 Months Treatment|Lost to Follow-up|0
4698886|NCT02321098|16188618|P3|Additional 15 Months Treatment|Lack of Efficacy|6
4698887|NCT02321098|16188619|P2|Additional 15 Months Treatment|Lack of Efficacy|0
4698888|NCT02321098|16188620|P1|Additional 15 Months Treatment|Lack of Efficacy|0
4698889|NCT02321098|16188618|P3|12 Weeks Treament|Lost to Follow-up|0
4698890|NCT02321098|16188619|P2|12 Weeks Treament|Lost to Follow-up|1
4698891|NCT02321098|16188620|P1|12 Weeks Treament|Lost to Follow-up|1
4698892|NCT02320903|16188632|P3|Overall Study|Lost to Follow-up|5
4698893|NCT02320903|16188633|P2|Overall Study|Lost to Follow-up|5
4698894|NCT02320903|16188634|P1|Overall Study|Lost to Follow-up|0
4698895|NCT02320903|16188632|P3|Overall Study|Exited therapy; no longer eligible|2
4698896|NCT02320903|16188633|P2|Overall Study|Exited therapy; no longer eligible|2
4698897|NCT02320903|16188634|P1|Overall Study|Exited therapy; no longer eligible|8
4698898|NCT02320903|16188632|P3|Overall Study|Withdrawal by Subject|9
4698899|NCT02320903|16188633|P2|Overall Study|Withdrawal by Subject|9
4698900|NCT02320903|16188634|P1|Overall Study|Withdrawal by Subject|0
4698901|NCT02320721|16188770|P2|Overall Study|Other than specified above|20
4698902|NCT02320721|16188771|P1|Overall Study|Other than specified above|15
4698903|NCT02320721|16188770|P2|Overall Study|Hypoglycemia|0
4698904|NCT02320721|16188771|P1|Overall Study|Hypoglycemia|1
4698905|NCT02320721|16188770|P2|Overall Study|Randomized but not treated|1
4698906|NCT02320721|16188771|P1|Overall Study|Randomized but not treated|0
4698907|NCT02320721|16188770|P2|Overall Study|Poor compliance to protocol|7
4698908|NCT02320721|16188771|P1|Overall Study|Poor compliance to protocol|3
4698909|NCT02320721|16188770|P2|Overall Study|Lack of Efficacy|0
4698910|NCT02320721|16188771|P1|Overall Study|Lack of Efficacy|2
4698911|NCT02320721|16188770|P2|Overall Study|Adverse Event|6
4698912|NCT02320721|16188771|P1|Overall Study|Adverse Event|6
4698913|NCT02320487|16188826|P1|Overall Study|Adverse Event|11
4698914|NCT02320487|16188826|P1|Overall Study|Death|3
4698915|NCT02320487|16188826|P1|Overall Study|Withdrawal by Subject|1
4698916|NCT02320487|16188826|P1|Overall Study|Physician Decision|5
4698917|NCT02320487|16188826|P1|Overall Study|Reason not Specified|1
4698918|NCT02320396|16188846|P2|Overall Study|Withdrawal by Subject|0
4698919|NCT02320396|16188847|P1|Overall Study|Withdrawal by Subject|2
4698920|NCT02320396|16188846|P2|Overall Study|Protocol Violation|1
4698921|NCT02320396|16188847|P1|Overall Study|Protocol Violation|0
4698922|NCT02320396|16188846|P2|Overall Study|Pregnancy|1
4698923|NCT02320396|16188847|P1|Overall Study|Pregnancy|0
4698924|NCT02320396|16188846|P2|Overall Study|Adverse Event|2
4698925|NCT02320396|16188847|P1|Overall Study|Adverse Event|2
4698926|NCT02320149|16188906|P2|Overall Study|Other Miscellaneous Reasons|3
4698927|NCT02320149|16188907|P1|Overall Study|Other Miscellaneous Reasons|2
4698928|NCT02320149|16188906|P2|Overall Study|Lack of Efficacy|1
4698929|NCT02320149|16188907|P1|Overall Study|Lack of Efficacy|0
4698930|NCT02320149|16188906|P2|Overall Study|Noncompliance with Study Treatment|2
4698931|NCT02320149|16188907|P1|Overall Study|Noncompliance with Study Treatment|7
4698932|NCT02320149|16188906|P2|Overall Study|Protocol Violation|1
4698933|NCT02320149|16188907|P1|Overall Study|Protocol Violation|2
4698934|NCT02320149|16188906|P2|Overall Study|Lost to Follow-up|34
4698935|NCT02320149|16188907|P1|Overall Study|Lost to Follow-up|21
4698936|NCT02320149|16188906|P2|Overall Study|Withdrawal of Consent|32
4698937|NCT02320149|16188907|P1|Overall Study|Withdrawal of Consent|28
4698938|NCT02320149|16188906|P2|Overall Study|Adverse Event|7
4698939|NCT02320149|16188907|P1|Overall Study|Adverse Event|3
4698940|NCT02320123|16188947|P2|Overall Study|Death|5
4698941|NCT02320123|16188948|P1|Overall Study|Death|6
4698942|NCT02320123|16188947|P2|Overall Study|Lost to Follow-up|6
4698943|NCT02320123|16188948|P1|Overall Study|Lost to Follow-up|4
4698944|NCT02319759|16189039|P5|Week 24 - 56|Lost to Follow-up|1
4698945|NCT02319759|16189040|P4|Week 24 - 56|Lost to Follow-up|0
4698946|NCT02319759|16189041|P3|Week 24 - 56|Lost to Follow-up|0
4698947|NCT02319759|16189042|P2|Week 24 - 56|Lost to Follow-up|0
4698948|NCT02319759|16189043|P1|Week 24 - 56|Lost to Follow-up|0
4698949|NCT02319759|16189039|P5|Week 24 - 56|Withdrawal by Subject|0
4698950|NCT02319759|16189040|P4|Week 24 - 56|Withdrawal by Subject|0
4698951|NCT02319759|16189041|P3|Week 24 - 56|Withdrawal by Subject|0
4698952|NCT02319759|16189042|P2|Week 24 - 56|Withdrawal by Subject|1
4698953|NCT02319759|16189043|P1|Week 24 - 56|Withdrawal by Subject|0
4698954|NCT02319759|16189039|P5|Week 24 - 56|Lack of Efficacy|1
4698955|NCT02319759|16189040|P4|Week 24 - 56|Lack of Efficacy|2
4698956|NCT02319759|16189041|P3|Week 24 - 56|Lack of Efficacy|0
4698957|NCT02319759|16189042|P2|Week 24 - 56|Lack of Efficacy|0
4698958|NCT02319759|16189043|P1|Week 24 - 56|Lack of Efficacy|0
4698959|NCT02319759|16189039|P5|Week 24 - 56|Adverse Event|0
4698960|NCT02319759|16189040|P4|Week 24 - 56|Adverse Event|0
4698961|NCT02319759|16189041|P3|Week 24 - 56|Adverse Event|2
4698962|NCT02319759|16189042|P2|Week 24 - 56|Adverse Event|0
4698963|NCT02319759|16189043|P1|Week 24 - 56|Adverse Event|0
4698964|NCT02319759|16189039|P5|Week 16 - 24|Withdrawal by Subject|0
4698965|NCT02319759|16189040|P4|Week 16 - 24|Withdrawal by Subject|0
4698966|NCT02319759|16189041|P3|Week 16 - 24|Withdrawal by Subject|2
4698967|NCT02319759|16189042|P2|Week 16 - 24|Withdrawal by Subject|0
4698968|NCT02319759|16189043|P1|Week 16 - 24|Withdrawal by Subject|0
4698969|NCT02319759|16189039|P5|Week 16 - 24|Lost to Follow-up|0
4698970|NCT02319759|16189040|P4|Week 16 - 24|Lost to Follow-up|0
4698971|NCT02319759|16189041|P3|Week 16 - 24|Lost to Follow-up|0
4698972|NCT02319759|16189042|P2|Week 16 - 24|Lost to Follow-up|0
4698973|NCT02319759|16189043|P1|Week 16 - 24|Lost to Follow-up|1
4698974|NCT02319759|16189039|P5|Week 16 - 24|Lack of Efficacy|0
4698975|NCT02319759|16189040|P4|Week 16 - 24|Lack of Efficacy|0
4698976|NCT02319759|16189041|P3|Week 16 - 24|Lack of Efficacy|1
4698977|NCT02319759|16189042|P2|Week 16 - 24|Lack of Efficacy|0
4698978|NCT02319759|16189043|P1|Week 16 - 24|Lack of Efficacy|1
4698979|NCT02319759|16189039|P5|Week 0 - 16|Not met all Inclusion Criteria|0
4698980|NCT02319759|16189040|P4|Week 0 - 16|Not met all Inclusion Criteria|0
4698981|NCT02319759|16189041|P3|Week 0 - 16|Not met all Inclusion Criteria|1
4698982|NCT02319759|16189042|P2|Week 0 - 16|Not met all Inclusion Criteria|0
4698983|NCT02319759|16189043|P1|Week 0 - 16|Not met all Inclusion Criteria|0
4698984|NCT02319759|16189039|P5|Week 0 - 16|Lack of Efficacy|0
4698985|NCT02319759|16189040|P4|Week 0 - 16|Lack of Efficacy|0
4698986|NCT02319759|16189041|P3|Week 0 - 16|Lack of Efficacy|0
4698987|NCT02319759|16189042|P2|Week 0 - 16|Lack of Efficacy|0
4698988|NCT02319759|16189043|P1|Week 0 - 16|Lack of Efficacy|1
4698989|NCT02319668|16189140|P2|Overall Study|Other (Not specified)|2
4698990|NCT02319668|16189141|P1|Overall Study|Other (Not specified)|0
4698991|NCT02319642|16189155|P2|Overall Study|Withdrawal by Subject|1
4698992|NCT02319642|16189156|P1|Overall Study|Withdrawal by Subject|1
4698993|NCT02319642|16189155|P2|Overall Study|Lack of Efficacy|1
4698994|NCT02319642|16189156|P1|Overall Study|Lack of Efficacy|1
4698995|NCT02319642|16189155|P2|Overall Study|Adverse Event|4
4698996|NCT02319642|16189156|P1|Overall Study|Adverse Event|2
4698997|NCT02319525|16189176|P2|Overall Study|Withdrawal by Subject|1
4698998|NCT02319525|16189177|P1|Overall Study|Withdrawal by Subject|2
4698999|NCT02319148|16189219|P4|Second Intervention Period|Other|1
4699000|NCT02319148|16189220|P3|Second Intervention Period|Other|0
4699001|NCT02319148|16189221|P2|Second Intervention Period|Other|0
4699002|NCT02319148|16189222|P1|Second Intervention Period|Other|0
4699003|NCT02319148|16189219|P4|Second Intervention Period|No longer willing to participate|0
4699004|NCT02319148|16189220|P3|Second Intervention Period|No longer willing to participate|0
4699005|NCT02319148|16189221|P2|Second Intervention Period|No longer willing to participate|1
4699006|NCT02319148|16189222|P1|Second Intervention Period|No longer willing to participate|0
4699007|NCT02319148|16189219|P4|Second Intervention Period|Adverse event (AE) related to study drug|1
4699008|NCT02319148|16189220|P3|Second Intervention Period|Adverse event (AE) related to study drug|1
4699009|NCT02319148|16189221|P2|Second Intervention Period|Adverse event (AE) related to study drug|0
4699010|NCT02319148|16189222|P1|Second Intervention Period|Adverse event (AE) related to study drug|0
4699011|NCT02319044|16189285|P3|Overall Study|Not treated|2
4699012|NCT02319044|16189286|P2|Overall Study|Not treated|2
4699013|NCT02319044|16189287|P1|Overall Study|Not treated|0
4699014|NCT02319044|16189285|P3|Overall Study|Study specific discontinuation criteria|1
4699015|NCT02319044|16189286|P2|Overall Study|Study specific discontinuation criteria|2
4699016|NCT02319044|16189287|P1|Overall Study|Study specific discontinuation criteria|2
4699017|NCT02319044|16189285|P3|Overall Study|Adverse Event|8
4699018|NCT02319044|16189286|P2|Overall Study|Adverse Event|2
4699019|NCT02319044|16189287|P1|Overall Study|Adverse Event|17
4699020|NCT02319044|16189285|P3|Overall Study|Condition under investigation worsened|46
4699021|NCT02319044|16189286|P2|Overall Study|Condition under investigation worsened|50
4699022|NCT02319044|16189287|P1|Overall Study|Condition under investigation worsened|100
4699023|NCT02319044|16189285|P3|Overall Study|Withdrawal by Subject|6
4699024|NCT02319044|16189286|P2|Overall Study|Withdrawal by Subject|3
4699025|NCT02319044|16189287|P1|Overall Study|Withdrawal by Subject|3
4699026|NCT02319044|16189285|P3|Overall Study|Death, PI/sponsor decision, med history|4
4699027|NCT02319044|16189286|P2|Overall Study|Death, PI/sponsor decision, med history|1
4699028|NCT02319044|16189287|P1|Overall Study|Death, PI/sponsor decision, med history|0
4699029|NCT02319031|16189343|P2|Treatment Period|Death|0
4699030|NCT02319031|16189344|P1|Treatment Period|Death|1
4699031|NCT02318940|16189408|P2|Overall Study|lost the record|0
4699032|NCT02318940|16189409|P1|Overall Study|lost the record|1
4699033|NCT02318797|16189451|P2|Overall Study|Lost to Follow-up|96
4699034|NCT02318797|16189452|P1|Overall Study|Lost to Follow-up|85
4699035|NCT02318797|16189451|P2|Overall Study|Death|6
4699036|NCT02318797|16189452|P1|Overall Study|Death|3
4699037|NCT02318693|16189492|P2|Overall Study|Protocol Violation|1
4699038|NCT02318693|16189493|P1|Overall Study|Protocol Violation|0
4699039|NCT02318667|16189507|P1|Overall Study|Protocol Violation|2
4699040|NCT02318667|16189507|P1|Overall Study|Lack of Efficacy|6
4699041|NCT02318667|16189507|P1|Overall Study|Adverse Event|1
4699042|NCT02318602|16189526|P3|Overall Study|Guardian decision to withdraw|1
4699043|NCT02318602|16189527|P2|Overall Study|Guardian decision to withdraw|0
4699044|NCT02318602|16189528|P1|Overall Study|Guardian decision to withdraw|0
4699045|NCT02318602|16189526|P3|Overall Study|Death|0
4699046|NCT02318602|16189527|P2|Overall Study|Death|0
4699047|NCT02318602|16189528|P1|Overall Study|Death|1
4699048|NCT02318602|16189526|P3|Overall Study|Withdrawal by Subject|0
4699049|NCT02318602|16189527|P2|Overall Study|Withdrawal by Subject|3
4699050|NCT02318602|16189528|P1|Overall Study|Withdrawal by Subject|0
4699051|NCT02318602|16189526|P3|Overall Study|Adverse Event|1
4699052|NCT02318602|16189527|P2|Overall Study|Adverse Event|1
4699053|NCT02318602|16189528|P1|Overall Study|Adverse Event|0
4699054|NCT02318368|16189561|P2|Overall Study|Death|1
4699055|NCT02318368|16189562|P1|Overall Study|Death|0
4699056|NCT02318368|16189561|P2|Overall Study|Study terminated by the sponsor|2
4699057|NCT02318368|16189562|P1|Overall Study|Study terminated by the sponsor|5
4699058|NCT02318368|16189561|P2|Overall Study|Withdrawal by Subject|0
4699059|NCT02318368|16189562|P1|Overall Study|Withdrawal by Subject|2
4699060|NCT02318329|16189580|P10|Overall Study|Other|1
4699061|NCT02318329|16189581|P9|Overall Study|Other|1
4699062|NCT02318329|16189582|P8|Overall Study|Other|0
4699063|NCT02318329|16189583|P7|Overall Study|Other|0
4699064|NCT02318329|16189584|P6|Overall Study|Other|0
4699065|NCT02318329|16189585|P5|Overall Study|Other|0
4699066|NCT02318329|16189586|P4|Overall Study|Other|0
4699067|NCT02318329|16189587|P3|Overall Study|Other|1
4699068|NCT02318329|16189588|P2|Overall Study|Other|1
4699069|NCT02318329|16189589|P1|Overall Study|Other|1
4699070|NCT02318329|16189580|P10|Overall Study|Withdrawal by Subject|6
4699071|NCT02318329|16189581|P9|Overall Study|Withdrawal by Subject|0
4699072|NCT02318329|16189582|P8|Overall Study|Withdrawal by Subject|0
4699073|NCT02318329|16189583|P7|Overall Study|Withdrawal by Subject|0
4699074|NCT02318329|16189584|P6|Overall Study|Withdrawal by Subject|0
4699075|NCT02318329|16189585|P5|Overall Study|Withdrawal by Subject|0
4699076|NCT02318329|16189586|P4|Overall Study|Withdrawal by Subject|0
4699077|NCT02318329|16189587|P3|Overall Study|Withdrawal by Subject|0
4699078|NCT02318329|16189588|P2|Overall Study|Withdrawal by Subject|0
4699079|NCT02318329|16189589|P1|Overall Study|Withdrawal by Subject|0
4699080|NCT02318329|16189580|P10|Overall Study|Lost to Follow-up|1
4699081|NCT02318329|16189581|P9|Overall Study|Lost to Follow-up|0
4699082|NCT02318329|16189582|P8|Overall Study|Lost to Follow-up|0
4699083|NCT02318329|16189583|P7|Overall Study|Lost to Follow-up|0
4699084|NCT02318329|16189584|P6|Overall Study|Lost to Follow-up|0
4699085|NCT02318329|16189585|P5|Overall Study|Lost to Follow-up|0
4699086|NCT02318329|16189586|P4|Overall Study|Lost to Follow-up|0
4699087|NCT02318329|16189587|P3|Overall Study|Lost to Follow-up|0
4699088|NCT02318329|16189588|P2|Overall Study|Lost to Follow-up|0
4699089|NCT02318329|16189589|P1|Overall Study|Lost to Follow-up|0
4699090|NCT02318329|16189580|P10|Overall Study|Death|5
4699091|NCT02318329|16189581|P9|Overall Study|Death|0
4699092|NCT02318329|16189582|P8|Overall Study|Death|0
4699093|NCT02318329|16189583|P7|Overall Study|Death|0
4699094|NCT02318329|16189584|P6|Overall Study|Death|0
4699095|NCT02318329|16189585|P5|Overall Study|Death|0
4699096|NCT02318329|16189586|P4|Overall Study|Death|0
4699097|NCT02318329|16189587|P3|Overall Study|Death|0
4699098|NCT02318329|16189588|P2|Overall Study|Death|0
4699099|NCT02318329|16189589|P1|Overall Study|Death|0
4699100|NCT02318329|16189580|P10|Overall Study|Progressive Disease|39
4699101|NCT02318329|16189581|P9|Overall Study|Progressive Disease|5
4699102|NCT02318329|16189582|P8|Overall Study|Progressive Disease|1
4699103|NCT02318329|16189583|P7|Overall Study|Progressive Disease|1
4699104|NCT02318329|16189584|P6|Overall Study|Progressive Disease|3
4699105|NCT02318329|16189585|P5|Overall Study|Progressive Disease|3
4699106|NCT02318329|16189586|P4|Overall Study|Progressive Disease|3
4699107|NCT02318329|16189587|P3|Overall Study|Progressive Disease|2
4699108|NCT02318329|16189588|P2|Overall Study|Progressive Disease|3
4699109|NCT02318329|16189589|P1|Overall Study|Progressive Disease|2
4699110|NCT02317809|16189681|P2|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0
4699111|NCT02317809|16189682|P1|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1
4699112|NCT02317809|16189681|P2|First Intervention Period (8 Days)|Protocol Non-Compliance|0
4699113|NCT02317809|16189682|P1|First Intervention Period (8 Days)|Protocol Non-Compliance|2
4699114|NCT02317614|16189770|P2|Overall Study|Death|1
4699115|NCT02317614|16189771|P1|Overall Study|Death|1
4699116|NCT02317614|16189770|P2|Overall Study|Withdrawal by Subject|0
4699117|NCT02317614|16189771|P1|Overall Study|Withdrawal by Subject|1
4699118|NCT02317614|16189770|P2|Overall Study|Lost to Follow-up|1
4699119|NCT02317614|16189771|P1|Overall Study|Lost to Follow-up|1
4699120|NCT02317575|16189787|P5|Period 1|Withdrawal by Subject|0
4699121|NCT02317575|16189788|P4|Period 1|Withdrawal by Subject|0
4699122|NCT02317575|16189789|P3|Period 1|Withdrawal by Subject|0
4699123|NCT02317575|16189790|P2|Period 1|Withdrawal by Subject|0
4699124|NCT02317575|16189791|P1|Period 1|Withdrawal by Subject|1
4699125|NCT02317575|16189787|P5|Period 1|Difficulty with venous cannulation|0
4699126|NCT02317575|16189788|P4|Period 1|Difficulty with venous cannulation|0
4699127|NCT02317575|16189789|P3|Period 1|Difficulty with venous cannulation|0
4699128|NCT02317575|16189790|P2|Period 1|Difficulty with venous cannulation|1
4699129|NCT02317575|16189791|P1|Period 1|Difficulty with venous cannulation|0
4699130|NCT02317510|16189826|P2|Overall Study|Adverse Event|1
4699131|NCT02317510|16189827|P1|Overall Study|Adverse Event|0
4699132|NCT02317016|16189859|P1|Part B: Day 35 to End Part B (AZD9291)|Death|5
4699133|NCT02317016|16189859|P1|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2
4699134|NCT02317016|16189859|P1|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1
4699135|NCT02317016|16189859|P1|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23
4699136|NCT02317016|16189859|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1
4699137|NCT02317016|16189859|P1|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1
4699138|NCT02317016|16189859|P1|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1
4699139|NCT02316847|16189887|P2|Overall Study|Withdrawn due to termination by Sponsor|67
4699140|NCT02316847|16189888|P1|Overall Study|Withdrawn due to termination by Sponsor|7
4699141|NCT02316847|16189887|P2|Overall Study|Noncompliance with study drug|3
4699142|NCT02316847|16189888|P1|Overall Study|Noncompliance with study drug|0
4699143|NCT02316847|16189887|P2|Overall Study|Withdrawal by Subject|9
4699144|NCT02316847|16189888|P1|Overall Study|Withdrawal by Subject|2
4699145|NCT02316847|16189887|P2|Overall Study|Pregnancy|1
4699146|NCT02316847|16189888|P1|Overall Study|Pregnancy|0
4699147|NCT02316847|16189887|P2|Overall Study|Physician Decision|1
4699148|NCT02316847|16189888|P1|Overall Study|Physician Decision|0
4699149|NCT02316847|16189887|P2|Overall Study|Lost to Follow-up|2
4699150|NCT02316847|16189888|P1|Overall Study|Lost to Follow-up|0
4699151|NCT02316847|16189887|P2|Overall Study|Adverse Event|3
4699152|NCT02316847|16189888|P1|Overall Study|Adverse Event|0
4699153|NCT02316769|16189899|P2|Overall Study|Withdrawal by Subject|0
4699154|NCT02316769|16189900|P1|Overall Study|Withdrawal by Subject|1
4699155|NCT02316769|16189899|P2|Overall Study|Physician Decision|0
4699156|NCT02316769|16189900|P1|Overall Study|Physician Decision|1
4699157|NCT02316717|16189911|P3|Overall Study|TBC|0
4699158|NCT02316717|16189912|P2|Overall Study|TBC|0
4699159|NCT02316717|16189913|P1|Overall Study|TBC|1
4699160|NCT02316717|16189911|P3|Overall Study|Physician Decision|0
4699161|NCT02316717|16189912|P2|Overall Study|Physician Decision|1
4699162|NCT02316717|16189913|P1|Overall Study|Physician Decision|0
4699163|NCT02316717|16189911|P3|Overall Study|Death|1
4699164|NCT02316717|16189912|P2|Overall Study|Death|0
4699165|NCT02316717|16189913|P1|Overall Study|Death|0
4699166|NCT02316717|16189911|P3|Overall Study|Withdrawal by Subject|1
4699167|NCT02316717|16189912|P2|Overall Study|Withdrawal by Subject|1
4699168|NCT02316717|16189913|P1|Overall Study|Withdrawal by Subject|2
4699169|NCT02316717|16189911|P3|Overall Study|Protocol Violation|0
4699170|NCT02316717|16189912|P2|Overall Study|Protocol Violation|0
4699171|NCT02316717|16189913|P1|Overall Study|Protocol Violation|2
4699172|NCT02316717|16189911|P3|Overall Study|Non compliance|0
4699173|NCT02316717|16189912|P2|Overall Study|Non compliance|1
4699174|NCT02316717|16189913|P1|Overall Study|Non compliance|3
4699175|NCT02316717|16189911|P3|Overall Study|Lost to Follow-up|1
4699176|NCT02316717|16189912|P2|Overall Study|Lost to Follow-up|2
4699177|NCT02316717|16189913|P1|Overall Study|Lost to Follow-up|1
4699178|NCT02316717|16189911|P3|Overall Study|Adverse Event|0
4699179|NCT02316717|16189912|P2|Overall Study|Adverse Event|2
4699180|NCT02316717|16189913|P1|Overall Study|Adverse Event|2
4699181|NCT02316613|16190050|P1|Overall Study|Did not met selection criteria|14
4699182|NCT02316613|16190050|P1|Overall Study|No data and duplicate cases|5
4699183|NCT02316613|16190050|P1|Overall Study|Participant moved/changed medical team|11
4699184|NCT02316613|16190050|P1|Overall Study|Lymphoma transformation|2
4699185|NCT02316613|16190050|P1|Overall Study|Lost to Follow-up|9
4699186|NCT02316613|16190050|P1|Overall Study|Death|63
4699187|NCT02316548|16190089|P2|Overall Study|Protocol Violation|1
4699188|NCT02316548|16190090|P1|Overall Study|Protocol Violation|0
4699189|NCT02316353|16190220|P2|Overall Study|Withdrawal by Subject|2
4699190|NCT02316353|16190221|P1|Overall Study|Withdrawal by Subject|6
4699191|NCT02316353|16190220|P2|Overall Study|Adverse Event|3
4699192|NCT02316353|16190221|P1|Overall Study|Adverse Event|1
4699193|NCT02316353|16190220|P2|Overall Study|Pregnancy|3
4699194|NCT02316353|16190221|P1|Overall Study|Pregnancy|1
4699195|NCT02316171|16190241|P4|Overall Study|difficulties with urinary catheter|0
4699196|NCT02316171|16190242|P3|Overall Study|difficulties with urinary catheter|0
4699197|NCT02316171|16190243|P2|Overall Study|difficulties with urinary catheter|0
4699198|NCT02316171|16190244|P1|Overall Study|difficulties with urinary catheter|1
4699199|NCT01615029|16190267|P5|Overall Study|Ongoing|23
4699200|NCT01615029|16190268|P4|Overall Study|Ongoing|2
4699201|NCT01615029|16190269|P3|Overall Study|Ongoing|3
4699202|NCT01615029|16190270|P2|Overall Study|Ongoing|2
4699203|NCT01615029|16190271|P1|Overall Study|Ongoing|1
4699204|NCT01615029|16190267|P5|Overall Study|Physician Decision|1
4699205|NCT01615029|16190268|P4|Overall Study|Physician Decision|0
4699206|NCT01615029|16190269|P3|Overall Study|Physician Decision|0
4699207|NCT01615029|16190270|P2|Overall Study|Physician Decision|0
4699208|NCT01615029|16190271|P1|Overall Study|Physician Decision|0
4699209|NCT01615029|16190267|P5|Overall Study|Progressive disease|5
4699210|NCT01615029|16190268|P4|Overall Study|Progressive disease|1
4699211|NCT01615029|16190269|P3|Overall Study|Progressive disease|1
4699212|NCT01615029|16190270|P2|Overall Study|Progressive disease|1
4699213|NCT01615029|16190271|P1|Overall Study|Progressive disease|2
4699214|NCT01615029|16190267|P5|Overall Study|Lost to Follow-up|1
4699215|NCT01615029|16190268|P4|Overall Study|Lost to Follow-up|0
4699216|NCT01615029|16190269|P3|Overall Study|Lost to Follow-up|0
4699217|NCT01615029|16190270|P2|Overall Study|Lost to Follow-up|0
4699218|NCT01615029|16190271|P1|Overall Study|Lost to Follow-up|0
4699219|NCT01615029|16190267|P5|Overall Study|Death|1
4699220|NCT01615029|16190268|P4|Overall Study|Death|0
4699221|NCT01615029|16190269|P3|Overall Study|Death|0
4699222|NCT01615029|16190270|P2|Overall Study|Death|0
4699223|NCT01615029|16190271|P1|Overall Study|Death|0
4699224|NCT01615029|16190267|P5|Overall Study|Adverse Event|1
4699225|NCT01615029|16190268|P4|Overall Study|Adverse Event|0
4699226|NCT01615029|16190269|P3|Overall Study|Adverse Event|0
4699227|NCT01615029|16190270|P2|Overall Study|Adverse Event|0
4699228|NCT01615029|16190271|P1|Overall Study|Adverse Event|0
4699229|NCT02315664|16190338|P2|Overall Study|Withdrawal by Subject|3
4699230|NCT02315664|16190339|P1|Overall Study|Withdrawal by Subject|0
4699231|NCT02315664|16190338|P2|Overall Study|Lost to Follow-up|1
4699232|NCT02315664|16190339|P1|Overall Study|Lost to Follow-up|1
4699233|NCT02315625|16190361|P2|Second Intervention|Disease Progression|0
4699234|NCT02315625|16190362|P1|Second Intervention|Disease Progression|1
4699235|NCT02315625|16190361|P2|Second Intervention|Study closure|0
4699236|NCT02315625|16190362|P1|Second Intervention|Study closure|1
4699237|NCT02315625|16190361|P2|Second Intervention|Physician Decision|1
4699238|NCT02315625|16190362|P1|Second Intervention|Physician Decision|2
4699239|NCT02315625|16190361|P2|First Intervention|Disease Progression|0
4699240|NCT02315625|16190362|P1|First Intervention|Disease Progression|1
4699241|NCT02315560|16190376|P1|Overall Study|noncompliance by subjects|3
4699242|NCT02314923|16190635|P10|Overall Study|Participant relocation|0
4699243|NCT02314923|16190636|P9|Overall Study|Participant relocation|0
4699244|NCT02314923|16190637|P8|Overall Study|Participant relocation|1
4699245|NCT02314923|16190638|P7|Overall Study|Participant relocation|0
4699246|NCT02314923|16190639|P6|Overall Study|Participant relocation|0
4699247|NCT02314923|16190640|P5|Overall Study|Participant relocation|0
4699248|NCT02314923|16190641|P4|Overall Study|Participant relocation|0
4699249|NCT02314923|16190642|P3|Overall Study|Participant relocation|0
4699250|NCT02314923|16190643|P2|Overall Study|Participant relocation|0
4699251|NCT02314923|16190644|P1|Overall Study|Participant relocation|1
4699252|NCT02314923|16190635|P10|Overall Study|Screen failure|0
4699253|NCT02314923|16190636|P9|Overall Study|Screen failure|0
4699254|NCT02314923|16190637|P8|Overall Study|Screen failure|0
4699255|NCT02314923|16190638|P7|Overall Study|Screen failure|1
4699256|NCT02314923|16190639|P6|Overall Study|Screen failure|0
4699257|NCT02314923|16190640|P5|Overall Study|Screen failure|0
4699258|NCT02314923|16190641|P4|Overall Study|Screen failure|0
4699259|NCT02314923|16190642|P3|Overall Study|Screen failure|0
4699260|NCT02314923|16190643|P2|Overall Study|Screen failure|0
4699261|NCT02314923|16190644|P1|Overall Study|Screen failure|0
4699262|NCT02314923|16190635|P10|Overall Study|Participant unavailable|0
4699263|NCT02314923|16190636|P9|Overall Study|Participant unavailable|0
4699264|NCT02314923|16190637|P8|Overall Study|Participant unavailable|0
4699265|NCT02314923|16190638|P7|Overall Study|Participant unavailable|0
4699266|NCT02314923|16190639|P6|Overall Study|Participant unavailable|1
4699267|NCT02314923|16190640|P5|Overall Study|Participant unavailable|0
4699268|NCT02314923|16190641|P4|Overall Study|Participant unavailable|0
4699269|NCT02314923|16190642|P3|Overall Study|Participant unavailable|0
4699270|NCT02314923|16190643|P2|Overall Study|Participant unavailable|0
4699271|NCT02314923|16190644|P1|Overall Study|Participant unavailable|0
4699272|NCT02314923|16190635|P10|Overall Study|Physician Decision|0
4699273|NCT02314923|16190636|P9|Overall Study|Physician Decision|0
4699274|NCT02314923|16190637|P8|Overall Study|Physician Decision|0
4699275|NCT02314923|16190638|P7|Overall Study|Physician Decision|0
4699276|NCT02314923|16190639|P6|Overall Study|Physician Decision|0
4699277|NCT02314923|16190640|P5|Overall Study|Physician Decision|0
4699278|NCT02314923|16190641|P4|Overall Study|Physician Decision|0
4699279|NCT02314923|16190642|P3|Overall Study|Physician Decision|0
4699280|NCT02314923|16190643|P2|Overall Study|Physician Decision|1
4699281|NCT02314923|16190644|P1|Overall Study|Physician Decision|0
4699282|NCT02314923|16190635|P10|Overall Study|Withdrawal by Subject|0
4699283|NCT02314923|16190636|P9|Overall Study|Withdrawal by Subject|0
4699284|NCT02314923|16190637|P8|Overall Study|Withdrawal by Subject|0
4699285|NCT02314923|16190638|P7|Overall Study|Withdrawal by Subject|1
4699286|NCT02314923|16190639|P6|Overall Study|Withdrawal by Subject|0
4699287|NCT02314923|16190640|P5|Overall Study|Withdrawal by Subject|1
4699288|NCT02314923|16190641|P4|Overall Study|Withdrawal by Subject|0
4699289|NCT02314923|16190642|P3|Overall Study|Withdrawal by Subject|1
4699290|NCT02314923|16190643|P2|Overall Study|Withdrawal by Subject|0
4699291|NCT02314923|16190644|P1|Overall Study|Withdrawal by Subject|0
4699292|NCT02314923|16190635|P10|Overall Study|Lost to Follow-up|0
4699293|NCT02314923|16190636|P9|Overall Study|Lost to Follow-up|2
4699294|NCT02314923|16190637|P8|Overall Study|Lost to Follow-up|4
4699295|NCT02314923|16190638|P7|Overall Study|Lost to Follow-up|3
4699296|NCT02314923|16190639|P6|Overall Study|Lost to Follow-up|0
4699297|NCT02314923|16190640|P5|Overall Study|Lost to Follow-up|0
4699298|NCT02314923|16190641|P4|Overall Study|Lost to Follow-up|0
4699299|NCT02314923|16190642|P3|Overall Study|Lost to Follow-up|1
4699300|NCT02314923|16190643|P2|Overall Study|Lost to Follow-up|3
4699301|NCT02314923|16190644|P1|Overall Study|Lost to Follow-up|2
4699302|NCT02314923|16190635|P10|Overall Study|Death|0
4699303|NCT02314923|16190636|P9|Overall Study|Death|0
4699304|NCT02314923|16190637|P8|Overall Study|Death|0
4699305|NCT02314923|16190638|P7|Overall Study|Death|0
4699306|NCT02314923|16190639|P6|Overall Study|Death|0
4699307|NCT02314923|16190640|P5|Overall Study|Death|0
4699308|NCT02314923|16190641|P4|Overall Study|Death|1
4699309|NCT02314923|16190642|P3|Overall Study|Death|0
4699310|NCT02314923|16190643|P2|Overall Study|Death|0
4699311|NCT02314923|16190644|P1|Overall Study|Death|0
4699312|NCT02314637|16190743|P2|Overall Study|Other Reason|0
4699313|NCT02314637|16190744|P1|Overall Study|Other Reason|1
4699314|NCT02314637|16190743|P2|Overall Study|Withdrawal by Subject|4
4699315|NCT02314637|16190744|P1|Overall Study|Withdrawal by Subject|5
4699316|NCT02314637|16190743|P2|Overall Study|Physician Decision|2
4699317|NCT02314637|16190744|P1|Overall Study|Physician Decision|5
4699318|NCT02314637|16190743|P2|Overall Study|Lack of Efficacy|0
4699319|NCT02314637|16190744|P1|Overall Study|Lack of Efficacy|1
4699320|NCT02314637|16190743|P2|Overall Study|Adverse Event|8
4699321|NCT02314637|16190744|P1|Overall Study|Adverse Event|4
4699322|NCT02314247|16190815|P3|Overall Study|Progression of Disease|0
4699323|NCT02314247|16190816|P2|Overall Study|Progression of Disease|2
4699324|NCT02314247|16190817|P1|Overall Study|Progression of Disease|6
4699325|NCT02314247|16190815|P3|Overall Study|Withdrawal by Subject|1
4699326|NCT02314247|16190816|P2|Overall Study|Withdrawal by Subject|3
4699327|NCT02314247|16190817|P1|Overall Study|Withdrawal by Subject|1
4699328|NCT02314247|16190815|P3|Overall Study|Adverse Event|0
4699329|NCT02314247|16190816|P2|Overall Study|Adverse Event|1
4699330|NCT02314247|16190817|P1|Overall Study|Adverse Event|2
4699331|NCT02314143|16190842|P3|Overall Study|Withdrawal by Subject|1
4699332|NCT02314143|16190843|P2|Overall Study|Withdrawal by Subject|0
4699333|NCT02314143|16190844|P1|Overall Study|Withdrawal by Subject|1
4699334|NCT02314143|16190842|P3|Overall Study|Physician Decision|0
4699335|NCT02314143|16190843|P2|Overall Study|Physician Decision|1
4699336|NCT02314143|16190844|P1|Overall Study|Physician Decision|2
4699337|NCT02314143|16190842|P3|Overall Study|Other (Study Closed/Terminated)|4
4699338|NCT02314143|16190843|P2|Overall Study|Other (Study Closed/Terminated)|3
4699339|NCT02314143|16190844|P1|Overall Study|Other (Study Closed/Terminated)|5
4699340|NCT02314143|16190842|P3|Overall Study|Adverse Event|4
4699341|NCT02314143|16190843|P2|Overall Study|Adverse Event|6
4699342|NCT02314143|16190844|P1|Overall Study|Adverse Event|0
4699343|NCT02314117|16190890|P2|Overall Study|No post-discontinuation follow-up|19
4699344|NCT02314117|16190891|P1|Overall Study|No post-discontinuation follow-up|21
4699345|NCT02314117|16190890|P2|Overall Study|Withdrawal by Subject|2
4699346|NCT02314117|16190891|P1|Overall Study|Withdrawal by Subject|2
4699347|NCT02314117|16190890|P2|Overall Study|On Treatment|6
4699348|NCT02314117|16190891|P1|Overall Study|On Treatment|10
4699349|NCT02314117|16190890|P2|Overall Study|Lost to Follow-up|11
4699350|NCT02314117|16190891|P1|Overall Study|Lost to Follow-up|8
4699351|NCT02314052|16190944|P6|Cycle One|Adverse Event|0
4699352|NCT02314052|16190945|P5|Cycle One|Adverse Event|0
4699353|NCT02314052|16190946|P4|Cycle One|Adverse Event|1
4699354|NCT02314052|16190947|P3|Cycle One|Adverse Event|0
4699355|NCT02314052|16190948|P2|Cycle One|Adverse Event|0
4699356|NCT02314052|16190949|P1|Cycle One|Adverse Event|0
4699357|NCT02314026|16191017|P1|Overall Study|Protocol Violation|28
4699358|NCT02313909|16191035|P2|Overall Study|Lost to Follow-up|17
4699359|NCT02313909|16191036|P1|Overall Study|Lost to Follow-up|24
4699360|NCT02313909|16191035|P2|Overall Study|Consent withdrawn by participant|33
4699361|NCT02313909|16191036|P1|Overall Study|Consent withdrawn by participant|33
4699362|NCT02313766|16191059|P3|Overall Study|Adverse Event|0
4699363|NCT02313766|16191060|P2|Overall Study|Adverse Event|1
4699364|NCT02313766|16191061|P1|Overall Study|Adverse Event|0
4699365|NCT02313766|16191059|P3|Overall Study|Lost to Follow-up|0
4699366|NCT02313766|16191060|P2|Overall Study|Lost to Follow-up|2
4699367|NCT02313766|16191061|P1|Overall Study|Lost to Follow-up|0
4699368|NCT02313766|16191059|P3|Overall Study|surgery cancelled|0
4699369|NCT02313766|16191060|P2|Overall Study|surgery cancelled|0
4699370|NCT02313766|16191061|P1|Overall Study|surgery cancelled|1
4699371|NCT02313558|16191098|P2|Overall Study|Lost to Follow-up|4
4699372|NCT02313558|16191099|P1|Overall Study|Lost to Follow-up|4
4699373|NCT02313558|16191098|P2|Overall Study|Withdrawal by Subject|0
4699374|NCT02313558|16191099|P1|Overall Study|Withdrawal by Subject|2
4699375|NCT02313233|16191145|P2|Overall Study|Administrative reason|1
4699376|NCT02313233|16191146|P1|Overall Study|Administrative reason|1
4699377|NCT02313233|16191145|P2|Overall Study|Withdrawal by Subject|2
4699378|NCT02313233|16191146|P1|Overall Study|Withdrawal by Subject|1
4699379|NCT02313155|16191168|P2|Overall Study|Lost to Follow-up|1
4699380|NCT02313155|16191169|P1|Overall Study|Lost to Follow-up|0
4699381|NCT02312934|16191219|P2|Overall Study|Physician Decision|0
4699382|NCT02312934|16191220|P1|Overall Study|Physician Decision|1
4699383|NCT02312934|16191219|P2|Overall Study|Lost to Follow-up|0
4699384|NCT02312934|16191220|P1|Overall Study|Lost to Follow-up|1
4699385|NCT02312856|16191232|P1|Overall Study|Lost to Follow-up|3
4699386|NCT02312856|16191232|P1|Overall Study|Death|1
4699387|NCT02312687|16191325|P1|Overall Study|Other, Not Specified|1
4699388|NCT02312219|16191417|P2|Overall Study|Not randomized. Ineligible|1
4699389|NCT02312219|16191418|P1|Overall Study|Not randomized. Ineligible|0
4699390|NCT02312219|16191417|P2|Overall Study|Other|1
4699391|NCT02312219|16191418|P1|Overall Study|Other|0
4699392|NCT02312219|16191417|P2|Overall Study|could not schedule imaging in time|2
4699393|NCT02312219|16191418|P1|Overall Study|could not schedule imaging in time|0
4699394|NCT02312219|16191417|P2|Overall Study|Withdrawal by Subject|2
4699395|NCT02312219|16191418|P1|Overall Study|Withdrawal by Subject|1
4699396|NCT02312206|16191428|P2|Overall Study|Subject missed 3 consecutive tx visits|1
4699397|NCT02312206|16191429|P1|Overall Study|Subject missed 3 consecutive tx visits|0
4699398|NCT02312206|16191428|P2|Overall Study|Patient transferred to hospice|1
4699399|NCT02312206|16191429|P1|Overall Study|Patient transferred to hospice|0
4699400|NCT02312206|16191428|P2|Overall Study|Patient progression and new therapy|0
4699401|NCT02312206|16191429|P1|Overall Study|Patient progression and new therapy|1
4699402|NCT02312206|16191428|P2|Overall Study|Disease Progression|0
4699403|NCT02312206|16191429|P1|Overall Study|Disease Progression|1
4699404|NCT02312206|16191428|P2|Overall Study|Study Terminated by Sponsor|74
4699405|NCT02312206|16191429|P1|Overall Study|Study Terminated by Sponsor|81
4699406|NCT02312206|16191428|P2|Overall Study|Death|36
4699407|NCT02312206|16191429|P1|Overall Study|Death|30
4699408|NCT02312206|16191428|P2|Overall Study|Physician Decision|6
4699409|NCT02312206|16191429|P1|Overall Study|Physician Decision|7
4699410|NCT02312206|16191428|P2|Overall Study|Withdrawal by Subject|6
4699411|NCT02312206|16191429|P1|Overall Study|Withdrawal by Subject|7
4699412|NCT02312206|16191428|P2|Overall Study|Adverse Event|6
4699413|NCT02312206|16191429|P1|Overall Study|Adverse Event|3
4699414|NCT02312063|16191452|P2|Overall Study|Withdrawal by Subject|1
4699415|NCT02312063|16191453|P1|Overall Study|Withdrawal by Subject|0
4699416|NCT02311894|16191506|P1|Overall Study|Withdrawal by Subject|1
4699417|NCT02311894|16191506|P1|Overall Study|Adverse Event|1
4699418|NCT02311894|16191506|P1|Overall Study|Lost to Follow-up|1
4699419|NCT02311894|16191506|P1|Overall Study|Discontinued in error|1
4699420|NCT02311881|16191518|P3|Overall Study|Serious Adverse Event|0
4699421|NCT02311881|16191519|P2|Overall Study|Serious Adverse Event|1
4699422|NCT02311881|16191520|P1|Overall Study|Serious Adverse Event|0
4699423|NCT02311881|16191518|P3|Overall Study|Participant taking another medication|1
4699424|NCT02311881|16191519|P2|Overall Study|Participant taking another medication|0
4699425|NCT02311881|16191520|P1|Overall Study|Participant taking another medication|0
4699426|NCT02311881|16191518|P3|Overall Study|Medical Monitor Discretion|1
4699427|NCT02311881|16191519|P2|Overall Study|Medical Monitor Discretion|0
4699428|NCT02311881|16191520|P1|Overall Study|Medical Monitor Discretion|0
4699429|NCT02311881|16191518|P3|Overall Study|Physician Decision|1
4699430|NCT02311881|16191519|P2|Overall Study|Physician Decision|0
4699431|NCT02311881|16191520|P1|Overall Study|Physician Decision|0
4699432|NCT02311881|16191518|P3|Overall Study|Non-Compliance|2
4699433|NCT02311881|16191519|P2|Overall Study|Non-Compliance|0
4699434|NCT02311881|16191520|P1|Overall Study|Non-Compliance|1
4699435|NCT02311881|16191518|P3|Overall Study|Protocol Deviation|0
4699436|NCT02311881|16191519|P2|Overall Study|Protocol Deviation|0
4699437|NCT02311881|16191520|P1|Overall Study|Protocol Deviation|1
4699438|NCT02311881|16191518|P3|Overall Study|Sponsor Decision|1
4699439|NCT02311881|16191519|P2|Overall Study|Sponsor Decision|1
4699440|NCT02311881|16191520|P1|Overall Study|Sponsor Decision|1
4699441|NCT02311881|16191518|P3|Overall Study|Withdrawal by Subject|4
4699442|NCT02311881|16191519|P2|Overall Study|Withdrawal by Subject|1
4699443|NCT02311881|16191520|P1|Overall Study|Withdrawal by Subject|3
4699444|NCT02311881|16191518|P3|Overall Study|Subject has border line pregnancy test|0
4699445|NCT02311881|16191519|P2|Overall Study|Subject has border line pregnancy test|0
4699446|NCT02311881|16191520|P1|Overall Study|Subject has border line pregnancy test|1
4699447|NCT02311881|16191518|P3|Overall Study|Lack of Efficacy|0
4699448|NCT02311881|16191519|P2|Overall Study|Lack of Efficacy|2
4699449|NCT02311881|16191520|P1|Overall Study|Lack of Efficacy|1
4699450|NCT02311881|16191518|P3|Overall Study|Other|1
4699451|NCT02311881|16191519|P2|Overall Study|Other|0
4699452|NCT02311881|16191520|P1|Overall Study|Other|0
4699453|NCT02311881|16191518|P3|Overall Study|Withdrawal of consent|17
4699454|NCT02311881|16191519|P2|Overall Study|Withdrawal of consent|16
4699455|NCT02311881|16191520|P1|Overall Study|Withdrawal of consent|14
4699456|NCT02311881|16191518|P3|Overall Study|Protocol Violation|3
4699457|NCT02311881|16191519|P2|Overall Study|Protocol Violation|2
4699458|NCT02311881|16191520|P1|Overall Study|Protocol Violation|1
4699459|NCT02311881|16191518|P3|Overall Study|Lost to Follow-up|2
4699460|NCT02311881|16191519|P2|Overall Study|Lost to Follow-up|3
4699461|NCT02311881|16191520|P1|Overall Study|Lost to Follow-up|3
4699462|NCT02311881|16191518|P3|Overall Study|Adverse Event|8
4699463|NCT02311881|16191519|P2|Overall Study|Adverse Event|15
4699464|NCT02311881|16191520|P1|Overall Study|Adverse Event|7
4699465|NCT02311881|16191518|P3|Overall Study|Did not meet the study criteria|0
4699466|NCT02311881|16191519|P2|Overall Study|Did not meet the study criteria|2
4699467|NCT02311881|16191520|P1|Overall Study|Did not meet the study criteria|2
4699468|NCT02311478|16191555|P1|Overall Study|Failed IUD Insertion|1
4699469|NCT02311478|16191555|P1|Overall Study|Lost to Follow-up|5
4699470|NCT02311478|16191555|P1|Overall Study|Withdrawal by Subject|1
4699471|NCT02311361|16191564|P4|Overall Study|Did not receive treatment|1
4699472|NCT02311361|16191565|P3|Overall Study|Did not receive treatment|0
4699473|NCT02311361|16191566|P2|Overall Study|Did not receive treatment|1
4699474|NCT02311361|16191567|P1|Overall Study|Did not receive treatment|0
4699475|NCT02311153|16191619|P2|Overall Study|Lost to Follow-up|7
4699476|NCT02311153|16191620|P1|Overall Study|Lost to Follow-up|5
4699477|NCT02310906|16191640|P4|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1
4699478|NCT02310906|16191641|P3|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
4699479|NCT02310906|16191642|P2|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
4699480|NCT02310906|16191643|P1|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0
4699481|NCT02310906|16191640|P4|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1
4699482|NCT02310906|16191641|P3|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
4699483|NCT02310906|16191642|P2|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
4699484|NCT02310906|16191643|P1|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0
4699485|NCT02310906|16191640|P4|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4
4699486|NCT02310906|16191641|P3|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2
4699487|NCT02310906|16191642|P2|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
4699488|NCT02310906|16191643|P1|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0
4699489|NCT02310906|16191640|P4|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2
4699490|NCT02310906|16191641|P3|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
4699491|NCT02310906|16191642|P2|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
4699492|NCT02310906|16191643|P1|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0
4699493|NCT02310789|16191722|P1|Overall Study|Adverse Event|1
4699494|NCT02310763|16191734|P3|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
4699495|NCT02310763|16191735|P2|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
4699496|NCT02310763|16191736|P1|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16
4699497|NCT02310763|16191734|P3|Period 1 (Weeks 1 to 48)|Adverse Event|0
4699498|NCT02310763|16191735|P2|Period 1 (Weeks 1 to 48)|Adverse Event|0
4699499|NCT02310763|16191736|P1|Period 1 (Weeks 1 to 48)|Adverse Event|1
4699500|NCT02310763|16191734|P3|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
4699501|NCT02310763|16191735|P2|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0
4699502|NCT02310763|16191736|P1|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1
4699503|NCT02310763|16191734|P3|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
4699504|NCT02310763|16191735|P2|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1
4699505|NCT02310763|16191736|P1|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0
4699506|NCT02310763|16191734|P3|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
4699507|NCT02310763|16191735|P2|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
4699508|NCT02310763|16191736|P1|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1
4699509|NCT02310750|16191939|P16|HP Washout 2|Lost to Follow-up|0
4699510|NCT02310750|16191940|P15|HP Washout 2|Lost to Follow-up|0
4699511|NCT02310750|16191941|P14|HP Washout 2|Lost to Follow-up|0
4699512|NCT02310750|16191942|P13|HP Washout 2|Lost to Follow-up|0
4699513|NCT02310750|16191943|P12|HP Washout 2|Lost to Follow-up|0
4699514|NCT02310750|16191944|P11|HP Washout 2|Lost to Follow-up|0
4699515|NCT02310750|16191945|P10|HP Washout 2|Lost to Follow-up|0
4699516|NCT02310750|16191946|P9|HP Washout 2|Lost to Follow-up|0
4699517|NCT02310750|16191947|P8|HP Washout 2|Lost to Follow-up|0
4699518|NCT02310750|16191948|P7|HP Washout 2|Lost to Follow-up|7
4699519|NCT02310750|16191949|P6|HP Washout 2|Lost to Follow-up|0
4699520|NCT02310750|16191950|P5|HP Washout 2|Lost to Follow-up|1
4699521|NCT02310750|16191951|P4|HP Washout 2|Lost to Follow-up|0
4699522|NCT02310750|16191952|P3|HP Washout 2|Lost to Follow-up|0
4699523|NCT02310750|16191953|P2|HP Washout 2|Lost to Follow-up|0
4699524|NCT02310750|16191954|P1|HP Washout 2|Lost to Follow-up|0
4699525|NCT02310750|16191939|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699526|NCT02310750|16191940|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699527|NCT02310750|16191941|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699528|NCT02310750|16191942|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699529|NCT02310750|16191943|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699530|NCT02310750|16191944|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699531|NCT02310750|16191945|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699532|NCT02310750|16191946|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
4699533|NCT02310750|16191947|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1
4699534|NCT02310750|16191948|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699535|NCT02310750|16191949|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699536|NCT02310750|16191950|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699537|NCT02310750|16191951|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699538|NCT02310750|16191952|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699539|NCT02310750|16191953|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699540|NCT02310750|16191954|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0
4699541|NCT02310750|16191939|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699542|NCT02310750|16191940|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699543|NCT02310750|16191941|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699544|NCT02310750|16191942|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699545|NCT02310750|16191943|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699546|NCT02310750|16191944|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699547|NCT02310750|16191945|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
4699548|NCT02310750|16191946|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
4699549|NCT02310750|16191947|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1
4699550|NCT02310750|16191948|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699551|NCT02310750|16191949|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699552|NCT02310750|16191950|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699553|NCT02310750|16191951|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699554|NCT02310750|16191952|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699555|NCT02310750|16191953|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699556|NCT02310750|16191954|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0
4699557|NCT02310750|16191939|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699558|NCT02310750|16191940|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699559|NCT02310750|16191941|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699560|NCT02310750|16191942|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699561|NCT02310750|16191943|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699562|NCT02310750|16191944|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699563|NCT02310750|16191945|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1
4699564|NCT02310750|16191946|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699565|NCT02310750|16191947|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699566|NCT02310750|16191948|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699567|NCT02310750|16191949|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699568|NCT02310750|16191950|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699569|NCT02310750|16191951|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699570|NCT02310750|16191952|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699571|NCT02310750|16191953|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699572|NCT02310750|16191954|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0
4699573|NCT02310750|16191939|P16|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699574|NCT02310750|16191940|P15|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699575|NCT02310750|16191941|P14|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699576|NCT02310750|16191942|P13|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699577|NCT02310750|16191943|P12|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699578|NCT02310750|16191944|P11|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699579|NCT02310750|16191945|P10|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
4699580|NCT02310750|16191946|P9|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6
4699581|NCT02310750|16191947|P8|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699582|NCT02310750|16191948|P7|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699583|NCT02310750|16191949|P6|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2
4699584|NCT02310750|16191950|P5|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699585|NCT02310750|16191951|P4|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1
4699586|NCT02310750|16191952|P3|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699587|NCT02310750|16191953|P2|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699588|NCT02310750|16191954|P1|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0
4699589|NCT02310750|16191939|P16|HP Washout 1|Lost to Follow-up|0
4699590|NCT02310750|16191940|P15|HP Washout 1|Lost to Follow-up|0
4699591|NCT02310750|16191941|P14|HP Washout 1|Lost to Follow-up|0
4699592|NCT02310750|16191942|P13|HP Washout 1|Lost to Follow-up|0
4699593|NCT02310750|16191943|P12|HP Washout 1|Lost to Follow-up|0
4699594|NCT02310750|16191944|P11|HP Washout 1|Lost to Follow-up|0
4699595|NCT02310750|16191945|P10|HP Washout 1|Lost to Follow-up|0
4699596|NCT02310750|16191946|P9|HP Washout 1|Lost to Follow-up|0
4699597|NCT02310750|16191947|P8|HP Washout 1|Lost to Follow-up|0
4699598|NCT02310750|16191948|P7|HP Washout 1|Lost to Follow-up|3
4699599|NCT02310750|16191949|P6|HP Washout 1|Lost to Follow-up|2
4699600|NCT02310750|16191950|P5|HP Washout 1|Lost to Follow-up|2
4699601|NCT02310750|16191951|P4|HP Washout 1|Lost to Follow-up|1
4699602|NCT02310750|16191952|P3|HP Washout 1|Lost to Follow-up|1
4699603|NCT02310750|16191953|P2|HP Washout 1|Lost to Follow-up|0
4699604|NCT02310750|16191954|P1|HP Washout 1|Lost to Follow-up|0
4699605|NCT02310750|16191939|P16|HP Period 1|Withdrawal by Subject|0
4699606|NCT02310750|16191940|P15|HP Period 1|Withdrawal by Subject|0
4699607|NCT02310750|16191941|P14|HP Period 1|Withdrawal by Subject|0
4699608|NCT02310750|16191942|P13|HP Period 1|Withdrawal by Subject|0
4699609|NCT02310750|16191943|P12|HP Period 1|Withdrawal by Subject|0
4699610|NCT02310750|16191944|P11|HP Period 1|Withdrawal by Subject|0
4699611|NCT02310750|16191945|P10|HP Period 1|Withdrawal by Subject|0
4699612|NCT02310750|16191946|P9|HP Period 1|Withdrawal by Subject|0
4699613|NCT02310750|16191947|P8|HP Period 1|Withdrawal by Subject|0
4699614|NCT02310750|16191948|P7|HP Period 1|Withdrawal by Subject|0
4699615|NCT02310750|16191949|P6|HP Period 1|Withdrawal by Subject|0
4699616|NCT02310750|16191950|P5|HP Period 1|Withdrawal by Subject|0
4699617|NCT02310750|16191951|P4|HP Period 1|Withdrawal by Subject|1
4699618|NCT02310750|16191952|P3|HP Period 1|Withdrawal by Subject|0
4699619|NCT02310750|16191953|P2|HP Period 1|Withdrawal by Subject|0
4699620|NCT02310750|16191954|P1|HP Period 1|Withdrawal by Subject|1
4699621|NCT02310750|16191939|P16|HP Period 1|Lost to Follow-up|0
4699622|NCT02310750|16191940|P15|HP Period 1|Lost to Follow-up|0
4699623|NCT02310750|16191941|P14|HP Period 1|Lost to Follow-up|0
4699624|NCT02310750|16191942|P13|HP Period 1|Lost to Follow-up|0
4699625|NCT02310750|16191943|P12|HP Period 1|Lost to Follow-up|0
4699626|NCT02310750|16191944|P11|HP Period 1|Lost to Follow-up|0
4699627|NCT02310750|16191945|P10|HP Period 1|Lost to Follow-up|0
4699628|NCT02310750|16191946|P9|HP Period 1|Lost to Follow-up|0
4699629|NCT02310750|16191947|P8|HP Period 1|Lost to Follow-up|0
4699630|NCT02310750|16191948|P7|HP Period 1|Lost to Follow-up|1
4699631|NCT02310750|16191949|P6|HP Period 1|Lost to Follow-up|0
4699632|NCT02310750|16191950|P5|HP Period 1|Lost to Follow-up|0
4699633|NCT02310750|16191951|P4|HP Period 1|Lost to Follow-up|0
4699634|NCT02310750|16191952|P3|HP Period 1|Lost to Follow-up|0
4699635|NCT02310750|16191953|P2|HP Period 1|Lost to Follow-up|0
4699636|NCT02310750|16191954|P1|HP Period 1|Lost to Follow-up|0
4699637|NCT02310672|16192393|P1|Overall Study|Sponsor's decision|12
4699638|NCT02310672|16192393|P1|Overall Study|Withdrawal by Subject|1
4699639|NCT02310672|16192393|P1|Overall Study|Lost to Follow-up|1
4699640|NCT02310672|16192393|P1|Overall Study|Death|1
4699641|NCT02310646|16192406|P2|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0
4699642|NCT02310646|16192407|P1|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1
4699643|NCT02310646|16192406|P2|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0
4699644|NCT02310646|16192407|P1|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1
4699645|NCT02310581|16192435|P4|Overall Study|Withdrawal by Subject|1
4699646|NCT02310581|16192436|P3|Overall Study|Withdrawal by Subject|0
4699647|NCT02310581|16192437|P2|Overall Study|Withdrawal by Subject|1
4699648|NCT02310581|16192438|P1|Overall Study|Withdrawal by Subject|2
4699649|NCT02310581|16192435|P4|Overall Study|Adverse Event|0
4699650|NCT02310581|16192436|P3|Overall Study|Adverse Event|1
4699651|NCT02310581|16192437|P2|Overall Study|Adverse Event|1
4699652|NCT02310581|16192438|P1|Overall Study|Adverse Event|1
4699653|NCT02310568|16192477|P5|Stage 2 (4 Weeks)|Lost to Follow-up|0
4699654|NCT02310568|16192478|P4|Stage 2 (4 Weeks)|Lost to Follow-up|2
4699655|NCT02310568|16192479|P3|Stage 2 (4 Weeks)|Lost to Follow-up|0
4699656|NCT02310568|16192480|P2|Stage 2 (4 Weeks)|Lost to Follow-up|0
4699657|NCT02310568|16192481|P1|Stage 2 (4 Weeks)|Lost to Follow-up|0
4699658|NCT02310568|16192477|P5|Stage 2 (4 Weeks)|Protocol Violation|0
4699659|NCT02310568|16192478|P4|Stage 2 (4 Weeks)|Protocol Violation|1
4699660|NCT02310568|16192479|P3|Stage 2 (4 Weeks)|Protocol Violation|0
4699661|NCT02310568|16192480|P2|Stage 2 (4 Weeks)|Protocol Violation|0
4699662|NCT02310568|16192481|P1|Stage 2 (4 Weeks)|Protocol Violation|0
4699663|NCT02310568|16192477|P5|Stage 2 (4 Weeks)|Adverse Event|1
4699664|NCT02310568|16192478|P4|Stage 2 (4 Weeks)|Adverse Event|1
4699665|NCT02310568|16192479|P3|Stage 2 (4 Weeks)|Adverse Event|0
4699666|NCT02310568|16192480|P2|Stage 2 (4 Weeks)|Adverse Event|0
4699667|NCT02310568|16192481|P1|Stage 2 (4 Weeks)|Adverse Event|0
4699668|NCT02310568|16192477|P5|Stage 2 (4 Weeks)|Other|0
4699669|NCT02310568|16192478|P4|Stage 2 (4 Weeks)|Other|0
4699670|NCT02310568|16192479|P3|Stage 2 (4 Weeks)|Other|1
4699671|NCT02310568|16192480|P2|Stage 2 (4 Weeks)|Other|1
4699672|NCT02310568|16192481|P1|Stage 2 (4 Weeks)|Other|0
4699673|NCT02310568|16192477|P5|Stage 2 (4 Weeks)|Withdrawal by Participants|0
4699674|NCT02310568|16192478|P4|Stage 2 (4 Weeks)|Withdrawal by Participants|1
4699675|NCT02310568|16192479|P3|Stage 2 (4 Weeks)|Withdrawal by Participants|0
4699676|NCT02310568|16192480|P2|Stage 2 (4 Weeks)|Withdrawal by Participants|0
4699677|NCT02310568|16192481|P1|Stage 2 (4 Weeks)|Withdrawal by Participants|1
4699678|NCT02310568|16192477|P5|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4699679|NCT02310568|16192478|P4|Stage 1 ( 4 Weeks)|Lost to Follow-up|1
4699680|NCT02310568|16192479|P3|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4699681|NCT02310568|16192480|P2|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4699682|NCT02310568|16192481|P1|Stage 1 ( 4 Weeks)|Lost to Follow-up|0
4699683|NCT02310568|16192477|P5|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4699684|NCT02310568|16192478|P4|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1
4699685|NCT02310568|16192479|P3|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4699686|NCT02310568|16192480|P2|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4699687|NCT02310568|16192481|P1|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0
4699688|NCT02310568|16192477|P5|Stage 1 ( 4 Weeks)|Adverse Event|0
4699689|NCT02310568|16192478|P4|Stage 1 ( 4 Weeks)|Adverse Event|0
4699690|NCT02310568|16192479|P3|Stage 1 ( 4 Weeks)|Adverse Event|1
4699691|NCT02310568|16192480|P2|Stage 1 ( 4 Weeks)|Adverse Event|1
4699692|NCT02310568|16192481|P1|Stage 1 ( 4 Weeks)|Adverse Event|1
4699693|NCT02310568|16192477|P5|Stage 1 ( 4 Weeks)|Other|0
4699694|NCT02310568|16192478|P4|Stage 1 ( 4 Weeks)|Other|0
4699695|NCT02310568|16192479|P3|Stage 1 ( 4 Weeks)|Other|0
4699696|NCT02310568|16192480|P2|Stage 1 ( 4 Weeks)|Other|1
4699697|NCT02310568|16192481|P1|Stage 1 ( 4 Weeks)|Other|1
4699698|NCT02310568|16192477|P5|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4699699|NCT02310568|16192478|P4|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4699700|NCT02310568|16192479|P3|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4699701|NCT02310568|16192480|P2|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0
4699702|NCT02310568|16192481|P1|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1
4699703|NCT02310568|16192477|P5|Stage 1 ( 4 Weeks)|Lack of Efficacy|1
4699704|NCT02310568|16192478|P4|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4699705|NCT02310568|16192479|P3|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4699706|NCT02310568|16192480|P2|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4699707|NCT02310568|16192481|P1|Stage 1 ( 4 Weeks)|Lack of Efficacy|0
4699708|NCT02310126|16192561|P2|Period 1 (15 Minutes)|Protocol Violation|1
4699709|NCT02310126|16192562|P1|Period 1 (15 Minutes)|Protocol Violation|0
4699710|NCT02310126|16192561|P2|Period 1 (15 Minutes)|Lost to Follow-up|1
4699711|NCT02310126|16192562|P1|Period 1 (15 Minutes)|Lost to Follow-up|0
4699712|NCT02310100|16192568|P1|Overall Study|Lost to Follow-up|2
4699713|NCT02310100|16192568|P1|Overall Study|Visit compliance|1
4699714|NCT02310100|16192568|P1|Overall Study|Unapproved ablation operator|1
4699715|NCT02310100|16192568|P1|Overall Study|Enrollment closure|1
4699716|NCT02310100|16192568|P1|Overall Study|Withdrawal by Subject|10
4699717|NCT02310100|16192568|P1|Overall Study|Physician Decision|3
4699718|NCT02309723|16192600|P3|Overall Study|Withdrawal by Subject|24
4699719|NCT02309723|16192601|P2|Overall Study|Withdrawal by Subject|23
4699720|NCT02309723|16192602|P1|Overall Study|Withdrawal by Subject|24
4699721|NCT02309411|16192645|P3|Overall Study|Withdrawal by Subject|0
4699722|NCT02309411|16192646|P2|Overall Study|Withdrawal by Subject|1
4699723|NCT02309411|16192647|P1|Overall Study|Withdrawal by Subject|1
4699724|NCT02309411|16192645|P3|Overall Study|Physician Decision|0
4699725|NCT02309411|16192646|P2|Overall Study|Physician Decision|0
4699726|NCT02309411|16192647|P1|Overall Study|Physician Decision|1
4699727|NCT02309372|16192668|P2|Overall Study|Lost to Follow-up|2
4699728|NCT02309372|16192669|P1|Overall Study|Lost to Follow-up|3
4699729|NCT02309359|16192686|P5|Overall Study|Other|2
4699730|NCT02309359|16192687|P4|Overall Study|Other|3
4699731|NCT02309359|16192688|P3|Overall Study|Other|2
4699732|NCT02309359|16192689|P2|Overall Study|Other|0
4699733|NCT02309359|16192690|P1|Overall Study|Other|2
4699734|NCT02309359|16192686|P5|Overall Study|Lost to Follow-up|0
4699735|NCT02309359|16192687|P4|Overall Study|Lost to Follow-up|1
4699736|NCT02309359|16192688|P3|Overall Study|Lost to Follow-up|0
4699737|NCT02309359|16192689|P2|Overall Study|Lost to Follow-up|0
4699738|NCT02309359|16192690|P1|Overall Study|Lost to Follow-up|0
4699739|NCT02309359|16192686|P5|Overall Study|Lack of Efficacy|3
4699740|NCT02309359|16192687|P4|Overall Study|Lack of Efficacy|0
4699741|NCT02309359|16192688|P3|Overall Study|Lack of Efficacy|0
4699742|NCT02309359|16192689|P2|Overall Study|Lack of Efficacy|1
4699743|NCT02309359|16192690|P1|Overall Study|Lack of Efficacy|3
4699744|NCT02309359|16192686|P5|Overall Study|Withdrawal by Subject|0
4699745|NCT02309359|16192687|P4|Overall Study|Withdrawal by Subject|4
4699746|NCT02309359|16192688|P3|Overall Study|Withdrawal by Subject|4
4699747|NCT02309359|16192689|P2|Overall Study|Withdrawal by Subject|2
4699748|NCT02309359|16192690|P1|Overall Study|Withdrawal by Subject|2
4699749|NCT02309359|16192686|P5|Overall Study|Death|0
4699750|NCT02309359|16192687|P4|Overall Study|Death|0
4699751|NCT02309359|16192688|P3|Overall Study|Death|0
4699752|NCT02309359|16192689|P2|Overall Study|Death|0
4699753|NCT02309359|16192690|P1|Overall Study|Death|1
4699754|NCT02309359|16192686|P5|Overall Study|Adverse Event|4
4699755|NCT02309359|16192687|P4|Overall Study|Adverse Event|4
4699756|NCT02309359|16192688|P3|Overall Study|Adverse Event|5
4699757|NCT02309359|16192689|P2|Overall Study|Adverse Event|5
4699758|NCT02309359|16192690|P1|Overall Study|Adverse Event|4
4699759|NCT02309294|16192817|P1|Overall Study|Withdrawal by Subject|2
4699760|NCT02309138|16192823|P2|Overall Study|delivered before visit 2|1
4699761|NCT02309138|16192824|P1|Overall Study|delivered before visit 2|0
4699762|NCT02309138|16192823|P2|Overall Study|Protocol Violation|2
4699763|NCT02309138|16192824|P1|Overall Study|Protocol Violation|4
4699764|NCT02309138|16192823|P2|Overall Study|Withdrawal by Subject|15
4699765|NCT02309138|16192824|P1|Overall Study|Withdrawal by Subject|44
4699766|NCT02309112|16192847|P3|Overall Study|Lost to Follow-up|0
4699767|NCT02309112|16192848|P2|Overall Study|Lost to Follow-up|1
4699768|NCT02309112|16192849|P1|Overall Study|Lost to Follow-up|0
4699769|NCT02309112|16192847|P3|Overall Study|Withdrawal by Subject|1
4699770|NCT02309112|16192848|P2|Overall Study|Withdrawal by Subject|0
4699771|NCT02309112|16192849|P1|Overall Study|Withdrawal by Subject|1
4699772|NCT02309099|16192872|P2|Overall Study|Adverse Event|0
4699773|NCT02309099|16192873|P1|Overall Study|Adverse Event|2
4699774|NCT02308748|16192944|P10|Period 5|Adverse Event|0
4699775|NCT02308748|16192945|P9|Period 5|Adverse Event|1
4699776|NCT02308748|16192946|P8|Period 5|Adverse Event|0
4699777|NCT02308748|16192947|P7|Period 5|Adverse Event|0
4699778|NCT02308748|16192948|P6|Period 5|Adverse Event|0
4699779|NCT02308748|16192949|P5|Period 5|Adverse Event|0
4699780|NCT02308748|16192950|P4|Period 5|Adverse Event|0
4699781|NCT02308748|16192951|P3|Period 5|Adverse Event|0
4699782|NCT02308748|16192952|P2|Period 5|Adverse Event|0
4699783|NCT02308748|16192953|P1|Period 5|Adverse Event|1
4699784|NCT02308748|16192944|P10|Period 3|Protocol Violation|1
4699785|NCT02308748|16192945|P9|Period 3|Protocol Violation|0
4699786|NCT02308748|16192946|P8|Period 3|Protocol Violation|0
4699787|NCT02308748|16192947|P7|Period 3|Protocol Violation|0
4699788|NCT02308748|16192948|P6|Period 3|Protocol Violation|0
4699789|NCT02308748|16192949|P5|Period 3|Protocol Violation|0
4699790|NCT02308748|16192950|P4|Period 3|Protocol Violation|0
4699791|NCT02308748|16192951|P3|Period 3|Protocol Violation|0
4699792|NCT02308748|16192952|P2|Period 3|Protocol Violation|0
4699793|NCT02308748|16192953|P1|Period 3|Protocol Violation|0
4699794|NCT02308748|16192944|P10|Period 2|Adverse Event|0
4699795|NCT02308748|16192945|P9|Period 2|Adverse Event|0
4699796|NCT02308748|16192946|P8|Period 2|Adverse Event|1
4699797|NCT02308748|16192947|P7|Period 2|Adverse Event|0
4699798|NCT02308748|16192948|P6|Period 2|Adverse Event|0
4699799|NCT02308748|16192949|P5|Period 2|Adverse Event|0
4699800|NCT02308748|16192950|P4|Period 2|Adverse Event|0
4699801|NCT02308748|16192951|P3|Period 2|Adverse Event|0
4699802|NCT02308748|16192952|P2|Period 2|Adverse Event|0
4699803|NCT02308748|16192953|P1|Period 2|Adverse Event|0
4699804|NCT02308748|16192944|P10|Period 1|Withdrawal by Subject|0
4699805|NCT02308748|16192945|P9|Period 1|Withdrawal by Subject|0
4699806|NCT02308748|16192946|P8|Period 1|Withdrawal by Subject|0
4699807|NCT02308748|16192947|P7|Period 1|Withdrawal by Subject|0
4699808|NCT02308748|16192948|P6|Period 1|Withdrawal by Subject|0
4699809|NCT02308748|16192949|P5|Period 1|Withdrawal by Subject|0
4699810|NCT02308748|16192950|P4|Period 1|Withdrawal by Subject|0
4699811|NCT02308748|16192951|P3|Period 1|Withdrawal by Subject|1
4699812|NCT02308748|16192952|P2|Period 1|Withdrawal by Subject|0
4699813|NCT02308748|16192953|P1|Period 1|Withdrawal by Subject|0
4699814|NCT02308696|16192967|P2|Overall Study|Moved to a Higher Level of Care|6
4699815|NCT02308696|16192968|P1|Overall Study|Moved to a Higher Level of Care|17
4699816|NCT02308696|16192967|P2|Overall Study|Death|4
4699817|NCT02308696|16192968|P1|Overall Study|Death|8
4699818|NCT02308696|16192967|P2|Overall Study|Lost to Follow-up|21
4699819|NCT02308696|16192968|P1|Overall Study|Lost to Follow-up|28
4699820|NCT02308540|16193002|P6|Overall Study|Lost to Follow-up|1
4699821|NCT02308540|16193003|P5|Overall Study|Lost to Follow-up|0
4699822|NCT02308540|16193004|P4|Overall Study|Lost to Follow-up|0
4699823|NCT02308540|16193005|P3|Overall Study|Lost to Follow-up|0
4699824|NCT02308540|16193006|P2|Overall Study|Lost to Follow-up|0
4699825|NCT02308540|16193007|P1|Overall Study|Lost to Follow-up|0
4699826|NCT02308228|16193096|P2|Overall Study|Withdrawal by Subject|3
4699827|NCT02308228|16193097|P1|Overall Study|Withdrawal by Subject|5
4699828|NCT02308228|16193096|P2|Overall Study|Adverse Event|4
4699829|NCT02308228|16193097|P1|Overall Study|Adverse Event|3
4699830|NCT02308163|16193126|P5|Overall Study|Miscellaneous|5
4699831|NCT02308163|16193127|P4|Overall Study|Miscellaneous|0
4699832|NCT02308163|16193128|P3|Overall Study|Miscellaneous|1
4699833|NCT02308163|16193129|P2|Overall Study|Miscellaneous|2
4699834|NCT02308163|16193130|P1|Overall Study|Miscellaneous|2
4699835|NCT02308163|16193126|P5|Overall Study|Lab data met discontinuation criteria|0
4699836|NCT02308163|16193127|P4|Overall Study|Lab data met discontinuation criteria|2
4699837|NCT02308163|16193128|P3|Overall Study|Lab data met discontinuation criteria|0
4699838|NCT02308163|16193129|P2|Overall Study|Lab data met discontinuation criteria|0
4699839|NCT02308163|16193130|P1|Overall Study|Lab data met discontinuation criteria|3
4699840|NCT02308163|16193126|P5|Overall Study|Protocol Violation|5
4699841|NCT02308163|16193127|P4|Overall Study|Protocol Violation|2
4699842|NCT02308163|16193128|P3|Overall Study|Protocol Violation|3
4699843|NCT02308163|16193129|P2|Overall Study|Protocol Violation|3
4699844|NCT02308163|16193130|P1|Overall Study|Protocol Violation|3
4699845|NCT02308163|16193126|P5|Overall Study|Withdrawal of consent|6
4699846|NCT02308163|16193127|P4|Overall Study|Withdrawal of consent|2
4699847|NCT02308163|16193128|P3|Overall Study|Withdrawal of consent|0
4699848|NCT02308163|16193129|P2|Overall Study|Withdrawal of consent|3
4699849|NCT02308163|16193130|P1|Overall Study|Withdrawal of consent|2
4699850|NCT02308163|16193126|P5|Overall Study|Lack of Efficacy|6
4699851|NCT02308163|16193127|P4|Overall Study|Lack of Efficacy|4
4699852|NCT02308163|16193128|P3|Overall Study|Lack of Efficacy|8
4699853|NCT02308163|16193129|P2|Overall Study|Lack of Efficacy|3
4699854|NCT02308163|16193130|P1|Overall Study|Lack of Efficacy|11
4699855|NCT02308163|16193126|P5|Overall Study|Adverse Event|11
4699856|NCT02308163|16193127|P4|Overall Study|Adverse Event|2
4699857|NCT02308163|16193128|P3|Overall Study|Adverse Event|2
4699858|NCT02308163|16193129|P2|Overall Study|Adverse Event|5
4699859|NCT02308163|16193130|P1|Overall Study|Adverse Event|9
4699860|NCT02308163|16193126|P5|Overall Study|Not fulfill eligible criteria|1
4699861|NCT02308163|16193127|P4|Overall Study|Not fulfill eligible criteria|1
4699862|NCT02308163|16193128|P3|Overall Study|Not fulfill eligible criteria|0
4699863|NCT02308163|16193129|P2|Overall Study|Not fulfill eligible criteria|2
4699864|NCT02308163|16193130|P1|Overall Study|Not fulfill eligible criteria|1
4699865|NCT02308124|16193440|P3|Overall Study|Adverse Event|2
4699866|NCT02308124|16193441|P2|Overall Study|Adverse Event|2
4699867|NCT02308124|16193442|P1|Overall Study|Adverse Event|0
4699868|NCT02308124|16193440|P3|Overall Study|Lost to Follow-up|6
4699869|NCT02308124|16193441|P2|Overall Study|Lost to Follow-up|6
4699870|NCT02308124|16193442|P1|Overall Study|Lost to Follow-up|6
4699871|NCT02308046|16193464|P2|Overall Study|Lost to Follow-up|3
4699872|NCT02308046|16193465|P1|Overall Study|Lost to Follow-up|1
4699873|NCT02308046|16193464|P2|Overall Study|Positive for STD at Baseline|2
4699874|NCT02308046|16193465|P1|Overall Study|Positive for STD at Baseline|1
4699875|NCT02308046|16193464|P2|Overall Study|Negative yeast culture at Baseline|33
4699876|NCT02308046|16193465|P1|Overall Study|Negative yeast culture at Baseline|32
4699877|NCT02308033|16193481|P2|Overall Study|Lost to Follow-up|5
4699878|NCT02308033|16193482|P1|Overall Study|Lost to Follow-up|6
4699879|NCT02308033|16193481|P2|Overall Study|Positive for STD at Baseline|4
4699880|NCT02308033|16193482|P1|Overall Study|Positive for STD at Baseline|7
4699881|NCT02308033|16193481|P2|Overall Study|Normal Gram stain at Baseline|10
4699882|NCT02308033|16193482|P1|Overall Study|Normal Gram stain at Baseline|13
4699883|NCT02308020|16193502|P6|Overall Study|On treatment|0
4699884|NCT02308020|16193503|P5|Overall Study|On treatment|0
4699885|NCT02308020|16193504|P4|Overall Study|On treatment|0
4699886|NCT02308020|16193505|P3|Overall Study|On treatment|0
4699887|NCT02308020|16193506|P2|Overall Study|On treatment|3
4699888|NCT02308020|16193507|P1|Overall Study|On treatment|0
4699889|NCT02308020|16193502|P6|Overall Study|Withdrawal by Subject|0
4699890|NCT02308020|16193503|P5|Overall Study|Withdrawal by Subject|2
4699891|NCT02308020|16193504|P4|Overall Study|Withdrawal by Subject|3
4699892|NCT02308020|16193505|P3|Overall Study|Withdrawal by Subject|0
4699893|NCT02308020|16193506|P2|Overall Study|Withdrawal by Subject|4
4699894|NCT02308020|16193507|P1|Overall Study|Withdrawal by Subject|0
4699895|NCT02308020|16193502|P6|Overall Study|Physician Decision|1
4699896|NCT02308020|16193503|P5|Overall Study|Physician Decision|0
4699897|NCT02308020|16193504|P4|Overall Study|Physician Decision|0
4699898|NCT02308020|16193505|P3|Overall Study|Physician Decision|0
4699899|NCT02308020|16193506|P2|Overall Study|Physician Decision|0
4699900|NCT02308020|16193507|P1|Overall Study|Physician Decision|0
4699901|NCT02308020|16193502|P6|Overall Study|Protocol Violation|0
4699902|NCT02308020|16193503|P5|Overall Study|Protocol Violation|0
4699903|NCT02308020|16193504|P4|Overall Study|Protocol Violation|0
4699904|NCT02308020|16193505|P3|Overall Study|Protocol Violation|1
4699905|NCT02308020|16193506|P2|Overall Study|Protocol Violation|0
4699906|NCT02308020|16193507|P1|Overall Study|Protocol Violation|0
4699907|NCT02308020|16193502|P6|Overall Study|Adverse Event|1
4699908|NCT02308020|16193503|P5|Overall Study|Adverse Event|0
4699909|NCT02308020|16193504|P4|Overall Study|Adverse Event|1
4699910|NCT02308020|16193505|P3|Overall Study|Adverse Event|0
4699911|NCT02308020|16193506|P2|Overall Study|Adverse Event|5
4699912|NCT02308020|16193507|P1|Overall Study|Adverse Event|3
4699913|NCT02308007|16193560|P3|Overall Study|Lost to Follow-up|1
4699914|NCT02308007|16193561|P2|Overall Study|Lost to Follow-up|0
4699915|NCT02308007|16193562|P1|Overall Study|Lost to Follow-up|3
4699916|NCT02308007|16193560|P3|Overall Study|Positive for STD at Baseline|7
4699917|NCT02308007|16193561|P2|Overall Study|Positive for STD at Baseline|11
4699918|NCT02308007|16193562|P1|Overall Study|Positive for STD at Baseline|7
4699919|NCT02308007|16193560|P3|Overall Study|Normal Gram stain or neg yeast culture|67
4699920|NCT02308007|16193561|P2|Overall Study|Normal Gram stain or neg yeast culture|64
4699921|NCT02308007|16193562|P1|Overall Study|Normal Gram stain or neg yeast culture|66
4699922|NCT02307682|16193653|P3|Overall Study|Other|0
4699923|NCT02307682|16193654|P2|Overall Study|Other|1
4699924|NCT02307682|16193655|P1|Overall Study|Other|1
4699925|NCT02307682|16193653|P3|Overall Study|Protocol Deviation|2
4699926|NCT02307682|16193654|P2|Overall Study|Protocol Deviation|0
4699927|NCT02307682|16193655|P1|Overall Study|Protocol Deviation|0
4699928|NCT02307682|16193653|P3|Overall Study|Lost to Follow-up|6
4699929|NCT02307682|16193654|P2|Overall Study|Lost to Follow-up|5
4699930|NCT02307682|16193655|P1|Overall Study|Lost to Follow-up|1
4699931|NCT02307682|16193653|P3|Overall Study|Death|12
4699932|NCT02307682|16193654|P2|Overall Study|Death|7
4699933|NCT02307682|16193655|P1|Overall Study|Death|9
4699934|NCT02307682|16193653|P3|Overall Study|Withdrawal by Subject|23
4699935|NCT02307682|16193654|P2|Overall Study|Withdrawal by Subject|34
4699936|NCT02307682|16193655|P1|Overall Study|Withdrawal by Subject|26
4699937|NCT02307682|16193653|P3|Overall Study|Progressive Disease|0
4699938|NCT02307682|16193654|P2|Overall Study|Progressive Disease|0
4699939|NCT02307682|16193655|P1|Overall Study|Progressive Disease|1
4699940|NCT02307682|16193653|P3|Overall Study|Physician Decision|8
4699941|NCT02307682|16193654|P2|Overall Study|Physician Decision|2
4699942|NCT02307682|16193655|P1|Overall Study|Physician Decision|2
4699943|NCT02307682|16193653|P3|Overall Study|Lack of Efficacy|1
4699944|NCT02307682|16193654|P2|Overall Study|Lack of Efficacy|0
4699945|NCT02307682|16193655|P1|Overall Study|Lack of Efficacy|1
4699946|NCT02307682|16193653|P3|Overall Study|Adverse Event|12
4699947|NCT02307682|16193654|P2|Overall Study|Adverse Event|8
4699948|NCT02307682|16193655|P1|Overall Study|Adverse Event|9
4699949|NCT02307513|16193771|P2|Active Treatment Phase (Weeks 13-64)|Pregnancy|1
4699950|NCT02307513|16193772|P1|Active Treatment Phase (Weeks 13-64)|Pregnancy|0
4699951|NCT02307513|16193771|P2|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
4699952|NCT02307513|16193772|P1|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1
4699953|NCT02307513|16193771|P2|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
4699954|NCT02307513|16193772|P1|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7
4699955|NCT02307513|16193771|P2|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
4699956|NCT02307513|16193772|P1|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2
4699957|NCT02307513|16193771|P2|Active Treatment Phase (Weeks 13-64)|Adverse Event|4
4699958|NCT02307513|16193772|P1|Active Treatment Phase (Weeks 13-64)|Adverse Event|9
4699959|NCT02307513|16193771|P2|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0
4699960|NCT02307513|16193772|P1|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1
4699961|NCT02307513|16193771|P2|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
4699962|NCT02307513|16193772|P1|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1
4699963|NCT02307513|16193771|P2|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1
4699964|NCT02307513|16193772|P1|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0
4699965|NCT02307513|16193771|P2|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5
4699966|NCT02307513|16193772|P1|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4
4699967|NCT02307513|16193771|P2|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1
4699968|NCT02307513|16193772|P1|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0
4699969|NCT02307513|16193771|P2|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8
4699970|NCT02307513|16193772|P1|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0
4699971|NCT02307513|16193771|P2|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4
4699972|NCT02307513|16193772|P1|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3
4699973|NCT02307266|16193823|P3|Overall Study|Lost to Follow-up|0
4699974|NCT02307266|16193824|P2|Overall Study|Lost to Follow-up|0
4699975|NCT02307266|16193825|P1|Overall Study|Lost to Follow-up|3
4699976|NCT02307266|16193823|P3|Overall Study|Withdrawal by Subject|1
4699977|NCT02307266|16193824|P2|Overall Study|Withdrawal by Subject|0
4699978|NCT02307266|16193825|P1|Overall Study|Withdrawal by Subject|2
4699979|NCT02307266|16193823|P3|Overall Study|Adverse Event|5
4699980|NCT02307266|16193824|P2|Overall Study|Adverse Event|1
4699981|NCT02307266|16193825|P1|Overall Study|Adverse Event|3
4699982|NCT02306850|16193850|P1|Overall Study|Lack of Efficacy|2
4699983|NCT02306694|16193872|P1|Overall Study|Lost to Follow-up|1
4699984|NCT02306694|16193872|P1|Overall Study|Withdrawal by Subject|3
4699985|NCT02306265|16193882|P1|Overall Study|Withdrawal by Subject|1
4699986|NCT02305888|16193891|P3|Overall Study|Adverse Event|0
4699987|NCT02305888|16193892|P2|Overall Study|Adverse Event|1
4699988|NCT02305888|16193893|P1|Overall Study|Adverse Event|0
4699989|NCT02305888|16193891|P3|Overall Study|Lost to Follow-up|1
4699990|NCT02305888|16193892|P2|Overall Study|Lost to Follow-up|0
4699991|NCT02305888|16193893|P1|Overall Study|Lost to Follow-up|0
4699992|NCT02305849|16193913|P4|Overall Study|Not fulfill eligibility criteria|0
4699993|NCT02305849|16193914|P3|Overall Study|Not fulfill eligibility criteria|0
4699994|NCT02305849|16193915|P2|Overall Study|Not fulfill eligibility criteria|1
4699995|NCT02305849|16193916|P1|Overall Study|Not fulfill eligibility criteria|1
4699996|NCT02305849|16193913|P4|Overall Study|Miscellaneous|1
4699997|NCT02305849|16193914|P3|Overall Study|Miscellaneous|4
4699998|NCT02305849|16193915|P2|Overall Study|Miscellaneous|2
4699999|NCT02305849|16193916|P1|Overall Study|Miscellaneous|1
4700000|NCT02305849|16193913|P4|Overall Study|Lab data met discontinuation criteria|1
4700001|NCT02305849|16193914|P3|Overall Study|Lab data met discontinuation criteria|2
4700002|NCT02305849|16193915|P2|Overall Study|Lab data met discontinuation criteria|1
4700003|NCT02305849|16193916|P1|Overall Study|Lab data met discontinuation criteria|0
4700004|NCT02305849|16193913|P4|Overall Study|Protocol Violation|1
4700005|NCT02305849|16193914|P3|Overall Study|Protocol Violation|1
4700006|NCT02305849|16193915|P2|Overall Study|Protocol Violation|2
4700007|NCT02305849|16193916|P1|Overall Study|Protocol Violation|3
4700008|NCT02305849|16193913|P4|Overall Study|Lost to Follow-up|0
4700009|NCT02305849|16193914|P3|Overall Study|Lost to Follow-up|0
4700010|NCT02305849|16193915|P2|Overall Study|Lost to Follow-up|2
4700011|NCT02305849|16193916|P1|Overall Study|Lost to Follow-up|0
4700012|NCT02305849|16193913|P4|Overall Study|Withdrawal by Subject|4
4700013|NCT02305849|16193914|P3|Overall Study|Withdrawal by Subject|1
4700014|NCT02305849|16193915|P2|Overall Study|Withdrawal by Subject|2
4700015|NCT02305849|16193916|P1|Overall Study|Withdrawal by Subject|2
4700016|NCT02305849|16193913|P4|Overall Study|Lack of Efficacy|9
4700017|NCT02305849|16193914|P3|Overall Study|Lack of Efficacy|3
4700018|NCT02305849|16193915|P2|Overall Study|Lack of Efficacy|6
4700019|NCT02305849|16193916|P1|Overall Study|Lack of Efficacy|10
4700020|NCT02305849|16193913|P4|Overall Study|Adverse Event|3
4700021|NCT02305849|16193914|P3|Overall Study|Adverse Event|7
4700022|NCT02305849|16193915|P2|Overall Study|Adverse Event|12
4700023|NCT02305849|16193916|P1|Overall Study|Adverse Event|10
4700024|NCT02305797|16194150|P2|Overall Study|Reason not collected|1
4700025|NCT02305797|16194151|P1|Overall Study|Reason not collected|0
4700026|NCT02305797|16194150|P2|Overall Study|Noncompliance|12
4700027|NCT02305797|16194151|P1|Overall Study|Noncompliance|14
4700028|NCT02305797|16194150|P2|Overall Study|Pregnancy|2
4700029|NCT02305797|16194151|P1|Overall Study|Pregnancy|0
4700030|NCT02305797|16194150|P2|Overall Study|Lost to Follow-up|11
4700031|NCT02305797|16194151|P1|Overall Study|Lost to Follow-up|5
4700032|NCT02305797|16194150|P2|Overall Study|Lack of Efficacy|0
4700033|NCT02305797|16194151|P1|Overall Study|Lack of Efficacy|6
4700034|NCT02305797|16194150|P2|Overall Study|Withdrawal by Subject|10
4700035|NCT02305797|16194151|P1|Overall Study|Withdrawal by Subject|9
4700036|NCT02305797|16194150|P2|Overall Study|Adverse Event|2
4700037|NCT02305797|16194151|P1|Overall Study|Adverse Event|11
4700038|NCT02305758|16194161|P2|Overall Study|Other, not specified|1
4700039|NCT02305758|16194162|P1|Overall Study|Other, not specified|2
4700040|NCT02305758|16194161|P2|Overall Study|Study Terminated by Sponsor|34
4700041|NCT02305758|16194162|P1|Overall Study|Study Terminated by Sponsor|21
4700042|NCT02305758|16194161|P2|Overall Study|Lost to Follow-up|1
4700043|NCT02305758|16194162|P1|Overall Study|Lost to Follow-up|6
4700044|NCT02305758|16194161|P2|Overall Study|Withdrew consent|2
4700045|NCT02305758|16194162|P1|Overall Study|Withdrew consent|9
4700046|NCT02305758|16194161|P2|Overall Study|Death|27
4700047|NCT02305758|16194162|P1|Overall Study|Death|27
4700048|NCT02305446|16194180|P1|Overall Study|Adverse Event|1
4700049|NCT02305381|16194188|P3|Overall Study|Unclassified|7
4700050|NCT02305381|16194189|P2|Overall Study|Unclassified|5
4700051|NCT02305381|16194190|P1|Overall Study|Unclassified|5
4700052|NCT02305238|16194303|P3|Overall Study|Required procedure failed|0
4700053|NCT02305238|16194304|P2|Overall Study|Required procedure failed|1
4700054|NCT02305238|16194305|P1|Overall Study|Required procedure failed|0
4700055|NCT02305238|16194303|P3|Overall Study|Randomized failure|8
4700056|NCT02305238|16194304|P2|Overall Study|Randomized failure|0
4700057|NCT02305238|16194305|P1|Overall Study|Randomized failure|0
4700058|NCT02305238|16194303|P3|Overall Study|Withdrawal by Subject|0
4700059|NCT02305238|16194304|P2|Overall Study|Withdrawal by Subject|4
4700060|NCT02305238|16194305|P1|Overall Study|Withdrawal by Subject|3
4700061|NCT02305238|16194303|P3|Overall Study|Adverse Event|0
4700062|NCT02305238|16194304|P2|Overall Study|Adverse Event|2
4700063|NCT02305238|16194305|P1|Overall Study|Adverse Event|4
4700064|NCT02305238|16194303|P3|Overall Study|Physician Decision|0
4700065|NCT02305238|16194304|P2|Overall Study|Physician Decision|1
4700066|NCT02305238|16194305|P1|Overall Study|Physician Decision|2
4700067|NCT02305238|16194303|P3|Overall Study|Protocol Violation|0
4700068|NCT02305238|16194304|P2|Overall Study|Protocol Violation|3
4700069|NCT02305238|16194305|P1|Overall Study|Protocol Violation|0
4700070|NCT02305238|16194303|P3|Overall Study|Logistical difficulties|0
4700071|NCT02305238|16194304|P2|Overall Study|Logistical difficulties|3
4700072|NCT02305238|16194305|P1|Overall Study|Logistical difficulties|1
4700073|NCT02305238|16194303|P3|Overall Study|Progressive disease|0
4700074|NCT02305238|16194304|P2|Overall Study|Progressive disease|4
4700075|NCT02305238|16194305|P1|Overall Study|Progressive disease|4
4700076|NCT02305238|16194303|P3|Overall Study|Death|0
4700077|NCT02305238|16194304|P2|Overall Study|Death|1
4700078|NCT02305238|16194305|P1|Overall Study|Death|2
4700079|NCT02304926|16194337|P2|Overall Study|Lost to Follow-up|1
4700080|NCT02304926|16194338|P1|Overall Study|Lost to Follow-up|2
4700081|NCT02304705|16194384|P2|Overall Study|Lost to Follow-up|2
4700082|NCT02304705|16194385|P1|Overall Study|Lost to Follow-up|0
4700083|NCT02304705|16194384|P2|Overall Study|Death|1
4700084|NCT02304705|16194385|P1|Overall Study|Death|0
4700085|NCT02304705|16194384|P2|Overall Study|Physician Decision|4
4700086|NCT02304705|16194385|P1|Overall Study|Physician Decision|2
4700087|NCT02304705|16194384|P2|Overall Study|Withdrawal by Subject|0
4700088|NCT02304705|16194385|P1|Overall Study|Withdrawal by Subject|2
4700089|NCT02304484|16194391|P1|Overall Study|Lost to Follow-up|2
4700090|NCT02304484|16194391|P1|Overall Study|Withdrawal by Subject|14
4700091|NCT02304484|16194391|P1|Overall Study|Death|9
4700092|NCT02304380|16194454|P6|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4700093|NCT02304380|16194455|P5|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4700094|NCT02304380|16194456|P4|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34
4700095|NCT02304380|16194457|P3|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4700096|NCT02304380|16194458|P2|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4700097|NCT02304380|16194459|P1|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0
4700098|NCT02304367|16194509|P1|Overall Study|Ongoing in Study|12
4700099|NCT02304367|16194509|P1|Overall Study|Death|1
4700100|NCT02304367|16194509|P1|Overall Study|Sponsor Decision|3
4700101|NCT02304367|16194509|P1|Overall Study|Lack of Phosphorus Increase|1
4700102|NCT01557504|16194569|P2|Overall Study|Physician Decision|0
4700103|NCT01557504|16194570|P1|Overall Study|Physician Decision|1
4700104|NCT02303704|16194619|P2|Overall Study|Protocol Violation|9
4700105|NCT02303704|16194620|P1|Overall Study|Protocol Violation|5
4700106|NCT02303574|16194648|P10|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700107|NCT02303574|16194649|P9|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700108|NCT02303574|16194650|P8|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1
4700109|NCT02303574|16194651|P7|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700110|NCT02303574|16194652|P6|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700111|NCT02303574|16194653|P5|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700112|NCT02303574|16194654|P4|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700113|NCT02303574|16194655|P3|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700114|NCT02303574|16194656|P2|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700115|NCT02303574|16194657|P1|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0
4700116|NCT02303574|16194648|P10|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700117|NCT02303574|16194649|P9|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700118|NCT02303574|16194650|P8|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700119|NCT02303574|16194651|P7|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700120|NCT02303574|16194652|P6|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700121|NCT02303574|16194653|P5|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700122|NCT02303574|16194654|P4|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700123|NCT02303574|16194655|P3|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1
4700124|NCT02303574|16194656|P2|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700125|NCT02303574|16194657|P1|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0
4700126|NCT02303262|16194878|P1|Overall Study|Withdrawal by Subject|2
4700127|NCT02303041|16194886|P2|Overall Study|Adverse Event|2
4700128|NCT02303041|16194887|P1|Overall Study|Adverse Event|1
4700129|NCT02302859|16194903|P2|Overall Study|Withdrawal by Subject|1
4700130|NCT02302859|16194904|P1|Overall Study|Withdrawal by Subject|0
4700131|NCT02302859|16194903|P2|Overall Study|Lost Phone|1
4700132|NCT02302859|16194904|P1|Overall Study|Lost Phone|1
4700133|NCT02302846|16194910|P1|Overall Study|Withdrawal by Subject|1
4700134|NCT02302807|16194916|P2|Overall Study|Physician Decision|1
4700135|NCT02302807|16194917|P1|Overall Study|Physician Decision|0
4700136|NCT02302807|16194916|P2|Overall Study|Study Terminated By Sponsor|64
4700137|NCT02302807|16194917|P1|Overall Study|Study Terminated By Sponsor|35
4700138|NCT02302807|16194916|P2|Overall Study|Death|385
4700139|NCT02302807|16194917|P1|Overall Study|Death|397
4700140|NCT02302807|16194916|P2|Overall Study|Lost to Follow-up|6
4700141|NCT02302807|16194917|P1|Overall Study|Lost to Follow-up|4
4700142|NCT02302807|16194916|P2|Overall Study|Withdrawal by Subject|11
4700143|NCT02302807|16194917|P1|Overall Study|Withdrawal by Subject|28
4700144|NCT02302716|16194964|P2|Overall Study|Protocol Violation|1
4700145|NCT02302716|16194965|P1|Overall Study|Protocol Violation|0
4700146|NCT02302716|16194964|P2|Overall Study|Withdrawal by Subject|7
4700147|NCT02302716|16194965|P1|Overall Study|Withdrawal by Subject|13
4700148|NCT02302716|16194964|P2|Overall Study|Physician Decision|4
4700149|NCT02302716|16194965|P1|Overall Study|Physician Decision|3
4700150|NCT02302716|16194964|P2|Overall Study|Lost to Follow-up|4
4700151|NCT02302716|16194965|P1|Overall Study|Lost to Follow-up|2
4700152|NCT02302716|16194964|P2|Overall Study|Lack of Efficacy|1
4700153|NCT02302716|16194965|P1|Overall Study|Lack of Efficacy|0
4700154|NCT02302716|16194964|P2|Overall Study|Death|1
4700155|NCT02302716|16194965|P1|Overall Study|Death|0
4700156|NCT02302716|16194964|P2|Overall Study|Adverse Event|1
4700157|NCT02302716|16194965|P1|Overall Study|Adverse Event|1
4700158|NCT02302339|16195013|P4|Overall Study|Withdrawal by Subject|0
4700159|NCT02302339|16195014|P3|Overall Study|Withdrawal by Subject|1
4700160|NCT02302339|16195015|P2|Overall Study|Withdrawal by Subject|2
4700161|NCT02302339|16195016|P1|Overall Study|Withdrawal by Subject|0
4700162|NCT02302339|16195013|P4|Overall Study|Lost to Follow-up|0
4700163|NCT02302339|16195014|P3|Overall Study|Lost to Follow-up|0
4700164|NCT02302339|16195015|P2|Overall Study|Lost to Follow-up|0
4700165|NCT02302339|16195016|P1|Overall Study|Lost to Follow-up|1
4700166|NCT02302222|16195049|P2|Overall Study|Withdrawn prior to any treatment|1
4700167|NCT02302222|16195050|P1|Overall Study|Withdrawn prior to any treatment|0
4700168|NCT02302222|16195049|P2|Overall Study|Treatment discontinued before day 5|1
4700169|NCT02302222|16195050|P1|Overall Study|Treatment discontinued before day 5|0
4700170|NCT02302222|16195049|P2|Overall Study|Lost to Follow-up|0
4700171|NCT02302222|16195050|P1|Overall Study|Lost to Follow-up|1
4700172|NCT02302222|16195049|P2|Overall Study|Physician Decision|4
4700173|NCT02302222|16195050|P1|Overall Study|Physician Decision|0
4700174|NCT02302066|16195089|P4|Overall Study|Reason Not Specified|1
4700175|NCT02302066|16195090|P3|Overall Study|Reason Not Specified|9
4700176|NCT02302066|16195091|P2|Overall Study|Reason Not Specified|1
4700177|NCT02302066|16195092|P1|Overall Study|Reason Not Specified|1
4700178|NCT02302066|16195089|P4|Overall Study|Pregnancy|0
4700179|NCT02302066|16195090|P3|Overall Study|Pregnancy|12
4700180|NCT02302066|16195091|P2|Overall Study|Pregnancy|10
4700181|NCT02302066|16195092|P1|Overall Study|Pregnancy|2
4700182|NCT02302066|16195089|P4|Overall Study|Withdrawal by Subject|33
4700183|NCT02302066|16195090|P3|Overall Study|Withdrawal by Subject|124
4700184|NCT02302066|16195091|P2|Overall Study|Withdrawal by Subject|58
4700185|NCT02302066|16195092|P1|Overall Study|Withdrawal by Subject|25
4700186|NCT02302066|16195089|P4|Overall Study|Lost to Follow-up|7
4700187|NCT02302066|16195090|P3|Overall Study|Lost to Follow-up|24
4700188|NCT02302066|16195091|P2|Overall Study|Lost to Follow-up|5
4700189|NCT02302066|16195092|P1|Overall Study|Lost to Follow-up|4
4700190|NCT02302066|16195089|P4|Overall Study|Adverse Event|0
4700191|NCT02302066|16195090|P3|Overall Study|Adverse Event|3
4700192|NCT02302066|16195091|P2|Overall Study|Adverse Event|1
4700193|NCT02302066|16195092|P1|Overall Study|Adverse Event|1
4700194|NCT02301988|16195136|P2|Overall Study|Adverse Event|1
4700195|NCT02301988|16195137|P1|Overall Study|Adverse Event|1
4700196|NCT02301988|16195136|P2|Overall Study|Death|0
4700197|NCT02301988|16195137|P1|Overall Study|Death|1
4700198|NCT02301988|16195136|P2|Overall Study|Lack of Efficacy|2
4700199|NCT02301988|16195137|P1|Overall Study|Lack of Efficacy|3
4700200|NCT02301988|16195136|P2|Overall Study|Unknown Reason|3
4700201|NCT02301988|16195137|P1|Overall Study|Unknown Reason|1
4700202|NCT02301988|16195136|P2|Overall Study|Physician Decision|2
4700203|NCT02301988|16195137|P1|Overall Study|Physician Decision|2
4700204|NCT02301988|16195136|P2|Overall Study|Withdrawal by Subject|1
4700205|NCT02301988|16195137|P1|Overall Study|Withdrawal by Subject|2
4700206|NCT02301975|16195170|P3|Overall Study|Withdrawal by Subject|11
4700207|NCT02301975|16195171|P2|Overall Study|Withdrawal by Subject|12
4700208|NCT02301975|16195172|P1|Overall Study|Withdrawal by Subject|15
4700209|NCT02301975|16195170|P3|Overall Study|Physician Decision|3
4700210|NCT02301975|16195171|P2|Overall Study|Physician Decision|2
4700211|NCT02301975|16195172|P1|Overall Study|Physician Decision|4
4700212|NCT02301975|16195170|P3|Overall Study|Lost to Follow-up|2
4700213|NCT02301975|16195171|P2|Overall Study|Lost to Follow-up|2
4700214|NCT02301975|16195172|P1|Overall Study|Lost to Follow-up|0
4700215|NCT02301975|16195170|P3|Overall Study|Protocol Violation|3
4700216|NCT02301975|16195171|P2|Overall Study|Protocol Violation|5
4700217|NCT02301975|16195172|P1|Overall Study|Protocol Violation|3
4700218|NCT02301975|16195170|P3|Overall Study|Lack of Efficacy|1
4700219|NCT02301975|16195171|P2|Overall Study|Lack of Efficacy|1
4700220|NCT02301975|16195172|P1|Overall Study|Lack of Efficacy|1
4700221|NCT02301975|16195170|P3|Overall Study|Adverse Event|2
4700222|NCT02301975|16195171|P2|Overall Study|Adverse Event|3
4700223|NCT02301975|16195172|P1|Overall Study|Adverse Event|8
4700224|NCT02301936|16195200|P2|Overall Study|Lost to Follow-up|0
4700225|NCT02301936|16195201|P1|Overall Study|Lost to Follow-up|1
4700226|NCT02301897|16195226|P3|Treatment Course 2|Other Miscellaneous Reasons|0
4700227|NCT02301897|16195227|P2|Treatment Course 2|Other Miscellaneous Reasons|0
4700228|NCT02301897|16195228|P1|Treatment Course 2|Other Miscellaneous Reasons|1
4700229|NCT02301897|16195226|P3|Treatment Course 2|Withdrawal by Subject|0
4700230|NCT02301897|16195227|P2|Treatment Course 2|Withdrawal by Subject|2
4700231|NCT02301897|16195228|P1|Treatment Course 2|Withdrawal by Subject|0
4700232|NCT02301897|16195226|P3|Treatment Course 2|Pregnancy|1
4700233|NCT02301897|16195227|P2|Treatment Course 2|Pregnancy|1
4700234|NCT02301897|16195228|P1|Treatment Course 2|Pregnancy|0
4700235|NCT02301897|16195226|P3|Treatment Course 2|Lost to Follow-up|0
4700236|NCT02301897|16195227|P2|Treatment Course 2|Lost to Follow-up|2
4700237|NCT02301897|16195228|P1|Treatment Course 2|Lost to Follow-up|0
4700238|NCT02301897|16195226|P3|Treatment Course 1|Other Miscellaneous Reasons|0
4700239|NCT02301897|16195227|P2|Treatment Course 1|Other Miscellaneous Reasons|0
4700240|NCT02301897|16195228|P1|Treatment Course 1|Other Miscellaneous Reasons|1
4700241|NCT02301897|16195226|P3|Treatment Course 1|Withdrawal by Subject|2
4700242|NCT02301897|16195227|P2|Treatment Course 1|Withdrawal by Subject|0
4700243|NCT02301897|16195228|P1|Treatment Course 1|Withdrawal by Subject|0
4700244|NCT02301897|16195226|P3|Treatment Course 1|Withdrawal by Sponsor|2
4700245|NCT02301897|16195227|P2|Treatment Course 1|Withdrawal by Sponsor|0
4700246|NCT02301897|16195228|P1|Treatment Course 1|Withdrawal by Sponsor|0
4700247|NCT02301897|16195226|P3|Treatment Course 1|Lost to Follow-up|1
4700248|NCT02301897|16195227|P2|Treatment Course 1|Lost to Follow-up|2
4700249|NCT02301897|16195228|P1|Treatment Course 1|Lost to Follow-up|1
4700250|NCT02301897|16195226|P3|Treatment Course 1|Adverse Event|0
4700251|NCT02301897|16195227|P2|Treatment Course 1|Adverse Event|1
4700252|NCT02301897|16195228|P1|Treatment Course 1|Adverse Event|1
4700253|NCT02301897|16195226|P3|Treatment Course 1|Non-Compliance|1
4700254|NCT02301897|16195227|P2|Treatment Course 1|Non-Compliance|0
4700255|NCT02301897|16195228|P1|Treatment Course 1|Non-Compliance|0
4700256|NCT02301624|16195294|P2|Open-label Maintenance Phase|Participant felt no change in condition|0
4700257|NCT02301624|16195295|P1|Open-label Maintenance Phase|Participant felt no change in condition|1
4700258|NCT02301624|16195294|P2|Open-label Maintenance Phase|Death|1
4700259|NCT02301624|16195295|P1|Open-label Maintenance Phase|Death|2
4700260|NCT02301624|16195294|P2|Open-label Maintenance Phase|Physician Decision|3
4700261|NCT02301624|16195295|P1|Open-label Maintenance Phase|Physician Decision|3
4700262|NCT02301624|16195294|P2|Open-label Maintenance Phase|Adverse Event|5
4700263|NCT02301624|16195295|P1|Open-label Maintenance Phase|Adverse Event|2
4700264|NCT02301624|16195294|P2|Open-label Maintenance Phase|Withdrawal by Subject|8
4700265|NCT02301624|16195295|P1|Open-label Maintenance Phase|Withdrawal by Subject|4
4700266|NCT02301624|16195294|P2|Blind Induction Phase|Withdrawal by Subject|0
4700267|NCT02301624|16195295|P1|Blind Induction Phase|Withdrawal by Subject|1
4700268|NCT02301546|16195306|P2|Long Term Effectiveness (~1 Year)|moved away|2
4700269|NCT02301546|16195307|P1|Long Term Effectiveness (~1 Year)|moved away|1
4700270|NCT02301546|16195306|P2|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2
4700271|NCT02301546|16195307|P1|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6
4700272|NCT02301546|16195306|P2|Long Term Effectiveness (~1 Year)|Death|0
4700273|NCT02301546|16195307|P1|Long Term Effectiveness (~1 Year)|Death|2
4700274|NCT02301546|16195306|P2|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
4700275|NCT02301546|16195307|P1|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3
4700276|NCT02301546|16195306|P2|Short-term Effectiveness (~13 Weeks)|screen fail|0
4700277|NCT02301546|16195307|P1|Short-term Effectiveness (~13 Weeks)|screen fail|1
4700278|NCT02301546|16195306|P2|Short-term Effectiveness (~13 Weeks)|non-compliant|7
4700279|NCT02301546|16195307|P1|Short-term Effectiveness (~13 Weeks)|non-compliant|10
4700280|NCT02301546|16195306|P2|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8
4700281|NCT02301546|16195307|P1|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7
4700282|NCT02301429|16195313|P1|Overall Study|not acceptable vascular anatomy|3
4700283|NCT02301403|16195359|P2|Overall Study|Withdrawal by Subject|41
4700284|NCT02301403|16195360|P1|Overall Study|Withdrawal by Subject|28
4700285|NCT02301390|16195368|P2|Overall Study|study terminated|0
4700286|NCT02301390|16195369|P1|Overall Study|study terminated|2
4700287|NCT02301390|16195368|P2|Overall Study|Missed multiple visits|1
4700288|NCT02301390|16195369|P1|Overall Study|Missed multiple visits|1
4700289|NCT02301390|16195368|P2|Overall Study|Procedure not completed|4
4700290|NCT02301390|16195369|P1|Overall Study|Procedure not completed|0
4700291|NCT02301390|16195368|P2|Overall Study|Death|2
4700292|NCT02301390|16195369|P1|Overall Study|Death|2
4700293|NCT02301390|16195368|P2|Overall Study|Lost to Follow-up|1
4700294|NCT02301390|16195369|P1|Overall Study|Lost to Follow-up|0
4700295|NCT02301390|16195368|P2|Overall Study|Physician Decision|0
4700296|NCT02301390|16195369|P1|Overall Study|Physician Decision|1
4700297|NCT02301390|16195368|P2|Overall Study|Protocol Violation|0
4700298|NCT02301390|16195369|P1|Overall Study|Protocol Violation|1
4700299|NCT02301390|16195368|P2|Overall Study|Withdrawal by Subject|5
4700300|NCT02301390|16195369|P1|Overall Study|Withdrawal by Subject|3
4700301|NCT02301169|16195419|P2|Overall Study|Adverse Event|0
4700302|NCT02301169|16195420|P1|Overall Study|Adverse Event|1
4700303|NCT02301143|16195434|P2|Investigator's Choice|Unresectable Surgery|1
4700304|NCT02301143|16195435|P1|Investigator's Choice|Unresectable Surgery|0
4700305|NCT02301143|16195434|P2|Investigator's Choice|Other|1
4700306|NCT02301143|16195435|P1|Investigator's Choice|Other|0
4700307|NCT02301143|16195434|P2|Investigator's Choice|Symptomatic Deterioration|1
4700308|NCT02301143|16195435|P1|Investigator's Choice|Symptomatic Deterioration|0
4700309|NCT02301143|16195434|P2|Investigator's Choice|Noncompliance With Study Drug|1
4700310|NCT02301143|16195435|P1|Investigator's Choice|Noncompliance With Study Drug|0
4700311|NCT02301143|16195434|P2|Investigator's Choice|Progressive Disease|3
4700312|NCT02301143|16195435|P1|Investigator's Choice|Progressive Disease|0
4700313|NCT02301143|16195434|P2|Investigator's Choice|Adverse Event|3
4700314|NCT02301143|16195435|P1|Investigator's Choice|Adverse Event|0
4700315|NCT02301143|16195434|P2|Induction Period|Other|0
4700316|NCT02301143|16195435|P1|Induction Period|Other|1
4700317|NCT02301143|16195434|P2|Induction Period|Protocol Violation|0
4700318|NCT02301143|16195435|P1|Induction Period|Protocol Violation|2
4700319|NCT02301143|16195434|P2|Induction Period|Symptomatic Deterioration|0
4700320|NCT02301143|16195435|P1|Induction Period|Symptomatic Deterioration|2
4700321|NCT02301143|16195434|P2|Induction Period|Physician Decision|0
4700322|NCT02301143|16195435|P1|Induction Period|Physician Decision|4
4700323|NCT02301143|16195434|P2|Induction Period|Noncompliance with Study Drug|0
4700324|NCT02301143|16195435|P1|Induction Period|Noncompliance with Study Drug|1
4700325|NCT02301143|16195434|P2|Induction Period|Withdrawal by Subject|0
4700326|NCT02301143|16195435|P1|Induction Period|Withdrawal by Subject|3
4700327|NCT02301143|16195434|P2|Induction Period|Progressive Disease|0
4700328|NCT02301143|16195435|P1|Induction Period|Progressive Disease|8
4700329|NCT02301143|16195434|P2|Induction Period|Adverse Event|0
4700330|NCT02301143|16195435|P1|Induction Period|Adverse Event|22
4700331|NCT02301143|16195434|P2|Induction Period|Death|0
4700332|NCT02301143|16195435|P1|Induction Period|Death|1
4700333|NCT02301143|16195434|P2|Induction Period|Enrolled But Not Treated|0
4700334|NCT02301143|16195435|P1|Induction Period|Enrolled But Not Treated|1
4700335|NCT02300987|16195478|P2|Secondary Phase : Cross-over to LEE011|Adverse Event|1
4700336|NCT02300987|16195479|P1|Secondary Phase : Cross-over to LEE011|Adverse Event|0
4700337|NCT02300987|16195478|P2|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0
4700338|NCT02300987|16195479|P1|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1
4700339|NCT02300987|16195478|P2|Primary Phase : Prior to Cross-over|progressive disease|2
4700340|NCT02300987|16195479|P1|Primary Phase : Prior to Cross-over|progressive disease|3
4700341|NCT02300987|16195478|P2|Primary Phase : Prior to Cross-over|Physician Decision|0
4700342|NCT02300987|16195479|P1|Primary Phase : Prior to Cross-over|Physician Decision|2
4700343|NCT02300987|16195478|P2|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0
4700344|NCT02300987|16195479|P1|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1
4700345|NCT02300610|16195526|P3|Overall Study|Withdrawal by Subject|1
4700346|NCT02300610|16195527|P2|Overall Study|Withdrawal by Subject|0
4700347|NCT02300610|16195528|P1|Overall Study|Withdrawal by Subject|1
4700348|NCT02300558|16195543|P1|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29
4700349|NCT02300558|16195543|P1|Open-Label (OL) Extension Phase|Withdrew Consent|1
4700350|NCT02300558|16195543|P1|Open-Label (OL) Extension Phase|Lack of Efficacy|2
4700351|NCT02300558|16195543|P1|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6
4700352|NCT02300311|16195582|P2|Overall Study|Refused to continue taking medication|0
4700353|NCT02300311|16195583|P1|Overall Study|Refused to continue taking medication|18
4700354|NCT02300311|16195582|P2|Overall Study|Other than the reason specified|0
4700355|NCT02300311|16195583|P1|Overall Study|Other than the reason specified|1
4700356|NCT02300298|16195595|P2|Disposition for Docetaxel|other adverse event|4
4700357|NCT02300298|16195596|P1|Disposition for Docetaxel|other adverse event|0
4700358|NCT02300298|16195595|P2|Disposition for Docetaxel|Progressive disease|6
4700359|NCT02300298|16195596|P1|Disposition for Docetaxel|Progressive disease|0
4700360|NCT02300298|16195595|P2|Disposition for Nintedanib|Progressive disease|0
4700361|NCT02300298|16195596|P1|Disposition for Nintedanib|Progressive disease|10
4700362|NCT02300259|16195609|P3|Period 2|Withdrawal by Subject|1
4700363|NCT02300259|16195610|P2|Period 2|Withdrawal by Subject|0
4700364|NCT02300259|16195611|P1|Period 2|Withdrawal by Subject|0
4700365|NCT02300259|16195609|P3|Period 2|Adverse Event|0
4700366|NCT02300259|16195610|P2|Period 2|Adverse Event|0
4700367|NCT02300259|16195611|P1|Period 2|Adverse Event|1
4700368|NCT02300259|16195609|P3|Period 1|Withdrawal by Subject|1
4700369|NCT02300259|16195610|P2|Period 1|Withdrawal by Subject|0
4700370|NCT02300259|16195611|P1|Period 1|Withdrawal by Subject|0
4700371|NCT02300259|16195609|P3|Period 1|Adverse Event|1
4700372|NCT02300259|16195610|P2|Period 1|Adverse Event|0
4700373|NCT02300259|16195611|P1|Period 1|Adverse Event|0
4700374|NCT02300129|16195640|P4|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
4700375|NCT02300129|16195641|P3|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
4700376|NCT02300129|16195642|P2|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0
4700377|NCT02300129|16195643|P1|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1
4700378|NCT02300129|16195640|P4|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1
4700379|NCT02300129|16195641|P3|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
4700380|NCT02300129|16195642|P2|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
4700381|NCT02300129|16195643|P1|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0
4700382|NCT02300129|16195640|P4|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
4700383|NCT02300129|16195641|P3|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
4700384|NCT02300129|16195642|P2|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1
4700385|NCT02300129|16195643|P1|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0
4700386|NCT02300103|16195653|P1|Overall Study|Withdrew Consent|2
4700387|NCT02300103|16195653|P1|Overall Study|Protocol Violation|1
4700388|NCT02300103|16195653|P1|Overall Study|Lack of Efficacy|3
4700389|NCT02299934|16195733|P1|Overall Study|Termination of study|13
4700390|NCT02299635|16195783|P1|Overall Study|Other|3
4700391|NCT02299635|16195783|P1|Overall Study|Withdrawal by Subject|2
4700392|NCT02299635|16195783|P1|Overall Study|Objective progression or relapse|10
4700393|NCT02299635|16195783|P1|Overall Study|Global deterioration of health status|1
4700394|NCT02299635|16195783|P1|Overall Study|Death|1
4700395|NCT02299635|16195783|P1|Overall Study|Adverse Event|2
4700396|NCT02299427|16195823|P2|Overall Study|not adherent to dog website use|0
4700397|NCT02299427|16195824|P1|Overall Study|not adherent to dog website use|21
4700398|NCT02299427|16195823|P2|Overall Study|Lost to Follow-up|3
4700399|NCT02299427|16195824|P1|Overall Study|Lost to Follow-up|1
4700400|NCT02299427|16195823|P2|Overall Study|Withdrawal by Subject|0
4700401|NCT02299427|16195824|P1|Overall Study|Withdrawal by Subject|1
4700402|NCT02299388|16195834|P2|Overall Study|Withdrawal by Subject|1
4700403|NCT02299388|16195835|P1|Overall Study|Withdrawal by Subject|0
4700404|NCT02299375|16195845|P2|Overall Study|Withdrawal by Subject|4
4700405|NCT02299375|16195846|P1|Overall Study|Withdrawal by Subject|1
4700406|NCT02299375|16195845|P2|Overall Study|Physician Decision|1
4700407|NCT02299375|16195846|P1|Overall Study|Physician Decision|1
4700408|NCT02299375|16195845|P2|Overall Study|Lost to Follow-up|2
4700409|NCT02299375|16195846|P1|Overall Study|Lost to Follow-up|0
4700410|NCT02299375|16195845|P2|Overall Study|Other: Study closed/terminated|55
4700411|NCT02299375|16195846|P1|Overall Study|Other: Study closed/terminated|66
4700412|NCT02299375|16195845|P2|Overall Study|Other: Met stopping criteria|0
4700413|NCT02299375|16195846|P1|Overall Study|Other: Met stopping criteria|1
4700414|NCT02299375|16195845|P2|Overall Study|Protocol Violation|3
4700415|NCT02299375|16195846|P1|Overall Study|Protocol Violation|1
4700416|NCT02299375|16195845|P2|Overall Study|Lack of Efficacy|3
4700417|NCT02299375|16195846|P1|Overall Study|Lack of Efficacy|1
4700418|NCT02299375|16195845|P2|Overall Study|Adverse Event, non-fatal|9
4700419|NCT02299375|16195846|P1|Overall Study|Adverse Event, non-fatal|8
4700420|NCT02299375|16195845|P2|Overall Study|Adverse Event, serious fatal|3
4700421|NCT02299375|16195846|P1|Overall Study|Adverse Event, serious fatal|1
4700422|NCT02299336|16195905|P1|Overall Study|Lost to Follow-up|1
4700423|NCT02299336|16195905|P1|Overall Study|Death|1
4700424|NCT02299336|16195905|P1|Overall Study|Adverse Event|1
4700425|NCT02299336|16195905|P1|Overall Study|Withdrawal by Subject|11
4700426|NCT02299206|16195940|P1|Overall Study|Withdrawal by Subject|1
4700427|NCT02299206|16195940|P1|Overall Study|Lost to Follow-up|1
4700428|NCT02299076|16196001|P2|Overall Study|Fraudulent Entries|14
4700429|NCT02299076|16196002|P1|Overall Study|Fraudulent Entries|20
4700430|NCT02298946|16196023|P2|Overall Study|Unevaluable|1
4700431|NCT02298946|16196024|P1|Overall Study|Unevaluable|2
4700432|NCT02298946|16196023|P2|Overall Study|Did not receive treatment|0
4700433|NCT02298946|16196024|P1|Overall Study|Did not receive treatment|2
4700434|NCT02298868|16196052|P1|Overall Study|Patient underwent transplant|1
4700435|NCT02298868|16196052|P1|Overall Study|Death|1
4700436|NCT02298868|16196052|P1|Overall Study|Adverse Event|1
4700437|NCT02298192|16196130|P2|Overall Study|Adverse Event|2
4700438|NCT02298192|16196131|P1|Overall Study|Adverse Event|6
4700439|NCT02298192|16196130|P2|Overall Study|Lost to Follow-up|1
4700440|NCT02298192|16196131|P1|Overall Study|Lost to Follow-up|2
4700441|NCT02298192|16196130|P2|Overall Study|Withdrawal by Subject|1
4700442|NCT02298192|16196131|P1|Overall Study|Withdrawal by Subject|6
4700443|NCT02298192|16196130|P2|Overall Study|Withdrawal criteria|0
4700444|NCT02298192|16196131|P1|Overall Study|Withdrawal criteria|2
4700445|NCT02298192|16196130|P2|Overall Study|Unclassified|2
4700446|NCT02298192|16196131|P1|Overall Study|Unclassified|3
4700447|NCT02298179|16196155|P12|Overall Study|Lost to Follow-up|0
4700448|NCT02298179|16196156|P11|Overall Study|Lost to Follow-up|0
4700449|NCT02298179|16196157|P10|Overall Study|Lost to Follow-up|0
4700450|NCT02298179|16196158|P9|Overall Study|Lost to Follow-up|0
4700451|NCT02298179|16196159|P8|Overall Study|Lost to Follow-up|1
4700452|NCT02298179|16196160|P7|Overall Study|Lost to Follow-up|0
4700453|NCT02298179|16196161|P6|Overall Study|Lost to Follow-up|0
4700454|NCT02298179|16196162|P5|Overall Study|Lost to Follow-up|0
4700455|NCT02298179|16196163|P4|Overall Study|Lost to Follow-up|0
4700456|NCT02298179|16196164|P3|Overall Study|Lost to Follow-up|1
4700457|NCT02298179|16196165|P2|Overall Study|Lost to Follow-up|0
4700458|NCT02298179|16196166|P1|Overall Study|Lost to Follow-up|0
4700459|NCT02297841|16196408|P1|Overall Study|Protocol Violation|7
4700460|NCT02297841|16196408|P1|Overall Study|Withdrawal by Subject|1
4700461|NCT02297815|16196414|P2|Overall Study|Lost to Follow-up|140
4700462|NCT02297815|16196415|P1|Overall Study|Lost to Follow-up|236
4700463|NCT02297516|16196433|P2|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1
4700464|NCT02297516|16196434|P1|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0
4700465|NCT02297516|16196433|P2|Single Treatment Phase (6 Months)|Protocol Violation|2
4700466|NCT02297516|16196434|P1|Single Treatment Phase (6 Months)|Protocol Violation|0
4700467|NCT02297516|16196433|P2|Single Treatment Phase (6 Months)|Medical reason|0
4700468|NCT02297516|16196434|P1|Single Treatment Phase (6 Months)|Medical reason|1
4700469|NCT02297503|16196455|P2|Overall Study|Medical reason|1
4700470|NCT02297503|16196456|P1|Overall Study|Medical reason|0
4700471|NCT02297503|16196455|P2|Overall Study|Lost to Follow-up|1
4700472|NCT02297503|16196456|P1|Overall Study|Lost to Follow-up|0
4700473|NCT02297503|16196455|P2|Overall Study|Pregnancy|1
4700474|NCT02297503|16196456|P1|Overall Study|Pregnancy|0
4700475|NCT02297503|16196455|P2|Overall Study|Protocol Violation|0
4700476|NCT02297503|16196456|P1|Overall Study|Protocol Violation|1
4700477|NCT02297503|16196455|P2|Overall Study|Withdrawal by Subject|1
4700478|NCT02297503|16196456|P1|Overall Study|Withdrawal by Subject|1
4700479|NCT02297412|16196483|P2|Overall Study|Canceled|1
4700480|NCT02297412|16196484|P1|Overall Study|Canceled|1
4700481|NCT02296931|16196545|P2|Overall Study|Protocol Violation|2
4700482|NCT02296931|16196546|P1|Overall Study|Protocol Violation|0
4700483|NCT02296892|16196555|P3|Overall Study|Lost to Follow-up|1
4700484|NCT02296892|16196556|P2|Overall Study|Lost to Follow-up|0
4700485|NCT02296892|16196557|P1|Overall Study|Lost to Follow-up|5
4700486|NCT02296892|16196555|P3|Overall Study|Exclusion Criteria at Day of Procedure|4
4700487|NCT02296892|16196556|P2|Overall Study|Exclusion Criteria at Day of Procedure|4
4700488|NCT02296892|16196557|P1|Overall Study|Exclusion Criteria at Day of Procedure|7
4700489|NCT02296840|16196576|P2|Overall Study|Lost to Follow-up|17
4700490|NCT02296840|16196577|P1|Overall Study|Lost to Follow-up|6
4700491|NCT02296840|16196576|P2|Overall Study|Protocol Violation|1
4700492|NCT02296840|16196577|P1|Overall Study|Protocol Violation|2
4700493|NCT02296840|16196576|P2|Overall Study|Adverse Event|1
4700494|NCT02296840|16196577|P1|Overall Study|Adverse Event|1
4700495|NCT01491737|16196660|P2|Overall Study|Reason Not Specified|9
4700496|NCT01491737|16196661|P1|Overall Study|Reason Not Specified|8
4700497|NCT01491737|16196660|P2|Overall Study|Study Termination by Sponsor|36
4700498|NCT01491737|16196661|P1|Overall Study|Study Termination by Sponsor|36
4700499|NCT01491737|16196660|P2|Overall Study|Death|57
4700500|NCT01491737|16196661|P1|Overall Study|Death|63
4700501|NCT01491737|16196660|P2|Overall Study|Lost to Follow-up|10
4700502|NCT01491737|16196661|P1|Overall Study|Lost to Follow-up|2
4700503|NCT01491737|16196660|P2|Overall Study|Withdrawal by Subject|17
4700504|NCT01491737|16196661|P1|Overall Study|Withdrawal by Subject|20
4700505|NCT02296476|16196712|P3|Overall Study|Disease Progression|2
4700506|NCT02296476|16196713|P2|Overall Study|Disease Progression|4
4700507|NCT02296476|16196714|P1|Overall Study|Disease Progression|6
4700508|NCT02296424|16196769|P4|Part 2|Lost to Follow-up|0
4700509|NCT02296424|16196770|P3|Part 2|Lost to Follow-up|1
4700510|NCT02296424|16196771|P2|Part 2|Lost to Follow-up|0
4700511|NCT02296424|16196772|P1|Part 2|Lost to Follow-up|0
4700512|NCT02296424|16196769|P4|Part 2|Adverse Event|0
4700513|NCT02296424|16196770|P3|Part 2|Adverse Event|1
4700514|NCT02296424|16196771|P2|Part 2|Adverse Event|0
4700515|NCT02296424|16196772|P1|Part 2|Adverse Event|0
4700516|NCT02296424|16196769|P4|Part 2|Lack of Efficacy|0
4700517|NCT02296424|16196770|P3|Part 2|Lack of Efficacy|1
4700518|NCT02296424|16196771|P2|Part 2|Lack of Efficacy|0
4700519|NCT02296424|16196772|P1|Part 2|Lack of Efficacy|0
4700520|NCT02296424|16196769|P4|Part 1|16 directly started part II|0
4700521|NCT02296424|16196770|P3|Part 1|16 directly started part II|0
4700522|NCT02296424|16196771|P2|Part 1|16 directly started part II|0
4700523|NCT02296424|16196772|P1|Part 1|16 directly started part II|16
4700524|NCT02296424|16196769|P4|Part 1|Lack of Efficacy|0
4700525|NCT02296424|16196770|P3|Part 1|Lack of Efficacy|0
4700526|NCT02296424|16196771|P2|Part 1|Lack of Efficacy|17
4700527|NCT02296424|16196772|P1|Part 1|Lack of Efficacy|5
4700528|NCT02296424|16196769|P4|Part 1|Adverse Event|0
4700529|NCT02296424|16196770|P3|Part 1|Adverse Event|0
4700530|NCT02296424|16196771|P2|Part 1|Adverse Event|11
4700531|NCT02296424|16196772|P1|Part 1|Adverse Event|2
4700532|NCT02296424|16196769|P4|Part 1|Study terminated by sponsor|0
4700533|NCT02296424|16196770|P3|Part 1|Study terminated by sponsor|0
4700534|NCT02296424|16196771|P2|Part 1|Study terminated by sponsor|1
4700535|NCT02296424|16196772|P1|Part 1|Study terminated by sponsor|0
4700536|NCT02296424|16196769|P4|Part 1|Withdrawal by Subject|0
4700537|NCT02296424|16196770|P3|Part 1|Withdrawal by Subject|0
4700538|NCT02296424|16196771|P2|Part 1|Withdrawal by Subject|2
4700539|NCT02296424|16196772|P1|Part 1|Withdrawal by Subject|0
4700540|NCT02296424|16196769|P4|Part 1|Protocol Violation|0
4700541|NCT02296424|16196770|P3|Part 1|Protocol Violation|0
4700542|NCT02296424|16196771|P2|Part 1|Protocol Violation|1
4700543|NCT02296424|16196772|P1|Part 1|Protocol Violation|0
4700544|NCT02296424|16196769|P4|Part 1|New therapy for study indication|0
4700545|NCT02296424|16196770|P3|Part 1|New therapy for study indication|0
4700546|NCT02296424|16196771|P2|Part 1|New therapy for study indication|1
4700547|NCT02296424|16196772|P1|Part 1|New therapy for study indication|0
4700548|NCT02296320|16196797|P3|Overall Study|Not - specified|1
4700549|NCT02296320|16196798|P2|Overall Study|Not - specified|0
4700550|NCT02296320|16196799|P1|Overall Study|Not - specified|0
4700551|NCT02296320|16196797|P3|Overall Study|Not treated|0
4700552|NCT02296320|16196798|P2|Overall Study|Not treated|0
4700553|NCT02296320|16196799|P1|Overall Study|Not treated|2
4700554|NCT02296320|16196797|P3|Overall Study|Lost to Follow-up|7
4700555|NCT02296320|16196798|P2|Overall Study|Lost to Follow-up|2
4700556|NCT02296320|16196799|P1|Overall Study|Lost to Follow-up|5
4700557|NCT02296320|16196797|P3|Overall Study|Death|27
4700558|NCT02296320|16196798|P2|Overall Study|Death|3
4700559|NCT02296320|16196799|P1|Overall Study|Death|24
4700560|NCT02296320|16196797|P3|Overall Study|Withdrawal by Subject|2
4700561|NCT02296320|16196798|P2|Overall Study|Withdrawal by Subject|0
4700562|NCT02296320|16196799|P1|Overall Study|Withdrawal by Subject|4
4700563|NCT02296242|16196838|P5|Overall Study|Lack of Efficacy|3
4700564|NCT02296242|16196839|P4|Overall Study|Lack of Efficacy|0
4700565|NCT02296242|16196840|P3|Overall Study|Lack of Efficacy|0
4700566|NCT02296242|16196841|P2|Overall Study|Lack of Efficacy|0
4700567|NCT02296242|16196842|P1|Overall Study|Lack of Efficacy|0
4700568|NCT02296242|16196838|P5|Overall Study|Adverse Event|0
4700569|NCT02296242|16196839|P4|Overall Study|Adverse Event|1
4700570|NCT02296242|16196840|P3|Overall Study|Adverse Event|0
4700571|NCT02296242|16196841|P2|Overall Study|Adverse Event|0
4700572|NCT02296242|16196842|P1|Overall Study|Adverse Event|0
4700573|NCT02296242|16196838|P5|Overall Study|Alternative Treatment|0
4700574|NCT02296242|16196839|P4|Overall Study|Alternative Treatment|1
4700575|NCT02296242|16196840|P3|Overall Study|Alternative Treatment|0
4700576|NCT02296242|16196841|P2|Overall Study|Alternative Treatment|0
4700577|NCT02296242|16196842|P1|Overall Study|Alternative Treatment|0
4700578|NCT02296242|16196838|P5|Overall Study|Physician Decision|0
4700579|NCT02296242|16196839|P4|Overall Study|Physician Decision|1
4700580|NCT02296242|16196840|P3|Overall Study|Physician Decision|0
4700581|NCT02296242|16196841|P2|Overall Study|Physician Decision|1
4700582|NCT02296242|16196842|P1|Overall Study|Physician Decision|0
4700583|NCT02296242|16196838|P5|Overall Study|Screened for Other Protocol|0
4700584|NCT02296242|16196839|P4|Overall Study|Screened for Other Protocol|0
4700585|NCT02296242|16196840|P3|Overall Study|Screened for Other Protocol|0
4700586|NCT02296242|16196841|P2|Overall Study|Screened for Other Protocol|1
4700587|NCT02296242|16196842|P1|Overall Study|Screened for Other Protocol|0
4700588|NCT02296242|16196838|P5|Overall Study|Need for Hydroxyurea|0
4700589|NCT02296242|16196839|P4|Overall Study|Need for Hydroxyurea|0
4700590|NCT02296242|16196840|P3|Overall Study|Need for Hydroxyurea|0
4700591|NCT02296242|16196841|P2|Overall Study|Need for Hydroxyurea|0
4700592|NCT02296242|16196842|P1|Overall Study|Need for Hydroxyurea|2
4700593|NCT02296242|16196838|P5|Overall Study|Lost to Follow-up|0
4700594|NCT02296242|16196839|P4|Overall Study|Lost to Follow-up|0
4700595|NCT02296242|16196840|P3|Overall Study|Lost to Follow-up|0
4700596|NCT02296242|16196841|P2|Overall Study|Lost to Follow-up|0
4700597|NCT02296242|16196842|P1|Overall Study|Lost to Follow-up|1
4700598|NCT02296242|16196838|P5|Overall Study|At Least 3 Drug Interruptions|1
4700599|NCT02296242|16196839|P4|Overall Study|At Least 3 Drug Interruptions|1
4700600|NCT02296242|16196840|P3|Overall Study|At Least 3 Drug Interruptions|1
4700601|NCT02296242|16196841|P2|Overall Study|At Least 3 Drug Interruptions|0
4700602|NCT02296242|16196842|P1|Overall Study|At Least 3 Drug Interruptions|0
4700603|NCT02296242|16196838|P5|Overall Study|Patient Condition Changed|1
4700604|NCT02296242|16196839|P4|Overall Study|Patient Condition Changed|0
4700605|NCT02296242|16196840|P3|Overall Study|Patient Condition Changed|2
4700606|NCT02296242|16196841|P2|Overall Study|Patient Condition Changed|0
4700607|NCT02296242|16196842|P1|Overall Study|Patient Condition Changed|0
4700608|NCT02296242|16196838|P5|Overall Study|Unacceptable Toxicity|1
4700609|NCT02296242|16196839|P4|Overall Study|Unacceptable Toxicity|0
4700610|NCT02296242|16196840|P3|Overall Study|Unacceptable Toxicity|0
4700611|NCT02296242|16196841|P2|Overall Study|Unacceptable Toxicity|0
4700612|NCT02296242|16196842|P1|Overall Study|Unacceptable Toxicity|0
4700613|NCT02296242|16196838|P5|Overall Study|Disease Progression|11
4700614|NCT02296242|16196839|P4|Overall Study|Disease Progression|8
4700615|NCT02296242|16196840|P3|Overall Study|Disease Progression|2
4700616|NCT02296242|16196841|P2|Overall Study|Disease Progression|3
4700617|NCT02296242|16196842|P1|Overall Study|Disease Progression|1
4700618|NCT02296242|16196838|P5|Overall Study|Withdrawal by Subject|3
4700619|NCT02296242|16196839|P4|Overall Study|Withdrawal by Subject|1
4700620|NCT02296242|16196840|P3|Overall Study|Withdrawal by Subject|1
4700621|NCT02296242|16196841|P2|Overall Study|Withdrawal by Subject|0
4700622|NCT02296242|16196842|P1|Overall Study|Withdrawal by Subject|0
4700623|NCT02296242|16196838|P5|Overall Study|Death|1
4700624|NCT02296242|16196839|P4|Overall Study|Death|1
4700625|NCT02296242|16196840|P3|Overall Study|Death|1
4700626|NCT02296242|16196841|P2|Overall Study|Death|1
4700627|NCT02296242|16196842|P1|Overall Study|Death|1
4700628|NCT02296138|16196870|P2|Overall Study|Other than specified|13
4700629|NCT02296138|16196871|P1|Overall Study|Other than specified|15
4700630|NCT02296138|16196870|P2|Overall Study|Patients with data irregularities|11
4700631|NCT02296138|16196871|P1|Overall Study|Patients with data irregularities|10
4700632|NCT02296138|16196870|P2|Overall Study|Not Treated|1
4700633|NCT02296138|16196871|P1|Overall Study|Not Treated|1
4700634|NCT02296138|16196870|P2|Overall Study|Withdrawal by Subject|131
4700635|NCT02296138|16196871|P1|Overall Study|Withdrawal by Subject|184
4700636|NCT02296138|16196870|P2|Overall Study|Lost to Follow-up|12
4700637|NCT02296138|16196871|P1|Overall Study|Lost to Follow-up|9
4700638|NCT02296138|16196870|P2|Overall Study|Protocol Violation|36
4700639|NCT02296138|16196871|P1|Overall Study|Protocol Violation|35
4700640|NCT02296138|16196870|P2|Overall Study|Lack of Efficacy|37
4700641|NCT02296138|16196871|P1|Overall Study|Lack of Efficacy|59
4700642|NCT02296138|16196870|P2|Overall Study|Adverse Event|259
4700643|NCT02296138|16196871|P1|Overall Study|Adverse Event|348
4700644|NCT02296125|16196887|P4|Overall Study|Any reason not specifically recorded|0
4700645|NCT02296125|16196888|P3|Overall Study|Any reason not specifically recorded|0
4700646|NCT02296125|16196889|P2|Overall Study|Any reason not specifically recorded|3
4700647|NCT02296125|16196890|P1|Overall Study|Any reason not specifically recorded|3
4700648|NCT02296125|16196887|P4|Overall Study|Condition under investigation worsened|39
4700649|NCT02296125|16196888|P3|Overall Study|Condition under investigation worsened|24
4700650|NCT02296125|16196889|P2|Overall Study|Condition under investigation worsened|151
4700651|NCT02296125|16196890|P1|Overall Study|Condition under investigation worsened|87
4700652|NCT02296125|16196887|P4|Overall Study|Severe non-compliance to protocol|0
4700653|NCT02296125|16196888|P3|Overall Study|Severe non-compliance to protocol|0
4700654|NCT02296125|16196889|P2|Overall Study|Severe non-compliance to protocol|1
4700655|NCT02296125|16196890|P1|Overall Study|Severe non-compliance to protocol|0
4700656|NCT02296125|16196887|P4|Overall Study|Adverse Event|4
4700657|NCT02296125|16196888|P3|Overall Study|Adverse Event|9
4700658|NCT02296125|16196889|P2|Overall Study|Adverse Event|50
4700659|NCT02296125|16196890|P1|Overall Study|Adverse Event|36
4700660|NCT02296125|16196887|P4|Overall Study|Withdrawal by Subject|1
4700661|NCT02296125|16196888|P3|Overall Study|Withdrawal by Subject|5
4700662|NCT02296125|16196889|P2|Overall Study|Withdrawal by Subject|8
4700663|NCT02296125|16196890|P1|Overall Study|Withdrawal by Subject|12
4700664|NCT02296112|16196942|P1|Overall Study|Began an alternate therapy|1
4700665|NCT02296112|16196942|P1|Overall Study|Toxicity|1
4700666|NCT02296112|16196942|P1|Overall Study|Disease progression|7
4700667|NCT02295995|16196984|P2|Overall Study|Lost to Follow-up|1
4700668|NCT02295995|16196985|P1|Overall Study|Lost to Follow-up|5
4700669|NCT02295774|16196996|P1|Overall Study|Withdrawal by Subject|2
4700670|NCT02295774|16196996|P1|Overall Study|Physician Decision|1
4700671|NCT02295644|16197036|P4|Overall Study|Did not meet inclusion criterion|2
4700672|NCT02295644|16197037|P3|Overall Study|Did not meet inclusion criterion|1
4700673|NCT02295644|16197038|P2|Overall Study|Did not meet inclusion criterion|0
4700674|NCT02295644|16197039|P1|Overall Study|Did not meet inclusion criterion|0
4700675|NCT02295280|16197088|P2|Overall Study|Adverse Event|1
4700676|NCT02295280|16197089|P1|Overall Study|Adverse Event|0
4700677|NCT02295020|16197097|P2|Overall Study|Withdrawal by Subject|2
4700678|NCT02295020|16197098|P1|Overall Study|Withdrawal by Subject|3
4700679|NCT02295020|16197097|P2|Overall Study|Adverse Event|1
4700680|NCT02295020|16197098|P1|Overall Study|Adverse Event|0
4700681|NCT02294981|16197128|P1|Overall Study|Lost to Follow-up|1
4700682|NCT02294786|16197134|P2|Overall Study|Death|3
4700683|NCT02294786|16197135|P1|Overall Study|Death|2
4700684|NCT02294786|16197134|P2|Overall Study|Adverse Event|1
4700685|NCT02294786|16197135|P1|Overall Study|Adverse Event|1
4700686|NCT02294786|16197134|P2|Overall Study|Protocol Violation|0
4700687|NCT02294786|16197135|P1|Overall Study|Protocol Violation|1
4700688|NCT02294786|16197134|P2|Overall Study|Lost to Follow-up|2
4700689|NCT02294786|16197135|P1|Overall Study|Lost to Follow-up|1
4700690|NCT02294786|16197134|P2|Overall Study|Physician Decision|7
4700691|NCT02294786|16197135|P1|Overall Study|Physician Decision|6
4700692|NCT02294786|16197134|P2|Overall Study|Withdrawal by Subject|1
4700693|NCT02294786|16197135|P1|Overall Study|Withdrawal by Subject|0
4700694|NCT02294773|16197182|P2|Overall Study|Withdrawal by Subject|2
4700695|NCT02294773|16197183|P1|Overall Study|Withdrawal by Subject|0
4700696|NCT02294734|16197199|P2|Overall Study|Withdrawal by Subject|2
4700697|NCT02294734|16197200|P1|Overall Study|Withdrawal by Subject|4
4700698|NCT02294734|16197199|P2|Overall Study|Physician Decision|1
4700699|NCT02294734|16197200|P1|Overall Study|Physician Decision|2
4700700|NCT02294734|16197199|P2|Overall Study|Lost to Follow-up|0
4700701|NCT02294734|16197200|P1|Overall Study|Lost to Follow-up|2
4700702|NCT02294734|16197199|P2|Overall Study|Met Protocol Defined Stopping Criteria|0
4700703|NCT02294734|16197200|P1|Overall Study|Met Protocol Defined Stopping Criteria|1
4700704|NCT02294734|16197199|P2|Overall Study|Adverse Event|5
4700705|NCT02294734|16197200|P1|Overall Study|Adverse Event|5
4700706|NCT02294682|16197252|P2|Overall Study|Could not swallow pills|0
4700707|NCT02294682|16197253|P1|Overall Study|Could not swallow pills|1
4700708|NCT02294604|16197296|P3|Overall Study|Culture contamination|0
4700709|NCT02294604|16197297|P2|Overall Study|Culture contamination|2
4700710|NCT02294604|16197298|P1|Overall Study|Culture contamination|1
4700711|NCT02294604|16197296|P3|Overall Study|Did not provide samples for culture|0
4700712|NCT02294604|16197297|P2|Overall Study|Did not provide samples for culture|1
4700713|NCT02294604|16197298|P1|Overall Study|Did not provide samples for culture|0
4700714|NCT02294474|16197317|P2|Overall Study|Other than specified above|12
4700715|NCT02294474|16197318|P1|Overall Study|Other than specified above|12
4700716|NCT02294474|16197317|P2|Overall Study|Protocol Violation|2
4700717|NCT02294474|16197318|P1|Overall Study|Protocol Violation|4
4700718|NCT02294474|16197317|P2|Overall Study|Lack of Efficacy|1
4700719|NCT02294474|16197318|P1|Overall Study|Lack of Efficacy|2
4700720|NCT02294474|16197317|P2|Overall Study|Adverse Event|7
4700721|NCT02294474|16197318|P1|Overall Study|Adverse Event|7
4700722|NCT01460160|16197342|P2|Follow-up|Lost to Follow-up|0
4700723|NCT01460160|16197343|P1|Follow-up|Lost to Follow-up|1
4700724|NCT01460160|16197342|P2|Follow-up|Death|2
4700725|NCT01460160|16197343|P1|Follow-up|Death|7
4700726|NCT01460160|16197342|P2|Follow-up|Withdrawal by Subject|0
4700727|NCT01460160|16197343|P1|Follow-up|Withdrawal by Subject|3
4700728|NCT01460160|16197342|P2|Treatment|Subject refused to continue Chemo|0
4700729|NCT01460160|16197343|P1|Treatment|Subject refused to continue Chemo|1
4700730|NCT01460160|16197342|P2|Treatment|Family did not wish to restart after SCT|0
4700731|NCT01460160|16197343|P1|Treatment|Family did not wish to restart after SCT|1
4700732|NCT01460160|16197342|P2|Treatment|PI decision to pursue other options|1
4700733|NCT01460160|16197343|P1|Treatment|PI decision to pursue other options|1
4700734|NCT01460160|16197342|P2|Treatment|PI not to follow protocol therapy|0
4700735|NCT01460160|16197343|P1|Treatment|PI not to follow protocol therapy|1
4700736|NCT01460160|16197342|P2|Treatment|PI decision to not re-initiate after SCT|2
4700737|NCT01460160|16197343|P1|Treatment|PI decision to not re-initiate after SCT|2
4700738|NCT01460160|16197342|P2|Treatment|Death|2
4700739|NCT01460160|16197343|P1|Treatment|Death|0
4700740|NCT01460160|16197342|P2|Treatment|Withdrawal by Subject|0
4700741|NCT01460160|16197343|P1|Treatment|Withdrawal by Subject|4
4700742|NCT01460160|16197342|P2|Treatment|Adverse Event|0
4700743|NCT01460160|16197343|P1|Treatment|Adverse Event|8
4700744|NCT01460160|16197342|P2|Treatment|Study Drug Toxicity|0
4700745|NCT01460160|16197343|P1|Treatment|Study Drug Toxicity|2
4700746|NCT01460160|16197342|P2|Treatment|Lack of Efficacy|0
4700747|NCT01460160|16197343|P1|Treatment|Lack of Efficacy|3
4700748|NCT02294461|16197382|P2|Overall Study|Miscellaneous|32
4700749|NCT02294461|16197383|P1|Overall Study|Miscellaneous|11
4700750|NCT02294461|16197382|P2|Overall Study|Adverse Event|10
4700751|NCT02294461|16197383|P1|Overall Study|Adverse Event|11
4700752|NCT02294461|16197382|P2|Overall Study|Disease Progression|39
4700753|NCT02294461|16197383|P1|Overall Study|Disease Progression|23
4700754|NCT02294461|16197382|P2|Overall Study|Withdrawal by Subject|45
4700755|NCT02294461|16197383|P1|Overall Study|Withdrawal by Subject|14
4700756|NCT02294461|16197382|P2|Overall Study|Protocol Violation|2
4700757|NCT02294461|16197383|P1|Overall Study|Protocol Violation|0
4700758|NCT02294461|16197382|P2|Overall Study|Death|3
4700759|NCT02294461|16197383|P1|Overall Study|Death|3
4700760|NCT02294396|16197439|P4|Overall Study|Miscellaneous|2
4700761|NCT02294396|16197440|P3|Overall Study|Miscellaneous|5
4700762|NCT02294396|16197441|P2|Overall Study|Miscellaneous|0
4700763|NCT02294396|16197442|P1|Overall Study|Miscellaneous|2
4700764|NCT02294396|16197439|P4|Overall Study|Protocol Deviation|1
4700765|NCT02294396|16197440|P3|Overall Study|Protocol Deviation|2
4700766|NCT02294396|16197441|P2|Overall Study|Protocol Deviation|2
4700767|NCT02294396|16197442|P1|Overall Study|Protocol Deviation|3
4700768|NCT02294396|16197439|P4|Overall Study|Lost to Follow-up|1
4700769|NCT02294396|16197440|P3|Overall Study|Lost to Follow-up|1
4700770|NCT02294396|16197441|P2|Overall Study|Lost to Follow-up|0
4700771|NCT02294396|16197442|P1|Overall Study|Lost to Follow-up|0
4700772|NCT02294396|16197439|P4|Overall Study|Withdrawal by Subject|8
4700773|NCT02294396|16197440|P3|Overall Study|Withdrawal by Subject|6
4700774|NCT02294396|16197441|P2|Overall Study|Withdrawal by Subject|6
4700775|NCT02294396|16197442|P1|Overall Study|Withdrawal by Subject|8
4700776|NCT02294396|16197439|P4|Overall Study|Electrocardiogram adviser's judgment|1
4700777|NCT02294396|16197440|P3|Overall Study|Electrocardiogram adviser's judgment|0
4700778|NCT02294396|16197441|P2|Overall Study|Electrocardiogram adviser's judgment|0
4700779|NCT02294396|16197442|P1|Overall Study|Electrocardiogram adviser's judgment|1
4700780|NCT02294396|16197439|P4|Overall Study|Adverse Event|24
4700781|NCT02294396|16197440|P3|Overall Study|Adverse Event|21
4700782|NCT02294396|16197441|P2|Overall Study|Adverse Event|25
4700783|NCT02294396|16197442|P1|Overall Study|Adverse Event|26
4700784|NCT02294318|16197514|P2|Overall Study|Not exposed to intervention|2
4700785|NCT02294318|16197515|P1|Overall Study|Not exposed to intervention|0
4700786|NCT02294318|16197514|P2|Overall Study|Worsening of drinking|0
4700787|NCT02294318|16197515|P1|Overall Study|Worsening of drinking|3
4700788|NCT02294227|16197534|P3|Overall Study|Adverse Event|2
4700789|NCT02294227|16197535|P2|Overall Study|Adverse Event|8
4700790|NCT02294227|16197536|P1|Overall Study|Adverse Event|6
4700791|NCT02294227|16197534|P3|Overall Study|Lack of Efficacy|8
4700792|NCT02294227|16197535|P2|Overall Study|Lack of Efficacy|12
4700793|NCT02294227|16197536|P1|Overall Study|Lack of Efficacy|11
4700794|NCT02294227|16197534|P3|Overall Study|Lost to Follow-up|0
4700795|NCT02294227|16197535|P2|Overall Study|Lost to Follow-up|0
4700796|NCT02294227|16197536|P1|Overall Study|Lost to Follow-up|1
4700797|NCT02294227|16197534|P3|Overall Study|Physician Decision|1
4700798|NCT02294227|16197535|P2|Overall Study|Physician Decision|2
4700799|NCT02294227|16197536|P1|Overall Study|Physician Decision|1
4700800|NCT02294227|16197534|P3|Overall Study|Subject/Guardian Decision|7
4700801|NCT02294227|16197535|P2|Overall Study|Subject/Guardian Decision|3
4700802|NCT02294227|16197536|P1|Overall Study|Subject/Guardian Decision|6
4700803|NCT02294227|16197534|P3|Overall Study|Death|1
4700804|NCT02294227|16197535|P2|Overall Study|Death|0
4700805|NCT02294227|16197536|P1|Overall Study|Death|0
4700806|NCT02294175|16197562|P2|Overall Study|wound healed|2
4700807|NCT02294175|16197563|P1|Overall Study|wound healed|0
4700808|NCT02294175|16197562|P2|Overall Study|Lost to Follow-up|1
4700809|NCT02294175|16197563|P1|Overall Study|Lost to Follow-up|0
4700810|NCT02294175|16197562|P2|Overall Study|Protocol Violation|0
4700811|NCT02294175|16197563|P1|Overall Study|Protocol Violation|1
4700812|NCT02294175|16197562|P2|Overall Study|pt taking excluded medication|1
4700813|NCT02294175|16197563|P1|Overall Study|pt taking excluded medication|3
4700814|NCT02294175|16197562|P2|Overall Study|Withdrawal by Subject|2
4700815|NCT02294175|16197563|P1|Overall Study|Withdrawal by Subject|1
4700816|NCT02294019|16197587|P1|Overall Study|Withdrawal by Subject|1
4700817|NCT02294019|16197587|P1|Overall Study|Other|1
4700818|NCT02294019|16197587|P1|Overall Study|Lost to Follow-up|31
4700819|NCT02294019|16197587|P1|Overall Study|Protocol Violation|68
4700820|NCT02294019|16197587|P1|Overall Study|Adverse Event|2
4700821|NCT02293902|16197595|P5|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
4700822|NCT02293902|16197596|P4|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
4700823|NCT02293902|16197597|P3|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
4700824|NCT02293902|16197598|P2|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1
4700825|NCT02293902|16197599|P1|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0
4700826|NCT02293902|16197595|P5|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6
4700827|NCT02293902|16197596|P4|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
4700828|NCT02293902|16197597|P3|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1
4700829|NCT02293902|16197598|P2|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7
4700830|NCT02293902|16197599|P1|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0
4700831|NCT02293902|16197595|P5|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4700832|NCT02293902|16197596|P4|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4700833|NCT02293902|16197597|P3|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4700834|NCT02293902|16197598|P2|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0
4700835|NCT02293902|16197599|P1|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1
4700836|NCT02293902|16197595|P5|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
4700837|NCT02293902|16197596|P4|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0
4700838|NCT02293902|16197597|P3|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2
4700839|NCT02293902|16197598|P2|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1
4700840|NCT02293902|16197599|P1|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5
4700841|NCT02293902|16197595|P5|Double-Blind Period (Up to Week 24)|Adverse Event|0
4700842|NCT02293902|16197596|P4|Double-Blind Period (Up to Week 24)|Adverse Event|0
4700843|NCT02293902|16197597|P3|Double-Blind Period (Up to Week 24)|Adverse Event|8
4700844|NCT02293902|16197598|P2|Double-Blind Period (Up to Week 24)|Adverse Event|6
4700845|NCT02293902|16197599|P1|Double-Blind Period (Up to Week 24)|Adverse Event|5
4700846|NCT02293863|16197661|P3|Overall Study|Reason Not Specified|2
4700847|NCT02293863|16197662|P2|Overall Study|Reason Not Specified|2
4700848|NCT02293863|16197663|P1|Overall Study|Reason Not Specified|0
4700849|NCT02293863|16197661|P3|Overall Study|Withdrawal by Subject|1
4700850|NCT02293863|16197662|P2|Overall Study|Withdrawal by Subject|3
4700851|NCT02293863|16197663|P1|Overall Study|Withdrawal by Subject|3
4700852|NCT02293863|16197661|P3|Overall Study|Lost to Follow-up|2
4700853|NCT02293863|16197662|P2|Overall Study|Lost to Follow-up|2
4700854|NCT02293863|16197663|P1|Overall Study|Lost to Follow-up|2
4700855|NCT02293863|16197661|P3|Overall Study|Death|4
4700856|NCT02293863|16197662|P2|Overall Study|Death|6
4700857|NCT02293863|16197663|P1|Overall Study|Death|4
4700858|NCT02293538|16197732|P2|Overall Study|Withdrawal by Subject|1
4700859|NCT02293538|16197733|P1|Overall Study|Withdrawal by Subject|0
4700860|NCT02293538|16197732|P2|Overall Study|Lost to Follow-up|0
4700861|NCT02293538|16197733|P1|Overall Study|Lost to Follow-up|1
4700862|NCT02293538|16197732|P2|Overall Study|Adverse Event|1
4700863|NCT02293538|16197733|P1|Overall Study|Adverse Event|0
4700864|NCT02293460|16197763|P1|Overall Study|Withdrawal by Subject|1
4700865|NCT02293460|16197763|P1|Overall Study|Adverse Event|2
4700866|NCT02293460|16197763|P1|Overall Study|Lack of Efficacy|2
4700867|NCT02293460|16197763|P1|Overall Study|Protocol Violation|1
4700868|NCT02293395|16197769|P2|Overall Study|Withdrawal by Subject|7
4700869|NCT02293395|16197770|P1|Overall Study|Withdrawal by Subject|8
4700870|NCT02293395|16197769|P2|Overall Study|Lost to Follow-up|0
4700871|NCT02293395|16197770|P1|Overall Study|Lost to Follow-up|1
4700872|NCT02292927|16197783|P2|Overall Study|Protocol Violation|7
4700873|NCT02292927|16197784|P1|Overall Study|Protocol Violation|13
4700874|NCT02292849|16197801|P3|Overall Study|Physician Decision|0
4700875|NCT02292849|16197802|P2|Overall Study|Physician Decision|0
4700876|NCT02292849|16197803|P1|Overall Study|Physician Decision|4
4700877|NCT02292849|16197801|P3|Overall Study|Lost to Follow-up|2
4700878|NCT02292849|16197802|P2|Overall Study|Lost to Follow-up|2
4700879|NCT02292849|16197803|P1|Overall Study|Lost to Follow-up|0
4700880|NCT02292784|16197831|P3|Overall Study|Withdrawal by Subject|3
4700881|NCT02292784|16197832|P2|Overall Study|Withdrawal by Subject|3
4700882|NCT02292784|16197833|P1|Overall Study|Withdrawal by Subject|0
4700883|NCT02292784|16197831|P3|Overall Study|Lost to Follow-up|18
4700884|NCT02292784|16197832|P2|Overall Study|Lost to Follow-up|17
4700885|NCT02292784|16197833|P1|Overall Study|Lost to Follow-up|1
4700886|NCT02292771|16197900|P2|Overall Study|Lost to Follow-up|1
4700887|NCT02292771|16197901|P1|Overall Study|Lost to Follow-up|2
4700888|NCT02292771|16197900|P2|Overall Study|Withdrawal by Subject|1
4700889|NCT02292771|16197901|P1|Overall Study|Withdrawal by Subject|2
4700890|NCT02292719|16198024|P6|Overall Study|Subject enrolled in new study.|0
4700891|NCT02292719|16198025|P5|Overall Study|Subject enrolled in new study.|0
4700892|NCT02292719|16198026|P4|Overall Study|Subject enrolled in new study.|0
4700893|NCT02292719|16198027|P3|Overall Study|Subject enrolled in new study.|1
4700894|NCT02292719|16198028|P2|Overall Study|Subject enrolled in new study.|0
4700895|NCT02292719|16198029|P1|Overall Study|Subject enrolled in new study.|0
4700896|NCT02292719|16198024|P6|Overall Study|Withdrawal by Subject|0
4700897|NCT02292719|16198025|P5|Overall Study|Withdrawal by Subject|1
4700898|NCT02292719|16198026|P4|Overall Study|Withdrawal by Subject|1
4700899|NCT02292719|16198027|P3|Overall Study|Withdrawal by Subject|0
4700900|NCT02292719|16198028|P2|Overall Study|Withdrawal by Subject|0
4700901|NCT02292719|16198029|P1|Overall Study|Withdrawal by Subject|0
4700902|NCT02292446|16198092|P1|Overall Study|Withdrawal by Subject|3
4700903|NCT02292446|16198092|P1|Overall Study|Subject/guardian decision|2
4700904|NCT02292446|16198092|P1|Overall Study|Disease progression|2
4700905|NCT02292446|16198092|P1|Overall Study|Death|1
4700906|NCT02292446|16198092|P1|Overall Study|Adverse Event|12
4700907|NCT02292212|16198181|P1|ViE Phase|Protocol Violation|2
4700908|NCT02292212|16198181|P1|ViE Phase|Withdrawal by Subject|1
4700909|NCT02291913|16198250|P1|Overall Study|Protocol Violation|1
4700910|NCT02291913|16198250|P1|Overall Study|Withdrawal by Subject|1
4700911|NCT02291913|16198250|P1|Overall Study|Physician Decision|1
4700912|NCT02291913|16198250|P1|Overall Study|Death|2
4700913|NCT02291913|16198250|P1|Overall Study|Adverse Event|11
4700914|NCT02291913|16198250|P1|Overall Study|Progressive Disease|32
4700915|NCT02291861|16198263|P4|Overall Study|Other|1
4700916|NCT02291861|16198264|P3|Overall Study|Other|0
4700917|NCT02291861|16198265|P2|Overall Study|Other|0
4700918|NCT02291861|16198266|P1|Overall Study|Other|0
4700919|NCT02291861|16198263|P4|Overall Study|Lost to Follow-up|0
4700920|NCT02291861|16198264|P3|Overall Study|Lost to Follow-up|4
4700921|NCT02291861|16198265|P2|Overall Study|Lost to Follow-up|1
4700922|NCT02291861|16198266|P1|Overall Study|Lost to Follow-up|2
4700923|NCT02291861|16198263|P4|Overall Study|Noncompliance|1
4700924|NCT02291861|16198264|P3|Overall Study|Noncompliance|2
4700925|NCT02291861|16198265|P2|Overall Study|Noncompliance|1
4700926|NCT02291861|16198266|P1|Overall Study|Noncompliance|1
4700927|NCT02291861|16198263|P4|Overall Study|Withdrawal by Subject|4
4700928|NCT02291861|16198264|P3|Overall Study|Withdrawal by Subject|1
4700929|NCT02291861|16198265|P2|Overall Study|Withdrawal by Subject|2
4700930|NCT02291861|16198266|P1|Overall Study|Withdrawal by Subject|1
4700931|NCT02291861|16198263|P4|Overall Study|Protocol Violation|1
4700932|NCT02291861|16198264|P3|Overall Study|Protocol Violation|0
4700933|NCT02291861|16198265|P2|Overall Study|Protocol Violation|0
4700934|NCT02291861|16198266|P1|Overall Study|Protocol Violation|1
4700935|NCT02291861|16198263|P4|Overall Study|Death|1
4700936|NCT02291861|16198264|P3|Overall Study|Death|1
4700937|NCT02291861|16198265|P2|Overall Study|Death|0
4700938|NCT02291861|16198266|P1|Overall Study|Death|0
4700939|NCT02291861|16198263|P4|Overall Study|Adverse Event|2
4700940|NCT02291861|16198264|P3|Overall Study|Adverse Event|1
4700941|NCT02291861|16198265|P2|Overall Study|Adverse Event|4
4700942|NCT02291861|16198266|P1|Overall Study|Adverse Event|2
4700943|NCT02291679|16198329|P3|Overall Study|Other|2
4700944|NCT02291679|16198330|P2|Overall Study|Other|4
4700945|NCT02291679|16198331|P1|Overall Study|Other|2
4700946|NCT02291679|16198329|P3|Overall Study|Insufficient Therapeutic Response|7
4700947|NCT02291679|16198330|P2|Overall Study|Insufficient Therapeutic Response|5
4700948|NCT02291679|16198331|P1|Overall Study|Insufficient Therapeutic Response|5
4700949|NCT02291679|16198329|P3|Overall Study|Lost to Follow-up|9
4700950|NCT02291679|16198330|P2|Overall Study|Lost to Follow-up|10
4700951|NCT02291679|16198331|P1|Overall Study|Lost to Follow-up|12
4700952|NCT02291679|16198329|P3|Overall Study|Withdrew Consent|15
4700953|NCT02291679|16198330|P2|Overall Study|Withdrew Consent|10
4700954|NCT02291679|16198331|P1|Overall Study|Withdrew Consent|18
4700955|NCT02291679|16198329|P3|Overall Study|Protocol Violation|7
4700956|NCT02291679|16198330|P2|Overall Study|Protocol Violation|1
4700957|NCT02291679|16198331|P1|Overall Study|Protocol Violation|5
4700958|NCT02291679|16198329|P3|Overall Study|Adverse Event|19
4700959|NCT02291679|16198330|P2|Overall Study|Adverse Event|12
4700960|NCT02291679|16198331|P1|Overall Study|Adverse Event|2
4700961|NCT02291549|16198362|P2|Overall Study|Withdrawal by Subject|1
4700962|NCT02291549|16198363|P1|Overall Study|Withdrawal by Subject|0
4700963|NCT02291549|16198362|P2|Overall Study|Lost to Follow-up|0
4700964|NCT02291549|16198363|P1|Overall Study|Lost to Follow-up|1
4700965|NCT02291510|16198385|P4|Overall Study|Adverse Event|1
4700966|NCT02291510|16198386|P3|Overall Study|Adverse Event|0
4700967|NCT02291510|16198387|P2|Overall Study|Adverse Event|0
4700968|NCT02291510|16198388|P1|Overall Study|Adverse Event|0
4700969|NCT02291419|16198404|P2|Overall Study|Early study termination|5
4700970|NCT02291419|16198405|P1|Overall Study|Early study termination|1
4700971|NCT02291289|16198442|P12|Maintenance Treatment Phase|No Treatment Received|0
4700972|NCT02291289|16198443|P11|Maintenance Treatment Phase|No Treatment Received|1
4700973|NCT02291289|16198444|P10|Maintenance Treatment Phase|No Treatment Received|0
4700974|NCT02291289|16198445|P9|Maintenance Treatment Phase|No Treatment Received|0
4700975|NCT02291289|16198446|P8|Maintenance Treatment Phase|No Treatment Received|0
4700976|NCT02291289|16198447|P7|Maintenance Treatment Phase|No Treatment Received|0
4700977|NCT02291289|16198448|P6|Maintenance Treatment Phase|No Treatment Received|5
4700978|NCT02291289|16198449|P5|Maintenance Treatment Phase|No Treatment Received|4
4700979|NCT02291289|16198450|P4|Maintenance Treatment Phase|No Treatment Received|0
4700980|NCT02291289|16198451|P3|Maintenance Treatment Phase|No Treatment Received|2
4700981|NCT02291289|16198452|P2|Maintenance Treatment Phase|No Treatment Received|0
4700982|NCT02291289|16198453|P1|Maintenance Treatment Phase|No Treatment Received|0
4700983|NCT02291289|16198442|P12|Maintenance Treatment Phase|Multiple Reasons|0
4700984|NCT02291289|16198443|P11|Maintenance Treatment Phase|Multiple Reasons|0
4700985|NCT02291289|16198444|P10|Maintenance Treatment Phase|Multiple Reasons|0
4700986|NCT02291289|16198445|P9|Maintenance Treatment Phase|Multiple Reasons|0
4700987|NCT02291289|16198446|P8|Maintenance Treatment Phase|Multiple Reasons|0
4700988|NCT02291289|16198447|P7|Maintenance Treatment Phase|Multiple Reasons|0
4700989|NCT02291289|16198448|P6|Maintenance Treatment Phase|Multiple Reasons|1
4700990|NCT02291289|16198449|P5|Maintenance Treatment Phase|Multiple Reasons|4
4700991|NCT02291289|16198450|P4|Maintenance Treatment Phase|Multiple Reasons|0
4700992|NCT02291289|16198451|P3|Maintenance Treatment Phase|Multiple Reasons|0
4700993|NCT02291289|16198452|P2|Maintenance Treatment Phase|Multiple Reasons|0
4700994|NCT02291289|16198453|P1|Maintenance Treatment Phase|Multiple Reasons|0
4700995|NCT02291289|16198442|P12|Maintenance Treatment Phase|Physician Decision|1
4700996|NCT02291289|16198443|P11|Maintenance Treatment Phase|Physician Decision|0
4700997|NCT02291289|16198444|P10|Maintenance Treatment Phase|Physician Decision|0
4700998|NCT02291289|16198445|P9|Maintenance Treatment Phase|Physician Decision|0
4700999|NCT02291289|16198446|P8|Maintenance Treatment Phase|Physician Decision|0
4701000|NCT02291289|16198447|P7|Maintenance Treatment Phase|Physician Decision|0
4701001|NCT02291289|16198448|P6|Maintenance Treatment Phase|Physician Decision|0
4701002|NCT02291289|16198449|P5|Maintenance Treatment Phase|Physician Decision|2
4701003|NCT02291289|16198450|P4|Maintenance Treatment Phase|Physician Decision|0
4701004|NCT02291289|16198451|P3|Maintenance Treatment Phase|Physician Decision|0
4701005|NCT02291289|16198452|P2|Maintenance Treatment Phase|Physician Decision|0
4701006|NCT02291289|16198453|P1|Maintenance Treatment Phase|Physician Decision|0
4701007|NCT02291289|16198442|P12|Maintenance Treatment Phase|Other|0
4701008|NCT02291289|16198443|P11|Maintenance Treatment Phase|Other|0
4701009|NCT02291289|16198444|P10|Maintenance Treatment Phase|Other|0
4701010|NCT02291289|16198445|P9|Maintenance Treatment Phase|Other|1
4701011|NCT02291289|16198446|P8|Maintenance Treatment Phase|Other|0
4701012|NCT02291289|16198447|P7|Maintenance Treatment Phase|Other|0
4701013|NCT02291289|16198448|P6|Maintenance Treatment Phase|Other|8
4701014|NCT02291289|16198449|P5|Maintenance Treatment Phase|Other|29
4701015|NCT02291289|16198450|P4|Maintenance Treatment Phase|Other|0
4701016|NCT02291289|16198451|P3|Maintenance Treatment Phase|Other|1
4701017|NCT02291289|16198452|P2|Maintenance Treatment Phase|Other|0
4701018|NCT02291289|16198453|P1|Maintenance Treatment Phase|Other|0
4701019|NCT02291289|16198442|P12|Maintenance Treatment Phase|Lost to Follow-up|1
4701020|NCT02291289|16198443|P11|Maintenance Treatment Phase|Lost to Follow-up|2
4701021|NCT02291289|16198444|P10|Maintenance Treatment Phase|Lost to Follow-up|0
4701022|NCT02291289|16198445|P9|Maintenance Treatment Phase|Lost to Follow-up|0
4701023|NCT02291289|16198446|P8|Maintenance Treatment Phase|Lost to Follow-up|1
4701024|NCT02291289|16198447|P7|Maintenance Treatment Phase|Lost to Follow-up|0
4701025|NCT02291289|16198448|P6|Maintenance Treatment Phase|Lost to Follow-up|3
4701026|NCT02291289|16198449|P5|Maintenance Treatment Phase|Lost to Follow-up|12
4701027|NCT02291289|16198450|P4|Maintenance Treatment Phase|Lost to Follow-up|0
4701028|NCT02291289|16198451|P3|Maintenance Treatment Phase|Lost to Follow-up|0
4701029|NCT02291289|16198452|P2|Maintenance Treatment Phase|Lost to Follow-up|0
4701030|NCT02291289|16198453|P1|Maintenance Treatment Phase|Lost to Follow-up|0
4701031|NCT02291289|16198442|P12|Maintenance Treatment Phase|Adverse Event|0
4701032|NCT02291289|16198443|P11|Maintenance Treatment Phase|Adverse Event|0
4701033|NCT02291289|16198444|P10|Maintenance Treatment Phase|Adverse Event|0
4701034|NCT02291289|16198445|P9|Maintenance Treatment Phase|Adverse Event|0
4701035|NCT02291289|16198446|P8|Maintenance Treatment Phase|Adverse Event|0
4701036|NCT02291289|16198447|P7|Maintenance Treatment Phase|Adverse Event|0
4701037|NCT02291289|16198448|P6|Maintenance Treatment Phase|Adverse Event|0
4701038|NCT02291289|16198449|P5|Maintenance Treatment Phase|Adverse Event|1
4701039|NCT02291289|16198450|P4|Maintenance Treatment Phase|Adverse Event|0
4701040|NCT02291289|16198451|P3|Maintenance Treatment Phase|Adverse Event|0
4701041|NCT02291289|16198452|P2|Maintenance Treatment Phase|Adverse Event|0
4701042|NCT02291289|16198453|P1|Maintenance Treatment Phase|Adverse Event|0
4701043|NCT02291289|16198442|P12|Maintenance Treatment Phase|Death|11
4701044|NCT02291289|16198443|P11|Maintenance Treatment Phase|Death|26
4701045|NCT02291289|16198444|P10|Maintenance Treatment Phase|Death|0
4701046|NCT02291289|16198445|P9|Maintenance Treatment Phase|Death|1
4701047|NCT02291289|16198446|P8|Maintenance Treatment Phase|Death|1
4701048|NCT02291289|16198447|P7|Maintenance Treatment Phase|Death|0
4701049|NCT02291289|16198448|P6|Maintenance Treatment Phase|Death|100
4701050|NCT02291289|16198449|P5|Maintenance Treatment Phase|Death|185
4701051|NCT02291289|16198450|P4|Maintenance Treatment Phase|Death|0
4701052|NCT02291289|16198451|P3|Maintenance Treatment Phase|Death|13
4701053|NCT02291289|16198452|P2|Maintenance Treatment Phase|Death|23
4701054|NCT02291289|16198453|P1|Maintenance Treatment Phase|Death|0
4701055|NCT02291289|16198442|P12|Maintenance Treatment Phase|Protocol Violation|0
4701056|NCT02291289|16198443|P11|Maintenance Treatment Phase|Protocol Violation|0
4701057|NCT02291289|16198444|P10|Maintenance Treatment Phase|Protocol Violation|0
4701058|NCT02291289|16198445|P9|Maintenance Treatment Phase|Protocol Violation|0
4701059|NCT02291289|16198446|P8|Maintenance Treatment Phase|Protocol Violation|0
4701060|NCT02291289|16198447|P7|Maintenance Treatment Phase|Protocol Violation|0
4701061|NCT02291289|16198448|P6|Maintenance Treatment Phase|Protocol Violation|1
4701062|NCT02291289|16198449|P5|Maintenance Treatment Phase|Protocol Violation|2
4701063|NCT02291289|16198450|P4|Maintenance Treatment Phase|Protocol Violation|0
4701064|NCT02291289|16198451|P3|Maintenance Treatment Phase|Protocol Violation|0
4701065|NCT02291289|16198452|P2|Maintenance Treatment Phase|Protocol Violation|1
4701066|NCT02291289|16198453|P1|Maintenance Treatment Phase|Protocol Violation|0
4701067|NCT02291289|16198442|P12|Maintenance Treatment Phase|Withdrawal by Subject|3
4701068|NCT02291289|16198443|P11|Maintenance Treatment Phase|Withdrawal by Subject|2
4701069|NCT02291289|16198444|P10|Maintenance Treatment Phase|Withdrawal by Subject|0
4701070|NCT02291289|16198445|P9|Maintenance Treatment Phase|Withdrawal by Subject|0
4701071|NCT02291289|16198446|P8|Maintenance Treatment Phase|Withdrawal by Subject|0
4701072|NCT02291289|16198447|P7|Maintenance Treatment Phase|Withdrawal by Subject|0
4701073|NCT02291289|16198448|P6|Maintenance Treatment Phase|Withdrawal by Subject|11
4701074|NCT02291289|16198449|P5|Maintenance Treatment Phase|Withdrawal by Subject|13
4701075|NCT02291289|16198450|P4|Maintenance Treatment Phase|Withdrawal by Subject|0
4701076|NCT02291289|16198451|P3|Maintenance Treatment Phase|Withdrawal by Subject|0
4701077|NCT02291289|16198452|P2|Maintenance Treatment Phase|Withdrawal by Subject|0
4701078|NCT02291289|16198453|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
4701079|NCT02291289|16198442|P12|Induction Treatment|Not Dosed|0
4701080|NCT02291289|16198443|P11|Induction Treatment|Not Dosed|0
4701081|NCT02291289|16198444|P10|Induction Treatment|Not Dosed|1
4701082|NCT02291289|16198445|P9|Induction Treatment|Not Dosed|0
4701083|NCT02291289|16198446|P8|Induction Treatment|Not Dosed|0
4701084|NCT02291289|16198447|P7|Induction Treatment|Not Dosed|0
4701085|NCT02291289|16198448|P6|Induction Treatment|Not Dosed|0
4701086|NCT02291289|16198449|P5|Induction Treatment|Not Dosed|0
4701087|NCT02291289|16198450|P4|Induction Treatment|Not Dosed|9
4701088|NCT02291289|16198451|P3|Induction Treatment|Not Dosed|0
4701089|NCT02291289|16198452|P2|Induction Treatment|Not Dosed|0
4701090|NCT02291289|16198453|P1|Induction Treatment|Not Dosed|2
4701091|NCT02291237|16198517|P2|Overall Study|Subject Required Prohibited Medication|0
4701092|NCT02291237|16198518|P1|Overall Study|Subject Required Prohibited Medication|2
4701093|NCT02291237|16198517|P2|Overall Study|Lost to Follow-up|2
4701094|NCT02291237|16198518|P1|Overall Study|Lost to Follow-up|0
4701095|NCT02291237|16198517|P2|Overall Study|Withdrew Consent|11
4701096|NCT02291237|16198518|P1|Overall Study|Withdrew Consent|11
4701097|NCT02291237|16198517|P2|Overall Study|Investigator's Discretion|3
4701098|NCT02291237|16198518|P1|Overall Study|Investigator's Discretion|0
4701099|NCT02291237|16198517|P2|Overall Study|Adverse Event|3
4701100|NCT02291237|16198518|P1|Overall Study|Adverse Event|1
4701101|NCT02291237|16198517|P2|Overall Study|Study Terminated by Sponsor|67
4701102|NCT02291237|16198518|P1|Overall Study|Study Terminated by Sponsor|72
4701103|NCT02291029|16198540|P6|Overall Study|Adverse Event|0
4701104|NCT02291029|16198541|P5|Overall Study|Adverse Event|0
4701105|NCT02291029|16198542|P4|Overall Study|Adverse Event|0
4701106|NCT02291029|16198543|P3|Overall Study|Adverse Event|0
4701107|NCT02291029|16198544|P2|Overall Study|Adverse Event|1
4701108|NCT02291029|16198545|P1|Overall Study|Adverse Event|0
4701109|NCT02291029|16198540|P6|Overall Study|Withdrawal by Subject|0
4701110|NCT02291029|16198541|P5|Overall Study|Withdrawal by Subject|0
4701111|NCT02291029|16198542|P4|Overall Study|Withdrawal by Subject|0
4701112|NCT02291029|16198543|P3|Overall Study|Withdrawal by Subject|1
4701113|NCT02291029|16198544|P2|Overall Study|Withdrawal by Subject|0
4701114|NCT02291029|16198545|P1|Overall Study|Withdrawal by Subject|0
4701115|NCT02290925|16198616|P2|Second Period of 3 Months|insulin started|1
4701116|NCT02290925|16198617|P1|Second Period of 3 Months|insulin started|0
4701117|NCT02290925|16198616|P2|Second Period of 3 Months|Lost to Follow-up|3
4701118|NCT02290925|16198617|P1|Second Period of 3 Months|Lost to Follow-up|1
4701119|NCT02290925|16198616|P2|First Period of Three Months|Insulin Started|1
4701120|NCT02290925|16198617|P1|First Period of Three Months|Insulin Started|1
4701121|NCT02290925|16198616|P2|First Period of Three Months|Death|0
4701122|NCT02290925|16198617|P1|First Period of Three Months|Death|1
4701123|NCT02290925|16198616|P2|First Period of Three Months|Lost to Follow-up|1
4701124|NCT02290925|16198617|P1|First Period of Three Months|Lost to Follow-up|2
4701125|NCT02290873|16198632|P3|Overall Study|Protocol Violation|1
4701126|NCT02290873|16198633|P2|Overall Study|Protocol Violation|0
4701127|NCT02290873|16198634|P1|Overall Study|Protocol Violation|0
4701128|NCT02290873|16198632|P3|Overall Study|Esophagogastroduodenoscopy was added|0
4701129|NCT02290873|16198633|P2|Overall Study|Esophagogastroduodenoscopy was added|0
4701130|NCT02290873|16198634|P1|Overall Study|Esophagogastroduodenoscopy was added|1
4701131|NCT02290873|16198632|P3|Overall Study|Nellcor device error|0
4701132|NCT02290873|16198633|P2|Overall Study|Nellcor device error|0
4701133|NCT02290873|16198634|P1|Overall Study|Nellcor device error|1
4701134|NCT02290873|16198632|P3|Overall Study|Withdrawal by Subject|1
4701135|NCT02290873|16198633|P2|Overall Study|Withdrawal by Subject|1
4701136|NCT02290873|16198634|P1|Overall Study|Withdrawal by Subject|0
4701137|NCT02290821|16198653|P2|Overall Study|Lost to Follow-up|2
4701138|NCT02290821|16198654|P1|Overall Study|Lost to Follow-up|3
4701139|NCT02290821|16198653|P2|Overall Study|Unable or unwilling to cooperate with|0
4701140|NCT02290821|16198654|P1|Overall Study|Unable or unwilling to cooperate with|2
4701141|NCT02290821|16198653|P2|Overall Study|Withdrawal by Subject|1
4701142|NCT02290821|16198654|P1|Overall Study|Withdrawal by Subject|1
4701143|NCT02290691|16198662|P2|Overall Study|Lost to Follow-up|7
4701144|NCT02290691|16198663|P1|Overall Study|Lost to Follow-up|7
4701145|NCT02290691|16198662|P2|Overall Study|Withdrawal by Subject|1
4701146|NCT02290691|16198663|P1|Overall Study|Withdrawal by Subject|1
4701147|NCT02290691|16198662|P2|Overall Study|Noncompliance|1
4701148|NCT02290691|16198663|P1|Overall Study|Noncompliance|0
4701149|NCT02290431|16198776|P1|Overall Study|Physician Decision|2
4701150|NCT02290431|16198776|P1|Overall Study|Study terminated by Sponsor|1
4701151|NCT02290431|16198776|P1|Overall Study|Progressive disease|4
4701152|NCT02290431|16198776|P1|Overall Study|Adverse Event|20
4701153|NCT02290340|16198799|P4|Overall Study|Other|1
4701154|NCT02290340|16198800|P3|Overall Study|Other|0
4701155|NCT02290340|16198801|P2|Overall Study|Other|0
4701156|NCT02290340|16198802|P1|Overall Study|Other|1
4701157|NCT02290340|16198799|P4|Overall Study|Withdrawal by Subject|0
4701158|NCT02290340|16198800|P3|Overall Study|Withdrawal by Subject|0
4701159|NCT02290340|16198801|P2|Overall Study|Withdrawal by Subject|0
4701160|NCT02290340|16198802|P1|Overall Study|Withdrawal by Subject|1
4701161|NCT02290340|16198799|P4|Overall Study|Lost to Follow-up|1
4701162|NCT02290340|16198800|P3|Overall Study|Lost to Follow-up|0
4701163|NCT02290340|16198801|P2|Overall Study|Lost to Follow-up|0
4701164|NCT02290340|16198802|P1|Overall Study|Lost to Follow-up|0
4701165|NCT02290223|16198847|P2|12 Months|Refusal|1
4701166|NCT02290223|16198848|P1|12 Months|Refusal|0
4701167|NCT02290223|16198847|P2|12 Months|Lost to Follow-up|10
4701168|NCT02290223|16198848|P1|12 Months|Lost to Follow-up|16
4701169|NCT02290223|16198847|P2|6 Months|deceased (not related to study)|0
4701170|NCT02290223|16198848|P1|6 Months|deceased (not related to study)|2
4701171|NCT02290223|16198847|P2|6 Months|Withdrawal by Subject|0
4701172|NCT02290223|16198848|P1|6 Months|Withdrawal by Subject|5
4701173|NCT02290223|16198847|P2|6 Months|Lost to Follow-up|6
4701174|NCT02290223|16198848|P1|6 Months|Lost to Follow-up|9
4701175|NCT02289963|16198963|P2|Overall Study|Other than specified above|2
4701176|NCT02289963|16198964|P1|Overall Study|Other than specified above|0
4701177|NCT02289963|16198963|P2|Overall Study|End treatment visit outside visit window|4
4701178|NCT02289963|16198964|P1|Overall Study|End treatment visit outside visit window|0
4701179|NCT02289963|16198963|P2|Overall Study|Last injection missed|2
4701180|NCT02289963|16198964|P1|Overall Study|Last injection missed|2
4701181|NCT02289963|16198963|P2|Overall Study|Withdrawal by Subject|0
4701182|NCT02289963|16198964|P1|Overall Study|Withdrawal by Subject|1
4701183|NCT02289963|16198963|P2|Overall Study|Poor compliance to protocol|0
4701184|NCT02289963|16198964|P1|Overall Study|Poor compliance to protocol|1
4701185|NCT02289963|16198963|P2|Overall Study|Adverse Event|2
4701186|NCT02289963|16198964|P1|Overall Study|Adverse Event|1
4701187|NCT02289898|16199015|P3|Overall Study|Other|10
4701188|NCT02289898|16199016|P2|Overall Study|Other|7
4701189|NCT02289898|16199017|P1|Overall Study|Other|8
4701190|NCT02289898|16199015|P3|Overall Study|Use of another anticancer therapy|1
4701191|NCT02289898|16199016|P2|Overall Study|Use of another anticancer therapy|0
4701192|NCT02289898|16199017|P1|Overall Study|Use of another anticancer therapy|0
4701193|NCT02289898|16199015|P3|Overall Study|Disease progression|34
4701194|NCT02289898|16199016|P2|Overall Study|Disease progression|28
4701195|NCT02289898|16199017|P1|Overall Study|Disease progression|34
4701196|NCT02289898|16199015|P3|Overall Study|Adverse Event|5
4701197|NCT02289898|16199016|P2|Overall Study|Adverse Event|5
4701198|NCT02289898|16199017|P1|Overall Study|Adverse Event|3
4701199|NCT02289898|16199015|P3|Overall Study|Withdrawal by Subject|1
4701200|NCT02289898|16199016|P2|Overall Study|Withdrawal by Subject|4
4701201|NCT02289898|16199017|P1|Overall Study|Withdrawal by Subject|0
4701202|NCT02289898|16199015|P3|Overall Study|Physician Decision|2
4701203|NCT02289898|16199016|P2|Overall Study|Physician Decision|5
4701204|NCT02289898|16199017|P1|Overall Study|Physician Decision|2
4701205|NCT02289898|16199015|P3|Overall Study|Death|3
4701206|NCT02289898|16199016|P2|Overall Study|Death|4
4701207|NCT02289898|16199017|P1|Overall Study|Death|5
4701208|NCT02289833|16199026|P2|Overall Study|Death|16
4701209|NCT02289833|16199027|P1|Overall Study|Death|23
4701210|NCT02289833|16199026|P2|Overall Study|Lost to Follow-up|0
4701211|NCT02289833|16199027|P1|Overall Study|Lost to Follow-up|4
4701212|NCT02289833|16199026|P2|Overall Study|Study discontinuation|1
4701213|NCT02289833|16199027|P1|Overall Study|Study discontinuation|0
4701214|NCT02289820|16199063|P7|Overall Study|withdrawal of consent|0
4701215|NCT02289820|16199064|P6|Overall Study|withdrawal of consent|0
4701216|NCT02289820|16199065|P5|Overall Study|withdrawal of consent|0
4701217|NCT02289820|16199066|P4|Overall Study|withdrawal of consent|0
4701218|NCT02289820|16199067|P3|Overall Study|withdrawal of consent|0
4701219|NCT02289820|16199068|P2|Overall Study|withdrawal of consent|1
4701220|NCT02289820|16199069|P1|Overall Study|withdrawal of consent|0
4701221|NCT02289820|16199063|P7|Overall Study|Lost to Follow-up|1
4701222|NCT02289820|16199064|P6|Overall Study|Lost to Follow-up|1
4701223|NCT02289820|16199065|P5|Overall Study|Lost to Follow-up|0
4701224|NCT02289820|16199066|P4|Overall Study|Lost to Follow-up|1
4701225|NCT02289820|16199067|P3|Overall Study|Lost to Follow-up|3
4701226|NCT02289820|16199068|P2|Overall Study|Lost to Follow-up|0
4701227|NCT02289820|16199069|P1|Overall Study|Lost to Follow-up|0
4701228|NCT02289820|16199063|P7|Overall Study|Death|0
4701229|NCT02289820|16199064|P6|Overall Study|Death|0
4701230|NCT02289820|16199065|P5|Overall Study|Death|0
4701231|NCT02289820|16199066|P4|Overall Study|Death|0
4701232|NCT02289820|16199067|P3|Overall Study|Death|1
4701233|NCT02289820|16199068|P2|Overall Study|Death|0
4701234|NCT02289820|16199069|P1|Overall Study|Death|0
4701235|NCT02289820|16199063|P7|Overall Study|Withdrawal by Subject|1
4701236|NCT02289820|16199064|P6|Overall Study|Withdrawal by Subject|0
4701237|NCT02289820|16199065|P5|Overall Study|Withdrawal by Subject|0
4701238|NCT02289820|16199066|P4|Overall Study|Withdrawal by Subject|1
4701239|NCT02289820|16199067|P3|Overall Study|Withdrawal by Subject|2
4701240|NCT02289820|16199068|P2|Overall Study|Withdrawal by Subject|1
4701241|NCT02289820|16199069|P1|Overall Study|Withdrawal by Subject|2
4701242|NCT02289742|16199187|P4|Third Wear Period|Reason not given|1
4701243|NCT02289742|16199188|P3|Third Wear Period|Reason not given|0
4701244|NCT02289742|16199189|P2|Third Wear Period|Reason not given|0
4701245|NCT02289742|16199190|P1|Third Wear Period|Reason not given|0
4701246|NCT02289742|16199187|P4|Third Wear Period|Adverse Event|0
4701247|NCT02289742|16199188|P3|Third Wear Period|Adverse Event|0
4701248|NCT02289742|16199189|P2|Third Wear Period|Adverse Event|1
4701249|NCT02289742|16199190|P1|Third Wear Period|Adverse Event|0
4701250|NCT02289742|16199187|P4|First Wear Period|Other prior to treatment|1
4701251|NCT02289742|16199188|P3|First Wear Period|Other prior to treatment|0
4701252|NCT02289742|16199189|P2|First Wear Period|Other prior to treatment|0
4701253|NCT02289742|16199190|P1|First Wear Period|Other prior to treatment|0
4701254|NCT02289742|16199187|P4|First Wear Period|Adverse Event|0
4701255|NCT02289742|16199188|P3|First Wear Period|Adverse Event|1
4701256|NCT02289742|16199189|P2|First Wear Period|Adverse Event|0
4701257|NCT02289742|16199190|P1|First Wear Period|Adverse Event|0
4701258|NCT02289742|16199187|P4|First Wear Period|Adverse event prior to treatment|0
4701259|NCT02289742|16199188|P3|First Wear Period|Adverse event prior to treatment|0
4701260|NCT02289742|16199189|P2|First Wear Period|Adverse event prior to treatment|1
4701261|NCT02289742|16199190|P1|First Wear Period|Adverse event prior to treatment|0
4701262|NCT02289729|16199207|P1|Overall Study|Death|1
4701263|NCT02289729|16199207|P1|Overall Study|Withdrawal by Subject|1
4701264|NCT02289729|16199207|P1|Overall Study|Very Narrow Therapeutic Margin|1
4701265|NCT02289729|16199207|P1|Overall Study|Lack of Efficacy|3
4701266|NCT02289690|16199271|P10|Overall Study|Other|1
4701267|NCT02289690|16199272|P9|Overall Study|Other|3
4701268|NCT02289690|16199273|P8|Overall Study|Other|2
4701269|NCT02289690|16199274|P7|Overall Study|Other|1
4701270|NCT02289690|16199275|P6|Overall Study|Other|0
4701271|NCT02289690|16199276|P5|Overall Study|Other|1
4701272|NCT02289690|16199277|P4|Overall Study|Other|1
4701273|NCT02289690|16199278|P3|Overall Study|Other|0
4701274|NCT02289690|16199279|P2|Overall Study|Other|0
4701275|NCT02289690|16199280|P1|Overall Study|Other|0
4701276|NCT02289690|16199271|P10|Overall Study|Sponsor Discontinued Study|15
4701277|NCT02289690|16199272|P9|Overall Study|Sponsor Discontinued Study|7
4701278|NCT02289690|16199273|P8|Overall Study|Sponsor Discontinued Study|9
4701279|NCT02289690|16199274|P7|Overall Study|Sponsor Discontinued Study|0
4701280|NCT02289690|16199275|P6|Overall Study|Sponsor Discontinued Study|0
4701281|NCT02289690|16199276|P5|Overall Study|Sponsor Discontinued Study|0
4701282|NCT02289690|16199277|P4|Overall Study|Sponsor Discontinued Study|0
4701283|NCT02289690|16199278|P3|Overall Study|Sponsor Discontinued Study|0
4701284|NCT02289690|16199279|P2|Overall Study|Sponsor Discontinued Study|0
4701285|NCT02289690|16199280|P1|Overall Study|Sponsor Discontinued Study|0
4701286|NCT02289690|16199271|P10|Overall Study|Death|41
4701287|NCT02289690|16199272|P9|Overall Study|Death|45
4701288|NCT02289690|16199273|P8|Overall Study|Death|49
4701289|NCT02289690|16199274|P7|Overall Study|Death|0
4701290|NCT02289690|16199275|P6|Overall Study|Death|0
4701291|NCT02289690|16199276|P5|Overall Study|Death|0
4701292|NCT02289690|16199277|P4|Overall Study|Death|0
4701293|NCT02289690|16199278|P3|Overall Study|Death|0
4701294|NCT02289690|16199279|P2|Overall Study|Death|0
4701295|NCT02289690|16199280|P1|Overall Study|Death|0
4701296|NCT02289690|16199271|P10|Overall Study|Lost to Follow-up|2
4701297|NCT02289690|16199272|P9|Overall Study|Lost to Follow-up|0
4701298|NCT02289690|16199273|P8|Overall Study|Lost to Follow-up|1
4701299|NCT02289690|16199274|P7|Overall Study|Lost to Follow-up|0
4701300|NCT02289690|16199275|P6|Overall Study|Lost to Follow-up|0
4701301|NCT02289690|16199276|P5|Overall Study|Lost to Follow-up|0
4701302|NCT02289690|16199277|P4|Overall Study|Lost to Follow-up|0
4701303|NCT02289690|16199278|P3|Overall Study|Lost to Follow-up|0
4701304|NCT02289690|16199279|P2|Overall Study|Lost to Follow-up|0
4701305|NCT02289690|16199280|P1|Overall Study|Lost to Follow-up|0
4701306|NCT02289690|16199271|P10|Overall Study|Progressive Disease, Per Protocol|0
4701307|NCT02289690|16199272|P9|Overall Study|Progressive Disease, Per Protocol|0
4701308|NCT02289690|16199273|P8|Overall Study|Progressive Disease, Per Protocol|0
4701309|NCT02289690|16199274|P7|Overall Study|Progressive Disease, Per Protocol|2
4701310|NCT02289690|16199275|P6|Overall Study|Progressive Disease, Per Protocol|13
4701311|NCT02289690|16199276|P5|Overall Study|Progressive Disease, Per Protocol|5
4701312|NCT02289690|16199277|P4|Overall Study|Progressive Disease, Per Protocol|2
4701313|NCT02289690|16199278|P3|Overall Study|Progressive Disease, Per Protocol|3
4701314|NCT02289690|16199279|P2|Overall Study|Progressive Disease, Per Protocol|2
4701315|NCT02289690|16199280|P1|Overall Study|Progressive Disease, Per Protocol|3
4701316|NCT02289690|16199271|P10|Overall Study|Withdrawal by Subject|2
4701317|NCT02289690|16199272|P9|Overall Study|Withdrawal by Subject|4
4701318|NCT02289690|16199273|P8|Overall Study|Withdrawal by Subject|0
4701319|NCT02289690|16199274|P7|Overall Study|Withdrawal by Subject|0
4701320|NCT02289690|16199275|P6|Overall Study|Withdrawal by Subject|1
4701321|NCT02289690|16199276|P5|Overall Study|Withdrawal by Subject|1
4701322|NCT02289690|16199277|P4|Overall Study|Withdrawal by Subject|0
4701323|NCT02289690|16199278|P3|Overall Study|Withdrawal by Subject|0
4701324|NCT02289690|16199279|P2|Overall Study|Withdrawal by Subject|0
4701325|NCT02289690|16199280|P1|Overall Study|Withdrawal by Subject|1
4701326|NCT02289690|16199271|P10|Overall Study|Adverse Event Related to Progression|0
4701327|NCT02289690|16199272|P9|Overall Study|Adverse Event Related to Progression|0
4701328|NCT02289690|16199273|P8|Overall Study|Adverse Event Related to Progression|0
4701329|NCT02289690|16199274|P7|Overall Study|Adverse Event Related to Progression|1
4701330|NCT02289690|16199275|P6|Overall Study|Adverse Event Related to Progression|0
4701331|NCT02289690|16199276|P5|Overall Study|Adverse Event Related to Progression|1
4701332|NCT02289690|16199277|P4|Overall Study|Adverse Event Related to Progression|0
4701333|NCT02289690|16199278|P3|Overall Study|Adverse Event Related to Progression|1
4701334|NCT02289690|16199279|P2|Overall Study|Adverse Event Related to Progression|1
4701335|NCT02289690|16199280|P1|Overall Study|Adverse Event Related to Progression|0
4701336|NCT02289469|16199368|P2|Overall Study|Unable to match a control|0
4701337|NCT02289469|16199369|P1|Overall Study|Unable to match a control|6
4701338|NCT02289456|16199377|P1|Monotherapy Period|Miscellaneous|1
4701339|NCT02289456|16199377|P1|Monotherapy Period|Study Terminated by Sponsor|2
4701340|NCT02289456|16199377|P1|Monotherapy Period|Withdrawal by Subject|2
4701341|NCT02289456|16199377|P1|Monotherapy Period|Symptomatic Deterioration|1
4701342|NCT02289456|16199377|P1|Monotherapy Period|Progressive Disease (PD)|8
4701343|NCT02289456|16199377|P1|Monotherapy Period|Adverse Event|1
4701344|NCT02289456|16199377|P1|Monotherapy Period|Death|1
4701345|NCT02289456|16199377|P1|Induction Period|Miscellaneous|1
4701346|NCT02289456|16199377|P1|Induction Period|Withdrawal by Subject|2
4701347|NCT02289456|16199377|P1|Induction Period|Symptomatic Deterioration|4
4701348|NCT02289456|16199377|P1|Induction Period|Progressive Disease (PD)|4
4701349|NCT02289456|16199377|P1|Induction Period|Adverse Event|11
4701350|NCT02289456|16199377|P1|Induction Period|Death|2
4701351|NCT02289417|16199400|P9|Extension Phase Weeks 52-104|Miscellaneous|0
4701352|NCT02289417|16199401|P8|Extension Phase Weeks 52-104|Miscellaneous|1
4701353|NCT02289417|16199402|P7|Extension Phase Weeks 52-104|Miscellaneous|0
4701354|NCT02289417|16199403|P6|Extension Phase Weeks 52-104|Miscellaneous|0
4701355|NCT02289417|16199404|P5|Extension Phase Weeks 52-104|Miscellaneous|0
4701356|NCT02289417|16199405|P4|Extension Phase Weeks 52-104|Miscellaneous|0
4701357|NCT02289417|16199406|P3|Extension Phase Weeks 52-104|Miscellaneous|0
4701358|NCT02289417|16199407|P2|Extension Phase Weeks 52-104|Miscellaneous|0
4701359|NCT02289417|16199408|P1|Extension Phase Weeks 52-104|Miscellaneous|0
4701360|NCT02289417|16199400|P9|Extension Phase Weeks 52-104|Withdrawal by Subject|1
4701361|NCT02289417|16199401|P8|Extension Phase Weeks 52-104|Withdrawal by Subject|2
4701362|NCT02289417|16199402|P7|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701363|NCT02289417|16199403|P6|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701364|NCT02289417|16199404|P5|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701365|NCT02289417|16199405|P4|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701366|NCT02289417|16199406|P3|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701367|NCT02289417|16199407|P2|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701368|NCT02289417|16199408|P1|Extension Phase Weeks 52-104|Withdrawal by Subject|0
4701369|NCT02289417|16199400|P9|Extension Phase Weeks 52-104|Lack of Efficacy|2
4701370|NCT02289417|16199401|P8|Extension Phase Weeks 52-104|Lack of Efficacy|2
4701371|NCT02289417|16199402|P7|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701372|NCT02289417|16199403|P6|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701373|NCT02289417|16199404|P5|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701374|NCT02289417|16199405|P4|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701375|NCT02289417|16199406|P3|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701376|NCT02289417|16199407|P2|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701377|NCT02289417|16199408|P1|Extension Phase Weeks 52-104|Lack of Efficacy|0
4701378|NCT02289417|16199400|P9|Extension Phase Weeks 52-104|Adverse Event|3
4701379|NCT02289417|16199401|P8|Extension Phase Weeks 52-104|Adverse Event|2
4701380|NCT02289417|16199402|P7|Extension Phase Weeks 52-104|Adverse Event|0
4701381|NCT02289417|16199403|P6|Extension Phase Weeks 52-104|Adverse Event|0
4701382|NCT02289417|16199404|P5|Extension Phase Weeks 52-104|Adverse Event|0
4701383|NCT02289417|16199405|P4|Extension Phase Weeks 52-104|Adverse Event|0
4701384|NCT02289417|16199406|P3|Extension Phase Weeks 52-104|Adverse Event|0
4701385|NCT02289417|16199407|P2|Extension Phase Weeks 52-104|Adverse Event|0
4701386|NCT02289417|16199408|P1|Extension Phase Weeks 52-104|Adverse Event|0
4701387|NCT02289417|16199400|P9|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701388|NCT02289417|16199401|P8|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701389|NCT02289417|16199402|P7|Active Treatment Phase Weeks 12-52|Miscellaneous|1
4701390|NCT02289417|16199403|P6|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701391|NCT02289417|16199404|P5|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701392|NCT02289417|16199405|P4|Active Treatment Phase Weeks 12-52|Miscellaneous|1
4701393|NCT02289417|16199406|P3|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701394|NCT02289417|16199407|P2|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701395|NCT02289417|16199408|P1|Active Treatment Phase Weeks 12-52|Miscellaneous|0
4701396|NCT02289417|16199400|P9|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701397|NCT02289417|16199401|P8|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701398|NCT02289417|16199402|P7|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1
4701399|NCT02289417|16199403|P6|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701400|NCT02289417|16199404|P5|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701401|NCT02289417|16199405|P4|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701402|NCT02289417|16199406|P3|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701403|NCT02289417|16199407|P2|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701404|NCT02289417|16199408|P1|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0
4701405|NCT02289417|16199400|P9|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4701406|NCT02289417|16199401|P8|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4701407|NCT02289417|16199402|P7|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4701408|NCT02289417|16199403|P6|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
4701409|NCT02289417|16199404|P5|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
4701410|NCT02289417|16199405|P4|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4701411|NCT02289417|16199406|P3|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1
4701412|NCT02289417|16199407|P2|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4701413|NCT02289417|16199408|P1|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0
4701414|NCT02289417|16199400|P9|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4701415|NCT02289417|16199401|P8|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4701416|NCT02289417|16199402|P7|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4701417|NCT02289417|16199403|P6|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3
4701418|NCT02289417|16199404|P5|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2
4701419|NCT02289417|16199405|P4|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6
4701420|NCT02289417|16199406|P3|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4
4701421|NCT02289417|16199407|P2|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1
4701422|NCT02289417|16199408|P1|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0
4701423|NCT02289417|16199400|P9|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701424|NCT02289417|16199401|P8|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701425|NCT02289417|16199402|P7|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701426|NCT02289417|16199403|P6|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701427|NCT02289417|16199404|P5|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701428|NCT02289417|16199405|P4|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701429|NCT02289417|16199406|P3|Active Treatment Phase Weeks 12-52|Pregnancy|1
4701430|NCT02289417|16199407|P2|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701431|NCT02289417|16199408|P1|Active Treatment Phase Weeks 12-52|Pregnancy|0
4701432|NCT02289417|16199400|P9|Active Treatment Phase Weeks 12-52|Adverse Event|0
4701433|NCT02289417|16199401|P8|Active Treatment Phase Weeks 12-52|Adverse Event|0
4701434|NCT02289417|16199402|P7|Active Treatment Phase Weeks 12-52|Adverse Event|0
4701435|NCT02289417|16199403|P6|Active Treatment Phase Weeks 12-52|Adverse Event|1
4701436|NCT02289417|16199404|P5|Active Treatment Phase Weeks 12-52|Adverse Event|2
4701437|NCT02289417|16199405|P4|Active Treatment Phase Weeks 12-52|Adverse Event|2
4701438|NCT02289417|16199406|P3|Active Treatment Phase Weeks 12-52|Adverse Event|4
4701439|NCT02289417|16199407|P2|Active Treatment Phase Weeks 12-52|Adverse Event|1
4701440|NCT02289417|16199408|P1|Active Treatment Phase Weeks 12-52|Adverse Event|0
4701441|NCT02289417|16199400|P9|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701442|NCT02289417|16199401|P8|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701443|NCT02289417|16199402|P7|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701444|NCT02289417|16199403|P6|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701445|NCT02289417|16199404|P5|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701446|NCT02289417|16199405|P4|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701447|NCT02289417|16199406|P3|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701448|NCT02289417|16199407|P2|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0
4701449|NCT02289417|16199408|P1|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3
4701450|NCT02289417|16199400|P9|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701451|NCT02289417|16199401|P8|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701452|NCT02289417|16199402|P7|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701453|NCT02289417|16199403|P6|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701454|NCT02289417|16199404|P5|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701455|NCT02289417|16199405|P4|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701456|NCT02289417|16199406|P3|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701457|NCT02289417|16199407|P2|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1
4701458|NCT02289417|16199408|P1|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0
4701459|NCT02289417|16199400|P9|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4701460|NCT02289417|16199401|P8|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4701461|NCT02289417|16199402|P7|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4701462|NCT02289417|16199403|P6|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4701463|NCT02289417|16199404|P5|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4701464|NCT02289417|16199405|P4|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0
4701465|NCT02289417|16199406|P3|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2
4701466|NCT02289417|16199407|P2|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3
4701467|NCT02289417|16199408|P1|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1
4701468|NCT02289417|16199400|P9|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701469|NCT02289417|16199401|P8|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701470|NCT02289417|16199402|P7|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701471|NCT02289417|16199403|P6|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701472|NCT02289417|16199404|P5|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701473|NCT02289417|16199405|P4|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701474|NCT02289417|16199406|P3|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1
4701475|NCT02289417|16199407|P2|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0
4701476|NCT02289417|16199408|P1|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3
4701477|NCT02289352|16199457|P3|Overall Study|Withdrawal by Subject|0
4701478|NCT02289352|16199458|P2|Overall Study|Withdrawal by Subject|1
4701479|NCT02289352|16199459|P1|Overall Study|Withdrawal by Subject|1
4701480|NCT02289079|16199526|P2|Overall Study|Lost to Follow-up|1
4701481|NCT02289079|16199527|P1|Overall Study|Lost to Follow-up|0
4701482|NCT02289079|16199526|P2|Overall Study|Physician Decision|0
4701483|NCT02289079|16199527|P1|Overall Study|Physician Decision|2
4701484|NCT02288559|16199556|P4|Overall Study|Reason Not Specified|0
4701485|NCT02288559|16199557|P3|Overall Study|Reason Not Specified|3
4701486|NCT02288559|16199558|P2|Overall Study|Reason Not Specified|0
4701487|NCT02288559|16199559|P1|Overall Study|Reason Not Specified|0
4701488|NCT02288559|16199556|P4|Overall Study|Withdrawal by Subject|1
4701489|NCT02288559|16199557|P3|Overall Study|Withdrawal by Subject|2
4701490|NCT02288559|16199558|P2|Overall Study|Withdrawal by Subject|0
4701491|NCT02288559|16199559|P1|Overall Study|Withdrawal by Subject|0
4701492|NCT02288559|16199556|P4|Overall Study|Lost to Follow-up|1
4701493|NCT02288559|16199557|P3|Overall Study|Lost to Follow-up|0
4701494|NCT02288559|16199558|P2|Overall Study|Lost to Follow-up|0
4701495|NCT02288559|16199559|P1|Overall Study|Lost to Follow-up|0
4701496|NCT02288559|16199556|P4|Overall Study|Death|0
4701497|NCT02288559|16199557|P3|Overall Study|Death|1
4701498|NCT02288559|16199558|P2|Overall Study|Death|0
4701499|NCT02288559|16199559|P1|Overall Study|Death|0
4701500|NCT02288559|16199556|P4|Overall Study|Adverse Event|0
4701501|NCT02288559|16199557|P3|Overall Study|Adverse Event|5
4701502|NCT02288559|16199558|P2|Overall Study|Adverse Event|1
4701503|NCT02288559|16199559|P1|Overall Study|Adverse Event|1
4701504|NCT02288325|16199610|P3|Double-blind Treatment Period|Multiple Reasons|2
4701505|NCT02288325|16199611|P2|Double-blind Treatment Period|Multiple Reasons|8
4701506|NCT02288325|16199612|P1|Double-blind Treatment Period|Multiple Reasons|0
4701507|NCT02288325|16199610|P3|Double-blind Treatment Period|Non-Compliance With Study Drug|4
4701508|NCT02288325|16199611|P2|Double-blind Treatment Period|Non-Compliance With Study Drug|1
4701509|NCT02288325|16199612|P1|Double-blind Treatment Period|Non-Compliance With Study Drug|0
4701510|NCT02288325|16199610|P3|Double-blind Treatment Period|Protocol Violation|2
4701511|NCT02288325|16199611|P2|Double-blind Treatment Period|Protocol Violation|1
4701512|NCT02288325|16199612|P1|Double-blind Treatment Period|Protocol Violation|0
4701513|NCT02288325|16199610|P3|Double-blind Treatment Period|Lost to Follow-up|5
4701514|NCT02288325|16199611|P2|Double-blind Treatment Period|Lost to Follow-up|4
4701515|NCT02288325|16199612|P1|Double-blind Treatment Period|Lost to Follow-up|0
4701516|NCT02288325|16199610|P3|Double-blind Treatment Period|Withdrawal of Consent|8
4701517|NCT02288325|16199611|P2|Double-blind Treatment Period|Withdrawal of Consent|8
4701518|NCT02288325|16199612|P1|Double-blind Treatment Period|Withdrawal of Consent|0
4701519|NCT02288325|16199610|P3|Double-blind Treatment Period|Adverse Event|5
4701520|NCT02288325|16199611|P2|Double-blind Treatment Period|Adverse Event|2
4701521|NCT02288325|16199612|P1|Double-blind Treatment Period|Adverse Event|0
4701522|NCT02288325|16199610|P3|Stabilization Period|Reason not Specified|0
4701523|NCT02288325|16199611|P2|Stabilization Period|Reason not Specified|0
4701524|NCT02288325|16199612|P1|Stabilization Period|Reason not Specified|15
4701525|NCT02288325|16199610|P3|Stabilization Period|Non-Compliance With Study Drug|0
4701526|NCT02288325|16199611|P2|Stabilization Period|Non-Compliance With Study Drug|0
4701527|NCT02288325|16199612|P1|Stabilization Period|Non-Compliance With Study Drug|5
4701528|NCT02288325|16199610|P3|Stabilization Period|Protocol Violation|0
4701529|NCT02288325|16199611|P2|Stabilization Period|Protocol Violation|0
4701530|NCT02288325|16199612|P1|Stabilization Period|Protocol Violation|8
4701531|NCT02288325|16199610|P3|Stabilization Period|Lost to Follow-up|0
4701532|NCT02288325|16199611|P2|Stabilization Period|Lost to Follow-up|0
4701533|NCT02288325|16199612|P1|Stabilization Period|Lost to Follow-up|12
4701534|NCT02288325|16199610|P3|Stabilization Period|Withdrawal of Consent|0
4701535|NCT02288325|16199611|P2|Stabilization Period|Withdrawal of Consent|0
4701536|NCT02288325|16199612|P1|Stabilization Period|Withdrawal of Consent|23
4701537|NCT02288325|16199610|P3|Stabilization Period|Lack of Efficacy|0
4701538|NCT02288325|16199611|P2|Stabilization Period|Lack of Efficacy|0
4701539|NCT02288325|16199612|P1|Stabilization Period|Lack of Efficacy|22
4701540|NCT02288325|16199610|P3|Stabilization Period|Adverse Event|0
4701541|NCT02288325|16199611|P2|Stabilization Period|Adverse Event|0
4701542|NCT02288325|16199612|P1|Stabilization Period|Adverse Event|13
4701543|NCT02288325|16199610|P3|Run-in Period|Reason not Specified|0
4701544|NCT02288325|16199611|P2|Run-in Period|Reason not Specified|0
4701545|NCT02288325|16199612|P1|Run-in Period|Reason not Specified|8
4701546|NCT02288325|16199610|P3|Run-in Period|Non-Compliance With Study Drug|0
4701547|NCT02288325|16199611|P2|Run-in Period|Non-Compliance With Study Drug|0
4701548|NCT02288325|16199612|P1|Run-in Period|Non-Compliance With Study Drug|3
4701549|NCT02288325|16199610|P3|Run-in Period|Protocol Violation|0
4701550|NCT02288325|16199611|P2|Run-in Period|Protocol Violation|0
4701551|NCT02288325|16199612|P1|Run-in Period|Protocol Violation|17
4701552|NCT02288325|16199610|P3|Run-in Period|Lost to Follow-up|0
4701553|NCT02288325|16199611|P2|Run-in Period|Lost to Follow-up|0
4701554|NCT02288325|16199612|P1|Run-in Period|Lost to Follow-up|25
4701555|NCT02288325|16199610|P3|Run-in Period|Withdrawal of Consent|0
4701556|NCT02288325|16199611|P2|Run-in Period|Withdrawal of Consent|0
4701557|NCT02288325|16199612|P1|Run-in Period|Withdrawal of Consent|28
4701558|NCT02288325|16199610|P3|Run-in Period|Lack of Efficacy|0
4701559|NCT02288325|16199611|P2|Run-in Period|Lack of Efficacy|0
4701560|NCT02288325|16199612|P1|Run-in Period|Lack of Efficacy|16
4701561|NCT02288325|16199610|P3|Run-in Period|Adverse Event|0
4701562|NCT02288325|16199611|P2|Run-in Period|Adverse Event|0
4701563|NCT02288325|16199612|P1|Run-in Period|Adverse Event|48
4701564|NCT02288312|16199622|P3|Overall Study|Pregnancy|0
4701565|NCT02288312|16199623|P2|Overall Study|Pregnancy|0
4701566|NCT02288312|16199624|P1|Overall Study|Pregnancy|1
4701567|NCT02288182|16199664|P2|Overall Study|Lost to Follow-up|1
4701568|NCT02288182|16199665|P1|Overall Study|Lost to Follow-up|0
4701569|NCT02288182|16199664|P2|Overall Study|Adverse Event|1
4701570|NCT02288182|16199665|P1|Overall Study|Adverse Event|0
4701571|NCT02288091|16199677|P1|Overall Study|Screen fail|7
4701572|NCT02288091|16199677|P1|Overall Study|Lost to Follow-up|1
4701573|NCT02287922|16199689|P4|Overall Study|Other|0
4701574|NCT02287922|16199690|P3|Overall Study|Other|2
4701575|NCT02287922|16199691|P2|Overall Study|Other|0
4701576|NCT02287922|16199692|P1|Overall Study|Other|1
4701577|NCT02287922|16199689|P4|Overall Study|Sponsor's decision|1
4701578|NCT02287922|16199690|P3|Overall Study|Sponsor's decision|0
4701579|NCT02287922|16199691|P2|Overall Study|Sponsor's decision|0
4701580|NCT02287922|16199692|P1|Overall Study|Sponsor's decision|0
4701581|NCT02287922|16199689|P4|Overall Study|Lost to Follow-up|0
4701582|NCT02287922|16199690|P3|Overall Study|Lost to Follow-up|1
4701583|NCT02287922|16199691|P2|Overall Study|Lost to Follow-up|0
4701584|NCT02287922|16199692|P1|Overall Study|Lost to Follow-up|0
4701585|NCT02287922|16199689|P4|Overall Study|Withdrawal by Subject|2
4701586|NCT02287922|16199690|P3|Overall Study|Withdrawal by Subject|1
4701587|NCT02287922|16199691|P2|Overall Study|Withdrawal by Subject|1
4701588|NCT02287922|16199692|P1|Overall Study|Withdrawal by Subject|1
4701589|NCT02287922|16199689|P4|Overall Study|Adverse Event|4
4701590|NCT02287922|16199690|P3|Overall Study|Adverse Event|3
4701591|NCT02287922|16199691|P2|Overall Study|Adverse Event|1
4701592|NCT02287922|16199692|P1|Overall Study|Adverse Event|1
4701593|NCT02287896|16199800|P2|Second Injection Visit|Withdrawal by Subject|1
4701594|NCT02287896|16199801|P1|Second Injection Visit|Withdrawal by Subject|0
4701595|NCT02287883|16199819|P2|Overall Study|Non-response to survey|237
4701596|NCT02287883|16199820|P1|Overall Study|Non-response to survey|229
4701597|NCT02287883|16199819|P2|Overall Study|No longer eligible|182
4701598|NCT02287883|16199820|P1|Overall Study|No longer eligible|222
4701599|NCT02287883|16199819|P2|Overall Study|Death|7
4701600|NCT02287883|16199820|P1|Overall Study|Death|8
4701601|NCT02287623|16200022|P2|Overall Study|Protocol Violation|1
4701602|NCT02287623|16200023|P1|Overall Study|Protocol Violation|0
4701603|NCT02287610|16200039|P1|Overall Study|Excluded-investigator non-responsiveness|5
4701604|NCT02287610|16200039|P1|Overall Study|Withdrawal by Subject|8
4701605|NCT02287610|16200039|P1|Overall Study|Lost to Follow-up|3
4701606|NCT02287467|16200074|P2|Overall Study|Protocol Violation|9
4701607|NCT02287467|16200075|P1|Overall Study|Protocol Violation|12
4701608|NCT02287402|16200123|P1|Follow-up|Voluntary Withdrawal|2
4701609|NCT02287402|16200123|P1|Follow-up|Lost to Follow-up|1
4701610|NCT02287402|16200123|P1|Treatment Period|Voluntary Withdrawal|10
4701611|NCT02287402|16200123|P1|Treatment Period|Adverse Event|17
4701612|NCT02287038|16200228|P2|Overall Study|Abnormal ECG after starting medication|0
4701613|NCT02287038|16200229|P1|Overall Study|Abnormal ECG after starting medication|1
4701614|NCT02287038|16200228|P2|Overall Study|Nausea after starting medication|0
4701615|NCT02287038|16200229|P1|Overall Study|Nausea after starting medication|1
4701616|NCT02287038|16200228|P2|Overall Study|Anxiety after starting medication|1
4701617|NCT02287038|16200229|P1|Overall Study|Anxiety after starting medication|0
4701618|NCT02287038|16200228|P2|Overall Study|Stopped attending appointments|2
4701619|NCT02287038|16200229|P1|Overall Study|Stopped attending appointments|3
4701620|NCT02287025|16200239|P2|Overall Study|Screening failed|1
4701621|NCT02287025|16200240|P1|Overall Study|Screening failed|1
4701622|NCT02287025|16200239|P2|Overall Study|Withdrawal by Subject|2
4701623|NCT02287025|16200240|P1|Overall Study|Withdrawal by Subject|2
4701624|NCT02287025|16200239|P2|Overall Study|Adverse Event|4
4701625|NCT02287025|16200240|P1|Overall Study|Adverse Event|2
4701626|NCT02287025|16200239|P2|Overall Study|Progression of disease|2
4701627|NCT02287025|16200240|P1|Overall Study|Progression of disease|3
4701628|NCT02287025|16200239|P2|Overall Study|Not treated|0
4701629|NCT02287025|16200240|P1|Overall Study|Not treated|2
4701630|NCT02286960|16200251|P2|Overall Study|Lost to Follow-up|3
4701631|NCT02286960|16200252|P1|Overall Study|Lost to Follow-up|3
4701632|NCT02286947|16200264|P1|Overall Study|Withdrawal by Subject|2
4701633|NCT02286895|16200306|P2|Assessed for Measles Seroconversion|Baseline measure non-negative|32
4701634|NCT02286895|16200307|P1|Assessed for Measles Seroconversion|Baseline measure non-negative|41
4701635|NCT02286895|16200306|P2|Assessed for Measles Seroconversion|Missing measurement|3
4701636|NCT02286895|16200307|P1|Assessed for Measles Seroconversion|Missing measurement|6
4701637|NCT02286895|16200306|P2|Assessed for Measles Seroconversion|Protocol Violation|4
4701638|NCT02286895|16200307|P1|Assessed for Measles Seroconversion|Protocol Violation|1
4701639|NCT02286713|16200351|P2|Six Month Follow-Up|Lost to Follow-up|27
4701640|NCT02286713|16200352|P1|Six Month Follow-Up|Lost to Follow-up|30
4701641|NCT02286713|16200351|P2|Six Month Follow-Up|Death|0
4701642|NCT02286713|16200352|P1|Six Month Follow-Up|Death|2
4701643|NCT02286713|16200351|P2|Three Month Follow-Up|Withdrawal by Subject|1
4701644|NCT02286713|16200352|P1|Three Month Follow-Up|Withdrawal by Subject|1
4701645|NCT02286713|16200351|P2|Three Month Follow-Up|Lost to Follow-up|24
4701646|NCT02286713|16200352|P1|Three Month Follow-Up|Lost to Follow-up|26
4701647|NCT02286713|16200351|P2|Three Month Follow-Up|Death|1
4701648|NCT02286713|16200352|P1|Three Month Follow-Up|Death|1
4701649|NCT02286713|16200351|P2|One Week Follow-Up|Withdrawal by Subject|3
4701650|NCT02286713|16200352|P1|One Week Follow-Up|Withdrawal by Subject|6
4701651|NCT02286713|16200351|P2|One Week Follow-Up|Lost to Follow-up|21
4701652|NCT02286713|16200352|P1|One Week Follow-Up|Lost to Follow-up|17
4701653|NCT02286713|16200351|P2|One Week Follow-Up|Death|0
4701654|NCT02286713|16200352|P1|One Week Follow-Up|Death|1
4701655|NCT02286466|16200533|P2|Overall Study|Declined Clinician Assessment|1
4701656|NCT02286466|16200534|P1|Overall Study|Declined Clinician Assessment|0
4701657|NCT02286466|16200533|P2|Overall Study|Lost to Follow-up|4
4701658|NCT02286466|16200534|P1|Overall Study|Lost to Follow-up|1
4701659|NCT02286466|16200533|P2|Overall Study|Withdrawal by Subject|2
4701660|NCT02286466|16200534|P1|Overall Study|Withdrawal by Subject|5
4701661|NCT02286466|16200533|P2|Overall Study|Death|3
4701662|NCT02286466|16200534|P1|Overall Study|Death|1
4701663|NCT02286193|16200546|P1|Overall Study|Referred: Declined service|38
4701664|NCT02286193|16200546|P1|Overall Study|Referred: unable to reach/resource sent|104
4701665|NCT02286193|16200546|P1|Overall Study|Referred: CRS unable to make contact|62
4701666|NCT02286102|16200553|P2|Overall Study|Screen Failure|1
4701667|NCT02286102|16200554|P1|Overall Study|Screen Failure|1
4701668|NCT02285998|16200566|P2|Overall Study|Other Reasons|10
4701669|NCT02285998|16200567|P1|Overall Study|Other Reasons|7
4701670|NCT02285998|16200566|P2|Overall Study|Withdrawal by Subject|61
4701671|NCT02285998|16200567|P1|Overall Study|Withdrawal by Subject|53
4701672|NCT02285998|16200566|P2|Overall Study|Lost to Follow-up|172
4701673|NCT02285998|16200567|P1|Overall Study|Lost to Follow-up|176
4701674|NCT02285998|16200566|P2|Overall Study|Physician Decision|2
4701675|NCT02285998|16200567|P1|Overall Study|Physician Decision|1
4701676|NCT02285998|16200566|P2|Overall Study|Adverse Event|8
4701677|NCT02285998|16200567|P1|Overall Study|Adverse Event|9
4701678|NCT02285920|16200595|P4|Overall Study|Death|1
4701679|NCT02285920|16200596|P3|Overall Study|Death|2
4701680|NCT02285920|16200597|P2|Overall Study|Death|0
4701681|NCT02285920|16200598|P1|Overall Study|Death|2
4701682|NCT02285920|16200595|P4|Overall Study|Dialysis discontinuation|0
4701683|NCT02285920|16200596|P3|Overall Study|Dialysis discontinuation|0
4701684|NCT02285920|16200597|P2|Overall Study|Dialysis discontinuation|1
4701685|NCT02285920|16200598|P1|Overall Study|Dialysis discontinuation|0
4701686|NCT02285920|16200595|P4|Overall Study|Transfer to non-participating unit|0
4701687|NCT02285920|16200596|P3|Overall Study|Transfer to non-participating unit|0
4701688|NCT02285920|16200597|P2|Overall Study|Transfer to non-participating unit|1
4701689|NCT02285920|16200598|P1|Overall Study|Transfer to non-participating unit|0
4701690|NCT02285920|16200595|P4|Overall Study|Change to peritoneal dialysis|0
4701691|NCT02285920|16200596|P3|Overall Study|Change to peritoneal dialysis|1
4701692|NCT02285920|16200597|P2|Overall Study|Change to peritoneal dialysis|0
4701693|NCT02285920|16200598|P1|Overall Study|Change to peritoneal dialysis|0
4701694|NCT02285920|16200595|P4|Overall Study|Kidney transplantation|0
4701695|NCT02285920|16200596|P3|Overall Study|Kidney transplantation|2
4701696|NCT02285920|16200597|P2|Overall Study|Kidney transplantation|2
4701697|NCT02285920|16200598|P1|Overall Study|Kidney transplantation|2
4701698|NCT02285855|16200688|P2|Overall Study|Withdrawal by Subject|1
4701699|NCT02285855|16200689|P1|Overall Study|Withdrawal by Subject|2
4701700|NCT02285777|16200697|P2|Overall Study|Lost to Follow-up|2
4701701|NCT02285777|16200698|P1|Overall Study|Lost to Follow-up|4
4701702|NCT02285777|16200697|P2|Overall Study|Withdrawal by Subject|1
4701703|NCT02285777|16200698|P1|Overall Study|Withdrawal by Subject|1
4701704|NCT02285270|16200779|P1|Overall Study|Determined to be ineligible|1
4701705|NCT02285270|16200779|P1|Overall Study|Physician Decision|3
4701706|NCT02285270|16200779|P1|Overall Study|Lost to Follow-up|1
4701707|NCT02285153|16200787|P2|Overall Study|Adverse Event|0
4701708|NCT02285153|16200788|P1|Overall Study|Adverse Event|1
4701709|NCT02285062|16200802|P2|Overall Study|Lost to Follow-up|5
4701710|NCT02285062|16200803|P1|Overall Study|Lost to Follow-up|8
4701711|NCT02285062|16200802|P2|Overall Study|Death|62
4701712|NCT02285062|16200803|P1|Overall Study|Death|58
4701713|NCT02285062|16200802|P2|Overall Study|Withdrawal by Subject|17
4701714|NCT02285062|16200803|P1|Overall Study|Withdrawal by Subject|12
4701715|NCT02285010|16200851|P2|Overall Study|Not spinal anesthesia|1
4701716|NCT02285010|16200852|P1|Overall Study|Not spinal anesthesia|3
4701717|NCT02285010|16200851|P2|Overall Study|not abdominal hysterectomy|0
4701718|NCT02285010|16200852|P1|Overall Study|not abdominal hysterectomy|2
4701719|NCT02284906|16200869|P3|Overall Study|Reason not Specified|0
4701720|NCT02284906|16200870|P2|Overall Study|Reason not Specified|1
4701721|NCT02284906|16200871|P1|Overall Study|Reason not Specified|1
4701722|NCT02284906|16200869|P3|Overall Study|Study Termination|14
4701723|NCT02284906|16200870|P2|Overall Study|Study Termination|11
4701724|NCT02284906|16200871|P1|Overall Study|Study Termination|0
4701725|NCT02284906|16200869|P3|Overall Study|Voluntary Withdrawal|5
4701726|NCT02284906|16200870|P2|Overall Study|Voluntary Withdrawal|4
4701727|NCT02284906|16200871|P1|Overall Study|Voluntary Withdrawal|2
4701728|NCT02284906|16200869|P3|Overall Study|Major Protocol Deviation|0
4701729|NCT02284906|16200870|P2|Overall Study|Major Protocol Deviation|1
4701730|NCT02284906|16200871|P1|Overall Study|Major Protocol Deviation|0
4701731|NCT02284906|16200869|P3|Overall Study|Pretreatment Event/Adverse Event|0
4701732|NCT02284906|16200870|P2|Overall Study|Pretreatment Event/Adverse Event|1
4701733|NCT02284906|16200871|P1|Overall Study|Pretreatment Event/Adverse Event|0
4701734|NCT02284893|16200884|P2|52 Week (Long Term)|Non-Compliance|3
4701735|NCT02284893|16200885|P1|52 Week (Long Term)|Non-Compliance|2
4701736|NCT02284893|16200884|P2|52 Week (Long Term)|Lost to Follow-up|2
4701737|NCT02284893|16200885|P1|52 Week (Long Term)|Lost to Follow-up|2
4701738|NCT02284893|16200884|P2|52 Week (Long Term)|Withrawal of the consent by the subject|6
4701739|NCT02284893|16200885|P1|52 Week (Long Term)|Withrawal of the consent by the subject|4
4701740|NCT02284893|16200884|P2|52 Week (Long Term)|Subject no longer meets study criteria|1
4701741|NCT02284893|16200885|P1|52 Week (Long Term)|Subject no longer meets study criteria|0
4701742|NCT02284893|16200884|P2|52 Week (Long Term)|Adverse Event|1
4701743|NCT02284893|16200885|P1|52 Week (Long Term)|Adverse Event|3
4701744|NCT02284893|16200884|P2|26 Week (Short Term)|Other|1
4701745|NCT02284893|16200885|P1|26 Week (Short Term)|Other|1
4701746|NCT02284893|16200884|P2|26 Week (Short Term)|Subject no longer meets study criteria|8
4701747|NCT02284893|16200885|P1|26 Week (Short Term)|Subject no longer meets study criteria|5
4701748|NCT02284893|16200884|P2|26 Week (Short Term)|Lost to Follow-up|1
4701749|NCT02284893|16200885|P1|26 Week (Short Term)|Lost to Follow-up|3
4701750|NCT02284893|16200884|P2|26 Week (Short Term)|Withrawal of the consent by the subject|10
4701751|NCT02284893|16200885|P1|26 Week (Short Term)|Withrawal of the consent by the subject|7
4701752|NCT02284893|16200884|P2|26 Week (Short Term)|Discontinuation by the subject|2
4701753|NCT02284893|16200885|P1|26 Week (Short Term)|Discontinuation by the subject|2
4701754|NCT02284893|16200884|P2|26 Week (Short Term)|Adverse Event|9
4701755|NCT02284893|16200885|P1|26 Week (Short Term)|Adverse Event|1
4701756|NCT01432574|16200959|P1|Overall Study|Not interested|1
4701757|NCT01432574|16200959|P1|Overall Study|Moved|2
4701758|NCT02284568|16200968|P3|Overall Study|Withdrew before taking study drug|0
4701759|NCT02284568|16200969|P2|Overall Study|Withdrew before taking study drug|1
4701760|NCT02284568|16200970|P1|Overall Study|Withdrew before taking study drug|0
4701761|NCT02284568|16200968|P3|Overall Study|Other|0
4701762|NCT02284568|16200969|P2|Overall Study|Other|2
4701763|NCT02284568|16200970|P1|Overall Study|Other|1
4701764|NCT02284568|16200968|P3|Overall Study|Lack of Efficacy|0
4701765|NCT02284568|16200969|P2|Overall Study|Lack of Efficacy|7
4701766|NCT02284568|16200970|P1|Overall Study|Lack of Efficacy|4
4701767|NCT02284568|16200968|P3|Overall Study|Lost to Follow-up|0
4701768|NCT02284568|16200969|P2|Overall Study|Lost to Follow-up|3
4701769|NCT02284568|16200970|P1|Overall Study|Lost to Follow-up|0
4701770|NCT02284568|16200968|P3|Overall Study|Sponsor requested patient stop treatment|90
4701771|NCT02284568|16200969|P2|Overall Study|Sponsor requested patient stop treatment|0
4701772|NCT02284568|16200970|P1|Overall Study|Sponsor requested patient stop treatment|0
4701773|NCT02284568|16200968|P3|Overall Study|Protocol Violation|0
4701774|NCT02284568|16200969|P2|Overall Study|Protocol Violation|1
4701775|NCT02284568|16200970|P1|Overall Study|Protocol Violation|0
4701776|NCT02284568|16200968|P3|Overall Study|Noncompliance|0
4701777|NCT02284568|16200969|P2|Overall Study|Noncompliance|0
4701778|NCT02284568|16200970|P1|Overall Study|Noncompliance|1
4701779|NCT02284568|16200968|P3|Overall Study|Noncompliance with study drug admin|0
4701780|NCT02284568|16200969|P2|Overall Study|Noncompliance with study drug admin|2
4701781|NCT02284568|16200970|P1|Overall Study|Noncompliance with study drug admin|1
4701782|NCT02284568|16200968|P3|Overall Study|Withdrawal by Subject|1
4701783|NCT02284568|16200969|P2|Overall Study|Withdrawal by Subject|21
4701784|NCT02284568|16200970|P1|Overall Study|Withdrawal by Subject|22
4701785|NCT02284568|16200968|P3|Overall Study|Adverse Event|4
4701786|NCT02284568|16200969|P2|Overall Study|Adverse Event|9
4701787|NCT02284568|16200970|P1|Overall Study|Adverse Event|2
4701788|NCT02284373|16201064|P3|Overall Study|Lost to Follow-up|0
4701789|NCT02284373|16201065|P2|Overall Study|Lost to Follow-up|1
4701790|NCT02284373|16201066|P1|Overall Study|Lost to Follow-up|0
4701791|NCT02284373|16201064|P3|Overall Study|Other|0
4701792|NCT02284373|16201065|P2|Overall Study|Other|1
4701793|NCT02284373|16201066|P1|Overall Study|Other|0
4701794|NCT02284373|16201064|P3|Overall Study|Withdrawal by Subject|0
4701795|NCT02284373|16201065|P2|Overall Study|Withdrawal by Subject|1
4701796|NCT02284373|16201066|P1|Overall Study|Withdrawal by Subject|0
4701797|NCT02284347|16201074|P1|Overall Study|Withdrawn prior to treatment|1
4701798|NCT02284347|16201074|P1|Overall Study|Lost to Follow-up|2
4701799|NCT02284243|16201082|P2|Overall Study|Adverse Event|0
4701800|NCT02284243|16201083|P1|Overall Study|Adverse Event|1
4701801|NCT02284243|16201082|P2|Overall Study|Lack of Efficacy|3
4701802|NCT02284243|16201083|P1|Overall Study|Lack of Efficacy|3
4701803|NCT02284178|16201103|P2|Overall Study|Met exclusion criteria|54
4701804|NCT02284178|16201104|P1|Overall Study|Met exclusion criteria|49
4701805|NCT02284009|16201147|P2|Overall Study|Withdrawal by Subject|5
4701806|NCT02284009|16201148|P1|Overall Study|Withdrawal by Subject|2
4701807|NCT02284009|16201147|P2|Overall Study|Physician Decision|2
4701808|NCT02284009|16201148|P1|Overall Study|Physician Decision|0
4701809|NCT02284009|16201147|P2|Overall Study|Lost to Follow-up|3
4701810|NCT02284009|16201148|P1|Overall Study|Lost to Follow-up|1
4701811|NCT02284009|16201147|P2|Overall Study|Adverse Event|0
4701812|NCT02284009|16201148|P1|Overall Study|Adverse Event|3
4701813|NCT02283788|16201247|P4|Overall Study|Withdrawal by Subject|1
4701814|NCT02283788|16201248|P3|Overall Study|Withdrawal by Subject|0
4701815|NCT02283788|16201249|P2|Overall Study|Withdrawal by Subject|1
4701816|NCT02283788|16201250|P1|Overall Study|Withdrawal by Subject|0
4701817|NCT02283788|16201247|P4|Overall Study|Adverse Event|1
4701818|NCT02283788|16201248|P3|Overall Study|Adverse Event|5
4701819|NCT02283788|16201249|P2|Overall Study|Adverse Event|3
4701820|NCT02283788|16201250|P1|Overall Study|Adverse Event|1
4701821|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Physician Decision|2
4701822|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Physician Decision|1
4701823|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Lost to Follow-up|1
4701824|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Lost to Follow-up|0
4701825|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Protocol Violation|1
4701826|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Protocol Violation|1
4701827|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Withdrawal by Subject|3
4701828|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Withdrawal by Subject|4
4701829|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Study terminated at site|0
4701830|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Study terminated at site|1
4701831|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Lack of Efficacy|1
4701832|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Lack of Efficacy|1
4701833|NCT02283762|16201262|P2|Long-term Extension Phase (LTE)|Adverse Event|6
4701834|NCT02283762|16201263|P1|Long-term Extension Phase (LTE)|Adverse Event|2
4701835|NCT02283762|16201262|P2|Main Treatment Phase (MT)|Withdrawal by Subject|4
4701836|NCT02283762|16201263|P1|Main Treatment Phase (MT)|Withdrawal by Subject|7
4701837|NCT02283762|16201262|P2|Main Treatment Phase (MT)|Pregnancy|1
4701838|NCT02283762|16201263|P1|Main Treatment Phase (MT)|Pregnancy|0
4701839|NCT02283762|16201262|P2|Main Treatment Phase (MT)|Physician Decision|1
4701840|NCT02283762|16201263|P1|Main Treatment Phase (MT)|Physician Decision|1
4701841|NCT02283762|16201262|P2|Main Treatment Phase (MT)|Lack of Efficacy|0
4701842|NCT02283762|16201263|P1|Main Treatment Phase (MT)|Lack of Efficacy|1
4701843|NCT02283762|16201262|P2|Main Treatment Phase (MT)|Adverse Event|9
4701844|NCT02283762|16201263|P1|Main Treatment Phase (MT)|Adverse Event|9
4701845|NCT02283658|16201287|P1|Overall Study|Withdrawal by Subject|1
4701846|NCT02283411|16201309|P1|Overall Study|Screen Failed|28
4701847|NCT02283411|16201309|P1|Overall Study|Withdrawal by Subject|3
4701848|NCT02283268|16201317|P1|Overall Study|Withdrawal by Subject|1
4701849|NCT02282982|16201378|P1|Overall Study|Other, not specified|18
4701850|NCT02282982|16201378|P1|Overall Study|Palivizumab is ended|11
4701851|NCT02282982|16201378|P1|Overall Study|Lack of product|156
4701852|NCT02282982|16201378|P1|Overall Study|Death|4
4701853|NCT02282982|16201378|P1|Overall Study|Withdrew consent|2
4701854|NCT02282982|16201378|P1|Overall Study|Lost to Follow-up|15
4701855|NCT02282813|16201406|P3|Overall Study|Administrative reasons|0
4701856|NCT02282813|16201407|P2|Overall Study|Administrative reasons|1
4701857|NCT02282813|16201408|P1|Overall Study|Administrative reasons|0
4701858|NCT02282813|16201406|P3|Overall Study|Lack of Efficacy|0
4701859|NCT02282813|16201407|P2|Overall Study|Lack of Efficacy|0
4701860|NCT02282813|16201408|P1|Overall Study|Lack of Efficacy|1
4701861|NCT02282813|16201406|P3|Overall Study|Serum Ca >/=11.0mg/dL|0
4701862|NCT02282813|16201407|P2|Overall Study|Serum Ca >/=11.0mg/dL|0
4701863|NCT02282813|16201408|P1|Overall Study|Serum Ca >/=11.0mg/dL|1
4701864|NCT02282813|16201406|P3|Overall Study|Lost to Follow-up|1
4701865|NCT02282813|16201407|P2|Overall Study|Lost to Follow-up|0
4701866|NCT02282813|16201408|P1|Overall Study|Lost to Follow-up|2
4701867|NCT02282813|16201406|P3|Overall Study|Physician Decision|1
4701868|NCT02282813|16201407|P2|Overall Study|Physician Decision|3
4701869|NCT02282813|16201408|P1|Overall Study|Physician Decision|0
4701870|NCT02282813|16201406|P3|Overall Study|Subject non-compliance|0
4701871|NCT02282813|16201407|P2|Overall Study|Subject non-compliance|4
4701872|NCT02282813|16201408|P1|Overall Study|Subject non-compliance|1
4701873|NCT02282813|16201406|P3|Overall Study|Adverse Event|1
4701874|NCT02282813|16201407|P2|Overall Study|Adverse Event|10
4701875|NCT02282813|16201408|P1|Overall Study|Adverse Event|3
4701876|NCT02282813|16201406|P3|Overall Study|Withdrawal by Subject|0
4701877|NCT02282813|16201407|P2|Overall Study|Withdrawal by Subject|5
4701878|NCT02282813|16201408|P1|Overall Study|Withdrawal by Subject|4
4701879|NCT02282631|16201454|P2|Overall Study|Lost to Follow-up|0
4701880|NCT02282631|16201455|P1|Overall Study|Lost to Follow-up|2
4701881|NCT02282605|16201496|P3|Overall Study|negative SA result on Day -1|0
4701882|NCT02282605|16201497|P2|Overall Study|negative SA result on Day -1|0
4701883|NCT02282605|16201498|P1|Overall Study|negative SA result on Day -1|3
4701884|NCT02282527|16201520|P2|Overall Study|Lack of home health aid|0
4701885|NCT02282527|16201521|P1|Overall Study|Lack of home health aid|1
4701886|NCT02282527|16201520|P2|Overall Study|Lost to Follow-up|1
4701887|NCT02282527|16201521|P1|Overall Study|Lost to Follow-up|0
4701888|NCT02282293|16201533|P2|Overall Study|Moved out of study area|1
4701889|NCT02282293|16201534|P1|Overall Study|Moved out of study area|0
4701890|NCT02282293|16201533|P2|Overall Study|Unable to comply with study procedures|0
4701891|NCT02282293|16201534|P1|Overall Study|Unable to comply with study procedures|1
4701892|NCT02282293|16201533|P2|Overall Study|Lost to Follow-up|2
4701893|NCT02282293|16201534|P1|Overall Study|Lost to Follow-up|2
4701894|NCT02282163|16201552|P1|Overall Study|Protocol Violation|1
4701895|NCT02281773|16201596|P5|Overall Study|Other Reason|1
4701896|NCT02281773|16201597|P4|Overall Study|Other Reason|3
4701897|NCT02281773|16201598|P3|Overall Study|Other Reason|2
4701898|NCT02281773|16201599|P2|Overall Study|Other Reason|4
4701899|NCT02281773|16201600|P1|Overall Study|Other Reason|0
4701900|NCT02281773|16201596|P5|Overall Study|Withdrawal by Subject|8
4701901|NCT02281773|16201597|P4|Overall Study|Withdrawal by Subject|6
4701902|NCT02281773|16201598|P3|Overall Study|Withdrawal by Subject|6
4701903|NCT02281773|16201599|P2|Overall Study|Withdrawal by Subject|8
4701904|NCT02281773|16201600|P1|Overall Study|Withdrawal by Subject|2
4701905|NCT02281773|16201596|P5|Overall Study|Lost to Follow-up|10
4701906|NCT02281773|16201597|P4|Overall Study|Lost to Follow-up|2
4701907|NCT02281773|16201598|P3|Overall Study|Lost to Follow-up|6
4701908|NCT02281773|16201599|P2|Overall Study|Lost to Follow-up|2
4701909|NCT02281773|16201600|P1|Overall Study|Lost to Follow-up|2
4701910|NCT02281773|16201596|P5|Overall Study|Protocol Violation|2
4701911|NCT02281773|16201597|P4|Overall Study|Protocol Violation|2
4701912|NCT02281773|16201598|P3|Overall Study|Protocol Violation|0
4701913|NCT02281773|16201599|P2|Overall Study|Protocol Violation|0
4701914|NCT02281773|16201600|P1|Overall Study|Protocol Violation|1
4701915|NCT02281773|16201596|P5|Overall Study|Adverse Event|9
4701916|NCT02281773|16201597|P4|Overall Study|Adverse Event|8
4701917|NCT02281773|16201598|P3|Overall Study|Adverse Event|4
4701918|NCT02281773|16201599|P2|Overall Study|Adverse Event|1
4701919|NCT02281773|16201600|P1|Overall Study|Adverse Event|6
4701920|NCT02281552|16201688|P2|Overall Study|Adverse Event|9
4701921|NCT02281552|16201689|P1|Overall Study|Adverse Event|3
4701922|NCT02281552|16201688|P2|Overall Study|Insufficient clinical response|1
4701923|NCT02281552|16201689|P1|Overall Study|Insufficient clinical response|0
4701924|NCT02281552|16201688|P2|Overall Study|Medication error|0
4701925|NCT02281552|16201689|P1|Overall Study|Medication error|1
4701926|NCT02281357|16201782|P2|Overall Study|Withdrawal by Subject|3
4701927|NCT02281357|16201783|P1|Overall Study|Withdrawal by Subject|4
4701928|NCT02281357|16201782|P2|Overall Study|Lost to Follow-up|0
4701929|NCT02281357|16201783|P1|Overall Study|Lost to Follow-up|1
4701930|NCT02281357|16201782|P2|Overall Study|Adverse Event|1
4701931|NCT02281357|16201783|P1|Overall Study|Adverse Event|2
4701932|NCT02281318|16201802|P2|Overall Study|Withdrawal by Subject|2
4701933|NCT02281318|16201803|P1|Overall Study|Withdrawal by Subject|6
4701934|NCT02281318|16201802|P2|Overall Study|Physician Decision|0
4701935|NCT02281318|16201803|P1|Overall Study|Physician Decision|2
4701936|NCT02281318|16201802|P2|Overall Study|Lost to Follow-up|1
4701937|NCT02281318|16201803|P1|Overall Study|Lost to Follow-up|2
4701938|NCT02281318|16201802|P2|Overall Study|Lack of Efficacy|0
4701939|NCT02281318|16201803|P1|Overall Study|Lack of Efficacy|2
4701940|NCT02281318|16201802|P2|Overall Study|Adverse Event|2
4701941|NCT02281318|16201803|P1|Overall Study|Adverse Event|2
4701942|NCT02281084|16201851|P4|Overall Study|Physician Decision|0
4701943|NCT02281084|16201852|P3|Overall Study|Physician Decision|1
4701944|NCT02281084|16201853|P2|Overall Study|Physician Decision|0
4701945|NCT02281084|16201854|P1|Overall Study|Physician Decision|0
4701946|NCT02281084|16201851|P4|Overall Study|Death|5
4701947|NCT02281084|16201852|P3|Overall Study|Death|3
4701948|NCT02281084|16201853|P2|Overall Study|Death|16
4701949|NCT02281084|16201854|P1|Overall Study|Death|20
4701950|NCT02281084|16201851|P4|Overall Study|Withdrawal by Subject|0
4701951|NCT02281084|16201852|P3|Overall Study|Withdrawal by Subject|0
4701952|NCT02281084|16201853|P2|Overall Study|Withdrawal by Subject|2
4701953|NCT02281084|16201854|P1|Overall Study|Withdrawal by Subject|1
4701954|NCT02281084|16201851|P4|Overall Study|Adverse Event|0
4701955|NCT02281084|16201852|P3|Overall Study|Adverse Event|0
4701956|NCT02281084|16201853|P2|Overall Study|Adverse Event|0
4701957|NCT02281084|16201854|P1|Overall Study|Adverse Event|1
4701958|NCT02280863|16201910|P2|Integrated Platform|Met stopping criteria|1
4701959|NCT02280863|16201911|P1|Integrated Platform|Met stopping criteria|0
4701960|NCT02280499|16201995|P1|Overall Study|Adverse Event|5
4701961|NCT02280499|16201995|P1|Overall Study|Lost to Follow-up|42
4701962|NCT02280499|16201995|P1|Overall Study|Death|14
4701963|NCT02280473|16202003|P2|Overall Study|Lost to Follow-up|1
4701964|NCT02280473|16202004|P1|Overall Study|Lost to Follow-up|0
4701965|NCT02280473|16202003|P2|Overall Study|Lack of Efficacy|1
4701966|NCT02280473|16202004|P1|Overall Study|Lack of Efficacy|0
4701967|NCT02280473|16202003|P2|Overall Study|Adverse Event|1
4701968|NCT02280473|16202004|P1|Overall Study|Adverse Event|1
4701969|NCT02280421|16202020|P2|Washout (2 Weeks)|Withdrawal by Subject|0
4701970|NCT02280421|16202021|P1|Washout (2 Weeks)|Withdrawal by Subject|1
4701971|NCT02280421|16202020|P2|Washout (2 Weeks)|Adverse Event|1
4701972|NCT02280421|16202021|P1|Washout (2 Weeks)|Adverse Event|0
4701973|NCT02280408|16202087|P4|Overall Study|Lost to Follow-up|0
4701974|NCT02280408|16202088|P3|Overall Study|Lost to Follow-up|0
4701975|NCT02280408|16202089|P2|Overall Study|Lost to Follow-up|2
4701976|NCT02280408|16202090|P1|Overall Study|Lost to Follow-up|0
4701977|NCT02280304|16202162|P2|Overall Study|Lost to Follow-up|8
4701978|NCT02280304|16202163|P1|Overall Study|Lost to Follow-up|7
4701979|NCT02280291|16202184|P4|Overall Study|Other|0
4701980|NCT02280291|16202185|P3|Overall Study|Other|0
4701981|NCT02280291|16202186|P2|Overall Study|Other|1
4701982|NCT02280291|16202187|P1|Overall Study|Other|1
4701983|NCT02280291|16202184|P4|Overall Study|Protocol Violation|0
4701984|NCT02280291|16202185|P3|Overall Study|Protocol Violation|0
4701985|NCT02280291|16202186|P2|Overall Study|Protocol Violation|0
4701986|NCT02280291|16202187|P1|Overall Study|Protocol Violation|1
4701987|NCT02280291|16202184|P4|Overall Study|Lost to Follow-up|8
4701988|NCT02280291|16202185|P3|Overall Study|Lost to Follow-up|3
4701989|NCT02280291|16202186|P2|Overall Study|Lost to Follow-up|1
4701990|NCT02280291|16202187|P1|Overall Study|Lost to Follow-up|2
4701991|NCT02280187|16202221|P1|Overall Study|Lost to Follow-up|218
4701992|NCT02280096|16202249|P2|Overall Study|Lack of attachment|1
4701993|NCT02280096|16202250|P1|Overall Study|Lack of attachment|0
4701994|NCT02280096|16202249|P2|Overall Study|Functional neurological disorder|0
4701995|NCT02280096|16202250|P1|Overall Study|Functional neurological disorder|1
4701996|NCT02280096|16202249|P2|Overall Study|Pregnancy|0
4701997|NCT02280096|16202250|P1|Overall Study|Pregnancy|1
4701998|NCT02280044|16202280|P2|Overall Study|Planned alternate|2
4701999|NCT02280044|16202281|P1|Overall Study|Planned alternate|0
4702000|NCT02279862|16202291|P2|Overall Study|Withdrawal by Subject|0
4702001|NCT02279862|16202292|P1|Overall Study|Withdrawal by Subject|1
4702002|NCT02279862|16202291|P2|Overall Study|Other|2
4702003|NCT02279862|16202292|P1|Overall Study|Other|1
4702004|NCT02279862|16202291|P2|Overall Study|Study closed by sponsor|13
4702005|NCT02279862|16202292|P1|Overall Study|Study closed by sponsor|16
4702006|NCT02279862|16202291|P2|Overall Study|Disease progression|2
4702007|NCT02279862|16202292|P1|Overall Study|Disease progression|5
4702008|NCT02279862|16202291|P2|Overall Study|Administrative reason by sponsor|1
4702009|NCT02279862|16202292|P1|Overall Study|Administrative reason by sponsor|0
4702010|NCT02279862|16202291|P2|Overall Study|No longer meets criteria|1
4702011|NCT02279862|16202292|P1|Overall Study|No longer meets criteria|0
4702012|NCT02279862|16202291|P2|Overall Study|Study drug toxicity|6
4702013|NCT02279862|16202292|P1|Overall Study|Study drug toxicity|3
4702014|NCT02279732|16202310|P2|Overall Study|Other|3
4702015|NCT02279732|16202311|P1|Overall Study|Other|3
4702016|NCT02279732|16202310|P2|Overall Study|Other|67
4702017|NCT02279732|16202311|P1|Overall Study|Other|53
4702018|NCT02279732|16202310|P2|Overall Study|Subject Requested to Discontinue|1
4702019|NCT02279732|16202311|P1|Overall Study|Subject Requested to Discontinue|0
4702020|NCT02279732|16202310|P2|Overall Study|Maximum Clinical Benefit|0
4702021|NCT02279732|16202311|P1|Overall Study|Maximum Clinical Benefit|1
4702022|NCT02279732|16202310|P2|Overall Study|Lost to Follow-up|1
4702023|NCT02279732|16202311|P1|Overall Study|Lost to Follow-up|0
4702024|NCT02279732|16202310|P2|Overall Study|Study Drug Toxicity|0
4702025|NCT02279732|16202311|P1|Overall Study|Study Drug Toxicity|2
4702026|NCT02279732|16202310|P2|Overall Study|Administrative Reason By Sponsor|2
4702027|NCT02279732|16202311|P1|Overall Study|Administrative Reason By Sponsor|0
4702028|NCT02279732|16202310|P2|Overall Study|Adverse Event|2
4702029|NCT02279732|16202311|P1|Overall Study|Adverse Event|1
4702030|NCT02279732|16202310|P2|Overall Study|Withdrawal by Subject|7
4702031|NCT02279732|16202311|P1|Overall Study|Withdrawal by Subject|2
4702032|NCT02279732|16202310|P2|Overall Study|Disease Progression|3
4702033|NCT02279732|16202311|P1|Overall Study|Disease Progression|13
4702034|NCT02279732|16202310|P2|Overall Study|Death|20
4702035|NCT02279732|16202311|P1|Overall Study|Death|23
4702036|NCT02279498|16202403|P2|Overall Study|Undefined|1
4702037|NCT02279498|16202404|P1|Overall Study|Undefined|2
4702038|NCT02279498|16202403|P2|Overall Study|Withdrawal by Subject|2
4702039|NCT02279498|16202404|P1|Overall Study|Withdrawal by Subject|9
4702040|NCT02279498|16202403|P2|Overall Study|Lost to Follow-up|1
4702041|NCT02279498|16202404|P1|Overall Study|Lost to Follow-up|0
4702042|NCT02279498|16202403|P2|Overall Study|Lack of Efficacy|0
4702043|NCT02279498|16202404|P1|Overall Study|Lack of Efficacy|4
4702044|NCT02279498|16202403|P2|Overall Study|Adverse Event|0
4702045|NCT02279498|16202404|P1|Overall Study|Adverse Event|3
4702046|NCT02279420|16202413|P1|Overall Study|Lost to Follow-up|23
4702047|NCT02279407|16202421|P4|Overall Study|Adverse Event|0
4702048|NCT02279407|16202422|P3|Overall Study|Adverse Event|2
4702049|NCT02279407|16202423|P2|Overall Study|Adverse Event|1
4702050|NCT02279407|16202424|P1|Overall Study|Adverse Event|1
4702051|NCT02279407|16202421|P4|Overall Study|Withdrawal by Subject|1
4702052|NCT02279407|16202422|P3|Overall Study|Withdrawal by Subject|1
4702053|NCT02279407|16202423|P2|Overall Study|Withdrawal by Subject|0
4702054|NCT02279407|16202424|P1|Overall Study|Withdrawal by Subject|1
4702055|NCT02279407|16202421|P4|Overall Study|Couldn't swallow IP; noncompliance|0
4702056|NCT02279407|16202422|P3|Overall Study|Couldn't swallow IP; noncompliance|2
4702057|NCT02279407|16202423|P2|Overall Study|Couldn't swallow IP; noncompliance|0
4702058|NCT02279407|16202424|P1|Overall Study|Couldn't swallow IP; noncompliance|0
4702059|NCT01358721|16202439|P4|Overall Study|Out of State/Unmet Criteria|0
4702060|NCT01358721|16202440|P3|Overall Study|Out of State/Unmet Criteria|1
4702061|NCT01358721|16202441|P2|Overall Study|Out of State/Unmet Criteria|0
4702062|NCT01358721|16202442|P1|Overall Study|Out of State/Unmet Criteria|0
4702063|NCT01358721|16202439|P4|Overall Study|Disease Progression|15
4702064|NCT01358721|16202440|P3|Overall Study|Disease Progression|17
4702065|NCT01358721|16202441|P2|Overall Study|Disease Progression|15
4702066|NCT01358721|16202442|P1|Overall Study|Disease Progression|19
4702067|NCT01358721|16202439|P4|Overall Study|Adverse Event related to study drug|1
4702068|NCT01358721|16202440|P3|Overall Study|Adverse Event related to study drug|0
4702069|NCT01358721|16202441|P2|Overall Study|Adverse Event related to study drug|0
4702070|NCT01358721|16202442|P1|Overall Study|Adverse Event related to study drug|1
4702071|NCT01358721|16202439|P4|Overall Study|Subject No Longer Meets Study Criteria|1
4702072|NCT01358721|16202440|P3|Overall Study|Subject No Longer Meets Study Criteria|0
4702073|NCT01358721|16202441|P2|Overall Study|Subject No Longer Meets Study Criteria|2
4702074|NCT01358721|16202442|P1|Overall Study|Subject No Longer Meets Study Criteria|0
4702075|NCT01358721|16202439|P4|Overall Study|SUBJ request to discontinue study TRT|1
4702076|NCT01358721|16202440|P3|Overall Study|SUBJ request to discontinue study TRT|0
4702077|NCT01358721|16202441|P2|Overall Study|SUBJ request to discontinue study TRT|0
4702078|NCT01358721|16202442|P1|Overall Study|SUBJ request to discontinue study TRT|0
4702079|NCT01358721|16202439|P4|Overall Study|Study Drug Toxicity|5
4702080|NCT01358721|16202440|P3|Overall Study|Study Drug Toxicity|4
4702081|NCT01358721|16202441|P2|Overall Study|Study Drug Toxicity|3
4702082|NCT01358721|16202442|P1|Overall Study|Study Drug Toxicity|1
4702083|NCT01358721|16202439|P4|Overall Study|Death|0
4702084|NCT01358721|16202440|P3|Overall Study|Death|0
4702085|NCT01358721|16202441|P2|Overall Study|Death|2
4702086|NCT01358721|16202442|P1|Overall Study|Death|0
4702087|NCT01358721|16202439|P4|Overall Study|Withdrawal by Subject|1
4702088|NCT01358721|16202440|P3|Overall Study|Withdrawal by Subject|0
4702089|NCT01358721|16202441|P2|Overall Study|Withdrawal by Subject|0
4702090|NCT01358721|16202442|P1|Overall Study|Withdrawal by Subject|0
4702091|NCT02279173|16202492|P1|Overall Study|Lost to Follow-up|3
4702092|NCT02279173|16202492|P1|Overall Study|Decision by Sponsor|4
4702093|NCT02279173|16202492|P1|Overall Study|Withdrawal by Subject|20
4702094|NCT02279173|16202492|P1|Overall Study|Protocol-specified Criteria|67
4702095|NCT02279043|16202552|P3|Overall Study|Lost to Follow-up|0
4702096|NCT02279043|16202553|P2|Overall Study|Lost to Follow-up|88
4702097|NCT02279043|16202554|P1|Overall Study|Lost to Follow-up|46
4702098|NCT02279043|16202552|P3|Overall Study|Post-rand. exclusion - not eligible|0
4702099|NCT02279043|16202553|P2|Overall Study|Post-rand. exclusion - not eligible|1
4702100|NCT02279043|16202554|P1|Overall Study|Post-rand. exclusion - not eligible|1
4702101|NCT02278952|16202584|P1|Overall Study|Insufficient Sample|6
4702102|NCT02278939|16202596|P2|Overall Study|family emergency unable to commit|0
4702103|NCT02278939|16202597|P1|Overall Study|family emergency unable to commit|2
4702104|NCT02278939|16202596|P2|Overall Study|death in family|0
4702105|NCT02278939|16202597|P1|Overall Study|death in family|1
4702106|NCT02278939|16202596|P2|Overall Study|Lost to Follow-up|1
4702107|NCT02278939|16202597|P1|Overall Study|Lost to Follow-up|1
4702108|NCT02278939|16202596|P2|Overall Study|lack of time|0
4702109|NCT02278939|16202597|P1|Overall Study|lack of time|1
4702110|NCT02278614|16202625|P2|Overall Study|left eye was not eligible|0
4702111|NCT02278614|16202626|P1|Overall Study|left eye was not eligible|1
4702112|NCT02278614|16202625|P2|Overall Study|Adverse Event|0
4702113|NCT02278614|16202626|P1|Overall Study|Adverse Event|1
4702114|NCT02278614|16202625|P2|Overall Study|Withdrawal by Subject|5
4702115|NCT02278614|16202626|P1|Overall Study|Withdrawal by Subject|3
4702116|NCT02278471|16202660|P2|Overall Study|Withdrawal by Subject|3
4702117|NCT02278471|16202661|P1|Overall Study|Withdrawal by Subject|0
4702118|NCT02278471|16202660|P2|Overall Study|Death|2
4702119|NCT02278471|16202661|P1|Overall Study|Death|2
4702120|NCT02278471|16202660|P2|Overall Study|Lost to Follow-up|15
4702121|NCT02278471|16202661|P1|Overall Study|Lost to Follow-up|6
4702122|NCT02278367|16202679|P2|Overall Study|Withdrawal by Subject|0
4702123|NCT02278367|16202680|P1|Overall Study|Withdrawal by Subject|5
4702124|NCT02278367|16202679|P2|Overall Study|Physician Decision|0
4702125|NCT02278367|16202680|P1|Overall Study|Physician Decision|5
4702126|NCT02278354|16202690|P2|Overall Study|<10 professional fights|0
4702127|NCT02278354|16202691|P1|Overall Study|<10 professional fights|2
4702128|NCT02278354|16202690|P2|Overall Study|Withdrawal by Subject|1
4702129|NCT02278354|16202691|P1|Overall Study|Withdrawal by Subject|0
4702130|NCT02278354|16202690|P2|Overall Study|Lost to Follow-up|2
4702131|NCT02278354|16202691|P1|Overall Study|Lost to Follow-up|2
4702132|NCT02278341|16202705|P2|Overall Study|Miscellaneous|14
4702133|NCT02278341|16202706|P1|Overall Study|Miscellaneous|15
4702134|NCT02278341|16202705|P2|Overall Study|Physician Decision|1
4702135|NCT02278341|16202706|P1|Overall Study|Physician Decision|1
4702136|NCT02278341|16202705|P2|Overall Study|Lost to Follow-up|1
4702137|NCT02278341|16202706|P1|Overall Study|Lost to Follow-up|0
4702138|NCT02278341|16202705|P2|Overall Study|Withdrawal by Subject|19
4702139|NCT02278341|16202706|P1|Overall Study|Withdrawal by Subject|30
4702140|NCT02278341|16202705|P2|Overall Study|Death|56
4702141|NCT02278341|16202706|P1|Overall Study|Death|68
4702142|NCT02278341|16202705|P2|Overall Study|Adverse Event|0
4702143|NCT02278341|16202706|P1|Overall Study|Adverse Event|3
4702144|NCT02278341|16202705|P2|Overall Study|Randomized but never received study drug|1
4702145|NCT02278341|16202706|P1|Overall Study|Randomized but never received study drug|1
4702146|NCT02278328|16202800|P3|Neuropsych Screening|incomplete consent|2
4702147|NCT02278328|16202801|P2|Neuropsych Screening|incomplete consent|0
4702148|NCT02278328|16202802|P1|Neuropsych Screening|incomplete consent|0
4702149|NCT02278328|16202800|P3|Neuropsych Screening|Withdrawal by Subject|0
4702150|NCT02278328|16202801|P2|Neuropsych Screening|Withdrawal by Subject|1
4702151|NCT02278328|16202802|P1|Neuropsych Screening|Withdrawal by Subject|0
4702152|NCT02278328|16202800|P3|Neuropsych Screening|found ineligible on neuropsych|0
4702153|NCT02278328|16202801|P2|Neuropsych Screening|found ineligible on neuropsych|0
4702154|NCT02278328|16202802|P1|Neuropsych Screening|found ineligible on neuropsych|1
4702155|NCT02278263|16202815|P3|Overall Study|Protocol Violation|9
4702156|NCT02278263|16202816|P2|Overall Study|Protocol Violation|0
4702157|NCT02278263|16202817|P1|Overall Study|Protocol Violation|7
4702158|NCT02278120|16202862|P2|Overall Study|Protocol Violation|2
4702159|NCT02278120|16202863|P1|Overall Study|Protocol Violation|0
4702160|NCT02278120|16202862|P2|Overall Study|Lost to Follow-up|0
4702161|NCT02278120|16202863|P1|Overall Study|Lost to Follow-up|2
4702162|NCT02278120|16202862|P2|Overall Study|Death|3
4702163|NCT02278120|16202863|P1|Overall Study|Death|3
4702164|NCT02278120|16202862|P2|Overall Study|Physician Decision|19
4702165|NCT02278120|16202863|P1|Overall Study|Physician Decision|8
4702166|NCT02278120|16202862|P2|Overall Study|Adverse Event|10
4702167|NCT02278120|16202863|P1|Overall Study|Adverse Event|12
4702168|NCT02278120|16202862|P2|Overall Study|Patient/guardian decision|8
4702169|NCT02278120|16202863|P1|Overall Study|Patient/guardian decision|14
4702170|NCT02278120|16202862|P2|Overall Study|Progressive disease|174
4702171|NCT02278120|16202863|P1|Overall Study|Progressive disease|122
4702172|NCT02278003|16202879|P2|Overall Study|Recognition task improperly completed|0
4702173|NCT02278003|16202880|P1|Overall Study|Recognition task improperly completed|7
4702174|NCT02278003|16202879|P2|Overall Study|Not Treated|0
4702175|NCT02278003|16202880|P1|Overall Study|Not Treated|1
4702176|NCT02278003|16202879|P2|Overall Study|Withdrawal by Subject|0
4702177|NCT02278003|16202880|P1|Overall Study|Withdrawal by Subject|11
4702178|NCT02277990|16202890|P2|Overall Study|Had other reason|32
4702179|NCT02277990|16202891|P1|Overall Study|Had other reason|26
4702180|NCT02277990|16202890|P2|Overall Study|Lost to Follow-up|69
4702181|NCT02277990|16202891|P1|Overall Study|Lost to Follow-up|66
4702182|NCT02277990|16202890|P2|Overall Study|Physician Decision|34
4702183|NCT02277990|16202891|P1|Overall Study|Physician Decision|40
4702184|NCT02277990|16202890|P2|Overall Study|Withdrawal by Subject|53
4702185|NCT02277990|16202891|P1|Overall Study|Withdrawal by Subject|64
4702186|NCT02277990|16202890|P2|Overall Study|Death|188
4702187|NCT02277990|16202891|P1|Overall Study|Death|170
4702188|NCT01355575|16202916|P1|Overall Study|Withdrawal by Subject|2
4702189|NCT02277769|16202929|P3|Overall Study|Other than specified above|5
4702190|NCT02277769|16202930|P2|Overall Study|Other than specified above|8
4702191|NCT02277769|16202931|P1|Overall Study|Other than specified above|12
4702192|NCT02277769|16202929|P3|Overall Study|Adverse Event|4
4702193|NCT02277769|16202930|P2|Overall Study|Adverse Event|2
4702194|NCT02277769|16202931|P1|Overall Study|Adverse Event|14
4702195|NCT02277769|16202929|P3|Overall Study|Lack of Efficacy|4
4702196|NCT02277769|16202930|P2|Overall Study|Lack of Efficacy|0
4702197|NCT02277769|16202931|P1|Overall Study|Lack of Efficacy|17
4702198|NCT02277769|16202929|P3|Overall Study|Protocol Violation|5
4702199|NCT02277769|16202930|P2|Overall Study|Protocol Violation|3
4702200|NCT02277769|16202931|P1|Overall Study|Protocol Violation|3
4702201|NCT02277743|16203002|P3|Overall Study|Other than specified above|16
4702202|NCT02277743|16203003|P2|Overall Study|Other than specified above|5
4702203|NCT02277743|16203004|P1|Overall Study|Other than specified above|18
4702204|NCT02277743|16203002|P3|Overall Study|Lack of Efficacy|3
4702205|NCT02277743|16203003|P2|Overall Study|Lack of Efficacy|4
4702206|NCT02277743|16203004|P1|Overall Study|Lack of Efficacy|11
4702207|NCT02277743|16203002|P3|Overall Study|Adverse Event|6
4702208|NCT02277743|16203003|P2|Overall Study|Adverse Event|6
4702209|NCT02277743|16203004|P1|Overall Study|Adverse Event|10
4702210|NCT02277743|16203002|P3|Overall Study|Protocol Violation|1
4702211|NCT02277743|16203003|P2|Overall Study|Protocol Violation|1
4702212|NCT02277743|16203004|P1|Overall Study|Protocol Violation|1
4702213|NCT02277691|16203072|P1|Overall Study|Used Other Antihypertensive Drug|1
4702214|NCT02277691|16203072|P1|Overall Study|Lack of Efficacy|5
4702215|NCT02277691|16203072|P1|Overall Study|Voluntary Withdrawal|7
4702216|NCT02277691|16203072|P1|Overall Study|Pretreatment Event/Adverse Event|33
4702217|NCT02277119|16203146|P3|Overall Study|Protocol Violation|7
4702218|NCT02277119|16203147|P2|Overall Study|Protocol Violation|3
4702219|NCT02277119|16203148|P1|Overall Study|Protocol Violation|2
4702220|NCT02277119|16203146|P3|Overall Study|Lack of Efficacy|1
4702221|NCT02277119|16203147|P2|Overall Study|Lack of Efficacy|1
4702222|NCT02277119|16203148|P1|Overall Study|Lack of Efficacy|1
4702223|NCT02276872|16203186|P3|Overall Study|Adverse Event|0
4702224|NCT02276872|16203187|P2|Overall Study|Adverse Event|0
4702225|NCT02276872|16203188|P1|Overall Study|Adverse Event|1
4702226|NCT02276807|16203264|P2|Overall Study|Lost to Follow-up|10
4702227|NCT02276807|16203265|P1|Overall Study|Lost to Follow-up|10
4702228|NCT02276807|16203264|P2|Overall Study|Withdrawal by Subject|7
4702229|NCT02276807|16203265|P1|Overall Study|Withdrawal by Subject|8
4702230|NCT02276612|16203300|P2|Overall Study|Lost to Follow-up|0
4702231|NCT02276612|16203301|P1|Overall Study|Lost to Follow-up|1
4702232|NCT02276612|16203300|P2|Overall Study|Withdrew Consent|0
4702233|NCT02276612|16203301|P1|Overall Study|Withdrew Consent|1
4702234|NCT02276612|16203300|P2|Overall Study|Pregnancy|0
4702235|NCT02276612|16203301|P1|Overall Study|Pregnancy|1
4702236|NCT02276612|16203300|P2|Overall Study|Death|0
4702237|NCT02276612|16203301|P1|Overall Study|Death|1
4702238|NCT02276560|16203324|P3|Overall Study|Adverse Event|0
4702239|NCT02276560|16203325|P2|Overall Study|Adverse Event|0
4702240|NCT02276560|16203326|P1|Overall Study|Adverse Event|1
4702241|NCT02276482|16203336|P2|Overall Study|Reason not specified|1
4702242|NCT02276482|16203337|P1|Overall Study|Reason not specified|0
4702243|NCT02276482|16203336|P2|Overall Study|Gram-negative infection|0
4702244|NCT02276482|16203337|P1|Overall Study|Gram-negative infection|1
4702245|NCT02276482|16203336|P2|Overall Study|Withdrawal by Subject|0
4702246|NCT02276482|16203337|P1|Overall Study|Withdrawal by Subject|1
4702247|NCT02276482|16203336|P2|Overall Study|Adverse Event|0
4702248|NCT02276482|16203337|P1|Overall Study|Adverse Event|1
4702249|NCT02276222|16203472|P2|Overall Study|subject withdrew after randomization|0
4702250|NCT02276222|16203473|P1|Overall Study|subject withdrew after randomization|1
4702251|NCT02276222|16203472|P2|Overall Study|sheduling conflict|0
4702252|NCT02276222|16203473|P1|Overall Study|sheduling conflict|1
4702253|NCT02276222|16203472|P2|Overall Study|Physician Decision|1
4702254|NCT02276222|16203473|P1|Overall Study|Physician Decision|2
4702255|NCT02276222|16203472|P2|Overall Study|Lost to Follow-up|5
4702256|NCT02276222|16203473|P1|Overall Study|Lost to Follow-up|15
4702257|NCT02276222|16203472|P2|Overall Study|sponsor decision|3
4702258|NCT02276222|16203473|P1|Overall Study|sponsor decision|0
4702259|NCT02276222|16203472|P2|Overall Study|non compliance with study medication|2
4702260|NCT02276222|16203473|P1|Overall Study|non compliance with study medication|6
4702261|NCT02276222|16203472|P2|Overall Study|Withdrawal by Subject|33
4702262|NCT02276222|16203473|P1|Overall Study|Withdrawal by Subject|79
4702263|NCT02276222|16203472|P2|Overall Study|Protocol Violation|2
4702264|NCT02276222|16203473|P1|Overall Study|Protocol Violation|3
4702265|NCT02276222|16203472|P2|Overall Study|Lack of Efficacy|3
4702266|NCT02276222|16203473|P1|Overall Study|Lack of Efficacy|13
4702267|NCT02276222|16203472|P2|Overall Study|Death|4
4702268|NCT02276222|16203473|P1|Overall Study|Death|3
4702269|NCT02276222|16203472|P2|Overall Study|Adverse Event|11
4702270|NCT02276222|16203473|P1|Overall Study|Adverse Event|62
4702271|NCT02276053|16203497|P1|Overall Study|Patient needs to increase baseline AED|1
4702272|NCT02276053|16203497|P1|Overall Study|Patient does not meet selection criteria|3
4702273|NCT02276053|16203497|P1|Overall Study|Withdrawal by Subject|1
4702274|NCT02276053|16203497|P1|Overall Study|Lack of Efficacy|2
4702275|NCT02276053|16203497|P1|Overall Study|Adverse Event|5
4702276|NCT02276053|16203497|P1|Overall Study|Death|2
4702277|NCT02276040|16203513|P1|Overall Study|Physician Decision|15
4702278|NCT02275780|16203524|P2|Extension Study: up to 192 Weeks|Ongoing|233
4702279|NCT02275780|16203525|P1|Extension Study: up to 192 Weeks|Ongoing|260
4702280|NCT02275780|16203524|P2|Base Study: 96 Weeks|Randomized not treated|1
4702281|NCT02275780|16203525|P1|Base Study: 96 Weeks|Randomized not treated|2
4702282|NCT02275780|16203524|P2|Base Study: 96 Weeks|Pregnancy|1
4702283|NCT02275780|16203525|P1|Base Study: 96 Weeks|Pregnancy|2
4702284|NCT02275780|16203524|P2|Base Study: 96 Weeks|Physician Decision|4
4702285|NCT02275780|16203525|P1|Base Study: 96 Weeks|Physician Decision|2
4702286|NCT02275780|16203524|P2|Base Study: 96 Weeks|Noncompliance with drug|6
4702287|NCT02275780|16203525|P1|Base Study: 96 Weeks|Noncompliance with drug|9
4702288|NCT02275780|16203524|P2|Base Study: 96 Weeks|Withdrawal by Subject|22
4702289|NCT02275780|16203525|P1|Base Study: 96 Weeks|Withdrawal by Subject|19
4702290|NCT02275780|16203524|P2|Base Study: 96 Weeks|Protocol Violation|6
4702291|NCT02275780|16203525|P1|Base Study: 96 Weeks|Protocol Violation|1
4702292|NCT02275780|16203524|P2|Base Study: 96 Weeks|Lost to Follow-up|24
4702293|NCT02275780|16203525|P1|Base Study: 96 Weeks|Lost to Follow-up|28
4702294|NCT02275780|16203524|P2|Base Study: 96 Weeks|Lack of Efficacy|32
4702295|NCT02275780|16203525|P1|Base Study: 96 Weeks|Lack of Efficacy|21
4702296|NCT02275780|16203524|P2|Base Study: 96 Weeks|Death|1
4702297|NCT02275780|16203525|P1|Base Study: 96 Weeks|Death|3
4702298|NCT02275780|16203524|P2|Base Study: 96 Weeks|Adverse Event|14
4702299|NCT02275780|16203525|P1|Base Study: 96 Weeks|Adverse Event|6
4702300|NCT02275611|16203581|P4|Inpatient Withdrawal|Withdrawal by Subject|0
4702301|NCT02275611|16203582|P3|Inpatient Withdrawal|Withdrawal by Subject|0
4702302|NCT02275611|16203583|P2|Inpatient Withdrawal|Withdrawal by Subject|0
4702303|NCT02275611|16203584|P1|Inpatient Withdrawal|Withdrawal by Subject|1
4702304|NCT02275546|16203596|P2|Treatment Period 2|Protocol Violation|1
4702305|NCT02275546|16203597|P1|Treatment Period 2|Protocol Violation|0
4702306|NCT02275546|16203596|P2|Treatment Period 2|Withdrawal by Subject|1
4702307|NCT02275546|16203597|P1|Treatment Period 2|Withdrawal by Subject|2
4702308|NCT02275481|16203607|P2|Overall Study|Physician Decision|1
4702309|NCT02275481|16203608|P1|Overall Study|Physician Decision|0
4702310|NCT02275481|16203607|P2|Overall Study|all other reasons combined|1
4702311|NCT02275481|16203608|P1|Overall Study|all other reasons combined|2
4702312|NCT02275481|16203607|P2|Overall Study|Withdrawal by Subject|0
4702313|NCT02275481|16203608|P1|Overall Study|Withdrawal by Subject|3
4702314|NCT02275481|16203607|P2|Overall Study|Lost to Follow-up|0
4702315|NCT02275481|16203608|P1|Overall Study|Lost to Follow-up|2
4702316|NCT02275481|16203607|P2|Overall Study|Death|1
4702317|NCT02275481|16203608|P1|Overall Study|Death|2
4702318|NCT02275364|16203614|P2|Period 1|Other reason|0
4702319|NCT02275364|16203615|P1|Period 1|Other reason|1
4702320|NCT02275364|16203614|P2|Period 1|Withdrawal by Subject|0
4702321|NCT02275364|16203615|P1|Period 1|Withdrawal by Subject|1
4702322|NCT02275338|16203644|P1|Overall Study|Does not meet entry criteria|1
4702323|NCT02275338|16203644|P1|Overall Study|Reason not specified|5
4702324|NCT02275338|16203644|P1|Overall Study|Ineligible to start Phase 2|4
4702325|NCT02275338|16203644|P1|Overall Study|Disease progression (death)|1
4702326|NCT02275338|16203644|P1|Overall Study|Withdrawal by Subject|4
4702327|NCT02275338|16203644|P1|Overall Study|Lack of Efficacy|3
4702328|NCT02275338|16203644|P1|Overall Study|Adverse Event|15
4702329|NCT01352221|16203658|P4|Open-label Phase|Worsening of IBD|0
4702330|NCT01352221|16203659|P3|Open-label Phase|Worsening of IBD|1
4702331|NCT01352221|16203660|P2|Open-label Phase|Worsening of IBD|0
4702332|NCT01352221|16203661|P1|Open-label Phase|Worsening of IBD|0
4702333|NCT01352221|16203658|P4|Open-label Phase|Withdrawal by Subject|6
4702334|NCT01352221|16203659|P3|Open-label Phase|Withdrawal by Subject|1
4702335|NCT01352221|16203660|P2|Open-label Phase|Withdrawal by Subject|0
4702336|NCT01352221|16203661|P1|Open-label Phase|Withdrawal by Subject|0
4702337|NCT01352221|16203658|P4|Open-label Phase|Adverse Event|4
4702338|NCT01352221|16203659|P3|Open-label Phase|Adverse Event|8
4702339|NCT01352221|16203660|P2|Open-label Phase|Adverse Event|0
4702340|NCT01352221|16203661|P1|Open-label Phase|Adverse Event|0
4702341|NCT01352221|16203658|P4|Open-label Phase|Pregnancy|0
4702342|NCT01352221|16203659|P3|Open-label Phase|Pregnancy|1
4702343|NCT01352221|16203660|P2|Open-label Phase|Pregnancy|0
4702344|NCT01352221|16203661|P1|Open-label Phase|Pregnancy|0
4702345|NCT01352221|16203658|P4|Open-label Phase|Physician Decision|1
4702346|NCT01352221|16203659|P3|Open-label Phase|Physician Decision|2
4702347|NCT01352221|16203660|P2|Open-label Phase|Physician Decision|0
4702348|NCT01352221|16203661|P1|Open-label Phase|Physician Decision|0
4702349|NCT01352221|16203658|P4|Double-blind Phase|Protocol Violation|0
4702350|NCT01352221|16203659|P3|Double-blind Phase|Protocol Violation|0
4702351|NCT01352221|16203660|P2|Double-blind Phase|Protocol Violation|1
4702352|NCT01352221|16203661|P1|Double-blind Phase|Protocol Violation|0
4702353|NCT01352221|16203658|P4|Double-blind Phase|Lost to Follow-up|0
4702354|NCT01352221|16203659|P3|Double-blind Phase|Lost to Follow-up|0
4702355|NCT01352221|16203660|P2|Double-blind Phase|Lost to Follow-up|1
4702356|NCT01352221|16203661|P1|Double-blind Phase|Lost to Follow-up|0
4702357|NCT01352221|16203658|P4|Double-blind Phase|Withdrawal by Subject|0
4702358|NCT01352221|16203659|P3|Double-blind Phase|Withdrawal by Subject|0
4702359|NCT01352221|16203660|P2|Double-blind Phase|Withdrawal by Subject|5
4702360|NCT01352221|16203661|P1|Double-blind Phase|Withdrawal by Subject|3
4702361|NCT01352221|16203658|P4|Double-blind Phase|Adverse Event|0
4702362|NCT01352221|16203659|P3|Double-blind Phase|Adverse Event|0
4702363|NCT01352221|16203660|P2|Double-blind Phase|Adverse Event|4
4702364|NCT01352221|16203661|P1|Double-blind Phase|Adverse Event|6
4702365|NCT02275117|16203756|P5|Overall Study|Other|2
4702366|NCT02275117|16203757|P4|Overall Study|Other|0
4702367|NCT02275117|16203758|P3|Overall Study|Other|0
4702368|NCT02275117|16203759|P2|Overall Study|Other|0
4702369|NCT02275117|16203760|P1|Overall Study|Other|1
4702370|NCT02275117|16203756|P5|Overall Study|Study Burden|7
4702371|NCT02275117|16203757|P4|Overall Study|Study Burden|5
4702372|NCT02275117|16203758|P3|Overall Study|Study Burden|7
4702373|NCT02275117|16203759|P2|Overall Study|Study Burden|4
4702374|NCT02275117|16203760|P1|Overall Study|Study Burden|5
4702375|NCT02275117|16203756|P5|Overall Study|Worsening of Study Indication|0
4702376|NCT02275117|16203757|P4|Overall Study|Worsening of Study Indication|0
4702377|NCT02275117|16203758|P3|Overall Study|Worsening of Study Indication|2
4702378|NCT02275117|16203759|P2|Overall Study|Worsening of Study Indication|1
4702379|NCT02275117|16203760|P1|Overall Study|Worsening of Study Indication|0
4702380|NCT02275117|16203756|P5|Overall Study|Terminated by Sponsor|4
4702381|NCT02275117|16203757|P4|Overall Study|Terminated by Sponsor|6
4702382|NCT02275117|16203758|P3|Overall Study|Terminated by Sponsor|4
4702383|NCT02275117|16203759|P2|Overall Study|Terminated by Sponsor|4
4702384|NCT02275117|16203760|P1|Overall Study|Terminated by Sponsor|4
4702385|NCT02275117|16203756|P5|Overall Study|Withdrawal by Subject|3
4702386|NCT02275117|16203757|P4|Overall Study|Withdrawal by Subject|3
4702387|NCT02275117|16203758|P3|Overall Study|Withdrawal by Subject|7
4702388|NCT02275117|16203759|P2|Overall Study|Withdrawal by Subject|4
4702389|NCT02275117|16203760|P1|Overall Study|Withdrawal by Subject|6
4702390|NCT02275117|16203756|P5|Overall Study|Protocol Violation|0
4702391|NCT02275117|16203757|P4|Overall Study|Protocol Violation|1
4702392|NCT02275117|16203758|P3|Overall Study|Protocol Violation|1
4702393|NCT02275117|16203759|P2|Overall Study|Protocol Violation|0
4702394|NCT02275117|16203760|P1|Overall Study|Protocol Violation|1
4702395|NCT02275117|16203756|P5|Overall Study|Physician Decision|1
4702396|NCT02275117|16203757|P4|Overall Study|Physician Decision|0
4702397|NCT02275117|16203758|P3|Overall Study|Physician Decision|1
4702398|NCT02275117|16203759|P2|Overall Study|Physician Decision|1
4702399|NCT02275117|16203760|P1|Overall Study|Physician Decision|0
4702400|NCT02275117|16203756|P5|Overall Study|Lost to Follow-up|8
4702401|NCT02275117|16203757|P4|Overall Study|Lost to Follow-up|16
4702402|NCT02275117|16203758|P3|Overall Study|Lost to Follow-up|15
4702403|NCT02275117|16203759|P2|Overall Study|Lost to Follow-up|16
4702404|NCT02275117|16203760|P1|Overall Study|Lost to Follow-up|11
4702405|NCT02275117|16203756|P5|Overall Study|Lack of Efficacy|10
4702406|NCT02275117|16203757|P4|Overall Study|Lack of Efficacy|2
4702407|NCT02275117|16203758|P3|Overall Study|Lack of Efficacy|5
4702408|NCT02275117|16203759|P2|Overall Study|Lack of Efficacy|7
4702409|NCT02275117|16203760|P1|Overall Study|Lack of Efficacy|6
4702410|NCT02275117|16203756|P5|Overall Study|Adverse Event|1
4702411|NCT02275117|16203757|P4|Overall Study|Adverse Event|0
4702412|NCT02275117|16203758|P3|Overall Study|Adverse Event|0
4702413|NCT02275117|16203759|P2|Overall Study|Adverse Event|0
4702414|NCT02275117|16203760|P1|Overall Study|Adverse Event|0
4702415|NCT02275065|16203872|P5|Overall Study|Randomized but not treated|0
4702416|NCT02275065|16203873|P4|Overall Study|Randomized but not treated|1
4702417|NCT02275065|16203874|P3|Overall Study|Randomized but not treated|1
4702418|NCT02275065|16203875|P2|Overall Study|Randomized but not treated|0
4702419|NCT02275065|16203876|P1|Overall Study|Randomized but not treated|1
4702420|NCT02275052|16203957|P4|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2
4702421|NCT02275052|16203958|P3|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4702422|NCT02275052|16203959|P2|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4702423|NCT02275052|16203960|P1|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4702424|NCT02275052|16203957|P4|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6
4702425|NCT02275052|16203958|P3|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4702426|NCT02275052|16203959|P2|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4702427|NCT02275052|16203960|P1|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4702428|NCT02275052|16203957|P4|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4
4702429|NCT02275052|16203958|P3|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4702430|NCT02275052|16203959|P2|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4702431|NCT02275052|16203960|P1|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4702432|NCT02275052|16203957|P4|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2
4702433|NCT02275052|16203958|P3|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3
4702434|NCT02275052|16203959|P2|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
4702435|NCT02275052|16203960|P1|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0
4702436|NCT02275052|16203957|P4|Washout Period (12-17 Days)|Lack of Efficacy|0
4702437|NCT02275052|16203958|P3|Washout Period (12-17 Days)|Lack of Efficacy|0
4702438|NCT02275052|16203959|P2|Washout Period (12-17 Days)|Lack of Efficacy|0
4702439|NCT02275052|16203960|P1|Washout Period (12-17 Days)|Lack of Efficacy|1
4702440|NCT02275052|16203957|P4|Washout Period (12-17 Days)|Withdrawal by Subject|0
4702441|NCT02275052|16203958|P3|Washout Period (12-17 Days)|Withdrawal by Subject|0
4702442|NCT02275052|16203959|P2|Washout Period (12-17 Days)|Withdrawal by Subject|0
4702443|NCT02275052|16203960|P1|Washout Period (12-17 Days)|Withdrawal by Subject|3
4702444|NCT02275052|16203957|P4|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4702445|NCT02275052|16203958|P3|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4702446|NCT02275052|16203959|P2|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0
4702447|NCT02275052|16203960|P1|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2
4702448|NCT02275052|16203957|P4|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4702449|NCT02275052|16203958|P3|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4702450|NCT02275052|16203959|P2|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0
4702451|NCT02275052|16203960|P1|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1
4702452|NCT02275052|16203957|P4|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4702453|NCT02275052|16203958|P3|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4702454|NCT02275052|16203959|P2|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4
4702455|NCT02275052|16203960|P1|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6
4702456|NCT02275052|16203957|P4|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4702457|NCT02275052|16203958|P3|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4702458|NCT02275052|16203959|P2|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1
4702459|NCT02275052|16203960|P1|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0
4702460|NCT02275052|16203957|P4|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4702461|NCT02275052|16203958|P3|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4702462|NCT02275052|16203959|P2|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4702463|NCT02275052|16203960|P1|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4702464|NCT02274948|16203974|P2|Overall Study|Left the area|3
4702465|NCT02274948|16203975|P1|Overall Study|Left the area|4
4702466|NCT02274948|16203974|P2|Overall Study|Stopped on family Practitioner advice|5
4702467|NCT02274948|16203975|P1|Overall Study|Stopped on family Practitioner advice|2
4702468|NCT02274948|16203974|P2|Overall Study|Withdrawal by Subject|58
4702469|NCT02274948|16203975|P1|Overall Study|Withdrawal by Subject|64
4702470|NCT02274948|16203974|P2|Overall Study|Lost to Follow-up|25
4702471|NCT02274948|16203975|P1|Overall Study|Lost to Follow-up|28
4702472|NCT02274857|16204018|P2|Overall Study|Other|0
4702473|NCT02274857|16204019|P1|Overall Study|Other|2
4702474|NCT02274857|16204018|P2|Overall Study|Withdrawal by Subject|2
4702475|NCT02274857|16204019|P1|Overall Study|Withdrawal by Subject|11
4702476|NCT02274857|16204018|P2|Overall Study|Trial screen failure|2
4702477|NCT02274857|16204019|P1|Overall Study|Trial screen failure|0
4702478|NCT02274857|16204018|P2|Overall Study|Physician Decision|0
4702479|NCT02274857|16204019|P1|Overall Study|Physician Decision|2
4702480|NCT02274857|16204018|P2|Overall Study|Lost to Follow-up|0
4702481|NCT02274857|16204019|P1|Overall Study|Lost to Follow-up|3
4702482|NCT02274857|16204018|P2|Overall Study|Death|2
4702483|NCT02274857|16204019|P1|Overall Study|Death|1
4702484|NCT02274857|16204018|P2|Overall Study|Adverse Event|0
4702485|NCT02274857|16204019|P1|Overall Study|Adverse Event|1
4702486|NCT02274792|16204032|P1|Overall Study|Sponsor Decision|2
4702487|NCT02274792|16204032|P1|Overall Study|Protocol Specified Criteria|2
4702488|NCT02274792|16204032|P1|Overall Study|Lost to Follow-up|8
4702489|NCT02274792|16204032|P1|Overall Study|Withdrawal by Subject|13
4702490|NCT02274766|16204042|P2|Overall Study|Adverse Event|1
4702491|NCT02274766|16204043|P1|Overall Study|Adverse Event|0
4702492|NCT02274766|16204042|P2|Overall Study|Subject Unwilling to Proceed|1
4702493|NCT02274766|16204043|P1|Overall Study|Subject Unwilling to Proceed|0
4702494|NCT02274766|16204042|P2|Overall Study|Did Not Receive Study Drug|1
4702495|NCT02274766|16204043|P1|Overall Study|Did Not Receive Study Drug|1
4702496|NCT02274766|16204042|P2|Overall Study|Withdrawal by Subject|6
4702497|NCT02274766|16204043|P1|Overall Study|Withdrawal by Subject|3
4702498|NCT02274558|16204110|P3|Overall Study|Physician Decision|1
4702499|NCT02274558|16204111|P2|Overall Study|Physician Decision|2
4702500|NCT02274558|16204112|P1|Overall Study|Physician Decision|0
4702501|NCT02274558|16204110|P3|Overall Study|Lost to Follow-up|1
4702502|NCT02274558|16204111|P2|Overall Study|Lost to Follow-up|1
4702503|NCT02274558|16204112|P1|Overall Study|Lost to Follow-up|2
4702504|NCT02274558|16204110|P3|Overall Study|Death|1
4702505|NCT02274558|16204111|P2|Overall Study|Death|0
4702506|NCT02274558|16204112|P1|Overall Study|Death|0
4702507|NCT02274558|16204110|P3|Overall Study|Withdrawal by Subject|4
4702508|NCT02274558|16204111|P2|Overall Study|Withdrawal by Subject|5
4702509|NCT02274558|16204112|P1|Overall Study|Withdrawal by Subject|1
4702510|NCT02274558|16204110|P3|Overall Study|Non-compliance|0
4702511|NCT02274558|16204111|P2|Overall Study|Non-compliance|1
4702512|NCT02274558|16204112|P1|Overall Study|Non-compliance|2
4702513|NCT02274558|16204110|P3|Overall Study|Adverse Event|2
4702514|NCT02274558|16204111|P2|Overall Study|Adverse Event|4
4702515|NCT02274558|16204112|P1|Overall Study|Adverse Event|2
4702516|NCT02274493|16204126|P1|Overall Study|Withdrawal by Subject|1
4702517|NCT02274311|16204133|P1|Three Months of Clomiphene Wash-out|Lost to Follow-up|1
4702518|NCT02273973|16204141|P2|Overall Study|Reason not specified|1
4702519|NCT02273973|16204142|P1|Overall Study|Reason not specified|0
4702520|NCT02273973|16204141|P2|Overall Study|Physician Decision|1
4702521|NCT02273973|16204142|P1|Overall Study|Physician Decision|0
4702522|NCT02273973|16204141|P2|Overall Study|Lost to Follow-up|1
4702523|NCT02273973|16204142|P1|Overall Study|Lost to Follow-up|0
4702524|NCT02273973|16204141|P2|Overall Study|Progression of disease|2
4702525|NCT02273973|16204142|P1|Overall Study|Progression of disease|0
4702526|NCT02273973|16204141|P2|Overall Study|Protocol Violation|0
4702527|NCT02273973|16204142|P1|Overall Study|Protocol Violation|1
4702528|NCT02273973|16204141|P2|Overall Study|Non-compliance|0
4702529|NCT02273973|16204142|P1|Overall Study|Non-compliance|1
4702530|NCT02273973|16204141|P2|Overall Study|Death|0
4702531|NCT02273973|16204142|P1|Overall Study|Death|1
4702532|NCT02273973|16204141|P2|Overall Study|Withdrawal by Subject|3
4702533|NCT02273973|16204142|P1|Overall Study|Withdrawal by Subject|2
4702534|NCT02273973|16204141|P2|Overall Study|Adverse Event|0
4702535|NCT02273973|16204142|P1|Overall Study|Adverse Event|4
4702536|NCT02273960|16204186|P4|Long Term Extension|Death|1
4702537|NCT02273960|16204187|P3|Long Term Extension|Death|0
4702538|NCT02273960|16204188|P2|Long Term Extension|Death|0
4702539|NCT02273960|16204189|P1|Long Term Extension|Death|0
4702540|NCT02273960|16204186|P4|Short Term Period|ST complete, not entering LTE|5
4702541|NCT02273960|16204187|P3|Short Term Period|ST complete, not entering LTE|4
4702542|NCT02273960|16204188|P2|Short Term Period|ST complete, not entering LTE|6
4702543|NCT02273960|16204189|P1|Short Term Period|ST complete, not entering LTE|4
4702544|NCT02273960|16204186|P4|Short Term Period|Lack of Efficacy|1
4702545|NCT02273960|16204187|P3|Short Term Period|Lack of Efficacy|0
4702546|NCT02273960|16204188|P2|Short Term Period|Lack of Efficacy|0
4702547|NCT02273960|16204189|P1|Short Term Period|Lack of Efficacy|0
4702548|NCT02273960|16204186|P4|Short Term Period|Lost to Follow-up|0
4702549|NCT02273960|16204187|P3|Short Term Period|Lost to Follow-up|0
4702550|NCT02273960|16204188|P2|Short Term Period|Lost to Follow-up|0
4702551|NCT02273960|16204189|P1|Short Term Period|Lost to Follow-up|1
4702552|NCT02273908|16204233|P2|Overall Study|Withdrawal by Subject|2
4702553|NCT02273908|16204234|P1|Overall Study|Withdrawal by Subject|4
4702554|NCT02273908|16204233|P2|Overall Study|Did not meet entrance criteria|2
4702555|NCT02273908|16204234|P1|Overall Study|Did not meet entrance criteria|3
4702556|NCT02273908|16204233|P2|Overall Study|Lost to Follow-up|1
4702557|NCT02273908|16204234|P1|Overall Study|Lost to Follow-up|10
4702558|NCT02273908|16204233|P2|Overall Study|Adverse Event|0
4702559|NCT02273908|16204234|P1|Overall Study|Adverse Event|16
4702560|NCT01340872|16204258|P4|Open-label Phase|Worsening of IBD|0
4702561|NCT01340872|16204259|P3|Open-label Phase|Worsening of IBD|1
4702562|NCT01340872|16204260|P2|Open-label Phase|Worsening of IBD|0
4702563|NCT01340872|16204261|P1|Open-label Phase|Worsening of IBD|0
4702564|NCT01340872|16204258|P4|Open-label Phase|Withdrawal by Subject|6
4702565|NCT01340872|16204259|P3|Open-label Phase|Withdrawal by Subject|1
4702566|NCT01340872|16204260|P2|Open-label Phase|Withdrawal by Subject|0
4702567|NCT01340872|16204261|P1|Open-label Phase|Withdrawal by Subject|0
4702568|NCT01340872|16204258|P4|Open-label Phase|Adverse Event|4
4702569|NCT01340872|16204259|P3|Open-label Phase|Adverse Event|8
4702570|NCT01340872|16204260|P2|Open-label Phase|Adverse Event|0
4702571|NCT01340872|16204261|P1|Open-label Phase|Adverse Event|0
4702572|NCT01340872|16204258|P4|Open-label Phase|Pregnancy|0
4702573|NCT01340872|16204259|P3|Open-label Phase|Pregnancy|1
4702574|NCT01340872|16204260|P2|Open-label Phase|Pregnancy|0
4702575|NCT01340872|16204261|P1|Open-label Phase|Pregnancy|0
4702576|NCT01340872|16204258|P4|Open-label Phase|Physician Decision|1
4702577|NCT01340872|16204259|P3|Open-label Phase|Physician Decision|2
4702578|NCT01340872|16204260|P2|Open-label Phase|Physician Decision|0
4702579|NCT01340872|16204261|P1|Open-label Phase|Physician Decision|0
4702580|NCT01340872|16204258|P4|Double-blind Phase|Protocol Violation|0
4702581|NCT01340872|16204259|P3|Double-blind Phase|Protocol Violation|0
4702582|NCT01340872|16204260|P2|Double-blind Phase|Protocol Violation|1
4702583|NCT01340872|16204261|P1|Double-blind Phase|Protocol Violation|0
4702584|NCT01340872|16204258|P4|Double-blind Phase|Lost to Follow-up|0
4702585|NCT01340872|16204259|P3|Double-blind Phase|Lost to Follow-up|0
4702586|NCT01340872|16204260|P2|Double-blind Phase|Lost to Follow-up|1
4702587|NCT01340872|16204261|P1|Double-blind Phase|Lost to Follow-up|0
4702588|NCT01340872|16204258|P4|Double-blind Phase|Withdrawal by Subject|0
4702589|NCT01340872|16204259|P3|Double-blind Phase|Withdrawal by Subject|0
4702590|NCT01340872|16204260|P2|Double-blind Phase|Withdrawal by Subject|5
4702591|NCT01340872|16204261|P1|Double-blind Phase|Withdrawal by Subject|3
4702592|NCT01340872|16204258|P4|Double-blind Phase|Adverse Event|0
4702593|NCT01340872|16204259|P3|Double-blind Phase|Adverse Event|0
4702594|NCT01340872|16204260|P2|Double-blind Phase|Adverse Event|4
4702595|NCT01340872|16204261|P1|Double-blind Phase|Adverse Event|6
4702596|NCT02273752|16204319|P1|Overall Study|Trial was terminated early|2
4702597|NCT02273180|16204410|P2|Overall Study|Other than specified above|10
4702598|NCT02273180|16204411|P1|Overall Study|Other than specified above|21
4702599|NCT02273180|16204410|P2|Overall Study|Hypoglycemia(not reported as serious AE)|0
4702600|NCT02273180|16204411|P1|Overall Study|Hypoglycemia(not reported as serious AE)|1
4702601|NCT02273180|16204410|P2|Overall Study|Randomized but not treated|0
4702602|NCT02273180|16204411|P1|Overall Study|Randomized but not treated|1
4702603|NCT02273180|16204410|P2|Overall Study|Protocol Violation|7
4702604|NCT02273180|16204411|P1|Overall Study|Protocol Violation|1
4702605|NCT02273180|16204410|P2|Overall Study|Lack of Efficacy|0
4702606|NCT02273180|16204411|P1|Overall Study|Lack of Efficacy|1
4702607|NCT02273180|16204410|P2|Overall Study|Adverse Event|2
4702608|NCT02273180|16204411|P1|Overall Study|Adverse Event|2
4702609|NCT02273167|16204436|P3|Overall Study|Various|8
4702610|NCT02273167|16204437|P2|Overall Study|Various|9
4702611|NCT02273167|16204438|P1|Overall Study|Various|10
4702612|NCT02273167|16204436|P3|Overall Study|Withdrawal by Subject|11
4702613|NCT02273167|16204437|P2|Overall Study|Withdrawal by Subject|12
4702614|NCT02273167|16204438|P1|Overall Study|Withdrawal by Subject|10
4702615|NCT02273167|16204436|P3|Overall Study|Lost to Follow-up|1
4702616|NCT02273167|16204437|P2|Overall Study|Lost to Follow-up|1
4702617|NCT02273167|16204438|P1|Overall Study|Lost to Follow-up|0
4702618|NCT02273167|16204436|P3|Overall Study|Protocol Violation|1
4702619|NCT02273167|16204437|P2|Overall Study|Protocol Violation|1
4702620|NCT02273167|16204438|P1|Overall Study|Protocol Violation|3
4702621|NCT02273167|16204436|P3|Overall Study|Adverse Event|0
4702622|NCT02273167|16204437|P2|Overall Study|Adverse Event|0
4702623|NCT02273167|16204438|P1|Overall Study|Adverse Event|1
4702624|NCT02273141|16204463|P2|Overall Study|Various|6
4702625|NCT02273141|16204464|P1|Overall Study|Various|6
4702626|NCT02273141|16204463|P2|Overall Study|Withdrawal by Subject|15
4702627|NCT02273141|16204464|P1|Overall Study|Withdrawal by Subject|10
4702628|NCT02273141|16204463|P2|Overall Study|Lost to Follow-up|3
4702629|NCT02273141|16204464|P1|Overall Study|Lost to Follow-up|1
4702630|NCT02273141|16204463|P2|Overall Study|Adverse Event|1
4702631|NCT02273141|16204464|P1|Overall Study|Adverse Event|0
4702632|NCT02273050|16204537|P3|Overall Study|Protocol Violation|4
4702633|NCT02273050|16204538|P2|Overall Study|Protocol Violation|1
4702634|NCT02273050|16204539|P1|Overall Study|Protocol Violation|3
4702635|NCT02273050|16204537|P3|Overall Study|Lost to Follow-up|3
4702636|NCT02273050|16204538|P2|Overall Study|Lost to Follow-up|2
4702637|NCT02273050|16204539|P1|Overall Study|Lost to Follow-up|0
4702638|NCT02273050|16204537|P3|Overall Study|Withdrawal by Subject|16
4702639|NCT02273050|16204538|P2|Overall Study|Withdrawal by Subject|14
4702640|NCT02273050|16204539|P1|Overall Study|Withdrawal by Subject|17
4702641|NCT02273050|16204537|P3|Overall Study|Lack of Efficacy|1
4702642|NCT02273050|16204538|P2|Overall Study|Lack of Efficacy|1
4702643|NCT02273050|16204539|P1|Overall Study|Lack of Efficacy|0
4702644|NCT02273050|16204537|P3|Overall Study|Dev. of study spec. withdrawal criteria|1
4702645|NCT02273050|16204538|P2|Overall Study|Dev. of study spec. withdrawal criteria|1
4702646|NCT02273050|16204539|P1|Overall Study|Dev. of study spec. withdrawal criteria|0
4702647|NCT02273050|16204537|P3|Overall Study|Death|1
4702648|NCT02273050|16204538|P2|Overall Study|Death|0
4702649|NCT02273050|16204539|P1|Overall Study|Death|0
4702650|NCT02273050|16204537|P3|Overall Study|Adverse Event|3
4702651|NCT02273050|16204538|P2|Overall Study|Adverse Event|3
4702652|NCT02273050|16204539|P1|Overall Study|Adverse Event|4
4702653|NCT02273037|16204567|P2|Overall Study|Other complication|0
4702654|NCT02273037|16204568|P1|Overall Study|Other complication|2
4702655|NCT02273037|16204567|P2|Overall Study|Multiple delivery|2
4702656|NCT02273037|16204568|P1|Overall Study|Multiple delivery|2
4702657|NCT02273037|16204567|P2|Overall Study|Breech delivery|3
4702658|NCT02273037|16204568|P1|Overall Study|Breech delivery|2
4702659|NCT02273037|16204567|P2|Overall Study|Delivered before monitoring initiated|3
4702660|NCT02273037|16204568|P1|Overall Study|Delivered before monitoring initiated|1
4702661|NCT02273037|16204567|P2|Overall Study|Lost to Follow-up|0
4702662|NCT02273037|16204568|P1|Overall Study|Lost to Follow-up|1
4702663|NCT02272985|16204578|P1|Overall Study|kidney transplantation|1
4702664|NCT02272985|16204578|P1|Overall Study|hip fracture|1
4702665|NCT02272985|16204578|P1|Overall Study|Withdrawal by Subject|1
4702666|NCT02272816|16204583|P1|Overall Study|Adverse Event|1
4702667|NCT02272803|16204591|P2|Overall Study|Withdrawal by Subject|0
4702668|NCT02272803|16204592|P1|Overall Study|Withdrawal by Subject|1
4702669|NCT02272803|16204591|P2|Overall Study|Poor/non-compliance|1
4702670|NCT02272803|16204592|P1|Overall Study|Poor/non-compliance|0
4702671|NCT02272803|16204591|P2|Overall Study|Subject moved to care facility|1
4702672|NCT02272803|16204592|P1|Overall Study|Subject moved to care facility|0
4702673|NCT02272803|16204591|P2|Overall Study|Maximum clinical benefit|1
4702674|NCT02272803|16204592|P1|Overall Study|Maximum clinical benefit|1
4702675|NCT02272803|16204591|P2|Overall Study|Subj request to discontinue study trt|4
4702676|NCT02272803|16204592|P1|Overall Study|Subj request to discontinue study trt|1
4702677|NCT02272803|16204591|P2|Overall Study|Study drug toxicity|4
4702678|NCT02272803|16204592|P1|Overall Study|Study drug toxicity|1
4702679|NCT02272803|16204591|P2|Overall Study|Adverse Event unrelated to study drug|4
4702680|NCT02272803|16204592|P1|Overall Study|Adverse Event unrelated to study drug|1
4702681|NCT02272803|16204591|P2|Overall Study|Disease progression|2
4702682|NCT02272803|16204592|P1|Overall Study|Disease progression|4
4702683|NCT02272790|16204609|P6|Overall Study|Physician Decision|0
4702684|NCT02272790|16204610|P5|Overall Study|Physician Decision|0
4702685|NCT02272790|16204611|P4|Overall Study|Physician Decision|0
4702686|NCT02272790|16204612|P3|Overall Study|Physician Decision|0
4702687|NCT02272790|16204613|P2|Overall Study|Physician Decision|1
4702688|NCT02272790|16204614|P1|Overall Study|Physician Decision|0
4702689|NCT02272777|16204750|P2|Overall Study|Other|0
4702690|NCT02272777|16204751|P1|Overall Study|Other|2
4702691|NCT02272777|16204750|P2|Overall Study|Lost to Follow-up|0
4702692|NCT02272777|16204751|P1|Overall Study|Lost to Follow-up|2
4702693|NCT02272777|16204750|P2|Overall Study|Withdrawal by Subject|3
4702694|NCT02272777|16204751|P1|Overall Study|Withdrawal by Subject|0
4702695|NCT02272777|16204750|P2|Overall Study|Adverse Event|1
4702696|NCT02272777|16204751|P1|Overall Study|Adverse Event|0
4702697|NCT02272725|16204759|P2|Overall Study|equipment malfunction|0
4702698|NCT02272725|16204760|P1|Overall Study|equipment malfunction|2
4702699|NCT02272413|16204777|P2|Post-switch Period|Other than listed|5
4702700|NCT02272413|16204778|P1|Post-switch Period|Other than listed|4
4702701|NCT02272413|16204777|P2|Post-switch Period|Study terminated by sponsor|11
4702702|NCT02272413|16204778|P1|Post-switch Period|Study terminated by sponsor|8
4702703|NCT02272413|16204777|P2|Post-switch Period|Progressive disease|21
4702704|NCT02272413|16204778|P1|Post-switch Period|Progressive disease|21
4702705|NCT02272413|16204777|P2|Post-switch Period|Physician Decision|1
4702706|NCT02272413|16204778|P1|Post-switch Period|Physician Decision|1
4702707|NCT02272413|16204777|P2|Post-switch Period|Withdrawal by Subject|2
4702708|NCT02272413|16204778|P1|Post-switch Period|Withdrawal by Subject|1
4702709|NCT02272413|16204777|P2|Post-switch Period|Death|2
4702710|NCT02272413|16204778|P1|Post-switch Period|Death|3
4702711|NCT02272413|16204777|P2|Post-switch Period|Adverse Event|4
4702712|NCT02272413|16204778|P1|Post-switch Period|Adverse Event|4
4702713|NCT02272413|16204777|P2|Pre-switch Period|Other than listed|11
4702714|NCT02272413|16204778|P1|Pre-switch Period|Other than listed|10
4702715|NCT02272413|16204777|P2|Pre-switch Period|Protocol Violation|0
4702716|NCT02272413|16204778|P1|Pre-switch Period|Protocol Violation|1
4702717|NCT02272413|16204777|P2|Pre-switch Period|Lost to Follow-up|2
4702718|NCT02272413|16204778|P1|Pre-switch Period|Lost to Follow-up|0
4702719|NCT02272413|16204777|P2|Pre-switch Period|Progressive disease|173
4702720|NCT02272413|16204778|P1|Pre-switch Period|Progressive disease|185
4702721|NCT02272413|16204777|P2|Pre-switch Period|Physician Decision|18
4702722|NCT02272413|16204778|P1|Pre-switch Period|Physician Decision|6
4702723|NCT02272413|16204777|P2|Pre-switch Period|Withdrawal by Subject|15
4702724|NCT02272413|16204778|P1|Pre-switch Period|Withdrawal by Subject|27
4702725|NCT02272413|16204777|P2|Pre-switch Period|Death|26
4702726|NCT02272413|16204778|P1|Pre-switch Period|Death|26
4702727|NCT02272413|16204777|P2|Pre-switch Period|Adverse Event|37
4702728|NCT02272413|16204778|P1|Pre-switch Period|Adverse Event|38
4702729|NCT02272413|16204777|P2|Randomized Through Treatment Start|Not treated|5
4702730|NCT02272413|16204778|P1|Randomized Through Treatment Start|Not treated|3
4702731|NCT02271984|16204809|P12|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702732|NCT02271984|16204810|P11|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702733|NCT02271984|16204811|P10|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702734|NCT02271984|16204812|P9|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702735|NCT02271984|16204813|P8|Washout Period 4 (7 Days)|Withdrawal by Subject|1
4702736|NCT02271984|16204814|P7|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702737|NCT02271984|16204815|P6|Washout Period 4 (7 Days)|Withdrawal by Subject|1
4702738|NCT02271984|16204816|P5|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702739|NCT02271984|16204817|P4|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702740|NCT02271984|16204818|P3|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702741|NCT02271984|16204819|P2|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702742|NCT02271984|16204820|P1|Washout Period 4 (7 Days)|Withdrawal by Subject|0
4702743|NCT02271945|16204909|P2|Overall Study|Other|1
4702744|NCT02271945|16204910|P1|Overall Study|Other|1
4702745|NCT02271945|16204909|P2|Overall Study|Withdrawal by Subject|1
4702746|NCT02271945|16204910|P1|Overall Study|Withdrawal by Subject|1
4702747|NCT02271945|16204909|P2|Overall Study|Death|3
4702748|NCT02271945|16204910|P1|Overall Study|Death|3
4702749|NCT02271880|16204953|P2|Overall Study|Premature discontinuation of study|4
4702750|NCT02271880|16204954|P1|Overall Study|Premature discontinuation of study|3
4702751|NCT02271854|16204984|P1|Overall Study|Lost to Follow-up|1
4702752|NCT02271854|16204984|P1|Overall Study|Unable or unwilling to cooperate with st|1
4702753|NCT02271854|16204984|P1|Overall Study|Withdrawal by Subject|2
4702754|NCT02271529|16205024|P1|Overall Study|Withdrawal by Subject|1
4702755|NCT01310127|16205144|P2|Overall Study|advanced psc cataract outlier|0
4702756|NCT01310127|16205145|P1|Overall Study|advanced psc cataract outlier|1
4702757|NCT01310127|16205144|P2|Overall Study|Protocol Violation|1
4702758|NCT01310127|16205145|P1|Overall Study|Protocol Violation|1
4702759|NCT02270983|16205160|P3|Overall Study|moved away from study site|0
4702760|NCT02270983|16205161|P2|Overall Study|moved away from study site|1
4702761|NCT02270983|16205162|P1|Overall Study|moved away from study site|0
4702762|NCT02270983|16205160|P3|Overall Study|study procedure non-compliance|0
4702763|NCT02270983|16205161|P2|Overall Study|study procedure non-compliance|0
4702764|NCT02270983|16205162|P1|Overall Study|study procedure non-compliance|1
4702765|NCT02270983|16205160|P3|Overall Study|family emergency|0
4702766|NCT02270983|16205161|P2|Overall Study|family emergency|1
4702767|NCT02270983|16205162|P1|Overall Study|family emergency|0
4702768|NCT02270983|16205160|P3|Overall Study|Protocol Violation|1
4702769|NCT02270983|16205161|P2|Overall Study|Protocol Violation|1
4702770|NCT02270983|16205162|P1|Overall Study|Protocol Violation|1
4702771|NCT02270983|16205160|P3|Overall Study|Lost to Follow-up|2
4702772|NCT02270983|16205161|P2|Overall Study|Lost to Follow-up|1
4702773|NCT02270983|16205162|P1|Overall Study|Lost to Follow-up|1
4702774|NCT02270983|16205160|P3|Overall Study|Withdrawal by Subject|2
4702775|NCT02270983|16205161|P2|Overall Study|Withdrawal by Subject|0
4702776|NCT02270983|16205162|P1|Overall Study|Withdrawal by Subject|1
4702777|NCT02270983|16205160|P3|Overall Study|Lack of Efficacy|1
4702778|NCT02270983|16205161|P2|Overall Study|Lack of Efficacy|1
4702779|NCT02270983|16205162|P1|Overall Study|Lack of Efficacy|2
4702780|NCT02270983|16205160|P3|Overall Study|Adverse Event|6
4702781|NCT02270983|16205161|P2|Overall Study|Adverse Event|2
4702782|NCT02270983|16205162|P1|Overall Study|Adverse Event|3
4702783|NCT02270944|16205187|P2|Overall Study|Withdrawal by Subject|1
4702784|NCT02270944|16205188|P1|Overall Study|Withdrawal by Subject|2
4702785|NCT02270944|16205187|P2|Overall Study|Lost to Follow-up|4
4702786|NCT02270944|16205188|P1|Overall Study|Lost to Follow-up|9
4702787|NCT02270684|16205206|P2|Overall Study|Study terminated|0
4702788|NCT02270684|16205207|P1|Overall Study|Study terminated|1
4702789|NCT02270684|16205206|P2|Overall Study|Lost to Follow-up|3
4702790|NCT02270684|16205207|P1|Overall Study|Lost to Follow-up|0
4702791|NCT02270671|16205215|P2|Overall Study|Lost to Follow-up|1
4702792|NCT02270671|16205216|P1|Overall Study|Lost to Follow-up|2
4702793|NCT02270671|16205215|P2|Overall Study|Missed Post-intervention Data Collection|2
4702794|NCT02270671|16205216|P1|Overall Study|Missed Post-intervention Data Collection|2
4702795|NCT02270671|16205215|P2|Overall Study|Protocol Violation|1
4702796|NCT02270671|16205216|P1|Overall Study|Protocol Violation|0
4702797|NCT02270671|16205215|P2|Overall Study|Withdrawal by Subject|1
4702798|NCT02270671|16205216|P1|Overall Study|Withdrawal by Subject|1
4702799|NCT02270515|16205241|P1|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16
4702800|NCT02270515|16205241|P1|Intervention Period 3: 12-18 Months|Death|3
4702801|NCT02270515|16205241|P1|Intervention Period 3: 12-18 Months|Received transplant|2
4702802|NCT02270515|16205241|P1|Intervention Period 3: 12-18 Months|No longer patient at study site|2
4702803|NCT02270515|16205241|P1|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1
4702804|NCT02270515|16205241|P1|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17
4702805|NCT02270515|16205241|P1|Intervention Period 2: 6-12 Months|Death|5
4702806|NCT02270515|16205241|P1|Intervention Period 2: 6-12 Months|Received transplant|1
4702807|NCT02270515|16205241|P1|Intervention Period 2: 6-12 Months|No longer patient at study site|7
4702808|NCT02270515|16205241|P1|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2
4702809|NCT02270515|16205241|P1|Intervention Period 1: 0-6 Months|Death|7
4702810|NCT02270515|16205241|P1|Intervention Period 1: 0-6 Months|Received transplant|3
4702811|NCT02270515|16205241|P1|Intervention Period 1: 0-6 Months|No longer patient at study site|5
4702812|NCT02270515|16205241|P1|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1
4702813|NCT02270242|16205269|P2|Overall Study|Physician Decision|1
4702814|NCT02270242|16205270|P1|Overall Study|Physician Decision|0
4702815|NCT02270242|16205269|P2|Overall Study|Lost to Follow-up|27
4702816|NCT02270242|16205270|P1|Overall Study|Lost to Follow-up|41
4702817|NCT02270242|16205269|P2|Overall Study|Withdrawal by Subject|25
4702818|NCT02270242|16205270|P1|Overall Study|Withdrawal by Subject|18
4702819|NCT02269943|16205311|P2|Follow-Up Survival Period|Alive|8
4702820|NCT02269943|16205312|P1|Follow-Up Survival Period|Alive|2
4702821|NCT02269943|16205311|P2|Follow-Up Survival Period|Lost to Follow-up|2
4702822|NCT02269943|16205312|P1|Follow-Up Survival Period|Lost to Follow-up|0
4702823|NCT02269943|16205311|P2|Follow-Up Survival Period|Death|16
4702824|NCT02269943|16205312|P1|Follow-Up Survival Period|Death|3
4702825|NCT02269943|16205311|P2|Treatment Period|Symptomatic Deterioration|2
4702826|NCT02269943|16205312|P1|Treatment Period|Symptomatic Deterioration|0
4702827|NCT02269943|16205311|P2|Treatment Period|Progressive Disease|17
4702828|NCT02269943|16205312|P1|Treatment Period|Progressive Disease|5
4702829|NCT02269943|16205311|P2|Treatment Period|Adverse Event|10
4702830|NCT02269943|16205312|P1|Treatment Period|Adverse Event|1
4702831|NCT02269943|16205311|P2|Treatment Period|Death|1
4702832|NCT02269943|16205312|P1|Treatment Period|Death|0
4702833|NCT02269917|16205342|P2|Overall Study|Randomized but not treated|5
4702834|NCT02269917|16205343|P1|Overall Study|Randomized but not treated|3
4702835|NCT02269917|16205342|P2|Overall Study|Non-compliance with study drug|0
4702836|NCT02269917|16205343|P1|Overall Study|Non-compliance with study drug|2
4702837|NCT02269917|16205342|P2|Overall Study|Adverse Event|4
4702838|NCT02269917|16205343|P1|Overall Study|Adverse Event|11
4702839|NCT02269917|16205342|P2|Overall Study|Withdrawal by Subject|8
4702840|NCT02269917|16205343|P1|Overall Study|Withdrawal by Subject|9
4702841|NCT02269917|16205342|P2|Overall Study|Other|3
4702842|NCT02269917|16205343|P1|Overall Study|Other|6
4702843|NCT02269917|16205342|P2|Overall Study|Ongoing|360
4702844|NCT02269917|16205343|P1|Overall Study|Ongoing|731
4702845|NCT02269917|16205342|P2|Overall Study|Lost to Follow-up|3
4702846|NCT02269917|16205343|P1|Overall Study|Lost to Follow-up|4
4702847|NCT02269787|16205396|P2|Overall Study|Incapacitated|1
4702848|NCT02269787|16205397|P1|Overall Study|Incapacitated|0
4702849|NCT02269787|16205396|P2|Overall Study|Death|3
4702850|NCT02269787|16205397|P1|Overall Study|Death|2
4702851|NCT02269787|16205396|P2|Overall Study|Lost to Follow-up|6
4702852|NCT02269787|16205397|P1|Overall Study|Lost to Follow-up|20
4702853|NCT02269709|16205403|P1|Six Month Follow-up|Lost to Follow-up|12
4702854|NCT02269709|16205403|P1|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1
4702855|NCT02269709|16205403|P1|Time of Enrollment|Withdrawal by Subject|3
4702856|NCT02269657|16205408|P1|Overall Study|Protocol Violation|3
4702857|NCT02269475|16205445|P2|Overall Study|Withdrawal by Subject|1
4702858|NCT02269475|16205446|P1|Overall Study|Withdrawal by Subject|0
4702859|NCT02269475|16205445|P2|Overall Study|Meet Exclusion Criteria No. 17|0
4702860|NCT02269475|16205446|P1|Overall Study|Meet Exclusion Criteria No. 17|3
4702861|NCT02269423|16205461|P4|Overall Study|Discontinued due to change in residence|1
4702862|NCT02269423|16205462|P3|Overall Study|Discontinued due to change in residence|0
4702863|NCT02269423|16205463|P2|Overall Study|Discontinued due to change in residence|1
4702864|NCT02269423|16205464|P1|Overall Study|Discontinued due to change in residence|0
4702865|NCT02269241|16205526|P1|Overall Study|Screening failures|546
4702866|NCT02269241|16205526|P1|Overall Study|Several reasons not classified|53
4702867|NCT02269241|16205526|P1|Overall Study|At the specific request of the sponsor|20
4702868|NCT02269241|16205526|P1|Overall Study|Adverse Event|113
4702869|NCT02269241|16205526|P1|Overall Study|Development of an exclusion criteria|16
4702870|NCT02269241|16205526|P1|Overall Study|Wish for pregnancy|5
4702871|NCT02269241|16205526|P1|Overall Study|Pregnancy|15
4702872|NCT02269241|16205526|P1|Overall Study|Physician Decision|7
4702873|NCT02269241|16205526|P1|Overall Study|Protocol Violation|1
4702874|NCT02269241|16205526|P1|Overall Study|Withdrawal by Subject|155
4702875|NCT02269241|16205526|P1|Overall Study|Lost to Follow-up|269
4702876|NCT02269098|16205540|P2|Overall Study|Lost to Follow-up|9
4702877|NCT02269098|16205541|P1|Overall Study|Lost to Follow-up|14
4702878|NCT02268864|16205602|P3|Overall Study|Death|0
4702879|NCT02268864|16205603|P2|Overall Study|Death|1
4702880|NCT02268864|16205604|P1|Overall Study|Death|0
4702881|NCT02268864|16205602|P3|Overall Study|Withdrawal by Subject|0
4702882|NCT02268864|16205603|P2|Overall Study|Withdrawal by Subject|0
4702883|NCT02268864|16205604|P1|Overall Study|Withdrawal by Subject|2
4702884|NCT02268851|16205632|P6|Overall Study|Co-Morbid Condition|1
4702885|NCT02268851|16205633|P5|Overall Study|Co-Morbid Condition|1
4702886|NCT02268851|16205634|P4|Overall Study|Co-Morbid Condition|0
4702887|NCT02268851|16205635|P3|Overall Study|Co-Morbid Condition|0
4702888|NCT02268851|16205636|P2|Overall Study|Co-Morbid Condition|0
4702889|NCT02268851|16205637|P1|Overall Study|Co-Morbid Condition|0
4702890|NCT02268851|16205632|P6|Overall Study|Patient Compliance|1
4702891|NCT02268851|16205633|P5|Overall Study|Patient Compliance|1
4702892|NCT02268851|16205634|P4|Overall Study|Patient Compliance|0
4702893|NCT02268851|16205635|P3|Overall Study|Patient Compliance|0
4702894|NCT02268851|16205636|P2|Overall Study|Patient Compliance|0
4702895|NCT02268851|16205637|P1|Overall Study|Patient Compliance|0
4702896|NCT02268851|16205632|P6|Overall Study|Physician Decision|1
4702897|NCT02268851|16205633|P5|Overall Study|Physician Decision|0
4702898|NCT02268851|16205634|P4|Overall Study|Physician Decision|0
4702899|NCT02268851|16205635|P3|Overall Study|Physician Decision|1
4702900|NCT02268851|16205636|P2|Overall Study|Physician Decision|0
4702901|NCT02268851|16205637|P1|Overall Study|Physician Decision|0
4702902|NCT02268851|16205632|P6|Overall Study|Progressive Disease|4
4702903|NCT02268851|16205633|P5|Overall Study|Progressive Disease|1
4702904|NCT02268851|16205634|P4|Overall Study|Progressive Disease|0
4702905|NCT02268851|16205635|P3|Overall Study|Progressive Disease|0
4702906|NCT02268851|16205636|P2|Overall Study|Progressive Disease|3
4702907|NCT02268851|16205637|P1|Overall Study|Progressive Disease|1
4702908|NCT02268851|16205632|P6|Overall Study|Withdrawal by Subject|1
4702909|NCT02268851|16205633|P5|Overall Study|Withdrawal by Subject|0
4702910|NCT02268851|16205634|P4|Overall Study|Withdrawal by Subject|2
4702911|NCT02268851|16205635|P3|Overall Study|Withdrawal by Subject|0
4702912|NCT02268851|16205636|P2|Overall Study|Withdrawal by Subject|0
4702913|NCT02268851|16205637|P1|Overall Study|Withdrawal by Subject|0
4702914|NCT02268851|16205632|P6|Overall Study|Adverse Event|2
4702915|NCT02268851|16205633|P5|Overall Study|Adverse Event|2
4702916|NCT02268851|16205634|P4|Overall Study|Adverse Event|0
4702917|NCT02268851|16205635|P3|Overall Study|Adverse Event|0
4702918|NCT02268851|16205636|P2|Overall Study|Adverse Event|0
4702919|NCT02268851|16205637|P1|Overall Study|Adverse Event|0
4702920|NCT02268851|16205632|P6|Overall Study|Death|1
4702921|NCT02268851|16205633|P5|Overall Study|Death|2
4702922|NCT02268851|16205634|P4|Overall Study|Death|1
4702923|NCT02268851|16205635|P3|Overall Study|Death|0
4702924|NCT02268851|16205636|P2|Overall Study|Death|0
4702925|NCT02268851|16205637|P1|Overall Study|Death|0
4702926|NCT02268812|16205655|P4|Overall Study|Other|3
4702927|NCT02268812|16205656|P3|Overall Study|Other|1
4702928|NCT02268812|16205657|P2|Overall Study|Other|4
4702929|NCT02268812|16205658|P1|Overall Study|Other|5
4702930|NCT02268812|16205655|P4|Overall Study|Physician Decision|1
4702931|NCT02268812|16205656|P3|Overall Study|Physician Decision|0
4702932|NCT02268812|16205657|P2|Overall Study|Physician Decision|1
4702933|NCT02268812|16205658|P1|Overall Study|Physician Decision|3
4702934|NCT02268812|16205655|P4|Overall Study|Withdrawal by Subject|0
4702935|NCT02268812|16205656|P3|Overall Study|Withdrawal by Subject|0
4702936|NCT02268812|16205657|P2|Overall Study|Withdrawal by Subject|1
4702937|NCT02268812|16205658|P1|Overall Study|Withdrawal by Subject|0
4702938|NCT02268812|16205655|P4|Overall Study|Protocol deviation|0
4702939|NCT02268812|16205656|P3|Overall Study|Protocol deviation|1
4702940|NCT02268812|16205657|P2|Overall Study|Protocol deviation|0
4702941|NCT02268812|16205658|P1|Overall Study|Protocol deviation|0
4702942|NCT02268812|16205655|P4|Overall Study|Adverse Event|10
4702943|NCT02268812|16205656|P3|Overall Study|Adverse Event|7
4702944|NCT02268812|16205657|P2|Overall Study|Adverse Event|26
4702945|NCT02268812|16205658|P1|Overall Study|Adverse Event|8
4702946|NCT02268786|16205690|P2|Overall Study|Protocol Violation|0
4702947|NCT02268786|16205691|P1|Overall Study|Protocol Violation|1
4702948|NCT02268786|16205690|P2|Overall Study|Thaw Failure|4
4702949|NCT02268786|16205691|P1|Overall Study|Thaw Failure|6
4702950|NCT02268786|16205690|P2|Overall Study|Withdrawal by Subject|14
4702951|NCT02268786|16205691|P1|Overall Study|Withdrawal by Subject|7
4702952|NCT02268786|16205690|P2|Overall Study|No Euploid Embryos available|0
4702953|NCT02268786|16205691|P1|Overall Study|No Euploid Embryos available|42
4702954|NCT02268526|16205700|P3|Overall Study|Subject/guardian decision|3
4702955|NCT02268526|16205701|P2|Overall Study|Subject/guardian decision|7
4702956|NCT02268526|16205702|P1|Overall Study|Subject/guardian decision|0
4702957|NCT02268526|16205700|P3|Overall Study|Physician Decision|1
4702958|NCT02268526|16205701|P2|Overall Study|Physician Decision|0
4702959|NCT02268526|16205702|P1|Overall Study|Physician Decision|0
4702960|NCT02268526|16205700|P3|Overall Study|protocol deviation|0
4702961|NCT02268526|16205701|P2|Overall Study|protocol deviation|1
4702962|NCT02268526|16205702|P1|Overall Study|protocol deviation|0
4702963|NCT02268526|16205700|P3|Overall Study|Death|0
4702964|NCT02268526|16205701|P2|Overall Study|Death|11
4702965|NCT02268526|16205702|P1|Overall Study|Death|1
4702966|NCT02268526|16205700|P3|Overall Study|Adverse Event|1
4702967|NCT02268526|16205701|P2|Overall Study|Adverse Event|2
4702968|NCT02268526|16205702|P1|Overall Study|Adverse Event|0
4702969|NCT02268396|16205723|P1|Overall Study|2 Subjects no Day 29 Assessment|2
4702970|NCT02268396|16205723|P1|Overall Study|Protocol-Specified Criteria|2
4702971|NCT02268396|16205723|P1|Overall Study|Lost to Follow-up|2
4702972|NCT02268396|16205723|P1|Overall Study|Withdrawal by Subject|1
4702973|NCT02268396|16205723|P1|Overall Study|Administrative|2
4702974|NCT02268396|16205723|P1|Overall Study|Adverse Event|3
4702975|NCT02268214|16205735|P3|Overall Study|Not entering long-term period|5
4702976|NCT02268214|16205736|P2|Overall Study|Not entering long-term period|3
4702977|NCT02268214|16205737|P1|Overall Study|Not entering long-term period|2
4702978|NCT02268214|16205735|P3|Overall Study|Other reasons|3
4702979|NCT02268214|16205736|P2|Overall Study|Other reasons|3
4702980|NCT02268214|16205737|P1|Overall Study|Other reasons|7
4702981|NCT02268214|16205735|P3|Overall Study|Poor/non-compliance|2
4702982|NCT02268214|16205736|P2|Overall Study|Poor/non-compliance|1
4702983|NCT02268214|16205737|P1|Overall Study|Poor/non-compliance|2
4702984|NCT02268214|16205735|P3|Overall Study|Subject request to discontinue treatment|6
4702985|NCT02268214|16205736|P2|Overall Study|Subject request to discontinue treatment|8
4702986|NCT02268214|16205737|P1|Overall Study|Subject request to discontinue treatment|10
4702987|NCT02268214|16205735|P3|Overall Study|Withdrawal by Subject|10
4702988|NCT02268214|16205736|P2|Overall Study|Withdrawal by Subject|5
4702989|NCT02268214|16205737|P1|Overall Study|Withdrawal by Subject|4
4702990|NCT02268214|16205735|P3|Overall Study|Adverse Event|9
4702991|NCT02268214|16205736|P2|Overall Study|Adverse Event|14
4702992|NCT02268214|16205737|P1|Overall Study|Adverse Event|11
4702993|NCT02268214|16205735|P3|Overall Study|Lack of Efficacy|2
4702994|NCT02268214|16205736|P2|Overall Study|Lack of Efficacy|0
4702995|NCT02268214|16205737|P1|Overall Study|Lack of Efficacy|1
4702996|NCT02268214|16205735|P3|Overall Study|Lost to Follow-up|4
4702997|NCT02268214|16205736|P2|Overall Study|Lost to Follow-up|3
4702998|NCT02268214|16205737|P1|Overall Study|Lost to Follow-up|3
4702999|NCT02268214|16205735|P3|Overall Study|Pregnancy|1
4703000|NCT02268214|16205736|P2|Overall Study|Pregnancy|2
4703001|NCT02268214|16205737|P1|Overall Study|Pregnancy|2
4703002|NCT02268214|16205735|P3|Overall Study|Subject no longer meets study criteria|0
4703003|NCT02268214|16205736|P2|Overall Study|Subject no longer meets study criteria|2
4703004|NCT02268214|16205737|P1|Overall Study|Subject no longer meets study criteria|0
4703005|NCT02268058|16205784|P4|Overall Study|Protocol Violation|0
4703006|NCT02268058|16205785|P3|Overall Study|Protocol Violation|0
4703007|NCT02268058|16205786|P2|Overall Study|Protocol Violation|0
4703008|NCT02268058|16205787|P1|Overall Study|Protocol Violation|1
4703009|NCT02268045|16205811|P2|Overall Study|Protocol Violation|1
4703010|NCT02268045|16205812|P1|Overall Study|Protocol Violation|1
4703011|NCT02268045|16205811|P2|Overall Study|Physician Decision|1
4703012|NCT02268045|16205812|P1|Overall Study|Physician Decision|0
4703013|NCT02268045|16205811|P2|Overall Study|Withdrawal by Subject|6
4703014|NCT02268045|16205812|P1|Overall Study|Withdrawal by Subject|2
4703015|NCT02268045|16205811|P2|Overall Study|Adverse Event|7
4703016|NCT02268045|16205812|P1|Overall Study|Adverse Event|7
4703017|NCT02268045|16205811|P2|Overall Study|Disease Progression|1
4703018|NCT02268045|16205812|P1|Overall Study|Disease Progression|2
4703019|NCT02268045|16205811|P2|Overall Study|Death|4
4703020|NCT02268045|16205812|P1|Overall Study|Death|4
4703021|NCT01244191|16205836|P2|Overall Study|'Missing' or 'Terminated by sponsor'|8
4703022|NCT01244191|16205837|P1|Overall Study|'Missing' or 'Terminated by sponsor'|12
4703023|NCT01244191|16205836|P2|Overall Study|Withdrawal by Subject|23
4703024|NCT01244191|16205837|P1|Overall Study|Withdrawal by Subject|31
4703025|NCT01244191|16205836|P2|Overall Study|Protocol Violation|2
4703026|NCT01244191|16205837|P1|Overall Study|Protocol Violation|1
4703027|NCT01244191|16205836|P2|Overall Study|Lost to Follow-up|2
4703028|NCT01244191|16205837|P1|Overall Study|Lost to Follow-up|0
4703029|NCT01244191|16205836|P2|Overall Study|Death|29
4703030|NCT01244191|16205837|P1|Overall Study|Death|22
4703031|NCT01244191|16205836|P2|Overall Study|Adverse Event|48
4703032|NCT01244191|16205837|P1|Overall Study|Adverse Event|65
4703033|NCT01244191|16205836|P2|Overall Study|Clinical disease progression|36
4703034|NCT01244191|16205837|P1|Overall Study|Clinical disease progression|54
4703035|NCT01244191|16205836|P2|Overall Study|Progressive disease|350
4703036|NCT01244191|16205837|P1|Overall Study|Progressive disease|295
4703037|NCT02267824|16205877|P2|Overall Study|Did Not Meet Initial Dental Criteria|0
4703038|NCT02267824|16205878|P1|Overall Study|Did Not Meet Initial Dental Criteria|2
4703039|NCT02267824|16205877|P2|Overall Study|Protocol Violation|0
4703040|NCT02267824|16205878|P1|Overall Study|Protocol Violation|3
4703041|NCT02267824|16205877|P2|Overall Study|Lost to Follow-up|0
4703042|NCT02267824|16205878|P1|Overall Study|Lost to Follow-up|4
4703043|NCT02267824|16205877|P2|Overall Study|Pregnancy|1
4703044|NCT02267824|16205878|P1|Overall Study|Pregnancy|1
4703045|NCT02267746|16205900|P3|Overall Study|Miscellaneous|1
4703046|NCT02267746|16205901|P2|Overall Study|Miscellaneous|0
4703047|NCT02267746|16205902|P1|Overall Study|Miscellaneous|1
4703048|NCT02267746|16205900|P3|Overall Study|Protocol Violation|1
4703049|NCT02267746|16205901|P2|Overall Study|Protocol Violation|2
4703050|NCT02267746|16205902|P1|Overall Study|Protocol Violation|1
4703051|NCT02267746|16205900|P3|Overall Study|Lack of Efficacy|15
4703052|NCT02267746|16205901|P2|Overall Study|Lack of Efficacy|11
4703053|NCT02267746|16205902|P1|Overall Study|Lack of Efficacy|11
4703054|NCT02267746|16205900|P3|Overall Study|Protocol Violation|3
4703055|NCT02267746|16205901|P2|Overall Study|Protocol Violation|7
4703056|NCT02267746|16205902|P1|Overall Study|Protocol Violation|8
4703057|NCT02267746|16205900|P3|Overall Study|Adverse Event|1
4703058|NCT02267746|16205901|P2|Overall Study|Adverse Event|2
4703059|NCT02267746|16205902|P1|Overall Study|Adverse Event|0
4703060|NCT02267317|16205986|P6|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4703061|NCT02267317|16205987|P5|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4703062|NCT02267317|16205988|P4|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4703063|NCT02267317|16205989|P3|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4703064|NCT02267317|16205990|P2|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0
4703065|NCT02267317|16205991|P1|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1
4703066|NCT02267317|16205986|P6|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4703067|NCT02267317|16205987|P5|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4703068|NCT02267317|16205988|P4|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4703069|NCT02267317|16205989|P3|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4703070|NCT02267317|16205990|P2|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0
4703071|NCT02267317|16205991|P1|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1
4703072|NCT02267278|16206041|P1|Overall Study|prescribed prohibited medication|1
4703073|NCT02267278|16206041|P1|Overall Study|Developed new cancer diagnoses|2
4703074|NCT02267278|16206041|P1|Overall Study|transformation to acute leukemia (AML)|1
4703075|NCT02267278|16206041|P1|Overall Study|Proceeded to transplantation (allo-HCT)|1
4703076|NCT02267187|16206065|P1|Overall Study|Screen fail|3
4703077|NCT02267187|16206065|P1|Overall Study|Physician Decision|2
4703078|NCT02267135|16206073|P2|Period 2 (Randomized Set)|Withdrawal by Subject|0
4703079|NCT02267135|16206074|P1|Period 2 (Randomized Set)|Withdrawal by Subject|1
4703080|NCT02267135|16206073|P2|Period 2 (Randomized Set)|Adverse Event|0
4703081|NCT02267135|16206074|P1|Period 2 (Randomized Set)|Adverse Event|2
4703082|NCT02267135|16206073|P2|Period 2 (Randomized Set)|Lost to Follow-up|1
4703083|NCT02267135|16206074|P1|Period 2 (Randomized Set)|Lost to Follow-up|1
4703084|NCT02267135|16206073|P2|Period 1 (Randomized Set)|Lost to Follow-up|1
4703085|NCT02267135|16206074|P1|Period 1 (Randomized Set)|Lost to Follow-up|0
4703086|NCT02267135|16206073|P2|Period 1 (Randomized Set)|Withdrawal by Subject|3
4703087|NCT02267135|16206074|P1|Period 1 (Randomized Set)|Withdrawal by Subject|1
4703088|NCT02266888|16206118|P4|Overall Study|Transfer of care|0
4703089|NCT02266888|16206119|P3|Overall Study|Transfer of care|1
4703090|NCT02266888|16206120|P2|Overall Study|Transfer of care|0
4703091|NCT02266888|16206121|P1|Overall Study|Transfer of care|0
4703092|NCT02266888|16206118|P4|Overall Study|Personnel unavailable at transplant|1
4703093|NCT02266888|16206119|P3|Overall Study|Personnel unavailable at transplant|0
4703094|NCT02266888|16206120|P2|Overall Study|Personnel unavailable at transplant|0
4703095|NCT02266888|16206121|P1|Overall Study|Personnel unavailable at transplant|0
4703096|NCT02266888|16206118|P4|Overall Study|Randomization Closed|0
4703097|NCT02266888|16206119|P3|Overall Study|Randomization Closed|4
4703098|NCT02266888|16206120|P2|Overall Study|Randomization Closed|0
4703099|NCT02266888|16206121|P1|Overall Study|Randomization Closed|0
4703100|NCT02266888|16206118|P4|Overall Study|No Longer Eligible|2
4703101|NCT02266888|16206119|P3|Overall Study|No Longer Eligible|0
4703102|NCT02266888|16206120|P2|Overall Study|No Longer Eligible|0
4703103|NCT02266888|16206121|P1|Overall Study|No Longer Eligible|0
4703104|NCT02266888|16206118|P4|Overall Study|Study Terminated|0
4703105|NCT02266888|16206119|P3|Overall Study|Study Terminated|0
4703106|NCT02266888|16206120|P2|Overall Study|Study Terminated|1
4703107|NCT02266888|16206121|P1|Overall Study|Study Terminated|5
4703108|NCT02266888|16206118|P4|Overall Study|Physician Decision|2
4703109|NCT02266888|16206119|P3|Overall Study|Physician Decision|2
4703110|NCT02266888|16206120|P2|Overall Study|Physician Decision|1
4703111|NCT02266888|16206121|P1|Overall Study|Physician Decision|0
4703112|NCT02266888|16206118|P4|Overall Study|Death|2
4703113|NCT02266888|16206119|P3|Overall Study|Death|4
4703114|NCT02266888|16206120|P2|Overall Study|Death|2
4703115|NCT02266888|16206121|P1|Overall Study|Death|2
4703116|NCT02266875|16206155|P2|Overall Study|Lost to Follow-up|0
4703117|NCT02266875|16206156|P1|Overall Study|Lost to Follow-up|2
4703118|NCT02266875|16206155|P2|Overall Study|Withdrawal by Subject|0
4703119|NCT02266875|16206156|P1|Overall Study|Withdrawal by Subject|9
4703120|NCT02266706|16206221|P9|Overall Study|Enrollment in another study|0
4703121|NCT02266706|16206222|P8|Overall Study|Enrollment in another study|0
4703122|NCT02266706|16206223|P7|Overall Study|Enrollment in another study|0
4703123|NCT02266706|16206224|P6|Overall Study|Enrollment in another study|0
4703124|NCT02266706|16206225|P5|Overall Study|Enrollment in another study|0
4703125|NCT02266706|16206226|P4|Overall Study|Enrollment in another study|1
4703126|NCT02266706|16206227|P3|Overall Study|Enrollment in another study|0
4703127|NCT02266706|16206228|P2|Overall Study|Enrollment in another study|0
4703128|NCT02266706|16206229|P1|Overall Study|Enrollment in another study|0
4703129|NCT02266706|16206221|P9|Overall Study|Screen failure|0
4703130|NCT02266706|16206222|P8|Overall Study|Screen failure|0
4703131|NCT02266706|16206223|P7|Overall Study|Screen failure|1
4703132|NCT02266706|16206224|P6|Overall Study|Screen failure|1
4703133|NCT02266706|16206225|P5|Overall Study|Screen failure|0
4703134|NCT02266706|16206226|P4|Overall Study|Screen failure|0
4703135|NCT02266706|16206227|P3|Overall Study|Screen failure|0
4703136|NCT02266706|16206228|P2|Overall Study|Screen failure|0
4703137|NCT02266706|16206229|P1|Overall Study|Screen failure|0
4703138|NCT02266706|16206221|P9|Overall Study|Withdrawal by Subject|0
4703139|NCT02266706|16206222|P8|Overall Study|Withdrawal by Subject|0
4703140|NCT02266706|16206223|P7|Overall Study|Withdrawal by Subject|0
4703141|NCT02266706|16206224|P6|Overall Study|Withdrawal by Subject|1
4703142|NCT02266706|16206225|P5|Overall Study|Withdrawal by Subject|0
4703143|NCT02266706|16206226|P4|Overall Study|Withdrawal by Subject|0
4703144|NCT02266706|16206227|P3|Overall Study|Withdrawal by Subject|1
4703145|NCT02266706|16206228|P2|Overall Study|Withdrawal by Subject|1
4703146|NCT02266706|16206229|P1|Overall Study|Withdrawal by Subject|0
4703147|NCT02266381|16206461|P3|Overall Study|Physician Decision|4
4703148|NCT02266381|16206462|P2|Overall Study|Physician Decision|5
4703149|NCT02266381|16206463|P1|Overall Study|Physician Decision|3
4703150|NCT02266225|16206513|P1|Overall Study|Withdrawal by Subject|13
4703151|NCT02266225|16206513|P1|Overall Study|Death|1
4703152|NCT02266225|16206513|P1|Overall Study|Lost to Follow-up|2
4703153|NCT02266147|16206538|P4|PART 2: Dose Expansion|Study Terminated by Sponsor|8
4703154|NCT02266147|16206539|P3|PART 2: Dose Expansion|Study Terminated by Sponsor|0
4703155|NCT02266147|16206540|P2|PART 2: Dose Expansion|Study Terminated by Sponsor|0
4703156|NCT02266147|16206541|P1|PART 2: Dose Expansion|Study Terminated by Sponsor|6
4703157|NCT02266147|16206538|P4|PART 2: Dose Expansion|Lack of Efficacy|1
4703158|NCT02266147|16206539|P3|PART 2: Dose Expansion|Lack of Efficacy|0
4703159|NCT02266147|16206540|P2|PART 2: Dose Expansion|Lack of Efficacy|0
4703160|NCT02266147|16206541|P1|PART 2: Dose Expansion|Lack of Efficacy|1
4703161|NCT02266147|16206538|P4|PART 1: Dose Escalation|Other|0
4703162|NCT02266147|16206539|P3|PART 1: Dose Escalation|Other|0
4703163|NCT02266147|16206540|P2|PART 1: Dose Escalation|Other|1
4703164|NCT02266147|16206541|P1|PART 1: Dose Escalation|Other|1
4703165|NCT02266147|16206538|P4|PART 1: Dose Escalation|Study Terminated by Sponsor|3
4703166|NCT02266147|16206539|P3|PART 1: Dose Escalation|Study Terminated by Sponsor|1
4703167|NCT02266147|16206540|P2|PART 1: Dose Escalation|Study Terminated by Sponsor|0
4703168|NCT02266147|16206541|P1|PART 1: Dose Escalation|Study Terminated by Sponsor|0
4703169|NCT02266147|16206538|P4|PART 1: Dose Escalation|Lack of Efficacy|1
4703170|NCT02266147|16206539|P3|PART 1: Dose Escalation|Lack of Efficacy|1
4703171|NCT02266147|16206540|P2|PART 1: Dose Escalation|Lack of Efficacy|2
4703172|NCT02266147|16206541|P1|PART 1: Dose Escalation|Lack of Efficacy|0
4703173|NCT02266147|16206538|P4|PART 1: Dose Escalation|Physician Decision|0
4703174|NCT02266147|16206539|P3|PART 1: Dose Escalation|Physician Decision|1
4703175|NCT02266147|16206540|P2|PART 1: Dose Escalation|Physician Decision|0
4703176|NCT02266147|16206541|P1|PART 1: Dose Escalation|Physician Decision|0
4703177|NCT02266004|16206584|P1|Overall Study|Physician Decision|1
4703178|NCT02266004|16206584|P1|Overall Study|unrelated adverse event|1
4703179|NCT02265952|16206622|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|1
4703180|NCT02265952|16206623|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
4703181|NCT02265952|16206622|P2|Open Label Extension (OLE) Period|Physician Decision|7
4703182|NCT02265952|16206623|P1|Open Label Extension (OLE) Period|Physician Decision|0
4703183|NCT02265796|16206670|P2|Overall Study|Withdrawal by Subject|1
4703184|NCT02265796|16206671|P1|Overall Study|Withdrawal by Subject|1
4703185|NCT02265796|16206670|P2|Overall Study|started on excluded medication|0
4703186|NCT02265796|16206671|P1|Overall Study|started on excluded medication|1
4703187|NCT02265796|16206670|P2|Overall Study|Death|0
4703188|NCT02265796|16206671|P1|Overall Study|Death|1
4703189|NCT02265744|16206690|P5|Overall Study|Pregnancy|0
4703190|NCT02265744|16206691|P4|Overall Study|Pregnancy|1
4703191|NCT02265744|16206692|P3|Overall Study|Pregnancy|1
4703192|NCT02265744|16206693|P2|Overall Study|Pregnancy|2
4703193|NCT02265744|16206694|P1|Overall Study|Pregnancy|1
4703194|NCT02265744|16206690|P5|Overall Study|Subject no longer meets study criteria|1
4703195|NCT02265744|16206691|P4|Overall Study|Subject no longer meets study criteria|0
4703196|NCT02265744|16206692|P3|Overall Study|Subject no longer meets study criteria|0
4703197|NCT02265744|16206693|P2|Overall Study|Subject no longer meets study criteria|0
4703198|NCT02265744|16206694|P1|Overall Study|Subject no longer meets study criteria|0
4703199|NCT02265744|16206690|P5|Overall Study|Administrative reason by sponsor|3
4703200|NCT02265744|16206691|P4|Overall Study|Administrative reason by sponsor|3
4703201|NCT02265744|16206692|P3|Overall Study|Administrative reason by sponsor|2
4703202|NCT02265744|16206693|P2|Overall Study|Administrative reason by sponsor|2
4703203|NCT02265744|16206694|P1|Overall Study|Administrative reason by sponsor|3
4703204|NCT02265744|16206690|P5|Overall Study|Reason not provided by Investigator|0
4703205|NCT02265744|16206691|P4|Overall Study|Reason not provided by Investigator|2
4703206|NCT02265744|16206692|P3|Overall Study|Reason not provided by Investigator|0
4703207|NCT02265744|16206693|P2|Overall Study|Reason not provided by Investigator|0
4703208|NCT02265744|16206694|P1|Overall Study|Reason not provided by Investigator|1
4703209|NCT02265744|16206690|P5|Overall Study|Lack of Efficacy|5
4703210|NCT02265744|16206691|P4|Overall Study|Lack of Efficacy|4
4703211|NCT02265744|16206692|P3|Overall Study|Lack of Efficacy|3
4703212|NCT02265744|16206693|P2|Overall Study|Lack of Efficacy|4
4703213|NCT02265744|16206694|P1|Overall Study|Lack of Efficacy|2
4703214|NCT02265744|16206690|P5|Overall Study|Adverse Event|2
4703215|NCT02265744|16206691|P4|Overall Study|Adverse Event|8
4703216|NCT02265744|16206692|P3|Overall Study|Adverse Event|9
4703217|NCT02265744|16206693|P2|Overall Study|Adverse Event|4
4703218|NCT02265744|16206694|P1|Overall Study|Adverse Event|8
4703219|NCT02265744|16206690|P5|Overall Study|Participant request to discontinue|0
4703220|NCT02265744|16206691|P4|Overall Study|Participant request to discontinue|0
4703221|NCT02265744|16206692|P3|Overall Study|Participant request to discontinue|2
4703222|NCT02265744|16206693|P2|Overall Study|Participant request to discontinue|2
4703223|NCT02265744|16206694|P1|Overall Study|Participant request to discontinue|2
4703224|NCT02265744|16206690|P5|Overall Study|Withdrawal by Subject|0
4703225|NCT02265744|16206691|P4|Overall Study|Withdrawal by Subject|2
4703226|NCT02265744|16206692|P3|Overall Study|Withdrawal by Subject|0
4703227|NCT02265744|16206693|P2|Overall Study|Withdrawal by Subject|0
4703228|NCT02265744|16206694|P1|Overall Study|Withdrawal by Subject|2
4703229|NCT02265744|16206690|P5|Overall Study|Death|0
4703230|NCT02265744|16206691|P4|Overall Study|Death|2
4703231|NCT02265744|16206692|P3|Overall Study|Death|0
4703232|NCT02265744|16206693|P2|Overall Study|Death|0
4703233|NCT02265744|16206694|P1|Overall Study|Death|0
4703234|NCT02265744|16206690|P5|Overall Study|Lost to Follow-up|0
4703235|NCT02265744|16206691|P4|Overall Study|Lost to Follow-up|1
4703236|NCT02265744|16206692|P3|Overall Study|Lost to Follow-up|0
4703237|NCT02265744|16206693|P2|Overall Study|Lost to Follow-up|0
4703238|NCT02265744|16206694|P1|Overall Study|Lost to Follow-up|0
4703239|NCT02265744|16206690|P5|Overall Study|Poor/Non-compliance|2
4703240|NCT02265744|16206691|P4|Overall Study|Poor/Non-compliance|0
4703241|NCT02265744|16206692|P3|Overall Study|Poor/Non-compliance|0
4703242|NCT02265744|16206693|P2|Overall Study|Poor/Non-compliance|1
4703243|NCT02265744|16206694|P1|Overall Study|Poor/Non-compliance|1
4703244|NCT02265705|16206873|P7|Follow-up Period|Withdrawal by Subject|1
4703245|NCT02265705|16206874|P6|Follow-up Period|Withdrawal by Subject|0
4703246|NCT02265705|16206875|P5|Follow-up Period|Withdrawal by Subject|0
4703247|NCT02265705|16206876|P4|Follow-up Period|Withdrawal by Subject|0
4703248|NCT02265705|16206877|P3|Follow-up Period|Withdrawal by Subject|0
4703249|NCT02265705|16206878|P2|Follow-up Period|Withdrawal by Subject|0
4703250|NCT02265705|16206879|P1|Follow-up Period|Withdrawal by Subject|0
4703251|NCT02265705|16206873|P7|Follow-up Period|Physician Decision|1
4703252|NCT02265705|16206874|P6|Follow-up Period|Physician Decision|0
4703253|NCT02265705|16206875|P5|Follow-up Period|Physician Decision|0
4703254|NCT02265705|16206876|P4|Follow-up Period|Physician Decision|0
4703255|NCT02265705|16206877|P3|Follow-up Period|Physician Decision|0
4703256|NCT02265705|16206878|P2|Follow-up Period|Physician Decision|0
4703257|NCT02265705|16206879|P1|Follow-up Period|Physician Decision|0
4703258|NCT02265705|16206873|P7|Follow-up Period|Adverse Event|3
4703259|NCT02265705|16206874|P6|Follow-up Period|Adverse Event|0
4703260|NCT02265705|16206875|P5|Follow-up Period|Adverse Event|0
4703261|NCT02265705|16206876|P4|Follow-up Period|Adverse Event|0
4703262|NCT02265705|16206877|P3|Follow-up Period|Adverse Event|0
4703263|NCT02265705|16206878|P2|Follow-up Period|Adverse Event|0
4703264|NCT02265705|16206879|P1|Follow-up Period|Adverse Event|0
4703265|NCT02265705|16206873|P7|Follow-up Period|Sponsor Decision|6
4703266|NCT02265705|16206874|P6|Follow-up Period|Sponsor Decision|1
4703267|NCT02265705|16206875|P5|Follow-up Period|Sponsor Decision|0
4703268|NCT02265705|16206876|P4|Follow-up Period|Sponsor Decision|0
4703269|NCT02265705|16206877|P3|Follow-up Period|Sponsor Decision|0
4703270|NCT02265705|16206878|P2|Follow-up Period|Sponsor Decision|0
4703271|NCT02265705|16206879|P1|Follow-up Period|Sponsor Decision|0
4703272|NCT02265705|16206873|P7|Open Label Period|Withdrawal by Subject|0
4703273|NCT02265705|16206874|P6|Open Label Period|Withdrawal by Subject|0
4703274|NCT02265705|16206875|P5|Open Label Period|Withdrawal by Subject|2
4703275|NCT02265705|16206876|P4|Open Label Period|Withdrawal by Subject|0
4703276|NCT02265705|16206877|P3|Open Label Period|Withdrawal by Subject|0
4703277|NCT02265705|16206878|P2|Open Label Period|Withdrawal by Subject|0
4703278|NCT02265705|16206879|P1|Open Label Period|Withdrawal by Subject|0
4703279|NCT02265705|16206873|P7|Open Label Period|Physician Decision|0
4703280|NCT02265705|16206874|P6|Open Label Period|Physician Decision|0
4703281|NCT02265705|16206875|P5|Open Label Period|Physician Decision|1
4703282|NCT02265705|16206876|P4|Open Label Period|Physician Decision|0
4703283|NCT02265705|16206877|P3|Open Label Period|Physician Decision|0
4703284|NCT02265705|16206878|P2|Open Label Period|Physician Decision|0
4703285|NCT02265705|16206879|P1|Open Label Period|Physician Decision|0
4703286|NCT02265705|16206873|P7|Open Label Period|Adverse Event|0
4703287|NCT02265705|16206874|P6|Open Label Period|Adverse Event|0
4703288|NCT02265705|16206875|P5|Open Label Period|Adverse Event|2
4703289|NCT02265705|16206876|P4|Open Label Period|Adverse Event|2
4703290|NCT02265705|16206877|P3|Open Label Period|Adverse Event|0
4703291|NCT02265705|16206878|P2|Open Label Period|Adverse Event|0
4703292|NCT02265705|16206879|P1|Open Label Period|Adverse Event|0
4703293|NCT02265705|16206873|P7|Rescue Period|Lack of Efficacy|0
4703294|NCT02265705|16206874|P6|Rescue Period|Lack of Efficacy|0
4703295|NCT02265705|16206875|P5|Rescue Period|Lack of Efficacy|0
4703296|NCT02265705|16206876|P4|Rescue Period|Lack of Efficacy|0
4703297|NCT02265705|16206877|P3|Rescue Period|Lack of Efficacy|1
4703298|NCT02265705|16206878|P2|Rescue Period|Lack of Efficacy|0
4703299|NCT02265705|16206879|P1|Rescue Period|Lack of Efficacy|0
4703300|NCT02265705|16206873|P7|Rescue Period|Death|0
4703301|NCT02265705|16206874|P6|Rescue Period|Death|0
4703302|NCT02265705|16206875|P5|Rescue Period|Death|0
4703303|NCT02265705|16206876|P4|Rescue Period|Death|0
4703304|NCT02265705|16206877|P3|Rescue Period|Death|1
4703305|NCT02265705|16206878|P2|Rescue Period|Death|0
4703306|NCT02265705|16206879|P1|Rescue Period|Death|0
4703307|NCT02265705|16206873|P7|Rescue Period|Withdrawal by Subject|0
4703308|NCT02265705|16206874|P6|Rescue Period|Withdrawal by Subject|0
4703309|NCT02265705|16206875|P5|Rescue Period|Withdrawal by Subject|0
4703310|NCT02265705|16206876|P4|Rescue Period|Withdrawal by Subject|0
4703311|NCT02265705|16206877|P3|Rescue Period|Withdrawal by Subject|1
4703312|NCT02265705|16206878|P2|Rescue Period|Withdrawal by Subject|0
4703313|NCT02265705|16206879|P1|Rescue Period|Withdrawal by Subject|0
4703314|NCT02265705|16206873|P7|Treatment Period Week 0-24|Lack of Efficacy|0
4703315|NCT02265705|16206874|P6|Treatment Period Week 0-24|Lack of Efficacy|0
4703316|NCT02265705|16206875|P5|Treatment Period Week 0-24|Lack of Efficacy|0
4703317|NCT02265705|16206876|P4|Treatment Period Week 0-24|Lack of Efficacy|0
4703318|NCT02265705|16206877|P3|Treatment Period Week 0-24|Lack of Efficacy|0
4703319|NCT02265705|16206878|P2|Treatment Period Week 0-24|Lack of Efficacy|1
4703320|NCT02265705|16206879|P1|Treatment Period Week 0-24|Lack of Efficacy|0
4703321|NCT02265705|16206873|P7|Treatment Period Week 0-24|Withdrawal by Subject|0
4703322|NCT02265705|16206874|P6|Treatment Period Week 0-24|Withdrawal by Subject|0
4703323|NCT02265705|16206875|P5|Treatment Period Week 0-24|Withdrawal by Subject|0
4703324|NCT02265705|16206876|P4|Treatment Period Week 0-24|Withdrawal by Subject|0
4703325|NCT02265705|16206877|P3|Treatment Period Week 0-24|Withdrawal by Subject|0
4703326|NCT02265705|16206878|P2|Treatment Period Week 0-24|Withdrawal by Subject|5
4703327|NCT02265705|16206879|P1|Treatment Period Week 0-24|Withdrawal by Subject|7
4703328|NCT02265705|16206873|P7|Treatment Period Week 0-24|Physician Decision|0
4703329|NCT02265705|16206874|P6|Treatment Period Week 0-24|Physician Decision|0
4703330|NCT02265705|16206875|P5|Treatment Period Week 0-24|Physician Decision|0
4703331|NCT02265705|16206876|P4|Treatment Period Week 0-24|Physician Decision|0
4703332|NCT02265705|16206877|P3|Treatment Period Week 0-24|Physician Decision|0
4703333|NCT02265705|16206878|P2|Treatment Period Week 0-24|Physician Decision|0
4703334|NCT02265705|16206879|P1|Treatment Period Week 0-24|Physician Decision|1
4703335|NCT02265705|16206873|P7|Treatment Period Week 0-24|Entry Criteria Not Met|0
4703336|NCT02265705|16206874|P6|Treatment Period Week 0-24|Entry Criteria Not Met|0
4703337|NCT02265705|16206875|P5|Treatment Period Week 0-24|Entry Criteria Not Met|0
4703338|NCT02265705|16206876|P4|Treatment Period Week 0-24|Entry Criteria Not Met|0
4703339|NCT02265705|16206877|P3|Treatment Period Week 0-24|Entry Criteria Not Met|0
4703340|NCT02265705|16206878|P2|Treatment Period Week 0-24|Entry Criteria Not Met|1
4703341|NCT02265705|16206879|P1|Treatment Period Week 0-24|Entry Criteria Not Met|1
4703342|NCT02265705|16206873|P7|Treatment Period Week 0-24|Adverse Event|0
4703343|NCT02265705|16206874|P6|Treatment Period Week 0-24|Adverse Event|0
4703344|NCT02265705|16206875|P5|Treatment Period Week 0-24|Adverse Event|0
4703345|NCT02265705|16206876|P4|Treatment Period Week 0-24|Adverse Event|0
4703346|NCT02265705|16206877|P3|Treatment Period Week 0-24|Adverse Event|0
4703347|NCT02265705|16206878|P2|Treatment Period Week 0-24|Adverse Event|2
4703348|NCT02265705|16206879|P1|Treatment Period Week 0-24|Adverse Event|3
4703349|NCT02265510|16206918|P14|Overall Study|Study Terminated by Sponsor|2
4703350|NCT02265510|16206919|P13|Overall Study|Study Terminated by Sponsor|1
4703351|NCT02265510|16206920|P12|Overall Study|Study Terminated by Sponsor|4
4703352|NCT02265510|16206921|P11|Overall Study|Study Terminated by Sponsor|1
4703353|NCT02265510|16206922|P10|Overall Study|Study Terminated by Sponsor|2
4703354|NCT02265510|16206923|P9|Overall Study|Study Terminated by Sponsor|1
4703355|NCT02265510|16206924|P8|Overall Study|Study Terminated by Sponsor|1
4703356|NCT02265510|16206925|P7|Overall Study|Study Terminated by Sponsor|1
4703357|NCT02265510|16206926|P6|Overall Study|Study Terminated by Sponsor|1
4703358|NCT02265510|16206927|P5|Overall Study|Study Terminated by Sponsor|0
4703359|NCT02265510|16206928|P4|Overall Study|Study Terminated by Sponsor|0
4703360|NCT02265510|16206929|P3|Overall Study|Study Terminated by Sponsor|0
4703361|NCT02265510|16206930|P2|Overall Study|Study Terminated by Sponsor|0
4703362|NCT02265510|16206931|P1|Overall Study|Study Terminated by Sponsor|0
4703363|NCT02265510|16206918|P14|Overall Study|Other|0
4703364|NCT02265510|16206919|P13|Overall Study|Other|0
4703365|NCT02265510|16206920|P12|Overall Study|Other|0
4703366|NCT02265510|16206921|P11|Overall Study|Other|0
4703367|NCT02265510|16206922|P10|Overall Study|Other|0
4703368|NCT02265510|16206923|P9|Overall Study|Other|0
4703369|NCT02265510|16206924|P8|Overall Study|Other|0
4703370|NCT02265510|16206925|P7|Overall Study|Other|0
4703371|NCT02265510|16206926|P6|Overall Study|Other|0
4703372|NCT02265510|16206927|P5|Overall Study|Other|0
4703373|NCT02265510|16206928|P4|Overall Study|Other|0
4703374|NCT02265510|16206929|P3|Overall Study|Other|0
4703375|NCT02265510|16206930|P2|Overall Study|Other|1
4703376|NCT02265510|16206931|P1|Overall Study|Other|0
4703377|NCT02265510|16206918|P14|Overall Study|Lost to Follow-up|2
4703378|NCT02265510|16206919|P13|Overall Study|Lost to Follow-up|0
4703379|NCT02265510|16206920|P12|Overall Study|Lost to Follow-up|0
4703380|NCT02265510|16206921|P11|Overall Study|Lost to Follow-up|0
4703381|NCT02265510|16206922|P10|Overall Study|Lost to Follow-up|2
4703382|NCT02265510|16206923|P9|Overall Study|Lost to Follow-up|0
4703383|NCT02265510|16206924|P8|Overall Study|Lost to Follow-up|0
4703384|NCT02265510|16206925|P7|Overall Study|Lost to Follow-up|0
4703385|NCT02265510|16206926|P6|Overall Study|Lost to Follow-up|0
4703386|NCT02265510|16206927|P5|Overall Study|Lost to Follow-up|1
4703387|NCT02265510|16206928|P4|Overall Study|Lost to Follow-up|0
4703388|NCT02265510|16206929|P3|Overall Study|Lost to Follow-up|0
4703389|NCT02265510|16206930|P2|Overall Study|Lost to Follow-up|0
4703390|NCT02265510|16206931|P1|Overall Study|Lost to Follow-up|0
4703391|NCT02265510|16206918|P14|Overall Study|Death|6
4703392|NCT02265510|16206919|P13|Overall Study|Death|7
4703393|NCT02265510|16206920|P12|Overall Study|Death|12
4703394|NCT02265510|16206921|P11|Overall Study|Death|4
4703395|NCT02265510|16206922|P10|Overall Study|Death|3
4703396|NCT02265510|16206923|P9|Overall Study|Death|3
4703397|NCT02265510|16206924|P8|Overall Study|Death|1
4703398|NCT02265510|16206925|P7|Overall Study|Death|2
4703399|NCT02265510|16206926|P6|Overall Study|Death|3
4703400|NCT02265510|16206927|P5|Overall Study|Death|1
4703401|NCT02265510|16206928|P4|Overall Study|Death|2
4703402|NCT02265510|16206929|P3|Overall Study|Death|2
4703403|NCT02265510|16206930|P2|Overall Study|Death|0
4703404|NCT02265510|16206931|P1|Overall Study|Death|2
4703405|NCT02265510|16206918|P14|Overall Study|Disease Progression|0
4703406|NCT02265510|16206919|P13|Overall Study|Disease Progression|0
4703407|NCT02265510|16206920|P12|Overall Study|Disease Progression|0
4703408|NCT02265510|16206921|P11|Overall Study|Disease Progression|0
4703409|NCT02265510|16206922|P10|Overall Study|Disease Progression|0
4703410|NCT02265510|16206923|P9|Overall Study|Disease Progression|0
4703411|NCT02265510|16206924|P8|Overall Study|Disease Progression|0
4703412|NCT02265510|16206925|P7|Overall Study|Disease Progression|0
4703413|NCT02265510|16206926|P6|Overall Study|Disease Progression|0
4703414|NCT02265510|16206927|P5|Overall Study|Disease Progression|1
4703415|NCT02265510|16206928|P4|Overall Study|Disease Progression|1
4703416|NCT02265510|16206929|P3|Overall Study|Disease Progression|2
4703417|NCT02265510|16206930|P2|Overall Study|Disease Progression|1
4703418|NCT02265510|16206931|P1|Overall Study|Disease Progression|0
4703419|NCT02265510|16206918|P14|Overall Study|Withdrawal by Subject|0
4703420|NCT02265510|16206919|P13|Overall Study|Withdrawal by Subject|1
4703421|NCT02265510|16206920|P12|Overall Study|Withdrawal by Subject|0
4703422|NCT02265510|16206921|P11|Overall Study|Withdrawal by Subject|0
4703423|NCT02265510|16206922|P10|Overall Study|Withdrawal by Subject|0
4703424|NCT02265510|16206923|P9|Overall Study|Withdrawal by Subject|0
4703425|NCT02265510|16206924|P8|Overall Study|Withdrawal by Subject|2
4703426|NCT02265510|16206925|P7|Overall Study|Withdrawal by Subject|0
4703427|NCT02265510|16206926|P6|Overall Study|Withdrawal by Subject|2
4703428|NCT02265510|16206927|P5|Overall Study|Withdrawal by Subject|0
4703429|NCT02265510|16206928|P4|Overall Study|Withdrawal by Subject|1
4703430|NCT02265510|16206929|P3|Overall Study|Withdrawal by Subject|2
4703431|NCT02265510|16206930|P2|Overall Study|Withdrawal by Subject|1
4703432|NCT02265510|16206931|P1|Overall Study|Withdrawal by Subject|1
4703433|NCT02265237|16207031|P4|As Treated (Overall Study)|Other|1
4703434|NCT02265237|16207032|P3|As Treated (Overall Study)|Other|3
4703435|NCT02265237|16207033|P2|As Treated (Overall Study)|Other|0
4703436|NCT02265237|16207034|P1|As Treated (Overall Study)|Other|2
4703437|NCT02265237|16207031|P4|As Treated (Overall Study)|Lost to Follow-up|0
4703438|NCT02265237|16207032|P3|As Treated (Overall Study)|Lost to Follow-up|6
4703439|NCT02265237|16207033|P2|As Treated (Overall Study)|Lost to Follow-up|2
4703440|NCT02265237|16207034|P1|As Treated (Overall Study)|Lost to Follow-up|1
4703441|NCT02265237|16207031|P4|As Treated (Overall Study)|Withdrawal by Subject|0
4703442|NCT02265237|16207032|P3|As Treated (Overall Study)|Withdrawal by Subject|1
4703443|NCT02265237|16207033|P2|As Treated (Overall Study)|Withdrawal by Subject|0
4703444|NCT02265237|16207034|P1|As Treated (Overall Study)|Withdrawal by Subject|1
4703445|NCT02265237|16207031|P4|As Treated (Overall Study)|Adverse Event|0
4703446|NCT02265237|16207032|P3|As Treated (Overall Study)|Adverse Event|0
4703447|NCT02265237|16207033|P2|As Treated (Overall Study)|Adverse Event|1
4703448|NCT02265237|16207034|P1|As Treated (Overall Study)|Adverse Event|1
4703449|NCT02264821|16207064|P3|Overall Study|Protocol Violation|6
4703450|NCT02264821|16207065|P2|Overall Study|Protocol Violation|3
4703451|NCT02264821|16207066|P1|Overall Study|Protocol Violation|1
4703452|NCT02264574|16207079|P2|Overall Study|Other, Not Specified|3
4703453|NCT02264574|16207080|P1|Overall Study|Other, Not Specified|0
4703454|NCT02264574|16207079|P2|Overall Study|Withdrawal by Subject|6
4703455|NCT02264574|16207080|P1|Overall Study|Withdrawal by Subject|8
4703456|NCT02264574|16207079|P2|Overall Study|Death|21
4703457|NCT02264574|16207080|P1|Overall Study|Death|21
4703458|NCT02263547|16207176|P1|Overall Study|Lost to Follow-up|2
4703459|NCT02263547|16207176|P1|Overall Study|Adverse Event|1
4703460|NCT01222078|16207181|P1|Overall Study|Early termination of the study|1
4703461|NCT02263365|16207217|P2|Overall Study|Physician Decision|18
4703462|NCT02263365|16207218|P1|Overall Study|Physician Decision|22
4703463|NCT02263326|16207232|P2|Overall Study|Lost to Follow-up|1
4703464|NCT02263326|16207233|P1|Overall Study|Lost to Follow-up|1
4703465|NCT02263079|16207306|P3|Overall Study|Withdrawal by Subject|0
4703466|NCT02263079|16207307|P2|Overall Study|Withdrawal by Subject|8
4703467|NCT02263079|16207308|P1|Overall Study|Withdrawal by Subject|2
4703468|NCT02263079|16207306|P3|Overall Study|Physician Decision|0
4703469|NCT02263079|16207307|P2|Overall Study|Physician Decision|0
4703470|NCT02263079|16207308|P1|Overall Study|Physician Decision|1
4703471|NCT02262754|16207379|P3|Overall Study|Other|2
4703472|NCT02262754|16207380|P2|Overall Study|Other|0
4703473|NCT02262754|16207381|P1|Overall Study|Other|4
4703474|NCT02262754|16207379|P3|Overall Study|Withdrawal by Subject|1
4703475|NCT02262754|16207380|P2|Overall Study|Withdrawal by Subject|0
4703476|NCT02262754|16207381|P1|Overall Study|Withdrawal by Subject|1
4703477|NCT02262754|16207379|P3|Overall Study|Protocol Violation|0
4703478|NCT02262754|16207380|P2|Overall Study|Protocol Violation|0
4703479|NCT02262754|16207381|P1|Overall Study|Protocol Violation|1
4703480|NCT02262754|16207379|P3|Overall Study|Study terminated by sponsor|4
4703481|NCT02262754|16207380|P2|Overall Study|Study terminated by sponsor|4
4703482|NCT02262754|16207381|P1|Overall Study|Study terminated by sponsor|5
4703483|NCT02262754|16207379|P3|Overall Study|No longer meets eligibility criteria|0
4703484|NCT02262754|16207380|P2|Overall Study|No longer meets eligibility criteria|1
4703485|NCT02262754|16207381|P1|Overall Study|No longer meets eligibility criteria|0
4703486|NCT02262754|16207379|P3|Overall Study|Lost to Follow-up|1
4703487|NCT02262754|16207380|P2|Overall Study|Lost to Follow-up|0
4703488|NCT02262754|16207381|P1|Overall Study|Lost to Follow-up|0
4703489|NCT02262754|16207379|P3|Overall Study|Lack of Efficacy|1
4703490|NCT02262754|16207380|P2|Overall Study|Lack of Efficacy|0
4703491|NCT02262754|16207381|P1|Overall Study|Lack of Efficacy|2
4703492|NCT02262754|16207379|P3|Overall Study|Adverse Event|0
4703493|NCT02262754|16207380|P2|Overall Study|Adverse Event|4
4703494|NCT02262754|16207381|P1|Overall Study|Adverse Event|3
4703495|NCT02262728|16207456|P2|Follow-up Phase (3 Years)|Withdrawal by Subject|1
4703496|NCT02262728|16207457|P1|Follow-up Phase (3 Years)|Withdrawal by Subject|0
4703497|NCT02262728|16207456|P2|Follow-up Phase (3 Years)|Lost to Follow-up|1
4703498|NCT02262728|16207457|P1|Follow-up Phase (3 Years)|Lost to Follow-up|4
4703499|NCT02262728|16207456|P2|Follow-up Phase (3 Years)|Death|1
4703500|NCT02262728|16207457|P1|Follow-up Phase (3 Years)|Death|0
4703501|NCT02262377|16207489|P2|Overall Study|Withdrawal by Subject|0
4703502|NCT02262377|16207490|P1|Overall Study|Withdrawal by Subject|4
4703503|NCT02262377|16207489|P2|Overall Study|Found ineligible after enrollment|0
4703504|NCT02262377|16207490|P1|Overall Study|Found ineligible after enrollment|3
4703505|NCT02262377|16207489|P2|Overall Study|Lost to Follow-up|6
4703506|NCT02262377|16207490|P1|Overall Study|Lost to Follow-up|5
4703507|NCT02262364|16207505|P1|Blood Draw for Device Processing|Insufficient blood could be drawn|1
4703508|NCT02262260|16207514|P2|Overall Study|Protocol deviation|5
4703509|NCT02262260|16207515|P1|Overall Study|Protocol deviation|2
4703510|NCT02262260|16207514|P2|Overall Study|Lost to Follow-up|2
4703511|NCT02262260|16207515|P1|Overall Study|Lost to Follow-up|1
4703512|NCT02262260|16207514|P2|Overall Study|Withdrawal of consent|2
4703513|NCT02262260|16207515|P1|Overall Study|Withdrawal of consent|4
4703514|NCT02262260|16207514|P2|Overall Study|Adverse Event|1
4703515|NCT02262260|16207515|P1|Overall Study|Adverse Event|4
4703516|NCT02261974|16207573|P2|Overall Study|Adverse Event|0
4703517|NCT02261974|16207574|P1|Overall Study|Adverse Event|1
4703518|NCT02261974|16207573|P2|Overall Study|Lost to Follow-up|0
4703519|NCT02261974|16207574|P1|Overall Study|Lost to Follow-up|2
4703520|NCT02261974|16207573|P2|Overall Study|Received partial treatment; FU to 1 mo|1
4703521|NCT02261974|16207574|P1|Overall Study|Received partial treatment; FU to 1 mo|3
4703522|NCT02261974|16207573|P2|Overall Study|Missed treatment cut-off date|3
4703523|NCT02261974|16207574|P1|Overall Study|Missed treatment cut-off date|6
4703524|NCT02261974|16207573|P2|Overall Study|Pregnancy|1
4703525|NCT02261974|16207574|P1|Overall Study|Pregnancy|0
4703526|NCT02261974|16207573|P2|Overall Study|Withdrawal by Subject|2
4703527|NCT02261974|16207574|P1|Overall Study|Withdrawal by Subject|3
4703528|NCT02261493|16207638|P3|Overall Study|Adverse Event|0
4703529|NCT02261493|16207639|P2|Overall Study|Adverse Event|1
4703530|NCT02261493|16207640|P1|Overall Study|Adverse Event|0
4703531|NCT02261493|16207638|P3|Overall Study|Lack of Efficacy|0
4703532|NCT02261493|16207639|P2|Overall Study|Lack of Efficacy|1
4703533|NCT02261493|16207640|P1|Overall Study|Lack of Efficacy|0
4703534|NCT02261493|16207638|P3|Overall Study|Pregnancy|0
4703535|NCT02261493|16207639|P2|Overall Study|Pregnancy|2
4703536|NCT02261493|16207640|P1|Overall Study|Pregnancy|1
4703537|NCT02261493|16207638|P3|Overall Study|Lost to Follow-up|8
4703538|NCT02261493|16207639|P2|Overall Study|Lost to Follow-up|27
4703539|NCT02261493|16207640|P1|Overall Study|Lost to Follow-up|14
4703540|NCT02261493|16207638|P3|Overall Study|Personal Reasons|16
4703541|NCT02261493|16207639|P2|Overall Study|Personal Reasons|14
4703542|NCT02261493|16207640|P1|Overall Study|Personal Reasons|14
4703543|NCT02261493|16207638|P3|Overall Study|Protocol Violation|0
4703544|NCT02261493|16207639|P2|Overall Study|Protocol Violation|0
4703545|NCT02261493|16207640|P1|Overall Study|Protocol Violation|1
4703546|NCT02261493|16207638|P3|Overall Study|Undisclosed alcohol abuse|0
4703547|NCT02261493|16207639|P2|Overall Study|Undisclosed alcohol abuse|1
4703548|NCT02261493|16207640|P1|Overall Study|Undisclosed alcohol abuse|0
4703549|NCT02261493|16207638|P3|Overall Study|Physician Decision|0
4703550|NCT02261493|16207639|P2|Overall Study|Physician Decision|1
4703551|NCT02261493|16207640|P1|Overall Study|Physician Decision|0
4703552|NCT02261493|16207638|P3|Overall Study|Noncompliance|2
4703553|NCT02261493|16207639|P2|Overall Study|Noncompliance|0
4703554|NCT02261493|16207640|P1|Overall Study|Noncompliance|0
4703555|NCT02261467|16207668|P2|Overall Study|Adverse Event|1
4703556|NCT02261467|16207669|P1|Overall Study|Adverse Event|1
4703557|NCT02261467|16207668|P2|Overall Study|Lost to Follow-up|13
4703558|NCT02261467|16207669|P1|Overall Study|Lost to Follow-up|2
4703559|NCT02261467|16207668|P2|Overall Study|Personal Reasons|22
4703560|NCT02261467|16207669|P1|Overall Study|Personal Reasons|17
4703561|NCT02261467|16207668|P2|Overall Study|Protocol Violation|1
4703562|NCT02261467|16207669|P1|Overall Study|Protocol Violation|0
4703563|NCT02261467|16207668|P2|Overall Study|Enrolled in Error|0
4703564|NCT02261467|16207669|P1|Overall Study|Enrolled in Error|1
4703565|NCT02260986|16207711|P3|Overall Study|Pregnancy|0
4703566|NCT02260986|16207712|P2|Overall Study|Pregnancy|0
4703567|NCT02260986|16207713|P1|Overall Study|Pregnancy|2
4703568|NCT02260986|16207711|P3|Overall Study|Lost to Follow-up|3
4703569|NCT02260986|16207712|P2|Overall Study|Lost to Follow-up|0
4703570|NCT02260986|16207713|P1|Overall Study|Lost to Follow-up|4
4703571|NCT02260986|16207711|P3|Overall Study|Lack of investigation product supply|1
4703572|NCT02260986|16207712|P2|Overall Study|Lack of investigation product supply|0
4703573|NCT02260986|16207713|P1|Overall Study|Lack of investigation product supply|2
4703574|NCT02260986|16207711|P3|Overall Study|Incorrect randomization|0
4703575|NCT02260986|16207712|P2|Overall Study|Incorrect randomization|1
4703576|NCT02260986|16207713|P1|Overall Study|Incorrect randomization|0
4703577|NCT02260986|16207711|P3|Overall Study|Withdrawal by Subject|9
4703578|NCT02260986|16207712|P2|Overall Study|Withdrawal by Subject|4
4703579|NCT02260986|16207713|P1|Overall Study|Withdrawal by Subject|17
4703580|NCT02260986|16207711|P3|Overall Study|Car accident|1
4703581|NCT02260986|16207712|P2|Overall Study|Car accident|0
4703582|NCT02260986|16207713|P1|Overall Study|Car accident|0
4703583|NCT02260986|16207711|P3|Overall Study|Protocol Violation|16
4703584|NCT02260986|16207712|P2|Overall Study|Protocol Violation|5
4703585|NCT02260986|16207713|P1|Overall Study|Protocol Violation|14
4703586|NCT02260986|16207711|P3|Overall Study|Lack of Efficacy|0
4703587|NCT02260986|16207712|P2|Overall Study|Lack of Efficacy|3
4703588|NCT02260986|16207713|P1|Overall Study|Lack of Efficacy|27
4703589|NCT02260986|16207711|P3|Overall Study|Adverse Event|11
4703590|NCT02260986|16207712|P2|Overall Study|Adverse Event|0
4703591|NCT02260986|16207713|P1|Overall Study|Adverse Event|24
4703592|NCT02260934|16207831|P2|Overall Study|Site error|1
4703593|NCT02260934|16207832|P1|Overall Study|Site error|0
4703594|NCT02260934|16207831|P2|Overall Study|Participant Relocated|0
4703595|NCT02260934|16207832|P1|Overall Study|Participant Relocated|1
4703596|NCT02260934|16207831|P2|Overall Study|Withdrawal by Subject|2
4703597|NCT02260934|16207832|P1|Overall Study|Withdrawal by Subject|0
4703598|NCT02260934|16207831|P2|Overall Study|Lost to Follow-up|1
4703599|NCT02260934|16207832|P1|Overall Study|Lost to Follow-up|2
4703600|NCT02260882|16207870|P2|Overall Study|Protocol Violation|1
4703601|NCT02260882|16207871|P1|Overall Study|Protocol Violation|0
4703602|NCT02260817|16207895|P2|Overall Study|Protocol Violation|14
4703603|NCT02260817|16207896|P1|Overall Study|Protocol Violation|0
4703604|NCT02260817|16207895|P2|Overall Study|Biopsy infeasible, ADT & rad. therapy|1
4703605|NCT02260817|16207896|P1|Overall Study|Biopsy infeasible, ADT & rad. therapy|0
4703606|NCT02260817|16207895|P2|Overall Study|Observation, no biopsy|1
4703607|NCT02260817|16207896|P1|Overall Study|Observation, no biopsy|0
4703608|NCT02260817|16207895|P2|Overall Study|Androgen deprivation therapy, no biopsy|7
4703609|NCT02260817|16207896|P1|Overall Study|Androgen deprivation therapy, no biopsy|0
4703610|NCT02260817|16207895|P2|Overall Study|Lost to Follow-up|14
4703611|NCT02260817|16207896|P1|Overall Study|Lost to Follow-up|0
4703612|NCT02260791|16207944|P2|Overall Study|Protocol deviation|3
4703613|NCT02260791|16207945|P1|Overall Study|Protocol deviation|2
4703614|NCT02260791|16207944|P2|Overall Study|Screen failure|1
4703615|NCT02260791|16207945|P1|Overall Study|Screen failure|0
4703616|NCT02260791|16207944|P2|Overall Study|Withdrawal by Subject|16
4703617|NCT02260791|16207945|P1|Overall Study|Withdrawal by Subject|11
4703618|NCT02260791|16207944|P2|Overall Study|Death|0
4703619|NCT02260791|16207945|P1|Overall Study|Death|1
4703620|NCT02260791|16207944|P2|Overall Study|Adverse Event|9
4703621|NCT02260791|16207945|P1|Overall Study|Adverse Event|13
4703622|NCT02260791|16207944|P2|Overall Study|Lack of Efficacy|1
4703623|NCT02260791|16207945|P1|Overall Study|Lack of Efficacy|2
4703624|NCT02260791|16207944|P2|Overall Study|Lost to Follow-up|4
4703625|NCT02260791|16207945|P1|Overall Study|Lost to Follow-up|4
4703626|NCT02260648|16207984|P3|Overall Study|Discontinue Due to Study Termination|7
4703627|NCT02260648|16207985|P2|Overall Study|Discontinue Due to Study Termination|12
4703628|NCT02260648|16207986|P1|Overall Study|Discontinue Due to Study Termination|13
4703629|NCT02260648|16207984|P3|Overall Study|Protocol Violation|0
4703630|NCT02260648|16207985|P2|Overall Study|Protocol Violation|0
4703631|NCT02260648|16207986|P1|Overall Study|Protocol Violation|1
4703632|NCT02260648|16207984|P3|Overall Study|Withdrawal by Subject|0
4703633|NCT02260648|16207985|P2|Overall Study|Withdrawal by Subject|1
4703634|NCT02260648|16207986|P1|Overall Study|Withdrawal by Subject|1
4703635|NCT02260648|16207984|P3|Overall Study|Adverse Event|1
4703636|NCT02260648|16207985|P2|Overall Study|Adverse Event|0
4703637|NCT02260648|16207986|P1|Overall Study|Adverse Event|3
4703638|NCT02260635|16208014|P2|Open-Label Extension|Withdrawal by Subject|0
4703639|NCT02260635|16208015|P1|Open-Label Extension|Withdrawal by Subject|1
4703640|NCT02260635|16208014|P2|Open-Label Extension|Study Termination|25
4703641|NCT02260635|16208015|P1|Open-Label Extension|Study Termination|25
4703642|NCT02260635|16208014|P2|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2
4703643|NCT02260635|16208015|P1|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1
4703644|NCT02260492|16208067|P3|Overall Study|Withdrawal by Subject|2
4703645|NCT02260492|16208068|P2|Overall Study|Withdrawal by Subject|2
4703646|NCT02260492|16208069|P1|Overall Study|Withdrawal by Subject|3
4703647|NCT02260492|16208067|P3|Overall Study|Physician Decision|1
4703648|NCT02260492|16208068|P2|Overall Study|Physician Decision|0
4703649|NCT02260492|16208069|P1|Overall Study|Physician Decision|2
4703650|NCT02260492|16208067|P3|Overall Study|Lost to Follow-up|0
4703651|NCT02260492|16208068|P2|Overall Study|Lost to Follow-up|9
4703652|NCT02260492|16208069|P1|Overall Study|Lost to Follow-up|12
4703653|NCT02260492|16208067|P3|Overall Study|Death|0
4703654|NCT02260492|16208068|P2|Overall Study|Death|1
4703655|NCT02260492|16208069|P1|Overall Study|Death|0
4703656|NCT02260492|16208067|P3|Overall Study|Adverse Event|2
4703657|NCT02260492|16208068|P2|Overall Study|Adverse Event|1
4703658|NCT02260492|16208069|P1|Overall Study|Adverse Event|6
4703659|NCT02260388|16208102|P4|Overall Study|Lost to Follow-up|4
4703660|NCT02260388|16208103|P3|Overall Study|Lost to Follow-up|3
4703661|NCT02260388|16208104|P2|Overall Study|Lost to Follow-up|8
4703662|NCT02260388|16208105|P1|Overall Study|Lost to Follow-up|2
4703663|NCT02260180|16208134|P3|Overall Study|Adverse Event|1
4703664|NCT02260180|16208135|P2|Overall Study|Adverse Event|0
4703665|NCT02260180|16208136|P1|Overall Study|Adverse Event|2
4703666|NCT02260154|16208147|P1|Overall Study|Screening failure|2
4703667|NCT02259582|16208187|P3|Overall Study|Lack of Subject Adherence to Protocol|1
4703668|NCT02259582|16208188|P2|Overall Study|Lack of Subject Adherence to Protocol|1
4703669|NCT02259582|16208189|P1|Overall Study|Lack of Subject Adherence to Protocol|1
4703670|NCT02259582|16208187|P3|Overall Study|Disease progression|17
4703671|NCT02259582|16208188|P2|Overall Study|Disease progression|15
4703672|NCT02259582|16208189|P1|Overall Study|Disease progression|14
4703673|NCT02259582|16208187|P3|Overall Study|Withdrawal by Subject|1
4703674|NCT02259582|16208188|P2|Overall Study|Withdrawal by Subject|0
4703675|NCT02259582|16208189|P1|Overall Study|Withdrawal by Subject|0
4703676|NCT02259582|16208187|P3|Overall Study|Adverse Event|1
4703677|NCT02259582|16208188|P2|Overall Study|Adverse Event|0
4703678|NCT02259582|16208189|P1|Overall Study|Adverse Event|1
4703679|NCT02259582|16208187|P3|Overall Study|Death|1
4703680|NCT02259582|16208188|P2|Overall Study|Death|0
4703681|NCT02259582|16208189|P1|Overall Study|Death|0
4703682|NCT02259582|16208187|P3|Overall Study|Physician Decision|0
4703683|NCT02259582|16208188|P2|Overall Study|Physician Decision|1
4703684|NCT02259582|16208189|P1|Overall Study|Physician Decision|0
4703685|NCT02259400|16208396|P2|Overall Study|Death|2
4703686|NCT02259400|16208397|P1|Overall Study|Death|0
4703687|NCT02259348|16208429|P1|Overall Study|Death|4
4703688|NCT02259348|16208429|P1|Overall Study|Donors|6
4703689|NCT02259114|16208446|P5|Overall Study|Not Treated|0
4703690|NCT02259114|16208447|P4|Overall Study|Not Treated|0
4703691|NCT02259114|16208448|P3|Overall Study|Not Treated|0
4703692|NCT02259114|16208449|P2|Overall Study|Not Treated|0
4703693|NCT02259114|16208450|P1|Overall Study|Not Treated|1
4703694|NCT02259114|16208446|P5|Overall Study|Treatment Delay >2 wks: Toxicity|0
4703695|NCT02259114|16208447|P4|Overall Study|Treatment Delay >2 wks: Toxicity|0
4703696|NCT02259114|16208448|P3|Overall Study|Treatment Delay >2 wks: Toxicity|0
4703697|NCT02259114|16208449|P2|Overall Study|Treatment Delay >2 wks: Toxicity|1
4703698|NCT02259114|16208450|P1|Overall Study|Treatment Delay >2 wks: Toxicity|1
4703699|NCT02259114|16208446|P5|Overall Study|Withdrawal by Subject|0
4703700|NCT02259114|16208447|P4|Overall Study|Withdrawal by Subject|1
4703701|NCT02259114|16208448|P3|Overall Study|Withdrawal by Subject|1
4703702|NCT02259114|16208449|P2|Overall Study|Withdrawal by Subject|0
4703703|NCT02259114|16208450|P1|Overall Study|Withdrawal by Subject|0
4703704|NCT02259114|16208446|P5|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4703705|NCT02259114|16208447|P4|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4703706|NCT02259114|16208448|P3|Overall Study|Treatment Delay >2 wks: Adverse Event|1
4703707|NCT02259114|16208449|P2|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4703708|NCT02259114|16208450|P1|Overall Study|Treatment Delay >2 wks: Adverse Event|0
4703709|NCT02259114|16208446|P5|Overall Study|Death|0
4703710|NCT02259114|16208447|P4|Overall Study|Death|0
4703711|NCT02259114|16208448|P3|Overall Study|Death|1
4703712|NCT02259114|16208449|P2|Overall Study|Death|0
4703713|NCT02259114|16208450|P1|Overall Study|Death|3
4703714|NCT02259114|16208446|P5|Overall Study|Adverse Event|1
4703715|NCT02259114|16208447|P4|Overall Study|Adverse Event|0
4703716|NCT02259114|16208448|P3|Overall Study|Adverse Event|0
4703717|NCT02259114|16208449|P2|Overall Study|Adverse Event|1
4703718|NCT02259114|16208450|P1|Overall Study|Adverse Event|2
4703719|NCT02259114|16208446|P5|Overall Study|Progressive Disease|5
4703720|NCT02259114|16208447|P4|Overall Study|Progressive Disease|2
4703721|NCT02259114|16208448|P3|Overall Study|Progressive Disease|10
4703722|NCT02259114|16208449|P2|Overall Study|Progressive Disease|2
4703723|NCT02259114|16208450|P1|Overall Study|Progressive Disease|14
4703724|NCT02259088|16208509|P2|Overall Study|Subject/guardian decision|8
4703725|NCT02259088|16208510|P1|Overall Study|Subject/guardian decision|8
4703726|NCT02259088|16208509|P2|Overall Study|Protocol deviation|0
4703727|NCT02259088|16208510|P1|Overall Study|Protocol deviation|5
4703728|NCT02259088|16208509|P2|Overall Study|Physician Decision|2
4703729|NCT02259088|16208510|P1|Overall Study|Physician Decision|5
4703730|NCT02259088|16208509|P2|Overall Study|Death|0
4703731|NCT02259088|16208510|P1|Overall Study|Death|2
4703732|NCT02259088|16208509|P2|Overall Study|Lost to Follow-up|0
4703733|NCT02259088|16208510|P1|Overall Study|Lost to Follow-up|2
4703734|NCT02259088|16208509|P2|Overall Study|Adverse Event|4
4703735|NCT02259088|16208510|P1|Overall Study|Adverse Event|6
4703736|NCT02259010|16208555|P1|Overall Study|Didn't Completed Dosing; PK Assessment|5
4703737|NCT02258542|16208584|P4|Overall Study|Eligibility criteria not fulfilled|0
4703738|NCT02258542|16208585|P3|Overall Study|Eligibility criteria not fulfilled|0
4703739|NCT02258542|16208586|P2|Overall Study|Eligibility criteria not fulfilled|2
4703740|NCT02258542|16208587|P1|Overall Study|Eligibility criteria not fulfilled|0
4703741|NCT02258542|16208584|P4|Overall Study|Protocol Violation|0
4703742|NCT02258542|16208585|P3|Overall Study|Protocol Violation|0
4703743|NCT02258542|16208586|P2|Overall Study|Protocol Violation|2
4703744|NCT02258542|16208587|P1|Overall Study|Protocol Violation|1
4703745|NCT02258542|16208584|P4|Overall Study|Adverse Event|0
4703746|NCT02258542|16208585|P3|Overall Study|Adverse Event|0
4703747|NCT02258542|16208586|P2|Overall Study|Adverse Event|4
4703748|NCT02258542|16208587|P1|Overall Study|Adverse Event|3
4703749|NCT02258542|16208584|P4|Overall Study|Death|1
4703750|NCT02258542|16208585|P3|Overall Study|Death|0
4703751|NCT02258542|16208586|P2|Overall Study|Death|4
4703752|NCT02258542|16208587|P1|Overall Study|Death|5
4703753|NCT02258542|16208584|P4|Overall Study|Lost to Follow-up|2
4703754|NCT02258542|16208585|P3|Overall Study|Lost to Follow-up|1
4703755|NCT02258542|16208586|P2|Overall Study|Lost to Follow-up|12
4703756|NCT02258542|16208587|P1|Overall Study|Lost to Follow-up|5
4703757|NCT02258542|16208584|P4|Overall Study|Withdrawal by Subject|1
4703758|NCT02258542|16208585|P3|Overall Study|Withdrawal by Subject|7
4703759|NCT02258542|16208586|P2|Overall Study|Withdrawal by Subject|20
4703760|NCT02258542|16208587|P1|Overall Study|Withdrawal by Subject|20
4703761|NCT02258542|16208584|P4|Overall Study|study specific discount. criteria|0
4703762|NCT02258542|16208585|P3|Overall Study|study specific discount. criteria|0
4703763|NCT02258542|16208586|P2|Overall Study|study specific discount. criteria|1
4703764|NCT02258542|16208587|P1|Overall Study|study specific discount. criteria|1
4703765|NCT02258542|16208584|P4|Overall Study|eg. not made to the visit|1
4703766|NCT02258542|16208585|P3|Overall Study|eg. not made to the visit|0
4703767|NCT02258542|16208586|P2|Overall Study|eg. not made to the visit|4
4703768|NCT02258542|16208587|P1|Overall Study|eg. not made to the visit|7
4703769|NCT02258529|16208811|P1|Overall Study|Adverse Event|1
4703770|NCT02258529|16208811|P1|Overall Study|Study Terminated by Sponsor|9
4703771|NCT02258464|16208843|P2|Overall Study|AE related to clinical PD|0
4703772|NCT02258464|16208844|P1|Overall Study|AE related to clinical PD|1
4703773|NCT02258464|16208843|P2|Overall Study|Withdrawal by Subject|4
4703774|NCT02258464|16208844|P1|Overall Study|Withdrawal by Subject|5
4703775|NCT02258464|16208843|P2|Overall Study|AE not related to clinical PD|3
4703776|NCT02258464|16208844|P1|Overall Study|AE not related to clinical PD|1
4703777|NCT02258464|16208843|P2|Overall Study|Study drug never administered|1
4703778|NCT02258464|16208844|P1|Overall Study|Study drug never administered|1
4703779|NCT02258464|16208843|P2|Overall Study|Progressive disease (PD)|17
4703780|NCT02258464|16208844|P1|Overall Study|Progressive disease (PD)|9
4703781|NCT02258334|16208925|P4|Overall Study|Adverse Event|0
4703782|NCT02258334|16208926|P3|Overall Study|Adverse Event|0
4703783|NCT02258334|16208927|P2|Overall Study|Adverse Event|0
4703784|NCT02258334|16208928|P1|Overall Study|Adverse Event|1
4703785|NCT02257918|16209020|P3|Overall Study|Pregnancy|1
4703786|NCT02257918|16209021|P2|Overall Study|Pregnancy|0
4703787|NCT02257918|16209022|P1|Overall Study|Pregnancy|0
4703788|NCT02257918|16209020|P3|Overall Study|Withdrawal by Subject|1
4703789|NCT02257918|16209021|P2|Overall Study|Withdrawal by Subject|0
4703790|NCT02257918|16209022|P1|Overall Study|Withdrawal by Subject|0
4703791|NCT02257918|16209020|P3|Overall Study|Lost to Follow-up|0
4703792|NCT02257918|16209021|P2|Overall Study|Lost to Follow-up|1
4703793|NCT02257918|16209022|P1|Overall Study|Lost to Follow-up|4
4703794|NCT02257684|16209072|P1|Overall Study|Sponsor's Decision|1
4703795|NCT02257684|16209072|P1|Overall Study|Lack of Efficacy|1
4703796|NCT02257684|16209072|P1|Overall Study|Adverse Event|2
4703797|NCT02257632|16209082|P2|Overall Study|Adverse Event|2
4703798|NCT02257632|16209083|P1|Overall Study|Adverse Event|1
4703799|NCT02257632|16209082|P2|Overall Study|Withdrawal by Subject|1
4703800|NCT02257632|16209083|P1|Overall Study|Withdrawal by Subject|0
4703801|NCT02257528|16209123|P1|Overall Study|Never received study treatment|1
4703802|NCT02257489|16209139|P9|Overall Study|Withdrawal by Subject|0
4703803|NCT02257489|16209140|P8|Overall Study|Withdrawal by Subject|0
4703804|NCT02257489|16209141|P7|Overall Study|Withdrawal by Subject|0
4703805|NCT02257489|16209142|P6|Overall Study|Withdrawal by Subject|0
4703806|NCT02257489|16209143|P5|Overall Study|Withdrawal by Subject|0
4703807|NCT02257489|16209144|P4|Overall Study|Withdrawal by Subject|1
4703808|NCT02257489|16209145|P3|Overall Study|Withdrawal by Subject|0
4703809|NCT02257489|16209146|P2|Overall Study|Withdrawal by Subject|0
4703810|NCT02257489|16209147|P1|Overall Study|Withdrawal by Subject|0
4703811|NCT02257385|16209183|P2|Overall Study|Withdrawal by Subject|4
4703812|NCT02257385|16209184|P1|Overall Study|Withdrawal by Subject|4
4703813|NCT02257385|16209183|P2|Overall Study|Lost to Follow-up|1
4703814|NCT02257385|16209184|P1|Overall Study|Lost to Follow-up|0
4703815|NCT02257385|16209183|P2|Overall Study|Protocol Violation|7
4703816|NCT02257385|16209184|P1|Overall Study|Protocol Violation|5
4703817|NCT02257385|16209183|P2|Overall Study|Lack of Efficacy|2
4703818|NCT02257385|16209184|P1|Overall Study|Lack of Efficacy|1
4703819|NCT02257385|16209183|P2|Overall Study|Adverse Event|8
4703820|NCT02257385|16209184|P1|Overall Study|Adverse Event|12
4703821|NCT02257372|16209194|P2|Overall Study|Withdrew consent|0
4703822|NCT02257372|16209195|P1|Overall Study|Withdrew consent|1
4703823|NCT02257372|16209194|P2|Overall Study|Lost to Follow-up|1
4703824|NCT02257372|16209195|P1|Overall Study|Lost to Follow-up|0
4703825|NCT02257372|16209194|P2|Overall Study|Protocol Violation|1
4703826|NCT02257372|16209195|P1|Overall Study|Protocol Violation|1
4703827|NCT02257372|16209194|P2|Overall Study|Lack of Efficacy|1
4703828|NCT02257372|16209195|P1|Overall Study|Lack of Efficacy|2
4703829|NCT02257372|16209194|P2|Overall Study|Adverse Event|7
4703830|NCT02257372|16209195|P1|Overall Study|Adverse Event|3
4703831|NCT02256982|16209212|P2|Overall Study|Disease Progression|1
4703832|NCT02256982|16209213|P1|Overall Study|Disease Progression|0
4703833|NCT02256969|16209222|P3|Overall Study|Screenfailed or withdrew|1
4703834|NCT02256969|16209223|P2|Overall Study|Screenfailed or withdrew|1
4703835|NCT02256969|16209224|P1|Overall Study|Screenfailed or withdrew|2
4703836|NCT02256917|16209241|P1|Prophylactic Treatment Phase II|Discontinued medication|1
4703837|NCT02256917|16209241|P1|Prophylactic Treatment Phase II|Did not attend completion visit|1
4703838|NCT02256917|16209241|P1|Prophylactic Treatment Phase II|Withdrawn Consent|1
4703839|NCT02256917|16209241|P1|Prophylactic Treatment Phase II|Lost to Follow-up|1
4703840|NCT02256917|16209241|P1|Prophylactic Treatment Phase I|Lost to Follow-up|1
4703841|NCT02256891|16209262|P2|Overall Study|Equipment Malfunction|1
4703842|NCT02256891|16209263|P1|Overall Study|Equipment Malfunction|0
4703843|NCT02256891|16209262|P2|Overall Study|Screen Fail|4
4703844|NCT02256891|16209263|P1|Overall Study|Screen Fail|5
4703845|NCT02256891|16209262|P2|Overall Study|Physician Decision|3
4703846|NCT02256891|16209263|P1|Overall Study|Physician Decision|7
4703847|NCT02256891|16209262|P2|Overall Study|Lost to Follow-up|3
4703848|NCT02256891|16209263|P1|Overall Study|Lost to Follow-up|0
4703849|NCT02256891|16209262|P2|Overall Study|Death|2
4703850|NCT02256891|16209263|P1|Overall Study|Death|0
4703851|NCT02256839|16209289|P2|Overall Study|Did not meet Eligibility Criteria|3
4703852|NCT02256839|16209290|P1|Overall Study|Did not meet Eligibility Criteria|2
4703853|NCT02256553|16209296|P1|Period III|Adverse Event|3
4703854|NCT02256553|16209296|P1|Period II|Subject Moved|1
4703855|NCT02256553|16209296|P1|Period II|Adverse Event|1
4703856|NCT02256553|16209296|P1|Period I|Protocol Violation|1
4703857|NCT02256553|16209296|P1|Period I|Adverse Event|5
4703858|NCT02256540|16209305|P3|Overall Study|Back pain preventing exercise|1
4703859|NCT02256540|16209306|P2|Overall Study|Back pain preventing exercise|0
4703860|NCT02256540|16209307|P1|Overall Study|Back pain preventing exercise|0
4703861|NCT02256540|16209305|P3|Overall Study|Withdrawal by Subject|1
4703862|NCT02256540|16209306|P2|Overall Study|Withdrawal by Subject|1
4703863|NCT02256540|16209307|P1|Overall Study|Withdrawal by Subject|0
4703864|NCT02256488|16209325|P4|Overall Study|Withdrawal by Subject|2
4703865|NCT02256488|16209326|P3|Overall Study|Withdrawal by Subject|0
4703866|NCT02256488|16209327|P2|Overall Study|Withdrawal by Subject|0
4703867|NCT02256488|16209328|P1|Overall Study|Withdrawal by Subject|1
4703868|NCT02256488|16209325|P4|Overall Study|OTHER|1
4703869|NCT02256488|16209326|P3|Overall Study|OTHER|1
4703870|NCT02256488|16209327|P2|Overall Study|OTHER|0
4703871|NCT02256488|16209328|P1|Overall Study|OTHER|1
4703872|NCT02256488|16209325|P4|Overall Study|Lost to Follow-up|3
4703873|NCT02256488|16209326|P3|Overall Study|Lost to Follow-up|9
4703874|NCT02256488|16209327|P2|Overall Study|Lost to Follow-up|6
4703875|NCT02256488|16209328|P1|Overall Study|Lost to Follow-up|6
4703876|NCT02256436|16209344|P2|Overall Study|Ongoing in Study|67
4703877|NCT02256436|16209345|P1|Overall Study|Ongoing in Study|108
4703878|NCT02256436|16209344|P2|Overall Study|Withdrawal by Subject|30
4703879|NCT02256436|16209345|P1|Overall Study|Withdrawal by Subject|7
4703880|NCT02256436|16209344|P2|Overall Study|Protocol Violation|0
4703881|NCT02256436|16209345|P1|Overall Study|Protocol Violation|1
4703882|NCT02256436|16209344|P2|Overall Study|Physician Decision|3
4703883|NCT02256436|16209345|P1|Overall Study|Physician Decision|1
4703884|NCT02256436|16209344|P2|Overall Study|Lost to Follow-up|1
4703885|NCT02256436|16209345|P1|Overall Study|Lost to Follow-up|1
4703886|NCT02256436|16209344|P2|Overall Study|Death|158
4703887|NCT02256436|16209345|P1|Overall Study|Death|137
4703888|NCT02256436|16209344|P2|Overall Study|Adverse Event|13
4703889|NCT02256436|16209345|P1|Overall Study|Adverse Event|15
4703890|NCT02256384|16209381|P1|Overall Study|Equipment not capturing data|2
4703891|NCT02256384|16209381|P1|Overall Study|Withdrawal by Subject|12
4703892|NCT02256267|16209414|P1|Period 2 (Day 7 to Day 14)|Adverse Event|1
4703893|NCT02256267|16209414|P1|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1
4703894|NCT02255981|16209487|P1|Overall Study|Withdrawal by Subject|1
4703895|NCT02255981|16209487|P1|Overall Study|Lost to Follow-up|3
4703896|NCT02255760|16209502|P5|Overall Study|Lost to Follow-up|0
4703897|NCT02255760|16209503|P4|Overall Study|Lost to Follow-up|0
4703898|NCT02255760|16209504|P3|Overall Study|Lost to Follow-up|0
4703899|NCT02255760|16209505|P2|Overall Study|Lost to Follow-up|1
4703900|NCT02255760|16209506|P1|Overall Study|Lost to Follow-up|0
4703901|NCT02255565|16209561|P3|Overall Study|Withdrawal by Subject|0
4703902|NCT02255565|16209562|P2|Overall Study|Withdrawal by Subject|1
4703903|NCT02255565|16209563|P1|Overall Study|Withdrawal by Subject|0
4703904|NCT02255552|16209624|P2|Overall Study|Withdrawal by Subject|4
4703905|NCT02255552|16209625|P1|Overall Study|Withdrawal by Subject|1
4703906|NCT02255552|16209624|P2|Overall Study|Participants enrolled into another study|11
4703907|NCT02255552|16209625|P1|Overall Study|Participants enrolled into another study|0
4703908|NCT02255461|16209645|P5|Overall Study|Not meet dose reduction BSA requirement|0
4703909|NCT02255461|16209646|P4|Overall Study|Not meet dose reduction BSA requirement|0
4703910|NCT02255461|16209647|P3|Overall Study|Not meet dose reduction BSA requirement|0
4703911|NCT02255461|16209648|P2|Overall Study|Not meet dose reduction BSA requirement|1
4703912|NCT02255461|16209649|P1|Overall Study|Not meet dose reduction BSA requirement|0
4703913|NCT02255461|16209645|P5|Overall Study|Withdrawal by Subject|1
4703914|NCT02255461|16209646|P4|Overall Study|Withdrawal by Subject|0
4703915|NCT02255461|16209647|P3|Overall Study|Withdrawal by Subject|1
4703916|NCT02255461|16209648|P2|Overall Study|Withdrawal by Subject|0
4703917|NCT02255461|16209649|P1|Overall Study|Withdrawal by Subject|0
4703918|NCT02255461|16209645|P5|Overall Study|Adverse Event|1
4703919|NCT02255461|16209646|P4|Overall Study|Adverse Event|0
4703920|NCT02255461|16209647|P3|Overall Study|Adverse Event|0
4703921|NCT02255461|16209648|P2|Overall Study|Adverse Event|1
4703922|NCT02255461|16209649|P1|Overall Study|Adverse Event|0
4703923|NCT02255279|16209732|P2|Overall Study|Withdrawal by Subject|6
4703924|NCT02255279|16209733|P1|Overall Study|Withdrawal by Subject|3
4703925|NCT02255279|16209732|P2|Overall Study|Protocol Violation|1
4703926|NCT02255279|16209733|P1|Overall Study|Protocol Violation|0
4703927|NCT02255279|16209732|P2|Overall Study|Lost to Follow-up|2
4703928|NCT02255279|16209733|P1|Overall Study|Lost to Follow-up|2
4703929|NCT02255149|16209786|P1|Overall Study|Implant Failure|1
4703930|NCT02255149|16209786|P1|Overall Study|Withdrawal by PI|1
4703931|NCT02255149|16209786|P1|Overall Study|Withdrawal by Subject|1
4703932|NCT02255149|16209786|P1|Overall Study|Lost to Follow-up|2
4703933|NCT02255097|16209802|P1|Overall Study|Treatment Ongoing|36
4703934|NCT02255097|16209802|P1|Overall Study|Allocated but not treated|1
4703935|NCT02255097|16209802|P1|Overall Study|Withdrawal by Subject|2
4703936|NCT02255097|16209802|P1|Overall Study|Progressive Disease|80
4703937|NCT02255097|16209802|P1|Overall Study|Physician Decision|1
4703938|NCT02255097|16209802|P1|Overall Study|Lost to Follow-up|1
4703939|NCT02255097|16209802|P1|Overall Study|Death|2
4703940|NCT02255097|16209802|P1|Overall Study|Excluded Medication|1
4703941|NCT02255097|16209802|P1|Overall Study|Complete Response|1
4703942|NCT02255097|16209802|P1|Overall Study|Clinical Progression|23
4703943|NCT02255097|16209802|P1|Overall Study|Adverse Event|24
4703944|NCT02254772|16209823|P1|Overall Study|Withdrawal by Subject|1
4703945|NCT02254772|16209823|P1|Overall Study|Ineligible|1
4703946|NCT02254681|16209829|P1|Overall Study|Lack of Efficacy|6
4703947|NCT02254551|16209839|P1|Dose Escalation|Dose-limiting toxicity|2
4703948|NCT02254551|16209839|P1|Dose Escalation|Physician Decision|1
4703949|NCT02254486|16209849|P2|Overall Study|Various|12
4703950|NCT02254486|16209850|P1|Overall Study|Various|12
4703951|NCT02254486|16209849|P2|Overall Study|GFR<60mL/min|21
4703952|NCT02254486|16209850|P1|Overall Study|GFR<60mL/min|16
4703953|NCT02254486|16209849|P2|Overall Study|Withdrawal by Subject|15
4703954|NCT02254486|16209850|P1|Overall Study|Withdrawal by Subject|17
4703955|NCT02254486|16209849|P2|Overall Study|Protocol Violation|2
4703956|NCT02254486|16209850|P1|Overall Study|Protocol Violation|1
4703957|NCT02254486|16209849|P2|Overall Study|Lost to Follow-up|4
4703958|NCT02254486|16209850|P1|Overall Study|Lost to Follow-up|2
4703959|NCT02254486|16209849|P2|Overall Study|Lack of Efficacy|0
4703960|NCT02254486|16209850|P1|Overall Study|Lack of Efficacy|1
4703961|NCT02254486|16209849|P2|Overall Study|Adverse Event|1
4703962|NCT02254486|16209850|P1|Overall Study|Adverse Event|1
4703963|NCT02254460|16209889|P2|Overall Study|Adverse Event|0
4703964|NCT02254460|16209890|P1|Overall Study|Adverse Event|1
4703965|NCT02254421|16209898|P2|Overall Study|Withdrew Consent|1
4703966|NCT02254421|16209899|P1|Overall Study|Withdrew Consent|1
4703967|NCT02254421|16209898|P2|Overall Study|Death|2
4703968|NCT02254421|16209899|P1|Overall Study|Death|0
4703969|NCT02254421|16209898|P2|Overall Study|Randomized but Not Treated|0
4703970|NCT02254421|16209899|P1|Overall Study|Randomized but Not Treated|1
4703971|NCT02254408|16209913|P2|Overall Study|Lost to Follow-up|0
4703972|NCT02254408|16209914|P1|Overall Study|Lost to Follow-up|1
4703973|NCT02254408|16209913|P2|Overall Study|Withdrawal by Subject|3
4703974|NCT02254408|16209914|P1|Overall Study|Withdrawal by Subject|3
4703975|NCT02254408|16209913|P2|Overall Study|Investigator's Discretion|1
4703976|NCT02254408|16209914|P1|Overall Study|Investigator's Discretion|0
4703977|NCT02254408|16209913|P2|Overall Study|Death|3
4703978|NCT02254408|16209914|P1|Overall Study|Death|2
4703979|NCT02254408|16209913|P2|Overall Study|Adverse Event|0
4703980|NCT02254408|16209914|P1|Overall Study|Adverse Event|1
4703981|NCT02254408|16209913|P2|Overall Study|Randomized But Not Treated|3
4703982|NCT02254408|16209914|P1|Overall Study|Randomized But Not Treated|1
4703983|NCT02254304|16209926|P2|Overall Study|Personal decision|0
4703984|NCT02254304|16209927|P1|Overall Study|Personal decision|1
4703985|NCT02254304|16209926|P2|Overall Study|Personal causes|1
4703986|NCT02254304|16209927|P1|Overall Study|Personal causes|4
4703987|NCT02254304|16209926|P2|Overall Study|Injection site pain and Injection fear|0
4703988|NCT02254304|16209927|P1|Overall Study|Injection site pain and Injection fear|1
4703989|NCT02254304|16209926|P2|Overall Study|Withdrawal by Subject|0
4703990|NCT02254304|16209927|P1|Overall Study|Withdrawal by Subject|3
4703991|NCT02254304|16209926|P2|Overall Study|Protocol Violation|0
4703992|NCT02254304|16209927|P1|Overall Study|Protocol Violation|1
4703993|NCT02254304|16209926|P2|Overall Study|Lost to Follow-up|2
4703994|NCT02254304|16209927|P1|Overall Study|Lost to Follow-up|2
4703995|NCT02254304|16209926|P2|Overall Study|Adverse Event|1
4703996|NCT02254304|16209927|P1|Overall Study|Adverse Event|2
4703997|NCT02254291|16209987|P3|Overall Study|Missing follow-up information|1
4703998|NCT02254291|16209988|P2|Overall Study|Missing follow-up information|0
4703999|NCT02254291|16209989|P1|Overall Study|Missing follow-up information|0
4704000|NCT02254291|16209987|P3|Overall Study|Withdrawal by Subject|1
4704001|NCT02254291|16209988|P2|Overall Study|Withdrawal by Subject|3
4704002|NCT02254291|16209989|P1|Overall Study|Withdrawal by Subject|0
4704003|NCT02254278|16210005|P2|Overall Study|Protocol Violation|1
4704004|NCT02254278|16210006|P1|Overall Study|Protocol Violation|1
4704005|NCT02253992|16210067|P3|Overall Study|Other|1
4704006|NCT02253992|16210068|P2|Overall Study|Other|0
4704007|NCT02253992|16210069|P1|Overall Study|Other|0
4704008|NCT02253992|16210067|P3|Overall Study|Completed treatment as per protocol|22
4704009|NCT02253992|16210068|P2|Overall Study|Completed treatment as per protocol|1
4704010|NCT02253992|16210069|P1|Overall Study|Completed treatment as per protocol|0
4704011|NCT02253992|16210067|P3|Overall Study|Subject discontinued study drug|1
4704012|NCT02253992|16210068|P2|Overall Study|Subject discontinued study drug|0
4704013|NCT02253992|16210069|P1|Overall Study|Subject discontinued study drug|1
4704014|NCT02253992|16210067|P3|Overall Study|Death|1
4704015|NCT02253992|16210068|P2|Overall Study|Death|0
4704016|NCT02253992|16210069|P1|Overall Study|Death|0
4704017|NCT02253992|16210067|P3|Overall Study|Adverse Event|8
4704018|NCT02253992|16210068|P2|Overall Study|Adverse Event|0
4704019|NCT02253992|16210069|P1|Overall Study|Adverse Event|0
4704020|NCT02253992|16210067|P3|Overall Study|Withdrawal by Subject|3
4704021|NCT02253992|16210068|P2|Overall Study|Withdrawal by Subject|0
4704022|NCT02253992|16210069|P1|Overall Study|Withdrawal by Subject|0
4704023|NCT02253992|16210067|P3|Overall Study|Disease progression|98
4704024|NCT02253992|16210068|P2|Overall Study|Disease progression|3
4704025|NCT02253992|16210069|P1|Overall Study|Disease progression|4
4704026|NCT02253992|16210067|P3|Overall Study|Study drug toxicity|10
4704027|NCT02253992|16210068|P2|Overall Study|Study drug toxicity|0
4704028|NCT02253992|16210069|P1|Overall Study|Study drug toxicity|1
4704029|NCT02253654|16210135|P2|Overall Study|Did Not Receive Study Treatment|1
4704030|NCT02253654|16210136|P1|Overall Study|Did Not Receive Study Treatment|4
4704031|NCT02253654|16210135|P2|Overall Study|Death|7
4704032|NCT02253654|16210136|P1|Overall Study|Death|4
4704033|NCT02253654|16210135|P2|Overall Study|Lost to Follow-up|5
4704034|NCT02253654|16210136|P1|Overall Study|Lost to Follow-up|2
4704035|NCT02253654|16210135|P2|Overall Study|Decision by Sponsor|1
4704036|NCT02253654|16210136|P1|Overall Study|Decision by Sponsor|1
4704037|NCT02253654|16210135|P2|Overall Study|Withdrawal by Subject|4
4704038|NCT02253654|16210136|P1|Overall Study|Withdrawal by Subject|12
4704039|NCT02253433|16210162|P2|Overall Study|Medical or Other Concerns|2
4704040|NCT02253433|16210163|P1|Overall Study|Medical or Other Concerns|1
4704041|NCT02253433|16210162|P2|Overall Study|Too Busy|4
4704042|NCT02253433|16210163|P1|Overall Study|Too Busy|0
4704043|NCT02253433|16210162|P2|Overall Study|Unstable Housing/Homeless|7
4704044|NCT02253433|16210163|P1|Overall Study|Unstable Housing/Homeless|0
4704045|NCT02253433|16210162|P2|Overall Study|Uncomfortable with home visitors|3
4704046|NCT02253433|16210163|P1|Overall Study|Uncomfortable with home visitors|0
4704047|NCT02253433|16210162|P2|Overall Study|Out of Study Area|7
4704048|NCT02253433|16210163|P1|Overall Study|Out of Study Area|2
4704049|NCT02253433|16210162|P2|Overall Study|No Longer Interested|15
4704050|NCT02253433|16210163|P1|Overall Study|No Longer Interested|3
4704051|NCT02253433|16210162|P2|Overall Study|Death|1
4704052|NCT02253433|16210163|P1|Overall Study|Death|1
4704053|NCT02253433|16210162|P2|Overall Study|Unable to Contact|16
4704054|NCT02253433|16210163|P1|Overall Study|Unable to Contact|9
4704055|NCT02253147|16210422|P1|Overall Study|Withdrawal by Subject|1
4704056|NCT02253147|16210422|P1|Overall Study|Lost to Follow-up|2
4704057|NCT02253147|16210422|P1|Overall Study|Conditional re-treatment at W52|5
4704058|NCT02253147|16210422|P1|Overall Study|Did not consent to study extension|9
4704059|NCT02253147|16210422|P1|Overall Study|Protocol Violation|30
4704060|NCT02252965|16210456|P2|Overall Study|Other|5
4704061|NCT02252965|16210457|P1|Overall Study|Other|4
4704062|NCT02252965|16210456|P2|Overall Study|Withdrawal by Subject|9
4704063|NCT02252965|16210457|P1|Overall Study|Withdrawal by Subject|7
4704064|NCT02252965|16210456|P2|Overall Study|Lack of Efficacy|2
4704065|NCT02252965|16210457|P1|Overall Study|Lack of Efficacy|0
4704066|NCT02252965|16210456|P2|Overall Study|Protocol Violation|5
4704067|NCT02252965|16210457|P1|Overall Study|Protocol Violation|4
4704068|NCT02252965|16210456|P2|Overall Study|Lost to Follow-up|8
4704069|NCT02252965|16210457|P1|Overall Study|Lost to Follow-up|16
4704070|NCT02252965|16210456|P2|Overall Study|Adverse Event|14
4704071|NCT02252965|16210457|P1|Overall Study|Adverse Event|9
4704072|NCT02252939|16210484|P1|Overall Study|Lost to Follow-up|3
4704073|NCT02252536|16210541|P2|Overall Study|Lost to Follow-up|3
4704074|NCT02252536|16210542|P1|Overall Study|Lost to Follow-up|5
4704075|NCT02252406|16210603|P2|Titrated to Ranolazine 1000mg BID|Adverse Event|0
4704076|NCT02252406|16210604|P1|Titrated to Ranolazine 1000mg BID|Adverse Event|2
4704077|NCT02252406|16210603|P2|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
4704078|NCT02252406|16210604|P1|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1
4704079|NCT02252406|16210603|P2|Starting Dose Ranolazine 500 mg BID|Adverse Event|0
4704080|NCT02252406|16210604|P1|Starting Dose Ranolazine 500 mg BID|Adverse Event|1
4704081|NCT02252406|16210603|P2|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0
4704082|NCT02252406|16210604|P1|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1
4704083|NCT02252406|16210603|P2|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3
4704084|NCT02252406|16210604|P1|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2
4704085|NCT02252211|16210662|P3|Overall Study|Serious Adverse Event During Screening|1
4704086|NCT02252211|16210663|P2|Overall Study|Serious Adverse Event During Screening|0
4704087|NCT02252211|16210664|P1|Overall Study|Serious Adverse Event During Screening|1
4704088|NCT02252211|16210662|P3|Overall Study|Withdrawal by Subject|0
4704089|NCT02252211|16210663|P2|Overall Study|Withdrawal by Subject|0
4704090|NCT02252211|16210664|P1|Overall Study|Withdrawal by Subject|1
4704091|NCT02252211|16210662|P3|Overall Study|Progressive disease|0
4704092|NCT02252211|16210663|P2|Overall Study|Progressive disease|2
4704093|NCT02252211|16210664|P1|Overall Study|Progressive disease|3
4704094|NCT02252211|16210662|P3|Overall Study|Adverse Event|0
4704095|NCT02252211|16210663|P2|Overall Study|Adverse Event|1
4704096|NCT02252211|16210664|P1|Overall Study|Adverse Event|0
4704097|NCT02252172|16210701|P2|Overall Study|Ongoing|298
4704098|NCT02252172|16210702|P1|Overall Study|Ongoing|276
4704099|NCT02252172|16210701|P2|Overall Study|Lost to Follow-up|1
4704100|NCT02252172|16210702|P1|Overall Study|Lost to Follow-up|3
4704101|NCT02252146|16210714|P1|Overall Study|Inability to travel to study site|1
4704102|NCT02252146|16210714|P1|Overall Study|Entered hospice care|1
4704103|NCT02252146|16210714|P1|Overall Study|Lack of Efficacy|4
4704104|NCT02252042|16210727|P2|Overall Study|Ongoing in study|35
4704105|NCT02252042|16210728|P1|Overall Study|Ongoing in study|64
4704106|NCT02252042|16210727|P2|Overall Study|Withdrawal by Subject|20
4704107|NCT02252042|16210728|P1|Overall Study|Withdrawal by Subject|13
4704108|NCT02252042|16210727|P2|Overall Study|Physician Decision|1
4704109|NCT02252042|16210728|P1|Overall Study|Physician Decision|0
4704110|NCT02252042|16210727|P2|Overall Study|Death|192
4704111|NCT02252042|16210728|P1|Overall Study|Death|170
4704112|NCT02252016|16210768|P2|Overall Study|Withdrawal by Subject|2
4704113|NCT02252016|16210769|P1|Overall Study|Withdrawal by Subject|0
4704114|NCT02252016|16210768|P2|Overall Study|Physician Decision|0
4704115|NCT02252016|16210769|P1|Overall Study|Physician Decision|1
4704116|NCT02252016|16210768|P2|Overall Study|Lost to Follow-up|1
4704117|NCT02252016|16210769|P1|Overall Study|Lost to Follow-up|2
4704118|NCT02251990|16210783|P2|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2
4704119|NCT02251990|16210784|P1|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0
4704120|NCT02251990|16210783|P2|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1
4704121|NCT02251990|16210784|P1|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0
4704122|NCT02251990|16210783|P2|Period 1 (Double-blind [DB])|Not Treated|0
4704123|NCT02251990|16210784|P1|Period 1 (Double-blind [DB])|Not Treated|1
4704124|NCT02251990|16210783|P2|Period 1 (Double-blind [DB])|Withdrawal by Subject|0
4704125|NCT02251990|16210784|P1|Period 1 (Double-blind [DB])|Withdrawal by Subject|1
4704126|NCT02251990|16210783|P2|Period 1 (Double-blind [DB])|Lack of Efficacy|0
4704127|NCT02251990|16210784|P1|Period 1 (Double-blind [DB])|Lack of Efficacy|5
4704128|NCT02251990|16210783|P2|Period 1 (Double-blind [DB])|Adverse Event|1
4704129|NCT02251990|16210784|P1|Period 1 (Double-blind [DB])|Adverse Event|1
4704130|NCT02251912|16210812|P2|Overall Study|Adverse Event|2
4704131|NCT02251912|16210813|P1|Overall Study|Adverse Event|0
4704132|NCT02251912|16210812|P2|Overall Study|Withdrawal by Subject|3
4704133|NCT02251912|16210813|P1|Overall Study|Withdrawal by Subject|2
4704134|NCT02251743|16210842|P2|Overall Study|Withdrawal by Subject|1
4704135|NCT02251743|16210843|P1|Overall Study|Withdrawal by Subject|1
4704136|NCT02251717|16210851|P2|Overall Study|Withdrew Consent|0
4704137|NCT02251717|16210852|P1|Overall Study|Withdrew Consent|1
4704138|NCT02251717|16210851|P2|Overall Study|Adverse Event|1
4704139|NCT02251717|16210852|P1|Overall Study|Adverse Event|0
4704140|NCT02251652|16210864|P1|Overall Study|Withdrawal by Subject|1
4704141|NCT02251275|16210920|P5|Overall Study|Withdrawal by Subject|0
4704142|NCT02251275|16210921|P4|Overall Study|Withdrawal by Subject|1
4704143|NCT02251275|16210922|P3|Overall Study|Withdrawal by Subject|35
4704144|NCT02251275|16210923|P2|Overall Study|Withdrawal by Subject|51
4704145|NCT02251275|16210924|P1|Overall Study|Withdrawal by Subject|25
4704146|NCT02251275|16210920|P5|Overall Study|Protocol Deviation|0
4704147|NCT02251275|16210921|P4|Overall Study|Protocol Deviation|0
4704148|NCT02251275|16210922|P3|Overall Study|Protocol Deviation|1
4704149|NCT02251275|16210923|P2|Overall Study|Protocol Deviation|0
4704150|NCT02251275|16210924|P1|Overall Study|Protocol Deviation|0
4704151|NCT02251275|16210920|P5|Overall Study|Physician Decision|1
4704152|NCT02251275|16210921|P4|Overall Study|Physician Decision|0
4704153|NCT02251275|16210922|P3|Overall Study|Physician Decision|26
4704154|NCT02251275|16210923|P2|Overall Study|Physician Decision|30
4704155|NCT02251275|16210924|P1|Overall Study|Physician Decision|19
4704156|NCT02251275|16210920|P5|Overall Study|Lost to Follow-up|0
4704157|NCT02251275|16210921|P4|Overall Study|Lost to Follow-up|0
4704158|NCT02251275|16210922|P3|Overall Study|Lost to Follow-up|4
4704159|NCT02251275|16210923|P2|Overall Study|Lost to Follow-up|6
4704160|NCT02251275|16210924|P1|Overall Study|Lost to Follow-up|5
4704161|NCT02251275|16210920|P5|Overall Study|Adverse Event|0
4704162|NCT02251275|16210921|P4|Overall Study|Adverse Event|0
4704163|NCT02251275|16210922|P3|Overall Study|Adverse Event|28
4704164|NCT02251275|16210923|P2|Overall Study|Adverse Event|60
4704165|NCT02251275|16210924|P1|Overall Study|Adverse Event|23
4704166|NCT02250443|16210997|P1|Overall Study|Adverse Event|3
4704167|NCT02250443|16210997|P1|Overall Study|Administrative problems|7
4704168|NCT02250326|16211026|P3|Follow-Up Period|Lost to Follow-up|3
4704169|NCT02250326|16211027|P2|Follow-Up Period|Lost to Follow-up|1
4704170|NCT02250326|16211028|P1|Follow-Up Period|Lost to Follow-up|1
4704171|NCT02250326|16211026|P3|Follow-Up Period|Unknown or Missing|3
4704172|NCT02250326|16211027|P2|Follow-Up Period|Unknown or Missing|3
4704173|NCT02250326|16211028|P1|Follow-Up Period|Unknown or Missing|2
4704174|NCT02250326|16211026|P3|Follow-Up Period|Death|32
4704175|NCT02250326|16211027|P2|Follow-Up Period|Death|26
4704176|NCT02250326|16211028|P1|Follow-Up Period|Death|46
4704177|NCT02250326|16211026|P3|Treatment Period|Randomized or assigned; not treated|1
4704178|NCT02250326|16211027|P2|Treatment Period|Randomized or assigned; not treated|1
4704179|NCT02250326|16211028|P1|Treatment Period|Randomized or assigned; not treated|2
4704180|NCT02250326|16211026|P3|Treatment Period|Miscellaneous|7
4704181|NCT02250326|16211027|P2|Treatment Period|Miscellaneous|2
4704182|NCT02250326|16211028|P1|Treatment Period|Miscellaneous|8
4704183|NCT02250326|16211026|P3|Treatment Period|Withdrawal by Subject|4
4704184|NCT02250326|16211027|P2|Treatment Period|Withdrawal by Subject|5
4704185|NCT02250326|16211028|P1|Treatment Period|Withdrawal by Subject|11
4704186|NCT02250326|16211026|P3|Treatment Period|Symptomatic Deterioration|10
4704187|NCT02250326|16211027|P2|Treatment Period|Symptomatic Deterioration|4
4704188|NCT02250326|16211028|P1|Treatment Period|Symptomatic Deterioration|9
4704189|NCT02250326|16211026|P3|Treatment Period|Progressive Disease|45
4704190|NCT02250326|16211027|P2|Treatment Period|Progressive Disease|36
4704191|NCT02250326|16211028|P1|Treatment Period|Progressive Disease|42
4704192|NCT02250326|16211026|P3|Treatment Period|Adverse Event|8
4704193|NCT02250326|16211027|P2|Treatment Period|Adverse Event|4
4704194|NCT02250326|16211028|P1|Treatment Period|Adverse Event|8
4704195|NCT02250326|16211026|P3|Treatment Period|Death|2
4704196|NCT02250326|16211027|P2|Treatment Period|Death|12
4704197|NCT02250326|16211028|P1|Treatment Period|Death|1
4704198|NCT02250274|16211061|P2|Overall Study|Insufficient blood draw amount|6
4704199|NCT02250274|16211062|P1|Overall Study|Insufficient blood draw amount|7
4704200|NCT02250183|16211078|P1|Overall Study|Lost to Follow-up|1
4704201|NCT02250183|16211078|P1|Overall Study|Adverse Event|5
4704202|NCT02250183|16211078|P1|Overall Study|Withdrawal by Subject|2
4704203|NCT02249949|16211100|P1|Overall Study|Cancelled prior to treatment|2
4704204|NCT02249832|16211107|P1|Overall Study|Lost to Follow-up|10
4704205|NCT02249832|16211107|P1|Overall Study|Withdrawal by Subject|3
4704206|NCT02249767|16211151|P3|Overall Study|Did not use medication|8
4704207|NCT02249767|16211152|P2|Overall Study|Did not use medication|9
4704208|NCT02249767|16211153|P1|Overall Study|Did not use medication|8
4704209|NCT02249182|16211219|P5|Treatment Phase|Lost to Follow-up|0
4704210|NCT02249182|16211220|P4|Treatment Phase|Lost to Follow-up|0
4704211|NCT02249182|16211221|P3|Treatment Phase|Lost to Follow-up|0
4704212|NCT02249182|16211222|P2|Treatment Phase|Lost to Follow-up|0
4704213|NCT02249182|16211223|P1|Treatment Phase|Lost to Follow-up|4
4704214|NCT02248974|16211373|P2|1-Month Follow-Up|Lost to Follow-up|3
4704215|NCT02248974|16211374|P1|1-Month Follow-Up|Lost to Follow-up|2
4704216|NCT02248974|16211373|P2|1-Week Follow-Up|Lost to Follow-up|8
4704217|NCT02248974|16211374|P1|1-Week Follow-Up|Lost to Follow-up|0
4704218|NCT02248974|16211373|P2|1-Week Follow-Up|Withdrawal by Subject|2
4704219|NCT02248974|16211374|P1|1-Week Follow-Up|Withdrawal by Subject|0
4704220|NCT02248974|16211373|P2|1-Week Follow-Up|Timing: implanted before survey|2
4704221|NCT02248974|16211374|P1|1-Week Follow-Up|Timing: implanted before survey|0
4704222|NCT02248974|16211373|P2|1-Week Follow-Up|Noncompliant with terms of participation|1
4704223|NCT02248974|16211374|P1|1-Week Follow-Up|Noncompliant with terms of participation|0
4704224|NCT02248974|16211373|P2|1-Week Follow-Up|Excluded because of age|1
4704225|NCT02248974|16211374|P1|1-Week Follow-Up|Excluded because of age|0
4704226|NCT02248974|16211373|P2|1-Week Follow-Up|Death|1
4704227|NCT02248974|16211374|P1|1-Week Follow-Up|Death|1
4704228|NCT02248974|16211373|P2|1-Week Follow-Up|Cognitive Difficulty|0
4704229|NCT02248974|16211374|P1|1-Week Follow-Up|Cognitive Difficulty|1
4704230|NCT02248974|16211373|P2|1-Week Follow-Up|Transferred to another facility|0
4704231|NCT02248974|16211374|P1|1-Week Follow-Up|Transferred to another facility|1
4704232|NCT02248974|16211373|P2|1-Week Follow-Up|Enrolled in another study|1
4704233|NCT02248974|16211374|P1|1-Week Follow-Up|Enrolled in another study|1
4704234|NCT02248974|16211373|P2|1-Week Follow-Up|Became ineligible for LVAD|1
4704235|NCT02248974|16211374|P1|1-Week Follow-Up|Became ineligible for LVAD|4
4704236|NCT02248974|16211373|P2|1-Day Follow-Up|Enrolled in another study|0
4704237|NCT02248974|16211374|P1|1-Day Follow-Up|Enrolled in another study|1
4704238|NCT02248974|16211373|P2|1-Day Follow-Up|Withdrawal by Subject|0
4704239|NCT02248974|16211374|P1|1-Day Follow-Up|Withdrawal by Subject|5
4704240|NCT02248974|16211373|P2|1-Day Follow-Up|Lost to Follow-up|0
4704241|NCT02248974|16211374|P1|1-Day Follow-Up|Lost to Follow-up|4
4704242|NCT02248961|16211452|P2|Overall Study|Unmet inclusion/exclusion criteria|0
4704243|NCT02248961|16211453|P1|Overall Study|Unmet inclusion/exclusion criteria|1
4704244|NCT02248961|16211452|P2|Overall Study|Withdrawal by Subject|2
4704245|NCT02248961|16211453|P1|Overall Study|Withdrawal by Subject|1
4704246|NCT02248961|16211452|P2|Overall Study|Adverse Event|0
4704247|NCT02248961|16211453|P1|Overall Study|Adverse Event|1
4704248|NCT02248857|16211488|P3|6 Month|Death|0
4704249|NCT02248857|16211489|P2|6 Month|Death|0
4704250|NCT02248857|16211490|P1|6 Month|Death|1
4704251|NCT02248857|16211488|P3|6 Month|Withdrawal by Subject|2
4704252|NCT02248857|16211489|P2|6 Month|Withdrawal by Subject|2
4704253|NCT02248857|16211490|P1|6 Month|Withdrawal by Subject|0
4704254|NCT02248857|16211488|P3|6 Month|Partially completed, unable to finish|0
4704255|NCT02248857|16211489|P2|6 Month|Partially completed, unable to finish|1
4704256|NCT02248857|16211490|P1|6 Month|Partially completed, unable to finish|0
4704257|NCT02248857|16211488|P3|6 Month|Lost to Follow-up|15
4704258|NCT02248857|16211489|P2|6 Month|Lost to Follow-up|26
4704259|NCT02248857|16211490|P1|6 Month|Lost to Follow-up|27
4704260|NCT02248857|16211488|P3|3 Month|Partially completed, unable to finish|1
4704261|NCT02248857|16211489|P2|3 Month|Partially completed, unable to finish|2
4704262|NCT02248857|16211490|P1|3 Month|Partially completed, unable to finish|2
4704263|NCT02248857|16211488|P3|3 Month|Unable to reach for 3 month|26
4704264|NCT02248857|16211489|P2|3 Month|Unable to reach for 3 month|29
4704265|NCT02248857|16211490|P1|3 Month|Unable to reach for 3 month|35
4704266|NCT02248857|16211488|P3|3 Month|Withdrawal by Subject|4
4704267|NCT02248857|16211489|P2|3 Month|Withdrawal by Subject|3
4704268|NCT02248857|16211490|P1|3 Month|Withdrawal by Subject|9
4704269|NCT02248818|16211527|P9|Randomised Study|Administrative - randomization error|0
4704270|NCT02248818|16211528|P8|Randomised Study|Administrative - randomization error|0
4704271|NCT02248818|16211529|P7|Randomised Study|Administrative - randomization error|0
4704272|NCT02248818|16211530|P6|Randomised Study|Administrative - randomization error|8
4704361|NCT02247804|16211906|P2|Treatment Period 2|Reason not Specified|0
4704273|NCT02248818|16211531|P5|Randomised Study|Administrative - randomization error|0
4704274|NCT02248818|16211532|P4|Randomised Study|Administrative - randomization error|0
4704275|NCT02248818|16211533|P3|Randomised Study|Administrative - randomization error|0
4704276|NCT02248818|16211534|P2|Randomised Study|Administrative - randomization error|0
4704277|NCT02248818|16211535|P1|Randomised Study|Administrative - randomization error|0
4704278|NCT02248818|16211527|P9|Screening|Lost to Follow-up|7
4704279|NCT02248818|16211528|P8|Screening|Lost to Follow-up|0
4704280|NCT02248818|16211529|P7|Screening|Lost to Follow-up|0
4704281|NCT02248818|16211530|P6|Screening|Lost to Follow-up|0
4704282|NCT02248818|16211531|P5|Screening|Lost to Follow-up|0
4704283|NCT02248818|16211532|P4|Screening|Lost to Follow-up|0
4704284|NCT02248818|16211533|P3|Screening|Lost to Follow-up|0
4704285|NCT02248818|16211534|P2|Screening|Lost to Follow-up|0
4704286|NCT02248818|16211535|P1|Screening|Lost to Follow-up|0
4704287|NCT02248818|16211527|P9|Screening|Withdrawal by Subject|6
4704288|NCT02248818|16211528|P8|Screening|Withdrawal by Subject|0
4704289|NCT02248818|16211529|P7|Screening|Withdrawal by Subject|0
4704290|NCT02248818|16211530|P6|Screening|Withdrawal by Subject|0
4704291|NCT02248818|16211531|P5|Screening|Withdrawal by Subject|0
4704292|NCT02248818|16211532|P4|Screening|Withdrawal by Subject|0
4704293|NCT02248818|16211533|P3|Screening|Withdrawal by Subject|0
4704294|NCT02248818|16211534|P2|Screening|Withdrawal by Subject|0
4704295|NCT02248818|16211535|P1|Screening|Withdrawal by Subject|0
4704296|NCT02248818|16211527|P9|Screening|Physician Decision|73
4704297|NCT02248818|16211528|P8|Screening|Physician Decision|0
4704298|NCT02248818|16211529|P7|Screening|Physician Decision|0
4704299|NCT02248818|16211530|P6|Screening|Physician Decision|0
4704300|NCT02248818|16211531|P5|Screening|Physician Decision|0
4704301|NCT02248818|16211532|P4|Screening|Physician Decision|0
4704302|NCT02248818|16211533|P3|Screening|Physician Decision|0
4704303|NCT02248818|16211534|P2|Screening|Physician Decision|0
4704304|NCT02248818|16211535|P1|Screening|Physician Decision|0
4704305|NCT02248818|16211527|P9|Screening|Study fully enrolled|14
4704306|NCT02248818|16211528|P8|Screening|Study fully enrolled|0
4704307|NCT02248818|16211529|P7|Screening|Study fully enrolled|0
4704308|NCT02248818|16211530|P6|Screening|Study fully enrolled|0
4704309|NCT02248818|16211531|P5|Screening|Study fully enrolled|0
4704310|NCT02248818|16211532|P4|Screening|Study fully enrolled|0
4704311|NCT02248818|16211533|P3|Screening|Study fully enrolled|0
4704312|NCT02248818|16211534|P2|Screening|Study fully enrolled|0
4704313|NCT02248818|16211535|P1|Screening|Study fully enrolled|0
4704314|NCT02248818|16211527|P9|Screening|Protocol Violation|7
4704315|NCT02248818|16211528|P8|Screening|Protocol Violation|0
4704316|NCT02248818|16211529|P7|Screening|Protocol Violation|0
4704317|NCT02248818|16211530|P6|Screening|Protocol Violation|0
4704318|NCT02248818|16211531|P5|Screening|Protocol Violation|0
4704319|NCT02248818|16211532|P4|Screening|Protocol Violation|0
4704320|NCT02248818|16211533|P3|Screening|Protocol Violation|0
4704321|NCT02248818|16211534|P2|Screening|Protocol Violation|0
4704322|NCT02248818|16211535|P1|Screening|Protocol Violation|0
4704323|NCT02248675|16211750|P2|Overall Study|Lost to Follow-up|1
4704324|NCT02248675|16211751|P1|Overall Study|Lost to Follow-up|3
4704325|NCT02248649|16211778|P2|Overall Study|Lost to Follow-up|10
4704326|NCT02248649|16211779|P1|Overall Study|Lost to Follow-up|14
4704327|NCT02248649|16211778|P2|Overall Study|Death|11
4704328|NCT02248649|16211779|P1|Overall Study|Death|7
4704329|NCT02248480|16211823|P2|Overall Study|Other:Physician Decision|1
4704330|NCT02248480|16211824|P1|Overall Study|Other:Physician Decision|0
4704331|NCT02248480|16211823|P2|Overall Study|Entry Criteria Not Met|1
4704332|NCT02248480|16211824|P1|Overall Study|Entry Criteria Not Met|0
4704333|NCT02248480|16211823|P2|Overall Study|Withdrawal by Subject|4
4704334|NCT02248480|16211824|P1|Overall Study|Withdrawal by Subject|2
4704335|NCT02248480|16211823|P2|Overall Study|Adverse Event|2
4704336|NCT02248480|16211824|P1|Overall Study|Adverse Event|11
4704337|NCT02248480|16211823|P2|Overall Study|Lack of Efficacy|6
4704338|NCT02248480|16211824|P1|Overall Study|Lack of Efficacy|4
4704339|NCT02247960|16211891|P2|Catheter Removed|Lost to Follow-up|10
4704340|NCT02247960|16211892|P1|Catheter Removed|Lost to Follow-up|7
4704341|NCT02247960|16211891|P2|Patient Consent and Randomization|Withdrawal by Subject|4
4704342|NCT02247960|16211892|P1|Patient Consent and Randomization|Withdrawal by Subject|0
4704343|NCT02247960|16211891|P2|Patient Consent and Randomization|Physician Decision|2
4704344|NCT02247960|16211892|P1|Patient Consent and Randomization|Physician Decision|2
4704345|NCT02247804|16211905|P3|Treatment Period 3|Reason not Specified|3
4704346|NCT02247804|16211906|P2|Treatment Period 3|Reason not Specified|1
4704347|NCT02247804|16211907|P1|Treatment Period 3|Reason not Specified|2
4704348|NCT02247804|16211905|P3|Treatment Period 3|Personal Reasons|2
4704349|NCT02247804|16211906|P2|Treatment Period 3|Personal Reasons|3
4704350|NCT02247804|16211907|P1|Treatment Period 3|Personal Reasons|4
4704351|NCT02247804|16211905|P3|Treatment Period 3|Lost to Follow-up|2
4704352|NCT02247804|16211906|P2|Treatment Period 3|Lost to Follow-up|2
4704353|NCT02247804|16211907|P1|Treatment Period 3|Lost to Follow-up|1
4704354|NCT02247804|16211905|P3|Treatment Period 3|Lack of Efficacy|0
4704355|NCT02247804|16211906|P2|Treatment Period 3|Lack of Efficacy|1
4704356|NCT02247804|16211907|P1|Treatment Period 3|Lack of Efficacy|0
4704357|NCT02247804|16211905|P3|Treatment Period 3|Adverse Event|3
4704358|NCT02247804|16211906|P2|Treatment Period 3|Adverse Event|3
4704359|NCT02247804|16211907|P1|Treatment Period 3|Adverse Event|4
4704360|NCT02247804|16211905|P3|Treatment Period 2|Reason not Specified|2
4704362|NCT02247804|16211907|P1|Treatment Period 2|Reason not Specified|0
4704363|NCT02247804|16211905|P3|Treatment Period 2|Personal Reasons|1
4704364|NCT02247804|16211906|P2|Treatment Period 2|Personal Reasons|1
4704365|NCT02247804|16211907|P1|Treatment Period 2|Personal Reasons|2
4704366|NCT02247804|16211905|P3|Treatment Period 2|Lost to Follow-up|1
4704367|NCT02247804|16211906|P2|Treatment Period 2|Lost to Follow-up|1
4704368|NCT02247804|16211907|P1|Treatment Period 2|Lost to Follow-up|0
4704369|NCT02247804|16211905|P3|Treatment Period 2|Lack of Efficacy|1
4704370|NCT02247804|16211906|P2|Treatment Period 2|Lack of Efficacy|0
4704371|NCT02247804|16211907|P1|Treatment Period 2|Lack of Efficacy|0
4704372|NCT02247804|16211905|P3|Treatment Period 2|Adverse Event|3
4704373|NCT02247804|16211906|P2|Treatment Period 2|Adverse Event|3
4704374|NCT02247804|16211907|P1|Treatment Period 2|Adverse Event|6
4704375|NCT02247804|16211905|P3|Treatment Period 1|Randomized but not Treated|1
4704376|NCT02247804|16211906|P2|Treatment Period 1|Randomized but not Treated|1
4704377|NCT02247804|16211907|P1|Treatment Period 1|Randomized but not Treated|5
4704378|NCT02247804|16211905|P3|Treatment Period 1|Protocol Deviation|1
4704379|NCT02247804|16211906|P2|Treatment Period 1|Protocol Deviation|0
4704380|NCT02247804|16211907|P1|Treatment Period 1|Protocol Deviation|0
4704381|NCT02247804|16211905|P3|Treatment Period 1|Personal Reasons|2
4704382|NCT02247804|16211906|P2|Treatment Period 1|Personal Reasons|1
4704383|NCT02247804|16211907|P1|Treatment Period 1|Personal Reasons|7
4704384|NCT02247804|16211905|P3|Treatment Period 1|Lost to Follow-up|2
4704385|NCT02247804|16211906|P2|Treatment Period 1|Lost to Follow-up|0
4704386|NCT02247804|16211907|P1|Treatment Period 1|Lost to Follow-up|1
4704387|NCT02247804|16211905|P3|Treatment Period 1|Lack of Efficacy|2
4704388|NCT02247804|16211906|P2|Treatment Period 1|Lack of Efficacy|0
4704389|NCT02247804|16211907|P1|Treatment Period 1|Lack of Efficacy|0
4704390|NCT02247804|16211905|P3|Treatment Period 1|Adverse Event|0
4704391|NCT02247804|16211906|P2|Treatment Period 1|Adverse Event|2
4704392|NCT02247804|16211907|P1|Treatment Period 1|Adverse Event|9
4704393|NCT02247531|16211965|P3|Overall Study|Unspecified Reason|4
4704394|NCT02247531|16211966|P2|Overall Study|Unspecified Reason|3
4704395|NCT02247531|16211967|P1|Overall Study|Unspecified Reason|2
4704396|NCT02247531|16211965|P3|Overall Study|Physician Decision|2
4704397|NCT02247531|16211966|P2|Overall Study|Physician Decision|2
4704398|NCT02247531|16211967|P1|Overall Study|Physician Decision|0
4704399|NCT02247531|16211965|P3|Overall Study|Study Terminated by Sponsor|62
4704400|NCT02247531|16211966|P2|Overall Study|Study Terminated by Sponsor|66
4704401|NCT02247531|16211967|P1|Overall Study|Study Terminated by Sponsor|64
4704402|NCT02247531|16211965|P3|Overall Study|Withdrawal by Subject|25
4704403|NCT02247531|16211966|P2|Overall Study|Withdrawal by Subject|31
4704404|NCT02247531|16211967|P1|Overall Study|Withdrawal by Subject|26
4704405|NCT02247531|16211965|P3|Overall Study|Non-compliance|0
4704406|NCT02247531|16211966|P2|Overall Study|Non-compliance|2
4704407|NCT02247531|16211967|P1|Overall Study|Non-compliance|2
4704408|NCT02247531|16211965|P3|Overall Study|Lost to Follow-up|3
4704409|NCT02247531|16211966|P2|Overall Study|Lost to Follow-up|8
4704410|NCT02247531|16211967|P1|Overall Study|Lost to Follow-up|1
4704411|NCT02247531|16211965|P3|Overall Study|Death|5
4704412|NCT02247531|16211966|P2|Overall Study|Death|9
4704413|NCT02247531|16211967|P1|Overall Study|Death|8
4704414|NCT02247531|16211965|P3|Overall Study|Adverse Event|9
4704415|NCT02247531|16211966|P2|Overall Study|Adverse Event|4
4704416|NCT02247531|16211967|P1|Overall Study|Adverse Event|3
4704417|NCT02247479|16212017|P3|Overall Study|Unspecified Reason|2
4704418|NCT02247479|16212018|P2|Overall Study|Unspecified Reason|5
4704419|NCT02247479|16212019|P1|Overall Study|Unspecified Reason|2
4704420|NCT02247479|16212017|P3|Overall Study|Physician Decision|2
4704421|NCT02247479|16212018|P2|Overall Study|Physician Decision|0
4704422|NCT02247479|16212019|P1|Overall Study|Physician Decision|1
4704423|NCT02247479|16212017|P3|Overall Study|Study Terminated by Sponsor|94
4704424|NCT02247479|16212018|P2|Overall Study|Study Terminated by Sponsor|88
4704425|NCT02247479|16212019|P1|Overall Study|Study Terminated by Sponsor|98
4704426|NCT02247479|16212017|P3|Overall Study|Withdrawal by Subject|24
4704427|NCT02247479|16212018|P2|Overall Study|Withdrawal by Subject|29
4704428|NCT02247479|16212019|P1|Overall Study|Withdrawal by Subject|25
4704429|NCT02247479|16212017|P3|Overall Study|Non-compliance|1
4704430|NCT02247479|16212018|P2|Overall Study|Non-compliance|0
4704431|NCT02247479|16212019|P1|Overall Study|Non-compliance|0
4704432|NCT02247479|16212017|P3|Overall Study|Lost to Follow-up|1
4704433|NCT02247479|16212018|P2|Overall Study|Lost to Follow-up|3
4704434|NCT02247479|16212019|P1|Overall Study|Lost to Follow-up|3
4704435|NCT02247479|16212017|P3|Overall Study|Death|6
4704436|NCT02247479|16212018|P2|Overall Study|Death|4
4704437|NCT02247479|16212019|P1|Overall Study|Death|5
4704438|NCT02247479|16212017|P3|Overall Study|Adverse Event|8
4704439|NCT02247479|16212018|P2|Overall Study|Adverse Event|9
4704440|NCT02247479|16212019|P1|Overall Study|Adverse Event|8
4704441|NCT02247466|16212068|P2|Overall Study|Procedure changed to open surgery|3
4704442|NCT02247466|16212069|P1|Overall Study|Procedure changed to open surgery|0
4704443|NCT02247440|16212087|P1|Overall Study|Lack of Efficacy|3
4704444|NCT02247440|16212087|P1|Overall Study|Withdrawal by Subject|1
4704445|NCT02247401|16212100|P3|Overall Study|Lost to Follow-up|1
4704446|NCT02247401|16212101|P2|Overall Study|Lost to Follow-up|1
4704447|NCT02247401|16212102|P1|Overall Study|Lost to Follow-up|1
4704448|NCT02247401|16212100|P3|Overall Study|Withdrawal by Subject|1
4704449|NCT02247401|16212101|P2|Overall Study|Withdrawal by Subject|1
4704450|NCT02247401|16212102|P1|Overall Study|Withdrawal by Subject|4
4704451|NCT02247401|16212100|P3|Overall Study|Adverse Event|0
4704452|NCT02247401|16212101|P2|Overall Study|Adverse Event|0
4704453|NCT02247401|16212102|P1|Overall Study|Adverse Event|1
4704454|NCT02247011|16212149|P1|Overall Study|Poor quality of radiological results|125
4704455|NCT02246998|16212170|P4|Overall Study|Randomized but Never Dosed|1
4704456|NCT02246998|16212171|P3|Overall Study|Randomized but Never Dosed|2
4704457|NCT02246998|16212172|P2|Overall Study|Randomized but Never Dosed|2
4704458|NCT02246998|16212173|P1|Overall Study|Randomized but Never Dosed|1
4704459|NCT02246998|16212170|P4|Overall Study|Lost to Follow-up|1
4704460|NCT02246998|16212171|P3|Overall Study|Lost to Follow-up|0
4704461|NCT02246998|16212172|P2|Overall Study|Lost to Follow-up|0
4704462|NCT02246998|16212173|P1|Overall Study|Lost to Follow-up|1
4704463|NCT02246998|16212170|P4|Overall Study|Adverse Event|0
4704464|NCT02246998|16212171|P3|Overall Study|Adverse Event|1
4704465|NCT02246998|16212172|P2|Overall Study|Adverse Event|1
4704466|NCT02246998|16212173|P1|Overall Study|Adverse Event|0
4704467|NCT02246777|16212283|P1|Overall Study|Change of residence|1
4704468|NCT02246777|16212283|P1|Overall Study|Adverse Event|2
4704469|NCT02246764|16212299|P3|Overall Study|Protocol Violation|1
4704470|NCT02246764|16212300|P2|Overall Study|Protocol Violation|1
4704471|NCT02246764|16212301|P1|Overall Study|Protocol Violation|2
4704472|NCT02246764|16212299|P3|Overall Study|Physician Decision|1
4704473|NCT02246764|16212300|P2|Overall Study|Physician Decision|2
4704474|NCT02246764|16212301|P1|Overall Study|Physician Decision|0
4704475|NCT02246764|16212299|P3|Overall Study|Disallowed Concomitant Medication|0
4704476|NCT02246764|16212300|P2|Overall Study|Disallowed Concomitant Medication|0
4704477|NCT02246764|16212301|P1|Overall Study|Disallowed Concomitant Medication|1
4704478|NCT02246764|16212299|P3|Overall Study|Withdrawal by Subject|1
4704479|NCT02246764|16212300|P2|Overall Study|Withdrawal by Subject|0
4704480|NCT02246764|16212301|P1|Overall Study|Withdrawal by Subject|0
4704481|NCT02246764|16212299|P3|Overall Study|Adverse Event|1
4704482|NCT02246764|16212300|P2|Overall Study|Adverse Event|29
4704483|NCT02246764|16212301|P1|Overall Study|Adverse Event|15
4704484|NCT02246673|16212314|P5|Overall Study|Protocol Violation|0
4704485|NCT02246673|16212315|P4|Overall Study|Protocol Violation|1
4704486|NCT02246673|16212316|P3|Overall Study|Protocol Violation|0
4704487|NCT02246673|16212317|P2|Overall Study|Protocol Violation|0
4704488|NCT02246673|16212318|P1|Overall Study|Protocol Violation|0
4704489|NCT02246673|16212314|P5|Overall Study|Lost to Follow-up|0
4704490|NCT02246673|16212315|P4|Overall Study|Lost to Follow-up|1
4704491|NCT02246673|16212316|P3|Overall Study|Lost to Follow-up|0
4704492|NCT02246673|16212317|P2|Overall Study|Lost to Follow-up|0
4704493|NCT02246673|16212318|P1|Overall Study|Lost to Follow-up|0
4704494|NCT02246673|16212314|P5|Overall Study|Withdrawal by Subject|1
4704495|NCT02246673|16212315|P4|Overall Study|Withdrawal by Subject|0
4704496|NCT02246673|16212316|P3|Overall Study|Withdrawal by Subject|0
4704497|NCT02246673|16212317|P2|Overall Study|Withdrawal by Subject|0
4704498|NCT02246673|16212318|P1|Overall Study|Withdrawal by Subject|0
4704499|NCT02246673|16212314|P5|Overall Study|Sponsor Decision|0
4704500|NCT02246673|16212315|P4|Overall Study|Sponsor Decision|0
4704501|NCT02246673|16212316|P3|Overall Study|Sponsor Decision|0
4704502|NCT02246673|16212317|P2|Overall Study|Sponsor Decision|0
4704503|NCT02246673|16212318|P1|Overall Study|Sponsor Decision|1
4704504|NCT02246660|16212426|P3|Overall Study|Death|1
4704505|NCT02246660|16212427|P2|Overall Study|Death|0
4704506|NCT02246660|16212428|P1|Overall Study|Death|0
4704507|NCT02246660|16212426|P3|Overall Study|Withdrawal by Subject|0
4704508|NCT02246660|16212427|P2|Overall Study|Withdrawal by Subject|1
4704509|NCT02246660|16212428|P1|Overall Study|Withdrawal by Subject|0
4704510|NCT02246647|16212438|P2|Overall Study|Withdrawal by Subject|1
4704511|NCT02246647|16212439|P1|Overall Study|Withdrawal by Subject|1
4704512|NCT02246621|16212473|P2|Overall Study|On Study Treatment/ Follow Up|133
4704513|NCT02246621|16212474|P1|Overall Study|On Study Treatment/ Follow Up|257
4704514|NCT02246621|16212473|P2|Overall Study|Lost to Follow-up|1
4704515|NCT02246621|16212474|P1|Overall Study|Lost to Follow-up|3
4704516|NCT02246621|16212473|P2|Overall Study|Withdrawal by Subject|14
4704517|NCT02246621|16212474|P1|Overall Study|Withdrawal by Subject|36
4704518|NCT02246582|16212511|P2|Overall Study|Withdrawal by Subject|4
4704519|NCT02246582|16212512|P1|Overall Study|Withdrawal by Subject|3
4704520|NCT02246439|16212520|P2|Overall Study|Withdrawal by Subject|0
4704521|NCT02246439|16212521|P1|Overall Study|Withdrawal by Subject|1
4704522|NCT02246439|16212520|P2|Overall Study|Unkonwn|3
4704523|NCT02246439|16212521|P1|Overall Study|Unkonwn|1
4704524|NCT02246439|16212520|P2|Overall Study|Physician Decision|1
4704525|NCT02246439|16212521|P1|Overall Study|Physician Decision|0
4704526|NCT02246439|16212520|P2|Overall Study|Protocol Violation|2
4704527|NCT02246439|16212521|P1|Overall Study|Protocol Violation|0
4704528|NCT02246439|16212520|P2|Overall Study|Lost to Follow-up|5
4704529|NCT02246439|16212521|P1|Overall Study|Lost to Follow-up|7
4704530|NCT02246439|16212520|P2|Overall Study|Adverse Event|0
4704531|NCT02246439|16212521|P1|Overall Study|Adverse Event|3
4704532|NCT02246218|16212653|P2|Overall Study|Lost to Follow-up|0
4704533|NCT02246218|16212654|P1|Overall Study|Lost to Follow-up|1
4704534|NCT02246218|16212653|P2|Overall Study|Adverse Event|1
4704535|NCT02246218|16212654|P1|Overall Study|Adverse Event|1
4704536|NCT02246218|16212653|P2|Overall Study|Stopping Rule: Liver Transplant|4
4704537|NCT02246218|16212654|P1|Overall Study|Stopping Rule: Liver Transplant|2
4704538|NCT02246218|16212653|P2|Overall Study|Withdrawal by Parent/Guardian|1
4704539|NCT02246218|16212654|P1|Overall Study|Withdrawal by Parent/Guardian|0
4704540|NCT02246166|16212714|P2|Overall Study|Protocol Violation|0
4704541|NCT02246166|16212715|P1|Overall Study|Protocol Violation|1
4704542|NCT02246114|16212751|P2|Overall Study|miscarriage|0
4704543|NCT02246114|16212752|P1|Overall Study|miscarriage|1
4704544|NCT02245737|16212803|P3|Overall Study|Sponsor Decision|432
4704545|NCT02245737|16212804|P2|Overall Study|Sponsor Decision|430
4704546|NCT02245737|16212805|P1|Overall Study|Sponsor Decision|445
4704547|NCT02245737|16212803|P3|Overall Study|Withdrawal due to Caregiver Circumstance|22
4704548|NCT02245737|16212804|P2|Overall Study|Withdrawal due to Caregiver Circumstance|20
4704549|NCT02245737|16212805|P1|Overall Study|Withdrawal due to Caregiver Circumstance|10
4704550|NCT02245737|16212803|P3|Overall Study|Withdrawal by Subject|44
4704551|NCT02245737|16212804|P2|Overall Study|Withdrawal by Subject|41
4704552|NCT02245737|16212805|P1|Overall Study|Withdrawal by Subject|40
4704553|NCT02245737|16212803|P3|Overall Study|Protocol Violation|3
4704554|NCT02245737|16212804|P2|Overall Study|Protocol Violation|2
4704555|NCT02245737|16212805|P1|Overall Study|Protocol Violation|3
4704556|NCT02245737|16212803|P3|Overall Study|Physician Decision|6
4704557|NCT02245737|16212804|P2|Overall Study|Physician Decision|3
4704558|NCT02245737|16212805|P1|Overall Study|Physician Decision|6
4704559|NCT02245737|16212803|P3|Overall Study|Other-determined by Investigator|10
4704560|NCT02245737|16212804|P2|Overall Study|Other-determined by Investigator|10
4704561|NCT02245737|16212805|P1|Overall Study|Other-determined by Investigator|9
4704562|NCT02245737|16212803|P3|Overall Study|Lost to Follow-up|4
4704563|NCT02245737|16212804|P2|Overall Study|Lost to Follow-up|5
4704564|NCT02245737|16212805|P1|Overall Study|Lost to Follow-up|2
4704565|NCT02245737|16212803|P3|Overall Study|Initiation of Symptomatic AD medication|0
4704566|NCT02245737|16212804|P2|Overall Study|Initiation of Symptomatic AD medication|0
4704567|NCT02245737|16212805|P1|Overall Study|Initiation of Symptomatic AD medication|2
4704568|NCT02245737|16212803|P3|Overall Study|Eligibility Criteria No Longer Met|4
4704569|NCT02245737|16212804|P2|Overall Study|Eligibility Criteria No Longer Met|4
4704570|NCT02245737|16212805|P1|Overall Study|Eligibility Criteria No Longer Met|2
4704571|NCT02245737|16212803|P3|Overall Study|Death|4
4704572|NCT02245737|16212804|P2|Overall Study|Death|4
4704573|NCT02245737|16212805|P1|Overall Study|Death|2
4704574|NCT02245737|16212803|P3|Overall Study|Condition Worsened|9
4704575|NCT02245737|16212804|P2|Overall Study|Condition Worsened|10
4704576|NCT02245737|16212805|P1|Overall Study|Condition Worsened|9
4704577|NCT02245737|16212803|P3|Overall Study|Adverse Event|33
4704578|NCT02245737|16212804|P2|Overall Study|Adverse Event|26
4704579|NCT02245737|16212805|P1|Overall Study|Adverse Event|23
4704580|NCT02245620|16212862|P2|Overall Study|Physician Decision|1
4704581|NCT02245620|16212863|P1|Overall Study|Physician Decision|1
4704582|NCT02245568|16212875|P1|Overall Study|Lost to Follow-up|5
4704583|NCT02245568|16212875|P1|Overall Study|Intolerance/dosing issues/interruption|5
4704584|NCT02245568|16212875|P1|Overall Study|Worsening dementia/caregiver withdrawal|6
4704585|NCT02245568|16212875|P1|Overall Study|Blue staining|6
4704586|NCT02245568|16212875|P1|Overall Study|Death|9
4704587|NCT02245568|16212875|P1|Overall Study|Non-compliance with study drug|11
4704588|NCT02245568|16212875|P1|Overall Study|Physician Decision|14
4704589|NCT02245568|16212875|P1|Overall Study|Missing (Site closure)|16
4704590|NCT02245568|16212875|P1|Overall Study|Withdrawal by Legal Representative|31
4704591|NCT02245568|16212875|P1|Overall Study|Withdrawal by Subject|77
4704592|NCT02245568|16212875|P1|Overall Study|Withdrawal by Caregiver|85
4704593|NCT02245568|16212875|P1|Overall Study|Lack of Efficacy|98
4704594|NCT02245568|16212875|P1|Overall Study|Adverse Event|144
4704595|NCT02245568|16212875|P1|Overall Study|Study terminated by Sponsor|346
4704596|NCT02245412|16212882|P3|Follow-Up Period|Other - Terminated by Sponsor|1
4704597|NCT02245412|16212883|P2|Follow-Up Period|Other - Terminated by Sponsor|0
4704598|NCT02245412|16212884|P1|Follow-Up Period|Other - Terminated by Sponsor|0
4704599|NCT02245412|16212882|P3|Follow-Up Period|Physician Decision|0
4704600|NCT02245412|16212883|P2|Follow-Up Period|Physician Decision|0
4704601|NCT02245412|16212884|P1|Follow-Up Period|Physician Decision|1
4704602|NCT02245412|16212882|P3|Follow-Up Period|Death|1
4704603|NCT02245412|16212883|P2|Follow-Up Period|Death|2
4704604|NCT02245412|16212884|P1|Follow-Up Period|Death|4
4704605|NCT02245412|16212882|P3|Treatment Period|Biopsy did not confirm GI GVHD|0
4704606|NCT02245412|16212883|P2|Treatment Period|Biopsy did not confirm GI GVHD|0
4704607|NCT02245412|16212884|P1|Treatment Period|Biopsy did not confirm GI GVHD|1
4704608|NCT02245412|16212882|P3|Treatment Period|Withdrawal by Subject|0
4704609|NCT02245412|16212883|P2|Treatment Period|Withdrawal by Subject|1
4704610|NCT02245412|16212884|P1|Treatment Period|Withdrawal by Subject|2
4704611|NCT02245412|16212882|P3|Treatment Period|Physician Decision|0
4704612|NCT02245412|16212883|P2|Treatment Period|Physician Decision|1
4704613|NCT02245412|16212884|P1|Treatment Period|Physician Decision|1
4704614|NCT02245412|16212882|P3|Treatment Period|Death|0
4704615|NCT02245412|16212883|P2|Treatment Period|Death|1
4704616|NCT02245412|16212884|P1|Treatment Period|Death|1
4704617|NCT02244996|16212931|P2|Overall Study|Lack of Efficacy|6
4704618|NCT02244996|16212932|P1|Overall Study|Lack of Efficacy|2
4704619|NCT02244957|16212946|P2|Overall Study|Lack of Efficacy|0
4704620|NCT02244957|16212947|P1|Overall Study|Lack of Efficacy|1
4704621|NCT02244944|16212991|P1|Overall Study|Study Terminated|1
4704622|NCT02244944|16212991|P1|Overall Study|Withdrawal by Subject|1
4704623|NCT02244619|16213022|P2|Overall Study|Did not receive study intervention|21
4704624|NCT02244619|16213023|P1|Overall Study|Did not receive study intervention|8
4704625|NCT02244580|16213041|P1|Overall Study|No cancer tissues available|241
4704626|NCT02244424|16213051|P2|Overall Study|Lost to Follow-up|10
4704627|NCT02244424|16213052|P1|Overall Study|Lost to Follow-up|20
4704628|NCT02243696|16213071|P1|Overall Study|Study Terminated for EP PASSION|961
4704629|NCT02243696|16213071|P1|Overall Study|Subject Withdrawn by Investigator|273
4704630|NCT02243696|16213071|P1|Overall Study|Subject No Longer has Study System|42
4704631|NCT02243696|16213071|P1|Overall Study|Lost to Follow-up|57
4704632|NCT02243696|16213071|P1|Overall Study|Withdrawal by Subject|79
4704633|NCT02243696|16213071|P1|Overall Study|Death|282
4704634|NCT02243605|16213083|P2|Stage 2 - Final Analysis Population|Progression|1
4704635|NCT02243605|16213084|P1|Stage 2 - Final Analysis Population|Progression|0
4704636|NCT02243605|16213083|P2|Stage 2 - Final Analysis Population|Adverse Event|1
4704637|NCT02243605|16213084|P1|Stage 2 - Final Analysis Population|Adverse Event|1
4704638|NCT02243605|16213083|P2|Stage 2 - Final Analysis Population|Protocol Violation|1
4704639|NCT02243605|16213084|P1|Stage 2 - Final Analysis Population|Protocol Violation|5
4704640|NCT02243605|16213083|P2|Stage 1 - Interim Analysis Population|Adverse Event|0
4704641|NCT02243605|16213084|P1|Stage 1 - Interim Analysis Population|Adverse Event|1
4704642|NCT02243605|16213083|P2|Stage 1 - Interim Analysis Population|Protocol Violation|1
4704643|NCT02243605|16213084|P1|Stage 1 - Interim Analysis Population|Protocol Violation|1
4704644|NCT01116440|16213118|P2|Follow-up|Withdrawal by Subject|1
4704645|NCT01116440|16213119|P1|Follow-up|Withdrawal by Subject|0
4704646|NCT01116440|16213118|P2|Follow-up|Lost to Follow-up|1
4704647|NCT01116440|16213119|P1|Follow-up|Lost to Follow-up|0
4704648|NCT01116440|16213118|P2|Withdrawal|Lost to Follow-up|1
4704649|NCT01116440|16213119|P1|Withdrawal|Lost to Follow-up|0
4704650|NCT01116440|16213118|P2|Withdrawal|Withdrawal by Subject|1
4704651|NCT01116440|16213119|P1|Withdrawal|Withdrawal by Subject|0
4704652|NCT01116440|16213118|P2|Treatment|Adverse Event|1
4704653|NCT01116440|16213119|P1|Treatment|Adverse Event|0
4704654|NCT01116440|16213118|P2|Treatment|Lack of Efficacy|1
4704655|NCT01116440|16213119|P1|Treatment|Lack of Efficacy|0
4704656|NCT01116440|16213118|P2|Treatment|Protocol Violation|2
4704657|NCT01116440|16213119|P1|Treatment|Protocol Violation|0
4704658|NCT01116440|16213118|P2|Treatment|Lost to Follow-up|1
4704659|NCT01116440|16213119|P1|Treatment|Lost to Follow-up|1
4704660|NCT01116440|16213118|P2|Treatment|Withdrawal by Subject|2
4704661|NCT01116440|16213119|P1|Treatment|Withdrawal by Subject|2
4704662|NCT02243371|16213135|P2|Overall Study|Withdrawal by Subject|2
4704663|NCT02243371|16213136|P1|Overall Study|Withdrawal by Subject|0
4704664|NCT02243371|16213135|P2|Overall Study|Lack of Clinical Benefit|1
4704665|NCT02243371|16213136|P1|Overall Study|Lack of Clinical Benefit|0
4704666|NCT02243371|16213135|P2|Overall Study|Adverse Event (unrelated)|1
4704667|NCT02243371|16213136|P1|Overall Study|Adverse Event (unrelated)|0
4704668|NCT02243371|16213135|P2|Overall Study|Death (unrelated)|4
4704669|NCT02243371|16213136|P1|Overall Study|Death (unrelated)|2
4704670|NCT02243371|16213135|P2|Overall Study|Progressive Disease (clinic & radio)|24
4704671|NCT02243371|16213136|P1|Overall Study|Progressive Disease (clinic & radio)|35
4704672|NCT02243306|16213156|P2|Overall Study|Physician Decision|1
4704673|NCT02243306|16213157|P1|Overall Study|Physician Decision|0
4704674|NCT02243306|16213156|P2|Overall Study|Other: Reached stopping criteria|1
4704675|NCT02243306|16213157|P1|Overall Study|Other: Reached stopping criteria|0
4704676|NCT02243306|16213156|P2|Overall Study|Adverse Event|1
4704677|NCT02243306|16213157|P1|Overall Study|Adverse Event|0
4704678|NCT02243293|16213232|P22|Overall Study|Randomized but did'nt receive study drug|0
4704679|NCT02243293|16213233|P21|Overall Study|Randomized but did'nt receive study drug|0
4704680|NCT02243293|16213234|P20|Overall Study|Randomized but did'nt receive study drug|1
4704681|NCT02243293|16213235|P19|Overall Study|Randomized but did'nt receive study drug|0
4704682|NCT02243293|16213236|P18|Overall Study|Randomized but did'nt receive study drug|0
4704683|NCT02243293|16213237|P17|Overall Study|Randomized but did'nt receive study drug|0
4704684|NCT02243293|16213238|P16|Overall Study|Randomized but did'nt receive study drug|0
4704685|NCT02243293|16213239|P15|Overall Study|Randomized but did'nt receive study drug|0
4704686|NCT02243293|16213240|P14|Overall Study|Randomized but did'nt receive study drug|0
4704687|NCT02243293|16213241|P13|Overall Study|Randomized but did'nt receive study drug|0
4704688|NCT02243293|16213242|P12|Overall Study|Randomized but did'nt receive study drug|0
4704689|NCT02243293|16213243|P11|Overall Study|Randomized but did'nt receive study drug|0
4704690|NCT02243293|16213244|P10|Overall Study|Randomized but did'nt receive study drug|1
4704691|NCT02243293|16213245|P9|Overall Study|Randomized but did'nt receive study drug|0
4704692|NCT02243293|16213246|P8|Overall Study|Randomized but did'nt receive study drug|0
4704693|NCT02243293|16213247|P7|Overall Study|Randomized but did'nt receive study drug|0
4704694|NCT02243293|16213248|P6|Overall Study|Randomized but did'nt receive study drug|0
4704695|NCT02243293|16213249|P5|Overall Study|Randomized but did'nt receive study drug|1
4704696|NCT02243293|16213250|P4|Overall Study|Randomized but did'nt receive study drug|0
4704697|NCT02243293|16213251|P3|Overall Study|Randomized but did'nt receive study drug|0
4704698|NCT02243293|16213252|P2|Overall Study|Randomized but did'nt receive study drug|0
4704699|NCT02243293|16213253|P1|Overall Study|Randomized but did'nt receive study drug|0
4704700|NCT02243293|16213232|P22|Overall Study|Enrolled into a Re-treatment Study|0
4704701|NCT02243293|16213233|P21|Overall Study|Enrolled into a Re-treatment Study|0
4704702|NCT02243293|16213234|P20|Overall Study|Enrolled into a Re-treatment Study|0
4704703|NCT02243293|16213235|P19|Overall Study|Enrolled into a Re-treatment Study|0
4704704|NCT02243293|16213236|P18|Overall Study|Enrolled into a Re-treatment Study|0
4704705|NCT02243293|16213237|P17|Overall Study|Enrolled into a Re-treatment Study|0
4704706|NCT02243293|16213238|P16|Overall Study|Enrolled into a Re-treatment Study|0
4704707|NCT02243293|16213239|P15|Overall Study|Enrolled into a Re-treatment Study|1
4704708|NCT02243293|16213240|P14|Overall Study|Enrolled into a Re-treatment Study|0
4704709|NCT02243293|16213241|P13|Overall Study|Enrolled into a Re-treatment Study|0
4704710|NCT02243293|16213242|P12|Overall Study|Enrolled into a Re-treatment Study|0
4704711|NCT02243293|16213243|P11|Overall Study|Enrolled into a Re-treatment Study|0
4704712|NCT02243293|16213244|P10|Overall Study|Enrolled into a Re-treatment Study|0
4704713|NCT02243293|16213245|P9|Overall Study|Enrolled into a Re-treatment Study|0
4704714|NCT02243293|16213246|P8|Overall Study|Enrolled into a Re-treatment Study|0
4704715|NCT02243293|16213247|P7|Overall Study|Enrolled into a Re-treatment Study|0
4704716|NCT02243293|16213248|P6|Overall Study|Enrolled into a Re-treatment Study|0
4704717|NCT02243293|16213249|P5|Overall Study|Enrolled into a Re-treatment Study|0
4704718|NCT02243293|16213250|P4|Overall Study|Enrolled into a Re-treatment Study|0
4704719|NCT02243293|16213251|P3|Overall Study|Enrolled into a Re-treatment Study|0
4704720|NCT02243293|16213252|P2|Overall Study|Enrolled into a Re-treatment Study|0
4704721|NCT02243293|16213253|P1|Overall Study|Enrolled into a Re-treatment Study|0
4704722|NCT02243293|16213232|P22|Overall Study|Lost to Follow-up|2
4704723|NCT02243293|16213233|P21|Overall Study|Lost to Follow-up|1
4704724|NCT02243293|16213234|P20|Overall Study|Lost to Follow-up|0
4704725|NCT02243293|16213235|P19|Overall Study|Lost to Follow-up|0
4704726|NCT02243293|16213236|P18|Overall Study|Lost to Follow-up|1
4704727|NCT02243293|16213237|P17|Overall Study|Lost to Follow-up|3
4704728|NCT02243293|16213238|P16|Overall Study|Lost to Follow-up|0
4704729|NCT02243293|16213239|P15|Overall Study|Lost to Follow-up|0
4704730|NCT02243293|16213240|P14|Overall Study|Lost to Follow-up|0
4704731|NCT02243293|16213241|P13|Overall Study|Lost to Follow-up|0
4704732|NCT02243293|16213242|P12|Overall Study|Lost to Follow-up|2
4704733|NCT02243293|16213243|P11|Overall Study|Lost to Follow-up|0
4704734|NCT02243293|16213244|P10|Overall Study|Lost to Follow-up|0
4704735|NCT02243293|16213245|P9|Overall Study|Lost to Follow-up|0
4704736|NCT02243293|16213246|P8|Overall Study|Lost to Follow-up|0
4704737|NCT02243293|16213247|P7|Overall Study|Lost to Follow-up|3
4704738|NCT02243293|16213248|P6|Overall Study|Lost to Follow-up|0
4704739|NCT02243293|16213249|P5|Overall Study|Lost to Follow-up|0
4704740|NCT02243293|16213250|P4|Overall Study|Lost to Follow-up|1
4704741|NCT02243293|16213251|P3|Overall Study|Lost to Follow-up|1
4704742|NCT02243293|16213252|P2|Overall Study|Lost to Follow-up|1
4704743|NCT02243293|16213253|P1|Overall Study|Lost to Follow-up|0
4704744|NCT02243293|16213232|P22|Overall Study|Withdrawal by Subject|1
4704745|NCT02243293|16213233|P21|Overall Study|Withdrawal by Subject|0
4704746|NCT02243293|16213234|P20|Overall Study|Withdrawal by Subject|0
4704747|NCT02243293|16213235|P19|Overall Study|Withdrawal by Subject|0
4704748|NCT02243293|16213236|P18|Overall Study|Withdrawal by Subject|0
4704749|NCT02243293|16213237|P17|Overall Study|Withdrawal by Subject|0
4704750|NCT02243293|16213238|P16|Overall Study|Withdrawal by Subject|0
4704751|NCT02243293|16213239|P15|Overall Study|Withdrawal by Subject|0
4704752|NCT02243293|16213240|P14|Overall Study|Withdrawal by Subject|0
4704753|NCT02243293|16213241|P13|Overall Study|Withdrawal by Subject|0
4704754|NCT02243293|16213242|P12|Overall Study|Withdrawal by Subject|1
4704755|NCT02243293|16213243|P11|Overall Study|Withdrawal by Subject|0
4704756|NCT02243293|16213244|P10|Overall Study|Withdrawal by Subject|1
4704757|NCT02243293|16213245|P9|Overall Study|Withdrawal by Subject|0
4704758|NCT02243293|16213246|P8|Overall Study|Withdrawal by Subject|0
4704759|NCT02243293|16213247|P7|Overall Study|Withdrawal by Subject|0
4704760|NCT02243293|16213248|P6|Overall Study|Withdrawal by Subject|0
4704761|NCT02243293|16213249|P5|Overall Study|Withdrawal by Subject|0
4704762|NCT02243293|16213250|P4|Overall Study|Withdrawal by Subject|0
4704763|NCT02243293|16213251|P3|Overall Study|Withdrawal by Subject|0
4704764|NCT02243293|16213252|P2|Overall Study|Withdrawal by Subject|0
4704765|NCT02243293|16213253|P1|Overall Study|Withdrawal by Subject|1
4704766|NCT02243293|16213232|P22|Overall Study|Adverse Event|0
4704767|NCT02243293|16213233|P21|Overall Study|Adverse Event|1
4704768|NCT02243293|16213234|P20|Overall Study|Adverse Event|0
4704769|NCT02243293|16213235|P19|Overall Study|Adverse Event|0
4704770|NCT02243293|16213236|P18|Overall Study|Adverse Event|0
4704771|NCT02243293|16213237|P17|Overall Study|Adverse Event|0
4704772|NCT02243293|16213238|P16|Overall Study|Adverse Event|1
4704773|NCT02243293|16213239|P15|Overall Study|Adverse Event|0
4704774|NCT02243293|16213240|P14|Overall Study|Adverse Event|0
4704775|NCT02243293|16213241|P13|Overall Study|Adverse Event|0
4704776|NCT02243293|16213242|P12|Overall Study|Adverse Event|0
4704777|NCT02243293|16213243|P11|Overall Study|Adverse Event|0
4704778|NCT02243293|16213244|P10|Overall Study|Adverse Event|0
4704779|NCT02243293|16213245|P9|Overall Study|Adverse Event|0
4704780|NCT02243293|16213246|P8|Overall Study|Adverse Event|0
4704781|NCT02243293|16213247|P7|Overall Study|Adverse Event|0
4704782|NCT02243293|16213248|P6|Overall Study|Adverse Event|0
4704783|NCT02243293|16213249|P5|Overall Study|Adverse Event|0
4704784|NCT02243293|16213250|P4|Overall Study|Adverse Event|0
4704785|NCT02243293|16213251|P3|Overall Study|Adverse Event|0
4704786|NCT02243293|16213252|P2|Overall Study|Adverse Event|0
4704787|NCT02243293|16213253|P1|Overall Study|Adverse Event|1
4704788|NCT02243280|16213352|P11|Treated|Lost to Follow-up|2
4704789|NCT02243280|16213353|P10|Treated|Lost to Follow-up|0
4704790|NCT02243280|16213354|P9|Treated|Lost to Follow-up|1
4704791|NCT02243280|16213355|P8|Treated|Lost to Follow-up|0
4704792|NCT02243280|16213356|P7|Treated|Lost to Follow-up|0
4704793|NCT02243280|16213357|P6|Treated|Lost to Follow-up|0
4704794|NCT02243280|16213358|P5|Treated|Lost to Follow-up|0
4704795|NCT02243280|16213359|P4|Treated|Lost to Follow-up|0
4704796|NCT02243280|16213360|P3|Treated|Lost to Follow-up|0
4704797|NCT02243280|16213361|P2|Treated|Lost to Follow-up|0
4704798|NCT02243280|16213362|P1|Treated|Lost to Follow-up|0
4704799|NCT02243280|16213352|P11|Treated|Adverse Event|1
4704800|NCT02243280|16213353|P10|Treated|Adverse Event|0
4704801|NCT02243280|16213354|P9|Treated|Adverse Event|0
4704802|NCT02243280|16213355|P8|Treated|Adverse Event|0
4704803|NCT02243280|16213356|P7|Treated|Adverse Event|0
4704804|NCT02243280|16213357|P6|Treated|Adverse Event|0
4704805|NCT02243280|16213358|P5|Treated|Adverse Event|0
4704806|NCT02243280|16213359|P4|Treated|Adverse Event|0
4704807|NCT02243280|16213360|P3|Treated|Adverse Event|0
4704808|NCT02243280|16213361|P2|Treated|Adverse Event|0
4704809|NCT02243280|16213362|P1|Treated|Adverse Event|1
4704810|NCT02243202|16213417|P4|Overall Study|Randomized but not received treatment|1
4704811|NCT02243202|16213418|P3|Overall Study|Randomized but not received treatment|0
4704812|NCT02243202|16213419|P2|Overall Study|Randomized but not received treatment|0
4704813|NCT02243202|16213420|P1|Overall Study|Randomized but not received treatment|0
4704814|NCT02243202|16213417|P4|Overall Study|Other|2
4704815|NCT02243202|16213418|P3|Overall Study|Other|1
4704816|NCT02243202|16213419|P2|Overall Study|Other|3
4704817|NCT02243202|16213420|P1|Overall Study|Other|1
4704818|NCT02243202|16213417|P4|Overall Study|Withdrawal by Subject|4
4704819|NCT02243202|16213418|P3|Overall Study|Withdrawal by Subject|4
4704820|NCT02243202|16213419|P2|Overall Study|Withdrawal by Subject|6
4704821|NCT02243202|16213420|P1|Overall Study|Withdrawal by Subject|7
4704822|NCT02243202|16213417|P4|Overall Study|Protocol Violation|1
4704823|NCT02243202|16213418|P3|Overall Study|Protocol Violation|2
4704824|NCT02243202|16213419|P2|Overall Study|Protocol Violation|1
4704825|NCT02243202|16213420|P1|Overall Study|Protocol Violation|3
4704826|NCT02243202|16213417|P4|Overall Study|Lost to Follow-up|11
4704827|NCT02243202|16213418|P3|Overall Study|Lost to Follow-up|14
4704828|NCT02243202|16213419|P2|Overall Study|Lost to Follow-up|9
4704829|NCT02243202|16213420|P1|Overall Study|Lost to Follow-up|9
4704830|NCT02243202|16213417|P4|Overall Study|Adverse Event|4
4704831|NCT02243202|16213418|P3|Overall Study|Adverse Event|10
4704832|NCT02243202|16213419|P2|Overall Study|Adverse Event|6
4704833|NCT02243202|16213420|P1|Overall Study|Adverse Event|5
4704834|NCT02243176|16213456|P2|Overall Study|Adverse Event|2
4704835|NCT02243176|16213457|P1|Overall Study|Adverse Event|2
4704836|NCT02243176|16213456|P2|Overall Study|Withdrawal by Subject|7
4704837|NCT02243176|16213457|P1|Overall Study|Withdrawal by Subject|8
4704838|NCT02243176|16213456|P2|Overall Study|Protocol Violation|1
4704839|NCT02243176|16213457|P1|Overall Study|Protocol Violation|2
4704840|NCT02243176|16213456|P2|Overall Study|protocol specified withdrawal critera|3
4704841|NCT02243176|16213457|P1|Overall Study|protocol specified withdrawal critera|1
4704842|NCT02243176|16213456|P2|Overall Study|Other reason|2
4704843|NCT02243176|16213457|P1|Overall Study|Other reason|1
4704844|NCT02243046|16213482|P3|Overall Study|Lost to Follow-up|4
4704845|NCT02243046|16213483|P2|Overall Study|Lost to Follow-up|1
4704846|NCT02243046|16213484|P1|Overall Study|Lost to Follow-up|1
4704847|NCT02242981|16213548|P1|Overall Study|Withdrawal by Subject|1
4704848|NCT02242942|16213559|P3|Overall Study|On-going in Study|11
4704849|NCT02242942|16213560|P2|Overall Study|On-going in Study|186
4704850|NCT02242942|16213561|P1|Overall Study|On-going in Study|190
4704851|NCT02242942|16213559|P3|Overall Study|Withdrawal by Subject|0
4704852|NCT02242942|16213560|P2|Overall Study|Withdrawal by Subject|10
4704853|NCT02242942|16213561|P1|Overall Study|Withdrawal by Subject|8
4704854|NCT02242942|16213559|P3|Overall Study|Physician Decision|0
4704855|NCT02242942|16213560|P2|Overall Study|Physician Decision|0
4704856|NCT02242942|16213561|P1|Overall Study|Physician Decision|1
4704857|NCT02242942|16213559|P3|Overall Study|Death|2
4704858|NCT02242942|16213560|P2|Overall Study|Death|20
4704859|NCT02242942|16213561|P1|Overall Study|Death|17
4704860|NCT02242903|16213595|P7|Overall Study|Withdrawal by Subject|0
4704861|NCT02242903|16213596|P6|Overall Study|Withdrawal by Subject|0
4704862|NCT02242903|16213597|P5|Overall Study|Withdrawal by Subject|0
4704863|NCT02242903|16213598|P4|Overall Study|Withdrawal by Subject|0
4704864|NCT02242903|16213599|P3|Overall Study|Withdrawal by Subject|0
4704865|NCT02242903|16213600|P2|Overall Study|Withdrawal by Subject|0
4704866|NCT02242903|16213601|P1|Overall Study|Withdrawal by Subject|1
4704867|NCT02242643|16213631|P2|Overall Study|Withdrawal by subject at Visit 2|1
4704868|NCT02242643|16213632|P1|Overall Study|Withdrawal by subject at Visit 2|0
4704869|NCT02242643|16213631|P2|Overall Study|Language barrier|0
4704870|NCT02242643|16213632|P1|Overall Study|Language barrier|1
4704871|NCT02242643|16213631|P2|Overall Study|Protocol requirements not followed|0
4704872|NCT02242643|16213632|P1|Overall Study|Protocol requirements not followed|1
4704873|NCT02242643|16213631|P2|Overall Study|Consent withdrawal by parent|0
4704874|NCT02242643|16213632|P1|Overall Study|Consent withdrawal by parent|1
4704875|NCT02242643|16213631|P2|Overall Study|Non-compliance|0
4704876|NCT02242643|16213632|P1|Overall Study|Non-compliance|1
4704877|NCT02242643|16213631|P2|Overall Study|Child placed in foster care by family|1
4704878|NCT02242643|16213632|P1|Overall Study|Child placed in foster care by family|0
4704879|NCT02242643|16213631|P2|Overall Study|Lost to Follow-up|61
4704880|NCT02242643|16213632|P1|Overall Study|Lost to Follow-up|54
4704881|NCT02242643|16213631|P2|Overall Study|Migrated/moved from study area|3
4704882|NCT02242643|16213632|P1|Overall Study|Migrated/moved from study area|1
4704883|NCT02242643|16213631|P2|Overall Study|Withdrawal by Subject|10
4704884|NCT02242643|16213632|P1|Overall Study|Withdrawal by Subject|15
4704885|NCT02242643|16213631|P2|Overall Study|Protocol Violation|2
4704886|NCT02242643|16213632|P1|Overall Study|Protocol Violation|1
4704887|NCT02242487|16213687|P2|Overall Study|Withdrawal by Subject|19
4704888|NCT02242487|16213688|P1|Overall Study|Withdrawal by Subject|37
4704889|NCT02242487|16213687|P2|Overall Study|Other - Miscellaneous|6
4704890|NCT02242487|16213688|P1|Overall Study|Other - Miscellaneous|4
4704891|NCT02242487|16213687|P2|Overall Study|Lost to Follow-up|1
4704892|NCT02242487|16213688|P1|Overall Study|Lost to Follow-up|2
4704893|NCT02242487|16213687|P2|Overall Study|Protocol Violation|0
4704894|NCT02242487|16213688|P1|Overall Study|Protocol Violation|2
4704895|NCT02242487|16213687|P2|Overall Study|Lack of Efficacy|6
4704896|NCT02242487|16213688|P1|Overall Study|Lack of Efficacy|4
4704897|NCT02242487|16213687|P2|Overall Study|Adverse Event|15
4704898|NCT02242487|16213688|P1|Overall Study|Adverse Event|13
4704899|NCT02242305|16213725|P2|Overall Study|Lost to Follow-up|0
4704900|NCT02242305|16213726|P1|Overall Study|Lost to Follow-up|2
4704901|NCT02242305|16213725|P2|Overall Study|Subject withdraws inform consent|4
4704902|NCT02242305|16213726|P1|Overall Study|Subject withdraws inform consent|0
4704903|NCT02242305|16213725|P2|Overall Study|Non-compliance dosing regimen or visit|2
4704904|NCT02242305|16213726|P1|Overall Study|Non-compliance dosing regimen or visit|2
4704905|NCT02242305|16213725|P2|Overall Study|Adverse Event|0
4704906|NCT02242305|16213726|P1|Overall Study|Adverse Event|1
4704907|NCT02242305|16213725|P2|Overall Study|Without spasm-like pain during 3 weeks|4
4704908|NCT02242305|16213726|P1|Overall Study|Without spasm-like pain during 3 weeks|1
4704909|NCT02242201|16213747|P3|Overall Study|preoperative opioid consumption|0
4704910|NCT02242201|16213748|P2|Overall Study|preoperative opioid consumption|1
4704911|NCT02242201|16213749|P1|Overall Study|preoperative opioid consumption|0
4704912|NCT02242201|16213747|P3|Overall Study|postponed surgery|1
4704913|NCT02242201|16213748|P2|Overall Study|postponed surgery|0
4704914|NCT02242201|16213749|P1|Overall Study|postponed surgery|0
4704915|NCT02242201|16213747|P3|Overall Study|changed surgical procedure|0
4704916|NCT02242201|16213748|P2|Overall Study|changed surgical procedure|0
4704917|NCT02242201|16213749|P1|Overall Study|changed surgical procedure|1
4704918|NCT02242201|16213747|P3|Overall Study|planned post-op anticoagulation|0
4704919|NCT02242201|16213748|P2|Overall Study|planned post-op anticoagulation|0
4704920|NCT02242201|16213749|P1|Overall Study|planned post-op anticoagulation|1
4704921|NCT02242201|16213747|P3|Overall Study|preoperative identified neuropathy|0
4704922|NCT02242201|16213748|P2|Overall Study|preoperative identified neuropathy|0
4704923|NCT02242201|16213749|P1|Overall Study|preoperative identified neuropathy|2
4704924|NCT02241889|16213787|P6|Overall Study|Withdrawal by Subject|1
4704925|NCT02241889|16213788|P5|Overall Study|Withdrawal by Subject|0
4704926|NCT02241889|16213789|P4|Overall Study|Withdrawal by Subject|0
4704927|NCT02241889|16213790|P3|Overall Study|Withdrawal by Subject|0
4704928|NCT02241889|16213791|P2|Overall Study|Withdrawal by Subject|0
4704929|NCT02241889|16213792|P1|Overall Study|Withdrawal by Subject|0
4704930|NCT02241889|16213787|P6|Overall Study|device issues|0
4704931|NCT02241889|16213788|P5|Overall Study|device issues|0
4704932|NCT02241889|16213789|P4|Overall Study|device issues|0
4704933|NCT02241889|16213790|P3|Overall Study|device issues|1
4704934|NCT02241889|16213791|P2|Overall Study|device issues|0
4704935|NCT02241889|16213792|P1|Overall Study|device issues|0
4704936|NCT02241785|16213827|P1|Overall Study|Adverse Event|1
4704937|NCT02241785|16213827|P1|Overall Study|Lost to Follow-up|2
4704938|NCT02241785|16213827|P1|Overall Study|Withdrawal by Subject|1
4704939|NCT02241785|16213827|P1|Overall Study|Sponsor Termination|43
4704940|NCT02241733|16213837|P2|Overall Study|Death|2
4704941|NCT02241733|16213838|P1|Overall Study|Death|0
4704942|NCT02241733|16213837|P2|Overall Study|Withdrawal by Subject|2
4704943|NCT02241733|16213838|P1|Overall Study|Withdrawal by Subject|0
4704944|NCT02241733|16213837|P2|Overall Study|Physician Decision|2
4704945|NCT02241733|16213838|P1|Overall Study|Physician Decision|6
4704946|NCT02241733|16213837|P2|Overall Study|Lost to Follow-up|4
4704947|NCT02241733|16213838|P1|Overall Study|Lost to Follow-up|9
4704948|NCT02241551|16213877|P2|Overall Study|Adverse Event|0
4704949|NCT02241551|16213878|P1|Overall Study|Adverse Event|1
4704950|NCT02241512|16213900|P2|Overall Study|Pump malfunction, drug not delivered|0
4704951|NCT02241512|16213901|P1|Overall Study|Pump malfunction, drug not delivered|1
4704952|NCT02241187|16213917|P1|Overall Study|Protocol closed due to lack of accrual.|2
4704953|NCT02240693|16213949|P5|Overall Study|Other than specified|0
4704954|NCT02240693|16213950|P4|Overall Study|Other than specified|0
4704955|NCT02240693|16213951|P3|Overall Study|Other than specified|2
4704956|NCT02240693|16213952|P2|Overall Study|Other than specified|0
4704957|NCT02240693|16213953|P1|Overall Study|Other than specified|0
4704958|NCT02240693|16213949|P5|Overall Study|Withdrawal by Subject|0
4704959|NCT02240693|16213950|P4|Overall Study|Withdrawal by Subject|1
4704960|NCT02240693|16213951|P3|Overall Study|Withdrawal by Subject|2
4704961|NCT02240693|16213952|P2|Overall Study|Withdrawal by Subject|0
4704962|NCT02240693|16213953|P1|Overall Study|Withdrawal by Subject|0
4704963|NCT02240693|16213949|P5|Overall Study|Adverse Event|1
4704964|NCT02240693|16213950|P4|Overall Study|Adverse Event|0
4704965|NCT02240693|16213951|P3|Overall Study|Adverse Event|0
4704966|NCT02240693|16213952|P2|Overall Study|Adverse Event|0
4704967|NCT02240693|16213953|P1|Overall Study|Adverse Event|0
4704968|NCT02240680|16213989|P4|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
4704969|NCT02240680|16213990|P3|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1
4704970|NCT02240680|16213991|P2|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
4704971|NCT02240680|16213992|P1|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0
4704972|NCT02240680|16213989|P4|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
4704973|NCT02240680|16213990|P3|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1
4704974|NCT02240680|16213991|P2|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
4704975|NCT02240680|16213992|P1|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0
4704976|NCT02240680|16213989|P4|Japanese Patients (Up to 52 Weeks)|Adverse Event|7
4704977|NCT02240680|16213990|P3|Japanese Patients (Up to 52 Weeks)|Adverse Event|6
4704978|NCT02240680|16213991|P2|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
4704979|NCT02240680|16213992|P1|Japanese Patients (Up to 52 Weeks)|Adverse Event|0
4704980|NCT02240680|16213989|P4|Overall Study (Up to 24 Weeks)|Other than specified|0
4704981|NCT02240680|16213990|P3|Overall Study (Up to 24 Weeks)|Other than specified|0
4704982|NCT02240680|16213991|P2|Overall Study (Up to 24 Weeks)|Other than specified|0
4704983|NCT02240680|16213992|P1|Overall Study (Up to 24 Weeks)|Other than specified|1
4704984|NCT02240680|16213989|P4|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
4704985|NCT02240680|16213990|P3|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0
4704986|NCT02240680|16213991|P2|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1
4704987|NCT02240680|16213992|P1|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3
4704988|NCT02240680|16213989|P4|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
4704989|NCT02240680|16213990|P3|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
4704990|NCT02240680|16213991|P2|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0
4704991|NCT02240680|16213992|P1|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1
4704992|NCT02240680|16213989|P4|Overall Study (Up to 24 Weeks)|Protocol Violation|0
4704993|NCT02240680|16213990|P3|Overall Study (Up to 24 Weeks)|Protocol Violation|0
4704994|NCT02240680|16213991|P2|Overall Study (Up to 24 Weeks)|Protocol Violation|1
4704995|NCT02240680|16213992|P1|Overall Study (Up to 24 Weeks)|Protocol Violation|4
4704996|NCT02240680|16213989|P4|Overall Study (Up to 24 Weeks)|Adverse Event|0
4704997|NCT02240680|16213990|P3|Overall Study (Up to 24 Weeks)|Adverse Event|0
4704998|NCT02240680|16213991|P2|Overall Study (Up to 24 Weeks)|Adverse Event|6
4704999|NCT02240680|16213992|P1|Overall Study (Up to 24 Weeks)|Adverse Event|6
4705000|NCT02240628|16214046|P2|Overall Study|Physician Decision|5
4705001|NCT02240628|16214047|P1|Overall Study|Physician Decision|6
4705002|NCT02240368|16214081|P3|Overall Study|Entropy failed to detect more than 50%|1
4705003|NCT02240368|16214082|P2|Overall Study|Entropy failed to detect more than 50%|0
4705004|NCT02240368|16214083|P1|Overall Study|Entropy failed to detect more than 50%|0
4705005|NCT02240368|16214081|P3|Overall Study|Surgery lasted less then 20 minutes|0
4705006|NCT02240368|16214082|P2|Overall Study|Surgery lasted less then 20 minutes|0
4705007|NCT02240368|16214083|P1|Overall Study|Surgery lasted less then 20 minutes|1
4705008|NCT02240121|16214115|P2|Overall Study|Other than specified|3
4705009|NCT02240121|16214116|P1|Overall Study|Other than specified|1
4705010|NCT02240121|16214115|P2|Overall Study|Lost to Follow-up|4
4705011|NCT02240121|16214116|P1|Overall Study|Lost to Follow-up|3
4705012|NCT02240121|16214115|P2|Overall Study|Withdrawal by Subject|2
4705013|NCT02240121|16214116|P1|Overall Study|Withdrawal by Subject|6
4705014|NCT02240121|16214115|P2|Overall Study|Adverse Event|4
4705015|NCT02240121|16214116|P1|Overall Study|Adverse Event|2
4705016|NCT02240121|16214115|P2|Overall Study|Pregnancy|0
4705017|NCT02240121|16214116|P1|Overall Study|Pregnancy|1
4705018|NCT02240121|16214115|P2|Overall Study|Site closed|1
4705019|NCT02240121|16214116|P1|Overall Study|Site closed|1
4705020|NCT02240121|16214115|P2|Overall Study|Lack of Efficacy|3
4705021|NCT02240121|16214116|P1|Overall Study|Lack of Efficacy|2
4705022|NCT02240121|16214115|P2|Overall Study|Change in protocol interpretation|0
4705023|NCT02240121|16214116|P1|Overall Study|Change in protocol interpretation|1
4705024|NCT02240121|16214115|P2|Overall Study|Physician Decision|1
4705025|NCT02240121|16214116|P1|Overall Study|Physician Decision|0
4705026|NCT02240121|16214115|P2|Overall Study|Protocol Violation|2
4705027|NCT02240121|16214116|P1|Overall Study|Protocol Violation|1
4705028|NCT02240108|16214144|P2|Overall Study|StudyTerminated by Sponsor|1
4705029|NCT02240108|16214145|P1|Overall Study|StudyTerminated by Sponsor|0
4705030|NCT02240108|16214144|P2|Overall Study|Withdrawal by Subject|9
4705031|NCT02240108|16214145|P1|Overall Study|Withdrawal by Subject|4
4705032|NCT02240108|16214144|P2|Overall Study|Pregnancy|0
4705033|NCT02240108|16214145|P1|Overall Study|Pregnancy|1
4705034|NCT02240108|16214144|P2|Overall Study|Adverse Event|9
4705035|NCT02240108|16214145|P1|Overall Study|Adverse Event|1
4705036|NCT02240108|16214144|P2|Overall Study|Other than specified|6
4705037|NCT02240108|16214145|P1|Overall Study|Other than specified|8
4705038|NCT02239978|16214200|P2|Overall Study|Withdrawal by Subject|0
4705039|NCT02239978|16214201|P1|Overall Study|Withdrawal by Subject|2
4705040|NCT02239939|16214218|P2|Overall Study|Lost to Follow-up|1
4705041|NCT02239939|16214219|P1|Overall Study|Lost to Follow-up|0
4705042|NCT02239939|16214218|P2|Overall Study|Withdrawal by Subject|1
4705043|NCT02239939|16214219|P1|Overall Study|Withdrawal by Subject|1
4705044|NCT02239939|16214218|P2|Overall Study|Adverse Event|0
4705045|NCT02239939|16214219|P1|Overall Study|Adverse Event|1
4705046|NCT02239926|16214235|P2|Overall Study|Withdrawal by Subject|1
4705047|NCT02239926|16214236|P1|Overall Study|Withdrawal by Subject|0
4705048|NCT02239692|16214298|P2|Overall Study|Other reason|0
4705049|NCT02239692|16214299|P1|Overall Study|Other reason|1
4705050|NCT02239692|16214298|P2|Overall Study|Withdrawal by Subject|5
4705051|NCT02239692|16214299|P1|Overall Study|Withdrawal by Subject|3
4705052|NCT02239692|16214298|P2|Overall Study|Lost to Follow-up|4
4705053|NCT02239692|16214299|P1|Overall Study|Lost to Follow-up|1
4705054|NCT02239692|16214298|P2|Overall Study|Physician Decision|1
4705055|NCT02239692|16214299|P1|Overall Study|Physician Decision|0
4705056|NCT02239692|16214298|P2|Overall Study|Adverse Event|1
4705057|NCT02239692|16214299|P1|Overall Study|Adverse Event|0
4705058|NCT02239692|16214298|P2|Overall Study|Incomplete colonoscopy|2
4705059|NCT02239692|16214299|P1|Overall Study|Incomplete colonoscopy|1
4705060|NCT02239679|16214318|P3|Overall Study|Withdrawal by Subject|1
4705061|NCT02239679|16214319|P2|Overall Study|Withdrawal by Subject|3
4705062|NCT02239679|16214320|P1|Overall Study|Withdrawal by Subject|2
4705063|NCT02239679|16214318|P3|Overall Study|Lost to Follow-up|0
4705064|NCT02239679|16214319|P2|Overall Study|Lost to Follow-up|0
4705065|NCT02239679|16214320|P1|Overall Study|Lost to Follow-up|1
4705066|NCT02239640|16214532|P1|Overall Study|Death|142
4705067|NCT02239640|16214532|P1|Overall Study|Lost to Follow-up|72
4705068|NCT02239640|16214532|P1|Overall Study|Withdrawal by Subject|3
4705069|NCT01097577|16214544|P2|Overall Study|Adverse Event|1
4705070|NCT01097577|16214545|P1|Overall Study|Adverse Event|0
4705071|NCT02239601|16214563|P2|Overall Study|Protocol Violation|2
4705072|NCT02239601|16214564|P1|Overall Study|Protocol Violation|4
4705073|NCT02239601|16214563|P2|Overall Study|Withdrawal by Subject|4
4705074|NCT02239601|16214564|P1|Overall Study|Withdrawal by Subject|3
4705075|NCT02239536|16214617|P2|Overall Study|Non-neoplastic polyp|17
4705076|NCT02239536|16214618|P1|Overall Study|Non-neoplastic polyp|23
4705077|NCT02239510|16214628|P2|Overall Study|Lost to Follow-up|1
4705078|NCT02239510|16214629|P1|Overall Study|Lost to Follow-up|2
4705079|NCT02239328|16214651|P1|Overall Study|Equipment or website malfunction|2
4705080|NCT02239328|16214651|P1|Overall Study|Benign disease noted at time of surgery|6
4705081|NCT02239120|16214676|P2|Overall Study|Lost to Follow-up|14
4705082|NCT02239120|16214677|P1|Overall Study|Lost to Follow-up|19
4705083|NCT02239120|16214676|P2|Overall Study|Death|58
4705084|NCT02239120|16214677|P1|Overall Study|Death|56
4705085|NCT02239094|16214701|P1|Overall Study|Remitted before started|1
4705086|NCT02239094|16214701|P1|Overall Study|Withdrawal by Subject|1
4705087|NCT02238483|16214756|P2|Overall Study|Illness in family member|0
4705088|NCT02238483|16214757|P1|Overall Study|Illness in family member|1
4705089|NCT02238483|16214756|P2|Overall Study|Completion status not recorded|1
4705090|NCT02238483|16214757|P1|Overall Study|Completion status not recorded|1
4705091|NCT02238483|16214756|P2|Overall Study|Withdrawn due to physician decision|0
4705092|NCT02238483|16214757|P1|Overall Study|Withdrawn due to physician decision|1
4705093|NCT02238483|16214756|P2|Overall Study|Adverse Event|3
4705094|NCT02238483|16214757|P1|Overall Study|Adverse Event|7
4705095|NCT02238483|16214756|P2|Overall Study|Death|0
4705096|NCT02238483|16214757|P1|Overall Study|Death|1
4705097|NCT02238483|16214756|P2|Overall Study|Protocol Violation|2
4705098|NCT02238483|16214757|P1|Overall Study|Protocol Violation|1
4705099|NCT02238483|16214756|P2|Overall Study|Lost to Follow-up|1
4705100|NCT02238483|16214757|P1|Overall Study|Lost to Follow-up|1
4705101|NCT02238483|16214756|P2|Overall Study|Withdrawal by Subject|7
4705102|NCT02238483|16214757|P1|Overall Study|Withdrawal by Subject|2
4705103|NCT02238379|16214795|P2|Overall Study|Lost to Follow-up|0
4705104|NCT02238379|16214796|P1|Overall Study|Lost to Follow-up|1
4705105|NCT02238080|16214822|P1|Overall Study|Other|4
4705106|NCT02238080|16214822|P1|Overall Study|Withdrawal by Subject|2
4705107|NCT02238080|16214822|P1|Overall Study|Treatment interrupted|6
4705108|NCT02238080|16214822|P1|Overall Study|Death|13
4705109|NCT02238067|16214836|P1|Overall Study|Not completed survey at Month 6|45
4705110|NCT02237911|16214924|P3|Overall Study|Lost to Follow-up|1
4705111|NCT02237911|16214925|P2|Overall Study|Lost to Follow-up|1
4705112|NCT02237911|16214926|P1|Overall Study|Lost to Follow-up|3
4705113|NCT02237911|16214924|P3|Overall Study|Withdrawal by Subject|2
4705114|NCT02237911|16214925|P2|Overall Study|Withdrawal by Subject|7
4705115|NCT02237911|16214926|P1|Overall Study|Withdrawal by Subject|4
4705116|NCT02237196|16214966|P4|Overall Study|Site Error|2
4705117|NCT02237196|16214967|P3|Overall Study|Site Error|0
4705118|NCT02237196|16214968|P2|Overall Study|Site Error|2
4705119|NCT02237196|16214969|P1|Overall Study|Site Error|1
4705120|NCT02237196|16214966|P4|Overall Study|Withdrawal by Subject|1
4705121|NCT02237196|16214967|P3|Overall Study|Withdrawal by Subject|4
4705122|NCT02237196|16214968|P2|Overall Study|Withdrawal by Subject|1
4705123|NCT02237196|16214969|P1|Overall Study|Withdrawal by Subject|1
4705124|NCT02237196|16214966|P4|Overall Study|Pregnancy|1
4705125|NCT02237196|16214967|P3|Overall Study|Pregnancy|1
4705126|NCT02237196|16214968|P2|Overall Study|Pregnancy|0
4705127|NCT02237196|16214969|P1|Overall Study|Pregnancy|0
4705128|NCT02237196|16214966|P4|Overall Study|Physician Decision|1
4705129|NCT02237196|16214967|P3|Overall Study|Physician Decision|0
4705130|NCT02237196|16214968|P2|Overall Study|Physician Decision|0
4705131|NCT02237196|16214969|P1|Overall Study|Physician Decision|2
4705132|NCT02237196|16214966|P4|Overall Study|Lost to Follow-up|6
4705133|NCT02237196|16214967|P3|Overall Study|Lost to Follow-up|4
4705134|NCT02237196|16214968|P2|Overall Study|Lost to Follow-up|2
4705135|NCT02237196|16214969|P1|Overall Study|Lost to Follow-up|4
4705136|NCT02237196|16214966|P4|Overall Study|Adverse Event|0
4705137|NCT02237196|16214967|P3|Overall Study|Adverse Event|1
4705138|NCT02237196|16214968|P2|Overall Study|Adverse Event|1
4705139|NCT02237196|16214969|P1|Overall Study|Adverse Event|0
4705140|NCT02237118|16215013|P2|Overall Study|consent withdrawn|0
4705141|NCT02237118|16215014|P1|Overall Study|consent withdrawn|1
4705142|NCT02237118|16215013|P2|Overall Study|Protocol Violation|1
4705143|NCT02237118|16215014|P1|Overall Study|Protocol Violation|0
4705144|NCT02237001|16215045|P1|Overall Study|Incarceration|1
4705145|NCT02237001|16215045|P1|Overall Study|Re-operation|4
4705146|NCT02237001|16215045|P1|Overall Study|Eligibility criteria/Late Screen Failure|3
4705147|NCT02237001|16215045|P1|Overall Study|Withdrawal by Subject|1
4705148|NCT02237001|16215045|P1|Overall Study|Lost to Follow-up|2
4705149|NCT02236611|16215063|P2|Overall Study|Withdrew consent|4
4705150|NCT02236611|16215064|P1|Overall Study|Withdrew consent|9
4705151|NCT02236611|16215063|P2|Overall Study|Protocol deviation|5
4705152|NCT02236611|16215064|P1|Overall Study|Protocol deviation|3
4705153|NCT02236611|16215063|P2|Overall Study|Lost to Follow-up|2
4705154|NCT02236611|16215064|P1|Overall Study|Lost to Follow-up|0
4705155|NCT02236611|16215063|P2|Overall Study|Lack of Efficacy|7
4705156|NCT02236611|16215064|P1|Overall Study|Lack of Efficacy|4
4705157|NCT02236611|16215063|P2|Overall Study|Adverse Event|16
4705158|NCT02236611|16215064|P1|Overall Study|Adverse Event|10
4705159|NCT02236598|16215072|P2|Overall Study|Withdrawal by Subject|1
4705160|NCT02236598|16215073|P1|Overall Study|Withdrawal by Subject|0
4705161|NCT02236598|16215072|P2|Overall Study|Adverse Event|1
4705162|NCT02236598|16215073|P1|Overall Study|Adverse Event|0
4705163|NCT02236559|16215087|P2|Overall Study|Withdrawal by Subject|0
4705164|NCT02236559|16215088|P1|Overall Study|Withdrawal by Subject|1
4705165|NCT02236559|16215087|P2|Overall Study|Physician Decision|1
4705166|NCT02236559|16215088|P1|Overall Study|Physician Decision|1
4705167|NCT02236559|16215087|P2|Overall Study|Subject Did Not Consent|2
4705168|NCT02236559|16215088|P1|Overall Study|Subject Did Not Consent|4
4705169|NCT02236559|16215087|P2|Overall Study|Did not Meet Inclusion|3
4705170|NCT02236559|16215088|P1|Overall Study|Did not Meet Inclusion|3
4705171|NCT02236559|16215087|P2|Overall Study|Met Exclusion|6
4705172|NCT02236559|16215088|P1|Overall Study|Met Exclusion|3
4705173|NCT02236520|16215125|P4|Overall Study|Pregnancy|0
4705174|NCT02236520|16215126|P3|Overall Study|Pregnancy|0
4705175|NCT02236520|16215127|P2|Overall Study|Pregnancy|0
4705176|NCT02236520|16215128|P1|Overall Study|Pregnancy|1
4705177|NCT02236520|16215125|P4|Overall Study|Withdrawal by Subject|1
4705178|NCT02236520|16215126|P3|Overall Study|Withdrawal by Subject|0
4705179|NCT02236520|16215127|P2|Overall Study|Withdrawal by Subject|0
4705180|NCT02236520|16215128|P1|Overall Study|Withdrawal by Subject|1
4705181|NCT02236520|16215125|P4|Overall Study|Physician Decision|0
4705182|NCT02236520|16215126|P3|Overall Study|Physician Decision|0
4705183|NCT02236520|16215127|P2|Overall Study|Physician Decision|5
4705184|NCT02236520|16215128|P1|Overall Study|Physician Decision|0
4705185|NCT02236130|16215155|P2|Overall Study|Lost to Follow-up|12
4705186|NCT02236130|16215156|P1|Overall Study|Lost to Follow-up|7
4705187|NCT02235454|16215206|P1|Overall Study|Withdrawal by Subject|2
4705188|NCT02235311|16215212|P2|Overall Study|Protocol Violation|1
4705189|NCT02235311|16215213|P1|Overall Study|Protocol Violation|0
4705190|NCT02235311|16215212|P2|Overall Study|Lost to Follow-up|1
4705191|NCT02235311|16215213|P1|Overall Study|Lost to Follow-up|0
4705192|NCT02235077|16215231|P2|Overall Study|Physician Decision|1
4705193|NCT02235077|16215232|P1|Overall Study|Physician Decision|0
4705194|NCT02235077|16215231|P2|Overall Study|Withdrawal by Subject|5
4705195|NCT02235077|16215232|P1|Overall Study|Withdrawal by Subject|8
4705196|NCT02235077|16215231|P2|Overall Study|Lost to Follow-up|6
4705197|NCT02235077|16215232|P1|Overall Study|Lost to Follow-up|5
4705198|NCT02235077|16215231|P2|Overall Study|Death|7
4705199|NCT02235077|16215232|P1|Overall Study|Death|5
4705200|NCT02234843|16215297|P10|Overall Study|Lost to Follow-up|0
4705201|NCT02234843|16215298|P9|Overall Study|Lost to Follow-up|0
4705202|NCT02234843|16215299|P8|Overall Study|Lost to Follow-up|0
4705203|NCT02234843|16215300|P7|Overall Study|Lost to Follow-up|1
4705204|NCT02234843|16215301|P6|Overall Study|Lost to Follow-up|0
4705205|NCT02234843|16215302|P5|Overall Study|Lost to Follow-up|0
4705206|NCT02234843|16215303|P4|Overall Study|Lost to Follow-up|0
4705207|NCT02234843|16215304|P3|Overall Study|Lost to Follow-up|0
4705208|NCT02234843|16215305|P2|Overall Study|Lost to Follow-up|1
4705209|NCT02234843|16215306|P1|Overall Study|Lost to Follow-up|0
4705210|NCT02234843|16215297|P10|Overall Study|Non-compliance with study drug|0
4705211|NCT02234843|16215298|P9|Overall Study|Non-compliance with study drug|0
4705212|NCT02234843|16215299|P8|Overall Study|Non-compliance with study drug|0
4705213|NCT02234843|16215300|P7|Overall Study|Non-compliance with study drug|1
4705214|NCT02234843|16215301|P6|Overall Study|Non-compliance with study drug|1
4705215|NCT02234843|16215302|P5|Overall Study|Non-compliance with study drug|0
4705216|NCT02234843|16215303|P4|Overall Study|Non-compliance with study drug|0
4705217|NCT02234843|16215304|P3|Overall Study|Non-compliance with study drug|0
4705218|NCT02234843|16215305|P2|Overall Study|Non-compliance with study drug|0
4705219|NCT02234843|16215306|P1|Overall Study|Non-compliance with study drug|1
4705220|NCT02234843|16215297|P10|Overall Study|Adverse Event|0
4705221|NCT02234843|16215298|P9|Overall Study|Adverse Event|1
4705222|NCT02234843|16215299|P8|Overall Study|Adverse Event|0
4705223|NCT02234843|16215300|P7|Overall Study|Adverse Event|0
4705224|NCT02234843|16215301|P6|Overall Study|Adverse Event|1
4705225|NCT02234843|16215302|P5|Overall Study|Adverse Event|2
4705226|NCT02234843|16215303|P4|Overall Study|Adverse Event|3
4705227|NCT02234843|16215304|P3|Overall Study|Adverse Event|1
4705228|NCT02234843|16215305|P2|Overall Study|Adverse Event|1
4705229|NCT02234843|16215306|P1|Overall Study|Adverse Event|5
4705230|NCT02234843|16215297|P10|Overall Study|Physician Decision|0
4705231|NCT02234843|16215298|P9|Overall Study|Physician Decision|0
4705232|NCT02234843|16215299|P8|Overall Study|Physician Decision|1
4705233|NCT02234843|16215300|P7|Overall Study|Physician Decision|0
4705234|NCT02234843|16215301|P6|Overall Study|Physician Decision|0
4705235|NCT02234843|16215302|P5|Overall Study|Physician Decision|0
4705236|NCT02234843|16215303|P4|Overall Study|Physician Decision|1
4705237|NCT02234843|16215304|P3|Overall Study|Physician Decision|0
4705238|NCT02234843|16215305|P2|Overall Study|Physician Decision|1
4705239|NCT02234843|16215306|P1|Overall Study|Physician Decision|4
4705240|NCT02234843|16215297|P10|Overall Study|Other|0
4705241|NCT02234843|16215298|P9|Overall Study|Other|0
4705242|NCT02234843|16215299|P8|Overall Study|Other|1
4705243|NCT02234843|16215300|P7|Overall Study|Other|0
4705244|NCT02234843|16215301|P6|Overall Study|Other|1
4705245|NCT02234843|16215302|P5|Overall Study|Other|0
4705246|NCT02234843|16215303|P4|Overall Study|Other|1
4705247|NCT02234843|16215304|P3|Overall Study|Other|0
4705248|NCT02234843|16215305|P2|Overall Study|Other|2
4705249|NCT02234843|16215306|P1|Overall Study|Other|0
4705250|NCT02234843|16215297|P10|Overall Study|Recovery|0
4705251|NCT02234843|16215298|P9|Overall Study|Recovery|0
4705252|NCT02234843|16215299|P8|Overall Study|Recovery|0
4705253|NCT02234843|16215300|P7|Overall Study|Recovery|0
4705254|NCT02234843|16215301|P6|Overall Study|Recovery|0
4705255|NCT02234843|16215302|P5|Overall Study|Recovery|0
4705256|NCT02234843|16215303|P4|Overall Study|Recovery|0
4705257|NCT02234843|16215304|P3|Overall Study|Recovery|0
4705258|NCT02234843|16215305|P2|Overall Study|Recovery|0
4705259|NCT02234843|16215306|P1|Overall Study|Recovery|1
4705260|NCT02234843|16215297|P10|Overall Study|Withdrawal by Subject|0
4705261|NCT02234843|16215298|P9|Overall Study|Withdrawal by Subject|0
4705262|NCT02234843|16215299|P8|Overall Study|Withdrawal by Subject|0
4705263|NCT02234843|16215300|P7|Overall Study|Withdrawal by Subject|0
4705264|NCT02234843|16215301|P6|Overall Study|Withdrawal by Subject|7
4705265|NCT02234843|16215302|P5|Overall Study|Withdrawal by Subject|0
4705266|NCT02234843|16215303|P4|Overall Study|Withdrawal by Subject|0
4705267|NCT02234843|16215304|P3|Overall Study|Withdrawal by Subject|1
4705268|NCT02234843|16215305|P2|Overall Study|Withdrawal by Subject|1
4705269|NCT02234843|16215306|P1|Overall Study|Withdrawal by Subject|5
4705270|NCT02234843|16215297|P10|Overall Study|Patient convenience|0
4705271|NCT02234843|16215298|P9|Overall Study|Patient convenience|0
4705272|NCT02234843|16215299|P8|Overall Study|Patient convenience|0
4705273|NCT02234843|16215300|P7|Overall Study|Patient convenience|0
4705274|NCT02234843|16215301|P6|Overall Study|Patient convenience|1
4705275|NCT02234843|16215302|P5|Overall Study|Patient convenience|0
4705276|NCT02234843|16215303|P4|Overall Study|Patient convenience|0
4705277|NCT02234843|16215304|P3|Overall Study|Patient convenience|0
4705278|NCT02234843|16215305|P2|Overall Study|Patient convenience|0
4705279|NCT02234843|16215306|P1|Overall Study|Patient convenience|2
4705280|NCT02234843|16215297|P10|Overall Study|Efficacy outcome reached|0
4705281|NCT02234843|16215298|P9|Overall Study|Efficacy outcome reached|0
4705282|NCT02234843|16215299|P8|Overall Study|Efficacy outcome reached|0
4705283|NCT02234843|16215300|P7|Overall Study|Efficacy outcome reached|0
4705284|NCT02234843|16215301|P6|Overall Study|Efficacy outcome reached|2
4705285|NCT02234843|16215302|P5|Overall Study|Efficacy outcome reached|0
4705286|NCT02234843|16215303|P4|Overall Study|Efficacy outcome reached|0
4705287|NCT02234843|16215304|P3|Overall Study|Efficacy outcome reached|0
4705288|NCT02234843|16215305|P2|Overall Study|Efficacy outcome reached|0
4705289|NCT02234843|16215306|P1|Overall Study|Efficacy outcome reached|2
4705290|NCT02234843|16215297|P10|Overall Study|Protocol Violation|0
4705291|NCT02234843|16215298|P9|Overall Study|Protocol Violation|0
4705292|NCT02234843|16215299|P8|Overall Study|Protocol Violation|0
4705293|NCT02234843|16215300|P7|Overall Study|Protocol Violation|0
4705294|NCT02234843|16215301|P6|Overall Study|Protocol Violation|0
4705295|NCT02234843|16215302|P5|Overall Study|Protocol Violation|0
4705296|NCT02234843|16215303|P4|Overall Study|Protocol Violation|0
4705297|NCT02234843|16215304|P3|Overall Study|Protocol Violation|1
4705298|NCT02234843|16215305|P2|Overall Study|Protocol Violation|0
4705299|NCT02234843|16215306|P1|Overall Study|Protocol Violation|1
4705300|NCT02234843|16215297|P10|Overall Study|Death|0
4705301|NCT02234843|16215298|P9|Overall Study|Death|0
4705302|NCT02234843|16215299|P8|Overall Study|Death|0
4705303|NCT02234843|16215300|P7|Overall Study|Death|0
4705304|NCT02234843|16215301|P6|Overall Study|Death|0
4705305|NCT02234843|16215302|P5|Overall Study|Death|0
4705306|NCT02234843|16215303|P4|Overall Study|Death|0
4705307|NCT02234843|16215304|P3|Overall Study|Death|0
4705308|NCT02234843|16215305|P2|Overall Study|Death|0
4705309|NCT02234843|16215306|P1|Overall Study|Death|1
4705310|NCT02234622|16215464|P2|Overall Study|Lost to Follow-up|14
4705311|NCT02234622|16215465|P1|Overall Study|Lost to Follow-up|27
4705312|NCT02234622|16215464|P2|Overall Study|Withdrawal by Subject|22
4705313|NCT02234622|16215465|P1|Overall Study|Withdrawal by Subject|16
4705314|NCT02234583|16215485|P2|Overall Study|Other|97
4705315|NCT02234583|16215486|P1|Overall Study|Other|39
4705316|NCT02234583|16215485|P2|Overall Study|Protocol Violation|42
4705317|NCT02234583|16215486|P1|Overall Study|Protocol Violation|35
4705318|NCT02234583|16215485|P2|Overall Study|Lack of Efficacy|103
4705319|NCT02234583|16215486|P1|Overall Study|Lack of Efficacy|58
4705320|NCT02234583|16215485|P2|Overall Study|Lost to Follow-up|1
4705321|NCT02234583|16215486|P1|Overall Study|Lost to Follow-up|0
4705322|NCT02234583|16215485|P2|Overall Study|Withdrawal by Subject|157
4705323|NCT02234583|16215486|P1|Overall Study|Withdrawal by Subject|109
4705324|NCT02234583|16215485|P2|Overall Study|Adverse Event|156
4705325|NCT02234583|16215486|P1|Overall Study|Adverse Event|172
4705326|NCT02234479|16215605|P2|Overall Study|Withdrawal by Subject|3
4705327|NCT02234479|16215606|P1|Overall Study|Withdrawal by Subject|1
4705328|NCT02234362|16215616|P1|Overall Study|Withdrawal by Subject|3
4705329|NCT02234362|16215616|P1|Overall Study|Lost to Follow-up|6
4705330|NCT02234362|16215616|P1|Overall Study|Not eligible after first screening visit|17
4705331|NCT02234323|16215633|P1|All Treated|Other|7
4705332|NCT02234323|16215633|P1|All Treated|Exceeded lab value limit|2
4705333|NCT02234323|16215633|P1|All Treated|Lack of Efficacy|3
4705334|NCT02234323|16215633|P1|All Treated|Physician Decision|5
4705335|NCT02234323|16215633|P1|All Treated|Death|1
4705336|NCT02234323|16215633|P1|All Enrolled|Not Treated: Exceeded lab value limit|1
4705337|NCT02234323|16215633|P1|All Enrolled|Not Treated:Consent withdrawn by subject|2
4705338|NCT02234323|16215633|P1|All Enrolled|Not Treated: Completed study in database|2
4705339|NCT02234310|16215646|P1|Overall Study|Withdrawal by Subject|2
4705340|NCT02234310|16215646|P1|Overall Study|Eligibility Criteria not fulfilled|2
4705341|NCT02234310|16215646|P1|Overall Study|Adverse Event|1
4705342|NCT02234310|16215646|P1|Overall Study|Physician Decision|1
4705343|NCT02234284|16215660|P2|Overall Study|Lost to Follow-up|7
4705344|NCT02234284|16215661|P1|Overall Study|Lost to Follow-up|20
4705345|NCT02234284|16215660|P2|Overall Study|Withdrawal by Subject|0
4705346|NCT02234284|16215661|P1|Overall Study|Withdrawal by Subject|1
4705347|NCT02234284|16215660|P2|Overall Study|Death|2
4705348|NCT02234284|16215661|P1|Overall Study|Death|4
4705349|NCT02234141|16215720|P7|Long-Term Treatment Period|Study Discontinued by Sponsor|8
4705350|NCT02234141|16215721|P6|Long-Term Treatment Period|Study Discontinued by Sponsor|10
4705351|NCT02234141|16215722|P5|Long-Term Treatment Period|Study Discontinued by Sponsor|9
4705352|NCT02234141|16215723|P4|Long-Term Treatment Period|Study Discontinued by Sponsor|0
4705353|NCT02234141|16215724|P3|Long-Term Treatment Period|Study Discontinued by Sponsor|25
4705354|NCT02234141|16215725|P2|Long-Term Treatment Period|Study Discontinued by Sponsor|27
4705355|NCT02234141|16215726|P1|Long-Term Treatment Period|Study Discontinued by Sponsor|28
4705356|NCT02234141|16215720|P7|Long-Term Treatment Period|Withdrew Consent|0
4705357|NCT02234141|16215721|P6|Long-Term Treatment Period|Withdrew Consent|0
4705358|NCT02234141|16215722|P5|Long-Term Treatment Period|Withdrew Consent|0
4705359|NCT02234141|16215723|P4|Long-Term Treatment Period|Withdrew Consent|0
4705360|NCT02234141|16215724|P3|Long-Term Treatment Period|Withdrew Consent|1
4705361|NCT02234141|16215725|P2|Long-Term Treatment Period|Withdrew Consent|1
4705362|NCT02234141|16215726|P1|Long-Term Treatment Period|Withdrew Consent|0
4705363|NCT02234141|16215720|P7|Long-Term Treatment Period|Adverse Event|1
4705364|NCT02234141|16215721|P6|Long-Term Treatment Period|Adverse Event|1
4705365|NCT02234141|16215722|P5|Long-Term Treatment Period|Adverse Event|1
4705366|NCT02234141|16215723|P4|Long-Term Treatment Period|Adverse Event|0
4705367|NCT02234141|16215724|P3|Long-Term Treatment Period|Adverse Event|5
4705368|NCT02234141|16215725|P2|Long-Term Treatment Period|Adverse Event|0
4705369|NCT02234141|16215726|P1|Long-Term Treatment Period|Adverse Event|4
4705370|NCT02234141|16215720|P7|Long-Term Treatment Period|Investigator's discretion|1
4705371|NCT02234141|16215721|P6|Long-Term Treatment Period|Investigator's discretion|0
4705372|NCT02234141|16215722|P5|Long-Term Treatment Period|Investigator's discretion|0
4705373|NCT02234141|16215723|P4|Long-Term Treatment Period|Investigator's discretion|0
4705374|NCT02234141|16215724|P3|Long-Term Treatment Period|Investigator's discretion|2
4705375|NCT02234141|16215725|P2|Long-Term Treatment Period|Investigator's discretion|3
4705376|NCT02234141|16215726|P1|Long-Term Treatment Period|Investigator's discretion|1
4705377|NCT02234141|16215720|P7|Long-Term Treatment Period|Death|0
4705378|NCT02234141|16215721|P6|Long-Term Treatment Period|Death|1
4705379|NCT02234141|16215722|P5|Long-Term Treatment Period|Death|0
4705380|NCT02234141|16215723|P4|Long-Term Treatment Period|Death|0
4705381|NCT02234141|16215724|P3|Long-Term Treatment Period|Death|0
4705382|NCT02234141|16215725|P2|Long-Term Treatment Period|Death|0
4705383|NCT02234141|16215726|P1|Long-Term Treatment Period|Death|0
4705384|NCT02234141|16215720|P7|Treatment Period (24 Weeks)|Randomized but not treated|0
4705385|NCT02234141|16215721|P6|Treatment Period (24 Weeks)|Randomized but not treated|0
4705386|NCT02234141|16215722|P5|Treatment Period (24 Weeks)|Randomized but not treated|0
4705387|NCT02234141|16215723|P4|Treatment Period (24 Weeks)|Randomized but not treated|0
4705388|NCT02234141|16215724|P3|Treatment Period (24 Weeks)|Randomized but not treated|0
4705389|NCT02234141|16215725|P2|Treatment Period (24 Weeks)|Randomized but not treated|1
4705390|NCT02234141|16215726|P1|Treatment Period (24 Weeks)|Randomized but not treated|0
4705391|NCT02234141|16215720|P7|Treatment Period (24 Weeks)|Adverse Event|0
4705392|NCT02234141|16215721|P6|Treatment Period (24 Weeks)|Adverse Event|0
4705393|NCT02234141|16215722|P5|Treatment Period (24 Weeks)|Adverse Event|0
4705394|NCT02234141|16215723|P4|Treatment Period (24 Weeks)|Adverse Event|3
4705395|NCT02234141|16215724|P3|Treatment Period (24 Weeks)|Adverse Event|2
4705396|NCT02234141|16215725|P2|Treatment Period (24 Weeks)|Adverse Event|1
4705397|NCT02234141|16215726|P1|Treatment Period (24 Weeks)|Adverse Event|3
4705398|NCT02234141|16215720|P7|Treatment Period (24 Weeks)|Death|0
4705399|NCT02234141|16215721|P6|Treatment Period (24 Weeks)|Death|0
4705400|NCT02234141|16215722|P5|Treatment Period (24 Weeks)|Death|0
4705401|NCT02234141|16215723|P4|Treatment Period (24 Weeks)|Death|1
4705402|NCT02234141|16215724|P3|Treatment Period (24 Weeks)|Death|0
4705403|NCT02234141|16215725|P2|Treatment Period (24 Weeks)|Death|2
4705404|NCT02234141|16215726|P1|Treatment Period (24 Weeks)|Death|1
4705405|NCT02234141|16215720|P7|Treatment Period (24 Weeks)|Investigator's discretion|0
4705406|NCT02234141|16215721|P6|Treatment Period (24 Weeks)|Investigator's discretion|0
4705407|NCT02234141|16215722|P5|Treatment Period (24 Weeks)|Investigator's discretion|0
4705408|NCT02234141|16215723|P4|Treatment Period (24 Weeks)|Investigator's discretion|0
4705409|NCT02234141|16215724|P3|Treatment Period (24 Weeks)|Investigator's discretion|0
4705410|NCT02234141|16215725|P2|Treatment Period (24 Weeks)|Investigator's discretion|2
4705411|NCT02234141|16215726|P1|Treatment Period (24 Weeks)|Investigator's discretion|0
4705412|NCT02234141|16215720|P7|Treatment Period (24 Weeks)|Protocol Violation|0
4705413|NCT02234141|16215721|P6|Treatment Period (24 Weeks)|Protocol Violation|0
4705414|NCT02234141|16215722|P5|Treatment Period (24 Weeks)|Protocol Violation|0
4705415|NCT02234141|16215723|P4|Treatment Period (24 Weeks)|Protocol Violation|1
4705416|NCT02234141|16215724|P3|Treatment Period (24 Weeks)|Protocol Violation|0
4705417|NCT02234141|16215725|P2|Treatment Period (24 Weeks)|Protocol Violation|0
4705418|NCT02234141|16215726|P1|Treatment Period (24 Weeks)|Protocol Violation|0
4705419|NCT02234063|16215831|P2|Overall Study|Withdrawal by Subject|1
4705420|NCT02234063|16215832|P1|Overall Study|Withdrawal by Subject|20
4705421|NCT02234063|16215831|P2|Overall Study|Lost to Follow-up|42
4705422|NCT02234063|16215832|P1|Overall Study|Lost to Follow-up|235
4705423|NCT02233803|16215911|P2|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2
4705424|NCT02233803|16215912|P1|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1
4705425|NCT02233803|16215911|P2|Treatment Period 2 (4-Wks)|Lost to Follow-up|0
4705426|NCT02233803|16215912|P1|Treatment Period 2 (4-Wks)|Lost to Follow-up|1
4705427|NCT02233803|16215911|P2|Washout Period (4-Wks)|Withdrawal by Subject|1
4705428|NCT02233803|16215912|P1|Washout Period (4-Wks)|Withdrawal by Subject|1
4705429|NCT02233803|16215911|P2|Washout Period (4-Wks)|Physician Decision|0
4705430|NCT02233803|16215912|P1|Washout Period (4-Wks)|Physician Decision|1
4705431|NCT02233803|16215911|P2|Washout Period (4-Wks)|Lost to Follow-up|1
4705432|NCT02233803|16215912|P1|Washout Period (4-Wks)|Lost to Follow-up|0
4705433|NCT02233803|16215911|P2|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1
4705434|NCT02233803|16215912|P1|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0
4705435|NCT02233803|16215911|P2|Treatment Period 1 (4-Wks)|Protocol Violation|2
4705436|NCT02233803|16215912|P1|Treatment Period 1 (4-Wks)|Protocol Violation|2
4705437|NCT02233803|16215911|P2|Treatment Period 1 (4-Wks)|Adverse Event|1
4705438|NCT02233803|16215912|P1|Treatment Period 1 (4-Wks)|Adverse Event|0
4705439|NCT02233803|16215911|P2|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0
4705440|NCT02233803|16215912|P1|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1
4705441|NCT02233738|16215945|P2|Overall Study|Did not return after Baseline|2
4705442|NCT02233738|16215946|P1|Overall Study|Did not return after Baseline|3
4705443|NCT02233738|16215945|P2|Overall Study|Withdrawal by Subject|1
4705444|NCT02233738|16215946|P1|Overall Study|Withdrawal by Subject|0
4705445|NCT02233738|16215945|P2|Overall Study|Death|1
4705446|NCT02233738|16215946|P1|Overall Study|Death|0
4705447|NCT02233738|16215945|P2|Overall Study|Lost to Follow-up|12
4705448|NCT02233738|16215946|P1|Overall Study|Lost to Follow-up|5
4705449|NCT02233647|16216116|P1|Overall Study|Adverse Event|1
4705450|NCT02233543|16216145|P2|Period 2|COPD exacerbation|0
4705451|NCT02233543|16216146|P1|Period 2|COPD exacerbation|1
4705452|NCT02233543|16216145|P2|Period 2|Participant required other treatment.|1
4705453|NCT02233543|16216146|P1|Period 2|Participant required other treatment.|0
4705454|NCT02233543|16216145|P2|Period 2|Adverse Event|0
4705455|NCT02233543|16216146|P1|Period 2|Adverse Event|1
4705456|NCT02233543|16216145|P2|Period 1|Participants required other treatment.|3
4705457|NCT02233543|16216146|P1|Period 1|Participants required other treatment.|2
4705458|NCT02233543|16216145|P2|Period 1|Withdrawal by Subject|0
4705459|NCT02233543|16216146|P1|Period 1|Withdrawal by Subject|1
4705460|NCT02233309|16216196|P1|Overall Study|Physician Decision|5
4705461|NCT02232984|16216230|P1|Overall Study|Protocol Violation|1
4705462|NCT02232984|16216230|P1|Overall Study|not disclosed by site|7
4705463|NCT02232984|16216230|P1|Overall Study|Device implant unsuccessful|53
4705464|NCT02232984|16216230|P1|Overall Study|Investigator withdrawal|10
4705465|NCT02232984|16216230|P1|Overall Study|Death|1
4705466|NCT02232984|16216230|P1|Overall Study|Withdrawal by Subject|5
4705467|NCT02232893|16216241|P2|Overall Study|Other|3
4705468|NCT02232893|16216242|P1|Overall Study|Other|0
4705469|NCT02232893|16216241|P2|Overall Study|Developed exclusion criteria|1
4705470|NCT02232893|16216242|P1|Overall Study|Developed exclusion criteria|0
4705471|NCT02232893|16216241|P2|Overall Study|Sponsor request early termination|1
4705472|NCT02232893|16216242|P1|Overall Study|Sponsor request early termination|0
4705473|NCT02232893|16216241|P2|Overall Study|Adverse Event|1
4705474|NCT02232893|16216242|P1|Overall Study|Adverse Event|0
4705475|NCT02232893|16216241|P2|Overall Study|Withdrawal by Subject|1
4705476|NCT02232893|16216242|P1|Overall Study|Withdrawal by Subject|4
4705477|NCT02232880|16216248|P1|Overall Study|study stopped prior to randomization|1
4705478|NCT02232802|16216257|P2|Period 1|Adverse Event|1
4705479|NCT02232802|16216258|P1|Period 1|Adverse Event|1
4705480|NCT02232802|16216257|P2|Period 1|Sponsor request|0
4705481|NCT02232802|16216258|P1|Period 1|Sponsor request|1
4705482|NCT02232698|16216324|P2|Overall Study|Withdrawal by Subject|11
4705483|NCT02232698|16216325|P1|Overall Study|Withdrawal by Subject|0
4705484|NCT02232698|16216324|P2|Overall Study|Allocated to control group|3
4705485|NCT02232698|16216325|P1|Overall Study|Allocated to control group|0
4705486|NCT02232698|16216324|P2|Overall Study|Non-compliance with study device|4
4705487|NCT02232698|16216325|P1|Overall Study|Non-compliance with study device|1
4705488|NCT02232698|16216324|P2|Overall Study|Had device-associated symptoms|0
4705489|NCT02232698|16216325|P1|Overall Study|Had device-associated symptoms|7
4705490|NCT02232698|16216324|P2|Overall Study|Met exclusion criteria|1
4705491|NCT02232698|16216325|P1|Overall Study|Met exclusion criteria|1
4705492|NCT02232698|16216324|P2|Overall Study|Pregnancy|1
4705493|NCT02232698|16216325|P1|Overall Study|Pregnancy|1
4705494|NCT02232425|16216348|P2|Overall Study|Lack of Efficacy|0
4705495|NCT02232425|16216349|P1|Overall Study|Lack of Efficacy|1
4705496|NCT02232425|16216348|P2|Overall Study|Withdrawal by Subject|6
4705497|NCT02232425|16216349|P1|Overall Study|Withdrawal by Subject|5
4705498|NCT02232425|16216348|P2|Overall Study|Adverse Event|0
4705499|NCT02232425|16216349|P1|Overall Study|Adverse Event|2
4705500|NCT02232425|16216348|P2|Overall Study|Lost to Follow-up|2
4705501|NCT02232425|16216349|P1|Overall Study|Lost to Follow-up|6
4705502|NCT02232243|16216382|P3|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
4705503|NCT02232243|16216383|P2|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1
4705504|NCT02232243|16216384|P1|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0
4705505|NCT02232178|16216396|P3|Overall Study|surgical complication|0
4705506|NCT02232178|16216397|P2|Overall Study|surgical complication|0
4705507|NCT02232178|16216398|P1|Overall Study|surgical complication|1
4705508|NCT02232178|16216396|P3|Overall Study|ineligibility|1
4705509|NCT02232178|16216397|P2|Overall Study|ineligibility|0
4705510|NCT02232178|16216398|P1|Overall Study|ineligibility|0
4705511|NCT02232178|16216396|P3|Overall Study|Lost to Follow-up|0
4705512|NCT02232178|16216397|P2|Overall Study|Lost to Follow-up|1
4705513|NCT02232178|16216398|P1|Overall Study|Lost to Follow-up|0
4705514|NCT02232074|16216428|P2|Overall Study|deemed ineligible|1
4705515|NCT02232074|16216429|P1|Overall Study|deemed ineligible|0
4705516|NCT02232074|16216428|P2|Overall Study|No legal concerns at baseline|41
4705517|NCT02232074|16216429|P1|Overall Study|No legal concerns at baseline|36
4705518|NCT02232074|16216428|P2|Overall Study|Withdrawal by Subject|3
4705519|NCT02232074|16216429|P1|Overall Study|Withdrawal by Subject|5
4705520|NCT02231918|16216496|P3|Overall Study|Adverse Event|1
4705521|NCT02231918|16216497|P2|Overall Study|Adverse Event|0
4705522|NCT02231918|16216498|P1|Overall Study|Adverse Event|0
4705523|NCT02231918|16216496|P3|Overall Study|Withdrawal by Subject|0
4705524|NCT02231918|16216497|P2|Overall Study|Withdrawal by Subject|1
4705525|NCT02231918|16216498|P1|Overall Study|Withdrawal by Subject|0
4705526|NCT02231892|16216563|P3|Overall Study|Could not find reliable motor hotspot|1
4705527|NCT02231892|16216564|P2|Overall Study|Could not find reliable motor hotspot|0
4705528|NCT02231892|16216565|P1|Overall Study|Could not find reliable motor hotspot|0
4705529|NCT02231892|16216563|P3|Overall Study|Could not find motor threshold|1
4705530|NCT02231892|16216564|P2|Overall Study|Could not find motor threshold|0
4705531|NCT02231892|16216565|P1|Overall Study|Could not find motor threshold|2
4705532|NCT02231892|16216563|P3|Overall Study|Participant motor threshold was >83%|9
4705533|NCT02231892|16216564|P2|Overall Study|Participant motor threshold was >83%|0
4705534|NCT02231892|16216565|P1|Overall Study|Participant motor threshold was >83%|0
4705535|NCT02231892|16216563|P3|Overall Study|Motor activity when stimulating ante ACC|12
4705536|NCT02231892|16216564|P2|Overall Study|Motor activity when stimulating ante ACC|7
4705537|NCT02231892|16216565|P1|Overall Study|Motor activity when stimulating ante ACC|4
4705538|NCT02231892|16216563|P3|Overall Study|Physician Decision|4
4705539|NCT02231892|16216564|P2|Overall Study|Physician Decision|2
4705540|NCT02231892|16216565|P1|Overall Study|Physician Decision|0
4705541|NCT02231892|16216563|P3|Overall Study|Withdrawal by Subject|15
4705542|NCT02231892|16216564|P2|Overall Study|Withdrawal by Subject|3
4705543|NCT02231892|16216565|P1|Overall Study|Withdrawal by Subject|4
4705544|NCT02231892|16216563|P3|Overall Study|Lost to Follow-up|3
4705545|NCT02231892|16216564|P2|Overall Study|Lost to Follow-up|0
4705546|NCT02231892|16216565|P1|Overall Study|Lost to Follow-up|1
4705547|NCT02231762|16216582|P4|Maintenance Phase|Adverse Event|2
4705548|NCT02231762|16216583|P3|Maintenance Phase|Adverse Event|1
4705549|NCT02231762|16216584|P2|Maintenance Phase|Adverse Event|0
4705550|NCT02231762|16216585|P1|Maintenance Phase|Adverse Event|0
4705551|NCT02231762|16216582|P4|Maintenance Phase|Disease progression|3
4705552|NCT02231762|16216583|P3|Maintenance Phase|Disease progression|4
4705553|NCT02231762|16216584|P2|Maintenance Phase|Disease progression|3
4705554|NCT02231762|16216585|P1|Maintenance Phase|Disease progression|0
4705555|NCT02231762|16216582|P4|Combination Phase|Protocol Violation|0
4705556|NCT02231762|16216583|P3|Combination Phase|Protocol Violation|0
4705557|NCT02231762|16216584|P2|Combination Phase|Protocol Violation|0
4705558|NCT02231762|16216585|P1|Combination Phase|Protocol Violation|1
4705559|NCT02231762|16216582|P4|Combination Phase|Did not meet inclusion criteria|0
4705560|NCT02231762|16216583|P3|Combination Phase|Did not meet inclusion criteria|0
4705561|NCT02231762|16216584|P2|Combination Phase|Did not meet inclusion criteria|0
4705562|NCT02231762|16216585|P1|Combination Phase|Did not meet inclusion criteria|1
4705563|NCT02231762|16216582|P4|Combination Phase|Disease Progression|0
4705564|NCT02231762|16216583|P3|Combination Phase|Disease Progression|0
4705565|NCT02231762|16216584|P2|Combination Phase|Disease Progression|0
4705566|NCT02231762|16216585|P1|Combination Phase|Disease Progression|6
4705567|NCT02231762|16216582|P4|Combination Phase|Withdrawal by Subject|0
4705568|NCT02231762|16216583|P3|Combination Phase|Withdrawal by Subject|0
4705569|NCT02231762|16216584|P2|Combination Phase|Withdrawal by Subject|0
4705570|NCT02231762|16216585|P1|Combination Phase|Withdrawal by Subject|2
4705571|NCT02231762|16216582|P4|Combination Phase|Adverse Event|0
4705572|NCT02231762|16216583|P3|Combination Phase|Adverse Event|0
4705573|NCT02231762|16216584|P2|Combination Phase|Adverse Event|0
4705574|NCT02231762|16216585|P1|Combination Phase|Adverse Event|10
4705575|NCT02231749|16216618|P2|Overall Study|No longer meets Study Criteria|0
4705576|NCT02231749|16216619|P1|Overall Study|No longer meets Study Criteria|1
4705577|NCT02231749|16216618|P2|Overall Study|other|8
4705578|NCT02231749|16216619|P1|Overall Study|other|0
4705579|NCT02231749|16216618|P2|Overall Study|Pregnancy|0
4705580|NCT02231749|16216619|P1|Overall Study|Pregnancy|1
4705581|NCT02231749|16216618|P2|Overall Study|Poor/Non-Compliance|3
4705582|NCT02231749|16216619|P1|Overall Study|Poor/Non-Compliance|0
4705583|NCT02231749|16216618|P2|Overall Study|Maximum Clinical Benefit|8
4705584|NCT02231749|16216619|P1|Overall Study|Maximum Clinical Benefit|5
4705585|NCT02231749|16216618|P2|Overall Study|Lost to Follow-up|2
4705586|NCT02231749|16216619|P1|Overall Study|Lost to Follow-up|1
4705587|NCT02231749|16216618|P2|Overall Study|Participant withdrew Consent|15
4705588|NCT02231749|16216619|P1|Overall Study|Participant withdrew Consent|8
4705589|NCT02231749|16216618|P2|Overall Study|Participant's request to discontinue|21
4705590|NCT02231749|16216619|P1|Overall Study|Participant's request to discontinue|10
4705591|NCT02231749|16216618|P2|Overall Study|AE unrelated to Study drug|31
4705592|NCT02231749|16216619|P1|Overall Study|AE unrelated to Study drug|32
4705593|NCT02231749|16216618|P2|Overall Study|Death|1
4705594|NCT02231749|16216619|P1|Overall Study|Death|1
4705595|NCT02231749|16216618|P2|Overall Study|Study Drug Toxicity|63
4705596|NCT02231749|16216619|P1|Overall Study|Study Drug Toxicity|134
4705597|NCT02231749|16216618|P2|Overall Study|Disease progression|297
4705598|NCT02231749|16216619|P1|Overall Study|Disease progression|229
4705599|NCT02231580|16216637|P2|Overall Study|Adverse Event|0
4705600|NCT02231580|16216638|P1|Overall Study|Adverse Event|5
4705601|NCT02231164|16216767|P2|Overall Study|Withdrawal by Subject|2
4705602|NCT02231164|16216768|P1|Overall Study|Withdrawal by Subject|1
4705603|NCT02231164|16216767|P2|Overall Study|Lack of Efficacy|3
4705604|NCT02231164|16216768|P1|Overall Study|Lack of Efficacy|4
4705605|NCT02231164|16216767|P2|Overall Study|Adverse Event|1
4705606|NCT02231164|16216768|P1|Overall Study|Adverse Event|1
4705607|NCT02230956|16216796|P3|Overall Study|Other Miscellaneous Reason|2
4705608|NCT02230956|16216797|P2|Overall Study|Other Miscellaneous Reason|1
4705609|NCT02230956|16216798|P1|Overall Study|Other Miscellaneous Reason|0
4705610|NCT02230956|16216796|P3|Overall Study|Protocol Violation|1
4705611|NCT02230956|16216797|P2|Overall Study|Protocol Violation|1
4705612|NCT02230956|16216798|P1|Overall Study|Protocol Violation|0
4705613|NCT02230956|16216796|P3|Overall Study|Personal Reasons|1
4705614|NCT02230956|16216797|P2|Overall Study|Personal Reasons|1
4705615|NCT02230956|16216798|P1|Overall Study|Personal Reasons|2
4705616|NCT02230956|16216796|P3|Overall Study|Lost to Follow-up|2
4705617|NCT02230956|16216797|P2|Overall Study|Lost to Follow-up|1
4705618|NCT02230956|16216798|P1|Overall Study|Lost to Follow-up|1
4705619|NCT02230956|16216796|P3|Overall Study|Lack of Efficacy|1
4705620|NCT02230956|16216797|P2|Overall Study|Lack of Efficacy|1
4705621|NCT02230956|16216798|P1|Overall Study|Lack of Efficacy|1
4705622|NCT02230956|16216796|P3|Overall Study|Adverse Event|0
4705623|NCT02230956|16216797|P2|Overall Study|Adverse Event|1
4705624|NCT02230956|16216798|P1|Overall Study|Adverse Event|1
4705625|NCT02230904|16216820|P2|Overall Study|Safety follow up could not take place|1
4705626|NCT02230904|16216821|P1|Overall Study|Safety follow up could not take place|0
4705627|NCT02230683|16216854|P1|Overall Study|Adverse Event|1
4705628|NCT02230670|16216871|P2|Overall Study|Progression to Child-Pugh C|2
4705629|NCT02230670|16216872|P1|Overall Study|Progression to Child-Pugh C|1
4705630|NCT02230670|16216871|P2|Overall Study|Protocol Violation|1
4705631|NCT02230670|16216872|P1|Overall Study|Protocol Violation|0
4705632|NCT02230670|16216871|P2|Overall Study|Physician Decision|1
4705633|NCT02230670|16216872|P1|Overall Study|Physician Decision|0
4705634|NCT02230670|16216871|P2|Overall Study|Withdrawal by Subject|2
4705635|NCT02230670|16216872|P1|Overall Study|Withdrawal by Subject|2
4705636|NCT02230670|16216871|P2|Overall Study|Adverse Event|2
4705637|NCT02230670|16216872|P1|Overall Study|Adverse Event|1
4705638|NCT02230384|16216958|P2|Phase 2 - Switch|Adverse Event|0
4705639|NCT02230384|16216959|P1|Phase 2 - Switch|Adverse Event|2
4705640|NCT02230384|16216958|P2|Phase 2 - Switch|Lost to Follow-up|0
4705641|NCT02230384|16216959|P1|Phase 2 - Switch|Lost to Follow-up|1
4705642|NCT02230384|16216958|P2|Phase 2 - Switch|Withdrawal by Subject|1
4705643|NCT02230384|16216959|P1|Phase 2 - Switch|Withdrawal by Subject|0
4705644|NCT02230384|16216958|P2|Phase 1|Physician Decision|1
4705645|NCT02230384|16216959|P1|Phase 1|Physician Decision|0
4705646|NCT02230384|16216958|P2|Phase 1|Lost to Follow-up|0
4705647|NCT02230384|16216959|P1|Phase 1|Lost to Follow-up|1
4705648|NCT02230332|16216979|P2|Overall Study|Protocol Violation|0
4705649|NCT02230332|16216980|P1|Overall Study|Protocol Violation|1
4705650|NCT02230332|16216979|P2|Overall Study|Lost to Follow-up|0
4705651|NCT02230332|16216980|P1|Overall Study|Lost to Follow-up|1
4705652|NCT02230332|16216979|P2|Overall Study|Adverse Event|1
4705653|NCT02230332|16216980|P1|Overall Study|Adverse Event|2
4705654|NCT02230306|16216996|P1|Overall Study|Did not receive study treatment|1
4705655|NCT00947115|16217010|P3|Overall Study|Lost to Follow-up|8
4705656|NCT00947115|16217011|P2|Overall Study|Lost to Follow-up|12
4705657|NCT00947115|16217012|P1|Overall Study|Lost to Follow-up|11
4705658|NCT00947115|16217010|P3|Overall Study|Withdrawal by Subject|4
4705659|NCT00947115|16217011|P2|Overall Study|Withdrawal by Subject|3
4705660|NCT00947115|16217012|P1|Overall Study|Withdrawal by Subject|1
4705661|NCT00947115|16217010|P3|Overall Study|Migrated from study area|0
4705662|NCT00947115|16217011|P2|Overall Study|Migrated from study area|0
4705663|NCT00947115|16217012|P1|Overall Study|Migrated from study area|2
4705664|NCT00947115|16217010|P3|Overall Study|Death|1
4705665|NCT00947115|16217011|P2|Overall Study|Death|1
4705666|NCT00947115|16217012|P1|Overall Study|Death|0
4705667|NCT00947115|16217010|P3|Overall Study|Physician Decision|0
4705668|NCT00947115|16217011|P2|Overall Study|Physician Decision|2
4705669|NCT00947115|16217012|P1|Overall Study|Physician Decision|0
4705670|NCT00947115|16217010|P3|Overall Study|Missed reporting interval|2
4705671|NCT00947115|16217011|P2|Overall Study|Missed reporting interval|4
4705672|NCT00947115|16217012|P1|Overall Study|Missed reporting interval|3
4705673|NCT02230085|16217074|P1|Overall Study|Withdrawal by Subject|3
4705674|NCT02230085|16217074|P1|Overall Study|Physician Decision|1
4705675|NCT02229864|16217078|P1|3 - Year Visit|Death|2
4705676|NCT02229864|16217078|P1|2 - Year Visit|Missed Visits|1
4705677|NCT02229851|16217133|P7|Extension Phase (Open-label Phase)|Death|1
4705678|NCT02229851|16217134|P6|Extension Phase (Open-label Phase)|Death|1
4705679|NCT02229851|16217135|P5|Extension Phase (Open-label Phase)|Death|0
4705680|NCT02229851|16217136|P4|Extension Phase (Open-label Phase)|Death|1
4705681|NCT02229851|16217137|P3|Extension Phase (Open-label Phase)|Death|0
4705682|NCT02229851|16217138|P2|Extension Phase (Open-label Phase)|Death|0
4705683|NCT02229851|16217139|P1|Extension Phase (Open-label Phase)|Death|0
4705684|NCT02229851|16217133|P7|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
4705685|NCT02229851|16217134|P6|Extension Phase (Open-label Phase)|Withdrawal by Subject|3
4705686|NCT02229851|16217135|P5|Extension Phase (Open-label Phase)|Withdrawal by Subject|4
4705687|NCT02229851|16217136|P4|Extension Phase (Open-label Phase)|Withdrawal by Subject|1
4705688|NCT02229851|16217137|P3|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
4705689|NCT02229851|16217138|P2|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
4705690|NCT02229851|16217139|P1|Extension Phase (Open-label Phase)|Withdrawal by Subject|0
4705691|NCT02229851|16217133|P7|Extension Phase (Open-label Phase)|Lost to Follow-up|1
4705692|NCT02229851|16217134|P6|Extension Phase (Open-label Phase)|Lost to Follow-up|1
4705693|NCT02229851|16217135|P5|Extension Phase (Open-label Phase)|Lost to Follow-up|1
4705694|NCT02229851|16217136|P4|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4705695|NCT02229851|16217137|P3|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4705696|NCT02229851|16217138|P2|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4705697|NCT02229851|16217139|P1|Extension Phase (Open-label Phase)|Lost to Follow-up|0
4705698|NCT02229851|16217133|P7|Main Phase (Double-blind Phase)|Death|0
4705699|NCT02229851|16217134|P6|Main Phase (Double-blind Phase)|Death|0
4705700|NCT02229851|16217135|P5|Main Phase (Double-blind Phase)|Death|0
4705701|NCT02229851|16217136|P4|Main Phase (Double-blind Phase)|Death|0
4705702|NCT02229851|16217137|P3|Main Phase (Double-blind Phase)|Death|0
4705703|NCT02229851|16217138|P2|Main Phase (Double-blind Phase)|Death|1
4705704|NCT02229851|16217139|P1|Main Phase (Double-blind Phase)|Death|1
4705705|NCT02229851|16217133|P7|Main Phase (Double-blind Phase)|Protocol Violation|0
4705706|NCT02229851|16217134|P6|Main Phase (Double-blind Phase)|Protocol Violation|0
4705707|NCT02229851|16217135|P5|Main Phase (Double-blind Phase)|Protocol Violation|0
4705708|NCT02229851|16217136|P4|Main Phase (Double-blind Phase)|Protocol Violation|0
4705709|NCT02229851|16217137|P3|Main Phase (Double-blind Phase)|Protocol Violation|2
4705710|NCT02229851|16217138|P2|Main Phase (Double-blind Phase)|Protocol Violation|0
4705711|NCT02229851|16217139|P1|Main Phase (Double-blind Phase)|Protocol Violation|0
4705712|NCT02229851|16217133|P7|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4705713|NCT02229851|16217134|P6|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4705714|NCT02229851|16217135|P5|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4705715|NCT02229851|16217136|P4|Main Phase (Double-blind Phase)|Withdrawal by Subject|0
4705716|NCT02229851|16217137|P3|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
4705717|NCT02229851|16217138|P2|Main Phase (Double-blind Phase)|Withdrawal by Subject|12
4705718|NCT02229851|16217139|P1|Main Phase (Double-blind Phase)|Withdrawal by Subject|4
4705719|NCT02229851|16217133|P7|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4705720|NCT02229851|16217134|P6|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4705721|NCT02229851|16217135|P5|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4705722|NCT02229851|16217136|P4|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4705723|NCT02229851|16217137|P3|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4705724|NCT02229851|16217138|P2|Main Phase (Double-blind Phase)|Lost to Follow-up|1
4705725|NCT02229851|16217139|P1|Main Phase (Double-blind Phase)|Lost to Follow-up|0
4705726|NCT02229851|16217133|P7|Main Phase (Double-blind Phase)|Unclassified|0
4705727|NCT02229851|16217134|P6|Main Phase (Double-blind Phase)|Unclassified|0
4705728|NCT02229851|16217135|P5|Main Phase (Double-blind Phase)|Unclassified|0
4705729|NCT02229851|16217136|P4|Main Phase (Double-blind Phase)|Unclassified|0
4705730|NCT02229851|16217137|P3|Main Phase (Double-blind Phase)|Unclassified|0
4705731|NCT02229851|16217138|P2|Main Phase (Double-blind Phase)|Unclassified|2
4705732|NCT02229851|16217139|P1|Main Phase (Double-blind Phase)|Unclassified|1
4705733|NCT02229552|16217571|P1|2-Year Follow up|Lost to Follow-up|17
4705734|NCT02229552|16217571|P1|2-Year Follow up|Withdrawal by Subject|9
4705735|NCT02229552|16217571|P1|1-year Follow up|Lost to Follow-up|18
4705736|NCT02229552|16217571|P1|1-year Follow up|Withdrawal by Subject|7
4705737|NCT02229552|16217571|P1|Baseline|Withdrawal by Subject|6
4705738|NCT02229539|16217578|P3|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|0
4705739|NCT02229539|16217579|P2|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|1
4705740|NCT02229539|16217580|P1|Cycle 2 (Optional Continuation Phase)|Data being queried at the time of report|2
4705741|NCT02229539|16217578|P3|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|3
4705742|NCT02229539|16217579|P2|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
4705743|NCT02229539|16217580|P1|Cycle 2 (Optional Continuation Phase)|Other Unknown Reason|0
4705744|NCT02229539|16217578|P3|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
4705745|NCT02229539|16217579|P2|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1
4705746|NCT02229539|16217580|P1|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0
4705747|NCT02229539|16217578|P3|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
4705748|NCT02229539|16217579|P2|Cycle 2 (Optional Continuation Phase)|Adverse Event|0
4705749|NCT02229539|16217580|P1|Cycle 2 (Optional Continuation Phase)|Adverse Event|2
4705750|NCT02229539|16217578|P3|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6
4705751|NCT02229539|16217579|P2|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
4705752|NCT02229539|16217580|P1|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5
4705753|NCT02229539|16217578|P3|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|1
4705754|NCT02229539|16217579|P2|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|4
4705755|NCT02229539|16217580|P1|Cycle 1 (Treatment Per Protocol)|Data being queried at the time of report|3
4705756|NCT02229539|16217578|P3|Cycle 1 (Treatment Per Protocol)|Medical Problems|1
4705757|NCT02229539|16217579|P2|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
4705758|NCT02229539|16217580|P1|Cycle 1 (Treatment Per Protocol)|Medical Problems|0
4705759|NCT02229539|16217578|P3|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1
4705760|NCT02229539|16217579|P2|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
4705761|NCT02229539|16217580|P1|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0
4705762|NCT02229539|16217578|P3|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
4705763|NCT02229539|16217579|P2|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1
4705764|NCT02229539|16217580|P1|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0
4705765|NCT02229396|16217711|P3|Overall Study|Withdrew; No Record on Termination Page|1
4705766|NCT02229396|16217712|P2|Overall Study|Withdrew; No Record on Termination Page|0
4705767|NCT02229396|16217713|P1|Overall Study|Withdrew; No Record on Termination Page|2
4705768|NCT02229396|16217711|P3|Overall Study|Study-Specific Withdrawal Criteria|3
4705769|NCT02229396|16217712|P2|Overall Study|Study-Specific Withdrawal Criteria|1
4705770|NCT02229396|16217713|P1|Overall Study|Study-Specific Withdrawal Criteria|0
4705771|NCT02229396|16217711|P3|Overall Study|Withdrawal by Subject|41
4705772|NCT02229396|16217712|P2|Overall Study|Withdrawal by Subject|28
4705773|NCT02229396|16217713|P1|Overall Study|Withdrawal by Subject|42
4705774|NCT02229396|16217711|P3|Overall Study|Other|15
4705775|NCT02229396|16217712|P2|Overall Study|Other|18
4705776|NCT02229396|16217713|P1|Overall Study|Other|10
4705777|NCT02229396|16217711|P3|Overall Study|Patient Incorrectly Randomized|1
4705778|NCT02229396|16217712|P2|Overall Study|Patient Incorrectly Randomized|0
4705779|NCT02229396|16217713|P1|Overall Study|Patient Incorrectly Randomized|0
4705780|NCT02229396|16217711|P3|Overall Study|Protocol Violation|0
4705781|NCT02229396|16217712|P2|Overall Study|Protocol Violation|1
4705782|NCT02229396|16217713|P1|Overall Study|Protocol Violation|2
4705783|NCT02229396|16217711|P3|Overall Study|Lost to Follow-up|21
4705784|NCT02229396|16217712|P2|Overall Study|Lost to Follow-up|14
4705785|NCT02229396|16217713|P1|Overall Study|Lost to Follow-up|14
4705786|NCT02229396|16217711|P3|Overall Study|Death|1
4705787|NCT02229396|16217712|P2|Overall Study|Death|3
4705788|NCT02229396|16217713|P1|Overall Study|Death|2
4705789|NCT02229396|16217711|P3|Overall Study|Adverse Event|12
4705790|NCT02229396|16217712|P2|Overall Study|Adverse Event|12
4705791|NCT02229396|16217713|P1|Overall Study|Adverse Event|6
4705792|NCT02229383|16217744|P2|Overall Study|Other|8
4705793|NCT02229383|16217745|P1|Overall Study|Other|3
4705794|NCT02229383|16217744|P2|Overall Study|Did not receive treatment|0
4705795|NCT02229383|16217745|P1|Overall Study|Did not receive treatment|1
4705796|NCT02229383|16217744|P2|Overall Study|Withdrawal by Subject|6
4705797|NCT02229383|16217745|P1|Overall Study|Withdrawal by Subject|4
4705798|NCT02229383|16217744|P2|Overall Study|Lost to Follow-up|3
4705799|NCT02229383|16217745|P1|Overall Study|Lost to Follow-up|5
4705800|NCT02229383|16217744|P2|Overall Study|Death|1
4705801|NCT02229383|16217745|P1|Overall Study|Death|0
4705802|NCT02229383|16217744|P2|Overall Study|Adverse Event|4
4705803|NCT02229383|16217745|P1|Overall Study|Adverse Event|7
4705804|NCT02229227|16217770|P2|Overall Study|Physician Decision|12
4705805|NCT02229227|16217771|P1|Overall Study|Physician Decision|5
4705806|NCT02229227|16217770|P2|Overall Study|Other|1
4705807|NCT02229227|16217771|P1|Overall Study|Other|0
4705808|NCT02229227|16217770|P2|Overall Study|Withdrawal by Subject|12
4705809|NCT02229227|16217771|P1|Overall Study|Withdrawal by Subject|8
4705810|NCT02229227|16217770|P2|Overall Study|Study terminated by sponsor|11
4705811|NCT02229227|16217771|P1|Overall Study|Study terminated by sponsor|11
4705812|NCT02229227|16217770|P2|Overall Study|Lost to Follow-up|3
4705813|NCT02229227|16217771|P1|Overall Study|Lost to Follow-up|3
4705814|NCT02229227|16217770|P2|Overall Study|Protocol defined stopping criteria|3
4705815|NCT02229227|16217771|P1|Overall Study|Protocol defined stopping criteria|1
4705816|NCT02229227|16217770|P2|Overall Study|Protocol Violation|8
4705817|NCT02229227|16217771|P1|Overall Study|Protocol Violation|6
4705818|NCT02229227|16217770|P2|Overall Study|Lack of Efficacy|3
4705819|NCT02229227|16217771|P1|Overall Study|Lack of Efficacy|3
4705820|NCT02229227|16217770|P2|Overall Study|Adverse Event|9
4705821|NCT02229227|16217771|P1|Overall Study|Adverse Event|14
4705822|NCT02229214|16217856|P2|Overall Study|Withdrawal by Subject|0
4705823|NCT02229214|16217857|P1|Overall Study|Withdrawal by Subject|4
4705824|NCT02229214|16217856|P2|Overall Study|Adverse Event|0
4705825|NCT02229214|16217857|P1|Overall Study|Adverse Event|2
4705826|NCT02228980|16217881|P4|Overall Study|Withdrawal by Subject|3
4705827|NCT02228980|16217882|P3|Overall Study|Withdrawal by Subject|2
4705828|NCT02228980|16217883|P2|Overall Study|Withdrawal by Subject|3
4705829|NCT02228980|16217884|P1|Overall Study|Withdrawal by Subject|3
4705830|NCT02228980|16217881|P4|Overall Study|Protocol Violation|0
4705831|NCT02228980|16217882|P3|Overall Study|Protocol Violation|0
4705832|NCT02228980|16217883|P2|Overall Study|Protocol Violation|0
4705833|NCT02228980|16217884|P1|Overall Study|Protocol Violation|7
4705834|NCT02228980|16217881|P4|Overall Study|Adverse Event|0
4705835|NCT02228980|16217882|P3|Overall Study|Adverse Event|0
4705836|NCT02228980|16217883|P2|Overall Study|Adverse Event|0
4705837|NCT02228980|16217884|P1|Overall Study|Adverse Event|14
4705838|NCT02228967|16217908|P2|Overall Study|Withdrawal by Subject|18
4705839|NCT02228967|16217909|P1|Overall Study|Withdrawal by Subject|13
4705840|NCT02228967|16217908|P2|Overall Study|Lost to Follow-up|142
4705841|NCT02228967|16217909|P1|Overall Study|Lost to Follow-up|146
4705842|NCT02228720|16217970|P1|Open Label - Day 30|Lost to Follow-up|1
4705843|NCT02228590|16217993|P1|Overall Study|Withdrawal by Subject|1
4705844|NCT02228564|16218006|P1|Overall Study|Other|6
4705845|NCT02228564|16218006|P1|Overall Study|Lost to Follow-up|17
4705846|NCT02228564|16218006|P1|Overall Study|Physician Decision|5
4705847|NCT02228564|16218006|P1|Overall Study|Death|11
4705848|NCT02228564|16218006|P1|Overall Study|Withdrawal by Subject|10
4705849|NCT02228460|16218030|P1|Overall Study|Lost to Follow-up|1
4705850|NCT02228460|16218030|P1|Overall Study|Adverse Event|1
4705851|NCT02228395|16218053|P3|First Intervention Period|Unable to comply with study dates|1
4705852|NCT02228395|16218054|P2|First Intervention Period|Unable to comply with study dates|1
4705853|NCT02228395|16218055|P1|First Intervention Period|Unable to comply with study dates|0
4705854|NCT02228395|16218053|P3|First Intervention Period|No longer willing to participate|0
4705855|NCT02228395|16218054|P2|First Intervention Period|No longer willing to participate|0
4705856|NCT02228395|16218055|P1|First Intervention Period|No longer willing to participate|1
4705857|NCT02227875|16218141|P2|Overall Study|Lost to Follow-up|10
4705858|NCT02227875|16218142|P1|Overall Study|Lost to Follow-up|10
4705859|NCT02227875|16218141|P2|Overall Study|Withdrawal by Subject|13
4705860|NCT02227875|16218142|P1|Overall Study|Withdrawal by Subject|12
4705861|NCT02227875|16218141|P2|Overall Study|Adverse Event|0
4705862|NCT02227875|16218142|P1|Overall Study|Adverse Event|3
4705863|NCT02227875|16218141|P2|Overall Study|Physician Decision|0
4705864|NCT02227875|16218142|P1|Overall Study|Physician Decision|1
4705865|NCT02227875|16218141|P2|Overall Study|Other|3
4705866|NCT02227875|16218142|P1|Overall Study|Other|1
4705867|NCT02227875|16218141|P2|Overall Study|Protocol Violation|7
4705868|NCT02227875|16218142|P1|Overall Study|Protocol Violation|10
4705869|NCT02227862|16218162|P2|Overall Study|Lost to Follow-up|2
4705870|NCT02227862|16218163|P1|Overall Study|Lost to Follow-up|1
4705871|NCT02227862|16218162|P2|Overall Study|Withdrawal by Subject|6
4705872|NCT02227862|16218163|P1|Overall Study|Withdrawal by Subject|7
4705873|NCT02227862|16218162|P2|Overall Study|Adverse Event|3
4705874|NCT02227862|16218163|P1|Overall Study|Adverse Event|4
4705875|NCT02227862|16218162|P2|Overall Study|Other|2
4705876|NCT02227862|16218163|P1|Overall Study|Other|0
4705877|NCT02227862|16218162|P2|Overall Study|Protocol Violation|9
4705878|NCT02227862|16218163|P1|Overall Study|Protocol Violation|7
4705879|NCT02227849|16218193|P1|Overall Study|Withdrawal by Subject|3
4705880|NCT02227849|16218193|P1|Overall Study|Physician Decision|1
4705881|NCT02227849|16218193|P1|Overall Study|Adverse Event|4
4705882|NCT02227784|16218224|P5|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3
4705883|NCT02227784|16218225|P4|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4705884|NCT02227784|16218226|P3|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4705885|NCT02227784|16218227|P2|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4705886|NCT02227784|16218228|P1|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0
4705887|NCT02227784|16218224|P5|Open-Label Extension Phase (OLE)|Sponsor Decision|243
4705888|NCT02227784|16218225|P4|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4705889|NCT02227784|16218226|P3|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4705890|NCT02227784|16218227|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4705891|NCT02227784|16218228|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4705892|NCT02227784|16218224|P5|Open-Label Extension Phase (OLE)|Death|1
4705893|NCT02227784|16218225|P4|Open-Label Extension Phase (OLE)|Death|0
4705894|NCT02227784|16218226|P3|Open-Label Extension Phase (OLE)|Death|0
4705895|NCT02227784|16218227|P2|Open-Label Extension Phase (OLE)|Death|0
4705896|NCT02227784|16218228|P1|Open-Label Extension Phase (OLE)|Death|0
4705897|NCT02227784|16218224|P5|Open-Label Extension Phase (OLE)|Adverse Event|1
4705898|NCT02227784|16218225|P4|Open-Label Extension Phase (OLE)|Adverse Event|0
4705899|NCT02227784|16218226|P3|Open-Label Extension Phase (OLE)|Adverse Event|0
4705900|NCT02227784|16218227|P2|Open-Label Extension Phase (OLE)|Adverse Event|0
4705901|NCT02227784|16218228|P1|Open-Label Extension Phase (OLE)|Adverse Event|0
4705902|NCT02227784|16218224|P5|Double-Blind Phase|Withdrawal by Subject|0
4705903|NCT02227784|16218225|P4|Double-Blind Phase|Withdrawal by Subject|2
4705904|NCT02227784|16218226|P3|Double-Blind Phase|Withdrawal by Subject|5
4705905|NCT02227784|16218227|P2|Double-Blind Phase|Withdrawal by Subject|1
4705906|NCT02227784|16218228|P1|Double-Blind Phase|Withdrawal by Subject|2
4705907|NCT02227784|16218224|P5|Double-Blind Phase|Sponsor Decision|0
4705908|NCT02227784|16218225|P4|Double-Blind Phase|Sponsor Decision|32
4705909|NCT02227784|16218226|P3|Double-Blind Phase|Sponsor Decision|14
4705910|NCT02227784|16218227|P2|Double-Blind Phase|Sponsor Decision|15
4705911|NCT02227784|16218228|P1|Double-Blind Phase|Sponsor Decision|34
4705912|NCT02227784|16218224|P5|Double-Blind Phase|Protocol Violation|0
4705913|NCT02227784|16218225|P4|Double-Blind Phase|Protocol Violation|1
4705914|NCT02227784|16218226|P3|Double-Blind Phase|Protocol Violation|1
4705915|NCT02227784|16218227|P2|Double-Blind Phase|Protocol Violation|0
4705916|NCT02227784|16218228|P1|Double-Blind Phase|Protocol Violation|0
4705917|NCT02227784|16218224|P5|Double-Blind Phase|Physician Decision|0
4705918|NCT02227784|16218225|P4|Double-Blind Phase|Physician Decision|1
4705919|NCT02227784|16218226|P3|Double-Blind Phase|Physician Decision|0
4705920|NCT02227784|16218227|P2|Double-Blind Phase|Physician Decision|0
4705921|NCT02227784|16218228|P1|Double-Blind Phase|Physician Decision|1
4705922|NCT02227784|16218224|P5|Double-Blind Phase|Adverse Event|0
4705923|NCT02227784|16218225|P4|Double-Blind Phase|Adverse Event|3
4705924|NCT02227784|16218226|P3|Double-Blind Phase|Adverse Event|1
4705925|NCT02227784|16218227|P2|Double-Blind Phase|Adverse Event|2
4705926|NCT02227784|16218228|P1|Double-Blind Phase|Adverse Event|3
4705927|NCT02227368|16218402|P2|Overall Study|Adverse Event|0
4705928|NCT02227368|16218403|P1|Overall Study|Adverse Event|1
4705929|NCT02227368|16218402|P2|Overall Study|Lost to Follow-up|0
4705930|NCT02227368|16218403|P1|Overall Study|Lost to Follow-up|1
4705931|NCT02227368|16218402|P2|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4
4705932|NCT02227368|16218403|P1|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0
4705933|NCT02227238|16218459|P2|Overall Study|Lost to Follow-up|5
4705934|NCT02227238|16218460|P1|Overall Study|Lost to Follow-up|7
4705935|NCT02227238|16218459|P2|Overall Study|Physician Decision|9
4705936|NCT02227238|16218460|P1|Overall Study|Physician Decision|0
4705937|NCT02227238|16218459|P2|Overall Study|Withdrawal by Subject|4
4705938|NCT02227238|16218460|P1|Overall Study|Withdrawal by Subject|5
4705939|NCT02227238|16218459|P2|Overall Study|Protocol Violation|8
4705940|NCT02227238|16218460|P1|Overall Study|Protocol Violation|7
4705941|NCT02227238|16218459|P2|Overall Study|Lack of Efficacy|22
4705942|NCT02227238|16218460|P1|Overall Study|Lack of Efficacy|10
4705943|NCT02227238|16218459|P2|Overall Study|Adverse Event|18
4705944|NCT02227238|16218460|P1|Overall Study|Adverse Event|8
4705945|NCT02227238|16218459|P2|Overall Study|Other: Reached stopping criteria|1
4705946|NCT02227238|16218460|P1|Overall Study|Other: Reached stopping criteria|0
4705947|NCT02227147|16218526|P2|Follow-up Period|Other|5
4705948|NCT02227147|16218527|P1|Follow-up Period|Other|3
4705949|NCT02227147|16218526|P2|Controlled Treatment Period|Other|0
4705950|NCT02227147|16218527|P1|Controlled Treatment Period|Other|2
4705951|NCT02227147|16218526|P2|Controlled Treatment Period|Adverse Event|3
4705952|NCT02227147|16218527|P1|Controlled Treatment Period|Adverse Event|4
4705953|NCT02227108|16218554|P1|Overall Study|Adverse Event|6
4705954|NCT02227108|16218554|P1|Overall Study|Investigator discretion|1
4705955|NCT02227108|16218554|P1|Overall Study|Initiation of alternative therapy|2
4705956|NCT02227108|16218554|P1|Overall Study|Progressive disease|17
4705957|NCT02227108|16218554|P1|Overall Study|Other|3
4705958|NCT02227108|16218554|P1|Overall Study|Did not receive treatment|2
4705959|NCT02226653|16218593|P2|Treatment Period 5 Fed State|Adverse Event|1
4705960|NCT02226653|16218594|P1|Treatment Period 5 Fed State|Adverse Event|0
4705961|NCT02226653|16218593|P2|Treatment Period 2 Fasted State|Lost to Follow-up|0
4705962|NCT02226653|16218594|P1|Treatment Period 2 Fasted State|Lost to Follow-up|1
4705963|NCT02226562|16218618|P2|Overall Study|Lost to Follow-up|1
4705964|NCT02226562|16218619|P1|Overall Study|Lost to Follow-up|0
4705965|NCT02226549|16218637|P2|Overall Study|Lost to Follow-up|1
4705966|NCT02226549|16218638|P1|Overall Study|Lost to Follow-up|0
4705967|NCT02226549|16218637|P2|Overall Study|Randomized but Never Treated|0
4705968|NCT02226549|16218638|P1|Overall Study|Randomized but Never Treated|1
4705969|NCT02226198|16218648|P3|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
4705970|NCT02226198|16218649|P2|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1
4705971|NCT02226198|16218650|P1|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0
4705972|NCT02226198|16218648|P3|Lead-in Phase|Protocol Violation|0
4705973|NCT02226198|16218649|P2|Lead-in Phase|Protocol Violation|0
4705974|NCT02226198|16218650|P1|Lead-in Phase|Protocol Violation|1
4705975|NCT02226172|16218723|P1|Overall Study|Adverse Event|6
4705976|NCT02226172|16218723|P1|Overall Study|Study terminated by sponsor|1
4705977|NCT02226172|16218723|P1|Overall Study|Death|1
4705978|NCT02226172|16218723|P1|Overall Study|Other|5
4705979|NCT02226172|16218723|P1|Overall Study|Participant refused further follow-up|4
4705980|NCT02226120|16218787|P1|Overall Study|missing treatment disposition pages|2
4705981|NCT02226120|16218787|P1|Overall Study|Protocol deviation|1
4705982|NCT02226120|16218787|P1|Overall Study|Non-compliance with study drug|10
4705983|NCT02226120|16218787|P1|Overall Study|Withdrawal by parent/guardian|36
4705984|NCT02226120|16218787|P1|Overall Study|Physician Decision|21
4705985|NCT02226120|16218787|P1|Overall Study|Lost to Follow-up|13
4705986|NCT02226120|16218787|P1|Overall Study|Technical problems|4
4705987|NCT02226120|16218787|P1|Overall Study|Study terminated by sponsor|1
4705988|NCT02226120|16218787|P1|Overall Study|Death|172
4705989|NCT02226120|16218787|P1|Overall Study|Adverse Event|60
4705990|NCT02226003|16218794|P3|Overall Study|Withdrawal by Subject|3
4705991|NCT02226003|16218795|P2|Overall Study|Withdrawal by Subject|0
4705992|NCT02226003|16218796|P1|Overall Study|Withdrawal by Subject|0
4705993|NCT02226003|16218794|P3|Overall Study|Lost to Follow-up|3
4705994|NCT02226003|16218795|P2|Overall Study|Lost to Follow-up|1
4705995|NCT02226003|16218796|P1|Overall Study|Lost to Follow-up|2
4705996|NCT02225743|16218852|P1|Overall Study|Withdrawal by Subject|18
4705997|NCT02225587|16218858|P2|Overall Study|Withdrawal by Subject|28
4705998|NCT02225587|16218859|P1|Overall Study|Withdrawal by Subject|13
4705999|NCT02225587|16218858|P2|Overall Study|Participant Moved|0
4706000|NCT02225587|16218859|P1|Overall Study|Participant Moved|1
4706001|NCT02225587|16218858|P2|Overall Study|Protocol Violation|0
4706002|NCT02225587|16218859|P1|Overall Study|Protocol Violation|1
4706003|NCT02225587|16218858|P2|Overall Study|Physician Decision|0
4706004|NCT02225587|16218859|P1|Overall Study|Physician Decision|2
4706005|NCT02225587|16218858|P2|Overall Study|Non-Compliance With Study Drug|0
4706006|NCT02225587|16218859|P1|Overall Study|Non-Compliance With Study Drug|1
4706007|NCT02225587|16218858|P2|Overall Study|Lost to Follow-up|5
4706008|NCT02225587|16218859|P1|Overall Study|Lost to Follow-up|5
4706009|NCT02225587|16218858|P2|Overall Study|Adverse Event|5
4706010|NCT02225587|16218859|P1|Overall Study|Adverse Event|5
4706011|NCT02225353|16218888|P3|Overall Study|Protocol Violation|12
4706012|NCT02225353|16218889|P2|Overall Study|Protocol Violation|5
4706013|NCT02225353|16218890|P1|Overall Study|Protocol Violation|4
4706014|NCT02225353|16218888|P3|Overall Study|Lost to Follow-up|3
4706015|NCT02225353|16218889|P2|Overall Study|Lost to Follow-up|1
4706016|NCT02225353|16218890|P1|Overall Study|Lost to Follow-up|0
4706017|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Sponsor Decision|1
4706018|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Sponsor Decision|2
4706019|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Physician Decision|2
4706020|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Physician Decision|0
4706021|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43
4706022|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25
4706023|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Protocol Violation|11
4706024|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Protocol Violation|4
4706025|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13
4706026|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7
4706027|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Death|0
4706028|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Death|1
4706029|NCT02224846|16218931|P2|Period 2 (Month 12 to Month 24)|Adverse Event|4
4706030|NCT02224846|16218932|P1|Period 2 (Month 12 to Month 24)|Adverse Event|3
4706031|NCT02224846|16218931|P2|Period 2 (Month 3 to Month 12)|Physician Decision|2
4706032|NCT02224846|16218932|P1|Period 2 (Month 3 to Month 12)|Physician Decision|0
4706033|NCT02224846|16218931|P2|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19
4706034|NCT02224846|16218932|P1|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15
4706035|NCT02224846|16218931|P2|Period 2 (Month 3 to Month 12)|Protocol Violation|3
4706036|NCT02224846|16218932|P1|Period 2 (Month 3 to Month 12)|Protocol Violation|0
4706037|NCT02224846|16218931|P2|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5
4706038|NCT02224846|16218932|P1|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3
4706039|NCT02224846|16218931|P2|Period 2 (Month 3 to Month 12)|Adverse Event|2
4706040|NCT02224846|16218932|P1|Period 2 (Month 3 to Month 12)|Adverse Event|1
4706041|NCT02224846|16218931|P2|Period 1 (Month 3)|Sponsor Decision|1
4706042|NCT02224846|16218932|P1|Period 1 (Month 3)|Sponsor Decision|2
4706043|NCT02224846|16218931|P2|Period 1 (Month 3)|Withdrawal by Subject|18
4706044|NCT02224846|16218932|P1|Period 1 (Month 3)|Withdrawal by Subject|8
4706045|NCT02224846|16218931|P2|Period 1 (Month 3)|Protocol Violation|8
4706046|NCT02224846|16218932|P1|Period 1 (Month 3)|Protocol Violation|4
4706047|NCT02224846|16218931|P2|Period 1 (Month 3)|Lost to Follow-up|8
4706048|NCT02224846|16218932|P1|Period 1 (Month 3)|Lost to Follow-up|3
4706049|NCT02224846|16218931|P2|Period 1 (Month 3)|Adverse Event|1
4706050|NCT02224846|16218932|P1|Period 1 (Month 3)|Adverse Event|2
4706051|NCT02224755|16218962|P2|Two Year Follow up Post-implant|Withdrawn post-implant|6
4706052|NCT02224755|16218963|P1|Two Year Follow up Post-implant|Withdrawn post-implant|15
4706053|NCT02224755|16218962|P2|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
4706054|NCT02224755|16218963|P1|Two Year Follow up Post-implant|Device explant or permanent deactivation|3
4706055|NCT02224755|16218962|P2|Two Year Follow up Post-implant|Heart transplant|119
4706056|NCT02224755|16218963|P1|Two Year Follow up Post-implant|Heart transplant|137
4706057|NCT02224755|16218962|P2|Two Year Follow up Post-implant|Death|98
4706058|NCT02224755|16218963|P1|Two Year Follow up Post-implant|Death|103
4706059|NCT02224755|16218962|P2|Randomization to Device Implant|Withdrawn prior to implant|1
4706060|NCT02224755|16218963|P1|Randomization to Device Implant|Withdrawn prior to implant|7
4706061|NCT02224703|16218998|P3|Overall Study|Lack of Efficacy|0
4706062|NCT02224703|16218999|P2|Overall Study|Lack of Efficacy|0
4706063|NCT02224703|16219000|P1|Overall Study|Lack of Efficacy|1
4706064|NCT02224703|16218998|P3|Overall Study|Withdrawn by parent/guardian|0
4706065|NCT02224703|16218999|P2|Overall Study|Withdrawn by parent/guardian|1
4706066|NCT02224703|16219000|P1|Overall Study|Withdrawn by parent/guardian|0
4706067|NCT02224703|16218998|P3|Overall Study|Advised by medical monitor|0
4706068|NCT02224703|16218999|P2|Overall Study|Advised by medical monitor|0
4706069|NCT02224703|16219000|P1|Overall Study|Advised by medical monitor|1
4706070|NCT02224703|16218998|P3|Overall Study|Withdrawn by investigator|0
4706071|NCT02224703|16218999|P2|Overall Study|Withdrawn by investigator|0
4706072|NCT02224703|16219000|P1|Overall Study|Withdrawn by investigator|1
4706073|NCT02224703|16218998|P3|Overall Study|Adverse Event|0
4706074|NCT02224703|16218999|P2|Overall Study|Adverse Event|5
4706075|NCT02224703|16219000|P1|Overall Study|Adverse Event|0
4706076|NCT02224690|16219019|P2|Overall Study|Did not meet eligibility criteria|0
4706077|NCT02224690|16219020|P1|Overall Study|Did not meet eligibility criteria|1
4706078|NCT02224690|16219019|P2|Overall Study|Use of G-tube|0
4706079|NCT02224690|16219020|P1|Overall Study|Use of G-tube|1
4706080|NCT02224690|16219019|P2|Overall Study|Met Withdrawal Criteria|0
4706081|NCT02224690|16219020|P1|Overall Study|Met Withdrawal Criteria|4
4706082|NCT02224690|16219019|P2|Overall Study|Adverse Event|1
4706083|NCT02224690|16219020|P1|Overall Study|Adverse Event|8
4706084|NCT02224664|16219032|P5|Dose Escalation Period (21 Days)|Withdrawal by Subject|4
4706085|NCT02224664|16219033|P4|Dose Escalation Period (21 Days)|Withdrawal by Subject|1
4706086|NCT02224664|16219034|P3|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4706087|NCT02224664|16219035|P2|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4706088|NCT02224664|16219036|P1|Dose Escalation Period (21 Days)|Withdrawal by Subject|0
4706089|NCT02224664|16219032|P5|Dose Escalation Period (21 Days)|Adverse Event|7
4706090|NCT02224664|16219033|P4|Dose Escalation Period (21 Days)|Adverse Event|2
4706091|NCT02224664|16219034|P3|Dose Escalation Period (21 Days)|Adverse Event|2
4706092|NCT02224664|16219035|P2|Dose Escalation Period (21 Days)|Adverse Event|0
4706093|NCT02224664|16219036|P1|Dose Escalation Period (21 Days)|Adverse Event|0
4706094|NCT02224664|16219032|P5|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4706095|NCT02224664|16219033|P4|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4706096|NCT02224664|16219034|P3|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4706097|NCT02224664|16219035|P2|Lead-in Period (3 Days)|Does not meet entrance criteria|0
4706098|NCT02224664|16219036|P1|Lead-in Period (3 Days)|Does not meet entrance criteria|5
4706099|NCT02224638|16219118|P2|Overall Study|Adverse Event|1
4706100|NCT02224638|16219119|P1|Overall Study|Adverse Event|1
4706101|NCT02224625|16219127|P1|Sensitization|Adverse Event|55
4706102|NCT02224625|16219127|P1|Irritation|Adverse Event|6
4706103|NCT02224599|16219148|P1|Overall Study|Progression of Disease|1
4706104|NCT02224599|16219148|P1|Overall Study|Physician Decision|1
4706105|NCT02224560|16219157|P3|Overall Study|Withdrawn by Investigator|0
4706106|NCT02224560|16219158|P2|Overall Study|Withdrawn by Investigator|1
4706107|NCT02224560|16219159|P1|Overall Study|Withdrawn by Investigator|1
4706108|NCT02224560|16219157|P3|Overall Study|Adverse Event|1
4706109|NCT02224560|16219158|P2|Overall Study|Adverse Event|1
4706110|NCT02224560|16219159|P1|Overall Study|Adverse Event|4
4706111|NCT02224560|16219157|P3|Overall Study|Met Withdrawal Criteria|0
4706112|NCT02224560|16219158|P2|Overall Study|Met Withdrawal Criteria|0
4706113|NCT02224560|16219159|P1|Overall Study|Met Withdrawal Criteria|1
4706114|NCT02224560|16219157|P3|Overall Study|Withdrawal by Subject|1
4706115|NCT02224560|16219158|P2|Overall Study|Withdrawal by Subject|0
4706116|NCT02224560|16219159|P1|Overall Study|Withdrawal by Subject|2
4706117|NCT02224560|16219157|P3|Overall Study|Protocol Deviation|0
4706118|NCT02224560|16219158|P2|Overall Study|Protocol Deviation|0
4706119|NCT02224560|16219159|P1|Overall Study|Protocol Deviation|1
4706120|NCT02224274|16219207|P2|Overall Study|Death|0
4706121|NCT02224274|16219208|P1|Overall Study|Death|1
4706122|NCT02224157|16219220|P2|Overall Study|Adverse Event|3
4706123|NCT02224157|16219221|P1|Overall Study|Adverse Event|1
4706124|NCT02224157|16219220|P2|Overall Study|Death|1
4706125|NCT02224157|16219221|P1|Overall Study|Death|1
4706126|NCT02224157|16219220|P2|Overall Study|Lost to Follow-up|35
4706127|NCT02224157|16219221|P1|Overall Study|Lost to Follow-up|27
4706128|NCT02224157|16219220|P2|Overall Study|Eligibility criteria not fulfilled|8
4706129|NCT02224157|16219221|P1|Overall Study|Eligibility criteria not fulfilled|4
4706130|NCT02224157|16219220|P2|Overall Study|Prematurely closed site|2
4706131|NCT02224157|16219221|P1|Overall Study|Prematurely closed site|4
4706132|NCT02224157|16219220|P2|Overall Study|Subject decision|50
4706133|NCT02224157|16219221|P1|Overall Study|Subject decision|58
4706134|NCT02224157|16219220|P2|Overall Study|Other|10
4706135|NCT02224157|16219221|P1|Overall Study|Other|13
4706136|NCT02224157|16219220|P2|Overall Study|Severe non-compliance to protocol|2
4706137|NCT02224157|16219221|P1|Overall Study|Severe non-compliance to protocol|2
4706138|NCT02224053|16219245|P1|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2
4706139|NCT02224053|16219245|P1|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1
4706140|NCT02224053|16219245|P1|AZD9291 and Omeprazole Co-administration|Adverse Event|3
4706141|NCT02224053|16219245|P1|AZD9291 and Omeprazole Co-administration|Protocol Violation|4
4706142|NCT02224053|16219245|P1|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11
4706143|NCT02223858|16219291|P2|Overall Study|Refused|9
4706144|NCT02223858|16219292|P1|Overall Study|Refused|9
4706145|NCT02223858|16219291|P2|Overall Study|Withdrawal by Subject|5
4706146|NCT02223858|16219292|P1|Overall Study|Withdrawal by Subject|8
4706147|NCT02223858|16219291|P2|Overall Study|Lost to Follow-up|11
4706148|NCT02223858|16219292|P1|Overall Study|Lost to Follow-up|6
4706149|NCT02223858|16219291|P2|Overall Study|Death|1
4706150|NCT02223858|16219292|P1|Overall Study|Death|1
4706151|NCT02223793|16219305|P3|Overall Study|Moved/studycenter unable to participate|8
4706152|NCT02223793|16219306|P2|Overall Study|Moved/studycenter unable to participate|6
4706153|NCT02223793|16219307|P1|Overall Study|Moved/studycenter unable to participate|4
4706154|NCT02223793|16219305|P3|Overall Study|Withdrawal by Subject|3
4706155|NCT02223793|16219306|P2|Overall Study|Withdrawal by Subject|2
4706156|NCT02223793|16219307|P1|Overall Study|Withdrawal by Subject|3
4706157|NCT02223793|16219305|P3|Overall Study|Lost to Follow-up|2
4706158|NCT02223793|16219306|P2|Overall Study|Lost to Follow-up|1
4706159|NCT02223793|16219307|P1|Overall Study|Lost to Follow-up|10
4706160|NCT02223754|16219320|P2|Period 2|Test Article No Longer Available|1
4706161|NCT02223754|16219321|P1|Period 2|Test Article No Longer Available|0
4706162|NCT02223754|16219320|P2|Period 2|Lost to Follow-up|0
4706163|NCT02223754|16219321|P1|Period 2|Lost to Follow-up|1
4706164|NCT02223754|16219320|P2|Period 2|Lens Discomfort|1
4706165|NCT02223754|16219321|P1|Period 2|Lens Discomfort|1
4706166|NCT02223754|16219320|P2|Period 2|Protocol Violation|0
4706167|NCT02223754|16219321|P1|Period 2|Protocol Violation|1
4706168|NCT02223754|16219320|P2|Period 2|Adverse Event|1
4706169|NCT02223754|16219321|P1|Period 2|Adverse Event|0
4706170|NCT02223754|16219320|P2|Period 1|Unsatisfactory Visual Response|1
4706171|NCT02223754|16219321|P1|Period 1|Unsatisfactory Visual Response|0
4706172|NCT02223754|16219320|P2|Period 1|Test Article No Longer Available|5
4706173|NCT02223754|16219321|P1|Period 1|Test Article No Longer Available|1
4706174|NCT02223754|16219320|P2|Period 1|Withdrawal by Subject|4
4706175|NCT02223754|16219321|P1|Period 1|Withdrawal by Subject|0
4706176|NCT02223754|16219320|P2|Period 1|Protocol Violation|4
4706177|NCT02223754|16219321|P1|Period 1|Protocol Violation|2
4706178|NCT02223754|16219320|P2|Period 1|Lost to Follow-up|1
4706179|NCT02223754|16219321|P1|Period 1|Lost to Follow-up|0
4706180|NCT02223754|16219320|P2|Period 1|Adverse Event|0
4706181|NCT02223754|16219321|P1|Period 1|Adverse Event|1
4706182|NCT02223715|16219341|P1|Overall Study|Lost to Follow-up|73
4706183|NCT02223715|16219341|P1|Overall Study|Death|31
4706184|NCT02223390|16219484|P2|Overall Study|Lost to Follow-up|4
4706185|NCT02223390|16219485|P1|Overall Study|Lost to Follow-up|9
4706186|NCT02223364|16219496|P3|Overall Study|Physician Decision|0
4706187|NCT02223364|16219497|P2|Overall Study|Physician Decision|0
4706188|NCT02223364|16219498|P1|Overall Study|Physician Decision|1
4706189|NCT02223364|16219496|P3|Overall Study|subject expired before surgery|0
4706190|NCT02223364|16219497|P2|Overall Study|subject expired before surgery|0
4706191|NCT02223364|16219498|P1|Overall Study|subject expired before surgery|1
4706192|NCT02223364|16219496|P3|Overall Study|Protocol Violation|3
4706193|NCT02223364|16219497|P2|Overall Study|Protocol Violation|0
4706194|NCT02223364|16219498|P1|Overall Study|Protocol Violation|3
4706195|NCT02222818|16219674|P2|Period 1|Eligibility criteria not met|3
4706196|NCT02222818|16219675|P1|Period 1|Eligibility criteria not met|0
4706197|NCT02222714|16219687|P5|Overall Study|Withdrawal by Subject|1
4706198|NCT02222714|16219688|P4|Overall Study|Withdrawal by Subject|0
4706199|NCT02222714|16219689|P3|Overall Study|Withdrawal by Subject|1
4706200|NCT02222714|16219690|P2|Overall Study|Withdrawal by Subject|0
4706201|NCT02222714|16219691|P1|Overall Study|Withdrawal by Subject|0
4706202|NCT02222714|16219687|P5|Overall Study|Death|6
4706203|NCT02222714|16219688|P4|Overall Study|Death|4
4706204|NCT02222714|16219689|P3|Overall Study|Death|3
4706205|NCT02222714|16219690|P2|Overall Study|Death|2
4706206|NCT02222714|16219691|P1|Overall Study|Death|0
4706207|NCT02222688|16219737|P7|Overall Study|Disease progression|0
4706208|NCT02222688|16219738|P6|Overall Study|Disease progression|0
4706209|NCT02222688|16219739|P5|Overall Study|Disease progression|0
4706210|NCT02222688|16219740|P4|Overall Study|Disease progression|0
4706211|NCT02222688|16219741|P3|Overall Study|Disease progression|0
4706212|NCT02222688|16219742|P2|Overall Study|Disease progression|0
4706213|NCT02222688|16219743|P1|Overall Study|Disease progression|1
4706214|NCT02222688|16219737|P7|Overall Study|Withdrawal by Subject|1
4706215|NCT02222688|16219738|P6|Overall Study|Withdrawal by Subject|0
4706216|NCT02222688|16219739|P5|Overall Study|Withdrawal by Subject|1
4706217|NCT02222688|16219740|P4|Overall Study|Withdrawal by Subject|2
4706218|NCT02222688|16219741|P3|Overall Study|Withdrawal by Subject|0
4706219|NCT02222688|16219742|P2|Overall Study|Withdrawal by Subject|0
4706220|NCT02222688|16219743|P1|Overall Study|Withdrawal by Subject|0
4706221|NCT02222558|16219781|P6|Period 3|Withdrawal by Subject|1
4706222|NCT02222558|16219782|P5|Period 3|Withdrawal by Subject|0
4706223|NCT02222558|16219783|P4|Period 3|Withdrawal by Subject|0
4706224|NCT02222558|16219784|P3|Period 3|Withdrawal by Subject|0
4706225|NCT02222558|16219785|P2|Period 3|Withdrawal by Subject|0
4706226|NCT02222558|16219786|P1|Period 3|Withdrawal by Subject|0
4706227|NCT02222558|16219781|P6|Period 1: Single Dose|Withdrawal by Subject|0
4706228|NCT02222558|16219782|P5|Period 1: Single Dose|Withdrawal by Subject|0
4706229|NCT02222558|16219783|P4|Period 1: Single Dose|Withdrawal by Subject|0
4706230|NCT02222558|16219784|P3|Period 1: Single Dose|Withdrawal by Subject|0
4706231|NCT02222558|16219785|P2|Period 1: Single Dose|Withdrawal by Subject|0
4706232|NCT02222558|16219786|P1|Period 1: Single Dose|Withdrawal by Subject|4
4706233|NCT00875056|16219803|P3|Overall Study|Withdrawal by Subject|1
4706234|NCT00875056|16219804|P2|Overall Study|Withdrawal by Subject|0
4706235|NCT00875056|16219805|P1|Overall Study|Withdrawal by Subject|3
4706236|NCT00875056|16219803|P3|Overall Study|Progressive Disease|3
4706237|NCT00875056|16219804|P2|Overall Study|Progressive Disease|8
4706238|NCT00875056|16219805|P1|Overall Study|Progressive Disease|14
4706239|NCT00875056|16219803|P3|Overall Study|Adverse Event|2
4706240|NCT00875056|16219804|P2|Overall Study|Adverse Event|1
4706241|NCT00875056|16219805|P1|Overall Study|Adverse Event|6
4706242|NCT02222493|16219827|P2|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0
4706243|NCT02222493|16219828|P1|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9
4706244|NCT02222493|16219827|P2|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0
4706245|NCT02222493|16219828|P1|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1
4706246|NCT02222493|16219827|P2|Period 3: Week 54 Dosing-Week 78 Visit|Other|0
4706247|NCT02222493|16219828|P1|Period 3: Week 54 Dosing-Week 78 Visit|Other|4
4706248|NCT02222493|16219827|P2|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0
4706249|NCT02222493|16219828|P1|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14
4706250|NCT02222493|16219827|P2|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0
4706251|NCT02222493|16219828|P1|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3
4706252|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3
4706253|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9
4706254|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
4706255|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1
4706256|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4
4706257|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6
4706258|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0
4706259|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1
4706260|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0
4706261|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3
4706262|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9
4706263|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22
4706264|NCT02222493|16219827|P2|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0
4706265|NCT02222493|16219828|P1|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1
4706266|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0
4706267|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1
4706268|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Other|0
4706269|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Other|4
4706270|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20
4706271|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18
4706272|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0
4706273|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2
4706274|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0
4706275|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1
4706276|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7
4706277|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0
4706278|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1
4706279|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5
4706280|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9
4706281|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11
4706282|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1
4706283|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0
4706284|NCT02222493|16219827|P2|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
4706285|NCT02222493|16219828|P1|Period 1: First Dose-Week 30 (Pre-dose)|Death|2
4706286|NCT02222246|16219979|P2|Overall Study|Physician Decision|1
4706287|NCT02222246|16219980|P1|Overall Study|Physician Decision|0
4706288|NCT02222246|16219979|P2|Overall Study|No Emergency Department Visits|26
4706289|NCT02222246|16219980|P1|Overall Study|No Emergency Department Visits|27
4706290|NCT02222207|16220008|P1|Overall Study|Adverse Event|1
4706291|NCT02222207|16220008|P1|Overall Study|Other reasons|2
4706292|NCT02222207|16220008|P1|Overall Study|Death|1
4706293|NCT02221882|16220055|P6|Overall Study|Death|0
4706294|NCT02221882|16220056|P5|Overall Study|Death|0
4706295|NCT02221882|16220057|P4|Overall Study|Death|0
4706296|NCT02221882|16220058|P3|Overall Study|Death|0
4706297|NCT02221882|16220059|P2|Overall Study|Death|1
4706298|NCT02221882|16220060|P1|Overall Study|Death|0
4706299|NCT02221882|16220055|P6|Overall Study|Withdrawal by Subject|2
4706300|NCT02221882|16220056|P5|Overall Study|Withdrawal by Subject|2
4706301|NCT02221882|16220057|P4|Overall Study|Withdrawal by Subject|2
4706302|NCT02221882|16220058|P3|Overall Study|Withdrawal by Subject|4
4706303|NCT02221882|16220059|P2|Overall Study|Withdrawal by Subject|0
4706304|NCT02221882|16220060|P1|Overall Study|Withdrawal by Subject|0
4706305|NCT02221674|16220127|P3|Overall Study|Lost to Follow-up|0
4706306|NCT02221674|16220128|P2|Overall Study|Lost to Follow-up|0
4706307|NCT02221674|16220129|P1|Overall Study|Lost to Follow-up|1
4706308|NCT02221648|16220145|P2|Overall Study|Withdrawal by Subject|3
4706309|NCT02221648|16220146|P1|Overall Study|Withdrawal by Subject|3
4706310|NCT02221284|16220175|P1|Overall Study|Protocol Deviation|5
4706311|NCT02221284|16220175|P1|Overall Study|Case Report Forms Uncollected|56
4706312|NCT02221037|16220207|P4|Overall Study|Physician Decision|0
4706313|NCT02221037|16220208|P3|Overall Study|Physician Decision|1
4706314|NCT02221037|16220209|P2|Overall Study|Physician Decision|0
4706315|NCT02221037|16220210|P1|Overall Study|Physician Decision|0
4706316|NCT02220998|16220296|P2|Overall Study|Lost to Follow-up|4
4706317|NCT02220998|16220297|P1|Overall Study|Lost to Follow-up|4
4706318|NCT02220998|16220296|P2|Overall Study|Lack of Efficacy|5
4706319|NCT02220998|16220297|P1|Overall Study|Lack of Efficacy|0
4706320|NCT02220998|16220296|P2|Overall Study|Death|0
4706321|NCT02220998|16220297|P1|Overall Study|Death|2
4706322|NCT02220998|16220296|P2|Overall Study|Randomized but Never Treated|2
4706323|NCT02220998|16220297|P1|Overall Study|Randomized but Never Treated|1
4706324|NCT02220920|16220315|P2|Overall Study|Conflict with the stopping criteria|2
4706325|NCT02220920|16220316|P1|Overall Study|Conflict with the stopping criteria|1
4706326|NCT02220920|16220315|P2|Overall Study|Withdrawal by Subject|0
4706327|NCT02220920|16220316|P1|Overall Study|Withdrawal by Subject|1
4706328|NCT02220920|16220315|P2|Overall Study|Lack of Efficacy|1
4706329|NCT02220920|16220316|P1|Overall Study|Lack of Efficacy|0
4706330|NCT02220920|16220315|P2|Overall Study|Adverse Event|0
4706331|NCT02220920|16220316|P1|Overall Study|Adverse Event|1
4706332|NCT02220907|16220330|P1|Overall Study|Conflict with the stopping criteria|1
4706333|NCT02220907|16220330|P1|Overall Study|Withdrawal by Subject|2
4706334|NCT02220907|16220330|P1|Overall Study|Physician Decision|1
4706335|NCT02220907|16220330|P1|Overall Study|Adverse Event|7
4706336|NCT02220894|16220339|P2|Overall Study|Ongoing in Study|183
4706337|NCT02220894|16220340|P1|Overall Study|Ongoing in Study|265
4706338|NCT02220894|16220339|P2|Overall Study|Withdrawal by Subject|13
4706339|NCT02220894|16220340|P1|Overall Study|Withdrawal by Subject|2
4706340|NCT02220894|16220339|P2|Overall Study|Withdrawal by Parent/Guardian|1
4706341|NCT02220894|16220340|P1|Overall Study|Withdrawal by Parent/Guardian|0
4706342|NCT02220894|16220339|P2|Overall Study|Lost to Follow-up|2
4706343|NCT02220894|16220340|P1|Overall Study|Lost to Follow-up|0
4706344|NCT02220894|16220339|P2|Overall Study|Death|368
4706345|NCT02220894|16220340|P1|Overall Study|Death|252
4706346|NCT02220894|16220339|P2|Overall Study|Adverse Event|70
4706347|NCT02220894|16220340|P1|Overall Study|Adverse Event|118
4706348|NCT02220764|16220368|P2|Overall Study|Death|0
4706349|NCT02220764|16220369|P1|Overall Study|Death|1
4706350|NCT02220764|16220368|P2|Overall Study|Lost to Follow-up|1
4706351|NCT02220764|16220369|P1|Overall Study|Lost to Follow-up|3
4706352|NCT02220725|16220383|P4|Overall Study|Withdrawal by Subject|1
4706353|NCT02220725|16220384|P3|Overall Study|Withdrawal by Subject|0
4706354|NCT02220725|16220385|P2|Overall Study|Withdrawal by Subject|0
4706355|NCT02220725|16220386|P1|Overall Study|Withdrawal by Subject|0
4706356|NCT02220725|16220383|P4|Overall Study|Lost to Follow-up|1
4706357|NCT02220725|16220384|P3|Overall Study|Lost to Follow-up|0
4706358|NCT02220725|16220385|P2|Overall Study|Lost to Follow-up|0
4706359|NCT02220725|16220386|P1|Overall Study|Lost to Follow-up|0
4706360|NCT02220205|16220416|P2|Overall Study|Withdrawal by Subject|0
4706361|NCT02220205|16220417|P1|Overall Study|Withdrawal by Subject|1
4706362|NCT02219932|16220442|P2|Overall Study|Adverse Event|21
4706363|NCT02219932|16220443|P1|Overall Study|Adverse Event|23
4706364|NCT02219932|16220442|P2|Overall Study|Lost to Follow-up|2
4706365|NCT02219932|16220443|P1|Overall Study|Lost to Follow-up|4
4706366|NCT02219932|16220442|P2|Overall Study|Pregnancy|0
4706367|NCT02219932|16220443|P1|Overall Study|Pregnancy|1
4706368|NCT02219932|16220442|P2|Overall Study|Protocol Violation|6
4706369|NCT02219932|16220443|P1|Overall Study|Protocol Violation|10
4706370|NCT02219932|16220442|P2|Overall Study|Lack of Efficacy (Subject Perception)|2
4706371|NCT02219932|16220443|P1|Overall Study|Lack of Efficacy (Subject Perception)|10
4706372|NCT02219932|16220442|P2|Overall Study|Consent Withdrawn|7
4706373|NCT02219932|16220443|P1|Overall Study|Consent Withdrawn|11
4706374|NCT02219932|16220442|P2|Overall Study|Investigator Decision|1
4706375|NCT02219932|16220443|P1|Overall Study|Investigator Decision|0
4706376|NCT02219932|16220442|P2|Overall Study|Death|1
4706377|NCT02219932|16220443|P1|Overall Study|Death|1
4706378|NCT02219932|16220442|P2|Overall Study|Other|11
4706379|NCT02219932|16220443|P1|Overall Study|Other|5
4706380|NCT02219685|16220459|P2|Blinded Treatment Phase|Withdrew Consent|0
4706381|NCT02219685|16220460|P1|Blinded Treatment Phase|Withdrew Consent|1
4706382|NCT02219685|16220459|P2|Blinded Treatment Phase|Lost to Follow-up|0
4706383|NCT02219685|16220460|P1|Blinded Treatment Phase|Lost to Follow-up|1
4706384|NCT00832117|16220506|P1|Overall Study|Disease Progression|11
4706385|NCT00832117|16220506|P1|Overall Study|Death|1
4706386|NCT02219477|16220585|P3|Overall Study|Withdrawal by Subject|0
4706387|NCT02219477|16220586|P2|Overall Study|Withdrawal by Subject|1
4706388|NCT02219477|16220587|P1|Overall Study|Withdrawal by Subject|0
4706389|NCT02219477|16220585|P3|Overall Study|Adverse Event|1
4706390|NCT02219477|16220586|P2|Overall Study|Adverse Event|1
4706391|NCT02219477|16220587|P1|Overall Study|Adverse Event|0
4706392|NCT02219464|16220615|P2|Overall Study|catheter malfunction|0
4706393|NCT02219464|16220616|P1|Overall Study|catheter malfunction|1
4706394|NCT02219464|16220615|P2|Overall Study|case cancelled|0
4706395|NCT02219464|16220616|P1|Overall Study|case cancelled|1
4706396|NCT02219464|16220615|P2|Overall Study|Withdrawal by Subject|0
4706397|NCT02219464|16220616|P1|Overall Study|Withdrawal by Subject|1
4706398|NCT02219334|16220626|P2|Overall Study|Protocol Violation|3
4706399|NCT02219334|16220627|P1|Overall Study|Protocol Violation|7
4706400|NCT02219334|16220626|P2|Overall Study|Withdrawal by Subject|0
4706401|NCT02219334|16220627|P1|Overall Study|Withdrawal by Subject|1
4706402|NCT02219308|16220650|P2|Overall Study|Withdrawal by Subject|2
4706403|NCT02219308|16220651|P1|Overall Study|Withdrawal by Subject|1
4706404|NCT02219087|16220811|P2|Overall Study|Randomization envelope pulled out of seq|1
4706405|NCT02219087|16220812|P1|Overall Study|Randomization envelope pulled out of seq|0
4706406|NCT02219048|16220832|P2|Overall Study|Other|1
4706407|NCT02219048|16220833|P1|Overall Study|Other|0
4706408|NCT02219048|16220832|P2|Overall Study|Withdrawal by Subject|0
4706409|NCT02219048|16220833|P1|Overall Study|Withdrawal by Subject|2
4706410|NCT02219048|16220832|P2|Overall Study|Study terminated by sponsor|15
4706411|NCT02219048|16220833|P1|Overall Study|Study terminated by sponsor|16
4706412|NCT02219048|16220832|P2|Overall Study|No longer meets eligibility criteria|0
4706413|NCT02219048|16220833|P1|Overall Study|No longer meets eligibility criteria|1
4706414|NCT02219048|16220832|P2|Overall Study|Adverse Event|5
4706415|NCT02219048|16220833|P1|Overall Study|Adverse Event|2
4706416|NCT02219009|16220859|P2|Overall Study|Physician Decision|1
4706417|NCT02219009|16220860|P1|Overall Study|Physician Decision|0
4706418|NCT02219009|16220859|P2|Overall Study|Protocol deviation|0
4706419|NCT02219009|16220860|P1|Overall Study|Protocol deviation|1
4706420|NCT02219009|16220859|P2|Overall Study|Lost to Follow-up|2
4706421|NCT02219009|16220860|P1|Overall Study|Lost to Follow-up|2
4706422|NCT02219009|16220859|P2|Overall Study|Adverse Event|4
4706423|NCT02219009|16220860|P1|Overall Study|Adverse Event|2
4706424|NCT02219009|16220859|P2|Overall Study|Withdrawal by Subject|1
4706425|NCT02219009|16220860|P1|Overall Study|Withdrawal by Subject|5
4706426|NCT02218736|16220872|P2|Overall Study|Protocol Violation|0
4706427|NCT02218736|16220873|P1|Overall Study|Protocol Violation|2
4706428|NCT02218736|16220872|P2|Overall Study|Withdrawal by Subject|9
4706429|NCT02218736|16220873|P1|Overall Study|Withdrawal by Subject|10
4706430|NCT02218697|16220885|P2|Overall Study|Withdrawal by Subject|3
4706431|NCT02218697|16220886|P1|Overall Study|Withdrawal by Subject|2
4706432|NCT02218697|16220885|P2|Overall Study|Unwilling to be vaccinated in left arm|1
4706433|NCT02218697|16220886|P1|Overall Study|Unwilling to be vaccinated in left arm|0
4706434|NCT02218697|16220885|P2|Overall Study|Adverse Event|2
4706435|NCT02218697|16220886|P1|Overall Study|Adverse Event|0
4706436|NCT02218541|16220926|P2|Overall Study|Implant Failure|1
4706437|NCT02218541|16220927|P1|Overall Study|Implant Failure|4
4706438|NCT02218541|16220926|P2|Overall Study|Lost to Follow-up|1
4706439|NCT02218541|16220927|P1|Overall Study|Lost to Follow-up|2
4706440|NCT02218372|16220973|P2|Overall Study|Withdrawal by Parent/Guardian|1
4706441|NCT02218372|16220974|P1|Overall Study|Withdrawal by Parent/Guardian|0
4706442|NCT02218372|16220973|P2|Overall Study|Randomized but did not receive treatment|3
4706443|NCT02218372|16220974|P1|Overall Study|Randomized but did not receive treatment|2
4706444|NCT02218372|16220973|P2|Overall Study|Miscellaneous|1
4706445|NCT02218372|16220974|P1|Overall Study|Miscellaneous|2
4706446|NCT02218372|16220973|P2|Overall Study|Adverse Event|1
4706447|NCT02218372|16220974|P1|Overall Study|Adverse Event|1
4706448|NCT02218268|16221054|P2|24 Hour Washout|Physician Decision|9
4706449|NCT02218268|16221055|P1|24 Hour Washout|Physician Decision|11
4706450|NCT02218216|16221067|P3|Overall Study|Study terminated before completed|0
4706451|NCT02218216|16221068|P2|Overall Study|Study terminated before completed|0
4706452|NCT02218216|16221069|P1|Overall Study|Study terminated before completed|6
4706453|NCT02218008|16221122|P6|Stage 2 (S2)|Lost to Follow-up|1
4706454|NCT02218008|16221123|P5|Stage 2 (S2)|Lost to Follow-up|0
4706455|NCT02218008|16221124|P4|Stage 2 (S2)|Lost to Follow-up|0
4706456|NCT02218008|16221125|P3|Stage 2 (S2)|Lost to Follow-up|0
4706457|NCT02218008|16221126|P2|Stage 2 (S2)|Lost to Follow-up|0
4706458|NCT02218008|16221127|P1|Stage 2 (S2)|Lost to Follow-up|0
4706459|NCT02218008|16221122|P6|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4706460|NCT02218008|16221123|P5|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4706461|NCT02218008|16221124|P4|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1
4706462|NCT02218008|16221125|P3|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4706463|NCT02218008|16221126|P2|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4706464|NCT02218008|16221127|P1|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0
4706465|NCT02218008|16221122|P6|Stage 2 (S2)|Lack of Efficacy|2
4706466|NCT02218008|16221123|P5|Stage 2 (S2)|Lack of Efficacy|0
4706467|NCT02218008|16221124|P4|Stage 2 (S2)|Lack of Efficacy|0
4706468|NCT02218008|16221125|P3|Stage 2 (S2)|Lack of Efficacy|0
4706469|NCT02218008|16221126|P2|Stage 2 (S2)|Lack of Efficacy|0
4706470|NCT02218008|16221127|P1|Stage 2 (S2)|Lack of Efficacy|0
4706471|NCT02218008|16221122|P6|Stage 2 (S2)|Withdrawal by Subject|0
4706472|NCT02218008|16221123|P5|Stage 2 (S2)|Withdrawal by Subject|1
4706473|NCT02218008|16221124|P4|Stage 2 (S2)|Withdrawal by Subject|1
4706474|NCT02218008|16221125|P3|Stage 2 (S2)|Withdrawal by Subject|0
4706475|NCT02218008|16221126|P2|Stage 2 (S2)|Withdrawal by Subject|0
4706476|NCT02218008|16221127|P1|Stage 2 (S2)|Withdrawal by Subject|0
4706477|NCT02218008|16221122|P6|Stage 2 (S2)|Adverse Event|3
4706478|NCT02218008|16221123|P5|Stage 2 (S2)|Adverse Event|3
4706479|NCT02218008|16221124|P4|Stage 2 (S2)|Adverse Event|2
4706480|NCT02218008|16221125|P3|Stage 2 (S2)|Adverse Event|0
4706481|NCT02218008|16221126|P2|Stage 2 (S2)|Adverse Event|0
4706482|NCT02218008|16221127|P1|Stage 2 (S2)|Adverse Event|0
4706483|NCT02218008|16221122|P6|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4706484|NCT02218008|16221123|P5|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4706485|NCT02218008|16221124|P4|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4706486|NCT02218008|16221125|P3|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4706487|NCT02218008|16221126|P2|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0
4706488|NCT02218008|16221127|P1|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1
4706489|NCT02218008|16221122|P6|Stage 1 (S1)|Protocol Violation|0
4706490|NCT02218008|16221123|P5|Stage 1 (S1)|Protocol Violation|0
4706491|NCT02218008|16221124|P4|Stage 1 (S1)|Protocol Violation|0
4706492|NCT02218008|16221125|P3|Stage 1 (S1)|Protocol Violation|1
4706493|NCT02218008|16221126|P2|Stage 1 (S1)|Protocol Violation|0
4706494|NCT02218008|16221127|P1|Stage 1 (S1)|Protocol Violation|0
4706495|NCT02218008|16221122|P6|Stage 1 (S1)|Pregnancy|0
4706496|NCT02218008|16221123|P5|Stage 1 (S1)|Pregnancy|0
4706497|NCT02218008|16221124|P4|Stage 1 (S1)|Pregnancy|0
4706498|NCT02218008|16221125|P3|Stage 1 (S1)|Pregnancy|1
4706499|NCT02218008|16221126|P2|Stage 1 (S1)|Pregnancy|0
4706500|NCT02218008|16221127|P1|Stage 1 (S1)|Pregnancy|0
4706501|NCT02218008|16221122|P6|Stage 1 (S1)|Non-compliance; drug use|0
4706502|NCT02218008|16221123|P5|Stage 1 (S1)|Non-compliance; drug use|0
4706503|NCT02218008|16221124|P4|Stage 1 (S1)|Non-compliance; drug use|0
4706504|NCT02218008|16221125|P3|Stage 1 (S1)|Non-compliance; drug use|0
4706505|NCT02218008|16221126|P2|Stage 1 (S1)|Non-compliance; drug use|0
4706506|NCT02218008|16221127|P1|Stage 1 (S1)|Non-compliance; drug use|1
4706507|NCT02218008|16221122|P6|Stage 1 (S1)|Non-compliance with Study Drug|0
4706508|NCT02218008|16221123|P5|Stage 1 (S1)|Non-compliance with Study Drug|0
4706509|NCT02218008|16221124|P4|Stage 1 (S1)|Non-compliance with Study Drug|0
4706510|NCT02218008|16221125|P3|Stage 1 (S1)|Non-compliance with Study Drug|0
4706511|NCT02218008|16221126|P2|Stage 1 (S1)|Non-compliance with Study Drug|1
4706512|NCT02218008|16221127|P1|Stage 1 (S1)|Non-compliance with Study Drug|2
4706513|NCT02218008|16221122|P6|Stage 1 (S1)|Lost to Follow-up|0
4706514|NCT02218008|16221123|P5|Stage 1 (S1)|Lost to Follow-up|0
4706515|NCT02218008|16221124|P4|Stage 1 (S1)|Lost to Follow-up|0
4706516|NCT02218008|16221125|P3|Stage 1 (S1)|Lost to Follow-up|1
4706517|NCT02218008|16221126|P2|Stage 1 (S1)|Lost to Follow-up|0
4706518|NCT02218008|16221127|P1|Stage 1 (S1)|Lost to Follow-up|3
4706519|NCT02218008|16221122|P6|Stage 1 (S1)|Lack of Efficacy|0
4706520|NCT02218008|16221123|P5|Stage 1 (S1)|Lack of Efficacy|0
4706521|NCT02218008|16221124|P4|Stage 1 (S1)|Lack of Efficacy|0
4706522|NCT02218008|16221125|P3|Stage 1 (S1)|Lack of Efficacy|0
4706523|NCT02218008|16221126|P2|Stage 1 (S1)|Lack of Efficacy|0
4706524|NCT02218008|16221127|P1|Stage 1 (S1)|Lack of Efficacy|3
4706525|NCT02218008|16221122|P6|Stage 1 (S1)|Withdrawal by Subject|0
4706526|NCT02218008|16221123|P5|Stage 1 (S1)|Withdrawal by Subject|0
4706527|NCT02218008|16221124|P4|Stage 1 (S1)|Withdrawal by Subject|0
4706528|NCT02218008|16221125|P3|Stage 1 (S1)|Withdrawal by Subject|1
4706529|NCT02218008|16221126|P2|Stage 1 (S1)|Withdrawal by Subject|1
4706530|NCT02218008|16221127|P1|Stage 1 (S1)|Withdrawal by Subject|6
4706531|NCT02218008|16221122|P6|Stage 1 (S1)|Adverse Event|0
4706532|NCT02218008|16221123|P5|Stage 1 (S1)|Adverse Event|0
4706533|NCT02218008|16221124|P4|Stage 1 (S1)|Adverse Event|0
4706534|NCT02218008|16221125|P3|Stage 1 (S1)|Adverse Event|11
4706535|NCT02218008|16221126|P2|Stage 1 (S1)|Adverse Event|5
4706536|NCT02218008|16221127|P1|Stage 1 (S1)|Adverse Event|6
4706537|NCT02217982|16221173|P2|Overall Study|Adverse Event|1
4706538|NCT02217982|16221174|P1|Overall Study|Adverse Event|0
4706539|NCT02217982|16221173|P2|Overall Study|Trial discontinued|0
4706540|NCT02217982|16221174|P1|Overall Study|Trial discontinued|1
4706541|NCT02217878|16221257|P2|Overall Study|initial diagnosis of STEMI not confirmed|0
4706542|NCT02217878|16221258|P1|Overall Study|initial diagnosis of STEMI not confirmed|1
4706543|NCT02217878|16221257|P2|Overall Study|required morphine due to chest pain|2
4706544|NCT02217878|16221258|P1|Overall Study|required morphine due to chest pain|1
4706545|NCT02217566|16221356|P1|Overall Study|Early study termination|6
4706546|NCT02217566|16221356|P1|Overall Study|Death|3
4706547|NCT02217566|16221356|P1|Overall Study|Lost to Follow-up|2
4706548|NCT02217527|16221367|P2|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1
4706549|NCT02217527|16221368|P1|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0
4706550|NCT02217527|16221367|P2|Drug Condition 1: First Study Phase|Withdrawal by Subject|3
4706551|NCT02217527|16221368|P1|Drug Condition 1: First Study Phase|Withdrawal by Subject|1
4706552|NCT02217475|16221381|P3|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1
4706553|NCT02217475|16221382|P2|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
4706554|NCT02217475|16221383|P1|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0
4706555|NCT02217475|16221381|P3|Treatment Period 2 (Year 2)|Physician Decision|2
4706556|NCT02217475|16221382|P2|Treatment Period 2 (Year 2)|Physician Decision|0
4706557|NCT02217475|16221383|P1|Treatment Period 2 (Year 2)|Physician Decision|0
4706558|NCT02217475|16221381|P3|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
4706559|NCT02217475|16221382|P2|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0
4706560|NCT02217475|16221383|P1|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2
4706561|NCT02217475|16221381|P3|Treatment Period 2 (Year 2)|Lost to Follow-up|2
4706562|NCT02217475|16221382|P2|Treatment Period 2 (Year 2)|Lost to Follow-up|1
4706563|NCT02217475|16221383|P1|Treatment Period 2 (Year 2)|Lost to Follow-up|0
4706564|NCT02217475|16221381|P3|Treatment Period 2 (Year 2)|Adverse Event|5
4706565|NCT02217475|16221382|P2|Treatment Period 2 (Year 2)|Adverse Event|1
4706566|NCT02217475|16221383|P1|Treatment Period 2 (Year 2)|Adverse Event|0
4706567|NCT02217475|16221381|P3|Discontinued After Period 1|Physician Decision|1
4706568|NCT02217475|16221382|P2|Discontinued After Period 1|Physician Decision|0
4706569|NCT02217475|16221383|P1|Discontinued After Period 1|Physician Decision|0
4706570|NCT02217475|16221381|P3|Discontinued After Period 1|Participant Withdrew Consent|2
4706571|NCT02217475|16221382|P2|Discontinued After Period 1|Participant Withdrew Consent|1
4706572|NCT02217475|16221383|P1|Discontinued After Period 1|Participant Withdrew Consent|1
4706573|NCT02217475|16221381|P3|Discontinued After Period 1|Adverse Event|0
4706574|NCT02217475|16221382|P2|Discontinued After Period 1|Adverse Event|2
4706575|NCT02217475|16221383|P1|Discontinued After Period 1|Adverse Event|1
4706576|NCT02217475|16221381|P3|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1
4706577|NCT02217475|16221382|P2|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
4706578|NCT02217475|16221383|P1|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0
4706579|NCT02217475|16221381|P3|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11
4706580|NCT02217475|16221382|P2|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2
4706581|NCT02217475|16221383|P1|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5
4706582|NCT02217475|16221381|P3|Treatment Period 1 (Year 1)|Lost to Follow-up|0
4706583|NCT02217475|16221382|P2|Treatment Period 1 (Year 1)|Lost to Follow-up|0
4706584|NCT02217475|16221383|P1|Treatment Period 1 (Year 1)|Lost to Follow-up|1
4706585|NCT02217475|16221381|P3|Treatment Period 1 (Year 1)|Adverse Event|9
4706586|NCT02217475|16221382|P2|Treatment Period 1 (Year 1)|Adverse Event|5
4706587|NCT02217475|16221383|P1|Treatment Period 1 (Year 1)|Adverse Event|4
4706588|NCT02217475|16221381|P3|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
4706589|NCT02217475|16221382|P2|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1
4706590|NCT02217475|16221383|P1|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0
4706591|NCT02217436|16221500|P2|Overall Study|Incomplete data|1
4706592|NCT02217436|16221501|P1|Overall Study|Incomplete data|0
4706593|NCT02217436|16221500|P2|Overall Study|Protocol Violation|1
4706594|NCT02217436|16221501|P1|Overall Study|Protocol Violation|1
4706595|NCT02217410|16221512|P3|Overall Study|Physician Decision|0
4706596|NCT02217410|16221513|P2|Overall Study|Physician Decision|3
4706597|NCT02217410|16221514|P1|Overall Study|Physician Decision|1
4706598|NCT02217410|16221512|P3|Overall Study|Lack of Efficacy|0
4706599|NCT02217410|16221513|P2|Overall Study|Lack of Efficacy|1
4706600|NCT02217410|16221514|P1|Overall Study|Lack of Efficacy|0
4706601|NCT02217410|16221512|P3|Overall Study|Lost to Follow-up|1
4706602|NCT02217410|16221513|P2|Overall Study|Lost to Follow-up|0
4706603|NCT02217410|16221514|P1|Overall Study|Lost to Follow-up|0
4706604|NCT02217410|16221512|P3|Overall Study|Withdrawal by Subject|2
4706605|NCT02217410|16221513|P2|Overall Study|Withdrawal by Subject|0
4706606|NCT02217410|16221514|P1|Overall Study|Withdrawal by Subject|0
4706607|NCT02217410|16221512|P3|Overall Study|Graft Loss|2
4706608|NCT02217410|16221513|P2|Overall Study|Graft Loss|0
4706609|NCT02217410|16221514|P1|Overall Study|Graft Loss|0
4706610|NCT02217280|16221537|P1|Overall Study|Post-consent sceen fail|2
4706611|NCT02217280|16221537|P1|Overall Study|Withdrawal by Subject|2
4706612|NCT00790582|16221544|P2|Overall Study|Withdrawal by Subject|51
4706613|NCT00790582|16221545|P1|Overall Study|Withdrawal by Subject|7
4706614|NCT00790582|16221544|P2|Overall Study|Lost to Follow-up|3
4706615|NCT00790582|16221545|P1|Overall Study|Lost to Follow-up|3
4706616|NCT00790582|16221544|P2|Overall Study|Physician Decision|1
4706617|NCT00790582|16221545|P1|Overall Study|Physician Decision|7
4706618|NCT00790582|16221544|P2|Overall Study|Death|32
4706619|NCT00790582|16221545|P1|Overall Study|Death|14
4706620|NCT02216812|16221555|P2|Overall Study|Lost to Follow-up|5
4706621|NCT02216812|16221556|P1|Overall Study|Lost to Follow-up|10
4706622|NCT02216773|16221572|P2|Overall Study|Abandoned|3
4706623|NCT02216773|16221573|P1|Overall Study|Abandoned|4
4706624|NCT02216773|16221572|P2|Overall Study|Insufficient FLRV|0
4706625|NCT02216773|16221573|P1|Overall Study|Insufficient FLRV|4
4706626|NCT02216773|16221572|P2|Overall Study|Disease progression|2
4706627|NCT02216773|16221573|P1|Overall Study|Disease progression|4
4706628|NCT02216591|16221594|P2|Overall Study|Lost to Follow-up|1
4706629|NCT02216591|16221595|P1|Overall Study|Lost to Follow-up|0
4706630|NCT02216526|16221608|P3|Overall Study|Hospitalization|3
4706631|NCT02216526|16221609|P2|Overall Study|Hospitalization|1
4706632|NCT02216526|16221610|P1|Overall Study|Hospitalization|2
4706633|NCT02216526|16221608|P3|Overall Study|Protocol Violation|2
4706634|NCT02216526|16221609|P2|Overall Study|Protocol Violation|0
4706635|NCT02216526|16221610|P1|Overall Study|Protocol Violation|2
4706636|NCT02216526|16221608|P3|Overall Study|Death|3
4706637|NCT02216526|16221609|P2|Overall Study|Death|1
4706638|NCT02216526|16221610|P1|Overall Study|Death|0
4706639|NCT02216526|16221608|P3|Overall Study|Adverse Event|0
4706640|NCT02216526|16221609|P2|Overall Study|Adverse Event|1
4706641|NCT02216526|16221610|P1|Overall Study|Adverse Event|1
4706642|NCT02216357|16221728|P2|Overall Study|Inclusion or exclusion criteria not met|1
4706643|NCT02216357|16221729|P1|Overall Study|Inclusion or exclusion criteria not met|2
4706644|NCT00759876|16221753|P1|Overall Study|Sponsor terminated study early|36
4706645|NCT02216214|16221777|P2|Overall Study|Miscellaneous|1
4706646|NCT02216214|16221778|P1|Overall Study|Miscellaneous|1
4706647|NCT02216214|16221777|P2|Overall Study|Study Terminated By Sponsor|1
4706648|NCT02216214|16221778|P1|Overall Study|Study Terminated By Sponsor|0
4706649|NCT02216214|16221777|P2|Overall Study|Withdrawal by Subject|20
4706650|NCT02216214|16221778|P1|Overall Study|Withdrawal by Subject|22
4706651|NCT02216214|16221777|P2|Overall Study|Protocol Violation|2
4706652|NCT02216214|16221778|P1|Overall Study|Protocol Violation|4
4706653|NCT02216214|16221777|P2|Overall Study|Lost to Follow-up|2
4706654|NCT02216214|16221778|P1|Overall Study|Lost to Follow-up|3
4706655|NCT02216214|16221777|P2|Overall Study|Lack of Efficacy|2
4706656|NCT02216214|16221778|P1|Overall Study|Lack of Efficacy|2
4706657|NCT02216214|16221777|P2|Overall Study|Adverse Event|8
4706658|NCT02216214|16221778|P1|Overall Study|Adverse Event|10
4706659|NCT02216214|16221777|P2|Overall Study|Randomized Never Received Study Drug|0
4706660|NCT02216214|16221778|P1|Overall Study|Randomized Never Received Study Drug|1
4706661|NCT02216123|16221849|P2|Overall Study|Withdrawal by Subject|0
4706662|NCT02216123|16221850|P1|Overall Study|Withdrawal by Subject|2
4706663|NCT02216123|16221849|P2|Overall Study|Lost to Follow-up|2
4706664|NCT02216123|16221850|P1|Overall Study|Lost to Follow-up|4
4706665|NCT02215967|16221943|P4|Overall Study|Patient did not get CAR T-Cells|0
4706666|NCT02215967|16221944|P3|Overall Study|Patient did not get CAR T-Cells|1
4706667|NCT02215967|16221945|P2|Overall Study|Patient did not get CAR T-Cells|0
4706668|NCT02215967|16221946|P1|Overall Study|Patient did not get CAR T-Cells|0
4706669|NCT02215967|16221943|P4|Overall Study|Patient became ineligible for treatment|3
4706670|NCT02215967|16221944|P3|Overall Study|Patient became ineligible for treatment|0
4706671|NCT02215967|16221945|P2|Overall Study|Patient became ineligible for treatment|0
4706672|NCT02215967|16221946|P1|Overall Study|Patient became ineligible for treatment|0
4706673|NCT02215954|16221967|P3|Overall Study|Not exposed|3
4706674|NCT02215954|16221968|P2|Overall Study|Not exposed|1
4706675|NCT02215954|16221969|P1|Overall Study|Not exposed|1
4706676|NCT02215954|16221967|P3|Overall Study|Withdrawal by Subject|2
4706677|NCT02215954|16221968|P2|Overall Study|Withdrawal by Subject|0
4706678|NCT02215954|16221969|P1|Overall Study|Withdrawal by Subject|0
4706679|NCT02215954|16221967|P3|Overall Study|Adverse Event|1
4706680|NCT02215954|16221968|P2|Overall Study|Adverse Event|0
4706681|NCT02215954|16221969|P1|Overall Study|Adverse Event|0
4706682|NCT02215616|16221993|P4|Overall Study|Other than specified|1
4706683|NCT02215616|16221994|P3|Overall Study|Other than specified|1
4706684|NCT02215616|16221995|P2|Overall Study|Other than specified|0
4706685|NCT02215616|16221996|P1|Overall Study|Other than specified|1
4706686|NCT02215616|16221993|P4|Overall Study|Lost to Follow-up|1
4706687|NCT02215616|16221994|P3|Overall Study|Lost to Follow-up|0
4706688|NCT02215616|16221995|P2|Overall Study|Lost to Follow-up|1
4706689|NCT02215616|16221996|P1|Overall Study|Lost to Follow-up|1
4706690|NCT02215616|16221993|P4|Overall Study|Protocol Violation|0
4706691|NCT02215616|16221994|P3|Overall Study|Protocol Violation|0
4706692|NCT02215616|16221995|P2|Overall Study|Protocol Violation|2
4706693|NCT02215616|16221996|P1|Overall Study|Protocol Violation|0
4706694|NCT02215616|16221993|P4|Overall Study|Non-compliance|0
4706695|NCT02215616|16221994|P3|Overall Study|Non-compliance|1
4706696|NCT02215616|16221995|P2|Overall Study|Non-compliance|2
4706697|NCT02215616|16221996|P1|Overall Study|Non-compliance|0
4706698|NCT02215616|16221993|P4|Overall Study|Withdrawal by Subject|5
4706699|NCT02215616|16221994|P3|Overall Study|Withdrawal by Subject|2
4706700|NCT02215616|16221995|P2|Overall Study|Withdrawal by Subject|8
4706701|NCT02215616|16221996|P1|Overall Study|Withdrawal by Subject|1
4706702|NCT02215616|16221993|P4|Overall Study|Adverse Event|2
4706703|NCT02215616|16221994|P3|Overall Study|Adverse Event|9
4706704|NCT02215616|16221995|P2|Overall Study|Adverse Event|4
4706705|NCT02215616|16221996|P1|Overall Study|Adverse Event|7
4706706|NCT02215616|16221993|P4|Overall Study|Death|0
4706707|NCT02215616|16221994|P3|Overall Study|Death|0
4706708|NCT02215616|16221995|P2|Overall Study|Death|0
4706709|NCT02215616|16221996|P1|Overall Study|Death|1
4706710|NCT02215616|16221993|P4|Overall Study|Sponsor requested to stop study drug|4
4706711|NCT02215616|16221994|P3|Overall Study|Sponsor requested to stop study drug|1
4706712|NCT02215616|16221995|P2|Overall Study|Sponsor requested to stop study drug|0
4706713|NCT02215616|16221996|P1|Overall Study|Sponsor requested to stop study drug|0
4706714|NCT02215252|16222037|P3|Overall Study|Other|1
4706715|NCT02215252|16222038|P2|Overall Study|Other|1
4706716|NCT02215252|16222039|P1|Overall Study|Other|0
4706717|NCT02215252|16222037|P3|Overall Study|Withdrawal by Subject|0
4706718|NCT02215252|16222038|P2|Overall Study|Withdrawal by Subject|0
4706719|NCT02215252|16222039|P1|Overall Study|Withdrawal by Subject|1
4706720|NCT02215252|16222037|P3|Overall Study|Protocol Violation|0
4706721|NCT02215252|16222038|P2|Overall Study|Protocol Violation|1
4706722|NCT02215252|16222039|P1|Overall Study|Protocol Violation|0
4706723|NCT02215252|16222037|P3|Overall Study|Does not Meet Entrance Criteria|0
4706724|NCT02215252|16222038|P2|Overall Study|Does not Meet Entrance Criteria|1
4706725|NCT02215252|16222039|P1|Overall Study|Does not Meet Entrance Criteria|0
4706726|NCT02215252|16222037|P3|Overall Study|Lost to Follow-up|1
4706727|NCT02215252|16222038|P2|Overall Study|Lost to Follow-up|0
4706728|NCT02215252|16222039|P1|Overall Study|Lost to Follow-up|0
4706729|NCT02215252|16222037|P3|Overall Study|Adverse Event|2
4706730|NCT02215252|16222038|P2|Overall Study|Adverse Event|5
4706731|NCT02215252|16222039|P1|Overall Study|Adverse Event|1
4706732|NCT02215096|16222127|P5|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
4706733|NCT02215096|16222128|P4|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
4706734|NCT02215096|16222129|P3|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1
4706735|NCT02215096|16222130|P2|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2
4706736|NCT02215096|16222131|P1|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0
4706737|NCT02215096|16222127|P5|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4706738|NCT02215096|16222128|P4|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1
4706739|NCT02215096|16222129|P3|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4706740|NCT02215096|16222130|P2|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4706741|NCT02215096|16222131|P1|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0
4706742|NCT02215096|16222127|P5|Combination TP (Up to Maximum 654 Days)|Physician Decision|1
4706743|NCT02215096|16222128|P4|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4706744|NCT02215096|16222129|P3|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4706745|NCT02215096|16222130|P2|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4706746|NCT02215096|16222131|P1|Combination TP (Up to Maximum 654 Days)|Physician Decision|0
4706747|NCT02215096|16222127|P5|Run-In Period (Up to Week 2)|Adverse Event|0
4706748|NCT02215096|16222128|P4|Run-In Period (Up to Week 2)|Adverse Event|0
4706749|NCT02215096|16222129|P3|Run-In Period (Up to Week 2)|Adverse Event|0
4706750|NCT02215096|16222130|P2|Run-In Period (Up to Week 2)|Adverse Event|0
4706751|NCT02215096|16222131|P1|Run-In Period (Up to Week 2)|Adverse Event|1
4706752|NCT00723957|16222246|P2|Overall Study|Never received treatment|3
4706753|NCT00723957|16222247|P1|Overall Study|Never received treatment|3
4706754|NCT00723957|16222246|P2|Overall Study|Reason not analyzed|0
4706755|NCT00723957|16222247|P1|Overall Study|Reason not analyzed|1
4706756|NCT00723957|16222246|P2|Overall Study|Withdrawal by Subject|5
4706757|NCT00723957|16222247|P1|Overall Study|Withdrawal by Subject|7
4706758|NCT00723957|16222246|P2|Overall Study|Study drug toxicity|6
4706759|NCT00723957|16222247|P1|Overall Study|Study drug toxicity|4
4706760|NCT00723957|16222246|P2|Overall Study|Investigator decision|1
4706761|NCT00723957|16222247|P1|Overall Study|Investigator decision|1
4706762|NCT00723957|16222246|P2|Overall Study|Maximum clinical benefit|5
4706763|NCT00723957|16222247|P1|Overall Study|Maximum clinical benefit|4
4706764|NCT00723957|16222246|P2|Overall Study|Disease progression|25
4706765|NCT00723957|16222247|P1|Overall Study|Disease progression|27
4706766|NCT00723957|16222246|P2|Overall Study|Death|4
4706767|NCT00723957|16222247|P1|Overall Study|Death|3
4706768|NCT00723957|16222246|P2|Overall Study|Adverse event unrelated to study drug|4
4706769|NCT00723957|16222247|P1|Overall Study|Adverse event unrelated to study drug|1
4706770|NCT02214225|16222307|P3|Overall Study|randomized in error, not vaccinated|1
4706771|NCT02214225|16222308|P2|Overall Study|randomized in error, not vaccinated|1
4706772|NCT02214225|16222309|P1|Overall Study|randomized in error, not vaccinated|2
4706773|NCT02214225|16222307|P3|Overall Study|Death|1
4706774|NCT02214225|16222308|P2|Overall Study|Death|0
4706775|NCT02214225|16222309|P1|Overall Study|Death|5
4706776|NCT02214225|16222307|P3|Overall Study|Withdrawal by Subject|2
4706777|NCT02214225|16222308|P2|Overall Study|Withdrawal by Subject|0
4706778|NCT02214225|16222309|P1|Overall Study|Withdrawal by Subject|2
4706779|NCT02214225|16222307|P3|Overall Study|Lost to Follow-up|18
4706780|NCT02214225|16222308|P2|Overall Study|Lost to Follow-up|18
4706781|NCT02214225|16222309|P1|Overall Study|Lost to Follow-up|46
4706782|NCT02214186|16222368|P2|Overall Study|Protocol Violation|1
4706783|NCT02214186|16222369|P1|Overall Study|Protocol Violation|1
4706784|NCT02214186|16222368|P2|Overall Study|Lost to Follow-up|1
4706785|NCT02214186|16222369|P1|Overall Study|Lost to Follow-up|1
4706786|NCT02214121|16222437|P3|Part B|Lost to Follow-up|1
4706787|NCT02214121|16222438|P2|Part B|Lost to Follow-up|0
4706788|NCT02214121|16222439|P1|Part B|Lost to Follow-up|0
4706789|NCT02214121|16222437|P3|Part B|Dev. of study-specific withdrawal crit.|0
4706790|NCT02214121|16222438|P2|Part B|Dev. of study-specific withdrawal crit.|2
4706791|NCT02214121|16222439|P1|Part B|Dev. of study-specific withdrawal crit.|0
4706792|NCT02214121|16222437|P3|Part B|Patient decision|0
4706793|NCT02214121|16222438|P2|Part B|Patient decision|1
4706794|NCT02214121|16222439|P1|Part B|Patient decision|0
4706795|NCT02214121|16222437|P3|Part A|Other|0
4706796|NCT02214121|16222438|P2|Part A|Other|0
4706797|NCT02214121|16222439|P1|Part A|Other|1
4706798|NCT02214121|16222437|P3|Part A|Dev. of study-specific withdrawal crit.|0
4706799|NCT02214121|16222438|P2|Part A|Dev. of study-specific withdrawal crit.|0
4706800|NCT02214121|16222439|P1|Part A|Dev. of study-specific withdrawal crit.|4
4706801|NCT02214121|16222437|P3|Part A|Patient decision|0
4706802|NCT02214121|16222438|P2|Part A|Patient decision|0
4706803|NCT02214121|16222439|P1|Part A|Patient decision|2
4706804|NCT02213666|16222548|P1|Overall Study|Withdrawal by Subject|1
4706805|NCT02213510|16222554|P2|Overall Study|Lost to Follow-up|0
4706806|NCT02213510|16222555|P1|Overall Study|Lost to Follow-up|1
4706807|NCT02213510|16222554|P2|Overall Study|Death|1
4706808|NCT02213510|16222555|P1|Overall Study|Death|0
4706809|NCT02213263|16222583|P2|Overall Study|Adverse Event|3
4706810|NCT02213263|16222584|P1|Overall Study|Adverse Event|1
4706811|NCT02213263|16222583|P2|Overall Study|Protocol Violation|1
4706812|NCT02213263|16222584|P1|Overall Study|Protocol Violation|0
4706813|NCT02213263|16222583|P2|Overall Study|Progressive disease|14
4706814|NCT02213263|16222584|P1|Overall Study|Progressive disease|20
4706815|NCT02213263|16222583|P2|Overall Study|No longer willing to participate|4
4706816|NCT02213263|16222584|P1|Overall Study|No longer willing to participate|3
4706817|NCT02213263|16222583|P2|Overall Study|Lost to Follow-up|1
4706818|NCT02213263|16222584|P1|Overall Study|Lost to Follow-up|0
4706819|NCT02213263|16222583|P2|Overall Study|Insufficient clinical response|3
4706820|NCT02213263|16222584|P1|Overall Study|Insufficient clinical response|4
4706821|NCT02213198|16222652|P2|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7
4706822|NCT02213198|16222653|P1|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23
4706823|NCT02213198|16222652|P2|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10
4706824|NCT02213198|16222653|P1|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17
4706825|NCT02213198|16222652|P2|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25
4706826|NCT02213198|16222653|P1|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68
4706827|NCT02213198|16222652|P2|Follow up 1 3 Mos Post BL End of TCC tx|Death|0
4706828|NCT02213198|16222653|P1|Follow up 1 3 Mos Post BL End of TCC tx|Death|1
4706829|NCT02213198|16222652|P2|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2
4706830|NCT02213198|16222653|P1|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3
4706831|NCT02213198|16222652|P2|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
4706832|NCT02213198|16222653|P1|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4
4706833|NCT02213198|16222652|P2|Baseline|incarcerated,violent|1
4706834|NCT02213198|16222653|P1|Baseline|incarcerated,violent|0
4706835|NCT02213198|16222652|P2|Baseline|Lost to Follow-up|21
4706836|NCT02213198|16222653|P1|Baseline|Lost to Follow-up|40
4706837|NCT02213198|16222652|P2|Baseline|transferred out of clinic|9
4706838|NCT02213198|16222653|P1|Baseline|transferred out of clinic|7
4706839|NCT02213198|16222652|P2|Baseline|Withdrawal by Subject|11
4706840|NCT02213198|16222653|P1|Baseline|Withdrawal by Subject|34
4706841|NCT02213198|16222652|P2|Baseline|No show for intake|9
4706842|NCT02213198|16222653|P1|Baseline|No show for intake|7
4706843|NCT02213094|16222663|P2|Overall Study|Adverse Event|0
4706844|NCT02213094|16222664|P1|Overall Study|Adverse Event|1
4706845|NCT02213055|16222672|P2|Overall Study|Did not Return to School|0
4706846|NCT02213055|16222673|P1|Overall Study|Did not Return to School|5
4706847|NCT02213055|16222672|P2|Overall Study|Did not meet Inclusion Criteria|0
4706848|NCT02213055|16222673|P1|Overall Study|Did not meet Inclusion Criteria|6
4706849|NCT02213055|16222672|P2|Overall Study|Had another Treatment during the Study|0
4706850|NCT02213055|16222673|P1|Overall Study|Had another Treatment during the Study|3
4706851|NCT02213055|16222672|P2|Overall Study|Did not have Live Lice|0
4706852|NCT02213055|16222673|P1|Overall Study|Did not have Live Lice|8
4706853|NCT02213055|16222672|P2|Overall Study|Documentation Issue during Study|0
4706854|NCT02213055|16222673|P1|Overall Study|Documentation Issue during Study|10
4706855|NCT02213055|16222672|P2|Overall Study|Documentation Issue at Enrollment|0
4706856|NCT02213055|16222673|P1|Overall Study|Documentation Issue at Enrollment|1
4706857|NCT02213055|16222672|P2|Overall Study|Protocol was not Followed during Study|0
4706858|NCT02213055|16222673|P1|Overall Study|Protocol was not Followed during Study|1
4706859|NCT02213055|16222672|P2|Overall Study|Protocol was not Followed at Enrollment|0
4706860|NCT02213055|16222673|P1|Overall Study|Protocol was not Followed at Enrollment|5
4706861|NCT02212730|16222707|P2|Overall Study|Disease progression prior to RCC surgery|1
4706862|NCT02212730|16222708|P1|Overall Study|Disease progression prior to RCC surgery|0
4706863|NCT02212730|16222707|P2|Overall Study|Withdrawal by Subject|0
4706864|NCT02212730|16222708|P1|Overall Study|Withdrawal by Subject|1
4706865|NCT02212730|16222707|P2|Overall Study|Tumor not of the required cell histology|0
4706866|NCT02212730|16222708|P1|Overall Study|Tumor not of the required cell histology|1
4706867|NCT02212678|16222730|P1|Overall Study|Adverse Event|1
4706868|NCT02212457|16222740|P6|Overall Study|Other|1
4706869|NCT02212457|16222741|P5|Overall Study|Other|0
4706870|NCT02212457|16222742|P4|Overall Study|Other|1
4706871|NCT02212457|16222743|P3|Overall Study|Other|2
4706872|NCT02212457|16222744|P2|Overall Study|Other|1
4706873|NCT02212457|16222745|P1|Overall Study|Other|2
4706874|NCT02212457|16222740|P6|Overall Study|Protocol Violation|3
4706875|NCT02212457|16222741|P5|Overall Study|Protocol Violation|2
4706876|NCT02212457|16222742|P4|Overall Study|Protocol Violation|1
4706877|NCT02212457|16222743|P3|Overall Study|Protocol Violation|0
4706878|NCT02212457|16222744|P2|Overall Study|Protocol Violation|1
4706879|NCT02212457|16222745|P1|Overall Study|Protocol Violation|2
4706880|NCT02212457|16222740|P6|Overall Study|Lost to Follow-up|4
4706881|NCT02212457|16222741|P5|Overall Study|Lost to Follow-up|8
4706882|NCT02212457|16222742|P4|Overall Study|Lost to Follow-up|1
4706883|NCT02212457|16222743|P3|Overall Study|Lost to Follow-up|4
4706884|NCT02212457|16222744|P2|Overall Study|Lost to Follow-up|7
4706885|NCT02212457|16222745|P1|Overall Study|Lost to Follow-up|6
4706886|NCT02212457|16222740|P6|Overall Study|Withdrawal by Subject|4
4706887|NCT02212457|16222741|P5|Overall Study|Withdrawal by Subject|5
4706888|NCT02212457|16222742|P4|Overall Study|Withdrawal by Subject|6
4706889|NCT02212457|16222743|P3|Overall Study|Withdrawal by Subject|8
4706890|NCT02212457|16222744|P2|Overall Study|Withdrawal by Subject|10
4706891|NCT02212457|16222745|P1|Overall Study|Withdrawal by Subject|8
4706892|NCT02212457|16222740|P6|Overall Study|Adverse Event|1
4706893|NCT02212457|16222741|P5|Overall Study|Adverse Event|0
4706894|NCT02212457|16222742|P4|Overall Study|Adverse Event|2
4706895|NCT02212457|16222743|P3|Overall Study|Adverse Event|2
4706896|NCT02212457|16222744|P2|Overall Study|Adverse Event|2
4706897|NCT02212457|16222745|P1|Overall Study|Adverse Event|1
4706898|NCT02212301|16222898|P2|Period 1|Lost to Follow-up|1
4706899|NCT02212301|16222899|P1|Period 1|Lost to Follow-up|0
4706900|NCT02212197|16222910|P3|Overall Study|Need for radiotherapy|0
4706901|NCT02212197|16222911|P2|Overall Study|Need for radiotherapy|0
4706902|NCT02212197|16222912|P1|Overall Study|Need for radiotherapy|1
4706903|NCT02211638|16222965|P1|Overall Study|Protocol Violation|692
4706904|NCT02211638|16222965|P1|Overall Study|Case Report Forms Uncollected|291
4706905|NCT02211313|16222999|P2|Overall Study|No Follow up Questionnaires|1
4706906|NCT02211313|16223000|P1|Overall Study|No Follow up Questionnaires|1
4706907|NCT02211313|16222999|P2|Overall Study|Treatment Failure|2
4706908|NCT02211313|16223000|P1|Overall Study|Treatment Failure|5
4706909|NCT02211261|16223017|P11|Overall Study|Lost to Follow-up|0
4706910|NCT02211261|16223018|P10|Overall Study|Lost to Follow-up|0
4706911|NCT02211261|16223019|P9|Overall Study|Lost to Follow-up|0
4706912|NCT02211261|16223020|P8|Overall Study|Lost to Follow-up|1
4706913|NCT02211261|16223021|P7|Overall Study|Lost to Follow-up|0
4706914|NCT02211261|16223022|P6|Overall Study|Lost to Follow-up|0
4706915|NCT02211261|16223023|P5|Overall Study|Lost to Follow-up|0
4706916|NCT02211261|16223024|P4|Overall Study|Lost to Follow-up|0
4706917|NCT02211261|16223025|P3|Overall Study|Lost to Follow-up|0
4706918|NCT02211261|16223026|P2|Overall Study|Lost to Follow-up|0
4706919|NCT02211261|16223027|P1|Overall Study|Lost to Follow-up|0
4706920|NCT02211261|16223017|P11|Overall Study|Other|0
4706921|NCT02211261|16223018|P10|Overall Study|Other|2
4706922|NCT02211261|16223019|P9|Overall Study|Other|0
4706923|NCT02211261|16223020|P8|Overall Study|Other|0
4706924|NCT02211261|16223021|P7|Overall Study|Other|0
4706925|NCT02211261|16223022|P6|Overall Study|Other|1
4706926|NCT02211261|16223023|P5|Overall Study|Other|0
4706927|NCT02211261|16223024|P4|Overall Study|Other|0
4706928|NCT02211261|16223025|P3|Overall Study|Other|0
4706929|NCT02211261|16223026|P2|Overall Study|Other|0
4706930|NCT02211261|16223027|P1|Overall Study|Other|0
4706931|NCT02211261|16223017|P11|Overall Study|Withdrawal by Subject|0
4706932|NCT02211261|16223018|P10|Overall Study|Withdrawal by Subject|0
4706933|NCT02211261|16223019|P9|Overall Study|Withdrawal by Subject|0
4706934|NCT02211261|16223020|P8|Overall Study|Withdrawal by Subject|0
4706935|NCT02211261|16223021|P7|Overall Study|Withdrawal by Subject|0
4706936|NCT02211261|16223022|P6|Overall Study|Withdrawal by Subject|0
4706937|NCT02211261|16223023|P5|Overall Study|Withdrawal by Subject|2
4706938|NCT02211261|16223024|P4|Overall Study|Withdrawal by Subject|0
4706939|NCT02211261|16223025|P3|Overall Study|Withdrawal by Subject|1
4706940|NCT02211261|16223026|P2|Overall Study|Withdrawal by Subject|0
4706941|NCT02211261|16223027|P1|Overall Study|Withdrawal by Subject|0
4706942|NCT02211131|16223150|P2|Overall Study|Continuing on Study|60
4706943|NCT02211131|16223151|P1|Overall Study|Continuing on Study|49
4706944|NCT02211131|16223150|P2|Overall Study|Withdrawal by Subject|4
4706945|NCT02211131|16223151|P1|Overall Study|Withdrawal by Subject|3
4706946|NCT02211131|16223150|P2|Overall Study|Decision by Sponsor|1
4706947|NCT02211131|16223151|P1|Overall Study|Decision by Sponsor|1
4706948|NCT02211131|16223150|P2|Overall Study|Lost to Follow-up|0
4706949|NCT02211131|16223151|P1|Overall Study|Lost to Follow-up|1
4706950|NCT02211131|16223150|P2|Overall Study|Death|11
4706951|NCT02211131|16223151|P1|Overall Study|Death|20
4706952|NCT02211014|16223185|P2|Overall Study|In agreement with patient, no benefit|1
4706953|NCT02211014|16223186|P1|Overall Study|In agreement with patient, no benefit|0
4706954|NCT02211014|16223185|P2|Overall Study|Withdrawal by Subject|1
4706955|NCT02211014|16223186|P1|Overall Study|Withdrawal by Subject|0
4706956|NCT02211014|16223185|P2|Overall Study|Started another cancer therapy|0
4706957|NCT02211014|16223186|P1|Overall Study|Started another cancer therapy|1
4706958|NCT02211014|16223185|P2|Overall Study|Physician Decision|2
4706959|NCT02211014|16223186|P1|Overall Study|Physician Decision|1
4706960|NCT02211014|16223185|P2|Overall Study|Adverse Event|2
4706961|NCT02211014|16223186|P1|Overall Study|Adverse Event|0
4706962|NCT00597012|16223212|P2|Overall Study|Lost to Follow-up|2
4706963|NCT00597012|16223213|P1|Overall Study|Lost to Follow-up|0
4706964|NCT00597012|16223212|P2|Overall Study|Ineligible|0
4706965|NCT00597012|16223213|P1|Overall Study|Ineligible|2
4706966|NCT00597012|16223212|P2|Overall Study|Withdrawal by Subject|4
4706967|NCT00597012|16223213|P1|Overall Study|Withdrawal by Subject|7
4706968|NCT00597012|16223212|P2|Overall Study|Underwent Total Knee Replacement (TKR)|1
4706969|NCT00597012|16223213|P1|Overall Study|Underwent Total Knee Replacement (TKR)|3
4706970|NCT00597012|16223212|P2|Overall Study|Death|1
4706971|NCT00597012|16223213|P1|Overall Study|Death|1
4706972|NCT02210780|16223229|P2|Overall Study|Other than specified above|1
4706973|NCT02210780|16223230|P1|Overall Study|Other than specified above|0
4706974|NCT02210780|16223229|P2|Overall Study|Protocol Violation|0
4706975|NCT02210780|16223230|P1|Overall Study|Protocol Violation|1
4706976|NCT02210780|16223229|P2|Overall Study|Physician Decision|0
4706977|NCT02210780|16223230|P1|Overall Study|Physician Decision|1
4706978|NCT02210780|16223229|P2|Overall Study|Withdrawal by Subject|1
4706979|NCT02210780|16223230|P1|Overall Study|Withdrawal by Subject|1
4706980|NCT02210780|16223229|P2|Overall Study|Lost to Follow-up|1
4706981|NCT02210780|16223230|P1|Overall Study|Lost to Follow-up|2
4706982|NCT02210780|16223229|P2|Overall Study|Adverse Event|5
4706983|NCT02210780|16223230|P1|Overall Study|Adverse Event|0
4706984|NCT02210689|16223259|P3|Overall Study|Other|8
4706985|NCT02210689|16223260|P2|Overall Study|Other|21
4706986|NCT02210689|16223261|P1|Overall Study|Other|25
4706987|NCT02210689|16223259|P3|Overall Study|Negative Nugent score at baseline|2
4706988|NCT02210689|16223260|P2|Overall Study|Negative Nugent score at baseline|2
4706989|NCT02210689|16223261|P1|Overall Study|Negative Nugent score at baseline|6
4706990|NCT02210689|16223259|P3|Overall Study|Prohibited medication|1
4706991|NCT02210689|16223260|P2|Overall Study|Prohibited medication|8
4706992|NCT02210689|16223261|P1|Overall Study|Prohibited medication|2
4706993|NCT02210689|16223259|P3|Overall Study|Lack of Efficacy|5
4706994|NCT02210689|16223260|P2|Overall Study|Lack of Efficacy|1
4706995|NCT02210689|16223261|P1|Overall Study|Lack of Efficacy|0
4706996|NCT02210689|16223259|P3|Overall Study|Pregnancy|0
4706997|NCT02210689|16223260|P2|Overall Study|Pregnancy|1
4706998|NCT02210689|16223261|P1|Overall Study|Pregnancy|0
4706999|NCT02210689|16223259|P3|Overall Study|Lost to Follow-up|5
4707000|NCT02210689|16223260|P2|Overall Study|Lost to Follow-up|9
4707001|NCT02210689|16223261|P1|Overall Study|Lost to Follow-up|11
4707002|NCT02210689|16223259|P3|Overall Study|Protocol Violation|0
4707003|NCT02210689|16223260|P2|Overall Study|Protocol Violation|0
4707004|NCT02210689|16223261|P1|Overall Study|Protocol Violation|1
4707005|NCT02210689|16223259|P3|Overall Study|Adverse Event|0
4707006|NCT02210689|16223260|P2|Overall Study|Adverse Event|1
4707007|NCT02210689|16223261|P1|Overall Study|Adverse Event|0
4707008|NCT02210689|16223259|P3|Overall Study|Withdrawal by Subject|2
4707009|NCT02210689|16223260|P2|Overall Study|Withdrawal by Subject|4
4707010|NCT02210689|16223261|P1|Overall Study|Withdrawal by Subject|7
4707011|NCT02210221|16223269|P1|Overall Study|Withdrawal by Subject|43
4707012|NCT02210221|16223269|P1|Overall Study|Lack of Efficacy|7
4707013|NCT02210208|16223275|P1|Period B (Donor Site)|7 subjects healed at or before Day 14|7
4707014|NCT02210208|16223275|P1|Period A (Graft Site)|Physician decided not to graft at OR|1
4707015|NCT02210208|16223275|P1|Period A (Graft Site)|Withdrawal by Subject|1
4707016|NCT02210091|16223295|P2|Overall Study|Withdrawal by Sponsor|1
4707017|NCT02210091|16223296|P1|Overall Study|Withdrawal by Sponsor|0
4707018|NCT02210091|16223295|P2|Overall Study|Physician Decision|1
4707019|NCT02210091|16223296|P1|Overall Study|Physician Decision|0
4707020|NCT02210000|16223383|P2|Overall Study|Physician Decision|1
4707021|NCT02210000|16223384|P1|Overall Study|Physician Decision|0
4707022|NCT02210000|16223383|P2|Overall Study|Lost to Follow-up|2
4707023|NCT02210000|16223384|P1|Overall Study|Lost to Follow-up|0
4707024|NCT02210000|16223383|P2|Overall Study|Adverse Event|5
4707025|NCT02210000|16223384|P1|Overall Study|Adverse Event|1
4707026|NCT02210000|16223383|P2|Overall Study|Withdrawal by Subject|1
4707027|NCT02210000|16223384|P1|Overall Study|Withdrawal by Subject|7
4707028|NCT02210000|16223383|P2|Overall Study|Study Terminated|12
4707029|NCT02210000|16223384|P1|Overall Study|Study Terminated|11
4707030|NCT02209766|16223410|P5|Overall Study|Withdrawal by Subject|0
4707031|NCT02209766|16223411|P4|Overall Study|Withdrawal by Subject|1
4707032|NCT02209766|16223412|P3|Overall Study|Withdrawal by Subject|0
4707033|NCT02209766|16223413|P2|Overall Study|Withdrawal by Subject|0
4707034|NCT02209766|16223414|P1|Overall Study|Withdrawal by Subject|0
4707035|NCT02209597|16223473|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1
4707036|NCT02209597|16223473|P1|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3
4707037|NCT02209597|16223473|P1|Phase 1 Current Tx (Non-randomized)|Adverse Event|1
4707038|NCT02209597|16223473|P1|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2
4707039|NCT02209506|16223518|P5|Overall Study|Withdrawal by Subject|1
4707040|NCT02209506|16223519|P4|Overall Study|Withdrawal by Subject|0
4707041|NCT02209506|16223520|P3|Overall Study|Withdrawal by Subject|0
4707042|NCT02209506|16223521|P2|Overall Study|Withdrawal by Subject|0
4707043|NCT02209506|16223522|P1|Overall Study|Withdrawal by Subject|0
4707044|NCT02209454|16223597|P2|Second Period|Adverse Event|0
4707045|NCT02209454|16223598|P1|Second Period|Adverse Event|1
4707046|NCT02209181|16223648|P4|Overall Study|Withdrawal by Subject|0
4707047|NCT02209181|16223649|P3|Overall Study|Withdrawal by Subject|0
4707048|NCT02209181|16223650|P2|Overall Study|Withdrawal by Subject|1
4707049|NCT02209181|16223651|P1|Overall Study|Withdrawal by Subject|0
4707050|NCT02209181|16223648|P4|Overall Study|Adverse Event|0
4707051|NCT02209181|16223649|P3|Overall Study|Adverse Event|1
4707052|NCT02209181|16223650|P2|Overall Study|Adverse Event|0
4707053|NCT02209181|16223651|P1|Overall Study|Adverse Event|1
4707054|NCT02208999|16223822|P1|Overall Study|Lost to Follow-up|1
4707055|NCT02208843|16223844|P1|Overall Study|Switched to commercial afatinib|20
4707056|NCT02208843|16223844|P1|Overall Study|Withdrawal by Subject|1
4707057|NCT02208843|16223844|P1|Overall Study|Protocol Violation|1
4707058|NCT02208843|16223844|P1|Overall Study|Adverse Event|12
4707059|NCT02208843|16223844|P1|Overall Study|Progression disease according to RECIST|24
4707060|NCT02208843|16223844|P1|Overall Study|Clinical symptoms of progression|2
4707061|NCT02208089|16223915|P2|Overall Study|Lost to Follow-up|0
4707062|NCT02208089|16223916|P1|Overall Study|Lost to Follow-up|6
4707063|NCT02208089|16223915|P2|Overall Study|Withdrawal by Subject|0
4707064|NCT02208089|16223916|P1|Overall Study|Withdrawal by Subject|1
4707065|NCT02208063|16223932|P2|Overall Study|Lost to Follow-up|0
4707066|NCT02208063|16223933|P1|Overall Study|Lost to Follow-up|1
4707067|NCT02208063|16223932|P2|Overall Study|Withdrawal by Subject|2
4707068|NCT02208063|16223933|P1|Overall Study|Withdrawal by Subject|5
4707069|NCT02208063|16223932|P2|Overall Study|Not Specified in report|4
4707070|NCT02208063|16223933|P1|Overall Study|Not Specified in report|3
4707071|NCT02208063|16223932|P2|Overall Study|Death|5
4707072|NCT02208063|16223933|P1|Overall Study|Death|3
4707073|NCT02207907|16224021|P2|Overall Study|Pregnancy|1
4707074|NCT02207907|16224022|P1|Overall Study|Pregnancy|0
4707075|NCT02207907|16224021|P2|Overall Study|Did not meet study criteria|0
4707076|NCT02207907|16224022|P1|Overall Study|Did not meet study criteria|3
4707077|NCT02207907|16224021|P2|Overall Study|Withdrawal by Subject|6
4707078|NCT02207907|16224022|P1|Overall Study|Withdrawal by Subject|5
4707079|NCT02207907|16224021|P2|Overall Study|Lost to Follow-up|1
4707080|NCT02207907|16224022|P1|Overall Study|Lost to Follow-up|3
4707081|NCT02207829|16224040|P2|Overall Study|Withdrew consent|14
4707082|NCT02207829|16224041|P1|Overall Study|Withdrew consent|18
4707083|NCT02207829|16224040|P2|Overall Study|Protocol deviation|4
4707084|NCT02207829|16224041|P1|Overall Study|Protocol deviation|5
4707085|NCT02207829|16224040|P2|Overall Study|Lost to Follow-up|2
4707086|NCT02207829|16224041|P1|Overall Study|Lost to Follow-up|2
4707087|NCT02207829|16224040|P2|Overall Study|Lack of Efficacy|5
4707088|NCT02207829|16224041|P1|Overall Study|Lack of Efficacy|7
4707089|NCT02207829|16224040|P2|Overall Study|Adverse Event|9
4707090|NCT02207829|16224041|P1|Overall Study|Adverse Event|10
4707091|NCT02207816|16224050|P3|Overall Study|Other|4
4707092|NCT02207816|16224051|P2|Overall Study|Other|2
4707093|NCT02207816|16224052|P1|Overall Study|Other|1
4707094|NCT02207816|16224050|P3|Overall Study|Lost to Follow-up|1
4707095|NCT02207816|16224051|P2|Overall Study|Lost to Follow-up|9
4707096|NCT02207816|16224052|P1|Overall Study|Lost to Follow-up|3
4707097|NCT02207816|16224050|P3|Overall Study|Migrated/Moved From Study Area|51
4707098|NCT02207816|16224051|P2|Overall Study|Migrated/Moved From Study Area|60
4707099|NCT02207816|16224052|P1|Overall Study|Migrated/Moved From Study Area|41
4707100|NCT02207816|16224050|P3|Overall Study|Withdrawal by Subject|7
4707101|NCT02207816|16224051|P2|Overall Study|Withdrawal by Subject|9
4707102|NCT02207816|16224052|P1|Overall Study|Withdrawal by Subject|4
4707103|NCT02207816|16224050|P3|Overall Study|Eligibility Criteria Not Fulfilled|2
4707104|NCT02207816|16224051|P2|Overall Study|Eligibility Criteria Not Fulfilled|1
4707105|NCT02207816|16224052|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
4707106|NCT02207816|16224050|P3|Overall Study|Serious Adverse Event|2
4707107|NCT02207816|16224051|P2|Overall Study|Serious Adverse Event|5
4707108|NCT02207816|16224052|P1|Overall Study|Serious Adverse Event|0
4707109|NCT02207725|16224210|P4|Overall Study|Did Not Receive Treatment|1
4707110|NCT02207725|16224211|P3|Overall Study|Did Not Receive Treatment|1
4707111|NCT02207725|16224212|P2|Overall Study|Did Not Receive Treatment|1
4707112|NCT02207725|16224213|P1|Overall Study|Did Not Receive Treatment|0
4707113|NCT02207634|16224243|P2|Overall Study|Lost to Follow-up|0
4707114|NCT02207634|16224244|P1|Overall Study|Lost to Follow-up|1
4707115|NCT02207634|16224243|P2|Overall Study|Withdrawal by Subject|31
4707116|NCT02207634|16224244|P1|Overall Study|Withdrawal by Subject|21
4707117|NCT02207621|16224259|P3|Overall Study|Other(Site,Sponsor and Subject request)|5
4707118|NCT02207621|16224260|P2|Overall Study|Other(Site,Sponsor and Subject request)|1
4707119|NCT02207621|16224261|P1|Overall Study|Other(Site,Sponsor and Subject request)|2
4707120|NCT02207621|16224259|P3|Overall Study|Death|0
4707121|NCT02207621|16224260|P2|Overall Study|Death|0
4707122|NCT02207621|16224261|P1|Overall Study|Death|2
4707123|NCT02207621|16224259|P3|Overall Study|Protocol Violation|6
4707124|NCT02207621|16224260|P2|Overall Study|Protocol Violation|10
4707125|NCT02207621|16224261|P1|Overall Study|Protocol Violation|4
4707126|NCT02207621|16224259|P3|Overall Study|Physician Decision|2
4707127|NCT02207621|16224260|P2|Overall Study|Physician Decision|2
4707128|NCT02207621|16224261|P1|Overall Study|Physician Decision|1
4707129|NCT02207621|16224259|P3|Overall Study|Disallowed Concurrent Medication|2
4707130|NCT02207621|16224260|P2|Overall Study|Disallowed Concurrent Medication|5
4707131|NCT02207621|16224261|P1|Overall Study|Disallowed Concurrent Medication|2
4707132|NCT02207621|16224259|P3|Overall Study|Lack of Efficacy|4
4707133|NCT02207621|16224260|P2|Overall Study|Lack of Efficacy|2
4707134|NCT02207621|16224261|P1|Overall Study|Lack of Efficacy|10
4707135|NCT02207621|16224259|P3|Overall Study|Lost to Follow-up|3
4707136|NCT02207621|16224260|P2|Overall Study|Lost to Follow-up|0
4707137|NCT02207621|16224261|P1|Overall Study|Lost to Follow-up|1
4707138|NCT02207621|16224259|P3|Overall Study|Non-Compliant|1
4707139|NCT02207621|16224260|P2|Overall Study|Non-Compliant|3
4707140|NCT02207621|16224261|P1|Overall Study|Non-Compliant|3
4707141|NCT02207621|16224259|P3|Overall Study|Withdrawal by Subject|13
4707142|NCT02207621|16224260|P2|Overall Study|Withdrawal by Subject|9
4707143|NCT02207621|16224261|P1|Overall Study|Withdrawal by Subject|9
4707144|NCT02207621|16224259|P3|Overall Study|Adverse Event|132
4707145|NCT02207621|16224260|P2|Overall Study|Adverse Event|15
4707146|NCT02207621|16224261|P1|Overall Study|Adverse Event|71
4707147|NCT02207608|16224274|P2|Overall Study|Adverse Event|0
4707148|NCT02207608|16224275|P1|Overall Study|Adverse Event|1
4707149|NCT02207556|16224301|P2|Overall Study|Death|5
4707150|NCT02207556|16224302|P1|Overall Study|Death|0
4707151|NCT02207556|16224301|P2|Overall Study|Withdrawal by Subject|0
4707152|NCT02207556|16224302|P1|Overall Study|Withdrawal by Subject|1
4707153|NCT02207556|16224301|P2|Overall Study|Physician Decision|0
4707154|NCT02207556|16224302|P1|Overall Study|Physician Decision|1
4707155|NCT02207530|16224307|P1|Overall Study|Adverse Event|8
4707156|NCT02207530|16224307|P1|Overall Study|Patient decision to stop study treatment|5
4707157|NCT02207530|16224307|P1|Overall Study|Worsening condition under investigation|78
4707158|NCT02207491|16224321|P2|Overall Study|Protocol Violation|5
4707159|NCT02207491|16224322|P1|Overall Study|Protocol Violation|3
4707160|NCT02207491|16224321|P2|Overall Study|Physician Decision|0
4707161|NCT02207491|16224322|P1|Overall Study|Physician Decision|2
4707162|NCT02207491|16224321|P2|Overall Study|Lack of Efficacy|0
4707163|NCT02207491|16224322|P1|Overall Study|Lack of Efficacy|3
4707164|NCT02207491|16224321|P2|Overall Study|Lost to Follow-up|1
4707165|NCT02207491|16224322|P1|Overall Study|Lost to Follow-up|0
4707166|NCT02207491|16224321|P2|Overall Study|Non-compliant|1
4707167|NCT02207491|16224322|P1|Overall Study|Non-compliant|0
4707168|NCT02207491|16224321|P2|Overall Study|Withdrawal by Subject|2
4707169|NCT02207491|16224322|P1|Overall Study|Withdrawal by Subject|3
4707170|NCT02207491|16224321|P2|Overall Study|Adverse Event|4
4707171|NCT02207491|16224322|P1|Overall Study|Adverse Event|20
4707172|NCT02207413|16224347|P6|Overall Study|Migrated/moved from study area|0
4707173|NCT02207413|16224348|P5|Overall Study|Migrated/moved from study area|1
4707174|NCT02207413|16224349|P4|Overall Study|Migrated/moved from study area|0
4707175|NCT02207413|16224350|P3|Overall Study|Migrated/moved from study area|0
4707176|NCT02207413|16224351|P2|Overall Study|Migrated/moved from study area|0
4707177|NCT02207413|16224352|P1|Overall Study|Migrated/moved from study area|0
4707178|NCT02207413|16224347|P6|Overall Study|Adverse Event|1
4707179|NCT02207413|16224348|P5|Overall Study|Adverse Event|2
4707180|NCT02207413|16224349|P4|Overall Study|Adverse Event|0
4707181|NCT02207413|16224350|P3|Overall Study|Adverse Event|0
4707182|NCT02207413|16224351|P2|Overall Study|Adverse Event|0
4707183|NCT02207413|16224352|P1|Overall Study|Adverse Event|0
4707184|NCT02207413|16224347|P6|Overall Study|Lost to Follow-up|5
4707185|NCT02207413|16224348|P5|Overall Study|Lost to Follow-up|1
4707186|NCT02207413|16224349|P4|Overall Study|Lost to Follow-up|1
4707187|NCT02207413|16224350|P3|Overall Study|Lost to Follow-up|0
4707188|NCT02207413|16224351|P2|Overall Study|Lost to Follow-up|0
4707189|NCT02207413|16224352|P1|Overall Study|Lost to Follow-up|0
4707190|NCT02207413|16224347|P6|Overall Study|Withdrawal by Subject|7
4707191|NCT02207413|16224348|P5|Overall Study|Withdrawal by Subject|3
4707192|NCT02207413|16224349|P4|Overall Study|Withdrawal by Subject|0
4707193|NCT02207413|16224350|P3|Overall Study|Withdrawal by Subject|0
4707194|NCT02207413|16224351|P2|Overall Study|Withdrawal by Subject|0
4707195|NCT02207413|16224352|P1|Overall Study|Withdrawal by Subject|1
4707196|NCT02207400|16224448|P2|Overall Study|Positive Urine Pregnancy Test|1
4707197|NCT02207400|16224449|P1|Overall Study|Positive Urine Pregnancy Test|0
4707198|NCT02207400|16224448|P2|Overall Study|Withdrawal by Subject|4
4707199|NCT02207400|16224449|P1|Overall Study|Withdrawal by Subject|8
4707200|NCT02207400|16224448|P2|Overall Study|Protocol Violation|1
4707201|NCT02207400|16224449|P1|Overall Study|Protocol Violation|1
4707202|NCT02207400|16224448|P2|Overall Study|Lost to Follow-up|7
4707203|NCT02207400|16224449|P1|Overall Study|Lost to Follow-up|6
4707204|NCT02207400|16224448|P2|Overall Study|Adverse Event|1
4707205|NCT02207400|16224449|P1|Overall Study|Adverse Event|1
4707206|NCT02207374|16224470|P3|Overall Study|Missing follow-up information|1
4707207|NCT02207374|16224471|P2|Overall Study|Missing follow-up information|1
4707208|NCT02207374|16224472|P1|Overall Study|Missing follow-up information|0
4707209|NCT02207374|16224470|P3|Overall Study|Death|1
4707210|NCT02207374|16224471|P2|Overall Study|Death|0
4707211|NCT02207374|16224472|P1|Overall Study|Death|1
4707212|NCT02207374|16224470|P3|Overall Study|Withdrawal by Subject|4
4707213|NCT02207374|16224471|P2|Overall Study|Withdrawal by Subject|9
4707214|NCT02207374|16224472|P1|Overall Study|Withdrawal by Subject|5
4707215|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Other|0
4707216|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Other|1
4707217|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Other|0
4707218|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Other|0
4707219|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Other|0
4707220|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Other|0
4707221|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Other|0
4707222|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Other|0
4707223|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Other|0
4707224|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707225|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707226|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Non-compliance|1
4707227|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707228|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707229|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707230|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707231|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707232|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Non-compliance|0
4707233|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707234|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707235|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|1
4707236|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707237|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707238|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707239|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707240|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707241|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Protocol Violation|0
4707242|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
4707243|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|2
4707244|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|1
4707245|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
4707246|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
4707247|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
4707248|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
4707249|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
4707250|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Withdrawal by Subject|0
4707251|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
4707252|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|5
4707253|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|2
4707254|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
4707255|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
4707256|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
4707257|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
4707258|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
4707259|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Lost to Follow-up|0
4707260|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
4707261|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|2
4707262|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707263|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707264|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707265|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707266|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707267|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707268|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Lack of Efficacy|0
4707269|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707270|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Pregnancy|2
4707271|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707272|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707273|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707274|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707275|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707276|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707277|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Pregnancy|0
4707278|NCT02207244|16224536|P9|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
4707279|NCT02207244|16224537|P8|Withdrawal, Retreatment Period:Week28-48|Adverse Event|1
4707280|NCT02207244|16224538|P7|Withdrawal, Retreatment Period:Week28-48|Adverse Event|3
4707281|NCT02207244|16224539|P6|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
4707282|NCT02207244|16224540|P5|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
4707283|NCT02207244|16224541|P4|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
4707284|NCT02207244|16224542|P3|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
4707285|NCT02207244|16224543|P2|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
4707286|NCT02207244|16224544|P1|Withdrawal, Retreatment Period:Week28-48|Adverse Event|0
4707287|NCT02207244|16224536|P9|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707288|NCT02207244|16224537|P8|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707289|NCT02207244|16224538|P7|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707290|NCT02207244|16224539|P6|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707291|NCT02207244|16224540|P5|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707292|NCT02207244|16224541|P4|Placebo Crossover and ACP: Week 16 - 28|Other|1
4707293|NCT02207244|16224542|P3|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707294|NCT02207244|16224543|P2|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707295|NCT02207244|16224544|P1|Placebo Crossover and ACP: Week 16 - 28|Other|0
4707296|NCT02207244|16224536|P9|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707297|NCT02207244|16224537|P8|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707298|NCT02207244|16224538|P7|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707299|NCT02207244|16224539|P6|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
4707300|NCT02207244|16224540|P5|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707301|NCT02207244|16224541|P4|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|1
4707302|NCT02207244|16224542|P3|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707303|NCT02207244|16224543|P2|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707304|NCT02207244|16224544|P1|Placebo Crossover and ACP: Week 16 - 28|Protocol Violation|0
4707305|NCT02207244|16224536|P9|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
4707306|NCT02207244|16224537|P8|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
4707307|NCT02207244|16224538|P7|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
4707308|NCT02207244|16224539|P6|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|2
4707309|NCT02207244|16224540|P5|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
4707310|NCT02207244|16224541|P4|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|3
4707311|NCT02207244|16224542|P3|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
4707312|NCT02207244|16224543|P2|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
4707313|NCT02207244|16224544|P1|Placebo Crossover and ACP: Week 16 - 28|Withdrawal by Subject|0
4707314|NCT02207244|16224536|P9|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
4707315|NCT02207244|16224537|P8|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
4707316|NCT02207244|16224538|P7|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
4707317|NCT02207244|16224539|P6|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
4707318|NCT02207244|16224540|P5|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|2
4707319|NCT02207244|16224541|P4|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|1
4707320|NCT02207244|16224542|P3|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
4707321|NCT02207244|16224543|P2|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
4707322|NCT02207244|16224544|P1|Placebo Crossover and ACP: Week 16 - 28|Lost to Follow-up|0
4707323|NCT02207244|16224536|P9|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707324|NCT02207244|16224537|P8|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707325|NCT02207244|16224538|P7|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707326|NCT02207244|16224539|P6|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|2
4707327|NCT02207244|16224540|P5|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707328|NCT02207244|16224541|P4|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707329|NCT02207244|16224542|P3|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707330|NCT02207244|16224543|P2|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707331|NCT02207244|16224544|P1|Placebo Crossover and ACP: Week 16 - 28|Lack of Efficacy|0
4707332|NCT02207244|16224536|P9|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707333|NCT02207244|16224537|P8|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707334|NCT02207244|16224538|P7|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707335|NCT02207244|16224539|P6|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|2
4707336|NCT02207244|16224540|P5|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|3
4707337|NCT02207244|16224541|P4|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707338|NCT02207244|16224542|P3|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707339|NCT02207244|16224543|P2|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707340|NCT02207244|16224544|P1|Placebo Crossover and ACP: Week 16 - 28|Adverse Event|0
4707341|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Other|0
4707342|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Other|0
4707343|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Other|0
4707344|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Other|0
4707345|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Other|0
4707346|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Other|0
4707347|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Other|0
4707348|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Other|1
4707349|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Other|0
4707350|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707351|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707352|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707353|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707354|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707355|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707356|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Non-Compliance|2
4707357|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Non-Compliance|1
4707358|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Non-Compliance|0
4707359|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707360|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707361|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707362|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707363|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707364|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707365|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
4707366|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|3
4707367|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
4707368|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707369|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707370|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707371|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707372|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707373|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707374|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707375|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|1
4707376|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|7
4707377|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4707378|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4707379|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4707380|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4707381|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4707382|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0
4707383|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|2
4707384|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|3
4707385|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4707386|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707387|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707388|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707389|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707390|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707391|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707392|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
4707393|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707394|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|4
4707395|NCT02207244|16224536|P9|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4707396|NCT02207244|16224537|P8|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4707397|NCT02207244|16224538|P7|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4707398|NCT02207244|16224539|P6|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4707399|NCT02207244|16224540|P5|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4707400|NCT02207244|16224541|P4|Placebo Controlled Period: Week 0 - 16|Adverse Event|0
4707401|NCT02207244|16224542|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
4707402|NCT02207244|16224543|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|9
4707403|NCT02207244|16224544|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
4707404|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Non-compliance|3
4707405|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Non-compliance|3
4707406|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Non-compliance|0
4707407|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Other|3
4707408|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Other|2
4707409|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Other|0
4707410|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Protocol Violation|0
4707411|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Protocol Violation|1
4707412|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Protocol Violation|0
4707413|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10
4707414|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4
4707415|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1
4707416|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5
4707417|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2
4707418|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1
4707419|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11
4707420|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3
4707421|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0
4707422|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Pregnancy|1
4707423|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Pregnancy|0
4707424|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Pregnancy|0
4707425|NCT02207231|16224585|P3|Active Controlled Period: Week 16 - 48|Adverse Event|9
4707426|NCT02207231|16224586|P2|Active Controlled Period: Week 16 - 48|Adverse Event|6
4707427|NCT02207231|16224587|P1|Active Controlled Period: Week 16 - 48|Adverse Event|1
4707428|NCT02207231|16224585|P3|Placebo Controlled Period: Week 0 - 16|Noncompliance|1
4707429|NCT02207231|16224586|P2|Placebo Controlled Period: Week 0 - 16|Noncompliance|2
4707430|NCT02207231|16224587|P1|Placebo Controlled Period: Week 0 - 16|Noncompliance|0
4707431|NCT02207231|16224585|P3|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1
4707432|NCT02207231|16224586|P2|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707433|NCT02207231|16224587|P1|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0
4707434|NCT02207231|16224585|P3|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4
4707435|NCT02207231|16224586|P2|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0
4707436|NCT02207231|16224587|P1|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2
4707437|NCT02207231|16224585|P3|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4707438|NCT02207231|16224586|P2|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4707439|NCT02207231|16224587|P1|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1
4707440|NCT02207231|16224585|P3|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1
4707441|NCT02207231|16224586|P2|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0
4707442|NCT02207231|16224587|P1|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2
4707443|NCT02207231|16224585|P3|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
4707444|NCT02207231|16224586|P2|Placebo Controlled Period: Week 0 - 16|Adverse Event|4
4707445|NCT02207231|16224587|P1|Placebo Controlled Period: Week 0 - 16|Adverse Event|2
4707446|NCT02207088|16224619|P1|Overall Study|Adverse Event|2
4707447|NCT02206828|16224625|P1|Overall Study|Lost to Follow-up|7
4707448|NCT02206620|16224661|P2|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2
4707449|NCT02206620|16224662|P1|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0
4707450|NCT02206620|16224661|P2|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
4707451|NCT02206620|16224662|P1|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1
4707452|NCT02206607|16224678|P5|Second Intervention Period|Insufficient Clinical Response|0
4707453|NCT02206607|16224679|P4|Second Intervention Period|Insufficient Clinical Response|1
4707454|NCT02206607|16224680|P3|Second Intervention Period|Insufficient Clinical Response|0
4707455|NCT02206607|16224681|P2|Second Intervention Period|Insufficient Clinical Response|0
4707456|NCT02206607|16224682|P1|Second Intervention Period|Insufficient Clinical Response|0
4707457|NCT02206607|16224678|P5|Open-Label Run-In|Withdrawal by Subject|0
4707458|NCT02206607|16224679|P4|Open-Label Run-In|Withdrawal by Subject|0
4707459|NCT02206607|16224680|P3|Open-Label Run-In|Withdrawal by Subject|0
4707460|NCT02206607|16224681|P2|Open-Label Run-In|Withdrawal by Subject|0
4707461|NCT02206607|16224682|P1|Open-Label Run-In|Withdrawal by Subject|3
4707462|NCT02206152|16224745|P1|Pre-Randomization|Withdrawal by Subject|2
4707463|NCT02205814|16224772|P4|Overall Study|not compliant with study procedures|0
4707464|NCT02205814|16224773|P3|Overall Study|not compliant with study procedures|1
4707465|NCT02205814|16224774|P2|Overall Study|not compliant with study procedures|0
4707466|NCT02205814|16224775|P1|Overall Study|not compliant with study procedures|0
4707467|NCT02205814|16224772|P4|Overall Study|Withdrawal by Subject|1
4707468|NCT02205814|16224773|P3|Overall Study|Withdrawal by Subject|2
4707469|NCT02205814|16224774|P2|Overall Study|Withdrawal by Subject|1
4707470|NCT02205814|16224775|P1|Overall Study|Withdrawal by Subject|0
4707471|NCT02205814|16224772|P4|Overall Study|Protocol Violation|1
4707472|NCT02205814|16224773|P3|Overall Study|Protocol Violation|0
4707473|NCT02205814|16224774|P2|Overall Study|Protocol Violation|0
4707474|NCT02205814|16224775|P1|Overall Study|Protocol Violation|1
4707475|NCT02205814|16224772|P4|Overall Study|Physician Decision|0
4707476|NCT02205814|16224773|P3|Overall Study|Physician Decision|1
4707477|NCT02205814|16224774|P2|Overall Study|Physician Decision|0
4707478|NCT02205814|16224775|P1|Overall Study|Physician Decision|0
4707479|NCT02205814|16224772|P4|Overall Study|Lack of Efficacy|1
4707480|NCT02205814|16224773|P3|Overall Study|Lack of Efficacy|1
4707481|NCT02205814|16224774|P2|Overall Study|Lack of Efficacy|0
4707482|NCT02205814|16224775|P1|Overall Study|Lack of Efficacy|1
4707483|NCT02205814|16224772|P4|Overall Study|Lost to Follow-up|1
4707484|NCT02205814|16224773|P3|Overall Study|Lost to Follow-up|0
4707485|NCT02205814|16224774|P2|Overall Study|Lost to Follow-up|0
4707486|NCT02205814|16224775|P1|Overall Study|Lost to Follow-up|0
4707487|NCT02205476|16224828|P2|Overall Study|Study termination by Sponsor|3
4707488|NCT02205476|16224829|P1|Overall Study|Study termination by Sponsor|7
4707489|NCT02205333|16224868|P9|Overall Study|Withdrawal by Subject|0
4707490|NCT02205333|16224869|P8|Overall Study|Withdrawal by Subject|0
4707491|NCT02205333|16224870|P7|Overall Study|Withdrawal by Subject|2
4707492|NCT02205333|16224871|P6|Overall Study|Withdrawal by Subject|0
4707493|NCT02205333|16224872|P5|Overall Study|Withdrawal by Subject|0
4707494|NCT02205333|16224873|P4|Overall Study|Withdrawal by Subject|1
4707495|NCT02205333|16224874|P3|Overall Study|Withdrawal by Subject|0
4707496|NCT02205333|16224875|P2|Overall Study|Withdrawal by Subject|0
4707497|NCT02205333|16224876|P1|Overall Study|Withdrawal by Subject|1
4707498|NCT02205333|16224868|P9|Overall Study|Death|0
4707499|NCT02205333|16224869|P8|Overall Study|Death|2
4707500|NCT02205333|16224870|P7|Overall Study|Death|3
4707501|NCT02205333|16224871|P6|Overall Study|Death|3
4707502|NCT02205333|16224872|P5|Overall Study|Death|5
4707503|NCT02205333|16224873|P4|Overall Study|Death|6
4707504|NCT02205333|16224874|P3|Overall Study|Death|2
4707505|NCT02205333|16224875|P2|Overall Study|Death|6
4707506|NCT02205333|16224876|P1|Overall Study|Death|5
4707507|NCT02204982|16225084|P2|Overall Study|Termination of Study bySponsor|1
4707508|NCT02204982|16225085|P1|Overall Study|Termination of Study bySponsor|0
4707509|NCT02204982|16225084|P2|Overall Study|Protocol-Specified Disease Progression|4
4707510|NCT02204982|16225085|P1|Overall Study|Protocol-Specified Disease Progression|0
4707511|NCT02204982|16225084|P2|Overall Study|Physician Decision|2
4707512|NCT02204982|16225085|P1|Overall Study|Physician Decision|0
4707513|NCT02204982|16225084|P2|Overall Study|Adverse Event and Investigator decision|0
4707514|NCT02204982|16225085|P1|Overall Study|Adverse Event and Investigator decision|1
4707515|NCT02204982|16225084|P2|Overall Study|Adverse Event|0
4707516|NCT02204982|16225085|P1|Overall Study|Adverse Event|1
4707517|NCT02204982|16225084|P2|Overall Study|Withdrawal by Subject|0
4707518|NCT02204982|16225085|P1|Overall Study|Withdrawal by Subject|1
4707519|NCT02204982|16225084|P2|Overall Study|Patient ineligible-medical monitor|0
4707520|NCT02204982|16225085|P1|Overall Study|Patient ineligible-medical monitor|1
4707521|NCT02204917|16225093|P1|Overall Study|Protocol Violation|1
4707522|NCT02204579|16225130|P1|Overall Study|Screen failures|2
4707523|NCT02204449|16225188|P2|Overall Study|Withdrawal by Subject|1
4707524|NCT02204449|16225189|P1|Overall Study|Withdrawal by Subject|0
4707525|NCT02204449|16225188|P2|Overall Study|Death|1
4707526|NCT02204449|16225189|P1|Overall Study|Death|0
4707527|NCT02204449|16225188|P2|Overall Study|Lost to Follow-up|9
4707528|NCT02204449|16225189|P1|Overall Study|Lost to Follow-up|7
4707529|NCT02204410|16225199|P1|Overall Study|Withdrawal by Subject|3
4707530|NCT02204410|16225199|P1|Overall Study|Protocol Violation|1
4707531|NCT02204410|16225199|P1|Overall Study|Physician Decision|2
4707532|NCT02204410|16225199|P1|Overall Study|Lost to Follow-up|5
4707533|NCT02204371|16225204|P1|Overall Study|Adverse Event|1
4707534|NCT02204319|16225227|P1|Overall Study|Withdrawal by Subject|2
4707535|NCT02204319|16225227|P1|Overall Study|Pregnancy|1
4707536|NCT02204293|16225235|P6|LTE Phase|Study Suspended|7
4707537|NCT02204293|16225236|P5|LTE Phase|Study Suspended|0
4707538|NCT02204293|16225237|P4|LTE Phase|Study Suspended|0
4707539|NCT02204293|16225238|P3|LTE Phase|Study Suspended|0
4707540|NCT02204293|16225239|P2|LTE Phase|Study Suspended|0
4707541|NCT02204293|16225240|P1|LTE Phase|Study Suspended|0
4707542|NCT02204293|16225235|P6|Core Study Part I|Physician Decision|0
4707543|NCT02204293|16225236|P5|Core Study Part I|Physician Decision|0
4707544|NCT02204293|16225237|P4|Core Study Part I|Physician Decision|0
4707545|NCT02204293|16225238|P3|Core Study Part I|Physician Decision|0
4707546|NCT02204293|16225239|P2|Core Study Part I|Physician Decision|3
4707547|NCT02204293|16225240|P1|Core Study Part I|Physician Decision|0
4707548|NCT02204293|16225235|P6|Core Study Part I|Adverse Event|0
4707549|NCT02204293|16225236|P5|Core Study Part I|Adverse Event|0
4707550|NCT02204293|16225237|P4|Core Study Part I|Adverse Event|0
4707551|NCT02204293|16225238|P3|Core Study Part I|Adverse Event|0
4707552|NCT02204293|16225239|P2|Core Study Part I|Adverse Event|0
4707553|NCT02204293|16225240|P1|Core Study Part I|Adverse Event|1
4707554|NCT02204293|16225235|P6|Core Study Part I|Met one or more exclusion criteria|0
4707555|NCT02204293|16225236|P5|Core Study Part I|Met one or more exclusion criteria|0
4707556|NCT02204293|16225237|P4|Core Study Part I|Met one or more exclusion criteria|0
4707557|NCT02204293|16225238|P3|Core Study Part I|Met one or more exclusion criteria|0
4707558|NCT02204293|16225239|P2|Core Study Part I|Met one or more exclusion criteria|0
4707559|NCT02204293|16225240|P1|Core Study Part I|Met one or more exclusion criteria|1
4707560|NCT02204007|16225361|P2|Overall Study|Surgery Canceled|1
4707561|NCT02204007|16225362|P1|Overall Study|Surgery Canceled|1
4707562|NCT02203916|16225373|P3|Overall Study|Reason Not Specified|1
4707563|NCT02203916|16225374|P2|Overall Study|Reason Not Specified|2
4707564|NCT02203916|16225375|P1|Overall Study|Reason Not Specified|0
4707565|NCT02203916|16225373|P3|Overall Study|Lack of Efficacy|0
4707566|NCT02203916|16225374|P2|Overall Study|Lack of Efficacy|0
4707567|NCT02203916|16225375|P1|Overall Study|Lack of Efficacy|3
4707568|NCT02203916|16225373|P3|Overall Study|Voluntary Withdrawal|8
4707569|NCT02203916|16225374|P2|Overall Study|Voluntary Withdrawal|3
4707570|NCT02203916|16225375|P1|Overall Study|Voluntary Withdrawal|3
4707571|NCT02203916|16225373|P3|Overall Study|Lost to Follow-up|0
4707572|NCT02203916|16225374|P2|Overall Study|Lost to Follow-up|1
4707573|NCT02203916|16225375|P1|Overall Study|Lost to Follow-up|0
4707574|NCT02203916|16225373|P3|Overall Study|Major Protocol Deviation|0
4707575|NCT02203916|16225374|P2|Overall Study|Major Protocol Deviation|1
4707576|NCT02203916|16225375|P1|Overall Study|Major Protocol Deviation|1
4707577|NCT02203916|16225373|P3|Overall Study|Pretreatment Event/Adverse Event|2
4707578|NCT02203916|16225374|P2|Overall Study|Pretreatment Event/Adverse Event|3
4707579|NCT02203916|16225375|P1|Overall Study|Pretreatment Event/Adverse Event|1
4707580|NCT02203851|16225395|P1|Overall Study|Other|1
4707581|NCT02203851|16225395|P1|Overall Study|Withdrawal by Subject|6
4707582|NCT02203851|16225395|P1|Overall Study|Lost to Follow-up|4
4707583|NCT02203838|16225433|P4|Overall Study|Other|0
4707584|NCT02203838|16225434|P3|Overall Study|Other|0
4707585|NCT02203838|16225435|P2|Overall Study|Other|0
4707586|NCT02203838|16225436|P1|Overall Study|Other|1
4707587|NCT02203838|16225433|P4|Overall Study|Physician Decision|3
4707588|NCT02203838|16225434|P3|Overall Study|Physician Decision|2
4707589|NCT02203838|16225435|P2|Overall Study|Physician Decision|0
4707590|NCT02203838|16225436|P1|Overall Study|Physician Decision|27
4707591|NCT02203838|16225433|P4|Overall Study|Withdrawal by Subject|11
4707592|NCT02203838|16225434|P3|Overall Study|Withdrawal by Subject|8
4707593|NCT02203838|16225435|P2|Overall Study|Withdrawal by Subject|10
4707594|NCT02203838|16225436|P1|Overall Study|Withdrawal by Subject|83
4707595|NCT02203838|16225433|P4|Overall Study|Protocol Violation|0
4707596|NCT02203838|16225434|P3|Overall Study|Protocol Violation|0
4707597|NCT02203838|16225435|P2|Overall Study|Protocol Violation|3
4707598|NCT02203838|16225436|P1|Overall Study|Protocol Violation|7
4707599|NCT02203838|16225433|P4|Overall Study|Lost to Follow-up|1
4707600|NCT02203838|16225434|P3|Overall Study|Lost to Follow-up|2
4707601|NCT02203838|16225435|P2|Overall Study|Lost to Follow-up|3
4707602|NCT02203838|16225436|P1|Overall Study|Lost to Follow-up|39
4707603|NCT02203838|16225433|P4|Overall Study|Adverse Event|2
4707604|NCT02203838|16225434|P3|Overall Study|Adverse Event|3
4707605|NCT02203838|16225435|P2|Overall Study|Adverse Event|6
4707606|NCT02203838|16225436|P1|Overall Study|Adverse Event|46
4707607|NCT02203838|16225433|P4|Overall Study|Lack of Efficacy|1
4707608|NCT02203838|16225434|P3|Overall Study|Lack of Efficacy|1
4707609|NCT02203838|16225435|P2|Overall Study|Lack of Efficacy|0
4707610|NCT02203838|16225436|P1|Overall Study|Lack of Efficacy|7
4707611|NCT02203721|16225516|P2|Overall Study|Illness|1
4707612|NCT02203721|16225517|P1|Overall Study|Illness|0
4707613|NCT02203721|16225516|P2|Overall Study|Death|2
4707614|NCT02203721|16225517|P1|Overall Study|Death|0
4707615|NCT02203721|16225516|P2|Overall Study|Lost to Follow-up|0
4707616|NCT02203721|16225517|P1|Overall Study|Lost to Follow-up|1
4707617|NCT02203357|16225617|P3|Overall Study|Lost to Follow-up|70
4707618|NCT02203357|16225618|P2|Overall Study|Lost to Follow-up|66
4707619|NCT02203357|16225619|P1|Overall Study|Lost to Follow-up|58
4707620|NCT02203331|16225642|P6|Overall Study|Lost to Follow-up|0
4707621|NCT02203331|16225643|P5|Overall Study|Lost to Follow-up|1
4707622|NCT02203331|16225644|P4|Overall Study|Lost to Follow-up|0
4707623|NCT02203331|16225645|P3|Overall Study|Lost to Follow-up|0
4707624|NCT02203331|16225646|P2|Overall Study|Lost to Follow-up|0
4707625|NCT02203331|16225647|P1|Overall Study|Lost to Follow-up|0
4707626|NCT02203331|16225642|P6|Overall Study|Protocol Violation|0
4707627|NCT02203331|16225643|P5|Overall Study|Protocol Violation|1
4707628|NCT02203331|16225644|P4|Overall Study|Protocol Violation|1
4707629|NCT02203331|16225645|P3|Overall Study|Protocol Violation|0
4707630|NCT02203331|16225646|P2|Overall Study|Protocol Violation|2
4707631|NCT02203331|16225647|P1|Overall Study|Protocol Violation|0
4707632|NCT02203331|16225642|P6|Overall Study|Lack of Efficacy|1
4707633|NCT02203331|16225643|P5|Overall Study|Lack of Efficacy|0
4707634|NCT02203331|16225644|P4|Overall Study|Lack of Efficacy|0
4707635|NCT02203331|16225645|P3|Overall Study|Lack of Efficacy|1
4707636|NCT02203331|16225646|P2|Overall Study|Lack of Efficacy|2
4707637|NCT02203331|16225647|P1|Overall Study|Lack of Efficacy|0
4707638|NCT02203331|16225642|P6|Overall Study|Other Reasons|0
4707639|NCT02203331|16225643|P5|Overall Study|Other Reasons|0
4707640|NCT02203331|16225644|P4|Overall Study|Other Reasons|2
4707641|NCT02203331|16225645|P3|Overall Study|Other Reasons|0
4707642|NCT02203331|16225646|P2|Overall Study|Other Reasons|2
4707643|NCT02203331|16225647|P1|Overall Study|Other Reasons|1
4707644|NCT02203331|16225642|P6|Overall Study|Adverse Event|3
4707645|NCT02203331|16225643|P5|Overall Study|Adverse Event|3
4707646|NCT02203331|16225644|P4|Overall Study|Adverse Event|4
4707647|NCT02203331|16225645|P3|Overall Study|Adverse Event|3
4707648|NCT02203331|16225646|P2|Overall Study|Adverse Event|8
4707649|NCT02203331|16225647|P1|Overall Study|Adverse Event|4
4707650|NCT02203331|16225642|P6|Overall Study|Withdrawal by Subject|3
4707651|NCT02203331|16225643|P5|Overall Study|Withdrawal by Subject|0
4707652|NCT02203331|16225644|P4|Overall Study|Withdrawal by Subject|0
4707653|NCT02203331|16225645|P3|Overall Study|Withdrawal by Subject|1
4707654|NCT02203331|16225646|P2|Overall Study|Withdrawal by Subject|0
4707655|NCT02203331|16225647|P1|Overall Study|Withdrawal by Subject|1
4707656|NCT02203331|16225642|P6|Overall Study|Pregnancy|0
4707657|NCT02203331|16225643|P5|Overall Study|Pregnancy|2
4707658|NCT02203331|16225644|P4|Overall Study|Pregnancy|0
4707659|NCT02203331|16225645|P3|Overall Study|Pregnancy|0
4707660|NCT02203331|16225646|P2|Overall Study|Pregnancy|0
4707661|NCT02203331|16225647|P1|Overall Study|Pregnancy|1
4707662|NCT02203149|16225706|P5|Part 2|Adverse Event|1
4707663|NCT02203149|16225707|P4|Part 2|Adverse Event|1
4707664|NCT02203149|16225708|P3|Part 2|Adverse Event|0
4707665|NCT02203149|16225709|P2|Part 2|Adverse Event|0
4707666|NCT02203149|16225710|P1|Part 2|Adverse Event|0
4707667|NCT02203149|16225706|P5|Part 2|Withdrawal by Subject|0
4707668|NCT02203149|16225707|P4|Part 2|Withdrawal by Subject|1
4707669|NCT02203149|16225708|P3|Part 2|Withdrawal by Subject|0
4707670|NCT02203149|16225709|P2|Part 2|Withdrawal by Subject|0
4707671|NCT02203149|16225710|P1|Part 2|Withdrawal by Subject|0
4707672|NCT02203149|16225706|P5|Part 2|Death|0
4707673|NCT02203149|16225707|P4|Part 2|Death|1
4707674|NCT02203149|16225708|P3|Part 2|Death|1
4707675|NCT02203149|16225709|P2|Part 2|Death|0
4707676|NCT02203149|16225710|P1|Part 2|Death|0
4707677|NCT02203149|16225706|P5|Part 1|Adverse Event|0
4707678|NCT02203149|16225707|P4|Part 1|Adverse Event|0
4707679|NCT02203149|16225708|P3|Part 1|Adverse Event|0
4707680|NCT02203149|16225709|P2|Part 1|Adverse Event|1
4707681|NCT02203149|16225710|P1|Part 1|Adverse Event|0
4707682|NCT02203071|16225745|P2|Overall Study|Lost to Follow-up|1
4707683|NCT02203071|16225746|P1|Overall Study|Lost to Follow-up|3
4707684|NCT02203032|16225770|P4|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2
4707685|NCT02203032|16225771|P3|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3
4707686|NCT02203032|16225772|P2|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1
4707687|NCT02203032|16225773|P1|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0
4707688|NCT02203032|16225770|P4|Blinded Phase (Week 16 to Week 44)|Death|1
4707689|NCT02203032|16225771|P3|Blinded Phase (Week 16 to Week 44)|Death|0
4707690|NCT02203032|16225772|P2|Blinded Phase (Week 16 to Week 44)|Death|0
4707691|NCT02203032|16225773|P1|Blinded Phase (Week 16 to Week 44)|Death|0
4707692|NCT02203032|16225770|P4|Blinded Phase (Week 16 to Week 44)|Other|15
4707693|NCT02203032|16225771|P3|Blinded Phase (Week 16 to Week 44)|Other|1
4707694|NCT02203032|16225772|P2|Blinded Phase (Week 16 to Week 44)|Other|4
4707695|NCT02203032|16225773|P1|Blinded Phase (Week 16 to Week 44)|Other|0
4707696|NCT02203032|16225770|P4|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20
4707697|NCT02203032|16225771|P3|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19
4707698|NCT02203032|16225772|P2|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8
4707699|NCT02203032|16225773|P1|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0
4707700|NCT02203032|16225770|P4|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8
4707701|NCT02203032|16225771|P3|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3
4707702|NCT02203032|16225772|P2|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2
4707703|NCT02203032|16225773|P1|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0
4707704|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
4707705|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
4707706|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0
4707707|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1
4707708|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Other|0
4707709|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Other|0
4707710|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Other|0
4707711|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Other|2
4707712|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
4707713|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
4707714|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0
4707715|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4
4707716|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
4707717|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
4707718|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0
4707719|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6
4707720|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
4707721|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
4707722|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0
4707723|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3
4707724|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
4707725|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
4707726|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0
4707727|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1
4707728|NCT02203032|16225770|P4|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
4707729|NCT02203032|16225771|P3|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
4707730|NCT02203032|16225772|P2|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0
4707731|NCT02203032|16225773|P1|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2
4707732|NCT02202980|16225816|P14|Overall Study|Withdrew Consent|0
4707733|NCT02202980|16225817|P13|Overall Study|Withdrew Consent|0
4707734|NCT02202980|16225818|P12|Overall Study|Withdrew Consent|0
4707735|NCT02202980|16225819|P11|Overall Study|Withdrew Consent|0
4707736|NCT02202980|16225820|P10|Overall Study|Withdrew Consent|0
4707737|NCT02202980|16225821|P9|Overall Study|Withdrew Consent|1
4707738|NCT02202980|16225822|P8|Overall Study|Withdrew Consent|0
4707739|NCT02202980|16225823|P7|Overall Study|Withdrew Consent|0
4707740|NCT02202980|16225824|P6|Overall Study|Withdrew Consent|0
4707741|NCT02202980|16225825|P5|Overall Study|Withdrew Consent|0
4707742|NCT02202980|16225826|P4|Overall Study|Withdrew Consent|0
4707743|NCT02202980|16225827|P3|Overall Study|Withdrew Consent|2
4707744|NCT02202980|16225828|P2|Overall Study|Withdrew Consent|1
4707745|NCT02202980|16225829|P1|Overall Study|Withdrew Consent|0
4707746|NCT02202980|16225816|P14|Overall Study|Lost to Follow-up|0
4707747|NCT02202980|16225817|P13|Overall Study|Lost to Follow-up|1
4707748|NCT02202980|16225818|P12|Overall Study|Lost to Follow-up|0
4707749|NCT02202980|16225819|P11|Overall Study|Lost to Follow-up|0
4707750|NCT02202980|16225820|P10|Overall Study|Lost to Follow-up|0
4707751|NCT02202980|16225821|P9|Overall Study|Lost to Follow-up|1
4707752|NCT02202980|16225822|P8|Overall Study|Lost to Follow-up|1
4707753|NCT02202980|16225823|P7|Overall Study|Lost to Follow-up|0
4707754|NCT02202980|16225824|P6|Overall Study|Lost to Follow-up|0
4707755|NCT02202980|16225825|P5|Overall Study|Lost to Follow-up|0
4707756|NCT02202980|16225826|P4|Overall Study|Lost to Follow-up|1
4707757|NCT02202980|16225827|P3|Overall Study|Lost to Follow-up|1
4707758|NCT02202980|16225828|P2|Overall Study|Lost to Follow-up|1
4707759|NCT02202980|16225829|P1|Overall Study|Lost to Follow-up|0
4707760|NCT02202980|16225816|P14|Overall Study|Protocol Violation|0
4707761|NCT02202980|16225817|P13|Overall Study|Protocol Violation|0
4707762|NCT02202980|16225818|P12|Overall Study|Protocol Violation|0
4707763|NCT02202980|16225819|P11|Overall Study|Protocol Violation|0
4707764|NCT02202980|16225820|P10|Overall Study|Protocol Violation|0
4707765|NCT02202980|16225821|P9|Overall Study|Protocol Violation|0
4707766|NCT02202980|16225822|P8|Overall Study|Protocol Violation|0
4707767|NCT02202980|16225823|P7|Overall Study|Protocol Violation|0
4707768|NCT02202980|16225824|P6|Overall Study|Protocol Violation|0
4707769|NCT02202980|16225825|P5|Overall Study|Protocol Violation|3
4707770|NCT02202980|16225826|P4|Overall Study|Protocol Violation|3
4707771|NCT02202980|16225827|P3|Overall Study|Protocol Violation|0
4707772|NCT02202980|16225828|P2|Overall Study|Protocol Violation|0
4707773|NCT02202980|16225829|P1|Overall Study|Protocol Violation|0
4707774|NCT02202980|16225816|P14|Overall Study|Lack of Efficacy|0
4707775|NCT02202980|16225817|P13|Overall Study|Lack of Efficacy|10
4707776|NCT02202980|16225818|P12|Overall Study|Lack of Efficacy|3
4707777|NCT02202980|16225819|P11|Overall Study|Lack of Efficacy|0
4707778|NCT02202980|16225820|P10|Overall Study|Lack of Efficacy|0
4707779|NCT02202980|16225821|P9|Overall Study|Lack of Efficacy|2
4707780|NCT02202980|16225822|P8|Overall Study|Lack of Efficacy|2
4707781|NCT02202980|16225823|P7|Overall Study|Lack of Efficacy|11
4707782|NCT02202980|16225824|P6|Overall Study|Lack of Efficacy|1
4707783|NCT02202980|16225825|P5|Overall Study|Lack of Efficacy|3
4707784|NCT02202980|16225826|P4|Overall Study|Lack of Efficacy|0
4707785|NCT02202980|16225827|P3|Overall Study|Lack of Efficacy|7
4707786|NCT02202980|16225828|P2|Overall Study|Lack of Efficacy|0
4707787|NCT02202980|16225829|P1|Overall Study|Lack of Efficacy|1
4707788|NCT02202850|16225917|P2|Overall Study|Lost to Follow-up|1
4707789|NCT02202850|16225918|P1|Overall Study|Lost to Follow-up|7
4707790|NCT02202850|16225917|P2|Overall Study|Enbrel treatment discontinued|3
4707791|NCT02202850|16225918|P1|Overall Study|Enbrel treatment discontinued|15
4707792|NCT02202850|16225917|P2|Overall Study|Other|2
4707793|NCT02202850|16225918|P1|Overall Study|Other|2
4707794|NCT02202837|16225970|P2|Overall Study|Lost to Follow-up|1
4707795|NCT02202837|16225971|P1|Overall Study|Lost to Follow-up|7
4707796|NCT02202837|16225970|P2|Overall Study|Other|0
4707797|NCT02202837|16225971|P1|Overall Study|Other|10
4707798|NCT02202837|16225970|P2|Overall Study|Enbrel treatment discontinued|4
4707799|NCT02202837|16225971|P1|Overall Study|Enbrel treatment discontinued|36
4707800|NCT02202785|16226022|P3|Overall Study|Reason not Specified|13
4707801|NCT02202785|16226023|P2|Overall Study|Reason not Specified|7
4707802|NCT02202785|16226024|P1|Overall Study|Reason not Specified|10
4707803|NCT02202785|16226022|P3|Overall Study|Lost to Follow-up|0
4707804|NCT02202785|16226023|P2|Overall Study|Lost to Follow-up|1
4707805|NCT02202785|16226024|P1|Overall Study|Lost to Follow-up|0
4707806|NCT02202785|16226022|P3|Overall Study|Withdrawal by Subject|0
4707807|NCT02202785|16226023|P2|Overall Study|Withdrawal by Subject|1
4707808|NCT02202785|16226024|P1|Overall Study|Withdrawal by Subject|0
4707809|NCT02202785|16226022|P3|Overall Study|Study Terminated by Sponsor|4
4707810|NCT02202785|16226023|P2|Overall Study|Study Terminated by Sponsor|6
4707811|NCT02202785|16226024|P1|Overall Study|Study Terminated by Sponsor|1
4707812|NCT02202759|16226061|P3|Overall Study|Reason not Specified|10
4707813|NCT02202759|16226062|P2|Overall Study|Reason not Specified|11
4707814|NCT02202759|16226063|P1|Overall Study|Reason not Specified|4
4707815|NCT02202759|16226061|P3|Overall Study|Withdrawal by Subject|1
4707816|NCT02202759|16226062|P2|Overall Study|Withdrawal by Subject|1
4707817|NCT02202759|16226063|P1|Overall Study|Withdrawal by Subject|2
4707818|NCT02202759|16226061|P3|Overall Study|Study Terminated by Sponsor|3
4707819|NCT02202759|16226062|P2|Overall Study|Study Terminated by Sponsor|3
4707820|NCT02202759|16226063|P1|Overall Study|Study Terminated by Sponsor|3
4707821|NCT02202616|16226130|P1|Overall Study|Unsatisfactory therapeutic effect|1
4707822|NCT02202616|16226130|P1|Overall Study|Abnormal test procedure result|1
4707823|NCT02202616|16226130|P1|Overall Study|Administrative problems|6
4707824|NCT02202616|16226130|P1|Overall Study|Lost to Follow-up|6
4707825|NCT02202616|16226130|P1|Overall Study|Patient withdrew consent|12
4707826|NCT02202616|16226130|P1|Overall Study|Protocol deviation|18
4707827|NCT02202616|16226130|P1|Overall Study|Adverse Event|32
4707828|NCT02202616|16226130|P1|Overall Study|Screen failed|24
4707829|NCT02202551|16226145|P4|Overall Study|eGFR<50mL/min/m2|1
4707830|NCT02202551|16226146|P3|Overall Study|eGFR<50mL/min/m2|0
4707831|NCT02202551|16226147|P2|Overall Study|eGFR<50mL/min/m2|2
4707832|NCT02202551|16226148|P1|Overall Study|eGFR<50mL/min/m2|2
4707833|NCT02202551|16226145|P4|Overall Study|Subject consent withdrawn|2
4707834|NCT02202551|16226146|P3|Overall Study|Subject consent withdrawn|1
4707835|NCT02202551|16226147|P2|Overall Study|Subject consent withdrawn|3
4707836|NCT02202551|16226148|P1|Overall Study|Subject consent withdrawn|0
4707837|NCT02202551|16226145|P4|Overall Study|Subject unwilling to proceed|5
4707838|NCT02202551|16226146|P3|Overall Study|Subject unwilling to proceed|3
4707839|NCT02202551|16226147|P2|Overall Study|Subject unwilling to proceed|5
4707840|NCT02202551|16226148|P1|Overall Study|Subject unwilling to proceed|1
4707841|NCT02202551|16226145|P4|Overall Study|Sponsor's decision|0
4707842|NCT02202551|16226146|P3|Overall Study|Sponsor's decision|0
4707843|NCT02202551|16226147|P2|Overall Study|Sponsor's decision|0
4707844|NCT02202551|16226148|P1|Overall Study|Sponsor's decision|2
4707845|NCT02202551|16226145|P4|Overall Study|Protocol Violation|0
4707846|NCT02202551|16226146|P3|Overall Study|Protocol Violation|0
4707847|NCT02202551|16226147|P2|Overall Study|Protocol Violation|1
4707848|NCT02202551|16226148|P1|Overall Study|Protocol Violation|0
4707849|NCT02202551|16226145|P4|Overall Study|Worsening Dyskinesia|1
4707850|NCT02202551|16226146|P3|Overall Study|Worsening Dyskinesia|0
4707851|NCT02202551|16226147|P2|Overall Study|Worsening Dyskinesia|0
4707852|NCT02202551|16226148|P1|Overall Study|Worsening Dyskinesia|0
4707853|NCT02202551|16226145|P4|Overall Study|Unable to complete visits per protocol|0
4707854|NCT02202551|16226146|P3|Overall Study|Unable to complete visits per protocol|0
4707855|NCT02202551|16226147|P2|Overall Study|Unable to complete visits per protocol|0
4707856|NCT02202551|16226148|P1|Overall Study|Unable to complete visits per protocol|1
4707857|NCT02202551|16226145|P4|Overall Study|Site closure|1
4707858|NCT02202551|16226146|P3|Overall Study|Site closure|0
4707859|NCT02202551|16226147|P2|Overall Study|Site closure|0
4707860|NCT02202551|16226148|P1|Overall Study|Site closure|3
4707861|NCT02202551|16226145|P4|Overall Study|Physician Decision|0
4707862|NCT02202551|16226146|P3|Overall Study|Physician Decision|0
4707863|NCT02202551|16226147|P2|Overall Study|Physician Decision|0
4707864|NCT02202551|16226148|P1|Overall Study|Physician Decision|1
4707865|NCT02202551|16226145|P4|Overall Study|Lack of Efficacy|0
4707866|NCT02202551|16226146|P3|Overall Study|Lack of Efficacy|0
4707867|NCT02202551|16226147|P2|Overall Study|Lack of Efficacy|1
4707868|NCT02202551|16226148|P1|Overall Study|Lack of Efficacy|0
4707869|NCT02202551|16226145|P4|Overall Study|Dyskinesia upon taper|0
4707870|NCT02202551|16226146|P3|Overall Study|Dyskinesia upon taper|0
4707871|NCT02202551|16226147|P2|Overall Study|Dyskinesia upon taper|0
4707872|NCT02202551|16226148|P1|Overall Study|Dyskinesia upon taper|1
4707873|NCT02202551|16226145|P4|Overall Study|DBS surgery|0
4707874|NCT02202551|16226146|P3|Overall Study|DBS surgery|0
4707875|NCT02202551|16226147|P2|Overall Study|DBS surgery|0
4707876|NCT02202551|16226148|P1|Overall Study|DBS surgery|3
4707877|NCT02202551|16226145|P4|Overall Study|Subject moved away|0
4707878|NCT02202551|16226146|P3|Overall Study|Subject moved away|0
4707879|NCT02202551|16226147|P2|Overall Study|Subject moved away|1
4707880|NCT02202551|16226148|P1|Overall Study|Subject moved away|0
4707881|NCT02202551|16226145|P4|Overall Study|Needed to take excluded medication|1
4707882|NCT02202551|16226146|P3|Overall Study|Needed to take excluded medication|0
4707883|NCT02202551|16226147|P2|Overall Study|Needed to take excluded medication|2
4707884|NCT02202551|16226148|P1|Overall Study|Needed to take excluded medication|0
4707885|NCT02202551|16226145|P4|Overall Study|Lost to Follow-up|1
4707886|NCT02202551|16226146|P3|Overall Study|Lost to Follow-up|0
4707887|NCT02202551|16226147|P2|Overall Study|Lost to Follow-up|1
4707888|NCT02202551|16226148|P1|Overall Study|Lost to Follow-up|0
4707889|NCT02202551|16226145|P4|Overall Study|Death|1
4707890|NCT02202551|16226146|P3|Overall Study|Death|1
4707891|NCT02202551|16226147|P2|Overall Study|Death|2
4707892|NCT02202551|16226148|P1|Overall Study|Death|3
4707893|NCT02202551|16226145|P4|Overall Study|Adverse Event|9
4707894|NCT02202551|16226146|P3|Overall Study|Adverse Event|5
4707895|NCT02202551|16226147|P2|Overall Study|Adverse Event|19
4707896|NCT02202551|16226148|P1|Overall Study|Adverse Event|8
4707897|NCT02202538|16226166|P1|Overall Study|Investigator Decision|1
4707898|NCT02202538|16226166|P1|Overall Study|Did not meet all inclusion criteria|2
4707899|NCT02202538|16226166|P1|Overall Study|Withdrawal by Subject|5
4707900|NCT02202499|16226180|P3|Overall Study|Auto accident|0
4707901|NCT02202499|16226181|P2|Overall Study|Auto accident|0
4707902|NCT02202499|16226182|P1|Overall Study|Auto accident|1
4707903|NCT02202499|16226180|P3|Overall Study|Declined before randomization|0
4707904|NCT02202499|16226181|P2|Overall Study|Declined before randomization|0
4707905|NCT02202499|16226182|P1|Overall Study|Declined before randomization|1
4707906|NCT02202499|16226180|P3|Overall Study|Moved from area|1
4707907|NCT02202499|16226181|P2|Overall Study|Moved from area|0
4707908|NCT02202499|16226182|P1|Overall Study|Moved from area|0
4707909|NCT02202499|16226180|P3|Overall Study|Cancer diagnosis|1
4707910|NCT02202499|16226181|P2|Overall Study|Cancer diagnosis|0
4707911|NCT02202499|16226182|P1|Overall Study|Cancer diagnosis|0
4707912|NCT02202434|16226209|P4|Overall Study|Other|1
4707913|NCT02202434|16226210|P3|Overall Study|Other|0
4707914|NCT02202434|16226211|P2|Overall Study|Other|0
4707915|NCT02202434|16226212|P1|Overall Study|Other|1
4707916|NCT02202434|16226209|P4|Overall Study|Visit Missed|5
4707917|NCT02202434|16226210|P3|Overall Study|Visit Missed|0
4707918|NCT02202434|16226211|P2|Overall Study|Visit Missed|12
4707919|NCT02202434|16226212|P1|Overall Study|Visit Missed|21
4707920|NCT02202434|16226209|P4|Overall Study|Completed Study|0
4707921|NCT02202434|16226210|P3|Overall Study|Completed Study|0
4707922|NCT02202434|16226211|P2|Overall Study|Completed Study|0
4707923|NCT02202434|16226212|P1|Overall Study|Completed Study|1
4707924|NCT02202434|16226209|P4|Overall Study|Withdrawal by Subject|4
4707925|NCT02202434|16226210|P3|Overall Study|Withdrawal by Subject|1
4707926|NCT02202434|16226211|P2|Overall Study|Withdrawal by Subject|14
4707927|NCT02202434|16226212|P1|Overall Study|Withdrawal by Subject|13
4707928|NCT02202434|16226209|P4|Overall Study|Physician Decision|0
4707929|NCT02202434|16226210|P3|Overall Study|Physician Decision|0
4707930|NCT02202434|16226211|P2|Overall Study|Physician Decision|3
4707931|NCT02202434|16226212|P1|Overall Study|Physician Decision|2
4707932|NCT02202434|16226209|P4|Overall Study|Lost to Follow-up|0
4707933|NCT02202434|16226210|P3|Overall Study|Lost to Follow-up|1
4707934|NCT02202434|16226211|P2|Overall Study|Lost to Follow-up|1
4707935|NCT02202434|16226212|P1|Overall Study|Lost to Follow-up|1
4707936|NCT02202434|16226209|P4|Overall Study|Death|27
4707937|NCT02202434|16226210|P3|Overall Study|Death|13
4707938|NCT02202434|16226211|P2|Overall Study|Death|39
4707939|NCT02202434|16226212|P1|Overall Study|Death|70
4707940|NCT02202317|16226336|P1|Overall Study|Lost to Follow-up|1
4707941|NCT02202161|16226363|P8|Overall Study|Withdrawal by Subject|0
4707942|NCT02202161|16226364|P7|Overall Study|Withdrawal by Subject|0
4707943|NCT02202161|16226365|P6|Overall Study|Withdrawal by Subject|0
4707944|NCT02202161|16226366|P5|Overall Study|Withdrawal by Subject|1
4707945|NCT02202161|16226367|P4|Overall Study|Withdrawal by Subject|0
4707946|NCT02202161|16226368|P3|Overall Study|Withdrawal by Subject|0
4707947|NCT02202161|16226369|P2|Overall Study|Withdrawal by Subject|0
4707948|NCT02202161|16226370|P1|Overall Study|Withdrawal by Subject|0
4707949|NCT02202161|16226363|P8|Overall Study|Physician Decision|3
4707950|NCT02202161|16226364|P7|Overall Study|Physician Decision|0
4707951|NCT02202161|16226365|P6|Overall Study|Physician Decision|0
4707952|NCT02202161|16226366|P5|Overall Study|Physician Decision|0
4707953|NCT02202161|16226367|P4|Overall Study|Physician Decision|0
4707954|NCT02202161|16226368|P3|Overall Study|Physician Decision|0
4707955|NCT02202161|16226369|P2|Overall Study|Physician Decision|0
4707956|NCT02202161|16226370|P1|Overall Study|Physician Decision|0
4707957|NCT02202161|16226363|P8|Overall Study|Did not meet continuation criteria|3
4707958|NCT02202161|16226364|P7|Overall Study|Did not meet continuation criteria|0
4707959|NCT02202161|16226365|P6|Overall Study|Did not meet continuation criteria|0
4707960|NCT02202161|16226366|P5|Overall Study|Did not meet continuation criteria|0
4707961|NCT02202161|16226367|P4|Overall Study|Did not meet continuation criteria|0
4707962|NCT02202161|16226368|P3|Overall Study|Did not meet continuation criteria|0
4707963|NCT02202161|16226369|P2|Overall Study|Did not meet continuation criteria|0
4707964|NCT02202161|16226370|P1|Overall Study|Did not meet continuation criteria|0
4707965|NCT02202161|16226363|P8|Overall Study|Adverse Event|0
4707966|NCT02202161|16226364|P7|Overall Study|Adverse Event|0
4707967|NCT02202161|16226365|P6|Overall Study|Adverse Event|1
4707968|NCT02202161|16226366|P5|Overall Study|Adverse Event|0
4707969|NCT02202161|16226367|P4|Overall Study|Adverse Event|0
4707970|NCT02202161|16226368|P3|Overall Study|Adverse Event|0
4707971|NCT02202161|16226369|P2|Overall Study|Adverse Event|1
4707972|NCT02202161|16226370|P1|Overall Study|Adverse Event|1
4707973|NCT02202109|16226530|P2|Overall Study|Withdrawal by Subject|0
4707974|NCT02202109|16226531|P1|Overall Study|Withdrawal by Subject|2
4707975|NCT02202109|16226530|P2|Overall Study|Lost to Follow-up|87
4707976|NCT02202109|16226531|P1|Overall Study|Lost to Follow-up|88
4707977|NCT02202031|16226548|P2|Overall Study|Intolerance/Lack of Improvement|0
4707978|NCT02202031|16226549|P1|Overall Study|Intolerance/Lack of Improvement|3
4707979|NCT02202031|16226548|P2|Overall Study|Illness/Medical Reason|2
4707980|NCT02202031|16226549|P1|Overall Study|Illness/Medical Reason|0
4707981|NCT02202031|16226548|P2|Overall Study|Too Busy|3
4707982|NCT02202031|16226549|P1|Overall Study|Too Busy|1
4707983|NCT02202031|16226548|P2|Overall Study|Lost to Follow-up|0
4707984|NCT02202031|16226549|P1|Overall Study|Lost to Follow-up|1
4707985|NCT02201953|16226606|P2|Overall Study|Death|3
4707986|NCT02201953|16226607|P1|Overall Study|Death|0
4707987|NCT02201953|16226606|P2|Overall Study|Adverse Event|5
4707988|NCT02201953|16226607|P1|Overall Study|Adverse Event|0
4707989|NCT02201953|16226606|P2|Overall Study|Withdrew Consent|5
4707990|NCT02201953|16226607|P1|Overall Study|Withdrew Consent|2
4707991|NCT02201953|16226606|P2|Overall Study|Lost to Follow-up|8
4707992|NCT02201953|16226607|P1|Overall Study|Lost to Follow-up|8
4707993|NCT02201953|16226606|P2|Overall Study|Lack of Efficacy|30
4707994|NCT02201953|16226607|P1|Overall Study|Lack of Efficacy|9
4707995|NCT02201953|16226606|P2|Overall Study|Randomized but Never Treated|5
4707996|NCT02201953|16226607|P1|Overall Study|Randomized but Never Treated|1
4707997|NCT02201940|16226625|P2|Overall Study|Adverse Event|1
4707998|NCT02201940|16226626|P1|Overall Study|Adverse Event|0
4707999|NCT02201940|16226625|P2|Overall Study|Death|0
4708000|NCT02201940|16226626|P1|Overall Study|Death|1
4708001|NCT02201940|16226625|P2|Overall Study|Investigator's Discretion|1
4708002|NCT02201940|16226626|P1|Overall Study|Investigator's Discretion|1
4708003|NCT02201940|16226625|P2|Overall Study|Withdrew Consent|1
4708004|NCT02201940|16226626|P1|Overall Study|Withdrew Consent|2
4708005|NCT02201940|16226625|P2|Overall Study|Lost to Follow-up|0
4708006|NCT02201940|16226626|P1|Overall Study|Lost to Follow-up|5
4708007|NCT02201940|16226625|P2|Overall Study|Lack of Efficacy|113
4708008|NCT02201940|16226626|P1|Overall Study|Lack of Efficacy|2
4708009|NCT02201940|16226625|P2|Overall Study|Randomized/Enrolled but Never Treated|0
4708010|NCT02201940|16226626|P1|Overall Study|Randomized/Enrolled but Never Treated|1
4708011|NCT02201901|16226645|P3|Overall Study|Adverse Event|0
4708012|NCT02201901|16226646|P2|Overall Study|Adverse Event|1
4708013|NCT02201901|16226647|P1|Overall Study|Adverse Event|1
4708014|NCT02201901|16226645|P3|Overall Study|Withdrew Consent|2
4708015|NCT02201901|16226646|P2|Overall Study|Withdrew Consent|0
4708016|NCT02201901|16226647|P1|Overall Study|Withdrew Consent|2
4708017|NCT02201901|16226645|P3|Overall Study|Lost to Follow-up|2
4708018|NCT02201901|16226646|P2|Overall Study|Lost to Follow-up|3
4708019|NCT02201901|16226647|P1|Overall Study|Lost to Follow-up|2
4708020|NCT02201901|16226645|P3|Overall Study|Death|3
4708021|NCT02201901|16226646|P2|Overall Study|Death|3
4708022|NCT02201901|16226647|P1|Overall Study|Death|3
4708023|NCT02201901|16226645|P3|Overall Study|Lack of Efficacy|6
4708024|NCT02201901|16226646|P2|Overall Study|Lack of Efficacy|1
4708025|NCT02201901|16226647|P1|Overall Study|Lack of Efficacy|7
4708026|NCT02201901|16226645|P3|Overall Study|Randomized but never treated|0
4708027|NCT02201901|16226646|P2|Overall Study|Randomized but never treated|1
4708028|NCT02201901|16226647|P1|Overall Study|Randomized but never treated|0
4708029|NCT02201784|16226678|P2|Overall Study|Failure to achieve adequate block|0
4708030|NCT02201784|16226679|P1|Overall Study|Failure to achieve adequate block|2
4708031|NCT02201771|16226696|P3|Overall Study|Protocol Violation|10
4708032|NCT02201771|16226697|P2|Overall Study|Protocol Violation|8
4708033|NCT02201771|16226698|P1|Overall Study|Protocol Violation|10
4708034|NCT02201771|16226696|P3|Overall Study|Death|0
4708035|NCT02201771|16226697|P2|Overall Study|Death|2
4708036|NCT02201771|16226698|P1|Overall Study|Death|3
4708037|NCT02201524|16226725|P4|Overall Study|Other|0
4708038|NCT02201524|16226726|P3|Overall Study|Other|0
4708039|NCT02201524|16226727|P2|Overall Study|Other|1
4708040|NCT02201524|16226728|P1|Overall Study|Other|1
4708041|NCT02201524|16226725|P4|Overall Study|Withdrawal by Subject|1
4708042|NCT02201524|16226726|P3|Overall Study|Withdrawal by Subject|1
4708043|NCT02201524|16226727|P2|Overall Study|Withdrawal by Subject|0
4708044|NCT02201524|16226728|P1|Overall Study|Withdrawal by Subject|0
4708045|NCT02201524|16226725|P4|Overall Study|Protocol Violation|1
4708046|NCT02201524|16226726|P3|Overall Study|Protocol Violation|0
4708047|NCT02201524|16226727|P2|Overall Study|Protocol Violation|0
4708048|NCT02201524|16226728|P1|Overall Study|Protocol Violation|0
4708049|NCT02201524|16226725|P4|Overall Study|No longer meets eligibility criteria|2
4708050|NCT02201524|16226726|P3|Overall Study|No longer meets eligibility criteria|0
4708051|NCT02201524|16226727|P2|Overall Study|No longer meets eligibility criteria|0
4708052|NCT02201524|16226728|P1|Overall Study|No longer meets eligibility criteria|0
4708053|NCT02201524|16226725|P4|Overall Study|Lost to Follow-up|0
4708054|NCT02201524|16226726|P3|Overall Study|Lost to Follow-up|2
4708055|NCT02201524|16226727|P2|Overall Study|Lost to Follow-up|0
4708056|NCT02201524|16226728|P1|Overall Study|Lost to Follow-up|0
4708057|NCT02201524|16226725|P4|Overall Study|Insufficient clinical response|0
4708058|NCT02201524|16226726|P3|Overall Study|Insufficient clinical response|0
4708059|NCT02201524|16226727|P2|Overall Study|Insufficient clinical response|0
4708060|NCT02201524|16226728|P1|Overall Study|Insufficient clinical response|1
4708061|NCT02201524|16226725|P4|Overall Study|Adverse Event|0
4708062|NCT02201524|16226726|P3|Overall Study|Adverse Event|1
4708063|NCT02201524|16226727|P2|Overall Study|Adverse Event|2
4708064|NCT02201524|16226728|P1|Overall Study|Adverse Event|0
4708065|NCT02201472|16226810|P1|Overall Study|Lack of Efficacy|2
4708066|NCT02201329|16226857|P1|Overall Study|Withdrawal by Subject|2
4708067|NCT02201329|16226857|P1|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3
4708068|NCT02201290|16226865|P1|Overall Study|Adverse Event|1
4708069|NCT02201290|16226865|P1|Overall Study|Lack of Efficacy|2
4708070|NCT02201290|16226865|P1|Overall Study|Withdrawal by Subject|2
4708071|NCT02201277|16226871|P2|Overall Study|Physician Decision|0
4708072|NCT02201277|16226872|P1|Overall Study|Physician Decision|1
4708073|NCT02201277|16226871|P2|Overall Study|Failed retrieval|0
4708074|NCT02201277|16226872|P1|Overall Study|Failed retrieval|1
4708075|NCT02201277|16226871|P2|Overall Study|Lost to Follow-up|1
4708076|NCT02201277|16226872|P1|Overall Study|Lost to Follow-up|2
4708077|NCT02201277|16226871|P2|Overall Study|Death|4
4708078|NCT02201277|16226872|P1|Overall Study|Death|3
4708079|NCT02200770|16226970|P2|Open-label Period (OLP)|Participants ongoing|162
4708080|NCT02200770|16226971|P1|Open-label Period (OLP)|Participants ongoing|51
4708081|NCT02200770|16226970|P2|Randomized-controlled Period (RCP)|Other|2
4708082|NCT02200770|16226971|P1|Randomized-controlled Period (RCP)|Other|1
4708083|NCT02200770|16226970|P2|Randomized-controlled Period (RCP)|Not treated|1
4708084|NCT02200770|16226971|P1|Randomized-controlled Period (RCP)|Not treated|0
4708085|NCT02200770|16226970|P2|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
4708086|NCT02200770|16226971|P1|Randomized-controlled Period (RCP)|Withdrawal by Subject|1
4708087|NCT02200770|16226970|P2|Randomized-controlled Period (RCP)|Adverse Event|2
4708088|NCT02200770|16226971|P1|Randomized-controlled Period (RCP)|Adverse Event|0
4708089|NCT02200614|16227002|P2|Open Label|Protocol deviation|1
4708090|NCT02200614|16227003|P1|Open Label|Protocol deviation|1
4708091|NCT02200614|16227002|P2|Open Label|Personal reason|3
4708092|NCT02200614|16227003|P1|Open Label|Personal reason|29
4708093|NCT02200614|16227002|P2|Open Label|Other reason|1
4708094|NCT02200614|16227003|P1|Open Label|Other reason|6
4708095|NCT02200614|16227002|P2|Open Label|Metastasis by local reading|10
4708096|NCT02200614|16227003|P1|Open Label|Metastasis by local reading|58
4708097|NCT02200614|16227002|P2|Open Label|Judgment of the investigator|0
4708098|NCT02200614|16227003|P1|Open Label|Judgment of the investigator|15
4708099|NCT02200614|16227002|P2|Open Label|Confirmed metastasis|0
4708100|NCT02200614|16227003|P1|Open Label|Confirmed metastasis|1
4708101|NCT02200614|16227002|P2|Open Label|Adverse Event|8
4708102|NCT02200614|16227003|P1|Open Label|Adverse Event|15
4708103|NCT02200614|16227002|P2|Double Blind Treatment|Not treated|0
4708104|NCT02200614|16227003|P1|Double Blind Treatment|Not treated|1
4708105|NCT02200614|16227002|P2|Double Blind Treatment|Protocol deviation|7
4708106|NCT02200614|16227003|P1|Double Blind Treatment|Protocol deviation|14
4708107|NCT02200614|16227002|P2|Double Blind Treatment|Personal reason|85
4708108|NCT02200614|16227003|P1|Double Blind Treatment|Personal reason|77
4708109|NCT02200614|16227002|P2|Double Blind Treatment|Other reason|2
4708110|NCT02200614|16227003|P1|Double Blind Treatment|Other reason|6
4708111|NCT02200614|16227002|P2|Double Blind Treatment|Metastasis by local reading|3
4708112|NCT02200614|16227003|P1|Double Blind Treatment|Metastasis by local reading|1
4708113|NCT02200614|16227002|P2|Double Blind Treatment|Judgment of the investigator|99
4708114|NCT02200614|16227003|P1|Double Blind Treatment|Judgment of the investigator|60
4708115|NCT02200614|16227002|P2|Double Blind Treatment|Confirmed metastasis|140
4708116|NCT02200614|16227003|P1|Double Blind Treatment|Confirmed metastasis|119
4708117|NCT02200614|16227002|P2|Double Blind Treatment|Adverse Event|48
4708118|NCT02200614|16227003|P1|Double Blind Treatment|Adverse Event|86
4708119|NCT02200510|16227052|P2|Overall Study|potential COI - joined study team|0
4708120|NCT02200510|16227053|P1|Overall Study|potential COI - joined study team|1
4708121|NCT02200510|16227052|P2|Overall Study|Lost to Follow-up|1
4708122|NCT02200510|16227053|P1|Overall Study|Lost to Follow-up|7
4708123|NCT02200510|16227052|P2|Overall Study|Protocol Violation|1
4708124|NCT02200510|16227053|P1|Overall Study|Protocol Violation|0
4708125|NCT02200510|16227052|P2|Overall Study|Death|1
4708126|NCT02200510|16227053|P1|Overall Study|Death|1
4708127|NCT02200211|16227078|P4|Overall Study|Withdrawal by Subject|0
4708128|NCT02200211|16227079|P3|Overall Study|Withdrawal by Subject|0
4708129|NCT02200211|16227080|P2|Overall Study|Withdrawal by Subject|0
4708130|NCT02200211|16227081|P1|Overall Study|Withdrawal by Subject|1
4708131|NCT02200211|16227078|P4|Overall Study|Lost to Follow-up|2
4708132|NCT02200211|16227079|P3|Overall Study|Lost to Follow-up|1
4708133|NCT02200211|16227080|P2|Overall Study|Lost to Follow-up|7
4708134|NCT02200211|16227081|P1|Overall Study|Lost to Follow-up|7
4708135|NCT02200042|16227194|P2|Overall Study|Withdrawal by Subject|1
4708136|NCT02200042|16227195|P1|Overall Study|Withdrawal by Subject|0
4708137|NCT02199795|16227224|P2|Overall Study|withdrew due to shoulder pain|0
4708138|NCT02199795|16227225|P1|Overall Study|withdrew due to shoulder pain|1
4708139|NCT02199795|16227224|P2|Overall Study|no longer met inclusion criteria|0
4708140|NCT02199795|16227225|P1|Overall Study|no longer met inclusion criteria|1
4708141|NCT02199691|16227248|P4|Overall Study|Lost to Follow-up|10
4708142|NCT02199691|16227249|P3|Overall Study|Lost to Follow-up|9
4708143|NCT02199691|16227250|P2|Overall Study|Lost to Follow-up|1
4708144|NCT02199691|16227251|P1|Overall Study|Lost to Follow-up|2
4708145|NCT02199691|16227248|P4|Overall Study|Withdrawal by Subject|13
4708146|NCT02199691|16227249|P3|Overall Study|Withdrawal by Subject|12
4708147|NCT02199691|16227250|P2|Overall Study|Withdrawal by Subject|3
4708148|NCT02199691|16227251|P1|Overall Study|Withdrawal by Subject|5
4708149|NCT02199691|16227248|P4|Overall Study|Protocol Violation|7
4708150|NCT02199691|16227249|P3|Overall Study|Protocol Violation|6
4708151|NCT02199691|16227250|P2|Overall Study|Protocol Violation|3
4708152|NCT02199691|16227251|P1|Overall Study|Protocol Violation|3
4708153|NCT02199509|16227293|P2|Overall Study|Misunderstood titration schedule|0
4708154|NCT02199509|16227294|P1|Overall Study|Misunderstood titration schedule|1
4708155|NCT02199509|16227293|P2|Overall Study|Suicidal Ideation|1
4708156|NCT02199509|16227294|P1|Overall Study|Suicidal Ideation|0
4708157|NCT02199314|16227317|P1|Overall Study|Physician Decision|10
4708158|NCT02199314|16227317|P1|Overall Study|Withdrawal by Subject|6
4708159|NCT02199080|16227321|P1|Overall Study|Protocol Violation|12
4708160|NCT02199028|16227346|P2|Week 3|Adverse Event|0
4708161|NCT02199028|16227347|P1|Week 3|Adverse Event|1
4708162|NCT02199028|16227346|P2|Week 1|Adverse Event|0
4708163|NCT02199028|16227347|P1|Week 1|Adverse Event|1
4708164|NCT02198963|16227356|P1|Overall Study|Withdrawal by Subject|6
4708165|NCT02198963|16227356|P1|Overall Study|Adverse Event|1
4708166|NCT02198651|16227380|P5|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4708167|NCT02198651|16227381|P4|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1
4708168|NCT02198651|16227382|P3|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4708169|NCT02198651|16227383|P2|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4708170|NCT02198651|16227384|P1|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0
4708171|NCT02198651|16227380|P5|Open-label Rescue Period|Withdrew consent|0
4708172|NCT02198651|16227381|P4|Open-label Rescue Period|Withdrew consent|2
4708173|NCT02198651|16227382|P3|Open-label Rescue Period|Withdrew consent|0
4708174|NCT02198651|16227383|P2|Open-label Rescue Period|Withdrew consent|0
4708175|NCT02198651|16227384|P1|Open-label Rescue Period|Withdrew consent|0
4708176|NCT02198651|16227380|P5|Double-blind Period|Other, not specified|0
4708177|NCT02198651|16227381|P4|Double-blind Period|Other, not specified|0
4708178|NCT02198651|16227382|P3|Double-blind Period|Other, not specified|1
4708179|NCT02198651|16227383|P2|Double-blind Period|Other, not specified|4
4708180|NCT02198651|16227384|P1|Double-blind Period|Other, not specified|0
4708181|NCT02198651|16227380|P5|Double-blind Period|Adverse Event|0
4708182|NCT02198651|16227381|P4|Double-blind Period|Adverse Event|0
4708183|NCT02198651|16227382|P3|Double-blind Period|Adverse Event|0
4708184|NCT02198651|16227383|P2|Double-blind Period|Adverse Event|1
4708185|NCT02198651|16227384|P1|Double-blind Period|Adverse Event|0
4708186|NCT02198651|16227380|P5|Double-blind Period|Withdrew consent|0
4708187|NCT02198651|16227381|P4|Double-blind Period|Withdrew consent|0
4708188|NCT02198651|16227382|P3|Double-blind Period|Withdrew consent|0
4708189|NCT02198651|16227383|P2|Double-blind Period|Withdrew consent|4
4708190|NCT02198651|16227384|P1|Double-blind Period|Withdrew consent|0
4708191|NCT02198651|16227380|P5|Lead-in Period|Other, not specified|0
4708192|NCT02198651|16227381|P4|Lead-in Period|Other, not specified|0
4708193|NCT02198651|16227382|P3|Lead-in Period|Other, not specified|0
4708194|NCT02198651|16227383|P2|Lead-in Period|Other, not specified|0
4708195|NCT02198651|16227384|P1|Lead-in Period|Other, not specified|22
4708196|NCT02198651|16227380|P5|Lead-in Period|Adverse Event|0
4708197|NCT02198651|16227381|P4|Lead-in Period|Adverse Event|0
4708198|NCT02198651|16227382|P3|Lead-in Period|Adverse Event|0
4708199|NCT02198651|16227383|P2|Lead-in Period|Adverse Event|0
4708200|NCT02198651|16227384|P1|Lead-in Period|Adverse Event|2
4708201|NCT02198651|16227380|P5|Lead-in Period|Withdrew consent|0
4708202|NCT02198651|16227381|P4|Lead-in Period|Withdrew consent|0
4708203|NCT02198651|16227382|P3|Lead-in Period|Withdrew consent|0
4708204|NCT02198651|16227383|P2|Lead-in Period|Withdrew consent|0
4708205|NCT02198651|16227384|P1|Lead-in Period|Withdrew consent|13
4708206|NCT02198235|16227485|P3|Overall Study|Lost to Follow-up|2
4708207|NCT02198235|16227486|P2|Overall Study|Lost to Follow-up|2
4708208|NCT02198235|16227487|P1|Overall Study|Lost to Follow-up|3
4708209|NCT02198040|16227507|P3|Overall Study|Withdrawal by Subject|1
4708210|NCT02198040|16227508|P2|Overall Study|Withdrawal by Subject|0
4708211|NCT02198040|16227509|P1|Overall Study|Withdrawal by Subject|0
4708212|NCT02198040|16227507|P3|Overall Study|Work reasons|0
4708213|NCT02198040|16227508|P2|Overall Study|Work reasons|1
4708214|NCT02198040|16227509|P1|Overall Study|Work reasons|0
4708215|NCT02197806|16227539|P4|Overall Study|Adverse Event|1
4708216|NCT02197806|16227540|P3|Overall Study|Adverse Event|0
4708217|NCT02197806|16227541|P2|Overall Study|Adverse Event|1
4708218|NCT02197806|16227542|P1|Overall Study|Adverse Event|0
4708219|NCT02197572|16227557|P1|Overall Study|Reason Not Specified|4
4708220|NCT02197572|16227557|P1|Overall Study|Adverse Event|3
4708221|NCT02197572|16227557|P1|Overall Study|Withdrawal by Subject|9
4708222|NCT02197572|16227557|P1|Overall Study|Progressive Disease|28
4708223|NCT02197520|16227574|P2|Period 2|Withdrawal by Subject|0
4708224|NCT02197520|16227575|P1|Period 2|Withdrawal by Subject|1
4708225|NCT02197520|16227574|P2|Period 2|Adverse Event|2
4708226|NCT02197520|16227575|P1|Period 2|Adverse Event|0
4708227|NCT02197520|16227574|P2|Period 1|Withdrawal by Subject|0
4708228|NCT02197520|16227575|P1|Period 1|Withdrawal by Subject|1
4708229|NCT02197416|16227622|P3|Overall Study|Adverse Event|1
4708230|NCT02197416|16227623|P2|Overall Study|Adverse Event|0
4708231|NCT02197416|16227624|P1|Overall Study|Adverse Event|0
4708232|NCT02197416|16227622|P3|Overall Study|Protocol Violation|1
4708233|NCT02197416|16227623|P2|Overall Study|Protocol Violation|0
4708234|NCT02197416|16227624|P1|Overall Study|Protocol Violation|1
4708235|NCT02197416|16227622|P3|Overall Study|Withdrawal by Subject|1
4708236|NCT02197416|16227623|P2|Overall Study|Withdrawal by Subject|2
4708237|NCT02197416|16227624|P1|Overall Study|Withdrawal by Subject|0
4708238|NCT02197416|16227622|P3|Overall Study|Other reasons|5
4708239|NCT02197416|16227623|P2|Overall Study|Other reasons|2
4708240|NCT02197416|16227624|P1|Overall Study|Other reasons|0
4708241|NCT02197377|16227662|P2|Overall Study|Insertion Failure|3
4708242|NCT02197377|16227663|P1|Overall Study|Insertion Failure|0
4708243|NCT02197247|16227684|P1|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9
4708244|NCT02197247|16227684|P1|Part B: Day 78 to End Part B (AZD9291)|Death|1
4708245|NCT02197247|16227684|P1|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1
4708246|NCT02197247|16227684|P1|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2
4708247|NCT02197247|16227684|P1|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2
4708248|NCT02197247|16227684|P1|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5
4708249|NCT02197247|16227684|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2
4708250|NCT02197247|16227684|P1|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2
4708251|NCT02197234|16227729|P1|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22
4708252|NCT02197234|16227729|P1|Part B: Day 33 to End Part B (AZD9291)|Death|6
4708253|NCT02197234|16227729|P1|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1
4708254|NCT02197234|16227729|P1|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1
4708255|NCT02197234|16227729|P1|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1
4708256|NCT02197234|16227729|P1|Part A: Day 3-30 (AZD9291 Alone)|Adverse Event|1
4708257|NCT02197234|16227729|P1|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1
4708258|NCT02197130|16227751|P3|Overall Study|Other|3
4708259|NCT02197130|16227752|P2|Overall Study|Other|0
4708260|NCT02197130|16227753|P1|Overall Study|Other|1
4708261|NCT02197130|16227751|P3|Overall Study|Withdrawal by Subject|4
4708262|NCT02197130|16227752|P2|Overall Study|Withdrawal by Subject|3
4708263|NCT02197130|16227753|P1|Overall Study|Withdrawal by Subject|0
4708264|NCT02197130|16227751|P3|Overall Study|Does not meet entrance criteria|1
4708265|NCT02197130|16227752|P2|Overall Study|Does not meet entrance criteria|0
4708266|NCT02197130|16227753|P1|Overall Study|Does not meet entrance criteria|0
4708267|NCT02197130|16227751|P3|Overall Study|Lost to Follow-up|1
4708268|NCT02197130|16227752|P2|Overall Study|Lost to Follow-up|0
4708269|NCT02197130|16227753|P1|Overall Study|Lost to Follow-up|2
4708270|NCT02197130|16227751|P3|Overall Study|Death|0
4708271|NCT02197130|16227752|P2|Overall Study|Death|1
4708272|NCT02197130|16227753|P1|Overall Study|Death|0
4708273|NCT02197130|16227751|P3|Overall Study|Adverse Event|23
4708274|NCT02197130|16227752|P2|Overall Study|Adverse Event|4
4708275|NCT02197130|16227753|P1|Overall Study|Adverse Event|13
4708276|NCT00430716|16227806|P3|Open Label Phase|Study terminated by sponsor|4
4708277|NCT00430716|16227807|P2|Open Label Phase|Study terminated by sponsor|5
4708278|NCT00430716|16227808|P1|Open Label Phase|Study terminated by sponsor|4
4708279|NCT00430716|16227806|P3|Open Label Phase|Protocol Violation|0
4708280|NCT00430716|16227807|P2|Open Label Phase|Protocol Violation|0
4708281|NCT00430716|16227808|P1|Open Label Phase|Protocol Violation|1
4708282|NCT00430716|16227806|P3|Open Label Phase|Other|1
4708283|NCT00430716|16227807|P2|Open Label Phase|Other|1
4708284|NCT00430716|16227808|P1|Open Label Phase|Other|3
4708285|NCT00430716|16227806|P3|Open Label Phase|No longer willing to participate|1
4708286|NCT00430716|16227807|P2|Open Label Phase|No longer willing to participate|1
4708287|NCT00430716|16227808|P1|Open Label Phase|No longer willing to participate|0
4708288|NCT00430716|16227806|P3|Open Label Phase|Lost to Follow-up|1
4708289|NCT00430716|16227807|P2|Open Label Phase|Lost to Follow-up|0
4708290|NCT00430716|16227808|P1|Open Label Phase|Lost to Follow-up|1
4708291|NCT00430716|16227806|P3|Double Blind Phase|Not treated|0
4708292|NCT00430716|16227807|P2|Double Blind Phase|Not treated|0
4708293|NCT00430716|16227808|P1|Double Blind Phase|Not treated|1
4708294|NCT00430716|16227806|P3|Double Blind Phase|Adverse Event|3
4708295|NCT00430716|16227807|P2|Double Blind Phase|Adverse Event|1
4708296|NCT00430716|16227808|P1|Double Blind Phase|Adverse Event|1
4708297|NCT00430716|16227806|P3|Double Blind Phase|Study terminated by sponsor|2
4708298|NCT00430716|16227807|P2|Double Blind Phase|Study terminated by sponsor|1
4708299|NCT00430716|16227808|P1|Double Blind Phase|Study terminated by sponsor|1
4708300|NCT00430716|16227806|P3|Double Blind Phase|Other|0
4708301|NCT00430716|16227807|P2|Double Blind Phase|Other|2
4708302|NCT00430716|16227808|P1|Double Blind Phase|Other|0
4708303|NCT00430716|16227806|P3|Double Blind Phase|No longer willing to participate|1
4708304|NCT00430716|16227807|P2|Double Blind Phase|No longer willing to participate|1
4708305|NCT00430716|16227808|P1|Double Blind Phase|No longer willing to participate|2
4708306|NCT00430716|16227806|P3|Double Blind Phase|Death|0
4708307|NCT00430716|16227807|P2|Double Blind Phase|Death|0
4708308|NCT00430716|16227808|P1|Double Blind Phase|Death|1
4708309|NCT02196714|16228033|P4|Overall Study|Protocol Violation|0
4708310|NCT02196714|16228034|P3|Overall Study|Protocol Violation|1
4708311|NCT02196714|16228035|P2|Overall Study|Protocol Violation|0
4708312|NCT02196714|16228036|P1|Overall Study|Protocol Violation|0
4708313|NCT02196701|16228158|P1|Overall Study|Non-adherence to Protocol|1
4708314|NCT02196701|16228158|P1|Overall Study|Lost to Follow-up|1
4708315|NCT02196701|16228158|P1|Overall Study|Adverse Event|1
4708316|NCT02196675|16228232|P3|Overall Study|Death|1
4708317|NCT02196675|16228233|P2|Overall Study|Death|0
4708318|NCT02196675|16228234|P1|Overall Study|Death|0
4708319|NCT02196675|16228232|P3|Overall Study|Protocol Violation|0
4708320|NCT02196675|16228233|P2|Overall Study|Protocol Violation|1
4708321|NCT02196675|16228234|P1|Overall Study|Protocol Violation|0
4708322|NCT02196675|16228232|P3|Overall Study|Intra-operative surgical exclusion|0
4708323|NCT02196675|16228233|P2|Overall Study|Intra-operative surgical exclusion|1
4708324|NCT02196675|16228234|P1|Overall Study|Intra-operative surgical exclusion|1
4708325|NCT02196675|16228232|P3|Overall Study|Withdrawal by Subject|0
4708326|NCT02196675|16228233|P2|Overall Study|Withdrawal by Subject|0
4708327|NCT02196675|16228234|P1|Overall Study|Withdrawal by Subject|1
4708328|NCT02196558|16228257|P3|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
4708329|NCT02196558|16228258|P2|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
4708330|NCT02196558|16228259|P1|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1
4708331|NCT02196558|16228257|P3|Extension Phase (40 Weeks)|Adverse Event|0
4708332|NCT02196558|16228258|P2|Extension Phase (40 Weeks)|Adverse Event|2
4708333|NCT02196558|16228259|P1|Extension Phase (40 Weeks)|Adverse Event|1
4708334|NCT02196558|16228257|P3|Treatment Phase (12 Weeks)|Progression of Disease|1
4708335|NCT02196558|16228258|P2|Treatment Phase (12 Weeks)|Progression of Disease|0
4708336|NCT02196558|16228259|P1|Treatment Phase (12 Weeks)|Progression of Disease|0
4708337|NCT02196558|16228257|P3|Treatment Phase (12 Weeks)|Participant Choice|1
4708338|NCT02196558|16228258|P2|Treatment Phase (12 Weeks)|Participant Choice|1
4708339|NCT02196558|16228259|P1|Treatment Phase (12 Weeks)|Participant Choice|0
4708340|NCT02196558|16228257|P3|Treatment Phase (12 Weeks)|Adverse Event|0
4708341|NCT02196558|16228258|P2|Treatment Phase (12 Weeks)|Adverse Event|2
4708342|NCT02196558|16228259|P1|Treatment Phase (12 Weeks)|Adverse Event|0
4708343|NCT02196506|16228275|P4|Phase A+|Participant withdrawn by investigator|1
4708344|NCT02196506|16228276|P3|Phase A+|Participant withdrawn by investigator|0
4708345|NCT02196506|16228277|P2|Phase A+|Participant withdrawn by investigator|0
4708436|NCT02195869|16228398|P1|Overall Study|Physician Decision|4
4708346|NCT02196506|16228278|P1|Phase A+|Participant withdrawn by investigator|0
4708347|NCT02196506|16228275|P4|Phase A+|Lost to Follow-up|6
4708348|NCT02196506|16228276|P3|Phase A+|Lost to Follow-up|0
4708349|NCT02196506|16228277|P2|Phase A+|Lost to Follow-up|0
4708350|NCT02196506|16228278|P1|Phase A+|Lost to Follow-up|0
4708351|NCT02196506|16228275|P4|Phase A+|Adverse Event|1
4708352|NCT02196506|16228276|P3|Phase A+|Adverse Event|0
4708353|NCT02196506|16228277|P2|Phase A+|Adverse Event|0
4708354|NCT02196506|16228278|P1|Phase A+|Adverse Event|0
4708355|NCT02196506|16228275|P4|Phase A+|Withdrawal by Participant|5
4708356|NCT02196506|16228276|P3|Phase A+|Withdrawal by Participant|0
4708357|NCT02196506|16228277|P2|Phase A+|Withdrawal by Participant|0
4708358|NCT02196506|16228278|P1|Phase A+|Withdrawal by Participant|0
4708359|NCT02196506|16228275|P4|Phase A+|Participant Met Withdrawal Criteria|1
4708360|NCT02196506|16228276|P3|Phase A+|Participant Met Withdrawal Criteria|0
4708361|NCT02196506|16228277|P2|Phase A+|Participant Met Withdrawal Criteria|0
4708362|NCT02196506|16228278|P1|Phase A+|Participant Met Withdrawal Criteria|0
4708363|NCT02196506|16228275|P4|Phase B|Lost to Follow-up|0
4708364|NCT02196506|16228276|P3|Phase B|Lost to Follow-up|1
4708365|NCT02196506|16228277|P2|Phase B|Lost to Follow-up|2
4708366|NCT02196506|16228278|P1|Phase B|Lost to Follow-up|0
4708367|NCT02196506|16228275|P4|Phase B|Adverse Event|0
4708368|NCT02196506|16228276|P3|Phase B|Adverse Event|1
4708369|NCT02196506|16228277|P2|Phase B|Adverse Event|4
4708370|NCT02196506|16228278|P1|Phase B|Adverse Event|0
4708371|NCT02196506|16228275|P4|Phase B|Withdrawal by Participant|0
4708372|NCT02196506|16228276|P3|Phase B|Withdrawal by Participant|1
4708373|NCT02196506|16228277|P2|Phase B|Withdrawal by Participant|8
4708374|NCT02196506|16228278|P1|Phase B|Withdrawal by Participant|0
4708375|NCT02196506|16228275|P4|Phase B|Lack of Efficacy|0
4708376|NCT02196506|16228276|P3|Phase B|Lack of Efficacy|2
4708377|NCT02196506|16228277|P2|Phase B|Lack of Efficacy|1
4708378|NCT02196506|16228278|P1|Phase B|Lack of Efficacy|0
4708379|NCT02196506|16228275|P4|Phase B|Participant Met Withdrawal Criteria|0
4708380|NCT02196506|16228276|P3|Phase B|Participant Met Withdrawal Criteria|1
4708381|NCT02196506|16228277|P2|Phase B|Participant Met Withdrawal Criteria|0
4708382|NCT02196506|16228278|P1|Phase B|Participant Met Withdrawal Criteria|0
4708383|NCT02196506|16228275|P4|Phase A|Participant withdrawn by investigator|0
4708384|NCT02196506|16228276|P3|Phase A|Participant withdrawn by investigator|0
4708385|NCT02196506|16228277|P2|Phase A|Participant withdrawn by investigator|0
4708386|NCT02196506|16228278|P1|Phase A|Participant withdrawn by investigator|10
4708387|NCT02196506|16228275|P4|Phase A|Protocol deviation|0
4708388|NCT02196506|16228276|P3|Phase A|Protocol deviation|0
4708389|NCT02196506|16228277|P2|Phase A|Protocol deviation|0
4708390|NCT02196506|16228278|P1|Phase A|Protocol deviation|12
4708391|NCT02196506|16228275|P4|Phase A|Lost to Follow-up|0
4708392|NCT02196506|16228276|P3|Phase A|Lost to Follow-up|0
4708393|NCT02196506|16228277|P2|Phase A|Lost to Follow-up|0
4708394|NCT02196506|16228278|P1|Phase A|Lost to Follow-up|9
4708395|NCT02196506|16228275|P4|Phase A|Adverse Event|0
4708396|NCT02196506|16228276|P3|Phase A|Adverse Event|0
4708397|NCT02196506|16228277|P2|Phase A|Adverse Event|0
4708398|NCT02196506|16228278|P1|Phase A|Adverse Event|22
4708399|NCT02196506|16228275|P4|Phase A|Withdrawal by Subject|0
4708400|NCT02196506|16228276|P3|Phase A|Withdrawal by Subject|0
4708401|NCT02196506|16228277|P2|Phase A|Withdrawal by Subject|0
4708402|NCT02196506|16228278|P1|Phase A|Withdrawal by Subject|34
4708403|NCT02196506|16228275|P4|Phase A|Participant Met Withdrawal Criteria|0
4708404|NCT02196506|16228276|P3|Phase A|Participant Met Withdrawal Criteria|0
4708405|NCT02196506|16228277|P2|Phase A|Participant Met Withdrawal Criteria|0
4708406|NCT02196506|16228278|P1|Phase A|Participant Met Withdrawal Criteria|34
4708407|NCT02196259|16228293|P3|Overall Study|Partial data analysis|0
4708408|NCT02196259|16228294|P2|Overall Study|Partial data analysis|3
4708409|NCT02196259|16228295|P1|Overall Study|Partial data analysis|0
4708410|NCT02196259|16228293|P3|Overall Study|Researcher choice|1
4708411|NCT02196259|16228294|P2|Overall Study|Researcher choice|0
4708412|NCT02196259|16228295|P1|Overall Study|Researcher choice|0
4708413|NCT02196077|16228323|P1|Overall Study|Protocol Violation|24
4708414|NCT02196077|16228323|P1|Overall Study|Lost to Follow-up|3
4708415|NCT02196077|16228323|P1|Overall Study|Physician Decision|1
4708416|NCT02196077|16228323|P1|Overall Study|Withdrawal by Subject|14
4708417|NCT02196077|16228323|P1|Overall Study|Lack of Efficacy|1
4708418|NCT02196077|16228323|P1|Overall Study|Adverse Event|4
4708419|NCT02195986|16228373|P3|Overall Study|Non-compliance|0
4708420|NCT02195986|16228374|P2|Overall Study|Non-compliance|1
4708421|NCT02195986|16228375|P1|Overall Study|Non-compliance|0
4708422|NCT02195986|16228373|P3|Overall Study|Protocol Violation|1
4708423|NCT02195986|16228374|P2|Overall Study|Protocol Violation|1
4708424|NCT02195986|16228375|P1|Overall Study|Protocol Violation|0
4708425|NCT02195986|16228373|P3|Overall Study|Family Emergency|1
4708426|NCT02195986|16228374|P2|Overall Study|Family Emergency|0
4708427|NCT02195986|16228375|P1|Overall Study|Family Emergency|0
4708428|NCT02195986|16228373|P3|Overall Study|Withdrawal by Subject|0
4708429|NCT02195986|16228374|P2|Overall Study|Withdrawal by Subject|3
4708430|NCT02195986|16228375|P1|Overall Study|Withdrawal by Subject|0
4708431|NCT02195986|16228373|P3|Overall Study|Adverse Event|0
4708432|NCT02195986|16228374|P2|Overall Study|Adverse Event|0
4708433|NCT02195986|16228375|P1|Overall Study|Adverse Event|3
4708434|NCT02195869|16228398|P1|Overall Study|Noncompliance with study drug|2
4708435|NCT02195869|16228398|P1|Overall Study|Study Terminated by Sponsor|7
4708437|NCT02195869|16228398|P1|Overall Study|Withdrawal by Subject|7
4708438|NCT02195869|16228398|P1|Overall Study|Adverse Event|15
4708439|NCT02195869|16228398|P1|Overall Study|Malignancy Progression/relapse|2
4708440|NCT02195869|16228398|P1|Overall Study|cGVHD Progression|5
4708441|NCT02195700|16228420|P2|Overall Study|Lost to Follow-up|1
4708442|NCT02195700|16228421|P1|Overall Study|Lost to Follow-up|1
4708443|NCT02195700|16228420|P2|Overall Study|Withdrawal by Subject|2
4708444|NCT02195700|16228421|P1|Overall Study|Withdrawal by Subject|3
4708445|NCT02195700|16228420|P2|Overall Study|Adverse Event|2
4708446|NCT02195700|16228421|P1|Overall Study|Adverse Event|1
4708447|NCT02195700|16228420|P2|Overall Study|Noncompliance|0
4708448|NCT02195700|16228421|P1|Overall Study|Noncompliance|1
4708449|NCT02195700|16228420|P2|Overall Study|Protocol Violation|2
4708450|NCT02195700|16228421|P1|Overall Study|Protocol Violation|0
4708451|NCT02195687|16228443|P2|Overall Study|Lost to Follow-up|1
4708452|NCT02195687|16228444|P1|Overall Study|Lost to Follow-up|4
4708453|NCT02195687|16228443|P2|Overall Study|Personal Reasons|1
4708454|NCT02195687|16228444|P1|Overall Study|Personal Reasons|1
4708455|NCT02195583|16228469|P1|Overall Study|Other Reason|2
4708456|NCT02195583|16228469|P1|Overall Study|Adverse Event|2
4708457|NCT02195583|16228469|P1|Overall Study|Withdrawal by Subject|4
4708458|NCT02195583|16228469|P1|Overall Study|Lost to Follow-up|1
4708459|NCT02195531|16228504|P3|Overall Study|Withdrawal by Subject|1
4708460|NCT02195531|16228505|P2|Overall Study|Withdrawal by Subject|1
4708461|NCT02195531|16228506|P1|Overall Study|Withdrawal by Subject|1
4708462|NCT02195518|16228531|P1|Overall Study|Lost to Follow-up|1
4708463|NCT02195518|16228531|P1|Overall Study|Withdrawal by Subject|1
4708464|NCT02195518|16228531|P1|Overall Study|Pregnancy|2
4708465|NCT02195518|16228531|P1|Overall Study|Protocol Violation|4
4708466|NCT02195518|16228531|P1|Overall Study|Adverse Event|1
4708467|NCT02195479|16228554|P2|Overall Study|Ongoing|297
4708468|NCT02195479|16228555|P1|Overall Study|Ongoing|291
4708469|NCT02195479|16228554|P2|Overall Study|Other|2
4708470|NCT02195479|16228555|P1|Overall Study|Other|2
4708471|NCT02195479|16228554|P2|Overall Study|Withdrawal by Subject|6
4708472|NCT02195479|16228555|P1|Overall Study|Withdrawal by Subject|11
4708473|NCT02195479|16228554|P2|Overall Study|Physician Decision|0
4708474|NCT02195479|16228555|P1|Overall Study|Physician Decision|1
4708475|NCT02195479|16228554|P2|Overall Study|Death|45
4708476|NCT02195479|16228555|P1|Overall Study|Death|48
4708477|NCT02195479|16228554|P2|Overall Study|Lost to Follow-up|0
4708478|NCT02195479|16228555|P1|Overall Study|Lost to Follow-up|3
4708479|NCT02195427|16228593|P2|Overall Study|Conditional re-treatment at W52|1
4708480|NCT02195427|16228594|P1|Overall Study|Conditional re-treatment at W52|2
4708481|NCT02195427|16228593|P2|Overall Study|Protocol Violation|14
4708482|NCT02195427|16228594|P1|Overall Study|Protocol Violation|7
4708483|NCT02195427|16228593|P2|Overall Study|Lost to Follow-up|1
4708484|NCT02195427|16228594|P1|Overall Study|Lost to Follow-up|0
4708485|NCT02195427|16228593|P2|Overall Study|Withdrawal by Subject|2
4708486|NCT02195427|16228594|P1|Overall Study|Withdrawal by Subject|4
4708487|NCT02195427|16228593|P2|Overall Study|Did not consent to study extension|9
4708488|NCT02195427|16228594|P1|Overall Study|Did not consent to study extension|13
4708489|NCT02195011|16228959|P2|Overall Study|Withdrawal by Subject|0
4708490|NCT02195011|16228960|P1|Overall Study|Withdrawal by Subject|3
4708491|NCT02195011|16228959|P2|Overall Study|Progressive Disease|1
4708492|NCT02195011|16228960|P1|Overall Study|Progressive Disease|18
4708493|NCT02195011|16228959|P2|Overall Study|Adverse Event|0
4708494|NCT02195011|16228960|P1|Overall Study|Adverse Event|4
4708495|NCT02194998|16228976|P4|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
4708496|NCT02194998|16228977|P3|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
4708497|NCT02194998|16228978|P2|Post-HCV Treatment Follow-Up|Lost to Follow-up|0
4708498|NCT02194998|16228979|P1|Post-HCV Treatment Follow-Up|Lost to Follow-up|1
4708499|NCT02194998|16228976|P4|On-HCV Treatment|Did not pick up study medication|0
4708500|NCT02194998|16228977|P3|On-HCV Treatment|Did not pick up study medication|0
4708501|NCT02194998|16228978|P2|On-HCV Treatment|Did not pick up study medication|1
4708502|NCT02194998|16228979|P1|On-HCV Treatment|Did not pick up study medication|0
4708503|NCT02194933|16229043|P2|Overall Study|Lack of Efficacy|2
4708504|NCT02194933|16229044|P1|Overall Study|Lack of Efficacy|1
4708505|NCT02194933|16229043|P2|Overall Study|Withdrawal by Subject|2
4708506|NCT02194933|16229044|P1|Overall Study|Withdrawal by Subject|0
4708507|NCT02194933|16229043|P2|Overall Study|Participant met withdrawal criteria|3
4708508|NCT02194933|16229044|P1|Overall Study|Participant met withdrawal criteria|1
4708509|NCT02194933|16229043|P2|Overall Study|Lost to Follow-up|2
4708510|NCT02194933|16229044|P1|Overall Study|Lost to Follow-up|1
4708511|NCT02194699|16229098|P2|With Potential to Receive 52 Weeks of IP|Other|16
4708512|NCT02194699|16229099|P1|With Potential to Receive 52 Weeks of IP|Other|24
4708513|NCT02194699|16229098|P2|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20
4708514|NCT02194699|16229099|P1|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14
4708515|NCT02194699|16229098|P2|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
4708516|NCT02194699|16229099|P1|With Potential to Receive 52 Weeks of IP|Protocol Violation|2
4708517|NCT02194699|16229098|P2|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8
4708518|NCT02194699|16229099|P1|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5
4708519|NCT02194699|16229098|P2|With Potential to Receive 52 Weeks of IP|Death|3
4708520|NCT02194699|16229099|P1|With Potential to Receive 52 Weeks of IP|Death|1
4708521|NCT02194699|16229098|P2|With Potential to Receive 52 Weeks of IP|Adverse Event|3
4708522|NCT02194699|16229099|P1|With Potential to Receive 52 Weeks of IP|Adverse Event|4
4708523|NCT02194699|16229098|P2|Randomised|Duplicate patient|1
4708524|NCT02194699|16229099|P1|Randomised|Duplicate patient|2
4708525|NCT02194699|16229098|P2|Randomised|Without potential for 52 weeks of IP|5
4708526|NCT02194699|16229099|P1|Randomised|Without potential for 52 weeks of IP|5
4708527|NCT02194699|16229098|P2|Randomised|Did not receive treatment|5
4708528|NCT02194699|16229099|P1|Randomised|Did not receive treatment|1
4708529|NCT02194621|16229207|P3|Overall Study|Withdrawal by Subject|7
4708530|NCT02194621|16229208|P2|Overall Study|Withdrawal by Subject|4
4708531|NCT02194621|16229209|P1|Overall Study|Withdrawal by Subject|4
4708532|NCT02194621|16229207|P3|Overall Study|6 withdrew prior to randomization|2
4708533|NCT02194621|16229208|P2|Overall Study|6 withdrew prior to randomization|2
4708534|NCT02194621|16229209|P1|Overall Study|6 withdrew prior to randomization|2
4708535|NCT02194465|16229233|P7|Overall Study|Discontinued follow-up period|0
4708536|NCT02194465|16229234|P6|Overall Study|Discontinued follow-up period|0
4708537|NCT02194465|16229235|P5|Overall Study|Discontinued follow-up period|2
4708538|NCT02194465|16229236|P4|Overall Study|Discontinued follow-up period|0
4708539|NCT02194465|16229237|P3|Overall Study|Discontinued follow-up period|1
4708540|NCT02194465|16229238|P2|Overall Study|Discontinued follow-up period|2
4708541|NCT02194465|16229239|P1|Overall Study|Discontinued follow-up period|0
4708542|NCT02194465|16229233|P7|Overall Study|Withdrawal by Subject|2
4708543|NCT02194465|16229234|P6|Overall Study|Withdrawal by Subject|1
4708544|NCT02194465|16229235|P5|Overall Study|Withdrawal by Subject|2
4708545|NCT02194465|16229236|P4|Overall Study|Withdrawal by Subject|2
4708546|NCT02194465|16229237|P3|Overall Study|Withdrawal by Subject|1
4708547|NCT02194465|16229238|P2|Overall Study|Withdrawal by Subject|3
4708548|NCT02194465|16229239|P1|Overall Study|Withdrawal by Subject|1
4708549|NCT02194465|16229233|P7|Overall Study|Protocol Violation|0
4708550|NCT02194465|16229234|P6|Overall Study|Protocol Violation|0
4708551|NCT02194465|16229235|P5|Overall Study|Protocol Violation|1
4708552|NCT02194465|16229236|P4|Overall Study|Protocol Violation|1
4708553|NCT02194465|16229237|P3|Overall Study|Protocol Violation|2
4708554|NCT02194465|16229238|P2|Overall Study|Protocol Violation|1
4708555|NCT02194465|16229239|P1|Overall Study|Protocol Violation|1
4708556|NCT02194465|16229233|P7|Overall Study|Physician Decision|0
4708557|NCT02194465|16229234|P6|Overall Study|Physician Decision|0
4708558|NCT02194465|16229235|P5|Overall Study|Physician Decision|0
4708559|NCT02194465|16229236|P4|Overall Study|Physician Decision|0
4708560|NCT02194465|16229237|P3|Overall Study|Physician Decision|0
4708561|NCT02194465|16229238|P2|Overall Study|Physician Decision|0
4708562|NCT02194465|16229239|P1|Overall Study|Physician Decision|1
4708563|NCT02194465|16229233|P7|Overall Study|Lost to Follow-up|0
4708564|NCT02194465|16229234|P6|Overall Study|Lost to Follow-up|1
4708565|NCT02194465|16229235|P5|Overall Study|Lost to Follow-up|0
4708566|NCT02194465|16229236|P4|Overall Study|Lost to Follow-up|1
4708567|NCT02194465|16229237|P3|Overall Study|Lost to Follow-up|0
4708568|NCT02194465|16229238|P2|Overall Study|Lost to Follow-up|0
4708569|NCT02194465|16229239|P1|Overall Study|Lost to Follow-up|0
4708570|NCT02194465|16229233|P7|Overall Study|Adverse Event|0
4708571|NCT02194465|16229234|P6|Overall Study|Adverse Event|2
4708572|NCT02194465|16229235|P5|Overall Study|Adverse Event|4
4708573|NCT02194465|16229236|P4|Overall Study|Adverse Event|4
4708574|NCT02194465|16229237|P3|Overall Study|Adverse Event|4
4708575|NCT02194465|16229238|P2|Overall Study|Adverse Event|1
4708576|NCT02194465|16229239|P1|Overall Study|Adverse Event|6
4708577|NCT02194062|16229296|P3|Overall Study|Lost to Follow-up|5
4708578|NCT02194062|16229297|P2|Overall Study|Lost to Follow-up|2
4708579|NCT02194062|16229298|P1|Overall Study|Lost to Follow-up|2
4708580|NCT02193880|16229309|P1|Overall Study|patients did not collect enough HPC|3
4708581|NCT02193867|16229314|P1|Overall Study|Sponsor Study Termination|2
4708582|NCT02193867|16229314|P1|Overall Study|Death|2
4708583|NCT02193828|16229332|P4|Overall Study|Withdrawal by Subject|1
4708584|NCT02193828|16229333|P3|Overall Study|Withdrawal by Subject|1
4708585|NCT02193828|16229334|P2|Overall Study|Withdrawal by Subject|0
4708586|NCT02193828|16229335|P1|Overall Study|Withdrawal by Subject|0
4708587|NCT02193776|16229412|P4|Overall Study|Adverse event/Specific toxicity|2
4708588|NCT02193776|16229413|P3|Overall Study|Adverse event/Specific toxicity|2
4708589|NCT02193776|16229414|P2|Overall Study|Adverse event/Specific toxicity|5
4708590|NCT02193776|16229415|P1|Overall Study|Adverse event/Specific toxicity|5
4708591|NCT02193776|16229412|P4|Overall Study|Death|0
4708592|NCT02193776|16229413|P3|Overall Study|Death|0
4708593|NCT02193776|16229414|P2|Overall Study|Death|0
4708594|NCT02193776|16229415|P1|Overall Study|Death|1
4708595|NCT02193776|16229412|P4|Overall Study|Investigator/Sponsor decision|0
4708596|NCT02193776|16229413|P3|Overall Study|Investigator/Sponsor decision|0
4708597|NCT02193776|16229414|P2|Overall Study|Investigator/Sponsor decision|1
4708598|NCT02193776|16229415|P1|Overall Study|Investigator/Sponsor decision|1
4708599|NCT02193776|16229412|P4|Overall Study|Failure to comply with protocol|0
4708600|NCT02193776|16229413|P3|Overall Study|Failure to comply with protocol|0
4708601|NCT02193776|16229414|P2|Overall Study|Failure to comply with protocol|1
4708602|NCT02193776|16229415|P1|Overall Study|Failure to comply with protocol|0
4708603|NCT02193776|16229412|P4|Overall Study|Consent withdrawn|0
4708604|NCT02193776|16229413|P3|Overall Study|Consent withdrawn|0
4708605|NCT02193776|16229414|P2|Overall Study|Consent withdrawn|0
4708606|NCT02193776|16229415|P1|Overall Study|Consent withdrawn|1
4708607|NCT02193178|16229442|P1|Overall Study|Dry eyes|1
4708608|NCT02193178|16229442|P1|Overall Study|Lost to Follow-up|1
4708609|NCT02193165|16229492|P3|6 Week Product Use|Lost to Follow-up|0
4708610|NCT02193165|16229493|P2|6 Week Product Use|Lost to Follow-up|1
4708611|NCT02193165|16229494|P1|6 Week Product Use|Lost to Follow-up|0
4708612|NCT02193165|16229492|P3|4 Week Product Use|Lost to Follow-up|1
4708613|NCT02193165|16229493|P2|4 Week Product Use|Lost to Follow-up|1
4708614|NCT02193165|16229494|P1|4 Week Product Use|Lost to Follow-up|1
4708615|NCT02193087|16229529|P4|Overall Study|Did Not Receive Any Vaccination|1
4708616|NCT02193087|16229530|P3|Overall Study|Did Not Receive Any Vaccination|0
4708617|NCT02193087|16229531|P2|Overall Study|Did Not Receive Any Vaccination|3
4708618|NCT02193087|16229532|P1|Overall Study|Did Not Receive Any Vaccination|2
4708619|NCT02193087|16229529|P4|Overall Study|Other Reason Not Specified|9
4708620|NCT02193087|16229530|P3|Overall Study|Other Reason Not Specified|1
4708621|NCT02193087|16229531|P2|Overall Study|Other Reason Not Specified|2
4708622|NCT02193087|16229532|P1|Overall Study|Other Reason Not Specified|7
4708623|NCT02193087|16229529|P4|Overall Study|Withdrawal by Subject|19
4708624|NCT02193087|16229530|P3|Overall Study|Withdrawal by Subject|1
4708625|NCT02193087|16229531|P2|Overall Study|Withdrawal by Subject|3
4708626|NCT02193087|16229532|P1|Overall Study|Withdrawal by Subject|10
4708627|NCT02193087|16229529|P4|Overall Study|Protocol Violation|2
4708628|NCT02193087|16229530|P3|Overall Study|Protocol Violation|1
4708629|NCT02193087|16229531|P2|Overall Study|Protocol Violation|0
4708630|NCT02193087|16229532|P1|Overall Study|Protocol Violation|2
4708631|NCT02193087|16229529|P4|Overall Study|Lost to Follow-up|37
4708632|NCT02193087|16229530|P3|Overall Study|Lost to Follow-up|4
4708633|NCT02193087|16229531|P2|Overall Study|Lost to Follow-up|6
4708634|NCT02193087|16229532|P1|Overall Study|Lost to Follow-up|14
4708635|NCT02193087|16229529|P4|Overall Study|Adverse Event|11
4708636|NCT02193087|16229530|P3|Overall Study|Adverse Event|0
4708637|NCT02193087|16229531|P2|Overall Study|Adverse Event|0
4708638|NCT02193087|16229532|P1|Overall Study|Adverse Event|2
4708639|NCT02193074|16229577|P2|Overall Study|Adverse Event|13
4708640|NCT02193074|16229578|P1|Overall Study|Adverse Event|16
4708641|NCT02193074|16229577|P2|Overall Study|Withdrawal by Subject|2
4708642|NCT02193074|16229578|P1|Overall Study|Withdrawal by Subject|1
4708643|NCT02192905|16229610|P1|Overall Study|Lost to Follow-up|1
4708644|NCT02192606|16229678|P2|Overall Study|3D equipment rep unable to join|1
4708645|NCT02192606|16229679|P1|Overall Study|3D equipment rep unable to join|0
4708646|NCT02192606|16229678|P2|Overall Study|Physician Decision|2
4708647|NCT02192606|16229679|P1|Overall Study|Physician Decision|1
4708648|NCT02192606|16229678|P2|Overall Study|surgery type was changed|1
4708649|NCT02192606|16229679|P1|Overall Study|surgery type was changed|1
4708650|NCT02192190|16229727|P6|Overall Study|Inadequate Pain Relief|0
4708651|NCT02192190|16229728|P5|Overall Study|Inadequate Pain Relief|0
4708652|NCT02192190|16229729|P4|Overall Study|Inadequate Pain Relief|0
4708653|NCT02192190|16229730|P3|Overall Study|Inadequate Pain Relief|1
4708654|NCT02192190|16229731|P2|Overall Study|Inadequate Pain Relief|1
4708655|NCT02192190|16229732|P1|Overall Study|Inadequate Pain Relief|0
4708656|NCT02192190|16229727|P6|Overall Study|Positive Drug Screen|0
4708657|NCT02192190|16229728|P5|Overall Study|Positive Drug Screen|0
4708658|NCT02192190|16229729|P4|Overall Study|Positive Drug Screen|1
4708659|NCT02192190|16229730|P3|Overall Study|Positive Drug Screen|0
4708660|NCT02192190|16229731|P2|Overall Study|Positive Drug Screen|0
4708661|NCT02192190|16229732|P1|Overall Study|Positive Drug Screen|0
4708662|NCT02192190|16229727|P6|Overall Study|Could not Keep Visit Schedule|0
4708663|NCT02192190|16229728|P5|Overall Study|Could not Keep Visit Schedule|0
4708664|NCT02192190|16229729|P4|Overall Study|Could not Keep Visit Schedule|0
4708665|NCT02192190|16229730|P3|Overall Study|Could not Keep Visit Schedule|0
4708666|NCT02192190|16229731|P2|Overall Study|Could not Keep Visit Schedule|0
4708667|NCT02192190|16229732|P1|Overall Study|Could not Keep Visit Schedule|1
4708668|NCT02192190|16229727|P6|Overall Study|Withdrawal by Subject|3
4708669|NCT02192190|16229728|P5|Overall Study|Withdrawal by Subject|5
4708670|NCT02192190|16229729|P4|Overall Study|Withdrawal by Subject|1
4708671|NCT02192190|16229730|P3|Overall Study|Withdrawal by Subject|2
4708672|NCT02192190|16229731|P2|Overall Study|Withdrawal by Subject|1
4708673|NCT02192190|16229732|P1|Overall Study|Withdrawal by Subject|4
4708674|NCT02192190|16229727|P6|Overall Study|Terminated by Sponsor|23
4708675|NCT02192190|16229728|P5|Overall Study|Terminated by Sponsor|21
4708676|NCT02192190|16229729|P4|Overall Study|Terminated by Sponsor|23
4708677|NCT02192190|16229730|P3|Overall Study|Terminated by Sponsor|20
4708678|NCT02192190|16229731|P2|Overall Study|Terminated by Sponsor|23
4708679|NCT02192190|16229732|P1|Overall Study|Terminated by Sponsor|43
4708680|NCT02192190|16229727|P6|Overall Study|Physician Decision|0
4708681|NCT02192190|16229728|P5|Overall Study|Physician Decision|0
4708682|NCT02192190|16229729|P4|Overall Study|Physician Decision|0
4708683|NCT02192190|16229730|P3|Overall Study|Physician Decision|0
4708684|NCT02192190|16229731|P2|Overall Study|Physician Decision|0
4708685|NCT02192190|16229732|P1|Overall Study|Physician Decision|2
4708686|NCT02192190|16229727|P6|Overall Study|Lost to Follow-up|3
4708687|NCT02192190|16229728|P5|Overall Study|Lost to Follow-up|4
4708688|NCT02192190|16229729|P4|Overall Study|Lost to Follow-up|1
4708689|NCT02192190|16229730|P3|Overall Study|Lost to Follow-up|2
4708690|NCT02192190|16229731|P2|Overall Study|Lost to Follow-up|3
4708691|NCT02192190|16229732|P1|Overall Study|Lost to Follow-up|3
4708692|NCT02192190|16229727|P6|Overall Study|Adverse Event|0
4708693|NCT02192190|16229728|P5|Overall Study|Adverse Event|0
4708694|NCT02192190|16229729|P4|Overall Study|Adverse Event|0
4708695|NCT02192190|16229730|P3|Overall Study|Adverse Event|0
4708696|NCT02192190|16229731|P2|Overall Study|Adverse Event|1
4708697|NCT02192190|16229732|P1|Overall Study|Adverse Event|1
4708698|NCT02192164|16229776|P1|Overall Study|Did not meet the exclusion criteria|1
4708699|NCT02192164|16229776|P1|Overall Study|Physician Decision|4
4708700|NCT02192164|16229776|P1|Overall Study|Withdrawal by Subject|1
4708701|NCT02192164|16229776|P1|Overall Study|Other|8
4708702|NCT02192099|16229792|P1|Overall Study|Miscellaneous Reasons|5
4708703|NCT02192099|16229792|P1|Overall Study|Withdrawal by Subject|11
4708704|NCT02192099|16229792|P1|Overall Study|Study Terminated by Sponsor|32
4708705|NCT02192099|16229792|P1|Overall Study|Protocol Violation|8
4708706|NCT02192099|16229792|P1|Overall Study|Pregnancy|1
4708707|NCT02192099|16229792|P1|Overall Study|Physician Decision|1
4708708|NCT02192099|16229792|P1|Overall Study|Lost to Follow-up|2
4708709|NCT02192099|16229792|P1|Overall Study|Adverse Event|1
4708710|NCT02191618|16229821|P1|Overall Study|Missed Visit|4
4708711|NCT02191618|16229821|P1|Overall Study|Withdrawal by Subject|3
4708712|NCT02191605|16229831|P5|Overall Study|Lost to Follow-up|4
4708713|NCT02191605|16229832|P4|Overall Study|Lost to Follow-up|3
4708714|NCT02191605|16229833|P3|Overall Study|Lost to Follow-up|7
4708715|NCT02191605|16229834|P2|Overall Study|Lost to Follow-up|4
4708716|NCT02191605|16229835|P1|Overall Study|Lost to Follow-up|9
4708717|NCT02191579|16229854|P2|Treatment 2|Multiple Reasons Specified|25
4708718|NCT02191579|16229855|P1|Treatment 2|Multiple Reasons Specified|0
4708719|NCT02191579|16229854|P2|Treatment 1|Multiple Reasons Specified|58
4708720|NCT02191579|16229855|P1|Treatment 1|Multiple Reasons Specified|27
4708721|NCT02191397|16229869|P2|Overall Study|Withdrawal by Subject|27
4708722|NCT02191397|16229870|P1|Overall Study|Withdrawal by Subject|22
4708723|NCT02191397|16229869|P2|Overall Study|Physician Decision|3
4708724|NCT02191397|16229870|P1|Overall Study|Physician Decision|8
4708725|NCT02191397|16229869|P2|Overall Study|Lost to Follow-up|11
4708726|NCT02191397|16229870|P1|Overall Study|Lost to Follow-up|10
4708727|NCT02191397|16229869|P2|Overall Study|Met protocol-defined stopping criteria|4
4708728|NCT02191397|16229870|P1|Overall Study|Met protocol-defined stopping criteria|5
4708729|NCT02191397|16229869|P2|Overall Study|Protocol Violation|3
4708730|NCT02191397|16229870|P1|Overall Study|Protocol Violation|0
4708731|NCT02191397|16229869|P2|Overall Study|Lack of Efficacy|5
4708732|NCT02191397|16229870|P1|Overall Study|Lack of Efficacy|10
4708733|NCT02191397|16229869|P2|Overall Study|Adverse Event|17
4708734|NCT02191397|16229870|P1|Overall Study|Adverse Event|28
4708735|NCT02191267|16229931|P3|Overall Study|Withdrawal by Subject|0
4708736|NCT02191267|16229932|P2|Overall Study|Withdrawal by Subject|0
4708737|NCT02191267|16229933|P1|Overall Study|Withdrawal by Subject|1
4708738|NCT02191137|16229944|P1|Follow-up|Adverse Event|1
4708739|NCT02191137|16229944|P1|Follow-up|Ongoing/unknown|2
4708740|NCT02191137|16229944|P1|Follow-up|Lost to Follow-up|2
4708741|NCT02191137|16229944|P1|Treatment|Other|1
4708742|NCT02191137|16229944|P1|Treatment|Adverse Event|2
4708743|NCT02191137|16229944|P1|Treatment|Withdrawal by Subject|3
4708744|NCT02191137|16229944|P1|Treatment|Death|4
4708745|NCT02191046|16229974|P2|Overall Study|low compliance|1
4708746|NCT02191046|16229975|P1|Overall Study|low compliance|5
4708747|NCT02190721|16230082|P3|Overall Study|Patient was out of the city|0
4708748|NCT02190721|16230083|P2|Overall Study|Patient was out of the city|1
4708749|NCT02190721|16230084|P1|Overall Study|Patient was out of the city|0
4708750|NCT02190604|16230207|P19|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708751|NCT02190604|16230208|P18|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708752|NCT02190604|16230209|P17|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708753|NCT02190604|16230210|P16|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708754|NCT02190604|16230211|P15|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708755|NCT02190604|16230212|P14|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1
4708756|NCT02190604|16230213|P13|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708757|NCT02190604|16230214|P12|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708758|NCT02190604|16230215|P11|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708759|NCT02190604|16230216|P10|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708760|NCT02190604|16230217|P9|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708761|NCT02190604|16230218|P8|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708762|NCT02190604|16230219|P7|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708763|NCT02190604|16230220|P6|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708764|NCT02190604|16230221|P5|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708765|NCT02190604|16230222|P4|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708766|NCT02190604|16230223|P3|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708767|NCT02190604|16230224|P2|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708768|NCT02190604|16230225|P1|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0
4708769|NCT02190604|16230207|P19|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708770|NCT02190604|16230208|P18|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708771|NCT02190604|16230209|P17|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708772|NCT02190604|16230210|P16|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708773|NCT02190604|16230211|P15|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2
4708774|NCT02190604|16230212|P14|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708775|NCT02190604|16230213|P13|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708776|NCT02190604|16230214|P12|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708777|NCT02190604|16230215|P11|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708778|NCT02190604|16230216|P10|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708779|NCT02190604|16230217|P9|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708780|NCT02190604|16230218|P8|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708781|NCT02190604|16230219|P7|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708782|NCT02190604|16230220|P6|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708783|NCT02190604|16230221|P5|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708784|NCT02190604|16230222|P4|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708785|NCT02190604|16230223|P3|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708786|NCT02190604|16230224|P2|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708787|NCT02190604|16230225|P1|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0
4708788|NCT02190591|16230416|P2|Overall Study|face presentation so she was ineligible|1
4708789|NCT02190591|16230417|P1|Overall Study|face presentation so she was ineligible|0
4708790|NCT02190591|16230416|P2|Overall Study|did not use peanut ball as instructed|2
4708791|NCT02190591|16230417|P1|Overall Study|did not use peanut ball as instructed|0
4708792|NCT02190591|16230416|P2|Overall Study|Protocol Violation|0
4708793|NCT02190591|16230417|P1|Overall Study|Protocol Violation|1
4708794|NCT02190591|16230416|P2|Overall Study|Withdrawal by Subject|8
4708795|NCT02190591|16230417|P1|Overall Study|Withdrawal by Subject|1
4708796|NCT02190435|16230440|P2|Overall Study|3 consented screen fails|0
4708797|NCT02190435|16230441|P1|Overall Study|3 consented screen fails|3
4708798|NCT02190435|16230440|P2|Overall Study|First 12 patients were lead-ins|0
4708799|NCT02190435|16230441|P1|Overall Study|First 12 patients were lead-ins|12
4708800|NCT02190279|16230452|P3|Overall Study|Screening failure|1
4708801|NCT02190279|16230453|P2|Overall Study|Screening failure|0
4708802|NCT02190279|16230454|P1|Overall Study|Screening failure|0
4708803|NCT02190279|16230452|P3|Overall Study|Refused further treatment|1
4708804|NCT02190279|16230453|P2|Overall Study|Refused further treatment|0
4708805|NCT02190279|16230454|P1|Overall Study|Refused further treatment|0
4708806|NCT02190279|16230452|P3|Overall Study|Lost to Follow-up|0
4708807|NCT02190279|16230453|P2|Overall Study|Lost to Follow-up|0
4708808|NCT02190279|16230454|P1|Overall Study|Lost to Follow-up|2
4708809|NCT02190279|16230452|P3|Overall Study|Withdrawal consent|1
4708810|NCT02190279|16230453|P2|Overall Study|Withdrawal consent|0
4708811|NCT02190279|16230454|P1|Overall Study|Withdrawal consent|1
4708812|NCT02189941|16230493|P3|Overall Study|Non-compliance|1
4708813|NCT02189941|16230494|P2|Overall Study|Non-compliance|0
4708814|NCT02189941|16230495|P1|Overall Study|Non-compliance|0
4708815|NCT02189863|16230540|P2|First 2 Weeks|Motion Sickness|2
4708816|NCT02189863|16230541|P1|First 2 Weeks|Motion Sickness|4
4708817|NCT02189837|16230556|P4|Overall Study|Sponsor Decision|1
4708818|NCT02189837|16230557|P3|Overall Study|Sponsor Decision|0
4708819|NCT02189837|16230558|P2|Overall Study|Sponsor Decision|0
4708820|NCT02189837|16230559|P1|Overall Study|Sponsor Decision|0
4708821|NCT02189837|16230556|P4|Overall Study|Withdrawal by Subject|1
4708822|NCT02189837|16230557|P3|Overall Study|Withdrawal by Subject|3
4708823|NCT02189837|16230558|P2|Overall Study|Withdrawal by Subject|1
4708824|NCT02189837|16230559|P1|Overall Study|Withdrawal by Subject|2
4708825|NCT02189759|16230589|P4|Overall Study|Lost to Follow-up|5
4708826|NCT02189759|16230590|P3|Overall Study|Lost to Follow-up|2
4708827|NCT02189759|16230591|P2|Overall Study|Lost to Follow-up|0
4708828|NCT02189759|16230592|P1|Overall Study|Lost to Follow-up|0
4708829|NCT02189473|16230628|P2|Overall Study|Lost to Follow-up|2
4708830|NCT02189473|16230629|P1|Overall Study|Lost to Follow-up|1
4708831|NCT02189473|16230628|P2|Overall Study|Death|23
4708832|NCT02189473|16230629|P1|Overall Study|Death|22
4708833|NCT02189252|16230677|P4|Period 1 (Visit 4b, Week 4)|Adverse Event|0
4708834|NCT02189252|16230678|P3|Period 1 (Visit 4b, Week 4)|Adverse Event|0
4708835|NCT02189252|16230679|P2|Period 1 (Visit 4b, Week 4)|Adverse Event|1
4708836|NCT02189252|16230680|P1|Period 1 (Visit 4b, Week 4)|Adverse Event|0
4708837|NCT02189252|16230677|P4|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
4708838|NCT02189252|16230678|P3|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
4708839|NCT02189252|16230679|P2|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1
4708840|NCT02189252|16230680|P1|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0
4708841|NCT02188849|16230739|P2|Overall Study|Lost to Follow-up|8
4708842|NCT02188849|16230740|P1|Overall Study|Lost to Follow-up|3
4708843|NCT02188784|16230754|P2|Overall Study|Physician Decision|3
4708844|NCT02188784|16230755|P1|Overall Study|Physician Decision|2
4708845|NCT02188784|16230754|P2|Overall Study|Withdrawal by Subject|9
4708846|NCT02188784|16230755|P1|Overall Study|Withdrawal by Subject|3
4708847|NCT02188784|16230754|P2|Overall Study|Lost to Follow-up|0
4708848|NCT02188784|16230755|P1|Overall Study|Lost to Follow-up|1
4708849|NCT02188784|16230754|P2|Overall Study|Death|1
4708850|NCT02188784|16230755|P1|Overall Study|Death|3
4708851|NCT02188719|16230775|P4|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
4708852|NCT02188719|16230776|P3|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
4708853|NCT02188719|16230777|P2|Overall Study|Screen B Ineligible (Page 55, Protocol)|1
4708854|NCT02188719|16230778|P1|Overall Study|Screen B Ineligible (Page 55, Protocol)|0
4708855|NCT02188589|16230802|P1|Overall Study|Withdrawal by Subject|5
4708856|NCT02187861|16230834|P4|Overall Study|Other|1
4708857|NCT02187861|16230835|P3|Overall Study|Other|7
4708858|NCT02187861|16230836|P2|Overall Study|Other|1
4708859|NCT02187861|16230837|P1|Overall Study|Other|0
4708860|NCT02187861|16230834|P4|Overall Study|Withdrawal by Subject|3
4708861|NCT02187861|16230835|P3|Overall Study|Withdrawal by Subject|3
4708862|NCT02187861|16230836|P2|Overall Study|Withdrawal by Subject|0
4708863|NCT02187861|16230837|P1|Overall Study|Withdrawal by Subject|0
4708864|NCT02187861|16230834|P4|Overall Study|Progressive Disease|22
4708865|NCT02187861|16230835|P3|Overall Study|Progressive Disease|19
4708866|NCT02187861|16230836|P2|Overall Study|Progressive Disease|42
4708867|NCT02187861|16230837|P1|Overall Study|Progressive Disease|4
4708868|NCT02187861|16230834|P4|Overall Study|Physician Decision|3
4708869|NCT02187861|16230835|P3|Overall Study|Physician Decision|0
4708870|NCT02187861|16230836|P2|Overall Study|Physician Decision|1
4708871|NCT02187861|16230837|P1|Overall Study|Physician Decision|0
4708872|NCT02187861|16230834|P4|Overall Study|Death|2
4708873|NCT02187861|16230835|P3|Overall Study|Death|1
4708874|NCT02187861|16230836|P2|Overall Study|Death|3
4708875|NCT02187861|16230837|P1|Overall Study|Death|0
4708876|NCT02187861|16230834|P4|Overall Study|Adverse Event|1
4708877|NCT02187861|16230835|P3|Overall Study|Adverse Event|2
4708878|NCT02187861|16230836|P2|Overall Study|Adverse Event|1
4708879|NCT02187861|16230837|P1|Overall Study|Adverse Event|2
4708880|NCT02187809|16230933|P1|Overall Study|The study was terminated|3
4708881|NCT02187783|16230943|P1|Overall Study|Study terminated by sponsor|1
4708882|NCT02187783|16230943|P1|Overall Study|Withdrawal by Subject|9
4708883|NCT02187783|16230943|P1|Overall Study|Physician Decision|2
4708884|NCT02187783|16230943|P1|Overall Study|Protocol Violation|3
4708885|NCT02187783|16230943|P1|Overall Study|Progressive disease|80
4708886|NCT02187783|16230943|P1|Overall Study|Death|3
4708887|NCT02187783|16230943|P1|Overall Study|Adverse Event|8
4708888|NCT02187744|16230954|P2|Treatment|Participant refused continued treatment|1
4708889|NCT02187744|16230955|P1|Treatment|Participant refused continued treatment|1
4708890|NCT02187744|16230954|P2|Treatment|Other|0
4708891|NCT02187744|16230955|P1|Treatment|Other|2
4708892|NCT02187744|16230954|P2|Treatment|Lost to Follow-up|1
4708893|NCT02187744|16230955|P1|Treatment|Lost to Follow-up|0
4708894|NCT02187744|16230954|P2|Treatment|Related adverse event, not serious|2
4708895|NCT02187744|16230955|P1|Treatment|Related adverse event, not serious|0
4708896|NCT02187744|16230954|P2|Treatment|Related adverse event, serious non-fatal|1
4708897|NCT02187744|16230955|P1|Treatment|Related adverse event, serious non-fatal|0
4708898|NCT02187744|16230954|P2|Treatment|Death|0
4708899|NCT02187744|16230955|P1|Treatment|Death|1
4708900|NCT02187744|16230954|P2|Study|Related adverse event, serious non-fatal|1
4708901|NCT02187744|16230955|P1|Study|Related adverse event, serious non-fatal|0
4708902|NCT02187744|16230954|P2|Study|Death|0
4708903|NCT02187744|16230955|P1|Study|Death|1
4708904|NCT02187744|16230954|P2|Study|Related adverse event, not serious|2
4708905|NCT02187744|16230955|P1|Study|Related adverse event, not serious|0
4708906|NCT02187744|16230954|P2|Study|Lost to Follow-up|2
4708907|NCT02187744|16230955|P1|Study|Lost to Follow-up|0
4708908|NCT02187744|16230954|P2|Study|Other|1
4708909|NCT02187744|16230955|P1|Study|Other|2
4708910|NCT02187744|16230954|P2|Study|Participant refused further follow-up|0
4708911|NCT02187744|16230955|P1|Study|Participant refused further follow-up|1
4708912|NCT02187172|16230973|P2|Overall Study|Physician Decision|1
4708913|NCT02187172|16230974|P1|Overall Study|Physician Decision|1
4708914|NCT02187172|16230973|P2|Overall Study|Adverse Event|1
4708915|NCT02187172|16230974|P1|Overall Study|Adverse Event|0
4708916|NCT02187172|16230973|P2|Overall Study|Lack of Efficacy|2
4708917|NCT02187172|16230974|P1|Overall Study|Lack of Efficacy|1
4708918|NCT02187172|16230973|P2|Overall Study|Lost to Follow-up|2
4708919|NCT02187172|16230974|P1|Overall Study|Lost to Follow-up|1
4708920|NCT02187055|16231141|P3|Overall Study|Death|0
4708921|NCT02187055|16231142|P2|Overall Study|Death|0
4708922|NCT02187055|16231143|P1|Overall Study|Death|2
4708923|NCT02187055|16231141|P3|Overall Study|Adverse Event|36
4708924|NCT02187055|16231142|P2|Overall Study|Adverse Event|26
4708925|NCT02187055|16231143|P1|Overall Study|Adverse Event|21
4708926|NCT02187055|16231141|P3|Overall Study|Withdrawal by Subject|11
4708927|NCT02187055|16231142|P2|Overall Study|Withdrawal by Subject|11
4708928|NCT02187055|16231143|P1|Overall Study|Withdrawal by Subject|11
4708929|NCT02187055|16231141|P3|Overall Study|Pregnancy|0
4708930|NCT02187055|16231142|P2|Overall Study|Pregnancy|1
4708931|NCT02187055|16231143|P1|Overall Study|Pregnancy|3
4708932|NCT02187055|16231141|P3|Overall Study|Protocol Violation|4
4708933|NCT02187055|16231142|P2|Overall Study|Protocol Violation|9
4708934|NCT02187055|16231143|P1|Overall Study|Protocol Violation|9
4708935|NCT02187055|16231141|P3|Overall Study|Other|3
4708936|NCT02187055|16231142|P2|Overall Study|Other|6
4708937|NCT02187055|16231143|P1|Overall Study|Other|5
4708938|NCT02187055|16231141|P3|Overall Study|No longer willing to participate|10
4708939|NCT02187055|16231142|P2|Overall Study|No longer willing to participate|8
4708940|NCT02187055|16231143|P1|Overall Study|No longer willing to participate|6
4708941|NCT02187055|16231141|P3|Overall Study|No longer meets eligibility criteria|0
4708942|NCT02187055|16231142|P2|Overall Study|No longer meets eligibility criteria|2
4708943|NCT02187055|16231143|P1|Overall Study|No longer meets eligibility criteria|0
4708944|NCT02187055|16231141|P3|Overall Study|Lost to Follow-up|3
4708945|NCT02187055|16231142|P2|Overall Study|Lost to Follow-up|7
4708946|NCT02187055|16231143|P1|Overall Study|Lost to Follow-up|2
4708947|NCT02187055|16231141|P3|Overall Study|Lack of Efficacy|7
4708948|NCT02187055|16231142|P2|Overall Study|Lack of Efficacy|3
4708949|NCT02187055|16231143|P1|Overall Study|Lack of Efficacy|10
4708950|NCT02187042|16231243|P2|Overall Study|Progressive disease|8
4708951|NCT02187042|16231244|P1|Overall Study|Progressive disease|4
4708952|NCT02187042|16231243|P2|Overall Study|Doctor choice|0
4708953|NCT02187042|16231244|P1|Overall Study|Doctor choice|1
4708954|NCT02187042|16231243|P2|Overall Study|Participant choice|0
4708955|NCT02187042|16231244|P1|Overall Study|Participant choice|1
4708956|NCT02187042|16231243|P2|Overall Study|Toxicity|5
4708957|NCT02187042|16231244|P1|Overall Study|Toxicity|6
4708958|NCT02187042|16231243|P2|Overall Study|Death|1
4708959|NCT02187042|16231244|P1|Overall Study|Death|1
4708960|NCT02187029|16231290|P4|Overall Study|Withdrawal by Subject|0
4708961|NCT02187029|16231291|P3|Overall Study|Withdrawal by Subject|0
4708962|NCT02187029|16231292|P2|Overall Study|Withdrawal by Subject|0
4708963|NCT02187029|16231293|P1|Overall Study|Withdrawal by Subject|1
4708964|NCT02187029|16231290|P4|Overall Study|Study Terminated by Sponsor|3
4708965|NCT02187029|16231291|P3|Overall Study|Study Terminated by Sponsor|10
4708966|NCT02187029|16231292|P2|Overall Study|Study Terminated by Sponsor|0
4708967|NCT02187029|16231293|P1|Overall Study|Study Terminated by Sponsor|0
4708968|NCT02187029|16231290|P4|Overall Study|Adverse Event|0
4708969|NCT02187029|16231291|P3|Overall Study|Adverse Event|1
4708970|NCT02187029|16231292|P2|Overall Study|Adverse Event|1
4708971|NCT02187029|16231293|P1|Overall Study|Adverse Event|0
4708972|NCT02186873|16231415|P2|Overall Study|Withdrawal by Subject|2
4708973|NCT02186873|16231416|P1|Overall Study|Withdrawal by Subject|7
4708974|NCT02186873|16231415|P2|Overall Study|Lost to Follow-up|2
4708975|NCT02186873|16231416|P1|Overall Study|Lost to Follow-up|1
4708976|NCT02186873|16231415|P2|Overall Study|Lack of Efficacy|1
4708977|NCT02186873|16231416|P1|Overall Study|Lack of Efficacy|0
4708978|NCT02186873|16231415|P2|Overall Study|Adverse Event|3
4708979|NCT02186873|16231416|P1|Overall Study|Adverse Event|1
4708980|NCT02186847|16231441|P2|Overall Study|Protocol Violation|0
4708981|NCT02186847|16231442|P1|Overall Study|Protocol Violation|3
4708982|NCT02186834|16231456|P6|Treatment at RP2D|Died prior to treatment|1
4708983|NCT02186834|16231457|P5|Treatment at RP2D|Died prior to treatment|0
4708984|NCT02186834|16231458|P4|Treatment at RP2D|Died prior to treatment|0
4708985|NCT02186834|16231459|P3|Treatment at RP2D|Died prior to treatment|0
4708986|NCT02186834|16231460|P2|Treatment at RP2D|Died prior to treatment|0
4708987|NCT02186834|16231461|P1|Treatment at RP2D|Died prior to treatment|0
4708988|NCT02186834|16231456|P6|Dose Escalation|Death|0
4708989|NCT02186834|16231457|P5|Dose Escalation|Death|0
4708990|NCT02186834|16231458|P4|Dose Escalation|Death|1
4708991|NCT02186834|16231459|P3|Dose Escalation|Death|0
4708992|NCT02186834|16231460|P2|Dose Escalation|Death|0
4708993|NCT02186834|16231461|P1|Dose Escalation|Death|0
4708994|NCT02186652|16231497|P2|Overall Study|Lost to Follow-up|0
4708995|NCT02186652|16231498|P1|Overall Study|Lost to Follow-up|2
4708996|NCT02186561|16231531|P1|1- Year Post Index Procedure Visit|Missed|1
4708997|NCT02186561|16231531|P1|1- Year Post Index Procedure Visit|Death|1
4708998|NCT02186561|16231531|P1|30-Day Post Index Procedure Visit|Death|1
4708999|NCT02186561|16231531|P1|Enrollment|Investigator Withdrew Consent|1
4709000|NCT02186561|16231531|P1|Enrollment|Withdrawal by Subject|2
4709001|NCT02186561|16231531|P1|Enrollment|Insurance Denial|2
4709002|NCT02186561|16231531|P1|Enrollment|Enrollment Cap Reached|5
4709003|NCT02186561|16231531|P1|Enrollment|Did Not Meet Inclusion Criteria|46
4709004|NCT02186301|16231551|P3|Overall Study|Other|1
4709005|NCT02186301|16231552|P2|Overall Study|Other|0
4709006|NCT02186301|16231553|P1|Overall Study|Other|0
4709007|NCT02186301|16231551|P3|Overall Study|Missing|2
4709008|NCT02186301|16231552|P2|Overall Study|Missing|0
4709009|NCT02186301|16231553|P1|Overall Study|Missing|0
4709010|NCT02186301|16231551|P3|Overall Study|Protocol Deviation|0
4709011|NCT02186301|16231552|P2|Overall Study|Protocol Deviation|2
4709012|NCT02186301|16231553|P1|Overall Study|Protocol Deviation|0
4709013|NCT02186301|16231551|P3|Overall Study|Study Terminated by Sponsor|11
4709014|NCT02186301|16231552|P2|Overall Study|Study Terminated by Sponsor|0
4709015|NCT02186301|16231553|P1|Overall Study|Study Terminated by Sponsor|1
4709016|NCT02186301|16231551|P3|Overall Study|Physician Decision|1
4709017|NCT02186301|16231552|P2|Overall Study|Physician Decision|0
4709018|NCT02186301|16231553|P1|Overall Study|Physician Decision|1
4709019|NCT02186301|16231551|P3|Overall Study|Withdrawal by Subject|3
4709020|NCT02186301|16231552|P2|Overall Study|Withdrawal by Subject|1
4709021|NCT02186301|16231553|P1|Overall Study|Withdrawal by Subject|5
4709022|NCT02186301|16231551|P3|Overall Study|Death|0
4709023|NCT02186301|16231552|P2|Overall Study|Death|0
4709024|NCT02186301|16231553|P1|Overall Study|Death|1
4709025|NCT02186301|16231551|P3|Overall Study|Adverse Event|5
4709026|NCT02186301|16231552|P2|Overall Study|Adverse Event|5
4709027|NCT02186301|16231553|P1|Overall Study|Adverse Event|5
4709028|NCT02186301|16231551|P3|Overall Study|Progressive Disease|27
4709029|NCT02186301|16231552|P2|Overall Study|Progressive Disease|22
4709030|NCT02186301|16231553|P1|Overall Study|Progressive Disease|7
4709031|NCT02186223|16231569|P1|Overall Study|Device in place less than 48 hours|9
4709032|NCT02186223|16231569|P1|Overall Study|Death|3
4709033|NCT02186223|16231569|P1|Overall Study|Unable to obtain femoral access|3
4709034|NCT02186223|16231569|P1|Overall Study|Not eligible for device placement|6
4709035|NCT02186171|16231591|P2|Overall Study|Protocol-specified Criteria|2
4709036|NCT02186171|16231592|P1|Overall Study|Protocol-specified Criteria|0
4709037|NCT02186171|16231591|P2|Overall Study|Death|2
4709038|NCT02186171|16231592|P1|Overall Study|Death|1
4709039|NCT02186171|16231591|P2|Overall Study|Lost to Follow-up|2
4709040|NCT02186171|16231592|P1|Overall Study|Lost to Follow-up|2
4709041|NCT02186171|16231591|P2|Overall Study|Withdrawal by Subject|9
4709042|NCT02186171|16231592|P1|Overall Study|Withdrawal by Subject|1
4709043|NCT02185794|16231614|P6|Overall Study|Lost to Follow-up|1
4709044|NCT02185794|16231615|P5|Overall Study|Lost to Follow-up|0
4709045|NCT02185794|16231616|P4|Overall Study|Lost to Follow-up|3
4709046|NCT02185794|16231617|P3|Overall Study|Lost to Follow-up|2
4709047|NCT02185794|16231618|P2|Overall Study|Lost to Follow-up|2
4709048|NCT02185794|16231619|P1|Overall Study|Lost to Follow-up|1
4709049|NCT02185794|16231614|P6|Overall Study|Withdrew Consent|0
4709050|NCT02185794|16231615|P5|Overall Study|Withdrew Consent|0
4709051|NCT02185794|16231616|P4|Overall Study|Withdrew Consent|2
4709052|NCT02185794|16231617|P3|Overall Study|Withdrew Consent|10
4709053|NCT02185794|16231618|P2|Overall Study|Withdrew Consent|5
4709054|NCT02185794|16231619|P1|Overall Study|Withdrew Consent|2
4709055|NCT02185794|16231614|P6|Overall Study|Investigator's Discretion|15
4709056|NCT02185794|16231615|P5|Overall Study|Investigator's Discretion|2
4709057|NCT02185794|16231616|P4|Overall Study|Investigator's Discretion|2
4709058|NCT02185794|16231617|P3|Overall Study|Investigator's Discretion|1
4709059|NCT02185794|16231618|P2|Overall Study|Investigator's Discretion|0
4709060|NCT02185794|16231619|P1|Overall Study|Investigator's Discretion|1
4709061|NCT02185794|16231614|P6|Overall Study|Enrolled but Never Dosed|0
4709062|NCT02185794|16231615|P5|Overall Study|Enrolled but Never Dosed|1
4709063|NCT02185794|16231616|P4|Overall Study|Enrolled but Never Dosed|1
4709064|NCT02185794|16231617|P3|Overall Study|Enrolled but Never Dosed|3
4709065|NCT02185794|16231618|P2|Overall Study|Enrolled but Never Dosed|6
4709066|NCT02185794|16231619|P1|Overall Study|Enrolled but Never Dosed|1
4709067|NCT02185534|16231712|P6|First Washout Period|Protocol Violation|1
4709068|NCT02185534|16231713|P5|First Washout Period|Protocol Violation|0
4709069|NCT02185534|16231714|P4|First Washout Period|Protocol Violation|0
4709070|NCT02185534|16231715|P3|First Washout Period|Protocol Violation|0
4709071|NCT02185534|16231716|P2|First Washout Period|Protocol Violation|0
4709072|NCT02185534|16231717|P1|First Washout Period|Protocol Violation|0
4709073|NCT02185534|16231712|P6|First Washout Period|Withdrawal by Subject|0
4709074|NCT02185534|16231713|P5|First Washout Period|Withdrawal by Subject|1
4709075|NCT02185534|16231714|P4|First Washout Period|Withdrawal by Subject|0
4709076|NCT02185534|16231715|P3|First Washout Period|Withdrawal by Subject|0
4709077|NCT02185534|16231716|P2|First Washout Period|Withdrawal by Subject|0
4709078|NCT02185534|16231717|P1|First Washout Period|Withdrawal by Subject|1
4709079|NCT02185534|16231712|P6|First Period|Withdrawal by Subject|0
4709080|NCT02185534|16231713|P5|First Period|Withdrawal by Subject|0
4709081|NCT02185534|16231714|P4|First Period|Withdrawal by Subject|1
4709082|NCT02185534|16231715|P3|First Period|Withdrawal by Subject|0
4709083|NCT02185534|16231716|P2|First Period|Withdrawal by Subject|0
4709084|NCT02185534|16231717|P1|First Period|Withdrawal by Subject|0
4709085|NCT02185521|16231732|P1|Overall Study|Protocol Violation|1
4709086|NCT02185521|16231732|P1|Overall Study|Withdrawal by Subject|1
4709087|NCT02185053|16231820|P3|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2
4709088|NCT02185053|16231821|P2|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
4709089|NCT02185053|16231822|P1|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0
4709090|NCT02185053|16231820|P3|Donepezil Dose Maintenance Phase|Cardiac symptoms|1
4709091|NCT02185053|16231821|P2|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
4709092|NCT02185053|16231822|P1|Donepezil Dose Maintenance Phase|Cardiac symptoms|0
4709093|NCT02185053|16231820|P3|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
4709094|NCT02185053|16231821|P2|Donepezil Dose Escalation Phase|Withdrawal by Subject|1
4709095|NCT02185053|16231822|P1|Donepezil Dose Escalation Phase|Withdrawal by Subject|0
4709096|NCT02185053|16231820|P3|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
4709097|NCT02185053|16231821|P2|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2
4709098|NCT02185053|16231822|P1|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0
4709099|NCT02185053|16231820|P3|Donepezil Dose Escalation Phase|Adverse Event|0
4709100|NCT02185053|16231821|P2|Donepezil Dose Escalation Phase|Adverse Event|1
4709101|NCT02185053|16231822|P1|Donepezil Dose Escalation Phase|Adverse Event|0
4709102|NCT02185053|16231820|P3|Donepezil Dose Escalation Phase|Cardiac symptoms|0
4709103|NCT02185053|16231821|P2|Donepezil Dose Escalation Phase|Cardiac symptoms|1
4709104|NCT02185053|16231822|P1|Donepezil Dose Escalation Phase|Cardiac symptoms|0
4709105|NCT02185053|16231820|P3|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
4709106|NCT02185053|16231821|P2|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0
4709107|NCT02185053|16231822|P1|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2
4709108|NCT02185053|16231820|P3|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
4709109|NCT02185053|16231821|P2|Solifenacin Dose Escalation Phase|Cardiac symptoms|0
4709110|NCT02185053|16231822|P1|Solifenacin Dose Escalation Phase|Cardiac symptoms|1
4709111|NCT02185040|16231836|P7|Active Treatment Extension Phase|Lost to Follow-up|2
4709112|NCT02185040|16231837|P6|Active Treatment Extension Phase|Lost to Follow-up|0
4709113|NCT02185040|16231838|P5|Active Treatment Extension Phase|Lost to Follow-up|0
4709114|NCT02185040|16231839|P4|Active Treatment Extension Phase|Lost to Follow-up|0
4709115|NCT02185040|16231840|P3|Active Treatment Extension Phase|Lost to Follow-up|0
4709116|NCT02185040|16231841|P2|Active Treatment Extension Phase|Lost to Follow-up|0
4709117|NCT02185040|16231842|P1|Active Treatment Extension Phase|Lost to Follow-up|0
4709118|NCT02185040|16231836|P7|Active Treatment Extension Phase|Withdrawal by Subject|1
4709119|NCT02185040|16231837|P6|Active Treatment Extension Phase|Withdrawal by Subject|1
4709120|NCT02185040|16231838|P5|Active Treatment Extension Phase|Withdrawal by Subject|0
4709121|NCT02185040|16231839|P4|Active Treatment Extension Phase|Withdrawal by Subject|0
4709205|NCT02184442|16232068|P2|Overall Study|Death|65
4709122|NCT02185040|16231840|P3|Active Treatment Extension Phase|Withdrawal by Subject|0
4709123|NCT02185040|16231841|P2|Active Treatment Extension Phase|Withdrawal by Subject|0
4709124|NCT02185040|16231842|P1|Active Treatment Extension Phase|Withdrawal by Subject|0
4709125|NCT02185040|16231836|P7|Active Treatment Extension Phase|Adverse Event|4
4709126|NCT02185040|16231837|P6|Active Treatment Extension Phase|Adverse Event|1
4709127|NCT02185040|16231838|P5|Active Treatment Extension Phase|Adverse Event|0
4709128|NCT02185040|16231839|P4|Active Treatment Extension Phase|Adverse Event|0
4709129|NCT02185040|16231840|P3|Active Treatment Extension Phase|Adverse Event|0
4709130|NCT02185040|16231841|P2|Active Treatment Extension Phase|Adverse Event|0
4709131|NCT02185040|16231842|P1|Active Treatment Extension Phase|Adverse Event|0
4709132|NCT02185040|16231836|P7|Active Treatment Extension Phase|Miscellaneous|0
4709133|NCT02185040|16231837|P6|Active Treatment Extension Phase|Miscellaneous|1
4709134|NCT02185040|16231838|P5|Active Treatment Extension Phase|Miscellaneous|0
4709135|NCT02185040|16231839|P4|Active Treatment Extension Phase|Miscellaneous|0
4709136|NCT02185040|16231840|P3|Active Treatment Extension Phase|Miscellaneous|0
4709137|NCT02185040|16231841|P2|Active Treatment Extension Phase|Miscellaneous|0
4709138|NCT02185040|16231842|P1|Active Treatment Extension Phase|Miscellaneous|0
4709139|NCT02185040|16231836|P7|Part 1 Treatment Phase|Lost to Follow-up|0
4709140|NCT02185040|16231837|P6|Part 1 Treatment Phase|Lost to Follow-up|0
4709141|NCT02185040|16231838|P5|Part 1 Treatment Phase|Lost to Follow-up|0
4709142|NCT02185040|16231839|P4|Part 1 Treatment Phase|Lost to Follow-up|0
4709143|NCT02185040|16231840|P3|Part 1 Treatment Phase|Lost to Follow-up|0
4709144|NCT02185040|16231841|P2|Part 1 Treatment Phase|Lost to Follow-up|1
4709145|NCT02185040|16231842|P1|Part 1 Treatment Phase|Lost to Follow-up|0
4709146|NCT02185040|16231836|P7|Part 1 Treatment Phase|Withdrawal by Subject|0
4709147|NCT02185040|16231837|P6|Part 1 Treatment Phase|Withdrawal by Subject|0
4709148|NCT02185040|16231838|P5|Part 1 Treatment Phase|Withdrawal by Subject|0
4709149|NCT02185040|16231839|P4|Part 1 Treatment Phase|Withdrawal by Subject|0
4709150|NCT02185040|16231840|P3|Part 1 Treatment Phase|Withdrawal by Subject|0
4709151|NCT02185040|16231841|P2|Part 1 Treatment Phase|Withdrawal by Subject|1
4709152|NCT02185040|16231842|P1|Part 1 Treatment Phase|Withdrawal by Subject|0
4709153|NCT02185040|16231836|P7|Part 1 Treatment Phase|Adverse Event|0
4709154|NCT02185040|16231837|P6|Part 1 Treatment Phase|Adverse Event|0
4709155|NCT02185040|16231838|P5|Part 1 Treatment Phase|Adverse Event|3
4709156|NCT02185040|16231839|P4|Part 1 Treatment Phase|Adverse Event|2
4709157|NCT02185040|16231840|P3|Part 1 Treatment Phase|Adverse Event|0
4709158|NCT02185040|16231841|P2|Part 1 Treatment Phase|Adverse Event|0
4709159|NCT02185040|16231842|P1|Part 1 Treatment Phase|Adverse Event|1
4709160|NCT02185040|16231836|P7|Part 1 Treatment Phase|Miscellaneous|0
4709161|NCT02185040|16231837|P6|Part 1 Treatment Phase|Miscellaneous|0
4709162|NCT02185040|16231838|P5|Part 1 Treatment Phase|Miscellaneous|0
4709163|NCT02185040|16231839|P4|Part 1 Treatment Phase|Miscellaneous|0
4709164|NCT02185040|16231840|P3|Part 1 Treatment Phase|Miscellaneous|1
4709165|NCT02185040|16231841|P2|Part 1 Treatment Phase|Miscellaneous|0
4709166|NCT02185040|16231842|P1|Part 1 Treatment Phase|Miscellaneous|0
4709167|NCT02185014|16231896|P1|Overall Study|Other|4
4709168|NCT02185014|16231896|P1|Overall Study|Subject Noncompliance|1
4709169|NCT02185014|16231896|P1|Overall Study|Requires Alternative/Prohibited Therapy|5
4709170|NCT02185014|16231896|P1|Overall Study|Lack of Efficacy|14
4709171|NCT02185014|16231896|P1|Overall Study|Lost to Follow-up|4
4709172|NCT02185014|16231896|P1|Overall Study|Withdrew Consent|8
4709173|NCT02185014|16231896|P1|Overall Study|Adverse Event|18
4709174|NCT02184988|16231900|P1|Overall Study|Lost to Follow-up|32
4709175|NCT02184988|16231900|P1|Overall Study|various other reasons|9
4709176|NCT02184988|16231900|P1|Overall Study|work scheduling issues|4
4709177|NCT02184988|16231900|P1|Overall Study|moving away/travelling/unable to complet|6
4709178|NCT02184988|16231900|P1|Overall Study|Adverse Event|2
4709179|NCT02184988|16231900|P1|Overall Study|Pregnancy|2
4709180|NCT02184611|16231958|P2|Overall Study|Protocol defined stopping criteria|1
4709181|NCT02184611|16231959|P1|Overall Study|Protocol defined stopping criteria|0
4709182|NCT02184611|16231958|P2|Overall Study|Protocol Violation|1
4709183|NCT02184611|16231959|P1|Overall Study|Protocol Violation|1
4709184|NCT02184611|16231958|P2|Overall Study|Adverse Event|5
4709185|NCT02184611|16231959|P1|Overall Study|Adverse Event|4
4709186|NCT02184611|16231958|P2|Overall Study|Withdrawal by Subject|6
4709187|NCT02184611|16231959|P1|Overall Study|Withdrawal by Subject|5
4709188|NCT02184611|16231958|P2|Overall Study|Lack of Efficacy|15
4709189|NCT02184611|16231959|P1|Overall Study|Lack of Efficacy|11
4709190|NCT02184572|16231995|P2|Overall Study|Withdrawal by Subject|9
4709191|NCT02184572|16231996|P1|Overall Study|Withdrawal by Subject|14
4709192|NCT02184572|16231995|P2|Overall Study|Traveling Outside The Country|0
4709193|NCT02184572|16231996|P1|Overall Study|Traveling Outside The Country|1
4709194|NCT02184572|16231995|P2|Overall Study|2nd blooddraw & diary card incomplete|0
4709195|NCT02184572|16231996|P1|Overall Study|2nd blooddraw & diary card incomplete|1
4709196|NCT02184572|16231995|P2|Overall Study|Loss Of Kaiser Insurance|0
4709197|NCT02184572|16231996|P1|Overall Study|Loss Of Kaiser Insurance|1
4709198|NCT02184572|16231995|P2|Overall Study|Family Out Of Country Until 9/29/2015|0
4709199|NCT02184572|16231996|P1|Overall Study|Family Out Of Country Until 9/29/2015|1
4709200|NCT02184572|16231995|P2|Overall Study|Lost to Follow-up|21
4709201|NCT02184572|16231996|P1|Overall Study|Lost to Follow-up|29
4709202|NCT02184455|16232057|P1|Overall Study|Lost to Follow-up|1
4709203|NCT02184442|16232068|P2|Overall Study|Withdrawal by Subject|11
4709204|NCT02184442|16232069|P1|Overall Study|Withdrawal by Subject|3
4709206|NCT02184442|16232069|P1|Overall Study|Death|61
4709207|NCT02184195|16232089|P2|Overall Study|Other|2
4709208|NCT02184195|16232090|P1|Overall Study|Other|0
4709209|NCT02184195|16232089|P2|Overall Study|Lost to Follow-up|2
4709210|NCT02184195|16232090|P1|Overall Study|Lost to Follow-up|0
4709211|NCT02184195|16232089|P2|Overall Study|Death|29
4709212|NCT02184195|16232090|P1|Overall Study|Death|40
4709213|NCT02184195|16232089|P2|Overall Study|Eligibility criteria not fulfilled|1
4709214|NCT02184195|16232090|P1|Overall Study|Eligibility criteria not fulfilled|0
4709215|NCT02184195|16232089|P2|Overall Study|Patient decision|1
4709216|NCT02184195|16232090|P1|Overall Study|Patient decision|3
4709217|NCT02184143|16232127|P2|Overall Study|Death|0
4709218|NCT02184143|16232128|P1|Overall Study|Death|1
4709219|NCT02184143|16232127|P2|Overall Study|Lost to Follow-up|3
4709220|NCT02184143|16232128|P1|Overall Study|Lost to Follow-up|5
4709221|NCT02184143|16232127|P2|Overall Study|Withdrawal by Subject|4
4709222|NCT02184143|16232128|P1|Overall Study|Withdrawal by Subject|4
4709223|NCT02183675|16232157|P6|Treatment Period 2 (10 Days)|Adverse Event|2
4709224|NCT02183675|16232158|P5|Treatment Period 2 (10 Days)|Adverse Event|0
4709225|NCT02183675|16232159|P4|Treatment Period 2 (10 Days)|Adverse Event|0
4709226|NCT02183675|16232160|P3|Treatment Period 2 (10 Days)|Adverse Event|0
4709227|NCT02183675|16232161|P2|Treatment Period 2 (10 Days)|Adverse Event|0
4709228|NCT02183675|16232162|P1|Treatment Period 2 (10 Days)|Adverse Event|0
4709229|NCT02183519|16232186|P2|Overall Study|Did not respond to cough inducter|3
4709230|NCT02183519|16232187|P1|Overall Study|Did not respond to cough inducter|0
4709231|NCT02183519|16232186|P2|Overall Study|computer error|0
4709232|NCT02183519|16232187|P1|Overall Study|computer error|3
4709233|NCT02182999|16232195|P2|Overall Study|Physician Decision|0
4709234|NCT02182999|16232196|P1|Overall Study|Physician Decision|1
4709235|NCT02182999|16232195|P2|Overall Study|Adverse Event|3
4709236|NCT02182999|16232196|P1|Overall Study|Adverse Event|4
4709237|NCT02182973|16232212|P2|Overall Study|Withdrawal by Subject|0
4709238|NCT02182973|16232213|P1|Overall Study|Withdrawal by Subject|3
4709239|NCT02182895|16232225|P2|Overall Study|Discharged from hospital within 24 hours|4
4709240|NCT02182895|16232226|P1|Overall Study|Discharged from hospital within 24 hours|2
4709241|NCT02182843|16232246|P1|Overall Study|Adverse Event|1
4709242|NCT02182843|16232246|P1|Overall Study|Lost to Follow-up|2
4709243|NCT02182843|16232246|P1|Overall Study|Withdrawal by Subject|7
4709244|NCT02182830|16232253|P2|Overall Study|Lost to Follow-up|3
4709245|NCT02182830|16232254|P1|Overall Study|Lost to Follow-up|3
4709246|NCT02182830|16232253|P2|Overall Study|Consent withdrawn|8
4709247|NCT02182830|16232254|P1|Overall Study|Consent withdrawn|8
4709248|NCT02182830|16232253|P2|Overall Study|Trial stopped, reason missing|3
4709249|NCT02182830|16232254|P1|Overall Study|Trial stopped, reason missing|3
4709250|NCT02182830|16232253|P2|Overall Study|Not Treated|1
4709251|NCT02182830|16232254|P1|Overall Study|Not Treated|1
4709252|NCT02182440|16232299|P4|Overall Study|different, e.g adm other hospital|10
4709253|NCT02182440|16232300|P3|Overall Study|different, e.g adm other hospital|3
4709254|NCT02182440|16232301|P2|Overall Study|different, e.g adm other hospital|3
4709255|NCT02182440|16232302|P1|Overall Study|different, e.g adm other hospital|12
4709256|NCT02182440|16232299|P4|Overall Study|Withdrawal by Subject|4
4709257|NCT02182440|16232300|P3|Overall Study|Withdrawal by Subject|3
4709258|NCT02182440|16232301|P2|Overall Study|Withdrawal by Subject|1
4709259|NCT02182440|16232302|P1|Overall Study|Withdrawal by Subject|1
4709260|NCT02182440|16232299|P4|Overall Study|Physician Decision|0
4709261|NCT02182440|16232300|P3|Overall Study|Physician Decision|0
4709262|NCT02182440|16232301|P2|Overall Study|Physician Decision|0
4709263|NCT02182440|16232302|P1|Overall Study|Physician Decision|1
4709264|NCT02182440|16232299|P4|Overall Study|Protocol Violation|0
4709265|NCT02182440|16232300|P3|Overall Study|Protocol Violation|0
4709266|NCT02182440|16232301|P2|Overall Study|Protocol Violation|1
4709267|NCT02182440|16232302|P1|Overall Study|Protocol Violation|0
4709268|NCT02182440|16232299|P4|Overall Study|Death|16
4709269|NCT02182440|16232300|P3|Overall Study|Death|5
4709270|NCT02182440|16232301|P2|Overall Study|Death|8
4709271|NCT02182440|16232302|P1|Overall Study|Death|31
4709272|NCT02182440|16232299|P4|Overall Study|Adverse Event|0
4709273|NCT02182440|16232300|P3|Overall Study|Adverse Event|0
4709274|NCT02182440|16232301|P2|Overall Study|Adverse Event|1
4709275|NCT02182440|16232302|P1|Overall Study|Adverse Event|0
4709276|NCT00338949|16232343|P2|Randomization|Adverse Event|5
4709277|NCT00338949|16232344|P1|Randomization|Adverse Event|0
4709278|NCT00338949|16232343|P2|Randomization|Withdrawal by Subject|0
4709279|NCT00338949|16232344|P1|Randomization|Withdrawal by Subject|1
4709280|NCT00338949|16232343|P2|Subject Screening|Screen failures|11
4709281|NCT00338949|16232344|P1|Subject Screening|Screen failures|11
4709282|NCT02181842|16232352|P1|Overall Study|Case Report Forms Uncollected|2
4709283|NCT02181816|16232369|P1|Overall Study|Protocol Deviation|21
4709284|NCT02181816|16232369|P1|Overall Study|Case Report Forms Uncollected|38
4709285|NCT02181803|16232384|P9|Overall Study|Adverse Event|0
4709286|NCT02181803|16232385|P8|Overall Study|Adverse Event|0
4709287|NCT02181803|16232386|P7|Overall Study|Adverse Event|1
4709288|NCT02181803|16232387|P6|Overall Study|Adverse Event|0
4709289|NCT02181803|16232388|P5|Overall Study|Adverse Event|0
4709290|NCT02181803|16232389|P4|Overall Study|Adverse Event|1
4709291|NCT02181803|16232390|P3|Overall Study|Adverse Event|0
4709292|NCT02181803|16232391|P2|Overall Study|Adverse Event|2
4709293|NCT02181803|16232392|P1|Overall Study|Adverse Event|0
4709294|NCT02181803|16232384|P9|Overall Study|Physician Decision|0
4709295|NCT02181803|16232385|P8|Overall Study|Physician Decision|1
4709296|NCT02181803|16232386|P7|Overall Study|Physician Decision|0
4709297|NCT02181803|16232387|P6|Overall Study|Physician Decision|0
4709298|NCT02181803|16232388|P5|Overall Study|Physician Decision|0
4709299|NCT02181803|16232389|P4|Overall Study|Physician Decision|1
4709300|NCT02181803|16232390|P3|Overall Study|Physician Decision|0
4709301|NCT02181803|16232391|P2|Overall Study|Physician Decision|0
4709302|NCT02181803|16232392|P1|Overall Study|Physician Decision|0
4709303|NCT02181803|16232384|P9|Overall Study|Withdrawal by Subject|0
4709304|NCT02181803|16232385|P8|Overall Study|Withdrawal by Subject|0
4709305|NCT02181803|16232386|P7|Overall Study|Withdrawal by Subject|0
4709306|NCT02181803|16232387|P6|Overall Study|Withdrawal by Subject|0
4709307|NCT02181803|16232388|P5|Overall Study|Withdrawal by Subject|0
4709308|NCT02181803|16232389|P4|Overall Study|Withdrawal by Subject|0
4709309|NCT02181803|16232390|P3|Overall Study|Withdrawal by Subject|0
4709310|NCT02181803|16232391|P2|Overall Study|Withdrawal by Subject|2
4709311|NCT02181803|16232392|P1|Overall Study|Withdrawal by Subject|0
4709312|NCT02181790|16232543|P2|Overall Study|study terminated|0
4709313|NCT02181790|16232544|P1|Overall Study|study terminated|2
4709314|NCT02181738|16232556|P4|Overall Study|Patient Return to Home Country|0
4709315|NCT02181738|16232557|P3|Overall Study|Patient Return to Home Country|0
4709316|NCT02181738|16232558|P2|Overall Study|Patient Return to Home Country|1
4709317|NCT02181738|16232559|P1|Overall Study|Patient Return to Home Country|0
4709318|NCT02181738|16232556|P4|Overall Study|Lost to Follow-up|0
4709319|NCT02181738|16232557|P3|Overall Study|Lost to Follow-up|2
4709320|NCT02181738|16232558|P2|Overall Study|Lost to Follow-up|4
4709321|NCT02181738|16232559|P1|Overall Study|Lost to Follow-up|0
4709322|NCT02181738|16232556|P4|Overall Study|Subject Withdrew Consent|1
4709323|NCT02181738|16232557|P3|Overall Study|Subject Withdrew Consent|2
4709324|NCT02181738|16232558|P2|Overall Study|Subject Withdrew Consent|3
4709325|NCT02181738|16232559|P1|Overall Study|Subject Withdrew Consent|1
4709326|NCT02181738|16232556|P4|Overall Study|Death|1
4709327|NCT02181738|16232557|P3|Overall Study|Death|6
4709328|NCT02181738|16232558|P2|Overall Study|Death|1
4709329|NCT02181738|16232559|P1|Overall Study|Death|1
4709330|NCT02181673|16232600|P3|Week 24-Week 60|Physician Decision|1
4709331|NCT02181673|16232601|P2|Week 24-Week 60|Physician Decision|0
4709332|NCT02181673|16232602|P1|Week 24-Week 60|Physician Decision|0
4709333|NCT02181673|16232600|P3|Week 24-Week 60|Lost to Follow-up|1
4709334|NCT02181673|16232601|P2|Week 24-Week 60|Lost to Follow-up|0
4709335|NCT02181673|16232602|P1|Week 24-Week 60|Lost to Follow-up|0
4709336|NCT02181673|16232600|P3|Week 24-Week 60|Lack of Efficacy|1
4709337|NCT02181673|16232601|P2|Week 24-Week 60|Lack of Efficacy|0
4709338|NCT02181673|16232602|P1|Week 24-Week 60|Lack of Efficacy|0
4709339|NCT02181673|16232600|P3|Week 24-Week 60|Pregnancy|1
4709340|NCT02181673|16232601|P2|Week 24-Week 60|Pregnancy|0
4709341|NCT02181673|16232602|P1|Week 24-Week 60|Pregnancy|0
4709342|NCT02181673|16232600|P3|Week 24-Week 60|Withdrawal by Subject|2
4709343|NCT02181673|16232601|P2|Week 24-Week 60|Withdrawal by Subject|2
4709344|NCT02181673|16232602|P1|Week 24-Week 60|Withdrawal by Subject|0
4709345|NCT02181673|16232600|P3|Week 24-Week 60|Other|1
4709346|NCT02181673|16232601|P2|Week 24-Week 60|Other|2
4709347|NCT02181673|16232602|P1|Week 24-Week 60|Other|0
4709348|NCT02181673|16232600|P3|Week 24-Week 60|Adverse Event|10
4709349|NCT02181673|16232601|P2|Week 24-Week 60|Adverse Event|4
4709350|NCT02181673|16232602|P1|Week 24-Week 60|Adverse Event|0
4709351|NCT02181673|16232600|P3|Up to Week 24|Randomized not Treated|1
4709352|NCT02181673|16232601|P2|Up to Week 24|Randomized not Treated|0
4709353|NCT02181673|16232602|P1|Up to Week 24|Randomized not Treated|0
4709354|NCT02181673|16232600|P3|Up to Week 24|Other|3
4709355|NCT02181673|16232601|P2|Up to Week 24|Other|0
4709356|NCT02181673|16232602|P1|Up to Week 24|Other|2
4709357|NCT02181673|16232600|P3|Up to Week 24|Withdrawal by Subject|1
4709358|NCT02181673|16232601|P2|Up to Week 24|Withdrawal by Subject|0
4709359|NCT02181673|16232602|P1|Up to Week 24|Withdrawal by Subject|10
4709360|NCT02181673|16232600|P3|Up to Week 24|Physician Decision|3
4709361|NCT02181673|16232601|P2|Up to Week 24|Physician Decision|0
4709362|NCT02181673|16232602|P1|Up to Week 24|Physician Decision|0
4709363|NCT02181673|16232600|P3|Up to Week 24|Lost to Follow-up|0
4709364|NCT02181673|16232601|P2|Up to Week 24|Lost to Follow-up|0
4709365|NCT02181673|16232602|P1|Up to Week 24|Lost to Follow-up|1
4709366|NCT02181673|16232600|P3|Up to Week 24|Lack of Efficacy|0
4709367|NCT02181673|16232601|P2|Up to Week 24|Lack of Efficacy|0
4709368|NCT02181673|16232602|P1|Up to Week 24|Lack of Efficacy|1
4709369|NCT02181673|16232600|P3|Up to Week 24|Death|0
4709370|NCT02181673|16232601|P2|Up to Week 24|Death|0
4709371|NCT02181673|16232602|P1|Up to Week 24|Death|1
4709372|NCT02181673|16232600|P3|Up to Week 24|Adverse Event|3
4709373|NCT02181673|16232601|P2|Up to Week 24|Adverse Event|0
4709374|NCT02181673|16232602|P1|Up to Week 24|Adverse Event|2
4709375|NCT02181634|16232629|P1|Overall Study|Patient opted to proceed to surgery|1
4709376|NCT02181634|16232629|P1|Overall Study|Symptomatic progression|1
4709377|NCT02181634|16232629|P1|Overall Study|Max number of dose reduction|1
4709378|NCT02181634|16232629|P1|Overall Study|Ineligible|1
4709379|NCT02181634|16232629|P1|Overall Study|Treatment delayed greater than 4 weeks|3
4709380|NCT02181634|16232629|P1|Overall Study|Death|2
4709381|NCT02181634|16232629|P1|Overall Study|Withdrawal by Subject|5
4709382|NCT02181634|16232629|P1|Overall Study|Physician Decision|8
4709383|NCT02181634|16232629|P1|Overall Study|Adverse Event|17
4709384|NCT02181634|16232629|P1|Overall Study|Lack of Efficacy|33
4709385|NCT02181504|16232678|P3|Overall Study|Adverse Event|1
4709386|NCT02181504|16232679|P2|Overall Study|Adverse Event|1
4709387|NCT02181504|16232680|P1|Overall Study|Adverse Event|1
4709388|NCT02181413|16232719|P2|Overall Study|Lost to Follow-up|1
4709389|NCT02181413|16232720|P1|Overall Study|Lost to Follow-up|0
4709390|NCT02181413|16232719|P2|Overall Study|Ongoing Study Treatment|1
4709391|NCT02181413|16232720|P1|Overall Study|Ongoing Study Treatment|0
4709392|NCT02181413|16232719|P2|Overall Study|Reason Not Specified|20
4709393|NCT02181413|16232720|P1|Overall Study|Reason Not Specified|19
4709394|NCT02181413|16232719|P2|Overall Study|Withdrawal by Subject|8
4709395|NCT02181413|16232720|P1|Overall Study|Withdrawal by Subject|5
4709396|NCT02181413|16232719|P2|Overall Study|Progressive Disease|143
4709397|NCT02181413|16232720|P1|Overall Study|Progressive Disease|121
4709398|NCT02181413|16232719|P2|Overall Study|Adverse Event|24
4709399|NCT02181413|16232720|P1|Overall Study|Adverse Event|7
4709400|NCT02181296|16232765|P2|Overall Study|Lost to Follow-up|6
4709401|NCT02181296|16232766|P1|Overall Study|Lost to Follow-up|7
4709402|NCT02180867|16232888|P7|Overall Study|Refusal of further protocol therapy|0
4709403|NCT02180867|16232889|P6|Overall Study|Refusal of further protocol therapy|0
4709404|NCT02180867|16232890|P5|Overall Study|Refusal of further protocol therapy|4
4709405|NCT02180867|16232891|P4|Overall Study|Refusal of further protocol therapy|6
4709406|NCT02180867|16232892|P3|Overall Study|Refusal of further protocol therapy|2
4709407|NCT02180867|16232893|P2|Overall Study|Refusal of further protocol therapy|0
4709408|NCT02180867|16232894|P1|Overall Study|Refusal of further protocol therapy|1
4709409|NCT02180867|16232888|P7|Overall Study|Repeat Eligibility Studies|0
4709410|NCT02180867|16232889|P6|Overall Study|Repeat Eligibility Studies|0
4709411|NCT02180867|16232890|P5|Overall Study|Repeat Eligibility Studies|1
4709412|NCT02180867|16232891|P4|Overall Study|Repeat Eligibility Studies|0
4709413|NCT02180867|16232892|P3|Overall Study|Repeat Eligibility Studies|0
4709414|NCT02180867|16232893|P2|Overall Study|Repeat Eligibility Studies|0
4709415|NCT02180867|16232894|P1|Overall Study|Repeat Eligibility Studies|0
4709416|NCT02180867|16232888|P7|Overall Study|Ineligible|0
4709417|NCT02180867|16232889|P6|Overall Study|Ineligible|0
4709418|NCT02180867|16232890|P5|Overall Study|Ineligible|5
4709419|NCT02180867|16232891|P4|Overall Study|Ineligible|3
4709420|NCT02180867|16232892|P3|Overall Study|Ineligible|0
4709421|NCT02180867|16232893|P2|Overall Study|Ineligible|2
4709422|NCT02180867|16232894|P1|Overall Study|Ineligible|1
4709423|NCT02180867|16232888|P7|Overall Study|Withdrawal by Subject|0
4709424|NCT02180867|16232889|P6|Overall Study|Withdrawal by Subject|0
4709425|NCT02180867|16232890|P5|Overall Study|Withdrawal by Subject|1
4709426|NCT02180867|16232891|P4|Overall Study|Withdrawal by Subject|1
4709427|NCT02180867|16232892|P3|Overall Study|Withdrawal by Subject|0
4709428|NCT02180867|16232893|P2|Overall Study|Withdrawal by Subject|0
4709429|NCT02180867|16232894|P1|Overall Study|Withdrawal by Subject|0
4709430|NCT02180867|16232888|P7|Overall Study|Physician Decision|4
4709431|NCT02180867|16232889|P6|Overall Study|Physician Decision|3
4709432|NCT02180867|16232890|P5|Overall Study|Physician Decision|9
4709433|NCT02180867|16232891|P4|Overall Study|Physician Decision|10
4709434|NCT02180867|16232892|P3|Overall Study|Physician Decision|1
4709435|NCT02180867|16232893|P2|Overall Study|Physician Decision|3
4709436|NCT02180867|16232894|P1|Overall Study|Physician Decision|1
4709437|NCT02180867|16232888|P7|Overall Study|Lack of Efficacy|1
4709438|NCT02180867|16232889|P6|Overall Study|Lack of Efficacy|0
4709439|NCT02180867|16232890|P5|Overall Study|Lack of Efficacy|6
4709440|NCT02180867|16232891|P4|Overall Study|Lack of Efficacy|1
4709441|NCT02180867|16232892|P3|Overall Study|Lack of Efficacy|0
4709442|NCT02180867|16232893|P2|Overall Study|Lack of Efficacy|2
4709443|NCT02180867|16232894|P1|Overall Study|Lack of Efficacy|0
4709444|NCT02180867|16232888|P7|Overall Study|Death|0
4709445|NCT02180867|16232889|P6|Overall Study|Death|0
4709446|NCT02180867|16232890|P5|Overall Study|Death|1
4709447|NCT02180867|16232891|P4|Overall Study|Death|0
4709448|NCT02180867|16232892|P3|Overall Study|Death|0
4709449|NCT02180867|16232893|P2|Overall Study|Death|0
4709450|NCT02180867|16232894|P1|Overall Study|Death|0
4709451|NCT02180867|16232888|P7|Overall Study|Adverse Event|0
4709452|NCT02180867|16232889|P6|Overall Study|Adverse Event|0
4709453|NCT02180867|16232890|P5|Overall Study|Adverse Event|0
4709454|NCT02180867|16232891|P4|Overall Study|Adverse Event|5
4709455|NCT02180867|16232892|P3|Overall Study|Adverse Event|1
4709456|NCT02180867|16232893|P2|Overall Study|Adverse Event|4
4709457|NCT02180867|16232894|P1|Overall Study|Adverse Event|3
4709458|NCT02180724|16232950|P2|Overall Study|Ongoing Study|11
4709459|NCT02180724|16232951|P1|Overall Study|Ongoing Study|78
4709460|NCT02180724|16232950|P2|Overall Study|Withdrawal by Subject|2
4709461|NCT02180724|16232951|P1|Overall Study|Withdrawal by Subject|1
4709462|NCT02180724|16232950|P2|Overall Study|Lost to Follow-up|0
4709463|NCT02180724|16232951|P1|Overall Study|Lost to Follow-up|1
4709464|NCT02180724|16232950|P2|Overall Study|Death|1
4709465|NCT02180724|16232951|P1|Overall Study|Death|12
4709466|NCT02180659|16232965|P2|Overall Study|AT REQUEST OF THE SPONSOR|1
4709467|NCT02180659|16232966|P1|Overall Study|AT REQUEST OF THE SPONSOR|0
4709468|NCT02180659|16232965|P2|Overall Study|Withdrawal by Subject|2
4709469|NCT02180659|16232966|P1|Overall Study|Withdrawal by Subject|0
4709470|NCT02180659|16232965|P2|Overall Study|Subject incarcerated during conduct|0
4709471|NCT02180659|16232966|P1|Overall Study|Subject incarcerated during conduct|1
4709472|NCT02180659|16232965|P2|Overall Study|Lost to Follow-up|2
4709473|NCT02180659|16232966|P1|Overall Study|Lost to Follow-up|4
4709474|NCT02180659|16232965|P2|Overall Study|Adverse Event|0
4709475|NCT02180659|16232966|P1|Overall Study|Adverse Event|1
4709476|NCT02180438|16233001|P1|Overall Study|Lost to Follow-up|1
4709477|NCT02180217|16233024|P3|Overall Study|Discontinued Prior to Ext. phase|25
4709478|NCT02180217|16233025|P2|Overall Study|Discontinued Prior to Ext. phase|5
4709479|NCT02180217|16233026|P1|Overall Study|Discontinued Prior to Ext. phase|1
4709480|NCT02180217|16233024|P3|Overall Study|Subject/guardian decision|2
4709481|NCT02180217|16233025|P2|Overall Study|Subject/guardian decision|2
4709482|NCT02180217|16233026|P1|Overall Study|Subject/guardian decision|0
4709483|NCT02180217|16233024|P3|Overall Study|Withdrawal by Subject|0
4709484|NCT02180217|16233025|P2|Overall Study|Withdrawal by Subject|0
4709485|NCT02180217|16233026|P1|Overall Study|Withdrawal by Subject|1
4709486|NCT02180217|16233024|P3|Overall Study|Death|0
4709487|NCT02180217|16233025|P2|Overall Study|Death|1
4709488|NCT02180217|16233026|P1|Overall Study|Death|0
4709489|NCT02180217|16233024|P3|Overall Study|Adverse Event|5
4709490|NCT02180217|16233025|P2|Overall Study|Adverse Event|0
4709491|NCT02180217|16233026|P1|Overall Study|Adverse Event|0
4709492|NCT02180165|16233041|P4|Overall Study|Withdrawal by Subject|1
4709493|NCT02180165|16233042|P3|Overall Study|Withdrawal by Subject|2
4709494|NCT02180165|16233043|P2|Overall Study|Withdrawal by Subject|0
4709495|NCT02180165|16233044|P1|Overall Study|Withdrawal by Subject|3
4709496|NCT02180165|16233041|P4|Overall Study|Physician Decision|0
4709497|NCT02180165|16233042|P3|Overall Study|Physician Decision|5
4709498|NCT02180165|16233043|P2|Overall Study|Physician Decision|0
4709499|NCT02180165|16233044|P1|Overall Study|Physician Decision|1
4709500|NCT02180165|16233041|P4|Overall Study|Lack of Efficacy|2
4709501|NCT02180165|16233042|P3|Overall Study|Lack of Efficacy|3
4709502|NCT02180165|16233043|P2|Overall Study|Lack of Efficacy|1
4709503|NCT02180165|16233044|P1|Overall Study|Lack of Efficacy|0
4709504|NCT02180165|16233041|P4|Overall Study|Adverse Event|3
4709505|NCT02180165|16233042|P3|Overall Study|Adverse Event|18
4709506|NCT02180165|16233043|P2|Overall Study|Adverse Event|0
4709507|NCT02180165|16233044|P1|Overall Study|Adverse Event|7
4709508|NCT02180165|16233041|P4|Overall Study|Not Treated|0
4709509|NCT02180165|16233042|P3|Overall Study|Not Treated|1
4709510|NCT02180165|16233043|P2|Overall Study|Not Treated|0
4709511|NCT02180165|16233044|P1|Overall Study|Not Treated|0
4709512|NCT02180061|16233143|P2|Overall Study|Physician Decision|0
4709513|NCT02180061|16233144|P1|Overall Study|Physician Decision|1
4709514|NCT02180061|16233143|P2|Overall Study|Progressive Disease|5
4709515|NCT02180061|16233144|P1|Overall Study|Progressive Disease|15
4709516|NCT02180061|16233143|P2|Overall Study|Clinical Progression|1
4709517|NCT02180061|16233144|P1|Overall Study|Clinical Progression|5
4709518|NCT02180061|16233143|P2|Overall Study|Adverse Event|2
4709519|NCT02180061|16233144|P1|Overall Study|Adverse Event|4
4709520|NCT02179918|16233163|P5|Overall Study|Subject refused further follow-up|1
4709521|NCT02179918|16233164|P4|Overall Study|Subject refused further follow-up|0
4709522|NCT02179918|16233165|P3|Overall Study|Subject refused further follow-up|0
4709523|NCT02179918|16233166|P2|Overall Study|Subject refused further follow-up|1
4709524|NCT02179918|16233167|P1|Overall Study|Subject refused further follow-up|0
4709525|NCT02179918|16233163|P5|Overall Study|Other|1
4709526|NCT02179918|16233164|P4|Overall Study|Other|0
4709527|NCT02179918|16233165|P3|Overall Study|Other|0
4709528|NCT02179918|16233166|P2|Overall Study|Other|1
4709529|NCT02179918|16233167|P1|Overall Study|Other|0
4709530|NCT02179918|16233163|P5|Overall Study|Progressive Disease|6
4709531|NCT02179918|16233164|P4|Overall Study|Progressive Disease|2
4709532|NCT02179918|16233165|P3|Overall Study|Progressive Disease|1
4709533|NCT02179918|16233166|P2|Overall Study|Progressive Disease|1
4709534|NCT02179918|16233167|P1|Overall Study|Progressive Disease|4
4709535|NCT02179918|16233163|P5|Overall Study|Lost to Follow-up|0
4709536|NCT02179918|16233164|P4|Overall Study|Lost to Follow-up|0
4709537|NCT02179918|16233165|P3|Overall Study|Lost to Follow-up|1
4709538|NCT02179918|16233166|P2|Overall Study|Lost to Follow-up|0
4709539|NCT02179918|16233167|P1|Overall Study|Lost to Follow-up|0
4709540|NCT02179918|16233163|P5|Overall Study|Death|0
4709541|NCT02179918|16233164|P4|Overall Study|Death|1
4709542|NCT02179918|16233165|P3|Overall Study|Death|0
4709543|NCT02179918|16233166|P2|Overall Study|Death|0
4709544|NCT02179918|16233167|P1|Overall Study|Death|0
4709545|NCT02179398|16233380|P2|Overall Study|Lost to Follow-up|1
4709546|NCT02179398|16233381|P1|Overall Study|Lost to Follow-up|0
4709547|NCT02179398|16233380|P2|Overall Study|Lack of obligatory data|3
4709548|NCT02179398|16233381|P1|Overall Study|Lack of obligatory data|3
4709549|NCT02179190|16233399|P1|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1
4709550|NCT02179190|16233399|P1|Follow-Up Post Barrel VRD Implanted|Physician Decision|2
4709551|NCT02179190|16233399|P1|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3
4709552|NCT02179190|16233399|P1|Follow-Up Post Barrel VRD Implanted|Death|3
4709553|NCT02179190|16233399|P1|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7
4709554|NCT02179190|16233399|P1|Enrollment|Exit Prior to Device Attempt|11
4709555|NCT02179177|16233412|P2|Overall Study|Withdrawal by Subject|1
4709556|NCT02179177|16233413|P1|Overall Study|Withdrawal by Subject|1
4709557|NCT02179177|16233412|P2|Overall Study|Lost to Follow-up|1
4709558|NCT02179177|16233413|P1|Overall Study|Lost to Follow-up|1
4709559|NCT02178995|16233453|P9|Open Label|Adverse Event|0
4709560|NCT02178995|16233454|P8|Open Label|Adverse Event|0
4709561|NCT02178995|16233455|P7|Open Label|Adverse Event|0
4709562|NCT02178995|16233456|P6|Open Label|Adverse Event|0
4709563|NCT02178995|16233457|P5|Open Label|Adverse Event|0
4709564|NCT02178995|16233458|P4|Open Label|Adverse Event|0
4709565|NCT02178995|16233459|P3|Open Label|Adverse Event|0
4709566|NCT02178995|16233460|P2|Open Label|Adverse Event|0
4709567|NCT02178995|16233461|P1|Open Label|Adverse Event|2
4709568|NCT02178995|16233453|P9|Double Blind|Lost to Follow-up|0
4709569|NCT02178995|16233454|P8|Double Blind|Lost to Follow-up|1
4709570|NCT02178995|16233455|P7|Double Blind|Lost to Follow-up|0
4709571|NCT02178995|16233456|P6|Double Blind|Lost to Follow-up|0
4709572|NCT02178995|16233457|P5|Double Blind|Lost to Follow-up|0
4709573|NCT02178995|16233458|P4|Double Blind|Lost to Follow-up|0
4709574|NCT02178995|16233459|P3|Double Blind|Lost to Follow-up|0
4709575|NCT02178995|16233460|P2|Double Blind|Lost to Follow-up|1
4709576|NCT02178995|16233461|P1|Double Blind|Lost to Follow-up|0
4709577|NCT02178995|16233453|P9|Double Blind|Adverse Event|1
4709578|NCT02178995|16233454|P8|Double Blind|Adverse Event|1
4709579|NCT02178995|16233455|P7|Double Blind|Adverse Event|0
4709580|NCT02178995|16233456|P6|Double Blind|Adverse Event|1
4709581|NCT02178995|16233457|P5|Double Blind|Adverse Event|0
4709582|NCT02178995|16233458|P4|Double Blind|Adverse Event|0
4709583|NCT02178995|16233459|P3|Double Blind|Adverse Event|0
4709584|NCT02178995|16233460|P2|Double Blind|Adverse Event|0
4709585|NCT02178995|16233461|P1|Double Blind|Adverse Event|0
4709586|NCT02178787|16233569|P2|Overall Study|Physician Decision|0
4709587|NCT02178787|16233570|P1|Overall Study|Physician Decision|1
4709588|NCT02178787|16233569|P2|Overall Study|No TCD window|7
4709589|NCT02178787|16233570|P1|Overall Study|No TCD window|3
4709590|NCT02178787|16233569|P2|Overall Study|Withdrawal by Subject|2
4709591|NCT02178787|16233570|P1|Overall Study|Withdrawal by Subject|0
4709592|NCT02178787|16233569|P2|Overall Study|Lost to Follow-up|0
4709593|NCT02178787|16233570|P1|Overall Study|Lost to Follow-up|1
4709594|NCT02178722|16233583|P5|Overall Study|Participants Ongoing in study|74
4709595|NCT02178722|16233584|P4|Overall Study|Participants Ongoing in study|2
4709596|NCT02178722|16233585|P3|Overall Study|Participants Ongoing in study|4
4709597|NCT02178722|16233586|P2|Overall Study|Participants Ongoing in study|1
4709598|NCT02178722|16233587|P1|Overall Study|Participants Ongoing in study|1
4709599|NCT02178722|16233583|P5|Overall Study|Other Unspecified|1
4709600|NCT02178722|16233584|P4|Overall Study|Other Unspecified|0
4709601|NCT02178722|16233585|P3|Overall Study|Other Unspecified|0
4709602|NCT02178722|16233586|P2|Overall Study|Other Unspecified|0
4709603|NCT02178722|16233587|P1|Overall Study|Other Unspecified|0
4709604|NCT02178722|16233583|P5|Overall Study|Physician Decision|2
4709605|NCT02178722|16233584|P4|Overall Study|Physician Decision|0
4709606|NCT02178722|16233585|P3|Overall Study|Physician Decision|0
4709607|NCT02178722|16233586|P2|Overall Study|Physician Decision|0
4709608|NCT02178722|16233587|P1|Overall Study|Physician Decision|0
4709609|NCT02178722|16233583|P5|Overall Study|Study Terminated by Sponsor|65
4709610|NCT02178722|16233584|P4|Overall Study|Study Terminated by Sponsor|3
4709611|NCT02178722|16233585|P3|Overall Study|Study Terminated by Sponsor|2
4709612|NCT02178722|16233586|P2|Overall Study|Study Terminated by Sponsor|6
4709613|NCT02178722|16233587|P1|Overall Study|Study Terminated by Sponsor|1
4709614|NCT02178722|16233583|P5|Overall Study|Lost to Follow-up|11
4709615|NCT02178722|16233584|P4|Overall Study|Lost to Follow-up|2
4709616|NCT02178722|16233585|P3|Overall Study|Lost to Follow-up|0
4709617|NCT02178722|16233586|P2|Overall Study|Lost to Follow-up|0
4709618|NCT02178722|16233587|P1|Overall Study|Lost to Follow-up|0
4709619|NCT02178722|16233583|P5|Overall Study|Death|199
4709620|NCT02178722|16233584|P4|Overall Study|Death|11
4709621|NCT02178722|16233585|P3|Overall Study|Death|12
4709622|NCT02178722|16233586|P2|Overall Study|Death|13
4709623|NCT02178722|16233587|P1|Overall Study|Death|2
4709624|NCT02178722|16233583|P5|Overall Study|Participant decision|30
4709625|NCT02178722|16233584|P4|Overall Study|Participant decision|2
4709626|NCT02178722|16233585|P3|Overall Study|Participant decision|0
4709627|NCT02178722|16233586|P2|Overall Study|Participant decision|0
4709628|NCT02178722|16233587|P1|Overall Study|Participant decision|0
4709629|NCT02178709|16233599|P1|Overall Study|Disease Progression|5
4709630|NCT02178709|16233599|P1|Overall Study|Physician Decision|2
4709631|NCT02178709|16233599|P1|Overall Study|Withdrawal by Subject|2
4709632|NCT02178709|16233599|P1|Overall Study|Death|2
4709633|NCT02178709|16233599|P1|Overall Study|Adverse Event|5
4709634|NCT00289185|16233626|P2|Overall Study|Death|1
4709635|NCT00289185|16233627|P1|Overall Study|Death|1
4709636|NCT00289185|16233626|P2|Overall Study|Lost to Follow-up|17
4709637|NCT00289185|16233627|P1|Overall Study|Lost to Follow-up|23
4709638|NCT00289185|16233626|P2|Overall Study|Withdrawal by Subject|8
4709639|NCT00289185|16233627|P1|Overall Study|Withdrawal by Subject|4
4709640|NCT02178592|16233674|P2|Overall Study|Physician Decision|0
4709641|NCT02178592|16233675|P1|Overall Study|Physician Decision|1
4709642|NCT02178592|16233674|P2|Overall Study|Lost to Follow-up|3
4709643|NCT02178592|16233675|P1|Overall Study|Lost to Follow-up|11
4709644|NCT02178592|16233674|P2|Overall Study|Withdrawal by Subject|1
4709645|NCT02178592|16233675|P1|Overall Study|Withdrawal by Subject|3
4709646|NCT02178592|16233674|P2|Overall Study|Protocol Violation|2
4709647|NCT02178592|16233675|P1|Overall Study|Protocol Violation|3
4709648|NCT02178592|16233674|P2|Overall Study|Lack of Efficacy|1
4709649|NCT02178592|16233675|P1|Overall Study|Lack of Efficacy|1
4709650|NCT02178592|16233674|P2|Overall Study|Adverse Event|2
4709651|NCT02178592|16233675|P1|Overall Study|Adverse Event|0
4709652|NCT02178553|16233703|P2|Overall Study|Technical problem with injection|3
4709653|NCT02178553|16233704|P1|Overall Study|Technical problem with injection|1
4709654|NCT02178553|16233703|P2|Overall Study|Physician Decision|4
4709655|NCT02178553|16233704|P1|Overall Study|Physician Decision|0
4709656|NCT02178553|16233703|P2|Overall Study|Did not proceed to open thoracotomy|3
4709657|NCT02178553|16233704|P1|Overall Study|Did not proceed to open thoracotomy|7
4709658|NCT02178475|16233723|P1|Overall Study|Protocol-specified Criteria|99
4709659|NCT02178475|16233723|P1|Overall Study|Death|13
4709660|NCT02178475|16233723|P1|Overall Study|Lost to Follow-up|10
4709661|NCT02178475|16233723|P1|Overall Study|Withdrawal by Subject|7
4709662|NCT02178059|16233750|P2|Washout|Physician Decision|0
4709663|NCT02178059|16233751|P1|Washout|Physician Decision|1
4709664|NCT02177942|16233769|P2|Overall Study|Withdrawal by Subject|81
4709665|NCT02177942|16233770|P1|Overall Study|Withdrawal by Subject|71
4709666|NCT02177942|16233769|P2|Overall Study|Protocol Violation|6
4709667|NCT02177942|16233770|P1|Overall Study|Protocol Violation|4
4709668|NCT02177942|16233769|P2|Overall Study|Lost to Follow-up|1
4709669|NCT02177942|16233770|P1|Overall Study|Lost to Follow-up|1
4709670|NCT02177942|16233769|P2|Overall Study|Adverse Event|0
4709671|NCT02177942|16233770|P1|Overall Study|Adverse Event|1
4709672|NCT02177812|16233801|P9|Part 1 (Median of 4 Weeks)|Adverse Event|0
4709673|NCT02177812|16233802|P8|Part 1 (Median of 4 Weeks)|Adverse Event|1
4709674|NCT02177812|16233803|P7|Part 1 (Median of 4 Weeks)|Adverse Event|6
4709675|NCT02177812|16233804|P6|Part 1 (Median of 4 Weeks)|Adverse Event|1
4709676|NCT02177812|16233805|P5|Part 1 (Median of 4 Weeks)|Adverse Event|1
4709677|NCT02177812|16233806|P4|Part 1 (Median of 4 Weeks)|Adverse Event|1
4709678|NCT02177812|16233807|P3|Part 1 (Median of 4 Weeks)|Adverse Event|0
4709679|NCT02177812|16233808|P2|Part 1 (Median of 4 Weeks)|Adverse Event|0
4709680|NCT02177812|16233809|P1|Part 1 (Median of 4 Weeks)|Adverse Event|0
4709681|NCT02177812|16233801|P9|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709682|NCT02177812|16233802|P8|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709683|NCT02177812|16233803|P7|Part 1 (Median of 4 Weeks)|Physician Decision|1
4709684|NCT02177812|16233804|P6|Part 1 (Median of 4 Weeks)|Physician Decision|1
4709685|NCT02177812|16233805|P5|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709686|NCT02177812|16233806|P4|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709687|NCT02177812|16233807|P3|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709688|NCT02177812|16233808|P2|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709689|NCT02177812|16233809|P1|Part 1 (Median of 4 Weeks)|Physician Decision|0
4709690|NCT02177812|16233801|P9|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4709691|NCT02177812|16233802|P8|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
4709692|NCT02177812|16233803|P7|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2
4709693|NCT02177812|16233804|P6|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1
4709694|NCT02177812|16233805|P5|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4709695|NCT02177812|16233806|P4|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4709696|NCT02177812|16233807|P3|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4709697|NCT02177812|16233808|P2|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4709698|NCT02177812|16233809|P1|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0
4709699|NCT02177786|16234026|P4|Overall Study|Missing study completion status|0
4709700|NCT02177786|16234027|P3|Overall Study|Missing study completion status|0
4709701|NCT02177786|16234028|P2|Overall Study|Missing study completion status|1
4709702|NCT02177786|16234029|P1|Overall Study|Missing study completion status|0
4709703|NCT02177786|16234026|P4|Overall Study|Progressive Disease|0
4709704|NCT02177786|16234027|P3|Overall Study|Progressive Disease|0
4709705|NCT02177786|16234028|P2|Overall Study|Progressive Disease|1
4709706|NCT02177786|16234029|P1|Overall Study|Progressive Disease|0
4709707|NCT02177786|16234026|P4|Overall Study|Protocol Violation|0
4709708|NCT02177786|16234027|P3|Overall Study|Protocol Violation|2
4709709|NCT02177786|16234028|P2|Overall Study|Protocol Violation|0
4709710|NCT02177786|16234029|P1|Overall Study|Protocol Violation|0
4709711|NCT02177786|16234026|P4|Overall Study|Non-Compliance with Study Drug|1
4709712|NCT02177786|16234027|P3|Overall Study|Non-Compliance with Study Drug|0
4709713|NCT02177786|16234028|P2|Overall Study|Non-Compliance with Study Drug|1
4709714|NCT02177786|16234029|P1|Overall Study|Non-Compliance with Study Drug|0
4709715|NCT02177786|16234026|P4|Overall Study|Lost to Follow-up|2
4709716|NCT02177786|16234027|P3|Overall Study|Lost to Follow-up|2
4709717|NCT02177786|16234028|P2|Overall Study|Lost to Follow-up|0
4709718|NCT02177786|16234029|P1|Overall Study|Lost to Follow-up|0
4709719|NCT02177786|16234026|P4|Overall Study|Death|1
4709720|NCT02177786|16234027|P3|Overall Study|Death|1
4709721|NCT02177786|16234028|P2|Overall Study|Death|1
4709722|NCT02177786|16234029|P1|Overall Study|Death|1
4709723|NCT02177786|16234026|P4|Overall Study|Adverse Event|3
4709724|NCT02177786|16234027|P3|Overall Study|Adverse Event|2
4709725|NCT02177786|16234028|P2|Overall Study|Adverse Event|1
4709726|NCT02177786|16234029|P1|Overall Study|Adverse Event|1
4709727|NCT02177786|16234026|P4|Overall Study|Progression to End Stage Renal Disease|1
4709728|NCT02177786|16234027|P3|Overall Study|Progression to End Stage Renal Disease|2
4709729|NCT02177786|16234028|P2|Overall Study|Progression to End Stage Renal Disease|3
4709730|NCT02177786|16234029|P1|Overall Study|Progression to End Stage Renal Disease|2
4709731|NCT02177786|16234026|P4|Overall Study|Withdrew Consent|5
4709732|NCT02177786|16234027|P3|Overall Study|Withdrew Consent|9
4709733|NCT02177786|16234028|P2|Overall Study|Withdrew Consent|6
4709734|NCT02177786|16234029|P1|Overall Study|Withdrew Consent|2
4709735|NCT02177266|16234052|P2|Overall Study|Withdrawal by Subject|0
4709736|NCT02177266|16234053|P1|Overall Study|Withdrawal by Subject|1
4709737|NCT02177266|16234052|P2|Overall Study|Adverse Event|1
4709738|NCT02177266|16234053|P1|Overall Study|Adverse Event|0
4709739|NCT02177136|16234075|P3|Overall Study|Protocol Violation|1
4709740|NCT02177136|16234076|P2|Overall Study|Protocol Violation|0
4709741|NCT02177136|16234077|P1|Overall Study|Protocol Violation|0
4709742|NCT02177136|16234075|P3|Overall Study|Adverse Event|3
4709743|NCT02177136|16234076|P2|Overall Study|Adverse Event|2
4709744|NCT02177136|16234077|P1|Overall Study|Adverse Event|3
4709745|NCT02177136|16234075|P3|Overall Study|Discontinued due to pruritus|0
4709746|NCT02177136|16234076|P2|Overall Study|Discontinued due to pruritus|3
4709747|NCT02177136|16234077|P1|Overall Study|Discontinued due to pruritus|1
4709748|NCT02177136|16234075|P3|Overall Study|Withdrawal by Subject|0
4709749|NCT02177136|16234076|P2|Overall Study|Withdrawal by Subject|0
4709750|NCT02177136|16234077|P1|Overall Study|Withdrawal by Subject|2
4709751|NCT02177032|16234110|P4|Overall Study|Withdrawal by Subject|0
4709752|NCT02177032|16234111|P3|Overall Study|Withdrawal by Subject|1
4709753|NCT02177032|16234112|P2|Overall Study|Withdrawal by Subject|0
4709754|NCT02177032|16234113|P1|Overall Study|Withdrawal by Subject|1
4709755|NCT02177032|16234110|P4|Overall Study|OTHER|0
4709756|NCT02177032|16234111|P3|Overall Study|OTHER|1
4709757|NCT02177032|16234112|P2|Overall Study|OTHER|0
4709758|NCT02177032|16234113|P1|Overall Study|OTHER|2
4709759|NCT02177032|16234110|P4|Overall Study|Lost to Follow-up|0
4709760|NCT02177032|16234111|P3|Overall Study|Lost to Follow-up|0
4709761|NCT02177032|16234112|P2|Overall Study|Lost to Follow-up|2
4709762|NCT02177032|16234113|P1|Overall Study|Lost to Follow-up|0
4709763|NCT02177032|16234110|P4|Overall Study|ADMINISTRATIVE REASON|0
4709764|NCT02177032|16234111|P3|Overall Study|ADMINISTRATIVE REASON|1
4709765|NCT02177032|16234112|P2|Overall Study|ADMINISTRATIVE REASON|0
4709766|NCT02177032|16234113|P1|Overall Study|ADMINISTRATIVE REASON|2
4709767|NCT02176655|16234151|P1|Overall Study|Subjects did not treat|6
4709768|NCT02176642|16234174|P2|Overall Study|Withdrawal by Subject|1
4709769|NCT02176642|16234175|P1|Overall Study|Withdrawal by Subject|0
4709770|NCT02176525|16234205|P8|Overall Study|not treated|0
4709771|NCT02176525|16234206|P7|Overall Study|not treated|0
4709772|NCT02176525|16234207|P6|Overall Study|not treated|1
4709773|NCT02176525|16234208|P5|Overall Study|not treated|0
4709774|NCT02176525|16234209|P4|Overall Study|not treated|0
4709775|NCT02176525|16234210|P3|Overall Study|not treated|0
4709776|NCT02176525|16234211|P2|Overall Study|not treated|0
4709777|NCT02176525|16234212|P1|Overall Study|not treated|1
4709778|NCT02176525|16234205|P8|Overall Study|Adverse Event|0
4709779|NCT02176525|16234206|P7|Overall Study|Adverse Event|1
4709780|NCT02176525|16234207|P6|Overall Study|Adverse Event|0
4709781|NCT02176525|16234208|P5|Overall Study|Adverse Event|1
4709782|NCT02176525|16234209|P4|Overall Study|Adverse Event|1
4709783|NCT02176525|16234210|P3|Overall Study|Adverse Event|0
4709784|NCT02176525|16234211|P2|Overall Study|Adverse Event|0
4709785|NCT02176525|16234212|P1|Overall Study|Adverse Event|0
4709786|NCT02176421|16234428|P1|Overall Study|Adverse Event|1
4709787|NCT02176421|16234428|P1|Overall Study|Lost to Follow-up|4
4709788|NCT02176356|16234460|P1|Overall Study|Other Miscellaneous Reasons|2
4709789|NCT02176356|16234460|P1|Overall Study|Personal Reasons|3
4709790|NCT02176356|16234460|P1|Overall Study|Lost to Follow-up|4
4709791|NCT02176356|16234460|P1|Overall Study|Screen Failure|14
4709792|NCT02176291|16234490|P2|Overall Study|Withdrawal by Subject|0
4709793|NCT02176291|16234491|P1|Overall Study|Withdrawal by Subject|2
4709794|NCT02176291|16234490|P2|Overall Study|non compliance with protocol|0
4709795|NCT02176291|16234491|P1|Overall Study|non compliance with protocol|2
4709796|NCT02176291|16234490|P2|Overall Study|Death|0
4709797|NCT02176291|16234491|P1|Overall Study|Death|1
4709798|NCT02176226|16234499|P1|Overall Study|Withdrew prior to treatment|6
4709799|NCT02176226|16234499|P1|Overall Study|Lost to Follow-up|3
4709800|NCT02176018|16234525|P2|Overall Study|Withdrawal by Subject|2
4709801|NCT02176018|16234526|P1|Overall Study|Withdrawal by Subject|1
4709802|NCT02176018|16234525|P2|Overall Study|Protocol Violation|1
4709803|NCT02176018|16234526|P1|Overall Study|Protocol Violation|1
4709804|NCT02176018|16234525|P2|Overall Study|Lost to Follow-up|1
4709805|NCT02176018|16234526|P1|Overall Study|Lost to Follow-up|3
4709806|NCT02176018|16234525|P2|Overall Study|Adverse Event|2
4709807|NCT02176018|16234526|P1|Overall Study|Adverse Event|0
4709808|NCT02175966|16234610|P2|Follow-up Period|Lack of Efficacy|6
4709809|NCT02175966|16234611|P1|Follow-up Period|Lack of Efficacy|10
4709810|NCT02175771|16234639|P9|Treatment Period|Other|0
4709811|NCT02175771|16234640|P8|Treatment Period|Other|2
4709812|NCT02175771|16234641|P7|Treatment Period|Other|0
4709813|NCT02175771|16234642|P6|Treatment Period|Other|0
4709814|NCT02175771|16234643|P5|Treatment Period|Other|1
4709815|NCT02175771|16234644|P4|Treatment Period|Other|3
4709816|NCT02175771|16234645|P3|Treatment Period|Other|0
4709817|NCT02175771|16234646|P2|Treatment Period|Other|1
4709818|NCT02175771|16234647|P1|Treatment Period|Other|0
4709819|NCT02175771|16234639|P9|Treatment Period|Lack of Efficacy|0
4709820|NCT02175771|16234640|P8|Treatment Period|Lack of Efficacy|1
4709821|NCT02175771|16234641|P7|Treatment Period|Lack of Efficacy|0
4709822|NCT02175771|16234642|P6|Treatment Period|Lack of Efficacy|1
4709823|NCT02175771|16234643|P5|Treatment Period|Lack of Efficacy|0
4709824|NCT02175771|16234644|P4|Treatment Period|Lack of Efficacy|0
4709825|NCT02175771|16234645|P3|Treatment Period|Lack of Efficacy|0
4709826|NCT02175771|16234646|P2|Treatment Period|Lack of Efficacy|0
4709827|NCT02175771|16234647|P1|Treatment Period|Lack of Efficacy|0
4709828|NCT02175771|16234639|P9|Treatment Period|Lost to Follow-up|2
4709829|NCT02175771|16234640|P8|Treatment Period|Lost to Follow-up|2
4709830|NCT02175771|16234641|P7|Treatment Period|Lost to Follow-up|1
4709831|NCT02175771|16234642|P6|Treatment Period|Lost to Follow-up|2
4709832|NCT02175771|16234643|P5|Treatment Period|Lost to Follow-up|1
4709833|NCT02175771|16234644|P4|Treatment Period|Lost to Follow-up|3
4709834|NCT02175771|16234645|P3|Treatment Period|Lost to Follow-up|1
4709835|NCT02175771|16234646|P2|Treatment Period|Lost to Follow-up|3
4709836|NCT02175771|16234647|P1|Treatment Period|Lost to Follow-up|0
4709837|NCT02175771|16234639|P9|Treatment Period|Disease progression|0
4709838|NCT02175771|16234640|P8|Treatment Period|Disease progression|2
4709839|NCT02175771|16234641|P7|Treatment Period|Disease progression|0
4709840|NCT02175771|16234642|P6|Treatment Period|Disease progression|0
4709841|NCT02175771|16234643|P5|Treatment Period|Disease progression|0
4709842|NCT02175771|16234644|P4|Treatment Period|Disease progression|0
4709843|NCT02175771|16234645|P3|Treatment Period|Disease progression|0
4709844|NCT02175771|16234646|P2|Treatment Period|Disease progression|0
4709845|NCT02175771|16234647|P1|Treatment Period|Disease progression|0
4709846|NCT02175771|16234639|P9|Treatment Period|Protocol Violation|0
4709847|NCT02175771|16234640|P8|Treatment Period|Protocol Violation|1
4709848|NCT02175771|16234641|P7|Treatment Period|Protocol Violation|0
4709849|NCT02175771|16234642|P6|Treatment Period|Protocol Violation|0
4709850|NCT02175771|16234643|P5|Treatment Period|Protocol Violation|0
4709851|NCT02175771|16234644|P4|Treatment Period|Protocol Violation|0
4709852|NCT02175771|16234645|P3|Treatment Period|Protocol Violation|0
4709853|NCT02175771|16234646|P2|Treatment Period|Protocol Violation|0
4709854|NCT02175771|16234647|P1|Treatment Period|Protocol Violation|0
4709855|NCT02175771|16234639|P9|Treatment Period|Noncompliance|1
4709856|NCT02175771|16234640|P8|Treatment Period|Noncompliance|0
4709857|NCT02175771|16234641|P7|Treatment Period|Noncompliance|0
4709858|NCT02175771|16234642|P6|Treatment Period|Noncompliance|0
4709859|NCT02175771|16234643|P5|Treatment Period|Noncompliance|0
4709860|NCT02175771|16234644|P4|Treatment Period|Noncompliance|0
4709861|NCT02175771|16234645|P3|Treatment Period|Noncompliance|2
4709862|NCT02175771|16234646|P2|Treatment Period|Noncompliance|1
4709863|NCT02175771|16234647|P1|Treatment Period|Noncompliance|0
4709864|NCT02175771|16234639|P9|Treatment Period|Withdrawal by Subject|2
4709865|NCT02175771|16234640|P8|Treatment Period|Withdrawal by Subject|9
4709866|NCT02175771|16234641|P7|Treatment Period|Withdrawal by Subject|2
4709867|NCT02175771|16234642|P6|Treatment Period|Withdrawal by Subject|4
4709868|NCT02175771|16234643|P5|Treatment Period|Withdrawal by Subject|2
4709869|NCT02175771|16234644|P4|Treatment Period|Withdrawal by Subject|6
4709870|NCT02175771|16234645|P3|Treatment Period|Withdrawal by Subject|3
4709871|NCT02175771|16234646|P2|Treatment Period|Withdrawal by Subject|9
4709872|NCT02175771|16234647|P1|Treatment Period|Withdrawal by Subject|0
4709873|NCT02175771|16234639|P9|Treatment Period|Adverse Event|1
4709874|NCT02175771|16234640|P8|Treatment Period|Adverse Event|0
4709875|NCT02175771|16234641|P7|Treatment Period|Adverse Event|2
4709876|NCT02175771|16234642|P6|Treatment Period|Adverse Event|3
4709877|NCT02175771|16234643|P5|Treatment Period|Adverse Event|1
4709878|NCT02175771|16234644|P4|Treatment Period|Adverse Event|1
4709879|NCT02175771|16234645|P3|Treatment Period|Adverse Event|1
4709880|NCT02175771|16234646|P2|Treatment Period|Adverse Event|2
4709881|NCT02175771|16234647|P1|Treatment Period|Adverse Event|0
4709882|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Other|0
4709883|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Other|0
4709884|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Other|0
4709885|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Other|0
4709886|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Other|0
4709887|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Other|0
4709888|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Other|0
4709889|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Other|0
4709890|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Other|8
4709891|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709892|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709893|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709894|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709895|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709896|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709897|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709898|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4709899|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
4709900|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709901|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709902|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709903|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709904|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709905|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709906|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709907|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4709908|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|7
4709909|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Adverse Event|0
4709910|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Adverse Event|0
4709911|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Adverse Event|0
4709912|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Adverse Event|0
4709913|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Adverse Event|0
4709914|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Adverse Event|0
4709915|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Adverse Event|0
4709916|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Adverse Event|0
4709917|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Adverse Event|9
4709918|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709919|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709920|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709921|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709922|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709923|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709924|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709925|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4709926|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|11
4709927|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709928|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709929|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709930|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709931|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709932|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709933|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709934|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4709935|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|20
4709936|NCT02175771|16234639|P9|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709937|NCT02175771|16234640|P8|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709938|NCT02175771|16234641|P7|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709939|NCT02175771|16234642|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709940|NCT02175771|16234643|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709941|NCT02175771|16234644|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709942|NCT02175771|16234645|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709943|NCT02175771|16234646|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4709944|NCT02175771|16234647|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|23
4709945|NCT02175758|16234711|P6|Treatment Phase|Adverse Event|0
4709946|NCT02175758|16234712|P5|Treatment Phase|Adverse Event|1
4709947|NCT02175758|16234713|P4|Treatment Phase|Adverse Event|0
4709948|NCT02175758|16234714|P3|Treatment Phase|Adverse Event|0
4709949|NCT02175758|16234715|P2|Treatment Phase|Adverse Event|0
4709950|NCT02175758|16234716|P1|Treatment Phase|Adverse Event|0
4709951|NCT02175758|16234711|P6|Treatment Phase|Lost to Follow-up|0
4709952|NCT02175758|16234712|P5|Treatment Phase|Lost to Follow-up|0
4709953|NCT02175758|16234713|P4|Treatment Phase|Lost to Follow-up|0
4709954|NCT02175758|16234714|P3|Treatment Phase|Lost to Follow-up|0
4709955|NCT02175758|16234715|P2|Treatment Phase|Lost to Follow-up|1
4709956|NCT02175758|16234716|P1|Treatment Phase|Lost to Follow-up|0
4709957|NCT02175745|16234819|P1|Overall Study|Not Eligible|1
4709958|NCT02175368|16234858|P1|Overall Study|Lost to Follow-up|1
4709959|NCT02175277|16234863|P1|Overall Study|Protocol-specified Criteria|1
4709960|NCT02175225|16234869|P2|Overall Study|Study drug not administered|2
4709961|NCT02175225|16234870|P1|Overall Study|Study drug not administered|1
4709962|NCT02175225|16234869|P2|Overall Study|Lost to Follow-up|7
4709963|NCT02175225|16234870|P1|Overall Study|Lost to Follow-up|6
4709964|NCT02175225|16234869|P2|Overall Study|Withdrawal by Subject|2
4709965|NCT02175225|16234870|P1|Overall Study|Withdrawal by Subject|1
4709966|NCT02175199|16234921|P2|Overall Study|Sponsor Decision|0
4709967|NCT02175199|16234922|P1|Overall Study|Sponsor Decision|1
4709968|NCT02175199|16234921|P2|Overall Study|Randomized in Error|0
4709969|NCT02175199|16234922|P1|Overall Study|Randomized in Error|1
4709970|NCT02175199|16234921|P2|Overall Study|Withdrawal by Subject|5
4709971|NCT02175199|16234922|P1|Overall Study|Withdrawal by Subject|1
4709972|NCT02175121|16234936|P5|Overall Study|Time issues|0
4709973|NCT02175121|16234937|P4|Overall Study|Time issues|0
4709974|NCT02175121|16234938|P3|Overall Study|Time issues|1
4709975|NCT02175121|16234939|P2|Overall Study|Time issues|0
4709976|NCT02175121|16234940|P1|Overall Study|Time issues|0
4709977|NCT02175121|16234936|P5|Overall Study|Schedule conflict|0
4709978|NCT02175121|16234937|P4|Overall Study|Schedule conflict|0
4709979|NCT02175121|16234938|P3|Overall Study|Schedule conflict|1
4709980|NCT02175121|16234939|P2|Overall Study|Schedule conflict|0
4709981|NCT02175121|16234940|P1|Overall Study|Schedule conflict|0
4709982|NCT02175121|16234936|P5|Overall Study|Personal emergency|1
4709983|NCT02175121|16234937|P4|Overall Study|Personal emergency|0
4709984|NCT02175121|16234938|P3|Overall Study|Personal emergency|0
4709985|NCT02175121|16234939|P2|Overall Study|Personal emergency|0
4709986|NCT02175121|16234940|P1|Overall Study|Personal emergency|0
4709987|NCT02175121|16234936|P5|Overall Study|Lost to Follow-up|0
4709988|NCT02175121|16234937|P4|Overall Study|Lost to Follow-up|1
4709989|NCT02175121|16234938|P3|Overall Study|Lost to Follow-up|0
4709990|NCT02175121|16234939|P2|Overall Study|Lost to Follow-up|1
4709991|NCT02175121|16234940|P1|Overall Study|Lost to Follow-up|0
4709992|NCT02175121|16234936|P5|Overall Study|Lack of Efficacy|0
4709993|NCT02175121|16234937|P4|Overall Study|Lack of Efficacy|0
4709994|NCT02175121|16234938|P3|Overall Study|Lack of Efficacy|0
4709995|NCT02175121|16234939|P2|Overall Study|Lack of Efficacy|0
4709996|NCT02175121|16234940|P1|Overall Study|Lack of Efficacy|1
4709997|NCT02174861|16235078|P1|Overall Study|Lost to Follow-up|26
4709998|NCT02174861|16235078|P1|Overall Study|Withdrawal by Subject|124
4709999|NCT02174861|16235078|P1|Overall Study|Decision by sponsor|8
4710000|NCT02174848|16235092|P2|Overall Study|Unable to comply with study requirements|0
4710001|NCT02174848|16235093|P1|Overall Study|Unable to comply with study requirements|1
4710002|NCT02174848|16235092|P2|Overall Study|Worsening of disease|1
4710003|NCT02174848|16235093|P1|Overall Study|Worsening of disease|1
4710004|NCT02174848|16235092|P2|Overall Study|Lost to Follow-up|1
4710005|NCT02174848|16235093|P1|Overall Study|Lost to Follow-up|0
4710006|NCT02174848|16235092|P2|Overall Study|Withdrawal by Subject|3
4710007|NCT02174848|16235093|P1|Overall Study|Withdrawal by Subject|3
4710008|NCT02174848|16235092|P2|Overall Study|Adverse Event|1
4710009|NCT02174848|16235093|P1|Overall Study|Adverse Event|2
4710010|NCT02174731|16235110|P2|Overall Study|Missing|0
4710011|NCT02174731|16235111|P1|Overall Study|Missing|2
4710012|NCT02174731|16235110|P2|Overall Study|Incorrect enrolment before randomization|1
4710013|NCT02174731|16235111|P1|Overall Study|Incorrect enrolment before randomization|0
4710014|NCT02174731|16235110|P2|Overall Study|Participant decision|64
4710015|NCT02174731|16235111|P1|Overall Study|Participant decision|67
4710016|NCT02174627|16235133|P2|Overall Study|Participant decision|128
4710017|NCT02174627|16235134|P1|Overall Study|Participant decision|84
4710018|NCT02174627|16235133|P2|Overall Study|Incorrect enrolment before randomization|1
4710019|NCT02174627|16235134|P1|Overall Study|Incorrect enrolment before randomization|0
4710020|NCT02174627|16235133|P2|Overall Study|Missing|1
4710021|NCT02174627|16235134|P1|Overall Study|Missing|0
4710022|NCT02174562|16235162|P2|Overall Study|Lost to Follow-up|3
4710023|NCT02174562|16235163|P1|Overall Study|Lost to Follow-up|0
4710024|NCT02174562|16235162|P2|Overall Study|Death|0
4710025|NCT02174562|16235163|P1|Overall Study|Death|2
4710026|NCT02174562|16235162|P2|Overall Study|Withdrawal by Subject|2
4710027|NCT02174562|16235163|P1|Overall Study|Withdrawal by Subject|7
4710028|NCT02174523|16235173|P2|Overall Study|Withdrawal by Subject|0
4710029|NCT02174523|16235174|P1|Overall Study|Withdrawal by Subject|1
4710030|NCT00206375|16235258|P3|Overall Study|Study terminated due to lack of funds|1
4710031|NCT00206375|16235259|P2|Overall Study|Study terminated due to lack of funds|1
4710032|NCT00206375|16235260|P1|Overall Study|Study terminated due to lack of funds|0
4710033|NCT00206375|16235258|P3|Overall Study|Withdrawal by Subject|3
4710034|NCT00206375|16235259|P2|Overall Study|Withdrawal by Subject|1
4710035|NCT00206375|16235260|P1|Overall Study|Withdrawal by Subject|2
4710036|NCT00206375|16235258|P3|Overall Study|Lost to Follow-up|0
4710037|NCT00206375|16235259|P2|Overall Study|Lost to Follow-up|0
4710038|NCT00206375|16235260|P1|Overall Study|Lost to Follow-up|1
4710039|NCT02174276|16235278|P4|OTEP (Weeks 48 to 144)|Withdrew Consent|2
4710040|NCT02174276|16235279|P3|OTEP (Weeks 48 to 144)|Withdrew Consent|1
4710041|NCT02174276|16235280|P2|OTEP (Weeks 48 to 144)|Withdrew Consent|0
4710042|NCT02174276|16235281|P1|OTEP (Weeks 48 to 144)|Withdrew Consent|1
4710043|NCT02174276|16235278|P4|OTEP (Weeks 48 to 144)|Pregnancy|0
4710044|NCT02174276|16235279|P3|OTEP (Weeks 48 to 144)|Pregnancy|1
4710045|NCT02174276|16235280|P2|OTEP (Weeks 48 to 144)|Pregnancy|0
4710046|NCT02174276|16235281|P1|OTEP (Weeks 48 to 144)|Pregnancy|0
4710047|NCT02174276|16235278|P4|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
4710048|NCT02174276|16235279|P3|OTEP (Weeks 48 to 144)|Lost to Follow-up|1
4710049|NCT02174276|16235280|P2|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
4710050|NCT02174276|16235281|P1|OTEP (Weeks 48 to 144)|Lost to Follow-up|0
4710051|NCT02174276|16235278|P4|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
4710052|NCT02174276|16235279|P3|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2
4710053|NCT02174276|16235280|P2|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1
4710054|NCT02174276|16235281|P1|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0
4710055|NCT02174276|16235278|P4|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
4710056|NCT02174276|16235279|P3|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1
4710057|NCT02174276|16235280|P2|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
4710058|NCT02174276|16235281|P1|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0
4710059|NCT02174276|16235278|P4|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
4710060|NCT02174276|16235279|P3|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
4710061|NCT02174276|16235280|P2|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0
4710062|NCT02174276|16235281|P1|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1
4710063|NCT02173769|16235397|P1|Overall Study|Protocol Violation|4
4710064|NCT02173704|16235410|P2|Overall Study|Withdrawal by Subject|4
4710065|NCT02173704|16235411|P1|Overall Study|Withdrawal by Subject|9
4710066|NCT02173704|16235410|P2|Overall Study|Protocol Violation|0
4710067|NCT02173704|16235411|P1|Overall Study|Protocol Violation|1
4710068|NCT02173704|16235410|P2|Overall Study|Other|0
4710069|NCT02173704|16235411|P1|Overall Study|Other|1
4710070|NCT02173704|16235410|P2|Overall Study|Lost to Follow-up|0
4710071|NCT02173704|16235411|P1|Overall Study|Lost to Follow-up|1
4710072|NCT02173704|16235410|P2|Overall Study|Adverse Event|0
4710073|NCT02173704|16235411|P1|Overall Study|Adverse Event|1
4710074|NCT02173548|16235439|P2|Overall Study|Withdrawal by Subject|0
4710075|NCT02173548|16235440|P1|Overall Study|Withdrawal by Subject|1
4710076|NCT02173548|16235439|P2|Overall Study|Lost to Follow-up|2
4710077|NCT02173548|16235440|P1|Overall Study|Lost to Follow-up|0
4710078|NCT02173379|16235572|P2|Overall Study|Death|22
4710079|NCT02173379|16235573|P1|Overall Study|Death|22
4710080|NCT02173379|16235572|P2|Overall Study|Physician Decision|4
4710081|NCT02173379|16235573|P1|Overall Study|Physician Decision|7
4710082|NCT02173379|16235572|P2|Overall Study|Withdrawal by Subject|17
4710083|NCT02173379|16235573|P1|Overall Study|Withdrawal by Subject|14
4710084|NCT02173379|16235572|P2|Overall Study|Lost to Follow-up|34
4710085|NCT02173379|16235573|P1|Overall Study|Lost to Follow-up|48
4710086|NCT02173158|16235817|P1|Efficacy Phase|Adverse Event|1
4710087|NCT02173054|16235834|P3|Overall Study|Withdrawal by Subject|1
4710088|NCT02173054|16235835|P2|Overall Study|Withdrawal by Subject|0
4710089|NCT02173054|16235836|P1|Overall Study|Withdrawal by Subject|0
4710090|NCT02173054|16235834|P3|Overall Study|lack of compliance|0
4710091|NCT02173054|16235835|P2|Overall Study|lack of compliance|0
4710092|NCT02173054|16235836|P1|Overall Study|lack of compliance|1
4710093|NCT02172664|16235892|P2|Overall Study|Moved out of area|1
4710094|NCT02172664|16235893|P1|Overall Study|Moved out of area|1
4710095|NCT02172664|16235892|P2|Overall Study|Death|1
4710096|NCT02172664|16235893|P1|Overall Study|Death|1
4710097|NCT02172664|16235892|P2|Overall Study|Lost to Follow-up|4
4710098|NCT02172664|16235893|P1|Overall Study|Lost to Follow-up|4
4710099|NCT02172625|16235902|P2|Overall Study|car accident|1
4710100|NCT02172625|16235903|P1|Overall Study|car accident|0
4710101|NCT02172625|16235902|P2|Overall Study|Pregnancy|1
4710102|NCT02172625|16235903|P1|Overall Study|Pregnancy|0
4710103|NCT02172625|16235902|P2|Overall Study|Adverse Event|1
4710104|NCT02172625|16235903|P1|Overall Study|Adverse Event|0
4710105|NCT02172040|16235949|P4|Overall Study|Family emergency abroad|1
4710106|NCT02172040|16235950|P3|Overall Study|Family emergency abroad|0
4710107|NCT02172040|16235951|P2|Overall Study|Family emergency abroad|0
4710108|NCT02172040|16235952|P1|Overall Study|Family emergency abroad|0
4710109|NCT02172040|16235949|P4|Overall Study|Not available for Day 13 & 14 visits|0
4710110|NCT02172040|16235950|P3|Overall Study|Not available for Day 13 & 14 visits|1
4710111|NCT02172040|16235951|P2|Overall Study|Not available for Day 13 & 14 visits|0
4710112|NCT02172040|16235952|P1|Overall Study|Not available for Day 13 & 14 visits|0
4710113|NCT02172040|16235949|P4|Overall Study|Withdrawal by Subject|0
4710114|NCT02172040|16235950|P3|Overall Study|Withdrawal by Subject|1
4710115|NCT02172040|16235951|P2|Overall Study|Withdrawal by Subject|0
4710116|NCT02172040|16235952|P1|Overall Study|Withdrawal by Subject|0
4710117|NCT02172040|16235949|P4|Overall Study|Protocol Violation|0
4710118|NCT02172040|16235950|P3|Overall Study|Protocol Violation|0
4710119|NCT02172040|16235951|P2|Overall Study|Protocol Violation|1
4710120|NCT02172040|16235952|P1|Overall Study|Protocol Violation|0
4710121|NCT02172040|16235949|P4|Overall Study|Adverse Event|0
4710122|NCT02172040|16235950|P3|Overall Study|Adverse Event|0
4710123|NCT02172040|16235951|P2|Overall Study|Adverse Event|2
4710124|NCT02172040|16235952|P1|Overall Study|Adverse Event|0
4710125|NCT02171260|16236115|P4|Overall Study|Evidence of progressive disease|4
4710126|NCT02171260|16236116|P3|Overall Study|Evidence of progressive disease|4
4710127|NCT02171260|16236117|P2|Overall Study|Evidence of progressive disease|6
4710128|NCT02171260|16236118|P1|Overall Study|Evidence of progressive disease|4
4710129|NCT02171260|16236115|P4|Overall Study|Withdrawal by Subject|0
4710130|NCT02171260|16236116|P3|Overall Study|Withdrawal by Subject|0
4710131|NCT02171260|16236117|P2|Overall Study|Withdrawal by Subject|0
4710132|NCT02171260|16236118|P1|Overall Study|Withdrawal by Subject|1
4710133|NCT02171260|16236115|P4|Overall Study|Physician Decision|0
4710134|NCT02171260|16236116|P3|Overall Study|Physician Decision|1
4710135|NCT02171260|16236117|P2|Overall Study|Physician Decision|0
4710136|NCT02171260|16236118|P1|Overall Study|Physician Decision|1
4710137|NCT02171260|16236115|P4|Overall Study|Death|1
4710138|NCT02171260|16236116|P3|Overall Study|Death|0
4710139|NCT02171260|16236117|P2|Overall Study|Death|0
4710140|NCT02171260|16236118|P1|Overall Study|Death|0
4710141|NCT02171130|16236254|P1|Overall Study|Met Exclusion Criteria|1
4710142|NCT02171130|16236254|P1|Overall Study|Lost to Follow-up|1
4710143|NCT02171130|16236254|P1|Overall Study|Physician Decision|1
4710144|NCT02171130|16236254|P1|Overall Study|Withdrawal by Subject|3
4710145|NCT02171130|16236254|P1|Overall Study|Discontinued; Site Termination|5
4710146|NCT02171130|16236254|P1|Overall Study|Discontinued; Clinical Material Issue|16
4710147|NCT02171130|16236254|P1|Overall Study|Death|1
4710148|NCT02170779|16236295|P2|Overall Study|Lost to Follow-up|1
4710149|NCT02170779|16236296|P1|Overall Study|Lost to Follow-up|0
4710150|NCT02170779|16236295|P2|Overall Study|Withdrawal by Subject|0
4710151|NCT02170779|16236296|P1|Overall Study|Withdrawal by Subject|1
4710152|NCT02170688|16236323|P5|Overall Study|Physician Decision|0
4710153|NCT02170688|16236324|P4|Overall Study|Physician Decision|0
4710154|NCT02170688|16236325|P3|Overall Study|Physician Decision|1
4710155|NCT02170688|16236326|P2|Overall Study|Physician Decision|0
4710156|NCT02170688|16236327|P1|Overall Study|Physician Decision|0
4710157|NCT02170688|16236323|P5|Overall Study|Full dose not received|0
4710158|NCT02170688|16236324|P4|Overall Study|Full dose not received|0
4710159|NCT02170688|16236325|P3|Overall Study|Full dose not received|0
4710160|NCT02170688|16236326|P2|Overall Study|Full dose not received|1
4710161|NCT02170688|16236327|P1|Overall Study|Full dose not received|0
4710162|NCT02170688|16236323|P5|Overall Study|Exclusion Criteria: Fatty Liver|0
4710163|NCT02170688|16236324|P4|Overall Study|Exclusion Criteria: Fatty Liver|2
4710164|NCT02170688|16236325|P3|Overall Study|Exclusion Criteria: Fatty Liver|3
4710165|NCT02170688|16236326|P2|Overall Study|Exclusion Criteria: Fatty Liver|2
4710166|NCT02170688|16236327|P1|Overall Study|Exclusion Criteria: Fatty Liver|4
4710167|NCT02170389|16236413|P1|Overall Study|Study terminated prior to start of treat|1
4710168|NCT02170298|16236478|P2|Overall Study|unblinded, rerandomized to intervention|0
4710169|NCT02170298|16236479|P1|Overall Study|unblinded, rerandomized to intervention|1
4710170|NCT02170298|16236478|P2|Overall Study|Withdrawal by Subject|1
4710171|NCT02170298|16236479|P1|Overall Study|Withdrawal by Subject|0
4710172|NCT02170207|16236516|P1|Overall Study|Case report forms unavailable|5
4710173|NCT02170077|16236527|P3|Overall Study|Exacerbation of seizures|1
4710174|NCT02170077|16236528|P2|Overall Study|Exacerbation of seizures|2
4710175|NCT02170077|16236529|P1|Overall Study|Exacerbation of seizures|0
4710176|NCT02170077|16236527|P3|Overall Study|Exclusion criteria|5
4710177|NCT02170077|16236528|P2|Overall Study|Exclusion criteria|2
4710178|NCT02170077|16236529|P1|Overall Study|Exclusion criteria|2
4710179|NCT02170077|16236527|P3|Overall Study|Lost to Follow-up|0
4710180|NCT02170077|16236528|P2|Overall Study|Lost to Follow-up|1
4710181|NCT02170077|16236529|P1|Overall Study|Lost to Follow-up|0
4710182|NCT02170077|16236527|P3|Overall Study|Adverse Event|4
4710183|NCT02170077|16236528|P2|Overall Study|Adverse Event|4
4710184|NCT02170077|16236529|P1|Overall Study|Adverse Event|4
4710185|NCT02170077|16236527|P3|Overall Study|Withdrawal by Subject|2
4710186|NCT02170077|16236528|P2|Overall Study|Withdrawal by Subject|4
4710187|NCT02170077|16236529|P1|Overall Study|Withdrawal by Subject|3
4710188|NCT02170064|16236540|P3|Overall Study|Physician Decision|0
4710189|NCT02170064|16236541|P2|Overall Study|Physician Decision|1
4710190|NCT02170064|16236542|P1|Overall Study|Physician Decision|1
4710191|NCT02170064|16236540|P3|Overall Study|Withdrawal by Subject|1
4710192|NCT02170064|16236541|P2|Overall Study|Withdrawal by Subject|1
4710193|NCT02170064|16236542|P1|Overall Study|Withdrawal by Subject|5
4710194|NCT02170025|16236558|P2|Overall Study|Adverse Event|0
4710195|NCT02170025|16236559|P1|Overall Study|Adverse Event|2
4710196|NCT02169674|16236603|P2|Overall Study|Lost to Follow-up|1
4710197|NCT02169674|16236604|P1|Overall Study|Lost to Follow-up|0
4710198|NCT02169674|16236603|P2|Overall Study|Seroprotected|76
4710199|NCT02169674|16236604|P1|Overall Study|Seroprotected|30
4710200|NCT02169674|16236603|P2|Overall Study|Withdrawal by Subject|1
4710201|NCT02169674|16236604|P1|Overall Study|Withdrawal by Subject|2
4710202|NCT02169505|16236618|P1|Overall Study|Withdrawal by Subject|1
4710203|NCT02169414|16236746|P4|Overall Study|Adverse Event|0
4710204|NCT02169414|16236747|P3|Overall Study|Adverse Event|0
4710205|NCT02169414|16236748|P2|Overall Study|Adverse Event|1
4710206|NCT02169414|16236749|P1|Overall Study|Adverse Event|0
4710207|NCT02169414|16236746|P4|Overall Study|Withdrawal by Subject|0
4710208|NCT02169414|16236747|P3|Overall Study|Withdrawal by Subject|0
4710209|NCT02169414|16236748|P2|Overall Study|Withdrawal by Subject|0
4710210|NCT02169414|16236749|P1|Overall Study|Withdrawal by Subject|1
4710211|NCT02169336|16236790|P3|Overall Study|Subject declined to continue dosing|1
4710212|NCT02169336|16236791|P2|Overall Study|Subject declined to continue dosing|0
4710213|NCT02169336|16236792|P1|Overall Study|Subject declined to continue dosing|0
4710214|NCT02169336|16236790|P3|Overall Study|Physician Decision|1
4710215|NCT02169336|16236791|P2|Overall Study|Physician Decision|0
4710216|NCT02169336|16236792|P1|Overall Study|Physician Decision|0
4710217|NCT02169336|16236790|P3|Overall Study|Withdrawal by Subject|0
4710218|NCT02169336|16236791|P2|Overall Study|Withdrawal by Subject|0
4710219|NCT02169336|16236792|P1|Overall Study|Withdrawal by Subject|1
4710220|NCT02169336|16236790|P3|Overall Study|Adverse Event|1
4710221|NCT02169336|16236791|P2|Overall Study|Adverse Event|3
4710222|NCT02169336|16236792|P1|Overall Study|Adverse Event|2
4710223|NCT02169336|16236790|P3|Overall Study|Lack of Efficacy|0
4710224|NCT02169336|16236791|P2|Overall Study|Lack of Efficacy|1
4710225|NCT02169336|16236792|P1|Overall Study|Lack of Efficacy|1
4710226|NCT02169284|16236802|P2|Overall Study|Physician Decision|1
4710227|NCT02169284|16236803|P1|Overall Study|Physician Decision|0
4710228|NCT02169271|16236829|P2|Overall Study|Protocol Violation|2
4710229|NCT02169271|16236830|P1|Overall Study|Protocol Violation|1
4710230|NCT02169219|16236852|P1|Overall Study|Lack of Efficacy|6
4710231|NCT02168946|16236878|P2|Overall Study|Subject unable to come back for visits|0
4710232|NCT02168946|16236879|P1|Overall Study|Subject unable to come back for visits|1
4710233|NCT02168946|16236878|P2|Overall Study|Lost to Follow-up|0
4710234|NCT02168946|16236879|P1|Overall Study|Lost to Follow-up|3
4710235|NCT02168946|16236878|P2|Overall Study|Adverse Event|5
4710236|NCT02168946|16236879|P1|Overall Study|Adverse Event|8
4710237|NCT02168842|16236938|P2|Overall Study|Physician Decision|2
4710238|NCT02168842|16236939|P1|Overall Study|Physician Decision|1
4710239|NCT02168842|16236938|P2|Overall Study|Death|1
4710240|NCT02168842|16236939|P1|Overall Study|Death|2
4710241|NCT02168842|16236938|P2|Overall Study|Lost to Follow-up|2
4710242|NCT02168842|16236939|P1|Overall Study|Lost to Follow-up|0
4710243|NCT02168842|16236938|P2|Overall Study|Withdrawal by Subject|3
4710244|NCT02168842|16236939|P1|Overall Study|Withdrawal by Subject|5
4710245|NCT02168816|16236997|P2|Overall Study|Lost to Follow-up|2
4710246|NCT02168816|16236998|P1|Overall Study|Lost to Follow-up|2
4710247|NCT02168803|16237009|P3|Overall Study|Sponsor Decision|1
4710248|NCT02168803|16237010|P2|Overall Study|Sponsor Decision|0
4710249|NCT02168803|16237011|P1|Overall Study|Sponsor Decision|0
4710250|NCT02168803|16237009|P3|Overall Study|Death|1
4710251|NCT02168803|16237010|P2|Overall Study|Death|0
4710252|NCT02168803|16237011|P1|Overall Study|Death|0
4710253|NCT02168803|16237009|P3|Overall Study|Adverse Event|1
4710254|NCT02168803|16237010|P2|Overall Study|Adverse Event|1
4710255|NCT02168803|16237011|P1|Overall Study|Adverse Event|0
4710256|NCT02168803|16237009|P3|Overall Study|Physician Decision|0
4710257|NCT02168803|16237010|P2|Overall Study|Physician Decision|1
4710258|NCT02168803|16237011|P1|Overall Study|Physician Decision|0
4710259|NCT02168803|16237009|P3|Overall Study|Withdrawal by Subject|2
4710260|NCT02168803|16237010|P2|Overall Study|Withdrawal by Subject|1
4710261|NCT02168803|16237011|P1|Overall Study|Withdrawal by Subject|1
4710262|NCT02168803|16237009|P3|Overall Study|Lost to Follow-up|1
4710263|NCT02168803|16237010|P2|Overall Study|Lost to Follow-up|0
4710264|NCT02168803|16237011|P1|Overall Study|Lost to Follow-up|1
4710265|NCT02168777|16237041|P3|Overall Study|Other reason|0
4710266|NCT02168777|16237042|P2|Overall Study|Other reason|1
4710267|NCT02168777|16237043|P1|Overall Study|Other reason|0
4710268|NCT02168777|16237041|P3|Overall Study|Clinical disease progression|2
4710269|NCT02168777|16237042|P2|Overall Study|Clinical disease progression|1
4710270|NCT02168777|16237043|P1|Overall Study|Clinical disease progression|0
4710271|NCT02168777|16237041|P3|Overall Study|Radiological disease progression|5
4710272|NCT02168777|16237042|P2|Overall Study|Radiological disease progression|5
4710273|NCT02168777|16237043|P1|Overall Study|Radiological disease progression|0
4710274|NCT02168777|16237041|P3|Overall Study|Disease recurrence|1
4710275|NCT02168777|16237042|P2|Overall Study|Disease recurrence|0
4710276|NCT02168777|16237043|P1|Overall Study|Disease recurrence|0
4710277|NCT02168777|16237041|P3|Overall Study|Adverse Event|1
4710278|NCT02168777|16237042|P2|Overall Study|Adverse Event|0
4710279|NCT02168777|16237043|P1|Overall Study|Adverse Event|1
4710280|NCT02168777|16237041|P3|Overall Study|Withdrawal by Subject|2
4710281|NCT02168777|16237042|P2|Overall Study|Withdrawal by Subject|0
4710282|NCT02168777|16237043|P1|Overall Study|Withdrawal by Subject|1
4710283|NCT02168491|16237139|P1|Overall Study|Withdrawal by Subject|1
4710284|NCT02168478|16237145|P1|Overall Study|Did Not Meet Exclusionary Criteria|1
4710285|NCT02168478|16237145|P1|Overall Study|Did Not Consent to Participation|2
4710286|NCT02168478|16237145|P1|Overall Study|Withdrawal by Subject|1
4710287|NCT02168439|16237151|P2|Overall Study|Protocol Violation|2
4710288|NCT02168439|16237152|P1|Overall Study|Protocol Violation|0
4710289|NCT02168387|16237170|P2|Overall Study|Death|0
4710290|NCT02168387|16237171|P1|Overall Study|Death|1
4710291|NCT02168387|16237170|P2|Overall Study|Planned exubation|3
4710292|NCT02168387|16237171|P1|Overall Study|Planned exubation|6
4710293|NCT02168270|16237203|P1|Overall Study|Lack of Efficacy|4
4710294|NCT02168101|16237230|P3|Overall Study|Death|1
4710295|NCT02168101|16237231|P2|Overall Study|Death|2
4710296|NCT02168101|16237232|P1|Overall Study|Death|2
4710297|NCT02167893|16237302|P1|Overall Study|Case report forms not collected|68
4710298|NCT02167893|16237302|P1|Overall Study|Investigator health reasons|10
4710299|NCT02167893|16237302|P1|Overall Study|Investigator transferred|85
4710300|NCT02167594|16237337|P3|Overall Study|Death|0
4710301|NCT02167594|16237338|P2|Overall Study|Death|1
4710302|NCT02167594|16237339|P1|Overall Study|Death|0
4710303|NCT02167594|16237337|P3|Overall Study|Withdrawal by Subject|0
4710304|NCT02167594|16237338|P2|Overall Study|Withdrawal by Subject|0
4710305|NCT02167594|16237339|P1|Overall Study|Withdrawal by Subject|2
4710306|NCT02167451|16237348|P1|Overall Study|Withdrawal by Subject|1
4710307|NCT02167256|16237365|P2|Overall Study|Study partner unable to participate|0
4710308|NCT02167256|16237366|P1|Overall Study|Study partner unable to participate|1
4710309|NCT02167256|16237365|P2|Overall Study|non-compliance|0
4710310|NCT02167256|16237366|P1|Overall Study|non-compliance|3
4710311|NCT02167256|16237365|P2|Overall Study|Withdrawal by Subject|4
4710312|NCT02167256|16237366|P1|Overall Study|Withdrawal by Subject|4
4710313|NCT02167256|16237365|P2|Overall Study|Adverse Event|6
4710314|NCT02167256|16237366|P1|Overall Study|Adverse Event|13
4710315|NCT02167139|16237399|P4|Transition-extension|Lost to Follow-up|0
4710316|NCT02167139|16237400|P3|Transition-extension|Lost to Follow-up|0
4710317|NCT02167139|16237401|P2|Transition-extension|Lost to Follow-up|0
4710318|NCT02167139|16237402|P1|Transition-extension|Lost to Follow-up|1
4710319|NCT02167139|16237399|P4|Transition-extension|Other|0
4710320|NCT02167139|16237400|P3|Transition-extension|Other|1
4710321|NCT02167139|16237401|P2|Transition-extension|Other|0
4710322|NCT02167139|16237402|P1|Transition-extension|Other|1
4710323|NCT02167139|16237399|P4|Transition-extension|Lack of Efficacy|1
4710324|NCT02167139|16237400|P3|Transition-extension|Lack of Efficacy|1
4710325|NCT02167139|16237401|P2|Transition-extension|Lack of Efficacy|0
4710326|NCT02167139|16237402|P1|Transition-extension|Lack of Efficacy|0
4710327|NCT02167139|16237399|P4|Transition-extension|Withdrawal by Subject|1
4710328|NCT02167139|16237400|P3|Transition-extension|Withdrawal by Subject|4
4710329|NCT02167139|16237401|P2|Transition-extension|Withdrawal by Subject|0
4710330|NCT02167139|16237402|P1|Transition-extension|Withdrawal by Subject|2
4710331|NCT02167139|16237399|P4|Transition-extension|Adverse Event|3
4710332|NCT02167139|16237400|P3|Transition-extension|Adverse Event|2
4710333|NCT02167139|16237401|P2|Transition-extension|Adverse Event|0
4710334|NCT02167139|16237402|P1|Transition-extension|Adverse Event|2
4710335|NCT02167139|16237399|P4|Randomised, Double-blind|Other|0
4710336|NCT02167139|16237400|P3|Randomised, Double-blind|Other|0
4710337|NCT02167139|16237401|P2|Randomised, Double-blind|Other|0
4710338|NCT02167139|16237402|P1|Randomised, Double-blind|Other|3
4710339|NCT02167139|16237399|P4|Randomised, Double-blind|Lack of Efficacy|0
4710340|NCT02167139|16237400|P3|Randomised, Double-blind|Lack of Efficacy|0
4710341|NCT02167139|16237401|P2|Randomised, Double-blind|Lack of Efficacy|2
4710342|NCT02167139|16237402|P1|Randomised, Double-blind|Lack of Efficacy|1
4710343|NCT02167139|16237399|P4|Randomised, Double-blind|Adverse Event|0
4710344|NCT02167139|16237400|P3|Randomised, Double-blind|Adverse Event|0
4710345|NCT02167139|16237401|P2|Randomised, Double-blind|Adverse Event|9
4710346|NCT02167139|16237402|P1|Randomised, Double-blind|Adverse Event|2
4710347|NCT02167139|16237399|P4|Randomised, Double-blind|Withdrawal by Subject|0
4710348|NCT02167139|16237400|P3|Randomised, Double-blind|Withdrawal by Subject|0
4710349|NCT02167139|16237401|P2|Randomised, Double-blind|Withdrawal by Subject|8
4710350|NCT02167139|16237402|P1|Randomised, Double-blind|Withdrawal by Subject|11
4710351|NCT02167035|16237437|P2|Overall Study|Randomized to incorrect Study Medication|1
4710352|NCT02167035|16237438|P1|Overall Study|Randomized to incorrect Study Medication|0
4710353|NCT02167035|16237437|P2|Overall Study|Lost to Follow-up|3
4710354|NCT02167035|16237438|P1|Overall Study|Lost to Follow-up|3
4710355|NCT02167035|16237437|P2|Overall Study|Adverse Event|2
4710356|NCT02167035|16237438|P1|Overall Study|Adverse Event|2
4710357|NCT02166697|16237446|P1|Overall Study|Protocol Violation|347
4710358|NCT02166606|16237455|P1|Overall Study|Enrolled after End of Enrollment|4
4710359|NCT02166606|16237455|P1|Overall Study|Device upgrade|1
4710360|NCT02166606|16237455|P1|Overall Study|Physician Decision|1
4710361|NCT02166606|16237455|P1|Overall Study|Withdrawal by Subject|1
4710362|NCT02166606|16237455|P1|Overall Study|Lost to Follow-up|30
4710363|NCT02166606|16237455|P1|Overall Study|Protocol Violation|7
4710364|NCT02166606|16237455|P1|Overall Study|Death|31
4710365|NCT02166606|16237455|P1|Overall Study|Adverse Event|3
4710366|NCT02166476|16237462|P2|Overall Study|Unable to Come for Visit|3
4710367|NCT02166476|16237463|P1|Overall Study|Unable to Come for Visit|0
4710368|NCT02166476|16237462|P2|Overall Study|Physician Decision|0
4710369|NCT02166476|16237463|P1|Overall Study|Physician Decision|1
4710370|NCT02166476|16237462|P2|Overall Study|Lost to Follow-up|10
4710371|NCT02166476|16237463|P1|Overall Study|Lost to Follow-up|5
4710372|NCT02166476|16237462|P2|Overall Study|Adverse Event|3
4710373|NCT02166476|16237463|P1|Overall Study|Adverse Event|3
4710374|NCT02166476|16237462|P2|Overall Study|Withdrawal by Subject|7
4710375|NCT02166476|16237463|P1|Overall Study|Withdrawal by Subject|5
4710376|NCT02166047|16237517|P12|Overall Study|Adverse Event|0
4710377|NCT02166047|16237518|P11|Overall Study|Adverse Event|2
4710378|NCT02166047|16237519|P10|Overall Study|Adverse Event|0
4710379|NCT02166047|16237520|P9|Overall Study|Adverse Event|0
4710380|NCT02166047|16237521|P8|Overall Study|Adverse Event|0
4710381|NCT02166047|16237522|P7|Overall Study|Adverse Event|1
4710382|NCT02166047|16237523|P6|Overall Study|Adverse Event|0
4710383|NCT02166047|16237524|P5|Overall Study|Adverse Event|1
4710384|NCT02166047|16237525|P4|Overall Study|Adverse Event|0
4710385|NCT02166047|16237526|P3|Overall Study|Adverse Event|0
4710386|NCT02166047|16237527|P2|Overall Study|Adverse Event|0
4710387|NCT02166047|16237528|P1|Overall Study|Adverse Event|0
4710388|NCT02166047|16237517|P12|Overall Study|Withdrawal by Participant|0
4710389|NCT02166047|16237518|P11|Overall Study|Withdrawal by Participant|0
4710390|NCT02166047|16237519|P10|Overall Study|Withdrawal by Participant|0
4710391|NCT02166047|16237520|P9|Overall Study|Withdrawal by Participant|0
4710392|NCT02166047|16237521|P8|Overall Study|Withdrawal by Participant|0
4710393|NCT02166047|16237522|P7|Overall Study|Withdrawal by Participant|1
4710394|NCT02166047|16237523|P6|Overall Study|Withdrawal by Participant|0
4710395|NCT02166047|16237524|P5|Overall Study|Withdrawal by Participant|0
4710396|NCT02166047|16237525|P4|Overall Study|Withdrawal by Participant|0
4710397|NCT02166047|16237526|P3|Overall Study|Withdrawal by Participant|2
4710398|NCT02166047|16237527|P2|Overall Study|Withdrawal by Participant|1
4710399|NCT02166047|16237528|P1|Overall Study|Withdrawal by Participant|0
4710400|NCT02165826|16237672|P3|Down-Titration Period|Reason Not Specified|2
4710401|NCT02165826|16237673|P2|Down-Titration Period|Reason Not Specified|0
4710402|NCT02165826|16237674|P1|Down-Titration Period|Reason Not Specified|1
4710403|NCT02165826|16237672|P3|Down-Titration Period|Voluntary Withdrawal|2
4710404|NCT02165826|16237673|P2|Down-Titration Period|Voluntary Withdrawal|1
4710405|NCT02165826|16237674|P1|Down-Titration Period|Voluntary Withdrawal|2
4710406|NCT02165826|16237672|P3|Down-Titration Period|Pre-treatment Event/Adverse Event|3
4710407|NCT02165826|16237673|P2|Down-Titration Period|Pre-treatment Event/Adverse Event|10
4710408|NCT02165826|16237674|P1|Down-Titration Period|Pre-treatment Event/Adverse Event|4
4710409|NCT02165826|16237672|P3|Main Treatment Period|Did Not Receive Study Drug|0
4710410|NCT02165826|16237673|P2|Main Treatment Period|Did Not Receive Study Drug|2
4710411|NCT02165826|16237674|P1|Main Treatment Period|Did Not Receive Study Drug|0
4710412|NCT02165826|16237672|P3|Main Treatment Period|Reason Not Specified|16
4710413|NCT02165826|16237673|P2|Main Treatment Period|Reason Not Specified|5
4710414|NCT02165826|16237674|P1|Main Treatment Period|Reason Not Specified|8
4710415|NCT02165826|16237672|P3|Main Treatment Period|Lack of Efficacy|0
4710416|NCT02165826|16237673|P2|Main Treatment Period|Lack of Efficacy|0
4710417|NCT02165826|16237674|P1|Main Treatment Period|Lack of Efficacy|2
4710418|NCT02165826|16237672|P3|Main Treatment Period|Voluntary Withdrawal|21
4710419|NCT02165826|16237673|P2|Main Treatment Period|Voluntary Withdrawal|23
4710420|NCT02165826|16237674|P1|Main Treatment Period|Voluntary Withdrawal|23
4710421|NCT02165826|16237672|P3|Main Treatment Period|Lost to Follow-up|1
4710422|NCT02165826|16237673|P2|Main Treatment Period|Lost to Follow-up|2
4710423|NCT02165826|16237674|P1|Main Treatment Period|Lost to Follow-up|4
4710424|NCT02165826|16237672|P3|Main Treatment Period|Major/Significant Protocol Deviation|3
4710425|NCT02165826|16237673|P2|Main Treatment Period|Major/Significant Protocol Deviation|1
4710426|NCT02165826|16237674|P1|Main Treatment Period|Major/Significant Protocol Deviation|0
4710427|NCT02165826|16237672|P3|Main Treatment Period|Pre-treatment Event/Adverse Event|68
4710428|NCT02165826|16237673|P2|Main Treatment Period|Pre-treatment Event/Adverse Event|57
4710429|NCT02165826|16237674|P1|Main Treatment Period|Pre-treatment Event/Adverse Event|44
4710430|NCT02165735|16237742|P2|Overall Study|Protocol Violation|1
4710431|NCT02165735|16237743|P1|Overall Study|Protocol Violation|0
4710432|NCT02165735|16237742|P2|Overall Study|Participant indicated lack of time|3
4710433|NCT02165735|16237743|P1|Overall Study|Participant indicated lack of time|1
4710434|NCT02165735|16237742|P2|Overall Study|Withdrawal by Subject|0
4710435|NCT02165735|16237743|P1|Overall Study|Withdrawal by Subject|3
4710436|NCT02165735|16237742|P2|Overall Study|Lost to Follow-up|10
4710437|NCT02165735|16237743|P1|Overall Study|Lost to Follow-up|12
4710438|NCT02165202|16237821|P2|Injection Phase|Participant unwilling to comply|0
4710439|NCT02165202|16237822|P1|Injection Phase|Participant unwilling to comply|1
4710440|NCT02165202|16237821|P2|Injection Phase|No longer interested|1
4710441|NCT02165202|16237822|P1|Injection Phase|No longer interested|0
4710442|NCT02165202|16237821|P2|Injection Phase|Study Product related Toxicity|0
4710443|NCT02165202|16237822|P1|Injection Phase|Study Product related Toxicity|1
4710444|NCT02165202|16237821|P2|Injection Phase|End of Study|1
4710445|NCT02165202|16237822|P1|Injection Phase|End of Study|2
4710446|NCT02165202|16237821|P2|Injection Phase|QTcF>500 ms or increase of>60 ms|1
4710447|NCT02165202|16237822|P1|Injection Phase|QTcF>500 ms or increase of>60 ms|0
4710448|NCT02165202|16237821|P2|Injection Phase|Unable to attend within Visit Window|0
4710449|NCT02165202|16237822|P1|Injection Phase|Unable to attend within Visit Window|1
4710450|NCT02165202|16237821|P2|Injection Phase|Reactive HIV or HIV Suspected|2
4710451|NCT02165202|16237822|P1|Injection Phase|Reactive HIV or HIV Suspected|0
4710452|NCT02165202|16237821|P2|Injection Phase|Abnormal Lab Value|1
4710453|NCT02165202|16237822|P1|Injection Phase|Abnormal Lab Value|5
4710454|NCT02165202|16237821|P2|Oral Phase|Abnormal EKG|1
4710455|NCT02165202|16237822|P1|Oral Phase|Abnormal EKG|0
4710456|NCT02165202|16237821|P2|Oral Phase|Relocated, no follow-up planned|0
4710457|NCT02165202|16237822|P1|Oral Phase|Relocated, no follow-up planned|1
4710458|NCT02165202|16237821|P2|Oral Phase|CMC advised termination|0
4710459|NCT02165202|16237822|P1|Oral Phase|CMC advised termination|1
4710460|NCT02165202|16237821|P2|Oral Phase|QTcF>500 ms or increase of>60 ms|0
4710461|NCT02165202|16237822|P1|Oral Phase|QTcF>500 ms or increase of>60 ms|1
4710462|NCT02165202|16237821|P2|Oral Phase|Clinical reasons|0
4710463|NCT02165202|16237822|P1|Oral Phase|Clinical reasons|1
4710464|NCT02165202|16237821|P2|Oral Phase|Unable to contact Participant|1
4710465|NCT02165202|16237822|P1|Oral Phase|Unable to contact Participant|1
4710466|NCT02165202|16237821|P2|Oral Phase|Study product Related Toxicity|0
4710467|NCT02165202|16237822|P1|Oral Phase|Study product Related Toxicity|1
4710468|NCT02165202|16237821|P2|Oral Phase|Refused further participation|1
4710469|NCT02165202|16237822|P1|Oral Phase|Refused further participation|5
4710470|NCT02164981|16237859|P3|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
4710471|NCT02164981|16237860|P2|Phase 2 (Day 14 - Day 28)|Protocol Violation|1
4710472|NCT02164981|16237861|P1|Phase 2 (Day 14 - Day 28)|Protocol Violation|0
4710473|NCT02164981|16237859|P3|Phase 2 (Day 14 - Day 28)|Adverse Event|0
4710474|NCT02164981|16237860|P2|Phase 2 (Day 14 - Day 28)|Adverse Event|1
4710475|NCT02164981|16237861|P1|Phase 2 (Day 14 - Day 28)|Adverse Event|2
4710476|NCT02164981|16237859|P3|Phase 1 (Day 0 - Day 14)|Adverse Event|0
4710477|NCT02164981|16237860|P2|Phase 1 (Day 0 - Day 14)|Adverse Event|2
4710478|NCT02164981|16237861|P1|Phase 1 (Day 0 - Day 14)|Adverse Event|0
4710479|NCT02164981|16237859|P3|Started|Adverse Event|0
4710480|NCT02164981|16237860|P2|Started|Adverse Event|2
4710481|NCT02164981|16237861|P1|Started|Adverse Event|1
4710482|NCT02164981|16237859|P3|Started|Protocol Violation|0
4710483|NCT02164981|16237860|P2|Started|Protocol Violation|0
4710484|NCT02164981|16237861|P1|Started|Protocol Violation|2
4710485|NCT02164981|16237859|P3|Started|Withdrawal by Subject|0
4710486|NCT02164981|16237860|P2|Started|Withdrawal by Subject|1
4710487|NCT02164981|16237861|P1|Started|Withdrawal by Subject|2
4710488|NCT02164929|16237934|P4|Overall Study|Failed regional block|0
4710489|NCT02164929|16237935|P3|Overall Study|Failed regional block|1
4710490|NCT02164929|16237936|P2|Overall Study|Failed regional block|0
4710491|NCT02164929|16237937|P1|Overall Study|Failed regional block|0
4710492|NCT02164929|16237934|P4|Overall Study|Converted to open procedure|2
4710493|NCT02164929|16237935|P3|Overall Study|Converted to open procedure|0
4710494|NCT02164929|16237936|P2|Overall Study|Converted to open procedure|0
4710495|NCT02164929|16237937|P1|Overall Study|Converted to open procedure|1
4710496|NCT02164916|16237981|P2|Overall Study|Not eligible|5
4710497|NCT02164916|16237982|P1|Overall Study|Not eligible|2
4710498|NCT02164916|16237981|P2|Overall Study|Reason under review|6
4710499|NCT02164916|16237982|P1|Overall Study|Reason under review|1
4710500|NCT02164916|16237981|P2|Overall Study|Not protocol specified|1
4710501|NCT02164916|16237982|P1|Overall Study|Not protocol specified|5
4710502|NCT02164916|16237981|P2|Overall Study|Progression|26
4710503|NCT02164916|16237982|P1|Overall Study|Progression|37
4710504|NCT02164916|16237981|P2|Overall Study|Refusal unrelated to adverse event|7
4710505|NCT02164916|16237982|P1|Overall Study|Refusal unrelated to adverse event|3
4710506|NCT02164916|16237981|P2|Overall Study|Death|1
4710507|NCT02164916|16237982|P1|Overall Study|Death|1
4710508|NCT02164916|16237981|P2|Overall Study|Adverse Event|8
4710509|NCT02164916|16237982|P1|Overall Study|Adverse Event|3
4710510|NCT02164864|16238002|P3|Overall Study|Other than stated|14
4710511|NCT02164864|16238003|P2|Overall Study|Other than stated|4
4710512|NCT02164864|16238004|P1|Overall Study|Other than stated|3
4710513|NCT02164864|16238002|P3|Overall Study|Consent withdrawn, not due to AE|56
4710514|NCT02164864|16238003|P2|Overall Study|Consent withdrawn, not due to AE|8
4710515|NCT02164864|16238004|P1|Overall Study|Consent withdrawn, not due to AE|21
4710516|NCT02164864|16238002|P3|Overall Study|Lost to Follow-up|2
4710517|NCT02164864|16238003|P2|Overall Study|Lost to Follow-up|3
4710518|NCT02164864|16238004|P1|Overall Study|Lost to Follow-up|4
4710519|NCT02164864|16238002|P3|Overall Study|Protocol Violation|1
4710520|NCT02164864|16238003|P2|Overall Study|Protocol Violation|4
4710521|NCT02164864|16238004|P1|Overall Study|Protocol Violation|2
4710522|NCT02164864|16238002|P3|Overall Study|Other Adverse Event (AE)|49
4710523|NCT02164864|16238003|P2|Overall Study|Other Adverse Event (AE)|32
4710524|NCT02164864|16238004|P1|Overall Study|Other Adverse Event (AE)|52
4710525|NCT02164864|16238002|P3|Overall Study|Other pre-existing disease worsening|9
4710526|NCT02164864|16238003|P2|Overall Study|Other pre-existing disease worsening|4
4710527|NCT02164864|16238004|P1|Overall Study|Other pre-existing disease worsening|6
4710528|NCT02164864|16238002|P3|Overall Study|Trial disease worsening|1
4710529|NCT02164864|16238003|P2|Overall Study|Trial disease worsening|5
4710530|NCT02164864|16238004|P1|Overall Study|Trial disease worsening|7
4710531|NCT02164539|16238079|P7|Treatment Phase C (1 Week)|Physician Decision|1
4710532|NCT02164539|16238080|P6|Treatment Phase C (1 Week)|Physician Decision|0
4710533|NCT02164539|16238081|P5|Treatment Phase C (1 Week)|Physician Decision|0
4710534|NCT02164539|16238082|P4|Treatment Phase C (1 Week)|Physician Decision|0
4710535|NCT02164539|16238083|P3|Treatment Phase C (1 Week)|Physician Decision|0
4710536|NCT02164539|16238084|P2|Treatment Phase C (1 Week)|Physician Decision|0
4710537|NCT02164539|16238085|P1|Treatment Phase C (1 Week)|Physician Decision|0
4710538|NCT02164539|16238079|P7|Treatment Phase C (1 Week)|Adverse Event|1
4710539|NCT02164539|16238080|P6|Treatment Phase C (1 Week)|Adverse Event|0
4710540|NCT02164539|16238081|P5|Treatment Phase C (1 Week)|Adverse Event|0
4710541|NCT02164539|16238082|P4|Treatment Phase C (1 Week)|Adverse Event|0
4710542|NCT02164539|16238083|P3|Treatment Phase C (1 Week)|Adverse Event|0
4710543|NCT02164539|16238084|P2|Treatment Phase C (1 Week)|Adverse Event|0
4710544|NCT02164539|16238085|P1|Treatment Phase C (1 Week)|Adverse Event|0
4710545|NCT02164539|16238079|P7|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4710546|NCT02164539|16238080|P6|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4710547|NCT02164539|16238081|P5|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4710548|NCT02164539|16238082|P4|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4710549|NCT02164539|16238083|P3|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4710550|NCT02164539|16238084|P2|Treatment Phase C (1 Week)|Withdrawal by Subject|0
4710551|NCT02164539|16238085|P1|Treatment Phase C (1 Week)|Withdrawal by Subject|1
4710552|NCT02164539|16238079|P7|Treatment Phase B (1 Week)|Physician Decision|1
4710553|NCT02164539|16238080|P6|Treatment Phase B (1 Week)|Physician Decision|0
4710554|NCT02164539|16238081|P5|Treatment Phase B (1 Week)|Physician Decision|1
4710555|NCT02164539|16238082|P4|Treatment Phase B (1 Week)|Physician Decision|0
4710556|NCT02164539|16238083|P3|Treatment Phase B (1 Week)|Physician Decision|0
4710557|NCT02164539|16238084|P2|Treatment Phase B (1 Week)|Physician Decision|0
4710558|NCT02164539|16238085|P1|Treatment Phase B (1 Week)|Physician Decision|0
4710559|NCT02164539|16238079|P7|Treatment Phase B (1 Week)|Adverse Event|0
4710560|NCT02164539|16238080|P6|Treatment Phase B (1 Week)|Adverse Event|0
4710561|NCT02164539|16238081|P5|Treatment Phase B (1 Week)|Adverse Event|2
4710562|NCT02164539|16238082|P4|Treatment Phase B (1 Week)|Adverse Event|0
4710563|NCT02164539|16238083|P3|Treatment Phase B (1 Week)|Adverse Event|0
4710564|NCT02164539|16238084|P2|Treatment Phase B (1 Week)|Adverse Event|0
4710565|NCT02164539|16238085|P1|Treatment Phase B (1 Week)|Adverse Event|0
4710566|NCT02164539|16238079|P7|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
4710567|NCT02164539|16238080|P6|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
4710568|NCT02164539|16238081|P5|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3
4710569|NCT02164539|16238082|P4|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
4710570|NCT02164539|16238083|P3|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1
4710571|NCT02164539|16238084|P2|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0
4710572|NCT02164539|16238085|P1|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2
4710573|NCT02164513|16238133|P3|Overall Study|Other: Reason not provided by site|0
4710574|NCT02164513|16238134|P2|Overall Study|Other: Reason not provided by site|0
4710575|NCT02164513|16238135|P1|Overall Study|Other: Reason not provided by site|1
4710576|NCT02164513|16238133|P3|Overall Study|Withdrawal by Subject|130
4710577|NCT02164513|16238134|P2|Overall Study|Withdrawal by Subject|261
4710578|NCT02164513|16238135|P1|Overall Study|Withdrawal by Subject|192
4710579|NCT02164513|16238133|P3|Overall Study|Physician Decision|28
4710580|NCT02164513|16238134|P2|Overall Study|Physician Decision|57
4710581|NCT02164513|16238135|P1|Overall Study|Physician Decision|47
4710582|NCT02164513|16238133|P3|Overall Study|Lost to Follow-up|22
4710583|NCT02164513|16238134|P2|Overall Study|Lost to Follow-up|36
4710584|NCT02164513|16238135|P1|Overall Study|Lost to Follow-up|30
4710585|NCT02164513|16238133|P3|Overall Study|Other: Study Closed or terminated|4
4710586|NCT02164513|16238134|P2|Overall Study|Other: Study Closed or terminated|2
4710587|NCT02164513|16238135|P1|Overall Study|Other: Study Closed or terminated|5
4710588|NCT02164513|16238133|P3|Overall Study|Adverse Event|111
4710589|NCT02164513|16238134|P2|Overall Study|Adverse Event|180
4710590|NCT02164513|16238135|P1|Overall Study|Adverse Event|162
4710591|NCT02164383|16238172|P2|Overall Study|Lost to Follow-up|0
4710592|NCT02164383|16238173|P1|Overall Study|Lost to Follow-up|1
4710593|NCT02164318|16238183|P4|Overall Study|Withdrawal by Subject|1
4710594|NCT02164318|16238184|P3|Overall Study|Withdrawal by Subject|0
4710595|NCT02164318|16238185|P2|Overall Study|Withdrawal by Subject|1
4710596|NCT02164318|16238186|P1|Overall Study|Withdrawal by Subject|0
4710597|NCT02163993|16238221|P5|Post-treatment Period|Withdrawal by Subject|2
4710598|NCT02163993|16238222|P4|Post-treatment Period|Withdrawal by Subject|1
4710599|NCT02163993|16238223|P3|Post-treatment Period|Withdrawal by Subject|0
4710600|NCT02163993|16238224|P2|Post-treatment Period|Withdrawal by Subject|4
4710601|NCT02163993|16238225|P1|Post-treatment Period|Withdrawal by Subject|2
4710602|NCT02163993|16238221|P5|Post-treatment Period|Protocol Violation|1
4710603|NCT02163993|16238222|P4|Post-treatment Period|Protocol Violation|0
4710604|NCT02163993|16238223|P3|Post-treatment Period|Protocol Violation|0
4710605|NCT02163993|16238224|P2|Post-treatment Period|Protocol Violation|0
4710606|NCT02163993|16238225|P1|Post-treatment Period|Protocol Violation|0
4710607|NCT02163993|16238221|P5|Post-treatment Period|Lost to Follow-up|0
4710608|NCT02163993|16238222|P4|Post-treatment Period|Lost to Follow-up|1
4710609|NCT02163993|16238223|P3|Post-treatment Period|Lost to Follow-up|3
4710610|NCT02163993|16238224|P2|Post-treatment Period|Lost to Follow-up|2
4710611|NCT02163993|16238225|P1|Post-treatment Period|Lost to Follow-up|2
4710612|NCT02163993|16238221|P5|Post-treatment Period|Adverse Event|0
4710613|NCT02163993|16238222|P4|Post-treatment Period|Adverse Event|0
4710614|NCT02163993|16238223|P3|Post-treatment Period|Adverse Event|1
4710615|NCT02163993|16238224|P2|Post-treatment Period|Adverse Event|0
4710616|NCT02163993|16238225|P1|Post-treatment Period|Adverse Event|0
4710617|NCT02163993|16238221|P5|Treatment Period|Not treated|2
4710618|NCT02163993|16238222|P4|Treatment Period|Not treated|1
4710619|NCT02163993|16238223|P3|Treatment Period|Not treated|0
4710620|NCT02163993|16238224|P2|Treatment Period|Not treated|0
4710621|NCT02163993|16238225|P1|Treatment Period|Not treated|1
4710622|NCT02163993|16238221|P5|Treatment Period|Withdrawal by Subject|1
4710623|NCT02163993|16238222|P4|Treatment Period|Withdrawal by Subject|4
4710624|NCT02163993|16238223|P3|Treatment Period|Withdrawal by Subject|1
4710625|NCT02163993|16238224|P2|Treatment Period|Withdrawal by Subject|4
4710626|NCT02163993|16238225|P1|Treatment Period|Withdrawal by Subject|6
4710627|NCT02163993|16238221|P5|Treatment Period|Protocol Violation|2
4710628|NCT02163993|16238222|P4|Treatment Period|Protocol Violation|1
4710629|NCT02163993|16238223|P3|Treatment Period|Protocol Violation|0
4710630|NCT02163993|16238224|P2|Treatment Period|Protocol Violation|1
4710631|NCT02163993|16238225|P1|Treatment Period|Protocol Violation|2
4710632|NCT02163993|16238221|P5|Treatment Period|Physician Decision|0
4710633|NCT02163993|16238222|P4|Treatment Period|Physician Decision|0
4710634|NCT02163993|16238223|P3|Treatment Period|Physician Decision|0
4710635|NCT02163993|16238224|P2|Treatment Period|Physician Decision|0
4710636|NCT02163993|16238225|P1|Treatment Period|Physician Decision|1
4710637|NCT02163993|16238221|P5|Treatment Period|Lost to Follow-up|1
4710638|NCT02163993|16238222|P4|Treatment Period|Lost to Follow-up|3
4710639|NCT02163993|16238223|P3|Treatment Period|Lost to Follow-up|1
4710640|NCT02163993|16238224|P2|Treatment Period|Lost to Follow-up|3
4710641|NCT02163993|16238225|P1|Treatment Period|Lost to Follow-up|2
4710642|NCT02163993|16238221|P5|Treatment Period|Adverse Event|1
4710643|NCT02163993|16238222|P4|Treatment Period|Adverse Event|0
4710644|NCT02163993|16238223|P3|Treatment Period|Adverse Event|0
4710645|NCT02163993|16238224|P2|Treatment Period|Adverse Event|1
4710646|NCT02163993|16238225|P1|Treatment Period|Adverse Event|0
4710647|NCT02163915|16238328|P5|Overall Study|Physician Decision|0
4710648|NCT02163915|16238329|P4|Overall Study|Physician Decision|1
4710649|NCT02163915|16238330|P3|Overall Study|Physician Decision|0
4710650|NCT02163915|16238331|P2|Overall Study|Physician Decision|0
4710651|NCT02163915|16238332|P1|Overall Study|Physician Decision|0
4710652|NCT02163915|16238328|P5|Overall Study|Study termination|2
4710653|NCT02163915|16238329|P4|Overall Study|Study termination|0
4710654|NCT02163915|16238330|P3|Overall Study|Study termination|0
4710655|NCT02163915|16238331|P2|Overall Study|Study termination|0
4710656|NCT02163915|16238332|P1|Overall Study|Study termination|1
4710657|NCT02163915|16238328|P5|Overall Study|Withdrawal by Subject|2
4710658|NCT02163915|16238329|P4|Overall Study|Withdrawal by Subject|2
4710659|NCT02163915|16238330|P3|Overall Study|Withdrawal by Subject|2
4710660|NCT02163915|16238331|P2|Overall Study|Withdrawal by Subject|0
4710661|NCT02163915|16238332|P1|Overall Study|Withdrawal by Subject|2
4710662|NCT02163902|16238387|P2|Overall Study|Administrative Decision|2
4710663|NCT02163902|16238388|P1|Overall Study|Administrative Decision|2
4710664|NCT02163902|16238387|P2|Overall Study|Lost to Follow-up|7
4710665|NCT02163902|16238388|P1|Overall Study|Lost to Follow-up|6
4710666|NCT02163902|16238387|P2|Overall Study|Subject's Request|4
4710667|NCT02163902|16238388|P1|Overall Study|Subject's Request|3
4710668|NCT02163733|16238437|P3|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19
4710669|NCT02163733|16238438|P2|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
4710670|NCT02163733|16238439|P1|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0
4710671|NCT02163733|16238437|P3|Part B: Day 15 to End Part B (AZD9291)|Death|5
4710672|NCT02163733|16238438|P2|Part B: Day 15 to End Part B (AZD9291)|Death|0
4710673|NCT02163733|16238439|P1|Part B: Day 15 to End Part B (AZD9291)|Death|0
4710674|NCT02163538|16238541|P2|Overall Study|Physician Decision|1
4710675|NCT02163538|16238542|P1|Overall Study|Physician Decision|0
4710676|NCT02163538|16238541|P2|Overall Study|Protocol Violation|0
4710677|NCT02163538|16238542|P1|Overall Study|Protocol Violation|1
4710678|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Various reasons|16
4710679|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Hyperkalemia|5
4710680|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Subject Compliance|17
4710681|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Death|8
4710682|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Protocol Violation|2
4710683|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Lost to Follow-up|31
4710684|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Physician Decision|8
4710685|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Withdrawal by Subject|81
4710686|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7
4710687|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Sponsor's Decision|5
4710688|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Hypokalemia|9
4710689|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Expected Progression of CKD|40
4710690|NCT02163499|16238558|P1|Extended Dosing Phase: ZS|Adverse Event|51
4710691|NCT02163499|16238558|P1|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1
4710692|NCT02163499|16238558|P1|Acute Phase: ZS 10 g TID|Physician Decision|1
4710693|NCT02163499|16238558|P1|Acute Phase: ZS 10 g TID|Protocol Violation|1
4710694|NCT02163499|16238558|P1|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1
4710695|NCT02163499|16238558|P1|Acute Phase: ZS 10 g TID|Participant's Compliance|1
4710696|NCT02163447|16238586|P3|Overall Study|Became HIV infected at time of delivery|0
4710697|NCT02163447|16238587|P2|Overall Study|Became HIV infected at time of delivery|0
4710698|NCT02163447|16238588|P1|Overall Study|Became HIV infected at time of delivery|1
4710699|NCT02163447|16238586|P3|Overall Study|Moved out of study area|2
4710700|NCT02163447|16238587|P2|Overall Study|Moved out of study area|3
4710701|NCT02163447|16238588|P1|Overall Study|Moved out of study area|2
4710702|NCT02163447|16238586|P3|Overall Study|Lost to Follow-up|0
4710703|NCT02163447|16238587|P2|Overall Study|Lost to Follow-up|3
4710704|NCT02163447|16238588|P1|Overall Study|Lost to Follow-up|1
4710705|NCT02163447|16238586|P3|Overall Study|Withdrawal by Subject|1
4710706|NCT02163447|16238587|P2|Overall Study|Withdrawal by Subject|0
4710707|NCT02163447|16238588|P1|Overall Study|Withdrawal by Subject|2
4710708|NCT02163395|16238663|P1|Overall Study|Adverse Event|1
4710709|NCT02163395|16238663|P1|Overall Study|Lost to Follow-up|3
4710710|NCT02163395|16238663|P1|Overall Study|Withdrawal by Subject|1
4710711|NCT02163187|16238672|P2|Overall Study|Progressive disease|0
4710712|NCT02163187|16238673|P1|Overall Study|Progressive disease|1
4710713|NCT02163187|16238672|P2|Overall Study|Device removed|0
4710714|NCT02163187|16238673|P1|Overall Study|Device removed|1
4710715|NCT02162862|16238708|P3|Overall Study|Subject did not feel the med was needed|4
4710716|NCT02162862|16238709|P2|Overall Study|Subject did not feel the med was needed|0
4710717|NCT02162862|16238710|P1|Overall Study|Subject did not feel the med was needed|0
4710718|NCT02162862|16238708|P3|Overall Study|Lost to Follow-up|0
4710719|NCT02162862|16238709|P2|Overall Study|Lost to Follow-up|11
4710720|NCT02162862|16238710|P1|Overall Study|Lost to Follow-up|0
4710721|NCT02162771|16238723|P2|Maintenance Study Period (Part 2)|Stable Disease|1
4710722|NCT02162771|16238724|P1|Maintenance Study Period (Part 2)|Stable Disease|0
4710723|NCT02162771|16238723|P2|Maintenance Study Period (Part 2)|Protocol Violation|1
4710724|NCT02162771|16238724|P1|Maintenance Study Period (Part 2)|Protocol Violation|0
4710725|NCT02162771|16238723|P2|Maintenance Study Period (Part 2)|Withdrawal by Subject|3
4710726|NCT02162771|16238724|P1|Maintenance Study Period (Part 2)|Withdrawal by Subject|0
4710727|NCT02162771|16238723|P2|Maintenance Study Period (Part 2)|Death|1
4710728|NCT02162771|16238724|P1|Maintenance Study Period (Part 2)|Death|2
4710729|NCT02162771|16238723|P2|Maintenance Study Period (Part 2)|Adverse Event|3
4710730|NCT02162771|16238724|P1|Maintenance Study Period (Part 2)|Adverse Event|3
4710731|NCT02162771|16238723|P2|Maintenance Study Period (Part 2)|Progressive Disease|13
4710732|NCT02162771|16238724|P1|Maintenance Study Period (Part 2)|Progressive Disease|11
4710733|NCT02162771|16238723|P2|Core Study Period (Part 2)|Death|0
4710734|NCT02162771|16238724|P1|Core Study Period (Part 2)|Death|1
4710735|NCT02162771|16238723|P2|Core Study Period (Part 2)|Physician Decision|2
4710736|NCT02162771|16238724|P1|Core Study Period (Part 2)|Physician Decision|0
4710737|NCT02162771|16238723|P2|Core Study Period (Part 2)|Withdrawal by Subject|2
4710738|NCT02162771|16238724|P1|Core Study Period (Part 2)|Withdrawal by Subject|1
4710739|NCT02162771|16238723|P2|Core Study Period (Part 2)|Adverse Event|1
4710740|NCT02162771|16238724|P1|Core Study Period (Part 2)|Adverse Event|4
4710741|NCT02162771|16238723|P2|Core Study Period (Part 2)|Progressive Disease|3
4710742|NCT02162771|16238724|P1|Core Study Period (Part 2)|Progressive Disease|2
4710743|NCT02162758|16238738|P2|Overall Study|Study termination|1
4710744|NCT02162758|16238739|P1|Overall Study|Study termination|0
4710745|NCT02161757|16238874|P3|Treatment Through Study Completion|Death|1
4710746|NCT02161757|16238875|P2|Treatment Through Study Completion|Death|1
4710747|NCT02161757|16238876|P1|Treatment Through Study Completion|Death|2
4710748|NCT02161757|16238874|P3|Treatment Through Study Completion|Other|12
4710749|NCT02161757|16238875|P2|Treatment Through Study Completion|Other|19
4710750|NCT02161757|16238876|P1|Treatment Through Study Completion|Other|20
4710751|NCT02161757|16238874|P3|Treatment Through Study Completion|Lost to Follow-up|4
4710752|NCT02161757|16238875|P2|Treatment Through Study Completion|Lost to Follow-up|2
4710753|NCT02161757|16238876|P1|Treatment Through Study Completion|Lost to Follow-up|7
4710754|NCT02161757|16238874|P3|Treatment Through Study Completion|Withdrawal by Subject|20
4710755|NCT02161757|16238875|P2|Treatment Through Study Completion|Withdrawal by Subject|19
4710756|NCT02161757|16238876|P1|Treatment Through Study Completion|Withdrawal by Subject|27
4710757|NCT02161757|16238874|P3|Treatment Through Study Completion|Protocol Violation|2
4710758|NCT02161757|16238875|P2|Treatment Through Study Completion|Protocol Violation|1
4710759|NCT02161757|16238876|P1|Treatment Through Study Completion|Protocol Violation|0
4710760|NCT02161757|16238874|P3|Treatment Through Study Completion|Adverse Event|0
4710761|NCT02161757|16238875|P2|Treatment Through Study Completion|Adverse Event|1
4710762|NCT02161757|16238876|P1|Treatment Through Study Completion|Adverse Event|1
4710763|NCT02161757|16238874|P3|Randomised Through Start Treatment|Did not receive treatment|0
4710764|NCT02161757|16238875|P2|Randomised Through Start Treatment|Did not receive treatment|2
4710765|NCT02161757|16238876|P1|Randomised Through Start Treatment|Did not receive treatment|3
4710766|NCT02161731|16238934|P2|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1
4710767|NCT02161731|16238935|P1|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0
4710768|NCT02161731|16238934|P2|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1
4710769|NCT02161731|16238935|P1|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0
4710770|NCT02161575|16238963|P1|Overall Study|Adverse Event|2
4710771|NCT02161575|16238963|P1|Overall Study|Lack of Efficacy|1
4710772|NCT02161575|16238963|P1|Overall Study|Protocol Violation|8
4710773|NCT02161562|16238983|P2|Overall Study|Participant moved out of province|0
4710774|NCT02161562|16238984|P1|Overall Study|Participant moved out of province|1
4710775|NCT02161562|16238983|P2|Overall Study|Withdrew due to being out of the country|0
4710776|NCT02161562|16238984|P1|Overall Study|Withdrew due to being out of the country|1
4710777|NCT02161562|16238983|P2|Overall Study|Participant moved back to home country|0
4710778|NCT02161562|16238984|P1|Overall Study|Participant moved back to home country|1
4710779|NCT02161562|16238983|P2|Overall Study|Adverse Event|1
4710780|NCT02161562|16238984|P1|Overall Study|Adverse Event|1
4710781|NCT02161562|16238983|P2|Overall Study|Lack of Efficacy|1
4710782|NCT02161562|16238984|P1|Overall Study|Lack of Efficacy|4
4710783|NCT02161562|16238983|P2|Overall Study|Lost to Follow-up|1
4710784|NCT02161562|16238984|P1|Overall Study|Lost to Follow-up|3
4710785|NCT02161562|16238983|P2|Overall Study|Pregnancy|2
4710786|NCT02161562|16238984|P1|Overall Study|Pregnancy|1
4710787|NCT02161562|16238983|P2|Overall Study|Protocol Violation|4
4710788|NCT02161562|16238984|P1|Overall Study|Protocol Violation|9
4710789|NCT02161562|16238983|P2|Overall Study|Withdrawal by Subject|8
4710790|NCT02161562|16238984|P1|Overall Study|Withdrawal by Subject|5
4710791|NCT02161549|16239012|P2|Overall Study|Physician Decision|2
4710792|NCT02161549|16239013|P1|Overall Study|Physician Decision|6
4710793|NCT02161458|16239061|P4|Overall Study|Lost to Follow-up|0
4710794|NCT02161458|16239062|P3|Overall Study|Lost to Follow-up|1
4710795|NCT02161458|16239063|P2|Overall Study|Lost to Follow-up|2
4710796|NCT02161458|16239064|P1|Overall Study|Lost to Follow-up|0
4710797|NCT02161458|16239061|P4|Overall Study|Withdrawal by Subject|0
4710798|NCT02161458|16239062|P3|Overall Study|Withdrawal by Subject|4
4710799|NCT02161458|16239063|P2|Overall Study|Withdrawal by Subject|4
4710800|NCT02161458|16239064|P1|Overall Study|Withdrawal by Subject|0
4710801|NCT02161406|16239076|P2|Overall Study|relocation|1
4710802|NCT02161406|16239077|P1|Overall Study|relocation|0
4710803|NCT02161406|16239076|P2|Overall Study|Lack of Efficacy|1
4710804|NCT02161406|16239077|P1|Overall Study|Lack of Efficacy|1
4710805|NCT02161406|16239076|P2|Overall Study|investigator withdrew subject|1
4710806|NCT02161406|16239077|P1|Overall Study|investigator withdrew subject|3
4710807|NCT02161406|16239076|P2|Overall Study|Withdrawal by Subject|4
4710808|NCT02161406|16239077|P1|Overall Study|Withdrawal by Subject|2
4710809|NCT02161406|16239076|P2|Overall Study|Lost to Follow-up|1
4710810|NCT02161406|16239077|P1|Overall Study|Lost to Follow-up|2
4710811|NCT02161406|16239076|P2|Overall Study|Death|1
4710812|NCT02161406|16239077|P1|Overall Study|Death|2
4710813|NCT02161185|16239151|P1|Treatment Phase|Administrative/Other|7
4710814|NCT02161146|16239161|P5|Overall Study|Other Miscellaneous Reasons|0
4710815|NCT02161146|16239162|P4|Overall Study|Other Miscellaneous Reasons|0
4710816|NCT02161146|16239163|P3|Overall Study|Other Miscellaneous Reasons|0
4710817|NCT02161146|16239164|P2|Overall Study|Other Miscellaneous Reasons|1
4710818|NCT02161146|16239165|P1|Overall Study|Other Miscellaneous Reasons|0
4710819|NCT02161146|16239161|P5|Overall Study|Personal Reasons|1
4710820|NCT02161146|16239162|P4|Overall Study|Personal Reasons|2
4710821|NCT02161146|16239163|P3|Overall Study|Personal Reasons|0
4710822|NCT02161146|16239164|P2|Overall Study|Personal Reasons|1
4710823|NCT02161146|16239165|P1|Overall Study|Personal Reasons|0
4710824|NCT02161146|16239161|P5|Overall Study|Lost to Follow-up|0
4710825|NCT02161146|16239162|P4|Overall Study|Lost to Follow-up|0
4710826|NCT02161146|16239163|P3|Overall Study|Lost to Follow-up|0
4710827|NCT02161146|16239164|P2|Overall Study|Lost to Follow-up|1
4710828|NCT02161146|16239165|P1|Overall Study|Lost to Follow-up|0
4710829|NCT02161146|16239161|P5|Overall Study|Adverse Event|0
4710830|NCT02161146|16239162|P4|Overall Study|Adverse Event|1
4710831|NCT02161146|16239163|P3|Overall Study|Adverse Event|0
4710832|NCT02161146|16239164|P2|Overall Study|Adverse Event|1
4710833|NCT02161146|16239165|P1|Overall Study|Adverse Event|1
4710834|NCT02161016|16239201|P1|Overall Study|withdrawn by IRB|1
4710835|NCT02160977|16239232|P2|Six Months After Surgery|Lost to Follow-up|1
4710836|NCT02160977|16239233|P1|Six Months After Surgery|Lost to Follow-up|2
4710837|NCT02160977|16239232|P2|Three Months After Surgery|Lost to Follow-up|2
4710838|NCT02160977|16239233|P1|Three Months After Surgery|Lost to Follow-up|0
4710839|NCT02160977|16239232|P2|Six Weeks After Surgery|Lost to Follow-up|0
4710840|NCT02160977|16239233|P1|Six Weeks After Surgery|Lost to Follow-up|1
4710841|NCT02160899|16239249|P6|Overall Study|Adverse Event or Serious Adverse Event|0
4710842|NCT02160899|16239250|P5|Overall Study|Adverse Event or Serious Adverse Event|2
4710843|NCT02160899|16239251|P4|Overall Study|Adverse Event or Serious Adverse Event|1
4710844|NCT02160899|16239252|P3|Overall Study|Adverse Event or Serious Adverse Event|0
4710845|NCT02160899|16239253|P2|Overall Study|Adverse Event or Serious Adverse Event|1
4710846|NCT02160899|16239254|P1|Overall Study|Adverse Event or Serious Adverse Event|0
4710847|NCT02160626|16239316|P3|Overall Study|Withdrawal by Subject|0
4710848|NCT02160626|16239317|P2|Overall Study|Withdrawal by Subject|1
4710849|NCT02160626|16239318|P1|Overall Study|Withdrawal by Subject|0
4710850|NCT02160626|16239316|P3|Overall Study|Schedule not conducive to study visits|1
4710851|NCT02160626|16239317|P2|Overall Study|Schedule not conducive to study visits|0
4710852|NCT02160626|16239318|P1|Overall Study|Schedule not conducive to study visits|0
4710853|NCT02160626|16239316|P3|Overall Study|Adverse Event|0
4710854|NCT02160626|16239317|P2|Overall Study|Adverse Event|0
4710855|NCT02160626|16239318|P1|Overall Study|Adverse Event|1
4710856|NCT02160314|16239341|P2|Overall Study|Lost to Follow-up|1
4710857|NCT02160314|16239342|P1|Overall Study|Lost to Follow-up|0
4710858|NCT02160314|16239341|P2|Overall Study|Withdrawal by Subject|2
4710859|NCT02160314|16239342|P1|Overall Study|Withdrawal by Subject|1
4710860|NCT02160314|16239341|P2|Overall Study|Protocol Violation|4
4710861|NCT02160314|16239342|P1|Overall Study|Protocol Violation|0
4710862|NCT02160314|16239341|P2|Overall Study|Adverse Event|6
4710863|NCT02160314|16239342|P1|Overall Study|Adverse Event|0
4710864|NCT02160145|16239377|P3|Randomized Double-blind Period|Physician Decision|5
4710865|NCT02160145|16239378|P2|Randomized Double-blind Period|Physician Decision|7
4710866|NCT02160145|16239379|P1|Randomized Double-blind Period|Physician Decision|0
4710867|NCT02160145|16239377|P3|Randomized Double-blind Period|Lost to Follow-up|3
4710868|NCT02160145|16239378|P2|Randomized Double-blind Period|Lost to Follow-up|1
4710869|NCT02160145|16239379|P1|Randomized Double-blind Period|Lost to Follow-up|0
4710870|NCT02160145|16239377|P3|Randomized Double-blind Period|Subject decision|20
4710871|NCT02160145|16239378|P2|Randomized Double-blind Period|Subject decision|21
4710872|NCT02160145|16239379|P1|Randomized Double-blind Period|Subject decision|0
4710873|NCT02160145|16239377|P3|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
4710874|NCT02160145|16239378|P2|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0
4710875|NCT02160145|16239379|P1|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126
4710876|NCT02160145|16239377|P3|Prerandomization Single-blind Period|Placebo run-in failure|0
4710877|NCT02160145|16239378|P2|Prerandomization Single-blind Period|Placebo run-in failure|0
4710878|NCT02160145|16239379|P1|Prerandomization Single-blind Period|Placebo run-in failure|23
4710879|NCT02160041|16239392|P1|Overall Study|study terminated by by sponsor|1
4710880|NCT02160041|16239392|P1|Overall Study|Withdrawal by Subject|8
4710881|NCT02160041|16239392|P1|Overall Study|Physician Decision|3
4710882|NCT02160041|16239392|P1|Overall Study|non-compliance with study|1
4710883|NCT02160041|16239392|P1|Overall Study|Protocol Violation|1
4710884|NCT02160041|16239392|P1|Overall Study|disease progression|57
4710885|NCT02160041|16239392|P1|Overall Study|Death|2
4710886|NCT02160041|16239392|P1|Overall Study|Adverse Event|11
4710887|NCT02160002|16239404|P2|Overall Study|Withdrawal by Subject|1
4710888|NCT02160002|16239405|P1|Overall Study|Withdrawal by Subject|2
4710889|NCT02159950|16239452|P2|Overall Study|Progression|1
4710890|NCT02159950|16239453|P1|Overall Study|Progression|0
4710891|NCT02159950|16239452|P2|Overall Study|Adverse Event|1
4710892|NCT02159950|16239453|P1|Overall Study|Adverse Event|0
4710893|NCT02159807|16239512|P3|Overall Study|elevated blood pressure|1
4710894|NCT02159807|16239513|P2|Overall Study|elevated blood pressure|0
4710895|NCT02159807|16239514|P1|Overall Study|elevated blood pressure|0
4710896|NCT02159807|16239512|P3|Overall Study|No CSF|1
4710897|NCT02159807|16239513|P2|Overall Study|No CSF|1
4710898|NCT02159807|16239514|P1|Overall Study|No CSF|1
4710899|NCT02159807|16239512|P3|Overall Study|Adverse Event|1
4710900|NCT02159807|16239513|P2|Overall Study|Adverse Event|0
4710901|NCT02159807|16239514|P1|Overall Study|Adverse Event|0
4710902|NCT02159729|16239535|P2|Overall Study|Other Unspecified|1
4710903|NCT02159729|16239536|P1|Overall Study|Other Unspecified|3
4710904|NCT02159729|16239535|P2|Overall Study|Non compliance|0
4710905|NCT02159729|16239536|P1|Overall Study|Non compliance|2
4710906|NCT02159729|16239535|P2|Overall Study|Lost to Follow-up|9
4710907|NCT02159729|16239536|P1|Overall Study|Lost to Follow-up|24
4710908|NCT02159729|16239535|P2|Overall Study|Subject's Request|10
4710909|NCT02159729|16239536|P1|Overall Study|Subject's Request|13
4710910|NCT02159729|16239535|P2|Overall Study|Adverse Event|1
4710911|NCT02159729|16239536|P1|Overall Study|Adverse Event|0
4710912|NCT02159521|16239563|P1|Overall Study|Other than specified|1
4710913|NCT02159521|16239563|P1|Overall Study|Death|1
4710914|NCT02159521|16239563|P1|Overall Study|Lost to Follow-up|6
4710915|NCT02159521|16239563|P1|Overall Study|Withdrawal by Subject|7
4710916|NCT02159521|16239563|P1|Overall Study|Enrolled but not treated|3
4710917|NCT02159482|16239584|P1|Overall Study|Physician Decision|3
4710918|NCT02159482|16239584|P1|Overall Study|Withdrawal by Subject|2
4710919|NCT02159469|16239589|P1|Overall Study|Multiple|29
4710920|NCT02159469|16239589|P1|Overall Study|Other|1
4710921|NCT02159469|16239589|P1|Overall Study|Met Stopping Criteria|3
4710922|NCT02159469|16239589|P1|Overall Study|Sponsor's request|2
4710923|NCT02159469|16239589|P1|Overall Study|Lost to Follow-up|1
4710924|NCT02159469|16239589|P1|Overall Study|Withdrawal by Subject|9
4710925|NCT02159469|16239589|P1|Overall Study|Non-compliance|2
4710926|NCT02159469|16239589|P1|Overall Study|Adverse Event|5
4710927|NCT02159469|16239589|P1|Overall Study|Missing Completion status|1
4710928|NCT02159365|16239594|P1|Overall Study|Lost to Follow-up|1
4710929|NCT02159365|16239594|P1|Overall Study|Death|1
4710930|NCT02159365|16239594|P1|Overall Study|Subject withdrew consent|3
4710931|NCT02159365|16239594|P1|Overall Study|Subject request to discontinue treatment|3
4710932|NCT02159365|16239594|P1|Overall Study|Maximum clinical benefit|3
4710933|NCT02159365|16239594|P1|Overall Study|Study drug toxicity|7
4710934|NCT02159365|16239594|P1|Overall Study|Adverse Event unrelated to study drug|9
4710935|NCT02159365|16239594|P1|Overall Study|Administrative reason by Sponsor|9
4710936|NCT02159365|16239594|P1|Overall Study|Other reasons|11
4710937|NCT02159365|16239594|P1|Overall Study|Disease Progression|23
4710938|NCT02159352|16239601|P2|Overall Study|Withdrawal by Subject|1
4710939|NCT02159352|16239602|P1|Overall Study|Withdrawal by Subject|0
4710940|NCT02159352|16239601|P2|Overall Study|Adverse Event|1
4710941|NCT02159352|16239602|P1|Overall Study|Adverse Event|3
4710942|NCT02159183|16239654|P2|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1
4710943|NCT02159183|16239655|P1|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2
4710944|NCT02159183|16239654|P2|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0
4710945|NCT02159183|16239655|P1|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1
4710946|NCT02159183|16239654|P2|Analysis After the 36 Months Follow-up|Death|1
4710947|NCT02159183|16239655|P1|Analysis After the 36 Months Follow-up|Death|0
4710948|NCT02159183|16239654|P2|Analysis After the 36 Months Follow-up|Adverse Event|0
4710949|NCT02159183|16239655|P1|Analysis After the 36 Months Follow-up|Adverse Event|1
4710950|NCT02159183|16239654|P2|Analysis After the 36 Months Follow-up|Protocol Violation|1
4710951|NCT02159183|16239655|P1|Analysis After the 36 Months Follow-up|Protocol Violation|2
4710952|NCT02159053|16239728|P3|Overall Study|Participants/guardian decision|6
4710953|NCT02159053|16239729|P2|Overall Study|Participants/guardian decision|10
4710954|NCT02159053|16239730|P1|Overall Study|Participants/guardian decision|8
4710955|NCT02159053|16239728|P3|Overall Study|Adverse Event|5
4710956|NCT02159053|16239729|P2|Overall Study|Adverse Event|6
4710957|NCT02159053|16239730|P1|Overall Study|Adverse Event|7
4710958|NCT02159053|16239728|P3|Overall Study|Lack of Efficacy|7
4710959|NCT02159053|16239729|P2|Overall Study|Lack of Efficacy|4
4710960|NCT02159053|16239730|P1|Overall Study|Lack of Efficacy|3
4710961|NCT02159053|16239728|P3|Overall Study|Physician Decision|1
4710962|NCT02159053|16239729|P2|Overall Study|Physician Decision|1
4710963|NCT02159053|16239730|P1|Overall Study|Physician Decision|0
4710964|NCT02159053|16239728|P3|Overall Study|Death|1
4710965|NCT02159053|16239729|P2|Overall Study|Death|0
4710966|NCT02159053|16239730|P1|Overall Study|Death|2
4710967|NCT02159040|16239767|P1|Overall Study|Death|1
4710968|NCT02158975|16239780|P1|Overall Study|Did not complete 1 cycle nor > 1dose|1
4710969|NCT02158949|16239790|P2|Overall Study|Lost to Follow-up|11
4710970|NCT02158949|16239791|P1|Overall Study|Lost to Follow-up|5
4710971|NCT02158949|16239790|P2|Overall Study|Withdrawal by Subject|0
4710972|NCT02158949|16239791|P1|Overall Study|Withdrawal by Subject|1
4710973|NCT02158936|16239807|P2|Overall Study|Lost to Follow-up|1
4710974|NCT02158936|16239808|P1|Overall Study|Lost to Follow-up|0
4710975|NCT02158936|16239807|P2|Overall Study|Physician Decision|13
4710976|NCT02158936|16239808|P1|Overall Study|Physician Decision|15
4710977|NCT02158936|16239807|P2|Overall Study|Withdrawal by Subject|16
4710978|NCT02158936|16239808|P1|Overall Study|Withdrawal by Subject|15
4710979|NCT02158936|16239807|P2|Overall Study|Adverse Event|24
4710980|NCT02158936|16239808|P1|Overall Study|Adverse Event|39
4710981|NCT02158936|16239807|P2|Overall Study|Azacitidine tx discontinued|46
4710982|NCT02158936|16239808|P1|Overall Study|Azacitidine tx discontinued|53
4710983|NCT02158936|16239807|P2|Overall Study|Study closed/ terminated|77
4710984|NCT02158936|16239808|P1|Overall Study|Study closed/ terminated|57
4710985|NCT02158884|16239850|P1|12 Month Assessment|Missed SMFA|17
4710986|NCT02158884|16239850|P1|6 Month Assessment|Missed SMFA|20
4710987|NCT02158884|16239850|P1|Post Intervention (~4 Weeks)|Did not complete performance assessment|10
4710988|NCT02158884|16239850|P1|Intervention: IDEO and PT Program|Did not complete PT intervention|6
4710989|NCT02158884|16239850|P1|Baseline Assessment|Missed SMFA|1
4710990|NCT02158884|16239850|P1|Baseline Assessment|Missed performance assessment|3
4710991|NCT02158806|16239885|P2|Overall Study|Transferred to palliative care|1
4710992|NCT02158806|16239886|P1|Overall Study|Transferred to palliative care|0
4710993|NCT02158806|16239885|P2|Overall Study|Moved out of area|1
4710994|NCT02158806|16239886|P1|Overall Study|Moved out of area|0
4710995|NCT02158806|16239885|P2|Overall Study|Lost to Follow-up|3
4710996|NCT02158806|16239886|P1|Overall Study|Lost to Follow-up|0
4710997|NCT02158806|16239885|P2|Overall Study|Withdrawal by Subject|0
4710998|NCT02158806|16239886|P1|Overall Study|Withdrawal by Subject|2
4710999|NCT02158806|16239885|P2|Overall Study|Death|0
4711000|NCT02158806|16239886|P1|Overall Study|Death|2
4711001|NCT02158728|16239906|P1|Overall Study|no qualified dataset|24
4711002|NCT02158728|16239906|P1|Overall Study|no procedure according to CIP done|3
4711003|NCT02158663|16239912|P2|Overall Study|Withdrawal by Subject|4
4711004|NCT02158663|16239913|P1|Overall Study|Withdrawal by Subject|5
4711005|NCT02158546|16239936|P4|Overall Study|Site Excluded|4
4711006|NCT02158546|16239937|P3|Overall Study|Site Excluded|3
4711007|NCT02158546|16239938|P2|Overall Study|Site Excluded|5
4711008|NCT02158546|16239939|P1|Overall Study|Site Excluded|5
4711009|NCT02158546|16239936|P4|Overall Study|Lost to Follow-up|1
4711010|NCT02158546|16239937|P3|Overall Study|Lost to Follow-up|0
4711011|NCT02158546|16239938|P2|Overall Study|Lost to Follow-up|4
4711012|NCT02158546|16239939|P1|Overall Study|Lost to Follow-up|5
4711013|NCT02158546|16239936|P4|Overall Study|Withdrawal by Subject|0
4711014|NCT02158546|16239937|P3|Overall Study|Withdrawal by Subject|1
4711015|NCT02158546|16239938|P2|Overall Study|Withdrawal by Subject|2
4711016|NCT02158546|16239939|P1|Overall Study|Withdrawal by Subject|6
4711017|NCT02158546|16239936|P4|Overall Study|Adverse Event|0
4711018|NCT02158546|16239937|P3|Overall Study|Adverse Event|0
4711019|NCT02158546|16239938|P2|Overall Study|Adverse Event|2
4711020|NCT02158546|16239939|P1|Overall Study|Adverse Event|2
4711021|NCT02158546|16239936|P4|Overall Study|Lack of Efficacy|0
4711022|NCT02158546|16239937|P3|Overall Study|Lack of Efficacy|0
4711023|NCT02158546|16239938|P2|Overall Study|Lack of Efficacy|1
4711024|NCT02158546|16239939|P1|Overall Study|Lack of Efficacy|1
4711025|NCT02158546|16239936|P4|Overall Study|Failure to meet eligibility criteria|0
4711026|NCT02158546|16239937|P3|Overall Study|Failure to meet eligibility criteria|0
4711027|NCT02158546|16239938|P2|Overall Study|Failure to meet eligibility criteria|1
4711028|NCT02158546|16239939|P1|Overall Study|Failure to meet eligibility criteria|0
4711029|NCT02158546|16239936|P4|Overall Study|Non-compliance|1
4711030|NCT02158546|16239937|P3|Overall Study|Non-compliance|0
4711031|NCT02158546|16239938|P2|Overall Study|Non-compliance|1
4711032|NCT02158546|16239939|P1|Overall Study|Non-compliance|0
4711033|NCT02158546|16239936|P4|Overall Study|Physician Decision|0
4711034|NCT02158546|16239937|P3|Overall Study|Physician Decision|0
4711035|NCT02158546|16239938|P2|Overall Study|Physician Decision|1
4711036|NCT02158546|16239939|P1|Overall Study|Physician Decision|0
4711037|NCT02158533|16239958|P6|Stage 2|Non-adherence with study visits|1
4711038|NCT02158533|16239959|P5|Stage 2|Non-adherence with study visits|0
4711039|NCT02158533|16239960|P4|Stage 2|Non-adherence with study visits|0
4711040|NCT02158533|16239961|P3|Stage 2|Non-adherence with study visits|0
4711041|NCT02158533|16239962|P2|Stage 2|Non-adherence with study visits|0
4711042|NCT02158533|16239963|P1|Stage 2|Non-adherence with study visits|0
4711043|NCT02158533|16239958|P6|Stage 2|Psychiatrist decision to try new tx|0
4711044|NCT02158533|16239959|P5|Stage 2|Psychiatrist decision to try new tx|0
4711045|NCT02158533|16239960|P4|Stage 2|Psychiatrist decision to try new tx|1
4711046|NCT02158533|16239961|P3|Stage 2|Psychiatrist decision to try new tx|0
4711047|NCT02158533|16239962|P2|Stage 2|Psychiatrist decision to try new tx|0
4711048|NCT02158533|16239963|P1|Stage 2|Psychiatrist decision to try new tx|0
4711049|NCT02158533|16239958|P6|Stage 2|Pregnancy|0
4711050|NCT02158533|16239959|P5|Stage 2|Pregnancy|0
4711051|NCT02158533|16239960|P4|Stage 2|Pregnancy|1
4711052|NCT02158533|16239961|P3|Stage 2|Pregnancy|0
4711053|NCT02158533|16239962|P2|Stage 2|Pregnancy|0
4711054|NCT02158533|16239963|P1|Stage 2|Pregnancy|0
4711055|NCT02158533|16239958|P6|Stage 2|Physician Decision|0
4711056|NCT02158533|16239959|P5|Stage 2|Physician Decision|1
4711057|NCT02158533|16239960|P4|Stage 2|Physician Decision|0
4711058|NCT02158533|16239961|P3|Stage 2|Physician Decision|0
4711059|NCT02158533|16239962|P2|Stage 2|Physician Decision|0
4711060|NCT02158533|16239963|P1|Stage 2|Physician Decision|0
4711061|NCT02158533|16239958|P6|Stage 2|Withdrawal by Subject|2
4711062|NCT02158533|16239959|P5|Stage 2|Withdrawal by Subject|1
4711063|NCT02158533|16239960|P4|Stage 2|Withdrawal by Subject|0
4711064|NCT02158533|16239961|P3|Stage 2|Withdrawal by Subject|0
4711065|NCT02158533|16239962|P2|Stage 2|Withdrawal by Subject|0
4711066|NCT02158533|16239963|P1|Stage 2|Withdrawal by Subject|0
4711067|NCT02158533|16239958|P6|Stage 2|Lost to Follow-up|2
4711068|NCT02158533|16239959|P5|Stage 2|Lost to Follow-up|1
4711069|NCT02158533|16239960|P4|Stage 2|Lost to Follow-up|1
4711070|NCT02158533|16239961|P3|Stage 2|Lost to Follow-up|0
4711071|NCT02158533|16239962|P2|Stage 2|Lost to Follow-up|0
4711072|NCT02158533|16239963|P1|Stage 2|Lost to Follow-up|0
4711073|NCT02158533|16239958|P6|Stage 2|Lack of Efficacy|0
4711074|NCT02158533|16239959|P5|Stage 2|Lack of Efficacy|1
4711075|NCT02158533|16239960|P4|Stage 2|Lack of Efficacy|0
4711076|NCT02158533|16239961|P3|Stage 2|Lack of Efficacy|0
4711077|NCT02158533|16239962|P2|Stage 2|Lack of Efficacy|0
4711078|NCT02158533|16239963|P1|Stage 2|Lack of Efficacy|0
4711079|NCT02158533|16239958|P6|Stage 2|Adverse Event|1
4711080|NCT02158533|16239959|P5|Stage 2|Adverse Event|0
4711081|NCT02158533|16239960|P4|Stage 2|Adverse Event|0
4711082|NCT02158533|16239961|P3|Stage 2|Adverse Event|0
4711083|NCT02158533|16239962|P2|Stage 2|Adverse Event|0
4711084|NCT02158533|16239963|P1|Stage 2|Adverse Event|0
4711085|NCT02158533|16239958|P6|Stage 1|Non-compliance with study visits|0
4711086|NCT02158533|16239959|P5|Stage 1|Non-compliance with study visits|0
4711087|NCT02158533|16239960|P4|Stage 1|Non-compliance with study visits|0
4711088|NCT02158533|16239961|P3|Stage 1|Non-compliance with study visits|0
4711089|NCT02158533|16239962|P2|Stage 1|Non-compliance with study visits|0
4711090|NCT02158533|16239963|P1|Stage 1|Non-compliance with study visits|1
4711091|NCT02158533|16239958|P6|Stage 1|Failure to Meet Eligibility Criteria|0
4711092|NCT02158533|16239959|P5|Stage 1|Failure to Meet Eligibility Criteria|0
4711093|NCT02158533|16239960|P4|Stage 1|Failure to Meet Eligibility Criteria|0
4711094|NCT02158533|16239961|P3|Stage 1|Failure to Meet Eligibility Criteria|0
4711095|NCT02158533|16239962|P2|Stage 1|Failure to Meet Eligibility Criteria|1
4711096|NCT02158533|16239963|P1|Stage 1|Failure to Meet Eligibility Criteria|0
4711097|NCT02158533|16239958|P6|Stage 1|Lost to Follow-up|0
4711098|NCT02158533|16239959|P5|Stage 1|Lost to Follow-up|0
4711099|NCT02158533|16239960|P4|Stage 1|Lost to Follow-up|0
4711100|NCT02158533|16239961|P3|Stage 1|Lost to Follow-up|0
4711101|NCT02158533|16239962|P2|Stage 1|Lost to Follow-up|1
4711102|NCT02158533|16239963|P1|Stage 1|Lost to Follow-up|3
4711103|NCT02158533|16239958|P6|Stage 1|Lack of Efficacy|0
4711104|NCT02158533|16239959|P5|Stage 1|Lack of Efficacy|0
4711105|NCT02158533|16239960|P4|Stage 1|Lack of Efficacy|0
4711106|NCT02158533|16239961|P3|Stage 1|Lack of Efficacy|0
4711107|NCT02158533|16239962|P2|Stage 1|Lack of Efficacy|0
4711108|NCT02158533|16239963|P1|Stage 1|Lack of Efficacy|1
4711109|NCT02158533|16239958|P6|Stage 1|Withdrawal by Subject|0
4711110|NCT02158533|16239959|P5|Stage 1|Withdrawal by Subject|0
4711111|NCT02158533|16239960|P4|Stage 1|Withdrawal by Subject|0
4711112|NCT02158533|16239961|P3|Stage 1|Withdrawal by Subject|1
4711113|NCT02158533|16239962|P2|Stage 1|Withdrawal by Subject|2
4711114|NCT02158533|16239963|P1|Stage 1|Withdrawal by Subject|3
4711115|NCT02158533|16239958|P6|Stage 1|Adverse Event|0
4711116|NCT02158533|16239959|P5|Stage 1|Adverse Event|0
4711117|NCT02158533|16239960|P4|Stage 1|Adverse Event|0
4711118|NCT02158533|16239961|P3|Stage 1|Adverse Event|7
4711119|NCT02158533|16239962|P2|Stage 1|Adverse Event|4
4711120|NCT02158533|16239963|P1|Stage 1|Adverse Event|6
4711121|NCT02158442|16240039|P2|Overall Study|Perfusion staff not available|0
4711122|NCT02158442|16240040|P1|Overall Study|Perfusion staff not available|1
4711123|NCT02158442|16240039|P2|Overall Study|Withdrawal by Subject|0
4711124|NCT02158442|16240040|P1|Overall Study|Withdrawal by Subject|1
4711125|NCT02158364|16240046|P1|Overall Study|Protocol Deviation|50
4711126|NCT02158364|16240046|P1|Overall Study|Case report forms uncollected|10
4711127|NCT02158247|16240064|P1|Overall Study|Invisible vocal cords|5
4711128|NCT02158091|16240083|P3|Overall Study|DLT|0
4711129|NCT02158091|16240084|P2|Overall Study|DLT|1
4711130|NCT02158091|16240085|P1|Overall Study|DLT|2
4711131|NCT02158039|16240093|P1|Overall Study|Screen Failure|9
4711132|NCT02158039|16240093|P1|Overall Study|Withdrawal by Subject|1
4711133|NCT02157948|16240100|P2|Overall Study|Decision by Sponsor|1
4711134|NCT02157948|16240101|P1|Overall Study|Decision by Sponsor|0
4711135|NCT02157948|16240100|P2|Overall Study|Protocol Specified Criteria|1
4711136|NCT02157948|16240101|P1|Overall Study|Protocol Specified Criteria|2
4711137|NCT02157948|16240100|P2|Overall Study|Lost to Follow-up|2
4711138|NCT02157948|16240101|P1|Overall Study|Lost to Follow-up|3
4711139|NCT02157948|16240100|P2|Overall Study|Withdrawal by Subject|5
4711140|NCT02157948|16240101|P1|Overall Study|Withdrawal by Subject|4
4711141|NCT02157935|16240113|P2|Overall Study|Adverse Event|5
4711142|NCT02157935|16240114|P1|Overall Study|Adverse Event|3
4711143|NCT02157935|16240113|P2|Overall Study|Death|4
4711144|NCT02157935|16240114|P1|Overall Study|Death|4
4711145|NCT02157935|16240113|P2|Overall Study|Lack of Efficacy|1
4711146|NCT02157935|16240114|P1|Overall Study|Lack of Efficacy|0
4711147|NCT02157935|16240113|P2|Overall Study|Other|12
4711148|NCT02157935|16240114|P1|Overall Study|Other|5
4711149|NCT02157935|16240113|P2|Overall Study|Progressive disease|2
4711150|NCT02157935|16240114|P1|Overall Study|Progressive disease|0
4711151|NCT02157935|16240113|P2|Overall Study|Protocol Violation|0
4711152|NCT02157935|16240114|P1|Overall Study|Protocol Violation|1
4711153|NCT02157935|16240113|P2|Overall Study|Screen failure|2
4711154|NCT02157935|16240114|P1|Overall Study|Screen failure|1
4711155|NCT02157935|16240113|P2|Overall Study|Withdrawal by Subject|39
4711156|NCT02157935|16240114|P1|Overall Study|Withdrawal by Subject|25
4711157|NCT02157883|16240140|P1|Part B: Day 19 to End Part B (AZD9291)|Death|3
4711158|NCT02157883|16240140|P1|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1
4711159|NCT02157883|16240140|P1|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15
4711160|NCT02157883|16240140|P1|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3
4711161|NCT02157883|16240140|P1|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1
4711162|NCT02157779|16240171|P2|Overall Study|Legal issue|0
4711163|NCT02157779|16240172|P1|Overall Study|Legal issue|1
4711164|NCT02157779|16240171|P2|Overall Study|Medical|0
4711165|NCT02157779|16240172|P1|Overall Study|Medical|1
4711166|NCT02157779|16240171|P2|Overall Study|Moved|0
4711167|NCT02157779|16240172|P1|Overall Study|Moved|1
4711168|NCT02157779|16240171|P2|Overall Study|No response to outreach after Baseline|1
4711169|NCT02157779|16240172|P1|Overall Study|No response to outreach after Baseline|1
4711170|NCT02157779|16240171|P2|Overall Study|Stopped attending, reason unknown|7
4711171|NCT02157779|16240172|P1|Overall Study|Stopped attending, reason unknown|11
4711172|NCT02157779|16240171|P2|Overall Study|Logistical|3
4711173|NCT02157779|16240172|P1|Overall Study|Logistical|9
4711174|NCT02157519|16240206|P2|Overall Study|Lost to Follow-up|0
4711175|NCT02157519|16240207|P1|Overall Study|Lost to Follow-up|1
4711176|NCT02157519|16240206|P2|Overall Study|Withdrawal by Subject|0
4711177|NCT02157519|16240207|P1|Overall Study|Withdrawal by Subject|7
4711178|NCT02157519|16240206|P2|Overall Study|Death|1
4711179|NCT02157519|16240207|P1|Overall Study|Death|3
4711180|NCT02157506|16240230|P5|Overall Study|Lost to Follow-up|0
4711181|NCT02157506|16240231|P4|Overall Study|Lost to Follow-up|0
4711182|NCT02157506|16240232|P3|Overall Study|Lost to Follow-up|1
4711183|NCT02157506|16240233|P2|Overall Study|Lost to Follow-up|0
4711184|NCT02157506|16240234|P1|Overall Study|Lost to Follow-up|0
4711185|NCT02157506|16240230|P5|Overall Study|Adverse Event|0
4711186|NCT02157506|16240231|P4|Overall Study|Adverse Event|0
4711187|NCT02157506|16240232|P3|Overall Study|Adverse Event|0
4711188|NCT02157506|16240233|P2|Overall Study|Adverse Event|1
4711189|NCT02157506|16240234|P1|Overall Study|Adverse Event|0
4711190|NCT02157376|16240293|P2|Overall Study|Investigator's misjudgement|2
4711191|NCT02157376|16240294|P1|Overall Study|Investigator's misjudgement|1
4711192|NCT02157376|16240293|P2|Overall Study|Not treated|3
4711193|NCT02157376|16240294|P1|Overall Study|Not treated|8
4711194|NCT02157376|16240293|P2|Overall Study|Withdrawal by Subject|8
4711195|NCT02157376|16240294|P1|Overall Study|Withdrawal by Subject|3
4711196|NCT02157376|16240293|P2|Overall Study|Eligibility criteria not fulfilled|1
4711197|NCT02157376|16240294|P1|Overall Study|Eligibility criteria not fulfilled|0
4711198|NCT02157376|16240293|P2|Overall Study|Death|4
4711199|NCT02157376|16240294|P1|Overall Study|Death|10
4711200|NCT02157298|16240304|P2|Overall Study|Withdrawal by Subject|0
4711201|NCT02157298|16240305|P1|Overall Study|Withdrawal by Subject|1
4711202|NCT02157298|16240304|P2|Overall Study|Poor/Non-compliance|0
4711203|NCT02157298|16240305|P1|Overall Study|Poor/Non-compliance|1
4711204|NCT02157298|16240304|P2|Overall Study|Subject no longer meets study criteria|2
4711205|NCT02157298|16240305|P1|Overall Study|Subject no longer meets study criteria|1
4711206|NCT02157298|16240304|P2|Overall Study|Adverse Event|0
4711207|NCT02157298|16240305|P1|Overall Study|Adverse Event|1
4711208|NCT02157116|16240344|P1|Overall Study|Failed Screening|2
4711209|NCT02157116|16240344|P1|Overall Study|Physician Decision|3
4711210|NCT02157116|16240344|P1|Overall Study|Withdrawal by Subject|4
4711211|NCT02156804|16240370|P1|Overall Study|Withdrawal by Subject|1
4711212|NCT02156492|16240381|P3|Period 3|Adverse Event|0
4711213|NCT02156492|16240382|P2|Period 3|Adverse Event|1
4711214|NCT02156492|16240383|P1|Period 3|Adverse Event|0
4711215|NCT02156492|16240381|P3|Period 1|No Reason Given|0
4711216|NCT02156492|16240382|P2|Period 1|No Reason Given|1
4711217|NCT02156492|16240383|P1|Period 1|No Reason Given|0
4711218|NCT02156466|16240409|P5|Overall Study|Quantiferon Positivity|0
4711219|NCT02156466|16240410|P4|Overall Study|Quantiferon Positivity|1
4711220|NCT02156466|16240411|P3|Overall Study|Quantiferon Positivity|0
4711221|NCT02156466|16240412|P2|Overall Study|Quantiferon Positivity|0
4711222|NCT02156466|16240413|P1|Overall Study|Quantiferon Positivity|0
4711223|NCT02156466|16240409|P5|Overall Study|Adverse Event|0
4711224|NCT02156466|16240410|P4|Overall Study|Adverse Event|1
4711225|NCT02156466|16240411|P3|Overall Study|Adverse Event|1
4711226|NCT02156466|16240412|P2|Overall Study|Adverse Event|0
4711227|NCT02156466|16240413|P1|Overall Study|Adverse Event|0
4711228|NCT02156271|16240594|P2|Overall Study|Physician Decision|3
4711229|NCT02156271|16240595|P1|Overall Study|Physician Decision|4
4711230|NCT02156076|16240648|P4|Follow-up Period|Withdrawal by Subject|0
4711231|NCT02156076|16240649|P3|Follow-up Period|Withdrawal by Subject|0
4711232|NCT02156076|16240650|P2|Follow-up Period|Withdrawal by Subject|0
4711233|NCT02156076|16240651|P1|Follow-up Period|Withdrawal by Subject|1
4711234|NCT02156076|16240648|P4|Treatment Period|Adverse Event|1
4711235|NCT02156076|16240649|P3|Treatment Period|Adverse Event|0
4711236|NCT02156076|16240650|P2|Treatment Period|Adverse Event|0
4711237|NCT02156076|16240651|P1|Treatment Period|Adverse Event|0
4711238|NCT02156076|16240648|P4|Treatment Period|Subject request to discontinue treatment|0
4711239|NCT02156076|16240649|P3|Treatment Period|Subject request to discontinue treatment|0
4711240|NCT02156076|16240650|P2|Treatment Period|Subject request to discontinue treatment|1
4711241|NCT02156076|16240651|P1|Treatment Period|Subject request to discontinue treatment|0
4711242|NCT02156076|16240648|P4|Treatment Period|Withdrawal by Subject|0
4711243|NCT02156076|16240649|P3|Treatment Period|Withdrawal by Subject|1
4711244|NCT02156076|16240650|P2|Treatment Period|Withdrawal by Subject|0
4711245|NCT02156076|16240651|P1|Treatment Period|Withdrawal by Subject|0
4711246|NCT02156076|16240648|P4|Treatment Period|Lost to Follow-up|1
4711247|NCT02156076|16240649|P3|Treatment Period|Lost to Follow-up|0
4711248|NCT02156076|16240650|P2|Treatment Period|Lost to Follow-up|0
4711249|NCT02156076|16240651|P1|Treatment Period|Lost to Follow-up|0
4711250|NCT02156076|16240648|P4|Treatment Period|Poor/non-compliance|0
4711251|NCT02156076|16240649|P3|Treatment Period|Poor/non-compliance|0
4711252|NCT02156076|16240650|P2|Treatment Period|Poor/non-compliance|1
4711253|NCT02156076|16240651|P1|Treatment Period|Poor/non-compliance|0
4711254|NCT02156076|16240648|P4|Treatment Period|no longer meets study criteria|0
4711255|NCT02156076|16240649|P3|Treatment Period|no longer meets study criteria|1
4711256|NCT02156076|16240650|P2|Treatment Period|no longer meets study criteria|0
4711257|NCT02156076|16240651|P1|Treatment Period|no longer meets study criteria|0
4711258|NCT02155985|16240708|P3|Overall Study|Lost to Follow-up|0
4711259|NCT02155985|16240709|P2|Overall Study|Lost to Follow-up|0
4711260|NCT02155985|16240710|P1|Overall Study|Lost to Follow-up|1
4711261|NCT02155985|16240708|P3|Overall Study|Withdrawal by Subject|1
4711262|NCT02155985|16240709|P2|Overall Study|Withdrawal by Subject|0
4711263|NCT02155985|16240710|P1|Overall Study|Withdrawal by Subject|0
4711264|NCT02155881|16240777|P2|Overall Study|Inappropriately randomized|2
4711265|NCT02155881|16240778|P1|Overall Study|Inappropriately randomized|2
4711266|NCT02155881|16240777|P2|Overall Study|Withdrawal by Subject|2
4711267|NCT02155881|16240778|P1|Overall Study|Withdrawal by Subject|0
4711268|NCT02155829|16240800|P2|Overall Study|Protocol Violation|0
4711269|NCT02155829|16240801|P1|Overall Study|Protocol Violation|2
4711270|NCT02155829|16240800|P2|Overall Study|Withdrawal by Subject|3
4711271|NCT02155829|16240801|P1|Overall Study|Withdrawal by Subject|3
4711272|NCT02155829|16240800|P2|Overall Study|Adverse Event|0
4711273|NCT02155829|16240801|P1|Overall Study|Adverse Event|1
4711274|NCT02155738|16240823|P4|Overall Study|Missing critical information|1
4711275|NCT02155738|16240824|P3|Overall Study|Missing critical information|0
4711276|NCT02155738|16240825|P2|Overall Study|Missing critical information|0
4711277|NCT02155738|16240826|P1|Overall Study|Missing critical information|1
4711278|NCT02155712|16240863|P2|Primary Objective|Withdrawal by Subject|0
4711279|NCT02155712|16240864|P1|Primary Objective|Withdrawal by Subject|21
4711280|NCT02155712|16240863|P2|Primary Objective|Revision/Removal of Tibial Baseplate|0
4711281|NCT02155712|16240864|P1|Primary Objective|Revision/Removal of Tibial Baseplate|1
4711282|NCT02155712|16240863|P2|Primary Objective|No 2-Year Forms but not Terminated|0
4711283|NCT02155712|16240864|P1|Primary Objective|No 2-Year Forms but not Terminated|13
4711284|NCT02155712|16240863|P2|Primary Objective|Lost to Follow-up|0
4711285|NCT02155712|16240864|P1|Primary Objective|Lost to Follow-up|22
4711286|NCT02155712|16240863|P2|Primary Objective|Death|0
4711287|NCT02155712|16240864|P1|Primary Objective|Death|3
4711288|NCT02155660|16240874|P4|Overall Study|Withdrawal by Subject|21
4711289|NCT02155660|16240875|P3|Overall Study|Withdrawal by Subject|24
4711290|NCT02155660|16240876|P2|Overall Study|Withdrawal by Subject|31
4711291|NCT02155660|16240877|P1|Overall Study|Withdrawal by Subject|28
4711292|NCT02155660|16240874|P4|Overall Study|Death|19
4711293|NCT02155660|16240875|P3|Overall Study|Death|17
4711294|NCT02155660|16240876|P2|Overall Study|Death|19
4711295|NCT02155660|16240877|P1|Overall Study|Death|17
4711296|NCT02155660|16240874|P4|Overall Study|Lost to Follow-up|8
4711297|NCT02155660|16240875|P3|Overall Study|Lost to Follow-up|5
4711298|NCT02155660|16240876|P2|Overall Study|Lost to Follow-up|6
4711299|NCT02155660|16240877|P1|Overall Study|Lost to Follow-up|3
4711300|NCT02155660|16240874|P4|Overall Study|Adverse Event|1
4711301|NCT02155660|16240875|P3|Overall Study|Adverse Event|3
4711302|NCT02155660|16240876|P2|Overall Study|Adverse Event|6
4711303|NCT02155660|16240877|P1|Overall Study|Adverse Event|2
4711304|NCT02155660|16240874|P4|Overall Study|Severe non-compliance|1
4711305|NCT02155660|16240875|P3|Overall Study|Severe non-compliance|0
4711306|NCT02155660|16240876|P2|Overall Study|Severe non-compliance|4
4711307|NCT02155660|16240877|P1|Overall Study|Severe non-compliance|0
4711308|NCT02155660|16240874|P4|Overall Study|Study-specific withdrawal criteria|1
4711309|NCT02155660|16240875|P3|Overall Study|Study-specific withdrawal criteria|1
4711310|NCT02155660|16240876|P2|Overall Study|Study-specific withdrawal criteria|1
4711311|NCT02155660|16240877|P1|Overall Study|Study-specific withdrawal criteria|0
4711312|NCT02155660|16240874|P4|Overall Study|Other Reason|10
4711313|NCT02155660|16240875|P3|Overall Study|Other Reason|10
4711314|NCT02155660|16240876|P2|Overall Study|Other Reason|6
4711315|NCT02155660|16240877|P1|Overall Study|Other Reason|8
4711316|NCT02155647|16240960|P2|Overall Study|Off-Treatment, but follow up ongoing|26
4711317|NCT02155647|16240961|P1|Overall Study|Off-Treatment, but follow up ongoing|15
4711318|NCT02155647|16240960|P2|Overall Study|Still on Treatment|26
4711319|NCT02155647|16240961|P1|Overall Study|Still on Treatment|26
4711320|NCT02155608|16240989|P2|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
4711321|NCT02155608|16240990|P1|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1
4711322|NCT02155608|16240989|P2|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1
4711323|NCT02155608|16240990|P1|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0
4711324|NCT02155322|16241087|P1|Overall Study|Withdrawal by Subject|4
4711325|NCT02155322|16241087|P1|Overall Study|Relapse/Recurrence|8
4711326|NCT02155322|16241087|P1|Overall Study|Physician Decision|1
4711327|NCT02155322|16241087|P1|Overall Study|Adverse Event|1
4711328|NCT02155309|16241094|P3|Overall Study|Protocol Violation|1
4711329|NCT02155309|16241095|P2|Overall Study|Protocol Violation|0
4711330|NCT02155309|16241096|P1|Overall Study|Protocol Violation|0
4711331|NCT02155283|16241103|P1|Overall Study|Protocol Violation|3
4711332|NCT02155283|16241103|P1|Overall Study|Withdrawal by Subject|1
4711333|NCT02155283|16241103|P1|Overall Study|Lost to Follow-up|3
4711334|NCT02154581|16241279|P2|Overall Study|Lost to Follow-up|8
4711335|NCT02154581|16241280|P1|Overall Study|Lost to Follow-up|7
4711336|NCT02154425|16241305|P1|Screening Period|Adverse Event|1
4711337|NCT02154347|16241350|P2|Open-label Period|Withdrawal by Subject|1
4711338|NCT02154347|16241351|P1|Open-label Period|Withdrawal by Subject|0
4711339|NCT02154347|16241350|P2|Open-label Period|Protocol Violation|1
4711340|NCT02154347|16241351|P1|Open-label Period|Protocol Violation|0
4711341|NCT02154347|16241350|P2|Open-label Period|Lack of Efficacy|19
4711342|NCT02154347|16241351|P1|Open-label Period|Lack of Efficacy|4
4711343|NCT02154347|16241350|P2|Open-label Period|Adverse Event|4
4711344|NCT02154347|16241351|P1|Open-label Period|Adverse Event|3
4711345|NCT02154347|16241350|P2|Double-blind Period|Withdrawal by Subject|1
4711346|NCT02154347|16241351|P1|Double-blind Period|Withdrawal by Subject|1
4711347|NCT02154347|16241350|P2|Double-blind Period|Physician Decision|1
4711348|NCT02154347|16241351|P1|Double-blind Period|Physician Decision|0
4711349|NCT02154347|16241350|P2|Double-blind Period|Lack of Efficacy|0
4711350|NCT02154347|16241351|P1|Double-blind Period|Lack of Efficacy|1
4711351|NCT02154347|16241350|P2|Double-blind Period|Adverse Event|2
4711352|NCT02154347|16241351|P1|Double-blind Period|Adverse Event|1
4711353|NCT02154139|16241374|P1|Overall Study|Investigator transferred|3
4711354|NCT02154139|16241374|P1|Overall Study|Other|2
4711355|NCT02154139|16241374|P1|Overall Study|Injection not administered|2
4711356|NCT02154087|16241382|P1|Overall Study|Study Termination|1
4711357|NCT02154061|16241388|P2|Overall Study|enrolled but not vaccinated|0
4711358|NCT02154061|16241389|P1|Overall Study|enrolled but not vaccinated|1
4711359|NCT02154061|16241388|P2|Overall Study|Pregnancy|0
4711360|NCT02154061|16241389|P1|Overall Study|Pregnancy|1
4711361|NCT02153918|16241436|P1|Overall Study|Refused further treatment|1
4711362|NCT02153905|16241447|P2|Overall Study|Death|0
4711363|NCT02153905|16241448|P1|Overall Study|Death|1
4711364|NCT02153827|16241466|P2|Overall Study|Lost to Follow-up|9
4711365|NCT02153827|16241467|P1|Overall Study|Lost to Follow-up|3
4711366|NCT02153788|16241483|P2|Overall Study|Physician Decision|1
4711367|NCT02153788|16241484|P1|Overall Study|Physician Decision|2
4711368|NCT02153736|16241504|P2|Overall Study|Withdrawal by Subject|1
4711369|NCT02153736|16241505|P1|Overall Study|Withdrawal by Subject|0
4711370|NCT02153736|16241504|P2|Overall Study|Death|1
4711371|NCT02153736|16241505|P1|Overall Study|Death|0
4711372|NCT02153736|16241504|P2|Overall Study|Medical status change made ineligible|0
4711373|NCT02153736|16241505|P1|Overall Study|Medical status change made ineligible|1
4711374|NCT02153736|16241504|P2|Overall Study|Lost to Follow-up|0
4711375|NCT02153736|16241505|P1|Overall Study|Lost to Follow-up|1
4711376|NCT02153398|16241732|P5|Overall Study|Adverse Event|0
4711377|NCT02153398|16241733|P4|Overall Study|Adverse Event|1
4711378|NCT02153398|16241734|P3|Overall Study|Adverse Event|1
4711379|NCT02153398|16241735|P2|Overall Study|Adverse Event|0
4711380|NCT02153398|16241736|P1|Overall Study|Adverse Event|0
4711381|NCT02153398|16241732|P5|Overall Study|Withdrawal by Subject|0
4711382|NCT02153398|16241733|P4|Overall Study|Withdrawal by Subject|0
4711383|NCT02153398|16241734|P3|Overall Study|Withdrawal by Subject|0
4711384|NCT02153398|16241735|P2|Overall Study|Withdrawal by Subject|0
4711385|NCT02153398|16241736|P1|Overall Study|Withdrawal by Subject|1
4711386|NCT02153359|16241858|P2|Intervention 2 (1 Month)|Lost to Follow-up|2
4711387|NCT02153359|16241859|P1|Intervention 2 (1 Month)|Lost to Follow-up|0
4711388|NCT02153346|16241893|P1|Overall Study|Lost to Follow-up|11
4711389|NCT02153112|16241910|P10|Overall Study|Reason not Specified|1
4711390|NCT02153112|16241911|P9|Overall Study|Reason not Specified|1
4711391|NCT02153112|16241912|P8|Overall Study|Reason not Specified|0
4711392|NCT02153112|16241913|P7|Overall Study|Reason not Specified|0
4711393|NCT02153112|16241914|P6|Overall Study|Reason not Specified|0
4711394|NCT02153112|16241915|P5|Overall Study|Reason not Specified|0
4711395|NCT02153112|16241916|P4|Overall Study|Reason not Specified|0
4711396|NCT02153112|16241917|P3|Overall Study|Reason not Specified|0
4711397|NCT02153112|16241918|P2|Overall Study|Reason not Specified|0
4711398|NCT02153112|16241919|P1|Overall Study|Reason not Specified|0
4711399|NCT02153112|16241910|P10|Overall Study|Withdrawal by Subject|12
4711400|NCT02153112|16241911|P9|Overall Study|Withdrawal by Subject|13
4711401|NCT02153112|16241912|P8|Overall Study|Withdrawal by Subject|2
4711402|NCT02153112|16241913|P7|Overall Study|Withdrawal by Subject|7
4711403|NCT02153112|16241914|P6|Overall Study|Withdrawal by Subject|1
4711404|NCT02153112|16241915|P5|Overall Study|Withdrawal by Subject|1
4711405|NCT02153112|16241916|P4|Overall Study|Withdrawal by Subject|2
4711406|NCT02153112|16241917|P3|Overall Study|Withdrawal by Subject|2
4711407|NCT02153112|16241918|P2|Overall Study|Withdrawal by Subject|1
4711408|NCT02153112|16241919|P1|Overall Study|Withdrawal by Subject|3
4711409|NCT02153112|16241910|P10|Overall Study|Lost to Follow-up|1
4711410|NCT02153112|16241911|P9|Overall Study|Lost to Follow-up|1
4711411|NCT02153112|16241912|P8|Overall Study|Lost to Follow-up|0
4711412|NCT02153112|16241913|P7|Overall Study|Lost to Follow-up|1
4711413|NCT02153112|16241914|P6|Overall Study|Lost to Follow-up|1
4711414|NCT02153112|16241915|P5|Overall Study|Lost to Follow-up|2
4711415|NCT02153112|16241916|P4|Overall Study|Lost to Follow-up|0
4711416|NCT02153112|16241917|P3|Overall Study|Lost to Follow-up|0
4711417|NCT02153112|16241918|P2|Overall Study|Lost to Follow-up|1
4711418|NCT02153112|16241919|P1|Overall Study|Lost to Follow-up|1
4711419|NCT02153112|16241910|P10|Overall Study|Adverse Event|0
4711420|NCT02153112|16241911|P9|Overall Study|Adverse Event|0
4711421|NCT02153112|16241912|P8|Overall Study|Adverse Event|0
4711422|NCT02153112|16241913|P7|Overall Study|Adverse Event|0
4711423|NCT02153112|16241914|P6|Overall Study|Adverse Event|0
4711424|NCT02153112|16241915|P5|Overall Study|Adverse Event|0
4711425|NCT02153112|16241916|P4|Overall Study|Adverse Event|0
4711426|NCT02153112|16241917|P3|Overall Study|Adverse Event|1
4711427|NCT02153112|16241918|P2|Overall Study|Adverse Event|0
4711428|NCT02153112|16241919|P1|Overall Study|Adverse Event|0
4711429|NCT02153086|16242258|P1|Overall Study|Other|2
4711430|NCT02153086|16242258|P1|Overall Study|Not enrolled >=28 days and <=56 days|2
4711431|NCT02153073|16242272|P1|Overall Study|Protocol Deviation|68
4711432|NCT02153073|16242272|P1|Overall Study|Case Report Forms Uncollected|230
4711433|NCT02152761|16242300|P4|Epoch: Post-treatment Follow-up Epoch|Death|1
4711434|NCT02152761|16242301|P3|Epoch: Post-treatment Follow-up Epoch|Death|0
4711435|NCT02152761|16242302|P2|Epoch: Post-treatment Follow-up Epoch|Death|0
4711436|NCT02152761|16242303|P1|Epoch: Post-treatment Follow-up Epoch|Death|1
4711437|NCT02152761|16242300|P4|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
4711438|NCT02152761|16242301|P3|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
4711439|NCT02152761|16242302|P2|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0
4711440|NCT02152761|16242303|P1|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1
4711441|NCT02152761|16242300|P4|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
4711442|NCT02152761|16242301|P3|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0
4711443|NCT02152761|16242302|P2|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4
4711444|NCT02152761|16242303|P1|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1
4711445|NCT02152761|16242300|P4|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
4711446|NCT02152761|16242301|P3|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0
4711447|NCT02152761|16242302|P2|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3
4711448|NCT02152761|16242303|P1|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1
4711449|NCT02152761|16242300|P4|Epoch: Treatment Epoch|Non-compliance with treatment|0
4711450|NCT02152761|16242301|P3|Epoch: Treatment Epoch|Non-compliance with treatment|0
4711451|NCT02152761|16242302|P2|Epoch: Treatment Epoch|Non-compliance with treatment|1
4711452|NCT02152761|16242303|P1|Epoch: Treatment Epoch|Non-compliance with treatment|1
4711453|NCT02152761|16242300|P4|Epoch: Treatment Epoch|Death|0
4711454|NCT02152761|16242301|P3|Epoch: Treatment Epoch|Death|1
4711455|NCT02152761|16242302|P2|Epoch: Treatment Epoch|Death|3
4711456|NCT02152761|16242303|P1|Epoch: Treatment Epoch|Death|0
4711457|NCT02152761|16242300|P4|Epoch: Treatment Epoch|Adverse Event|2
4711458|NCT02152761|16242301|P3|Epoch: Treatment Epoch|Adverse Event|1
4711459|NCT02152761|16242302|P2|Epoch: Treatment Epoch|Adverse Event|6
4711460|NCT02152761|16242303|P1|Epoch: Treatment Epoch|Adverse Event|3
4711461|NCT02152761|16242300|P4|Epoch: Treatment Epoch|Withdrawal by Subject|5
4711462|NCT02152761|16242301|P3|Epoch: Treatment Epoch|Withdrawal by Subject|3
4711463|NCT02152761|16242302|P2|Epoch: Treatment Epoch|Withdrawal by Subject|8
4711464|NCT02152761|16242303|P1|Epoch: Treatment Epoch|Withdrawal by Subject|7
4711465|NCT02152761|16242300|P4|Epoch: Treatment Epoch|Lost to Follow-up|0
4711466|NCT02152761|16242301|P3|Epoch: Treatment Epoch|Lost to Follow-up|0
4711467|NCT02152761|16242302|P2|Epoch: Treatment Epoch|Lost to Follow-up|2
4711468|NCT02152761|16242303|P1|Epoch: Treatment Epoch|Lost to Follow-up|0
4711469|NCT02152761|16242300|P4|Epoch: Treatment Epoch|Technical problems|1
4711470|NCT02152761|16242301|P3|Epoch: Treatment Epoch|Technical problems|0
4711471|NCT02152761|16242302|P2|Epoch: Treatment Epoch|Technical problems|0
4711472|NCT02152761|16242303|P1|Epoch: Treatment Epoch|Technical problems|0
4711473|NCT02152631|16242343|P2|Overall Study|On Treatment|3
4711474|NCT02152631|16242344|P1|Overall Study|On Treatment|19
4711475|NCT02152631|16242343|P2|Overall Study|Lost to Follow-up|1
4711476|NCT02152631|16242344|P1|Overall Study|Lost to Follow-up|0
4711477|NCT02152631|16242343|P2|Overall Study|Physician Decision|2
4711478|NCT02152631|16242344|P1|Overall Study|Physician Decision|1
4711479|NCT02152631|16242343|P2|Overall Study|Noncompliance with study drug|0
4711480|NCT02152631|16242344|P1|Overall Study|Noncompliance with study drug|1
4711481|NCT02152631|16242343|P2|Overall Study|Withdrawal by Subject|16
4711482|NCT02152631|16242344|P1|Overall Study|Withdrawal by Subject|13
4711483|NCT02152631|16242343|P2|Overall Study|Adverse Event|4
4711484|NCT02152631|16242344|P1|Overall Study|Adverse Event|32
4711485|NCT02152605|16242363|P2|Overall Study|Withdrew consent|2
4711486|NCT02152605|16242364|P1|Overall Study|Withdrew consent|4
4711487|NCT02152605|16242363|P2|Overall Study|Lost to Follow-up|0
4711488|NCT02152605|16242364|P1|Overall Study|Lost to Follow-up|1
4711489|NCT02152605|16242363|P2|Overall Study|Protocol deviation|4
4711490|NCT02152605|16242364|P1|Overall Study|Protocol deviation|1
4711491|NCT02152605|16242363|P2|Overall Study|Lack of Efficacy|4
4711492|NCT02152605|16242364|P1|Overall Study|Lack of Efficacy|7
4711493|NCT02152605|16242363|P2|Overall Study|Adverse Event|8
4711494|NCT02152605|16242364|P1|Overall Study|Adverse Event|6
4711495|NCT02152566|16242374|P1|Overall Study|Withdrawal by Subject|2
4711496|NCT02152566|16242374|P1|Overall Study|Lost to Follow-up|1
4711497|NCT02152384|16242387|P2|Period 1|Adverse Event|1
4711498|NCT02152384|16242388|P1|Period 1|Adverse Event|1
4711499|NCT02152384|16242387|P2|Period 1|Withdrawal by Subject|1
4711500|NCT02152384|16242388|P1|Period 1|Withdrawal by Subject|0
4711501|NCT02152371|16242408|P2|Overall Study|Reason Not Given|1
4711502|NCT02152371|16242409|P1|Overall Study|Reason Not Given|0
4711503|NCT02152371|16242408|P2|Overall Study|Physician Decision|2
4711504|NCT02152371|16242409|P1|Overall Study|Physician Decision|0
4711505|NCT02152371|16242408|P2|Overall Study|Lack of Efficacy|1
4711506|NCT02152371|16242409|P1|Overall Study|Lack of Efficacy|0
4711507|NCT02152371|16242408|P2|Overall Study|Lost to Follow-up|0
4711508|NCT02152371|16242409|P1|Overall Study|Lost to Follow-up|1
4711509|NCT02152371|16242408|P2|Overall Study|Protocol Violation|3
4711510|NCT02152371|16242409|P1|Overall Study|Protocol Violation|2
4711511|NCT02152371|16242408|P2|Overall Study|Withdrawal by Subject|7
4711512|NCT02152371|16242409|P1|Overall Study|Withdrawal by Subject|3
4711513|NCT02152371|16242408|P2|Overall Study|Adverse Event|2
4711514|NCT02152371|16242409|P1|Overall Study|Adverse Event|6
4711515|NCT02152345|16242447|P2|Overall Study|Withdrawal by Subject|1
4711516|NCT02152345|16242448|P1|Overall Study|Withdrawal by Subject|2
4711517|NCT02152345|16242447|P2|Overall Study|Case Cancellations|4
4711518|NCT02152345|16242448|P1|Overall Study|Case Cancellations|2
4711519|NCT02152137|16242460|P1|Overall Study|Originally assigned to Arm B|3
4711520|NCT02152137|16242460|P1|Overall Study|Withdrawal by Subject|1
4711521|NCT02152007|16242468|P1|Overall Study|Withdrawal by Subject|1
4711522|NCT02151981|16242529|P2|Overall Study|Eligibility criteria not fulfilled|1
4711523|NCT02151981|16242530|P1|Overall Study|Eligibility criteria not fulfilled|0
4711524|NCT02151981|16242529|P2|Overall Study|Ongoing Study at Data Cut-off|95
4711525|NCT02151981|16242530|P1|Overall Study|Ongoing Study at Data Cut-off|224
4711526|NCT02151981|16242529|P2|Overall Study|Withdrawal by Subject|18
4711527|NCT02151981|16242530|P1|Overall Study|Withdrawal by Subject|19
4711528|NCT02151981|16242529|P2|Overall Study|Lost to Follow-up|0
4711529|NCT02151981|16242530|P1|Overall Study|Lost to Follow-up|1
4711530|NCT02151981|16242529|P2|Overall Study|Death|26
4711531|NCT02151981|16242530|P1|Overall Study|Death|35
4711532|NCT02151851|16242567|P2|Overall Study|Adverse Event|28
4711533|NCT02151851|16242568|P1|Overall Study|Adverse Event|6
4711534|NCT02151851|16242567|P2|Overall Study|Subject entered into study in error|1
4711535|NCT02151851|16242568|P1|Overall Study|Subject entered into study in error|0
4711536|NCT02151851|16242567|P2|Overall Study|Low compliance to study visits|1
4711537|NCT02151851|16242568|P1|Overall Study|Low compliance to study visits|0
4711538|NCT02151851|16242567|P2|Overall Study|Medical impairment|0
4711539|NCT02151851|16242568|P1|Overall Study|Medical impairment|1
4711540|NCT02151851|16242567|P2|Overall Study|Withdrawal by Subject|5
4711541|NCT02151851|16242568|P1|Overall Study|Withdrawal by Subject|2
4711542|NCT02151851|16242567|P2|Overall Study|Protocol Violation|1
4711543|NCT02151851|16242568|P1|Overall Study|Protocol Violation|0
4711544|NCT02151851|16242567|P2|Overall Study|Lack of Efficacy|94
4711545|NCT02151851|16242568|P1|Overall Study|Lack of Efficacy|67
4711546|NCT02151786|16242580|P1|Overall Study|Unavailability of Information|8
4711547|NCT02151786|16242580|P1|Overall Study|Randomized, not Treated|1
4711548|NCT02151786|16242580|P1|Overall Study|Outside the Contract Period|1
4711549|NCT02151786|16242580|P1|Overall Study|Unavailability of Case Report Form|26
4711550|NCT02151773|16242591|P1|Overall Study|Protocol Deviation|64
4711551|NCT02151682|16242598|P6|Part 2: Observ. Aft. Tapent. Extension|Various other|2
4711552|NCT02151682|16242599|P5|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4711553|NCT02151682|16242600|P4|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4711554|NCT02151682|16242601|P3|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4711555|NCT02151682|16242602|P2|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4711556|NCT02151682|16242603|P1|Part 2: Observ. Aft. Tapent. Extension|Various other|0
4711557|NCT02151682|16242598|P6|Part 2: Observ. Aft. Tapent. Extension|Missing|3
4711558|NCT02151682|16242599|P5|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4711559|NCT02151682|16242600|P4|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4711560|NCT02151682|16242601|P3|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4711561|NCT02151682|16242602|P2|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4711562|NCT02151682|16242603|P1|Part 2: Observ. Aft. Tapent. Extension|Missing|0
4711563|NCT02151682|16242598|P6|Part 2: Observ. Aft. Tapent. Extension|Death|1
4711564|NCT02151682|16242599|P5|Part 2: Observ. Aft. Tapent. Extension|Death|0
4711565|NCT02151682|16242600|P4|Part 2: Observ. Aft. Tapent. Extension|Death|0
4711566|NCT02151682|16242601|P3|Part 2: Observ. Aft. Tapent. Extension|Death|0
4711567|NCT02151682|16242602|P2|Part 2: Observ. Aft. Tapent. Extension|Death|0
4711568|NCT02151682|16242603|P1|Part 2: Observ. Aft. Tapent. Extension|Death|0
4711569|NCT02151682|16242598|P6|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1
4711570|NCT02151682|16242599|P5|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4711571|NCT02151682|16242600|P4|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4711572|NCT02151682|16242601|P3|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4711573|NCT02151682|16242602|P2|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4711574|NCT02151682|16242603|P1|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0
4711575|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4711576|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4711577|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4711578|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1
4711579|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4711580|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0
4711581|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Various other|0
4711582|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Various other|0
4711583|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Various other|0
4711584|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Various other|6
4711585|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Various other|0
4711586|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Various other|0
4711587|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Missing|0
4711588|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Missing|0
4711589|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Missing|1
4711590|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Missing|0
4711591|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Missing|0
4711592|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Missing|0
4711593|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|No need for opioid|0
4711594|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|No need for opioid|0
4711595|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|No need for opioid|0
4711596|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|No need for opioid|13
4711597|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|No need for opioid|0
4711598|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|No need for opioid|0
4711599|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4711600|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4711601|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4711602|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Protocol Violation|1
4711603|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4711604|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Protocol Violation|0
4711605|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4711606|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4711607|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4711608|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3
4711609|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4711610|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0
4711611|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4711612|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4711613|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
4711614|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1
4711615|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4711616|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0
4711617|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Death|0
4711618|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Death|0
4711619|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Death|2
4711620|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Death|0
4711621|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Death|0
4711622|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Death|0
4711623|NCT02151682|16242598|P6|Part 2: Tapent. Extension or Observation|Adverse Event|0
4711624|NCT02151682|16242599|P5|Part 2: Tapent. Extension or Observation|Adverse Event|0
4711625|NCT02151682|16242600|P4|Part 2: Tapent. Extension or Observation|Adverse Event|0
4711626|NCT02151682|16242601|P3|Part 2: Tapent. Extension or Observation|Adverse Event|3
4711627|NCT02151682|16242602|P2|Part 2: Tapent. Extension or Observation|Adverse Event|0
4711628|NCT02151682|16242603|P1|Part 2: Tapent. Extension or Observation|Adverse Event|0
4711629|NCT02151682|16242598|P6|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4711630|NCT02151682|16242599|P5|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4711631|NCT02151682|16242600|P4|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4711632|NCT02151682|16242601|P3|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4711633|NCT02151682|16242602|P2|Part 1: 14 Days Morphine or Tapentadol|Missing|0
4711634|NCT02151682|16242603|P1|Part 1: 14 Days Morphine or Tapentadol|Missing|1
4711635|NCT02151682|16242598|P6|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4711636|NCT02151682|16242599|P5|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4711637|NCT02151682|16242600|P4|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4711638|NCT02151682|16242601|P3|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0
4711639|NCT02151682|16242602|P2|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
4711640|NCT02151682|16242603|P1|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1
4711641|NCT02151682|16242598|P6|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4711642|NCT02151682|16242599|P5|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4711643|NCT02151682|16242600|P4|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4711644|NCT02151682|16242601|P3|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4711645|NCT02151682|16242602|P2|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1
4711646|NCT02151682|16242603|P1|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0
4711647|NCT02151682|16242598|P6|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4711648|NCT02151682|16242599|P5|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4711649|NCT02151682|16242600|P4|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4711650|NCT02151682|16242601|P3|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4711651|NCT02151682|16242602|P2|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1
4711652|NCT02151682|16242603|P1|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0
4711653|NCT02151682|16242598|P6|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4711654|NCT02151682|16242599|P5|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4711655|NCT02151682|16242600|P4|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4711656|NCT02151682|16242601|P3|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4711657|NCT02151682|16242602|P2|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2
4711658|NCT02151682|16242603|P1|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0
4711659|NCT02151643|16242653|P5|Overall Study|High Ferritin levels|1
4711660|NCT02151643|16242654|P4|Overall Study|High Ferritin levels|2
4711661|NCT02151643|16242655|P3|Overall Study|High Ferritin levels|2
4711662|NCT02151643|16242656|P2|Overall Study|High Ferritin levels|3
4711663|NCT02151643|16242657|P1|Overall Study|High Ferritin levels|3
4711664|NCT02151643|16242653|P5|Overall Study|Hyperphosphataemia|1
4711665|NCT02151643|16242654|P4|Overall Study|Hyperphosphataemia|0
4711666|NCT02151643|16242655|P3|Overall Study|Hyperphosphataemia|0
4711667|NCT02151643|16242656|P2|Overall Study|Hyperphosphataemia|0
4711668|NCT02151643|16242657|P1|Overall Study|Hyperphosphataemia|1
4711669|NCT02151643|16242653|P5|Overall Study|Withdrawal by Subject|1
4711670|NCT02151643|16242654|P4|Overall Study|Withdrawal by Subject|1
4711671|NCT02151643|16242655|P3|Overall Study|Withdrawal by Subject|1
4711672|NCT02151643|16242656|P2|Overall Study|Withdrawal by Subject|1
4711673|NCT02151643|16242657|P1|Overall Study|Withdrawal by Subject|0
4711674|NCT02151643|16242653|P5|Overall Study|Adverse Event|0
4711675|NCT02151643|16242654|P4|Overall Study|Adverse Event|4
4711676|NCT02151643|16242655|P3|Overall Study|Adverse Event|1
4711677|NCT02151643|16242656|P2|Overall Study|Adverse Event|0
4711678|NCT02151643|16242657|P1|Overall Study|Adverse Event|2
4711679|NCT02151591|16242696|P2|Overall Study|Lost to Follow-up|3
4711680|NCT02151591|16242697|P1|Overall Study|Lost to Follow-up|6
4711681|NCT02151461|16242768|P4|Overall Study|Treatment discontinuation|0
4711682|NCT02151461|16242769|P3|Overall Study|Treatment discontinuation|1
4711683|NCT02151461|16242770|P2|Overall Study|Treatment discontinuation|0
4711684|NCT02151461|16242771|P1|Overall Study|Treatment discontinuation|0
4711685|NCT02151461|16242768|P4|Overall Study|Withdrawal by Subject|1
4711686|NCT02151461|16242769|P3|Overall Study|Withdrawal by Subject|1
4711687|NCT02151461|16242770|P2|Overall Study|Withdrawal by Subject|0
4711688|NCT02151461|16242771|P1|Overall Study|Withdrawal by Subject|1
4711689|NCT02151461|16242768|P4|Overall Study|Lost to Follow-up|1
4711690|NCT02151461|16242769|P3|Overall Study|Lost to Follow-up|1
4711691|NCT02151461|16242770|P2|Overall Study|Lost to Follow-up|0
4711692|NCT02151461|16242771|P1|Overall Study|Lost to Follow-up|0
4711693|NCT02151461|16242768|P4|Overall Study|Adverse Event|2
4711694|NCT02151461|16242769|P3|Overall Study|Adverse Event|0
4711695|NCT02151461|16242770|P2|Overall Study|Adverse Event|1
4711696|NCT02151461|16242771|P1|Overall Study|Adverse Event|5
4711697|NCT02151266|16242903|P3|Overall Study|Not able to exercise|4
4711698|NCT02151266|16242904|P2|Overall Study|Not able to exercise|5
4711699|NCT02151266|16242905|P1|Overall Study|Not able to exercise|4
4711700|NCT02151266|16242903|P3|Overall Study|Did NOT receive intervention|2
4711701|NCT02151266|16242904|P2|Overall Study|Did NOT receive intervention|6
4711702|NCT02151266|16242905|P1|Overall Study|Did NOT receive intervention|3
4711703|NCT02151266|16242903|P3|Overall Study|Lost to Follow-up|1
4711704|NCT02151266|16242904|P2|Overall Study|Lost to Follow-up|4
4711705|NCT02151266|16242905|P1|Overall Study|Lost to Follow-up|1
4711706|NCT02151149|16242948|P2|Follow-Up Period|Death|34
4711707|NCT02151149|16242949|P1|Follow-Up Period|Death|37
4711708|NCT02151149|16242948|P2|Follow-Up Period|Lost to Follow-up|3
4711709|NCT02151149|16242949|P1|Follow-Up Period|Lost to Follow-up|2
4711710|NCT02151149|16242948|P2|Treatment Period|Participants randomized but not treated|2
4711711|NCT02151149|16242949|P1|Treatment Period|Participants randomized but not treated|3
4711712|NCT02151149|16242948|P2|Treatment Period|Miscellaneous|7
4711713|NCT02151149|16242949|P1|Treatment Period|Miscellaneous|8
4711714|NCT02151149|16242948|P2|Treatment Period|Withdrawal by Subject|11
4711715|NCT02151149|16242949|P1|Treatment Period|Withdrawal by Subject|13
4711716|NCT02151149|16242948|P2|Treatment Period|Symptomatic Deterioration|10
4711717|NCT02151149|16242949|P1|Treatment Period|Symptomatic Deterioration|2
4711718|NCT02151149|16242948|P2|Treatment Period|Progressive Disease|24
4711719|NCT02151149|16242949|P1|Treatment Period|Progressive Disease|25
4711720|NCT02151149|16242948|P2|Treatment Period|Adverse Event|14
4711721|NCT02151149|16242949|P1|Treatment Period|Adverse Event|17
4711722|NCT02151149|16242948|P2|Treatment Period|Death|3
4711723|NCT02151149|16242949|P1|Treatment Period|Death|2
4711724|NCT02151110|16242981|P8|Overall Study|Lost to Follow-up|2
4711725|NCT02151110|16242982|P7|Overall Study|Lost to Follow-up|0
4711726|NCT02151110|16242983|P6|Overall Study|Lost to Follow-up|0
4711727|NCT02151110|16242984|P5|Overall Study|Lost to Follow-up|0
4711728|NCT02151110|16242985|P4|Overall Study|Lost to Follow-up|0
4711729|NCT02151110|16242986|P3|Overall Study|Lost to Follow-up|0
4711730|NCT02151110|16242987|P2|Overall Study|Lost to Follow-up|0
4711731|NCT02151110|16242988|P1|Overall Study|Lost to Follow-up|0
4711732|NCT02151110|16242981|P8|Overall Study|Withdrawal by Subject|1
4711733|NCT02151110|16242982|P7|Overall Study|Withdrawal by Subject|0
4711734|NCT02151110|16242983|P6|Overall Study|Withdrawal by Subject|0
4711735|NCT02151110|16242984|P5|Overall Study|Withdrawal by Subject|0
4711736|NCT02151110|16242985|P4|Overall Study|Withdrawal by Subject|0
4711737|NCT02151110|16242986|P3|Overall Study|Withdrawal by Subject|0
4711738|NCT02151110|16242987|P2|Overall Study|Withdrawal by Subject|0
4711739|NCT02151110|16242988|P1|Overall Study|Withdrawal by Subject|0
4711740|NCT02151058|16243081|P3|Overall Study|Lost to Follow-up|2
4711741|NCT02151058|16243082|P2|Overall Study|Lost to Follow-up|0
4711742|NCT02151058|16243083|P1|Overall Study|Lost to Follow-up|1
4711743|NCT02151058|16243081|P3|Overall Study|Withdrawal by Subject|3
4711744|NCT02151058|16243082|P2|Overall Study|Withdrawal by Subject|1
4711745|NCT02151058|16243083|P1|Overall Study|Withdrawal by Subject|1
4711746|NCT02150954|16243117|P2|Overall Study|Protocol Violation|0
4711747|NCT02150954|16243118|P1|Overall Study|Protocol Violation|1
4711748|NCT02150863|16243143|P3|Overall Study|Lost to Follow-up|0
4711749|NCT02150863|16243144|P2|Overall Study|Lost to Follow-up|1
4711750|NCT02150863|16243145|P1|Overall Study|Lost to Follow-up|0
4711751|NCT02150343|16243391|P4|Overall Study|Other|2
4711752|NCT02150343|16243392|P3|Overall Study|Other|0
4711753|NCT02150343|16243393|P2|Overall Study|Other|6
4711754|NCT02150343|16243394|P1|Overall Study|Other|2
4711755|NCT02150343|16243391|P4|Overall Study|Lost to Follow-up|3
4711756|NCT02150343|16243392|P3|Overall Study|Lost to Follow-up|2
4711757|NCT02150343|16243393|P2|Overall Study|Lost to Follow-up|4
4711758|NCT02150343|16243394|P1|Overall Study|Lost to Follow-up|4
4711759|NCT02150343|16243391|P4|Overall Study|Withdrawal by Subject|4
4711760|NCT02150343|16243392|P3|Overall Study|Withdrawal by Subject|9
4711761|NCT02150343|16243393|P2|Overall Study|Withdrawal by Subject|10
4711762|NCT02150343|16243394|P1|Overall Study|Withdrawal by Subject|13
4711763|NCT02150343|16243391|P4|Overall Study|Adverse Event|1
4711764|NCT02150343|16243392|P3|Overall Study|Adverse Event|1
4711765|NCT02150343|16243393|P2|Overall Study|Adverse Event|0
4711766|NCT02150343|16243394|P1|Overall Study|Adverse Event|2
4711767|NCT02150213|16243432|P1|Overall Study|Withdrawal by Subject|1
4711768|NCT02150213|16243432|P1|Overall Study|Lost to Follow-up|1
4711769|NCT02150057|16243451|P2|Overall Study|Lost to Follow-up|4
4711770|NCT02150057|16243452|P1|Overall Study|Lost to Follow-up|6
4711771|NCT02149875|16243467|P3|Overall Study|Physician Decision|2
4711772|NCT02149875|16243468|P2|Overall Study|Physician Decision|2
4711773|NCT02149875|16243469|P1|Overall Study|Physician Decision|1
4711774|NCT02149875|16243467|P3|Overall Study|Withdrawal by Subject|2
4711775|NCT02149875|16243468|P2|Overall Study|Withdrawal by Subject|2
4711776|NCT02149875|16243469|P1|Overall Study|Withdrawal by Subject|3
4711777|NCT02149875|16243467|P3|Overall Study|Lost to Follow-up|5
4711778|NCT02149875|16243468|P2|Overall Study|Lost to Follow-up|4
4711779|NCT02149875|16243469|P1|Overall Study|Lost to Follow-up|3
4711780|NCT02149836|16243480|P1|Overall Study|Withdrawal by Subject|1
4711781|NCT02149420|16243507|P3|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
4711782|NCT02149420|16243508|P2|Open Label VAY736 10 mg/kg Extension|Administrative problems|0
4711783|NCT02149420|16243509|P1|Open Label VAY736 10 mg/kg Extension|Administrative problems|1
4711784|NCT02149420|16243507|P3|Core Study|Administrative problems|2
4711785|NCT02149420|16243508|P2|Core Study|Administrative problems|1
4711786|NCT02149420|16243509|P1|Core Study|Administrative problems|0
4711787|NCT02149264|16243585|P1|Overall Study|Protocol Violation|1
4711788|NCT02149264|16243585|P1|Overall Study|Physician Decision|3
4711789|NCT02149264|16243585|P1|Overall Study|Adverse Event|7
4711790|NCT02149264|16243585|P1|Overall Study|Withdrawal by Subject|9
4711791|NCT02149199|16243601|P3|Overall Study|Adverse Event|9
4711792|NCT02149199|16243602|P2|Overall Study|Adverse Event|15
4711793|NCT02149199|16243603|P1|Overall Study|Adverse Event|6
4711794|NCT02149199|16243601|P3|Overall Study|Death|1
4711795|NCT02149199|16243602|P2|Overall Study|Death|0
4711796|NCT02149199|16243603|P1|Overall Study|Death|0
4711797|NCT02149199|16243601|P3|Overall Study|Lost to Follow-up|11
4711798|NCT02149199|16243602|P2|Overall Study|Lost to Follow-up|12
4711799|NCT02149199|16243603|P1|Overall Study|Lost to Follow-up|3
4711800|NCT02149199|16243601|P3|Overall Study|Protocol Violation|15
4711801|NCT02149199|16243602|P2|Overall Study|Protocol Violation|13
4711802|NCT02149199|16243603|P1|Overall Study|Protocol Violation|16
4711803|NCT02149199|16243601|P3|Overall Study|Withdrawal by Subject|77
4711804|NCT02149199|16243602|P2|Overall Study|Withdrawal by Subject|93
4711805|NCT02149199|16243603|P1|Overall Study|Withdrawal by Subject|75
4711806|NCT02149199|16243601|P3|Overall Study|Eligibility criteria not fulfilled|8
4711807|NCT02149199|16243602|P2|Overall Study|Eligibility criteria not fulfilled|14
4711808|NCT02149199|16243603|P1|Overall Study|Eligibility criteria not fulfilled|9
4711809|NCT02149199|16243601|P3|Overall Study|Other|20
4711810|NCT02149199|16243602|P2|Overall Study|Other|25
4711811|NCT02149199|16243603|P1|Overall Study|Other|20
4711812|NCT02149199|16243601|P3|Overall Study|Study specific withdrawal criteria|6
4711813|NCT02149199|16243602|P2|Overall Study|Study specific withdrawal criteria|21
4711814|NCT02149199|16243603|P1|Overall Study|Study specific withdrawal criteria|4
4711815|NCT02149108|16243682|P2|Overall Study|Lost to Follow-up|0
4711816|NCT02149108|16243683|P1|Overall Study|Lost to Follow-up|1
4711817|NCT02149108|16243682|P2|Overall Study|Refusal to continue trial medication|11
4711818|NCT02149108|16243683|P1|Overall Study|Refusal to continue trial medication|15
4711819|NCT02149108|16243682|P2|Overall Study|Other not defined above|2
4711820|NCT02149108|16243683|P1|Overall Study|Other not defined above|0
4711821|NCT02149108|16243682|P2|Overall Study|Other Adverse Event (AE)|18
4711822|NCT02149108|16243683|P1|Overall Study|Other Adverse Event (AE)|8
4711823|NCT02149108|16243682|P2|Overall Study|Worsening/adverse event cancer disease|32
4711824|NCT02149108|16243683|P1|Overall Study|Worsening/adverse event cancer disease|31
4711825|NCT02149108|16243682|P2|Overall Study|Progressive Disease (PD)|318
4711826|NCT02149108|16243683|P1|Overall Study|Progressive Disease (PD)|324
4711827|NCT02149108|16243682|P2|Overall Study|Not treated|2
4711828|NCT02149108|16243683|P1|Overall Study|Not treated|1
4711829|NCT02148952|16243697|P2|Follow-Up|Withdrawal by Subject|48
4711830|NCT02148952|16243698|P1|Follow-Up|Withdrawal by Subject|46
4711831|NCT02148952|16243697|P2|Follow-Up|Lost to Follow-up|231
4711832|NCT02148952|16243698|P1|Follow-Up|Lost to Follow-up|219
4711833|NCT02148952|16243697|P2|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556
4711834|NCT02148952|16243698|P1|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862
4711835|NCT02148952|16243697|P2|Assessing Eligibility and Consent|Were not eligible for inclusion|1591
4711836|NCT02148952|16243698|P1|Assessing Eligibility and Consent|Were not eligible for inclusion|1241
4711837|NCT02148718|16243781|P1|Overall Study|Discontinued Study Prematurely|5
4711838|NCT02148718|16243781|P1|Overall Study|Protocol Violation|26
4711839|NCT02148445|16243829|P2|Overall Study|Death|3
4711840|NCT02148445|16243830|P1|Overall Study|Death|1
4711841|NCT02148250|16243881|P2|Screening|Withdrawal by Subject|0
4711842|NCT02148250|16243882|P1|Screening|Withdrawal by Subject|5
4711843|NCT02148211|16243896|P1|Overall Study|Lost to Follow-up|352
4711844|NCT02148133|16243905|P1|Overall Study|Protocol-defined stopping criteria|2
4711845|NCT02148133|16243905|P1|Overall Study|Protocol deviation|1
4711846|NCT02148133|16243905|P1|Overall Study|Lack of Efficacy|1
4711847|NCT02148133|16243905|P1|Overall Study|Investigator discretion|1
4711848|NCT02147691|16244048|P2|Overall Study|Lost to Follow-up|1
4711849|NCT02147691|16244049|P1|Overall Study|Lost to Follow-up|0
4711850|NCT02147691|16244048|P2|Overall Study|Adverse Event|0
4711851|NCT02147691|16244049|P1|Overall Study|Adverse Event|2
4711852|NCT02147691|16244048|P2|Overall Study|Withdrawal by Subject|0
4711853|NCT02147691|16244049|P1|Overall Study|Withdrawal by Subject|2
4711854|NCT02147587|16244108|P2|Overall Study|Lack of Efficacy|1
4711855|NCT02147587|16244109|P1|Overall Study|Lack of Efficacy|2
4711856|NCT02147587|16244108|P2|Overall Study|Adverse Event|4
4711857|NCT02147587|16244109|P1|Overall Study|Adverse Event|9
4711858|NCT02147561|16244129|P1|Overall Study|Subjects who didn't receive BOTOX|1
4711859|NCT02147561|16244129|P1|Overall Study|Lost to Follow-up|3
4711860|NCT02147353|16244150|P2|Overall Study|medication noncompliance|0
4711861|NCT02147353|16244151|P1|Overall Study|medication noncompliance|3
4711862|NCT02147353|16244150|P2|Overall Study|unable to make visits|0
4711863|NCT02147353|16244151|P1|Overall Study|unable to make visits|4
4711864|NCT02147353|16244150|P2|Overall Study|Lost to Follow-up|0
4711865|NCT02147353|16244151|P1|Overall Study|Lost to Follow-up|2
4711866|NCT02147288|16244184|P10|Overall Study|complications from concurrent hernia rep|0
4711867|NCT02147288|16244185|P9|Overall Study|complications from concurrent hernia rep|0
4711868|NCT02147288|16244186|P8|Overall Study|complications from concurrent hernia rep|0
4711869|NCT02147288|16244187|P7|Overall Study|complications from concurrent hernia rep|0
4711870|NCT02147288|16244188|P6|Overall Study|complications from concurrent hernia rep|0
4711871|NCT02147288|16244189|P5|Overall Study|complications from concurrent hernia rep|0
4711872|NCT02147288|16244190|P4|Overall Study|complications from concurrent hernia rep|0
4711873|NCT02147288|16244191|P3|Overall Study|complications from concurrent hernia rep|0
4711874|NCT02147288|16244192|P2|Overall Study|complications from concurrent hernia rep|1
4711875|NCT02147288|16244193|P1|Overall Study|complications from concurrent hernia rep|0
4711876|NCT02147288|16244184|P10|Overall Study|post-operative hematoma|0
4711877|NCT02147288|16244185|P9|Overall Study|post-operative hematoma|0
4711878|NCT02147288|16244186|P8|Overall Study|post-operative hematoma|0
4711879|NCT02147288|16244187|P7|Overall Study|post-operative hematoma|0
4711880|NCT02147288|16244188|P6|Overall Study|post-operative hematoma|0
4711881|NCT02147288|16244189|P5|Overall Study|post-operative hematoma|0
4711882|NCT02147288|16244190|P4|Overall Study|post-operative hematoma|0
4711883|NCT02147288|16244191|P3|Overall Study|post-operative hematoma|0
4711884|NCT02147288|16244192|P2|Overall Study|post-operative hematoma|1
4711885|NCT02147288|16244193|P1|Overall Study|post-operative hematoma|1
4711886|NCT02147197|16244202|P3|Overall Study|Other Miscellaneous Reasons|3
4711887|NCT02147197|16244203|P2|Overall Study|Other Miscellaneous Reasons|0
4711888|NCT02147197|16244204|P1|Overall Study|Other Miscellaneous Reasons|1
4711889|NCT02147197|16244202|P3|Overall Study|Protocol Violation|3
4711890|NCT02147197|16244203|P2|Overall Study|Protocol Violation|0
4711891|NCT02147197|16244204|P1|Overall Study|Protocol Violation|1
4711892|NCT02147197|16244202|P3|Overall Study|Lost to Follow-up|1
4711893|NCT02147197|16244203|P2|Overall Study|Lost to Follow-up|3
4711894|NCT02147197|16244204|P1|Overall Study|Lost to Follow-up|2
4711895|NCT02147197|16244202|P3|Overall Study|Withdrawal of Consent|2
4711896|NCT02147197|16244203|P2|Overall Study|Withdrawal of Consent|3
4711897|NCT02147197|16244204|P1|Overall Study|Withdrawal of Consent|4
4711898|NCT02147197|16244202|P3|Overall Study|Adverse Event|0
4711899|NCT02147197|16244203|P2|Overall Study|Adverse Event|0
4711900|NCT02147197|16244204|P1|Overall Study|Adverse Event|1
4711901|NCT02147184|16244223|P2|Overall Study|Other|0
4711902|NCT02147184|16244224|P1|Overall Study|Other|1
4711903|NCT02147184|16244223|P2|Overall Study|Physician Decision|2
4711904|NCT02147184|16244224|P1|Overall Study|Physician Decision|0
4711905|NCT02147184|16244223|P2|Overall Study|Moved out of state|3
4711906|NCT02147184|16244224|P1|Overall Study|Moved out of state|3
4711907|NCT02147184|16244223|P2|Overall Study|Pregnancy|0
4711908|NCT02147184|16244224|P1|Overall Study|Pregnancy|6
4711909|NCT02147184|16244223|P2|Overall Study|Study Burden|7
4711910|NCT02147184|16244224|P1|Overall Study|Study Burden|11
4711911|NCT02147184|16244223|P2|Overall Study|Lost to Follow-up|15
4711912|NCT02147184|16244224|P1|Overall Study|Lost to Follow-up|28
4711913|NCT02147158|16244248|P6|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
4711914|NCT02147158|16244249|P5|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
4711915|NCT02147158|16244250|P4|Off-Treatment Interval 2|Other Miscellaneous Reasons|4
4711916|NCT02147158|16244251|P3|Off-Treatment Interval 2|Other Miscellaneous Reasons|1
4711917|NCT02147158|16244252|P2|Off-Treatment Interval 2|Other Miscellaneous Reasons|3
4711918|NCT02147158|16244253|P1|Off-Treatment Interval 2|Other Miscellaneous Reasons|0
4711919|NCT02147158|16244248|P6|Off-Treatment Interval 2|Protocol Violation|0
4711920|NCT02147158|16244249|P5|Off-Treatment Interval 2|Protocol Violation|0
4711921|NCT02147158|16244250|P4|Off-Treatment Interval 2|Protocol Violation|1
4711922|NCT02147158|16244251|P3|Off-Treatment Interval 2|Protocol Violation|0
4711923|NCT02147158|16244252|P2|Off-Treatment Interval 2|Protocol Violation|0
4711924|NCT02147158|16244253|P1|Off-Treatment Interval 2|Protocol Violation|0
4711925|NCT02147158|16244248|P6|Off-Treatment Interval 2|Lost to Follow-up|2
4711926|NCT02147158|16244249|P5|Off-Treatment Interval 2|Lost to Follow-up|2
4711927|NCT02147158|16244250|P4|Off-Treatment Interval 2|Lost to Follow-up|2
4711928|NCT02147158|16244251|P3|Off-Treatment Interval 2|Lost to Follow-up|3
4711929|NCT02147158|16244252|P2|Off-Treatment Interval 2|Lost to Follow-up|0
4711930|NCT02147158|16244253|P1|Off-Treatment Interval 2|Lost to Follow-up|0
4711931|NCT02147158|16244248|P6|Off-Treatment Interval 2|Withdrawal of Consent|1
4711932|NCT02147158|16244249|P5|Off-Treatment Interval 2|Withdrawal of Consent|0
4711933|NCT02147158|16244250|P4|Off-Treatment Interval 2|Withdrawal of Consent|4
4711934|NCT02147158|16244251|P3|Off-Treatment Interval 2|Withdrawal of Consent|5
4711935|NCT02147158|16244252|P2|Off-Treatment Interval 2|Withdrawal of Consent|0
4711936|NCT02147158|16244253|P1|Off-Treatment Interval 2|Withdrawal of Consent|4
4711937|NCT02147158|16244248|P6|Off-Treatment Interval 2|Lack of Efficacy|0
4711938|NCT02147158|16244249|P5|Off-Treatment Interval 2|Lack of Efficacy|0
4711939|NCT02147158|16244250|P4|Off-Treatment Interval 2|Lack of Efficacy|0
4711940|NCT02147158|16244251|P3|Off-Treatment Interval 2|Lack of Efficacy|1
4711941|NCT02147158|16244252|P2|Off-Treatment Interval 2|Lack of Efficacy|1
4711942|NCT02147158|16244253|P1|Off-Treatment Interval 2|Lack of Efficacy|0
4711943|NCT02147158|16244248|P6|Treatment Course 2|Lost to Follow-up|1
4711944|NCT02147158|16244249|P5|Treatment Course 2|Lost to Follow-up|0
4711945|NCT02147158|16244250|P4|Treatment Course 2|Lost to Follow-up|1
4711946|NCT02147158|16244251|P3|Treatment Course 2|Lost to Follow-up|1
4711947|NCT02147158|16244252|P2|Treatment Course 2|Lost to Follow-up|0
4711948|NCT02147158|16244253|P1|Treatment Course 2|Lost to Follow-up|1
4711949|NCT02147158|16244248|P6|Treatment Course 2|Withdrawal of Consent|0
4711950|NCT02147158|16244249|P5|Treatment Course 2|Withdrawal of Consent|0
4711951|NCT02147158|16244250|P4|Treatment Course 2|Withdrawal of Consent|3
4711952|NCT02147158|16244251|P3|Treatment Course 2|Withdrawal of Consent|2
4711953|NCT02147158|16244252|P2|Treatment Course 2|Withdrawal of Consent|1
4711954|NCT02147158|16244253|P1|Treatment Course 2|Withdrawal of Consent|0
4711955|NCT02147158|16244248|P6|Treatment Course 2|Adverse Event|1
4711956|NCT02147158|16244249|P5|Treatment Course 2|Adverse Event|0
4711957|NCT02147158|16244250|P4|Treatment Course 2|Adverse Event|1
4711958|NCT02147158|16244251|P3|Treatment Course 2|Adverse Event|2
4711959|NCT02147158|16244252|P2|Treatment Course 2|Adverse Event|4
4711960|NCT02147158|16244253|P1|Treatment Course 2|Adverse Event|0
4711961|NCT02147158|16244248|P6|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
4711962|NCT02147158|16244249|P5|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
4711963|NCT02147158|16244250|P4|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
4711964|NCT02147158|16244251|P3|Off-Treatment Interval 1|Other Miscellaneous Reasons|3
4711965|NCT02147158|16244252|P2|Off-Treatment Interval 1|Other Miscellaneous Reasons|0
4711966|NCT02147158|16244253|P1|Off-Treatment Interval 1|Other Miscellaneous Reasons|2
4711967|NCT02147158|16244248|P6|Off-Treatment Interval 1|Lack of Efficacy|0
4711968|NCT02147158|16244249|P5|Off-Treatment Interval 1|Lack of Efficacy|1
4711969|NCT02147158|16244250|P4|Off-Treatment Interval 1|Lack of Efficacy|0
4711970|NCT02147158|16244251|P3|Off-Treatment Interval 1|Lack of Efficacy|2
4711971|NCT02147158|16244252|P2|Off-Treatment Interval 1|Lack of Efficacy|0
4711972|NCT02147158|16244253|P1|Off-Treatment Interval 1|Lack of Efficacy|0
4711973|NCT02147158|16244248|P6|Off-Treatment Interval 1|Withdrawal of Consent|3
4711974|NCT02147158|16244249|P5|Off-Treatment Interval 1|Withdrawal of Consent|2
4711975|NCT02147158|16244250|P4|Off-Treatment Interval 1|Withdrawal of Consent|10
4711976|NCT02147158|16244251|P3|Off-Treatment Interval 1|Withdrawal of Consent|5
4711977|NCT02147158|16244252|P2|Off-Treatment Interval 1|Withdrawal of Consent|3
4711978|NCT02147158|16244253|P1|Off-Treatment Interval 1|Withdrawal of Consent|4
4711979|NCT02147158|16244248|P6|Off-Treatment Interval 1|Protocol Violation|0
4711980|NCT02147158|16244249|P5|Off-Treatment Interval 1|Protocol Violation|1
4711981|NCT02147158|16244250|P4|Off-Treatment Interval 1|Protocol Violation|0
4711982|NCT02147158|16244251|P3|Off-Treatment Interval 1|Protocol Violation|2
4711983|NCT02147158|16244252|P2|Off-Treatment Interval 1|Protocol Violation|0
4711984|NCT02147158|16244253|P1|Off-Treatment Interval 1|Protocol Violation|1
4711985|NCT02147158|16244248|P6|Off-Treatment Interval 1|Lost to Follow-up|2
4711986|NCT02147158|16244249|P5|Off-Treatment Interval 1|Lost to Follow-up|4
4711987|NCT02147158|16244250|P4|Off-Treatment Interval 1|Lost to Follow-up|2
4711988|NCT02147158|16244251|P3|Off-Treatment Interval 1|Lost to Follow-up|3
4711989|NCT02147158|16244252|P2|Off-Treatment Interval 1|Lost to Follow-up|1
4711990|NCT02147158|16244253|P1|Off-Treatment Interval 1|Lost to Follow-up|2
4711991|NCT02147158|16244248|P6|Off-Treatment Interval 1|Adverse Event|0
4711992|NCT02147158|16244249|P5|Off-Treatment Interval 1|Adverse Event|0
4711993|NCT02147158|16244250|P4|Off-Treatment Interval 1|Adverse Event|1
4711994|NCT02147158|16244251|P3|Off-Treatment Interval 1|Adverse Event|0
4711995|NCT02147158|16244252|P2|Off-Treatment Interval 1|Adverse Event|0
4711996|NCT02147158|16244253|P1|Off-Treatment Interval 1|Adverse Event|1
4711997|NCT02147158|16244248|P6|Treatment Course 1|Withdrawal of Consent|2
4711998|NCT02147158|16244249|P5|Treatment Course 1|Withdrawal of Consent|3
4711999|NCT02147158|16244250|P4|Treatment Course 1|Withdrawal of Consent|5
4712000|NCT02147158|16244251|P3|Treatment Course 1|Withdrawal of Consent|1
4712001|NCT02147158|16244252|P2|Treatment Course 1|Withdrawal of Consent|1
4712002|NCT02147158|16244253|P1|Treatment Course 1|Withdrawal of Consent|1
4712003|NCT02147158|16244248|P6|Treatment Course 1|Protocol Violation|0
4712004|NCT02147158|16244249|P5|Treatment Course 1|Protocol Violation|0
4712005|NCT02147158|16244250|P4|Treatment Course 1|Protocol Violation|1
4712006|NCT02147158|16244251|P3|Treatment Course 1|Protocol Violation|1
4712007|NCT02147158|16244252|P2|Treatment Course 1|Protocol Violation|0
4712008|NCT02147158|16244253|P1|Treatment Course 1|Protocol Violation|0
4712009|NCT02147158|16244248|P6|Treatment Course 1|Lost to Follow-up|4
4712010|NCT02147158|16244249|P5|Treatment Course 1|Lost to Follow-up|2
4712011|NCT02147158|16244250|P4|Treatment Course 1|Lost to Follow-up|3
4712012|NCT02147158|16244251|P3|Treatment Course 1|Lost to Follow-up|3
4712013|NCT02147158|16244252|P2|Treatment Course 1|Lost to Follow-up|4
4712014|NCT02147158|16244253|P1|Treatment Course 1|Lost to Follow-up|2
4712015|NCT02147158|16244248|P6|Treatment Course 1|Adverse Event|2
4712016|NCT02147158|16244249|P5|Treatment Course 1|Adverse Event|1
4712017|NCT02147158|16244250|P4|Treatment Course 1|Adverse Event|4
4712018|NCT02147158|16244251|P3|Treatment Course 1|Adverse Event|3
4712019|NCT02147158|16244252|P2|Treatment Course 1|Adverse Event|4
4712020|NCT02147158|16244253|P1|Treatment Course 1|Adverse Event|1
4712021|NCT02147132|16244282|P4|Overall Study|Lost to Follow-up|0
4712022|NCT02147132|16244283|P3|Overall Study|Lost to Follow-up|0
4712023|NCT02147132|16244284|P2|Overall Study|Lost to Follow-up|0
4712024|NCT02147132|16244285|P1|Overall Study|Lost to Follow-up|1
4712025|NCT02147093|16244305|P2|Period 2|Protocol Violation|0
4712026|NCT02147093|16244306|P1|Period 2|Protocol Violation|2
4712027|NCT02147093|16244305|P2|Period 1|Lost to Follow-up|1
4712028|NCT02147093|16244306|P1|Period 1|Lost to Follow-up|0
4712029|NCT02147067|16244316|P2|Overall Study|Withdrawal by Subject|2
4712030|NCT02147067|16244317|P1|Overall Study|Withdrawal by Subject|2
4712031|NCT02146599|16244343|P1|Overall Study|Failed to meet inclusion criteria|5
4712032|NCT02146365|16244362|P8|Overall Study|Other|0
4712033|NCT02146365|16244363|P7|Overall Study|Other|0
4712034|NCT02146365|16244364|P6|Overall Study|Other|0
4712035|NCT02146365|16244365|P5|Overall Study|Other|0
4712036|NCT02146365|16244366|P4|Overall Study|Other|1
4712037|NCT02146365|16244367|P3|Overall Study|Other|2
4712038|NCT02146365|16244368|P2|Overall Study|Other|0
4712039|NCT02146365|16244369|P1|Overall Study|Other|1
4712040|NCT02146365|16244362|P8|Overall Study|Unable to Comply with Protocol|0
4712041|NCT02146365|16244363|P7|Overall Study|Unable to Comply with Protocol|0
4712042|NCT02146365|16244364|P6|Overall Study|Unable to Comply with Protocol|0
4712043|NCT02146365|16244365|P5|Overall Study|Unable to Comply with Protocol|0
4712044|NCT02146365|16244366|P4|Overall Study|Unable to Comply with Protocol|0
4712045|NCT02146365|16244367|P3|Overall Study|Unable to Comply with Protocol|1
4712046|NCT02146365|16244368|P2|Overall Study|Unable to Comply with Protocol|1
4712047|NCT02146365|16244369|P1|Overall Study|Unable to Comply with Protocol|0
4712048|NCT02146365|16244362|P8|Overall Study|Withdrawal by Subject|0
4712049|NCT02146365|16244363|P7|Overall Study|Withdrawal by Subject|0
4712050|NCT02146365|16244364|P6|Overall Study|Withdrawal by Subject|0
4712051|NCT02146365|16244365|P5|Overall Study|Withdrawal by Subject|1
4712052|NCT02146365|16244366|P4|Overall Study|Withdrawal by Subject|5
4712053|NCT02146365|16244367|P3|Overall Study|Withdrawal by Subject|1
4712054|NCT02146365|16244368|P2|Overall Study|Withdrawal by Subject|2
4712055|NCT02146365|16244369|P1|Overall Study|Withdrawal by Subject|1
4712056|NCT02146365|16244362|P8|Overall Study|Lost to Follow-up|1
4712057|NCT02146365|16244363|P7|Overall Study|Lost to Follow-up|0
4712058|NCT02146365|16244364|P6|Overall Study|Lost to Follow-up|1
4712059|NCT02146365|16244365|P5|Overall Study|Lost to Follow-up|1
4712060|NCT02146365|16244366|P4|Overall Study|Lost to Follow-up|3
4712061|NCT02146365|16244367|P3|Overall Study|Lost to Follow-up|3
4712062|NCT02146365|16244368|P2|Overall Study|Lost to Follow-up|1
4712063|NCT02146365|16244369|P1|Overall Study|Lost to Follow-up|2
4712064|NCT02146352|16244495|P1|Overall Study|Patient entered hospice care|1
4712065|NCT02146352|16244495|P1|Overall Study|Death|1
4712066|NCT02146326|16244513|P4|Overall Study|Unable to complete interview|6
4712067|NCT02146326|16244514|P3|Overall Study|Unable to complete interview|10
4712068|NCT02146326|16244515|P2|Overall Study|Unable to complete interview|0
4712069|NCT02146326|16244516|P1|Overall Study|Unable to complete interview|0
4712070|NCT02146326|16244513|P4|Overall Study|Death|4
4712071|NCT02146326|16244514|P3|Overall Study|Death|4
4712072|NCT02146326|16244515|P2|Overall Study|Death|0
4712073|NCT02146326|16244516|P1|Overall Study|Death|0
4712074|NCT02146326|16244513|P4|Overall Study|Incarcerated|8
4712075|NCT02146326|16244514|P3|Overall Study|Incarcerated|3
4712076|NCT02146326|16244515|P2|Overall Study|Incarcerated|0
4712077|NCT02146326|16244516|P1|Overall Study|Incarcerated|0
4712078|NCT02146326|16244513|P4|Overall Study|Separated from mental health center|0
4712079|NCT02146326|16244514|P3|Overall Study|Separated from mental health center|0
4712080|NCT02146326|16244515|P2|Overall Study|Separated from mental health center|33
4712081|NCT02146326|16244516|P1|Overall Study|Separated from mental health center|23
4712082|NCT02146326|16244513|P4|Overall Study|Withdrawal by Subject|11
4712083|NCT02146326|16244514|P3|Overall Study|Withdrawal by Subject|15
4712084|NCT02146326|16244515|P2|Overall Study|Withdrawal by Subject|1
4712085|NCT02146326|16244516|P1|Overall Study|Withdrawal by Subject|2
4712086|NCT02146326|16244513|P4|Overall Study|Lost to Follow-up|19
4712087|NCT02146326|16244514|P3|Overall Study|Lost to Follow-up|11
4712088|NCT02146326|16244515|P2|Overall Study|Lost to Follow-up|3
4712089|NCT02146326|16244516|P1|Overall Study|Lost to Follow-up|3
4712090|NCT02146274|16244678|P1|Overall Study|Protocol Violation|73
4712091|NCT02146248|16244685|P1|Overall Study|Withdrawal by Subject|2
4712092|NCT02146131|16244695|P2|Overall Study|Physician Decision|56
4712093|NCT02146131|16244696|P1|Overall Study|Physician Decision|61
4712094|NCT02146105|16244702|P1|Overall Study|Withdrawal by Subject|5
4712095|NCT02146105|16244702|P1|Overall Study|Adverse Event|1
4712096|NCT02145468|16244753|P2|Overall Study|Withdrawal by Subject|8
4712097|NCT02145468|16244754|P1|Overall Study|Withdrawal by Subject|5
4712098|NCT02145429|16244812|P2|Overall Study|Withdrawal by Subject|3
4712099|NCT02145429|16244813|P1|Overall Study|Withdrawal by Subject|8
4712100|NCT02145429|16244812|P2|Overall Study|Lost to Follow-up|3
4712101|NCT02145429|16244813|P1|Overall Study|Lost to Follow-up|4
4712102|NCT02145429|16244812|P2|Overall Study|Death|5
4712103|NCT02145429|16244813|P1|Overall Study|Death|4
4712104|NCT02145390|16244844|P1|Overall Study|Withdrawal by Subject|1
4712105|NCT02145182|16244893|P2|Overall Study|Withdrawal by Subject|4
4712106|NCT02145182|16244894|P1|Overall Study|Withdrawal by Subject|5
4712107|NCT02145182|16244893|P2|Overall Study|Pre-transplant Withdrawal|2
4712108|NCT02145182|16244894|P1|Overall Study|Pre-transplant Withdrawal|0
4712109|NCT02145182|16244893|P2|Overall Study|Lost to Follow-up|2
4712110|NCT02145182|16244894|P1|Overall Study|Lost to Follow-up|2
4712111|NCT02145182|16244893|P2|Overall Study|Death|7
4712112|NCT02145182|16244894|P1|Overall Study|Death|7
4712113|NCT02145182|16244893|P2|Overall Study|Adverse Event|1
4712114|NCT02145182|16244894|P1|Overall Study|Adverse Event|4
4712115|NCT02145156|16244927|P3|Overall Study|No match to vaccination records|41
4712116|NCT02145156|16244928|P2|Overall Study|No match to vaccination records|52
4712117|NCT02145156|16244929|P1|Overall Study|No match to vaccination records|60
4712118|NCT02145078|16244970|P1|Overall Study|Reason not given|3
4712119|NCT02145078|16244970|P1|Overall Study|Death|1
4712120|NCT02145026|16244987|P1|Overall Study|Physician Decision|4
4712121|NCT02145026|16244987|P1|Overall Study|Withdrawal by Subject|2
4712122|NCT02145026|16244987|P1|Overall Study|Death|4
4712123|NCT02145026|16244987|P1|Overall Study|Adverse Event|2
4712124|NCT02144701|16245018|P2|Overall Study|development of relapse, GVHD or death|3
4712125|NCT02144701|16245019|P1|Overall Study|development of relapse, GVHD or death|9
4712126|NCT02144610|16245046|P2|Overall Study|Other|1
4712127|NCT02144610|16245047|P1|Overall Study|Other|0
4712128|NCT02144610|16245046|P2|Overall Study|Study Discontinuation by Sponsor|14
4712129|NCT02144610|16245047|P1|Overall Study|Study Discontinuation by Sponsor|19
4712130|NCT02144610|16245046|P2|Overall Study|Death|2
4712131|NCT02144610|16245047|P1|Overall Study|Death|2
4712132|NCT02144610|16245046|P2|Overall Study|Withdrawal by Subject|5
4712133|NCT02144610|16245047|P1|Overall Study|Withdrawal by Subject|1
4712134|NCT02144610|16245046|P2|Overall Study|Physician Decision|0
4712135|NCT02144610|16245047|P1|Overall Study|Physician Decision|1
4712136|NCT02144337|16245088|P2|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0
4712137|NCT02144337|16245089|P1|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1
4712138|NCT02144337|16245088|P2|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0
4712139|NCT02144337|16245089|P1|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2
4712140|NCT02144337|16245088|P2|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0
4712141|NCT02144337|16245089|P1|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1
4712142|NCT02144337|16245088|P2|T2 Follow-up (Post-intervention)|Lost to Follow-up|0
4712143|NCT02144337|16245089|P1|T2 Follow-up (Post-intervention)|Lost to Follow-up|2
4712144|NCT02144337|16245088|P2|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
4712145|NCT02144337|16245089|P1|T2 Follow-up (Post-intervention)|Lack of Efficacy|1
4712146|NCT02144285|16245109|P10|Overall Study|Withdrawal by Subject|0
4712147|NCT02144285|16245110|P9|Overall Study|Withdrawal by Subject|0
4712148|NCT02144285|16245111|P8|Overall Study|Withdrawal by Subject|0
4712149|NCT02144285|16245112|P7|Overall Study|Withdrawal by Subject|0
4712150|NCT02144285|16245113|P6|Overall Study|Withdrawal by Subject|0
4712151|NCT02144285|16245114|P5|Overall Study|Withdrawal by Subject|1
4712152|NCT02144285|16245115|P4|Overall Study|Withdrawal by Subject|0
4712153|NCT02144285|16245116|P3|Overall Study|Withdrawal by Subject|0
4712154|NCT02144285|16245117|P2|Overall Study|Withdrawal by Subject|0
4712155|NCT02144285|16245118|P1|Overall Study|Withdrawal by Subject|0
4712156|NCT02144220|16245244|P1|Overall Study|Protocol Violation|1
4712157|NCT02144220|16245244|P1|Overall Study|Withdrawal by Subject|2
4712158|NCT02144220|16245244|P1|Overall Study|Physician Decision|3
4712159|NCT02144220|16245244|P1|Overall Study|Lack of Efficacy|4
4712160|NCT02144220|16245244|P1|Overall Study|technology incompatibility|9
4712161|NCT02144077|16245263|P2|Overall Study|no visits 7 & 8/no visits after visit 4|0
4712162|NCT02144077|16245264|P1|Overall Study|no visits 7 & 8/no visits after visit 4|2
4712163|NCT02144077|16245263|P2|Overall Study|Death|1
4712164|NCT02144077|16245264|P1|Overall Study|Death|0
4712165|NCT02144077|16245263|P2|Overall Study|Protocol Violation|2
4712166|NCT02144077|16245264|P1|Overall Study|Protocol Violation|1
4712167|NCT02144077|16245263|P2|Overall Study|Lost to Follow-up|2
4712168|NCT02144077|16245264|P1|Overall Study|Lost to Follow-up|2
4712169|NCT02144077|16245263|P2|Overall Study|Adverse Event|3
4712170|NCT02144077|16245264|P1|Overall Study|Adverse Event|2
4712171|NCT02144077|16245263|P2|Overall Study|Withdrawal by Subject|3
4712172|NCT02144077|16245264|P1|Overall Study|Withdrawal by Subject|3
4712173|NCT02144012|16245282|P2|Overall Study|Other|0
4712174|NCT02144012|16245283|P1|Overall Study|Other|3
4712175|NCT02144012|16245282|P2|Overall Study|Study Terminated by Sponsor|12
4712176|NCT02144012|16245283|P1|Overall Study|Study Terminated by Sponsor|18
4712177|NCT02144012|16245282|P2|Overall Study|Withdrawal by Subject|3
4712178|NCT02144012|16245283|P1|Overall Study|Withdrawal by Subject|11
4712179|NCT02144012|16245282|P2|Overall Study|Death|0
4712180|NCT02144012|16245283|P1|Overall Study|Death|1
4712181|NCT02144012|16245282|P2|Overall Study|Adverse Event|0
4712182|NCT02144012|16245283|P1|Overall Study|Adverse Event|1
4712183|NCT02143947|16245324|P2|Overall Study|Lost to Follow-up|2
4712184|NCT02143947|16245325|P1|Overall Study|Lost to Follow-up|4
4712185|NCT02143843|16245337|P1|Overall Study|Withdrawal by Subject|2
4712186|NCT02143843|16245337|P1|Overall Study|Lack of Efficacy|2
4712187|NCT02143843|16245337|P1|Overall Study|Adverse Event|8
4712188|NCT02143778|16245342|P1|Overall Study|Device malfunction|1
4712189|NCT02143778|16245342|P1|Overall Study|Withdrawal by Subject|2
4712190|NCT02143713|16245351|P4|Post-treatment Follow-up (12 Months)|Other|7
4712191|NCT02143713|16245352|P3|Post-treatment Follow-up (12 Months)|Other|7
4712192|NCT02143713|16245353|P2|Post-treatment Follow-up (12 Months)|Other|4
4712193|NCT02143713|16245354|P1|Post-treatment Follow-up (12 Months)|Other|3
4712194|NCT02143713|16245351|P4|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
4712195|NCT02143713|16245352|P3|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
4712196|NCT02143713|16245353|P2|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1
4712197|NCT02143713|16245354|P1|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0
4712198|NCT02143713|16245351|P4|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1
4712199|NCT02143713|16245352|P3|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
4712200|NCT02143713|16245353|P2|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4
4712201|NCT02143713|16245354|P1|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2
4712202|NCT02143713|16245351|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
4712203|NCT02143713|16245352|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11
4712204|NCT02143713|16245353|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8
4712205|NCT02143713|16245354|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3
4712206|NCT02143713|16245351|P4|Post-treatment Follow-up (12 Months)|Adverse Event|0
4712207|NCT02143713|16245352|P3|Post-treatment Follow-up (12 Months)|Adverse Event|1
4712208|NCT02143713|16245353|P2|Post-treatment Follow-up (12 Months)|Adverse Event|0
4712209|NCT02143713|16245354|P1|Post-treatment Follow-up (12 Months)|Adverse Event|0
4712210|NCT02143713|16245351|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10
4712211|NCT02143713|16245352|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
4712212|NCT02143713|16245353|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7
4712213|NCT02143713|16245354|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
4712214|NCT02143713|16245351|P4|Treatment Period (6 Months)|Lack of Efficacy|1
4712215|NCT02143713|16245352|P3|Treatment Period (6 Months)|Lack of Efficacy|0
4712216|NCT02143713|16245353|P2|Treatment Period (6 Months)|Lack of Efficacy|0
4712217|NCT02143713|16245354|P1|Treatment Period (6 Months)|Lack of Efficacy|1
4712218|NCT02143713|16245351|P4|Treatment Period (6 Months)|Exclusionary Medication|0
4712219|NCT02143713|16245352|P3|Treatment Period (6 Months)|Exclusionary Medication|0
4712220|NCT02143713|16245353|P2|Treatment Period (6 Months)|Exclusionary Medication|0
4712221|NCT02143713|16245354|P1|Treatment Period (6 Months)|Exclusionary Medication|2
4712222|NCT02143713|16245351|P4|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4
4712223|NCT02143713|16245352|P3|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
4712224|NCT02143713|16245353|P2|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
4712225|NCT02143713|16245354|P1|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0
4712226|NCT02143713|16245351|P4|Treatment Period (6 Months)|Other|2
4712227|NCT02143713|16245352|P3|Treatment Period (6 Months)|Other|3
4712228|NCT02143713|16245353|P2|Treatment Period (6 Months)|Other|0
4712229|NCT02143713|16245354|P1|Treatment Period (6 Months)|Other|3
4712230|NCT02143713|16245351|P4|Treatment Period (6 Months)|Non-compliance|3
4712231|NCT02143713|16245352|P3|Treatment Period (6 Months)|Non-compliance|0
4712232|NCT02143713|16245353|P2|Treatment Period (6 Months)|Non-compliance|0
4712233|NCT02143713|16245354|P1|Treatment Period (6 Months)|Non-compliance|1
4712234|NCT02143713|16245351|P4|Treatment Period (6 Months)|Pregnancy|0
4712235|NCT02143713|16245352|P3|Treatment Period (6 Months)|Pregnancy|2
4712236|NCT02143713|16245353|P2|Treatment Period (6 Months)|Pregnancy|2
4712237|NCT02143713|16245354|P1|Treatment Period (6 Months)|Pregnancy|0
4712238|NCT02143713|16245351|P4|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
4712239|NCT02143713|16245352|P3|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
4712240|NCT02143713|16245353|P2|Treatment Period (6 Months)|Surgery or Invasive Intervention|0
4712241|NCT02143713|16245354|P1|Treatment Period (6 Months)|Surgery or Invasive Intervention|2
4712242|NCT02143713|16245351|P4|Treatment Period (6 Months)|Lost to Follow-up|3
4712243|NCT02143713|16245352|P3|Treatment Period (6 Months)|Lost to Follow-up|4
4712244|NCT02143713|16245353|P2|Treatment Period (6 Months)|Lost to Follow-up|0
4712245|NCT02143713|16245354|P1|Treatment Period (6 Months)|Lost to Follow-up|3
4712246|NCT02143713|16245351|P4|Treatment Period (6 Months)|Adverse Event|9
4712247|NCT02143713|16245352|P3|Treatment Period (6 Months)|Adverse Event|8
4712248|NCT02143713|16245353|P2|Treatment Period (6 Months)|Adverse Event|8
4712249|NCT02143713|16245354|P1|Treatment Period (6 Months)|Adverse Event|7
4712250|NCT02143713|16245351|P4|Treatment Period (6 Months)|Withdrawal by Subject|4
4712251|NCT02143713|16245352|P3|Treatment Period (6 Months)|Withdrawal by Subject|5
4712252|NCT02143713|16245353|P2|Treatment Period (6 Months)|Withdrawal by Subject|2
4712253|NCT02143713|16245354|P1|Treatment Period (6 Months)|Withdrawal by Subject|1
4712254|NCT02143583|16245448|P3|Overall Study|husband illness|1
4712255|NCT02143583|16245449|P2|Overall Study|husband illness|0
4712256|NCT02143583|16245450|P1|Overall Study|husband illness|0
4712257|NCT02143583|16245448|P3|Overall Study|Withdrawal by Subject|1
4712258|NCT02143583|16245449|P2|Overall Study|Withdrawal by Subject|0
4712259|NCT02143583|16245450|P1|Overall Study|Withdrawal by Subject|1
4712260|NCT02143141|16245473|P2|Overall Study|pain scores at 24 hours not collected|0
4712261|NCT02143141|16245474|P1|Overall Study|pain scores at 24 hours not collected|1
4712262|NCT02143102|16245486|P2|Overall Study|Lost to Follow-up|0
4712263|NCT02143102|16245487|P1|Overall Study|Lost to Follow-up|11
4712264|NCT02143024|16245497|P2|Overall Study|Withdrawal by Subject|0
4712265|NCT02143024|16245498|P1|Overall Study|Withdrawal by Subject|1
4712266|NCT02143024|16245497|P2|Overall Study|Lost to Follow-up|1
4712267|NCT02143024|16245498|P1|Overall Study|Lost to Follow-up|1
4712268|NCT02142894|16245504|P1|Overall Study|Protocol Violation|8
4712269|NCT02142738|16245510|P2|Overall Study|Ongoing in Study|82
4712270|NCT02142738|16245511|P1|Overall Study|Ongoing in Study|107
4712271|NCT02142738|16245510|P2|Overall Study|Withdrawal by Subject|5
4712272|NCT02142738|16245511|P1|Overall Study|Withdrawal by Subject|5
4712273|NCT02142738|16245510|P2|Overall Study|Progressive Disease|1
4712274|NCT02142738|16245511|P1|Overall Study|Progressive Disease|0
4712275|NCT02142738|16245510|P2|Overall Study|Death|55
4712276|NCT02142738|16245511|P1|Overall Study|Death|33
4712277|NCT02142738|16245510|P2|Overall Study|Adverse Event|8
4712278|NCT02142738|16245511|P1|Overall Study|Adverse Event|9
4712279|NCT02142712|16245524|P4|Overall Study|Lost to Follow-up|0
4712280|NCT02142712|16245525|P3|Overall Study|Lost to Follow-up|1
4712281|NCT02142712|16245526|P2|Overall Study|Lost to Follow-up|1
4712282|NCT02142712|16245527|P1|Overall Study|Lost to Follow-up|1
4712283|NCT02142504|16245555|P3|Overall Study|Reason Not Specified|4
4712284|NCT02142504|16245556|P2|Overall Study|Reason Not Specified|5
4712285|NCT02142504|16245557|P1|Overall Study|Reason Not Specified|4
4712286|NCT02142504|16245555|P3|Overall Study|Physician Decision|3
4712287|NCT02142504|16245556|P2|Overall Study|Physician Decision|1
4712288|NCT02142504|16245557|P1|Overall Study|Physician Decision|0
4712289|NCT02142504|16245555|P3|Overall Study|Pregnancy|2
4712290|NCT02142504|16245556|P2|Overall Study|Pregnancy|4
4712291|NCT02142504|16245557|P1|Overall Study|Pregnancy|4
4712292|NCT02142504|16245555|P3|Overall Study|Withdrawal by Subject|11
4712293|NCT02142504|16245556|P2|Overall Study|Withdrawal by Subject|9
4712294|NCT02142504|16245557|P1|Overall Study|Withdrawal by Subject|7
4712295|NCT02142504|16245555|P3|Overall Study|Lost to Follow-up|17
4712296|NCT02142504|16245556|P2|Overall Study|Lost to Follow-up|19
4712297|NCT02142504|16245557|P1|Overall Study|Lost to Follow-up|12
4712298|NCT02142504|16245555|P3|Overall Study|Adverse Event|4
4712299|NCT02142504|16245556|P2|Overall Study|Adverse Event|3
4712300|NCT02142504|16245557|P1|Overall Study|Adverse Event|2
4712301|NCT02142504|16245555|P3|Overall Study|Protocol Violation|2
4712302|NCT02142504|16245556|P2|Overall Study|Protocol Violation|1
4712303|NCT02142504|16245557|P1|Overall Study|Protocol Violation|2
4712304|NCT02142387|16245645|P2|Overall Study|occurred not at home|2474
4712305|NCT02142387|16245646|P1|Overall Study|occurred not at home|298
4712306|NCT02142387|16245645|P2|Overall Study|incomplete data|9
4712307|NCT02142387|16245646|P1|Overall Study|incomplete data|1
4712308|NCT02142387|16245645|P2|Overall Study|witnessed by paramedic|917
4712309|NCT02142387|16245646|P1|Overall Study|witnessed by paramedic|139
4712310|NCT02142387|16245645|P2|Overall Study|CPR not performed|473
4712311|NCT02142387|16245646|P1|Overall Study|CPR not performed|74
4712312|NCT02142387|16245645|P2|Overall Study|non-cardiac etiology|3431
4712313|NCT02142387|16245646|P1|Overall Study|non-cardiac etiology|504
4712314|NCT02142387|16245645|P2|Overall Study|<19 years old|326
4712315|NCT02142387|16245646|P1|Overall Study|<19 years old|49
4712316|NCT02142283|16245759|P2|Overall Study|Withdrawal by Subject|3
4712317|NCT02142283|16245760|P1|Overall Study|Withdrawal by Subject|1
4712318|NCT02142283|16245759|P2|Overall Study|Death|18
4712319|NCT02142283|16245760|P1|Overall Study|Death|20
4712320|NCT02141997|16245869|P4|Overall Study|Other|0
4712321|NCT02141997|16245870|P3|Overall Study|Other|0
4712322|NCT02141997|16245871|P2|Overall Study|Other|4
4712323|NCT02141997|16245872|P1|Overall Study|Other|1
4712324|NCT02141997|16245869|P4|Overall Study|Withdrew consent|0
4712325|NCT02141997|16245870|P3|Overall Study|Withdrew consent|3
4712326|NCT02141997|16245871|P2|Overall Study|Withdrew consent|0
4712327|NCT02141997|16245872|P1|Overall Study|Withdrew consent|1
4712328|NCT02141997|16245869|P4|Overall Study|Participant noncompliance|0
4712329|NCT02141997|16245870|P3|Overall Study|Participant noncompliance|0
4712330|NCT02141997|16245871|P2|Overall Study|Participant noncompliance|0
4712331|NCT02141997|16245872|P1|Overall Study|Participant noncompliance|1
4712332|NCT02141997|16245869|P4|Overall Study|Adverse Event|1
4712333|NCT02141997|16245870|P3|Overall Study|Adverse Event|0
4712334|NCT02141997|16245871|P2|Overall Study|Adverse Event|2
4712335|NCT02141997|16245872|P1|Overall Study|Adverse Event|0
4712336|NCT02141984|16245910|P1|Overall Study|Lack of Efficacy|2
4712337|NCT02141854|16245929|P6|Treatment Period|Lost to Follow-up|1
4712338|NCT02141854|16245930|P5|Treatment Period|Lost to Follow-up|0
4712339|NCT02141854|16245931|P4|Treatment Period|Lost to Follow-up|1
4712340|NCT02141854|16245932|P3|Treatment Period|Lost to Follow-up|1
4712341|NCT02141854|16245933|P2|Treatment Period|Lost to Follow-up|1
4712342|NCT02141854|16245934|P1|Treatment Period|Lost to Follow-up|0
4712343|NCT02141854|16245929|P6|Treatment Period|Disease progression|18
4712344|NCT02141854|16245930|P5|Treatment Period|Disease progression|0
4712345|NCT02141854|16245931|P4|Treatment Period|Disease progression|3
4712346|NCT02141854|16245932|P3|Treatment Period|Disease progression|1
4712347|NCT02141854|16245933|P2|Treatment Period|Disease progression|2
4712348|NCT02141854|16245934|P1|Treatment Period|Disease progression|0
4712349|NCT02141854|16245929|P6|Treatment Period|Withdrawal by Subject|7
4712350|NCT02141854|16245930|P5|Treatment Period|Withdrawal by Subject|4
4712351|NCT02141854|16245931|P4|Treatment Period|Withdrawal by Subject|3
4712352|NCT02141854|16245932|P3|Treatment Period|Withdrawal by Subject|3
4712353|NCT02141854|16245933|P2|Treatment Period|Withdrawal by Subject|2
4712354|NCT02141854|16245934|P1|Treatment Period|Withdrawal by Subject|0
4712355|NCT02141854|16245929|P6|Treatment Period|Adverse Event|2
4712356|NCT02141854|16245930|P5|Treatment Period|Adverse Event|2
4712357|NCT02141854|16245931|P4|Treatment Period|Adverse Event|0
4712358|NCT02141854|16245932|P3|Treatment Period|Adverse Event|2
4712359|NCT02141854|16245933|P2|Treatment Period|Adverse Event|2
4712360|NCT02141854|16245934|P1|Treatment Period|Adverse Event|0
4712361|NCT02141854|16245929|P6|Treatment Period|Other|2
4712362|NCT02141854|16245930|P5|Treatment Period|Other|1
4712363|NCT02141854|16245931|P4|Treatment Period|Other|0
4712364|NCT02141854|16245932|P3|Treatment Period|Other|2
4712365|NCT02141854|16245933|P2|Treatment Period|Other|1
4712366|NCT02141854|16245934|P1|Treatment Period|Other|0
4712367|NCT02141854|16245929|P6|Treatment Period|Pregnancy|0
4712368|NCT02141854|16245930|P5|Treatment Period|Pregnancy|0
4712369|NCT02141854|16245931|P4|Treatment Period|Pregnancy|0
4712370|NCT02141854|16245932|P3|Treatment Period|Pregnancy|0
4712371|NCT02141854|16245933|P2|Treatment Period|Pregnancy|1
4712372|NCT02141854|16245934|P1|Treatment Period|Pregnancy|0
4712373|NCT02141854|16245929|P6|Treatment Period|Lack of Efficacy|7
4712374|NCT02141854|16245930|P5|Treatment Period|Lack of Efficacy|1
4712375|NCT02141854|16245931|P4|Treatment Period|Lack of Efficacy|1
4712376|NCT02141854|16245932|P3|Treatment Period|Lack of Efficacy|0
4712377|NCT02141854|16245933|P2|Treatment Period|Lack of Efficacy|0
4712378|NCT02141854|16245934|P1|Treatment Period|Lack of Efficacy|0
4712379|NCT02141854|16245929|P6|Treatment Period|Noncompliance|0
4712380|NCT02141854|16245930|P5|Treatment Period|Noncompliance|0
4712381|NCT02141854|16245931|P4|Treatment Period|Noncompliance|1
4712382|NCT02141854|16245932|P3|Treatment Period|Noncompliance|0
4712383|NCT02141854|16245933|P2|Treatment Period|Noncompliance|0
4712384|NCT02141854|16245934|P1|Treatment Period|Noncompliance|0
4712385|NCT02141854|16245929|P6|Treatment Period|Protocol Violation|1
4712386|NCT02141854|16245930|P5|Treatment Period|Protocol Violation|2
4712387|NCT02141854|16245931|P4|Treatment Period|Protocol Violation|2
4712388|NCT02141854|16245932|P3|Treatment Period|Protocol Violation|0
4712389|NCT02141854|16245933|P2|Treatment Period|Protocol Violation|1
4712390|NCT02141854|16245934|P1|Treatment Period|Protocol Violation|0
4712391|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712392|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712393|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712394|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712395|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712396|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|6
4712397|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712398|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712399|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712400|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712401|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712402|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|9
4712403|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Adverse Event|0
4712404|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Adverse Event|0
4712405|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Adverse Event|0
4712406|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Adverse Event|0
4712407|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Adverse Event|0
4712408|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Adverse Event|10
4712409|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Other|0
4712410|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Other|0
4712411|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Other|0
4712412|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Other|0
4712413|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Other|0
4712414|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Other|14
4712415|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712416|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712417|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712418|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712419|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712420|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|14
4712421|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712422|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712423|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712424|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712425|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712426|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|76
4712427|NCT02141854|16245929|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712428|NCT02141854|16245930|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712429|NCT02141854|16245931|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712430|NCT02141854|16245932|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712431|NCT02141854|16245933|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712432|NCT02141854|16245934|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|25
4712433|NCT02141659|16245992|P6|Overall Study|Pretreatment Event/ Adverse Event|1
4712434|NCT02141659|16245993|P5|Overall Study|Pretreatment Event/ Adverse Event|2
4712435|NCT02141659|16245994|P4|Overall Study|Pretreatment Event/ Adverse Event|0
4712436|NCT02141659|16245995|P3|Overall Study|Pretreatment Event/ Adverse Event|0
4712437|NCT02141659|16245996|P2|Overall Study|Pretreatment Event/ Adverse Event|0
4712438|NCT02141659|16245997|P1|Overall Study|Pretreatment Event/ Adverse Event|0
4712439|NCT02141659|16245992|P6|Overall Study|Lack of Efficacy|1
4712440|NCT02141659|16245993|P5|Overall Study|Lack of Efficacy|0
4712441|NCT02141659|16245994|P4|Overall Study|Lack of Efficacy|0
4712442|NCT02141659|16245995|P3|Overall Study|Lack of Efficacy|0
4712443|NCT02141659|16245996|P2|Overall Study|Lack of Efficacy|0
4712444|NCT02141659|16245997|P1|Overall Study|Lack of Efficacy|0
4712445|NCT02141659|16245992|P6|Overall Study|Major Protocol Deviation|0
4712446|NCT02141659|16245993|P5|Overall Study|Major Protocol Deviation|0
4712447|NCT02141659|16245994|P4|Overall Study|Major Protocol Deviation|0
4712448|NCT02141659|16245995|P3|Overall Study|Major Protocol Deviation|0
4712449|NCT02141659|16245996|P2|Overall Study|Major Protocol Deviation|1
4712450|NCT02141659|16245997|P1|Overall Study|Major Protocol Deviation|0
4712451|NCT02141633|16246053|P2|Overall Study|Physician Decision|0
4712452|NCT02141633|16246054|P1|Overall Study|Physician Decision|1
4712453|NCT02141620|16246062|P2|Treatment Condition 1 (7 Days)|Adverse Event|0
4712454|NCT02141620|16246063|P1|Treatment Condition 1 (7 Days)|Adverse Event|1
4712455|NCT02141516|16246155|P3|Overall Study|Other|0
4712456|NCT02141516|16246156|P2|Overall Study|Other|3
4712457|NCT02141516|16246157|P1|Overall Study|Other|0
4712458|NCT02141516|16246155|P3|Overall Study|Lost to Follow-up|0
4712459|NCT02141516|16246156|P2|Overall Study|Lost to Follow-up|1
4712460|NCT02141516|16246157|P1|Overall Study|Lost to Follow-up|0
4712461|NCT02141516|16246155|P3|Overall Study|Adverse Event|0
4712462|NCT02141516|16246156|P2|Overall Study|Adverse Event|1
4712463|NCT02141516|16246157|P1|Overall Study|Adverse Event|0
4712464|NCT02141490|16246208|P3|Overall Study|Screening failures|0
4712465|NCT02141490|16246209|P2|Overall Study|Screening failures|0
4712466|NCT02141490|16246210|P1|Overall Study|Screening failures|4
4712467|NCT02141399|16246255|P1|Overall Study|Failure to meet eligibility criteria|14
4712468|NCT02141399|16246255|P1|Overall Study|Withdrawal by Subject|238
4712469|NCT02141399|16246255|P1|Overall Study|Protocol Violation|38
4712470|NCT02141399|16246255|P1|Overall Study|Pregnancy|3
4712471|NCT02141399|16246255|P1|Overall Study|Physician Decision|17
4712472|NCT02141399|16246255|P1|Overall Study|Other|45
4712473|NCT02141399|16246255|P1|Overall Study|Non-compliance with study drug|18
4712474|NCT02141399|16246255|P1|Overall Study|Lost to Follow-up|151
4712475|NCT02141399|16246255|P1|Overall Study|Lack of Efficacy|62
4712476|NCT02141399|16246255|P1|Overall Study|Adverse Event|158
4712477|NCT02141360|16246261|P3|Overall Study|Study Terminated before Visit|0
4712478|NCT02141360|16246262|P2|Overall Study|Study Terminated before Visit|0
4712479|NCT02141360|16246263|P1|Overall Study|Study Terminated before Visit|1
4712480|NCT02141360|16246261|P3|Overall Study|Withdrawal by Subject|0
4712481|NCT02141360|16246262|P2|Overall Study|Withdrawal by Subject|0
4712482|NCT02141360|16246263|P1|Overall Study|Withdrawal by Subject|6
4712483|NCT02141295|16246274|P3|Overall Study|Withdrawal by Subject|4
4712484|NCT02141295|16246275|P2|Overall Study|Withdrawal by Subject|9
4712485|NCT02141295|16246276|P1|Overall Study|Withdrawal by Subject|0
4712486|NCT02141295|16246274|P3|Overall Study|Reason not specified|10
4712487|NCT02141295|16246275|P2|Overall Study|Reason not specified|9
4712488|NCT02141295|16246276|P1|Overall Study|Reason not specified|0
4712489|NCT02141295|16246274|P3|Overall Study|Progressive disease|50
4712490|NCT02141295|16246275|P2|Overall Study|Progressive disease|32
4712491|NCT02141295|16246276|P1|Overall Study|Progressive disease|3
4712492|NCT02141295|16246274|P3|Overall Study|Non-compliance|0
4712493|NCT02141295|16246275|P2|Overall Study|Non-compliance|1
4712494|NCT02141295|16246276|P1|Overall Study|Non-compliance|0
4712495|NCT02141295|16246274|P3|Overall Study|Study terminated by sponsor|6
4712496|NCT02141295|16246275|P2|Overall Study|Study terminated by sponsor|6
4712497|NCT02141295|16246276|P1|Overall Study|Study terminated by sponsor|0
4712498|NCT02141295|16246274|P3|Overall Study|Physician Decision|14
4712499|NCT02141295|16246275|P2|Overall Study|Physician Decision|19
4712500|NCT02141295|16246276|P1|Overall Study|Physician Decision|2
4712501|NCT02141295|16246274|P3|Overall Study|Adverse Event|11
4712502|NCT02141295|16246275|P2|Overall Study|Adverse Event|18
4712503|NCT02141295|16246276|P1|Overall Study|Adverse Event|1
4712504|NCT02141217|16246312|P2|Overall Study|Surgical Intervention|1
4712505|NCT02141217|16246313|P1|Overall Study|Surgical Intervention|1
4712506|NCT02141217|16246312|P2|Overall Study|Physician Decision|0
4712507|NCT02141217|16246313|P1|Overall Study|Physician Decision|1
4712508|NCT02141217|16246312|P2|Overall Study|Lost to Follow-up|1
4712509|NCT02141217|16246313|P1|Overall Study|Lost to Follow-up|1
4712510|NCT02141217|16246312|P2|Overall Study|Withdrawal by Subject|0
4712511|NCT02141217|16246313|P1|Overall Study|Withdrawal by Subject|6
4712512|NCT02141217|16246312|P2|Overall Study|Protocol Violation|4
4712513|NCT02141217|16246313|P1|Overall Study|Protocol Violation|1
4712514|NCT02141217|16246312|P2|Overall Study|Adverse Event|2
4712515|NCT02141217|16246313|P1|Overall Study|Adverse Event|1
4712516|NCT02140775|16246375|P2|Overall Study|Withdrawal by Subject|7
4712517|NCT02140775|16246376|P1|Overall Study|Withdrawal by Subject|30
4712518|NCT02140762|16246388|P2|Overall Study|Other|1
4712519|NCT02140762|16246389|P1|Overall Study|Other|0
4712520|NCT02140762|16246388|P2|Overall Study|Withdrawal by Subject|4
4712521|NCT02140762|16246389|P1|Overall Study|Withdrawal by Subject|6
4712522|NCT02140762|16246388|P2|Overall Study|Protocol Violation|1
4712523|NCT02140762|16246389|P1|Overall Study|Protocol Violation|1
4712524|NCT02140762|16246388|P2|Overall Study|Lost to Follow-up|5
4712525|NCT02140762|16246389|P1|Overall Study|Lost to Follow-up|9
4712526|NCT02140762|16246388|P2|Overall Study|Adverse Event|1
4712527|NCT02140762|16246389|P1|Overall Study|Adverse Event|1
4712528|NCT02140645|16246455|P6|Overall Study|Not linked|70896
4712529|NCT02140645|16246456|P5|Overall Study|Not linked|3286
4712530|NCT02140645|16246457|P4|Overall Study|Not linked|13833
4712531|NCT02140645|16246458|P3|Overall Study|Not linked|4236
4712532|NCT02140645|16246459|P2|Overall Study|Not linked|61654
4712533|NCT02140645|16246460|P1|Overall Study|Not linked|5489
4712534|NCT02140567|16246558|P1|Overall Study|Problems with recording equipment|6
4712535|NCT02140411|16246563|P1|Overall Study|Adverse Event|1
4712536|NCT02140164|16246583|P1|Overall Study|Cystoid Macular Edema (CME) resolved|2
4712537|NCT02140060|16246604|P6|Overall Study|Lack of Efficacy|0
4712538|NCT02140060|16246605|P5|Overall Study|Lack of Efficacy|0
4712539|NCT02140060|16246606|P4|Overall Study|Lack of Efficacy|1
4712540|NCT02140060|16246607|P3|Overall Study|Lack of Efficacy|0
4712541|NCT02140060|16246608|P2|Overall Study|Lack of Efficacy|0
4712542|NCT02140060|16246609|P1|Overall Study|Lack of Efficacy|0
4712543|NCT02140060|16246604|P6|Overall Study|Adverse Event|1
4712544|NCT02140060|16246605|P5|Overall Study|Adverse Event|1
4712545|NCT02140060|16246606|P4|Overall Study|Adverse Event|1
4712546|NCT02140060|16246607|P3|Overall Study|Adverse Event|0
4712547|NCT02140060|16246608|P2|Overall Study|Adverse Event|0
4712548|NCT02140060|16246609|P1|Overall Study|Adverse Event|0
4712549|NCT02139982|16246634|P10|Overall Study|Lack of Efficacy|0
4712550|NCT02139982|16246635|P9|Overall Study|Lack of Efficacy|0
4712551|NCT02139982|16246636|P8|Overall Study|Lack of Efficacy|0
4712552|NCT02139982|16246637|P7|Overall Study|Lack of Efficacy|0
4712553|NCT02139982|16246638|P6|Overall Study|Lack of Efficacy|0
4712554|NCT02139982|16246639|P5|Overall Study|Lack of Efficacy|0
4712555|NCT02139982|16246640|P4|Overall Study|Lack of Efficacy|1
4712556|NCT02139982|16246641|P3|Overall Study|Lack of Efficacy|0
4712557|NCT02139982|16246642|P2|Overall Study|Lack of Efficacy|1
4712558|NCT02139982|16246643|P1|Overall Study|Lack of Efficacy|0
4712559|NCT02139943|16246688|P3|Overall Study|eGFR Withdrawal Criteria|1
4712560|NCT02139943|16246689|P2|Overall Study|eGFR Withdrawal Criteria|0
4712561|NCT02139943|16246690|P1|Overall Study|eGFR Withdrawal Criteria|0
4712562|NCT02139943|16246688|P3|Overall Study|Participant in Poor Compliance|1
4712563|NCT02139943|16246689|P2|Overall Study|Participant in Poor Compliance|0
4712564|NCT02139943|16246690|P1|Overall Study|Participant in Poor Compliance|1
4712565|NCT02139943|16246688|P3|Overall Study|Participant wishes to discontinue|0
4712566|NCT02139943|16246689|P2|Overall Study|Participant wishes to discontinue|0
4712567|NCT02139943|16246690|P1|Overall Study|Participant wishes to discontinue|2
4712568|NCT02139943|16246688|P3|Overall Study|Other|1
4712569|NCT02139943|16246689|P2|Overall Study|Other|0
4712570|NCT02139943|16246690|P1|Overall Study|Other|0
4712571|NCT02139943|16246688|P3|Overall Study|Withdrawal by Subject|0
4712572|NCT02139943|16246689|P2|Overall Study|Withdrawal by Subject|3
4712573|NCT02139943|16246690|P1|Overall Study|Withdrawal by Subject|4
4712574|NCT02139943|16246688|P3|Overall Study|Lost to Follow-up|2
4712575|NCT02139943|16246689|P2|Overall Study|Lost to Follow-up|2
4712576|NCT02139943|16246690|P1|Overall Study|Lost to Follow-up|3
4712577|NCT02139943|16246688|P3|Overall Study|Adverse Event|2
4712578|NCT02139943|16246689|P2|Overall Study|Adverse Event|1
4712579|NCT02139943|16246690|P1|Overall Study|Adverse Event|0
4712580|NCT02139826|16246710|P1|Overall Study|Adverse Event|1
4712581|NCT02139644|16246755|P6|Treatment Period|Other|1
4712582|NCT02139644|16246756|P5|Treatment Period|Other|0
4712583|NCT02139644|16246757|P4|Treatment Period|Other|1
4712584|NCT02139644|16246758|P3|Treatment Period|Other|1
4712585|NCT02139644|16246759|P2|Treatment Period|Other|3
4712586|NCT02139644|16246760|P1|Treatment Period|Other|0
4712587|NCT02139644|16246755|P6|Treatment Period|Lack of Efficacy|4
4712588|NCT02139644|16246756|P5|Treatment Period|Lack of Efficacy|1
4712589|NCT02139644|16246757|P4|Treatment Period|Lack of Efficacy|0
4712590|NCT02139644|16246758|P3|Treatment Period|Lack of Efficacy|1
4712591|NCT02139644|16246759|P2|Treatment Period|Lack of Efficacy|0
4712592|NCT02139644|16246760|P1|Treatment Period|Lack of Efficacy|0
4712593|NCT02139644|16246755|P6|Treatment Period|Lost to Follow-up|1
4712594|NCT02139644|16246756|P5|Treatment Period|Lost to Follow-up|1
4712595|NCT02139644|16246757|P4|Treatment Period|Lost to Follow-up|1
4712596|NCT02139644|16246758|P3|Treatment Period|Lost to Follow-up|1
4712597|NCT02139644|16246759|P2|Treatment Period|Lost to Follow-up|0
4712598|NCT02139644|16246760|P1|Treatment Period|Lost to Follow-up|0
4712599|NCT02139644|16246755|P6|Treatment Period|Disease progression|2
4712600|NCT02139644|16246756|P5|Treatment Period|Disease progression|1
4712601|NCT02139644|16246757|P4|Treatment Period|Disease progression|1
4712602|NCT02139644|16246758|P3|Treatment Period|Disease progression|0
4712603|NCT02139644|16246759|P2|Treatment Period|Disease progression|0
4712604|NCT02139644|16246760|P1|Treatment Period|Disease progression|0
4712605|NCT02139644|16246755|P6|Treatment Period|Protocol Violation|1
4712606|NCT02139644|16246756|P5|Treatment Period|Protocol Violation|1
4712607|NCT02139644|16246757|P4|Treatment Period|Protocol Violation|1
4712608|NCT02139644|16246758|P3|Treatment Period|Protocol Violation|0
4712609|NCT02139644|16246759|P2|Treatment Period|Protocol Violation|0
4712610|NCT02139644|16246760|P1|Treatment Period|Protocol Violation|0
4712611|NCT02139644|16246755|P6|Treatment Period|Non-compliance|0
4712612|NCT02139644|16246756|P5|Treatment Period|Non-compliance|0
4712613|NCT02139644|16246757|P4|Treatment Period|Non-compliance|1
4712614|NCT02139644|16246758|P3|Treatment Period|Non-compliance|0
4712615|NCT02139644|16246759|P2|Treatment Period|Non-compliance|0
4712616|NCT02139644|16246760|P1|Treatment Period|Non-compliance|0
4712617|NCT02139644|16246755|P6|Treatment Period|Withdrawal by Subject|2
4712618|NCT02139644|16246756|P5|Treatment Period|Withdrawal by Subject|3
4712619|NCT02139644|16246757|P4|Treatment Period|Withdrawal by Subject|2
4712620|NCT02139644|16246758|P3|Treatment Period|Withdrawal by Subject|2
4712621|NCT02139644|16246759|P2|Treatment Period|Withdrawal by Subject|0
4712622|NCT02139644|16246760|P1|Treatment Period|Withdrawal by Subject|0
4712623|NCT02139644|16246755|P6|Treatment Period|Adverse Event|6
4712624|NCT02139644|16246756|P5|Treatment Period|Adverse Event|1
4712625|NCT02139644|16246757|P4|Treatment Period|Adverse Event|2
4712626|NCT02139644|16246758|P3|Treatment Period|Adverse Event|3
4712627|NCT02139644|16246759|P2|Treatment Period|Adverse Event|0
4712628|NCT02139644|16246760|P1|Treatment Period|Adverse Event|0
4712629|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Other|0
4712630|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Other|0
4712631|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Other|0
4712632|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Other|0
4712633|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Other|0
4712634|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Other|6
4712635|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Adverse Event|0
4712636|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Adverse Event|0
4712637|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Adverse Event|0
4712638|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Adverse Event|0
4712639|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Adverse Event|0
4712640|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Adverse Event|3
4712641|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712642|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712643|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712644|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712645|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Lost to Follow-up|0
4712646|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Lost to Follow-up|8
4712647|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712648|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712649|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712650|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712651|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Exclusion criteria met|0
4712652|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Exclusion criteria met|11
4712653|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712654|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712655|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712656|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712657|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Withdrawal by Subject|0
4712658|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Withdrawal by Subject|12
4712659|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712660|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712661|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712662|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712663|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Inclusion criteria not met|0
4712664|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Inclusion criteria not met|30
4712665|NCT02139644|16246755|P6|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712666|NCT02139644|16246756|P5|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712667|NCT02139644|16246757|P4|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712668|NCT02139644|16246758|P3|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712669|NCT02139644|16246759|P2|Run-In Period (Pre-assignment)|Randomization criteria not met|0
4712670|NCT02139644|16246760|P1|Run-In Period (Pre-assignment)|Randomization criteria not met|70
4712671|NCT02139592|16246812|P1|Overall Study|Case Report Forms Uncollected|8
4712672|NCT02139306|16246838|P2|Overall Study|Protocol Violation|0
4712673|NCT02139306|16246839|P1|Overall Study|Protocol Violation|4
4712674|NCT02139306|16246838|P2|Overall Study|Other Unspecified|3
4712675|NCT02139306|16246839|P1|Overall Study|Other Unspecified|2
4712676|NCT02139306|16246838|P2|Overall Study|Physician Decision|1
4712677|NCT02139306|16246839|P1|Overall Study|Physician Decision|0
4712678|NCT02139306|16246838|P2|Overall Study|Adverse Event|4
4712679|NCT02139306|16246839|P1|Overall Study|Adverse Event|3
4712680|NCT02139306|16246838|P2|Overall Study|Withdrawal by Subject|6
4712681|NCT02139306|16246839|P1|Overall Study|Withdrawal by Subject|4
4712682|NCT02139124|16246909|P5|Overall Study|Lost to Follow-up|4
4712683|NCT02139124|16246910|P4|Overall Study|Lost to Follow-up|5
4712684|NCT02139124|16246911|P3|Overall Study|Lost to Follow-up|0
4712685|NCT02139124|16246912|P2|Overall Study|Lost to Follow-up|2
4712686|NCT02139124|16246913|P1|Overall Study|Lost to Follow-up|3
4712687|NCT02139124|16246909|P5|Overall Study|subject moved|0
4712688|NCT02139124|16246910|P4|Overall Study|subject moved|0
4712689|NCT02139124|16246911|P3|Overall Study|subject moved|0
4712690|NCT02139124|16246912|P2|Overall Study|subject moved|0
4712691|NCT02139124|16246913|P1|Overall Study|subject moved|1
4712692|NCT02139124|16246909|P5|Overall Study|incarceration|0
4712693|NCT02139124|16246910|P4|Overall Study|incarceration|0
4712694|NCT02139124|16246911|P3|Overall Study|incarceration|1
4712695|NCT02139124|16246912|P2|Overall Study|incarceration|0
4712696|NCT02139124|16246913|P1|Overall Study|incarceration|0
4712697|NCT02139124|16246909|P5|Overall Study|non-compliant|0
4712698|NCT02139124|16246910|P4|Overall Study|non-compliant|2
4712699|NCT02139124|16246911|P3|Overall Study|non-compliant|0
4712700|NCT02139124|16246912|P2|Overall Study|non-compliant|0
4712701|NCT02139124|16246913|P1|Overall Study|non-compliant|1
4712702|NCT02139124|16246909|P5|Overall Study|Protocol Violation|1
4712703|NCT02139124|16246910|P4|Overall Study|Protocol Violation|1
4712704|NCT02139124|16246911|P3|Overall Study|Protocol Violation|0
4712705|NCT02139124|16246912|P2|Overall Study|Protocol Violation|0
4712706|NCT02139124|16246913|P1|Overall Study|Protocol Violation|0
4712707|NCT02139124|16246909|P5|Overall Study|Withdrawal by Subject|3
4712708|NCT02139124|16246910|P4|Overall Study|Withdrawal by Subject|2
4712709|NCT02139124|16246911|P3|Overall Study|Withdrawal by Subject|2
4712710|NCT02139124|16246912|P2|Overall Study|Withdrawal by Subject|2
4712711|NCT02139124|16246913|P1|Overall Study|Withdrawal by Subject|2
4712712|NCT02139124|16246909|P5|Overall Study|Adverse Event|5
4712713|NCT02139124|16246910|P4|Overall Study|Adverse Event|2
4712714|NCT02139124|16246911|P3|Overall Study|Adverse Event|1
4712715|NCT02139124|16246912|P2|Overall Study|Adverse Event|0
4712716|NCT02139124|16246913|P1|Overall Study|Adverse Event|2
4712717|NCT02139046|16246930|P5|Overall Study|Other Miscellaneous Reasons|12
4712718|NCT02139046|16246931|P4|Overall Study|Other Miscellaneous Reasons|9
4712719|NCT02139046|16246932|P3|Overall Study|Other Miscellaneous Reasons|4
4712720|NCT02139046|16246933|P2|Overall Study|Other Miscellaneous Reasons|9
4712721|NCT02139046|16246934|P1|Overall Study|Other Miscellaneous Reasons|10
4712722|NCT02139046|16246930|P5|Overall Study|Withdrawal due to a Gout Flare|1
4712723|NCT02139046|16246931|P4|Overall Study|Withdrawal due to a Gout Flare|0
4712724|NCT02139046|16246932|P3|Overall Study|Withdrawal due to a Gout Flare|1
4712725|NCT02139046|16246933|P2|Overall Study|Withdrawal due to a Gout Flare|1
4712726|NCT02139046|16246934|P1|Overall Study|Withdrawal due to a Gout Flare|1
4712727|NCT02139046|16246930|P5|Overall Study|Lack of Efficacy|2
4712728|NCT02139046|16246931|P4|Overall Study|Lack of Efficacy|1
4712729|NCT02139046|16246932|P3|Overall Study|Lack of Efficacy|2
4712730|NCT02139046|16246933|P2|Overall Study|Lack of Efficacy|1
4712731|NCT02139046|16246934|P1|Overall Study|Lack of Efficacy|0
4712732|NCT02139046|16246930|P5|Overall Study|Voluntary Withdrawal|16
4712733|NCT02139046|16246931|P4|Overall Study|Voluntary Withdrawal|15
4712734|NCT02139046|16246932|P3|Overall Study|Voluntary Withdrawal|10
4712735|NCT02139046|16246933|P2|Overall Study|Voluntary Withdrawal|8
4712736|NCT02139046|16246934|P1|Overall Study|Voluntary Withdrawal|20
4712737|NCT02139046|16246930|P5|Overall Study|Lost to Follow-up|13
4712738|NCT02139046|16246931|P4|Overall Study|Lost to Follow-up|18
4712739|NCT02139046|16246932|P3|Overall Study|Lost to Follow-up|16
4712740|NCT02139046|16246933|P2|Overall Study|Lost to Follow-up|16
4712741|NCT02139046|16246934|P1|Overall Study|Lost to Follow-up|13
4712742|NCT02139046|16246930|P5|Overall Study|Major Protocol Deviation|6
4712743|NCT02139046|16246931|P4|Overall Study|Major Protocol Deviation|12
4712744|NCT02139046|16246932|P3|Overall Study|Major Protocol Deviation|16
4712745|NCT02139046|16246933|P2|Overall Study|Major Protocol Deviation|10
4712746|NCT02139046|16246934|P1|Overall Study|Major Protocol Deviation|9
4712747|NCT02139046|16246930|P5|Overall Study|Pretreatment Event/Adverse Event|7
4712748|NCT02139046|16246931|P4|Overall Study|Pretreatment Event/Adverse Event|13
4712749|NCT02139046|16246932|P3|Overall Study|Pretreatment Event/Adverse Event|10
4712750|NCT02139046|16246933|P2|Overall Study|Pretreatment Event/Adverse Event|9
4712751|NCT02139046|16246934|P1|Overall Study|Pretreatment Event/Adverse Event|9
4712752|NCT02138916|16246975|P3|Overall Study|Adverse Event|3
4712753|NCT02138916|16246976|P2|Overall Study|Adverse Event|4
4712754|NCT02138916|16246977|P1|Overall Study|Adverse Event|4
4712755|NCT02138916|16246975|P3|Overall Study|Lost to Follow-up|3
4712756|NCT02138916|16246976|P2|Overall Study|Lost to Follow-up|2
4712757|NCT02138916|16246977|P1|Overall Study|Lost to Follow-up|4
4712758|NCT02138916|16246975|P3|Overall Study|Severe non-compliance|1
4712759|NCT02138916|16246976|P2|Overall Study|Severe non-compliance|2
4712760|NCT02138916|16246977|P1|Overall Study|Severe non-compliance|1
4712761|NCT02138916|16246975|P3|Overall Study|incorrect enrolment|0
4712762|NCT02138916|16246976|P2|Overall Study|incorrect enrolment|1
4712763|NCT02138916|16246977|P1|Overall Study|incorrect enrolment|1
4712764|NCT02138916|16246975|P3|Overall Study|Study specific withdrawal criteria|1
4712765|NCT02138916|16246976|P2|Overall Study|Study specific withdrawal criteria|0
4712766|NCT02138916|16246977|P1|Overall Study|Study specific withdrawal criteria|0
4712767|NCT02138916|16246975|P3|Overall Study|Withdrawal by Subject|32
4712768|NCT02138916|16246976|P2|Overall Study|Withdrawal by Subject|31
4712769|NCT02138916|16246977|P1|Overall Study|Withdrawal by Subject|27
4712770|NCT02138916|16246975|P3|Overall Study|Death|12
4712771|NCT02138916|16246976|P2|Overall Study|Death|11
4712772|NCT02138916|16246977|P1|Overall Study|Death|14
4712773|NCT02138916|16246975|P3|Overall Study|eg., meds change, lack of efficacy, etc.|7
4712774|NCT02138916|16246976|P2|Overall Study|eg., meds change, lack of efficacy, etc.|9
4712775|NCT02138916|16246977|P1|Overall Study|eg., meds change, lack of efficacy, etc.|6
4712776|NCT02138890|16247040|P2|Overall Study|Adverse Event|0
4712777|NCT02138890|16247041|P1|Overall Study|Adverse Event|1
4712778|NCT02138838|16247083|P2|Overall Study|Withdrawal by Subject|5
4712779|NCT02138838|16247084|P1|Overall Study|Withdrawal by Subject|1
4712780|NCT02138838|16247083|P2|Overall Study|Study Closure|6
4712781|NCT02138838|16247084|P1|Overall Study|Study Closure|7
4712782|NCT02138825|16247102|P2|Safety Follow-up|withdrawn due to lung transplant|1
4712783|NCT02138825|16247103|P1|Safety Follow-up|withdrawn due to lung transplant|0
4712784|NCT02138825|16247102|P2|Safety Follow-up|treatment unblinded|1
4712785|NCT02138825|16247103|P1|Safety Follow-up|treatment unblinded|0
4712786|NCT02138825|16247102|P2|Safety Follow-up|too unwell to attend the visit|1
4712787|NCT02138825|16247103|P1|Safety Follow-up|too unwell to attend the visit|0
4712788|NCT02138825|16247102|P2|Safety Follow-up|progressive disease|2
4712789|NCT02138825|16247103|P1|Safety Follow-up|progressive disease|0
4712790|NCT02138825|16247102|P2|Safety Follow-up|logistical difficulties|1
4712791|NCT02138825|16247103|P1|Safety Follow-up|logistical difficulties|0
4712792|NCT02138825|16247102|P2|Safety Follow-up|withdrawal by PI|0
4712793|NCT02138825|16247103|P1|Safety Follow-up|withdrawal by PI|1
4712794|NCT02138825|16247102|P2|Safety Follow-up|clinic worsening|0
4712795|NCT02138825|16247103|P1|Safety Follow-up|clinic worsening|1
4712796|NCT02138825|16247102|P2|Safety Follow-up|Withdrawal by Subject|3
4712797|NCT02138825|16247103|P1|Safety Follow-up|Withdrawal by Subject|5
4712798|NCT02138825|16247102|P2|Safety Follow-up|Death|5
4712799|NCT02138825|16247103|P1|Safety Follow-up|Death|11
4712800|NCT02138825|16247102|P2|Safety Follow-up|Adverse Event|3
4712801|NCT02138825|16247103|P1|Safety Follow-up|Adverse Event|4
4712802|NCT02138825|16247102|P2|Long-term Extension|Study termination by sponsor|38
4712803|NCT02138825|16247103|P1|Long-term Extension|Study termination by sponsor|32
4712804|NCT02138825|16247102|P2|Main Study Treatment|Medical decision|0
4712805|NCT02138825|16247103|P1|Main Study Treatment|Medical decision|1
4712806|NCT02138825|16247102|P2|Main Study Treatment|Withdrawal by Subject|1
4712807|NCT02138825|16247103|P1|Main Study Treatment|Withdrawal by Subject|3
4712808|NCT02138825|16247102|P2|Main Study Treatment|Study terminated by sponsor|9
4712809|NCT02138825|16247103|P1|Main Study Treatment|Study terminated by sponsor|10
4712810|NCT02138825|16247102|P2|Main Study Treatment|Sponsor decision|18
4712811|NCT02138825|16247103|P1|Main Study Treatment|Sponsor decision|12
4712812|NCT02138825|16247102|P2|Main Study Treatment|Protocol Violation|2
4712813|NCT02138825|16247103|P1|Main Study Treatment|Protocol Violation|2
4712814|NCT02138825|16247102|P2|Main Study Treatment|Death|2
4712815|NCT02138825|16247103|P1|Main Study Treatment|Death|1
4712816|NCT02138825|16247102|P2|Main Study Treatment|Adverse Event|3
4712817|NCT02138825|16247103|P1|Main Study Treatment|Adverse Event|11
4712818|NCT02138786|16247120|P3|Overall Study|Non-Compliance|1
4712819|NCT02138786|16247121|P2|Overall Study|Non-Compliance|0
4712820|NCT02138786|16247122|P1|Overall Study|Non-Compliance|0
4712821|NCT02138786|16247120|P3|Overall Study|Sponsor Terminated Study|1
4712822|NCT02138786|16247121|P2|Overall Study|Sponsor Terminated Study|1
4712823|NCT02138786|16247122|P1|Overall Study|Sponsor Terminated Study|0
4712824|NCT02138786|16247120|P3|Overall Study|Patient's Wish|0
4712825|NCT02138786|16247121|P2|Overall Study|Patient's Wish|2
4712826|NCT02138786|16247122|P1|Overall Study|Patient's Wish|0
4712827|NCT02138786|16247120|P3|Overall Study|Withdrawal by Subject|0
4712828|NCT02138786|16247121|P2|Overall Study|Withdrawal by Subject|2
4712829|NCT02138786|16247122|P1|Overall Study|Withdrawal by Subject|1
4712830|NCT02138786|16247120|P3|Overall Study|Disease Progression|3
4712831|NCT02138786|16247121|P2|Overall Study|Disease Progression|1
4712832|NCT02138786|16247122|P1|Overall Study|Disease Progression|1
4712833|NCT02138786|16247120|P3|Overall Study|Death|2
4712834|NCT02138786|16247121|P2|Overall Study|Death|7
4712835|NCT02138786|16247122|P1|Overall Study|Death|1
4712836|NCT02138786|16247120|P3|Overall Study|Adverse Event|1
4712837|NCT02138786|16247121|P2|Overall Study|Adverse Event|2
4712838|NCT02138786|16247122|P1|Overall Study|Adverse Event|0
4712839|NCT02138747|16247139|P4|Treatment Period 2|Other - Miscellaneous|0
4712840|NCT02138747|16247140|P3|Treatment Period 2|Other - Miscellaneous|0
4712841|NCT02138747|16247141|P2|Treatment Period 2|Other - Miscellaneous|0
4712842|NCT02138747|16247142|P1|Treatment Period 2|Other - Miscellaneous|3
4712843|NCT02138747|16247139|P4|Treatment Period 2|Withdrawal by Subject|2
4712844|NCT02138747|16247140|P3|Treatment Period 2|Withdrawal by Subject|1
4712845|NCT02138747|16247141|P2|Treatment Period 2|Withdrawal by Subject|4
4712846|NCT02138747|16247142|P1|Treatment Period 2|Withdrawal by Subject|5
4712847|NCT02138747|16247139|P4|Treatment Period 2|Protocol Violation|0
4712848|NCT02138747|16247140|P3|Treatment Period 2|Protocol Violation|0
4712849|NCT02138747|16247141|P2|Treatment Period 2|Protocol Violation|0
4712850|NCT02138747|16247142|P1|Treatment Period 2|Protocol Violation|1
4712851|NCT02138747|16247139|P4|Treatment Period 2|Lost to Follow-up|0
4712852|NCT02138747|16247140|P3|Treatment Period 2|Lost to Follow-up|0
4712853|NCT02138747|16247141|P2|Treatment Period 2|Lost to Follow-up|0
4712854|NCT02138747|16247142|P1|Treatment Period 2|Lost to Follow-up|2
4712855|NCT02138747|16247139|P4|Treatment Period 2|Adverse Event|1
4712856|NCT02138747|16247140|P3|Treatment Period 2|Adverse Event|1
4712857|NCT02138747|16247141|P2|Treatment Period 2|Adverse Event|3
4712858|NCT02138747|16247142|P1|Treatment Period 2|Adverse Event|6
4712859|NCT02138747|16247139|P4|Treatment Period 1|Other - Miscellaneous|0
4712860|NCT02138747|16247140|P3|Treatment Period 1|Other - Miscellaneous|0
4712861|NCT02138747|16247141|P2|Treatment Period 1|Other - Miscellaneous|4
4712862|NCT02138747|16247142|P1|Treatment Period 1|Other - Miscellaneous|2
4712863|NCT02138747|16247139|P4|Treatment Period 1|Withdrawal by Subject|3
4712864|NCT02138747|16247140|P3|Treatment Period 1|Withdrawal by Subject|1
4712865|NCT02138747|16247141|P2|Treatment Period 1|Withdrawal by Subject|4
4712866|NCT02138747|16247142|P1|Treatment Period 1|Withdrawal by Subject|8
4712867|NCT02138747|16247139|P4|Treatment Period 1|Protocol Violation|0
4712868|NCT02138747|16247140|P3|Treatment Period 1|Protocol Violation|0
4712869|NCT02138747|16247141|P2|Treatment Period 1|Protocol Violation|2
4712870|NCT02138747|16247142|P1|Treatment Period 1|Protocol Violation|0
4712871|NCT02138747|16247139|P4|Treatment Period 1|Lost to Follow-up|0
4712872|NCT02138747|16247140|P3|Treatment Period 1|Lost to Follow-up|1
4712873|NCT02138747|16247141|P2|Treatment Period 1|Lost to Follow-up|1
4712874|NCT02138747|16247142|P1|Treatment Period 1|Lost to Follow-up|0
4712875|NCT02138747|16247139|P4|Treatment Period 1|Adverse Event|1
4712876|NCT02138747|16247140|P3|Treatment Period 1|Adverse Event|2
4712877|NCT02138747|16247141|P2|Treatment Period 1|Adverse Event|14
4712878|NCT02138747|16247142|P1|Treatment Period 1|Adverse Event|10
4712879|NCT02138253|16247216|P2|Overall Study|Withdrawal by Subject|0
4712880|NCT02138253|16247217|P1|Overall Study|Withdrawal by Subject|1
4712881|NCT02138253|16247216|P2|Overall Study|Non compliance|0
4712882|NCT02138253|16247217|P1|Overall Study|Non compliance|1
4712883|NCT02138253|16247216|P2|Overall Study|Physician Decision|0
4712884|NCT02138253|16247217|P1|Overall Study|Physician Decision|2
4712885|NCT02138253|16247216|P2|Overall Study|Lost to Follow-up|1
4712886|NCT02138253|16247217|P1|Overall Study|Lost to Follow-up|2
4712887|NCT02138253|16247216|P2|Overall Study|Adverse Event|3
4712888|NCT02138253|16247217|P1|Overall Study|Adverse Event|3
4712889|NCT02138136|16247289|P1|Overall Study|Withdrawn by Sponsor|5
4712890|NCT02138136|16247289|P1|Overall Study|Lost to Follow-up|32
4712891|NCT02138136|16247289|P1|Overall Study|Withdrawal by Subject|36
4712892|NCT02138136|16247289|P1|Overall Study|Adverse Event|18
4712893|NCT02138136|16247289|P1|Overall Study|Pregnancy|2
4712894|NCT02138136|16247289|P1|Overall Study|Lack of Efficacy|35
4712895|NCT02138136|16247289|P1|Overall Study|Physician Decision|7
4712896|NCT02138136|16247289|P1|Overall Study|Protocol Violation|4
4712897|NCT02138110|16247296|P1|Overall Scaffold Implantation|Death|3
4712898|NCT02138110|16247296|P1|Enrolled for Scaffold Implantation|Physician Decision|1
4712899|NCT02137785|16247528|P2|Overall Study|subject moved out of state|0
4712900|NCT02137785|16247529|P1|Overall Study|subject moved out of state|1
4712901|NCT02137785|16247528|P2|Overall Study|Withdrawal by Subject|4
4712902|NCT02137785|16247529|P1|Overall Study|Withdrawal by Subject|1
4712903|NCT02137785|16247528|P2|Overall Study|Lost to Follow-up|0
4712904|NCT02137785|16247529|P1|Overall Study|Lost to Follow-up|1
4712905|NCT02137772|16247637|P2|Overall Study|Not treated|2
4712906|NCT02137772|16247638|P1|Overall Study|Not treated|3
4712907|NCT02137772|16247637|P2|Overall Study|Non-compliance with study drug|0
4712908|NCT02137772|16247638|P1|Overall Study|Non-compliance with study drug|1
4712909|NCT02137772|16247637|P2|Overall Study|Withdrawal by Subject|17
4712910|NCT02137772|16247638|P1|Overall Study|Withdrawal by Subject|28
4712911|NCT02137772|16247637|P2|Overall Study|Physician Decision|5
4712912|NCT02137772|16247638|P1|Overall Study|Physician Decision|15
4712913|NCT02137772|16247637|P2|Overall Study|Lost to Follow-up|4
4712914|NCT02137772|16247638|P1|Overall Study|Lost to Follow-up|8
4712915|NCT02137772|16247637|P2|Overall Study|Death|44
4712916|NCT02137772|16247638|P1|Overall Study|Death|71
4712917|NCT02137772|16247637|P2|Overall Study|Adverse Event|3
4712918|NCT02137772|16247638|P1|Overall Study|Adverse Event|6
4712919|NCT02137226|16247896|P5|Period 2 (Re - Randomization)|Other Reason|1
4712920|NCT02137226|16247897|P4|Period 2 (Re - Randomization)|Other Reason|1
4712921|NCT02137226|16247898|P3|Period 2 (Re - Randomization)|Other Reason|1
4712922|NCT02137226|16247899|P2|Period 2 (Re - Randomization)|Other Reason|0
4712923|NCT02137226|16247900|P1|Period 2 (Re - Randomization)|Other Reason|0
4712924|NCT02137226|16247896|P5|Period 2 (Re - Randomization)|Lack of Efficacy|0
4712925|NCT02137226|16247897|P4|Period 2 (Re - Randomization)|Lack of Efficacy|0
4712926|NCT02137226|16247898|P3|Period 2 (Re - Randomization)|Lack of Efficacy|2
4712927|NCT02137226|16247899|P2|Period 2 (Re - Randomization)|Lack of Efficacy|0
4712928|NCT02137226|16247900|P1|Period 2 (Re - Randomization)|Lack of Efficacy|0
4712929|NCT02137226|16247896|P5|Period 2 (Re - Randomization)|Lost to Follow-up|0
4712930|NCT02137226|16247897|P4|Period 2 (Re - Randomization)|Lost to Follow-up|0
4712931|NCT02137226|16247898|P3|Period 2 (Re - Randomization)|Lost to Follow-up|3
4712932|NCT02137226|16247899|P2|Period 2 (Re - Randomization)|Lost to Follow-up|0
4712933|NCT02137226|16247900|P1|Period 2 (Re - Randomization)|Lost to Follow-up|0
4712934|NCT02137226|16247896|P5|Period 2 (Re - Randomization)|Physician Decision|0
4712935|NCT02137226|16247897|P4|Period 2 (Re - Randomization)|Physician Decision|1
4712936|NCT02137226|16247898|P3|Period 2 (Re - Randomization)|Physician Decision|0
4712937|NCT02137226|16247899|P2|Period 2 (Re - Randomization)|Physician Decision|0
4712938|NCT02137226|16247900|P1|Period 2 (Re - Randomization)|Physician Decision|0
4712939|NCT02137226|16247896|P5|Period 2 (Re - Randomization)|Withdrawal by Subject|4
4712940|NCT02137226|16247897|P4|Period 2 (Re - Randomization)|Withdrawal by Subject|5
4712941|NCT02137226|16247898|P3|Period 2 (Re - Randomization)|Withdrawal by Subject|8
4712942|NCT02137226|16247899|P2|Period 2 (Re - Randomization)|Withdrawal by Subject|0
4712943|NCT02137226|16247900|P1|Period 2 (Re - Randomization)|Withdrawal by Subject|0
4712944|NCT02137226|16247896|P5|Period 2 (Re - Randomization)|Adverse Event|4
4712945|NCT02137226|16247897|P4|Period 2 (Re - Randomization)|Adverse Event|1
4712946|NCT02137226|16247898|P3|Period 2 (Re - Randomization)|Adverse Event|3
4712947|NCT02137226|16247899|P2|Period 2 (Re - Randomization)|Adverse Event|0
4712948|NCT02137226|16247900|P1|Period 2 (Re - Randomization)|Adverse Event|0
4712949|NCT02137226|16247896|P5|Period 1 (Initial Randomization)|Other Reason|0
4712950|NCT02137226|16247897|P4|Period 1 (Initial Randomization)|Other Reason|0
4712951|NCT02137226|16247898|P3|Period 1 (Initial Randomization)|Other Reason|0
4712952|NCT02137226|16247899|P2|Period 1 (Initial Randomization)|Other Reason|3
4712953|NCT02137226|16247900|P1|Period 1 (Initial Randomization)|Other Reason|1
4712954|NCT02137226|16247896|P5|Period 1 (Initial Randomization)|Lack of Efficacy|0
4712955|NCT02137226|16247897|P4|Period 1 (Initial Randomization)|Lack of Efficacy|0
4712956|NCT02137226|16247898|P3|Period 1 (Initial Randomization)|Lack of Efficacy|0
4712957|NCT02137226|16247899|P2|Period 1 (Initial Randomization)|Lack of Efficacy|0
4712958|NCT02137226|16247900|P1|Period 1 (Initial Randomization)|Lack of Efficacy|1
4712959|NCT02137226|16247896|P5|Period 1 (Initial Randomization)|Lost to Follow-up|0
4712960|NCT02137226|16247897|P4|Period 1 (Initial Randomization)|Lost to Follow-up|0
4712961|NCT02137226|16247898|P3|Period 1 (Initial Randomization)|Lost to Follow-up|0
4712962|NCT02137226|16247899|P2|Period 1 (Initial Randomization)|Lost to Follow-up|2
4712963|NCT02137226|16247900|P1|Period 1 (Initial Randomization)|Lost to Follow-up|3
4712964|NCT02137226|16247896|P5|Period 1 (Initial Randomization)|Physician Decision|0
4712965|NCT02137226|16247897|P4|Period 1 (Initial Randomization)|Physician Decision|0
4712966|NCT02137226|16247898|P3|Period 1 (Initial Randomization)|Physician Decision|0
4712967|NCT02137226|16247899|P2|Period 1 (Initial Randomization)|Physician Decision|3
4712968|NCT02137226|16247900|P1|Period 1 (Initial Randomization)|Physician Decision|1
4712969|NCT02137226|16247896|P5|Period 1 (Initial Randomization)|Withdrawal by Subject|0
4712970|NCT02137226|16247897|P4|Period 1 (Initial Randomization)|Withdrawal by Subject|0
4712971|NCT02137226|16247898|P3|Period 1 (Initial Randomization)|Withdrawal by Subject|0
4712972|NCT02137226|16247899|P2|Period 1 (Initial Randomization)|Withdrawal by Subject|5
4712973|NCT02137226|16247900|P1|Period 1 (Initial Randomization)|Withdrawal by Subject|11
4712974|NCT02137226|16247896|P5|Period 1 (Initial Randomization)|Adverse Event|0
4712975|NCT02137226|16247897|P4|Period 1 (Initial Randomization)|Adverse Event|0
4712976|NCT02137226|16247898|P3|Period 1 (Initial Randomization)|Adverse Event|0
4712977|NCT02137226|16247899|P2|Period 1 (Initial Randomization)|Adverse Event|3
4712978|NCT02137226|16247900|P1|Period 1 (Initial Randomization)|Adverse Event|3
4712979|NCT02136914|16247918|P2|Overall Study|Death|1
4712980|NCT02136914|16247919|P1|Overall Study|Death|0
4712981|NCT02136914|16247918|P2|Overall Study|Lack of Efficacy|0
4712982|NCT02136914|16247919|P1|Overall Study|Lack of Efficacy|1
4712983|NCT02136914|16247918|P2|Overall Study|Did Not Receive Study Drug|0
4712984|NCT02136914|16247919|P1|Overall Study|Did Not Receive Study Drug|2
4712985|NCT02136914|16247918|P2|Overall Study|Lost to Follow-up|1
4712986|NCT02136914|16247919|P1|Overall Study|Lost to Follow-up|1
4712987|NCT02136914|16247918|P2|Overall Study|Subject Unwilling to Proceed|2
4712988|NCT02136914|16247919|P1|Overall Study|Subject Unwilling to Proceed|7
4712989|NCT02136914|16247918|P2|Overall Study|Withdrawal by Subject|10
4712990|NCT02136914|16247919|P1|Overall Study|Withdrawal by Subject|3
4712991|NCT02136914|16247918|P2|Overall Study|Sponsor's Decision to Stop the Study|7
4712992|NCT02136914|16247919|P1|Overall Study|Sponsor's Decision to Stop the Study|7
4712993|NCT02136680|16247939|P2|Overall Study|Study ended before interview due|3
4712994|NCT02136680|16247940|P1|Overall Study|Study ended before interview due|6
4712995|NCT02136680|16247939|P2|Overall Study|Unable to schedule|16
4712996|NCT02136680|16247940|P1|Overall Study|Unable to schedule|17
4712997|NCT02136680|16247939|P2|Overall Study|Moved away|4
4712998|NCT02136680|16247940|P1|Overall Study|Moved away|5
4712999|NCT02136680|16247939|P2|Overall Study|No longer receiving care at clinic|5
4713000|NCT02136680|16247940|P1|Overall Study|No longer receiving care at clinic|3
4713001|NCT02136680|16247939|P2|Overall Study|No Longer Interested|1
4713002|NCT02136680|16247940|P1|Overall Study|No Longer Interested|1
4713003|NCT02136134|16248015|P2|Overall Study|Subjects randomized but not treated|8
4713004|NCT02136134|16248016|P1|Overall Study|Subjects randomized but not treated|10
4713005|NCT02136134|16248015|P2|Overall Study|Ongoing|207
4713006|NCT02136134|16248016|P1|Overall Study|Ongoing|185
4713007|NCT02136134|16248015|P2|Overall Study|Other|3
4713008|NCT02136134|16248016|P1|Overall Study|Other|3
4713009|NCT02136134|16248015|P2|Overall Study|Withdrawal by Subject|4
4713010|NCT02136134|16248016|P1|Overall Study|Withdrawal by Subject|14
4713011|NCT02136134|16248015|P2|Overall Study|Death|29
4713012|NCT02136134|16248016|P1|Overall Study|Death|35
4713013|NCT02135848|16248078|P2|Overall Study|Withdrawal by Subject|1
4713014|NCT02135848|16248079|P1|Overall Study|Withdrawal by Subject|1
4713015|NCT02135848|16248078|P2|Overall Study|Adverse Event|0
4713016|NCT02135848|16248079|P1|Overall Study|Adverse Event|2
4713017|NCT02135692|16248137|P1|Overall Study|Withdrawal by Subject|15
4713018|NCT02135692|16248137|P1|Overall Study|Lost to Follow-up|4
4713019|NCT02135692|16248137|P1|Overall Study|Study closed/terminated|153
4713020|NCT02135692|16248137|P1|Overall Study|Product commercially available|159
4713021|NCT02135692|16248137|P1|Overall Study|Subject met Liver Stopping Criteria|1
4713022|NCT02135692|16248137|P1|Overall Study|Protocol Violation|2
4713023|NCT02135692|16248137|P1|Overall Study|Lack of Efficacy|2
4713024|NCT02135692|16248137|P1|Overall Study|Adverse Event|3
4713025|NCT02135614|16248156|P2|Overall Study|Lost to Follow-up|0
4713026|NCT02135614|16248157|P1|Overall Study|Lost to Follow-up|3
4713027|NCT02135614|16248156|P2|Overall Study|Withdrew Consent|2
4713028|NCT02135614|16248157|P1|Overall Study|Withdrew Consent|2
4713029|NCT02135614|16248156|P2|Overall Study|Investigator's Discretion|1
4713030|NCT02135614|16248157|P1|Overall Study|Investigator's Discretion|0
4713031|NCT02135614|16248156|P2|Overall Study|Death|0
4713032|NCT02135614|16248157|P1|Overall Study|Death|1
4713033|NCT02135614|16248156|P2|Overall Study|Adverse Event|1
4713034|NCT02135614|16248157|P1|Overall Study|Adverse Event|0
4713035|NCT02135614|16248156|P2|Overall Study|Randomized but Not Treated|1
4713036|NCT02135614|16248157|P1|Overall Study|Randomized but Not Treated|2
4713037|NCT02135445|16248171|P2|Overall Study|Withdrawal by Subject|0
4713038|NCT02135445|16248172|P1|Overall Study|Withdrawal by Subject|1
4713039|NCT02135445|16248171|P2|Overall Study|Lost to Follow-up|0
4713040|NCT02135445|16248172|P1|Overall Study|Lost to Follow-up|1
4713041|NCT02135107|16248257|P4|Maintenance Therapy Period|Other|8
4713042|NCT02135107|16248258|P3|Maintenance Therapy Period|Other|7
4713043|NCT02135107|16248259|P2|Maintenance Therapy Period|Other|0
4713044|NCT02135107|16248260|P1|Maintenance Therapy Period|Other|0
4713045|NCT02135107|16248257|P4|Maintenance Therapy Period|Pregnancy|1
4713046|NCT02135107|16248258|P3|Maintenance Therapy Period|Pregnancy|0
4713047|NCT02135107|16248259|P2|Maintenance Therapy Period|Pregnancy|0
4713048|NCT02135107|16248260|P1|Maintenance Therapy Period|Pregnancy|0
4713049|NCT02135107|16248257|P4|Maintenance Therapy Period|Withdrawal by Subject|4
4713050|NCT02135107|16248258|P3|Maintenance Therapy Period|Withdrawal by Subject|5
4713051|NCT02135107|16248259|P2|Maintenance Therapy Period|Withdrawal by Subject|0
4713052|NCT02135107|16248260|P1|Maintenance Therapy Period|Withdrawal by Subject|0
4713053|NCT02135107|16248257|P4|Maintenance Therapy Period|Adverse Event|7
4713054|NCT02135107|16248258|P3|Maintenance Therapy Period|Adverse Event|3
4713055|NCT02135107|16248259|P2|Maintenance Therapy Period|Adverse Event|0
4713056|NCT02135107|16248260|P1|Maintenance Therapy Period|Adverse Event|0
4713057|NCT02135107|16248257|P4|Treatment Period|Other|0
4713058|NCT02135107|16248258|P3|Treatment Period|Other|0
4713059|NCT02135107|16248259|P2|Treatment Period|Other|24
4713060|NCT02135107|16248260|P1|Treatment Period|Other|115
4713061|NCT02135107|16248257|P4|Treatment Period|Pregnancy|0
4713062|NCT02135107|16248258|P3|Treatment Period|Pregnancy|0
4713063|NCT02135107|16248259|P2|Treatment Period|Pregnancy|0
4713064|NCT02135107|16248260|P1|Treatment Period|Pregnancy|1
4713065|NCT02135107|16248257|P4|Treatment Period|Adverse Event|0
4713066|NCT02135107|16248258|P3|Treatment Period|Adverse Event|0
4713067|NCT02135107|16248259|P2|Treatment Period|Adverse Event|2
4713068|NCT02135107|16248260|P1|Treatment Period|Adverse Event|5
4713069|NCT02135107|16248257|P4|Treatment Period|Withdrawal by Subject|0
4713070|NCT02135107|16248258|P3|Treatment Period|Withdrawal by Subject|0
4713071|NCT02135107|16248259|P2|Treatment Period|Withdrawal by Subject|0
4713072|NCT02135107|16248260|P1|Treatment Period|Withdrawal by Subject|11
4713073|NCT02135029|16248306|P3|Overall Study|Death|0
4713074|NCT02135029|16248307|P2|Overall Study|Death|1
4713075|NCT02135029|16248308|P1|Overall Study|Death|0
4713076|NCT02135029|16248306|P3|Overall Study|Other|0
4713077|NCT02135029|16248307|P2|Overall Study|Other|1
4713078|NCT02135029|16248308|P1|Overall Study|Other|0
4713079|NCT02135029|16248306|P3|Overall Study|Withdrawal by Subject|1
4713080|NCT02135029|16248307|P2|Overall Study|Withdrawal by Subject|0
4713081|NCT02135029|16248308|P1|Overall Study|Withdrawal by Subject|2
4713082|NCT02135029|16248306|P3|Overall Study|Lost to Follow-up|0
4713083|NCT02135029|16248307|P2|Overall Study|Lost to Follow-up|1
4713084|NCT02135029|16248308|P1|Overall Study|Lost to Follow-up|0
4713085|NCT02135029|16248306|P3|Overall Study|Adverse Event|2
4713086|NCT02135029|16248307|P2|Overall Study|Adverse Event|2
4713087|NCT02135029|16248308|P1|Overall Study|Adverse Event|2
4713088|NCT02134977|16248413|P1|Overall Study|Protocol Deviation|102
4713089|NCT02134925|16248447|P2|Overall Study|Cancel|6
4713090|NCT02134925|16248448|P1|Overall Study|Cancel|1
4713091|NCT02134925|16248447|P2|Overall Study|Withdrawal by Subject|0
4713092|NCT02134925|16248448|P1|Overall Study|Withdrawal by Subject|1
4713093|NCT02134587|16248489|P1|Overall Study|Did not completed all meetings|30
4713094|NCT02134015|16248628|P2|Overall Study|Withdrawal by Subject|7
4713095|NCT02134015|16248629|P1|Overall Study|Withdrawal by Subject|3
4713096|NCT02134015|16248628|P2|Overall Study|Adverse Event|10
4713097|NCT02134015|16248629|P1|Overall Study|Adverse Event|9
4713098|NCT02134015|16248628|P2|Overall Study|Study terminated by sponsor|3
4713099|NCT02134015|16248629|P1|Overall Study|Study terminated by sponsor|2
4713100|NCT02134015|16248628|P2|Overall Study|Progressive disease (per RECIST 1.1)|43
4713101|NCT02134015|16248629|P1|Overall Study|Progressive disease (per RECIST 1.1)|40
4713102|NCT02134015|16248628|P2|Overall Study|Clinical progression|7
4713103|NCT02134015|16248629|P1|Overall Study|Clinical progression|14
4713104|NCT02134015|16248628|P2|Overall Study|Reason not provided|2
4713105|NCT02134015|16248629|P1|Overall Study|Reason not provided|1
4713106|NCT02134015|16248628|P2|Overall Study|Death|1
4713107|NCT02134015|16248629|P1|Overall Study|Death|2
4713108|NCT02134015|16248628|P2|Overall Study|Protocol Violation|1
4713109|NCT02134015|16248629|P1|Overall Study|Protocol Violation|0
4713110|NCT02133742|16248665|P1|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1
4713111|NCT02133742|16248665|P1|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5
4713112|NCT02133742|16248665|P1|Period 2:Dose Expansion Phase (1344days)|Death|13
4713113|NCT02133742|16248665|P1|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31
4713114|NCT02133742|16248665|P1|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2
4713115|NCT02133664|16248694|P2|Overall Study|Adverse Event|6
4713116|NCT02133664|16248695|P1|Overall Study|Adverse Event|3
4713117|NCT02133664|16248694|P2|Overall Study|Lost to Follow-up|1
4713118|NCT02133664|16248695|P1|Overall Study|Lost to Follow-up|2
4713119|NCT02133508|16248711|P1|Overall Study|Lost to Follow-up|2
4713120|NCT02133508|16248711|P1|Overall Study|Death|12
4713121|NCT02133508|16248711|P1|Overall Study|Decision of Investigator or Sponsor|1
4713122|NCT02133352|16248719|P1|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6
4713123|NCT02133131|16248750|P7|Overall Study|Protocol Violation|1
4713124|NCT02133131|16248751|P6|Overall Study|Protocol Violation|0
4713125|NCT02133131|16248752|P5|Overall Study|Protocol Violation|0
4713126|NCT02133131|16248753|P4|Overall Study|Protocol Violation|0
4713127|NCT02133131|16248754|P3|Overall Study|Protocol Violation|0
4713128|NCT02133131|16248755|P2|Overall Study|Protocol Violation|0
4713129|NCT02133131|16248756|P1|Overall Study|Protocol Violation|0
4713130|NCT02133131|16248750|P7|Overall Study|Ongoing in study|11
4713131|NCT02133131|16248751|P6|Overall Study|Ongoing in study|14
4713132|NCT02133131|16248752|P5|Overall Study|Ongoing in study|15
4713133|NCT02133131|16248753|P4|Overall Study|Ongoing in study|0
4713134|NCT02133131|16248754|P3|Overall Study|Ongoing in study|0
4713135|NCT02133131|16248755|P2|Overall Study|Ongoing in study|0
4713136|NCT02133131|16248756|P1|Overall Study|Ongoing in study|0
4713137|NCT02133131|16248750|P7|Overall Study|Status not recorded|0
4713138|NCT02133131|16248751|P6|Overall Study|Status not recorded|0
4713139|NCT02133131|16248752|P5|Overall Study|Status not recorded|0
4713140|NCT02133131|16248753|P4|Overall Study|Status not recorded|4
4713141|NCT02133131|16248754|P3|Overall Study|Status not recorded|1
4713142|NCT02133131|16248755|P2|Overall Study|Status not recorded|5
4713143|NCT02133131|16248756|P1|Overall Study|Status not recorded|4
4713144|NCT02133131|16248750|P7|Overall Study|Lost to Follow-up|0
4713145|NCT02133131|16248751|P6|Overall Study|Lost to Follow-up|0
4713146|NCT02133131|16248752|P5|Overall Study|Lost to Follow-up|0
4713147|NCT02133131|16248753|P4|Overall Study|Lost to Follow-up|1
4713148|NCT02133131|16248754|P3|Overall Study|Lost to Follow-up|0
4713149|NCT02133131|16248755|P2|Overall Study|Lost to Follow-up|0
4713150|NCT02133131|16248756|P1|Overall Study|Lost to Follow-up|1
4713151|NCT02133131|16248750|P7|Overall Study|Adverse Event|0
4713152|NCT02133131|16248751|P6|Overall Study|Adverse Event|0
4713153|NCT02133131|16248752|P5|Overall Study|Adverse Event|0
4713154|NCT02133131|16248753|P4|Overall Study|Adverse Event|1
4713155|NCT02133131|16248754|P3|Overall Study|Adverse Event|0
4713156|NCT02133131|16248755|P2|Overall Study|Adverse Event|0
4713157|NCT02133131|16248756|P1|Overall Study|Adverse Event|0
4713158|NCT02133001|16248810|P2|Follow-Up Phase (Day 26-81)|Other|1
4713159|NCT02133001|16248811|P1|Follow-Up Phase (Day 26-81)|Other|0
4713160|NCT02133001|16248810|P2|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
4713161|NCT02133001|16248811|P1|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1
4713162|NCT02133001|16248810|P2|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
4713163|NCT02133001|16248811|P1|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1
4713164|NCT02133001|16248810|P2|Double Blind (Day 1-25)|Withdrawal by Subject|1
4713165|NCT02133001|16248811|P1|Double Blind (Day 1-25)|Withdrawal by Subject|1
4713166|NCT02133001|16248810|P2|Double Blind (Day 1-25)|Other|2
4713167|NCT02133001|16248811|P1|Double Blind (Day 1-25)|Other|2
4713168|NCT02133001|16248810|P2|Double Blind (Day 1-25)|Lost to Follow-up|0
4713169|NCT02133001|16248811|P1|Double Blind (Day 1-25)|Lost to Follow-up|2
4713170|NCT02133001|16248810|P2|Double Blind (Day 1-25)|Lack of Efficacy|1
4713171|NCT02133001|16248811|P1|Double Blind (Day 1-25)|Lack of Efficacy|4
4713172|NCT02133001|16248810|P2|Double Blind (Day 1-25)|Adverse Event|5
4713173|NCT02133001|16248811|P1|Double Blind (Day 1-25)|Adverse Event|1
4713174|NCT02132949|16248859|P2|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|157
4713175|NCT02132949|16248860|P1|Adjuvant Treatment Period|Ongoing in Adjuvant Treatment|142
4713176|NCT02132949|16248859|P2|Adjuvant Treatment Period|Protocol Deviation|0
4713177|NCT02132949|16248860|P1|Adjuvant Treatment Period|Protocol Deviation|1
4713178|NCT02132949|16248859|P2|Adjuvant Treatment Period|Withdrawal by Subject|1
4713179|NCT02132949|16248860|P1|Adjuvant Treatment Period|Withdrawal by Subject|1
4713180|NCT02132949|16248859|P2|Adjuvant Treatment Period|Physician Decision|0
4713181|NCT02132949|16248860|P1|Adjuvant Treatment Period|Physician Decision|1
4713182|NCT02132949|16248859|P2|Adjuvant Treatment Period|Disease Relapse|1
4713183|NCT02132949|16248860|P1|Adjuvant Treatment Period|Disease Relapse|0
4713184|NCT02132949|16248859|P2|Adjuvant Treatment Period|Disease Progression|1
4713185|NCT02132949|16248860|P1|Adjuvant Treatment Period|Disease Progression|0
4713186|NCT02132949|16248859|P2|Adjuvant Treatment Period|Reason unspecified|1
4713187|NCT02132949|16248860|P1|Adjuvant Treatment Period|Reason unspecified|0
4713188|NCT02132949|16248859|P2|Adjuvant Treatment Period|Adverse Event|6
4713189|NCT02132949|16248860|P1|Adjuvant Treatment Period|Adverse Event|4
4713190|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Withdrew prior to treatment|3
4713191|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Withdrew prior to treatment|0
4713192|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Adverse Event|3
4713193|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Adverse Event|6
4713194|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Disease Progression|1
4713195|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Disease Progression|1
4713196|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Withdrawal by Subject|0
4713197|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Withdrawal by Subject|1
4713198|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Physician Decision|0
4713199|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Physician Decision|2
4713200|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Lack of Efficacy|1
4713201|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Lack of Efficacy|0
4713202|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Reason unspecified|1
4713203|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Reason unspecified|3
4713204|NCT02132949|16248859|P2|Neoadjuvant Treatment Period|Early surgery|3
4713205|NCT02132949|16248860|P1|Neoadjuvant Treatment Period|Early surgery|4
4713206|NCT02132767|16248972|P2|Overall Study|Lost to Follow-up|4
4713207|NCT02132767|16248973|P1|Overall Study|Lost to Follow-up|4
4713208|NCT02132767|16248972|P2|Overall Study|Withdrawal by Subject|9
4713209|NCT02132767|16248973|P1|Overall Study|Withdrawal by Subject|10
4713210|NCT02132767|16248972|P2|Overall Study|Death|2
4713211|NCT02132767|16248973|P1|Overall Study|Death|3
4713212|NCT02132754|16249027|P34|Overall Study|Withdrawal by Subject|2
4713213|NCT02132754|16249028|P33|Overall Study|Withdrawal by Subject|0
4713214|NCT02132754|16249029|P32|Overall Study|Withdrawal by Subject|1
4713215|NCT02132754|16249030|P31|Overall Study|Withdrawal by Subject|0
4713216|NCT02132754|16249031|P30|Overall Study|Withdrawal by Subject|0
4713217|NCT02132754|16249032|P29|Overall Study|Withdrawal by Subject|0
4713218|NCT02132754|16249033|P28|Overall Study|Withdrawal by Subject|1
4713219|NCT02132754|16249034|P27|Overall Study|Withdrawal by Subject|0
4713220|NCT02132754|16249035|P26|Overall Study|Withdrawal by Subject|0
4713221|NCT02132754|16249036|P25|Overall Study|Withdrawal by Subject|1
4713222|NCT02132754|16249037|P24|Overall Study|Withdrawal by Subject|0
4713223|NCT02132754|16249038|P23|Overall Study|Withdrawal by Subject|0
4713224|NCT02132754|16249039|P22|Overall Study|Withdrawal by Subject|0
4713225|NCT02132754|16249040|P21|Overall Study|Withdrawal by Subject|1
4713226|NCT02132754|16249041|P20|Overall Study|Withdrawal by Subject|0
4713227|NCT02132754|16249042|P19|Overall Study|Withdrawal by Subject|0
4713228|NCT02132754|16249043|P18|Overall Study|Withdrawal by Subject|0
4713229|NCT02132754|16249044|P17|Overall Study|Withdrawal by Subject|1
4713230|NCT02132754|16249045|P16|Overall Study|Withdrawal by Subject|2
4713231|NCT02132754|16249046|P15|Overall Study|Withdrawal by Subject|1
4713232|NCT02132754|16249047|P14|Overall Study|Withdrawal by Subject|0
4713233|NCT02132754|16249048|P13|Overall Study|Withdrawal by Subject|1
4713234|NCT02132754|16249049|P12|Overall Study|Withdrawal by Subject|0
4713235|NCT02132754|16249050|P11|Overall Study|Withdrawal by Subject|0
4713236|NCT02132754|16249051|P10|Overall Study|Withdrawal by Subject|1
4713237|NCT02132754|16249052|P9|Overall Study|Withdrawal by Subject|0
4713238|NCT02132754|16249053|P8|Overall Study|Withdrawal by Subject|0
4713239|NCT02132754|16249054|P7|Overall Study|Withdrawal by Subject|0
4713240|NCT02132754|16249055|P6|Overall Study|Withdrawal by Subject|0
4713241|NCT02132754|16249056|P5|Overall Study|Withdrawal by Subject|0
4713242|NCT02132754|16249057|P4|Overall Study|Withdrawal by Subject|0
4713243|NCT02132754|16249058|P3|Overall Study|Withdrawal by Subject|0
4713244|NCT02132754|16249059|P2|Overall Study|Withdrawal by Subject|0
4713245|NCT02132754|16249060|P1|Overall Study|Withdrawal by Subject|0
4713246|NCT02132754|16249027|P34|Overall Study|Transferred to Extension Study|6
4713247|NCT02132754|16249028|P33|Overall Study|Transferred to Extension Study|0
4713248|NCT02132754|16249029|P32|Overall Study|Transferred to Extension Study|0
4713249|NCT02132754|16249030|P31|Overall Study|Transferred to Extension Study|0
4713250|NCT02132754|16249031|P30|Overall Study|Transferred to Extension Study|0
4713251|NCT02132754|16249032|P29|Overall Study|Transferred to Extension Study|0
4713252|NCT02132754|16249033|P28|Overall Study|Transferred to Extension Study|0
4713253|NCT02132754|16249034|P27|Overall Study|Transferred to Extension Study|0
4713254|NCT02132754|16249035|P26|Overall Study|Transferred to Extension Study|0
4713255|NCT02132754|16249036|P25|Overall Study|Transferred to Extension Study|0
4713256|NCT02132754|16249037|P24|Overall Study|Transferred to Extension Study|0
4713257|NCT02132754|16249038|P23|Overall Study|Transferred to Extension Study|0
4713258|NCT02132754|16249039|P22|Overall Study|Transferred to Extension Study|0
4713259|NCT02132754|16249040|P21|Overall Study|Transferred to Extension Study|0
4713260|NCT02132754|16249041|P20|Overall Study|Transferred to Extension Study|0
4713261|NCT02132754|16249042|P19|Overall Study|Transferred to Extension Study|0
4713262|NCT02132754|16249043|P18|Overall Study|Transferred to Extension Study|0
4713263|NCT02132754|16249044|P17|Overall Study|Transferred to Extension Study|0
4713264|NCT02132754|16249045|P16|Overall Study|Transferred to Extension Study|0
4713265|NCT02132754|16249046|P15|Overall Study|Transferred to Extension Study|0
4713266|NCT02132754|16249047|P14|Overall Study|Transferred to Extension Study|0
4713267|NCT02132754|16249048|P13|Overall Study|Transferred to Extension Study|0
4713268|NCT02132754|16249049|P12|Overall Study|Transferred to Extension Study|0
4713269|NCT02132754|16249050|P11|Overall Study|Transferred to Extension Study|0
4713270|NCT02132754|16249051|P10|Overall Study|Transferred to Extension Study|0
4713271|NCT02132754|16249052|P9|Overall Study|Transferred to Extension Study|0
4713272|NCT02132754|16249053|P8|Overall Study|Transferred to Extension Study|0
4713273|NCT02132754|16249054|P7|Overall Study|Transferred to Extension Study|0
4713274|NCT02132754|16249055|P6|Overall Study|Transferred to Extension Study|0
4713275|NCT02132754|16249056|P5|Overall Study|Transferred to Extension Study|0
4713276|NCT02132754|16249057|P4|Overall Study|Transferred to Extension Study|0
4713277|NCT02132754|16249058|P3|Overall Study|Transferred to Extension Study|0
4713278|NCT02132754|16249059|P2|Overall Study|Transferred to Extension Study|0
4713279|NCT02132754|16249060|P1|Overall Study|Transferred to Extension Study|0
4713280|NCT02132754|16249027|P34|Overall Study|Screen Failure|0
4713281|NCT02132754|16249028|P33|Overall Study|Screen Failure|0
4713282|NCT02132754|16249029|P32|Overall Study|Screen Failure|0
4713283|NCT02132754|16249030|P31|Overall Study|Screen Failure|0
4713284|NCT02132754|16249031|P30|Overall Study|Screen Failure|0
4713285|NCT02132754|16249032|P29|Overall Study|Screen Failure|0
4713286|NCT02132754|16249033|P28|Overall Study|Screen Failure|0
4713287|NCT02132754|16249034|P27|Overall Study|Screen Failure|0
4713288|NCT02132754|16249035|P26|Overall Study|Screen Failure|0
4713289|NCT02132754|16249036|P25|Overall Study|Screen Failure|0
4713290|NCT02132754|16249037|P24|Overall Study|Screen Failure|0
4713291|NCT02132754|16249038|P23|Overall Study|Screen Failure|0
4713292|NCT02132754|16249039|P22|Overall Study|Screen Failure|1
4713293|NCT02132754|16249040|P21|Overall Study|Screen Failure|0
4713294|NCT02132754|16249041|P20|Overall Study|Screen Failure|1
4713295|NCT02132754|16249042|P19|Overall Study|Screen Failure|0
4713296|NCT02132754|16249043|P18|Overall Study|Screen Failure|0
4713297|NCT02132754|16249044|P17|Overall Study|Screen Failure|0
4713298|NCT02132754|16249045|P16|Overall Study|Screen Failure|0
4713299|NCT02132754|16249046|P15|Overall Study|Screen Failure|0
4713300|NCT02132754|16249047|P14|Overall Study|Screen Failure|0
4713301|NCT02132754|16249048|P13|Overall Study|Screen Failure|0
4713302|NCT02132754|16249049|P12|Overall Study|Screen Failure|0
4713303|NCT02132754|16249050|P11|Overall Study|Screen Failure|0
4713304|NCT02132754|16249051|P10|Overall Study|Screen Failure|0
4713305|NCT02132754|16249052|P9|Overall Study|Screen Failure|0
4713306|NCT02132754|16249053|P8|Overall Study|Screen Failure|0
4713307|NCT02132754|16249054|P7|Overall Study|Screen Failure|0
4713308|NCT02132754|16249055|P6|Overall Study|Screen Failure|0
4713309|NCT02132754|16249056|P5|Overall Study|Screen Failure|0
4713310|NCT02132754|16249057|P4|Overall Study|Screen Failure|0
4713311|NCT02132754|16249058|P3|Overall Study|Screen Failure|0
4713312|NCT02132754|16249059|P2|Overall Study|Screen Failure|0
4713313|NCT02132754|16249060|P1|Overall Study|Screen Failure|0
4713314|NCT02132754|16249027|P34|Overall Study|Progressive Disease|6
4713315|NCT02132754|16249028|P33|Overall Study|Progressive Disease|3
4713316|NCT02132754|16249029|P32|Overall Study|Progressive Disease|1
4713317|NCT02132754|16249030|P31|Overall Study|Progressive Disease|1
4713318|NCT02132754|16249031|P30|Overall Study|Progressive Disease|3
4713319|NCT02132754|16249032|P29|Overall Study|Progressive Disease|2
4713320|NCT02132754|16249033|P28|Overall Study|Progressive Disease|1
4713321|NCT02132754|16249034|P27|Overall Study|Progressive Disease|2
4713322|NCT02132754|16249035|P26|Overall Study|Progressive Disease|1
4713323|NCT02132754|16249036|P25|Overall Study|Progressive Disease|0
4713324|NCT02132754|16249037|P24|Overall Study|Progressive Disease|3
4713325|NCT02132754|16249038|P23|Overall Study|Progressive Disease|2
4713326|NCT02132754|16249039|P22|Overall Study|Progressive Disease|3
4713327|NCT02132754|16249040|P21|Overall Study|Progressive Disease|1
4713328|NCT02132754|16249041|P20|Overall Study|Progressive Disease|1
4713329|NCT02132754|16249042|P19|Overall Study|Progressive Disease|3
4713330|NCT02132754|16249043|P18|Overall Study|Progressive Disease|1
4713331|NCT02132754|16249044|P17|Overall Study|Progressive Disease|2
4713332|NCT02132754|16249045|P16|Overall Study|Progressive Disease|1
4713333|NCT02132754|16249046|P15|Overall Study|Progressive Disease|2
4713334|NCT02132754|16249047|P14|Overall Study|Progressive Disease|3
4713335|NCT02132754|16249048|P13|Overall Study|Progressive Disease|2
4713336|NCT02132754|16249049|P12|Overall Study|Progressive Disease|2
4713337|NCT02132754|16249050|P11|Overall Study|Progressive Disease|3
4713338|NCT02132754|16249051|P10|Overall Study|Progressive Disease|3
4713339|NCT02132754|16249052|P9|Overall Study|Progressive Disease|1
4713340|NCT02132754|16249053|P8|Overall Study|Progressive Disease|1
4713341|NCT02132754|16249054|P7|Overall Study|Progressive Disease|1
4713342|NCT02132754|16249055|P6|Overall Study|Progressive Disease|1
4713343|NCT02132754|16249056|P5|Overall Study|Progressive Disease|1
4713344|NCT02132754|16249057|P4|Overall Study|Progressive Disease|1
4713345|NCT02132754|16249058|P3|Overall Study|Progressive Disease|1
4713346|NCT02132754|16249059|P2|Overall Study|Progressive Disease|1
4713347|NCT02132754|16249060|P1|Overall Study|Progressive Disease|1
4713348|NCT02132754|16249027|P34|Overall Study|Physician Decision|3
4713349|NCT02132754|16249028|P33|Overall Study|Physician Decision|0
4713350|NCT02132754|16249029|P32|Overall Study|Physician Decision|1
4713351|NCT02132754|16249030|P31|Overall Study|Physician Decision|0
4713352|NCT02132754|16249031|P30|Overall Study|Physician Decision|0
4713353|NCT02132754|16249032|P29|Overall Study|Physician Decision|0
4713354|NCT02132754|16249033|P28|Overall Study|Physician Decision|0
4713355|NCT02132754|16249034|P27|Overall Study|Physician Decision|0
4713356|NCT02132754|16249035|P26|Overall Study|Physician Decision|0
4713357|NCT02132754|16249036|P25|Overall Study|Physician Decision|1
4713358|NCT02132754|16249037|P24|Overall Study|Physician Decision|0
4713359|NCT02132754|16249038|P23|Overall Study|Physician Decision|0
4713360|NCT02132754|16249039|P22|Overall Study|Physician Decision|0
4713361|NCT02132754|16249040|P21|Overall Study|Physician Decision|0
4713362|NCT02132754|16249041|P20|Overall Study|Physician Decision|0
4713363|NCT02132754|16249042|P19|Overall Study|Physician Decision|0
4713364|NCT02132754|16249043|P18|Overall Study|Physician Decision|0
4713365|NCT02132754|16249044|P17|Overall Study|Physician Decision|0
4713366|NCT02132754|16249045|P16|Overall Study|Physician Decision|1
4713367|NCT02132754|16249046|P15|Overall Study|Physician Decision|0
4713368|NCT02132754|16249047|P14|Overall Study|Physician Decision|0
4713369|NCT02132754|16249048|P13|Overall Study|Physician Decision|1
4713370|NCT02132754|16249049|P12|Overall Study|Physician Decision|1
4713371|NCT02132754|16249050|P11|Overall Study|Physician Decision|0
4713372|NCT02132754|16249051|P10|Overall Study|Physician Decision|1
4713373|NCT02132754|16249052|P9|Overall Study|Physician Decision|0
4713374|NCT02132754|16249053|P8|Overall Study|Physician Decision|0
4713375|NCT02132754|16249054|P7|Overall Study|Physician Decision|0
4713376|NCT02132754|16249055|P6|Overall Study|Physician Decision|0
4713377|NCT02132754|16249056|P5|Overall Study|Physician Decision|0
4713378|NCT02132754|16249057|P4|Overall Study|Physician Decision|0
4713379|NCT02132754|16249058|P3|Overall Study|Physician Decision|0
4713380|NCT02132754|16249059|P2|Overall Study|Physician Decision|0
4713381|NCT02132754|16249060|P1|Overall Study|Physician Decision|0
4713382|NCT02132754|16249027|P34|Overall Study|Excluded Medication|1
4713383|NCT02132754|16249028|P33|Overall Study|Excluded Medication|0
4713384|NCT02132754|16249029|P32|Overall Study|Excluded Medication|0
4713385|NCT02132754|16249030|P31|Overall Study|Excluded Medication|0
4713386|NCT02132754|16249031|P30|Overall Study|Excluded Medication|0
4713387|NCT02132754|16249032|P29|Overall Study|Excluded Medication|0
4713388|NCT02132754|16249033|P28|Overall Study|Excluded Medication|0
4713389|NCT02132754|16249034|P27|Overall Study|Excluded Medication|0
4713390|NCT02132754|16249035|P26|Overall Study|Excluded Medication|0
4713391|NCT02132754|16249036|P25|Overall Study|Excluded Medication|0
4713392|NCT02132754|16249037|P24|Overall Study|Excluded Medication|0
4713393|NCT02132754|16249038|P23|Overall Study|Excluded Medication|0
4713394|NCT02132754|16249039|P22|Overall Study|Excluded Medication|0
4713395|NCT02132754|16249040|P21|Overall Study|Excluded Medication|1
4713396|NCT02132754|16249041|P20|Overall Study|Excluded Medication|0
4713397|NCT02132754|16249042|P19|Overall Study|Excluded Medication|0
4713398|NCT02132754|16249043|P18|Overall Study|Excluded Medication|0
4713399|NCT02132754|16249044|P17|Overall Study|Excluded Medication|0
4713400|NCT02132754|16249045|P16|Overall Study|Excluded Medication|0
4713401|NCT02132754|16249046|P15|Overall Study|Excluded Medication|0
4713402|NCT02132754|16249047|P14|Overall Study|Excluded Medication|0
4713403|NCT02132754|16249048|P13|Overall Study|Excluded Medication|0
4713404|NCT02132754|16249049|P12|Overall Study|Excluded Medication|0
4713405|NCT02132754|16249050|P11|Overall Study|Excluded Medication|0
4713406|NCT02132754|16249051|P10|Overall Study|Excluded Medication|0
4713407|NCT02132754|16249052|P9|Overall Study|Excluded Medication|0
4713408|NCT02132754|16249053|P8|Overall Study|Excluded Medication|0
4713409|NCT02132754|16249054|P7|Overall Study|Excluded Medication|0
4713410|NCT02132754|16249055|P6|Overall Study|Excluded Medication|0
4713411|NCT02132754|16249056|P5|Overall Study|Excluded Medication|0
4713412|NCT02132754|16249057|P4|Overall Study|Excluded Medication|0
4713413|NCT02132754|16249058|P3|Overall Study|Excluded Medication|0
4713414|NCT02132754|16249059|P2|Overall Study|Excluded Medication|0
4713415|NCT02132754|16249060|P1|Overall Study|Excluded Medication|0
4713416|NCT02132754|16249027|P34|Overall Study|Death|2
4713417|NCT02132754|16249028|P33|Overall Study|Death|0
4713418|NCT02132754|16249029|P32|Overall Study|Death|0
4713419|NCT02132754|16249030|P31|Overall Study|Death|0
4713420|NCT02132754|16249031|P30|Overall Study|Death|0
4713421|NCT02132754|16249032|P29|Overall Study|Death|0
4713422|NCT02132754|16249033|P28|Overall Study|Death|0
4713423|NCT02132754|16249034|P27|Overall Study|Death|1
4713424|NCT02132754|16249035|P26|Overall Study|Death|0
4713425|NCT02132754|16249036|P25|Overall Study|Death|0
4713426|NCT02132754|16249037|P24|Overall Study|Death|0
4713427|NCT02132754|16249038|P23|Overall Study|Death|0
4713428|NCT02132754|16249039|P22|Overall Study|Death|1
4713429|NCT02132754|16249040|P21|Overall Study|Death|0
4713430|NCT02132754|16249041|P20|Overall Study|Death|1
4713431|NCT02132754|16249042|P19|Overall Study|Death|0
4713432|NCT02132754|16249043|P18|Overall Study|Death|0
4713433|NCT02132754|16249044|P17|Overall Study|Death|0
4713434|NCT02132754|16249045|P16|Overall Study|Death|1
4713435|NCT02132754|16249046|P15|Overall Study|Death|0
4713436|NCT02132754|16249047|P14|Overall Study|Death|0
4713437|NCT02132754|16249048|P13|Overall Study|Death|0
4713438|NCT02132754|16249049|P12|Overall Study|Death|0
4713439|NCT02132754|16249050|P11|Overall Study|Death|0
4713440|NCT02132754|16249051|P10|Overall Study|Death|0
4713441|NCT02132754|16249052|P9|Overall Study|Death|0
4713442|NCT02132754|16249053|P8|Overall Study|Death|0
4713443|NCT02132754|16249054|P7|Overall Study|Death|0
4713444|NCT02132754|16249055|P6|Overall Study|Death|0
4713445|NCT02132754|16249056|P5|Overall Study|Death|0
4713446|NCT02132754|16249057|P4|Overall Study|Death|0
4713447|NCT02132754|16249058|P3|Overall Study|Death|0
4713448|NCT02132754|16249059|P2|Overall Study|Death|0
4713449|NCT02132754|16249060|P1|Overall Study|Death|0
4713450|NCT02132754|16249027|P34|Overall Study|Clinical Progression|2
4713451|NCT02132754|16249028|P33|Overall Study|Clinical Progression|0
4713452|NCT02132754|16249029|P32|Overall Study|Clinical Progression|0
4713453|NCT02132754|16249030|P31|Overall Study|Clinical Progression|1
4713454|NCT02132754|16249031|P30|Overall Study|Clinical Progression|0
4713455|NCT02132754|16249032|P29|Overall Study|Clinical Progression|1
4713456|NCT02132754|16249033|P28|Overall Study|Clinical Progression|1
4713457|NCT02132754|16249034|P27|Overall Study|Clinical Progression|0
4713458|NCT02132754|16249035|P26|Overall Study|Clinical Progression|1
4713459|NCT02132754|16249036|P25|Overall Study|Clinical Progression|1
4713460|NCT02132754|16249037|P24|Overall Study|Clinical Progression|0
4713461|NCT02132754|16249038|P23|Overall Study|Clinical Progression|1
4713462|NCT02132754|16249039|P22|Overall Study|Clinical Progression|0
4713463|NCT02132754|16249040|P21|Overall Study|Clinical Progression|0
4713464|NCT02132754|16249041|P20|Overall Study|Clinical Progression|1
4713465|NCT02132754|16249042|P19|Overall Study|Clinical Progression|0
4713466|NCT02132754|16249043|P18|Overall Study|Clinical Progression|1
4713467|NCT02132754|16249044|P17|Overall Study|Clinical Progression|1
4713468|NCT02132754|16249045|P16|Overall Study|Clinical Progression|0
4713469|NCT02132754|16249046|P15|Overall Study|Clinical Progression|0
4713470|NCT02132754|16249047|P14|Overall Study|Clinical Progression|0
4713471|NCT02132754|16249048|P13|Overall Study|Clinical Progression|0
4713472|NCT02132754|16249049|P12|Overall Study|Clinical Progression|0
4713473|NCT02132754|16249050|P11|Overall Study|Clinical Progression|0
4713474|NCT02132754|16249051|P10|Overall Study|Clinical Progression|1
4713475|NCT02132754|16249052|P9|Overall Study|Clinical Progression|0
4713476|NCT02132754|16249053|P8|Overall Study|Clinical Progression|0
4713477|NCT02132754|16249054|P7|Overall Study|Clinical Progression|0
4713478|NCT02132754|16249055|P6|Overall Study|Clinical Progression|0
4713479|NCT02132754|16249056|P5|Overall Study|Clinical Progression|0
4713480|NCT02132754|16249057|P4|Overall Study|Clinical Progression|0
4713481|NCT02132754|16249058|P3|Overall Study|Clinical Progression|0
4713482|NCT02132754|16249059|P2|Overall Study|Clinical Progression|0
4713483|NCT02132754|16249060|P1|Overall Study|Clinical Progression|0
4713484|NCT02132754|16249027|P34|Overall Study|Adverse Event|1
4713485|NCT02132754|16249028|P33|Overall Study|Adverse Event|1
4713486|NCT02132754|16249029|P32|Overall Study|Adverse Event|0
4713487|NCT02132754|16249030|P31|Overall Study|Adverse Event|1
4713488|NCT02132754|16249031|P30|Overall Study|Adverse Event|0
4713489|NCT02132754|16249032|P29|Overall Study|Adverse Event|0
4713490|NCT02132754|16249033|P28|Overall Study|Adverse Event|0
4713491|NCT02132754|16249034|P27|Overall Study|Adverse Event|1
4713492|NCT02132754|16249035|P26|Overall Study|Adverse Event|1
4713493|NCT02132754|16249036|P25|Overall Study|Adverse Event|0
4713494|NCT02132754|16249037|P24|Overall Study|Adverse Event|0
4713495|NCT02132754|16249038|P23|Overall Study|Adverse Event|0
4713496|NCT02132754|16249039|P22|Overall Study|Adverse Event|0
4713497|NCT02132754|16249040|P21|Overall Study|Adverse Event|0
4713498|NCT02132754|16249041|P20|Overall Study|Adverse Event|0
4713499|NCT02132754|16249042|P19|Overall Study|Adverse Event|0
4713500|NCT02132754|16249043|P18|Overall Study|Adverse Event|1
4713501|NCT02132754|16249044|P17|Overall Study|Adverse Event|0
4713502|NCT02132754|16249045|P16|Overall Study|Adverse Event|0
4713503|NCT02132754|16249046|P15|Overall Study|Adverse Event|0
4713504|NCT02132754|16249047|P14|Overall Study|Adverse Event|0
4713505|NCT02132754|16249048|P13|Overall Study|Adverse Event|0
4713506|NCT02132754|16249049|P12|Overall Study|Adverse Event|0
4713507|NCT02132754|16249050|P11|Overall Study|Adverse Event|0
4713508|NCT02132754|16249051|P10|Overall Study|Adverse Event|0
4713509|NCT02132754|16249052|P9|Overall Study|Adverse Event|0
4713510|NCT02132754|16249053|P8|Overall Study|Adverse Event|0
4713511|NCT02132754|16249054|P7|Overall Study|Adverse Event|0
4713512|NCT02132754|16249055|P6|Overall Study|Adverse Event|0
4713513|NCT02132754|16249056|P5|Overall Study|Adverse Event|0
4713514|NCT02132754|16249057|P4|Overall Study|Adverse Event|0
4713515|NCT02132754|16249058|P3|Overall Study|Adverse Event|0
4713516|NCT02132754|16249059|P2|Overall Study|Adverse Event|0
4713517|NCT02132754|16249060|P1|Overall Study|Adverse Event|0
4713518|NCT02132637|16249828|P2|Study Period 2 (Crossover)|Physician Decision|0
4713519|NCT02132637|16249829|P1|Study Period 2 (Crossover)|Physician Decision|2
4713520|NCT02132637|16249828|P2|Study Period 2 (Crossover)|Adverse Event|1
4713521|NCT02132637|16249829|P1|Study Period 2 (Crossover)|Adverse Event|0
4713522|NCT02132637|16249828|P2|Study Period 1|Physician Decision|0
4713523|NCT02132637|16249829|P1|Study Period 1|Physician Decision|1
4713524|NCT02132637|16249828|P2|Study Period 1|Withdrawal by Subject|4
4713525|NCT02132637|16249829|P1|Study Period 1|Withdrawal by Subject|0
4713526|NCT02132611|16249853|P1|Overall Study|Death|2
4713527|NCT02132247|16249916|P2|Overall Study|Protocol Violation|0
4713528|NCT02132247|16249917|P1|Overall Study|Protocol Violation|1
4713529|NCT02132195|16249932|P3|Rescue Therapy|Adverse Event|2
4713530|NCT02132195|16249933|P2|Rescue Therapy|Adverse Event|0
4713531|NCT02132195|16249934|P1|Rescue Therapy|Adverse Event|0
4713532|NCT02132195|16249932|P3|Rescue Therapy|Withdrawal by Subject|1
4713533|NCT02132195|16249933|P2|Rescue Therapy|Withdrawal by Subject|0
4713534|NCT02132195|16249934|P1|Rescue Therapy|Withdrawal by Subject|0
4713535|NCT02132195|16249932|P3|Rescue Therapy|Physician Decision|1
4713536|NCT02132195|16249933|P2|Rescue Therapy|Physician Decision|0
4713537|NCT02132195|16249934|P1|Rescue Therapy|Physician Decision|0
4713538|NCT02132195|16249932|P3|Rescue Therapy|Relapsed|7
4713539|NCT02132195|16249933|P2|Rescue Therapy|Relapsed|0
4713540|NCT02132195|16249934|P1|Rescue Therapy|Relapsed|0
4713541|NCT02132195|16249932|P3|Initial Assignment|Relapsed|0
4713542|NCT02132195|16249933|P2|Initial Assignment|Relapsed|0
4713543|NCT02132195|16249934|P1|Initial Assignment|Relapsed|14
4713544|NCT02132117|16249965|P2|Overall Study|Other Miscellaneous Reasons|0
4713545|NCT02132117|16249966|P1|Overall Study|Other Miscellaneous Reasons|2
4713546|NCT02132117|16249965|P2|Overall Study|Personal Reasons|2
4713547|NCT02132117|16249966|P1|Overall Study|Personal Reasons|1
4713548|NCT02132117|16249965|P2|Overall Study|Lost to Follow-up|2
4713549|NCT02132117|16249966|P1|Overall Study|Lost to Follow-up|2
4713550|NCT02132117|16249965|P2|Overall Study|Adverse Event|1
4713551|NCT02132117|16249966|P1|Overall Study|Adverse Event|6
4713552|NCT02131766|16249982|P1|Overall Study|Withdrawal by Subject|4
4713553|NCT02131662|16249998|P5|Overall Study|Not treated|3
4713554|NCT02131662|16249999|P4|Overall Study|Not treated|2
4713555|NCT02131662|16250000|P3|Overall Study|Not treated|2
4713556|NCT02131662|16250001|P2|Overall Study|Not treated|0
4713557|NCT02131662|16250002|P1|Overall Study|Not treated|2
4713558|NCT02131662|16249998|P5|Overall Study|Lost to Follow-up|0
4713559|NCT02131662|16249999|P4|Overall Study|Lost to Follow-up|9
4713560|NCT02131662|16250000|P3|Overall Study|Lost to Follow-up|0
4713561|NCT02131662|16250001|P2|Overall Study|Lost to Follow-up|3
4713562|NCT02131662|16250002|P1|Overall Study|Lost to Follow-up|1
4713563|NCT02131662|16249998|P5|Overall Study|Withdrawal by Subject|6
4713564|NCT02131662|16249999|P4|Overall Study|Withdrawal by Subject|5
4713565|NCT02131662|16250000|P3|Overall Study|Withdrawal by Subject|1
4713566|NCT02131662|16250001|P2|Overall Study|Withdrawal by Subject|5
4713567|NCT02131662|16250002|P1|Overall Study|Withdrawal by Subject|1
4713568|NCT02131662|16249998|P5|Overall Study|Lack of Efficacy|1
4713569|NCT02131662|16249999|P4|Overall Study|Lack of Efficacy|0
4713570|NCT02131662|16250000|P3|Overall Study|Lack of Efficacy|0
4713571|NCT02131662|16250001|P2|Overall Study|Lack of Efficacy|0
4713572|NCT02131662|16250002|P1|Overall Study|Lack of Efficacy|1
4713573|NCT02131662|16249998|P5|Overall Study|Wish for pregnancy|1
4713574|NCT02131662|16249999|P4|Overall Study|Wish for pregnancy|0
4713575|NCT02131662|16250000|P3|Overall Study|Wish for pregnancy|0
4713576|NCT02131662|16250001|P2|Overall Study|Wish for pregnancy|0
4713577|NCT02131662|16250002|P1|Overall Study|Wish for pregnancy|0
4713578|NCT02131662|16249998|P5|Overall Study|Pregnancy|0
4713579|NCT02131662|16249999|P4|Overall Study|Pregnancy|1
4713580|NCT02131662|16250000|P3|Overall Study|Pregnancy|0
4713581|NCT02131662|16250001|P2|Overall Study|Pregnancy|1
4713582|NCT02131662|16250002|P1|Overall Study|Pregnancy|0
4713583|NCT02131662|16249998|P5|Overall Study|Adverse Event|3
4713584|NCT02131662|16249999|P4|Overall Study|Adverse Event|1
4713585|NCT02131662|16250000|P3|Overall Study|Adverse Event|1
4713586|NCT02131662|16250001|P2|Overall Study|Adverse Event|1
4713587|NCT02131662|16250002|P1|Overall Study|Adverse Event|0
4713588|NCT02131662|16249998|P5|Overall Study|Other|4
4713589|NCT02131662|16249999|P4|Overall Study|Other|3
4713590|NCT02131662|16250000|P3|Overall Study|Other|3
4713591|NCT02131662|16250001|P2|Overall Study|Other|4
4713592|NCT02131662|16250002|P1|Overall Study|Other|2
4713593|NCT02131662|16249998|P5|Overall Study|Protocol Violation|0
4713594|NCT02131662|16249999|P4|Overall Study|Protocol Violation|0
4713595|NCT02131662|16250000|P3|Overall Study|Protocol Violation|0
4713596|NCT02131662|16250001|P2|Overall Study|Protocol Violation|0
4713597|NCT02131662|16250002|P1|Overall Study|Protocol Violation|1
4713598|NCT02131636|16250048|P2|Overall Study|Adverse Event|1
4713599|NCT02131636|16250049|P1|Overall Study|Adverse Event|4
4713600|NCT02131636|16250048|P2|Overall Study|Lost to Follow-up|0
4713601|NCT02131636|16250049|P1|Overall Study|Lost to Follow-up|4
4713602|NCT02131636|16250048|P2|Overall Study|Personal Reasons|4
4713603|NCT02131636|16250049|P1|Overall Study|Personal Reasons|4
4713604|NCT02131532|16250065|P1|Overall Study|Other health conditions|2
4713605|NCT02131532|16250065|P1|Overall Study|Physician Decision|1
4713606|NCT02131532|16250065|P1|Overall Study|Withdrawal by Subject|1
4713607|NCT02131324|16250157|P2|Overall Study|Lost to Follow-up|1
4713608|NCT02131324|16250158|P1|Overall Study|Lost to Follow-up|1
4713609|NCT02131324|16250157|P2|Overall Study|Withdrawal by Subject|2
4713610|NCT02131324|16250158|P1|Overall Study|Withdrawal by Subject|1
4713611|NCT02131311|16250164|P1|Overall Study|Lost to Follow-up|1
4713612|NCT02131311|16250164|P1|Overall Study|Protocol Violation|1
4713613|NCT02131311|16250164|P1|Overall Study|Adverse Event|2
4713614|NCT02131272|16250176|P2|Overall Study|Withdrawal Criteria|0
4713615|NCT02131272|16250177|P1|Overall Study|Withdrawal Criteria|1
4713616|NCT02131272|16250176|P2|Overall Study|Withdrawal by Subject|1
4713617|NCT02131272|16250177|P1|Overall Study|Withdrawal by Subject|0
4713618|NCT02131272|16250176|P2|Overall Study|Withdrawal by parent|1
4713619|NCT02131272|16250177|P1|Overall Study|Withdrawal by parent|0
4713620|NCT02131259|16250195|P1|Overall Study|Missing|3
4713621|NCT02131259|16250195|P1|Overall Study|Progressive disease/AE/other|1
4713622|NCT02131259|16250195|P1|Overall Study|AE/other|1
4713623|NCT02131259|16250195|P1|Overall Study|AE/lost to follow-up|1
4713624|NCT02131259|16250195|P1|Overall Study|Progressive disease/other|2
4713625|NCT02131259|16250195|P1|Overall Study|Progressive disease/relocation|1
4713626|NCT02131259|16250195|P1|Overall Study|Progressive disease/Adverse Event (AE)|22
4713627|NCT02131259|16250195|P1|Overall Study|Other|63
4713628|NCT02131259|16250195|P1|Overall Study|Relocation|32
4713629|NCT02131259|16250195|P1|Overall Study|Lost to Follow-up|7
4713630|NCT02131259|16250195|P1|Overall Study|Adverse Event|341
4713631|NCT02131259|16250195|P1|Overall Study|Progressive disease|751
4713632|NCT02131233|16250202|P2|Overall Study|Withdrawal by Subject|11
4713633|NCT02131233|16250203|P1|Overall Study|Withdrawal by Subject|18
4713634|NCT02131233|16250202|P2|Overall Study|Pregnancy|0
4713635|NCT02131233|16250203|P1|Overall Study|Pregnancy|4
4713636|NCT02131233|16250202|P2|Overall Study|Physician Decision|0
4713637|NCT02131233|16250203|P1|Overall Study|Physician Decision|7
4713638|NCT02131233|16250202|P2|Overall Study|Non-Compliance With Study Drug|5
4713639|NCT02131233|16250203|P1|Overall Study|Non-Compliance With Study Drug|8
4713640|NCT02131233|16250202|P2|Overall Study|Lost to Follow-up|13
4713641|NCT02131233|16250203|P1|Overall Study|Lost to Follow-up|14
4713642|NCT02131233|16250202|P2|Overall Study|Lack of Efficacy|3
4713643|NCT02131233|16250203|P1|Overall Study|Lack of Efficacy|6
4713644|NCT02131233|16250202|P2|Overall Study|Death|1
4713645|NCT02131233|16250203|P1|Overall Study|Death|0
4713646|NCT02131233|16250202|P2|Overall Study|Adverse Event|6
4713647|NCT02131233|16250203|P1|Overall Study|Adverse Event|7
4713648|NCT02131233|16250202|P2|Overall Study|Not Treated|3
4713649|NCT02131233|16250203|P1|Overall Study|Not Treated|2
4713650|NCT02131155|16250237|P2|Overall Study|Study early termination|10
4713651|NCT02131155|16250238|P1|Overall Study|Study early termination|20
4713652|NCT02131155|16250237|P2|Overall Study|Refused to continue study medication|0
4713653|NCT02131155|16250238|P1|Overall Study|Refused to continue study medication|1
4713654|NCT02131155|16250237|P2|Overall Study|Primary tumour recurrence|1
4713655|NCT02131155|16250238|P1|Overall Study|Primary tumour recurrence|2
4713656|NCT02131155|16250237|P2|Overall Study|Treatment completed|0
4713657|NCT02131155|16250238|P1|Overall Study|Treatment completed|1
4713658|NCT02131155|16250237|P2|Overall Study|Adverse Event|0
4713659|NCT02131155|16250238|P1|Overall Study|Adverse Event|1
4713660|NCT02131129|16250252|P2|Overall Study|Withdrawal by Subject|0
4713661|NCT02131129|16250253|P1|Overall Study|Withdrawal by Subject|1
4713662|NCT02131064|16250271|P2|Overall Study|Other|2
4713663|NCT02131064|16250272|P1|Overall Study|Other|2
4713664|NCT02131064|16250271|P2|Overall Study|Withdrawal by Subject|18
4713665|NCT02131064|16250272|P1|Overall Study|Withdrawal by Subject|14
4713666|NCT02131064|16250271|P2|Overall Study|Lost to Follow-up|8
4713667|NCT02131064|16250272|P1|Overall Study|Lost to Follow-up|4
4713668|NCT02131064|16250271|P2|Overall Study|Death|6
4713669|NCT02131064|16250272|P1|Overall Study|Death|5
4713670|NCT02130986|16250341|P2|Overall Study|Lost to Follow-up|160
4713671|NCT02130986|16250342|P1|Overall Study|Lost to Follow-up|151
4713672|NCT02130986|16250341|P2|Overall Study|Withdrawal by Subject|4
4713673|NCT02130986|16250342|P1|Overall Study|Withdrawal by Subject|4
4713674|NCT02130765|16250356|P4|Overall Study|Did not receive treatment|0
4713675|NCT02130765|16250357|P3|Overall Study|Did not receive treatment|0
4713676|NCT02130765|16250358|P2|Overall Study|Did not receive treatment|0
4713677|NCT02130765|16250359|P1|Overall Study|Did not receive treatment|4
4713678|NCT02130570|16250605|P2|Overall Study|Part of practice that discontinued study|5
4713679|NCT02130570|16250606|P1|Overall Study|Part of practice that discontinued study|0
4713680|NCT02130570|16250605|P2|Overall Study|Withdrawal by Subject|3
4713681|NCT02130570|16250606|P1|Overall Study|Withdrawal by Subject|6
4713682|NCT02130570|16250605|P2|Overall Study|Death|5
4713683|NCT02130570|16250606|P1|Overall Study|Death|3
4713684|NCT02130557|16250624|P2|Overall Study|Ongoing|255
4713685|NCT02130557|16250625|P1|Overall Study|Ongoing|260
4713686|NCT02130557|16250624|P2|Overall Study|Deceased|6
4713687|NCT02130557|16250625|P1|Overall Study|Deceased|1
4713688|NCT02130557|16250624|P2|Overall Study|Lost to Follow-up|2
4713689|NCT02130557|16250625|P1|Overall Study|Lost to Follow-up|2
4713690|NCT02130557|16250624|P2|Overall Study|Withdrawal by Subject|2
4713691|NCT02130557|16250625|P1|Overall Study|Withdrawal by Subject|5
4713692|NCT02130557|16250624|P2|Overall Study|Randomized, not treated|3
4713693|NCT02130557|16250625|P1|Overall Study|Randomized, not treated|0
4713694|NCT02130284|16250657|P1|Overall Study|Screen Failure|1
4713695|NCT02130284|16250657|P1|Overall Study|Subject was screened as backup for study|3
4713696|NCT02130284|16250657|P1|Overall Study|Subject's sensor failed at Visit 2, Day|1
4713697|NCT02130284|16250657|P1|Overall Study|Subject Withdrew Consent|1
4713698|NCT02130284|16250657|P1|Overall Study|Withdrawal by Subject|3
4713699|NCT02130193|16250683|P3|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
4713700|NCT02130193|16250684|P2|Part B: 52-week Double-blind Period|Withdrawal by Subject|3
4713701|NCT02130193|16250685|P1|Part B: 52-week Double-blind Period|Withdrawal by Subject|0
4713702|NCT02130193|16250683|P3|Part B: 52-week Double-blind Period|Physician Decision|1
4713703|NCT02130193|16250684|P2|Part B: 52-week Double-blind Period|Physician Decision|0
4713704|NCT02130193|16250685|P1|Part B: 52-week Double-blind Period|Physician Decision|0
4713705|NCT02130193|16250683|P3|Part B: 52-week Double-blind Period|Protocol Violation|1
4713706|NCT02130193|16250684|P2|Part B: 52-week Double-blind Period|Protocol Violation|2
4713707|NCT02130193|16250685|P1|Part B: 52-week Double-blind Period|Protocol Violation|0
4713708|NCT02130193|16250683|P3|Part B: 52-week Double-blind Period|Adverse Event|3
4713709|NCT02130193|16250684|P2|Part B: 52-week Double-blind Period|Adverse Event|5
4713710|NCT02130193|16250685|P1|Part B: 52-week Double-blind Period|Adverse Event|0
4713711|NCT02130024|16250766|P2|Overall Study|Subject Withdrew Consent|14
4713712|NCT02130024|16250767|P1|Overall Study|Subject Withdrew Consent|6
4713713|NCT02130024|16250766|P2|Overall Study|Site Administration Problems|0
4713714|NCT02130024|16250767|P1|Overall Study|Site Administration Problems|1
4713715|NCT02130024|16250766|P2|Overall Study|Protocol Deviation|0
4713716|NCT02130024|16250767|P1|Overall Study|Protocol Deviation|4
4713717|NCT02130024|16250766|P2|Overall Study|Physician Decision|3
4713718|NCT02130024|16250767|P1|Overall Study|Physician Decision|1
4713719|NCT02130024|16250766|P2|Overall Study|Lost to Follow-up|1
4713720|NCT02130024|16250767|P1|Overall Study|Lost to Follow-up|1
4713721|NCT02130024|16250766|P2|Overall Study|Death|2
4713722|NCT02130024|16250767|P1|Overall Study|Death|2
4713723|NCT02130024|16250766|P2|Overall Study|Adverse Event|11
4713724|NCT02130024|16250767|P1|Overall Study|Adverse Event|10
4713725|NCT02129777|16250804|P7|Open-Label Period|Study Termination|39
4713726|NCT02129777|16250805|P6|Open-Label Period|Study Termination|10
4713727|NCT02129777|16250806|P5|Open-Label Period|Study Termination|0
4713728|NCT02129777|16250807|P4|Open-Label Period|Study Termination|0
4713729|NCT02129777|16250808|P3|Open-Label Period|Study Termination|0
4713730|NCT02129777|16250809|P2|Open-Label Period|Study Termination|0
4713731|NCT02129777|16250810|P1|Open-Label Period|Study Termination|0
4713732|NCT02129777|16250804|P7|Open-Label Period|Withdrawal by Subject|3
4713733|NCT02129777|16250805|P6|Open-Label Period|Withdrawal by Subject|1
4713734|NCT02129777|16250806|P5|Open-Label Period|Withdrawal by Subject|0
4713735|NCT02129777|16250807|P4|Open-Label Period|Withdrawal by Subject|0
4713736|NCT02129777|16250808|P3|Open-Label Period|Withdrawal by Subject|0
4713737|NCT02129777|16250809|P2|Open-Label Period|Withdrawal by Subject|0
4713738|NCT02129777|16250810|P1|Open-Label Period|Withdrawal by Subject|0
4713739|NCT02129777|16250804|P7|Open-Label Period|Lost to Follow-up|1
4713740|NCT02129777|16250805|P6|Open-Label Period|Lost to Follow-up|1
4713741|NCT02129777|16250806|P5|Open-Label Period|Lost to Follow-up|0
4713742|NCT02129777|16250807|P4|Open-Label Period|Lost to Follow-up|0
4713743|NCT02129777|16250808|P3|Open-Label Period|Lost to Follow-up|0
4713744|NCT02129777|16250809|P2|Open-Label Period|Lost to Follow-up|0
4713745|NCT02129777|16250810|P1|Open-Label Period|Lost to Follow-up|0
4713746|NCT02129777|16250804|P7|Open-Label Period|Lack of Efficacy|5
4713747|NCT02129777|16250805|P6|Open-Label Period|Lack of Efficacy|0
4713748|NCT02129777|16250806|P5|Open-Label Period|Lack of Efficacy|0
4713749|NCT02129777|16250807|P4|Open-Label Period|Lack of Efficacy|0
4713750|NCT02129777|16250808|P3|Open-Label Period|Lack of Efficacy|0
4713751|NCT02129777|16250809|P2|Open-Label Period|Lack of Efficacy|0
4713752|NCT02129777|16250810|P1|Open-Label Period|Lack of Efficacy|0
4713753|NCT02129777|16250804|P7|Double-Blind Period|Other|0
4713754|NCT02129777|16250805|P6|Double-Blind Period|Other|0
4713755|NCT02129777|16250806|P5|Double-Blind Period|Other|0
4713756|NCT02129777|16250807|P4|Double-Blind Period|Other|0
4713757|NCT02129777|16250808|P3|Double-Blind Period|Other|0
4713758|NCT02129777|16250809|P2|Double-Blind Period|Other|2
4713759|NCT02129777|16250810|P1|Double-Blind Period|Other|1
4713760|NCT02129777|16250804|P7|Double-Blind Period|Lack of Efficacy|0
4713761|NCT02129777|16250805|P6|Double-Blind Period|Lack of Efficacy|0
4713762|NCT02129777|16250806|P5|Double-Blind Period|Lack of Efficacy|2
4713763|NCT02129777|16250807|P4|Double-Blind Period|Lack of Efficacy|3
4713764|NCT02129777|16250808|P3|Double-Blind Period|Lack of Efficacy|0
4713765|NCT02129777|16250809|P2|Double-Blind Period|Lack of Efficacy|1
4713766|NCT02129777|16250810|P1|Double-Blind Period|Lack of Efficacy|3
4713767|NCT02129777|16250804|P7|Double-Blind Period|Pregnancy|0
4713768|NCT02129777|16250805|P6|Double-Blind Period|Pregnancy|0
4713769|NCT02129777|16250806|P5|Double-Blind Period|Pregnancy|1
4713770|NCT02129777|16250807|P4|Double-Blind Period|Pregnancy|0
4713771|NCT02129777|16250808|P3|Double-Blind Period|Pregnancy|0
4713772|NCT02129777|16250809|P2|Double-Blind Period|Pregnancy|0
4713773|NCT02129777|16250810|P1|Double-Blind Period|Pregnancy|0
4713774|NCT02129777|16250804|P7|Double-Blind Period|Withdrawal by Subject|0
4713775|NCT02129777|16250805|P6|Double-Blind Period|Withdrawal by Subject|0
4713776|NCT02129777|16250806|P5|Double-Blind Period|Withdrawal by Subject|3
4713777|NCT02129777|16250807|P4|Double-Blind Period|Withdrawal by Subject|2
4713778|NCT02129777|16250808|P3|Double-Blind Period|Withdrawal by Subject|3
4713779|NCT02129777|16250809|P2|Double-Blind Period|Withdrawal by Subject|4
4713780|NCT02129777|16250810|P1|Double-Blind Period|Withdrawal by Subject|2
4713781|NCT02129777|16250804|P7|Double-Blind Period|Lost to Follow-up|0
4713782|NCT02129777|16250805|P6|Double-Blind Period|Lost to Follow-up|0
4713783|NCT02129777|16250806|P5|Double-Blind Period|Lost to Follow-up|0
4713784|NCT02129777|16250807|P4|Double-Blind Period|Lost to Follow-up|2
4713785|NCT02129777|16250808|P3|Double-Blind Period|Lost to Follow-up|1
4713786|NCT02129777|16250809|P2|Double-Blind Period|Lost to Follow-up|1
4713787|NCT02129777|16250810|P1|Double-Blind Period|Lost to Follow-up|1
4713788|NCT02129777|16250804|P7|Double-Blind Period|Adverse Event|0
4713789|NCT02129777|16250805|P6|Double-Blind Period|Adverse Event|0
4713790|NCT02129777|16250806|P5|Double-Blind Period|Adverse Event|1
4713791|NCT02129777|16250807|P4|Double-Blind Period|Adverse Event|0
4713792|NCT02129777|16250808|P3|Double-Blind Period|Adverse Event|0
4713793|NCT02129777|16250809|P2|Double-Blind Period|Adverse Event|0
4713794|NCT02129777|16250810|P1|Double-Blind Period|Adverse Event|0
4713795|NCT02129608|16250977|P3|Overall Study|Withdrawal by Subject|2
4713796|NCT02129608|16250978|P2|Overall Study|Withdrawal by Subject|0
4713797|NCT02129608|16250979|P1|Overall Study|Withdrawal by Subject|0
4713798|NCT02129608|16250977|P3|Overall Study|Lost to Follow-up|1
4713799|NCT02129608|16250978|P2|Overall Study|Lost to Follow-up|1
4713800|NCT02129608|16250979|P1|Overall Study|Lost to Follow-up|0
4713801|NCT02129205|16251036|P10|Overall Study|Other|0
4713802|NCT02129205|16251037|P9|Overall Study|Other|1
4713803|NCT02129205|16251038|P8|Overall Study|Other|2
4713804|NCT02129205|16251039|P7|Overall Study|Other|3
4713805|NCT02129205|16251040|P6|Overall Study|Other|3
4713806|NCT02129205|16251041|P5|Overall Study|Other|2
4713807|NCT02129205|16251042|P4|Overall Study|Other|0
4713808|NCT02129205|16251043|P3|Overall Study|Other|0
4713809|NCT02129205|16251044|P2|Overall Study|Other|0
4713810|NCT02129205|16251045|P1|Overall Study|Other|1
4713811|NCT02129205|16251036|P10|Overall Study|Withdrawal by Subject|0
4713812|NCT02129205|16251037|P9|Overall Study|Withdrawal by Subject|1
4713813|NCT02129205|16251038|P8|Overall Study|Withdrawal by Subject|0
4713814|NCT02129205|16251039|P7|Overall Study|Withdrawal by Subject|1
4713815|NCT02129205|16251040|P6|Overall Study|Withdrawal by Subject|1
4713816|NCT02129205|16251041|P5|Overall Study|Withdrawal by Subject|1
4713817|NCT02129205|16251042|P4|Overall Study|Withdrawal by Subject|0
4713818|NCT02129205|16251043|P3|Overall Study|Withdrawal by Subject|0
4713819|NCT02129205|16251044|P2|Overall Study|Withdrawal by Subject|0
4713820|NCT02129205|16251045|P1|Overall Study|Withdrawal by Subject|0
4713821|NCT02129192|16251198|P2|Period 1 Including Washout Period|Withdrawal by Subject|1
4713822|NCT02129192|16251199|P1|Period 1 Including Washout Period|Withdrawal by Subject|0
4713823|NCT02129062|16251216|P1|Overall Study|Disease Progression|2
4713824|NCT02129062|16251216|P1|Overall Study|Death|1
4713825|NCT02128997|16251223|P2|Overall Study|Lost to Follow-up|11
4713826|NCT02128997|16251224|P1|Overall Study|Lost to Follow-up|6
4713827|NCT02128932|16251239|P3|Overall Study|No reason for withdrawal|7
4713828|NCT02128932|16251240|P2|Overall Study|No reason for withdrawal|11
4713829|NCT02128932|16251241|P1|Overall Study|No reason for withdrawal|12
4713830|NCT02128932|16251239|P3|Overall Study|Lost to Follow-up|1
4713831|NCT02128932|16251240|P2|Overall Study|Lost to Follow-up|1
4713832|NCT02128932|16251241|P1|Overall Study|Lost to Follow-up|2
4713833|NCT02128932|16251239|P3|Overall Study|Death|2
4713834|NCT02128932|16251240|P2|Overall Study|Death|0
4713835|NCT02128932|16251241|P1|Overall Study|Death|2
4713836|NCT02128932|16251239|P3|Overall Study|Withdrawal by Subject|8
4713837|NCT02128932|16251240|P2|Overall Study|Withdrawal by Subject|7
4713838|NCT02128932|16251241|P1|Overall Study|Withdrawal by Subject|11
4713839|NCT02128763|16251302|P2|Overall Study|Lost to Follow-up|16
4713840|NCT02128763|16251303|P1|Overall Study|Lost to Follow-up|19
4713841|NCT02128763|16251302|P2|Overall Study|Death|0
4713842|NCT02128763|16251303|P1|Overall Study|Death|1
4713843|NCT02128724|16251349|P4|Overall Study|Withdrawal by Subject|1
4713844|NCT02128724|16251350|P3|Overall Study|Withdrawal by Subject|0
4713845|NCT02128724|16251351|P2|Overall Study|Withdrawal by Subject|0
4713846|NCT02128724|16251352|P1|Overall Study|Withdrawal by Subject|0
4713847|NCT02128724|16251349|P4|Overall Study|Physician Decision|2
4713848|NCT02128724|16251350|P3|Overall Study|Physician Decision|0
4713849|NCT02128724|16251351|P2|Overall Study|Physician Decision|0
4713850|NCT02128724|16251352|P1|Overall Study|Physician Decision|0
4713851|NCT02128724|16251349|P4|Overall Study|Adverse Event|0
4713852|NCT02128724|16251350|P3|Overall Study|Adverse Event|0
4713853|NCT02128724|16251351|P2|Overall Study|Adverse Event|1
4713854|NCT02128724|16251352|P1|Overall Study|Adverse Event|0
4713855|NCT02128724|16251349|P4|Overall Study|Death|0
4713856|NCT02128724|16251350|P3|Overall Study|Death|0
4713857|NCT02128724|16251351|P2|Overall Study|Death|0
4713858|NCT02128724|16251352|P1|Overall Study|Death|1
4713859|NCT02128542|16251407|P2|Overall Study|Withdrew Consent|0
4713860|NCT02128542|16251408|P1|Overall Study|Withdrew Consent|1
4713861|NCT02128542|16251407|P2|Overall Study|Lost to Follow-up|0
4713862|NCT02128542|16251408|P1|Overall Study|Lost to Follow-up|3
4713863|NCT02128490|16251426|P5|Overall Study|Other Miscellaneous Reasons|1
4713864|NCT02128490|16251427|P4|Overall Study|Other Miscellaneous Reasons|1
4713865|NCT02128490|16251428|P3|Overall Study|Other Miscellaneous Reasons|2
4713866|NCT02128490|16251429|P2|Overall Study|Other Miscellaneous Reasons|0
4713867|NCT02128490|16251430|P1|Overall Study|Other Miscellaneous Reasons|0
4713868|NCT02128490|16251426|P5|Overall Study|Withdraw from Study Drug, Gout Flare|1
4713869|NCT02128490|16251427|P4|Overall Study|Withdraw from Study Drug, Gout Flare|0
4713870|NCT02128490|16251428|P3|Overall Study|Withdraw from Study Drug, Gout Flare|0
4713871|NCT02128490|16251429|P2|Overall Study|Withdraw from Study Drug, Gout Flare|0
4713872|NCT02128490|16251430|P1|Overall Study|Withdraw from Study Drug, Gout Flare|0
4713873|NCT02128490|16251426|P5|Overall Study|Lack of Efficacy|0
4713874|NCT02128490|16251427|P4|Overall Study|Lack of Efficacy|0
4713875|NCT02128490|16251428|P3|Overall Study|Lack of Efficacy|0
4713876|NCT02128490|16251429|P2|Overall Study|Lack of Efficacy|1
4713877|NCT02128490|16251430|P1|Overall Study|Lack of Efficacy|0
4713878|NCT02128490|16251426|P5|Overall Study|Voluntary Withdrawal|2
4713879|NCT02128490|16251427|P4|Overall Study|Voluntary Withdrawal|1
4713880|NCT02128490|16251428|P3|Overall Study|Voluntary Withdrawal|1
4713881|NCT02128490|16251429|P2|Overall Study|Voluntary Withdrawal|3
4713882|NCT02128490|16251430|P1|Overall Study|Voluntary Withdrawal|3
4713883|NCT02128490|16251426|P5|Overall Study|Lost to Follow-up|1
4713884|NCT02128490|16251427|P4|Overall Study|Lost to Follow-up|1
4713885|NCT02128490|16251428|P3|Overall Study|Lost to Follow-up|1
4713886|NCT02128490|16251429|P2|Overall Study|Lost to Follow-up|0
4713887|NCT02128490|16251430|P1|Overall Study|Lost to Follow-up|0
4713888|NCT02128490|16251426|P5|Overall Study|Major Protocol Deviation|2
4713889|NCT02128490|16251427|P4|Overall Study|Major Protocol Deviation|2
4713890|NCT02128490|16251428|P3|Overall Study|Major Protocol Deviation|0
4713891|NCT02128490|16251429|P2|Overall Study|Major Protocol Deviation|2
4713892|NCT02128490|16251430|P1|Overall Study|Major Protocol Deviation|1
4713893|NCT02128490|16251426|P5|Overall Study|Pretreatment Event/Adverse Event|0
4713894|NCT02128490|16251427|P4|Overall Study|Pretreatment Event/Adverse Event|1
4713895|NCT02128490|16251428|P3|Overall Study|Pretreatment Event/Adverse Event|1
4713896|NCT02128490|16251429|P2|Overall Study|Pretreatment Event/Adverse Event|0
4713897|NCT02128490|16251430|P1|Overall Study|Pretreatment Event/Adverse Event|1
4713898|NCT02128269|16251452|P1|Treatment Period|Physician Decision|1
4713899|NCT02128269|16251452|P1|Treatment Period|Adverse Event|1
4713900|NCT02128217|16251458|P2|Overall Study|Lost to Follow-up|1
4713901|NCT02128217|16251459|P1|Overall Study|Lost to Follow-up|0
4713902|NCT02127970|16251507|P2|Overall Study|Subject Withdrew Consent|3
4713903|NCT02127970|16251508|P1|Overall Study|Subject Withdrew Consent|5
4713904|NCT02127970|16251507|P2|Overall Study|Pregnancy|1
4713905|NCT02127970|16251508|P1|Overall Study|Pregnancy|0
4713906|NCT02127970|16251507|P2|Overall Study|Reason not Specified|7
4713907|NCT02127970|16251508|P1|Overall Study|Reason not Specified|4
4713908|NCT02127970|16251507|P2|Overall Study|Lost to Follow-up|14
4713909|NCT02127970|16251508|P1|Overall Study|Lost to Follow-up|14
4713910|NCT02127970|16251507|P2|Overall Study|Death|1
4713911|NCT02127970|16251508|P1|Overall Study|Death|1
4713912|NCT02127970|16251507|P2|Overall Study|Adverse Event|1
4713913|NCT02127970|16251508|P1|Overall Study|Adverse Event|2
4713914|NCT02127931|16251530|P1|Overall Study|Glitch in Game|1
4713915|NCT02127372|16251656|P2|Overall Study|Withdrawal by Subject|0
4713916|NCT02127372|16251657|P1|Overall Study|Withdrawal by Subject|1
4713917|NCT02127307|16251667|P1|Overall Study|Other than specified above|169
4713918|NCT02127307|16251667|P1|Overall Study|Death|101
4713919|NCT02127307|16251667|P1|Overall Study|Lost to Follow-up|2
4713920|NCT02127307|16251667|P1|Overall Study|Protocol Violation|36
4713921|NCT02127281|16251673|P2|Overall Study|Lost to Follow-up|0
4713922|NCT02127281|16251674|P1|Overall Study|Lost to Follow-up|1
4713923|NCT02127125|16251709|P9|Overall Study|Physician Decision|0
4713924|NCT02127125|16251710|P8|Overall Study|Physician Decision|0
4713925|NCT02127125|16251711|P7|Overall Study|Physician Decision|0
4713926|NCT02127125|16251712|P6|Overall Study|Physician Decision|2
4713927|NCT02127125|16251713|P5|Overall Study|Physician Decision|1
4713928|NCT02127125|16251714|P4|Overall Study|Physician Decision|0
4713929|NCT02127125|16251715|P3|Overall Study|Physician Decision|1
4713930|NCT02127125|16251716|P2|Overall Study|Physician Decision|0
4713931|NCT02127125|16251717|P1|Overall Study|Physician Decision|0
4713932|NCT02127125|16251709|P9|Overall Study|Withdrawal by Subject|0
4713933|NCT02127125|16251710|P8|Overall Study|Withdrawal by Subject|0
4713934|NCT02127125|16251711|P7|Overall Study|Withdrawal by Subject|0
4713935|NCT02127125|16251712|P6|Overall Study|Withdrawal by Subject|0
4713936|NCT02127125|16251713|P5|Overall Study|Withdrawal by Subject|0
4713937|NCT02127125|16251714|P4|Overall Study|Withdrawal by Subject|1
4713938|NCT02127125|16251715|P3|Overall Study|Withdrawal by Subject|0
4713939|NCT02127125|16251716|P2|Overall Study|Withdrawal by Subject|0
4713940|NCT02127125|16251717|P1|Overall Study|Withdrawal by Subject|0
4713941|NCT02127125|16251709|P9|Overall Study|Lost to Follow-up|0
4713942|NCT02127125|16251710|P8|Overall Study|Lost to Follow-up|0
4713943|NCT02127125|16251711|P7|Overall Study|Lost to Follow-up|0
4713944|NCT02127125|16251712|P6|Overall Study|Lost to Follow-up|1
4713945|NCT02127125|16251713|P5|Overall Study|Lost to Follow-up|2
4713946|NCT02127125|16251714|P4|Overall Study|Lost to Follow-up|0
4713947|NCT02127125|16251715|P3|Overall Study|Lost to Follow-up|0
4713948|NCT02127125|16251716|P2|Overall Study|Lost to Follow-up|0
4713949|NCT02127125|16251717|P1|Overall Study|Lost to Follow-up|0
4713950|NCT02126969|16251757|P2|Overall Study|Withdrawal by Subject|2
4713951|NCT02126969|16251758|P1|Overall Study|Withdrawal by Subject|1
4713952|NCT02126839|16251770|P2|Overall Study|Other|5
4713953|NCT02126839|16251771|P1|Overall Study|Other|5
4713954|NCT02126839|16251770|P2|Overall Study|Lost to Follow-up|4
4713955|NCT02126839|16251771|P1|Overall Study|Lost to Follow-up|1
4713956|NCT02126839|16251770|P2|Overall Study|Sponsor request|1
4713957|NCT02126839|16251771|P1|Overall Study|Sponsor request|0
4713958|NCT02126839|16251770|P2|Overall Study|Protocol Violation|3
4713959|NCT02126839|16251771|P1|Overall Study|Protocol Violation|2
4713960|NCT02126839|16251770|P2|Overall Study|Withdrawal by parent/guardian|0
4713961|NCT02126839|16251771|P1|Overall Study|Withdrawal by parent/guardian|1
4713962|NCT02126839|16251770|P2|Overall Study|Withdrawal by Subject|0
4713963|NCT02126839|16251771|P1|Overall Study|Withdrawal by Subject|1
4713964|NCT02126839|16251770|P2|Overall Study|Adverse Event|1
4713965|NCT02126839|16251771|P1|Overall Study|Adverse Event|0
4713966|NCT02126826|16251788|P7|Overall Study|Withdrawal by Subject|0
4713967|NCT02126826|16251789|P6|Overall Study|Withdrawal by Subject|0
4713968|NCT02126826|16251790|P5|Overall Study|Withdrawal by Subject|0
4713969|NCT02126826|16251791|P4|Overall Study|Withdrawal by Subject|1
4713970|NCT02126826|16251792|P3|Overall Study|Withdrawal by Subject|0
4713971|NCT02126826|16251793|P2|Overall Study|Withdrawal by Subject|0
4713972|NCT02126826|16251794|P1|Overall Study|Withdrawal by Subject|0
4713973|NCT02126670|16251862|P4|Overall Study|Withdrawal by Subject|1
4713974|NCT02126670|16251863|P3|Overall Study|Withdrawal by Subject|0
4713975|NCT02126670|16251864|P2|Overall Study|Withdrawal by Subject|0
4713976|NCT02126670|16251865|P1|Overall Study|Withdrawal by Subject|1
4713977|NCT02125877|16251917|P2|Overall Study|Adverse Event|4
4713978|NCT02125877|16251918|P1|Overall Study|Adverse Event|6
4713979|NCT02125877|16251917|P2|Overall Study|Protocol deviation|1
4713980|NCT02125877|16251918|P1|Overall Study|Protocol deviation|4
4713981|NCT02125877|16251917|P2|Overall Study|Withdrawal by Subject|1
4713982|NCT02125877|16251918|P1|Overall Study|Withdrawal by Subject|2
4713983|NCT02125877|16251917|P2|Overall Study|Participant/guardian decision|2
4713984|NCT02125877|16251918|P1|Overall Study|Participant/guardian decision|0
4713985|NCT02125877|16251917|P2|Overall Study|Administrative problems|1
4713986|NCT02125877|16251918|P1|Overall Study|Administrative problems|0
4713987|NCT02125877|16251917|P2|Overall Study|Death|1
4713988|NCT02125877|16251918|P1|Overall Study|Death|0
4713989|NCT02125877|16251917|P2|Overall Study|Physician Decision|0
4713990|NCT02125877|16251918|P1|Overall Study|Physician Decision|1
4713991|NCT02125838|16251948|P2|Overall Study|Lost to Follow-up|4
4713992|NCT02125838|16251949|P1|Overall Study|Lost to Follow-up|4
4713993|NCT02125734|16251967|P2|Period 2|Adverse Event|1
4713994|NCT02125734|16251968|P1|Period 2|Adverse Event|0
4713995|NCT02125604|16251978|P1|Overall Study|Adverse Event|20
4713996|NCT02125604|16251978|P1|Overall Study|Consent Withdrawn|4
4713997|NCT02125604|16251978|P1|Overall Study|Lost to Follow-up|2
4713998|NCT02125604|16251978|P1|Overall Study|Investigator Decision|1
4713999|NCT02125604|16251978|P1|Overall Study|Other|4
4714000|NCT02125461|16251994|P2|Overall Study|Death|115
4714001|NCT02125461|16251995|P1|Overall Study|Death|180
4714002|NCT02125461|16251994|P2|Overall Study|Lost to Follow-up|0
4714003|NCT02125461|16251995|P1|Overall Study|Lost to Follow-up|1
4714004|NCT02125461|16251994|P2|Overall Study|Withdrawal by Subject|14
4714005|NCT02125461|16251995|P1|Overall Study|Withdrawal by Subject|22
4714006|NCT02125331|16252026|P2|Overall Study|screen failure|0
4714007|NCT02125331|16252027|P1|Overall Study|screen failure|2
4714008|NCT02125331|16252026|P2|Overall Study|technical problem|0
4714009|NCT02125331|16252027|P1|Overall Study|technical problem|2
4714010|NCT02125331|16252026|P2|Overall Study|Protocol Violation|0
4714011|NCT02125331|16252027|P1|Overall Study|Protocol Violation|1
4714012|NCT02125279|16252059|P1|Overall Study|Lost to Follow-up|4
4714013|NCT02125279|16252059|P1|Overall Study|Protocol Violation|1
4714014|NCT02125279|16252059|P1|Overall Study|Withdrawal by Subject|6
4714015|NCT02125279|16252059|P1|Overall Study|Lack of Efficacy|2
4714016|NCT02124811|16252103|P2|Overall Study|Withdrawal by Subject|0
4714017|NCT02124811|16252104|P1|Overall Study|Withdrawal by Subject|1
4714018|NCT02124811|16252103|P2|Overall Study|Early termination|2
4714019|NCT02124811|16252104|P1|Overall Study|Early termination|2
4714020|NCT02124798|16252120|P1|Overall Study|Lost to Follow-up|1
4714021|NCT02124798|16252120|P1|Overall Study|Adverse Event|3
4714022|NCT02124707|16252126|P1|Overall Study|Death|1
4714023|NCT02124707|16252126|P1|Overall Study|Physician Decision|1
4714024|NCT02124707|16252126|P1|Overall Study|Adverse Event|5
4714025|NCT02124564|16252140|P1|Treatment Period|Withdrawal by Subject|2
4714026|NCT02124564|16252140|P1|Treatment Period|Lack of Efficacy|3
4714027|NCT02124564|16252140|P1|Treatment Period|Adverse Event|2
4714028|NCT02124265|16252205|P1|Overall Study|Adverse Event|1
4714029|NCT02124161|16252211|P2|Overall Study|Lost to Follow-up|4
4714030|NCT02124161|16252212|P1|Overall Study|Lost to Follow-up|3
4714031|NCT02124161|16252211|P2|Overall Study|No longer meets eligibility criteria|4
4714032|NCT02124161|16252212|P1|Overall Study|No longer meets eligibility criteria|5
4714033|NCT02124161|16252211|P2|Overall Study|Does not meet entrance criteria|3
4714034|NCT02124161|16252212|P1|Overall Study|Does not meet entrance criteria|2
4714035|NCT02124161|16252211|P2|Overall Study|Adverse Event|0
4714036|NCT02124161|16252212|P1|Overall Study|Adverse Event|2
4714037|NCT02124161|16252211|P2|Overall Study|Withdrawal by Subject|2
4714038|NCT02124161|16252212|P1|Overall Study|Withdrawal by Subject|1
4714039|NCT02124161|16252211|P2|Overall Study|Protocol Violation|1
4714040|NCT02124161|16252212|P1|Overall Study|Protocol Violation|2
4714041|NCT02124161|16252211|P2|Overall Study|Death|0
4714042|NCT02124161|16252212|P1|Overall Study|Death|1
4714043|NCT02124161|16252211|P2|Overall Study|Other unspecified|1
4714044|NCT02124161|16252212|P1|Overall Study|Other unspecified|0
4714045|NCT02123966|16252287|P1|Overall Study|Intercurrent Illness|1
4714046|NCT02123797|16252321|P5|6-month Follow up (Cumulative Counts)|Relocation|0
4714047|NCT02123797|16252322|P4|6-month Follow up (Cumulative Counts)|Relocation|0
4714048|NCT02123797|16252323|P3|6-month Follow up (Cumulative Counts)|Relocation|0
4714049|NCT02123797|16252324|P2|6-month Follow up (Cumulative Counts)|Relocation|2
4714050|NCT02123797|16252325|P1|6-month Follow up (Cumulative Counts)|Relocation|0
4714051|NCT02123797|16252321|P5|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4714052|NCT02123797|16252322|P4|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4714053|NCT02123797|16252323|P3|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4714054|NCT02123797|16252324|P2|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9
4714055|NCT02123797|16252325|P1|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1
4714056|NCT02123797|16252321|P5|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
4714057|NCT02123797|16252322|P4|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113
4714058|NCT02123797|16252323|P3|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66
4714059|NCT02123797|16252324|P2|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20
4714060|NCT02123797|16252325|P1|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3
4714061|NCT02123797|16252321|P5|6-month Follow up (Cumulative Counts)|Death|0
4714062|NCT02123797|16252322|P4|6-month Follow up (Cumulative Counts)|Death|0
4714063|NCT02123797|16252323|P3|6-month Follow up (Cumulative Counts)|Death|0
4714064|NCT02123797|16252324|P2|6-month Follow up (Cumulative Counts)|Death|97
4714065|NCT02123797|16252325|P1|6-month Follow up (Cumulative Counts)|Death|51
4714066|NCT02123797|16252321|P5|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
4714067|NCT02123797|16252322|P4|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
4714068|NCT02123797|16252323|P3|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0
4714069|NCT02123797|16252324|P2|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36
4714070|NCT02123797|16252325|P1|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16
4714071|NCT02123797|16252321|P5|3-month Follow up (Cumulative Counts)|Relocation|0
4714072|NCT02123797|16252322|P4|3-month Follow up (Cumulative Counts)|Relocation|0
4714073|NCT02123797|16252323|P3|3-month Follow up (Cumulative Counts)|Relocation|0
4714074|NCT02123797|16252324|P2|3-month Follow up (Cumulative Counts)|Relocation|1
4714075|NCT02123797|16252325|P1|3-month Follow up (Cumulative Counts)|Relocation|0
4714076|NCT02123797|16252321|P5|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4714077|NCT02123797|16252322|P4|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4714078|NCT02123797|16252323|P3|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0
4714079|NCT02123797|16252324|P2|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16
4714080|NCT02123797|16252325|P1|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6
4714081|NCT02123797|16252321|P5|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3
4714082|NCT02123797|16252322|P4|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82
4714083|NCT02123797|16252323|P3|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50
4714084|NCT02123797|16252324|P2|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7
4714085|NCT02123797|16252325|P1|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2
4714086|NCT02123797|16252321|P5|3-month Follow up (Cumulative Counts)|Death|0
4714087|NCT02123797|16252322|P4|3-month Follow up (Cumulative Counts)|Death|0
4714088|NCT02123797|16252323|P3|3-month Follow up (Cumulative Counts)|Death|0
4714089|NCT02123797|16252324|P2|3-month Follow up (Cumulative Counts)|Death|57
4714090|NCT02123797|16252325|P1|3-month Follow up (Cumulative Counts)|Death|33
4714091|NCT02123797|16252321|P5|Baseline Intervention|Other Disease|0
4714092|NCT02123797|16252322|P4|Baseline Intervention|Other Disease|0
4714093|NCT02123797|16252323|P3|Baseline Intervention|Other Disease|0
4714094|NCT02123797|16252324|P2|Baseline Intervention|Other Disease|0
4714095|NCT02123797|16252325|P1|Baseline Intervention|Other Disease|3
4714096|NCT02123797|16252321|P5|Baseline Intervention|Lost to Follow-up|0
4714097|NCT02123797|16252322|P4|Baseline Intervention|Lost to Follow-up|0
4714098|NCT02123797|16252323|P3|Baseline Intervention|Lost to Follow-up|0
4714099|NCT02123797|16252324|P2|Baseline Intervention|Lost to Follow-up|5
4714100|NCT02123797|16252325|P1|Baseline Intervention|Lost to Follow-up|0
4714101|NCT02123797|16252321|P5|Baseline Intervention|Out of window for initial survey|0
4714102|NCT02123797|16252322|P4|Baseline Intervention|Out of window for initial survey|0
4714103|NCT02123797|16252323|P3|Baseline Intervention|Out of window for initial survey|0
4714104|NCT02123797|16252324|P2|Baseline Intervention|Out of window for initial survey|13
4714105|NCT02123797|16252325|P1|Baseline Intervention|Out of window for initial survey|6
4714106|NCT02123797|16252321|P5|Baseline Intervention|Relocation|0
4714107|NCT02123797|16252322|P4|Baseline Intervention|Relocation|0
4714108|NCT02123797|16252323|P3|Baseline Intervention|Relocation|0
4714109|NCT02123797|16252324|P2|Baseline Intervention|Relocation|0
4714110|NCT02123797|16252325|P1|Baseline Intervention|Relocation|2
4714111|NCT02123797|16252321|P5|Baseline Intervention|Withdrawal by Subject|0
4714112|NCT02123797|16252322|P4|Baseline Intervention|Withdrawal by Subject|0
4714113|NCT02123797|16252323|P3|Baseline Intervention|Withdrawal by Subject|0
4714114|NCT02123797|16252324|P2|Baseline Intervention|Withdrawal by Subject|8
4714115|NCT02123797|16252325|P1|Baseline Intervention|Withdrawal by Subject|2
4714116|NCT02123797|16252321|P5|Baseline Intervention|Death|0
4714117|NCT02123797|16252322|P4|Baseline Intervention|Death|0
4714118|NCT02123797|16252323|P3|Baseline Intervention|Death|0
4714119|NCT02123797|16252324|P2|Baseline Intervention|Death|16
4714120|NCT02123797|16252325|P1|Baseline Intervention|Death|9
4714121|NCT02123576|16252434|P2|Overall Study|Adverse Event|0
4714122|NCT02123576|16252435|P1|Overall Study|Adverse Event|1
4714123|NCT02123511|16252453|P2|Overall Study|Ineligible|1
4714124|NCT02123511|16252454|P1|Overall Study|Ineligible|0
4714125|NCT02123511|16252453|P2|Overall Study|Incomplete data|3
4714126|NCT02123511|16252454|P1|Overall Study|Incomplete data|1
4714127|NCT02123511|16252453|P2|Overall Study|Cancelled treatment|0
4714128|NCT02123511|16252454|P1|Overall Study|Cancelled treatment|1
4714129|NCT02123472|16252478|P2|Period 2 (7 Days)|Withdrawal by Subject|1
4714130|NCT02123472|16252479|P1|Period 2 (7 Days)|Withdrawal by Subject|0
4714131|NCT02123459|16252489|P2|Washout Period (1 Day)|Adverse Event|0
4714132|NCT02123459|16252490|P1|Washout Period (1 Day)|Adverse Event|1
4714133|NCT02123446|16252500|P2|Washout Period (1 Day)|Physician Decision|0
4714134|NCT02123446|16252501|P1|Washout Period (1 Day)|Physician Decision|1
4714135|NCT02123251|16252542|P2|Overall Study|Switched Managed Care Organization (MCO)|4
4714136|NCT02123251|16252543|P1|Overall Study|Switched Managed Care Organization (MCO)|4
4714137|NCT02123251|16252542|P2|Overall Study|Lost Medicaid eligibility|22
4714138|NCT02123251|16252543|P1|Overall Study|Lost Medicaid eligibility|29
4714139|NCT02123251|16252542|P2|Overall Study|Withdrawal by Subject|3
4714140|NCT02123251|16252543|P1|Overall Study|Withdrawal by Subject|0
4714141|NCT02123251|16252542|P2|Overall Study|Death|1
4714142|NCT02123251|16252543|P1|Overall Study|Death|1
4714143|NCT02123134|16252569|P2|Overall Study|Administrative decision|1
4714144|NCT02123134|16252570|P1|Overall Study|Administrative decision|0
4714145|NCT02123134|16252569|P2|Overall Study|Withdrawal of consent|2
4714146|NCT02123134|16252570|P1|Overall Study|Withdrawal of consent|3
4714147|NCT02122887|16252627|P2|Overall Study|Withdrawal by Subject|2
4714148|NCT02122887|16252628|P1|Overall Study|Withdrawal by Subject|20
4714149|NCT02122783|16252666|P2|Overall Study|Adverse Event|1
4714150|NCT02122783|16252667|P1|Overall Study|Adverse Event|0
4714151|NCT02122770|16252681|P6|Part B: Standard of Care|Progressive Disease|8
4714152|NCT02122770|16252682|P5|Part B: Standard of Care|Progressive Disease|10
4714153|NCT02122770|16252683|P4|Part B: Standard of Care|Progressive Disease|0
4714154|NCT02122770|16252684|P3|Part B: Standard of Care|Progressive Disease|0
4714155|NCT02122770|16252685|P2|Part B: Standard of Care|Progressive Disease|0
4714156|NCT02122770|16252686|P1|Part B: Standard of Care|Progressive Disease|0
4714157|NCT02122770|16252681|P6|Part B: Standard of Care|Symptomatic Deterioration|0
4714158|NCT02122770|16252682|P5|Part B: Standard of Care|Symptomatic Deterioration|5
4714159|NCT02122770|16252683|P4|Part B: Standard of Care|Symptomatic Deterioration|0
4714160|NCT02122770|16252684|P3|Part B: Standard of Care|Symptomatic Deterioration|0
4714161|NCT02122770|16252685|P2|Part B: Standard of Care|Symptomatic Deterioration|0
4714162|NCT02122770|16252686|P1|Part B: Standard of Care|Symptomatic Deterioration|0
4714163|NCT02122770|16252681|P6|Part B: Standard of Care|Withdrawal by Subject|2
4714164|NCT02122770|16252682|P5|Part B: Standard of Care|Withdrawal by Subject|4
4714165|NCT02122770|16252683|P4|Part B: Standard of Care|Withdrawal by Subject|0
4714166|NCT02122770|16252684|P3|Part B: Standard of Care|Withdrawal by Subject|0
4714167|NCT02122770|16252685|P2|Part B: Standard of Care|Withdrawal by Subject|0
4714168|NCT02122770|16252686|P1|Part B: Standard of Care|Withdrawal by Subject|0
4714169|NCT02122770|16252681|P6|Part B: Standard of Care|Other|2
4714170|NCT02122770|16252682|P5|Part B: Standard of Care|Other|0
4714171|NCT02122770|16252683|P4|Part B: Standard of Care|Other|0
4714172|NCT02122770|16252684|P3|Part B: Standard of Care|Other|0
4714173|NCT02122770|16252685|P2|Part B: Standard of Care|Other|0
4714174|NCT02122770|16252686|P1|Part B: Standard of Care|Other|0
4714175|NCT02122770|16252681|P6|Part B: Standard of Care|Adverse Event|1
4714176|NCT02122770|16252682|P5|Part B: Standard of Care|Adverse Event|4
4714177|NCT02122770|16252683|P4|Part B: Standard of Care|Adverse Event|0
4714178|NCT02122770|16252684|P3|Part B: Standard of Care|Adverse Event|0
4714179|NCT02122770|16252685|P2|Part B: Standard of Care|Adverse Event|0
4714180|NCT02122770|16252686|P1|Part B: Standard of Care|Adverse Event|0
4714181|NCT02122770|16252681|P6|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
4714182|NCT02122770|16252682|P5|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
4714183|NCT02122770|16252683|P4|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
4714184|NCT02122770|16252684|P3|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0
4714185|NCT02122770|16252685|P2|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5
4714186|NCT02122770|16252686|P1|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1
4714187|NCT02122770|16252681|P6|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4714188|NCT02122770|16252682|P5|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4714189|NCT02122770|16252683|P4|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4714190|NCT02122770|16252684|P3|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4714191|NCT02122770|16252685|P2|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1
4714192|NCT02122770|16252686|P1|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0
4714193|NCT02122770|16252681|P6|Part A: Drug-drug Interaction 2|Other|0
4714194|NCT02122770|16252682|P5|Part A: Drug-drug Interaction 2|Other|0
4714195|NCT02122770|16252683|P4|Part A: Drug-drug Interaction 2|Other|0
4714196|NCT02122770|16252684|P3|Part A: Drug-drug Interaction 2|Other|1
4714197|NCT02122770|16252685|P2|Part A: Drug-drug Interaction 2|Other|0
4714198|NCT02122770|16252686|P1|Part A: Drug-drug Interaction 2|Other|0
4714199|NCT02122770|16252681|P6|Part A: Drug-drug Interaction 2|Adverse Event|0
4714200|NCT02122770|16252682|P5|Part A: Drug-drug Interaction 2|Adverse Event|0
4714201|NCT02122770|16252683|P4|Part A: Drug-drug Interaction 2|Adverse Event|2
4714202|NCT02122770|16252684|P3|Part A: Drug-drug Interaction 2|Adverse Event|1
4714203|NCT02122770|16252685|P2|Part A: Drug-drug Interaction 2|Adverse Event|0
4714204|NCT02122770|16252686|P1|Part A: Drug-drug Interaction 2|Adverse Event|3
4714205|NCT02122380|16252806|P2|Second Intervention (30 Days)|2 did not complete all of inpatient day|2
4714206|NCT02122380|16252807|P1|Second Intervention (30 Days)|2 did not complete all of inpatient day|0
4714207|NCT02122380|16252806|P2|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2
4714208|NCT02122380|16252807|P1|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0
4714209|NCT02122380|16252806|P2|Washout (8 Weeks)|Lost to Follow-up|0
4714210|NCT02122380|16252807|P1|Washout (8 Weeks)|Lost to Follow-up|1
4714211|NCT02122380|16252806|P2|First Intervention (30 Days)|Physician Decision|1
4714212|NCT02122380|16252807|P1|First Intervention (30 Days)|Physician Decision|0
4714213|NCT02122380|16252806|P2|First Intervention (30 Days)|Adverse Event|0
4714214|NCT02122380|16252807|P1|First Intervention (30 Days)|Adverse Event|1
4714215|NCT02122146|16252846|P8|Part 1: Dose Escalation|Other|2
4714216|NCT02122146|16252847|P7|Part 1: Dose Escalation|Other|1
4714217|NCT02122146|16252848|P6|Part 1: Dose Escalation|Other|1
4714218|NCT02122146|16252849|P5|Part 1: Dose Escalation|Other|0
4714219|NCT02122146|16252850|P4|Part 1: Dose Escalation|Other|0
4714220|NCT02122146|16252851|P3|Part 1: Dose Escalation|Other|0
4714221|NCT02122146|16252852|P2|Part 1: Dose Escalation|Other|0
4714222|NCT02122146|16252853|P1|Part 1: Dose Escalation|Other|1
4714223|NCT02122146|16252846|P8|Part 1: Dose Escalation|Withdrawal by Subject|0
4714224|NCT02122146|16252847|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
4714225|NCT02122146|16252848|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
4714226|NCT02122146|16252849|P5|Part 1: Dose Escalation|Withdrawal by Subject|0
4714227|NCT02122146|16252850|P4|Part 1: Dose Escalation|Withdrawal by Subject|1
4714228|NCT02122146|16252851|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
4714229|NCT02122146|16252852|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
4714230|NCT02122146|16252853|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
4714231|NCT02122146|16252846|P8|Part 1: Dose Escalation|Lost to Follow-up|0
4714232|NCT02122146|16252847|P7|Part 1: Dose Escalation|Lost to Follow-up|0
4714233|NCT02122146|16252848|P6|Part 1: Dose Escalation|Lost to Follow-up|0
4714234|NCT02122146|16252849|P5|Part 1: Dose Escalation|Lost to Follow-up|1
4714235|NCT02122146|16252850|P4|Part 1: Dose Escalation|Lost to Follow-up|0
4714236|NCT02122146|16252851|P3|Part 1: Dose Escalation|Lost to Follow-up|1
4714237|NCT02122146|16252852|P2|Part 1: Dose Escalation|Lost to Follow-up|0
4714238|NCT02122146|16252853|P1|Part 1: Dose Escalation|Lost to Follow-up|0
4714239|NCT02122146|16252846|P8|Part 1: Dose Escalation|Death|0
4714240|NCT02122146|16252847|P7|Part 1: Dose Escalation|Death|0
4714241|NCT02122146|16252848|P6|Part 1: Dose Escalation|Death|0
4714242|NCT02122146|16252849|P5|Part 1: Dose Escalation|Death|0
4714243|NCT02122146|16252850|P4|Part 1: Dose Escalation|Death|0
4714244|NCT02122146|16252851|P3|Part 1: Dose Escalation|Death|1
4714245|NCT02122146|16252852|P2|Part 1: Dose Escalation|Death|1
4714246|NCT02122146|16252853|P1|Part 1: Dose Escalation|Death|0
4714247|NCT02121847|16253127|P1|Overall Study|Adverse Event|2
4714248|NCT02121847|16253127|P1|Overall Study|Administrative Reasons|1
4714249|NCT02121834|16253153|P7|Overall Study|Lost to Follow-up|0
4714250|NCT02121834|16253154|P6|Overall Study|Lost to Follow-up|0
4714251|NCT02121834|16253155|P5|Overall Study|Lost to Follow-up|0
4714252|NCT02121834|16253156|P4|Overall Study|Lost to Follow-up|0
4714253|NCT02121834|16253157|P3|Overall Study|Lost to Follow-up|1
4714254|NCT02121834|16253158|P2|Overall Study|Lost to Follow-up|0
4714255|NCT02121834|16253159|P1|Overall Study|Lost to Follow-up|0
4714256|NCT02121834|16253153|P7|Overall Study|Withdrawal by Subject|0
4714257|NCT02121834|16253154|P6|Overall Study|Withdrawal by Subject|0
4714258|NCT02121834|16253155|P5|Overall Study|Withdrawal by Subject|0
4714259|NCT02121834|16253156|P4|Overall Study|Withdrawal by Subject|0
4714260|NCT02121834|16253157|P3|Overall Study|Withdrawal by Subject|1
4714261|NCT02121834|16253158|P2|Overall Study|Withdrawal by Subject|1
4714262|NCT02121834|16253159|P1|Overall Study|Withdrawal by Subject|0
4714263|NCT02121834|16253153|P7|Overall Study|Protocol Violation|0
4714264|NCT02121834|16253154|P6|Overall Study|Protocol Violation|0
4714265|NCT02121834|16253155|P5|Overall Study|Protocol Violation|0
4714266|NCT02121834|16253156|P4|Overall Study|Protocol Violation|0
4714267|NCT02121834|16253157|P3|Overall Study|Protocol Violation|0
4714268|NCT02121834|16253158|P2|Overall Study|Protocol Violation|1
4714269|NCT02121834|16253159|P1|Overall Study|Protocol Violation|0
4714270|NCT02121808|16253185|P1|Overall Study|Technical problem|3
4714271|NCT02121795|16253196|P2|Open-Label Phase|Lost to Follow-up|0
4714272|NCT02121795|16253197|P1|Open-Label Phase|Lost to Follow-up|1
4714273|NCT02121795|16253196|P2|Open-Label Phase|Withdrawal by Subject|2
4714274|NCT02121795|16253197|P1|Open-Label Phase|Withdrawal by Subject|3
4714275|NCT02121795|16253196|P2|Open-Label Phase|Physician Decision|8
4714276|NCT02121795|16253197|P1|Open-Label Phase|Physician Decision|8
4714277|NCT02121795|16253196|P2|Double-Blind Phase|Death|1
4714278|NCT02121795|16253197|P1|Double-Blind Phase|Death|1
4714279|NCT02121795|16253196|P2|Double-Blind Phase|Protocol Violation|3
4714280|NCT02121795|16253197|P1|Double-Blind Phase|Protocol Violation|0
4714281|NCT02121795|16253196|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
4714282|NCT02121795|16253197|P1|Double-Blind Phase|Non-Compliance with Study Drug|3
4714283|NCT02121795|16253196|P2|Double-Blind Phase|Adverse Event|0
4714284|NCT02121795|16253197|P1|Double-Blind Phase|Adverse Event|5
4714285|NCT02121795|16253196|P2|Double-Blind Phase|Physician Decision|5
4714286|NCT02121795|16253197|P1|Double-Blind Phase|Physician Decision|2
4714287|NCT02121795|16253196|P2|Double-Blind Phase|Lost to Follow-up|4
4714288|NCT02121795|16253197|P1|Double-Blind Phase|Lost to Follow-up|7
4714289|NCT02121795|16253196|P2|Double-Blind Phase|Withdrawal by Subject|16
4714290|NCT02121795|16253197|P1|Double-Blind Phase|Withdrawal by Subject|19
4714291|NCT02121795|16253196|P2|Double-Blind Phase|Randomized but Never Treated|4
4714292|NCT02121795|16253197|P1|Double-Blind Phase|Randomized but Never Treated|1
4714293|NCT02121756|16253225|P2|Overall Study|Physician Decision|1
4714294|NCT02121756|16253226|P1|Overall Study|Physician Decision|2
4714295|NCT02121756|16253225|P2|Overall Study|Protocol Violation|1
4714296|NCT02121756|16253226|P1|Overall Study|Protocol Violation|1
4714297|NCT02121756|16253225|P2|Overall Study|Adverse Event|0
4714298|NCT02121756|16253226|P1|Overall Study|Adverse Event|3
4714299|NCT02121535|16253263|P2|Period 3 (8 Trial Days)|Withdrawal by Subject|0
4714300|NCT02121535|16253264|P1|Period 3 (8 Trial Days)|Withdrawal by Subject|1
4714301|NCT02121535|16253263|P2|Period 1 (8 Trial Days)|Withdrawal by Subject|1
4714302|NCT02121535|16253264|P1|Period 1 (8 Trial Days)|Withdrawal by Subject|0
4714303|NCT02121522|16253287|P1|Overall Study|Adverse Event|1
4714304|NCT02121509|16253294|P4|Washout Period (35 Days)|elevated AST and ALT levels|0
4714305|NCT02121509|16253295|P3|Washout Period (35 Days)|elevated AST and ALT levels|0
4714306|NCT02121509|16253296|P2|Washout Period (35 Days)|elevated AST and ALT levels|0
4714307|NCT02121509|16253297|P1|Washout Period (35 Days)|elevated AST and ALT levels|1
4714308|NCT02121509|16253294|P4|Washout Period (35 Days)|Withdrawal by Subject|0
4714309|NCT02121509|16253295|P3|Washout Period (35 Days)|Withdrawal by Subject|0
4714310|NCT02121509|16253296|P2|Washout Period (35 Days)|Withdrawal by Subject|3
4714311|NCT02121509|16253297|P1|Washout Period (35 Days)|Withdrawal by Subject|0
4714312|NCT02121509|16253294|P4|Washout Period (35 Days)|Adverse Event|0
4714313|NCT02121509|16253295|P3|Washout Period (35 Days)|Adverse Event|0
4714314|NCT02121509|16253296|P2|Washout Period (35 Days)|Adverse Event|1
4714315|NCT02121509|16253297|P1|Washout Period (35 Days)|Adverse Event|1
4714316|NCT02121392|16253368|P2|After Placement of AC Block vs Sham|Lost to Follow-up|1
4714317|NCT02121392|16253369|P1|After Placement of AC Block vs Sham|Lost to Follow-up|0
4714318|NCT02121392|16253368|P2|After Placement of AC Block vs Sham|Protocol Violation|2
4714319|NCT02121392|16253369|P1|After Placement of AC Block vs Sham|Protocol Violation|3
4714320|NCT02121392|16253368|P2|Prior to Intervention|Withdrawal by Subject|6
4714321|NCT02121392|16253369|P1|Prior to Intervention|Withdrawal by Subject|8
4714322|NCT02121392|16253368|P2|Prior to Intervention|Protocol Violation|35
4714323|NCT02121392|16253369|P1|Prior to Intervention|Protocol Violation|40
4714324|NCT02121301|16253394|P3|Overall Study|Protocol Violation|1
4714325|NCT02121301|16253395|P2|Overall Study|Protocol Violation|4
4714326|NCT02121301|16253396|P1|Overall Study|Protocol Violation|1
4714327|NCT02121210|16253409|P2|Overall Study|Other than specified above|2
4714328|NCT02121210|16253410|P1|Overall Study|Other than specified above|0
4714329|NCT02121210|16253409|P2|Overall Study|Lack of Efficacy|0
4714330|NCT02121210|16253410|P1|Overall Study|Lack of Efficacy|2
4714331|NCT02121210|16253409|P2|Overall Study|Adverse Event|7
4714332|NCT02121210|16253410|P1|Overall Study|Adverse Event|5
4714333|NCT02120950|16253435|P3|Overall Study|Lost to Follow-up|1
4714334|NCT02120950|16253436|P2|Overall Study|Lost to Follow-up|2
4714335|NCT02120950|16253437|P1|Overall Study|Lost to Follow-up|0
4714336|NCT02120950|16253435|P3|Overall Study|Other reasons|1
4714337|NCT02120950|16253436|P2|Overall Study|Other reasons|4
4714338|NCT02120950|16253437|P1|Overall Study|Other reasons|5
4714339|NCT02120950|16253435|P3|Overall Study|Protocol Violation|7
4714340|NCT02120950|16253436|P2|Overall Study|Protocol Violation|1
4714341|NCT02120950|16253437|P1|Overall Study|Protocol Violation|1
4714342|NCT02120950|16253435|P3|Overall Study|Withdrawal by Subject|2
4714343|NCT02120950|16253436|P2|Overall Study|Withdrawal by Subject|3
4714344|NCT02120950|16253437|P1|Overall Study|Withdrawal by Subject|6
4714345|NCT02120950|16253435|P3|Overall Study|Death|1
4714346|NCT02120950|16253436|P2|Overall Study|Death|0
4714347|NCT02120950|16253437|P1|Overall Study|Death|3
4714348|NCT02120950|16253435|P3|Overall Study|Adverse Event|3
4714349|NCT02120950|16253436|P2|Overall Study|Adverse Event|4
4714350|NCT02120950|16253437|P1|Overall Study|Adverse Event|5
4714351|NCT02120924|16253473|P3|Overall Study|Compliance with IP|1
4714352|NCT02120924|16253474|P2|Overall Study|Compliance with IP|1
4714353|NCT02120924|16253475|P1|Overall Study|Compliance with IP|5
4714354|NCT02120924|16253473|P3|Overall Study|Death|0
4714355|NCT02120924|16253474|P2|Overall Study|Death|0
4714356|NCT02120924|16253475|P1|Overall Study|Death|1
4714357|NCT02120924|16253473|P3|Overall Study|Physician Decision|1
4714358|NCT02120924|16253474|P2|Overall Study|Physician Decision|1
4714359|NCT02120924|16253475|P1|Overall Study|Physician Decision|0
4714360|NCT02120924|16253473|P3|Overall Study|Protocol Violation|2
4714361|NCT02120924|16253474|P2|Overall Study|Protocol Violation|7
4714362|NCT02120924|16253475|P1|Overall Study|Protocol Violation|3
4714363|NCT02120924|16253473|P3|Overall Study|Pregnancy|0
4714364|NCT02120924|16253474|P2|Overall Study|Pregnancy|0
4714365|NCT02120924|16253475|P1|Overall Study|Pregnancy|2
4714366|NCT02120924|16253473|P3|Overall Study|Lost to Follow-up|11
4714367|NCT02120924|16253474|P2|Overall Study|Lost to Follow-up|14
4714368|NCT02120924|16253475|P1|Overall Study|Lost to Follow-up|14
4714369|NCT02120924|16253473|P3|Overall Study|Withdrawal by Subject|8
4714370|NCT02120924|16253474|P2|Overall Study|Withdrawal by Subject|20
4714371|NCT02120924|16253475|P1|Overall Study|Withdrawal by Subject|16
4714372|NCT02120924|16253473|P3|Overall Study|Adverse Event|3
4714373|NCT02120924|16253474|P2|Overall Study|Adverse Event|1
4714374|NCT02120924|16253475|P1|Overall Study|Adverse Event|0
4714375|NCT02120924|16253473|P3|Overall Study|Lack of Efficacy|3
4714376|NCT02120924|16253474|P2|Overall Study|Lack of Efficacy|2
4714377|NCT02120924|16253475|P1|Overall Study|Lack of Efficacy|1
4714378|NCT02120898|16253489|P3|Overall Study|Lost to Follow-up|1
4714379|NCT02120898|16253490|P2|Overall Study|Lost to Follow-up|0
4714380|NCT02120898|16253491|P1|Overall Study|Lost to Follow-up|0
4714381|NCT02120898|16253489|P3|Overall Study|Protocol Violation|0
4714382|NCT02120898|16253490|P2|Overall Study|Protocol Violation|2
4714383|NCT02120898|16253491|P1|Overall Study|Protocol Violation|1
4714384|NCT02120898|16253489|P3|Overall Study|Adverse Event|1
4714385|NCT02120898|16253490|P2|Overall Study|Adverse Event|2
4714386|NCT02120898|16253491|P1|Overall Study|Adverse Event|1
4714387|NCT02120898|16253489|P3|Overall Study|Non-compliance with study drug|0
4714388|NCT02120898|16253490|P2|Overall Study|Non-compliance with study drug|0
4714389|NCT02120898|16253491|P1|Overall Study|Non-compliance with study drug|3
4714390|NCT02120898|16253489|P3|Overall Study|Withdrawal by Subject|2
4714391|NCT02120898|16253490|P2|Overall Study|Withdrawal by Subject|2
4714392|NCT02120898|16253491|P1|Overall Study|Withdrawal by Subject|4
4714393|NCT02120833|16253513|P2|Overall Study|Lost to Follow-up|1
4714394|NCT02120833|16253514|P1|Overall Study|Lost to Follow-up|1
4714395|NCT02120833|16253513|P2|Overall Study|Withdrawal by Subject|0
4714396|NCT02120833|16253514|P1|Overall Study|Withdrawal by Subject|2
4714397|NCT02120833|16253513|P2|Overall Study|Adverse Event|0
4714398|NCT02120833|16253514|P1|Overall Study|Adverse Event|1
4714399|NCT02120794|16253668|P1|Overall Study|Due to insurance coverage|1
4714400|NCT02120794|16253668|P1|Overall Study|Physician Decision|4
4714401|NCT02120794|16253668|P1|Overall Study|Adverse Event|10
4714402|NCT02120794|16253668|P1|Overall Study|Withdrawal by Subject|43
4714403|NCT02120664|16253692|P5|Overall Study|Withdrawal by Subject|0
4714404|NCT02120664|16253693|P4|Overall Study|Withdrawal by Subject|1
4714405|NCT02120664|16253694|P3|Overall Study|Withdrawal by Subject|0
4714406|NCT02120664|16253695|P2|Overall Study|Withdrawal by Subject|0
4714407|NCT02120664|16253696|P1|Overall Study|Withdrawal by Subject|0
4714408|NCT02120625|16253714|P1|Overall Study|Physician Decision|2
4714409|NCT02120456|16253730|P9|Part 2 Double-blind Phase|Unable to attend visit due to work|1
4714410|NCT02120456|16253731|P8|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714411|NCT02120456|16253732|P7|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714412|NCT02120456|16253733|P6|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714413|NCT02120456|16253734|P5|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714414|NCT02120456|16253735|P4|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714415|NCT02120456|16253736|P3|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714416|NCT02120456|16253737|P2|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714417|NCT02120456|16253738|P1|Part 2 Double-blind Phase|Unable to attend visit due to work|0
4714418|NCT02120456|16253730|P9|Part 2 Double-blind Phase|Withdrawal of consent|0
4714419|NCT02120456|16253731|P8|Part 2 Double-blind Phase|Withdrawal of consent|0
4714420|NCT02120456|16253732|P7|Part 2 Double-blind Phase|Withdrawal of consent|1
4714421|NCT02120456|16253733|P6|Part 2 Double-blind Phase|Withdrawal of consent|0
4714422|NCT02120456|16253734|P5|Part 2 Double-blind Phase|Withdrawal of consent|0
4714423|NCT02120456|16253735|P4|Part 2 Double-blind Phase|Withdrawal of consent|0
4714424|NCT02120456|16253736|P3|Part 2 Double-blind Phase|Withdrawal of consent|0
4714425|NCT02120456|16253737|P2|Part 2 Double-blind Phase|Withdrawal of consent|0
4714426|NCT02120456|16253738|P1|Part 2 Double-blind Phase|Withdrawal of consent|0
4714427|NCT02120456|16253730|P9|Part 2 Double-blind Phase|Lost to Follow-up|0
4714428|NCT02120456|16253731|P8|Part 2 Double-blind Phase|Lost to Follow-up|0
4714429|NCT02120456|16253732|P7|Part 2 Double-blind Phase|Lost to Follow-up|1
4714430|NCT02120456|16253733|P6|Part 2 Double-blind Phase|Lost to Follow-up|0
4714431|NCT02120456|16253734|P5|Part 2 Double-blind Phase|Lost to Follow-up|0
4714432|NCT02120456|16253735|P4|Part 2 Double-blind Phase|Lost to Follow-up|0
4714433|NCT02120456|16253736|P3|Part 2 Double-blind Phase|Lost to Follow-up|0
4714434|NCT02120456|16253737|P2|Part 2 Double-blind Phase|Lost to Follow-up|0
4714435|NCT02120456|16253738|P1|Part 2 Double-blind Phase|Lost to Follow-up|0
4714436|NCT02120417|16253772|P2|Overall Study|Other unspecified|4
4714437|NCT02120417|16253773|P1|Overall Study|Other unspecified|5
4714438|NCT02120417|16253772|P2|Overall Study|Physician Decision|3
4714439|NCT02120417|16253773|P1|Overall Study|Physician Decision|2
4714440|NCT02120417|16253772|P2|Overall Study|Noncompliance with study treatment|2
4714441|NCT02120417|16253773|P1|Overall Study|Noncompliance with study treatment|0
4714442|NCT02120417|16253772|P2|Overall Study|Disease progression|45
4714443|NCT02120417|16253773|P1|Overall Study|Disease progression|41
4714444|NCT02120417|16253772|P2|Overall Study|Participant decision|4
4714445|NCT02120417|16253773|P1|Overall Study|Participant decision|4
4714446|NCT02120417|16253772|P2|Overall Study|Adverse Event|9
4714447|NCT02120417|16253773|P1|Overall Study|Adverse Event|3
4714448|NCT02120417|16253772|P2|Overall Study|Death|1
4714449|NCT02120417|16253773|P1|Overall Study|Death|5
4714450|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|50
4714451|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|105
4714452|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|112
4714453|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Ongoing at the time of interim analysis|0
4714454|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
4714455|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Withdrawal by Subject|1
4714456|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Withdrawal by Subject|2
4714457|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Withdrawal by Subject|0
4714458|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Lost to Follow-up|1
4714459|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Lost to Follow-up|0
4714460|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Lost to Follow-up|0
4714461|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Lost to Follow-up|0
4714462|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
4714463|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|1
4714464|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
4714465|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Met protocol-defined stopping criteria|0
4714466|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Protocol Violation|0
4714467|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Protocol Violation|2
4714468|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Protocol Violation|0
4714469|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Protocol Violation|0
4714470|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Lack of Efficacy|1
4714471|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Lack of Efficacy|0
4714472|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Lack of Efficacy|1
4714473|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Lack of Efficacy|0
4714474|NCT02120352|16253791|P4|Maintenance Period (32 Weeks)|Adverse Event|1
4714475|NCT02120352|16253792|P3|Maintenance Period (32 Weeks)|Adverse Event|6
4714476|NCT02120352|16253793|P2|Maintenance Period (32 Weeks)|Adverse Event|0
4714477|NCT02120352|16253794|P1|Maintenance Period (32 Weeks)|Adverse Event|0
4714478|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Physician Decision|0
4714479|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Physician Decision|0
4714480|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Physician Decision|0
4714481|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Physician Decision|1
4714482|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Withdrawal by Subject|0
4714483|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Withdrawal by Subject|0
4714484|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Withdrawal by Subject|0
4714485|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Withdrawal by Subject|5
4714486|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Lost to Follow-up|0
4714487|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Lost to Follow-up|0
4714488|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Lost to Follow-up|0
4714489|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Lost to Follow-up|2
4714490|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
4714491|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
4714492|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0
4714493|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3
4714494|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Protocol Violation|0
4714495|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Protocol Violation|0
4714496|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Protocol Violation|0
4714497|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Protocol Violation|2
4714498|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Lack of Efficacy|0
4714499|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Lack of Efficacy|0
4714500|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Lack of Efficacy|0
4714501|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Lack of Efficacy|5
4714502|NCT02120352|16253791|P4|Induction Period (20 Weeks)|Adverse Event|0
4714503|NCT02120352|16253792|P3|Induction Period (20 Weeks)|Adverse Event|0
4714504|NCT02120352|16253793|P2|Induction Period (20 Weeks)|Adverse Event|0
4714505|NCT02120352|16253794|P1|Induction Period (20 Weeks)|Adverse Event|3
4714506|NCT02120300|16253945|P4|Overall Study|Lost to Follow-up|0
4714507|NCT02120300|16253946|P3|Overall Study|Lost to Follow-up|0
4714508|NCT02120300|16253947|P2|Overall Study|Lost to Follow-up|0
4714509|NCT02120300|16253948|P1|Overall Study|Lost to Follow-up|1
4714510|NCT02120300|16253945|P4|Overall Study|Lack of Efficacy|1
4714511|NCT02120300|16253946|P3|Overall Study|Lack of Efficacy|0
4714512|NCT02120300|16253947|P2|Overall Study|Lack of Efficacy|0
4714513|NCT02120300|16253948|P1|Overall Study|Lack of Efficacy|0
4714514|NCT02120300|16253945|P4|Overall Study|Enrolled but Never Treated|0
4714515|NCT02120300|16253946|P3|Overall Study|Enrolled but Never Treated|0
4714516|NCT02120300|16253947|P2|Overall Study|Enrolled but Never Treated|0
4714517|NCT02120300|16253948|P1|Overall Study|Enrolled but Never Treated|2
4714518|NCT02120157|16254019|P2|Overall Study|Graft Failure before Day 100|0
4714519|NCT02120157|16254020|P1|Overall Study|Graft Failure before Day 100|2
4714520|NCT02120157|16254019|P2|Overall Study|Death|2
4714521|NCT02120157|16254020|P1|Overall Study|Death|4
4714522|NCT02120027|16254030|P2|Overall Study|Withdrawal by Subject|25
4714523|NCT02120027|16254031|P1|Overall Study|Withdrawal by Subject|33
4714524|NCT02120027|16254030|P2|Overall Study|Study terminated by Sponsor|47
4714525|NCT02120027|16254031|P1|Overall Study|Study terminated by Sponsor|45
4714526|NCT02120027|16254030|P2|Overall Study|Protocol Violation|21
4714527|NCT02120027|16254031|P1|Overall Study|Protocol Violation|18
4714528|NCT02120027|16254030|P2|Overall Study|Physician Decision|3
4714529|NCT02120027|16254031|P1|Overall Study|Physician Decision|4
4714530|NCT02120027|16254030|P2|Overall Study|Other|0
4714531|NCT02120027|16254031|P1|Overall Study|Other|4
4714532|NCT02120027|16254030|P2|Overall Study|Lost to Follow-up|13
4714533|NCT02120027|16254031|P1|Overall Study|Lost to Follow-up|5
4714534|NCT02120027|16254030|P2|Overall Study|Lack of Efficacy|5
4714535|NCT02120027|16254031|P1|Overall Study|Lack of Efficacy|3
4714536|NCT02120027|16254030|P2|Overall Study|Adverse Event|5
4714537|NCT02120027|16254031|P1|Overall Study|Adverse Event|4
4714538|NCT02119936|16254056|P1|Overall Study|Lost to Follow-up|10
4714539|NCT02119676|16254090|P4|Overall Study|Did not receive study med|5
4714540|NCT02119676|16254091|P3|Overall Study|Did not receive study med|4
4714541|NCT02119676|16254092|P2|Overall Study|Did not receive study med|2
4714542|NCT02119676|16254093|P1|Overall Study|Did not receive study med|2
4714543|NCT02119676|16254090|P4|Overall Study|Other, unspecified|4
4714544|NCT02119676|16254091|P3|Overall Study|Other, unspecified|3
4714545|NCT02119676|16254092|P2|Overall Study|Other, unspecified|1
4714546|NCT02119676|16254093|P1|Overall Study|Other, unspecified|2
4714547|NCT02119676|16254090|P4|Overall Study|Protocol deviation|0
4714548|NCT02119676|16254091|P3|Overall Study|Protocol deviation|1
4714549|NCT02119676|16254092|P2|Overall Study|Protocol deviation|0
4714550|NCT02119676|16254093|P1|Overall Study|Protocol deviation|0
4714551|NCT02119676|16254090|P4|Overall Study|Lost to Follow-up|0
4714552|NCT02119676|16254091|P3|Overall Study|Lost to Follow-up|1
4714553|NCT02119676|16254092|P2|Overall Study|Lost to Follow-up|0
4714554|NCT02119676|16254093|P1|Overall Study|Lost to Follow-up|0
4714555|NCT02119676|16254090|P4|Overall Study|Noncompliance|0
4714556|NCT02119676|16254091|P3|Overall Study|Noncompliance|0
4714557|NCT02119676|16254092|P2|Overall Study|Noncompliance|1
4714558|NCT02119676|16254093|P1|Overall Study|Noncompliance|0
4714559|NCT02119676|16254090|P4|Overall Study|Death|1
4714560|NCT02119676|16254091|P3|Overall Study|Death|2
4714561|NCT02119676|16254092|P2|Overall Study|Death|3
4714562|NCT02119676|16254093|P1|Overall Study|Death|9
4714563|NCT02119676|16254090|P4|Overall Study|Physician Decision|2
4714564|NCT02119676|16254091|P3|Overall Study|Physician Decision|3
4714565|NCT02119676|16254092|P2|Overall Study|Physician Decision|2
4714566|NCT02119676|16254093|P1|Overall Study|Physician Decision|4
4714567|NCT02119676|16254090|P4|Overall Study|Patient decision, inc. consent withdrawn|6
4714568|NCT02119676|16254091|P3|Overall Study|Patient decision, inc. consent withdrawn|5
4714569|NCT02119676|16254092|P2|Overall Study|Patient decision, inc. consent withdrawn|5
4714570|NCT02119676|16254093|P1|Overall Study|Patient decision, inc. consent withdrawn|4
4714571|NCT02119676|16254090|P4|Overall Study|Disease progression|73
4714572|NCT02119676|16254091|P3|Overall Study|Disease progression|68
4714573|NCT02119676|16254092|P2|Overall Study|Disease progression|55
4714574|NCT02119676|16254093|P1|Overall Study|Disease progression|53
4714575|NCT02119676|16254090|P4|Overall Study|Adverse Event|10
4714576|NCT02119676|16254091|P3|Overall Study|Adverse Event|10
4714577|NCT02119676|16254092|P2|Overall Study|Adverse Event|17
4714578|NCT02119676|16254093|P1|Overall Study|Adverse Event|9
4714579|NCT02119663|16254125|P2|Overall Study|Study Terminated by the Sponsor|4
4714580|NCT02119663|16254126|P1|Overall Study|Study Terminated by the Sponsor|3
4714581|NCT02119663|16254125|P2|Overall Study|Subject decision|1
4714582|NCT02119663|16254126|P1|Overall Study|Subject decision|0
4714583|NCT02119663|16254125|P2|Overall Study|Other unspecified|0
4714584|NCT02119663|16254126|P1|Overall Study|Other unspecified|2
4714585|NCT02119663|16254125|P2|Overall Study|Physician Decision|2
4714586|NCT02119663|16254126|P1|Overall Study|Physician Decision|1
4714587|NCT02119663|16254125|P2|Overall Study|Death|2
4714588|NCT02119663|16254126|P1|Overall Study|Death|3
4714589|NCT02119663|16254125|P2|Overall Study|Adverse Event|5
4714590|NCT02119663|16254126|P1|Overall Study|Adverse Event|5
4714591|NCT02119663|16254125|P2|Overall Study|Disease progression|27
4714592|NCT02119663|16254126|P1|Overall Study|Disease progression|26
4714593|NCT02119650|16254144|P2|Overall Study|Multiple reasons for termination|1
4714594|NCT02119650|16254145|P1|Overall Study|Multiple reasons for termination|2
4714595|NCT02119650|16254144|P2|Overall Study|Physician Decision|2
4714596|NCT02119650|16254145|P1|Overall Study|Physician Decision|0
4714597|NCT02119650|16254144|P2|Overall Study|Study terminated by the sponsor|0
4714598|NCT02119650|16254145|P1|Overall Study|Study terminated by the sponsor|1
4714599|NCT02119650|16254144|P2|Overall Study|Noncompliance with study treatment|1
4714600|NCT02119650|16254145|P1|Overall Study|Noncompliance with study treatment|1
4714601|NCT02119650|16254144|P2|Overall Study|Death|1
4714602|NCT02119650|16254145|P1|Overall Study|Death|5
4714603|NCT02119650|16254144|P2|Overall Study|Disease progression|14
4714604|NCT02119650|16254145|P1|Overall Study|Disease progression|11
4714605|NCT02119650|16254144|P2|Overall Study|Subject decision|3
4714606|NCT02119650|16254145|P1|Overall Study|Subject decision|2
4714607|NCT02119650|16254144|P2|Overall Study|Adverse Event|4
4714608|NCT02119650|16254145|P1|Overall Study|Adverse Event|3
4714609|NCT02119325|16254180|P2|Washout Period 1|Adverse Event|1
4714610|NCT02119325|16254181|P1|Washout Period 1|Adverse Event|0
4714611|NCT02119299|16254225|P1|Overall Study|Pregnancy|1
4714612|NCT02119299|16254225|P1|Overall Study|Lack of Efficacy|1
4714613|NCT02119299|16254225|P1|Overall Study|Withdrawal by Subject|7
4714614|NCT02119286|16254239|P3|Overall Study|Withdrawal by Subject|0
4714615|NCT02119286|16254240|P2|Overall Study|Withdrawal by Subject|1
4714616|NCT02119286|16254241|P1|Overall Study|Withdrawal by Subject|4
4714617|NCT02119286|16254239|P3|Overall Study|Lost to Follow-up|1
4714618|NCT02119286|16254240|P2|Overall Study|Lost to Follow-up|0
4714619|NCT02119286|16254241|P1|Overall Study|Lost to Follow-up|2
4714620|NCT02119286|16254239|P3|Overall Study|Lack of Efficacy|4
4714621|NCT02119286|16254240|P2|Overall Study|Lack of Efficacy|3
4714622|NCT02119286|16254241|P1|Overall Study|Lack of Efficacy|11
4714623|NCT02119286|16254239|P3|Overall Study|Adverse Event|2
4714624|NCT02119286|16254240|P2|Overall Study|Adverse Event|7
4714625|NCT02119286|16254241|P1|Overall Study|Adverse Event|9
4714626|NCT02119260|16254259|P7|Overall Study|Withdrew consent|0
4714627|NCT02119260|16254260|P6|Overall Study|Withdrew consent|0
4714628|NCT02119260|16254261|P5|Overall Study|Withdrew consent|0
4714629|NCT02119260|16254262|P4|Overall Study|Withdrew consent|0
4714630|NCT02119260|16254263|P3|Overall Study|Withdrew consent|1
4714631|NCT02119260|16254264|P2|Overall Study|Withdrew consent|1
4714632|NCT02119260|16254265|P1|Overall Study|Withdrew consent|0
4714633|NCT02119260|16254259|P7|Overall Study|Adverse Event|0
4714634|NCT02119260|16254260|P6|Overall Study|Adverse Event|0
4714635|NCT02119260|16254261|P5|Overall Study|Adverse Event|0
4714636|NCT02119260|16254262|P4|Overall Study|Adverse Event|0
4714637|NCT02119260|16254263|P3|Overall Study|Adverse Event|0
4714638|NCT02119260|16254264|P2|Overall Study|Adverse Event|0
4714639|NCT02119260|16254265|P1|Overall Study|Adverse Event|1
4714640|NCT02119156|16254338|P3|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7
4714641|NCT02119156|16254339|P2|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10
4714642|NCT02119156|16254340|P1|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0
4714643|NCT02119156|16254338|P3|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
4714644|NCT02119156|16254339|P2|Treatment Phase (Up to 52 Weeks)|Physician Decision|0
4714645|NCT02119156|16254340|P1|Treatment Phase (Up to 52 Weeks)|Physician Decision|1
4714646|NCT02119156|16254338|P3|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0
4714647|NCT02119156|16254339|P2|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2
4714648|NCT02119156|16254340|P1|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1
4714649|NCT02119156|16254338|P3|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
4714650|NCT02119156|16254339|P2|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0
4714651|NCT02119156|16254340|P1|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4
4714652|NCT02119156|16254338|P3|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1
4714653|NCT02119156|16254339|P2|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
4714654|NCT02119156|16254340|P1|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0
4714655|NCT02119104|16254398|P1|Overall Study|Protocol Violation|16
4714656|NCT02119026|16254404|P2|2nd-line Treatment|Adverse Event|1
4714657|NCT02119026|16254405|P1|2nd-line Treatment|Adverse Event|4
4714658|NCT02119026|16254404|P2|2nd-line Treatment|Withdrawal by Subject|1
4714659|NCT02119026|16254405|P1|2nd-line Treatment|Withdrawal by Subject|3
4714660|NCT02119026|16254404|P2|2nd-line Treatment|Lost to Follow-up|0
4714661|NCT02119026|16254405|P1|2nd-line Treatment|Lost to Follow-up|2
4714662|NCT02119026|16254404|P2|1st-line Treatment|Death|1
4714663|NCT02119026|16254405|P1|1st-line Treatment|Death|2
4714664|NCT02119026|16254404|P2|1st-line Treatment|Surgery of metastases|1
4714665|NCT02119026|16254405|P1|1st-line Treatment|Surgery of metastases|2
4714666|NCT02119026|16254404|P2|1st-line Treatment|Patient condition or compliance|4
4714667|NCT02119026|16254405|P1|1st-line Treatment|Patient condition or compliance|6
4714668|NCT02119026|16254404|P2|1st-line Treatment|Withdrawal by Subject|10
4714669|NCT02119026|16254405|P1|1st-line Treatment|Withdrawal by Subject|4
4714670|NCT02119026|16254404|P2|1st-line Treatment|Physician Decision|8
4714671|NCT02119026|16254405|P1|1st-line Treatment|Physician Decision|3
4714672|NCT02119026|16254404|P2|1st-line Treatment|Adverse Event|14
4714673|NCT02119026|16254405|P1|1st-line Treatment|Adverse Event|9
4714674|NCT02118961|16254429|P2|Overall Study|Withdrawal by Subject|0
4714675|NCT02118961|16254430|P1|Overall Study|Withdrawal by Subject|1
4714676|NCT02118896|16254458|P10|Overall Study|Miscellaneous|0
4714677|NCT02118896|16254459|P9|Overall Study|Miscellaneous|0
4714678|NCT02118896|16254460|P8|Overall Study|Miscellaneous|0
4714679|NCT02118896|16254461|P7|Overall Study|Miscellaneous|0
4714680|NCT02118896|16254462|P6|Overall Study|Miscellaneous|4
4714681|NCT02118896|16254463|P5|Overall Study|Miscellaneous|0
4714682|NCT02118896|16254464|P4|Overall Study|Miscellaneous|2
4714683|NCT02118896|16254465|P3|Overall Study|Miscellaneous|0
4714684|NCT02118896|16254466|P2|Overall Study|Miscellaneous|2
4714685|NCT02118896|16254467|P1|Overall Study|Miscellaneous|1
4714686|NCT02118896|16254458|P10|Overall Study|Prohibited medication|0
4714687|NCT02118896|16254459|P9|Overall Study|Prohibited medication|0
4714688|NCT02118896|16254460|P8|Overall Study|Prohibited medication|0
4714689|NCT02118896|16254461|P7|Overall Study|Prohibited medication|0
4714690|NCT02118896|16254462|P6|Overall Study|Prohibited medication|3
4714691|NCT02118896|16254463|P5|Overall Study|Prohibited medication|1
4714692|NCT02118896|16254464|P4|Overall Study|Prohibited medication|0
4714693|NCT02118896|16254465|P3|Overall Study|Prohibited medication|0
4714694|NCT02118896|16254466|P2|Overall Study|Prohibited medication|0
4714695|NCT02118896|16254467|P1|Overall Study|Prohibited medication|0
4714696|NCT02118896|16254458|P10|Overall Study|Immunosuppressive regimen (not MR4)|2
4714697|NCT02118896|16254459|P9|Overall Study|Immunosuppressive regimen (not MR4)|0
4714698|NCT02118896|16254460|P8|Overall Study|Immunosuppressive regimen (not MR4)|0
4714699|NCT02118896|16254461|P7|Overall Study|Immunosuppressive regimen (not MR4)|0
4714700|NCT02118896|16254462|P6|Overall Study|Immunosuppressive regimen (not MR4)|2
4714701|NCT02118896|16254463|P5|Overall Study|Immunosuppressive regimen (not MR4)|4
4714702|NCT02118896|16254464|P4|Overall Study|Immunosuppressive regimen (not MR4)|2
4714703|NCT02118896|16254465|P3|Overall Study|Immunosuppressive regimen (not MR4)|1
4714704|NCT02118896|16254466|P2|Overall Study|Immunosuppressive regimen (not MR4)|5
4714705|NCT02118896|16254467|P1|Overall Study|Immunosuppressive regimen (not MR4)|1
4714706|NCT02118896|16254458|P10|Overall Study|Lost to Follow-up|0
4714707|NCT02118896|16254459|P9|Overall Study|Lost to Follow-up|0
4714708|NCT02118896|16254460|P8|Overall Study|Lost to Follow-up|0
4714709|NCT02118896|16254461|P7|Overall Study|Lost to Follow-up|0
4714710|NCT02118896|16254462|P6|Overall Study|Lost to Follow-up|1
4714711|NCT02118896|16254463|P5|Overall Study|Lost to Follow-up|2
4714712|NCT02118896|16254464|P4|Overall Study|Lost to Follow-up|0
4714713|NCT02118896|16254465|P3|Overall Study|Lost to Follow-up|1
4714714|NCT02118896|16254466|P2|Overall Study|Lost to Follow-up|2
4714715|NCT02118896|16254467|P1|Overall Study|Lost to Follow-up|1
4714716|NCT02118896|16254458|P10|Overall Study|Pregnancy|0
4714717|NCT02118896|16254459|P9|Overall Study|Pregnancy|0
4714718|NCT02118896|16254460|P8|Overall Study|Pregnancy|0
4714719|NCT02118896|16254461|P7|Overall Study|Pregnancy|1
4714720|NCT02118896|16254462|P6|Overall Study|Pregnancy|3
4714721|NCT02118896|16254463|P5|Overall Study|Pregnancy|1
4714722|NCT02118896|16254464|P4|Overall Study|Pregnancy|0
4714723|NCT02118896|16254465|P3|Overall Study|Pregnancy|0
4714724|NCT02118896|16254466|P2|Overall Study|Pregnancy|1
4714725|NCT02118896|16254467|P1|Overall Study|Pregnancy|1
4714726|NCT02118896|16254458|P10|Overall Study|Non-compliance|0
4714727|NCT02118896|16254459|P9|Overall Study|Non-compliance|0
4714728|NCT02118896|16254460|P8|Overall Study|Non-compliance|1
4714729|NCT02118896|16254461|P7|Overall Study|Non-compliance|0
4714730|NCT02118896|16254462|P6|Overall Study|Non-compliance|1
4714731|NCT02118896|16254463|P5|Overall Study|Non-compliance|0
4714732|NCT02118896|16254464|P4|Overall Study|Non-compliance|5
4714733|NCT02118896|16254465|P3|Overall Study|Non-compliance|1
4714734|NCT02118896|16254466|P2|Overall Study|Non-compliance|1
4714735|NCT02118896|16254467|P1|Overall Study|Non-compliance|2
4714736|NCT02118896|16254458|P10|Overall Study|Consent withdrawn|0
4714737|NCT02118896|16254459|P9|Overall Study|Consent withdrawn|0
4714738|NCT02118896|16254460|P8|Overall Study|Consent withdrawn|0
4714739|NCT02118896|16254461|P7|Overall Study|Consent withdrawn|0
4714740|NCT02118896|16254462|P6|Overall Study|Consent withdrawn|4
4714741|NCT02118896|16254463|P5|Overall Study|Consent withdrawn|1
4714742|NCT02118896|16254464|P4|Overall Study|Consent withdrawn|4
4714743|NCT02118896|16254465|P3|Overall Study|Consent withdrawn|3
4714744|NCT02118896|16254466|P2|Overall Study|Consent withdrawn|0
4714745|NCT02118896|16254467|P1|Overall Study|Consent withdrawn|2
4714746|NCT02118896|16254458|P10|Overall Study|Adverse Event|0
4714747|NCT02118896|16254459|P9|Overall Study|Adverse Event|4
4714748|NCT02118896|16254460|P8|Overall Study|Adverse Event|1
4714749|NCT02118896|16254461|P7|Overall Study|Adverse Event|1
4714750|NCT02118896|16254462|P6|Overall Study|Adverse Event|9
4714751|NCT02118896|16254463|P5|Overall Study|Adverse Event|5
4714752|NCT02118896|16254464|P4|Overall Study|Adverse Event|5
4714753|NCT02118896|16254465|P3|Overall Study|Adverse Event|4
4714754|NCT02118896|16254466|P2|Overall Study|Adverse Event|4
4714755|NCT02118896|16254467|P1|Overall Study|Adverse Event|5
4714756|NCT02118896|16254458|P10|Overall Study|Death|0
4714757|NCT02118896|16254459|P9|Overall Study|Death|0
4714758|NCT02118896|16254460|P8|Overall Study|Death|0
4714759|NCT02118896|16254461|P7|Overall Study|Death|0
4714760|NCT02118896|16254462|P6|Overall Study|Death|1
4714761|NCT02118896|16254463|P5|Overall Study|Death|3
4714762|NCT02118896|16254464|P4|Overall Study|Death|6
4714763|NCT02118896|16254465|P3|Overall Study|Death|4
4714764|NCT02118896|16254466|P2|Overall Study|Death|0
4714765|NCT02118896|16254467|P1|Overall Study|Death|4
4714766|NCT02118792|16254557|P2|Overall Study|Randomised but not treated|0
4714767|NCT02118792|16254558|P1|Overall Study|Randomised but not treated|1
4714768|NCT02118792|16254557|P2|Overall Study|Other|6
4714769|NCT02118792|16254558|P1|Overall Study|Other|1
4714770|NCT02118792|16254557|P2|Overall Study|Withdrawal by parent/guardian|20
4714771|NCT02118792|16254558|P1|Overall Study|Withdrawal by parent/guardian|14
4714772|NCT02118792|16254557|P2|Overall Study|Adverse Event|4
4714773|NCT02118792|16254558|P1|Overall Study|Adverse Event|5
4714774|NCT02118792|16254557|P2|Overall Study|Lost to Follow-up|4
4714775|NCT02118792|16254558|P1|Overall Study|Lost to Follow-up|4
4714776|NCT02118792|16254557|P2|Overall Study|Withdrawal by Subject|3
4714777|NCT02118792|16254558|P1|Overall Study|Withdrawal by Subject|6
4714778|NCT02118766|16254600|P2|Overall Study|Other|1
4714779|NCT02118766|16254601|P1|Overall Study|Other|3
4714780|NCT02118766|16254600|P2|Overall Study|Withdrawal by parent/guardian|18
4714781|NCT02118766|16254601|P1|Overall Study|Withdrawal by parent/guardian|12
4714782|NCT02118766|16254600|P2|Overall Study|Lost to Follow-up|4
4714783|NCT02118766|16254601|P1|Overall Study|Lost to Follow-up|5
4714784|NCT02118766|16254600|P2|Overall Study|Withdrawal by Subject|6
4714785|NCT02118766|16254601|P1|Overall Study|Withdrawal by Subject|3
4714786|NCT02118766|16254600|P2|Overall Study|Adverse Event|2
4714787|NCT02118766|16254601|P1|Overall Study|Adverse Event|7
4714788|NCT02118714|16254623|P1|Overall Study|Protocol Violation|1
4714789|NCT02118714|16254623|P1|Overall Study|Lost to Follow-up|2
4714790|NCT02118597|16254648|P1|Overall Study|Investigator's decision|1
4714791|NCT02118597|16254648|P1|Overall Study|Serious Adverse Event|1
4714792|NCT02118597|16254648|P1|Overall Study|Sponsor terminated the study|14
4714793|NCT02118428|16254679|P3|Overall Study|Screen Failure or Became Inelegible|1
4714794|NCT02118428|16254680|P2|Overall Study|Screen Failure or Became Inelegible|0
4714795|NCT02118428|16254681|P1|Overall Study|Screen Failure or Became Inelegible|1
4714796|NCT02118428|16254679|P3|Overall Study|Lost to Follow-up|0
4714797|NCT02118428|16254680|P2|Overall Study|Lost to Follow-up|1
4714798|NCT02118428|16254681|P1|Overall Study|Lost to Follow-up|3
4714799|NCT02118428|16254679|P3|Overall Study|Death|0
4714800|NCT02118428|16254680|P2|Overall Study|Death|5
4714801|NCT02118428|16254681|P1|Overall Study|Death|7
4714802|NCT02118428|16254679|P3|Overall Study|Withdrawal by Subject|0
4714803|NCT02118428|16254680|P2|Overall Study|Withdrawal by Subject|2
4714804|NCT02118428|16254681|P1|Overall Study|Withdrawal by Subject|2
4714805|NCT02118428|16254679|P3|Overall Study|Physician Decision|0
4714806|NCT02118428|16254680|P2|Overall Study|Physician Decision|1
4714807|NCT02118428|16254681|P1|Overall Study|Physician Decision|0
4714808|NCT02118012|16254721|P2|Overall Study|Physician Decision|1
4714809|NCT02118012|16254722|P1|Overall Study|Physician Decision|0
4714810|NCT02118012|16254721|P2|Overall Study|Adverse Event|1
4714811|NCT02118012|16254722|P1|Overall Study|Adverse Event|0
4714812|NCT02117687|16254766|P2|Overall Study|Other Reasons|1
4714813|NCT02117687|16254767|P1|Overall Study|Other Reasons|1
4714814|NCT02117687|16254766|P2|Overall Study|Adverse Event|2
4714815|NCT02117687|16254767|P1|Overall Study|Adverse Event|0
4714816|NCT02117687|16254766|P2|Overall Study|Lost to Follow-up|1
4714817|NCT02117687|16254767|P1|Overall Study|Lost to Follow-up|0
4714818|NCT02117648|16254799|P1|Abemaciclib Safety-Extension Phase|Adverse Event|2
4714819|NCT02117648|16254799|P1|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2
4714820|NCT02117648|16254799|P1|Abemaciclib Safety-Extension Phase|Death|3
4714821|NCT02117648|16254799|P1|Abemaciclib Safety-Extension Phase|Physician Decision|1
4714822|NCT02117648|16254799|P1|Abemaciclib Safety-Extension Phase|Progressive Disease|12
4714823|NCT02117648|16254799|P1|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1
4714824|NCT02117648|16254799|P1|Abemaciclib + Clarithromycin Period 2|Adverse Event|1
4714825|NCT02117648|16254799|P1|Abemaciclib + Clarithromycin Period 2|Death|1
4714826|NCT02117648|16254799|P1|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1
4714827|NCT02117648|16254799|P1|Abemaciclib Alone Period 1|Adverse Event|1
4714828|NCT02117648|16254799|P1|Abemaciclib Alone Period 1|Withdrawal by Subject|1
4714829|NCT02117570|16254812|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
4714830|NCT02117570|16254813|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1
4714831|NCT02117570|16254814|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0
4714832|NCT02117570|16254812|P3|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
4714833|NCT02117570|16254813|P2|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2
4714834|NCT02117570|16254814|P1|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1
4714835|NCT02117570|16254812|P3|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1
4714836|NCT02117570|16254813|P2|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
4714837|NCT02117570|16254814|P1|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0
4714838|NCT02117570|16254812|P3|Stage 2 Participants Aged 65 to 85 Years|Death|1
4714839|NCT02117570|16254813|P2|Stage 2 Participants Aged 65 to 85 Years|Death|0
4714840|NCT02117570|16254814|P1|Stage 2 Participants Aged 65 to 85 Years|Death|0
4714841|NCT02117570|16254812|P3|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2
4714842|NCT02117570|16254813|P2|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
4714843|NCT02117570|16254814|P1|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0
4714844|NCT02117570|16254812|P3|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0
4714845|NCT02117570|16254813|P2|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
4714846|NCT02117570|16254814|P1|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1
4714847|NCT02117570|16254812|P3|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1
4714848|NCT02117570|16254813|P2|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2
4714849|NCT02117570|16254814|P1|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0
4714850|NCT02117544|16254864|P2|Period 1|Lost to follow-up (prior to treatment)|0
4714851|NCT02117544|16254865|P1|Period 1|Lost to follow-up (prior to treatment)|2
4714852|NCT02117479|16254880|P2|Overall Study|Other unspecified|7
4714853|NCT02117479|16254881|P1|Overall Study|Other unspecified|11
4714854|NCT02117479|16254880|P2|Overall Study|Physician Decision|2
4714855|NCT02117479|16254881|P1|Overall Study|Physician Decision|7
4714856|NCT02117479|16254880|P2|Overall Study|Study terminated by the sponsor|6
4714857|NCT02117479|16254881|P1|Overall Study|Study terminated by the sponsor|4
4714858|NCT02117479|16254880|P2|Overall Study|Noncompliance with study treatment|0
4714859|NCT02117479|16254881|P1|Overall Study|Noncompliance with study treatment|1
4714860|NCT02117479|16254880|P2|Overall Study|Disease progression|108
4714861|NCT02117479|16254881|P1|Overall Study|Disease progression|104
4714862|NCT02117479|16254880|P2|Overall Study|Subject decision|9
4714863|NCT02117479|16254881|P1|Overall Study|Subject decision|8
4714864|NCT02117479|16254880|P2|Overall Study|Adverse Event|16
4714865|NCT02117479|16254881|P1|Overall Study|Adverse Event|8
4714866|NCT02117479|16254880|P2|Overall Study|Death|8
4714867|NCT02117479|16254881|P1|Overall Study|Death|13
4714868|NCT02117427|16254900|P3|Overall Study|Death|0
4714869|NCT02117427|16254901|P2|Overall Study|Death|1
4714870|NCT02117427|16254902|P1|Overall Study|Death|0
4714871|NCT02117427|16254900|P3|Overall Study|No longer meets inclusion criteria|0
4714872|NCT02117427|16254901|P2|Overall Study|No longer meets inclusion criteria|1
4714873|NCT02117427|16254902|P1|Overall Study|No longer meets inclusion criteria|0
4714874|NCT02117427|16254900|P3|Overall Study|Physician Decision|0
4714875|NCT02117427|16254901|P2|Overall Study|Physician Decision|2
4714876|NCT02117427|16254902|P1|Overall Study|Physician Decision|0
4714877|NCT02117427|16254900|P3|Overall Study|Permanent need for exogenous ESA Tx|0
4714878|NCT02117427|16254901|P2|Overall Study|Permanent need for exogenous ESA Tx|1
4714879|NCT02117427|16254902|P1|Overall Study|Permanent need for exogenous ESA Tx|3
4714880|NCT02117427|16254900|P3|Overall Study|Permanent need for exogenous EPO Tx|0
4714881|NCT02117427|16254901|P2|Overall Study|Permanent need for exogenous EPO Tx|0
4714882|NCT02117427|16254902|P1|Overall Study|Permanent need for exogenous EPO Tx|2
4714883|NCT02117414|16254912|P2|Overall Study|Withdrawal by Subject|4
4714884|NCT02117414|16254913|P1|Overall Study|Withdrawal by Subject|10
4714885|NCT02117414|16254912|P2|Overall Study|Death|2
4714886|NCT02117414|16254913|P1|Overall Study|Death|5
4714887|NCT02117349|16254933|P2|Overall Study|Death|0
4714888|NCT02117349|16254934|P1|Overall Study|Death|1
4714889|NCT02117349|16254933|P2|Overall Study|Lost to Follow-up|1
4714890|NCT02117349|16254934|P1|Overall Study|Lost to Follow-up|1
4714891|NCT02117349|16254933|P2|Overall Study|Withdrawal by Subject|0
4714892|NCT02117349|16254934|P1|Overall Study|Withdrawal by Subject|1
4714893|NCT02117050|16254970|P1|Overall Study|Subject Enrolled but not Dosed|1
4714894|NCT02117024|16254984|P2|Overall Study|Physician Decision|2
4714895|NCT02117024|16254985|P1|Overall Study|Physician Decision|0
4714896|NCT02117024|16254984|P2|Overall Study|Patient took treatment break|1
4714897|NCT02117024|16254985|P1|Overall Study|Patient took treatment break|0
4714898|NCT02117024|16254984|P2|Overall Study|Patient returned to primary oncologist|1
4714899|NCT02117024|16254985|P1|Overall Study|Patient returned to primary oncologist|0
4714900|NCT02117024|16254984|P2|Overall Study|Randomized in Error|0
4714901|NCT02117024|16254985|P1|Overall Study|Randomized in Error|1
4714902|NCT02117024|16254984|P2|Overall Study|Adverse Event|2
4714903|NCT02117024|16254985|P1|Overall Study|Adverse Event|1
4714904|NCT02117024|16254984|P2|Overall Study|Protocol Violation|0
4714905|NCT02117024|16254985|P1|Overall Study|Protocol Violation|1
4714906|NCT02117024|16254984|P2|Overall Study|Withdrawal by Subject|1
4714907|NCT02117024|16254985|P1|Overall Study|Withdrawal by Subject|3
4714908|NCT02117024|16254984|P2|Overall Study|Death|0
4714909|NCT02117024|16254985|P1|Overall Study|Death|5
4714910|NCT02117024|16254984|P2|Overall Study|Significant Clinical Progression|4
4714911|NCT02117024|16254985|P1|Overall Study|Significant Clinical Progression|7
4714912|NCT02117024|16254984|P2|Overall Study|Progressive Disease|9
4714913|NCT02117024|16254985|P1|Overall Study|Progressive Disease|26
4714914|NCT02116972|16255012|P3|Overall Study|scheduling conflicts and relocation|6
4714915|NCT02116972|16255013|P2|Overall Study|scheduling conflicts and relocation|3
4714916|NCT02116972|16255014|P1|Overall Study|scheduling conflicts and relocation|3
4714917|NCT02116972|16255012|P3|Overall Study|Lack of Efficacy|5
4714918|NCT02116972|16255013|P2|Overall Study|Lack of Efficacy|6
4714919|NCT02116972|16255014|P1|Overall Study|Lack of Efficacy|6
4714920|NCT02116972|16255012|P3|Overall Study|Lost to Follow-up|1
4714921|NCT02116972|16255013|P2|Overall Study|Lost to Follow-up|3
4714922|NCT02116972|16255014|P1|Overall Study|Lost to Follow-up|4
4714923|NCT02116972|16255012|P3|Overall Study|Protocol Violation|1
4714924|NCT02116972|16255013|P2|Overall Study|Protocol Violation|0
4714925|NCT02116972|16255014|P1|Overall Study|Protocol Violation|1
4714926|NCT02116972|16255012|P3|Overall Study|Withdrawal by Subject|5
4714927|NCT02116972|16255013|P2|Overall Study|Withdrawal by Subject|1
4714928|NCT02116972|16255014|P1|Overall Study|Withdrawal by Subject|1
4714929|NCT02116972|16255012|P3|Overall Study|Adverse Event|1
4714930|NCT02116972|16255013|P2|Overall Study|Adverse Event|4
4714931|NCT02116972|16255014|P1|Overall Study|Adverse Event|4
4714932|NCT02116803|16255046|P2|Overall Study|Death|0
4714933|NCT02116803|16255047|P1|Overall Study|Death|1
4714934|NCT02116803|16255046|P2|Overall Study|Study terminated by sponsor|1
4714935|NCT02116803|16255047|P1|Overall Study|Study terminated by sponsor|2
4714936|NCT02116803|16255046|P2|Overall Study|Progressive disease|0
4714937|NCT02116803|16255047|P1|Overall Study|Progressive disease|4
4714938|NCT02116803|16255046|P2|Overall Study|Physician Decision|0
4714939|NCT02116803|16255047|P1|Overall Study|Physician Decision|1
4714940|NCT02116803|16255046|P2|Overall Study|Adverse Event|1
4714941|NCT02116803|16255047|P1|Overall Study|Adverse Event|2
4714942|NCT02116660|16255055|P2|Overall Study|Organization reason|0
4714943|NCT02116660|16255056|P1|Overall Study|Organization reason|1
4714944|NCT02116660|16255055|P2|Overall Study|Withdrawal by Subject|2
4714945|NCT02116660|16255056|P1|Overall Study|Withdrawal by Subject|0
4714946|NCT02116660|16255055|P2|Overall Study|Adverse Event|1
4714947|NCT02116660|16255056|P1|Overall Study|Adverse Event|1
4714948|NCT02116660|16255055|P2|Overall Study|Deteriorating renal function|1
4714949|NCT02116660|16255056|P1|Overall Study|Deteriorating renal function|0
4714950|NCT02116621|16255100|P2|Twelve Month Follow-up|Enrolled within 12 months of study end|8
4714951|NCT02116621|16255101|P1|Twelve Month Follow-up|Enrolled within 12 months of study end|14
4714952|NCT02116621|16255100|P2|Twelve Month Follow-up|Did not complete follow-up survey|3
4714953|NCT02116621|16255101|P1|Twelve Month Follow-up|Did not complete follow-up survey|1
4714954|NCT02116621|16255100|P2|Twelve Month Follow-up|Lost to Follow-up|1
4714955|NCT02116621|16255101|P1|Twelve Month Follow-up|Lost to Follow-up|0
4714956|NCT02116621|16255100|P2|Twelve Month Follow-up|Withdrawal by Subject|0
4714957|NCT02116621|16255101|P1|Twelve Month Follow-up|Withdrawal by Subject|1
4714958|NCT02116621|16255100|P2|Six Month Follow-up|Did not complete follow-up survey|1
4714959|NCT02116621|16255101|P1|Six Month Follow-up|Did not complete follow-up survey|1
4714960|NCT02116621|16255100|P2|Six Month Follow-up|Lost to Follow-up|1
4714961|NCT02116621|16255101|P1|Six Month Follow-up|Lost to Follow-up|2
4714962|NCT02116621|16255100|P2|Six Month Follow-up|Withdrawal by Subject|1
4714963|NCT02116621|16255101|P1|Six Month Follow-up|Withdrawal by Subject|1
4714964|NCT02116621|16255100|P2|Three Month Follow-up|Did not complete follow-up survey|4
4714965|NCT02116621|16255101|P1|Three Month Follow-up|Did not complete follow-up survey|14
4714966|NCT02116621|16255100|P2|Three Month Follow-up|Lost to Follow-up|1
4714967|NCT02116621|16255101|P1|Three Month Follow-up|Lost to Follow-up|0
4714968|NCT02116621|16255100|P2|Three Month Follow-up|Withdrawal by Subject|1
4714969|NCT02116621|16255101|P1|Three Month Follow-up|Withdrawal by Subject|4
4714970|NCT02116621|16255100|P2|Three Month Follow-up|Death|1
4714971|NCT02116621|16255101|P1|Three Month Follow-up|Death|1
4714972|NCT02116621|16255100|P2|Baseline|Withdrawal by Subject|4
4714973|NCT02116621|16255101|P1|Baseline|Withdrawal by Subject|0
4714974|NCT02116582|16255189|P1|Overall Study|Other: Transitioned to 9785-CL-0123|12
4714975|NCT02116582|16255189|P1|Overall Study|Lost to Follow-up|1
4714976|NCT02116582|16255189|P1|Overall Study|Other: Miscellaneous|11
4714977|NCT02116582|16255189|P1|Overall Study|Withdrawal by Subject|8
4714978|NCT02116582|16255189|P1|Overall Study|Protocol Violation|3
4714979|NCT02116582|16255189|P1|Overall Study|Progressive Disease|148
4714980|NCT02116582|16255189|P1|Overall Study|Death|9
4714981|NCT02116582|16255189|P1|Overall Study|Adverse Event|22
4714982|NCT02116582|16255189|P1|Overall Study|Enrolled but Never Received Study Drug|1
4714983|NCT02116530|16255199|P2|Overall Study|Other Medical Problems|2
4714984|NCT02116530|16255200|P1|Overall Study|Other Medical Problems|2
4714985|NCT02116530|16255199|P2|Overall Study|Lost to Follow-up|0
4714986|NCT02116530|16255200|P1|Overall Study|Lost to Follow-up|1
4714987|NCT02116530|16255199|P2|Overall Study|Physician Decision|0
4714988|NCT02116530|16255200|P1|Overall Study|Physician Decision|1
4714989|NCT02116530|16255199|P2|Overall Study|Adverse Event|0
4714990|NCT02116530|16255200|P1|Overall Study|Adverse Event|4
4714991|NCT02116530|16255199|P2|Overall Study|Withdrawal by Subject|2
4714992|NCT02116530|16255200|P1|Overall Study|Withdrawal by Subject|1
4714993|NCT02116361|16255218|P4|Overall Study|Investigator Decision - Relapse|5
4714994|NCT02116361|16255219|P3|Overall Study|Investigator Decision - Relapse|8
4714995|NCT02116361|16255220|P2|Overall Study|Investigator Decision - Relapse|7
4714996|NCT02116361|16255221|P1|Overall Study|Investigator Decision - Relapse|9
4714997|NCT02116361|16255218|P4|Overall Study|Personal Reasons|9
4714998|NCT02116361|16255219|P3|Overall Study|Personal Reasons|4
4714999|NCT02116361|16255220|P2|Overall Study|Personal Reasons|6
4715000|NCT02116361|16255221|P1|Overall Study|Personal Reasons|6
4715001|NCT02116361|16255218|P4|Overall Study|Lost to Follow-up|5
4715002|NCT02116361|16255219|P3|Overall Study|Lost to Follow-up|7
4715003|NCT02116361|16255220|P2|Overall Study|Lost to Follow-up|5
4715004|NCT02116361|16255221|P1|Overall Study|Lost to Follow-up|4
4715005|NCT02116361|16255218|P4|Overall Study|Lack of Efficacy|3
4715006|NCT02116361|16255219|P3|Overall Study|Lack of Efficacy|4
4715007|NCT02116361|16255220|P2|Overall Study|Lack of Efficacy|7
4715008|NCT02116361|16255221|P1|Overall Study|Lack of Efficacy|5
4715009|NCT02116361|16255218|P4|Overall Study|Other Reasons|3
4715010|NCT02116361|16255219|P3|Overall Study|Other Reasons|3
4715011|NCT02116361|16255220|P2|Overall Study|Other Reasons|3
4715012|NCT02116361|16255221|P1|Overall Study|Other Reasons|3
4715013|NCT02116361|16255218|P4|Overall Study|Adverse Event|3
4715014|NCT02116361|16255219|P3|Overall Study|Adverse Event|0
4715015|NCT02116361|16255220|P2|Overall Study|Adverse Event|0
4715016|NCT02116361|16255221|P1|Overall Study|Adverse Event|1
4715017|NCT02116361|16255218|P4|Overall Study|Physician Decision|0
4715018|NCT02116361|16255219|P3|Overall Study|Physician Decision|0
4715019|NCT02116361|16255220|P2|Overall Study|Physician Decision|3
4715020|NCT02116361|16255221|P1|Overall Study|Physician Decision|2
4715021|NCT02116361|16255218|P4|Overall Study|Protocol Violation|2
4715022|NCT02116361|16255219|P3|Overall Study|Protocol Violation|0
4715023|NCT02116361|16255220|P2|Overall Study|Protocol Violation|0
4715024|NCT02116361|16255221|P1|Overall Study|Protocol Violation|1
4715025|NCT02116361|16255218|P4|Overall Study|Pregnancy|1
4715026|NCT02116361|16255219|P3|Overall Study|Pregnancy|0
4715027|NCT02116361|16255220|P2|Overall Study|Pregnancy|0
4715028|NCT02116361|16255221|P1|Overall Study|Pregnancy|0
4715029|NCT02116309|16255258|P2|Overall Study|Lost to Follow-up|1
4715030|NCT02116309|16255259|P1|Overall Study|Lost to Follow-up|0
4715031|NCT02115815|16255291|P7|Overall Study|Missed appointment, randomized in error|0
4715032|NCT02115815|16255292|P6|Overall Study|Missed appointment, randomized in error|1
4715033|NCT02115815|16255293|P5|Overall Study|Missed appointment, randomized in error|0
4715034|NCT02115815|16255294|P4|Overall Study|Missed appointment, randomized in error|0
4715035|NCT02115815|16255295|P3|Overall Study|Missed appointment, randomized in error|0
4715036|NCT02115815|16255296|P2|Overall Study|Missed appointment, randomized in error|0
4715037|NCT02115815|16255297|P1|Overall Study|Missed appointment, randomized in error|0
4715038|NCT02115815|16255291|P7|Overall Study|Not enough drug to dose participant|0
4715039|NCT02115815|16255292|P6|Overall Study|Not enough drug to dose participant|1
4715040|NCT02115815|16255293|P5|Overall Study|Not enough drug to dose participant|0
4715041|NCT02115815|16255294|P4|Overall Study|Not enough drug to dose participant|0
4715042|NCT02115815|16255295|P3|Overall Study|Not enough drug to dose participant|0
4715043|NCT02115815|16255296|P2|Overall Study|Not enough drug to dose participant|0
4715044|NCT02115815|16255297|P1|Overall Study|Not enough drug to dose participant|0
4715045|NCT02115815|16255291|P7|Overall Study|Withdrawal by Subject|0
4715046|NCT02115815|16255292|P6|Overall Study|Withdrawal by Subject|0
4715047|NCT02115815|16255293|P5|Overall Study|Withdrawal by Subject|0
4715048|NCT02115815|16255294|P4|Overall Study|Withdrawal by Subject|0
4715049|NCT02115815|16255295|P3|Overall Study|Withdrawal by Subject|0
4715050|NCT02115815|16255296|P2|Overall Study|Withdrawal by Subject|0
4715051|NCT02115815|16255297|P1|Overall Study|Withdrawal by Subject|2
4715052|NCT02115607|16255439|P1|Overall Study|Withdrawal by Subject|1
4715053|NCT02115386|16255465|P1|Overall Study|Administrative - trial was terminated|6
4715054|NCT02115386|16255465|P1|Overall Study|Protocol Violation|1
4715055|NCT02115321|16255568|P2|Overall Study|Death|0
4715056|NCT02115321|16255569|P1|Overall Study|Death|1
4715057|NCT02115308|16255591|P2|Overall Study|Safety Screening|2
4715058|NCT02115308|16255592|P1|Overall Study|Safety Screening|2
4715059|NCT02115269|16255608|P1|Overall Study|Didn't take study drug|2
4715060|NCT02115269|16255608|P1|Overall Study|Withdrawal by Subject|2
4715061|NCT02115269|16255608|P1|Overall Study|Moved to another city|7
4715062|NCT02115269|16255608|P1|Overall Study|Did not complete patient diary|3
4715063|NCT02115269|16255608|P1|Overall Study|Lost to Follow-up|43
4715064|NCT02115256|16255628|P2|Overall Study|Withdrawal by Subject|1
4715065|NCT02115256|16255629|P1|Overall Study|Withdrawal by Subject|0
4715066|NCT02115113|16255641|P3|Participants Randomized|Death|0
4715067|NCT02115113|16255642|P2|Participants Randomized|Death|0
4715068|NCT02115113|16255643|P1|Participants Randomized|Death|1
4715069|NCT02115113|16255641|P3|Participants Randomized|Lost to Follow-up|0
4715070|NCT02115113|16255642|P2|Participants Randomized|Lost to Follow-up|0
4715071|NCT02115113|16255643|P1|Participants Randomized|Lost to Follow-up|1
4715072|NCT02115113|16255641|P3|Participants in Run-in Period|Withdrawal by Subject|3
4715073|NCT02115113|16255642|P2|Participants in Run-in Period|Withdrawal by Subject|0
4715074|NCT02115113|16255643|P1|Participants in Run-in Period|Withdrawal by Subject|0
4715075|NCT02115113|16255641|P3|Participants in Run-in Period|Lost to Follow-up|5
4715076|NCT02115113|16255642|P2|Participants in Run-in Period|Lost to Follow-up|0
4715077|NCT02115113|16255643|P1|Participants in Run-in Period|Lost to Follow-up|0
4715078|NCT02115113|16255641|P3|Participants in Run-in Period|Administrative problems|1
4715079|NCT02115113|16255642|P2|Participants in Run-in Period|Administrative problems|0
4715080|NCT02115113|16255643|P1|Participants in Run-in Period|Administrative problems|0
4715081|NCT02115113|16255641|P3|Participants in Run-in Period|Death|1
4715082|NCT02115113|16255642|P2|Participants in Run-in Period|Death|0
4715083|NCT02115113|16255643|P1|Participants in Run-in Period|Death|0
4715084|NCT02114931|16255675|P2|Overall Study|Other|1
4715085|NCT02114931|16255676|P1|Overall Study|Other|2
4715086|NCT02114931|16255675|P2|Overall Study|Physician Decision|2
4715087|NCT02114931|16255676|P1|Overall Study|Physician Decision|1
4715088|NCT02114931|16255675|P2|Overall Study|Lost to Follow-up|3
4715089|NCT02114931|16255676|P1|Overall Study|Lost to Follow-up|3
4715090|NCT02114931|16255675|P2|Overall Study|Adverse Event|6
4715091|NCT02114931|16255676|P1|Overall Study|Adverse Event|4
4715092|NCT02114931|16255675|P2|Overall Study|Withdrawal by Subject|18
4715093|NCT02114931|16255676|P1|Overall Study|Withdrawal by Subject|15
4715094|NCT02114892|16255692|P2|Overall Study|Lost to Follow-up|2
4715095|NCT02114892|16255693|P1|Overall Study|Lost to Follow-up|1
4715096|NCT02114879|16255729|P2|Overall Study|Physician Decision|2
4715097|NCT02114879|16255730|P1|Overall Study|Physician Decision|0
4715098|NCT02114879|16255729|P2|Overall Study|Lost to Follow-up|6
4715099|NCT02114879|16255730|P1|Overall Study|Lost to Follow-up|4
4715100|NCT02114879|16255729|P2|Overall Study|Death|11
4715101|NCT02114879|16255730|P1|Overall Study|Death|6
4715102|NCT02114879|16255729|P2|Overall Study|Withdrawal by Subject|5
4715103|NCT02114879|16255730|P1|Overall Study|Withdrawal by Subject|9
4715104|NCT02114697|16255748|P2|Overall Study|Study terminated|4
4715105|NCT02114697|16255749|P1|Overall Study|Study terminated|5
4715106|NCT02114684|16255757|P2|Overall Study|Patient Incarcerated|0
4715107|NCT02114684|16255758|P1|Overall Study|Patient Incarcerated|1
4715108|NCT02114684|16255757|P2|Overall Study|Rifampicin resistant on culture|1
4715109|NCT02114684|16255758|P1|Overall Study|Rifampicin resistant on culture|0
4715110|NCT02114684|16255757|P2|Overall Study|Relocation|1
4715111|NCT02114684|16255758|P1|Overall Study|Relocation|3
4715112|NCT02114684|16255757|P2|Overall Study|Withdrawal by Subject|2
4715113|NCT02114684|16255758|P1|Overall Study|Withdrawal by Subject|1
4715114|NCT02114684|16255757|P2|Overall Study|Lost to Follow-up|2
4715115|NCT02114684|16255758|P1|Overall Study|Lost to Follow-up|1
4715116|NCT02114684|16255757|P2|Overall Study|Death|4
4715117|NCT02114684|16255758|P1|Overall Study|Death|6
4715118|NCT02114515|16255776|P2|Overall Study|Other|61
4715119|NCT02114515|16255777|P1|Overall Study|Other|65
4715120|NCT02114515|16255776|P2|Overall Study|Withdrawal by Subject|22
4715121|NCT02114515|16255777|P1|Overall Study|Withdrawal by Subject|4
4715122|NCT02114515|16255776|P2|Overall Study|Death|12
4715123|NCT02114515|16255777|P1|Overall Study|Death|12
4715124|NCT02114515|16255776|P2|Overall Study|Lost to Follow-up|55
4715125|NCT02114515|16255777|P1|Overall Study|Lost to Follow-up|52
4715126|NCT02114385|16255823|P2|Overall Study|Lost to Follow-up|6
4715127|NCT02114385|16255824|P1|Overall Study|Lost to Follow-up|0
4715128|NCT02114385|16255823|P2|Overall Study|Withdrawal by Subject|2
4715129|NCT02114385|16255824|P1|Overall Study|Withdrawal by Subject|3
4715130|NCT02114268|16255865|P6|Overall Study|Withdrawn by site due to noncompliance|0
4715131|NCT02114268|16255866|P5|Overall Study|Withdrawn by site due to noncompliance|0
4715132|NCT02114268|16255867|P4|Overall Study|Withdrawn by site due to noncompliance|0
4715133|NCT02114268|16255868|P3|Overall Study|Withdrawn by site due to noncompliance|0
4715134|NCT02114268|16255869|P2|Overall Study|Withdrawn by site due to noncompliance|0
4715135|NCT02114268|16255870|P1|Overall Study|Withdrawn by site due to noncompliance|1
4715136|NCT02114268|16255865|P6|Overall Study|Withdrawal by Subject|1
4715137|NCT02114268|16255866|P5|Overall Study|Withdrawal by Subject|0
4715138|NCT02114268|16255867|P4|Overall Study|Withdrawal by Subject|0
4715139|NCT02114268|16255868|P3|Overall Study|Withdrawal by Subject|0
4715140|NCT02114268|16255869|P2|Overall Study|Withdrawal by Subject|0
4715141|NCT02114268|16255870|P1|Overall Study|Withdrawal by Subject|1
4715142|NCT02114268|16255865|P6|Overall Study|Lost to Follow-up|2
4715143|NCT02114268|16255866|P5|Overall Study|Lost to Follow-up|0
4715144|NCT02114268|16255867|P4|Overall Study|Lost to Follow-up|0
4715145|NCT02114268|16255868|P3|Overall Study|Lost to Follow-up|1
4715146|NCT02114268|16255869|P2|Overall Study|Lost to Follow-up|1
4715147|NCT02114268|16255870|P1|Overall Study|Lost to Follow-up|4
4715148|NCT02114203|16255939|P3|Overall Study|Withdrawal by Subject|0
4715149|NCT02114203|16255940|P2|Overall Study|Withdrawal by Subject|1
4715150|NCT02114203|16255941|P1|Overall Study|Withdrawal by Subject|0
4715151|NCT02114203|16255939|P3|Overall Study|Adverse Event|0
4715152|NCT02114203|16255940|P2|Overall Study|Adverse Event|1
4715153|NCT02114203|16255941|P1|Overall Study|Adverse Event|0
4715154|NCT02114177|16255975|P2|Overall Study|Other|1
4715155|NCT02114177|16255976|P1|Overall Study|Other|2
4715156|NCT02114177|16255975|P2|Overall Study|Withdrawal by Subject|1
4715157|NCT02114177|16255976|P1|Overall Study|Withdrawal by Subject|6
4715158|NCT02114177|16255975|P2|Overall Study|Lost to Follow-up|2
4715159|NCT02114177|16255976|P1|Overall Study|Lost to Follow-up|1
4715160|NCT02114151|16256000|P1|Overall Study|Withdrawal by Subject|5
4715161|NCT02114151|16256000|P1|Overall Study|Lost to Follow-up|1
4715162|NCT02114151|16256000|P1|Overall Study|Death|1
4715163|NCT02113956|16256017|P2|3 Month Post-intervention|Lost to Follow-up|2
4715164|NCT02113956|16256018|P1|3 Month Post-intervention|Lost to Follow-up|4
4715165|NCT02113956|16256017|P2|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3
4715166|NCT02113956|16256018|P1|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4
4715167|NCT02113956|16256017|P2|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1
4715168|NCT02113956|16256018|P1|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5
4715169|NCT02113579|16256052|P2|Overall Study|Lost to Follow-up|2
4715170|NCT02113579|16256053|P1|Overall Study|Lost to Follow-up|6
4715171|NCT02113579|16256052|P2|Overall Study|Withdrawal by Subject|2
4715172|NCT02113579|16256053|P1|Overall Study|Withdrawal by Subject|3
4715173|NCT02113579|16256052|P2|Overall Study|Adverse Event|0
4715174|NCT02113579|16256053|P1|Overall Study|Adverse Event|1
4715175|NCT02113449|16256077|P1|Overall Study|Adverse Event|4
4715176|NCT02113436|16256093|P4|Period 2: 16 Weeks|Withdrawal by Subject|1
4715177|NCT02113436|16256094|P3|Period 2: 16 Weeks|Withdrawal by Subject|1
4715178|NCT02113436|16256095|P2|Period 2: 16 Weeks|Withdrawal by Subject|0
4715179|NCT02113436|16256096|P1|Period 2: 16 Weeks|Withdrawal by Subject|0
4715180|NCT02113436|16256093|P4|Period 2: 16 Weeks|Physician Decision|0
4715181|NCT02113436|16256094|P3|Period 2: 16 Weeks|Physician Decision|2
4715182|NCT02113436|16256095|P2|Period 2: 16 Weeks|Physician Decision|0
4715183|NCT02113436|16256096|P1|Period 2: 16 Weeks|Physician Decision|0
4715184|NCT02113436|16256093|P4|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5
4715185|NCT02113436|16256094|P3|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2
4715186|NCT02113436|16256095|P2|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
4715187|NCT02113436|16256096|P1|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0
4715188|NCT02113436|16256093|P4|Period 2: 16 Weeks|Adverse Event|5
4715189|NCT02113436|16256094|P3|Period 2: 16 Weeks|Adverse Event|4
4715190|NCT02113436|16256095|P2|Period 2: 16 Weeks|Adverse Event|0
4715191|NCT02113436|16256096|P1|Period 2: 16 Weeks|Adverse Event|0
4715192|NCT02113436|16256093|P4|Period 1: 8 Weeks|Withdrawal by Subject|0
4715193|NCT02113436|16256094|P3|Period 1: 8 Weeks|Withdrawal by Subject|0
4715194|NCT02113436|16256095|P2|Period 1: 8 Weeks|Withdrawal by Subject|0
4715195|NCT02113436|16256096|P1|Period 1: 8 Weeks|Withdrawal by Subject|1
4715196|NCT02113436|16256093|P4|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
4715197|NCT02113436|16256094|P3|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0
4715198|NCT02113436|16256095|P2|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2
4715199|NCT02113436|16256096|P1|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5
4715200|NCT02113436|16256093|P4|Period 1: 8 Weeks|Protocol Violation|0
4715201|NCT02113436|16256094|P3|Period 1: 8 Weeks|Protocol Violation|0
4715202|NCT02113436|16256095|P2|Period 1: 8 Weeks|Protocol Violation|0
4715203|NCT02113436|16256096|P1|Period 1: 8 Weeks|Protocol Violation|1
4715204|NCT02113436|16256093|P4|Period 1: 8 Weeks|Adverse Event|0
4715205|NCT02113436|16256094|P3|Period 1: 8 Weeks|Adverse Event|0
4715206|NCT02113436|16256095|P2|Period 1: 8 Weeks|Adverse Event|0
4715207|NCT02113436|16256096|P1|Period 1: 8 Weeks|Adverse Event|1
4715208|NCT02113189|16256147|P3|Overall Study|Lost to follow up|3
4715209|NCT02113189|16256148|P2|Overall Study|Lost to follow up|1
4715210|NCT02113189|16256149|P1|Overall Study|Lost to follow up|2
4715211|NCT02113124|16256165|P2|Overall Study|Unable to retrieve blood sample|1
4715212|NCT02113124|16256166|P1|Overall Study|Unable to retrieve blood sample|1
4715213|NCT02113007|16256172|P1|Overall Study|Progressive disease|2
4715214|NCT02112994|16256178|P3|Overall Study|Withdrawal by Subject|1
4715215|NCT02112994|16256179|P2|Overall Study|Withdrawal by Subject|0
4715216|NCT02112994|16256180|P1|Overall Study|Withdrawal by Subject|0
4715217|NCT02112994|16256178|P3|Overall Study|Liver Transplant|0
4715218|NCT02112994|16256179|P2|Overall Study|Liver Transplant|1
4715219|NCT02112994|16256180|P1|Overall Study|Liver Transplant|0
4715220|NCT02112994|16256178|P3|Overall Study|Pregnancy|1
4715221|NCT02112994|16256179|P2|Overall Study|Pregnancy|1
4715222|NCT02112994|16256180|P1|Overall Study|Pregnancy|0
4715223|NCT02112994|16256178|P3|Overall Study|Progressive Disease|1
4715224|NCT02112994|16256179|P2|Overall Study|Progressive Disease|0
4715225|NCT02112994|16256180|P1|Overall Study|Progressive Disease|0
4715226|NCT02112877|16256198|P2|Overall Study|Visit Missed|6
4715227|NCT02112877|16256199|P1|Overall Study|Visit Missed|1
4715228|NCT02112877|16256198|P2|Overall Study|Withdrawal by Subject|7
4715229|NCT02112877|16256199|P1|Overall Study|Withdrawal by Subject|1
4715230|NCT02112448|16256287|P2|Overall Study|required heparin so could not use ketoro|0
4715231|NCT02112448|16256288|P1|Overall Study|required heparin so could not use ketoro|1
4715232|NCT02112448|16256287|P2|Overall Study|Physician Decision|6
4715233|NCT02112448|16256288|P1|Overall Study|Physician Decision|4
4715234|NCT02112448|16256287|P2|Overall Study|Protocol Violation|2
4715235|NCT02112448|16256288|P1|Overall Study|Protocol Violation|1
4715236|NCT02112448|16256287|P2|Overall Study|lab values precluding use of ketorolac|2
4715237|NCT02112448|16256288|P1|Overall Study|lab values precluding use of ketorolac|2
4715238|NCT02112045|16256321|P2|Overall Study|Withdrawal by Subject|0
4715239|NCT02112045|16256322|P1|Overall Study|Withdrawal by Subject|1
4715240|NCT02111993|16256342|P2|Overall Study|Physician Decision|4
4715241|NCT02111993|16256343|P1|Overall Study|Physician Decision|5
4715242|NCT02111811|16256384|P2|Follow up Period (Aim 2)|Death|0
4715243|NCT02111811|16256385|P1|Follow up Period (Aim 2)|Death|2
4715244|NCT02111811|16256384|P2|Follow up Period (Aim 2)|Lost to Follow-up|17
4715245|NCT02111811|16256385|P1|Follow up Period (Aim 2)|Lost to Follow-up|26
4715246|NCT02111811|16256384|P2|Treatment Phase|Death|0
4715247|NCT02111811|16256385|P1|Treatment Phase|Death|2
4715248|NCT02111811|16256384|P2|Treatment Phase|Lost to Follow-up|18
4715249|NCT02111811|16256385|P1|Treatment Phase|Lost to Follow-up|22
4715250|NCT02111785|16256398|P4|Overall Study|Death|0
4715251|NCT02111785|16256399|P3|Overall Study|Death|0
4715252|NCT02111785|16256400|P2|Overall Study|Death|1
4715253|NCT02111785|16256401|P1|Overall Study|Death|0
4715254|NCT02111603|16256463|P1|Overall Study|Withdrawal by Subject|1
4715255|NCT02111564|16256474|P2|Overall Study|Withdrawal by Subject|20
4715256|NCT02111564|16256475|P1|Overall Study|Withdrawal by Subject|20
4715257|NCT02111564|16256474|P2|Overall Study|Lost to Follow-up|3
4715258|NCT02111564|16256475|P1|Overall Study|Lost to Follow-up|2
4715259|NCT02111564|16256474|P2|Overall Study|Death|120
4715260|NCT02111564|16256475|P1|Overall Study|Death|109
4715261|NCT02111369|16256514|P1|Overall Study|Withdrawal by Subject|1
4715262|NCT02111369|16256514|P1|Overall Study|Lost to Follow-up|2
4715263|NCT02111213|16256538|P2|Overall Study|Lost to Follow-up|4
4715264|NCT02111213|16256539|P1|Overall Study|Lost to Follow-up|3
4715265|NCT02111213|16256538|P2|Overall Study|Withdrawal by Subject|2
4715266|NCT02111213|16256539|P1|Overall Study|Withdrawal by Subject|3
4715267|NCT02111174|16256583|P2|Secondary Outcomes (2 and 3 Month f/u)|Death|1
4715268|NCT02111174|16256584|P1|Secondary Outcomes (2 and 3 Month f/u)|Death|0
4715269|NCT02111174|16256583|P2|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6
4715270|NCT02111174|16256584|P1|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8
4715271|NCT02111174|16256583|P2|Treatment and Primary Outcome|Withdrawal by Subject|2
4715272|NCT02111174|16256584|P1|Treatment and Primary Outcome|Withdrawal by Subject|2
4715273|NCT02111174|16256583|P2|Treatment and Primary Outcome|Ineligible (not used in analysis)|0
4715274|NCT02111174|16256584|P1|Treatment and Primary Outcome|Ineligible (not used in analysis)|1
4715275|NCT02111096|16256613|P3|Overall Study|Withdrawal by Subject|8
4715276|NCT02111096|16256614|P2|Overall Study|Withdrawal by Subject|2
4715277|NCT02111096|16256615|P1|Overall Study|Withdrawal by Subject|4
4715278|NCT02111096|16256613|P3|Overall Study|Terminated by Sponsor|54
4715279|NCT02111096|16256614|P2|Overall Study|Terminated by Sponsor|35
4715280|NCT02111096|16256615|P1|Overall Study|Terminated by Sponsor|53
4715281|NCT02111096|16256613|P3|Overall Study|Protocol Violation|1
4715282|NCT02111096|16256614|P2|Overall Study|Protocol Violation|0
4715283|NCT02111096|16256615|P1|Overall Study|Protocol Violation|1
4715284|NCT02111096|16256613|P3|Overall Study|Physician Decision|0
4715285|NCT02111096|16256614|P2|Overall Study|Physician Decision|1
4715286|NCT02111096|16256615|P1|Overall Study|Physician Decision|0
4715287|NCT02111096|16256613|P3|Overall Study|Lost to Follow Up|1
4715288|NCT02111096|16256614|P2|Overall Study|Lost to Follow Up|1
4715289|NCT02111096|16256615|P1|Overall Study|Lost to Follow Up|1
4715290|NCT02111096|16256613|P3|Overall Study|Non-Compliance with Study Drug|0
4715291|NCT02111096|16256614|P2|Overall Study|Non-Compliance with Study Drug|1
4715292|NCT02111096|16256615|P1|Overall Study|Non-Compliance with Study Drug|1
4715293|NCT02111096|16256613|P3|Overall Study|Adverse Event|2
4715294|NCT02111096|16256614|P2|Overall Study|Adverse Event|1
4715295|NCT02111096|16256615|P1|Overall Study|Adverse Event|4
4715296|NCT02111083|16256663|P2|Interval Between Dosing (7-8 Days)|Adverse Event|1
4715297|NCT02111083|16256664|P1|Interval Between Dosing (7-8 Days)|Adverse Event|1
4715298|NCT02110901|16256684|P2|Overall Study|received a kidney transplant|0
4715299|NCT02110901|16256685|P1|Overall Study|received a kidney transplant|5
4715300|NCT02110901|16256684|P2|Overall Study|Withdrawal by Subject|3
4715301|NCT02110901|16256685|P1|Overall Study|Withdrawal by Subject|7
4715302|NCT02110901|16256684|P2|Overall Study|Lost to Follow-up|8
4715303|NCT02110901|16256685|P1|Overall Study|Lost to Follow-up|12
4715304|NCT02110901|16256684|P2|Overall Study|Death|3
4715305|NCT02110901|16256685|P1|Overall Study|Death|6
4715306|NCT02110706|16256699|P2|Overall Study|Patients who didn't receive 2nd infusion|1
4715307|NCT02110706|16256700|P1|Overall Study|Patients who didn't receive 2nd infusion|3
4715308|NCT02110706|16256699|P2|Overall Study|Adverse Event|3
4715309|NCT02110706|16256700|P1|Overall Study|Adverse Event|2
4715310|NCT02110693|16256712|P2|Overall Study|Other|0
4715311|NCT02110693|16256713|P1|Overall Study|Other|1
4715312|NCT02110693|16256712|P2|Overall Study|technical difficulties|4
4715313|NCT02110693|16256713|P1|Overall Study|technical difficulties|6
4715314|NCT02110693|16256712|P2|Overall Study|skipped assessment|18
4715315|NCT02110693|16256713|P1|Overall Study|skipped assessment|15
4715316|NCT02110693|16256712|P2|Overall Study|Withdrawal by Subject|7
4715317|NCT02110693|16256713|P1|Overall Study|Withdrawal by Subject|6
4715318|NCT02110238|16256794|P2|14 Week Blinded Extension Phase|Withdrawal by Subject|3
4715319|NCT02110238|16256795|P1|14 Week Blinded Extension Phase|Withdrawal by Subject|4
4715320|NCT02110238|16256794|P2|14 Week Blinded Extension Phase|Protocol Violation|3
4715321|NCT02110238|16256795|P1|14 Week Blinded Extension Phase|Protocol Violation|2
4715322|NCT02110238|16256794|P2|14 Week Blinded Extension Phase|Lost to Follow-up|1
4715323|NCT02110238|16256795|P1|14 Week Blinded Extension Phase|Lost to Follow-up|3
4715324|NCT02110238|16256794|P2|14 Week Blinded Extension Phase|Lack of Efficacy|4
4715325|NCT02110238|16256795|P1|14 Week Blinded Extension Phase|Lack of Efficacy|2
4715326|NCT02110238|16256794|P2|14 Week Blinded Extension Phase|Adverse Event|1
4715327|NCT02110238|16256795|P1|14 Week Blinded Extension Phase|Adverse Event|1
4715328|NCT02110238|16256794|P2|12 Week Pivotal Phase|Withdrawal by Subject|3
4715329|NCT02110238|16256795|P1|12 Week Pivotal Phase|Withdrawal by Subject|3
4715330|NCT02110238|16256794|P2|12 Week Pivotal Phase|Protocol Violation|1
4715331|NCT02110238|16256795|P1|12 Week Pivotal Phase|Protocol Violation|0
4715332|NCT02110238|16256794|P2|12 Week Pivotal Phase|Physician Decision|2
4715333|NCT02110238|16256795|P1|12 Week Pivotal Phase|Physician Decision|0
4715334|NCT02110238|16256794|P2|12 Week Pivotal Phase|Lost to Follow-up|0
4715335|NCT02110238|16256795|P1|12 Week Pivotal Phase|Lost to Follow-up|2
4715336|NCT02110238|16256794|P2|12 Week Pivotal Phase|Lack of Efficacy|3
4715337|NCT02110238|16256795|P1|12 Week Pivotal Phase|Lack of Efficacy|2
4715338|NCT02110238|16256794|P2|12 Week Pivotal Phase|Adverse Event|0
4715339|NCT02110238|16256795|P1|12 Week Pivotal Phase|Adverse Event|3
4715340|NCT02110225|16256804|P3|Overall Study|Lost to Follow-up|0
4715341|NCT02110225|16256805|P2|Overall Study|Lost to Follow-up|1
4715342|NCT02110225|16256806|P1|Overall Study|Lost to Follow-up|0
4715343|NCT02109562|16256916|P3|Overall Study|Physician Decision|5
4715344|NCT02109562|16256917|P2|Overall Study|Physician Decision|4
4715345|NCT02109562|16256918|P1|Overall Study|Physician Decision|3
4715346|NCT02109562|16256916|P3|Overall Study|Withdrawal by Subject|21
4715347|NCT02109562|16256917|P2|Overall Study|Withdrawal by Subject|25
4715348|NCT02109562|16256918|P1|Overall Study|Withdrawal by Subject|20
4715349|NCT02109562|16256916|P3|Overall Study|Protocol Violation|1
4715350|NCT02109562|16256917|P2|Overall Study|Protocol Violation|3
4715351|NCT02109562|16256918|P1|Overall Study|Protocol Violation|0
4715352|NCT02109562|16256916|P3|Overall Study|Lost to Follow-up|1
4715353|NCT02109562|16256917|P2|Overall Study|Lost to Follow-up|0
4715354|NCT02109562|16256918|P1|Overall Study|Lost to Follow-up|1
4715355|NCT02109562|16256916|P3|Overall Study|Adverse Event|3
4715356|NCT02109562|16256917|P2|Overall Study|Adverse Event|2
4715357|NCT02109562|16256918|P1|Overall Study|Adverse Event|0
4715358|NCT02109562|16256916|P3|Overall Study|Insufficient clinical response|4
4715359|NCT02109562|16256917|P2|Overall Study|Insufficient clinical response|0
4715360|NCT02109562|16256918|P1|Overall Study|Insufficient clinical response|2
4715361|NCT02109484|16256945|P8|Overall Study|Moved away from study area|1
4715362|NCT02109484|16256946|P7|Overall Study|Moved away from study area|1
4715363|NCT02109484|16256947|P6|Overall Study|Moved away from study area|0
4715364|NCT02109484|16256948|P5|Overall Study|Moved away from study area|0
4715365|NCT02109484|16256949|P4|Overall Study|Moved away from study area|0
4715366|NCT02109484|16256950|P3|Overall Study|Moved away from study area|0
4715367|NCT02109484|16256951|P2|Overall Study|Moved away from study area|0
4715368|NCT02109484|16256952|P1|Overall Study|Moved away from study area|0
4715369|NCT02109484|16256945|P8|Overall Study|Death|2
4715370|NCT02109484|16256946|P7|Overall Study|Death|0
4715371|NCT02109484|16256947|P6|Overall Study|Death|0
4715372|NCT02109484|16256948|P5|Overall Study|Death|0
4715373|NCT02109484|16256949|P4|Overall Study|Death|0
4715374|NCT02109484|16256950|P3|Overall Study|Death|0
4715375|NCT02109484|16256951|P2|Overall Study|Death|0
4715376|NCT02109484|16256952|P1|Overall Study|Death|0
4715377|NCT02109484|16256945|P8|Overall Study|Physician Decision|0
4715378|NCT02109484|16256946|P7|Overall Study|Physician Decision|0
4715379|NCT02109484|16256947|P6|Overall Study|Physician Decision|0
4715380|NCT02109484|16256948|P5|Overall Study|Physician Decision|2
4715381|NCT02109484|16256949|P4|Overall Study|Physician Decision|0
4715382|NCT02109484|16256950|P3|Overall Study|Physician Decision|0
4715383|NCT02109484|16256951|P2|Overall Study|Physician Decision|0
4715384|NCT02109484|16256952|P1|Overall Study|Physician Decision|0
4715385|NCT02109484|16256945|P8|Overall Study|Withdrawal by Subject|0
4715386|NCT02109484|16256946|P7|Overall Study|Withdrawal by Subject|1
4715387|NCT02109484|16256947|P6|Overall Study|Withdrawal by Subject|1
4715388|NCT02109484|16256948|P5|Overall Study|Withdrawal by Subject|1
4715389|NCT02109484|16256949|P4|Overall Study|Withdrawal by Subject|0
4715390|NCT02109484|16256950|P3|Overall Study|Withdrawal by Subject|0
4715391|NCT02109484|16256951|P2|Overall Study|Withdrawal by Subject|0
4715392|NCT02109484|16256952|P1|Overall Study|Withdrawal by Subject|0
4715393|NCT02109484|16256945|P8|Overall Study|Lost to Follow-up|0
4715394|NCT02109484|16256946|P7|Overall Study|Lost to Follow-up|1
4715395|NCT02109484|16256947|P6|Overall Study|Lost to Follow-up|0
4715396|NCT02109484|16256948|P5|Overall Study|Lost to Follow-up|1
4715397|NCT02109484|16256949|P4|Overall Study|Lost to Follow-up|1
4715398|NCT02109484|16256950|P3|Overall Study|Lost to Follow-up|0
4715399|NCT02109484|16256951|P2|Overall Study|Lost to Follow-up|0
4715400|NCT02109484|16256952|P1|Overall Study|Lost to Follow-up|0
4715401|NCT02109445|16257008|P1|Overall Study|Adverse Event|1
4715402|NCT02109445|16257008|P1|Overall Study|Symptomatic deterioration|2
4715403|NCT02109432|16257041|P1|Overall Study|Withdrawal by Subject|1
4715404|NCT02109172|16257051|P6|Overall Study|Death|0
4715405|NCT02109172|16257052|P5|Overall Study|Death|1
4715406|NCT02109172|16257053|P4|Overall Study|Death|0
4715407|NCT02109172|16257054|P3|Overall Study|Death|0
4715408|NCT02109172|16257055|P2|Overall Study|Death|0
4715409|NCT02109172|16257056|P1|Overall Study|Death|0
4715410|NCT02109172|16257051|P6|Overall Study|Adverse Event|1
4715411|NCT02109172|16257052|P5|Overall Study|Adverse Event|0
4715412|NCT02109172|16257053|P4|Overall Study|Adverse Event|0
4715413|NCT02109172|16257054|P3|Overall Study|Adverse Event|1
4715414|NCT02109172|16257055|P2|Overall Study|Adverse Event|0
4715415|NCT02109172|16257056|P1|Overall Study|Adverse Event|0
4715416|NCT02109172|16257051|P6|Overall Study|Withdrawal by Subject|0
4715417|NCT02109172|16257052|P5|Overall Study|Withdrawal by Subject|0
4715418|NCT02109172|16257053|P4|Overall Study|Withdrawal by Subject|1
4715419|NCT02109172|16257054|P3|Overall Study|Withdrawal by Subject|0
4715420|NCT02109172|16257055|P2|Overall Study|Withdrawal by Subject|0
4715421|NCT02109172|16257056|P1|Overall Study|Withdrawal by Subject|1
4715422|NCT02109133|16257077|P2|Overall Study|Lost to Follow-up|0
4715423|NCT02109133|16257078|P1|Overall Study|Lost to Follow-up|1
4715424|NCT02109107|16257090|P1|Overall Study|Lost to Follow-up|2
4715425|NCT02109042|16257097|P1|Overall Study|Sponsor Decision|15
4715426|NCT02109029|16257106|P6|Part B|Adverse Event|1
4715427|NCT02109029|16257107|P5|Part B|Adverse Event|1
4715428|NCT02109029|16257108|P4|Part B|Adverse Event|0
4715429|NCT02109029|16257109|P3|Part B|Adverse Event|0
4715430|NCT02109029|16257110|P2|Part B|Adverse Event|0
4715431|NCT02109029|16257111|P1|Part B|Adverse Event|0
4715432|NCT02108964|16257148|P8|Overall Study|Subject/Guardian decision|1
4715433|NCT02108964|16257149|P7|Overall Study|Subject/Guardian decision|1
4715434|NCT02108964|16257150|P6|Overall Study|Subject/Guardian decision|0
4715435|NCT02108964|16257151|P5|Overall Study|Subject/Guardian decision|2
4715436|NCT02108964|16257152|P4|Overall Study|Subject/Guardian decision|0
4715437|NCT02108964|16257153|P3|Overall Study|Subject/Guardian decision|3
4715438|NCT02108964|16257154|P2|Overall Study|Subject/Guardian decision|1
4715439|NCT02108964|16257155|P1|Overall Study|Subject/Guardian decision|0
4715440|NCT02108964|16257148|P8|Overall Study|Death|1
4715441|NCT02108964|16257149|P7|Overall Study|Death|0
4715442|NCT02108964|16257150|P6|Overall Study|Death|0
4715443|NCT02108964|16257151|P5|Overall Study|Death|3
4715444|NCT02108964|16257152|P4|Overall Study|Death|0
4715445|NCT02108964|16257153|P3|Overall Study|Death|2
4715446|NCT02108964|16257154|P2|Overall Study|Death|1
4715447|NCT02108964|16257155|P1|Overall Study|Death|1
4715448|NCT02108964|16257148|P8|Overall Study|Adverse Event|1
4715449|NCT02108964|16257149|P7|Overall Study|Adverse Event|3
4715450|NCT02108964|16257150|P6|Overall Study|Adverse Event|0
4715451|NCT02108964|16257151|P5|Overall Study|Adverse Event|1
4715452|NCT02108964|16257152|P4|Overall Study|Adverse Event|0
4715453|NCT02108964|16257153|P3|Overall Study|Adverse Event|4
4715454|NCT02108964|16257154|P2|Overall Study|Adverse Event|0
4715455|NCT02108964|16257155|P1|Overall Study|Adverse Event|0
4715456|NCT02108964|16257148|P8|Overall Study|Physician Decision|0
4715457|NCT02108964|16257149|P7|Overall Study|Physician Decision|0
4715458|NCT02108964|16257150|P6|Overall Study|Physician Decision|0
4715459|NCT02108964|16257151|P5|Overall Study|Physician Decision|1
4715460|NCT02108964|16257152|P4|Overall Study|Physician Decision|0
4715461|NCT02108964|16257153|P3|Overall Study|Physician Decision|6
4715462|NCT02108964|16257154|P2|Overall Study|Physician Decision|5
4715463|NCT02108964|16257155|P1|Overall Study|Physician Decision|1
4715464|NCT02108964|16257148|P8|Overall Study|Progressive disease|9
4715465|NCT02108964|16257149|P7|Overall Study|Progressive disease|7
4715466|NCT02108964|16257150|P6|Overall Study|Progressive disease|5
4715467|NCT02108964|16257151|P5|Overall Study|Progressive disease|18
4715468|NCT02108964|16257152|P4|Overall Study|Progressive disease|6
4715469|NCT02108964|16257153|P3|Overall Study|Progressive disease|50
4715470|NCT02108964|16257154|P2|Overall Study|Progressive disease|25
4715471|NCT02108964|16257155|P1|Overall Study|Progressive disease|12
4715472|NCT02108951|16257174|P1|Overall Study|Study Terminated by Sponsor|14
4715473|NCT02108951|16257174|P1|Overall Study|Patient's/guardian's decision|1
4715474|NCT02108951|16257174|P1|Overall Study|Lost to Follow-up|1
4715475|NCT02108912|16257193|P2|Overall Study|high blood pressure|0
4715476|NCT02108912|16257194|P1|Overall Study|high blood pressure|1
4715477|NCT02108912|16257193|P2|Overall Study|lack of transportation|0
4715478|NCT02108912|16257194|P1|Overall Study|lack of transportation|1
4715479|NCT02108912|16257193|P2|Overall Study|Lost to Follow-up|1
4715480|NCT02108912|16257194|P1|Overall Study|Lost to Follow-up|1
4715481|NCT02108652|16257223|P1|Overall Study|Ongoing at data cutoff 04 July 2016|74
4715482|NCT02108652|16257223|P1|Overall Study|Withdrawal by Subject|8
4715483|NCT02108652|16257223|P1|Overall Study|Lost to Follow-up|2
4715484|NCT02108652|16257223|P1|Overall Study|Death|226
4715485|NCT02107898|16257401|P2|Overall Study|Randomized but not treated|1
4715486|NCT02107898|16257402|P1|Overall Study|Randomized but not treated|0
4715487|NCT02107898|16257401|P2|Overall Study|Consent withdrawn by participant|1
4715488|NCT02107898|16257402|P1|Overall Study|Consent withdrawn by participant|2
4715489|NCT02107898|16257401|P2|Overall Study|Participant moved|2
4715490|NCT02107898|16257402|P1|Overall Study|Participant moved|0
4715491|NCT02107898|16257401|P2|Overall Study|Poor compliance to protocol|1
4715492|NCT02107898|16257402|P1|Overall Study|Poor compliance to protocol|0
4715493|NCT02107898|16257401|P2|Overall Study|Adverse Event|7
4715494|NCT02107898|16257402|P1|Overall Study|Adverse Event|4
4715495|NCT02107859|16257454|P1|Overall Study|Other than specified|3
4715496|NCT02107859|16257454|P1|Overall Study|Study closure|41
4715497|NCT02107859|16257454|P1|Overall Study|Adverse Event|3
4715498|NCT02107859|16257454|P1|Overall Study|Withdrawal by Subject|14
4715499|NCT02107703|16257470|P2|Overall Study|On study treatment/follow up|152
4715500|NCT02107703|16257471|P1|Overall Study|On study treatment/follow up|319
4715501|NCT02107703|16257470|P2|Overall Study|Lost to Follow-up|4
4715502|NCT02107703|16257471|P1|Overall Study|Lost to Follow-up|6
4715503|NCT02107703|16257470|P2|Overall Study|Withdrawal by Subject|19
4715504|NCT02107703|16257471|P1|Overall Study|Withdrawal by Subject|36
4715505|NCT02107482|16257503|P1|Overall Study|Lack of Efficacy|1
4715506|NCT02107482|16257503|P1|Overall Study|Lost to Follow-up|1
4715507|NCT02107482|16257503|P1|Overall Study|inconveinence|2
4715508|NCT02107443|16257511|P2|Overall Study|Withdrawal: Personal Issues|3
4715509|NCT02107443|16257512|P1|Overall Study|Withdrawal: Personal Issues|0
4715510|NCT02107443|16257511|P2|Overall Study|Withdrawal: Disease Progression|2
4715511|NCT02107443|16257512|P1|Overall Study|Withdrawal: Disease Progression|4
4715512|NCT02107443|16257511|P2|Overall Study|Withdrawal: Other Medical|5
4715513|NCT02107443|16257512|P1|Overall Study|Withdrawal: Other Medical|9
4715514|NCT02107443|16257511|P2|Overall Study|Withdrawal: Feeling Overwhelmed|1
4715515|NCT02107443|16257512|P1|Overall Study|Withdrawal: Feeling Overwhelmed|2
4715516|NCT02107443|16257511|P2|Overall Study|Withdrawal: Too Time Consuming|6
4715517|NCT02107443|16257512|P1|Overall Study|Withdrawal: Too Time Consuming|3
4715518|NCT02107443|16257511|P2|Overall Study|Withdrawal: Too Many Forms|1
4715519|NCT02107443|16257512|P1|Overall Study|Withdrawal: Too Many Forms|3
4715520|NCT02107443|16257511|P2|Overall Study|Withdrawal: Changed MD/Facility|3
4715521|NCT02107443|16257512|P1|Overall Study|Withdrawal: Changed MD/Facility|1
4715522|NCT02107443|16257511|P2|Overall Study|Withdrawal: Changed Mind|0
4715523|NCT02107443|16257512|P1|Overall Study|Withdrawal: Changed Mind|2
4715524|NCT02107443|16257511|P2|Overall Study|Withdrawal: Disliked Study Procedures|2
4715525|NCT02107443|16257512|P1|Overall Study|Withdrawal: Disliked Study Procedures|1
4715526|NCT02107443|16257511|P2|Overall Study|Withdrawal: Hospitalization/Hospice|28
4715527|NCT02107443|16257512|P1|Overall Study|Withdrawal: Hospitalization/Hospice|28
4715528|NCT02107443|16257511|P2|Overall Study|Registered but Not Eligible|1
4715529|NCT02107443|16257512|P1|Overall Study|Registered but Not Eligible|0
4715530|NCT02107443|16257511|P2|Overall Study|Study Protocol Violation|1
4715531|NCT02107443|16257512|P1|Overall Study|Study Protocol Violation|3
4715532|NCT02107443|16257511|P2|Overall Study|Death|30
4715533|NCT02107443|16257512|P1|Overall Study|Death|42
4715534|NCT02107313|16257565|P2|Overall Study|One participant did not do the FED cohor|1
4715535|NCT02107313|16257566|P1|Overall Study|One participant did not do the FED cohor|0
4715536|NCT02107274|16257587|P2|Control Phase|Adverse Event|1
4715537|NCT02107274|16257588|P1|Control Phase|Adverse Event|0
4715538|NCT02107274|16257587|P2|Control Phase|Death|0
4715539|NCT02107274|16257588|P1|Control Phase|Death|2
4715540|NCT02107274|16257587|P2|Control Phase|Lost to Follow-up|1
4715541|NCT02107274|16257588|P1|Control Phase|Lost to Follow-up|1
4715542|NCT02107274|16257587|P2|Treatment vs. Placebo|Lost to Follow-up|2
4715543|NCT02107274|16257588|P1|Treatment vs. Placebo|Lost to Follow-up|0
4715544|NCT02107274|16257587|P2|Treatment vs. Placebo|Adverse Event|0
4715545|NCT02107274|16257588|P1|Treatment vs. Placebo|Adverse Event|3
4715546|NCT02107196|16257602|P2|4-week Randomized Withdrawal (RW) Period|Reason Missing|5
4715547|NCT02107196|16257603|P1|4-week Randomized Withdrawal (RW) Period|Reason Missing|18
4715548|NCT02107196|16257602|P2|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0
4715549|NCT02107196|16257603|P1|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2
4715550|NCT02107196|16257602|P2|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0
4715551|NCT02107196|16257603|P1|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1
4715552|NCT02107196|16257602|P2|4-week Randomized Withdrawal (RW) Period|Adverse Event|0
4715553|NCT02107196|16257603|P1|4-week Randomized Withdrawal (RW) Period|Adverse Event|2
4715554|NCT02107196|16257602|P2|12-week Treatment Period|Reason Missing|8
4715555|NCT02107196|16257603|P1|12-week Treatment Period|Reason Missing|11
4715556|NCT02107196|16257602|P2|12-week Treatment Period|Protocol Violation|8
4715557|NCT02107196|16257603|P1|12-week Treatment Period|Protocol Violation|7
4715558|NCT02107196|16257602|P2|12-week Treatment Period|Withdrawal by Subject|12
4715559|NCT02107196|16257603|P1|12-week Treatment Period|Withdrawal by Subject|15
4715560|NCT02107196|16257602|P2|12-week Treatment Period|Physician Decision|1
4715561|NCT02107196|16257603|P1|12-week Treatment Period|Physician Decision|0
4715562|NCT02107196|16257602|P2|12-week Treatment Period|Lost to Follow-up|6
4715563|NCT02107196|16257603|P1|12-week Treatment Period|Lost to Follow-up|3
4715564|NCT02107196|16257602|P2|12-week Treatment Period|Lack of Efficacy|1
4715565|NCT02107196|16257603|P1|12-week Treatment Period|Lack of Efficacy|2
4715566|NCT02107196|16257602|P2|12-week Treatment Period|Adverse Event|3
4715567|NCT02107196|16257603|P1|12-week Treatment Period|Adverse Event|6
4715568|NCT02107131|16257618|P2|Overall Study|Protocol Violation|4
4715569|NCT02107131|16257619|P1|Overall Study|Protocol Violation|0
4715570|NCT02107131|16257618|P2|Overall Study|Death|1
4715571|NCT02107131|16257619|P1|Overall Study|Death|0
4715572|NCT02107131|16257618|P2|Overall Study|mental instability|0
4715573|NCT02107131|16257619|P1|Overall Study|mental instability|1
4715574|NCT02107131|16257618|P2|Overall Study|Withdrawal by Subject|0
4715575|NCT02107131|16257619|P1|Overall Study|Withdrawal by Subject|2
4715576|NCT02107131|16257618|P2|Overall Study|Physician Decision|0
4715577|NCT02107131|16257619|P1|Overall Study|Physician Decision|1
4715578|NCT02107131|16257618|P2|Overall Study|Lost to Follow-up|4
4715579|NCT02107131|16257619|P1|Overall Study|Lost to Follow-up|4
4715580|NCT02107092|16257631|P1|Overall Study|Expected progression of CKD|12
4715581|NCT02107092|16257631|P1|Overall Study|Adverse Event|7
4715582|NCT02107092|16257631|P1|Overall Study|Withdrawal by Subject|9
4715583|NCT02107092|16257631|P1|Overall Study|Lost to Follow-up|2
4715584|NCT02107092|16257631|P1|Overall Study|Physician Decision|3
4715585|NCT02107092|16257631|P1|Overall Study|Met ECG withdrawal criteria|3
4715586|NCT02107092|16257631|P1|Overall Study|Hypo-or hyperkalemia|2
4715587|NCT02107092|16257631|P1|Overall Study|Subject compliance|3
4715588|NCT02107092|16257631|P1|Overall Study|Miscellaneous|3
4715589|NCT02107014|16257636|P1|Overall Study|Withdrew before drug: moving interstate|1
4715590|NCT02106975|16257706|P2|Overall Study|Death|39
4715591|NCT02106975|16257707|P1|Overall Study|Death|25
4715592|NCT02106923|16257767|P6|Overall Study|Protocol Violation|1
4715593|NCT02106923|16257768|P5|Overall Study|Protocol Violation|0
4715594|NCT02106923|16257769|P4|Overall Study|Protocol Violation|0
4715595|NCT02106923|16257770|P3|Overall Study|Protocol Violation|0
4715596|NCT02106923|16257771|P2|Overall Study|Protocol Violation|0
4715597|NCT02106923|16257772|P1|Overall Study|Protocol Violation|0
4715598|NCT02106884|16257818|P2|Overall Study|Change of diagnosis/exclusion|1
4715599|NCT02106884|16257819|P1|Overall Study|Change of diagnosis/exclusion|0
4715600|NCT02106832|16257843|P4|Overall Study|Technical problems|0
4715601|NCT02106832|16257844|P3|Overall Study|Technical problems|0
4715602|NCT02106832|16257845|P2|Overall Study|Technical problems|1
4715603|NCT02106832|16257846|P1|Overall Study|Technical problems|0
4715604|NCT02106832|16257843|P4|Overall Study|Withdrawal by Subject|7
4715605|NCT02106832|16257844|P3|Overall Study|Withdrawal by Subject|10
4715606|NCT02106832|16257845|P2|Overall Study|Withdrawal by Subject|17
4715607|NCT02106832|16257846|P1|Overall Study|Withdrawal by Subject|17
4715608|NCT02106832|16257843|P4|Overall Study|Protocol Violation|1
4715609|NCT02106832|16257844|P3|Overall Study|Protocol Violation|0
4715610|NCT02106832|16257845|P2|Overall Study|Protocol Violation|0
4715611|NCT02106832|16257846|P1|Overall Study|Protocol Violation|0
4715612|NCT02106832|16257843|P4|Overall Study|Physician Decision|0
4715613|NCT02106832|16257844|P3|Overall Study|Physician Decision|0
4715614|NCT02106832|16257845|P2|Overall Study|Physician Decision|0
4715615|NCT02106832|16257846|P1|Overall Study|Physician Decision|1
4715616|NCT02106832|16257843|P4|Overall Study|Lost to Follow-up|3
4715617|NCT02106832|16257844|P3|Overall Study|Lost to Follow-up|1
4715618|NCT02106832|16257845|P2|Overall Study|Lost to Follow-up|1
4715619|NCT02106832|16257846|P1|Overall Study|Lost to Follow-up|0
4715620|NCT02106832|16257843|P4|Overall Study|Deterioration of general conditions|0
4715621|NCT02106832|16257844|P3|Overall Study|Deterioration of general conditions|1
4715622|NCT02106832|16257845|P2|Overall Study|Deterioration of general conditions|0
4715623|NCT02106832|16257846|P1|Overall Study|Deterioration of general conditions|0
4715624|NCT02106832|16257843|P4|Overall Study|Death|4
4715625|NCT02106832|16257844|P3|Overall Study|Death|1
4715626|NCT02106832|16257845|P2|Overall Study|Death|4
4715627|NCT02106832|16257846|P1|Overall Study|Death|4
4715628|NCT02106832|16257843|P4|Overall Study|Adverse Event|0
4715629|NCT02106832|16257844|P3|Overall Study|Adverse Event|3
4715630|NCT02106832|16257845|P2|Overall Study|Adverse Event|2
4715631|NCT02106832|16257846|P1|Overall Study|Adverse Event|1
4715632|NCT02106455|16257913|P1|Overall Study|Protocol Deviation|2
4715633|NCT02106455|16257913|P1|Overall Study|Case Report Form Uncollected|6
4715634|NCT02106442|16257927|P1|Overall Study|Protocol Deviation|30
4715635|NCT02106442|16257927|P1|Overall Study|Case Report Forms Uncollected|7
4715636|NCT02106403|16257945|P6|Follow-Up Visit 3|Other Reason|1
4715637|NCT02106403|16257946|P5|Follow-Up Visit 3|Other Reason|0
4715638|NCT02106403|16257947|P4|Follow-Up Visit 3|Other Reason|0
4715639|NCT02106403|16257948|P3|Follow-Up Visit 3|Other Reason|0
4715640|NCT02106403|16257949|P2|Follow-Up Visit 3|Other Reason|0
4715641|NCT02106403|16257950|P1|Follow-Up Visit 3|Other Reason|0
4715642|NCT02106390|16257973|P3|Overall Study|Protocol Violation|0
4715643|NCT02106390|16257974|P2|Overall Study|Protocol Violation|1
4715644|NCT02106390|16257975|P1|Overall Study|Protocol Violation|0
4715645|NCT02106390|16257973|P3|Overall Study|Adverse Event|1
4715646|NCT02106390|16257974|P2|Overall Study|Adverse Event|2
4715647|NCT02106390|16257975|P1|Overall Study|Adverse Event|0
4715648|NCT02106390|16257973|P3|Overall Study|Other: Unspecified|2
4715649|NCT02106390|16257974|P2|Overall Study|Other: Unspecified|4
4715650|NCT02106390|16257975|P1|Overall Study|Other: Unspecified|1
4715651|NCT02106390|16257973|P3|Overall Study|Other: Administrative Reason|12
4715652|NCT02106390|16257974|P2|Overall Study|Other: Administrative Reason|5
4715653|NCT02106390|16257975|P1|Overall Study|Other: Administrative Reason|8
4715654|NCT02106390|16257973|P3|Overall Study|Lost to Follow-up|13
4715655|NCT02106390|16257974|P2|Overall Study|Lost to Follow-up|20
4715656|NCT02106390|16257975|P1|Overall Study|Lost to Follow-up|25
4715657|NCT02106390|16257973|P3|Overall Study|Withdrawal by Subject|15
4715658|NCT02106390|16257974|P2|Overall Study|Withdrawal by Subject|16
4715659|NCT02106390|16257975|P1|Overall Study|Withdrawal by Subject|15
4715660|NCT02106351|16258052|P3|Treatment Cycle 4|Other|0
4715661|NCT02106351|16258053|P2|Treatment Cycle 4|Other|1
4715662|NCT02106351|16258054|P1|Treatment Cycle 4|Other|0
4715663|NCT02106351|16258052|P3|Treatment Cycle 4|Consent withdrawn|2
4715664|NCT02106351|16258053|P2|Treatment Cycle 4|Consent withdrawn|0
4715665|NCT02106351|16258054|P1|Treatment Cycle 4|Consent withdrawn|0
4715666|NCT02106351|16258052|P3|Treatment Cycle 3|Other|3
4715667|NCT02106351|16258053|P2|Treatment Cycle 3|Other|2
4715668|NCT02106351|16258054|P1|Treatment Cycle 3|Other|0
4715669|NCT02106351|16258052|P3|Treatment Cycle 3|Lost to Follow-up|0
4715670|NCT02106351|16258053|P2|Treatment Cycle 3|Lost to Follow-up|1
4715671|NCT02106351|16258054|P1|Treatment Cycle 3|Lost to Follow-up|0
4715672|NCT02106351|16258052|P3|Treatment Cycle 3|Consent withdrawn|2
4715673|NCT02106351|16258053|P2|Treatment Cycle 3|Consent withdrawn|0
4715674|NCT02106351|16258054|P1|Treatment Cycle 3|Consent withdrawn|0
4715675|NCT02106351|16258052|P3|Treatment Cycle 3|Adverse Event|0
4715676|NCT02106351|16258053|P2|Treatment Cycle 3|Adverse Event|1
4715677|NCT02106351|16258054|P1|Treatment Cycle 3|Adverse Event|0
4715678|NCT02106351|16258052|P3|Treatment Cycle 2|Other|2
4715679|NCT02106351|16258053|P2|Treatment Cycle 2|Other|2
4715680|NCT02106351|16258054|P1|Treatment Cycle 2|Other|0
4715681|NCT02106351|16258052|P3|Treatment Cycle 2|Consent withdrawn|1
4715682|NCT02106351|16258053|P2|Treatment Cycle 2|Consent withdrawn|1
4715683|NCT02106351|16258054|P1|Treatment Cycle 2|Consent withdrawn|0
4715684|NCT02106351|16258052|P3|Treatment Cycle 2|Adverse Event|0
4715685|NCT02106351|16258053|P2|Treatment Cycle 2|Adverse Event|2
4715686|NCT02106351|16258054|P1|Treatment Cycle 2|Adverse Event|0
4715687|NCT02106351|16258052|P3|Treatment Cycle 1|Randomised but not treated|1
4715688|NCT02106351|16258053|P2|Treatment Cycle 1|Randomised but not treated|0
4715689|NCT02106351|16258054|P1|Treatment Cycle 1|Randomised but not treated|1
4715690|NCT02106351|16258052|P3|Treatment Cycle 1|Other|1
4715691|NCT02106351|16258053|P2|Treatment Cycle 1|Other|3
4715692|NCT02106351|16258054|P1|Treatment Cycle 1|Other|0
4715693|NCT02106351|16258052|P3|Treatment Cycle 1|Lost to Follow-up|0
4715694|NCT02106351|16258053|P2|Treatment Cycle 1|Lost to Follow-up|0
4715695|NCT02106351|16258054|P1|Treatment Cycle 1|Lost to Follow-up|1
4715696|NCT02106351|16258052|P3|Treatment Cycle 1|Consent withdrawn|2
4715697|NCT02106351|16258053|P2|Treatment Cycle 1|Consent withdrawn|0
4715698|NCT02106351|16258054|P1|Treatment Cycle 1|Consent withdrawn|1
4715699|NCT02106351|16258052|P3|Treatment Cycle 1|Adverse Event|0
4715700|NCT02106351|16258053|P2|Treatment Cycle 1|Adverse Event|0
4715701|NCT02106351|16258054|P1|Treatment Cycle 1|Adverse Event|2
4715702|NCT02106325|16258097|P2|Phase 3|Lost to Follow-up|1
4715703|NCT02106325|16258098|P1|Phase 3|Lost to Follow-up|2
4715704|NCT02106325|16258097|P2|Phase 2|Lost to Follow-up|3
4715705|NCT02106325|16258098|P1|Phase 2|Lost to Follow-up|2
4715706|NCT02106325|16258097|P2|Phase 1|Lost to Follow-up|2
4715707|NCT02106325|16258098|P1|Phase 1|Lost to Follow-up|2
4715708|NCT02106156|16258123|P3|Overall Study|Relocation/Change of Physician|0
4715709|NCT02106156|16258124|P2|Overall Study|Relocation/Change of Physician|1
4715710|NCT02106156|16258125|P1|Overall Study|Relocation/Change of Physician|40
4715711|NCT02106156|16258123|P3|Overall Study|Hospitalization/Surgical Intervention|0
4715712|NCT02106156|16258124|P2|Overall Study|Hospitalization/Surgical Intervention|0
4715713|NCT02106156|16258125|P1|Overall Study|Hospitalization/Surgical Intervention|6
4715714|NCT02106156|16258123|P3|Overall Study|Change of Laboratory Parameter|0
4715715|NCT02106156|16258124|P2|Overall Study|Change of Laboratory Parameter|0
4715716|NCT02106156|16258125|P1|Overall Study|Change of Laboratory Parameter|10
4715717|NCT02106156|16258123|P3|Overall Study|Unplanned Event|0
4715718|NCT02106156|16258124|P2|Overall Study|Unplanned Event|2
4715719|NCT02106156|16258125|P1|Overall Study|Unplanned Event|82
4715720|NCT02106156|16258123|P3|Overall Study|Lost to Follow-up|0
4715721|NCT02106156|16258124|P2|Overall Study|Lost to Follow-up|8
4715722|NCT02106156|16258125|P1|Overall Study|Lost to Follow-up|451
4715723|NCT02106156|16258123|P3|Overall Study|Patients Request|0
4715724|NCT02106156|16258124|P2|Overall Study|Patients Request|9
4715725|NCT02106156|16258125|P1|Overall Study|Patients Request|307
4715726|NCT02106156|16258123|P3|Overall Study|Lack of Compliance|0
4715727|NCT02106156|16258124|P2|Overall Study|Lack of Compliance|7
4715728|NCT02106156|16258125|P1|Overall Study|Lack of Compliance|211
4715729|NCT02106156|16258123|P3|Overall Study|Concomitant Disease|0
4715730|NCT02106156|16258124|P2|Overall Study|Concomitant Disease|2
4715731|NCT02106156|16258125|P1|Overall Study|Concomitant Disease|74
4715732|NCT02106156|16258123|P3|Overall Study|Lack of Virological Response|0
4715733|NCT02106156|16258124|P2|Overall Study|Lack of Virological Response|8
4715734|NCT02106156|16258125|P1|Overall Study|Lack of Virological Response|1044
4715735|NCT02106156|16258123|P3|Overall Study|Lack of Tolerability|0
4715736|NCT02106156|16258124|P2|Overall Study|Lack of Tolerability|3
4715737|NCT02106156|16258125|P1|Overall Study|Lack of Tolerability|305
4715738|NCT02106156|16258123|P3|Overall Study|Patient Died|0
4715739|NCT02106156|16258124|P2|Overall Study|Patient Died|0
4715740|NCT02106156|16258125|P1|Overall Study|Patient Died|19
4715741|NCT02105987|16258149|P6|Continuation Phase|Protocol Violation|0
4715742|NCT02105987|16258150|P5|Continuation Phase|Protocol Violation|1
4715743|NCT02105987|16258151|P4|Continuation Phase|Protocol Violation|0
4715744|NCT02105987|16258152|P3|Continuation Phase|Protocol Violation|0
4715745|NCT02105987|16258153|P2|Continuation Phase|Protocol Violation|0
4715746|NCT02105987|16258154|P1|Continuation Phase|Protocol Violation|0
4715747|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|Per sponsor request|0
4715748|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|Per sponsor request|0
4715749|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|Per sponsor request|0
4715750|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|Per sponsor request|1
4715751|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|Per sponsor request|0
4715752|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|Per sponsor request|0
4715753|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4715754|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4715755|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1
4715756|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4715757|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4715758|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0
4715759|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|Physician Decision|0
4715760|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|Physician Decision|0
4715761|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|Physician Decision|0
4715762|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|Physician Decision|5
4715763|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|Physician Decision|0
4715764|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|Physician Decision|0
4715765|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4715766|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4715767|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|Lost to Follow-up|3
4715768|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|Lost to Follow-up|8
4715769|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4715770|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|Lost to Follow-up|0
4715771|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715772|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715773|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5
4715774|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6
4715775|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715776|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715777|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|Protocol Violation|0
4715778|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|Protocol Violation|0
4715779|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|Protocol Violation|1
4715780|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|Protocol Violation|15
4715781|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|Protocol Violation|0
4715782|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|Protocol Violation|0
4715783|NCT02105987|16258149|P6|Late Switch Phase (24 Weeks)|Adverse Event|0
4715784|NCT02105987|16258150|P5|Late Switch Phase (24 Weeks)|Adverse Event|0
4715785|NCT02105987|16258151|P4|Late Switch Phase (24 Weeks)|Adverse Event|4
4715786|NCT02105987|16258152|P3|Late Switch Phase (24 Weeks)|Adverse Event|10
4715787|NCT02105987|16258153|P2|Late Switch Phase (24 Weeks)|Adverse Event|0
4715788|NCT02105987|16258154|P1|Late Switch Phase (24 Weeks)|Adverse Event|0
4715789|NCT02105987|16258149|P6|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4715790|NCT02105987|16258150|P5|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4715791|NCT02105987|16258151|P4|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4715792|NCT02105987|16258152|P3|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4715793|NCT02105987|16258153|P2|Early Switch Phase (24 Weeks)|Missing Disposition Data|1
4715794|NCT02105987|16258154|P1|Early Switch Phase (24 Weeks)|Missing Disposition Data|0
4715795|NCT02105987|16258149|P6|Early Switch Phase (24 Weeks)|Physician Decision|0
4715796|NCT02105987|16258150|P5|Early Switch Phase (24 Weeks)|Physician Decision|0
4715797|NCT02105987|16258151|P4|Early Switch Phase (24 Weeks)|Physician Decision|0
4715798|NCT02105987|16258152|P3|Early Switch Phase (24 Weeks)|Physician Decision|0
4715799|NCT02105987|16258153|P2|Early Switch Phase (24 Weeks)|Physician Decision|3
4715800|NCT02105987|16258154|P1|Early Switch Phase (24 Weeks)|Physician Decision|4
4715801|NCT02105987|16258149|P6|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4715802|NCT02105987|16258150|P5|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4715803|NCT02105987|16258151|P4|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4715804|NCT02105987|16258152|P3|Early Switch Phase (24 Weeks)|Lost to Follow-up|0
4715805|NCT02105987|16258153|P2|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
4715806|NCT02105987|16258154|P1|Early Switch Phase (24 Weeks)|Lost to Follow-up|3
4715807|NCT02105987|16258149|P6|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715808|NCT02105987|16258150|P5|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715809|NCT02105987|16258151|P4|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715810|NCT02105987|16258152|P3|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0
4715811|NCT02105987|16258153|P2|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10
4715812|NCT02105987|16258154|P1|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4
4715813|NCT02105987|16258149|P6|Early Switch Phase (24 Weeks)|Protocol Violation|0
4715814|NCT02105987|16258150|P5|Early Switch Phase (24 Weeks)|Protocol Violation|0
4715815|NCT02105987|16258151|P4|Early Switch Phase (24 Weeks)|Protocol Violation|0
4715816|NCT02105987|16258152|P3|Early Switch Phase (24 Weeks)|Protocol Violation|0
4715817|NCT02105987|16258153|P2|Early Switch Phase (24 Weeks)|Protocol Violation|17
4715818|NCT02105987|16258154|P1|Early Switch Phase (24 Weeks)|Protocol Violation|15
4715819|NCT02105987|16258149|P6|Early Switch Phase (24 Weeks)|Adverse Event|0
4715820|NCT02105987|16258150|P5|Early Switch Phase (24 Weeks)|Adverse Event|0
4715821|NCT02105987|16258151|P4|Early Switch Phase (24 Weeks)|Adverse Event|0
4715822|NCT02105987|16258152|P3|Early Switch Phase (24 Weeks)|Adverse Event|0
4715823|NCT02105987|16258153|P2|Early Switch Phase (24 Weeks)|Adverse Event|0
4715824|NCT02105987|16258154|P1|Early Switch Phase (24 Weeks)|Adverse Event|10
4715825|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18
4715826|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12
4715827|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0
4715828|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Physician Decision|4
4715829|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Physician Decision|7
4715830|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Physician Decision|0
4715831|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1
4715832|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
4715833|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0
4715834|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2
4715835|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1
4715836|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0
4715837|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6
4715838|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2
4715839|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0
4715840|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9
4715841|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6
4715842|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0
4715843|NCT02105974|16258208|P3|12 Week (Wk) Treatment Period (TP)|Adverse Event|18
4715844|NCT02105974|16258209|P2|12 Week (Wk) Treatment Period (TP)|Adverse Event|14
4715845|NCT02105974|16258210|P1|12 Week (Wk) Treatment Period (TP)|Adverse Event|0
4715846|NCT02105974|16258208|P3|2 Week Run-in Period|Investigator discretion|0
4715847|NCT02105974|16258209|P2|2 Week Run-in Period|Investigator discretion|0
4715848|NCT02105974|16258210|P1|2 Week Run-in Period|Investigator discretion|8
4715849|NCT02105974|16258208|P3|2 Week Run-in Period|Withdrew consent|0
4715850|NCT02105974|16258209|P2|2 Week Run-in Period|Withdrew consent|0
4715851|NCT02105974|16258210|P1|2 Week Run-in Period|Withdrew consent|23
4715852|NCT02105974|16258208|P3|2 Week Run-in Period|Lost to Follow-up|0
4715853|NCT02105974|16258209|P2|2 Week Run-in Period|Lost to Follow-up|0
4715854|NCT02105974|16258210|P1|2 Week Run-in Period|Lost to Follow-up|2
4715855|NCT02105974|16258208|P3|2 Week Run-in Period|Study closed/terminated|0
4715856|NCT02105974|16258209|P2|2 Week Run-in Period|Study closed/terminated|0
4715857|NCT02105974|16258210|P1|2 Week Run-in Period|Study closed/terminated|1
4715858|NCT02105974|16258208|P3|2 Week Run-in Period|Adverse Event|0
4715859|NCT02105974|16258209|P2|2 Week Run-in Period|Adverse Event|0
4715860|NCT02105974|16258210|P1|2 Week Run-in Period|Adverse Event|6
4715861|NCT02105974|16258208|P3|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
4715862|NCT02105974|16258209|P2|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0
4715863|NCT02105974|16258210|P1|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603
4715864|NCT02105974|16258208|P3|2 Week Run-in Period|Withdrew during pre-screen period|0
4715865|NCT02105974|16258209|P2|2 Week Run-in Period|Withdrew during pre-screen period|0
4715866|NCT02105974|16258210|P1|2 Week Run-in Period|Withdrew during pre-screen period|158
4715867|NCT02105961|16258223|P3|Overall Study|Withdrawal by Subject|11
4715868|NCT02105961|16258224|P2|Overall Study|Withdrawal by Subject|7
4715869|NCT02105961|16258225|P1|Overall Study|Withdrawal by Subject|15
4715870|NCT02105961|16258223|P3|Overall Study|Physician Decision|2
4715871|NCT02105961|16258224|P2|Overall Study|Physician Decision|3
4715872|NCT02105961|16258225|P1|Overall Study|Physician Decision|3
4715873|NCT02105961|16258223|P3|Overall Study|Lost to Follow-up|1
4715874|NCT02105961|16258224|P2|Overall Study|Lost to Follow-up|0
4715875|NCT02105961|16258225|P1|Overall Study|Lost to Follow-up|2
4715876|NCT02105961|16258223|P3|Overall Study|Lack of Efficacy|3
4715877|NCT02105961|16258224|P2|Overall Study|Lack of Efficacy|0
4715878|NCT02105961|16258225|P1|Overall Study|Lack of Efficacy|3
4715879|NCT02105961|16258223|P3|Overall Study|Adverse Event|13
4715880|NCT02105961|16258224|P2|Overall Study|Adverse Event|7
4715881|NCT02105961|16258225|P1|Overall Study|Adverse Event|18
4715882|NCT02105948|16258249|P4|Overall Study|Withdrawal by Subject|11
4715883|NCT02105948|16258250|P3|Overall Study|Withdrawal by Subject|10
4715884|NCT02105948|16258251|P2|Overall Study|Withdrawal by Subject|10
4715885|NCT02105948|16258252|P1|Overall Study|Withdrawal by Subject|15
4715886|NCT02105948|16258249|P4|Overall Study|Physician Decision|2
4715887|NCT02105948|16258250|P3|Overall Study|Physician Decision|2
4715888|NCT02105948|16258251|P2|Overall Study|Physician Decision|2
4715889|NCT02105948|16258252|P1|Overall Study|Physician Decision|2
4715890|NCT02105948|16258249|P4|Overall Study|Lost to Follow-up|1
4715891|NCT02105948|16258250|P3|Overall Study|Lost to Follow-up|2
4715892|NCT02105948|16258251|P2|Overall Study|Lost to Follow-up|0
4715893|NCT02105948|16258252|P1|Overall Study|Lost to Follow-up|0
4715894|NCT02105948|16258249|P4|Overall Study|Lack of Efficacy|2
4715895|NCT02105948|16258250|P3|Overall Study|Lack of Efficacy|3
4715896|NCT02105948|16258251|P2|Overall Study|Lack of Efficacy|1
4715897|NCT02105948|16258252|P1|Overall Study|Lack of Efficacy|0
4715898|NCT02105948|16258249|P4|Overall Study|Adverse Event|11
4715899|NCT02105948|16258250|P3|Overall Study|Adverse Event|11
4715900|NCT02105948|16258251|P2|Overall Study|Adverse Event|7
4715901|NCT02105948|16258252|P1|Overall Study|Adverse Event|10
4715902|NCT02105701|16258293|P4|Overall Study|Death|0
4715903|NCT02105701|16258294|P3|Overall Study|Death|0
4715904|NCT02105701|16258295|P2|Overall Study|Death|0
4715905|NCT02105701|16258296|P1|Overall Study|Death|1
4715906|NCT02105701|16258293|P4|Overall Study|Withdrawal by Subject|1
4715907|NCT02105701|16258294|P3|Overall Study|Withdrawal by Subject|0
4715908|NCT02105701|16258295|P2|Overall Study|Withdrawal by Subject|1
4715909|NCT02105701|16258296|P1|Overall Study|Withdrawal by Subject|2
4715910|NCT02105701|16258293|P4|Overall Study|Protocol Violation|0
4715911|NCT02105701|16258294|P3|Overall Study|Protocol Violation|1
4715912|NCT02105701|16258295|P2|Overall Study|Protocol Violation|0
4715913|NCT02105701|16258296|P1|Overall Study|Protocol Violation|0
4715914|NCT02105701|16258293|P4|Overall Study|Lost to Follow-up|1
4715915|NCT02105701|16258294|P3|Overall Study|Lost to Follow-up|2
4715916|NCT02105701|16258295|P2|Overall Study|Lost to Follow-up|0
4715917|NCT02105701|16258296|P1|Overall Study|Lost to Follow-up|1
4715918|NCT02105688|16258320|P2|Part B: Observational Follow-up|Physician Decision|1
4715919|NCT02105688|16258321|P1|Part B: Observational Follow-up|Physician Decision|3
4715920|NCT02105688|16258320|P2|Part B: Observational Follow-up|Withdrawal by Subject|3
4715921|NCT02105688|16258321|P1|Part B: Observational Follow-up|Withdrawal by Subject|9
4715922|NCT02105688|16258320|P2|Part B: Observational Follow-up|Lost to Follow-up|15
4715923|NCT02105688|16258321|P1|Part B: Observational Follow-up|Lost to Follow-up|23
4715924|NCT02105688|16258320|P2|Part B: Observational Follow-up|Death|1
4715925|NCT02105688|16258321|P1|Part B: Observational Follow-up|Death|2
4715926|NCT02105688|16258320|P2|Part A: Double-Blind|Withdrawal by Subject|2
4715927|NCT02105688|16258321|P1|Part A: Double-Blind|Withdrawal by Subject|4
4715928|NCT02105688|16258320|P2|Part A: Double-Blind|Status Unknown|2
4715929|NCT02105688|16258321|P1|Part A: Double-Blind|Status Unknown|0
4715930|NCT02105688|16258320|P2|Part A: Double-Blind|Physician Decision|1
4715931|NCT02105688|16258321|P1|Part A: Double-Blind|Physician Decision|0
4715932|NCT02105688|16258320|P2|Part A: Double-Blind|Lost to Follow-up|11
4715933|NCT02105688|16258321|P1|Part A: Double-Blind|Lost to Follow-up|15
4715934|NCT02105688|16258320|P2|Part A: Double-Blind|Death|1
4715935|NCT02105688|16258321|P1|Part A: Double-Blind|Death|0
4715936|NCT02105688|16258320|P2|Part A: Double-Blind|Adverse Event|0
4715937|NCT02105688|16258321|P1|Part A: Double-Blind|Adverse Event|1
4715938|NCT02105662|16258334|P1|Overall Study|Withdrawal by Subject|1
4715939|NCT02105662|16258334|P1|Overall Study|Lost to Follow-up|5
4715940|NCT02105636|16258343|P2|Overall Study|Not Reported|0
4715941|NCT02105636|16258344|P1|Overall Study|Not Reported|3
4715942|NCT02105636|16258343|P2|Overall Study|Reason Not Specified|2
4715943|NCT02105636|16258344|P1|Overall Study|Reason Not Specified|0
4715944|NCT02105636|16258343|P2|Overall Study|Poor/Non-compliance|1
4715945|NCT02105636|16258344|P1|Overall Study|Poor/Non-compliance|0
4715946|NCT02105636|16258343|P2|Overall Study|Maximum Clinical Benefit|1
4715947|NCT02105636|16258344|P1|Overall Study|Maximum Clinical Benefit|1
4715948|NCT02105636|16258343|P2|Overall Study|Subject Withdrew Consent|1
4715949|NCT02105636|16258344|P1|Overall Study|Subject Withdrew Consent|4
4715950|NCT02105636|16258343|P2|Overall Study|Subject Request to Discontinue Treatment|6
4715951|NCT02105636|16258344|P1|Overall Study|Subject Request to Discontinue Treatment|4
4715952|NCT02105636|16258343|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
4715953|NCT02105636|16258344|P1|Overall Study|Adverse Event Unrelated to Study Drug|12
4715954|NCT02105636|16258343|P2|Overall Study|Study Drug Toxicity|11
4715955|NCT02105636|16258344|P1|Overall Study|Study Drug Toxicity|9
4715956|NCT02105636|16258343|P2|Overall Study|Disease Progression|83
4715957|NCT02105636|16258344|P1|Overall Study|Disease Progression|162
4715958|NCT02105467|16258387|P2|Period 3|Lost to Follow-up|1
4715959|NCT02105467|16258388|P1|Period 3|Lost to Follow-up|0
4715960|NCT02105467|16258387|P2|Period 2|Withdrawal by Subject|2
4715961|NCT02105467|16258388|P1|Period 2|Withdrawal by Subject|0
4715962|NCT02105467|16258387|P2|Period 2|Death|0
4715963|NCT02105467|16258388|P1|Period 2|Death|1
4715964|NCT02105467|16258387|P2|Period 2|Lost to Follow-up|0
4715965|NCT02105467|16258388|P1|Period 2|Lost to Follow-up|1
4715966|NCT02105467|16258387|P2|Period 1|Death|0
4715967|NCT02105467|16258388|P1|Period 1|Death|1
4715968|NCT02105467|16258387|P2|Period 1|Lost to Follow-up|0
4715969|NCT02105467|16258388|P1|Period 1|Lost to Follow-up|1
4715970|NCT02105454|16258400|P1|Overall Study|Withdrawal by Subject|1
4715971|NCT02105285|16258512|P3|Overall Study|Withdrawal by Subject|0
4715972|NCT02105285|16258513|P2|Overall Study|Withdrawal by Subject|0
4715973|NCT02105285|16258514|P1|Overall Study|Withdrawal by Subject|1
4715974|NCT02105285|16258512|P3|Overall Study|Protocol Violation|0
4715975|NCT02105285|16258513|P2|Overall Study|Protocol Violation|1
4715976|NCT02105285|16258514|P1|Overall Study|Protocol Violation|0
4715977|NCT02105285|16258512|P3|Overall Study|Adverse Event|0
4715978|NCT02105285|16258513|P2|Overall Study|Adverse Event|1
4715979|NCT02105285|16258514|P1|Overall Study|Adverse Event|1
4715980|NCT02105272|16258533|P2|Overall Study|Withdrawal by Subject|0
4715981|NCT02105272|16258534|P1|Overall Study|Withdrawal by Subject|2
4715982|NCT02105272|16258533|P2|Overall Study|Protocol Violation|0
4715983|NCT02105272|16258534|P1|Overall Study|Protocol Violation|2
4715984|NCT02105272|16258533|P2|Overall Study|Physician Decision|1
4715985|NCT02105272|16258534|P1|Overall Study|Physician Decision|0
4715986|NCT02105272|16258533|P2|Overall Study|Adverse Event|2
4715987|NCT02105272|16258534|P1|Overall Study|Adverse Event|1
4715988|NCT02105116|16258563|P1|Overall Study|Death|1
4715989|NCT02105116|16258563|P1|Overall Study|not eligible for step 2 of trial|5
4715990|NCT02105012|16258570|P1|Overall Study|Lack of Efficacy|1
4715991|NCT02105012|16258570|P1|Overall Study|Adverse Event|1
4715992|NCT02105012|16258570|P1|Overall Study|Physician Decision|3
4715993|NCT02105012|16258570|P1|Overall Study|Protocol Violation|4
4715994|NCT02105012|16258570|P1|Overall Study|Lost to Follow-up|4
4715995|NCT02105012|16258570|P1|Overall Study|Protocol Specified Criteria|9
4715996|NCT02105012|16258570|P1|Overall Study|Withdrawal by Subject|11
4715997|NCT02104947|16258604|P2|Overall Study|Other than stated above|3
4715998|NCT02104947|16258605|P1|Overall Study|Other than stated above|2
4715999|NCT02104947|16258604|P2|Overall Study|Adverse Event|38
4716000|NCT02104947|16258605|P1|Overall Study|Adverse Event|57
4716001|NCT02104947|16258604|P2|Overall Study|Protocol Violation|8
4716002|NCT02104947|16258605|P1|Overall Study|Protocol Violation|6
4716003|NCT02104947|16258604|P2|Overall Study|Lost to Follow-up|4
4716004|NCT02104947|16258605|P1|Overall Study|Lost to Follow-up|4
4716005|NCT02104947|16258604|P2|Overall Study|Withdrawal by Subject|3
4716006|NCT02104947|16258605|P1|Overall Study|Withdrawal by Subject|10
4716007|NCT02104895|16258623|P2|Overall Study|Withdrawal by Subject|14
4716008|NCT02104895|16258624|P1|Overall Study|Withdrawal by Subject|0
4716009|NCT02104804|16258664|P2|Overall Study|Withdrawal by Subject|12
4716010|NCT02104804|16258665|P1|Overall Study|Withdrawal by Subject|4
4716011|NCT02104804|16258664|P2|Overall Study|Adverse Event|3
4716012|NCT02104804|16258665|P1|Overall Study|Adverse Event|4
4716013|NCT02104804|16258664|P2|Overall Study|Protocol Violation|1
4716014|NCT02104804|16258665|P1|Overall Study|Protocol Violation|0
4716015|NCT02104804|16258664|P2|Overall Study|Other listed|1
4716016|NCT02104804|16258665|P1|Overall Study|Other listed|2
4716017|NCT02104804|16258664|P2|Overall Study|Study specific discontinuation criteria|1
4716018|NCT02104804|16258665|P1|Overall Study|Study specific discontinuation criteria|6
4716019|NCT02104804|16258664|P2|Overall Study|Did not take study medication|1
4716020|NCT02104804|16258665|P1|Overall Study|Did not take study medication|0
4716021|NCT02104765|16258688|P7|Overall Study|Withdrawal by Subject|1
4716022|NCT02104765|16258689|P6|Overall Study|Withdrawal by Subject|0
4716023|NCT02104765|16258690|P5|Overall Study|Withdrawal by Subject|1
4716024|NCT02104765|16258691|P4|Overall Study|Withdrawal by Subject|1
4716025|NCT02104765|16258692|P3|Overall Study|Withdrawal by Subject|0
4716026|NCT02104765|16258693|P2|Overall Study|Withdrawal by Subject|0
4716027|NCT02104765|16258694|P1|Overall Study|Withdrawal by Subject|0
4716028|NCT02104765|16258688|P7|Overall Study|Lost to Follow-up|0
4716029|NCT02104765|16258689|P6|Overall Study|Lost to Follow-up|0
4716030|NCT02104765|16258690|P5|Overall Study|Lost to Follow-up|0
4716031|NCT02104765|16258691|P4|Overall Study|Lost to Follow-up|0
4716032|NCT02104765|16258692|P3|Overall Study|Lost to Follow-up|1
4716033|NCT02104765|16258693|P2|Overall Study|Lost to Follow-up|0
4716034|NCT02104765|16258694|P1|Overall Study|Lost to Follow-up|0
4716035|NCT02104752|16258722|P2|Overall Study|Weight gain; unrelated anxiety|2
4716036|NCT02104752|16258723|P1|Overall Study|Weight gain; unrelated anxiety|0
4716037|NCT02104752|16258722|P2|Overall Study|Withdrawal by Subject|0
4716038|NCT02104752|16258723|P1|Overall Study|Withdrawal by Subject|1
4716039|NCT02104583|16258806|P5|Overall Study|Randomized but Never Treated|0
4716040|NCT02104583|16258807|P4|Overall Study|Randomized but Never Treated|1
4716041|NCT02104583|16258808|P3|Overall Study|Randomized but Never Treated|0
4716042|NCT02104583|16258809|P2|Overall Study|Randomized but Never Treated|0
4716043|NCT02104583|16258810|P1|Overall Study|Randomized but Never Treated|0
4716044|NCT02104583|16258806|P5|Overall Study|Lost to Follow-up|0
4716045|NCT02104583|16258807|P4|Overall Study|Lost to Follow-up|0
4716046|NCT02104583|16258808|P3|Overall Study|Lost to Follow-up|0
4716047|NCT02104583|16258809|P2|Overall Study|Lost to Follow-up|0
4716048|NCT02104583|16258810|P1|Overall Study|Lost to Follow-up|1
4716049|NCT02104583|16258806|P5|Overall Study|Adverse Event|1
4716050|NCT02104583|16258807|P4|Overall Study|Adverse Event|6
4716051|NCT02104583|16258808|P3|Overall Study|Adverse Event|6
4716052|NCT02104583|16258809|P2|Overall Study|Adverse Event|3
4716053|NCT02104583|16258810|P1|Overall Study|Adverse Event|3
4716054|NCT02104583|16258806|P5|Overall Study|Protocol Violation|0
4716055|NCT02104583|16258807|P4|Overall Study|Protocol Violation|0
4716056|NCT02104583|16258808|P3|Overall Study|Protocol Violation|1
4716057|NCT02104583|16258809|P2|Overall Study|Protocol Violation|0
4716058|NCT02104583|16258810|P1|Overall Study|Protocol Violation|0
4716059|NCT02104583|16258806|P5|Overall Study|Investigator's Discretion|0
4716060|NCT02104583|16258807|P4|Overall Study|Investigator's Discretion|0
4716061|NCT02104583|16258808|P3|Overall Study|Investigator's Discretion|0
4716062|NCT02104583|16258809|P2|Overall Study|Investigator's Discretion|0
4716063|NCT02104583|16258810|P1|Overall Study|Investigator's Discretion|1
4716064|NCT02104583|16258806|P5|Overall Study|Withdrew Consent|1
4716065|NCT02104583|16258807|P4|Overall Study|Withdrew Consent|2
4716066|NCT02104583|16258808|P3|Overall Study|Withdrew Consent|0
4716067|NCT02104583|16258809|P2|Overall Study|Withdrew Consent|2
4716068|NCT02104583|16258810|P1|Overall Study|Withdrew Consent|3
4716069|NCT02104583|16258806|P5|Overall Study|Subject required prohibited medication|1
4716070|NCT02104583|16258807|P4|Overall Study|Subject required prohibited medication|0
4716071|NCT02104583|16258808|P3|Overall Study|Subject required prohibited medication|1
4716072|NCT02104583|16258809|P2|Overall Study|Subject required prohibited medication|1
4716073|NCT02104583|16258810|P1|Overall Study|Subject required prohibited medication|0
4716074|NCT02104583|16258806|P5|Overall Study|Subject required cardiac ablation|4
4716075|NCT02104583|16258807|P4|Overall Study|Subject required cardiac ablation|5
4716076|NCT02104583|16258808|P3|Overall Study|Subject required cardiac ablation|4
4716077|NCT02104583|16258809|P2|Overall Study|Subject required cardiac ablation|4
4716078|NCT02104583|16258810|P1|Overall Study|Subject required cardiac ablation|6
4716079|NCT02104583|16258806|P5|Overall Study|Death|5
4716080|NCT02104583|16258807|P4|Overall Study|Death|3
4716081|NCT02104583|16258808|P3|Overall Study|Death|3
4716082|NCT02104583|16258809|P2|Overall Study|Death|1
4716083|NCT02104583|16258810|P1|Overall Study|Death|2
4716084|NCT02104583|16258806|P5|Overall Study|New ICD or CRT-D implanted|0
4716085|NCT02104583|16258807|P4|Overall Study|New ICD or CRT-D implanted|0
4716086|NCT02104583|16258808|P3|Overall Study|New ICD or CRT-D implanted|1
4716087|NCT02104583|16258809|P2|Overall Study|New ICD or CRT-D implanted|0
4716088|NCT02104583|16258810|P1|Overall Study|New ICD or CRT-D implanted|2
4716089|NCT02104505|16258873|P2|Second Intervention (14 Days)|Adverse Event|0
4716090|NCT02104505|16258874|P1|Second Intervention (14 Days)|Adverse Event|2
4716091|NCT02104505|16258873|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
4716092|NCT02104505|16258874|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
4716093|NCT02104505|16258873|P2|First Intervention (14 Days)|exclusionary condition|1
4716094|NCT02104505|16258874|P1|First Intervention (14 Days)|exclusionary condition|0
4716095|NCT02104505|16258873|P2|First Intervention (14 Days)|Lost to Follow-up|1
4716096|NCT02104505|16258874|P1|First Intervention (14 Days)|Lost to Follow-up|0
4716097|NCT02104505|16258873|P2|First Intervention (14 Days)|Withdrawal by Subject|1
4716098|NCT02104505|16258874|P1|First Intervention (14 Days)|Withdrawal by Subject|0
4716099|NCT02104505|16258873|P2|First Intervention (14 Days)|Adverse Event|0
4716100|NCT02104505|16258874|P1|First Intervention (14 Days)|Adverse Event|2
4716101|NCT02104180|16258946|P2|Overall Study|Protocol Violation|0
4716102|NCT02104180|16258947|P1|Overall Study|Protocol Violation|1
4716103|NCT02103478|16258982|P9|Overall Study|Other|2
4716104|NCT02103478|16258983|P8|Overall Study|Other|2
4716105|NCT02103478|16258984|P7|Overall Study|Other|5
4716106|NCT02103478|16258985|P6|Overall Study|Other|2
4716107|NCT02103478|16258986|P5|Overall Study|Other|1
4716108|NCT02103478|16258987|P4|Overall Study|Other|0
4716109|NCT02103478|16258988|P3|Overall Study|Other|1
4716110|NCT02103478|16258989|P2|Overall Study|Other|1
4716111|NCT02103478|16258990|P1|Overall Study|Other|1
4716112|NCT02103478|16258982|P9|Overall Study|Withdrawal by Subject|0
4716113|NCT02103478|16258983|P8|Overall Study|Withdrawal by Subject|1
4716114|NCT02103478|16258984|P7|Overall Study|Withdrawal by Subject|2
4716115|NCT02103478|16258985|P6|Overall Study|Withdrawal by Subject|2
4716116|NCT02103478|16258986|P5|Overall Study|Withdrawal by Subject|0
4716117|NCT02103478|16258987|P4|Overall Study|Withdrawal by Subject|3
4716118|NCT02103478|16258988|P3|Overall Study|Withdrawal by Subject|1
4716119|NCT02103478|16258989|P2|Overall Study|Withdrawal by Subject|0
4716120|NCT02103478|16258990|P1|Overall Study|Withdrawal by Subject|0
4716121|NCT02103478|16258982|P9|Overall Study|Bone Marrow/Stem Cell Transplant|2
4716122|NCT02103478|16258983|P8|Overall Study|Bone Marrow/Stem Cell Transplant|3
4716123|NCT02103478|16258984|P7|Overall Study|Bone Marrow/Stem Cell Transplant|2
4716124|NCT02103478|16258985|P6|Overall Study|Bone Marrow/Stem Cell Transplant|5
4716125|NCT02103478|16258986|P5|Overall Study|Bone Marrow/Stem Cell Transplant|2
4716126|NCT02103478|16258987|P4|Overall Study|Bone Marrow/Stem Cell Transplant|0
4716127|NCT02103478|16258988|P3|Overall Study|Bone Marrow/Stem Cell Transplant|1
4716128|NCT02103478|16258989|P2|Overall Study|Bone Marrow/Stem Cell Transplant|2
4716129|NCT02103478|16258990|P1|Overall Study|Bone Marrow/Stem Cell Transplant|1
4716130|NCT02103478|16258982|P9|Overall Study|Progressive Disease|4
4716131|NCT02103478|16258983|P8|Overall Study|Progressive Disease|3
4716132|NCT02103478|16258984|P7|Overall Study|Progressive Disease|7
4716133|NCT02103478|16258985|P6|Overall Study|Progressive Disease|7
4716134|NCT02103478|16258986|P5|Overall Study|Progressive Disease|10
4716135|NCT02103478|16258987|P4|Overall Study|Progressive Disease|1
4716136|NCT02103478|16258988|P3|Overall Study|Progressive Disease|2
4716137|NCT02103478|16258989|P2|Overall Study|Progressive Disease|1
4716138|NCT02103478|16258990|P1|Overall Study|Progressive Disease|2
4716139|NCT02103478|16258982|P9|Overall Study|Death|3
4716140|NCT02103478|16258983|P8|Overall Study|Death|3
4716141|NCT02103478|16258984|P7|Overall Study|Death|3
4716142|NCT02103478|16258985|P6|Overall Study|Death|3
4716143|NCT02103478|16258986|P5|Overall Study|Death|3
4716144|NCT02103478|16258987|P4|Overall Study|Death|0
4716145|NCT02103478|16258988|P3|Overall Study|Death|0
4716146|NCT02103478|16258989|P2|Overall Study|Death|0
4716147|NCT02103478|16258990|P1|Overall Study|Death|1
4716148|NCT02103478|16258982|P9|Overall Study|Adverse Event|1
4716149|NCT02103478|16258983|P8|Overall Study|Adverse Event|2
4716150|NCT02103478|16258984|P7|Overall Study|Adverse Event|2
4716151|NCT02103478|16258985|P6|Overall Study|Adverse Event|1
4716152|NCT02103478|16258986|P5|Overall Study|Adverse Event|1
4716153|NCT02103478|16258987|P4|Overall Study|Adverse Event|2
4716154|NCT02103478|16258988|P3|Overall Study|Adverse Event|1
4716155|NCT02103478|16258989|P2|Overall Study|Adverse Event|0
4716156|NCT02103478|16258990|P1|Overall Study|Adverse Event|0
4716157|NCT02103439|16259099|P2|Overall Study|Withdrawal by Subject|1
4716158|NCT02103439|16259100|P1|Overall Study|Withdrawal by Subject|3
4716159|NCT02103439|16259099|P2|Overall Study|Adverse Event|2
4716160|NCT02103439|16259100|P1|Overall Study|Adverse Event|0
4716161|NCT02103062|16259259|P2|Overall Study|Death|1
4716162|NCT02103062|16259260|P1|Overall Study|Death|0
4716163|NCT02103062|16259259|P2|Overall Study|Progressive Disease|20
4716164|NCT02103062|16259260|P1|Overall Study|Progressive Disease|17
4716165|NCT02103062|16259259|P2|Overall Study|Adverse Event|2
4716166|NCT02103062|16259260|P1|Overall Study|Adverse Event|1
4716167|NCT02102724|16259353|P2|Overall Study|surgery for brain aneurysm|1
4716168|NCT02102724|16259354|P1|Overall Study|surgery for brain aneurysm|1
4716169|NCT02102724|16259353|P2|Overall Study|Lost to Follow-up|0
4716170|NCT02102724|16259354|P1|Overall Study|Lost to Follow-up|1
4716171|NCT02102490|16259360|P1|Overall Study|Lost to Follow-up|1
4716172|NCT02102490|16259360|P1|Overall Study|Death|6
4716173|NCT02102464|16259374|P3|Randomized Study|Withdrawal by Subject|0
4716174|NCT02102464|16259375|P2|Randomized Study|Withdrawal by Subject|1
4716175|NCT02102464|16259376|P1|Randomized Study|Withdrawal by Subject|0
4716176|NCT02102399|16259395|P2|Overall Study|Withdrawal by Subject|4
4716177|NCT02102399|16259396|P1|Overall Study|Withdrawal by Subject|6
4716178|NCT02102204|16259466|P1|Overall Study|Ongoing|5
4716179|NCT02102204|16259466|P1|Overall Study|Sponsor Decision|5
4716180|NCT02102204|16259466|P1|Overall Study|Lost to Follow-up|65
4716181|NCT02102204|16259466|P1|Overall Study|Death|92
4716182|NCT02102204|16259466|P1|Overall Study|Withdrawal by Subject|137
4716183|NCT02101983|16259486|P2|Overall Study|Physician Decision|0
4716184|NCT02101983|16259487|P1|Overall Study|Physician Decision|1
4716185|NCT02101554|16259533|P3|Overall Study|Withdrawl by Parents/Guardians|0
4716186|NCT02101554|16259534|P2|Overall Study|Withdrawl by Parents/Guardians|0
4716187|NCT02101554|16259535|P1|Overall Study|Withdrawl by Parents/Guardians|1
4716188|NCT02101554|16259533|P3|Overall Study|Lost to Follow-up|0
4716189|NCT02101554|16259534|P2|Overall Study|Lost to Follow-up|1
4716190|NCT02101554|16259535|P1|Overall Study|Lost to Follow-up|0
4716191|NCT02101554|16259533|P3|Overall Study|Adverse Event|1
4716192|NCT02101554|16259534|P2|Overall Study|Adverse Event|1
4716193|NCT02101554|16259535|P1|Overall Study|Adverse Event|2
4716194|NCT02101554|16259533|P3|Overall Study|Insufficient Clinical Response|0
4716195|NCT02101554|16259534|P2|Overall Study|Insufficient Clinical Response|2
4716196|NCT02101554|16259535|P1|Overall Study|Insufficient Clinical Response|0
4716197|NCT02101554|16259533|P3|Overall Study|Protocol Violation|0
4716198|NCT02101554|16259534|P2|Overall Study|Protocol Violation|1
4716199|NCT02101554|16259535|P1|Overall Study|Protocol Violation|0
4716200|NCT02101359|16259688|P2|Overall Study|Protocol Violation|2
4716201|NCT02101359|16259689|P1|Overall Study|Protocol Violation|0
4716202|NCT02101359|16259688|P2|Overall Study|Lost to Follow-up|0
4716203|NCT02101359|16259689|P1|Overall Study|Lost to Follow-up|1
4716204|NCT02101359|16259688|P2|Overall Study|Withdrawal by Subject|4
4716205|NCT02101359|16259689|P1|Overall Study|Withdrawal by Subject|5
4716206|NCT02101359|16259688|P2|Overall Study|Not included|13
4716207|NCT02101359|16259689|P1|Overall Study|Not included|23
4716208|NCT02101294|16259695|P1|Overall Study|Lost to Follow-up|6
4716209|NCT02101294|16259695|P1|Overall Study|Withdrawal by Subject|5
4716210|NCT02101281|16259704|P2|Overall Study|Adverse Event|1
4716211|NCT02101281|16259705|P1|Overall Study|Adverse Event|0
4716212|NCT02101112|16259758|P6|Overall Study|Withdrawal by Subject|0
4716213|NCT02101112|16259759|P5|Overall Study|Withdrawal by Subject|1
4716214|NCT02101112|16259760|P4|Overall Study|Withdrawal by Subject|0
4716215|NCT02101112|16259761|P3|Overall Study|Withdrawal by Subject|0
4716216|NCT02101112|16259762|P2|Overall Study|Withdrawal by Subject|0
4716217|NCT02101112|16259763|P1|Overall Study|Withdrawal by Subject|0
4716218|NCT02101112|16259758|P6|Overall Study|Adverse Event|0
4716219|NCT02101112|16259759|P5|Overall Study|Adverse Event|0
4716220|NCT02101112|16259760|P4|Overall Study|Adverse Event|0
4716221|NCT02101112|16259761|P3|Overall Study|Adverse Event|1
4716222|NCT02101112|16259762|P2|Overall Study|Adverse Event|0
4716223|NCT02101112|16259763|P1|Overall Study|Adverse Event|0
4716224|NCT02101021|16259793|P5|Overall Study|Study Terminated by Sponsor|1
4716225|NCT02101021|16259794|P4|Overall Study|Study Terminated by Sponsor|1
4716226|NCT02101021|16259795|P3|Overall Study|Study Terminated by Sponsor|1
4716227|NCT02101021|16259796|P2|Overall Study|Study Terminated by Sponsor|0
4716228|NCT02101021|16259797|P1|Overall Study|Study Terminated by Sponsor|1
4716229|NCT02101021|16259793|P5|Overall Study|Lost to Follow-up|0
4716230|NCT02101021|16259794|P4|Overall Study|Lost to Follow-up|0
4716231|NCT02101021|16259795|P3|Overall Study|Lost to Follow-up|0
4716232|NCT02101021|16259796|P2|Overall Study|Lost to Follow-up|0
4716233|NCT02101021|16259797|P1|Overall Study|Lost to Follow-up|1
4716234|NCT02101021|16259793|P5|Overall Study|Withdrew Consent from study|0
4716235|NCT02101021|16259794|P4|Overall Study|Withdrew Consent from study|2
4716236|NCT02101021|16259795|P3|Overall Study|Withdrew Consent from study|0
4716237|NCT02101021|16259796|P2|Overall Study|Withdrew Consent from study|1
4716238|NCT02101021|16259797|P1|Overall Study|Withdrew Consent from study|1
4716239|NCT02101021|16259793|P5|Overall Study|Death|3
4716240|NCT02101021|16259794|P4|Overall Study|Death|0
4716241|NCT02101021|16259795|P3|Overall Study|Death|6
4716242|NCT02101021|16259796|P2|Overall Study|Death|3
4716243|NCT02101021|16259797|P1|Overall Study|Death|4
4716244|NCT02100969|16259844|P1|Overall Study|Did not pass screening phase|1
4716245|NCT02100839|16259863|P2|Multiple Ascending Dose|Withdrawal by Subject|0
4716246|NCT02100839|16259864|P1|Multiple Ascending Dose|Withdrawal by Subject|2
4716247|NCT02100839|16259863|P2|Multiple Ascending Dose|Adverse Event|0
4716248|NCT02100839|16259864|P1|Multiple Ascending Dose|Adverse Event|2
4716249|NCT02100813|16259895|P8|Overall Study|Adverse Event|1
4716250|NCT02100813|16259896|P7|Overall Study|Adverse Event|0
4716251|NCT02100813|16259897|P6|Overall Study|Adverse Event|0
4716252|NCT02100813|16259898|P5|Overall Study|Adverse Event|0
4716253|NCT02100813|16259899|P4|Overall Study|Adverse Event|0
4716254|NCT02100813|16259900|P3|Overall Study|Adverse Event|0
4716255|NCT02100813|16259901|P2|Overall Study|Adverse Event|0
4716256|NCT02100813|16259902|P1|Overall Study|Adverse Event|0
4716257|NCT02100670|16259979|P4|Overall Study|Withdrawal by Subject|0
4716258|NCT02100670|16259980|P3|Overall Study|Withdrawal by Subject|0
4716259|NCT02100670|16259981|P2|Overall Study|Withdrawal by Subject|0
4716260|NCT02100670|16259982|P1|Overall Study|Withdrawal by Subject|1
4716261|NCT02100670|16259979|P4|Overall Study|Physician Decision|0
4716262|NCT02100670|16259980|P3|Overall Study|Physician Decision|0
4716263|NCT02100670|16259981|P2|Overall Study|Physician Decision|1
4716264|NCT02100670|16259982|P1|Overall Study|Physician Decision|0
4716265|NCT02100670|16259979|P4|Overall Study|Poor Efficacy|0
4716266|NCT02100670|16259980|P3|Overall Study|Poor Efficacy|0
4716267|NCT02100670|16259981|P2|Overall Study|Poor Efficacy|1
4716268|NCT02100670|16259982|P1|Overall Study|Poor Efficacy|0
4716269|NCT02100670|16259979|P4|Overall Study|No swelling no pain|0
4716270|NCT02100670|16259980|P3|Overall Study|No swelling no pain|0
4716271|NCT02100670|16259981|P2|Overall Study|No swelling no pain|0
4716272|NCT02100670|16259982|P1|Overall Study|No swelling no pain|1
4716273|NCT02100670|16259979|P4|Overall Study|Withdrawal of Consent|0
4716274|NCT02100670|16259980|P3|Overall Study|Withdrawal of Consent|1
4716275|NCT02100670|16259981|P2|Overall Study|Withdrawal of Consent|1
4716276|NCT02100670|16259982|P1|Overall Study|Withdrawal of Consent|0
4716277|NCT02100670|16259979|P4|Overall Study|Protocol Violation|1
4716278|NCT02100670|16259980|P3|Overall Study|Protocol Violation|0
4716279|NCT02100670|16259981|P2|Overall Study|Protocol Violation|1
4716280|NCT02100670|16259982|P1|Overall Study|Protocol Violation|0
4716281|NCT02100670|16259979|P4|Overall Study|Lost to Follow-up|0
4716282|NCT02100670|16259980|P3|Overall Study|Lost to Follow-up|0
4716283|NCT02100670|16259981|P2|Overall Study|Lost to Follow-up|0
4716284|NCT02100670|16259982|P1|Overall Study|Lost to Follow-up|1
4716285|NCT02100670|16259979|P4|Overall Study|Adverse Event|0
4716286|NCT02100670|16259980|P3|Overall Study|Adverse Event|3
4716287|NCT02100670|16259981|P2|Overall Study|Adverse Event|3
4716288|NCT02100670|16259982|P1|Overall Study|Adverse Event|10
4716289|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Withdrawal by Subject|3
4716290|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Withdrawal by Subject|0
4716291|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Withdrawal by Subject|0
4716292|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Treatment-related adverse event|3
4716293|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Treatment-related adverse event|0
4716294|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Treatment-related adverse event|0
4716295|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Never were treated|3
4716296|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Never were treated|0
4716297|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Never were treated|0
4716298|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Physician Decision|1
4716299|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Physician Decision|0
4716300|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Physician Decision|0
4716301|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Non-treatment related adverse event|1
4716302|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
4716303|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Non-treatment related adverse event|0
4716304|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Death|1
4716305|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Death|0
4716306|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Death|0
4716307|NCT02100657|16260045|P3|Cohort 3: Dose Level 3|Progressive disease|15
4716308|NCT02100657|16260046|P2|Cohort 3: Dose Level 3|Progressive disease|0
4716309|NCT02100657|16260047|P1|Cohort 3: Dose Level 3|Progressive disease|0
4716395|NCT02100228|16260244|P2|Overall Study|Administrative reason|1
4716310|NCT02100657|16260045|P3|Cohort 2: Dose Level 2|Treatment-related adverse event|0
4716311|NCT02100657|16260046|P2|Cohort 2: Dose Level 2|Treatment-related adverse event|1
4716312|NCT02100657|16260047|P1|Cohort 2: Dose Level 2|Treatment-related adverse event|0
4716313|NCT02100657|16260045|P3|Cohort 2: Dose Level 2|Physician Decision|0
4716314|NCT02100657|16260046|P2|Cohort 2: Dose Level 2|Physician Decision|1
4716315|NCT02100657|16260047|P1|Cohort 2: Dose Level 2|Physician Decision|0
4716316|NCT02100657|16260045|P3|Cohort 2: Dose Level 2|Progressive disease|0
4716317|NCT02100657|16260046|P2|Cohort 2: Dose Level 2|Progressive disease|2
4716318|NCT02100657|16260047|P1|Cohort 2: Dose Level 2|Progressive disease|0
4716319|NCT02100657|16260045|P3|Cohort 1: Dose Level 1|Withdrawal by Subject|0
4716320|NCT02100657|16260046|P2|Cohort 1: Dose Level 1|Withdrawal by Subject|0
4716321|NCT02100657|16260047|P1|Cohort 1: Dose Level 1|Withdrawal by Subject|1
4716322|NCT02100657|16260045|P3|Cohort 1: Dose Level 1|Treatment-related adverse event|0
4716323|NCT02100657|16260046|P2|Cohort 1: Dose Level 1|Treatment-related adverse event|0
4716324|NCT02100657|16260047|P1|Cohort 1: Dose Level 1|Treatment-related adverse event|1
4716325|NCT02100657|16260045|P3|Cohort 1: Dose Level 1|Progressive disease|0
4716326|NCT02100657|16260046|P2|Cohort 1: Dose Level 1|Progressive disease|0
4716327|NCT02100657|16260047|P1|Cohort 1: Dose Level 1|Progressive disease|6
4716328|NCT02100644|16260085|P3|LTG Escalation Phase|Withdrawal by Subject|0
4716329|NCT02100644|16260086|P2|LTG Escalation Phase|Withdrawal by Subject|0
4716330|NCT02100644|16260087|P1|LTG Escalation Phase|Withdrawal by Subject|3
4716331|NCT02100644|16260085|P3|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
4716332|NCT02100644|16260086|P2|LTG Escalation Phase|Protocol-defined Stopping Criteria|0
4716333|NCT02100644|16260087|P1|LTG Escalation Phase|Protocol-defined Stopping Criteria|1
4716334|NCT02100644|16260085|P3|LTG Escalation Phase|Adverse Event|0
4716335|NCT02100644|16260086|P2|LTG Escalation Phase|Adverse Event|0
4716336|NCT02100644|16260087|P1|LTG Escalation Phase|Adverse Event|9
4716337|NCT02100514|16260112|P5|Extension Period|Withdrew consent|0
4716338|NCT02100514|16260113|P4|Extension Period|Withdrew consent|0
4716339|NCT02100514|16260114|P3|Extension Period|Withdrew consent|2
4716340|NCT02100514|16260115|P2|Extension Period|Withdrew consent|0
4716341|NCT02100514|16260116|P1|Extension Period|Withdrew consent|0
4716342|NCT02100514|16260112|P5|Treatment Period|Other|0
4716343|NCT02100514|16260113|P4|Treatment Period|Other|0
4716344|NCT02100514|16260114|P3|Treatment Period|Other|0
4716345|NCT02100514|16260115|P2|Treatment Period|Other|11
4716346|NCT02100514|16260116|P1|Treatment Period|Other|9
4716347|NCT02100514|16260112|P5|Treatment Period|Withdrawal by Subject|0
4716348|NCT02100514|16260113|P4|Treatment Period|Withdrawal by Subject|0
4716349|NCT02100514|16260114|P3|Treatment Period|Withdrawal by Subject|0
4716350|NCT02100514|16260115|P2|Treatment Period|Withdrawal by Subject|37
4716351|NCT02100514|16260116|P1|Treatment Period|Withdrawal by Subject|12
4716352|NCT02100514|16260112|P5|Treatment Period|Protocol Violation|0
4716353|NCT02100514|16260113|P4|Treatment Period|Protocol Violation|0
4716354|NCT02100514|16260114|P3|Treatment Period|Protocol Violation|0
4716355|NCT02100514|16260115|P2|Treatment Period|Protocol Violation|1
4716356|NCT02100514|16260116|P1|Treatment Period|Protocol Violation|1
4716357|NCT02100514|16260112|P5|Treatment Period|Did Not Meet Entrance Criteria|0
4716358|NCT02100514|16260113|P4|Treatment Period|Did Not Meet Entrance Criteria|0
4716359|NCT02100514|16260114|P3|Treatment Period|Did Not Meet Entrance Criteria|0
4716360|NCT02100514|16260115|P2|Treatment Period|Did Not Meet Entrance Criteria|1
4716361|NCT02100514|16260116|P1|Treatment Period|Did Not Meet Entrance Criteria|0
4716362|NCT02100514|16260112|P5|Treatment Period|Lost to Follow-up|0
4716363|NCT02100514|16260113|P4|Treatment Period|Lost to Follow-up|0
4716364|NCT02100514|16260114|P3|Treatment Period|Lost to Follow-up|0
4716365|NCT02100514|16260115|P2|Treatment Period|Lost to Follow-up|17
4716366|NCT02100514|16260116|P1|Treatment Period|Lost to Follow-up|5
4716367|NCT02100514|16260112|P5|Treatment Period|Death|0
4716368|NCT02100514|16260113|P4|Treatment Period|Death|0
4716369|NCT02100514|16260114|P3|Treatment Period|Death|0
4716370|NCT02100514|16260115|P2|Treatment Period|Death|2
4716371|NCT02100514|16260116|P1|Treatment Period|Death|2
4716372|NCT02100514|16260112|P5|Treatment Period|Adverse Event|0
4716373|NCT02100514|16260113|P4|Treatment Period|Adverse Event|0
4716374|NCT02100514|16260114|P3|Treatment Period|Adverse Event|0
4716375|NCT02100514|16260115|P2|Treatment Period|Adverse Event|5
4716376|NCT02100514|16260116|P1|Treatment Period|Adverse Event|0
4716377|NCT02100475|16260184|P2|Overall Study|Withdrawal criteria|0
4716378|NCT02100475|16260185|P1|Overall Study|Withdrawal criteria|1
4716379|NCT02100475|16260184|P2|Overall Study|Unclassified|2
4716380|NCT02100475|16260185|P1|Overall Study|Unclassified|1
4716381|NCT02100319|16260216|P1|Overall Study|Protocol Deviation|5
4716382|NCT02100319|16260216|P1|Overall Study|Case Report Forms Uncollected|11
4716383|NCT02100228|16260244|P2|Overall Study|Death|1
4716384|NCT02100228|16260245|P1|Overall Study|Death|1
4716385|NCT02100228|16260244|P2|Overall Study|Adverse Event|12
4716386|NCT02100228|16260245|P1|Overall Study|Adverse Event|16
4716387|NCT02100228|16260244|P2|Overall Study|Withdrawal by Subject|37
4716388|NCT02100228|16260245|P1|Overall Study|Withdrawal by Subject|27
4716389|NCT02100228|16260244|P2|Overall Study|Lost to Follow-up|1
4716390|NCT02100228|16260245|P1|Overall Study|Lost to Follow-up|0
4716391|NCT02100228|16260244|P2|Overall Study|Non-compliance|3
4716392|NCT02100228|16260245|P1|Overall Study|Non-compliance|0
4716393|NCT02100228|16260244|P2|Overall Study|Inclusion/Exclusion criteria not met|16
4716394|NCT02100228|16260245|P1|Overall Study|Inclusion/Exclusion criteria not met|12
4716396|NCT02100228|16260245|P1|Overall Study|Administrative reason|0
4716397|NCT02100228|16260244|P2|Overall Study|Other|19
4716398|NCT02100228|16260245|P1|Overall Study|Other|19
4716399|NCT02100124|16260281|P3|Overall Study|Withdrawal by Subject|0
4716400|NCT02100124|16260282|P2|Overall Study|Withdrawal by Subject|0
4716401|NCT02100124|16260283|P1|Overall Study|Withdrawal by Subject|1
4716402|NCT02100124|16260281|P3|Overall Study|Lost to Follow-up|3
4716403|NCT02100124|16260282|P2|Overall Study|Lost to Follow-up|11
4716404|NCT02100124|16260283|P1|Overall Study|Lost to Follow-up|5
4716405|NCT02099838|16260313|P2|Overall Study|Withdrawal by Subject|1
4716406|NCT02099838|16260314|P1|Overall Study|Withdrawal by Subject|0
4716407|NCT02099838|16260313|P2|Overall Study|Lost to Follow-up|1
4716408|NCT02099838|16260314|P1|Overall Study|Lost to Follow-up|3
4716409|NCT02099838|16260313|P2|Overall Study|Death|0
4716410|NCT02099838|16260314|P1|Overall Study|Death|1
4716411|NCT02099708|16260359|P1|Overall Study|Other|29
4716412|NCT02099708|16260359|P1|Overall Study|Lost to Follow-up|141
4716413|NCT02099708|16260359|P1|Overall Study|Data Not Available|30
4716414|NCT02099682|16260370|P1|Overall Study|Other|29
4716415|NCT02099682|16260370|P1|Overall Study|Lost to Follow-up|31
4716416|NCT02099682|16260370|P1|Overall Study|Data Not Available|51
4716417|NCT02099344|16260396|P2|Overall Study|Physician Decision|0
4716418|NCT02099344|16260397|P1|Overall Study|Physician Decision|1
4716419|NCT02099110|16260434|P5|Overall Study|Physician Decision|1
4716420|NCT02099110|16260435|P4|Overall Study|Physician Decision|2
4716421|NCT02099110|16260436|P3|Overall Study|Physician Decision|1
4716422|NCT02099110|16260437|P2|Overall Study|Physician Decision|0
4716423|NCT02099110|16260438|P1|Overall Study|Physician Decision|3
4716424|NCT02099110|16260434|P5|Overall Study|Non-compliance with study drug|1
4716425|NCT02099110|16260435|P4|Overall Study|Non-compliance with study drug|0
4716426|NCT02099110|16260436|P3|Overall Study|Non-compliance with study drug|0
4716427|NCT02099110|16260437|P2|Overall Study|Non-compliance with study drug|0
4716428|NCT02099110|16260438|P1|Overall Study|Non-compliance with study drug|2
4716429|NCT02099110|16260434|P5|Overall Study|Screen failure|1
4716430|NCT02099110|16260435|P4|Overall Study|Screen failure|0
4716431|NCT02099110|16260436|P3|Overall Study|Screen failure|0
4716432|NCT02099110|16260437|P2|Overall Study|Screen failure|0
4716433|NCT02099110|16260438|P1|Overall Study|Screen failure|0
4716434|NCT02099110|16260434|P5|Overall Study|Death|0
4716435|NCT02099110|16260435|P4|Overall Study|Death|0
4716436|NCT02099110|16260436|P3|Overall Study|Death|0
4716437|NCT02099110|16260437|P2|Overall Study|Death|1
4716438|NCT02099110|16260438|P1|Overall Study|Death|0
4716439|NCT02099110|16260434|P5|Overall Study|Lost to Follow-up|6
4716440|NCT02099110|16260435|P4|Overall Study|Lost to Follow-up|5
4716441|NCT02099110|16260436|P3|Overall Study|Lost to Follow-up|11
4716442|NCT02099110|16260437|P2|Overall Study|Lost to Follow-up|12
4716443|NCT02099110|16260438|P1|Overall Study|Lost to Follow-up|6
4716444|NCT02099110|16260434|P5|Overall Study|Adverse Event|2
4716445|NCT02099110|16260435|P4|Overall Study|Adverse Event|3
4716446|NCT02099110|16260436|P3|Overall Study|Adverse Event|2
4716447|NCT02099110|16260437|P2|Overall Study|Adverse Event|5
4716448|NCT02099110|16260438|P1|Overall Study|Adverse Event|3
4716449|NCT02099110|16260434|P5|Overall Study|Withdrawal by Subject|13
4716450|NCT02099110|16260435|P4|Overall Study|Withdrawal by Subject|9
4716451|NCT02099110|16260436|P3|Overall Study|Withdrawal by Subject|13
4716452|NCT02099110|16260437|P2|Overall Study|Withdrawal by Subject|11
4716453|NCT02099110|16260438|P1|Overall Study|Withdrawal by Subject|7
4716454|NCT02099110|16260434|P5|Overall Study|Participant moved|2
4716455|NCT02099110|16260435|P4|Overall Study|Participant moved|0
4716456|NCT02099110|16260436|P3|Overall Study|Participant moved|1
4716457|NCT02099110|16260437|P2|Overall Study|Participant moved|1
4716458|NCT02099110|16260438|P1|Overall Study|Participant moved|1
4716459|NCT02099110|16260434|P5|Overall Study|Protocol Violation|1
4716460|NCT02099110|16260435|P4|Overall Study|Protocol Violation|3
4716461|NCT02099110|16260436|P3|Overall Study|Protocol Violation|0
4716462|NCT02099110|16260437|P2|Overall Study|Protocol Violation|1
4716463|NCT02099110|16260438|P1|Overall Study|Protocol Violation|2
4716464|NCT02098746|16260539|P1|Overall Study|Data Not Available After Treatment|1
4716465|NCT02098746|16260539|P1|Overall Study|Enrolled 15 Days After the First Dose|1
4716466|NCT02098746|16260539|P1|Overall Study|Other Miscellaneous Reasons|1
4716467|NCT02098746|16260539|P1|Overall Study|Changes of Investigator|2
4716468|NCT02098733|16260547|P1|Overall Study|Lost to Follow-up|5
4716469|NCT02098733|16260547|P1|Overall Study|Data Not Available|5
4716470|NCT02098395|16260561|P4|Overall Study|Unclassified|2
4716471|NCT02098395|16260562|P3|Overall Study|Unclassified|3
4716472|NCT02098395|16260563|P2|Overall Study|Unclassified|0
4716473|NCT02098395|16260564|P1|Overall Study|Unclassified|0
4716474|NCT02098395|16260561|P4|Overall Study|Lost to Follow-up|3
4716475|NCT02098395|16260562|P3|Overall Study|Lost to Follow-up|0
4716476|NCT02098395|16260563|P2|Overall Study|Lost to Follow-up|1
4716477|NCT02098395|16260564|P1|Overall Study|Lost to Follow-up|2
4716478|NCT02098395|16260561|P4|Overall Study|Adverse Event|2
4716479|NCT02098395|16260562|P3|Overall Study|Adverse Event|34
4716480|NCT02098395|16260563|P2|Overall Study|Adverse Event|19
4716481|NCT02098395|16260564|P1|Overall Study|Adverse Event|12
4716482|NCT02098395|16260561|P4|Overall Study|Withdrawal by Subject|13
4716483|NCT02098395|16260562|P3|Overall Study|Withdrawal by Subject|5
4716484|NCT02098395|16260563|P2|Overall Study|Withdrawal by Subject|10
4716485|NCT02098395|16260564|P1|Overall Study|Withdrawal by Subject|10
4716486|NCT02098395|16260561|P4|Overall Study|Protocol Violation|7
4716487|NCT02098395|16260562|P3|Overall Study|Protocol Violation|0
4716488|NCT02098395|16260563|P2|Overall Study|Protocol Violation|2
4716489|NCT02098395|16260564|P1|Overall Study|Protocol Violation|2
4716490|NCT02098369|16260585|P3|Overall Study|Other|1
4716491|NCT02098369|16260586|P2|Overall Study|Other|2
4716492|NCT02098369|16260587|P1|Overall Study|Other|0
4716493|NCT02098369|16260585|P3|Overall Study|Death|1
4716494|NCT02098369|16260586|P2|Overall Study|Death|1
4716495|NCT02098369|16260587|P1|Overall Study|Death|1
4716496|NCT02098369|16260585|P3|Overall Study|Lost to Follow-up|3
4716497|NCT02098369|16260586|P2|Overall Study|Lost to Follow-up|1
4716498|NCT02098369|16260587|P1|Overall Study|Lost to Follow-up|5
4716499|NCT02098369|16260585|P3|Overall Study|Withdrawal by Subject|0
4716500|NCT02098369|16260586|P2|Overall Study|Withdrawal by Subject|5
4716501|NCT02098369|16260587|P1|Overall Study|Withdrawal by Subject|1
4716502|NCT02098109|16260625|P2|Overall Study|Protocol Violation|0
4716503|NCT02098109|16260626|P1|Overall Study|Protocol Violation|3
4716504|NCT02097823|16260704|P2|Overall Study|Withdrawal by Subject|1
4716505|NCT02097823|16260705|P1|Overall Study|Withdrawal by Subject|1
4716506|NCT02097745|16260720|P1|Overall Study|Reason Not Specified|96
4716507|NCT02097745|16260720|P1|Overall Study|Administrative/Other|27
4716508|NCT02097745|16260720|P1|Overall Study|Failure to Return|14
4716509|NCT02097745|16260720|P1|Overall Study|Death|16
4716510|NCT02097745|16260720|P1|Overall Study|Adverse Event|25
4716511|NCT02097719|16260758|P2|Overall Study|Adverse Event|0
4716512|NCT02097719|16260759|P1|Overall Study|Adverse Event|2
4716513|NCT02097719|16260758|P2|Overall Study|Lost to Follow-up|1
4716514|NCT02097719|16260759|P1|Overall Study|Lost to Follow-up|0
4716515|NCT02097719|16260758|P2|Overall Study|Subject Withdrew Consent|0
4716516|NCT02097719|16260759|P1|Overall Study|Subject Withdrew Consent|1
4716517|NCT02097472|16260824|P8|Received Vaccination 2|Adverse Event|0
4716518|NCT02097472|16260825|P7|Received Vaccination 2|Adverse Event|1
4716519|NCT02097472|16260826|P6|Received Vaccination 2|Adverse Event|0
4716520|NCT02097472|16260827|P5|Received Vaccination 2|Adverse Event|0
4716521|NCT02097472|16260828|P4|Received Vaccination 2|Adverse Event|0
4716522|NCT02097472|16260829|P3|Received Vaccination 2|Adverse Event|0
4716523|NCT02097472|16260830|P2|Received Vaccination 2|Adverse Event|0
4716524|NCT02097472|16260831|P1|Received Vaccination 2|Adverse Event|0
4716525|NCT02097420|16261252|P1|Overall Study|Not reached 12-month visit|7
4716526|NCT02097420|16261252|P1|Overall Study|Device explanted|3
4716527|NCT02097420|16261252|P1|Overall Study|Death|4
4716528|NCT02097290|16261275|P1|Overall Study|Attempt|8
4716529|NCT02097290|16261275|P1|Overall Study|Total Withdrawals|3
4716530|NCT02097290|16261275|P1|Overall Study|Death|6
4716531|NCT02097277|16261290|P5|Overall Study|Adverse Event|0
4716532|NCT02097277|16261291|P4|Overall Study|Adverse Event|2
4716533|NCT02097277|16261292|P3|Overall Study|Adverse Event|1
4716534|NCT02097277|16261293|P2|Overall Study|Adverse Event|0
4716535|NCT02097277|16261294|P1|Overall Study|Adverse Event|0
4716536|NCT02097277|16261290|P5|Overall Study|Withdrawal by Subject|0
4716537|NCT02097277|16261291|P4|Overall Study|Withdrawal by Subject|1
4716538|NCT02097277|16261292|P3|Overall Study|Withdrawal by Subject|0
4716539|NCT02097277|16261293|P2|Overall Study|Withdrawal by Subject|1
4716540|NCT02097277|16261294|P1|Overall Study|Withdrawal by Subject|2
4716541|NCT02097277|16261290|P5|Overall Study|Lost to Follow-up|0
4716542|NCT02097277|16261291|P4|Overall Study|Lost to Follow-up|0
4716543|NCT02097277|16261292|P3|Overall Study|Lost to Follow-up|1
4716544|NCT02097277|16261293|P2|Overall Study|Lost to Follow-up|1
4716545|NCT02097277|16261294|P1|Overall Study|Lost to Follow-up|0
4716546|NCT02097277|16261290|P5|Overall Study|Subject request to discontinue treatment|1
4716547|NCT02097277|16261291|P4|Overall Study|Subject request to discontinue treatment|0
4716548|NCT02097277|16261292|P3|Overall Study|Subject request to discontinue treatment|0
4716549|NCT02097277|16261293|P2|Overall Study|Subject request to discontinue treatment|0
4716550|NCT02097277|16261294|P1|Overall Study|Subject request to discontinue treatment|0
4716551|NCT02097277|16261290|P5|Overall Study|Subject no longer meets study criteria|0
4716552|NCT02097277|16261291|P4|Overall Study|Subject no longer meets study criteria|1
4716553|NCT02097277|16261292|P3|Overall Study|Subject no longer meets study criteria|0
4716554|NCT02097277|16261293|P2|Overall Study|Subject no longer meets study criteria|1
4716555|NCT02097277|16261294|P1|Overall Study|Subject no longer meets study criteria|0
4716556|NCT02097238|16261377|P1|Overall Study|Progressive Disease|17
4716557|NCT02097238|16261377|P1|Overall Study|Physician Decision|1
4716558|NCT02097238|16261377|P1|Overall Study|Death|1
4716559|NCT02097134|16261386|P1|Overall Study|Refusal of Further Protocol Therapy|1
4716560|NCT02097134|16261386|P1|Overall Study|Progressive Disease|3
4716561|NCT02097134|16261386|P1|Overall Study|Non-Protocol Therapy|1
4716562|NCT02097134|16261386|P1|Overall Study|Physician Decision|4
4716563|NCT02097108|16261394|P1|Overall Study|patient was abroad for 6 months|1
4716564|NCT02097108|16261394|P1|Overall Study|Adverse Event|1
4716565|NCT02097056|16261401|P1|Overall Study|Other|2
4716566|NCT02097056|16261401|P1|Overall Study|Adverse Event|37
4716567|NCT02097056|16261401|P1|Overall Study|Lost to Follow-up|2
4716568|NCT02097056|16261401|P1|Overall Study|Withdrawal by Subject|15
4716569|NCT02097056|16261401|P1|Overall Study|Protocol Violation|2
4716570|NCT02097030|16261409|P2|First Intervention (3 Days)|Visual Acuity|1
4716571|NCT02097030|16261410|P1|First Intervention (3 Days)|Visual Acuity|0
4716572|NCT02097030|16261409|P2|First Intervention (3 Days)|Lost to Follow-up|0
4716573|NCT02097030|16261410|P1|First Intervention (3 Days)|Lost to Follow-up|1
4716574|NCT02096952|16261471|P1|Overall Study|Adverse Event|1
4716575|NCT02096900|16261477|P2|Overall Study|Surgery cancelled- medication received|1
4716576|NCT02096900|16261478|P1|Overall Study|Surgery cancelled- medication received|1
4716577|NCT02096900|16261477|P2|Overall Study|Did not receive medication|1
4716578|NCT02096900|16261478|P1|Overall Study|Did not receive medication|3
4716579|NCT02096835|16261530|P3|Overall Study|Lost to Follow-up|1
4716580|NCT02096835|16261531|P2|Overall Study|Lost to Follow-up|0
4716581|NCT02096835|16261532|P1|Overall Study|Lost to Follow-up|1
4716582|NCT02096835|16261530|P3|Overall Study|converted to open procedures|0
4716583|NCT02096835|16261531|P2|Overall Study|converted to open procedures|0
4716584|NCT02096835|16261532|P1|Overall Study|converted to open procedures|1
4716585|NCT02096835|16261530|P3|Overall Study|Withdrawal by Subject|0
4716586|NCT02096835|16261531|P2|Overall Study|Withdrawal by Subject|0
4716587|NCT02096835|16261532|P1|Overall Study|Withdrawal by Subject|1
4716588|NCT02096744|16261549|P2|Treatment Period 3 (7 Days)|Withdrawal by Subject|1
4716589|NCT02096744|16261550|P1|Treatment Period 3 (7 Days)|Withdrawal by Subject|0
4716590|NCT02096744|16261549|P2|Treatment Period 1(7 Days)|Non compliance with the site rule|0
4716591|NCT02096744|16261550|P1|Treatment Period 1(7 Days)|Non compliance with the site rule|1
4716592|NCT02096744|16261549|P2|Treatment Period 1(7 Days)|Accidental early removal of the patch|1
4716593|NCT02096744|16261550|P1|Treatment Period 1(7 Days)|Accidental early removal of the patch|0
4716594|NCT02096705|16261604|P2|Follow-up|Subjects not reporting status|2
4716595|NCT02096705|16261605|P1|Follow-up|Subjects not reporting status|1
4716596|NCT02096705|16261604|P2|Follow-up|Adverse Event|2
4716597|NCT02096705|16261605|P1|Follow-up|Adverse Event|2
4716598|NCT02096705|16261604|P2|Follow-up|Withdrawal by Subject|0
4716599|NCT02096705|16261605|P1|Follow-up|Withdrawal by Subject|1
4716600|NCT02096705|16261604|P2|Treatment|Other|1
4716601|NCT02096705|16261605|P1|Treatment|Other|1
4716602|NCT02096705|16261604|P2|Treatment|Withdrawal by Subject|0
4716603|NCT02096705|16261605|P1|Treatment|Withdrawal by Subject|1
4716604|NCT02096705|16261604|P2|Treatment|Subject request to discontinue treatment|1
4716605|NCT02096705|16261605|P1|Treatment|Subject request to discontinue treatment|1
4716606|NCT02096705|16261604|P2|Treatment|Adverse Event|3
4716607|NCT02096705|16261605|P1|Treatment|Adverse Event|6
4716608|NCT02096588|16261648|P2|Overall Study|Withdrawal by Subject|1
4716609|NCT02096588|16261649|P1|Overall Study|Withdrawal by Subject|0
4716610|NCT02096588|16261648|P2|Overall Study|Lack of Efficacy|0
4716611|NCT02096588|16261649|P1|Overall Study|Lack of Efficacy|2
4716612|NCT02096471|16261675|P1|Overall Study|Non-Compliant|2
4716613|NCT02096471|16261675|P1|Overall Study|Withdrawal by Subject|3
4716614|NCT02096471|16261675|P1|Overall Study|Lack of Efficacy|7
4716615|NCT02096471|16261675|P1|Overall Study|Adverse Event|1
4716616|NCT02096263|16261693|P3|Overall Study|Withdrawal by Subject|8
4716617|NCT02096263|16261694|P2|Overall Study|Withdrawal by Subject|7
4716618|NCT02096263|16261695|P1|Overall Study|Withdrawal by Subject|5
4716619|NCT02096263|16261693|P3|Overall Study|Protocol Violation|8
4716620|NCT02096263|16261694|P2|Overall Study|Protocol Violation|2
4716621|NCT02096263|16261695|P1|Overall Study|Protocol Violation|7
4716622|NCT02096263|16261693|P3|Overall Study|Sponsor study termination|1
4716623|NCT02096263|16261694|P2|Overall Study|Sponsor study termination|0
4716624|NCT02096263|16261695|P1|Overall Study|Sponsor study termination|0
4716625|NCT02096263|16261693|P3|Overall Study|Other|6
4716626|NCT02096263|16261694|P2|Overall Study|Other|9
4716627|NCT02096263|16261695|P1|Overall Study|Other|7
4716628|NCT02096263|16261693|P3|Overall Study|Lost to Follow-up|15
4716629|NCT02096263|16261694|P2|Overall Study|Lost to Follow-up|18
4716630|NCT02096263|16261695|P1|Overall Study|Lost to Follow-up|14
4716631|NCT02096263|16261693|P3|Overall Study|Adverse Event|1
4716632|NCT02096263|16261694|P2|Overall Study|Adverse Event|0
4716633|NCT02096263|16261695|P1|Overall Study|Adverse Event|1
4716634|NCT02096042|16261883|P3|Overall Study|Disease Progression|0
4716635|NCT02096042|16261884|P2|Overall Study|Disease Progression|0
4716636|NCT02096042|16261885|P1|Overall Study|Disease Progression|1
4716637|NCT02096003|16261907|P2|Overall Study|additional surgery|1
4716638|NCT02096003|16261908|P1|Overall Study|additional surgery|2
4716639|NCT02096003|16261907|P2|Overall Study|Protocol Violation|2
4716640|NCT02096003|16261908|P1|Overall Study|Protocol Violation|0
4716641|NCT02095951|16261924|P2|Overall Study|NO POSITIVE BLOOD CULTURE|6
4716642|NCT02095951|16261925|P1|Overall Study|NO POSITIVE BLOOD CULTURE|9
4716643|NCT02095873|16261945|P2|Second Intervention (8 Weeks)|Protocol Violation|0
4716644|NCT02095873|16261946|P1|Second Intervention (8 Weeks)|Protocol Violation|1
4716645|NCT02095873|16261945|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
4716646|NCT02095873|16261946|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
4716647|NCT02095873|16261945|P2|First Intervention (8 Weeks)|Withdrawal by Subject|0
4716648|NCT02095873|16261946|P1|First Intervention (8 Weeks)|Withdrawal by Subject|1
4716649|NCT02095691|16261958|P1|Overall Study|Physician Decision|1
4716650|NCT02095535|16261990|P1|Recruitment|Protocol Violation|2
4716651|NCT02095223|16262012|P2|Overall Study|Withdrawal by Subject|0
4716652|NCT02095223|16262013|P1|Overall Study|Withdrawal by Subject|1
4716653|NCT02095197|16262023|P2|Overall Study|Lost to Follow-up|3
4716654|NCT02095197|16262024|P1|Overall Study|Lost to Follow-up|0
4716655|NCT02095158|16262036|P1|Overall Study|Other Miscellaneous Reasons|1
4716656|NCT02095158|16262036|P1|Overall Study|Protocol Violation|1
4716657|NCT02095158|16262036|P1|Overall Study|Personal Reasons|35
4716658|NCT02095158|16262036|P1|Overall Study|Lost to Follow-up|20
4716659|NCT02095158|16262036|P1|Overall Study|Pregnancy|1
4716660|NCT02095158|16262036|P1|Overall Study|Lack of Efficacy|3
4716661|NCT02095158|16262036|P1|Overall Study|Adverse Event|14
4716662|NCT02095145|16262043|P2|Overall Study|Withdrawal by Subject|0
4716663|NCT02095145|16262044|P1|Overall Study|Withdrawal by Subject|1
4716664|NCT02095106|16262090|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
4716665|NCT02095106|16262091|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
4716666|NCT02094937|16262107|P4|12 Weeks in Period 2|Randomized incorrectly|0
4716667|NCT02094937|16262108|P3|12 Weeks in Period 2|Randomized incorrectly|0
4716668|NCT02094937|16262109|P2|12 Weeks in Period 2|Randomized incorrectly|1
4716669|NCT02094937|16262110|P1|12 Weeks in Period 2|Randomized incorrectly|0
4716670|NCT02094937|16262107|P4|12 Weeks in Period 2|Withdrawal by Subject|0
4716671|NCT02094937|16262108|P3|12 Weeks in Period 2|Withdrawal by Subject|2
4716672|NCT02094937|16262109|P2|12 Weeks in Period 2|Withdrawal by Subject|2
4716673|NCT02094937|16262110|P1|12 Weeks in Period 2|Withdrawal by Subject|0
4716674|NCT02094937|16262107|P4|12 Weeks in Period 2|Protocol defined stopping criteria|11
4716675|NCT02094937|16262108|P3|12 Weeks in Period 2|Protocol defined stopping criteria|6
4716676|NCT02094937|16262109|P2|12 Weeks in Period 2|Protocol defined stopping criteria|5
4716677|NCT02094937|16262110|P1|12 Weeks in Period 2|Protocol defined stopping criteria|0
4716678|NCT02094937|16262107|P4|12 Weeks in Period 2|Lack of Efficacy|0
4716679|NCT02094937|16262108|P3|12 Weeks in Period 2|Lack of Efficacy|0
4716680|NCT02094937|16262109|P2|12 Weeks in Period 2|Lack of Efficacy|1
4716681|NCT02094937|16262110|P1|12 Weeks in Period 2|Lack of Efficacy|0
4716682|NCT02094937|16262107|P4|12 Weeks in Period 2|Adverse Event|1
4716683|NCT02094937|16262108|P3|12 Weeks in Period 2|Adverse Event|4
4716684|NCT02094937|16262109|P2|12 Weeks in Period 2|Adverse Event|2
4716685|NCT02094937|16262110|P1|12 Weeks in Period 2|Adverse Event|0
4716686|NCT02094937|16262107|P4|8 Weeks in Period 1|Withdrawal by Subject|0
4716687|NCT02094937|16262108|P3|8 Weeks in Period 1|Withdrawal by Subject|0
4716688|NCT02094937|16262109|P2|8 Weeks in Period 1|Withdrawal by Subject|0
4716689|NCT02094937|16262110|P1|8 Weeks in Period 1|Withdrawal by Subject|4
4716690|NCT02094937|16262107|P4|8 Weeks in Period 1|Physician Decision|0
4716691|NCT02094937|16262108|P3|8 Weeks in Period 1|Physician Decision|0
4716692|NCT02094937|16262109|P2|8 Weeks in Period 1|Physician Decision|0
4716693|NCT02094937|16262110|P1|8 Weeks in Period 1|Physician Decision|1
4716694|NCT02094937|16262107|P4|8 Weeks in Period 1|Protocol defined stopping criteria|0
4716695|NCT02094937|16262108|P3|8 Weeks in Period 1|Protocol defined stopping criteria|0
4716696|NCT02094937|16262109|P2|8 Weeks in Period 1|Protocol defined stopping criteria|0
4716697|NCT02094937|16262110|P1|8 Weeks in Period 1|Protocol defined stopping criteria|41
4716698|NCT02094937|16262107|P4|8 Weeks in Period 1|Protocol Violation|0
4716699|NCT02094937|16262108|P3|8 Weeks in Period 1|Protocol Violation|0
4716700|NCT02094937|16262109|P2|8 Weeks in Period 1|Protocol Violation|0
4716701|NCT02094937|16262110|P1|8 Weeks in Period 1|Protocol Violation|2
4716702|NCT02094937|16262107|P4|8 Weeks in Period 1|Lack of Efficacy|0
4716703|NCT02094937|16262108|P3|8 Weeks in Period 1|Lack of Efficacy|0
4716704|NCT02094937|16262109|P2|8 Weeks in Period 1|Lack of Efficacy|0
4716705|NCT02094937|16262110|P1|8 Weeks in Period 1|Lack of Efficacy|3
4716706|NCT02094937|16262107|P4|8 Weeks in Period 1|Adverse Event|0
4716707|NCT02094937|16262108|P3|8 Weeks in Period 1|Adverse Event|0
4716708|NCT02094937|16262109|P2|8 Weeks in Period 1|Adverse Event|0
4716709|NCT02094937|16262110|P1|8 Weeks in Period 1|Adverse Event|9
4716710|NCT02094898|16262140|P1|Overall Study|Lack of Efficacy|1
4716711|NCT02094898|16262140|P1|Overall Study|Adverse Event|2
4716712|NCT02094898|16262140|P1|Overall Study|Clinical Worsening|2
4716713|NCT02094885|16262187|P2|Overall Study|Withdrawn due to age|0
4716714|NCT02094885|16262188|P1|Overall Study|Withdrawn due to age|1
4716715|NCT02094885|16262187|P2|Overall Study|Death|5
4716716|NCT02094885|16262188|P1|Overall Study|Death|1
4716717|NCT02094677|16262211|P2|Overall Study|Screening|1
4716718|NCT02094677|16262212|P1|Overall Study|Screening|3
4716719|NCT02094612|16262291|P2|Overall Study|Never started ADHD medication|23
4716720|NCT02094612|16262292|P1|Overall Study|Never started ADHD medication|32
4716721|NCT02094612|16262291|P2|Overall Study|Lost to Follow-up|47
4716722|NCT02094612|16262292|P1|Overall Study|Lost to Follow-up|47
4716723|NCT02094573|16262312|P2|Overall Study|Ongoing|76
4716724|NCT02094573|16262313|P1|Overall Study|Ongoing|64
4716725|NCT02094573|16262312|P2|Overall Study|Randomized but not treated|0
4716726|NCT02094573|16262313|P1|Overall Study|Randomized but not treated|3
4716727|NCT02094573|16262312|P2|Overall Study|Withdrawal by Subject|4
4716728|NCT02094573|16262313|P1|Overall Study|Withdrawal by Subject|2
4716729|NCT02094573|16262312|P2|Overall Study|Non-compliance with study drug|1
4716730|NCT02094573|16262313|P1|Overall Study|Non-compliance with study drug|0
4716731|NCT02094573|16262312|P2|Overall Study|Death|1
4716732|NCT02094573|16262313|P1|Overall Study|Death|7
4716733|NCT02094573|16262312|P2|Overall Study|Adverse Event|9
4716734|NCT02094573|16262313|P1|Overall Study|Adverse Event|3
4716735|NCT02094573|16262312|P2|Overall Study|Clinical Progressive Disease|3
4716736|NCT02094573|16262313|P1|Overall Study|Clinical Progressive Disease|4
4716737|NCT02094573|16262312|P2|Overall Study|Documented Progressive Disease|16
4716738|NCT02094573|16262313|P1|Overall Study|Documented Progressive Disease|29
4716739|NCT02094300|16262395|P1|Overall Study|Still be eligible for follow-up|3
4716740|NCT02094300|16262395|P1|Overall Study|Lost to Follow-up|10
4716741|NCT02094300|16262395|P1|Overall Study|Death|7
4716742|NCT02094261|16262399|P1|Overall Study|Ongoing Study at Data Cut-off|181
4716743|NCT02094261|16262399|P1|Overall Study|Withdrawal by Subject|4
4716744|NCT02094261|16262399|P1|Overall Study|Lost to Follow-up|1
4716745|NCT02094261|16262399|P1|Overall Study|Death|24
4716746|NCT02093923|16262441|P5|Overall Study|Screen failure after randomization|0
4716747|NCT02093923|16262442|P4|Overall Study|Screen failure after randomization|1
4716748|NCT02093923|16262443|P3|Overall Study|Screen failure after randomization|0
4716749|NCT02093923|16262444|P2|Overall Study|Screen failure after randomization|0
4716750|NCT02093923|16262445|P1|Overall Study|Screen failure after randomization|0
4716751|NCT02093923|16262441|P5|Overall Study|Lost to Follow-up|0
4716752|NCT02093923|16262442|P4|Overall Study|Lost to Follow-up|1
4716753|NCT02093923|16262443|P3|Overall Study|Lost to Follow-up|0
4716754|NCT02093923|16262444|P2|Overall Study|Lost to Follow-up|0
4716755|NCT02093923|16262445|P1|Overall Study|Lost to Follow-up|0
4716756|NCT02093897|16262500|P1|Overall Study|Adverse event, non-fatal|1
4716757|NCT02093897|16262500|P1|Overall Study|Planned age group closure - no's reached|17
4716758|NCT02093897|16262500|P1|Overall Study|Physician Decision|1
4716759|NCT02093689|16262616|P3|Overall Study|Physician Decision|0
4716760|NCT02093689|16262617|P2|Overall Study|Physician Decision|0
4716761|NCT02093689|16262618|P1|Overall Study|Physician Decision|4
4716762|NCT02093663|16262624|P5|Double Blind Maintenance Phase(26 Weeks)|Missing|1
4716763|NCT02093663|16262625|P4|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4716764|NCT02093663|16262626|P3|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4716765|NCT02093663|16262627|P2|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4716766|NCT02093663|16262628|P1|Double Blind Maintenance Phase(26 Weeks)|Missing|0
4716767|NCT02093663|16262624|P5|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
4716768|NCT02093663|16262625|P4|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1
4716769|NCT02093663|16262626|P3|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
4716770|NCT02093663|16262627|P2|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
4716771|NCT02093663|16262628|P1|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0
4716772|NCT02093663|16262624|P5|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7
4716773|NCT02093663|16262625|P4|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6
4716774|NCT02093663|16262626|P3|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
4716775|NCT02093663|16262627|P2|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
4716776|NCT02093663|16262628|P1|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0
4716777|NCT02093663|16262624|P5|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2
4716778|NCT02093663|16262625|P4|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3
4716779|NCT02093663|16262626|P3|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
4716780|NCT02093663|16262627|P2|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
4716781|NCT02093663|16262628|P1|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0
4716782|NCT02093663|16262624|P5|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4716783|NCT02093663|16262625|P4|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4716784|NCT02093663|16262626|P3|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5
4716785|NCT02093663|16262627|P2|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4716786|NCT02093663|16262628|P1|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0
4716787|NCT02093663|16262624|P5|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4716788|NCT02093663|16262625|P4|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4716789|NCT02093663|16262626|P3|Open Label Acute Phase (8 Weeks)|Adverse Event|1
4716790|NCT02093663|16262627|P2|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4716791|NCT02093663|16262628|P1|Open Label Acute Phase (8 Weeks)|Adverse Event|0
4716792|NCT02093663|16262624|P5|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
4716793|NCT02093663|16262625|P4|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
4716794|NCT02093663|16262626|P3|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0
4716795|NCT02093663|16262627|P2|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4
4716796|NCT02093663|16262628|P1|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2
4716797|NCT02093663|16262624|P5|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4716798|NCT02093663|16262625|P4|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4716799|NCT02093663|16262626|P3|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4716800|NCT02093663|16262627|P2|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0
4716801|NCT02093663|16262628|P1|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5
4716802|NCT02093663|16262624|P5|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4716803|NCT02093663|16262625|P4|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4716804|NCT02093663|16262626|P3|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4716805|NCT02093663|16262627|P2|Double Blind Acute Phase (8 Weeks)|Adverse Event|0
4716806|NCT02093663|16262628|P1|Double Blind Acute Phase (8 Weeks)|Adverse Event|1
4716807|NCT02093520|16262657|P2|Overall Study|Not treated|22
4716808|NCT02093520|16262658|P1|Overall Study|Not treated|6
4716809|NCT02093390|16262670|P2|Overall Study|Withdrawal by Subject|1
4716810|NCT02093390|16262671|P1|Overall Study|Withdrawal by Subject|0
4716811|NCT02093351|16262710|P4|Part B|Death|1
4716812|NCT02093351|16262711|P3|Part B|Death|0
4716813|NCT02093351|16262712|P2|Part B|Death|0
4716814|NCT02093351|16262713|P1|Part B|Death|0
4716815|NCT02093351|16262710|P4|Part B|Adverse Event|2
4716816|NCT02093351|16262711|P3|Part B|Adverse Event|0
4716817|NCT02093351|16262712|P2|Part B|Adverse Event|0
4716818|NCT02093351|16262713|P1|Part B|Adverse Event|0
4716819|NCT02093351|16262710|P4|Part B|Condition under investigation worsened|39
4716820|NCT02093351|16262711|P3|Part B|Condition under investigation worsened|0
4716821|NCT02093351|16262712|P2|Part B|Condition under investigation worsened|0
4716822|NCT02093351|16262713|P1|Part B|Condition under investigation worsened|0
4716823|NCT02093351|16262710|P4|Part B|Lack of therapeutic response|12
4716824|NCT02093351|16262711|P3|Part B|Lack of therapeutic response|0
4716825|NCT02093351|16262712|P2|Part B|Lack of therapeutic response|0
4716826|NCT02093351|16262713|P1|Part B|Lack of therapeutic response|0
4716827|NCT02093351|16262710|P4|Part B|Adverse event + disease progression|1
4716828|NCT02093351|16262711|P3|Part B|Adverse event + disease progression|0
4716829|NCT02093351|16262712|P2|Part B|Adverse event + disease progression|0
4716830|NCT02093351|16262713|P1|Part B|Adverse event + disease progression|0
4716831|NCT02093351|16262710|P4|Part B|Complete response|1
4716832|NCT02093351|16262711|P3|Part B|Complete response|0
4716833|NCT02093351|16262712|P2|Part B|Complete response|0
4716834|NCT02093351|16262713|P1|Part B|Complete response|0
4716835|NCT02093351|16262710|P4|Part B|Disease progression|4
4716836|NCT02093351|16262711|P3|Part B|Disease progression|0
4716837|NCT02093351|16262712|P2|Part B|Disease progression|0
4716838|NCT02093351|16262713|P1|Part B|Disease progression|0
4716839|NCT02093351|16262710|P4|Part B|Patient decision|3
4716840|NCT02093351|16262711|P3|Part B|Patient decision|0
4716841|NCT02093351|16262712|P2|Part B|Patient decision|0
4716842|NCT02093351|16262713|P1|Part B|Patient decision|0
4716843|NCT02093351|16262710|P4|Part A|Death|0
4716844|NCT02093351|16262711|P3|Part A|Death|0
4716845|NCT02093351|16262712|P2|Part A|Death|1
4716846|NCT02093351|16262713|P1|Part A|Death|0
4716847|NCT02093351|16262710|P4|Part A|Condition under investigation worsened|0
4716848|NCT02093351|16262711|P3|Part A|Condition under investigation worsened|2
4716849|NCT02093351|16262712|P2|Part A|Condition under investigation worsened|0
4716850|NCT02093351|16262713|P1|Part A|Condition under investigation worsened|2
4716851|NCT02093351|16262710|P4|Part A|Adverse Event|0
4716852|NCT02093351|16262711|P3|Part A|Adverse Event|1
4716853|NCT02093351|16262712|P2|Part A|Adverse Event|1
4716854|NCT02093351|16262713|P1|Part A|Adverse Event|0
4716855|NCT02093221|16262770|P5|Overall Study|Study termination|7
4716856|NCT02093221|16262771|P4|Overall Study|Study termination|6
4716857|NCT02093221|16262772|P3|Overall Study|Study termination|4
4716858|NCT02093221|16262773|P2|Overall Study|Study termination|5
4716859|NCT02093221|16262774|P1|Overall Study|Study termination|6
4716860|NCT02093221|16262770|P5|Overall Study|Protocol Violation|0
4716861|NCT02093221|16262771|P4|Overall Study|Protocol Violation|0
4716862|NCT02093221|16262772|P3|Overall Study|Protocol Violation|0
4716863|NCT02093221|16262773|P2|Overall Study|Protocol Violation|1
4716864|NCT02093221|16262774|P1|Overall Study|Protocol Violation|0
4716865|NCT02093221|16262770|P5|Overall Study|Death|0
4716866|NCT02093221|16262771|P4|Overall Study|Death|0
4716867|NCT02093221|16262772|P3|Overall Study|Death|0
4716868|NCT02093221|16262773|P2|Overall Study|Death|1
4716869|NCT02093221|16262774|P1|Overall Study|Death|0
4716870|NCT02093221|16262770|P5|Overall Study|Lost to Follow-up|0
4716871|NCT02093221|16262771|P4|Overall Study|Lost to Follow-up|1
4716872|NCT02093221|16262772|P3|Overall Study|Lost to Follow-up|1
4716873|NCT02093221|16262773|P2|Overall Study|Lost to Follow-up|0
4716874|NCT02093221|16262774|P1|Overall Study|Lost to Follow-up|2
4716875|NCT02093221|16262770|P5|Overall Study|Withdrawal by Subject|1
4716876|NCT02093221|16262771|P4|Overall Study|Withdrawal by Subject|1
4716877|NCT02093221|16262772|P3|Overall Study|Withdrawal by Subject|4
4716878|NCT02093221|16262773|P2|Overall Study|Withdrawal by Subject|1
4716879|NCT02093221|16262774|P1|Overall Study|Withdrawal by Subject|1
4716880|NCT02093221|16262770|P5|Overall Study|Adverse Event|0
4716881|NCT02093221|16262771|P4|Overall Study|Adverse Event|0
4716882|NCT02093221|16262772|P3|Overall Study|Adverse Event|0
4716883|NCT02093221|16262773|P2|Overall Study|Adverse Event|0
4716884|NCT02093221|16262774|P1|Overall Study|Adverse Event|1
4716885|NCT02093026|16262811|P1|Overall Study|Other|157
4716886|NCT02093026|16262811|P1|Overall Study|Death|10
4716887|NCT02093026|16262811|P1|Overall Study|Adverse Event|26
4716888|NCT02092961|16262833|P3|Overall Study|Adverse Event|0
4716889|NCT02092961|16262834|P2|Overall Study|Adverse Event|4
4716890|NCT02092961|16262835|P1|Overall Study|Adverse Event|2
4716891|NCT02092961|16262833|P3|Overall Study|Dev. of study specific discont. criteria|0
4716892|NCT02092961|16262834|P2|Overall Study|Dev. of study specific discont. criteria|0
4716893|NCT02092961|16262835|P1|Overall Study|Dev. of study specific discont. criteria|3
4716894|NCT02092961|16262833|P3|Overall Study|Lack of therapeutic response|3
4716895|NCT02092961|16262834|P2|Overall Study|Lack of therapeutic response|1
4716896|NCT02092961|16262835|P1|Overall Study|Lack of therapeutic response|2
4716897|NCT02092961|16262833|P3|Overall Study|Study stopped|12
4716898|NCT02092961|16262834|P2|Overall Study|Study stopped|9
4716899|NCT02092961|16262835|P1|Overall Study|Study stopped|13
4716900|NCT02092961|16262833|P3|Overall Study|Not reported|1
4716901|NCT02092961|16262834|P2|Overall Study|Not reported|0
4716902|NCT02092961|16262835|P1|Overall Study|Not reported|1
4716903|NCT02092909|16262860|P4|Overall Study|Miscellaneous|1
4716904|NCT02092909|16262861|P3|Overall Study|Miscellaneous|2
4716905|NCT02092909|16262862|P2|Overall Study|Miscellaneous|1
4716906|NCT02092909|16262863|P1|Overall Study|Miscellaneous|1
4716907|NCT02092909|16262860|P4|Overall Study|Study terminated by Sponsor|2
4716908|NCT02092909|16262861|P3|Overall Study|Study terminated by Sponsor|0
4716909|NCT02092909|16262862|P2|Overall Study|Study terminated by Sponsor|0
4716910|NCT02092909|16262863|P1|Overall Study|Study terminated by Sponsor|0
4716911|NCT02092909|16262860|P4|Overall Study|Withdrawal by Subject|1
4716912|NCT02092909|16262861|P3|Overall Study|Withdrawal by Subject|2
4716913|NCT02092909|16262862|P2|Overall Study|Withdrawal by Subject|0
4716914|NCT02092909|16262863|P1|Overall Study|Withdrawal by Subject|0
4716915|NCT02092909|16262860|P4|Overall Study|Lack of Efficacy|0
4716916|NCT02092909|16262861|P3|Overall Study|Lack of Efficacy|1
4716917|NCT02092909|16262862|P2|Overall Study|Lack of Efficacy|2
4716918|NCT02092909|16262863|P1|Overall Study|Lack of Efficacy|0
4716919|NCT02092909|16262860|P4|Overall Study|Adverse Event|2
4716920|NCT02092909|16262861|P3|Overall Study|Adverse Event|4
4716921|NCT02092909|16262862|P2|Overall Study|Adverse Event|0
4716922|NCT02092909|16262863|P1|Overall Study|Adverse Event|0
4716923|NCT02092662|16262904|P2|Overall Study|Lost to Follow-up|0
4716924|NCT02092662|16262905|P1|Overall Study|Lost to Follow-up|13
4716925|NCT02092389|16262964|P1|Overall Study|Other|5
4716926|NCT02092389|16262964|P1|Overall Study|Adverse Event|1
4716927|NCT02092350|16262976|P2|Overall Study|Withdrawal by Subject|2
4716928|NCT02092350|16262977|P1|Overall Study|Withdrawal by Subject|2
4716929|NCT02092350|16262976|P2|Overall Study|Screen Failure|0
4716930|NCT02092350|16262977|P1|Overall Study|Screen Failure|1
4716931|NCT02092350|16262976|P2|Overall Study|Physician Decision|1
4716932|NCT02092350|16262977|P1|Overall Study|Physician Decision|1
4716933|NCT02092350|16262976|P2|Overall Study|Protocol Violation|0
4716934|NCT02092350|16262977|P1|Overall Study|Protocol Violation|1
4716935|NCT02092350|16262976|P2|Overall Study|Lost to Follow-up|1
4716936|NCT02092350|16262977|P1|Overall Study|Lost to Follow-up|3
4716937|NCT02092350|16262976|P2|Overall Study|Death|5
4716938|NCT02092350|16262977|P1|Overall Study|Death|2
4716939|NCT02092350|16262976|P2|Overall Study|Adverse Event|3
4716940|NCT02092350|16262977|P1|Overall Study|Adverse Event|0
4716941|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Lack of Efficacy|23
4716942|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Withdrawal by Subject|11
4716943|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Relapse/recurrence|29
4716944|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Protocol Violation|11
4716945|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Pregnancy|1
4716946|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Physician Decision|10
4716947|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Non-compliance with study drug|2
4716948|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Lost to Follow-up|1
4716949|NCT02092285|16263005|P1|Maintenance Phase & Follow-up|Adverse Event|22
4716950|NCT02092285|16263005|P1|Induction Phase|Lack of Efficacy|14
4716951|NCT02092285|16263005|P1|Induction Phase|Withdrawal by Subject|2
4716952|NCT02092285|16263005|P1|Induction Phase|Relapse/Recurrence|7
4716953|NCT02092285|16263005|P1|Induction Phase|Pregnancy|1
4716954|NCT02092285|16263005|P1|Induction Phase|Physician Decision|4
4716955|NCT02092285|16263005|P1|Induction Phase|Adverse Event|7
4716956|NCT02092220|16263009|P2|Period 2|Nausea, Anxiety, Inconvenience|1
4716957|NCT02092220|16263010|P1|Period 2|Nausea, Anxiety, Inconvenience|0
4716958|NCT02092220|16263009|P2|Period 2|Severe Hypoglycaemia|0
4716959|NCT02092220|16263010|P1|Period 2|Severe Hypoglycaemia|1
4716960|NCT02092220|16263009|P2|Period 1|Unrelated Illness|2
4716961|NCT02092220|16263010|P1|Period 1|Unrelated Illness|0
4716962|NCT02092116|16263083|P2|Overall Study|Adverse Event|1
4716963|NCT02092116|16263084|P1|Overall Study|Adverse Event|0
4716964|NCT02092116|16263083|P2|Overall Study|Withdrawal by Subject|3
4716965|NCT02092116|16263084|P1|Overall Study|Withdrawal by Subject|0
4716966|NCT02092025|16263093|P1|Overall Study|Protocol Deviation|24
4716967|NCT02092025|16263093|P1|Overall Study|Case Report Forms Uncollected|44
4716968|NCT02091986|16263102|P3|Overall Study|Adverse Event|2
4716969|NCT02091986|16263103|P2|Overall Study|Adverse Event|0
4716970|NCT02091986|16263104|P1|Overall Study|Adverse Event|0
4716971|NCT02091986|16263102|P3|Overall Study|Withdrawal by Subject|3
4716972|NCT02091986|16263103|P2|Overall Study|Withdrawal by Subject|8
4716973|NCT02091986|16263104|P1|Overall Study|Withdrawal by Subject|4
4716974|NCT02091986|16263102|P3|Overall Study|Lost to Follow-up|0
4716975|NCT02091986|16263103|P2|Overall Study|Lost to Follow-up|0
4716976|NCT02091986|16263104|P1|Overall Study|Lost to Follow-up|1
4716977|NCT02091986|16263102|P3|Overall Study|7 rand in error 1 patient decision|3
4716978|NCT02091986|16263103|P2|Overall Study|7 rand in error 1 patient decision|3
4716979|NCT02091986|16263104|P1|Overall Study|7 rand in error 1 patient decision|2
4716980|NCT02091960|16263151|P1|Overall Study|On Study at Data Cut-off|12
4716981|NCT02091960|16263151|P1|Overall Study|Miscellaneous Reasons|31
4716982|NCT02091960|16263151|P1|Overall Study|Withdrawal by Subject|1
4716983|NCT02091960|16263151|P1|Overall Study|Death|7
4716984|NCT02091921|16263162|P1|Overall Study|Adverse Event|3
4716985|NCT02091869|16263171|P2|Overall Study|Withdrawal by Subject|3
4716986|NCT02091869|16263172|P1|Overall Study|Withdrawal by Subject|0
4716987|NCT02091752|16263213|P1|Overall Study|Adverse Event|1
4716988|NCT02091752|16263213|P1|Overall Study|Study terminated by Sponsor|2
4716989|NCT02091739|16263227|P5|EP: 48 Weeks|Withdrawal by Subject|6
4716990|NCT02091739|16263228|P4|EP: 48 Weeks|Withdrawal by Subject|2
4716991|NCT02091739|16263229|P3|EP: 48 Weeks|Withdrawal by Subject|0
4716992|NCT02091739|16263230|P2|EP: 48 Weeks|Withdrawal by Subject|0
4716993|NCT02091739|16263231|P1|EP: 48 Weeks|Withdrawal by Subject|0
4716994|NCT02091739|16263227|P5|EP: 48 Weeks|Adverse Event|6
4716995|NCT02091739|16263228|P4|EP: 48 Weeks|Adverse Event|2
4716996|NCT02091739|16263229|P3|EP: 48 Weeks|Adverse Event|0
4716997|NCT02091739|16263230|P2|EP: 48 Weeks|Adverse Event|0
4716998|NCT02091739|16263231|P1|EP: 48 Weeks|Adverse Event|0
4716999|NCT02091739|16263227|P5|EP: 48 Weeks|Death|2
4717000|NCT02091739|16263228|P4|EP: 48 Weeks|Death|3
4717001|NCT02091739|16263229|P3|EP: 48 Weeks|Death|0
4717002|NCT02091739|16263230|P2|EP: 48 Weeks|Death|0
4717003|NCT02091739|16263231|P1|EP: 48 Weeks|Death|0
4717004|NCT02091739|16263227|P5|EP: 48 Weeks|Other|0
4717005|NCT02091739|16263228|P4|EP: 48 Weeks|Other|1
4717006|NCT02091739|16263229|P3|EP: 48 Weeks|Other|0
4717007|NCT02091739|16263230|P2|EP: 48 Weeks|Other|0
4717008|NCT02091739|16263231|P1|EP: 48 Weeks|Other|0
4717009|NCT02091739|16263227|P5|MP: 16 Weeks|Lost to Follow-up|0
4717010|NCT02091739|16263228|P4|MP: 16 Weeks|Lost to Follow-up|0
4717011|NCT02091739|16263229|P3|MP: 16 Weeks|Lost to Follow-up|1
4717012|NCT02091739|16263230|P2|MP: 16 Weeks|Lost to Follow-up|0
4717013|NCT02091739|16263231|P1|MP: 16 Weeks|Lost to Follow-up|0
4717014|NCT02091739|16263227|P5|MP: 16 Weeks|Withdrawal by Subject|0
4717015|NCT02091739|16263228|P4|MP: 16 Weeks|Withdrawal by Subject|0
4717016|NCT02091739|16263229|P3|MP: 16 Weeks|Withdrawal by Subject|0
4717017|NCT02091739|16263230|P2|MP: 16 Weeks|Withdrawal by Subject|4
4717018|NCT02091739|16263231|P1|MP: 16 Weeks|Withdrawal by Subject|3
4717019|NCT02091739|16263227|P5|MP: 16 Weeks|Adverse Event|0
4717020|NCT02091739|16263228|P4|MP: 16 Weeks|Adverse Event|0
4717021|NCT02091739|16263229|P3|MP: 16 Weeks|Adverse Event|1
4717022|NCT02091739|16263230|P2|MP: 16 Weeks|Adverse Event|1
4717023|NCT02091739|16263231|P1|MP: 16 Weeks|Adverse Event|1
4717024|NCT02091726|16263250|P1|Overall Study|Lost to Follow-up|6
4717025|NCT02091440|16263273|P1|Overall Study|Death|2
4717026|NCT02091414|16263283|P1|Overall Study|Death|2
4717027|NCT02091414|16263283|P1|Overall Study|Withdrawal by Subject|2
4717028|NCT02091375|16263297|P2|Overall Study|Withdrawn by the investigator|0
4717029|NCT02091375|16263298|P1|Overall Study|Withdrawn by the investigator|1
4717030|NCT02091375|16263297|P2|Overall Study|Withdrawal by Subject|1
4717031|NCT02091375|16263298|P1|Overall Study|Withdrawal by Subject|0
4717032|NCT02091375|16263297|P2|Overall Study|Lost to Follow-up|1
4717033|NCT02091375|16263298|P1|Overall Study|Lost to Follow-up|0
4717034|NCT02091375|16263297|P2|Overall Study|Adverse Event|1
4717035|NCT02091375|16263298|P1|Overall Study|Adverse Event|8
4717036|NCT02091362|16263328|P2|Period 2|Withdrawal by Subject|1
4717037|NCT02091362|16263329|P1|Period 2|Withdrawal by Subject|1
4717038|NCT02091362|16263328|P2|Period 2|Lost to Follow-up|1
4717039|NCT02091362|16263329|P1|Period 2|Lost to Follow-up|0
4717040|NCT02091362|16263328|P2|Period 2|Adverse Event|0
4717041|NCT02091362|16263329|P1|Period 2|Adverse Event|1
4717042|NCT02091362|16263328|P2|Wash-out|Withdrawal by Subject|2
4717043|NCT02091362|16263329|P1|Wash-out|Withdrawal by Subject|0
4717044|NCT02091362|16263328|P2|Wash-out|Lost to Follow-up|1
4717045|NCT02091362|16263329|P1|Wash-out|Lost to Follow-up|1
4717046|NCT02091362|16263328|P2|Period 1|Adverse Event|0
4717047|NCT02091362|16263329|P1|Period 1|Adverse Event|2
4717048|NCT02091362|16263328|P2|Period 1|Lost to Follow-up|1
4717049|NCT02091362|16263329|P1|Period 1|Lost to Follow-up|0
4717050|NCT02091362|16263328|P2|Period 1|Withdrawal by Subject|3
4717051|NCT02091362|16263329|P1|Period 1|Withdrawal by Subject|2
4717052|NCT02091362|16263328|P2|Period 1|Protocol Violation|0
4717053|NCT02091362|16263329|P1|Period 1|Protocol Violation|1
4717054|NCT02091284|16263351|P2|Overall Study|unreliable data|0
4717055|NCT02091284|16263352|P1|Overall Study|unreliable data|1
4717056|NCT02091284|16263351|P2|Overall Study|Withdrawal by Subject|1
4717057|NCT02091284|16263352|P1|Overall Study|Withdrawal by Subject|2
4717058|NCT02091206|16263374|P4|Taper Period|Lost to Follow-up|1
4717059|NCT02091206|16263375|P3|Taper Period|Lost to Follow-up|0
4717060|NCT02091206|16263376|P2|Taper Period|Lost to Follow-up|0
4717061|NCT02091206|16263377|P1|Taper Period|Lost to Follow-up|0
4717062|NCT02091206|16263374|P4|Taper Period|Participant refused study drug|1
4717063|NCT02091206|16263375|P3|Taper Period|Participant refused study drug|0
4717064|NCT02091206|16263376|P2|Taper Period|Participant refused study drug|0
4717065|NCT02091206|16263377|P1|Taper Period|Participant refused study drug|1
4717066|NCT02091206|16263374|P4|Treatment Period|Met withdrawal criteria|0
4717067|NCT02091206|16263375|P3|Treatment Period|Met withdrawal criteria|1
4717068|NCT02091206|16263376|P2|Treatment Period|Met withdrawal criteria|0
4717069|NCT02091206|16263377|P1|Treatment Period|Met withdrawal criteria|0
4717070|NCT02091206|16263374|P4|Treatment Period|Adverse Event|0
4717071|NCT02091206|16263375|P3|Treatment Period|Adverse Event|0
4717072|NCT02091206|16263376|P2|Treatment Period|Adverse Event|1
4717073|NCT02091206|16263377|P1|Treatment Period|Adverse Event|0
4717074|NCT02091167|16263396|P2|Overall Study|Lost to Follow-up|2
4717075|NCT02091167|16263397|P1|Overall Study|Lost to Follow-up|0
4717076|NCT02090959|16263405|P1|Overall Study|Other than specified|2
4717077|NCT02090959|16263405|P1|Overall Study|Switched to commercial supply|88
4717078|NCT02090959|16263405|P1|Overall Study|Entered in to other study|34
4717079|NCT02090959|16263405|P1|Overall Study|Move to medical need program|3
4717080|NCT02090959|16263405|P1|Overall Study|Transfer for compassionate use medicine|4
4717081|NCT02090959|16263405|P1|Overall Study|Enrolled but not treated|1
4717082|NCT02090959|16263405|P1|Overall Study|Study termination|6
4717083|NCT02090959|16263405|P1|Overall Study|Investigator decision|2
4717084|NCT02090959|16263405|P1|Overall Study|Adverse Event|1
4717085|NCT02090959|16263405|P1|Overall Study|Withdrawal by Subject|10
4717086|NCT02090855|16263432|P1|Overall Study|no evaluable Standard of Truth results|2
4717087|NCT02090764|16263445|P2|Overall Study|Lost to Follow-up|2
4717088|NCT02090764|16263446|P1|Overall Study|Lost to Follow-up|2
4717089|NCT02090764|16263445|P2|Overall Study|Intercurrent illness and other|1
4717090|NCT02090764|16263446|P1|Overall Study|Intercurrent illness and other|1
4717091|NCT02090764|16263445|P2|Overall Study|Withdrawal by Subject|1
4717092|NCT02090764|16263446|P1|Overall Study|Withdrawal by Subject|2
4717093|NCT02090764|16263445|P2|Overall Study|Lack of Efficacy|13
4717094|NCT02090764|16263446|P1|Overall Study|Lack of Efficacy|0
4717095|NCT02090764|16263445|P2|Overall Study|Adverse Event|3
4717096|NCT02090764|16263446|P1|Overall Study|Adverse Event|1
4717097|NCT02090725|16263452|P1|Overall Study|participants moved from area|3
4717098|NCT02090725|16263452|P1|Overall Study|Withdrawal by Subject|1
4717099|NCT02090426|16263458|P2|Overall Study|Lost to Follow-up|6
4717100|NCT02090426|16263459|P1|Overall Study|Lost to Follow-up|12
4717101|NCT02090413|16263490|P3|Overall Study|Lost to Follow-up|0
4717102|NCT02090413|16263491|P2|Overall Study|Lost to Follow-up|1
4717103|NCT02090413|16263492|P1|Overall Study|Lost to Follow-up|1
4717104|NCT02090413|16263490|P3|Overall Study|Other|0
4717105|NCT02090413|16263491|P2|Overall Study|Other|1
4717106|NCT02090413|16263492|P1|Overall Study|Other|2
4717107|NCT02090413|16263490|P3|Overall Study|Investigator Decision|0
4717108|NCT02090413|16263491|P2|Overall Study|Investigator Decision|1
4717109|NCT02090413|16263492|P1|Overall Study|Investigator Decision|1
4717110|NCT02090413|16263490|P3|Overall Study|Withdrawal by Subject|2
4717111|NCT02090413|16263491|P2|Overall Study|Withdrawal by Subject|2
4717112|NCT02090413|16263492|P1|Overall Study|Withdrawal by Subject|2
4717113|NCT02090413|16263490|P3|Overall Study|Flushing event|1
4717114|NCT02090413|16263491|P2|Overall Study|Flushing event|0
4717115|NCT02090413|16263492|P1|Overall Study|Flushing event|2
4717116|NCT02090413|16263490|P3|Overall Study|Adverse Event|20
4717117|NCT02090413|16263491|P2|Overall Study|Adverse Event|15
4717118|NCT02090413|16263492|P1|Overall Study|Adverse Event|11
4717119|NCT02090283|16263569|P3|Overall Study|Protocol Violation|0
4717120|NCT02090283|16263570|P2|Overall Study|Protocol Violation|0
4717121|NCT02090283|16263571|P1|Overall Study|Protocol Violation|2
4717122|NCT02090283|16263569|P3|Overall Study|Adverse Event|0
4717123|NCT02090283|16263570|P2|Overall Study|Adverse Event|1
4717124|NCT02090283|16263571|P1|Overall Study|Adverse Event|1
4717125|NCT02090283|16263569|P3|Overall Study|Lost to Follow-up|3
4717126|NCT02090283|16263570|P2|Overall Study|Lost to Follow-up|2
4717127|NCT02090283|16263571|P1|Overall Study|Lost to Follow-up|2
4717128|NCT02090283|16263569|P3|Overall Study|Sponsor Terminated Study|1
4717129|NCT02090283|16263570|P2|Overall Study|Sponsor Terminated Study|6
4717130|NCT02090283|16263571|P1|Overall Study|Sponsor Terminated Study|6
4717131|NCT02090283|16263569|P3|Overall Study|Withdrawal by Subject|6
4717132|NCT02090283|16263570|P2|Overall Study|Withdrawal by Subject|6
4717133|NCT02090283|16263571|P1|Overall Study|Withdrawal by Subject|6
4717134|NCT02089997|16263605|P1|Overall Study|Protocol Violation|147
4717135|NCT02089997|16263605|P1|Overall Study|Case report forms uncollected|99
4717136|NCT02089737|16263620|P1|Overall Study|Not treated|1
4717137|NCT02089737|16263620|P1|Overall Study|Survey form not completed|5
4717138|NCT02089347|16263670|P2|Overall Study|Protocol Violation|0
4717139|NCT02089347|16263671|P1|Overall Study|Protocol Violation|1
4717140|NCT02089334|16263697|P4|Overall Study|Physician Decision|1
4717141|NCT02089334|16263698|P3|Overall Study|Physician Decision|1
4717142|NCT02089334|16263699|P2|Overall Study|Physician Decision|0
4717143|NCT02089334|16263700|P1|Overall Study|Physician Decision|0
4717144|NCT02089334|16263697|P4|Overall Study|Progressive disease|2
4717145|NCT02089334|16263698|P3|Overall Study|Progressive disease|0
4717146|NCT02089334|16263699|P2|Overall Study|Progressive disease|0
4717147|NCT02089334|16263700|P1|Overall Study|Progressive disease|0
4717148|NCT02089334|16263697|P4|Overall Study|Adverse Event|2
4717149|NCT02089334|16263698|P3|Overall Study|Adverse Event|0
4717150|NCT02089334|16263699|P2|Overall Study|Adverse Event|0
4717151|NCT02089334|16263700|P1|Overall Study|Adverse Event|0
4717152|NCT02089334|16263697|P4|Overall Study|Withdrawal by Subject|2
4717153|NCT02089334|16263698|P3|Overall Study|Withdrawal by Subject|0
4717154|NCT02089334|16263699|P2|Overall Study|Withdrawal by Subject|0
4717155|NCT02089334|16263700|P1|Overall Study|Withdrawal by Subject|0
4717156|NCT02088957|16263737|P2|Overall Study|Lack of Efficacy|0
4717157|NCT02088957|16263738|P1|Overall Study|Lack of Efficacy|1
4717158|NCT02088905|16263756|P2|Overall Study|Withdrawal by Subject|1
4717159|NCT02088905|16263757|P1|Overall Study|Withdrawal by Subject|5
4717160|NCT02088541|16263793|P5|Overall Study|Other|1
4717161|NCT02088541|16263794|P4|Overall Study|Other|1
4717162|NCT02088541|16263795|P3|Overall Study|Other|3
4717163|NCT02088541|16263796|P2|Overall Study|Other|1
4717164|NCT02088541|16263797|P1|Overall Study|Other|2
4717165|NCT02088541|16263793|P5|Overall Study|Withdrawal by Subject|10
4717166|NCT02088541|16263794|P4|Overall Study|Withdrawal by Subject|7
4717167|NCT02088541|16263795|P3|Overall Study|Withdrawal by Subject|9
4717168|NCT02088541|16263796|P2|Overall Study|Withdrawal by Subject|2
4717169|NCT02088541|16263797|P1|Overall Study|Withdrawal by Subject|3
4717170|NCT02088541|16263793|P5|Overall Study|Study terminated by sponsor|6
4717171|NCT02088541|16263794|P4|Overall Study|Study terminated by sponsor|2
4717172|NCT02088541|16263795|P3|Overall Study|Study terminated by sponsor|12
4717173|NCT02088541|16263796|P2|Overall Study|Study terminated by sponsor|1
4717174|NCT02088541|16263797|P1|Overall Study|Study terminated by sponsor|1
4717175|NCT02088541|16263793|P5|Overall Study|Disease progression|1
4717176|NCT02088541|16263794|P4|Overall Study|Disease progression|3
4717177|NCT02088541|16263795|P3|Overall Study|Disease progression|2
4717178|NCT02088541|16263796|P2|Overall Study|Disease progression|1
4717179|NCT02088541|16263797|P1|Overall Study|Disease progression|7
4717180|NCT02088541|16263793|P5|Overall Study|Physician Decision|2
4717181|NCT02088541|16263794|P4|Overall Study|Physician Decision|0
4717182|NCT02088541|16263795|P3|Overall Study|Physician Decision|2
4717183|NCT02088541|16263796|P2|Overall Study|Physician Decision|1
4717184|NCT02088541|16263797|P1|Overall Study|Physician Decision|2
4717185|NCT02088541|16263793|P5|Overall Study|Lost to Follow-up|0
4717186|NCT02088541|16263794|P4|Overall Study|Lost to Follow-up|0
4717187|NCT02088541|16263795|P3|Overall Study|Lost to Follow-up|1
4717188|NCT02088541|16263796|P2|Overall Study|Lost to Follow-up|0
4717189|NCT02088541|16263797|P1|Overall Study|Lost to Follow-up|2
4717190|NCT02088541|16263793|P5|Overall Study|Death|38
4717191|NCT02088541|16263794|P4|Overall Study|Death|28
4717192|NCT02088541|16263795|P3|Overall Study|Death|85
4717193|NCT02088541|16263796|P2|Overall Study|Death|21
4717194|NCT02088541|16263797|P1|Overall Study|Death|51
4717195|NCT02088541|16263793|P5|Overall Study|Adverse Event|0
4717196|NCT02088541|16263794|P4|Overall Study|Adverse Event|3
4717197|NCT02088541|16263795|P3|Overall Study|Adverse Event|3
4717198|NCT02088541|16263796|P2|Overall Study|Adverse Event|0
4717199|NCT02088541|16263797|P1|Overall Study|Adverse Event|3
4717200|NCT02088177|16263868|P1|Overall Study|Lost to Follow-up|3
4717201|NCT02088073|16263878|P5|Maintanance Phase|Subject compliance|0
4717202|NCT02088073|16263879|P4|Maintanance Phase|Subject compliance|0
4717203|NCT02088073|16263880|P3|Maintanance Phase|Subject compliance|0
4717204|NCT02088073|16263881|P2|Maintanance Phase|Subject compliance|1
4717205|NCT02088073|16263882|P1|Maintanance Phase|Subject compliance|0
4717206|NCT02088073|16263878|P5|Maintanance Phase|Met ECG withdrawal criteria|2
4717207|NCT02088073|16263879|P4|Maintanance Phase|Met ECG withdrawal criteria|0
4717208|NCT02088073|16263880|P3|Maintanance Phase|Met ECG withdrawal criteria|1
4717209|NCT02088073|16263881|P2|Maintanance Phase|Met ECG withdrawal criteria|0
4717210|NCT02088073|16263882|P1|Maintanance Phase|Met ECG withdrawal criteria|0
4717211|NCT02088073|16263878|P5|Maintanance Phase|Miscellaneous|1
4717212|NCT02088073|16263879|P4|Maintanance Phase|Miscellaneous|2
4717213|NCT02088073|16263880|P3|Maintanance Phase|Miscellaneous|1
4717214|NCT02088073|16263881|P2|Maintanance Phase|Miscellaneous|2
4717215|NCT02088073|16263882|P1|Maintanance Phase|Miscellaneous|0
4717216|NCT02088073|16263878|P5|Maintanance Phase|Hypo- or hyperkalemia|1
4717217|NCT02088073|16263879|P4|Maintanance Phase|Hypo- or hyperkalemia|3
4717218|NCT02088073|16263880|P3|Maintanance Phase|Hypo- or hyperkalemia|0
4717219|NCT02088073|16263881|P2|Maintanance Phase|Hypo- or hyperkalemia|3
4717220|NCT02088073|16263882|P1|Maintanance Phase|Hypo- or hyperkalemia|0
4717221|NCT02088073|16263878|P5|Maintanance Phase|Sponsor's decision|1
4717222|NCT02088073|16263879|P4|Maintanance Phase|Sponsor's decision|2
4717223|NCT02088073|16263880|P3|Maintanance Phase|Sponsor's decision|0
4717224|NCT02088073|16263881|P2|Maintanance Phase|Sponsor's decision|2
4717225|NCT02088073|16263882|P1|Maintanance Phase|Sponsor's decision|0
4717226|NCT02088073|16263878|P5|Maintanance Phase|Physician Decision|1
4717227|NCT02088073|16263879|P4|Maintanance Phase|Physician Decision|0
4717228|NCT02088073|16263880|P3|Maintanance Phase|Physician Decision|0
4717229|NCT02088073|16263881|P2|Maintanance Phase|Physician Decision|0
4717230|NCT02088073|16263882|P1|Maintanance Phase|Physician Decision|0
4717231|NCT02088073|16263878|P5|Maintanance Phase|Adverse Event|1
4717232|NCT02088073|16263879|P4|Maintanance Phase|Adverse Event|0
4717233|NCT02088073|16263880|P3|Maintanance Phase|Adverse Event|3
4717234|NCT02088073|16263881|P2|Maintanance Phase|Adverse Event|0
4717235|NCT02088073|16263882|P1|Maintanance Phase|Adverse Event|0
4717236|NCT02088073|16263878|P5|Maintanance Phase|Withdrawal by Subject|0
4717237|NCT02088073|16263879|P4|Maintanance Phase|Withdrawal by Subject|0
4717238|NCT02088073|16263880|P3|Maintanance Phase|Withdrawal by Subject|0
4717239|NCT02088073|16263881|P2|Maintanance Phase|Withdrawal by Subject|2
4717240|NCT02088073|16263882|P1|Maintanance Phase|Withdrawal by Subject|0
4717241|NCT02088073|16263878|P5|Acute Phase|Hyperkalemia|0
4717242|NCT02088073|16263879|P4|Acute Phase|Hyperkalemia|0
4717243|NCT02088073|16263880|P3|Acute Phase|Hyperkalemia|0
4717244|NCT02088073|16263881|P2|Acute Phase|Hyperkalemia|0
4717245|NCT02088073|16263882|P1|Acute Phase|Hyperkalemia|2
4717246|NCT02088073|16263878|P5|Acute Phase|Withdrawal by Subject|0
4717247|NCT02088073|16263879|P4|Acute Phase|Withdrawal by Subject|0
4717248|NCT02088073|16263880|P3|Acute Phase|Withdrawal by Subject|0
4717249|NCT02088073|16263881|P2|Acute Phase|Withdrawal by Subject|0
4717250|NCT02088073|16263882|P1|Acute Phase|Withdrawal by Subject|5
4717251|NCT02088047|16263936|P2|Overall Study|Withdrawal by Subject|0
4717252|NCT02088047|16263937|P1|Overall Study|Withdrawal by Subject|1
4717253|NCT02087943|16263965|P5|Active Treatment Phase Week 12-24|Other-Unspecified|0
4717254|NCT02087943|16263966|P4|Active Treatment Phase Week 12-24|Other-Unspecified|1
4717255|NCT02087943|16263967|P3|Active Treatment Phase Week 12-24|Other-Unspecified|1
4717256|NCT02087943|16263968|P2|Active Treatment Phase Week 12-24|Other-Unspecified|0
4717257|NCT02087943|16263969|P1|Active Treatment Phase Week 12-24|Other-Unspecified|0
4717258|NCT02087943|16263965|P5|Active Treatment Phase Week 12-24|Lost to Follow-up|1
4717259|NCT02087943|16263966|P4|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4717260|NCT02087943|16263967|P3|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4717261|NCT02087943|16263968|P2|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4717262|NCT02087943|16263969|P1|Active Treatment Phase Week 12-24|Lost to Follow-up|0
4717263|NCT02087943|16263965|P5|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4717264|NCT02087943|16263966|P4|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4717265|NCT02087943|16263967|P3|Active Treatment Phase Week 12-24|Withdrawal by Subject|1
4717266|NCT02087943|16263968|P2|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4717267|NCT02087943|16263969|P1|Active Treatment Phase Week 12-24|Withdrawal by Subject|0
4717268|NCT02087943|16263965|P5|Active Treatment Phase Week 12-24|Lack of Efficacy|0
4717269|NCT02087943|16263966|P4|Active Treatment Phase Week 12-24|Lack of Efficacy|1
4717270|NCT02087943|16263967|P3|Active Treatment Phase Week 12-24|Lack of Efficacy|1
4717271|NCT02087943|16263968|P2|Active Treatment Phase Week 12-24|Lack of Efficacy|3
4717272|NCT02087943|16263969|P1|Active Treatment Phase Week 12-24|Lack of Efficacy|0
4717273|NCT02087943|16263965|P5|Active Treatment Phase Week 12-24|Adverse Event|1
4717274|NCT02087943|16263966|P4|Active Treatment Phase Week 12-24|Adverse Event|0
4717275|NCT02087943|16263967|P3|Active Treatment Phase Week 12-24|Adverse Event|2
4717276|NCT02087943|16263968|P2|Active Treatment Phase Week 12-24|Adverse Event|1
4717277|NCT02087943|16263969|P1|Active Treatment Phase Week 12-24|Adverse Event|0
4717278|NCT02087943|16263965|P5|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4717279|NCT02087943|16263966|P4|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4717280|NCT02087943|16263967|P3|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4717281|NCT02087943|16263968|P2|Placebo-Controlled Phase Week 0-12|Protocol Violation|1
4717282|NCT02087943|16263969|P1|Placebo-Controlled Phase Week 0-12|Protocol Violation|0
4717283|NCT02087943|16263965|P5|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4717284|NCT02087943|16263966|P4|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4717285|NCT02087943|16263967|P3|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
4717286|NCT02087943|16263968|P2|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0
4717287|NCT02087943|16263969|P1|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1
4717288|NCT02087943|16263965|P5|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
4717289|NCT02087943|16263966|P4|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0
4717290|NCT02087943|16263967|P3|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
4717291|NCT02087943|16263968|P2|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2
4717292|NCT02087943|16263969|P1|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4
4717293|NCT02087943|16263965|P5|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
4717294|NCT02087943|16263966|P4|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0
4717295|NCT02087943|16263967|P3|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4
4717296|NCT02087943|16263968|P2|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7
4717297|NCT02087943|16263969|P1|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8
4717298|NCT02087943|16263965|P5|Placebo-Controlled Phase Week 0-12|Adverse Event|0
4717299|NCT02087943|16263966|P4|Placebo-Controlled Phase Week 0-12|Adverse Event|0
4717300|NCT02087943|16263967|P3|Placebo-Controlled Phase Week 0-12|Adverse Event|6
4717301|NCT02087943|16263968|P2|Placebo-Controlled Phase Week 0-12|Adverse Event|2
4717302|NCT02087943|16263969|P1|Placebo-Controlled Phase Week 0-12|Adverse Event|1
4717303|NCT02087904|16263997|P4|Overall Study|Lost to Follow-up|2
4717304|NCT02087904|16263998|P3|Overall Study|Lost to Follow-up|2
4717305|NCT02087904|16263999|P2|Overall Study|Lost to Follow-up|4
4717306|NCT02087904|16264000|P1|Overall Study|Lost to Follow-up|0
4717307|NCT02087904|16263997|P4|Overall Study|Withdrawal by Subject|4
4717308|NCT02087904|16263998|P3|Overall Study|Withdrawal by Subject|7
4717309|NCT02087904|16263999|P2|Overall Study|Withdrawal by Subject|3
4717310|NCT02087904|16264000|P1|Overall Study|Withdrawal by Subject|8
4717311|NCT02087904|16263997|P4|Overall Study|Other|4
4717312|NCT02087904|16263998|P3|Overall Study|Other|4
4717313|NCT02087904|16263999|P2|Overall Study|Other|2
4717314|NCT02087904|16264000|P1|Overall Study|Other|6
4717315|NCT02087904|16263997|P4|Overall Study|Lack of Efficacy|2
4717316|NCT02087904|16263998|P3|Overall Study|Lack of Efficacy|3
4717317|NCT02087904|16263999|P2|Overall Study|Lack of Efficacy|6
4717318|NCT02087904|16264000|P1|Overall Study|Lack of Efficacy|3
4717319|NCT02087904|16263997|P4|Overall Study|Adverse Event|12
4717320|NCT02087904|16263998|P3|Overall Study|Adverse Event|4
4717321|NCT02087904|16263999|P2|Overall Study|Adverse Event|4
4717322|NCT02087904|16264000|P1|Overall Study|Adverse Event|8
4717323|NCT02087904|16263997|P4|Overall Study|Did Not Receive Study Drug|1
4717324|NCT02087904|16263998|P3|Overall Study|Did Not Receive Study Drug|2
4717325|NCT02087904|16263999|P2|Overall Study|Did Not Receive Study Drug|0
4717326|NCT02087904|16264000|P1|Overall Study|Did Not Receive Study Drug|0
4717327|NCT02087774|16264116|P2|Overall Study|Were absent day of data collection|20
4717328|NCT02087774|16264117|P1|Overall Study|Were absent day of data collection|8
4717329|NCT02087670|16264137|P2|Overall Study|Withdrawal by Subject|2
4717330|NCT02087670|16264138|P1|Overall Study|Withdrawal by Subject|3
4717331|NCT02087423|16264174|P3|Overall Study|Terminated from study at final DCO|25
4717332|NCT02087423|16264175|P2|Overall Study|Terminated from study at final DCO|36
4717333|NCT02087423|16264176|P1|Overall Study|Terminated from study at final DCO|23
4717334|NCT02087423|16264174|P3|Overall Study|Lost to Follow-up|0
4717335|NCT02087423|16264175|P2|Overall Study|Lost to Follow-up|2
4717336|NCT02087423|16264176|P1|Overall Study|Lost to Follow-up|0
4717337|NCT02087423|16264174|P3|Overall Study|Death|40
4717338|NCT02087423|16264175|P2|Overall Study|Death|207
4717339|NCT02087423|16264176|P1|Overall Study|Death|68
4717340|NCT02087423|16264174|P3|Overall Study|Withdrawal by Subject|3
4717341|NCT02087423|16264175|P2|Overall Study|Withdrawal by Subject|20
4717342|NCT02087423|16264176|P1|Overall Study|Withdrawal by Subject|20
4717343|NCT02087241|16264205|P4|Overall Study|Study Terminated by Sponsor|4
4717344|NCT02087241|16264206|P3|Overall Study|Study Terminated by Sponsor|0
4717345|NCT02087241|16264207|P2|Overall Study|Study Terminated by Sponsor|2
4717346|NCT02087241|16264208|P1|Overall Study|Study Terminated by Sponsor|0
4717347|NCT02087241|16264205|P4|Overall Study|Progressive Disease|1
4717348|NCT02087241|16264206|P3|Overall Study|Progressive Disease|0
4717349|NCT02087241|16264207|P2|Overall Study|Progressive Disease|0
4717350|NCT02087241|16264208|P1|Overall Study|Progressive Disease|0
4717351|NCT02087241|16264205|P4|Overall Study|Withdrawal by Subject|1
4717352|NCT02087241|16264206|P3|Overall Study|Withdrawal by Subject|0
4717353|NCT02087241|16264207|P2|Overall Study|Withdrawal by Subject|0
4717354|NCT02087241|16264208|P1|Overall Study|Withdrawal by Subject|1
4717355|NCT02087241|16264205|P4|Overall Study|Death|1
4717356|NCT02087241|16264206|P3|Overall Study|Death|1
4717357|NCT02087241|16264207|P2|Overall Study|Death|1
4717358|NCT02087241|16264208|P1|Overall Study|Death|2
4717359|NCT02087176|16264234|P1|Overall Study|Study Terminated by Sponsor|2
4717360|NCT02087176|16264234|P1|Overall Study|Censored|19
4717361|NCT02087176|16264234|P1|Overall Study|Death|10
4717362|NCT02087176|16264234|P1|Overall Study|Withdrawal by Subject|1
4717363|NCT02087150|16264247|P3|Overall Study|Pt moved out of town|0
4717364|NCT02087150|16264248|P2|Overall Study|Pt moved out of town|1
4717365|NCT02087150|16264249|P1|Overall Study|Pt moved out of town|0
4717366|NCT02087150|16264247|P3|Overall Study|Other|0
4717367|NCT02087150|16264248|P2|Overall Study|Other|0
4717368|NCT02087150|16264249|P1|Overall Study|Other|1
4717369|NCT02087150|16264247|P3|Overall Study|F/U not completed w/in study window|1
4717370|NCT02087150|16264248|P2|Overall Study|F/U not completed w/in study window|0
4717371|NCT02087150|16264249|P1|Overall Study|F/U not completed w/in study window|0
4717372|NCT02087150|16264247|P3|Overall Study|Procedure not done|0
4717373|NCT02087150|16264248|P2|Overall Study|Procedure not done|13
4717374|NCT02087150|16264249|P1|Overall Study|Procedure not done|1
4717375|NCT02087150|16264247|P3|Overall Study|Physician Decision|0
4717376|NCT02087150|16264248|P2|Overall Study|Physician Decision|1
4717377|NCT02087150|16264249|P1|Overall Study|Physician Decision|0
4717378|NCT02087150|16264247|P3|Overall Study|Withdrawal by Subject|3
4717379|NCT02087150|16264248|P2|Overall Study|Withdrawal by Subject|5
4717380|NCT02087150|16264249|P1|Overall Study|Withdrawal by Subject|2
4717381|NCT02087150|16264247|P3|Overall Study|Lost to Follow-up|7
4717382|NCT02087150|16264248|P2|Overall Study|Lost to Follow-up|13
4717383|NCT02087150|16264249|P1|Overall Study|Lost to Follow-up|6
4717384|NCT02087150|16264247|P3|Overall Study|Death|0
4717385|NCT02087150|16264248|P2|Overall Study|Death|1
4717386|NCT02087150|16264249|P1|Overall Study|Death|0
4717387|NCT02087085|16264268|P2|Overall Study|Other Miscellaneous Reasons|4
4717388|NCT02087085|16264269|P1|Overall Study|Other Miscellaneous Reasons|3
4717389|NCT02087085|16264268|P2|Overall Study|Study Terminated by Sponsor|80
4717390|NCT02087085|16264269|P1|Overall Study|Study Terminated by Sponsor|87
4717391|NCT02087085|16264268|P2|Overall Study|Protocol Violation|0
4717392|NCT02087085|16264269|P1|Overall Study|Protocol Violation|1
4717393|NCT02087085|16264268|P2|Overall Study|Withdrawal by Subject|11
4717394|NCT02087085|16264269|P1|Overall Study|Withdrawal by Subject|9
4717395|NCT02087085|16264268|P2|Overall Study|Lost to Follow-up|4
4717396|NCT02087085|16264269|P1|Overall Study|Lost to Follow-up|6
4717397|NCT02087085|16264268|P2|Overall Study|Lack of Efficacy|3
4717398|NCT02087085|16264269|P1|Overall Study|Lack of Efficacy|4
4717399|NCT02087085|16264268|P2|Overall Study|Adverse Event|14
4717400|NCT02087085|16264269|P1|Overall Study|Adverse Event|10
4717401|NCT02087059|16264279|P1|Overall Study|Lost to Follow-up|1
4717402|NCT02087059|16264279|P1|Overall Study|Adverse Event|5
4717403|NCT02087059|16264279|P1|Overall Study|Disease Progression|1
4717404|NCT02086968|16264289|P2|Overall Study|Withdrawal by Subject|4
4717405|NCT02086968|16264290|P1|Overall Study|Withdrawal by Subject|1
4717406|NCT02086968|16264289|P2|Overall Study|Physician Decision|0
4717407|NCT02086968|16264290|P1|Overall Study|Physician Decision|4
4717408|NCT02086968|16264289|P2|Overall Study|Study drug received outside protocol|1
4717409|NCT02086968|16264290|P1|Overall Study|Study drug received outside protocol|0
4717410|NCT02086968|16264289|P2|Overall Study|Lost to Follow-up|3
4717411|NCT02086968|16264290|P1|Overall Study|Lost to Follow-up|2
4717412|NCT02086968|16264289|P2|Overall Study|Adverse Event|5
4717413|NCT02086968|16264290|P1|Overall Study|Adverse Event|1
4717414|NCT02086591|16264344|P1|Overall Study|protocol terminated|3
4717415|NCT02086591|16264344|P1|Overall Study|Withdrawal by Subject|1
4717416|NCT02086591|16264344|P1|Overall Study|Adverse Event|1
4717417|NCT02086565|16264352|P2|Overall Study|withdrawn by research team|2
4717418|NCT02086565|16264353|P1|Overall Study|withdrawn by research team|2
4717419|NCT02086565|16264352|P2|Overall Study|Death|2
4717420|NCT02086565|16264353|P1|Overall Study|Death|3
4717421|NCT02086565|16264352|P2|Overall Study|Withdrawal by Subject|1
4717422|NCT02086565|16264353|P1|Overall Study|Withdrawal by Subject|2
4717423|NCT02086565|16264352|P2|Overall Study|Lost to Follow-up|7
4717424|NCT02086565|16264353|P1|Overall Study|Lost to Follow-up|9
4717425|NCT02086552|16264367|P1|Overall Study|Withdrawal by Subject|1
4717426|NCT02086162|16264397|P2|Overall Study|Death|0
4717427|NCT02086162|16264398|P1|Overall Study|Death|1
4717428|NCT02086162|16264397|P2|Overall Study|Lost to Follow-up|2
4717429|NCT02086162|16264398|P1|Overall Study|Lost to Follow-up|4
4717430|NCT02086162|16264397|P2|Overall Study|moved|1
4717431|NCT02086162|16264398|P1|Overall Study|moved|1
4717432|NCT02086162|16264397|P2|Overall Study|Withdrawal by Subject|4
4717433|NCT02086162|16264398|P1|Overall Study|Withdrawal by Subject|4
4717434|NCT02086110|16264410|P2|Overall Study|Withdrawal by Subject|1
4717435|NCT02086110|16264411|P1|Overall Study|Withdrawal by Subject|1
4717436|NCT02085785|16264422|P2|Overall Study|Lost to Follow-up|1
4717437|NCT02085785|16264423|P1|Overall Study|Lost to Follow-up|0
4717438|NCT02085785|16264422|P2|Overall Study|Withdrawal by Subject|1
4717439|NCT02085785|16264423|P1|Overall Study|Withdrawal by Subject|2
4717440|NCT02085252|16264577|P2|Overall Study|Reason Unknown|1
4717441|NCT02085252|16264578|P1|Overall Study|Reason Unknown|0
4717442|NCT02085252|16264577|P2|Overall Study|Reason Not Specified|1
4717443|NCT02085252|16264578|P1|Overall Study|Reason Not Specified|0
4717444|NCT02085252|16264577|P2|Overall Study|Discontinuation Due to Patient Decision|1
4717445|NCT02085252|16264578|P1|Overall Study|Discontinuation Due to Patient Decision|0
4717446|NCT02085252|16264577|P2|Overall Study|Adverse Event|1
4717447|NCT02085252|16264578|P1|Overall Study|Adverse Event|0
4717448|NCT02085252|16264577|P2|Overall Study|Withdrawal of Consent|0
4717449|NCT02085252|16264578|P1|Overall Study|Withdrawal of Consent|1
4717450|NCT02085161|16264602|P4|Overall Study|Other Reason|1
4717451|NCT02085161|16264603|P3|Overall Study|Other Reason|1
4717452|NCT02085161|16264604|P2|Overall Study|Other Reason|0
4717453|NCT02085161|16264605|P1|Overall Study|Other Reason|1
4717454|NCT02085161|16264602|P4|Overall Study|Withdrawal by Subject|3
4717455|NCT02085161|16264603|P3|Overall Study|Withdrawal by Subject|0
4717456|NCT02085161|16264604|P2|Overall Study|Withdrawal by Subject|4
4717457|NCT02085161|16264605|P1|Overall Study|Withdrawal by Subject|2
4717458|NCT02085161|16264602|P4|Overall Study|Protocol Violation|1
4717459|NCT02085161|16264603|P3|Overall Study|Protocol Violation|0
4717460|NCT02085161|16264604|P2|Overall Study|Protocol Violation|1
4717461|NCT02085161|16264605|P1|Overall Study|Protocol Violation|0
4717462|NCT02085161|16264602|P4|Overall Study|Adverse Event|5
4717463|NCT02085161|16264603|P3|Overall Study|Adverse Event|4
4717464|NCT02085161|16264604|P2|Overall Study|Adverse Event|5
4717465|NCT02085161|16264605|P1|Overall Study|Adverse Event|8
4717466|NCT02085161|16264602|P4|Overall Study|Not Treated|0
4717467|NCT02085161|16264603|P3|Overall Study|Not Treated|0
4717468|NCT02085161|16264604|P2|Overall Study|Not Treated|0
4717469|NCT02085161|16264605|P1|Overall Study|Not Treated|1
4717470|NCT02085135|16264646|P2|Overall Study|Lack of Efficacy|0
4717471|NCT02085135|16264647|P1|Overall Study|Lack of Efficacy|2
4717472|NCT02085135|16264646|P2|Overall Study|Withdrawal by Subject|0
4717473|NCT02085135|16264647|P1|Overall Study|Withdrawal by Subject|3
4717474|NCT02085135|16264646|P2|Overall Study|Lost to Follow-up|2
4717475|NCT02085135|16264647|P1|Overall Study|Lost to Follow-up|2
4717476|NCT02085135|16264646|P2|Overall Study|Adverse Event|7
4717477|NCT02085135|16264647|P1|Overall Study|Adverse Event|4
4717478|NCT02084238|16264719|P1|Overall Study|Lost to Follow-up|2
4717479|NCT02084134|16264744|P2|Overall Study|Death|1
4717480|NCT02084134|16264745|P1|Overall Study|Death|0
4717481|NCT02084134|16264744|P2|Overall Study|Protocol Violation|2
4717482|NCT02084134|16264745|P1|Overall Study|Protocol Violation|4
4717483|NCT02084082|16264755|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|1
4717484|NCT02084082|16264756|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4717485|NCT02084082|16264757|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4717486|NCT02084082|16264758|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4717487|NCT02084082|16264755|P4|Washout Period 1 (35 Days)|Adverse Event|1
4717488|NCT02084082|16264756|P3|Washout Period 1 (35 Days)|Adverse Event|1
4717489|NCT02084082|16264757|P2|Washout Period 1 (35 Days)|Adverse Event|0
4717490|NCT02084082|16264758|P1|Washout Period 1 (35 Days)|Adverse Event|0
4717491|NCT02084056|16264799|P4|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4717492|NCT02084056|16264800|P3|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4717493|NCT02084056|16264801|P2|Washout Period 1 (35 Days)|Withdrawal by Subject|0
4717494|NCT02084056|16264802|P1|Washout Period 1 (35 Days)|Withdrawal by Subject|1
4717495|NCT02084056|16264799|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4717496|NCT02084056|16264800|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4717497|NCT02084056|16264801|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4717498|NCT02084056|16264802|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
4717499|NCT02083965|16264834|P2|Treatment Period|Other|0
4717500|NCT02083965|16264835|P1|Treatment Period|Other|1
4717501|NCT02083783|16264908|P2|Overall Study|Withdrawal by Subject|0
4717502|NCT02083783|16264909|P1|Overall Study|Withdrawal by Subject|1
4717503|NCT02083653|16264941|P3|Overall Study|Reason Missing|4
4717504|NCT02083653|16264942|P2|Overall Study|Reason Missing|0
4717505|NCT02083653|16264943|P1|Overall Study|Reason Missing|0
4717506|NCT02083653|16264941|P3|Overall Study|Other Events|2
4717507|NCT02083653|16264942|P2|Overall Study|Other Events|2
4717508|NCT02083653|16264943|P1|Overall Study|Other Events|0
4717509|NCT02083653|16264941|P3|Overall Study|Withdrawal by Subject|2
4717510|NCT02083653|16264942|P2|Overall Study|Withdrawal by Subject|1
4717511|NCT02083653|16264943|P1|Overall Study|Withdrawal by Subject|2
4717512|NCT02083653|16264941|P3|Overall Study|Progressive Disease|63
4717513|NCT02083653|16264942|P2|Overall Study|Progressive Disease|73
4717514|NCT02083653|16264943|P1|Overall Study|Progressive Disease|65
4717515|NCT02083653|16264941|P3|Overall Study|Death|2
4717516|NCT02083653|16264942|P2|Overall Study|Death|2
4717517|NCT02083653|16264943|P1|Overall Study|Death|2
4717518|NCT02083653|16264941|P3|Overall Study|Lost to Follow-up|0
4717519|NCT02083653|16264942|P2|Overall Study|Lost to Follow-up|0
4717520|NCT02083653|16264943|P1|Overall Study|Lost to Follow-up|1
4717521|NCT02083653|16264941|P3|Overall Study|Adverse Event|4
4717522|NCT02083653|16264942|P2|Overall Study|Adverse Event|5
4717523|NCT02083653|16264943|P1|Overall Study|Adverse Event|12
4717524|NCT02083653|16264941|P3|Overall Study|Randomized but not Treated|7
4717525|NCT02083653|16264942|P2|Overall Study|Randomized but not Treated|2
4717526|NCT02083653|16264943|P1|Overall Study|Randomized but not Treated|0
4717527|NCT02083380|16265011|P3|Overall Study|Other|6
4717528|NCT02083380|16265012|P2|Overall Study|Other|4
4717529|NCT02083380|16265013|P1|Overall Study|Other|8
4717530|NCT02083380|16265011|P3|Overall Study|Lost to Follow-up|3
4717531|NCT02083380|16265012|P2|Overall Study|Lost to Follow-up|3
4717532|NCT02083380|16265013|P1|Overall Study|Lost to Follow-up|5
4717533|NCT02083380|16265011|P3|Overall Study|Adverse Event|1
4717534|NCT02083380|16265012|P2|Overall Study|Adverse Event|0
4717535|NCT02083380|16265013|P1|Overall Study|Adverse Event|0
4717536|NCT02083380|16265011|P3|Overall Study|Physician Decision|3
4717537|NCT02083380|16265012|P2|Overall Study|Physician Decision|6
4717538|NCT02083380|16265013|P1|Overall Study|Physician Decision|1
4717539|NCT02083380|16265011|P3|Overall Study|Withdrawal by Subject|7
4717540|NCT02083380|16265012|P2|Overall Study|Withdrawal by Subject|3
4717541|NCT02083380|16265013|P1|Overall Study|Withdrawal by Subject|9
4717542|NCT02083380|16265011|P3|Overall Study|Lack of Efficacy|64
4717543|NCT02083380|16265012|P2|Overall Study|Lack of Efficacy|79
4717544|NCT02083380|16265013|P1|Overall Study|Lack of Efficacy|68
4717545|NCT02083185|16265118|P3|Overall Study|Did not Receive Study Drug|0
4717546|NCT02083185|16265119|P2|Overall Study|Did not Receive Study Drug|2
4717547|NCT02083185|16265120|P1|Overall Study|Did not Receive Study Drug|0
4717548|NCT02083185|16265118|P3|Overall Study|Study Terminated by Sponsor|0
4717549|NCT02083185|16265119|P2|Overall Study|Study Terminated by Sponsor|1
4717550|NCT02083185|16265120|P1|Overall Study|Study Terminated by Sponsor|0
4717551|NCT02083185|16265118|P3|Overall Study|Reason not Specified|5
4717552|NCT02083185|16265119|P2|Overall Study|Reason not Specified|6
4717553|NCT02083185|16265120|P1|Overall Study|Reason not Specified|9
4717554|NCT02083185|16265118|P3|Overall Study|Death|1
4717555|NCT02083185|16265119|P2|Overall Study|Death|2
4717556|NCT02083185|16265120|P1|Overall Study|Death|2
4717557|NCT02083185|16265118|P3|Overall Study|Withdrawal by Subject|1
4717558|NCT02083185|16265119|P2|Overall Study|Withdrawal by Subject|15
4717559|NCT02083185|16265120|P1|Overall Study|Withdrawal by Subject|9
4717560|NCT02083185|16265118|P3|Overall Study|Lost to Follow-up|0
4717561|NCT02083185|16265119|P2|Overall Study|Lost to Follow-up|3
4717562|NCT02083185|16265120|P1|Overall Study|Lost to Follow-up|0
4717563|NCT02082977|16265225|P10|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717564|NCT02082977|16265226|P9|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717565|NCT02082977|16265227|P8|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2
4717566|NCT02082977|16265228|P7|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717567|NCT02082977|16265229|P6|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717568|NCT02082977|16265230|P5|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717569|NCT02082977|16265231|P4|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717570|NCT02082977|16265232|P3|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717571|NCT02082977|16265233|P2|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717572|NCT02082977|16265234|P1|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0
4717573|NCT02082977|16265225|P10|Part 1 (Up to 3.2 Years)|Physician Decision|0
4717574|NCT02082977|16265226|P9|Part 1 (Up to 3.2 Years)|Physician Decision|2
4717575|NCT02082977|16265227|P8|Part 1 (Up to 3.2 Years)|Physician Decision|1
4717576|NCT02082977|16265228|P7|Part 1 (Up to 3.2 Years)|Physician Decision|4
4717577|NCT02082977|16265229|P6|Part 1 (Up to 3.2 Years)|Physician Decision|1
4717578|NCT02082977|16265230|P5|Part 1 (Up to 3.2 Years)|Physician Decision|1
4717579|NCT02082977|16265231|P4|Part 1 (Up to 3.2 Years)|Physician Decision|0
4717580|NCT02082977|16265232|P3|Part 1 (Up to 3.2 Years)|Physician Decision|0
4717581|NCT02082977|16265233|P2|Part 1 (Up to 3.2 Years)|Physician Decision|0
4717582|NCT02082977|16265234|P1|Part 1 (Up to 3.2 Years)|Physician Decision|0
4717583|NCT02082977|16265225|P10|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717584|NCT02082977|16265226|P9|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717585|NCT02082977|16265227|P8|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717586|NCT02082977|16265228|P7|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717587|NCT02082977|16265229|P6|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1
4717588|NCT02082977|16265230|P5|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717589|NCT02082977|16265231|P4|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717590|NCT02082977|16265232|P3|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717591|NCT02082977|16265233|P2|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717592|NCT02082977|16265234|P1|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0
4717593|NCT02082977|16265225|P10|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717594|NCT02082977|16265226|P9|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717595|NCT02082977|16265227|P8|Part 1 (Up to 3.2 Years)|Study closed/terminated|2
4717596|NCT02082977|16265228|P7|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717597|NCT02082977|16265229|P6|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717598|NCT02082977|16265230|P5|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717599|NCT02082977|16265231|P4|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717600|NCT02082977|16265232|P3|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717601|NCT02082977|16265233|P2|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717602|NCT02082977|16265234|P1|Part 1 (Up to 3.2 Years)|Study closed/terminated|0
4717603|NCT02082977|16265225|P10|Part 1 (Up to 3.2 Years)|Death|0
4717604|NCT02082977|16265226|P9|Part 1 (Up to 3.2 Years)|Death|1
4717605|NCT02082977|16265227|P8|Part 1 (Up to 3.2 Years)|Death|0
4717606|NCT02082977|16265228|P7|Part 1 (Up to 3.2 Years)|Death|2
4717607|NCT02082977|16265229|P6|Part 1 (Up to 3.2 Years)|Death|1
4717608|NCT02082977|16265230|P5|Part 1 (Up to 3.2 Years)|Death|0
4717609|NCT02082977|16265231|P4|Part 1 (Up to 3.2 Years)|Death|0
4717610|NCT02082977|16265232|P3|Part 1 (Up to 3.2 Years)|Death|0
4717611|NCT02082977|16265233|P2|Part 1 (Up to 3.2 Years)|Death|0
4717612|NCT02082977|16265234|P1|Part 1 (Up to 3.2 Years)|Death|1
4717613|NCT02082912|16265488|P2|Overall Study|Physician Decision|1
4717614|NCT02082912|16265489|P1|Overall Study|Physician Decision|0
4717615|NCT02082522|16265537|P2|Overall Study|Chemotherapy change|3
4717616|NCT02082522|16265538|P1|Overall Study|Chemotherapy change|1
4717617|NCT02082522|16265537|P2|Overall Study|Disease progression|2
4717618|NCT02082522|16265538|P1|Overall Study|Disease progression|2
4717619|NCT02082522|16265537|P2|Overall Study|Physician Decision|1
4717620|NCT02082522|16265538|P1|Overall Study|Physician Decision|3
4717621|NCT02082522|16265537|P2|Overall Study|Lost to Follow-up|0
4717622|NCT02082522|16265538|P1|Overall Study|Lost to Follow-up|1
4717623|NCT02082522|16265537|P2|Overall Study|Death|0
4717624|NCT02082522|16265538|P1|Overall Study|Death|1
4717625|NCT02082522|16265537|P2|Overall Study|Withdrawal by Subject|4
4717626|NCT02082522|16265538|P1|Overall Study|Withdrawal by Subject|2
4717627|NCT02082522|16265537|P2|Overall Study|Sponsor termination|3
4717628|NCT02082522|16265538|P1|Overall Study|Sponsor termination|5
4717629|NCT02082483|16265588|P2|Overall Study|Death|3
4717630|NCT02082483|16265589|P1|Overall Study|Death|2
4717631|NCT02082483|16265588|P2|Overall Study|Physician Decision|1
4717632|NCT02082483|16265589|P1|Overall Study|Physician Decision|1
4717633|NCT02082483|16265588|P2|Overall Study|Withdrawal by Subject|1
4717634|NCT02082483|16265589|P1|Overall Study|Withdrawal by Subject|2
4717635|NCT02082483|16265588|P2|Overall Study|Lost to Follow-up|1
4717636|NCT02082483|16265589|P1|Overall Study|Lost to Follow-up|1
4717637|NCT02082340|16265641|P2|Overall Study|Lost to Follow-up|1
4717638|NCT02082340|16265642|P1|Overall Study|Lost to Follow-up|1
4717639|NCT02082262|16265652|P1|Overall Study|Adverse Event|48
4717640|NCT02082262|16265652|P1|Overall Study|Withdrawal by Subject|3
4717641|NCT02082184|16265658|P2|Overall Study|Subject non-compliance|1
4717642|NCT02082184|16265659|P1|Overall Study|Subject non-compliance|0
4717643|NCT02082184|16265658|P2|Overall Study|Lost to Follow-up|2
4717644|NCT02082184|16265659|P1|Overall Study|Lost to Follow-up|0
4717645|NCT02082184|16265658|P2|Overall Study|Protocol Violation|6
4717646|NCT02082184|16265659|P1|Overall Study|Protocol Violation|0
4717647|NCT02082184|16265658|P2|Overall Study|Withdrawal by Subject|2
4717648|NCT02082184|16265659|P1|Overall Study|Withdrawal by Subject|3
4717649|NCT02082184|16265658|P2|Overall Study|Device associated symptoms|0
4717650|NCT02082184|16265659|P1|Overall Study|Device associated symptoms|5
4717651|NCT02082184|16265658|P2|Overall Study|Medical diagnosis|2
4717652|NCT02082184|16265659|P1|Overall Study|Medical diagnosis|1
4717653|NCT02082184|16265658|P2|Overall Study|Adverse Event|0
4717654|NCT02082184|16265659|P1|Overall Study|Adverse Event|1
4717655|NCT02082158|16265684|P6|Overall Study|Failed Fit-testing|7
4717656|NCT02082158|16265685|P5|Overall Study|Failed Fit-testing|3
4717657|NCT02082158|16265686|P4|Overall Study|Failed Fit-testing|4
4717658|NCT02082158|16265687|P3|Overall Study|Failed Fit-testing|14
4717659|NCT02082158|16265688|P2|Overall Study|Failed Fit-testing|8
4717660|NCT02082158|16265689|P1|Overall Study|Failed Fit-testing|8
4717661|NCT02082158|16265684|P6|Overall Study|Withdrawal by Subject|0
4717662|NCT02082158|16265685|P5|Overall Study|Withdrawal by Subject|1
4717663|NCT02082158|16265686|P4|Overall Study|Withdrawal by Subject|0
4717664|NCT02082158|16265687|P3|Overall Study|Withdrawal by Subject|0
4717665|NCT02082158|16265688|P2|Overall Study|Withdrawal by Subject|0
4717666|NCT02082158|16265689|P1|Overall Study|Withdrawal by Subject|0
4717667|NCT02081859|16265819|P2|Overall Study|Other reasons|0
4717668|NCT02081859|16265820|P1|Overall Study|Other reasons|2
4717669|NCT02081859|16265819|P2|Overall Study|< 4 embryos|23
4717670|NCT02081859|16265820|P1|Overall Study|< 4 embryos|27
4717671|NCT02081859|16265819|P2|Overall Study|Unanticipated freeze all cycle|6
4717672|NCT02081859|16265820|P1|Overall Study|Unanticipated freeze all cycle|2
4717673|NCT02081859|16265819|P2|Overall Study|No sperm|0
4717674|NCT02081859|16265820|P1|Overall Study|No sperm|1
4717675|NCT02081859|16265819|P2|Overall Study|No fertilization|2
4717676|NCT02081859|16265820|P1|Overall Study|No fertilization|2
4717677|NCT02081846|16265830|P2|Overall Study|invalid consent|0
4717678|NCT02081846|16265831|P1|Overall Study|invalid consent|1
4717679|NCT02081846|16265830|P2|Overall Study|Withdrawal by Subject|0
4717680|NCT02081846|16265831|P1|Overall Study|Withdrawal by Subject|1
4717681|NCT02081690|16266000|P1|Overall Study|Withdrawal by Subject|1
4717682|NCT02081690|16266000|P1|Overall Study|Physician Decision|3
4717683|NCT02081690|16266000|P1|Overall Study|Death|3
4717684|NCT02081677|16266011|P4|Overall Study|Unsatisfactory Lens Fitting|0
4717685|NCT02081677|16266012|P3|Overall Study|Unsatisfactory Lens Fitting|0
4717686|NCT02081677|16266013|P2|Overall Study|Unsatisfactory Lens Fitting|1
4717687|NCT02081677|16266014|P1|Overall Study|Unsatisfactory Lens Fitting|0
4717688|NCT02081677|16266011|P4|Overall Study|Not comfortable with lens care system|0
4717689|NCT02081677|16266012|P3|Overall Study|Not comfortable with lens care system|0
4717690|NCT02081677|16266013|P2|Overall Study|Not comfortable with lens care system|0
4717691|NCT02081677|16266014|P1|Overall Study|Not comfortable with lens care system|1
4717692|NCT02081677|16266011|P4|Overall Study|No Longer Meets Eligibility Criteria|0
4717693|NCT02081677|16266012|P3|Overall Study|No Longer Meets Eligibility Criteria|1
4717694|NCT02081677|16266013|P2|Overall Study|No Longer Meets Eligibility Criteria|0
4717695|NCT02081677|16266014|P1|Overall Study|No Longer Meets Eligibility Criteria|0
4717696|NCT02081677|16266011|P4|Overall Study|Adverse Event|0
4717697|NCT02081677|16266012|P3|Overall Study|Adverse Event|1
4717698|NCT02081677|16266013|P2|Overall Study|Adverse Event|0
4717699|NCT02081677|16266014|P1|Overall Study|Adverse Event|0
4717700|NCT02081599|16266106|P2|Period 2：Open-label Period|Withdrawal by Subject|0
4717701|NCT02081599|16266107|P1|Period 2：Open-label Period|Withdrawal by Subject|2
4717702|NCT02081599|16266106|P2|Period 2：Open-label Period|Physician Decision|0
4717703|NCT02081599|16266107|P1|Period 2：Open-label Period|Physician Decision|1
4717704|NCT02081599|16266106|P2|Period 2：Open-label Period|Lack of Efficacy|4
4717705|NCT02081599|16266107|P1|Period 2：Open-label Period|Lack of Efficacy|2
4717706|NCT02081599|16266106|P2|Period 2：Open-label Period|Adverse Event|0
4717707|NCT02081599|16266107|P1|Period 2：Open-label Period|Adverse Event|1
4717708|NCT02081599|16266106|P2|Period 1：Double-blind Period|stopping criteria|0
4717709|NCT02081599|16266107|P1|Period 1：Double-blind Period|stopping criteria|1
4717710|NCT02081599|16266106|P2|Period 1：Double-blind Period|Withdrawal by Subject|0
4717711|NCT02081599|16266107|P1|Period 1：Double-blind Period|Withdrawal by Subject|1
4717712|NCT02081599|16266106|P2|Period 1：Double-blind Period|Protocol Violation|1
4717713|NCT02081599|16266107|P1|Period 1：Double-blind Period|Protocol Violation|0
4717714|NCT02081599|16266106|P2|Period 1：Double-blind Period|Physician Decision|0
4717715|NCT02081599|16266107|P1|Period 1：Double-blind Period|Physician Decision|1
4717716|NCT02081599|16266106|P2|Period 1：Double-blind Period|Lack of Efficacy|1
4717717|NCT02081599|16266107|P1|Period 1：Double-blind Period|Lack of Efficacy|2
4717718|NCT02081599|16266106|P2|Period 1：Double-blind Period|Adverse Event|0
4717719|NCT02081599|16266107|P1|Period 1：Double-blind Period|Adverse Event|3
4717720|NCT02081586|16266125|P4|Overall Study|Head injury not related to study|0
4717721|NCT02081586|16266126|P3|Overall Study|Head injury not related to study|1
4717722|NCT02081586|16266127|P2|Overall Study|Head injury not related to study|0
4717723|NCT02081586|16266128|P1|Overall Study|Head injury not related to study|0
4717724|NCT02081586|16266125|P4|Overall Study|Lost to Follow-up|1
4717725|NCT02081586|16266126|P3|Overall Study|Lost to Follow-up|0
4717726|NCT02081586|16266127|P2|Overall Study|Lost to Follow-up|1
4717727|NCT02081586|16266128|P1|Overall Study|Lost to Follow-up|0
4717728|NCT02081534|16266171|P7|Overall Study|Lost to Follow-up|0
4717729|NCT02081534|16266172|P6|Overall Study|Lost to Follow-up|1
4717730|NCT02081534|16266173|P5|Overall Study|Lost to Follow-up|1
4717731|NCT02081534|16266174|P4|Overall Study|Lost to Follow-up|2
4717732|NCT02081534|16266175|P3|Overall Study|Lost to Follow-up|0
4717733|NCT02081534|16266176|P2|Overall Study|Lost to Follow-up|0
4717734|NCT02081534|16266177|P1|Overall Study|Lost to Follow-up|0
4717735|NCT02081534|16266171|P7|Overall Study|Protocol Violation|1
4717736|NCT02081534|16266172|P6|Overall Study|Protocol Violation|0
4717737|NCT02081534|16266173|P5|Overall Study|Protocol Violation|0
4717738|NCT02081534|16266174|P4|Overall Study|Protocol Violation|0
4717739|NCT02081534|16266175|P3|Overall Study|Protocol Violation|0
4717740|NCT02081534|16266176|P2|Overall Study|Protocol Violation|3
4717741|NCT02081534|16266177|P1|Overall Study|Protocol Violation|0
4717742|NCT02081534|16266171|P7|Overall Study|Withdrawal by Subject|1
4717743|NCT02081534|16266172|P6|Overall Study|Withdrawal by Subject|0
4717744|NCT02081534|16266173|P5|Overall Study|Withdrawal by Subject|1
4717745|NCT02081534|16266174|P4|Overall Study|Withdrawal by Subject|1
4717746|NCT02081534|16266175|P3|Overall Study|Withdrawal by Subject|1
4717747|NCT02081534|16266176|P2|Overall Study|Withdrawal by Subject|1
4717748|NCT02081534|16266177|P1|Overall Study|Withdrawal by Subject|0
4717749|NCT02081534|16266171|P7|Overall Study|Adverse Event|2
4717750|NCT02081534|16266172|P6|Overall Study|Adverse Event|8
4717751|NCT02081534|16266173|P5|Overall Study|Adverse Event|2
4717752|NCT02081534|16266174|P4|Overall Study|Adverse Event|10
4717753|NCT02081534|16266175|P3|Overall Study|Adverse Event|3
4717754|NCT02081534|16266176|P2|Overall Study|Adverse Event|4
4717755|NCT02081534|16266177|P1|Overall Study|Adverse Event|5
4717756|NCT02081417|16266230|P2|Overall Study|Did not start treatment|21
4717757|NCT02081417|16266231|P1|Overall Study|Did not start treatment|17
4717758|NCT02081417|16266230|P2|Overall Study|Admitted to Residential Treatment|0
4717759|NCT02081417|16266231|P1|Overall Study|Admitted to Residential Treatment|2
4717760|NCT02081417|16266230|P2|Overall Study|Withdrawal by Subject|0
4717761|NCT02081417|16266231|P1|Overall Study|Withdrawal by Subject|4
4717762|NCT02081417|16266230|P2|Overall Study|Death|3
4717763|NCT02081417|16266231|P1|Overall Study|Death|4
4717764|NCT02081417|16266230|P2|Overall Study|Incarcerated|2
4717765|NCT02081417|16266231|P1|Overall Study|Incarcerated|2
4717766|NCT02081417|16266230|P2|Overall Study|Moved Away|2
4717767|NCT02081417|16266231|P1|Overall Study|Moved Away|1
4717768|NCT02081417|16266230|P2|Overall Study|Lost to Follow-up|23
4717769|NCT02081417|16266231|P1|Overall Study|Lost to Follow-up|26
4717770|NCT02081391|16266251|P4|24-hour Treatment and Trial Completion|Further reasons|0
4717771|NCT02081391|16266252|P3|24-hour Treatment and Trial Completion|Further reasons|0
4717772|NCT02081391|16266253|P2|24-hour Treatment and Trial Completion|Further reasons|4
4717773|NCT02081391|16266254|P1|24-hour Treatment and Trial Completion|Further reasons|3
4717774|NCT02081391|16266251|P4|24-hour Treatment and Trial Completion|Technical Problems|0
4717775|NCT02081391|16266252|P3|24-hour Treatment and Trial Completion|Technical Problems|0
4717776|NCT02081391|16266253|P2|24-hour Treatment and Trial Completion|Technical Problems|1
4717777|NCT02081391|16266254|P1|24-hour Treatment and Trial Completion|Technical Problems|1
4717778|NCT02081391|16266251|P4|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0
4717779|NCT02081391|16266252|P3|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1
4717780|NCT02081391|16266253|P2|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5
4717781|NCT02081391|16266254|P1|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11
4717782|NCT02081391|16266251|P4|24-hour Treatment and Trial Completion|Adverse Event|0
4717870|NCT02079909|16266906|P1|Overall Study|Death|2
4717783|NCT02081391|16266252|P3|24-hour Treatment and Trial Completion|Adverse Event|0
4717784|NCT02081391|16266253|P2|24-hour Treatment and Trial Completion|Adverse Event|0
4717785|NCT02081391|16266254|P1|24-hour Treatment and Trial Completion|Adverse Event|1
4717786|NCT02081391|16266251|P4|24-hour Treatment and Trial Completion|Lack of Efficacy|0
4717787|NCT02081391|16266252|P3|24-hour Treatment and Trial Completion|Lack of Efficacy|0
4717788|NCT02081391|16266253|P2|24-hour Treatment and Trial Completion|Lack of Efficacy|3
4717789|NCT02081391|16266254|P1|24-hour Treatment and Trial Completion|Lack of Efficacy|1
4717790|NCT02081391|16266251|P4|24-hour Treatment and Trial Completion|Physician Decision|0
4717791|NCT02081391|16266252|P3|24-hour Treatment and Trial Completion|Physician Decision|0
4717792|NCT02081391|16266253|P2|24-hour Treatment and Trial Completion|Physician Decision|5
4717793|NCT02081391|16266254|P1|24-hour Treatment and Trial Completion|Physician Decision|10
4717794|NCT02081391|16266251|P4|12-hour Treatment|Further reasons|0
4717795|NCT02081391|16266252|P3|12-hour Treatment|Further reasons|0
4717796|NCT02081391|16266253|P2|12-hour Treatment|Further reasons|1
4717797|NCT02081391|16266254|P1|12-hour Treatment|Further reasons|2
4717798|NCT02081391|16266251|P4|12-hour Treatment|Recovery (opioid no longer needed)|0
4717799|NCT02081391|16266252|P3|12-hour Treatment|Recovery (opioid no longer needed)|1
4717800|NCT02081391|16266253|P2|12-hour Treatment|Recovery (opioid no longer needed)|0
4717801|NCT02081391|16266254|P1|12-hour Treatment|Recovery (opioid no longer needed)|2
4717802|NCT02081391|16266251|P4|12-hour Treatment|Adverse Event|0
4717803|NCT02081391|16266252|P3|12-hour Treatment|Adverse Event|0
4717804|NCT02081391|16266253|P2|12-hour Treatment|Adverse Event|2
4717805|NCT02081391|16266254|P1|12-hour Treatment|Adverse Event|4
4717806|NCT02081391|16266251|P4|12-hour Treatment|Lack of Efficacy|0
4717807|NCT02081391|16266252|P3|12-hour Treatment|Lack of Efficacy|0
4717808|NCT02081391|16266253|P2|12-hour Treatment|Lack of Efficacy|0
4717809|NCT02081391|16266254|P1|12-hour Treatment|Lack of Efficacy|3
4717810|NCT02081391|16266251|P4|12-hour Treatment|Physician Decision|0
4717811|NCT02081391|16266252|P3|12-hour Treatment|Physician Decision|0
4717812|NCT02081391|16266253|P2|12-hour Treatment|Physician Decision|1
4717813|NCT02081391|16266254|P1|12-hour Treatment|Physician Decision|4
4717814|NCT02081391|16266251|P4|12-hour Treatment|Withdrawal by Subject|0
4717815|NCT02081391|16266252|P3|12-hour Treatment|Withdrawal by Subject|0
4717816|NCT02081391|16266253|P2|12-hour Treatment|Withdrawal by Subject|2
4717817|NCT02081391|16266254|P1|12-hour Treatment|Withdrawal by Subject|3
4717818|NCT02081183|16266348|P2|Overall Study|Other|3
4717819|NCT02081183|16266349|P1|Overall Study|Other|3
4717820|NCT02081183|16266348|P2|Overall Study|Protocol Violation|0
4717821|NCT02081183|16266349|P1|Overall Study|Protocol Violation|1
4717822|NCT02081183|16266348|P2|Overall Study|Lost to Follow-up|1
4717823|NCT02081183|16266349|P1|Overall Study|Lost to Follow-up|0
4717824|NCT02081079|16266365|P2|Overall Study|Lost to Follow-up|0
4717825|NCT02081079|16266366|P1|Overall Study|Lost to Follow-up|1
4717826|NCT02081079|16266365|P2|Overall Study|Lack of Efficacy|2
4717827|NCT02081079|16266366|P1|Overall Study|Lack of Efficacy|3
4717828|NCT02081001|16266439|P12|Overall Study|Adverse Event|0
4717829|NCT02081001|16266440|P11|Overall Study|Adverse Event|0
4717830|NCT02081001|16266441|P10|Overall Study|Adverse Event|0
4717831|NCT02081001|16266442|P9|Overall Study|Adverse Event|0
4717832|NCT02081001|16266443|P8|Overall Study|Adverse Event|0
4717833|NCT02081001|16266444|P7|Overall Study|Adverse Event|0
4717834|NCT02081001|16266445|P6|Overall Study|Adverse Event|0
4717835|NCT02081001|16266446|P5|Overall Study|Adverse Event|1
4717836|NCT02081001|16266447|P4|Overall Study|Adverse Event|0
4717837|NCT02081001|16266448|P3|Overall Study|Adverse Event|0
4717838|NCT02081001|16266449|P2|Overall Study|Adverse Event|0
4717839|NCT02081001|16266450|P1|Overall Study|Adverse Event|0
4717840|NCT02080871|16266514|P1|Overall Study|Lost to Follow-up|1
4717841|NCT02080871|16266514|P1|Overall Study|Death|1
4717842|NCT02080832|16266598|P3|Overall Study|Lost to Follow-up|2
4717843|NCT02080832|16266599|P2|Overall Study|Lost to Follow-up|2
4717844|NCT02080832|16266600|P1|Overall Study|Lost to Follow-up|0
4717845|NCT02080832|16266598|P3|Overall Study|Excluded from analysis by MRI|14
4717846|NCT02080832|16266599|P2|Overall Study|Excluded from analysis by MRI|10
4717847|NCT02080832|16266600|P1|Overall Study|Excluded from analysis by MRI|9
4717848|NCT02080481|16266672|P2|Overall Study|Never received a block.|0
4717849|NCT02080481|16266673|P1|Overall Study|Never received a block.|1
4717850|NCT02080260|16266859|P1|Overall Study|Withdrawal by Subject|1
4717851|NCT02080260|16266859|P1|Overall Study|Death|18
4717852|NCT02080091|16266876|P1|Overall Study|Other|1
4717853|NCT02080091|16266876|P1|Overall Study|Withdrawal by Subject|1
4717854|NCT02080091|16266876|P1|Overall Study|Death|1
4717855|NCT02080091|16266876|P1|Overall Study|Study Terminated|22
4717856|NCT02079909|16266904|P3|Overall Study|Relocation etc.|3
4717857|NCT02079909|16266905|P2|Overall Study|Relocation etc.|2
4717858|NCT02079909|16266906|P1|Overall Study|Relocation etc.|2
4717859|NCT02079909|16266904|P3|Overall Study|Physician Decision|1
4717860|NCT02079909|16266905|P2|Overall Study|Physician Decision|1
4717861|NCT02079909|16266906|P1|Overall Study|Physician Decision|0
4717862|NCT02079909|16266904|P3|Overall Study|Protocol Violation|1
4717863|NCT02079909|16266905|P2|Overall Study|Protocol Violation|1
4717864|NCT02079909|16266906|P1|Overall Study|Protocol Violation|0
4717865|NCT02079909|16266904|P3|Overall Study|Lack of Efficacy|1
4717866|NCT02079909|16266905|P2|Overall Study|Lack of Efficacy|0
4717867|NCT02079909|16266906|P1|Overall Study|Lack of Efficacy|0
4717868|NCT02079909|16266904|P3|Overall Study|Death|0
4717869|NCT02079909|16266905|P2|Overall Study|Death|2
4717871|NCT02079909|16266904|P3|Overall Study|Lost to Follow-up|1
4717872|NCT02079909|16266905|P2|Overall Study|Lost to Follow-up|3
4717873|NCT02079909|16266906|P1|Overall Study|Lost to Follow-up|2
4717874|NCT02079909|16266904|P3|Overall Study|Withdrawal by Subject|4
4717875|NCT02079909|16266905|P2|Overall Study|Withdrawal by Subject|17
4717876|NCT02079909|16266906|P1|Overall Study|Withdrawal by Subject|9
4717877|NCT02079909|16266904|P3|Overall Study|Adverse Event|7
4717878|NCT02079909|16266905|P2|Overall Study|Adverse Event|23
4717879|NCT02079909|16266906|P1|Overall Study|Adverse Event|23
4717880|NCT02079844|16266923|P3|Treatment Period 2|Voluntary Withdrawal|0
4717881|NCT02079844|16266924|P2|Treatment Period 2|Voluntary Withdrawal|1
4717882|NCT02079844|16266925|P1|Treatment Period 2|Voluntary Withdrawal|0
4717883|NCT02079844|16266923|P3|Treatment Period 1|Voluntary Withdrawal|2
4717884|NCT02079844|16266924|P2|Treatment Period 1|Voluntary Withdrawal|0
4717885|NCT02079844|16266925|P1|Treatment Period 1|Voluntary Withdrawal|0
4717886|NCT02079805|16266983|P2|Overall Study|Voluntary Withdrawal|1
4717887|NCT02079805|16266984|P1|Overall Study|Voluntary Withdrawal|0
4717888|NCT02079805|16266983|P2|Overall Study|Pretreatment Event/Adverse Event|1
4717889|NCT02079805|16266984|P1|Overall Study|Pretreatment Event/Adverse Event|0
4717890|NCT02079766|16267004|P2|Overall Study|Withdrawal by Subject|0
4717891|NCT02079766|16267005|P1|Overall Study|Withdrawal by Subject|1
4717892|NCT02079766|16267004|P2|Overall Study|Physician Decision|0
4717893|NCT02079766|16267005|P1|Overall Study|Physician Decision|1
4717894|NCT02079649|16267016|P4|Overall Study|Randomization error (prior to treatment)|0
4717895|NCT02079649|16267017|P3|Overall Study|Randomization error (prior to treatment)|1
4717896|NCT02079649|16267018|P2|Overall Study|Randomization error (prior to treatment)|0
4717897|NCT02079649|16267019|P1|Overall Study|Randomization error (prior to treatment)|1
4717898|NCT02079649|16267016|P4|Overall Study|Withdrawal by Subject|1
4717899|NCT02079649|16267017|P3|Overall Study|Withdrawal by Subject|0
4717900|NCT02079649|16267018|P2|Overall Study|Withdrawal by Subject|0
4717901|NCT02079649|16267019|P1|Overall Study|Withdrawal by Subject|0
4717902|NCT02079649|16267016|P4|Overall Study|Lost to Follow-up|1
4717903|NCT02079649|16267017|P3|Overall Study|Lost to Follow-up|0
4717904|NCT02079649|16267018|P2|Overall Study|Lost to Follow-up|0
4717905|NCT02079649|16267019|P1|Overall Study|Lost to Follow-up|0
4717906|NCT02079636|16267049|P15|Overall Study|Lost to Follow-up|0
4717907|NCT02079636|16267050|P14|Overall Study|Lost to Follow-up|0
4717908|NCT02079636|16267051|P13|Overall Study|Lost to Follow-up|0
4717909|NCT02079636|16267052|P12|Overall Study|Lost to Follow-up|0
4717910|NCT02079636|16267053|P11|Overall Study|Lost to Follow-up|0
4717911|NCT02079636|16267054|P10|Overall Study|Lost to Follow-up|0
4717912|NCT02079636|16267055|P9|Overall Study|Lost to Follow-up|0
4717913|NCT02079636|16267056|P8|Overall Study|Lost to Follow-up|1
4717914|NCT02079636|16267057|P7|Overall Study|Lost to Follow-up|0
4717915|NCT02079636|16267058|P6|Overall Study|Lost to Follow-up|0
4717916|NCT02079636|16267059|P5|Overall Study|Lost to Follow-up|0
4717917|NCT02079636|16267060|P4|Overall Study|Lost to Follow-up|0
4717918|NCT02079636|16267061|P3|Overall Study|Lost to Follow-up|0
4717919|NCT02079636|16267062|P2|Overall Study|Lost to Follow-up|0
4717920|NCT02079636|16267063|P1|Overall Study|Lost to Follow-up|0
4717921|NCT02079636|16267049|P15|Overall Study|Physician Decision|1
4717922|NCT02079636|16267050|P14|Overall Study|Physician Decision|0
4717923|NCT02079636|16267051|P13|Overall Study|Physician Decision|0
4717924|NCT02079636|16267052|P12|Overall Study|Physician Decision|0
4717925|NCT02079636|16267053|P11|Overall Study|Physician Decision|1
4717926|NCT02079636|16267054|P10|Overall Study|Physician Decision|1
4717927|NCT02079636|16267055|P9|Overall Study|Physician Decision|0
4717928|NCT02079636|16267056|P8|Overall Study|Physician Decision|0
4717929|NCT02079636|16267057|P7|Overall Study|Physician Decision|0
4717930|NCT02079636|16267058|P6|Overall Study|Physician Decision|1
4717931|NCT02079636|16267059|P5|Overall Study|Physician Decision|0
4717932|NCT02079636|16267060|P4|Overall Study|Physician Decision|0
4717933|NCT02079636|16267061|P3|Overall Study|Physician Decision|0
4717934|NCT02079636|16267062|P2|Overall Study|Physician Decision|0
4717935|NCT02079636|16267063|P1|Overall Study|Physician Decision|0
4717936|NCT02079636|16267049|P15|Overall Study|Withdrawal by Subject|2
4717937|NCT02079636|16267050|P14|Overall Study|Withdrawal by Subject|0
4717938|NCT02079636|16267051|P13|Overall Study|Withdrawal by Subject|1
4717939|NCT02079636|16267052|P12|Overall Study|Withdrawal by Subject|1
4717940|NCT02079636|16267053|P11|Overall Study|Withdrawal by Subject|1
4717941|NCT02079636|16267054|P10|Overall Study|Withdrawal by Subject|2
4717942|NCT02079636|16267055|P9|Overall Study|Withdrawal by Subject|0
4717943|NCT02079636|16267056|P8|Overall Study|Withdrawal by Subject|0
4717944|NCT02079636|16267057|P7|Overall Study|Withdrawal by Subject|0
4717945|NCT02079636|16267058|P6|Overall Study|Withdrawal by Subject|1
4717946|NCT02079636|16267059|P5|Overall Study|Withdrawal by Subject|0
4717947|NCT02079636|16267060|P4|Overall Study|Withdrawal by Subject|4
4717948|NCT02079636|16267061|P3|Overall Study|Withdrawal by Subject|0
4717949|NCT02079636|16267062|P2|Overall Study|Withdrawal by Subject|0
4717950|NCT02079636|16267063|P1|Overall Study|Withdrawal by Subject|0
4717951|NCT02079636|16267049|P15|Overall Study|Progressive disease|0
4717952|NCT02079636|16267050|P14|Overall Study|Progressive disease|0
4717953|NCT02079636|16267051|P13|Overall Study|Progressive disease|1
4717954|NCT02079636|16267052|P12|Overall Study|Progressive disease|0
4717955|NCT02079636|16267053|P11|Overall Study|Progressive disease|0
4717956|NCT02079636|16267054|P10|Overall Study|Progressive disease|0
4717957|NCT02079636|16267055|P9|Overall Study|Progressive disease|0
4717958|NCT02079636|16267056|P8|Overall Study|Progressive disease|0
4717959|NCT02079636|16267057|P7|Overall Study|Progressive disease|0
4717960|NCT02079636|16267058|P6|Overall Study|Progressive disease|0
4717961|NCT02079636|16267059|P5|Overall Study|Progressive disease|0
4717962|NCT02079636|16267060|P4|Overall Study|Progressive disease|2
4717963|NCT02079636|16267061|P3|Overall Study|Progressive disease|0
4717964|NCT02079636|16267062|P2|Overall Study|Progressive disease|0
4717965|NCT02079636|16267063|P1|Overall Study|Progressive disease|0
4717966|NCT02079636|16267049|P15|Overall Study|Adverse Event|0
4717967|NCT02079636|16267050|P14|Overall Study|Adverse Event|0
4717968|NCT02079636|16267051|P13|Overall Study|Adverse Event|0
4717969|NCT02079636|16267052|P12|Overall Study|Adverse Event|0
4717970|NCT02079636|16267053|P11|Overall Study|Adverse Event|0
4717971|NCT02079636|16267054|P10|Overall Study|Adverse Event|0
4717972|NCT02079636|16267055|P9|Overall Study|Adverse Event|0
4717973|NCT02079636|16267056|P8|Overall Study|Adverse Event|0
4717974|NCT02079636|16267057|P7|Overall Study|Adverse Event|0
4717975|NCT02079636|16267058|P6|Overall Study|Adverse Event|2
4717976|NCT02079636|16267059|P5|Overall Study|Adverse Event|1
4717977|NCT02079636|16267060|P4|Overall Study|Adverse Event|1
4717978|NCT02079636|16267061|P3|Overall Study|Adverse Event|0
4717979|NCT02079636|16267062|P2|Overall Study|Adverse Event|1
4717980|NCT02079636|16267063|P1|Overall Study|Adverse Event|1
4717981|NCT02079636|16267049|P15|Overall Study|Death|2
4717982|NCT02079636|16267050|P14|Overall Study|Death|0
4717983|NCT02079636|16267051|P13|Overall Study|Death|1
4717984|NCT02079636|16267052|P12|Overall Study|Death|1
4717985|NCT02079636|16267053|P11|Overall Study|Death|0
4717986|NCT02079636|16267054|P10|Overall Study|Death|0
4717987|NCT02079636|16267055|P9|Overall Study|Death|0
4717988|NCT02079636|16267056|P8|Overall Study|Death|0
4717989|NCT02079636|16267057|P7|Overall Study|Death|1
4717990|NCT02079636|16267058|P6|Overall Study|Death|2
4717991|NCT02079636|16267059|P5|Overall Study|Death|1
4717992|NCT02079636|16267060|P4|Overall Study|Death|5
4717993|NCT02079636|16267061|P3|Overall Study|Death|0
4717994|NCT02079636|16267062|P2|Overall Study|Death|1
4717995|NCT02079636|16267063|P1|Overall Study|Death|2
4717996|NCT02079610|16267174|P2|Overall Study|Withdrawal by Subject|1
4717997|NCT02079610|16267175|P1|Overall Study|Withdrawal by Subject|1
4717998|NCT02079532|16267185|P1|Overall Study|Other|3
4717999|NCT02079532|16267185|P1|Overall Study|Inclusion into ReFIRST|3
4718000|NCT02079532|16267185|P1|Overall Study|Administrative problems|1
4718001|NCT02079532|16267185|P1|Overall Study|Withdrawal by Subject|1
4718002|NCT02079532|16267185|P1|Overall Study|Protocol Violation|3
4718003|NCT02079532|16267185|P1|Overall Study|Lack of Efficacy|9
4718004|NCT02079532|16267185|P1|Overall Study|Additional or changed therapy|2
4718005|NCT02079532|16267185|P1|Overall Study|Adverse Event|7
4718006|NCT02079519|16267207|P1|Overall Study|Adverse Event|1
4718007|NCT02079519|16267207|P1|Overall Study|Disease Progression|9
4718008|NCT02079246|16267220|P2|OLEX-MEM|Other: Moved to nursing home|3
4718009|NCT02079246|16267221|P1|OLEX-MEM|Other: Moved to nursing home|0
4718010|NCT02079246|16267220|P2|OLEX-MEM|Lost to Follow-up|1
4718011|NCT02079246|16267221|P1|OLEX-MEM|Lost to Follow-up|0
4718012|NCT02079246|16267220|P2|OLEX-MEM|Protocol Violation|2
4718013|NCT02079246|16267221|P1|OLEX-MEM|Protocol Violation|0
4718014|NCT02079246|16267220|P2|OLEX-MEM|Withdrawal by Subject|7
4718015|NCT02079246|16267221|P1|OLEX-MEM|Withdrawal by Subject|0
4718016|NCT02079246|16267220|P2|OLEX-MEM|Adverse Event|6
4718017|NCT02079246|16267221|P1|OLEX-MEM|Adverse Event|0
4718018|NCT02079246|16267220|P2|OLEX|Other: Withdrawal of caregiver consent|0
4718019|NCT02079246|16267221|P1|OLEX|Other: Withdrawal of caregiver consent|1
4718020|NCT02079246|16267220|P2|OLEX|Other: Moved to nursing home|0
4718021|NCT02079246|16267221|P1|OLEX|Other: Moved to nursing home|1
4718022|NCT02079246|16267220|P2|OLEX|Other: Worsening of condition|0
4718023|NCT02079246|16267221|P1|OLEX|Other: Worsening of condition|1
4718024|NCT02079246|16267220|P2|OLEX|Other: Coordinator decision|0
4718025|NCT02079246|16267221|P1|OLEX|Other: Coordinator decision|1
4718026|NCT02079246|16267220|P2|OLEX|Other: Caregiver unavailable|0
4718027|NCT02079246|16267221|P1|OLEX|Other: Caregiver unavailable|3
4718028|NCT02079246|16267220|P2|OLEX|Other: Insufficient compliance|0
4718029|NCT02079246|16267221|P1|OLEX|Other: Insufficient compliance|2
4718030|NCT02079246|16267220|P2|OLEX|Other: Disallowed medication|0
4718031|NCT02079246|16267221|P1|OLEX|Other: Disallowed medication|8
4718032|NCT02079246|16267220|P2|OLEX|Results of the lead-in studies|0
4718033|NCT02079246|16267221|P1|OLEX|Results of the lead-in studies|58
4718034|NCT02079246|16267220|P2|OLEX|Lack of Efficacy|0
4718035|NCT02079246|16267221|P1|OLEX|Lack of Efficacy|3
4718036|NCT02079246|16267220|P2|OLEX|Protocol Violation|0
4718037|NCT02079246|16267221|P1|OLEX|Protocol Violation|6
4718038|NCT02079246|16267220|P2|OLEX|Lost to Follow-up|0
4718039|NCT02079246|16267221|P1|OLEX|Lost to Follow-up|6
4718040|NCT02079246|16267220|P2|OLEX|Withdrawal by Subject|0
4718041|NCT02079246|16267221|P1|OLEX|Withdrawal by Subject|60
4718042|NCT02079246|16267220|P2|OLEX|Adverse Event|0
4718043|NCT02079246|16267221|P1|OLEX|Adverse Event|66
4718044|NCT02079246|16267220|P2|OLEX|Death|0
4718045|NCT02079246|16267221|P1|OLEX|Death|11
4718046|NCT02079246|16267220|P2|OLEX|Withdrawal before treatment|0
4718047|NCT02079246|16267221|P1|OLEX|Withdrawal before treatment|1
4718048|NCT02079077|16267240|P2|Overall Study|Became STIs Positive|2
4718049|NCT02079077|16267241|P1|Overall Study|Became STIs Positive|1
4718050|NCT02079077|16267240|P2|Overall Study|Lost to Follow-up|7
4718051|NCT02079077|16267241|P1|Overall Study|Lost to Follow-up|5
4718052|NCT02079038|16267251|P2|Completed 6 Months|Lost to Follow-up|1
4718053|NCT02079038|16267252|P1|Completed 6 Months|Lost to Follow-up|2
4718054|NCT02079038|16267251|P2|Modified Intent to Treat Population|Death|0
4718055|NCT02079038|16267252|P1|Modified Intent to Treat Population|Death|1
4718056|NCT02079038|16267251|P2|Modified Intent to Treat Population|Withdrawal by Subject|5
4718057|NCT02079038|16267252|P1|Modified Intent to Treat Population|Withdrawal by Subject|6
4718058|NCT02078960|16267273|P3|Follow-up Period|Lost to Follow-up|0
4718059|NCT02078960|16267274|P2|Follow-up Period|Lost to Follow-up|1
4718060|NCT02078960|16267275|P1|Follow-up Period|Lost to Follow-up|0
4718061|NCT02078960|16267273|P3|Follow-up Period|Death|0
4718062|NCT02078960|16267274|P2|Follow-up Period|Death|0
4718063|NCT02078960|16267275|P1|Follow-up Period|Death|2
4718064|NCT02078960|16267273|P3|Treatment Period|Death|1
4718065|NCT02078960|16267274|P2|Treatment Period|Death|0
4718066|NCT02078960|16267275|P1|Treatment Period|Death|0
4718067|NCT02078960|16267273|P3|Treatment Period|Adverse Event|0
4718068|NCT02078960|16267274|P2|Treatment Period|Adverse Event|0
4718069|NCT02078960|16267275|P1|Treatment Period|Adverse Event|1
4718070|NCT02078960|16267273|P3|Treatment Period|Withdrawal by Subject|1
4718071|NCT02078960|16267274|P2|Treatment Period|Withdrawal by Subject|1
4718072|NCT02078960|16267275|P1|Treatment Period|Withdrawal by Subject|0
4718073|NCT02078960|16267273|P3|Treatment Period|Disease progression - blast phase|0
4718074|NCT02078960|16267274|P2|Treatment Period|Disease progression - blast phase|0
4718075|NCT02078960|16267275|P1|Treatment Period|Disease progression - blast phase|1
4718076|NCT02078960|16267273|P3|Treatment Period|Disease progression - accelerated phase|0
4718077|NCT02078960|16267274|P2|Treatment Period|Disease progression - accelerated phase|1
4718078|NCT02078960|16267275|P1|Treatment Period|Disease progression - accelerated phase|0
4718079|NCT02078960|16267273|P3|Treatment Period|Lack of Efficacy|0
4718080|NCT02078960|16267274|P2|Treatment Period|Lack of Efficacy|1
4718081|NCT02078960|16267275|P1|Treatment Period|Lack of Efficacy|0
4718082|NCT02078960|16267273|P3|Treatment Period|Other|1
4718083|NCT02078960|16267274|P2|Treatment Period|Other|0
4718084|NCT02078960|16267275|P1|Treatment Period|Other|0
4718085|NCT02078817|16267309|P1|Overall Study|Withdrawal by Subject|1
4718086|NCT02078752|16267331|P10|Overall Study|Study terminated by sponsor|5
4718087|NCT02078752|16267332|P9|Overall Study|Study terminated by sponsor|0
4718088|NCT02078752|16267333|P8|Overall Study|Study terminated by sponsor|0
4718089|NCT02078752|16267334|P7|Overall Study|Study terminated by sponsor|0
4718090|NCT02078752|16267335|P6|Overall Study|Study terminated by sponsor|0
4718091|NCT02078752|16267336|P5|Overall Study|Study terminated by sponsor|0
4718092|NCT02078752|16267337|P4|Overall Study|Study terminated by sponsor|0
4718093|NCT02078752|16267338|P3|Overall Study|Study terminated by sponsor|0
4718094|NCT02078752|16267339|P2|Overall Study|Study terminated by sponsor|0
4718095|NCT02078752|16267340|P1|Overall Study|Study terminated by sponsor|0
4718096|NCT02078752|16267331|P10|Overall Study|Other|0
4718097|NCT02078752|16267332|P9|Overall Study|Other|0
4718098|NCT02078752|16267333|P8|Overall Study|Other|1
4718099|NCT02078752|16267334|P7|Overall Study|Other|0
4718100|NCT02078752|16267335|P6|Overall Study|Other|0
4718101|NCT02078752|16267336|P5|Overall Study|Other|1
4718102|NCT02078752|16267337|P4|Overall Study|Other|0
4718103|NCT02078752|16267338|P3|Overall Study|Other|0
4718104|NCT02078752|16267339|P2|Overall Study|Other|3
4718105|NCT02078752|16267340|P1|Overall Study|Other|0
4718106|NCT02078752|16267331|P10|Overall Study|Withdrawal by Subject|1
4718107|NCT02078752|16267332|P9|Overall Study|Withdrawal by Subject|0
4718108|NCT02078752|16267333|P8|Overall Study|Withdrawal by Subject|1
4718109|NCT02078752|16267334|P7|Overall Study|Withdrawal by Subject|2
4718110|NCT02078752|16267335|P6|Overall Study|Withdrawal by Subject|3
4718111|NCT02078752|16267336|P5|Overall Study|Withdrawal by Subject|0
4718112|NCT02078752|16267337|P4|Overall Study|Withdrawal by Subject|1
4718113|NCT02078752|16267338|P3|Overall Study|Withdrawal by Subject|1
4718114|NCT02078752|16267339|P2|Overall Study|Withdrawal by Subject|1
4718115|NCT02078752|16267340|P1|Overall Study|Withdrawal by Subject|1
4718116|NCT02078752|16267331|P10|Overall Study|Lost to Follow-up|0
4718117|NCT02078752|16267332|P9|Overall Study|Lost to Follow-up|0
4718118|NCT02078752|16267333|P8|Overall Study|Lost to Follow-up|0
4718119|NCT02078752|16267334|P7|Overall Study|Lost to Follow-up|0
4718120|NCT02078752|16267335|P6|Overall Study|Lost to Follow-up|0
4718121|NCT02078752|16267336|P5|Overall Study|Lost to Follow-up|0
4718122|NCT02078752|16267337|P4|Overall Study|Lost to Follow-up|1
4718123|NCT02078752|16267338|P3|Overall Study|Lost to Follow-up|0
4718124|NCT02078752|16267339|P2|Overall Study|Lost to Follow-up|0
4718125|NCT02078752|16267340|P1|Overall Study|Lost to Follow-up|1
4718126|NCT02078752|16267331|P10|Overall Study|Death|4
4718127|NCT02078752|16267332|P9|Overall Study|Death|0
4718128|NCT02078752|16267333|P8|Overall Study|Death|1
4718129|NCT02078752|16267334|P7|Overall Study|Death|0
4718130|NCT02078752|16267335|P6|Overall Study|Death|1
4718131|NCT02078752|16267336|P5|Overall Study|Death|0
4718132|NCT02078752|16267337|P4|Overall Study|Death|0
4718133|NCT02078752|16267338|P3|Overall Study|Death|0
4718134|NCT02078752|16267339|P2|Overall Study|Death|3
4718135|NCT02078752|16267340|P1|Overall Study|Death|0
4718136|NCT02078713|16267616|P4|Overall Study|Enrolled twice|0
4718137|NCT02078713|16267617|P3|Overall Study|Enrolled twice|0
4718138|NCT02078713|16267618|P2|Overall Study|Enrolled twice|1
4718139|NCT02078713|16267619|P1|Overall Study|Enrolled twice|0
4718140|NCT02078713|16267616|P4|Overall Study|Pregnant at baseline|0
4718141|NCT02078713|16267617|P3|Overall Study|Pregnant at baseline|0
4718142|NCT02078713|16267618|P2|Overall Study|Pregnant at baseline|5
4718143|NCT02078713|16267619|P1|Overall Study|Pregnant at baseline|3
4718144|NCT02078713|16267616|P4|Overall Study|Lost to Follow-up|0
4718145|NCT02078713|16267617|P3|Overall Study|Lost to Follow-up|0
4718146|NCT02078713|16267618|P2|Overall Study|Lost to Follow-up|55
4718147|NCT02078713|16267619|P1|Overall Study|Lost to Follow-up|49
4718148|NCT02078219|16267704|P5|Overall Study|Adverse Event|0
4718149|NCT02078219|16267705|P4|Overall Study|Adverse Event|1
4718150|NCT02078219|16267706|P3|Overall Study|Adverse Event|3
4718151|NCT02078219|16267707|P2|Overall Study|Adverse Event|1
4718152|NCT02078219|16267708|P1|Overall Study|Adverse Event|1
4718153|NCT02078219|16267704|P5|Overall Study|Death|0
4718154|NCT02078219|16267705|P4|Overall Study|Death|1
4718155|NCT02078219|16267706|P3|Overall Study|Death|0
4718156|NCT02078219|16267707|P2|Overall Study|Death|0
4718157|NCT02078219|16267708|P1|Overall Study|Death|0
4718158|NCT02078219|16267704|P5|Overall Study|Protocol Violation|0
4718159|NCT02078219|16267705|P4|Overall Study|Protocol Violation|1
4718160|NCT02078219|16267706|P3|Overall Study|Protocol Violation|0
4718161|NCT02078219|16267707|P2|Overall Study|Protocol Violation|0
4718162|NCT02078219|16267708|P1|Overall Study|Protocol Violation|0
4718163|NCT02078219|16267704|P5|Overall Study|Withdrawal by Subject|1
4718164|NCT02078219|16267705|P4|Overall Study|Withdrawal by Subject|1
4718165|NCT02078219|16267706|P3|Overall Study|Withdrawal by Subject|0
4718166|NCT02078219|16267707|P2|Overall Study|Withdrawal by Subject|1
4718167|NCT02078219|16267708|P1|Overall Study|Withdrawal by Subject|0
4718168|NCT02078219|16267704|P5|Overall Study|Other|1
4718169|NCT02078219|16267705|P4|Overall Study|Other|0
4718170|NCT02078219|16267706|P3|Overall Study|Other|3
4718171|NCT02078219|16267707|P2|Overall Study|Other|2
4718172|NCT02078219|16267708|P1|Overall Study|Other|2
4718173|NCT02077465|16267758|P2|Overall Study|Lost to Follow-up|0
4718174|NCT02077465|16267759|P1|Overall Study|Lost to Follow-up|1
4718175|NCT02077465|16267758|P2|Overall Study|Withdrew Consent|1
4718176|NCT02077465|16267759|P1|Overall Study|Withdrew Consent|0
4718177|NCT02077374|16267782|P2|Overall Study|Protocol Violation|1
4718178|NCT02077374|16267783|P1|Overall Study|Protocol Violation|0
4718179|NCT02077374|16267782|P2|Overall Study|Withdrawal by Subject|1
4718180|NCT02077374|16267783|P1|Overall Study|Withdrawal by Subject|0
4718181|NCT02077140|16267804|P5|Overall Study|Withdrawal by Subject|2
4718182|NCT02077140|16267805|P4|Overall Study|Withdrawal by Subject|2
4718183|NCT02077140|16267806|P3|Overall Study|Withdrawal by Subject|0
4718184|NCT02077140|16267807|P2|Overall Study|Withdrawal by Subject|1
4718185|NCT02077140|16267808|P1|Overall Study|Withdrawal by Subject|0
4718186|NCT02077140|16267804|P5|Overall Study|Lost to Follow-up|3
4718187|NCT02077140|16267805|P4|Overall Study|Lost to Follow-up|2
4718188|NCT02077140|16267806|P3|Overall Study|Lost to Follow-up|2
4718189|NCT02077140|16267807|P2|Overall Study|Lost to Follow-up|1
4718190|NCT02077140|16267808|P1|Overall Study|Lost to Follow-up|4
4718191|NCT02076334|16268086|P4|Overall Study|muscle soreness|1
4718192|NCT02076334|16268087|P3|Overall Study|muscle soreness|0
4718193|NCT02076334|16268088|P2|Overall Study|muscle soreness|0
4718194|NCT02076334|16268089|P1|Overall Study|muscle soreness|0
4718195|NCT02076334|16268086|P4|Overall Study|Lost to Follow-up|0
4718196|NCT02076334|16268087|P3|Overall Study|Lost to Follow-up|1
4718197|NCT02076334|16268088|P2|Overall Study|Lost to Follow-up|1
4718198|NCT02076334|16268089|P1|Overall Study|Lost to Follow-up|0
4718199|NCT02076334|16268086|P4|Overall Study|Protocol Violation|0
4718200|NCT02076334|16268087|P3|Overall Study|Protocol Violation|0
4718201|NCT02076334|16268088|P2|Overall Study|Protocol Violation|0
4718202|NCT02076334|16268089|P1|Overall Study|Protocol Violation|1
4718203|NCT02076178|16268122|P2|Injection Phase|Lost to Follow-up|1
4718204|NCT02076178|16268123|P1|Injection Phase|Lost to Follow-up|0
4718205|NCT02076178|16268122|P2|Injection Phase|Physician Decision|3
4718206|NCT02076178|16268123|P1|Injection Phase|Physician Decision|0
4718207|NCT02076178|16268122|P2|Injection Phase|Withdrawal by Subject|3
4718208|NCT02076178|16268123|P1|Injection Phase|Withdrawal by Subject|0
4718209|NCT02076178|16268122|P2|Injection Phase|Protocol defined stopping criteria|0
4718210|NCT02076178|16268123|P1|Injection Phase|Protocol defined stopping criteria|1
4718211|NCT02076178|16268122|P2|Oral Phase|Physician Decision|1
4718212|NCT02076178|16268123|P1|Oral Phase|Physician Decision|0
4718213|NCT02076178|16268122|P2|Oral Phase|Withdrawal by Subject|4
4718214|NCT02076178|16268123|P1|Oral Phase|Withdrawal by Subject|0
4718215|NCT02076178|16268122|P2|Oral Phase|Adverse Event|7
4718216|NCT02076178|16268123|P1|Oral Phase|Adverse Event|0
4718217|NCT02076165|16268157|P2|Overall Study|Refused follow-up assessment|1
4718218|NCT02076165|16268158|P1|Overall Study|Refused follow-up assessment|1
4718219|NCT02076165|16268157|P2|Overall Study|Lost to Follow-up|5
4718220|NCT02076165|16268158|P1|Overall Study|Lost to Follow-up|7
4718221|NCT02076022|16268228|P2|Overall Study|Withdrawal by Subject|0
4718222|NCT02076022|16268229|P1|Overall Study|Withdrawal by Subject|2
4718223|NCT02076009|16268241|P2|Overall Study|Subjects randomized but not treated|3
4718224|NCT02076009|16268242|P1|Overall Study|Subjects randomized but not treated|2
4718225|NCT02076009|16268241|P2|Overall Study|Ongoing|249
4718226|NCT02076009|16268242|P1|Overall Study|Ongoing|226
4718227|NCT02076009|16268241|P2|Overall Study|Progressive disease|0
4718228|NCT02076009|16268242|P1|Overall Study|Progressive disease|1
4718229|NCT02076009|16268241|P2|Overall Study|Lost to Follow-up|1
4718230|NCT02076009|16268242|P1|Overall Study|Lost to Follow-up|1
4718231|NCT02076009|16268241|P2|Overall Study|Withdrawal by Subject|3
4718232|NCT02076009|16268242|P1|Overall Study|Withdrawal by Subject|9
4718233|NCT02076009|16268241|P2|Overall Study|Death|30
4718234|NCT02076009|16268242|P1|Overall Study|Death|44
4718235|NCT02075840|16268264|P2|Overall Study|Ongoing at CCOD|82
4718236|NCT02075840|16268265|P1|Overall Study|Ongoing at CCOD|99
4718237|NCT02075840|16268264|P2|Overall Study|Physician Decision|3
4718238|NCT02075840|16268265|P1|Overall Study|Physician Decision|1
4718239|NCT02075840|16268264|P2|Overall Study|Lost to Follow-up|2
4718240|NCT02075840|16268265|P1|Overall Study|Lost to Follow-up|3
4718241|NCT02075840|16268264|P2|Overall Study|Death|40
4718242|NCT02075840|16268265|P1|Overall Study|Death|35
4718243|NCT02075840|16268264|P2|Overall Study|Adverse Event|2
4718244|NCT02075840|16268265|P1|Overall Study|Adverse Event|0
4718245|NCT02075840|16268264|P2|Overall Study|Reason not specified|0
4718246|NCT02075840|16268265|P1|Overall Study|Reason not specified|1
4718247|NCT02075840|16268264|P2|Overall Study|Withdrawal by Subject|22
4718248|NCT02075840|16268265|P1|Overall Study|Withdrawal by Subject|13
4718249|NCT02075658|16268321|P2|Overall Study|Physician Decision|2
4718250|NCT02075658|16268322|P1|Overall Study|Physician Decision|2
4718251|NCT02075632|16268332|P2|Overall Study|Withdrawal by Subject|1
4718252|NCT02075632|16268333|P1|Overall Study|Withdrawal by Subject|0
4718253|NCT02075632|16268332|P2|Overall Study|Lost to Follow-up|3
4718254|NCT02075632|16268333|P1|Overall Study|Lost to Follow-up|0
4718255|NCT02075632|16268332|P2|Overall Study|Adverse Event|1
4718256|NCT02075632|16268333|P1|Overall Study|Adverse Event|1
4718257|NCT02075606|16268343|P1|Overall Study|Increasing Symptoms|1
4718258|NCT02075606|16268343|P1|Overall Study|Symptom management|1
4718259|NCT02075606|16268343|P1|Overall Study|Investigator's decision|1
4718260|NCT02075606|16268343|P1|Overall Study|Death|1
4718261|NCT02075606|16268343|P1|Overall Study|Withdrawal by Subject|1
4718262|NCT02075606|16268343|P1|Overall Study|Adverse Event|5
4718263|NCT02075541|16268367|P2|Overall Study|Other- unable to perform study procedure|0
4718264|NCT02075541|16268368|P1|Overall Study|Other- unable to perform study procedure|1
4718265|NCT02075541|16268367|P2|Overall Study|Sponsor study termination|1
4718266|NCT02075541|16268368|P1|Overall Study|Sponsor study termination|0
4718267|NCT02075541|16268367|P2|Overall Study|Withdrawal by Subject|3
4718268|NCT02075541|16268368|P1|Overall Study|Withdrawal by Subject|1
4718269|NCT02075541|16268367|P2|Overall Study|Protocol Violation|0
4718270|NCT02075541|16268368|P1|Overall Study|Protocol Violation|1
4718271|NCT02075541|16268367|P2|Overall Study|Serious Adverse Event|4
4718272|NCT02075541|16268368|P1|Overall Study|Serious Adverse Event|1
4718273|NCT02075515|16268417|P3|Overall Study|Lost to Follow-up|6
4718274|NCT02075515|16268418|P2|Overall Study|Lost to Follow-up|3
4718275|NCT02075515|16268419|P1|Overall Study|Lost to Follow-up|1
4718276|NCT02075515|16268417|P3|Overall Study|Withdrawal by Subject|1
4718277|NCT02075515|16268418|P2|Overall Study|Withdrawal by Subject|0
4718278|NCT02075515|16268419|P1|Overall Study|Withdrawal by Subject|2
4718279|NCT02075515|16268417|P3|Overall Study|Non-Serious Adverse Event|0
4718280|NCT02075515|16268418|P2|Overall Study|Non-Serious Adverse Event|1
4718281|NCT02075515|16268419|P1|Overall Study|Non-Serious Adverse Event|0
4718282|NCT02075515|16268417|P3|Overall Study|Serious Adverse Event|1
4718283|NCT02075515|16268418|P2|Overall Study|Serious Adverse Event|1
4718284|NCT02075515|16268419|P1|Overall Study|Serious Adverse Event|1
4718285|NCT02075476|16268456|P2|Overall Study|Lost to Follow-up|3
4718286|NCT02075476|16268457|P1|Overall Study|Lost to Follow-up|1
4718287|NCT02075476|16268456|P2|Overall Study|Death|2
4718288|NCT02075476|16268457|P1|Overall Study|Death|2
4718289|NCT02075463|16268467|P1|Overall Study|Withdrawal by Subject|1
4718290|NCT02075463|16268467|P1|Overall Study|Par. reached stopping criteria|4
4718291|NCT02075463|16268467|P1|Overall Study|Adverse Event|3
4718292|NCT02075320|16268517|P1|Overall Study|Withdrawal by Subject|2
4718293|NCT02075255|16268527|P3|Overall Study|Death|0
4718294|NCT02075255|16268528|P2|Overall Study|Death|2
4718295|NCT02075255|16268529|P1|Overall Study|Death|0
4718296|NCT02075255|16268527|P3|Overall Study|Adverse Event|1
4718297|NCT02075255|16268528|P2|Overall Study|Adverse Event|0
4718298|NCT02075255|16268529|P1|Overall Study|Adverse Event|0
4718299|NCT02075255|16268527|P3|Overall Study|Lost to Follow-up|1
4718300|NCT02075255|16268528|P2|Overall Study|Lost to Follow-up|0
4718301|NCT02075255|16268529|P1|Overall Study|Lost to Follow-up|0
4718302|NCT02075255|16268527|P3|Overall Study|Withdrawal by Subject|0
4718303|NCT02075255|16268528|P2|Overall Study|Withdrawal by Subject|1
4718304|NCT02075255|16268529|P1|Overall Study|Withdrawal by Subject|4
4718305|NCT02075255|16268527|P3|Overall Study|Study specific withdrawal criteria|1
4718306|NCT02075255|16268528|P2|Overall Study|Study specific withdrawal criteria|1
4718307|NCT02075255|16268529|P1|Overall Study|Study specific withdrawal criteria|0
4718308|NCT02075203|16268639|P3|Overall Study|participant refused to use contraception|0
4718309|NCT02075203|16268640|P2|Overall Study|participant refused to use contraception|0
4718310|NCT02075203|16268641|P1|Overall Study|participant refused to use contraception|1
4718311|NCT02075203|16268639|P3|Overall Study|Adverse Event|0
4718312|NCT02075203|16268640|P2|Overall Study|Adverse Event|0
4718313|NCT02075203|16268641|P1|Overall Study|Adverse Event|1
4718314|NCT02075203|16268639|P3|Overall Study|Withdrawal by Subject|1
4718315|NCT02075203|16268640|P2|Overall Study|Withdrawal by Subject|0
4718316|NCT02075203|16268641|P1|Overall Study|Withdrawal by Subject|1
4718317|NCT02075073|16268682|P3|Overall Study|Withdrawal by Subject|0
4718318|NCT02075073|16268683|P2|Overall Study|Withdrawal by Subject|1
4718319|NCT02075073|16268684|P1|Overall Study|Withdrawal by Subject|0
4718320|NCT02075008|16268706|P1|Overall Study|Study terminated by Sponsor|159
4718321|NCT02075008|16268706|P1|Overall Study|Withdrawal by Subject|6
4718322|NCT02075008|16268706|P1|Overall Study|Adverse Event|5
4718323|NCT02075008|16268706|P1|Overall Study|Death|1
4718324|NCT02075008|16268706|P1|Overall Study|Lack of Efficacy|1
4718325|NCT02075008|16268706|P1|Overall Study|Lost to Follow-up|1
4718326|NCT02075008|16268706|P1|Overall Study|Physician Decision|1
4718327|NCT02075008|16268706|P1|Overall Study|Pregnancy|1
4718328|NCT02075008|16268706|P1|Overall Study|Technical problems|1
4718329|NCT02074982|16268729|P2|Overall Study|Death|2
4718330|NCT02074982|16268730|P1|Overall Study|Death|0
4718331|NCT02074982|16268729|P2|Overall Study|Subject/guardian decision|24
4718332|NCT02074982|16268730|P1|Overall Study|Subject/guardian decision|15
4718333|NCT02074982|16268729|P2|Overall Study|Technical problems|2
4718334|NCT02074982|16268730|P1|Overall Study|Technical problems|0
4718335|NCT02074982|16268729|P2|Overall Study|Protocol deviation|3
4718336|NCT02074982|16268730|P1|Overall Study|Protocol deviation|4
4718337|NCT02074982|16268729|P2|Overall Study|Pregnancy|2
4718338|NCT02074982|16268730|P1|Overall Study|Pregnancy|1
4718339|NCT02074982|16268729|P2|Overall Study|Physician Decision|1
4718340|NCT02074982|16268730|P1|Overall Study|Physician Decision|1
4718341|NCT02074982|16268729|P2|Overall Study|Non-compliance with study treatment|2
4718342|NCT02074982|16268730|P1|Overall Study|Non-compliance with study treatment|0
4718343|NCT02074982|16268729|P2|Overall Study|Lost to Follow-up|10
4718344|NCT02074982|16268730|P1|Overall Study|Lost to Follow-up|9
4718345|NCT02074982|16268729|P2|Overall Study|Lack of Efficacy|1
4718346|NCT02074982|16268730|P1|Overall Study|Lack of Efficacy|6
4718347|NCT02074982|16268729|P2|Overall Study|Adverse Event|7
4718348|NCT02074982|16268730|P1|Overall Study|Adverse Event|15
4718349|NCT02074553|16268777|P8|Washout Period 3|Physician Decision|1
4718350|NCT02074553|16268778|P7|Washout Period 3|Physician Decision|0
4718351|NCT02074553|16268779|P6|Washout Period 3|Physician Decision|0
4718352|NCT02074553|16268780|P5|Washout Period 3|Physician Decision|0
4718353|NCT02074553|16268781|P4|Washout Period 3|Physician Decision|0
4718354|NCT02074553|16268782|P3|Washout Period 3|Physician Decision|0
4718355|NCT02074553|16268783|P2|Washout Period 3|Physician Decision|0
4718356|NCT02074553|16268784|P1|Washout Period 3|Physician Decision|0
4718357|NCT02074553|16268777|P8|Washout Period 2|Lost to Follow-up|0
4718358|NCT02074553|16268778|P7|Washout Period 2|Lost to Follow-up|0
4718359|NCT02074553|16268779|P6|Washout Period 2|Lost to Follow-up|0
4718360|NCT02074553|16268780|P5|Washout Period 2|Lost to Follow-up|0
4718361|NCT02074553|16268781|P4|Washout Period 2|Lost to Follow-up|0
4718362|NCT02074553|16268782|P3|Washout Period 2|Lost to Follow-up|1
4718363|NCT02074553|16268783|P2|Washout Period 2|Lost to Follow-up|0
4718364|NCT02074553|16268784|P1|Washout Period 2|Lost to Follow-up|0
4718365|NCT02074553|16268777|P8|Washout Period 2|Physician Decision|0
4718366|NCT02074553|16268778|P7|Washout Period 2|Physician Decision|0
4718367|NCT02074553|16268779|P6|Washout Period 2|Physician Decision|1
4718368|NCT02074553|16268780|P5|Washout Period 2|Physician Decision|0
4718369|NCT02074553|16268781|P4|Washout Period 2|Physician Decision|0
4718370|NCT02074553|16268782|P3|Washout Period 2|Physician Decision|0
4718371|NCT02074553|16268783|P2|Washout Period 2|Physician Decision|0
4718372|NCT02074553|16268784|P1|Washout Period 2|Physician Decision|0
4718373|NCT02074553|16268777|P8|Washout Period 2|Adverse Event|0
4718374|NCT02074553|16268778|P7|Washout Period 2|Adverse Event|1
4718375|NCT02074553|16268779|P6|Washout Period 2|Adverse Event|0
4718376|NCT02074553|16268780|P5|Washout Period 2|Adverse Event|0
4718377|NCT02074553|16268781|P4|Washout Period 2|Adverse Event|0
4718378|NCT02074553|16268782|P3|Washout Period 2|Adverse Event|0
4718379|NCT02074553|16268783|P2|Washout Period 2|Adverse Event|0
4718380|NCT02074553|16268784|P1|Washout Period 2|Adverse Event|0
4718381|NCT02074553|16268777|P8|Washout Period 1|Other|0
4718382|NCT02074553|16268778|P7|Washout Period 1|Other|0
4718383|NCT02074553|16268779|P6|Washout Period 1|Other|1
4718384|NCT02074553|16268780|P5|Washout Period 1|Other|0
4718385|NCT02074553|16268781|P4|Washout Period 1|Other|0
4718386|NCT02074553|16268782|P3|Washout Period 1|Other|0
4718387|NCT02074553|16268783|P2|Washout Period 1|Other|0
4718388|NCT02074553|16268784|P1|Washout Period 1|Other|0
4718389|NCT02074553|16268777|P8|Washout Period 1|Physician Decision|0
4718390|NCT02074553|16268778|P7|Washout Period 1|Physician Decision|0
4718391|NCT02074553|16268779|P6|Washout Period 1|Physician Decision|0
4718392|NCT02074553|16268780|P5|Washout Period 1|Physician Decision|0
4718393|NCT02074553|16268781|P4|Washout Period 1|Physician Decision|1
4718394|NCT02074553|16268782|P3|Washout Period 1|Physician Decision|0
4718395|NCT02074553|16268783|P2|Washout Period 1|Physician Decision|0
4718396|NCT02074553|16268784|P1|Washout Period 1|Physician Decision|0
4718397|NCT02074553|16268777|P8|Washout Period 1|Adverse Event|0
4718398|NCT02074553|16268778|P7|Washout Period 1|Adverse Event|0
4718399|NCT02074553|16268779|P6|Washout Period 1|Adverse Event|0
4718400|NCT02074553|16268780|P5|Washout Period 1|Adverse Event|0
4718401|NCT02074553|16268781|P4|Washout Period 1|Adverse Event|0
4718402|NCT02074553|16268782|P3|Washout Period 1|Adverse Event|0
4718403|NCT02074553|16268783|P2|Washout Period 1|Adverse Event|0
4718404|NCT02074553|16268784|P1|Washout Period 1|Adverse Event|1
4718405|NCT02074553|16268777|P8|Intervention Period 1|Family Emergency|0
4718406|NCT02074553|16268778|P7|Intervention Period 1|Family Emergency|0
4718407|NCT02074553|16268779|P6|Intervention Period 1|Family Emergency|0
4718408|NCT02074553|16268780|P5|Intervention Period 1|Family Emergency|0
4718409|NCT02074553|16268781|P4|Intervention Period 1|Family Emergency|1
4718410|NCT02074553|16268782|P3|Intervention Period 1|Family Emergency|0
4718411|NCT02074553|16268783|P2|Intervention Period 1|Family Emergency|0
4718412|NCT02074553|16268784|P1|Intervention Period 1|Family Emergency|0
4718413|NCT02074514|16268966|P2|Overall Study|Withdrew Consent|1
4718414|NCT02074514|16268967|P1|Overall Study|Withdrew Consent|0
4718415|NCT02074514|16268966|P2|Overall Study|Lost to Follow-up|1
4718416|NCT02074514|16268967|P1|Overall Study|Lost to Follow-up|0
4718417|NCT02074514|16268966|P2|Overall Study|Lack of Efficacy|2
4718418|NCT02074514|16268967|P1|Overall Study|Lack of Efficacy|3
4718419|NCT02074059|16269108|P6|Overall Study|Death|1
4718420|NCT02074059|16269109|P5|Overall Study|Death|1
4718421|NCT02074059|16269110|P4|Overall Study|Death|0
4718422|NCT02074059|16269111|P3|Overall Study|Death|0
4718423|NCT02074059|16269112|P2|Overall Study|Death|0
4718424|NCT02074059|16269113|P1|Overall Study|Death|0
4718425|NCT02073929|16269157|P2|Overall Study|Withdrawal by Subject|1
4718426|NCT02073929|16269158|P1|Overall Study|Withdrawal by Subject|0
4718427|NCT02073929|16269157|P2|Overall Study|Adverse Event|1
4718428|NCT02073929|16269158|P1|Overall Study|Adverse Event|2
4718429|NCT02073929|16269157|P2|Overall Study|Lost to Follow-up|1
4718430|NCT02073929|16269158|P1|Overall Study|Lost to Follow-up|2
4718431|NCT02073682|16269195|P2|Overall Study|ID: Benefit/Risk Judgment|46
4718432|NCT02073682|16269196|P1|Overall Study|ID: Benefit/Risk Judgment|32
4718433|NCT02073682|16269195|P2|Overall Study|Lost to Follow-up|1
4718434|NCT02073682|16269196|P1|Overall Study|Lost to Follow-up|1
4718435|NCT02073682|16269195|P2|Overall Study|PD: Inconvenience of Dosing|78
4718436|NCT02073682|16269196|P1|Overall Study|PD: Inconvenience of Dosing|21
4718437|NCT02073682|16269195|P2|Overall Study|No reason provided|9
4718438|NCT02073682|16269196|P1|Overall Study|No reason provided|11
4718439|NCT02073682|16269195|P2|Overall Study|Adverse Event|62
4718440|NCT02073682|16269196|P1|Overall Study|Adverse Event|79
4718441|NCT02073682|16269195|P2|Overall Study|Protocol Violation|0
4718442|NCT02073682|16269196|P1|Overall Study|Protocol Violation|1
4718443|NCT02073682|16269195|P2|Overall Study|Cancer Progression|33
4718444|NCT02073682|16269196|P1|Overall Study|Cancer Progression|53
4718445|NCT02073682|16269195|P2|Overall Study|Start of New Chemotherapy Regimen|3
4718446|NCT02073682|16269196|P1|Overall Study|Start of New Chemotherapy Regimen|6
4718447|NCT02073682|16269195|P2|Overall Study|Withdrawal by Subject|8
4718448|NCT02073682|16269196|P1|Overall Study|Withdrawal by Subject|6
4718449|NCT02073682|16269195|P2|Overall Study|Surgery/Medical Procedure|1
4718450|NCT02073682|16269196|P1|Overall Study|Surgery/Medical Procedure|3
4718451|NCT02073682|16269195|P2|Overall Study|Platelet Count <50,000/mL|2
4718452|NCT02073682|16269196|P1|Overall Study|Platelet Count <50,000/mL|1
4718453|NCT02073682|16269195|P2|Overall Study|Prohibited Concomitant Medication Use|1
4718454|NCT02073682|16269196|P1|Overall Study|Prohibited Concomitant Medication Use|0
4718455|NCT02073682|16269195|P2|Overall Study|ID: Palliative Treatment Only|7
4718456|NCT02073682|16269196|P1|Overall Study|ID: Palliative Treatment Only|10
4718457|NCT02073682|16269195|P2|Overall Study|ID: Patient Noncompliance|2
4718458|NCT02073682|16269196|P1|Overall Study|ID: Patient Noncompliance|1
4718459|NCT02073682|16269195|P2|Overall Study|Cancer Cured|15
4718460|NCT02073682|16269196|P1|Overall Study|Cancer Cured|10
4718461|NCT02073682|16269195|P2|Overall Study|Death|100
4718462|NCT02073682|16269196|P1|Overall Study|Death|86
4718463|NCT02073682|16269195|P2|Overall Study|Low Creatinine Clearance|2
4718464|NCT02073682|16269196|P1|Overall Study|Low Creatinine Clearance|1
4718465|NCT02073656|16269214|P1|Primary Study|Withdrew Consent|1
4718466|NCT02073656|16269214|P1|Primary Study|Death|1
4718467|NCT02073656|16269214|P1|Primary Study|Lost to Follow-up|6
4718468|NCT02073643|16269230|P1|Overall Study|Lost to Follow-up|24
4718469|NCT02073565|16269241|P2|Cohort C|Lost to Follow-up|2
4718470|NCT02073565|16269242|P1|Cohort C|Lost to Follow-up|0
4718471|NCT02073565|16269241|P2|Cohort C|Withdrawal by Subject|2
4718472|NCT02073565|16269242|P1|Cohort C|Withdrawal by Subject|0
4718473|NCT02073565|16269241|P2|Cohort B|Withdrawal by Subject|2
4718474|NCT02073565|16269242|P1|Cohort B|Withdrawal by Subject|1
4718475|NCT02073565|16269241|P2|Cohort A|Withdrawal by Subject|0
4718476|NCT02073565|16269242|P1|Cohort A|Withdrawal by Subject|1
4718477|NCT02072980|16269362|P2|Period 2, Second Wear|Adverse Event|1
4718478|NCT02072980|16269363|P1|Period 2, Second Wear|Adverse Event|0
4718479|NCT02072941|16269371|P2|Overall Study|Removed by Study Staff|2
4718480|NCT02072941|16269372|P1|Overall Study|Removed by Study Staff|2
4718481|NCT02072941|16269371|P2|Overall Study|Death|2
4718482|NCT02072941|16269372|P1|Overall Study|Death|3
4718483|NCT02072941|16269371|P2|Overall Study|Lost to Follow-up|4
4718484|NCT02072941|16269372|P1|Overall Study|Lost to Follow-up|4
4718485|NCT02072941|16269371|P2|Overall Study|Withdrawal by Subject|21
4718486|NCT02072941|16269372|P1|Overall Study|Withdrawal by Subject|29
4718487|NCT02072824|16269387|P3|Overall Study|Adverse Event|1
4718488|NCT02072824|16269388|P2|Overall Study|Adverse Event|0
4718489|NCT02072824|16269389|P1|Overall Study|Adverse Event|0
4718490|NCT02072824|16269387|P3|Overall Study|Medication error|0
4718491|NCT02072824|16269388|P2|Overall Study|Medication error|1
4718492|NCT02072824|16269389|P1|Overall Study|Medication error|0
4718493|NCT02072824|16269387|P3|Overall Study|No longer willing to participate|1
4718494|NCT02072824|16269388|P2|Overall Study|No longer willing to participate|0
4718495|NCT02072824|16269389|P1|Overall Study|No longer willing to participate|1
4718496|NCT02072824|16269387|P3|Overall Study|Insufficient clinical response|1
4718497|NCT02072824|16269388|P2|Overall Study|Insufficient clinical response|0
4718498|NCT02072824|16269389|P1|Overall Study|Insufficient clinical response|1
4718499|NCT02072668|16269424|P2|Second Intervention|Lost to Follow-up|0
4718500|NCT02072668|16269425|P1|Second Intervention|Lost to Follow-up|1
4718501|NCT02072434|16269465|P2|Overall Study|Lost to Follow-up|1
4718502|NCT02072434|16269466|P1|Overall Study|Lost to Follow-up|0
4718503|NCT02072434|16269465|P2|Overall Study|Other|29
4718504|NCT02072434|16269466|P1|Overall Study|Other|14
4718505|NCT02072434|16269465|P2|Overall Study|Withdrawal by Subject|29
4718506|NCT02072434|16269466|P1|Overall Study|Withdrawal by Subject|17
4718507|NCT02072434|16269465|P2|Overall Study|Adverse Event|6
4718508|NCT02072434|16269466|P1|Overall Study|Adverse Event|7
4718509|NCT02072434|16269465|P2|Overall Study|Adverse event, serious fatal|6
4718510|NCT02072434|16269466|P1|Overall Study|Adverse event, serious fatal|1
4718511|NCT02072434|16269465|P2|Overall Study|Physician Decision|10
4718512|NCT02072434|16269466|P1|Overall Study|Physician Decision|5
4718513|NCT02072434|16269465|P2|Overall Study|Protocol Violation|9
4718514|NCT02072434|16269466|P1|Overall Study|Protocol Violation|10
4718515|NCT02072226|16269486|P2|Overall Study|Patient Withdrawal of Consent|0
4718516|NCT02072226|16269487|P1|Overall Study|Patient Withdrawal of Consent|1
4718517|NCT02072226|16269486|P2|Overall Study|Death|0
4718518|NCT02072226|16269487|P1|Overall Study|Death|1
4718519|NCT02072226|16269486|P2|Overall Study|Patient Non-compliance|3
4718520|NCT02072226|16269487|P1|Overall Study|Patient Non-compliance|2
4718521|NCT02072226|16269486|P2|Overall Study|Lost to Follow-up|7
4718522|NCT02072226|16269487|P1|Overall Study|Lost to Follow-up|11
4718523|NCT02072174|16269517|P2|Overall Study|Non-compliance with protocol requirement|0
4718524|NCT02072174|16269518|P1|Overall Study|Non-compliance with protocol requirement|2
4718525|NCT02072174|16269517|P2|Overall Study|Physician Decision|1
4718526|NCT02072174|16269518|P1|Overall Study|Physician Decision|0
4718527|NCT02072174|16269517|P2|Overall Study|Protocol Violation|23
4718528|NCT02072174|16269518|P1|Overall Study|Protocol Violation|16
4718529|NCT02072174|16269517|P2|Overall Study|Did Not Meet In-/Exclusion Criteria|15
4718530|NCT02072174|16269518|P1|Overall Study|Did Not Meet In-/Exclusion Criteria|14
4718531|NCT02072096|16269542|P2|Overall Study|Lost to Follow-up|0
4718532|NCT02072096|16269543|P1|Overall Study|Lost to Follow-up|1
4718533|NCT02072096|16269542|P2|Overall Study|Study Terminated by Sponsor|30
4718534|NCT02072096|16269543|P1|Overall Study|Study Terminated by Sponsor|43
4718535|NCT02072096|16269542|P2|Overall Study|Physician Decision|1
4718536|NCT02072096|16269543|P1|Overall Study|Physician Decision|0
4718537|NCT02072096|16269542|P2|Overall Study|Death|0
4718538|NCT02072096|16269543|P1|Overall Study|Death|2
4718539|NCT02072096|16269542|P2|Overall Study|No Reason Provided|2
4718540|NCT02072096|16269543|P1|Overall Study|No Reason Provided|4
4718541|NCT02072096|16269542|P2|Overall Study|Adverse Event|2
4718542|NCT02072096|16269543|P1|Overall Study|Adverse Event|5
4718543|NCT02072096|16269542|P2|Overall Study|Withdrawal by Subject|7
4718544|NCT02072096|16269543|P1|Overall Study|Withdrawal by Subject|5
4718545|NCT02072096|16269542|P2|Overall Study|Protocol Violation|7
4718546|NCT02072096|16269543|P1|Overall Study|Protocol Violation|7
4718547|NCT02072096|16269542|P2|Overall Study|Lack of Efficacy|29
4718548|NCT02072096|16269543|P1|Overall Study|Lack of Efficacy|18
4718549|NCT02071849|16269578|P1|2-year Extended Follow-up|Adverse Event|1
4718550|NCT02071849|16269578|P1|6-month Primary Endpoint|Adverse Event|1
4718551|NCT02071849|16269578|P1|6-month Primary Endpoint|Did not receive device|4
4718552|NCT02071771|16269644|P2|Period 1: First 10 Days|Unavailable lens power|0
4718553|NCT02071771|16269645|P1|Period 1: First 10 Days|Unavailable lens power|1
4718554|NCT02071771|16269644|P2|Period 1: First 10 Days|Unacceptable lens fit|0
4718555|NCT02071771|16269645|P1|Period 1: First 10 Days|Unacceptable lens fit|1
4718556|NCT02071706|16269653|P1|Overall Study|Withdrawal by Subject|2
4718557|NCT02071706|16269653|P1|Overall Study|Adverse Event|1
4718558|NCT02071290|16269669|P2|Overall Study|Physician Decision|1
4718559|NCT02071290|16269670|P1|Overall Study|Physician Decision|0
4718560|NCT02071290|16269669|P2|Overall Study|Protocol Violation|5
4718561|NCT02071290|16269670|P1|Overall Study|Protocol Violation|3
4718562|NCT02071290|16269669|P2|Overall Study|Withdrawal by Subject|1
4718563|NCT02071290|16269670|P1|Overall Study|Withdrawal by Subject|0
4718564|NCT02071290|16269669|P2|Overall Study|Death|0
4718565|NCT02071290|16269670|P1|Overall Study|Death|1
4718566|NCT02071225|16269724|P1|Overall Study|Death|25
4718567|NCT02071225|16269724|P1|Overall Study|Lost to Follow-up|2
4718568|NCT02071225|16269724|P1|Overall Study|Protocol Deviation|1
4718569|NCT02071225|16269724|P1|Overall Study|Withdrawal of Consent|2
4718570|NCT02071082|16269780|P2|Overall Study|Lost to Follow-up|1
4718571|NCT02071082|16269781|P1|Overall Study|Lost to Follow-up|1
4718572|NCT02071082|16269780|P2|Overall Study|Withdrew Consent|4
4718573|NCT02071082|16269781|P1|Overall Study|Withdrew Consent|0
4718574|NCT02071082|16269780|P2|Overall Study|Adverse Event|1
4718575|NCT02071082|16269781|P1|Overall Study|Adverse Event|0
4718576|NCT02071082|16269780|P2|Overall Study|Enrolled and Never Treated|1
4718577|NCT02071082|16269781|P1|Overall Study|Enrolled and Never Treated|1
4718578|NCT02070991|16269811|P2|Overall Study|Withdrawal by Subject|0
4718579|NCT02070991|16269812|P1|Overall Study|Withdrawal by Subject|1
4718580|NCT02070991|16269811|P2|Overall Study|Death|0
4718581|NCT02070991|16269812|P1|Overall Study|Death|2
4718582|NCT02070978|16269835|P3|Overall Study|Terminated by Sponsor|39
4718583|NCT02070978|16269836|P2|Overall Study|Terminated by Sponsor|40
4718584|NCT02070978|16269837|P1|Overall Study|Terminated by Sponsor|33
4718585|NCT02070978|16269835|P3|Overall Study|Un-specified|2
4718586|NCT02070978|16269836|P2|Overall Study|Un-specified|2
4718587|NCT02070978|16269837|P1|Overall Study|Un-specified|3
4718588|NCT02070978|16269835|P3|Overall Study|Death|2
4718589|NCT02070978|16269836|P2|Overall Study|Death|0
4718590|NCT02070978|16269837|P1|Overall Study|Death|0
4718591|NCT02070978|16269835|P3|Overall Study|Lack of Efficacy|0
4718592|NCT02070978|16269836|P2|Overall Study|Lack of Efficacy|1
4718593|NCT02070978|16269837|P1|Overall Study|Lack of Efficacy|0
4718594|NCT02070978|16269835|P3|Overall Study|Protocol Violation|3
4718595|NCT02070978|16269836|P2|Overall Study|Protocol Violation|0
4718596|NCT02070978|16269837|P1|Overall Study|Protocol Violation|1
4718597|NCT02070978|16269835|P3|Overall Study|Withdrawal by Subject|3
4718598|NCT02070978|16269836|P2|Overall Study|Withdrawal by Subject|5
4718599|NCT02070978|16269837|P1|Overall Study|Withdrawal by Subject|3
4718600|NCT02070978|16269835|P3|Overall Study|Lost to Follow-up|4
4718601|NCT02070978|16269836|P2|Overall Study|Lost to Follow-up|3
4718602|NCT02070978|16269837|P1|Overall Study|Lost to Follow-up|1
4718603|NCT02070978|16269835|P3|Overall Study|Adverse Event|0
4718604|NCT02070978|16269836|P2|Overall Study|Adverse Event|2
4718605|NCT02070978|16269837|P1|Overall Study|Adverse Event|6
4718606|NCT02070965|16269899|P3|Overall Study|Subject moved|0
4718607|NCT02070965|16269900|P2|Overall Study|Subject moved|0
4718608|NCT02070965|16269901|P1|Overall Study|Subject moved|1
4718609|NCT02070965|16269899|P3|Overall Study|Withdrawal by Subject|1
4718610|NCT02070965|16269900|P2|Overall Study|Withdrawal by Subject|1
4718611|NCT02070965|16269901|P1|Overall Study|Withdrawal by Subject|1
4718612|NCT02070965|16269899|P3|Overall Study|Lost to Follow-up|0
4718613|NCT02070965|16269900|P2|Overall Study|Lost to Follow-up|1
4718614|NCT02070965|16269901|P1|Overall Study|Lost to Follow-up|0
4718615|NCT02070757|16269911|P2|Overall Study|Discharged from Study Hospital|2
4718616|NCT02070757|16269912|P1|Overall Study|Discharged from Study Hospital|2
4718617|NCT02070757|16269911|P2|Overall Study|Investigator Decision|2
4718618|NCT02070757|16269912|P1|Overall Study|Investigator Decision|0
4718619|NCT02070757|16269911|P2|Overall Study|Withdrawal by Subject|3
4718620|NCT02070757|16269912|P1|Overall Study|Withdrawal by Subject|1
4718621|NCT02070757|16269911|P2|Overall Study|Protocol Violation|4
4718622|NCT02070757|16269912|P1|Overall Study|Protocol Violation|0
4718623|NCT02070757|16269911|P2|Overall Study|Lost to Follow-up|4
4718624|NCT02070757|16269912|P1|Overall Study|Lost to Follow-up|7
4718625|NCT02070757|16269911|P2|Overall Study|Adverse Event|99
4718626|NCT02070757|16269912|P1|Overall Study|Adverse Event|107
4718627|NCT02070744|16269946|P5|OLE Phase (48 Weeks)|Other|1
4718628|NCT02070744|16269947|P4|OLE Phase (48 Weeks)|Other|0
4718629|NCT02070744|16269948|P3|OLE Phase (48 Weeks)|Other|0
4718630|NCT02070744|16269949|P2|OLE Phase (48 Weeks)|Other|0
4718631|NCT02070744|16269950|P1|OLE Phase (48 Weeks)|Other|0
4718632|NCT02070744|16269946|P5|OLE Phase (48 Weeks)|Withdrawal by Subject|2
4718633|NCT02070744|16269947|P4|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4718634|NCT02070744|16269948|P3|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4718635|NCT02070744|16269949|P2|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4718636|NCT02070744|16269950|P1|OLE Phase (48 Weeks)|Withdrawal by Subject|0
4718637|NCT02070744|16269946|P5|PC Phase (12 Weeks)|Randomized, but not treated|0
4718638|NCT02070744|16269947|P4|PC Phase (12 Weeks)|Randomized, but not treated|1
4718639|NCT02070744|16269948|P3|PC Phase (12 Weeks)|Randomized, but not treated|0
4718640|NCT02070744|16269949|P2|PC Phase (12 Weeks)|Randomized, but not treated|0
4718641|NCT02070744|16269950|P1|PC Phase (12 Weeks)|Randomized, but not treated|0
4718642|NCT02070588|16270033|P3|Overall Study|Adverse Event|0
4718643|NCT02070588|16270034|P2|Overall Study|Adverse Event|0
4718644|NCT02070588|16270035|P1|Overall Study|Adverse Event|1
4718645|NCT02070588|16270033|P3|Overall Study|Writhdrawal due to early termination|0
4718646|NCT02070588|16270034|P2|Overall Study|Writhdrawal due to early termination|0
4718647|NCT02070588|16270035|P1|Overall Study|Writhdrawal due to early termination|9
4718648|NCT02070588|16270033|P3|Overall Study|Withdrawal by Subject|0
4718649|NCT02070588|16270034|P2|Overall Study|Withdrawal by Subject|1
4718650|NCT02070588|16270035|P1|Overall Study|Withdrawal by Subject|29
4718651|NCT02070484|16270051|P2|Overall Study|Withdrawal by Subject|0
4718652|NCT02070484|16270052|P1|Overall Study|Withdrawal by Subject|1
4718653|NCT02070380|16270074|P4|Second Injection|Protocol Violation|5
4718654|NCT02070380|16270075|P3|Second Injection|Protocol Violation|1
4718655|NCT02070380|16270076|P2|Second Injection|Protocol Violation|1
4718656|NCT02070380|16270077|P1|Second Injection|Protocol Violation|0
4718657|NCT02070380|16270074|P4|Second Injection|Image sets missing or technically inadeq|0
4718658|NCT02070380|16270075|P3|Second Injection|Image sets missing or technically inadeq|0
4718659|NCT02070380|16270076|P2|Second Injection|Image sets missing or technically inadeq|1
4718660|NCT02070380|16270077|P1|Second Injection|Image sets missing or technically inadeq|0
4718661|NCT02070380|16270074|P4|Washout (no Second Injection/MRI)|Withdrawal by Subject|3
4718662|NCT02070380|16270075|P3|Washout (no Second Injection/MRI)|Withdrawal by Subject|2
4718663|NCT02070380|16270076|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|5
4718664|NCT02070380|16270077|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|0
4718665|NCT02069392|16270219|P2|Overall Study|Withdrawal by Subject|2
4718666|NCT02069392|16270220|P1|Overall Study|Withdrawal by Subject|4
4718667|NCT02069379|16270244|P4|Second Treatment Arm|Lost to Follow-up|0
4718668|NCT02069379|16270245|P3|Second Treatment Arm|Lost to Follow-up|1
4718669|NCT02069379|16270246|P2|Second Treatment Arm|Lost to Follow-up|0
4718670|NCT02069379|16270247|P1|Second Treatment Arm|Lost to Follow-up|0
4718671|NCT02069379|16270244|P4|Washout Period (4 Weeks)|Unrelated event|0
4718672|NCT02069379|16270245|P3|Washout Period (4 Weeks)|Unrelated event|0
4718673|NCT02069379|16270246|P2|Washout Period (4 Weeks)|Unrelated event|1
4718674|NCT02069379|16270247|P1|Washout Period (4 Weeks)|Unrelated event|0
4718675|NCT02069379|16270244|P4|Washout Period (4 Weeks)|Lost to Follow-up|0
4718676|NCT02069379|16270245|P3|Washout Period (4 Weeks)|Lost to Follow-up|0
4718677|NCT02069379|16270246|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
4718678|NCT02069379|16270247|P1|Washout Period (4 Weeks)|Lost to Follow-up|0
4718679|NCT02069379|16270244|P4|First Treatment Arm|Lost to Follow-up|0
4718680|NCT02069379|16270245|P3|First Treatment Arm|Lost to Follow-up|1
4718681|NCT02069379|16270246|P2|First Treatment Arm|Lost to Follow-up|1
4718682|NCT02069379|16270247|P1|First Treatment Arm|Lost to Follow-up|0
4718683|NCT02069379|16270244|P4|Baseline Measurements|Ineligible based on initial assessments|2
4718684|NCT02069379|16270245|P3|Baseline Measurements|Ineligible based on initial assessments|0
4718685|NCT02069379|16270246|P2|Baseline Measurements|Ineligible based on initial assessments|0
4718686|NCT02069379|16270247|P1|Baseline Measurements|Ineligible based on initial assessments|2
4718687|NCT02069379|16270244|P4|Baseline Measurements|Lost to Follow-up|0
4718688|NCT02069379|16270245|P3|Baseline Measurements|Lost to Follow-up|0
4718689|NCT02069379|16270246|P2|Baseline Measurements|Lost to Follow-up|0
4718690|NCT02069379|16270247|P1|Baseline Measurements|Lost to Follow-up|1
4718691|NCT02069093|16270334|P1|Overall Study|Adverse Event|10
4718692|NCT02069093|16270334|P1|Overall Study|Abnormal laboratory values|1
4718693|NCT02069093|16270334|P1|Overall Study|Withdrawal by Subject|2
4718694|NCT02069093|16270334|P1|Overall Study|Administrative problems|1
4718695|NCT02069093|16270334|P1|Overall Study|Death|1
4718696|NCT02069093|16270334|P1|Overall Study|New cancer therapy|1
4718697|NCT02069093|16270334|P1|Overall Study|Disease progression|14
4718698|NCT02068768|16270384|P1|Overall Study|Early Termination by Sponsor|2
4718699|NCT02068768|16270384|P1|Overall Study|Lost to Follow-up|5
4718700|NCT02068599|16270393|P3|Overall Study|Noncompliance|1
4718701|NCT02068599|16270394|P2|Overall Study|Noncompliance|0
4718702|NCT02068599|16270395|P1|Overall Study|Noncompliance|0
4718703|NCT02068599|16270393|P3|Overall Study|Lack of Efficacy|3
4718704|NCT02068599|16270394|P2|Overall Study|Lack of Efficacy|0
4718705|NCT02068599|16270395|P1|Overall Study|Lack of Efficacy|0
4718706|NCT02068599|16270393|P3|Overall Study|Lost to Follow-up|0
4718707|NCT02068599|16270394|P2|Overall Study|Lost to Follow-up|0
4718708|NCT02068599|16270395|P1|Overall Study|Lost to Follow-up|1
4718709|NCT02068599|16270393|P3|Overall Study|Protocol Violation|3
4718710|NCT02068599|16270394|P2|Overall Study|Protocol Violation|2
4718711|NCT02068599|16270395|P1|Overall Study|Protocol Violation|4
4718712|NCT02068599|16270393|P3|Overall Study|Withdrawal by Subject|5
4718713|NCT02068599|16270394|P2|Overall Study|Withdrawal by Subject|7
4718714|NCT02068599|16270395|P1|Overall Study|Withdrawal by Subject|2
4718715|NCT02068599|16270393|P3|Overall Study|Adverse Event|1
4718716|NCT02068599|16270394|P2|Overall Study|Adverse Event|1
4718717|NCT02068599|16270395|P1|Overall Study|Adverse Event|4
4718718|NCT02068547|16270435|P2|Overall Study|Physician Decision|0
4718719|NCT02068547|16270436|P1|Overall Study|Physician Decision|1
4718720|NCT02068547|16270435|P2|Overall Study|Lost to Follow-up|3
4718721|NCT02068547|16270436|P1|Overall Study|Lost to Follow-up|3
4718722|NCT02068508|16270446|P1|Overall Study|Protocol Violation|4
4718723|NCT02068508|16270446|P1|Overall Study|Patient did not visit the study site|1
4718724|NCT02068508|16270446|P1|Overall Study|Case report forms uncollected|27
4718725|NCT02068495|16270456|P1|Overall Study|Protocol Deviation|49
4718726|NCT02068495|16270456|P1|Overall Study|Case Report Forms Uncollected|60
4718727|NCT02068443|16270468|P3|Overall Study|Other Reason Not Specified|0
4718728|NCT02068443|16270469|P2|Overall Study|Other Reason Not Specified|0
4718729|NCT02068443|16270470|P1|Overall Study|Other Reason Not Specified|1
4718730|NCT02068443|16270468|P3|Overall Study|Lack of Efficacy|0
4718731|NCT02068443|16270469|P2|Overall Study|Lack of Efficacy|1
4718732|NCT02068443|16270470|P1|Overall Study|Lack of Efficacy|2
4718733|NCT02068443|16270468|P3|Overall Study|Voluntary Withdrawal|1
4718734|NCT02068443|16270469|P2|Overall Study|Voluntary Withdrawal|0
4718735|NCT02068443|16270470|P1|Overall Study|Voluntary Withdrawal|4
4718736|NCT02068443|16270468|P3|Overall Study|Pretreatment Event/Adverse Event|2
4718737|NCT02068443|16270469|P2|Overall Study|Pretreatment Event/Adverse Event|5
4718738|NCT02068443|16270470|P1|Overall Study|Pretreatment Event/Adverse Event|0
4718739|NCT02068222|16270505|P1|Overall Study|Lost to Follow-up|1
4718740|NCT02067728|16270536|P2|6 Month Measurements|Unable to attend|97
4718741|NCT02067728|16270537|P1|6 Month Measurements|Unable to attend|114
4718742|NCT02067728|16270536|P2|6 Month Follow up Survey|Lost to Follow-up|60
4718743|NCT02067728|16270537|P1|6 Month Follow up Survey|Lost to Follow-up|48
4718744|NCT02067728|16270536|P2|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28
4718745|NCT02067728|16270537|P1|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7
4718746|NCT02067676|16270571|P6|Overall Study|Withdrawal by Subject|0
4718747|NCT02067676|16270572|P5|Overall Study|Withdrawal by Subject|0
4718748|NCT02067676|16270573|P4|Overall Study|Withdrawal by Subject|0
4718749|NCT02067676|16270574|P3|Overall Study|Withdrawal by Subject|0
4718750|NCT02067676|16270575|P2|Overall Study|Withdrawal by Subject|0
4718751|NCT02067676|16270576|P1|Overall Study|Withdrawal by Subject|1
4718752|NCT02067663|16270616|P2|Overall Study|Lost to Follow-up|14
4718753|NCT02067663|16270617|P1|Overall Study|Lost to Follow-up|13
4718754|NCT02067533|16270716|P2|Overall Study|Lost to Follow-up|2
4718755|NCT02067533|16270717|P1|Overall Study|Lost to Follow-up|4
4718756|NCT02067104|16270768|P2|Overall Study|Study termination due to low accrual|5
4718757|NCT02067104|16270769|P1|Overall Study|Study termination due to low accrual|4
4718758|NCT02066922|16270798|P1|Overall Study|Adverse Event|1
4718759|NCT02066467|16270867|P1|Overall Study|Not defined|4
4718760|NCT02066467|16270867|P1|Overall Study|Physician Decision|2
4718761|NCT02066467|16270867|P1|Overall Study|Withdrawal by Subject|16
4718762|NCT02066467|16270867|P1|Overall Study|Adverse Event|20
4718763|NCT02066467|16270867|P1|Overall Study|Lost to Follow-up|51
4718764|NCT02066467|16270867|P1|Overall Study|Death|54
4718765|NCT02066467|16270867|P1|Overall Study|Consent ineligible|1
4718766|NCT02066467|16270867|P1|Overall Study|Attempted to implant withoput success|43
4718767|NCT02066467|16270867|P1|Overall Study|Did not undergo implant procedure|24
4718768|NCT02066415|16270876|P3|Overall Study|Lost to Follow-up|2
4718769|NCT02066415|16270877|P2|Overall Study|Lost to Follow-up|2
4718770|NCT02066415|16270878|P1|Overall Study|Lost to Follow-up|7
4718771|NCT02066415|16270876|P3|Overall Study|Withdrawal by Subject|4
4718772|NCT02066415|16270877|P2|Overall Study|Withdrawal by Subject|1
4718773|NCT02066415|16270878|P1|Overall Study|Withdrawal by Subject|9
4718774|NCT02066415|16270876|P3|Overall Study|Decision by Sponsor|2
4718775|NCT02066415|16270877|P2|Overall Study|Decision by Sponsor|4
4718776|NCT02066415|16270878|P1|Overall Study|Decision by Sponsor|5
4718777|NCT02066402|16270903|P2|Overall Study|Protocol driven decision point|1
4718778|NCT02066402|16270904|P1|Overall Study|Protocol driven decision point|0
4718779|NCT02066402|16270903|P2|Overall Study|Progressive disease-clinical progression|1
4718780|NCT02066402|16270904|P1|Overall Study|Progressive disease-clinical progression|0
4718781|NCT02066402|16270903|P2|Overall Study|Withdrawal by Subject|11
4718782|NCT02066402|16270904|P1|Overall Study|Withdrawal by Subject|14
4718783|NCT02066402|16270903|P2|Overall Study|Lost to Follow-up|8
4718784|NCT02066402|16270904|P1|Overall Study|Lost to Follow-up|11
4718785|NCT02066402|16270903|P2|Overall Study|Adverse Event|2
4718786|NCT02066402|16270904|P1|Overall Study|Adverse Event|1
4718787|NCT02066389|16270936|P6|Overall Study|Randomized in Error|1
4718788|NCT02066389|16270937|P5|Overall Study|Randomized in Error|0
4718789|NCT02066389|16270938|P4|Overall Study|Randomized in Error|0
4718790|NCT02066389|16270939|P3|Overall Study|Randomized in Error|0
4718791|NCT02066389|16270940|P2|Overall Study|Randomized in Error|0
4718792|NCT02066389|16270941|P1|Overall Study|Randomized in Error|0
4718793|NCT02066389|16270936|P6|Overall Study|Lost to Follow-up|1
4718794|NCT02066389|16270937|P5|Overall Study|Lost to Follow-up|1
4718795|NCT02066389|16270938|P4|Overall Study|Lost to Follow-up|1
4718796|NCT02066389|16270939|P3|Overall Study|Lost to Follow-up|0
4718797|NCT02066389|16270940|P2|Overall Study|Lost to Follow-up|0
4718798|NCT02066389|16270941|P1|Overall Study|Lost to Follow-up|0
4718799|NCT02066389|16270936|P6|Overall Study|Withdrawal by Subject|2
4718800|NCT02066389|16270937|P5|Overall Study|Withdrawal by Subject|1
4718801|NCT02066389|16270938|P4|Overall Study|Withdrawal by Subject|1
4718802|NCT02066389|16270939|P3|Overall Study|Withdrawal by Subject|5
4718803|NCT02066389|16270940|P2|Overall Study|Withdrawal by Subject|0
4718804|NCT02066389|16270941|P1|Overall Study|Withdrawal by Subject|4
4718805|NCT02066389|16270936|P6|Overall Study|Adverse Event|1
4718806|NCT02066389|16270937|P5|Overall Study|Adverse Event|5
4718807|NCT02066389|16270938|P4|Overall Study|Adverse Event|1
4718808|NCT02066389|16270939|P3|Overall Study|Adverse Event|1
4718809|NCT02066389|16270940|P2|Overall Study|Adverse Event|1
4718810|NCT02066389|16270941|P1|Overall Study|Adverse Event|1
4718811|NCT02066311|16270991|P1|Overall Study|Withdrawal by Subject|1
4718812|NCT02066311|16270991|P1|Overall Study|Adverse Event|4
4718813|NCT02066298|16271001|P6|Overall Study|Physician Decision|0
4718814|NCT02066298|16271002|P5|Overall Study|Physician Decision|1
4718815|NCT02066298|16271003|P4|Overall Study|Physician Decision|0
4718816|NCT02066298|16271004|P3|Overall Study|Physician Decision|1
4718817|NCT02066298|16271005|P2|Overall Study|Physician Decision|0
4718818|NCT02066298|16271006|P1|Overall Study|Physician Decision|0
4718819|NCT02066298|16271001|P6|Overall Study|Withdrawal by Subject|8
4718820|NCT02066298|16271002|P5|Overall Study|Withdrawal by Subject|5
4718821|NCT02066298|16271003|P4|Overall Study|Withdrawal by Subject|4
4718822|NCT02066298|16271004|P3|Overall Study|Withdrawal by Subject|6
4718823|NCT02066298|16271005|P2|Overall Study|Withdrawal by Subject|6
4718824|NCT02066298|16271006|P1|Overall Study|Withdrawal by Subject|6
4718825|NCT02066298|16271001|P6|Overall Study|Lost to Follow-up|4
4718826|NCT02066298|16271002|P5|Overall Study|Lost to Follow-up|3
4718827|NCT02066298|16271003|P4|Overall Study|Lost to Follow-up|2
4718828|NCT02066298|16271004|P3|Overall Study|Lost to Follow-up|3
4718829|NCT02066298|16271005|P2|Overall Study|Lost to Follow-up|2
4718830|NCT02066298|16271006|P1|Overall Study|Lost to Follow-up|3
4718831|NCT02066233|16271030|P2|EG Scan II (Day 1)|difficulty intubating subject|6
4718832|NCT02066233|16271031|P1|EG Scan II (Day 1)|difficulty intubating subject|6
4718833|NCT02066181|16271041|P2|Overall Study|Withdrawal by Subject|1
4718834|NCT02066181|16271042|P1|Overall Study|Withdrawal by Subject|1
4718835|NCT02066129|16271064|P2|Overall Study|Physician Decision|1
4718836|NCT02066129|16271065|P1|Overall Study|Physician Decision|1
4718837|NCT02066129|16271064|P2|Overall Study|Lack of Efficacy|10
4718838|NCT02066129|16271065|P1|Overall Study|Lack of Efficacy|8
4718839|NCT02066129|16271064|P2|Overall Study|Withdrawal by Subject|10
4718840|NCT02066129|16271065|P1|Overall Study|Withdrawal by Subject|7
4718841|NCT02066129|16271064|P2|Overall Study|Lost to Follow-up|12
4718842|NCT02066129|16271065|P1|Overall Study|Lost to Follow-up|13
4718843|NCT02066051|16271079|P1|Overall Study|Subject developed active GVHD|1
4718844|NCT02065895|16271084|P6|Overall Study|Scheduling conflicts|0
4718845|NCT02065895|16271085|P5|Overall Study|Scheduling conflicts|0
4718846|NCT02065895|16271086|P4|Overall Study|Scheduling conflicts|0
4718847|NCT02065895|16271087|P3|Overall Study|Scheduling conflicts|0
4718848|NCT02065895|16271088|P2|Overall Study|Scheduling conflicts|1
4718849|NCT02065895|16271089|P1|Overall Study|Scheduling conflicts|0
4718850|NCT02065895|16271084|P6|Overall Study|Protocol Violation|0
4718851|NCT02065895|16271085|P5|Overall Study|Protocol Violation|0
4718852|NCT02065895|16271086|P4|Overall Study|Protocol Violation|1
4718853|NCT02065895|16271087|P3|Overall Study|Protocol Violation|0
4718854|NCT02065895|16271088|P2|Overall Study|Protocol Violation|0
4718855|NCT02065895|16271089|P1|Overall Study|Protocol Violation|1
4718856|NCT02065791|16271108|P2|Overall Study|Lost to Follow-up|9
4718857|NCT02065791|16271109|P1|Overall Study|Lost to Follow-up|13
4718858|NCT02065791|16271108|P2|Overall Study|Withdrawal by Subject|5
4718859|NCT02065791|16271109|P1|Overall Study|Withdrawal by Subject|11
4718860|NCT02065791|16271108|P2|Overall Study|Closed Site|1
4718861|NCT02065791|16271109|P1|Overall Study|Closed Site|1
4718862|NCT02065713|16271131|P2|Overall Study|Unsatisfactory therapeutic effect|0
4718863|NCT02065713|16271132|P1|Overall Study|Unsatisfactory therapeutic effect|1
4718864|NCT02065713|16271131|P2|Overall Study|Adverse Event|1
4718865|NCT02065713|16271132|P1|Overall Study|Adverse Event|0
4718866|NCT02065622|16271140|P5|Maintenance Study|Unknown Reason|0
4718867|NCT02065622|16271141|P4|Maintenance Study|Unknown Reason|1
4718868|NCT02065622|16271142|P3|Maintenance Study|Unknown Reason|0
4718869|NCT02065622|16271143|P2|Maintenance Study|Unknown Reason|0
4718870|NCT02065622|16271144|P1|Maintenance Study|Unknown Reason|0
4718871|NCT02065622|16271140|P5|Maintenance Study|Other, Not Specified|2
4718872|NCT02065622|16271141|P4|Maintenance Study|Other, Not Specified|14
4718873|NCT02065622|16271142|P3|Maintenance Study|Other, Not Specified|6
4718874|NCT02065622|16271143|P2|Maintenance Study|Other, Not Specified|0
4718875|NCT02065622|16271144|P1|Maintenance Study|Other, Not Specified|0
4718876|NCT02065622|16271140|P5|Maintenance Study|Subject Non-Compliance|2
4718877|NCT02065622|16271141|P4|Maintenance Study|Subject Non-Compliance|3
4718878|NCT02065622|16271142|P3|Maintenance Study|Subject Non-Compliance|1
4718879|NCT02065622|16271143|P2|Maintenance Study|Subject Non-Compliance|0
4718880|NCT02065622|16271144|P1|Maintenance Study|Subject Non-Compliance|0
4718881|NCT02065622|16271140|P5|Maintenance Study|Requires Alternative/Prohibited Therapy|4
4718882|NCT02065622|16271141|P4|Maintenance Study|Requires Alternative/Prohibited Therapy|3
4718883|NCT02065622|16271142|P3|Maintenance Study|Requires Alternative/Prohibited Therapy|7
4718884|NCT02065622|16271143|P2|Maintenance Study|Requires Alternative/Prohibited Therapy|0
4718885|NCT02065622|16271144|P1|Maintenance Study|Requires Alternative/Prohibited Therapy|0
4718886|NCT02065622|16271140|P5|Maintenance Study|Lack of Efficacy|19
4718887|NCT02065622|16271141|P4|Maintenance Study|Lack of Efficacy|55
4718888|NCT02065622|16271142|P3|Maintenance Study|Lack of Efficacy|70
4718889|NCT02065622|16271143|P2|Maintenance Study|Lack of Efficacy|0
4718890|NCT02065622|16271144|P1|Maintenance Study|Lack of Efficacy|0
4718891|NCT02065622|16271140|P5|Maintenance Study|Lost to Follow-up|1
4718892|NCT02065622|16271141|P4|Maintenance Study|Lost to Follow-up|1
4718893|NCT02065622|16271142|P3|Maintenance Study|Lost to Follow-up|4
4718894|NCT02065622|16271143|P2|Maintenance Study|Lost to Follow-up|0
4718895|NCT02065622|16271144|P1|Maintenance Study|Lost to Follow-up|0
4718896|NCT02065622|16271140|P5|Maintenance Study|Withdrawal by Subject|7
4718897|NCT02065622|16271141|P4|Maintenance Study|Withdrawal by Subject|5
4718898|NCT02065622|16271142|P3|Maintenance Study|Withdrawal by Subject|11
4718899|NCT02065622|16271143|P2|Maintenance Study|Withdrawal by Subject|0
4718900|NCT02065622|16271144|P1|Maintenance Study|Withdrawal by Subject|0
4718901|NCT02065622|16271140|P5|Maintenance Study|Adverse Event|11
4718902|NCT02065622|16271141|P4|Maintenance Study|Adverse Event|22
4718903|NCT02065622|16271142|P3|Maintenance Study|Adverse Event|25
4718904|NCT02065622|16271143|P2|Maintenance Study|Adverse Event|0
4718905|NCT02065622|16271144|P1|Maintenance Study|Adverse Event|0
4718906|NCT02065622|16271140|P5|Induction Study|Other, Not Specified|0
4718907|NCT02065622|16271141|P4|Induction Study|Other, Not Specified|0
4718908|NCT02065622|16271142|P3|Induction Study|Other, Not Specified|0
4718909|NCT02065622|16271143|P2|Induction Study|Other, Not Specified|2
4718910|NCT02065622|16271144|P1|Induction Study|Other, Not Specified|3
4718911|NCT02065622|16271140|P5|Induction Study|Subject Noncompliance|0
4718912|NCT02065622|16271141|P4|Induction Study|Subject Noncompliance|0
4718913|NCT02065622|16271142|P3|Induction Study|Subject Noncompliance|0
4718914|NCT02065622|16271143|P2|Induction Study|Subject Noncompliance|1
4718915|NCT02065622|16271144|P1|Induction Study|Subject Noncompliance|1
4718916|NCT02065622|16271140|P5|Induction Study|Requires Alternative/Prohibited Therapy|0
4718917|NCT02065622|16271141|P4|Induction Study|Requires Alternative/Prohibited Therapy|0
4718918|NCT02065622|16271142|P3|Induction Study|Requires Alternative/Prohibited Therapy|0
4718919|NCT02065622|16271143|P2|Induction Study|Requires Alternative/Prohibited Therapy|5
4718920|NCT02065622|16271144|P1|Induction Study|Requires Alternative/Prohibited Therapy|4
4718921|NCT02065622|16271140|P5|Induction Study|Lack of Efficacy|0
4718922|NCT02065622|16271141|P4|Induction Study|Lack of Efficacy|0
4718923|NCT02065622|16271142|P3|Induction Study|Lack of Efficacy|0
4718924|NCT02065622|16271143|P2|Induction Study|Lack of Efficacy|27
4718925|NCT02065622|16271144|P1|Induction Study|Lack of Efficacy|22
4718926|NCT02065622|16271140|P5|Induction Study|Lost to Follow-up|0
4718927|NCT02065622|16271141|P4|Induction Study|Lost to Follow-up|0
4718928|NCT02065622|16271142|P3|Induction Study|Lost to Follow-up|0
4718929|NCT02065622|16271143|P2|Induction Study|Lost to Follow-up|0
4718930|NCT02065622|16271144|P1|Induction Study|Lost to Follow-up|1
4718931|NCT02065622|16271140|P5|Induction Study|Withdrawal by Subject|0
4718932|NCT02065622|16271141|P4|Induction Study|Withdrawal by Subject|0
4718933|NCT02065622|16271142|P3|Induction Study|Withdrawal by Subject|0
4718934|NCT02065622|16271143|P2|Induction Study|Withdrawal by Subject|5
4718935|NCT02065622|16271144|P1|Induction Study|Withdrawal by Subject|3
4718936|NCT02065622|16271140|P5|Induction Study|Adverse Event|0
4718937|NCT02065622|16271141|P4|Induction Study|Adverse Event|0
4718938|NCT02065622|16271142|P3|Induction Study|Adverse Event|0
4718939|NCT02065622|16271143|P2|Induction Study|Adverse Event|19
4718940|NCT02065622|16271144|P1|Induction Study|Adverse Event|13
4718941|NCT02065557|16271246|P6|Maintenance Period|Subject Non-Compliance|1
4718942|NCT02065557|16271247|P5|Maintenance Period|Subject Non-Compliance|0
4718943|NCT02065557|16271248|P4|Maintenance Period|Subject Non-Compliance|0
4718944|NCT02065557|16271249|P3|Maintenance Period|Subject Non-Compliance|0
4718945|NCT02065557|16271250|P2|Maintenance Period|Subject Non-Compliance|0
4718946|NCT02065557|16271251|P1|Maintenance Period|Subject Non-Compliance|0
4718947|NCT02065557|16271246|P6|Maintenance Period|Lack of Efficacy|2
4718948|NCT02065557|16271247|P5|Maintenance Period|Lack of Efficacy|5
4718949|NCT02065557|16271248|P4|Maintenance Period|Lack of Efficacy|0
4718950|NCT02065557|16271249|P3|Maintenance Period|Lack of Efficacy|0
4718951|NCT02065557|16271250|P2|Maintenance Period|Lack of Efficacy|0
4718952|NCT02065557|16271251|P1|Maintenance Period|Lack of Efficacy|0
4718953|NCT02065557|16271246|P6|Maintenance Period|Withdrawal by Subject|1
4718954|NCT02065557|16271247|P5|Maintenance Period|Withdrawal by Subject|2
4718955|NCT02065557|16271248|P4|Maintenance Period|Withdrawal by Subject|0
4718956|NCT02065557|16271249|P3|Maintenance Period|Withdrawal by Subject|0
4718957|NCT02065557|16271250|P2|Maintenance Period|Withdrawal by Subject|0
4718958|NCT02065557|16271251|P1|Maintenance Period|Withdrawal by Subject|0
4718959|NCT02065557|16271246|P6|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4718960|NCT02065557|16271247|P5|Maintenance Period|Requires Alternative/Prohibited Therapy|1
4718961|NCT02065557|16271248|P4|Maintenance Period|Requires Alternative/Prohibited Therapy|1
4718962|NCT02065557|16271249|P3|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4718963|NCT02065557|16271250|P2|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4718964|NCT02065557|16271251|P1|Maintenance Period|Requires Alternative/Prohibited Therapy|0
4718965|NCT02065557|16271246|P6|Induction Period|Adverse Event|0
4718966|NCT02065557|16271247|P5|Induction Period|Adverse Event|0
4718967|NCT02065557|16271248|P4|Induction Period|Adverse Event|0
4718968|NCT02065557|16271249|P3|Induction Period|Adverse Event|0
4718969|NCT02065557|16271250|P2|Induction Period|Adverse Event|1
4718970|NCT02065557|16271251|P1|Induction Period|Adverse Event|1
4718971|NCT02065557|16271246|P6|Induction Period|Non-Responder at Week 8|0
4718972|NCT02065557|16271247|P5|Induction Period|Non-Responder at Week 8|0
4718973|NCT02065557|16271248|P4|Induction Period|Non-Responder at Week 8|0
4718974|NCT02065557|16271249|P3|Induction Period|Non-Responder at Week 8|0
4718975|NCT02065557|16271250|P2|Induction Period|Non-Responder at Week 8|4
4718976|NCT02065557|16271251|P1|Induction Period|Non-Responder at Week 8|4
4718977|NCT02065557|16271246|P6|Induction Period|Requires Alternative/Prohibited Therapy|0
4718978|NCT02065557|16271247|P5|Induction Period|Requires Alternative/Prohibited Therapy|0
4718979|NCT02065557|16271248|P4|Induction Period|Requires Alternative/Prohibited Therapy|0
4718980|NCT02065557|16271249|P3|Induction Period|Requires Alternative/Prohibited Therapy|1
4718981|NCT02065557|16271250|P2|Induction Period|Requires Alternative/Prohibited Therapy|1
4718982|NCT02065557|16271251|P1|Induction Period|Requires Alternative/Prohibited Therapy|1
4718983|NCT02065557|16271246|P6|Induction Period|Lack of Efficacy|0
4718984|NCT02065557|16271247|P5|Induction Period|Lack of Efficacy|0
4718985|NCT02065557|16271248|P4|Induction Period|Lack of Efficacy|0
4718986|NCT02065557|16271249|P3|Induction Period|Lack of Efficacy|1
4718987|NCT02065557|16271250|P2|Induction Period|Lack of Efficacy|1
4718988|NCT02065557|16271251|P1|Induction Period|Lack of Efficacy|2
4718989|NCT02065557|16271246|P6|Induction Period|Withdrawal by Subject|0
4718990|NCT02065557|16271247|P5|Induction Period|Withdrawal by Subject|0
4718991|NCT02065557|16271248|P4|Induction Period|Withdrawal by Subject|0
4718992|NCT02065557|16271249|P3|Induction Period|Withdrawal by Subject|0
4718993|NCT02065557|16271250|P2|Induction Period|Withdrawal by Subject|1
4718994|NCT02065557|16271251|P1|Induction Period|Withdrawal by Subject|2
4718995|NCT02065518|16271312|P4|Overall Study|Withdrawal by Subject|2
4718996|NCT02065518|16271313|P3|Overall Study|Withdrawal by Subject|9
4718997|NCT02065518|16271314|P2|Overall Study|Withdrawal by Subject|4
4718998|NCT02065518|16271315|P1|Overall Study|Withdrawal by Subject|3
4718999|NCT02065518|16271312|P4|Overall Study|Lost to Follow-up|3
4719000|NCT02065518|16271313|P3|Overall Study|Lost to Follow-up|0
4719001|NCT02065518|16271314|P2|Overall Study|Lost to Follow-up|4
4719002|NCT02065518|16271315|P1|Overall Study|Lost to Follow-up|3
4719003|NCT02065336|16271390|P10|Extension Phase|Study Terminated by Sponsor|8
4719004|NCT02065336|16271391|P9|Extension Phase|Study Terminated by Sponsor|2
4719005|NCT02065336|16271392|P8|Extension Phase|Study Terminated by Sponsor|0
4719006|NCT02065336|16271393|P7|Extension Phase|Study Terminated by Sponsor|0
4719007|NCT02065336|16271394|P6|Extension Phase|Study Terminated by Sponsor|0
4719008|NCT02065336|16271395|P5|Extension Phase|Study Terminated by Sponsor|0
4719009|NCT02065336|16271396|P4|Extension Phase|Study Terminated by Sponsor|0
4719010|NCT02065336|16271397|P3|Extension Phase|Study Terminated by Sponsor|0
4719011|NCT02065336|16271398|P2|Extension Phase|Study Terminated by Sponsor|0
4719012|NCT02065336|16271399|P1|Extension Phase|Study Terminated by Sponsor|0
4719013|NCT02064920|16271676|P2|Overall Study|Withdrawal by Subject|3
4719014|NCT02064920|16271677|P1|Overall Study|Withdrawal by Subject|1
4719015|NCT02064920|16271676|P2|Overall Study|Technical Problems|1
4719016|NCT02064920|16271677|P1|Overall Study|Technical Problems|0
4719017|NCT02064920|16271676|P2|Overall Study|Physician Decision|1
4719018|NCT02064920|16271677|P1|Overall Study|Physician Decision|0
4719019|NCT02064920|16271676|P2|Overall Study|Adverse Event|4
4719020|NCT02064920|16271677|P1|Overall Study|Adverse Event|0
4719021|NCT02064894|16271707|P3|Overall Study|Withdrawal by Subject|115
4719022|NCT02064894|16271708|P2|Overall Study|Withdrawal by Subject|102
4719023|NCT02064894|16271709|P1|Overall Study|Withdrawal by Subject|43
4719024|NCT02064868|16271722|P2|Overall Study|Technical Problems or Missing|2
4719025|NCT02064868|16271723|P1|Overall Study|Technical Problems or Missing|5
4719026|NCT02064868|16271722|P2|Overall Study|Withdrawal by Subject|3
4719027|NCT02064868|16271723|P1|Overall Study|Withdrawal by Subject|14
4719028|NCT02064868|16271722|P2|Overall Study|Physician Decision|0
4719029|NCT02064868|16271723|P1|Overall Study|Physician Decision|1
4719030|NCT02064868|16271722|P2|Overall Study|Lost to Follow-up|8
4719031|NCT02064868|16271723|P1|Overall Study|Lost to Follow-up|14
4719032|NCT02064816|16271743|P2|Overall Study|Other|3
4719033|NCT02064816|16271744|P1|Overall Study|Other|1
4719034|NCT02064816|16271743|P2|Overall Study|Therapeutic failure|1
4719035|NCT02064816|16271744|P1|Overall Study|Therapeutic failure|0
4719036|NCT02064816|16271743|P2|Overall Study|Lost to Follow-up|1
4719037|NCT02064816|16271744|P1|Overall Study|Lost to Follow-up|2
4719038|NCT02064816|16271743|P2|Overall Study|Withdrawal by Subject|1
4719039|NCT02064816|16271744|P1|Overall Study|Withdrawal by Subject|2
4719040|NCT02064816|16271743|P2|Overall Study|Adverse Event|2
4719041|NCT02064816|16271744|P1|Overall Study|Adverse Event|3
4719042|NCT02064439|16271790|P3|Overall Study|Other|7
4719043|NCT02064439|16271791|P2|Overall Study|Other|2
4719044|NCT02064439|16271792|P1|Overall Study|Other|2
4719045|NCT02064439|16271790|P3|Overall Study|Safety outcome reached|10
4719046|NCT02064439|16271791|P2|Overall Study|Safety outcome reached|20
4719047|NCT02064439|16271792|P1|Overall Study|Safety outcome reached|12
4719048|NCT02064439|16271790|P3|Overall Study|Efficacy outcome reached|57
4719049|NCT02064439|16271791|P2|Overall Study|Efficacy outcome reached|16
4719050|NCT02064439|16271792|P1|Overall Study|Efficacy outcome reached|18
4719051|NCT02064439|16271790|P3|Overall Study|Logistical difficulties|2
4719052|NCT02064439|16271791|P2|Overall Study|Logistical difficulties|5
4719053|NCT02064439|16271792|P1|Overall Study|Logistical difficulties|6
4719054|NCT02064439|16271790|P3|Overall Study|Physician Decision|1
4719055|NCT02064439|16271791|P2|Overall Study|Physician Decision|1
4719056|NCT02064439|16271792|P1|Overall Study|Physician Decision|0
4719057|NCT02064439|16271790|P3|Overall Study|Non-compliance with study medication|23
4719058|NCT02064439|16271791|P2|Overall Study|Non-compliance with study medication|19
4719059|NCT02064439|16271792|P1|Overall Study|Non-compliance with study medication|21
4719060|NCT02064439|16271790|P3|Overall Study|Lost to Follow-up|4
4719061|NCT02064439|16271791|P2|Overall Study|Lost to Follow-up|3
4719062|NCT02064439|16271792|P1|Overall Study|Lost to Follow-up|1
4719063|NCT02064439|16271790|P3|Overall Study|Protocol Violation|3
4719064|NCT02064439|16271791|P2|Overall Study|Protocol Violation|5
4719065|NCT02064439|16271792|P1|Overall Study|Protocol Violation|3
4719066|NCT02064439|16271790|P3|Overall Study|Withdrawal by Subject|26
4719067|NCT02064439|16271791|P2|Overall Study|Withdrawal by Subject|18
4719068|NCT02064439|16271792|P1|Overall Study|Withdrawal by Subject|29
4719069|NCT02064439|16271790|P3|Overall Study|Death|3
4719070|NCT02064439|16271791|P2|Overall Study|Death|2
4719071|NCT02064439|16271792|P1|Overall Study|Death|0
4719072|NCT02064439|16271790|P3|Overall Study|Adverse Event|46
4719073|NCT02064439|16271791|P2|Overall Study|Adverse Event|47
4719074|NCT02064439|16271792|P1|Overall Study|Adverse Event|51
4719075|NCT02064387|16271821|P12|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719076|NCT02064387|16271822|P11|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1
4719077|NCT02064387|16271823|P10|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719078|NCT02064387|16271824|P9|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719079|NCT02064387|16271825|P8|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719080|NCT02064387|16271826|P7|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719081|NCT02064387|16271827|P6|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719082|NCT02064387|16271828|P5|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719083|NCT02064387|16271829|P4|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719084|NCT02064387|16271830|P3|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719085|NCT02064387|16271831|P2|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719086|NCT02064387|16271832|P1|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0
4719087|NCT02064387|16271821|P12|Part 2 Max 35 Months Followup Duration|Death|3
4719088|NCT02064387|16271822|P11|Part 2 Max 35 Months Followup Duration|Death|5
4719089|NCT02064387|16271823|P10|Part 2 Max 35 Months Followup Duration|Death|0
4719090|NCT02064387|16271824|P9|Part 2 Max 35 Months Followup Duration|Death|0
4719091|NCT02064387|16271825|P8|Part 2 Max 35 Months Followup Duration|Death|0
4719092|NCT02064387|16271826|P7|Part 2 Max 35 Months Followup Duration|Death|0
4719093|NCT02064387|16271827|P6|Part 2 Max 35 Months Followup Duration|Death|0
4719094|NCT02064387|16271828|P5|Part 2 Max 35 Months Followup Duration|Death|0
4719095|NCT02064387|16271829|P4|Part 2 Max 35 Months Followup Duration|Death|0
4719096|NCT02064387|16271830|P3|Part 2 Max 35 Months Followup Duration|Death|0
4719097|NCT02064387|16271831|P2|Part 2 Max 35 Months Followup Duration|Death|0
4719098|NCT02064387|16271832|P1|Part 2 Max 35 Months Followup Duration|Death|0
4719099|NCT02064387|16271821|P12|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719100|NCT02064387|16271822|P11|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719101|NCT02064387|16271823|P10|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719102|NCT02064387|16271824|P9|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1
4719103|NCT02064387|16271825|P8|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719104|NCT02064387|16271826|P7|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719105|NCT02064387|16271827|P6|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719106|NCT02064387|16271828|P5|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719107|NCT02064387|16271829|P4|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719108|NCT02064387|16271830|P3|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719109|NCT02064387|16271831|P2|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719110|NCT02064387|16271832|P1|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0
4719111|NCT02064387|16271821|P12|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719112|NCT02064387|16271822|P11|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719113|NCT02064387|16271823|P10|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719114|NCT02064387|16271824|P9|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719115|NCT02064387|16271825|P8|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1
4719116|NCT02064387|16271826|P7|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719117|NCT02064387|16271827|P6|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719118|NCT02064387|16271828|P5|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719119|NCT02064387|16271829|P4|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719120|NCT02064387|16271830|P3|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719121|NCT02064387|16271831|P2|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719122|NCT02064387|16271832|P1|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0
4719123|NCT02064387|16271821|P12|Part 1 Max 23.5 Months Followup Duration|Death|0
4719124|NCT02064387|16271822|P11|Part 1 Max 23.5 Months Followup Duration|Death|0
4719125|NCT02064387|16271823|P10|Part 1 Max 23.5 Months Followup Duration|Death|1
4719126|NCT02064387|16271824|P9|Part 1 Max 23.5 Months Followup Duration|Death|0
4719127|NCT02064387|16271825|P8|Part 1 Max 23.5 Months Followup Duration|Death|1
4719128|NCT02064387|16271826|P7|Part 1 Max 23.5 Months Followup Duration|Death|0
4719129|NCT02064387|16271827|P6|Part 1 Max 23.5 Months Followup Duration|Death|0
4719130|NCT02064387|16271828|P5|Part 1 Max 23.5 Months Followup Duration|Death|0
4719131|NCT02064387|16271829|P4|Part 1 Max 23.5 Months Followup Duration|Death|0
4719132|NCT02064387|16271830|P3|Part 1 Max 23.5 Months Followup Duration|Death|0
4719133|NCT02064387|16271831|P2|Part 1 Max 23.5 Months Followup Duration|Death|0
4719134|NCT02064387|16271832|P1|Part 1 Max 23.5 Months Followup Duration|Death|0
4719135|NCT02064231|16272161|P4|Second Test Period (Test B or Test D)|Lack of Efficacy|0
4719136|NCT02064231|16272162|P3|Second Test Period (Test B or Test D)|Lack of Efficacy|0
4719137|NCT02064231|16272163|P2|Second Test Period (Test B or Test D)|Lack of Efficacy|1
4719138|NCT02064231|16272164|P1|Second Test Period (Test B or Test D)|Lack of Efficacy|1
4719139|NCT02064231|16272161|P4|First Test Period (Test A or Test C)|Adverse Event|0
4719140|NCT02064231|16272162|P3|First Test Period (Test A or Test C)|Adverse Event|1
4719141|NCT02064231|16272163|P2|First Test Period (Test A or Test C)|Adverse Event|0
4719142|NCT02064231|16272164|P1|First Test Period (Test A or Test C)|Adverse Event|1
4719143|NCT02064231|16272161|P4|First Test Period (Test A or Test C)|Withdrawal by Subject|0
4719144|NCT02064231|16272162|P3|First Test Period (Test A or Test C)|Withdrawal by Subject|0
4719145|NCT02064231|16272163|P2|First Test Period (Test A or Test C)|Withdrawal by Subject|1
4719146|NCT02064231|16272164|P1|First Test Period (Test A or Test C)|Withdrawal by Subject|1
4719147|NCT02064231|16272161|P4|First Test Period (Test A or Test C)|Lack of Efficacy|0
4719148|NCT02064231|16272162|P3|First Test Period (Test A or Test C)|Lack of Efficacy|0
4719149|NCT02064231|16272163|P2|First Test Period (Test A or Test C)|Lack of Efficacy|3
4719150|NCT02064231|16272164|P1|First Test Period (Test A or Test C)|Lack of Efficacy|5
4719151|NCT02064205|16272176|P1|Overall Study|Withdrawal by Subject|1
4719152|NCT02064166|16272194|P2|Overall Study|Adverse Event|0
4719153|NCT02064166|16272195|P1|Overall Study|Adverse Event|1
4719154|NCT02063880|16272225|P2|Overall Study|Ineligible|2
4719155|NCT02063880|16272226|P1|Overall Study|Ineligible|0
4719156|NCT02063880|16272225|P2|Overall Study|Lost to Follow-up|7
4719157|NCT02063880|16272226|P1|Overall Study|Lost to Follow-up|7
4719158|NCT02063880|16272225|P2|Overall Study|Death|18
4719159|NCT02063880|16272226|P1|Overall Study|Death|21
4719160|NCT02063854|16272264|P7|Overall Study|Did Not Receive Study Drug|0
4719161|NCT02063854|16272265|P6|Overall Study|Did Not Receive Study Drug|1
4719162|NCT02063854|16272266|P5|Overall Study|Did Not Receive Study Drug|0
4719163|NCT02063854|16272267|P4|Overall Study|Did Not Receive Study Drug|0
4719164|NCT02063854|16272268|P3|Overall Study|Did Not Receive Study Drug|0
4719165|NCT02063854|16272269|P2|Overall Study|Did Not Receive Study Drug|0
4719166|NCT02063854|16272270|P1|Overall Study|Did Not Receive Study Drug|0
4719167|NCT02063854|16272264|P7|Overall Study|Reason Not Specified|0
4719168|NCT02063854|16272265|P6|Overall Study|Reason Not Specified|0
4719169|NCT02063854|16272266|P5|Overall Study|Reason Not Specified|0
4719170|NCT02063854|16272267|P4|Overall Study|Reason Not Specified|0
4719171|NCT02063854|16272268|P3|Overall Study|Reason Not Specified|0
4719172|NCT02063854|16272269|P2|Overall Study|Reason Not Specified|0
4719173|NCT02063854|16272270|P1|Overall Study|Reason Not Specified|1
4719174|NCT02063854|16272264|P7|Overall Study|Surgical Dental Work Performed/Planned|1
4719175|NCT02063854|16272265|P6|Overall Study|Surgical Dental Work Performed/Planned|6
4719176|NCT02063854|16272266|P5|Overall Study|Surgical Dental Work Performed/Planned|1
4719177|NCT02063854|16272267|P4|Overall Study|Surgical Dental Work Performed/Planned|1
4719178|NCT02063854|16272268|P3|Overall Study|Surgical Dental Work Performed/Planned|6
4719179|NCT02063854|16272269|P2|Overall Study|Surgical Dental Work Performed/Planned|2
4719180|NCT02063854|16272270|P1|Overall Study|Surgical Dental Work Performed/Planned|5
4719181|NCT02063854|16272264|P7|Overall Study|Voluntary Withdrawal|1
4719182|NCT02063854|16272265|P6|Overall Study|Voluntary Withdrawal|6
4719183|NCT02063854|16272266|P5|Overall Study|Voluntary Withdrawal|3
4719184|NCT02063854|16272267|P4|Overall Study|Voluntary Withdrawal|1
4719185|NCT02063854|16272268|P3|Overall Study|Voluntary Withdrawal|8
4719186|NCT02063854|16272269|P2|Overall Study|Voluntary Withdrawal|0
4719187|NCT02063854|16272270|P1|Overall Study|Voluntary Withdrawal|2
4719188|NCT02063854|16272264|P7|Overall Study|Major Protocol Deviation|0
4719189|NCT02063854|16272265|P6|Overall Study|Major Protocol Deviation|0
4719190|NCT02063854|16272266|P5|Overall Study|Major Protocol Deviation|0
4719191|NCT02063854|16272267|P4|Overall Study|Major Protocol Deviation|0
4719192|NCT02063854|16272268|P3|Overall Study|Major Protocol Deviation|3
4719193|NCT02063854|16272269|P2|Overall Study|Major Protocol Deviation|0
4719194|NCT02063854|16272270|P1|Overall Study|Major Protocol Deviation|0
4719195|NCT02063854|16272264|P7|Overall Study|Pretreatment Event/Adverse Event|4
4719196|NCT02063854|16272265|P6|Overall Study|Pretreatment Event/Adverse Event|18
4719197|NCT02063854|16272266|P5|Overall Study|Pretreatment Event/Adverse Event|7
4719198|NCT02063854|16272267|P4|Overall Study|Pretreatment Event/Adverse Event|8
4719199|NCT02063854|16272268|P3|Overall Study|Pretreatment Event/Adverse Event|13
4719200|NCT02063854|16272269|P2|Overall Study|Pretreatment Event/Adverse Event|10
4719201|NCT02063854|16272270|P1|Overall Study|Pretreatment Event/Adverse Event|13
4719202|NCT02063737|16272354|P2|Overall Study|Lost to Follow-up|4
4719203|NCT02063737|16272355|P1|Overall Study|Lost to Follow-up|11
4719204|NCT02063724|16272387|P1|Overall Study|Disease progression|1
4719205|NCT02063698|16272395|P2|Overall Study|did not complete booklet for days 2-8|2
4719206|NCT02063698|16272396|P1|Overall Study|did not complete booklet for days 2-8|1
4719207|NCT02063672|16272420|P2|Overall Study|Withdrawal by Subject|2
4719208|NCT02063672|16272421|P1|Overall Study|Withdrawal by Subject|2
4719209|NCT02063672|16272420|P2|Overall Study|Lost to Follow-up|3
4719210|NCT02063672|16272421|P1|Overall Study|Lost to Follow-up|1
4719211|NCT02063672|16272420|P2|Overall Study|Death|3
4719212|NCT02063672|16272421|P1|Overall Study|Death|5
4719213|NCT02063672|16272420|P2|Overall Study|Ongoing Follow-up|14
4719214|NCT02063672|16272421|P1|Overall Study|Ongoing Follow-up|27
4719215|NCT02063659|16272468|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
4719216|NCT02063659|16272469|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
4719217|NCT02063659|16272470|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
4719218|NCT02063659|16272471|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
4719219|NCT02063659|16272468|P4|Open-Label Extension Period (OLE)|Adverse Event|7
4719220|NCT02063659|16272469|P3|Open-Label Extension Period (OLE)|Adverse Event|0
4719221|NCT02063659|16272470|P2|Open-Label Extension Period (OLE)|Adverse Event|0
4719222|NCT02063659|16272471|P1|Open-Label Extension Period (OLE)|Adverse Event|0
4719223|NCT02063659|16272468|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|1
4719224|NCT02063659|16272469|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4719225|NCT02063659|16272470|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4719226|NCT02063659|16272471|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4719227|NCT02063659|16272468|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
4719228|NCT02063659|16272469|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4719229|NCT02063659|16272470|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4719230|NCT02063659|16272471|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4719231|NCT02063659|16272468|P4|Open-Label Extension Period (OLE)|Physician Decision|1
4719232|NCT02063659|16272469|P3|Open-Label Extension Period (OLE)|Physician Decision|0
4719233|NCT02063659|16272470|P2|Open-Label Extension Period (OLE)|Physician Decision|0
4719234|NCT02063659|16272471|P1|Open-Label Extension Period (OLE)|Physician Decision|0
4719235|NCT02063659|16272468|P4|Double-Blind Treatment Period|Withdrawal of consent|0
4719236|NCT02063659|16272469|P3|Double-Blind Treatment Period|Withdrawal of consent|3
4719237|NCT02063659|16272470|P2|Double-Blind Treatment Period|Withdrawal of consent|1
4719238|NCT02063659|16272471|P1|Double-Blind Treatment Period|Withdrawal of consent|0
4719239|NCT02063659|16272468|P4|Double-Blind Treatment Period|Physician Decision|0
4719240|NCT02063659|16272469|P3|Double-Blind Treatment Period|Physician Decision|0
4719241|NCT02063659|16272470|P2|Double-Blind Treatment Period|Physician Decision|0
4719242|NCT02063659|16272471|P1|Double-Blind Treatment Period|Physician Decision|1
4719243|NCT02063659|16272468|P4|Double-Blind Treatment Period|Adverse Event|0
4719244|NCT02063659|16272469|P3|Double-Blind Treatment Period|Adverse Event|0
4719245|NCT02063659|16272470|P2|Double-Blind Treatment Period|Adverse Event|2
4719246|NCT02063659|16272471|P1|Double-Blind Treatment Period|Adverse Event|1
4719247|NCT02063217|16272554|P3|Overall Study|Withdrawal by Subject|0
4719248|NCT02063217|16272555|P2|Overall Study|Withdrawal by Subject|0
4719249|NCT02063217|16272556|P1|Overall Study|Withdrawal by Subject|1
4719250|NCT02062879|16272632|P2|Overall Study|Withdrawal by Subject|1
4719251|NCT02062879|16272633|P1|Overall Study|Withdrawal by Subject|4
4719252|NCT02062658|16272669|P1|Overall Study|Lack of Efficacy|1
4719253|NCT02062658|16272669|P1|Overall Study|Withdrawal by Subject|1
4719254|NCT02062645|16272673|P1|Overall Study|Lost to Follow-up|5
4719255|NCT02062645|16272673|P1|Overall Study|Protocol Violation|8
4719256|NCT02062645|16272673|P1|Overall Study|Adverse Event|2
4719257|NCT02062632|16272681|P1|Overall Study|No treatment data|1
4719258|NCT02062450|16272722|P1|Overall Study|No follow-up visit|124
4719259|NCT02062437|16272736|P1|Overall Study|Pt. couldn't come due to med. condition|1
4719260|NCT02062437|16272736|P1|Overall Study|Death|2
4719261|NCT02062437|16272736|P1|Overall Study|Patient not available for the 2y visit|18
4719262|NCT02062437|16272736|P1|Overall Study|Pt. didn't want to come for the 2y visit|31
4719263|NCT02062398|16272745|P1|Overall Study|Implant removal|1
4719264|NCT02062385|16272757|P4|Overall Study|Lost to Follow-up|0
4719265|NCT02062385|16272758|P3|Overall Study|Lost to Follow-up|1
4719266|NCT02062385|16272759|P2|Overall Study|Lost to Follow-up|0
4719267|NCT02062385|16272760|P1|Overall Study|Lost to Follow-up|0
4719268|NCT02062385|16272757|P4|Overall Study|Death|1
4719269|NCT02062385|16272758|P3|Overall Study|Death|0
4719270|NCT02062385|16272759|P2|Overall Study|Death|0
4719271|NCT02062385|16272760|P1|Overall Study|Death|0
4719272|NCT02062385|16272757|P4|Overall Study|Withdrawn by parent/guardian|8
4719273|NCT02062385|16272758|P3|Overall Study|Withdrawn by parent/guardian|9
4719274|NCT02062385|16272759|P2|Overall Study|Withdrawn by parent/guardian|41
4719275|NCT02062385|16272760|P1|Overall Study|Withdrawn by parent/guardian|46
4719276|NCT02062385|16272757|P4|Overall Study|Moved|0
4719277|NCT02062385|16272758|P3|Overall Study|Moved|1
4719278|NCT02062385|16272759|P2|Overall Study|Moved|11
4719279|NCT02062385|16272760|P1|Overall Study|Moved|10
4719280|NCT02062385|16272757|P4|Overall Study|Incomplete EPI by database lock|0
4719281|NCT02062385|16272758|P3|Overall Study|Incomplete EPI by database lock|0
4719282|NCT02062385|16272759|P2|Overall Study|Incomplete EPI by database lock|0
4719283|NCT02062385|16272760|P1|Overall Study|Incomplete EPI by database lock|2
4719284|NCT02062385|16272757|P4|Overall Study|Protocol Violation|0
4719285|NCT02062385|16272758|P3|Overall Study|Protocol Violation|0
4719286|NCT02062385|16272759|P2|Overall Study|Protocol Violation|0
4719287|NCT02062385|16272760|P1|Overall Study|Protocol Violation|1
4719288|NCT02062385|16272757|P4|Overall Study|Adverse Event|0
4719289|NCT02062385|16272758|P3|Overall Study|Adverse Event|1
4719290|NCT02062385|16272759|P2|Overall Study|Adverse Event|13
4719291|NCT02062385|16272760|P1|Overall Study|Adverse Event|19
4719292|NCT02062151|16272804|P1|Overall Study|screen failure|1
4719293|NCT02061592|16272964|P2|Period 2|Lost to Follow-up|1
4719294|NCT02061592|16272965|P1|Period 2|Lost to Follow-up|0
4719295|NCT02061592|16272964|P2|Period 1|Protocol Violation|0
4719296|NCT02061592|16272965|P1|Period 1|Protocol Violation|1
4719297|NCT02061592|16272964|P2|Period 1|Withdrawal by Subject|0
4719298|NCT02061592|16272965|P1|Period 1|Withdrawal by Subject|1
4719299|NCT02061540|16272977|P1|Overall Study|Withdrawal by Subject|2
4719300|NCT02061540|16272977|P1|Overall Study|Adverse Event|2
4719301|NCT02061280|16273150|P2|Overall Study|Lost to Follow-up|1
4719302|NCT02061280|16273151|P1|Overall Study|Lost to Follow-up|5
4719303|NCT02061280|16273150|P2|Overall Study|Withdrawal by Subject|2
4719304|NCT02061280|16273151|P1|Overall Study|Withdrawal by Subject|1
4719305|NCT02061280|16273150|P2|Overall Study|moved out of state|1
4719306|NCT02061280|16273151|P1|Overall Study|moved out of state|0
4719307|NCT02061280|16273150|P2|Overall Study|Protocol Violation|8
4719308|NCT02061280|16273151|P1|Overall Study|Protocol Violation|12
4719309|NCT02061202|16273183|P2|Overall Study|Lost to Follow-up|1
4719310|NCT02061202|16273184|P1|Overall Study|Lost to Follow-up|1
4719311|NCT02060903|16273210|P2|Overall Study|Withdrawal by Subject|7
4719312|NCT02060903|16273211|P1|Overall Study|Withdrawal by Subject|0
4719313|NCT02060903|16273210|P2|Overall Study|Lost to Follow-up|0
4719314|NCT02060903|16273211|P1|Overall Study|Lost to Follow-up|4
4719315|NCT02060383|16273332|P5|Extension Phase|Protocol Violation|1
4719316|NCT02060383|16273333|P4|Extension Phase|Protocol Violation|0
4719317|NCT02060383|16273334|P3|Extension Phase|Protocol Violation|0
4719318|NCT02060383|16273335|P2|Extension Phase|Protocol Violation|0
4719319|NCT02060383|16273336|P1|Extension Phase|Protocol Violation|0
4719320|NCT02060383|16273332|P5|Extension Phase|Death|1
4719321|NCT02060383|16273333|P4|Extension Phase|Death|0
4719322|NCT02060383|16273334|P3|Extension Phase|Death|1
4719323|NCT02060383|16273335|P2|Extension Phase|Death|0
4719324|NCT02060383|16273336|P1|Extension Phase|Death|0
4719325|NCT02060383|16273332|P5|Extension Phase|Administrative problems|0
4719326|NCT02060383|16273333|P4|Extension Phase|Administrative problems|0
4719327|NCT02060383|16273334|P3|Extension Phase|Administrative problems|0
4719328|NCT02060383|16273335|P2|Extension Phase|Administrative problems|0
4719329|NCT02060383|16273336|P1|Extension Phase|Administrative problems|1
4719330|NCT02060383|16273332|P5|Extension Phase|Withdrawal by Subject|2
4719331|NCT02060383|16273333|P4|Extension Phase|Withdrawal by Subject|0
4719332|NCT02060383|16273334|P3|Extension Phase|Withdrawal by Subject|0
4719333|NCT02060383|16273335|P2|Extension Phase|Withdrawal by Subject|1
4719334|NCT02060383|16273336|P1|Extension Phase|Withdrawal by Subject|0
4719335|NCT02060383|16273332|P5|Extension Phase|Adverse Event|1
4719336|NCT02060383|16273333|P4|Extension Phase|Adverse Event|0
4719337|NCT02060383|16273334|P3|Extension Phase|Adverse Event|2
4719338|NCT02060383|16273335|P2|Extension Phase|Adverse Event|1
4719339|NCT02060383|16273336|P1|Extension Phase|Adverse Event|1
4719340|NCT02060383|16273332|P5|Extension Phase|Unsatisfactory therapeutic effect|2
4719341|NCT02060383|16273333|P4|Extension Phase|Unsatisfactory therapeutic effect|2
4719342|NCT02060383|16273334|P3|Extension Phase|Unsatisfactory therapeutic effect|0
4719343|NCT02060383|16273335|P2|Extension Phase|Unsatisfactory therapeutic effect|1
4719344|NCT02060383|16273336|P1|Extension Phase|Unsatisfactory therapeutic effect|1
4719345|NCT02060383|16273332|P5|Core Phase|Withdrawal by Subject|2
4719346|NCT02060383|16273333|P4|Core Phase|Withdrawal by Subject|4
4719347|NCT02060383|16273334|P3|Core Phase|Withdrawal by Subject|0
4719348|NCT02060383|16273335|P2|Core Phase|Withdrawal by Subject|0
4719349|NCT02060383|16273336|P1|Core Phase|Withdrawal by Subject|0
4719350|NCT02060383|16273332|P5|Core Phase|Protocol Violation|0
4719351|NCT02060383|16273333|P4|Core Phase|Protocol Violation|1
4719352|NCT02060383|16273334|P3|Core Phase|Protocol Violation|0
4719353|NCT02060383|16273335|P2|Core Phase|Protocol Violation|0
4719354|NCT02060383|16273336|P1|Core Phase|Protocol Violation|0
4719355|NCT02060383|16273332|P5|Core Phase|Administrative problems|0
4719356|NCT02060383|16273333|P4|Core Phase|Administrative problems|0
4719357|NCT02060383|16273334|P3|Core Phase|Administrative problems|0
4719358|NCT02060383|16273335|P2|Core Phase|Administrative problems|1
4719359|NCT02060383|16273336|P1|Core Phase|Administrative problems|0
4719360|NCT02060383|16273332|P5|Core Phase|Adverse Event|6
4719361|NCT02060383|16273333|P4|Core Phase|Adverse Event|2
4719362|NCT02060383|16273334|P3|Core Phase|Adverse Event|0
4719363|NCT02060383|16273335|P2|Core Phase|Adverse Event|0
4719364|NCT02060383|16273336|P1|Core Phase|Adverse Event|2
4719365|NCT02060383|16273332|P5|Core Phase|Unsatisfactory therapeutic effect|0
4719366|NCT02060383|16273333|P4|Core Phase|Unsatisfactory therapeutic effect|0
4719367|NCT02060383|16273334|P3|Core Phase|Unsatisfactory therapeutic effect|0
4719368|NCT02060383|16273335|P2|Core Phase|Unsatisfactory therapeutic effect|5
4719369|NCT02060383|16273336|P1|Core Phase|Unsatisfactory therapeutic effect|1
4719370|NCT02060370|16273362|P1|Overall Study|Physician Decision|1
4719371|NCT02059980|16273403|P2|Overall Study|Lost to Follow-up|1
4719372|NCT02059980|16273404|P1|Overall Study|Lost to Follow-up|2
4719373|NCT02059434|16273449|P9|Washout Between Periods 7 and 8|Withdrawal by Subject|1
4719374|NCT02059434|16273450|P8|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719375|NCT02059434|16273451|P7|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719376|NCT02059434|16273452|P6|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719377|NCT02059434|16273453|P5|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719378|NCT02059434|16273454|P4|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719379|NCT02059434|16273455|P3|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719380|NCT02059434|16273456|P2|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719381|NCT02059434|16273457|P1|Washout Between Periods 7 and 8|Withdrawal by Subject|0
4719382|NCT02059434|16273449|P9|Washout Between Periods 7 and 8|Adverse Event|1
4719383|NCT02059434|16273450|P8|Washout Between Periods 7 and 8|Adverse Event|0
4719384|NCT02059434|16273451|P7|Washout Between Periods 7 and 8|Adverse Event|0
4719385|NCT02059434|16273452|P6|Washout Between Periods 7 and 8|Adverse Event|0
4719386|NCT02059434|16273453|P5|Washout Between Periods 7 and 8|Adverse Event|0
4719387|NCT02059434|16273454|P4|Washout Between Periods 7 and 8|Adverse Event|0
4719388|NCT02059434|16273455|P3|Washout Between Periods 7 and 8|Adverse Event|0
4719389|NCT02059434|16273456|P2|Washout Between Periods 7 and 8|Adverse Event|0
4719390|NCT02059434|16273457|P1|Washout Between Periods 7 and 8|Adverse Event|0
4719391|NCT02059434|16273449|P9|Washout Between Periods 6 and 7|Physician Decision|1
4719392|NCT02059434|16273450|P8|Washout Between Periods 6 and 7|Physician Decision|0
4719393|NCT02059434|16273451|P7|Washout Between Periods 6 and 7|Physician Decision|0
4719394|NCT02059434|16273452|P6|Washout Between Periods 6 and 7|Physician Decision|0
4719395|NCT02059434|16273453|P5|Washout Between Periods 6 and 7|Physician Decision|0
4719396|NCT02059434|16273454|P4|Washout Between Periods 6 and 7|Physician Decision|0
4719397|NCT02059434|16273455|P3|Washout Between Periods 6 and 7|Physician Decision|0
4719398|NCT02059434|16273456|P2|Washout Between Periods 6 and 7|Physician Decision|0
4719399|NCT02059434|16273457|P1|Washout Between Periods 6 and 7|Physician Decision|0
4719400|NCT02059434|16273449|P9|Washout Between Periods 4 and 5|Adverse Event|1
4719401|NCT02059434|16273450|P8|Washout Between Periods 4 and 5|Adverse Event|0
4719402|NCT02059434|16273451|P7|Washout Between Periods 4 and 5|Adverse Event|0
4719403|NCT02059434|16273452|P6|Washout Between Periods 4 and 5|Adverse Event|0
4719404|NCT02059434|16273453|P5|Washout Between Periods 4 and 5|Adverse Event|0
4719405|NCT02059434|16273454|P4|Washout Between Periods 4 and 5|Adverse Event|0
4719406|NCT02059434|16273455|P3|Washout Between Periods 4 and 5|Adverse Event|0
4719407|NCT02059434|16273456|P2|Washout Between Periods 4 and 5|Adverse Event|0
4719408|NCT02059434|16273457|P1|Washout Between Periods 4 and 5|Adverse Event|0
4719409|NCT02059434|16273449|P9|Washout Between Periods 1 and 2|Physician Decision|0
4719410|NCT02059434|16273450|P8|Washout Between Periods 1 and 2|Physician Decision|1
4719411|NCT02059434|16273451|P7|Washout Between Periods 1 and 2|Physician Decision|0
4719412|NCT02059434|16273452|P6|Washout Between Periods 1 and 2|Physician Decision|0
4719413|NCT02059434|16273453|P5|Washout Between Periods 1 and 2|Physician Decision|0
4719414|NCT02059434|16273454|P4|Washout Between Periods 1 and 2|Physician Decision|0
4719415|NCT02059434|16273455|P3|Washout Between Periods 1 and 2|Physician Decision|0
4719416|NCT02059434|16273456|P2|Washout Between Periods 1 and 2|Physician Decision|0
4719417|NCT02059434|16273457|P1|Washout Between Periods 1 and 2|Physician Decision|0
4719418|NCT02059408|16273522|P3|Overall Study|Did not get tested|358
4719419|NCT02059408|16273523|P2|Overall Study|Did not get tested|330
4719420|NCT02059408|16273524|P1|Overall Study|Did not get tested|0
4719421|NCT02059395|16273543|P2|Overall Study|Lost to Follow-up|4
4719422|NCT02059395|16273544|P1|Overall Study|Lost to Follow-up|2
4719423|NCT02059291|16273559|P25|Epoch 4|Lack of Efficacy|0
4719424|NCT02059291|16273560|P24|Epoch 4|Lack of Efficacy|1
4719425|NCT02059291|16273561|P23|Epoch 4|Lack of Efficacy|0
4719426|NCT02059291|16273562|P22|Epoch 4|Lack of Efficacy|0
4719427|NCT02059291|16273563|P21|Epoch 4|Lack of Efficacy|0
4719428|NCT02059291|16273564|P20|Epoch 4|Lack of Efficacy|0
4719429|NCT02059291|16273565|P19|Epoch 4|Lack of Efficacy|0
4719430|NCT02059291|16273566|P18|Epoch 4|Lack of Efficacy|0
4719431|NCT02059291|16273567|P17|Epoch 4|Lack of Efficacy|0
4719432|NCT02059291|16273568|P16|Epoch 4|Lack of Efficacy|0
4719433|NCT02059291|16273569|P15|Epoch 4|Lack of Efficacy|0
4719434|NCT02059291|16273570|P14|Epoch 4|Lack of Efficacy|0
4719435|NCT02059291|16273571|P13|Epoch 4|Lack of Efficacy|0
4719436|NCT02059291|16273572|P12|Epoch 4|Lack of Efficacy|0
4719437|NCT02059291|16273573|P11|Epoch 4|Lack of Efficacy|0
4719438|NCT02059291|16273574|P10|Epoch 4|Lack of Efficacy|0
4719439|NCT02059291|16273575|P9|Epoch 4|Lack of Efficacy|0
4719440|NCT02059291|16273576|P8|Epoch 4|Lack of Efficacy|0
4719441|NCT02059291|16273577|P7|Epoch 4|Lack of Efficacy|0
4719442|NCT02059291|16273578|P6|Epoch 4|Lack of Efficacy|0
4719443|NCT02059291|16273579|P5|Epoch 4|Lack of Efficacy|0
4719444|NCT02059291|16273580|P4|Epoch 4|Lack of Efficacy|0
4719445|NCT02059291|16273581|P3|Epoch 4|Lack of Efficacy|0
4719446|NCT02059291|16273582|P2|Epoch 4|Lack of Efficacy|0
4719447|NCT02059291|16273583|P1|Epoch 4|Lack of Efficacy|0
4719448|NCT02059291|16273559|P25|Epoch 4|Withdrawal by Subject|0
4719449|NCT02059291|16273560|P24|Epoch 4|Withdrawal by Subject|0
4719450|NCT02059291|16273561|P23|Epoch 4|Withdrawal by Subject|0
4719451|NCT02059291|16273562|P22|Epoch 4|Withdrawal by Subject|0
4719452|NCT02059291|16273563|P21|Epoch 4|Withdrawal by Subject|1
4719453|NCT02059291|16273564|P20|Epoch 4|Withdrawal by Subject|0
4719454|NCT02059291|16273565|P19|Epoch 4|Withdrawal by Subject|0
4719455|NCT02059291|16273566|P18|Epoch 4|Withdrawal by Subject|0
4719456|NCT02059291|16273567|P17|Epoch 4|Withdrawal by Subject|0
4719457|NCT02059291|16273568|P16|Epoch 4|Withdrawal by Subject|0
4719458|NCT02059291|16273569|P15|Epoch 4|Withdrawal by Subject|0
4719459|NCT02059291|16273570|P14|Epoch 4|Withdrawal by Subject|0
4719460|NCT02059291|16273571|P13|Epoch 4|Withdrawal by Subject|0
4719461|NCT02059291|16273572|P12|Epoch 4|Withdrawal by Subject|0
4719462|NCT02059291|16273573|P11|Epoch 4|Withdrawal by Subject|0
4719463|NCT02059291|16273574|P10|Epoch 4|Withdrawal by Subject|0
4719464|NCT02059291|16273575|P9|Epoch 4|Withdrawal by Subject|0
4719465|NCT02059291|16273576|P8|Epoch 4|Withdrawal by Subject|0
4719466|NCT02059291|16273577|P7|Epoch 4|Withdrawal by Subject|0
4719467|NCT02059291|16273578|P6|Epoch 4|Withdrawal by Subject|0
4719468|NCT02059291|16273579|P5|Epoch 4|Withdrawal by Subject|0
4719469|NCT02059291|16273580|P4|Epoch 4|Withdrawal by Subject|0
4719470|NCT02059291|16273581|P3|Epoch 4|Withdrawal by Subject|0
4719471|NCT02059291|16273582|P2|Epoch 4|Withdrawal by Subject|0
4719472|NCT02059291|16273583|P1|Epoch 4|Withdrawal by Subject|0
4719473|NCT02059291|16273559|P25|Epoch 4|Pregnancy|0
4719474|NCT02059291|16273560|P24|Epoch 4|Pregnancy|0
4719475|NCT02059291|16273561|P23|Epoch 4|Pregnancy|0
4719476|NCT02059291|16273562|P22|Epoch 4|Pregnancy|0
4719477|NCT02059291|16273563|P21|Epoch 4|Pregnancy|0
4719478|NCT02059291|16273564|P20|Epoch 4|Pregnancy|0
4719479|NCT02059291|16273565|P19|Epoch 4|Pregnancy|0
4719480|NCT02059291|16273566|P18|Epoch 4|Pregnancy|0
4719481|NCT02059291|16273567|P17|Epoch 4|Pregnancy|1
4719482|NCT02059291|16273568|P16|Epoch 4|Pregnancy|0
4719483|NCT02059291|16273569|P15|Epoch 4|Pregnancy|0
4719484|NCT02059291|16273570|P14|Epoch 4|Pregnancy|0
4719485|NCT02059291|16273571|P13|Epoch 4|Pregnancy|0
4719486|NCT02059291|16273572|P12|Epoch 4|Pregnancy|0
4719487|NCT02059291|16273573|P11|Epoch 4|Pregnancy|0
4719488|NCT02059291|16273574|P10|Epoch 4|Pregnancy|0
4719489|NCT02059291|16273575|P9|Epoch 4|Pregnancy|0
4719490|NCT02059291|16273576|P8|Epoch 4|Pregnancy|0
4719491|NCT02059291|16273577|P7|Epoch 4|Pregnancy|0
4719492|NCT02059291|16273578|P6|Epoch 4|Pregnancy|0
4719493|NCT02059291|16273579|P5|Epoch 4|Pregnancy|0
4719494|NCT02059291|16273580|P4|Epoch 4|Pregnancy|0
4719495|NCT02059291|16273581|P3|Epoch 4|Pregnancy|0
4719496|NCT02059291|16273582|P2|Epoch 4|Pregnancy|0
4719497|NCT02059291|16273583|P1|Epoch 4|Pregnancy|0
4719498|NCT02059291|16273559|P25|Epoch 4|Adverse Event|0
4719499|NCT02059291|16273560|P24|Epoch 4|Adverse Event|0
4719500|NCT02059291|16273561|P23|Epoch 4|Adverse Event|1
4719501|NCT02059291|16273562|P22|Epoch 4|Adverse Event|0
4719502|NCT02059291|16273563|P21|Epoch 4|Adverse Event|0
4719503|NCT02059291|16273564|P20|Epoch 4|Adverse Event|0
4719504|NCT02059291|16273565|P19|Epoch 4|Adverse Event|0
4719505|NCT02059291|16273566|P18|Epoch 4|Adverse Event|0
4719506|NCT02059291|16273567|P17|Epoch 4|Adverse Event|1
4719507|NCT02059291|16273568|P16|Epoch 4|Adverse Event|0
4719508|NCT02059291|16273569|P15|Epoch 4|Adverse Event|0
4719509|NCT02059291|16273570|P14|Epoch 4|Adverse Event|0
4719510|NCT02059291|16273571|P13|Epoch 4|Adverse Event|0
4719511|NCT02059291|16273572|P12|Epoch 4|Adverse Event|0
4719512|NCT02059291|16273573|P11|Epoch 4|Adverse Event|0
4719513|NCT02059291|16273574|P10|Epoch 4|Adverse Event|0
4719514|NCT02059291|16273575|P9|Epoch 4|Adverse Event|0
4719515|NCT02059291|16273576|P8|Epoch 4|Adverse Event|0
4719516|NCT02059291|16273577|P7|Epoch 4|Adverse Event|0
4719517|NCT02059291|16273578|P6|Epoch 4|Adverse Event|0
4719518|NCT02059291|16273579|P5|Epoch 4|Adverse Event|0
4719519|NCT02059291|16273580|P4|Epoch 4|Adverse Event|0
4719520|NCT02059291|16273581|P3|Epoch 4|Adverse Event|0
4719521|NCT02059291|16273582|P2|Epoch 4|Adverse Event|0
4719522|NCT02059291|16273583|P1|Epoch 4|Adverse Event|0
4719523|NCT02059291|16273559|P25|Epoch 3|Withdrawal by Subject|0
4719524|NCT02059291|16273560|P24|Epoch 3|Withdrawal by Subject|0
4719525|NCT02059291|16273561|P23|Epoch 3|Withdrawal by Subject|0
4719526|NCT02059291|16273562|P22|Epoch 3|Withdrawal by Subject|0
4719527|NCT02059291|16273563|P21|Epoch 3|Withdrawal by Subject|0
4719528|NCT02059291|16273564|P20|Epoch 3|Withdrawal by Subject|0
4719529|NCT02059291|16273565|P19|Epoch 3|Withdrawal by Subject|0
4719530|NCT02059291|16273566|P18|Epoch 3|Withdrawal by Subject|0
4719531|NCT02059291|16273567|P17|Epoch 3|Withdrawal by Subject|0
4719532|NCT02059291|16273568|P16|Epoch 3|Withdrawal by Subject|1
4719533|NCT02059291|16273569|P15|Epoch 3|Withdrawal by Subject|0
4719534|NCT02059291|16273570|P14|Epoch 3|Withdrawal by Subject|0
4719535|NCT02059291|16273571|P13|Epoch 3|Withdrawal by Subject|0
4719536|NCT02059291|16273572|P12|Epoch 3|Withdrawal by Subject|0
4719537|NCT02059291|16273573|P11|Epoch 3|Withdrawal by Subject|0
4719538|NCT02059291|16273574|P10|Epoch 3|Withdrawal by Subject|0
4719539|NCT02059291|16273575|P9|Epoch 3|Withdrawal by Subject|0
4719540|NCT02059291|16273576|P8|Epoch 3|Withdrawal by Subject|0
4719541|NCT02059291|16273577|P7|Epoch 3|Withdrawal by Subject|0
4719542|NCT02059291|16273578|P6|Epoch 3|Withdrawal by Subject|0
4719543|NCT02059291|16273579|P5|Epoch 3|Withdrawal by Subject|0
4719544|NCT02059291|16273580|P4|Epoch 3|Withdrawal by Subject|0
4719545|NCT02059291|16273581|P3|Epoch 3|Withdrawal by Subject|0
4719546|NCT02059291|16273582|P2|Epoch 3|Withdrawal by Subject|0
4719547|NCT02059291|16273583|P1|Epoch 3|Withdrawal by Subject|0
4719548|NCT02059291|16273559|P25|Epoch 3|Lack of Efficacy|0
4719549|NCT02059291|16273560|P24|Epoch 3|Lack of Efficacy|0
4719550|NCT02059291|16273561|P23|Epoch 3|Lack of Efficacy|0
4719551|NCT02059291|16273562|P22|Epoch 3|Lack of Efficacy|0
4719552|NCT02059291|16273563|P21|Epoch 3|Lack of Efficacy|0
4719553|NCT02059291|16273564|P20|Epoch 3|Lack of Efficacy|0
4719554|NCT02059291|16273565|P19|Epoch 3|Lack of Efficacy|0
4719555|NCT02059291|16273566|P18|Epoch 3|Lack of Efficacy|0
4719556|NCT02059291|16273567|P17|Epoch 3|Lack of Efficacy|0
4719557|NCT02059291|16273568|P16|Epoch 3|Lack of Efficacy|3
4719558|NCT02059291|16273569|P15|Epoch 3|Lack of Efficacy|0
4719559|NCT02059291|16273570|P14|Epoch 3|Lack of Efficacy|0
4719560|NCT02059291|16273571|P13|Epoch 3|Lack of Efficacy|0
4719561|NCT02059291|16273572|P12|Epoch 3|Lack of Efficacy|0
4719562|NCT02059291|16273573|P11|Epoch 3|Lack of Efficacy|0
4719563|NCT02059291|16273574|P10|Epoch 3|Lack of Efficacy|0
4719564|NCT02059291|16273575|P9|Epoch 3|Lack of Efficacy|0
4719565|NCT02059291|16273576|P8|Epoch 3|Lack of Efficacy|0
4719566|NCT02059291|16273577|P7|Epoch 3|Lack of Efficacy|0
4719567|NCT02059291|16273578|P6|Epoch 3|Lack of Efficacy|0
4719568|NCT02059291|16273579|P5|Epoch 3|Lack of Efficacy|0
4719569|NCT02059291|16273580|P4|Epoch 3|Lack of Efficacy|0
4719570|NCT02059291|16273581|P3|Epoch 3|Lack of Efficacy|0
4719571|NCT02059291|16273582|P2|Epoch 3|Lack of Efficacy|0
4719572|NCT02059291|16273583|P1|Epoch 3|Lack of Efficacy|0
4719573|NCT02059291|16273559|P25|Epoch 3|Adverse Event|0
4719574|NCT02059291|16273560|P24|Epoch 3|Adverse Event|0
4719575|NCT02059291|16273561|P23|Epoch 3|Adverse Event|0
4719576|NCT02059291|16273562|P22|Epoch 3|Adverse Event|0
4719577|NCT02059291|16273563|P21|Epoch 3|Adverse Event|0
4719578|NCT02059291|16273564|P20|Epoch 3|Adverse Event|0
4719579|NCT02059291|16273565|P19|Epoch 3|Adverse Event|0
4719580|NCT02059291|16273566|P18|Epoch 3|Adverse Event|0
4719581|NCT02059291|16273567|P17|Epoch 3|Adverse Event|0
4719582|NCT02059291|16273568|P16|Epoch 3|Adverse Event|1
4719583|NCT02059291|16273569|P15|Epoch 3|Adverse Event|0
4719584|NCT02059291|16273570|P14|Epoch 3|Adverse Event|0
4719585|NCT02059291|16273571|P13|Epoch 3|Adverse Event|0
4719586|NCT02059291|16273572|P12|Epoch 3|Adverse Event|0
4719587|NCT02059291|16273573|P11|Epoch 3|Adverse Event|0
4719588|NCT02059291|16273574|P10|Epoch 3|Adverse Event|0
4719589|NCT02059291|16273575|P9|Epoch 3|Adverse Event|0
4719590|NCT02059291|16273576|P8|Epoch 3|Adverse Event|0
4719591|NCT02059291|16273577|P7|Epoch 3|Adverse Event|0
4719592|NCT02059291|16273578|P6|Epoch 3|Adverse Event|0
4719593|NCT02059291|16273579|P5|Epoch 3|Adverse Event|0
4719594|NCT02059291|16273580|P4|Epoch 3|Adverse Event|0
4719595|NCT02059291|16273581|P3|Epoch 3|Adverse Event|0
4719596|NCT02059291|16273582|P2|Epoch 3|Adverse Event|0
4719597|NCT02059291|16273583|P1|Epoch 3|Adverse Event|0
4719598|NCT02059291|16273559|P25|Epoch 3|Physician Decision|0
4719599|NCT02059291|16273560|P24|Epoch 3|Physician Decision|0
4719600|NCT02059291|16273561|P23|Epoch 3|Physician Decision|0
4719601|NCT02059291|16273562|P22|Epoch 3|Physician Decision|0
4719602|NCT02059291|16273563|P21|Epoch 3|Physician Decision|0
4719603|NCT02059291|16273564|P20|Epoch 3|Physician Decision|0
4719604|NCT02059291|16273565|P19|Epoch 3|Physician Decision|0
4719605|NCT02059291|16273566|P18|Epoch 3|Physician Decision|0
4719606|NCT02059291|16273567|P17|Epoch 3|Physician Decision|0
4719607|NCT02059291|16273568|P16|Epoch 3|Physician Decision|1
4719608|NCT02059291|16273569|P15|Epoch 3|Physician Decision|0
4719609|NCT02059291|16273570|P14|Epoch 3|Physician Decision|1
4719610|NCT02059291|16273571|P13|Epoch 3|Physician Decision|0
4719611|NCT02059291|16273572|P12|Epoch 3|Physician Decision|0
4719612|NCT02059291|16273573|P11|Epoch 3|Physician Decision|0
4719613|NCT02059291|16273574|P10|Epoch 3|Physician Decision|0
4719614|NCT02059291|16273575|P9|Epoch 3|Physician Decision|0
4719615|NCT02059291|16273576|P8|Epoch 3|Physician Decision|0
4719616|NCT02059291|16273577|P7|Epoch 3|Physician Decision|0
4719617|NCT02059291|16273578|P6|Epoch 3|Physician Decision|0
4719618|NCT02059291|16273579|P5|Epoch 3|Physician Decision|0
4719619|NCT02059291|16273580|P4|Epoch 3|Physician Decision|0
4719620|NCT02059291|16273581|P3|Epoch 3|Physician Decision|0
4719621|NCT02059291|16273582|P2|Epoch 3|Physician Decision|0
4719622|NCT02059291|16273583|P1|Epoch 3|Physician Decision|0
4719623|NCT02059291|16273559|P25|Epoch 2|Withdrawal by Subject|0
4719624|NCT02059291|16273560|P24|Epoch 2|Withdrawal by Subject|0
4719625|NCT02059291|16273561|P23|Epoch 2|Withdrawal by Subject|0
4719626|NCT02059291|16273562|P22|Epoch 2|Withdrawal by Subject|0
4719627|NCT02059291|16273563|P21|Epoch 2|Withdrawal by Subject|0
4719628|NCT02059291|16273564|P20|Epoch 2|Withdrawal by Subject|0
4719629|NCT02059291|16273565|P19|Epoch 2|Withdrawal by Subject|0
4719630|NCT02059291|16273566|P18|Epoch 2|Withdrawal by Subject|0
4719631|NCT02059291|16273567|P17|Epoch 2|Withdrawal by Subject|0
4719632|NCT02059291|16273568|P16|Epoch 2|Withdrawal by Subject|0
4719633|NCT02059291|16273569|P15|Epoch 2|Withdrawal by Subject|0
4719634|NCT02059291|16273570|P14|Epoch 2|Withdrawal by Subject|0
4719635|NCT02059291|16273571|P13|Epoch 2|Withdrawal by Subject|0
4719636|NCT02059291|16273572|P12|Epoch 2|Withdrawal by Subject|0
4719637|NCT02059291|16273573|P11|Epoch 2|Withdrawal by Subject|0
4719638|NCT02059291|16273574|P10|Epoch 2|Withdrawal by Subject|0
4719639|NCT02059291|16273575|P9|Epoch 2|Withdrawal by Subject|1
4719640|NCT02059291|16273576|P8|Epoch 2|Withdrawal by Subject|0
4719641|NCT02059291|16273577|P7|Epoch 2|Withdrawal by Subject|0
4719642|NCT02059291|16273578|P6|Epoch 2|Withdrawal by Subject|1
4719643|NCT02059291|16273579|P5|Epoch 2|Withdrawal by Subject|0
4719644|NCT02059291|16273580|P4|Epoch 2|Withdrawal by Subject|0
4719645|NCT02059291|16273581|P3|Epoch 2|Withdrawal by Subject|0
4719646|NCT02059291|16273582|P2|Epoch 2|Withdrawal by Subject|1
4719647|NCT02059291|16273583|P1|Epoch 2|Withdrawal by Subject|0
4719648|NCT02059291|16273559|P25|Epoch 2|Adverse Event|0
4719649|NCT02059291|16273560|P24|Epoch 2|Adverse Event|0
4719650|NCT02059291|16273561|P23|Epoch 2|Adverse Event|0
4719651|NCT02059291|16273562|P22|Epoch 2|Adverse Event|0
4719652|NCT02059291|16273563|P21|Epoch 2|Adverse Event|0
4719653|NCT02059291|16273564|P20|Epoch 2|Adverse Event|0
4719654|NCT02059291|16273565|P19|Epoch 2|Adverse Event|0
4719655|NCT02059291|16273566|P18|Epoch 2|Adverse Event|0
4719656|NCT02059291|16273567|P17|Epoch 2|Adverse Event|0
4719657|NCT02059291|16273568|P16|Epoch 2|Adverse Event|0
4719658|NCT02059291|16273569|P15|Epoch 2|Adverse Event|0
4719659|NCT02059291|16273570|P14|Epoch 2|Adverse Event|0
4719660|NCT02059291|16273571|P13|Epoch 2|Adverse Event|0
4719661|NCT02059291|16273572|P12|Epoch 2|Adverse Event|0
4719662|NCT02059291|16273573|P11|Epoch 2|Adverse Event|0
4719663|NCT02059291|16273574|P10|Epoch 2|Adverse Event|0
4719664|NCT02059291|16273575|P9|Epoch 2|Adverse Event|1
4719665|NCT02059291|16273576|P8|Epoch 2|Adverse Event|1
4719666|NCT02059291|16273577|P7|Epoch 2|Adverse Event|0
4719667|NCT02059291|16273578|P6|Epoch 2|Adverse Event|0
4719668|NCT02059291|16273579|P5|Epoch 2|Adverse Event|0
4719669|NCT02059291|16273580|P4|Epoch 2|Adverse Event|1
4719670|NCT02059291|16273581|P3|Epoch 2|Adverse Event|1
4719671|NCT02059291|16273582|P2|Epoch 2|Adverse Event|0
4719672|NCT02059291|16273583|P1|Epoch 2|Adverse Event|0
4719673|NCT02059291|16273559|P25|Epoch 2|Lack of Efficacy|0
4719674|NCT02059291|16273560|P24|Epoch 2|Lack of Efficacy|0
4719675|NCT02059291|16273561|P23|Epoch 2|Lack of Efficacy|0
4719676|NCT02059291|16273562|P22|Epoch 2|Lack of Efficacy|0
4719677|NCT02059291|16273563|P21|Epoch 2|Lack of Efficacy|0
4719678|NCT02059291|16273564|P20|Epoch 2|Lack of Efficacy|0
4719679|NCT02059291|16273565|P19|Epoch 2|Lack of Efficacy|0
4719680|NCT02059291|16273566|P18|Epoch 2|Lack of Efficacy|0
4719681|NCT02059291|16273567|P17|Epoch 2|Lack of Efficacy|0
4719682|NCT02059291|16273568|P16|Epoch 2|Lack of Efficacy|0
4719683|NCT02059291|16273569|P15|Epoch 2|Lack of Efficacy|0
4719684|NCT02059291|16273570|P14|Epoch 2|Lack of Efficacy|0
4719685|NCT02059291|16273571|P13|Epoch 2|Lack of Efficacy|0
4719686|NCT02059291|16273572|P12|Epoch 2|Lack of Efficacy|0
4719687|NCT02059291|16273573|P11|Epoch 2|Lack of Efficacy|0
4719688|NCT02059291|16273574|P10|Epoch 2|Lack of Efficacy|0
4719689|NCT02059291|16273575|P9|Epoch 2|Lack of Efficacy|0
4719690|NCT02059291|16273576|P8|Epoch 2|Lack of Efficacy|0
4719691|NCT02059291|16273577|P7|Epoch 2|Lack of Efficacy|0
4719692|NCT02059291|16273578|P6|Epoch 2|Lack of Efficacy|1
4719693|NCT02059291|16273579|P5|Epoch 2|Lack of Efficacy|0
4719694|NCT02059291|16273580|P4|Epoch 2|Lack of Efficacy|1
4719695|NCT02059291|16273581|P3|Epoch 2|Lack of Efficacy|0
4719696|NCT02059291|16273582|P2|Epoch 2|Lack of Efficacy|0
4719697|NCT02059291|16273583|P1|Epoch 2|Lack of Efficacy|0
4719698|NCT02059278|16273637|P2|Overall Study|Ran out of IP and decided to discontinue|0
4719699|NCT02059278|16273638|P1|Overall Study|Ran out of IP and decided to discontinue|1
4719700|NCT02059278|16273637|P2|Overall Study|Withdrawal by Subject|3
4719701|NCT02059278|16273638|P1|Overall Study|Withdrawal by Subject|0
4719702|NCT02059278|16273637|P2|Overall Study|Lost to Follow-up|0
4719703|NCT02059278|16273638|P1|Overall Study|Lost to Follow-up|1
4719704|NCT02059278|16273637|P2|Overall Study|Adverse Event|1
4719705|NCT02059278|16273638|P1|Overall Study|Adverse Event|1
4719706|NCT02059265|16273652|P1|Overall Study|Ineligible|4
4719707|NCT02059187|16273684|P2|Overall Study|Withdrawal by Subject|8
4719708|NCT02059187|16273685|P1|Overall Study|Withdrawal by Subject|12
4719709|NCT02059187|16273684|P2|Overall Study|Protocol Violation|0
4719710|NCT02059187|16273685|P1|Overall Study|Protocol Violation|1
4719711|NCT02059187|16273684|P2|Overall Study|Physician Decision|2
4719712|NCT02059187|16273685|P1|Overall Study|Physician Decision|1
4719713|NCT02059187|16273684|P2|Overall Study|Non-compliance with study drug|0
4719714|NCT02059187|16273685|P1|Overall Study|Non-compliance with study drug|1
4719715|NCT02059187|16273684|P2|Overall Study|Lost to Follow-up|8
4719716|NCT02059187|16273685|P1|Overall Study|Lost to Follow-up|9
4719717|NCT02059187|16273684|P2|Overall Study|Death|1
4719718|NCT02059187|16273685|P1|Overall Study|Death|1
4719719|NCT02059187|16273684|P2|Overall Study|Adverse Event|3
4719720|NCT02059187|16273685|P1|Overall Study|Adverse Event|0
4719721|NCT02059174|16273711|P2|Period 3|Physician Decision|0
4719722|NCT02059174|16273712|P1|Period 3|Physician Decision|1
4719723|NCT02059174|16273711|P2|Period 2|Protocol Violation|0
4719724|NCT02059174|16273712|P1|Period 2|Protocol Violation|1
4719725|NCT02059174|16273711|P2|Period 2|Withdrawal by Subject|2
4719726|NCT02059174|16273712|P1|Period 2|Withdrawal by Subject|0
4719727|NCT02059174|16273711|P2|Period 1|Withdrawal by Subject|2
4719728|NCT02059174|16273712|P1|Period 1|Withdrawal by Subject|0
4719729|NCT02059161|16273736|P2|Overall Study|Non-compliance with study drug|2
4719730|NCT02059161|16273737|P1|Overall Study|Non-compliance with study drug|6
4719731|NCT02059161|16273736|P2|Overall Study|Randomized in error, no study drug|1
4719732|NCT02059161|16273737|P1|Overall Study|Randomized in error, no study drug|0
4719733|NCT02059161|16273736|P2|Overall Study|Withdrawal by Subject|13
4719734|NCT02059161|16273737|P1|Overall Study|Withdrawal by Subject|16
4719735|NCT02059161|16273736|P2|Overall Study|Protocol Violation|1
4719736|NCT02059161|16273737|P1|Overall Study|Protocol Violation|1
4719737|NCT02059161|16273736|P2|Overall Study|Physician Decision|4
4719738|NCT02059161|16273737|P1|Overall Study|Physician Decision|4
4719739|NCT02059161|16273736|P2|Overall Study|Lost to Follow-up|12
4719740|NCT02059161|16273737|P1|Overall Study|Lost to Follow-up|20
4719741|NCT02059161|16273736|P2|Overall Study|Adverse Event|6
4719742|NCT02059161|16273737|P1|Overall Study|Adverse Event|2
4719743|NCT02059161|16273736|P2|Overall Study|Pregnancy|2
4719744|NCT02059161|16273737|P1|Overall Study|Pregnancy|0
4719745|NCT02059148|16273797|P6|Treatment 1|Protocol Violation|1
4719746|NCT02059148|16273798|P5|Treatment 1|Protocol Violation|0
4719747|NCT02059148|16273799|P4|Treatment 1|Protocol Violation|0
4719748|NCT02059148|16273800|P3|Treatment 1|Protocol Violation|0
4719749|NCT02059148|16273801|P2|Treatment 1|Protocol Violation|0
4719750|NCT02059148|16273802|P1|Treatment 1|Protocol Violation|0
4719751|NCT02059135|16273821|P2|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1
4719752|NCT02059135|16273822|P1|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0
4719753|NCT02059135|16273821|P2|Neonatal Follow-up (Safety Population)|delivered at another hospital|1
4719754|NCT02059135|16273822|P1|Neonatal Follow-up (Safety Population)|delivered at another hospital|0
4719755|NCT02059135|16273821|P2|Neonatal Follow-up (Safety Population)|Death|2
4719756|NCT02059135|16273822|P1|Neonatal Follow-up (Safety Population)|Death|3
4719757|NCT02059135|16273821|P2|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0
4719758|NCT02059135|16273822|P1|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1
4719759|NCT02059135|16273821|P2|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1
4719760|NCT02059135|16273822|P1|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0
4719761|NCT02059135|16273821|P2|Maternal Follow-up (ITT Population)|declined to see site staff|1
4719762|NCT02059135|16273822|P1|Maternal Follow-up (ITT Population)|declined to see site staff|0
4719763|NCT02059135|16273821|P2|Maternal Follow-up (ITT Population)|Lost to Follow-up|3
4719764|NCT02059135|16273822|P1|Maternal Follow-up (ITT Population)|Lost to Follow-up|0
4719765|NCT02059135|16273821|P2|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2
4719766|NCT02059135|16273822|P1|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3
4719767|NCT02059005|16273858|P2|Overall Study|Inpatient|1
4719768|NCT02059005|16273859|P1|Overall Study|Inpatient|0
4719769|NCT02059005|16273858|P2|Overall Study|Incarceration|1
4719770|NCT02059005|16273859|P1|Overall Study|Incarceration|0
4719771|NCT02059005|16273858|P2|Overall Study|Lost to Follow-up|19
4719772|NCT02059005|16273859|P1|Overall Study|Lost to Follow-up|19
4719773|NCT02059005|16273858|P2|Overall Study|Death|3
4719774|NCT02059005|16273859|P1|Overall Study|Death|1
4719775|NCT02058992|16273869|P1|Overall Study|CRF Uncollected|20
4719776|NCT02058992|16273869|P1|Overall Study|Protocol Violation|92
4719777|NCT02058992|16273869|P1|Overall Study|Lost to Follow-up|4
4719778|NCT02058966|16273878|P1|First Intervention|Withdrawal by Subject|1
4719779|NCT02058966|16273878|P1|Open-Label Methamphetamine|Adverse Event|1
4719780|NCT02058940|16273905|P1|Overall Study|Discharged from Critical Care Unit|1
4719781|NCT02058849|16273929|P2|Overall Study|Withdrawal by Subject|0
4719782|NCT02058849|16273930|P1|Overall Study|Withdrawal by Subject|4
4719783|NCT02058849|16273929|P2|Overall Study|Lost to Follow-up|0
4719784|NCT02058849|16273930|P1|Overall Study|Lost to Follow-up|1
4719785|NCT02058849|16273929|P2|Overall Study|Death|0
4719786|NCT02058849|16273930|P1|Overall Study|Death|1
4719787|NCT02058849|16273929|P2|Overall Study|Hospitalization|1
4719788|NCT02058849|16273930|P1|Overall Study|Hospitalization|1
4719789|NCT02058836|16273958|P2|Overall Study|Withdrawal by Subject|1
4719790|NCT02058836|16273959|P1|Overall Study|Withdrawal by Subject|1
4719791|NCT02058628|16273989|P2|Overall Study|Non compliance|0
4719792|NCT02058628|16273990|P1|Overall Study|Non compliance|1
4719793|NCT02058628|16273989|P2|Overall Study|A lot of time for study for participant|0
4719794|NCT02058628|16273990|P1|Overall Study|A lot of time for study for participant|1
4719795|NCT02058628|16273989|P2|Overall Study|The visit date was not in timeline|1
4719796|NCT02058628|16273990|P1|Overall Study|The visit date was not in timeline|0
4719797|NCT02058628|16273989|P2|Overall Study|Not in time schedule|1
4719798|NCT02058628|16273990|P1|Overall Study|Not in time schedule|0
4719799|NCT02058628|16273989|P2|Overall Study|Lost to Follow-up|4
4719800|NCT02058628|16273990|P1|Overall Study|Lost to Follow-up|2
4719801|NCT02058628|16273989|P2|Overall Study|Withdrawal by Subject|2
4719802|NCT02058628|16273990|P1|Overall Study|Withdrawal by Subject|2
4719803|NCT02058628|16273989|P2|Overall Study|Adverse Event|0
4719804|NCT02058628|16273990|P1|Overall Study|Adverse Event|1
4719805|NCT02058589|16274022|P2|Overall Study|Withdrawal by Subject|1
4719806|NCT02058589|16274023|P1|Overall Study|Withdrawal by Subject|0
4719807|NCT02058589|16274022|P2|Overall Study|Non-Serious Adverse Event|0
4719808|NCT02058589|16274023|P1|Overall Study|Non-Serious Adverse Event|1
4719809|NCT02058589|16274022|P2|Overall Study|Serious Adverse Event|1
4719810|NCT02058589|16274023|P1|Overall Study|Serious Adverse Event|1
4719811|NCT02058563|16274065|P2|Overall Study|Other (patient incarcerated)|1
4719812|NCT02058563|16274066|P1|Overall Study|Other (patient incarcerated)|0
4719813|NCT02058563|16274065|P2|Overall Study|Consent Withdrawal|1
4719814|NCT02058563|16274066|P1|Overall Study|Consent Withdrawal|1
4719815|NCT02058563|16274065|P2|Overall Study|Other (vaccinated later as new subject)|0
4719816|NCT02058563|16274066|P1|Overall Study|Other (vaccinated later as new subject)|1
4719817|NCT02058563|16274065|P2|Overall Study|Lost to Follow-up|22
4719818|NCT02058563|16274066|P1|Overall Study|Lost to Follow-up|26
4719819|NCT02058537|16274102|P1|Overall Study|Withdrawal by Subject|1
4719820|NCT02058498|16274113|P1|Overall Study|Withdrawal by Subject|4
4719821|NCT02058368|16274121|P2|Overall Study|Withdrawal by Subject|26
4719822|NCT02058368|16274122|P1|Overall Study|Withdrawal by Subject|22
4719823|NCT02058368|16274121|P2|Overall Study|Physician Decision|3
4719824|NCT02058368|16274122|P1|Overall Study|Physician Decision|2
4719825|NCT02058368|16274121|P2|Overall Study|Lost to Follow-up|0
4719826|NCT02058368|16274122|P1|Overall Study|Lost to Follow-up|2
4719827|NCT02058368|16274121|P2|Overall Study|Protocol Violation|4
4719828|NCT02058368|16274122|P1|Overall Study|Protocol Violation|0
4719829|NCT02058368|16274121|P2|Overall Study|Lack of Efficacy|1
4719830|NCT02058368|16274122|P1|Overall Study|Lack of Efficacy|0
4719831|NCT02058368|16274121|P2|Overall Study|Adverse Event|20
4719832|NCT02058368|16274122|P1|Overall Study|Adverse Event|15
4719833|NCT02058290|16274174|P2|Overall Study|Withdrawal by Subject|1
4719834|NCT02058290|16274175|P1|Overall Study|Withdrawal by Subject|0
4719835|NCT02058290|16274174|P2|Overall Study|Didn't meet intraoperative criteria|7
4719836|NCT02058290|16274175|P1|Overall Study|Didn't meet intraoperative criteria|8
4719837|NCT02058290|16274174|P2|Overall Study|Physician Decision|0
4719838|NCT02058290|16274175|P1|Overall Study|Physician Decision|1
4719839|NCT02058290|16274174|P2|Overall Study|Protocol Violation|1
4719840|NCT02058290|16274175|P1|Overall Study|Protocol Violation|2
4719841|NCT02058160|16274202|P2|Overall Study|Other than specified above|6
4719842|NCT02058160|16274203|P1|Overall Study|Other than specified above|12
4719843|NCT02058160|16274202|P2|Overall Study|Lost to Follow-up|0
4719844|NCT02058160|16274203|P1|Overall Study|Lost to Follow-up|1
4719845|NCT02058160|16274202|P2|Overall Study|Adverse Event|3
4719846|NCT02058160|16274203|P1|Overall Study|Adverse Event|12
4719847|NCT02058160|16274202|P2|Overall Study|Poor compliance to protocol|1
4719848|NCT02058160|16274203|P1|Overall Study|Poor compliance to protocol|4
4719849|NCT02058160|16274202|P2|Overall Study|Randomized but not treated|4
4719850|NCT02058160|16274203|P1|Overall Study|Randomized but not treated|2
4719851|NCT02058147|16274240|P3|Overall Study|Other than specified|0
4719852|NCT02058147|16274241|P2|Overall Study|Other than specified|9
4719853|NCT02058147|16274242|P1|Overall Study|Other than specified|8
4719854|NCT02058147|16274240|P3|Overall Study|Poor compliance to protocol|4
4719855|NCT02058147|16274241|P2|Overall Study|Poor compliance to protocol|9
4719856|NCT02058147|16274242|P1|Overall Study|Poor compliance to protocol|8
4719857|NCT02058147|16274240|P3|Overall Study|Lack of Efficacy|3
4719858|NCT02058147|16274241|P2|Overall Study|Lack of Efficacy|0
4719859|NCT02058147|16274242|P1|Overall Study|Lack of Efficacy|1
4719860|NCT02058147|16274240|P3|Overall Study|Adverse Event|21
4719861|NCT02058147|16274241|P2|Overall Study|Adverse Event|9
4719862|NCT02058147|16274242|P1|Overall Study|Adverse Event|12
4719863|NCT02058147|16274240|P3|Overall Study|Randomized but not treated|1
4719864|NCT02058147|16274241|P2|Overall Study|Randomized but not treated|0
4719865|NCT02058147|16274242|P1|Overall Study|Randomized but not treated|0
4719866|NCT02058108|16274293|P2|Overall Study|Protocol Violation|1
4719867|NCT02058108|16274294|P1|Overall Study|Protocol Violation|0
4719868|NCT02058108|16274293|P2|Overall Study|Administrative problems|3
4719869|NCT02058108|16274294|P1|Overall Study|Administrative problems|3
4719870|NCT02058108|16274293|P2|Overall Study|Withdrawal by Subject|0
4719871|NCT02058108|16274294|P1|Overall Study|Withdrawal by Subject|1
4719872|NCT02058108|16274293|P2|Overall Study|No longer requires study drug|1
4719873|NCT02058108|16274294|P1|Overall Study|No longer requires study drug|0
4719874|NCT02058108|16274293|P2|Overall Study|Unsatisfactory therapeutic effect|4
4719875|NCT02058108|16274294|P1|Overall Study|Unsatisfactory therapeutic effect|37
4719876|NCT02058108|16274293|P2|Overall Study|Abnormal Laboratory Values|1
4719877|NCT02058108|16274294|P1|Overall Study|Abnormal Laboratory Values|0
4719878|NCT02058069|16274318|P1|Overall Study|Withdrawal by Subject|6
4719879|NCT02058069|16274318|P1|Overall Study|Exclusion due to implant size|5
4719880|NCT02057874|16274377|P1|Overall Study|participant did not return for scan|1
4719881|NCT02057835|16274395|P10|Overall Study|Withdrawal by Subject|0
4719882|NCT02057835|16274396|P9|Overall Study|Withdrawal by Subject|0
4719883|NCT02057835|16274397|P8|Overall Study|Withdrawal by Subject|0
4719884|NCT02057835|16274398|P7|Overall Study|Withdrawal by Subject|0
4719885|NCT02057835|16274399|P6|Overall Study|Withdrawal by Subject|0
4719886|NCT02057835|16274400|P5|Overall Study|Withdrawal by Subject|0
4719887|NCT02057835|16274401|P4|Overall Study|Withdrawal by Subject|0
4719888|NCT02057835|16274402|P3|Overall Study|Withdrawal by Subject|0
4719889|NCT02057835|16274403|P2|Overall Study|Withdrawal by Subject|2
4719890|NCT02057835|16274404|P1|Overall Study|Withdrawal by Subject|0
4719891|NCT02057757|16274483|P2|Overall Study|Non-compliance|0
4719892|NCT02057757|16274484|P1|Overall Study|Non-compliance|1
4719893|NCT02057757|16274483|P2|Overall Study|Lost to Follow-up|3
4719894|NCT02057757|16274484|P1|Overall Study|Lost to Follow-up|8
4719895|NCT02057757|16274483|P2|Overall Study|Death|0
4719896|NCT02057757|16274484|P1|Overall Study|Death|2
4719897|NCT02057757|16274483|P2|Overall Study|Withdrawal by Subject|5
4719898|NCT02057757|16274484|P1|Overall Study|Withdrawal by Subject|3
4719899|NCT02057692|16274538|P4|Overall Study|Lost to Follow-up|1
4719900|NCT02057692|16274539|P3|Overall Study|Lost to Follow-up|0
4719901|NCT02057692|16274540|P2|Overall Study|Lost to Follow-up|0
4719902|NCT02057692|16274541|P1|Overall Study|Lost to Follow-up|0
4719903|NCT02057692|16274538|P4|Overall Study|Adverse Event|0
4719904|NCT02057692|16274539|P3|Overall Study|Adverse Event|0
4719905|NCT02057692|16274540|P2|Overall Study|Adverse Event|0
4719906|NCT02057692|16274541|P1|Overall Study|Adverse Event|1
4719907|NCT02057575|16274587|P4|Overall Study|Protocol Violation|0
4719908|NCT02057575|16274588|P3|Overall Study|Protocol Violation|0
4719909|NCT02057575|16274589|P2|Overall Study|Protocol Violation|1
4719910|NCT02057575|16274590|P1|Overall Study|Protocol Violation|0
4719911|NCT02057575|16274587|P4|Overall Study|Dissallowed Concurrent Medication|0
4719912|NCT02057575|16274588|P3|Overall Study|Dissallowed Concurrent Medication|0
4719913|NCT02057575|16274589|P2|Overall Study|Dissallowed Concurrent Medication|1
4719914|NCT02057575|16274590|P1|Overall Study|Dissallowed Concurrent Medication|0
4719915|NCT02057575|16274587|P4|Overall Study|Withdrawal by Subject|0
4719916|NCT02057575|16274588|P3|Overall Study|Withdrawal by Subject|0
4719917|NCT02057575|16274589|P2|Overall Study|Withdrawal by Subject|0
4719918|NCT02057575|16274590|P1|Overall Study|Withdrawal by Subject|1
4719919|NCT02057575|16274587|P4|Overall Study|Adverse Event|1
4719920|NCT02057575|16274588|P3|Overall Study|Adverse Event|0
4719921|NCT02057575|16274589|P2|Overall Study|Adverse Event|2
4719922|NCT02057575|16274590|P1|Overall Study|Adverse Event|0
4719923|NCT02057549|16274602|P2|Overall Study|Withdrawal by Subject|0
4719924|NCT02057549|16274603|P1|Overall Study|Withdrawal by Subject|1
4719925|NCT02057549|16274602|P2|Overall Study|Physician Decision|0
4719926|NCT02057549|16274603|P1|Overall Study|Physician Decision|1
4719927|NCT02057549|16274602|P2|Overall Study|Lost to Follow-up|0
4719928|NCT02057549|16274603|P1|Overall Study|Lost to Follow-up|1
4719929|NCT02057523|16274623|P1|Overall Study|Lack of Efficacy|1
4719930|NCT02057523|16274623|P1|Overall Study|Withdrawal by Subject|1
4719931|NCT02057458|16274628|P3|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
4719932|NCT02057458|16274629|P2|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0
4719933|NCT02057458|16274630|P1|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1
4719934|NCT02057458|16274628|P3|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
4719935|NCT02057458|16274629|P2|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0
4719936|NCT02057458|16274630|P1|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2
4719937|NCT02057458|16274628|P3|Met Inclusion Criteria|Prior history of migraine headaches|0
4719938|NCT02057458|16274629|P2|Met Inclusion Criteria|Prior history of migraine headaches|1
4719939|NCT02057458|16274630|P1|Met Inclusion Criteria|Prior history of migraine headaches|0
4719940|NCT02057406|16274668|P3|Overall Study|Patient transportation issues|1
4719941|NCT02057406|16274669|P2|Overall Study|Patient transportation issues|0
4719942|NCT02057406|16274670|P1|Overall Study|Patient transportation issues|0
4719943|NCT02057406|16274668|P3|Overall Study|Protocol Violation|0
4719944|NCT02057406|16274669|P2|Overall Study|Protocol Violation|1
4719945|NCT02057406|16274670|P1|Overall Study|Protocol Violation|0
4719946|NCT02057406|16274668|P3|Overall Study|Death|0
4719947|NCT02057406|16274669|P2|Overall Study|Death|0
4719948|NCT02057406|16274670|P1|Overall Study|Death|1
4719949|NCT02057406|16274668|P3|Overall Study|Lost to Follow-up|1
4719950|NCT02057406|16274669|P2|Overall Study|Lost to Follow-up|0
4719951|NCT02057406|16274670|P1|Overall Study|Lost to Follow-up|0
4719952|NCT02057406|16274668|P3|Overall Study|Withdrawal by Subject|0
4719953|NCT02057406|16274669|P2|Overall Study|Withdrawal by Subject|2
4719954|NCT02057406|16274670|P1|Overall Study|Withdrawal by Subject|0
4719955|NCT02057406|16274668|P3|Overall Study|Physician Decision|2
4719956|NCT02057406|16274669|P2|Overall Study|Physician Decision|0
4719957|NCT02057406|16274670|P1|Overall Study|Physician Decision|0
4719958|NCT02057393|16274681|P1|Overall Study|Patient did not meet criteria|1
4719959|NCT02057393|16274681|P1|Overall Study|Withdrawal by Subject|1
4719960|NCT02057250|16274702|P5|Extension Phase|Other than specified above|7
4719961|NCT02057250|16274703|P4|Extension Phase|Other than specified above|0
4719962|NCT02057250|16274704|P3|Extension Phase|Other than specified above|0
4719963|NCT02057250|16274705|P2|Extension Phase|Other than specified above|0
4719964|NCT02057250|16274706|P1|Extension Phase|Other than specified above|0
4719965|NCT02057250|16274702|P5|Extension Phase|Entered in this period but not treated|4
4719966|NCT02057250|16274703|P4|Extension Phase|Entered in this period but not treated|0
4719967|NCT02057250|16274704|P3|Extension Phase|Entered in this period but not treated|0
4719968|NCT02057250|16274705|P2|Extension Phase|Entered in this period but not treated|0
4719969|NCT02057250|16274706|P1|Extension Phase|Entered in this period but not treated|0
4719970|NCT02057250|16274702|P5|Extension Phase|Lack of Efficacy|10
4719971|NCT02057250|16274703|P4|Extension Phase|Lack of Efficacy|0
4719972|NCT02057250|16274704|P3|Extension Phase|Lack of Efficacy|0
4719973|NCT02057250|16274705|P2|Extension Phase|Lack of Efficacy|0
4719974|NCT02057250|16274706|P1|Extension Phase|Lack of Efficacy|0
4719975|NCT02057250|16274702|P5|Extension Phase|Adverse Event|15
4719976|NCT02057250|16274703|P4|Extension Phase|Adverse Event|0
4719977|NCT02057250|16274704|P3|Extension Phase|Adverse Event|0
4719978|NCT02057250|16274705|P2|Extension Phase|Adverse Event|0
4719979|NCT02057250|16274706|P1|Extension Phase|Adverse Event|0
4719980|NCT02057250|16274702|P5|AID Assessment Phase|Other than specified above|0
4719981|NCT02057250|16274703|P4|AID Assessment Phase|Other than specified above|1
4719982|NCT02057250|16274704|P3|AID Assessment Phase|Other than specified above|1
4719983|NCT02057250|16274705|P2|AID Assessment Phase|Other than specified above|1
4719984|NCT02057250|16274706|P1|AID Assessment Phase|Other than specified above|1
4719985|NCT02057250|16274702|P5|AID Assessment Phase|Adverse Event|0
4719986|NCT02057250|16274703|P4|AID Assessment Phase|Adverse Event|1
4719987|NCT02057250|16274704|P3|AID Assessment Phase|Adverse Event|6
4719988|NCT02057250|16274705|P2|AID Assessment Phase|Adverse Event|2
4719989|NCT02057250|16274706|P1|AID Assessment Phase|Adverse Event|3
4719990|NCT02057198|16274727|P3|Overall Study|Discharged early; lost to followup|0
4719991|NCT02057198|16274728|P2|Overall Study|Discharged early; lost to followup|1
4719992|NCT02057198|16274729|P1|Overall Study|Discharged early; lost to followup|0
4719993|NCT02057198|16274727|P3|Overall Study|Death|1
4719994|NCT02057198|16274728|P2|Overall Study|Death|0
4719995|NCT02057198|16274729|P1|Overall Study|Death|0
4719996|NCT02057068|16274765|P2|Overall Study|Lost to Follow-up|2
4719997|NCT02057068|16274766|P1|Overall Study|Lost to Follow-up|2
4719998|NCT02057068|16274765|P2|Overall Study|Carepartner (CP) Health|2
4719999|NCT02057068|16274766|P1|Overall Study|Carepartner (CP) Health|4
4720000|NCT02057068|16274765|P2|Overall Study|Caregiver (CG) Health|2
4720001|NCT02057068|16274766|P1|Overall Study|Caregiver (CG) Health|0
4720002|NCT02057068|16274765|P2|Overall Study|Withdrawal by Subject|2
4720003|NCT02057068|16274766|P1|Overall Study|Withdrawal by Subject|2
4720004|NCT02056834|16274795|P1|Overall Study|Lost to Follow-up|7
4720005|NCT02056652|16274816|P2|Overall Study|Lost to Follow-up|3
4720006|NCT02056652|16274817|P1|Overall Study|Lost to Follow-up|0
4720007|NCT02056652|16274816|P2|Overall Study|Withdrawal by Subject|0
4720008|NCT02056652|16274817|P1|Overall Study|Withdrawal by Subject|1
4720009|NCT02056626|16274854|P4|Overall Study|patient did not follow directions|0
4720010|NCT02056626|16274855|P3|Overall Study|patient did not follow directions|0
4720011|NCT02056626|16274856|P2|Overall Study|patient did not follow directions|1
4720012|NCT02056626|16274857|P1|Overall Study|patient did not follow directions|3
4720013|NCT02056392|16274892|P6|Overall Study|Withdrawal by Subject|0
4720014|NCT02056392|16274893|P5|Overall Study|Withdrawal by Subject|1
4720015|NCT02056392|16274894|P4|Overall Study|Withdrawal by Subject|0
4720016|NCT02056392|16274895|P3|Overall Study|Withdrawal by Subject|0
4720017|NCT02056392|16274896|P2|Overall Study|Withdrawal by Subject|0
4720018|NCT02056392|16274897|P1|Overall Study|Withdrawal by Subject|1
4720019|NCT02056392|16274892|P6|Overall Study|Protocol Violation|0
4720020|NCT02056392|16274893|P5|Overall Study|Protocol Violation|0
4720021|NCT02056392|16274894|P4|Overall Study|Protocol Violation|0
4720022|NCT02056392|16274895|P3|Overall Study|Protocol Violation|1
4720023|NCT02056392|16274896|P2|Overall Study|Protocol Violation|0
4720024|NCT02056392|16274897|P1|Overall Study|Protocol Violation|1
4720025|NCT02056392|16274892|P6|Overall Study|Lost to Follow-up|0
4720026|NCT02056392|16274893|P5|Overall Study|Lost to Follow-up|0
4720027|NCT02056392|16274894|P4|Overall Study|Lost to Follow-up|0
4720028|NCT02056392|16274895|P3|Overall Study|Lost to Follow-up|2
4720029|NCT02056392|16274896|P2|Overall Study|Lost to Follow-up|1
4720030|NCT02056392|16274897|P1|Overall Study|Lost to Follow-up|0
4720031|NCT02056340|16274934|P2|Overall Study|Withdrawal by Subject|6
4720032|NCT02056340|16274935|P1|Overall Study|Withdrawal by Subject|2
4720033|NCT02056340|16274934|P2|Overall Study|Lost to Follow-up|5
4720034|NCT02056340|16274935|P1|Overall Study|Lost to Follow-up|5
4720035|NCT02056301|16274945|P2|Overall Study|Issues with epidural|3
4720036|NCT02056301|16274946|P1|Overall Study|Issues with epidural|0
4720037|NCT02056301|16274945|P2|Overall Study|Withdrawal by Subject|1
4720038|NCT02056301|16274946|P1|Overall Study|Withdrawal by Subject|0
4720039|NCT02056301|16274945|P2|Overall Study|Surgical complications req. 2nd surgery|0
4720040|NCT02056301|16274946|P1|Overall Study|Surgical complications req. 2nd surgery|1
4720041|NCT02056301|16274945|P2|Overall Study|Protocol Violation|2
4720042|NCT02056301|16274946|P1|Overall Study|Protocol Violation|1
4720043|NCT02055976|16274978|P9|Overall Study|Lost to Follow-up|0
4720044|NCT02055976|16274979|P8|Overall Study|Lost to Follow-up|0
4720045|NCT02055976|16274980|P7|Overall Study|Lost to Follow-up|0
4720046|NCT02055976|16274981|P6|Overall Study|Lost to Follow-up|0
4720047|NCT02055976|16274982|P5|Overall Study|Lost to Follow-up|0
4720048|NCT02055976|16274983|P4|Overall Study|Lost to Follow-up|1
4720049|NCT02055976|16274984|P3|Overall Study|Lost to Follow-up|0
4720050|NCT02055976|16274985|P2|Overall Study|Lost to Follow-up|0
4720051|NCT02055976|16274986|P1|Overall Study|Lost to Follow-up|0
4720052|NCT02055976|16274978|P9|Overall Study|Does not meet entrance criteria|0
4720053|NCT02055976|16274979|P8|Overall Study|Does not meet entrance criteria|0
4720054|NCT02055976|16274980|P7|Overall Study|Does not meet entrance criteria|1
4720055|NCT02055976|16274981|P6|Overall Study|Does not meet entrance criteria|0
4720056|NCT02055976|16274982|P5|Overall Study|Does not meet entrance criteria|0
4720057|NCT02055976|16274983|P4|Overall Study|Does not meet entrance criteria|0
4720058|NCT02055976|16274984|P3|Overall Study|Does not meet entrance criteria|0
4720059|NCT02055976|16274985|P2|Overall Study|Does not meet entrance criteria|0
4720060|NCT02055976|16274986|P1|Overall Study|Does not meet entrance criteria|0
4720061|NCT02055976|16274978|P9|Overall Study|Adverse Event|0
4720062|NCT02055976|16274979|P8|Overall Study|Adverse Event|0
4720063|NCT02055976|16274980|P7|Overall Study|Adverse Event|1
4720064|NCT02055976|16274981|P6|Overall Study|Adverse Event|1
4720065|NCT02055976|16274982|P5|Overall Study|Adverse Event|0
4720066|NCT02055976|16274983|P4|Overall Study|Adverse Event|0
4720067|NCT02055976|16274984|P3|Overall Study|Adverse Event|0
4720068|NCT02055976|16274985|P2|Overall Study|Adverse Event|0
4720069|NCT02055976|16274986|P1|Overall Study|Adverse Event|0
4720070|NCT02055976|16274978|P9|Overall Study|Other|0
4720071|NCT02055976|16274979|P8|Overall Study|Other|0
4720072|NCT02055976|16274980|P7|Overall Study|Other|0
4720073|NCT02055976|16274981|P6|Overall Study|Other|0
4720074|NCT02055976|16274982|P5|Overall Study|Other|0
4720075|NCT02055976|16274983|P4|Overall Study|Other|0
4720076|NCT02055976|16274984|P3|Overall Study|Other|1
4720077|NCT02055976|16274985|P2|Overall Study|Other|0
4720078|NCT02055976|16274986|P1|Overall Study|Other|0
4720079|NCT02055820|16275415|P10|Phase II: Expansion|Withdrawal by Subject|0
4720080|NCT02055820|16275416|P9|Phase II: Expansion|Withdrawal by Subject|0
4720081|NCT02055820|16275417|P8|Phase II: Expansion|Withdrawal by Subject|0
4720082|NCT02055820|16275418|P7|Phase II: Expansion|Withdrawal by Subject|0
4720083|NCT02055820|16275419|P6|Phase II: Expansion|Withdrawal by Subject|0
4720084|NCT02055820|16275420|P5|Phase II: Expansion|Withdrawal by Subject|12
4720085|NCT02055820|16275421|P4|Phase II: Expansion|Withdrawal by Subject|0
4720086|NCT02055820|16275422|P3|Phase II: Expansion|Withdrawal by Subject|0
4720087|NCT02055820|16275423|P2|Phase II: Expansion|Withdrawal by Subject|0
4720088|NCT02055820|16275424|P1|Phase II: Expansion|Withdrawal by Subject|0
4720089|NCT02055820|16275415|P10|Phase II: Expansion|Lost to Follow-up|0
4720090|NCT02055820|16275416|P9|Phase II: Expansion|Lost to Follow-up|0
4720091|NCT02055820|16275417|P8|Phase II: Expansion|Lost to Follow-up|0
4720092|NCT02055820|16275418|P7|Phase II: Expansion|Lost to Follow-up|0
4720093|NCT02055820|16275419|P6|Phase II: Expansion|Lost to Follow-up|0
4720094|NCT02055820|16275420|P5|Phase II: Expansion|Lost to Follow-up|4
4720095|NCT02055820|16275421|P4|Phase II: Expansion|Lost to Follow-up|0
4720096|NCT02055820|16275422|P3|Phase II: Expansion|Lost to Follow-up|0
4720097|NCT02055820|16275423|P2|Phase II: Expansion|Lost to Follow-up|0
4720098|NCT02055820|16275424|P1|Phase II: Expansion|Lost to Follow-up|0
4720099|NCT02055820|16275415|P10|Phase II: Expansion|Death|0
4720100|NCT02055820|16275416|P9|Phase II: Expansion|Death|0
4720101|NCT02055820|16275417|P8|Phase II: Expansion|Death|0
4720102|NCT02055820|16275418|P7|Phase II: Expansion|Death|0
4720103|NCT02055820|16275419|P6|Phase II: Expansion|Death|0
4720104|NCT02055820|16275420|P5|Phase II: Expansion|Death|33
4720105|NCT02055820|16275421|P4|Phase II: Expansion|Death|0
4720106|NCT02055820|16275422|P3|Phase II: Expansion|Death|0
4720107|NCT02055820|16275423|P2|Phase II: Expansion|Death|0
4720108|NCT02055820|16275424|P1|Phase II: Expansion|Death|0
4720109|NCT02055820|16275415|P10|Phase I: Dose-Finding|Lost to Follow-up|0
4720110|NCT02055820|16275416|P9|Phase I: Dose-Finding|Lost to Follow-up|0
4720111|NCT02055820|16275417|P8|Phase I: Dose-Finding|Lost to Follow-up|0
4720112|NCT02055820|16275418|P7|Phase I: Dose-Finding|Lost to Follow-up|1
4720113|NCT02055820|16275419|P6|Phase I: Dose-Finding|Lost to Follow-up|0
4720114|NCT02055820|16275420|P5|Phase I: Dose-Finding|Lost to Follow-up|0
4720115|NCT02055820|16275421|P4|Phase I: Dose-Finding|Lost to Follow-up|1
4720116|NCT02055820|16275422|P3|Phase I: Dose-Finding|Lost to Follow-up|0
4720117|NCT02055820|16275423|P2|Phase I: Dose-Finding|Lost to Follow-up|0
4720118|NCT02055820|16275424|P1|Phase I: Dose-Finding|Lost to Follow-up|0
4720119|NCT02055820|16275415|P10|Phase I: Dose-Finding|Withdrawal by Subject|0
4720120|NCT02055820|16275416|P9|Phase I: Dose-Finding|Withdrawal by Subject|0
4720121|NCT02055820|16275417|P8|Phase I: Dose-Finding|Withdrawal by Subject|0
4720122|NCT02055820|16275418|P7|Phase I: Dose-Finding|Withdrawal by Subject|0
4720123|NCT02055820|16275419|P6|Phase I: Dose-Finding|Withdrawal by Subject|1
4720124|NCT02055820|16275420|P5|Phase I: Dose-Finding|Withdrawal by Subject|0
4720125|NCT02055820|16275421|P4|Phase I: Dose-Finding|Withdrawal by Subject|0
4720126|NCT02055820|16275422|P3|Phase I: Dose-Finding|Withdrawal by Subject|0
4720127|NCT02055820|16275423|P2|Phase I: Dose-Finding|Withdrawal by Subject|0
4720128|NCT02055820|16275424|P1|Phase I: Dose-Finding|Withdrawal by Subject|0
4720129|NCT02055820|16275415|P10|Phase I: Dose-Finding|Death|0
4720130|NCT02055820|16275416|P9|Phase I: Dose-Finding|Death|0
4720131|NCT02055820|16275417|P8|Phase I: Dose-Finding|Death|0
4720132|NCT02055820|16275418|P7|Phase I: Dose-Finding|Death|1
4720133|NCT02055820|16275419|P6|Phase I: Dose-Finding|Death|1
4720134|NCT02055820|16275420|P5|Phase I: Dose-Finding|Death|0
4720135|NCT02055820|16275421|P4|Phase I: Dose-Finding|Death|2
4720136|NCT02055820|16275422|P3|Phase I: Dose-Finding|Death|1
4720137|NCT02055820|16275423|P2|Phase I: Dose-Finding|Death|0
4720138|NCT02055820|16275424|P1|Phase I: Dose-Finding|Death|1
4720139|NCT02055547|16275535|P19|Overall Study|Lost to Follow-up|0
4720140|NCT02055547|16275536|P18|Overall Study|Lost to Follow-up|0
4720141|NCT02055547|16275537|P17|Overall Study|Lost to Follow-up|0
4720142|NCT02055547|16275538|P16|Overall Study|Lost to Follow-up|0
4720143|NCT02055547|16275539|P15|Overall Study|Lost to Follow-up|0
4720144|NCT02055547|16275540|P14|Overall Study|Lost to Follow-up|0
4720145|NCT02055547|16275541|P13|Overall Study|Lost to Follow-up|0
4720146|NCT02055547|16275542|P12|Overall Study|Lost to Follow-up|0
4720147|NCT02055547|16275543|P11|Overall Study|Lost to Follow-up|0
4720148|NCT02055547|16275544|P10|Overall Study|Lost to Follow-up|0
4720149|NCT02055547|16275545|P9|Overall Study|Lost to Follow-up|0
4720150|NCT02055547|16275546|P8|Overall Study|Lost to Follow-up|0
4720151|NCT02055547|16275547|P7|Overall Study|Lost to Follow-up|0
4720152|NCT02055547|16275548|P6|Overall Study|Lost to Follow-up|0
4720153|NCT02055547|16275549|P5|Overall Study|Lost to Follow-up|0
4720154|NCT02055547|16275550|P4|Overall Study|Lost to Follow-up|0
4720155|NCT02055547|16275551|P3|Overall Study|Lost to Follow-up|1
4720156|NCT02055547|16275552|P2|Overall Study|Lost to Follow-up|0
4720157|NCT02055547|16275553|P1|Overall Study|Lost to Follow-up|0
4720158|NCT02055547|16275535|P19|Overall Study|Withdrawal by Subject|0
4720159|NCT02055547|16275536|P18|Overall Study|Withdrawal by Subject|0
4720160|NCT02055547|16275537|P17|Overall Study|Withdrawal by Subject|0
4720161|NCT02055547|16275538|P16|Overall Study|Withdrawal by Subject|1
4720162|NCT02055547|16275539|P15|Overall Study|Withdrawal by Subject|0
4720163|NCT02055547|16275540|P14|Overall Study|Withdrawal by Subject|1
4720164|NCT02055547|16275541|P13|Overall Study|Withdrawal by Subject|0
4720165|NCT02055547|16275542|P12|Overall Study|Withdrawal by Subject|0
4720166|NCT02055547|16275543|P11|Overall Study|Withdrawal by Subject|0
4720167|NCT02055547|16275544|P10|Overall Study|Withdrawal by Subject|0
4720168|NCT02055547|16275545|P9|Overall Study|Withdrawal by Subject|1
4720169|NCT02055547|16275546|P8|Overall Study|Withdrawal by Subject|0
4720170|NCT02055547|16275547|P7|Overall Study|Withdrawal by Subject|0
4720171|NCT02055547|16275548|P6|Overall Study|Withdrawal by Subject|1
4720172|NCT02055547|16275549|P5|Overall Study|Withdrawal by Subject|0
4720173|NCT02055547|16275550|P4|Overall Study|Withdrawal by Subject|0
4720174|NCT02055547|16275551|P3|Overall Study|Withdrawal by Subject|0
4720175|NCT02055547|16275552|P2|Overall Study|Withdrawal by Subject|0
4720176|NCT02055547|16275553|P1|Overall Study|Withdrawal by Subject|0
4720177|NCT02055547|16275535|P19|Overall Study|Adverse Event|0
4720178|NCT02055547|16275536|P18|Overall Study|Adverse Event|0
4720179|NCT02055547|16275537|P17|Overall Study|Adverse Event|0
4720180|NCT02055547|16275538|P16|Overall Study|Adverse Event|0
4720181|NCT02055547|16275539|P15|Overall Study|Adverse Event|0
4720182|NCT02055547|16275540|P14|Overall Study|Adverse Event|0
4720183|NCT02055547|16275541|P13|Overall Study|Adverse Event|0
4720184|NCT02055547|16275542|P12|Overall Study|Adverse Event|0
4720185|NCT02055547|16275543|P11|Overall Study|Adverse Event|0
4720186|NCT02055547|16275544|P10|Overall Study|Adverse Event|0
4720187|NCT02055547|16275545|P9|Overall Study|Adverse Event|1
4720188|NCT02055547|16275546|P8|Overall Study|Adverse Event|0
4720189|NCT02055547|16275547|P7|Overall Study|Adverse Event|1
4720190|NCT02055547|16275548|P6|Overall Study|Adverse Event|0
4720191|NCT02055547|16275549|P5|Overall Study|Adverse Event|0
4720192|NCT02055547|16275550|P4|Overall Study|Adverse Event|0
4720193|NCT02055547|16275551|P3|Overall Study|Adverse Event|0
4720194|NCT02055547|16275552|P2|Overall Study|Adverse Event|0
4720195|NCT02055547|16275553|P1|Overall Study|Adverse Event|0
4720196|NCT02055547|16275535|P19|Overall Study|Physician Decision|0
4720197|NCT02055547|16275536|P18|Overall Study|Physician Decision|0
4720198|NCT02055547|16275537|P17|Overall Study|Physician Decision|0
4720199|NCT02055547|16275538|P16|Overall Study|Physician Decision|0
4720200|NCT02055547|16275539|P15|Overall Study|Physician Decision|0
4720201|NCT02055547|16275540|P14|Overall Study|Physician Decision|0
4720202|NCT02055547|16275541|P13|Overall Study|Physician Decision|0
4720203|NCT02055547|16275542|P12|Overall Study|Physician Decision|0
4720204|NCT02055547|16275543|P11|Overall Study|Physician Decision|1
4720205|NCT02055547|16275544|P10|Overall Study|Physician Decision|1
4720206|NCT02055547|16275545|P9|Overall Study|Physician Decision|0
4720207|NCT02055547|16275546|P8|Overall Study|Physician Decision|0
4720208|NCT02055547|16275547|P7|Overall Study|Physician Decision|0
4720209|NCT02055547|16275548|P6|Overall Study|Physician Decision|0
4720210|NCT02055547|16275549|P5|Overall Study|Physician Decision|1
4720211|NCT02055547|16275550|P4|Overall Study|Physician Decision|0
4720212|NCT02055547|16275551|P3|Overall Study|Physician Decision|1
4720213|NCT02055547|16275552|P2|Overall Study|Physician Decision|1
4720214|NCT02055547|16275553|P1|Overall Study|Physician Decision|0
4720215|NCT02055547|16275535|P19|Overall Study|Protocol Violation|0
4720216|NCT02055547|16275536|P18|Overall Study|Protocol Violation|0
4720217|NCT02055547|16275537|P17|Overall Study|Protocol Violation|0
4720218|NCT02055547|16275538|P16|Overall Study|Protocol Violation|0
4720219|NCT02055547|16275539|P15|Overall Study|Protocol Violation|0
4720220|NCT02055547|16275540|P14|Overall Study|Protocol Violation|0
4720221|NCT02055547|16275541|P13|Overall Study|Protocol Violation|0
4720222|NCT02055547|16275542|P12|Overall Study|Protocol Violation|0
4720223|NCT02055547|16275543|P11|Overall Study|Protocol Violation|0
4720224|NCT02055547|16275544|P10|Overall Study|Protocol Violation|0
4720225|NCT02055547|16275545|P9|Overall Study|Protocol Violation|0
4720226|NCT02055547|16275546|P8|Overall Study|Protocol Violation|0
4720227|NCT02055547|16275547|P7|Overall Study|Protocol Violation|1
4720228|NCT02055547|16275548|P6|Overall Study|Protocol Violation|0
4720229|NCT02055547|16275549|P5|Overall Study|Protocol Violation|0
4720230|NCT02055547|16275550|P4|Overall Study|Protocol Violation|0
4720231|NCT02055547|16275551|P3|Overall Study|Protocol Violation|1
4720232|NCT02055547|16275552|P2|Overall Study|Protocol Violation|0
4720233|NCT02055547|16275553|P1|Overall Study|Protocol Violation|0
4720234|NCT02055365|16275722|P1|Overall Study|Prematurely Withdrawn|1
4720235|NCT02055352|16275735|P2|Overall Study|Reason unknown|5
4720236|NCT02055352|16275736|P1|Overall Study|Reason unknown|1
4720237|NCT02055352|16275735|P2|Overall Study|Withdrawal of informed consent|0
4720238|NCT02055352|16275736|P1|Overall Study|Withdrawal of informed consent|1
4720239|NCT02055352|16275735|P2|Overall Study|AE, study drug would be detrimental|3
4720240|NCT02055352|16275736|P1|Overall Study|AE, study drug would be detrimental|1
4720241|NCT02055352|16275735|P2|Overall Study|Use of prohibited treatment|3
4720242|NCT02055352|16275736|P1|Overall Study|Use of prohibited treatment|0
4720243|NCT02055352|16275735|P2|Overall Study|Patient decision|1
4720244|NCT02055352|16275736|P1|Overall Study|Patient decision|1
4720245|NCT02055352|16275735|P2|Overall Study|Death|2
4720246|NCT02055352|16275736|P1|Overall Study|Death|1
4720247|NCT02055352|16275735|P2|Overall Study|Poor compliance|1
4720248|NCT02055352|16275736|P1|Overall Study|Poor compliance|1
4720249|NCT02055352|16275735|P2|Overall Study|Non-eligible|1
4720250|NCT02055352|16275736|P1|Overall Study|Non-eligible|0
4720251|NCT02055352|16275735|P2|Overall Study|Adverse Event|1
4720252|NCT02055352|16275736|P1|Overall Study|Adverse Event|0
4720253|NCT02055118|16275753|P3|Overall Study|Withdrawal by Subject|0
4720254|NCT02055118|16275754|P2|Overall Study|Withdrawal by Subject|2
4720255|NCT02055118|16275755|P1|Overall Study|Withdrawal by Subject|0
4720256|NCT02054910|16275814|P2|Overall Study|Lost to Follow-up|1
4720257|NCT02054910|16275815|P1|Overall Study|Lost to Follow-up|4
4720258|NCT02054897|16275834|P3|Overall Study|Randomized but not exposed|0
4720259|NCT02054897|16275835|P2|Overall Study|Randomized but not exposed|0
4720260|NCT02054897|16275836|P1|Overall Study|Randomized but not exposed|1
4720261|NCT02054897|16275834|P3|Overall Study|Lost to Follow-up|7
4720262|NCT02054897|16275835|P2|Overall Study|Lost to Follow-up|2
4720263|NCT02054897|16275836|P1|Overall Study|Lost to Follow-up|4
4720264|NCT02054897|16275834|P3|Overall Study|Missing follow-up information|3
4720265|NCT02054897|16275835|P2|Overall Study|Missing follow-up information|5
4720266|NCT02054897|16275836|P1|Overall Study|Missing follow-up information|3
4720267|NCT02054897|16275834|P3|Overall Study|Withdrawal by Subject|2
4720268|NCT02054897|16275835|P2|Overall Study|Withdrawal by Subject|0
4720269|NCT02054897|16275836|P1|Overall Study|Withdrawal by Subject|2
4720270|NCT02054715|16275883|P2|Follow-up 2|Treatment Change or Delay|0
4720271|NCT02054715|16275884|P1|Follow-up 2|Treatment Change or Delay|1
4720272|NCT02054715|16275883|P2|Follow-up 2|No Reason|0
4720273|NCT02054715|16275884|P1|Follow-up 2|No Reason|2
4720274|NCT02054715|16275883|P2|Follow-up 2|Changed Mind|1
4720275|NCT02054715|16275884|P1|Follow-up 2|Changed Mind|0
4720276|NCT02054715|16275883|P2|Follow-up 2|Changed MD/Facility|1
4720277|NCT02054715|16275884|P1|Follow-up 2|Changed MD/Facility|0
4720278|NCT02054715|16275883|P2|Follow-up 2|Hospitalization|2
4720279|NCT02054715|16275884|P1|Follow-up 2|Hospitalization|0
4720280|NCT02054715|16275883|P2|Follow-up 2|Death|3
4720281|NCT02054715|16275884|P1|Follow-up 2|Death|3
4720282|NCT02054715|16275883|P2|Follow-up 2|Ineligible|5
4720283|NCT02054715|16275884|P1|Follow-up 2|Ineligible|4
4720284|NCT02054715|16275883|P2|Follow-up 2|Followup Not Completed|4
4720285|NCT02054715|16275884|P1|Follow-up 2|Followup Not Completed|3
4720286|NCT02054715|16275883|P2|Follow-up 2|Refused|2
4720287|NCT02054715|16275884|P1|Follow-up 2|Refused|3
4720288|NCT02054715|16275883|P2|Follow-up 2|Lost to Followup|1
4720289|NCT02054715|16275884|P1|Follow-up 2|Lost to Followup|3
4720290|NCT02054715|16275883|P2|Baseline/Follow-up 1|Changed Mind|0
4720291|NCT02054715|16275884|P1|Baseline/Follow-up 1|Changed Mind|1
4720292|NCT02054715|16275883|P2|Baseline/Follow-up 1|Hospitalization|0
4720293|NCT02054715|16275884|P1|Baseline/Follow-up 1|Hospitalization|1
4720294|NCT02054715|16275883|P2|Baseline/Follow-up 1|Ineligible|0
4720295|NCT02054715|16275884|P1|Baseline/Follow-up 1|Ineligible|3
4720296|NCT02054715|16275883|P2|Baseline/Follow-up 1|Overwhelmed|0
4720297|NCT02054715|16275884|P1|Baseline/Follow-up 1|Overwhelmed|2
4720298|NCT02054715|16275883|P2|Baseline/Follow-up 1|No Reason|1
4720299|NCT02054715|16275884|P1|Baseline/Follow-up 1|No Reason|0
4720300|NCT02054715|16275883|P2|Baseline/Follow-up 1|Disliked Procedure|1
4720301|NCT02054715|16275884|P1|Baseline/Follow-up 1|Disliked Procedure|0
4720302|NCT02054715|16275883|P2|Baseline/Follow-up 1|Changed MD/Facility|1
4720303|NCT02054715|16275884|P1|Baseline/Follow-up 1|Changed MD/Facility|0
4720304|NCT02054715|16275883|P2|Baseline/Follow-up 1|Medical|1
4720305|NCT02054715|16275884|P1|Baseline/Follow-up 1|Medical|0
4720306|NCT02054715|16275883|P2|Baseline/Follow-up 1|Refused|3
4720307|NCT02054715|16275884|P1|Baseline/Follow-up 1|Refused|1
4720308|NCT02054702|16275898|P2|Overall Study|Withdrawal by Subject|4
4720309|NCT02054702|16275899|P1|Overall Study|Withdrawal by Subject|14
4720310|NCT02054702|16275898|P2|Overall Study|Physician Decision|1
4720311|NCT02054702|16275899|P1|Overall Study|Physician Decision|0
4720312|NCT02054702|16275898|P2|Overall Study|Met Withdrawal Criteria|1
4720313|NCT02054702|16275899|P1|Overall Study|Met Withdrawal Criteria|4
4720314|NCT02054702|16275898|P2|Overall Study|Adverse Event|1
4720315|NCT02054702|16275899|P1|Overall Study|Adverse Event|3
4720316|NCT02054702|16275898|P2|Overall Study|Lost to Follow-up|5
4720317|NCT02054702|16275899|P1|Overall Study|Lost to Follow-up|3
4720318|NCT02054520|16275956|P6|Overall Study|Study terminated by Sponsor|0
4720319|NCT02054520|16275957|P5|Overall Study|Study terminated by Sponsor|0
4720320|NCT02054520|16275958|P4|Overall Study|Study terminated by Sponsor|1
4720321|NCT02054520|16275959|P3|Overall Study|Study terminated by Sponsor|2
4720322|NCT02054520|16275960|P2|Overall Study|Study terminated by Sponsor|0
4720323|NCT02054520|16275961|P1|Overall Study|Study terminated by Sponsor|0
4720324|NCT02054520|16275956|P6|Overall Study|Physician Decision|1
4720325|NCT02054520|16275957|P5|Overall Study|Physician Decision|0
4720326|NCT02054520|16275958|P4|Overall Study|Physician Decision|1
4720327|NCT02054520|16275959|P3|Overall Study|Physician Decision|0
4720328|NCT02054520|16275960|P2|Overall Study|Physician Decision|1
4720329|NCT02054520|16275961|P1|Overall Study|Physician Decision|0
4720330|NCT02054520|16275956|P6|Overall Study|Withdrawal by Subject|0
4720331|NCT02054520|16275957|P5|Overall Study|Withdrawal by Subject|1
4720332|NCT02054520|16275958|P4|Overall Study|Withdrawal by Subject|2
4720333|NCT02054520|16275959|P3|Overall Study|Withdrawal by Subject|0
4720334|NCT02054520|16275960|P2|Overall Study|Withdrawal by Subject|0
4720335|NCT02054520|16275961|P1|Overall Study|Withdrawal by Subject|1
4720336|NCT02054520|16275956|P6|Overall Study|Lack of Efficacy|2
4720337|NCT02054520|16275957|P5|Overall Study|Lack of Efficacy|3
4720338|NCT02054520|16275958|P4|Overall Study|Lack of Efficacy|1
4720339|NCT02054520|16275959|P3|Overall Study|Lack of Efficacy|2
4720340|NCT02054520|16275960|P2|Overall Study|Lack of Efficacy|0
4720341|NCT02054520|16275961|P1|Overall Study|Lack of Efficacy|7
4720342|NCT02054520|16275956|P6|Overall Study|Adverse Event|0
4720343|NCT02054520|16275957|P5|Overall Study|Adverse Event|1
4720344|NCT02054520|16275958|P4|Overall Study|Adverse Event|1
4720345|NCT02054520|16275959|P3|Overall Study|Adverse Event|2
4720346|NCT02054520|16275960|P2|Overall Study|Adverse Event|4
4720347|NCT02054520|16275961|P1|Overall Study|Adverse Event|1
4720348|NCT02054481|16275985|P4|Overall Study|Other reason|0
4720349|NCT02054481|16275986|P3|Overall Study|Other reason|2
4720350|NCT02054481|16275987|P2|Overall Study|Other reason|1
4720351|NCT02054481|16275988|P1|Overall Study|Other reason|2
4720352|NCT02054481|16275985|P4|Overall Study|Lost to Follow-up|0
4720353|NCT02054481|16275986|P3|Overall Study|Lost to Follow-up|0
4720354|NCT02054481|16275987|P2|Overall Study|Lost to Follow-up|0
4720355|NCT02054481|16275988|P1|Overall Study|Lost to Follow-up|1
4720356|NCT02054481|16275985|P4|Overall Study|Adverse Event|1
4720357|NCT02054481|16275986|P3|Overall Study|Adverse Event|0
4720358|NCT02054481|16275987|P2|Overall Study|Adverse Event|1
4720359|NCT02054481|16275988|P1|Overall Study|Adverse Event|1
4720360|NCT02054325|16276049|P2|Overall Study|Lost to Follow-up|5
4720361|NCT02054325|16276050|P1|Overall Study|Lost to Follow-up|8
4720362|NCT02054130|16276077|P4|Overall Study|Missed dose|10
4720363|NCT02054130|16276078|P3|Overall Study|Missed dose|7
4720364|NCT02054130|16276079|P2|Overall Study|Missed dose|6
4720365|NCT02054130|16276080|P1|Overall Study|Missed dose|4
4720366|NCT02054130|16276077|P4|Overall Study|Lost to Follow-up|2
4720367|NCT02054130|16276078|P3|Overall Study|Lost to Follow-up|1
4720368|NCT02054130|16276079|P2|Overall Study|Lost to Follow-up|0
4720369|NCT02054130|16276080|P1|Overall Study|Lost to Follow-up|0
4720370|NCT02054130|16276077|P4|Overall Study|Death|0
4720371|NCT02054130|16276078|P3|Overall Study|Death|0
4720372|NCT02054130|16276079|P2|Overall Study|Death|1
4720373|NCT02054130|16276080|P1|Overall Study|Death|0
4720374|NCT02054130|16276077|P4|Overall Study|Withdrawal by Subject|10
4720375|NCT02054130|16276078|P3|Overall Study|Withdrawal by Subject|7
4720376|NCT02054130|16276079|P2|Overall Study|Withdrawal by Subject|4
4720377|NCT02054130|16276080|P1|Overall Study|Withdrawal by Subject|4
4720378|NCT02053753|16276174|P2|Overall Study|Lost to Follow-up|3
4720379|NCT02053753|16276175|P1|Overall Study|Lost to Follow-up|4
4720380|NCT02053753|16276174|P2|Overall Study|Decision by Sponsor|1
4720381|NCT02053753|16276175|P1|Overall Study|Decision by Sponsor|1
4720382|NCT02053753|16276174|P2|Overall Study|Withdrawal by Subject|4
4720383|NCT02053753|16276175|P1|Overall Study|Withdrawal by Subject|2
4720384|NCT02053610|16276199|P2|Overall Study|Violation of Selection Criteria|0
4720385|NCT02053610|16276200|P1|Overall Study|Violation of Selection Criteria|1
4720386|NCT02053610|16276199|P2|Overall Study|Insufficient Therapeutic Response|1
4720387|NCT02053610|16276200|P1|Overall Study|Insufficient Therapeutic Response|1
4720388|NCT02053610|16276199|P2|Overall Study|Did not Receive Treatment|2
4720389|NCT02053610|16276200|P1|Overall Study|Did not Receive Treatment|4
4720390|NCT02053610|16276199|P2|Overall Study|Refused treatment/Did not cooperate|3
4720391|NCT02053610|16276200|P1|Overall Study|Refused treatment/Did not cooperate|1
4720392|NCT02053610|16276199|P2|Overall Study|Disease Progression|3
4720393|NCT02053610|16276200|P1|Overall Study|Disease Progression|2
4720394|NCT02053610|16276199|P2|Overall Study|Administrative/Other|1
4720395|NCT02053610|16276200|P1|Overall Study|Administrative/Other|1
4720396|NCT02053610|16276199|P2|Overall Study|Death|5
4720397|NCT02053610|16276200|P1|Overall Study|Death|5
4720398|NCT02053610|16276199|P2|Overall Study|Withdrew Consent|9
4720399|NCT02053610|16276200|P1|Overall Study|Withdrew Consent|2
4720400|NCT02053610|16276199|P2|Overall Study|Adverse Event/Intercurrent Illness|43
4720401|NCT02053610|16276200|P1|Overall Study|Adverse Event/Intercurrent Illness|25
4720402|NCT02053493|16276232|P2|Overall Study|Withdrawal by Subject|1
4720403|NCT02053493|16276233|P1|Overall Study|Withdrawal by Subject|1
4720404|NCT02053168|16276299|P1|Overall Study|Lost to Follow-up|1
4720405|NCT02053168|16276299|P1|Overall Study|Physician Decision|1
4720406|NCT02053168|16276299|P1|Overall Study|Withdrawal by Subject|1
4720407|NCT02052596|16276378|P2|Safety Phase|Lost due to Crohn's disease|1
4720408|NCT02052596|16276379|P1|Safety Phase|Lost due to Crohn's disease|0
4720409|NCT02052596|16276378|P2|Safety Phase|Enrolled in error|0
4720410|NCT02052596|16276379|P1|Safety Phase|Enrolled in error|1
4720411|NCT02052596|16276378|P2|Safety Phase|Withdrawal by Subject|11
4720412|NCT02052596|16276379|P1|Safety Phase|Withdrawal by Subject|8
4720413|NCT02052596|16276378|P2|Safety Phase|Protocol Violation|2
4720414|NCT02052596|16276379|P1|Safety Phase|Protocol Violation|1
4720415|NCT02052596|16276378|P2|Safety Phase|Lost to Follow-up|18
4720416|NCT02052596|16276379|P1|Safety Phase|Lost to Follow-up|11
4720417|NCT02052596|16276378|P2|Safety Phase|Adverse Event|3
4720418|NCT02052596|16276379|P1|Safety Phase|Adverse Event|6
4720419|NCT02052596|16276378|P2|Active Phase|Lost due to Crohn's disease|1
4720420|NCT02052596|16276379|P1|Active Phase|Lost due to Crohn's disease|0
4720421|NCT02052596|16276378|P2|Active Phase|Enrolled in error|0
4720422|NCT02052596|16276379|P1|Active Phase|Enrolled in error|1
4720423|NCT02052596|16276378|P2|Active Phase|Withdrawal by Subject|4
4720424|NCT02052596|16276379|P1|Active Phase|Withdrawal by Subject|3
4720425|NCT02052596|16276378|P2|Active Phase|Protocol Violation|2
4720426|NCT02052596|16276379|P1|Active Phase|Protocol Violation|1
4720427|NCT02052596|16276378|P2|Active Phase|Lost to Follow-up|11
4720428|NCT02052596|16276379|P1|Active Phase|Lost to Follow-up|8
4720429|NCT02052596|16276378|P2|Active Phase|Adverse Event|2
4720430|NCT02052596|16276379|P1|Active Phase|Adverse Event|3
4720431|NCT02052466|16276409|P1|Overall Study|Acromial fracture|1
4720432|NCT02052466|16276409|P1|Overall Study|Withdrawal by Subject|1
4720433|NCT02052440|16276426|P2|Overall Study|Withdrawal by Subject|1
4720434|NCT02052440|16276427|P1|Overall Study|Withdrawal by Subject|0
4720435|NCT02052414|16276439|P1|Overall Study|Withdrawal by Subject|3
4720436|NCT02052414|16276439|P1|Overall Study|Lack of Efficacy|2
4720437|NCT02052414|16276439|P1|Overall Study|Adverse Event|12
4720438|NCT02052011|16276474|P2|Overall Study|Withdrawal by Subject|2
4720439|NCT02052011|16276475|P1|Overall Study|Withdrawal by Subject|1
4720440|NCT02052011|16276474|P2|Overall Study|Lost to Follow-up|0
4720441|NCT02052011|16276475|P1|Overall Study|Lost to Follow-up|3
4720442|NCT02051764|16276532|P2|Overall Study|Study terminated by sponsor|7
4720443|NCT02051764|16276533|P1|Overall Study|Study terminated by sponsor|0
4720444|NCT02051296|16276639|P2|Overall Study|withdraw prior to treatment|7
4720445|NCT02051296|16276640|P1|Overall Study|withdraw prior to treatment|7
4720446|NCT02051296|16276639|P2|Overall Study|Lost to Follow-up|2
4720447|NCT02051296|16276640|P1|Overall Study|Lost to Follow-up|1
4720448|NCT02050321|16276700|P1|Overall Study|Adverse Event|1
4720449|NCT02050321|16276700|P1|Overall Study|Withdrawal by Subject|1
4720450|NCT02050048|16276716|P2|Overall Study|Ineligible after ERCP|1
4720451|NCT02050048|16276717|P1|Overall Study|Ineligible after ERCP|4
4720452|NCT02050048|16276716|P2|Overall Study|Death|0
4720453|NCT02050048|16276717|P1|Overall Study|Death|1
4720454|NCT02050048|16276716|P2|Overall Study|Lost to Follow-up|1
4720455|NCT02050048|16276717|P1|Overall Study|Lost to Follow-up|0
4720456|NCT02049957|16276732|P9|Overall Study|Physician Decision|0
4720457|NCT02049957|16276733|P8|Overall Study|Physician Decision|0
4720458|NCT02049957|16276734|P7|Overall Study|Physician Decision|0
4720459|NCT02049957|16276735|P6|Overall Study|Physician Decision|1
4720460|NCT02049957|16276736|P5|Overall Study|Physician Decision|0
4720461|NCT02049957|16276737|P4|Overall Study|Physician Decision|0
4720462|NCT02049957|16276738|P3|Overall Study|Physician Decision|0
4720463|NCT02049957|16276739|P2|Overall Study|Physician Decision|0
4720464|NCT02049957|16276740|P1|Overall Study|Physician Decision|0
4720465|NCT02049957|16276732|P9|Overall Study|Withdrawal by Subject|1
4720466|NCT02049957|16276733|P8|Overall Study|Withdrawal by Subject|3
4720467|NCT02049957|16276734|P7|Overall Study|Withdrawal by Subject|0
4720468|NCT02049957|16276735|P6|Overall Study|Withdrawal by Subject|2
4720469|NCT02049957|16276736|P5|Overall Study|Withdrawal by Subject|0
4720470|NCT02049957|16276737|P4|Overall Study|Withdrawal by Subject|1
4720471|NCT02049957|16276738|P3|Overall Study|Withdrawal by Subject|0
4720472|NCT02049957|16276739|P2|Overall Study|Withdrawal by Subject|0
4720473|NCT02049957|16276740|P1|Overall Study|Withdrawal by Subject|0
4720474|NCT02049957|16276732|P9|Overall Study|Study Terminated by Sponsor|0
4720475|NCT02049957|16276733|P8|Overall Study|Study Terminated by Sponsor|0
4720476|NCT02049957|16276734|P7|Overall Study|Study Terminated by Sponsor|1
4720477|NCT02049957|16276735|P6|Overall Study|Study Terminated by Sponsor|0
4720478|NCT02049957|16276736|P5|Overall Study|Study Terminated by Sponsor|0
4720479|NCT02049957|16276737|P4|Overall Study|Study Terminated by Sponsor|0
4720480|NCT02049957|16276738|P3|Overall Study|Study Terminated by Sponsor|0
4720481|NCT02049957|16276739|P2|Overall Study|Study Terminated by Sponsor|1
4720482|NCT02049957|16276740|P1|Overall Study|Study Terminated by Sponsor|0
4720483|NCT02049957|16276732|P9|Overall Study|Adverse Event|1
4720484|NCT02049957|16276733|P8|Overall Study|Adverse Event|6
4720485|NCT02049957|16276734|P7|Overall Study|Adverse Event|0
4720486|NCT02049957|16276735|P6|Overall Study|Adverse Event|5
4720487|NCT02049957|16276736|P5|Overall Study|Adverse Event|0
4720488|NCT02049957|16276737|P4|Overall Study|Adverse Event|0
4720489|NCT02049957|16276738|P3|Overall Study|Adverse Event|1
4720490|NCT02049957|16276739|P2|Overall Study|Adverse Event|1
4720491|NCT02049957|16276740|P1|Overall Study|Adverse Event|1
4720492|NCT02049957|16276732|P9|Overall Study|Progressive Disease|6
4720493|NCT02049957|16276733|P8|Overall Study|Progressive Disease|26
4720494|NCT02049957|16276734|P7|Overall Study|Progressive Disease|7
4720495|NCT02049957|16276735|P6|Overall Study|Progressive Disease|35
4720496|NCT02049957|16276736|P5|Overall Study|Progressive Disease|6
4720497|NCT02049957|16276737|P4|Overall Study|Progressive Disease|2
4720498|NCT02049957|16276738|P3|Overall Study|Progressive Disease|2
4720499|NCT02049957|16276739|P2|Overall Study|Progressive Disease|4
4720500|NCT02049957|16276740|P1|Overall Study|Progressive Disease|5
4720501|NCT02049814|16276832|P2|Overall Study|Voluntary withdrawal|8
4720502|NCT02049814|16276833|P1|Overall Study|Voluntary withdrawal|9
4720503|NCT02049814|16276832|P2|Overall Study|Pretreatment event/Adverse Event (AE)|5
4720504|NCT02049814|16276833|P1|Overall Study|Pretreatment event/Adverse Event (AE)|8
4720505|NCT02049814|16276832|P2|Overall Study|Study Termination|1
4720506|NCT02049814|16276833|P1|Overall Study|Study Termination|0
4720507|NCT02049814|16276832|P2|Overall Study|Serious Protocol Violation|7
4720508|NCT02049814|16276833|P1|Overall Study|Serious Protocol Violation|5
4720509|NCT02049814|16276832|P2|Overall Study|Lost to Follow-up|3
4720510|NCT02049814|16276833|P1|Overall Study|Lost to Follow-up|2
4720511|NCT02049814|16276832|P2|Overall Study|Pregnancy|0
4720512|NCT02049814|16276833|P1|Overall Study|Pregnancy|1
4720513|NCT02049814|16276832|P2|Overall Study|Reason not Specified|3
4720514|NCT02049814|16276833|P1|Overall Study|Reason not Specified|4
4720515|NCT02049450|16276882|P1|Overall Study|Patients/guardian decision|1
4720516|NCT02049450|16276882|P1|Overall Study|Withdrawal by Subject|1
4720517|NCT02049450|16276882|P1|Overall Study|Adverse Event|2
4720518|NCT02048904|16276931|P1|Overall Study|Physician Decision|70
4720519|NCT02048904|16276931|P1|Overall Study|Withdrawal by Subject|7
4720520|NCT02048722|16276963|P1|Follow up for 5 Years|Still in follow up|4
4720521|NCT02048722|16276963|P1|Follow up for 5 Years|Withdrawal by Subject|3
4720522|NCT02048722|16276963|P1|Follow up for 5 Years|Death|22
4720523|NCT02048722|16276963|P1|Reached 1st Response/Continued Treatment|Progressive Disease|10
4720524|NCT02048722|16276963|P1|2 Cycles of Treatment|Progressive Disease|2
4720525|NCT02048722|16276963|P1|2 Cycles of Treatment|Withdrawal by Subject|4
4720526|NCT02048722|16276963|P1|2 Cycles of Treatment|Adverse Event|2
4720527|NCT02048241|16276986|P2|Overall Study|Withdrawal by Subject|1
4720528|NCT02048241|16276987|P1|Overall Study|Withdrawal by Subject|0
4720529|NCT02048072|16276993|P1|Overall Study|Lost to Follow-up|1
4720530|NCT02048072|16276993|P1|Overall Study|Adverse Event|3
4720531|NCT02047903|16277032|P1|Overall Study|Not Treated|9
4720532|NCT02047903|16277032|P1|Overall Study|Reason not listed|6
4720533|NCT02047903|16277032|P1|Overall Study|Lost to Follow-up|4
4720534|NCT02047903|16277032|P1|Overall Study|Withdrawal by Subject|16
4720535|NCT02047903|16277032|P1|Overall Study|Serious adverse event|10
4720536|NCT02047903|16277032|P1|Overall Study|Adverse Event|14
4720537|NCT02047253|16277087|P1|Overall Study|Lost to Follow-up|8
4720538|NCT02047227|16277097|P2|Overall Study|Other|9
4720539|NCT02047227|16277098|P1|Overall Study|Other|10
4720540|NCT02047227|16277097|P2|Overall Study|All embryos discarded|11
4720541|NCT02047227|16277098|P1|Overall Study|All embryos discarded|12
4720542|NCT02047227|16277097|P2|Overall Study|Intention to freeze all embryos|0
4720543|NCT02047227|16277098|P1|Overall Study|Intention to freeze all embryos|1
4720544|NCT02047227|16277097|P2|Overall Study|No fertilization|51
4720545|NCT02047227|16277098|P1|Overall Study|No fertilization|61
4720546|NCT02047227|16277097|P2|Overall Study|No oocytes retrieved|20
4720547|NCT02047227|16277098|P1|Overall Study|No oocytes retrieved|21
4720548|NCT02047227|16277097|P2|Overall Study|Lack of ovarian response to stimulation|32
4720549|NCT02047227|16277098|P1|Overall Study|Lack of ovarian response to stimulation|35
4720550|NCT02047227|16277097|P2|Overall Study|Spontaneous pregnancy|0
4720551|NCT02047227|16277098|P1|Overall Study|Spontaneous pregnancy|1
4720552|NCT02047227|16277097|P2|Overall Study|Protocol Violation|0
4720553|NCT02047227|16277098|P1|Overall Study|Protocol Violation|1
4720554|NCT02047227|16277097|P2|Overall Study|Lost to Follow-up|3
4720555|NCT02047227|16277098|P1|Overall Study|Lost to Follow-up|0
4720556|NCT02047227|16277097|P2|Overall Study|Adverse Event|4
4720557|NCT02047227|16277098|P1|Overall Study|Adverse Event|2
4720558|NCT02047110|16277118|P4|OLE Treatment Period|Other than specified|0
4720559|NCT02047110|16277119|P3|OLE Treatment Period|Other than specified|1
4720560|NCT02047110|16277120|P2|OLE Treatment Period|Other than specified|0
4720561|NCT02047110|16277121|P1|OLE Treatment Period|Other than specified|0
4720562|NCT02047110|16277118|P4|Escape Treatment Period|Other than specified|1
4720563|NCT02047110|16277119|P3|Escape Treatment Period|Other than specified|0
4720564|NCT02047110|16277120|P2|Escape Treatment Period|Other than specified|2
4720565|NCT02047110|16277121|P1|Escape Treatment Period|Other than specified|1
4720566|NCT02047110|16277118|P4|Escape Treatment Period|Adverse Event|0
4720567|NCT02047110|16277119|P3|Escape Treatment Period|Adverse Event|2
4720568|NCT02047110|16277120|P2|Escape Treatment Period|Adverse Event|2
4720569|NCT02047110|16277121|P1|Escape Treatment Period|Adverse Event|1
4720570|NCT02047110|16277118|P4|Escape Treatment Period|Withdrawal by Subject|1
4720571|NCT02047110|16277119|P3|Escape Treatment Period|Withdrawal by Subject|1
4720572|NCT02047110|16277120|P2|Escape Treatment Period|Withdrawal by Subject|2
4720573|NCT02047110|16277121|P1|Escape Treatment Period|Withdrawal by Subject|1
4720574|NCT02047110|16277118|P4|DB (Week 12 up to Week 24)|Other than specified|0
4720575|NCT02047110|16277119|P3|DB (Week 12 up to Week 24)|Other than specified|1
4720576|NCT02047110|16277120|P2|DB (Week 12 up to Week 24)|Other than specified|1
4720577|NCT02047110|16277121|P1|DB (Week 12 up to Week 24)|Other than specified|0
4720578|NCT02047110|16277118|P4|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
4720579|NCT02047110|16277119|P3|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
4720580|NCT02047110|16277120|P2|DB (Week 12 up to Week 24)|Withdrawal by Subject|1
4720581|NCT02047110|16277121|P1|DB (Week 12 up to Week 24)|Withdrawal by Subject|0
4720582|NCT02047110|16277118|P4|DB Treatment Period up to Week 24|Other than specified|1
4720583|NCT02047110|16277119|P3|DB Treatment Period up to Week 24|Other than specified|3
4720584|NCT02047110|16277120|P2|DB Treatment Period up to Week 24|Other than specified|2
4720585|NCT02047110|16277121|P1|DB Treatment Period up to Week 24|Other than specified|1
4720586|NCT02047110|16277118|P4|DB Treatment Period up to Week 24|Withdrawal by Subject|1
4720587|NCT02047110|16277119|P3|DB Treatment Period up to Week 24|Withdrawal by Subject|0
4720588|NCT02047110|16277120|P2|DB Treatment Period up to Week 24|Withdrawal by Subject|0
4720589|NCT02047110|16277121|P1|DB Treatment Period up to Week 24|Withdrawal by Subject|1
4720590|NCT02047110|16277118|P4|DB Treatment Period up to Week 24|Protocol Violation|0
4720591|NCT02047110|16277119|P3|DB Treatment Period up to Week 24|Protocol Violation|0
4720592|NCT02047110|16277120|P2|DB Treatment Period up to Week 24|Protocol Violation|0
4720593|NCT02047110|16277121|P1|DB Treatment Period up to Week 24|Protocol Violation|1
4720594|NCT02047110|16277118|P4|DB Treatment Period up to Week 24|Lost to Follow-up|0
4720595|NCT02047110|16277119|P3|DB Treatment Period up to Week 24|Lost to Follow-up|0
4720596|NCT02047110|16277120|P2|DB Treatment Period up to Week 24|Lost to Follow-up|0
4720597|NCT02047110|16277121|P1|DB Treatment Period up to Week 24|Lost to Follow-up|1
4720598|NCT02047110|16277118|P4|DB Treatment Period up to Week 24|Adverse Event|0
4720599|NCT02047110|16277119|P3|DB Treatment Period up to Week 24|Adverse Event|0
4720600|NCT02047110|16277120|P2|DB Treatment Period up to Week 24|Adverse Event|0
4720601|NCT02047110|16277121|P1|DB Treatment Period up to Week 24|Adverse Event|1
4720602|NCT02047045|16277164|P2|Treatment Period (8 Weeks )|Withdrawal by Subject|2
4720603|NCT02047045|16277165|P1|Treatment Period (8 Weeks )|Withdrawal by Subject|4
4720604|NCT02047045|16277164|P2|Treatment Period (8 Weeks )|Lost to Follow-up|0
4720605|NCT02047045|16277165|P1|Treatment Period (8 Weeks )|Lost to Follow-up|1
4720606|NCT02047045|16277164|P2|Treatment Period (8 Weeks )|Adverse Event|1
4720607|NCT02047045|16277165|P1|Treatment Period (8 Weeks )|Adverse Event|2
4720608|NCT02047045|16277164|P2|Baseline|Withdrawal by Subject|15
4720609|NCT02047045|16277165|P1|Baseline|Withdrawal by Subject|8
4720610|NCT02046993|16277229|P2|Overall Study|Lost to Follow-up|1
4720611|NCT02046993|16277230|P1|Overall Study|Lost to Follow-up|1
4720612|NCT02046993|16277229|P2|Overall Study|Withdrawal by Subject|10
4720613|NCT02046993|16277230|P1|Overall Study|Withdrawal by Subject|2
4720614|NCT02046616|16277302|P1|8-Week FU Period|Lost to Follow-up|1
4720615|NCT02046616|16277302|P1|24-Week Treatment Period|Other|1
4720616|NCT02046616|16277302|P1|24-Week Treatment Period|Physician Decision|3
4720617|NCT02046616|16277302|P1|24-Week Treatment Period|Insufficient Therapeutic Response|1
4720618|NCT02046616|16277302|P1|24-Week Treatment Period|Any Other Adverse Event|13
4720619|NCT02046616|16277302|P1|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1
4720620|NCT02046603|16277324|P2|Overall Study|Adverse Event|1
4720621|NCT02046603|16277325|P1|Overall Study|Adverse Event|0
4720622|NCT02046603|16277324|P2|Overall Study|Death|1
4720623|NCT02046603|16277325|P1|Overall Study|Death|0
4720624|NCT02046603|16277324|P2|Overall Study|Lost to Follow-up|2
4720625|NCT02046603|16277325|P1|Overall Study|Lost to Follow-up|1
4720626|NCT02046603|16277324|P2|Overall Study|Physician Decision|1
4720627|NCT02046603|16277325|P1|Overall Study|Physician Decision|2
4720628|NCT02046603|16277324|P2|Overall Study|Participant/legal guardian decision|3
4720629|NCT02046603|16277325|P1|Overall Study|Participant/legal guardian decision|1
4720630|NCT02046603|16277324|P2|Overall Study|Protocol Violation|1
4720631|NCT02046603|16277325|P1|Overall Study|Protocol Violation|0
4720632|NCT02046603|16277324|P2|Overall Study|Other|66
4720633|NCT02046603|16277325|P1|Overall Study|Other|11
4720634|NCT02046564|16277404|P2|Overall Study|Subject met withdrawal criteria|5
4720635|NCT02046564|16277405|P1|Overall Study|Subject met withdrawal criteria|2
4720636|NCT02046564|16277404|P2|Overall Study|Withdrawal by Subject|10
4720637|NCT02046564|16277405|P1|Overall Study|Withdrawal by Subject|4
4720638|NCT02046564|16277404|P2|Overall Study|Protocol Violation|1
4720639|NCT02046564|16277405|P1|Overall Study|Protocol Violation|3
4720640|NCT02046564|16277404|P2|Overall Study|Physician Decision|1
4720641|NCT02046564|16277405|P1|Overall Study|Physician Decision|0
4720642|NCT02046564|16277404|P2|Overall Study|Adverse Event|3
4720643|NCT02046564|16277405|P1|Overall Study|Adverse Event|6
4720644|NCT02046369|16277453|P2|Overall Study|non compliance|0
4720645|NCT02046369|16277454|P1|Overall Study|non compliance|1
4720646|NCT02046369|16277453|P2|Overall Study|never received study drug|1
4720647|NCT02046369|16277454|P1|Overall Study|never received study drug|0
4720648|NCT02046369|16277453|P2|Overall Study|Withdrawal by Subject|6
4720649|NCT02046369|16277454|P1|Overall Study|Withdrawal by Subject|3
4720650|NCT02046369|16277453|P2|Overall Study|Protocol Violation|2
4720651|NCT02046369|16277454|P1|Overall Study|Protocol Violation|1
4720652|NCT02046369|16277453|P2|Overall Study|Lost to Follow-up|3
4720653|NCT02046369|16277454|P1|Overall Study|Lost to Follow-up|3
4720654|NCT02046369|16277453|P2|Overall Study|Lack of Efficacy|3
4720655|NCT02046369|16277454|P1|Overall Study|Lack of Efficacy|3
4720656|NCT02046369|16277453|P2|Overall Study|Adverse Event|3
4720657|NCT02046369|16277454|P1|Overall Study|Adverse Event|3
4720658|NCT02046226|16277498|P1|Overall Study|Lost to Follow-up|7
4720659|NCT02046148|16277546|P2|Overall Study|Withdrawal by Subject|2
4720660|NCT02046148|16277547|P1|Overall Study|Withdrawal by Subject|0
4720661|NCT02046148|16277546|P2|Overall Study|Lost to Follow-up|1
4720662|NCT02046148|16277547|P1|Overall Study|Lost to Follow-up|1
4720663|NCT02046122|16277607|P1|Overall Study|Withdrawal by Subject|1
4720664|NCT02046122|16277607|P1|Overall Study|Physician Decision|8
4720665|NCT02046070|16277621|P3|Overall Study|Reason not Specified|6
4720666|NCT02046070|16277622|P2|Overall Study|Reason not Specified|4
4720667|NCT02046070|16277623|P1|Overall Study|Reason not Specified|4
4720668|NCT02046070|16277621|P3|Overall Study|Study Terminated by Sponsor|1
4720669|NCT02046070|16277622|P2|Overall Study|Study Terminated by Sponsor|1
4720670|NCT02046070|16277623|P1|Overall Study|Study Terminated by Sponsor|1
4720671|NCT02046070|16277621|P3|Overall Study|Withdrawal by Subject|6
4720672|NCT02046070|16277622|P2|Overall Study|Withdrawal by Subject|2
4720673|NCT02046070|16277623|P1|Overall Study|Withdrawal by Subject|1
4720674|NCT02046070|16277621|P3|Overall Study|Adverse Event|17
4720675|NCT02046070|16277622|P2|Overall Study|Adverse Event|10
4720676|NCT02046070|16277623|P1|Overall Study|Adverse Event|8
4720677|NCT02046070|16277621|P3|Overall Study|Progressive Disease|40
4720678|NCT02046070|16277622|P2|Overall Study|Progressive Disease|11
4720679|NCT02046070|16277623|P1|Overall Study|Progressive Disease|18
4720680|NCT02045979|16277683|P3|Overall Study|not specified above|0
4720681|NCT02045979|16277684|P2|Overall Study|not specified above|1
4720682|NCT02045979|16277685|P1|Overall Study|not specified above|0
4720683|NCT02045979|16277683|P3|Overall Study|Informed Consent Withdrawn|1
4720684|NCT02045979|16277684|P2|Overall Study|Informed Consent Withdrawn|0
4720685|NCT02045979|16277685|P1|Overall Study|Informed Consent Withdrawn|2
4720686|NCT02045875|16277722|P2|Overall Study|Withdrawal by Subject|3
4720687|NCT02045875|16277723|P1|Overall Study|Withdrawal by Subject|4
4720688|NCT02045875|16277722|P2|Overall Study|Lost to Follow-up|0
4720689|NCT02045875|16277723|P1|Overall Study|Lost to Follow-up|3
4720690|NCT02045862|16277734|P3|Overall Study|Lost to Follow-up|6
4720691|NCT02045862|16277735|P2|Overall Study|Lost to Follow-up|2
4720692|NCT02045862|16277736|P1|Overall Study|Lost to Follow-up|1
4720693|NCT02045862|16277734|P3|Overall Study|Adverse Event|27
4720694|NCT02045862|16277735|P2|Overall Study|Adverse Event|5
4720695|NCT02045862|16277736|P1|Overall Study|Adverse Event|7
4720696|NCT02045862|16277734|P3|Overall Study|Randomized but not Received Study Drug|8
4720697|NCT02045862|16277735|P2|Overall Study|Randomized but not Received Study Drug|2
4720698|NCT02045862|16277736|P1|Overall Study|Randomized but not Received Study Drug|0
4720699|NCT02045862|16277734|P3|Overall Study|Lack of Efficacy|13
4720700|NCT02045862|16277735|P2|Overall Study|Lack of Efficacy|4
4720701|NCT02045862|16277736|P1|Overall Study|Lack of Efficacy|8
4720702|NCT02045862|16277734|P3|Overall Study|Protocol Violation|6
4720703|NCT02045862|16277735|P2|Overall Study|Protocol Violation|0
4720704|NCT02045862|16277736|P1|Overall Study|Protocol Violation|0
4720705|NCT02045862|16277734|P3|Overall Study|Withdrawal by Patient|57
4720706|NCT02045862|16277735|P2|Overall Study|Withdrawal by Patient|27
4720707|NCT02045862|16277736|P1|Overall Study|Withdrawal by Patient|18
4720708|NCT02045862|16277734|P3|Overall Study|Miscellaneous|8
4720709|NCT02045862|16277735|P2|Overall Study|Miscellaneous|0
4720710|NCT02045862|16277736|P1|Overall Study|Miscellaneous|5
4720711|NCT02045862|16277734|P3|Overall Study|Death|1
4720712|NCT02045862|16277735|P2|Overall Study|Death|0
4720713|NCT02045862|16277736|P1|Overall Study|Death|0
4720714|NCT02045836|16277917|P2|Overall Study|Migrated from study area|2
4720715|NCT02045836|16277918|P1|Overall Study|Migrated from study area|0
4720716|NCT02045836|16277917|P2|Overall Study|Lost to Follow-up|7
4720717|NCT02045836|16277918|P1|Overall Study|Lost to Follow-up|4
4720718|NCT02045836|16277917|P2|Overall Study|Withdrawal by Subject|1
4720719|NCT02045836|16277918|P1|Overall Study|Withdrawal by Subject|1
4720720|NCT02045836|16277917|P2|Overall Study|Adverse Event|4
4720721|NCT02045836|16277918|P1|Overall Study|Adverse Event|4
4720722|NCT02045797|16277950|P3|Overall Study|Withdrawal by Subject|0
4720723|NCT02045797|16277951|P2|Overall Study|Withdrawal by Subject|2
4720724|NCT02045797|16277952|P1|Overall Study|Withdrawal by Subject|1
4720725|NCT02045797|16277950|P3|Overall Study|Physician Decision|0
4720726|NCT02045797|16277951|P2|Overall Study|Physician Decision|1
4720727|NCT02045797|16277952|P1|Overall Study|Physician Decision|0
4720728|NCT02045797|16277950|P3|Overall Study|Lost to Follow-up|1
4720729|NCT02045797|16277951|P2|Overall Study|Lost to Follow-up|3
4720730|NCT02045797|16277952|P1|Overall Study|Lost to Follow-up|2
4720731|NCT02045797|16277950|P3|Overall Study|Lack of Efficacy|0
4720732|NCT02045797|16277951|P2|Overall Study|Lack of Efficacy|0
4720733|NCT02045797|16277952|P1|Overall Study|Lack of Efficacy|1
4720734|NCT02045797|16277950|P3|Overall Study|Adverse Event|0
4720735|NCT02045797|16277951|P2|Overall Study|Adverse Event|1
4720736|NCT02045797|16277952|P1|Overall Study|Adverse Event|3
4720737|NCT02045732|16278097|P2|Overall Study|At the discretion of the investigator|1
4720738|NCT02045732|16278098|P1|Overall Study|At the discretion of the investigator|1
4720739|NCT02045433|16278135|P1|Overall Study|Withdrawal by Subject|1
4720740|NCT02045212|16278188|P2|Overall Study|Finished 13 weeks, chose not to extend|0
4720741|NCT02045212|16278189|P1|Overall Study|Finished 13 weeks, chose not to extend|1
4720742|NCT02045212|16278188|P2|Overall Study|Withdrawal by Subject|0
4720743|NCT02045212|16278189|P1|Overall Study|Withdrawal by Subject|1
4720744|NCT02045212|16278188|P2|Overall Study|Adverse Event|1
4720745|NCT02045212|16278189|P1|Overall Study|Adverse Event|0
4720746|NCT02045095|16278254|P7|Overall Study|Adverse Event|0
4720747|NCT02045095|16278255|P6|Overall Study|Adverse Event|2
4720748|NCT02045095|16278256|P5|Overall Study|Adverse Event|0
4720749|NCT02045095|16278257|P4|Overall Study|Adverse Event|0
4720750|NCT02045095|16278258|P3|Overall Study|Adverse Event|1
4720751|NCT02045095|16278259|P2|Overall Study|Adverse Event|1
4720752|NCT02045095|16278260|P1|Overall Study|Adverse Event|0
4720753|NCT02045095|16278254|P7|Overall Study|Withdrawal by Subject|0
4720754|NCT02045095|16278255|P6|Overall Study|Withdrawal by Subject|0
4720755|NCT02045095|16278256|P5|Overall Study|Withdrawal by Subject|3
4720756|NCT02045095|16278257|P4|Overall Study|Withdrawal by Subject|0
4720757|NCT02045095|16278258|P3|Overall Study|Withdrawal by Subject|0
4720758|NCT02045095|16278259|P2|Overall Study|Withdrawal by Subject|0
4720759|NCT02045095|16278260|P1|Overall Study|Withdrawal by Subject|0
4720760|NCT02045095|16278254|P7|Overall Study|Progressive Disease|1
4720761|NCT02045095|16278255|P6|Overall Study|Progressive Disease|4
4720762|NCT02045095|16278256|P5|Overall Study|Progressive Disease|2
4720763|NCT02045095|16278257|P4|Overall Study|Progressive Disease|4
4720764|NCT02045095|16278258|P3|Overall Study|Progressive Disease|2
4720765|NCT02045095|16278259|P2|Overall Study|Progressive Disease|3
4720766|NCT02045095|16278260|P1|Overall Study|Progressive Disease|3
4720767|NCT02045095|16278254|P7|Overall Study|Other|0
4720768|NCT02045095|16278255|P6|Overall Study|Other|2
4720769|NCT02045095|16278256|P5|Overall Study|Other|0
4720770|NCT02045095|16278257|P4|Overall Study|Other|0
4720771|NCT02045095|16278258|P3|Overall Study|Other|1
4720772|NCT02045095|16278259|P2|Overall Study|Other|0
4720773|NCT02045095|16278260|P1|Overall Study|Other|0
4720774|NCT02044874|16278418|P3|Overall Study|Other|8
4720775|NCT02044874|16278419|P2|Overall Study|Other|3
4720776|NCT02044874|16278420|P1|Overall Study|Other|7
4720777|NCT02044874|16278418|P3|Overall Study|Sponsor Decision|1
4720778|NCT02044874|16278419|P2|Overall Study|Sponsor Decision|1
4720779|NCT02044874|16278420|P1|Overall Study|Sponsor Decision|0
4720780|NCT02044874|16278418|P3|Overall Study|Lost to Follow-up|21
4720781|NCT02044874|16278419|P2|Overall Study|Lost to Follow-up|27
4720782|NCT02044874|16278420|P1|Overall Study|Lost to Follow-up|10
4720783|NCT02044874|16278418|P3|Overall Study|Physician Decision|1
4720784|NCT02044874|16278419|P2|Overall Study|Physician Decision|2
4720785|NCT02044874|16278420|P1|Overall Study|Physician Decision|0
4720786|NCT02044874|16278418|P3|Overall Study|Withdrawal by Subject|23
4720787|NCT02044874|16278419|P2|Overall Study|Withdrawal by Subject|16
4720788|NCT02044874|16278420|P1|Overall Study|Withdrawal by Subject|8
4720789|NCT02044874|16278418|P3|Overall Study|Adverse Event|6
4720790|NCT02044874|16278419|P2|Overall Study|Adverse Event|6
4720791|NCT02044874|16278420|P1|Overall Study|Adverse Event|5
4720792|NCT02044848|16278442|P2|Overall Study|Administrative Problems|3
4720793|NCT02044848|16278443|P1|Overall Study|Administrative Problems|2
4720794|NCT02044822|16278449|P1|Overall Study|Lost to Follow-up|1
4720795|NCT02044822|16278449|P1|Overall Study|Initiation of Anti-Neoplastic Therapy|2
4720796|NCT02044822|16278449|P1|Overall Study|Withdrew Consent|3
4720797|NCT02044822|16278449|P1|Overall Study|Investigator's Discretion|10
4720798|NCT02044822|16278449|P1|Overall Study|Study Terminated by Sponsor|77
4720799|NCT02044510|16278491|P2|Overall Study|Adverse Event|2
4720800|NCT02044510|16278492|P1|Overall Study|Adverse Event|1
4720801|NCT02044458|16278500|P2|Overall Study|Protocol Violation|8
4720802|NCT02044458|16278501|P1|Overall Study|Protocol Violation|3
4720803|NCT02044302|16278587|P2|Overall Study|study terminated|0
4720804|NCT02044302|16278588|P1|Overall Study|study terminated|2
4720805|NCT02044159|16278596|P2|Overall Study|Nurse declined to give study drug|0
4720806|NCT02044159|16278597|P1|Overall Study|Nurse declined to give study drug|1
4720807|NCT02044159|16278596|P2|Overall Study|No longer eligible, drug not given|0
4720808|NCT02044159|16278597|P1|Overall Study|No longer eligible, drug not given|1
4720809|NCT02044159|16278596|P2|Overall Study|Consent declined (deferred consent)|4
4720810|NCT02044159|16278597|P1|Overall Study|Consent declined (deferred consent)|2
4720811|NCT02044094|16278610|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1
4720812|NCT02044094|16278610|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1
4720813|NCT02044094|16278610|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2
4720814|NCT02044094|16278610|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5
4720815|NCT02044094|16278610|P1|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4
4720816|NCT02044094|16278610|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3
4720817|NCT02044094|16278610|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3
4720818|NCT02044094|16278610|P1|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3
4720819|NCT02043938|16278667|P1|Overall Study|Investigator decision|1
4720820|NCT02043938|16278667|P1|Overall Study|No show by subject|1
4720821|NCT02043938|16278667|P1|Overall Study|Unable to place EEG sensors on patient|1
4720822|NCT02043938|16278667|P1|Overall Study|Withdrawal by Subject|7
4720823|NCT02043782|16278722|P6|Period 1|Adverse Event|0
4720824|NCT02043782|16278723|P5|Period 1|Adverse Event|0
4720825|NCT02043782|16278724|P4|Period 1|Adverse Event|0
4720826|NCT02043782|16278725|P3|Period 1|Adverse Event|1
4720827|NCT02043782|16278726|P2|Period 1|Adverse Event|0
4720828|NCT02043782|16278727|P1|Period 1|Adverse Event|0
4720829|NCT02043678|16278770|P2|Overall Study|Ongoing with treatment|104
4720830|NCT02043678|16278771|P1|Overall Study|Ongoing with treatment|87
4720831|NCT02043678|16278770|P2|Overall Study|Withdrawal by Subject|13
4720832|NCT02043678|16278771|P1|Overall Study|Withdrawal by Subject|10
4720833|NCT02043678|16278770|P2|Overall Study|Protocol-driven decision point|45
4720834|NCT02043678|16278771|P1|Overall Study|Protocol-driven decision point|53
4720835|NCT02043678|16278770|P2|Overall Study|Radiological PD|67
4720836|NCT02043678|16278771|P1|Overall Study|Radiological PD|78
4720837|NCT02043678|16278770|P2|Overall Study|Clinical PD|112
4720838|NCT02043678|16278771|P1|Overall Study|Clinical PD|88
4720839|NCT02043678|16278770|P2|Overall Study|Other|8
4720840|NCT02043678|16278771|P1|Overall Study|Other|15
4720841|NCT02043678|16278770|P2|Overall Study|Lost to Follow-up|1
4720842|NCT02043678|16278771|P1|Overall Study|Lost to Follow-up|1
4720843|NCT02043678|16278770|P2|Overall Study|AE without clinical PD|31
4720844|NCT02043678|16278771|P1|Overall Study|AE without clinical PD|41
4720845|NCT02043678|16278770|P2|Overall Study|AE with clinical progressive disease(PD)|15
4720846|NCT02043678|16278771|P1|Overall Study|AE with clinical progressive disease(PD)|17
4720847|NCT02043678|16278770|P2|Overall Study|Never treated|9
4720848|NCT02043678|16278771|P1|Overall Study|Never treated|11
4720849|NCT02043509|16278807|P2|Baseline to 2nd Follow-up|Withdrawal by Subject|5
4720850|NCT02043509|16278808|P1|Baseline to 2nd Follow-up|Withdrawal by Subject|7
4720851|NCT02043509|16278807|P2|Baseline to 2nd Follow-up|Lost to Follow-up|67
4720852|NCT02043509|16278808|P1|Baseline to 2nd Follow-up|Lost to Follow-up|67
4720853|NCT02043509|16278807|P2|Baseline to 1st Follow-up|Withdrawal by Subject|0
4720854|NCT02043509|16278808|P1|Baseline to 1st Follow-up|Withdrawal by Subject|4
4720855|NCT02043509|16278807|P2|Baseline to 1st Follow-up|Lost to Follow-up|47
4720856|NCT02043509|16278808|P1|Baseline to 1st Follow-up|Lost to Follow-up|61
4720857|NCT02043366|16278896|P6|Overall Study|Lost to Follow-up|2
4720858|NCT02043366|16278897|P5|Overall Study|Lost to Follow-up|2
4720859|NCT02043366|16278898|P4|Overall Study|Lost to Follow-up|2
4720860|NCT02043366|16278899|P3|Overall Study|Lost to Follow-up|2
4720861|NCT02043366|16278900|P2|Overall Study|Lost to Follow-up|2
4720862|NCT02043366|16278901|P1|Overall Study|Lost to Follow-up|2
4720863|NCT02043301|16278924|P3|Overall Study|Discontinued|0
4720864|NCT02043301|16278925|P2|Overall Study|Discontinued|1
4720865|NCT02043301|16278926|P1|Overall Study|Discontinued|0
4720866|NCT02043132|16279023|P2|Overall Study|screen failures|8
4720867|NCT02043132|16279024|P1|Overall Study|screen failures|4
4720868|NCT02043132|16279023|P2|Overall Study|Lost to Follow-up|1
4720869|NCT02043132|16279024|P1|Overall Study|Lost to Follow-up|1
4720870|NCT02043015|16279044|P1|Overall Study|Incarceration|1
4720871|NCT02043015|16279044|P1|Overall Study|Participant moved away from study city|4
4720872|NCT02043015|16279044|P1|Overall Study|Removed once target enrollment reached|15
4720873|NCT02043015|16279044|P1|Overall Study|Withdrawal by Subject|4
4720874|NCT02043015|16279044|P1|Overall Study|Lost to Follow-up|4
4720875|NCT02042950|16279057|P1|Overall Study|Progressive Disease|4
4720876|NCT02042924|16279063|P1|Overall Study|Early Death|1
4720877|NCT02042443|16279111|P2|Overall Study|Not eligible/not analyzable|6
4720878|NCT02042443|16279112|P1|Overall Study|Not eligible/not analyzable|3
4720879|NCT02042443|16279111|P2|Overall Study|not protocol specified|1
4720880|NCT02042443|16279112|P1|Overall Study|not protocol specified|1
4720881|NCT02042443|16279111|P2|Overall Study|Progression|17
4720882|NCT02042443|16279112|P1|Overall Study|Progression|21
4720883|NCT02042443|16279111|P2|Overall Study|Withdrawal by Subject|1
4720884|NCT02042443|16279112|P1|Overall Study|Withdrawal by Subject|0
4720885|NCT02042443|16279111|P2|Overall Study|Adverse Event|1
4720886|NCT02042443|16279112|P1|Overall Study|Adverse Event|2
4720887|NCT02042404|16279124|P2|Overall Study|Inability to meet time requirements|0
4720888|NCT02042404|16279125|P1|Overall Study|Inability to meet time requirements|1
4720889|NCT02042404|16279124|P2|Overall Study|Unrelated Adverse Event|0
4720890|NCT02042404|16279125|P1|Overall Study|Unrelated Adverse Event|3
4720891|NCT02042404|16279124|P2|Overall Study|Death|0
4720892|NCT02042404|16279125|P1|Overall Study|Death|1
4720893|NCT02042183|16279143|P2|Overall Study|Lost to Follow-up|2
4720894|NCT02042183|16279144|P1|Overall Study|Lost to Follow-up|9
4720895|NCT02042183|16279143|P2|Overall Study|Site Terminated by Sponsor|1
4720896|NCT02042183|16279144|P1|Overall Study|Site Terminated by Sponsor|2
4720897|NCT02042183|16279143|P2|Overall Study|Withdrawal by Subject|16
4720898|NCT02042183|16279144|P1|Overall Study|Withdrawal by Subject|21
4720899|NCT02042183|16279143|P2|Overall Study|Other|3
4720900|NCT02042183|16279144|P1|Overall Study|Other|3
4720901|NCT02042183|16279143|P2|Overall Study|Adverse Event|6
4720902|NCT02042183|16279144|P1|Overall Study|Adverse Event|17
4720903|NCT02042183|16279143|P2|Overall Study|Non-compliance with Study Drug|3
4720904|NCT02042183|16279144|P1|Overall Study|Non-compliance with Study Drug|2
4720905|NCT02042183|16279143|P2|Overall Study|Lack of Efficacy|3
4720906|NCT02042183|16279144|P1|Overall Study|Lack of Efficacy|4
4720907|NCT02042183|16279143|P2|Overall Study|Physician Decision|2
4720908|NCT02042183|16279144|P1|Overall Study|Physician Decision|7
4720909|NCT02042014|16279174|P1|Overall Study|Physician Decision|7
4720910|NCT02042014|16279174|P1|Overall Study|Adverse Event|1
4720911|NCT02041962|16279180|P2|Overall Study|Withdrawal by Subject|11
4720912|NCT02041962|16279181|P1|Overall Study|Withdrawal by Subject|0
4720913|NCT02041962|16279180|P2|Overall Study|Lost to Follow-up|32
4720914|NCT02041962|16279181|P1|Overall Study|Lost to Follow-up|37
4720915|NCT02041962|16279180|P2|Overall Study|Death|1
4720916|NCT02041962|16279181|P1|Overall Study|Death|1
4720917|NCT02041962|16279180|P2|Overall Study|Lost Aetna Coverage|40
4720918|NCT02041962|16279181|P1|Overall Study|Lost Aetna Coverage|43
4720919|NCT02041702|16279191|P2|Overall Study|Cardiac Resynchronization Therapy|0
4720920|NCT02041702|16279192|P1|Overall Study|Cardiac Resynchronization Therapy|1
4720921|NCT02041702|16279191|P2|Overall Study|Patient not confirmed as MRI compatible|0
4720922|NCT02041702|16279192|P1|Overall Study|Patient not confirmed as MRI compatible|1
4720923|NCT02041702|16279191|P2|Overall Study|Withdrawal by Subject|3
4720924|NCT02041702|16279192|P1|Overall Study|Withdrawal by Subject|4
4720925|NCT02041702|16279191|P2|Overall Study|Death|0
4720926|NCT02041702|16279192|P1|Overall Study|Death|4
4720927|NCT02041702|16279191|P2|Overall Study|Lost to Follow-up|6
4720928|NCT02041702|16279192|P1|Overall Study|Lost to Follow-up|1
4720929|NCT02041533|16279207|P2|Overall Study|Randomized, not treated|7
4720930|NCT02041533|16279208|P1|Overall Study|Randomized, not treated|4
4720931|NCT02041533|16279207|P2|Overall Study|Completed max number of chemo cycles|29
4720932|NCT02041533|16279208|P1|Overall Study|Completed max number of chemo cycles|0
4720933|NCT02041533|16279207|P2|Overall Study|Other reasons|1
4720934|NCT02041533|16279208|P1|Overall Study|Other reasons|0
4720935|NCT02041533|16279207|P2|Overall Study|Poor/non-compliance|0
4720936|NCT02041533|16279208|P1|Overall Study|Poor/non-compliance|1
4720937|NCT02041533|16279207|P2|Overall Study|Maximum clinical benefit|18
4720938|NCT02041533|16279208|P1|Overall Study|Maximum clinical benefit|0
4720939|NCT02041533|16279207|P2|Overall Study|Withdrawal by Subject|1
4720940|NCT02041533|16279208|P1|Overall Study|Withdrawal by Subject|2
4720941|NCT02041533|16279207|P2|Overall Study|Subject request to discontinue treatment|9
4720942|NCT02041533|16279208|P1|Overall Study|Subject request to discontinue treatment|5
4720943|NCT02041533|16279207|P2|Overall Study|Adverse Event unrelated to study drug|21
4720944|NCT02041533|16279208|P1|Overall Study|Adverse Event unrelated to study drug|20
4720945|NCT02041533|16279207|P2|Overall Study|Death|0
4720946|NCT02041533|16279208|P1|Overall Study|Death|1
4720947|NCT02041533|16279207|P2|Overall Study|Study drug toxicity|30
4720948|NCT02041533|16279208|P1|Overall Study|Study drug toxicity|27
4720949|NCT02041533|16279207|P2|Overall Study|Disease Progression|142
4720950|NCT02041533|16279208|P1|Overall Study|Disease Progression|168
4720951|NCT02041520|16279230|P2|Overall Study|Hypothiroidism identified during follow-|1
4720952|NCT02041520|16279231|P1|Overall Study|Hypothiroidism identified during follow-|0
4720953|NCT02041520|16279230|P2|Overall Study|Lost to Follow-up|1
4720954|NCT02041520|16279231|P1|Overall Study|Lost to Follow-up|0
4720955|NCT02041520|16279230|P2|Overall Study|Protocol Violation|0
4720956|NCT02041520|16279231|P1|Overall Study|Protocol Violation|1
4720957|NCT02041520|16279230|P2|Overall Study|Withdrawal by Subject|4
4720958|NCT02041520|16279231|P1|Overall Study|Withdrawal by Subject|3
4720959|NCT02041520|16279230|P2|Overall Study|Adverse Event|1
4720960|NCT02041520|16279231|P1|Overall Study|Adverse Event|2
4720961|NCT02041286|16279274|P1|Overall Study|Adverse Event|1
4720962|NCT02041104|16279309|P2|Overall Study|discomfort during OGTT|3
4720963|NCT02041104|16279310|P1|Overall Study|discomfort during OGTT|0
4720964|NCT02041104|16279309|P2|Overall Study|Lost to Follow-up|4
4720965|NCT02041104|16279310|P1|Overall Study|Lost to Follow-up|1
4720966|NCT02041091|16279350|P2|Optional Safety Extension Period|Lost to Follow-up|3
4720967|NCT02041091|16279351|P1|Optional Safety Extension Period|Lost to Follow-up|2
4720968|NCT02041091|16279350|P2|Optional Safety Extension Period|Sponsor Decision|74
4720969|NCT02041091|16279351|P1|Optional Safety Extension Period|Sponsor Decision|70
4720970|NCT02041091|16279350|P2|Optional Safety Extension Period|Physician Decision|1
4720971|NCT02041091|16279351|P1|Optional Safety Extension Period|Physician Decision|2
4720972|NCT02041091|16279350|P2|Optional Safety Extension Period|Protocol Violation|0
4720973|NCT02041091|16279351|P1|Optional Safety Extension Period|Protocol Violation|2
4720974|NCT02041091|16279350|P2|Optional Safety Extension Period|Withdrawal by Subject|2
4720975|NCT02041091|16279351|P1|Optional Safety Extension Period|Withdrawal by Subject|5
4720976|NCT02041091|16279350|P2|Optional Safety Extension Period|Adverse Event|2
4720977|NCT02041091|16279351|P1|Optional Safety Extension Period|Adverse Event|4
4720978|NCT02041091|16279350|P2|Treatment|Lost to Follow-up|0
4720979|NCT02041091|16279351|P1|Treatment|Lost to Follow-up|1
4720980|NCT02041091|16279350|P2|Treatment|Sponsor Decision|16
4720981|NCT02041091|16279351|P1|Treatment|Sponsor Decision|15
4720982|NCT02041091|16279350|P2|Treatment|Physician Decision|0
4720983|NCT02041091|16279351|P1|Treatment|Physician Decision|1
4720984|NCT02041091|16279350|P2|Treatment|Withdrawal by Subject|4
4720985|NCT02041091|16279351|P1|Treatment|Withdrawal by Subject|2
4720986|NCT02041091|16279350|P2|Treatment|Adverse Event|3
4720987|NCT02041091|16279351|P1|Treatment|Adverse Event|3
4720988|NCT02040870|16279373|P1|Overall Study|Death|13
4720989|NCT02040870|16279373|P1|Overall Study|Lost to Follow-up|3
4720990|NCT02040870|16279373|P1|Overall Study|Subject/guardian decision|10
4720991|NCT02040870|16279373|P1|Overall Study|Physician Decision|6
4720992|NCT02040870|16279373|P1|Overall Study|Progressive disease|58
4720993|NCT02040870|16279373|P1|Overall Study|Adverse Event|7
4720994|NCT02040870|16279373|P1|Overall Study|Completed treatment phase|6
4720995|NCT02040844|16279397|P3|Overall Study|Concomitant medication|1
4720996|NCT02040844|16279398|P2|Overall Study|Concomitant medication|3
4720997|NCT02040844|16279399|P1|Overall Study|Concomitant medication|1
4720998|NCT02040844|16279397|P3|Overall Study|Non-specified|5
4720999|NCT02040844|16279398|P2|Overall Study|Non-specified|2
4721000|NCT02040844|16279399|P1|Overall Study|Non-specified|8
4721001|NCT02040844|16279397|P3|Overall Study|Missing|2
4721002|NCT02040844|16279398|P2|Overall Study|Missing|3
4721003|NCT02040844|16279399|P1|Overall Study|Missing|13
4721004|NCT02040844|16279397|P3|Overall Study|Lost to Follow-up|13
4721005|NCT02040844|16279398|P2|Overall Study|Lost to Follow-up|9
4721006|NCT02040844|16279399|P1|Overall Study|Lost to Follow-up|12
4721007|NCT02040844|16279397|P3|Overall Study|Withdrawal by Subject|25
4721008|NCT02040844|16279398|P2|Overall Study|Withdrawal by Subject|22
4721009|NCT02040844|16279399|P1|Overall Study|Withdrawal by Subject|16
4721010|NCT02040844|16279397|P3|Overall Study|Adverse Event|1
4721011|NCT02040844|16279398|P2|Overall Study|Adverse Event|0
4721012|NCT02040844|16279399|P1|Overall Study|Adverse Event|0
4721013|NCT02040805|16279424|P2|Overall Study|Withdrawal by Subject|41
4721014|NCT02040805|16279425|P1|Overall Study|Withdrawal by Subject|28
4721015|NCT02040805|16279424|P2|Overall Study|Lost to Follow-up|9
4721016|NCT02040805|16279425|P1|Overall Study|Lost to Follow-up|14
4721017|NCT02040779|16279461|P3|Overall Study|Lack of Efficacy|0
4721018|NCT02040779|16279462|P2|Overall Study|Lack of Efficacy|2
4721019|NCT02040779|16279463|P1|Overall Study|Lack of Efficacy|4
4721020|NCT02040779|16279461|P3|Overall Study|Lost to Follow-up|1
4721021|NCT02040779|16279462|P2|Overall Study|Lost to Follow-up|2
4721022|NCT02040779|16279463|P1|Overall Study|Lost to Follow-up|1
4721023|NCT02040779|16279461|P3|Overall Study|Protocol Violation|0
4721024|NCT02040779|16279462|P2|Overall Study|Protocol Violation|1
4721025|NCT02040779|16279463|P1|Overall Study|Protocol Violation|2
4721026|NCT02040779|16279461|P3|Overall Study|Non-compliance|0
4721027|NCT02040779|16279462|P2|Overall Study|Non-compliance|1
4721028|NCT02040779|16279463|P1|Overall Study|Non-compliance|0
4721029|NCT02040779|16279461|P3|Overall Study|Withdrawal by Subject|3
4721030|NCT02040779|16279462|P2|Overall Study|Withdrawal by Subject|1
4721031|NCT02040779|16279463|P1|Overall Study|Withdrawal by Subject|4
4721032|NCT02040779|16279461|P3|Overall Study|Adverse Event|0
4721033|NCT02040779|16279462|P2|Overall Study|Adverse Event|0
4721034|NCT02040779|16279463|P1|Overall Study|Adverse Event|1
4721035|NCT02040766|16279503|P5|Overall Study|Lack of Efficacy|5
4721036|NCT02040766|16279504|P4|Overall Study|Lack of Efficacy|6
4721037|NCT02040766|16279505|P3|Overall Study|Lack of Efficacy|4
4721038|NCT02040766|16279506|P2|Overall Study|Lack of Efficacy|3
4721039|NCT02040766|16279507|P1|Overall Study|Lack of Efficacy|6
4721040|NCT02040766|16279503|P5|Overall Study|Not reported|0
4721041|NCT02040766|16279504|P4|Overall Study|Not reported|0
4721042|NCT02040766|16279505|P3|Overall Study|Not reported|0
4721043|NCT02040766|16279506|P2|Overall Study|Not reported|0
4721044|NCT02040766|16279507|P1|Overall Study|Not reported|1
4721045|NCT02040766|16279503|P5|Overall Study|Lost to Follow-up|4
4721046|NCT02040766|16279504|P4|Overall Study|Lost to Follow-up|1
4721047|NCT02040766|16279505|P3|Overall Study|Lost to Follow-up|3
4721048|NCT02040766|16279506|P2|Overall Study|Lost to Follow-up|1
4721049|NCT02040766|16279507|P1|Overall Study|Lost to Follow-up|4
4721050|NCT02040766|16279503|P5|Overall Study|Protocol Violation|0
4721051|NCT02040766|16279504|P4|Overall Study|Protocol Violation|3
4721052|NCT02040766|16279505|P3|Overall Study|Protocol Violation|2
4721053|NCT02040766|16279506|P2|Overall Study|Protocol Violation|1
4721054|NCT02040766|16279507|P1|Overall Study|Protocol Violation|2
4721055|NCT02040766|16279503|P5|Overall Study|Non-compliance|0
4721056|NCT02040766|16279504|P4|Overall Study|Non-compliance|0
4721057|NCT02040766|16279505|P3|Overall Study|Non-compliance|0
4721058|NCT02040766|16279506|P2|Overall Study|Non-compliance|1
4721059|NCT02040766|16279507|P1|Overall Study|Non-compliance|0
4721060|NCT02040766|16279503|P5|Overall Study|Withdrawal by Subject|2
4721061|NCT02040766|16279504|P4|Overall Study|Withdrawal by Subject|3
4721062|NCT02040766|16279505|P3|Overall Study|Withdrawal by Subject|2
4721063|NCT02040766|16279506|P2|Overall Study|Withdrawal by Subject|3
4721064|NCT02040766|16279507|P1|Overall Study|Withdrawal by Subject|4
4721065|NCT02040766|16279503|P5|Overall Study|Adverse Event|2
4721066|NCT02040766|16279504|P4|Overall Study|Adverse Event|0
4721067|NCT02040766|16279505|P3|Overall Study|Adverse Event|1
4721068|NCT02040766|16279506|P2|Overall Study|Adverse Event|1
4721069|NCT02040766|16279507|P1|Overall Study|Adverse Event|1
4721070|NCT02040584|16279560|P2|Overall Study|Immunosuppressant/prohibited med use|10
4721071|NCT02040584|16279561|P1|Overall Study|Immunosuppressant/prohibited med use|7
4721072|NCT02040584|16279560|P2|Overall Study|Transplant rejection/retransplant|1
4721073|NCT02040584|16279561|P1|Overall Study|Transplant rejection/retransplant|0
4721074|NCT02040584|16279560|P2|Overall Study|Death|3
4721075|NCT02040584|16279561|P1|Overall Study|Death|6
4721076|NCT02040584|16279560|P2|Overall Study|Unsatisfactory therapeutic effect|1
4721077|NCT02040584|16279561|P1|Overall Study|Unsatisfactory therapeutic effect|0
4721078|NCT02040584|16279560|P2|Overall Study|Protocol Violation|11
4721079|NCT02040584|16279561|P1|Overall Study|Protocol Violation|9
4721080|NCT02040584|16279560|P2|Overall Study|Adverse Event|6
4721081|NCT02040584|16279561|P1|Overall Study|Adverse Event|13
4721082|NCT02040532|16279594|P1|Overall Study|Withdrawal by Subject|3
4721083|NCT02040532|16279594|P1|Overall Study|Adverse Event|4
4721084|NCT02040532|16279594|P1|Overall Study|Physician Decision|4
4721085|NCT02040532|16279594|P1|Overall Study|Lost to Follow-up|1
4721086|NCT02040428|16279607|P2|Overall Study|Withdrawal by Subject|1
4721087|NCT02040428|16279608|P1|Overall Study|Withdrawal by Subject|1
4721088|NCT02040428|16279607|P2|Overall Study|Death|3
4721089|NCT02040428|16279608|P1|Overall Study|Death|4
4721090|NCT02040259|16279620|P1|Overall Study|Withdrawal by Subject|4
4721091|NCT02040259|16279620|P1|Overall Study|Assessment not completed|3
4721092|NCT02040259|16279620|P1|Overall Study|Lost to Follow-up|76
4721093|NCT02040259|16279620|P1|Overall Study|Death|280
4721094|NCT02039908|16279694|P4|Phase 2-School Year|Withdrawal by Subject|5
4721095|NCT02039908|16279695|P3|Phase 2-School Year|Withdrawal by Subject|8
4721096|NCT02039908|16279696|P2|Phase 2-School Year|Withdrawal by Subject|0
4721097|NCT02039908|16279697|P1|Phase 2-School Year|Withdrawal by Subject|0
4721098|NCT02039908|16279694|P4|Phase 2-School Year|Protocol Violation|0
4721099|NCT02039908|16279695|P3|Phase 2-School Year|Protocol Violation|3
4721100|NCT02039908|16279696|P2|Phase 2-School Year|Protocol Violation|0
4721101|NCT02039908|16279697|P1|Phase 2-School Year|Protocol Violation|0
4721102|NCT02039908|16279694|P4|Phase 2-School Year|Lost to Follow-up|3
4721103|NCT02039908|16279695|P3|Phase 2-School Year|Lost to Follow-up|1
4721104|NCT02039908|16279696|P2|Phase 2-School Year|Lost to Follow-up|0
4721105|NCT02039908|16279697|P1|Phase 2-School Year|Lost to Follow-up|0
4721106|NCT02039908|16279694|P4|Phase 1-Summer|Protocol Violation|0
4721107|NCT02039908|16279695|P3|Phase 1-Summer|Protocol Violation|0
4721108|NCT02039908|16279696|P2|Phase 1-Summer|Protocol Violation|0
4721109|NCT02039908|16279697|P1|Phase 1-Summer|Protocol Violation|6
4721110|NCT02039908|16279694|P4|Phase 1-Summer|Withdrawal by Subject|0
4721111|NCT02039908|16279695|P3|Phase 1-Summer|Withdrawal by Subject|0
4721112|NCT02039908|16279696|P2|Phase 1-Summer|Withdrawal by Subject|6
4721113|NCT02039908|16279697|P1|Phase 1-Summer|Withdrawal by Subject|7
4721114|NCT02039856|16279711|P2|Overall Study|Withdrawal by Subject|618
4721115|NCT02039856|16279712|P1|Overall Study|Withdrawal by Subject|1573
4721116|NCT02039856|16279711|P2|Overall Study|Lost to Follow-up|206
4721117|NCT02039856|16279712|P1|Overall Study|Lost to Follow-up|388
4721118|NCT02039856|16279711|P2|Overall Study|Partial survey completion|26
4721119|NCT02039856|16279712|P1|Overall Study|Partial survey completion|61
4721120|NCT02039856|16279711|P2|Overall Study|Death|3
4721121|NCT02039856|16279712|P1|Overall Study|Death|5
4721122|NCT02039778|16279744|P1|Overall Study|Never started the protocol treatment|1
4721123|NCT02039778|16279744|P1|Overall Study|Withdrawal by Subject|1
4721124|NCT02039778|16279744|P1|Overall Study|Death|2
4721125|NCT02039687|16279767|P4|Overall Study|treatment assignment could not be confir|0
4721126|NCT02039687|16279768|P3|Overall Study|treatment assignment could not be confir|2
4721127|NCT02039687|16279769|P2|Overall Study|treatment assignment could not be confir|0
4721128|NCT02039687|16279770|P1|Overall Study|treatment assignment could not be confir|0
4721129|NCT02039687|16279767|P4|Overall Study|Withdrawal by Subject|0
4721130|NCT02039687|16279768|P3|Overall Study|Withdrawal by Subject|0
4721131|NCT02039687|16279769|P2|Overall Study|Withdrawal by Subject|1
4721132|NCT02039687|16279770|P1|Overall Study|Withdrawal by Subject|0
4721133|NCT02039687|16279767|P4|Overall Study|Adverse Event|0
4721134|NCT02039687|16279768|P3|Overall Study|Adverse Event|1
4721135|NCT02039687|16279769|P2|Overall Study|Adverse Event|0
4721136|NCT02039687|16279770|P1|Overall Study|Adverse Event|0
4721137|NCT02039674|16279810|P14|Overall Study|Ongoing in Study|3
4721138|NCT02039674|16279811|P13|Overall Study|Ongoing in Study|33
4721139|NCT02039674|16279812|P12|Overall Study|Ongoing in Study|34
4721140|NCT02039674|16279813|P11|Overall Study|Ongoing in Study|1
4721141|NCT02039674|16279814|P10|Overall Study|Ongoing in Study|6
4721142|NCT02039674|16279815|P9|Overall Study|Ongoing in Study|1
4721143|NCT02039674|16279816|P8|Overall Study|Ongoing in Study|0
4721144|NCT02039674|16279817|P7|Overall Study|Ongoing in Study|2
4721145|NCT02039674|16279818|P6|Overall Study|Ongoing in Study|1
4721146|NCT02039674|16279819|P5|Overall Study|Ongoing in Study|3
4721147|NCT02039674|16279820|P4|Overall Study|Ongoing in Study|2
4721148|NCT02039674|16279821|P3|Overall Study|Ongoing in Study|3
4721149|NCT02039674|16279822|P2|Overall Study|Ongoing in Study|2
4721150|NCT02039674|16279823|P1|Overall Study|Ongoing in Study|5
4721151|NCT02039674|16279810|P14|Overall Study|Withdrawal by Subject|2
4721152|NCT02039674|16279811|P13|Overall Study|Withdrawal by Subject|5
4721153|NCT02039674|16279812|P12|Overall Study|Withdrawal by Subject|3
4721154|NCT02039674|16279813|P11|Overall Study|Withdrawal by Subject|1
4721155|NCT02039674|16279814|P10|Overall Study|Withdrawal by Subject|2
4721156|NCT02039674|16279815|P9|Overall Study|Withdrawal by Subject|0
4721157|NCT02039674|16279816|P8|Overall Study|Withdrawal by Subject|0
4721158|NCT02039674|16279817|P7|Overall Study|Withdrawal by Subject|0
4721159|NCT02039674|16279818|P6|Overall Study|Withdrawal by Subject|0
4721160|NCT02039674|16279819|P5|Overall Study|Withdrawal by Subject|1
4721161|NCT02039674|16279820|P4|Overall Study|Withdrawal by Subject|0
4721162|NCT02039674|16279821|P3|Overall Study|Withdrawal by Subject|1
4721163|NCT02039674|16279822|P2|Overall Study|Withdrawal by Subject|2
4721164|NCT02039674|16279823|P1|Overall Study|Withdrawal by Subject|0
4721165|NCT02039674|16279810|P14|Overall Study|Progressive Disease|16
4721166|NCT02039674|16279811|P13|Overall Study|Progressive Disease|18
4721167|NCT02039674|16279812|P12|Overall Study|Progressive Disease|17
4721168|NCT02039674|16279813|P11|Overall Study|Progressive Disease|0
4721169|NCT02039674|16279814|P10|Overall Study|Progressive Disease|2
4721170|NCT02039674|16279815|P9|Overall Study|Progressive Disease|7
4721171|NCT02039674|16279816|P8|Overall Study|Progressive Disease|3
4721172|NCT02039674|16279817|P7|Overall Study|Progressive Disease|1
4721173|NCT02039674|16279818|P6|Overall Study|Progressive Disease|10
4721174|NCT02039674|16279819|P5|Overall Study|Progressive Disease|8
4721175|NCT02039674|16279820|P4|Overall Study|Progressive Disease|7
4721176|NCT02039674|16279821|P3|Overall Study|Progressive Disease|6
4721177|NCT02039674|16279822|P2|Overall Study|Progressive Disease|7
4721178|NCT02039674|16279823|P1|Overall Study|Progressive Disease|6
4721179|NCT02039674|16279810|P14|Overall Study|Physician Decision|0
4721180|NCT02039674|16279811|P13|Overall Study|Physician Decision|0
4721181|NCT02039674|16279812|P12|Overall Study|Physician Decision|1
4721182|NCT02039674|16279813|P11|Overall Study|Physician Decision|0
4721183|NCT02039674|16279814|P10|Overall Study|Physician Decision|0
4721184|NCT02039674|16279815|P9|Overall Study|Physician Decision|0
4721185|NCT02039674|16279816|P8|Overall Study|Physician Decision|0
4721186|NCT02039674|16279817|P7|Overall Study|Physician Decision|0
4721187|NCT02039674|16279818|P6|Overall Study|Physician Decision|0
4721188|NCT02039674|16279819|P5|Overall Study|Physician Decision|0
4721189|NCT02039674|16279820|P4|Overall Study|Physician Decision|0
4721190|NCT02039674|16279821|P3|Overall Study|Physician Decision|0
4721191|NCT02039674|16279822|P2|Overall Study|Physician Decision|0
4721192|NCT02039674|16279823|P1|Overall Study|Physician Decision|0
4721193|NCT02039674|16279810|P14|Overall Study|Lost to Follow-up|0
4721194|NCT02039674|16279811|P13|Overall Study|Lost to Follow-up|1
4721195|NCT02039674|16279812|P12|Overall Study|Lost to Follow-up|0
4721196|NCT02039674|16279813|P11|Overall Study|Lost to Follow-up|0
4721197|NCT02039674|16279814|P10|Overall Study|Lost to Follow-up|0
4721198|NCT02039674|16279815|P9|Overall Study|Lost to Follow-up|0
4721199|NCT02039674|16279816|P8|Overall Study|Lost to Follow-up|0
4721200|NCT02039674|16279817|P7|Overall Study|Lost to Follow-up|0
4721201|NCT02039674|16279818|P6|Overall Study|Lost to Follow-up|0
4721202|NCT02039674|16279819|P5|Overall Study|Lost to Follow-up|0
4721203|NCT02039674|16279820|P4|Overall Study|Lost to Follow-up|0
4721204|NCT02039674|16279821|P3|Overall Study|Lost to Follow-up|0
4721205|NCT02039674|16279822|P2|Overall Study|Lost to Follow-up|0
4721206|NCT02039674|16279823|P1|Overall Study|Lost to Follow-up|0
4721207|NCT02039674|16279810|P14|Overall Study|Excluded Medication|3
4721208|NCT02039674|16279811|P13|Overall Study|Excluded Medication|4
4721209|NCT02039674|16279812|P12|Overall Study|Excluded Medication|2
4721210|NCT02039674|16279813|P11|Overall Study|Excluded Medication|4
4721211|NCT02039674|16279814|P10|Overall Study|Excluded Medication|2
4721212|NCT02039674|16279815|P9|Overall Study|Excluded Medication|2
4721213|NCT02039674|16279816|P8|Overall Study|Excluded Medication|0
4721214|NCT02039674|16279817|P7|Overall Study|Excluded Medication|0
4721215|NCT02039674|16279818|P6|Overall Study|Excluded Medication|1
4721216|NCT02039674|16279819|P5|Overall Study|Excluded Medication|0
4721217|NCT02039674|16279820|P4|Overall Study|Excluded Medication|1
4721218|NCT02039674|16279821|P3|Overall Study|Excluded Medication|0
4721219|NCT02039674|16279822|P2|Overall Study|Excluded Medication|1
4721220|NCT02039674|16279823|P1|Overall Study|Excluded Medication|1
4721221|NCT02039674|16279810|P14|Overall Study|Death|8
4721222|NCT02039674|16279811|P13|Overall Study|Death|0
4721223|NCT02039674|16279812|P12|Overall Study|Death|1
4721224|NCT02039674|16279813|P11|Overall Study|Death|1
4721225|NCT02039674|16279814|P10|Overall Study|Death|0
4721226|NCT02039674|16279815|P9|Overall Study|Death|0
4721227|NCT02039674|16279816|P8|Overall Study|Death|0
4721228|NCT02039674|16279817|P7|Overall Study|Death|0
4721229|NCT02039674|16279818|P6|Overall Study|Death|0
4721230|NCT02039674|16279819|P5|Overall Study|Death|0
4721231|NCT02039674|16279820|P4|Overall Study|Death|2
4721232|NCT02039674|16279821|P3|Overall Study|Death|1
4721233|NCT02039674|16279822|P2|Overall Study|Death|0
4721234|NCT02039674|16279823|P1|Overall Study|Death|0
4721235|NCT02039674|16279810|P14|Overall Study|Adverse Event|1
4721236|NCT02039674|16279811|P13|Overall Study|Adverse Event|2
4721237|NCT02039674|16279812|P12|Overall Study|Adverse Event|2
4721238|NCT02039674|16279813|P11|Overall Study|Adverse Event|0
4721239|NCT02039674|16279814|P10|Overall Study|Adverse Event|0
4721240|NCT02039674|16279815|P9|Overall Study|Adverse Event|2
4721241|NCT02039674|16279816|P8|Overall Study|Adverse Event|0
4721242|NCT02039674|16279817|P7|Overall Study|Adverse Event|0
4721243|NCT02039674|16279818|P6|Overall Study|Adverse Event|0
4721244|NCT02039674|16279819|P5|Overall Study|Adverse Event|0
4721245|NCT02039674|16279820|P4|Overall Study|Adverse Event|1
4721246|NCT02039674|16279821|P3|Overall Study|Adverse Event|1
4721247|NCT02039674|16279822|P2|Overall Study|Adverse Event|0
4721248|NCT02039674|16279823|P1|Overall Study|Adverse Event|0
4721249|NCT02039505|16279865|P7|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1
4721250|NCT02039505|16279866|P6|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4721251|NCT02039505|16279867|P5|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4721252|NCT02039505|16279868|P4|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4721253|NCT02039505|16279869|P3|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4721254|NCT02039505|16279870|P2|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4721255|NCT02039505|16279871|P1|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0
4721256|NCT02039505|16279865|P7|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7
4721257|NCT02039505|16279866|P6|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4721258|NCT02039505|16279867|P5|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4721259|NCT02039505|16279868|P4|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4721260|NCT02039505|16279869|P3|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4721261|NCT02039505|16279870|P2|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4721262|NCT02039505|16279871|P1|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0
4721263|NCT02039505|16279865|P7|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19
4721264|NCT02039505|16279866|P6|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4721265|NCT02039505|16279867|P5|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4721266|NCT02039505|16279868|P4|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4721267|NCT02039505|16279869|P3|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4721268|NCT02039505|16279870|P2|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4721269|NCT02039505|16279871|P1|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0
4721270|NCT02039505|16279865|P7|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44
4721271|NCT02039505|16279866|P6|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4721272|NCT02039505|16279867|P5|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4721273|NCT02039505|16279868|P4|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4721274|NCT02039505|16279869|P3|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4721275|NCT02039505|16279870|P2|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4721276|NCT02039505|16279871|P1|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0
4721277|NCT02039505|16279865|P7|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4721278|NCT02039505|16279866|P6|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4721279|NCT02039505|16279867|P5|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4721280|NCT02039505|16279868|P4|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2
4721281|NCT02039505|16279869|P3|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4721282|NCT02039505|16279870|P2|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4721283|NCT02039505|16279871|P1|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0
4721284|NCT02039505|16279865|P7|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4721285|NCT02039505|16279866|P6|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1
4721286|NCT02039505|16279867|P5|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2
4721287|NCT02039505|16279868|P4|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3
4721288|NCT02039505|16279869|P3|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4721289|NCT02039505|16279870|P2|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4721290|NCT02039505|16279871|P1|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0
4721291|NCT02039505|16279865|P7|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4721292|NCT02039505|16279866|P6|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
4721293|NCT02039505|16279867|P5|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1
4721294|NCT02039505|16279868|P4|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6
4721295|NCT02039505|16279869|P3|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4721296|NCT02039505|16279870|P2|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4721297|NCT02039505|16279871|P1|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0
4721298|NCT02039505|16279865|P7|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4721299|NCT02039505|16279866|P6|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12
4721300|NCT02039505|16279867|P5|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8
4721301|NCT02039505|16279868|P4|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13
4721302|NCT02039505|16279869|P3|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4721303|NCT02039505|16279870|P2|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4721304|NCT02039505|16279871|P1|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0
4721305|NCT02039505|16279865|P7|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4721306|NCT02039505|16279866|P6|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4721307|NCT02039505|16279867|P5|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4721308|NCT02039505|16279868|P4|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4721309|NCT02039505|16279869|P3|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4721310|NCT02039505|16279870|P2|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0
4721311|NCT02039505|16279871|P1|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1
4721312|NCT02039505|16279865|P7|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4721313|NCT02039505|16279866|P6|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4721314|NCT02039505|16279867|P5|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4721315|NCT02039505|16279868|P4|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0
4721316|NCT02039505|16279869|P3|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3
4721317|NCT02039505|16279870|P2|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
4721318|NCT02039505|16279871|P1|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1
4721319|NCT02039505|16279865|P7|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4721320|NCT02039505|16279866|P6|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4721321|NCT02039505|16279867|P5|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4721322|NCT02039505|16279868|P4|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0
4721323|NCT02039505|16279869|P3|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7
4721324|NCT02039505|16279870|P2|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8
4721325|NCT02039505|16279871|P1|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2
4721326|NCT02039427|16279947|P4|Overall Study|Steroid Use|0
4721327|NCT02039427|16279948|P3|Overall Study|Steroid Use|0
4721328|NCT02039427|16279949|P2|Overall Study|Steroid Use|0
4721329|NCT02039427|16279950|P1|Overall Study|Steroid Use|1
4721330|NCT02039427|16279947|P4|Overall Study|Loss of follow - up|4
4721331|NCT02039427|16279948|P3|Overall Study|Loss of follow - up|2
4721332|NCT02039427|16279949|P2|Overall Study|Loss of follow - up|0
4721333|NCT02039427|16279950|P1|Overall Study|Loss of follow - up|1
4721334|NCT02039427|16279947|P4|Overall Study|Cancellation of surgery|0
4721335|NCT02039427|16279948|P3|Overall Study|Cancellation of surgery|1
4721336|NCT02039427|16279949|P2|Overall Study|Cancellation of surgery|0
4721337|NCT02039427|16279950|P1|Overall Study|Cancellation of surgery|0
4721338|NCT02039427|16279947|P4|Overall Study|Withdrawal on concent|1
4721339|NCT02039427|16279948|P3|Overall Study|Withdrawal on concent|0
4721340|NCT02039427|16279949|P2|Overall Study|Withdrawal on concent|0
4721341|NCT02039427|16279950|P1|Overall Study|Withdrawal on concent|0
4721342|NCT02039427|16279947|P4|Overall Study|Duration of surgery > 3h|0
4721343|NCT02039427|16279948|P3|Overall Study|Duration of surgery > 3h|0
4721344|NCT02039427|16279949|P2|Overall Study|Duration of surgery > 3h|1
4721345|NCT02039427|16279950|P1|Overall Study|Duration of surgery > 3h|1
4721346|NCT02039414|16279970|P2|Overall Study|Protocol Violation|1
4721347|NCT02039414|16279971|P1|Overall Study|Protocol Violation|3
4721348|NCT02039414|16279970|P2|Overall Study|Lost to Follow-up|0
4721349|NCT02039414|16279971|P1|Overall Study|Lost to Follow-up|2
4721350|NCT02039414|16279970|P2|Overall Study|Delivered|1
4721351|NCT02039414|16279971|P1|Overall Study|Delivered|1
4721352|NCT02039375|16279983|P1|Overall Study|Lost to Follow-up|2
4721353|NCT02039219|16279994|P2|Follow up|Adverse Event|1
4721354|NCT02039219|16279995|P1|Follow up|Adverse Event|0
4721355|NCT02039219|16279994|P2|Treatment|Death|0
4721356|NCT02039219|16279995|P1|Treatment|Death|1
4721357|NCT02039219|16279994|P2|Treatment|Protocol Violation|0
4721358|NCT02039219|16279995|P1|Treatment|Protocol Violation|1
4721359|NCT02039219|16279994|P2|Treatment|Lost to Follow-up|1
4721360|NCT02039219|16279995|P1|Treatment|Lost to Follow-up|0
4721361|NCT02039219|16279994|P2|Treatment|Physician Decision|0
4721362|NCT02039219|16279995|P1|Treatment|Physician Decision|1
4721363|NCT02039219|16279994|P2|Treatment|Adverse Event|1
4721364|NCT02039219|16279995|P1|Treatment|Adverse Event|0
4721365|NCT02039219|16279994|P2|Treatment|Withdrawal by Subject|0
4721366|NCT02039219|16279995|P1|Treatment|Withdrawal by Subject|1
4721367|NCT02038959|16280044|P2|Overall Study|Withdrawal by Subject|8
4721368|NCT02038959|16280045|P1|Overall Study|Withdrawal by Subject|6
4721369|NCT02038946|16280071|P1|Overall Study|Other reasons|1
4721370|NCT02038946|16280071|P1|Overall Study|Lost to Follow-up|2
4721371|NCT02038946|16280071|P1|Overall Study|Withdrawal by Subject|3
4721372|NCT02038946|16280071|P1|Overall Study|Death|5
4721373|NCT02038933|16280082|P1|Follow-up|Disease Progression|2
4721374|NCT02038933|16280082|P1|Follow-up|Withdrawal by Subject|1
4721375|NCT02038933|16280082|P1|Follow-up|Lost to Follow-up|1
4721376|NCT02038933|16280082|P1|Follow-up|Adverse event unrelated to study drug|4
4721377|NCT02038933|16280082|P1|Follow-up|Death|11
4721378|NCT02038933|16280082|P1|Treatment|Withdrawal by Subject|1
4721379|NCT02038933|16280082|P1|Treatment|Disease Progression|101
4721380|NCT02038933|16280082|P1|Treatment|Study Drug Toxicity|4
4721381|NCT02038933|16280082|P1|Treatment|Adverse Event Unrelated to Study Drug|6
4721382|NCT02038933|16280082|P1|Treatment|Lost to Follow-up|1
4721383|NCT02038933|16280082|P1|Treatment|No longer meets study criteria|1
4721384|NCT02038920|16280103|P6|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2
4721385|NCT02038920|16280104|P5|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4721386|NCT02038920|16280105|P4|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4721387|NCT02038920|16280106|P3|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4721388|NCT02038920|16280107|P2|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4721389|NCT02038920|16280108|P1|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0
4721390|NCT02038920|16280103|P6|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23
4721391|NCT02038920|16280104|P5|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4721392|NCT02038920|16280105|P4|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4721393|NCT02038920|16280106|P3|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4721394|NCT02038920|16280107|P2|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4721395|NCT02038920|16280108|P1|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0
4721396|NCT02038920|16280103|P6|Open Label Cohort (Week 10 to 154)|Pregnancy|1
4721397|NCT02038920|16280104|P5|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4721398|NCT02038920|16280105|P4|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4721399|NCT02038920|16280106|P3|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4721400|NCT02038920|16280107|P2|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4721401|NCT02038920|16280108|P1|Open Label Cohort (Week 10 to 154)|Pregnancy|0
4721402|NCT02038920|16280103|P6|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7
4721403|NCT02038920|16280104|P5|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4721404|NCT02038920|16280105|P4|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4721405|NCT02038920|16280106|P3|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4721406|NCT02038920|16280107|P2|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4721407|NCT02038920|16280108|P1|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0
4721408|NCT02038920|16280103|P6|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1
4721409|NCT02038920|16280104|P5|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4721410|NCT02038920|16280105|P4|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4721411|NCT02038920|16280106|P3|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4721412|NCT02038920|16280107|P2|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4721413|NCT02038920|16280108|P1|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0
4721414|NCT02038920|16280103|P6|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43
4721415|NCT02038920|16280104|P5|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4721416|NCT02038920|16280105|P4|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4721417|NCT02038920|16280106|P3|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4721418|NCT02038920|16280107|P2|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4721419|NCT02038920|16280108|P1|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0
4721420|NCT02038920|16280103|P6|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
4721421|NCT02038920|16280104|P5|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10
4721422|NCT02038920|16280105|P4|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4
4721423|NCT02038920|16280106|P3|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2
4721424|NCT02038920|16280107|P2|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
4721425|NCT02038920|16280108|P1|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0
4721426|NCT02038920|16280103|P6|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4721427|NCT02038920|16280104|P5|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4721428|NCT02038920|16280105|P4|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4721429|NCT02038920|16280106|P3|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1
4721430|NCT02038920|16280107|P2|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4721431|NCT02038920|16280108|P1|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0
4721432|NCT02038920|16280103|P6|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
4721433|NCT02038920|16280104|P5|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
4721434|NCT02038920|16280105|P4|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4
4721435|NCT02038920|16280106|P3|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2
4721436|NCT02038920|16280107|P2|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
4721437|NCT02038920|16280108|P1|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0
4721438|NCT02038920|16280103|P6|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4721439|NCT02038920|16280104|P5|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4721440|NCT02038920|16280105|P4|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4721441|NCT02038920|16280106|P3|Induction Phase (Week 0 to 14)|Lack of Efficacy|0
4721442|NCT02038920|16280107|P2|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
4721443|NCT02038920|16280108|P1|Induction Phase (Week 0 to 14)|Lack of Efficacy|1
4721444|NCT02038920|16280103|P6|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4721445|NCT02038920|16280104|P5|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4721446|NCT02038920|16280105|P4|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4721447|NCT02038920|16280106|P3|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4721448|NCT02038920|16280107|P2|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0
4721449|NCT02038920|16280108|P1|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2
4721450|NCT02038920|16280103|P6|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4721451|NCT02038920|16280104|P5|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4721452|NCT02038920|16280105|P4|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4721453|NCT02038920|16280106|P3|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0
4721454|NCT02038920|16280107|P2|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11
4721455|NCT02038920|16280108|P1|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3
4721456|NCT02038907|16280185|P14|Overall Study|Withdrawal by Subject|0
4721457|NCT02038907|16280186|P13|Overall Study|Withdrawal by Subject|0
4721458|NCT02038907|16280187|P12|Overall Study|Withdrawal by Subject|0
4721459|NCT02038907|16280188|P11|Overall Study|Withdrawal by Subject|1
4721460|NCT02038907|16280189|P10|Overall Study|Withdrawal by Subject|0
4721461|NCT02038907|16280190|P9|Overall Study|Withdrawal by Subject|0
4721462|NCT02038907|16280191|P8|Overall Study|Withdrawal by Subject|0
4721463|NCT02038907|16280192|P7|Overall Study|Withdrawal by Subject|0
4721464|NCT02038907|16280193|P6|Overall Study|Withdrawal by Subject|0
4721465|NCT02038907|16280194|P5|Overall Study|Withdrawal by Subject|0
4721466|NCT02038907|16280195|P4|Overall Study|Withdrawal by Subject|0
4721467|NCT02038907|16280196|P3|Overall Study|Withdrawal by Subject|0
4721468|NCT02038907|16280197|P2|Overall Study|Withdrawal by Subject|0
4721469|NCT02038907|16280198|P1|Overall Study|Withdrawal by Subject|0
4721470|NCT02038907|16280185|P14|Overall Study|Protocol Violation|0
4721471|NCT02038907|16280186|P13|Overall Study|Protocol Violation|0
4721472|NCT02038907|16280187|P12|Overall Study|Protocol Violation|0
4721473|NCT02038907|16280188|P11|Overall Study|Protocol Violation|1
4721474|NCT02038907|16280189|P10|Overall Study|Protocol Violation|0
4721475|NCT02038907|16280190|P9|Overall Study|Protocol Violation|0
4721476|NCT02038907|16280191|P8|Overall Study|Protocol Violation|0
4721477|NCT02038907|16280192|P7|Overall Study|Protocol Violation|0
4721478|NCT02038907|16280193|P6|Overall Study|Protocol Violation|0
4721479|NCT02038907|16280194|P5|Overall Study|Protocol Violation|0
4721480|NCT02038907|16280195|P4|Overall Study|Protocol Violation|0
4721481|NCT02038907|16280196|P3|Overall Study|Protocol Violation|0
4721482|NCT02038907|16280197|P2|Overall Study|Protocol Violation|0
4721483|NCT02038907|16280198|P1|Overall Study|Protocol Violation|0
4721484|NCT02038881|16280749|P3|Overall Study|incarcerated|0
4721485|NCT02038881|16280750|P2|Overall Study|incarcerated|0
4721486|NCT02038881|16280751|P1|Overall Study|incarcerated|1
4721487|NCT02038881|16280749|P3|Overall Study|Lost to Follow-up|0
4721488|NCT02038881|16280750|P2|Overall Study|Lost to Follow-up|0
4721489|NCT02038881|16280751|P1|Overall Study|Lost to Follow-up|2
4721490|NCT02038881|16280749|P3|Overall Study|Withdrawal by Subject|1
4721491|NCT02038881|16280750|P2|Overall Study|Withdrawal by Subject|0
4721492|NCT02038881|16280751|P1|Overall Study|Withdrawal by Subject|0
4721493|NCT02038829|16280824|P12|Treatment Period 6|Adverse Event|0
4721494|NCT02038829|16280825|P11|Treatment Period 6|Adverse Event|0
4721495|NCT02038829|16280826|P10|Treatment Period 6|Adverse Event|0
4721496|NCT02038829|16280827|P9|Treatment Period 6|Adverse Event|0
4721497|NCT02038829|16280828|P8|Treatment Period 6|Adverse Event|0
4721498|NCT02038829|16280829|P7|Treatment Period 6|Adverse Event|0
4721499|NCT02038829|16280830|P6|Treatment Period 6|Adverse Event|0
4721500|NCT02038829|16280831|P5|Treatment Period 6|Adverse Event|0
4721501|NCT02038829|16280832|P4|Treatment Period 6|Adverse Event|0
4721502|NCT02038829|16280833|P3|Treatment Period 6|Adverse Event|1
4721503|NCT02038829|16280834|P2|Treatment Period 6|Adverse Event|0
4721504|NCT02038829|16280835|P1|Treatment Period 6|Adverse Event|0
4721505|NCT02038829|16280824|P12|Washout Period 4|Adverse Event|0
4721506|NCT02038829|16280825|P11|Washout Period 4|Adverse Event|0
4721507|NCT02038829|16280826|P10|Washout Period 4|Adverse Event|0
4721508|NCT02038829|16280827|P9|Washout Period 4|Adverse Event|0
4721509|NCT02038829|16280828|P8|Washout Period 4|Adverse Event|0
4721510|NCT02038829|16280829|P7|Washout Period 4|Adverse Event|1
4721511|NCT02038829|16280830|P6|Washout Period 4|Adverse Event|0
4721512|NCT02038829|16280831|P5|Washout Period 4|Adverse Event|0
4721513|NCT02038829|16280832|P4|Washout Period 4|Adverse Event|0
4721514|NCT02038829|16280833|P3|Washout Period 4|Adverse Event|0
4721515|NCT02038829|16280834|P2|Washout Period 4|Adverse Event|0
4721516|NCT02038829|16280835|P1|Washout Period 4|Adverse Event|0
4721517|NCT02038829|16280824|P12|Treatment Period 4|Adverse Event|0
4721518|NCT02038829|16280825|P11|Treatment Period 4|Adverse Event|0
4721519|NCT02038829|16280826|P10|Treatment Period 4|Adverse Event|0
4721520|NCT02038829|16280827|P9|Treatment Period 4|Adverse Event|0
4721521|NCT02038829|16280828|P8|Treatment Period 4|Adverse Event|0
4721522|NCT02038829|16280829|P7|Treatment Period 4|Adverse Event|0
4721523|NCT02038829|16280830|P6|Treatment Period 4|Adverse Event|0
4721524|NCT02038829|16280831|P5|Treatment Period 4|Adverse Event|0
4721525|NCT02038829|16280832|P4|Treatment Period 4|Adverse Event|0
4721526|NCT02038829|16280833|P3|Treatment Period 4|Adverse Event|0
4721527|NCT02038829|16280834|P2|Treatment Period 4|Adverse Event|1
4721528|NCT02038829|16280835|P1|Treatment Period 4|Adverse Event|0
4721529|NCT02038829|16280824|P12|Washout Period 2|Withdrawal by Subject|0
4721530|NCT02038829|16280825|P11|Washout Period 2|Withdrawal by Subject|0
4721531|NCT02038829|16280826|P10|Washout Period 2|Withdrawal by Subject|0
4721532|NCT02038829|16280827|P9|Washout Period 2|Withdrawal by Subject|0
4721533|NCT02038829|16280828|P8|Washout Period 2|Withdrawal by Subject|0
4721534|NCT02038829|16280829|P7|Washout Period 2|Withdrawal by Subject|0
4721535|NCT02038829|16280830|P6|Washout Period 2|Withdrawal by Subject|1
4721536|NCT02038829|16280831|P5|Washout Period 2|Withdrawal by Subject|0
4721537|NCT02038829|16280832|P4|Washout Period 2|Withdrawal by Subject|0
4721538|NCT02038829|16280833|P3|Washout Period 2|Withdrawal by Subject|0
4721539|NCT02038829|16280834|P2|Washout Period 2|Withdrawal by Subject|0
4721540|NCT02038829|16280835|P1|Washout Period 2|Withdrawal by Subject|0
4721541|NCT02038829|16280824|P12|Washout Period 2|Adverse Event|0
4721542|NCT02038829|16280825|P11|Washout Period 2|Adverse Event|0
4721543|NCT02038829|16280826|P10|Washout Period 2|Adverse Event|0
4721544|NCT02038829|16280827|P9|Washout Period 2|Adverse Event|1
4721545|NCT02038829|16280828|P8|Washout Period 2|Adverse Event|0
4721546|NCT02038829|16280829|P7|Washout Period 2|Adverse Event|0
4721547|NCT02038829|16280830|P6|Washout Period 2|Adverse Event|0
4721548|NCT02038829|16280831|P5|Washout Period 2|Adverse Event|0
4721549|NCT02038829|16280832|P4|Washout Period 2|Adverse Event|0
4721550|NCT02038829|16280833|P3|Washout Period 2|Adverse Event|0
4721551|NCT02038829|16280834|P2|Washout Period 2|Adverse Event|0
4721552|NCT02038829|16280835|P1|Washout Period 2|Adverse Event|0
4721553|NCT02038829|16280824|P12|Treatment Period 2|Withdrawal by Subject|0
4721554|NCT02038829|16280825|P11|Treatment Period 2|Withdrawal by Subject|0
4721555|NCT02038829|16280826|P10|Treatment Period 2|Withdrawal by Subject|0
4721556|NCT02038829|16280827|P9|Treatment Period 2|Withdrawal by Subject|0
4721557|NCT02038829|16280828|P8|Treatment Period 2|Withdrawal by Subject|0
4721558|NCT02038829|16280829|P7|Treatment Period 2|Withdrawal by Subject|0
4721559|NCT02038829|16280830|P6|Treatment Period 2|Withdrawal by Subject|0
4721560|NCT02038829|16280831|P5|Treatment Period 2|Withdrawal by Subject|0
4721561|NCT02038829|16280832|P4|Treatment Period 2|Withdrawal by Subject|0
4721562|NCT02038829|16280833|P3|Treatment Period 2|Withdrawal by Subject|0
4721563|NCT02038829|16280834|P2|Treatment Period 2|Withdrawal by Subject|0
4721564|NCT02038829|16280835|P1|Treatment Period 2|Withdrawal by Subject|1
4721565|NCT02038829|16280824|P12|Treatment Period 2|Adverse Event|0
4721566|NCT02038829|16280825|P11|Treatment Period 2|Adverse Event|1
4721567|NCT02038829|16280826|P10|Treatment Period 2|Adverse Event|0
4721568|NCT02038829|16280827|P9|Treatment Period 2|Adverse Event|0
4721569|NCT02038829|16280828|P8|Treatment Period 2|Adverse Event|0
4721570|NCT02038829|16280829|P7|Treatment Period 2|Adverse Event|0
4721571|NCT02038829|16280830|P6|Treatment Period 2|Adverse Event|0
4721572|NCT02038829|16280831|P5|Treatment Period 2|Adverse Event|0
4721573|NCT02038829|16280832|P4|Treatment Period 2|Adverse Event|0
4721574|NCT02038829|16280833|P3|Treatment Period 2|Adverse Event|0
4721575|NCT02038829|16280834|P2|Treatment Period 2|Adverse Event|0
4721576|NCT02038829|16280835|P1|Treatment Period 2|Adverse Event|0
4721577|NCT02038829|16280824|P12|Washout Period 1|Death|0
4721578|NCT02038829|16280825|P11|Washout Period 1|Death|0
4721579|NCT02038829|16280826|P10|Washout Period 1|Death|0
4721580|NCT02038829|16280827|P9|Washout Period 1|Death|0
4721581|NCT02038829|16280828|P8|Washout Period 1|Death|0
4721582|NCT02038829|16280829|P7|Washout Period 1|Death|0
4721583|NCT02038829|16280830|P6|Washout Period 1|Death|0
4721584|NCT02038829|16280831|P5|Washout Period 1|Death|1
4721585|NCT02038829|16280832|P4|Washout Period 1|Death|0
4721586|NCT02038829|16280833|P3|Washout Period 1|Death|0
4721587|NCT02038829|16280834|P2|Washout Period 1|Death|0
4721588|NCT02038829|16280835|P1|Washout Period 1|Death|0
4721589|NCT02038790|16280869|P2|Day 0 - First Treatment|Withdrawal by Subject|1
4721590|NCT02038790|16280870|P1|Day 0 - First Treatment|Withdrawal by Subject|1
4721591|NCT02038764|16280906|P5|Overall Study|Other|0
4721592|NCT02038764|16280907|P4|Overall Study|Other|0
4721593|NCT02038764|16280908|P3|Overall Study|Other|1
4721594|NCT02038764|16280909|P2|Overall Study|Other|0
4721595|NCT02038764|16280910|P1|Overall Study|Other|1
4721596|NCT02038764|16280906|P5|Overall Study|Withdrawal by Subject|1
4721597|NCT02038764|16280907|P4|Overall Study|Withdrawal by Subject|0
4721598|NCT02038764|16280908|P3|Overall Study|Withdrawal by Subject|0
4721599|NCT02038764|16280909|P2|Overall Study|Withdrawal by Subject|0
4721600|NCT02038764|16280910|P1|Overall Study|Withdrawal by Subject|0
4721601|NCT02038764|16280906|P5|Overall Study|Lost to Follow-up|0
4721602|NCT02038764|16280907|P4|Overall Study|Lost to Follow-up|0
4721603|NCT02038764|16280908|P3|Overall Study|Lost to Follow-up|0
4721604|NCT02038764|16280909|P2|Overall Study|Lost to Follow-up|1
4721605|NCT02038764|16280910|P1|Overall Study|Lost to Follow-up|0
4721606|NCT02038764|16280906|P5|Overall Study|Adverse Event|0
4721607|NCT02038764|16280907|P4|Overall Study|Adverse Event|0
4721608|NCT02038764|16280908|P3|Overall Study|Adverse Event|1
4721609|NCT02038764|16280909|P2|Overall Study|Adverse Event|0
4721610|NCT02038764|16280910|P1|Overall Study|Adverse Event|0
4721611|NCT02038647|16281012|P2|Overall Study|Ongoing at Datacut|10
4721612|NCT02038647|16281013|P1|Overall Study|Ongoing at Datacut|9
4721613|NCT02038647|16281012|P2|Overall Study|Not Reported|1
4721614|NCT02038647|16281013|P1|Overall Study|Not Reported|0
4721615|NCT02038647|16281012|P2|Overall Study|Withdrawal by Subject|2
4721616|NCT02038647|16281013|P1|Overall Study|Withdrawal by Subject|5
4721617|NCT02038647|16281012|P2|Overall Study|Symptomatic Deterioration|7
4721618|NCT02038647|16281013|P1|Overall Study|Symptomatic Deterioration|7
4721619|NCT02038647|16281012|P2|Overall Study|Adverse Event|10
4721620|NCT02038647|16281013|P1|Overall Study|Adverse Event|18
4721621|NCT02038647|16281012|P2|Overall Study|Progressive Disease|59
4721622|NCT02038647|16281013|P1|Overall Study|Progressive Disease|50
4721623|NCT02038543|16281076|P4|Overall Study|Withdrawal by Subject|1
4721624|NCT02038543|16281077|P3|Overall Study|Withdrawal by Subject|0
4721625|NCT02038543|16281078|P2|Overall Study|Withdrawal by Subject|0
4721626|NCT02038543|16281079|P1|Overall Study|Withdrawal by Subject|0
4721627|NCT02038543|16281076|P4|Overall Study|Screen Failure|1
4721628|NCT02038543|16281077|P3|Overall Study|Screen Failure|0
4721629|NCT02038543|16281078|P2|Overall Study|Screen Failure|0
4721630|NCT02038543|16281079|P1|Overall Study|Screen Failure|0
4721631|NCT02038153|16281115|P1|Overall Study|Withdrawal by Subject|1
4721632|NCT02038075|16281122|P2|Overall Study|Withdrawal by Subject|0
4721633|NCT02038075|16281123|P1|Overall Study|Withdrawal by Subject|3
4721634|NCT02038049|16281131|P2|Overall Study|Lost to Follow-up|0
4721635|NCT02038049|16281132|P1|Overall Study|Lost to Follow-up|1
4721636|NCT02038010|16281161|P4|Follow Up|Other|0
4721637|NCT02038010|16281162|P3|Follow Up|Other|0
4721638|NCT02038010|16281163|P2|Follow Up|Other|0
4721639|NCT02038010|16281164|P1|Follow Up|Other|3
4721640|NCT02038010|16281161|P4|Follow Up|Death|0
4721641|NCT02038010|16281162|P3|Follow Up|Death|0
4721642|NCT02038010|16281163|P2|Follow Up|Death|3
4721643|NCT02038010|16281164|P1|Follow Up|Death|4
4721644|NCT02038010|16281161|P4|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
4721645|NCT02038010|16281162|P3|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0
4721646|NCT02038010|16281163|P2|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
4721647|NCT02038010|16281164|P1|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1
4721648|NCT02038010|16281161|P4|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
4721649|NCT02038010|16281162|P3|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
4721650|NCT02038010|16281163|P2|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1
4721651|NCT02038010|16281164|P1|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0
4721652|NCT02038010|16281161|P4|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
4721653|NCT02038010|16281162|P3|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
4721654|NCT02038010|16281163|P2|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0
4721655|NCT02038010|16281164|P1|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1
4721656|NCT02038010|16281161|P4|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
4721657|NCT02038010|16281162|P3|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
4721658|NCT02038010|16281163|P2|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1
4721659|NCT02038010|16281164|P1|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0
4721660|NCT02037984|16281191|P8|Overall Study|Withdrawal by Subject|1
4721661|NCT02037984|16281192|P7|Overall Study|Withdrawal by Subject|0
4721662|NCT02037984|16281193|P6|Overall Study|Withdrawal by Subject|3
4721663|NCT02037984|16281194|P5|Overall Study|Withdrawal by Subject|1
4721664|NCT02037984|16281195|P4|Overall Study|Withdrawal by Subject|1
4721665|NCT02037984|16281196|P3|Overall Study|Withdrawal by Subject|0
4721666|NCT02037984|16281197|P2|Overall Study|Withdrawal by Subject|0
4721667|NCT02037984|16281198|P1|Overall Study|Withdrawal by Subject|0
4721668|NCT02037984|16281191|P8|Overall Study|Withdrawal by Parent/Guardian|2
4721669|NCT02037984|16281192|P7|Overall Study|Withdrawal by Parent/Guardian|4
4721670|NCT02037984|16281193|P6|Overall Study|Withdrawal by Parent/Guardian|1
4721671|NCT02037984|16281194|P5|Overall Study|Withdrawal by Parent/Guardian|5
4721672|NCT02037984|16281195|P4|Overall Study|Withdrawal by Parent/Guardian|2
4721673|NCT02037984|16281196|P3|Overall Study|Withdrawal by Parent/Guardian|3
4721674|NCT02037984|16281197|P2|Overall Study|Withdrawal by Parent/Guardian|0
4721675|NCT02037984|16281198|P1|Overall Study|Withdrawal by Parent/Guardian|0
4721676|NCT02037984|16281191|P8|Overall Study|Technical Problems|2
4721677|NCT02037984|16281192|P7|Overall Study|Technical Problems|4
4721678|NCT02037984|16281193|P6|Overall Study|Technical Problems|3
4721679|NCT02037984|16281194|P5|Overall Study|Technical Problems|2
4721680|NCT02037984|16281195|P4|Overall Study|Technical Problems|3
4721681|NCT02037984|16281196|P3|Overall Study|Technical Problems|3
4721682|NCT02037984|16281197|P2|Overall Study|Technical Problems|0
4721683|NCT02037984|16281198|P1|Overall Study|Technical Problems|0
4721684|NCT02037984|16281191|P8|Overall Study|Protocol Violation|0
4721685|NCT02037984|16281192|P7|Overall Study|Protocol Violation|2
4721686|NCT02037984|16281193|P6|Overall Study|Protocol Violation|1
4721687|NCT02037984|16281194|P5|Overall Study|Protocol Violation|0
4721688|NCT02037984|16281195|P4|Overall Study|Protocol Violation|0
4721689|NCT02037984|16281196|P3|Overall Study|Protocol Violation|0
4721690|NCT02037984|16281197|P2|Overall Study|Protocol Violation|0
4721691|NCT02037984|16281198|P1|Overall Study|Protocol Violation|0
4721692|NCT02037984|16281191|P8|Overall Study|Physician Decision|0
4721693|NCT02037984|16281192|P7|Overall Study|Physician Decision|1
4721694|NCT02037984|16281193|P6|Overall Study|Physician Decision|0
4721695|NCT02037984|16281194|P5|Overall Study|Physician Decision|0
4721696|NCT02037984|16281195|P4|Overall Study|Physician Decision|0
4721697|NCT02037984|16281196|P3|Overall Study|Physician Decision|0
4721698|NCT02037984|16281197|P2|Overall Study|Physician Decision|0
4721699|NCT02037984|16281198|P1|Overall Study|Physician Decision|0
4721700|NCT02037984|16281191|P8|Overall Study|Lost to Follow-up|4
4721701|NCT02037984|16281192|P7|Overall Study|Lost to Follow-up|2
4721702|NCT02037984|16281193|P6|Overall Study|Lost to Follow-up|2
4721703|NCT02037984|16281194|P5|Overall Study|Lost to Follow-up|2
4721704|NCT02037984|16281195|P4|Overall Study|Lost to Follow-up|5
4721705|NCT02037984|16281196|P3|Overall Study|Lost to Follow-up|3
4721706|NCT02037984|16281197|P2|Overall Study|Lost to Follow-up|0
4721707|NCT02037984|16281198|P1|Overall Study|Lost to Follow-up|1
4721708|NCT02037984|16281191|P8|Overall Study|Lack of Efficacy|3
4721709|NCT02037984|16281192|P7|Overall Study|Lack of Efficacy|4
4721710|NCT02037984|16281193|P6|Overall Study|Lack of Efficacy|2
4721711|NCT02037984|16281194|P5|Overall Study|Lack of Efficacy|2
4721712|NCT02037984|16281195|P4|Overall Study|Lack of Efficacy|10
4721713|NCT02037984|16281196|P3|Overall Study|Lack of Efficacy|3
4721714|NCT02037984|16281197|P2|Overall Study|Lack of Efficacy|0
4721715|NCT02037984|16281198|P1|Overall Study|Lack of Efficacy|0
4721716|NCT02037568|16281343|P2|Overall Study|Patient did not receive transplant|1
4721717|NCT02037568|16281344|P1|Overall Study|Patient did not receive transplant|0
4721718|NCT02037568|16281343|P2|Overall Study|Screen Failure|1
4721719|NCT02037568|16281344|P1|Overall Study|Screen Failure|3
4721720|NCT02037568|16281343|P2|Overall Study|Lost to Follow-up|13
4721721|NCT02037568|16281344|P1|Overall Study|Lost to Follow-up|16
4721722|NCT02037568|16281343|P2|Overall Study|Withdrawal by Subject|24
4721723|NCT02037568|16281344|P1|Overall Study|Withdrawal by Subject|17
4721724|NCT02037477|16281379|P4|Treatment Period 1|Pre-treatment Event/Adverse Event|0
4721725|NCT02037477|16281380|P3|Treatment Period 1|Pre-treatment Event/Adverse Event|1
4721726|NCT02037477|16281381|P2|Treatment Period 1|Pre-treatment Event/Adverse Event|0
4721727|NCT02037477|16281382|P1|Treatment Period 1|Pre-treatment Event/Adverse Event|0
4721728|NCT02037295|16281477|P4|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
4721729|NCT02037295|16281478|P3|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
4721730|NCT02037295|16281479|P2|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0
4721731|NCT02037295|16281480|P1|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1
4721732|NCT02037165|16281536|P5|Washout Period 4 (6 Days)|Withdrawal by Subject|1
4721733|NCT02037165|16281537|P4|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4721734|NCT02037165|16281538|P3|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4721735|NCT02037165|16281539|P2|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4721736|NCT02037165|16281540|P1|Washout Period 4 (6 Days)|Withdrawal by Subject|0
4721737|NCT02036775|16281600|P6|Treatment Period 2 (6 Days)|Withdrawal by Subject|1
4721738|NCT02036775|16281601|P5|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4721739|NCT02036775|16281602|P4|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4721740|NCT02036775|16281603|P3|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4721741|NCT02036775|16281604|P2|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4721742|NCT02036775|16281605|P1|Treatment Period 2 (6 Days)|Withdrawal by Subject|0
4721743|NCT02036645|16281655|P12|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721744|NCT02036645|16281656|P11|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721745|NCT02036645|16281657|P10|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721746|NCT02036645|16281658|P9|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721747|NCT02036645|16281659|P8|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721748|NCT02036645|16281660|P7|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721749|NCT02036645|16281661|P6|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721750|NCT02036645|16281662|P5|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721751|NCT02036645|16281663|P4|SAD Cohorts : Study Part 1|Withdrawal by Subject|1
4721752|NCT02036645|16281664|P3|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721753|NCT02036645|16281665|P2|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721754|NCT02036645|16281666|P1|SAD Cohorts : Study Part 1|Withdrawal by Subject|0
4721755|NCT02036645|16281655|P12|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721756|NCT02036645|16281656|P11|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721757|NCT02036645|16281657|P10|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721758|NCT02036645|16281658|P9|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721759|NCT02036645|16281659|P8|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721760|NCT02036645|16281660|P7|SAD Cohorts : Study Part 1|Lost to Follow-up|1
4721761|NCT02036645|16281661|P6|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721762|NCT02036645|16281662|P5|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721763|NCT02036645|16281663|P4|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721764|NCT02036645|16281664|P3|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721765|NCT02036645|16281665|P2|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721766|NCT02036645|16281666|P1|SAD Cohorts : Study Part 1|Lost to Follow-up|0
4721767|NCT02036580|16281771|P3|Overall Study|Adverse Event|0
4721768|NCT02036580|16281772|P2|Overall Study|Adverse Event|0
4721769|NCT02036580|16281773|P1|Overall Study|Adverse Event|1
4721770|NCT02036580|16281771|P3|Overall Study|Withdrawal by Subject|0
4721771|NCT02036580|16281772|P2|Overall Study|Withdrawal by Subject|1
4721772|NCT02036580|16281773|P1|Overall Study|Withdrawal by Subject|0
4721773|NCT02036515|16281794|P3|Overall Study|Hyperglycemia|1
4721774|NCT02036515|16281795|P2|Overall Study|Hyperglycemia|0
4721775|NCT02036515|16281796|P1|Overall Study|Hyperglycemia|0
4721776|NCT02036515|16281794|P3|Overall Study|Withdrawal by Subject|9
4721777|NCT02036515|16281795|P2|Overall Study|Withdrawal by Subject|7
4721778|NCT02036515|16281796|P1|Overall Study|Withdrawal by Subject|4
4721779|NCT02036515|16281794|P3|Overall Study|Screen failure|0
4721780|NCT02036515|16281795|P2|Overall Study|Screen failure|2
4721781|NCT02036515|16281796|P1|Overall Study|Screen failure|0
4721782|NCT02036515|16281794|P3|Overall Study|Non-compliance with study drug|2
4721783|NCT02036515|16281795|P2|Overall Study|Non-compliance with study drug|0
4721784|NCT02036515|16281796|P1|Overall Study|Non-compliance with study drug|0
4721785|NCT02036515|16281794|P3|Overall Study|Lost to Follow-up|0
4721786|NCT02036515|16281795|P2|Overall Study|Lost to Follow-up|2
4721787|NCT02036515|16281796|P1|Overall Study|Lost to Follow-up|0
4721788|NCT02036515|16281794|P3|Overall Study|Adverse Event|2
4721789|NCT02036515|16281795|P2|Overall Study|Adverse Event|1
4721790|NCT02036515|16281796|P1|Overall Study|Adverse Event|1
4721791|NCT02036294|16281897|P2|Overall Study|Withdrawal by Subject|3
4721792|NCT02036294|16281898|P1|Overall Study|Withdrawal by Subject|2
4721793|NCT02036294|16281897|P2|Overall Study|Death|8
4721794|NCT02036294|16281898|P1|Overall Study|Death|7
4721795|NCT02035748|16281914|P1|Overall Study|Progressive Disease|1
4721796|NCT02035748|16281914|P1|Overall Study|Withdrawal by Subject|6
4721797|NCT02035748|16281914|P1|Overall Study|Physician Decision|3
4721798|NCT02035748|16281914|P1|Overall Study|Lost to Follow-up|2
4721799|NCT02035748|16281914|P1|Overall Study|Death|3
4721800|NCT02035748|16281914|P1|Overall Study|Adverse Event|5
4721801|NCT02035696|16281928|P4|Overall Study|Withdrawal by Subject|1
4721802|NCT02035696|16281929|P3|Overall Study|Withdrawal by Subject|2
4721803|NCT02035696|16281930|P2|Overall Study|Withdrawal by Subject|0
4721804|NCT02035696|16281931|P1|Overall Study|Withdrawal by Subject|3
4721805|NCT02035696|16281928|P4|Overall Study|Lost to Follow-up|2
4721806|NCT02035696|16281929|P3|Overall Study|Lost to Follow-up|1
4721807|NCT02035696|16281930|P2|Overall Study|Lost to Follow-up|3
4721808|NCT02035696|16281931|P1|Overall Study|Lost to Follow-up|0
4721809|NCT02035553|16281987|P2|Overall Study|Other Reason|4
4721810|NCT02035553|16281988|P1|Overall Study|Other Reason|0
4721811|NCT02035553|16281987|P2|Overall Study|Lost to Follow-up|1
4721812|NCT02035553|16281988|P1|Overall Study|Lost to Follow-up|0
4721813|NCT02035553|16281987|P2|Overall Study|Non-compliance with Study Drug|1
4721814|NCT02035553|16281988|P1|Overall Study|Non-compliance with Study Drug|0
4721815|NCT02035553|16281987|P2|Overall Study|Withdrawal by Subject|7
4721816|NCT02035553|16281988|P1|Overall Study|Withdrawal by Subject|4
4721817|NCT02035553|16281987|P2|Overall Study|Lack of Efficacy|1
4721818|NCT02035553|16281988|P1|Overall Study|Lack of Efficacy|1
4721819|NCT02035553|16281987|P2|Overall Study|Physician Decision|2
4721820|NCT02035553|16281988|P1|Overall Study|Physician Decision|3
4721821|NCT02035553|16281987|P2|Overall Study|Adverse Event|6
4721822|NCT02035553|16281988|P1|Overall Study|Adverse Event|10
4721823|NCT02035553|16281987|P2|Overall Study|Death (See All-Cause Mortality Table)|1
4721824|NCT02035553|16281988|P1|Overall Study|Death (See All-Cause Mortality Table)|0
4721825|NCT02035475|16281994|P1|Overall Study|Equipment Error|1
4721826|NCT02035475|16281994|P1|Overall Study|Physician Decision|1
4721827|NCT02035475|16281994|P1|Overall Study|Withdrawal by Subject|4
4721828|NCT02035332|16282005|P1|Overall Study|Procedure Aborted due to Uterine Width|1
4721829|NCT02035267|16282015|P4|Overall Study|Other unspecified|0
4721830|NCT02035267|16282016|P3|Overall Study|Other unspecified|0
4721831|NCT02035267|16282017|P2|Overall Study|Other unspecified|1
4721832|NCT02035267|16282018|P1|Overall Study|Other unspecified|0
4721833|NCT02035267|16282015|P4|Overall Study|Lost to Follow-up|1
4721834|NCT02035267|16282016|P3|Overall Study|Lost to Follow-up|0
4721835|NCT02035267|16282017|P2|Overall Study|Lost to Follow-up|0
4721836|NCT02035267|16282018|P1|Overall Study|Lost to Follow-up|0
4721837|NCT02035267|16282015|P4|Overall Study|Adverse Event|0
4721838|NCT02035267|16282016|P3|Overall Study|Adverse Event|1
4721839|NCT02035267|16282017|P2|Overall Study|Adverse Event|0
4721840|NCT02035267|16282018|P1|Overall Study|Adverse Event|0
4721841|NCT02035267|16282015|P4|Overall Study|Withdrawal consent-subject convenience|0
4721842|NCT02035267|16282016|P3|Overall Study|Withdrawal consent-subject convenience|1
4721843|NCT02035267|16282017|P2|Overall Study|Withdrawal consent-subject convenience|0
4721844|NCT02035267|16282018|P1|Overall Study|Withdrawal consent-subject convenience|0
4721845|NCT02035202|16282049|P3|Overall Study|Lost to Follow-up|2
4721846|NCT02035202|16282050|P2|Overall Study|Lost to Follow-up|16
4721847|NCT02035202|16282051|P1|Overall Study|Lost to Follow-up|8
4721848|NCT02034916|16282067|P2|Overall Study|Study terminated by sponsor|5
4721849|NCT02034916|16282068|P1|Overall Study|Study terminated by sponsor|4
4721850|NCT02034916|16282067|P2|Overall Study|Lost to Follow-up|1
4721851|NCT02034916|16282068|P1|Overall Study|Lost to Follow-up|4
4721852|NCT02034916|16282067|P2|Overall Study|Withdrawal by Subject|1
4721853|NCT02034916|16282068|P1|Overall Study|Withdrawal by Subject|2
4721854|NCT02034916|16282067|P2|Overall Study|Death|28
4721855|NCT02034916|16282068|P1|Overall Study|Death|39
4721856|NCT02034877|16282105|P2|Overall Study|No Longer Willing to Participate|3
4721857|NCT02034877|16282106|P1|Overall Study|No Longer Willing to Participate|0
4721858|NCT02034877|16282105|P2|Overall Study|Lost to Follow-up|3
4721859|NCT02034877|16282106|P1|Overall Study|Lost to Follow-up|0
4721860|NCT02034799|16282124|P2|Overall Study|Death|1
4721861|NCT02034799|16282125|P1|Overall Study|Death|2
4721862|NCT02034799|16282124|P2|Overall Study|Lost to Follow-up|1
4721863|NCT02034799|16282125|P1|Overall Study|Lost to Follow-up|0
4721864|NCT02034799|16282124|P2|Overall Study|Withdrawal by Subject|2
4721865|NCT02034799|16282125|P1|Overall Study|Withdrawal by Subject|0
4721866|NCT02034708|16282139|P2|Wash-out (From 2 Days up to 14 Days)|other reason|2
4721867|NCT02034708|16282140|P1|Wash-out (From 2 Days up to 14 Days)|other reason|3
4721868|NCT02034708|16282139|P2|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
4721869|NCT02034708|16282140|P1|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3
4721870|NCT02034708|16282139|P2|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0
4721871|NCT02034708|16282140|P1|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1
4721872|NCT02034708|16282139|P2|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5
4721873|NCT02034708|16282140|P1|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2
4721874|NCT02034591|16282151|P6|Overall Study|Withdrawal by Subject|0
4721875|NCT02034591|16282152|P5|Overall Study|Withdrawal by Subject|1
4721876|NCT02034591|16282153|P4|Overall Study|Withdrawal by Subject|0
4721877|NCT02034591|16282154|P3|Overall Study|Withdrawal by Subject|0
4721878|NCT02034591|16282155|P2|Overall Study|Withdrawal by Subject|0
4721879|NCT02034591|16282156|P1|Overall Study|Withdrawal by Subject|0
4721880|NCT02034565|16282211|P2|Overall Study|Adverse Event|0
4721881|NCT02034565|16282212|P1|Overall Study|Adverse Event|1
4721882|NCT02034552|16282229|P3|Overall Study|Clinical progression|9
4721883|NCT02034552|16282230|P2|Overall Study|Clinical progression|7
4721884|NCT02034552|16282231|P1|Overall Study|Clinical progression|5
4721885|NCT02034552|16282229|P3|Overall Study|Non-compliance with study drug|1
4721886|NCT02034552|16282230|P2|Overall Study|Non-compliance with study drug|0
4721887|NCT02034552|16282231|P1|Overall Study|Non-compliance with study drug|0
4721888|NCT02034552|16282229|P3|Overall Study|Withdrawal by Subject|1
4721889|NCT02034552|16282230|P2|Overall Study|Withdrawal by Subject|1
4721890|NCT02034552|16282231|P1|Overall Study|Withdrawal by Subject|2
4721891|NCT02034552|16282229|P3|Overall Study|AE associated with disease progression|0
4721892|NCT02034552|16282230|P2|Overall Study|AE associated with disease progression|1
4721893|NCT02034552|16282231|P1|Overall Study|AE associated with disease progression|0
4721894|NCT02034552|16282229|P3|Overall Study|AE not assoc. with disease progression|2
4721895|NCT02034552|16282230|P2|Overall Study|AE not assoc. with disease progression|4
4721896|NCT02034552|16282231|P1|Overall Study|AE not assoc. with disease progression|1
4721897|NCT02034552|16282229|P3|Overall Study|Radiological progression|4
4721898|NCT02034552|16282230|P2|Overall Study|Radiological progression|5
4721899|NCT02034552|16282231|P1|Overall Study|Radiological progression|3
4721900|NCT02034552|16282229|P3|Overall Study|Never treated|0
4721901|NCT02034552|16282230|P2|Overall Study|Never treated|2
4721902|NCT02034552|16282231|P1|Overall Study|Never treated|3
4721903|NCT02034513|16282262|P2|Overall Study|Unclassified|1
4721904|NCT02034513|16282263|P1|Overall Study|Unclassified|0
4721905|NCT02034513|16282262|P2|Overall Study|Withdrawal by Subject|25
4721906|NCT02034513|16282263|P1|Overall Study|Withdrawal by Subject|25
4721907|NCT02034513|16282262|P2|Overall Study|Protocol Violation|10
4721908|NCT02034513|16282263|P1|Overall Study|Protocol Violation|7
4721909|NCT02034513|16282262|P2|Overall Study|Pregnancy|3
4721910|NCT02034513|16282263|P1|Overall Study|Pregnancy|0
4721911|NCT02034513|16282262|P2|Overall Study|Lost to Follow-up|7
4721912|NCT02034513|16282263|P1|Overall Study|Lost to Follow-up|6
4721913|NCT02034513|16282262|P2|Overall Study|Lack of Efficacy|1
4721914|NCT02034513|16282263|P1|Overall Study|Lack of Efficacy|0
4721915|NCT02034513|16282262|P2|Overall Study|Adverse Event|10
4721916|NCT02034513|16282263|P1|Overall Study|Adverse Event|11
4721917|NCT02034474|16282281|P2|Overall Study|Withdrawal by Subject|2
4721918|NCT02034474|16282282|P1|Overall Study|Withdrawal by Subject|1
4721919|NCT02034474|16282281|P2|Overall Study|Adverse Event|2
4721920|NCT02034474|16282282|P1|Overall Study|Adverse Event|3
4721921|NCT02034162|16282298|P3|Double-blind|Withdrawal by Subject|0
4721922|NCT02034162|16282299|P2|Double-blind|Withdrawal by Subject|7
4721923|NCT02034162|16282300|P1|Double-blind|Withdrawal by Subject|5
4721924|NCT02034162|16282298|P3|Double-blind|Protocol Violation|0
4721925|NCT02034162|16282299|P2|Double-blind|Protocol Violation|1
4721926|NCT02034162|16282300|P1|Double-blind|Protocol Violation|0
4721927|NCT02034162|16282298|P3|Double-blind|Physician Decision|0
4721928|NCT02034162|16282299|P2|Double-blind|Physician Decision|0
4721929|NCT02034162|16282300|P1|Double-blind|Physician Decision|1
4721930|NCT02034162|16282298|P3|Double-blind|Lost to Follow-up|0
4721931|NCT02034162|16282299|P2|Double-blind|Lost to Follow-up|0
4721932|NCT02034162|16282300|P1|Double-blind|Lost to Follow-up|3
4721933|NCT02034123|16282346|P18|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721934|NCT02034123|16282347|P17|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721935|NCT02034123|16282348|P16|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721936|NCT02034123|16282349|P15|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721937|NCT02034123|16282350|P14|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721938|NCT02034123|16282351|P13|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721939|NCT02034123|16282352|P12|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721940|NCT02034123|16282353|P11|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721941|NCT02034123|16282354|P10|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721942|NCT02034123|16282355|P9|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721943|NCT02034123|16282356|P8|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721944|NCT02034123|16282357|P7|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721945|NCT02034123|16282358|P6|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721946|NCT02034123|16282359|P5|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
4721947|NCT02034123|16282360|P4|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1
4721948|NCT02034123|16282361|P3|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721949|NCT02034123|16282362|P2|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721950|NCT02034123|16282363|P1|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0
4721951|NCT02034123|16282346|P18|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721952|NCT02034123|16282347|P17|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721953|NCT02034123|16282348|P16|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721954|NCT02034123|16282349|P15|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721955|NCT02034123|16282350|P14|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721956|NCT02034123|16282351|P13|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721957|NCT02034123|16282352|P12|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721958|NCT02034123|16282353|P11|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721959|NCT02034123|16282354|P10|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721960|NCT02034123|16282355|P9|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1
4721961|NCT02034123|16282356|P8|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721962|NCT02034123|16282357|P7|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721963|NCT02034123|16282358|P6|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721964|NCT02034123|16282359|P5|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721965|NCT02034123|16282360|P4|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721966|NCT02034123|16282361|P3|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721967|NCT02034123|16282362|P2|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721968|NCT02034123|16282363|P1|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0
4721969|NCT02034123|16282346|P18|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721970|NCT02034123|16282347|P17|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721971|NCT02034123|16282348|P16|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721972|NCT02034123|16282349|P15|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721973|NCT02034123|16282350|P14|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721974|NCT02034123|16282351|P13|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721975|NCT02034123|16282352|P12|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721976|NCT02034123|16282353|P11|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721977|NCT02034123|16282354|P10|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721978|NCT02034123|16282355|P9|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721979|NCT02034123|16282356|P8|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721980|NCT02034123|16282357|P7|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721981|NCT02034123|16282358|P6|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721982|NCT02034123|16282359|P5|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721983|NCT02034123|16282360|P4|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1
4721984|NCT02034123|16282361|P3|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721985|NCT02034123|16282362|P2|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721986|NCT02034123|16282363|P1|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0
4721987|NCT02034123|16282346|P18|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721988|NCT02034123|16282347|P17|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721989|NCT02034123|16282348|P16|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721990|NCT02034123|16282349|P15|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721991|NCT02034123|16282350|P14|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721992|NCT02034123|16282351|P13|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721993|NCT02034123|16282352|P12|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721994|NCT02034123|16282353|P11|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721995|NCT02034123|16282354|P10|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721996|NCT02034123|16282355|P9|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
4721997|NCT02034123|16282356|P8|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
4721998|NCT02034123|16282357|P7|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4721999|NCT02034123|16282358|P6|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4722000|NCT02034123|16282359|P5|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1
4722001|NCT02034123|16282360|P4|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4722002|NCT02034123|16282361|P3|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4722003|NCT02034123|16282362|P2|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4722004|NCT02034123|16282363|P1|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0
4722005|NCT02034058|16282682|P1|Overall Study|Death|3
4722006|NCT02034006|16282703|P1|Overall Study|Pregnancy|1
4722007|NCT02034006|16282703|P1|Overall Study|Death|1
4722008|NCT02034006|16282703|P1|Overall Study|Lost to Follow-up|5
4722009|NCT02034006|16282703|P1|Overall Study|Withdrawal by Subject|7
4722010|NCT02033889|16282754|P3|Overall Study|Withdrawal by Subject|13
4722011|NCT02033889|16282755|P2|Overall Study|Withdrawal by Subject|10
4722012|NCT02033889|16282756|P1|Overall Study|Withdrawal by Subject|18
4722013|NCT02033889|16282754|P3|Overall Study|Participant moved|0
4722014|NCT02033889|16282755|P2|Overall Study|Participant moved|1
4722015|NCT02033889|16282756|P1|Overall Study|Participant moved|0
4722016|NCT02033889|16282754|P3|Overall Study|Physician Decision|1
4722017|NCT02033889|16282755|P2|Overall Study|Physician Decision|1
4722018|NCT02033889|16282756|P1|Overall Study|Physician Decision|0
4722019|NCT02033889|16282754|P3|Overall Study|Non-Compliance With Study Drug|0
4722020|NCT02033889|16282755|P2|Overall Study|Non-Compliance With Study Drug|0
4722021|NCT02033889|16282756|P1|Overall Study|Non-Compliance With Study Drug|1
4722022|NCT02033889|16282754|P3|Overall Study|Lost to Follow-up|6
4722023|NCT02033889|16282755|P2|Overall Study|Lost to Follow-up|5
4722024|NCT02033889|16282756|P1|Overall Study|Lost to Follow-up|8
4722025|NCT02033889|16282754|P3|Overall Study|Excluded Medication|0
4722026|NCT02033889|16282755|P2|Overall Study|Excluded Medication|1
4722027|NCT02033889|16282756|P1|Overall Study|Excluded Medication|1
4722028|NCT02033889|16282754|P3|Overall Study|Death|2
4722029|NCT02033889|16282755|P2|Overall Study|Death|1
4722030|NCT02033889|16282756|P1|Overall Study|Death|3
4722031|NCT02033889|16282754|P3|Overall Study|Adverse Event|3
4722032|NCT02033889|16282755|P2|Overall Study|Adverse Event|1
4722033|NCT02033889|16282756|P1|Overall Study|Adverse Event|3
4722034|NCT02033850|16282933|P2|Overall Study|unrelated medical reason|1
4722035|NCT02033850|16282934|P1|Overall Study|unrelated medical reason|1
4722036|NCT02033850|16282933|P2|Overall Study|Death|0
4722037|NCT02033850|16282934|P1|Overall Study|Death|1
4722038|NCT02033759|16282958|P2|Overall Study|Protocol Violation|1
4722039|NCT02033759|16282959|P1|Overall Study|Protocol Violation|1
4722040|NCT02033759|16282958|P2|Overall Study|Withdrawal by Subject|1
4722041|NCT02033759|16282959|P1|Overall Study|Withdrawal by Subject|2
4722042|NCT02033369|16283019|P2|Overall Study|Protocol Violation|0
4722043|NCT02033369|16283020|P1|Overall Study|Protocol Violation|2
4722044|NCT02033369|16283019|P2|Overall Study|Lost to Follow-up|0
4722045|NCT02033369|16283020|P1|Overall Study|Lost to Follow-up|1
4722046|NCT02033369|16283019|P2|Overall Study|Withdrawal by Subject|1
4722047|NCT02033369|16283020|P1|Overall Study|Withdrawal by Subject|1
4722048|NCT02033369|16283019|P2|Overall Study|Not a good demographic match|2
4722049|NCT02033369|16283020|P1|Overall Study|Not a good demographic match|0
4722050|NCT02033369|16283019|P2|Overall Study|Physician Decision|2
4722051|NCT02033369|16283020|P1|Overall Study|Physician Decision|1
4722052|NCT02032901|16283114|P2|Follow-Up Period (24 Weeks)|Lost to Follow-up|1
4722053|NCT02032901|16283115|P1|Follow-Up Period (24 Weeks)|Lost to Follow-up|0
4722054|NCT02032901|16283114|P2|Treatment Period (12 Weeks)|Pregnancy|0
4722055|NCT02032901|16283115|P1|Treatment Period (12 Weeks)|Pregnancy|1
4722056|NCT02032888|16283139|P3|Follow-up Period|Other|0
4722057|NCT02032888|16283140|P2|Follow-up Period|Other|0
4722058|NCT02032888|16283141|P1|Follow-up Period|Other|1
4722059|NCT02032888|16283139|P3|Follow-up Period|Death|0
4722060|NCT02032888|16283140|P2|Follow-up Period|Death|1
4722061|NCT02032888|16283141|P1|Follow-up Period|Death|1
4722062|NCT02032888|16283139|P3|Follow-up Period|Lost to Follow-up|0
4722063|NCT02032888|16283140|P2|Follow-up Period|Lost to Follow-up|1
4722064|NCT02032888|16283141|P1|Follow-up Period|Lost to Follow-up|1
4722065|NCT02032888|16283139|P3|Treatment Period|Other|0
4722066|NCT02032888|16283140|P2|Treatment Period|Other|1
4722067|NCT02032888|16283141|P1|Treatment Period|Other|1
4722068|NCT02032888|16283139|P3|Treatment Period|Poor compliance/noncompliance|0
4722069|NCT02032888|16283140|P2|Treatment Period|Poor compliance/noncompliance|1
4722070|NCT02032888|16283141|P1|Treatment Period|Poor compliance/noncompliance|1
4722071|NCT02032875|16283172|P2|Follow-up Period|Virologic Relapse|10
4722072|NCT02032875|16283173|P1|Follow-up Period|Virologic Relapse|3
4722073|NCT02032875|16283172|P2|Follow-up Period|Death|1
4722074|NCT02032875|16283173|P1|Follow-up Period|Death|0
4722075|NCT02032875|16283172|P2|Treatment Period|Liver transplant, Treatment extension|3
4722076|NCT02032875|16283173|P1|Treatment Period|Liver transplant, Treatment extension|0
4722077|NCT02032875|16283172|P2|Treatment Period|Liver transplant, No extension needed|1
4722078|NCT02032875|16283173|P1|Treatment Period|Liver transplant, No extension needed|0
4722079|NCT02032875|16283172|P2|Treatment Period|Adverse Event|0
4722080|NCT02032875|16283173|P1|Treatment Period|Adverse Event|1
4722081|NCT02032706|16283216|P1|Overall Study|Protocol Violation|1
4722082|NCT02032706|16283216|P1|Overall Study|Did not qualify|5
4722083|NCT02032407|16283399|P1|Overall Study|Other Miscellaneous Reasons|2
4722084|NCT02032407|16283399|P1|Overall Study|Pregnancy|1
4722085|NCT02032407|16283399|P1|Overall Study|Lost to Follow-up|2
4722086|NCT02032238|16283412|P2|Overall Study|Lost to Follow-up|0
4722087|NCT02032238|16283413|P1|Overall Study|Lost to Follow-up|2
4722088|NCT02032173|16283452|P1|Overall Study|Discontinuation due to sponsor decision|31
4722089|NCT02031679|16283474|P2|Overall Study|Lack of Efficacy|1
4722090|NCT02031679|16283475|P1|Overall Study|Lack of Efficacy|0
4722091|NCT02031679|16283474|P2|Overall Study|Protocol Violation|1
4722092|NCT02031679|16283475|P1|Overall Study|Protocol Violation|0
4722093|NCT02031640|16283490|P6|Double-blind Treatment Period|Lost to Follow-up|0
4722094|NCT02031640|16283491|P5|Double-blind Treatment Period|Lost to Follow-up|1
4722095|NCT02031640|16283492|P4|Double-blind Treatment Period|Lost to Follow-up|0
4722096|NCT02031640|16283493|P3|Double-blind Treatment Period|Lost to Follow-up|0
4722097|NCT02031640|16283494|P2|Double-blind Treatment Period|Lost to Follow-up|3
4722098|NCT02031640|16283495|P1|Double-blind Treatment Period|Lost to Follow-up|0
4722099|NCT02031640|16283490|P6|Double-blind Treatment Period|Withdrawal by Subject|1
4722100|NCT02031640|16283491|P5|Double-blind Treatment Period|Withdrawal by Subject|1
4722101|NCT02031640|16283492|P4|Double-blind Treatment Period|Withdrawal by Subject|1
4722102|NCT02031640|16283493|P3|Double-blind Treatment Period|Withdrawal by Subject|3
4722103|NCT02031640|16283494|P2|Double-blind Treatment Period|Withdrawal by Subject|2
4722104|NCT02031640|16283495|P1|Double-blind Treatment Period|Withdrawal by Subject|0
4722105|NCT02031640|16283490|P6|Double-blind Treatment Period|Adverse Event|0
4722106|NCT02031640|16283491|P5|Double-blind Treatment Period|Adverse Event|0
4722107|NCT02031640|16283492|P4|Double-blind Treatment Period|Adverse Event|2
4722108|NCT02031640|16283493|P3|Double-blind Treatment Period|Adverse Event|0
4722109|NCT02031640|16283494|P2|Double-blind Treatment Period|Adverse Event|0
4722110|NCT02031640|16283495|P1|Double-blind Treatment Period|Adverse Event|0
4722111|NCT02031640|16283490|P6|Double-blind Treatment Period|Non-compliance|0
4722112|NCT02031640|16283491|P5|Double-blind Treatment Period|Non-compliance|1
4722113|NCT02031640|16283492|P4|Double-blind Treatment Period|Non-compliance|1
4722114|NCT02031640|16283493|P3|Double-blind Treatment Period|Non-compliance|0
4722115|NCT02031640|16283494|P2|Double-blind Treatment Period|Non-compliance|1
4722116|NCT02031640|16283495|P1|Double-blind Treatment Period|Non-compliance|0
4722117|NCT02031640|16283490|P6|Double-blind Treatment Period|Lack of Efficacy|1
4722118|NCT02031640|16283491|P5|Double-blind Treatment Period|Lack of Efficacy|5
4722119|NCT02031640|16283492|P4|Double-blind Treatment Period|Lack of Efficacy|2
4722120|NCT02031640|16283493|P3|Double-blind Treatment Period|Lack of Efficacy|3
4722121|NCT02031640|16283494|P2|Double-blind Treatment Period|Lack of Efficacy|14
4722122|NCT02031640|16283495|P1|Double-blind Treatment Period|Lack of Efficacy|0
4722123|NCT02031640|16283490|P6|Double-blind Treatment Period|Protocol deviation|1
4722124|NCT02031640|16283491|P5|Double-blind Treatment Period|Protocol deviation|3
4722125|NCT02031640|16283492|P4|Double-blind Treatment Period|Protocol deviation|1
4722126|NCT02031640|16283493|P3|Double-blind Treatment Period|Protocol deviation|0
4722127|NCT02031640|16283494|P2|Double-blind Treatment Period|Protocol deviation|2
4722128|NCT02031640|16283495|P1|Double-blind Treatment Period|Protocol deviation|0
4722129|NCT02031640|16283490|P6|Run-In Period|Various administrative reasons|0
4722130|NCT02031640|16283491|P5|Run-In Period|Various administrative reasons|0
4722131|NCT02031640|16283492|P4|Run-In Period|Various administrative reasons|0
4722132|NCT02031640|16283493|P3|Run-In Period|Various administrative reasons|0
4722133|NCT02031640|16283494|P2|Run-In Period|Various administrative reasons|0
4722134|NCT02031640|16283495|P1|Run-In Period|Various administrative reasons|17
4722135|NCT02031640|16283490|P6|Run-In Period|Randomization criteria not met|0
4722136|NCT02031640|16283491|P5|Run-In Period|Randomization criteria not met|0
4722137|NCT02031640|16283492|P4|Run-In Period|Randomization criteria not met|0
4722138|NCT02031640|16283493|P3|Run-In Period|Randomization criteria not met|0
4722139|NCT02031640|16283494|P2|Run-In Period|Randomization criteria not met|0
4722140|NCT02031640|16283495|P1|Run-In Period|Randomization criteria not met|85
4722141|NCT02031640|16283490|P6|Run-In Period|Exclusion criteria met|0
4722142|NCT02031640|16283491|P5|Run-In Period|Exclusion criteria met|0
4722143|NCT02031640|16283492|P4|Run-In Period|Exclusion criteria met|0
4722144|NCT02031640|16283493|P3|Run-In Period|Exclusion criteria met|0
4722145|NCT02031640|16283494|P2|Run-In Period|Exclusion criteria met|0
4722146|NCT02031640|16283495|P1|Run-In Period|Exclusion criteria met|8
4722147|NCT02031640|16283490|P6|Run-In Period|Inclusion criteria not met|0
4722148|NCT02031640|16283491|P5|Run-In Period|Inclusion criteria not met|0
4722149|NCT02031640|16283492|P4|Run-In Period|Inclusion criteria not met|0
4722150|NCT02031640|16283493|P3|Run-In Period|Inclusion criteria not met|0
4722151|NCT02031640|16283494|P2|Run-In Period|Inclusion criteria not met|0
4722152|NCT02031640|16283495|P1|Run-In Period|Inclusion criteria not met|38
4722153|NCT02031640|16283490|P6|Run-In Period|Withdrawal by Subject|0
4722154|NCT02031640|16283491|P5|Run-In Period|Withdrawal by Subject|0
4722155|NCT02031640|16283492|P4|Run-In Period|Withdrawal by Subject|0
4722156|NCT02031640|16283493|P3|Run-In Period|Withdrawal by Subject|0
4722157|NCT02031640|16283494|P2|Run-In Period|Withdrawal by Subject|0
4722158|NCT02031640|16283495|P1|Run-In Period|Withdrawal by Subject|17
4722159|NCT02031640|16283490|P6|Run-In Period|Adverse Event|0
4722160|NCT02031640|16283491|P5|Run-In Period|Adverse Event|0
4722161|NCT02031640|16283492|P4|Run-In Period|Adverse Event|0
4722162|NCT02031640|16283493|P3|Run-In Period|Adverse Event|0
4722163|NCT02031640|16283494|P2|Run-In Period|Adverse Event|0
4722164|NCT02031640|16283495|P1|Run-In Period|Adverse Event|4
4722165|NCT02031640|16283490|P6|Screening Period|Enrollment closed|0
4722166|NCT02031640|16283491|P5|Screening Period|Enrollment closed|0
4722167|NCT02031640|16283492|P4|Screening Period|Enrollment closed|0
4722168|NCT02031640|16283493|P3|Screening Period|Enrollment closed|0
4722169|NCT02031640|16283494|P2|Screening Period|Enrollment closed|0
4722170|NCT02031640|16283495|P1|Screening Period|Enrollment closed|26
4722171|NCT02031640|16283490|P6|Screening Period|Lost to Follow-up|0
4722172|NCT02031640|16283491|P5|Screening Period|Lost to Follow-up|0
4722173|NCT02031640|16283492|P4|Screening Period|Lost to Follow-up|0
4722174|NCT02031640|16283493|P3|Screening Period|Lost to Follow-up|0
4722175|NCT02031640|16283494|P2|Screening Period|Lost to Follow-up|0
4722176|NCT02031640|16283495|P1|Screening Period|Lost to Follow-up|14
4722177|NCT02031640|16283490|P6|Screening Period|Exclusion criteria met|0
4722178|NCT02031640|16283491|P5|Screening Period|Exclusion criteria met|0
4722179|NCT02031640|16283492|P4|Screening Period|Exclusion criteria met|0
4722180|NCT02031640|16283493|P3|Screening Period|Exclusion criteria met|0
4722181|NCT02031640|16283494|P2|Screening Period|Exclusion criteria met|0
4722182|NCT02031640|16283495|P1|Screening Period|Exclusion criteria met|30
4722183|NCT02031640|16283490|P6|Screening Period|Inclusion criteria not met|0
4722184|NCT02031640|16283491|P5|Screening Period|Inclusion criteria not met|0
4722185|NCT02031640|16283492|P4|Screening Period|Inclusion criteria not met|0
4722186|NCT02031640|16283493|P3|Screening Period|Inclusion criteria not met|0
4722187|NCT02031640|16283494|P2|Screening Period|Inclusion criteria not met|0
4722188|NCT02031640|16283495|P1|Screening Period|Inclusion criteria not met|312
4722189|NCT02031640|16283490|P6|Screening Period|Withdrawal by Subject|0
4722190|NCT02031640|16283491|P5|Screening Period|Withdrawal by Subject|0
4722191|NCT02031640|16283492|P4|Screening Period|Withdrawal by Subject|0
4722192|NCT02031640|16283493|P3|Screening Period|Withdrawal by Subject|0
4722193|NCT02031640|16283494|P2|Screening Period|Withdrawal by Subject|0
4722194|NCT02031640|16283495|P1|Screening Period|Withdrawal by Subject|29
4722195|NCT02031640|16283490|P6|Screening Period|Adverse Event|0
4722196|NCT02031640|16283491|P5|Screening Period|Adverse Event|0
4722197|NCT02031640|16283492|P4|Screening Period|Adverse Event|0
4722198|NCT02031640|16283493|P3|Screening Period|Adverse Event|0
4722199|NCT02031640|16283494|P2|Screening Period|Adverse Event|0
4722200|NCT02031640|16283495|P1|Screening Period|Adverse Event|1
4722201|NCT02031471|16283538|P1|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1
4722202|NCT02031471|16283538|P1|Long Term Extension (LTE) Period|Adverse Event|1
4722203|NCT02031471|16283538|P1|24 Week Treatment Period|Hypersensitivity Reaction|1
4722204|NCT02031471|16283538|P1|24 Week Treatment Period|Insufficient Therapeutic Response|1
4722205|NCT02031471|16283538|P1|24 Week Treatment Period|Protocol Violation|1
4722206|NCT02031471|16283538|P1|24 Week Treatment Period|Participant Decision to Withdraw|2
4722207|NCT02031471|16283538|P1|24 Week Treatment Period|Adverse Event|6
4722208|NCT02031458|16283571|P3|Baseline to May 8, 2015|Lost to Follow-up|2
4722209|NCT02031458|16283572|P2|Baseline to May 8, 2015|Lost to Follow-up|1
4722210|NCT02031458|16283573|P1|Baseline to May 8, 2015|Lost to Follow-up|1
4722211|NCT02031458|16283571|P3|Baseline to May 8, 2015|On Treatment|73
4722212|NCT02031458|16283572|P2|Baseline to May 8, 2015|On Treatment|81
4722213|NCT02031458|16283573|P1|Baseline to May 8, 2015|On Treatment|43
4722214|NCT02031458|16283571|P3|Baseline to May 8, 2015|On Survival Follow-Up|73
4722215|NCT02031458|16283572|P2|Baseline to May 8, 2015|On Survival Follow-Up|83
4722216|NCT02031458|16283573|P1|Baseline to May 8, 2015|On Survival Follow-Up|46
4722217|NCT02031458|16283571|P3|Baseline to May 8, 2015|Withdrawal by Subject|3
4722218|NCT02031458|16283572|P2|Baseline to May 8, 2015|Withdrawal by Subject|9
4722219|NCT02031458|16283573|P1|Baseline to May 8, 2015|Withdrawal by Subject|6
4722220|NCT02031458|16283571|P3|Baseline to May 8, 2015|Unknown Reason|2
4722221|NCT02031458|16283572|P2|Baseline to May 8, 2015|Unknown Reason|1
4722222|NCT02031458|16283573|P1|Baseline to May 8, 2015|Unknown Reason|0
4722223|NCT02031458|16283571|P3|Baseline to May 8, 2015|Physician Decision|0
4722224|NCT02031458|16283572|P2|Baseline to May 8, 2015|Physician Decision|1
4722225|NCT02031458|16283573|P1|Baseline to May 8, 2015|Physician Decision|0
4722226|NCT02031458|16283571|P3|Baseline to May 8, 2015|Protocol Violation|0
4722227|NCT02031458|16283572|P2|Baseline to May 8, 2015|Protocol Violation|4
4722228|NCT02031458|16283573|P1|Baseline to May 8, 2015|Protocol Violation|7
4722229|NCT02031458|16283571|P3|Baseline to May 8, 2015|Death|100
4722230|NCT02031458|16283572|P2|Baseline to May 8, 2015|Death|87
4722231|NCT02031458|16283573|P1|Baseline to May 8, 2015|Death|36
4722232|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14
4722233|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16
4722234|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13
4722235|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23
4722236|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42
4722237|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24
4722238|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Protocol Violation|0
4722239|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Protocol Violation|4
4722240|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Protocol Violation|7
4722241|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Physician Decision|3
4722242|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Physician Decision|3
4722243|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Physician Decision|2
4722326|NCT02030834|16283782|P3|Overall Study|Disease progression|2
4722244|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
4722245|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6
4722246|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1
4722247|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Lost to Follow-up|8
4722248|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Lost to Follow-up|5
4722249|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Lost to Follow-up|2
4722250|NCT02031458|16283571|P3|May 8, 2015 to January 11, 2019|Death|198
4722251|NCT02031458|16283572|P2|May 8, 2015 to January 11, 2019|Death|193
4722252|NCT02031458|16283573|P1|May 8, 2015 to January 11, 2019|Death|89
4722253|NCT02031432|16283667|P1|Overall Study|Death|10
4722254|NCT02031432|16283667|P1|Overall Study|Inclusion/Exclusion criteria not met|5
4722255|NCT02031432|16283667|P1|Overall Study|Lost to Follow-up|1
4722256|NCT02031432|16283667|P1|Overall Study|Withdrawal by Subject|5
4722257|NCT02031432|16283667|P1|Overall Study|Adverse Event|8
4722258|NCT02031432|16283667|P1|Overall Study|Withdrawn as forbidden meds required|1
4722259|NCT02031432|16283667|P1|Overall Study|Cancer Progression|2
4722260|NCT02031432|16283667|P1|Overall Study|Lack of Efficacy|5
4722261|NCT02031432|16283667|P1|Overall Study|Protocol Violation|1
4722262|NCT02031302|16283694|P2|Overall Study|Lost to Follow-up|0
4722263|NCT02031302|16283695|P1|Overall Study|Lost to Follow-up|4
4722264|NCT02031302|16283694|P2|Overall Study|Missed Follow Up|0
4722265|NCT02031302|16283695|P1|Overall Study|Missed Follow Up|27
4722266|NCT02031302|16283694|P2|Overall Study|Not treated with study valve system|0
4722267|NCT02031302|16283695|P1|Overall Study|Not treated with study valve system|18
4722268|NCT02031302|16283694|P2|Overall Study|Death|0
4722269|NCT02031302|16283695|P1|Overall Study|Death|115
4722270|NCT02031276|16283716|P3|Period 3 Open-label Risankizumab SC|Other|1
4722271|NCT02031276|16283717|P2|Period 3 Open-label Risankizumab SC|Other|0
4722272|NCT02031276|16283718|P1|Period 3 Open-label Risankizumab SC|Other|0
4722273|NCT02031276|16283716|P3|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
4722274|NCT02031276|16283717|P2|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
4722275|NCT02031276|16283718|P1|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1
4722276|NCT02031276|16283716|P3|Period 3 Open-label Risankizumab SC|Protocol Violation|0
4722277|NCT02031276|16283717|P2|Period 3 Open-label Risankizumab SC|Protocol Violation|0
4722278|NCT02031276|16283718|P1|Period 3 Open-label Risankizumab SC|Protocol Violation|2
4722279|NCT02031276|16283716|P3|Period 3 Open-label Risankizumab SC|Adverse Event|0
4722280|NCT02031276|16283717|P2|Period 3 Open-label Risankizumab SC|Adverse Event|2
4722281|NCT02031276|16283718|P1|Period 3 Open-label Risankizumab SC|Adverse Event|0
4722282|NCT02031276|16283716|P3|Period 2 Open-label Risankizumab IV|Other|1
4722283|NCT02031276|16283717|P2|Period 2 Open-label Risankizumab IV|Other|2
4722284|NCT02031276|16283718|P1|Period 2 Open-label Risankizumab IV|Other|0
4722285|NCT02031276|16283716|P3|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
4722286|NCT02031276|16283717|P2|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0
4722287|NCT02031276|16283718|P1|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3
4722288|NCT02031276|16283716|P3|Period 2 Open-label Risankizumab IV|Adverse Event|0
4722289|NCT02031276|16283717|P2|Period 2 Open-label Risankizumab IV|Adverse Event|0
4722290|NCT02031276|16283718|P1|Period 2 Open-label Risankizumab IV|Adverse Event|1
4722291|NCT02031276|16283716|P3|Period 1 Double-blind IV|Other|0
4722292|NCT02031276|16283717|P2|Period 1 Double-blind IV|Other|1
4722293|NCT02031276|16283718|P1|Period 1 Double-blind IV|Other|0
4722294|NCT02031276|16283716|P3|Period 1 Double-blind IV|Adverse Event|1
4722295|NCT02031276|16283717|P2|Period 1 Double-blind IV|Adverse Event|5
4722296|NCT02031276|16283718|P1|Period 1 Double-blind IV|Adverse Event|6
4722297|NCT02031237|16283752|P3|Overall Study|Alternate Treatment Given|3
4722298|NCT02031237|16283753|P2|Overall Study|Alternate Treatment Given|0
4722299|NCT02031237|16283754|P1|Overall Study|Alternate Treatment Given|0
4722300|NCT02031237|16283752|P3|Overall Study|Protocol Violation|0
4722301|NCT02031237|16283753|P2|Overall Study|Protocol Violation|6
4722302|NCT02031237|16283754|P1|Overall Study|Protocol Violation|2
4722303|NCT02031237|16283752|P3|Overall Study|Withdrawal by Subject|0
4722304|NCT02031237|16283753|P2|Overall Study|Withdrawal by Subject|2
4722305|NCT02031237|16283754|P1|Overall Study|Withdrawal by Subject|2
4722306|NCT02031237|16283752|P3|Overall Study|Physician Decision|0
4722307|NCT02031237|16283753|P2|Overall Study|Physician Decision|1
4722308|NCT02031237|16283754|P1|Overall Study|Physician Decision|0
4722309|NCT02031237|16283752|P3|Overall Study|Death|0
4722310|NCT02031237|16283753|P2|Overall Study|Death|5
4722311|NCT02031237|16283754|P1|Overall Study|Death|1
4722312|NCT02030847|16283774|P1|Overall Study|Withdrawal by Subject|1
4722313|NCT02030847|16283774|P1|Overall Study|Physician Decision|3
4722314|NCT02030847|16283774|P1|Overall Study|New Cancer Therapy|8
4722315|NCT02030847|16283774|P1|Overall Study|Disease Progression|15
4722316|NCT02030847|16283774|P1|Overall Study|Death|10
4722317|NCT02030834|16283782|P3|Overall Study|Lack of funding|0
4722318|NCT02030834|16283783|P2|Overall Study|Lack of funding|0
4722319|NCT02030834|16283784|P1|Overall Study|Lack of funding|1
4722320|NCT02030834|16283782|P3|Overall Study|Withdrawal by Subject|0
4722321|NCT02030834|16283783|P2|Overall Study|Withdrawal by Subject|0
4722322|NCT02030834|16283784|P1|Overall Study|Withdrawal by Subject|1
4722323|NCT02030834|16283782|P3|Overall Study|Lost to Follow-up|0
4722324|NCT02030834|16283783|P2|Overall Study|Lost to Follow-up|0
4722325|NCT02030834|16283784|P1|Overall Study|Lost to Follow-up|1
4722327|NCT02030834|16283783|P2|Overall Study|Disease progression|0
4722328|NCT02030834|16283784|P1|Overall Study|Disease progression|2
4722329|NCT02030834|16283782|P3|Overall Study|Manufacturing failure|1
4722330|NCT02030834|16283783|P2|Overall Study|Manufacturing failure|0
4722331|NCT02030834|16283784|P1|Overall Study|Manufacturing failure|2
4722332|NCT02030834|16283782|P3|Overall Study|Death|0
4722333|NCT02030834|16283783|P2|Overall Study|Death|0
4722334|NCT02030834|16283784|P1|Overall Study|Death|4
4722335|NCT02030821|16283796|P4|Overall Study|Physician Decision|2
4722336|NCT02030821|16283797|P3|Overall Study|Physician Decision|5
4722337|NCT02030821|16283798|P2|Overall Study|Physician Decision|2
4722338|NCT02030821|16283799|P1|Overall Study|Physician Decision|2
4722339|NCT02030600|16283827|P2|Treatment Period 2|Unclassified|0
4722340|NCT02030600|16283828|P1|Treatment Period 2|Unclassified|1
4722341|NCT02030600|16283827|P2|Treatment Period 2|Withdrawal by Subject|9
4722342|NCT02030600|16283828|P1|Treatment Period 2|Withdrawal by Subject|13
4722343|NCT02030600|16283827|P2|Treatment Period 2|Protocol Violation|2
4722344|NCT02030600|16283828|P1|Treatment Period 2|Protocol Violation|1
4722345|NCT02030600|16283827|P2|Treatment Period 2|Lost to Follow-up|2
4722346|NCT02030600|16283828|P1|Treatment Period 2|Lost to Follow-up|4
4722347|NCT02030600|16283827|P2|Treatment Period 2|Lack of Efficacy|1
4722348|NCT02030600|16283828|P1|Treatment Period 2|Lack of Efficacy|2
4722349|NCT02030600|16283827|P2|Treatment Period 2|Adverse Event|4
4722350|NCT02030600|16283828|P1|Treatment Period 2|Adverse Event|4
4722351|NCT02030600|16283827|P2|Treatment Period 1|Unclassified|0
4722352|NCT02030600|16283828|P1|Treatment Period 1|Unclassified|1
4722353|NCT02030600|16283827|P2|Treatment Period 1|Casebook Unsigned|0
4722354|NCT02030600|16283828|P1|Treatment Period 1|Casebook Unsigned|1
4722355|NCT02030600|16283827|P2|Treatment Period 1|Withdrawal by Subject|17
4722356|NCT02030600|16283828|P1|Treatment Period 1|Withdrawal by Subject|13
4722357|NCT02030600|16283827|P2|Treatment Period 1|Protocol Violation|17
4722358|NCT02030600|16283828|P1|Treatment Period 1|Protocol Violation|22
4722359|NCT02030600|16283827|P2|Treatment Period 1|Lost to Follow-up|3
4722360|NCT02030600|16283828|P1|Treatment Period 1|Lost to Follow-up|11
4722361|NCT02030600|16283827|P2|Treatment Period 1|Lack of Efficacy|1
4722362|NCT02030600|16283828|P1|Treatment Period 1|Lack of Efficacy|0
4722363|NCT02030600|16283827|P2|Treatment Period 1|Adverse Event|7
4722364|NCT02030600|16283828|P1|Treatment Period 1|Adverse Event|5
4722365|NCT02030535|16283849|P1|Washout Period 1 (21 Days)|Adverse Event|1
4722366|NCT02030405|16283917|P1|Overall Study|Lost to Follow-up|1
4722367|NCT02030405|16283917|P1|Overall Study|Withdrawal by Subject|1
4722368|NCT02030119|16283943|P4|Overall Study|Ineligible (see Pre-assignment Details)|0
4722369|NCT02030119|16283944|P3|Overall Study|Ineligible (see Pre-assignment Details)|1
4722370|NCT02030119|16283945|P2|Overall Study|Ineligible (see Pre-assignment Details)|1
4722371|NCT02030119|16283946|P1|Overall Study|Ineligible (see Pre-assignment Details)|0
4722372|NCT02030119|16283943|P4|Overall Study|Withdrawal by Subject|3
4722373|NCT02030119|16283944|P3|Overall Study|Withdrawal by Subject|5
4722374|NCT02030119|16283945|P2|Overall Study|Withdrawal by Subject|1
4722375|NCT02030119|16283946|P1|Overall Study|Withdrawal by Subject|3
4722376|NCT02030041|16283984|P3|Overall Study|Withdrawal by Subject|1
4722377|NCT02030041|16283985|P2|Overall Study|Withdrawal by Subject|2
4722378|NCT02030041|16283986|P1|Overall Study|Withdrawal by Subject|2
4722379|NCT02029989|16283999|P2|Overall Study|Protocol Violation|0
4722380|NCT02029989|16284000|P1|Overall Study|Protocol Violation|1
4722381|NCT02029989|16283999|P2|Overall Study|Death|1
4722382|NCT02029989|16284000|P1|Overall Study|Death|0
4722383|NCT02029989|16283999|P2|Overall Study|Lost to Follow-up|7
4722384|NCT02029989|16284000|P1|Overall Study|Lost to Follow-up|9
4722385|NCT02029989|16283999|P2|Overall Study|Physician Decision|0
4722386|NCT02029989|16284000|P1|Overall Study|Physician Decision|2
4722387|NCT02029989|16283999|P2|Overall Study|Change of location|3
4722388|NCT02029989|16284000|P1|Overall Study|Change of location|2
4722389|NCT02029989|16283999|P2|Overall Study|Withdrawal: Fear of needles|0
4722390|NCT02029989|16284000|P1|Overall Study|Withdrawal: Fear of needles|1
4722391|NCT02029989|16283999|P2|Overall Study|Withdrawal by Subject|0
4722392|NCT02029989|16284000|P1|Overall Study|Withdrawal by Subject|1
4722393|NCT02029976|16284008|P2|YR-2 Follow Up vs Baseline|Moved from area|2
4722394|NCT02029976|16284009|P1|YR-2 Follow Up vs Baseline|Moved from area|0
4722395|NCT02029976|16284008|P2|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
4722396|NCT02029976|16284009|P1|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2
4722397|NCT02029976|16284008|P2|YR-2 Follow Up vs Baseline|Lost to Follow-up|4
4722398|NCT02029976|16284009|P1|YR-2 Follow Up vs Baseline|Lost to Follow-up|8
4722399|NCT02029976|16284008|P2|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8
4722400|NCT02029976|16284009|P1|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12
4722401|NCT02029846|16284038|P2|Overall Study|n=1 each arm|1
4722402|NCT02029846|16284039|P1|Overall Study|n=1 each arm|1
4722403|NCT02029638|16284077|P3|Overall Study|Decision by Study Sponsor or Regulatory|0
4722404|NCT02029638|16284078|P2|Overall Study|Decision by Study Sponsor or Regulatory|0
4722405|NCT02029638|16284079|P1|Overall Study|Decision by Study Sponsor or Regulatory|2
4722406|NCT02029638|16284077|P3|Overall Study|Death|1
4722407|NCT02029638|16284078|P2|Overall Study|Death|0
4722408|NCT02029638|16284079|P1|Overall Study|Death|0
4722409|NCT02029521|16284108|P2|Overall Study|Withdrawal by Subject|1
4722410|NCT02029521|16284109|P1|Overall Study|Withdrawal by Subject|1
4722411|NCT02029521|16284108|P2|Overall Study|Protocol Violation|0
4722412|NCT02029521|16284109|P1|Overall Study|Protocol Violation|1
4722413|NCT02029417|16284207|P1|Overall Study|Adverse Event|1
4722414|NCT02029417|16284207|P1|Overall Study|Death|1
4722415|NCT02029274|16284216|P4|Overall Study|Adverse Event|2
4722416|NCT02029274|16284217|P3|Overall Study|Adverse Event|2
4722417|NCT02029274|16284218|P2|Overall Study|Adverse Event|0
4722418|NCT02029274|16284219|P1|Overall Study|Adverse Event|1
4722419|NCT02029235|16284251|P2|Overall Study|Non-compliance with study meds or diary|1
4722420|NCT02029235|16284252|P1|Overall Study|Non-compliance with study meds or diary|4
4722421|NCT02028871|16284284|P2|Overall Study|Current Illness|0
4722422|NCT02028871|16284285|P1|Overall Study|Current Illness|1
4722423|NCT02028871|16284284|P2|Overall Study|IV placement difficulty|0
4722424|NCT02028871|16284285|P1|Overall Study|IV placement difficulty|1
4722425|NCT02028871|16284284|P2|Overall Study|Withdrawal by Subject|2
4722426|NCT02028871|16284285|P1|Overall Study|Withdrawal by Subject|1
4722427|NCT02028871|16284284|P2|Overall Study|Positive urine drug screen|1
4722428|NCT02028871|16284285|P1|Overall Study|Positive urine drug screen|1
4722429|NCT02028767|16284382|P2|Treatment Period 2|Reason other than those specified above|0
4722430|NCT02028767|16284383|P1|Treatment Period 2|Reason other than those specified above|1
4722431|NCT02028767|16284382|P2|Treatment Period 2|Non compliant with protocol|0
4722432|NCT02028767|16284383|P1|Treatment Period 2|Non compliant with protocol|1
4722433|NCT02028715|16284416|P2|Overall Study|Did not complete satisfaction surveys|2
4722434|NCT02028715|16284417|P1|Overall Study|Did not complete satisfaction surveys|2
4722435|NCT02028715|16284416|P2|Overall Study|Physician Decision|0
4722436|NCT02028715|16284417|P1|Overall Study|Physician Decision|1
4722437|NCT02028715|16284416|P2|Overall Study|Adverse Event|2
4722438|NCT02028715|16284417|P1|Overall Study|Adverse Event|2
4722439|NCT02028182|16284645|P1|Overall Study|Protocol Violation|2
4722440|NCT02028169|16284651|P1|Overall Study|Concomitant Medication Usage|1
4722441|NCT02028169|16284651|P1|Overall Study|Cessation of Drug|1
4722442|NCT02028169|16284651|P1|Overall Study|Adverse Event|1
4722443|NCT02028169|16284651|P1|Overall Study|Withdrawal by Subject|2
4722444|NCT02028169|16284651|P1|Overall Study|Lack of Efficacy|2
4722445|NCT02028169|16284651|P1|Overall Study|Lost to Follow-up|21
4722446|NCT02028065|16284677|P3|Treatment Through Study Completion|Adverse Event|5
4722447|NCT02028065|16284678|P2|Treatment Through Study Completion|Adverse Event|3
4722448|NCT02028065|16284679|P1|Treatment Through Study Completion|Adverse Event|3
4722449|NCT02028065|16284677|P3|Treatment Through Study Completion|Withdrawal by Subject|3
4722450|NCT02028065|16284678|P2|Treatment Through Study Completion|Withdrawal by Subject|4
4722451|NCT02028065|16284679|P1|Treatment Through Study Completion|Withdrawal by Subject|5
4722452|NCT02028065|16284677|P3|Treatment Through Study Completion|Protocol Violation|0
4722453|NCT02028065|16284678|P2|Treatment Through Study Completion|Protocol Violation|4
4722454|NCT02028065|16284679|P1|Treatment Through Study Completion|Protocol Violation|1
4722455|NCT02028065|16284677|P3|Treatment Through Study Completion|Physician Decision|0
4722456|NCT02028065|16284678|P2|Treatment Through Study Completion|Physician Decision|0
4722457|NCT02028065|16284679|P1|Treatment Through Study Completion|Physician Decision|1
4722458|NCT02028065|16284677|P3|Treatment Through Study Completion|Lost to Follow-up|6
4722459|NCT02028065|16284678|P2|Treatment Through Study Completion|Lost to Follow-up|4
4722460|NCT02028065|16284679|P1|Treatment Through Study Completion|Lost to Follow-up|2
4722461|NCT02028065|16284677|P3|Randomization Through Start Treatment|Not treated|3
4722462|NCT02028065|16284678|P2|Randomization Through Start Treatment|Not treated|3
4722463|NCT02028065|16284679|P1|Randomization Through Start Treatment|Not treated|1
4722464|NCT02027844|16284706|P3|Overall Study|Incomlete data|0
4722465|NCT02027844|16284707|P2|Overall Study|Incomlete data|0
4722466|NCT02027844|16284708|P1|Overall Study|Incomlete data|2
4722467|NCT02027844|16284706|P3|Overall Study|Protocol Violation|0
4722468|NCT02027844|16284707|P2|Overall Study|Protocol Violation|2
4722469|NCT02027844|16284708|P1|Overall Study|Protocol Violation|0
4722470|NCT02027844|16284706|P3|Overall Study|Lost to Follow-up|1
4722471|NCT02027844|16284707|P2|Overall Study|Lost to Follow-up|2
4722472|NCT02027844|16284708|P1|Overall Study|Lost to Follow-up|0
4722473|NCT02027844|16284706|P3|Overall Study|Withdrawal by Subject|1
4722474|NCT02027844|16284707|P2|Overall Study|Withdrawal by Subject|2
4722475|NCT02027844|16284708|P1|Overall Study|Withdrawal by Subject|3
4722476|NCT02027701|16284725|P1|Overall Study|Withdrawal by Subject|3
4722477|NCT02027701|16284725|P1|Overall Study|Physician Decision|2
4722478|NCT02027701|16284725|P1|Overall Study|Lack of Efficacy|8
4722479|NCT02027701|16284725|P1|Overall Study|Adverse Event|3
4722480|NCT02027623|16284743|P2|Overall Study|Withdrawal by Subject|9
4722481|NCT02027623|16284744|P1|Overall Study|Withdrawal by Subject|6
4722482|NCT02027623|16284743|P2|Overall Study|Lost to Follow-up|3
4722483|NCT02027623|16284744|P1|Overall Study|Lost to Follow-up|3
4722484|NCT02027558|16284840|P2|Overall Study|Refused assessment|0
4722485|NCT02027558|16284841|P1|Overall Study|Refused assessment|3
4722486|NCT02027558|16284840|P2|Overall Study|Lost to Follow-up|1
4722487|NCT02027558|16284841|P1|Overall Study|Lost to Follow-up|4
4722488|NCT02027558|16284840|P2|Overall Study|Withdrawal by Subject|0
4722489|NCT02027558|16284841|P1|Overall Study|Withdrawal by Subject|2
4722490|NCT02027558|16284840|P2|Overall Study|Death|1
4722491|NCT02027558|16284841|P1|Overall Study|Death|0
4722492|NCT02027545|16284859|P2|Overall Study|Failed to attend study visit|0
4722493|NCT02027545|16284860|P1|Overall Study|Failed to attend study visit|2
4722494|NCT02027545|16284859|P2|Overall Study|Failed to sign HIPAA|2
4722495|NCT02027545|16284860|P1|Overall Study|Failed to sign HIPAA|0
4722496|NCT02027428|16284872|P3|Survival Follow-up|Lost to Follow-up|1
4722497|NCT02027428|16284873|P2|Survival Follow-up|Lost to Follow-up|1
4722498|NCT02027428|16284874|P1|Survival Follow-up|Lost to Follow-up|0
4722499|NCT02027428|16284872|P3|Survival Follow-up|Death|45
4722500|NCT02027428|16284873|P2|Survival Follow-up|Death|78
4722501|NCT02027428|16284874|P1|Survival Follow-up|Death|0
4722502|NCT02027428|16284872|P3|Maintenance|Other|3
4722503|NCT02027428|16284873|P2|Maintenance|Other|6
4722504|NCT02027428|16284874|P1|Maintenance|Other|0
4722505|NCT02027428|16284872|P3|Maintenance|Protocol Violation|1
4722506|NCT02027428|16284873|P2|Maintenance|Protocol Violation|0
4722507|NCT02027428|16284874|P1|Maintenance|Protocol Violation|0
4722508|NCT02027428|16284872|P3|Maintenance|Withdrawal by Subject|5
4722509|NCT02027428|16284873|P2|Maintenance|Withdrawal by Subject|6
4722510|NCT02027428|16284874|P1|Maintenance|Withdrawal by Subject|0
4722511|NCT02027428|16284872|P3|Maintenance|Symptomatic deterioration|1
4722512|NCT02027428|16284873|P2|Maintenance|Symptomatic deterioration|4
4722513|NCT02027428|16284874|P1|Maintenance|Symptomatic deterioration|0
4722514|NCT02027428|16284872|P3|Maintenance|Progressive disease|47
4722515|NCT02027428|16284873|P2|Maintenance|Progressive disease|84
4722516|NCT02027428|16284874|P1|Maintenance|Progressive disease|0
4722517|NCT02027428|16284872|P3|Maintenance|Adverse Event|1
4722518|NCT02027428|16284873|P2|Maintenance|Adverse Event|21
4722519|NCT02027428|16284874|P1|Maintenance|Adverse Event|0
4722520|NCT02027428|16284872|P3|Maintenance|Death|2
4722521|NCT02027428|16284873|P2|Maintenance|Death|3
4722522|NCT02027428|16284874|P1|Maintenance|Death|0
4722523|NCT02027428|16284872|P3|Induction|Induction Treatment Ongoing|0
4722524|NCT02027428|16284873|P2|Induction|Induction Treatment Ongoing|0
4722525|NCT02027428|16284874|P1|Induction|Induction Treatment Ongoing|4
4722526|NCT02027428|16284872|P3|Induction|Miscellaneous|0
4722527|NCT02027428|16284873|P2|Induction|Miscellaneous|0
4722528|NCT02027428|16284874|P1|Induction|Miscellaneous|14
4722529|NCT02027428|16284872|P3|Induction|Protocol Violation|0
4722530|NCT02027428|16284873|P2|Induction|Protocol Violation|0
4722531|NCT02027428|16284874|P1|Induction|Protocol Violation|1
4722532|NCT02027428|16284872|P3|Induction|Study terminated by sponsor|0
4722533|NCT02027428|16284873|P2|Induction|Study terminated by sponsor|0
4722534|NCT02027428|16284874|P1|Induction|Study terminated by sponsor|12
4722535|NCT02027428|16284872|P3|Induction|Symptomatic deterioration|0
4722536|NCT02027428|16284873|P2|Induction|Symptomatic deterioration|0
4722537|NCT02027428|16284874|P1|Induction|Symptomatic deterioration|16
4722538|NCT02027428|16284872|P3|Induction|Death|0
4722539|NCT02027428|16284873|P2|Induction|Death|0
4722540|NCT02027428|16284874|P1|Induction|Death|21
4722541|NCT02027428|16284872|P3|Induction|Withdrawal by Subject|0
4722542|NCT02027428|16284873|P2|Induction|Withdrawal by Subject|0
4722543|NCT02027428|16284874|P1|Induction|Withdrawal by Subject|22
4722544|NCT02027428|16284872|P3|Induction|Adverse Event|0
4722545|NCT02027428|16284873|P2|Induction|Adverse Event|0
4722546|NCT02027428|16284874|P1|Induction|Adverse Event|51
4722547|NCT02027428|16284872|P3|Induction|Progressive disease|0
4722548|NCT02027428|16284873|P2|Induction|Progressive disease|0
4722549|NCT02027428|16284874|P1|Induction|Progressive disease|77
4722550|NCT02027428|16284872|P3|Induction|Never treated|0
4722551|NCT02027428|16284873|P2|Induction|Never treated|0
4722552|NCT02027428|16284874|P1|Induction|Never treated|7
4722553|NCT02027402|16284912|P2|Overall Study|Withdrawal by Subject|1
4722554|NCT02027402|16284913|P1|Overall Study|Withdrawal by Subject|4
4722555|NCT02027376|16284925|P3|Overall Study|Death|0
4722556|NCT02027376|16284926|P2|Overall Study|Death|0
4722557|NCT02027376|16284927|P1|Overall Study|Death|1
4722558|NCT02027311|16284953|P2|Overall Study|Protocol Violation|2
4722559|NCT02027311|16284954|P1|Overall Study|Protocol Violation|3
4722560|NCT02027025|16284974|P3|Overall Study|Sponsor's decision|0
4722561|NCT02027025|16284975|P2|Overall Study|Sponsor's decision|1
4722562|NCT02027025|16284976|P1|Overall Study|Sponsor's decision|0
4722563|NCT02027025|16284974|P3|Overall Study|Withdrawal by Subject|0
4722564|NCT02027025|16284975|P2|Overall Study|Withdrawal by Subject|1
4722565|NCT02027025|16284976|P1|Overall Study|Withdrawal by Subject|0
4722566|NCT02027025|16284974|P3|Overall Study|Lost to Follow-up|0
4722567|NCT02027025|16284975|P2|Overall Study|Lost to Follow-up|2
4722568|NCT02027025|16284976|P1|Overall Study|Lost to Follow-up|0
4722569|NCT02027025|16284974|P3|Overall Study|Protocol Violation|0
4722570|NCT02027025|16284975|P2|Overall Study|Protocol Violation|0
4722571|NCT02027025|16284976|P1|Overall Study|Protocol Violation|1
4722572|NCT02027025|16284974|P3|Overall Study|Adverse Event|1
4722573|NCT02027025|16284975|P2|Overall Study|Adverse Event|1
4722574|NCT02027025|16284976|P1|Overall Study|Adverse Event|0
4722575|NCT02026258|16285039|P2|Recieved Allocated Intervention|Lost to Follow-up|1
4722576|NCT02026258|16285040|P1|Recieved Allocated Intervention|Lost to Follow-up|0
4722577|NCT02026258|16285039|P2|Recieved Allocated Intervention|Withdrawal by Subject|1
4722578|NCT02026258|16285040|P1|Recieved Allocated Intervention|Withdrawal by Subject|1
4722579|NCT02026258|16285039|P2|Randomized|Presence of periodontal disease|1
4722580|NCT02026258|16285040|P1|Randomized|Presence of periodontal disease|1
4722581|NCT02026258|16285039|P2|Randomized|Change in treatment plan|0
4722582|NCT02026258|16285040|P1|Randomized|Change in treatment plan|1
4722583|NCT02026258|16285039|P2|Randomized|Did not start treatment|1
4722584|NCT02026258|16285040|P1|Randomized|Did not start treatment|2
4722585|NCT02026141|16285074|P2|Overall Study|Protocol Violation|1
4722586|NCT02026141|16285075|P1|Overall Study|Protocol Violation|0
4722587|NCT02026063|16285083|P2|Overall Study|Reason not Specified|7
4722588|NCT02026063|16285084|P1|Overall Study|Reason not Specified|2
4722589|NCT02026063|16285083|P2|Overall Study|Lost to Follow-up|1
4722590|NCT02026063|16285084|P1|Overall Study|Lost to Follow-up|0
4722591|NCT02026063|16285083|P2|Overall Study|Lack of Efficacy|4
4722592|NCT02026063|16285084|P1|Overall Study|Lack of Efficacy|0
4722593|NCT02026063|16285083|P2|Overall Study|Adverse Event|20
4722594|NCT02026063|16285084|P1|Overall Study|Adverse Event|5
4722595|NCT02026063|16285083|P2|Overall Study|Withdrawal of Consent|6
4722596|NCT02026063|16285084|P1|Overall Study|Withdrawal of Consent|1
4722597|NCT02026063|16285083|P2|Overall Study|Noncompliance with Study Drug|1
4722598|NCT02026063|16285084|P1|Overall Study|Noncompliance with Study Drug|1
4722599|NCT02026063|16285083|P2|Overall Study|Physician Decision|10
4722600|NCT02026063|16285084|P1|Overall Study|Physician Decision|0
4722601|NCT02026011|16285096|P2|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2
4722602|NCT02026011|16285097|P1|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1
4722603|NCT02026011|16285096|P2|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0
4722604|NCT02026011|16285097|P1|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1
4722605|NCT02026011|16285096|P2|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2
4722606|NCT02026011|16285097|P1|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1
4722607|NCT02026011|16285096|P2|Allocation 1 (First Set of Medication)|Side Effects|0
4722608|NCT02026011|16285097|P1|Allocation 1 (First Set of Medication)|Side Effects|6
4722609|NCT02025907|16285123|P2|Overall Study|Potential misconduct,GCPcompliance issue|1
4722610|NCT02025907|16285124|P1|Overall Study|Potential misconduct,GCPcompliance issue|2
4722611|NCT02025907|16285123|P2|Overall Study|Adverse Event|1
4722612|NCT02025907|16285124|P1|Overall Study|Adverse Event|3
4722613|NCT02025907|16285123|P2|Overall Study|Lost to Follow-up|2
4722614|NCT02025907|16285124|P1|Overall Study|Lost to Follow-up|2
4722615|NCT02025907|16285123|P2|Overall Study|Physician Decision|0
4722616|NCT02025907|16285124|P1|Overall Study|Physician Decision|2
4722617|NCT02025907|16285123|P2|Overall Study|Protocol Violation|0
4722618|NCT02025907|16285124|P1|Overall Study|Protocol Violation|2
4722619|NCT02025907|16285123|P2|Overall Study|Withdrawal by Subject|8
4722620|NCT02025907|16285124|P1|Overall Study|Withdrawal by Subject|15
4722621|NCT02025907|16285123|P2|Overall Study|Lack of Efficacy|0
4722622|NCT02025907|16285124|P1|Overall Study|Lack of Efficacy|1
4722623|NCT02025751|16285152|P2|Overall Study|Withdrawal by Subject|1
4722624|NCT02025751|16285153|P1|Overall Study|Withdrawal by Subject|0
4722625|NCT02025751|16285152|P2|Overall Study|Physician Decision|1
4722626|NCT02025751|16285153|P1|Overall Study|Physician Decision|0
4722627|NCT02025751|16285152|P2|Overall Study|Adverse Event|1
4722628|NCT02025751|16285153|P1|Overall Study|Adverse Event|0
4722629|NCT02025751|16285152|P2|Overall Study|Lost to Follow-up|0
4722630|NCT02025751|16285153|P1|Overall Study|Lost to Follow-up|1
4722631|NCT02025725|16285161|P2|Overall Study|Post-dose QTcB > 270 msec|1
4722632|NCT02025725|16285162|P1|Overall Study|Post-dose QTcB > 270 msec|0
4722633|NCT02025725|16285161|P2|Overall Study|Withdrawal by Subject|2
4722634|NCT02025725|16285162|P1|Overall Study|Withdrawal by Subject|3
4722635|NCT02025725|16285161|P2|Overall Study|Protocol Violation|1
4722636|NCT02025725|16285162|P1|Overall Study|Protocol Violation|1
4722637|NCT02025725|16285161|P2|Overall Study|Lost to Follow-up|0
4722638|NCT02025725|16285162|P1|Overall Study|Lost to Follow-up|2
4722639|NCT02025725|16285161|P2|Overall Study|Adverse Event|0
4722640|NCT02025725|16285162|P1|Overall Study|Adverse Event|5
4722641|NCT02025621|16285214|P2|Overall Study|Surgery initiated before infusion|3
4722642|NCT02025621|16285215|P1|Overall Study|Surgery initiated before infusion|3
4722643|NCT02025621|16285214|P2|Overall Study|No longer eligible|15
4722644|NCT02025621|16285215|P1|Overall Study|No longer eligible|10
4722645|NCT02025621|16285214|P2|Overall Study|Death|1
4722646|NCT02025621|16285215|P1|Overall Study|Death|0
4722647|NCT02025621|16285214|P2|Overall Study|Withdrawal by Subject|0
4722648|NCT02025621|16285215|P1|Overall Study|Withdrawal by Subject|1
4722649|NCT02025530|16285235|P2|Overall Study|No longer met elligibility criteria|1
4722650|NCT02025530|16285236|P1|Overall Study|No longer met elligibility criteria|5
4722651|NCT02025205|16285282|P2|Overall Study|Death|1
4722652|NCT02025205|16285283|P1|Overall Study|Death|0
4722653|NCT02025205|16285282|P2|Overall Study|Protocol Violation|1
4722654|NCT02025205|16285283|P1|Overall Study|Protocol Violation|2
4722655|NCT02025205|16285282|P2|Overall Study|Withdrawal by Subject|1
4722656|NCT02025205|16285283|P1|Overall Study|Withdrawal by Subject|1
4722657|NCT02025179|16285327|P3|Overall Study|Lost to Follow-up|1
4722658|NCT02025179|16285328|P2|Overall Study|Lost to Follow-up|0
4722659|NCT02025179|16285329|P1|Overall Study|Lost to Follow-up|0
4722660|NCT02024971|16285379|P1|Overall Study|Lost to Follow-up|6
4722661|NCT02024971|16285379|P1|Overall Study|Data Not Available|30
4722662|NCT02024932|16285392|P6|Overall Study|Abnormal laboratory value|0
4722663|NCT02024932|16285393|P5|Overall Study|Abnormal laboratory value|0
4722664|NCT02024932|16285394|P4|Overall Study|Abnormal laboratory value|2
4722665|NCT02024932|16285395|P3|Overall Study|Abnormal laboratory value|0
4722666|NCT02024932|16285396|P2|Overall Study|Abnormal laboratory value|0
4722667|NCT02024932|16285397|P1|Overall Study|Abnormal laboratory value|0
4722668|NCT02024932|16285392|P6|Overall Study|Adverse Event|0
4722669|NCT02024932|16285393|P5|Overall Study|Adverse Event|2
4722670|NCT02024932|16285394|P4|Overall Study|Adverse Event|0
4722671|NCT02024932|16285395|P3|Overall Study|Adverse Event|0
4722672|NCT02024932|16285396|P2|Overall Study|Adverse Event|3
4722673|NCT02024932|16285397|P1|Overall Study|Adverse Event|2
4722674|NCT02024867|16285456|P2|Overall Study|Lost to Follow-up|4
4722675|NCT02024867|16285457|P1|Overall Study|Lost to Follow-up|6
4722676|NCT02024867|16285456|P2|Overall Study|Protocol Violation|3
4722677|NCT02024867|16285457|P1|Overall Study|Protocol Violation|3
4722678|NCT02024750|16285475|P2|Overall Study|Withdrawal by Subject|1
4722679|NCT02024750|16285476|P1|Overall Study|Withdrawal by Subject|2
4722680|NCT02024698|16285512|P2|First Intervention (7 Days)|Withdrawal by Subject|1
4722681|NCT02024698|16285513|P1|First Intervention (7 Days)|Withdrawal by Subject|0
4722682|NCT02024555|16285554|P2|Overall Study|Withdrawal by Subject|1
4722683|NCT02024555|16285555|P1|Overall Study|Withdrawal by Subject|5
4722684|NCT02024555|16285554|P2|Overall Study|Lost to Follow-up|1
4722685|NCT02024555|16285555|P1|Overall Study|Lost to Follow-up|1
4722686|NCT02023879|16285667|P3|Extension Open Label Treatment|Other than specified above|2
4722687|NCT02023879|16285668|P2|Extension Open Label Treatment|Other than specified above|7
4722688|NCT02023879|16285669|P1|Extension Open Label Treatment|Other than specified above|2
4722689|NCT02023879|16285667|P3|Extension Open Label Treatment|Participant moved|0
4722690|NCT02023879|16285668|P2|Extension Open Label Treatment|Participant moved|2
4722691|NCT02023879|16285669|P1|Extension Open Label Treatment|Participant moved|1
4722692|NCT02023879|16285667|P3|Extension Open Label Treatment|Poor compliance to protocol|0
4722693|NCT02023879|16285668|P2|Extension Open Label Treatment|Poor compliance to protocol|1
4722694|NCT02023879|16285669|P1|Extension Open Label Treatment|Poor compliance to protocol|1
4722695|NCT02023879|16285667|P3|Extension Open Label Treatment|Adverse Event|3
4722696|NCT02023879|16285668|P2|Extension Open Label Treatment|Adverse Event|7
4722697|NCT02023879|16285669|P1|Extension Open Label Treatment|Adverse Event|1
4722698|NCT02023879|16285667|P3|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
4722699|NCT02023879|16285668|P2|Period 1: 24-Week Double-blind Treatment|Other than specified above|3
4722700|NCT02023879|16285669|P1|Period 1: 24-Week Double-blind Treatment|Other than specified above|1
4722701|NCT02023879|16285667|P3|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
4722702|NCT02023879|16285668|P2|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1
4722703|NCT02023879|16285669|P1|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0
4722704|NCT02023879|16285667|P3|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
4722705|NCT02023879|16285668|P2|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0
4722706|NCT02023879|16285669|P1|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1
4722707|NCT02023879|16285667|P3|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
4722708|NCT02023879|16285668|P2|Period 1: 24-Week Double-blind Treatment|Physician Decision|1
4722709|NCT02023879|16285669|P1|Period 1: 24-Week Double-blind Treatment|Physician Decision|0
4722710|NCT02023879|16285667|P3|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1
4722711|NCT02023879|16285668|P2|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2
4722712|NCT02023879|16285669|P1|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0
4722713|NCT02023879|16285667|P3|Period 1: 24-Week Double-blind Treatment|Adverse Event|5
4722714|NCT02023879|16285668|P2|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
4722715|NCT02023879|16285669|P1|Period 1: 24-Week Double-blind Treatment|Adverse Event|2
4722716|NCT02023866|16285758|P1|Overall Study|Withdrawal by Subject|1
4722717|NCT02023866|16285758|P1|Overall Study|Adverse Event|3
4722718|NCT02023866|16285758|P1|Overall Study|Non-compliance|2
4722719|NCT02023697|16285780|P3|Long-term Follow-up Period|Other unspecified|5
4722720|NCT02023697|16285781|P2|Long-term Follow-up Period|Other unspecified|3
4722721|NCT02023697|16285782|P1|Long-term Follow-up Period|Other unspecified|6
4722722|NCT02023697|16285780|P3|Long-term Follow-up Period|Technical problems|1
4722723|NCT02023697|16285781|P2|Long-term Follow-up Period|Technical problems|0
4722724|NCT02023697|16285782|P1|Long-term Follow-up Period|Technical problems|0
4722725|NCT02023697|16285780|P3|Long-term Follow-up Period|Entered the long-term follow-up study|6
4722726|NCT02023697|16285781|P2|Long-term Follow-up Period|Entered the long-term follow-up study|9
4722727|NCT02023697|16285782|P1|Long-term Follow-up Period|Entered the long-term follow-up study|6
4722728|NCT02023697|16285780|P3|Long-term Follow-up Period|Lost to Follow-up|1
4722729|NCT02023697|16285781|P2|Long-term Follow-up Period|Lost to Follow-up|0
4722730|NCT02023697|16285782|P1|Long-term Follow-up Period|Lost to Follow-up|1
4722731|NCT02023697|16285780|P3|Long-term Follow-up Period|Withdrawal by Subject|0
4722732|NCT02023697|16285781|P2|Long-term Follow-up Period|Withdrawal by Subject|3
4722733|NCT02023697|16285782|P1|Long-term Follow-up Period|Withdrawal by Subject|6
4722734|NCT02023697|16285780|P3|Long-term Follow-up Period|Death|4
4722735|NCT02023697|16285781|P2|Long-term Follow-up Period|Death|6
4722736|NCT02023697|16285782|P1|Long-term Follow-up Period|Death|9
4722737|NCT02023697|16285780|P3|Active Follow-up Period|Death|87
4722738|NCT02023697|16285781|P2|Active Follow-up Period|Death|82
4722739|NCT02023697|16285782|P1|Active Follow-up Period|Death|83
4722740|NCT02023697|16285780|P3|Active Follow-up Period|Radiological progression|1
4722741|NCT02023697|16285781|P2|Active Follow-up Period|Radiological progression|0
4722742|NCT02023697|16285782|P1|Active Follow-up Period|Radiological progression|0
4722743|NCT02023697|16285780|P3|Active Follow-up Period|Clinical progression|1
4722744|NCT02023697|16285781|P2|Active Follow-up Period|Clinical progression|2
4722745|NCT02023697|16285782|P1|Active Follow-up Period|Clinical progression|0
4722746|NCT02023697|16285780|P3|Active Follow-up Period|Other unspecified|1
4722747|NCT02023697|16285781|P2|Active Follow-up Period|Other unspecified|0
4722748|NCT02023697|16285782|P1|Active Follow-up Period|Other unspecified|2
4722749|NCT02023697|16285780|P3|Active Follow-up Period|Deterioration of general condition|1
4722750|NCT02023697|16285781|P2|Active Follow-up Period|Deterioration of general condition|1
4722751|NCT02023697|16285782|P1|Active Follow-up Period|Deterioration of general condition|1
4722752|NCT02023697|16285780|P3|Active Follow-up Period|Lost to Follow-up|1
4722753|NCT02023697|16285781|P2|Active Follow-up Period|Lost to Follow-up|1
4722754|NCT02023697|16285782|P1|Active Follow-up Period|Lost to Follow-up|1
4722755|NCT02023697|16285780|P3|Active Follow-up Period|Withdrawal by Subject|7
4722756|NCT02023697|16285781|P2|Active Follow-up Period|Withdrawal by Subject|13
4722757|NCT02023697|16285782|P1|Active Follow-up Period|Withdrawal by Subject|5
4722758|NCT02023697|16285780|P3|Treatment Period|Physician Decision|1
4722759|NCT02023697|16285781|P2|Treatment Period|Physician Decision|0
4722760|NCT02023697|16285782|P1|Treatment Period|Physician Decision|0
4722761|NCT02023697|16285780|P3|Treatment Period|Safety outcome reached|0
4722762|NCT02023697|16285781|P2|Treatment Period|Safety outcome reached|1
4722763|NCT02023697|16285782|P1|Treatment Period|Safety outcome reached|0
4722764|NCT02023697|16285780|P3|Treatment Period|Withdrawal by Subject|13
4722765|NCT02023697|16285781|P2|Treatment Period|Withdrawal by Subject|5
4722766|NCT02023697|16285782|P1|Treatment Period|Withdrawal by Subject|4
4722767|NCT02023697|16285780|P3|Treatment Period|Clinical progression|28
4722768|NCT02023697|16285781|P2|Treatment Period|Clinical progression|8
4722769|NCT02023697|16285782|P1|Treatment Period|Clinical progression|10
4722770|NCT02023697|16285780|P3|Treatment Period|Logistical difficulties|1
4722771|NCT02023697|16285781|P2|Treatment Period|Logistical difficulties|1
4722772|NCT02023697|16285782|P1|Treatment Period|Logistical difficulties|1
4722773|NCT02023697|16285780|P3|Treatment Period|Adverse Event|23
4722774|NCT02023697|16285781|P2|Treatment Period|Adverse Event|25
4722775|NCT02023697|16285782|P1|Treatment Period|Adverse Event|13
4722776|NCT02023697|16285780|P3|Treatment Period|Never Treated|10
4722777|NCT02023697|16285781|P2|Treatment Period|Never Treated|6
4722778|NCT02023697|16285782|P1|Treatment Period|Never Treated|5
4722779|NCT02023697|16285780|P3|Treatment Period|Radiological progression|26
4722780|NCT02023697|16285781|P2|Treatment Period|Radiological progression|17
4722781|NCT02023697|16285782|P1|Treatment Period|Radiological progression|13
4722782|NCT02023268|16285906|P2|Overall Study|Withdrawal by Subject|1
4722783|NCT02023268|16285907|P1|Overall Study|Withdrawal by Subject|0
4722784|NCT02023268|16285906|P2|Overall Study|Adverse Event|2
4722785|NCT02023268|16285907|P1|Overall Study|Adverse Event|0
4722786|NCT02023268|16285906|P2|Overall Study|Lack of Efficacy|1
4722787|NCT02023268|16285907|P1|Overall Study|Lack of Efficacy|0
4722788|NCT02023242|16285915|P2|Overall Study|Death|1
4722789|NCT02023242|16285916|P1|Overall Study|Death|0
4722790|NCT02023242|16285915|P2|Overall Study|Lost to Follow-up|1
4722791|NCT02023242|16285916|P1|Overall Study|Lost to Follow-up|3
4722792|NCT02023151|16285930|P1|Overall Study|Lost to Follow-up|4
4722793|NCT02023112|16286000|P2|Overall Study|Withdrawal by Subject|1
4722794|NCT02023112|16286001|P1|Overall Study|Withdrawal by Subject|2
4722795|NCT02023099|16286022|P3|Overall Study|Non-treatment-emergent Fatal AE|1
4722796|NCT02023099|16286023|P2|Overall Study|Non-treatment-emergent Fatal AE|0
4722797|NCT02023099|16286024|P1|Overall Study|Non-treatment-emergent Fatal AE|0
4722798|NCT02023099|16286022|P3|Overall Study|Withdrawn Consent|1
4722799|NCT02023099|16286023|P2|Overall Study|Withdrawn Consent|0
4722800|NCT02023099|16286024|P1|Overall Study|Withdrawn Consent|3
4722801|NCT02023099|16286022|P3|Overall Study|Non-fatal Adverse Event (AE)|1
4722802|NCT02023099|16286023|P2|Overall Study|Non-fatal Adverse Event (AE)|0
4722803|NCT02023099|16286024|P1|Overall Study|Non-fatal Adverse Event (AE)|0
4722804|NCT02022748|16286047|P3|Overall Study|Withdrawal by Subject|0
4722805|NCT02022748|16286048|P2|Overall Study|Withdrawal by Subject|1
4722806|NCT02022748|16286049|P1|Overall Study|Withdrawal by Subject|0
4722807|NCT02022748|16286047|P3|Overall Study|Adverse Event|0
4722808|NCT02022748|16286048|P2|Overall Study|Adverse Event|1
4722809|NCT02022748|16286049|P1|Overall Study|Adverse Event|1
4722810|NCT02022670|16286075|P3|Overall Study|Adverse Event|1
4722811|NCT02022670|16286076|P2|Overall Study|Adverse Event|0
4722812|NCT02022670|16286077|P1|Overall Study|Adverse Event|1
4722813|NCT02022657|16286091|P6|Overall Study|Physician Decision|1
4722814|NCT02022657|16286092|P5|Overall Study|Physician Decision|0
4722815|NCT02022657|16286093|P4|Overall Study|Physician Decision|0
4722816|NCT02022657|16286094|P3|Overall Study|Physician Decision|0
4722817|NCT02022657|16286095|P2|Overall Study|Physician Decision|0
4722818|NCT02022657|16286096|P1|Overall Study|Physician Decision|0
4722819|NCT02022657|16286091|P6|Overall Study|Withdrawal by Subject|0
4722820|NCT02022657|16286092|P5|Overall Study|Withdrawal by Subject|0
4722821|NCT02022657|16286093|P4|Overall Study|Withdrawal by Subject|0
4722822|NCT02022657|16286094|P3|Overall Study|Withdrawal by Subject|1
4722823|NCT02022657|16286095|P2|Overall Study|Withdrawal by Subject|0
4722824|NCT02022657|16286096|P1|Overall Study|Withdrawal by Subject|2
4722825|NCT02022007|16286146|P3|Overall Study|Noncompliant|1
4722826|NCT02022007|16286147|P2|Overall Study|Noncompliant|0
4722827|NCT02022007|16286148|P1|Overall Study|Noncompliant|0
4722828|NCT02022007|16286146|P3|Overall Study|Withdrawal by Subject|1
4722829|NCT02022007|16286147|P2|Overall Study|Withdrawal by Subject|1
4722830|NCT02022007|16286148|P1|Overall Study|Withdrawal by Subject|1
4722831|NCT02021656|16286231|P1|Overall Study|Withdrew Consent|2
4722832|NCT02021656|16286231|P1|Overall Study|Lost to Follow-up|1
4722833|NCT02021656|16286231|P1|Overall Study|Lack of Efficacy|2
4722834|NCT02021656|16286231|P1|Overall Study|Adverse Event|1
4722835|NCT02021643|16286251|P4|Overall Study|Withdrew Consent|0
4722836|NCT02021643|16286252|P3|Overall Study|Withdrew Consent|0
4722837|NCT02021643|16286253|P2|Overall Study|Withdrew Consent|1
4722838|NCT02021643|16286254|P1|Overall Study|Withdrew Consent|0
4722839|NCT02021643|16286251|P4|Overall Study|Lost to Follow-up|0
4722840|NCT02021643|16286252|P3|Overall Study|Lost to Follow-up|0
4722841|NCT02021643|16286253|P2|Overall Study|Lost to Follow-up|1
4722842|NCT02021643|16286254|P1|Overall Study|Lost to Follow-up|0
4722843|NCT02021643|16286251|P4|Overall Study|Lack of Efficacy|12
4722844|NCT02021643|16286252|P3|Overall Study|Lack of Efficacy|0
4722845|NCT02021643|16286253|P2|Overall Study|Lack of Efficacy|6
4722846|NCT02021643|16286254|P1|Overall Study|Lack of Efficacy|7
4722847|NCT02021643|16286251|P4|Overall Study|Investigator's Discretion|0
4722848|NCT02021643|16286252|P3|Overall Study|Investigator's Discretion|0
4722849|NCT02021643|16286253|P2|Overall Study|Investigator's Discretion|0
4722850|NCT02021643|16286254|P1|Overall Study|Investigator's Discretion|1
4722851|NCT02021643|16286251|P4|Overall Study|Death|0
4722852|NCT02021643|16286252|P3|Overall Study|Death|0
4722853|NCT02021643|16286253|P2|Overall Study|Death|1
4722854|NCT02021643|16286254|P1|Overall Study|Death|0
4722855|NCT02021643|16286251|P4|Overall Study|Adverse Event|0
4722856|NCT02021643|16286252|P3|Overall Study|Adverse Event|0
4722857|NCT02021643|16286253|P2|Overall Study|Adverse Event|1
4722858|NCT02021643|16286254|P1|Overall Study|Adverse Event|0
4722859|NCT02021643|16286251|P4|Overall Study|Enrolled but Never Treated|0
4722860|NCT02021643|16286252|P3|Overall Study|Enrolled but Never Treated|0
4722861|NCT02021643|16286253|P2|Overall Study|Enrolled but Never Treated|0
4722862|NCT02021643|16286254|P1|Overall Study|Enrolled but Never Treated|1
4722863|NCT02021565|16286296|P2|3-month Follow-up|Protocol Violation|2
4722864|NCT02021565|16286297|P1|3-month Follow-up|Protocol Violation|3
4722865|NCT02021565|16286296|P2|3-month Follow-up|Withdrawal by Subject|0
4722866|NCT02021565|16286297|P1|3-month Follow-up|Withdrawal by Subject|4
4722867|NCT02021565|16286296|P2|3-month Follow-up|Death|0
4722868|NCT02021565|16286297|P1|3-month Follow-up|Death|3
4722869|NCT02021565|16286296|P2|Baseline Through Intervention|Lost to Follow-up|2
4722870|NCT02021565|16286297|P1|Baseline Through Intervention|Lost to Follow-up|4
4722871|NCT02021565|16286296|P2|Baseline Through Intervention|Protocol Violation|7
4722872|NCT02021565|16286297|P1|Baseline Through Intervention|Protocol Violation|0
4722873|NCT02021565|16286296|P2|Baseline Through Intervention|Withdrawal by Subject|8
4722874|NCT02021565|16286297|P1|Baseline Through Intervention|Withdrawal by Subject|8
4722875|NCT02021565|16286296|P2|Baseline Through Intervention|Death|1
4722876|NCT02021565|16286297|P1|Baseline Through Intervention|Death|0
4722877|NCT02021331|16286317|P2|Overall Study|Adverse Event|2
4722878|NCT02021331|16286318|P1|Overall Study|Adverse Event|0
4722879|NCT02021292|16286330|P2|Overall Study|Death|1
4722880|NCT02021292|16286331|P1|Overall Study|Death|0
4722881|NCT02021292|16286330|P2|Overall Study|Lost to Follow-up|1
4722882|NCT02021292|16286331|P1|Overall Study|Lost to Follow-up|0
4722883|NCT02021292|16286330|P2|Overall Study|Physician Decision|1
4722884|NCT02021292|16286331|P1|Overall Study|Physician Decision|0
4722885|NCT02020941|16286361|P1|Overall Study|Disease Progression|4
4722886|NCT02020941|16286361|P1|Overall Study|Withdrawal by Subject|1
4722887|NCT02020941|16286361|P1|Overall Study|Physician Decision|2
4722888|NCT02020941|16286361|P1|Overall Study|Adverse Event|1
4722889|NCT02020889|16286372|P2|Overall Study|Withdrawal by Subject|2
4722890|NCT02020889|16286373|P1|Overall Study|Withdrawal by Subject|3
4722891|NCT02020889|16286372|P2|Overall Study|Physician Decision|0
4722892|NCT02020889|16286373|P1|Overall Study|Physician Decision|2
4722893|NCT02020889|16286372|P2|Overall Study|Lost to Follow-up|0
4722894|NCT02020889|16286373|P1|Overall Study|Lost to Follow-up|1
4722895|NCT02020889|16286372|P2|Overall Study|Lack of Efficacy|0
4722896|NCT02020889|16286373|P1|Overall Study|Lack of Efficacy|1
4722897|NCT02020889|16286372|P2|Overall Study|Adverse Event|1
4722898|NCT02020889|16286373|P1|Overall Study|Adverse Event|0
4722899|NCT02020863|16286427|P1|Overall Study|Team chose not to place an a line|1
4722900|NCT02020863|16286427|P1|Overall Study|Discovery of Metastatic disease|4
4722901|NCT02020616|16286457|P7|Overall Study|Lack of Efficacy|0
4722902|NCT02020616|16286458|P6|Overall Study|Lack of Efficacy|0
4722903|NCT02020616|16286459|P5|Overall Study|Lack of Efficacy|1
4722904|NCT02020616|16286460|P4|Overall Study|Lack of Efficacy|0
4722905|NCT02020616|16286461|P3|Overall Study|Lack of Efficacy|0
4722906|NCT02020616|16286462|P2|Overall Study|Lack of Efficacy|0
4722907|NCT02020616|16286463|P1|Overall Study|Lack of Efficacy|0
4722908|NCT02020616|16286457|P7|Overall Study|Randomized in Error|0
4722909|NCT02020616|16286458|P6|Overall Study|Randomized in Error|0
4722910|NCT02020616|16286459|P5|Overall Study|Randomized in Error|0
4722911|NCT02020616|16286460|P4|Overall Study|Randomized in Error|1
4722912|NCT02020616|16286461|P3|Overall Study|Randomized in Error|0
4722913|NCT02020616|16286462|P2|Overall Study|Randomized in Error|0
4722914|NCT02020616|16286463|P1|Overall Study|Randomized in Error|0
4722915|NCT02020616|16286457|P7|Overall Study|Early Termination Criteria Met|0
4722916|NCT02020616|16286458|P6|Overall Study|Early Termination Criteria Met|1
4722917|NCT02020616|16286459|P5|Overall Study|Early Termination Criteria Met|0
4722918|NCT02020616|16286460|P4|Overall Study|Early Termination Criteria Met|0
4722919|NCT02020616|16286461|P3|Overall Study|Early Termination Criteria Met|1
4722920|NCT02020616|16286462|P2|Overall Study|Early Termination Criteria Met|0
4722921|NCT02020616|16286463|P1|Overall Study|Early Termination Criteria Met|0
4722922|NCT02020616|16286457|P7|Overall Study|Lost to Follow-up|0
4722923|NCT02020616|16286458|P6|Overall Study|Lost to Follow-up|1
4722924|NCT02020616|16286459|P5|Overall Study|Lost to Follow-up|1
4722925|NCT02020616|16286460|P4|Overall Study|Lost to Follow-up|1
4722926|NCT02020616|16286461|P3|Overall Study|Lost to Follow-up|0
4722927|NCT02020616|16286462|P2|Overall Study|Lost to Follow-up|1
4722928|NCT02020616|16286463|P1|Overall Study|Lost to Follow-up|0
4722929|NCT02020616|16286457|P7|Overall Study|Withdrawal by Subject|1
4722930|NCT02020616|16286458|P6|Overall Study|Withdrawal by Subject|1
4722931|NCT02020616|16286459|P5|Overall Study|Withdrawal by Subject|0
4722932|NCT02020616|16286460|P4|Overall Study|Withdrawal by Subject|0
4722933|NCT02020616|16286461|P3|Overall Study|Withdrawal by Subject|1
4722934|NCT02020616|16286462|P2|Overall Study|Withdrawal by Subject|0
4722935|NCT02020616|16286463|P1|Overall Study|Withdrawal by Subject|0
4722936|NCT02020616|16286457|P7|Overall Study|Physician Decision|2
4722937|NCT02020616|16286458|P6|Overall Study|Physician Decision|1
4722938|NCT02020616|16286459|P5|Overall Study|Physician Decision|0
4722939|NCT02020616|16286460|P4|Overall Study|Physician Decision|0
4722940|NCT02020616|16286461|P3|Overall Study|Physician Decision|0
4722941|NCT02020616|16286462|P2|Overall Study|Physician Decision|0
4722942|NCT02020616|16286463|P1|Overall Study|Physician Decision|0
4722943|NCT02020616|16286457|P7|Overall Study|Adverse Event|1
4722944|NCT02020616|16286458|P6|Overall Study|Adverse Event|1
4722945|NCT02020616|16286459|P5|Overall Study|Adverse Event|0
4722946|NCT02020616|16286460|P4|Overall Study|Adverse Event|0
4722947|NCT02020616|16286461|P3|Overall Study|Adverse Event|0
4722948|NCT02020616|16286462|P2|Overall Study|Adverse Event|0
4722949|NCT02020616|16286463|P1|Overall Study|Adverse Event|0
4722950|NCT02020577|16286556|P2|Overall Study|Other than stated above|1
4722951|NCT02020577|16286557|P1|Overall Study|Other than stated above|0
4722952|NCT02020577|16286556|P2|Overall Study|Withdrawal by Subject|1
4722953|NCT02020577|16286557|P1|Overall Study|Withdrawal by Subject|0
4722954|NCT02020577|16286556|P2|Overall Study|Other AE or clinical progression|15
4722955|NCT02020577|16286557|P1|Overall Study|Other AE or clinical progression|0
4722956|NCT02020577|16286556|P2|Overall Study|Progressive disease|38
4722957|NCT02020577|16286557|P1|Overall Study|Progressive disease|3
4722958|NCT02020512|16286584|P1|Overall Study|Protocol Violation|4
4722959|NCT02020512|16286584|P1|Overall Study|Lost to Follow-up|3
4722960|NCT02020512|16286584|P1|Overall Study|Adverse Event|1
4722961|NCT02020031|16286663|P2|Overall Study|Physician Decision|1
4722962|NCT02020031|16286664|P1|Overall Study|Physician Decision|1
4722963|NCT02019979|16286685|P1|Overall Study|study terminated|14
4722964|NCT02019927|16286701|P6|Overall Study|Lost to Follow-up|1
4722965|NCT02019927|16286702|P5|Overall Study|Lost to Follow-up|3
4722966|NCT02019927|16286703|P4|Overall Study|Lost to Follow-up|2
4722967|NCT02019927|16286704|P3|Overall Study|Lost to Follow-up|1
4722968|NCT02019927|16286705|P2|Overall Study|Lost to Follow-up|4
4722969|NCT02019927|16286706|P1|Overall Study|Lost to Follow-up|2
4722970|NCT02019719|16286806|P5|Overall Study|Physician Decision|0
4722971|NCT02019719|16286807|P4|Overall Study|Physician Decision|0
4722972|NCT02019719|16286808|P3|Overall Study|Physician Decision|0
4722973|NCT02019719|16286809|P2|Overall Study|Physician Decision|0
4722974|NCT02019719|16286810|P1|Overall Study|Physician Decision|2
4722975|NCT02019719|16286806|P5|Overall Study|Protocol defined stopping criteria|1
4722976|NCT02019719|16286807|P4|Overall Study|Protocol defined stopping criteria|1
4722977|NCT02019719|16286808|P3|Overall Study|Protocol defined stopping criteria|0
4722978|NCT02019719|16286809|P2|Overall Study|Protocol defined stopping criteria|0
4722979|NCT02019719|16286810|P1|Overall Study|Protocol defined stopping criteria|2
4722980|NCT02019719|16286806|P5|Overall Study|Protocol Violation|0
4722981|NCT02019719|16286807|P4|Overall Study|Protocol Violation|0
4722982|NCT02019719|16286808|P3|Overall Study|Protocol Violation|0
4722983|NCT02019719|16286809|P2|Overall Study|Protocol Violation|1
4722984|NCT02019719|16286810|P1|Overall Study|Protocol Violation|1
4722985|NCT02019719|16286806|P5|Overall Study|Adverse Event|1
4722986|NCT02019719|16286807|P4|Overall Study|Adverse Event|1
4722987|NCT02019719|16286808|P3|Overall Study|Adverse Event|0
4722988|NCT02019719|16286809|P2|Overall Study|Adverse Event|0
4722989|NCT02019719|16286810|P1|Overall Study|Adverse Event|1
4722990|NCT02019667|16286907|P2|2nd Intervention (6 Months)|Physician Decision|1
4722991|NCT02019667|16286908|P1|2nd Intervention (6 Months)|Physician Decision|0
4722992|NCT02019667|16286907|P2|2nd Intervention (6 Months)|Adverse Event|1
4722993|NCT02019667|16286908|P1|2nd Intervention (6 Months)|Adverse Event|0
4722994|NCT02019667|16286907|P2|First Intervention (6 Months)|Adverse Event|1
4722995|NCT02019667|16286908|P1|First Intervention (6 Months)|Adverse Event|0
4722996|NCT02019602|16286928|P2|Screening Period|Adverse Event|0
4722997|NCT02019602|16286929|P1|Screening Period|Adverse Event|1
4722998|NCT02019602|16286928|P2|Screening Period|Ineligibility|0
4722999|NCT02019602|16286929|P1|Screening Period|Ineligibility|4
4723000|NCT02019550|16286958|P2|Treatment Period 1 (4 Weeks)|Adverse Event|1
4723001|NCT02019550|16286959|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
4723002|NCT02019472|16287000|P3|Overall Study|Other|6
4723003|NCT02019472|16287001|P2|Overall Study|Other|8
4723004|NCT02019472|16287002|P1|Overall Study|Other|3
4723005|NCT02019472|16287000|P3|Overall Study|Withdrawal by Subject|11
4723006|NCT02019472|16287001|P2|Overall Study|Withdrawal by Subject|10
4723007|NCT02019472|16287002|P1|Overall Study|Withdrawal by Subject|11
4723008|NCT02019472|16287000|P3|Overall Study|Pregnancy|2
4723009|NCT02019472|16287001|P2|Overall Study|Pregnancy|2
4723010|NCT02019472|16287002|P1|Overall Study|Pregnancy|1
4723011|NCT02019472|16287000|P3|Overall Study|Physician Decision|0
4723012|NCT02019472|16287001|P2|Overall Study|Physician Decision|2
4723013|NCT02019472|16287002|P1|Overall Study|Physician Decision|1
4723014|NCT02019472|16287000|P3|Overall Study|Lost to Follow-up|1
4723015|NCT02019472|16287001|P2|Overall Study|Lost to Follow-up|2
4723016|NCT02019472|16287002|P1|Overall Study|Lost to Follow-up|0
4723017|NCT02019472|16287000|P3|Overall Study|Lack of Efficacy|4
4723018|NCT02019472|16287001|P2|Overall Study|Lack of Efficacy|4
4723019|NCT02019472|16287002|P1|Overall Study|Lack of Efficacy|7
4723020|NCT02019472|16287000|P3|Overall Study|Death|1
4723021|NCT02019472|16287001|P2|Overall Study|Death|1
4723022|NCT02019472|16287002|P1|Overall Study|Death|0
4723023|NCT02019472|16287000|P3|Overall Study|Adverse Event|17
4723024|NCT02019472|16287001|P2|Overall Study|Adverse Event|23
4723025|NCT02019472|16287002|P1|Overall Study|Adverse Event|14
4723026|NCT02019420|16287025|P2|Overall Study|Transferred to other care facility|1
4723027|NCT02019420|16287026|P1|Overall Study|Transferred to other care facility|1
4723028|NCT02019420|16287025|P2|Overall Study|Death|99
4723029|NCT02019420|16287026|P1|Overall Study|Death|104
4723030|NCT02019420|16287025|P2|Overall Study|At request of sponsor or investigator|1
4723031|NCT02019420|16287026|P1|Overall Study|At request of sponsor or investigator|0
4723032|NCT02019420|16287025|P2|Overall Study|Withdrawal by Subject|3
4723033|NCT02019420|16287026|P1|Overall Study|Withdrawal by Subject|1
4723034|NCT02019420|16287025|P2|Overall Study|Did not receive study drug|2
4723035|NCT02019420|16287026|P1|Overall Study|Did not receive study drug|2
4723036|NCT02019277|16287054|P1|Overall Study|Adverse Event|1
4723037|NCT02019277|16287054|P1|Overall Study|Did no Cooperate|1
4723038|NCT02019277|16287054|P1|Overall Study|Death|7
4723039|NCT02019277|16287054|P1|Overall Study|Withdrawal by Subject|3
4723040|NCT02019264|16287073|P2|Overall Study|Missing|11
4723041|NCT02019264|16287074|P1|Overall Study|Missing|14
4723042|NCT02019264|16287073|P2|Overall Study|Administrative reason|28
4723043|NCT02019264|16287074|P1|Overall Study|Administrative reason|36
4723044|NCT02019264|16287073|P2|Overall Study|Withdrawal by Subject|117
4723045|NCT02019264|16287074|P1|Overall Study|Withdrawal by Subject|142
4723046|NCT02019264|16287073|P2|Overall Study|Lost to Follow-up|47
4723047|NCT02019264|16287074|P1|Overall Study|Lost to Follow-up|50
4723048|NCT02019264|16287073|P2|Overall Study|Not treated|4
4723049|NCT02019264|16287074|P1|Overall Study|Not treated|6
4723050|NCT02019108|16287110|P2|Overall Study|Lost to Follow-up|7
4723051|NCT02019108|16287111|P1|Overall Study|Lost to Follow-up|5
4723052|NCT02018887|16287153|P11|Part C: Cohort 8 Overall|Physician Decision|1
4723053|NCT02018887|16287154|P10|Part C: Cohort 8 Overall|Physician Decision|0
4723054|NCT02018887|16287155|P9|Part C: Cohort 8 Overall|Physician Decision|2
4723055|NCT02018887|16287156|P8|Part C: Cohort 8 Overall|Physician Decision|0
4723056|NCT02018887|16287157|P7|Part C: Cohort 8 Overall|Physician Decision|0
4723057|NCT02018887|16287158|P6|Part C: Cohort 8 Overall|Physician Decision|0
4723058|NCT02018887|16287159|P5|Part C: Cohort 8 Overall|Physician Decision|0
4723059|NCT02018887|16287160|P4|Part C: Cohort 8 Overall|Physician Decision|0
4723060|NCT02018887|16287161|P3|Part C: Cohort 8 Overall|Physician Decision|0
4723061|NCT02018887|16287162|P2|Part C: Cohort 8 Overall|Physician Decision|0
4723062|NCT02018887|16287163|P1|Part C: Cohort 8 Overall|Physician Decision|0
4723063|NCT02018887|16287153|P11|Part C: Cohort 8 Overall|Adverse Event|0
4723064|NCT02018887|16287154|P10|Part C: Cohort 8 Overall|Adverse Event|3
4723065|NCT02018887|16287155|P9|Part C: Cohort 8 Overall|Adverse Event|1
4723066|NCT02018887|16287156|P8|Part C: Cohort 8 Overall|Adverse Event|0
4723067|NCT02018887|16287157|P7|Part C: Cohort 8 Overall|Adverse Event|0
4723068|NCT02018887|16287158|P6|Part C: Cohort 8 Overall|Adverse Event|0
4723069|NCT02018887|16287159|P5|Part C: Cohort 8 Overall|Adverse Event|0
4723070|NCT02018887|16287160|P4|Part C: Cohort 8 Overall|Adverse Event|0
4723071|NCT02018887|16287161|P3|Part C: Cohort 8 Overall|Adverse Event|0
4723072|NCT02018887|16287162|P2|Part C: Cohort 8 Overall|Adverse Event|0
4723073|NCT02018887|16287163|P1|Part C: Cohort 8 Overall|Adverse Event|0
4723074|NCT02018887|16287153|P11|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723075|NCT02018887|16287154|P10|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723076|NCT02018887|16287155|P9|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723077|NCT02018887|16287156|P8|Part B: Cohorts 3-7 Overall|Adverse Event|4
4723078|NCT02018887|16287157|P7|Part B: Cohorts 3-7 Overall|Adverse Event|1
4723079|NCT02018887|16287158|P6|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723080|NCT02018887|16287159|P5|Part B: Cohorts 3-7 Overall|Adverse Event|1
4723081|NCT02018887|16287160|P4|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723082|NCT02018887|16287161|P3|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723083|NCT02018887|16287162|P2|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723084|NCT02018887|16287163|P1|Part B: Cohorts 3-7 Overall|Adverse Event|0
4723085|NCT02018887|16287153|P11|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723086|NCT02018887|16287154|P10|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723087|NCT02018887|16287155|P9|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723088|NCT02018887|16287156|P8|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723089|NCT02018887|16287157|P7|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723090|NCT02018887|16287158|P6|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723091|NCT02018887|16287159|P5|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723092|NCT02018887|16287160|P4|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723093|NCT02018887|16287161|P3|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723094|NCT02018887|16287162|P2|Part A: Cohorts 1-2: Period 3|Adverse Event|0
4723095|NCT02018887|16287163|P1|Part A: Cohorts 1-2: Period 3|Adverse Event|1
4723096|NCT02018822|16287252|P3|Overall Study|Lost to Follow-up|5
4723097|NCT02018822|16287253|P2|Overall Study|Lost to Follow-up|6
4723098|NCT02018822|16287254|P1|Overall Study|Lost to Follow-up|6
4723099|NCT02018822|16287252|P3|Overall Study|Physician Decision|1
4723100|NCT02018822|16287253|P2|Overall Study|Physician Decision|1
4723101|NCT02018822|16287254|P1|Overall Study|Physician Decision|0
4723102|NCT02018822|16287252|P3|Overall Study|filling replaced by crown|0
4723103|NCT02018822|16287253|P2|Overall Study|filling replaced by crown|1
4723104|NCT02018822|16287254|P1|Overall Study|filling replaced by crown|0
4723105|NCT02018562|16287334|P2|Overall Study|Discharged prior to study completion|0
4723106|NCT02018562|16287335|P1|Overall Study|Discharged prior to study completion|1
4723107|NCT02018562|16287334|P2|Overall Study|Withdrawal by Subject|0
4723108|NCT02018562|16287335|P1|Overall Study|Withdrawal by Subject|2
4723109|NCT02018458|16287353|P1|Overall Study|Death|4
4723110|NCT02018042|16287380|P1|Overall Study|Withdrawal by Subject|1
4723111|NCT02017964|16287386|P1|Overall Study|Patient deemed ineligible|1
4723112|NCT02017899|16287400|P6|Overall Study|Withdrawal by Subject|0
4723113|NCT02017899|16287401|P5|Overall Study|Withdrawal by Subject|1
4723114|NCT02017899|16287402|P4|Overall Study|Withdrawal by Subject|1
4723115|NCT02017899|16287403|P3|Overall Study|Withdrawal by Subject|0
4723116|NCT02017899|16287404|P2|Overall Study|Withdrawal by Subject|0
4723117|NCT02017899|16287405|P1|Overall Study|Withdrawal by Subject|0
4723118|NCT02017860|16287479|P1|Overall Study|Withdrawal by Subject|1
4723119|NCT02017860|16287479|P1|Overall Study|Adverse Event|1
4723120|NCT02017535|16287498|P4|Overall Study|Withdrawal by Subject|0
4723121|NCT02017535|16287499|P3|Overall Study|Withdrawal by Subject|0
4723122|NCT02017535|16287500|P2|Overall Study|Withdrawal by Subject|0
4723123|NCT02017535|16287501|P1|Overall Study|Withdrawal by Subject|1
4723124|NCT02017522|16287523|P1|Overall Study|Withdrawal by Subject|1
4723125|NCT02017223|16287541|P1|Overall Study|Algorithm problems|2
4723126|NCT02017015|16287596|P1|Overall Study|Physician Decision|2
4723127|NCT02017015|16287596|P1|Overall Study|Non-compliance with study drug|2
4723128|NCT02017015|16287596|P1|Overall Study|Progressive Disease|31
4723129|NCT02017015|16287596|P1|Overall Study|Death|4
4723130|NCT02017015|16287596|P1|Overall Study|Withdrawal by Subject|21
4723131|NCT02017015|16287596|P1|Overall Study|Adverse Event|9
4723132|NCT02016898|16287621|P2|Overall Study|Lost to Follow-up|4
4723133|NCT02016898|16287622|P1|Overall Study|Lost to Follow-up|4
4723134|NCT02016898|16287621|P2|Overall Study|Death|1
4723135|NCT02016898|16287622|P1|Overall Study|Death|1
4723136|NCT02016716|16287679|P3|Overall Study|Lost to Follow-up|1
4723137|NCT02016716|16287680|P2|Overall Study|Lost to Follow-up|2
4723138|NCT02016716|16287681|P1|Overall Study|Lost to Follow-up|1
4723139|NCT02016716|16287679|P3|Overall Study|Protocol-specified Criteria|0
4723140|NCT02016716|16287680|P2|Overall Study|Protocol-specified Criteria|1
4723141|NCT02016716|16287681|P1|Overall Study|Protocol-specified Criteria|0
4723142|NCT02016716|16287679|P3|Overall Study|Withdrawal by Subject|5
4723143|NCT02016716|16287680|P2|Overall Study|Withdrawal by Subject|5
4723144|NCT02016716|16287681|P1|Overall Study|Withdrawal by Subject|5
4723145|NCT02016690|16287702|P1|Overall Study|Hospitalized for RSV at study start|3
4723146|NCT02016690|16287702|P1|Overall Study|Did not meet inclusion criteria|13
4723147|NCT02016690|16287702|P1|Overall Study|Excluded from SAS: Ineligible for study|2
4723148|NCT02016690|16287702|P1|Overall Study|Excluded from SAS: Early treatment|2
4723149|NCT02016690|16287702|P1|Overall Study|Excluded from SAS: Duplication|2
4723150|NCT02016690|16287702|P1|Overall Study|Excluded from SAS: Enrollment violation|2
4723151|NCT02016625|16287715|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0
4723152|NCT02016625|16287716|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2
4723153|NCT02016625|16287715|P2|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0
4723154|NCT02016625|16287716|P1|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1
4723155|NCT02016625|16287715|P2|Cyclo or Tac (Single Dose, Day 1)|not treated|1
4723156|NCT02016625|16287716|P1|Cyclo or Tac (Single Dose, Day 1)|not treated|0
4723157|NCT02016482|16287804|P2|Period B|Required Alternative/Prohibited Therapy|2
4723158|NCT02016482|16287805|P1|Period B|Required Alternative/Prohibited Therapy|0
4723159|NCT02016482|16287804|P2|Period B|Other|0
4723160|NCT02016482|16287805|P1|Period B|Other|4
4723161|NCT02016482|16287804|P2|Period B|Lack of Efficacy|4
4723162|NCT02016482|16287805|P1|Period B|Lack of Efficacy|6
4723163|NCT02016482|16287804|P2|Period B|Lost to Follow-up|0
4723164|NCT02016482|16287805|P1|Period B|Lost to Follow-up|2
4723165|NCT02016482|16287804|P2|Period B|Withdrawal by Subject|1
4723166|NCT02016482|16287805|P1|Period B|Withdrawal by Subject|1
4723167|NCT02016482|16287804|P2|Period A|Required Alternative/Prohibited Therapy|1
4723168|NCT02016482|16287805|P1|Period A|Required Alternative/Prohibited Therapy|0
4723169|NCT02016482|16287804|P2|Period A|Protocol Violation|1
4723170|NCT02016482|16287805|P1|Period A|Protocol Violation|0
4723171|NCT02016482|16287804|P2|Period A|Other|0
4723172|NCT02016482|16287805|P1|Period A|Other|3
4723173|NCT02016482|16287804|P2|Period A|Lack of Efficacy|1
4723174|NCT02016482|16287805|P1|Period A|Lack of Efficacy|2
4723175|NCT02016482|16287804|P2|Period A|Lost to Follow-up|3
4723176|NCT02016482|16287805|P1|Period A|Lost to Follow-up|3
4723177|NCT02016482|16287804|P2|Period A|Withdrawal by Subject|4
4723178|NCT02016482|16287805|P1|Period A|Withdrawal by Subject|3
4723179|NCT02016482|16287804|P2|Period A|Adverse Event|5
4723180|NCT02016482|16287805|P1|Period A|Adverse Event|3
4723181|NCT02016300|16287895|P2|Overall Study|Lost to Follow-up|3
4723182|NCT02016300|16287896|P1|Overall Study|Lost to Follow-up|0
4723183|NCT02016183|16287927|P1|Overall Study|Protocol Violation|52
4723184|NCT02016183|16287927|P1|Overall Study|Case Report Forms Uncollected|13
4723185|NCT02016170|16287937|P3|Overall Study|Protocol Violation|0
4723186|NCT02016170|16287938|P2|Overall Study|Protocol Violation|0
4723187|NCT02016170|16287939|P1|Overall Study|Protocol Violation|1
4723188|NCT02016170|16287937|P3|Overall Study|Adverse Event|0
4723189|NCT02016170|16287938|P2|Overall Study|Adverse Event|1
4723190|NCT02016170|16287939|P1|Overall Study|Adverse Event|1
4723191|NCT02016105|16287950|P6|EXTENSION PERIOD|Lost to Follow-up|2
4723192|NCT02016105|16287951|P5|EXTENSION PERIOD|Lost to Follow-up|0
4723193|NCT02016105|16287952|P4|EXTENSION PERIOD|Lost to Follow-up|0
4723194|NCT02016105|16287953|P3|EXTENSION PERIOD|Lost to Follow-up|0
4723195|NCT02016105|16287954|P2|EXTENSION PERIOD|Lost to Follow-up|0
4723196|NCT02016105|16287955|P1|EXTENSION PERIOD|Lost to Follow-up|0
4723197|NCT02016105|16287950|P6|EXTENSION PERIOD|Non-compliance with study indication|0
4723198|NCT02016105|16287951|P5|EXTENSION PERIOD|Non-compliance with study indication|1
4723199|NCT02016105|16287952|P4|EXTENSION PERIOD|Non-compliance with study indication|0
4723200|NCT02016105|16287953|P3|EXTENSION PERIOD|Non-compliance with study indication|0
4723201|NCT02016105|16287954|P2|EXTENSION PERIOD|Non-compliance with study indication|0
4723202|NCT02016105|16287955|P1|EXTENSION PERIOD|Non-compliance with study indication|0
4723203|NCT02016105|16287950|P6|EXTENSION PERIOD|Withdrawal by Subject|2
4723204|NCT02016105|16287951|P5|EXTENSION PERIOD|Withdrawal by Subject|2
4723205|NCT02016105|16287952|P4|EXTENSION PERIOD|Withdrawal by Subject|2
4723206|NCT02016105|16287953|P3|EXTENSION PERIOD|Withdrawal by Subject|2
4723207|NCT02016105|16287954|P2|EXTENSION PERIOD|Withdrawal by Subject|0
4723208|NCT02016105|16287955|P1|EXTENSION PERIOD|Withdrawal by Subject|0
4723209|NCT02016105|16287950|P6|EXTENSION PERIOD|Adverse Event|0
4723210|NCT02016105|16287951|P5|EXTENSION PERIOD|Adverse Event|1
4723211|NCT02016105|16287952|P4|EXTENSION PERIOD|Adverse Event|0
4723212|NCT02016105|16287953|P3|EXTENSION PERIOD|Adverse Event|2
4723213|NCT02016105|16287954|P2|EXTENSION PERIOD|Adverse Event|0
4723214|NCT02016105|16287955|P1|EXTENSION PERIOD|Adverse Event|0
4723215|NCT02016105|16287950|P6|EXTENSION PERIOD|Lack of Efficacy|1
4723216|NCT02016105|16287951|P5|EXTENSION PERIOD|Lack of Efficacy|1
4723217|NCT02016105|16287952|P4|EXTENSION PERIOD|Lack of Efficacy|3
4723218|NCT02016105|16287953|P3|EXTENSION PERIOD|Lack of Efficacy|1
4723219|NCT02016105|16287954|P2|EXTENSION PERIOD|Lack of Efficacy|0
4723220|NCT02016105|16287955|P1|EXTENSION PERIOD|Lack of Efficacy|0
4723221|NCT02016105|16287950|P6|EXTENSION PERIOD|New therapy for study indication|1
4723222|NCT02016105|16287951|P5|EXTENSION PERIOD|New therapy for study indication|1
4723223|NCT02016105|16287952|P4|EXTENSION PERIOD|New therapy for study indication|0
4723224|NCT02016105|16287953|P3|EXTENSION PERIOD|New therapy for study indication|0
4723225|NCT02016105|16287954|P2|EXTENSION PERIOD|New therapy for study indication|0
4723226|NCT02016105|16287955|P1|EXTENSION PERIOD|New therapy for study indication|0
4723227|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Lost to Follow-up|1
4723228|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Lost to Follow-up|0
4723229|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Lost to Follow-up|0
4723230|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Lost to Follow-up|1
4723231|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Lost to Follow-up|0
4723232|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Lost to Follow-up|0
4723233|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Withdrawal by Subject|7
4723234|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Withdrawal by Subject|1
4723235|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Withdrawal by Subject|1
4723236|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Withdrawal by Subject|3
4723237|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Withdrawal by Subject|0
4723238|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Withdrawal by Subject|0
4723239|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Adverse Event|1
4723240|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Adverse Event|0
4723241|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Adverse Event|4
4723242|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Adverse Event|0
4723243|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Adverse Event|0
4723244|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Adverse Event|0
4723245|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Death|1
4723246|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Death|0
4723247|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Death|0
4723248|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Death|0
4723249|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Death|0
4723250|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Death|0
4723251|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Pregnancy|1
4723252|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Pregnancy|0
4723253|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Pregnancy|0
4723254|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Pregnancy|0
4723255|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Pregnancy|0
4723256|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Pregnancy|0
4723257|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Lack of Efficacy|2
4723258|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Lack of Efficacy|3
4723259|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Lack of Efficacy|6
4723260|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Lack of Efficacy|2
4723261|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Lack of Efficacy|0
4723262|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Lack of Efficacy|0
4723263|NCT02016105|16287950|P6|TREATMENT PERIOD 2|Non compliance study medication|1
4723264|NCT02016105|16287951|P5|TREATMENT PERIOD 2|Non compliance study medication|0
4723265|NCT02016105|16287952|P4|TREATMENT PERIOD 2|Non compliance study medication|0
4723266|NCT02016105|16287953|P3|TREATMENT PERIOD 2|Non compliance study medication|0
4723267|NCT02016105|16287954|P2|TREATMENT PERIOD 2|Non compliance study medication|0
4723268|NCT02016105|16287955|P1|TREATMENT PERIOD 2|Non compliance study medication|0
4723269|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Lost to Follow-up|0
4723270|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Lost to Follow-up|0
4723271|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Lost to Follow-up|0
4723272|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Lost to Follow-up|0
4723273|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Lost to Follow-up|4
4723274|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Lost to Follow-up|6
4723275|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Withdrawal by Subject|0
4723276|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Withdrawal by Subject|0
4723277|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Withdrawal by Subject|0
4723278|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Withdrawal by Subject|0
4723279|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Withdrawal by Subject|11
4723280|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Withdrawal by Subject|15
4723281|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Adverse Event|0
4723282|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Adverse Event|0
4723283|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Adverse Event|0
4723284|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Adverse Event|0
4723285|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Adverse Event|5
4723286|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Adverse Event|3
4723287|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Pregnancy|0
4723288|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Pregnancy|0
4723289|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Pregnancy|0
4723290|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Pregnancy|0
4723291|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Pregnancy|1
4723292|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Pregnancy|0
4723293|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Lack of Efficacy|0
4723294|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Lack of Efficacy|0
4723295|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Lack of Efficacy|0
4723296|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Lack of Efficacy|0
4723297|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Lack of Efficacy|2
4723298|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Lack of Efficacy|4
4723299|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Physician Decision|0
4723300|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Physician Decision|0
4723301|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Physician Decision|0
4723302|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Physician Decision|0
4723303|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Physician Decision|2
4723304|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Physician Decision|0
4723305|NCT02016105|16287950|P6|TREATMENT PERIOD 1|Protocol Violation|0
4723306|NCT02016105|16287951|P5|TREATMENT PERIOD 1|Protocol Violation|0
4723307|NCT02016105|16287952|P4|TREATMENT PERIOD 1|Protocol Violation|0
4723308|NCT02016105|16287953|P3|TREATMENT PERIOD 1|Protocol Violation|0
4723309|NCT02016105|16287954|P2|TREATMENT PERIOD 1|Protocol Violation|8
4723310|NCT02016105|16287955|P1|TREATMENT PERIOD 1|Protocol Violation|2
4723311|NCT02015793|16288014|P2|Overall Study|Withdrawal by Subject|1
4723312|NCT02015793|16288015|P1|Overall Study|Withdrawal by Subject|1
4723313|NCT02015793|16288014|P2|Overall Study|Adverse Event|3
4723314|NCT02015793|16288015|P1|Overall Study|Adverse Event|3
4723315|NCT02015754|16288045|P1|Overall Study|Lost to Follow-up|1
4723316|NCT02015754|16288045|P1|Overall Study|Change in treatment modality|5
4723317|NCT02015754|16288045|P1|Overall Study|Disease progression|5
4723318|NCT02015676|16288065|P3|Overall Study|Disease progression|1
4723319|NCT02015676|16288066|P2|Overall Study|Disease progression|1
4723320|NCT02015676|16288067|P1|Overall Study|Disease progression|3
4723321|NCT02015676|16288065|P3|Overall Study|Death|0
4723322|NCT02015676|16288066|P2|Overall Study|Death|1
4723323|NCT02015676|16288067|P1|Overall Study|Death|0
4723324|NCT02015676|16288065|P3|Overall Study|Administrative reasons|1
4723325|NCT02015676|16288066|P2|Overall Study|Administrative reasons|3
4723326|NCT02015676|16288067|P1|Overall Study|Administrative reasons|0
4723327|NCT02015676|16288065|P3|Overall Study|Withdrawal by Subject|1
4723328|NCT02015676|16288066|P2|Overall Study|Withdrawal by Subject|7
4723329|NCT02015676|16288067|P1|Overall Study|Withdrawal by Subject|1
4723330|NCT02015676|16288065|P3|Overall Study|Protocol Violation|0
4723331|NCT02015676|16288066|P2|Overall Study|Protocol Violation|0
4723332|NCT02015676|16288067|P1|Overall Study|Protocol Violation|1
4723333|NCT02015676|16288065|P3|Overall Study|Lack of Efficacy|0
4723334|NCT02015676|16288066|P2|Overall Study|Lack of Efficacy|4
4723335|NCT02015676|16288067|P1|Overall Study|Lack of Efficacy|2
4723336|NCT02015676|16288065|P3|Overall Study|Adverse Event|0
4723337|NCT02015676|16288066|P2|Overall Study|Adverse Event|18
4723338|NCT02015676|16288067|P1|Overall Study|Adverse Event|2
4723339|NCT02015663|16288083|P2|Overall Study|Administrative problems|11
4723340|NCT02015663|16288084|P1|Overall Study|Administrative problems|10
4723341|NCT02015663|16288083|P2|Overall Study|Adverse Event|0
4723342|NCT02015663|16288084|P1|Overall Study|Adverse Event|3
4723343|NCT02015663|16288083|P2|Overall Study|Protocol Violation|1
4723344|NCT02015663|16288084|P1|Overall Study|Protocol Violation|0
4723345|NCT02015663|16288083|P2|Overall Study|Withdrawal by Subject|0
4723346|NCT02015663|16288084|P1|Overall Study|Withdrawal by Subject|1
4723347|NCT02015663|16288083|P2|Overall Study|unsatisfactory therapeutic effect|0
4723348|NCT02015663|16288084|P1|Overall Study|unsatisfactory therapeutic effect|1
4723349|NCT02015637|16288115|P2|Overall Study|Did not take study drug|0
4723350|NCT02015637|16288116|P1|Overall Study|Did not take study drug|2
4723351|NCT02015637|16288115|P2|Overall Study|Adverse Event|0
4723352|NCT02015637|16288116|P1|Overall Study|Adverse Event|3
4723353|NCT02015637|16288115|P2|Overall Study|Lost to Follow-up|5
4723354|NCT02015637|16288116|P1|Overall Study|Lost to Follow-up|3
4723355|NCT02015546|16288127|P3|Overall Study|Screem Failure|3
4723356|NCT02015546|16288128|P2|Overall Study|Screem Failure|1
4723357|NCT02015546|16288129|P1|Overall Study|Screem Failure|2
4723358|NCT02015546|16288127|P3|Overall Study|Withdrawal by Subject|1
4723359|NCT02015546|16288128|P2|Overall Study|Withdrawal by Subject|1
4723360|NCT02015546|16288129|P1|Overall Study|Withdrawal by Subject|1
4723361|NCT02015481|16288161|P1|Overall Study|Death|1
4723362|NCT02015221|16288194|P2|Overall Study|Lost to Follow-up|0
4723363|NCT02015221|16288195|P1|Overall Study|Lost to Follow-up|1
4723364|NCT02015221|16288194|P2|Overall Study|Withdrawal by Subject|6
4723365|NCT02015221|16288195|P1|Overall Study|Withdrawal by Subject|8
4723366|NCT02015195|16288208|P7|Overall Study|Adverse Event|0
4723367|NCT02015195|16288209|P6|Overall Study|Adverse Event|0
4723368|NCT02015195|16288210|P5|Overall Study|Adverse Event|0
4723369|NCT02015195|16288211|P4|Overall Study|Adverse Event|1
4723370|NCT02015195|16288212|P3|Overall Study|Adverse Event|0
4723371|NCT02015195|16288213|P2|Overall Study|Adverse Event|0
4723372|NCT02015195|16288214|P1|Overall Study|Adverse Event|0
4723373|NCT02015104|16288237|P2|Overall Study|Withdrew consent prior to treatment|1
4723374|NCT02015104|16288238|P1|Overall Study|Withdrew consent prior to treatment|0
4723375|NCT02015104|16288237|P2|Overall Study|Withdrew consent after first dose drug|0
4723376|NCT02015104|16288238|P1|Overall Study|Withdrew consent after first dose drug|1
4723377|NCT02015065|16288255|P3|Overall Study|Death on study|1
4723378|NCT02015065|16288256|P2|Overall Study|Death on study|2
4723379|NCT02015065|16288257|P1|Overall Study|Death on study|1
4723380|NCT02015039|16288279|P2|Overall Study|Not eligible|1
4723381|NCT02015039|16288280|P1|Overall Study|Not eligible|0
4723382|NCT02014740|16288300|P2|Overall Study|Withdrawal by Subject|1
4723383|NCT02014740|16288301|P1|Overall Study|Withdrawal by Subject|2
4723384|NCT02014740|16288300|P2|Overall Study|Lost to Follow-up|4
4723385|NCT02014740|16288301|P1|Overall Study|Lost to Follow-up|4
4723386|NCT02014584|16288309|P6|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4723387|NCT02014584|16288310|P5|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1
4723388|NCT02014584|16288311|P4|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4723389|NCT02014584|16288312|P3|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4723390|NCT02014584|16288313|P2|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4723391|NCT02014584|16288314|P1|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0
4723392|NCT02014584|16288309|P6|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4723393|NCT02014584|16288310|P5|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4723394|NCT02014584|16288311|P4|Open-Label Period (24 Weeks)|Withdrawal by Subject|1
4723395|NCT02014584|16288312|P3|Open-Label Period (24 Weeks)|Withdrawal by Subject|3
4723396|NCT02014584|16288313|P2|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4723397|NCT02014584|16288314|P1|Open-Label Period (24 Weeks)|Withdrawal by Subject|0
4723398|NCT02014584|16288309|P6|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4723399|NCT02014584|16288310|P5|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4723400|NCT02014584|16288311|P4|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4723401|NCT02014584|16288312|P3|Open-Label Period (24 Weeks)|Lost to Follow-up|2
4723402|NCT02014584|16288313|P2|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4723403|NCT02014584|16288314|P1|Open-Label Period (24 Weeks)|Lost to Follow-up|0
4723404|NCT02014584|16288309|P6|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4723405|NCT02014584|16288310|P5|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4723406|NCT02014584|16288311|P4|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4723407|NCT02014584|16288312|P3|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0
4723408|NCT02014584|16288313|P2|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5
4723409|NCT02014584|16288314|P1|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2
4723410|NCT02014584|16288309|P6|Double-Blind Period (24 Weeks)|Protocol Violation|0
4723411|NCT02014584|16288310|P5|Double-Blind Period (24 Weeks)|Protocol Violation|0
4723412|NCT02014584|16288311|P4|Double-Blind Period (24 Weeks)|Protocol Violation|0
4723413|NCT02014584|16288312|P3|Double-Blind Period (24 Weeks)|Protocol Violation|0
4723414|NCT02014584|16288313|P2|Double-Blind Period (24 Weeks)|Protocol Violation|1
4723415|NCT02014584|16288314|P1|Double-Blind Period (24 Weeks)|Protocol Violation|0
4723416|NCT02014558|16288444|P13|Overall Study|Miscellaneous|1
4723417|NCT02014558|16288445|P12|Overall Study|Miscellaneous|11
4723418|NCT02014558|16288446|P11|Overall Study|Miscellaneous|12
4723419|NCT02014558|16288447|P10|Overall Study|Miscellaneous|3
4723420|NCT02014558|16288448|P9|Overall Study|Miscellaneous|1
4723421|NCT02014558|16288449|P8|Overall Study|Miscellaneous|1
4723422|NCT02014558|16288450|P7|Overall Study|Miscellaneous|0
4723423|NCT02014558|16288451|P6|Overall Study|Miscellaneous|1
4723424|NCT02014558|16288452|P5|Overall Study|Miscellaneous|0
4723425|NCT02014558|16288453|P4|Overall Study|Miscellaneous|1
4723426|NCT02014558|16288454|P3|Overall Study|Miscellaneous|1
4723427|NCT02014558|16288455|P2|Overall Study|Miscellaneous|1
4723428|NCT02014558|16288456|P1|Overall Study|Miscellaneous|2
4723429|NCT02014558|16288444|P13|Overall Study|Withdrawal by Subject|0
4723430|NCT02014558|16288445|P12|Overall Study|Withdrawal by Subject|10
4723431|NCT02014558|16288446|P11|Overall Study|Withdrawal by Subject|6
4723432|NCT02014558|16288447|P10|Overall Study|Withdrawal by Subject|2
4723433|NCT02014558|16288448|P9|Overall Study|Withdrawal by Subject|0
4723434|NCT02014558|16288449|P8|Overall Study|Withdrawal by Subject|0
4723435|NCT02014558|16288450|P7|Overall Study|Withdrawal by Subject|0
4723436|NCT02014558|16288451|P6|Overall Study|Withdrawal by Subject|0
4723437|NCT02014558|16288452|P5|Overall Study|Withdrawal by Subject|1
4723438|NCT02014558|16288453|P4|Overall Study|Withdrawal by Subject|0
4723439|NCT02014558|16288454|P3|Overall Study|Withdrawal by Subject|0
4723440|NCT02014558|16288455|P2|Overall Study|Withdrawal by Subject|0
4723441|NCT02014558|16288456|P1|Overall Study|Withdrawal by Subject|0
4723442|NCT02014558|16288444|P13|Overall Study|Progressive Disease|6
4723443|NCT02014558|16288445|P12|Overall Study|Progressive Disease|31
4723444|NCT02014558|16288446|P11|Overall Study|Progressive Disease|22
4723445|NCT02014558|16288447|P10|Overall Study|Progressive Disease|6
4723446|NCT02014558|16288448|P9|Overall Study|Progressive Disease|5
4723447|NCT02014558|16288449|P8|Overall Study|Progressive Disease|6
4723448|NCT02014558|16288450|P7|Overall Study|Progressive Disease|1
4723449|NCT02014558|16288451|P6|Overall Study|Progressive Disease|2
4723450|NCT02014558|16288452|P5|Overall Study|Progressive Disease|1
4723451|NCT02014558|16288453|P4|Overall Study|Progressive Disease|1
4723452|NCT02014558|16288454|P3|Overall Study|Progressive Disease|1
4723453|NCT02014558|16288455|P2|Overall Study|Progressive Disease|0
4723454|NCT02014558|16288456|P1|Overall Study|Progressive Disease|1
4723455|NCT02014558|16288444|P13|Overall Study|Lost to Follow-up|0
4723456|NCT02014558|16288445|P12|Overall Study|Lost to Follow-up|0
4723457|NCT02014558|16288446|P11|Overall Study|Lost to Follow-up|1
4723458|NCT02014558|16288447|P10|Overall Study|Lost to Follow-up|0
4723459|NCT02014558|16288448|P9|Overall Study|Lost to Follow-up|0
4723460|NCT02014558|16288449|P8|Overall Study|Lost to Follow-up|0
4723461|NCT02014558|16288450|P7|Overall Study|Lost to Follow-up|0
4723462|NCT02014558|16288451|P6|Overall Study|Lost to Follow-up|0
4723463|NCT02014558|16288452|P5|Overall Study|Lost to Follow-up|0
4723464|NCT02014558|16288453|P4|Overall Study|Lost to Follow-up|0
4723465|NCT02014558|16288454|P3|Overall Study|Lost to Follow-up|0
4723466|NCT02014558|16288455|P2|Overall Study|Lost to Follow-up|0
4723467|NCT02014558|16288456|P1|Overall Study|Lost to Follow-up|0
4723468|NCT02014558|16288444|P13|Overall Study|Lack of Efficacy|5
4723469|NCT02014558|16288445|P12|Overall Study|Lack of Efficacy|8
4723470|NCT02014558|16288446|P11|Overall Study|Lack of Efficacy|16
4723471|NCT02014558|16288447|P10|Overall Study|Lack of Efficacy|3
4723472|NCT02014558|16288448|P9|Overall Study|Lack of Efficacy|3
4723473|NCT02014558|16288449|P8|Overall Study|Lack of Efficacy|3
4723474|NCT02014558|16288450|P7|Overall Study|Lack of Efficacy|1
4723475|NCT02014558|16288451|P6|Overall Study|Lack of Efficacy|0
4723476|NCT02014558|16288452|P5|Overall Study|Lack of Efficacy|0
4723477|NCT02014558|16288453|P4|Overall Study|Lack of Efficacy|1
4723478|NCT02014558|16288454|P3|Overall Study|Lack of Efficacy|1
4723479|NCT02014558|16288455|P2|Overall Study|Lack of Efficacy|2
4723480|NCT02014558|16288456|P1|Overall Study|Lack of Efficacy|1
4723481|NCT02014558|16288444|P13|Overall Study|Death|2
4723482|NCT02014558|16288445|P12|Overall Study|Death|19
4723483|NCT02014558|16288446|P11|Overall Study|Death|5
4723484|NCT02014558|16288447|P10|Overall Study|Death|5
4723485|NCT02014558|16288448|P9|Overall Study|Death|2
4723486|NCT02014558|16288449|P8|Overall Study|Death|1
4723487|NCT02014558|16288450|P7|Overall Study|Death|1
4723488|NCT02014558|16288451|P6|Overall Study|Death|0
4723489|NCT02014558|16288452|P5|Overall Study|Death|0
4723490|NCT02014558|16288453|P4|Overall Study|Death|0
4723491|NCT02014558|16288454|P3|Overall Study|Death|0
4723492|NCT02014558|16288455|P2|Overall Study|Death|0
4723493|NCT02014558|16288456|P1|Overall Study|Death|1
4723494|NCT02014558|16288444|P13|Overall Study|Adverse Event|3
4723495|NCT02014558|16288445|P12|Overall Study|Adverse Event|21
4723496|NCT02014558|16288446|P11|Overall Study|Adverse Event|5
4723497|NCT02014558|16288447|P10|Overall Study|Adverse Event|2
4723498|NCT02014558|16288448|P9|Overall Study|Adverse Event|2
4723499|NCT02014558|16288449|P8|Overall Study|Adverse Event|0
4723500|NCT02014558|16288450|P7|Overall Study|Adverse Event|0
4723501|NCT02014558|16288451|P6|Overall Study|Adverse Event|0
4723502|NCT02014558|16288452|P5|Overall Study|Adverse Event|1
4723503|NCT02014558|16288453|P4|Overall Study|Adverse Event|0
4723504|NCT02014558|16288454|P3|Overall Study|Adverse Event|0
4723505|NCT02014558|16288455|P2|Overall Study|Adverse Event|0
4723506|NCT02014558|16288456|P1|Overall Study|Adverse Event|0
4723507|NCT02014558|16288444|P13|Overall Study|Never Received Study Drug|0
4723508|NCT02014558|16288445|P12|Overall Study|Never Received Study Drug|2
4723509|NCT02014558|16288446|P11|Overall Study|Never Received Study Drug|2
4723510|NCT02014558|16288447|P10|Overall Study|Never Received Study Drug|0
4723511|NCT02014558|16288448|P9|Overall Study|Never Received Study Drug|2
4723512|NCT02014558|16288449|P8|Overall Study|Never Received Study Drug|0
4723513|NCT02014558|16288450|P7|Overall Study|Never Received Study Drug|1
4723514|NCT02014558|16288451|P6|Overall Study|Never Received Study Drug|0
4723515|NCT02014558|16288452|P5|Overall Study|Never Received Study Drug|1
4723516|NCT02014558|16288453|P4|Overall Study|Never Received Study Drug|0
4723517|NCT02014558|16288454|P3|Overall Study|Never Received Study Drug|0
4723518|NCT02014558|16288455|P2|Overall Study|Never Received Study Drug|0
4723519|NCT02014558|16288456|P1|Overall Study|Never Received Study Drug|0
4723520|NCT02014480|16288821|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|1
4723521|NCT02014480|16288822|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4723522|NCT02014480|16288823|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4723523|NCT02014480|16288824|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4723524|NCT02014480|16288825|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4723525|NCT02014480|16288826|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4723526|NCT02014480|16288821|P6|Treatment Period 3 (14 Days)|Adverse Event|1
4723527|NCT02014480|16288822|P5|Treatment Period 3 (14 Days)|Adverse Event|0
4723528|NCT02014480|16288823|P4|Treatment Period 3 (14 Days)|Adverse Event|0
4723529|NCT02014480|16288824|P3|Treatment Period 3 (14 Days)|Adverse Event|1
4723530|NCT02014480|16288825|P2|Treatment Period 3 (14 Days)|Adverse Event|0
4723531|NCT02014480|16288826|P1|Treatment Period 3 (14 Days)|Adverse Event|0
4723532|NCT02014480|16288821|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4723533|NCT02014480|16288822|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4723534|NCT02014480|16288823|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4723535|NCT02014480|16288824|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4723536|NCT02014480|16288825|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
4723537|NCT02014480|16288826|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4723538|NCT02014480|16288821|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
4723539|NCT02014480|16288822|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
4723540|NCT02014480|16288823|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
4723541|NCT02014480|16288824|P3|Treatment Period 2 (14 Days)|Protocol Violation|2
4723542|NCT02014480|16288825|P2|Treatment Period 2 (14 Days)|Protocol Violation|1
4723543|NCT02014480|16288826|P1|Treatment Period 2 (14 Days)|Protocol Violation|1
4723544|NCT02014480|16288821|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4723545|NCT02014480|16288822|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4723546|NCT02014480|16288823|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4723547|NCT02014480|16288824|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
4723548|NCT02014480|16288825|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4723549|NCT02014480|16288826|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4723550|NCT02014480|16288821|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4723551|NCT02014480|16288822|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4723552|NCT02014480|16288823|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|2
4723553|NCT02014480|16288824|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4723554|NCT02014480|16288825|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4723555|NCT02014480|16288826|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4723556|NCT02014480|16288821|P6|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4723557|NCT02014480|16288822|P5|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4723558|NCT02014480|16288823|P4|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4723559|NCT02014480|16288824|P3|Treatment Period 1 (14 Days)|Lack of Efficacy|1
4723560|NCT02014480|16288825|P2|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4723561|NCT02014480|16288826|P1|Treatment Period 1 (14 Days)|Lack of Efficacy|0
4723562|NCT02014467|16288845|P2|Overall Study|Withdrawal by Subject|4
4723563|NCT02014467|16288846|P1|Overall Study|Withdrawal by Subject|16
4723564|NCT02014467|16288845|P2|Overall Study|Physician Decision|3
4723565|NCT02014467|16288846|P1|Overall Study|Physician Decision|2
4723566|NCT02014467|16288845|P2|Overall Study|Protocol Violation|0
4723567|NCT02014467|16288846|P1|Overall Study|Protocol Violation|3
4723568|NCT02014467|16288845|P2|Overall Study|Adverse Event|0
4723569|NCT02014467|16288846|P1|Overall Study|Adverse Event|4
4723570|NCT02014441|16288906|P1|Overall Study|Withdrawal by Subject|12
4723571|NCT02014402|16289002|P4|Overall Study|Lost to Follow-up|2
4723572|NCT02014402|16289003|P3|Overall Study|Lost to Follow-up|1
4723573|NCT02014402|16289004|P2|Overall Study|Lost to Follow-up|0
4723574|NCT02014402|16289005|P1|Overall Study|Lost to Follow-up|0
4723575|NCT02014402|16289002|P4|Overall Study|Subject did not have transportation|0
4723576|NCT02014402|16289003|P3|Overall Study|Subject did not have transportation|0
4723577|NCT02014402|16289004|P2|Overall Study|Subject did not have transportation|1
4723578|NCT02014402|16289005|P1|Overall Study|Subject did not have transportation|0
4723579|NCT02014402|16289002|P4|Overall Study|Withdrawal by Subject|1
4723580|NCT02014402|16289003|P3|Overall Study|Withdrawal by Subject|2
4723581|NCT02014402|16289004|P2|Overall Study|Withdrawal by Subject|2
4723582|NCT02014402|16289005|P1|Overall Study|Withdrawal by Subject|1
4723583|NCT02014402|16289002|P4|Overall Study|Adverse Event|0
4723584|NCT02014402|16289003|P3|Overall Study|Adverse Event|0
4723585|NCT02014402|16289004|P2|Overall Study|Adverse Event|0
4723586|NCT02014402|16289005|P1|Overall Study|Adverse Event|1
4723587|NCT02014376|16289035|P3|Overall Study|Lost to Follow-up|0
4723588|NCT02014376|16289036|P2|Overall Study|Lost to Follow-up|0
4723589|NCT02014376|16289037|P1|Overall Study|Lost to Follow-up|2
4723590|NCT02014376|16289035|P3|Overall Study|Adverse Event|0
4723591|NCT02014376|16289036|P2|Overall Study|Adverse Event|1
4723592|NCT02014376|16289037|P1|Overall Study|Adverse Event|1
4723593|NCT02014272|16289073|P2|Intervention Period 1|Adverse Event|1
4723594|NCT02014272|16289074|P1|Intervention Period 1|Adverse Event|0
4723595|NCT02014272|16289073|P2|Intervention Period 1|Withdrawal by Subject|0
4723596|NCT02014272|16289074|P1|Intervention Period 1|Withdrawal by Subject|1
4723597|NCT02014116|16289123|P9|Overall Study|Physician Decision|1
4723598|NCT02014116|16289124|P8|Overall Study|Physician Decision|0
4723599|NCT02014116|16289125|P7|Overall Study|Physician Decision|0
4723600|NCT02014116|16289126|P6|Overall Study|Physician Decision|0
4723601|NCT02014116|16289127|P5|Overall Study|Physician Decision|0
4723602|NCT02014116|16289128|P4|Overall Study|Physician Decision|0
4723603|NCT02014116|16289129|P3|Overall Study|Physician Decision|0
4723604|NCT02014116|16289130|P2|Overall Study|Physician Decision|0
4723605|NCT02014116|16289131|P1|Overall Study|Physician Decision|0
4723606|NCT02014116|16289123|P9|Overall Study|Withdrawal Caregiver Decision|0
4723607|NCT02014116|16289124|P8|Overall Study|Withdrawal Caregiver Decision|0
4723608|NCT02014116|16289125|P7|Overall Study|Withdrawal Caregiver Decision|0
4723609|NCT02014116|16289126|P6|Overall Study|Withdrawal Caregiver Decision|1
4723610|NCT02014116|16289127|P5|Overall Study|Withdrawal Caregiver Decision|0
4723611|NCT02014116|16289128|P4|Overall Study|Withdrawal Caregiver Decision|0
4723612|NCT02014116|16289129|P3|Overall Study|Withdrawal Caregiver Decision|0
4723613|NCT02014116|16289130|P2|Overall Study|Withdrawal Caregiver Decision|0
4723614|NCT02014116|16289131|P1|Overall Study|Withdrawal Caregiver Decision|0
4723615|NCT02014116|16289123|P9|Overall Study|Withdrawal by Subject|0
4723616|NCT02014116|16289124|P8|Overall Study|Withdrawal by Subject|0
4723617|NCT02014116|16289125|P7|Overall Study|Withdrawal by Subject|0
4723618|NCT02014116|16289126|P6|Overall Study|Withdrawal by Subject|1
4723619|NCT02014116|16289127|P5|Overall Study|Withdrawal by Subject|0
4723620|NCT02014116|16289128|P4|Overall Study|Withdrawal by Subject|1
4723621|NCT02014116|16289129|P3|Overall Study|Withdrawal by Subject|1
4723622|NCT02014116|16289130|P2|Overall Study|Withdrawal by Subject|0
4723623|NCT02014116|16289131|P1|Overall Study|Withdrawal by Subject|0
4723624|NCT02014116|16289123|P9|Overall Study|Death|1
4723625|NCT02014116|16289124|P8|Overall Study|Death|1
4723626|NCT02014116|16289125|P7|Overall Study|Death|0
4723627|NCT02014116|16289126|P6|Overall Study|Death|0
4723628|NCT02014116|16289127|P5|Overall Study|Death|0
4723629|NCT02014116|16289128|P4|Overall Study|Death|0
4723630|NCT02014116|16289129|P3|Overall Study|Death|0
4723631|NCT02014116|16289130|P2|Overall Study|Death|0
4723632|NCT02014116|16289131|P1|Overall Study|Death|0
4723633|NCT02014116|16289123|P9|Overall Study|Lost to Follow-up|1
4723634|NCT02014116|16289124|P8|Overall Study|Lost to Follow-up|0
4723635|NCT02014116|16289125|P7|Overall Study|Lost to Follow-up|0
4723636|NCT02014116|16289126|P6|Overall Study|Lost to Follow-up|1
4723637|NCT02014116|16289127|P5|Overall Study|Lost to Follow-up|0
4723638|NCT02014116|16289128|P4|Overall Study|Lost to Follow-up|0
4723639|NCT02014116|16289129|P3|Overall Study|Lost to Follow-up|0
4723640|NCT02014116|16289130|P2|Overall Study|Lost to Follow-up|0
4723641|NCT02014116|16289131|P1|Overall Study|Lost to Follow-up|0
4723642|NCT02014116|16289123|P9|Overall Study|Adverse Event|0
4723643|NCT02014116|16289124|P8|Overall Study|Adverse Event|1
4723644|NCT02014116|16289125|P7|Overall Study|Adverse Event|0
4723645|NCT02014116|16289126|P6|Overall Study|Adverse Event|0
4723646|NCT02014116|16289127|P5|Overall Study|Adverse Event|1
4723647|NCT02014116|16289128|P4|Overall Study|Adverse Event|0
4723648|NCT02014116|16289129|P3|Overall Study|Adverse Event|0
4723649|NCT02014116|16289130|P2|Overall Study|Adverse Event|0
4723650|NCT02014116|16289131|P1|Overall Study|Adverse Event|0
4723651|NCT02014116|16289123|P9|Overall Study|Progressive Disease|7
4723652|NCT02014116|16289124|P8|Overall Study|Progressive Disease|3
4723653|NCT02014116|16289125|P7|Overall Study|Progressive Disease|1
4723654|NCT02014116|16289126|P6|Overall Study|Progressive Disease|13
4723655|NCT02014116|16289127|P5|Overall Study|Progressive Disease|1
4723656|NCT02014116|16289128|P4|Overall Study|Progressive Disease|6
4723657|NCT02014116|16289129|P3|Overall Study|Progressive Disease|2
4723658|NCT02014116|16289130|P2|Overall Study|Progressive Disease|4
4723659|NCT02014116|16289131|P1|Overall Study|Progressive Disease|3
4723660|NCT02013830|16289196|P1|Overall Study|Refused treatment|1
4723661|NCT02013830|16289196|P1|Overall Study|Insufficient therapeutic response|25
4723662|NCT02013830|16289196|P1|Overall Study|Death|1
4723663|NCT02013830|16289196|P1|Overall Study|Adverse Event|3
4723664|NCT02013817|16289207|P1|Overall Study|Other|9
4723665|NCT02013817|16289207|P1|Overall Study|Death|2
4723666|NCT02013817|16289207|P1|Overall Study|Withdrawal by Subject|4
4723667|NCT02013817|16289207|P1|Overall Study|Adverse Event|12
4723668|NCT02013791|16289225|P9|Period 1|Other Miscellaneous Reasons|0
4723669|NCT02013791|16289226|P8|Period 1|Other Miscellaneous Reasons|0
4723670|NCT02013791|16289227|P7|Period 1|Other Miscellaneous Reasons|0
4723671|NCT02013791|16289228|P6|Period 1|Other Miscellaneous Reasons|0
4723672|NCT02013791|16289229|P5|Period 1|Other Miscellaneous Reasons|0
4723673|NCT02013791|16289230|P4|Period 1|Other Miscellaneous Reasons|0
4723674|NCT02013791|16289231|P3|Period 1|Other Miscellaneous Reasons|0
4723675|NCT02013791|16289232|P2|Period 1|Other Miscellaneous Reasons|2
4723676|NCT02013791|16289233|P1|Period 1|Other Miscellaneous Reasons|0
4723677|NCT02013791|16289225|P9|Period 1|Lost to Follow-up|0
4723678|NCT02013791|16289226|P8|Period 1|Lost to Follow-up|1
4723679|NCT02013791|16289227|P7|Period 1|Lost to Follow-up|1
4723680|NCT02013791|16289228|P6|Period 1|Lost to Follow-up|0
4723681|NCT02013791|16289229|P5|Period 1|Lost to Follow-up|0
4723682|NCT02013791|16289230|P4|Period 1|Lost to Follow-up|1
4723683|NCT02013791|16289231|P3|Period 1|Lost to Follow-up|0
4723684|NCT02013791|16289232|P2|Period 1|Lost to Follow-up|0
4723685|NCT02013791|16289233|P1|Period 1|Lost to Follow-up|0
4723686|NCT02013778|16289254|P1|Overall Study|Adverse Event|1
4723687|NCT02013778|16289254|P1|Overall Study|Physician Decision|1
4723688|NCT02013778|16289254|P1|Overall Study|Withdrawal by Subject|1
4723689|NCT02013778|16289254|P1|Overall Study|Death|4
4723690|NCT02013765|16289258|P1|Overall Study|Trial was terminated by sponsor|1
4723691|NCT02013687|16289272|P4|Overall Study|Missed visits due to patient travel|0
4723692|NCT02013687|16289273|P3|Overall Study|Missed visits due to patient travel|1
4723693|NCT02013687|16289274|P2|Overall Study|Missed visits due to patient travel|0
4723694|NCT02013687|16289275|P1|Overall Study|Missed visits due to patient travel|0
4723695|NCT02013687|16289272|P4|Overall Study|Withdrawal by Subject|1
4723696|NCT02013687|16289273|P3|Overall Study|Withdrawal by Subject|0
4723697|NCT02013687|16289274|P2|Overall Study|Withdrawal by Subject|0
4723698|NCT02013687|16289275|P1|Overall Study|Withdrawal by Subject|0
4723699|NCT02013687|16289272|P4|Overall Study|Protocol Violation|1
4723700|NCT02013687|16289273|P3|Overall Study|Protocol Violation|0
4723701|NCT02013687|16289274|P2|Overall Study|Protocol Violation|0
4723702|NCT02013687|16289275|P1|Overall Study|Protocol Violation|0
4723703|NCT02013687|16289272|P4|Overall Study|Lost to Follow-up|0
4723704|NCT02013687|16289273|P3|Overall Study|Lost to Follow-up|1
4723705|NCT02013687|16289274|P2|Overall Study|Lost to Follow-up|0
4723706|NCT02013687|16289275|P1|Overall Study|Lost to Follow-up|0
4723707|NCT02013674|16289307|P2|Overall Study|Lost to Follow-up|0
4723708|NCT02013674|16289308|P1|Overall Study|Lost to Follow-up|1
4723709|NCT02013674|16289307|P2|Overall Study|Death|1
4723710|NCT02013674|16289308|P1|Overall Study|Death|0
4723711|NCT02013622|16289358|P1|Overall Study|Lack of Efficacy|1
4723712|NCT02013622|16289358|P1|Overall Study|Protocol Deviation|1
4723713|NCT02013622|16289358|P1|Overall Study|Withdrawal by Subject|6
4723714|NCT02013622|16289358|P1|Overall Study|Met Withdrawal Criteria|3
4723715|NCT02013622|16289358|P1|Overall Study|Adverse Event|3
4723716|NCT02013622|16289358|P1|Overall Study|Lost to Follow-up|10
4723717|NCT02013609|16289378|P1|Overall Study|Met Withdrawal Criteria|3
4723718|NCT02013609|16289378|P1|Overall Study|Adverse Event|3
4723719|NCT02013609|16289378|P1|Overall Study|Lost to Follow-up|3
4723720|NCT02013609|16289378|P1|Overall Study|Withdrawal by Subject|9
4723721|NCT02013544|16289403|P2|Overall Study|Entry criteria not met/non-compliance|3
4723722|NCT02013544|16289404|P1|Overall Study|Entry criteria not met/non-compliance|2
4723723|NCT02013544|16289403|P2|Overall Study|Physician Decision|1
4723724|NCT02013544|16289404|P1|Overall Study|Physician Decision|0
4723725|NCT02013544|16289403|P2|Overall Study|Withdrawal by Subject|8
4723726|NCT02013544|16289404|P1|Overall Study|Withdrawal by Subject|2
4723727|NCT02013544|16289403|P2|Overall Study|Lost to Follow-up|3
4723728|NCT02013544|16289404|P1|Overall Study|Lost to Follow-up|2
4723729|NCT02013544|16289403|P2|Overall Study|Adverse Event|5
4723730|NCT02013544|16289404|P1|Overall Study|Adverse Event|5
4723731|NCT02013531|16289426|P1|Overall Study|Withdrawal by Subject|1
4723732|NCT02013531|16289426|P1|Overall Study|Met Withdrawal Criteria|1
4723733|NCT02013531|16289426|P1|Overall Study|Lost to Follow-up|3
4723734|NCT02013388|16289462|P8|Overall Study|work emergency|0
4723735|NCT02013388|16289463|P7|Overall Study|work emergency|0
4723736|NCT02013388|16289464|P6|Overall Study|work emergency|0
4723737|NCT02013388|16289465|P5|Overall Study|work emergency|1
4723738|NCT02013388|16289466|P4|Overall Study|work emergency|0
4723739|NCT02013388|16289467|P3|Overall Study|work emergency|0
4723740|NCT02013388|16289468|P2|Overall Study|work emergency|0
4723741|NCT02013388|16289469|P1|Overall Study|work emergency|1
4723742|NCT02013375|16289503|P1|Overall Study|Did not engraft|1
4723743|NCT02013375|16289503|P1|Overall Study|Did not engraft|1
4723744|NCT02013206|16289533|P2|Overall Study|Other reasons off treatment|2
4723745|NCT02013206|16289534|P1|Overall Study|Other reasons off treatment|5
4723746|NCT02013206|16289533|P2|Overall Study|Death|2
4723747|NCT02013206|16289534|P1|Overall Study|Death|1
4723748|NCT02013206|16289533|P2|Overall Study|Patient non-compliance|0
4723749|NCT02013206|16289534|P1|Overall Study|Patient non-compliance|1
4723750|NCT02013206|16289533|P2|Overall Study|Patient refusal|0
4723751|NCT02013206|16289534|P1|Overall Study|Patient refusal|2
4723752|NCT02013206|16289533|P2|Overall Study|Adverse Event|0
4723753|NCT02013206|16289534|P1|Overall Study|Adverse Event|1
4723754|NCT02013206|16289533|P2|Overall Study|Symptomatic deterioration|1
4723755|NCT02013206|16289534|P1|Overall Study|Symptomatic deterioration|3
4723756|NCT02013206|16289533|P2|Overall Study|Progressive disease (PD)|17
4723757|NCT02013206|16289534|P1|Overall Study|Progressive disease (PD)|14
4723758|NCT02013167|16289565|P2|Overall Study|Death|160
4723759|NCT02013167|16289566|P1|Overall Study|Death|85
4723760|NCT02013167|16289565|P2|Overall Study|Lost to Follow-up|1
4723761|NCT02013167|16289566|P1|Overall Study|Lost to Follow-up|0
4723762|NCT02013167|16289565|P2|Overall Study|Sponsor Decision|3
4723763|NCT02013167|16289566|P1|Overall Study|Sponsor Decision|1
4723764|NCT02013167|16289565|P2|Overall Study|Withdrawal by Subject|14
4723765|NCT02013167|16289566|P1|Overall Study|Withdrawal by Subject|15
4723766|NCT02012959|16289642|P5|Treatment Phase A|Adverse Event|0
4723767|NCT02012959|16289643|P4|Treatment Phase A|Adverse Event|0
4723768|NCT02012959|16289644|P3|Treatment Phase A|Adverse Event|0
4723769|NCT02012959|16289645|P2|Treatment Phase A|Adverse Event|0
4723770|NCT02012959|16289646|P1|Treatment Phase A|Adverse Event|2
4723771|NCT02012686|16289659|P2|Overall Study|electrocardiography monitoring noise|1
4723772|NCT02012686|16289660|P1|Overall Study|electrocardiography monitoring noise|0
4723773|NCT02012686|16289659|P2|Overall Study|muscle contraction|1
4723774|NCT02012686|16289660|P1|Overall Study|muscle contraction|0
4723775|NCT02012491|16289722|P2|Overall Study|Withdrawal by Subject|0
4723776|NCT02012491|16289723|P1|Overall Study|Withdrawal by Subject|1
4723777|NCT02012491|16289722|P2|Overall Study|Protocol Violation|1
4723778|NCT02012491|16289723|P1|Overall Study|Protocol Violation|0
4723779|NCT02012491|16289722|P2|Overall Study|Lost to Follow-up|0
4723780|NCT02012491|16289723|P1|Overall Study|Lost to Follow-up|1
4723781|NCT02012452|16289741|P2|Overall Study|Withdrawal by Subject|0
4723782|NCT02012452|16289742|P1|Overall Study|Withdrawal by Subject|4
4723783|NCT02012452|16289741|P2|Overall Study|Lost to Follow-up|1
4723784|NCT02012452|16289742|P1|Overall Study|Lost to Follow-up|2
4723785|NCT02012218|16289785|P5|Overall Study|Protocol Deviation|0
4723786|NCT02012218|16289786|P4|Overall Study|Protocol Deviation|0
4723787|NCT02012218|16289787|P3|Overall Study|Protocol Deviation|0
4723788|NCT02012218|16289788|P2|Overall Study|Protocol Deviation|0
4723789|NCT02012218|16289789|P1|Overall Study|Protocol Deviation|1
4723790|NCT02012218|16289785|P5|Overall Study|Protocol Specified|0
4723791|NCT02012218|16289786|P4|Overall Study|Protocol Specified|0
4723792|NCT02012218|16289787|P3|Overall Study|Protocol Specified|0
4723793|NCT02012218|16289788|P2|Overall Study|Protocol Specified|0
4723794|NCT02012218|16289789|P1|Overall Study|Protocol Specified|1
4723795|NCT02012218|16289785|P5|Overall Study|Lost to Follow-up|0
4723796|NCT02012218|16289786|P4|Overall Study|Lost to Follow-up|0
4723797|NCT02012218|16289787|P3|Overall Study|Lost to Follow-up|1
4723798|NCT02012218|16289788|P2|Overall Study|Lost to Follow-up|1
4723799|NCT02012218|16289789|P1|Overall Study|Lost to Follow-up|0
4723800|NCT02012218|16289785|P5|Overall Study|Adverse Event|0
4723801|NCT02012218|16289786|P4|Overall Study|Adverse Event|1
4723802|NCT02012218|16289787|P3|Overall Study|Adverse Event|0
4723803|NCT02012218|16289788|P2|Overall Study|Adverse Event|0
4723804|NCT02012218|16289789|P1|Overall Study|Adverse Event|1
4723805|NCT02012218|16289785|P5|Overall Study|Withdrawal by Subject|1
4723806|NCT02012218|16289786|P4|Overall Study|Withdrawal by Subject|1
4723807|NCT02012218|16289787|P3|Overall Study|Withdrawal by Subject|1
4723808|NCT02012218|16289788|P2|Overall Study|Withdrawal by Subject|0
4723809|NCT02012218|16289789|P1|Overall Study|Withdrawal by Subject|1
4723810|NCT02011945|16289813|P3|Overall Study|Sub-Optimal Response to dasatinib|0
4723811|NCT02011945|16289814|P2|Overall Study|Sub-Optimal Response to dasatinib|0
4723812|NCT02011945|16289815|P1|Overall Study|Sub-Optimal Response to dasatinib|1
4723813|NCT02011945|16289813|P3|Overall Study|Proceeded to stem cell transplant|1
4723814|NCT02011945|16289814|P2|Overall Study|Proceeded to stem cell transplant|0
4723815|NCT02011945|16289815|P1|Overall Study|Proceeded to stem cell transplant|0
4723816|NCT02011945|16289813|P3|Overall Study|No Longer Meets Study Criteria|0
4723817|NCT02011945|16289814|P2|Overall Study|No Longer Meets Study Criteria|0
4723818|NCT02011945|16289815|P1|Overall Study|No Longer Meets Study Criteria|1
4723819|NCT02011945|16289813|P3|Overall Study|Treatment Failure|6
4723820|NCT02011945|16289814|P2|Overall Study|Treatment Failure|7
4723821|NCT02011945|16289815|P1|Overall Study|Treatment Failure|0
4723822|NCT02011945|16289813|P3|Overall Study|Study Drug Toxicity|1
4723823|NCT02011945|16289814|P2|Overall Study|Study Drug Toxicity|0
4723824|NCT02011945|16289815|P1|Overall Study|Study Drug Toxicity|0
4723825|NCT02011945|16289813|P3|Overall Study|Adverse Event unrelated to Drug|1
4723826|NCT02011945|16289814|P2|Overall Study|Adverse Event unrelated to Drug|2
4723827|NCT02011945|16289815|P1|Overall Study|Adverse Event unrelated to Drug|0
4723828|NCT02011945|16289813|P3|Overall Study|Participant requested to Discontinue|1
4723829|NCT02011945|16289814|P2|Overall Study|Participant requested to Discontinue|1
4723830|NCT02011945|16289815|P1|Overall Study|Participant requested to Discontinue|0
4723831|NCT02011893|16289892|P3|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1
4723832|NCT02011893|16289893|P2|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
4723833|NCT02011893|16289894|P1|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0
4723834|NCT02011893|16289892|P3|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2
4723835|NCT02011893|16289893|P2|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
4723836|NCT02011893|16289894|P1|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0
4723837|NCT02011893|16289892|P3|Period 1 (Randomization to 12 Weeks)|Physician Decision|1
4723838|NCT02011893|16289893|P2|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
4723839|NCT02011893|16289894|P1|Period 1 (Randomization to 12 Weeks)|Physician Decision|0
4723840|NCT02011893|16289892|P3|Enrollment to Randomization|Insurance/Financial Reasons|0
4723841|NCT02011893|16289893|P2|Enrollment to Randomization|Insurance/Financial Reasons|0
4723842|NCT02011893|16289894|P1|Enrollment to Randomization|Insurance/Financial Reasons|2
4723843|NCT02011893|16289892|P3|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
4723844|NCT02011893|16289893|P2|Enrollment to Randomization|Temporary Trial Stimulation Failure|0
4723845|NCT02011893|16289894|P1|Enrollment to Randomization|Temporary Trial Stimulation Failure|9
4723846|NCT02011893|16289892|P3|Enrollment to Randomization|Screening Failure|0
4723847|NCT02011893|16289893|P2|Enrollment to Randomization|Screening Failure|0
4723848|NCT02011893|16289894|P1|Enrollment to Randomization|Screening Failure|29
4723849|NCT02011893|16289892|P3|Enrollment to Randomization|Withdrawal by Subject|0
4723850|NCT02011893|16289893|P2|Enrollment to Randomization|Withdrawal by Subject|0
4723851|NCT02011893|16289894|P1|Enrollment to Randomization|Withdrawal by Subject|21
4723852|NCT02011893|16289892|P3|Enrollment to Randomization|Physician Decision|0
4723853|NCT02011893|16289893|P2|Enrollment to Randomization|Physician Decision|0
4723854|NCT02011893|16289894|P1|Enrollment to Randomization|Physician Decision|10
4723855|NCT02011893|16289892|P3|Enrollment to Randomization|Adverse Event|0
4723856|NCT02011893|16289893|P2|Enrollment to Randomization|Adverse Event|0
4723857|NCT02011893|16289894|P1|Enrollment to Randomization|Adverse Event|2
4723858|NCT02011542|16289905|P1|Overall Study|Physician Decision|1
4723859|NCT02011386|16290036|P1|Overall Study|Lack of Efficacy|3
4723860|NCT02011386|16290036|P1|Overall Study|Non-compliance|2
4723861|NCT02011113|16290050|P1|Overall Study|Study terminated by sponsor|11
4723862|NCT02011113|16290050|P1|Overall Study|Investigator's judgement- DP|3
4723863|NCT02011113|16290050|P1|Overall Study|Insufficient effect of Pomalidomide|1
4723864|NCT02011113|16290050|P1|Overall Study|Death|1
4723865|NCT02011113|16290050|P1|Overall Study|Disease Progression (DP)|16
4723866|NCT02011113|16290050|P1|Overall Study|Adverse Event|4
4723867|NCT02010775|16290082|P5|Overall Study|Personal Reasons|4
4723868|NCT02010775|16290083|P4|Overall Study|Personal Reasons|2
4723869|NCT02010775|16290084|P3|Overall Study|Personal Reasons|1
4723870|NCT02010775|16290085|P2|Overall Study|Personal Reasons|3
4723871|NCT02010775|16290086|P1|Overall Study|Personal Reasons|3
4723872|NCT02010775|16290082|P5|Overall Study|Lost to Follow-up|1
4723873|NCT02010775|16290083|P4|Overall Study|Lost to Follow-up|1
4723874|NCT02010775|16290084|P3|Overall Study|Lost to Follow-up|0
4723875|NCT02010775|16290085|P2|Overall Study|Lost to Follow-up|0
4723876|NCT02010775|16290086|P1|Overall Study|Lost to Follow-up|2
4723877|NCT02010775|16290082|P5|Overall Study|Pregnancy|0
4723878|NCT02010775|16290083|P4|Overall Study|Pregnancy|0
4723879|NCT02010775|16290084|P3|Overall Study|Pregnancy|2
4723880|NCT02010775|16290085|P2|Overall Study|Pregnancy|0
4723881|NCT02010775|16290086|P1|Overall Study|Pregnancy|0
4723882|NCT02010775|16290082|P5|Overall Study|Adverse Event|1
4723883|NCT02010775|16290083|P4|Overall Study|Adverse Event|0
4723884|NCT02010775|16290084|P3|Overall Study|Adverse Event|0
4723885|NCT02010775|16290085|P2|Overall Study|Adverse Event|0
4723886|NCT02010775|16290086|P1|Overall Study|Adverse Event|0
4723887|NCT02010684|16290127|P2|Overall Study|Withdrawal by Subject|5
4723888|NCT02010684|16290128|P1|Overall Study|Withdrawal by Subject|4
4723889|NCT02010684|16290127|P2|Overall Study|Lost to Follow-up|18
4723890|NCT02010684|16290128|P1|Overall Study|Lost to Follow-up|8
4723891|NCT02010632|16290150|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
4723892|NCT02010632|16290151|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
4723893|NCT02010567|16290162|P5|Overall Study|Adverse Event|1
4723894|NCT02010567|16290163|P4|Overall Study|Adverse Event|0
4723895|NCT02010567|16290164|P3|Overall Study|Adverse Event|1
4723896|NCT02010567|16290165|P2|Overall Study|Adverse Event|0
4723897|NCT02010567|16290166|P1|Overall Study|Adverse Event|0
4723898|NCT02010255|16290218|P14|Overall Study|Randomized but Not Treated|1
4723899|NCT02010255|16290219|P13|Overall Study|Randomized but Not Treated|0
4723900|NCT02010255|16290220|P12|Overall Study|Randomized but Not Treated|0
4723901|NCT02010255|16290221|P11|Overall Study|Randomized but Not Treated|0
4723902|NCT02010255|16290222|P10|Overall Study|Randomized but Not Treated|0
4723903|NCT02010255|16290223|P9|Overall Study|Randomized but Not Treated|0
4723904|NCT02010255|16290224|P8|Overall Study|Randomized but Not Treated|0
4723905|NCT02010255|16290225|P7|Overall Study|Randomized but Not Treated|0
4723906|NCT02010255|16290226|P6|Overall Study|Randomized but Not Treated|0
4723907|NCT02010255|16290227|P5|Overall Study|Randomized but Not Treated|0
4723908|NCT02010255|16290228|P4|Overall Study|Randomized but Not Treated|0
4723909|NCT02010255|16290229|P3|Overall Study|Randomized but Not Treated|0
4723910|NCT02010255|16290230|P2|Overall Study|Randomized but Not Treated|0
4723911|NCT02010255|16290231|P1|Overall Study|Randomized but Not Treated|0
4723912|NCT02010255|16290218|P14|Overall Study|Lost to Follow-up|0
4723913|NCT02010255|16290219|P13|Overall Study|Lost to Follow-up|0
4723914|NCT02010255|16290220|P12|Overall Study|Lost to Follow-up|0
4723915|NCT02010255|16290221|P11|Overall Study|Lost to Follow-up|0
4723916|NCT02010255|16290222|P10|Overall Study|Lost to Follow-up|0
4723917|NCT02010255|16290223|P9|Overall Study|Lost to Follow-up|0
4723918|NCT02010255|16290224|P8|Overall Study|Lost to Follow-up|0
4723919|NCT02010255|16290225|P7|Overall Study|Lost to Follow-up|0
4723920|NCT02010255|16290226|P6|Overall Study|Lost to Follow-up|0
4723921|NCT02010255|16290227|P5|Overall Study|Lost to Follow-up|1
4723922|NCT02010255|16290228|P4|Overall Study|Lost to Follow-up|0
4723923|NCT02010255|16290229|P3|Overall Study|Lost to Follow-up|1
4723924|NCT02010255|16290230|P2|Overall Study|Lost to Follow-up|0
4723925|NCT02010255|16290231|P1|Overall Study|Lost to Follow-up|0
4723926|NCT02010255|16290218|P14|Overall Study|Adverse Event|0
4723927|NCT02010255|16290219|P13|Overall Study|Adverse Event|0
4723928|NCT02010255|16290220|P12|Overall Study|Adverse Event|0
4723929|NCT02010255|16290221|P11|Overall Study|Adverse Event|0
4723930|NCT02010255|16290222|P10|Overall Study|Adverse Event|0
4723931|NCT02010255|16290223|P9|Overall Study|Adverse Event|0
4723932|NCT02010255|16290224|P8|Overall Study|Adverse Event|0
4723933|NCT02010255|16290225|P7|Overall Study|Adverse Event|0
4723934|NCT02010255|16290226|P6|Overall Study|Adverse Event|0
4723935|NCT02010255|16290227|P5|Overall Study|Adverse Event|0
4723936|NCT02010255|16290228|P4|Overall Study|Adverse Event|0
4723937|NCT02010255|16290229|P3|Overall Study|Adverse Event|0
4723938|NCT02010255|16290230|P2|Overall Study|Adverse Event|0
4723939|NCT02010255|16290231|P1|Overall Study|Adverse Event|1
4723940|NCT02010255|16290218|P14|Overall Study|Withdrew Consent|0
4723941|NCT02010255|16290219|P13|Overall Study|Withdrew Consent|0
4723942|NCT02010255|16290220|P12|Overall Study|Withdrew Consent|0
4723943|NCT02010255|16290221|P11|Overall Study|Withdrew Consent|0
4723944|NCT02010255|16290222|P10|Overall Study|Withdrew Consent|0
4723945|NCT02010255|16290223|P9|Overall Study|Withdrew Consent|0
4723946|NCT02010255|16290224|P8|Overall Study|Withdrew Consent|0
4723947|NCT02010255|16290225|P7|Overall Study|Withdrew Consent|0
4723948|NCT02010255|16290226|P6|Overall Study|Withdrew Consent|0
4723949|NCT02010255|16290227|P5|Overall Study|Withdrew Consent|0
4723950|NCT02010255|16290228|P4|Overall Study|Withdrew Consent|1
4723951|NCT02010255|16290229|P3|Overall Study|Withdrew Consent|0
4723952|NCT02010255|16290230|P2|Overall Study|Withdrew Consent|0
4723953|NCT02010255|16290231|P1|Overall Study|Withdrew Consent|1
4723954|NCT02010255|16290218|P14|Overall Study|Lack of Efficacy|0
4723955|NCT02010255|16290219|P13|Overall Study|Lack of Efficacy|0
4723956|NCT02010255|16290220|P12|Overall Study|Lack of Efficacy|0
4723957|NCT02010255|16290221|P11|Overall Study|Lack of Efficacy|1
4723958|NCT02010255|16290222|P10|Overall Study|Lack of Efficacy|0
4723959|NCT02010255|16290223|P9|Overall Study|Lack of Efficacy|0
4723960|NCT02010255|16290224|P8|Overall Study|Lack of Efficacy|0
4723961|NCT02010255|16290225|P7|Overall Study|Lack of Efficacy|0
4723962|NCT02010255|16290226|P6|Overall Study|Lack of Efficacy|0
4723963|NCT02010255|16290227|P5|Overall Study|Lack of Efficacy|1
4723964|NCT02010255|16290228|P4|Overall Study|Lack of Efficacy|1
4723965|NCT02010255|16290229|P3|Overall Study|Lack of Efficacy|2
4723966|NCT02010255|16290230|P2|Overall Study|Lack of Efficacy|1
4723967|NCT02010255|16290231|P1|Overall Study|Lack of Efficacy|4
4723968|NCT02010255|16290218|P14|Overall Study|Death|0
4723969|NCT02010255|16290219|P13|Overall Study|Death|0
4723970|NCT02010255|16290220|P12|Overall Study|Death|1
4723971|NCT02010255|16290221|P11|Overall Study|Death|1
4723972|NCT02010255|16290222|P10|Overall Study|Death|0
4723973|NCT02010255|16290223|P9|Overall Study|Death|1
4723974|NCT02010255|16290224|P8|Overall Study|Death|1
4723975|NCT02010255|16290225|P7|Overall Study|Death|1
4723976|NCT02010255|16290226|P6|Overall Study|Death|0
4723977|NCT02010255|16290227|P5|Overall Study|Death|2
4723978|NCT02010255|16290228|P4|Overall Study|Death|4
4723979|NCT02010255|16290229|P3|Overall Study|Death|4
4723980|NCT02010255|16290230|P2|Overall Study|Death|1
4723981|NCT02010255|16290231|P1|Overall Study|Death|0
4723982|NCT02009930|16290676|P1|Overall Study|withdrawn|5
4723983|NCT02009878|16290701|P3|Overall Study|Participant Met Withdrawal Criteria|0
4723984|NCT02009878|16290702|P2|Overall Study|Participant Met Withdrawal Criteria|1
4723985|NCT02009878|16290703|P1|Overall Study|Participant Met Withdrawal Criteria|0
4723986|NCT02009865|16290737|P2|Overall Study|Withdrawal by Subject|1
4723987|NCT02009865|16290738|P1|Overall Study|Withdrawal by Subject|1
4723988|NCT02009865|16290737|P2|Overall Study|Protocol Violation|2
4723989|NCT02009865|16290738|P1|Overall Study|Protocol Violation|0
4723990|NCT02009865|16290737|P2|Overall Study|Adverse Event|2
4723991|NCT02009865|16290738|P1|Overall Study|Adverse Event|0
4723992|NCT02009722|16290754|P2|Overall Study|Did not receive intervention|1
4723993|NCT02009722|16290755|P1|Overall Study|Did not receive intervention|0
4723994|NCT02009722|16290754|P2|Overall Study|Protocol Violation|2
4723995|NCT02009722|16290755|P1|Overall Study|Protocol Violation|1
4723996|NCT02009696|16290779|P1|Overall Study|Withdrawal by Subject|2
4723997|NCT02009163|16290796|P3|Randomized-withdrawal Period|Other|5
4723998|NCT02009163|16290797|P2|Randomized-withdrawal Period|Other|9
4723999|NCT02009163|16290798|P1|Randomized-withdrawal Period|Other|0
4724000|NCT02009163|16290796|P3|Randomized-withdrawal Period|Pregnancy|2
4724001|NCT02009163|16290797|P2|Randomized-withdrawal Period|Pregnancy|0
4724002|NCT02009163|16290798|P1|Randomized-withdrawal Period|Pregnancy|0
4724003|NCT02009163|16290796|P3|Randomized-withdrawal Period|Protocol Violation|2
4724004|NCT02009163|16290797|P2|Randomized-withdrawal Period|Protocol Violation|1
4724005|NCT02009163|16290798|P1|Randomized-withdrawal Period|Protocol Violation|0
4724006|NCT02009163|16290796|P3|Randomized-withdrawal Period|Relapse Criteria Met|5
4724007|NCT02009163|16290797|P2|Randomized-withdrawal Period|Relapse Criteria Met|40
4724008|NCT02009163|16290798|P1|Randomized-withdrawal Period|Relapse Criteria Met|0
4724009|NCT02009163|16290796|P3|Randomized-withdrawal Period|Adverse Event|6
4724010|NCT02009163|16290797|P2|Randomized-withdrawal Period|Adverse Event|0
4724011|NCT02009163|16290798|P1|Randomized-withdrawal Period|Adverse Event|0
4724012|NCT02009163|16290796|P3|Randomized-withdrawal Period|Lost to Follow-up|6
4724013|NCT02009163|16290797|P2|Randomized-withdrawal Period|Lost to Follow-up|13
4724014|NCT02009163|16290798|P1|Randomized-withdrawal Period|Lost to Follow-up|0
4724015|NCT02009163|16290796|P3|Randomized-withdrawal Period|Withdrawal by Subject|9
4724016|NCT02009163|16290797|P2|Randomized-withdrawal Period|Withdrawal by Subject|25
4724017|NCT02009163|16290798|P1|Randomized-withdrawal Period|Withdrawal by Subject|0
4724018|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Other|0
4724019|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Other|0
4724020|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Other|13
4724021|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Pregnancy|0
4724022|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Pregnancy|0
4724023|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Pregnancy|1
4724024|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Protocol Violation|0
4724025|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Protocol Violation|0
4724026|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Protocol Violation|10
4724027|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Lost to Follow-up|0
4724028|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Lost to Follow-up|0
4724029|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Lost to Follow-up|20
4724030|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Adverse Event|0
4724031|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Adverse Event|0
4724032|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Adverse Event|22
4724033|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Withdrawal by Subject|0
4724034|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Withdrawal by Subject|0
4724035|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Withdrawal by Subject|29
4724036|NCT02009163|16290796|P3|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
4724037|NCT02009163|16290797|P2|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0
4724038|NCT02009163|16290798|P1|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48
4724039|NCT02009046|16290833|P2|Overall Study|Lost to Follow-up|206
4724040|NCT02009046|16290834|P1|Overall Study|Lost to Follow-up|256
4724041|NCT02008916|16290894|P3|Week 16 - 156|Physician Decision|0
4724042|NCT02008916|16290895|P2|Week 16 - 156|Physician Decision|1
4724043|NCT02008916|16290896|P1|Week 16 - 156|Physician Decision|0
4724044|NCT02008916|16290894|P3|Week 16 - 156|Pregnancy|0
4724045|NCT02008916|16290895|P2|Week 16 - 156|Pregnancy|1
4724046|NCT02008916|16290896|P1|Week 16 - 156|Pregnancy|0
4724047|NCT02008916|16290894|P3|Week 16 - 156|Lack of Efficacy|2
4724048|NCT02008916|16290895|P2|Week 16 - 156|Lack of Efficacy|5
4724049|NCT02008916|16290896|P1|Week 16 - 156|Lack of Efficacy|3
4724050|NCT02008916|16290894|P3|Week 16 - 156|Lost to Follow-up|0
4724051|NCT02008916|16290895|P2|Week 16 - 156|Lost to Follow-up|0
4724052|NCT02008916|16290896|P1|Week 16 - 156|Lost to Follow-up|5
4724053|NCT02008916|16290894|P3|Week 16 - 156|No longer requires treatment|0
4724054|NCT02008916|16290895|P2|Week 16 - 156|No longer requires treatment|1
4724055|NCT02008916|16290896|P1|Week 16 - 156|No longer requires treatment|0
4724056|NCT02008916|16290894|P3|Week 16 - 156|Withdrawal by Subject|5
4724057|NCT02008916|16290895|P2|Week 16 - 156|Withdrawal by Subject|3
4724058|NCT02008916|16290896|P1|Week 16 - 156|Withdrawal by Subject|7
4724059|NCT02008916|16290894|P3|Week 16 - 156|Adverse Event|3
4724060|NCT02008916|16290895|P2|Week 16 - 156|Adverse Event|2
4724061|NCT02008916|16290896|P1|Week 16 - 156|Adverse Event|4
4724062|NCT02008916|16290894|P3|Primary Assessment (up to Week 16)|Withdrawal by Subject|3
4724063|NCT02008916|16290895|P2|Primary Assessment (up to Week 16)|Withdrawal by Subject|1
4724064|NCT02008916|16290896|P1|Primary Assessment (up to Week 16)|Withdrawal by Subject|0
4724065|NCT02008890|16290932|P5|Extension Period|Adverse Event|2
4724066|NCT02008890|16290933|P4|Extension Period|Adverse Event|0
4724067|NCT02008890|16290934|P3|Extension Period|Adverse Event|0
4724068|NCT02008890|16290935|P2|Extension Period|Adverse Event|3
4724069|NCT02008890|16290936|P1|Extension Period|Adverse Event|1
4724070|NCT02008890|16290932|P5|Extension Period|Lost to Follow-up|0
4724071|NCT02008890|16290933|P4|Extension Period|Lost to Follow-up|0
4724072|NCT02008890|16290934|P3|Extension Period|Lost to Follow-up|0
4724073|NCT02008890|16290935|P2|Extension Period|Lost to Follow-up|0
4724074|NCT02008890|16290936|P1|Extension Period|Lost to Follow-up|1
4724075|NCT02008890|16290932|P5|Extension Period|Withdrawal by Subject|2
4724076|NCT02008890|16290933|P4|Extension Period|Withdrawal by Subject|4
4724077|NCT02008890|16290934|P3|Extension Period|Withdrawal by Subject|0
4724078|NCT02008890|16290935|P2|Extension Period|Withdrawal by Subject|2
4724079|NCT02008890|16290936|P1|Extension Period|Withdrawal by Subject|3
4724080|NCT02008890|16290932|P5|Period 2|Lost to Follow-up|0
4724081|NCT02008890|16290933|P4|Period 2|Lost to Follow-up|0
4724082|NCT02008890|16290934|P3|Period 2|Lost to Follow-up|1
4724083|NCT02008890|16290935|P2|Period 2|Lost to Follow-up|0
4724084|NCT02008890|16290936|P1|Period 2|Lost to Follow-up|0
4724085|NCT02008890|16290932|P5|Period 2|Physician Decision|1
4724086|NCT02008890|16290933|P4|Period 2|Physician Decision|2
4724087|NCT02008890|16290934|P3|Period 2|Physician Decision|0
4724088|NCT02008890|16290935|P2|Period 2|Physician Decision|0
4724089|NCT02008890|16290936|P1|Period 2|Physician Decision|4
4724090|NCT02008890|16290932|P5|Period 2|Withdrawal by Subject|2
4724091|NCT02008890|16290933|P4|Period 2|Withdrawal by Subject|7
4724092|NCT02008890|16290934|P3|Period 2|Withdrawal by Subject|0
4724093|NCT02008890|16290935|P2|Period 2|Withdrawal by Subject|8
4724094|NCT02008890|16290936|P1|Period 2|Withdrawal by Subject|11
4724095|NCT02008890|16290932|P5|Period 2|Adverse Event|5
4724096|NCT02008890|16290933|P4|Period 2|Adverse Event|5
4724097|NCT02008890|16290934|P3|Period 2|Adverse Event|0
4724098|NCT02008890|16290935|P2|Period 2|Adverse Event|7
4724099|NCT02008890|16290936|P1|Period 2|Adverse Event|12
4724100|NCT02008890|16290932|P5|Period 1|Adverse Event|0
4724101|NCT02008890|16290933|P4|Period 1|Adverse Event|0
4724102|NCT02008890|16290934|P3|Period 1|Adverse Event|6
4724103|NCT02008890|16290935|P2|Period 1|Adverse Event|8
4724104|NCT02008890|16290936|P1|Period 1|Adverse Event|6
4724105|NCT02008890|16290932|P5|Period 1|Physician Decision|0
4724106|NCT02008890|16290933|P4|Period 1|Physician Decision|0
4724107|NCT02008890|16290934|P3|Period 1|Physician Decision|1
4724108|NCT02008890|16290935|P2|Period 1|Physician Decision|0
4724109|NCT02008890|16290936|P1|Period 1|Physician Decision|1
4724110|NCT02008890|16290932|P5|Period 1|Pregnancy|0
4724111|NCT02008890|16290933|P4|Period 1|Pregnancy|0
4724112|NCT02008890|16290934|P3|Period 1|Pregnancy|0
4724113|NCT02008890|16290935|P2|Period 1|Pregnancy|0
4724114|NCT02008890|16290936|P1|Period 1|Pregnancy|1
4724115|NCT02008890|16290932|P5|Period 1|Withdrawal by Subject|0
4724116|NCT02008890|16290933|P4|Period 1|Withdrawal by Subject|0
4724117|NCT02008890|16290934|P3|Period 1|Withdrawal by Subject|5
4724118|NCT02008890|16290935|P2|Period 1|Withdrawal by Subject|7
4724119|NCT02008890|16290936|P1|Period 1|Withdrawal by Subject|7
4724120|NCT02008877|16290972|P3|Overall Study|Inevaluable|0
4724121|NCT02008877|16290973|P2|Overall Study|Inevaluable|1
4724122|NCT02008877|16290974|P1|Overall Study|Inevaluable|0
4724123|NCT02008773|16290993|P4|Overall Study|Lost to Follow-up|2
4724124|NCT02008773|16290994|P3|Overall Study|Lost to Follow-up|3
4724125|NCT02008773|16290995|P2|Overall Study|Lost to Follow-up|1
4724126|NCT02008773|16290996|P1|Overall Study|Lost to Follow-up|0
4724127|NCT02008773|16290993|P4|Overall Study|Withdrawal by Subject|6
4724128|NCT02008773|16290994|P3|Overall Study|Withdrawal by Subject|7
4724129|NCT02008773|16290995|P2|Overall Study|Withdrawal by Subject|4
4724130|NCT02008773|16290996|P1|Overall Study|Withdrawal by Subject|8
4724131|NCT02008773|16290993|P4|Overall Study|Medication Non-compliance|2
4724132|NCT02008773|16290994|P3|Overall Study|Medication Non-compliance|3
4724133|NCT02008773|16290995|P2|Overall Study|Medication Non-compliance|1
4724134|NCT02008773|16290996|P1|Overall Study|Medication Non-compliance|2
4724135|NCT02008773|16290993|P4|Overall Study|Adverse Event|2
4724136|NCT02008773|16290994|P3|Overall Study|Adverse Event|1
4724137|NCT02008773|16290995|P2|Overall Study|Adverse Event|3
4724138|NCT02008773|16290996|P1|Overall Study|Adverse Event|3
4724139|NCT02008565|16291062|P4|Overall Study|Protocol Violation|0
4724140|NCT02008565|16291063|P3|Overall Study|Protocol Violation|2
4724141|NCT02008565|16291064|P2|Overall Study|Protocol Violation|1
4724142|NCT02008565|16291065|P1|Overall Study|Protocol Violation|1
4724143|NCT02008526|16291126|P3|Overall Study|Lost to Follow-up|6
4724144|NCT02008526|16291127|P2|Overall Study|Lost to Follow-up|9
4724145|NCT02008526|16291128|P1|Overall Study|Lost to Follow-up|5
4724146|NCT02008526|16291126|P3|Overall Study|Withdrawal by Subject|2
4724147|NCT02008526|16291127|P2|Overall Study|Withdrawal by Subject|3
4724148|NCT02008526|16291128|P1|Overall Study|Withdrawal by Subject|3
4724149|NCT02008526|16291126|P3|Overall Study|Death|1
4724150|NCT02008526|16291127|P2|Overall Study|Death|2
4724151|NCT02008526|16291128|P1|Overall Study|Death|0
4724152|NCT02008396|16291141|P2|Overall Study|Protocol Violation|1
4724153|NCT02008396|16291142|P1|Overall Study|Protocol Violation|0
4724154|NCT02008370|16291152|P1|Overall Study|Lost to Follow-up|7
4724155|NCT02008318|16291160|P2|Overall Study|Withdrawal by Subject|0
4724156|NCT02008318|16291161|P1|Overall Study|Withdrawal by Subject|3
4724157|NCT02008318|16291160|P2|Overall Study|Protocol Violation|1
4724158|NCT02008318|16291161|P1|Overall Study|Protocol Violation|1
4724159|NCT02008318|16291160|P2|Overall Study|Progressive Disease|0
4724160|NCT02008318|16291161|P1|Overall Study|Progressive Disease|2
4724161|NCT02008318|16291160|P2|Overall Study|Physician Decision|0
4724162|NCT02008318|16291161|P1|Overall Study|Physician Decision|2
4724163|NCT02008318|16291160|P2|Overall Study|Adverse Event|0
4724164|NCT02008318|16291161|P1|Overall Study|Adverse Event|4
4724165|NCT02008227|16291182|P2|Overall Study|Study Terminated By Sponsor|83
4724166|NCT02008227|16291183|P1|Overall Study|Study Terminated By Sponsor|44
4724167|NCT02008227|16291182|P2|Overall Study|Withdrawal by Subject|36
4724168|NCT02008227|16291183|P1|Overall Study|Withdrawal by Subject|67
4724169|NCT02008227|16291182|P2|Overall Study|Death|485
4724170|NCT02008227|16291183|P1|Overall Study|Death|494
4724171|NCT02008227|16291182|P2|Overall Study|Lost to Follow-up|9
4724172|NCT02008227|16291183|P1|Overall Study|Lost to Follow-up|7
4724173|NCT02007954|16291271|P1|Overall Study|Death|1
4724174|NCT02007954|16291271|P1|Overall Study|Disease progression and unrelated AE|1
4724175|NCT02007954|16291271|P1|Overall Study|Switch in treatment modality|2
4724176|NCT02007954|16291271|P1|Overall Study|Received liver transplant|3
4724177|NCT02007720|16291290|P2|Overall Study|patient followd less than 165 days|5
4724178|NCT02007720|16291291|P1|Overall Study|patient followd less than 165 days|11
4724179|NCT02007720|16291290|P2|Overall Study|technical problem|2
4724180|NCT02007720|16291291|P1|Overall Study|technical problem|4
4724181|NCT02007720|16291290|P2|Overall Study|study terminated by sponsor|54
4724182|NCT02007720|16291291|P1|Overall Study|study terminated by sponsor|58
4724183|NCT02007720|16291290|P2|Overall Study|Withdrawal by Subject|11
4724184|NCT02007720|16291291|P1|Overall Study|Withdrawal by Subject|9
4724185|NCT02007577|16291326|P2|Overall Study|Withdrawal by Subject|1
4724186|NCT02007577|16291327|P1|Overall Study|Withdrawal by Subject|0
4724187|NCT02007577|16291326|P2|Overall Study|Adverse Event|0
4724188|NCT02007577|16291327|P1|Overall Study|Adverse Event|1
4724189|NCT02007512|16291339|P4|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
4724190|NCT02007512|16291340|P3|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
4724191|NCT02007512|16291341|P2|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|3
4724192|NCT02007512|16291342|P1|Open Label Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|0
4724193|NCT02007512|16291339|P4|Open Label Treatment Period|Disease progression|11
4724194|NCT02007512|16291340|P3|Open Label Treatment Period|Disease progression|0
4724195|NCT02007512|16291341|P2|Open Label Treatment Period|Disease progression|17
4724196|NCT02007512|16291342|P1|Open Label Treatment Period|Disease progression|0
4724197|NCT02007512|16291339|P4|Open Label Treatment Period|Other|1
4724198|NCT02007512|16291340|P3|Open Label Treatment Period|Other|0
4724199|NCT02007512|16291341|P2|Open Label Treatment Period|Other|0
4724200|NCT02007512|16291342|P1|Open Label Treatment Period|Other|0
4724201|NCT02007512|16291339|P4|Open Label Treatment Period|Adverse Event|0
4724202|NCT02007512|16291340|P3|Open Label Treatment Period|Adverse Event|0
4724203|NCT02007512|16291341|P2|Open Label Treatment Period|Adverse Event|1
4724204|NCT02007512|16291342|P1|Open Label Treatment Period|Adverse Event|0
4724205|NCT02007512|16291339|P4|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|1
4724206|NCT02007512|16291340|P3|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|5
4724207|NCT02007512|16291341|P2|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|11
4724208|NCT02007512|16291342|P1|Double Blind Treatment Period|Ongoing as of data cutoff (23 Sep 2016)|10
4724209|NCT02007512|16291339|P4|Double Blind Treatment Period|Other|2
4724210|NCT02007512|16291340|P3|Double Blind Treatment Period|Other|1
4724211|NCT02007512|16291341|P2|Double Blind Treatment Period|Other|0
4724212|NCT02007512|16291342|P1|Double Blind Treatment Period|Other|0
4724213|NCT02007512|16291339|P4|Double Blind Treatment Period|Protocol Violation|1
4724214|NCT02007512|16291340|P3|Double Blind Treatment Period|Protocol Violation|0
4724215|NCT02007512|16291341|P2|Double Blind Treatment Period|Protocol Violation|0
4724216|NCT02007512|16291342|P1|Double Blind Treatment Period|Protocol Violation|0
4724217|NCT02007512|16291339|P4|Double Blind Treatment Period|Withdrawal by Subject|3
4724218|NCT02007512|16291340|P3|Double Blind Treatment Period|Withdrawal by Subject|3
4724219|NCT02007512|16291341|P2|Double Blind Treatment Period|Withdrawal by Subject|2
4724220|NCT02007512|16291342|P1|Double Blind Treatment Period|Withdrawal by Subject|4
4724221|NCT02007512|16291339|P4|Double Blind Treatment Period|Disease progression|51
4724222|NCT02007512|16291340|P3|Double Blind Treatment Period|Disease progression|45
4724223|NCT02007512|16291341|P2|Double Blind Treatment Period|Disease progression|49
4724224|NCT02007512|16291342|P1|Double Blind Treatment Period|Disease progression|44
4724225|NCT02007512|16291339|P4|Double Blind Treatment Period|Death|0
4724226|NCT02007512|16291340|P3|Double Blind Treatment Period|Death|0
4724227|NCT02007512|16291341|P2|Double Blind Treatment Period|Death|0
4724228|NCT02007512|16291342|P1|Double Blind Treatment Period|Death|1
4724229|NCT02007512|16291339|P4|Double Blind Treatment Period|Adverse Event|2
4724230|NCT02007512|16291340|P3|Double Blind Treatment Period|Adverse Event|6
4724231|NCT02007512|16291341|P2|Double Blind Treatment Period|Adverse Event|2
4724232|NCT02007512|16291342|P1|Double Blind Treatment Period|Adverse Event|4
4724233|NCT02007434|16291420|P8|Overall Study|Non-compliance|0
4724234|NCT02007434|16291421|P7|Overall Study|Non-compliance|0
4724235|NCT02007434|16291422|P6|Overall Study|Non-compliance|0
4724236|NCT02007434|16291423|P5|Overall Study|Non-compliance|0
4724237|NCT02007434|16291424|P4|Overall Study|Non-compliance|0
4724238|NCT02007434|16291425|P3|Overall Study|Non-compliance|1
4724239|NCT02007434|16291426|P2|Overall Study|Non-compliance|0
4724240|NCT02007434|16291427|P1|Overall Study|Non-compliance|1
4724241|NCT02007434|16291420|P8|Overall Study|Lost to Follow-up|0
4724242|NCT02007434|16291421|P7|Overall Study|Lost to Follow-up|0
4724243|NCT02007434|16291422|P6|Overall Study|Lost to Follow-up|0
4724244|NCT02007434|16291423|P5|Overall Study|Lost to Follow-up|0
4724245|NCT02007434|16291424|P4|Overall Study|Lost to Follow-up|0
4724246|NCT02007434|16291425|P3|Overall Study|Lost to Follow-up|0
4724247|NCT02007434|16291426|P2|Overall Study|Lost to Follow-up|1
4724248|NCT02007434|16291427|P1|Overall Study|Lost to Follow-up|0
4724249|NCT02007278|16291558|P2|Overall Study|Mis-randomization|1
4724250|NCT02007278|16291559|P1|Overall Study|Mis-randomization|1
4724251|NCT02007278|16291558|P2|Overall Study|Incorrect medication administration|0
4724252|NCT02007278|16291559|P1|Overall Study|Incorrect medication administration|1
4724253|NCT02007278|16291558|P2|Overall Study|Ingestion of drugs not allowed in study|1
4724254|NCT02007278|16291559|P1|Overall Study|Ingestion of drugs not allowed in study|0
4724255|NCT02007278|16291558|P2|Overall Study|Failure to comply with an eligibility|1
4724256|NCT02007278|16291559|P1|Overall Study|Failure to comply with an eligibility|0
4724257|NCT02007252|16291581|P2|Overall Study|Adverse Event|4
4724258|NCT02007252|16291582|P1|Overall Study|Adverse Event|7
4724259|NCT02007252|16291581|P2|Overall Study|Abnormal laboratory value(s)|0
4724260|NCT02007252|16291582|P1|Overall Study|Abnormal laboratory value(s)|1
4724261|NCT02007252|16291581|P2|Overall Study|Administrative problems|7
4724262|NCT02007252|16291582|P1|Overall Study|Administrative problems|3
4724263|NCT02007109|16291595|P1|Overall Study|Excluded - Age<7yo|9
4724264|NCT02007109|16291595|P1|Overall Study|Diary not returned or excluded|102
4724265|NCT02007096|16291604|P2|Overall Study|no mesh placed|1
4724266|NCT02007096|16291605|P1|Overall Study|no mesh placed|0
4724267|NCT02007096|16291604|P2|Overall Study|converted to open surgery|1
4724268|NCT02007096|16291605|P1|Overall Study|converted to open surgery|1
4724269|NCT02007096|16291604|P2|Overall Study|did not follow postoperative protocol|11
4724270|NCT02007096|16291605|P1|Overall Study|did not follow postoperative protocol|8
4724271|NCT02007096|16291604|P2|Overall Study|did not inject saline|3
4724272|NCT02007096|16291605|P1|Overall Study|did not inject saline|0
4724273|NCT02007096|16291604|P2|Overall Study|medication not available|0
4724274|NCT02007096|16291605|P1|Overall Study|medication not available|2
4724275|NCT02007070|16291617|P1|Overall Study|Progressive Disease|21
4724276|NCT02007070|16291617|P1|Overall Study|Physician Decision|1
4724277|NCT02007070|16291617|P1|Overall Study|Protocol Violation|2
4724278|NCT02007070|16291617|P1|Overall Study|Death|1
4724279|NCT02007070|16291617|P1|Overall Study|Clinical Progression|4
4724280|NCT02007070|16291617|P1|Overall Study|Adverse Event|4
4724281|NCT02006979|16291638|P2|Overall Study|Protocol Violation|1
4724282|NCT02006979|16291639|P1|Overall Study|Protocol Violation|0
4724283|NCT02006979|16291638|P2|Overall Study|Withdrawal by Subject|1
4724284|NCT02006979|16291639|P1|Overall Study|Withdrawal by Subject|1
4724285|NCT02006927|16291651|P1|Overall Study|Withdrawal by Subject|1
4724286|NCT02006927|16291651|P1|Overall Study|Adverse Event|2
4724287|NCT02006758|16291690|P1|Overall Study|Other|2
4724288|NCT02006758|16291690|P1|Overall Study|Procedurally excluded|1
4724289|NCT02006758|16291690|P1|Overall Study|Withdrawal by Subject|4
4724290|NCT02006758|16291690|P1|Overall Study|Lost to Follow-up|4
4724291|NCT02006758|16291690|P1|Overall Study|Death|1
4724292|NCT02006758|16291690|P1|Overall Study|Protocol Violation|1
4724293|NCT02006732|16291721|P4|Overall Study|Withdrawal by Subject|1
4724294|NCT02006732|16291722|P3|Overall Study|Withdrawal by Subject|4
4724295|NCT02006732|16291723|P2|Overall Study|Withdrawal by Subject|0
4724296|NCT02006732|16291724|P1|Overall Study|Withdrawal by Subject|3
4724297|NCT02006732|16291721|P4|Overall Study|Lost to Follow-up|0
4724298|NCT02006732|16291722|P3|Overall Study|Lost to Follow-up|0
4724299|NCT02006732|16291723|P2|Overall Study|Lost to Follow-up|1
4724300|NCT02006732|16291724|P1|Overall Study|Lost to Follow-up|0
4724301|NCT02006732|16291721|P4|Overall Study|Protocol Violation|0
4724302|NCT02006732|16291722|P3|Overall Study|Protocol Violation|0
4724303|NCT02006732|16291723|P2|Overall Study|Protocol Violation|1
4724304|NCT02006732|16291724|P1|Overall Study|Protocol Violation|1
4724305|NCT02006732|16291721|P4|Overall Study|Lack of Efficacy|1
4724306|NCT02006732|16291722|P3|Overall Study|Lack of Efficacy|1
4724307|NCT02006732|16291723|P2|Overall Study|Lack of Efficacy|3
4724308|NCT02006732|16291724|P1|Overall Study|Lack of Efficacy|6
4724309|NCT02006732|16291721|P4|Overall Study|Adverse Event|2
4724310|NCT02006732|16291722|P3|Overall Study|Adverse Event|4
4724311|NCT02006732|16291723|P2|Overall Study|Adverse Event|7
4724312|NCT02006732|16291724|P1|Overall Study|Adverse Event|10
4724313|NCT02006719|16291764|P2|Overall Study|Other/Unknown|1
4724314|NCT02006719|16291765|P1|Overall Study|Other/Unknown|0
4724315|NCT02006719|16291764|P2|Overall Study|Adverse Event|1
4724316|NCT02006719|16291765|P1|Overall Study|Adverse Event|1
4724317|NCT02006719|16291764|P2|Overall Study|Protocol Violation|0
4724318|NCT02006719|16291765|P1|Overall Study|Protocol Violation|2
4724319|NCT02006719|16291764|P2|Overall Study|Lost to Follow-up|1
4724320|NCT02006719|16291765|P1|Overall Study|Lost to Follow-up|5
4724321|NCT02006719|16291764|P2|Overall Study|Withdrawal by Subject|2
4724322|NCT02006719|16291765|P1|Overall Study|Withdrawal by Subject|10
4724323|NCT02006706|16291795|P1|Overall Study|Lost to Follow-up|1
4724324|NCT02006693|16291802|P2|Overall Study|Patient Decision|0
4724325|NCT02006693|16291803|P1|Overall Study|Patient Decision|4
4724326|NCT02006693|16291802|P2|Overall Study|Lost to Follow-up|1
4724327|NCT02006693|16291803|P1|Overall Study|Lost to Follow-up|4
4724328|NCT02006693|16291802|P2|Overall Study|Death|2
4724329|NCT02006693|16291803|P1|Overall Study|Death|2
4724330|NCT02006693|16291802|P2|Overall Study|XEN Implant Explantation|1
4724331|NCT02006693|16291803|P1|Overall Study|XEN Implant Explantation|0
4724332|NCT02006693|16291802|P2|Overall Study|Another Glaucoma-related Surgery|1
4724333|NCT02006693|16291803|P1|Overall Study|Another Glaucoma-related Surgery|12
4724334|NCT02006693|16291802|P2|Overall Study|No Reason Specified|8
4724335|NCT02006693|16291803|P1|Overall Study|No Reason Specified|6
4724336|NCT02006667|16291815|P1|Overall Study|Withdrawal by Subject|1
4724337|NCT02006667|16291815|P1|Overall Study|Death|2
4724338|NCT02006667|16291815|P1|Overall Study|Adverse Event|3
4724339|NCT02006654|16291827|P2|Overall Study|moving out of state|1
4724340|NCT02006654|16291828|P1|Overall Study|moving out of state|0
4724341|NCT02006654|16291827|P2|Overall Study|disallowed medication|0
4724342|NCT02006654|16291828|P1|Overall Study|disallowed medication|1
4724343|NCT02006654|16291827|P2|Overall Study|mood disorder|1
4724344|NCT02006654|16291828|P1|Overall Study|mood disorder|0
4724345|NCT02006654|16291827|P2|Overall Study|faecal incontinence|1
4724346|NCT02006654|16291828|P1|Overall Study|faecal incontinence|0
4724347|NCT02006654|16291827|P2|Overall Study|worsening cognitive condition|1
4724348|NCT02006654|16291828|P1|Overall Study|worsening cognitive condition|0
4724349|NCT02006654|16291827|P2|Overall Study|insufficient compliance|0
4724350|NCT02006654|16291828|P1|Overall Study|insufficient compliance|1
4724351|NCT02006654|16291827|P2|Overall Study|patient's will|1
4724352|NCT02006654|16291828|P1|Overall Study|patient's will|2
4724353|NCT02006654|16291827|P2|Overall Study|Lost to Follow-up|0
4724354|NCT02006654|16291828|P1|Overall Study|Lost to Follow-up|1
4724355|NCT02006654|16291827|P2|Overall Study|Protocol Violation|8
4724356|NCT02006654|16291828|P1|Overall Study|Protocol Violation|5
4724357|NCT02006654|16291827|P2|Overall Study|Withdrawal by Subject|12
4724358|NCT02006654|16291828|P1|Overall Study|Withdrawal by Subject|14
4724359|NCT02006654|16291827|P2|Overall Study|Death|0
4724360|NCT02006654|16291828|P1|Overall Study|Death|1
4724361|NCT02006654|16291827|P2|Overall Study|Adverse Event|17
4724362|NCT02006654|16291828|P1|Overall Study|Adverse Event|16
4724363|NCT02006654|16291827|P2|Overall Study|Withdrawal before treatment|2
4724364|NCT02006654|16291828|P1|Overall Study|Withdrawal before treatment|4
4724365|NCT02006641|16291857|P3|Overall Study|Other reason: protocol non-compliance|1
4724366|NCT02006641|16291858|P2|Overall Study|Other reason: protocol non-compliance|0
4724367|NCT02006641|16291859|P1|Overall Study|Other reason: protocol non-compliance|0
4724368|NCT02006641|16291857|P3|Overall Study|Other reason: caregiver impossibility|1
4724369|NCT02006641|16291858|P2|Overall Study|Other reason: caregiver impossibility|0
4724370|NCT02006641|16291859|P1|Overall Study|Other reason: caregiver impossibility|0
4724371|NCT02006641|16291857|P3|Overall Study|Other reason: hospitalisation|0
4724372|NCT02006641|16291858|P2|Overall Study|Other reason: hospitalisation|1
4724373|NCT02006641|16291859|P1|Overall Study|Other reason: hospitalisation|0
4724374|NCT02006641|16291857|P3|Overall Study|Other reason: patient's wife has died|1
4724375|NCT02006641|16291858|P2|Overall Study|Other reason: patient's wife has died|0
4724376|NCT02006641|16291859|P1|Overall Study|Other reason: patient's wife has died|0
4724377|NCT02006641|16291857|P3|Overall Study|Other reason: caregiver in hospital|0
4724378|NCT02006641|16291858|P2|Overall Study|Other reason: caregiver in hospital|1
4724379|NCT02006641|16291859|P1|Overall Study|Other reason: caregiver in hospital|0
4724380|NCT02006641|16291857|P3|Overall Study|Other reason: patient has moved|1
4724381|NCT02006641|16291858|P2|Overall Study|Other reason: patient has moved|0
4724382|NCT02006641|16291859|P1|Overall Study|Other reason: patient has moved|1
4724383|NCT02006641|16291857|P3|Overall Study|Other reason:patient didn't want to come|1
4724384|NCT02006641|16291858|P2|Overall Study|Other reason:patient didn't want to come|0
4724385|NCT02006641|16291859|P1|Overall Study|Other reason:patient didn't want to come|0
4724386|NCT02006641|16291857|P3|Overall Study|Other reason: patient didn't show up|0
4724474|NCT02005471|16292194|P1|Overall Study|Death|26
4724387|NCT02006641|16291858|P2|Overall Study|Other reason: patient didn't show up|0
4724388|NCT02006641|16291859|P1|Overall Study|Other reason: patient didn't show up|1
4724389|NCT02006641|16291857|P3|Overall Study|Withdrawal by Subject|11
4724390|NCT02006641|16291858|P2|Overall Study|Withdrawal by Subject|12
4724391|NCT02006641|16291859|P1|Overall Study|Withdrawal by Subject|7
4724392|NCT02006641|16291857|P3|Overall Study|Lost to Follow-up|0
4724393|NCT02006641|16291858|P2|Overall Study|Lost to Follow-up|1
4724394|NCT02006641|16291859|P1|Overall Study|Lost to Follow-up|0
4724395|NCT02006641|16291857|P3|Overall Study|Protocol Violation|2
4724396|NCT02006641|16291858|P2|Overall Study|Protocol Violation|2
4724397|NCT02006641|16291859|P1|Overall Study|Protocol Violation|0
4724398|NCT02006641|16291857|P3|Overall Study|Adverse Event|15
4724399|NCT02006641|16291858|P2|Overall Study|Adverse Event|11
4724400|NCT02006641|16291859|P1|Overall Study|Adverse Event|15
4724401|NCT02006641|16291857|P3|Overall Study|Withdrawal before treatment|3
4724402|NCT02006641|16291858|P2|Overall Study|Withdrawal before treatment|5
4724403|NCT02006641|16291859|P1|Overall Study|Withdrawal before treatment|2
4724404|NCT02006628|16291899|P2|Overall Study|Withdrawal by Subject|1
4724405|NCT02006628|16291900|P1|Overall Study|Withdrawal by Subject|2
4724406|NCT02006628|16291899|P2|Overall Study|Adverse Event|1
4724407|NCT02006628|16291900|P1|Overall Study|Adverse Event|1
4724408|NCT02006576|16291925|P3|Overall Study|Screen Failure, too sick, other|13
4724409|NCT02006576|16291926|P2|Overall Study|Screen Failure, too sick, other|1
4724410|NCT02006576|16291927|P1|Overall Study|Screen Failure, too sick, other|13
4724411|NCT02006576|16291925|P3|Overall Study|Lost to Follow-up|1
4724412|NCT02006576|16291926|P2|Overall Study|Lost to Follow-up|0
4724413|NCT02006576|16291927|P1|Overall Study|Lost to Follow-up|1
4724414|NCT02006576|16291925|P3|Overall Study|Death|1
4724415|NCT02006576|16291926|P2|Overall Study|Death|0
4724416|NCT02006576|16291927|P1|Overall Study|Death|0
4724417|NCT02006576|16291925|P3|Overall Study|Withdrawal by Subject|2
4724418|NCT02006576|16291926|P2|Overall Study|Withdrawal by Subject|6
4724419|NCT02006576|16291927|P1|Overall Study|Withdrawal by Subject|4
4724420|NCT02006121|16292010|P2|Open Label Phase|Non-compliance with study drug|0
4724421|NCT02006121|16292011|P1|Open Label Phase|Non-compliance with study drug|3
4724422|NCT02006121|16292010|P2|Open Label Phase|Withdrawal by Subject|0
4724423|NCT02006121|16292011|P1|Open Label Phase|Withdrawal by Subject|3
4724424|NCT02006121|16292010|P2|Open Label Phase|Protocol Violation|0
4724425|NCT02006121|16292011|P1|Open Label Phase|Protocol Violation|2
4724426|NCT02006121|16292010|P2|Open Label Phase|Lack of Efficacy|0
4724427|NCT02006121|16292011|P1|Open Label Phase|Lack of Efficacy|2
4724428|NCT02006121|16292010|P2|Open Label Phase|Adverse Event|0
4724429|NCT02006121|16292011|P1|Open Label Phase|Adverse Event|15
4724430|NCT02006121|16292010|P2|Double Blind Phase|Inconvenience of infusion system|1
4724431|NCT02006121|16292011|P1|Double Blind Phase|Inconvenience of infusion system|0
4724432|NCT02006121|16292010|P2|Double Blind Phase|Minimum infusion rate poorly tolerated|0
4724433|NCT02006121|16292011|P1|Double Blind Phase|Minimum infusion rate poorly tolerated|1
4724434|NCT02006121|16292010|P2|Double Blind Phase|Non-compliance with study drug|3
4724435|NCT02006121|16292011|P1|Double Blind Phase|Non-compliance with study drug|1
4724436|NCT02006121|16292010|P2|Double Blind Phase|Withdrawal by Subject|4
4724437|NCT02006121|16292011|P1|Double Blind Phase|Withdrawal by Subject|3
4724438|NCT02006121|16292010|P2|Double Blind Phase|Lack of Efficacy|16
4724439|NCT02006121|16292011|P1|Double Blind Phase|Lack of Efficacy|1
4724440|NCT02006121|16292010|P2|Double Blind Phase|Adverse Event|0
4724441|NCT02006121|16292011|P1|Double Blind Phase|Adverse Event|6
4724442|NCT02005887|16292044|P2|Overall Study|Protocol Violation|2
4724443|NCT02005887|16292045|P1|Overall Study|Protocol Violation|0
4724444|NCT02005692|16292063|P1|Overall Study|Discharged earlier than anticipated|5
4724445|NCT02005692|16292063|P1|Overall Study|Withdrawal by Subject|1
4724446|NCT02005692|16292063|P1|Overall Study|Protocol Violation|1
4724447|NCT02005627|16292089|P2|Overall Study|Withdrawal by Subject|2
4724448|NCT02005627|16292090|P1|Overall Study|Withdrawal by Subject|1
4724449|NCT02005627|16292089|P2|Overall Study|Lost to Follow-up|2
4724450|NCT02005627|16292090|P1|Overall Study|Lost to Follow-up|1
4724451|NCT02005562|16292119|P2|Overall Study|Physician Decision|1
4724452|NCT02005562|16292120|P1|Overall Study|Physician Decision|0
4724453|NCT02005562|16292119|P2|Overall Study|No transplant|4
4724454|NCT02005562|16292120|P1|Overall Study|No transplant|1
4724455|NCT02005562|16292119|P2|Overall Study|Withdrawal by Subject|2
4724456|NCT02005562|16292120|P1|Overall Study|Withdrawal by Subject|2
4724457|NCT02005562|16292119|P2|Overall Study|Graft loss|6
4724458|NCT02005562|16292120|P1|Overall Study|Graft loss|7
4724459|NCT02005562|16292119|P2|Overall Study|Death|2
4724460|NCT02005562|16292120|P1|Overall Study|Death|2
4724461|NCT02005484|16292181|P1|Overall Study|Sponsor decision|1
4724462|NCT02005484|16292181|P1|Overall Study|Changed to a Different Study|1
4724463|NCT02005484|16292181|P1|Overall Study|Disease progression|1
4724464|NCT02005484|16292181|P1|Overall Study|Death|1
4724465|NCT02005471|16292193|P2|Overall Study|Withdrawal by Subject|7
4724466|NCT02005471|16292194|P1|Overall Study|Withdrawal by Subject|18
4724467|NCT02005471|16292193|P2|Overall Study|Progressive Disease|0
4724468|NCT02005471|16292194|P1|Overall Study|Progressive Disease|3
4724469|NCT02005471|16292193|P2|Overall Study|Physician Decision|1
4724470|NCT02005471|16292194|P1|Overall Study|Physician Decision|2
4724471|NCT02005471|16292193|P2|Overall Study|Lost to Follow-up|0
4724472|NCT02005471|16292194|P1|Overall Study|Lost to Follow-up|1
4724473|NCT02005471|16292193|P2|Overall Study|Death|15
4724475|NCT02005471|16292193|P2|Overall Study|Adverse Event|0
4724476|NCT02005471|16292194|P1|Overall Study|Adverse Event|1
4724477|NCT02005471|16292193|P2|Overall Study|Ongoing in Study|171
4724478|NCT02005471|16292194|P1|Overall Study|Ongoing in Study|144
4724479|NCT02005445|16292249|P2|Overall Study|Dual study enrollment|1
4724480|NCT02005445|16292250|P1|Overall Study|Dual study enrollment|0
4724481|NCT02005276|16292273|P4|Overall Study|No longer interested|3
4724482|NCT02005276|16292274|P3|Overall Study|No longer interested|3
4724483|NCT02005276|16292275|P2|Overall Study|No longer interested|2
4724484|NCT02005276|16292276|P1|Overall Study|No longer interested|5
4724485|NCT02005250|16292292|P2|Overall Study|Lost to Follow-up|5
4724486|NCT02005250|16292293|P1|Overall Study|Lost to Follow-up|15
4724487|NCT02005211|16292306|P7|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4724488|NCT02005211|16292307|P6|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4724489|NCT02005211|16292308|P5|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1
4724490|NCT02005211|16292309|P4|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4724491|NCT02005211|16292310|P3|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4724492|NCT02005211|16292311|P2|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4724493|NCT02005211|16292312|P1|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0
4724494|NCT02005029|16292347|P2|First Intervention (1 Day)|participant withdrawn for noncompliance|0
4724495|NCT02005029|16292348|P1|First Intervention (1 Day)|participant withdrawn for noncompliance|1
4724496|NCT02004886|16292405|P4|Overall Study|Unable to attend future visits|0
4724497|NCT02004886|16292406|P3|Overall Study|Unable to attend future visits|0
4724498|NCT02004886|16292407|P2|Overall Study|Unable to attend future visits|0
4724499|NCT02004886|16292408|P1|Overall Study|Unable to attend future visits|1
4724500|NCT02004886|16292405|P4|Overall Study|Adverse Event|0
4724501|NCT02004886|16292406|P3|Overall Study|Adverse Event|0
4724502|NCT02004886|16292407|P2|Overall Study|Adverse Event|1
4724503|NCT02004886|16292408|P1|Overall Study|Adverse Event|0
4724504|NCT02004873|16292458|P1|Overall Study|Withdrawal by Subject|1
4724505|NCT02004873|16292458|P1|Overall Study|Death|23
4724506|NCT02004873|16292458|P1|Overall Study|Missed 6-month visit|4
4724507|NCT02004873|16292458|P1|Overall Study|Awaiting 6-month visit|390
4724508|NCT02004873|16292458|P1|Overall Study|Implant unsuccessful|6
4724509|NCT02004847|16292467|P2|Overall Study|Protocol Violation|1
4724510|NCT02004847|16292468|P1|Overall Study|Protocol Violation|1
4724511|NCT02004522|16292514|P2|Overall Study|Completed Treatrment Cycles Per Protocol|103
4724512|NCT02004522|16292515|P1|Overall Study|Completed Treatrment Cycles Per Protocol|1
4724513|NCT02004522|16292514|P2|Overall Study|Disease Progression|31
4724514|NCT02004522|16292515|P1|Overall Study|Disease Progression|35
4724515|NCT02004522|16292514|P2|Overall Study|Never Dosed|4
4724516|NCT02004522|16292515|P1|Overall Study|Never Dosed|2
4724517|NCT02004522|16292514|P2|Overall Study|Other is reason listed by PI.|1
4724518|NCT02004522|16292515|P1|Overall Study|Other is reason listed by PI.|4
4724519|NCT02004522|16292514|P2|Overall Study|Protocol Violation|0
4724520|NCT02004522|16292515|P1|Overall Study|Protocol Violation|1
4724521|NCT02004522|16292514|P2|Overall Study|Physician Decision|4
4724522|NCT02004522|16292515|P1|Overall Study|Physician Decision|3
4724523|NCT02004522|16292514|P2|Overall Study|Death|3
4724524|NCT02004522|16292515|P1|Overall Study|Death|12
4724525|NCT02004522|16292514|P2|Overall Study|Withdrawal by Subject|7
4724526|NCT02004522|16292515|P1|Overall Study|Withdrawal by Subject|13
4724527|NCT02004522|16292514|P2|Overall Study|Adverse Event|6
4724528|NCT02004522|16292515|P1|Overall Study|Adverse Event|55
4724529|NCT02004262|16292636|P6|Overall Study|Study Terminated by Sponsor|5
4724530|NCT02004262|16292637|P5|Overall Study|Study Terminated by Sponsor|1
4724531|NCT02004262|16292638|P4|Overall Study|Study Terminated by Sponsor|1
4724532|NCT02004262|16292639|P3|Overall Study|Study Terminated by Sponsor|2
4724533|NCT02004262|16292640|P2|Overall Study|Study Terminated by Sponsor|3
4724534|NCT02004262|16292641|P1|Overall Study|Study Terminated by Sponsor|4
4724535|NCT02004262|16292636|P6|Overall Study|Lost to Follow-up|0
4724536|NCT02004262|16292637|P5|Overall Study|Lost to Follow-up|0
4724537|NCT02004262|16292638|P4|Overall Study|Lost to Follow-up|0
4724538|NCT02004262|16292639|P3|Overall Study|Lost to Follow-up|0
4724539|NCT02004262|16292640|P2|Overall Study|Lost to Follow-up|1
4724540|NCT02004262|16292641|P1|Overall Study|Lost to Follow-up|1
4724541|NCT02004262|16292636|P6|Overall Study|Withdrawal by Subject|3
4724542|NCT02004262|16292637|P5|Overall Study|Withdrawal by Subject|1
4724543|NCT02004262|16292638|P4|Overall Study|Withdrawal by Subject|0
4724544|NCT02004262|16292639|P3|Overall Study|Withdrawal by Subject|4
4724545|NCT02004262|16292640|P2|Overall Study|Withdrawal by Subject|0
4724546|NCT02004262|16292641|P1|Overall Study|Withdrawal by Subject|1
4724547|NCT02004262|16292636|P6|Overall Study|Death|22
4724548|NCT02004262|16292637|P5|Overall Study|Death|29
4724549|NCT02004262|16292638|P4|Overall Study|Death|28
4724550|NCT02004262|16292639|P3|Overall Study|Death|66
4724551|NCT02004262|16292640|P2|Overall Study|Death|64
4724552|NCT02004262|16292641|P1|Overall Study|Death|67
4724553|NCT02004236|16292661|P3|Overall Study|Lack of Efficacy|16
4724554|NCT02004236|16292662|P2|Overall Study|Lack of Efficacy|0
4724555|NCT02004236|16292663|P1|Overall Study|Lack of Efficacy|0
4724556|NCT02004093|16292723|P2|Overall Study|Other|1
4724557|NCT02004093|16292724|P1|Overall Study|Other|3
4724558|NCT02004093|16292723|P2|Overall Study|Withdrawal by Subject|7
4724559|NCT02004093|16292724|P1|Overall Study|Withdrawal by Subject|3
4724560|NCT02004093|16292723|P2|Overall Study|Lost to Follow-up|1
4724561|NCT02004093|16292724|P1|Overall Study|Lost to Follow-up|0
4724562|NCT02004093|16292723|P2|Overall Study|Protocol Violation|1
4724563|NCT02004093|16292724|P1|Overall Study|Protocol Violation|0
4724564|NCT02004093|16292723|P2|Overall Study|Lack of Efficacy|62
4724565|NCT02004093|16292724|P1|Overall Study|Lack of Efficacy|66
4724566|NCT02004093|16292723|P2|Overall Study|Death|1
4724567|NCT02004093|16292724|P1|Overall Study|Death|2
4724568|NCT02003963|16292756|P2|Overall Study|Lost to Follow-up|1
4724569|NCT02003963|16292757|P1|Overall Study|Lost to Follow-up|2
4724570|NCT02003924|16292779|P3|Long-term Follow-up Phase|Other|1
4724571|NCT02003924|16292780|P2|Long-term Follow-up Phase|Other|2
4724572|NCT02003924|16292781|P1|Long-term Follow-up Phase|Other|5
4724573|NCT02003924|16292779|P3|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1
4724574|NCT02003924|16292780|P2|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55
4724575|NCT02003924|16292781|P1|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66
4724576|NCT02003924|16292779|P3|Long-term Follow-up Phase|Lost to Follow-up|1
4724577|NCT02003924|16292780|P2|Long-term Follow-up Phase|Lost to Follow-up|6
4724578|NCT02003924|16292781|P1|Long-term Follow-up Phase|Lost to Follow-up|8
4724579|NCT02003924|16292779|P3|Long-term Follow-up Phase|Death|4
4724580|NCT02003924|16292780|P2|Long-term Follow-up Phase|Death|174
4724581|NCT02003924|16292781|P1|Long-term Follow-up Phase|Death|288
4724582|NCT02003924|16292779|P3|Open-label Phase|Other|0
4724583|NCT02003924|16292780|P2|Open-label Phase|Other|0
4724584|NCT02003924|16292781|P1|Open-label Phase|Other|7
4724585|NCT02003924|16292779|P3|Open-label Phase|Adverse Event|10
4724586|NCT02003924|16292780|P2|Open-label Phase|Adverse Event|0
4724587|NCT02003924|16292781|P1|Open-label Phase|Adverse Event|25
4724588|NCT02003924|16292779|P3|Open-label Phase|Disease Progression|5
4724589|NCT02003924|16292780|P2|Open-label Phase|Disease Progression|0
4724590|NCT02003924|16292781|P1|Open-label Phase|Disease Progression|59
4724591|NCT02003924|16292779|P3|Open-label Phase|Withdrawal Consent to Continue Treatment|1
4724592|NCT02003924|16292780|P2|Open-label Phase|Withdrawal Consent to Continue Treatment|0
4724593|NCT02003924|16292781|P1|Open-label Phase|Withdrawal Consent to Continue Treatment|9
4724594|NCT02003924|16292779|P3|Open-label Phase|Lost to Follow-up|1
4724595|NCT02003924|16292780|P2|Open-label Phase|Lost to Follow-up|0
4724596|NCT02003924|16292781|P1|Open-label Phase|Lost to Follow-up|0
4724597|NCT02003924|16292779|P3|Double-blind Phase|Other|0
4724598|NCT02003924|16292780|P2|Double-blind Phase|Other|50
4724599|NCT02003924|16292781|P1|Double-blind Phase|Other|29
4724600|NCT02003924|16292779|P3|Double-blind Phase|Randomized But not Treated|0
4724601|NCT02003924|16292780|P2|Double-blind Phase|Randomized But not Treated|3
4724602|NCT02003924|16292781|P1|Double-blind Phase|Randomized But not Treated|3
4724603|NCT02003924|16292779|P3|Double-blind Phase|Adverse Event|0
4724604|NCT02003924|16292780|P2|Double-blind Phase|Adverse Event|31
4724605|NCT02003924|16292781|P1|Double-blind Phase|Adverse Event|120
4724606|NCT02003924|16292779|P3|Double-blind Phase|Disease Progression|0
4724607|NCT02003924|16292780|P2|Double-blind Phase|Disease Progression|247
4724608|NCT02003924|16292781|P1|Double-blind Phase|Disease Progression|229
4724609|NCT02003924|16292779|P3|Double-blind Phase|Withdrawal Consent to Continue Treatment|0
4724610|NCT02003924|16292780|P2|Double-blind Phase|Withdrawal Consent to Continue Treatment|47
4724611|NCT02003924|16292781|P1|Double-blind Phase|Withdrawal Consent to Continue Treatment|71
4724612|NCT02003924|16292779|P3|Double-blind Phase|Protocol Violation|0
4724613|NCT02003924|16292780|P2|Double-blind Phase|Protocol Violation|2
4724614|NCT02003924|16292781|P1|Double-blind Phase|Protocol Violation|1
4724615|NCT02003924|16292779|P3|Double-blind Phase|Lost to Follow-up|0
4724616|NCT02003924|16292780|P2|Double-blind Phase|Lost to Follow-up|1
4724617|NCT02003924|16292781|P1|Double-blind Phase|Lost to Follow-up|2
4724618|NCT02003898|16292903|P1|Overall Study|Withdrawal by Subject|52
4724619|NCT02003898|16292903|P1|Overall Study|Lost to Follow-up|12
4724620|NCT02003898|16292903|P1|Overall Study|Death|3
4724621|NCT02003638|16292912|P2|Overall Study|Withdrawal by Subject|0
4724622|NCT02003638|16292913|P1|Overall Study|Withdrawal by Subject|1
4724623|NCT02003573|16292943|P3|Overall Study|Other than specified|3
4724624|NCT02003573|16292944|P2|Overall Study|Other than specified|2
4724625|NCT02003573|16292945|P1|Overall Study|Other than specified|1
4724626|NCT02003573|16292943|P3|Overall Study|Refuse to take trial medication|1
4724627|NCT02003573|16292944|P2|Overall Study|Refuse to take trial medication|1
4724628|NCT02003573|16292945|P1|Overall Study|Refuse to take trial medication|0
4724629|NCT02003573|16292943|P3|Overall Study|Other Adverse event|1
4724630|NCT02003573|16292944|P2|Overall Study|Other Adverse event|1
4724631|NCT02003573|16292945|P1|Overall Study|Other Adverse event|0
4724632|NCT02003573|16292943|P3|Overall Study|Progressive disease|1
4724633|NCT02003573|16292944|P2|Overall Study|Progressive disease|0
4724634|NCT02003573|16292945|P1|Overall Study|Progressive disease|2
4724635|NCT02003534|16292955|P1|Overall Study|Lost to Follow-up|47
4724636|NCT02003391|16292976|P2|Overall Study|Adverse Event|0
4724637|NCT02003391|16292977|P1|Overall Study|Adverse Event|1
4724638|NCT02003391|16292976|P2|Overall Study|Protocol Violation|1
4724639|NCT02003391|16292977|P1|Overall Study|Protocol Violation|0
4724640|NCT02003391|16292976|P2|Overall Study|Withdrawal by Subject|1
4724641|NCT02003391|16292977|P1|Overall Study|Withdrawal by Subject|2
4724642|NCT02003365|16292990|P3|Overall Study|Lost to Follow-up|1
4724643|NCT02003365|16292991|P2|Overall Study|Lost to Follow-up|0
4724644|NCT02003365|16292992|P1|Overall Study|Lost to Follow-up|0
4724645|NCT02003183|16293009|P2|Overall Study|Lost to Follow-up|2
4724646|NCT02003183|16293010|P1|Overall Study|Lost to Follow-up|0
4724647|NCT02003014|16293025|P1|Overall Study|Investigator's transfer|4
4724648|NCT02003014|16293025|P1|Overall Study|Patient did not visit the study site|5
4724649|NCT02003014|16293025|P1|Overall Study|Treatment started after contract period|1
4724650|NCT02003014|16293025|P1|Overall Study|Case report forms uncollected|9
4724651|NCT02002975|16293035|P1|Overall Study|Protocol Deviation|437
4724652|NCT02002975|16293035|P1|Overall Study|Case Report Forms Uncollected|135
4724653|NCT02002884|16293063|P4|Open-Label Extension Period (OLEX)|Lost to Follow-up|10
4724654|NCT02002884|16293064|P3|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
4724655|NCT02002884|16293065|P2|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
4724656|NCT02002884|16293066|P1|Open-Label Extension Period (OLEX)|Lost to Follow-up|0
4724657|NCT02002884|16293063|P4|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10
4724658|NCT02002884|16293064|P3|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
4724659|NCT02002884|16293065|P2|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
4724660|NCT02002884|16293066|P1|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0
4724661|NCT02002884|16293063|P4|Open-Label Extension Period (OLEX)|Adverse Event|5
4724662|NCT02002884|16293064|P3|Open-Label Extension Period (OLEX)|Adverse Event|0
4724663|NCT02002884|16293065|P2|Open-Label Extension Period (OLEX)|Adverse Event|0
4724664|NCT02002884|16293066|P1|Open-Label Extension Period (OLEX)|Adverse Event|0
4724665|NCT02002884|16293063|P4|Open-Label Extension Period (OLEX)|Physician Decision|1
4724666|NCT02002884|16293064|P3|Open-Label Extension Period (OLEX)|Physician Decision|0
4724667|NCT02002884|16293065|P2|Open-Label Extension Period (OLEX)|Physician Decision|0
4724668|NCT02002884|16293066|P1|Open-Label Extension Period (OLEX)|Physician Decision|0
4724669|NCT02002884|16293063|P4|Open-Label Extension Period (OLEX)|Other|24
4724670|NCT02002884|16293064|P3|Open-Label Extension Period (OLEX)|Other|0
4724671|NCT02002884|16293065|P2|Open-Label Extension Period (OLEX)|Other|0
4724672|NCT02002884|16293066|P1|Open-Label Extension Period (OLEX)|Other|0
4724673|NCT02002884|16293063|P4|Main Period (MP)|Lost to Follow-up|0
4724674|NCT02002884|16293064|P3|Main Period (MP)|Lost to Follow-up|2
4724675|NCT02002884|16293065|P2|Main Period (MP)|Lost to Follow-up|0
4724676|NCT02002884|16293066|P1|Main Period (MP)|Lost to Follow-up|0
4724677|NCT02002884|16293063|P4|Main Period (MP)|Withdrawal by Subject|0
4724678|NCT02002884|16293064|P3|Main Period (MP)|Withdrawal by Subject|2
4724679|NCT02002884|16293065|P2|Main Period (MP)|Withdrawal by Subject|2
4724680|NCT02002884|16293066|P1|Main Period (MP)|Withdrawal by Subject|6
4724681|NCT02002884|16293063|P4|Main Period (MP)|Adverse Event|0
4724682|NCT02002884|16293064|P3|Main Period (MP)|Adverse Event|1
4724683|NCT02002884|16293065|P2|Main Period (MP)|Adverse Event|1
4724684|NCT02002884|16293066|P1|Main Period (MP)|Adverse Event|0
4724685|NCT02002884|16293063|P4|Main Period (MP)|Other|0
4724686|NCT02002884|16293064|P3|Main Period (MP)|Other|3
4724687|NCT02002884|16293065|P2|Main Period (MP)|Other|3
4724688|NCT02002884|16293066|P1|Main Period (MP)|Other|0
4724689|NCT02002689|16293199|P1|Overall Study|Adverse Event|3
4724690|NCT02002689|16293199|P1|Overall Study|Disease Progression|7
4724691|NCT02002533|16293218|P2|Overall Study|Lost to Follow-up|1
4724692|NCT02002533|16293219|P1|Overall Study|Lost to Follow-up|0
4724693|NCT02002533|16293218|P2|Overall Study|Adverse Event|3
4724694|NCT02002533|16293219|P1|Overall Study|Adverse Event|0
4724695|NCT02002533|16293218|P2|Overall Study|Protocol Violation|1
4724696|NCT02002533|16293219|P1|Overall Study|Protocol Violation|0
4724697|NCT02002533|16293218|P2|Overall Study|Withdrawal by Subject|13
4724698|NCT02002533|16293219|P1|Overall Study|Withdrawal by Subject|6
4724699|NCT02002221|16293259|P2|Overall Study|Patient withdrew consent|1
4724700|NCT02002221|16293260|P1|Overall Study|Patient withdrew consent|0
4724701|NCT02002221|16293259|P2|Overall Study|Unsatisfactory therapeutic effect|1
4724702|NCT02002221|16293260|P1|Overall Study|Unsatisfactory therapeutic effect|0
4724703|NCT02002221|16293259|P2|Overall Study|Adverse Event|1
4724704|NCT02002221|16293260|P1|Overall Study|Adverse Event|2
4724705|NCT02002182|16293287|P2|Overall Study|Death|0
4724706|NCT02002182|16293288|P1|Overall Study|Death|1
4724707|NCT02002182|16293287|P2|Overall Study|Health Reasons|0
4724708|NCT02002182|16293288|P1|Overall Study|Health Reasons|1
4724709|NCT02002182|16293287|P2|Overall Study|Withdraw from study|1
4724710|NCT02002182|16293288|P1|Overall Study|Withdraw from study|3
4724711|NCT02002091|16293300|P2|Screening|Death|2
4724712|NCT02002091|16293301|P1|Screening|Death|3
4724713|NCT02002091|16293300|P2|Screening|Lost to Follow-up|12
4724714|NCT02002091|16293301|P1|Screening|Lost to Follow-up|10
4724715|NCT02001987|16293336|P1|LTE Period (52 Weeks)|Other|3
4724716|NCT02001987|16293336|P1|LTE Period (52 Weeks)|Lack of Efficacy|1
4724717|NCT02001987|16293336|P1|LTE Period (52 Weeks)|Withdrawal by Subject|1
4724718|NCT02001987|16293336|P1|LTE Period (52 Weeks)|Physician Decision|2
4724719|NCT02001987|16293336|P1|LTE Period (52 Weeks)|Lost to Follow-up|2
4724720|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Lack of Efficacy|3
4724721|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Protocol Violation|3
4724722|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Withdrawal by Subject|4
4724723|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Physician Decision|1
4724724|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2
4724725|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Death|1
4724726|NCT02001987|16293336|P1|Core Study Period (24 Weeks)|Adverse Event|9
4724727|NCT02001688|16293422|P3|Overall Study|Adverse Event|0
4724728|NCT02001688|16293423|P2|Overall Study|Adverse Event|1
4724729|NCT02001688|16293424|P1|Overall Study|Adverse Event|0
4724730|NCT02001688|16293422|P3|Overall Study|Withdrawal by Subject|1
4724731|NCT02001688|16293423|P2|Overall Study|Withdrawal by Subject|0
4724732|NCT02001688|16293424|P1|Overall Study|Withdrawal by Subject|0
4724733|NCT02001558|16293443|P2|Overall Study|Lost to Follow-up|14
4724734|NCT02001558|16293444|P1|Overall Study|Lost to Follow-up|8
4724735|NCT02001194|16293480|P4|Follow-Up Period (13 Weeks)|No longer interested|0
4724736|NCT02001194|16293481|P3|Follow-Up Period (13 Weeks)|No longer interested|1
4724737|NCT02001194|16293482|P2|Follow-Up Period (13 Weeks)|No longer interested|2
4724738|NCT02001194|16293483|P1|Follow-Up Period (13 Weeks)|No longer interested|3
4724739|NCT02001194|16293480|P4|Intervention Period (13 Weeks)|No longer interested|2
4724740|NCT02001194|16293481|P3|Intervention Period (13 Weeks)|No longer interested|2
4724741|NCT02001194|16293482|P2|Intervention Period (13 Weeks)|No longer interested|0
4724742|NCT02001194|16293483|P1|Intervention Period (13 Weeks)|No longer interested|1
4724743|NCT02001181|16293499|P2|Overall Study|Withdrawal by Subject|1
4724744|NCT02001181|16293500|P1|Overall Study|Withdrawal by Subject|0
4724745|NCT02001181|16293499|P2|Overall Study|Lost to Follow-up|0
4724746|NCT02001181|16293500|P1|Overall Study|Lost to Follow-up|1
4724747|NCT02001181|16293499|P2|Overall Study|Adverse Event|2
4724748|NCT02001181|16293500|P1|Overall Study|Adverse Event|0
4724749|NCT02001051|16293516|P2|Overall Study|Deemed not eligible following enrollment|1
4724750|NCT02001051|16293517|P1|Overall Study|Deemed not eligible following enrollment|0
4724751|NCT02000921|16293569|P3|Overall Study|Physician Decision|0
4724752|NCT02000921|16293570|P2|Overall Study|Physician Decision|2
4724753|NCT02000921|16293571|P1|Overall Study|Physician Decision|0
4724754|NCT02000921|16293569|P3|Overall Study|Lost to Follow-up|5
4724755|NCT02000921|16293570|P2|Overall Study|Lost to Follow-up|4
4724756|NCT02000921|16293571|P1|Overall Study|Lost to Follow-up|2
4724757|NCT02000921|16293569|P3|Overall Study|Withdrawal by Subject|5
4724758|NCT02000921|16293570|P2|Overall Study|Withdrawal by Subject|10
4724759|NCT02000921|16293571|P1|Overall Study|Withdrawal by Subject|3
4724760|NCT02000817|16293601|P4|Overall Study|Lost to Follow-up|0
4724761|NCT02000817|16293602|P3|Overall Study|Lost to Follow-up|1
4724762|NCT02000817|16293603|P2|Overall Study|Lost to Follow-up|0
4724763|NCT02000817|16293604|P1|Overall Study|Lost to Follow-up|0
4724764|NCT02000817|16293601|P4|Overall Study|Adverse Event|0
4724765|NCT02000817|16293602|P3|Overall Study|Adverse Event|0
4724766|NCT02000817|16293603|P2|Overall Study|Adverse Event|1
4724767|NCT02000817|16293604|P1|Overall Study|Adverse Event|0
4724768|NCT02000817|16293601|P4|Overall Study|Withdrawal by Subject|0
4724769|NCT02000817|16293602|P3|Overall Study|Withdrawal by Subject|0
4724770|NCT02000817|16293603|P2|Overall Study|Withdrawal by Subject|0
4724771|NCT02000817|16293604|P1|Overall Study|Withdrawal by Subject|2
4724772|NCT02000752|16293699|P2|Overall Study|Shift Changes|5
4724773|NCT02000752|16293700|P1|Overall Study|Shift Changes|12
4724774|NCT02000752|16293699|P2|Overall Study|Dystocic delivery|8
4724775|NCT02000752|16293700|P1|Overall Study|Dystocic delivery|19
4724776|NCT02000622|16293714|P2|Overall Study|Withdrawal by Subject|7
4724777|NCT02000622|16293715|P1|Overall Study|Withdrawal by Subject|5
4724778|NCT02000622|16293714|P2|Overall Study|Death|46
4724779|NCT02000622|16293715|P1|Overall Study|Death|94
4724780|NCT02000622|16293714|P2|Overall Study|Lost to Follow-up|0
4724781|NCT02000622|16293715|P1|Overall Study|Lost to Follow-up|1
4724782|NCT02000622|16293714|P2|Overall Study|Withdrawn due to site closure|0
4724783|NCT02000622|16293715|P1|Overall Study|Withdrawn due to site closure|1
4724784|NCT02000531|16293750|P2|Overall Study|Discontinued due to data cut-off|8
4724785|NCT02000531|16293751|P1|Overall Study|Discontinued due to data cut-off|3
4724786|NCT02000531|16293750|P2|Overall Study|Lost to Follow-up|0
4724787|NCT02000531|16293751|P1|Overall Study|Lost to Follow-up|1
4724788|NCT02000440|16293759|P1|Overall Study|Other-Protocol-defined Stopping Criteria|1
4724789|NCT02000440|16293759|P1|Overall Study|Adverse Event|3
4724790|NCT02000427|16293779|P1|Overall Study|Death|22
4724791|NCT01999972|16293833|P6|Dose Expansion Part|Changed to standard of care|0
4724792|NCT01999972|16293834|P5|Dose Expansion Part|Changed to standard of care|1
4724793|NCT01999972|16293835|P4|Dose Expansion Part|Changed to standard of care|0
4724794|NCT01999972|16293836|P3|Dose Expansion Part|Changed to standard of care|0
4724795|NCT01999972|16293837|P2|Dose Expansion Part|Changed to standard of care|0
4724796|NCT01999972|16293838|P1|Dose Expansion Part|Changed to standard of care|0
4724797|NCT01999972|16293833|P6|Dose Expansion Part|Participant refused further follow-up|0
4724798|NCT01999972|16293834|P5|Dose Expansion Part|Participant refused further follow-up|4
4724799|NCT01999972|16293835|P4|Dose Expansion Part|Participant refused further follow-up|0
4724800|NCT01999972|16293836|P3|Dose Expansion Part|Participant refused further follow-up|0
4724801|NCT01999972|16293837|P2|Dose Expansion Part|Participant refused further follow-up|0
4724802|NCT01999972|16293838|P1|Dose Expansion Part|Participant refused further follow-up|0
4724803|NCT01999972|16293833|P6|Dose Expansion Part|Participant's non-compliance|1
4724804|NCT01999972|16293834|P5|Dose Expansion Part|Participant's non-compliance|0
4724805|NCT01999972|16293835|P4|Dose Expansion Part|Participant's non-compliance|0
4724806|NCT01999972|16293836|P3|Dose Expansion Part|Participant's non-compliance|0
4724807|NCT01999972|16293837|P2|Dose Expansion Part|Participant's non-compliance|0
4724808|NCT01999972|16293838|P1|Dose Expansion Part|Participant's non-compliance|0
4724809|NCT01999972|16293833|P6|Dose Expansion Part|Adverse Event|2
4724810|NCT01999972|16293834|P5|Dose Expansion Part|Adverse Event|4
4724811|NCT01999972|16293835|P4|Dose Expansion Part|Adverse Event|0
4724812|NCT01999972|16293836|P3|Dose Expansion Part|Adverse Event|0
4724813|NCT01999972|16293837|P2|Dose Expansion Part|Adverse Event|0
4724814|NCT01999972|16293838|P1|Dose Expansion Part|Adverse Event|0
4724815|NCT01999972|16293833|P6|Dose Expansion Part|Sponsor decision|0
4724816|NCT01999972|16293834|P5|Dose Expansion Part|Sponsor decision|1
4724817|NCT01999972|16293835|P4|Dose Expansion Part|Sponsor decision|0
4724818|NCT01999972|16293836|P3|Dose Expansion Part|Sponsor decision|0
4724819|NCT01999972|16293837|P2|Dose Expansion Part|Sponsor decision|0
4724820|NCT01999972|16293838|P1|Dose Expansion Part|Sponsor decision|0
4724821|NCT01999972|16293833|P6|Dose Expansion Part|Disease progression|3
4724822|NCT01999972|16293834|P5|Dose Expansion Part|Disease progression|9
4724823|NCT01999972|16293835|P4|Dose Expansion Part|Disease progression|0
4724824|NCT01999972|16293836|P3|Dose Expansion Part|Disease progression|0
4724825|NCT01999972|16293837|P2|Dose Expansion Part|Disease progression|0
4724826|NCT01999972|16293838|P1|Dose Expansion Part|Disease progression|0
4724827|NCT01999972|16293833|P6|Dose Expansion Part|Death|1
4724828|NCT01999972|16293834|P5|Dose Expansion Part|Death|2
4724829|NCT01999972|16293835|P4|Dose Expansion Part|Death|0
4724830|NCT01999972|16293836|P3|Dose Expansion Part|Death|0
4724831|NCT01999972|16293837|P2|Dose Expansion Part|Death|0
4724832|NCT01999972|16293838|P1|Dose Expansion Part|Death|0
4724833|NCT01999972|16293833|P6|Dose Escalation Part|Global deterioration of health status|0
4724834|NCT01999972|16293834|P5|Dose Escalation Part|Global deterioration of health status|0
4724835|NCT01999972|16293835|P4|Dose Escalation Part|Global deterioration of health status|1
4724836|NCT01999972|16293836|P3|Dose Escalation Part|Global deterioration of health status|0
4724837|NCT01999972|16293837|P2|Dose Escalation Part|Global deterioration of health status|0
4724838|NCT01999972|16293838|P1|Dose Escalation Part|Global deterioration of health status|1
4724839|NCT01999972|16293833|P6|Dose Escalation Part|Adverse Event|0
4724840|NCT01999972|16293834|P5|Dose Escalation Part|Adverse Event|0
4724841|NCT01999972|16293835|P4|Dose Escalation Part|Adverse Event|2
4724842|NCT01999972|16293836|P3|Dose Escalation Part|Adverse Event|0
4724843|NCT01999972|16293837|P2|Dose Escalation Part|Adverse Event|0
4724844|NCT01999972|16293838|P1|Dose Escalation Part|Adverse Event|0
4724845|NCT01999972|16293833|P6|Dose Escalation Part|Disease progression|0
4724846|NCT01999972|16293834|P5|Dose Escalation Part|Disease progression|0
4724847|NCT01999972|16293835|P4|Dose Escalation Part|Disease progression|6
4724848|NCT01999972|16293836|P3|Dose Escalation Part|Disease progression|3
4724849|NCT01999972|16293837|P2|Dose Escalation Part|Disease progression|2
4724850|NCT01999972|16293838|P1|Dose Escalation Part|Disease progression|3
4724851|NCT01999972|16293833|P6|Dose Escalation Part|Enrolled but not treated|0
4724852|NCT01999972|16293834|P5|Dose Escalation Part|Enrolled but not treated|0
4724853|NCT01999972|16293835|P4|Dose Escalation Part|Enrolled but not treated|1
4724854|NCT01999972|16293836|P3|Dose Escalation Part|Enrolled but not treated|1
4724855|NCT01999972|16293837|P2|Dose Escalation Part|Enrolled but not treated|0
4724856|NCT01999972|16293838|P1|Dose Escalation Part|Enrolled but not treated|0
4724857|NCT01999972|16293833|P6|Dose Escalation Part|Death|0
4724858|NCT01999972|16293834|P5|Dose Escalation Part|Death|0
4724859|NCT01999972|16293835|P4|Dose Escalation Part|Death|0
4724860|NCT01999972|16293836|P3|Dose Escalation Part|Death|0
4724861|NCT01999972|16293837|P2|Dose Escalation Part|Death|1
4724862|NCT01999972|16293838|P1|Dose Escalation Part|Death|0
4724863|NCT01999972|16293833|P6|Dose Escalation Part|Participant refused further follow-up|0
4724864|NCT01999972|16293834|P5|Dose Escalation Part|Participant refused further follow-up|0
4724865|NCT01999972|16293835|P4|Dose Escalation Part|Participant refused further follow-up|1
4724866|NCT01999972|16293836|P3|Dose Escalation Part|Participant refused further follow-up|1
4724867|NCT01999972|16293837|P2|Dose Escalation Part|Participant refused further follow-up|0
4724868|NCT01999972|16293838|P1|Dose Escalation Part|Participant refused further follow-up|1
4724869|NCT01999946|16293953|P3|Overall Study|Not included in primary outcome analysis|79
4724870|NCT01999946|16293954|P2|Overall Study|Not included in primary outcome analysis|0
4724871|NCT01999946|16293955|P1|Overall Study|Not included in primary outcome analysis|0
4724872|NCT01999946|16293953|P3|Overall Study|Participant not released from jail|0
4724873|NCT01999946|16293954|P2|Overall Study|Participant not released from jail|2
4724874|NCT01999946|16293955|P1|Overall Study|Participant not released from jail|2
4724875|NCT01999894|16293981|P1|Overall Study|Inclusion/exclusion criteria not met|1
4724876|NCT01999894|16293981|P1|Overall Study|Other Reason|3
4724877|NCT01999894|16293981|P1|Overall Study|Lost to Follow-up|10
4724878|NCT01999894|16293981|P1|Overall Study|Withdrawal by Subject|7
4724879|NCT01999894|16293981|P1|Overall Study|Protocol Violation|1
4724880|NCT01999894|16293981|P1|Overall Study|Lack of Efficacy|5
4724881|NCT01999894|16293981|P1|Overall Study|Adverse Event|9
4724882|NCT01999868|16293989|P3|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0
4724883|NCT01999868|16293990|P2|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4
4724884|NCT01999868|16293991|P1|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12
4724885|NCT01999868|16293989|P3|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
4724886|NCT01999868|16293990|P2|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2
4724887|NCT01999868|16293991|P1|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0
4724888|NCT01999868|16293989|P3|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0
4724889|NCT01999868|16293990|P2|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19
4724890|NCT01999868|16293991|P1|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10
4724891|NCT01999868|16293989|P3|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0
4724892|NCT01999868|16293990|P2|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2
4724893|NCT01999868|16293991|P1|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1
4724894|NCT01999868|16293989|P3|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
4724895|NCT01999868|16293990|P2|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1
4724896|NCT01999868|16293991|P1|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0
4724897|NCT01999868|16293989|P3|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
4724898|NCT01999868|16293990|P2|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1
4724899|NCT01999868|16293991|P1|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0
4724900|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
4724901|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0
4724902|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4
4724903|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
4724904|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0
4724905|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1
4724906|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0
4724907|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1
4724908|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8
4724909|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0
4724910|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2
4724911|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1
4724912|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
4724913|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2
4724914|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0
4724915|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
4724916|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1
4724917|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0
4724918|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0
4724919|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4
4724920|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3
4724921|NCT01999868|16293989|P3|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0
4724922|NCT01999868|16293990|P2|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
4724923|NCT01999868|16293991|P1|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1
4724924|NCT01999868|16293989|P3|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5
4724925|NCT01999868|16293990|P2|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
4724926|NCT01999868|16293991|P1|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0
4724927|NCT01999465|16294042|P2|Overall Study|Protocol Violation|1
4724928|NCT01999465|16294043|P1|Overall Study|Protocol Violation|0
4724929|NCT01999465|16294042|P2|Overall Study|Lost to Follow-up|2
4724930|NCT01999465|16294043|P1|Overall Study|Lost to Follow-up|0
4724931|NCT01999322|16294088|P2|Overall Study|Adverse Event|0
4724932|NCT01999322|16294089|P1|Overall Study|Adverse Event|1
4724933|NCT01999218|16294141|P3|Overall Study|Treated but excluded at 1 trial site|2
4724934|NCT01999218|16294142|P2|Overall Study|Treated but excluded at 1 trial site|5
4724935|NCT01999218|16294143|P1|Overall Study|Treated but excluded at 1 trial site|3
4724936|NCT01999218|16294141|P3|Overall Study|Adverse Event|7
4724937|NCT01999218|16294142|P2|Overall Study|Adverse Event|7
4724938|NCT01999218|16294143|P1|Overall Study|Adverse Event|9
4724939|NCT01999218|16294141|P3|Overall Study|Excluded Medication|2
4724940|NCT01999218|16294142|P2|Overall Study|Excluded Medication|1
4724941|NCT01999218|16294143|P1|Overall Study|Excluded Medication|1
4724942|NCT01999218|16294141|P3|Overall Study|Death|2
4724943|NCT01999218|16294142|P2|Overall Study|Death|1
4724944|NCT01999218|16294143|P1|Overall Study|Death|7
4724945|NCT01999218|16294141|P3|Overall Study|Creatinine/eGFR|1
4724946|NCT01999218|16294142|P2|Overall Study|Creatinine/eGFR|0
4724947|NCT01999218|16294143|P1|Overall Study|Creatinine/eGFR|0
4724948|NCT01999218|16294141|P3|Overall Study|Withdrawal by Subject|34
4724949|NCT01999218|16294142|P2|Overall Study|Withdrawal by Subject|29
4724950|NCT01999218|16294143|P1|Overall Study|Withdrawal by Subject|28
4724951|NCT01999218|16294141|P3|Overall Study|Participant moves|3
4724952|NCT01999218|16294142|P2|Overall Study|Participant moves|5
4724953|NCT01999218|16294143|P1|Overall Study|Participant moves|2
4724954|NCT01999218|16294141|P3|Overall Study|Study Terminated By Sponsor|12
4724955|NCT01999218|16294142|P2|Overall Study|Study Terminated By Sponsor|5
4724956|NCT01999218|16294143|P1|Overall Study|Study Terminated By Sponsor|7
4724957|NCT01999218|16294141|P3|Overall Study|Screen failure|0
4724958|NCT01999218|16294142|P2|Overall Study|Screen failure|1
4724959|NCT01999218|16294143|P1|Overall Study|Screen failure|0
4724960|NCT01999218|16294141|P3|Overall Study|Protocol Violation|4
4724961|NCT01999218|16294142|P2|Overall Study|Protocol Violation|5
4724962|NCT01999218|16294143|P1|Overall Study|Protocol Violation|4
4724963|NCT01999218|16294141|P3|Overall Study|Physician Decision|6
4724964|NCT01999218|16294142|P2|Overall Study|Physician Decision|4
4724965|NCT01999218|16294143|P1|Overall Study|Physician Decision|1
4724966|NCT01999218|16294141|P3|Overall Study|Non-Compliance With Study Drug|1
4724967|NCT01999218|16294142|P2|Overall Study|Non-Compliance With Study Drug|4
4724968|NCT01999218|16294143|P1|Overall Study|Non-Compliance With Study Drug|6
4724969|NCT01999218|16294141|P3|Overall Study|Lost to Follow-up|18
4724970|NCT01999218|16294142|P2|Overall Study|Lost to Follow-up|17
4724971|NCT01999218|16294143|P1|Overall Study|Lost to Follow-up|22
4724972|NCT01999218|16294141|P3|Overall Study|Lack of Efficacy|1
4724973|NCT01999218|16294142|P2|Overall Study|Lack of Efficacy|0
4724974|NCT01999218|16294143|P1|Overall Study|Lack of Efficacy|1
4724975|NCT01999218|16294141|P3|Overall Study|Hyperglycemia|17
4724976|NCT01999218|16294142|P2|Overall Study|Hyperglycemia|17
4724977|NCT01999218|16294143|P1|Overall Study|Hyperglycemia|18
4724978|NCT01999114|16294188|P5|Overall Study|Administrative|2
4724979|NCT01999114|16294189|P4|Overall Study|Administrative|1
4724980|NCT01999114|16294190|P3|Overall Study|Administrative|1
4724981|NCT01999114|16294191|P2|Overall Study|Administrative|0
4724982|NCT01999114|16294192|P1|Overall Study|Administrative|0
4724983|NCT01999114|16294188|P5|Overall Study|Lost to Follow-up|0
4724984|NCT01999114|16294189|P4|Overall Study|Lost to Follow-up|0
4724985|NCT01999114|16294190|P3|Overall Study|Lost to Follow-up|1
4724986|NCT01999114|16294191|P2|Overall Study|Lost to Follow-up|0
4724987|NCT01999114|16294192|P1|Overall Study|Lost to Follow-up|0
4724988|NCT01999114|16294188|P5|Overall Study|Withdrawal by Subject|1
4724989|NCT01999114|16294189|P4|Overall Study|Withdrawal by Subject|0
4724990|NCT01999114|16294190|P3|Overall Study|Withdrawal by Subject|1
4724991|NCT01999114|16294191|P2|Overall Study|Withdrawal by Subject|0
4724992|NCT01999114|16294192|P1|Overall Study|Withdrawal by Subject|0
4724993|NCT01999114|16294188|P5|Overall Study|Adverse Event|1
4724994|NCT01999114|16294189|P4|Overall Study|Adverse Event|2
4724995|NCT01999114|16294190|P3|Overall Study|Adverse Event|2
4724996|NCT01999114|16294191|P2|Overall Study|Adverse Event|7
4724997|NCT01999114|16294192|P1|Overall Study|Adverse Event|8
4724998|NCT01998984|16294260|P4|Overall Study|Other|1
4724999|NCT01998984|16294261|P3|Overall Study|Other|0
4725000|NCT01998984|16294262|P2|Overall Study|Other|0
4725001|NCT01998984|16294263|P1|Overall Study|Other|0
4725002|NCT01998984|16294260|P4|Overall Study|Withdrawal by Subject|0
4725003|NCT01998984|16294261|P3|Overall Study|Withdrawal by Subject|1
4725004|NCT01998984|16294262|P2|Overall Study|Withdrawal by Subject|0
4725005|NCT01998984|16294263|P1|Overall Study|Withdrawal by Subject|0
4725006|NCT01998984|16294260|P4|Overall Study|Lost to Follow-up|1
4725007|NCT01998984|16294261|P3|Overall Study|Lost to Follow-up|0
4725008|NCT01998984|16294262|P2|Overall Study|Lost to Follow-up|1
4725009|NCT01998984|16294263|P1|Overall Study|Lost to Follow-up|0
4725010|NCT01998984|16294260|P4|Overall Study|Adverse Event|1
4725011|NCT01998984|16294261|P3|Overall Study|Adverse Event|0
4725012|NCT01998984|16294262|P2|Overall Study|Adverse Event|0
4725013|NCT01998984|16294263|P1|Overall Study|Adverse Event|0
4725014|NCT01998958|16294288|P32|Open Label Phase (Optional)|Withdrawal by Subject|0
4725015|NCT01998958|16294289|P31|Open Label Phase (Optional)|Withdrawal by Subject|0
4725016|NCT01998958|16294290|P30|Open Label Phase (Optional)|Withdrawal by Subject|0
4725017|NCT01998958|16294291|P29|Open Label Phase (Optional)|Withdrawal by Subject|0
4725018|NCT01998958|16294292|P28|Open Label Phase (Optional)|Withdrawal by Subject|0
4725019|NCT01998958|16294293|P27|Open Label Phase (Optional)|Withdrawal by Subject|0
4725020|NCT01998958|16294294|P26|Open Label Phase (Optional)|Withdrawal by Subject|0
4725021|NCT01998958|16294295|P25|Open Label Phase (Optional)|Withdrawal by Subject|0
4725022|NCT01998958|16294296|P24|Open Label Phase (Optional)|Withdrawal by Subject|2
4725023|NCT01998958|16294297|P23|Open Label Phase (Optional)|Withdrawal by Subject|1
4725024|NCT01998958|16294298|P22|Open Label Phase (Optional)|Withdrawal by Subject|2
4725025|NCT01998958|16294299|P21|Open Label Phase (Optional)|Withdrawal by Subject|0
4725026|NCT01998958|16294300|P20|Open Label Phase (Optional)|Withdrawal by Subject|0
4725027|NCT01998958|16294301|P19|Open Label Phase (Optional)|Withdrawal by Subject|0
4725028|NCT01998958|16294302|P18|Open Label Phase (Optional)|Withdrawal by Subject|0
4725029|NCT01998958|16294303|P17|Open Label Phase (Optional)|Withdrawal by Subject|0
4725030|NCT01998958|16294304|P16|Open Label Phase (Optional)|Withdrawal by Subject|0
4725031|NCT01998958|16294305|P15|Open Label Phase (Optional)|Withdrawal by Subject|0
4725032|NCT01998958|16294306|P14|Open Label Phase (Optional)|Withdrawal by Subject|0
4725033|NCT01998958|16294307|P13|Open Label Phase (Optional)|Withdrawal by Subject|0
4725034|NCT01998958|16294308|P12|Open Label Phase (Optional)|Withdrawal by Subject|0
4725035|NCT01998958|16294309|P11|Open Label Phase (Optional)|Withdrawal by Subject|0
4725036|NCT01998958|16294310|P10|Open Label Phase (Optional)|Withdrawal by Subject|0
4725037|NCT01998958|16294311|P9|Open Label Phase (Optional)|Withdrawal by Subject|0
4725038|NCT01998958|16294312|P8|Open Label Phase (Optional)|Withdrawal by Subject|0
4725039|NCT01998958|16294313|P7|Open Label Phase (Optional)|Withdrawal by Subject|0
4725040|NCT01998958|16294314|P6|Open Label Phase (Optional)|Withdrawal by Subject|0
4725041|NCT01998958|16294315|P5|Open Label Phase (Optional)|Withdrawal by Subject|0
4725042|NCT01998958|16294316|P4|Open Label Phase (Optional)|Withdrawal by Subject|0
4725043|NCT01998958|16294317|P3|Open Label Phase (Optional)|Withdrawal by Subject|0
4725044|NCT01998958|16294318|P2|Open Label Phase (Optional)|Withdrawal by Subject|0
4725045|NCT01998958|16294319|P1|Open Label Phase (Optional)|Withdrawal by Subject|0
4725046|NCT01998958|16294288|P32|Open Label Phase (Optional)|Lack of Efficacy|0
4725047|NCT01998958|16294289|P31|Open Label Phase (Optional)|Lack of Efficacy|0
4725048|NCT01998958|16294290|P30|Open Label Phase (Optional)|Lack of Efficacy|0
4725049|NCT01998958|16294291|P29|Open Label Phase (Optional)|Lack of Efficacy|0
4725050|NCT01998958|16294292|P28|Open Label Phase (Optional)|Lack of Efficacy|0
4725051|NCT01998958|16294293|P27|Open Label Phase (Optional)|Lack of Efficacy|0
4725052|NCT01998958|16294294|P26|Open Label Phase (Optional)|Lack of Efficacy|0
4725053|NCT01998958|16294295|P25|Open Label Phase (Optional)|Lack of Efficacy|0
4725054|NCT01998958|16294296|P24|Open Label Phase (Optional)|Lack of Efficacy|0
4725055|NCT01998958|16294297|P23|Open Label Phase (Optional)|Lack of Efficacy|2
4725056|NCT01998958|16294298|P22|Open Label Phase (Optional)|Lack of Efficacy|1
4725057|NCT01998958|16294299|P21|Open Label Phase (Optional)|Lack of Efficacy|0
4725058|NCT01998958|16294300|P20|Open Label Phase (Optional)|Lack of Efficacy|0
4725059|NCT01998958|16294301|P19|Open Label Phase (Optional)|Lack of Efficacy|0
4725060|NCT01998958|16294302|P18|Open Label Phase (Optional)|Lack of Efficacy|0
4725061|NCT01998958|16294303|P17|Open Label Phase (Optional)|Lack of Efficacy|0
4725062|NCT01998958|16294304|P16|Open Label Phase (Optional)|Lack of Efficacy|0
4725063|NCT01998958|16294305|P15|Open Label Phase (Optional)|Lack of Efficacy|0
4725064|NCT01998958|16294306|P14|Open Label Phase (Optional)|Lack of Efficacy|0
4725065|NCT01998958|16294307|P13|Open Label Phase (Optional)|Lack of Efficacy|0
4725066|NCT01998958|16294308|P12|Open Label Phase (Optional)|Lack of Efficacy|0
4725067|NCT01998958|16294309|P11|Open Label Phase (Optional)|Lack of Efficacy|0
4725068|NCT01998958|16294310|P10|Open Label Phase (Optional)|Lack of Efficacy|0
4725069|NCT01998958|16294311|P9|Open Label Phase (Optional)|Lack of Efficacy|0
4725070|NCT01998958|16294312|P8|Open Label Phase (Optional)|Lack of Efficacy|0
4725071|NCT01998958|16294313|P7|Open Label Phase (Optional)|Lack of Efficacy|0
4725072|NCT01998958|16294314|P6|Open Label Phase (Optional)|Lack of Efficacy|0
4725073|NCT01998958|16294315|P5|Open Label Phase (Optional)|Lack of Efficacy|0
4725074|NCT01998958|16294316|P4|Open Label Phase (Optional)|Lack of Efficacy|0
4725075|NCT01998958|16294317|P3|Open Label Phase (Optional)|Lack of Efficacy|0
4725076|NCT01998958|16294318|P2|Open Label Phase (Optional)|Lack of Efficacy|0
4725077|NCT01998958|16294319|P1|Open Label Phase (Optional)|Lack of Efficacy|0
4725078|NCT01998958|16294288|P32|Open Label Phase (Optional)|Lost to Follow-up|0
4725079|NCT01998958|16294289|P31|Open Label Phase (Optional)|Lost to Follow-up|0
4725080|NCT01998958|16294290|P30|Open Label Phase (Optional)|Lost to Follow-up|0
4725081|NCT01998958|16294291|P29|Open Label Phase (Optional)|Lost to Follow-up|0
4725082|NCT01998958|16294292|P28|Open Label Phase (Optional)|Lost to Follow-up|0
4725083|NCT01998958|16294293|P27|Open Label Phase (Optional)|Lost to Follow-up|0
4725084|NCT01998958|16294294|P26|Open Label Phase (Optional)|Lost to Follow-up|0
4725085|NCT01998958|16294295|P25|Open Label Phase (Optional)|Lost to Follow-up|0
4725086|NCT01998958|16294296|P24|Open Label Phase (Optional)|Lost to Follow-up|0
4725087|NCT01998958|16294297|P23|Open Label Phase (Optional)|Lost to Follow-up|1
4725088|NCT01998958|16294298|P22|Open Label Phase (Optional)|Lost to Follow-up|0
4725089|NCT01998958|16294299|P21|Open Label Phase (Optional)|Lost to Follow-up|0
4725090|NCT01998958|16294300|P20|Open Label Phase (Optional)|Lost to Follow-up|0
4725091|NCT01998958|16294301|P19|Open Label Phase (Optional)|Lost to Follow-up|0
4725092|NCT01998958|16294302|P18|Open Label Phase (Optional)|Lost to Follow-up|0
4725093|NCT01998958|16294303|P17|Open Label Phase (Optional)|Lost to Follow-up|0
4725094|NCT01998958|16294304|P16|Open Label Phase (Optional)|Lost to Follow-up|0
4725095|NCT01998958|16294305|P15|Open Label Phase (Optional)|Lost to Follow-up|0
4725096|NCT01998958|16294306|P14|Open Label Phase (Optional)|Lost to Follow-up|0
4725097|NCT01998958|16294307|P13|Open Label Phase (Optional)|Lost to Follow-up|0
4725098|NCT01998958|16294308|P12|Open Label Phase (Optional)|Lost to Follow-up|0
4725099|NCT01998958|16294309|P11|Open Label Phase (Optional)|Lost to Follow-up|0
4725100|NCT01998958|16294310|P10|Open Label Phase (Optional)|Lost to Follow-up|0
4725101|NCT01998958|16294311|P9|Open Label Phase (Optional)|Lost to Follow-up|0
4725102|NCT01998958|16294312|P8|Open Label Phase (Optional)|Lost to Follow-up|0
4725103|NCT01998958|16294313|P7|Open Label Phase (Optional)|Lost to Follow-up|0
4725104|NCT01998958|16294314|P6|Open Label Phase (Optional)|Lost to Follow-up|0
4725105|NCT01998958|16294315|P5|Open Label Phase (Optional)|Lost to Follow-up|0
4725106|NCT01998958|16294316|P4|Open Label Phase (Optional)|Lost to Follow-up|0
4725107|NCT01998958|16294317|P3|Open Label Phase (Optional)|Lost to Follow-up|0
4725108|NCT01998958|16294318|P2|Open Label Phase (Optional)|Lost to Follow-up|0
4725109|NCT01998958|16294319|P1|Open Label Phase (Optional)|Lost to Follow-up|0
4725110|NCT01998958|16294288|P32|Open Label Phase (Optional)|Other|0
4725111|NCT01998958|16294289|P31|Open Label Phase (Optional)|Other|0
4725112|NCT01998958|16294290|P30|Open Label Phase (Optional)|Other|0
4725113|NCT01998958|16294291|P29|Open Label Phase (Optional)|Other|0
4725114|NCT01998958|16294292|P28|Open Label Phase (Optional)|Other|0
4725115|NCT01998958|16294293|P27|Open Label Phase (Optional)|Other|0
4725116|NCT01998958|16294294|P26|Open Label Phase (Optional)|Other|0
4725117|NCT01998958|16294295|P25|Open Label Phase (Optional)|Other|0
4725118|NCT01998958|16294296|P24|Open Label Phase (Optional)|Other|1
4725119|NCT01998958|16294297|P23|Open Label Phase (Optional)|Other|5
4725120|NCT01998958|16294298|P22|Open Label Phase (Optional)|Other|0
4725121|NCT01998958|16294299|P21|Open Label Phase (Optional)|Other|0
4725122|NCT01998958|16294300|P20|Open Label Phase (Optional)|Other|0
4725123|NCT01998958|16294301|P19|Open Label Phase (Optional)|Other|0
4725124|NCT01998958|16294302|P18|Open Label Phase (Optional)|Other|0
4725125|NCT01998958|16294303|P17|Open Label Phase (Optional)|Other|0
4725126|NCT01998958|16294304|P16|Open Label Phase (Optional)|Other|0
4725127|NCT01998958|16294305|P15|Open Label Phase (Optional)|Other|0
4725128|NCT01998958|16294306|P14|Open Label Phase (Optional)|Other|0
4725129|NCT01998958|16294307|P13|Open Label Phase (Optional)|Other|0
4725130|NCT01998958|16294308|P12|Open Label Phase (Optional)|Other|0
4725131|NCT01998958|16294309|P11|Open Label Phase (Optional)|Other|0
4725132|NCT01998958|16294310|P10|Open Label Phase (Optional)|Other|0
4725133|NCT01998958|16294311|P9|Open Label Phase (Optional)|Other|0
4725134|NCT01998958|16294312|P8|Open Label Phase (Optional)|Other|0
4725135|NCT01998958|16294313|P7|Open Label Phase (Optional)|Other|0
4725136|NCT01998958|16294314|P6|Open Label Phase (Optional)|Other|0
4725137|NCT01998958|16294315|P5|Open Label Phase (Optional)|Other|0
4725138|NCT01998958|16294316|P4|Open Label Phase (Optional)|Other|0
4725139|NCT01998958|16294317|P3|Open Label Phase (Optional)|Other|0
4725140|NCT01998958|16294318|P2|Open Label Phase (Optional)|Other|0
4725141|NCT01998958|16294319|P1|Open Label Phase (Optional)|Other|0
4725142|NCT01998958|16294288|P32|Open Label Phase (Optional)|Adverse Event|0
4725143|NCT01998958|16294289|P31|Open Label Phase (Optional)|Adverse Event|0
4725144|NCT01998958|16294290|P30|Open Label Phase (Optional)|Adverse Event|0
4725145|NCT01998958|16294291|P29|Open Label Phase (Optional)|Adverse Event|0
4725146|NCT01998958|16294292|P28|Open Label Phase (Optional)|Adverse Event|0
4725147|NCT01998958|16294293|P27|Open Label Phase (Optional)|Adverse Event|0
4725148|NCT01998958|16294294|P26|Open Label Phase (Optional)|Adverse Event|0
4725149|NCT01998958|16294295|P25|Open Label Phase (Optional)|Adverse Event|0
4725150|NCT01998958|16294296|P24|Open Label Phase (Optional)|Adverse Event|1
4725151|NCT01998958|16294297|P23|Open Label Phase (Optional)|Adverse Event|0
4725152|NCT01998958|16294298|P22|Open Label Phase (Optional)|Adverse Event|0
4725153|NCT01998958|16294299|P21|Open Label Phase (Optional)|Adverse Event|0
4725154|NCT01998958|16294300|P20|Open Label Phase (Optional)|Adverse Event|0
4725155|NCT01998958|16294301|P19|Open Label Phase (Optional)|Adverse Event|0
4725156|NCT01998958|16294302|P18|Open Label Phase (Optional)|Adverse Event|0
4725157|NCT01998958|16294303|P17|Open Label Phase (Optional)|Adverse Event|0
4725158|NCT01998958|16294304|P16|Open Label Phase (Optional)|Adverse Event|0
4725159|NCT01998958|16294305|P15|Open Label Phase (Optional)|Adverse Event|0
4725160|NCT01998958|16294306|P14|Open Label Phase (Optional)|Adverse Event|0
4725161|NCT01998958|16294307|P13|Open Label Phase (Optional)|Adverse Event|0
4725162|NCT01998958|16294308|P12|Open Label Phase (Optional)|Adverse Event|0
4725163|NCT01998958|16294309|P11|Open Label Phase (Optional)|Adverse Event|0
4725164|NCT01998958|16294310|P10|Open Label Phase (Optional)|Adverse Event|0
4725165|NCT01998958|16294311|P9|Open Label Phase (Optional)|Adverse Event|0
4725166|NCT01998958|16294312|P8|Open Label Phase (Optional)|Adverse Event|0
4725167|NCT01998958|16294313|P7|Open Label Phase (Optional)|Adverse Event|0
4725168|NCT01998958|16294314|P6|Open Label Phase (Optional)|Adverse Event|0
4725169|NCT01998958|16294315|P5|Open Label Phase (Optional)|Adverse Event|0
4725170|NCT01998958|16294316|P4|Open Label Phase (Optional)|Adverse Event|0
4725171|NCT01998958|16294317|P3|Open Label Phase (Optional)|Adverse Event|0
4725172|NCT01998958|16294318|P2|Open Label Phase (Optional)|Adverse Event|0
4725173|NCT01998958|16294319|P1|Open Label Phase (Optional)|Adverse Event|0
4725174|NCT01998958|16294288|P32|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725175|NCT01998958|16294289|P31|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725176|NCT01998958|16294290|P30|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725177|NCT01998958|16294291|P29|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725178|NCT01998958|16294292|P28|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725179|NCT01998958|16294293|P27|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725180|NCT01998958|16294294|P26|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725181|NCT01998958|16294295|P25|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725182|NCT01998958|16294296|P24|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725183|NCT01998958|16294297|P23|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725184|NCT01998958|16294298|P22|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725185|NCT01998958|16294299|P21|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725186|NCT01998958|16294300|P20|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725187|NCT01998958|16294301|P19|Period 2 (Panel A and B)|Withdrawal by Subject|1
4725188|NCT01998958|16294302|P18|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725189|NCT01998958|16294303|P17|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725190|NCT01998958|16294304|P16|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725191|NCT01998958|16294305|P15|Period 2 (Panel A and B)|Withdrawal by Subject|1
4725192|NCT01998958|16294306|P14|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725193|NCT01998958|16294307|P13|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725194|NCT01998958|16294308|P12|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725195|NCT01998958|16294309|P11|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725196|NCT01998958|16294310|P10|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725197|NCT01998958|16294311|P9|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725198|NCT01998958|16294312|P8|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725199|NCT01998958|16294313|P7|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725200|NCT01998958|16294314|P6|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725201|NCT01998958|16294315|P5|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725202|NCT01998958|16294316|P4|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725203|NCT01998958|16294317|P3|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725204|NCT01998958|16294318|P2|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725205|NCT01998958|16294319|P1|Period 2 (Panel A and B)|Withdrawal by Subject|0
4725206|NCT01998958|16294288|P32|Period 2 (Panel A and B)|Adverse Event|0
4725207|NCT01998958|16294289|P31|Period 2 (Panel A and B)|Adverse Event|0
4725208|NCT01998958|16294290|P30|Period 2 (Panel A and B)|Adverse Event|0
4725209|NCT01998958|16294291|P29|Period 2 (Panel A and B)|Adverse Event|0
4725210|NCT01998958|16294292|P28|Period 2 (Panel A and B)|Adverse Event|0
4725211|NCT01998958|16294293|P27|Period 2 (Panel A and B)|Adverse Event|0
4725212|NCT01998958|16294294|P26|Period 2 (Panel A and B)|Adverse Event|0
4725213|NCT01998958|16294295|P25|Period 2 (Panel A and B)|Adverse Event|0
4725214|NCT01998958|16294296|P24|Period 2 (Panel A and B)|Adverse Event|0
4725215|NCT01998958|16294297|P23|Period 2 (Panel A and B)|Adverse Event|0
4725216|NCT01998958|16294298|P22|Period 2 (Panel A and B)|Adverse Event|0
4725217|NCT01998958|16294299|P21|Period 2 (Panel A and B)|Adverse Event|0
4725218|NCT01998958|16294300|P20|Period 2 (Panel A and B)|Adverse Event|0
4725219|NCT01998958|16294301|P19|Period 2 (Panel A and B)|Adverse Event|0
4725220|NCT01998958|16294302|P18|Period 2 (Panel A and B)|Adverse Event|0
4725221|NCT01998958|16294303|P17|Period 2 (Panel A and B)|Adverse Event|0
4725222|NCT01998958|16294304|P16|Period 2 (Panel A and B)|Adverse Event|0
4725223|NCT01998958|16294305|P15|Period 2 (Panel A and B)|Adverse Event|1
4725224|NCT01998958|16294306|P14|Period 2 (Panel A and B)|Adverse Event|0
4725225|NCT01998958|16294307|P13|Period 2 (Panel A and B)|Adverse Event|0
4725226|NCT01998958|16294308|P12|Period 2 (Panel A and B)|Adverse Event|0
4725227|NCT01998958|16294309|P11|Period 2 (Panel A and B)|Adverse Event|1
4725228|NCT01998958|16294310|P10|Period 2 (Panel A and B)|Adverse Event|0
4725229|NCT01998958|16294311|P9|Period 2 (Panel A and B)|Adverse Event|0
4725230|NCT01998958|16294312|P8|Period 2 (Panel A and B)|Adverse Event|0
4725231|NCT01998958|16294313|P7|Period 2 (Panel A and B)|Adverse Event|0
4725232|NCT01998958|16294314|P6|Period 2 (Panel A and B)|Adverse Event|0
4725233|NCT01998958|16294315|P5|Period 2 (Panel A and B)|Adverse Event|0
4725234|NCT01998958|16294316|P4|Period 2 (Panel A and B)|Adverse Event|0
4725235|NCT01998958|16294317|P3|Period 2 (Panel A and B)|Adverse Event|0
4725236|NCT01998958|16294318|P2|Period 2 (Panel A and B)|Adverse Event|0
4725237|NCT01998958|16294319|P1|Period 2 (Panel A and B)|Adverse Event|0
4725238|NCT01998958|16294288|P32|Period 1 (Panel A and B)|Other|0
4725239|NCT01998958|16294289|P31|Period 1 (Panel A and B)|Other|0
4725240|NCT01998958|16294290|P30|Period 1 (Panel A and B)|Other|0
4725241|NCT01998958|16294291|P29|Period 1 (Panel A and B)|Other|0
4725242|NCT01998958|16294292|P28|Period 1 (Panel A and B)|Other|0
4725243|NCT01998958|16294293|P27|Period 1 (Panel A and B)|Other|0
4725244|NCT01998958|16294294|P26|Period 1 (Panel A and B)|Other|0
4725245|NCT01998958|16294295|P25|Period 1 (Panel A and B)|Other|0
4725246|NCT01998958|16294296|P24|Period 1 (Panel A and B)|Other|0
4725247|NCT01998958|16294297|P23|Period 1 (Panel A and B)|Other|0
4725248|NCT01998958|16294298|P22|Period 1 (Panel A and B)|Other|0
4725249|NCT01998958|16294299|P21|Period 1 (Panel A and B)|Other|0
4725250|NCT01998958|16294300|P20|Period 1 (Panel A and B)|Other|0
4725251|NCT01998958|16294301|P19|Period 1 (Panel A and B)|Other|0
4725252|NCT01998958|16294302|P18|Period 1 (Panel A and B)|Other|0
4725253|NCT01998958|16294303|P17|Period 1 (Panel A and B)|Other|0
4725254|NCT01998958|16294304|P16|Period 1 (Panel A and B)|Other|0
4725255|NCT01998958|16294305|P15|Period 1 (Panel A and B)|Other|0
4725256|NCT01998958|16294306|P14|Period 1 (Panel A and B)|Other|0
4725257|NCT01998958|16294307|P13|Period 1 (Panel A and B)|Other|0
4725258|NCT01998958|16294308|P12|Period 1 (Panel A and B)|Other|0
4725259|NCT01998958|16294309|P11|Period 1 (Panel A and B)|Other|0
4725260|NCT01998958|16294310|P10|Period 1 (Panel A and B)|Other|0
4725261|NCT01998958|16294311|P9|Period 1 (Panel A and B)|Other|0
4725262|NCT01998958|16294312|P8|Period 1 (Panel A and B)|Other|0
4725263|NCT01998958|16294313|P7|Period 1 (Panel A and B)|Other|0
4725264|NCT01998958|16294314|P6|Period 1 (Panel A and B)|Other|0
4725265|NCT01998958|16294315|P5|Period 1 (Panel A and B)|Other|0
4725266|NCT01998958|16294316|P4|Period 1 (Panel A and B)|Other|0
4725267|NCT01998958|16294317|P3|Period 1 (Panel A and B)|Other|0
4725268|NCT01998958|16294318|P2|Period 1 (Panel A and B)|Other|0
4725269|NCT01998958|16294319|P1|Period 1 (Panel A and B)|Other|1
4725270|NCT01998958|16294288|P32|Period 1 (Panel A and B)|Adverse Event|0
4725271|NCT01998958|16294289|P31|Period 1 (Panel A and B)|Adverse Event|0
4725272|NCT01998958|16294290|P30|Period 1 (Panel A and B)|Adverse Event|0
4725273|NCT01998958|16294291|P29|Period 1 (Panel A and B)|Adverse Event|0
4725274|NCT01998958|16294292|P28|Period 1 (Panel A and B)|Adverse Event|0
4725275|NCT01998958|16294293|P27|Period 1 (Panel A and B)|Adverse Event|0
4725276|NCT01998958|16294294|P26|Period 1 (Panel A and B)|Adverse Event|0
4725277|NCT01998958|16294295|P25|Period 1 (Panel A and B)|Adverse Event|0
4725278|NCT01998958|16294296|P24|Period 1 (Panel A and B)|Adverse Event|0
4725279|NCT01998958|16294297|P23|Period 1 (Panel A and B)|Adverse Event|0
4725280|NCT01998958|16294298|P22|Period 1 (Panel A and B)|Adverse Event|0
4725281|NCT01998958|16294299|P21|Period 1 (Panel A and B)|Adverse Event|0
4725282|NCT01998958|16294300|P20|Period 1 (Panel A and B)|Adverse Event|0
4725283|NCT01998958|16294301|P19|Period 1 (Panel A and B)|Adverse Event|0
4725284|NCT01998958|16294302|P18|Period 1 (Panel A and B)|Adverse Event|0
4725285|NCT01998958|16294303|P17|Period 1 (Panel A and B)|Adverse Event|0
4725286|NCT01998958|16294304|P16|Period 1 (Panel A and B)|Adverse Event|0
4725287|NCT01998958|16294305|P15|Period 1 (Panel A and B)|Adverse Event|0
4725288|NCT01998958|16294306|P14|Period 1 (Panel A and B)|Adverse Event|0
4725289|NCT01998958|16294307|P13|Period 1 (Panel A and B)|Adverse Event|0
4725290|NCT01998958|16294308|P12|Period 1 (Panel A and B)|Adverse Event|0
4725291|NCT01998958|16294309|P11|Period 1 (Panel A and B)|Adverse Event|0
4725292|NCT01998958|16294310|P10|Period 1 (Panel A and B)|Adverse Event|0
4725293|NCT01998958|16294311|P9|Period 1 (Panel A and B)|Adverse Event|0
4725294|NCT01998958|16294312|P8|Period 1 (Panel A and B)|Adverse Event|0
4725295|NCT01998958|16294313|P7|Period 1 (Panel A and B)|Adverse Event|0
4725296|NCT01998958|16294314|P6|Period 1 (Panel A and B)|Adverse Event|0
4725297|NCT01998958|16294315|P5|Period 1 (Panel A and B)|Adverse Event|0
4725298|NCT01998958|16294316|P4|Period 1 (Panel A and B)|Adverse Event|0
4725299|NCT01998958|16294317|P3|Period 1 (Panel A and B)|Adverse Event|0
4725300|NCT01998958|16294318|P2|Period 1 (Panel A and B)|Adverse Event|1
4725301|NCT01998958|16294319|P1|Period 1 (Panel A and B)|Adverse Event|0
4725302|NCT01998958|16294288|P32|Period 1 (Panel A and B)|Lack of Efficacy|0
4725303|NCT01998958|16294289|P31|Period 1 (Panel A and B)|Lack of Efficacy|0
4725304|NCT01998958|16294290|P30|Period 1 (Panel A and B)|Lack of Efficacy|0
4725305|NCT01998958|16294291|P29|Period 1 (Panel A and B)|Lack of Efficacy|0
4725306|NCT01998958|16294292|P28|Period 1 (Panel A and B)|Lack of Efficacy|0
4725307|NCT01998958|16294293|P27|Period 1 (Panel A and B)|Lack of Efficacy|0
4725308|NCT01998958|16294294|P26|Period 1 (Panel A and B)|Lack of Efficacy|0
4725309|NCT01998958|16294295|P25|Period 1 (Panel A and B)|Lack of Efficacy|0
4725310|NCT01998958|16294296|P24|Period 1 (Panel A and B)|Lack of Efficacy|0
4725311|NCT01998958|16294297|P23|Period 1 (Panel A and B)|Lack of Efficacy|0
4725312|NCT01998958|16294298|P22|Period 1 (Panel A and B)|Lack of Efficacy|0
4725313|NCT01998958|16294299|P21|Period 1 (Panel A and B)|Lack of Efficacy|0
4725314|NCT01998958|16294300|P20|Period 1 (Panel A and B)|Lack of Efficacy|0
4725315|NCT01998958|16294301|P19|Period 1 (Panel A and B)|Lack of Efficacy|0
4725316|NCT01998958|16294302|P18|Period 1 (Panel A and B)|Lack of Efficacy|0
4725317|NCT01998958|16294303|P17|Period 1 (Panel A and B)|Lack of Efficacy|0
4725318|NCT01998958|16294304|P16|Period 1 (Panel A and B)|Lack of Efficacy|0
4725319|NCT01998958|16294305|P15|Period 1 (Panel A and B)|Lack of Efficacy|0
4725320|NCT01998958|16294306|P14|Period 1 (Panel A and B)|Lack of Efficacy|0
4725321|NCT01998958|16294307|P13|Period 1 (Panel A and B)|Lack of Efficacy|0
4725322|NCT01998958|16294308|P12|Period 1 (Panel A and B)|Lack of Efficacy|0
4725323|NCT01998958|16294309|P11|Period 1 (Panel A and B)|Lack of Efficacy|0
4725324|NCT01998958|16294310|P10|Period 1 (Panel A and B)|Lack of Efficacy|0
4725325|NCT01998958|16294311|P9|Period 1 (Panel A and B)|Lack of Efficacy|0
4725326|NCT01998958|16294312|P8|Period 1 (Panel A and B)|Lack of Efficacy|0
4725327|NCT01998958|16294313|P7|Period 1 (Panel A and B)|Lack of Efficacy|0
4725328|NCT01998958|16294314|P6|Period 1 (Panel A and B)|Lack of Efficacy|0
4725329|NCT01998958|16294315|P5|Period 1 (Panel A and B)|Lack of Efficacy|0
4725330|NCT01998958|16294316|P4|Period 1 (Panel A and B)|Lack of Efficacy|0
4725331|NCT01998958|16294317|P3|Period 1 (Panel A and B)|Lack of Efficacy|0
4725332|NCT01998958|16294318|P2|Period 1 (Panel A and B)|Lack of Efficacy|1
4725333|NCT01998958|16294319|P1|Period 1 (Panel A and B)|Lack of Efficacy|0
4725334|NCT01998958|16294288|P32|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725335|NCT01998958|16294289|P31|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725336|NCT01998958|16294290|P30|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725337|NCT01998958|16294291|P29|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725338|NCT01998958|16294292|P28|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725339|NCT01998958|16294293|P27|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725340|NCT01998958|16294294|P26|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725341|NCT01998958|16294295|P25|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725342|NCT01998958|16294296|P24|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725343|NCT01998958|16294297|P23|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725344|NCT01998958|16294298|P22|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725345|NCT01998958|16294299|P21|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725346|NCT01998958|16294300|P20|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725347|NCT01998958|16294301|P19|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725348|NCT01998958|16294302|P18|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725349|NCT01998958|16294303|P17|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725350|NCT01998958|16294304|P16|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725351|NCT01998958|16294305|P15|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725352|NCT01998958|16294306|P14|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725353|NCT01998958|16294307|P13|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725354|NCT01998958|16294308|P12|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725355|NCT01998958|16294309|P11|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725356|NCT01998958|16294310|P10|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725357|NCT01998958|16294311|P9|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725358|NCT01998958|16294312|P8|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725359|NCT01998958|16294313|P7|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725360|NCT01998958|16294314|P6|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725361|NCT01998958|16294315|P5|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725362|NCT01998958|16294316|P4|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725363|NCT01998958|16294317|P3|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725364|NCT01998958|16294318|P2|Period 1 (Panel A and B)|Withdrawal by Subject|1
4725365|NCT01998958|16294319|P1|Period 1 (Panel A and B)|Withdrawal by Subject|0
4725366|NCT01998919|16294458|P2|Overall Study|Other|2
4725367|NCT01998919|16294459|P1|Overall Study|Other|5
4725368|NCT01998919|16294458|P2|Overall Study|Lost to Follow-up|0
4725369|NCT01998919|16294459|P1|Overall Study|Lost to Follow-up|2
4725370|NCT01998919|16294458|P2|Overall Study|Withdrawal by Subject|4
4725371|NCT01998919|16294459|P1|Overall Study|Withdrawal by Subject|2
4725372|NCT01998919|16294458|P2|Overall Study|Disease progression|22
4725373|NCT01998919|16294459|P1|Overall Study|Disease progression|31
4725374|NCT01998919|16294458|P2|Overall Study|Adverse Event|5
4725375|NCT01998919|16294459|P1|Overall Study|Adverse Event|0
4725376|NCT01998919|16294458|P2|Overall Study|Death|2
4725377|NCT01998919|16294459|P1|Overall Study|Death|2
4725378|NCT01998906|16294480|P3|Overall Study|Other|4
4725379|NCT01998906|16294481|P2|Overall Study|Other|8
4725380|NCT01998906|16294482|P1|Overall Study|Other|3
4725381|NCT01998906|16294480|P3|Overall Study|Administrative/Other|3
4725382|NCT01998906|16294481|P2|Overall Study|Administrative/Other|1
4725383|NCT01998906|16294482|P1|Overall Study|Administrative/Other|2
4725384|NCT01998906|16294480|P3|Overall Study|Withdrawal by Subject|3
4725385|NCT01998906|16294481|P2|Overall Study|Withdrawal by Subject|4
4725386|NCT01998906|16294482|P1|Overall Study|Withdrawal by Subject|1
4725387|NCT01998906|16294480|P3|Overall Study|Violation of Selection Criteria|1
4725388|NCT01998906|16294481|P2|Overall Study|Violation of Selection Criteria|0
4725389|NCT01998906|16294482|P1|Overall Study|Violation of Selection Criteria|0
4725390|NCT01998906|16294480|P3|Overall Study|Failure to return|4
4725391|NCT01998906|16294481|P2|Overall Study|Failure to return|2
4725392|NCT01998906|16294482|P1|Overall Study|Failure to return|0
4725393|NCT01998906|16294480|P3|Overall Study|Lack of Efficacy|8
4725394|NCT01998906|16294481|P2|Overall Study|Lack of Efficacy|9
4725395|NCT01998906|16294482|P1|Overall Study|Lack of Efficacy|10
4725396|NCT01998906|16294480|P3|Overall Study|Death|17
4725397|NCT01998906|16294481|P2|Overall Study|Death|30
4725398|NCT01998906|16294482|P1|Overall Study|Death|21
4725399|NCT01998906|16294480|P3|Overall Study|Participants ongoing in follow-up|58
4725400|NCT01998906|16294481|P2|Overall Study|Participants ongoing in follow-up|60
4725401|NCT01998906|16294482|P1|Overall Study|Participants ongoing in follow-up|77
4725402|NCT01998893|16294526|P1|Overall Study|Transformation to high-grade lymphoma|1
4725403|NCT01998893|16294526|P1|Overall Study|Withdrawal by Subject|1
4725404|NCT01998893|16294526|P1|Overall Study|Protocol Violation|2
4725405|NCT01998893|16294526|P1|Overall Study|Physician Decision|2
4725406|NCT01998893|16294526|P1|Overall Study|Lost to Follow-up|8
4725407|NCT01998893|16294526|P1|Overall Study|Death|1
4725408|NCT01998893|16294526|P1|Overall Study|Adverse Event|2
4725409|NCT01998880|16294538|P2|Overall Study|Did Not Receive Treatment|2
4725410|NCT01998880|16294539|P1|Overall Study|Did Not Receive Treatment|3
4725411|NCT01998880|16294538|P2|Overall Study|Violation of Selection Criteria at Entry|1
4725412|NCT01998880|16294539|P1|Overall Study|Violation of Selection Criteria at Entry|0
4725413|NCT01998880|16294538|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
4725414|NCT01998880|16294539|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
4725415|NCT01998880|16294538|P2|Overall Study|Administrative/Other|1
4725416|NCT01998880|16294539|P1|Overall Study|Administrative/Other|1
4725417|NCT01998880|16294538|P2|Overall Study|Insufficient Therapeutic Response|5
4725418|NCT01998880|16294539|P1|Overall Study|Insufficient Therapeutic Response|1
4725419|NCT01998880|16294538|P2|Overall Study|Death|6
4725420|NCT01998880|16294539|P1|Overall Study|Death|3
4725421|NCT01998880|16294538|P2|Overall Study|Withdrew Consent|1
4725422|NCT01998880|16294539|P1|Overall Study|Withdrew Consent|2
4725423|NCT01998880|16294538|P2|Overall Study|Disease Progression|8
4725424|NCT01998880|16294539|P1|Overall Study|Disease Progression|1
4725425|NCT01998880|16294538|P2|Overall Study|Adverse Events or Intercurrent Illness|16
4725426|NCT01998880|16294539|P1|Overall Study|Adverse Events or Intercurrent Illness|16
4725427|NCT01998737|16294571|P2|Overall Study|Corrupted database|0
4725428|NCT01998737|16294572|P1|Overall Study|Corrupted database|23
4725429|NCT01998633|16294584|P1|Overall Study|Death|1
4725430|NCT01998581|16294602|P2|Overall Study|Randomized but withdrew before treatment|0
4725431|NCT01998581|16294603|P1|Overall Study|Randomized but withdrew before treatment|1
4725432|NCT01998581|16294602|P2|Overall Study|Other reasons|2
4725433|NCT01998581|16294603|P1|Overall Study|Other reasons|3
4725434|NCT01998581|16294602|P2|Overall Study|Adverse Event|1
4725435|NCT01998581|16294603|P1|Overall Study|Adverse Event|1
4725436|NCT01998581|16294602|P2|Overall Study|Lost to Follow-up|4
4725437|NCT01998581|16294603|P1|Overall Study|Lost to Follow-up|12
4725438|NCT01998581|16294602|P2|Overall Study|Withdrawal by Subject|1
4725439|NCT01998581|16294603|P1|Overall Study|Withdrawal by Subject|8
4725440|NCT01998581|16294602|P2|Overall Study|Protocol Violation|0
4725441|NCT01998581|16294603|P1|Overall Study|Protocol Violation|1
4725442|NCT01998581|16294602|P2|Overall Study|Refused repeat treatment|4
4725443|NCT01998581|16294603|P1|Overall Study|Refused repeat treatment|20
4725444|NCT01998477|16294616|P2|Overall Study|Withdrawal by Subject|0
4725445|NCT01998477|16294617|P1|Overall Study|Withdrawal by Subject|6
4725446|NCT01998477|16294616|P2|Overall Study|Lost to Follow-up|5
4725447|NCT01998477|16294617|P1|Overall Study|Lost to Follow-up|4
4725448|NCT01998399|16294663|P2|Overall Study|Withdrawal by Subject|1
4725449|NCT01998399|16294664|P1|Overall Study|Withdrawal by Subject|0
4725450|NCT01998399|16294663|P2|Overall Study|Study stopped before dosing completed|3
4725451|NCT01998399|16294664|P1|Overall Study|Study stopped before dosing completed|3
4725452|NCT01998399|16294663|P2|Overall Study|Death|2
4725453|NCT01998399|16294664|P1|Overall Study|Death|4
4725454|NCT01998399|16294663|P2|Overall Study|Lost to Follow-up|3
4725455|NCT01998399|16294664|P1|Overall Study|Lost to Follow-up|1
4725456|NCT01998243|16294719|P2|Overall Study|Withdrawal by Subject|4
4725457|NCT01998243|16294720|P1|Overall Study|Withdrawal by Subject|3
4725458|NCT01998243|16294719|P2|Overall Study|Protocol Violation|2
4725459|NCT01998243|16294720|P1|Overall Study|Protocol Violation|5
4725460|NCT01998243|16294719|P2|Overall Study|Pregnancy|1
4725461|NCT01998243|16294720|P1|Overall Study|Pregnancy|0
4725462|NCT01997892|16294743|P1|Overall Study|Study completion data not recorded|35
4725463|NCT01997892|16294743|P1|Overall Study|Other|3
4725464|NCT01997892|16294743|P1|Overall Study|Renal transplant|8
4725465|NCT01997892|16294743|P1|Overall Study|Death|14
4725466|NCT01997892|16294743|P1|Overall Study|Lost to Follow-up|6
4725467|NCT01997892|16294743|P1|Overall Study|Physician Decision|2
4725468|NCT01997333|16294917|P2|Survival Follow up|Various|2
4725469|NCT01997333|16294918|P1|Survival Follow up|Various|1
4725470|NCT01997333|16294917|P2|Survival Follow up|Lost to Follow-up|6
4725471|NCT01997333|16294918|P1|Survival Follow up|Lost to Follow-up|0
4725472|NCT01997333|16294917|P2|Survival Follow up|Withdrawal by Subject|6
4725473|NCT01997333|16294918|P1|Survival Follow up|Withdrawal by Subject|15
4725474|NCT01997333|16294917|P2|Randomization and Treatment|Did not receive treatment|5
4725475|NCT01997333|16294918|P1|Randomization and Treatment|Did not receive treatment|17
4725476|NCT01997333|16294917|P2|Randomization and Treatment|Withdrawal by Subject|3
4725477|NCT01997333|16294918|P1|Randomization and Treatment|Withdrawal by Subject|6
4725478|NCT01997333|16294917|P2|Randomization and Treatment|Physician Decision|4
4725479|NCT01997333|16294918|P1|Randomization and Treatment|Physician Decision|0
4725480|NCT01997333|16294917|P2|Randomization and Treatment|Adverse Event|32
4725481|NCT01997333|16294918|P1|Randomization and Treatment|Adverse Event|10
4725482|NCT01997333|16294917|P2|Randomization and Treatment|Disease Progression|159
4725483|NCT01997333|16294918|P1|Randomization and Treatment|Disease Progression|70
4725484|NCT01996982|16294953|P1|Overall Study|PI/team left institution|7
4725485|NCT01996904|16294969|P2|Overall Study|Lost to Follow-up|27
4725486|NCT01996904|16294970|P1|Overall Study|Lost to Follow-up|38
4725487|NCT01996826|16295055|P2|Overall Study|Physician Decision|1
4725488|NCT01996826|16295056|P1|Overall Study|Physician Decision|1
4725489|NCT01996826|16295055|P2|Overall Study|Lost to Follow-up|2
4725490|NCT01996826|16295056|P1|Overall Study|Lost to Follow-up|6
4725491|NCT01996748|16295079|P2|Overall Study|Lost to Follow-up|1
4725492|NCT01996748|16295080|P1|Overall Study|Lost to Follow-up|4
4725493|NCT01996748|16295079|P2|Overall Study|Withdrawal by Subject|1
4725494|NCT01996748|16295080|P1|Overall Study|Withdrawal by Subject|0
4725495|NCT01996748|16295079|P2|Overall Study|Adverse Event|4
4725496|NCT01996748|16295080|P1|Overall Study|Adverse Event|1
4725497|NCT01996748|16295079|P2|Overall Study|Physician Decision|0
4725498|NCT01996748|16295080|P1|Overall Study|Physician Decision|2
4725499|NCT01996748|16295079|P2|Overall Study|Personal reason|0
4725500|NCT01996748|16295080|P1|Overall Study|Personal reason|1
4725501|NCT01996709|16295094|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
4725502|NCT01996709|16295095|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
4725503|NCT01996709|16295094|P2|Overall Study|Subject Non-Compliant|0
4725504|NCT01996709|16295095|P1|Overall Study|Subject Non-Compliant|1
4725505|NCT01996709|16295094|P2|Overall Study|Lost to Follow-up|0
4725506|NCT01996709|16295095|P1|Overall Study|Lost to Follow-up|3
4725507|NCT01996709|16295094|P2|Overall Study|Withdrawal by Subject|0
4725508|NCT01996709|16295095|P1|Overall Study|Withdrawal by Subject|1
4725509|NCT01996592|16295142|P1|Overall Study|change in mode of delivery|4
4725510|NCT01996592|16295142|P1|Overall Study|Withdrawal by Subject|5
4725511|NCT01996592|16295142|P1|Overall Study|change in surgical date|4
4725512|NCT01996592|16295142|P1|Overall Study|no response to text/no diary entry|32
4725513|NCT01996332|16295178|P1|Overall Study|Lost to Follow-up|34
4725514|NCT01996332|16295178|P1|Overall Study|Physician Decision|17
4725515|NCT01996332|16295178|P1|Overall Study|Clinical Deterioration|28
4725516|NCT01996332|16295178|P1|Overall Study|Other|20
4725517|NCT01996332|16295178|P1|Overall Study|Withdrawal by Subject|71
4725518|NCT01996332|16295178|P1|Overall Study|Protocol Violation|9
4725519|NCT01996332|16295178|P1|Overall Study|Death|264
4725520|NCT01996332|16295178|P1|Overall Study|Lack of Efficacy|1245
4725521|NCT01996332|16295178|P1|Overall Study|Adverse Event|117
4725522|NCT01996319|16295186|P2|Overall Study|Adverse Event|2
4725523|NCT01996319|16295187|P1|Overall Study|Adverse Event|2
4725524|NCT01996319|16295186|P2|Overall Study|Severe or moderate (COPD) Exacerbation|1
4725525|NCT01996319|16295187|P1|Overall Study|Severe or moderate (COPD) Exacerbation|5
4725526|NCT01996319|16295186|P2|Overall Study|Protocol Violation|0
4725527|NCT01996319|16295187|P1|Overall Study|Protocol Violation|1
4725528|NCT01996254|16295209|P3|Overall Study|Lost to Follow-up|4
4725529|NCT01996254|16295210|P2|Overall Study|Lost to Follow-up|0
4725530|NCT01996254|16295211|P1|Overall Study|Lost to Follow-up|1
4725531|NCT01996254|16295209|P3|Overall Study|Withdrawal by Subject|4
4725532|NCT01996254|16295210|P2|Overall Study|Withdrawal by Subject|3
4725533|NCT01996254|16295211|P1|Overall Study|Withdrawal by Subject|0
4725534|NCT01996254|16295209|P3|Overall Study|Change in Eligibility|0
4725535|NCT01996254|16295210|P2|Overall Study|Change in Eligibility|2
4725536|NCT01996254|16295211|P1|Overall Study|Change in Eligibility|0
4725537|NCT01996241|16295239|P2|Overall Study|Lost to Follow-up|235
4725538|NCT01996241|16295240|P1|Overall Study|Lost to Follow-up|252
4725539|NCT01996033|16295256|P1|Overall Study|Lost to Follow-up|3
4725540|NCT01996033|16295256|P1|Overall Study|Withdrawal by Subject|4
4725541|NCT01996033|16295256|P1|Overall Study|Physician Decision|1
4725542|NCT01996033|16295256|P1|Overall Study|Death|1
4725543|NCT01995838|16295276|P7|Overall Study|Other|2
4725544|NCT01995838|16295277|P6|Overall Study|Other|1
4725545|NCT01995838|16295278|P5|Overall Study|Other|1
4725546|NCT01995838|16295279|P4|Overall Study|Other|2
4725547|NCT01995838|16295280|P3|Overall Study|Other|0
4725548|NCT01995838|16295281|P2|Overall Study|Other|1
4725549|NCT01995838|16295282|P1|Overall Study|Other|3
4725550|NCT01995838|16295276|P7|Overall Study|Withdrawal by Subject|0
4725551|NCT01995838|16295277|P6|Overall Study|Withdrawal by Subject|0
4725552|NCT01995838|16295278|P5|Overall Study|Withdrawal by Subject|1
4725553|NCT01995838|16295279|P4|Overall Study|Withdrawal by Subject|0
4725554|NCT01995838|16295280|P3|Overall Study|Withdrawal by Subject|0
4725555|NCT01995838|16295281|P2|Overall Study|Withdrawal by Subject|0
4725556|NCT01995838|16295282|P1|Overall Study|Withdrawal by Subject|0
4725557|NCT01995838|16295276|P7|Overall Study|Adverse Event|1
4725558|NCT01995838|16295277|P6|Overall Study|Adverse Event|0
4725559|NCT01995838|16295278|P5|Overall Study|Adverse Event|0
4725560|NCT01995838|16295279|P4|Overall Study|Adverse Event|0
4725561|NCT01995838|16295280|P3|Overall Study|Adverse Event|0
4725562|NCT01995838|16295281|P2|Overall Study|Adverse Event|0
4725563|NCT01995838|16295282|P1|Overall Study|Adverse Event|0
4725564|NCT01995838|16295276|P7|Overall Study|Participant choice|1
4725565|NCT01995838|16295277|P6|Overall Study|Participant choice|1
4725566|NCT01995838|16295278|P5|Overall Study|Participant choice|0
4725567|NCT01995838|16295279|P4|Overall Study|Participant choice|0
4725568|NCT01995838|16295280|P3|Overall Study|Participant choice|0
4725569|NCT01995838|16295281|P2|Overall Study|Participant choice|0
4725570|NCT01995838|16295282|P1|Overall Study|Participant choice|2
4725571|NCT01995838|16295276|P7|Overall Study|Lost to Follow-up|1
4725572|NCT01995838|16295277|P6|Overall Study|Lost to Follow-up|0
4725573|NCT01995838|16295278|P5|Overall Study|Lost to Follow-up|0
4725574|NCT01995838|16295279|P4|Overall Study|Lost to Follow-up|0
4725575|NCT01995838|16295280|P3|Overall Study|Lost to Follow-up|0
4725576|NCT01995838|16295281|P2|Overall Study|Lost to Follow-up|1
4725577|NCT01995838|16295282|P1|Overall Study|Lost to Follow-up|0
4725578|NCT01995552|16295381|P1|Overall Study|Death|1
4725579|NCT01995552|16295381|P1|Overall Study|Lack of Efficacy|15
4725580|NCT01995552|16295381|P1|Overall Study|Protocol Violation|1
4725581|NCT01995539|16295387|P1|Overall Study|Subject missed visit 3,4, came in for V5|1
4725582|NCT01995539|16295387|P1|Overall Study|Lost to Follow-up|5
4725583|NCT01995539|16295387|P1|Overall Study|Withdrawal by Subject|11
4725584|NCT01995539|16295387|P1|Overall Study|Withdrawal by Investigator|15
4725585|NCT01995539|16295387|P1|Overall Study|Screening Failure|1
4725586|NCT01995526|16295392|P1|Overall Study|Physician Decision|1
4725587|NCT01995513|16295400|P3|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|18
4725588|NCT01995513|16295401|P2|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|27
4725589|NCT01995513|16295402|P1|Double Blind Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
4725590|NCT01995513|16295400|P3|Double Blind Treatment Period|Disease Progression|93
4725591|NCT01995513|16295401|P2|Double Blind Treatment Period|Disease Progression|82
4725592|NCT01995513|16295402|P1|Double Blind Treatment Period|Disease Progression|0
4725593|NCT01995513|16295400|P3|Double Blind Treatment Period|Death|1
4725594|NCT01995513|16295401|P2|Double Blind Treatment Period|Death|0
4725595|NCT01995513|16295402|P1|Double Blind Treatment Period|Death|0
4725596|NCT01995513|16295400|P3|Double Blind Treatment Period|Withdrawal by Subject|6
4725597|NCT01995513|16295401|P2|Double Blind Treatment Period|Withdrawal by Subject|4
4725598|NCT01995513|16295402|P1|Double Blind Treatment Period|Withdrawal by Subject|0
4725599|NCT01995513|16295400|P3|Double Blind Treatment Period|Other|2
4725600|NCT01995513|16295401|P2|Double Blind Treatment Period|Other|1
4725601|NCT01995513|16295402|P1|Double Blind Treatment Period|Other|0
4725602|NCT01995513|16295400|P3|Double Blind Treatment Period|Adverse Event|5
4725603|NCT01995513|16295401|P2|Double Blind Treatment Period|Adverse Event|12
4725604|NCT01995513|16295402|P1|Double Blind Treatment Period|Adverse Event|0
4725605|NCT01995513|16295400|P3|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
4725606|NCT01995513|16295401|P2|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|0
4725607|NCT01995513|16295402|P1|Open Label Treatment Period|Ongoing as of data cutoff (07 Oct 2016)|84
4725608|NCT01995513|16295400|P3|Open Label Treatment Period|Death|0
4725609|NCT01995513|16295401|P2|Open Label Treatment Period|Death|0
4725610|NCT01995513|16295402|P1|Open Label Treatment Period|Death|8
4725611|NCT01995513|16295400|P3|Open Label Treatment Period|Adverse Event|0
4725612|NCT01995513|16295401|P2|Open Label Treatment Period|Adverse Event|0
4725613|NCT01995513|16295402|P1|Open Label Treatment Period|Adverse Event|35
4725614|NCT01995513|16295400|P3|Open Label Treatment Period|No PSA response at week 13|0
4725615|NCT01995513|16295401|P2|Open Label Treatment Period|No PSA response at week 13|0
4725616|NCT01995513|16295402|P1|Open Label Treatment Period|No PSA response at week 13|43
4725617|NCT01995513|16295400|P3|Open Label Treatment Period|Disease Progression|0
4725618|NCT01995513|16295401|P2|Open Label Treatment Period|Disease Progression|0
4725619|NCT01995513|16295402|P1|Open Label Treatment Period|Disease Progression|64
4725620|NCT01995513|16295400|P3|Open Label Treatment Period|Protocol Violation|0
4725621|NCT01995513|16295401|P2|Open Label Treatment Period|Protocol Violation|0
4725622|NCT01995513|16295402|P1|Open Label Treatment Period|Protocol Violation|1
4725623|NCT01995513|16295400|P3|Open Label Treatment Period|Withdrawal by Subject|0
4725624|NCT01995513|16295401|P2|Open Label Treatment Period|Withdrawal by Subject|0
4725625|NCT01995513|16295402|P1|Open Label Treatment Period|Withdrawal by Subject|14
4725626|NCT01995513|16295400|P3|Open Label Treatment Period|Other|0
4725627|NCT01995513|16295401|P2|Open Label Treatment Period|Other|0
4725628|NCT01995513|16295402|P1|Open Label Treatment Period|Other|9
4725629|NCT01995461|16295445|P1|Overall Study|Withdrawal by Subject|2
4725630|NCT01995461|16295445|P1|Overall Study|Lost to Follow-up|2
4725631|NCT01995461|16295445|P1|Overall Study|Death|1
4725632|NCT01995357|16295451|P6|Period 5|Adverse Event|0
4725633|NCT01995357|16295452|P5|Period 5|Adverse Event|0
4725634|NCT01995357|16295453|P4|Period 5|Adverse Event|0
4725635|NCT01995357|16295454|P3|Period 5|Adverse Event|1
4725636|NCT01995357|16295455|P2|Period 5|Adverse Event|0
4725637|NCT01995357|16295456|P1|Period 5|Adverse Event|1
4725638|NCT01995357|16295451|P6|Period 5|Lack of Efficacy|0
4725639|NCT01995357|16295452|P5|Period 5|Lack of Efficacy|0
4725640|NCT01995357|16295453|P4|Period 5|Lack of Efficacy|0
4725641|NCT01995357|16295454|P3|Period 5|Lack of Efficacy|0
4725642|NCT01995357|16295455|P2|Period 5|Lack of Efficacy|0
4725643|NCT01995357|16295456|P1|Period 5|Lack of Efficacy|1
4725644|NCT01995266|16295472|P1|Overall Study|Adverse Event|2
4725645|NCT01995266|16295472|P1|Overall Study|Lack of Efficacy|6
4725646|NCT01995266|16295472|P1|Overall Study|Death|1
4725647|NCT01995201|16295487|P7|From Week 24 Until Week 48|Protocol Violation|0
4725648|NCT01995201|16295488|P6|From Week 24 Until Week 48|Protocol Violation|0
4725649|NCT01995201|16295489|P5|From Week 24 Until Week 48|Protocol Violation|2
4725650|NCT01995201|16295490|P4|From Week 24 Until Week 48|Protocol Violation|0
4725651|NCT01995201|16295491|P3|From Week 24 Until Week 48|Protocol Violation|1
4725652|NCT01995201|16295492|P2|From Week 24 Until Week 48|Protocol Violation|0
4725653|NCT01995201|16295493|P1|From Week 24 Until Week 48|Protocol Violation|0
4725654|NCT01995201|16295487|P7|From Week 24 Until Week 48|Physician Decision|0
4725655|NCT01995201|16295488|P6|From Week 24 Until Week 48|Physician Decision|0
4725656|NCT01995201|16295489|P5|From Week 24 Until Week 48|Physician Decision|1
4725657|NCT01995201|16295490|P4|From Week 24 Until Week 48|Physician Decision|0
4725658|NCT01995201|16295491|P3|From Week 24 Until Week 48|Physician Decision|0
4725659|NCT01995201|16295492|P2|From Week 24 Until Week 48|Physician Decision|0
4725660|NCT01995201|16295493|P1|From Week 24 Until Week 48|Physician Decision|0
4725661|NCT01995201|16295487|P7|From Week 24 Until Week 48|Withdrawal by Subject|0
4725662|NCT01995201|16295488|P6|From Week 24 Until Week 48|Withdrawal by Subject|0
4725663|NCT01995201|16295489|P5|From Week 24 Until Week 48|Withdrawal by Subject|1
4725664|NCT01995201|16295490|P4|From Week 24 Until Week 48|Withdrawal by Subject|0
4725665|NCT01995201|16295491|P3|From Week 24 Until Week 48|Withdrawal by Subject|1
4725666|NCT01995201|16295492|P2|From Week 24 Until Week 48|Withdrawal by Subject|0
4725667|NCT01995201|16295493|P1|From Week 24 Until Week 48|Withdrawal by Subject|0
4725668|NCT01995201|16295487|P7|From Week 24 Until Week 48|Lost to Follow-up|0
4725669|NCT01995201|16295488|P6|From Week 24 Until Week 48|Lost to Follow-up|1
4725670|NCT01995201|16295489|P5|From Week 24 Until Week 48|Lost to Follow-up|1
4725671|NCT01995201|16295490|P4|From Week 24 Until Week 48|Lost to Follow-up|0
4725672|NCT01995201|16295491|P3|From Week 24 Until Week 48|Lost to Follow-up|0
4725673|NCT01995201|16295492|P2|From Week 24 Until Week 48|Lost to Follow-up|0
4725674|NCT01995201|16295493|P1|From Week 24 Until Week 48|Lost to Follow-up|0
4725675|NCT01995201|16295487|P7|From Week 24 Until Week 48|Lack of Efficacy|1
4725676|NCT01995201|16295488|P6|From Week 24 Until Week 48|Lack of Efficacy|2
4725677|NCT01995201|16295489|P5|From Week 24 Until Week 48|Lack of Efficacy|0
4725678|NCT01995201|16295490|P4|From Week 24 Until Week 48|Lack of Efficacy|0
4725679|NCT01995201|16295491|P3|From Week 24 Until Week 48|Lack of Efficacy|1
4725680|NCT01995201|16295492|P2|From Week 24 Until Week 48|Lack of Efficacy|0
4725681|NCT01995201|16295493|P1|From Week 24 Until Week 48|Lack of Efficacy|0
4725682|NCT01995201|16295487|P7|From Week 24 Until Week 48|Death|0
4725683|NCT01995201|16295488|P6|From Week 24 Until Week 48|Death|2
4725684|NCT01995201|16295489|P5|From Week 24 Until Week 48|Death|0
4725685|NCT01995201|16295490|P4|From Week 24 Until Week 48|Death|0
4725686|NCT01995201|16295491|P3|From Week 24 Until Week 48|Death|0
4725687|NCT01995201|16295492|P2|From Week 24 Until Week 48|Death|0
4725688|NCT01995201|16295493|P1|From Week 24 Until Week 48|Death|0
4725689|NCT01995201|16295487|P7|From Week 24 Until Week 48|Adverse Event|1
4725690|NCT01995201|16295488|P6|From Week 24 Until Week 48|Adverse Event|3
4725691|NCT01995201|16295489|P5|From Week 24 Until Week 48|Adverse Event|1
4725692|NCT01995201|16295490|P4|From Week 24 Until Week 48|Adverse Event|1
4725693|NCT01995201|16295491|P3|From Week 24 Until Week 48|Adverse Event|2
4725694|NCT01995201|16295492|P2|From Week 24 Until Week 48|Adverse Event|0
4725695|NCT01995201|16295493|P1|From Week 24 Until Week 48|Adverse Event|0
4725696|NCT01995201|16295487|P7|From Baseline Until Week 24|Protocol Violation|0
4725697|NCT01995201|16295488|P6|From Baseline Until Week 24|Protocol Violation|0
4725698|NCT01995201|16295489|P5|From Baseline Until Week 24|Protocol Violation|0
4725699|NCT01995201|16295490|P4|From Baseline Until Week 24|Protocol Violation|0
4725700|NCT01995201|16295491|P3|From Baseline Until Week 24|Protocol Violation|0
4725701|NCT01995201|16295492|P2|From Baseline Until Week 24|Protocol Violation|9
4725702|NCT01995201|16295493|P1|From Baseline Until Week 24|Protocol Violation|0
4725703|NCT01995201|16295487|P7|From Baseline Until Week 24|Physician Decision|0
4725704|NCT01995201|16295488|P6|From Baseline Until Week 24|Physician Decision|0
4725705|NCT01995201|16295489|P5|From Baseline Until Week 24|Physician Decision|0
4725706|NCT01995201|16295490|P4|From Baseline Until Week 24|Physician Decision|0
4725707|NCT01995201|16295491|P3|From Baseline Until Week 24|Physician Decision|0
4725708|NCT01995201|16295492|P2|From Baseline Until Week 24|Physician Decision|2
4725709|NCT01995201|16295493|P1|From Baseline Until Week 24|Physician Decision|0
4725710|NCT01995201|16295487|P7|From Baseline Until Week 24|Withdrawal by Subject|0
4725711|NCT01995201|16295488|P6|From Baseline Until Week 24|Withdrawal by Subject|0
4725712|NCT01995201|16295489|P5|From Baseline Until Week 24|Withdrawal by Subject|0
4725713|NCT01995201|16295490|P4|From Baseline Until Week 24|Withdrawal by Subject|0
4725714|NCT01995201|16295491|P3|From Baseline Until Week 24|Withdrawal by Subject|0
4725715|NCT01995201|16295492|P2|From Baseline Until Week 24|Withdrawal by Subject|8
4725716|NCT01995201|16295493|P1|From Baseline Until Week 24|Withdrawal by Subject|2
4725717|NCT01995201|16295487|P7|From Baseline Until Week 24|Lost to Follow-up|0
4725718|NCT01995201|16295488|P6|From Baseline Until Week 24|Lost to Follow-up|0
4725719|NCT01995201|16295489|P5|From Baseline Until Week 24|Lost to Follow-up|0
4725720|NCT01995201|16295490|P4|From Baseline Until Week 24|Lost to Follow-up|0
4725721|NCT01995201|16295491|P3|From Baseline Until Week 24|Lost to Follow-up|0
4725722|NCT01995201|16295492|P2|From Baseline Until Week 24|Lost to Follow-up|3
4725723|NCT01995201|16295493|P1|From Baseline Until Week 24|Lost to Follow-up|2
4725724|NCT01995201|16295487|P7|From Baseline Until Week 24|Lack of Efficacy|0
4725725|NCT01995201|16295488|P6|From Baseline Until Week 24|Lack of Efficacy|0
4725726|NCT01995201|16295489|P5|From Baseline Until Week 24|Lack of Efficacy|0
4725727|NCT01995201|16295490|P4|From Baseline Until Week 24|Lack of Efficacy|0
4725728|NCT01995201|16295491|P3|From Baseline Until Week 24|Lack of Efficacy|0
4725729|NCT01995201|16295492|P2|From Baseline Until Week 24|Lack of Efficacy|5
4725730|NCT01995201|16295493|P1|From Baseline Until Week 24|Lack of Efficacy|2
4725731|NCT01995201|16295487|P7|From Baseline Until Week 24|Death|0
4725732|NCT01995201|16295488|P6|From Baseline Until Week 24|Death|0
4725733|NCT01995201|16295489|P5|From Baseline Until Week 24|Death|0
4725734|NCT01995201|16295490|P4|From Baseline Until Week 24|Death|0
4725735|NCT01995201|16295491|P3|From Baseline Until Week 24|Death|0
4725736|NCT01995201|16295492|P2|From Baseline Until Week 24|Death|1
4725737|NCT01995201|16295493|P1|From Baseline Until Week 24|Death|0
4725738|NCT01995201|16295487|P7|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4725739|NCT01995201|16295488|P6|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4725740|NCT01995201|16295489|P5|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4725741|NCT01995201|16295490|P4|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4725742|NCT01995201|16295491|P3|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4725743|NCT01995201|16295492|P2|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3
4725744|NCT01995201|16295493|P1|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0
4725745|NCT01995201|16295487|P7|From Baseline Until Week 24|Adverse Event|0
4725746|NCT01995201|16295488|P6|From Baseline Until Week 24|Adverse Event|0
4725747|NCT01995201|16295489|P5|From Baseline Until Week 24|Adverse Event|0
4725748|NCT01995201|16295490|P4|From Baseline Until Week 24|Adverse Event|0
4725749|NCT01995201|16295491|P3|From Baseline Until Week 24|Adverse Event|0
4725750|NCT01995201|16295492|P2|From Baseline Until Week 24|Adverse Event|15
4725751|NCT01995201|16295493|P1|From Baseline Until Week 24|Adverse Event|4
4725752|NCT01995175|16295602|P1|Overall Study|Migrated / moved from the study area|49
4725753|NCT01995175|16295602|P1|Overall Study|Other|67
4725754|NCT01995175|16295602|P1|Overall Study|Lost to Follow-up|102
4725755|NCT01995175|16295602|P1|Overall Study|Withdrawal by Subject|35
4725756|NCT01995136|16295617|P1|Overall Study|Change in residence|1
4725757|NCT01995071|16295646|P12|Overall Study|Incarcerated|0
4725758|NCT01995071|16295647|P11|Overall Study|Incarcerated|0
4725759|NCT01995071|16295648|P10|Overall Study|Incarcerated|0
4725760|NCT01995071|16295649|P9|Overall Study|Incarcerated|0
4725761|NCT01995071|16295650|P8|Overall Study|Incarcerated|1
4725762|NCT01995071|16295651|P7|Overall Study|Incarcerated|0
4725763|NCT01995071|16295652|P6|Overall Study|Incarcerated|0
4725764|NCT01995071|16295653|P5|Overall Study|Incarcerated|0
4725765|NCT01995071|16295654|P4|Overall Study|Incarcerated|0
4725766|NCT01995071|16295655|P3|Overall Study|Incarcerated|0
4725767|NCT01995071|16295656|P2|Overall Study|Incarcerated|0
4725768|NCT01995071|16295657|P1|Overall Study|Incarcerated|0
4725769|NCT01995071|16295646|P12|Overall Study|Lost to Follow-up|0
4725770|NCT01995071|16295647|P11|Overall Study|Lost to Follow-up|0
4725771|NCT01995071|16295648|P10|Overall Study|Lost to Follow-up|0
4725772|NCT01995071|16295649|P9|Overall Study|Lost to Follow-up|1
4725773|NCT01995071|16295650|P8|Overall Study|Lost to Follow-up|1
4725774|NCT01995071|16295651|P7|Overall Study|Lost to Follow-up|0
4725775|NCT01995071|16295652|P6|Overall Study|Lost to Follow-up|0
4725776|NCT01995071|16295653|P5|Overall Study|Lost to Follow-up|0
4725777|NCT01995071|16295654|P4|Overall Study|Lost to Follow-up|0
4725778|NCT01995071|16295655|P3|Overall Study|Lost to Follow-up|0
4725779|NCT01995071|16295656|P2|Overall Study|Lost to Follow-up|0
4725780|NCT01995071|16295657|P1|Overall Study|Lost to Follow-up|1
4725781|NCT01995071|16295646|P12|Overall Study|Moved|0
4725782|NCT01995071|16295647|P11|Overall Study|Moved|1
4725783|NCT01995071|16295648|P10|Overall Study|Moved|0
4725784|NCT01995071|16295649|P9|Overall Study|Moved|0
4725785|NCT01995071|16295650|P8|Overall Study|Moved|0
4725786|NCT01995071|16295651|P7|Overall Study|Moved|0
4725787|NCT01995071|16295652|P6|Overall Study|Moved|0
4725788|NCT01995071|16295653|P5|Overall Study|Moved|1
4725789|NCT01995071|16295654|P4|Overall Study|Moved|0
4725790|NCT01995071|16295655|P3|Overall Study|Moved|1
4725791|NCT01995071|16295656|P2|Overall Study|Moved|0
4725792|NCT01995071|16295657|P1|Overall Study|Moved|0
4725793|NCT01995071|16295646|P12|Overall Study|Adverse Event|0
4725794|NCT01995071|16295647|P11|Overall Study|Adverse Event|0
4725795|NCT01995071|16295648|P10|Overall Study|Adverse Event|0
4725796|NCT01995071|16295649|P9|Overall Study|Adverse Event|0
4725797|NCT01995071|16295650|P8|Overall Study|Adverse Event|0
4725798|NCT01995071|16295651|P7|Overall Study|Adverse Event|1
4725799|NCT01995071|16295652|P6|Overall Study|Adverse Event|0
4725800|NCT01995071|16295653|P5|Overall Study|Adverse Event|0
4725801|NCT01995071|16295654|P4|Overall Study|Adverse Event|0
4725802|NCT01995071|16295655|P3|Overall Study|Adverse Event|0
4725803|NCT01995071|16295656|P2|Overall Study|Adverse Event|0
4725804|NCT01995071|16295657|P1|Overall Study|Adverse Event|0
4725805|NCT01994954|16295794|P2|Overall Study|6 Month Follow-up Not Complete|4
4725806|NCT01994954|16295795|P1|Overall Study|6 Month Follow-up Not Complete|5
4725807|NCT01994954|16295794|P2|Overall Study|Lost to Follow-up|10
4725808|NCT01994954|16295795|P1|Overall Study|Lost to Follow-up|8
4725809|NCT01994954|16295794|P2|Overall Study|Physician Decision|2
4725810|NCT01994954|16295795|P1|Overall Study|Physician Decision|2
4725811|NCT01994954|16295794|P2|Overall Study|Withdrawal by Subject|14
4725812|NCT01994954|16295795|P1|Overall Study|Withdrawal by Subject|9
4725813|NCT01994954|16295794|P2|Overall Study|Death|0
4725814|NCT01994954|16295795|P1|Overall Study|Death|1
4725815|NCT01994902|16295813|P2|Test Period 2|Other|3
4725816|NCT01994902|16295814|P1|Test Period 2|Other|0
4725817|NCT01994902|16295813|P2|Test Period 2|Lack of Efficacy|1
4725818|NCT01994902|16295814|P1|Test Period 2|Lack of Efficacy|0
4725819|NCT01994902|16295813|P2|Test Period 2|Withdrawal by Subject|2
4725820|NCT01994902|16295814|P1|Test Period 2|Withdrawal by Subject|0
4725821|NCT01994902|16295813|P2|Test Period 1|bag too small|0
4725822|NCT01994902|16295814|P1|Test Period 1|bag too small|1
4725823|NCT01994902|16295813|P2|Test Period 1|Lack of Efficacy|1
4725824|NCT01994902|16295814|P1|Test Period 1|Lack of Efficacy|0
4725825|NCT01994902|16295813|P2|Test Period 1|Adverse Event|1
4725826|NCT01994902|16295814|P1|Test Period 1|Adverse Event|2
4725827|NCT01994902|16295813|P2|Test Period 1|device deficiency with adverse event|1
4725828|NCT01994902|16295814|P1|Test Period 1|device deficiency with adverse event|0
4725829|NCT01994902|16295813|P2|Test Period 1|Withdrawal by Subject|0
4725830|NCT01994902|16295814|P1|Test Period 1|Withdrawal by Subject|3
4725831|NCT01994889|16295823|P3|Overall Study|Death|38
4725832|NCT01994889|16295824|P2|Overall Study|Death|25
4725833|NCT01994889|16295825|P1|Overall Study|Death|14
4725834|NCT01994889|16295823|P3|Overall Study|Protocol Violation|1
4725835|NCT01994889|16295824|P2|Overall Study|Protocol Violation|1
4725836|NCT01994889|16295825|P1|Overall Study|Protocol Violation|0
4725837|NCT01994889|16295823|P3|Overall Study|Lost to Follow-up|0
4725838|NCT01994889|16295824|P2|Overall Study|Lost to Follow-up|1
4725839|NCT01994889|16295825|P1|Overall Study|Lost to Follow-up|0
4725840|NCT01994889|16295823|P3|Overall Study|No longer willing to participate|37
4725841|NCT01994889|16295824|P2|Overall Study|No longer willing to participate|17
4725842|NCT01994889|16295825|P1|Overall Study|No longer willing to participate|8
4725843|NCT01994889|16295823|P3|Overall Study|Organ Transplantation|5
4725844|NCT01994889|16295824|P2|Overall Study|Organ Transplantation|5
4725845|NCT01994889|16295825|P1|Overall Study|Organ Transplantation|1
4725846|NCT01994889|16295823|P3|Overall Study|Cardiac Device Implantation|0
4725847|NCT01994889|16295824|P2|Overall Study|Cardiac Device Implantation|2
4725848|NCT01994889|16295825|P1|Overall Study|Cardiac Device Implantation|0
4725849|NCT01994889|16295823|P3|Overall Study|Adverse Event|11
4725850|NCT01994889|16295824|P2|Overall Study|Adverse Event|12
4725851|NCT01994889|16295825|P1|Overall Study|Adverse Event|5
4725852|NCT01994876|16295844|P2|Test Period 2|Protocol Violation|1
4725853|NCT01994876|16295845|P1|Test Period 2|Protocol Violation|0
4725854|NCT01994876|16295844|P2|Test Period 2|Adverse Event|0
4725855|NCT01994876|16295845|P1|Test Period 2|Adverse Event|1
4725856|NCT01994876|16295844|P2|Test Period 1|Adverse Event|1
4725857|NCT01994876|16295845|P1|Test Period 1|Adverse Event|0
4725858|NCT01994876|16295844|P2|Test Period 1|Withdrawal by Subject|1
4725859|NCT01994876|16295845|P1|Test Period 1|Withdrawal by Subject|0
4725860|NCT01994863|16295853|P2|Period 2|Withdrawal by Subject|1
4725861|NCT01994863|16295854|P1|Period 2|Withdrawal by Subject|1
4725862|NCT01994863|16295853|P2|Period 2|Lack of Efficacy|2
4725863|NCT01994863|16295854|P1|Period 2|Lack of Efficacy|0
4725864|NCT01994863|16295853|P2|Period 2|Adverse Event|1
4725865|NCT01994863|16295854|P1|Period 2|Adverse Event|0
4725866|NCT01994863|16295853|P2|Period 1|Lack of Efficacy|0
4725867|NCT01994863|16295854|P1|Period 1|Lack of Efficacy|1
4725868|NCT01994863|16295853|P2|Period 1|Trial stopped by sponsor|3
4725869|NCT01994863|16295854|P1|Period 1|Trial stopped by sponsor|1
4725870|NCT01994863|16295853|P2|Period 1|Withdrawal by Subject|0
4725871|NCT01994863|16295854|P1|Period 1|Withdrawal by Subject|1
4725872|NCT01994863|16295853|P2|Period 1|Adverse Event|0
4725873|NCT01994863|16295854|P1|Period 1|Adverse Event|4
4725874|NCT01994850|16295860|P1|Overall Study|Withdrawal by Subject|1
4725875|NCT01994850|16295860|P1|Overall Study|Physician Decision|1
4725876|NCT01994837|16295865|P1|Overall Study|Removed from study due to no response|1
4725877|NCT01994837|16295865|P1|Overall Study|Proceeded to transplant|1
4725878|NCT01994837|16295865|P1|Overall Study|Chose palliative care|1
4725879|NCT01994837|16295865|P1|Overall Study|Adverse event not related to progression|1
4725880|NCT01994837|16295865|P1|Overall Study|Fatal progressive disease|2
4725881|NCT01994837|16295865|P1|Overall Study|Adv event related to progressive disease|3
4725882|NCT01994837|16295865|P1|Overall Study|Progressive disease per protocol|23
4725883|NCT01994720|16295922|P2|Overall Study|Withdrawal by Subject|56
4725884|NCT01994720|16295923|P1|Overall Study|Withdrawal by Subject|46
4725885|NCT01994629|16295965|P2|Overall Study|Lost to Follow-up|3
4725886|NCT01994629|16295966|P1|Overall Study|Lost to Follow-up|0
4725887|NCT01994629|16295965|P2|Overall Study|Withdrawal by Subject|0
4725888|NCT01994629|16295966|P1|Overall Study|Withdrawal by Subject|1
4725889|NCT01994590|16295990|P1|Overall Study|Trial Terminated|1
4725890|NCT01994590|16295990|P1|Overall Study|Adverse Event|1
4725891|NCT01994395|16296005|P2|Overall Study|Withdrawal by Subject|2
4725892|NCT01994395|16296006|P1|Overall Study|Withdrawal by Subject|1
4725893|NCT01994291|16296031|P3|Overall Study|Other|0
4725894|NCT01994291|16296032|P2|Overall Study|Other|2
4725895|NCT01994291|16296033|P1|Overall Study|Other|1
4725896|NCT01994291|16296031|P3|Overall Study|Withdrawal by Subject|5
4725897|NCT01994291|16296032|P2|Overall Study|Withdrawal by Subject|3
4725898|NCT01994291|16296033|P1|Overall Study|Withdrawal by Subject|6
4725899|NCT01994291|16296031|P3|Overall Study|Protocol Violation|0
4725900|NCT01994291|16296032|P2|Overall Study|Protocol Violation|0
4725901|NCT01994291|16296033|P1|Overall Study|Protocol Violation|1
4725902|NCT01994291|16296031|P3|Overall Study|Medication error without associated AE|1
4725903|NCT01994291|16296032|P2|Overall Study|Medication error without associated AE|0
4725904|NCT01994291|16296033|P1|Overall Study|Medication error without associated AE|1
4725905|NCT01994291|16296031|P3|Overall Study|Does not meet entrance criteria|0
4725906|NCT01994291|16296032|P2|Overall Study|Does not meet entrance criteria|0
4725907|NCT01994291|16296033|P1|Overall Study|Does not meet entrance criteria|1
4725908|NCT01994291|16296031|P3|Overall Study|Lost to Follow-up|0
4725909|NCT01994291|16296032|P2|Overall Study|Lost to Follow-up|1
4725910|NCT01994291|16296033|P1|Overall Study|Lost to Follow-up|1
4725911|NCT01994291|16296031|P3|Overall Study|Adverse Event|3
4725912|NCT01994291|16296032|P2|Overall Study|Adverse Event|1
4725913|NCT01994291|16296033|P1|Overall Study|Adverse Event|4
4725914|NCT01994226|16296089|P2|Overall Study|Early Cessation of treatment|11
4725915|NCT01994226|16296090|P1|Overall Study|Early Cessation of treatment|6
4725916|NCT01994226|16296089|P2|Overall Study|Protocol Violation|10
4725917|NCT01994226|16296090|P1|Overall Study|Protocol Violation|13
4725918|NCT01993940|16296116|P2|Overall Study|Other - Miscellaneous|1
4725919|NCT01993940|16296117|P1|Overall Study|Other - Miscellaneous|1
4725920|NCT01993940|16296116|P2|Overall Study|Death|0
4725921|NCT01993940|16296117|P1|Overall Study|Death|1
4725922|NCT01993940|16296116|P2|Overall Study|Protocol Violation|8
4725923|NCT01993940|16296117|P1|Overall Study|Protocol Violation|5
4725924|NCT01993940|16296116|P2|Overall Study|Lost to Follow-up|5
4725925|NCT01993940|16296117|P1|Overall Study|Lost to Follow-up|2
4725926|NCT01993940|16296116|P2|Overall Study|Withdrawal by Subject|19
4725927|NCT01993940|16296117|P1|Overall Study|Withdrawal by Subject|15
4725928|NCT01993940|16296116|P2|Overall Study|Adverse Event|11
4725929|NCT01993940|16296117|P1|Overall Study|Adverse Event|16
4725930|NCT01993927|16296131|P1|Overall Study|Protocol Violation|11
4725931|NCT01993927|16296131|P1|Overall Study|Case Report Forms Uncollected|18
4725932|NCT01993888|16296139|P2|Overall Study|Withdrawal by Subject|1
4725933|NCT01993888|16296140|P1|Overall Study|Withdrawal by Subject|0
4725934|NCT01993888|16296139|P2|Overall Study|Lost to Follow-up|1
4725935|NCT01993888|16296140|P1|Overall Study|Lost to Follow-up|1
4725936|NCT01993888|16296139|P2|Overall Study|Death|1
4725937|NCT01993888|16296140|P1|Overall Study|Death|1
4725938|NCT01993836|16296189|P3|Overall Study|Withdrawal by Subject|5
4725939|NCT01993836|16296190|P2|Overall Study|Withdrawal by Subject|10
4725940|NCT01993836|16296191|P1|Overall Study|Withdrawal by Subject|12
4725941|NCT01993836|16296189|P3|Overall Study|Death|0
4725942|NCT01993836|16296190|P2|Overall Study|Death|2
4725943|NCT01993836|16296191|P1|Overall Study|Death|0
4725944|NCT01993836|16296189|P3|Overall Study|Physician Decision|0
4725945|NCT01993836|16296190|P2|Overall Study|Physician Decision|1
4725946|NCT01993836|16296191|P1|Overall Study|Physician Decision|2
4725947|NCT01993836|16296189|P3|Overall Study|Surgery Cancelled|0
4725948|NCT01993836|16296190|P2|Overall Study|Surgery Cancelled|0
4725949|NCT01993836|16296191|P1|Overall Study|Surgery Cancelled|3
4725950|NCT01993823|16296207|P2|Overall Study|Lost to Follow-up|4
4725951|NCT01993823|16296208|P1|Overall Study|Lost to Follow-up|1
4725952|NCT01993823|16296207|P2|Overall Study|Protocol Violation|1
4725953|NCT01993823|16296208|P1|Overall Study|Protocol Violation|0
4725954|NCT01993823|16296207|P2|Overall Study|Requested by the patient|11
4725955|NCT01993823|16296208|P1|Overall Study|Requested by the patient|6
4725956|NCT01993667|16296218|P2|Overall Study|Lost to Follow-up|2
4725957|NCT01993667|16296219|P1|Overall Study|Lost to Follow-up|2
4725958|NCT01993667|16296218|P2|Overall Study|Insufficient altitude reached|1
4725959|NCT01993667|16296219|P1|Overall Study|Insufficient altitude reached|3
4725960|NCT01993667|16296218|P2|Overall Study|Insufficient data to analyze|16
4725961|NCT01993667|16296219|P1|Overall Study|Insufficient data to analyze|16
4725962|NCT01993615|16296229|P2|Overall Study|Death|0
4725963|NCT01993615|16296230|P1|Overall Study|Death|1
4725964|NCT01993186|16296249|P2|Open-Label Extension Period|Subject Non-Compliance|0
4725965|NCT01993186|16296250|P1|Open-Label Extension Period|Subject Non-Compliance|1
4725966|NCT01993186|16296249|P2|Open-Label Extension Period|Withdrawal by Subject|5
4725967|NCT01993186|16296250|P1|Open-Label Extension Period|Withdrawal by Subject|4
4725968|NCT01993186|16296249|P2|Open-Label Extension Period|Principal Investigator Decision|0
4725969|NCT01993186|16296250|P1|Open-Label Extension Period|Principal Investigator Decision|1
4725970|NCT01993186|16296249|P2|Open-Label Extension Period|Adverse Event|0
4725971|NCT01993186|16296250|P1|Open-Label Extension Period|Adverse Event|1
4725972|NCT01993186|16296249|P2|Open-Label Extension Period|Other, Not Specified|1
4725973|NCT01993186|16296250|P1|Open-Label Extension Period|Other, Not Specified|0
4725974|NCT01993186|16296249|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0
4725975|NCT01993186|16296250|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1
4725976|NCT01993186|16296249|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
4725977|NCT01993186|16296250|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|1
4725978|NCT01993030|16296327|P2|Overall Study|Adverse Event|4
4725979|NCT01993030|16296328|P1|Overall Study|Adverse Event|0
4725980|NCT01993017|16296345|P3|Overall Study|Ineligible after randomization|5
4725981|NCT01993017|16296346|P2|Overall Study|Ineligible after randomization|5
4725982|NCT01993017|16296347|P1|Overall Study|Ineligible after randomization|4
4725983|NCT01993017|16296345|P3|Overall Study|Other reasons|7
4725984|NCT01993017|16296346|P2|Overall Study|Other reasons|11
4725985|NCT01993017|16296347|P1|Overall Study|Other reasons|17
4725986|NCT01993017|16296345|P3|Overall Study|Dropped out|11
4725987|NCT01993017|16296346|P2|Overall Study|Dropped out|6
4725988|NCT01993017|16296347|P1|Overall Study|Dropped out|19
4725989|NCT01993017|16296345|P3|Overall Study|Could not be contacted|38
4725990|NCT01993017|16296346|P2|Overall Study|Could not be contacted|42
4725991|NCT01993017|16296347|P1|Overall Study|Could not be contacted|43
4725992|NCT01993017|16296345|P3|Overall Study|Death|18
4725993|NCT01993017|16296346|P2|Overall Study|Death|26
4725994|NCT01993017|16296347|P1|Overall Study|Death|23
4725995|NCT01992757|16296388|P1|Overall Study|2 patients excluded due to FFP given.|2
4725996|NCT01992653|16296401|P8|Overall Study|Disease Progression|0
4725997|NCT01992653|16296402|P7|Overall Study|Disease Progression|4
4725998|NCT01992653|16296403|P6|Overall Study|Disease Progression|0
4725999|NCT01992653|16296404|P5|Overall Study|Disease Progression|0
4726000|NCT01992653|16296405|P4|Overall Study|Disease Progression|0
4726001|NCT01992653|16296406|P3|Overall Study|Disease Progression|0
4726002|NCT01992653|16296407|P2|Overall Study|Disease Progression|0
4726003|NCT01992653|16296408|P1|Overall Study|Disease Progression|0
4726004|NCT01992653|16296401|P8|Overall Study|Study Completed|1
4726005|NCT01992653|16296402|P7|Overall Study|Study Completed|0
4726006|NCT01992653|16296403|P6|Overall Study|Study Completed|0
4726007|NCT01992653|16296404|P5|Overall Study|Study Completed|0
4726008|NCT01992653|16296405|P4|Overall Study|Study Completed|0
4726009|NCT01992653|16296406|P3|Overall Study|Study Completed|0
4726010|NCT01992653|16296407|P2|Overall Study|Study Completed|0
4726011|NCT01992653|16296408|P1|Overall Study|Study Completed|0
4726012|NCT01992653|16296401|P8|Overall Study|Lost to Follow-up|1
4726013|NCT01992653|16296402|P7|Overall Study|Lost to Follow-up|0
4726014|NCT01992653|16296403|P6|Overall Study|Lost to Follow-up|0
4726015|NCT01992653|16296404|P5|Overall Study|Lost to Follow-up|0
4726016|NCT01992653|16296405|P4|Overall Study|Lost to Follow-up|0
4726017|NCT01992653|16296406|P3|Overall Study|Lost to Follow-up|0
4726018|NCT01992653|16296407|P2|Overall Study|Lost to Follow-up|0
4726019|NCT01992653|16296408|P1|Overall Study|Lost to Follow-up|0
4726020|NCT01992653|16296401|P8|Overall Study|Death|2
4726021|NCT01992653|16296402|P7|Overall Study|Death|4
4726022|NCT01992653|16296403|P6|Overall Study|Death|0
4726023|NCT01992653|16296404|P5|Overall Study|Death|1
4726024|NCT01992653|16296405|P4|Overall Study|Death|0
4726025|NCT01992653|16296406|P3|Overall Study|Death|1
4726026|NCT01992653|16296407|P2|Overall Study|Death|0
4726027|NCT01992653|16296408|P1|Overall Study|Death|0
4726028|NCT01992549|16296634|P1|Overall Study|Product Switch to Extend Half Life|1
4726029|NCT01992549|16296634|P1|Overall Study|Serious Adverse Event|1
4726030|NCT01992549|16296634|P1|Overall Study|Lost to Follow-up|2
4726031|NCT01992536|16296654|P10|Overall Study|Withdrawal by Subject|0
4726032|NCT01992536|16296655|P9|Overall Study|Withdrawal by Subject|0
4726033|NCT01992536|16296656|P8|Overall Study|Withdrawal by Subject|0
4726034|NCT01992536|16296657|P7|Overall Study|Withdrawal by Subject|0
4726035|NCT01992536|16296658|P6|Overall Study|Withdrawal by Subject|0
4726036|NCT01992536|16296659|P5|Overall Study|Withdrawal by Subject|0
4726037|NCT01992536|16296660|P4|Overall Study|Withdrawal by Subject|2
4726038|NCT01992536|16296661|P3|Overall Study|Withdrawal by Subject|0
4726039|NCT01992536|16296662|P2|Overall Study|Withdrawal by Subject|1
4726040|NCT01992536|16296663|P1|Overall Study|Withdrawal by Subject|0
4726041|NCT01992536|16296654|P10|Overall Study|Lost to Follow-up|1
4726042|NCT01992536|16296655|P9|Overall Study|Lost to Follow-up|1
4726043|NCT01992536|16296656|P8|Overall Study|Lost to Follow-up|0
4726044|NCT01992536|16296657|P7|Overall Study|Lost to Follow-up|0
4726045|NCT01992536|16296658|P6|Overall Study|Lost to Follow-up|1
4726046|NCT01992536|16296659|P5|Overall Study|Lost to Follow-up|0
4726047|NCT01992536|16296660|P4|Overall Study|Lost to Follow-up|0
4726048|NCT01992536|16296661|P3|Overall Study|Lost to Follow-up|1
4726049|NCT01992536|16296662|P2|Overall Study|Lost to Follow-up|2
4726050|NCT01992536|16296663|P1|Overall Study|Lost to Follow-up|4
4726051|NCT01992536|16296654|P10|Overall Study|Administrative Reason|0
4726052|NCT01992536|16296655|P9|Overall Study|Administrative Reason|0
4726053|NCT01992536|16296656|P8|Overall Study|Administrative Reason|0
4726054|NCT01992536|16296657|P7|Overall Study|Administrative Reason|7
4726055|NCT01992536|16296658|P6|Overall Study|Administrative Reason|0
4726056|NCT01992536|16296659|P5|Overall Study|Administrative Reason|0
4726057|NCT01992536|16296660|P4|Overall Study|Administrative Reason|0
4726058|NCT01992536|16296661|P3|Overall Study|Administrative Reason|0
4726059|NCT01992536|16296662|P2|Overall Study|Administrative Reason|0
4726060|NCT01992536|16296663|P1|Overall Study|Administrative Reason|0
4726061|NCT01992159|16296932|P4|Overall Study|Death|0
4726062|NCT01992159|16296933|P3|Overall Study|Death|1
4726063|NCT01992159|16296934|P2|Overall Study|Death|0
4726064|NCT01992159|16296935|P1|Overall Study|Death|0
4726065|NCT01992159|16296932|P4|Overall Study|Adverse Event|1
4726066|NCT01992159|16296933|P3|Overall Study|Adverse Event|0
4726067|NCT01992159|16296934|P2|Overall Study|Adverse Event|1
4726068|NCT01992159|16296935|P1|Overall Study|Adverse Event|0
4726069|NCT01992159|16296932|P4|Overall Study|Withdrawal by Subject|3
4726070|NCT01992159|16296933|P3|Overall Study|Withdrawal by Subject|0
4726071|NCT01992159|16296934|P2|Overall Study|Withdrawal by Subject|7
4726072|NCT01992159|16296935|P1|Overall Study|Withdrawal by Subject|4
4726073|NCT01992107|16296988|P3|Overall Study|Withdrawal by Subject|8
4726074|NCT01992107|16296989|P2|Overall Study|Withdrawal by Subject|7
4726075|NCT01992107|16296990|P1|Overall Study|Withdrawal by Subject|13
4726076|NCT01992107|16296988|P3|Overall Study|noncompliance and were unavailable|2
4726077|NCT01992107|16296989|P2|Overall Study|noncompliance and were unavailable|3
4726078|NCT01992107|16296990|P1|Overall Study|noncompliance and were unavailable|7
4726079|NCT01992107|16296988|P3|Overall Study|Lost to Follow-up|26
4726080|NCT01992107|16296989|P2|Overall Study|Lost to Follow-up|22
4726081|NCT01992107|16296990|P1|Overall Study|Lost to Follow-up|46
4726082|NCT01992107|16296988|P3|Overall Study|Adverse Event|0
4726083|NCT01992107|16296989|P2|Overall Study|Adverse Event|1
4726084|NCT01992107|16296990|P1|Overall Study|Adverse Event|0
4726085|NCT01992107|16296988|P3|Overall Study|Administrative reasons|0
4726086|NCT01992107|16296989|P2|Overall Study|Administrative reasons|0
4726087|NCT01992107|16296990|P1|Overall Study|Administrative reasons|2
4726088|NCT01992094|16297046|P3|Overall Study|Withdrawal by Subject|4
4726089|NCT01992094|16297047|P2|Overall Study|Withdrawal by Subject|3
4726090|NCT01992094|16297048|P1|Overall Study|Withdrawal by Subject|7
4726091|NCT01992094|16297046|P3|Overall Study|Protocol Violation|1
4726092|NCT01992094|16297047|P2|Overall Study|Protocol Violation|0
4726093|NCT01992094|16297048|P1|Overall Study|Protocol Violation|1
4726094|NCT01992094|16297046|P3|Overall Study|OTHER|0
4726095|NCT01992094|16297047|P2|Overall Study|OTHER|0
4726096|NCT01992094|16297048|P1|Overall Study|OTHER|4
4726097|NCT01992094|16297046|P3|Overall Study|Lost to Follow-up|13
4726098|NCT01992094|16297047|P2|Overall Study|Lost to Follow-up|9
4726099|NCT01992094|16297048|P1|Overall Study|Lost to Follow-up|26
4726100|NCT01992094|16297046|P3|Overall Study|Death|2
4726101|NCT01992094|16297047|P2|Overall Study|Death|5
4726102|NCT01992094|16297048|P1|Overall Study|Death|5
4726103|NCT01992094|16297046|P3|Overall Study|Adverse Event|0
4726104|NCT01992094|16297047|P2|Overall Study|Adverse Event|0
4726105|NCT01992094|16297048|P1|Overall Study|Adverse Event|1
4726106|NCT01992094|16297046|P3|Overall Study|ADMINISTRATIVE REASON|1
4726107|NCT01992094|16297047|P2|Overall Study|ADMINISTRATIVE REASON|7
4726108|NCT01992094|16297048|P1|Overall Study|ADMINISTRATIVE REASON|6
4726109|NCT01991977|16297156|P1|Overall Study|Withdrew after start of treatment|5
4726110|NCT01991977|16297156|P1|Overall Study|Withdrew prior to receiving treatment|7
4726111|NCT01991795|16297208|P2|Overall Study|Site prematurely closed by sponsor|25
4726112|NCT01991795|16297209|P1|Overall Study|Site prematurely closed by sponsor|26
4726113|NCT01991795|16297208|P2|Overall Study|Withdrawal by Subject|94
4726114|NCT01991795|16297209|P1|Overall Study|Withdrawal by Subject|117
4726115|NCT01991795|16297208|P2|Overall Study|Lost to Follow-up|4
4726116|NCT01991795|16297209|P1|Overall Study|Lost to Follow-up|6
4726117|NCT01991743|16297235|P4|Overall Study|external cephalic version not performed|0
4726118|NCT01991743|16297236|P3|Overall Study|external cephalic version not performed|1
4726119|NCT01991743|16297237|P2|Overall Study|external cephalic version not performed|0
4726120|NCT01991743|16297238|P1|Overall Study|external cephalic version not performed|0
4726121|NCT01991483|16297283|P4|Dose Level 1000 mg|Protocol Violation|1
4726122|NCT01991483|16297284|P3|Dose Level 1000 mg|Protocol Violation|0
4726123|NCT01991483|16297285|P2|Dose Level 1000 mg|Protocol Violation|0
4726124|NCT01991483|16297286|P1|Dose Level 1000 mg|Protocol Violation|0
4726125|NCT01991483|16297283|P4|Dose Level 600 mg|Physician Decision|0
4726126|NCT01991483|16297284|P3|Dose Level 600 mg|Physician Decision|1
4726127|NCT01991483|16297285|P2|Dose Level 600 mg|Physician Decision|0
4726128|NCT01991483|16297286|P1|Dose Level 600 mg|Physician Decision|0
4726129|NCT01991483|16297283|P4|Dose Level 600 mg|Withdrawal by Subject|0
4726130|NCT01991483|16297284|P3|Dose Level 600 mg|Withdrawal by Subject|1
4726131|NCT01991483|16297285|P2|Dose Level 600 mg|Withdrawal by Subject|0
4726132|NCT01991483|16297286|P1|Dose Level 600 mg|Withdrawal by Subject|0
4726133|NCT01991470|16297352|P1|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1
4726134|NCT01991470|16297352|P1|Enlite 3 Period|Physician Decision|8
4726135|NCT01991470|16297352|P1|Enlite 3 Period|Physician Decision|2
4726136|NCT01991470|16297352|P1|Enlite 3 Period|Lost to Follow-up|1
4726137|NCT01991470|16297352|P1|Enlite 1 Period|Inclusion/Exclusion not met|1
4726138|NCT01991470|16297352|P1|Enlite 1 Period|Adverse Event|1
4726139|NCT01991470|16297352|P1|Enlite 1 Period|Withdrawal by Subject|18
4726140|NCT01991314|16297366|P2|Overall Study|Lost to Follow-up|10
4726141|NCT01991314|16297367|P1|Overall Study|Lost to Follow-up|6
4726142|NCT01991314|16297366|P2|Overall Study|Adverse Event|1
4726143|NCT01991314|16297367|P1|Overall Study|Adverse Event|5
4726144|NCT01991197|16297387|P2|Overall Study|Withdrawal by Subject|0
4726145|NCT01991197|16297388|P1|Overall Study|Withdrawal by Subject|2
4726146|NCT01991197|16297387|P2|Overall Study|Physician Decision|2
4726147|NCT01991197|16297388|P1|Overall Study|Physician Decision|0
4726148|NCT01991197|16297387|P2|Overall Study|Lost to Follow-up|1
4726149|NCT01991197|16297388|P1|Overall Study|Lost to Follow-up|1
4726150|NCT01991067|16297426|P2|Overall Study|Lost to Follow-up|5
4726151|NCT01991067|16297427|P1|Overall Study|Lost to Follow-up|6
4726152|NCT01990859|16297441|P1|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17
4726153|NCT01990859|16297441|P1|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5
4726154|NCT01990768|16297576|P3|6-Month Follow-up|Patient at psychiatric hospital|0
4726155|NCT01990768|16297577|P2|6-Month Follow-up|Patient at psychiatric hospital|0
4726156|NCT01990768|16297578|P1|6-Month Follow-up|Patient at psychiatric hospital|1
4726157|NCT01990768|16297576|P3|6-Month Follow-up|Prisoner at time of follow-up|0
4726158|NCT01990768|16297577|P2|6-Month Follow-up|Prisoner at time of follow-up|2
4726159|NCT01990768|16297578|P1|6-Month Follow-up|Prisoner at time of follow-up|0
4726160|NCT01990768|16297576|P3|6-Month Follow-up|Prisoner at time of enrollment|1
4726161|NCT01990768|16297577|P2|6-Month Follow-up|Prisoner at time of enrollment|0
4726162|NCT01990768|16297578|P1|6-Month Follow-up|Prisoner at time of enrollment|0
4726163|NCT01990768|16297576|P3|6-Month Follow-up|Homeless|6
4726164|NCT01990768|16297577|P2|6-Month Follow-up|Homeless|3
4726165|NCT01990768|16297578|P1|6-Month Follow-up|Homeless|4
4726166|NCT01990768|16297576|P3|6-Month Follow-up|No contact information|5
4726167|NCT01990768|16297577|P2|6-Month Follow-up|No contact information|6
4726168|NCT01990768|16297578|P1|6-Month Follow-up|No contact information|5
4726169|NCT01990768|16297576|P3|6-Month Follow-up|Calls unreturned or refused contact|20
4726170|NCT01990768|16297577|P2|6-Month Follow-up|Calls unreturned or refused contact|15
4726171|NCT01990768|16297578|P1|6-Month Follow-up|Calls unreturned or refused contact|4
4726172|NCT01990768|16297576|P3|6-Month Follow-up|Withdrawal by Subject|26
4726173|NCT01990768|16297577|P2|6-Month Follow-up|Withdrawal by Subject|25
4726174|NCT01990768|16297578|P1|6-Month Follow-up|Withdrawal by Subject|25
4726175|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Unknown if completed|1
4726176|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Unknown if completed|0
4726177|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Unknown if completed|0
4726178|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Other procoagulant administered|2
4726179|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Other procoagulant administered|1
4726180|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Other procoagulant administered|0
4726181|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0
4726182|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
4726183|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1
4726184|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Found not to be injured|1
4726185|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Found not to be injured|1
4726186|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Found not to be injured|1
4726187|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Taken into police custody|3
4726188|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Taken into police custody|0
4726189|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Taken into police custody|4
4726190|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Other safety concern|3
4726191|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Other safety concern|2
4726192|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Other safety concern|4
4726193|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Required CPR|1
4726194|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Required CPR|7
4726195|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Required CPR|3
4726196|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4
4726197|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
4726198|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5
4726199|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17
4726200|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9
4726201|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8
4726202|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Emergency unblinding|7
4726203|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Emergency unblinding|4
4726204|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Emergency unblinding|11
4726205|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Death or comfort care|6
4726206|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Death or comfort care|11
4726207|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Death or comfort care|12
4726208|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Withdrawal by Subject|12
4726209|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Withdrawal by Subject|7
4726210|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Withdrawal by Subject|13
4726211|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Protocol non-compliance|10
4726212|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Protocol non-compliance|17
4726213|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Protocol non-compliance|14
4726214|NCT01990768|16297576|P3|In-Hospital Study Drug Infusion|Discharged|13
4726215|NCT01990768|16297577|P2|In-Hospital Study Drug Infusion|Discharged|18
4726216|NCT01990768|16297578|P1|In-Hospital Study Drug Infusion|Discharged|19
4726217|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Unknown if completed|2
4726218|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Unknown if completed|4
4726219|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Unknown if completed|1
4726220|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Emergency unblinding|1
4726221|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Emergency unblinding|0
4726222|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Emergency unblinding|0
4726223|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Withdrawal by Subject|0
4726224|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Withdrawal by Subject|0
4726225|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Withdrawal by Subject|1
4726226|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Discharged|0
4726227|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Discharged|1
4726228|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Discharged|2
4726229|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Death|1
4726230|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Death|1
4726231|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Death|3
4726232|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Other safety concern|1
4726233|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Other safety concern|1
4726234|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Other safety concern|2
4726235|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Required CPR|0
4726236|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Required CPR|6
4726237|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Required CPR|2
4726238|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
4726239|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Seizure or concern for seizure|3
4726240|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Seizure or concern for seizure|4
4726241|NCT01990768|16297576|P3|Prehospital Study Drug Infusion|Protocol non-compliance|10
4726242|NCT01990768|16297577|P2|Prehospital Study Drug Infusion|Protocol non-compliance|11
4726243|NCT01990768|16297578|P1|Prehospital Study Drug Infusion|Protocol non-compliance|4
4726244|NCT01990768|16297576|P3|Intervention Started|Discovered to be pregnant|0
4726245|NCT01990768|16297577|P2|Intervention Started|Discovered to be pregnant|1
4726246|NCT01990768|16297578|P1|Intervention Started|Discovered to be pregnant|0
4726247|NCT01990768|16297576|P3|Intervention Started|Seizure or hx of seizure|2
4726248|NCT01990768|16297577|P2|Intervention Started|Seizure or hx of seizure|0
4726249|NCT01990768|16297578|P1|Intervention Started|Seizure or hx of seizure|0
4726250|NCT01990768|16297576|P3|Intervention Started|Required CPR|0
4726251|NCT01990768|16297577|P2|Intervention Started|Required CPR|1
4726252|NCT01990768|16297578|P1|Intervention Started|Required CPR|1
4726253|NCT01990768|16297576|P3|Intervention Started|IV lost|2
4726254|NCT01990768|16297577|P2|Intervention Started|IV lost|2
4726255|NCT01990768|16297578|P1|Intervention Started|IV lost|2
4726256|NCT01990768|16297576|P3|Intervention Started|Patient care priority|3
4726257|NCT01990768|16297577|P2|Intervention Started|Patient care priority|2
4726258|NCT01990768|16297578|P1|Intervention Started|Patient care priority|1
4726259|NCT01990768|16297576|P3|Intervention Started|Not enough time for EMS to enroll|0
4726260|NCT01990768|16297577|P2|Intervention Started|Not enough time for EMS to enroll|3
4726261|NCT01990768|16297578|P1|Intervention Started|Not enough time for EMS to enroll|4
4726262|NCT01990768|16297576|P3|Intervention Started|Patient became ineligible due to vitals|2
4726263|NCT01990768|16297577|P2|Intervention Started|Patient became ineligible due to vitals|5
4726264|NCT01990768|16297578|P1|Intervention Started|Patient became ineligible due to vitals|5
4726265|NCT01990768|16297576|P3|Intervention Started|Study drug issue or kit malfunction|7
4726266|NCT01990768|16297577|P2|Intervention Started|Study drug issue or kit malfunction|6
4726267|NCT01990768|16297578|P1|Intervention Started|Study drug issue or kit malfunction|9
4726268|NCT01990768|16297576|P3|Intervention Started|Found to be ineligible|11
4726269|NCT01990768|16297577|P2|Intervention Started|Found to be ineligible|13
4726270|NCT01990768|16297578|P1|Intervention Started|Found to be ineligible|14
4726271|NCT01990742|16297643|P2|Overall Study|Facility closed|270
4726272|NCT01990742|16297644|P1|Overall Study|Facility closed|0
4726273|NCT01990742|16297643|P2|Overall Study|Withdrawal by facility|1083
4726274|NCT01990742|16297644|P1|Overall Study|Withdrawal by facility|407
4726275|NCT01990664|16297680|P2|Overall Study|Unsatisfactory Visual Response|1
4726276|NCT01990664|16297681|P1|Overall Study|Unsatisfactory Visual Response|0
4726277|NCT01990664|16297680|P2|Overall Study|Lens Handling Difficulties|0
4726278|NCT01990664|16297681|P1|Overall Study|Lens Handling Difficulties|1
4726279|NCT01990664|16297680|P2|Overall Study|Lens Discomfort|1
4726280|NCT01990664|16297681|P1|Overall Study|Lens Discomfort|1
4726281|NCT01990664|16297680|P2|Overall Study|Protocol Violation|0
4726282|NCT01990664|16297681|P1|Overall Study|Protocol Violation|1
4726283|NCT01990664|16297680|P2|Overall Study|Withdrawal by Subject|3
4726284|NCT01990664|16297681|P1|Overall Study|Withdrawal by Subject|2
4726285|NCT01990664|16297680|P2|Overall Study|Lost to Follow-up|6
4726286|NCT01990664|16297681|P1|Overall Study|Lost to Follow-up|2
4726287|NCT01990612|16297689|P2|Overall Study|Withdrawal by Subject|2
4726288|NCT01990612|16297690|P1|Overall Study|Withdrawal by Subject|5
4726289|NCT01990612|16297689|P2|Overall Study|Lost to Follow-up|1
4726290|NCT01990612|16297690|P1|Overall Study|Lost to Follow-up|2
4726291|NCT01990573|16297771|P3|Overall Study|Physician Decision|1
4726292|NCT01990573|16297772|P2|Overall Study|Physician Decision|0
4726293|NCT01990573|16297773|P1|Overall Study|Physician Decision|0
4726294|NCT01990560|16297786|P1|Overall Study|Withdrawal by Subject|1
4726295|NCT01990534|16297800|P1|Overall Study|Overall Survival Follow-up|25
4726296|NCT01990534|16297800|P1|Overall Study|Progression Free Survival Follow-up|11
4726297|NCT01990534|16297800|P1|Overall Study|Reason Not Specified|2
4726298|NCT01990534|16297800|P1|Overall Study|Withdrawal by Subject|3
4726299|NCT01990534|16297800|P1|Overall Study|Symptomatic Deterioration|1
4726300|NCT01990534|16297800|P1|Overall Study|Withdrawal of Informed Consent|2
4726301|NCT01990534|16297800|P1|Overall Study|Protocol Violation|1
4726302|NCT01990534|16297800|P1|Overall Study|Progressive disease|3
4726303|NCT01990534|16297800|P1|Overall Study|Death|12
4726304|NCT01990339|16297816|P1|Overall Study|Lost to Follow-up|861
4726305|NCT01990339|16297816|P1|Overall Study|Voluntary Withdrawal|1402
4726306|NCT01990339|16297816|P1|Overall Study|Data Not Available|49
4726307|NCT01990313|16297821|P1|Overall Study|Lost to Follow-up|1
4726308|NCT01990300|16297826|P1|Overall Study|Protocol Deviation|53
4726309|NCT01990300|16297826|P1|Overall Study|Case Report Forms Uncollected|89
4726310|NCT01990261|16297832|P1|Overall Study|Lost to Follow-up|2
4726311|NCT01990261|16297832|P1|Overall Study|Dossier not Approved|1
4726312|NCT01990261|16297832|P1|Overall Study|PD Before Treatment Start|1
4726313|NCT01990261|16297832|P1|Overall Study|Disease Progression (PD)|8
4726314|NCT01990261|16297832|P1|Overall Study|Death From other Causes|1
4726315|NCT01990261|16297832|P1|Overall Study|Death due to Disease Progression (PD)|10
4726316|NCT01990261|16297832|P1|Overall Study|Death Before Treatment Start|2
4726317|NCT01989754|16297889|P2|Overall Study|Closed Site|1
4726318|NCT01989754|16297890|P1|Overall Study|Closed Site|1
4726319|NCT01989754|16297889|P2|Overall Study|Lost to Follow-up|20
4726320|NCT01989754|16297890|P1|Overall Study|Lost to Follow-up|28
4726321|NCT01989754|16297889|P2|Overall Study|Withdrawal by Subject|14
4726322|NCT01989754|16297890|P1|Overall Study|Withdrawal by Subject|10
4726323|NCT01989689|16297902|P2|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1
4726324|NCT01989689|16297903|P1|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0
4726325|NCT01989689|16297902|P2|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2
4726326|NCT01989689|16297903|P1|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0
4726327|NCT01989676|16297915|P2|Overall Study|Discontinued|68
4726328|NCT01989676|16297916|P1|Overall Study|Discontinued|59
4726329|NCT01989676|16297915|P2|Overall Study|Ongoing at data cutoff|279
4726330|NCT01989676|16297916|P1|Overall Study|Ongoing at data cutoff|279
4726331|NCT01989572|16297942|P6|Overall Study|alternative therapy|3
4726332|NCT01989572|16297943|P5|Overall Study|alternative therapy|1
4726333|NCT01989572|16297944|P4|Overall Study|alternative therapy|0
4726334|NCT01989572|16297945|P3|Overall Study|alternative therapy|0
4726335|NCT01989572|16297946|P2|Overall Study|alternative therapy|0
4726336|NCT01989572|16297947|P1|Overall Study|alternative therapy|3
4726337|NCT01989572|16297942|P6|Overall Study|not start protocol therapy|18
4726338|NCT01989572|16297943|P5|Overall Study|not start protocol therapy|4
4726339|NCT01989572|16297944|P4|Overall Study|not start protocol therapy|3
4726340|NCT01989572|16297945|P3|Overall Study|not start protocol therapy|2
4726341|NCT01989572|16297946|P2|Overall Study|not start protocol therapy|1
4726342|NCT01989572|16297947|P1|Overall Study|not start protocol therapy|5
4726343|NCT01989572|16297942|P6|Overall Study|unknown/not specify|5
4726344|NCT01989572|16297943|P5|Overall Study|unknown/not specify|3
4726345|NCT01989572|16297944|P4|Overall Study|unknown/not specify|3
4726346|NCT01989572|16297945|P3|Overall Study|unknown/not specify|1
4726347|NCT01989572|16297946|P2|Overall Study|unknown/not specify|4
4726348|NCT01989572|16297947|P1|Overall Study|unknown/not specify|3
4726349|NCT01989572|16297942|P6|Overall Study|maximum dose reached|0
4726350|NCT01989572|16297943|P5|Overall Study|maximum dose reached|1
4726351|NCT01989572|16297944|P4|Overall Study|maximum dose reached|0
4726352|NCT01989572|16297945|P3|Overall Study|maximum dose reached|0
4726353|NCT01989572|16297946|P2|Overall Study|maximum dose reached|1
4726354|NCT01989572|16297947|P1|Overall Study|maximum dose reached|0
4726355|NCT01989572|16297942|P6|Overall Study|error|1
4726356|NCT01989572|16297943|P5|Overall Study|error|1
4726357|NCT01989572|16297944|P4|Overall Study|error|1
4726358|NCT01989572|16297945|P3|Overall Study|error|1
4726359|NCT01989572|16297946|P2|Overall Study|error|1
4726360|NCT01989572|16297947|P1|Overall Study|error|2
4726361|NCT01989572|16297942|P6|Overall Study|complicating disease|0
4726362|NCT01989572|16297943|P5|Overall Study|complicating disease|1
4726363|NCT01989572|16297944|P4|Overall Study|complicating disease|0
4726364|NCT01989572|16297945|P3|Overall Study|complicating disease|2
4726365|NCT01989572|16297946|P2|Overall Study|complicating disease|1
4726366|NCT01989572|16297947|P1|Overall Study|complicating disease|1
4726367|NCT01989572|16297942|P6|Overall Study|Withdrawal by Subject|4
4726368|NCT01989572|16297943|P5|Overall Study|Withdrawal by Subject|12
4726369|NCT01989572|16297944|P4|Overall Study|Withdrawal by Subject|1
4726370|NCT01989572|16297945|P3|Overall Study|Withdrawal by Subject|5
4726371|NCT01989572|16297946|P2|Overall Study|Withdrawal by Subject|1
4726372|NCT01989572|16297947|P1|Overall Study|Withdrawal by Subject|4
4726373|NCT01989572|16297942|P6|Overall Study|Death|0
4726374|NCT01989572|16297943|P5|Overall Study|Death|1
4726375|NCT01989572|16297944|P4|Overall Study|Death|0
4726376|NCT01989572|16297945|P3|Overall Study|Death|0
4726377|NCT01989572|16297946|P2|Overall Study|Death|0
4726378|NCT01989572|16297947|P1|Overall Study|Death|0
4726379|NCT01989572|16297942|P6|Overall Study|Adverse Event|0
4726380|NCT01989572|16297943|P5|Overall Study|Adverse Event|3
4726381|NCT01989572|16297944|P4|Overall Study|Adverse Event|0
4726382|NCT01989572|16297945|P3|Overall Study|Adverse Event|3
4726383|NCT01989572|16297946|P2|Overall Study|Adverse Event|1
4726384|NCT01989572|16297947|P1|Overall Study|Adverse Event|2
4726385|NCT01989572|16297942|P6|Overall Study|Lack of Efficacy|79
4726386|NCT01989572|16297943|P5|Overall Study|Lack of Efficacy|71
4726387|NCT01989572|16297944|P4|Overall Study|Lack of Efficacy|43
4726388|NCT01989572|16297945|P3|Overall Study|Lack of Efficacy|48
4726389|NCT01989572|16297946|P2|Overall Study|Lack of Efficacy|48
4726390|NCT01989572|16297947|P1|Overall Study|Lack of Efficacy|35
4726391|NCT01989468|16297978|P5|Overall Study|Death|0
4726392|NCT01989468|16297979|P4|Overall Study|Death|0
4726393|NCT01989468|16297980|P3|Overall Study|Death|1
4726394|NCT01989468|16297981|P2|Overall Study|Death|0
4726395|NCT01989468|16297982|P1|Overall Study|Death|3
4726396|NCT01989468|16297978|P5|Overall Study|Subject Guardian Decision|1
4726397|NCT01989468|16297979|P4|Overall Study|Subject Guardian Decision|4
4726398|NCT01989468|16297980|P3|Overall Study|Subject Guardian Decision|4
4726399|NCT01989468|16297981|P2|Overall Study|Subject Guardian Decision|6
4726400|NCT01989468|16297982|P1|Overall Study|Subject Guardian Decision|11
4726401|NCT01989468|16297978|P5|Overall Study|Technical Problems|0
4726402|NCT01989468|16297979|P4|Overall Study|Technical Problems|1
4726403|NCT01989468|16297980|P3|Overall Study|Technical Problems|3
4726404|NCT01989468|16297981|P2|Overall Study|Technical Problems|1
4726405|NCT01989468|16297982|P1|Overall Study|Technical Problems|3
4726406|NCT01989468|16297978|P5|Overall Study|Pregnancy|0
4726407|NCT01989468|16297979|P4|Overall Study|Pregnancy|0
4726408|NCT01989468|16297980|P3|Overall Study|Pregnancy|0
4726409|NCT01989468|16297981|P2|Overall Study|Pregnancy|1
4726410|NCT01989468|16297982|P1|Overall Study|Pregnancy|0
4726411|NCT01989468|16297978|P5|Overall Study|Physician Decision|0
4726412|NCT01989468|16297979|P4|Overall Study|Physician Decision|1
4726413|NCT01989468|16297980|P3|Overall Study|Physician Decision|0
4726414|NCT01989468|16297981|P2|Overall Study|Physician Decision|1
4726415|NCT01989468|16297982|P1|Overall Study|Physician Decision|4
4726416|NCT01989468|16297978|P5|Overall Study|Lost to Follow-up|1
4726417|NCT01989468|16297979|P4|Overall Study|Lost to Follow-up|1
4726418|NCT01989468|16297980|P3|Overall Study|Lost to Follow-up|0
4726419|NCT01989468|16297981|P2|Overall Study|Lost to Follow-up|2
4726420|NCT01989468|16297982|P1|Overall Study|Lost to Follow-up|5
4726421|NCT01989468|16297978|P5|Overall Study|Lack of Efficacy|2
4726422|NCT01989468|16297979|P4|Overall Study|Lack of Efficacy|4
4726423|NCT01989468|16297980|P3|Overall Study|Lack of Efficacy|7
4726424|NCT01989468|16297981|P2|Overall Study|Lack of Efficacy|11
4726425|NCT01989468|16297982|P1|Overall Study|Lack of Efficacy|11
4726426|NCT01989468|16297978|P5|Overall Study|Adverse Event|4
4726427|NCT01989468|16297979|P4|Overall Study|Adverse Event|5
4726428|NCT01989468|16297980|P3|Overall Study|Adverse Event|4
4726429|NCT01989468|16297981|P2|Overall Study|Adverse Event|15
4726430|NCT01989468|16297982|P1|Overall Study|Adverse Event|10
4726431|NCT01989455|16298024|P5|Overall Study|Technical problems with infusion|1
4726432|NCT01989455|16298025|P4|Overall Study|Technical problems with infusion|0
4726433|NCT01989455|16298026|P3|Overall Study|Technical problems with infusion|1
4726434|NCT01989455|16298027|P2|Overall Study|Technical problems with infusion|0
4726435|NCT01989455|16298028|P1|Overall Study|Technical problems with infusion|0
4726436|NCT01989455|16298024|P5|Overall Study|Withdrawal by Subject|0
4726437|NCT01989455|16298025|P4|Overall Study|Withdrawal by Subject|0
4726438|NCT01989455|16298026|P3|Overall Study|Withdrawal by Subject|0
4726439|NCT01989455|16298027|P2|Overall Study|Withdrawal by Subject|1
4726440|NCT01989455|16298028|P1|Overall Study|Withdrawal by Subject|0
4726441|NCT01989455|16298024|P5|Overall Study|Adverse Event|0
4726442|NCT01989455|16298025|P4|Overall Study|Adverse Event|0
4726443|NCT01989455|16298026|P3|Overall Study|Adverse Event|0
4726444|NCT01989455|16298027|P2|Overall Study|Adverse Event|1
4726445|NCT01989455|16298028|P1|Overall Study|Adverse Event|0
4726446|NCT01989208|16298064|P2|200 mg (7 Days)|Protocol Violation|1
4726447|NCT01989208|16298065|P1|200 mg (7 Days)|Protocol Violation|0
4726448|NCT01989169|16298093|P2|Period 2|Adverse Event|1
4726449|NCT01989169|16298094|P1|Period 2|Adverse Event|0
4726450|NCT01989156|16298107|P3|End of Study (Population at Day 90)|Employment Conflict|0
4726451|NCT01989156|16298108|P2|End of Study (Population at Day 90)|Employment Conflict|1
4726452|NCT01989156|16298109|P1|End of Study (Population at Day 90)|Employment Conflict|0
4726453|NCT01989156|16298107|P3|End of Study (Population at Day 90)|Moved out of state|0
4726454|NCT01989156|16298108|P2|End of Study (Population at Day 90)|Moved out of state|0
4726455|NCT01989156|16298109|P1|End of Study (Population at Day 90)|Moved out of state|1
4726456|NCT01989156|16298107|P3|End of Study (Population at Day 90)|Physician Decision|1
4726457|NCT01989156|16298108|P2|End of Study (Population at Day 90)|Physician Decision|0
4726458|NCT01989156|16298109|P1|End of Study (Population at Day 90)|Physician Decision|1
4726459|NCT01989156|16298107|P3|End of Study (Population at Day 90)|Lost to Follow-up|0
4726460|NCT01989156|16298108|P2|End of Study (Population at Day 90)|Lost to Follow-up|2
4726461|NCT01989156|16298109|P1|End of Study (Population at Day 90)|Lost to Follow-up|3
4726462|NCT01989156|16298107|P3|End of Study (Population at Day 90)|Withdrawal by Subject|2
4726463|NCT01989156|16298108|P2|End of Study (Population at Day 90)|Withdrawal by Subject|2
4726464|NCT01989156|16298109|P1|End of Study (Population at Day 90)|Withdrawal by Subject|2
4726465|NCT01989156|16298107|P3|Confinement Period (Population at Day 5)|Adverse Event|1
4726466|NCT01989156|16298108|P2|Confinement Period (Population at Day 5)|Adverse Event|0
4726467|NCT01989156|16298109|P1|Confinement Period (Population at Day 5)|Adverse Event|0
4726468|NCT01989156|16298107|P3|Confinement Period (Population at Day 5)|Patient Anxiety|1
4726469|NCT01989156|16298108|P2|Confinement Period (Population at Day 5)|Patient Anxiety|0
4726470|NCT01989156|16298109|P1|Confinement Period (Population at Day 5)|Patient Anxiety|0
4726471|NCT01989156|16298107|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|3
4726472|NCT01989156|16298108|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4726473|NCT01989156|16298109|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|0
4726474|NCT01988779|16298169|P2|Overall Study|Protocol Violation|0
4726475|NCT01988779|16298170|P1|Overall Study|Protocol Violation|1
4726476|NCT01988779|16298169|P2|Overall Study|Withdrawal by Subject|2
4726477|NCT01988779|16298170|P1|Overall Study|Withdrawal by Subject|2
4726478|NCT01988662|16298186|P2|Overall Study|Adverse Event|1
4726479|NCT01988662|16298187|P1|Overall Study|Adverse Event|3
4726480|NCT01988662|16298186|P2|Overall Study|Subject/guardian decision|1
4726481|NCT01988662|16298187|P1|Overall Study|Subject/guardian decision|1
4726482|NCT01988493|16298209|P5|Overall Study|Ongoing|0
4726483|NCT01988493|16298210|P4|Overall Study|Ongoing|2
4726484|NCT01988493|16298211|P3|Overall Study|Ongoing|0
4726485|NCT01988493|16298212|P2|Overall Study|Ongoing|0
4726486|NCT01988493|16298213|P1|Overall Study|Ongoing|0
4726487|NCT01988493|16298209|P5|Overall Study|Randomized but not treated|1
4726488|NCT01988493|16298210|P4|Overall Study|Randomized but not treated|0
4726489|NCT01988493|16298211|P3|Overall Study|Randomized but not treated|0
4726490|NCT01988493|16298212|P2|Overall Study|Randomized but not treated|0
4726491|NCT01988493|16298213|P1|Overall Study|Randomized but not treated|0
4726492|NCT01988402|16298292|P2|Overall Study|Withdrawal by Subject|0
4726493|NCT01988402|16298293|P1|Overall Study|Withdrawal by Subject|1
4726494|NCT01988402|16298292|P2|Overall Study|Adverse Event|2
4726495|NCT01988402|16298293|P1|Overall Study|Adverse Event|1
4726496|NCT01988103|16298360|P5|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
4726497|NCT01988103|16298361|P4|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
4726498|NCT01988103|16298362|P3|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2
4726499|NCT01988103|16298363|P2|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1
4726500|NCT01988103|16298364|P1|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0
4726501|NCT01988103|16298360|P5|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1
4726502|NCT01988103|16298361|P4|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
4726503|NCT01988103|16298362|P3|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4
4726504|NCT01988103|16298363|P2|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5
4726505|NCT01988103|16298364|P1|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0
4726506|NCT01988103|16298360|P5|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
4726507|NCT01988103|16298361|P4|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
4726508|NCT01988103|16298362|P3|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2
4726509|NCT01988103|16298363|P2|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1
4726510|NCT01988103|16298364|P1|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0
4726511|NCT01988103|16298360|P5|Active Treatment Phase (Weeks 16-68)|Adverse Event|2
4726512|NCT01988103|16298361|P4|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
4726513|NCT01988103|16298362|P3|Active Treatment Phase (Weeks 16-68)|Adverse Event|3
4726514|NCT01988103|16298363|P2|Active Treatment Phase (Weeks 16-68)|Adverse Event|6
4726515|NCT01988103|16298364|P1|Active Treatment Phase (Weeks 16-68)|Adverse Event|0
4726516|NCT01988103|16298360|P5|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
4726517|NCT01988103|16298361|P4|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0
4726518|NCT01988103|16298362|P3|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1
4726519|NCT01988103|16298363|P2|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4
4726520|NCT01988103|16298364|P1|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8
4726521|NCT01988103|16298360|P5|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
4726522|NCT01988103|16298361|P4|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0
4726523|NCT01988103|16298362|P3|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
4726524|NCT01988103|16298363|P2|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2
4726525|NCT01988103|16298364|P1|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1
4726526|NCT01988103|16298360|P5|Placebo-Controlled Phase Week 0-16|Adverse Event|0
4726527|NCT01988103|16298361|P4|Placebo-Controlled Phase Week 0-16|Adverse Event|0
4726528|NCT01988103|16298362|P3|Placebo-Controlled Phase Week 0-16|Adverse Event|6
4726529|NCT01988103|16298363|P2|Placebo-Controlled Phase Week 0-16|Adverse Event|10
4726530|NCT01988103|16298364|P1|Placebo-Controlled Phase Week 0-16|Adverse Event|3
4726531|NCT01988090|16298411|P2|Complete Study After Start|Protocol Violation|1
4726532|NCT01988090|16298412|P1|Complete Study After Start|Protocol Violation|1
4726533|NCT01988090|16298411|P2|Complete Study After Start|Withdrawal by Subject|0
4726534|NCT01988090|16298412|P1|Complete Study After Start|Withdrawal by Subject|2
4726535|NCT01988090|16298411|P2|Start Treament After Randomization|Protocol Violation|1
4726536|NCT01988090|16298412|P1|Start Treament After Randomization|Protocol Violation|0
4726537|NCT01988090|16298411|P2|Start Treament After Randomization|Withdrawal by Subject|3
4726538|NCT01988090|16298412|P1|Start Treament After Randomization|Withdrawal by Subject|2
4726539|NCT01988012|16298422|P1|Overall Study|Protocol Violation|1
4726540|NCT01988012|16298422|P1|Overall Study|Physician Decision|1
4726541|NCT01988012|16298422|P1|Overall Study|Lost to Follow-up|1
4726542|NCT01988012|16298422|P1|Overall Study|Patient Withdrawal of Consent|4
4726543|NCT01988012|16298422|P1|Overall Study|Insufficient Therapeutic Response|3
4726544|NCT01988012|16298422|P1|Overall Study|Adverse Event|5
4726545|NCT01987986|16298448|P4|Overall Study|Adverse Event|0
4726546|NCT01987986|16298449|P3|Overall Study|Adverse Event|2
4726547|NCT01987986|16298450|P2|Overall Study|Adverse Event|0
4726548|NCT01987986|16298451|P1|Overall Study|Adverse Event|1
4726549|NCT01987986|16298448|P4|Overall Study|Lost to Follow-up|0
4726550|NCT01987986|16298449|P3|Overall Study|Lost to Follow-up|0
4726551|NCT01987986|16298450|P2|Overall Study|Lost to Follow-up|0
4726552|NCT01987986|16298451|P1|Overall Study|Lost to Follow-up|1
4726553|NCT01987960|16298491|P4|Period 3|Administrative or other reason|43
4726554|NCT01987960|16298492|P3|Period 3|Administrative or other reason|0
4726555|NCT01987960|16298493|P2|Period 3|Administrative or other reason|0
4726556|NCT01987960|16298494|P1|Period 3|Administrative or other reason|0
4726557|NCT01987960|16298491|P4|Period 3|Lost to Follow-up|5
4726558|NCT01987960|16298492|P3|Period 3|Lost to Follow-up|0
4726559|NCT01987960|16298493|P2|Period 3|Lost to Follow-up|0
4726560|NCT01987960|16298494|P1|Period 3|Lost to Follow-up|0
4726561|NCT01987960|16298491|P4|Period 3|Withdrawal by Subject|9
4726562|NCT01987960|16298492|P3|Period 3|Withdrawal by Subject|0
4726563|NCT01987960|16298493|P2|Period 3|Withdrawal by Subject|0
4726564|NCT01987960|16298494|P1|Period 3|Withdrawal by Subject|0
4726565|NCT01987960|16298491|P4|Period 3|Protocol Violation|6
4726566|NCT01987960|16298492|P3|Period 3|Protocol Violation|0
4726567|NCT01987960|16298493|P2|Period 3|Protocol Violation|0
4726568|NCT01987960|16298494|P1|Period 3|Protocol Violation|0
4726569|NCT01987960|16298491|P4|Period 3|Non-compliance with IMP|1
4726570|NCT01987960|16298492|P3|Period 3|Non-compliance with IMP|0
4726571|NCT01987960|16298493|P2|Period 3|Non-compliance with IMP|0
4726572|NCT01987960|16298494|P1|Period 3|Non-compliance with IMP|0
4726573|NCT01987960|16298491|P4|Period 3|Adverse Event|7
4726574|NCT01987960|16298492|P3|Period 3|Adverse Event|0
4726575|NCT01987960|16298493|P2|Period 3|Adverse Event|0
4726576|NCT01987960|16298494|P1|Period 3|Adverse Event|0
4726577|NCT01987960|16298491|P4|Period 2|Administrative or other reason|0
4726578|NCT01987960|16298492|P3|Period 2|Administrative or other reason|7
4726579|NCT01987960|16298493|P2|Period 2|Administrative or other reason|5
4726580|NCT01987960|16298494|P1|Period 2|Administrative or other reason|0
4726581|NCT01987960|16298491|P4|Period 2|Withdrawal by Subject|0
4726582|NCT01987960|16298492|P3|Period 2|Withdrawal by Subject|1
4726583|NCT01987960|16298493|P2|Period 2|Withdrawal by Subject|0
4726584|NCT01987960|16298494|P1|Period 2|Withdrawal by Subject|0
4726585|NCT01987960|16298491|P4|Period 2|Adverse Event|0
4726586|NCT01987960|16298492|P3|Period 2|Adverse Event|1
4726587|NCT01987960|16298493|P2|Period 2|Adverse Event|0
4726588|NCT01987960|16298494|P1|Period 2|Adverse Event|0
4726589|NCT01987960|16298491|P4|Period 1|Withdrawal of consent before treatment|0
4726590|NCT01987960|16298492|P3|Period 1|Withdrawal of consent before treatment|0
4726591|NCT01987960|16298493|P2|Period 1|Withdrawal of consent before treatment|0
4726592|NCT01987960|16298494|P1|Period 1|Withdrawal of consent before treatment|4
4726593|NCT01987960|16298491|P4|Period 1|administrative or other reason|0
4726594|NCT01987960|16298492|P3|Period 1|administrative or other reason|0
4726595|NCT01987960|16298493|P2|Period 1|administrative or other reason|0
4726596|NCT01987960|16298494|P1|Period 1|administrative or other reason|75
4726597|NCT01987960|16298491|P4|Period 1|Lost to Follow-up|0
4726598|NCT01987960|16298492|P3|Period 1|Lost to Follow-up|0
4726599|NCT01987960|16298493|P2|Period 1|Lost to Follow-up|0
4726600|NCT01987960|16298494|P1|Period 1|Lost to Follow-up|40
4726601|NCT01987960|16298491|P4|Period 1|Withdrawal by Subject|0
4726602|NCT01987960|16298492|P3|Period 1|Withdrawal by Subject|0
4726603|NCT01987960|16298493|P2|Period 1|Withdrawal by Subject|0
4726604|NCT01987960|16298494|P1|Period 1|Withdrawal by Subject|21
4726605|NCT01987960|16298491|P4|Period 1|Protocol Violation|0
4726606|NCT01987960|16298492|P3|Period 1|Protocol Violation|0
4726607|NCT01987960|16298493|P2|Period 1|Protocol Violation|0
4726608|NCT01987960|16298494|P1|Period 1|Protocol Violation|12
4726609|NCT01987960|16298491|P4|Period 1|Non-compliance with IMP|0
4726610|NCT01987960|16298492|P3|Period 1|Non-compliance with IMP|0
4726611|NCT01987960|16298493|P2|Period 1|Non-compliance with IMP|0
4726612|NCT01987960|16298494|P1|Period 1|Non-compliance with IMP|6
4726613|NCT01987960|16298491|P4|Period 1|Lack of Efficacy|0
4726614|NCT01987960|16298492|P3|Period 1|Lack of Efficacy|0
4726615|NCT01987960|16298493|P2|Period 1|Lack of Efficacy|0
4726616|NCT01987960|16298494|P1|Period 1|Lack of Efficacy|4
4726617|NCT01987960|16298491|P4|Period 1|Adverse Event|0
4726618|NCT01987960|16298492|P3|Period 1|Adverse Event|0
4726619|NCT01987960|16298493|P2|Period 1|Adverse Event|0
4726620|NCT01987960|16298494|P1|Period 1|Adverse Event|24
4726621|NCT01987908|16298506|P3|Post-Treatment Observation Period|Other: Bad Veins|0
4726622|NCT01987908|16298507|P2|Post-Treatment Observation Period|Other: Bad Veins|1
4726623|NCT01987908|16298508|P1|Post-Treatment Observation Period|Other: Bad Veins|0
4726624|NCT01987908|16298506|P3|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
4726625|NCT01987908|16298507|P2|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2
4726626|NCT01987908|16298508|P1|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0
4726627|NCT01987908|16298506|P3|Treatment Period|Adverse Event|1
4726628|NCT01987908|16298507|P2|Treatment Period|Adverse Event|1
4726629|NCT01987908|16298508|P1|Treatment Period|Adverse Event|0
4726630|NCT01987908|16298506|P3|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
4726631|NCT01987908|16298507|P2|Placebo Lead-in Period|Other: Study Termination by Sponsor|0
4726632|NCT01987908|16298508|P1|Placebo Lead-in Period|Other: Study Termination by Sponsor|4
4726633|NCT01987908|16298506|P3|Placebo Lead-in Period|Withdrawal by Subject|0
4726634|NCT01987908|16298507|P2|Placebo Lead-in Period|Withdrawal by Subject|0
4726635|NCT01987908|16298508|P1|Placebo Lead-in Period|Withdrawal by Subject|1
4726636|NCT01987908|16298506|P3|Placebo Lead-in Period|Physician Decision|0
4726637|NCT01987908|16298507|P2|Placebo Lead-in Period|Physician Decision|0
4726638|NCT01987908|16298508|P1|Placebo Lead-in Period|Physician Decision|2
4726639|NCT01987908|16298506|P3|Placebo Lead-in Period|Adverse Event|0
4726640|NCT01987908|16298507|P2|Placebo Lead-in Period|Adverse Event|0
4726641|NCT01987908|16298508|P1|Placebo Lead-in Period|Adverse Event|2
4726642|NCT01987895|16298591|P2|Overall Study|randomized before giving IC|1
4726643|NCT01987895|16298592|P1|Overall Study|randomized before giving IC|0
4726644|NCT01987895|16298591|P2|Overall Study|Lost to Follow-up|5
4726645|NCT01987895|16298592|P1|Overall Study|Lost to Follow-up|3
4726646|NCT01987895|16298591|P2|Overall Study|Death|7
4726647|NCT01987895|16298592|P1|Overall Study|Death|7
4726648|NCT01987895|16298591|P2|Overall Study|Physician Decision|10
4726649|NCT01987895|16298592|P1|Overall Study|Physician Decision|8
4726650|NCT01987895|16298591|P2|Overall Study|Withdrawal by Subject|7
4726651|NCT01987895|16298592|P1|Overall Study|Withdrawal by Subject|12
4726652|NCT01987830|16298616|P1|Overall Study|Never received baseline scan|1
4726653|NCT01987765|16298620|P1|Overall Study|Lost to Follow-up|37
4726654|NCT01987765|16298620|P1|Overall Study|Protocol Violation|65
4726655|NCT01987609|16298630|P1|Overall Study|Adverse Event|1
4726656|NCT01987557|16298675|P3|Overall Study|Adverse Event|0
4726657|NCT01987557|16298676|P2|Overall Study|Adverse Event|2
4726658|NCT01987557|16298677|P1|Overall Study|Adverse Event|0
4726659|NCT01987557|16298675|P3|Overall Study|Withdrawal by Subject|2
4726660|NCT01987557|16298676|P2|Overall Study|Withdrawal by Subject|1
4726661|NCT01987557|16298677|P1|Overall Study|Withdrawal by Subject|2
4726662|NCT01987557|16298675|P3|Overall Study|Protocol Violation|1
4726663|NCT01987557|16298676|P2|Overall Study|Protocol Violation|0
4726664|NCT01987557|16298677|P1|Overall Study|Protocol Violation|1
4726665|NCT01987505|16298687|P1|Overall Study|Death|4
4726666|NCT01987505|16298687|P1|Overall Study|Investigator Decision|2
4726667|NCT01987505|16298687|P1|Overall Study|Lost to Follow-up|15
4726668|NCT01987505|16298687|P1|Overall Study|Other Reason|2
4726669|NCT01987505|16298687|P1|Overall Study|Withdrawal by Subject|2
4726670|NCT01987505|16298687|P1|Overall Study|Other|9
4726671|NCT01987479|16298717|P1|Overall Study|Adverse Event|7
4726672|NCT01987479|16298717|P1|Overall Study|Lost to Follow-up|1
4726673|NCT01987479|16298717|P1|Overall Study|Other|5
4726674|NCT01987479|16298717|P1|Overall Study|Participant/legal guardian decision|1
4726675|NCT01987479|16298717|P1|Overall Study|Physician Decision|2
4726676|NCT01987479|16298717|P1|Overall Study|Protocol Violation|1
4726677|NCT01987453|16298745|P3|Overall Study|Lack of Efficacy|0
4726678|NCT01987453|16298746|P2|Overall Study|Lack of Efficacy|12
4726679|NCT01987453|16298747|P1|Overall Study|Lack of Efficacy|1
4726680|NCT01987453|16298745|P3|Overall Study|Death|1
4726681|NCT01987453|16298746|P2|Overall Study|Death|0
4726682|NCT01987453|16298747|P1|Overall Study|Death|0
4726683|NCT01987427|16298773|P3|Overall Study|Other|0
4726684|NCT01987427|16298774|P2|Overall Study|Other|1
4726685|NCT01987427|16298775|P1|Overall Study|Other|1
4726686|NCT01987427|16298773|P3|Overall Study|Lack of Efficacy|0
4726687|NCT01987427|16298774|P2|Overall Study|Lack of Efficacy|0
4726688|NCT01987427|16298775|P1|Overall Study|Lack of Efficacy|1
4726689|NCT01987427|16298773|P3|Overall Study|Withdrawal by Subject|3
4726690|NCT01987427|16298774|P2|Overall Study|Withdrawal by Subject|1
4726691|NCT01987427|16298775|P1|Overall Study|Withdrawal by Subject|2
4726692|NCT01987427|16298773|P3|Overall Study|Lost to Follow-up|9
4726693|NCT01987427|16298774|P2|Overall Study|Lost to Follow-up|6
4726694|NCT01987427|16298775|P1|Overall Study|Lost to Follow-up|6
4726695|NCT01987427|16298773|P3|Overall Study|Adverse Event|8
4726696|NCT01987427|16298774|P2|Overall Study|Adverse Event|2
4726697|NCT01987427|16298775|P1|Overall Study|Adverse Event|4
4726698|NCT01987232|16298912|P5|Overall Study|Ongoing in Study|0
4726699|NCT01987232|16298913|P4|Overall Study|Ongoing in Study|1
4726700|NCT01987232|16298914|P3|Overall Study|Ongoing in Study|0
4726701|NCT01987232|16298915|P2|Overall Study|Ongoing in Study|0
4726702|NCT01987232|16298916|P1|Overall Study|Ongoing in Study|0
4726703|NCT01987102|16299005|P2|2 Courses of HDMTX With MOD Rescue|Adverse Event|1
4726704|NCT01987102|16299006|P1|2 Courses of HDMTX With MOD Rescue|Adverse Event|0
4726705|NCT01987102|16299005|P2|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1
4726706|NCT01987102|16299006|P1|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0
4726707|NCT01987102|16299005|P2|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1
4726708|NCT01987102|16299006|P1|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0
4726709|NCT01987102|16299005|P2|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0
4726710|NCT01987102|16299006|P1|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1
4726711|NCT01987102|16299005|P2|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2
4726712|NCT01987102|16299006|P1|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1
4726713|NCT01987102|16299005|P2|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
4726714|NCT01987102|16299006|P1|2 Courses of HDMTX With SOC Rescue|Adverse Event|2
4726715|NCT01986985|16299053|P1|Overall Study|Scan not completed due to malfunction|3
4726716|NCT01986985|16299053|P1|Overall Study|Withdrawal by Subject|4
4726717|NCT01986920|16299090|P4|Placebo|Withdrawal by Subject|1
4726718|NCT01986920|16299091|P3|Placebo|Withdrawal by Subject|0
4726719|NCT01986920|16299092|P2|Placebo|Withdrawal by Subject|0
4726720|NCT01986920|16299093|P1|Placebo|Withdrawal by Subject|0
4726721|NCT01986920|16299090|P4|A-101 40%|Withdrawal by Subject|0
4726722|NCT01986920|16299091|P3|A-101 40%|Withdrawal by Subject|1
4726723|NCT01986920|16299092|P2|A-101 40%|Withdrawal by Subject|0
4726724|NCT01986920|16299093|P1|A-101 40%|Withdrawal by Subject|0
4726725|NCT01986920|16299090|P4|A-101 32.5%|Withdrawal by Subject|0
4726726|NCT01986920|16299091|P3|A-101 32.5%|Withdrawal by Subject|0
4726727|NCT01986920|16299092|P2|A-101 32.5%|Withdrawal by Subject|1
4726728|NCT01986920|16299093|P1|A-101 32.5%|Withdrawal by Subject|0
4726729|NCT01986920|16299090|P4|A- 101 25%|Withdrawal by Subject|0
4726730|NCT01986920|16299091|P3|A- 101 25%|Withdrawal by Subject|0
4726731|NCT01986920|16299092|P2|A- 101 25%|Withdrawal by Subject|0
4726732|NCT01986920|16299093|P1|A- 101 25%|Withdrawal by Subject|1
4726733|NCT01986907|16299107|P1|Overall Study|Death|9
4726734|NCT01986907|16299107|P1|Overall Study|Lost to Follow-up|38
4726735|NCT01986907|16299107|P1|Overall Study|Withdrawal by Subject|76
4726736|NCT01986907|16299107|P1|Overall Study|Protocol Violation|4
4726737|NCT01986907|16299107|P1|Overall Study|Unsatisfactory therapeutic effect|24
4726738|NCT01986907|16299107|P1|Overall Study|Adverse Event|11
4726739|NCT01986855|16299120|P3|Overall Study|Withdrawal by Subject|5
4726740|NCT01986855|16299121|P2|Overall Study|Withdrawal by Subject|8
4726741|NCT01986855|16299122|P1|Overall Study|Withdrawal by Subject|7
4726742|NCT01986855|16299120|P3|Overall Study|Participant Moved|2
4726743|NCT01986855|16299121|P2|Overall Study|Participant Moved|0
4726744|NCT01986855|16299122|P1|Overall Study|Participant Moved|0
4726745|NCT01986855|16299120|P3|Overall Study|Screen Failure|0
4726746|NCT01986855|16299121|P2|Overall Study|Screen Failure|1
4726747|NCT01986855|16299122|P1|Overall Study|Screen Failure|0
4726748|NCT01986855|16299120|P3|Overall Study|Lost to Follow-up|0
4726749|NCT01986855|16299121|P2|Overall Study|Lost to Follow-up|1
4726750|NCT01986855|16299122|P1|Overall Study|Lost to Follow-up|2
4726751|NCT01986855|16299120|P3|Overall Study|Death|4
4726752|NCT01986855|16299121|P2|Overall Study|Death|4
4726753|NCT01986855|16299122|P1|Overall Study|Death|3
4726754|NCT01986855|16299120|P3|Overall Study|Adverse Event|0
4726755|NCT01986855|16299121|P2|Overall Study|Adverse Event|0
4726756|NCT01986855|16299122|P1|Overall Study|Adverse Event|1
4726757|NCT01986829|16299151|P1|Overall Study|Death|1
4726758|NCT01986751|16299199|P2|Overall Study|improperly consented|2
4726759|NCT01986751|16299200|P1|Overall Study|improperly consented|10
4726760|NCT01986647|16299233|P4|Overall Study|Health|4
4726761|NCT01986647|16299234|P3|Overall Study|Health|6
4726762|NCT01986647|16299235|P2|Overall Study|Health|3
4726763|NCT01986647|16299236|P1|Overall Study|Health|5
4726764|NCT01986647|16299233|P4|Overall Study|Withdrawal by Subject|3
4726765|NCT01986647|16299234|P3|Overall Study|Withdrawal by Subject|2
4726766|NCT01986647|16299235|P2|Overall Study|Withdrawal by Subject|3
4726767|NCT01986647|16299236|P1|Overall Study|Withdrawal by Subject|1
4726768|NCT01986647|16299233|P4|Overall Study|Lost to Follow-up|4
4726769|NCT01986647|16299234|P3|Overall Study|Lost to Follow-up|4
4726770|NCT01986647|16299235|P2|Overall Study|Lost to Follow-up|1
4726771|NCT01986647|16299236|P1|Overall Study|Lost to Follow-up|4
4726772|NCT01986231|16299331|P1|Overall Study|Adverse Event|1
4726773|NCT01986140|16299338|P2|Overall Study|progression disease|1
4726774|NCT01986140|16299339|P1|Overall Study|progression disease|0
4726775|NCT01986140|16299338|P2|Overall Study|Adverse Event|1
4726776|NCT01986140|16299339|P1|Overall Study|Adverse Event|0
4726777|NCT01986140|16299338|P2|Overall Study|found not eligible|0
4726778|NCT01986140|16299339|P1|Overall Study|found not eligible|3
4726779|NCT01986140|16299338|P2|Overall Study|alternative treatment|1
4726780|NCT01986140|16299339|P1|Overall Study|alternative treatment|1
4726781|NCT01986140|16299338|P2|Overall Study|Withdrawal by Subject|25
4726782|NCT01986140|16299339|P1|Overall Study|Withdrawal by Subject|31
4726783|NCT01986114|16299345|P1|Overall Study|Other reason|7
4726784|NCT01986114|16299345|P1|Overall Study|Lost to Follow-up|5
4726785|NCT01986114|16299345|P1|Overall Study|Protocol Violation|1
4726786|NCT01986114|16299345|P1|Overall Study|Noncompliance|3
4726787|NCT01986114|16299345|P1|Overall Study|Withdrawal by Subject|58
4726788|NCT01986114|16299345|P1|Overall Study|Lack of Efficacy|23
4726789|NCT01986114|16299345|P1|Overall Study|Adverse Event|59
4726790|NCT01986062|16299384|P2|Overall Study|Withdrawal by Subject|1
4726791|NCT01986062|16299385|P1|Overall Study|Withdrawal by Subject|0
4726792|NCT01986062|16299384|P2|Overall Study|Lost to Follow-up|0
4726793|NCT01986062|16299385|P1|Overall Study|Lost to Follow-up|1
4726794|NCT01985360|16299483|P2|Overall Study|Lost to Follow-up|3
4726795|NCT01985360|16299484|P1|Overall Study|Lost to Follow-up|5
4726796|NCT01985360|16299483|P2|Overall Study|Withdrawal by Subject|0
4726797|NCT01985360|16299484|P1|Overall Study|Withdrawal by Subject|4
4726798|NCT01985334|16299500|P8|Overall Study|Lost to Follow-up|3
4726799|NCT01985334|16299501|P7|Overall Study|Lost to Follow-up|0
4726800|NCT01985334|16299502|P6|Overall Study|Lost to Follow-up|4
4726801|NCT01985334|16299503|P5|Overall Study|Lost to Follow-up|1
4726802|NCT01985334|16299504|P4|Overall Study|Lost to Follow-up|3
4726803|NCT01985334|16299505|P3|Overall Study|Lost to Follow-up|0
4726804|NCT01985334|16299506|P2|Overall Study|Lost to Follow-up|2
4726805|NCT01985334|16299507|P1|Overall Study|Lost to Follow-up|0
4726806|NCT01985334|16299500|P8|Overall Study|Investigator decision|4
4726807|NCT01985334|16299501|P7|Overall Study|Investigator decision|0
4726808|NCT01985334|16299502|P6|Overall Study|Investigator decision|1
4726809|NCT01985334|16299503|P5|Overall Study|Investigator decision|1
4726810|NCT01985334|16299504|P4|Overall Study|Investigator decision|7
4726811|NCT01985334|16299505|P3|Overall Study|Investigator decision|0
4726812|NCT01985334|16299506|P2|Overall Study|Investigator decision|3
4726813|NCT01985334|16299507|P1|Overall Study|Investigator decision|0
4726814|NCT01985334|16299500|P8|Overall Study|Use of prohibited treatment|0
4726815|NCT01985334|16299501|P7|Overall Study|Use of prohibited treatment|2
4726816|NCT01985334|16299502|P6|Overall Study|Use of prohibited treatment|6
4726817|NCT01985334|16299503|P5|Overall Study|Use of prohibited treatment|1
4726818|NCT01985334|16299504|P4|Overall Study|Use of prohibited treatment|2
4726819|NCT01985334|16299505|P3|Overall Study|Use of prohibited treatment|1
4726820|NCT01985334|16299506|P2|Overall Study|Use of prohibited treatment|4
4726821|NCT01985334|16299507|P1|Overall Study|Use of prohibited treatment|1
4726822|NCT01985334|16299500|P8|Overall Study|Medication non-compliance|3
4726823|NCT01985334|16299501|P7|Overall Study|Medication non-compliance|1
4726824|NCT01985334|16299502|P6|Overall Study|Medication non-compliance|3
4726825|NCT01985334|16299503|P5|Overall Study|Medication non-compliance|2
4726826|NCT01985334|16299504|P4|Overall Study|Medication non-compliance|6
4726827|NCT01985334|16299505|P3|Overall Study|Medication non-compliance|1
4726828|NCT01985334|16299506|P2|Overall Study|Medication non-compliance|4
4726829|NCT01985334|16299507|P1|Overall Study|Medication non-compliance|0
4726830|NCT01985334|16299500|P8|Overall Study|Other|2
4726831|NCT01985334|16299501|P7|Overall Study|Other|2
4726832|NCT01985334|16299502|P6|Overall Study|Other|6
4726833|NCT01985334|16299503|P5|Overall Study|Other|1
4726834|NCT01985334|16299504|P4|Overall Study|Other|10
4726835|NCT01985334|16299505|P3|Overall Study|Other|3
4726836|NCT01985334|16299506|P2|Overall Study|Other|2
4726837|NCT01985334|16299507|P1|Overall Study|Other|4
4726838|NCT01985334|16299500|P8|Overall Study|Adverse Event|15
4726839|NCT01985334|16299501|P7|Overall Study|Adverse Event|3
4726840|NCT01985334|16299502|P6|Overall Study|Adverse Event|18
4726841|NCT01985334|16299503|P5|Overall Study|Adverse Event|3
4726842|NCT01985334|16299504|P4|Overall Study|Adverse Event|26
4726843|NCT01985334|16299505|P3|Overall Study|Adverse Event|2
4726844|NCT01985334|16299506|P2|Overall Study|Adverse Event|8
4726845|NCT01985334|16299507|P1|Overall Study|Adverse Event|0
4726846|NCT01985334|16299500|P8|Overall Study|Subject withdrawal of consent|20
4726847|NCT01985334|16299501|P7|Overall Study|Subject withdrawal of consent|0
4726848|NCT01985334|16299502|P6|Overall Study|Subject withdrawal of consent|19
4726849|NCT01985334|16299503|P5|Overall Study|Subject withdrawal of consent|4
4726850|NCT01985334|16299504|P4|Overall Study|Subject withdrawal of consent|28
4726851|NCT01985334|16299505|P3|Overall Study|Subject withdrawal of consent|2
4726852|NCT01985334|16299506|P2|Overall Study|Subject withdrawal of consent|6
4726853|NCT01985334|16299507|P1|Overall Study|Subject withdrawal of consent|3
4726854|NCT01985334|16299500|P8|Overall Study|Moderate / severe COPD exacerbation|19
4726855|NCT01985334|16299501|P7|Overall Study|Moderate / severe COPD exacerbation|8
4726856|NCT01985334|16299502|P6|Overall Study|Moderate / severe COPD exacerbation|40
4726857|NCT01985334|16299503|P5|Overall Study|Moderate / severe COPD exacerbation|6
4726858|NCT01985334|16299504|P4|Overall Study|Moderate / severe COPD exacerbation|40
4726859|NCT01985334|16299505|P3|Overall Study|Moderate / severe COPD exacerbation|12
4726860|NCT01985334|16299506|P2|Overall Study|Moderate / severe COPD exacerbation|14
4726861|NCT01985334|16299507|P1|Overall Study|Moderate / severe COPD exacerbation|5
4726862|NCT01985334|16299500|P8|Overall Study|Protocol deviation|42
4726863|NCT01985334|16299501|P7|Overall Study|Protocol deviation|15
4726864|NCT01985334|16299502|P6|Overall Study|Protocol deviation|47
4726865|NCT01985334|16299503|P5|Overall Study|Protocol deviation|17
4726866|NCT01985334|16299504|P4|Overall Study|Protocol deviation|84
4726867|NCT01985334|16299505|P3|Overall Study|Protocol deviation|25
4726868|NCT01985334|16299506|P2|Overall Study|Protocol deviation|31
4726869|NCT01985334|16299507|P1|Overall Study|Protocol deviation|6
4726870|NCT01985334|16299500|P8|Overall Study|Other|7
4726871|NCT01985334|16299501|P7|Overall Study|Other|4
4726872|NCT01985334|16299502|P6|Overall Study|Other|8
4726873|NCT01985334|16299503|P5|Overall Study|Other|4
4726874|NCT01985334|16299504|P4|Overall Study|Other|17
4726875|NCT01985334|16299505|P3|Overall Study|Other|7
4726876|NCT01985334|16299506|P2|Overall Study|Other|9
4726877|NCT01985334|16299507|P1|Overall Study|Other|2
4726878|NCT01985334|16299500|P8|Overall Study|Worsening of disease|1
4726879|NCT01985334|16299501|P7|Overall Study|Worsening of disease|0
4726880|NCT01985334|16299502|P6|Overall Study|Worsening of disease|3
4726881|NCT01985334|16299503|P5|Overall Study|Worsening of disease|0
4726882|NCT01985334|16299504|P4|Overall Study|Worsening of disease|1
4726883|NCT01985334|16299505|P3|Overall Study|Worsening of disease|0
4726884|NCT01985334|16299506|P2|Overall Study|Worsening of disease|0
4726885|NCT01985334|16299507|P1|Overall Study|Worsening of disease|0
4726886|NCT01985334|16299500|P8|Overall Study|Death|2
4726887|NCT01985334|16299501|P7|Overall Study|Death|1
4726888|NCT01985334|16299502|P6|Overall Study|Death|0
4726889|NCT01985334|16299503|P5|Overall Study|Death|0
4726890|NCT01985334|16299504|P4|Overall Study|Death|3
4726891|NCT01985334|16299505|P3|Overall Study|Death|0
4726892|NCT01985334|16299506|P2|Overall Study|Death|0
4726893|NCT01985334|16299507|P1|Overall Study|Death|1
4726894|NCT01985334|16299500|P8|Overall Study|Administrative problems|3
4726895|NCT01985334|16299501|P7|Overall Study|Administrative problems|1
4726896|NCT01985334|16299502|P6|Overall Study|Administrative problems|1
4726897|NCT01985334|16299503|P5|Overall Study|Administrative problems|0
4726898|NCT01985334|16299504|P4|Overall Study|Administrative problems|2
4726899|NCT01985334|16299505|P3|Overall Study|Administrative problems|0
4726900|NCT01985334|16299506|P2|Overall Study|Administrative problems|1
4726901|NCT01985334|16299507|P1|Overall Study|Administrative problems|1
4726902|NCT01985321|16299575|P2|Overall Study|Subject treated wrong type of sore|0
4726903|NCT01985321|16299576|P1|Overall Study|Subject treated wrong type of sore|1
4726904|NCT01985321|16299575|P2|Overall Study|Lost to Follow-up|2
4726905|NCT01985321|16299576|P1|Overall Study|Lost to Follow-up|5
4726906|NCT01985321|16299575|P2|Overall Study|Withdrawal by Subject|0
4726907|NCT01985321|16299576|P1|Overall Study|Withdrawal by Subject|1
4726908|NCT01985321|16299575|P2|Overall Study|Protocol Violation|3
4726909|NCT01985321|16299576|P1|Overall Study|Protocol Violation|4
4726910|NCT01985126|16299586|P2|Overall Study|Withdrawal by Subject|7
4726911|NCT01985126|16299587|P1|Overall Study|Withdrawal by Subject|2
4726912|NCT01985126|16299586|P2|Overall Study|Study Terminated By Sponsor|22
4726913|NCT01985126|16299587|P1|Overall Study|Study Terminated By Sponsor|1
4726914|NCT01985126|16299586|P2|Overall Study|Lost to Follow-up|8
4726915|NCT01985126|16299587|P1|Overall Study|Lost to Follow-up|0
4726916|NCT01985126|16299586|P2|Overall Study|Death|69
4726917|NCT01985126|16299587|P1|Overall Study|Death|15
4726918|NCT01984892|16299605|P1|Overall Study|Progressive disease|7
4726919|NCT01984697|16299616|P5|Overall Study|Pregnancy|1
4726920|NCT01984697|16299617|P4|Overall Study|Pregnancy|0
4726921|NCT01984697|16299618|P3|Overall Study|Pregnancy|1
4726922|NCT01984697|16299619|P2|Overall Study|Pregnancy|0
4726923|NCT01984697|16299620|P1|Overall Study|Pregnancy|2
4726924|NCT01984697|16299616|P5|Overall Study|Death|0
4726925|NCT01984697|16299617|P4|Overall Study|Death|1
4726926|NCT01984697|16299618|P3|Overall Study|Death|0
4726927|NCT01984697|16299619|P2|Overall Study|Death|0
4726928|NCT01984697|16299620|P1|Overall Study|Death|0
4726929|NCT01984697|16299616|P5|Overall Study|Missed last follow-up visit|0
4726930|NCT01984697|16299617|P4|Overall Study|Missed last follow-up visit|0
4726931|NCT01984697|16299618|P3|Overall Study|Missed last follow-up visit|0
4726932|NCT01984697|16299619|P2|Overall Study|Missed last follow-up visit|0
4726933|NCT01984697|16299620|P1|Overall Study|Missed last follow-up visit|1
4726934|NCT01984697|16299616|P5|Overall Study|Withdrawal by Subject|13
4726935|NCT01984697|16299617|P4|Overall Study|Withdrawal by Subject|11
4726936|NCT01984697|16299618|P3|Overall Study|Withdrawal by Subject|13
4726937|NCT01984697|16299619|P2|Overall Study|Withdrawal by Subject|21
4726938|NCT01984697|16299620|P1|Overall Study|Withdrawal by Subject|15
4726939|NCT01984697|16299616|P5|Overall Study|Protocol Violation|0
4726940|NCT01984697|16299617|P4|Overall Study|Protocol Violation|2
4726941|NCT01984697|16299618|P3|Overall Study|Protocol Violation|3
4726942|NCT01984697|16299619|P2|Overall Study|Protocol Violation|5
4726943|NCT01984697|16299620|P1|Overall Study|Protocol Violation|8
4726944|NCT01984697|16299616|P5|Overall Study|Physician Decision|0
4726945|NCT01984697|16299617|P4|Overall Study|Physician Decision|1
4726946|NCT01984697|16299618|P3|Overall Study|Physician Decision|0
4726947|NCT01984697|16299619|P2|Overall Study|Physician Decision|0
4726948|NCT01984697|16299620|P1|Overall Study|Physician Decision|3
4726949|NCT01984697|16299616|P5|Overall Study|Lost to Follow-up|21
4726950|NCT01984697|16299617|P4|Overall Study|Lost to Follow-up|6
4726951|NCT01984697|16299618|P3|Overall Study|Lost to Follow-up|10
4726952|NCT01984697|16299619|P2|Overall Study|Lost to Follow-up|5
4726953|NCT01984697|16299620|P1|Overall Study|Lost to Follow-up|14
4726954|NCT01984697|16299616|P5|Overall Study|Adverse Event|0
4726955|NCT01984697|16299617|P4|Overall Study|Adverse Event|0
4726956|NCT01984697|16299618|P3|Overall Study|Adverse Event|2
4726957|NCT01984697|16299619|P2|Overall Study|Adverse Event|0
4726958|NCT01984697|16299620|P1|Overall Study|Adverse Event|0
4726959|NCT01984684|16299739|P2|Overall Study|Subject had inadequate IV access|1
4726960|NCT01984684|16299740|P1|Overall Study|Subject had inadequate IV access|0
4726961|NCT01984684|16299739|P2|Overall Study|Study drug not available at site|1
4726962|NCT01984684|16299740|P1|Overall Study|Study drug not available at site|1
4726963|NCT01984684|16299739|P2|Overall Study|Subject incarcerated|0
4726964|NCT01984684|16299740|P1|Overall Study|Subject incarcerated|1
4726965|NCT01984684|16299739|P2|Overall Study|Noncompliance with study drug|1
4726966|NCT01984684|16299740|P1|Overall Study|Noncompliance with study drug|2
4726967|NCT01984684|16299739|P2|Overall Study|Death|1
4726968|NCT01984684|16299740|P1|Overall Study|Death|0
4726969|NCT01984684|16299739|P2|Overall Study|Protocol Violation|2
4726970|NCT01984684|16299740|P1|Overall Study|Protocol Violation|4
4726971|NCT01984684|16299739|P2|Overall Study|Physician Decision|2
4726972|NCT01984684|16299740|P1|Overall Study|Physician Decision|4
4726973|NCT01984684|16299739|P2|Overall Study|Lack of Efficacy|6
4726974|NCT01984684|16299740|P1|Overall Study|Lack of Efficacy|3
4726975|NCT01984684|16299739|P2|Overall Study|Withdrawal by Subject|9
4726976|NCT01984684|16299740|P1|Overall Study|Withdrawal by Subject|9
4726977|NCT01984684|16299739|P2|Overall Study|Adverse Event|12
4726978|NCT01984684|16299740|P1|Overall Study|Adverse Event|8
4726979|NCT01984684|16299739|P2|Overall Study|Lost to Follow-up|24
4726980|NCT01984684|16299740|P1|Overall Study|Lost to Follow-up|25
4726981|NCT01984424|16299758|P2|Overall Study|Lost to Follow-up|1
4726982|NCT01984424|16299759|P1|Overall Study|Lost to Follow-up|0
4726983|NCT01984424|16299758|P2|Overall Study|Sponsor Decision|1
4726984|NCT01984424|16299759|P1|Overall Study|Sponsor Decision|0
4726985|NCT01984424|16299758|P2|Overall Study|Withdrawal by Subject|5
4726986|NCT01984424|16299759|P1|Overall Study|Withdrawal by Subject|3
4726987|NCT01984294|16299829|P3|Overall Study|Adverse Event|0
4726988|NCT01984294|16299830|P2|Overall Study|Adverse Event|1
4726989|NCT01984294|16299831|P1|Overall Study|Adverse Event|0
4726990|NCT01984294|16299829|P3|Overall Study|Lack of Efficacy|6
4726991|NCT01984294|16299830|P2|Overall Study|Lack of Efficacy|2
4726992|NCT01984294|16299831|P1|Overall Study|Lack of Efficacy|4
4726993|NCT01984294|16299829|P3|Overall Study|Randomized but Never Treated|1
4726994|NCT01984294|16299830|P2|Overall Study|Randomized but Never Treated|0
4726995|NCT01984294|16299831|P1|Overall Study|Randomized but Never Treated|0
4726996|NCT01984242|16299854|P3|Overall Study|Disease Progression|1
4726997|NCT01984242|16299855|P2|Overall Study|Disease Progression|0
4726998|NCT01984242|16299856|P1|Overall Study|Disease Progression|0
4726999|NCT01984242|16299854|P3|Overall Study|Study terminated by Sponsor|34
4727000|NCT01984242|16299855|P2|Overall Study|Study terminated by Sponsor|50
4727001|NCT01984242|16299856|P1|Overall Study|Study terminated by Sponsor|38
4727002|NCT01984242|16299854|P3|Overall Study|Non-Compliance|0
4727003|NCT01984242|16299855|P2|Overall Study|Non-Compliance|0
4727004|NCT01984242|16299856|P1|Overall Study|Non-Compliance|1
4727005|NCT01984242|16299854|P3|Overall Study|Sponsor Decision|0
4727006|NCT01984242|16299855|P2|Overall Study|Sponsor Decision|0
4727007|NCT01984242|16299856|P1|Overall Study|Sponsor Decision|1
4727008|NCT01984242|16299854|P3|Overall Study|Lost to Follow-up|3
4727009|NCT01984242|16299855|P2|Overall Study|Lost to Follow-up|0
4727010|NCT01984242|16299856|P1|Overall Study|Lost to Follow-up|4
4727011|NCT01984242|16299854|P3|Overall Study|Physician Decision|1
4727012|NCT01984242|16299855|P2|Overall Study|Physician Decision|0
4727013|NCT01984242|16299856|P1|Overall Study|Physician Decision|0
4727014|NCT01984242|16299854|P3|Overall Study|Withdrawal by Subject|10
4727015|NCT01984242|16299855|P2|Overall Study|Withdrawal by Subject|3
4727016|NCT01984242|16299856|P1|Overall Study|Withdrawal by Subject|5
4727017|NCT01984242|16299854|P3|Overall Study|Death|52
4727018|NCT01984242|16299855|P2|Overall Study|Death|50
4727019|NCT01984242|16299856|P1|Overall Study|Death|52
4727020|NCT01984229|16300006|P2|Safety Follow-up Period|Lost to Follow-up|0
4727021|NCT01984229|16300007|P1|Safety Follow-up Period|Lost to Follow-up|1
4727022|NCT01984229|16300006|P2|Safety Follow-up Period|Adverse Event|1
4727023|NCT01984229|16300007|P1|Safety Follow-up Period|Adverse Event|1
4727024|NCT01983969|16300060|P3|Overall Study|Disease Progression|0
4727025|NCT01983969|16300061|P2|Overall Study|Disease Progression|1
4727026|NCT01983969|16300062|P1|Overall Study|Disease Progression|0
4727027|NCT01983930|16300076|P2|Overall Study|Adverse Event|1
4727028|NCT01983930|16300077|P1|Overall Study|Adverse Event|0
4727029|NCT01983930|16300076|P2|Overall Study|Withdrawal by Subject|8
4727030|NCT01983930|16300077|P1|Overall Study|Withdrawal by Subject|9
4727031|NCT01983683|16300151|P2|Overall Study|Sponsor Decision|1
4727032|NCT01983683|16300152|P1|Overall Study|Sponsor Decision|1
4727033|NCT01983683|16300151|P2|Overall Study|Lost to Follow-up|8
4727034|NCT01983683|16300152|P1|Overall Study|Lost to Follow-up|4
4727035|NCT01983683|16300151|P2|Overall Study|Physician Decision|9
4727036|NCT01983683|16300152|P1|Overall Study|Physician Decision|8
4727037|NCT01983683|16300151|P2|Overall Study|Death|15
4727038|NCT01983683|16300152|P1|Overall Study|Death|11
4727039|NCT01983683|16300151|P2|Overall Study|Withdrawal by Subject|18
4727040|NCT01983683|16300152|P1|Overall Study|Withdrawal by Subject|14
4727041|NCT01983293|16300239|P2|Overall Study|Missing NYHA/Patient Global Assessment|1
4727042|NCT01983293|16300240|P1|Overall Study|Missing NYHA/Patient Global Assessment|1
4727043|NCT01983293|16300239|P2|Overall Study|Missing 12-month visit|3
4727044|NCT01983293|16300240|P1|Overall Study|Missing 12-month visit|3
4727045|NCT01983293|16300239|P2|Overall Study|Withdrawal by Subject|15
4727046|NCT01983293|16300240|P1|Overall Study|Withdrawal by Subject|29
4727047|NCT01983254|16300248|P2|Overall Study|too ill|8
4727048|NCT01983254|16300249|P1|Overall Study|too ill|11
4727049|NCT01983254|16300248|P2|Overall Study|Lost to Follow-up|16
4727050|NCT01983254|16300249|P1|Overall Study|Lost to Follow-up|17
4727051|NCT01983254|16300248|P2|Overall Study|Death|6
4727052|NCT01983254|16300249|P1|Overall Study|Death|6
4727053|NCT01983111|16300261|P2|Overall Study|Protocol Violation|1
4727054|NCT01983111|16300262|P1|Overall Study|Protocol Violation|0
4727055|NCT01983111|16300261|P2|Overall Study|Adverse Event|0
4727056|NCT01983111|16300262|P1|Overall Study|Adverse Event|4
4727057|NCT01983111|16300261|P2|Overall Study|Withdrawal by Subject|6
4727058|NCT01983111|16300262|P1|Overall Study|Withdrawal by Subject|8
4727059|NCT01982955|16300300|P5|Overall Study|Ongoing|0
4727060|NCT01982955|16300301|P4|Overall Study|Ongoing|0
4727061|NCT01982955|16300302|P3|Overall Study|Ongoing|4
4727062|NCT01982955|16300303|P2|Overall Study|Ongoing|0
4727063|NCT01982955|16300304|P1|Overall Study|Ongoing|0
4727064|NCT01982955|16300300|P5|Overall Study|Randomized but not treated|0
4727065|NCT01982955|16300301|P4|Overall Study|Randomized but not treated|1
4727066|NCT01982955|16300302|P3|Overall Study|Randomized but not treated|0
4727067|NCT01982955|16300303|P2|Overall Study|Randomized but not treated|0
4727068|NCT01982955|16300304|P1|Overall Study|Randomized but not treated|0
4727069|NCT01982942|16300406|P2|Overall Study|Subject bedridden, rapidly declining|1
4727070|NCT01982942|16300407|P1|Overall Study|Subject bedridden, rapidly declining|0
4727071|NCT01982942|16300406|P2|Overall Study|Chose to join a stem cell trial|1
4727072|NCT01982942|16300407|P1|Overall Study|Chose to join a stem cell trial|0
4727073|NCT01982942|16300406|P2|Overall Study|MS Relapse|1
4727074|NCT01982942|16300407|P1|Overall Study|MS Relapse|0
4727075|NCT01982942|16300406|P2|Overall Study|Too many pills|0
4727076|NCT01982942|16300407|P1|Overall Study|Too many pills|1
4727077|NCT01982942|16300406|P2|Overall Study|Left geographical area|0
4727078|NCT01982942|16300407|P1|Overall Study|Left geographical area|2
4727079|NCT01982942|16300406|P2|Overall Study|Subject declined future visits|1
4727080|NCT01982942|16300407|P1|Overall Study|Subject declined future visits|0
4727081|NCT01982942|16300406|P2|Overall Study|Wanted to try therapy not permitted|0
4727082|NCT01982942|16300407|P1|Overall Study|Wanted to try therapy not permitted|1
4727083|NCT01982942|16300406|P2|Overall Study|Multiple sclerosis progression|2
4727084|NCT01982942|16300407|P1|Overall Study|Multiple sclerosis progression|3
4727085|NCT01982942|16300406|P2|Overall Study|Lost to Follow-up|3
4727086|NCT01982942|16300407|P1|Overall Study|Lost to Follow-up|4
4727087|NCT01982942|16300406|P2|Overall Study|Adverse Event|5
4727088|NCT01982942|16300407|P1|Overall Study|Adverse Event|10
4727089|NCT01982812|16300425|P2|Overall Study|Adverse Event|5
4727090|NCT01982812|16300426|P1|Overall Study|Adverse Event|0
4727091|NCT01982812|16300425|P2|Overall Study|Death|5
4727092|NCT01982812|16300426|P1|Overall Study|Death|1
4727093|NCT01982773|16300455|P2|Overall Study|Lost to Follow-up|1
4727094|NCT01982773|16300456|P1|Overall Study|Lost to Follow-up|7
4727095|NCT01982773|16300455|P2|Overall Study|Withdrawal by Subject|3
4727096|NCT01982773|16300456|P1|Overall Study|Withdrawal by Subject|1
4727097|NCT01982682|16300477|P1|Overall Study|Physician Decision|1
4727098|NCT01982435|16300497|P2|Overall Study|Adverse Event|0
4727099|NCT01982435|16300498|P1|Overall Study|Adverse Event|1
4727100|NCT01982331|16300537|P2|Completed Study (Day 112)|Withdrawal by Subject|0
4727101|NCT01982331|16300538|P1|Completed Study (Day 112)|Withdrawal by Subject|2
4727102|NCT01982331|16300537|P2|Received Vaccination 2|Withdrawal by Subject|1
4727103|NCT01982331|16300538|P1|Received Vaccination 2|Withdrawal by Subject|0
4727104|NCT01982331|16300537|P2|Received Vaccination 2|Adverse Event|2
4727105|NCT01982331|16300538|P1|Received Vaccination 2|Adverse Event|1
4727106|NCT01982292|16300574|P2|Overall Study|Technical Problems|0
4727107|NCT01982292|16300575|P1|Overall Study|Technical Problems|2
4727108|NCT01982292|16300574|P2|Overall Study|Patient/Guardian Decision|1
4727109|NCT01982292|16300575|P1|Overall Study|Patient/Guardian Decision|3
4727110|NCT01982292|16300574|P2|Overall Study|Protocol Deviation|0
4727111|NCT01982292|16300575|P1|Overall Study|Protocol Deviation|1
4727112|NCT01982292|16300574|P2|Overall Study|Non-Compliance With Study Treatment|0
4727113|NCT01982292|16300575|P1|Overall Study|Non-Compliance With Study Treatment|1
4727114|NCT01982292|16300574|P2|Overall Study|Lost to Follow-up|0
4727115|NCT01982292|16300575|P1|Overall Study|Lost to Follow-up|2
4727116|NCT01982292|16300574|P2|Overall Study|Death|0
4727117|NCT01982292|16300575|P1|Overall Study|Death|1
4727118|NCT01982292|16300574|P2|Overall Study|Adverse Event|0
4727119|NCT01982292|16300575|P1|Overall Study|Adverse Event|2
4727120|NCT01982253|16300596|P3|Overall Study|Study terminated by sponsor|4
4727121|NCT01982253|16300597|P2|Overall Study|Study terminated by sponsor|4
4727122|NCT01982253|16300598|P1|Overall Study|Study terminated by sponsor|1
4727123|NCT01982253|16300596|P3|Overall Study|Withdrawal by Subject|0
4727124|NCT01982253|16300597|P2|Overall Study|Withdrawal by Subject|0
4727125|NCT01982253|16300598|P1|Overall Study|Withdrawal by Subject|1
4727126|NCT01981954|16300652|P1|Fixed-Dose Assessment Period|Lack of Efficacy|1
4727127|NCT01981954|16300652|P1|Titration Period|Protocol Deviation|1
4727128|NCT01981616|16300736|P2|Overall Study|Protocol Violation|0
4727129|NCT01981616|16300737|P1|Overall Study|Protocol Violation|1
4727130|NCT01981616|16300736|P2|Overall Study|Adverse Event|1
4727131|NCT01981616|16300737|P1|Overall Study|Adverse Event|0
4727132|NCT01981551|16300767|P1|Overall Study|Adverse Event|1
4727133|NCT01981551|16300767|P1|Overall Study|Refused further treatment|8
4727134|NCT01981473|16300777|P3|Overall Study|Received treatment for >24 months|6
4727135|NCT01981473|16300778|P2|Overall Study|Received treatment for >24 months|0
4727136|NCT01981473|16300779|P1|Overall Study|Received treatment for >24 months|2
4727137|NCT01981473|16300777|P3|Overall Study|Received treatment for < 6 months|1
4727138|NCT01981473|16300778|P2|Overall Study|Received treatment for < 6 months|0
4727139|NCT01981473|16300779|P1|Overall Study|Received treatment for < 6 months|0
4727140|NCT01981473|16300777|P3|Overall Study|Incorrect diagnosis of RA|1
4727141|NCT01981473|16300778|P2|Overall Study|Incorrect diagnosis of RA|0
4727142|NCT01981473|16300779|P1|Overall Study|Incorrect diagnosis of RA|0
4727143|NCT01981356|16300820|P2|Overall Study|Protocol Violation|0
4727144|NCT01981356|16300821|P1|Overall Study|Protocol Violation|2
4727145|NCT01981356|16300820|P2|Overall Study|Withdrawal by Subject|1
4727146|NCT01981356|16300821|P1|Overall Study|Withdrawal by Subject|1
4727147|NCT01981356|16300820|P2|Overall Study|Lost to Follow-up|1
4727148|NCT01981356|16300821|P1|Overall Study|Lost to Follow-up|4
4727149|NCT01981122|16300848|P2|Overall Study|Death|15
4727150|NCT01981122|16300849|P1|Overall Study|Death|14
4727151|NCT01981122|16300848|P2|Overall Study|Investigator Or Dendreon Discretion|1
4727152|NCT01981122|16300849|P1|Overall Study|Investigator Or Dendreon Discretion|0
4727153|NCT01981122|16300848|P2|Overall Study|Lost to Follow-up|1
4727154|NCT01981122|16300849|P1|Overall Study|Lost to Follow-up|0
4727155|NCT01981122|16300848|P2|Overall Study|Protocol Violation|1
4727156|NCT01981122|16300849|P1|Overall Study|Protocol Violation|0
4727157|NCT01981122|16300848|P2|Overall Study|Withdrawal by Subject|2
4727158|NCT01981122|16300849|P1|Overall Study|Withdrawal by Subject|0
4727159|NCT01981109|16300855|P1|Overall Study|No data available|2
4727160|NCT01981109|16300855|P1|Overall Study|Study Termination|100
4727161|NCT01981109|16300855|P1|Overall Study|No Discontinuation Documentation|37
4727162|NCT01981109|16300855|P1|Overall Study|Lost to Follow-up|9
4727163|NCT01981109|16300855|P1|Overall Study|Withdrawal by Subject|40
4727164|NCT01981109|16300855|P1|Overall Study|Death|36
4727165|NCT01981096|16300862|P2|Overall Study|Lost to Follow-up|0
4727166|NCT01981096|16300863|P1|Overall Study|Lost to Follow-up|2
4727167|NCT01981096|16300862|P2|Overall Study|Withdrawal by Subject|1
4727168|NCT01981096|16300863|P1|Overall Study|Withdrawal by Subject|0
4727169|NCT01981096|16300862|P2|Overall Study|Parent illness|0
4727170|NCT01981096|16300863|P1|Overall Study|Parent illness|1
4727171|NCT01980992|16300884|P2|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1
4727172|NCT01980992|16300885|P1|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0
4727173|NCT01980992|16300884|P2|52 Weeks Open Label Active Wheat OIT|Non-compliance|0
4727174|NCT01980992|16300885|P1|52 Weeks Open Label Active Wheat OIT|Non-compliance|1
4727175|NCT01980992|16300884|P2|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0
4727176|NCT01980992|16300885|P1|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2
4727177|NCT01980992|16300884|P2|52 Weeks Blinded Study Treatment|Non-compliance|0
4727178|NCT01980992|16300885|P1|52 Weeks Blinded Study Treatment|Non-compliance|1
4727179|NCT01980992|16300884|P2|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
4727180|NCT01980992|16300885|P1|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1
4727181|NCT01980992|16300884|P2|52 Weeks Blinded Study Treatment|Dosing Symptoms|3
4727182|NCT01980992|16300885|P1|52 Weeks Blinded Study Treatment|Dosing Symptoms|0
4727183|NCT01980940|16300910|P8|Overall Study|Protocol Violation|0
4727184|NCT01980940|16300911|P7|Overall Study|Protocol Violation|0
4727185|NCT01980940|16300912|P6|Overall Study|Protocol Violation|2
4727186|NCT01980940|16300913|P5|Overall Study|Protocol Violation|0
4727187|NCT01980940|16300914|P4|Overall Study|Protocol Violation|0
4727188|NCT01980940|16300915|P3|Overall Study|Protocol Violation|0
4727189|NCT01980940|16300916|P2|Overall Study|Protocol Violation|0
4727190|NCT01980940|16300917|P1|Overall Study|Protocol Violation|0
4727191|NCT01980888|16300976|P2|Overall Study|Non-Compliance with Study Drug|2
4727192|NCT01980888|16300977|P1|Overall Study|Non-Compliance with Study Drug|3
4727193|NCT01980888|16300976|P2|Overall Study|Investigator's Discretion|3
4727194|NCT01980888|16300977|P1|Overall Study|Investigator's Discretion|8
4727195|NCT01980888|16300976|P2|Overall Study|Withdrew Consent|6
4727196|NCT01980888|16300977|P1|Overall Study|Withdrew Consent|17
4727197|NCT01980888|16300976|P2|Overall Study|Study Terminated by Sponsor|122
4727198|NCT01980888|16300977|P1|Overall Study|Study Terminated by Sponsor|116
4727199|NCT01980875|16300996|P3|Overall Study|Lost to Follow-up|1
4727200|NCT01980875|16300997|P2|Overall Study|Lost to Follow-up|0
4727201|NCT01980875|16300998|P1|Overall Study|Lost to Follow-up|0
4727202|NCT01980875|16300996|P3|Overall Study|Study Terminated by Sponsor|22
4727203|NCT01980875|16300997|P2|Overall Study|Study Terminated by Sponsor|24
4727204|NCT01980875|16300998|P1|Overall Study|Study Terminated by Sponsor|7
4727205|NCT01980875|16300996|P3|Overall Study|Withdrew Consent|1
4727206|NCT01980875|16300997|P2|Overall Study|Withdrew Consent|1
4727207|NCT01980875|16300998|P1|Overall Study|Withdrew Consent|1
4727208|NCT01980706|16301033|P3|Overall Study|miscellaneous|3
4727209|NCT01980706|16301034|P2|Overall Study|miscellaneous|5
4727210|NCT01980706|16301035|P1|Overall Study|miscellaneous|4
4727211|NCT01980706|16301033|P3|Overall Study|Lost to Follow-up|3
4727212|NCT01980706|16301034|P2|Overall Study|Lost to Follow-up|4
4727213|NCT01980706|16301035|P1|Overall Study|Lost to Follow-up|3
4727214|NCT01980706|16301033|P3|Overall Study|Adverse Event|5
4727215|NCT01980706|16301034|P2|Overall Study|Adverse Event|2
4727216|NCT01980706|16301035|P1|Overall Study|Adverse Event|1
4727217|NCT01980706|16301033|P3|Overall Study|Withdrawal by Subject|2
4727218|NCT01980706|16301034|P2|Overall Study|Withdrawal by Subject|6
4727219|NCT01980706|16301035|P1|Overall Study|Withdrawal by Subject|9
4727220|NCT01980628|16301075|P1|Overall Study|PD, Subj non-Compliant,Study Terminated|42
4727221|NCT01980628|16301075|P1|Overall Study|Withdrawal by Subject|4
4727222|NCT01980628|16301075|P1|Overall Study|Physician Decision|5
4727223|NCT01980628|16301075|P1|Overall Study|Adverse Event|12
4727224|NCT01980095|16301134|P2|Overall Study|Randomized by mistake|0
4727225|NCT01980095|16301135|P1|Overall Study|Randomized by mistake|1
4727226|NCT01980095|16301134|P2|Overall Study|Study drug discontinued|0
4727227|NCT01980095|16301135|P1|Overall Study|Study drug discontinued|1
4727228|NCT01980095|16301134|P2|Overall Study|Safety issue|1
4727229|NCT01980095|16301135|P1|Overall Study|Safety issue|0
4727230|NCT01980095|16301134|P2|Overall Study|Poor compliance|0
4727231|NCT01980095|16301135|P1|Overall Study|Poor compliance|5
4727232|NCT01980095|16301134|P2|Overall Study|Withdrawal by Subject|3
4727233|NCT01980095|16301135|P1|Overall Study|Withdrawal by Subject|2
4727234|NCT01980095|16301134|P2|Overall Study|Lost to Follow-up|7
4727235|NCT01980095|16301135|P1|Overall Study|Lost to Follow-up|6
4727236|NCT01980056|16301146|P3|Overall Study|Death|0
4727237|NCT01980056|16301147|P2|Overall Study|Death|1
4727238|NCT01980056|16301148|P1|Overall Study|Death|1
4727239|NCT01979952|16301162|P2|Overall Study|Other than specified above|0
4727240|NCT01979952|16301163|P1|Overall Study|Other than specified above|1
4727241|NCT01979952|16301162|P2|Overall Study|Withdrawal by Subject|1
4727242|NCT01979952|16301163|P1|Overall Study|Withdrawal by Subject|2
4727243|NCT01979952|16301162|P2|Overall Study|Protocol Violation|0
4727244|NCT01979952|16301163|P1|Overall Study|Protocol Violation|1
4727245|NCT01979952|16301162|P2|Overall Study|Adverse Event|5
4727246|NCT01979952|16301163|P1|Overall Study|Adverse Event|4
4727247|NCT01979835|16301191|P1|Follow-up|Lost to Follow-up|32
4727248|NCT01979835|16301191|P1|Primary Outcome SA Measurment|failed insertion|18
4727249|NCT01979614|16301198|P2|Overall Study|Adverse Event|1
4727250|NCT01979614|16301199|P1|Overall Study|Adverse Event|1
4727251|NCT01979523|16301221|P2|Overall Study|Withdrawal by Subject|0
4727252|NCT01979523|16301222|P1|Overall Study|Withdrawal by Subject|1
4727253|NCT01979185|16301282|P2|Period 2|Other|1
4727254|NCT01979185|16301283|P1|Period 2|Other|0
4727255|NCT01979016|16301331|P2|Overall Study|Adverse Event|1
4727256|NCT01979016|16301332|P1|Overall Study|Adverse Event|0
4727257|NCT01979016|16301331|P2|Overall Study|Withdrawal by Subject|0
4727258|NCT01979016|16301332|P1|Overall Study|Withdrawal by Subject|2
4727259|NCT01978938|16301366|P2|Overall Study|Previously scheduled procedure|1
4727260|NCT01978938|16301367|P1|Overall Study|Previously scheduled procedure|0
4727261|NCT01978938|16301366|P2|Overall Study|Did not meet inclusion criteria|1
4727262|NCT01978938|16301367|P1|Overall Study|Did not meet inclusion criteria|0
4727263|NCT01978938|16301366|P2|Overall Study|Participant noncompliance|1
4727264|NCT01978938|16301367|P1|Overall Study|Participant noncompliance|1
4727265|NCT01978938|16301366|P2|Overall Study|Adverse Event, non-fatal|1
4727266|NCT01978938|16301367|P1|Overall Study|Adverse Event, non-fatal|2
4727267|NCT01978938|16301366|P2|Overall Study|Withdrawal by Subject|4
4727268|NCT01978938|16301367|P1|Overall Study|Withdrawal by Subject|8
4727269|NCT01978938|16301366|P2|Overall Study|Lost to Follow-up|6
4727270|NCT01978938|16301367|P1|Overall Study|Lost to Follow-up|12
4727271|NCT01978912|16301381|P4|Overall Study|Intradiscal Steroid Injection|0
4727272|NCT01978912|16301382|P3|Overall Study|Intradiscal Steroid Injection|0
4727273|NCT01978912|16301383|P2|Overall Study|Intradiscal Steroid Injection|1
4727274|NCT01978912|16301384|P1|Overall Study|Intradiscal Steroid Injection|0
4727275|NCT01978912|16301381|P4|Overall Study|Lumbar Surgery|0
4727276|NCT01978912|16301382|P3|Overall Study|Lumbar Surgery|1
4727277|NCT01978912|16301383|P2|Overall Study|Lumbar Surgery|0
4727278|NCT01978912|16301384|P1|Overall Study|Lumbar Surgery|1
4727279|NCT01978912|16301381|P4|Overall Study|Withdrawal by Subject|2
4727280|NCT01978912|16301382|P3|Overall Study|Withdrawal by Subject|2
4727281|NCT01978912|16301383|P2|Overall Study|Withdrawal by Subject|0
4727282|NCT01978912|16301384|P1|Overall Study|Withdrawal by Subject|1
4727283|NCT01978912|16301381|P4|Overall Study|Lost to Follow-up|1
4727284|NCT01978912|16301382|P3|Overall Study|Lost to Follow-up|0
4727285|NCT01978912|16301383|P2|Overall Study|Lost to Follow-up|1
4727286|NCT01978912|16301384|P1|Overall Study|Lost to Follow-up|1
4727287|NCT01978912|16301381|P4|Overall Study|Adverse Event|0
4727288|NCT01978912|16301382|P3|Overall Study|Adverse Event|0
4727289|NCT01978912|16301383|P2|Overall Study|Adverse Event|1
4727290|NCT01978912|16301384|P1|Overall Study|Adverse Event|0
4727291|NCT01978262|16301577|P1|Overall Study|Lost to Follow-up|2
4727292|NCT01978262|16301577|P1|Overall Study|Withdrawal by Subject|9
4727293|NCT01978236|16301582|P1|Overall Study|Discontinued due to study close|2
4727294|NCT01978184|16301603|P2|Overall Study|Withdrew- toxicities or physical decline|8
4727295|NCT01978184|16301604|P1|Overall Study|Withdrew- toxicities or physical decline|4
4727296|NCT01978184|16301603|P2|Overall Study|Death|0
4727297|NCT01978184|16301604|P1|Overall Study|Death|1
4727298|NCT01978184|16301603|P2|Overall Study|Noncompliance|2
4727299|NCT01978184|16301604|P1|Overall Study|Noncompliance|1
4727300|NCT01978184|16301603|P2|Overall Study|Physician Decision|3
4727301|NCT01978184|16301604|P1|Overall Study|Physician Decision|0
4727302|NCT01978184|16301603|P2|Overall Study|Other than PDA|2
4727303|NCT01978184|16301604|P1|Overall Study|Other than PDA|2
4727304|NCT01978184|16301603|P2|Overall Study|Progressive disease|5
4727305|NCT01978184|16301604|P1|Overall Study|Progressive disease|5
4727306|NCT01978145|16301630|P2|Treatment Period 2|Par. reached defined stopping criteria|5
4727307|NCT01978145|16301631|P1|Treatment Period 2|Par. reached defined stopping criteria|8
4727308|NCT01978145|16301630|P2|Treatment Period 2|Withdrawal by Subject|4
4727309|NCT01978145|16301631|P1|Treatment Period 2|Withdrawal by Subject|7
4727310|NCT01978145|16301630|P2|Treatment Period 2|Lost to Follow-up|1
4727311|NCT01978145|16301631|P1|Treatment Period 2|Lost to Follow-up|1
4727312|NCT01978145|16301630|P2|Treatment Period 2|Protocol Violation|1
4727313|NCT01978145|16301631|P1|Treatment Period 2|Protocol Violation|0
4727314|NCT01978145|16301630|P2|Treatment Period 2|Adverse Event|3
4727315|NCT01978145|16301631|P1|Treatment Period 2|Adverse Event|3
4727316|NCT01978145|16301630|P2|Washout Period 1|Par. reached defined stopping criteria|1
4727317|NCT01978145|16301631|P1|Washout Period 1|Par. reached defined stopping criteria|0
4727318|NCT01978145|16301630|P2|Washout Period 1|Withdrawal by Subject|1
4727319|NCT01978145|16301631|P1|Washout Period 1|Withdrawal by Subject|1
4727320|NCT01978145|16301630|P2|Washout Period 1|Adverse Event|1
4727321|NCT01978145|16301631|P1|Washout Period 1|Adverse Event|0
4727322|NCT01978145|16301630|P2|Treatment Period 1|Par. reached defined stopping criteria|3
4727323|NCT01978145|16301631|P1|Treatment Period 1|Par. reached defined stopping criteria|2
4727324|NCT01978145|16301630|P2|Treatment Period 1|Withdrawal by Subject|4
4727325|NCT01978145|16301631|P1|Treatment Period 1|Withdrawal by Subject|5
4727326|NCT01978145|16301630|P2|Treatment Period 1|Physician Decision|0
4727327|NCT01978145|16301631|P1|Treatment Period 1|Physician Decision|1
4727328|NCT01978145|16301630|P2|Treatment Period 1|Adverse Event|9
4727329|NCT01978145|16301631|P1|Treatment Period 1|Adverse Event|1
4727330|NCT01978119|16301647|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
4727331|NCT01978119|16301648|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4727332|NCT01978119|16301647|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4727333|NCT01978119|16301648|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4727334|NCT01978119|16301647|P2|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0
4727335|NCT01978119|16301648|P1|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1
4727336|NCT01978093|16301674|P2|Overall Study|N/A for vaccine administration|1
4727337|NCT01978093|16301675|P1|Overall Study|N/A for vaccine administration|0
4727338|NCT01978093|16301674|P2|Overall Study|Child was in care of grandmother|1
4727339|NCT01978093|16301675|P1|Overall Study|Child was in care of grandmother|0
4727340|NCT01978093|16301674|P2|Overall Study|Mother lost custody of child|1
4727341|NCT01978093|16301675|P1|Overall Study|Mother lost custody of child|0
4727342|NCT01978093|16301674|P2|Overall Study|Lost kaiser health plan unable to contac|0
4727343|NCT01978093|16301675|P1|Overall Study|Lost kaiser health plan unable to contac|1
4727344|NCT01978093|16301674|P2|Overall Study|Loss of kaiser coverage|10
4727345|NCT01978093|16301675|P1|Overall Study|Loss of kaiser coverage|4
4727346|NCT01978093|16301674|P2|Overall Study|Migrated/moved from study area|13
4727347|NCT01978093|16301675|P1|Overall Study|Migrated/moved from study area|11
4727348|NCT01978093|16301674|P2|Overall Study|Lost to Follow-up|15
4727349|NCT01978093|16301675|P1|Overall Study|Lost to Follow-up|11
4727350|NCT01978093|16301674|P2|Overall Study|Withdrawal by Subject|25
4727351|NCT01978093|16301675|P1|Overall Study|Withdrawal by Subject|29
4727352|NCT01978093|16301674|P2|Overall Study|Protocol Violation|2
4727353|NCT01978093|16301675|P1|Overall Study|Protocol Violation|8
4727354|NCT01978093|16301674|P2|Overall Study|Adverse Event|5
4727355|NCT01978093|16301675|P1|Overall Study|Adverse Event|0
4727356|NCT01978093|16301674|P2|Overall Study|Death|0
4727357|NCT01978093|16301675|P1|Overall Study|Death|1
4727358|NCT01977937|16301719|P2|Overall Study|Physician Decision|1
4727359|NCT01977937|16301720|P1|Overall Study|Physician Decision|0
4727360|NCT01977937|16301719|P2|Overall Study|Adverse Event|0
4727361|NCT01977937|16301720|P1|Overall Study|Adverse Event|1
4727362|NCT01977937|16301719|P2|Overall Study|Withdrawal by Subject|1
4727363|NCT01977937|16301720|P1|Overall Study|Withdrawal by Subject|2
4727364|NCT01977846|16301730|P2|Total Study - Prospective|Protocol Violation|1
4727365|NCT01977846|16301731|P1|Total Study - Prospective|Protocol Violation|0
4727366|NCT01977846|16301730|P2|Total Study - Prospective|No show|1
4727367|NCT01977846|16301731|P1|Total Study - Prospective|No show|0
4727368|NCT01977846|16301730|P2|Total Study - Prospective|Not available at time of visit|5
4727369|NCT01977846|16301731|P1|Total Study - Prospective|Not available at time of visit|0
4727370|NCT01977846|16301730|P2|Total Study - Prospective|Withdrawal by Subject|13
4727371|NCT01977846|16301731|P1|Total Study - Prospective|Withdrawal by Subject|0
4727372|NCT01977846|16301730|P2|Total Study - Prospective|Lost to Follow-up|8
4727373|NCT01977846|16301731|P1|Total Study - Prospective|Lost to Follow-up|0
4727374|NCT01977846|16301730|P2|Total Study - Prospective|Death|1
4727375|NCT01977846|16301731|P1|Total Study - Prospective|Death|0
4727376|NCT01977820|16301749|P2|Overall Study|Sponsor terminated the study|1
4727377|NCT01977820|16301750|P1|Overall Study|Sponsor terminated the study|1
4727378|NCT01977794|16301758|P2|Overall Study|Other|1
4727379|NCT01977794|16301759|P1|Overall Study|Other|0
4727380|NCT01977794|16301758|P2|Overall Study|Withdrew consent|1
4727381|NCT01977794|16301759|P1|Overall Study|Withdrew consent|2
4727382|NCT01977794|16301758|P2|Overall Study|Death|1
4727383|NCT01977794|16301759|P1|Overall Study|Death|1
4727384|NCT01977794|16301758|P2|Overall Study|Protocol Violation|0
4727385|NCT01977794|16301759|P1|Overall Study|Protocol Violation|1
4727386|NCT01977794|16301758|P2|Overall Study|Lost to Follow-up|1
4727387|NCT01977794|16301759|P1|Overall Study|Lost to Follow-up|2
4727388|NCT01977794|16301758|P2|Overall Study|Adverse Event|2
4727389|NCT01977794|16301759|P1|Overall Study|Adverse Event|2
4727390|NCT01977729|16301794|P1|Overall Study|Study terminated|1
4727391|NCT01977690|16301806|P2|Overall Study|Withdrawal by Subject|4
4727392|NCT01977690|16301807|P1|Overall Study|Withdrawal by Subject|0
4727393|NCT01977677|16301816|P3|Overall Study|Unrelated Adverse Event|1
4727394|NCT01977677|16301817|P2|Overall Study|Unrelated Adverse Event|0
4727395|NCT01977677|16301818|P1|Overall Study|Unrelated Adverse Event|0
4727396|NCT01977625|16301829|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4727397|NCT01977625|16301830|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4727398|NCT01977625|16301829|P2|First Intervention (4 Weeks)|Withdrawal by Subject|0
4727399|NCT01977625|16301830|P1|First Intervention (4 Weeks)|Withdrawal by Subject|3
4727400|NCT01977612|16301840|P2|Overall Study|Lost to Follow-up|1
4727401|NCT01977612|16301841|P1|Overall Study|Lost to Follow-up|1
4727402|NCT01977573|16301863|P4|Overall Study|Withdrawal by Subject|1
4727403|NCT01977573|16301864|P3|Overall Study|Withdrawal by Subject|1
4727404|NCT01977573|16301865|P2|Overall Study|Withdrawal by Subject|1
4727405|NCT01977573|16301866|P1|Overall Study|Withdrawal by Subject|6
4727406|NCT01977573|16301863|P4|Overall Study|Reached Defined Stopping Criteria|0
4727407|NCT01977573|16301864|P3|Overall Study|Reached Defined Stopping Criteria|1
4727408|NCT01977573|16301865|P2|Overall Study|Reached Defined Stopping Criteria|1
4727409|NCT01977573|16301866|P1|Overall Study|Reached Defined Stopping Criteria|2
4727410|NCT01977573|16301863|P4|Overall Study|Protocol Violation|0
4727411|NCT01977573|16301864|P3|Overall Study|Protocol Violation|0
4727412|NCT01977573|16301865|P2|Overall Study|Protocol Violation|1
4727413|NCT01977573|16301866|P1|Overall Study|Protocol Violation|3
4727414|NCT01977573|16301863|P4|Overall Study|Physician Decision|0
4727415|NCT01977573|16301864|P3|Overall Study|Physician Decision|0
4727416|NCT01977573|16301865|P2|Overall Study|Physician Decision|0
4727417|NCT01977573|16301866|P1|Overall Study|Physician Decision|1
4727418|NCT01977573|16301863|P4|Overall Study|Lost to Follow-up|1
4727419|NCT01977573|16301864|P3|Overall Study|Lost to Follow-up|0
4727420|NCT01977573|16301865|P2|Overall Study|Lost to Follow-up|0
4727421|NCT01977573|16301866|P1|Overall Study|Lost to Follow-up|1
4727422|NCT01977573|16301863|P4|Overall Study|Adverse Event|1
4727423|NCT01977573|16301864|P3|Overall Study|Adverse Event|2
4727424|NCT01977573|16301865|P2|Overall Study|Adverse Event|0
4727425|NCT01977573|16301866|P1|Overall Study|Adverse Event|7
4727426|NCT01977482|16301980|P6|Overall Study|Withdrawal by Subject|5
4727427|NCT01977482|16301981|P5|Overall Study|Withdrawal by Subject|1
4727428|NCT01977482|16301982|P4|Overall Study|Withdrawal by Subject|3
4727429|NCT01977482|16301983|P3|Overall Study|Withdrawal by Subject|1
4727430|NCT01977482|16301984|P2|Overall Study|Withdrawal by Subject|4
4727431|NCT01977482|16301985|P1|Overall Study|Withdrawal by Subject|2
4727432|NCT01977482|16301980|P6|Overall Study|Other-Protocol-defined Stopping Criteria|0
4727433|NCT01977482|16301981|P5|Overall Study|Other-Protocol-defined Stopping Criteria|0
4727434|NCT01977482|16301982|P4|Overall Study|Other-Protocol-defined Stopping Criteria|1
4727435|NCT01977482|16301983|P3|Overall Study|Other-Protocol-defined Stopping Criteria|2
4727436|NCT01977482|16301984|P2|Overall Study|Other-Protocol-defined Stopping Criteria|3
4727437|NCT01977482|16301985|P1|Overall Study|Other-Protocol-defined Stopping Criteria|0
4727438|NCT01977482|16301980|P6|Overall Study|Protocol Violation|0
4727439|NCT01977482|16301981|P5|Overall Study|Protocol Violation|0
4727440|NCT01977482|16301982|P4|Overall Study|Protocol Violation|0
4727441|NCT01977482|16301983|P3|Overall Study|Protocol Violation|1
4727442|NCT01977482|16301984|P2|Overall Study|Protocol Violation|0
4727443|NCT01977482|16301985|P1|Overall Study|Protocol Violation|0
4727444|NCT01977482|16301980|P6|Overall Study|Physician Decision|0
4727445|NCT01977482|16301981|P5|Overall Study|Physician Decision|0
4727446|NCT01977482|16301982|P4|Overall Study|Physician Decision|0
4727447|NCT01977482|16301983|P3|Overall Study|Physician Decision|0
4727448|NCT01977482|16301984|P2|Overall Study|Physician Decision|1
4727449|NCT01977482|16301985|P1|Overall Study|Physician Decision|0
4727450|NCT01977482|16301980|P6|Overall Study|Lost to Follow-up|0
4727451|NCT01977482|16301981|P5|Overall Study|Lost to Follow-up|0
4727452|NCT01977482|16301982|P4|Overall Study|Lost to Follow-up|0
4727453|NCT01977482|16301983|P3|Overall Study|Lost to Follow-up|0
4727454|NCT01977482|16301984|P2|Overall Study|Lost to Follow-up|0
4727455|NCT01977482|16301985|P1|Overall Study|Lost to Follow-up|1
4727456|NCT01977482|16301980|P6|Overall Study|Adverse Event|0
4727457|NCT01977482|16301981|P5|Overall Study|Adverse Event|2
4727458|NCT01977482|16301982|P4|Overall Study|Adverse Event|0
4727459|NCT01977482|16301983|P3|Overall Study|Adverse Event|1
4727460|NCT01977482|16301984|P2|Overall Study|Adverse Event|1
4727461|NCT01977482|16301985|P1|Overall Study|Adverse Event|0
4727462|NCT01977456|16302100|P1|Overall Study|Death|5
4727463|NCT01977352|16302109|P2|Overall Study|Lost to Follow-up|2
4727464|NCT01977352|16302110|P1|Overall Study|Lost to Follow-up|1
4727465|NCT01977222|16302128|P1|Overall Study|Withdrawal by Subject|1
4727466|NCT01977092|16302141|P2|Overall Study|In prison|11
4727467|NCT01977092|16302142|P1|Overall Study|In prison|3
4727468|NCT01977092|16302141|P2|Overall Study|Withdrawal by Subject|1
4727469|NCT01977092|16302142|P1|Overall Study|Withdrawal by Subject|2
4727470|NCT01977092|16302141|P2|Overall Study|Lost to Follow-up|14
4727471|NCT01977092|16302142|P1|Overall Study|Lost to Follow-up|23
4727472|NCT01977092|16302141|P2|Overall Study|Death|4
4727473|NCT01977092|16302142|P1|Overall Study|Death|3
4727474|NCT01977040|16302152|P1|Overall Study|Vasa previa not confirmed|2
4727475|NCT01976845|16302206|P3|Overall Study|Physician Decision|3
4727476|NCT01976845|16302207|P2|Overall Study|Physician Decision|8
4727477|NCT01976845|16302208|P1|Overall Study|Physician Decision|8
4727478|NCT01976806|16302233|P2|Overall Study|Withdrawal by Subject|1
4727479|NCT01976806|16302234|P1|Overall Study|Withdrawal by Subject|1
4727480|NCT01976806|16302233|P2|Overall Study|Adverse Event|1
4727481|NCT01976806|16302234|P1|Overall Study|Adverse Event|1
4727482|NCT01976806|16302233|P2|Overall Study|Lost to Follow-up|4
4727483|NCT01976806|16302234|P1|Overall Study|Lost to Follow-up|1
4727484|NCT01976741|16302272|P10|Overall Study|Adverse Event|4
4727485|NCT01976741|16302273|P9|Overall Study|Adverse Event|1
4727486|NCT01976741|16302274|P8|Overall Study|Adverse Event|8
4727487|NCT01976741|16302275|P7|Overall Study|Adverse Event|3
4727488|NCT01976741|16302276|P6|Overall Study|Adverse Event|0
4727489|NCT01976741|16302277|P5|Overall Study|Adverse Event|0
4727490|NCT01976741|16302278|P4|Overall Study|Adverse Event|0
4727491|NCT01976741|16302279|P3|Overall Study|Adverse Event|2
4727492|NCT01976741|16302280|P2|Overall Study|Adverse Event|0
4727493|NCT01976741|16302281|P1|Overall Study|Adverse Event|0
4727494|NCT01976741|16302272|P10|Overall Study|Withdrawal by Subject|0
4727495|NCT01976741|16302273|P9|Overall Study|Withdrawal by Subject|0
4727496|NCT01976741|16302274|P8|Overall Study|Withdrawal by Subject|4
4727497|NCT01976741|16302275|P7|Overall Study|Withdrawal by Subject|1
4727498|NCT01976741|16302276|P6|Overall Study|Withdrawal by Subject|0
4727499|NCT01976741|16302277|P5|Overall Study|Withdrawal by Subject|0
4727500|NCT01976741|16302278|P4|Overall Study|Withdrawal by Subject|1
4727501|NCT01976741|16302279|P3|Overall Study|Withdrawal by Subject|1
4727502|NCT01976741|16302280|P2|Overall Study|Withdrawal by Subject|0
4727503|NCT01976741|16302281|P1|Overall Study|Withdrawal by Subject|1
4727504|NCT01976663|16302519|P1|Overall Study|Lost to Follow-up|3
4727505|NCT01976663|16302519|P1|Overall Study|Adverse Event|2
4727506|NCT01976663|16302519|P1|Overall Study|Screen Failure|3
4727507|NCT01976663|16302519|P1|Overall Study|Withdrawal by Subject|4
4727508|NCT01976663|16302519|P1|Overall Study|Personal Reasons|6
4727509|NCT01976663|16302519|P1|Overall Study|Completed 18 mos but no repeat treatment|24
4727510|NCT01976624|16302538|P1|Overall Study|Participants age less than 19 years|12
4727511|NCT01976624|16302538|P1|Overall Study|Participants contraindicated|2
4727512|NCT01976507|16302566|P1|Overall Study|ablation not done, drug not given|1
4727513|NCT01976507|16302566|P1|Overall Study|Adverse Event|6
4727514|NCT01976364|16302597|P3|Sub-study (12 Months)|Adverse Event|3
4727515|NCT01976364|16302598|P2|Sub-study (12 Months)|Adverse Event|4
4727516|NCT01976364|16302599|P1|Sub-study (12 Months)|Adverse Event|0
4727517|NCT01976364|16302597|P3|Sub-study (12 Months)|Protocol Violation|1
4727518|NCT01976364|16302598|P2|Sub-study (12 Months)|Protocol Violation|1
4727519|NCT01976364|16302599|P1|Sub-study (12 Months)|Protocol Violation|0
4727520|NCT01976364|16302597|P3|Sub-study (12 Months)|Withdrawal by Subject|1
4727521|NCT01976364|16302598|P2|Sub-study (12 Months)|Withdrawal by Subject|0
4727522|NCT01976364|16302599|P1|Sub-study (12 Months)|Withdrawal by Subject|0
4727523|NCT01976364|16302597|P3|Sub-study (12 Months)|Lost to Follow-up|0
4727524|NCT01976364|16302598|P2|Sub-study (12 Months)|Lost to Follow-up|1
4727525|NCT01976364|16302599|P1|Sub-study (12 Months)|Lost to Follow-up|0
4727526|NCT01976364|16302597|P3|Main Study (36 Months)|Death|0
4727527|NCT01976364|16302598|P2|Main Study (36 Months)|Death|0
4727528|NCT01976364|16302599|P1|Main Study (36 Months)|Death|5
4727529|NCT01976364|16302597|P3|Main Study (36 Months)|Withdrawal by Subject|0
4727530|NCT01976364|16302598|P2|Main Study (36 Months)|Withdrawal by Subject|0
4727531|NCT01976364|16302599|P1|Main Study (36 Months)|Withdrawal by Subject|69
4727532|NCT01976364|16302597|P3|Main Study (36 Months)|Protocol Violation|0
4727533|NCT01976364|16302598|P2|Main Study (36 Months)|Protocol Violation|0
4727534|NCT01976364|16302599|P1|Main Study (36 Months)|Protocol Violation|13
4727535|NCT01976364|16302597|P3|Main Study (36 Months)|Lack of Efficacy|0
4727536|NCT01976364|16302598|P2|Main Study (36 Months)|Lack of Efficacy|0
4727537|NCT01976364|16302599|P1|Main Study (36 Months)|Lack of Efficacy|40
4727538|NCT01976364|16302597|P3|Main Study (36 Months)|Lost to Follow-up|0
4727539|NCT01976364|16302598|P2|Main Study (36 Months)|Lost to Follow-up|0
4727540|NCT01976364|16302599|P1|Main Study (36 Months)|Lost to Follow-up|10
4727541|NCT01976364|16302597|P3|Main Study (36 Months)|Medication error|0
4727542|NCT01976364|16302598|P2|Main Study (36 Months)|Medication error|0
4727543|NCT01976364|16302599|P1|Main Study (36 Months)|Medication error|1
4727544|NCT01976364|16302597|P3|Main Study (36 Months)|No longer met eligibility criteria|0
4727545|NCT01976364|16302598|P2|Main Study (36 Months)|No longer met eligibility criteria|0
4727546|NCT01976364|16302599|P1|Main Study (36 Months)|No longer met eligibility criteria|2
4727547|NCT01976364|16302597|P3|Main Study (36 Months)|Other|0
4727548|NCT01976364|16302598|P2|Main Study (36 Months)|Other|0
4727549|NCT01976364|16302599|P1|Main Study (36 Months)|Other|13
4727550|NCT01976364|16302597|P3|Main Study (36 Months)|Withdrawn due to pregnancy|0
4727551|NCT01976364|16302598|P2|Main Study (36 Months)|Withdrawn due to pregnancy|0
4727552|NCT01976364|16302599|P1|Main Study (36 Months)|Withdrawn due to pregnancy|5
4727553|NCT01976364|16302597|P3|Main Study (36 Months)|Adverse Event|0
4727554|NCT01976364|16302598|P2|Main Study (36 Months)|Adverse Event|0
4727555|NCT01976364|16302599|P1|Main Study (36 Months)|Adverse Event|63
4727556|NCT01976338|16302719|P2|Overall Study|Adverse Event|1
4727557|NCT01976338|16302720|P1|Overall Study|Adverse Event|5
4727558|NCT01976338|16302719|P2|Overall Study|Withdrawal by Subject|2
4727559|NCT01976338|16302720|P1|Overall Study|Withdrawal by Subject|5
4727560|NCT01976338|16302719|P2|Overall Study|Lost to Follow-up|0
4727561|NCT01976338|16302720|P1|Overall Study|Lost to Follow-up|3
4727562|NCT01976338|16302719|P2|Overall Study|Physician Decision|1
4727563|NCT01976338|16302720|P1|Overall Study|Physician Decision|0
4727564|NCT01976312|16302747|P2|Overall Study|Protocol Violation|0
4727565|NCT01976312|16302748|P1|Overall Study|Protocol Violation|2
4727566|NCT01976312|16302747|P2|Overall Study|Adverse Event|6
4727567|NCT01976312|16302748|P1|Overall Study|Adverse Event|6
4727568|NCT01976312|16302747|P2|Overall Study|Withdrawal by Subject|2
4727569|NCT01976312|16302748|P1|Overall Study|Withdrawal by Subject|7
4727570|NCT01976312|16302747|P2|Overall Study|Lost to Follow-up|0
4727571|NCT01976312|16302748|P1|Overall Study|Lost to Follow-up|2
4727572|NCT01976312|16302747|P2|Overall Study|Pregnancy|1
4727573|NCT01976312|16302748|P1|Overall Study|Pregnancy|0
4727574|NCT01976299|16302769|P2|Overall Study|See clarification above in comments|2
4727575|NCT01976299|16302770|P1|Overall Study|See clarification above in comments|9
4727576|NCT01976299|16302769|P2|Overall Study|Lost to Follow-up|1
4727577|NCT01976299|16302770|P1|Overall Study|Lost to Follow-up|7
4727578|NCT01976299|16302769|P2|Overall Study|Death|2
4727579|NCT01976299|16302770|P1|Overall Study|Death|4
4727580|NCT01976299|16302769|P2|Overall Study|Withdrawal by Subject|1
4727581|NCT01976299|16302770|P1|Overall Study|Withdrawal by Subject|3
4727582|NCT01976104|16302797|P4|Overall Study|Other|0
4727583|NCT01976104|16302798|P3|Overall Study|Other|0
4727584|NCT01976104|16302799|P2|Overall Study|Other|1
4727585|NCT01976104|16302800|P1|Overall Study|Other|0
4727586|NCT01976104|16302797|P4|Overall Study|Withdrawal by Subject|1
4727587|NCT01976104|16302798|P3|Overall Study|Withdrawal by Subject|0
4727588|NCT01976104|16302799|P2|Overall Study|Withdrawal by Subject|0
4727589|NCT01976104|16302800|P1|Overall Study|Withdrawal by Subject|3
4727590|NCT01976104|16302797|P4|Overall Study|Subject Choice|1
4727591|NCT01976104|16302798|P3|Overall Study|Subject Choice|0
4727592|NCT01976104|16302799|P2|Overall Study|Subject Choice|1
4727593|NCT01976104|16302800|P1|Overall Study|Subject Choice|0
4727594|NCT01976104|16302797|P4|Overall Study|Lost to Follow-up|1
4727595|NCT01976104|16302798|P3|Overall Study|Lost to Follow-up|1
4727596|NCT01976104|16302799|P2|Overall Study|Lost to Follow-up|0
4727597|NCT01976104|16302800|P1|Overall Study|Lost to Follow-up|3
4727598|NCT01976104|16302797|P4|Overall Study|Adverse Event|0
4727599|NCT01976104|16302798|P3|Overall Study|Adverse Event|1
4727600|NCT01976104|16302799|P2|Overall Study|Adverse Event|0
4727601|NCT01976104|16302800|P1|Overall Study|Adverse Event|0
4727602|NCT01975948|16302834|P4|Overall Study|Withdrawal by Subject|6
4727603|NCT01975948|16302835|P3|Overall Study|Withdrawal by Subject|7
4727604|NCT01975948|16302836|P2|Overall Study|Withdrawal by Subject|21
4727605|NCT01975948|16302837|P1|Overall Study|Withdrawal by Subject|17
4727606|NCT01975831|16302913|P9|Overall Study|Unable to Treat Within Protocol Windows|1
4727607|NCT01975831|16302914|P8|Overall Study|Unable to Treat Within Protocol Windows|0
4727608|NCT01975831|16302915|P7|Overall Study|Unable to Treat Within Protocol Windows|1
4727609|NCT01975831|16302916|P6|Overall Study|Unable to Treat Within Protocol Windows|0
4727610|NCT01975831|16302917|P5|Overall Study|Unable to Treat Within Protocol Windows|0
4727611|NCT01975831|16302918|P4|Overall Study|Unable to Treat Within Protocol Windows|0
4727612|NCT01975831|16302919|P3|Overall Study|Unable to Treat Within Protocol Windows|0
4727613|NCT01975831|16302920|P2|Overall Study|Unable to Treat Within Protocol Windows|0
4727614|NCT01975831|16302921|P1|Overall Study|Unable to Treat Within Protocol Windows|0
4727615|NCT01975831|16302913|P9|Overall Study|Entered Hospice|0
4727616|NCT01975831|16302914|P8|Overall Study|Entered Hospice|0
4727617|NCT01975831|16302915|P7|Overall Study|Entered Hospice|0
4727618|NCT01975831|16302916|P6|Overall Study|Entered Hospice|1
4727619|NCT01975831|16302917|P5|Overall Study|Entered Hospice|0
4727620|NCT01975831|16302918|P4|Overall Study|Entered Hospice|0
4727621|NCT01975831|16302919|P3|Overall Study|Entered Hospice|0
4727622|NCT01975831|16302920|P2|Overall Study|Entered Hospice|0
4727623|NCT01975831|16302921|P1|Overall Study|Entered Hospice|0
4727624|NCT01975831|16302913|P9|Overall Study|Initiation of Subsequent Therapy|0
4727625|NCT01975831|16302914|P8|Overall Study|Initiation of Subsequent Therapy|2
4727626|NCT01975831|16302915|P7|Overall Study|Initiation of Subsequent Therapy|0
4727627|NCT01975831|16302916|P6|Overall Study|Initiation of Subsequent Therapy|1
4727628|NCT01975831|16302917|P5|Overall Study|Initiation of Subsequent Therapy|0
4727629|NCT01975831|16302918|P4|Overall Study|Initiation of Subsequent Therapy|0
4727630|NCT01975831|16302919|P3|Overall Study|Initiation of Subsequent Therapy|0
4727631|NCT01975831|16302920|P2|Overall Study|Initiation of Subsequent Therapy|0
4727632|NCT01975831|16302921|P1|Overall Study|Initiation of Subsequent Therapy|0
4727633|NCT01975831|16302913|P9|Overall Study|Physician Decision|0
4727634|NCT01975831|16302914|P8|Overall Study|Physician Decision|1
4727635|NCT01975831|16302915|P7|Overall Study|Physician Decision|0
4727636|NCT01975831|16302916|P6|Overall Study|Physician Decision|1
4727637|NCT01975831|16302917|P5|Overall Study|Physician Decision|0
4727638|NCT01975831|16302918|P4|Overall Study|Physician Decision|0
4727639|NCT01975831|16302919|P3|Overall Study|Physician Decision|0
4727640|NCT01975831|16302920|P2|Overall Study|Physician Decision|0
4727641|NCT01975831|16302921|P1|Overall Study|Physician Decision|0
4727642|NCT01975831|16302913|P9|Overall Study|Withdrawal by Subject|0
4727643|NCT01975831|16302914|P8|Overall Study|Withdrawal by Subject|0
4727644|NCT01975831|16302915|P7|Overall Study|Withdrawal by Subject|1
4727645|NCT01975831|16302916|P6|Overall Study|Withdrawal by Subject|1
4727646|NCT01975831|16302917|P5|Overall Study|Withdrawal by Subject|3
4727647|NCT01975831|16302918|P4|Overall Study|Withdrawal by Subject|0
4727648|NCT01975831|16302919|P3|Overall Study|Withdrawal by Subject|0
4727649|NCT01975831|16302920|P2|Overall Study|Withdrawal by Subject|3
4727650|NCT01975831|16302921|P1|Overall Study|Withdrawal by Subject|0
4727651|NCT01975831|16302913|P9|Overall Study|Progressive Disease|10
4727652|NCT01975831|16302914|P8|Overall Study|Progressive Disease|8
4727653|NCT01975831|16302915|P7|Overall Study|Progressive Disease|10
4727654|NCT01975831|16302916|P6|Overall Study|Progressive Disease|9
4727655|NCT01975831|16302917|P5|Overall Study|Progressive Disease|13
4727656|NCT01975831|16302918|P4|Overall Study|Progressive Disease|4
4727657|NCT01975831|16302919|P3|Overall Study|Progressive Disease|2
4727658|NCT01975831|16302920|P2|Overall Study|Progressive Disease|3
4727659|NCT01975831|16302921|P1|Overall Study|Progressive Disease|1
4727660|NCT01975831|16302913|P9|Overall Study|Death|0
4727661|NCT01975831|16302914|P8|Overall Study|Death|0
4727662|NCT01975831|16302915|P7|Overall Study|Death|1
4727663|NCT01975831|16302916|P6|Overall Study|Death|0
4727664|NCT01975831|16302917|P5|Overall Study|Death|1
4727665|NCT01975831|16302918|P4|Overall Study|Death|0
4727666|NCT01975831|16302919|P3|Overall Study|Death|0
4727667|NCT01975831|16302920|P2|Overall Study|Death|1
4727668|NCT01975831|16302921|P1|Overall Study|Death|1
4727669|NCT01975831|16302913|P9|Overall Study|Adverse Event|1
4727670|NCT01975831|16302914|P8|Overall Study|Adverse Event|4
4727671|NCT01975831|16302915|P7|Overall Study|Adverse Event|3
4727672|NCT01975831|16302916|P6|Overall Study|Adverse Event|1
4727673|NCT01975831|16302917|P5|Overall Study|Adverse Event|1
4727674|NCT01975831|16302918|P4|Overall Study|Adverse Event|0
4727675|NCT01975831|16302919|P3|Overall Study|Adverse Event|2
4727676|NCT01975831|16302920|P2|Overall Study|Adverse Event|2
4727677|NCT01975831|16302921|P1|Overall Study|Adverse Event|1
4727678|NCT01975701|16302986|P1|Overall Study|Physician Decision|1
4727679|NCT01975701|16302986|P1|Overall Study|Death|23
4727680|NCT01975701|16302986|P1|Overall Study|Lost to Follow-up|1
4727681|NCT01975675|16302997|P4|Overall Study|Death|0
4727682|NCT01975675|16302998|P3|Overall Study|Death|0
4727683|NCT01975675|16302999|P2|Overall Study|Death|1
4727684|NCT01975675|16303000|P1|Overall Study|Death|0
4727685|NCT01975389|16303051|P2|Overall Study|Randomized, not treated|5
4727686|NCT01975389|16303052|P1|Overall Study|Randomized, not treated|4
4727687|NCT01975389|16303051|P2|Overall Study|Other|9
4727688|NCT01975389|16303052|P1|Overall Study|Other|6
4727689|NCT01975389|16303051|P2|Overall Study|Withdrawal by Subject|76
4727690|NCT01975389|16303052|P1|Overall Study|Withdrawal by Subject|90
4727691|NCT01975389|16303051|P2|Overall Study|Lost to Follow-up|86
4727692|NCT01975389|16303052|P1|Overall Study|Lost to Follow-up|81
4727693|NCT01975389|16303051|P2|Overall Study|Death|54
4727694|NCT01975389|16303052|P1|Overall Study|Death|61
4727695|NCT01975389|16303051|P2|Overall Study|Adverse Event|6
4727696|NCT01975389|16303052|P1|Overall Study|Adverse Event|10
4727697|NCT01975376|16303112|P2|Overall Study|Randomized, Not Treated|8
4727698|NCT01975376|16303113|P1|Overall Study|Randomized, Not Treated|16
4727699|NCT01975376|16303112|P2|Overall Study|Other|4
4727700|NCT01975376|16303113|P1|Overall Study|Other|2
4727701|NCT01975376|16303112|P2|Overall Study|Withdrew consent|62
4727702|NCT01975376|16303113|P1|Overall Study|Withdrew consent|68
4727703|NCT01975376|16303112|P2|Overall Study|Lost to Follow-up|66
4727704|NCT01975376|16303113|P1|Overall Study|Lost to Follow-up|70
4727705|NCT01975376|16303112|P2|Overall Study|Death|72
4727706|NCT01975376|16303113|P1|Overall Study|Death|65
4727707|NCT01975376|16303112|P2|Overall Study|Adverse Event|5
4727708|NCT01975376|16303113|P1|Overall Study|Adverse Event|5
4727709|NCT01975285|16303173|P2|Overall Study|Failed Block and follow up|2
4727710|NCT01975285|16303174|P1|Overall Study|Failed Block and follow up|2
4727711|NCT01975246|16303190|P2|Overall Study|Other than stated|1
4727712|NCT01975246|16303191|P1|Overall Study|Other than stated|0
4727713|NCT01975246|16303190|P2|Overall Study|Protocol Violation|0
4727714|NCT01975246|16303191|P1|Overall Study|Protocol Violation|1
4727715|NCT01975246|16303190|P2|Overall Study|Lack of Efficacy|0
4727716|NCT01975246|16303191|P1|Overall Study|Lack of Efficacy|1
4727717|NCT01975246|16303190|P2|Overall Study|Adverse Event|1
4727718|NCT01975246|16303191|P1|Overall Study|Adverse Event|2
4727719|NCT01975220|16303204|P6|Test Period 1|Not treated|0
4727720|NCT01975220|16303205|P5|Test Period 1|Not treated|0
4727721|NCT01975220|16303206|P4|Test Period 1|Not treated|0
4727722|NCT01975220|16303207|P3|Test Period 1|Not treated|0
4727723|NCT01975220|16303208|P2|Test Period 1|Not treated|1
4727724|NCT01975220|16303209|P1|Test Period 1|Not treated|0
4727725|NCT01974895|16303265|P2|Overall Study|Other (Reason unknown)|8
4727726|NCT01974895|16303266|P1|Overall Study|Other (Reason unknown)|9
4727727|NCT01974895|16303265|P2|Overall Study|Other (Missed Visit)|0
4727728|NCT01974895|16303266|P1|Overall Study|Other (Missed Visit)|1
4727729|NCT01974895|16303265|P2|Overall Study|Withdrawal by Subject|1
4727730|NCT01974895|16303266|P1|Overall Study|Withdrawal by Subject|0
4727731|NCT01974895|16303265|P2|Overall Study|Lost to Follow-up|6
4727732|NCT01974895|16303266|P1|Overall Study|Lost to Follow-up|4
4727733|NCT01974895|16303265|P2|Overall Study|Protocol Violation|0
4727734|NCT01974895|16303266|P1|Overall Study|Protocol Violation|1
4727735|NCT01974817|16303296|P1|Overall Study|Protocol Violation|2
4727736|NCT01974817|16303296|P1|Overall Study|Lost to Follow-up|2
4727737|NCT01974817|16303296|P1|Overall Study|Death|4
4727738|NCT01974752|16303302|P2|Overall Study|Other Eligibility Criteria|1
4727739|NCT01974752|16303303|P1|Overall Study|Other Eligibility Criteria|0
4727740|NCT01974752|16303302|P2|Overall Study|Withdrawal by Subject|3
4727741|NCT01974752|16303303|P1|Overall Study|Withdrawal by Subject|2
4727742|NCT01974752|16303302|P2|Overall Study|Lost to Follow-up|0
4727743|NCT01974752|16303303|P1|Overall Study|Lost to Follow-up|2
4727744|NCT01974752|16303302|P2|Overall Study|Death|11
4727745|NCT01974752|16303303|P1|Overall Study|Death|33
4727746|NCT01974323|16303731|P2|Overall Study|Adverse Event|2
4727747|NCT01974323|16303732|P1|Overall Study|Adverse Event|2
4727748|NCT01974323|16303731|P2|Overall Study|Lack of Efficacy|1
4727749|NCT01974323|16303732|P1|Overall Study|Lack of Efficacy|1
4727750|NCT01974323|16303731|P2|Overall Study|Pregnancy|1
4727751|NCT01974323|16303732|P1|Overall Study|Pregnancy|2
4727752|NCT01974323|16303731|P2|Overall Study|Lost to Follow-up|40
4727753|NCT01974323|16303732|P1|Overall Study|Lost to Follow-up|45
4727754|NCT01974323|16303731|P2|Overall Study|Personal Reasons|19
4727755|NCT01974323|16303732|P1|Overall Study|Personal Reasons|15
4727756|NCT01974323|16303731|P2|Overall Study|Protocol Violation|2
4727757|NCT01974323|16303732|P1|Overall Study|Protocol Violation|2
4727758|NCT01974323|16303731|P2|Overall Study|Other Reasons|28
4727759|NCT01974323|16303732|P1|Overall Study|Other Reasons|25
4727760|NCT01974141|16303772|P2|Overall Study|Adverse Event|5
4727761|NCT01974141|16303773|P1|Overall Study|Adverse Event|4
4727762|NCT01974141|16303772|P2|Overall Study|Lack of Efficacy|1
4727763|NCT01974141|16303773|P1|Overall Study|Lack of Efficacy|0
4727764|NCT01974141|16303772|P2|Overall Study|Pregnancy|3
4727765|NCT01974141|16303773|P1|Overall Study|Pregnancy|3
4727766|NCT01974141|16303772|P2|Overall Study|Lost to Follow-up|29
4727767|NCT01974141|16303773|P1|Overall Study|Lost to Follow-up|38
4727768|NCT01974141|16303772|P2|Overall Study|Personal Reasons|20
4727769|NCT01974141|16303773|P1|Overall Study|Personal Reasons|21
4727770|NCT01974141|16303772|P2|Overall Study|Protocol Violation|6
4727771|NCT01974141|16303773|P1|Overall Study|Protocol Violation|2
4727772|NCT01974141|16303772|P2|Overall Study|Other Reasons|18
4727773|NCT01974141|16303773|P1|Overall Study|Other Reasons|28
4727774|NCT01973998|16303817|P2|Overall Study|Death|2
4727775|NCT01973998|16303818|P1|Overall Study|Death|2
4727776|NCT01973595|16303880|P4|Washout|Withdrawal by Subject|0
4727777|NCT01973595|16303881|P3|Washout|Withdrawal by Subject|1
4727778|NCT01973595|16303882|P2|Washout|Withdrawal by Subject|0
4727779|NCT01973595|16303883|P1|Washout|Withdrawal by Subject|1
4727780|NCT01973569|16303900|P3|Overall Study|Did not receive study drug|3
4727781|NCT01973569|16303901|P2|Overall Study|Did not receive study drug|3
4727782|NCT01973569|16303902|P1|Overall Study|Did not receive study drug|6
4727783|NCT01973569|16303900|P3|Overall Study|Other|0
4727784|NCT01973569|16303901|P2|Overall Study|Other|1
4727785|NCT01973569|16303902|P1|Overall Study|Other|1
4727786|NCT01973569|16303900|P3|Overall Study|Disease progression|0
4727787|NCT01973569|16303901|P2|Overall Study|Disease progression|3
4727788|NCT01973569|16303902|P1|Overall Study|Disease progression|0
4727789|NCT01973569|16303900|P3|Overall Study|Prohibited concomitant d|0
4727790|NCT01973569|16303901|P2|Overall Study|Prohibited concomitant d|5
4727791|NCT01973569|16303902|P1|Overall Study|Prohibited concomitant d|1
4727792|NCT01973569|16303900|P3|Overall Study|Invasive dental treatment|6
4727793|NCT01973569|16303901|P2|Overall Study|Invasive dental treatment|5
4727794|NCT01973569|16303902|P1|Overall Study|Invasive dental treatment|3
4727795|NCT01973569|16303900|P3|Overall Study|Withdrawal by Subject|2
4727796|NCT01973569|16303901|P2|Overall Study|Withdrawal by Subject|5
4727797|NCT01973569|16303902|P1|Overall Study|Withdrawal by Subject|7
4727798|NCT01973569|16303900|P3|Overall Study|Protocol Violation|3
4727799|NCT01973569|16303901|P2|Overall Study|Protocol Violation|1
4727800|NCT01973569|16303902|P1|Overall Study|Protocol Violation|2
4727801|NCT01973569|16303900|P3|Overall Study|Adverse Event|4
4727802|NCT01973569|16303901|P2|Overall Study|Adverse Event|2
4727803|NCT01973569|16303902|P1|Overall Study|Adverse Event|9
4727804|NCT01973491|16303928|P1|Treatment Period (16 Weeks)|Adverse Event|1
4727805|NCT01973491|16303928|P1|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1
4727806|NCT01973491|16303928|P1|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17
4727807|NCT01973439|16303944|P1|Overall Study|PK curve incomplete|2
4727808|NCT01973439|16303944|P1|Overall Study|Vomiting after commencing once daily|1
4727809|NCT01973439|16303944|P1|Overall Study|Lost samples from one PK Day|2
4727810|NCT01973387|16303966|P2|Overall Study|Randomized, not treated|2
4727811|NCT01973387|16303967|P1|Overall Study|Randomized, not treated|2
4727812|NCT01973387|16303966|P2|Overall Study|Death|3
4727813|NCT01973387|16303967|P1|Overall Study|Death|4
4727814|NCT01973387|16303966|P2|Overall Study|Progressive disease or relapse|5
4727815|NCT01973387|16303967|P1|Overall Study|Progressive disease or relapse|16
4727816|NCT01973387|16303966|P2|Overall Study|Study terminated by sponsor|0
4727817|NCT01973387|16303967|P1|Overall Study|Study terminated by sponsor|63
4727818|NCT01973387|16303966|P2|Overall Study|Withdrawal by Subject|4
4727819|NCT01973387|16303967|P1|Overall Study|Withdrawal by Subject|7
4727820|NCT01973387|16303966|P2|Overall Study|Adverse Event|4
4727821|NCT01973387|16303967|P1|Overall Study|Adverse Event|14
4727822|NCT01973231|16304049|P2|Overall Study|Withdrawal by Subject|9
4727823|NCT01973231|16304050|P1|Overall Study|Withdrawal by Subject|7
4727824|NCT01973231|16304049|P2|Overall Study|unclassified|1
4727825|NCT01973231|16304050|P1|Overall Study|unclassified|2
4727826|NCT01973231|16304049|P2|Overall Study|Lost to Follow-up|1
4727827|NCT01973231|16304050|P1|Overall Study|Lost to Follow-up|1
4727828|NCT01973231|16304049|P2|Overall Study|Protocol Violation|1
4727829|NCT01973231|16304050|P1|Overall Study|Protocol Violation|1
4727830|NCT01973218|16304070|P2|Overall Study|Withdrawal by Subject|0
4727831|NCT01973218|16304071|P1|Overall Study|Withdrawal by Subject|1
4727832|NCT01973218|16304070|P2|Overall Study|Adverse Event|0
4727833|NCT01973218|16304071|P1|Overall Study|Adverse Event|1
4727834|NCT01972841|16304164|P6|Overall Study|Did not have end of treatment page|0
4727835|NCT01972841|16304165|P5|Overall Study|Did not have end of treatment page|1
4727836|NCT01972841|16304166|P4|Overall Study|Did not have end of treatment page|0
4727837|NCT01972841|16304167|P3|Overall Study|Did not have end of treatment page|0
4727838|NCT01972841|16304168|P2|Overall Study|Did not have end of treatment page|0
4727839|NCT01972841|16304169|P1|Overall Study|Did not have end of treatment page|0
4727840|NCT01972841|16304164|P6|Overall Study|Miscellaneous|4
4727841|NCT01972841|16304165|P5|Overall Study|Miscellaneous|0
4727842|NCT01972841|16304166|P4|Overall Study|Miscellaneous|1
4727843|NCT01972841|16304167|P3|Overall Study|Miscellaneous|4
4727844|NCT01972841|16304168|P2|Overall Study|Miscellaneous|0
4727845|NCT01972841|16304169|P1|Overall Study|Miscellaneous|0
4727846|NCT01972841|16304164|P6|Overall Study|Withdrawal by participants|34
4727847|NCT01972841|16304165|P5|Overall Study|Withdrawal by participants|33
4727848|NCT01972841|16304166|P4|Overall Study|Withdrawal by participants|16
4727849|NCT01972841|16304167|P3|Overall Study|Withdrawal by participants|23
4727850|NCT01972841|16304168|P2|Overall Study|Withdrawal by participants|27
4727851|NCT01972841|16304169|P1|Overall Study|Withdrawal by participants|21
4727852|NCT01972841|16304164|P6|Overall Study|Protocol Violation|4
4727853|NCT01972841|16304165|P5|Overall Study|Protocol Violation|9
4727854|NCT01972841|16304166|P4|Overall Study|Protocol Violation|5
4727855|NCT01972841|16304167|P3|Overall Study|Protocol Violation|3
4727856|NCT01972841|16304168|P2|Overall Study|Protocol Violation|2
4727857|NCT01972841|16304169|P1|Overall Study|Protocol Violation|2
4727858|NCT01972841|16304164|P6|Overall Study|Lost to Follow-up|3
4727859|NCT01972841|16304165|P5|Overall Study|Lost to Follow-up|9
4727860|NCT01972841|16304166|P4|Overall Study|Lost to Follow-up|2
4727861|NCT01972841|16304167|P3|Overall Study|Lost to Follow-up|4
4727862|NCT01972841|16304168|P2|Overall Study|Lost to Follow-up|2
4727863|NCT01972841|16304169|P1|Overall Study|Lost to Follow-up|4
4727864|NCT01972841|16304164|P6|Overall Study|Lack of Efficacy|1
4727865|NCT01972841|16304165|P5|Overall Study|Lack of Efficacy|4
4727866|NCT01972841|16304166|P4|Overall Study|Lack of Efficacy|2
4727867|NCT01972841|16304167|P3|Overall Study|Lack of Efficacy|0
4727868|NCT01972841|16304168|P2|Overall Study|Lack of Efficacy|0
4727869|NCT01972841|16304169|P1|Overall Study|Lack of Efficacy|1
4727870|NCT01972841|16304164|P6|Overall Study|Adverse Event|26
4727871|NCT01972841|16304165|P5|Overall Study|Adverse Event|21
4727872|NCT01972841|16304166|P4|Overall Study|Adverse Event|9
4727873|NCT01972841|16304167|P3|Overall Study|Adverse Event|12
4727874|NCT01972841|16304168|P2|Overall Study|Adverse Event|8
4727875|NCT01972841|16304169|P1|Overall Study|Adverse Event|13
4727876|NCT01972841|16304164|P6|Overall Study|Randomized but Never Received Treatment|13
4727877|NCT01972841|16304165|P5|Overall Study|Randomized but Never Received Treatment|6
4727878|NCT01972841|16304166|P4|Overall Study|Randomized but Never Received Treatment|2
4727879|NCT01972841|16304167|P3|Overall Study|Randomized but Never Received Treatment|4
4727880|NCT01972841|16304168|P2|Overall Study|Randomized but Never Received Treatment|5
4727881|NCT01972841|16304169|P1|Overall Study|Randomized but Never Received Treatment|2
4727882|NCT01972789|16304599|P2|Overall Study|Physician Decision|2
4727883|NCT01972789|16304600|P1|Overall Study|Physician Decision|3
4727884|NCT01972789|16304599|P2|Overall Study|Protocol deviation|0
4727885|NCT01972789|16304600|P1|Overall Study|Protocol deviation|1
4727886|NCT01972789|16304599|P2|Overall Study|Death|5
4727887|NCT01972789|16304600|P1|Overall Study|Death|7
4727888|NCT01972789|16304599|P2|Overall Study|Lost to Follow-up|7
4727889|NCT01972789|16304600|P1|Overall Study|Lost to Follow-up|4
4727890|NCT01972789|16304599|P2|Overall Study|Subject withdrew consent|12
4727891|NCT01972789|16304600|P1|Overall Study|Subject withdrew consent|14
4727892|NCT01972789|16304599|P2|Overall Study|Adverse Event|4
4727893|NCT01972789|16304600|P1|Overall Study|Adverse Event|11
4727894|NCT01972776|16304634|P6|Part 2|Administrative problems|7
4727895|NCT01972776|16304635|P5|Part 2|Administrative problems|10
4727896|NCT01972776|16304636|P4|Part 2|Administrative problems|0
4727897|NCT01972776|16304637|P3|Part 2|Administrative problems|0
4727898|NCT01972776|16304638|P2|Part 2|Administrative problems|0
4727899|NCT01972776|16304639|P1|Part 2|Administrative problems|0
4727900|NCT01972776|16304634|P6|Part 2|Adverse Event|0
4727901|NCT01972776|16304635|P5|Part 2|Adverse Event|3
4727902|NCT01972776|16304636|P4|Part 2|Adverse Event|0
4727903|NCT01972776|16304637|P3|Part 2|Adverse Event|0
4727904|NCT01972776|16304638|P2|Part 2|Adverse Event|0
4727905|NCT01972776|16304639|P1|Part 2|Adverse Event|0
4727906|NCT01972776|16304634|P6|Part 1|Adverse Event|0
4727907|NCT01972776|16304635|P5|Part 1|Adverse Event|0
4727908|NCT01972776|16304636|P4|Part 1|Adverse Event|1
4727909|NCT01972776|16304637|P3|Part 1|Adverse Event|1
4727910|NCT01972776|16304638|P2|Part 1|Adverse Event|0
4727911|NCT01972776|16304639|P1|Part 1|Adverse Event|0
4727912|NCT01972776|16304634|P6|Part 1|Withdrawal by Subject|0
4727913|NCT01972776|16304635|P5|Part 1|Withdrawal by Subject|0
4727914|NCT01972776|16304636|P4|Part 1|Withdrawal by Subject|0
4727915|NCT01972776|16304637|P3|Part 1|Withdrawal by Subject|1
4727916|NCT01972776|16304638|P2|Part 1|Withdrawal by Subject|0
4727917|NCT01972776|16304639|P1|Part 1|Withdrawal by Subject|0
4727918|NCT01972724|16304710|P3|Open-Label|Significant Protocol Deviation|2
4727919|NCT01972724|16304711|P2|Open-Label|Significant Protocol Deviation|0
4727920|NCT01972724|16304712|P1|Open-Label|Significant Protocol Deviation|0
4727921|NCT01972724|16304710|P3|Open-Label|Withdrew Consent|3
4727922|NCT01972724|16304711|P2|Open-Label|Withdrew Consent|0
4727923|NCT01972724|16304712|P1|Open-Label|Withdrew Consent|0
4727924|NCT01972724|16304710|P3|Double-Blind|Significant Protocol Deviation|0
4727925|NCT01972724|16304711|P2|Double-Blind|Significant Protocol Deviation|8
4727926|NCT01972724|16304712|P1|Double-Blind|Significant Protocol Deviation|5
4727927|NCT01972724|16304710|P3|Double-Blind|Withdrawal of Consent|0
4727928|NCT01972724|16304711|P2|Double-Blind|Withdrawal of Consent|1
4727929|NCT01972724|16304712|P1|Double-Blind|Withdrawal of Consent|2
4727930|NCT01972724|16304710|P3|Double-Blind|Adverse Event|0
4727931|NCT01972724|16304711|P2|Double-Blind|Adverse Event|0
4727932|NCT01972724|16304712|P1|Double-Blind|Adverse Event|1
4727933|NCT01972724|16304710|P3|Double-Blind|Rescue Criteria Met|0
4727934|NCT01972724|16304711|P2|Double-Blind|Rescue Criteria Met|0
4727935|NCT01972724|16304712|P1|Double-Blind|Rescue Criteria Met|1
4727936|NCT01972659|16304725|P2|Overall Study|problems realted to acceleromyograph|1
4727937|NCT01972659|16304726|P1|Overall Study|problems realted to acceleromyograph|2
4727938|NCT01972659|16304725|P2|Overall Study|Protocol Violation|2
4727939|NCT01972659|16304726|P1|Overall Study|Protocol Violation|2
4727940|NCT01972568|16304735|P3|Overall Study|Adverse Event|5
4727941|NCT01972568|16304736|P2|Overall Study|Adverse Event|6
4727942|NCT01972568|16304737|P1|Overall Study|Adverse Event|5
4727943|NCT01972568|16304735|P3|Overall Study|Lost to Follow-up|0
4727944|NCT01972568|16304736|P2|Overall Study|Lost to Follow-up|0
4727945|NCT01972568|16304737|P1|Overall Study|Lost to Follow-up|1
4727946|NCT01972568|16304735|P3|Overall Study|Withdrawal by Subject|7
4727947|NCT01972568|16304736|P2|Overall Study|Withdrawal by Subject|3
4727948|NCT01972568|16304737|P1|Overall Study|Withdrawal by Subject|6
4727949|NCT01972568|16304735|P3|Overall Study|Protocol Violation|2
4727950|NCT01972568|16304736|P2|Overall Study|Protocol Violation|2
4727951|NCT01972568|16304737|P1|Overall Study|Protocol Violation|1
4727952|NCT01972568|16304735|P3|Overall Study|Lack of Efficacy|2
4727953|NCT01972568|16304736|P2|Overall Study|Lack of Efficacy|1
4727954|NCT01972568|16304737|P1|Overall Study|Lack of Efficacy|0
4727955|NCT01972568|16304735|P3|Overall Study|Other events|0
4727956|NCT01972568|16304736|P2|Overall Study|Other events|0
4727957|NCT01972568|16304737|P1|Overall Study|Other events|3
4727958|NCT01972529|16304776|P4|Overall Study|Not treated|1
4727959|NCT01972529|16304777|P3|Overall Study|Not treated|2
4727960|NCT01972529|16304778|P2|Overall Study|Not treated|1
4727961|NCT01972529|16304779|P1|Overall Study|Not treated|0
4727962|NCT01972529|16304776|P4|Overall Study|Other|2
4727963|NCT01972529|16304777|P3|Overall Study|Other|0
4727964|NCT01972529|16304778|P2|Overall Study|Other|0
4727965|NCT01972529|16304779|P1|Overall Study|Other|0
4727966|NCT01972529|16304776|P4|Overall Study|Withdrawl of Consent|1
4727967|NCT01972529|16304777|P3|Overall Study|Withdrawl of Consent|0
4727968|NCT01972529|16304778|P2|Overall Study|Withdrawl of Consent|2
4727969|NCT01972529|16304779|P1|Overall Study|Withdrawl of Consent|1
4727970|NCT01972529|16304776|P4|Overall Study|Participant Choice|0
4727971|NCT01972529|16304777|P3|Overall Study|Participant Choice|0
4727972|NCT01972529|16304778|P2|Overall Study|Participant Choice|1
4727973|NCT01972529|16304779|P1|Overall Study|Participant Choice|0
4727974|NCT01972529|16304776|P4|Overall Study|Lost to Follow-up|0
4727975|NCT01972529|16304777|P3|Overall Study|Lost to Follow-up|0
4727976|NCT01972529|16304778|P2|Overall Study|Lost to Follow-up|0
4727977|NCT01972529|16304779|P1|Overall Study|Lost to Follow-up|1
4727978|NCT01972529|16304776|P4|Overall Study|Adverse Event|0
4727979|NCT01972529|16304777|P3|Overall Study|Adverse Event|0
4727980|NCT01972529|16304778|P2|Overall Study|Adverse Event|1
4727981|NCT01972529|16304779|P1|Overall Study|Adverse Event|0
4727982|NCT01972464|16304824|P2|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
4727983|NCT01972464|16304825|P1|3-Month Follow-Up (Week 20)|Lost to Follow-up|1
4727984|NCT01972464|16304824|P2|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1
4727985|NCT01972464|16304825|P1|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0
4727986|NCT01972464|16304824|P2|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0
4727987|NCT01972464|16304825|P1|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1
4727988|NCT01972464|16304824|P2|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3
4727989|NCT01972464|16304825|P1|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2
4727990|NCT01972438|16304841|P2|Post Month 12 Study Period|Early Study Closure|4
4727991|NCT01972438|16304842|P1|Post Month 12 Study Period|Early Study Closure|3
4727992|NCT01972438|16304841|P2|Months 6-12 Study Period|Early Study Closure|2
4727993|NCT01972438|16304842|P1|Months 6-12 Study Period|Early Study Closure|2
4727994|NCT01972438|16304841|P2|Months 6-12 Study Period|Death|0
4727995|NCT01972438|16304842|P1|Months 6-12 Study Period|Death|1
4727996|NCT01972438|16304841|P2|Months 3-6 Crossover Period|Early Study Closure|1
4727997|NCT01972438|16304842|P1|Months 3-6 Crossover Period|Early Study Closure|0
4727998|NCT01972438|16304841|P2|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2
4727999|NCT01972438|16304842|P1|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1
4728000|NCT01972438|16304841|P2|Baseline-Month 3 Crossover Period|Unable to donate blood|1
4728001|NCT01972438|16304842|P1|Baseline-Month 3 Crossover Period|Unable to donate blood|0
4728002|NCT01972438|16304841|P2|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0
4728003|NCT01972438|16304842|P1|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1
4728004|NCT01972438|16304841|P2|Baseline-Month 3 Crossover Period|Death|0
4728005|NCT01972438|16304842|P1|Baseline-Month 3 Crossover Period|Death|1
4728006|NCT01972308|16304896|P2|Overall Study|Death|1
4728007|NCT01972308|16304897|P1|Overall Study|Death|4
4728008|NCT01972308|16304896|P2|Overall Study|Lost to Follow-up|6
4728009|NCT01972308|16304897|P1|Overall Study|Lost to Follow-up|4
4728010|NCT01972308|16304896|P2|Overall Study|Withdrawal by Subject|1
4728011|NCT01972308|16304897|P1|Overall Study|Withdrawal by Subject|0
4728012|NCT01972217|16304923|P4|Part B Double-blind, Randomised Period|Withdrawal by Subject|1
4728013|NCT01972217|16304924|P3|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
4728014|NCT01972217|16304925|P2|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
4728015|NCT01972217|16304926|P1|Part B Double-blind, Randomised Period|Withdrawal by Subject|0
4728016|NCT01972217|16304923|P4|Part B Double-blind, Randomised Period|Lost to Follow-up|1
4728017|NCT01972217|16304924|P3|Part B Double-blind, Randomised Period|Lost to Follow-up|2
4728018|NCT01972217|16304925|P2|Part B Double-blind, Randomised Period|Lost to Follow-up|0
4728019|NCT01972217|16304926|P1|Part B Double-blind, Randomised Period|Lost to Follow-up|0
4728020|NCT01972217|16304923|P4|Part B Double-blind, Randomised Period|Screen failure|1
4728021|NCT01972217|16304924|P3|Part B Double-blind, Randomised Period|Screen failure|0
4728022|NCT01972217|16304925|P2|Part B Double-blind, Randomised Period|Screen failure|0
4728023|NCT01972217|16304926|P1|Part B Double-blind, Randomised Period|Screen failure|0
4728024|NCT01972217|16304923|P4|Part B Double-blind, Randomised Period|Reason not recorded|0
4728025|NCT01972217|16304924|P3|Part B Double-blind, Randomised Period|Reason not recorded|1
4728026|NCT01972217|16304925|P2|Part B Double-blind, Randomised Period|Reason not recorded|0
4728027|NCT01972217|16304926|P1|Part B Double-blind, Randomised Period|Reason not recorded|0
4728028|NCT01972217|16304923|P4|Part B Double-blind, Randomised Period|Death|44
4728029|NCT01972217|16304924|P3|Part B Double-blind, Randomised Period|Death|43
4728030|NCT01972217|16304925|P2|Part B Double-blind, Randomised Period|Death|0
4728031|NCT01972217|16304926|P1|Part B Double-blind, Randomised Period|Death|0
4728032|NCT01972217|16304923|P4|Part A: Open-label Safety Run-in Period|Death|0
4728033|NCT01972217|16304924|P3|Part A: Open-label Safety Run-in Period|Death|0
4728034|NCT01972217|16304925|P2|Part A: Open-label Safety Run-in Period|Death|1
4728035|NCT01972217|16304926|P1|Part A: Open-label Safety Run-in Period|Death|0
4728036|NCT01972217|16304923|P4|Part A: Open-label Safety Run-in Period|Adverse Event|0
4728037|NCT01972217|16304924|P3|Part A: Open-label Safety Run-in Period|Adverse Event|0
4728038|NCT01972217|16304925|P2|Part A: Open-label Safety Run-in Period|Adverse Event|1
4728039|NCT01972217|16304926|P1|Part A: Open-label Safety Run-in Period|Adverse Event|0
4728040|NCT01972217|16304923|P4|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
4728041|NCT01972217|16304924|P3|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0
4728042|NCT01972217|16304925|P2|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9
4728043|NCT01972217|16304926|P1|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1
4728044|NCT01972217|16304923|P4|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
4728045|NCT01972217|16304924|P3|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
4728046|NCT01972217|16304925|P2|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1
4728047|NCT01972217|16304926|P1|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0
4728048|NCT01972152|16304987|P6|Second Treatment Visit|Protocol Violation|0
4728049|NCT01972152|16304988|P5|Second Treatment Visit|Protocol Violation|0
4728050|NCT01972152|16304989|P4|Second Treatment Visit|Protocol Violation|0
4728051|NCT01972152|16304990|P3|Second Treatment Visit|Protocol Violation|0
4728052|NCT01972152|16304991|P2|Second Treatment Visit|Protocol Violation|1
4728053|NCT01972152|16304992|P1|Second Treatment Visit|Protocol Violation|0
4728054|NCT01972152|16304987|P6|First Treatment Visit|Lost to Follow-up|0
4728055|NCT01972152|16304988|P5|First Treatment Visit|Lost to Follow-up|0
4728056|NCT01972152|16304989|P4|First Treatment Visit|Lost to Follow-up|0
4728057|NCT01972152|16304990|P3|First Treatment Visit|Lost to Follow-up|0
4728058|NCT01972152|16304991|P2|First Treatment Visit|Lost to Follow-up|1
4728059|NCT01972152|16304992|P1|First Treatment Visit|Lost to Follow-up|0
4728060|NCT01972074|16305030|P3|Overall Study|Scanner Unavailable|1
4728061|NCT01972074|16305031|P2|Overall Study|Scanner Unavailable|0
4728062|NCT01972074|16305032|P1|Overall Study|Scanner Unavailable|0
4728063|NCT01972074|16305030|P3|Overall Study|Withdrawal by Subject|1
4728064|NCT01972074|16305031|P2|Overall Study|Withdrawal by Subject|1
4728065|NCT01972074|16305032|P1|Overall Study|Withdrawal by Subject|1
4728066|NCT01972074|16305030|P3|Overall Study|Lost to Follow-up|1
4728067|NCT01972074|16305031|P2|Overall Study|Lost to Follow-up|1
4728068|NCT01972074|16305032|P1|Overall Study|Lost to Follow-up|0
4728069|NCT01972074|16305030|P3|Overall Study|Lack of Efficacy|0
4728070|NCT01972074|16305031|P2|Overall Study|Lack of Efficacy|1
4728071|NCT01972074|16305032|P1|Overall Study|Lack of Efficacy|1
4728072|NCT01972074|16305030|P3|Overall Study|Adverse Event|0
4728073|NCT01972074|16305031|P2|Overall Study|Adverse Event|1
4728074|NCT01972074|16305032|P1|Overall Study|Adverse Event|4
4728075|NCT01971723|16305058|P2|Overall Study|Protocol Violation|2
4728076|NCT01971723|16305059|P1|Overall Study|Protocol Violation|1
4728077|NCT01971723|16305058|P2|Overall Study|Withdrawal by Subject|1
4728078|NCT01971723|16305059|P1|Overall Study|Withdrawal by Subject|1
4728079|NCT01971645|16305092|P3|Overall Study|Protocol Violation|1
4728080|NCT01971645|16305093|P2|Overall Study|Protocol Violation|0
4728081|NCT01971645|16305094|P1|Overall Study|Protocol Violation|0
4728082|NCT01971645|16305092|P3|Overall Study|Lost to Follow-up|1
4728083|NCT01971645|16305093|P2|Overall Study|Lost to Follow-up|0
4728084|NCT01971645|16305094|P1|Overall Study|Lost to Follow-up|1
4728085|NCT01971645|16305092|P3|Overall Study|Adverse Event|0
4728086|NCT01971645|16305093|P2|Overall Study|Adverse Event|0
4728087|NCT01971645|16305094|P1|Overall Study|Adverse Event|1
4728088|NCT01971567|16305128|P2|Overall Study|Lost to Follow-up|0
4728089|NCT01971567|16305129|P1|Overall Study|Lost to Follow-up|1
4728090|NCT01971567|16305128|P2|Overall Study|Withdrawal by Subject|2
4728091|NCT01971567|16305129|P1|Overall Study|Withdrawal by Subject|3
4728092|NCT01971554|16305155|P4|Overall Study|Lost to Follow-up|0
4728093|NCT01971554|16305156|P3|Overall Study|Lost to Follow-up|0
4728094|NCT01971554|16305157|P2|Overall Study|Lost to Follow-up|0
4728095|NCT01971554|16305158|P1|Overall Study|Lost to Follow-up|1
4728096|NCT01971476|16305195|P3|Cohort 2: 12 to <18 Years|Adverse Event|0
4728097|NCT01971476|16305196|P2|Cohort 2: 12 to <18 Years|Adverse Event|1
4728098|NCT01971476|16305197|P1|Cohort 2: 12 to <18 Years|Adverse Event|0
4728099|NCT01971476|16305195|P3|Cohort 2: 12 to <18 Years|Other not defined|0
4728100|NCT01971476|16305196|P2|Cohort 2: 12 to <18 Years|Other not defined|3
4728101|NCT01971476|16305197|P1|Cohort 2: 12 to <18 Years|Other not defined|6
4728102|NCT01971476|16305195|P3|Cohort 1: 2 to <12 Years|Other not defined|6
4728103|NCT01971476|16305196|P2|Cohort 1: 2 to <12 Years|Other not defined|3
4728104|NCT01971476|16305197|P1|Cohort 1: 2 to <12 Years|Other not defined|3
4728105|NCT01971346|16305291|P1|Overall Study|Physician Decision|1
4728106|NCT01971346|16305291|P1|Overall Study|Withdrawal by Subject|2
4728107|NCT01971346|16305291|P1|Overall Study|Lost to Follow-up|2
4728108|NCT01971346|16305291|P1|Overall Study|Protocol Violation|3
4728109|NCT01971203|16305324|P2|Overall Study|Adverse Event|0
4728110|NCT01971203|16305325|P1|Overall Study|Adverse Event|1
4728111|NCT01971203|16305324|P2|Overall Study|Withdrawal by Subject|6
4728112|NCT01971203|16305325|P1|Overall Study|Withdrawal by Subject|5
4728113|NCT01971203|16305324|P2|Overall Study|Protocol Violation|2
4728114|NCT01971203|16305325|P1|Overall Study|Protocol Violation|3
4728115|NCT01970995|16305352|P3|End of Study (Population at Day 90)|Withdrawal by Subject|1
4728116|NCT01970995|16305353|P2|End of Study (Population at Day 90)|Withdrawal by Subject|0
4728117|NCT01970995|16305354|P1|End of Study (Population at Day 90)|Withdrawal by Subject|1
4728118|NCT01970995|16305352|P3|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4728119|NCT01970995|16305353|P2|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4728120|NCT01970995|16305354|P1|Confinement Period (Population at Day 5)|Withdrawal by Subject|1
4728121|NCT01970982|16305377|P3|Overall Study|Withdrawal by Subject|2
4728122|NCT01970982|16305378|P2|Overall Study|Withdrawal by Subject|0
4728123|NCT01970982|16305379|P1|Overall Study|Withdrawal by Subject|0
4728124|NCT01970878|16305414|P4|Overall Study|No Completion Status|0
4728125|NCT01970878|16305415|P3|Overall Study|No Completion Status|0
4728126|NCT01970878|16305416|P2|Overall Study|No Completion Status|1
4728127|NCT01970878|16305417|P1|Overall Study|No Completion Status|0
4728128|NCT01970878|16305414|P4|Overall Study|Physician Decision|0
4728129|NCT01970878|16305415|P3|Overall Study|Physician Decision|1
4728130|NCT01970878|16305416|P2|Overall Study|Physician Decision|1
4728131|NCT01970878|16305417|P1|Overall Study|Physician Decision|0
4728132|NCT01970878|16305414|P4|Overall Study|Protocol Specified Criteria|6
4728133|NCT01970878|16305415|P3|Overall Study|Protocol Specified Criteria|3
4728134|NCT01970878|16305416|P2|Overall Study|Protocol Specified Criteria|4
4728135|NCT01970878|16305417|P1|Overall Study|Protocol Specified Criteria|10
4728136|NCT01970878|16305414|P4|Overall Study|Adverse Event|3
4728137|NCT01970878|16305415|P3|Overall Study|Adverse Event|4
4728138|NCT01970878|16305416|P2|Overall Study|Adverse Event|7
4728139|NCT01970878|16305417|P1|Overall Study|Adverse Event|12
4728140|NCT01970878|16305414|P4|Overall Study|Lack of Efficacy|0
4728141|NCT01970878|16305415|P3|Overall Study|Lack of Efficacy|2
4728142|NCT01970878|16305416|P2|Overall Study|Lack of Efficacy|1
4728143|NCT01970878|16305417|P1|Overall Study|Lack of Efficacy|2
4728144|NCT01970878|16305414|P4|Overall Study|Administrative Reasons|4
4728145|NCT01970878|16305415|P3|Overall Study|Administrative Reasons|0
4728146|NCT01970878|16305416|P2|Overall Study|Administrative Reasons|0
4728147|NCT01970878|16305417|P1|Overall Study|Administrative Reasons|1
4728148|NCT01970878|16305414|P4|Overall Study|Lost to Follow-up|4
4728149|NCT01970878|16305415|P3|Overall Study|Lost to Follow-up|2
4728150|NCT01970878|16305416|P2|Overall Study|Lost to Follow-up|3
4728151|NCT01970878|16305417|P1|Overall Study|Lost to Follow-up|1
4728152|NCT01970878|16305414|P4|Overall Study|Withdrawal by Subject|7
4728153|NCT01970878|16305415|P3|Overall Study|Withdrawal by Subject|14
4728154|NCT01970878|16305416|P2|Overall Study|Withdrawal by Subject|10
4728155|NCT01970878|16305417|P1|Overall Study|Withdrawal by Subject|11
4728156|NCT01970865|16305460|P17|Overall Study|Study ongoing|2
4728157|NCT01970865|16305461|P16|Overall Study|Study ongoing|29
4728158|NCT01970865|16305462|P15|Overall Study|Study ongoing|29
4728159|NCT01970865|16305463|P14|Overall Study|Study ongoing|41
4728160|NCT01970865|16305464|P13|Overall Study|Study ongoing|43
4728161|NCT01970865|16305465|P12|Overall Study|Study ongoing|22
4728162|NCT01970865|16305466|P11|Overall Study|Study ongoing|29
4728163|NCT01970865|16305467|P10|Overall Study|Study ongoing|3
4728164|NCT01970865|16305468|P9|Overall Study|Study ongoing|1
4728165|NCT01970865|16305469|P8|Overall Study|Study ongoing|0
4728166|NCT01970865|16305470|P7|Overall Study|Study ongoing|2
4728167|NCT01970865|16305471|P6|Overall Study|Study ongoing|0
4728168|NCT01970865|16305472|P5|Overall Study|Study ongoing|8
4728169|NCT01970865|16305473|P4|Overall Study|Study ongoing|6
4728170|NCT01970865|16305474|P3|Overall Study|Study ongoing|0
4728171|NCT01970865|16305475|P2|Overall Study|Study ongoing|2
4728172|NCT01970865|16305476|P1|Overall Study|Study ongoing|0
4728173|NCT01970865|16305460|P17|Overall Study|Other|0
4728174|NCT01970865|16305461|P16|Overall Study|Other|1
4728175|NCT01970865|16305462|P15|Overall Study|Other|0
4728176|NCT01970865|16305463|P14|Overall Study|Other|1
4728177|NCT01970865|16305464|P13|Overall Study|Other|0
4728178|NCT01970865|16305465|P12|Overall Study|Other|0
4728179|NCT01970865|16305466|P11|Overall Study|Other|0
4728180|NCT01970865|16305467|P10|Overall Study|Other|0
4728181|NCT01970865|16305468|P9|Overall Study|Other|0
4728182|NCT01970865|16305469|P8|Overall Study|Other|0
4728183|NCT01970865|16305470|P7|Overall Study|Other|0
4728184|NCT01970865|16305471|P6|Overall Study|Other|0
4728185|NCT01970865|16305472|P5|Overall Study|Other|0
4728186|NCT01970865|16305473|P4|Overall Study|Other|1
4728187|NCT01970865|16305474|P3|Overall Study|Other|0
4728188|NCT01970865|16305475|P2|Overall Study|Other|0
4728189|NCT01970865|16305476|P1|Overall Study|Other|0
4728190|NCT01970865|16305460|P17|Overall Study|Withdrawal by Subject|0
4728191|NCT01970865|16305461|P16|Overall Study|Withdrawal by Subject|7
4728192|NCT01970865|16305462|P15|Overall Study|Withdrawal by Subject|2
4728193|NCT01970865|16305463|P14|Overall Study|Withdrawal by Subject|5
4728194|NCT01970865|16305464|P13|Overall Study|Withdrawal by Subject|2
4728195|NCT01970865|16305465|P12|Overall Study|Withdrawal by Subject|1
4728196|NCT01970865|16305466|P11|Overall Study|Withdrawal by Subject|0
4728197|NCT01970865|16305467|P10|Overall Study|Withdrawal by Subject|0
4728198|NCT01970865|16305468|P9|Overall Study|Withdrawal by Subject|0
4728199|NCT01970865|16305469|P8|Overall Study|Withdrawal by Subject|0
4728200|NCT01970865|16305470|P7|Overall Study|Withdrawal by Subject|0
4728201|NCT01970865|16305471|P6|Overall Study|Withdrawal by Subject|0
4728202|NCT01970865|16305472|P5|Overall Study|Withdrawal by Subject|2
4728203|NCT01970865|16305473|P4|Overall Study|Withdrawal by Subject|1
4728204|NCT01970865|16305474|P3|Overall Study|Withdrawal by Subject|0
4728205|NCT01970865|16305475|P2|Overall Study|Withdrawal by Subject|0
4728206|NCT01970865|16305476|P1|Overall Study|Withdrawal by Subject|0
4728207|NCT01970865|16305460|P17|Overall Study|Lost to Follow-up|0
4728208|NCT01970865|16305461|P16|Overall Study|Lost to Follow-up|0
4728209|NCT01970865|16305462|P15|Overall Study|Lost to Follow-up|0
4728210|NCT01970865|16305463|P14|Overall Study|Lost to Follow-up|0
4728211|NCT01970865|16305464|P13|Overall Study|Lost to Follow-up|1
4728212|NCT01970865|16305465|P12|Overall Study|Lost to Follow-up|0
4728213|NCT01970865|16305466|P11|Overall Study|Lost to Follow-up|0
4728214|NCT01970865|16305467|P10|Overall Study|Lost to Follow-up|0
4728215|NCT01970865|16305468|P9|Overall Study|Lost to Follow-up|0
4728216|NCT01970865|16305469|P8|Overall Study|Lost to Follow-up|0
4728217|NCT01970865|16305470|P7|Overall Study|Lost to Follow-up|0
4728218|NCT01970865|16305471|P6|Overall Study|Lost to Follow-up|0
4728219|NCT01970865|16305472|P5|Overall Study|Lost to Follow-up|1
4728220|NCT01970865|16305473|P4|Overall Study|Lost to Follow-up|1
4728221|NCT01970865|16305474|P3|Overall Study|Lost to Follow-up|0
4728222|NCT01970865|16305475|P2|Overall Study|Lost to Follow-up|0
4728223|NCT01970865|16305476|P1|Overall Study|Lost to Follow-up|0
4728224|NCT01970865|16305460|P17|Overall Study|Death|1
4728225|NCT01970865|16305461|P16|Overall Study|Death|10
4728226|NCT01970865|16305462|P15|Overall Study|Death|15
4728227|NCT01970865|16305463|P14|Overall Study|Death|19
4728228|NCT01970865|16305464|P13|Overall Study|Death|14
4728229|NCT01970865|16305465|P12|Overall Study|Death|4
4728230|NCT01970865|16305466|P11|Overall Study|Death|1
4728231|NCT01970865|16305467|P10|Overall Study|Death|1
4728232|NCT01970865|16305468|P9|Overall Study|Death|2
4728233|NCT01970865|16305469|P8|Overall Study|Death|3
4728234|NCT01970865|16305470|P7|Overall Study|Death|1
4728235|NCT01970865|16305471|P6|Overall Study|Death|3
4728236|NCT01970865|16305472|P5|Overall Study|Death|6
4728237|NCT01970865|16305473|P4|Overall Study|Death|4
4728238|NCT01970865|16305474|P3|Overall Study|Death|3
4728239|NCT01970865|16305475|P2|Overall Study|Death|1
4728240|NCT01970865|16305476|P1|Overall Study|Death|3
4728241|NCT01970592|16305908|P1|Overall Study|Adverse Event|1
4728242|NCT01970592|16305908|P1|Overall Study|Physician Decision|1
4728243|NCT01970592|16305908|P1|Overall Study|Withdrawal by Subject|4
4728244|NCT01970540|16305916|P3|Overall Study|Clinical deterioration|0
4728245|NCT01970540|16305917|P2|Overall Study|Clinical deterioration|0
4728246|NCT01970540|16305918|P1|Overall Study|Clinical deterioration|1
4728247|NCT01970540|16305916|P3|Overall Study|Withdrawal by Subject|1
4728248|NCT01970540|16305917|P2|Overall Study|Withdrawal by Subject|0
4728249|NCT01970540|16305918|P1|Overall Study|Withdrawal by Subject|4
4728250|NCT01970540|16305916|P3|Overall Study|Treatment-related AE|2
4728251|NCT01970540|16305917|P2|Overall Study|Treatment-related AE|0
4728252|NCT01970540|16305918|P1|Overall Study|Treatment-related AE|4
4728253|NCT01970540|16305916|P3|Overall Study|Adverse Event|1
4728254|NCT01970540|16305917|P2|Overall Study|Adverse Event|2
4728255|NCT01970540|16305918|P1|Overall Study|Adverse Event|0
4728256|NCT01970540|16305916|P3|Overall Study|End of study|2
4728257|NCT01970540|16305917|P2|Overall Study|End of study|0
4728258|NCT01970540|16305918|P1|Overall Study|End of study|2
4728259|NCT01970540|16305916|P3|Overall Study|Clinical progression|1
4728260|NCT01970540|16305917|P2|Overall Study|Clinical progression|1
4728261|NCT01970540|16305918|P1|Overall Study|Clinical progression|0
4728262|NCT01970540|16305916|P3|Overall Study|Physician Decision|0
4728263|NCT01970540|16305917|P2|Overall Study|Physician Decision|2
4728264|NCT01970540|16305918|P1|Overall Study|Physician Decision|7
4728265|NCT01970540|16305916|P3|Overall Study|Treatment delay over protocol|1
4728266|NCT01970540|16305917|P2|Overall Study|Treatment delay over protocol|0
4728267|NCT01970540|16305918|P1|Overall Study|Treatment delay over protocol|0
4728268|NCT01970540|16305916|P3|Overall Study|Progressive disease|10
4728269|NCT01970540|16305917|P2|Overall Study|Progressive disease|23
4728270|NCT01970540|16305918|P1|Overall Study|Progressive disease|55
4728271|NCT01970540|16305916|P3|Overall Study|Non-treatment-related AE|1
4728272|NCT01970540|16305917|P2|Overall Study|Non-treatment-related AE|0
4728273|NCT01970540|16305918|P1|Overall Study|Non-treatment-related AE|0
4728274|NCT01970527|16305949|P2|Follow-up Clinic Visit|Lost to Follow-up|1
4728275|NCT01970527|16305950|P1|Follow-up Clinic Visit|Lost to Follow-up|0
4728276|NCT01970527|16305949|P2|Follow-up Clinic Visit|Withdrawal by Subject|1
4728277|NCT01970527|16305950|P1|Follow-up Clinic Visit|Withdrawal by Subject|0
4728278|NCT01970527|16305949|P2|Follow-up Clinic Visit|Disease progression|1
4728279|NCT01970527|16305950|P1|Follow-up Clinic Visit|Disease progression|1
4728280|NCT01970527|16305949|P2|Treatment|Death|1
4728281|NCT01970527|16305950|P1|Treatment|Death|0
4728282|NCT01970527|16305949|P2|Treatment|Participant did not tolerate Ipilimumab|1
4728283|NCT01970527|16305950|P1|Treatment|Participant did not tolerate Ipilimumab|0
4728284|NCT01970527|16305949|P2|Treatment|Disease progression|1
4728285|NCT01970527|16305950|P1|Treatment|Disease progression|0
4728286|NCT01970527|16305949|P2|Pre-treatment/Baseline|Screen fail- participant had brain mets|0
4728287|NCT01970527|16305950|P1|Pre-treatment/Baseline|Screen fail- participant had brain mets|1
4728288|NCT01970488|16305963|P5|Part 2: Post Week 16|Lost to Follow-up|2
4728289|NCT01970488|16305964|P4|Part 2: Post Week 16|Lost to Follow-up|1
4728290|NCT01970488|16305965|P3|Part 2: Post Week 16|Lost to Follow-up|1
4728291|NCT01970488|16305966|P2|Part 2: Post Week 16|Lost to Follow-up|0
4728292|NCT01970488|16305967|P1|Part 2: Post Week 16|Lost to Follow-up|0
4728293|NCT01970488|16305963|P5|Part 2: Post Week 16|Withdrawal by Subject|3
4728294|NCT01970488|16305964|P4|Part 2: Post Week 16|Withdrawal by Subject|3
4728295|NCT01970488|16305965|P3|Part 2: Post Week 16|Withdrawal by Subject|8
4728296|NCT01970488|16305966|P2|Part 2: Post Week 16|Withdrawal by Subject|0
4728297|NCT01970488|16305967|P1|Part 2: Post Week 16|Withdrawal by Subject|0
4728298|NCT01970488|16305963|P5|Part 2: Post Week 16|Adverse Event|1
4728299|NCT01970488|16305964|P4|Part 2: Post Week 16|Adverse Event|1
4728300|NCT01970488|16305965|P3|Part 2: Post Week 16|Adverse Event|5
4728301|NCT01970488|16305966|P2|Part 2: Post Week 16|Adverse Event|0
4728302|NCT01970488|16305967|P1|Part 2: Post Week 16|Adverse Event|0
4728303|NCT01970488|16305963|P5|Part 2: Post Week 16|Lack of Efficacy|1
4728304|NCT01970488|16305964|P4|Part 2: Post Week 16|Lack of Efficacy|3
4728305|NCT01970488|16305965|P3|Part 2: Post Week 16|Lack of Efficacy|2
4728306|NCT01970488|16305966|P2|Part 2: Post Week 16|Lack of Efficacy|0
4728307|NCT01970488|16305967|P1|Part 2: Post Week 16|Lack of Efficacy|0
4728308|NCT01970488|16305963|P5|Part 2: Post Week 16|Non-compliance|0
4728309|NCT01970488|16305964|P4|Part 2: Post Week 16|Non-compliance|0
4728310|NCT01970488|16305965|P3|Part 2: Post Week 16|Non-compliance|1
4728311|NCT01970488|16305966|P2|Part 2: Post Week 16|Non-compliance|0
4728312|NCT01970488|16305967|P1|Part 2: Post Week 16|Non-compliance|0
4728313|NCT01970488|16305963|P5|Part 2: Post Week 16|Physician Decision|1
4728314|NCT01970488|16305964|P4|Part 2: Post Week 16|Physician Decision|0
4728315|NCT01970488|16305965|P3|Part 2: Post Week 16|Physician Decision|0
4728316|NCT01970488|16305966|P2|Part 2: Post Week 16|Physician Decision|0
4728317|NCT01970488|16305967|P1|Part 2: Post Week 16|Physician Decision|0
4728318|NCT01970488|16305963|P5|Part 1: Through Week 16|Lost to Follow-up|0
4728319|NCT01970488|16305964|P4|Part 1: Through Week 16|Lost to Follow-up|0
4728320|NCT01970488|16305965|P3|Part 1: Through Week 16|Lost to Follow-up|0
4728321|NCT01970488|16305966|P2|Part 1: Through Week 16|Lost to Follow-up|2
4728322|NCT01970488|16305967|P1|Part 1: Through Week 16|Lost to Follow-up|0
4728323|NCT01970488|16305963|P5|Part 1: Through Week 16|Withdrawal by Subject|0
4728324|NCT01970488|16305964|P4|Part 1: Through Week 16|Withdrawal by Subject|0
4728325|NCT01970488|16305965|P3|Part 1: Through Week 16|Withdrawal by Subject|0
4728326|NCT01970488|16305966|P2|Part 1: Through Week 16|Withdrawal by Subject|2
4728327|NCT01970488|16305967|P1|Part 1: Through Week 16|Withdrawal by Subject|3
4728328|NCT01970488|16305963|P5|Part 1: Through Week 16|Adverse Event|0
4728329|NCT01970488|16305964|P4|Part 1: Through Week 16|Adverse Event|0
4728330|NCT01970488|16305965|P3|Part 1: Through Week 16|Adverse Event|0
4728331|NCT01970488|16305966|P2|Part 1: Through Week 16|Adverse Event|5
4728332|NCT01970488|16305967|P1|Part 1: Through Week 16|Adverse Event|6
4728333|NCT01970488|16305963|P5|Part 1: Through Week 16|Protocol Violation|0
4728334|NCT01970488|16305964|P4|Part 1: Through Week 16|Protocol Violation|0
4728335|NCT01970488|16305965|P3|Part 1: Through Week 16|Protocol Violation|0
4728336|NCT01970488|16305966|P2|Part 1: Through Week 16|Protocol Violation|2
4728337|NCT01970488|16305967|P1|Part 1: Through Week 16|Protocol Violation|1
4728338|NCT01970488|16305963|P5|Part 1: Through Week 16|Protocol-specified Criteria|0
4728339|NCT01970488|16305964|P4|Part 1: Through Week 16|Protocol-specified Criteria|0
4728340|NCT01970488|16305965|P3|Part 1: Through Week 16|Protocol-specified Criteria|0
4728341|NCT01970488|16305966|P2|Part 1: Through Week 16|Protocol-specified Criteria|2
4728342|NCT01970488|16305967|P1|Part 1: Through Week 16|Protocol-specified Criteria|1
4728343|NCT01970475|16306034|P2|Overall Study|Protocol Violation|0
4728344|NCT01970475|16306035|P1|Overall Study|Protocol Violation|1
4728345|NCT01970475|16306034|P2|Overall Study|Lost to Follow-up|2
4728346|NCT01970475|16306035|P1|Overall Study|Lost to Follow-up|2
4728347|NCT01970475|16306034|P2|Overall Study|Adverse Event|3
4728348|NCT01970475|16306035|P1|Overall Study|Adverse Event|7
4728349|NCT01970475|16306034|P2|Overall Study|Withdrawal by Subject|6
4728350|NCT01970475|16306035|P1|Overall Study|Withdrawal by Subject|11
4728351|NCT01970462|16306055|P2|Overall Study|Lost to Follow-up|2
4728352|NCT01970462|16306056|P1|Overall Study|Lost to Follow-up|0
4728353|NCT01970397|16306070|P2|Overall Study|Protocol Violation|1
4728354|NCT01970397|16306071|P1|Overall Study|Protocol Violation|1
4728355|NCT01970397|16306070|P2|Overall Study|Personal Reasons|2
4728356|NCT01970397|16306071|P1|Overall Study|Personal Reasons|1
4728357|NCT01970397|16306070|P2|Overall Study|Lost to Follow-up|1
4728358|NCT01970397|16306071|P1|Overall Study|Lost to Follow-up|0
4728359|NCT01970397|16306070|P2|Overall Study|Adverse Event|1
4728360|NCT01970397|16306071|P1|Overall Study|Adverse Event|0
4728361|NCT01970371|16306084|P3|Overall Study|Lost to Follow-up|1
4728362|NCT01970371|16306085|P2|Overall Study|Lost to Follow-up|0
4728363|NCT01970371|16306086|P1|Overall Study|Lost to Follow-up|0
4728364|NCT01970371|16306084|P3|Overall Study|Death|12
4728365|NCT01970371|16306085|P2|Overall Study|Death|13
4728366|NCT01970371|16306086|P1|Overall Study|Death|8
4728367|NCT01970241|16306111|P2|Overall Study|Steroid d/c;discharge<48 hrs.|8
4728368|NCT01970241|16306112|P1|Overall Study|Steroid d/c;discharge<48 hrs.|15
4728369|NCT01970241|16306111|P2|Overall Study|Withdrawal by Subject|0
4728370|NCT01970241|16306112|P1|Overall Study|Withdrawal by Subject|2
4728371|NCT01969851|16306172|P3|Overall Study|Sponsor decision|1
4728372|NCT01969851|16306173|P2|Overall Study|Sponsor decision|0
4728373|NCT01969851|16306174|P1|Overall Study|Sponsor decision|0
4728374|NCT01969851|16306172|P3|Overall Study|No effective dose in Titration period|1
4728375|NCT01969851|16306173|P2|Overall Study|No effective dose in Titration period|0
4728376|NCT01969851|16306174|P1|Overall Study|No effective dose in Titration period|0
4728377|NCT01969851|16306172|P3|Overall Study|Withdrawal by Subject|1
4728378|NCT01969851|16306173|P2|Overall Study|Withdrawal by Subject|0
4728379|NCT01969851|16306174|P1|Overall Study|Withdrawal by Subject|1
4728380|NCT01969851|16306172|P3|Overall Study|Lack of Efficacy|1
4728381|NCT01969851|16306173|P2|Overall Study|Lack of Efficacy|3
4728382|NCT01969851|16306174|P1|Overall Study|Lack of Efficacy|0
4728383|NCT01969851|16306172|P3|Overall Study|Adverse Event|3
4728384|NCT01969851|16306173|P2|Overall Study|Adverse Event|0
4728385|NCT01969851|16306174|P1|Overall Study|Adverse Event|0
4728386|NCT01969799|16306196|P2|Overall Study|Physician Decision|0
4728387|NCT01969799|16306197|P1|Overall Study|Physician Decision|1
4728388|NCT01969799|16306196|P2|Overall Study|Lost to Follow-up|2
4728389|NCT01969799|16306197|P1|Overall Study|Lost to Follow-up|0
4728390|NCT01969799|16306196|P2|Overall Study|Death|11
4728391|NCT01969799|16306197|P1|Overall Study|Death|16
4728392|NCT01969799|16306196|P2|Overall Study|Adverse Event|1
4728393|NCT01969799|16306197|P1|Overall Study|Adverse Event|0
4728394|NCT01969721|16306234|P4|Overall Study|Discontinued during washout periods.|2
4728395|NCT01969721|16306235|P3|Overall Study|Discontinued during washout periods.|1
4728396|NCT01969721|16306236|P2|Overall Study|Discontinued during washout periods.|1
4728397|NCT01969721|16306237|P1|Overall Study|Discontinued during washout periods.|0
4728398|NCT01969721|16306234|P4|Overall Study|Other not defined above|0
4728399|NCT01969721|16306235|P3|Overall Study|Other not defined above|0
4728400|NCT01969721|16306236|P2|Overall Study|Other not defined above|2
4728401|NCT01969721|16306237|P1|Overall Study|Other not defined above|0
4728402|NCT01969721|16306234|P4|Overall Study|Non compliant with protocol|2
4728403|NCT01969721|16306235|P3|Overall Study|Non compliant with protocol|0
4728404|NCT01969721|16306236|P2|Overall Study|Non compliant with protocol|1
4728405|NCT01969721|16306237|P1|Overall Study|Non compliant with protocol|1
4728406|NCT01969721|16306234|P4|Overall Study|Lack of Efficacy|0
4728407|NCT01969721|16306235|P3|Overall Study|Lack of Efficacy|1
4728408|NCT01969721|16306236|P2|Overall Study|Lack of Efficacy|0
4728409|NCT01969721|16306237|P1|Overall Study|Lack of Efficacy|0
4728410|NCT01969721|16306234|P4|Overall Study|Adverse Event|2
4728411|NCT01969721|16306235|P3|Overall Study|Adverse Event|3
4728412|NCT01969721|16306236|P2|Overall Study|Adverse Event|8
4728413|NCT01969721|16306237|P1|Overall Study|Adverse Event|3
4728414|NCT01969565|16306282|P1|Overall Study|Withdrawal by Subject|1
4728415|NCT01969500|16306296|P2|Overall Study|extended hospitalization|1
4728416|NCT01969500|16306297|P1|Overall Study|extended hospitalization|1
4728417|NCT01969500|16306296|P2|Overall Study|Death|1
4728418|NCT01969500|16306297|P1|Overall Study|Death|0
4728419|NCT01969084|16306418|P2|Overall Study|Adverse Event|1
4728420|NCT01969084|16306419|P1|Overall Study|Adverse Event|0
4728421|NCT01969058|16306435|P2|Overall Study|Adverse Event|0
4728422|NCT01969058|16306436|P1|Overall Study|Adverse Event|1
4728423|NCT01969058|16306435|P2|Overall Study|Withdrawal by Subject|0
4728424|NCT01969058|16306436|P1|Overall Study|Withdrawal by Subject|2
4728425|NCT01968980|16306480|P2|Overall Study|Other unspecified|2
4728426|NCT01968980|16306481|P1|Overall Study|Other unspecified|1
4728427|NCT01968980|16306480|P2|Overall Study|Withdrawal by Subject|5
4728428|NCT01968980|16306481|P1|Overall Study|Withdrawal by Subject|13
4728429|NCT01968980|16306480|P2|Overall Study|Does not meet entry criteria|3
4728430|NCT01968980|16306481|P1|Overall Study|Does not meet entry criteria|1
4728431|NCT01968980|16306480|P2|Overall Study|Adverse Event|3
4728432|NCT01968980|16306481|P1|Overall Study|Adverse Event|1
4728433|NCT01968980|16306480|P2|Overall Study|Death|1
4728434|NCT01968980|16306481|P1|Overall Study|Death|0
4728435|NCT01968967|16306543|P5|Extension Period|Withdrew Consent|5
4728436|NCT01968967|16306544|P4|Extension Period|Withdrew Consent|0
4728437|NCT01968967|16306545|P3|Extension Period|Withdrew Consent|2
4728438|NCT01968967|16306546|P2|Extension Period|Withdrew Consent|0
4728439|NCT01968967|16306547|P1|Extension Period|Withdrew Consent|0
4728440|NCT01968967|16306543|P5|Treatment Period|Randomized Not Treated|0
4728441|NCT01968967|16306544|P4|Treatment Period|Randomized Not Treated|0
4728442|NCT01968967|16306545|P3|Treatment Period|Randomized Not Treated|0
4728443|NCT01968967|16306546|P2|Treatment Period|Randomized Not Treated|5
4728444|NCT01968967|16306547|P1|Treatment Period|Randomized Not Treated|6
4728445|NCT01968967|16306543|P5|Treatment Period|Death|0
4728446|NCT01968967|16306544|P4|Treatment Period|Death|0
4728447|NCT01968967|16306545|P3|Treatment Period|Death|0
4728448|NCT01968967|16306546|P2|Treatment Period|Death|2
4728449|NCT01968967|16306547|P1|Treatment Period|Death|9
4728450|NCT01968967|16306543|P5|Treatment Period|Adverse Event|0
4728451|NCT01968967|16306544|P4|Treatment Period|Adverse Event|0
4728452|NCT01968967|16306545|P3|Treatment Period|Adverse Event|0
4728453|NCT01968967|16306546|P2|Treatment Period|Adverse Event|8
4728454|NCT01968967|16306547|P1|Treatment Period|Adverse Event|9
4728455|NCT01968967|16306543|P5|Treatment Period|Protocol Violation|0
4728456|NCT01968967|16306544|P4|Treatment Period|Protocol Violation|0
4728457|NCT01968967|16306545|P3|Treatment Period|Protocol Violation|0
4728458|NCT01968967|16306546|P2|Treatment Period|Protocol Violation|2
4728459|NCT01968967|16306547|P1|Treatment Period|Protocol Violation|1
4728460|NCT01968967|16306543|P5|Treatment Period|Lost to Follow-up|0
4728461|NCT01968967|16306544|P4|Treatment Period|Lost to Follow-up|0
4728462|NCT01968967|16306545|P3|Treatment Period|Lost to Follow-up|0
4728463|NCT01968967|16306546|P2|Treatment Period|Lost to Follow-up|31
4728464|NCT01968967|16306547|P1|Treatment Period|Lost to Follow-up|26
4728465|NCT01968967|16306543|P5|Treatment Period|Did Not Meet Entrance Criteria|0
4728466|NCT01968967|16306544|P4|Treatment Period|Did Not Meet Entrance Criteria|0
4728467|NCT01968967|16306545|P3|Treatment Period|Did Not Meet Entrance Criteria|0
4728468|NCT01968967|16306546|P2|Treatment Period|Did Not Meet Entrance Criteria|3
4728469|NCT01968967|16306547|P1|Treatment Period|Did Not Meet Entrance Criteria|2
4728470|NCT01968967|16306543|P5|Treatment Period|Withdrawal by Subject|0
4728471|NCT01968967|16306544|P4|Treatment Period|Withdrawal by Subject|0
4728472|NCT01968967|16306545|P3|Treatment Period|Withdrawal by Subject|0
4728473|NCT01968967|16306546|P2|Treatment Period|Withdrawal by Subject|61
4728474|NCT01968967|16306547|P1|Treatment Period|Withdrawal by Subject|71
4728475|NCT01968967|16306543|P5|Treatment Period|Other|0
4728476|NCT01968967|16306544|P4|Treatment Period|Other|0
4728477|NCT01968967|16306545|P3|Treatment Period|Other|0
4728478|NCT01968967|16306546|P2|Treatment Period|Other|22
4728479|NCT01968967|16306547|P1|Treatment Period|Other|22
4728480|NCT01968954|16306616|P2|Overall Study|Did not met inclusion criteria|2
4728481|NCT01968954|16306617|P1|Overall Study|Did not met inclusion criteria|0
4728482|NCT01968954|16306616|P2|Overall Study|Protocol Violation|1
4728483|NCT01968954|16306617|P1|Overall Study|Protocol Violation|0
4728484|NCT01968954|16306616|P2|Overall Study|Other|8
4728485|NCT01968954|16306617|P1|Overall Study|Other|7
4728486|NCT01968954|16306616|P2|Overall Study|Withdrawal by Subject|23
4728487|NCT01968954|16306617|P1|Overall Study|Withdrawal by Subject|20
4728488|NCT01968954|16306616|P2|Overall Study|Lost to Follow-up|4
4728489|NCT01968954|16306617|P1|Overall Study|Lost to Follow-up|6
4728490|NCT01968954|16306616|P2|Overall Study|Death|2
4728491|NCT01968954|16306617|P1|Overall Study|Death|1
4728492|NCT01968954|16306616|P2|Overall Study|Adverse Event|3
4728493|NCT01968954|16306617|P1|Overall Study|Adverse Event|6
4728494|NCT01968811|16306681|P1|Overall Study|post op.ref. of subject to other hospita|1
4728495|NCT01968811|16306681|P1|Overall Study|Protocol Violation|4
4728496|NCT01968694|16306688|P2|Washout (1 Month)|Lost to Follow-up|1
4728497|NCT01968694|16306689|P1|Washout (1 Month)|Lost to Follow-up|0
4728498|NCT01968551|16306706|P3|Extension Phase|Lost to Follow-up|1
4728499|NCT01968551|16306707|P2|Extension Phase|Lost to Follow-up|0
4728500|NCT01968551|16306708|P1|Extension Phase|Lost to Follow-up|1
4728501|NCT01968551|16306706|P3|Extension Phase|Withdrew Consent|1
4728502|NCT01968551|16306707|P2|Extension Phase|Withdrew Consent|0
4728503|NCT01968551|16306708|P1|Extension Phase|Withdrew Consent|0
4728504|NCT01968551|16306706|P3|Extension Phase|Death|0
4728505|NCT01968551|16306707|P2|Extension Phase|Death|1
4728506|NCT01968551|16306708|P1|Extension Phase|Death|0
4728507|NCT01968551|16306706|P3|Extension Phase|Adverse Event|2
4728508|NCT01968551|16306707|P2|Extension Phase|Adverse Event|0
4728509|NCT01968551|16306708|P1|Extension Phase|Adverse Event|0
4728510|NCT01968551|16306706|P3|Open Label Phase (48 Weeks)|Lost to Follow-up|2
4728511|NCT01968551|16306707|P2|Open Label Phase (48 Weeks)|Lost to Follow-up|0
4728512|NCT01968551|16306708|P1|Open Label Phase (48 Weeks)|Lost to Follow-up|0
4728513|NCT01968551|16306706|P3|Open Label Phase (48 Weeks)|Withdrew Consent|3
4728514|NCT01968551|16306707|P2|Open Label Phase (48 Weeks)|Withdrew Consent|1
4728515|NCT01968551|16306708|P1|Open Label Phase (48 Weeks)|Withdrew Consent|1
4728516|NCT01968551|16306706|P3|Open Label Phase (48 Weeks)|Investigator's Discretion|0
4728517|NCT01968551|16306707|P2|Open Label Phase (48 Weeks)|Investigator's Discretion|1
4728518|NCT01968551|16306708|P1|Open Label Phase (48 Weeks)|Investigator's Discretion|0
4728519|NCT01968551|16306706|P3|Open Label Phase (48 Weeks)|Randomized but Never Treated|0
4728520|NCT01968551|16306707|P2|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
4728521|NCT01968551|16306708|P1|Open Label Phase (48 Weeks)|Randomized but Never Treated|1
4728522|NCT01968434|16306745|P2|Overall Study|Lost to Follow-up|6
4728523|NCT01968434|16306746|P1|Overall Study|Lost to Follow-up|3
4728524|NCT01968226|16306814|P1|Overall Study|[F-18] RDG-K5 was not available|2
4728525|NCT01968213|16306820|P2|Overall Study|Ongoing|9
4728526|NCT01968213|16306821|P1|Overall Study|Ongoing|90
4728527|NCT01968070|16306863|P18|Period 2|Withdrawal by Subject|0
4728528|NCT01968070|16306864|P17|Period 2|Withdrawal by Subject|0
4728529|NCT01968070|16306865|P16|Period 2|Withdrawal by Subject|0
4728530|NCT01968070|16306866|P15|Period 2|Withdrawal by Subject|0
4728531|NCT01968070|16306867|P14|Period 2|Withdrawal by Subject|0
4728532|NCT01968070|16306868|P13|Period 2|Withdrawal by Subject|0
4728533|NCT01968070|16306869|P12|Period 2|Withdrawal by Subject|0
4728534|NCT01968070|16306870|P11|Period 2|Withdrawal by Subject|0
4728535|NCT01968070|16306871|P10|Period 2|Withdrawal by Subject|0
4728536|NCT01968070|16306872|P9|Period 2|Withdrawal by Subject|0
4728537|NCT01968070|16306873|P8|Period 2|Withdrawal by Subject|0
4728538|NCT01968070|16306874|P7|Period 2|Withdrawal by Subject|0
4728539|NCT01968070|16306875|P6|Period 2|Withdrawal by Subject|0
4728540|NCT01968070|16306876|P5|Period 2|Withdrawal by Subject|1
4728541|NCT01968070|16306877|P4|Period 2|Withdrawal by Subject|0
4728542|NCT01968070|16306878|P3|Period 2|Withdrawal by Subject|0
4728543|NCT01968070|16306879|P2|Period 2|Withdrawal by Subject|0
4728544|NCT01968070|16306880|P1|Period 2|Withdrawal by Subject|0
4728545|NCT01968070|16306863|P18|Period 1|Physician Decision|0
4728546|NCT01968070|16306864|P17|Period 1|Physician Decision|0
4728547|NCT01968070|16306865|P16|Period 1|Physician Decision|0
4728548|NCT01968070|16306866|P15|Period 1|Physician Decision|0
4728549|NCT01968070|16306867|P14|Period 1|Physician Decision|0
4728550|NCT01968070|16306868|P13|Period 1|Physician Decision|0
4728551|NCT01968070|16306869|P12|Period 1|Physician Decision|1
4728552|NCT01968070|16306870|P11|Period 1|Physician Decision|0
4728553|NCT01968070|16306871|P10|Period 1|Physician Decision|0
4728554|NCT01968070|16306872|P9|Period 1|Physician Decision|0
4728555|NCT01968070|16306873|P8|Period 1|Physician Decision|0
4728556|NCT01968070|16306874|P7|Period 1|Physician Decision|0
4728557|NCT01968070|16306875|P6|Period 1|Physician Decision|0
4728558|NCT01968070|16306876|P5|Period 1|Physician Decision|0
4728559|NCT01968070|16306877|P4|Period 1|Physician Decision|0
4728560|NCT01968070|16306878|P3|Period 1|Physician Decision|0
4728561|NCT01968070|16306879|P2|Period 1|Physician Decision|0
4728562|NCT01968070|16306880|P1|Period 1|Physician Decision|0
4728563|NCT01968070|16306863|P18|Period 1|Adverse Event|0
4728564|NCT01968070|16306864|P17|Period 1|Adverse Event|0
4728565|NCT01968070|16306865|P16|Period 1|Adverse Event|0
4728566|NCT01968070|16306866|P15|Period 1|Adverse Event|0
4728567|NCT01968070|16306867|P14|Period 1|Adverse Event|0
4728568|NCT01968070|16306868|P13|Period 1|Adverse Event|0
4728569|NCT01968070|16306869|P12|Period 1|Adverse Event|0
4728570|NCT01968070|16306870|P11|Period 1|Adverse Event|0
4728571|NCT01968070|16306871|P10|Period 1|Adverse Event|0
4728572|NCT01968070|16306872|P9|Period 1|Adverse Event|0
4728573|NCT01968070|16306873|P8|Period 1|Adverse Event|0
4728574|NCT01968070|16306874|P7|Period 1|Adverse Event|1
4728575|NCT01968070|16306875|P6|Period 1|Adverse Event|0
4728576|NCT01968070|16306876|P5|Period 1|Adverse Event|0
4728577|NCT01968070|16306877|P4|Period 1|Adverse Event|0
4728578|NCT01968070|16306878|P3|Period 1|Adverse Event|0
4728579|NCT01968070|16306879|P2|Period 1|Adverse Event|0
4728580|NCT01968070|16306880|P1|Period 1|Adverse Event|0
4728581|NCT01968070|16306863|P18|Period 1|Lost to Follow-up|0
4728582|NCT01968070|16306864|P17|Period 1|Lost to Follow-up|0
4728583|NCT01968070|16306865|P16|Period 1|Lost to Follow-up|0
4728584|NCT01968070|16306866|P15|Period 1|Lost to Follow-up|0
4728585|NCT01968070|16306867|P14|Period 1|Lost to Follow-up|0
4728586|NCT01968070|16306868|P13|Period 1|Lost to Follow-up|0
4728587|NCT01968070|16306869|P12|Period 1|Lost to Follow-up|0
4728588|NCT01968070|16306870|P11|Period 1|Lost to Follow-up|0
4728589|NCT01968070|16306871|P10|Period 1|Lost to Follow-up|0
4728590|NCT01968070|16306872|P9|Period 1|Lost to Follow-up|0
4728591|NCT01968070|16306873|P8|Period 1|Lost to Follow-up|0
4728592|NCT01968070|16306874|P7|Period 1|Lost to Follow-up|0
4728593|NCT01968070|16306875|P6|Period 1|Lost to Follow-up|0
4728594|NCT01968070|16306876|P5|Period 1|Lost to Follow-up|0
4728595|NCT01968070|16306877|P4|Period 1|Lost to Follow-up|1
4728596|NCT01968070|16306878|P3|Period 1|Lost to Follow-up|0
4728597|NCT01968070|16306879|P2|Period 1|Lost to Follow-up|0
4728598|NCT01968070|16306880|P1|Period 1|Lost to Follow-up|0
4728599|NCT01968070|16306863|P18|Period 1|Protocol Violation|0
4728600|NCT01968070|16306864|P17|Period 1|Protocol Violation|0
4728601|NCT01968070|16306865|P16|Period 1|Protocol Violation|0
4728602|NCT01968070|16306866|P15|Period 1|Protocol Violation|0
4728603|NCT01968070|16306867|P14|Period 1|Protocol Violation|0
4728604|NCT01968070|16306868|P13|Period 1|Protocol Violation|0
4728605|NCT01968070|16306869|P12|Period 1|Protocol Violation|0
4728606|NCT01968070|16306870|P11|Period 1|Protocol Violation|0
4728607|NCT01968070|16306871|P10|Period 1|Protocol Violation|0
4728608|NCT01968070|16306872|P9|Period 1|Protocol Violation|0
4728609|NCT01968070|16306873|P8|Period 1|Protocol Violation|0
4728610|NCT01968070|16306874|P7|Period 1|Protocol Violation|0
4728611|NCT01968070|16306875|P6|Period 1|Protocol Violation|0
4728612|NCT01968070|16306876|P5|Period 1|Protocol Violation|1
4728613|NCT01968070|16306877|P4|Period 1|Protocol Violation|1
4728614|NCT01968070|16306878|P3|Period 1|Protocol Violation|0
4728615|NCT01968070|16306879|P2|Period 1|Protocol Violation|0
4728616|NCT01968070|16306880|P1|Period 1|Protocol Violation|0
4728617|NCT01968070|16306863|P18|Period 1|Withdrawal by Subject|0
4728618|NCT01968070|16306864|P17|Period 1|Withdrawal by Subject|0
4728619|NCT01968070|16306865|P16|Period 1|Withdrawal by Subject|1
4728620|NCT01968070|16306866|P15|Period 1|Withdrawal by Subject|0
4728621|NCT01968070|16306867|P14|Period 1|Withdrawal by Subject|0
4728622|NCT01968070|16306868|P13|Period 1|Withdrawal by Subject|0
4728623|NCT01968070|16306869|P12|Period 1|Withdrawal by Subject|0
4728624|NCT01968070|16306870|P11|Period 1|Withdrawal by Subject|0
4728625|NCT01968070|16306871|P10|Period 1|Withdrawal by Subject|0
4728626|NCT01968070|16306872|P9|Period 1|Withdrawal by Subject|0
4728627|NCT01968070|16306873|P8|Period 1|Withdrawal by Subject|0
4728628|NCT01968070|16306874|P7|Period 1|Withdrawal by Subject|1
4728629|NCT01968070|16306875|P6|Period 1|Withdrawal by Subject|0
4728630|NCT01968070|16306876|P5|Period 1|Withdrawal by Subject|0
4728631|NCT01968070|16306877|P4|Period 1|Withdrawal by Subject|0
4728632|NCT01968070|16306878|P3|Period 1|Withdrawal by Subject|0
4728633|NCT01968070|16306879|P2|Period 1|Withdrawal by Subject|1
4728634|NCT01968070|16306880|P1|Period 1|Withdrawal by Subject|0
4728635|NCT01967940|16306951|P4|Part 2|Unknown Reason|1
4728636|NCT01967940|16306952|P3|Part 2|Unknown Reason|0
4728637|NCT01967940|16306953|P2|Part 2|Unknown Reason|0
4728638|NCT01967940|16306954|P1|Part 2|Unknown Reason|0
4728639|NCT01967940|16306951|P4|Part 2|Adverse Event|1
4728640|NCT01967940|16306952|P3|Part 2|Adverse Event|0
4728641|NCT01967940|16306953|P2|Part 2|Adverse Event|0
4728642|NCT01967940|16306954|P1|Part 2|Adverse Event|0
4728643|NCT01967940|16306951|P4|Part 2|Enrolled in Part 2 and Never Treated|1
4728644|NCT01967940|16306952|P3|Part 2|Enrolled in Part 2 and Never Treated|0
4728645|NCT01967940|16306953|P2|Part 2|Enrolled in Part 2 and Never Treated|0
4728646|NCT01967940|16306954|P1|Part 2|Enrolled in Part 2 and Never Treated|0
4728647|NCT01967888|16306982|P2|Overall Study|Subject Unable To Comply With Final Day|1
4728648|NCT01967888|16306983|P1|Overall Study|Subject Unable To Comply With Final Day|0
4728649|NCT01967888|16306982|P2|Overall Study|Patient didn't proceed to pancreatectomy|1
4728650|NCT01967888|16306983|P1|Overall Study|Patient didn't proceed to pancreatectomy|0
4728651|NCT01967888|16306982|P2|Overall Study|Subject excluded after randomization|0
4728652|NCT01967888|16306983|P1|Overall Study|Subject excluded after randomization|1
4728653|NCT01967888|16306982|P2|Overall Study|Research visit not done, data recorded|0
4728654|NCT01967888|16306983|P1|Overall Study|Research visit not done, data recorded|1
4728655|NCT01967888|16306982|P2|Overall Study|Did Not Have Transplant|0
4728656|NCT01967888|16306983|P1|Overall Study|Did Not Have Transplant|1
4728657|NCT01967888|16306982|P2|Overall Study|Withdrawal by Subject|1
4728658|NCT01967888|16306983|P1|Overall Study|Withdrawal by Subject|1
4728659|NCT01967888|16306982|P2|Overall Study|Lost to Follow-up|4
4728660|NCT01967888|16306983|P1|Overall Study|Lost to Follow-up|6
4728661|NCT01967732|16307071|P4|First Intervention (Day 1)|Poor venous access|0
4728662|NCT01967732|16307072|P3|First Intervention (Day 1)|Poor venous access|0
4728663|NCT01967732|16307073|P2|First Intervention (Day 1)|Poor venous access|1
4728664|NCT01967732|16307074|P1|First Intervention (Day 1)|Poor venous access|0
4728665|NCT01967732|16307071|P4|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
4728666|NCT01967732|16307072|P3|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
4728667|NCT01967732|16307073|P2|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1
4728668|NCT01967732|16307074|P1|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0
4728669|NCT01967719|16307088|P4|Second Intervention (Day 3)|Withdrawal by Subject|0
4728670|NCT01967719|16307089|P3|Second Intervention (Day 3)|Withdrawal by Subject|0
4728671|NCT01967719|16307090|P2|Second Intervention (Day 3)|Withdrawal by Subject|1
4728672|NCT01967719|16307091|P1|Second Intervention (Day 3)|Withdrawal by Subject|0
4728673|NCT01967719|16307088|P4|First Intervention (Day 1)|Withdrawal by Subject|1
4728674|NCT01967719|16307089|P3|First Intervention (Day 1)|Withdrawal by Subject|0
4728675|NCT01967719|16307090|P2|First Intervention (Day 1)|Withdrawal by Subject|1
4728676|NCT01967719|16307091|P1|First Intervention (Day 1)|Withdrawal by Subject|0
4728677|NCT01967706|16307106|P4|First Intervention (Day 1)|Withdrawal by Subject|0
4728678|NCT01967706|16307107|P3|First Intervention (Day 1)|Withdrawal by Subject|0
4728679|NCT01967706|16307108|P2|First Intervention (Day 1)|Withdrawal by Subject|0
4728680|NCT01967706|16307109|P1|First Intervention (Day 1)|Withdrawal by Subject|1
4728681|NCT01967628|16307130|P2|Overall Study|Low protein concentration in sample|25
4728682|NCT01967628|16307131|P1|Overall Study|Low protein concentration in sample|20
4728683|NCT01967628|16307130|P2|Overall Study|Lost to Follow-up|0
4728684|NCT01967628|16307131|P1|Overall Study|Lost to Follow-up|1
4728685|NCT01967628|16307130|P2|Overall Study|Unable to complete bronchoscopy|6
4728686|NCT01967628|16307131|P1|Overall Study|Unable to complete bronchoscopy|4
4728687|NCT01967628|16307130|P2|Overall Study|Withdrawal by Subject|0
4728688|NCT01967628|16307131|P1|Overall Study|Withdrawal by Subject|2
4728689|NCT01967576|16307137|P1|Overall Study|Refused further treatment|1
4728690|NCT01967576|16307137|P1|Overall Study|Adverse Event|1
4728691|NCT01967576|16307137|P1|Overall Study|Study closing at site|1
4728692|NCT01967576|16307137|P1|Overall Study|Progressed/Removed from treatment|1
4728693|NCT01967576|16307137|P1|Overall Study|Withdrawal by Subject|3
4728694|NCT01967550|16307148|P2|Overall Study|Non Compliance|1
4728695|NCT01967550|16307149|P1|Overall Study|Non Compliance|0
4728696|NCT01967550|16307148|P2|Overall Study|Protocol Violation|1
4728697|NCT01967550|16307149|P1|Overall Study|Protocol Violation|2
4728698|NCT01967550|16307148|P2|Overall Study|Adverse Event|0
4728699|NCT01967550|16307149|P1|Overall Study|Adverse Event|2
4728700|NCT01967550|16307148|P2|Overall Study|Withdrawal by Subject|0
4728701|NCT01967550|16307149|P1|Overall Study|Withdrawal by Subject|1
4728702|NCT01967537|16307155|P1|Overall Study|Lost to Follow-up|6
4728703|NCT01967537|16307155|P1|Overall Study|Refuse treatment|2
4728704|NCT01967537|16307155|P1|Overall Study|Withdrawal by Subject|52
4728705|NCT01967277|16307209|P2|Overall Study|Unrelated illness|1
4728706|NCT01967277|16307210|P1|Overall Study|Unrelated illness|0
4728707|NCT01967277|16307209|P2|Overall Study|Lost to Follow-up|2
4728708|NCT01967277|16307210|P1|Overall Study|Lost to Follow-up|1
4728709|NCT01967225|16307222|P2|Overall Study|Protocol Violation|0
4728710|NCT01967225|16307223|P1|Overall Study|Protocol Violation|2
4728711|NCT01967225|16307222|P2|Overall Study|Logistical difficulties|0
4728712|NCT01967225|16307223|P1|Overall Study|Logistical difficulties|1
4728713|NCT01967225|16307222|P2|Overall Study|Protocol driven decision point|0
4728714|NCT01967225|16307223|P1|Overall Study|Protocol driven decision point|1
4728715|NCT01967225|16307222|P2|Overall Study|Switching to other therapy|0
4728716|NCT01967225|16307223|P1|Overall Study|Switching to other therapy|2
4728717|NCT01967225|16307222|P2|Overall Study|Lack of Efficacy|1
4728718|NCT01967225|16307223|P1|Overall Study|Lack of Efficacy|1
4728719|NCT01967225|16307222|P2|Overall Study|Withdrawal by Subject|1
4728720|NCT01967225|16307223|P1|Overall Study|Withdrawal by Subject|2
4728721|NCT01967225|16307222|P2|Overall Study|Adverse Event|1
4728722|NCT01967225|16307223|P1|Overall Study|Adverse Event|3
4728723|NCT01967173|16307255|P8|Overall Study|Withdrawal by Subject|12
4728724|NCT01967173|16307256|P7|Overall Study|Withdrawal by Subject|10
4728725|NCT01967173|16307257|P6|Overall Study|Withdrawal by Subject|9
4728726|NCT01967173|16307258|P5|Overall Study|Withdrawal by Subject|8
4728727|NCT01967173|16307259|P4|Overall Study|Withdrawal by Subject|7
4728728|NCT01967173|16307260|P3|Overall Study|Withdrawal by Subject|10
4728729|NCT01967173|16307261|P2|Overall Study|Withdrawal by Subject|14
4728730|NCT01967173|16307262|P1|Overall Study|Withdrawal by Subject|15
4728731|NCT01967173|16307255|P8|Overall Study|Adverse Event|1
4728732|NCT01967173|16307256|P7|Overall Study|Adverse Event|0
4728733|NCT01967173|16307257|P6|Overall Study|Adverse Event|0
4728734|NCT01967173|16307258|P5|Overall Study|Adverse Event|0
4728735|NCT01967173|16307259|P4|Overall Study|Adverse Event|0
4728736|NCT01967173|16307260|P3|Overall Study|Adverse Event|0
4728737|NCT01967173|16307261|P2|Overall Study|Adverse Event|0
4728738|NCT01967173|16307262|P1|Overall Study|Adverse Event|0
4728739|NCT01967173|16307255|P8|Overall Study|Pregnancy|1
4728740|NCT01967173|16307256|P7|Overall Study|Pregnancy|1
4728741|NCT01967173|16307257|P6|Overall Study|Pregnancy|0
4728742|NCT01967173|16307258|P5|Overall Study|Pregnancy|0
4728743|NCT01967173|16307259|P4|Overall Study|Pregnancy|0
4728744|NCT01967173|16307260|P3|Overall Study|Pregnancy|0
4728745|NCT01967173|16307261|P2|Overall Study|Pregnancy|0
4728746|NCT01967173|16307262|P1|Overall Study|Pregnancy|0
4728747|NCT01967173|16307255|P8|Overall Study|Lack of Efficacy|2
4728748|NCT01967173|16307256|P7|Overall Study|Lack of Efficacy|0
4728749|NCT01967173|16307257|P6|Overall Study|Lack of Efficacy|1
4728750|NCT01967173|16307258|P5|Overall Study|Lack of Efficacy|0
4728751|NCT01967173|16307259|P4|Overall Study|Lack of Efficacy|2
4728752|NCT01967173|16307260|P3|Overall Study|Lack of Efficacy|2
4728753|NCT01967173|16307261|P2|Overall Study|Lack of Efficacy|0
4728754|NCT01967173|16307262|P1|Overall Study|Lack of Efficacy|2
4728755|NCT01967173|16307255|P8|Overall Study|Physician Decision|0
4728756|NCT01967173|16307256|P7|Overall Study|Physician Decision|1
4728757|NCT01967173|16307257|P6|Overall Study|Physician Decision|1
4728758|NCT01967173|16307258|P5|Overall Study|Physician Decision|1
4728759|NCT01967173|16307259|P4|Overall Study|Physician Decision|1
4728760|NCT01967173|16307260|P3|Overall Study|Physician Decision|2
4728761|NCT01967173|16307261|P2|Overall Study|Physician Decision|0
4728762|NCT01967173|16307262|P1|Overall Study|Physician Decision|2
4728763|NCT01967173|16307255|P8|Overall Study|Lost to Follow-up|8
4728764|NCT01967173|16307256|P7|Overall Study|Lost to Follow-up|6
4728765|NCT01967173|16307257|P6|Overall Study|Lost to Follow-up|12
4728766|NCT01967173|16307258|P5|Overall Study|Lost to Follow-up|8
4728767|NCT01967173|16307259|P4|Overall Study|Lost to Follow-up|4
4728768|NCT01967173|16307260|P3|Overall Study|Lost to Follow-up|2
4728769|NCT01967173|16307261|P2|Overall Study|Lost to Follow-up|3
4728770|NCT01967173|16307262|P1|Overall Study|Lost to Follow-up|5
4728771|NCT01967147|16307276|P2|Overall Study|Other|5
4728772|NCT01967147|16307277|P1|Overall Study|Other|4
4728773|NCT01967147|16307276|P2|Overall Study|Non-compliance with Study Drug|3
4728774|NCT01967147|16307277|P1|Overall Study|Non-compliance with Study Drug|0
4728775|NCT01967147|16307276|P2|Overall Study|Withdrawal by Subject|4
4728776|NCT01967147|16307277|P1|Overall Study|Withdrawal by Subject|2
4728777|NCT01967147|16307276|P2|Overall Study|Lost to Follow-up|2
4728778|NCT01967147|16307277|P1|Overall Study|Lost to Follow-up|1
4728779|NCT01967147|16307276|P2|Overall Study|Lack of Efficacy|4
4728780|NCT01967147|16307277|P1|Overall Study|Lack of Efficacy|1
4728781|NCT01967147|16307276|P2|Overall Study|Adverse Event|2
4728782|NCT01967147|16307277|P1|Overall Study|Adverse Event|5
4728783|NCT01967134|16307295|P3|Overall Study|Lost to Follow-up|0
4728784|NCT01967134|16307296|P2|Overall Study|Lost to Follow-up|1
4728785|NCT01967134|16307297|P1|Overall Study|Lost to Follow-up|0
4728786|NCT01967069|16307332|P2|Overall Study|Lack of Efficacy|1
4728787|NCT01967069|16307333|P1|Overall Study|Lack of Efficacy|0
4728788|NCT01967069|16307332|P2|Overall Study|Withdrawal by Subject|3
4728789|NCT01967069|16307333|P1|Overall Study|Withdrawal by Subject|1
4728790|NCT01967069|16307332|P2|Overall Study|Lost to Follow-up|2
4728791|NCT01967069|16307333|P1|Overall Study|Lost to Follow-up|5
4728792|NCT01967069|16307332|P2|Overall Study|Adverse Event|2
4728793|NCT01967069|16307333|P1|Overall Study|Adverse Event|2
4728794|NCT01966445|16307557|P7|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2
4728795|NCT01966445|16307558|P6|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4728796|NCT01966445|16307559|P5|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4728797|NCT01966445|16307560|P4|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4728798|NCT01966445|16307561|P3|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4728799|NCT01966445|16307562|P2|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4728800|NCT01966445|16307563|P1|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0
4728801|NCT01966445|16307557|P7|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3
4728802|NCT01966445|16307558|P6|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4728803|NCT01966445|16307559|P5|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4728804|NCT01966445|16307560|P4|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4728805|NCT01966445|16307561|P3|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4728806|NCT01966445|16307562|P2|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4728807|NCT01966445|16307563|P1|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0
4728808|NCT01966445|16307557|P7|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4728809|NCT01966445|16307558|P6|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4728810|NCT01966445|16307559|P5|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2
4728811|NCT01966445|16307560|P4|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4728812|NCT01966445|16307561|P3|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
4728813|NCT01966445|16307562|P2|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1
4728814|NCT01966445|16307563|P1|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0
4728815|NCT01966445|16307557|P7|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4728816|NCT01966445|16307558|P6|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4728817|NCT01966445|16307559|P5|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
4728818|NCT01966445|16307560|P4|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
4728819|NCT01966445|16307561|P3|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4728820|NCT01966445|16307562|P2|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1
4728821|NCT01966445|16307563|P1|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0
4728822|NCT01966445|16307557|P7|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4729079|NCT01963611|16308723|P4|Overall Study|Withdrawal by Subject|1
4728823|NCT01966445|16307558|P6|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1
4728824|NCT01966445|16307559|P5|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4728825|NCT01966445|16307560|P4|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2
4728826|NCT01966445|16307561|P3|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4728827|NCT01966445|16307562|P2|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4728828|NCT01966445|16307563|P1|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0
4728829|NCT01966432|16307673|P3|Overall Study|SBIRT program ended|20
4728830|NCT01966432|16307674|P2|Overall Study|SBIRT program ended|8
4728831|NCT01966432|16307675|P1|Overall Study|SBIRT program ended|1
4728832|NCT01966432|16307673|P3|Overall Study|Subject Incarcerated|1
4728833|NCT01966432|16307674|P2|Overall Study|Subject Incarcerated|0
4728834|NCT01966432|16307675|P1|Overall Study|Subject Incarcerated|0
4728835|NCT01966432|16307673|P3|Overall Study|Withdrawal by Subject|0
4728836|NCT01966432|16307674|P2|Overall Study|Withdrawal by Subject|3
4728837|NCT01966432|16307675|P1|Overall Study|Withdrawal by Subject|1
4728838|NCT01966432|16307673|P3|Overall Study|Lost to Follow-up|5
4728839|NCT01966432|16307674|P2|Overall Study|Lost to Follow-up|2
4728840|NCT01966432|16307675|P1|Overall Study|Lost to Follow-up|3
4728841|NCT01966120|16307745|P2|Overall Study|Lost to Follow-up|1
4728842|NCT01966120|16307746|P1|Overall Study|Lost to Follow-up|1
4728843|NCT01966120|16307745|P2|Overall Study|Withdrawal by Subject|5
4728844|NCT01966120|16307746|P1|Overall Study|Withdrawal by Subject|0
4728845|NCT01966107|16307770|P2|Overall Study|withdrew from the study|303
4728846|NCT01966107|16307771|P1|Overall Study|withdrew from the study|272
4728847|NCT01966107|16307770|P2|Overall Study|due to study closure|186
4728848|NCT01966107|16307771|P1|Overall Study|due to study closure|164
4728849|NCT01966107|16307770|P2|Overall Study|discontinued treatment|372
4728850|NCT01966107|16307771|P1|Overall Study|discontinued treatment|345
4728851|NCT01966107|16307770|P2|Overall Study|excluded from FAS|20
4728852|NCT01966107|16307771|P1|Overall Study|excluded from FAS|21
4728853|NCT01966068|16307785|P1|Overall Study|Lost to Follow-up|81
4728854|NCT01966068|16307785|P1|Overall Study|Withdrawal by Subject|57
4728855|NCT01966042|16307790|P1|Overall Study|Death|2
4728856|NCT01966003|16307799|P2|Overall Study|Other|1
4728857|NCT01966003|16307800|P1|Overall Study|Other|1
4728858|NCT01966003|16307799|P2|Overall Study|Plan to Receive Commercial Bevacizumab|67
4728859|NCT01966003|16307800|P1|Overall Study|Plan to Receive Commercial Bevacizumab|44
4728860|NCT01966003|16307799|P2|Overall Study|Plan to Receive Other Anticancer Therapy|127
4728861|NCT01966003|16307800|P1|Overall Study|Plan to Receive Other Anticancer Therapy|131
4728862|NCT01966003|16307799|P2|Overall Study|Withdrawal by Subject|19
4728863|NCT01966003|16307800|P1|Overall Study|Withdrawal by Subject|29
4728864|NCT01966003|16307799|P2|Overall Study|Physician Decision|13
4728865|NCT01966003|16307800|P1|Overall Study|Physician Decision|12
4728866|NCT01966003|16307799|P2|Overall Study|Lost to Follow-up|3
4728867|NCT01966003|16307800|P1|Overall Study|Lost to Follow-up|4
4728868|NCT01966003|16307799|P2|Overall Study|Protocol Violation|4
4728869|NCT01966003|16307800|P1|Overall Study|Protocol Violation|6
4728870|NCT01966003|16307799|P2|Overall Study|Death|36
4728871|NCT01966003|16307800|P1|Overall Study|Death|43
4728872|NCT01965938|16307818|P2|Overall Study|Withdrawal by Subject|0
4728873|NCT01965938|16307819|P1|Overall Study|Withdrawal by Subject|1
4728874|NCT01965834|16307850|P1|Overall Study|Lack of Efficacy|4
4728875|NCT01965652|16307891|P2|Overall Study|Pregnancy|1
4728876|NCT01965652|16307892|P1|Overall Study|Pregnancy|0
4728877|NCT01965652|16307891|P2|Overall Study|Other - Miscellaneous|21
4728878|NCT01965652|16307892|P1|Overall Study|Other - Miscellaneous|18
4728879|NCT01965652|16307891|P2|Overall Study|Death|4
4728880|NCT01965652|16307892|P1|Overall Study|Death|3
4728881|NCT01965652|16307891|P2|Overall Study|Protocol Violation|38
4728882|NCT01965652|16307892|P1|Overall Study|Protocol Violation|34
4728883|NCT01965652|16307891|P2|Overall Study|Lost to Follow-up|40
4728884|NCT01965652|16307892|P1|Overall Study|Lost to Follow-up|53
4728885|NCT01965652|16307891|P2|Overall Study|Withdrawal by Subject|69
4728886|NCT01965652|16307892|P1|Overall Study|Withdrawal by Subject|62
4728887|NCT01965652|16307891|P2|Overall Study|Adverse Event|37
4728888|NCT01965652|16307892|P1|Overall Study|Adverse Event|40
4728889|NCT01965600|16307922|P4|Second Intervention|Study terminated by Sponsor|2
4728890|NCT01965600|16307923|P3|Second Intervention|Study terminated by Sponsor|2
4728891|NCT01965600|16307924|P2|Second Intervention|Study terminated by Sponsor|0
4728892|NCT01965600|16307925|P1|Second Intervention|Study terminated by Sponsor|0
4728893|NCT01965600|16307922|P4|Washout Period of Approximately 15 Days|Adverse Event|1
4728894|NCT01965600|16307923|P3|Washout Period of Approximately 15 Days|Adverse Event|0
4728895|NCT01965600|16307924|P2|Washout Period of Approximately 15 Days|Adverse Event|0
4728896|NCT01965600|16307925|P1|Washout Period of Approximately 15 Days|Adverse Event|0
4728897|NCT01965600|16307922|P4|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
4728898|NCT01965600|16307923|P3|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
4728899|NCT01965600|16307924|P2|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0
4728900|NCT01965600|16307925|P1|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1
4728901|NCT01965600|16307922|P4|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
4728902|NCT01965600|16307923|P3|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
4728903|NCT01965600|16307924|P2|Washout Period of Approximately 15 Days|Withdrawal by Subject|1
4728904|NCT01965600|16307925|P1|Washout Period of Approximately 15 Days|Withdrawal by Subject|0
4728905|NCT01965600|16307922|P4|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
4728906|NCT01965600|16307923|P3|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2
4728907|NCT01965600|16307924|P2|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3
4728908|NCT01965600|16307925|P1|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1
4728909|NCT01965535|16307982|P2|Overall Study|Lack of Efficacy|1
4728910|NCT01965535|16307983|P1|Overall Study|Lack of Efficacy|2
4728911|NCT01965431|16307997|P6|Overall Study|Other than stated above|6
4728912|NCT01965431|16307998|P5|Overall Study|Other than stated above|6
4728913|NCT01965431|16307999|P4|Overall Study|Other than stated above|6
4728914|NCT01965431|16308000|P3|Overall Study|Other than stated above|6
4728915|NCT01965431|16308001|P2|Overall Study|Other than stated above|5
4728916|NCT01965431|16308002|P1|Overall Study|Other than stated above|6
4728917|NCT01965431|16307997|P6|Overall Study|Adverse Event|0
4728918|NCT01965431|16307998|P5|Overall Study|Adverse Event|0
4728919|NCT01965431|16307999|P4|Overall Study|Adverse Event|0
4728920|NCT01965431|16308000|P3|Overall Study|Adverse Event|0
4728921|NCT01965431|16308001|P2|Overall Study|Adverse Event|1
4728922|NCT01965431|16308002|P1|Overall Study|Adverse Event|0
4728923|NCT01965327|16308026|P1|Overall Study|Physician Decision|2
4728924|NCT01965262|16308240|P2|Second Intervention (7 Days)|Poor visual acuity|0
4728925|NCT01965262|16308241|P1|Second Intervention (7 Days)|Poor visual acuity|1
4728926|NCT01965262|16308240|P2|Second Intervention (7 Days)|Poor lens fit|9
4728927|NCT01965262|16308241|P1|Second Intervention (7 Days)|Poor lens fit|0
4728928|NCT01965262|16308240|P2|Second Intervention (7 Days)|Discontinued|1
4728929|NCT01965262|16308241|P1|Second Intervention (7 Days)|Discontinued|0
4728930|NCT01965158|16308305|P2|Overall Study|Other - Miscellaneous|0
4728931|NCT01965158|16308306|P1|Overall Study|Other - Miscellaneous|3
4728932|NCT01965158|16308305|P2|Overall Study|Protocol Violation|1
4728933|NCT01965158|16308306|P1|Overall Study|Protocol Violation|1
4728934|NCT01965158|16308305|P2|Overall Study|Lost to Follow-up|5
4728935|NCT01965158|16308306|P1|Overall Study|Lost to Follow-up|7
4728936|NCT01965158|16308305|P2|Overall Study|Withdrawal by Subject|24
4728937|NCT01965158|16308306|P1|Overall Study|Withdrawal by Subject|16
4728938|NCT01965158|16308305|P2|Overall Study|Adverse Event|5
4728939|NCT01965158|16308306|P1|Overall Study|Adverse Event|14
4728940|NCT01964976|16308347|P1|Overall Study|Protocol Violation|31
4728941|NCT01964963|16308359|P1|Overall Study|Data Reliability was not Assured|5
4728942|NCT01964963|16308359|P1|Overall Study|Protocol Deviation|50
4728943|NCT01964963|16308359|P1|Overall Study|Case Report Forms Uncollected|888
4728944|NCT01964950|16308367|P1|Overall Study|Protocol Violation|25
4728945|NCT01964924|16308379|P2|Trametinib Monotherapy|Progression|0
4728946|NCT01964924|16308380|P1|Trametinib Monotherapy|Progression|19
4728947|NCT01964898|16308404|P2|Overall Study|Withdrawal by Subject|0
4728948|NCT01964898|16308405|P1|Overall Study|Withdrawal by Subject|1
4728949|NCT01964898|16308404|P2|Overall Study|Lost to Follow-up|5
4728950|NCT01964898|16308405|P1|Overall Study|Lost to Follow-up|3
4728951|NCT01964898|16308404|P2|Overall Study|did not receive the allocated interventi|1
4728952|NCT01964898|16308405|P1|Overall Study|did not receive the allocated interventi|2
4728953|NCT01964898|16308404|P2|Overall Study|ineligible post-randomization|1
4728954|NCT01964898|16308405|P1|Overall Study|ineligible post-randomization|1
4728955|NCT01964755|16308425|P1|Overall Study|Death|2
4728956|NCT01964716|16308440|P2|Overall Study|Death|0
4728957|NCT01964716|16308441|P1|Overall Study|Death|1
4728958|NCT01964716|16308440|P2|Overall Study|No longer met eligibility criteria|1
4728959|NCT01964716|16308441|P1|Overall Study|No longer met eligibility criteria|1
4728960|NCT01964716|16308440|P2|Overall Study|Lost to Follow-up|2
4728961|NCT01964716|16308441|P1|Overall Study|Lost to Follow-up|1
4728962|NCT01964716|16308440|P2|Overall Study|Withdrawal by Subject|3
4728963|NCT01964716|16308441|P1|Overall Study|Withdrawal by Subject|2
4728964|NCT01964547|16308479|P2|Overall Study|Withdrawal by Investigator|1
4728965|NCT01964547|16308480|P1|Overall Study|Withdrawal by Investigator|0
4728966|NCT01964547|16308479|P2|Overall Study|Lost to Follow-up|1
4728967|NCT01964547|16308480|P1|Overall Study|Lost to Follow-up|0
4728968|NCT01964547|16308479|P2|Overall Study|Withdrawal by Subject|7
4728969|NCT01964547|16308480|P1|Overall Study|Withdrawal by Subject|4
4728970|NCT01964547|16308479|P2|Overall Study|Adverse Event|2
4728971|NCT01964547|16308480|P1|Overall Study|Adverse Event|8
4728972|NCT01964521|16308504|P1|Overall Study|Lost to Follow-up|4
4728973|NCT01964430|16308511|P2|Overall Study|Randomized but not Treated|11
4728974|NCT01964430|16308512|P1|Overall Study|Randomized but not Treated|3
4728975|NCT01964430|16308511|P2|Overall Study|Miscellaneous|3
4728976|NCT01964430|16308512|P1|Overall Study|Miscellaneous|1
4728977|NCT01964430|16308511|P2|Overall Study|Disease Relapse|38
4728978|NCT01964430|16308512|P1|Overall Study|Disease Relapse|28
4728979|NCT01964430|16308511|P2|Overall Study|Physician Decision|4
4728980|NCT01964430|16308512|P1|Overall Study|Physician Decision|5
4728981|NCT01964430|16308511|P2|Overall Study|Protocol Deviation|1
4728982|NCT01964430|16308512|P1|Overall Study|Protocol Deviation|0
4728983|NCT01964430|16308511|P2|Overall Study|Death|3
4728984|NCT01964430|16308512|P1|Overall Study|Death|1
4728985|NCT01964430|16308511|P2|Overall Study|Withdrawal by Subject|27
4728986|NCT01964430|16308512|P1|Overall Study|Withdrawal by Subject|36
4728987|NCT01964430|16308511|P2|Overall Study|Adverse Event|37
4728988|NCT01964430|16308512|P1|Overall Study|Adverse Event|71
4728989|NCT01964378|16308524|P2|Overall Study|Other|2
4728990|NCT01964378|16308525|P1|Overall Study|Other|1
4728991|NCT01964378|16308524|P2|Overall Study|Inclusion/exclusion criteria not met|3
4728992|NCT01964378|16308525|P1|Overall Study|Inclusion/exclusion criteria not met|1
4728993|NCT01964378|16308524|P2|Overall Study|Withdrawal by Subject|5
4728994|NCT01964378|16308525|P1|Overall Study|Withdrawal by Subject|7
4728995|NCT01964378|16308524|P2|Overall Study|Lost to Follow-up|1
4728996|NCT01964378|16308525|P1|Overall Study|Lost to Follow-up|0
4728997|NCT01964378|16308524|P2|Overall Study|Protocol Violation|1
4728998|NCT01964378|16308525|P1|Overall Study|Protocol Violation|0
4728999|NCT01964378|16308524|P2|Overall Study|Lack of Efficacy|1
4729000|NCT01964378|16308525|P1|Overall Study|Lack of Efficacy|0
4729001|NCT01964378|16308524|P2|Overall Study|Adverse Event|5
4729002|NCT01964378|16308525|P1|Overall Study|Adverse Event|12
4729003|NCT01964378|16308524|P2|Overall Study|Death|2
4729004|NCT01964378|16308525|P1|Overall Study|Death|3
4729005|NCT01964378|16308524|P2|Overall Study|Disc. due to AE before first dosing|0
4729006|NCT01964378|16308525|P1|Overall Study|Disc. due to AE before first dosing|1
4729007|NCT01964378|16308524|P2|Overall Study|Disc. due to death before first dosing|1
4729008|NCT01964378|16308525|P1|Overall Study|Disc. due to death before first dosing|0
4729009|NCT01964352|16308561|P4|Overall Study|Other than stated above|2
4729010|NCT01964352|16308562|P3|Overall Study|Other than stated above|1
4729011|NCT01964352|16308563|P2|Overall Study|Other than stated above|2
4729012|NCT01964352|16308564|P1|Overall Study|Other than stated above|0
4729013|NCT01964352|16308561|P4|Overall Study|Withdrawal by Subject|0
4729014|NCT01964352|16308562|P3|Overall Study|Withdrawal by Subject|1
4729015|NCT01964352|16308563|P2|Overall Study|Withdrawal by Subject|2
4729016|NCT01964352|16308564|P1|Overall Study|Withdrawal by Subject|4
4729017|NCT01964352|16308561|P4|Overall Study|Lost to Follow-up|1
4729018|NCT01964352|16308562|P3|Overall Study|Lost to Follow-up|0
4729019|NCT01964352|16308563|P2|Overall Study|Lost to Follow-up|0
4729020|NCT01964352|16308564|P1|Overall Study|Lost to Follow-up|1
4729021|NCT01964352|16308561|P4|Overall Study|Protocol Violation|2
4729022|NCT01964352|16308562|P3|Overall Study|Protocol Violation|0
4729023|NCT01964352|16308563|P2|Overall Study|Protocol Violation|4
4729024|NCT01964352|16308564|P1|Overall Study|Protocol Violation|2
4729025|NCT01964352|16308561|P4|Overall Study|Lack of Efficacy|0
4729026|NCT01964352|16308562|P3|Overall Study|Lack of Efficacy|0
4729027|NCT01964352|16308563|P2|Overall Study|Lack of Efficacy|0
4729028|NCT01964352|16308564|P1|Overall Study|Lack of Efficacy|6
4729029|NCT01964352|16308561|P4|Overall Study|Adverse Event|3
4729030|NCT01964352|16308562|P3|Overall Study|Adverse Event|4
4729031|NCT01964352|16308563|P2|Overall Study|Adverse Event|3
4729032|NCT01964352|16308564|P1|Overall Study|Adverse Event|13
4729033|NCT01964326|16308594|P1|Overall Study|Did not meet eligibility criteria|1
4729034|NCT01964326|16308594|P1|Overall Study|Other|9
4729035|NCT01964326|16308594|P1|Overall Study|Investigator Discretion|1
4729036|NCT01964326|16308594|P1|Overall Study|Physician Decision|55
4729037|NCT01964326|16308594|P1|Overall Study|No Longer Meets Eligibility Criteria|1
4729038|NCT01964326|16308594|P1|Overall Study|Pregnancy|1
4729039|NCT01964326|16308594|P1|Overall Study|Withdrawal by Subject|87
4729040|NCT01964326|16308594|P1|Overall Study|Lost to Follow-up|88
4729041|NCT01964326|16308594|P1|Overall Study|Protocol Violation|4
4729042|NCT01964326|16308594|P1|Overall Study|Death|2
4729043|NCT01964326|16308594|P1|Overall Study|Adverse Event|48
4729044|NCT01964300|16308603|P2|Overall Study|Weight criteria not met|1
4729045|NCT01964300|16308604|P1|Overall Study|Weight criteria not met|0
4729046|NCT01964300|16308603|P2|Overall Study|Enlargement of cyst requiring drainage|0
4729047|NCT01964300|16308604|P1|Overall Study|Enlargement of cyst requiring drainage|1
4729048|NCT01964300|16308603|P2|Overall Study|To receive alternative therapy|2
4729049|NCT01964300|16308604|P1|Overall Study|To receive alternative therapy|1
4729050|NCT01964300|16308603|P2|Overall Study|Withdrawal by Subject|1
4729051|NCT01964300|16308604|P1|Overall Study|Withdrawal by Subject|0
4729052|NCT01964300|16308603|P2|Overall Study|Lack of Efficacy|5
4729053|NCT01964300|16308604|P1|Overall Study|Lack of Efficacy|3
4729054|NCT01964300|16308603|P2|Overall Study|Adverse Event|1
4729055|NCT01964300|16308604|P1|Overall Study|Adverse Event|1
4729056|NCT01964300|16308603|P2|Overall Study|Ineligible after enrollment|1
4729057|NCT01964300|16308604|P1|Overall Study|Ineligible after enrollment|0
4729058|NCT01964222|16308618|P2|Overall Study|Screening Failure|0
4729059|NCT01964222|16308619|P1|Overall Study|Screening Failure|2
4729060|NCT01964222|16308618|P2|Overall Study|Withdrawal by Subject|6
4729061|NCT01964222|16308619|P1|Overall Study|Withdrawal by Subject|6
4729062|NCT01964222|16308618|P2|Overall Study|Lost to Follow-up|5
4729063|NCT01964222|16308619|P1|Overall Study|Lost to Follow-up|7
4729064|NCT01964105|16308636|P3|Overall Study|Lost to Follow-up|0
4729065|NCT01964105|16308637|P2|Overall Study|Lost to Follow-up|13
4729066|NCT01964105|16308638|P1|Overall Study|Lost to Follow-up|2
4729067|NCT01963767|16308697|P2|Overall Study|Adverse Event|0
4729068|NCT01963767|16308698|P1|Overall Study|Adverse Event|2
4729069|NCT01963767|16308697|P2|Overall Study|Withdrawal by Subject|2
4729070|NCT01963767|16308698|P1|Overall Study|Withdrawal by Subject|4
4729071|NCT01963676|16308708|P2|Overall Study|Withdrawal by Subject|0
4729072|NCT01963676|16308709|P1|Overall Study|Withdrawal by Subject|1
4729073|NCT01963611|16308722|P5|Overall Study|Other|45
4729074|NCT01963611|16308723|P4|Overall Study|Other|45
4729075|NCT01963611|16308724|P3|Overall Study|Other|48
4729076|NCT01963611|16308725|P2|Overall Study|Other|46
4729077|NCT01963611|16308726|P1|Overall Study|Other|47
4729078|NCT01963611|16308722|P5|Overall Study|Withdrawal by Subject|3
4729080|NCT01963611|16308724|P3|Overall Study|Withdrawal by Subject|1
4729081|NCT01963611|16308725|P2|Overall Study|Withdrawal by Subject|2
4729082|NCT01963611|16308726|P1|Overall Study|Withdrawal by Subject|3
4729083|NCT01963611|16308722|P5|Overall Study|Lack of Efficacy|0
4729084|NCT01963611|16308723|P4|Overall Study|Lack of Efficacy|1
4729085|NCT01963611|16308724|P3|Overall Study|Lack of Efficacy|0
4729086|NCT01963611|16308725|P2|Overall Study|Lack of Efficacy|0
4729087|NCT01963611|16308726|P1|Overall Study|Lack of Efficacy|0
4729088|NCT01963611|16308722|P5|Overall Study|Protocol Violation|0
4729089|NCT01963611|16308723|P4|Overall Study|Protocol Violation|1
4729090|NCT01963611|16308724|P3|Overall Study|Protocol Violation|0
4729091|NCT01963611|16308725|P2|Overall Study|Protocol Violation|0
4729092|NCT01963611|16308726|P1|Overall Study|Protocol Violation|0
4729093|NCT01963611|16308722|P5|Overall Study|Adverse Event|3
4729094|NCT01963611|16308723|P4|Overall Study|Adverse Event|4
4729095|NCT01963611|16308724|P3|Overall Study|Adverse Event|3
4729096|NCT01963611|16308725|P2|Overall Study|Adverse Event|1
4729097|NCT01963611|16308726|P1|Overall Study|Adverse Event|1
4729098|NCT01963403|16308791|P2|Overall Study|Implant removal|1
4729099|NCT01963403|16308792|P1|Overall Study|Implant removal|0
4729100|NCT01963403|16308791|P2|Overall Study|Lost to Follow-up|3
4729101|NCT01963403|16308792|P1|Overall Study|Lost to Follow-up|2
4729102|NCT01963260|16308814|P10|Overall Study|Withdrawal by Subject|0
4729103|NCT01963260|16308815|P9|Overall Study|Withdrawal by Subject|0
4729104|NCT01963260|16308816|P8|Overall Study|Withdrawal by Subject|0
4729105|NCT01963260|16308817|P7|Overall Study|Withdrawal by Subject|0
4729106|NCT01963260|16308818|P6|Overall Study|Withdrawal by Subject|0
4729107|NCT01963260|16308819|P5|Overall Study|Withdrawal by Subject|2
4729108|NCT01963260|16308820|P4|Overall Study|Withdrawal by Subject|1
4729109|NCT01963260|16308821|P3|Overall Study|Withdrawal by Subject|0
4729110|NCT01963260|16308822|P2|Overall Study|Withdrawal by Subject|0
4729111|NCT01963260|16308823|P1|Overall Study|Withdrawal by Subject|2
4729112|NCT01963117|16308937|P1|Overall Study|Death|1
4729113|NCT01962987|16308979|P3|Overall Study|Randomized in Error|2
4729114|NCT01962987|16308980|P2|Overall Study|Randomized in Error|2
4729115|NCT01962987|16308981|P1|Overall Study|Randomized in Error|4
4729116|NCT01962987|16308979|P3|Overall Study|Withdrawal by Subject|6
4729117|NCT01962987|16308980|P2|Overall Study|Withdrawal by Subject|10
4729118|NCT01962987|16308981|P1|Overall Study|Withdrawal by Subject|11
4729119|NCT01962987|16308979|P3|Overall Study|Serious Adverse Event|0
4729120|NCT01962987|16308980|P2|Overall Study|Serious Adverse Event|0
4729121|NCT01962987|16308981|P1|Overall Study|Serious Adverse Event|1
4729122|NCT01962987|16308979|P3|Overall Study|Restricted medication|1
4729123|NCT01962987|16308980|P2|Overall Study|Restricted medication|1
4729124|NCT01962987|16308981|P1|Overall Study|Restricted medication|5
4729125|NCT01962987|16308979|P3|Overall Study|Miscellaneous|2
4729126|NCT01962987|16308980|P2|Overall Study|Miscellaneous|9
4729127|NCT01962987|16308981|P1|Overall Study|Miscellaneous|1
4729128|NCT01962987|16308979|P3|Overall Study|Non compliance with dosing requirements|0
4729129|NCT01962987|16308980|P2|Overall Study|Non compliance with dosing requirements|2
4729130|NCT01962987|16308981|P1|Overall Study|Non compliance with dosing requirements|4
4729131|NCT01962987|16308979|P3|Overall Study|Lost to Follow-up|1
4729132|NCT01962987|16308980|P2|Overall Study|Lost to Follow-up|0
4729133|NCT01962987|16308981|P1|Overall Study|Lost to Follow-up|0
4729134|NCT01962987|16308979|P3|Overall Study|Adverse Event|0
4729135|NCT01962987|16308980|P2|Overall Study|Adverse Event|4
4729136|NCT01962987|16308981|P1|Overall Study|Adverse Event|4
4729137|NCT01962974|16308989|P1|Overall Study|Study termination|7
4729138|NCT01962922|16309016|P2|Extendion Portion (up to Month 6)|Physician Decision|0
4729139|NCT01962922|16309017|P1|Extendion Portion (up to Month 6)|Physician Decision|1
4729140|NCT01962922|16309016|P2|Extendion Portion (up to Month 6)|no longer wished to participate in study|3
4729141|NCT01962922|16309017|P1|Extendion Portion (up to Month 6)|no longer wished to participate in study|4
4729142|NCT01962922|16309016|P2|PK Portion Day 7|non-compliance|0
4729143|NCT01962922|16309017|P1|PK Portion Day 7|non-compliance|1
4729144|NCT01962922|16309016|P2|PK Portion Day 7|Withdrawal by Subject|0
4729145|NCT01962922|16309017|P1|PK Portion Day 7|Withdrawal by Subject|3
4729146|NCT01962896|16309039|P1|Overall Study|Lack of Efficacy|4
4729147|NCT01962493|16309161|P2|Overall Study|Withdrawal by Subject|2
4729148|NCT01962493|16309162|P1|Overall Study|Withdrawal by Subject|4
4729149|NCT01962493|16309161|P2|Overall Study|Protocol Violation|1
4729150|NCT01962493|16309162|P1|Overall Study|Protocol Violation|0
4729151|NCT01962493|16309161|P2|Overall Study|Adverse Event|2
4729152|NCT01962493|16309162|P1|Overall Study|Adverse Event|1
4729153|NCT01962441|16309185|P3|Retreatment Substudy|Lost to Follow-up|0
4729154|NCT01962441|16309186|P2|Retreatment Substudy|Lost to Follow-up|0
4729155|NCT01962441|16309187|P1|Retreatment Substudy|Lost to Follow-up|1
4729156|NCT01962441|16309185|P3|Retreatment Substudy|Lack of Efficacy|0
4729157|NCT01962441|16309186|P2|Retreatment Substudy|Lack of Efficacy|0
4729158|NCT01962441|16309187|P1|Retreatment Substudy|Lack of Efficacy|1
4729159|NCT01962441|16309185|P3|Randomized Period|Protocol Violation|0
4729160|NCT01962441|16309186|P2|Randomized Period|Protocol Violation|1
4729161|NCT01962441|16309187|P1|Randomized Period|Protocol Violation|0
4729162|NCT01962441|16309185|P3|Randomized Period|Death|2
4729163|NCT01962441|16309186|P2|Randomized Period|Death|0
4729164|NCT01962441|16309187|P1|Randomized Period|Death|0
4729165|NCT01962441|16309185|P3|Randomized Period|Adverse Event|0
4729166|NCT01962441|16309186|P2|Randomized Period|Adverse Event|1
4729167|NCT01962441|16309187|P1|Randomized Period|Adverse Event|1
4729168|NCT01962441|16309185|P3|Randomized Period|Withdrew Consent|2
4729169|NCT01962441|16309186|P2|Randomized Period|Withdrew Consent|3
4729170|NCT01962441|16309187|P1|Randomized Period|Withdrew Consent|3
4729171|NCT01962441|16309185|P3|Randomized Period|Lost to Follow-up|4
4729172|NCT01962441|16309186|P2|Randomized Period|Lost to Follow-up|4
4729173|NCT01962441|16309187|P1|Randomized Period|Lost to Follow-up|2
4729174|NCT01962441|16309185|P3|Randomized Period|Randomized but Never Treated|3
4729175|NCT01962441|16309186|P2|Randomized Period|Randomized but Never Treated|2
4729176|NCT01962441|16309187|P1|Randomized Period|Randomized but Never Treated|4
4729177|NCT01962298|16309231|P5|Overall Study|Physician Decision|1
4729178|NCT01962298|16309232|P4|Overall Study|Physician Decision|0
4729179|NCT01962298|16309233|P3|Overall Study|Physician Decision|0
4729180|NCT01962298|16309234|P2|Overall Study|Physician Decision|1
4729181|NCT01962298|16309235|P1|Overall Study|Physician Decision|0
4729182|NCT01962298|16309231|P5|Overall Study|Incorrect data recorded|0
4729183|NCT01962298|16309232|P4|Overall Study|Incorrect data recorded|0
4729184|NCT01962298|16309233|P3|Overall Study|Incorrect data recorded|0
4729185|NCT01962298|16309234|P2|Overall Study|Incorrect data recorded|1
4729186|NCT01962298|16309235|P1|Overall Study|Incorrect data recorded|0
4729187|NCT01962298|16309231|P5|Overall Study|Insufficient data|1
4729188|NCT01962298|16309232|P4|Overall Study|Insufficient data|0
4729189|NCT01962298|16309233|P3|Overall Study|Insufficient data|1
4729190|NCT01962298|16309234|P2|Overall Study|Insufficient data|2
4729191|NCT01962298|16309235|P1|Overall Study|Insufficient data|0
4729192|NCT01962298|16309231|P5|Overall Study|Data quality insufficient|4
4729193|NCT01962298|16309232|P4|Overall Study|Data quality insufficient|1
4729194|NCT01962298|16309233|P3|Overall Study|Data quality insufficient|3
4729195|NCT01962298|16309234|P2|Overall Study|Data quality insufficient|0
4729196|NCT01962298|16309235|P1|Overall Study|Data quality insufficient|2
4729197|NCT01962298|16309231|P5|Overall Study|Protocol Violation|0
4729198|NCT01962298|16309232|P4|Overall Study|Protocol Violation|1
4729199|NCT01962298|16309233|P3|Overall Study|Protocol Violation|1
4729200|NCT01962298|16309234|P2|Overall Study|Protocol Violation|0
4729201|NCT01962298|16309235|P1|Overall Study|Protocol Violation|1
4729202|NCT01962207|16309256|P4|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5
4729203|NCT01962207|16309257|P3|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13
4729204|NCT01962207|16309258|P2|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7
4729205|NCT01962207|16309259|P1|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21
4729206|NCT01962207|16309256|P4|Persistence Phase (5 Years)|Adverse Event|0
4729207|NCT01962207|16309257|P3|Persistence Phase (5 Years)|Adverse Event|1
4729208|NCT01962207|16309258|P2|Persistence Phase (5 Years)|Adverse Event|0
4729209|NCT01962207|16309259|P1|Persistence Phase (5 Years)|Adverse Event|0
4729210|NCT01962207|16309256|P4|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1
4729211|NCT01962207|16309257|P3|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3
4729212|NCT01962207|16309258|P2|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
4729213|NCT01962207|16309259|P1|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0
4729214|NCT01962207|16309256|P4|Persistence Phase (5 Years)|Withdrawal by Subject|4
4729215|NCT01962207|16309257|P3|Persistence Phase (5 Years)|Withdrawal by Subject|18
4729216|NCT01962207|16309258|P2|Persistence Phase (5 Years)|Withdrawal by Subject|5
4729217|NCT01962207|16309259|P1|Persistence Phase (5 Years)|Withdrawal by Subject|4
4729218|NCT01962207|16309256|P4|Persistence Phase (5 Years)|Migrated/moved from study area|0
4729219|NCT01962207|16309257|P3|Persistence Phase (5 Years)|Migrated/moved from study area|4
4729220|NCT01962207|16309258|P2|Persistence Phase (5 Years)|Migrated/moved from study area|0
4729221|NCT01962207|16309259|P1|Persistence Phase (5 Years)|Migrated/moved from study area|2
4729222|NCT01962207|16309256|P4|Persistence Phase (5 Years)|Lost to Follow-up|2
4729223|NCT01962207|16309257|P3|Persistence Phase (5 Years)|Lost to Follow-up|5
4729224|NCT01962207|16309258|P2|Persistence Phase (5 Years)|Lost to Follow-up|1
4729225|NCT01962207|16309259|P1|Persistence Phase (5 Years)|Lost to Follow-up|2
4729226|NCT01962103|16309370|P9|Phase 2|Symptomatic Deterioration|0
4729227|NCT01962103|16309371|P8|Phase 2|Symptomatic Deterioration|2
4729228|NCT01962103|16309372|P7|Phase 2|Symptomatic Deterioration|2
4729229|NCT01962103|16309373|P6|Phase 2|Symptomatic Deterioration|0
4729230|NCT01962103|16309374|P5|Phase 2|Symptomatic Deterioration|0
4729231|NCT01962103|16309375|P4|Phase 2|Symptomatic Deterioration|0
4729232|NCT01962103|16309376|P3|Phase 2|Symptomatic Deterioration|0
4729233|NCT01962103|16309377|P2|Phase 2|Symptomatic Deterioration|0
4729234|NCT01962103|16309378|P1|Phase 2|Symptomatic Deterioration|0
4729235|NCT01962103|16309370|P9|Phase 2|Progressive Disease|11
4729236|NCT01962103|16309371|P8|Phase 2|Progressive Disease|12
4729237|NCT01962103|16309372|P7|Phase 2|Progressive Disease|11
4729238|NCT01962103|16309373|P6|Phase 2|Progressive Disease|0
4729239|NCT01962103|16309374|P5|Phase 2|Progressive Disease|0
4729240|NCT01962103|16309375|P4|Phase 2|Progressive Disease|0
4729241|NCT01962103|16309376|P3|Phase 2|Progressive Disease|0
4729242|NCT01962103|16309377|P2|Phase 2|Progressive Disease|0
4729243|NCT01962103|16309378|P1|Phase 2|Progressive Disease|0
4729244|NCT01962103|16309370|P9|Phase 2|Adverse Event|3
4729245|NCT01962103|16309371|P8|Phase 2|Adverse Event|0
4729246|NCT01962103|16309372|P7|Phase 2|Adverse Event|1
4729247|NCT01962103|16309373|P6|Phase 2|Adverse Event|0
4729248|NCT01962103|16309374|P5|Phase 2|Adverse Event|0
4729249|NCT01962103|16309375|P4|Phase 2|Adverse Event|0
4729250|NCT01962103|16309376|P3|Phase 2|Adverse Event|0
4729251|NCT01962103|16309377|P2|Phase 2|Adverse Event|0
4729252|NCT01962103|16309378|P1|Phase 2|Adverse Event|0
4729253|NCT01962103|16309370|P9|Phase 1|Miscellaneous|0
4729254|NCT01962103|16309371|P8|Phase 1|Miscellaneous|0
4729255|NCT01962103|16309372|P7|Phase 1|Miscellaneous|0
4729256|NCT01962103|16309373|P6|Phase 1|Miscellaneous|0
4729257|NCT01962103|16309374|P5|Phase 1|Miscellaneous|0
4729258|NCT01962103|16309375|P4|Phase 1|Miscellaneous|0
4729259|NCT01962103|16309376|P3|Phase 1|Miscellaneous|0
4729260|NCT01962103|16309377|P2|Phase 1|Miscellaneous|0
4729261|NCT01962103|16309378|P1|Phase 1|Miscellaneous|1
4729262|NCT01962103|16309370|P9|Phase 1|Symptomatic Deterioration|0
4729263|NCT01962103|16309371|P8|Phase 1|Symptomatic Deterioration|0
4729264|NCT01962103|16309372|P7|Phase 1|Symptomatic Deterioration|0
4729265|NCT01962103|16309373|P6|Phase 1|Symptomatic Deterioration|1
4729266|NCT01962103|16309374|P5|Phase 1|Symptomatic Deterioration|1
4729267|NCT01962103|16309375|P4|Phase 1|Symptomatic Deterioration|2
4729268|NCT01962103|16309376|P3|Phase 1|Symptomatic Deterioration|2
4729269|NCT01962103|16309377|P2|Phase 1|Symptomatic Deterioration|2
4729270|NCT01962103|16309378|P1|Phase 1|Symptomatic Deterioration|3
4729271|NCT01962103|16309370|P9|Phase 1|Physician Decision|0
4729272|NCT01962103|16309371|P8|Phase 1|Physician Decision|0
4729273|NCT01962103|16309372|P7|Phase 1|Physician Decision|0
4729274|NCT01962103|16309373|P6|Phase 1|Physician Decision|0
4729275|NCT01962103|16309374|P5|Phase 1|Physician Decision|0
4729276|NCT01962103|16309375|P4|Phase 1|Physician Decision|1
4729277|NCT01962103|16309376|P3|Phase 1|Physician Decision|0
4729278|NCT01962103|16309377|P2|Phase 1|Physician Decision|0
4729279|NCT01962103|16309378|P1|Phase 1|Physician Decision|0
4729280|NCT01962103|16309370|P9|Phase 1|Withdrawal by Parent/Guardian|0
4729281|NCT01962103|16309371|P8|Phase 1|Withdrawal by Parent/Guardian|0
4729282|NCT01962103|16309372|P7|Phase 1|Withdrawal by Parent/Guardian|0
4729283|NCT01962103|16309373|P6|Phase 1|Withdrawal by Parent/Guardian|0
4729284|NCT01962103|16309374|P5|Phase 1|Withdrawal by Parent/Guardian|0
4729285|NCT01962103|16309375|P4|Phase 1|Withdrawal by Parent/Guardian|1
4729286|NCT01962103|16309376|P3|Phase 1|Withdrawal by Parent/Guardian|2
4729287|NCT01962103|16309377|P2|Phase 1|Withdrawal by Parent/Guardian|0
4729288|NCT01962103|16309378|P1|Phase 1|Withdrawal by Parent/Guardian|0
4729289|NCT01962103|16309370|P9|Phase 1|Withdrawal by Subject|0
4729290|NCT01962103|16309371|P8|Phase 1|Withdrawal by Subject|0
4729291|NCT01962103|16309372|P7|Phase 1|Withdrawal by Subject|0
4729292|NCT01962103|16309373|P6|Phase 1|Withdrawal by Subject|0
4729293|NCT01962103|16309374|P5|Phase 1|Withdrawal by Subject|0
4729294|NCT01962103|16309375|P4|Phase 1|Withdrawal by Subject|2
4729295|NCT01962103|16309376|P3|Phase 1|Withdrawal by Subject|0
4729296|NCT01962103|16309377|P2|Phase 1|Withdrawal by Subject|0
4729297|NCT01962103|16309378|P1|Phase 1|Withdrawal by Subject|0
4729298|NCT01962103|16309370|P9|Phase 1|Progressive Disease|0
4729299|NCT01962103|16309371|P8|Phase 1|Progressive Disease|0
4729300|NCT01962103|16309372|P7|Phase 1|Progressive Disease|0
4729301|NCT01962103|16309373|P6|Phase 1|Progressive Disease|4
4729302|NCT01962103|16309374|P5|Phase 1|Progressive Disease|5
4729303|NCT01962103|16309375|P4|Phase 1|Progressive Disease|4
4729304|NCT01962103|16309376|P3|Phase 1|Progressive Disease|8
4729305|NCT01962103|16309377|P2|Phase 1|Progressive Disease|6
4729306|NCT01962103|16309378|P1|Phase 1|Progressive Disease|8
4729307|NCT01962103|16309370|P9|Phase 1|Adverse Event|0
4729308|NCT01962103|16309371|P8|Phase 1|Adverse Event|0
4729309|NCT01962103|16309372|P7|Phase 1|Adverse Event|0
4729310|NCT01962103|16309373|P6|Phase 1|Adverse Event|2
4729311|NCT01962103|16309374|P5|Phase 1|Adverse Event|2
4729312|NCT01962103|16309375|P4|Phase 1|Adverse Event|1
4729313|NCT01962103|16309376|P3|Phase 1|Adverse Event|2
4729314|NCT01962103|16309377|P2|Phase 1|Adverse Event|0
4729315|NCT01962103|16309378|P1|Phase 1|Adverse Event|4
4729316|NCT01961609|16309507|P4|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2
4729317|NCT01961609|16309508|P3|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
4729318|NCT01961609|16309509|P2|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0
4729319|NCT01961609|16309510|P1|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1
4729320|NCT01961609|16309507|P4|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1
4729321|NCT01961609|16309508|P3|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
4729322|NCT01961609|16309509|P2|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0
4729323|NCT01961609|16309510|P1|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3
4729324|NCT01961609|16309507|P4|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
4729325|NCT01961609|16309508|P3|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
4729326|NCT01961609|16309509|P2|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1
4729327|NCT01961609|16309510|P1|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0
4729328|NCT01961609|16309507|P4|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
4729329|NCT01961609|16309508|P3|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
4729330|NCT01961609|16309509|P2|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0
4729331|NCT01961609|16309510|P1|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1
4729332|NCT01961609|16309507|P4|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
4729333|NCT01961609|16309508|P3|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1
4729334|NCT01961609|16309509|P2|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
4729335|NCT01961609|16309510|P1|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0
4729336|NCT01961609|16309507|P4|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4
4729337|NCT01961609|16309508|P3|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0
4729338|NCT01961609|16309509|P2|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5
4729339|NCT01961609|16309510|P1|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7
4729340|NCT01961609|16309507|P4|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
4729341|NCT01961609|16309508|P3|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1
4729342|NCT01961609|16309509|P2|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
4729343|NCT01961609|16309510|P1|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0
4729344|NCT01961609|16309507|P4|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0
4729345|NCT01961609|16309508|P3|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3
4729346|NCT01961609|16309509|P2|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
4729347|NCT01961609|16309510|P1|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6
4729348|NCT01961609|16309507|P4|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0
4729349|NCT01961609|16309508|P3|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10
4729350|NCT01961609|16309509|P2|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4
4729351|NCT01961609|16309510|P1|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13
4729352|NCT01961609|16309507|P4|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
4729353|NCT01961609|16309508|P3|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
4729354|NCT01961609|16309509|P2|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1
4729355|NCT01961609|16309510|P1|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0
4729356|NCT01961609|16309507|P4|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
4729357|NCT01961609|16309508|P3|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1
4729358|NCT01961609|16309509|P2|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0
4729359|NCT01961609|16309510|P1|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3
4729360|NCT01961609|16309507|P4|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
4729361|NCT01961609|16309508|P3|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3
4729362|NCT01961609|16309509|P2|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0
4729363|NCT01961609|16309510|P1|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1
4729364|NCT01961609|16309507|P4|Initiation|Randomized but not treated|0
4729365|NCT01961609|16309508|P3|Initiation|Randomized but not treated|0
4729366|NCT01961609|16309509|P2|Initiation|Randomized but not treated|1
4729367|NCT01961609|16309510|P1|Initiation|Randomized but not treated|1
4729368|NCT01961609|16309507|P4|Initiation|Adverse Event|0
4729369|NCT01961609|16309508|P3|Initiation|Adverse Event|0
4729370|NCT01961609|16309509|P2|Initiation|Adverse Event|5
4729371|NCT01961609|16309510|P1|Initiation|Adverse Event|3
4729372|NCT01961609|16309507|P4|Initiation|Abnormal lab values|0
4729373|NCT01961609|16309508|P3|Initiation|Abnormal lab values|0
4729374|NCT01961609|16309509|P2|Initiation|Abnormal lab values|1
4729375|NCT01961609|16309510|P1|Initiation|Abnormal lab values|0
4729376|NCT01961609|16309507|P4|Initiation|Lack of Efficacy|0
4729377|NCT01961609|16309508|P3|Initiation|Lack of Efficacy|0
4729378|NCT01961609|16309509|P2|Initiation|Lack of Efficacy|1
4729379|NCT01961609|16309510|P1|Initiation|Lack of Efficacy|2
4729380|NCT01961609|16309507|P4|Initiation|Withdrawal by Subject|0
4729381|NCT01961609|16309508|P3|Initiation|Withdrawal by Subject|0
4729382|NCT01961609|16309509|P2|Initiation|Withdrawal by Subject|2
4729383|NCT01961609|16309510|P1|Initiation|Withdrawal by Subject|1
4729384|NCT01961609|16309507|P4|Initiation|Administrative problems|0
4729385|NCT01961609|16309508|P3|Initiation|Administrative problems|0
4729386|NCT01961609|16309509|P2|Initiation|Administrative problems|0
4729387|NCT01961609|16309510|P1|Initiation|Administrative problems|1
4729388|NCT01961609|16309507|P4|Initiation|Death|0
4729389|NCT01961609|16309508|P3|Initiation|Death|0
4729390|NCT01961609|16309509|P2|Initiation|Death|1
4729391|NCT01961609|16309510|P1|Initiation|Death|0
4729392|NCT01961609|16309507|P4|Initiation|Protocol deviation|0
4729393|NCT01961609|16309508|P3|Initiation|Protocol deviation|0
4729394|NCT01961609|16309509|P2|Initiation|Protocol deviation|0
4729395|NCT01961609|16309510|P1|Initiation|Protocol deviation|1
4729396|NCT01961609|16309507|P4|Initiation|Missing|0
4729397|NCT01961609|16309508|P3|Initiation|Missing|0
4729398|NCT01961609|16309509|P2|Initiation|Missing|2
4729399|NCT01961609|16309510|P1|Initiation|Missing|3
4729400|NCT01961544|16309562|P1|Overall Study|Aggravation of Steral Pain|1
4729401|NCT01961544|16309562|P1|Overall Study|Poor Tolerance|1
4729402|NCT01961544|16309562|P1|Overall Study|Physician Decision|2
4729403|NCT01961544|16309562|P1|Overall Study|Adverse Event|1
4729404|NCT01961544|16309562|P1|Overall Study|Withdrawal by Subject|7
4729405|NCT01961544|16309562|P1|Overall Study|Protocol Violation|1
4729406|NCT01961349|16309581|P3|Overall Study|registration error, personal reason etc|1
4729407|NCT01961349|16309582|P2|Overall Study|registration error, personal reason etc|2
4729408|NCT01961349|16309583|P1|Overall Study|registration error, personal reason etc|2
4729409|NCT01961349|16309581|P3|Overall Study|Adverse Event|1
4729410|NCT01961349|16309582|P2|Overall Study|Adverse Event|0
4729411|NCT01961349|16309583|P1|Overall Study|Adverse Event|0
4729412|NCT01961349|16309581|P3|Overall Study|Withdrawal by Subject|0
4729413|NCT01961349|16309582|P2|Overall Study|Withdrawal by Subject|4
4729414|NCT01961349|16309583|P1|Overall Study|Withdrawal by Subject|1
4729415|NCT01961323|16309594|P1|Overall Study|screen failure|34
4729416|NCT01961323|16309594|P1|Overall Study|Lost to Follow-up|8
4729417|NCT01961323|16309594|P1|Overall Study|Withdrawal by Subject|7
4729418|NCT01961297|16309602|P2|Overall Study|unconfirmed diagnosis of SD|1
4729419|NCT01961297|16309603|P1|Overall Study|unconfirmed diagnosis of SD|2
4729420|NCT01961115|16309667|P3|Overall Study|Adverse Event|1
4729421|NCT01961115|16309668|P2|Overall Study|Adverse Event|0
4729422|NCT01961115|16309669|P1|Overall Study|Adverse Event|1
4729423|NCT01961115|16309667|P3|Overall Study|Disease Progression|3
4729424|NCT01961115|16309668|P2|Overall Study|Disease Progression|0
4729425|NCT01961115|16309669|P1|Overall Study|Disease Progression|1
4729426|NCT01960907|16309712|P2|Overall Study|Withdrawal by Subject|42
4729427|NCT01960907|16309713|P1|Overall Study|Withdrawal by Subject|32
4729428|NCT01960907|16309712|P2|Overall Study|Death|3
4729429|NCT01960907|16309713|P1|Overall Study|Death|4
4729430|NCT01960855|16309728|P5|Overall Study|Lost to Follow-up|2
4729431|NCT01960855|16309729|P4|Overall Study|Lost to Follow-up|0
4729432|NCT01960855|16309730|P3|Overall Study|Lost to Follow-up|0
4729433|NCT01960855|16309731|P2|Overall Study|Lost to Follow-up|1
4729434|NCT01960855|16309732|P1|Overall Study|Lost to Follow-up|2
4729435|NCT01960855|16309728|P5|Overall Study|Consent withdrawn by subject|1
4729436|NCT01960855|16309729|P4|Overall Study|Consent withdrawn by subject|1
4729437|NCT01960855|16309730|P3|Overall Study|Consent withdrawn by subject|2
4729438|NCT01960855|16309731|P2|Overall Study|Consent withdrawn by subject|1
4729439|NCT01960855|16309732|P1|Overall Study|Consent withdrawn by subject|3
4729440|NCT01960855|16309728|P5|Overall Study|Other|0
4729441|NCT01960855|16309729|P4|Overall Study|Other|1
4729442|NCT01960855|16309730|P3|Overall Study|Other|1
4729443|NCT01960855|16309731|P2|Overall Study|Other|1
4729444|NCT01960855|16309732|P1|Overall Study|Other|2
4729445|NCT01960855|16309728|P5|Overall Study|Lack of Efficacy|0
4729446|NCT01960855|16309729|P4|Overall Study|Lack of Efficacy|0
4729447|NCT01960855|16309730|P3|Overall Study|Lack of Efficacy|0
4729448|NCT01960855|16309731|P2|Overall Study|Lack of Efficacy|1
4729449|NCT01960855|16309732|P1|Overall Study|Lack of Efficacy|1
4729450|NCT01960855|16309728|P5|Overall Study|Adverse Event|2
4729451|NCT01960855|16309729|P4|Overall Study|Adverse Event|2
4729452|NCT01960855|16309730|P3|Overall Study|Adverse Event|6
4729453|NCT01960855|16309731|P2|Overall Study|Adverse Event|0
4729454|NCT01960855|16309732|P1|Overall Study|Adverse Event|2
4729455|NCT01960855|16309728|P5|Overall Study|Subject noncompliant|0
4729456|NCT01960855|16309729|P4|Overall Study|Subject noncompliant|0
4729457|NCT01960855|16309730|P3|Overall Study|Subject noncompliant|0
4729458|NCT01960855|16309731|P2|Overall Study|Subject noncompliant|0
4729459|NCT01960855|16309732|P1|Overall Study|Subject noncompliant|1
4729460|NCT01960842|16309764|P1|Overall Study|Withdrawal by Subject|2
4729461|NCT01960842|16309764|P1|Overall Study|Adverse Event|1
4729462|NCT01960816|16309787|P1|Overall Study|Lost to Follow-up|1
4729463|NCT01960790|16309793|P1|Overall Study|Unevaluable for safety|1
4729464|NCT01960790|16309793|P1|Overall Study|Transferred to another hospital|4
4729465|NCT01960790|16309793|P1|Overall Study|Treat with Humira outside survey period|3
4729466|NCT01960790|16309793|P1|Overall Study|Survey forms could not be recovered|3
4729467|NCT01960725|16309805|P2|Overall Study|unable to obtain blood sample|2
4729468|NCT01960725|16309806|P1|Overall Study|unable to obtain blood sample|1
4729469|NCT01960725|16309805|P2|Overall Study|Withdrawal by Subject|0
4729470|NCT01960725|16309806|P1|Overall Study|Withdrawal by Subject|1
4729471|NCT01960725|16309805|P2|Overall Study|Lost to Follow-up|3
4729472|NCT01960725|16309806|P1|Overall Study|Lost to Follow-up|4
4729473|NCT01960413|16309863|P2|Overall Study|Lost to Follow-up|0
4729474|NCT01960413|16309864|P1|Overall Study|Lost to Follow-up|2
4729475|NCT01960413|16309863|P2|Overall Study|Physician Decision|0
4729476|NCT01960413|16309864|P1|Overall Study|Physician Decision|1
4729477|NCT01960413|16309863|P2|Overall Study|Withdrawal by Subject|1
4729478|NCT01960413|16309864|P1|Overall Study|Withdrawal by Subject|1
4729479|NCT01960348|16309894|P2|Overall Study|Protocol Violation|0
4729480|NCT01960348|16309895|P1|Overall Study|Protocol Violation|1
4729481|NCT01960348|16309894|P2|Overall Study|Physician Decision|1
4729482|NCT01960348|16309895|P1|Overall Study|Physician Decision|0
4729483|NCT01960348|16309894|P2|Overall Study|Withdrawal by Subject|11
4729484|NCT01960348|16309895|P1|Overall Study|Withdrawal by Subject|1
4729485|NCT01960348|16309894|P2|Overall Study|Adverse event, serious non-fatal|3
4729486|NCT01960348|16309895|P1|Overall Study|Adverse event, serious non-fatal|0
4729487|NCT01960348|16309894|P2|Overall Study|Adverse event, serious fatal|5
4729488|NCT01960348|16309895|P1|Overall Study|Adverse event, serious fatal|6
4729489|NCT01960348|16309894|P2|Overall Study|Adverse event, not serious|2
4729490|NCT01960348|16309895|P1|Overall Study|Adverse event, not serious|2
4729491|NCT01960296|16309915|P2|Overall Study|Received different procedure|3
4729492|NCT01960296|16309916|P1|Overall Study|Received different procedure|1
4729493|NCT01960296|16309915|P2|Overall Study|Postponed surgery|0
4729494|NCT01960296|16309916|P1|Overall Study|Postponed surgery|1
4729495|NCT01960140|16309936|P1|Period 2 (Days 3-18)|Adverse Event|2
4729496|NCT01960114|16309947|P2|Overall Study|Could not swallow study medication|1
4729497|NCT01960114|16309948|P1|Overall Study|Could not swallow study medication|0
4729498|NCT01960114|16309947|P2|Overall Study|Adverse Event|0
4729499|NCT01960114|16309948|P1|Overall Study|Adverse Event|1
4729500|NCT01959932|16310055|P3|Overall Study|Withdrawal by Subject|0
4729501|NCT01959932|16310056|P2|Overall Study|Withdrawal by Subject|0
4729502|NCT01959932|16310057|P1|Overall Study|Withdrawal by Subject|1
4729503|NCT01959919|16310075|P1|Overall Study|Did not meet the eligibility criteria|2
4729504|NCT01959880|16310089|P4|Overall Study|Study completed early-FDA approved|152
4729505|NCT01959880|16310090|P3|Overall Study|Study completed early-FDA approved|179
4729506|NCT01959880|16310091|P2|Overall Study|Study completed early-FDA approved|311
4729507|NCT01959880|16310092|P1|Overall Study|Study completed early-FDA approved|1003
4729508|NCT01959880|16310089|P4|Overall Study|Explantation w/o study device reimplant.|12
4729509|NCT01959880|16310090|P3|Overall Study|Explantation w/o study device reimplant.|5
4729510|NCT01959880|16310091|P2|Overall Study|Explantation w/o study device reimplant.|17
4729511|NCT01959880|16310092|P1|Overall Study|Explantation w/o study device reimplant.|22
4729512|NCT01959880|16310089|P4|Overall Study|Lost to Follow-up|8
4729513|NCT01959880|16310090|P3|Overall Study|Lost to Follow-up|15
4729514|NCT01959880|16310091|P2|Overall Study|Lost to Follow-up|18
4729515|NCT01959880|16310092|P1|Overall Study|Lost to Follow-up|95
4729516|NCT01959880|16310089|P4|Overall Study|Death|2
4729517|NCT01959880|16310090|P3|Overall Study|Death|1
4729518|NCT01959880|16310091|P2|Overall Study|Death|10
4729519|NCT01959880|16310092|P1|Overall Study|Death|1
4729520|NCT01959880|16310089|P4|Overall Study|Withdrawal by Subject|7
4729521|NCT01959880|16310090|P3|Overall Study|Withdrawal by Subject|8
4729522|NCT01959880|16310091|P2|Overall Study|Withdrawal by Subject|13
4729523|NCT01959880|16310092|P1|Overall Study|Withdrawal by Subject|11
4729524|NCT01959841|16310117|P3|Overall Study|Platelet count below on day1 or 4|11
4729525|NCT01959841|16310118|P2|Overall Study|Platelet count below on day1 or 4|15
4729526|NCT01959841|16310119|P1|Overall Study|Platelet count below on day1 or 4|11
4729527|NCT01959841|16310117|P3|Overall Study|Clinical laboratory value|6
4729528|NCT01959841|16310118|P2|Overall Study|Clinical laboratory value|6
4729529|NCT01959841|16310119|P1|Overall Study|Clinical laboratory value|2
4729530|NCT01959841|16310117|P3|Overall Study|Withdrawal by Subject|5
4729531|NCT01959841|16310118|P2|Overall Study|Withdrawal by Subject|7
4729532|NCT01959841|16310119|P1|Overall Study|Withdrawal by Subject|7
4729533|NCT01959841|16310117|P3|Overall Study|Protocol Violation|16
4729534|NCT01959841|16310118|P2|Overall Study|Protocol Violation|23
4729535|NCT01959841|16310119|P1|Overall Study|Protocol Violation|16
4729536|NCT01959841|16310117|P3|Overall Study|Physician Decision|3
4729537|NCT01959841|16310118|P2|Overall Study|Physician Decision|2
4729538|NCT01959841|16310119|P1|Overall Study|Physician Decision|0
4729539|NCT01959841|16310117|P3|Overall Study|Lost to Follow-up|0
4729540|NCT01959841|16310118|P2|Overall Study|Lost to Follow-up|1
4729541|NCT01959841|16310119|P1|Overall Study|Lost to Follow-up|1
4729542|NCT01959841|16310117|P3|Overall Study|Lack of Efficacy|0
4729543|NCT01959841|16310118|P2|Overall Study|Lack of Efficacy|0
4729544|NCT01959841|16310119|P1|Overall Study|Lack of Efficacy|5
4729545|NCT01959841|16310117|P3|Overall Study|Adverse Event|2
4729546|NCT01959841|16310118|P2|Overall Study|Adverse Event|3
4729547|NCT01959841|16310119|P1|Overall Study|Adverse Event|1
4729548|NCT01959672|16310147|P1|Overall Study|Death|1
4729549|NCT01959607|16310158|P4|First Intervention (Day 1)|Withdrawal by Subject|0
4729550|NCT01959607|16310159|P3|First Intervention (Day 1)|Withdrawal by Subject|0
4729551|NCT01959607|16310160|P2|First Intervention (Day 1)|Withdrawal by Subject|1
4729552|NCT01959607|16310161|P1|First Intervention (Day 1)|Withdrawal by Subject|1
4729553|NCT01959581|16310174|P1|Overall Study|Lost to Follow-up|5
4729554|NCT01959529|16310185|P2|Overall Study|Lack of glycaemic control|1
4729555|NCT01959529|16310186|P1|Overall Study|Lack of glycaemic control|1
4729556|NCT01959529|16310185|P2|Overall Study|Hypoglycaemia|1
4729557|NCT01959529|16310186|P1|Overall Study|Hypoglycaemia|1
4729558|NCT01959529|16310185|P2|Overall Study|Other|68
4729559|NCT01959529|16310186|P1|Overall Study|Other|70
4729560|NCT01959529|16310185|P2|Overall Study|Lost to Follow-up|1
4729561|NCT01959529|16310186|P1|Overall Study|Lost to Follow-up|4
4729562|NCT01959529|16310185|P2|Overall Study|Adverse event (not hypoglycaemia)|1
4729563|NCT01959529|16310186|P1|Overall Study|Adverse event (not hypoglycaemia)|0
4729564|NCT01959516|16310198|P2|Epoch 2|Moderate or severe COPD exacerbation|1
4729565|NCT01959516|16310199|P1|Epoch 2|Moderate or severe COPD exacerbation|0
4729566|NCT01959516|16310198|P2|Epoch 2|Subject withdrew consent|0
4729567|NCT01959516|16310199|P1|Epoch 2|Subject withdrew consent|1
4729568|NCT01959516|16310198|P2|Epoch 2|unsatisfactory therapeutic effect|0
4729569|NCT01959516|16310199|P1|Epoch 2|unsatisfactory therapeutic effect|1
4729570|NCT01959516|16310198|P2|Epoch 1|Protocol deviation|1
4729571|NCT01959516|16310199|P1|Epoch 1|Protocol deviation|0
4729572|NCT01959516|16310198|P2|Epoch 1|Moderate or severe COPD exacerbation|1
4729573|NCT01959516|16310199|P1|Epoch 1|Moderate or severe COPD exacerbation|0
4729574|NCT01959516|16310198|P2|Epoch 1|Use of prohibited treatment|0
4729575|NCT01959516|16310199|P1|Epoch 1|Use of prohibited treatment|1
4729576|NCT01959516|16310198|P2|Epoch 1|Administrative problems|0
4729577|NCT01959516|16310199|P1|Epoch 1|Administrative problems|1
4729578|NCT01959516|16310198|P2|Epoch 1|Subject withdrew consent|2
4729579|NCT01959516|16310199|P1|Epoch 1|Subject withdrew consent|3
4729580|NCT01959516|16310198|P2|Epoch 1|unsatisfactory therapeutic effect|0
4729581|NCT01959516|16310199|P1|Epoch 1|unsatisfactory therapeutic effect|1
4729582|NCT01959516|16310198|P2|Epoch 1|Adverse Event|1
4729583|NCT01959516|16310199|P1|Epoch 1|Adverse Event|4
4729584|NCT01959503|16310209|P2|Overall Study|Randomized but not treated|1
4729585|NCT01959503|16310210|P1|Overall Study|Randomized but not treated|1
4729586|NCT01959503|16310209|P2|Overall Study|Death|1
4729587|NCT01959503|16310210|P1|Overall Study|Death|2
4729588|NCT01959412|16310261|P6|Overall Study|Adverse Event|0
4729589|NCT01959412|16310262|P5|Overall Study|Adverse Event|0
4729590|NCT01959412|16310263|P4|Overall Study|Adverse Event|1
4729591|NCT01959412|16310264|P3|Overall Study|Adverse Event|0
4729592|NCT01959412|16310265|P2|Overall Study|Adverse Event|0
4729593|NCT01959412|16310266|P1|Overall Study|Adverse Event|0
4729594|NCT01959412|16310261|P6|Overall Study|Protocol deviation|0
4729595|NCT01959412|16310262|P5|Overall Study|Protocol deviation|3
4729596|NCT01959412|16310263|P4|Overall Study|Protocol deviation|1
4729597|NCT01959412|16310264|P3|Overall Study|Protocol deviation|0
4729598|NCT01959412|16310265|P2|Overall Study|Protocol deviation|1
4729599|NCT01959412|16310266|P1|Overall Study|Protocol deviation|1
4729600|NCT01959347|16310306|P2|Overall Study|Protocol Violation|7
4729601|NCT01959347|16310307|P1|Overall Study|Protocol Violation|9
4729602|NCT01959334|16310413|P2|Third Dose|Adverse Event|1
4729603|NCT01959334|16310414|P1|Third Dose|Adverse Event|0
4729604|NCT01959334|16310413|P2|Second Dose|Adverse Event|0
4729605|NCT01959334|16310414|P1|Second Dose|Adverse Event|1
4729606|NCT01959243|16310426|P2|Overall Study|Lost to Follow-up|1
4729607|NCT01959243|16310427|P1|Overall Study|Lost to Follow-up|3
4729608|NCT01959243|16310426|P2|Overall Study|Administrative reasons|1
4729609|NCT01959243|16310427|P1|Overall Study|Administrative reasons|2
4729610|NCT01959243|16310426|P2|Overall Study|Adverse Event|2
4729611|NCT01959243|16310427|P1|Overall Study|Adverse Event|5
4729612|NCT01959243|16310426|P2|Overall Study|Investigator Decision|0
4729613|NCT01959243|16310427|P1|Overall Study|Investigator Decision|3
4729614|NCT01959230|16310439|P2|Overall Study|Withdrawal by Subject|0
4729615|NCT01959230|16310440|P1|Overall Study|Withdrawal by Subject|2
4729616|NCT01959230|16310439|P2|Overall Study|Administrative reasons|0
4729617|NCT01959230|16310440|P1|Overall Study|Administrative reasons|2
4729618|NCT01959230|16310439|P2|Overall Study|Failure to follow study procedures|1
4729619|NCT01959230|16310440|P1|Overall Study|Failure to follow study procedures|0
4729620|NCT01959165|16310463|P4|Overall Study|Welfare recipient|0
4729621|NCT01959165|16310464|P3|Overall Study|Welfare recipient|0
4729622|NCT01959165|16310465|P2|Overall Study|Welfare recipient|1
4729623|NCT01959165|16310466|P1|Overall Study|Welfare recipient|0
4729624|NCT01959165|16310463|P4|Overall Study|overdose|1
4729625|NCT01959165|16310464|P3|Overall Study|overdose|0
4729626|NCT01959165|16310465|P2|Overall Study|overdose|0
4729627|NCT01959165|16310466|P1|Overall Study|overdose|0
4729628|NCT01959165|16310463|P4|Overall Study|Lack of Efficacy|0
4729629|NCT01959165|16310464|P3|Overall Study|Lack of Efficacy|0
4729630|NCT01959165|16310465|P2|Overall Study|Lack of Efficacy|0
4729631|NCT01959165|16310466|P1|Overall Study|Lack of Efficacy|1
4729632|NCT01959165|16310463|P4|Overall Study|Adverse Event|1
4729633|NCT01959165|16310464|P3|Overall Study|Adverse Event|0
4729634|NCT01959165|16310465|P2|Overall Study|Adverse Event|0
4729635|NCT01959165|16310466|P1|Overall Study|Adverse Event|0
4729636|NCT01959139|16310492|P4|Phase II|On treatment|0
4729637|NCT01959139|16310493|P3|Phase II|On treatment|4
4729638|NCT01959139|16310494|P2|Phase II|On treatment|0
4729639|NCT01959139|16310495|P1|Phase II|On treatment|0
4729640|NCT01959139|16310492|P4|Phase II|Other/Unknown|5
4729641|NCT01959139|16310493|P3|Phase II|Other/Unknown|8
4729642|NCT01959139|16310494|P2|Phase II|Other/Unknown|0
4729643|NCT01959139|16310495|P1|Phase II|Other/Unknown|0
4729644|NCT01959139|16310492|P4|Phase II|Death|1
4729645|NCT01959139|16310493|P3|Phase II|Death|3
4729646|NCT01959139|16310494|P2|Phase II|Death|0
4729647|NCT01959139|16310495|P1|Phase II|Death|0
4729648|NCT01959139|16310492|P4|Phase II|Patient Refusal|4
4729649|NCT01959139|16310493|P3|Phase II|Patient Refusal|5
4729650|NCT01959139|16310494|P2|Phase II|Patient Refusal|0
4729651|NCT01959139|16310495|P1|Phase II|Patient Refusal|0
4729652|NCT01959139|16310492|P4|Phase II|Adverse Event|11
4729653|NCT01959139|16310493|P3|Phase II|Adverse Event|10
4729654|NCT01959139|16310494|P2|Phase II|Adverse Event|0
4729655|NCT01959139|16310495|P1|Phase II|Adverse Event|0
4729656|NCT01959139|16310492|P4|Phase II|Disease progression|34
4729657|NCT01959139|16310493|P3|Phase II|Disease progression|26
4729658|NCT01959139|16310494|P2|Phase II|Disease progression|0
4729659|NCT01959139|16310495|P1|Phase II|Disease progression|0
4729660|NCT01959035|16310528|P1|Overall Study|Other (no primary reason given)|1
4729661|NCT01959035|16310528|P1|Overall Study|Lost to Follow-up|1
4729662|NCT01959035|16310528|P1|Overall Study|Withdrawal by Subject|4
4729663|NCT01959035|16310528|P1|Overall Study|Adverse Event|5
4729664|NCT01958918|16310556|P2|Overall Study|administrative problems|2
4729665|NCT01958918|16310557|P1|Overall Study|administrative problems|0
4729666|NCT01958918|16310556|P2|Overall Study|Adverse Event|12
4729667|NCT01958918|16310557|P1|Overall Study|Adverse Event|12
4729668|NCT01958918|16310556|P2|Overall Study|Lack of Efficacy|10
4729669|NCT01958918|16310557|P1|Overall Study|Lack of Efficacy|13
4729670|NCT01958918|16310556|P2|Overall Study|Withdrawal by Subject|8
4729671|NCT01958918|16310557|P1|Overall Study|Withdrawal by Subject|13
4729672|NCT01958918|16310556|P2|Overall Study|Lost to Follow-up|7
4729673|NCT01958918|16310557|P1|Overall Study|Lost to Follow-up|4
4729674|NCT01958918|16310556|P2|Overall Study|Death|3
4729675|NCT01958918|16310557|P1|Overall Study|Death|1
4729676|NCT01958827|16310571|P1|Overall Study|Concomitant Prohibited Medicine for AE|1
4729677|NCT01958827|16310571|P1|Overall Study|Lack of Efficacy|6
4729678|NCT01958827|16310571|P1|Overall Study|Adverse Event|3
4729679|NCT01958671|16310602|P3|Overall Study|Withdrawal by Subject|13
4729680|NCT01958671|16310603|P2|Overall Study|Withdrawal by Subject|10
4729681|NCT01958671|16310604|P1|Overall Study|Withdrawal by Subject|8
4729682|NCT01958671|16310602|P3|Overall Study|Participant moved|1
4729683|NCT01958671|16310603|P2|Overall Study|Participant moved|0
4729684|NCT01958671|16310604|P1|Overall Study|Participant moved|0
4729685|NCT01958671|16310602|P3|Overall Study|Study site terminated by sponsor|1
4729941|NCT01957202|16311362|P18|Treatment Period 3 (8 Days)|Adverse Event|0
4729686|NCT01958671|16310603|P2|Overall Study|Study site terminated by sponsor|0
4729687|NCT01958671|16310604|P1|Overall Study|Study site terminated by sponsor|1
4729688|NCT01958671|16310602|P3|Overall Study|Protocol Violation|0
4729689|NCT01958671|16310603|P2|Overall Study|Protocol Violation|1
4729690|NCT01958671|16310604|P1|Overall Study|Protocol Violation|0
4729691|NCT01958671|16310602|P3|Overall Study|Pregnancy|1
4729692|NCT01958671|16310603|P2|Overall Study|Pregnancy|0
4729693|NCT01958671|16310604|P1|Overall Study|Pregnancy|0
4729694|NCT01958671|16310602|P3|Overall Study|Non-compliance with study drug|1
4729695|NCT01958671|16310603|P2|Overall Study|Non-compliance with study drug|1
4729696|NCT01958671|16310604|P1|Overall Study|Non-compliance with study drug|1
4729697|NCT01958671|16310602|P3|Overall Study|Lost to Follow-up|7
4729698|NCT01958671|16310603|P2|Overall Study|Lost to Follow-up|11
4729699|NCT01958671|16310604|P1|Overall Study|Lost to Follow-up|7
4729700|NCT01958671|16310602|P3|Overall Study|Hyperglycemia|2
4729701|NCT01958671|16310603|P2|Overall Study|Hyperglycemia|0
4729702|NCT01958671|16310604|P1|Overall Study|Hyperglycemia|0
4729703|NCT01958671|16310602|P3|Overall Study|Excluded medication|1
4729704|NCT01958671|16310603|P2|Overall Study|Excluded medication|0
4729705|NCT01958671|16310604|P1|Overall Study|Excluded medication|0
4729706|NCT01958671|16310602|P3|Overall Study|Death|0
4729707|NCT01958671|16310603|P2|Overall Study|Death|0
4729708|NCT01958671|16310604|P1|Overall Study|Death|1
4729709|NCT01958671|16310602|P3|Overall Study|Adverse Event|5
4729710|NCT01958671|16310603|P2|Overall Study|Adverse Event|1
4729711|NCT01958671|16310604|P1|Overall Study|Adverse Event|1
4729712|NCT01958619|16310678|P4|Overall Study|Protocol Violation|0
4729713|NCT01958619|16310679|P3|Overall Study|Protocol Violation|1
4729714|NCT01958619|16310680|P2|Overall Study|Protocol Violation|0
4729715|NCT01958619|16310681|P1|Overall Study|Protocol Violation|2
4729716|NCT01958489|16310742|P2|Period 2|Adverse Event|1
4729717|NCT01958489|16310743|P1|Period 2|Adverse Event|0
4729718|NCT01958476|16310759|P2|Overall Study|Parent requested exclusion from analysis|0
4729719|NCT01958476|16310760|P1|Overall Study|Parent requested exclusion from analysis|1
4729720|NCT01958437|16310790|P4|Overall Study|Incidental MRI findings|1
4729721|NCT01958437|16310791|P3|Overall Study|Incidental MRI findings|1
4729722|NCT01958437|16310792|P2|Overall Study|Incidental MRI findings|0
4729723|NCT01958437|16310793|P1|Overall Study|Incidental MRI findings|0
4729724|NCT01958294|16310857|P1|Overall Study|Clinical Circumstances|2
4729725|NCT01958281|16310866|P3|Overall Study|Withdrew Consent|0
4729726|NCT01958281|16310867|P2|Overall Study|Withdrew Consent|0
4729727|NCT01958281|16310868|P1|Overall Study|Withdrew Consent|1
4729728|NCT01958281|16310866|P3|Overall Study|Adverse Event|0
4729729|NCT01958281|16310867|P2|Overall Study|Adverse Event|2
4729730|NCT01958281|16310868|P1|Overall Study|Adverse Event|0
4729731|NCT01958281|16310866|P3|Overall Study|Lack of Efficacy|0
4729732|NCT01958281|16310867|P2|Overall Study|Lack of Efficacy|2
4729733|NCT01958281|16310868|P1|Overall Study|Lack of Efficacy|5
4729734|NCT01958164|16310944|P2|Overall Study|Lost to Follow-up|3
4729735|NCT01958164|16310945|P1|Overall Study|Lost to Follow-up|2
4729736|NCT01958164|16310944|P2|Overall Study|Adverse Event|2
4729737|NCT01958164|16310945|P1|Overall Study|Adverse Event|0
4729738|NCT01958125|16310960|P2|Overall Study|No headache attacks|2
4729739|NCT01958125|16310961|P1|Overall Study|No headache attacks|0
4729740|NCT01958125|16310960|P2|Overall Study|Missing diary data|6
4729741|NCT01958125|16310961|P1|Overall Study|Missing diary data|2
4729742|NCT01958060|16311024|P6|Overall Study|Not treated|0
4729743|NCT01958060|16311025|P5|Overall Study|Not treated|1
4729744|NCT01958060|16311026|P4|Overall Study|Not treated|0
4729745|NCT01958060|16311027|P3|Overall Study|Not treated|0
4729746|NCT01958060|16311028|P2|Overall Study|Not treated|0
4729747|NCT01958060|16311029|P1|Overall Study|Not treated|2
4729748|NCT01958021|16311054|P2|Overall Study|Death|0
4729749|NCT01958021|16311055|P1|Overall Study|Death|2
4729750|NCT01958021|16311054|P2|Overall Study|Protocol Violation|1
4729751|NCT01958021|16311055|P1|Overall Study|Protocol Violation|3
4729752|NCT01958021|16311054|P2|Overall Study|Physician Decision|13
4729753|NCT01958021|16311055|P1|Overall Study|Physician Decision|10
4729754|NCT01958021|16311054|P2|Overall Study|Subject/guardian decision|13
4729755|NCT01958021|16311055|P1|Overall Study|Subject/guardian decision|12
4729756|NCT01958021|16311054|P2|Overall Study|Adverse Event|7
4729757|NCT01958021|16311055|P1|Overall Study|Adverse Event|25
4729758|NCT01958021|16311054|P2|Overall Study|Progressive disease|146
4729759|NCT01958021|16311055|P1|Overall Study|Progressive disease|87
4729760|NCT01958008|16311067|P4|Overall Study|Other adverse event|0
4729761|NCT01958008|16311068|P3|Overall Study|Other adverse event|0
4729762|NCT01958008|16311069|P2|Overall Study|Other adverse event|0
4729763|NCT01958008|16311070|P1|Overall Study|Other adverse event|1
4729764|NCT01958008|16311067|P4|Overall Study|Worsening of disease under study|0
4729765|NCT01958008|16311068|P3|Overall Study|Worsening of disease under study|1
4729766|NCT01958008|16311069|P2|Overall Study|Worsening of disease under study|0
4729767|NCT01958008|16311070|P1|Overall Study|Worsening of disease under study|0
4729768|NCT01957865|16311113|P3|Overall Study|Lost to Follow-up|2
4729769|NCT01957865|16311114|P2|Overall Study|Lost to Follow-up|2
4729770|NCT01957865|16311115|P1|Overall Study|Lost to Follow-up|0
4729771|NCT01957865|16311113|P3|Overall Study|Found HIV negative|1
4729772|NCT01957865|16311114|P2|Overall Study|Found HIV negative|0
4729773|NCT01957865|16311115|P1|Overall Study|Found HIV negative|0
4729774|NCT01957787|16311126|P1|Overall Study|Local therapy, not cryoablation|6
4729775|NCT01957787|16311126|P1|Overall Study|Index Tumor was Primary Lung Cancer|2
4729776|NCT01957787|16311126|P1|Overall Study|Index Tumor(s) Resected|2
4729777|NCT01957787|16311126|P1|Overall Study|Entered Hospice or Similar Program|2
4729778|NCT01957787|16311126|P1|Overall Study|Withdrawal by Subject|3
4729779|NCT01957787|16311126|P1|Overall Study|Lost to Follow-up|3
4729780|NCT01957787|16311126|P1|Overall Study|Death|18
4729781|NCT01957709|16311145|P1|Overall Study|Patient refused to complete post-tx bx|1
4729782|NCT01957644|16311170|P5|Overall Study|Protocol Violation|0
4729783|NCT01957644|16311171|P4|Overall Study|Protocol Violation|0
4729784|NCT01957644|16311172|P3|Overall Study|Protocol Violation|0
4729785|NCT01957644|16311173|P2|Overall Study|Protocol Violation|1
4729786|NCT01957644|16311174|P1|Overall Study|Protocol Violation|0
4729787|NCT01957644|16311170|P5|Overall Study|Withdrawal by Subject|0
4729788|NCT01957644|16311171|P4|Overall Study|Withdrawal by Subject|0
4729789|NCT01957644|16311172|P3|Overall Study|Withdrawal by Subject|0
4729790|NCT01957644|16311173|P2|Overall Study|Withdrawal by Subject|0
4729791|NCT01957644|16311174|P1|Overall Study|Withdrawal by Subject|1
4729792|NCT01957644|16311170|P5|Overall Study|Other reason|0
4729793|NCT01957644|16311171|P4|Overall Study|Other reason|1
4729794|NCT01957644|16311172|P3|Overall Study|Other reason|1
4729795|NCT01957644|16311173|P2|Overall Study|Other reason|2
4729796|NCT01957644|16311174|P1|Overall Study|Other reason|1
4729797|NCT01957644|16311170|P5|Overall Study|Progressive disease / relapse|0
4729798|NCT01957644|16311171|P4|Overall Study|Progressive disease / relapse|1
4729799|NCT01957644|16311172|P3|Overall Study|Progressive disease / relapse|0
4729800|NCT01957644|16311173|P2|Overall Study|Progressive disease / relapse|1
4729801|NCT01957644|16311174|P1|Overall Study|Progressive disease / relapse|0
4729802|NCT01957644|16311170|P5|Overall Study|Adverse Event|1
4729803|NCT01957644|16311171|P4|Overall Study|Adverse Event|0
4729804|NCT01957644|16311172|P3|Overall Study|Adverse Event|0
4729805|NCT01957644|16311173|P2|Overall Study|Adverse Event|2
4729806|NCT01957644|16311174|P1|Overall Study|Adverse Event|4
4729807|NCT01957579|16311198|P4|Overall Study|Death|0
4729808|NCT01957579|16311199|P3|Overall Study|Death|2
4729809|NCT01957579|16311200|P2|Overall Study|Death|0
4729810|NCT01957579|16311201|P1|Overall Study|Death|0
4729811|NCT01957579|16311198|P4|Overall Study|Withdrawal of concent|0
4729812|NCT01957579|16311199|P3|Overall Study|Withdrawal of concent|0
4729813|NCT01957579|16311200|P2|Overall Study|Withdrawal of concent|1
4729814|NCT01957579|16311201|P1|Overall Study|Withdrawal of concent|0
4729815|NCT01957553|16311268|P2|Test Period 2 (21 +- 1 Days)|Other|0
4729816|NCT01957553|16311269|P1|Test Period 2 (21 +- 1 Days)|Other|1
4729817|NCT01957553|16311268|P2|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1
4729818|NCT01957553|16311269|P1|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0
4729819|NCT01957553|16311268|P2|Test Period 2 (21 +- 1 Days)|completed early by mistake|1
4729820|NCT01957553|16311269|P1|Test Period 2 (21 +- 1 Days)|completed early by mistake|0
4729821|NCT01957553|16311268|P2|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2
4729822|NCT01957553|16311269|P1|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1
4729823|NCT01957553|16311268|P2|Test Period 2 (21 +- 1 Days)|Adverse Event|3
4729824|NCT01957553|16311269|P1|Test Period 2 (21 +- 1 Days)|Adverse Event|1
4729825|NCT01957553|16311268|P2|Test Period 1 (21 +- 1 Days)|screen failure|0
4729826|NCT01957553|16311269|P1|Test Period 1 (21 +- 1 Days)|screen failure|1
4729827|NCT01957553|16311268|P2|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0
4729828|NCT01957553|16311269|P1|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2
4729829|NCT01957553|16311268|P2|Test Period 1 (21 +- 1 Days)|Adverse Event|0
4729830|NCT01957553|16311269|P1|Test Period 1 (21 +- 1 Days)|Adverse Event|2
4729831|NCT01957553|16311268|P2|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3
4729832|NCT01957553|16311269|P1|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2
4729833|NCT01957488|16311275|P6|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4729834|NCT01957488|16311276|P5|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4729835|NCT01957488|16311277|P4|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4729836|NCT01957488|16311278|P3|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4729837|NCT01957488|16311279|P2|Test Period 3 (2 Weeks)|Lack of Efficacy|1
4729838|NCT01957488|16311280|P1|Test Period 3 (2 Weeks)|Lack of Efficacy|0
4729839|NCT01957488|16311275|P6|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4729840|NCT01957488|16311276|P5|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4729841|NCT01957488|16311277|P4|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4729842|NCT01957488|16311278|P3|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4729843|NCT01957488|16311279|P2|Test Period 3 (2 Weeks)|Withdrawal by Subject|0
4729844|NCT01957488|16311280|P1|Test Period 3 (2 Weeks)|Withdrawal by Subject|1
4729845|NCT01957488|16311275|P6|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1
4729846|NCT01957488|16311276|P5|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4729847|NCT01957488|16311277|P4|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4729848|NCT01957488|16311278|P3|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4729849|NCT01957488|16311279|P2|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4729850|NCT01957488|16311280|P1|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0
4729851|NCT01957488|16311275|P6|Test Period 2 (2 Weeks)|Adverse Event|0
4729852|NCT01957488|16311276|P5|Test Period 2 (2 Weeks)|Adverse Event|2
4729853|NCT01957488|16311277|P4|Test Period 2 (2 Weeks)|Adverse Event|0
4729854|NCT01957488|16311278|P3|Test Period 2 (2 Weeks)|Adverse Event|0
4729855|NCT01957488|16311279|P2|Test Period 2 (2 Weeks)|Adverse Event|0
4729856|NCT01957488|16311280|P1|Test Period 2 (2 Weeks)|Adverse Event|0
4729857|NCT01957488|16311275|P6|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4729858|NCT01957488|16311276|P5|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4729859|NCT01957488|16311277|P4|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4729860|NCT01957488|16311278|P3|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4729861|NCT01957488|16311279|P2|Test Period 2 (2 Weeks)|Withdrawal by Subject|1
4729862|NCT01957488|16311280|P1|Test Period 2 (2 Weeks)|Withdrawal by Subject|0
4729863|NCT01957488|16311275|P6|Test Period 2 (2 Weeks)|Other|0
4729864|NCT01957488|16311276|P5|Test Period 2 (2 Weeks)|Other|0
4729865|NCT01957488|16311277|P4|Test Period 2 (2 Weeks)|Other|0
4729866|NCT01957488|16311278|P3|Test Period 2 (2 Weeks)|Other|0
4729867|NCT01957488|16311279|P2|Test Period 2 (2 Weeks)|Other|0
4729868|NCT01957488|16311280|P1|Test Period 2 (2 Weeks)|Other|1
4729869|NCT01957488|16311275|P6|Test Period 2 (2 Weeks)|Protocol Violation|0
4729870|NCT01957488|16311276|P5|Test Period 2 (2 Weeks)|Protocol Violation|0
4729871|NCT01957488|16311277|P4|Test Period 2 (2 Weeks)|Protocol Violation|1
4729872|NCT01957488|16311278|P3|Test Period 2 (2 Weeks)|Protocol Violation|1
4729873|NCT01957488|16311279|P2|Test Period 2 (2 Weeks)|Protocol Violation|0
4729874|NCT01957488|16311280|P1|Test Period 2 (2 Weeks)|Protocol Violation|2
4729875|NCT01957488|16311275|P6|Test Period 1 (2 Weeks)|screen failure|1
4729876|NCT01957488|16311276|P5|Test Period 1 (2 Weeks)|screen failure|0
4729877|NCT01957488|16311277|P4|Test Period 1 (2 Weeks)|screen failure|0
4729878|NCT01957488|16311278|P3|Test Period 1 (2 Weeks)|screen failure|0
4729879|NCT01957488|16311279|P2|Test Period 1 (2 Weeks)|screen failure|0
4729880|NCT01957488|16311280|P1|Test Period 1 (2 Weeks)|screen failure|0
4729881|NCT01957488|16311275|P6|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4729882|NCT01957488|16311276|P5|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1
4729883|NCT01957488|16311277|P4|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4729884|NCT01957488|16311278|P3|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4729885|NCT01957488|16311279|P2|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4729886|NCT01957488|16311280|P1|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0
4729887|NCT01957488|16311275|P6|Test Period 1 (2 Weeks)|Withdrawal by Subject|2
4729888|NCT01957488|16311276|P5|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
4729889|NCT01957488|16311277|P4|Test Period 1 (2 Weeks)|Withdrawal by Subject|1
4729890|NCT01957488|16311278|P3|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
4729891|NCT01957488|16311279|P2|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
4729892|NCT01957488|16311280|P1|Test Period 1 (2 Weeks)|Withdrawal by Subject|0
4729893|NCT01957488|16311275|P6|Test Period 1 (2 Weeks)|Adverse Event|0
4729894|NCT01957488|16311276|P5|Test Period 1 (2 Weeks)|Adverse Event|1
4729895|NCT01957488|16311277|P4|Test Period 1 (2 Weeks)|Adverse Event|0
4729896|NCT01957488|16311278|P3|Test Period 1 (2 Weeks)|Adverse Event|1
4729897|NCT01957488|16311279|P2|Test Period 1 (2 Weeks)|Adverse Event|1
4729898|NCT01957488|16311280|P1|Test Period 1 (2 Weeks)|Adverse Event|0
4729899|NCT01957488|16311275|P6|Test Period 1 (2 Weeks)|Protocol Violation|3
4729900|NCT01957488|16311276|P5|Test Period 1 (2 Weeks)|Protocol Violation|0
4729901|NCT01957488|16311277|P4|Test Period 1 (2 Weeks)|Protocol Violation|1
4729902|NCT01957488|16311278|P3|Test Period 1 (2 Weeks)|Protocol Violation|2
4729903|NCT01957488|16311279|P2|Test Period 1 (2 Weeks)|Protocol Violation|2
4729904|NCT01957488|16311280|P1|Test Period 1 (2 Weeks)|Protocol Violation|1
4729905|NCT01957488|16311275|P6|Test Period 1 (2 Weeks)|Lost to Follow-up|0
4729906|NCT01957488|16311276|P5|Test Period 1 (2 Weeks)|Lost to Follow-up|0
4729907|NCT01957488|16311277|P4|Test Period 1 (2 Weeks)|Lost to Follow-up|1
4729908|NCT01957488|16311278|P3|Test Period 1 (2 Weeks)|Lost to Follow-up|1
4729909|NCT01957488|16311279|P2|Test Period 1 (2 Weeks)|Lost to Follow-up|0
4729910|NCT01957488|16311280|P1|Test Period 1 (2 Weeks)|Lost to Follow-up|2
4729911|NCT01957475|16311288|P2|Test Period 2|Adverse Event|0
4729912|NCT01957475|16311289|P1|Test Period 2|Adverse Event|1
4729913|NCT01957475|16311288|P2|Test Period 1|Lack of Efficacy|1
4729914|NCT01957475|16311289|P1|Test Period 1|Lack of Efficacy|0
4729915|NCT01957475|16311288|P2|Test Period 1|Other|0
4729916|NCT01957475|16311289|P1|Test Period 1|Other|1
4729917|NCT01957475|16311288|P2|Test Period 1|Withdrawal by Subject|0
4729918|NCT01957475|16311289|P1|Test Period 1|Withdrawal by Subject|1
4729919|NCT01957462|16311295|P2|Test Period 1|Adverse Event|0
4729920|NCT01957462|16311296|P1|Test Period 1|Adverse Event|1
4729921|NCT01957462|16311295|P2|Test Period 1|Withdrawal by Subject|0
4729922|NCT01957462|16311296|P1|Test Period 1|Withdrawal by Subject|1
4729923|NCT01957397|16311307|P2|Test Period 3|the adhesive did not work|0
4729924|NCT01957397|16311308|P1|Test Period 3|the adhesive did not work|1
4729925|NCT01957397|16311307|P2|Test Period 3|Adverse Event|2
4729926|NCT01957397|16311308|P1|Test Period 3|Adverse Event|1
4729927|NCT01957397|16311307|P2|Test Period 2|Adverse Event|1
4729928|NCT01957397|16311308|P1|Test Period 2|Adverse Event|0
4729929|NCT01957397|16311307|P2|Test Period 1|Withdrawal by Subject|0
4729930|NCT01957397|16311308|P1|Test Period 1|Withdrawal by Subject|1
4729931|NCT01957397|16311307|P2|Test Period 1|sudden leakage/small bag|1
4729932|NCT01957397|16311308|P1|Test Period 1|sudden leakage/small bag|1
4729933|NCT01957215|16311333|P2|Overall Study|Withdrawal by Subject|5
4729934|NCT01957215|16311334|P1|Overall Study|Withdrawal by Subject|7
4729935|NCT01957215|16311333|P2|Overall Study|Protocol Violation|2
4729936|NCT01957215|16311334|P1|Overall Study|Protocol Violation|1
4729937|NCT01957215|16311333|P2|Overall Study|Lost to Follow-up|3
4729938|NCT01957215|16311334|P1|Overall Study|Lost to Follow-up|3
4729939|NCT01957215|16311333|P2|Overall Study|Adverse Event|2
4729940|NCT01957215|16311334|P1|Overall Study|Adverse Event|2
4729942|NCT01957202|16311363|P17|Treatment Period 3 (8 Days)|Adverse Event|1
4729943|NCT01957202|16311364|P16|Treatment Period 3 (8 Days)|Adverse Event|0
4729944|NCT01957202|16311365|P15|Treatment Period 3 (8 Days)|Adverse Event|0
4729945|NCT01957202|16311366|P14|Treatment Period 3 (8 Days)|Adverse Event|0
4729946|NCT01957202|16311367|P13|Treatment Period 3 (8 Days)|Adverse Event|0
4729947|NCT01957202|16311368|P12|Treatment Period 3 (8 Days)|Adverse Event|0
4729948|NCT01957202|16311369|P11|Treatment Period 3 (8 Days)|Adverse Event|0
4729949|NCT01957202|16311370|P10|Treatment Period 3 (8 Days)|Adverse Event|0
4729950|NCT01957202|16311371|P9|Treatment Period 3 (8 Days)|Adverse Event|0
4729951|NCT01957202|16311372|P8|Treatment Period 3 (8 Days)|Adverse Event|0
4729952|NCT01957202|16311373|P7|Treatment Period 3 (8 Days)|Adverse Event|0
4729953|NCT01957202|16311374|P6|Treatment Period 3 (8 Days)|Adverse Event|0
4729954|NCT01957202|16311375|P5|Treatment Period 3 (8 Days)|Adverse Event|0
4729955|NCT01957202|16311376|P4|Treatment Period 3 (8 Days)|Adverse Event|0
4729956|NCT01957202|16311377|P3|Treatment Period 3 (8 Days)|Adverse Event|0
4729957|NCT01957202|16311378|P2|Treatment Period 3 (8 Days)|Adverse Event|0
4729958|NCT01957202|16311379|P1|Treatment Period 3 (8 Days)|Adverse Event|0
4729959|NCT01957202|16311362|P18|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729960|NCT01957202|16311363|P17|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
4729961|NCT01957202|16311364|P16|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729962|NCT01957202|16311365|P15|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729963|NCT01957202|16311366|P14|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729964|NCT01957202|16311367|P13|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729965|NCT01957202|16311368|P12|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729966|NCT01957202|16311369|P11|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729967|NCT01957202|16311370|P10|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729968|NCT01957202|16311371|P9|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729969|NCT01957202|16311372|P8|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729970|NCT01957202|16311373|P7|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729971|NCT01957202|16311374|P6|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729972|NCT01957202|16311375|P5|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729973|NCT01957202|16311376|P4|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729974|NCT01957202|16311377|P3|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729975|NCT01957202|16311378|P2|Treatment Period 2 (8 Days)|Withdrawal by Subject|1
4729976|NCT01957202|16311379|P1|Treatment Period 2 (8 Days)|Withdrawal by Subject|0
4729977|NCT01957163|16311404|P3|Overall Study|Withdrawal by Subject|4
4729978|NCT01957163|16311405|P2|Overall Study|Withdrawal by Subject|2
4729979|NCT01957163|16311406|P1|Overall Study|Withdrawal by Subject|4
4729980|NCT01957163|16311404|P3|Overall Study|Lost to Follow-up|0
4729981|NCT01957163|16311405|P2|Overall Study|Lost to Follow-up|1
4729982|NCT01957163|16311406|P1|Overall Study|Lost to Follow-up|0
4729983|NCT01957163|16311404|P3|Overall Study|Met Protocol-Defined Stopping Criteria|1
4729984|NCT01957163|16311405|P2|Overall Study|Met Protocol-Defined Stopping Criteria|0
4729985|NCT01957163|16311406|P1|Overall Study|Met Protocol-Defined Stopping Criteria|0
4729986|NCT01957163|16311404|P3|Overall Study|Protocol Violation|0
4729987|NCT01957163|16311405|P2|Overall Study|Protocol Violation|2
4729988|NCT01957163|16311406|P1|Overall Study|Protocol Violation|1
4729989|NCT01957163|16311404|P3|Overall Study|Lack of Efficacy|9
4729990|NCT01957163|16311405|P2|Overall Study|Lack of Efficacy|4
4729991|NCT01957163|16311406|P1|Overall Study|Lack of Efficacy|5
4729992|NCT01957163|16311404|P3|Overall Study|Adverse Event|4
4729993|NCT01957163|16311405|P2|Overall Study|Adverse Event|2
4729994|NCT01957163|16311406|P1|Overall Study|Adverse Event|5
4729995|NCT01957150|16311419|P2|Overall Study|Lack of Efficacy|11
4729996|NCT01957150|16311420|P1|Overall Study|Lack of Efficacy|11
4729997|NCT01957150|16311419|P2|Overall Study|Protocol Violation|0
4729998|NCT01957150|16311420|P1|Overall Study|Protocol Violation|1
4729999|NCT01957150|16311419|P2|Overall Study|Lost to Follow-up|4
4730000|NCT01957150|16311420|P1|Overall Study|Lost to Follow-up|4
4730001|NCT01957150|16311419|P2|Overall Study|Physician Decision|6
4730002|NCT01957150|16311420|P1|Overall Study|Physician Decision|3
4730003|NCT01957150|16311419|P2|Overall Study|Withdrawal by Subject|17
4730004|NCT01957150|16311420|P1|Overall Study|Withdrawal by Subject|13
4730005|NCT01957150|16311419|P2|Overall Study|Adverse Event|20
4730006|NCT01957150|16311420|P1|Overall Study|Adverse Event|23
4730007|NCT01957137|16311436|P1|Randomized Portion|Withdrawal by Subject|1
4730008|NCT01957137|16311436|P1|Randomized Portion|Adverse Event|1
4730009|NCT01957111|16311466|P2|Overall Study|Withdrawal by Subject|1
4730010|NCT01957111|16311467|P1|Overall Study|Withdrawal by Subject|1
4730011|NCT01956773|16311486|P2|Overall Study|Lost to Follow-up|1
4730012|NCT01956773|16311487|P1|Overall Study|Lost to Follow-up|628
4730013|NCT01956669|16311505|P7|Overall Study|Withdrawal by Subject|1
4730014|NCT01956669|16311506|P6|Overall Study|Withdrawal by Subject|0
4730015|NCT01956669|16311507|P5|Overall Study|Withdrawal by Subject|0
4730016|NCT01956669|16311508|P4|Overall Study|Withdrawal by Subject|1
4730017|NCT01956669|16311509|P3|Overall Study|Withdrawal by Subject|1
4730018|NCT01956669|16311510|P2|Overall Study|Withdrawal by Subject|0
4730019|NCT01956669|16311511|P1|Overall Study|Withdrawal by Subject|0
4730020|NCT01956669|16311505|P7|Overall Study|Physician Decision|0
4730021|NCT01956669|16311506|P6|Overall Study|Physician Decision|1
4730022|NCT01956669|16311507|P5|Overall Study|Physician Decision|0
4730023|NCT01956669|16311508|P4|Overall Study|Physician Decision|0
4730024|NCT01956669|16311509|P3|Overall Study|Physician Decision|0
4730025|NCT01956669|16311510|P2|Overall Study|Physician Decision|2
4730026|NCT01956669|16311511|P1|Overall Study|Physician Decision|0
4730027|NCT01956669|16311505|P7|Overall Study|Adverse Event|0
4730028|NCT01956669|16311506|P6|Overall Study|Adverse Event|0
4730029|NCT01956669|16311507|P5|Overall Study|Adverse Event|0
4730030|NCT01956669|16311508|P4|Overall Study|Adverse Event|1
4730031|NCT01956669|16311509|P3|Overall Study|Adverse Event|2
4730032|NCT01956669|16311510|P2|Overall Study|Adverse Event|2
4730033|NCT01956669|16311511|P1|Overall Study|Adverse Event|0
4730034|NCT01956669|16311505|P7|Overall Study|Disease Progression|5
4730035|NCT01956669|16311506|P6|Overall Study|Disease Progression|3
4730036|NCT01956669|16311507|P5|Overall Study|Disease Progression|4
4730037|NCT01956669|16311508|P4|Overall Study|Disease Progression|8
4730038|NCT01956669|16311509|P3|Overall Study|Disease Progression|7
4730039|NCT01956669|16311510|P2|Overall Study|Disease Progression|7
4730040|NCT01956669|16311511|P1|Overall Study|Disease Progression|12
4730041|NCT01956240|16311633|P2|Overall Study|Adverse Event|4
4730042|NCT01956240|16311634|P1|Overall Study|Adverse Event|17
4730043|NCT01956240|16311633|P2|Overall Study|Lost to Follow-up|20
4730044|NCT01956240|16311634|P1|Overall Study|Lost to Follow-up|6
4730045|NCT01956123|16311644|P4|COS Cycle 3|Withdrawal by Subject|1
4730046|NCT01956123|16311645|P3|COS Cycle 3|Withdrawal by Subject|0
4730047|NCT01956123|16311646|P2|COS Cycle 3|Withdrawal by Subject|0
4730048|NCT01956123|16311647|P1|COS Cycle 3|Withdrawal by Subject|0
4730049|NCT01956123|16311644|P4|COS Cycle 3|Personal Reasons|0
4730050|NCT01956123|16311645|P3|COS Cycle 3|Personal Reasons|1
4730051|NCT01956123|16311646|P2|COS Cycle 3|Personal Reasons|0
4730052|NCT01956123|16311647|P1|COS Cycle 3|Personal Reasons|0
4730053|NCT01956123|16311644|P4|COS Cycle 3|Adverse Event|0
4730054|NCT01956123|16311645|P3|COS Cycle 3|Adverse Event|3
4730055|NCT01956123|16311646|P2|COS Cycle 3|Adverse Event|0
4730056|NCT01956123|16311647|P1|COS Cycle 3|Adverse Event|0
4730057|NCT01956123|16311644|P4|COS Cycle 3|Protocol Violation|1
4730058|NCT01956123|16311645|P3|COS Cycle 3|Protocol Violation|2
4730059|NCT01956123|16311646|P2|COS Cycle 3|Protocol Violation|0
4730060|NCT01956123|16311647|P1|COS Cycle 3|Protocol Violation|0
4730061|NCT01956123|16311644|P4|COS Cycle 2|Withdrawal by Subject|0
4730062|NCT01956123|16311645|P3|COS Cycle 2|Withdrawal by Subject|0
4730063|NCT01956123|16311646|P2|COS Cycle 2|Withdrawal by Subject|0
4730064|NCT01956123|16311647|P1|COS Cycle 2|Withdrawal by Subject|1
4730065|NCT01956123|16311644|P4|COS Cycle 2|Personal Reasons|0
4730066|NCT01956123|16311645|P3|COS Cycle 2|Personal Reasons|0
4730067|NCT01956123|16311646|P2|COS Cycle 2|Personal Reasons|0
4730068|NCT01956123|16311647|P1|COS Cycle 2|Personal Reasons|2
4730069|NCT01956123|16311644|P4|COS Cycle 2|Adverse Event|0
4730070|NCT01956123|16311645|P3|COS Cycle 2|Adverse Event|0
4730071|NCT01956123|16311646|P2|COS Cycle 2|Adverse Event|4
4730072|NCT01956123|16311647|P1|COS Cycle 2|Adverse Event|3
4730073|NCT01956123|16311644|P4|COS Cycle 2|Protocol Violation|0
4730074|NCT01956123|16311645|P3|COS Cycle 2|Protocol Violation|0
4730075|NCT01956123|16311646|P2|COS Cycle 2|Protocol Violation|3
4730076|NCT01956123|16311647|P1|COS Cycle 2|Protocol Violation|8
4730077|NCT01956110|16311699|P2|Overall Study|Personal reasons|1
4730078|NCT01956110|16311700|P1|Overall Study|Personal reasons|1
4730079|NCT01956110|16311699|P2|Overall Study|Adverse Event|10
4730080|NCT01956110|16311700|P1|Overall Study|Adverse Event|9
4730081|NCT01956110|16311699|P2|Overall Study|Protocol Violation|11
4730082|NCT01956110|16311700|P1|Overall Study|Protocol Violation|25
4730083|NCT01955733|16311835|P3|Period 2|Other not defined above|2
4730084|NCT01955733|16311836|P2|Period 2|Other not defined above|2
4730085|NCT01955733|16311837|P1|Period 2|Other not defined above|0
4730086|NCT01955733|16311835|P3|Period 2|Lost to Follow-up|0
4730087|NCT01955733|16311836|P2|Period 2|Lost to Follow-up|0
4730088|NCT01955733|16311837|P1|Period 2|Lost to Follow-up|2
4730089|NCT01955733|16311835|P3|Period 2|Study terminated by sponsor|16
4730090|NCT01955733|16311836|P2|Period 2|Study terminated by sponsor|14
4730091|NCT01955733|16311837|P1|Period 2|Study terminated by sponsor|8
4730092|NCT01955733|16311835|P3|Period 2|Withdrawal by Subject|2
4730093|NCT01955733|16311836|P2|Period 2|Withdrawal by Subject|3
4730094|NCT01955733|16311837|P1|Period 2|Withdrawal by Subject|1
4730095|NCT01955733|16311835|P3|Period 2|Physician Decision|1
4730096|NCT01955733|16311836|P2|Period 2|Physician Decision|0
4730097|NCT01955733|16311837|P1|Period 2|Physician Decision|0
4730098|NCT01955733|16311835|P3|Period 2|Adverse Event|0
4730099|NCT01955733|16311836|P2|Period 2|Adverse Event|0
4730100|NCT01955733|16311837|P1|Period 2|Adverse Event|1
4730101|NCT01955733|16311835|P3|Period 1|Lost to Follow-up|0
4730102|NCT01955733|16311836|P2|Period 1|Lost to Follow-up|0
4730103|NCT01955733|16311837|P1|Period 1|Lost to Follow-up|1
4730104|NCT01955707|16311930|P2|Overall Study|Other|2
4730105|NCT01955707|16311931|P1|Overall Study|Other|4
4730106|NCT01955707|16311930|P2|Overall Study|Death|14
4730107|NCT01955707|16311931|P1|Overall Study|Death|13
4730108|NCT01955707|16311930|P2|Overall Study|Withdrawal by Subject|3
4730109|NCT01955707|16311931|P1|Overall Study|Withdrawal by Subject|0
4730110|NCT01955707|16311930|P2|Overall Study|Lost to Follow-up|1
4730111|NCT01955707|16311931|P1|Overall Study|Lost to Follow-up|2
4730112|NCT01955707|16311930|P2|Overall Study|Adverse Event|2
4730113|NCT01955707|16311931|P1|Overall Study|Adverse Event|1
4730114|NCT01955161|16312199|P3|Overall Study|Other reason: patient's will|1
4730115|NCT01955161|16312200|P2|Overall Study|Other reason: patient's will|0
4730116|NCT01955161|16312201|P1|Overall Study|Other reason: patient's will|0
4730117|NCT01955161|16312199|P3|Overall Study|Other reason: primary biliary cirrhosis|0
4730118|NCT01955161|16312200|P2|Overall Study|Other reason: primary biliary cirrhosis|0
4730119|NCT01955161|16312201|P1|Overall Study|Other reason: primary biliary cirrhosis|1
4730120|NCT01955161|16312199|P3|Overall Study|Other reason: insufficient compliance|1
4730121|NCT01955161|16312200|P2|Overall Study|Other reason: insufficient compliance|0
4730122|NCT01955161|16312201|P1|Overall Study|Other reason: insufficient compliance|0
4730123|NCT01955161|16312199|P3|Overall Study|Other reason: moved to nursing home|0
4730124|NCT01955161|16312200|P2|Overall Study|Other reason: moved to nursing home|1
4730125|NCT01955161|16312201|P1|Overall Study|Other reason: moved to nursing home|0
4730126|NCT01955161|16312199|P3|Overall Study|Other reason: caregiver unavailable|0
4730127|NCT01955161|16312200|P2|Overall Study|Other reason: caregiver unavailable|0
4730128|NCT01955161|16312201|P1|Overall Study|Other reason: caregiver unavailable|1
4730129|NCT01955161|16312199|P3|Overall Study|Other reason: disallowed medication|1
4730130|NCT01955161|16312200|P2|Overall Study|Other reason: disallowed medication|0
4730131|NCT01955161|16312201|P1|Overall Study|Other reason: disallowed medication|1
4730132|NCT01955161|16312199|P3|Overall Study|Other reason: physician decision|1
4730133|NCT01955161|16312200|P2|Overall Study|Other reason: physician decision|1
4730134|NCT01955161|16312201|P1|Overall Study|Other reason: physician decision|0
4730135|NCT01955161|16312199|P3|Overall Study|Protocol Violation|0
4730136|NCT01955161|16312200|P2|Overall Study|Protocol Violation|0
4730137|NCT01955161|16312201|P1|Overall Study|Protocol Violation|2
4730138|NCT01955161|16312199|P3|Overall Study|Withdrawal by Subject|12
4730139|NCT01955161|16312200|P2|Overall Study|Withdrawal by Subject|8
4730140|NCT01955161|16312201|P1|Overall Study|Withdrawal by Subject|9
4730141|NCT01955161|16312199|P3|Overall Study|Death|3
4730142|NCT01955161|16312200|P2|Overall Study|Death|1
4730143|NCT01955161|16312201|P1|Overall Study|Death|1
4730144|NCT01955161|16312199|P3|Overall Study|Adverse Event|15
4730145|NCT01955161|16312200|P2|Overall Study|Adverse Event|14
4730146|NCT01955161|16312201|P1|Overall Study|Adverse Event|10
4730147|NCT01955161|16312199|P3|Overall Study|Withdrawal before treatment|1
4730148|NCT01955161|16312200|P2|Overall Study|Withdrawal before treatment|0
4730149|NCT01955161|16312201|P1|Overall Study|Withdrawal before treatment|2
4730150|NCT01955122|16312241|P2|Overall Study|Physician Decision|5
4730151|NCT01955122|16312242|P1|Overall Study|Physician Decision|5
4730152|NCT01955083|16312262|P2|Overall Study|Lost to Follow-up|1
4730153|NCT01955083|16312263|P1|Overall Study|Lost to Follow-up|1
4730154|NCT01955044|16312296|P3|Overall Study|Death|0
4730155|NCT01955044|16312297|P2|Overall Study|Death|1
4730156|NCT01955044|16312298|P1|Overall Study|Death|1
4730157|NCT01955005|16312311|P2|Overall Study|Withdrawal by Subject|5
4730158|NCT01955005|16312312|P1|Overall Study|Withdrawal by Subject|3
4730159|NCT01954927|16312324|P2|Overall Study|Withdrawal by Subject|1
4730160|NCT01954927|16312325|P1|Overall Study|Withdrawal by Subject|3
4730161|NCT01954771|16312346|P3|Overall Study|Missing HbA1c and CGMS of end-point|3
4730162|NCT01954771|16312347|P2|Overall Study|Missing HbA1c and CGMS of end-point|1
4730163|NCT01954771|16312348|P1|Overall Study|Missing HbA1c and CGMS of end-point|5
4730164|NCT01954771|16312346|P3|Overall Study|Missing CGMS of end-point|0
4730165|NCT01954771|16312347|P2|Overall Study|Missing CGMS of end-point|1
4730166|NCT01954771|16312348|P1|Overall Study|Missing CGMS of end-point|1
4730167|NCT01954771|16312346|P3|Overall Study|Missing HbA1c of end-point|0
4730168|NCT01954771|16312347|P2|Overall Study|Missing HbA1c of end-point|1
4730169|NCT01954771|16312348|P1|Overall Study|Missing HbA1c of end-point|1
4730170|NCT01954745|16312365|P1|Overall Study|Death|1
4730171|NCT01954745|16312365|P1|Overall Study|Adverse Event|2
4730172|NCT01954745|16312365|P1|Overall Study|Clinical Progression|5
4730173|NCT01954745|16312365|P1|Overall Study|Radiological Progression|11
4730174|NCT01954394|16312396|P2|Overall Study|Other than specified above|21
4730175|NCT01954394|16312397|P1|Overall Study|Other than specified above|10
4730176|NCT01954394|16312396|P2|Overall Study|Related to Study Drug administration|2
4730177|NCT01954394|16312397|P1|Overall Study|Related to Study Drug administration|2
4730178|NCT01954394|16312396|P2|Overall Study|Participant Moved|4
4730179|NCT01954394|16312397|P1|Overall Study|Participant Moved|0
4730180|NCT01954394|16312396|P2|Overall Study|Poor compliance to protocol|7
4730181|NCT01954394|16312397|P1|Overall Study|Poor compliance to protocol|7
4730182|NCT01954394|16312396|P2|Overall Study|Adverse Event|23
4730183|NCT01954394|16312397|P1|Overall Study|Adverse Event|10
4730184|NCT01954394|16312396|P2|Overall Study|Enrolled but not treated|0
4730185|NCT01954394|16312397|P1|Overall Study|Enrolled but not treated|1
4730186|NCT01954342|16312451|P4|Overall Study|Unreliable Data|2
4730187|NCT01954342|16312452|P3|Overall Study|Unreliable Data|0
4730188|NCT01954342|16312453|P2|Overall Study|Unreliable Data|0
4730189|NCT01954342|16312454|P1|Overall Study|Unreliable Data|0
4730190|NCT01954342|16312451|P4|Overall Study|Pre-eclampsia|4
4730191|NCT01954342|16312452|P3|Overall Study|Pre-eclampsia|0
4730192|NCT01954342|16312453|P2|Overall Study|Pre-eclampsia|0
4730193|NCT01954342|16312454|P1|Overall Study|Pre-eclampsia|0
4730194|NCT01954342|16312451|P4|Overall Study|Preterm delivery|3
4730195|NCT01954342|16312452|P3|Overall Study|Preterm delivery|0
4730196|NCT01954342|16312453|P2|Overall Study|Preterm delivery|0
4730197|NCT01954342|16312454|P1|Overall Study|Preterm delivery|0
4730198|NCT01954342|16312451|P4|Overall Study|Lost to Follow-up|5
4730199|NCT01954342|16312452|P3|Overall Study|Lost to Follow-up|0
4730200|NCT01954342|16312453|P2|Overall Study|Lost to Follow-up|0
4730201|NCT01954342|16312454|P1|Overall Study|Lost to Follow-up|0
4730202|NCT01954342|16312451|P4|Overall Study|Miscarriage|3
4730203|NCT01954342|16312452|P3|Overall Study|Miscarriage|0
4730204|NCT01954342|16312453|P2|Overall Study|Miscarriage|0
4730205|NCT01954342|16312454|P1|Overall Study|Miscarriage|0
4730206|NCT01954342|16312451|P4|Overall Study|Missing data from 13-16week study visit|1
4730207|NCT01954342|16312452|P3|Overall Study|Missing data from 13-16week study visit|0
4730208|NCT01954342|16312453|P2|Overall Study|Missing data from 13-16week study visit|0
4730209|NCT01954342|16312454|P1|Overall Study|Missing data from 13-16week study visit|0
4730210|NCT01954251|16312556|P2|Overall Study|Withdrawal by Subject|6
4730211|NCT01954251|16312557|P1|Overall Study|Withdrawal by Subject|2
4730212|NCT01954251|16312556|P2|Overall Study|Lost to Follow-up|6
4730213|NCT01954251|16312557|P1|Overall Study|Lost to Follow-up|6
4730214|NCT01954251|16312556|P2|Overall Study|Adverse Event|7
4730215|NCT01954251|16312557|P1|Overall Study|Adverse Event|5
4730216|NCT01954121|16312654|P2|Overall Study|Subject did not follow instructions|2
4730217|NCT01954121|16312655|P1|Overall Study|Subject did not follow instructions|0
4730218|NCT01954121|16312654|P2|Overall Study|Non-compliant patient|1
4730219|NCT01954121|16312655|P1|Overall Study|Non-compliant patient|1
4730220|NCT01954121|16312654|P2|Overall Study|Non-compliant with study procedures|0
4730221|NCT01954121|16312655|P1|Overall Study|Non-compliant with study procedures|1
4730222|NCT01954121|16312654|P2|Overall Study|SAE, non-fatal|4
4730223|NCT01954121|16312655|P1|Overall Study|SAE, non-fatal|1
4730224|NCT01954121|16312654|P2|Overall Study|AE, non-serious non-fatal|22
4730225|NCT01954121|16312655|P1|Overall Study|AE, non-serious non-fatal|5
4730226|NCT01954121|16312654|P2|Overall Study|AE, serious fatal|0
4730227|NCT01954121|16312655|P1|Overall Study|AE, serious fatal|1
4730228|NCT01954121|16312654|P2|Overall Study|Pregnancy|1
4730229|NCT01954121|16312655|P1|Overall Study|Pregnancy|1
4730230|NCT01954121|16312654|P2|Overall Study|Withdrawal by Subject|12
4730231|NCT01954121|16312655|P1|Overall Study|Withdrawal by Subject|18
4730232|NCT01954121|16312654|P2|Overall Study|Lost to Follow-up|6
4730233|NCT01954121|16312655|P1|Overall Study|Lost to Follow-up|5
4730234|NCT01954121|16312654|P2|Overall Study|Protocol Violation|2
4730235|NCT01954121|16312655|P1|Overall Study|Protocol Violation|0
4730236|NCT01954121|16312654|P2|Overall Study|Lack of Efficacy|41
4730237|NCT01954121|16312655|P1|Overall Study|Lack of Efficacy|94
4730238|NCT01954082|16312671|P2|Overall Study|Randomized not Treated|2
4730239|NCT01954082|16312672|P1|Overall Study|Randomized not Treated|4
4730240|NCT01954082|16312671|P2|Overall Study|Infant Moved|1
4730241|NCT01954082|16312672|P1|Overall Study|Infant Moved|0
4730242|NCT01954082|16312671|P2|Overall Study|Comfort Care|1
4730243|NCT01954082|16312672|P1|Overall Study|Comfort Care|0
4730244|NCT01954082|16312671|P2|Overall Study|Miscalculation of Final Dose Day|3
4730245|NCT01954082|16312672|P1|Overall Study|Miscalculation of Final Dose Day|0
4730246|NCT01954082|16312671|P2|Overall Study|Redirection of Care|2
4730247|NCT01954082|16312672|P1|Overall Study|Redirection of Care|0
4730248|NCT01954082|16312671|P2|Overall Study|Discontinued Early Prior to Transfer|2
4730249|NCT01954082|16312672|P1|Overall Study|Discontinued Early Prior to Transfer|3
4730250|NCT01954082|16312671|P2|Overall Study|Withdrawal by Subject|1
4730251|NCT01954082|16312672|P1|Overall Study|Withdrawal by Subject|0
4730252|NCT01954082|16312671|P2|Overall Study|Parent Decision|0
4730253|NCT01954082|16312672|P1|Overall Study|Parent Decision|1
4730254|NCT01954082|16312671|P2|Overall Study|Physician Decision|0
4730255|NCT01954082|16312672|P1|Overall Study|Physician Decision|2
4730256|NCT01954082|16312671|P2|Overall Study|Non-compliance|4
4730257|NCT01954082|16312672|P1|Overall Study|Non-compliance|6
4730258|NCT01954082|16312671|P2|Overall Study|Intolerance|1
4730259|NCT01954082|16312672|P1|Overall Study|Intolerance|0
4730260|NCT01954082|16312671|P2|Overall Study|Adverse Event|4
4730261|NCT01954082|16312672|P1|Overall Study|Adverse Event|10
4730262|NCT01954082|16312671|P2|Overall Study|Study Suspension|36
4730263|NCT01954082|16312672|P1|Overall Study|Study Suspension|42
4730264|NCT01954056|16312692|P2|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0
4730265|NCT01954056|16312693|P1|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1
4730266|NCT01954017|16312738|P3|Overall Study|All other reasons|7
4730267|NCT01954017|16312739|P2|Overall Study|All other reasons|2
4730268|NCT01954017|16312740|P1|Overall Study|All other reasons|2
4730269|NCT01954017|16312738|P3|Overall Study|Enteral intake stopped >7 days|1
4730270|NCT01954017|16312739|P2|Overall Study|Enteral intake stopped >7 days|1
4730271|NCT01954017|16312740|P1|Overall Study|Enteral intake stopped >7 days|0
4730272|NCT01954017|16312738|P3|Overall Study|Necrotizing enterocolitis|1
4730273|NCT01954017|16312739|P2|Overall Study|Necrotizing enterocolitis|0
4730274|NCT01954017|16312740|P1|Overall Study|Necrotizing enterocolitis|1
4730275|NCT01954017|16312738|P3|Overall Study|Protocol Violation|2
4730276|NCT01954017|16312739|P2|Overall Study|Protocol Violation|3
4730277|NCT01954017|16312740|P1|Overall Study|Protocol Violation|0
4730278|NCT01954017|16312738|P3|Overall Study|Withdrawal by Subject|0
4730279|NCT01954017|16312739|P2|Overall Study|Withdrawal by Subject|1
4730280|NCT01954017|16312740|P1|Overall Study|Withdrawal by Subject|0
4730281|NCT01954017|16312738|P3|Overall Study|Death|1
4730282|NCT01954017|16312739|P2|Overall Study|Death|1
4730283|NCT01954017|16312740|P1|Overall Study|Death|2
4730284|NCT01954017|16312738|P3|Overall Study|Adverse Event|1
4730285|NCT01954017|16312739|P2|Overall Study|Adverse Event|0
4730286|NCT01954017|16312740|P1|Overall Study|Adverse Event|0
4730287|NCT01953913|16312966|P1|Overall Study|Not Treated|1
4730288|NCT01953913|16312966|P1|Overall Study|Other than listed|108
4730289|NCT01953913|16312966|P1|Overall Study|Withdrawal by Subject|32
4730290|NCT01953913|16312966|P1|Overall Study|Lost to Follow-up|4
4730291|NCT01953913|16312966|P1|Overall Study|Protocol Violation|6
4730292|NCT01953913|16312966|P1|Overall Study|Adverse Event|20
4730293|NCT01953913|16312966|P1|Overall Study|Worsening of underlying cancer|22
4730294|NCT01953913|16312966|P1|Overall Study|Disease Progression|349
4730295|NCT01953783|16313018|P1|Overall Study|Progressive disease|2
4730296|NCT01953601|16313043|P3|Part 2 (Extension Study)|Withdrawal by Subject|2
4730297|NCT01953601|16313044|P2|Part 2 (Extension Study)|Withdrawal by Subject|4
4730298|NCT01953601|16313045|P1|Part 2 (Extension Study)|Withdrawal by Subject|5
4730299|NCT01953601|16313043|P3|Part 2 (Extension Study)|Subject moved|1
4730300|NCT01953601|16313044|P2|Part 2 (Extension Study)|Subject moved|0
4730301|NCT01953601|16313045|P1|Part 2 (Extension Study)|Subject moved|0
4730302|NCT01953601|16313043|P3|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0
4730303|NCT01953601|16313044|P2|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3
4730304|NCT01953601|16313045|P1|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1
4730305|NCT01953601|16313043|P3|Part 2 (Extension Study)|Study terminated by sponsor|187
4730306|NCT01953601|16313044|P2|Part 2 (Extension Study)|Study terminated by sponsor|178
4730307|NCT01953601|16313045|P1|Part 2 (Extension Study)|Study terminated by sponsor|185
4730308|NCT01953601|16313043|P3|Part 2 (Extension Study)|Site discontinued study participation|1
4730309|NCT01953601|16313044|P2|Part 2 (Extension Study)|Site discontinued study participation|1
4730310|NCT01953601|16313045|P1|Part 2 (Extension Study)|Site discontinued study participation|0
4730311|NCT01953601|16313043|P3|Part 2 (Extension Study)|Physician Decision|2
4730312|NCT01953601|16313044|P2|Part 2 (Extension Study)|Physician Decision|0
4730313|NCT01953601|16313045|P1|Part 2 (Extension Study)|Physician Decision|2
4730314|NCT01953601|16313043|P3|Part 2 (Extension Study)|Lost to Follow-up|1
4730315|NCT01953601|16313044|P2|Part 2 (Extension Study)|Lost to Follow-up|1
4730316|NCT01953601|16313045|P1|Part 2 (Extension Study)|Lost to Follow-up|2
4730317|NCT01953601|16313043|P3|Part 2 (Extension Study)|Lack of Efficacy|0
4730318|NCT01953601|16313044|P2|Part 2 (Extension Study)|Lack of Efficacy|0
4730319|NCT01953601|16313045|P1|Part 2 (Extension Study)|Lack of Efficacy|2
4730320|NCT01953601|16313043|P3|Part 2 (Extension Study)|Death|0
4730321|NCT01953601|16313044|P2|Part 2 (Extension Study)|Death|3
4730322|NCT01953601|16313045|P1|Part 2 (Extension Study)|Death|0
4730323|NCT01953601|16313043|P3|Part 2 (Extension Study)|Adverse Event|10
4730324|NCT01953601|16313044|P2|Part 2 (Extension Study)|Adverse Event|1
4730325|NCT01953601|16313045|P1|Part 2 (Extension Study)|Adverse Event|1
4730326|NCT01953601|16313043|P3|Part 1 (Base Study)|Withdrawal by Subject|22
4730327|NCT01953601|16313044|P2|Part 1 (Base Study)|Withdrawal by Subject|23
4730328|NCT01953601|16313045|P1|Part 1 (Base Study)|Withdrawal by Subject|32
4730329|NCT01953601|16313043|P3|Part 1 (Base Study)|Subject moved|1
4730330|NCT01953601|16313044|P2|Part 1 (Base Study)|Subject moved|2
4730331|NCT01953601|16313045|P1|Part 1 (Base Study)|Subject moved|2
4730332|NCT01953601|16313043|P3|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10
4730333|NCT01953601|16313044|P2|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8
4730334|NCT01953601|16313045|P1|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7
4730335|NCT01953601|16313043|P3|Part 1 (Base Study)|Study terminated by sponsor|179
4730336|NCT01953601|16313044|P2|Part 1 (Base Study)|Study terminated by sponsor|169
4730337|NCT01953601|16313045|P1|Part 1 (Base Study)|Study terminated by sponsor|174
4730338|NCT01953601|16313043|P3|Part 1 (Base Study)|Site discontinued study participation|0
4730339|NCT01953601|16313044|P2|Part 1 (Base Study)|Site discontinued study participation|0
4730340|NCT01953601|16313045|P1|Part 1 (Base Study)|Site discontinued study participation|2
4730341|NCT01953601|16313043|P3|Part 1 (Base Study)|Screen failure|1
4730342|NCT01953601|16313044|P2|Part 1 (Base Study)|Screen failure|0
4730343|NCT01953601|16313045|P1|Part 1 (Base Study)|Screen failure|1
4730344|NCT01953601|16313043|P3|Part 1 (Base Study)|Physician Decision|4
4730345|NCT01953601|16313044|P2|Part 1 (Base Study)|Physician Decision|7
4730346|NCT01953601|16313045|P1|Part 1 (Base Study)|Physician Decision|3
4730347|NCT01953601|16313043|P3|Part 1 (Base Study)|Non-compliance with study drug|1
4730348|NCT01953601|16313044|P2|Part 1 (Base Study)|Non-compliance with study drug|3
4730349|NCT01953601|16313045|P1|Part 1 (Base Study)|Non-compliance with study drug|0
4730350|NCT01953601|16313043|P3|Part 1 (Base Study)|Lost to Follow-up|6
4730351|NCT01953601|16313044|P2|Part 1 (Base Study)|Lost to Follow-up|3
4730352|NCT01953601|16313045|P1|Part 1 (Base Study)|Lost to Follow-up|1
4730353|NCT01953601|16313043|P3|Part 1 (Base Study)|Lack of Efficacy|4
4730354|NCT01953601|16313044|P2|Part 1 (Base Study)|Lack of Efficacy|1
4730355|NCT01953601|16313045|P1|Part 1 (Base Study)|Lack of Efficacy|3
4730356|NCT01953601|16313043|P3|Part 1 (Base Study)|Death|3
4730357|NCT01953601|16313044|P2|Part 1 (Base Study)|Death|0
4730358|NCT01953601|16313045|P1|Part 1 (Base Study)|Death|2
4730359|NCT01953601|16313043|P3|Part 1 (Base Study)|Adverse Event|15
4730360|NCT01953601|16313044|P2|Part 1 (Base Study)|Adverse Event|37
4730361|NCT01953601|16313045|P1|Part 1 (Base Study)|Adverse Event|24
4730362|NCT01953354|16313116|P2|Overall Study|Disease Exacerbation|0
4730363|NCT01953354|16313117|P1|Overall Study|Disease Exacerbation|1
4730364|NCT01953354|16313116|P2|Overall Study|Decision of Sponsor|1
4730365|NCT01953354|16313117|P1|Overall Study|Decision of Sponsor|0
4730366|NCT01953354|16313116|P2|Overall Study|Withdrawal by Subject|1
4730367|NCT01953354|16313117|P1|Overall Study|Withdrawal by Subject|0
4730368|NCT01953328|16313145|P8|Overall Study|Lost to Follow-up|0
4730369|NCT01953328|16313146|P7|Overall Study|Lost to Follow-up|0
4730370|NCT01953328|16313147|P6|Overall Study|Lost to Follow-up|0
4730371|NCT01953328|16313148|P5|Overall Study|Lost to Follow-up|1
4730372|NCT01953328|16313149|P4|Overall Study|Lost to Follow-up|0
4730373|NCT01953328|16313150|P3|Overall Study|Lost to Follow-up|0
4730374|NCT01953328|16313151|P2|Overall Study|Lost to Follow-up|0
4730375|NCT01953328|16313152|P1|Overall Study|Lost to Follow-up|0
4730376|NCT01953328|16313145|P8|Overall Study|Withdrawal by Subject|0
4730377|NCT01953328|16313146|P7|Overall Study|Withdrawal by Subject|0
4730378|NCT01953328|16313147|P6|Overall Study|Withdrawal by Subject|0
4730379|NCT01953328|16313148|P5|Overall Study|Withdrawal by Subject|1
4730380|NCT01953328|16313149|P4|Overall Study|Withdrawal by Subject|0
4730381|NCT01953328|16313150|P3|Overall Study|Withdrawal by Subject|0
4730382|NCT01953328|16313151|P2|Overall Study|Withdrawal by Subject|0
4730383|NCT01953328|16313152|P1|Overall Study|Withdrawal by Subject|0
4730384|NCT01953224|16313365|P2|Overall Study|Withdrawal by Subject|2
4730385|NCT01953224|16313366|P1|Overall Study|Withdrawal by Subject|1
4730386|NCT01953224|16313365|P2|Overall Study|Lost to Follow-up|1
4730387|NCT01953224|16313366|P1|Overall Study|Lost to Follow-up|1
4730388|NCT01953003|16313415|P2|Overall Study|Withdrawal by Subject|4
4730389|NCT01953003|16313416|P1|Overall Study|Withdrawal by Subject|14
4730390|NCT01953003|16313415|P2|Overall Study|Protocol Violation|1
4730391|NCT01953003|16313416|P1|Overall Study|Protocol Violation|0
4730392|NCT01953003|16313415|P2|Overall Study|Non-related adverse events|2
4730393|NCT01953003|16313416|P1|Overall Study|Non-related adverse events|0
4730394|NCT01953003|16313415|P2|Overall Study|Related Adverse events|2
4730395|NCT01953003|16313416|P1|Overall Study|Related Adverse events|7
4730396|NCT01953003|16313415|P2|Overall Study|Progressive disease|45
4730397|NCT01953003|16313416|P1|Overall Study|Progressive disease|35
4730398|NCT01953003|16313415|P2|Overall Study|Not treated|1
4730399|NCT01953003|16313416|P1|Overall Study|Not treated|0
4730400|NCT01952834|16313422|P1|Overall Study|Adverse Event|1
4730401|NCT01952691|16313429|P1|Overall Study|Lost to Follow-up|2
4730402|NCT01952665|16313456|P2|Overall Study|Protocol Violation|1
4730403|NCT01952665|16313457|P1|Overall Study|Protocol Violation|0
4730404|NCT01952665|16313456|P2|Overall Study|Adverse Event|1
4730405|NCT01952665|16313457|P1|Overall Study|Adverse Event|2
4730406|NCT01952665|16313456|P2|Overall Study|Lost to Follow-up|2
4730407|NCT01952665|16313457|P1|Overall Study|Lost to Follow-up|1
4730408|NCT01952665|16313456|P2|Overall Study|Physician Decision|2
4730409|NCT01952665|16313457|P1|Overall Study|Physician Decision|3
4730410|NCT01952574|16313612|P4|Overall Study|Lost to Follow-up|0
4730411|NCT01952574|16313613|P3|Overall Study|Lost to Follow-up|1
4730412|NCT01952574|16313614|P2|Overall Study|Lost to Follow-up|0
4730413|NCT01952574|16313615|P1|Overall Study|Lost to Follow-up|2
4730414|NCT01952574|16313612|P4|Overall Study|Sponsor Decision|2
4730415|NCT01952574|16313613|P3|Overall Study|Sponsor Decision|5
4730416|NCT01952574|16313614|P2|Overall Study|Sponsor Decision|0
4730417|NCT01952574|16313615|P1|Overall Study|Sponsor Decision|6
4730418|NCT01952574|16313612|P4|Overall Study|Withdrawal by Subject|4
4730419|NCT01952574|16313613|P3|Overall Study|Withdrawal by Subject|3
4730420|NCT01952574|16313614|P2|Overall Study|Withdrawal by Subject|3
4730421|NCT01952574|16313615|P1|Overall Study|Withdrawal by Subject|9
4730422|NCT01952366|16313714|P1|Overall Study|Withdrawal by Subject|9
4730423|NCT01952366|16313714|P1|Overall Study|Death|22
4730424|NCT01952145|16313729|P2|Overall Study|Unclassified|1
4730425|NCT01952145|16313730|P1|Overall Study|Unclassified|1
4730426|NCT01952145|16313729|P2|Overall Study|Withdrawal Criteria|11
4730427|NCT01952145|16313730|P1|Overall Study|Withdrawal Criteria|16
4730428|NCT01952145|16313729|P2|Overall Study|Adverse Event|0
4730429|NCT01952145|16313730|P1|Overall Study|Adverse Event|9
4730430|NCT01952145|16313729|P2|Overall Study|Death|1
4730431|NCT01952145|16313730|P1|Overall Study|Death|0
4730432|NCT01952145|16313729|P2|Overall Study|Protocol Violation|1
4730433|NCT01952145|16313730|P1|Overall Study|Protocol Violation|2
4730434|NCT01952080|16313744|P4|Overall Study|Protocol Non-compliance|0
4730435|NCT01952080|16313745|P3|Overall Study|Protocol Non-compliance|0
4730436|NCT01952080|16313746|P2|Overall Study|Protocol Non-compliance|1
4730437|NCT01952080|16313747|P1|Overall Study|Protocol Non-compliance|0
4730438|NCT01952080|16313744|P4|Overall Study|Withdrawal by Subject|1
4730439|NCT01952080|16313745|P3|Overall Study|Withdrawal by Subject|0
4730440|NCT01952080|16313746|P2|Overall Study|Withdrawal by Subject|0
4730441|NCT01952080|16313747|P1|Overall Study|Withdrawal by Subject|0
4730442|NCT01952054|16313793|P1|Overall Study|Physician Decision|1
4730443|NCT01952041|16313801|P2|Overall Study|Death|0
4730444|NCT01952041|16313802|P1|Overall Study|Death|1
4730445|NCT01952041|16313801|P2|Overall Study|Withdrawal by Subject|5
4730446|NCT01952041|16313802|P1|Overall Study|Withdrawal by Subject|7
4730447|NCT01952041|16313801|P2|Overall Study|Lost to Follow-up|16
4730448|NCT01952041|16313802|P1|Overall Study|Lost to Follow-up|9
4730449|NCT01952015|16313816|P1|Treatment Period 3|Physician Decision|9
4730450|NCT01952015|16313816|P1|Maintenance|Adverse Event|2
4730451|NCT01952015|16313816|P1|Induction|Protocol Violation|1
4730452|NCT01951703|16313883|P2|Second Intervention|Unsatisfactory Lens fitting|1
4730453|NCT01951703|16313884|P1|Second Intervention|Unsatisfactory Lens fitting|0
4730454|NCT01951703|16313883|P2|Second Intervention|Protocol Violation|1
4730455|NCT01951703|16313884|P1|Second Intervention|Protocol Violation|0
4730456|NCT01951703|16313883|P2|First Intervention|Physician Decision|0
4730457|NCT01951703|16313884|P1|First Intervention|Physician Decision|1
4730458|NCT01951703|16313883|P2|First Intervention|Subject was not compliant|1
4730459|NCT01951703|16313884|P1|First Intervention|Subject was not compliant|1
4730460|NCT01951703|16313883|P2|First Intervention|Withdrawal by Subject|0
4730461|NCT01951703|16313884|P1|First Intervention|Withdrawal by Subject|1
4730462|NCT01951586|16313909|P2|Overall Study|Sponsor Decision|10
4730463|NCT01951586|16313910|P1|Overall Study|Sponsor Decision|9
4730464|NCT01951586|16313909|P2|Overall Study|Lost to Follow-up|1
4730465|NCT01951586|16313910|P1|Overall Study|Lost to Follow-up|0
4730466|NCT01951586|16313909|P2|Overall Study|Withdrawal by Subject|17
4730467|NCT01951586|16313910|P1|Overall Study|Withdrawal by Subject|8
4730468|NCT01951586|16313909|P2|Overall Study|Death|120
4730469|NCT01951586|16313910|P1|Overall Study|Death|61
4730470|NCT01951573|16313934|P2|Washout Period|Adverse Event|1
4730471|NCT01951573|16313935|P1|Washout Period|Adverse Event|0
4730472|NCT01951417|16313945|P1|Overall Study|Lost to Follow-up|6
4730473|NCT01951417|16313945|P1|Overall Study|Protocol Violation|2
4730474|NCT01951417|16313945|P1|Overall Study|Withdrawal by Subject|1
4730475|NCT01951378|16313981|P2|Overall Study|Study Terminated-Not completed|17
4730476|NCT01951378|16313982|P1|Overall Study|Study Terminated-Not completed|23
4730477|NCT01951261|16314059|P2|Overall Study|Protocol Violation|3
4730478|NCT01951261|16314060|P1|Overall Study|Protocol Violation|4
4730479|NCT01951261|16314059|P2|Overall Study|Lost to Follow-up|3
4730480|NCT01951261|16314060|P1|Overall Study|Lost to Follow-up|4
4730481|NCT01951261|16314059|P2|Overall Study|Death|0
4730482|NCT01951261|16314060|P1|Overall Study|Death|1
4730483|NCT01951170|16314078|P1|Overall Study|Investigator decision|1
4730484|NCT01951157|16314104|P3|Overall Study|Treatment-related death|0
4730485|NCT01951157|16314105|P2|Overall Study|Treatment-related death|2
4730486|NCT01951157|16314106|P1|Overall Study|Treatment-related death|0
4730487|NCT01951157|16314104|P3|Overall Study|Consent withdrawn by subject|3
4730488|NCT01951157|16314105|P2|Overall Study|Consent withdrawn by subject|1
4730489|NCT01951157|16314106|P1|Overall Study|Consent withdrawn by subject|0
4730490|NCT01951157|16314104|P3|Overall Study|Treatment-related AE|4
4730491|NCT01951157|16314105|P2|Overall Study|Treatment-related AE|0
4730492|NCT01951157|16314106|P1|Overall Study|Treatment-related AE|2
4730493|NCT01951157|16314104|P3|Overall Study|No treated|0
4730494|NCT01951157|16314105|P2|Overall Study|No treated|1
4730495|NCT01951157|16314106|P1|Overall Study|No treated|0
4730496|NCT01951157|16314104|P3|Overall Study|Non-treatmentrelated death|2
4730497|NCT01951157|16314105|P2|Overall Study|Non-treatmentrelated death|2
4730498|NCT01951157|16314106|P1|Overall Study|Non-treatmentrelated death|2
4730499|NCT01951157|16314104|P3|Overall Study|Physician Decision|2
4730500|NCT01951157|16314105|P2|Overall Study|Physician Decision|3
4730501|NCT01951157|16314106|P1|Overall Study|Physician Decision|5
4730502|NCT01951157|16314104|P3|Overall Study|Study Termination|1
4730503|NCT01951157|16314105|P2|Overall Study|Study Termination|0
4730504|NCT01951157|16314106|P1|Overall Study|Study Termination|0
4730505|NCT01951157|16314104|P3|Overall Study|Treatment-unrelated AE|3
4730506|NCT01951157|16314105|P2|Overall Study|Treatment-unrelated AE|0
4730507|NCT01951157|16314106|P1|Overall Study|Treatment-unrelated AE|1
4730508|NCT01951157|16314104|P3|Overall Study|Progressive Disease|10
4730509|NCT01951157|16314105|P2|Overall Study|Progressive Disease|13
4730510|NCT01951157|16314106|P1|Overall Study|Progressive Disease|12
4730511|NCT01951105|16314157|P3|Overall Study|Withdrawal by Subject|1
4730512|NCT01951105|16314158|P2|Overall Study|Withdrawal by Subject|3
4730513|NCT01951105|16314159|P1|Overall Study|Withdrawal by Subject|0
4730514|NCT01951105|16314157|P3|Overall Study|Protocol Violation|1
4730515|NCT01951105|16314158|P2|Overall Study|Protocol Violation|1
4730516|NCT01951105|16314159|P1|Overall Study|Protocol Violation|1
4730517|NCT01951105|16314157|P3|Overall Study|Lost to Follow-up|0
4730518|NCT01951105|16314158|P2|Overall Study|Lost to Follow-up|1
4730519|NCT01951105|16314159|P1|Overall Study|Lost to Follow-up|0
4730520|NCT01951105|16314157|P3|Overall Study|Adverse Event|0
4730521|NCT01951105|16314158|P2|Overall Study|Adverse Event|5
4730522|NCT01951105|16314159|P1|Overall Study|Adverse Event|0
4730523|NCT01951092|16314173|P1|Overall Study|Transfer of Care|1
4730524|NCT01951092|16314173|P1|Overall Study|Incarceration|1
4730525|NCT01951092|16314173|P1|Overall Study|Lost to Follow-up|10
4730526|NCT01950819|16314186|P2|Overall Study|Lost to Follow-up|17
4730527|NCT01950819|16314187|P1|Overall Study|Lost to Follow-up|9
4730528|NCT01950819|16314186|P2|Overall Study|Pregnancy|2
4730529|NCT01950819|16314187|P1|Overall Study|Pregnancy|0
4730530|NCT01950819|16314186|P2|Overall Study|technical problems|0
4730531|NCT01950819|16314187|P1|Overall Study|technical problems|2
4730532|NCT01950819|16314186|P2|Overall Study|Subject / Gardian decision|51
4730533|NCT01950819|16314187|P1|Overall Study|Subject / Gardian decision|54
4730534|NCT01950819|16314186|P2|Overall Study|Death|34
4730535|NCT01950819|16314187|P1|Overall Study|Death|29
4730536|NCT01950819|16314186|P2|Overall Study|Graft Loss|30
4730537|NCT01950819|16314187|P1|Overall Study|Graft Loss|35
4730538|NCT01950741|16314240|P1|Overall Study|Withdrawal by Subject|1
4730539|NCT01950741|16314240|P1|Overall Study|Death|1
4730540|NCT01950741|16314240|P1|Overall Study|Lost to Follow-up|1
4730541|NCT01950364|16314255|P2|Overall Study|Protocol Violation|1
4730542|NCT01950364|16314256|P1|Overall Study|Protocol Violation|0
4730543|NCT01950364|16314255|P2|Overall Study|Withdrawal by Subject|1
4730544|NCT01950364|16314256|P1|Overall Study|Withdrawal by Subject|0
4730545|NCT01950364|16314255|P2|Overall Study|Disease Progression|2
4730546|NCT01950364|16314256|P1|Overall Study|Disease Progression|5
4730547|NCT01950364|16314255|P2|Overall Study|Stem Cell Transplant|6
4730548|NCT01950364|16314256|P1|Overall Study|Stem Cell Transplant|2
4730549|NCT01950364|16314255|P2|Overall Study|Adverse Event|0
4730550|NCT01950364|16314256|P1|Overall Study|Adverse Event|3
4730551|NCT01950273|16314378|P2|Overall Study|Other not defined above|0
4730552|NCT01950273|16314379|P1|Overall Study|Other not defined above|1
4730553|NCT01950273|16314378|P2|Overall Study|Withdrawal by Subject|0
4730554|NCT01950273|16314379|P1|Overall Study|Withdrawal by Subject|2
4730555|NCT01950273|16314378|P2|Overall Study|Protocol Violation|0
4730556|NCT01950273|16314379|P1|Overall Study|Protocol Violation|1
4730557|NCT01950013|16314426|P3|Overall Study|Withdrawal by Subject|0
4730558|NCT01950013|16314427|P2|Overall Study|Withdrawal by Subject|2
4730559|NCT01950013|16314428|P1|Overall Study|Withdrawal by Subject|0
4730560|NCT01949870|16314439|P1|Overall Study|Eligibility requirements not fulfilled|2
4730561|NCT01949870|16314439|P1|Overall Study|Study termination|1
4730562|NCT01949870|16314439|P1|Overall Study|Adverse Event|1
4730563|NCT01949870|16314439|P1|Overall Study|Lack of Efficacy|2
4730564|NCT01949532|16314608|P2|Overall Study|On-study at the Data Cut-off Date|3
4730565|NCT01949532|16314609|P1|Overall Study|On-study at the Data Cut-off Date|3
4730566|NCT01949480|16314679|P2|Overall Study|Physician Decision|8
4730567|NCT01949480|16314680|P1|Overall Study|Physician Decision|5
4730568|NCT01949155|16314726|P2|Overall Study|Protocol Violation|0
4730569|NCT01949155|16314727|P1|Overall Study|Protocol Violation|1
4730570|NCT01949155|16314726|P2|Overall Study|Lost to Follow-up|0
4730571|NCT01949155|16314727|P1|Overall Study|Lost to Follow-up|1
4730572|NCT01949142|16314739|P2|Overall Study|Parent changed their mind|0
4730573|NCT01949142|16314740|P1|Overall Study|Parent changed their mind|1
4730574|NCT01949142|16314739|P2|Overall Study|Lost to Follow-up|1
4730575|NCT01949142|16314740|P1|Overall Study|Lost to Follow-up|1
4730576|NCT01949142|16314739|P2|Overall Study|Withdrawal of consent|0
4730577|NCT01949142|16314740|P1|Overall Study|Withdrawal of consent|1
4730578|NCT01949116|16314752|P2|Overall Study|Withdrawal by Subject|3
4730579|NCT01949116|16314753|P1|Overall Study|Withdrawal by Subject|5
4730580|NCT01949116|16314752|P2|Overall Study|Lost to Follow-up|3
4730581|NCT01949116|16314753|P1|Overall Study|Lost to Follow-up|1
4730582|NCT01949116|16314752|P2|Overall Study|Death|0
4730583|NCT01949116|16314753|P1|Overall Study|Death|2
4730584|NCT01949090|16314790|P5|Overall Study|Lost to Follow-up|1
4730585|NCT01949090|16314791|P4|Overall Study|Lost to Follow-up|1
4730586|NCT01949090|16314792|P3|Overall Study|Lost to Follow-up|0
4730587|NCT01949090|16314793|P2|Overall Study|Lost to Follow-up|1
4730588|NCT01949090|16314794|P1|Overall Study|Lost to Follow-up|2
4730589|NCT01949090|16314790|P5|Overall Study|Protocol non-compliance|1
4730590|NCT01949090|16314791|P4|Overall Study|Protocol non-compliance|0
4730591|NCT01949090|16314792|P3|Overall Study|Protocol non-compliance|0
4730592|NCT01949090|16314793|P2|Overall Study|Protocol non-compliance|0
4730593|NCT01949090|16314794|P1|Overall Study|Protocol non-compliance|0
4730594|NCT01949090|16314790|P5|Overall Study|Withdrawal by Subject|1
4730595|NCT01949090|16314791|P4|Overall Study|Withdrawal by Subject|0
4730596|NCT01949090|16314792|P3|Overall Study|Withdrawal by Subject|0
4730597|NCT01949090|16314793|P2|Overall Study|Withdrawal by Subject|0
4730598|NCT01949090|16314794|P1|Overall Study|Withdrawal by Subject|2
4730599|NCT01949090|16314790|P5|Overall Study|Serious Adverse Event|1
4730600|NCT01949090|16314791|P4|Overall Study|Serious Adverse Event|0
4730601|NCT01949090|16314792|P3|Overall Study|Serious Adverse Event|2
4730602|NCT01949090|16314793|P2|Overall Study|Serious Adverse Event|1
4730603|NCT01949090|16314794|P1|Overall Study|Serious Adverse Event|0
4730604|NCT01949051|16314971|P6|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4730605|NCT01949051|16314972|P5|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4730606|NCT01949051|16314973|P4|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4730607|NCT01949051|16314974|P3|Treatment Period 2 (7 Days)|Withdrawal by Subject|1
4730608|NCT01949051|16314975|P2|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4730609|NCT01949051|16314976|P1|Treatment Period 2 (7 Days)|Withdrawal by Subject|0
4730610|NCT01949051|16314971|P6|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4730611|NCT01949051|16314972|P5|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4730612|NCT01949051|16314973|P4|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4730613|NCT01949051|16314974|P3|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4730614|NCT01949051|16314975|P2|Treatment Period 2 (7 Days)|Lost to Follow-up|1
4730615|NCT01949051|16314976|P1|Treatment Period 2 (7 Days)|Lost to Follow-up|0
4730616|NCT01949051|16314971|P6|Treatment Period 2 (7 Days)|Protocol Violation|1
4730617|NCT01949051|16314972|P5|Treatment Period 2 (7 Days)|Protocol Violation|0
4730618|NCT01949051|16314973|P4|Treatment Period 2 (7 Days)|Protocol Violation|0
4730619|NCT01949051|16314974|P3|Treatment Period 2 (7 Days)|Protocol Violation|0
4730620|NCT01949051|16314975|P2|Treatment Period 2 (7 Days)|Protocol Violation|0
4730621|NCT01949051|16314976|P1|Treatment Period 2 (7 Days)|Protocol Violation|0
4730622|NCT01949051|16314971|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4730623|NCT01949051|16314972|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4730624|NCT01949051|16314973|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4730625|NCT01949051|16314974|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4730626|NCT01949051|16314975|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4730627|NCT01949051|16314976|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|1
4730628|NCT01949051|16314971|P6|Treatment Period 1 (7 Days)|Protocol Violation|0
4730629|NCT01949051|16314972|P5|Treatment Period 1 (7 Days)|Protocol Violation|0
4730630|NCT01949051|16314973|P4|Treatment Period 1 (7 Days)|Protocol Violation|1
4730631|NCT01949051|16314974|P3|Treatment Period 1 (7 Days)|Protocol Violation|0
4730632|NCT01949051|16314975|P2|Treatment Period 1 (7 Days)|Protocol Violation|0
4730633|NCT01949051|16314976|P1|Treatment Period 1 (7 Days)|Protocol Violation|1
4730634|NCT01948908|16315171|P3|Overall Study|Protocol Violation|2
4730635|NCT01948908|16315172|P2|Overall Study|Protocol Violation|0
4730636|NCT01948908|16315173|P1|Overall Study|Protocol Violation|1
4730637|NCT01948830|16315189|P2|Overall Study|Death|4
4730638|NCT01948830|16315190|P1|Overall Study|Death|3
4730639|NCT01948830|16315189|P2|Overall Study|Adverse Event|2
4730640|NCT01948830|16315190|P1|Overall Study|Adverse Event|9
4730641|NCT01948830|16315189|P2|Overall Study|Withdrawal by Subject|17
4730642|NCT01948830|16315190|P1|Overall Study|Withdrawal by Subject|14
4730643|NCT01948830|16315189|P2|Overall Study|Lost to Follow-up|4
4730644|NCT01948830|16315190|P1|Overall Study|Lost to Follow-up|5
4730645|NCT01948830|16315189|P2|Overall Study|Protocol deviation|2
4730646|NCT01948830|16315190|P1|Overall Study|Protocol deviation|1
4730647|NCT01948830|16315189|P2|Overall Study|Physician Decision|3
4730648|NCT01948830|16315190|P1|Overall Study|Physician Decision|1
4730649|NCT01948791|16315222|P1|Overall Study|Screening failure|35
4730650|NCT01948791|16315222|P1|Overall Study|Others|7
4730651|NCT01948791|16315222|P1|Overall Study|Management issues|1
4730652|NCT01948791|16315222|P1|Overall Study|Lost to Follow-up|6
4730653|NCT01948791|16315222|P1|Overall Study|Withdrawal by Subject|5
4730654|NCT01948791|16315222|P1|Overall Study|Protocol Violation|2
4730655|NCT01948791|16315222|P1|Overall Study|Lack of Efficacy|3
4730656|NCT01948791|16315222|P1|Overall Study|Adverse Event|12
4730657|NCT01948258|16315282|P1|Overall Study|Removed from statistical analysis|2
4730658|NCT01948258|16315282|P1|Overall Study|Health Care Professional|43
4730659|NCT01948258|16315282|P1|Overall Study|Withdrawal by Subject|6
4730660|NCT01948258|16315282|P1|Overall Study|Withdrawal by SPD|8
4730661|NCT01948258|16315282|P1|Overall Study|Lost to Follow-up|27
4730662|NCT01948258|16315282|P1|Overall Study|Did not complete by cut-off date|35
4730663|NCT01948258|16315282|P1|Overall Study|Pregnancy|41
4730664|NCT01948193|16315288|P1|Overall Study|Lost to Follow-up|7
4730665|NCT01948193|16315288|P1|Overall Study|Serious event|2
4730666|NCT01948076|16315310|P2|Overall Study|Withdrawal by Subject|1
4730667|NCT01948076|16315311|P1|Overall Study|Withdrawal by Subject|0
4730668|NCT01948063|16315321|P2|Overall Study|Blood samples were accidentally thawed|0
4730669|NCT01948063|16315322|P1|Overall Study|Blood samples were accidentally thawed|1
4730670|NCT01948063|16315321|P2|Overall Study|Discovered an enrollment in other study|1
4730671|NCT01948063|16315322|P1|Overall Study|Discovered an enrollment in other study|0
4730672|NCT01948063|16315321|P2|Overall Study|Boston MCI halted research protocol|1
4730673|NCT01948063|16315322|P1|Overall Study|Boston MCI halted research protocol|0
4730674|NCT01948050|16315330|P2|Overall Study|Withdrawal by Subject|1
4730675|NCT01948050|16315331|P1|Overall Study|Withdrawal by Subject|0
4730676|NCT01947894|16315399|P3|Overall Study|Switched to other growth hormone brand|23
4730677|NCT01947894|16315400|P2|Overall Study|Switched to other growth hormone brand|8
4730678|NCT01947894|16315401|P1|Overall Study|Switched to other growth hormone brand|53
4730679|NCT01947894|16315399|P3|Overall Study|Adverse Event|0
4730680|NCT01947894|16315400|P2|Overall Study|Adverse Event|1
4730681|NCT01947894|16315401|P1|Overall Study|Adverse Event|5
4730682|NCT01947894|16315399|P3|Overall Study|Physician Decision|0
4730683|NCT01947894|16315400|P2|Overall Study|Physician Decision|0
4730684|NCT01947894|16315401|P1|Overall Study|Physician Decision|2
4730685|NCT01947894|16315399|P3|Overall Study|Death|0
4730686|NCT01947894|16315400|P2|Overall Study|Death|1
4730687|NCT01947894|16315401|P1|Overall Study|Death|12
4730688|NCT01947894|16315399|P3|Overall Study|Withdrawal by Subject|1
4730689|NCT01947894|16315400|P2|Overall Study|Withdrawal by Subject|4
4730690|NCT01947894|16315401|P1|Overall Study|Withdrawal by Subject|12
4730691|NCT01947894|16315399|P3|Overall Study|Other|3
4730692|NCT01947894|16315400|P2|Overall Study|Other|4
4730693|NCT01947894|16315401|P1|Overall Study|Other|3
4730694|NCT01947855|16315466|P3|Overall Study|Withdrawal by Subject|0
4730695|NCT01947855|16315467|P2|Overall Study|Withdrawal by Subject|0
4730696|NCT01947855|16315468|P1|Overall Study|Withdrawal by Subject|1
4730697|NCT01947582|16315503|P1|Overall Study|Withdrawal by Subject|1
4730698|NCT01947517|16315512|P2|Overall Study|Withdrawal by Subject|1
4730699|NCT01947517|16315513|P1|Overall Study|Withdrawal by Subject|1
4730700|NCT01947491|16315531|P4|Overall Study|Adverse Event|2
4730701|NCT01947491|16315532|P3|Overall Study|Adverse Event|0
4730702|NCT01947491|16315533|P2|Overall Study|Adverse Event|1
4730703|NCT01947491|16315534|P1|Overall Study|Adverse Event|0
4730704|NCT01947491|16315531|P4|Overall Study|Worsening of condition|0
4730705|NCT01947491|16315532|P3|Overall Study|Worsening of condition|0
4730706|NCT01947491|16315533|P2|Overall Study|Worsening of condition|1
4730707|NCT01947491|16315534|P1|Overall Study|Worsening of condition|0
4730708|NCT01947491|16315531|P4|Overall Study|Withdrawal by Subject|0
4730709|NCT01947491|16315532|P3|Overall Study|Withdrawal by Subject|1
4730710|NCT01947491|16315533|P2|Overall Study|Withdrawal by Subject|1
4730711|NCT01947491|16315534|P1|Overall Study|Withdrawal by Subject|1
4730712|NCT01947491|16315531|P4|Overall Study|Protocol Violation|0
4730713|NCT01947491|16315532|P3|Overall Study|Protocol Violation|0
4730714|NCT01947491|16315533|P2|Overall Study|Protocol Violation|0
4730715|NCT01947491|16315534|P1|Overall Study|Protocol Violation|1
4730716|NCT01947491|16315531|P4|Overall Study|Lack of Efficacy|1
4730717|NCT01947491|16315532|P3|Overall Study|Lack of Efficacy|0
4730718|NCT01947491|16315533|P2|Overall Study|Lack of Efficacy|0
4730719|NCT01947491|16315534|P1|Overall Study|Lack of Efficacy|1
4730720|NCT01947491|16315531|P4|Overall Study|Lost to Follow-up|2
4730721|NCT01947491|16315532|P3|Overall Study|Lost to Follow-up|1
4730722|NCT01947491|16315533|P2|Overall Study|Lost to Follow-up|3
4730723|NCT01947491|16315534|P1|Overall Study|Lost to Follow-up|5
4730724|NCT01947283|16315564|P7|Overall Study|No patients were enrolled in study|1
4730725|NCT01947283|16315565|P6|Overall Study|No patients were enrolled in study|3
4730726|NCT01947283|16315566|P5|Overall Study|No patients were enrolled in study|0
4730727|NCT01947283|16315567|P4|Overall Study|No patients were enrolled in study|0
4730728|NCT01947283|16315568|P3|Overall Study|No patients were enrolled in study|0
4730729|NCT01947283|16315569|P2|Overall Study|No patients were enrolled in study|0
4730730|NCT01947283|16315570|P1|Overall Study|No patients were enrolled in study|0
4730731|NCT01947283|16315564|P7|Overall Study|Missing Follow-up Assessment|0
4730732|NCT01947283|16315565|P6|Overall Study|Missing Follow-up Assessment|2
4730733|NCT01947283|16315566|P5|Overall Study|Missing Follow-up Assessment|0
4730734|NCT01947283|16315567|P4|Overall Study|Missing Follow-up Assessment|0
4730735|NCT01947283|16315568|P3|Overall Study|Missing Follow-up Assessment|3
4730736|NCT01947283|16315569|P2|Overall Study|Missing Follow-up Assessment|2
4730737|NCT01947283|16315570|P1|Overall Study|Missing Follow-up Assessment|2
4730738|NCT01947283|16315564|P7|Overall Study|Non-coding Clinical Recording language|0
4730739|NCT01947283|16315565|P6|Overall Study|Non-coding Clinical Recording language|0
4730740|NCT01947283|16315566|P5|Overall Study|Non-coding Clinical Recording language|0
4730741|NCT01947283|16315567|P4|Overall Study|Non-coding Clinical Recording language|1
4730742|NCT01947283|16315568|P3|Overall Study|Non-coding Clinical Recording language|0
4730743|NCT01947283|16315569|P2|Overall Study|Non-coding Clinical Recording language|0
4730744|NCT01947283|16315570|P1|Overall Study|Non-coding Clinical Recording language|0
4730745|NCT01947283|16315564|P7|Overall Study|No Clinical Recording|0
4730746|NCT01947283|16315565|P6|Overall Study|No Clinical Recording|0
4730747|NCT01947283|16315566|P5|Overall Study|No Clinical Recording|0
4730748|NCT01947283|16315567|P4|Overall Study|No Clinical Recording|10
4730749|NCT01947283|16315568|P3|Overall Study|No Clinical Recording|8
4730750|NCT01947283|16315569|P2|Overall Study|No Clinical Recording|6
4730751|NCT01947283|16315570|P1|Overall Study|No Clinical Recording|12
4730752|NCT01947283|16315564|P7|Overall Study|Withdrawal by Subject|2
4730753|NCT01947283|16315565|P6|Overall Study|Withdrawal by Subject|0
4730754|NCT01947283|16315566|P5|Overall Study|Withdrawal by Subject|0
4730755|NCT01947283|16315567|P4|Overall Study|Withdrawal by Subject|1
4730756|NCT01947283|16315568|P3|Overall Study|Withdrawal by Subject|4
4730757|NCT01947283|16315569|P2|Overall Study|Withdrawal by Subject|8
4730758|NCT01947283|16315570|P1|Overall Study|Withdrawal by Subject|10
4730759|NCT01947283|16315564|P7|Overall Study|Lost to Follow-up|5
4730760|NCT01947283|16315565|P6|Overall Study|Lost to Follow-up|2
4730761|NCT01947283|16315566|P5|Overall Study|Lost to Follow-up|0
4730762|NCT01947283|16315567|P4|Overall Study|Lost to Follow-up|5
4730763|NCT01947283|16315568|P3|Overall Study|Lost to Follow-up|5
4730764|NCT01947283|16315569|P2|Overall Study|Lost to Follow-up|6
4730765|NCT01947283|16315570|P1|Overall Study|Lost to Follow-up|4
4730766|NCT01947283|16315564|P7|Overall Study|Death|0
4730767|NCT01947283|16315565|P6|Overall Study|Death|0
4730768|NCT01947283|16315566|P5|Overall Study|Death|0
4730769|NCT01947283|16315567|P4|Overall Study|Death|0
4730770|NCT01947283|16315568|P3|Overall Study|Death|1
4730771|NCT01947283|16315569|P2|Overall Study|Death|1
4730772|NCT01947283|16315570|P1|Overall Study|Death|1
4730773|NCT01947127|16315642|P2|Overall Study|Data loss|4
4730774|NCT01947127|16315643|P1|Overall Study|Data loss|4
4730775|NCT01947127|16315642|P2|Overall Study|Withdrawal by Subject|1
4730776|NCT01947127|16315643|P1|Overall Study|Withdrawal by Subject|1
4730777|NCT01947127|16315642|P2|Overall Study|Protocol Violation|38
4730778|NCT01947127|16315643|P1|Overall Study|Protocol Violation|18
4730779|NCT01946880|16315655|P2|Overall Study|Personal and Family Issues|0
4730780|NCT01946880|16315656|P1|Overall Study|Personal and Family Issues|1
4730781|NCT01946880|16315655|P2|Overall Study|Met Primary Endpoint|0
4730782|NCT01946880|16315656|P1|Overall Study|Met Primary Endpoint|1
4730783|NCT01946880|16315655|P2|Overall Study|Withdrawal by Subject|2
4730784|NCT01946880|16315656|P1|Overall Study|Withdrawal by Subject|3
4730785|NCT01946880|16315655|P2|Overall Study|Physician Decision|1
4730786|NCT01946880|16315656|P1|Overall Study|Physician Decision|1
4730787|NCT01946880|16315655|P2|Overall Study|Lost to Follow-up|0
4730788|NCT01946880|16315656|P1|Overall Study|Lost to Follow-up|1
4730789|NCT01946529|16315746|P3|Completion of All Therapy|Some pts. still receiving study therapy|6
4730790|NCT01946529|16315747|P2|Completion of All Therapy|Some pts. still receiving study therapy|16
4730791|NCT01946529|16315748|P1|Completion of All Therapy|Some pts. still receiving study therapy|1
4730792|NCT01946529|16315746|P3|End of Window Therapy (2 Courses)|Physician Decision|0
4730793|NCT01946529|16315747|P2|End of Window Therapy (2 Courses)|Physician Decision|1
4730794|NCT01946529|16315748|P1|End of Window Therapy (2 Courses)|Physician Decision|0
4730795|NCT01946438|16315759|P4|Overall Study|Withdrawal by Subject|0
4730796|NCT01946438|16315760|P3|Overall Study|Withdrawal by Subject|0
4730797|NCT01946438|16315761|P2|Overall Study|Withdrawal by Subject|0
4730798|NCT01946438|16315762|P1|Overall Study|Withdrawal by Subject|1
4730799|NCT01946438|16315759|P4|Overall Study|Protocol Violation|0
4730800|NCT01946438|16315760|P3|Overall Study|Protocol Violation|1
4730801|NCT01946438|16315761|P2|Overall Study|Protocol Violation|0
4730802|NCT01946438|16315762|P1|Overall Study|Protocol Violation|0
4730803|NCT01946438|16315759|P4|Overall Study|Serious Adverse event|0
4730804|NCT01946438|16315760|P3|Overall Study|Serious Adverse event|0
4730805|NCT01946438|16315761|P2|Overall Study|Serious Adverse event|0
4730806|NCT01946438|16315762|P1|Overall Study|Serious Adverse event|1
4730807|NCT01946438|16315759|P4|Overall Study|Adverse Event|1
4730808|NCT01946438|16315760|P3|Overall Study|Adverse Event|0
4730809|NCT01946438|16315761|P2|Overall Study|Adverse Event|0
4730810|NCT01946438|16315762|P1|Overall Study|Adverse Event|0
4730811|NCT01946425|16315790|P2|Overall Study|Withdrawal by Subject|0
4730812|NCT01946425|16315791|P1|Overall Study|Withdrawal by Subject|1
4730813|NCT01946425|16315790|P2|Overall Study|Protocol Violation|0
4730814|NCT01946425|16315791|P1|Overall Study|Protocol Violation|1
4730815|NCT01946412|16315805|P1|Overall Study|Difficulty in swallowing|1
4730816|NCT01946412|16315805|P1|Overall Study|Continued with commercial Kalydeco|2
4730817|NCT01946412|16315805|P1|Overall Study|Non-Compliance|1
4730818|NCT01946412|16315805|P1|Overall Study|Adverse Event|1
4730819|NCT01946282|16315830|P3|Year 3|Did not return FIT kit|30
4730820|NCT01946282|16315831|P2|Year 3|Did not return FIT kit|43
4730821|NCT01946282|16315832|P1|Year 3|Did not return FIT kit|288
4730822|NCT01946282|16315830|P3|Year 2|Did not return FIT kit|115
4730823|NCT01946282|16315831|P2|Year 2|Did not return FIT kit|131
4730824|NCT01946282|16315832|P1|Year 2|Did not return FIT kit|803
4730825|NCT01946282|16315830|P3|Year 1|Did not return FIT kit|654
4730826|NCT01946282|16315831|P2|Year 1|Did not return FIT kit|608
4730827|NCT01946282|16315832|P1|Year 1|Did not return FIT kit|4186
4730828|NCT01946204|16315865|P2|Overall Study|Other|3
4730829|NCT01946204|16315866|P1|Overall Study|Other|7
4730830|NCT01946204|16315865|P2|Overall Study|Ongoing|687
4730831|NCT01946204|16315866|P1|Overall Study|Ongoing|316
4730832|NCT01946204|16315865|P2|Overall Study|Lost to Follow-up|7
4730833|NCT01946204|16315866|P1|Overall Study|Lost to Follow-up|3
4730834|NCT01946204|16315865|P2|Overall Study|Withdrawal by Subject|50
4730835|NCT01946204|16315866|P1|Overall Study|Withdrawal by Subject|37
4730836|NCT01946204|16315865|P2|Overall Study|Death|59
4730837|NCT01946204|16315866|P1|Overall Study|Death|38
4730838|NCT01946178|16315882|P1|Overall Study|Lost to Follow-up|1
4730839|NCT01946178|16315882|P1|Overall Study|Pregnancy|1
4730840|NCT01946165|16315892|P2|Overall Study|Withdrawal by Subject|2
4730841|NCT01946165|16315893|P1|Overall Study|Withdrawal by Subject|0
4730842|NCT01946165|16315892|P2|Overall Study|Physician Decision|0
4730843|NCT01946165|16315893|P1|Overall Study|Physician Decision|2
4730844|NCT01945996|16315920|P2|Overall Study|Lost to Follow-up|5
4730845|NCT01945996|16315921|P1|Overall Study|Lost to Follow-up|3
4730846|NCT01945944|16315997|P2|Overall Study|Withdrawal by Subject|1
4730847|NCT01945944|16315998|P1|Overall Study|Withdrawal by Subject|0
4730848|NCT01945944|16315997|P2|Overall Study|Physician Decision|0
4730849|NCT01945944|16315998|P1|Overall Study|Physician Decision|1
4730850|NCT01945944|16315997|P2|Overall Study|Adverse Event|2
4730851|NCT01945944|16315998|P1|Overall Study|Adverse Event|0
4730852|NCT01945866|16316022|P2|Overall Study|Eyes did not complete or were dropped|0
4730853|NCT01945866|16316023|P1|Overall Study|Eyes did not complete or were dropped|2
4730854|NCT01945775|16316044|P2|Overall Study|Lost to Follow-up|6
4730855|NCT01945775|16316045|P1|Overall Study|Lost to Follow-up|7
4730856|NCT01945775|16316044|P2|Overall Study|Withdrawal by Subject|20
4730857|NCT01945775|16316045|P1|Overall Study|Withdrawal by Subject|7
4730858|NCT01945775|16316044|P2|Overall Study|Death|53
4730859|NCT01945775|16316045|P1|Overall Study|Death|107
4730860|NCT01945775|16316044|P2|Overall Study|On going|65
4730861|NCT01945775|16316045|P1|Overall Study|On going|166
4730862|NCT01945710|16316081|P7|Overall Study|Withdrawal by Subject|0
4730863|NCT01945710|16316082|P6|Overall Study|Withdrawal by Subject|0
4730864|NCT01945710|16316083|P5|Overall Study|Withdrawal by Subject|1
4730865|NCT01945710|16316084|P4|Overall Study|Withdrawal by Subject|0
4730866|NCT01945710|16316085|P3|Overall Study|Withdrawal by Subject|1
4730867|NCT01945710|16316086|P2|Overall Study|Withdrawal by Subject|1
4730868|NCT01945710|16316087|P1|Overall Study|Withdrawal by Subject|0
4730869|NCT01945710|16316081|P7|Overall Study|Other|4
4730870|NCT01945710|16316082|P6|Overall Study|Other|0
4730871|NCT01945710|16316083|P5|Overall Study|Other|1
4730872|NCT01945710|16316084|P4|Overall Study|Other|1
4730873|NCT01945710|16316085|P3|Overall Study|Other|3
4730874|NCT01945710|16316086|P2|Overall Study|Other|0
4730875|NCT01945710|16316087|P1|Overall Study|Other|2
4730876|NCT01945710|16316081|P7|Overall Study|Adverse Event|0
4730877|NCT01945710|16316082|P6|Overall Study|Adverse Event|0
4730878|NCT01945710|16316083|P5|Overall Study|Adverse Event|0
4730879|NCT01945710|16316084|P4|Overall Study|Adverse Event|0
4730880|NCT01945710|16316085|P3|Overall Study|Adverse Event|0
4730881|NCT01945710|16316086|P2|Overall Study|Adverse Event|1
4730882|NCT01945710|16316087|P1|Overall Study|Adverse Event|0
4730883|NCT01945710|16316081|P7|Overall Study|Progressive Disease|19
4730884|NCT01945710|16316082|P6|Overall Study|Progressive Disease|3
4730885|NCT01945710|16316083|P5|Overall Study|Progressive Disease|7
4730886|NCT01945710|16316084|P4|Overall Study|Progressive Disease|2
4730887|NCT01945710|16316085|P3|Overall Study|Progressive Disease|3
4730888|NCT01945710|16316086|P2|Overall Study|Progressive Disease|4
4730889|NCT01945710|16316087|P1|Overall Study|Progressive Disease|5
4730890|NCT01945593|16316206|P4|Overall Study|Other: Screen Failure|0
4730891|NCT01945593|16316207|P3|Overall Study|Other: Screen Failure|0
4730892|NCT01945593|16316208|P2|Overall Study|Other: Screen Failure|2
4730893|NCT01945593|16316209|P1|Overall Study|Other: Screen Failure|0
4730894|NCT01945593|16316206|P4|Overall Study|Other: Surgical Procedure|6
4730895|NCT01945593|16316207|P3|Overall Study|Other: Surgical Procedure|0
4730896|NCT01945593|16316208|P2|Overall Study|Other: Surgical Procedure|2
4730897|NCT01945593|16316209|P1|Overall Study|Other: Surgical Procedure|0
4730898|NCT01945593|16316206|P4|Overall Study|Other: Terminated|1
4730899|NCT01945593|16316207|P3|Overall Study|Other: Terminated|0
4730900|NCT01945593|16316208|P2|Overall Study|Other: Terminated|0
4730901|NCT01945593|16316209|P1|Overall Study|Other: Terminated|0
4730902|NCT01945593|16316206|P4|Overall Study|Death|0
4730903|NCT01945593|16316207|P3|Overall Study|Death|1
4730904|NCT01945593|16316208|P2|Overall Study|Death|0
4730905|NCT01945593|16316209|P1|Overall Study|Death|0
4730906|NCT01945593|16316206|P4|Overall Study|Protocol Violation|3
4730907|NCT01945593|16316207|P3|Overall Study|Protocol Violation|1
4730908|NCT01945593|16316208|P2|Overall Study|Protocol Violation|2
4730909|NCT01945593|16316209|P1|Overall Study|Protocol Violation|0
4730910|NCT01945593|16316206|P4|Overall Study|Withdrawal by Subject|4
4730911|NCT01945593|16316207|P3|Overall Study|Withdrawal by Subject|0
4730912|NCT01945593|16316208|P2|Overall Study|Withdrawal by Subject|2
4730913|NCT01945593|16316209|P1|Overall Study|Withdrawal by Subject|0
4730914|NCT01945593|16316206|P4|Overall Study|Physician Decision|1
4730915|NCT01945593|16316207|P3|Overall Study|Physician Decision|1
4730916|NCT01945593|16316208|P2|Overall Study|Physician Decision|0
4730917|NCT01945593|16316209|P1|Overall Study|Physician Decision|0
4730918|NCT01945593|16316206|P4|Overall Study|Adverse Event|5
4730919|NCT01945593|16316207|P3|Overall Study|Adverse Event|0
4730920|NCT01945593|16316208|P2|Overall Study|Adverse Event|0
4730921|NCT01945593|16316209|P1|Overall Study|Adverse Event|0
4730922|NCT01945489|16316291|P2|Cycle 2|Lost to Follow-up|1
4730923|NCT01945489|16316292|P1|Cycle 2|Lost to Follow-up|0
4730924|NCT01945489|16316291|P2|Cycle 2|Adverse Event|0
4730925|NCT01945489|16316292|P1|Cycle 2|Adverse Event|1
4730926|NCT01945489|16316291|P2|Cycle 1|Other Miscellaneous Reasons|1
4730927|NCT01945489|16316292|P1|Cycle 1|Other Miscellaneous Reasons|3
4730928|NCT01945489|16316291|P2|Cycle 1|Protocol Violation|1
4730929|NCT01945489|16316292|P1|Cycle 1|Protocol Violation|0
4730930|NCT01945489|16316291|P2|Cycle 1|Personal Reasons|2
4730931|NCT01945489|16316292|P1|Cycle 1|Personal Reasons|4
4730932|NCT01945489|16316291|P2|Cycle 1|Lost to Follow-up|0
4730933|NCT01945489|16316292|P1|Cycle 1|Lost to Follow-up|4
4730934|NCT01945489|16316291|P2|Cycle 1|Adverse Event|0
4730935|NCT01945489|16316292|P1|Cycle 1|Adverse Event|2
4730936|NCT01945281|16316346|P2|Overall Study|Technical Problems|0
4730937|NCT01945281|16316347|P1|Overall Study|Technical Problems|1
4730938|NCT01945281|16316346|P2|Overall Study|Physician Decision|1
4730939|NCT01945281|16316347|P1|Overall Study|Physician Decision|1
4730940|NCT01945281|16316346|P2|Overall Study|Death|3
4730941|NCT01945281|16316347|P1|Overall Study|Death|3
4730942|NCT01945281|16316346|P2|Overall Study|Adverse Event|0
4730943|NCT01945281|16316347|P1|Overall Study|Adverse Event|1
4730944|NCT01945242|16316359|P2|Overall Study|Physician Decision|3
4730945|NCT01945242|16316360|P1|Overall Study|Physician Decision|3
4730946|NCT01945216|16316375|P1|Overall Study|CRF not assured by investigators|5
4730947|NCT01945216|16316375|P1|Overall Study|Protocol Violation|42
4730948|NCT01945216|16316375|P1|Overall Study|Case report forms (CRF) uncollected|52
4730949|NCT01945086|16316433|P3|Overall Study|Adverse Event|1
4730950|NCT01945086|16316434|P2|Overall Study|Adverse Event|0
4730951|NCT01945086|16316435|P1|Overall Study|Adverse Event|0
4730952|NCT01945086|16316433|P3|Overall Study|Withdrawal by Subject|1
4730953|NCT01945086|16316434|P2|Overall Study|Withdrawal by Subject|0
4730954|NCT01945086|16316435|P1|Overall Study|Withdrawal by Subject|1
4730955|NCT01945034|16316479|P3|Overall Study|Protocol Violation|1
4730956|NCT01945034|16316480|P2|Overall Study|Protocol Violation|0
4730957|NCT01945034|16316481|P1|Overall Study|Protocol Violation|1
4730958|NCT01945034|16316479|P3|Overall Study|Lost to Follow-up|2
4730959|NCT01945034|16316480|P2|Overall Study|Lost to Follow-up|0
4730960|NCT01945034|16316481|P1|Overall Study|Lost to Follow-up|0
4730961|NCT01945034|16316479|P3|Overall Study|Other|3
4730962|NCT01945034|16316480|P2|Overall Study|Other|1
4730963|NCT01945034|16316481|P1|Overall Study|Other|0
4730964|NCT01945034|16316479|P3|Overall Study|Withdrawal by Subject|1
4730965|NCT01945034|16316480|P2|Overall Study|Withdrawal by Subject|3
4730966|NCT01945034|16316481|P1|Overall Study|Withdrawal by Subject|0
4730967|NCT01945034|16316479|P3|Overall Study|Medication Error|0
4730968|NCT01945034|16316480|P2|Overall Study|Medication Error|1
4730969|NCT01945034|16316481|P1|Overall Study|Medication Error|0
4730970|NCT01945021|16316531|P1|Overall Study|Non-RECIST disease progression|1
4730971|NCT01945021|16316531|P1|Overall Study|Withdrawal of consent|3
4730972|NCT01945021|16316531|P1|Overall Study|Withdrawal by Subject|2
4730973|NCT01945021|16316531|P1|Overall Study|Global deterioration of health-related s|1
4730974|NCT01945021|16316531|P1|Overall Study|Disease progression by RECIST v1.1|30
4730975|NCT01945021|16316531|P1|Overall Study|Pregnancy|1
4730976|NCT01945021|16316531|P1|Overall Study|Death|1
4730977|NCT01945021|16316531|P1|Overall Study|Adverse Event|8
4730978|NCT01944969|16316545|P1|Overall Study|Administrative or other reasons|23
4730979|NCT01944969|16316545|P1|Overall Study|Non-compliance with IMP|1
4730980|NCT01944969|16316545|P1|Overall Study|Lack of Efficacy|1
4730981|NCT01944969|16316545|P1|Overall Study|Adverse Event|1
4730982|NCT01944839|16316569|P2|Overall Study|Subject non-compliance|3
4730983|NCT01944839|16316570|P1|Overall Study|Subject non-compliance|0
4730984|NCT01944839|16316569|P2|Overall Study|Lost to Follow-up|0
4730985|NCT01944839|16316570|P1|Overall Study|Lost to Follow-up|1
4730986|NCT01944839|16316569|P2|Overall Study|Withdrawal by Subject|17
4730987|NCT01944839|16316570|P1|Overall Study|Withdrawal by Subject|9
4730988|NCT01944839|16316569|P2|Overall Study|Adverse Event|5
4730989|NCT01944839|16316570|P1|Overall Study|Adverse Event|10
4730990|NCT01944839|16316569|P2|Overall Study|Protocol Violation|1
4730991|NCT01944839|16316570|P1|Overall Study|Protocol Violation|0
4730992|NCT01944839|16316569|P2|Overall Study|Physician Decision|2
4730993|NCT01944839|16316570|P1|Overall Study|Physician Decision|2
4730994|NCT01944774|16316579|P3|Overall Study|Lost to Follow-up|0
4730995|NCT01944774|16316580|P2|Overall Study|Lost to Follow-up|1
4730996|NCT01944774|16316581|P1|Overall Study|Lost to Follow-up|0
4730997|NCT01944774|16316579|P3|Overall Study|Lack of Efficacy|2
4730998|NCT01944774|16316580|P2|Overall Study|Lack of Efficacy|2
4730999|NCT01944774|16316581|P1|Overall Study|Lack of Efficacy|1
4731000|NCT01944774|16316579|P3|Overall Study|Adverse Event|3
4731001|NCT01944774|16316580|P2|Overall Study|Adverse Event|2
4731002|NCT01944774|16316581|P1|Overall Study|Adverse Event|3
4731003|NCT01944774|16316579|P3|Overall Study|Withdrawal by Subject|3
4731004|NCT01944774|16316580|P2|Overall Study|Withdrawal by Subject|3
4731005|NCT01944774|16316581|P1|Overall Study|Withdrawal by Subject|2
4731006|NCT01944722|16316624|P1|Overall Study|>ASCUS Cytology|1122
4731007|NCT01944722|16316624|P1|Overall Study|Unsatisfactory Cytology Result|63
4731008|NCT01944722|16316624|P1|Overall Study|NILM Subjects <30 years old|8106
4731009|NCT01944722|16316624|P1|Overall Study|Withdrawal by Subject|8
4731010|NCT01944722|16316624|P1|Overall Study|Specimens Mislabeled|2
4731011|NCT01944722|16316624|P1|Overall Study|Missing Specimens|3
4731012|NCT01944722|16316624|P1|Overall Study|Insufficient Volume for Test|1
4731013|NCT01944722|16316624|P1|Overall Study|Improper Storage/Transport|5
4731014|NCT01944722|16316624|P1|Overall Study|Specimen Shipping Issues|34
4731015|NCT01944722|16316624|P1|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171
4731016|NCT01944670|16316658|P1|Overall Study|Lost to Follow-up|2
4731017|NCT01944631|16316680|P2|Overall Study|Withdrawal by Subject|1
4731018|NCT01944631|16316681|P1|Overall Study|Withdrawal by Subject|0
4731019|NCT01944631|16316680|P2|Overall Study|Lost to Follow-up|1
4731020|NCT01944631|16316681|P1|Overall Study|Lost to Follow-up|3
4731021|NCT01944631|16316680|P2|Overall Study|Adverse Event|0
4731022|NCT01944631|16316681|P1|Overall Study|Adverse Event|1
4731023|NCT01944462|16316697|P1|PPPP Educational Program|Lost to Follow-up|60
4731024|NCT01944098|16316760|P2|Overall Study|Physician Decision|0
4731025|NCT01944098|16316761|P1|Overall Study|Physician Decision|1
4731026|NCT01944059|16316773|P1|Overall Study|Adverse Event|2
4731027|NCT01944059|16316773|P1|Overall Study|Withdrawal by Subject|1
4731028|NCT01944059|16316773|P1|Overall Study|Physician Decision|3
4731029|NCT01944059|16316773|P1|Overall Study|Lost to Follow-up|1
4731030|NCT01943825|16316814|P4|Overall Study|Other than specified above|1
4731031|NCT01943825|16316815|P3|Overall Study|Other than specified above|0
4731032|NCT01943825|16316816|P2|Overall Study|Other than specified above|1
4731033|NCT01943825|16316817|P1|Overall Study|Other than specified above|0
4731034|NCT01943825|16316814|P4|Overall Study|Withdrawal by Subject|2
4731035|NCT01943825|16316815|P3|Overall Study|Withdrawal by Subject|3
4731036|NCT01943825|16316816|P2|Overall Study|Withdrawal by Subject|0
4731037|NCT01943825|16316817|P1|Overall Study|Withdrawal by Subject|1
4731038|NCT01943825|16316814|P4|Overall Study|Lost to Follow-up|8
4731039|NCT01943825|16316815|P3|Overall Study|Lost to Follow-up|12
4731040|NCT01943825|16316816|P2|Overall Study|Lost to Follow-up|3
4731041|NCT01943825|16316817|P1|Overall Study|Lost to Follow-up|9
4731042|NCT01943799|16316859|P4|Overall Study|Withdrawal by Subject|0
4731043|NCT01943799|16316860|P3|Overall Study|Withdrawal by Subject|1
4731044|NCT01943799|16316861|P2|Overall Study|Withdrawal by Subject|2
4731045|NCT01943799|16316862|P1|Overall Study|Withdrawal by Subject|4
4731046|NCT01943799|16316859|P4|Overall Study|Protocol Violation|0
4731047|NCT01943799|16316860|P3|Overall Study|Protocol Violation|0
4731048|NCT01943799|16316861|P2|Overall Study|Protocol Violation|0
4731049|NCT01943799|16316862|P1|Overall Study|Protocol Violation|1
4731050|NCT01943799|16316859|P4|Overall Study|Lost to Follow-up|0
4731051|NCT01943799|16316860|P3|Overall Study|Lost to Follow-up|1
4731052|NCT01943799|16316861|P2|Overall Study|Lost to Follow-up|1
4731053|NCT01943799|16316862|P1|Overall Study|Lost to Follow-up|0
4731054|NCT01943591|16316902|P2|Overall Study|Death|7
4731055|NCT01943591|16316903|P1|Overall Study|Death|2
4731056|NCT01943591|16316902|P2|Overall Study|Lost to Follow-up|4
4731057|NCT01943591|16316903|P1|Overall Study|Lost to Follow-up|3
4731058|NCT01943552|16316961|P2|Overall Study|Other Reasons|17
4731059|NCT01943552|16316962|P1|Overall Study|Other Reasons|16
4731060|NCT01943552|16316961|P2|Overall Study|Withdrawal by Subject|6
4731061|NCT01943552|16316962|P1|Overall Study|Withdrawal by Subject|6
4731062|NCT01943552|16316961|P2|Overall Study|Adverse Event|2
4731063|NCT01943552|16316962|P1|Overall Study|Adverse Event|3
4731064|NCT01943539|16316978|P2|Overall Study|Non-compliance with at-home intervention|0
4731065|NCT01943539|16316979|P1|Overall Study|Non-compliance with at-home intervention|4
4731066|NCT01943435|16317076|P3|6 Month Follow up|Lost to Follow-up|15
4731067|NCT01943435|16317077|P2|6 Month Follow up|Lost to Follow-up|7
4731068|NCT01943435|16317078|P1|6 Month Follow up|Lost to Follow-up|12
4731069|NCT01943435|16317076|P3|2 Month Follow up|Lost to Follow-up|0
4731070|NCT01943435|16317077|P2|2 Month Follow up|Lost to Follow-up|3
4731071|NCT01943435|16317078|P1|2 Month Follow up|Lost to Follow-up|2
4731072|NCT01943435|16317076|P3|Intervention Period|Withdrawal by Subject|4
4731073|NCT01943435|16317077|P2|Intervention Period|Withdrawal by Subject|3
4731074|NCT01943435|16317078|P1|Intervention Period|Withdrawal by Subject|3
4731075|NCT01943435|16317076|P3|Baseline Eligibility and Randomization|Withdrawal by Subject|3
4731076|NCT01943435|16317077|P2|Baseline Eligibility and Randomization|Withdrawal by Subject|12
4731077|NCT01943435|16317078|P1|Baseline Eligibility and Randomization|Withdrawal by Subject|4
4731078|NCT01943292|16317101|P3|Overall Study|Withdrawal by Subject|0
4731079|NCT01943292|16317102|P2|Overall Study|Withdrawal by Subject|0
4731080|NCT01943292|16317103|P1|Overall Study|Withdrawal by Subject|1
4731081|NCT01942993|16317139|P1|Overall Study|Physician Decision|1
4731082|NCT01942993|16317139|P1|Overall Study|Lost to Follow-up|1
4731083|NCT01942785|16317156|P1|Overall Study|Protocol Violation|1
4731084|NCT01942785|16317156|P1|Overall Study|Withdrawal by Subject|1
4731085|NCT01942785|16317156|P1|Overall Study|Adverse Event|2
4731086|NCT01942733|16317185|P1|Overall Study|Administrative|1
4731087|NCT01942733|16317185|P1|Overall Study|Non-compliance with IMP|1
4731088|NCT01942733|16317185|P1|Overall Study|Lost to Follow-up|1
4731089|NCT01942590|16318326|P2|Overall Study|Adverse Event|0
4731090|NCT01942590|16318327|P1|Overall Study|Adverse Event|1
4731091|NCT01942590|16318326|P2|Overall Study|Withdrawal by Subject|1
4731092|NCT01942590|16318327|P1|Overall Study|Withdrawal by Subject|0
4731093|NCT01942486|16318357|P1|Overall Study|Lost to Follow-up|27
4731094|NCT01942161|16318364|P3|Overall Study|Withdrawal by Subject|1
4731095|NCT01942161|16318365|P2|Overall Study|Withdrawal by Subject|3
4731096|NCT01942161|16318366|P1|Overall Study|Withdrawal by Subject|3
4731097|NCT01942161|16318364|P3|Overall Study|Protocol Violation|0
4731098|NCT01942161|16318365|P2|Overall Study|Protocol Violation|0
4731099|NCT01942161|16318366|P1|Overall Study|Protocol Violation|1
4731100|NCT01942161|16318364|P3|Overall Study|Physician Decision|0
4731101|NCT01942161|16318365|P2|Overall Study|Physician Decision|1
4731102|NCT01942161|16318366|P1|Overall Study|Physician Decision|3
4731103|NCT01942161|16318364|P3|Overall Study|Adverse Event|5
4731104|NCT01942161|16318365|P2|Overall Study|Adverse Event|2
4731105|NCT01942161|16318366|P1|Overall Study|Adverse Event|1
4731106|NCT01942148|16318386|P1|Overall Study|Use of the prohibition medicine|1
4731107|NCT01942148|16318386|P1|Overall Study|Withdrawal by Subject|8
4731108|NCT01942148|16318386|P1|Overall Study|Protocol Violation|1
4731109|NCT01942148|16318386|P1|Overall Study|Physician Decision|11
4731110|NCT01942148|16318386|P1|Overall Study|Lack of Efficacy|2
4731111|NCT01942148|16318386|P1|Overall Study|Adverse Event|4
4731112|NCT01942135|16318394|P2|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|75
4731113|NCT01942135|16318395|P1|Overall Study|Ongoing at date of cut-off (05 Dec 2014)|238
4731114|NCT01942135|16318394|P2|Overall Study|Withdrawal by Subject|2
4731115|NCT01942135|16318395|P1|Overall Study|Withdrawal by Subject|4
4731116|NCT01942135|16318394|P2|Overall Study|Participant Refused toContinue Treatment|1
4731117|NCT01942135|16318395|P1|Overall Study|Participant Refused toContinue Treatment|1
4731118|NCT01942135|16318394|P2|Overall Study|ObjectiveProgression+Progressive Disease|87
4731119|NCT01942135|16318395|P1|Overall Study|ObjectiveProgression+Progressive Disease|85
4731120|NCT01942135|16318394|P2|Overall Study|Death|1
4731121|NCT01942135|16318395|P1|Overall Study|Death|0
4731122|NCT01942135|16318394|P2|Overall Study|Randomized Not Treated|2
4731123|NCT01942135|16318395|P1|Overall Study|Randomized Not Treated|2
4731124|NCT01942135|16318394|P2|Overall Study|Global deterioration of health status|3
4731125|NCT01942135|16318395|P1|Overall Study|Global deterioration of health status|8
4731126|NCT01942135|16318394|P2|Overall Study|Adverse Event|3
4731127|NCT01942135|16318395|P1|Overall Study|Adverse Event|9
4731128|NCT01941940|16318432|P1|Overall Study|Other|1
4731129|NCT01941940|16318432|P1|Overall Study|Other|1
4731130|NCT01941940|16318432|P1|Overall Study|Death|1
4731131|NCT01941940|16318432|P1|Overall Study|Withdrawal by Subject|15
4731132|NCT01941940|16318432|P1|Overall Study|Physician Decision|2
4731133|NCT01941940|16318432|P1|Overall Study|Lost to Follow-up|2
4731134|NCT01941940|16318432|P1|Overall Study|Adverse Event|11
4731135|NCT01941537|16318540|P2|Overall Study|Withdrawal by Subject|1
4731136|NCT01941537|16318541|P1|Overall Study|Withdrawal by Subject|0
4731137|NCT01941537|16318540|P2|Overall Study|Adverse Event|0
4731138|NCT01941537|16318541|P1|Overall Study|Adverse Event|1
4731139|NCT01941537|16318540|P2|Overall Study|Pregnancy|0
4731140|NCT01941537|16318541|P1|Overall Study|Pregnancy|1
4731141|NCT01941537|16318540|P2|Overall Study|Lost to Follow-up|0
4731142|NCT01941537|16318541|P1|Overall Study|Lost to Follow-up|1
4731143|NCT01941537|16318540|P2|Overall Study|Lack of Efficacy|2
4731144|NCT01941537|16318541|P1|Overall Study|Lack of Efficacy|1
4731145|NCT01941498|16318553|P1|Overall Study|Relocated out of state|1
4731146|NCT01941186|16318671|P2|Follow-up|Lost to Follow-up|0
4731147|NCT01941186|16318672|P1|Follow-up|Lost to Follow-up|1
4731148|NCT01941095|16318698|P1|Overall Study|Lost to Follow-up|10
4731149|NCT01941095|16318698|P1|Overall Study|Withdrawal by Subject|17
4731150|NCT01941095|16318698|P1|Overall Study|Physician Decision|3
4731151|NCT01941095|16318698|P1|Overall Study|Adverse Event|11
4731152|NCT01941095|16318698|P1|Overall Study|Anaphylaxis or serious hypersensitivity|2
4731153|NCT01941095|16318698|P1|Overall Study|Insufficient therapeutic response|13
4731154|NCT01941030|16318723|P2|Overall Study|Withdrawal by Subject|6
4731155|NCT01941030|16318724|P1|Overall Study|Withdrawal by Subject|4
4731156|NCT01941030|16318723|P2|Overall Study|Lost to Follow-up|5
4731157|NCT01941030|16318724|P1|Overall Study|Lost to Follow-up|6
4731158|NCT01941030|16318723|P2|Overall Study|Death|2
4731159|NCT01941030|16318724|P1|Overall Study|Death|3
4731160|NCT01940939|16318746|P2|Overall Study|Withdrawal by Subject|8
4731161|NCT01940939|16318747|P1|Overall Study|Withdrawal by Subject|2
4731162|NCT01940900|16318759|P2|Overall Study|other|0
4731163|NCT01940900|16318760|P1|Overall Study|other|1
4731164|NCT01940900|16318759|P2|Overall Study|subject non-compliance|1
4731165|NCT01940900|16318760|P1|Overall Study|subject non-compliance|1
4731166|NCT01940900|16318759|P2|Overall Study|Sponsor Decision|0
4731167|NCT01940900|16318760|P1|Overall Study|Sponsor Decision|1
4731168|NCT01940900|16318759|P2|Overall Study|Lost to Follow-up|0
4731169|NCT01940900|16318760|P1|Overall Study|Lost to Follow-up|1
4731170|NCT01940900|16318759|P2|Overall Study|Withdrawal by Subject|15
4731171|NCT01940900|16318760|P1|Overall Study|Withdrawal by Subject|11
4731172|NCT01940900|16318759|P2|Overall Study|Adverse Event|15
4731173|NCT01940900|16318760|P1|Overall Study|Adverse Event|10
4731174|NCT01940900|16318759|P2|Overall Study|Physician Decision|0
4731175|NCT01940900|16318760|P1|Overall Study|Physician Decision|4
4731176|NCT01940887|16318768|P2|Year 2|Lost to Follow-up|6
4731177|NCT01940887|16318769|P1|Year 2|Lost to Follow-up|1
4731178|NCT01940887|16318768|P2|Year 2|Withdrawal by Subject|8
4731179|NCT01940887|16318769|P1|Year 2|Withdrawal by Subject|8
4731180|NCT01940887|16318768|P2|Year 2|Adverse Event|2
4731181|NCT01940887|16318769|P1|Year 2|Adverse Event|8
4731182|NCT01940887|16318768|P2|Year 2|Sponsor Decision, early termination|203
4731183|NCT01940887|16318769|P1|Year 2|Sponsor Decision, early termination|192
4731184|NCT01940887|16318768|P2|Year 2|Death|2
4731185|NCT01940887|16318769|P1|Year 2|Death|0
4731186|NCT01940887|16318768|P2|Year 2|Physician Decision|1
4731187|NCT01940887|16318769|P1|Year 2|Physician Decision|8
4731188|NCT01940887|16318768|P2|Year 1|Lost to Follow-up|1
4731189|NCT01940887|16318769|P1|Year 1|Lost to Follow-up|2
4731190|NCT01940887|16318768|P2|Year 1|Withdrawal by Subject|9
4731191|NCT01940887|16318769|P1|Year 1|Withdrawal by Subject|18
4731192|NCT01940887|16318768|P2|Year 1|Adverse Event|6
4731193|NCT01940887|16318769|P1|Year 1|Adverse Event|7
4731194|NCT01940887|16318768|P2|Year 1|Death|3
4731195|NCT01940887|16318769|P1|Year 1|Death|5
4731196|NCT01940887|16318768|P2|Year 1|Physician Decision|3
4731197|NCT01940887|16318769|P1|Year 1|Physician Decision|7
4731198|NCT01940887|16318768|P2|Year 1|Protocol Violation|1
4731199|NCT01940887|16318769|P1|Year 1|Protocol Violation|0
4731200|NCT01940705|16318779|P4|Overall Study|Withdrawal by team - hearing aid change|0
4731201|NCT01940705|16318780|P3|Overall Study|Withdrawal by team - hearing aid change|0
4731202|NCT01940705|16318781|P2|Overall Study|Withdrawal by team - hearing aid change|0
4731203|NCT01940705|16318782|P1|Overall Study|Withdrawal by team - hearing aid change|1
4731204|NCT01940705|16318779|P4|Overall Study|Intervention not given|0
4731205|NCT01940705|16318780|P3|Overall Study|Intervention not given|3
4731206|NCT01940705|16318781|P2|Overall Study|Intervention not given|3
4731207|NCT01940705|16318782|P1|Overall Study|Intervention not given|0
4731208|NCT01940705|16318779|P4|Overall Study|Withdrawal by Subject|2
4731209|NCT01940705|16318780|P3|Overall Study|Withdrawal by Subject|3
4731210|NCT01940705|16318781|P2|Overall Study|Withdrawal by Subject|2
4731211|NCT01940705|16318782|P1|Overall Study|Withdrawal by Subject|2
4731212|NCT01940705|16318779|P4|Overall Study|Lost to Follow-up|2
4731213|NCT01940705|16318780|P3|Overall Study|Lost to Follow-up|2
4731214|NCT01940705|16318781|P2|Overall Study|Lost to Follow-up|3
4731215|NCT01940705|16318782|P1|Overall Study|Lost to Follow-up|1
4731216|NCT01940497|16318846|P2|Overall Study|Administrative/Other|1
4731217|NCT01940497|16318847|P1|Overall Study|Administrative/Other|1
4731218|NCT01940497|16318846|P2|Overall Study|Withdrew Consent|2
4731219|NCT01940497|16318847|P1|Overall Study|Withdrew Consent|6
4731220|NCT01940497|16318846|P2|Overall Study|Refused Treatment|3
4731221|NCT01940497|16318847|P1|Overall Study|Refused Treatment|1
4731222|NCT01940497|16318846|P2|Overall Study|Violation of Entry Criteria|1
4731223|NCT01940497|16318847|P1|Overall Study|Violation of Entry Criteria|1
4731224|NCT01940497|16318846|P2|Overall Study|Recurrence of Disease Postsurgery|3
4731225|NCT01940497|16318847|P1|Overall Study|Recurrence of Disease Postsurgery|1
4731226|NCT01940497|16318846|P2|Overall Study|Adverse Event/Intercurrent Illness|8
4731227|NCT01940497|16318847|P1|Overall Study|Adverse Event/Intercurrent Illness|11
4731228|NCT01940484|16318888|P1|Overall Study|Adverse Event|1
4731229|NCT01940484|16318888|P1|Overall Study|Death|2
4731230|NCT01940484|16318888|P1|Overall Study|Underwent transplantation|4
4731231|NCT01940484|16318888|P1|Overall Study|Withdrawal by Subject|3
4731232|NCT01940471|16318908|P2|Open-Label Extension|Still in Open-Label Extension Phase|8
4731233|NCT01940471|16318909|P1|Open-Label Extension|Still in Open-Label Extension Phase|14
4731234|NCT01940471|16318908|P2|Double-Blind Phase|Still in Double-Blind Phase|270
4731235|NCT01940471|16318909|P1|Double-Blind Phase|Still in Double-Blind Phase|539
4731236|NCT01940471|16318908|P2|Double-Blind Phase|Protocol Violation|1
4731237|NCT01940471|16318909|P1|Double-Blind Phase|Protocol Violation|0
4731238|NCT01940471|16318908|P2|Double-Blind Phase|Lack of Efficacy|0
4731239|NCT01940471|16318909|P1|Double-Blind Phase|Lack of Efficacy|1
4731240|NCT01940471|16318908|P2|Double-Blind Phase|Death|0
4731241|NCT01940471|16318909|P1|Double-Blind Phase|Death|1
4731242|NCT01940471|16318908|P2|Double-Blind Phase|Protocol-Specified Criteria|0
4731243|NCT01940471|16318909|P1|Double-Blind Phase|Protocol-Specified Criteria|1
4731244|NCT01940471|16318908|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
4731245|NCT01940471|16318909|P1|Double-Blind Phase|Non-Compliance with Study Drug|1
4731246|NCT01940471|16318908|P2|Double-Blind Phase|Investigator's Discretion|0
4731247|NCT01940471|16318909|P1|Double-Blind Phase|Investigator's Discretion|5
4731248|NCT01940471|16318908|P2|Double-Blind Phase|Pregnancy|1
4731249|NCT01940471|16318909|P1|Double-Blind Phase|Pregnancy|2
4731250|NCT01940471|16318908|P2|Double-Blind Phase|Lost to Follow-up|2
4731251|NCT01940471|16318909|P1|Double-Blind Phase|Lost to Follow-up|3
4731252|NCT01940471|16318908|P2|Double-Blind Phase|Adverse Event|2
4731253|NCT01940471|16318909|P1|Double-Blind Phase|Adverse Event|1
4731254|NCT01940471|16318908|P2|Double-Blind Phase|Withdrew Consent|7
4731255|NCT01940471|16318909|P1|Double-Blind Phase|Withdrew Consent|13
4731256|NCT01940471|16318908|P2|Double-Blind Phase|Randomized but Never Treated|1
4731257|NCT01940471|16318909|P1|Double-Blind Phase|Randomized but Never Treated|1
4731258|NCT01940354|16318927|P2|Overall Study|Withdrawal by Subject|2
4731259|NCT01940354|16318928|P1|Overall Study|Withdrawal by Subject|4
4731260|NCT01940341|16318940|P2|Open-label Extension Phase|Still on Study|1
4731261|NCT01940341|16318941|P1|Open-label Extension Phase|Still on Study|4
4731262|NCT01940341|16318940|P2|Double-Blind Phase|Still on Double-Blind Treatment|132
4731263|NCT01940341|16318941|P1|Double-Blind Phase|Still on Double-Blind Treatment|269
4731264|NCT01940341|16318940|P2|Double-Blind Phase|Protocol Specified Criteria|0
4731265|NCT01940341|16318941|P1|Double-Blind Phase|Protocol Specified Criteria|1
4731266|NCT01940341|16318940|P2|Double-Blind Phase|Non-Compliance with Study Drug|1
4731267|NCT01940341|16318941|P1|Double-Blind Phase|Non-Compliance with Study Drug|0
4731268|NCT01940341|16318940|P2|Double-Blind Phase|Investigator's Discretion|0
4731269|NCT01940341|16318941|P1|Double-Blind Phase|Investigator's Discretion|1
4731270|NCT01940341|16318940|P2|Double-Blind Phase|Pregnancy|1
4731271|NCT01940341|16318941|P1|Double-Blind Phase|Pregnancy|0
4731272|NCT01940341|16318940|P2|Double-Blind Phase|Lost to Follow-up|1
4731273|NCT01940341|16318941|P1|Double-Blind Phase|Lost to Follow-up|4
4731274|NCT01940341|16318940|P2|Double-Blind Phase|Withdrew Consent|2
4731275|NCT01940341|16318941|P1|Double-Blind Phase|Withdrew Consent|3
4731276|NCT01940341|16318940|P2|Double-Blind Phase|Adverse Event|2
4731277|NCT01940341|16318941|P1|Double-Blind Phase|Adverse Event|3
4731278|NCT01940341|16318940|P2|Double-Blind Phase|Randomized but Never Treated|1
4731279|NCT01940341|16318941|P1|Double-Blind Phase|Randomized but Never Treated|0
4731280|NCT01940120|16318972|P1|Overall Study|Withdrawal by Subject|8
4731281|NCT01940120|16318972|P1|Overall Study|Death|40
4731282|NCT01939977|16319128|P2|Overall Study|Did not receive study medication|1
4731283|NCT01939977|16319129|P1|Overall Study|Did not receive study medication|0
4731284|NCT01939977|16319128|P2|Overall Study|Did not meet inclusion criteria|0
4731285|NCT01939977|16319129|P1|Overall Study|Did not meet inclusion criteria|1
4731286|NCT01939977|16319128|P2|Overall Study|Withdrawal by Subject|2
4731287|NCT01939977|16319129|P1|Overall Study|Withdrawal by Subject|0
4731288|NCT01939977|16319128|P2|Overall Study|Physician Decision|1
4731289|NCT01939977|16319129|P1|Overall Study|Physician Decision|1
4731290|NCT01939977|16319128|P2|Overall Study|Lack of Efficacy|0
4731291|NCT01939977|16319129|P1|Overall Study|Lack of Efficacy|3
4731292|NCT01939977|16319128|P2|Overall Study|Adverse Event|3
4731293|NCT01939977|16319129|P1|Overall Study|Adverse Event|4
4731294|NCT01939899|16319176|P5|Phase 2|Disease Progression|1
4731295|NCT01939899|16319177|P4|Phase 2|Disease Progression|9
4731296|NCT01939899|16319178|P3|Phase 2|Disease Progression|0
4731297|NCT01939899|16319179|P2|Phase 2|Disease Progression|0
4731298|NCT01939899|16319180|P1|Phase 2|Disease Progression|0
4731299|NCT01939899|16319176|P5|Phase 2|Withdrawal by Subject|0
4731300|NCT01939899|16319177|P4|Phase 2|Withdrawal by Subject|2
4731301|NCT01939899|16319178|P3|Phase 2|Withdrawal by Subject|0
4731302|NCT01939899|16319179|P2|Phase 2|Withdrawal by Subject|0
4731303|NCT01939899|16319180|P1|Phase 2|Withdrawal by Subject|0
4731304|NCT01939899|16319176|P5|Lead-in Dose Finding Phase|Other|0
4731305|NCT01939899|16319177|P4|Lead-in Dose Finding Phase|Other|0
4731306|NCT01939899|16319178|P3|Lead-in Dose Finding Phase|Other|1
4731307|NCT01939899|16319179|P2|Lead-in Dose Finding Phase|Other|0
4731308|NCT01939899|16319180|P1|Lead-in Dose Finding Phase|Other|0
4731309|NCT01939899|16319176|P5|Lead-in Dose Finding Phase|Disease Progression|0
4731310|NCT01939899|16319177|P4|Lead-in Dose Finding Phase|Disease Progression|0
4731311|NCT01939899|16319178|P3|Lead-in Dose Finding Phase|Disease Progression|3
4731312|NCT01939899|16319179|P2|Lead-in Dose Finding Phase|Disease Progression|4
4731313|NCT01939899|16319180|P1|Lead-in Dose Finding Phase|Disease Progression|2
4731314|NCT01939899|16319176|P5|Lead-in Dose Finding Phase|Death|0
4731315|NCT01939899|16319177|P4|Lead-in Dose Finding Phase|Death|0
4731316|NCT01939899|16319178|P3|Lead-in Dose Finding Phase|Death|1
4731317|NCT01939899|16319179|P2|Lead-in Dose Finding Phase|Death|3
4731318|NCT01939899|16319180|P1|Lead-in Dose Finding Phase|Death|0
4731319|NCT01939548|16319227|P3|Overall Study|Did not complete follow-up|0
4731320|NCT01939548|16319228|P2|Overall Study|Did not complete follow-up|1
4731321|NCT01939548|16319229|P1|Overall Study|Did not complete follow-up|0
4731322|NCT01939548|16319227|P3|Overall Study|Participant withdrew consent|0
4731323|NCT01939548|16319228|P2|Overall Study|Participant withdrew consent|2
4731324|NCT01939548|16319229|P1|Overall Study|Participant withdrew consent|0
4731325|NCT01939548|16319227|P3|Overall Study|Participant unwilling to continue|0
4731326|NCT01939548|16319228|P2|Overall Study|Participant unwilling to continue|1
4731327|NCT01939548|16319229|P1|Overall Study|Participant unwilling to continue|0
4731328|NCT01939548|16319227|P3|Overall Study|Participant dropped|1
4731329|NCT01939548|16319228|P2|Overall Study|Participant dropped|0
4731330|NCT01939548|16319229|P1|Overall Study|Participant dropped|0
4731331|NCT01939548|16319227|P3|Overall Study|Death|1
4731332|NCT01939548|16319228|P2|Overall Study|Death|0
4731333|NCT01939548|16319229|P1|Overall Study|Death|0
4731334|NCT01939548|16319227|P3|Overall Study|Adverse Event|7
4731335|NCT01939548|16319228|P2|Overall Study|Adverse Event|9
4731336|NCT01939548|16319229|P1|Overall Study|Adverse Event|2
4731337|NCT01939548|16319227|P3|Overall Study|Lost to Follow-up|3
4731338|NCT01939548|16319228|P2|Overall Study|Lost to Follow-up|5
4731339|NCT01939548|16319229|P1|Overall Study|Lost to Follow-up|5
4731340|NCT01939548|16319227|P3|Overall Study|Protocol Violation|5
4731341|NCT01939548|16319228|P2|Overall Study|Protocol Violation|6
4731342|NCT01939548|16319229|P1|Overall Study|Protocol Violation|7
4731343|NCT01939548|16319227|P3|Overall Study|Withdrawal by Subject|1
4731344|NCT01939548|16319228|P2|Overall Study|Withdrawal by Subject|4
4731345|NCT01939548|16319229|P1|Overall Study|Withdrawal by Subject|4
4731346|NCT01939548|16319227|P3|Overall Study|Did Not Meet Entrance Criteria|0
4731347|NCT01939548|16319228|P2|Overall Study|Did Not Meet Entrance Criteria|0
4731348|NCT01939548|16319229|P1|Overall Study|Did Not Meet Entrance Criteria|1
4731349|NCT01939548|16319227|P3|Overall Study|Insufficient Clinical Response|0
4731350|NCT01939548|16319228|P2|Overall Study|Insufficient Clinical Response|0
4731351|NCT01939548|16319229|P1|Overall Study|Insufficient Clinical Response|1
4731352|NCT01939548|16319227|P3|Overall Study|Study Terminated by Sponsor|12
4731353|NCT01939548|16319228|P2|Overall Study|Study Terminated by Sponsor|19
4731354|NCT01939548|16319229|P1|Overall Study|Study Terminated by Sponsor|17
4731355|NCT01939548|16319227|P3|Overall Study|Non compliance|0
4731356|NCT01939548|16319228|P2|Overall Study|Non compliance|2
4731357|NCT01939548|16319229|P1|Overall Study|Non compliance|0
4731358|NCT01939496|16319303|P3|Overall Study|Other|1
4731359|NCT01939496|16319304|P2|Overall Study|Other|0
4731360|NCT01939496|16319305|P1|Overall Study|Other|2
4731361|NCT01939496|16319303|P3|Overall Study|Blood Pressure Withdrawal Criteria|0
4731362|NCT01939496|16319304|P2|Overall Study|Blood Pressure Withdrawal Criteria|1
4731363|NCT01939496|16319305|P1|Overall Study|Blood Pressure Withdrawal Criteria|0
4731364|NCT01939496|16319303|P3|Overall Study|Withdrawal by Subject|1
4731365|NCT01939496|16319304|P2|Overall Study|Withdrawal by Subject|1
4731366|NCT01939496|16319305|P1|Overall Study|Withdrawal by Subject|0
4731367|NCT01939496|16319303|P3|Overall Study|Protocol Violation|0
4731368|NCT01939496|16319304|P2|Overall Study|Protocol Violation|0
4731369|NCT01939496|16319305|P1|Overall Study|Protocol Violation|3
4731370|NCT01939496|16319303|P3|Overall Study|Physician Decision|0
4731371|NCT01939496|16319304|P2|Overall Study|Physician Decision|0
4731372|NCT01939496|16319305|P1|Overall Study|Physician Decision|1
4731373|NCT01939496|16319303|P3|Overall Study|Lost to Follow-up|0
4731374|NCT01939496|16319304|P2|Overall Study|Lost to Follow-up|1
4731375|NCT01939496|16319305|P1|Overall Study|Lost to Follow-up|1
4731376|NCT01939496|16319303|P3|Overall Study|Adverse Event|0
4731377|NCT01939496|16319304|P2|Overall Study|Adverse Event|0
4731378|NCT01939496|16319305|P1|Overall Study|Adverse Event|2
4731379|NCT01939366|16319375|P5|Overall Study|GCP non-compliance at site|3
4731380|NCT01939366|16319376|P4|Overall Study|GCP non-compliance at site|3
4731381|NCT01939366|16319377|P3|Overall Study|GCP non-compliance at site|2
4731382|NCT01939366|16319378|P2|Overall Study|GCP non-compliance at site|3
4731383|NCT01939366|16319379|P1|Overall Study|GCP non-compliance at site|2
4731384|NCT01939366|16319375|P5|Overall Study|Sponsor decision|2
4731385|NCT01939366|16319376|P4|Overall Study|Sponsor decision|0
4731386|NCT01939366|16319377|P3|Overall Study|Sponsor decision|0
4731387|NCT01939366|16319378|P2|Overall Study|Sponsor decision|0
4731388|NCT01939366|16319379|P1|Overall Study|Sponsor decision|0
4731389|NCT01939366|16319375|P5|Overall Study|Protocol Violation|0
4731390|NCT01939366|16319376|P4|Overall Study|Protocol Violation|1
4731391|NCT01939366|16319377|P3|Overall Study|Protocol Violation|0
4731392|NCT01939366|16319378|P2|Overall Study|Protocol Violation|0
4731393|NCT01939366|16319379|P1|Overall Study|Protocol Violation|0
4731394|NCT01939366|16319375|P5|Overall Study|Other|1
4731395|NCT01939366|16319376|P4|Overall Study|Other|2
4731396|NCT01939366|16319377|P3|Overall Study|Other|2
4731397|NCT01939366|16319378|P2|Overall Study|Other|0
4731398|NCT01939366|16319379|P1|Overall Study|Other|0
4731399|NCT01939366|16319375|P5|Overall Study|Inclusion criteria not met|1
4731400|NCT01939366|16319376|P4|Overall Study|Inclusion criteria not met|0
4731401|NCT01939366|16319377|P3|Overall Study|Inclusion criteria not met|1
4731402|NCT01939366|16319378|P2|Overall Study|Inclusion criteria not met|1
4731403|NCT01939366|16319379|P1|Overall Study|Inclusion criteria not met|0
4731404|NCT01939366|16319375|P5|Overall Study|Withdrawal by Subject|3
4731405|NCT01939366|16319376|P4|Overall Study|Withdrawal by Subject|2
4731406|NCT01939366|16319377|P3|Overall Study|Withdrawal by Subject|2
4731407|NCT01939366|16319378|P2|Overall Study|Withdrawal by Subject|0
4731408|NCT01939366|16319379|P1|Overall Study|Withdrawal by Subject|1
4731409|NCT01939366|16319375|P5|Overall Study|Lost to Follow-up|0
4731410|NCT01939366|16319376|P4|Overall Study|Lost to Follow-up|0
4731411|NCT01939366|16319377|P3|Overall Study|Lost to Follow-up|0
4731412|NCT01939366|16319378|P2|Overall Study|Lost to Follow-up|1
4731413|NCT01939366|16319379|P1|Overall Study|Lost to Follow-up|1
4731414|NCT01939366|16319375|P5|Overall Study|Lack of Efficacy|3
4731415|NCT01939366|16319376|P4|Overall Study|Lack of Efficacy|1
4731416|NCT01939366|16319377|P3|Overall Study|Lack of Efficacy|1
4731417|NCT01939366|16319378|P2|Overall Study|Lack of Efficacy|1
4731418|NCT01939366|16319379|P1|Overall Study|Lack of Efficacy|2
4731419|NCT01939366|16319375|P5|Overall Study|Adverse Event|5
4731420|NCT01939366|16319376|P4|Overall Study|Adverse Event|8
4731421|NCT01939366|16319377|P3|Overall Study|Adverse Event|30
4731422|NCT01939366|16319378|P2|Overall Study|Adverse Event|17
4731423|NCT01939366|16319379|P1|Overall Study|Adverse Event|8
4731424|NCT01939314|16319393|P2|Overall Study|Lost to Follow-up|6
4731425|NCT01939314|16319394|P1|Overall Study|Lost to Follow-up|5
4731426|NCT01939314|16319393|P2|Overall Study|Pregnancy|1
4731427|NCT01939314|16319394|P1|Overall Study|Pregnancy|0
4731428|NCT01939314|16319393|P2|Overall Study|Protocol Violation|0
4731429|NCT01939314|16319394|P1|Overall Study|Protocol Violation|1
4731430|NCT01939314|16319393|P2|Overall Study|Withdrawal by Subject|1
4731431|NCT01939314|16319394|P1|Overall Study|Withdrawal by Subject|3
4731432|NCT01939223|16319428|P2|Overall Study|Withdrawal by Subject|0
4731433|NCT01939223|16319429|P1|Overall Study|Withdrawal by Subject|6
4731434|NCT01939223|16319428|P2|Overall Study|Study stopped by Sponsor|7
4731435|NCT01939223|16319429|P1|Overall Study|Study stopped by Sponsor|5
4731436|NCT01939223|16319428|P2|Overall Study|Disease recurrence (radiological)|3
4731437|NCT01939223|16319429|P1|Overall Study|Disease recurrence (radiological)|1
4731438|NCT01939223|16319428|P2|Overall Study|AE not assoc. with disease recurrence|1
4731439|NCT01939223|16319429|P1|Overall Study|AE not assoc. with disease recurrence|1
4731440|NCT01939197|16319444|P7|Overall Study|Lost to Follow-up|2
4731441|NCT01939197|16319445|P6|Overall Study|Lost to Follow-up|1
4731442|NCT01939197|16319446|P5|Overall Study|Lost to Follow-up|3
4731443|NCT01939197|16319447|P4|Overall Study|Lost to Follow-up|1
4731444|NCT01939197|16319448|P3|Overall Study|Lost to Follow-up|0
4731445|NCT01939197|16319449|P2|Overall Study|Lost to Follow-up|1
4731446|NCT01939197|16319450|P1|Overall Study|Lost to Follow-up|0
4731447|NCT01939197|16319444|P7|Overall Study|Withdrawal by Subject|0
4731448|NCT01939197|16319445|P6|Overall Study|Withdrawal by Subject|0
4731449|NCT01939197|16319446|P5|Overall Study|Withdrawal by Subject|1
4731450|NCT01939197|16319447|P4|Overall Study|Withdrawal by Subject|0
4731451|NCT01939197|16319448|P3|Overall Study|Withdrawal by Subject|0
4731452|NCT01939197|16319449|P2|Overall Study|Withdrawal by Subject|0
4731453|NCT01939197|16319450|P1|Overall Study|Withdrawal by Subject|1
4731454|NCT01939028|16319519|P1|Overall Study|Physician Decision|7
4731455|NCT01939028|16319519|P1|Overall Study|Withdrawal by Subject|5
4731456|NCT01939002|16319532|P2|Overall Study|Other|2
4731457|NCT01939002|16319533|P1|Overall Study|Other|1
4731458|NCT01939002|16319532|P2|Overall Study|Withdrawal by Subject|3
4731459|NCT01939002|16319533|P1|Overall Study|Withdrawal by Subject|5
4731460|NCT01939002|16319532|P2|Overall Study|Adverse Event|13
4731461|NCT01939002|16319533|P1|Overall Study|Adverse Event|13
4731462|NCT01938846|16319609|P3|Overall Study|Other than listed|4
4731463|NCT01938846|16319610|P2|Overall Study|Other than listed|1
4731464|NCT01938846|16319611|P1|Overall Study|Other than listed|5
4731465|NCT01938846|16319609|P3|Overall Study|Withdrawal by Subject|1
4731466|NCT01938846|16319610|P2|Overall Study|Withdrawal by Subject|2
4731467|NCT01938846|16319611|P1|Overall Study|Withdrawal by Subject|2
4731468|NCT01938846|16319609|P3|Overall Study|Adverse Event|3
4731469|NCT01938846|16319610|P2|Overall Study|Adverse Event|4
4731470|NCT01938846|16319611|P1|Overall Study|Adverse Event|8
4731471|NCT01938846|16319609|P3|Overall Study|Progressive disease|16
4731472|NCT01938846|16319610|P2|Overall Study|Progressive disease|18
4731473|NCT01938846|16319611|P1|Overall Study|Progressive disease|26
4731474|NCT01938625|16319826|P2|Overall Study|Adverse Event|1
4731475|NCT01938625|16319827|P1|Overall Study|Adverse Event|0
4731476|NCT01938625|16319826|P2|Overall Study|Withdrawal by Subject|1
4731477|NCT01938625|16319827|P1|Overall Study|Withdrawal by Subject|0
4731478|NCT01938573|16319847|P2|Overall Study|Operation at other hospital|0
4731479|NCT01938573|16319848|P1|Overall Study|Operation at other hospital|1
4731480|NCT01938573|16319847|P2|Overall Study|Lack of Efficacy|0
4731481|NCT01938573|16319848|P1|Overall Study|Lack of Efficacy|1
4731482|NCT01938430|16319868|P14|Overall Study|Withdrew Consent|0
4731483|NCT01938430|16319869|P13|Overall Study|Withdrew Consent|0
4731484|NCT01938430|16319870|P12|Overall Study|Withdrew Consent|0
4731485|NCT01938430|16319871|P11|Overall Study|Withdrew Consent|0
4731486|NCT01938430|16319872|P10|Overall Study|Withdrew Consent|0
4731487|NCT01938430|16319873|P9|Overall Study|Withdrew Consent|1
4731488|NCT01938430|16319874|P8|Overall Study|Withdrew Consent|0
4731489|NCT01938430|16319875|P7|Overall Study|Withdrew Consent|0
4731490|NCT01938430|16319876|P6|Overall Study|Withdrew Consent|0
4731491|NCT01938430|16319877|P5|Overall Study|Withdrew Consent|0
4731492|NCT01938430|16319878|P4|Overall Study|Withdrew Consent|0
4731493|NCT01938430|16319879|P3|Overall Study|Withdrew Consent|0
4731494|NCT01938430|16319880|P2|Overall Study|Withdrew Consent|0
4731495|NCT01938430|16319881|P1|Overall Study|Withdrew Consent|0
4731496|NCT01938430|16319868|P14|Overall Study|Lost to Follow-up|0
4731497|NCT01938430|16319869|P13|Overall Study|Lost to Follow-up|0
4731498|NCT01938430|16319870|P12|Overall Study|Lost to Follow-up|0
4731499|NCT01938430|16319871|P11|Overall Study|Lost to Follow-up|0
4731500|NCT01938430|16319872|P10|Overall Study|Lost to Follow-up|0
4731501|NCT01938430|16319873|P9|Overall Study|Lost to Follow-up|0
4731502|NCT01938430|16319874|P8|Overall Study|Lost to Follow-up|0
4731503|NCT01938430|16319875|P7|Overall Study|Lost to Follow-up|0
4731504|NCT01938430|16319876|P6|Overall Study|Lost to Follow-up|1
4731505|NCT01938430|16319877|P5|Overall Study|Lost to Follow-up|0
4731506|NCT01938430|16319878|P4|Overall Study|Lost to Follow-up|0
4731507|NCT01938430|16319879|P3|Overall Study|Lost to Follow-up|1
4731508|NCT01938430|16319880|P2|Overall Study|Lost to Follow-up|0
4731509|NCT01938430|16319881|P1|Overall Study|Lost to Follow-up|0
4731510|NCT01938430|16319868|P14|Overall Study|Lack of Efficacy|0
4731511|NCT01938430|16319869|P13|Overall Study|Lack of Efficacy|0
4731512|NCT01938430|16319870|P12|Overall Study|Lack of Efficacy|1
4731513|NCT01938430|16319871|P11|Overall Study|Lack of Efficacy|2
4731514|NCT01938430|16319872|P10|Overall Study|Lack of Efficacy|0
4731515|NCT01938430|16319873|P9|Overall Study|Lack of Efficacy|1
4731516|NCT01938430|16319874|P8|Overall Study|Lack of Efficacy|0
4731517|NCT01938430|16319875|P7|Overall Study|Lack of Efficacy|0
4731518|NCT01938430|16319876|P6|Overall Study|Lack of Efficacy|0
4731519|NCT01938430|16319877|P5|Overall Study|Lack of Efficacy|0
4731520|NCT01938430|16319878|P4|Overall Study|Lack of Efficacy|1
4731521|NCT01938430|16319879|P3|Overall Study|Lack of Efficacy|1
4731522|NCT01938430|16319880|P2|Overall Study|Lack of Efficacy|1
4731523|NCT01938430|16319881|P1|Overall Study|Lack of Efficacy|3
4731524|NCT01938430|16319868|P14|Overall Study|Investigator's Discretion|0
4731525|NCT01938430|16319869|P13|Overall Study|Investigator's Discretion|0
4731526|NCT01938430|16319870|P12|Overall Study|Investigator's Discretion|0
4731527|NCT01938430|16319871|P11|Overall Study|Investigator's Discretion|0
4731528|NCT01938430|16319872|P10|Overall Study|Investigator's Discretion|0
4731529|NCT01938430|16319873|P9|Overall Study|Investigator's Discretion|0
4731530|NCT01938430|16319874|P8|Overall Study|Investigator's Discretion|0
4731531|NCT01938430|16319875|P7|Overall Study|Investigator's Discretion|0
4731532|NCT01938430|16319876|P6|Overall Study|Investigator's Discretion|0
4731533|NCT01938430|16319877|P5|Overall Study|Investigator's Discretion|0
4731534|NCT01938430|16319878|P4|Overall Study|Investigator's Discretion|0
4731535|NCT01938430|16319879|P3|Overall Study|Investigator's Discretion|1
4731536|NCT01938430|16319880|P2|Overall Study|Investigator's Discretion|0
4731537|NCT01938430|16319881|P1|Overall Study|Investigator's Discretion|0
4731538|NCT01938430|16319868|P14|Overall Study|Death|0
4731539|NCT01938430|16319869|P13|Overall Study|Death|0
4731540|NCT01938430|16319870|P12|Overall Study|Death|0
4731541|NCT01938430|16319871|P11|Overall Study|Death|0
4731542|NCT01938430|16319872|P10|Overall Study|Death|3
4731543|NCT01938430|16319873|P9|Overall Study|Death|2
4731544|NCT01938430|16319874|P8|Overall Study|Death|1
4731545|NCT01938430|16319875|P7|Overall Study|Death|1
4731546|NCT01938430|16319876|P6|Overall Study|Death|0
4731547|NCT01938430|16319877|P5|Overall Study|Death|0
4731548|NCT01938430|16319878|P4|Overall Study|Death|1
4731549|NCT01938430|16319879|P3|Overall Study|Death|2
4731550|NCT01938430|16319880|P2|Overall Study|Death|2
4731551|NCT01938430|16319881|P1|Overall Study|Death|1
4731552|NCT01938430|16319868|P14|Overall Study|Adverse Event|0
4731553|NCT01938430|16319869|P13|Overall Study|Adverse Event|0
4731554|NCT01938430|16319870|P12|Overall Study|Adverse Event|0
4731555|NCT01938430|16319871|P11|Overall Study|Adverse Event|0
4731556|NCT01938430|16319872|P10|Overall Study|Adverse Event|0
4731557|NCT01938430|16319873|P9|Overall Study|Adverse Event|0
4731558|NCT01938430|16319874|P8|Overall Study|Adverse Event|0
4731559|NCT01938430|16319875|P7|Overall Study|Adverse Event|1
4731560|NCT01938430|16319876|P6|Overall Study|Adverse Event|0
4731561|NCT01938430|16319877|P5|Overall Study|Adverse Event|0
4731562|NCT01938430|16319878|P4|Overall Study|Adverse Event|0
4731563|NCT01938430|16319879|P3|Overall Study|Adverse Event|0
4731564|NCT01938430|16319880|P2|Overall Study|Adverse Event|0
4731565|NCT01938430|16319881|P1|Overall Study|Adverse Event|0
4731566|NCT01938430|16319868|P14|Overall Study|Randomized but Not Treated|1
4731567|NCT01938430|16319869|P13|Overall Study|Randomized but Not Treated|0
4731568|NCT01938430|16319870|P12|Overall Study|Randomized but Not Treated|0
4731569|NCT01938430|16319871|P11|Overall Study|Randomized but Not Treated|1
4731570|NCT01938430|16319872|P10|Overall Study|Randomized but Not Treated|0
4731571|NCT01938430|16319873|P9|Overall Study|Randomized but Not Treated|0
4731572|NCT01938430|16319874|P8|Overall Study|Randomized but Not Treated|0
4731573|NCT01938430|16319875|P7|Overall Study|Randomized but Not Treated|0
4731574|NCT01938430|16319876|P6|Overall Study|Randomized but Not Treated|0
4731575|NCT01938430|16319877|P5|Overall Study|Randomized but Not Treated|0
4731576|NCT01938430|16319878|P4|Overall Study|Randomized but Not Treated|0
4731577|NCT01938430|16319879|P3|Overall Study|Randomized but Not Treated|0
4731578|NCT01938430|16319880|P2|Overall Study|Randomized but Not Treated|0
4731579|NCT01938430|16319881|P1|Overall Study|Randomized but Not Treated|0
4731580|NCT01938391|16320206|P1|12 Month Follow up|Withdrawal by Subject|1
4731581|NCT01938391|16320206|P1|12 Month Follow up|Physician Decision|1
4731582|NCT01938391|16320206|P1|6 Month Follow up|Withdrawal by Subject|1
4731583|NCT01938001|16320340|P2|Overall Study|Death|26
4731584|NCT01938001|16320341|P1|Overall Study|Death|16
4731585|NCT01938001|16320340|P2|Overall Study|Lost to Follow-up|3
4731586|NCT01938001|16320341|P1|Overall Study|Lost to Follow-up|1
4731587|NCT01938001|16320340|P2|Overall Study|Participant Moved|1
4731588|NCT01938001|16320341|P1|Overall Study|Participant Moved|0
4731589|NCT01938001|16320340|P2|Overall Study|Non-compliant|0
4731590|NCT01938001|16320341|P1|Overall Study|Non-compliant|1
4731591|NCT01938001|16320340|P2|Overall Study|Withdrawal by Subject|17
4731592|NCT01938001|16320341|P1|Overall Study|Withdrawal by Subject|25
4731593|NCT01937871|16320420|P3|Overall Study|Entry Criteria Not Met|1
4731594|NCT01937871|16320421|P2|Overall Study|Entry Criteria Not Met|2
4731595|NCT01937871|16320422|P1|Overall Study|Entry Criteria Not Met|1
4731596|NCT01937871|16320420|P3|Overall Study|Physician Decision|0
4731597|NCT01937871|16320421|P2|Overall Study|Physician Decision|1
4731598|NCT01937871|16320422|P1|Overall Study|Physician Decision|0
4731599|NCT01937871|16320420|P3|Overall Study|Withdrawal by Subject|4
4731600|NCT01937871|16320421|P2|Overall Study|Withdrawal by Subject|6
4731601|NCT01937871|16320422|P1|Overall Study|Withdrawal by Subject|9
4731602|NCT01937871|16320420|P3|Overall Study|Lost to Follow-up|4
4731603|NCT01937871|16320421|P2|Overall Study|Lost to Follow-up|2
4731604|NCT01937871|16320422|P1|Overall Study|Lost to Follow-up|8
4731605|NCT01937871|16320420|P3|Overall Study|Adverse Event|2
4731606|NCT01937871|16320421|P2|Overall Study|Adverse Event|6
4731607|NCT01937871|16320422|P1|Overall Study|Adverse Event|6
4731608|NCT01937715|16320498|P5|Overall Study|Other|0
4731609|NCT01937715|16320499|P4|Overall Study|Other|3
4731610|NCT01937715|16320500|P3|Overall Study|Other|0
4731611|NCT01937715|16320501|P2|Overall Study|Other|0
4731612|NCT01937715|16320502|P1|Overall Study|Other|0
4731613|NCT01937715|16320498|P5|Overall Study|Withdrawal by Subject|2
4731614|NCT01937715|16320499|P4|Overall Study|Withdrawal by Subject|0
4731615|NCT01937715|16320500|P3|Overall Study|Withdrawal by Subject|0
4731616|NCT01937715|16320501|P2|Overall Study|Withdrawal by Subject|1
4731617|NCT01937715|16320502|P1|Overall Study|Withdrawal by Subject|0
4731618|NCT01937715|16320498|P5|Overall Study|Death|0
4731619|NCT01937715|16320499|P4|Overall Study|Death|1
4731620|NCT01937715|16320500|P3|Overall Study|Death|0
4731621|NCT01937715|16320501|P2|Overall Study|Death|0
4731622|NCT01937715|16320502|P1|Overall Study|Death|0
4731623|NCT01937559|16320654|P3|Overall Study|screen fail|0
4731624|NCT01937559|16320655|P2|Overall Study|screen fail|4
4731625|NCT01937559|16320656|P1|Overall Study|screen fail|2
4731626|NCT01937559|16320654|P3|Overall Study|Withdrawal by Subject|0
4731627|NCT01937559|16320655|P2|Overall Study|Withdrawal by Subject|4
4731628|NCT01937559|16320656|P1|Overall Study|Withdrawal by Subject|6
4731629|NCT01937559|16320654|P3|Overall Study|Physician Decision|0
4731630|NCT01937559|16320655|P2|Overall Study|Physician Decision|3
4731631|NCT01937559|16320656|P1|Overall Study|Physician Decision|3
4731632|NCT01937390|16320726|P1|Overall Study|Fail to return|21
4731633|NCT01937390|16320726|P1|Overall Study|Withdrawal by Subject|5
4731634|NCT01937390|16320726|P1|Overall Study|Lost to Follow-up|7
4731635|NCT01937390|16320726|P1|Overall Study|Death|2
4731636|NCT01937364|16320736|P2|Overall Study|Adverse Event|1
4731637|NCT01937364|16320737|P1|Overall Study|Adverse Event|2
4731638|NCT01937351|16320749|P2|Overall Study|Not treated w device, per protocol fail|0
4731639|NCT01937351|16320750|P1|Overall Study|Not treated w device, per protocol fail|4
4731640|NCT01937351|16320749|P2|Overall Study|Death|0
4731641|NCT01937351|16320750|P1|Overall Study|Death|1
4731642|NCT01937351|16320749|P2|Overall Study|Withdrawal by Subject|2
4731643|NCT01937351|16320750|P1|Overall Study|Withdrawal by Subject|4
4731644|NCT01937312|16320758|P2|Overall Study|Withdrawal of subject prior to treatment|1
4731645|NCT01937312|16320759|P1|Overall Study|Withdrawal of subject prior to treatment|1
4731646|NCT01937312|16320758|P2|Overall Study|Lack of Efficacy|1
4731647|NCT01937312|16320759|P1|Overall Study|Lack of Efficacy|0
4731648|NCT01937312|16320758|P2|Overall Study|Adverse Event|1
4731649|NCT01937312|16320759|P1|Overall Study|Adverse Event|10
4731650|NCT01937299|16320774|P2|Overall Study|Withdrawal by Subject|0
4731651|NCT01937299|16320775|P1|Overall Study|Withdrawal by Subject|1
4731652|NCT01937299|16320774|P2|Overall Study|Lack of Efficacy|4
4731653|NCT01937299|16320775|P1|Overall Study|Lack of Efficacy|0
4731654|NCT01937299|16320774|P2|Overall Study|Adverse Event|0
4731655|NCT01937299|16320775|P1|Overall Study|Adverse Event|13
4731656|NCT01937130|16320810|P4|Overall Study|Patient lost to FU due to death|0
4731657|NCT01937130|16320811|P3|Overall Study|Patient lost to FU due to death|0
4731658|NCT01937130|16320812|P2|Overall Study|Patient lost to FU due to death|0
4731659|NCT01937130|16320813|P1|Overall Study|Patient lost to FU due to death|2
4731660|NCT01937130|16320810|P4|Overall Study|Patients unable to swallow|0
4731661|NCT01937130|16320811|P3|Overall Study|Patients unable to swallow|0
4731662|NCT01937130|16320812|P2|Overall Study|Patients unable to swallow|1
4731663|NCT01937130|16320813|P1|Overall Study|Patients unable to swallow|0
4731664|NCT01937130|16320810|P4|Overall Study|Physician Decision|0
4731665|NCT01937130|16320811|P3|Overall Study|Physician Decision|0
4731666|NCT01937130|16320812|P2|Overall Study|Physician Decision|1
4731667|NCT01937130|16320813|P1|Overall Study|Physician Decision|0
4731668|NCT01937130|16320810|P4|Overall Study|Lost to Follow-up|0
4731669|NCT01937130|16320811|P3|Overall Study|Lost to Follow-up|2
4731670|NCT01937130|16320812|P2|Overall Study|Lost to Follow-up|0
4731671|NCT01937130|16320813|P1|Overall Study|Lost to Follow-up|2
4731672|NCT01937130|16320810|P4|Overall Study|Death|0
4731673|NCT01937130|16320811|P3|Overall Study|Death|1
4731674|NCT01937130|16320812|P2|Overall Study|Death|1
4731675|NCT01937130|16320813|P1|Overall Study|Death|1
4731676|NCT01937130|16320810|P4|Overall Study|Adverse Event|1
4731677|NCT01937130|16320811|P3|Overall Study|Adverse Event|0
4731678|NCT01937130|16320812|P2|Overall Study|Adverse Event|1
4731679|NCT01937130|16320813|P1|Overall Study|Adverse Event|0
4731680|NCT01937130|16320810|P4|Overall Study|Withdrawal by Subject|1
4731681|NCT01937130|16320811|P3|Overall Study|Withdrawal by Subject|0
4731682|NCT01937130|16320812|P2|Overall Study|Withdrawal by Subject|0
4731683|NCT01937130|16320813|P1|Overall Study|Withdrawal by Subject|0
4731684|NCT01937117|16320840|P1|Overall Study|Adverse Event|2
4731685|NCT01937117|16320840|P1|Overall Study|Physician Decision|4
4731686|NCT01937117|16320840|P1|Overall Study|Disease Progression|7
4731687|NCT01936974|16320855|P2|Overall Study|Physician Decision|5
4731688|NCT01936974|16320856|P1|Overall Study|Physician Decision|2
4731689|NCT01936870|16320886|P1|Overall Study|No Drug Administration|1
4731690|NCT01936870|16320886|P1|Overall Study|Protocol Violation|12
4731691|NCT01936870|16320886|P1|Overall Study|No Visit After Treatment|176
4731692|NCT01936857|16320901|P2|Overall Study|Other|2
4731693|NCT01936857|16320902|P1|Overall Study|Other|2
4731694|NCT01936857|16320901|P2|Overall Study|Side effect of medication|0
4731695|NCT01936857|16320902|P1|Overall Study|Side effect of medication|1
4731696|NCT01936857|16320901|P2|Overall Study|Withdrawal by Subject|0
4731697|NCT01936857|16320902|P1|Overall Study|Withdrawal by Subject|1
4731698|NCT01936857|16320901|P2|Overall Study|Moved|1
4731699|NCT01936857|16320902|P1|Overall Study|Moved|2
4731700|NCT01936857|16320901|P2|Overall Study|Death|3
4731701|NCT01936857|16320902|P1|Overall Study|Death|7
4731702|NCT01936857|16320901|P2|Overall Study|Lost to Follow-up|7
4731703|NCT01936857|16320902|P1|Overall Study|Lost to Follow-up|10
4731704|NCT01936857|16320901|P2|Overall Study|Sent to prison or 06 center|12
4731705|NCT01936857|16320902|P1|Overall Study|Sent to prison or 06 center|11
4731706|NCT01936649|16320932|P1|Overall Study|Other than specified above|5
4731707|NCT01936649|16320932|P1|Overall Study|Protocol Violation|2
4731708|NCT01936649|16320932|P1|Overall Study|Physician Decision|2
4731709|NCT01936649|16320932|P1|Overall Study|Withdrawal by Subject|4
4731710|NCT01936623|16320939|P2|Overall Study|Lost to Follow-up|5
4731711|NCT01936623|16320940|P1|Overall Study|Lost to Follow-up|0
4731712|NCT01936181|16321048|P4|Transition-extension|Withdrawal by Subject|1
4731713|NCT01936181|16321049|P3|Transition-extension|Withdrawal by Subject|2
4731714|NCT01936181|16321050|P2|Transition-extension|Withdrawal by Subject|0
4731715|NCT01936181|16321051|P1|Transition-extension|Withdrawal by Subject|7
4731716|NCT01936181|16321048|P4|Transition-extension|Physician Decision|1
4731717|NCT01936181|16321049|P3|Transition-extension|Physician Decision|0
4731718|NCT01936181|16321050|P2|Transition-extension|Physician Decision|0
4731719|NCT01936181|16321051|P1|Transition-extension|Physician Decision|2
4731720|NCT01936181|16321048|P4|Transition-extension|Lost to Follow-up|2
4731721|NCT01936181|16321049|P3|Transition-extension|Lost to Follow-up|1
4731722|NCT01936181|16321050|P2|Transition-extension|Lost to Follow-up|0
4731723|NCT01936181|16321051|P1|Transition-extension|Lost to Follow-up|3
4731724|NCT01936181|16321048|P4|Transition-extension|Adverse Event|1
4731725|NCT01936181|16321049|P3|Transition-extension|Adverse Event|3
4731726|NCT01936181|16321050|P2|Transition-extension|Adverse Event|0
4731727|NCT01936181|16321051|P1|Transition-extension|Adverse Event|3
4731728|NCT01936181|16321048|P4|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
4731729|NCT01936181|16321049|P3|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0
4731730|NCT01936181|16321050|P2|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
4731731|NCT01936181|16321051|P1|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4
4731732|NCT01936181|16321048|P4|Randomised, Double-blind|Withdrawal by Subject|0
4731733|NCT01936181|16321049|P3|Randomised, Double-blind|Withdrawal by Subject|0
4731734|NCT01936181|16321050|P2|Randomised, Double-blind|Withdrawal by Subject|26
4731735|NCT01936181|16321051|P1|Randomised, Double-blind|Withdrawal by Subject|23
4731736|NCT01936181|16321048|P4|Randomised, Double-blind|Physician Decision|0
4731737|NCT01936181|16321049|P3|Randomised, Double-blind|Physician Decision|0
4731738|NCT01936181|16321050|P2|Randomised, Double-blind|Physician Decision|4
4731739|NCT01936181|16321051|P1|Randomised, Double-blind|Physician Decision|4
4731740|NCT01936181|16321048|P4|Randomised, Double-blind|Pregnancy|0
4731741|NCT01936181|16321049|P3|Randomised, Double-blind|Pregnancy|0
4731742|NCT01936181|16321050|P2|Randomised, Double-blind|Pregnancy|1
4731743|NCT01936181|16321051|P1|Randomised, Double-blind|Pregnancy|0
4731744|NCT01936181|16321048|P4|Randomised, Double-blind|Lost to Follow-up|0
4731745|NCT01936181|16321049|P3|Randomised, Double-blind|Lost to Follow-up|0
4731746|NCT01936181|16321050|P2|Randomised, Double-blind|Lost to Follow-up|1
4731747|NCT01936181|16321051|P1|Randomised, Double-blind|Lost to Follow-up|0
4731748|NCT01936181|16321048|P4|Randomised, Double-blind|Lack of Efficacy|0
4731749|NCT01936181|16321049|P3|Randomised, Double-blind|Lack of Efficacy|0
4731750|NCT01936181|16321050|P2|Randomised, Double-blind|Lack of Efficacy|6
4731751|NCT01936181|16321051|P1|Randomised, Double-blind|Lack of Efficacy|5
4731752|NCT01936181|16321048|P4|Randomised, Double-blind|Protocol Violation|0
4731753|NCT01936181|16321049|P3|Randomised, Double-blind|Protocol Violation|0
4731754|NCT01936181|16321050|P2|Randomised, Double-blind|Protocol Violation|5
4731755|NCT01936181|16321051|P1|Randomised, Double-blind|Protocol Violation|1
4731756|NCT01936181|16321048|P4|Randomised, Double-blind|Adverse Event|0
4731757|NCT01936181|16321049|P3|Randomised, Double-blind|Adverse Event|0
4731758|NCT01936181|16321050|P2|Randomised, Double-blind|Adverse Event|21
4731759|NCT01936181|16321051|P1|Randomised, Double-blind|Adverse Event|27
4731760|NCT01935947|16321065|P3|Overall Study|Death|0
4731761|NCT01935947|16321066|P2|Overall Study|Death|0
4731762|NCT01935947|16321067|P1|Overall Study|Death|1
4731763|NCT01935947|16321065|P3|Overall Study|Diease Progression|2
4731764|NCT01935947|16321066|P2|Overall Study|Diease Progression|2
4731765|NCT01935947|16321067|P1|Overall Study|Diease Progression|2
4731766|NCT01935947|16321065|P3|Overall Study|Adverse Event|0
4731767|NCT01935947|16321066|P2|Overall Study|Adverse Event|2
4731768|NCT01935947|16321067|P1|Overall Study|Adverse Event|0
4731769|NCT01935700|16321102|P2|Overall Study|Physician Decision|0
4731770|NCT01935700|16321103|P1|Overall Study|Physician Decision|4
4731771|NCT01935700|16321102|P2|Overall Study|Withdrawal by Subject|0
4731772|NCT01935700|16321103|P1|Overall Study|Withdrawal by Subject|1
4731773|NCT01934972|16321147|P2|Overall Study|Withdrawal by Subject|6
4731774|NCT01934972|16321148|P1|Overall Study|Withdrawal by Subject|9
4731775|NCT01934894|16321178|P2|Overall Study|Progressive Disease|2
4731776|NCT01934894|16321179|P1|Overall Study|Progressive Disease|3
4731777|NCT01934894|16321178|P2|Overall Study|Withdrawal by Subject|1
4731778|NCT01934894|16321179|P1|Overall Study|Withdrawal by Subject|0
4731779|NCT01934894|16321178|P2|Overall Study|Death|0
4731780|NCT01934894|16321179|P1|Overall Study|Death|2
4731781|NCT01934894|16321178|P2|Overall Study|Adverse Event|2
4731782|NCT01934894|16321179|P1|Overall Study|Adverse Event|1
4731783|NCT01934790|16321194|P1|Active Follow up|Other reason|1
4731784|NCT01934790|16321194|P1|Active Follow up|Progressive disease|1
4731785|NCT01934790|16321194|P1|Active Follow up|Physician Decision|2
4731786|NCT01934790|16321194|P1|Active Follow up|Death|20
4731787|NCT01934790|16321194|P1|Treatment|Study drug never administered|1
4731788|NCT01934790|16321194|P1|Treatment|Withdrawal by Subject|2
4731789|NCT01934790|16321194|P1|Treatment|Radiological progression|4
4731790|NCT01934790|16321194|P1|Treatment|Clinical progression|6
4731791|NCT01934790|16321194|P1|Treatment|Adverse Event|3
4731792|NCT01934504|16321261|P4|Overall Study|Study Terminated by Sponsor|5
4731793|NCT01934504|16321262|P3|Overall Study|Study Terminated by Sponsor|5
4731794|NCT01934504|16321263|P2|Overall Study|Study Terminated by Sponsor|0
4731795|NCT01934504|16321264|P1|Overall Study|Study Terminated by Sponsor|1
4731796|NCT01934504|16321261|P4|Overall Study|Protocol Deviation|2
4731797|NCT01934504|16321262|P3|Overall Study|Protocol Deviation|0
4731798|NCT01934504|16321263|P2|Overall Study|Protocol Deviation|0
4731799|NCT01934504|16321264|P1|Overall Study|Protocol Deviation|0
4731800|NCT01934218|16321297|P2|Open-Label Phase|Failure to Exam Primary Evaluation|1
4731801|NCT01934218|16321298|P1|Open-Label Phase|Failure to Exam Primary Evaluation|0
4731802|NCT01934218|16321297|P2|Open-Label Phase|Noncompliance with Study Protocol|2
4731803|NCT01934218|16321298|P1|Open-Label Phase|Noncompliance with Study Protocol|4
4731804|NCT01934218|16321297|P2|Open-Label Phase|Withdrawal by Subject|11
4731805|NCT01934218|16321298|P1|Open-Label Phase|Withdrawal by Subject|13
4731806|NCT01934218|16321297|P2|Open-Label Phase|Protocol Violation|0
4731807|NCT01934218|16321298|P1|Open-Label Phase|Protocol Violation|1
4731808|NCT01934218|16321297|P2|Open-Label Phase|Physician Decision|0
4731809|NCT01934218|16321298|P1|Open-Label Phase|Physician Decision|1
4731810|NCT01934218|16321297|P2|Open-Label Phase|Lost to Follow-up|2
4731811|NCT01934218|16321298|P1|Open-Label Phase|Lost to Follow-up|4
4731812|NCT01934218|16321297|P2|Open-Label Phase|Lack of Efficacy|4
4731813|NCT01934218|16321298|P1|Open-Label Phase|Lack of Efficacy|1
4731814|NCT01934218|16321297|P2|Open-Label Phase|Adverse Event|4
4731815|NCT01934218|16321298|P1|Open-Label Phase|Adverse Event|2
4731816|NCT01934218|16321297|P2|Double-blind Phase|Protocol Violation of Study Eligibility|2
4731817|NCT01934218|16321298|P1|Double-blind Phase|Protocol Violation of Study Eligibility|1
4731818|NCT01934218|16321297|P2|Double-blind Phase|Noncompliance with Study Protocol|8
4731819|NCT01934218|16321298|P1|Double-blind Phase|Noncompliance with Study Protocol|5
4731820|NCT01934218|16321297|P2|Double-blind Phase|Withdrawal by Subject|13
4731821|NCT01934218|16321298|P1|Double-blind Phase|Withdrawal by Subject|16
4731822|NCT01934218|16321297|P2|Double-blind Phase|Protocol Violation|0
4731823|NCT01934218|16321298|P1|Double-blind Phase|Protocol Violation|4
4731824|NCT01934218|16321297|P2|Double-blind Phase|Physician Decision|2
4731825|NCT01934218|16321298|P1|Double-blind Phase|Physician Decision|1
4731826|NCT01934218|16321297|P2|Double-blind Phase|Lost to Follow-up|14
4731827|NCT01934218|16321298|P1|Double-blind Phase|Lost to Follow-up|7
4731828|NCT01934218|16321297|P2|Double-blind Phase|Lack of Efficacy|7
4731829|NCT01934218|16321298|P1|Double-blind Phase|Lack of Efficacy|6
4731830|NCT01934218|16321297|P2|Double-blind Phase|Adverse Event|8
4731831|NCT01934218|16321298|P1|Double-blind Phase|Adverse Event|8
4731832|NCT01934192|16321309|P4|Overall Study|Physician Decision|0
4731833|NCT01934192|16321310|P3|Overall Study|Physician Decision|0
4731834|NCT01934192|16321311|P2|Overall Study|Physician Decision|2
4731835|NCT01934192|16321312|P1|Overall Study|Physician Decision|3
4731836|NCT01934192|16321309|P4|Overall Study|Other: reached stopping criteria|0
4731837|NCT01934192|16321310|P3|Overall Study|Other: reached stopping criteria|1
4731838|NCT01934192|16321311|P2|Overall Study|Other: reached stopping criteria|5
4731839|NCT01934192|16321312|P1|Overall Study|Other: reached stopping criteria|6
4731840|NCT01934192|16321309|P4|Overall Study|Protocol Violation|1
4731841|NCT01934192|16321310|P3|Overall Study|Protocol Violation|0
4731842|NCT01934192|16321311|P2|Overall Study|Protocol Violation|0
4731843|NCT01934192|16321312|P1|Overall Study|Protocol Violation|0
4731844|NCT01934140|16321448|P2|Booster Phase (6 Months)|Migrated/moved from study area|2
4731845|NCT01934140|16321449|P1|Booster Phase (6 Months)|Migrated/moved from study area|2
4731846|NCT01934140|16321448|P2|Booster Phase (6 Months)|Missed at least 1 booster visit|1
4731847|NCT01934140|16321449|P1|Booster Phase (6 Months)|Missed at least 1 booster visit|2
4731848|NCT01934140|16321448|P2|Booster Phase (6 Months)|Lost to Follow-up|0
4731849|NCT01934140|16321449|P1|Booster Phase (6 Months)|Lost to Follow-up|1
4731850|NCT01934140|16321448|P2|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7
4731851|NCT01934140|16321449|P1|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21
4731852|NCT01934140|16321448|P2|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0
4731853|NCT01934140|16321449|P1|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2
4731854|NCT01934140|16321448|P2|Persistence Phase (Year 6-10)|Migrated/moved from study area|10
4731855|NCT01934140|16321449|P1|Persistence Phase (Year 6-10)|Migrated/moved from study area|31
4731856|NCT01934140|16321448|P2|Persistence Phase (Year 6-10)|Lost to Follow-up|2
4731857|NCT01934140|16321449|P1|Persistence Phase (Year 6-10)|Lost to Follow-up|5
4731858|NCT01934140|16321448|P2|Persistence Phase (Year 6-10)|Other|6
4731859|NCT01934140|16321449|P1|Persistence Phase (Year 6-10)|Other|24
4731860|NCT01934010|16321500|P3|Overall Study|Lost to Follow-up|0
4731861|NCT01934010|16321501|P2|Overall Study|Lost to Follow-up|4
4731862|NCT01934010|16321502|P1|Overall Study|Lost to Follow-up|7
4731863|NCT01934010|16321500|P3|Overall Study|Withdrawal by Subject|2
4731864|NCT01934010|16321501|P2|Overall Study|Withdrawal by Subject|6
4731865|NCT01934010|16321502|P1|Overall Study|Withdrawal by Subject|15
4731866|NCT01934010|16321500|P3|Overall Study|Adverse Event|0
4731867|NCT01934010|16321501|P2|Overall Study|Adverse Event|1
4731868|NCT01934010|16321502|P1|Overall Study|Adverse Event|1
4731869|NCT01933932|16321544|P2|Overall Study|Eligibility criteria not fulfilled|1
4731870|NCT01933932|16321545|P1|Overall Study|Eligibility criteria not fulfilled|0
4731871|NCT01933932|16321544|P2|Overall Study|Withdrawal by Subject|14
4731872|NCT01933932|16321545|P1|Overall Study|Withdrawal by Subject|11
4731873|NCT01933932|16321544|P2|Overall Study|Death|163
4731874|NCT01933932|16321545|P1|Overall Study|Death|173
4731875|NCT01933919|16321563|P2|Open-label Long-term Phase|Other|2
4731876|NCT01933919|16321564|P1|Open-label Long-term Phase|Other|1
4731877|NCT01933919|16321563|P2|Open-label Long-term Phase|Lost to Follow-up|0
4731878|NCT01933919|16321564|P1|Open-label Long-term Phase|Lost to Follow-up|1
4731879|NCT01933919|16321563|P2|Open-label Long-term Phase|Withdrawal by Subject|4
4731880|NCT01933919|16321564|P1|Open-label Long-term Phase|Withdrawal by Subject|3
4731881|NCT01933919|16321563|P2|Open-label Long-term Phase|Adverse Event|0
4731882|NCT01933919|16321564|P1|Open-label Long-term Phase|Adverse Event|2
4731883|NCT01933919|16321563|P2|Double-blind Placebo-controlled Phase|Lack of Efficacy|2
4731884|NCT01933919|16321564|P1|Double-blind Placebo-controlled Phase|Lack of Efficacy|0
4731885|NCT01933919|16321563|P2|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1
4731886|NCT01933919|16321564|P1|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0
4731887|NCT01933919|16321563|P2|Double-blind Placebo-controlled Phase|Adverse Event|1
4731888|NCT01933919|16321564|P1|Double-blind Placebo-controlled Phase|Adverse Event|0
4731889|NCT01933880|16321600|P2|Overall Study|Protocol Violation|0
4731890|NCT01933880|16321601|P1|Overall Study|Protocol Violation|1
4731891|NCT01933880|16321600|P2|Overall Study|Other|0
4731892|NCT01933880|16321601|P1|Overall Study|Other|4
4731893|NCT01933880|16321600|P2|Overall Study|Followup exceeded 4 days to visit window|0
4731894|NCT01933880|16321601|P1|Overall Study|Followup exceeded 4 days to visit window|19
4731895|NCT01933880|16321600|P2|Overall Study|Concomitant medication Interference|1
4731896|NCT01933880|16321601|P1|Overall Study|Concomitant medication Interference|0
4731897|NCT01933880|16321600|P2|Overall Study|Lack of Efficacy|0
4731898|NCT01933880|16321601|P1|Overall Study|Lack of Efficacy|1
4731899|NCT01933880|16321600|P2|Overall Study|Withdrawal by Subject|0
4731900|NCT01933880|16321601|P1|Overall Study|Withdrawal by Subject|5
4731901|NCT01933789|16321675|P9|Overall Study|Became Ineligible|0
4731902|NCT01933789|16321676|P8|Overall Study|Became Ineligible|6
4731903|NCT01933789|16321677|P7|Overall Study|Became Ineligible|13
4731904|NCT01933789|16321678|P6|Overall Study|Became Ineligible|10
4731905|NCT01933789|16321679|P5|Overall Study|Became Ineligible|13
4731906|NCT01933789|16321680|P4|Overall Study|Became Ineligible|0
4731907|NCT01933789|16321681|P3|Overall Study|Became Ineligible|0
4731908|NCT01933789|16321682|P2|Overall Study|Became Ineligible|0
4731909|NCT01933789|16321683|P1|Overall Study|Became Ineligible|4
4731910|NCT01933789|16321675|P9|Overall Study|Withdrawal by Subject|0
4731911|NCT01933789|16321676|P8|Overall Study|Withdrawal by Subject|4
4731912|NCT01933789|16321677|P7|Overall Study|Withdrawal by Subject|1
4731913|NCT01933789|16321678|P6|Overall Study|Withdrawal by Subject|16
4731914|NCT01933789|16321679|P5|Overall Study|Withdrawal by Subject|17
4731915|NCT01933789|16321680|P4|Overall Study|Withdrawal by Subject|0
4731916|NCT01933789|16321681|P3|Overall Study|Withdrawal by Subject|0
4731917|NCT01933789|16321682|P2|Overall Study|Withdrawal by Subject|1
4731918|NCT01933789|16321683|P1|Overall Study|Withdrawal by Subject|2
4731919|NCT01933789|16321675|P9|Overall Study|Lost to Follow-up|0
4731920|NCT01933789|16321676|P8|Overall Study|Lost to Follow-up|4
4731921|NCT01933789|16321677|P7|Overall Study|Lost to Follow-up|1
4731922|NCT01933789|16321678|P6|Overall Study|Lost to Follow-up|9
4731923|NCT01933789|16321679|P5|Overall Study|Lost to Follow-up|8
4731924|NCT01933789|16321680|P4|Overall Study|Lost to Follow-up|1
4731925|NCT01933789|16321681|P3|Overall Study|Lost to Follow-up|0
4731926|NCT01933789|16321682|P2|Overall Study|Lost to Follow-up|0
4731927|NCT01933789|16321683|P1|Overall Study|Lost to Follow-up|0
4731928|NCT01933789|16321675|P9|Overall Study|Death|0
4731929|NCT01933789|16321676|P8|Overall Study|Death|0
4731930|NCT01933789|16321677|P7|Overall Study|Death|0
4731931|NCT01933789|16321678|P6|Overall Study|Death|32
4731932|NCT01933789|16321679|P5|Overall Study|Death|21
4731933|NCT01933789|16321680|P4|Overall Study|Death|0
4731934|NCT01933789|16321681|P3|Overall Study|Death|0
4731935|NCT01933789|16321682|P2|Overall Study|Death|0
4731936|NCT01933789|16321683|P1|Overall Study|Death|0
4731937|NCT01933672|16321993|P7|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4731938|NCT01933672|16321994|P6|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4731939|NCT01933672|16321995|P5|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4731940|NCT01933672|16321996|P4|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4731941|NCT01933672|16321997|P3|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4731942|NCT01933672|16321998|P2|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1
4731943|NCT01933672|16321999|P1|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0
4731944|NCT01933672|16321993|P7|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4731945|NCT01933672|16321994|P6|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4731946|NCT01933672|16321995|P5|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4731947|NCT01933672|16321996|P4|Third Intervention Period (12-16 Days)|Lost to Follow-up|1
4731948|NCT01933672|16321997|P3|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4731949|NCT01933672|16321998|P2|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4731950|NCT01933672|16321999|P1|Third Intervention Period (12-16 Days)|Lost to Follow-up|0
4731951|NCT01933672|16321993|P7|Second Intervention Period (12-16 Days)|Other|0
4731952|NCT01933672|16321994|P6|Second Intervention Period (12-16 Days)|Other|0
4731953|NCT01933672|16321995|P5|Second Intervention Period (12-16 Days)|Other|0
4731954|NCT01933672|16321996|P4|Second Intervention Period (12-16 Days)|Other|0
4731955|NCT01933672|16321997|P3|Second Intervention Period (12-16 Days)|Other|1
4731956|NCT01933672|16321998|P2|Second Intervention Period (12-16 Days)|Other|1
4731957|NCT01933672|16321999|P1|Second Intervention Period (12-16 Days)|Other|0
4731958|NCT01933672|16321993|P7|First Intervention Period (12-16 Days)|Other|0
4731959|NCT01933672|16321994|P6|First Intervention Period (12-16 Days)|Other|1
4731960|NCT01933672|16321995|P5|First Intervention Period (12-16 Days)|Other|0
4731961|NCT01933672|16321996|P4|First Intervention Period (12-16 Days)|Other|0
4731962|NCT01933672|16321997|P3|First Intervention Period (12-16 Days)|Other|1
4731963|NCT01933672|16321998|P2|First Intervention Period (12-16 Days)|Other|0
4731964|NCT01933672|16321999|P1|First Intervention Period (12-16 Days)|Other|0
4731965|NCT01933672|16321993|P7|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4731966|NCT01933672|16321994|P6|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4731967|NCT01933672|16321995|P5|First Intervention Period (12-16 Days)|Lost to Follow-up|1
4731968|NCT01933672|16321996|P4|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4731969|NCT01933672|16321997|P3|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4731970|NCT01933672|16321998|P2|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4731971|NCT01933672|16321999|P1|First Intervention Period (12-16 Days)|Lost to Follow-up|0
4731972|NCT01933672|16321993|P7|Metformin Run-in Period|Other|0
4731973|NCT01933672|16321994|P6|Metformin Run-in Period|Other|0
4731974|NCT01933672|16321995|P5|Metformin Run-in Period|Other|0
4731975|NCT01933672|16321996|P4|Metformin Run-in Period|Other|0
4731976|NCT01933672|16321997|P3|Metformin Run-in Period|Other|0
4731977|NCT01933672|16321998|P2|Metformin Run-in Period|Other|0
4731978|NCT01933672|16321999|P1|Metformin Run-in Period|Other|5
4731979|NCT01933672|16321993|P7|Metformin Run-in Period|No longer meets eligibility criteria|0
4731980|NCT01933672|16321994|P6|Metformin Run-in Period|No longer meets eligibility criteria|0
4731981|NCT01933672|16321995|P5|Metformin Run-in Period|No longer meets eligibility criteria|0
4731982|NCT01933672|16321996|P4|Metformin Run-in Period|No longer meets eligibility criteria|0
4731983|NCT01933672|16321997|P3|Metformin Run-in Period|No longer meets eligibility criteria|0
4731984|NCT01933672|16321998|P2|Metformin Run-in Period|No longer meets eligibility criteria|0
4731985|NCT01933672|16321999|P1|Metformin Run-in Period|No longer meets eligibility criteria|4
4731986|NCT01933672|16321993|P7|Metformin Run-in Period|Adverse Event|0
4731987|NCT01933672|16321994|P6|Metformin Run-in Period|Adverse Event|0
4731988|NCT01933672|16321995|P5|Metformin Run-in Period|Adverse Event|0
4731989|NCT01933672|16321996|P4|Metformin Run-in Period|Adverse Event|0
4731990|NCT01933672|16321997|P3|Metformin Run-in Period|Adverse Event|0
4731991|NCT01933672|16321998|P2|Metformin Run-in Period|Adverse Event|0
4731992|NCT01933672|16321999|P1|Metformin Run-in Period|Adverse Event|1
4731993|NCT01933594|16322051|P6|Overall Study|Ineligible for subsequent study step|0
4731994|NCT01933594|16322052|P5|Overall Study|Ineligible for subsequent study step|1
4731995|NCT01933594|16322053|P4|Overall Study|Ineligible for subsequent study step|0
4731996|NCT01933594|16322054|P3|Overall Study|Ineligible for subsequent study step|0
4731997|NCT01933594|16322055|P2|Overall Study|Ineligible for subsequent study step|0
4731998|NCT01933594|16322056|P1|Overall Study|Ineligible for subsequent study step|0
4731999|NCT01933594|16322051|P6|Overall Study|Lost to Follow-up|0
4732000|NCT01933594|16322052|P5|Overall Study|Lost to Follow-up|1
4732001|NCT01933594|16322053|P4|Overall Study|Lost to Follow-up|0
4732002|NCT01933594|16322054|P3|Overall Study|Lost to Follow-up|0
4732003|NCT01933594|16322055|P2|Overall Study|Lost to Follow-up|0
4732004|NCT01933594|16322056|P1|Overall Study|Lost to Follow-up|1
4732005|NCT01933334|16322190|P2|Overall Study|Withdrawal by Subject|1
4732006|NCT01933334|16322191|P1|Overall Study|Withdrawal by Subject|0
4732007|NCT01933334|16322190|P2|Overall Study|Adverse Event|1
4732008|NCT01933334|16322191|P1|Overall Study|Adverse Event|5
4732009|NCT01933217|16322220|P2|Randomization (4 Weeks)|Lost to Follow-up|1
4732010|NCT01933217|16322221|P1|Randomization (4 Weeks)|Lost to Follow-up|1
4732011|NCT01933217|16322220|P2|Randomization (4 Weeks)|Withdrawal by Subject|3
4732012|NCT01933217|16322221|P1|Randomization (4 Weeks)|Withdrawal by Subject|1
4732013|NCT01933113|16322233|P1|Overall Study|Fractured nonfunctioning lead.|1
4732014|NCT01933048|16322239|P2|Overall Study|unknown reasons|1
4732015|NCT01933048|16322240|P1|Overall Study|unknown reasons|1
4732016|NCT01933048|16322239|P2|Overall Study|Physician Decision|0
4732017|NCT01933048|16322240|P1|Overall Study|Physician Decision|1
4732018|NCT01933048|16322239|P2|Overall Study|Protocol Violation|8
4732019|NCT01933048|16322240|P1|Overall Study|Protocol Violation|7
4732020|NCT01933048|16322239|P2|Overall Study|personal reasons|1
4732021|NCT01933048|16322240|P1|Overall Study|personal reasons|1
4732022|NCT01933048|16322239|P2|Overall Study|Lost to Follow-up|18
4732023|NCT01933048|16322240|P1|Overall Study|Lost to Follow-up|15
4732024|NCT01932970|16322253|P1|Overall Study|Protocol Specified Criteria|10
4732025|NCT01932970|16322253|P1|Overall Study|Lost to Follow-up|2
4732026|NCT01932970|16322253|P1|Overall Study|Death|1
4732027|NCT01932970|16322253|P1|Overall Study|Withdrawal by Subject|5
4732028|NCT01932788|16322263|P2|Overall Study|Withdrawal by Subject|5
4732029|NCT01932788|16322264|P1|Overall Study|Withdrawal by Subject|0
4732030|NCT01932788|16322263|P2|Overall Study|Lack of Efficacy|0
4732031|NCT01932788|16322264|P1|Overall Study|Lack of Efficacy|2
4732032|NCT01932788|16322263|P2|Overall Study|Lost to Follow-up|46
4732033|NCT01932788|16322264|P1|Overall Study|Lost to Follow-up|18
4732034|NCT01932788|16322263|P2|Overall Study|Protocol Violation|0
4732035|NCT01932788|16322264|P1|Overall Study|Protocol Violation|18
4732036|NCT01932762|16322274|P4|Overall Study|Physician Decision|0
4732037|NCT01932762|16322275|P3|Overall Study|Physician Decision|0
4732038|NCT01932762|16322276|P2|Overall Study|Physician Decision|0
4732039|NCT01932762|16322277|P1|Overall Study|Physician Decision|1
4732040|NCT01932762|16322274|P4|Overall Study|Lost to Follow-up|1
4732041|NCT01932762|16322275|P3|Overall Study|Lost to Follow-up|0
4732042|NCT01932762|16322276|P2|Overall Study|Lost to Follow-up|0
4732043|NCT01932762|16322277|P1|Overall Study|Lost to Follow-up|4
4732044|NCT01932762|16322274|P4|Overall Study|Withdrawal by Subject|0
4732045|NCT01932762|16322275|P3|Overall Study|Withdrawal by Subject|0
4732046|NCT01932762|16322276|P2|Overall Study|Withdrawal by Subject|2
4732047|NCT01932762|16322277|P1|Overall Study|Withdrawal by Subject|1
4732048|NCT01932697|16322313|P2|Overall Study|Ineligible|0
4732049|NCT01932697|16322314|P1|Overall Study|Ineligible|1
4732050|NCT01932697|16322313|P2|Overall Study|Received a different amount of tx|0
4732051|NCT01932697|16322314|P1|Overall Study|Received a different amount of tx|1
4732052|NCT01932437|16322381|P6|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1
4732053|NCT01932437|16322382|P5|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4732054|NCT01932437|16322383|P4|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4732055|NCT01932437|16322384|P3|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4732056|NCT01932437|16322385|P2|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4732057|NCT01932437|16322386|P1|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0
4732058|NCT01932294|16322436|P1|Overall Study|Transferred to other hospitals|12
4732059|NCT01932294|16322436|P1|Overall Study|Heart Transplantation|16
4732060|NCT01932294|16322436|P1|Overall Study|VAD Implantation|20
4732061|NCT01932294|16322436|P1|Overall Study|Lost to Follow-up|8
4732062|NCT01932294|16322436|P1|Overall Study|Death|43
4732063|NCT01931956|16322513|P4|Overall Study|Not due|0
4732064|NCT01931956|16322514|P3|Overall Study|Not due|21
4732065|NCT01931956|16322515|P2|Overall Study|Not due|0
4732066|NCT01931956|16322516|P1|Overall Study|Not due|0
4732067|NCT01931956|16322513|P4|Overall Study|Expected|0
4732068|NCT01931956|16322514|P3|Overall Study|Expected|6
4732069|NCT01931956|16322515|P2|Overall Study|Expected|0
4732070|NCT01931956|16322516|P1|Overall Study|Expected|2
4732071|NCT01931956|16322513|P4|Overall Study|Lost to Follow-up|7
4732072|NCT01931956|16322514|P3|Overall Study|Lost to Follow-up|11
4732073|NCT01931956|16322515|P2|Overall Study|Lost to Follow-up|0
4732074|NCT01931956|16322516|P1|Overall Study|Lost to Follow-up|2
4732075|NCT01931956|16322513|P4|Overall Study|Withdrawal by Subject|30
4732076|NCT01931956|16322514|P3|Overall Study|Withdrawal by Subject|70
4732077|NCT01931956|16322515|P2|Overall Study|Withdrawal by Subject|0
4732078|NCT01931956|16322516|P1|Overall Study|Withdrawal by Subject|5
4732079|NCT01931956|16322513|P4|Overall Study|Death|96
4732080|NCT01931956|16322514|P3|Overall Study|Death|379
4732081|NCT01931956|16322515|P2|Overall Study|Death|7
4732082|NCT01931956|16322516|P1|Overall Study|Death|42
4732083|NCT01931865|16322883|P1|Overall Study|Withdrawal by Subject|2
4732084|NCT01931865|16322883|P1|Overall Study|Lost to Follow-up|2
4732085|NCT01931839|16322896|P7|Overall Study|Other|0
4732086|NCT01931839|16322897|P6|Overall Study|Other|0
4732087|NCT01931839|16322898|P5|Overall Study|Other|0
4732088|NCT01931839|16322899|P4|Overall Study|Other|0
4732089|NCT01931839|16322900|P3|Overall Study|Other|6
4732090|NCT01931839|16322901|P2|Overall Study|Other|2
4732091|NCT01931839|16322902|P1|Overall Study|Other|4
4732092|NCT01931839|16322896|P7|Overall Study|Lost to Follow-up|0
4732093|NCT01931839|16322897|P6|Overall Study|Lost to Follow-up|0
4732094|NCT01931839|16322898|P5|Overall Study|Lost to Follow-up|0
4732095|NCT01931839|16322899|P4|Overall Study|Lost to Follow-up|5
4732096|NCT01931839|16322900|P3|Overall Study|Lost to Follow-up|4
4732097|NCT01931839|16322901|P2|Overall Study|Lost to Follow-up|2
4732098|NCT01931839|16322902|P1|Overall Study|Lost to Follow-up|1
4732099|NCT01931839|16322896|P7|Overall Study|Other non-compliance|0
4732100|NCT01931839|16322897|P6|Overall Study|Other non-compliance|3
4732101|NCT01931839|16322898|P5|Overall Study|Other non-compliance|0
4732102|NCT01931839|16322899|P4|Overall Study|Other non-compliance|3
4732103|NCT01931839|16322900|P3|Overall Study|Other non-compliance|12
4732104|NCT01931839|16322901|P2|Overall Study|Other non-compliance|9
4732105|NCT01931839|16322902|P1|Overall Study|Other non-compliance|15
4732106|NCT01931839|16322896|P7|Overall Study|Withdrawal of consent (not due to AE)|2
4732107|NCT01931839|16322897|P6|Overall Study|Withdrawal of consent (not due to AE)|2
4732108|NCT01931839|16322898|P5|Overall Study|Withdrawal of consent (not due to AE)|0
4732109|NCT01931839|16322899|P4|Overall Study|Withdrawal of consent (not due to AE)|3
4732110|NCT01931839|16322900|P3|Overall Study|Withdrawal of consent (not due to AE)|13
4732111|NCT01931839|16322901|P2|Overall Study|Withdrawal of consent (not due to AE)|8
4732112|NCT01931839|16322902|P1|Overall Study|Withdrawal of consent (not due to AE)|11
4732113|NCT01931839|16322896|P7|Overall Study|Adverse Event|1
4732114|NCT01931839|16322897|P6|Overall Study|Adverse Event|0
4732115|NCT01931839|16322898|P5|Overall Study|Adverse Event|0
4732116|NCT01931839|16322899|P4|Overall Study|Adverse Event|3
4732117|NCT01931839|16322900|P3|Overall Study|Adverse Event|1
4732118|NCT01931839|16322901|P2|Overall Study|Adverse Event|4
4732119|NCT01931839|16322902|P1|Overall Study|Adverse Event|9
4732120|NCT01931839|16322896|P7|Overall Study|Withdrawal of consent|0
4732121|NCT01931839|16322897|P6|Overall Study|Withdrawal of consent|0
4732122|NCT01931839|16322898|P5|Overall Study|Withdrawal of consent|1
4732123|NCT01931839|16322899|P4|Overall Study|Withdrawal of consent|0
4732124|NCT01931839|16322900|P3|Overall Study|Withdrawal of consent|0
4732125|NCT01931839|16322901|P2|Overall Study|Withdrawal of consent|0
4732126|NCT01931839|16322902|P1|Overall Study|Withdrawal of consent|0
4732127|NCT01931839|16322896|P7|Overall Study|Physician Decision|1
4732128|NCT01931839|16322897|P6|Overall Study|Physician Decision|0
4732129|NCT01931839|16322898|P5|Overall Study|Physician Decision|0
4732130|NCT01931839|16322899|P4|Overall Study|Physician Decision|0
4732131|NCT01931839|16322900|P3|Overall Study|Physician Decision|1
4732132|NCT01931839|16322901|P2|Overall Study|Physician Decision|0
4732133|NCT01931839|16322902|P1|Overall Study|Physician Decision|1
4732134|NCT01931839|16322896|P7|Overall Study|Death|0
4732135|NCT01931839|16322897|P6|Overall Study|Death|0
4732136|NCT01931839|16322898|P5|Overall Study|Death|0
4732137|NCT01931839|16322899|P4|Overall Study|Death|0
4732138|NCT01931839|16322900|P3|Overall Study|Death|2
4732139|NCT01931839|16322901|P2|Overall Study|Death|1
4732140|NCT01931839|16322902|P1|Overall Study|Death|0
4732141|NCT01931735|16322974|P4|Observational Non-Randomized Phase|Withdrawal by Subject|1
4732142|NCT01931735|16322975|P3|Observational Non-Randomized Phase|Withdrawal by Subject|0
4732143|NCT01931735|16322976|P2|Observational Non-Randomized Phase|Withdrawal by Subject|0
4732144|NCT01931735|16322977|P1|Observational Non-Randomized Phase|Withdrawal by Subject|0
4732145|NCT01931735|16322974|P4|Observational Non-Randomized Phase|Adverse Event|1
4732146|NCT01931735|16322975|P3|Observational Non-Randomized Phase|Adverse Event|0
4732147|NCT01931735|16322976|P2|Observational Non-Randomized Phase|Adverse Event|0
4732148|NCT01931735|16322977|P1|Observational Non-Randomized Phase|Adverse Event|0
4732149|NCT01931735|16322974|P4|Randomized Phase|Lost to Follow-up|0
4732150|NCT01931735|16322975|P3|Randomized Phase|Lost to Follow-up|5
4732151|NCT01931735|16322976|P2|Randomized Phase|Lost to Follow-up|2
4732152|NCT01931735|16322977|P1|Randomized Phase|Lost to Follow-up|2
4732153|NCT01931670|16323024|P3|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2
4732154|NCT01931670|16323025|P2|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
4732155|NCT01931670|16323026|P1|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0
4732156|NCT01931670|16323024|P3|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13
4732157|NCT01931670|16323025|P2|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3
4732158|NCT01931670|16323026|P1|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6
4732159|NCT01931670|16323024|P3|Post-Treatment Follow-Up (PTFU) Period|Other|3
4732160|NCT01931670|16323025|P2|Post-Treatment Follow-Up (PTFU) Period|Other|3
4732161|NCT01931670|16323026|P1|Post-Treatment Follow-Up (PTFU) Period|Other|6
4732162|NCT01931670|16323024|P3|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2
4732163|NCT01931670|16323025|P2|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
4732164|NCT01931670|16323026|P1|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4
4732165|NCT01931670|16323024|P3|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1
4732166|NCT01931670|16323025|P2|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2
4732167|NCT01931670|16323026|P1|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0
4732168|NCT01931670|16323024|P3|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
4732169|NCT01931670|16323025|P2|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0
4732170|NCT01931670|16323026|P1|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3
4732171|NCT01931670|16323024|P3|Treatment Period|Lost to Follow-up|7
4732172|NCT01931670|16323025|P2|Treatment Period|Lost to Follow-up|5
4732173|NCT01931670|16323026|P1|Treatment Period|Lost to Follow-up|19
4732174|NCT01931670|16323024|P3|Treatment Period|Consent Withdrawn by Subject|7
4732175|NCT01931670|16323025|P2|Treatment Period|Consent Withdrawn by Subject|12
4732176|NCT01931670|16323026|P1|Treatment Period|Consent Withdrawn by Subject|17
4732177|NCT01931670|16323024|P3|Treatment Period|Other|2
4732178|NCT01931670|16323025|P2|Treatment Period|Other|7
4732179|NCT01931670|16323026|P1|Treatment Period|Other|8
4732180|NCT01931670|16323024|P3|Treatment Period|Pregnancy|0
4732181|NCT01931670|16323025|P2|Treatment Period|Pregnancy|2
4732182|NCT01931670|16323026|P1|Treatment Period|Pregnancy|7
4732183|NCT01931670|16323024|P3|Treatment Period|Lack of Efficacy|2
4732184|NCT01931670|16323025|P2|Treatment Period|Lack of Efficacy|2
4732185|NCT01931670|16323026|P1|Treatment Period|Lack of Efficacy|11
4732186|NCT01931670|16323024|P3|Treatment Period|Adverse Event|21
4732187|NCT01931670|16323025|P2|Treatment Period|Adverse Event|8
4732188|NCT01931670|16323026|P1|Treatment Period|Adverse Event|19
4732189|NCT01931670|16323024|P3|Treatment Period|Subject Noncompliant|5
4732190|NCT01931670|16323025|P2|Treatment Period|Subject Noncompliant|9
4732191|NCT01931670|16323026|P1|Treatment Period|Subject Noncompliant|4
4732192|NCT01931670|16323024|P3|Treatment Period|Surgery/Invasive Intervention|0
4732193|NCT01931670|16323025|P2|Treatment Period|Surgery/Invasive Intervention|2
4732194|NCT01931670|16323026|P1|Treatment Period|Surgery/Invasive Intervention|4
4732278|NCT01930890|16323307|P2|Overall Study|Investigator Decision|1
4732195|NCT01931670|16323024|P3|Treatment Period|Exclusionary Medication Received|1
4732196|NCT01931670|16323025|P2|Treatment Period|Exclusionary Medication Received|1
4732197|NCT01931670|16323026|P1|Treatment Period|Exclusionary Medication Received|1
4732198|NCT01931566|16323127|P3|Overall Study|Missing|1
4732199|NCT01931566|16323128|P2|Overall Study|Missing|0
4732200|NCT01931566|16323129|P1|Overall Study|Missing|0
4732201|NCT01931566|16323127|P3|Overall Study|Reason Not Specified|53
4732202|NCT01931566|16323128|P2|Overall Study|Reason Not Specified|47
4732203|NCT01931566|16323129|P1|Overall Study|Reason Not Specified|11
4732204|NCT01931566|16323127|P3|Overall Study|Study Termination|1037
4732205|NCT01931566|16323128|P2|Overall Study|Study Termination|968
4732206|NCT01931566|16323129|P1|Overall Study|Study Termination|289
4732207|NCT01931566|16323127|P3|Overall Study|Voluntary Withdrawal|225
4732208|NCT01931566|16323128|P2|Overall Study|Voluntary Withdrawal|245
4732209|NCT01931566|16323129|P1|Overall Study|Voluntary Withdrawal|78
4732210|NCT01931566|16323127|P3|Overall Study|Lost to Follow-up|23
4732211|NCT01931566|16323128|P2|Overall Study|Lost to Follow-up|26
4732212|NCT01931566|16323129|P1|Overall Study|Lost to Follow-up|3
4732213|NCT01931566|16323127|P3|Overall Study|Major Protocol Deviation|21
4732214|NCT01931566|16323128|P2|Overall Study|Major Protocol Deviation|14
4732215|NCT01931566|16323129|P1|Overall Study|Major Protocol Deviation|5
4732216|NCT01931566|16323127|P3|Overall Study|Adverse Event|132
4732217|NCT01931566|16323128|P2|Overall Study|Adverse Event|167
4732218|NCT01931566|16323129|P1|Overall Study|Adverse Event|37
4732219|NCT01931566|16323127|P3|Overall Study|Randomized But Not Treated|14
4732220|NCT01931566|16323128|P2|Overall Study|Randomized But Not Treated|9
4732221|NCT01931566|16323129|P1|Overall Study|Randomized But Not Treated|6
4732222|NCT01931475|16323167|P2|Period 2: Extension Treatment Phase|Lack of Efficacy|1
4732223|NCT01931475|16323168|P1|Period 2: Extension Treatment Phase|Lack of Efficacy|1
4732224|NCT01931475|16323167|P2|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0
4732225|NCT01931475|16323168|P1|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1
4732226|NCT01931475|16323167|P2|Period 2: Extension Treatment Phase|Physician Decision|1
4732227|NCT01931475|16323168|P1|Period 2: Extension Treatment Phase|Physician Decision|1
4732228|NCT01931475|16323167|P2|Period 2: Extension Treatment Phase|Withdrawal by Subject|9
4732229|NCT01931475|16323168|P1|Period 2: Extension Treatment Phase|Withdrawal by Subject|0
4732230|NCT01931475|16323167|P2|Period 2: Extension Treatment Phase|Protocol Violation|0
4732231|NCT01931475|16323168|P1|Period 2: Extension Treatment Phase|Protocol Violation|1
4732232|NCT01931475|16323167|P2|Period 2: Extension Treatment Phase|Adverse Event|8
4732233|NCT01931475|16323168|P1|Period 2: Extension Treatment Phase|Adverse Event|0
4732234|NCT01931475|16323167|P2|Period 1: Double-Blind Treatment Phase|Physician Decision|1
4732235|NCT01931475|16323168|P1|Period 1: Double-Blind Treatment Phase|Physician Decision|0
4732236|NCT01931475|16323167|P2|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3
4732237|NCT01931475|16323168|P1|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2
4732238|NCT01931475|16323167|P2|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12
4732239|NCT01931475|16323168|P1|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16
4732240|NCT01931475|16323167|P2|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0
4732241|NCT01931475|16323168|P1|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1
4732242|NCT01931475|16323167|P2|Period 1: Double-Blind Treatment Phase|Adverse Event|10
4732243|NCT01931475|16323168|P1|Period 1: Double-Blind Treatment Phase|Adverse Event|20
4732244|NCT01931462|16323195|P1|Overall Study|Withdrawal by Subject|1
4732245|NCT01931397|16323206|P1|Overall Study|moved out of state|1
4732246|NCT01931397|16323206|P1|Overall Study|Withdrawal by Subject|8
4732247|NCT01931397|16323206|P1|Overall Study|Physician Decision|2
4732248|NCT01931202|16323218|P3|Overall Study|Lost to Follow-up|2
4732249|NCT01931202|16323219|P2|Overall Study|Lost to Follow-up|5
4732250|NCT01931202|16323220|P1|Overall Study|Lost to Follow-up|0
4732251|NCT01931202|16323218|P3|Overall Study|Withdrawal by Subject|2
4732252|NCT01931202|16323219|P2|Overall Study|Withdrawal by Subject|0
4732253|NCT01931202|16323220|P1|Overall Study|Withdrawal by Subject|0
4732254|NCT01931150|16323266|P2|Overall Study|Withdrawal by Subject|2
4732255|NCT01931150|16323267|P1|Overall Study|Withdrawal by Subject|1
4732256|NCT01931098|16323275|P2|Overall Study|Refused further treatment|1
4732257|NCT01931098|16323276|P1|Overall Study|Refused further treatment|0
4732258|NCT01931098|16323275|P2|Overall Study|Unable to begin trmt:active infection|1
4732259|NCT01931098|16323276|P1|Overall Study|Unable to begin trmt:active infection|0
4732260|NCT01931098|16323275|P2|Overall Study|Enrolled in different protocol|1
4732261|NCT01931098|16323276|P1|Overall Study|Enrolled in different protocol|0
4732262|NCT01931098|16323275|P2|Overall Study|Withdrawal by Subject|1
4732263|NCT01931098|16323276|P1|Overall Study|Withdrawal by Subject|0
4732264|NCT01931059|16323288|P2|Day3|Lost to Follow-up|0
4732265|NCT01931059|16323289|P1|Day3|Lost to Follow-up|1
4732266|NCT01931059|16323288|P2|Day 1|Pregnancy|1
4732267|NCT01931059|16323289|P1|Day 1|Pregnancy|0
4732268|NCT01930890|16323305|P4|Overall Study|Adverse Event|0
4732269|NCT01930890|16323306|P3|Overall Study|Adverse Event|0
4732270|NCT01930890|16323307|P2|Overall Study|Adverse Event|1
4732271|NCT01930890|16323308|P1|Overall Study|Adverse Event|0
4732272|NCT01930890|16323305|P4|Overall Study|Consent Withdrawn|1
4732273|NCT01930890|16323306|P3|Overall Study|Consent Withdrawn|0
4732274|NCT01930890|16323307|P2|Overall Study|Consent Withdrawn|3
4732275|NCT01930890|16323308|P1|Overall Study|Consent Withdrawn|0
4732276|NCT01930890|16323305|P4|Overall Study|Investigator Decision|0
4732277|NCT01930890|16323306|P3|Overall Study|Investigator Decision|0
4732279|NCT01930890|16323308|P1|Overall Study|Investigator Decision|0
4732280|NCT01930890|16323305|P4|Overall Study|Death|1
4732281|NCT01930890|16323306|P3|Overall Study|Death|0
4732282|NCT01930890|16323307|P2|Overall Study|Death|0
4732283|NCT01930890|16323308|P1|Overall Study|Death|0
4732284|NCT01930890|16323305|P4|Overall Study|Study Termination|25
4732285|NCT01930890|16323306|P3|Overall Study|Study Termination|13
4732286|NCT01930890|16323307|P2|Overall Study|Study Termination|28
4732287|NCT01930890|16323308|P1|Overall Study|Study Termination|14
4732288|NCT01930799|16323322|P1|Overall Study|Lost to Follow-up|5
4732289|NCT01930799|16323322|P1|Overall Study|Withdrawal by Subject|3
4732290|NCT01930214|16323461|P3|Overall Study|Physician Decision|0
4732291|NCT01930214|16323462|P2|Overall Study|Physician Decision|0
4732292|NCT01930214|16323463|P1|Overall Study|Physician Decision|2
4732293|NCT01930214|16323461|P3|Overall Study|Voluntary withdrawal of infomed consent|2
4732294|NCT01930214|16323462|P2|Overall Study|Voluntary withdrawal of infomed consent|4
4732295|NCT01930214|16323463|P1|Overall Study|Voluntary withdrawal of infomed consent|2
4732296|NCT01930214|16323461|P3|Overall Study|Lost to Follow-up|12
4732297|NCT01930214|16323462|P2|Overall Study|Lost to Follow-up|13
4732298|NCT01930214|16323463|P1|Overall Study|Lost to Follow-up|12
4732299|NCT01930214|16323461|P3|Overall Study|Death|11
4732300|NCT01930214|16323462|P2|Overall Study|Death|4
4732301|NCT01930214|16323463|P1|Overall Study|Death|4
4732302|NCT01930188|16323483|P3|Overall Study|Withdrawal by Subject|8
4732303|NCT01930188|16323484|P2|Overall Study|Withdrawal by Subject|11
4732304|NCT01930188|16323485|P1|Overall Study|Withdrawal by Subject|9
4732305|NCT01930188|16323483|P3|Overall Study|Death|3
4732306|NCT01930188|16323484|P2|Overall Study|Death|1
4732307|NCT01930188|16323485|P1|Overall Study|Death|2
4732308|NCT01930188|16323483|P3|Overall Study|Lost to Follow-up|2
4732309|NCT01930188|16323484|P2|Overall Study|Lost to Follow-up|2
4732310|NCT01930188|16323485|P1|Overall Study|Lost to Follow-up|5
4732311|NCT01930188|16323483|P3|Overall Study|Missing follow-up information|3
4732312|NCT01930188|16323484|P2|Overall Study|Missing follow-up information|2
4732313|NCT01930188|16323485|P1|Overall Study|Missing follow-up information|2
4732314|NCT01930188|16323483|P3|Overall Study|unclassified|3
4732315|NCT01930188|16323484|P2|Overall Study|unclassified|5
4732316|NCT01930188|16323485|P1|Overall Study|unclassified|4
4732317|NCT01930175|16323512|P3|Core Study|Adverse Event|1
4732318|NCT01930175|16323513|P2|Core Study|Adverse Event|0
4732319|NCT01930175|16323514|P1|Core Study|Adverse Event|0
4732320|NCT01930175|16323512|P3|Core Study|Lost to Follow-up|0
4732321|NCT01930175|16323513|P2|Core Study|Lost to Follow-up|1
4732322|NCT01930175|16323514|P1|Core Study|Lost to Follow-up|0
4732323|NCT01930162|16323544|P1|Overall Study|Death|1
4732324|NCT01930162|16323544|P1|Overall Study|Abnormal test procedure result(s)|4
4732325|NCT01930045|16323580|P6|Pause (up to 37 Days)|Protocol Violation|1
4732326|NCT01930045|16323581|P5|Pause (up to 37 Days)|Protocol Violation|0
4732327|NCT01930045|16323582|P4|Pause (up to 37 Days)|Protocol Violation|0
4732328|NCT01930045|16323583|P3|Pause (up to 37 Days)|Protocol Violation|0
4732329|NCT01930045|16323584|P2|Pause (up to 37 Days)|Protocol Violation|0
4732330|NCT01930045|16323585|P1|Pause (up to 37 Days)|Protocol Violation|0
4732331|NCT01930045|16323580|P6|Pause (up to 37 Days)|Withdrawal by Subject|1
4732332|NCT01930045|16323581|P5|Pause (up to 37 Days)|Withdrawal by Subject|0
4732333|NCT01930045|16323582|P4|Pause (up to 37 Days)|Withdrawal by Subject|0
4732334|NCT01930045|16323583|P3|Pause (up to 37 Days)|Withdrawal by Subject|0
4732335|NCT01930045|16323584|P2|Pause (up to 37 Days)|Withdrawal by Subject|0
4732336|NCT01930045|16323585|P1|Pause (up to 37 Days)|Withdrawal by Subject|0
4732337|NCT01929993|16323612|P2|Overall Study|Absent CIN, invasion present or artifact|22
4732338|NCT01929993|16323613|P1|Overall Study|Absent CIN, invasion present or artifact|26
4732339|NCT01929993|16323612|P2|Overall Study|Protocol Violation|6
4732340|NCT01929993|16323613|P1|Overall Study|Protocol Violation|4
4732341|NCT01929980|16323619|P1|Overall Study|Physician Decision|1
4732342|NCT01929876|16323627|P1|Period 2|Non-Compliance|1
4732343|NCT01929863|16323640|P2|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1
4732344|NCT01929863|16323641|P1|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0
4732345|NCT01929863|16323640|P2|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1
4732346|NCT01929863|16323641|P1|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0
4732347|NCT01929863|16323640|P2|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0
4732348|NCT01929863|16323641|P1|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1
4732349|NCT01929707|16323696|P8|Intervention Period 2|Withdrawal by Subject|0
4732350|NCT01929707|16323697|P7|Intervention Period 2|Withdrawal by Subject|0
4732351|NCT01929707|16323698|P6|Intervention Period 2|Withdrawal by Subject|2
4732352|NCT01929707|16323699|P5|Intervention Period 2|Withdrawal by Subject|0
4732353|NCT01929707|16323700|P4|Intervention Period 2|Withdrawal by Subject|0
4732354|NCT01929707|16323701|P3|Intervention Period 2|Withdrawal by Subject|0
4732355|NCT01929707|16323702|P2|Intervention Period 2|Withdrawal by Subject|0
4732356|NCT01929707|16323703|P1|Intervention Period 2|Withdrawal by Subject|0
4732357|NCT01929707|16323696|P8|Intervention Period 1|Withdrawal by Subject|0
4732358|NCT01929707|16323697|P7|Intervention Period 1|Withdrawal by Subject|0
4732359|NCT01929707|16323698|P6|Intervention Period 1|Withdrawal by Subject|0
4732360|NCT01929707|16323699|P5|Intervention Period 1|Withdrawal by Subject|0
4732361|NCT01929707|16323700|P4|Intervention Period 1|Withdrawal by Subject|2
4732362|NCT01929707|16323701|P3|Intervention Period 1|Withdrawal by Subject|0
4732363|NCT01929707|16323702|P2|Intervention Period 1|Withdrawal by Subject|0
4732364|NCT01929707|16323703|P1|Intervention Period 1|Withdrawal by Subject|0
4732365|NCT01929707|16323696|P8|Intervention Period 1|Lost to Follow-up|0
4732366|NCT01929707|16323697|P7|Intervention Period 1|Lost to Follow-up|0
4732367|NCT01929707|16323698|P6|Intervention Period 1|Lost to Follow-up|0
4732368|NCT01929707|16323699|P5|Intervention Period 1|Lost to Follow-up|0
4732369|NCT01929707|16323700|P4|Intervention Period 1|Lost to Follow-up|1
4732370|NCT01929707|16323701|P3|Intervention Period 1|Lost to Follow-up|0
4732371|NCT01929707|16323702|P2|Intervention Period 1|Lost to Follow-up|0
4732372|NCT01929707|16323703|P1|Intervention Period 1|Lost to Follow-up|0
4732373|NCT01929681|16323735|P2|Overall Study|Physician Decision|1
4732374|NCT01929681|16323736|P1|Overall Study|Physician Decision|1
4732375|NCT01929681|16323735|P2|Overall Study|Withdrawal by Subject|0
4732376|NCT01929681|16323736|P1|Overall Study|Withdrawal by Subject|1
4732377|NCT01929408|16323779|P1|Overall Study|received HCT as initial treatment|8
4732378|NCT01929395|16323787|P3|Overall Study|Screen Fail|1
4732379|NCT01929395|16323788|P2|Overall Study|Screen Fail|0
4732380|NCT01929395|16323789|P1|Overall Study|Screen Fail|0
4732381|NCT01929395|16323787|P3|Overall Study|Withdrawal by Subject|0
4732382|NCT01929395|16323788|P2|Overall Study|Withdrawal by Subject|1
4732383|NCT01929395|16323789|P1|Overall Study|Withdrawal by Subject|0
4732384|NCT01929395|16323787|P3|Overall Study|Did not complete - non-related toxicity|0
4732385|NCT01929395|16323788|P2|Overall Study|Did not complete - non-related toxicity|0
4732386|NCT01929395|16323789|P1|Overall Study|Did not complete - non-related toxicity|1
4732387|NCT01929317|16323801|P2|Long-term Phase|Study Closed/Terminated|3
4732388|NCT01929317|16323802|P1|Long-term Phase|Study Closed/Terminated|5
4732389|NCT01929317|16323801|P2|Long-term Phase|Protocol-defined Stopping Criteria|0
4732390|NCT01929317|16323802|P1|Long-term Phase|Protocol-defined Stopping Criteria|1
4732391|NCT01929317|16323801|P2|Long-term Phase|Protocol Violation|0
4732392|NCT01929317|16323802|P1|Long-term Phase|Protocol Violation|1
4732393|NCT01929317|16323801|P2|Long-term Phase|Withdrawal by Subject|0
4732394|NCT01929317|16323802|P1|Long-term Phase|Withdrawal by Subject|4
4732395|NCT01929317|16323801|P2|Long-term Phase|Physician Decision|0
4732396|NCT01929317|16323802|P1|Long-term Phase|Physician Decision|3
4732397|NCT01929317|16323801|P2|Long-term Phase|Adverse Event|1
4732398|NCT01929317|16323802|P1|Long-term Phase|Adverse Event|5
4732399|NCT01929317|16323801|P2|Dose Increase Effect Verification Phase|Withdrawal by Subject|0
4732400|NCT01929317|16323802|P1|Dose Increase Effect Verification Phase|Withdrawal by Subject|3
4732401|NCT01929317|16323801|P2|Dose Increase Effect Verification Phase|Physician Decision|0
4732402|NCT01929317|16323802|P1|Dose Increase Effect Verification Phase|Physician Decision|1
4732403|NCT01929317|16323801|P2|Dose Increase Effect Verification Phase|Adverse Event|1
4732404|NCT01929317|16323802|P1|Dose Increase Effect Verification Phase|Adverse Event|5
4732405|NCT01929226|16323877|P2|Overall Study|Withdrawal by Subject|1
4732406|NCT01929226|16323878|P1|Overall Study|Withdrawal by Subject|1
4732407|NCT01929226|16323877|P2|Overall Study|Lost to Follow-up|0
4732408|NCT01929226|16323878|P1|Overall Study|Lost to Follow-up|4
4732409|NCT01929135|16323904|P2|Overall Study|Lost to Follow-up|1
4732410|NCT01929135|16323905|P1|Overall Study|Lost to Follow-up|1
4732411|NCT01929109|16323924|P5|Period 1 (All Groups)|Deviation from protocol|0
4732412|NCT01929109|16323925|P4|Period 1 (All Groups)|Deviation from protocol|0
4732413|NCT01929109|16323926|P3|Period 1 (All Groups)|Deviation from protocol|1
4732414|NCT01929109|16323927|P2|Period 1 (All Groups)|Deviation from protocol|0
4732415|NCT01929109|16323928|P1|Period 1 (All Groups)|Deviation from protocol|0
4732416|NCT01929083|16323947|P2|Intervention 2|Adverse Event|1
4732417|NCT01929083|16323948|P1|Intervention 2|Adverse Event|0
4732418|NCT01929083|16323947|P2|Intervention 1|Nonadherent to study medications|0
4732419|NCT01929083|16323948|P1|Intervention 1|Nonadherent to study medications|1
4732420|NCT01929083|16323947|P2|Intervention 1|Lost to Follow-up|0
4732421|NCT01929083|16323948|P1|Intervention 1|Lost to Follow-up|2
4732422|NCT01929044|16323985|P2|Overall Study|Not Treated|3
4732423|NCT01929044|16323986|P1|Overall Study|Not Treated|1
4732424|NCT01929044|16323985|P2|Overall Study|Protocol Violation|14
4732425|NCT01929044|16323986|P1|Overall Study|Protocol Violation|9
4732426|NCT01929044|16323985|P2|Overall Study|Adverse Event|0
4732427|NCT01929044|16323986|P1|Overall Study|Adverse Event|1
4732428|NCT01929031|16324008|P6|Overall Study|Reason other than specified above|0
4732429|NCT01929031|16324009|P5|Overall Study|Reason other than specified above|1
4732430|NCT01929031|16324010|P4|Overall Study|Reason other than specified above|0
4732431|NCT01929031|16324011|P3|Overall Study|Reason other than specified above|0
4732432|NCT01929031|16324012|P2|Overall Study|Reason other than specified above|1
4732433|NCT01929031|16324013|P1|Overall Study|Reason other than specified above|0
4732434|NCT01929031|16324008|P6|Overall Study|Protocol Violation|1
4732435|NCT01929031|16324009|P5|Overall Study|Protocol Violation|0
4732436|NCT01929031|16324010|P4|Overall Study|Protocol Violation|0
4732437|NCT01929031|16324011|P3|Overall Study|Protocol Violation|0
4732438|NCT01929031|16324012|P2|Overall Study|Protocol Violation|0
4732439|NCT01929031|16324013|P1|Overall Study|Protocol Violation|1
4732440|NCT01929031|16324008|P6|Overall Study|Adverse Event|0
4732441|NCT01929031|16324009|P5|Overall Study|Adverse Event|0
4732442|NCT01929031|16324010|P4|Overall Study|Adverse Event|0
4732443|NCT01929031|16324011|P3|Overall Study|Adverse Event|1
4732444|NCT01929031|16324012|P2|Overall Study|Adverse Event|1
4732445|NCT01929031|16324013|P1|Overall Study|Adverse Event|3
4732446|NCT01929018|16324037|P2|Overall Study|Hospitalization|1
4732447|NCT01929018|16324038|P1|Overall Study|Hospitalization|0
4732448|NCT01929018|16324037|P2|Overall Study|Lost to Follow-up|0
4732449|NCT01929018|16324038|P1|Overall Study|Lost to Follow-up|1
4732450|NCT01928940|16324062|P2|Overall Study|Adverse Event|1
4732451|NCT01928940|16324063|P1|Overall Study|Adverse Event|0
4732452|NCT01928927|16324106|P2|Overall Study|Withdrawal by Subject|1
4732453|NCT01928927|16324107|P1|Overall Study|Withdrawal by Subject|1
4732454|NCT01928927|16324106|P2|Overall Study|Lost to Follow-up|0
4732455|NCT01928927|16324107|P1|Overall Study|Lost to Follow-up|1
4732456|NCT01928862|16324248|P5|Overall Study|Lost to Follow-up|1
4732457|NCT01928862|16324249|P4|Overall Study|Lost to Follow-up|0
4732458|NCT01928862|16324250|P3|Overall Study|Lost to Follow-up|0
4732459|NCT01928862|16324251|P2|Overall Study|Lost to Follow-up|0
4732460|NCT01928862|16324252|P1|Overall Study|Lost to Follow-up|1
4732461|NCT01928771|16324326|P3|Overall Study|Severe Non-Compliance to Protocol|2
4732462|NCT01928771|16324327|P2|Overall Study|Severe Non-Compliance to Protocol|2
4732463|NCT01928771|16324328|P1|Overall Study|Severe Non-Compliance to Protocol|4
4732464|NCT01928771|16324326|P3|Overall Study|Other Reasons|14
4732465|NCT01928771|16324327|P2|Overall Study|Other Reasons|9
4732466|NCT01928771|16324328|P1|Overall Study|Other Reasons|9
4732467|NCT01928771|16324326|P3|Overall Study|Study-Specific Withdrawal Criteria|1
4732468|NCT01928771|16324327|P2|Overall Study|Study-Specific Withdrawal Criteria|1
4732469|NCT01928771|16324328|P1|Overall Study|Study-Specific Withdrawal Criteria|0
4732470|NCT01928771|16324326|P3|Overall Study|Withdrawal by Subject|17
4732471|NCT01928771|16324327|P2|Overall Study|Withdrawal by Subject|15
4732472|NCT01928771|16324328|P1|Overall Study|Withdrawal by Subject|20
4732473|NCT01928771|16324326|P3|Overall Study|Lost to Follow-up|3
4732474|NCT01928771|16324327|P2|Overall Study|Lost to Follow-up|6
4732475|NCT01928771|16324328|P1|Overall Study|Lost to Follow-up|5
4732476|NCT01928771|16324326|P3|Overall Study|Death|2
4732477|NCT01928771|16324327|P2|Overall Study|Death|2
4732478|NCT01928771|16324328|P1|Overall Study|Death|2
4732479|NCT01928771|16324326|P3|Overall Study|Adverse Event|1
4732480|NCT01928771|16324327|P2|Overall Study|Adverse Event|5
4732481|NCT01928771|16324328|P1|Overall Study|Adverse Event|6
4732482|NCT01928758|16324407|P2|Overall Study|Protocol Violation|4
4732483|NCT01928758|16324408|P1|Overall Study|Protocol Violation|3
4732484|NCT01928758|16324407|P2|Overall Study|Adverse Event|5
4732485|NCT01928758|16324408|P1|Overall Study|Adverse Event|3
4732486|NCT01928758|16324407|P2|Overall Study|Withdrawal by Subject|2
4732487|NCT01928758|16324408|P1|Overall Study|Withdrawal by Subject|5
4732488|NCT01928758|16324407|P2|Overall Study|Lost to Follow-up|9
4732489|NCT01928758|16324408|P1|Overall Study|Lost to Follow-up|14
4732490|NCT01928719|16324426|P2|Overall Study|Adverse Event|0
4732491|NCT01928719|16324427|P1|Overall Study|Adverse Event|1
4732492|NCT01928719|16324426|P2|Overall Study|Protocol Violation|1
4732493|NCT01928719|16324427|P1|Overall Study|Protocol Violation|3
4732494|NCT01928719|16324426|P2|Overall Study|Withdrawal by Subject|7
4732495|NCT01928719|16324427|P1|Overall Study|Withdrawal by Subject|22
4732496|NCT01928719|16324426|P2|Overall Study|Lost to Follow-up|11
4732497|NCT01928719|16324427|P1|Overall Study|Lost to Follow-up|26
4732498|NCT01928615|16324479|P1|Overall Study|Study Terminated by Sponsor|2
4732499|NCT01928485|16324496|P2|Overall Study|Physician Decision|1
4732500|NCT01928485|16324497|P1|Overall Study|Physician Decision|0
4732501|NCT01928472|16324549|P4|Overall Study|Unclassified|0
4732502|NCT01928472|16324550|P3|Overall Study|Unclassified|1
4732503|NCT01928472|16324551|P2|Overall Study|Unclassified|0
4732504|NCT01928472|16324552|P1|Overall Study|Unclassified|0
4732505|NCT01928472|16324549|P4|Overall Study|Administrative Reason|0
4732506|NCT01928472|16324550|P3|Overall Study|Administrative Reason|0
4732507|NCT01928472|16324551|P2|Overall Study|Administrative Reason|1
4732508|NCT01928472|16324552|P1|Overall Study|Administrative Reason|2
4732509|NCT01928472|16324549|P4|Overall Study|Lost to Follow-up|0
4732510|NCT01928472|16324550|P3|Overall Study|Lost to Follow-up|4
4732511|NCT01928472|16324551|P2|Overall Study|Lost to Follow-up|3
4732512|NCT01928472|16324552|P1|Overall Study|Lost to Follow-up|2
4732513|NCT01928472|16324549|P4|Overall Study|Withdrawal by Subject|2
4732514|NCT01928472|16324550|P3|Overall Study|Withdrawal by Subject|1
4732515|NCT01928472|16324551|P2|Overall Study|Withdrawal by Subject|4
4732516|NCT01928472|16324552|P1|Overall Study|Withdrawal by Subject|4
4732517|NCT01928472|16324549|P4|Overall Study|Death|0
4732518|NCT01928472|16324550|P3|Overall Study|Death|1
4732519|NCT01928472|16324551|P2|Overall Study|Death|0
4732520|NCT01928472|16324552|P1|Overall Study|Death|0
4732521|NCT01928433|16324622|P3|Overall Study|Other reasons|4
4732522|NCT01928433|16324623|P2|Overall Study|Other reasons|3
4732523|NCT01928433|16324624|P1|Overall Study|Other reasons|3
4732524|NCT01928433|16324622|P3|Overall Study|Lost to Follow-up|3
4732525|NCT01928433|16324623|P2|Overall Study|Lost to Follow-up|2
4732526|NCT01928433|16324624|P1|Overall Study|Lost to Follow-up|0
4732527|NCT01928433|16324622|P3|Overall Study|Negative screening urine culture|10
4732528|NCT01928433|16324623|P2|Overall Study|Negative screening urine culture|6
4732529|NCT01928433|16324624|P1|Overall Study|Negative screening urine culture|7
4732530|NCT01928433|16324622|P3|Overall Study|Withdrawal by Subject|0
4732531|NCT01928433|16324623|P2|Overall Study|Withdrawal by Subject|4
4732532|NCT01928433|16324624|P1|Overall Study|Withdrawal by Subject|0
4732533|NCT01928433|16324622|P3|Overall Study|Lack of Efficacy|4
4732534|NCT01928433|16324623|P2|Overall Study|Lack of Efficacy|4
4732535|NCT01928433|16324624|P1|Overall Study|Lack of Efficacy|5
4732536|NCT01928433|16324622|P3|Overall Study|Protocol Violation|2
4732537|NCT01928433|16324623|P2|Overall Study|Protocol Violation|0
4732538|NCT01928433|16324624|P1|Overall Study|Protocol Violation|0
4732539|NCT01928433|16324622|P3|Overall Study|Adverse Event|5
4732540|NCT01928433|16324623|P2|Overall Study|Adverse Event|2
4732541|NCT01928433|16324624|P1|Overall Study|Adverse Event|5
4732542|NCT01928394|16324670|P23|Follow-up Period|Lost to Follow-up|1
4732543|NCT01928394|16324671|P22|Follow-up Period|Lost to Follow-up|0
4732544|NCT01928394|16324672|P21|Follow-up Period|Lost to Follow-up|0
4732545|NCT01928394|16324673|P20|Follow-up Period|Lost to Follow-up|0
4732546|NCT01928394|16324674|P19|Follow-up Period|Lost to Follow-up|0
4732547|NCT01928394|16324675|P18|Follow-up Period|Lost to Follow-up|0
4732548|NCT01928394|16324676|P17|Follow-up Period|Lost to Follow-up|1
4732549|NCT01928394|16324677|P16|Follow-up Period|Lost to Follow-up|0
4732550|NCT01928394|16324678|P15|Follow-up Period|Lost to Follow-up|1
4732551|NCT01928394|16324679|P14|Follow-up Period|Lost to Follow-up|0
4732552|NCT01928394|16324680|P13|Follow-up Period|Lost to Follow-up|1
4732553|NCT01928394|16324681|P12|Follow-up Period|Lost to Follow-up|1
4732554|NCT01928394|16324682|P11|Follow-up Period|Lost to Follow-up|0
4732555|NCT01928394|16324683|P10|Follow-up Period|Lost to Follow-up|0
4732556|NCT01928394|16324684|P9|Follow-up Period|Lost to Follow-up|0
4732557|NCT01928394|16324685|P8|Follow-up Period|Lost to Follow-up|0
4732558|NCT01928394|16324686|P7|Follow-up Period|Lost to Follow-up|0
4732559|NCT01928394|16324687|P6|Follow-up Period|Lost to Follow-up|0
4732560|NCT01928394|16324688|P5|Follow-up Period|Lost to Follow-up|0
4732561|NCT01928394|16324689|P4|Follow-up Period|Lost to Follow-up|0
4732562|NCT01928394|16324690|P3|Follow-up Period|Lost to Follow-up|0
4732563|NCT01928394|16324691|P2|Follow-up Period|Lost to Follow-up|0
4732564|NCT01928394|16324692|P1|Follow-up Period|Lost to Follow-up|0
4732565|NCT01928394|16324670|P23|Follow-up Period|other reason|1
4732566|NCT01928394|16324671|P22|Follow-up Period|other reason|0
4732567|NCT01928394|16324672|P21|Follow-up Period|other reason|0
4732568|NCT01928394|16324673|P20|Follow-up Period|other reason|1
4732569|NCT01928394|16324674|P19|Follow-up Period|other reason|1
4732570|NCT01928394|16324675|P18|Follow-up Period|other reason|0
4732571|NCT01928394|16324676|P17|Follow-up Period|other reason|2
4732572|NCT01928394|16324677|P16|Follow-up Period|other reason|0
4732573|NCT01928394|16324678|P15|Follow-up Period|other reason|4
4732574|NCT01928394|16324679|P14|Follow-up Period|other reason|1
4732575|NCT01928394|16324680|P13|Follow-up Period|other reason|0
4732576|NCT01928394|16324681|P12|Follow-up Period|other reason|1
4732577|NCT01928394|16324682|P11|Follow-up Period|other reason|2
4732578|NCT01928394|16324683|P10|Follow-up Period|other reason|0
4732579|NCT01928394|16324684|P9|Follow-up Period|other reason|0
4732580|NCT01928394|16324685|P8|Follow-up Period|other reason|3
4732581|NCT01928394|16324686|P7|Follow-up Period|other reason|1
4732582|NCT01928394|16324687|P6|Follow-up Period|other reason|0
4732583|NCT01928394|16324688|P5|Follow-up Period|other reason|0
4732584|NCT01928394|16324689|P4|Follow-up Period|other reason|0
4732585|NCT01928394|16324690|P3|Follow-up Period|other reason|0
4732586|NCT01928394|16324691|P2|Follow-up Period|other reason|0
4732587|NCT01928394|16324692|P1|Follow-up Period|other reason|0
4732588|NCT01928394|16324670|P23|Follow-up Period|Death|2
4732589|NCT01928394|16324671|P22|Follow-up Period|Death|3
4732590|NCT01928394|16324672|P21|Follow-up Period|Death|5
4732591|NCT01928394|16324673|P20|Follow-up Period|Death|13
4732592|NCT01928394|16324674|P19|Follow-up Period|Death|13
4732593|NCT01928394|16324675|P18|Follow-up Period|Death|5
4732594|NCT01928394|16324676|P17|Follow-up Period|Death|6
4732595|NCT01928394|16324677|P16|Follow-up Period|Death|0
4732596|NCT01928394|16324678|P15|Follow-up Period|Death|18
4732597|NCT01928394|16324679|P14|Follow-up Period|Death|25
4732598|NCT01928394|16324680|P13|Follow-up Period|Death|11
4732599|NCT01928394|16324681|P12|Follow-up Period|Death|12
4732600|NCT01928394|16324682|P11|Follow-up Period|Death|4
4732601|NCT01928394|16324683|P10|Follow-up Period|Death|2
4732602|NCT01928394|16324684|P9|Follow-up Period|Death|1
4732603|NCT01928394|16324685|P8|Follow-up Period|Death|2
4732604|NCT01928394|16324686|P7|Follow-up Period|Death|6
4732605|NCT01928394|16324687|P6|Follow-up Period|Death|6
4732606|NCT01928394|16324688|P5|Follow-up Period|Death|0
4732607|NCT01928394|16324689|P4|Follow-up Period|Death|6
4732608|NCT01928394|16324690|P3|Follow-up Period|Death|2
4732609|NCT01928394|16324691|P2|Follow-up Period|Death|0
4732610|NCT01928394|16324692|P1|Follow-up Period|Death|0
4732611|NCT01928394|16324670|P23|Follow-up Period|Participant withdrew consent|2
4732612|NCT01928394|16324671|P22|Follow-up Period|Participant withdrew consent|6
4732613|NCT01928394|16324672|P21|Follow-up Period|Participant withdrew consent|4
4732614|NCT01928394|16324673|P20|Follow-up Period|Participant withdrew consent|7
4732615|NCT01928394|16324674|P19|Follow-up Period|Participant withdrew consent|2
4732616|NCT01928394|16324675|P18|Follow-up Period|Participant withdrew consent|3
4732617|NCT01928394|16324676|P17|Follow-up Period|Participant withdrew consent|5
4732618|NCT01928394|16324677|P16|Follow-up Period|Participant withdrew consent|0
4732619|NCT01928394|16324678|P15|Follow-up Period|Participant withdrew consent|7
4732620|NCT01928394|16324679|P14|Follow-up Period|Participant withdrew consent|12
4732621|NCT01928394|16324680|P13|Follow-up Period|Participant withdrew consent|2
4732622|NCT01928394|16324681|P12|Follow-up Period|Participant withdrew consent|8
4732623|NCT01928394|16324682|P11|Follow-up Period|Participant withdrew consent|5
4732624|NCT01928394|16324683|P10|Follow-up Period|Participant withdrew consent|0
4732625|NCT01928394|16324684|P9|Follow-up Period|Participant withdrew consent|0
4732626|NCT01928394|16324685|P8|Follow-up Period|Participant withdrew consent|1
4732627|NCT01928394|16324686|P7|Follow-up Period|Participant withdrew consent|5
4732628|NCT01928394|16324687|P6|Follow-up Period|Participant withdrew consent|2
4732629|NCT01928394|16324688|P5|Follow-up Period|Participant withdrew consent|0
4732630|NCT01928394|16324689|P4|Follow-up Period|Participant withdrew consent|4
4732631|NCT01928394|16324690|P3|Follow-up Period|Participant withdrew consent|1
4732632|NCT01928394|16324691|P2|Follow-up Period|Participant withdrew consent|0
4732633|NCT01928394|16324692|P1|Follow-up Period|Participant withdrew consent|3
4732634|NCT01928394|16324670|P23|Treatment Period|Death|0
4732635|NCT01928394|16324671|P22|Treatment Period|Death|0
4732636|NCT01928394|16324672|P21|Treatment Period|Death|0
4732637|NCT01928394|16324673|P20|Treatment Period|Death|0
4732638|NCT01928394|16324674|P19|Treatment Period|Death|0
4732639|NCT01928394|16324675|P18|Treatment Period|Death|0
4732640|NCT01928394|16324676|P17|Treatment Period|Death|0
4732641|NCT01928394|16324677|P16|Treatment Period|Death|0
4732642|NCT01928394|16324678|P15|Treatment Period|Death|2
4732643|NCT01928394|16324679|P14|Treatment Period|Death|1
4732644|NCT01928394|16324680|P13|Treatment Period|Death|0
4732645|NCT01928394|16324681|P12|Treatment Period|Death|0
4732646|NCT01928394|16324682|P11|Treatment Period|Death|0
4732647|NCT01928394|16324683|P10|Treatment Period|Death|0
4732648|NCT01928394|16324684|P9|Treatment Period|Death|0
4732649|NCT01928394|16324685|P8|Treatment Period|Death|0
4732650|NCT01928394|16324686|P7|Treatment Period|Death|0
4732651|NCT01928394|16324687|P6|Treatment Period|Death|0
4732652|NCT01928394|16324688|P5|Treatment Period|Death|0
4732653|NCT01928394|16324689|P4|Treatment Period|Death|0
4732654|NCT01928394|16324690|P3|Treatment Period|Death|0
4732655|NCT01928394|16324691|P2|Treatment Period|Death|0
4732656|NCT01928394|16324692|P1|Treatment Period|Death|0
4732657|NCT01928394|16324670|P23|Treatment Period|Lost to Follow-up|1
4732658|NCT01928394|16324671|P22|Treatment Period|Lost to Follow-up|0
4732659|NCT01928394|16324672|P21|Treatment Period|Lost to Follow-up|0
4732660|NCT01928394|16324673|P20|Treatment Period|Lost to Follow-up|0
4732661|NCT01928394|16324674|P19|Treatment Period|Lost to Follow-up|0
4732662|NCT01928394|16324675|P18|Treatment Period|Lost to Follow-up|0
4732663|NCT01928394|16324676|P17|Treatment Period|Lost to Follow-up|0
4732664|NCT01928394|16324677|P16|Treatment Period|Lost to Follow-up|0
4732665|NCT01928394|16324678|P15|Treatment Period|Lost to Follow-up|0
4732666|NCT01928394|16324679|P14|Treatment Period|Lost to Follow-up|0
4732667|NCT01928394|16324680|P13|Treatment Period|Lost to Follow-up|0
4732668|NCT01928394|16324681|P12|Treatment Period|Lost to Follow-up|0
4732669|NCT01928394|16324682|P11|Treatment Period|Lost to Follow-up|0
4732670|NCT01928394|16324683|P10|Treatment Period|Lost to Follow-up|0
4732671|NCT01928394|16324684|P9|Treatment Period|Lost to Follow-up|0
4732672|NCT01928394|16324685|P8|Treatment Period|Lost to Follow-up|0
4732673|NCT01928394|16324686|P7|Treatment Period|Lost to Follow-up|0
4732674|NCT01928394|16324687|P6|Treatment Period|Lost to Follow-up|0
4732675|NCT01928394|16324688|P5|Treatment Period|Lost to Follow-up|0
4732676|NCT01928394|16324689|P4|Treatment Period|Lost to Follow-up|0
4732677|NCT01928394|16324690|P3|Treatment Period|Lost to Follow-up|0
4732678|NCT01928394|16324691|P2|Treatment Period|Lost to Follow-up|0
4732679|NCT01928394|16324692|P1|Treatment Period|Lost to Follow-up|0
4732680|NCT01928394|16324670|P23|Treatment Period|Maximum clinical benefit|0
4732681|NCT01928394|16324671|P22|Treatment Period|Maximum clinical benefit|0
4732682|NCT01928394|16324672|P21|Treatment Period|Maximum clinical benefit|2
4732683|NCT01928394|16324673|P20|Treatment Period|Maximum clinical benefit|0
4732684|NCT01928394|16324674|P19|Treatment Period|Maximum clinical benefit|1
4732685|NCT01928394|16324675|P18|Treatment Period|Maximum clinical benefit|1
4732686|NCT01928394|16324676|P17|Treatment Period|Maximum clinical benefit|0
4732687|NCT01928394|16324677|P16|Treatment Period|Maximum clinical benefit|0
4732688|NCT01928394|16324678|P15|Treatment Period|Maximum clinical benefit|1
4732689|NCT01928394|16324679|P14|Treatment Period|Maximum clinical benefit|0
4732690|NCT01928394|16324680|P13|Treatment Period|Maximum clinical benefit|0
4732691|NCT01928394|16324681|P12|Treatment Period|Maximum clinical benefit|1
4732692|NCT01928394|16324682|P11|Treatment Period|Maximum clinical benefit|1
4732693|NCT01928394|16324683|P10|Treatment Period|Maximum clinical benefit|0
4732694|NCT01928394|16324684|P9|Treatment Period|Maximum clinical benefit|0
4732695|NCT01928394|16324685|P8|Treatment Period|Maximum clinical benefit|0
4732696|NCT01928394|16324686|P7|Treatment Period|Maximum clinical benefit|0
4732697|NCT01928394|16324687|P6|Treatment Period|Maximum clinical benefit|0
4732698|NCT01928394|16324688|P5|Treatment Period|Maximum clinical benefit|0
4732699|NCT01928394|16324689|P4|Treatment Period|Maximum clinical benefit|0
4732700|NCT01928394|16324690|P3|Treatment Period|Maximum clinical benefit|0
4732701|NCT01928394|16324691|P2|Treatment Period|Maximum clinical benefit|0
4732702|NCT01928394|16324692|P1|Treatment Period|Maximum clinical benefit|0
4732703|NCT01928394|16324670|P23|Treatment Period|other reason|0
4732704|NCT01928394|16324671|P22|Treatment Period|other reason|0
4732705|NCT01928394|16324672|P21|Treatment Period|other reason|0
4732706|NCT01928394|16324673|P20|Treatment Period|other reason|2
4732707|NCT01928394|16324674|P19|Treatment Period|other reason|2
4732708|NCT01928394|16324675|P18|Treatment Period|other reason|0
4732709|NCT01928394|16324676|P17|Treatment Period|other reason|0
4732710|NCT01928394|16324677|P16|Treatment Period|other reason|0
4732711|NCT01928394|16324678|P15|Treatment Period|other reason|1
4732712|NCT01928394|16324679|P14|Treatment Period|other reason|0
4732713|NCT01928394|16324680|P13|Treatment Period|other reason|1
4732714|NCT01928394|16324681|P12|Treatment Period|other reason|1
4732715|NCT01928394|16324682|P11|Treatment Period|other reason|1
4732716|NCT01928394|16324683|P10|Treatment Period|other reason|0
4732717|NCT01928394|16324684|P9|Treatment Period|other reason|0
4732718|NCT01928394|16324685|P8|Treatment Period|other reason|0
4732719|NCT01928394|16324686|P7|Treatment Period|other reason|0
4732720|NCT01928394|16324687|P6|Treatment Period|other reason|0
4732721|NCT01928394|16324688|P5|Treatment Period|other reason|0
4732722|NCT01928394|16324689|P4|Treatment Period|other reason|0
4732723|NCT01928394|16324690|P3|Treatment Period|other reason|0
4732724|NCT01928394|16324691|P2|Treatment Period|other reason|0
4732725|NCT01928394|16324692|P1|Treatment Period|other reason|0
4732726|NCT01928394|16324670|P23|Treatment Period|Poor/non-compliance|0
4732727|NCT01928394|16324671|P22|Treatment Period|Poor/non-compliance|0
4732728|NCT01928394|16324672|P21|Treatment Period|Poor/non-compliance|0
4732729|NCT01928394|16324673|P20|Treatment Period|Poor/non-compliance|1
4732730|NCT01928394|16324674|P19|Treatment Period|Poor/non-compliance|0
4732731|NCT01928394|16324675|P18|Treatment Period|Poor/non-compliance|1
4732732|NCT01928394|16324676|P17|Treatment Period|Poor/non-compliance|0
4732733|NCT01928394|16324677|P16|Treatment Period|Poor/non-compliance|0
4732734|NCT01928394|16324678|P15|Treatment Period|Poor/non-compliance|1
4732735|NCT01928394|16324679|P14|Treatment Period|Poor/non-compliance|0
4732736|NCT01928394|16324680|P13|Treatment Period|Poor/non-compliance|1
4732737|NCT01928394|16324681|P12|Treatment Period|Poor/non-compliance|0
4732738|NCT01928394|16324682|P11|Treatment Period|Poor/non-compliance|0
4732739|NCT01928394|16324683|P10|Treatment Period|Poor/non-compliance|0
4732740|NCT01928394|16324684|P9|Treatment Period|Poor/non-compliance|0
4732741|NCT01928394|16324685|P8|Treatment Period|Poor/non-compliance|0
4732742|NCT01928394|16324686|P7|Treatment Period|Poor/non-compliance|0
4732743|NCT01928394|16324687|P6|Treatment Period|Poor/non-compliance|0
4732744|NCT01928394|16324688|P5|Treatment Period|Poor/non-compliance|0
4732745|NCT01928394|16324689|P4|Treatment Period|Poor/non-compliance|1
4732746|NCT01928394|16324690|P3|Treatment Period|Poor/non-compliance|0
4732747|NCT01928394|16324691|P2|Treatment Period|Poor/non-compliance|0
4732748|NCT01928394|16324692|P1|Treatment Period|Poor/non-compliance|0
4732749|NCT01928394|16324670|P23|Treatment Period|Participant withdrew consent|0
4732750|NCT01928394|16324671|P22|Treatment Period|Participant withdrew consent|2
4732751|NCT01928394|16324672|P21|Treatment Period|Participant withdrew consent|0
4732752|NCT01928394|16324673|P20|Treatment Period|Participant withdrew consent|1
4732753|NCT01928394|16324674|P19|Treatment Period|Participant withdrew consent|1
4732754|NCT01928394|16324675|P18|Treatment Period|Participant withdrew consent|1
4732755|NCT01928394|16324676|P17|Treatment Period|Participant withdrew consent|2
4732756|NCT01928394|16324677|P16|Treatment Period|Participant withdrew consent|0
4732757|NCT01928394|16324678|P15|Treatment Period|Participant withdrew consent|2
4732758|NCT01928394|16324679|P14|Treatment Period|Participant withdrew consent|0
4732759|NCT01928394|16324680|P13|Treatment Period|Participant withdrew consent|1
4732760|NCT01928394|16324681|P12|Treatment Period|Participant withdrew consent|1
4732761|NCT01928394|16324682|P11|Treatment Period|Participant withdrew consent|1
4732762|NCT01928394|16324683|P10|Treatment Period|Participant withdrew consent|0
4732763|NCT01928394|16324684|P9|Treatment Period|Participant withdrew consent|0
4732764|NCT01928394|16324685|P8|Treatment Period|Participant withdrew consent|1
4732765|NCT01928394|16324686|P7|Treatment Period|Participant withdrew consent|0
4732766|NCT01928394|16324687|P6|Treatment Period|Participant withdrew consent|1
4732767|NCT01928394|16324688|P5|Treatment Period|Participant withdrew consent|0
4732768|NCT01928394|16324689|P4|Treatment Period|Participant withdrew consent|1
4732769|NCT01928394|16324690|P3|Treatment Period|Participant withdrew consent|1
4732770|NCT01928394|16324691|P2|Treatment Period|Participant withdrew consent|0
4732771|NCT01928394|16324692|P1|Treatment Period|Participant withdrew consent|0
4732772|NCT01928394|16324670|P23|Treatment Period|Participant request to stop therapy|3
4732773|NCT01928394|16324671|P22|Treatment Period|Participant request to stop therapy|1
4732774|NCT01928394|16324672|P21|Treatment Period|Participant request to stop therapy|3
4732775|NCT01928394|16324673|P20|Treatment Period|Participant request to stop therapy|1
4732776|NCT01928394|16324674|P19|Treatment Period|Participant request to stop therapy|1
4732777|NCT01928394|16324675|P18|Treatment Period|Participant request to stop therapy|3
4732778|NCT01928394|16324676|P17|Treatment Period|Participant request to stop therapy|1
4732779|NCT01928394|16324677|P16|Treatment Period|Participant request to stop therapy|0
4732780|NCT01928394|16324678|P15|Treatment Period|Participant request to stop therapy|4
4732781|NCT01928394|16324679|P14|Treatment Period|Participant request to stop therapy|2
4732782|NCT01928394|16324680|P13|Treatment Period|Participant request to stop therapy|1
4732783|NCT01928394|16324681|P12|Treatment Period|Participant request to stop therapy|2
4732784|NCT01928394|16324682|P11|Treatment Period|Participant request to stop therapy|3
4732785|NCT01928394|16324683|P10|Treatment Period|Participant request to stop therapy|0
4732786|NCT01928394|16324684|P9|Treatment Period|Participant request to stop therapy|0
4732787|NCT01928394|16324685|P8|Treatment Period|Participant request to stop therapy|0
4732788|NCT01928394|16324686|P7|Treatment Period|Participant request to stop therapy|3
4732789|NCT01928394|16324687|P6|Treatment Period|Participant request to stop therapy|3
4732790|NCT01928394|16324688|P5|Treatment Period|Participant request to stop therapy|0
4732791|NCT01928394|16324689|P4|Treatment Period|Participant request to stop therapy|0
4732792|NCT01928394|16324690|P3|Treatment Period|Participant request to stop therapy|0
4732793|NCT01928394|16324691|P2|Treatment Period|Participant request to stop therapy|0
4732794|NCT01928394|16324692|P1|Treatment Period|Participant request to stop therapy|0
4732795|NCT01928394|16324670|P23|Treatment Period|AE unrelated to study drug|0
4732796|NCT01928394|16324671|P22|Treatment Period|AE unrelated to study drug|1
4732797|NCT01928394|16324672|P21|Treatment Period|AE unrelated to study drug|1
4732798|NCT01928394|16324673|P20|Treatment Period|AE unrelated to study drug|5
4732799|NCT01928394|16324674|P19|Treatment Period|AE unrelated to study drug|3
4732800|NCT01928394|16324675|P18|Treatment Period|AE unrelated to study drug|6
4732801|NCT01928394|16324676|P17|Treatment Period|AE unrelated to study drug|1
4732802|NCT01928394|16324677|P16|Treatment Period|AE unrelated to study drug|1
4732803|NCT01928394|16324678|P15|Treatment Period|AE unrelated to study drug|6
4732804|NCT01928394|16324679|P14|Treatment Period|AE unrelated to study drug|13
4732805|NCT01928394|16324680|P13|Treatment Period|AE unrelated to study drug|6
4732806|NCT01928394|16324681|P12|Treatment Period|AE unrelated to study drug|12
4732807|NCT01928394|16324682|P11|Treatment Period|AE unrelated to study drug|0
4732808|NCT01928394|16324683|P10|Treatment Period|AE unrelated to study drug|2
4732809|NCT01928394|16324684|P9|Treatment Period|AE unrelated to study drug|0
4732810|NCT01928394|16324685|P8|Treatment Period|AE unrelated to study drug|0
4732811|NCT01928394|16324686|P7|Treatment Period|AE unrelated to study drug|1
4732812|NCT01928394|16324687|P6|Treatment Period|AE unrelated to study drug|5
4732813|NCT01928394|16324688|P5|Treatment Period|AE unrelated to study drug|0
4732814|NCT01928394|16324689|P4|Treatment Period|AE unrelated to study drug|3
4732815|NCT01928394|16324690|P3|Treatment Period|AE unrelated to study drug|2
4732816|NCT01928394|16324691|P2|Treatment Period|AE unrelated to study drug|0
4732817|NCT01928394|16324692|P1|Treatment Period|AE unrelated to study drug|0
4732818|NCT01928394|16324670|P23|Treatment Period|Study drug toxicity|4
4732819|NCT01928394|16324671|P22|Treatment Period|Study drug toxicity|7
4732820|NCT01928394|16324672|P21|Treatment Period|Study drug toxicity|4
4732821|NCT01928394|16324673|P20|Treatment Period|Study drug toxicity|15
4732822|NCT01928394|16324674|P19|Treatment Period|Study drug toxicity|12
4732823|NCT01928394|16324675|P18|Treatment Period|Study drug toxicity|3
4732824|NCT01928394|16324676|P17|Treatment Period|Study drug toxicity|3
4732825|NCT01928394|16324677|P16|Treatment Period|Study drug toxicity|0
4732826|NCT01928394|16324678|P15|Treatment Period|Study drug toxicity|12
4732827|NCT01928394|16324679|P14|Treatment Period|Study drug toxicity|5
4732828|NCT01928394|16324680|P13|Treatment Period|Study drug toxicity|7
4732829|NCT01928394|16324681|P12|Treatment Period|Study drug toxicity|3
4732830|NCT01928394|16324682|P11|Treatment Period|Study drug toxicity|2
4732831|NCT01928394|16324683|P10|Treatment Period|Study drug toxicity|5
4732832|NCT01928394|16324684|P9|Treatment Period|Study drug toxicity|0
4732833|NCT01928394|16324685|P8|Treatment Period|Study drug toxicity|1
4732834|NCT01928394|16324686|P7|Treatment Period|Study drug toxicity|7
4732835|NCT01928394|16324687|P6|Treatment Period|Study drug toxicity|9
4732836|NCT01928394|16324688|P5|Treatment Period|Study drug toxicity|0
4732837|NCT01928394|16324689|P4|Treatment Period|Study drug toxicity|3
4732838|NCT01928394|16324690|P3|Treatment Period|Study drug toxicity|3
4732839|NCT01928394|16324691|P2|Treatment Period|Study drug toxicity|1
4732840|NCT01928394|16324692|P1|Treatment Period|Study drug toxicity|1
4732841|NCT01928394|16324670|P23|Treatment Period|Disease progression|31
4732842|NCT01928394|16324671|P22|Treatment Period|Disease progression|31
4732843|NCT01928394|16324672|P21|Treatment Period|Disease progression|30
4732844|NCT01928394|16324673|P20|Treatment Period|Disease progression|71
4732845|NCT01928394|16324674|P19|Treatment Period|Disease progression|50
4732846|NCT01928394|16324675|P18|Treatment Period|Disease progression|56
4732847|NCT01928394|16324676|P17|Treatment Period|Disease progression|43
4732848|NCT01928394|16324677|P16|Treatment Period|Disease progression|1
4732849|NCT01928394|16324678|P15|Treatment Period|Disease progression|59
4732850|NCT01928394|16324679|P14|Treatment Period|Disease progression|118
4732851|NCT01928394|16324680|P13|Treatment Period|Disease progression|38
4732852|NCT01928394|16324681|P12|Treatment Period|Disease progression|73
4732853|NCT01928394|16324682|P11|Treatment Period|Disease progression|22
4732854|NCT01928394|16324683|P10|Treatment Period|Disease progression|11
4732855|NCT01928394|16324684|P9|Treatment Period|Disease progression|3
4732856|NCT01928394|16324685|P8|Treatment Period|Disease progression|16
4732857|NCT01928394|16324686|P7|Treatment Period|Disease progression|38
4732858|NCT01928394|16324687|P6|Treatment Period|Disease progression|25
4732859|NCT01928394|16324688|P5|Treatment Period|Disease progression|3
4732860|NCT01928394|16324689|P4|Treatment Period|Disease progression|48
4732861|NCT01928394|16324690|P3|Treatment Period|Disease progression|12
4732862|NCT01928394|16324691|P2|Treatment Period|Disease progression|2
4732863|NCT01928394|16324692|P1|Treatment Period|Disease progression|17
4732864|NCT01928381|16324740|P7|Part 2 - Post Third Intervention|Protocol Violation|0
4732865|NCT01928381|16324741|P6|Part 2 - Post Third Intervention|Protocol Violation|0
4732866|NCT01928381|16324742|P5|Part 2 - Post Third Intervention|Protocol Violation|0
4732867|NCT01928381|16324743|P4|Part 2 - Post Third Intervention|Protocol Violation|0
4732868|NCT01928381|16324744|P3|Part 2 - Post Third Intervention|Protocol Violation|1
4732869|NCT01928381|16324745|P2|Part 2 - Post Third Intervention|Protocol Violation|0
4732870|NCT01928381|16324746|P1|Part 2 - Post Third Intervention|Protocol Violation|0
4732871|NCT01928381|16324740|P7|Part 2 - Second Intervention|Lost to Follow-up|0
4732872|NCT01928381|16324741|P6|Part 2 - Second Intervention|Lost to Follow-up|0
4732873|NCT01928381|16324742|P5|Part 2 - Second Intervention|Lost to Follow-up|0
4732874|NCT01928381|16324743|P4|Part 2 - Second Intervention|Lost to Follow-up|1
4732875|NCT01928381|16324744|P3|Part 2 - Second Intervention|Lost to Follow-up|0
4732876|NCT01928381|16324745|P2|Part 2 - Second Intervention|Lost to Follow-up|1
4732877|NCT01928381|16324746|P1|Part 2 - Second Intervention|Lost to Follow-up|0
4732878|NCT01928381|16324740|P7|Washout First Intervention|Protocol Violation|0
4732879|NCT01928381|16324741|P6|Washout First Intervention|Protocol Violation|0
4732880|NCT01928381|16324742|P5|Washout First Intervention|Protocol Violation|1
4732881|NCT01928381|16324743|P4|Washout First Intervention|Protocol Violation|0
4732882|NCT01928381|16324744|P3|Washout First Intervention|Protocol Violation|0
4732883|NCT01928381|16324745|P2|Washout First Intervention|Protocol Violation|0
4732884|NCT01928381|16324746|P1|Washout First Intervention|Protocol Violation|0
4732885|NCT01928381|16324740|P7|Part 2 - First Intervention|Lost to Follow-up|0
4732886|NCT01928381|16324741|P6|Part 2 - First Intervention|Lost to Follow-up|0
4732887|NCT01928381|16324742|P5|Part 2 - First Intervention|Lost to Follow-up|0
4732888|NCT01928381|16324743|P4|Part 2 - First Intervention|Lost to Follow-up|1
4732889|NCT01928381|16324744|P3|Part 2 - First Intervention|Lost to Follow-up|0
4732890|NCT01928381|16324745|P2|Part 2 - First Intervention|Lost to Follow-up|0
4732891|NCT01928381|16324746|P1|Part 2 - First Intervention|Lost to Follow-up|0
4732892|NCT01928381|16324740|P7|Part 2 - First Intervention|Eligibility criterion not met|1
4732893|NCT01928381|16324741|P6|Part 2 - First Intervention|Eligibility criterion not met|1
4732894|NCT01928381|16324742|P5|Part 2 - First Intervention|Eligibility criterion not met|0
4732895|NCT01928381|16324743|P4|Part 2 - First Intervention|Eligibility criterion not met|0
4732896|NCT01928381|16324744|P3|Part 2 - First Intervention|Eligibility criterion not met|0
4732897|NCT01928381|16324745|P2|Part 2 - First Intervention|Eligibility criterion not met|0
4732898|NCT01928381|16324746|P1|Part 2 - First Intervention|Eligibility criterion not met|0
4732899|NCT01928381|16324740|P7|Part 2 - First Intervention|Study specific withdrawal criteria|0
4732900|NCT01928381|16324741|P6|Part 2 - First Intervention|Study specific withdrawal criteria|0
4732901|NCT01928381|16324742|P5|Part 2 - First Intervention|Study specific withdrawal criteria|0
4732902|NCT01928381|16324743|P4|Part 2 - First Intervention|Study specific withdrawal criteria|0
4732903|NCT01928381|16324744|P3|Part 2 - First Intervention|Study specific withdrawal criteria|1
4732904|NCT01928381|16324745|P2|Part 2 - First Intervention|Study specific withdrawal criteria|0
4732905|NCT01928381|16324746|P1|Part 2 - First Intervention|Study specific withdrawal criteria|0
4732906|NCT01928381|16324740|P7|Part 2 - First Intervention|Withdrawal by Subject|0
4732907|NCT01928381|16324741|P6|Part 2 - First Intervention|Withdrawal by Subject|0
4732908|NCT01928381|16324742|P5|Part 2 - First Intervention|Withdrawal by Subject|0
4732909|NCT01928381|16324743|P4|Part 2 - First Intervention|Withdrawal by Subject|0
4732910|NCT01928381|16324744|P3|Part 2 - First Intervention|Withdrawal by Subject|1
4732911|NCT01928381|16324745|P2|Part 2 - First Intervention|Withdrawal by Subject|0
4732912|NCT01928381|16324746|P1|Part 2 - First Intervention|Withdrawal by Subject|0
4732913|NCT01928381|16324740|P7|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4732914|NCT01928381|16324741|P6|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4732915|NCT01928381|16324742|P5|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4732916|NCT01928381|16324743|P4|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4732917|NCT01928381|16324744|P3|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4732918|NCT01928381|16324745|P2|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0
4732919|NCT01928381|16324746|P1|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10
4732920|NCT01928381|16324740|P7|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4732921|NCT01928381|16324741|P6|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4732922|NCT01928381|16324742|P5|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4732923|NCT01928381|16324743|P4|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4732924|NCT01928381|16324744|P3|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4732925|NCT01928381|16324745|P2|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0
4732926|NCT01928381|16324746|P1|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1
4732927|NCT01928381|16324740|P7|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4732928|NCT01928381|16324741|P6|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4732929|NCT01928381|16324742|P5|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4732930|NCT01928381|16324743|P4|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4732931|NCT01928381|16324744|P3|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4732932|NCT01928381|16324745|P2|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0
4732933|NCT01928381|16324746|P1|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2
4732934|NCT01928381|16324740|P7|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4732935|NCT01928381|16324741|P6|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4732936|NCT01928381|16324742|P5|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4732937|NCT01928381|16324743|P4|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4732938|NCT01928381|16324744|P3|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4732939|NCT01928381|16324745|P2|Placebo run-in & Part 2 Eligibility|Adverse Event|0
4732940|NCT01928381|16324746|P1|Placebo run-in & Part 2 Eligibility|Adverse Event|1
4732941|NCT01928381|16324740|P7|Part 1 - Pain Training|Protocol Violation|0
4732942|NCT01928381|16324741|P6|Part 1 - Pain Training|Protocol Violation|0
4732943|NCT01928381|16324742|P5|Part 1 - Pain Training|Protocol Violation|0
4732944|NCT01928381|16324743|P4|Part 1 - Pain Training|Protocol Violation|0
4732945|NCT01928381|16324744|P3|Part 1 - Pain Training|Protocol Violation|0
4732946|NCT01928381|16324745|P2|Part 1 - Pain Training|Protocol Violation|0
4732947|NCT01928381|16324746|P1|Part 1 - Pain Training|Protocol Violation|1
4732948|NCT01928381|16324740|P7|Part 1 - Pain Training|Lost to Follow-up|0
4732949|NCT01928381|16324741|P6|Part 1 - Pain Training|Lost to Follow-up|0
4732950|NCT01928381|16324742|P5|Part 1 - Pain Training|Lost to Follow-up|0
4732951|NCT01928381|16324743|P4|Part 1 - Pain Training|Lost to Follow-up|0
4732952|NCT01928381|16324744|P3|Part 1 - Pain Training|Lost to Follow-up|0
4732953|NCT01928381|16324745|P2|Part 1 - Pain Training|Lost to Follow-up|0
4732954|NCT01928381|16324746|P1|Part 1 - Pain Training|Lost to Follow-up|4
4732955|NCT01928381|16324740|P7|Part 1 - Pain Training|Withdrawal by Subject|0
4732956|NCT01928381|16324741|P6|Part 1 - Pain Training|Withdrawal by Subject|0
4732957|NCT01928381|16324742|P5|Part 1 - Pain Training|Withdrawal by Subject|0
4732958|NCT01928381|16324743|P4|Part 1 - Pain Training|Withdrawal by Subject|0
4732959|NCT01928381|16324744|P3|Part 1 - Pain Training|Withdrawal by Subject|0
4732960|NCT01928381|16324745|P2|Part 1 - Pain Training|Withdrawal by Subject|0
4732961|NCT01928381|16324746|P1|Part 1 - Pain Training|Withdrawal by Subject|1
4732962|NCT01928381|16324740|P7|Part 1 - Pain Training|Pain training criteria not met|0
4732963|NCT01928381|16324741|P6|Part 1 - Pain Training|Pain training criteria not met|0
4732964|NCT01928381|16324742|P5|Part 1 - Pain Training|Pain training criteria not met|0
4732965|NCT01928381|16324743|P4|Part 1 - Pain Training|Pain training criteria not met|0
4732966|NCT01928381|16324744|P3|Part 1 - Pain Training|Pain training criteria not met|0
4732967|NCT01928381|16324745|P2|Part 1 - Pain Training|Pain training criteria not met|0
4732968|NCT01928381|16324746|P1|Part 1 - Pain Training|Pain training criteria not met|29
4732969|NCT01928381|16324740|P7|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4732970|NCT01928381|16324741|P6|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4732971|NCT01928381|16324742|P5|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4732972|NCT01928381|16324743|P4|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4732973|NCT01928381|16324744|P3|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4732974|NCT01928381|16324745|P2|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0
4732975|NCT01928381|16324746|P1|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60
4732976|NCT01928329|16324761|P2|Overall Study|Physician Decision|1
4732977|NCT01928329|16324762|P1|Overall Study|Physician Decision|1
4732978|NCT01928329|16324761|P2|Overall Study|Withdrawal by Subject|5
4732979|NCT01928329|16324762|P1|Overall Study|Withdrawal by Subject|1
4732980|NCT01928329|16324761|P2|Overall Study|Stopping Rule: Lost Greater than 5kg|1
4732981|NCT01928329|16324762|P1|Overall Study|Stopping Rule: Lost Greater than 5kg|4
4732982|NCT01928329|16324761|P2|Overall Study|Adverse Event|3
4732983|NCT01928329|16324762|P1|Overall Study|Adverse Event|5
4732984|NCT01928329|16324761|P2|Overall Study|Removed from Study Prior to Receiving Dr|1
4732985|NCT01928329|16324762|P1|Overall Study|Removed from Study Prior to Receiving Dr|0
4732986|NCT01928329|16324761|P2|Overall Study|Withdrew Consent Prior to Receiving Drug|3
4732987|NCT01928329|16324762|P1|Overall Study|Withdrew Consent Prior to Receiving Drug|1
4732988|NCT01928225|16324797|P2|Overall Study|Lost to Follow-up|3
4732989|NCT01928225|16324798|P1|Overall Study|Lost to Follow-up|1
4732990|NCT01928225|16324797|P2|Overall Study|basaloid cervical cancer|0
4732991|NCT01928225|16324798|P1|Overall Study|basaloid cervical cancer|1
4732992|NCT01928225|16324797|P2|Overall Study|Pregnancy|0
4732993|NCT01928225|16324798|P1|Overall Study|Pregnancy|1
4732994|NCT01928082|16324820|P1|Overall Study|Study terminated.|1
4732995|NCT01927861|16324854|P2|Extension Phase (104 Weeks)|Unclassified|1
4732996|NCT01927861|16324855|P1|Extension Phase (104 Weeks)|Unclassified|0
4732997|NCT01927861|16324854|P2|Extension Phase (104 Weeks)|Adverse Event|2
4732998|NCT01927861|16324855|P1|Extension Phase (104 Weeks)|Adverse Event|0
4732999|NCT01927757|16324993|P1|Overall Study|Ethical Reasons|4
4733000|NCT01927757|16324993|P1|Overall Study|Other|1
4733001|NCT01927757|16324993|P1|Overall Study|Decision by Sponsor|2
4733002|NCT01927757|16324993|P1|Overall Study|Lost to Follow-up|2
4733003|NCT01927757|16324993|P1|Overall Study|Withdrawal by Subject|14
4733004|NCT01927627|16325015|P1|Overall Study|Financial Concerns|1
4733005|NCT01927627|16325015|P1|Overall Study|Lack of Efficacy|1
4733006|NCT01927627|16325015|P1|Overall Study|Adverse Event|3
4733007|NCT01927562|16325028|P1|Overall Study|Physician Decision|5
4733008|NCT01927562|16325028|P1|Overall Study|Withdrawal by Subject|3
4733009|NCT01927562|16325028|P1|Overall Study|Lost to Follow-up|30
4733010|NCT01927419|16325034|P2|Overall Study|Not reported|0
4733011|NCT01927419|16325035|P1|Overall Study|Not reported|1
4733012|NCT01927419|16325034|P2|Overall Study|Other|1
4733013|NCT01927419|16325035|P1|Overall Study|Other|2
4733014|NCT01927419|16325034|P2|Overall Study|Withdrawal by Subject|1
4733015|NCT01927419|16325035|P1|Overall Study|Withdrawal by Subject|3
4733016|NCT01927419|16325034|P2|Overall Study|Adverse event unrelated to study drug|1
4733017|NCT01927419|16325035|P1|Overall Study|Adverse event unrelated to study drug|6
4733018|NCT01927419|16325034|P2|Overall Study|Death|1
4733019|NCT01927419|16325035|P1|Overall Study|Death|0
4733020|NCT01927419|16325034|P2|Overall Study|Study drug toxicity|7
4733021|NCT01927419|16325035|P1|Overall Study|Study drug toxicity|43
4733022|NCT01927419|16325034|P2|Overall Study|Disease progression|17
4733023|NCT01927419|16325035|P1|Overall Study|Disease progression|15
4733024|NCT01927367|16325053|P2|Overall Study|No baseline data|1
4733025|NCT01927367|16325054|P1|Overall Study|No baseline data|0
4733026|NCT01927367|16325053|P2|Overall Study|Withdrawal by Subject|4
4733027|NCT01927367|16325054|P1|Overall Study|Withdrawal by Subject|7
4733028|NCT01927055|16325086|P3|Double-Blind|Extended Vacation|0
4733029|NCT01927055|16325087|P2|Double-Blind|Extended Vacation|1
4733030|NCT01927055|16325088|P1|Double-Blind|Extended Vacation|0
4733031|NCT01927055|16325086|P3|Double-Blind|Supine Hypertension|1
4733032|NCT01927055|16325087|P2|Double-Blind|Supine Hypertension|0
4733033|NCT01927055|16325088|P1|Double-Blind|Supine Hypertension|0
4733034|NCT01927055|16325086|P3|Double-Blind|Study Stopped|7
4733035|NCT01927055|16325087|P2|Double-Blind|Study Stopped|7
4733036|NCT01927055|16325088|P1|Double-Blind|Study Stopped|0
4733037|NCT01927055|16325086|P3|Double-Blind|Withdrawal by Subject|3
4733038|NCT01927055|16325087|P2|Double-Blind|Withdrawal by Subject|2
4733039|NCT01927055|16325088|P1|Double-Blind|Withdrawal by Subject|0
4733040|NCT01927055|16325086|P3|Double-Blind|Protocol Violation|1
4733041|NCT01927055|16325087|P2|Double-Blind|Protocol Violation|0
4733042|NCT01927055|16325088|P1|Double-Blind|Protocol Violation|0
4733043|NCT01927055|16325086|P3|Double-Blind|Adverse Event|1
4733044|NCT01927055|16325087|P2|Double-Blind|Adverse Event|1
4733045|NCT01927055|16325088|P1|Double-Blind|Adverse Event|0
4733046|NCT01927055|16325086|P3|Open-label|Difficulty attending study visits|0
4733047|NCT01927055|16325087|P2|Open-label|Difficulty attending study visits|0
4733048|NCT01927055|16325088|P1|Open-label|Difficulty attending study visits|1
4733049|NCT01927055|16325086|P3|Open-label|Supine Hypertension|0
4733050|NCT01927055|16325087|P2|Open-label|Supine Hypertension|0
4733051|NCT01927055|16325088|P1|Open-label|Supine Hypertension|4
4733052|NCT01927055|16325086|P3|Open-label|Study Stopped|0
4733053|NCT01927055|16325087|P2|Open-label|Study Stopped|0
4733054|NCT01927055|16325088|P1|Open-label|Study Stopped|4
4733055|NCT01927055|16325086|P3|Open-label|Withdrawal by Subject|0
4733056|NCT01927055|16325087|P2|Open-label|Withdrawal by Subject|0
4733057|NCT01927055|16325088|P1|Open-label|Withdrawal by Subject|1
4733058|NCT01927055|16325086|P3|Open-label|Adverse Event|0
4733059|NCT01927055|16325087|P2|Open-label|Adverse Event|0
4733060|NCT01927055|16325088|P1|Open-label|Adverse Event|6
4733061|NCT01926886|16325106|P2|Overall Study|Did not cooperate|0
4733062|NCT01926886|16325107|P1|Overall Study|Did not cooperate|1
4733063|NCT01926886|16325106|P2|Overall Study|Death|0
4733064|NCT01926886|16325107|P1|Overall Study|Death|1
4733065|NCT01926886|16325106|P2|Overall Study|Progression of disease|0
4733066|NCT01926886|16325107|P1|Overall Study|Progression of disease|2
4733067|NCT01926886|16325106|P2|Overall Study|Recurrence of disease|0
4733068|NCT01926886|16325107|P1|Overall Study|Recurrence of disease|1
4733069|NCT01926886|16325106|P2|Overall Study|Failure to return|0
4733070|NCT01926886|16325107|P1|Overall Study|Failure to return|3
4733071|NCT01926886|16325106|P2|Overall Study|Withdrawal by Subject|0
4733072|NCT01926886|16325107|P1|Overall Study|Withdrawal by Subject|15
4733073|NCT01926886|16325106|P2|Overall Study|Disease progression/recurrence|0
4733074|NCT01926886|16325107|P1|Overall Study|Disease progression/recurrence|4
4733075|NCT01926886|16325106|P2|Overall Study|Adverse event/intercurrent illness|0
4733076|NCT01926886|16325107|P1|Overall Study|Adverse event/intercurrent illness|4
4733077|NCT01926886|16325106|P2|Overall Study|Administrative/other|0
4733078|NCT01926886|16325107|P1|Overall Study|Administrative/other|1
4733079|NCT01926782|16325126|P6|Overall Study|Related to study drug administration|2
4733080|NCT01926782|16325127|P5|Overall Study|Related to study drug administration|0
4733081|NCT01926782|16325128|P4|Overall Study|Related to study drug administration|0
4733082|NCT01926782|16325129|P3|Overall Study|Related to study drug administration|0
4733083|NCT01926782|16325130|P2|Overall Study|Related to study drug administration|0
4733084|NCT01926782|16325131|P1|Overall Study|Related to study drug administration|0
4733085|NCT01926782|16325126|P6|Overall Study|Withdrawal by Subject|5
4733086|NCT01926782|16325127|P5|Overall Study|Withdrawal by Subject|0
4733087|NCT01926782|16325128|P4|Overall Study|Withdrawal by Subject|1
4733088|NCT01926782|16325129|P3|Overall Study|Withdrawal by Subject|8
4733089|NCT01926782|16325130|P2|Overall Study|Withdrawal by Subject|1
4733090|NCT01926782|16325131|P1|Overall Study|Withdrawal by Subject|6
4733091|NCT01926782|16325126|P6|Overall Study|Randomized and not treated|0
4733092|NCT01926782|16325127|P5|Overall Study|Randomized and not treated|0
4733093|NCT01926782|16325128|P4|Overall Study|Randomized and not treated|1
4733094|NCT01926782|16325129|P3|Overall Study|Randomized and not treated|0
4733095|NCT01926782|16325130|P2|Overall Study|Randomized and not treated|0
4733096|NCT01926782|16325131|P1|Overall Study|Randomized and not treated|0
4733097|NCT01926782|16325126|P6|Overall Study|Poor compliance to protocol|6
4733098|NCT01926782|16325127|P5|Overall Study|Poor compliance to protocol|1
4733099|NCT01926782|16325128|P4|Overall Study|Poor compliance to protocol|0
4733100|NCT01926782|16325129|P3|Overall Study|Poor compliance to protocol|8
4733101|NCT01926782|16325130|P2|Overall Study|Poor compliance to protocol|3
4733102|NCT01926782|16325131|P1|Overall Study|Poor compliance to protocol|5
4733103|NCT01926782|16325126|P6|Overall Study|Adverse Event|14
4733104|NCT01926782|16325127|P5|Overall Study|Adverse Event|3
4733105|NCT01926782|16325128|P4|Overall Study|Adverse Event|4
4733106|NCT01926782|16325129|P3|Overall Study|Adverse Event|17
4733107|NCT01926782|16325130|P2|Overall Study|Adverse Event|4
4733108|NCT01926782|16325131|P1|Overall Study|Adverse Event|13
4733109|NCT01926782|16325126|P6|Overall Study|Other than specified|11
4733110|NCT01926782|16325127|P5|Overall Study|Other than specified|4
4733111|NCT01926782|16325128|P4|Overall Study|Other than specified|12
4733112|NCT01926782|16325129|P3|Overall Study|Other than specified|5
4733113|NCT01926782|16325130|P2|Overall Study|Other than specified|3
4733114|NCT01926782|16325131|P1|Overall Study|Other than specified|2
4733115|NCT01926782|16325126|P6|Overall Study|Physician Decision|0
4733116|NCT01926782|16325127|P5|Overall Study|Physician Decision|0
4733117|NCT01926782|16325128|P4|Overall Study|Physician Decision|1
4733118|NCT01926782|16325129|P3|Overall Study|Physician Decision|1
4733119|NCT01926782|16325130|P2|Overall Study|Physician Decision|2
4733120|NCT01926782|16325131|P1|Overall Study|Physician Decision|0
4733121|NCT01926782|16325126|P6|Overall Study|Participant moved|3
4733122|NCT01926782|16325127|P5|Overall Study|Participant moved|0
4733123|NCT01926782|16325128|P4|Overall Study|Participant moved|1
4733124|NCT01926782|16325129|P3|Overall Study|Participant moved|1
4733125|NCT01926782|16325130|P2|Overall Study|Participant moved|0
4733126|NCT01926782|16325131|P1|Overall Study|Participant moved|2
4733127|NCT01926626|16325280|P1|Overall Study|Lost to Follow-up|7
4733128|NCT01926626|16325280|P1|Overall Study|Withdrawal by Subject|15
4733129|NCT01926509|16325294|P4|Overall Study|vital sign met discontinuation criteria|0
4733130|NCT01926509|16325295|P3|Overall Study|vital sign met discontinuation criteria|0
4733131|NCT01926509|16325296|P2|Overall Study|vital sign met discontinuation criteria|0
4733132|NCT01926509|16325297|P1|Overall Study|vital sign met discontinuation criteria|1
4733133|NCT01926444|16325337|P4|Overall Study|Colonoscopy not performed|2
4733134|NCT01926444|16325338|P3|Overall Study|Colonoscopy not performed|4
4733135|NCT01926444|16325339|P2|Overall Study|Colonoscopy not performed|0
4733136|NCT01926444|16325340|P1|Overall Study|Colonoscopy not performed|0
4733137|NCT01926119|16325382|P1|Overall Study|Withdrawal by Subject|1
4733138|NCT01926028|16325395|P3|Overall Study|Non compliance or other reasons|0
4733139|NCT01926028|16325396|P2|Overall Study|Non compliance or other reasons|2
4733140|NCT01926028|16325397|P1|Overall Study|Non compliance or other reasons|4
4733141|NCT01926028|16325395|P3|Overall Study|Withdrawal by Subject|2
4733142|NCT01926028|16325396|P2|Overall Study|Withdrawal by Subject|9
4733143|NCT01926028|16325397|P1|Overall Study|Withdrawal by Subject|9
4733144|NCT01926028|16325395|P3|Overall Study|Physician Decision|0
4733145|NCT01926028|16325396|P2|Overall Study|Physician Decision|5
4733146|NCT01926028|16325397|P1|Overall Study|Physician Decision|1
4733147|NCT01926028|16325395|P3|Overall Study|Lost to Follow-up|0
4733148|NCT01926028|16325396|P2|Overall Study|Lost to Follow-up|6
4733149|NCT01926028|16325397|P1|Overall Study|Lost to Follow-up|7
4733150|NCT01926015|16325433|P2|Overall Study|Randomized not treated|0
4733151|NCT01926015|16325434|P1|Overall Study|Randomized not treated|2
4733152|NCT01926015|16325433|P2|Overall Study|Withdrawal by parent/guardian|1
4733153|NCT01926015|16325434|P1|Overall Study|Withdrawal by parent/guardian|0
4733154|NCT01925989|16325466|P3|Period 1|Withdrawal by Subject|0
4733155|NCT01925989|16325467|P2|Period 1|Withdrawal by Subject|1
4733156|NCT01925989|16325468|P1|Period 1|Withdrawal by Subject|0
4733157|NCT01925989|16325466|P3|Period 1|Sponsor Decision|0
4733158|NCT01925989|16325467|P2|Period 1|Sponsor Decision|1
4733159|NCT01925989|16325468|P1|Period 1|Sponsor Decision|1
4733160|NCT01925950|16325488|P2|Part 2|Withdrawal by Subject|0
4733161|NCT01925950|16325489|P1|Part 2|Withdrawal by Subject|1
4733162|NCT01925768|16325508|P2|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1
4733163|NCT01925768|16325509|P1|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5
4733164|NCT01925768|16325508|P2|ActiveTreatment/Extension (Weeks 24-104)|Death|1
4733165|NCT01925768|16325509|P1|ActiveTreatment/Extension (Weeks 24-104)|Death|0
4733166|NCT01925768|16325508|P2|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1
4733167|NCT01925768|16325509|P1|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2
4733168|NCT01925768|16325508|P2|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9
4733169|NCT01925768|16325509|P1|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7
4733170|NCT01925768|16325508|P2|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
4733171|NCT01925768|16325509|P1|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6
4733172|NCT01925768|16325508|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1
4733173|NCT01925768|16325509|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0
4733174|NCT01925768|16325508|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
4733175|NCT01925768|16325509|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
4733176|NCT01925768|16325508|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
4733177|NCT01925768|16325509|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
4733178|NCT01925768|16325508|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
4733179|NCT01925768|16325509|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
4733180|NCT01925768|16325508|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2
4733181|NCT01925768|16325509|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4733182|NCT01925768|16325508|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4733183|NCT01925768|16325509|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4733184|NCT01925703|16325557|P1|Overall Study|Discharge prior to full iron repletion|1
4733185|NCT01925703|16325557|P1|Overall Study|Lost to Follow-up|2
4733186|NCT01925703|16325557|P1|Overall Study|Physician Decision|1
4733187|NCT01925612|16325575|P5|Overall Study|Adverse Event|2
4733188|NCT01925612|16325576|P4|Overall Study|Adverse Event|1
4733189|NCT01925612|16325577|P3|Overall Study|Adverse Event|0
4733190|NCT01925612|16325578|P2|Overall Study|Adverse Event|3
4733191|NCT01925612|16325579|P1|Overall Study|Adverse Event|3
4733192|NCT01925612|16325575|P5|Overall Study|Progressive Disease|0
4733193|NCT01925612|16325576|P4|Overall Study|Progressive Disease|0
4733194|NCT01925612|16325577|P3|Overall Study|Progressive Disease|1
4733195|NCT01925612|16325578|P2|Overall Study|Progressive Disease|1
4733196|NCT01925612|16325579|P1|Overall Study|Progressive Disease|1
4733197|NCT01925417|16325629|P1|Overall Study|Death|1
4733198|NCT01925417|16325629|P1|Overall Study|Withdrawal by Subject|2
4733199|NCT01925339|16325660|P2|Overall Study|Adverse Event|0
4733200|NCT01925339|16325661|P1|Overall Study|Adverse Event|2
4733201|NCT01925274|16325672|P3|Overall Study|Protocol amendment|6
4733202|NCT01925274|16325673|P2|Overall Study|Protocol amendment|3
4733203|NCT01925274|16325674|P1|Overall Study|Protocol amendment|1
4733204|NCT01925274|16325672|P3|Overall Study|Study terminated by sponsor|0
4733205|NCT01925274|16325673|P2|Overall Study|Study terminated by sponsor|0
4733206|NCT01925274|16325674|P1|Overall Study|Study terminated by sponsor|4
4733207|NCT01925274|16325672|P3|Overall Study|Withdrawal by Subject|0
4733208|NCT01925274|16325673|P2|Overall Study|Withdrawal by Subject|2
4733209|NCT01925274|16325674|P1|Overall Study|Withdrawal by Subject|1
4733210|NCT01925274|16325672|P3|Overall Study|Lost to Follow-up|0
4733211|NCT01925274|16325673|P2|Overall Study|Lost to Follow-up|1
4733212|NCT01925274|16325674|P1|Overall Study|Lost to Follow-up|0
4733213|NCT01925274|16325672|P3|Overall Study|Death|0
4733214|NCT01925274|16325673|P2|Overall Study|Death|0
4733215|NCT01925274|16325674|P1|Overall Study|Death|1
4733216|NCT01925209|16325755|P4|Follow-up|Withdrawal by Subject|2
4733217|NCT01925209|16325756|P3|Follow-up|Withdrawal by Subject|0
4733218|NCT01925209|16325757|P2|Follow-up|Withdrawal by Subject|2
4733219|NCT01925209|16325758|P1|Follow-up|Withdrawal by Subject|0
4733220|NCT01925209|16325755|P4|Follow-up|Non-compliance with study treatment|1
4733221|NCT01925209|16325756|P3|Follow-up|Non-compliance with study treatment|0
4733222|NCT01925209|16325757|P2|Follow-up|Non-compliance with study treatment|0
4733223|NCT01925209|16325758|P1|Follow-up|Non-compliance with study treatment|0
4733224|NCT01925209|16325755|P4|Follow-up|Physician Decision|0
4733225|NCT01925209|16325756|P3|Follow-up|Physician Decision|1
4733226|NCT01925209|16325757|P2|Follow-up|Physician Decision|0
4733227|NCT01925209|16325758|P1|Follow-up|Physician Decision|0
4733228|NCT01925209|16325755|P4|Follow-up|Adverse Event|1
4733229|NCT01925209|16325756|P3|Follow-up|Adverse Event|0
4733230|NCT01925209|16325757|P2|Follow-up|Adverse Event|4
4733231|NCT01925209|16325758|P1|Follow-up|Adverse Event|1
4733232|NCT01925209|16325755|P4|Maintenance Treatment Epoch|Adverse Event|0
4733233|NCT01925209|16325756|P3|Maintenance Treatment Epoch|Adverse Event|1
4733234|NCT01925209|16325757|P2|Maintenance Treatment Epoch|Adverse Event|0
4733235|NCT01925209|16325758|P1|Maintenance Treatment Epoch|Adverse Event|0
4733236|NCT01925209|16325755|P4|Maintenance Treatment Epoch|Withdrawal by Subject|2
4733237|NCT01925209|16325756|P3|Maintenance Treatment Epoch|Withdrawal by Subject|1
4733238|NCT01925209|16325757|P2|Maintenance Treatment Epoch|Withdrawal by Subject|1
4733239|NCT01925209|16325758|P1|Maintenance Treatment Epoch|Withdrawal by Subject|0
4733240|NCT01925209|16325755|P4|Treatment Epoch|Adverse Event|1
4733241|NCT01925209|16325756|P3|Treatment Epoch|Adverse Event|3
4733242|NCT01925209|16325757|P2|Treatment Epoch|Adverse Event|5
4733243|NCT01925209|16325758|P1|Treatment Epoch|Adverse Event|3
4733244|NCT01925209|16325755|P4|Treatment Epoch|Withdrawal by Subject|2
4733245|NCT01925209|16325756|P3|Treatment Epoch|Withdrawal by Subject|3
4733246|NCT01925209|16325757|P2|Treatment Epoch|Withdrawal by Subject|3
4733247|NCT01925209|16325758|P1|Treatment Epoch|Withdrawal by Subject|4
4733248|NCT01925209|16325755|P4|Treatment Epoch|Protocol deviation|1
4733249|NCT01925209|16325756|P3|Treatment Epoch|Protocol deviation|1
4733250|NCT01925209|16325757|P2|Treatment Epoch|Protocol deviation|0
4733251|NCT01925209|16325758|P1|Treatment Epoch|Protocol deviation|0
4733252|NCT01925209|16325755|P4|Treatment Epoch|Death|0
4733253|NCT01925209|16325756|P3|Treatment Epoch|Death|0
4733254|NCT01925209|16325757|P2|Treatment Epoch|Death|0
4733255|NCT01925209|16325758|P1|Treatment Epoch|Death|1
4733256|NCT01925209|16325755|P4|Treatment Epoch|Non-compliance with study treatment|1
4733257|NCT01925209|16325756|P3|Treatment Epoch|Non-compliance with study treatment|0
4733258|NCT01925209|16325757|P2|Treatment Epoch|Non-compliance with study treatment|0
4733259|NCT01925209|16325758|P1|Treatment Epoch|Non-compliance with study treatment|0
4733260|NCT01925209|16325755|P4|Treatment Epoch|Physician Decision|0
4733261|NCT01925209|16325756|P3|Treatment Epoch|Physician Decision|0
4733262|NCT01925209|16325757|P2|Treatment Epoch|Physician Decision|0
4733263|NCT01925209|16325758|P1|Treatment Epoch|Physician Decision|1
4733264|NCT01925183|16325790|P2|Overall Study|Adverse Event|0
4733265|NCT01925183|16325791|P1|Overall Study|Adverse Event|1
4733266|NCT01925170|16325799|P1|Overall Study|Unverified cancer status|53
4733267|NCT01925014|16325830|P2|Overall Study|Withdrawal by Subject|13
4733268|NCT01925014|16325831|P1|Overall Study|Withdrawal by Subject|5
4733269|NCT01925014|16325830|P2|Overall Study|Inappropriate enrollment|6
4733270|NCT01925014|16325831|P1|Overall Study|Inappropriate enrollment|4
4733271|NCT01924845|16325906|P1|Overall Study|Protocol Violation|1
4733272|NCT01924845|16325906|P1|Overall Study|Withdrawal by Subject|2
4733273|NCT01924845|16325906|P1|Overall Study|Adverse Event|3
4733274|NCT01924806|16325916|P2|Overall Study|Physician Decision|1
4733275|NCT01924806|16325917|P1|Overall Study|Physician Decision|2
4733276|NCT01924767|16325934|P5|Overall Study|Adverse Event|0
4733277|NCT01924767|16325935|P4|Overall Study|Adverse Event|0
4733278|NCT01924767|16325936|P3|Overall Study|Adverse Event|1
4733279|NCT01924767|16325937|P2|Overall Study|Adverse Event|0
4733280|NCT01924767|16325938|P1|Overall Study|Adverse Event|1
4733281|NCT01924689|16326044|P6|Overall Study|Other|0
4733282|NCT01924689|16326045|P5|Overall Study|Other|1
4733283|NCT01924689|16326046|P4|Overall Study|Other|0
4733284|NCT01924689|16326047|P3|Overall Study|Other|0
4733285|NCT01924689|16326048|P2|Overall Study|Other|0
4733286|NCT01924689|16326049|P1|Overall Study|Other|0
4733287|NCT01924689|16326044|P6|Overall Study|Withdrawal of consent|0
4733288|NCT01924689|16326045|P5|Overall Study|Withdrawal of consent|0
4733289|NCT01924689|16326046|P4|Overall Study|Withdrawal of consent|1
4733290|NCT01924689|16326047|P3|Overall Study|Withdrawal of consent|1
4733291|NCT01924689|16326048|P2|Overall Study|Withdrawal of consent|0
4733292|NCT01924689|16326049|P1|Overall Study|Withdrawal of consent|0
4733293|NCT01924689|16326044|P6|Overall Study|New therapy or study|0
4733294|NCT01924689|16326045|P5|Overall Study|New therapy or study|2
4733295|NCT01924689|16326046|P4|Overall Study|New therapy or study|4
4733296|NCT01924689|16326047|P3|Overall Study|New therapy or study|1
4733297|NCT01924689|16326048|P2|Overall Study|New therapy or study|2
4733298|NCT01924689|16326049|P1|Overall Study|New therapy or study|3
4733299|NCT01924689|16326044|P6|Overall Study|Disease progression|2
4733300|NCT01924689|16326045|P5|Overall Study|Disease progression|3
4733301|NCT01924689|16326046|P4|Overall Study|Disease progression|0
4733302|NCT01924689|16326047|P3|Overall Study|Disease progression|2
4733303|NCT01924689|16326048|P2|Overall Study|Disease progression|0
4733304|NCT01924689|16326049|P1|Overall Study|Disease progression|0
4733305|NCT01924689|16326044|P6|Overall Study|Death|0
4733306|NCT01924689|16326045|P5|Overall Study|Death|0
4733307|NCT01924689|16326046|P4|Overall Study|Death|1
4733308|NCT01924689|16326047|P3|Overall Study|Death|0
4733309|NCT01924689|16326048|P2|Overall Study|Death|1
4733310|NCT01924689|16326049|P1|Overall Study|Death|0
4733311|NCT01924533|16326123|P2|Overall Study|Other Eligibility criteria|1
4733312|NCT01924533|16326124|P1|Overall Study|Other Eligibility criteria|1
4733313|NCT01924533|16326123|P2|Overall Study|Withdrawal by Subject|3
4733314|NCT01924533|16326124|P1|Overall Study|Withdrawal by Subject|7
4733315|NCT01924533|16326123|P2|Overall Study|Lost to Follow-up|1
4733316|NCT01924533|16326124|P1|Overall Study|Lost to Follow-up|0
4733317|NCT01924533|16326123|P2|Overall Study|Death|200
4733318|NCT01924533|16326124|P1|Overall Study|Death|181
4733319|NCT01924429|16326165|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
4733320|NCT01924429|16326166|P1|Washout Period (2 Weeks)|Withdrawal by Subject|3
4733321|NCT01924364|16326209|P1|Overall Study|Physician Decision|3
4733322|NCT01924299|16326226|P2|Period 2|Adverse Event|1
4733323|NCT01924299|16326227|P1|Period 2|Adverse Event|0
4733324|NCT01924299|16326226|P2|Period 2|Withdrawal by Subject|0
4733325|NCT01924299|16326227|P1|Period 2|Withdrawal by Subject|1
4733326|NCT01924182|16326249|P2|Overall Study|Withdrawal by Subject|0
4733327|NCT01924182|16326250|P1|Overall Study|Withdrawal by Subject|1
4733328|NCT01923896|16326291|P2|Overall Study|Adverse Event|0
4733329|NCT01923896|16326292|P1|Overall Study|Adverse Event|1
4733330|NCT01923740|16326315|P2|Overall Study|Withdrawal by Subject|0
4733331|NCT01923740|16326316|P1|Overall Study|Withdrawal by Subject|2
4733332|NCT01923740|16326315|P2|Overall Study|Lost to Follow-up|9
4733333|NCT01923740|16326316|P1|Overall Study|Lost to Follow-up|4
4733334|NCT01923467|16326741|P1|Overall Study|Subject non-interest|479
4733335|NCT01923467|16326741|P1|Overall Study|Lost to Follow-up|62
4733336|NCT01923428|16326749|P4|Overall Study|Lack of Efficacy|1
4733337|NCT01923428|16326750|P3|Overall Study|Lack of Efficacy|1
4733338|NCT01923428|16326751|P2|Overall Study|Lack of Efficacy|0
4733339|NCT01923428|16326752|P1|Overall Study|Lack of Efficacy|0
4733340|NCT01923428|16326749|P4|Overall Study|Non Compliance to treatment|1
4733341|NCT01923428|16326750|P3|Overall Study|Non Compliance to treatment|0
4733342|NCT01923428|16326751|P2|Overall Study|Non Compliance to treatment|2
4733343|NCT01923428|16326752|P1|Overall Study|Non Compliance to treatment|1
4733344|NCT01923428|16326749|P4|Overall Study|Protocol Violation|1
4733345|NCT01923428|16326750|P3|Overall Study|Protocol Violation|2
4733346|NCT01923428|16326751|P2|Overall Study|Protocol Violation|0
4733347|NCT01923428|16326752|P1|Overall Study|Protocol Violation|3
4733348|NCT01923428|16326749|P4|Overall Study|Lost to Follow-up|0
4733349|NCT01923428|16326750|P3|Overall Study|Lost to Follow-up|5
4733350|NCT01923428|16326751|P2|Overall Study|Lost to Follow-up|1
4733351|NCT01923428|16326752|P1|Overall Study|Lost to Follow-up|2
4733352|NCT01923428|16326749|P4|Overall Study|Withdrawal by Subject|4
4733353|NCT01923428|16326750|P3|Overall Study|Withdrawal by Subject|0
4733354|NCT01923428|16326751|P2|Overall Study|Withdrawal by Subject|3
4733355|NCT01923428|16326752|P1|Overall Study|Withdrawal by Subject|5
4733356|NCT01923428|16326749|P4|Overall Study|Adverse Event|3
4733357|NCT01923428|16326750|P3|Overall Study|Adverse Event|3
4733358|NCT01923428|16326751|P2|Overall Study|Adverse Event|6
4733359|NCT01923428|16326752|P1|Overall Study|Adverse Event|8
4733360|NCT01923389|16326764|P2|Overall Study|Protocol Violation|0
4733361|NCT01923389|16326765|P1|Overall Study|Protocol Violation|1
4733362|NCT01923363|16326787|P1|Overall Study|Protocol Violation|1
4733363|NCT01923311|16326796|P2|Overall Study|Study Terminated by Sponsor|0
4733364|NCT01923311|16326797|P1|Overall Study|Study Terminated by Sponsor|12
4733365|NCT01923311|16326796|P2|Overall Study|Withdrew Consent|0
4733366|NCT01923311|16326797|P1|Overall Study|Withdrew Consent|1
4733367|NCT01923311|16326796|P2|Overall Study|Non-Compliance with Study Drug|1
4733368|NCT01923311|16326797|P1|Overall Study|Non-Compliance with Study Drug|2
4733369|NCT01923311|16326796|P2|Overall Study|Investigator's Discretion|0
4733370|NCT01923311|16326797|P1|Overall Study|Investigator's Discretion|1
4733371|NCT01923311|16326796|P2|Overall Study|Pregnancy|0
4733372|NCT01923311|16326797|P1|Overall Study|Pregnancy|1
4733373|NCT01923181|16326849|P9|Overall Study|Lost to Follow-up|1
4733374|NCT01923181|16326850|P8|Overall Study|Lost to Follow-up|3
4733375|NCT01923181|16326851|P7|Overall Study|Lost to Follow-up|3
4733376|NCT01923181|16326852|P6|Overall Study|Lost to Follow-up|1
4733377|NCT01923181|16326853|P5|Overall Study|Lost to Follow-up|2
4733378|NCT01923181|16326854|P4|Overall Study|Lost to Follow-up|1
4733379|NCT01923181|16326855|P3|Overall Study|Lost to Follow-up|2
4733380|NCT01923181|16326856|P2|Overall Study|Lost to Follow-up|3
4733381|NCT01923181|16326857|P1|Overall Study|Lost to Follow-up|0
4733382|NCT01923181|16326849|P9|Overall Study|Other|0
4733383|NCT01923181|16326850|P8|Overall Study|Other|0
4733384|NCT01923181|16326851|P7|Overall Study|Other|0
4733385|NCT01923181|16326852|P6|Overall Study|Other|0
4733386|NCT01923181|16326853|P5|Overall Study|Other|0
4733387|NCT01923181|16326854|P4|Overall Study|Other|1
4733388|NCT01923181|16326855|P3|Overall Study|Other|0
4733389|NCT01923181|16326856|P2|Overall Study|Other|0
4733390|NCT01923181|16326857|P1|Overall Study|Other|1
4733391|NCT01923181|16326849|P9|Overall Study|Withdrawal by Subject|1
4733392|NCT01923181|16326850|P8|Overall Study|Withdrawal by Subject|3
4733393|NCT01923181|16326851|P7|Overall Study|Withdrawal by Subject|4
4733394|NCT01923181|16326852|P6|Overall Study|Withdrawal by Subject|2
4733395|NCT01923181|16326853|P5|Overall Study|Withdrawal by Subject|4
4733396|NCT01923181|16326854|P4|Overall Study|Withdrawal by Subject|1
4733397|NCT01923181|16326855|P3|Overall Study|Withdrawal by Subject|0
4733398|NCT01923181|16326856|P2|Overall Study|Withdrawal by Subject|1
4733399|NCT01923181|16326857|P1|Overall Study|Withdrawal by Subject|0
4733400|NCT01923181|16326849|P9|Overall Study|Protocol Violation|1
4733401|NCT01923181|16326850|P8|Overall Study|Protocol Violation|2
4733402|NCT01923181|16326851|P7|Overall Study|Protocol Violation|1
4733403|NCT01923181|16326852|P6|Overall Study|Protocol Violation|1
4733404|NCT01923181|16326853|P5|Overall Study|Protocol Violation|2
4733405|NCT01923181|16326854|P4|Overall Study|Protocol Violation|2
4733406|NCT01923181|16326855|P3|Overall Study|Protocol Violation|0
4733407|NCT01923181|16326856|P2|Overall Study|Protocol Violation|2
4733408|NCT01923181|16326857|P1|Overall Study|Protocol Violation|2
4733409|NCT01923168|16326935|P3|Overall Study|Death|1
4733410|NCT01923168|16326936|P2|Overall Study|Death|0
4733411|NCT01923168|16326937|P1|Overall Study|Death|0
4733412|NCT01923168|16326935|P3|Overall Study|Progressive disease|7
4733413|NCT01923168|16326936|P2|Overall Study|Progressive disease|3
4733414|NCT01923168|16326937|P1|Overall Study|Progressive disease|4
4733415|NCT01923168|16326935|P3|Overall Study|Physician Decision|5
4733416|NCT01923168|16326936|P2|Overall Study|Physician Decision|9
4733417|NCT01923168|16326937|P1|Overall Study|Physician Decision|6
4733418|NCT01923168|16326935|P3|Overall Study|Adverse Event|0
4733419|NCT01923168|16326936|P2|Overall Study|Adverse Event|12
4733420|NCT01923168|16326937|P1|Overall Study|Adverse Event|12
4733421|NCT01923168|16326935|P3|Overall Study|Subject/guardian decision|4
4733422|NCT01923168|16326936|P2|Overall Study|Subject/guardian decision|14
4733423|NCT01923168|16326937|P1|Overall Study|Subject/guardian decision|14
4733424|NCT01923168|16326935|P3|Overall Study|Protocol Violation|0
4733425|NCT01923168|16326936|P2|Overall Study|Protocol Violation|1
4733426|NCT01923168|16326937|P1|Overall Study|Protocol Violation|1
4733427|NCT01922934|16327020|P2|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284
4733428|NCT01922934|16327021|P1|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21
4733429|NCT01922934|16327020|P2|Visit 0 - Patient Contacted & Consented|No response or could not reach|0
4733430|NCT01922934|16327021|P1|Visit 0 - Patient Contacted & Consented|No response or could not reach|66
4733431|NCT01922934|16327020|P2|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0
4733432|NCT01922934|16327021|P1|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169
4733433|NCT01922934|16327020|P2|Eligible Patients|Did not meet inclusion criteria|81
4733434|NCT01922934|16327021|P1|Eligible Patients|Did not meet inclusion criteria|36
4733435|NCT01922934|16327020|P2|Eligible Patients|Physician Decision|0
4733436|NCT01922934|16327021|P1|Eligible Patients|Physician Decision|17
4733437|NCT01922934|16327020|P2|Eligible Patients|Death|7
4733438|NCT01922934|16327021|P1|Eligible Patients|Death|0
4733439|NCT01922739|16327033|P1|Open-label Treatment Period|Sponsor request - investigator leaving|1
4733440|NCT01922739|16327033|P1|Open-label Treatment Period|Physician Decision|1
4733441|NCT01922739|16327033|P1|Open-label Treatment Period|Lost to Follow-up|2
4733442|NCT01922739|16327033|P1|Open-label Treatment Period|Noncompliance to study procedures|1
4733443|NCT01922739|16327033|P1|Open-label Treatment Period|Pregnancy|1
4733444|NCT01922739|16327033|P1|Open-label Treatment Period|Protocol Violation|5
4733445|NCT01922739|16327033|P1|Open-label Treatment Period|Noncompliance to study medication|3
4733446|NCT01922739|16327033|P1|Open-label Treatment Period|Withdrawal by Subject|14
4733447|NCT01922739|16327033|P1|Open-label Treatment Period|Adverse Event|6
4733448|NCT01922739|16327033|P1|Titration/Adjustment Period|Lack of Efficacy|3
4733449|NCT01922739|16327033|P1|Titration/Adjustment Period|Lost to Follow-up|1
4733450|NCT01922739|16327033|P1|Titration/Adjustment Period|Withdrawal by Subject|5
4733451|NCT01922739|16327033|P1|Titration/Adjustment Period|Adverse Event|3
4733452|NCT01922349|16327062|P4|Multiple Rising Dose (MRD) Period|Adverse Event|1
4733453|NCT01922349|16327063|P3|Multiple Rising Dose (MRD) Period|Adverse Event|0
4733454|NCT01922349|16327064|P2|Multiple Rising Dose (MRD) Period|Adverse Event|0
4733455|NCT01922349|16327065|P1|Multiple Rising Dose (MRD) Period|Adverse Event|0
4733456|NCT01922271|16327194|P2|WASHOUT Period|Withdrawal by Subject|0
4733457|NCT01922271|16327195|P1|WASHOUT Period|Withdrawal by Subject|1
4733458|NCT01922258|16327215|P2|Overall Study|Withdrawal by participant|5
4733459|NCT01922258|16327216|P1|Overall Study|Withdrawal by participant|5
4733460|NCT01922258|16327215|P2|Overall Study|Withdrawn by the Investigator|4
4733461|NCT01922258|16327216|P1|Overall Study|Withdrawn by the Investigator|1
4733462|NCT01922258|16327215|P2|Overall Study|Met Withdrawal Criteria|4
4733463|NCT01922258|16327216|P1|Overall Study|Met Withdrawal Criteria|0
4733464|NCT01922258|16327215|P2|Overall Study|Adverse Event|2
4733465|NCT01922258|16327216|P1|Overall Study|Adverse Event|9
4733466|NCT01922258|16327215|P2|Overall Study|Lost to Follow-up|1
4733467|NCT01922258|16327216|P1|Overall Study|Lost to Follow-up|1
4733468|NCT01922102|16327248|P3|Overall Study|Administrative problems|0
4733469|NCT01922102|16327249|P2|Overall Study|Administrative problems|2
4733470|NCT01922102|16327250|P1|Overall Study|Administrative problems|0
4733471|NCT01922102|16327248|P3|Overall Study|Lost to Follow-up|0
4733472|NCT01922102|16327249|P2|Overall Study|Lost to Follow-up|0
4733473|NCT01922102|16327250|P1|Overall Study|Lost to Follow-up|1
4733474|NCT01922102|16327248|P3|Overall Study|Adverse Event|0
4733475|NCT01922102|16327249|P2|Overall Study|Adverse Event|2
4733476|NCT01922102|16327250|P1|Overall Study|Adverse Event|1
4733477|NCT01922102|16327248|P3|Overall Study|Physician Decision|1
4733478|NCT01922102|16327249|P2|Overall Study|Physician Decision|2
4733479|NCT01922102|16327250|P1|Overall Study|Physician Decision|0
4733480|NCT01922102|16327248|P3|Overall Study|Withdrawal by Subject|7
4733481|NCT01922102|16327249|P2|Overall Study|Withdrawal by Subject|3
4733482|NCT01922102|16327250|P1|Overall Study|Withdrawal by Subject|7
4733483|NCT01922089|16327286|P2|Overall Study|Lost to Follow-up|1
4733484|NCT01922089|16327287|P1|Overall Study|Lost to Follow-up|0
4733485|NCT01922089|16327286|P2|Overall Study|Death|1
4733486|NCT01922089|16327287|P1|Overall Study|Death|2
4733487|NCT01922089|16327286|P2|Overall Study|Physician Decision|3
4733488|NCT01922089|16327287|P1|Overall Study|Physician Decision|2
4733489|NCT01922089|16327286|P2|Overall Study|administrative problems|1
4733490|NCT01922089|16327287|P1|Overall Study|administrative problems|4
4733491|NCT01922089|16327286|P2|Overall Study|Withdrawal by Subject|4
4733492|NCT01922089|16327287|P1|Overall Study|Withdrawal by Subject|3
4733493|NCT01922089|16327286|P2|Overall Study|Protocol Deviation|7
4733494|NCT01922089|16327287|P1|Overall Study|Protocol Deviation|10
4733495|NCT01922089|16327286|P2|Overall Study|Adverse Event|13
4733496|NCT01922089|16327287|P1|Overall Study|Adverse Event|18
4733497|NCT01922037|16327364|P2|Overall Study|Other unspecified|66
4733498|NCT01922037|16327365|P1|Overall Study|Other unspecified|2
4733499|NCT01922037|16327364|P2|Overall Study|Investigator/Sponsor decision|4
4733500|NCT01922037|16327365|P1|Overall Study|Investigator/Sponsor decision|1
4733501|NCT01922037|16327364|P2|Overall Study|Participant non-compliance|46
4733502|NCT01922037|16327365|P1|Overall Study|Participant non-compliance|4
4733503|NCT01922037|16327364|P2|Overall Study|Pregnancy|2
4733504|NCT01922037|16327365|P1|Overall Study|Pregnancy|0
4733505|NCT01922037|16327364|P2|Overall Study|Death|5
4733506|NCT01922037|16327365|P1|Overall Study|Death|0
4733507|NCT01922037|16327364|P2|Overall Study|Adverse Event|7
4733508|NCT01922037|16327365|P1|Overall Study|Adverse Event|1
4733509|NCT01922037|16327364|P2|Overall Study|Withdrawal by Subject|44
4733510|NCT01922037|16327365|P1|Overall Study|Withdrawal by Subject|2
4733511|NCT01922011|16327468|P2|Overall Study|Randomized in error|0
4733512|NCT01922011|16327469|P1|Overall Study|Randomized in error|1
4733513|NCT01922011|16327468|P2|Overall Study|Lack of willing home health agency|0
4733514|NCT01922011|16327469|P1|Overall Study|Lack of willing home health agency|1
4733515|NCT01922011|16327468|P2|Overall Study|Not Treated|0
4733516|NCT01922011|16327469|P1|Overall Study|Not Treated|1
4733517|NCT01922011|16327468|P2|Overall Study|Missed Test-of-Cure Visit|2
4733518|NCT01922011|16327469|P1|Overall Study|Missed Test-of-Cure Visit|0
4733519|NCT01922011|16327468|P2|Overall Study|Lost to Follow-up|1
4733520|NCT01922011|16327469|P1|Overall Study|Lost to Follow-up|0
4733521|NCT01922011|16327468|P2|Overall Study|Parent/Guardian Decision|0
4733522|NCT01922011|16327469|P1|Overall Study|Parent/Guardian Decision|3
4733523|NCT01922011|16327468|P2|Overall Study|Physician Decision|1
4733524|NCT01922011|16327469|P1|Overall Study|Physician Decision|0
4733525|NCT01922011|16327468|P2|Overall Study|Protocol Violation|1
4733526|NCT01922011|16327469|P1|Overall Study|Protocol Violation|0
4733527|NCT01921829|16327536|P2|Overall Study|Withdrawal by Subject|1
4733528|NCT01921829|16327537|P1|Overall Study|Withdrawal by Subject|0
4733529|NCT01921517|16327613|P2|Overall Study|Subject missed final imaging|4
4733530|NCT01921517|16327614|P1|Overall Study|Subject missed final imaging|1
4733531|NCT01921517|16327613|P2|Overall Study|Withdrawal by Subject|3
4733532|NCT01921517|16327614|P1|Overall Study|Withdrawal by Subject|7
4733533|NCT01921517|16327613|P2|Overall Study|Physician Decision|2
4733534|NCT01921517|16327614|P1|Overall Study|Physician Decision|0
4733535|NCT01921517|16327613|P2|Overall Study|Newly diagnosed health concern|0
4733536|NCT01921517|16327614|P1|Overall Study|Newly diagnosed health concern|2
4733537|NCT01921517|16327613|P2|Overall Study|Lost to Follow-up|0
4733538|NCT01921517|16327614|P1|Overall Study|Lost to Follow-up|5
4733539|NCT01921387|16327625|P1|Overall Study|Adverse Event|1
4733540|NCT01921348|16327634|P2|Overall Study|Lost to Follow-up|2
4733541|NCT01921348|16327635|P1|Overall Study|Lost to Follow-up|0
4733542|NCT01921348|16327634|P2|Overall Study|Withdrawal by Subject|0
4733543|NCT01921348|16327635|P1|Overall Study|Withdrawal by Subject|1
4733544|NCT01921270|16327664|P1|Overall Study|Withdrawal by Subject|1
4733545|NCT01921257|16327680|P1|Overall Study|Withdrawal by Subject|1
4733546|NCT01921257|16327680|P1|Overall Study|Protocol Violation|1
4733547|NCT01921257|16327680|P1|Overall Study|Adverse Event|1
4733548|NCT01921205|16327687|P2|Overall Study|Non Compliance Of Child|1
4733549|NCT01921205|16327688|P1|Overall Study|Non Compliance Of Child|0
4733550|NCT01921205|16327687|P2|Overall Study|Non Compliance Of The Parent|1
4733551|NCT01921205|16327688|P1|Overall Study|Non Compliance Of The Parent|0
4733552|NCT01921205|16327687|P2|Overall Study|The Excessive Use Of Rescue Medication|1
4733553|NCT01921205|16327688|P1|Overall Study|The Excessive Use Of Rescue Medication|0
4733554|NCT01921205|16327687|P2|Overall Study|Use Of Prohibited Medication|1
4733555|NCT01921205|16327688|P1|Overall Study|Use Of Prohibited Medication|0
4733556|NCT01921205|16327687|P2|Overall Study|Withdrawal by Subject|5
4733557|NCT01921205|16327688|P1|Overall Study|Withdrawal by Subject|6
4733558|NCT01921205|16327687|P2|Overall Study|Lost to Follow-up|1
4733559|NCT01921205|16327688|P1|Overall Study|Lost to Follow-up|1
4733560|NCT01921205|16327687|P2|Overall Study|Protocol Violation|3
4733561|NCT01921205|16327688|P1|Overall Study|Protocol Violation|1
4733562|NCT01921205|16327687|P2|Overall Study|Lack of Efficacy|0
4733563|NCT01921205|16327688|P1|Overall Study|Lack of Efficacy|1
4733564|NCT01921205|16327687|P2|Overall Study|Adverse Event|7
4733565|NCT01921205|16327688|P1|Overall Study|Adverse Event|12
4733566|NCT01921179|16327718|P2|Long Term Follow-up After GOALS Training|Lost to Follow-up|0
4733567|NCT01921179|16327719|P1|Long Term Follow-up After GOALS Training|Lost to Follow-up|2
4733568|NCT01921179|16327718|P2|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
4733569|NCT01921179|16327719|P1|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3
4733570|NCT01921101|16327756|P2|Overall Study|Death|6
4733571|NCT01921101|16327757|P1|Overall Study|Death|16
4733572|NCT01920958|16327765|P1|Overall Study|Did Not Fulfill Inclusion Criteria|5
4733573|NCT01920893|16327783|P2|Overall Study|Lack of Efficacy|0
4733574|NCT01920893|16327784|P1|Overall Study|Lack of Efficacy|2
4733575|NCT01920893|16327783|P2|Overall Study|Adverse Event|2
4733576|NCT01920893|16327784|P1|Overall Study|Adverse Event|5
4733577|NCT01920854|16327817|P7|Overall Study|Withdrawal by Subject|1
4733578|NCT01920854|16327818|P6|Overall Study|Withdrawal by Subject|0
4733579|NCT01920854|16327819|P5|Overall Study|Withdrawal by Subject|1
4733580|NCT01920854|16327820|P4|Overall Study|Withdrawal by Subject|0
4733581|NCT01920854|16327821|P3|Overall Study|Withdrawal by Subject|0
4733582|NCT01920854|16327822|P2|Overall Study|Withdrawal by Subject|0
4733583|NCT01920854|16327823|P1|Overall Study|Withdrawal by Subject|1
4733584|NCT01920711|16327983|P2|Overall Study|Withdrawal by Subject|3
4733585|NCT01920711|16327984|P1|Overall Study|Withdrawal by Subject|4
4733586|NCT01920711|16327983|P2|Overall Study|Lost to Follow-up|14
4733587|NCT01920711|16327984|P1|Overall Study|Lost to Follow-up|13
4733588|NCT01920711|16327983|P2|Overall Study|Death|356
4733589|NCT01920711|16327984|P1|Overall Study|Death|347
4733590|NCT01920594|16328001|P2|Overall Study|Investigator discretion|1
4733591|NCT01920594|16328002|P1|Overall Study|Investigator discretion|0
4733592|NCT01920594|16328001|P2|Overall Study|Recovery|0
4733593|NCT01920594|16328002|P1|Overall Study|Recovery|2
4733594|NCT01920594|16328001|P2|Overall Study|Lost to Follow-up|0
4733595|NCT01920594|16328002|P1|Overall Study|Lost to Follow-up|1
4733596|NCT01920594|16328001|P2|Overall Study|Adverse Event|2
4733597|NCT01920594|16328002|P1|Overall Study|Adverse Event|4
4733598|NCT01920568|16328052|P2|Overall Study|Death due to disease progression|12
4733599|NCT01920568|16328053|P1|Overall Study|Death due to disease progression|25
4733600|NCT01920568|16328052|P2|Overall Study|Withdrawal by Subject|55
4733601|NCT01920568|16328053|P1|Overall Study|Withdrawal by Subject|79
4733602|NCT01920568|16328052|P2|Overall Study|Physician Decision|4
4733603|NCT01920568|16328053|P1|Overall Study|Physician Decision|13
4733604|NCT01920568|16328052|P2|Overall Study|Lost to Follow-up|2
4733605|NCT01920568|16328053|P1|Overall Study|Lost to Follow-up|2
4733606|NCT01920568|16328052|P2|Overall Study|Protocol Violation|3
4733607|NCT01920568|16328053|P1|Overall Study|Protocol Violation|5
4733608|NCT01920568|16328052|P2|Overall Study|Adverse Event|8
4733609|NCT01920568|16328053|P1|Overall Study|Adverse Event|27
4733610|NCT01920555|16328079|P5|Overall Study|Lost to Follow-up|0
4733611|NCT01920555|16328080|P4|Overall Study|Lost to Follow-up|1
4733612|NCT01920555|16328081|P3|Overall Study|Lost to Follow-up|0
4733613|NCT01920555|16328082|P2|Overall Study|Lost to Follow-up|1
4733614|NCT01920555|16328083|P1|Overall Study|Lost to Follow-up|0
4733615|NCT01920555|16328079|P5|Overall Study|Travel Difficulties|1
4733616|NCT01920555|16328080|P4|Overall Study|Travel Difficulties|0
4733617|NCT01920555|16328081|P3|Overall Study|Travel Difficulties|0
4733618|NCT01920555|16328082|P2|Overall Study|Travel Difficulties|1
4733619|NCT01920555|16328083|P1|Overall Study|Travel Difficulties|1
4733620|NCT01920555|16328079|P5|Overall Study|Lack of Efficacy|0
4733621|NCT01920555|16328080|P4|Overall Study|Lack of Efficacy|0
4733622|NCT01920555|16328081|P3|Overall Study|Lack of Efficacy|0
4733623|NCT01920555|16328082|P2|Overall Study|Lack of Efficacy|0
4733624|NCT01920555|16328083|P1|Overall Study|Lack of Efficacy|2
4733625|NCT01920555|16328079|P5|Overall Study|Physician Decision|0
4733626|NCT01920555|16328080|P4|Overall Study|Physician Decision|2
4733627|NCT01920555|16328081|P3|Overall Study|Physician Decision|1
4733628|NCT01920555|16328082|P2|Overall Study|Physician Decision|2
4733629|NCT01920555|16328083|P1|Overall Study|Physician Decision|1
4733630|NCT01920477|16328142|P2|Overall Study|Withdrawal by Subject|1
4733631|NCT01920477|16328143|P1|Overall Study|Withdrawal by Subject|0
4733632|NCT01920477|16328142|P2|Overall Study|Study closed/terminated|15
4733633|NCT01920477|16328143|P1|Overall Study|Study closed/terminated|14
4733634|NCT01920477|16328142|P2|Overall Study|Lack of Efficacy|0
4733635|NCT01920477|16328143|P1|Overall Study|Lack of Efficacy|1
4733636|NCT01920477|16328142|P2|Overall Study|Adverse Event|1
4733637|NCT01920477|16328143|P1|Overall Study|Adverse Event|0
4733638|NCT01920178|16328192|P2|Overall Study|Lost to Follow-up|1
4733639|NCT01920178|16328193|P1|Overall Study|Lost to Follow-up|2
4733640|NCT01919970|16328211|P2|Overall Study|Withdrawal by Subject|0
4733641|NCT01919970|16328212|P1|Overall Study|Withdrawal by Subject|3
4733642|NCT01919814|16328220|P2|Overall Study|Withdrawal by Subject|0
4733643|NCT01919814|16328221|P1|Overall Study|Withdrawal by Subject|1
4733644|NCT01919814|16328220|P2|Overall Study|Protocol Violation|0
4733645|NCT01919814|16328221|P1|Overall Study|Protocol Violation|1
4733646|NCT01919814|16328220|P2|Overall Study|Adverse Event|0
4733647|NCT01919814|16328221|P1|Overall Study|Adverse Event|1
4733648|NCT01919801|16328233|P2|Overall Study|Other|1
4733649|NCT01919801|16328234|P1|Overall Study|Other|0
4733650|NCT01919801|16328233|P2|Overall Study|Lost to Follow-up|1
4733651|NCT01919801|16328234|P1|Overall Study|Lost to Follow-up|0
4733652|NCT01919801|16328233|P2|Overall Study|Physician Decision|1
4733653|NCT01919801|16328234|P1|Overall Study|Physician Decision|0
4733654|NCT01919801|16328233|P2|Overall Study|Withdrawal by Subject|0
4733655|NCT01919801|16328234|P1|Overall Study|Withdrawal by Subject|1
4733656|NCT01919723|16328259|P2|Overall Study|Blood Samples Hemolyzed|2
4733657|NCT01919723|16328260|P1|Overall Study|Blood Samples Hemolyzed|2
4733658|NCT01919411|16328333|P2|Overall Study|Protocol Violation|1
4733659|NCT01919411|16328334|P1|Overall Study|Protocol Violation|2
4733660|NCT01919411|16328333|P2|Overall Study|Physician Decision|0
4733661|NCT01919411|16328334|P1|Overall Study|Physician Decision|1
4733662|NCT01919411|16328333|P2|Overall Study|Lost to Follow-up|4
4733663|NCT01919411|16328334|P1|Overall Study|Lost to Follow-up|2
4733664|NCT01919398|16328353|P3|Overall Study|Progressive Disease|4
4733665|NCT01919398|16328354|P2|Overall Study|Progressive Disease|0
4733666|NCT01919398|16328355|P1|Overall Study|Progressive Disease|0
4733667|NCT01919307|16328375|P1|Overall Study|Withdrawal by Subject|9
4733668|NCT01919229|16328385|P3|Overall Study|Subject/guardian decision|1
4733669|NCT01919229|16328386|P2|Overall Study|Subject/guardian decision|0
4733670|NCT01919229|16328387|P1|Overall Study|Subject/guardian decision|0
4733671|NCT01919164|16328434|P5|Overall Study|Other Un-specified|15
4733672|NCT01919164|16328435|P4|Overall Study|Other Un-specified|7
4733673|NCT01919164|16328436|P3|Overall Study|Other Un-specified|8
4733674|NCT01919164|16328437|P2|Overall Study|Other Un-specified|9
4733675|NCT01919164|16328438|P1|Overall Study|Other Un-specified|13
4733676|NCT01919164|16328434|P5|Overall Study|Withdrew consent|9
4733677|NCT01919164|16328435|P4|Overall Study|Withdrew consent|14
4733678|NCT01919164|16328436|P3|Overall Study|Withdrew consent|14
4733679|NCT01919164|16328437|P2|Overall Study|Withdrew consent|13
4733680|NCT01919164|16328438|P1|Overall Study|Withdrew consent|13
4733681|NCT01919164|16328434|P5|Overall Study|Disease progression|1
4733682|NCT01919164|16328435|P4|Overall Study|Disease progression|2
4733683|NCT01919164|16328436|P3|Overall Study|Disease progression|1
4733684|NCT01919164|16328437|P2|Overall Study|Disease progression|2
4733685|NCT01919164|16328438|P1|Overall Study|Disease progression|2
4733686|NCT01919164|16328434|P5|Overall Study|Protocol Violation|2
4733687|NCT01919164|16328435|P4|Overall Study|Protocol Violation|2
4733688|NCT01919164|16328436|P3|Overall Study|Protocol Violation|3
4733689|NCT01919164|16328437|P2|Overall Study|Protocol Violation|0
4733690|NCT01919164|16328438|P1|Overall Study|Protocol Violation|6
4733691|NCT01919164|16328434|P5|Overall Study|Death|0
4733692|NCT01919164|16328435|P4|Overall Study|Death|0
4733693|NCT01919164|16328436|P3|Overall Study|Death|0
4733694|NCT01919164|16328437|P2|Overall Study|Death|0
4733695|NCT01919164|16328438|P1|Overall Study|Death|1
4733696|NCT01919164|16328434|P5|Overall Study|Lost to Follow-up|4
4733697|NCT01919164|16328435|P4|Overall Study|Lost to Follow-up|0
4733698|NCT01919164|16328436|P3|Overall Study|Lost to Follow-up|2
4733699|NCT01919164|16328437|P2|Overall Study|Lost to Follow-up|2
4733700|NCT01919164|16328438|P1|Overall Study|Lost to Follow-up|2
4733701|NCT01919164|16328434|P5|Overall Study|Adverse Event|2
4733702|NCT01919164|16328435|P4|Overall Study|Adverse Event|3
4733703|NCT01919164|16328436|P3|Overall Study|Adverse Event|9
4733704|NCT01919164|16328437|P2|Overall Study|Adverse Event|4
4733705|NCT01919164|16328438|P1|Overall Study|Adverse Event|6
4733706|NCT01919112|16328493|P3|Secondary Analysis-day 30|Lost to Follow-up|0
4733707|NCT01919112|16328494|P2|Secondary Analysis-day 30|Lost to Follow-up|0
4733708|NCT01919112|16328495|P1|Secondary Analysis-day 30|Lost to Follow-up|1
4733709|NCT01919112|16328493|P3|Secondary Analysis-day 30|Death|1
4733710|NCT01919112|16328494|P2|Secondary Analysis-day 30|Death|1
4733711|NCT01919112|16328495|P1|Secondary Analysis-day 30|Death|1
4733712|NCT01918774|16328554|P1|Overall Study|Lost to Follow-up|1
4733713|NCT01918774|16328554|P1|Overall Study|Lost prior to first CBTw session|4
4733714|NCT01918371|16328578|P2|Overall Study|Missing Data|1
4733715|NCT01918371|16328579|P1|Overall Study|Missing Data|1
4733716|NCT01918332|16328657|P4|Overall Study|lipid result by central lab did not meet|0
4733717|NCT01918332|16328658|P3|Overall Study|lipid result by central lab did not meet|1
4733718|NCT01918332|16328659|P2|Overall Study|lipid result by central lab did not meet|0
4733719|NCT01918332|16328660|P1|Overall Study|lipid result by central lab did not meet|0
4733720|NCT01918332|16328657|P4|Overall Study|Protocol Violation|3
4733721|NCT01918332|16328658|P3|Overall Study|Protocol Violation|6
4733722|NCT01918332|16328659|P2|Overall Study|Protocol Violation|2
4733723|NCT01918332|16328660|P1|Overall Study|Protocol Violation|6
4733724|NCT01918332|16328657|P4|Overall Study|Withdrawal by Subject|3
4733725|NCT01918332|16328658|P3|Overall Study|Withdrawal by Subject|2
4733726|NCT01918332|16328659|P2|Overall Study|Withdrawal by Subject|3
4733727|NCT01918332|16328660|P1|Overall Study|Withdrawal by Subject|2
4733728|NCT01918332|16328657|P4|Overall Study|Adverse Event|1
4733729|NCT01918332|16328658|P3|Overall Study|Adverse Event|0
4733730|NCT01918332|16328659|P2|Overall Study|Adverse Event|0
4733731|NCT01918332|16328660|P1|Overall Study|Adverse Event|0
4733732|NCT01918306|16328672|P4|Overall Study|progress disease, crossover|0
4733733|NCT01918306|16328673|P3|Overall Study|progress disease, crossover|1
4733734|NCT01918306|16328674|P2|Overall Study|progress disease, crossover|0
4733735|NCT01918306|16328675|P1|Overall Study|progress disease, crossover|0
4733736|NCT01918306|16328672|P4|Overall Study|Lack of Efficacy|0
4733737|NCT01918306|16328673|P3|Overall Study|Lack of Efficacy|0
4733738|NCT01918306|16328674|P2|Overall Study|Lack of Efficacy|0
4733739|NCT01918306|16328675|P1|Overall Study|Lack of Efficacy|1
4733740|NCT01918306|16328672|P4|Overall Study|neutropenia|0
4733741|NCT01918306|16328673|P3|Overall Study|neutropenia|0
4733742|NCT01918306|16328674|P2|Overall Study|neutropenia|0
4733743|NCT01918306|16328675|P1|Overall Study|neutropenia|1
4733744|NCT01918306|16328672|P4|Overall Study|Withdrawal by Subject|2
4733745|NCT01918306|16328673|P3|Overall Study|Withdrawal by Subject|0
4733746|NCT01918306|16328674|P2|Overall Study|Withdrawal by Subject|0
4733747|NCT01918306|16328675|P1|Overall Study|Withdrawal by Subject|0
4733748|NCT01918306|16328672|P4|Overall Study|progresive disease|1
4733749|NCT01918306|16328673|P3|Overall Study|progresive disease|1
4733750|NCT01918306|16328674|P2|Overall Study|progresive disease|0
4733751|NCT01918306|16328675|P1|Overall Study|progresive disease|4
4733752|NCT01918085|16328706|P2|Test Period 1: Strata Strip|Adverse Event|1
4733753|NCT01918085|16328707|P1|Test Period 1: Strata Strip|Adverse Event|0
4733754|NCT01918033|16328731|P3|Overall Study|Withdrawal by Subject|0
4733755|NCT01918033|16328732|P2|Overall Study|Withdrawal by Subject|1
4733756|NCT01918033|16328733|P1|Overall Study|Withdrawal by Subject|2
4733757|NCT01918033|16328731|P3|Overall Study|Protocol Violation|1
4733758|NCT01918033|16328732|P2|Overall Study|Protocol Violation|0
4733759|NCT01918033|16328733|P1|Overall Study|Protocol Violation|2
4733760|NCT01918033|16328731|P3|Overall Study|Lost to Follow-up|0
4733761|NCT01918033|16328732|P2|Overall Study|Lost to Follow-up|1
4733762|NCT01918033|16328733|P1|Overall Study|Lost to Follow-up|0
4733763|NCT01918033|16328731|P3|Overall Study|Adverse Event|2
4733764|NCT01918033|16328732|P2|Overall Study|Adverse Event|0
4733765|NCT01918033|16328733|P1|Overall Study|Adverse Event|1
4733766|NCT01917747|16328804|P2|Overall Study|Lost to Follow-up|9
4733767|NCT01917747|16328805|P1|Overall Study|Lost to Follow-up|18
4733768|NCT01917747|16328804|P2|Overall Study|Withdrawal by Subject|2
4733769|NCT01917747|16328805|P1|Overall Study|Withdrawal by Subject|1
4733770|NCT01917656|16328819|P2|Overall Study|Lost to Follow-up|4
4733771|NCT01917656|16328820|P1|Overall Study|Lost to Follow-up|3
4733772|NCT01917656|16328819|P2|Overall Study|Withdrawal by Subject|3
4733773|NCT01917656|16328820|P1|Overall Study|Withdrawal by Subject|4
4733774|NCT01917656|16328819|P2|Overall Study|Unclassified|3
4733775|NCT01917656|16328820|P1|Overall Study|Unclassified|0
4733776|NCT01917656|16328819|P2|Overall Study|Withdrawal criteria|14
4733777|NCT01917656|16328820|P1|Overall Study|Withdrawal criteria|8
4733778|NCT01917656|16328819|P2|Overall Study|Adverse Event|0
4733779|NCT01917656|16328820|P1|Overall Study|Adverse Event|11
4733780|NCT01917526|16328846|P2|Overall Study|Protocol Violation|1
4733781|NCT01917526|16328847|P1|Overall Study|Protocol Violation|1
4733782|NCT01917344|16328864|P1|Overall Study|Withdrawal by Subject|1
4733783|NCT01917318|16328870|P2|First Treatment|Withdrawal by Subject|1
4733784|NCT01917318|16328871|P1|First Treatment|Withdrawal by Subject|0
4733785|NCT01917006|16328924|P8|Open-label Period|Lost to Follow-up|1
4733786|NCT01917006|16328925|P7|Open-label Period|Lost to Follow-up|0
4733787|NCT01917006|16328926|P6|Open-label Period|Lost to Follow-up|0
4733788|NCT01917006|16328927|P5|Open-label Period|Lost to Follow-up|0
4733789|NCT01917006|16328928|P4|Open-label Period|Lost to Follow-up|0
4733790|NCT01917006|16328929|P3|Open-label Period|Lost to Follow-up|0
4733791|NCT01917006|16328930|P2|Open-label Period|Lost to Follow-up|0
4733792|NCT01917006|16328931|P1|Open-label Period|Lost to Follow-up|0
4733793|NCT01917006|16328924|P8|Open-label Period|Adverse Event|1
4733794|NCT01917006|16328925|P7|Open-label Period|Adverse Event|0
4733795|NCT01917006|16328926|P6|Open-label Period|Adverse Event|0
4733796|NCT01917006|16328927|P5|Open-label Period|Adverse Event|0
4733797|NCT01917006|16328928|P4|Open-label Period|Adverse Event|0
4733798|NCT01917006|16328929|P3|Open-label Period|Adverse Event|0
4733799|NCT01917006|16328930|P2|Open-label Period|Adverse Event|0
4733800|NCT01917006|16328931|P1|Open-label Period|Adverse Event|0
4733801|NCT01917006|16328924|P8|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733802|NCT01917006|16328925|P7|Randomized-treatment Period|Other Miscellaneous Reasons|1
4733803|NCT01917006|16328926|P6|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733804|NCT01917006|16328927|P5|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733805|NCT01917006|16328928|P4|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733806|NCT01917006|16328929|P3|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733807|NCT01917006|16328930|P2|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733808|NCT01917006|16328931|P1|Randomized-treatment Period|Other Miscellaneous Reasons|0
4733809|NCT01917006|16328924|P8|Randomized-treatment Period|Protocol Violation|0
4733810|NCT01917006|16328925|P7|Randomized-treatment Period|Protocol Violation|0
4733811|NCT01917006|16328926|P6|Randomized-treatment Period|Protocol Violation|0
4733812|NCT01917006|16328927|P5|Randomized-treatment Period|Protocol Violation|0
4733813|NCT01917006|16328928|P4|Randomized-treatment Period|Protocol Violation|0
4733814|NCT01917006|16328929|P3|Randomized-treatment Period|Protocol Violation|0
4733815|NCT01917006|16328930|P2|Randomized-treatment Period|Protocol Violation|0
4733816|NCT01917006|16328931|P1|Randomized-treatment Period|Protocol Violation|1
4733817|NCT01917006|16328924|P8|Randomized-treatment Period|Personal Reasons|0
4733818|NCT01917006|16328925|P7|Randomized-treatment Period|Personal Reasons|0
4733819|NCT01917006|16328926|P6|Randomized-treatment Period|Personal Reasons|1
4733820|NCT01917006|16328927|P5|Randomized-treatment Period|Personal Reasons|0
4733821|NCT01917006|16328928|P4|Randomized-treatment Period|Personal Reasons|0
4733822|NCT01917006|16328929|P3|Randomized-treatment Period|Personal Reasons|0
4733823|NCT01917006|16328930|P2|Randomized-treatment Period|Personal Reasons|0
4733824|NCT01917006|16328931|P1|Randomized-treatment Period|Personal Reasons|0
4733825|NCT01917006|16328924|P8|Randomized-treatment Period|Lost to Follow-up|0
4733826|NCT01917006|16328925|P7|Randomized-treatment Period|Lost to Follow-up|0
4733827|NCT01917006|16328926|P6|Randomized-treatment Period|Lost to Follow-up|0
4733828|NCT01917006|16328927|P5|Randomized-treatment Period|Lost to Follow-up|0
4733829|NCT01917006|16328928|P4|Randomized-treatment Period|Lost to Follow-up|1
4733830|NCT01917006|16328929|P3|Randomized-treatment Period|Lost to Follow-up|0
4733831|NCT01917006|16328930|P2|Randomized-treatment Period|Lost to Follow-up|0
4733832|NCT01917006|16328931|P1|Randomized-treatment Period|Lost to Follow-up|1
4733833|NCT01916980|16328964|P2|Overall Study|Withdrawal by Subject|0
4733834|NCT01916980|16328965|P1|Overall Study|Withdrawal by Subject|1
4733835|NCT01916980|16328964|P2|Overall Study|Lack of Efficacy|2
4733836|NCT01916980|16328965|P1|Overall Study|Lack of Efficacy|2
4733837|NCT01916980|16328964|P2|Overall Study|Adverse Event|2
4733838|NCT01916980|16328965|P1|Overall Study|Adverse Event|4
4733839|NCT01916967|16328984|P3|Overall Study|Protocol Violation|0
4733840|NCT01916967|16328985|P2|Overall Study|Protocol Violation|1
4733841|NCT01916967|16328986|P1|Overall Study|Protocol Violation|0
4733842|NCT01916967|16328984|P3|Overall Study|Physician Decision|1
4733843|NCT01916967|16328985|P2|Overall Study|Physician Decision|0
4733844|NCT01916967|16328986|P1|Overall Study|Physician Decision|0
4733845|NCT01916967|16328984|P3|Overall Study|Lack of Efficacy|6
4733846|NCT01916967|16328985|P2|Overall Study|Lack of Efficacy|0
4733847|NCT01916967|16328986|P1|Overall Study|Lack of Efficacy|0
4733848|NCT01916967|16328984|P3|Overall Study|Adverse Event|2
4733849|NCT01916967|16328985|P2|Overall Study|Adverse Event|0
4733850|NCT01916967|16328986|P1|Overall Study|Adverse Event|0
4733851|NCT01916824|16329042|P2|Overall Study|Withdrawal by Subject|3
4733852|NCT01916824|16329043|P1|Overall Study|Withdrawal by Subject|2
4733853|NCT01916824|16329042|P2|Overall Study|Physician Decision|0
4733854|NCT01916824|16329043|P1|Overall Study|Physician Decision|2
4733855|NCT01916824|16329042|P2|Overall Study|Lost to Follow-up|6
4733856|NCT01916824|16329043|P1|Overall Study|Lost to Follow-up|3
4733857|NCT01916304|16329125|P1|Overall Study|Screening failure|17
4733858|NCT01916226|16329137|P4|Overall Study|Physician Decision|1
4733859|NCT01916226|16329138|P3|Overall Study|Physician Decision|0
4733860|NCT01916226|16329139|P2|Overall Study|Physician Decision|0
4733861|NCT01916226|16329140|P1|Overall Study|Physician Decision|0
4733862|NCT01916226|16329137|P4|Overall Study|Protocol Violation|1
4733863|NCT01916226|16329138|P3|Overall Study|Protocol Violation|0
4733864|NCT01916226|16329139|P2|Overall Study|Protocol Violation|1
4733865|NCT01916226|16329140|P1|Overall Study|Protocol Violation|0
4733866|NCT01916226|16329137|P4|Overall Study|Lack of Efficacy|1
4733867|NCT01916226|16329138|P3|Overall Study|Lack of Efficacy|2
4733868|NCT01916226|16329139|P2|Overall Study|Lack of Efficacy|0
4733869|NCT01916226|16329140|P1|Overall Study|Lack of Efficacy|0
4733870|NCT01916226|16329137|P4|Overall Study|Adverse Event|1
4733871|NCT01916226|16329138|P3|Overall Study|Adverse Event|1
4733872|NCT01916226|16329139|P2|Overall Study|Adverse Event|0
4733873|NCT01916226|16329140|P1|Overall Study|Adverse Event|1
4733874|NCT01916109|16329174|P1|Overall Study|Withdrawal by Subject|1
4733875|NCT01915940|16329180|P3|Treatment Period|Other Miscellaneous Reasons|0
4733876|NCT01915940|16329181|P2|Treatment Period|Other Miscellaneous Reasons|1
4733877|NCT01915940|16329182|P1|Treatment Period|Other Miscellaneous Reasons|0
4733878|NCT01915940|16329180|P3|Treatment Period|Adverse Event|1
4733879|NCT01915940|16329181|P2|Treatment Period|Adverse Event|9
4733880|NCT01915940|16329182|P1|Treatment Period|Adverse Event|0
4733881|NCT01915940|16329180|P3|Treatment Period|Decision of Participant|3
4733882|NCT01915940|16329181|P2|Treatment Period|Decision of Participant|1
4733883|NCT01915940|16329182|P1|Treatment Period|Decision of Participant|0
4733884|NCT01915940|16329180|P3|Pre-randomization Washout Period|Not Qualified for Randomization|0
4733885|NCT01915940|16329181|P2|Pre-randomization Washout Period|Not Qualified for Randomization|0
4733886|NCT01915940|16329182|P1|Pre-randomization Washout Period|Not Qualified for Randomization|39
4733887|NCT01915914|16329198|P4|Follow-up Phase|Physician Decision|1
4733888|NCT01915914|16329199|P3|Follow-up Phase|Physician Decision|0
4733889|NCT01915914|16329200|P2|Follow-up Phase|Physician Decision|0
4733890|NCT01915914|16329201|P1|Follow-up Phase|Physician Decision|0
4733891|NCT01915914|16329198|P4|Follow-up Phase|Withdrawal by Subject|1
4733892|NCT01915914|16329199|P3|Follow-up Phase|Withdrawal by Subject|0
4733893|NCT01915914|16329200|P2|Follow-up Phase|Withdrawal by Subject|0
4733894|NCT01915914|16329201|P1|Follow-up Phase|Withdrawal by Subject|0
4733895|NCT01915914|16329198|P4|Maintenance Phase|Missing|0
4733896|NCT01915914|16329199|P3|Maintenance Phase|Missing|0
4733897|NCT01915914|16329200|P2|Maintenance Phase|Missing|1
4733898|NCT01915914|16329201|P1|Maintenance Phase|Missing|0
4733899|NCT01915914|16329198|P4|Maintenance Phase|Lost to Follow-up|0
4733900|NCT01915914|16329199|P3|Maintenance Phase|Lost to Follow-up|1
4733901|NCT01915914|16329200|P2|Maintenance Phase|Lost to Follow-up|4
4733902|NCT01915914|16329201|P1|Maintenance Phase|Lost to Follow-up|0
4733903|NCT01915914|16329198|P4|Maintenance Phase|Withdrawal by Subject|0
4733904|NCT01915914|16329199|P3|Maintenance Phase|Withdrawal by Subject|1
4733905|NCT01915914|16329200|P2|Maintenance Phase|Withdrawal by Subject|1
4733906|NCT01915914|16329201|P1|Maintenance Phase|Withdrawal by Subject|0
4733907|NCT01915914|16329198|P4|Acute Phase|Missing|0
4733908|NCT01915914|16329199|P3|Acute Phase|Missing|0
4733909|NCT01915914|16329200|P2|Acute Phase|Missing|0
4733910|NCT01915914|16329201|P1|Acute Phase|Missing|1
4733911|NCT01915914|16329198|P4|Acute Phase|"Not Achieved treatment success"|0
4733912|NCT01915914|16329199|P3|Acute Phase|"Not Achieved treatment success"|0
4733913|NCT01915914|16329200|P2|Acute Phase|"Not Achieved treatment success"|0
4733914|NCT01915914|16329201|P1|Acute Phase|"Not Achieved treatment success"|1
4733915|NCT01915914|16329198|P4|Acute Phase|Accepted Other Topic Therapies|0
4733916|NCT01915914|16329199|P3|Acute Phase|Accepted Other Topic Therapies|0
4733917|NCT01915914|16329200|P2|Acute Phase|Accepted Other Topic Therapies|0
4733918|NCT01915914|16329201|P1|Acute Phase|Accepted Other Topic Therapies|1
4733919|NCT01915914|16329198|P4|Acute Phase|Physician Decision|0
4733920|NCT01915914|16329199|P3|Acute Phase|Physician Decision|0
4733921|NCT01915914|16329200|P2|Acute Phase|Physician Decision|0
4733922|NCT01915914|16329201|P1|Acute Phase|Physician Decision|1
4733923|NCT01915914|16329198|P4|Acute Phase|Lost to Follow-up|0
4733924|NCT01915914|16329199|P3|Acute Phase|Lost to Follow-up|0
4733925|NCT01915914|16329200|P2|Acute Phase|Lost to Follow-up|0
4733926|NCT01915914|16329201|P1|Acute Phase|Lost to Follow-up|4
4733927|NCT01915914|16329198|P4|Acute Phase|Withdrawal by Subject|0
4733928|NCT01915914|16329199|P3|Acute Phase|Withdrawal by Subject|0
4733929|NCT01915914|16329200|P2|Acute Phase|Withdrawal by Subject|0
4733930|NCT01915914|16329201|P1|Acute Phase|Withdrawal by Subject|4
4733931|NCT01915849|16329233|P4|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4733932|NCT01915849|16329234|P3|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4733933|NCT01915849|16329235|P2|Treatment Period 1 (4 Days)|Withdrawal by Subject|0
4733934|NCT01915849|16329236|P1|Treatment Period 1 (4 Days)|Withdrawal by Subject|1
4733935|NCT01915849|16329233|P4|Treatment Period 1 (4 Days)|Protocol Violation|0
4733936|NCT01915849|16329234|P3|Treatment Period 1 (4 Days)|Protocol Violation|0
4733937|NCT01915849|16329235|P2|Treatment Period 1 (4 Days)|Protocol Violation|0
4733938|NCT01915849|16329236|P1|Treatment Period 1 (4 Days)|Protocol Violation|1
4733939|NCT01915771|16329259|P1|Day 15|Withdrawal by Subject|1
4733940|NCT01915771|16329259|P1|Day 1|Withdrawal by Subject|1
4733941|NCT01915732|16329283|P2|Overall Study|Poor Conscious Effect|1
4733942|NCT01915732|16329284|P1|Overall Study|Poor Conscious Effect|0
4733943|NCT01915732|16329283|P2|Overall Study|Improper Facial Procedure|1
4733944|NCT01915732|16329284|P1|Overall Study|Improper Facial Procedure|0
4733945|NCT01915732|16329283|P2|Overall Study|Job Transfer|1
4733946|NCT01915732|16329284|P1|Overall Study|Job Transfer|0
4733947|NCT01915732|16329283|P2|Overall Study|Par. Refused to Hospital Visits|1
4733948|NCT01915732|16329284|P1|Overall Study|Par. Refused to Hospital Visits|0
4733949|NCT01915732|16329283|P2|Overall Study|Par. not Willing to Continue Treatment|1
4733950|NCT01915732|16329284|P1|Overall Study|Par. not Willing to Continue Treatment|0
4733951|NCT01915732|16329283|P2|Overall Study|Got Well|1
4733952|NCT01915732|16329284|P1|Overall Study|Got Well|0
4733953|NCT01915732|16329283|P2|Overall Study|Par. Unable to Come to the Hospital|1
4733954|NCT01915732|16329284|P1|Overall Study|Par. Unable to Come to the Hospital|0
4733955|NCT01915732|16329283|P2|Overall Study|Poor Perceived Efficacy|0
4733956|NCT01915732|16329284|P1|Overall Study|Poor Perceived Efficacy|1
4733957|NCT01915732|16329283|P2|Overall Study|Pregnancy|0
4733958|NCT01915732|16329284|P1|Overall Study|Pregnancy|1
4733959|NCT01915732|16329283|P2|Overall Study|Recovered|0
4733960|NCT01915732|16329284|P1|Overall Study|Recovered|1
4733961|NCT01915732|16329283|P2|Overall Study|Drug Release Error|0
4733962|NCT01915732|16329284|P1|Overall Study|Drug Release Error|1
4733963|NCT01915732|16329283|P2|Overall Study|Par. Conscious Ineffective Vol Exit|0
4733964|NCT01915732|16329284|P1|Overall Study|Par. Conscious Ineffective Vol Exit|1
4733965|NCT01915732|16329283|P2|Overall Study|Par. Improved, Voluntary (Vol) exit|0
4733966|NCT01915732|16329284|P1|Overall Study|Par. Improved, Voluntary (Vol) exit|1
4733967|NCT01915732|16329283|P2|Overall Study|Lost to Follow-up|26
4733968|NCT01915732|16329284|P1|Overall Study|Lost to Follow-up|22
4733969|NCT01915732|16329283|P2|Overall Study|Lack of Efficacy|11
4733970|NCT01915732|16329284|P1|Overall Study|Lack of Efficacy|6
4733971|NCT01915732|16329283|P2|Overall Study|Protocol Violation|5
4733972|NCT01915732|16329284|P1|Overall Study|Protocol Violation|5
4733973|NCT01915732|16329283|P2|Overall Study|Adverse Event|4
4733974|NCT01915732|16329284|P1|Overall Study|Adverse Event|12
4733975|NCT01915732|16329283|P2|Overall Study|Failure to Meet Randomization Criteria|0
4733976|NCT01915732|16329284|P1|Overall Study|Failure to Meet Randomization Criteria|1
4733977|NCT01915732|16329283|P2|Overall Study|Withdrawal by Subject|18
4733978|NCT01915732|16329284|P1|Overall Study|Withdrawal by Subject|18
4733979|NCT01915498|16329337|P19|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|2
4733980|NCT01915498|16329338|P18|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733981|NCT01915498|16329339|P17|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733982|NCT01915498|16329340|P16|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733983|NCT01915498|16329341|P15|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733984|NCT01915498|16329342|P14|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733985|NCT01915498|16329343|P13|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733986|NCT01915498|16329344|P12|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733987|NCT01915498|16329345|P11|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733988|NCT01915498|16329346|P10|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733989|NCT01915498|16329347|P9|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733990|NCT01915498|16329348|P8|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733991|NCT01915498|16329349|P7|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733992|NCT01915498|16329350|P6|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733993|NCT01915498|16329351|P5|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733994|NCT01915498|16329352|P4|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733995|NCT01915498|16329353|P3|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733996|NCT01915498|16329354|P2|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733997|NCT01915498|16329355|P1|Safety Follow-up (Sept 2017 to July 2019|Ongoing Treatment|0
4733998|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4733999|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4734000|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4734001|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
4734002|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4734003|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
4734004|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734005|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734006|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734007|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2
4734008|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734009|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734010|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734011|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1
4734012|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734013|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734014|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734015|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734016|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0
4734017|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734018|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|2
4734019|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734020|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734021|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
4734022|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734023|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734024|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734025|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734026|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734027|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734028|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734029|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734030|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
4734031|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734032|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734033|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734034|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|0
4734035|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Other Medical Condition|1
4734036|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734037|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4734038|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4734039|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734040|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734041|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4734042|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734043|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734044|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1
4734045|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734046|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734047|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734048|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734049|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734050|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734051|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734052|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734053|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734054|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0
4734055|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734056|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9
4734057|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
4734058|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
4734059|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5
4734060|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6
4734061|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4734062|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734063|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4734064|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734065|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734066|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734067|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4734068|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734069|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734070|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4734071|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0
4734072|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2
4734073|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1
4734074|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734075|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8
4734076|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4
4734077|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734078|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734079|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734080|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734081|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734082|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734083|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734084|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734085|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734086|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734087|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734088|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734089|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734090|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2
4734091|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1
4734092|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0
4734093|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734094|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734095|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734096|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734097|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734098|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734099|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734100|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734101|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734102|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
4734103|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734104|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734105|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734106|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734107|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1
4734108|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734109|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734110|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734111|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0
4734112|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4734113|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Death|16
4734114|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Death|3
4734115|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Death|4
4734116|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4734117|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Death|4
4734118|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4734119|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4734120|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Death|2
4734121|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4734122|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4734123|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4734124|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Death|0
4734125|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Death|2
4734126|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4734127|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4734128|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4734129|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Death|1
4734130|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Death|2
4734131|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734132|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734133|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734134|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734135|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734136|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734137|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734138|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734139|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1
4734140|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734141|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734142|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734143|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734144|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734145|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734146|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734147|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734148|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734149|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0
4734150|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0
4734151|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41
4734152|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8
4734153|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9
4734154|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14
4734155|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24
4734156|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4734157|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
4734158|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4734159|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7
4734160|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
4734161|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15
4734162|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
4734163|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5
4734164|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2
4734165|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4
4734166|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4734167|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3
4734168|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1
4734169|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4734170|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16
4734171|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4734172|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
4734173|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734174|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
4734175|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4734176|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734177|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734178|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4734179|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734180|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4
4734181|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734182|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4734183|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4734184|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734185|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1
4734186|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0
4734187|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2
4734188|NCT01915498|16329337|P19|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734189|NCT01915498|16329338|P18|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
4734190|NCT01915498|16329339|P17|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
4734191|NCT01915498|16329340|P16|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2
4734192|NCT01915498|16329341|P15|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4734193|NCT01915498|16329342|P14|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5
4734194|NCT01915498|16329343|P13|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4734195|NCT01915498|16329344|P12|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734196|NCT01915498|16329345|P11|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734197|NCT01915498|16329346|P10|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4734198|NCT01915498|16329347|P9|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734199|NCT01915498|16329348|P8|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734200|NCT01915498|16329349|P7|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734201|NCT01915498|16329350|P6|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734202|NCT01915498|16329351|P5|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4734203|NCT01915498|16329352|P4|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1
4734204|NCT01915498|16329353|P3|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734205|NCT01915498|16329354|P2|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734206|NCT01915498|16329355|P1|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0
4734207|NCT01915303|16329879|P1|Extension Phase|Protocol Violation|1
4734208|NCT01915303|16329879|P1|Extension Phase|Death|1
4734209|NCT01915303|16329879|P1|Extension Phase|Adverse Event|3
4734210|NCT01915303|16329879|P1|Extension Phase|Withdrawal by Subject|4
4734211|NCT01915303|16329879|P1|Extension Phase|Unsatisfactory therapeutic effect|8
4734212|NCT01915303|16329879|P1|Core Phase|Withdrawal by Subject|1
4734213|NCT01915303|16329879|P1|Core Phase|Abnormal lab value|1
4734214|NCT01915303|16329879|P1|Core Phase|Protocol Violation|2
4734215|NCT01915303|16329879|P1|Core Phase|Death|2
4734216|NCT01915303|16329879|P1|Core Phase|Unsatisfactory therapeutic effect|3
4734217|NCT01915303|16329879|P1|Core Phase|Adverse Event|7
4734218|NCT01914926|16329948|P2|Overall Study|uncooperative, agitated and removed|1
4734219|NCT01914926|16329949|P1|Overall Study|uncooperative, agitated and removed|0
4734220|NCT01914926|16329948|P2|Overall Study|Adverse Event|0
4734221|NCT01914926|16329949|P1|Overall Study|Adverse Event|1
4734222|NCT01914757|16329958|P3|Overall Study|Other reasons|4
4734223|NCT01914757|16329959|P2|Overall Study|Other reasons|9
4734224|NCT01914757|16329960|P1|Overall Study|Other reasons|5
4734225|NCT01914757|16329958|P3|Overall Study|Eligibility criteria not fulfilled|2
4734226|NCT01914757|16329959|P2|Overall Study|Eligibility criteria not fulfilled|0
4734227|NCT01914757|16329960|P1|Overall Study|Eligibility criteria not fulfilled|2
4734228|NCT01914757|16329958|P3|Overall Study|Study specific withdrawal criteria|0
4734229|NCT01914757|16329959|P2|Overall Study|Study specific withdrawal criteria|1
4734230|NCT01914757|16329960|P1|Overall Study|Study specific withdrawal criteria|0
4734231|NCT01914757|16329958|P3|Overall Study|Adverse Event|4
4734232|NCT01914757|16329959|P2|Overall Study|Adverse Event|3
4734233|NCT01914757|16329960|P1|Overall Study|Adverse Event|4
4734234|NCT01914757|16329958|P3|Overall Study|Death|1
4734235|NCT01914757|16329959|P2|Overall Study|Death|2
4734236|NCT01914757|16329960|P1|Overall Study|Death|2
4734237|NCT01914757|16329958|P3|Overall Study|Withdrawal by Subject|19
4734238|NCT01914757|16329959|P2|Overall Study|Withdrawal by Subject|27
4734239|NCT01914757|16329960|P1|Overall Study|Withdrawal by Subject|15
4734240|NCT01914757|16329958|P3|Overall Study|Lost to Follow-up|6
4734241|NCT01914757|16329959|P2|Overall Study|Lost to Follow-up|8
4734242|NCT01914757|16329960|P1|Overall Study|Lost to Follow-up|5
4734243|NCT01914757|16329958|P3|Overall Study|Severe non-compliance to protocol|2
4734244|NCT01914757|16329959|P2|Overall Study|Severe non-compliance to protocol|1
4734245|NCT01914757|16329960|P1|Overall Study|Severe non-compliance to protocol|3
4734246|NCT01914679|16330034|P1|Overall Study|Sponsor terminated study|4
4734247|NCT01914679|16330034|P1|Overall Study|Lack of Efficacy|1
4734248|NCT01914666|16330041|P3|Treatment Period|Physician Decision|2
4734249|NCT01914666|16330042|P2|Treatment Period|Physician Decision|0
4734250|NCT01914666|16330043|P1|Treatment Period|Physician Decision|0
4734251|NCT01914666|16330041|P3|Treatment Period|Withdrawal by Subject|2
4734252|NCT01914666|16330042|P2|Treatment Period|Withdrawal by Subject|2
4734253|NCT01914666|16330043|P1|Treatment Period|Withdrawal by Subject|3
4734254|NCT01914666|16330041|P3|Treatment Period|Adverse Event|2
4734255|NCT01914666|16330042|P2|Treatment Period|Adverse Event|4
4734256|NCT01914666|16330043|P1|Treatment Period|Adverse Event|10
4734257|NCT01914666|16330041|P3|Treatment Period|Lack of Efficacy|2
4734258|NCT01914666|16330042|P2|Treatment Period|Lack of Efficacy|0
4734259|NCT01914666|16330043|P1|Treatment Period|Lack of Efficacy|0
4734260|NCT01914393|16330086|P3|Overall Study|subject never dosed|1
4734261|NCT01914393|16330087|P2|Overall Study|subject never dosed|0
4734262|NCT01914393|16330088|P1|Overall Study|subject never dosed|0
4734263|NCT01914393|16330086|P3|Overall Study|Lost to Follow-up|19
4734264|NCT01914393|16330087|P2|Overall Study|Lost to Follow-up|6
4734265|NCT01914393|16330088|P1|Overall Study|Lost to Follow-up|12
4734266|NCT01914393|16330086|P3|Overall Study|Withdrawal by Subject|47
4734267|NCT01914393|16330087|P2|Overall Study|Withdrawal by Subject|20
4734268|NCT01914393|16330088|P1|Overall Study|Withdrawal by Subject|38
4734269|NCT01914393|16330086|P3|Overall Study|Adverse Event|31
4734270|NCT01914393|16330087|P2|Overall Study|Adverse Event|18
4734271|NCT01914393|16330088|P1|Overall Study|Adverse Event|29
4734272|NCT01914393|16330086|P3|Overall Study|no reason given|16
4734273|NCT01914393|16330087|P2|Overall Study|no reason given|8
4734274|NCT01914393|16330088|P1|Overall Study|no reason given|14
4734275|NCT01914393|16330086|P3|Overall Study|Lack of Efficacy|5
4734276|NCT01914393|16330087|P2|Overall Study|Lack of Efficacy|16
4734277|NCT01914393|16330088|P1|Overall Study|Lack of Efficacy|11
4734278|NCT01914393|16330086|P3|Overall Study|Protocol Violation|19
4734279|NCT01914393|16330087|P2|Overall Study|Protocol Violation|3
4734280|NCT01914393|16330088|P1|Overall Study|Protocol Violation|11
4734281|NCT01913639|16330156|P1|Overall Study|Not Eligible|3
4734282|NCT01913483|16330222|P2|Overall Study|Death|17
4734283|NCT01913483|16330223|P1|Overall Study|Death|14
4734284|NCT01913483|16330222|P2|Overall Study|Lost to Follow-up|3
4734285|NCT01913483|16330223|P1|Overall Study|Lost to Follow-up|6
4734286|NCT01913483|16330222|P2|Overall Study|Withdrawal by Subject|2
4734287|NCT01913483|16330223|P1|Overall Study|Withdrawal by Subject|1
4734288|NCT01913470|16330235|P2|Overall Study|Withdrawal by Subject|1
4734289|NCT01913470|16330236|P1|Overall Study|Withdrawal by Subject|0
4734290|NCT01913470|16330235|P2|Overall Study|Physician Decision|1
4734291|NCT01913470|16330236|P1|Overall Study|Physician Decision|0
4734292|NCT01913470|16330235|P2|Overall Study|Lost to Follow-up|1
4734293|NCT01913470|16330236|P1|Overall Study|Lost to Follow-up|0
4734294|NCT01913405|16330254|P1|Overall Study|Adverse Event|1
4734295|NCT01913405|16330254|P1|Overall Study|Withdrawal by Subject|1
4734296|NCT01913353|16330310|P2|Overall Study|multiple reasons|7
4734297|NCT01913353|16330311|P1|Overall Study|multiple reasons|10
4734298|NCT01913353|16330310|P2|Overall Study|Withdrawal by Subject|6
4734299|NCT01913353|16330311|P1|Overall Study|Withdrawal by Subject|20
4734300|NCT01913353|16330310|P2|Overall Study|Physician Decision|2
4734301|NCT01913353|16330311|P1|Overall Study|Physician Decision|0
4734302|NCT01913353|16330310|P2|Overall Study|Adverse Event|0
4734303|NCT01913353|16330311|P1|Overall Study|Adverse Event|2
4734304|NCT01913340|16330381|P2|Overall Study|Lost to Follow-up|1
4734305|NCT01913340|16330382|P1|Overall Study|Lost to Follow-up|1
4734306|NCT01913340|16330381|P2|Overall Study|Death|5
4734307|NCT01913340|16330382|P1|Overall Study|Death|2
4734308|NCT01913327|16330406|P2|Overall Study|Withdrawal by Subject|1
4734309|NCT01913327|16330407|P1|Overall Study|Withdrawal by Subject|0
4734310|NCT01913041|16330432|P1|Overall Study|Physician Decision|1
4734311|NCT01913041|16330432|P1|Overall Study|Withdrawal by Subject|3
4734312|NCT01913041|16330432|P1|Overall Study|Protocol Violation|35
4734313|NCT01912963|16330439|P3|Overall Study|Sought treatment locally|0
4734314|NCT01912963|16330440|P2|Overall Study|Sought treatment locally|1
4734315|NCT01912963|16330441|P1|Overall Study|Sought treatment locally|0
4734316|NCT01912963|16330439|P3|Overall Study|Withdrawal by Subject|0
4734317|NCT01912963|16330440|P2|Overall Study|Withdrawal by Subject|1
4734318|NCT01912963|16330441|P1|Overall Study|Withdrawal by Subject|0
4734319|NCT01912963|16330439|P3|Overall Study|Adverse Event|1
4734320|NCT01912963|16330440|P2|Overall Study|Adverse Event|1
4734321|NCT01912963|16330441|P1|Overall Study|Adverse Event|0
4734322|NCT01912963|16330439|P3|Overall Study|Disease Progression (not RECIST1.1)|1
4734323|NCT01912963|16330440|P2|Overall Study|Disease Progression (not RECIST1.1)|7
4734324|NCT01912963|16330441|P1|Overall Study|Disease Progression (not RECIST1.1)|0
4734325|NCT01912963|16330439|P3|Overall Study|Disease Progression (RECIST1.1)|5
4734326|NCT01912963|16330440|P2|Overall Study|Disease Progression (RECIST1.1)|9
4734327|NCT01912963|16330441|P1|Overall Study|Disease Progression (RECIST1.1)|6
4734328|NCT01912872|16330464|P4|Overall Study|Missing|1
4734329|NCT01912872|16330465|P3|Overall Study|Missing|0
4734330|NCT01912872|16330466|P2|Overall Study|Missing|0
4734331|NCT01912872|16330467|P1|Overall Study|Missing|0
4734332|NCT01912872|16330464|P4|Overall Study|Withdrawal of study medication|2
4734333|NCT01912872|16330465|P3|Overall Study|Withdrawal of study medication|0
4734334|NCT01912872|16330466|P2|Overall Study|Withdrawal of study medication|0
4734335|NCT01912872|16330467|P1|Overall Study|Withdrawal of study medication|0
4734336|NCT01912872|16330464|P4|Overall Study|Unsatisfactory therapeutic effect|2
4734337|NCT01912872|16330465|P3|Overall Study|Unsatisfactory therapeutic effect|0
4734338|NCT01912872|16330466|P2|Overall Study|Unsatisfactory therapeutic effect|0
4734339|NCT01912872|16330467|P1|Overall Study|Unsatisfactory therapeutic effect|0
4734340|NCT01912872|16330464|P4|Overall Study|Protocol Violation|0
4734341|NCT01912872|16330465|P3|Overall Study|Protocol Violation|1
4734342|NCT01912872|16330466|P2|Overall Study|Protocol Violation|0
4734343|NCT01912872|16330467|P1|Overall Study|Protocol Violation|0
4734344|NCT01912872|16330464|P4|Overall Study|Non-compliance with lab inc/exclusion|1
4734345|NCT01912872|16330465|P3|Overall Study|Non-compliance with lab inc/exclusion|0
4734346|NCT01912872|16330466|P2|Overall Study|Non-compliance with lab inc/exclusion|0
4734347|NCT01912872|16330467|P1|Overall Study|Non-compliance with lab inc/exclusion|0
4734348|NCT01912872|16330464|P4|Overall Study|Informed consent withdrawn|1
4734349|NCT01912872|16330465|P3|Overall Study|Informed consent withdrawn|1
4734350|NCT01912872|16330466|P2|Overall Study|Informed consent withdrawn|0
4734351|NCT01912872|16330467|P1|Overall Study|Informed consent withdrawn|0
4734352|NCT01912872|16330464|P4|Overall Study|Other unspecified|0
4734353|NCT01912872|16330465|P3|Overall Study|Other unspecified|3
4734354|NCT01912872|16330466|P2|Overall Study|Other unspecified|1
4734355|NCT01912872|16330467|P1|Overall Study|Other unspecified|3
4734356|NCT01912872|16330464|P4|Overall Study|Lost to Follow-up|5
4734357|NCT01912872|16330465|P3|Overall Study|Lost to Follow-up|5
4734358|NCT01912872|16330466|P2|Overall Study|Lost to Follow-up|3
4734359|NCT01912872|16330467|P1|Overall Study|Lost to Follow-up|2
4734360|NCT01912781|16330511|P2|Overall Study|Withdrawal by Subject|0
4734361|NCT01912781|16330512|P1|Overall Study|Withdrawal by Subject|2
4734362|NCT01912768|16330543|P2|Overall Study|Randomized in error|0
4734363|NCT01912768|16330544|P1|Overall Study|Randomized in error|1
4734364|NCT01912768|16330543|P2|Overall Study|Withdrawal by Subject|3
4734365|NCT01912768|16330544|P1|Overall Study|Withdrawal by Subject|5
4734366|NCT01912768|16330543|P2|Overall Study|Lost to Follow-up|1
4734367|NCT01912768|16330544|P1|Overall Study|Lost to Follow-up|2
4734368|NCT01912768|16330543|P2|Overall Study|Adverse Event|0
4734369|NCT01912768|16330544|P1|Overall Study|Adverse Event|2
4734370|NCT01912729|16330575|P2|Overall Study|Withdrawal by Subject|1
4734371|NCT01912729|16330576|P1|Overall Study|Withdrawal by Subject|0
4734372|NCT01912612|16330599|P3|Overall Study|Study design change|3
4734373|NCT01912612|16330600|P2|Overall Study|Study design change|0
4734374|NCT01912612|16330601|P1|Overall Study|Study design change|0
4734375|NCT01912612|16330599|P3|Overall Study|Withdrew consent|0
4734376|NCT01912612|16330600|P2|Overall Study|Withdrew consent|0
4734377|NCT01912612|16330601|P1|Overall Study|Withdrew consent|1
4734378|NCT01912612|16330599|P3|Overall Study|Adverse Event|0
4734379|NCT01912612|16330600|P2|Overall Study|Adverse Event|0
4734380|NCT01912612|16330601|P1|Overall Study|Adverse Event|4
4734381|NCT01912599|16330645|P2|Overall Study|Withdrawal by Subject|1
4734382|NCT01912599|16330646|P1|Overall Study|Withdrawal by Subject|0
4734383|NCT01912404|16330671|P2|Overall Study|Due to personal reasons|0
4734384|NCT01912404|16330672|P1|Overall Study|Due to personal reasons|1
4734385|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46
4734386|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0
4734387|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120
4734388|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1
4734389|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
4734390|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0
4734391|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1
4734392|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
4734393|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0
4734394|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1
4734395|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
4734396|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0
4734397|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1
4734398|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
4734399|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0
4734400|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
4734401|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0
4734402|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1
4734403|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
4734404|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0
4734405|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1
4734406|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3
4734407|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0
4734408|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1
4734409|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
4734410|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0
4734411|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5
4734412|NCT01912339|16330685|P3|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
4734413|NCT01912339|16330686|P2|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0
4734414|NCT01912339|16330687|P1|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5
4734415|NCT01912339|16330685|P3|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
4734416|NCT01912339|16330686|P2|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0
4734417|NCT01912339|16330687|P1|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1
4734418|NCT01912339|16330685|P3|Blinded (0 to 3 Months)|Open Prostatectomy|0
4734419|NCT01912339|16330686|P2|Blinded (0 to 3 Months)|Open Prostatectomy|0
4734420|NCT01912339|16330687|P1|Blinded (0 to 3 Months)|Open Prostatectomy|1
4734421|NCT01912339|16330685|P3|Blinded (0 to 3 Months)|Declined to participate|0
4734422|NCT01912339|16330686|P2|Blinded (0 to 3 Months)|Declined to participate|0
4734423|NCT01912339|16330687|P1|Blinded (0 to 3 Months)|Declined to participate|1
4734424|NCT01912287|16330704|P3|Overall Study|Scheduling/change in availability|8
4734425|NCT01912287|16330705|P2|Overall Study|Scheduling/change in availability|10
4734426|NCT01912287|16330706|P1|Overall Study|Scheduling/change in availability|17
4734427|NCT01912287|16330704|P3|Overall Study|Missed Assesment|1
4734428|NCT01912287|16330705|P2|Overall Study|Missed Assesment|1
4734429|NCT01912287|16330706|P1|Overall Study|Missed Assesment|1
4734430|NCT01912287|16330704|P3|Overall Study|Uknown reason - subject drop out|3
4734431|NCT01912287|16330705|P2|Overall Study|Uknown reason - subject drop out|7
4734432|NCT01912287|16330706|P1|Overall Study|Uknown reason - subject drop out|5
4734433|NCT01912287|16330704|P3|Overall Study|Lost Interest|0
4734434|NCT01912287|16330705|P2|Overall Study|Lost Interest|0
4734435|NCT01912287|16330706|P1|Overall Study|Lost Interest|1
4734436|NCT01912287|16330704|P3|Overall Study|Life circumstances|0
4734437|NCT01912287|16330705|P2|Overall Study|Life circumstances|2
4734438|NCT01912287|16330706|P1|Overall Study|Life circumstances|4
4734439|NCT01912287|16330704|P3|Overall Study|Felt treatment no longer needed|0
4734440|NCT01912287|16330705|P2|Overall Study|Felt treatment no longer needed|1
4734441|NCT01912287|16330706|P1|Overall Study|Felt treatment no longer needed|0
4734442|NCT01912287|16330704|P3|Overall Study|Dissatisfaction with assigned treatment|1
4734443|NCT01912287|16330705|P2|Overall Study|Dissatisfaction with assigned treatment|2
4734444|NCT01912287|16330706|P1|Overall Study|Dissatisfaction with assigned treatment|4
4734445|NCT01912287|16330704|P3|Overall Study|No-show|1
4734446|NCT01912287|16330705|P2|Overall Study|No-show|0
4734447|NCT01912287|16330706|P1|Overall Study|No-show|0
4734448|NCT01912287|16330704|P3|Overall Study|Ineligible|1
4734449|NCT01912287|16330705|P2|Overall Study|Ineligible|0
4734450|NCT01912287|16330706|P1|Overall Study|Ineligible|1
4734451|NCT01912222|16330717|P3|Part B: Treatment Period|Withdrawal by Subject|2
4734452|NCT01912222|16330718|P2|Part B: Treatment Period|Withdrawal by Subject|1
4734453|NCT01912222|16330719|P1|Part B: Treatment Period|Withdrawal by Subject|2
4734454|NCT01912222|16330717|P3|Part B: Treatment Period|Adverse Event|3
4734455|NCT01912222|16330718|P2|Part B: Treatment Period|Adverse Event|2
4734456|NCT01912222|16330719|P1|Part B: Treatment Period|Adverse Event|1
4734457|NCT01912222|16330717|P3|Part B: Treatment Period|Progressive disease|15
4734458|NCT01912222|16330718|P2|Part B: Treatment Period|Progressive disease|12
4734459|NCT01912222|16330719|P1|Part B: Treatment Period|Progressive disease|10
4734460|NCT01912222|16330717|P3|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
4734461|NCT01912222|16330718|P2|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2
4734462|NCT01912222|16330719|P1|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1
4734463|NCT01911845|16330777|P1|Overall Study|Other (not specified)|3
4734464|NCT01911845|16330777|P1|Overall Study|Lost to Follow-up|1
4734465|NCT01911845|16330777|P1|Overall Study|Adverse Event|2
4734466|NCT01911819|16330794|P3|Overall Study|Withdrawal by Subject|0
4734467|NCT01911819|16330795|P2|Overall Study|Withdrawal by Subject|1
4734468|NCT01911819|16330796|P1|Overall Study|Withdrawal by Subject|1
4734469|NCT01911819|16330794|P3|Overall Study|Adverse Event|0
4734470|NCT01911819|16330795|P2|Overall Study|Adverse Event|1
4734471|NCT01911819|16330796|P1|Overall Study|Adverse Event|0
4734472|NCT01911793|16330809|P2|Overall Study|Physician Decision|5
4734473|NCT01911793|16330810|P1|Overall Study|Physician Decision|1
4734474|NCT01911780|16330834|P2|Extension Period (52 Weeks)|Personal reason|1
4734475|NCT01911780|16330835|P1|Extension Period (52 Weeks)|Personal reason|1
4734476|NCT01911780|16330834|P2|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2
4734477|NCT01911780|16330835|P1|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0
4734478|NCT01911780|16330834|P2|Extension Period (52 Weeks)|Adverse Event|0
4734479|NCT01911780|16330835|P1|Extension Period (52 Weeks)|Adverse Event|3
4734480|NCT01911780|16330834|P2|Double-blind Period (8 Weeks)|Personal reason|0
4734481|NCT01911780|16330835|P1|Double-blind Period (8 Weeks)|Personal reason|1
4734482|NCT01911780|16330834|P2|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
4734483|NCT01911780|16330835|P1|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1
4734484|NCT01911780|16330834|P2|Double-blind Period (8 Weeks)|Adverse Event|2
4734485|NCT01911780|16330835|P1|Double-blind Period (8 Weeks)|Adverse Event|1
4734486|NCT01911546|16330869|P1|Overall Study|Everolimus was discontinued|5
4734487|NCT01911546|16330869|P1|Overall Study|Lost to Follow-up|1
4734488|NCT01911442|16330879|P3|Overall Study|Mother's Work Schedule|0
4734489|NCT01911442|16330880|P2|Overall Study|Mother's Work Schedule|1
4734490|NCT01911442|16330881|P1|Overall Study|Mother's Work Schedule|0
4734491|NCT01911442|16330879|P3|Overall Study|Withdrawal by Subject|6
4734492|NCT01911442|16330880|P2|Overall Study|Withdrawal by Subject|0
4734493|NCT01911442|16330881|P1|Overall Study|Withdrawal by Subject|1
4734494|NCT01911442|16330879|P3|Overall Study|Lost to Follow-up|1
4734495|NCT01911442|16330880|P2|Overall Study|Lost to Follow-up|0
4734496|NCT01911442|16330881|P1|Overall Study|Lost to Follow-up|2
4734497|NCT01911442|16330879|P3|Overall Study|Lack of Efficacy|1
4734498|NCT01911442|16330880|P2|Overall Study|Lack of Efficacy|1
4734499|NCT01911442|16330881|P1|Overall Study|Lack of Efficacy|1
4734500|NCT01911442|16330879|P3|Overall Study|Adverse Event|4
4734501|NCT01911442|16330880|P2|Overall Study|Adverse Event|2
4734502|NCT01911442|16330881|P1|Overall Study|Adverse Event|2
4734503|NCT01911429|16330910|P3|Overall Study|subject left study|0
4734504|NCT01911429|16330911|P2|Overall Study|subject left study|0
4734505|NCT01911429|16330912|P1|Overall Study|subject left study|1
4734506|NCT01911429|16330910|P3|Overall Study|Accidental randomization|1
4734507|NCT01911429|16330911|P2|Overall Study|Accidental randomization|0
4734508|NCT01911429|16330912|P1|Overall Study|Accidental randomization|0
4734509|NCT01911429|16330910|P3|Overall Study|Withdrawal by Subject|4
4734510|NCT01911429|16330911|P2|Overall Study|Withdrawal by Subject|5
4734511|NCT01911429|16330912|P1|Overall Study|Withdrawal by Subject|5
4734512|NCT01911429|16330910|P3|Overall Study|Protocol Violation|1
4734513|NCT01911429|16330911|P2|Overall Study|Protocol Violation|0
4734514|NCT01911429|16330912|P1|Overall Study|Protocol Violation|0
4734515|NCT01911429|16330910|P3|Overall Study|Lost to Follow-up|1
4734516|NCT01911429|16330911|P2|Overall Study|Lost to Follow-up|0
4734517|NCT01911429|16330912|P1|Overall Study|Lost to Follow-up|0
4734518|NCT01911429|16330910|P3|Overall Study|Lack of Efficacy|4
4734519|NCT01911429|16330911|P2|Overall Study|Lack of Efficacy|2
4734520|NCT01911429|16330912|P1|Overall Study|Lack of Efficacy|1
4734521|NCT01911429|16330910|P3|Overall Study|Adverse Event|9
4734522|NCT01911429|16330911|P2|Overall Study|Adverse Event|3
4734523|NCT01911429|16330912|P1|Overall Study|Adverse Event|5
4734524|NCT01911273|16331004|P2|Overall Study|Withdrawal by Subject|2
4734525|NCT01911273|16331005|P1|Overall Study|Withdrawal by Subject|0
4734526|NCT01911273|16331004|P2|Overall Study|Progression of Disease|0
4734527|NCT01911273|16331005|P1|Overall Study|Progression of Disease|1
4734528|NCT01911260|16331039|P4|Follow-up Period|transference or evasion of school|12
4734529|NCT01911260|16331040|P3|Follow-up Period|transference or evasion of school|15
4734530|NCT01911260|16331041|P2|Follow-up Period|transference or evasion of school|20
4734531|NCT01911260|16331042|P1|Follow-up Period|transference or evasion of school|13
4734532|NCT01911260|16331039|P4|Supplementation Period|less than 12 weeks supplementation|2
4734533|NCT01911260|16331040|P3|Supplementation Period|less than 12 weeks supplementation|1
4734534|NCT01911260|16331041|P2|Supplementation Period|less than 12 weeks supplementation|3
4734535|NCT01911260|16331042|P1|Supplementation Period|less than 12 weeks supplementation|0
4734536|NCT01911260|16331039|P4|Supplementation Period|refused to receive supplement|0
4734537|NCT01911260|16331040|P3|Supplementation Period|refused to receive supplement|1
4734538|NCT01911260|16331041|P2|Supplementation Period|refused to receive supplement|0
4734539|NCT01911260|16331042|P1|Supplementation Period|refused to receive supplement|1
4734540|NCT01911260|16331039|P4|Supplementation Period|Adverse Event|0
4734541|NCT01911260|16331040|P3|Supplementation Period|Adverse Event|1
4734542|NCT01911260|16331041|P2|Supplementation Period|Adverse Event|0
4734543|NCT01911260|16331042|P1|Supplementation Period|Adverse Event|2
4734544|NCT01911260|16331039|P4|Supplementation Period|transference or evasion of school|6
4734545|NCT01911260|16331040|P3|Supplementation Period|transference or evasion of school|7
4734546|NCT01911260|16331041|P2|Supplementation Period|transference or evasion of school|9
4734547|NCT01911260|16331042|P1|Supplementation Period|transference or evasion of school|7
4734548|NCT01910519|16331128|P2|Overall Study|Adverse Event|0
4734549|NCT01910519|16331129|P1|Overall Study|Adverse Event|2
4734550|NCT01910519|16331128|P2|Overall Study|Withdrawal by Subject|0
4734551|NCT01910519|16331129|P1|Overall Study|Withdrawal by Subject|2
4734552|NCT01910441|16331155|P2|Overall Study|Physician Decision|1
4734553|NCT01910441|16331156|P1|Overall Study|Physician Decision|0
4734554|NCT01910441|16331155|P2|Overall Study|Adverse Event|0
4734555|NCT01910441|16331156|P1|Overall Study|Adverse Event|1
4734556|NCT01910441|16331155|P2|Overall Study|Non-compliance|1
4734557|NCT01910441|16331156|P1|Overall Study|Non-compliance|0
4734558|NCT01910441|16331155|P2|Overall Study|Withdrawal by Subject|1
4734559|NCT01910441|16331156|P1|Overall Study|Withdrawal by Subject|0
4734560|NCT01910441|16331155|P2|Overall Study|Lost to Follow-up|5
4734561|NCT01910441|16331156|P1|Overall Study|Lost to Follow-up|6
4734562|NCT01910441|16331155|P2|Overall Study|Sponsor decision|2
4734563|NCT01910441|16331156|P1|Overall Study|Sponsor decision|0
4734564|NCT01910402|16331164|P2|Continuation Phase|Withdrawal by Subject|0
4734565|NCT01910402|16331165|P1|Continuation Phase|Withdrawal by Subject|2
4734566|NCT01910402|16331164|P2|Continuation Phase|Protocol Violation|0
4734567|NCT01910402|16331165|P1|Continuation Phase|Protocol Violation|3
4734568|NCT01910402|16331164|P2|Continuation Phase|Adverse Event|0
4734569|NCT01910402|16331165|P1|Continuation Phase|Adverse Event|1
4734570|NCT01910402|16331164|P2|Continuation Phase|Ongoing|0
4734571|NCT01910402|16331165|P1|Continuation Phase|Ongoing|84
4734572|NCT01910402|16331164|P2|Randomized Phase|Withdrawal by Subject|7
4734573|NCT01910402|16331165|P1|Randomized Phase|Withdrawal by Subject|5
4734574|NCT01910402|16331164|P2|Randomized Phase|Protocol Violation|13
4734575|NCT01910402|16331165|P1|Randomized Phase|Protocol Violation|10
4734576|NCT01910402|16331164|P2|Randomized Phase|Lost to Follow-up|13
4734577|NCT01910402|16331165|P1|Randomized Phase|Lost to Follow-up|11
4734578|NCT01910402|16331164|P2|Randomized Phase|Lack of Efficacy|4
4734579|NCT01910402|16331165|P1|Randomized Phase|Lack of Efficacy|5
4734580|NCT01910402|16331164|P2|Randomized Phase|Physician Decision|0
4734581|NCT01910402|16331165|P1|Randomized Phase|Physician Decision|1
4734582|NCT01910402|16331164|P2|Randomized Phase|Adverse Event|18
4734583|NCT01910402|16331165|P1|Randomized Phase|Adverse Event|10
4734584|NCT01910389|16331235|P2|Overall Study|Study Closed|8
4734585|NCT01910389|16331236|P1|Overall Study|Study Closed|13
4734586|NCT01910389|16331235|P2|Overall Study|Withdrawal by Subject|0
4734587|NCT01910389|16331236|P1|Overall Study|Withdrawal by Subject|2
4734588|NCT01910298|16331279|P2|Overall Study|Other Miscellaneous Reasons|2
4734589|NCT01910298|16331280|P1|Overall Study|Other Miscellaneous Reasons|0
4734590|NCT01910298|16331279|P2|Overall Study|Study Terminated by Sponsor|17
4734591|NCT01910298|16331280|P1|Overall Study|Study Terminated by Sponsor|1
4734592|NCT01910298|16331279|P2|Overall Study|Lost to Follow-up|1
4734593|NCT01910298|16331280|P1|Overall Study|Lost to Follow-up|1
4734594|NCT01910298|16331279|P2|Overall Study|Protocol Deviation|5
4734595|NCT01910298|16331280|P1|Overall Study|Protocol Deviation|0
4734596|NCT01910298|16331279|P2|Overall Study|Withdrawal by Subject|7
4734597|NCT01910298|16331280|P1|Overall Study|Withdrawal by Subject|2
4734598|NCT01910298|16331279|P2|Overall Study|Adverse Event|0
4734599|NCT01910298|16331280|P1|Overall Study|Adverse Event|1
4734600|NCT01910181|16331298|P1|Overall Study|Study Terminated by Sponsor|6
4734601|NCT01910181|16331298|P1|Overall Study|Lost to Follow-up|3
4734602|NCT01910181|16331298|P1|Overall Study|Death|37
4734603|NCT01910129|16331325|P3|Randomized Phase 3|Withdrawal by Subject|0
4734604|NCT01910129|16331326|P2|Randomized Phase 3|Withdrawal by Subject|1
4734605|NCT01910129|16331327|P1|Randomized Phase 3|Withdrawal by Subject|0
4734606|NCT01910129|16331325|P3|Randomized Phase 2|Withdrawal by Subject|0
4734607|NCT01910129|16331326|P2|Randomized Phase 2|Withdrawal by Subject|1
4734608|NCT01910129|16331327|P1|Randomized Phase 2|Withdrawal by Subject|2
4734609|NCT01910116|16331351|P2|Overall Study|incomplete data|1
4734610|NCT01910116|16331352|P1|Overall Study|incomplete data|0
4734611|NCT01910116|16331351|P2|Overall Study|uncertain allocation|3
4734612|NCT01910116|16331352|P1|Overall Study|uncertain allocation|1
4734613|NCT01910116|16331351|P2|Overall Study|Withdrawal by Subject|3
4734614|NCT01910116|16331352|P1|Overall Study|Withdrawal by Subject|8
4734615|NCT01910116|16331351|P2|Overall Study|Protocol Violation|2
4734616|NCT01910116|16331352|P1|Overall Study|Protocol Violation|1
4734617|NCT01910116|16331351|P2|Overall Study|Lost to Follow-up|0
4734618|NCT01910116|16331352|P1|Overall Study|Lost to Follow-up|1
4734619|NCT01910116|16331351|P2|Overall Study|Lack of Efficacy|4
4734620|NCT01910116|16331352|P1|Overall Study|Lack of Efficacy|3
4734621|NCT01910116|16331351|P2|Overall Study|Adverse Event|3
4734622|NCT01910116|16331352|P1|Overall Study|Adverse Event|0
4734623|NCT01909973|16331439|P2|Overall Study|Lost to Follow-up|0
4734624|NCT01909973|16331440|P1|Overall Study|Lost to Follow-up|1
4734625|NCT01909804|16331460|P12|Overall Study|Protocol Violation|1
4734626|NCT01909804|16331461|P11|Overall Study|Protocol Violation|0
4734627|NCT01909804|16331462|P10|Overall Study|Protocol Violation|0
4734628|NCT01909804|16331463|P9|Overall Study|Protocol Violation|0
4734629|NCT01909804|16331464|P8|Overall Study|Protocol Violation|0
4734630|NCT01909804|16331465|P7|Overall Study|Protocol Violation|0
4734631|NCT01909804|16331466|P6|Overall Study|Protocol Violation|0
4734632|NCT01909804|16331467|P5|Overall Study|Protocol Violation|0
4734633|NCT01909804|16331468|P4|Overall Study|Protocol Violation|0
4734634|NCT01909804|16331469|P3|Overall Study|Protocol Violation|0
4734635|NCT01909804|16331470|P2|Overall Study|Protocol Violation|0
4734636|NCT01909804|16331471|P1|Overall Study|Protocol Violation|0
4734637|NCT01909804|16331460|P12|Overall Study|Withdrew Consent|0
4734638|NCT01909804|16331461|P11|Overall Study|Withdrew Consent|0
4734639|NCT01909804|16331462|P10|Overall Study|Withdrew Consent|0
4734640|NCT01909804|16331463|P9|Overall Study|Withdrew Consent|0
4734641|NCT01909804|16331464|P8|Overall Study|Withdrew Consent|0
4734642|NCT01909804|16331465|P7|Overall Study|Withdrew Consent|0
4734643|NCT01909804|16331466|P6|Overall Study|Withdrew Consent|1
4734644|NCT01909804|16331467|P5|Overall Study|Withdrew Consent|1
4734645|NCT01909804|16331468|P4|Overall Study|Withdrew Consent|0
4734646|NCT01909804|16331469|P3|Overall Study|Withdrew Consent|0
4734647|NCT01909804|16331470|P2|Overall Study|Withdrew Consent|0
4734648|NCT01909804|16331471|P1|Overall Study|Withdrew Consent|0
4734649|NCT01909804|16331460|P12|Overall Study|Lack of Efficacy|1
4734650|NCT01909804|16331461|P11|Overall Study|Lack of Efficacy|0
4734651|NCT01909804|16331462|P10|Overall Study|Lack of Efficacy|1
4734652|NCT01909804|16331463|P9|Overall Study|Lack of Efficacy|0
4734653|NCT01909804|16331464|P8|Overall Study|Lack of Efficacy|1
4734654|NCT01909804|16331465|P7|Overall Study|Lack of Efficacy|1
4734655|NCT01909804|16331466|P6|Overall Study|Lack of Efficacy|3
4734656|NCT01909804|16331467|P5|Overall Study|Lack of Efficacy|7
4734657|NCT01909804|16331468|P4|Overall Study|Lack of Efficacy|0
4734658|NCT01909804|16331469|P3|Overall Study|Lack of Efficacy|0
4734659|NCT01909804|16331470|P2|Overall Study|Lack of Efficacy|1
4734660|NCT01909804|16331471|P1|Overall Study|Lack of Efficacy|4
4734661|NCT01909804|16331460|P12|Overall Study|Death|0
4734662|NCT01909804|16331461|P11|Overall Study|Death|1
4734663|NCT01909804|16331462|P10|Overall Study|Death|0
4734664|NCT01909804|16331463|P9|Overall Study|Death|0
4734665|NCT01909804|16331464|P8|Overall Study|Death|0
4734666|NCT01909804|16331465|P7|Overall Study|Death|0
4734667|NCT01909804|16331466|P6|Overall Study|Death|0
4734668|NCT01909804|16331467|P5|Overall Study|Death|0
4734669|NCT01909804|16331468|P4|Overall Study|Death|0
4734670|NCT01909804|16331469|P3|Overall Study|Death|0
4734671|NCT01909804|16331470|P2|Overall Study|Death|0
4734672|NCT01909804|16331471|P1|Overall Study|Death|0
4734673|NCT01909804|16331460|P12|Overall Study|Randomized but Never Treated|1
4734674|NCT01909804|16331461|P11|Overall Study|Randomized but Never Treated|0
4734675|NCT01909804|16331462|P10|Overall Study|Randomized but Never Treated|0
4734676|NCT01909804|16331463|P9|Overall Study|Randomized but Never Treated|0
4734677|NCT01909804|16331464|P8|Overall Study|Randomized but Never Treated|0
4734678|NCT01909804|16331465|P7|Overall Study|Randomized but Never Treated|1
4734679|NCT01909804|16331466|P6|Overall Study|Randomized but Never Treated|0
4734680|NCT01909804|16331467|P5|Overall Study|Randomized but Never Treated|0
4734681|NCT01909804|16331468|P4|Overall Study|Randomized but Never Treated|0
4734682|NCT01909804|16331469|P3|Overall Study|Randomized but Never Treated|0
4734683|NCT01909804|16331470|P2|Overall Study|Randomized but Never Treated|0
4734684|NCT01909804|16331471|P1|Overall Study|Randomized but Never Treated|0
4734685|NCT01909791|16331520|P3|Overall Study|Missed Visit|1
4734686|NCT01909791|16331521|P2|Overall Study|Missed Visit|0
4734687|NCT01909791|16331522|P1|Overall Study|Missed Visit|2
4734688|NCT01909791|16331520|P3|Overall Study|Lost to Follow-up|10
4734689|NCT01909791|16331521|P2|Overall Study|Lost to Follow-up|11
4734690|NCT01909791|16331522|P1|Overall Study|Lost to Follow-up|5
4734691|NCT01909791|16331520|P3|Overall Study|Withdrawal by Subject|13
4734692|NCT01909791|16331521|P2|Overall Study|Withdrawal by Subject|9
4734693|NCT01909791|16331522|P1|Overall Study|Withdrawal by Subject|5
4734694|NCT01909791|16331520|P3|Overall Study|Death|4
4734695|NCT01909791|16331521|P2|Overall Study|Death|8
4734696|NCT01909791|16331522|P1|Overall Study|Death|9
4734697|NCT01909778|16331580|P1|Overall Study|failed screening|1
4734698|NCT01909674|16331659|P2|Overall Study|Withdrawal by Subject|2
4734699|NCT01909674|16331660|P1|Overall Study|Withdrawal by Subject|5
4734700|NCT01909466|16331679|P2|Overall Study|Lack of Efficacy|0
4734701|NCT01909466|16331680|P1|Overall Study|Lack of Efficacy|1
4734702|NCT01909466|16331679|P2|Overall Study|Withdrawal by Subject|9
4734703|NCT01909466|16331680|P1|Overall Study|Withdrawal by Subject|11
4734704|NCT01909466|16331679|P2|Overall Study|Physician Decision|0
4734705|NCT01909466|16331680|P1|Overall Study|Physician Decision|2
4734706|NCT01909466|16331679|P2|Overall Study|Met Withdrawal Criteria|3
4734707|NCT01909466|16331680|P1|Overall Study|Met Withdrawal Criteria|0
4734708|NCT01909466|16331679|P2|Overall Study|Adverse Event|4
4734709|NCT01909466|16331680|P1|Overall Study|Adverse Event|3
4734710|NCT01909466|16331679|P2|Overall Study|Lost to Follow-up|7
4734711|NCT01909466|16331680|P1|Overall Study|Lost to Follow-up|5
4734712|NCT01909336|16331703|P3|Overall Study|Physician Decision|1
4734713|NCT01909336|16331704|P2|Overall Study|Physician Decision|1
4734714|NCT01909336|16331705|P1|Overall Study|Physician Decision|0
4734715|NCT01909336|16331703|P3|Overall Study|Lost to Follow-up|2
4734716|NCT01909336|16331704|P2|Overall Study|Lost to Follow-up|2
4734717|NCT01909336|16331705|P1|Overall Study|Lost to Follow-up|4
4734718|NCT01908907|16331803|P2|Overall Study|Protocol Violation|0
4734719|NCT01908907|16331804|P1|Overall Study|Protocol Violation|1
4734720|NCT01908907|16331803|P2|Overall Study|Physician Decision|0
4734721|NCT01908907|16331804|P1|Overall Study|Physician Decision|1
4734722|NCT01908829|16331848|P3|Overall Study|Withdrawal by Subject|22
4734723|NCT01908829|16331849|P2|Overall Study|Withdrawal by Subject|29
4734724|NCT01908829|16331850|P1|Overall Study|Withdrawal by Subject|26
4734725|NCT01908829|16331848|P3|Overall Study|Lack of Efficacy|2
4734726|NCT01908829|16331849|P2|Overall Study|Lack of Efficacy|3
4734727|NCT01908829|16331850|P1|Overall Study|Lack of Efficacy|1
4734728|NCT01908829|16331848|P3|Overall Study|Protocol Violation|0
4734729|NCT01908829|16331849|P2|Overall Study|Protocol Violation|2
4734730|NCT01908829|16331850|P1|Overall Study|Protocol Violation|2
4734731|NCT01908829|16331848|P3|Overall Study|Miscellaneous|0
4734732|NCT01908829|16331849|P2|Overall Study|Miscellaneous|2
4734733|NCT01908829|16331850|P1|Overall Study|Miscellaneous|0
4734734|NCT01908829|16331848|P3|Overall Study|Discontinued (no EoT page)|0
4734735|NCT01908829|16331849|P2|Overall Study|Discontinued (no EoT page)|0
4734736|NCT01908829|16331850|P1|Overall Study|Discontinued (no EoT page)|2
4734737|NCT01908829|16331848|P3|Overall Study|Randomized no double-blind drug received|1
4734738|NCT01908829|16331849|P2|Overall Study|Randomized no double-blind drug received|0
4734739|NCT01908829|16331850|P1|Overall Study|Randomized no double-blind drug received|1
4734740|NCT01908829|16331848|P3|Overall Study|Lost to Follow-up|1
4734741|NCT01908829|16331849|P2|Overall Study|Lost to Follow-up|2
4734742|NCT01908829|16331850|P1|Overall Study|Lost to Follow-up|4
4734743|NCT01908829|16331848|P3|Overall Study|Adverse Event|13
4734744|NCT01908829|16331849|P2|Overall Study|Adverse Event|11
4734745|NCT01908829|16331850|P1|Overall Study|Adverse Event|13
4734746|NCT01908816|16331967|P4|Overall Study|Early termination|28
4734747|NCT01908816|16331968|P3|Overall Study|Early termination|43
4734748|NCT01908816|16331969|P2|Overall Study|Early termination|60
4734749|NCT01908816|16331970|P1|Overall Study|Early termination|87
4734750|NCT01908816|16331967|P4|Overall Study|Unsatisfactory therapeutic effect|0
4734751|NCT01908816|16331968|P3|Overall Study|Unsatisfactory therapeutic effect|1
4734752|NCT01908816|16331969|P2|Overall Study|Unsatisfactory therapeutic effect|13
4734753|NCT01908816|16331970|P1|Overall Study|Unsatisfactory therapeutic effect|1
4734754|NCT01908816|16331967|P4|Overall Study|Death|1
4734755|NCT01908816|16331968|P3|Overall Study|Death|7
4734756|NCT01908816|16331969|P2|Overall Study|Death|0
4734757|NCT01908816|16331970|P1|Overall Study|Death|1
4734758|NCT01908816|16331967|P4|Overall Study|Lost to Follow-up|2
4734759|NCT01908816|16331968|P3|Overall Study|Lost to Follow-up|4
4734760|NCT01908816|16331969|P2|Overall Study|Lost to Follow-up|5
4734761|NCT01908816|16331970|P1|Overall Study|Lost to Follow-up|3
4734762|NCT01908816|16331967|P4|Overall Study|Withdrawal by Subject|2
4734763|NCT01908816|16331968|P3|Overall Study|Withdrawal by Subject|2
4734764|NCT01908816|16331969|P2|Overall Study|Withdrawal by Subject|4
4734765|NCT01908816|16331970|P1|Overall Study|Withdrawal by Subject|0
4734766|NCT01908816|16331967|P4|Overall Study|Protocol deviation|1
4734767|NCT01908816|16331968|P3|Overall Study|Protocol deviation|1
4734768|NCT01908816|16331969|P2|Overall Study|Protocol deviation|2
4734769|NCT01908816|16331970|P1|Overall Study|Protocol deviation|1
4734770|NCT01908816|16331967|P4|Overall Study|Subject's no longer requires study drug|1
4734771|NCT01908816|16331968|P3|Overall Study|Subject's no longer requires study drug|0
4734772|NCT01908816|16331969|P2|Overall Study|Subject's no longer requires study drug|0
4734773|NCT01908816|16331970|P1|Overall Study|Subject's no longer requires study drug|0
4734774|NCT01908803|16331995|P2|Overall Study|Adverse Event (pre-treatment)|0
4734775|NCT01908803|16331996|P1|Overall Study|Adverse Event (pre-treatment)|1
4734776|NCT01908803|16331995|P2|Overall Study|Randomization Error|0
4734777|NCT01908803|16331996|P1|Overall Study|Randomization Error|1
4734778|NCT01908803|16331995|P2|Overall Study|Withdrawal by Subject|0
4734779|NCT01908803|16331996|P1|Overall Study|Withdrawal by Subject|1
4734780|NCT01908803|16331995|P2|Overall Study|Physician Decision|1
4734781|NCT01908803|16331996|P1|Overall Study|Physician Decision|0
4734782|NCT01908803|16331995|P2|Overall Study|Adverse Event|0
4734783|NCT01908803|16331996|P1|Overall Study|Adverse Event|1
4734784|NCT01908699|16332009|P2|Overall Study|Progressive Disease|29
4734785|NCT01908699|16332010|P1|Overall Study|Progressive Disease|30
4734786|NCT01908699|16332009|P2|Overall Study|Death|12
4734787|NCT01908699|16332010|P1|Overall Study|Death|9
4734788|NCT01908699|16332009|P2|Overall Study|Randomized in Error|0
4734789|NCT01908699|16332010|P1|Overall Study|Randomized in Error|1
4734790|NCT01908699|16332009|P2|Overall Study|Pregnancy|1
4734791|NCT01908699|16332010|P1|Overall Study|Pregnancy|0
4734792|NCT01908699|16332009|P2|Overall Study|Withdrawal by Subject|10
4734793|NCT01908699|16332010|P1|Overall Study|Withdrawal by Subject|15
4734794|NCT01908699|16332009|P2|Overall Study|Physician Decision|8
4734795|NCT01908699|16332010|P1|Overall Study|Physician Decision|8
4734796|NCT01908699|16332009|P2|Overall Study|Lost to Follow-up|4
4734797|NCT01908699|16332010|P1|Overall Study|Lost to Follow-up|2
4734798|NCT01908699|16332009|P2|Overall Study|Lack of Efficacy|2
4734799|NCT01908699|16332010|P1|Overall Study|Lack of Efficacy|2
4734800|NCT01908699|16332009|P2|Overall Study|Adverse Event|12
4734801|NCT01908699|16332010|P1|Overall Study|Adverse Event|8
4734802|NCT01908582|16332026|P1|Period 2|Withdrawal by Subject|1
4734803|NCT01908582|16332026|P1|Period 2|Physician Decision|1
4734804|NCT01908426|16332070|P2|Overall Study|No Study Treatment Given|0
4734805|NCT01908426|16332071|P1|Overall Study|No Study Treatment Given|3
4734806|NCT01908426|16332070|P2|Overall Study|Protocol Violation|0
4734807|NCT01908426|16332071|P1|Overall Study|Protocol Violation|1
4734808|NCT01908426|16332070|P2|Overall Study|Progressive Disease|152
4734809|NCT01908426|16332071|P1|Overall Study|Progressive Disease|206
4734810|NCT01908426|16332070|P2|Overall Study|Withdrawal by Subject|6
4734811|NCT01908426|16332071|P1|Overall Study|Withdrawal by Subject|11
4734812|NCT01908426|16332070|P2|Overall Study|Physician Decision|3
4734813|NCT01908426|16332071|P1|Overall Study|Physician Decision|3
4734814|NCT01908426|16332070|P2|Overall Study|Lost to Follow-up|1
4734815|NCT01908426|16332071|P1|Overall Study|Lost to Follow-up|0
4734816|NCT01908426|16332070|P2|Overall Study|Lack of Efficacy|0
4734817|NCT01908426|16332071|P1|Overall Study|Lack of Efficacy|3
4734818|NCT01908426|16332070|P2|Overall Study|Clinical Deterioration|38
4734819|NCT01908426|16332071|P1|Overall Study|Clinical Deterioration|72
4734820|NCT01908426|16332070|P2|Overall Study|Adverse Event|11
4734821|NCT01908426|16332071|P1|Overall Study|Adverse Event|98
4734822|NCT01908140|16332083|P2|Overall Study|Adverse Event|23
4734823|NCT01908140|16332084|P1|Overall Study|Adverse Event|22
4734824|NCT01908140|16332083|P2|Overall Study|Protocol Violation|9
4734825|NCT01908140|16332084|P1|Overall Study|Protocol Violation|8
4734826|NCT01908140|16332083|P2|Overall Study|Lost to Follow-up|6
4734827|NCT01908140|16332084|P1|Overall Study|Lost to Follow-up|1
4734828|NCT01908140|16332083|P2|Overall Study|Withdrawal by Subject|24
4734829|NCT01908140|16332084|P1|Overall Study|Withdrawal by Subject|23
4734830|NCT01908140|16332083|P2|Overall Study|Lack of Efficacy|5
4734831|NCT01908140|16332084|P1|Overall Study|Lack of Efficacy|7
4734832|NCT01908140|16332083|P2|Overall Study|Other or Progressive Disease|12
4734833|NCT01908140|16332084|P1|Overall Study|Other or Progressive Disease|5
4734834|NCT01908101|16332103|P1|Overall Study|Did not complete the first cycle|4
4734835|NCT01908101|16332103|P1|Overall Study|Incorrect Starting Dose|1
4734836|NCT01908101|16332103|P1|Overall Study|Incorrect Diagnosis|2
4734837|NCT01908101|16332103|P1|Overall Study|Withdrawal by Subject|1
4734838|NCT01908101|16332103|P1|Overall Study|Physician Decision|1
4734839|NCT01907906|16332137|P2|Overall Study|Physician Decision|1
4734840|NCT01907906|16332138|P1|Overall Study|Physician Decision|3
4734841|NCT01907906|16332137|P2|Overall Study|Withdrawal by Subject|0
4734842|NCT01907906|16332138|P1|Overall Study|Withdrawal by Subject|1
4734843|NCT01907854|16332218|P2|Overall Study|Unclassified|3
4734844|NCT01907854|16332219|P1|Overall Study|Unclassified|4
4734845|NCT01907854|16332218|P2|Overall Study|Lost to Follow-up|2
4734846|NCT01907854|16332219|P1|Overall Study|Lost to Follow-up|2
4734847|NCT01907854|16332218|P2|Overall Study|Withdrawal by Subject|7
4734848|NCT01907854|16332219|P1|Overall Study|Withdrawal by Subject|9
4734849|NCT01907854|16332218|P2|Overall Study|Protocol Violation|1
4734850|NCT01907854|16332219|P1|Overall Study|Protocol Violation|1
4734851|NCT01907828|16332239|P2|Overall Study|Participant met exclusion criteria|1
4734852|NCT01907828|16332240|P1|Overall Study|Participant met exclusion criteria|0
4734853|NCT01907828|16332239|P2|Overall Study|Participant refused 24-month follow-up|0
4734854|NCT01907828|16332240|P1|Overall Study|Participant refused 24-month follow-up|1
4734855|NCT01907828|16332239|P2|Overall Study|Lost to Follow-up|0
4734856|NCT01907828|16332240|P1|Overall Study|Lost to Follow-up|3
4734857|NCT01907828|16332239|P2|Overall Study|Withdrawal by Subject|4
4734858|NCT01907828|16332240|P1|Overall Study|Withdrawal by Subject|3
4734859|NCT01907828|16332239|P2|Overall Study|Exclusion criteria not met|1
4734860|NCT01907828|16332240|P1|Overall Study|Exclusion criteria not met|0
4734861|NCT01907815|16332268|P2|Overall Study|Withdrawal by Subject|0
4734862|NCT01907815|16332269|P1|Overall Study|Withdrawal by Subject|1
4734863|NCT01907737|16332283|P1|Overall Study|Withdrawal by Subject|1
4734864|NCT01907516|16332295|P2|First Intervention (3 Weeks)|Developed DKA during study|0
4734865|NCT01907516|16332296|P1|First Intervention (3 Weeks)|Developed DKA during study|1
4734866|NCT01907516|16332295|P2|First Intervention (3 Weeks)|Delivered before second arm|4
4734867|NCT01907516|16332296|P1|First Intervention (3 Weeks)|Delivered before second arm|3
4734868|NCT01907516|16332295|P2|First Intervention (3 Weeks)|Lost to Follow-up|3
4734869|NCT01907516|16332296|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
4734870|NCT01907516|16332295|P2|First Intervention (3 Weeks)|Withdrawal by Subject|9
4734871|NCT01907516|16332296|P1|First Intervention (3 Weeks)|Withdrawal by Subject|5
4734872|NCT01907217|16332340|P2|Overall Study|Withdrawal by Subject|2
4734873|NCT01907217|16332341|P1|Overall Study|Withdrawal by Subject|0
4734874|NCT01907100|16332453|P4|Overall Study|Worsening/AE underlying cancer disease|8
4734875|NCT01907100|16332454|P3|Overall Study|Worsening/AE underlying cancer disease|8
4734876|NCT01907100|16332455|P2|Overall Study|Worsening/AE underlying cancer disease|0
4734877|NCT01907100|16332456|P1|Overall Study|Worsening/AE underlying cancer disease|0
4734878|NCT01907100|16332453|P4|Overall Study|Adverse event (AE)|23
4734879|NCT01907100|16332454|P3|Overall Study|Adverse event (AE)|22
4734880|NCT01907100|16332455|P2|Overall Study|Adverse event (AE)|3
4734881|NCT01907100|16332456|P1|Overall Study|Adverse event (AE)|6
4734882|NCT01907100|16332453|P4|Overall Study|Other than reasons specified|6
4734883|NCT01907100|16332454|P3|Overall Study|Other than reasons specified|10
4734884|NCT01907100|16332455|P2|Overall Study|Other than reasons specified|0
4734885|NCT01907100|16332456|P1|Overall Study|Other than reasons specified|1
4734886|NCT01907100|16332453|P4|Overall Study|Not treated|2
4734887|NCT01907100|16332454|P3|Overall Study|Not treated|1
4734888|NCT01907100|16332455|P2|Overall Study|Not treated|0
4734889|NCT01907100|16332456|P1|Overall Study|Not treated|2
4734890|NCT01907100|16332453|P4|Overall Study|Lost to Follow-up|1
4734891|NCT01907100|16332454|P3|Overall Study|Lost to Follow-up|0
4734892|NCT01907100|16332455|P2|Overall Study|Lost to Follow-up|0
4734893|NCT01907100|16332456|P1|Overall Study|Lost to Follow-up|0
4734894|NCT01907100|16332453|P4|Overall Study|Protocol Violation|1
4734895|NCT01907100|16332454|P3|Overall Study|Protocol Violation|1
4734896|NCT01907100|16332455|P2|Overall Study|Protocol Violation|0
4734897|NCT01907100|16332456|P1|Overall Study|Protocol Violation|0
4734898|NCT01907100|16332453|P4|Overall Study|Withdrawal by Subject|13
4734899|NCT01907100|16332454|P3|Overall Study|Withdrawal by Subject|10
4734900|NCT01907100|16332455|P2|Overall Study|Withdrawal by Subject|5
4734901|NCT01907100|16332456|P1|Overall Study|Withdrawal by Subject|2
4734902|NCT01907100|16332453|P4|Overall Study|PD based on modified RECIST criteria|92
4734903|NCT01907100|16332454|P3|Overall Study|PD based on modified RECIST criteria|95
4734904|NCT01907100|16332455|P2|Overall Study|PD based on modified RECIST criteria|32
4734905|NCT01907100|16332456|P1|Overall Study|PD based on modified RECIST criteria|31
4734906|NCT01907087|16332470|P1|Overall Study|Withdrawal by Subject|1
4734907|NCT01906476|16332533|P2|Overall Study|Lost to Follow-up|16
4734908|NCT01906476|16332534|P1|Overall Study|Lost to Follow-up|17
4734909|NCT01906372|16332542|P1|Overall Study|Withdrawal by Subject|2
4734910|NCT01906346|16332547|P1|Overall Study|AEs|1
4734911|NCT01906008|16332555|P2|Overall Study|Adverse Event|3
4734912|NCT01906008|16332556|P1|Overall Study|Adverse Event|0
4734913|NCT01906008|16332555|P2|Overall Study|Lack of compliance of study med|3
4734914|NCT01906008|16332556|P1|Overall Study|Lack of compliance of study med|5
4734915|NCT01906008|16332555|P2|Overall Study|Physician Decision|3
4734916|NCT01906008|16332556|P1|Overall Study|Physician Decision|3
4734917|NCT01906008|16332555|P2|Overall Study|Hospice|0
4734918|NCT01906008|16332556|P1|Overall Study|Hospice|1
4734919|NCT01906008|16332555|P2|Overall Study|Oxaliplatin stops|8
4734920|NCT01906008|16332556|P1|Overall Study|Oxaliplatin stops|10
4734921|NCT01906008|16332555|P2|Overall Study|Did not start study med|4
4734922|NCT01906008|16332556|P1|Overall Study|Did not start study med|3
4734923|NCT01906008|16332555|P2|Overall Study|Withdrawal by Subject|5
4734924|NCT01906008|16332556|P1|Overall Study|Withdrawal by Subject|1
4734925|NCT01906008|16332555|P2|Overall Study|Protocol Violation|1
4734926|NCT01906008|16332556|P1|Overall Study|Protocol Violation|0
4734927|NCT01906008|16332555|P2|Overall Study|Oxaliplatin toxicity|0
4734928|NCT01906008|16332556|P1|Overall Study|Oxaliplatin toxicity|2
4734929|NCT01906008|16332555|P2|Overall Study|Lost to Follow-up|0
4734930|NCT01906008|16332556|P1|Overall Study|Lost to Follow-up|2
4734931|NCT01905943|16332589|P1|Overall Study|Other|12
4734932|NCT01905943|16332589|P1|Overall Study|Adverse Event|3
4734933|NCT01905943|16332589|P1|Overall Study|Death|186
4734934|NCT01905943|16332589|P1|Overall Study|Investigator discretion|7
4734935|NCT01905943|16332589|P1|Overall Study|Lost to Follow-up|16
4734936|NCT01905943|16332589|P1|Overall Study|Withdrawal of consent|90
4734937|NCT01905683|16332706|P1|Overall Study|Lost to Follow-up|4
4734938|NCT01905683|16332706|P1|Overall Study|Adverse Event|4
4734939|NCT01905683|16332706|P1|Overall Study|Withdrawal by Subject|20
4734940|NCT01905683|16332706|P1|Overall Study|Lack of Efficacy|8
4734941|NCT01905683|16332706|P1|Overall Study|Physician Decision|1
4734942|NCT01905683|16332706|P1|Overall Study|Re-injection criteria not met; others|13
4734943|NCT01905683|16332706|P1|Overall Study|Protocol Violation|1
4734944|NCT01905592|16332721|P2|Overall Study|Withdrawal by Subject|2
4734945|NCT01905592|16332722|P1|Overall Study|Withdrawal by Subject|10
4734946|NCT01905592|16332721|P2|Overall Study|Ongoing in Study|7
4734947|NCT01905592|16332722|P1|Overall Study|Ongoing in Study|0
4734948|NCT01905592|16332721|P2|Overall Study|Not treated|3
4734949|NCT01905592|16332722|P1|Overall Study|Not treated|7
4734950|NCT01905592|16332721|P2|Overall Study|Sponsor's decision|0
4734951|NCT01905592|16332722|P1|Overall Study|Sponsor's decision|1
4734952|NCT01905592|16332721|P2|Overall Study|Protocol Violation|1
4734953|NCT01905592|16332722|P1|Overall Study|Protocol Violation|0
4734954|NCT01905592|16332721|P2|Overall Study|New anti-cancer|0
4734955|NCT01905592|16332722|P1|Overall Study|New anti-cancer|1
4734956|NCT01905592|16332721|P2|Overall Study|Physician Decision|2
4734957|NCT01905592|16332722|P1|Overall Study|Physician Decision|0
4734958|NCT01905592|16332721|P2|Overall Study|Toxicity|16
4734959|NCT01905592|16332722|P1|Overall Study|Toxicity|1
4734960|NCT01905592|16332721|P2|Overall Study|Disease Progression|104
4734961|NCT01905592|16332722|P1|Overall Study|Disease Progression|51
4734962|NCT01905553|16332736|P2|Period 2|Adverse Event|0
4734963|NCT01905553|16332737|P1|Period 2|Adverse Event|1
4734964|NCT01905540|16332751|P4|Period 3|Other|1
4734965|NCT01905540|16332752|P3|Period 3|Other|1
4734966|NCT01905540|16332753|P2|Period 3|Other|0
4734967|NCT01905540|16332754|P1|Period 3|Other|1
4734968|NCT01905267|16332789|P2|Overall Study|Physician Decision|2
4734969|NCT01905267|16332790|P1|Overall Study|Physician Decision|2
4734970|NCT01904773|16332811|P9|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734971|NCT01904773|16332812|P8|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734972|NCT01904773|16332813|P7|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734973|NCT01904773|16332814|P6|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734974|NCT01904773|16332815|P5|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734975|NCT01904773|16332816|P4|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734976|NCT01904773|16332817|P3|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734977|NCT01904773|16332818|P2|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1
4734978|NCT01904773|16332819|P1|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0
4734979|NCT01904773|16332811|P9|Fifth Intervention|Adverse Event|0
4734980|NCT01904773|16332812|P8|Fifth Intervention|Adverse Event|1
4734981|NCT01904773|16332813|P7|Fifth Intervention|Adverse Event|0
4734982|NCT01904773|16332814|P6|Fifth Intervention|Adverse Event|0
4734983|NCT01904773|16332815|P5|Fifth Intervention|Adverse Event|0
4734984|NCT01904773|16332816|P4|Fifth Intervention|Adverse Event|0
4734985|NCT01904773|16332817|P3|Fifth Intervention|Adverse Event|0
4734986|NCT01904773|16332818|P2|Fifth Intervention|Adverse Event|0
4734987|NCT01904773|16332819|P1|Fifth Intervention|Adverse Event|0
4734988|NCT01904773|16332811|P9|Placebo Washout First Intervention|Condition worsened|0
4734989|NCT01904773|16332812|P8|Placebo Washout First Intervention|Condition worsened|0
4734990|NCT01904773|16332813|P7|Placebo Washout First Intervention|Condition worsened|0
4734991|NCT01904773|16332814|P6|Placebo Washout First Intervention|Condition worsened|0
4734992|NCT01904773|16332815|P5|Placebo Washout First Intervention|Condition worsened|0
4734993|NCT01904773|16332816|P4|Placebo Washout First Intervention|Condition worsened|0
4734994|NCT01904773|16332817|P3|Placebo Washout First Intervention|Condition worsened|0
4734995|NCT01904773|16332818|P2|Placebo Washout First Intervention|Condition worsened|1
4734996|NCT01904773|16332819|P1|Placebo Washout First Intervention|Condition worsened|0
4734997|NCT01904773|16332811|P9|First Intervention|Adverse Event|0
4734998|NCT01904773|16332812|P8|First Intervention|Adverse Event|0
4734999|NCT01904773|16332813|P7|First Intervention|Adverse Event|1
4735000|NCT01904773|16332814|P6|First Intervention|Adverse Event|0
4735001|NCT01904773|16332815|P5|First Intervention|Adverse Event|0
4735002|NCT01904773|16332816|P4|First Intervention|Adverse Event|0
4735003|NCT01904773|16332817|P3|First Intervention|Adverse Event|0
4735004|NCT01904773|16332818|P2|First Intervention|Adverse Event|0
4735005|NCT01904773|16332819|P1|First Intervention|Adverse Event|0
4735006|NCT01904773|16332811|P9|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735007|NCT01904773|16332812|P8|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735008|NCT01904773|16332813|P7|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735009|NCT01904773|16332814|P6|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735010|NCT01904773|16332815|P5|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735011|NCT01904773|16332816|P4|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735012|NCT01904773|16332817|P3|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735013|NCT01904773|16332818|P2|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0
4735014|NCT01904773|16332819|P1|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1
4735015|NCT01904773|16332811|P9|Screen|Withdrawal by Subject|0
4735016|NCT01904773|16332812|P8|Screen|Withdrawal by Subject|0
4735017|NCT01904773|16332813|P7|Screen|Withdrawal by Subject|0
4735018|NCT01904773|16332814|P6|Screen|Withdrawal by Subject|0
4735019|NCT01904773|16332815|P5|Screen|Withdrawal by Subject|0
4735020|NCT01904773|16332816|P4|Screen|Withdrawal by Subject|0
4735021|NCT01904773|16332817|P3|Screen|Withdrawal by Subject|0
4735022|NCT01904773|16332818|P2|Screen|Withdrawal by Subject|0
4735023|NCT01904773|16332819|P1|Screen|Withdrawal by Subject|1
4735024|NCT01904773|16332811|P9|Screen|Screen failure|0
4735025|NCT01904773|16332812|P8|Screen|Screen failure|0
4735026|NCT01904773|16332813|P7|Screen|Screen failure|0
4735027|NCT01904773|16332814|P6|Screen|Screen failure|0
4735028|NCT01904773|16332815|P5|Screen|Screen failure|0
4735029|NCT01904773|16332816|P4|Screen|Screen failure|0
4735030|NCT01904773|16332817|P3|Screen|Screen failure|0
4735031|NCT01904773|16332818|P2|Screen|Screen failure|0
4735032|NCT01904773|16332819|P1|Screen|Screen failure|3
4735033|NCT01904760|16332836|P2|Overall Study|Protocol Violation|0
4735034|NCT01904760|16332837|P1|Overall Study|Protocol Violation|1
4735035|NCT01904721|16332852|P7|Overall Study|Adverse Event|0
4735036|NCT01904721|16332853|P6|Overall Study|Adverse Event|1
4735037|NCT01904721|16332854|P5|Overall Study|Adverse Event|3
4735038|NCT01904721|16332855|P4|Overall Study|Adverse Event|0
4735039|NCT01904721|16332856|P3|Overall Study|Adverse Event|0
4735040|NCT01904721|16332857|P2|Overall Study|Adverse Event|0
4735041|NCT01904721|16332858|P1|Overall Study|Adverse Event|0
4735042|NCT01904721|16332852|P7|Overall Study|Lack of Efficacy|1
4735043|NCT01904721|16332853|P6|Overall Study|Lack of Efficacy|0
4735044|NCT01904721|16332854|P5|Overall Study|Lack of Efficacy|0
4735045|NCT01904721|16332855|P4|Overall Study|Lack of Efficacy|0
4735046|NCT01904721|16332856|P3|Overall Study|Lack of Efficacy|0
4735047|NCT01904721|16332857|P2|Overall Study|Lack of Efficacy|0
4735048|NCT01904721|16332858|P1|Overall Study|Lack of Efficacy|0
4735049|NCT01904721|16332852|P7|Overall Study|Lost to Follow-up|1
4735050|NCT01904721|16332853|P6|Overall Study|Lost to Follow-up|3
4735051|NCT01904721|16332854|P5|Overall Study|Lost to Follow-up|1
4735052|NCT01904721|16332855|P4|Overall Study|Lost to Follow-up|0
4735053|NCT01904721|16332856|P3|Overall Study|Lost to Follow-up|0
4735054|NCT01904721|16332857|P2|Overall Study|Lost to Follow-up|0
4735055|NCT01904721|16332858|P1|Overall Study|Lost to Follow-up|0
4735056|NCT01904721|16332852|P7|Overall Study|Personal Reasons|3
4735057|NCT01904721|16332853|P6|Overall Study|Personal Reasons|3
4735058|NCT01904721|16332854|P5|Overall Study|Personal Reasons|2
4735059|NCT01904721|16332855|P4|Overall Study|Personal Reasons|0
4735060|NCT01904721|16332856|P3|Overall Study|Personal Reasons|0
4735061|NCT01904721|16332857|P2|Overall Study|Personal Reasons|0
4735062|NCT01904721|16332858|P1|Overall Study|Personal Reasons|0
4735063|NCT01904721|16332852|P7|Overall Study|Other Reasons|2
4735064|NCT01904721|16332853|P6|Overall Study|Other Reasons|2
4735065|NCT01904721|16332854|P5|Overall Study|Other Reasons|2
4735066|NCT01904721|16332855|P4|Overall Study|Other Reasons|1
4735067|NCT01904721|16332856|P3|Overall Study|Other Reasons|1
4735068|NCT01904721|16332857|P2|Overall Study|Other Reasons|0
4735069|NCT01904721|16332858|P1|Overall Study|Other Reasons|0
4735070|NCT01904604|16332888|P3|Overall Study|Lost to Follow-up|1
4735071|NCT01904604|16332889|P2|Overall Study|Lost to Follow-up|0
4735072|NCT01904604|16332890|P1|Overall Study|Lost to Follow-up|0
4735073|NCT01904604|16332888|P3|Overall Study|Participant Relocated|1
4735074|NCT01904604|16332889|P2|Overall Study|Participant Relocated|1
4735075|NCT01904604|16332890|P1|Overall Study|Participant Relocated|1
4735076|NCT01904604|16332888|P3|Overall Study|Withdrawal by Subject|0
4735077|NCT01904604|16332889|P2|Overall Study|Withdrawal by Subject|2
4735078|NCT01904604|16332890|P1|Overall Study|Withdrawal by Subject|1
4735079|NCT01904604|16332888|P3|Overall Study|Passed Week 52 OFC|0
4735080|NCT01904604|16332889|P2|Overall Study|Passed Week 52 OFC|0
4735081|NCT01904604|16332890|P1|Overall Study|Passed Week 52 OFC|1
4735082|NCT01904604|16332888|P3|Overall Study|Unrelated illness|0
4735083|NCT01904604|16332889|P2|Overall Study|Unrelated illness|1
4735084|NCT01904604|16332890|P1|Overall Study|Unrelated illness|0
4735085|NCT01904604|16332888|P3|Overall Study|Increased syncope|0
4735086|NCT01904604|16332889|P2|Overall Study|Increased syncope|1
4735087|NCT01904604|16332890|P1|Overall Study|Increased syncope|0
4735088|NCT01904604|16332888|P3|Overall Study|Patch site reactions|0
4735089|NCT01904604|16332889|P2|Overall Study|Patch site reactions|1
4735090|NCT01904604|16332890|P1|Overall Study|Patch site reactions|1
4735091|NCT01904604|16332888|P3|Overall Study|Anxiety about OFC/Refused OFC|0
4735092|NCT01904604|16332889|P2|Overall Study|Anxiety about OFC/Refused OFC|0
4735093|NCT01904604|16332890|P1|Overall Study|Anxiety about OFC/Refused OFC|2
4735094|NCT01904604|16332888|P3|Overall Study|Non-compliance|0
4735095|NCT01904604|16332889|P2|Overall Study|Non-compliance|0
4735096|NCT01904604|16332890|P1|Overall Study|Non-compliance|1
4735097|NCT01904604|16332888|P3|Overall Study|Withdrew before receiving dosing|0
4735098|NCT01904604|16332889|P2|Overall Study|Withdrew before receiving dosing|1
4735099|NCT01904604|16332890|P1|Overall Study|Withdrew before receiving dosing|0
4735100|NCT01904383|16332955|P1|Overall Study|No patient visit after entry|54
4735101|NCT01904383|16332955|P1|Overall Study|Adverse Event|271
4735102|NCT01904383|16332955|P1|Overall Study|Improvement|141
4735103|NCT01904383|16332955|P1|Overall Study|Lack of Efficacy|370
4735104|NCT01904383|16332955|P1|Overall Study|Lost to Follow-up|674
4735105|NCT01904383|16332955|P1|Overall Study|Reason not listed|147
4735106|NCT01904383|16332955|P1|Overall Study|CRF not collected|117
4735107|NCT01904279|16332962|P2|Overall Study|Withdrawal by Subject|0
4735108|NCT01904279|16332963|P1|Overall Study|Withdrawal by Subject|1
4735109|NCT01904279|16332962|P2|Overall Study|Lack of Efficacy|3
4735110|NCT01904279|16332963|P1|Overall Study|Lack of Efficacy|2
4735111|NCT01904149|16332989|P6|Overall Study|non compliance with study drug|0
4735112|NCT01904149|16332990|P5|Overall Study|non compliance with study drug|0
4735113|NCT01904149|16332991|P4|Overall Study|non compliance with study drug|0
4735114|NCT01904149|16332992|P3|Overall Study|non compliance with study drug|0
4735115|NCT01904149|16332993|P2|Overall Study|non compliance with study drug|0
4735116|NCT01904149|16332994|P1|Overall Study|non compliance with study drug|1
4735117|NCT01904149|16332989|P6|Overall Study|Protocol Violation|0
4735118|NCT01904149|16332990|P5|Overall Study|Protocol Violation|0
4735119|NCT01904149|16332991|P4|Overall Study|Protocol Violation|0
4735120|NCT01904149|16332992|P3|Overall Study|Protocol Violation|0
4735121|NCT01904149|16332993|P2|Overall Study|Protocol Violation|1
4735122|NCT01904149|16332994|P1|Overall Study|Protocol Violation|0
4735123|NCT01904149|16332989|P6|Overall Study|Withdrawal by Subject|0
4735124|NCT01904149|16332990|P5|Overall Study|Withdrawal by Subject|1
4735125|NCT01904149|16332991|P4|Overall Study|Withdrawal by Subject|0
4735126|NCT01904149|16332992|P3|Overall Study|Withdrawal by Subject|1
4735127|NCT01904149|16332993|P2|Overall Study|Withdrawal by Subject|3
4735128|NCT01904149|16332994|P1|Overall Study|Withdrawal by Subject|1
4735129|NCT01904149|16332989|P6|Overall Study|Lack of Efficacy|1
4735130|NCT01904149|16332990|P5|Overall Study|Lack of Efficacy|3
4735131|NCT01904149|16332991|P4|Overall Study|Lack of Efficacy|3
4735132|NCT01904149|16332992|P3|Overall Study|Lack of Efficacy|1
4735133|NCT01904149|16332993|P2|Overall Study|Lack of Efficacy|3
4735134|NCT01904149|16332994|P1|Overall Study|Lack of Efficacy|0
4735135|NCT01904149|16332989|P6|Overall Study|Adverse Event|2
4735136|NCT01904149|16332990|P5|Overall Study|Adverse Event|1
4735137|NCT01904149|16332991|P4|Overall Study|Adverse Event|1
4735138|NCT01904149|16332992|P3|Overall Study|Adverse Event|0
4735139|NCT01904149|16332993|P2|Overall Study|Adverse Event|4
4735140|NCT01904149|16332994|P1|Overall Study|Adverse Event|3
4735141|NCT01904058|16333045|P4|Overall Study|Pregnancy|1
4735142|NCT01904058|16333046|P3|Overall Study|Pregnancy|0
4735143|NCT01904058|16333047|P2|Overall Study|Pregnancy|0
4735144|NCT01904058|16333048|P1|Overall Study|Pregnancy|0
4735145|NCT01904058|16333045|P4|Overall Study|Withdrawal by Subject|0
4735146|NCT01904058|16333046|P3|Overall Study|Withdrawal by Subject|1
4735147|NCT01904058|16333047|P2|Overall Study|Withdrawal by Subject|0
4735148|NCT01904058|16333048|P1|Overall Study|Withdrawal by Subject|1
4735149|NCT01904058|16333045|P4|Overall Study|Adverse Event|0
4735150|NCT01904058|16333046|P3|Overall Study|Adverse Event|0
4735151|NCT01904058|16333047|P2|Overall Study|Adverse Event|0
4735152|NCT01904058|16333048|P1|Overall Study|Adverse Event|2
4735153|NCT01903993|16333088|P2|Overall Study|Terminated by Sponsor After 31 Aug 2018|2
4735154|NCT01903993|16333089|P1|Overall Study|Terminated by Sponsor After 31 Aug 2018|0
4735155|NCT01903993|16333088|P2|Overall Study|Study Terminated by Sponsor|14
4735156|NCT01903993|16333089|P1|Overall Study|Study Terminated by Sponsor|8
4735157|NCT01903993|16333088|P2|Overall Study|Lost to Follow-up|3
4735158|NCT01903993|16333089|P1|Overall Study|Lost to Follow-up|2
4735159|NCT01903993|16333088|P2|Overall Study|Withdrawal by Subject|4
4735160|NCT01903993|16333089|P1|Overall Study|Withdrawal by Subject|15
4735161|NCT01903993|16333088|P2|Overall Study|Death|121
4735162|NCT01903993|16333089|P1|Overall Study|Death|118
4735163|NCT01903876|16333106|P2|Six-Month Follow-up Period|Lost to Follow-up|145
4735164|NCT01903876|16333107|P1|Six-Month Follow-up Period|Lost to Follow-up|91
4735165|NCT01903876|16333106|P2|Baseline to Post-Intervention Period|Lost to Follow-up|108
4735166|NCT01903876|16333107|P1|Baseline to Post-Intervention Period|Lost to Follow-up|184
4735167|NCT01903863|16333117|P2|Overall Study|Physician Decision|0
4735168|NCT01903863|16333118|P1|Overall Study|Physician Decision|2
4735169|NCT01903811|16333140|P2|Overall Study|Withdrawal by Subject|1
4735170|NCT01903811|16333141|P1|Overall Study|Withdrawal by Subject|0
4735171|NCT01903811|16333140|P2|Overall Study|Baseline lab missing/incomplete/untimely|11
4735172|NCT01903811|16333141|P1|Overall Study|Baseline lab missing/incomplete/untimely|6
4735173|NCT01903811|16333140|P2|Overall Study|Incomplete/discontinued prior therapy|1
4735174|NCT01903811|16333141|P1|Overall Study|Incomplete/discontinued prior therapy|1
4735175|NCT01903811|16333140|P2|Overall Study|No measurable disease|1
4735176|NCT01903811|16333141|P1|Overall Study|No measurable disease|1
4735177|NCT01903720|16333175|P1|Overall Study|Treatment with alternative drug|1
4735178|NCT01903720|16333175|P1|Overall Study|Lost to Follow-up|2
4735179|NCT01903720|16333175|P1|Overall Study|Rescinding of informed consent|2
4735180|NCT01903720|16333175|P1|Overall Study|Adverse Event|1
4735181|NCT01903720|16333175|P1|Overall Study|Inclusion / exclusion criteria not met|6
4735182|NCT01903460|16333213|P4|Overall Study|Adverse Event|1
4735183|NCT01903460|16333214|P3|Overall Study|Adverse Event|0
4735184|NCT01903460|16333215|P2|Overall Study|Adverse Event|0
4735185|NCT01903460|16333216|P1|Overall Study|Adverse Event|0
4735186|NCT01903434|16333233|P2|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2
4735187|NCT01903434|16333234|P1|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0
4735188|NCT01903434|16333233|P2|Washout Period 1 (at Least 14 Days)|Adverse Event|0
4735189|NCT01903434|16333234|P1|Washout Period 1 (at Least 14 Days)|Adverse Event|1
4735190|NCT01903356|16333242|P1|Overall Study|Violated the dosage and administration|3
4735191|NCT01903356|16333242|P1|Overall Study|Violated inclusion/exclusion criteria|5
4735192|NCT01903356|16333242|P1|Overall Study|Lost to Follow-up|7
4735193|NCT01903252|16333269|P6|Maintenance, Open-Label|Other|2
4735194|NCT01903252|16333270|P5|Maintenance, Open-Label|Other|6
4735195|NCT01903252|16333271|P4|Maintenance, Open-Label|Other|2
4735196|NCT01903252|16333272|P3|Maintenance, Open-Label|Other|0
4735197|NCT01903252|16333273|P2|Maintenance, Open-Label|Other|0
4735198|NCT01903252|16333274|P1|Maintenance, Open-Label|Other|0
4735199|NCT01903252|16333269|P6|Maintenance, Open-Label|Withdrawal by Subject|2
4735200|NCT01903252|16333270|P5|Maintenance, Open-Label|Withdrawal by Subject|6
4735201|NCT01903252|16333271|P4|Maintenance, Open-Label|Withdrawal by Subject|1
4735202|NCT01903252|16333272|P3|Maintenance, Open-Label|Withdrawal by Subject|0
4735203|NCT01903252|16333273|P2|Maintenance, Open-Label|Withdrawal by Subject|0
4735204|NCT01903252|16333274|P1|Maintenance, Open-Label|Withdrawal by Subject|0
4735205|NCT01903252|16333269|P6|Maintenance, Open-Label|Adverse Event|14
4735206|NCT01903252|16333270|P5|Maintenance, Open-Label|Adverse Event|9
4735207|NCT01903252|16333271|P4|Maintenance, Open-Label|Adverse Event|3
4735208|NCT01903252|16333272|P3|Maintenance, Open-Label|Adverse Event|0
4735209|NCT01903252|16333273|P2|Maintenance, Open-Label|Adverse Event|0
4735210|NCT01903252|16333274|P1|Maintenance, Open-Label|Adverse Event|0
4735211|NCT01903252|16333269|P6|Extended Induction, Open-Label|Physician Decision|0
4735212|NCT01903252|16333270|P5|Extended Induction, Open-Label|Physician Decision|0
4735213|NCT01903252|16333271|P4|Extended Induction, Open-Label|Physician Decision|0
4735214|NCT01903252|16333272|P3|Extended Induction, Open-Label|Physician Decision|1
4735215|NCT01903252|16333273|P2|Extended Induction, Open-Label|Physician Decision|0
4735216|NCT01903252|16333274|P1|Extended Induction, Open-Label|Physician Decision|0
4735217|NCT01903252|16333269|P6|Extended Induction, Open-Label|Withdrawal by Subject|0
4735218|NCT01903252|16333270|P5|Extended Induction, Open-Label|Withdrawal by Subject|0
4735219|NCT01903252|16333271|P4|Extended Induction, Open-Label|Withdrawal by Subject|0
4735220|NCT01903252|16333272|P3|Extended Induction, Open-Label|Withdrawal by Subject|5
4735221|NCT01903252|16333273|P2|Extended Induction, Open-Label|Withdrawal by Subject|0
4735222|NCT01903252|16333274|P1|Extended Induction, Open-Label|Withdrawal by Subject|0
4735223|NCT01903252|16333269|P6|Extended Induction, Open-Label|Adverse Event|0
4735224|NCT01903252|16333270|P5|Extended Induction, Open-Label|Adverse Event|0
4735225|NCT01903252|16333271|P4|Extended Induction, Open-Label|Adverse Event|0
4735226|NCT01903252|16333272|P3|Extended Induction, Open-Label|Adverse Event|17
4735227|NCT01903252|16333273|P2|Extended Induction, Open-Label|Adverse Event|0
4735228|NCT01903252|16333274|P1|Extended Induction, Open-Label|Adverse Event|0
4735229|NCT01903252|16333269|P6|Double-Blind Induction|non-compliance,|0
4735230|NCT01903252|16333270|P5|Double-Blind Induction|non-compliance,|0
4735231|NCT01903252|16333271|P4|Double-Blind Induction|non-compliance,|0
4735232|NCT01903252|16333272|P3|Double-Blind Induction|non-compliance,|0
4735233|NCT01903252|16333273|P2|Double-Blind Induction|non-compliance,|7
4735234|NCT01903252|16333274|P1|Double-Blind Induction|non-compliance,|7
4735235|NCT01903252|16333269|P6|Double-Blind Induction|Physician Decision|0
4735236|NCT01903252|16333270|P5|Double-Blind Induction|Physician Decision|0
4735237|NCT01903252|16333271|P4|Double-Blind Induction|Physician Decision|0
4735238|NCT01903252|16333272|P3|Double-Blind Induction|Physician Decision|0
4735239|NCT01903252|16333273|P2|Double-Blind Induction|Physician Decision|3
4735240|NCT01903252|16333274|P1|Double-Blind Induction|Physician Decision|2
4735241|NCT01903252|16333269|P6|Double-Blind Induction|Withdrawal by Subject|0
4735242|NCT01903252|16333270|P5|Double-Blind Induction|Withdrawal by Subject|0
4735243|NCT01903252|16333271|P4|Double-Blind Induction|Withdrawal by Subject|0
4735244|NCT01903252|16333272|P3|Double-Blind Induction|Withdrawal by Subject|0
4735245|NCT01903252|16333273|P2|Double-Blind Induction|Withdrawal by Subject|13
4735246|NCT01903252|16333274|P1|Double-Blind Induction|Withdrawal by Subject|10
4735247|NCT01903252|16333269|P6|Double-Blind Induction|Adverse Event|0
4735248|NCT01903252|16333270|P5|Double-Blind Induction|Adverse Event|0
4735249|NCT01903252|16333271|P4|Double-Blind Induction|Adverse Event|0
4735250|NCT01903252|16333272|P3|Double-Blind Induction|Adverse Event|0
4735251|NCT01903252|16333273|P2|Double-Blind Induction|Adverse Event|18
4735252|NCT01903252|16333274|P1|Double-Blind Induction|Adverse Event|20
4735253|NCT01903031|16333387|P3|Overall Study|NuvaRing removed prior to Day 21 visit|1
4735254|NCT01903031|16333388|P2|Overall Study|NuvaRing removed prior to Day 21 visit|0
4735255|NCT01903031|16333389|P1|Overall Study|NuvaRing removed prior to Day 21 visit|0
4735256|NCT01903031|16333387|P3|Overall Study|Lost to Follow-up|1
4735257|NCT01903031|16333388|P2|Overall Study|Lost to Follow-up|0
4735258|NCT01903031|16333389|P1|Overall Study|Lost to Follow-up|0
4735259|NCT01903031|16333387|P3|Overall Study|Protocol Violation|2
4735260|NCT01903031|16333388|P2|Overall Study|Protocol Violation|0
4735261|NCT01903031|16333389|P1|Overall Study|Protocol Violation|0
4735262|NCT01903031|16333387|P3|Overall Study|Withdrawal by Subject|1
4735263|NCT01903031|16333388|P2|Overall Study|Withdrawal by Subject|1
4735264|NCT01903031|16333389|P1|Overall Study|Withdrawal by Subject|0
4735265|NCT01903031|16333387|P3|Overall Study|Adverse Event|0
4735266|NCT01903031|16333388|P2|Overall Study|Adverse Event|1
4735267|NCT01903031|16333389|P1|Overall Study|Adverse Event|0
4735268|NCT01903031|16333387|P3|Overall Study|Missed Day 21 Primary Endpoint Visit|0
4735269|NCT01903031|16333388|P2|Overall Study|Missed Day 21 Primary Endpoint Visit|0
4735270|NCT01903031|16333389|P1|Overall Study|Missed Day 21 Primary Endpoint Visit|1
4735271|NCT01903031|16333387|P3|Overall Study|Not Able to Attend Clinic|0
4735272|NCT01903031|16333388|P2|Overall Study|Not Able to Attend Clinic|1
4735273|NCT01903031|16333389|P1|Overall Study|Not Able to Attend Clinic|1
4735274|NCT01902888|16333463|P1|Overall Study|Study Terminated|3
4735275|NCT01902628|16333477|P1|Overall Study|Lost to Follow-up|35
4735276|NCT01902628|16333477|P1|Overall Study|Adverse Event|41
4735277|NCT01902628|16333477|P1|Overall Study|Withdrawal of participant's consent|7
4735278|NCT01902303|16333505|P2|Overall Study|Did not develop a cold sore|19
4735279|NCT01902303|16333506|P1|Overall Study|Did not develop a cold sore|21
4735280|NCT01902303|16333505|P2|Overall Study|subject lost investigational product|1
4735281|NCT01902303|16333506|P1|Overall Study|subject lost investigational product|0
4735282|NCT01902303|16333505|P2|Overall Study|Protocol Violation|2
4735283|NCT01902303|16333506|P1|Overall Study|Protocol Violation|2
4735284|NCT01902303|16333505|P2|Overall Study|Lost to Follow-up|1
4735285|NCT01902303|16333506|P1|Overall Study|Lost to Follow-up|0
4735286|NCT01902303|16333505|P2|Overall Study|Adverse Event|1
4735287|NCT01902303|16333506|P1|Overall Study|Adverse Event|0
4735288|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 4|Death|1
4735289|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 4|Death|0
4735290|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 4|Death|0
4735291|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 4|Death|0
4735292|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 4|Death|0
4735293|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 4|Death|0
4735294|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3
4735295|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4735296|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4735297|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4735298|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4735299|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0
4735300|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1
4735301|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4735302|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4735303|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4735304|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4735305|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0
4735306|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4735307|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2
4735308|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4735309|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4735310|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4735311|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0
4735312|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4735313|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 3|Ongoing|1
4735314|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4735315|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4735316|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4735317|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 3|Ongoing|0
4735318|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4735319|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4735320|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2
4735321|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4735322|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4735323|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0
4735324|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4735325|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4735326|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1
4735327|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4735328|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4735329|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0
4735330|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4735331|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4735332|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4735333|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 1|Ineligible|1
4735334|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4735335|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 1|Ineligible|0
4735336|NCT01902173|16333520|P6|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4735337|NCT01902173|16333521|P5|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4735338|NCT01902173|16333522|P4|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4735339|NCT01902173|16333523|P3|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3
4735340|NCT01902173|16333524|P2|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4735341|NCT01902173|16333525|P1|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0
4735342|NCT01902173|16333520|P6|Phase 1 Doublet Regimen Cohort 2|No treated|0
4735343|NCT01902173|16333521|P5|Phase 1 Doublet Regimen Cohort 2|No treated|0
4735344|NCT01902173|16333522|P4|Phase 1 Doublet Regimen Cohort 2|No treated|0
4735345|NCT01902173|16333523|P3|Phase 1 Doublet Regimen Cohort 2|No treated|0
4735346|NCT01902173|16333524|P2|Phase 1 Doublet Regimen Cohort 2|No treated|3
4735347|NCT01902173|16333525|P1|Phase 1 Doublet Regimen Cohort 2|No treated|0
4735348|NCT01902173|16333520|P6|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4735349|NCT01902173|16333521|P5|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4735350|NCT01902173|16333522|P4|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4735351|NCT01902173|16333523|P3|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4735352|NCT01902173|16333524|P2|Phase 1 Doublet Regimen Cohort 2|Ineligible|1
4735353|NCT01902173|16333525|P1|Phase 1 Doublet Regimen Cohort 2|Ineligible|0
4735354|NCT01902173|16333520|P6|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4735355|NCT01902173|16333521|P5|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4735356|NCT01902173|16333522|P4|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4735357|NCT01902173|16333523|P3|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4735358|NCT01902173|16333524|P2|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5
4735359|NCT01902173|16333525|P1|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0
4735360|NCT01902173|16333520|P6|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4735361|NCT01902173|16333521|P5|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4735362|NCT01902173|16333522|P4|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4735363|NCT01902173|16333523|P3|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4735364|NCT01902173|16333524|P2|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0
4735365|NCT01902173|16333525|P1|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2
4735366|NCT01902173|16333520|P6|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4735367|NCT01902173|16333521|P5|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4735368|NCT01902173|16333522|P4|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4735369|NCT01902173|16333523|P3|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4735370|NCT01902173|16333524|P2|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0
4735371|NCT01902173|16333525|P1|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1
4735372|NCT01902134|16333548|P6|Overall Study|Other|0
4735373|NCT01902134|16333549|P5|Overall Study|Other|1
4735374|NCT01902134|16333550|P4|Overall Study|Other|0
4735375|NCT01902134|16333551|P3|Overall Study|Other|2
4735376|NCT01902134|16333552|P2|Overall Study|Other|1
4735377|NCT01902134|16333553|P1|Overall Study|Other|0
4735378|NCT01902134|16333548|P6|Overall Study|no compliance|0
4735379|NCT01902134|16333549|P5|Overall Study|no compliance|0
4735380|NCT01902134|16333550|P4|Overall Study|no compliance|0
4735381|NCT01902134|16333551|P3|Overall Study|no compliance|0
4735382|NCT01902134|16333552|P2|Overall Study|no compliance|0
4735383|NCT01902134|16333553|P1|Overall Study|no compliance|1
4735384|NCT01902134|16333548|P6|Overall Study|Withdrawal by Subject|4
4735385|NCT01902134|16333549|P5|Overall Study|Withdrawal by Subject|5
4735386|NCT01902134|16333550|P4|Overall Study|Withdrawal by Subject|1
4735387|NCT01902134|16333551|P3|Overall Study|Withdrawal by Subject|9
4735388|NCT01902134|16333552|P2|Overall Study|Withdrawal by Subject|8
4735389|NCT01902134|16333553|P1|Overall Study|Withdrawal by Subject|4
4735390|NCT01902134|16333548|P6|Overall Study|Protocol Violation|1
4735391|NCT01902134|16333549|P5|Overall Study|Protocol Violation|0
4735392|NCT01902134|16333550|P4|Overall Study|Protocol Violation|0
4735393|NCT01902134|16333551|P3|Overall Study|Protocol Violation|0
4735394|NCT01902134|16333552|P2|Overall Study|Protocol Violation|0
4735395|NCT01902134|16333553|P1|Overall Study|Protocol Violation|0
4735396|NCT01902134|16333548|P6|Overall Study|Physician Decision|0
4735397|NCT01902134|16333549|P5|Overall Study|Physician Decision|0
4735398|NCT01902134|16333550|P4|Overall Study|Physician Decision|0
4735399|NCT01902134|16333551|P3|Overall Study|Physician Decision|0
4735400|NCT01902134|16333552|P2|Overall Study|Physician Decision|1
4735401|NCT01902134|16333553|P1|Overall Study|Physician Decision|0
4735402|NCT01902134|16333548|P6|Overall Study|Lack of Efficacy|1
4735403|NCT01902134|16333549|P5|Overall Study|Lack of Efficacy|0
4735404|NCT01902134|16333550|P4|Overall Study|Lack of Efficacy|0
4735405|NCT01902134|16333551|P3|Overall Study|Lack of Efficacy|2
4735406|NCT01902134|16333552|P2|Overall Study|Lack of Efficacy|0
4735407|NCT01902134|16333553|P1|Overall Study|Lack of Efficacy|0
4735408|NCT01902134|16333548|P6|Overall Study|Adverse Event|3
4735409|NCT01902134|16333549|P5|Overall Study|Adverse Event|1
4735410|NCT01902134|16333550|P4|Overall Study|Adverse Event|1
4735411|NCT01902134|16333551|P3|Overall Study|Adverse Event|2
4735412|NCT01902134|16333552|P2|Overall Study|Adverse Event|1
4735413|NCT01902134|16333553|P1|Overall Study|Adverse Event|3
4735414|NCT01901848|16333592|P2|Removed From Analyses|CPT practice cases to establish fidelity|0
4735415|NCT01901848|16333593|P1|Removed From Analyses|CPT practice cases to establish fidelity|10
4735416|NCT01901848|16333592|P2|Randomized and Treated|Lost to Follow-up|6
4735417|NCT01901848|16333593|P1|Randomized and Treated|Lost to Follow-up|3
4735418|NCT01901653|16333635|P13|Overall Study|Alive at Study Termination by Sponsor|1
4735419|NCT01901653|16333636|P12|Overall Study|Alive at Study Termination by Sponsor|1
4735420|NCT01901653|16333637|P11|Overall Study|Alive at Study Termination by Sponsor|0
4735421|NCT01901653|16333638|P10|Overall Study|Alive at Study Termination by Sponsor|2
4735422|NCT01901653|16333639|P9|Overall Study|Alive at Study Termination by Sponsor|0
4735423|NCT01901653|16333640|P8|Overall Study|Alive at Study Termination by Sponsor|0
4735424|NCT01901653|16333641|P7|Overall Study|Alive at Study Termination by Sponsor|0
4735425|NCT01901653|16333642|P6|Overall Study|Alive at Study Termination by Sponsor|0
4735426|NCT01901653|16333643|P5|Overall Study|Alive at Study Termination by Sponsor|0
4735427|NCT01901653|16333644|P4|Overall Study|Alive at Study Termination by Sponsor|0
4735428|NCT01901653|16333645|P3|Overall Study|Alive at Study Termination by Sponsor|1
4735429|NCT01901653|16333646|P2|Overall Study|Alive at Study Termination by Sponsor|0
4735430|NCT01901653|16333647|P1|Overall Study|Alive at Study Termination by Sponsor|0
4735431|NCT01901653|16333635|P13|Overall Study|Withdrawal by Subject|0
4735432|NCT01901653|16333636|P12|Overall Study|Withdrawal by Subject|0
4735433|NCT01901653|16333637|P11|Overall Study|Withdrawal by Subject|0
4735434|NCT01901653|16333638|P10|Overall Study|Withdrawal by Subject|0
4735435|NCT01901653|16333639|P9|Overall Study|Withdrawal by Subject|0
4735436|NCT01901653|16333640|P8|Overall Study|Withdrawal by Subject|0
4735437|NCT01901653|16333641|P7|Overall Study|Withdrawal by Subject|1
4735438|NCT01901653|16333642|P6|Overall Study|Withdrawal by Subject|0
4735439|NCT01901653|16333643|P5|Overall Study|Withdrawal by Subject|0
4735440|NCT01901653|16333644|P4|Overall Study|Withdrawal by Subject|0
4735441|NCT01901653|16333645|P3|Overall Study|Withdrawal by Subject|0
4735442|NCT01901653|16333646|P2|Overall Study|Withdrawal by Subject|0
4735443|NCT01901653|16333647|P1|Overall Study|Withdrawal by Subject|0
4735444|NCT01901653|16333635|P13|Overall Study|Lost to Follow-up|0
4735445|NCT01901653|16333636|P12|Overall Study|Lost to Follow-up|0
4735446|NCT01901653|16333637|P11|Overall Study|Lost to Follow-up|0
4735447|NCT01901653|16333638|P10|Overall Study|Lost to Follow-up|0
4735448|NCT01901653|16333639|P9|Overall Study|Lost to Follow-up|0
4735449|NCT01901653|16333640|P8|Overall Study|Lost to Follow-up|1
4735450|NCT01901653|16333641|P7|Overall Study|Lost to Follow-up|0
4735451|NCT01901653|16333642|P6|Overall Study|Lost to Follow-up|1
4735452|NCT01901653|16333643|P5|Overall Study|Lost to Follow-up|0
4735453|NCT01901653|16333644|P4|Overall Study|Lost to Follow-up|0
4735454|NCT01901653|16333645|P3|Overall Study|Lost to Follow-up|2
4735455|NCT01901653|16333646|P2|Overall Study|Lost to Follow-up|0
4735456|NCT01901653|16333647|P1|Overall Study|Lost to Follow-up|1
4735457|NCT01901653|16333635|P13|Overall Study|Death|4
4735458|NCT01901653|16333636|P12|Overall Study|Death|15
4735459|NCT01901653|16333637|P11|Overall Study|Death|2
4735460|NCT01901653|16333638|P10|Overall Study|Death|16
4735461|NCT01901653|16333639|P9|Overall Study|Death|1
4735462|NCT01901653|16333640|P8|Overall Study|Death|9
4735463|NCT01901653|16333641|P7|Overall Study|Death|6
4735464|NCT01901653|16333642|P6|Overall Study|Death|2
4735465|NCT01901653|16333643|P5|Overall Study|Death|2
4735466|NCT01901653|16333644|P4|Overall Study|Death|3
4735467|NCT01901653|16333645|P3|Overall Study|Death|8
4735468|NCT01901653|16333646|P2|Overall Study|Death|1
4735469|NCT01901653|16333647|P1|Overall Study|Death|2
4735470|NCT01901614|16333691|P2|Overall Study|Screen Fail|0
4735471|NCT01901614|16333692|P1|Overall Study|Screen Fail|1
4735472|NCT01901614|16333691|P2|Overall Study|Lost to Follow-up|0
4735473|NCT01901614|16333692|P1|Overall Study|Lost to Follow-up|1
4735474|NCT01901614|16333691|P2|Overall Study|Adverse Event|1
4735475|NCT01901614|16333692|P1|Overall Study|Adverse Event|0
4735476|NCT01901432|16333727|P5|Overall Study|Patient decision to stop study drug|1
4735477|NCT01901432|16333728|P4|Overall Study|Patient decision to stop study drug|0
4735478|NCT01901432|16333729|P3|Overall Study|Patient decision to stop study drug|0
4735479|NCT01901432|16333730|P2|Overall Study|Patient decision to stop study drug|0
4735480|NCT01901432|16333731|P1|Overall Study|Patient decision to stop study drug|0
4735481|NCT01901432|16333727|P5|Overall Study|Physician Decision|2
4735482|NCT01901432|16333728|P4|Overall Study|Physician Decision|0
4735483|NCT01901432|16333729|P3|Overall Study|Physician Decision|0
4735484|NCT01901432|16333730|P2|Overall Study|Physician Decision|0
4735485|NCT01901432|16333731|P1|Overall Study|Physician Decision|0
4735486|NCT01901432|16333727|P5|Overall Study|Withdrawal by Subject|5
4735487|NCT01901432|16333728|P4|Overall Study|Withdrawal by Subject|0
4735488|NCT01901432|16333729|P3|Overall Study|Withdrawal by Subject|1
4735489|NCT01901432|16333730|P2|Overall Study|Withdrawal by Subject|0
4735490|NCT01901432|16333731|P1|Overall Study|Withdrawal by Subject|0
4735491|NCT01901432|16333727|P5|Overall Study|Adverse Event|1
4735492|NCT01901432|16333728|P4|Overall Study|Adverse Event|0
4735493|NCT01901432|16333729|P3|Overall Study|Adverse Event|1
4735494|NCT01901432|16333730|P2|Overall Study|Adverse Event|1
4735495|NCT01901432|16333731|P1|Overall Study|Adverse Event|0
4735496|NCT01901393|16333783|P2|Overall Study|Adverse Event|0
4735497|NCT01901393|16333784|P1|Overall Study|Adverse Event|1
4735498|NCT01901341|16333802|P2|Overall Study|Withdrawal by Subject|1
4735499|NCT01901341|16333803|P1|Overall Study|Withdrawal by Subject|1
4735500|NCT01901341|16333802|P2|Overall Study|Study Terminated by Sponsor|15
4735501|NCT01901341|16333803|P1|Overall Study|Study Terminated by Sponsor|13
4735502|NCT01901341|16333802|P2|Overall Study|Protocol Violation|0
4735503|NCT01901341|16333803|P1|Overall Study|Protocol Violation|2
4735504|NCT01901341|16333802|P2|Overall Study|Lost to Follow-up|1
4735505|NCT01901341|16333803|P1|Overall Study|Lost to Follow-up|0
4735506|NCT01901341|16333802|P2|Overall Study|Lack of Efficacy|2
4735507|NCT01901341|16333803|P1|Overall Study|Lack of Efficacy|0
4735508|NCT01901341|16333802|P2|Overall Study|Adverse Event|2
4735509|NCT01901341|16333803|P1|Overall Study|Adverse Event|4
4735510|NCT01901328|16333817|P2|Overall Study|Lack of Efficacy|1
4735511|NCT01901328|16333818|P1|Overall Study|Lack of Efficacy|0
4735512|NCT01901328|16333817|P2|Overall Study|Withdrawal by Subject|2
4735513|NCT01901328|16333818|P1|Overall Study|Withdrawal by Subject|1
4735514|NCT01901328|16333817|P2|Overall Study|Study Terminated by Sponsor|16
4735515|NCT01901328|16333818|P1|Overall Study|Study Terminated by Sponsor|19
4735516|NCT01901328|16333817|P2|Overall Study|Protocol Violation|1
4735517|NCT01901328|16333818|P1|Overall Study|Protocol Violation|1
4735518|NCT01901328|16333817|P2|Overall Study|Physician Decision|1
4735519|NCT01901328|16333818|P1|Overall Study|Physician Decision|0
4735520|NCT01901328|16333817|P2|Overall Study|Lost to Follow-up|0
4735521|NCT01901328|16333818|P1|Overall Study|Lost to Follow-up|1
4735522|NCT01901302|16333832|P2|Overall Study|Withdrawal by Subject|0
4735523|NCT01901302|16333833|P1|Overall Study|Withdrawal by Subject|2
4735524|NCT01901302|16333832|P2|Overall Study|Study Terminated by Sponsor|20
4735525|NCT01901302|16333833|P1|Overall Study|Study Terminated by Sponsor|23
4735526|NCT01901302|16333832|P2|Overall Study|Lack of Efficacy|2
4735527|NCT01901302|16333833|P1|Overall Study|Lack of Efficacy|0
4735528|NCT01901302|16333832|P2|Overall Study|Adverse Event|1
4735529|NCT01901302|16333833|P1|Overall Study|Adverse Event|2
4735530|NCT01901224|16333858|P1|Overall Study|study was not funded and terminated|2
4735531|NCT01901185|16333893|P1|Overall Study|Withdrawal by Subject|2
4735532|NCT01901146|16333902|P5|Adjuvant Phase|Withdrawal by Subject|4
4735533|NCT01901146|16333903|P4|Adjuvant Phase|Withdrawal by Subject|1
4735534|NCT01901146|16333904|P3|Adjuvant Phase|Withdrawal by Subject|4
4735535|NCT01901146|16333905|P2|Adjuvant Phase|Withdrawal by Subject|0
4735536|NCT01901146|16333906|P1|Adjuvant Phase|Withdrawal by Subject|0
4735537|NCT01901146|16333902|P5|Adjuvant Phase|Physician Decision|4
4735538|NCT01901146|16333903|P4|Adjuvant Phase|Physician Decision|2
4735539|NCT01901146|16333904|P3|Adjuvant Phase|Physician Decision|9
4735540|NCT01901146|16333905|P2|Adjuvant Phase|Physician Decision|0
4735541|NCT01901146|16333906|P1|Adjuvant Phase|Physician Decision|0
4735542|NCT01901146|16333902|P5|Adjuvant Phase|Disease Progression or Recurrence|3
4735543|NCT01901146|16333903|P4|Adjuvant Phase|Disease Progression or Recurrence|4
4735544|NCT01901146|16333904|P3|Adjuvant Phase|Disease Progression or Recurrence|12
4735545|NCT01901146|16333905|P2|Adjuvant Phase|Disease Progression or Recurrence|0
4735546|NCT01901146|16333906|P1|Adjuvant Phase|Disease Progression or Recurrence|0
4735547|NCT01901146|16333902|P5|Adjuvant Phase|Death|3
4735548|NCT01901146|16333903|P4|Adjuvant Phase|Death|0
4735549|NCT01901146|16333904|P3|Adjuvant Phase|Death|0
4735550|NCT01901146|16333905|P2|Adjuvant Phase|Death|0
4735551|NCT01901146|16333906|P1|Adjuvant Phase|Death|0
4735552|NCT01901146|16333902|P5|Adjuvant Phase|Other|0
4735553|NCT01901146|16333903|P4|Adjuvant Phase|Other|0
4735554|NCT01901146|16333904|P3|Adjuvant Phase|Other|1
4735555|NCT01901146|16333905|P2|Adjuvant Phase|Other|0
4735556|NCT01901146|16333906|P1|Adjuvant Phase|Other|0
4735557|NCT01901146|16333902|P5|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4735558|NCT01901146|16333903|P4|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4735559|NCT01901146|16333904|P3|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4735560|NCT01901146|16333905|P2|Neoadjuvant Phase|Requirement for Alternative Therapy|1
4735561|NCT01901146|16333906|P1|Neoadjuvant Phase|Requirement for Alternative Therapy|0
4735562|NCT01901146|16333902|P5|Neoadjuvant Phase|Withdrawal by Subject|0
4735563|NCT01901146|16333903|P4|Neoadjuvant Phase|Withdrawal by Subject|0
4735564|NCT01901146|16333904|P3|Neoadjuvant Phase|Withdrawal by Subject|0
4735565|NCT01901146|16333905|P2|Neoadjuvant Phase|Withdrawal by Subject|5
4735566|NCT01901146|16333906|P1|Neoadjuvant Phase|Withdrawal by Subject|2
4735567|NCT01901146|16333902|P5|Neoadjuvant Phase|Physician Decision|0
4735568|NCT01901146|16333903|P4|Neoadjuvant Phase|Physician Decision|0
4735569|NCT01901146|16333904|P3|Neoadjuvant Phase|Physician Decision|0
4735570|NCT01901146|16333905|P2|Neoadjuvant Phase|Physician Decision|2
4735571|NCT01901146|16333906|P1|Neoadjuvant Phase|Physician Decision|1
4735572|NCT01901146|16333902|P5|Neoadjuvant Phase|Lost to Follow-up|0
4735573|NCT01901146|16333903|P4|Neoadjuvant Phase|Lost to Follow-up|0
4735574|NCT01901146|16333904|P3|Neoadjuvant Phase|Lost to Follow-up|0
4735575|NCT01901146|16333905|P2|Neoadjuvant Phase|Lost to Follow-up|1
4735576|NCT01901146|16333906|P1|Neoadjuvant Phase|Lost to Follow-up|0
4735577|NCT01901146|16333902|P5|Neoadjuvant Phase|Disease Progression or Recurrence|0
4735578|NCT01901146|16333903|P4|Neoadjuvant Phase|Disease Progression or Recurrence|0
4735579|NCT01901146|16333904|P3|Neoadjuvant Phase|Disease Progression or Recurrence|0
4735580|NCT01901146|16333905|P2|Neoadjuvant Phase|Disease Progression or Recurrence|3
4735581|NCT01901146|16333906|P1|Neoadjuvant Phase|Disease Progression or Recurrence|2
4735582|NCT01901146|16333902|P5|Neoadjuvant Phase|Death|0
4735583|NCT01901146|16333903|P4|Neoadjuvant Phase|Death|0
4735584|NCT01901146|16333904|P3|Neoadjuvant Phase|Death|0
4735585|NCT01901146|16333905|P2|Neoadjuvant Phase|Death|2
4735586|NCT01901146|16333906|P1|Neoadjuvant Phase|Death|1
4735587|NCT01900899|16333921|P2|Overall Study|Migrated from study area|0
4735588|NCT01900899|16333922|P1|Overall Study|Migrated from study area|2
4735589|NCT01900899|16333921|P2|Overall Study|Withdrawal by Subject|1
4735590|NCT01900899|16333922|P1|Overall Study|Withdrawal by Subject|7
4735591|NCT01900730|16333948|P2|Overall Study|Screen Failure|0
4735592|NCT01900730|16333949|P1|Overall Study|Screen Failure|1
4735593|NCT01900730|16333948|P2|Overall Study|Withdrawal by Subject|0
4735594|NCT01900730|16333949|P1|Overall Study|Withdrawal by Subject|1
4735595|NCT01900665|16333957|P2|Open Label Period|Withdrawal by Subject|28
4735596|NCT01900665|16333958|P1|Open Label Period|Withdrawal by Subject|20
4735597|NCT01900665|16333957|P2|Open Label Period|Sponsor Decision|765
4735598|NCT01900665|16333958|P1|Open Label Period|Sponsor Decision|802
4735599|NCT01900665|16333957|P2|Open Label Period|Protocol Violation|1
4735600|NCT01900665|16333958|P1|Open Label Period|Protocol Violation|0
4735601|NCT01900665|16333957|P2|Open Label Period|Physician Decision|4
4735602|NCT01900665|16333958|P1|Open Label Period|Physician Decision|4
4735603|NCT01900665|16333957|P2|Open Label Period|Parent/Caregiver Decision|34
4735604|NCT01900665|16333958|P1|Open Label Period|Parent/Caregiver Decision|33
4735605|NCT01900665|16333957|P2|Open Label Period|Lost to Follow-up|1
4735606|NCT01900665|16333958|P1|Open Label Period|Lost to Follow-up|1
4735607|NCT01900665|16333957|P2|Open Label Period|Death|6
4735608|NCT01900665|16333958|P1|Open Label Period|Death|5
4735609|NCT01900665|16333957|P2|Open Label Period|Adverse Event|20
4735610|NCT01900665|16333958|P1|Open Label Period|Adverse Event|16
4735611|NCT01900665|16333957|P2|Placebo Controlled Period|Entry Criteria Not Met|9
4735612|NCT01900665|16333958|P1|Placebo Controlled Period|Entry Criteria Not Met|5
4735613|NCT01900665|16333957|P2|Placebo Controlled Period|Caregiver Decision|41
4735614|NCT01900665|16333958|P1|Placebo Controlled Period|Caregiver Decision|33
4735615|NCT01900665|16333957|P2|Placebo Controlled Period|Lost to Follow-up|0
4735616|NCT01900665|16333958|P1|Placebo Controlled Period|Lost to Follow-up|3
4735617|NCT01900665|16333957|P2|Placebo Controlled Period|Physician Decision|7
4735618|NCT01900665|16333958|P1|Placebo Controlled Period|Physician Decision|11
4735619|NCT01900665|16333957|P2|Placebo Controlled Period|Withdrawal by Subject|45
4735620|NCT01900665|16333958|P1|Placebo Controlled Period|Withdrawal by Subject|33
4735621|NCT01900665|16333957|P2|Placebo Controlled Period|Protocol Violation|7
4735622|NCT01900665|16333958|P1|Placebo Controlled Period|Protocol Violation|1
4735623|NCT01900665|16333957|P2|Placebo Controlled Period|Adverse Event|39
4735624|NCT01900665|16333958|P1|Placebo Controlled Period|Adverse Event|48
4735625|NCT01900665|16333957|P2|Placebo Controlled Period|Death|16
4735626|NCT01900665|16333958|P1|Placebo Controlled Period|Death|9
4735627|NCT01900652|16334001|P2|Overall Study|Physician Decision|1
4735628|NCT01900652|16334002|P1|Overall Study|Physician Decision|1
4735629|NCT01900652|16334001|P2|Overall Study|Adverse Event|1
4735630|NCT01900652|16334002|P1|Overall Study|Adverse Event|2
4735631|NCT01900652|16334001|P2|Overall Study|Death|0
4735632|NCT01900652|16334002|P1|Overall Study|Death|3
4735633|NCT01900652|16334001|P2|Overall Study|Consent withdrawn by subject|1
4735634|NCT01900652|16334002|P1|Overall Study|Consent withdrawn by subject|1
4735635|NCT01900652|16334001|P2|Overall Study|Progressive Disease|0
4735636|NCT01900652|16334002|P1|Overall Study|Progressive Disease|1
4735637|NCT01900626|16334038|P2|Overall Study|study was closed due to low enrollment|1
4735638|NCT01900626|16334039|P1|Overall Study|study was closed due to low enrollment|1
4735639|NCT01900444|16334118|P1|Overall Study|Lost to Follow-up|1
4735640|NCT01900444|16334118|P1|Overall Study|Protocol Violation|2
4735641|NCT01900431|16334131|P3|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3
4735642|NCT01900431|16334132|P2|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
4735643|NCT01900431|16334133|P1|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0
4735644|NCT01900431|16334131|P3|Open-Label Treatment Period (Part C)|Lack of Efficacy|3
4735645|NCT01900431|16334132|P2|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
4735646|NCT01900431|16334133|P1|Open-Label Treatment Period (Part C)|Lack of Efficacy|0
4735647|NCT01900431|16334131|P3|Open-Label Treatment Period (Part C)|Adverse Event|2
4735648|NCT01900431|16334132|P2|Open-Label Treatment Period (Part C)|Adverse Event|0
4735649|NCT01900431|16334133|P1|Open-Label Treatment Period (Part C)|Adverse Event|0
4735650|NCT01900431|16334131|P3|Extended Treatment Period (Part B)|Other than specified above|0
4735651|NCT01900431|16334132|P2|Extended Treatment Period (Part B)|Other than specified above|1
4735652|NCT01900431|16334133|P1|Extended Treatment Period (Part B)|Other than specified above|0
4735653|NCT01900431|16334131|P3|Extended Treatment Period (Part B)|Lack of Efficacy|0
4735654|NCT01900431|16334132|P2|Extended Treatment Period (Part B)|Lack of Efficacy|7
4735655|NCT01900431|16334133|P1|Extended Treatment Period (Part B)|Lack of Efficacy|1
4735656|NCT01900431|16334131|P3|Extended Treatment Period (Part B)|Adverse Event|0
4735657|NCT01900431|16334132|P2|Extended Treatment Period (Part B)|Adverse Event|2
4735658|NCT01900431|16334133|P1|Extended Treatment Period (Part B)|Adverse Event|0
4735659|NCT01900431|16334131|P3|Principal Treatment Period (Part A)|Other than specified above|0
4735660|NCT01900431|16334132|P2|Principal Treatment Period (Part A)|Other than specified above|1
4735661|NCT01900431|16334133|P1|Principal Treatment Period (Part A)|Other than specified above|0
4735662|NCT01900431|16334131|P3|Principal Treatment Period (Part A)|Lack of Efficacy|0
4735663|NCT01900431|16334132|P2|Principal Treatment Period (Part A)|Lack of Efficacy|6
4735664|NCT01900431|16334133|P1|Principal Treatment Period (Part A)|Lack of Efficacy|6
4735665|NCT01900431|16334131|P3|Principal Treatment Period (Part A)|Adverse Event|0
4735666|NCT01900431|16334132|P2|Principal Treatment Period (Part A)|Adverse Event|3
4735667|NCT01900431|16334133|P1|Principal Treatment Period (Part A)|Adverse Event|1
4735668|NCT01900314|16334175|P2|Overall Study|Withdrawal by Subject|3
4735669|NCT01900314|16334176|P1|Overall Study|Withdrawal by Subject|3
4735670|NCT01900314|16334175|P2|Overall Study|Protocol Violation|1
4735671|NCT01900314|16334176|P1|Overall Study|Protocol Violation|0
4735672|NCT01900314|16334175|P2|Overall Study|Lost to Follow-up|0
4735673|NCT01900314|16334176|P1|Overall Study|Lost to Follow-up|1
4735674|NCT01900054|16334206|P1|Overall Study|Withdrawal by Subject|1
4735675|NCT01900054|16334206|P1|Overall Study|Physician Decision|1
4735676|NCT01899768|16334215|P1|Part B|Withdrawal by Subject|1
4735677|NCT01899768|16334215|P1|Part B|Adverse Event|1
4735678|NCT01899768|16334215|P1|Part A|Withdrawal by Subject|1
4735679|NCT01899768|16334215|P1|Part A|Adverse Event|2
4735680|NCT01899742|16334289|P2|Overall Study|Withdrawal by Subject|5
4735681|NCT01899742|16334290|P1|Overall Study|Withdrawal by Subject|9
4735682|NCT01899742|16334289|P2|Overall Study|Protocol Violation|2
4735683|NCT01899742|16334290|P1|Overall Study|Protocol Violation|2
4735684|NCT01899742|16334289|P2|Overall Study|Lack of Efficacy|5
4735685|NCT01899742|16334290|P1|Overall Study|Lack of Efficacy|1
4735686|NCT01899742|16334289|P2|Overall Study|Adverse Event|4
4735687|NCT01899742|16334290|P1|Overall Study|Adverse Event|5
4735688|NCT01899729|16334303|P5|Overall Study|Lack of Efficacy|1
4735689|NCT01899729|16334304|P4|Overall Study|Lack of Efficacy|0
4735690|NCT01899729|16334305|P3|Overall Study|Lack of Efficacy|2
4735691|NCT01899729|16334306|P2|Overall Study|Lack of Efficacy|0
4735692|NCT01899729|16334307|P1|Overall Study|Lack of Efficacy|0
4735693|NCT01899729|16334303|P5|Overall Study|Withdrawal by Subject|0
4735694|NCT01899729|16334304|P4|Overall Study|Withdrawal by Subject|0
4735695|NCT01899729|16334305|P3|Overall Study|Withdrawal by Subject|0
4735696|NCT01899729|16334306|P2|Overall Study|Withdrawal by Subject|2
4735697|NCT01899729|16334307|P1|Overall Study|Withdrawal by Subject|1
4735698|NCT01899729|16334303|P5|Overall Study|Adverse Event|1
4735699|NCT01899729|16334304|P4|Overall Study|Adverse Event|0
4735700|NCT01899729|16334305|P3|Overall Study|Adverse Event|0
4735701|NCT01899729|16334306|P2|Overall Study|Adverse Event|0
4735702|NCT01899729|16334307|P1|Overall Study|Adverse Event|1
4735703|NCT01899144|16334354|P1|Treatment Period 5|Other|1
4735704|NCT01899144|16334354|P1|Treatment Period 3|Other|2
4735705|NCT01899144|16334354|P1|Treatment Period 2|Other|1
4735706|NCT01899053|16334390|P14|Overall Study|Symptomatic Deterioration|0
4735707|NCT01899053|16334391|P13|Overall Study|Symptomatic Deterioration|2
4735708|NCT01899053|16334392|P12|Overall Study|Symptomatic Deterioration|1
4735709|NCT01899053|16334393|P11|Overall Study|Symptomatic Deterioration|0
4735710|NCT01899053|16334394|P10|Overall Study|Symptomatic Deterioration|0
4735711|NCT01899053|16334395|P9|Overall Study|Symptomatic Deterioration|0
4735712|NCT01899053|16334396|P8|Overall Study|Symptomatic Deterioration|1
4735713|NCT01899053|16334397|P7|Overall Study|Symptomatic Deterioration|0
4735714|NCT01899053|16334398|P6|Overall Study|Symptomatic Deterioration|1
4735715|NCT01899053|16334399|P5|Overall Study|Symptomatic Deterioration|0
4735716|NCT01899053|16334400|P4|Overall Study|Symptomatic Deterioration|0
4735717|NCT01899053|16334401|P3|Overall Study|Symptomatic Deterioration|0
4735718|NCT01899053|16334402|P2|Overall Study|Symptomatic Deterioration|0
4735719|NCT01899053|16334403|P1|Overall Study|Symptomatic Deterioration|0
4735720|NCT01899053|16334390|P14|Overall Study|Unsatisfactory Therapeutic Response|0
4735721|NCT01899053|16334391|P13|Overall Study|Unsatisfactory Therapeutic Response|0
4735722|NCT01899053|16334392|P12|Overall Study|Unsatisfactory Therapeutic Response|0
4735723|NCT01899053|16334393|P11|Overall Study|Unsatisfactory Therapeutic Response|1
4735724|NCT01899053|16334394|P10|Overall Study|Unsatisfactory Therapeutic Response|0
4735725|NCT01899053|16334395|P9|Overall Study|Unsatisfactory Therapeutic Response|0
4735726|NCT01899053|16334396|P8|Overall Study|Unsatisfactory Therapeutic Response|0
4735727|NCT01899053|16334397|P7|Overall Study|Unsatisfactory Therapeutic Response|0
4735728|NCT01899053|16334398|P6|Overall Study|Unsatisfactory Therapeutic Response|0
4735729|NCT01899053|16334399|P5|Overall Study|Unsatisfactory Therapeutic Response|0
4735730|NCT01899053|16334400|P4|Overall Study|Unsatisfactory Therapeutic Response|0
4735731|NCT01899053|16334401|P3|Overall Study|Unsatisfactory Therapeutic Response|0
4735732|NCT01899053|16334402|P2|Overall Study|Unsatisfactory Therapeutic Response|1
4735733|NCT01899053|16334403|P1|Overall Study|Unsatisfactory Therapeutic Response|1
4735734|NCT01899053|16334390|P14|Overall Study|Protocol Violation|0
4735735|NCT01899053|16334391|P13|Overall Study|Protocol Violation|0
4735736|NCT01899053|16334392|P12|Overall Study|Protocol Violation|0
4735737|NCT01899053|16334393|P11|Overall Study|Protocol Violation|0
4735738|NCT01899053|16334394|P10|Overall Study|Protocol Violation|0
4735739|NCT01899053|16334395|P9|Overall Study|Protocol Violation|0
4735740|NCT01899053|16334396|P8|Overall Study|Protocol Violation|0
4735741|NCT01899053|16334397|P7|Overall Study|Protocol Violation|0
4735742|NCT01899053|16334398|P6|Overall Study|Protocol Violation|0
4735743|NCT01899053|16334399|P5|Overall Study|Protocol Violation|0
4735744|NCT01899053|16334400|P4|Overall Study|Protocol Violation|0
4735745|NCT01899053|16334401|P3|Overall Study|Protocol Violation|1
4735746|NCT01899053|16334402|P2|Overall Study|Protocol Violation|0
4735747|NCT01899053|16334403|P1|Overall Study|Protocol Violation|0
4735748|NCT01899053|16334390|P14|Overall Study|Withdrawal by Subject|1
4735749|NCT01899053|16334391|P13|Overall Study|Withdrawal by Subject|1
4735750|NCT01899053|16334392|P12|Overall Study|Withdrawal by Subject|0
4735751|NCT01899053|16334393|P11|Overall Study|Withdrawal by Subject|0
4735752|NCT01899053|16334394|P10|Overall Study|Withdrawal by Subject|0
4735753|NCT01899053|16334395|P9|Overall Study|Withdrawal by Subject|0
4735754|NCT01899053|16334396|P8|Overall Study|Withdrawal by Subject|1
4735755|NCT01899053|16334397|P7|Overall Study|Withdrawal by Subject|0
4735756|NCT01899053|16334398|P6|Overall Study|Withdrawal by Subject|0
4735757|NCT01899053|16334399|P5|Overall Study|Withdrawal by Subject|2
4735758|NCT01899053|16334400|P4|Overall Study|Withdrawal by Subject|0
4735759|NCT01899053|16334401|P3|Overall Study|Withdrawal by Subject|2
4735760|NCT01899053|16334402|P2|Overall Study|Withdrawal by Subject|1
4735761|NCT01899053|16334403|P1|Overall Study|Withdrawal by Subject|1
4735762|NCT01899053|16334390|P14|Overall Study|Reason Not Specified|0
4735763|NCT01899053|16334391|P13|Overall Study|Reason Not Specified|1
4735764|NCT01899053|16334392|P12|Overall Study|Reason Not Specified|0
4735765|NCT01899053|16334393|P11|Overall Study|Reason Not Specified|0
4735766|NCT01899053|16334394|P10|Overall Study|Reason Not Specified|0
4735767|NCT01899053|16334395|P9|Overall Study|Reason Not Specified|0
4735768|NCT01899053|16334396|P8|Overall Study|Reason Not Specified|0
4735769|NCT01899053|16334397|P7|Overall Study|Reason Not Specified|1
4735770|NCT01899053|16334398|P6|Overall Study|Reason Not Specified|0
4735771|NCT01899053|16334399|P5|Overall Study|Reason Not Specified|0
4735772|NCT01899053|16334400|P4|Overall Study|Reason Not Specified|0
4735773|NCT01899053|16334401|P3|Overall Study|Reason Not Specified|0
4735774|NCT01899053|16334402|P2|Overall Study|Reason Not Specified|0
4735775|NCT01899053|16334403|P1|Overall Study|Reason Not Specified|0
4735776|NCT01899053|16334390|P14|Overall Study|Adverse Event|2
4735777|NCT01899053|16334391|P13|Overall Study|Adverse Event|2
4735778|NCT01899053|16334392|P12|Overall Study|Adverse Event|1
4735779|NCT01899053|16334393|P11|Overall Study|Adverse Event|3
4735780|NCT01899053|16334394|P10|Overall Study|Adverse Event|0
4735781|NCT01899053|16334395|P9|Overall Study|Adverse Event|2
4735782|NCT01899053|16334396|P8|Overall Study|Adverse Event|0
4735783|NCT01899053|16334397|P7|Overall Study|Adverse Event|1
4735784|NCT01899053|16334398|P6|Overall Study|Adverse Event|1
4735785|NCT01899053|16334399|P5|Overall Study|Adverse Event|1
4735786|NCT01899053|16334400|P4|Overall Study|Adverse Event|3
4735787|NCT01899053|16334401|P3|Overall Study|Adverse Event|1
4735788|NCT01899053|16334402|P2|Overall Study|Adverse Event|1
4735789|NCT01899053|16334403|P1|Overall Study|Adverse Event|1
4735790|NCT01899053|16334390|P14|Overall Study|Progressive Disease|17
4735791|NCT01899053|16334391|P13|Overall Study|Progressive Disease|8
4735792|NCT01899053|16334392|P12|Overall Study|Progressive Disease|5
4735793|NCT01899053|16334393|P11|Overall Study|Progressive Disease|12
4735794|NCT01899053|16334394|P10|Overall Study|Progressive Disease|3
4735795|NCT01899053|16334395|P9|Overall Study|Progressive Disease|4
4735796|NCT01899053|16334396|P8|Overall Study|Progressive Disease|1
4735797|NCT01899053|16334397|P7|Overall Study|Progressive Disease|1
4735798|NCT01899053|16334398|P6|Overall Study|Progressive Disease|1
4735799|NCT01899053|16334399|P5|Overall Study|Progressive Disease|3
4735800|NCT01899053|16334400|P4|Overall Study|Progressive Disease|0
4735801|NCT01899053|16334401|P3|Overall Study|Progressive Disease|3
4735802|NCT01899053|16334402|P2|Overall Study|Progressive Disease|0
4735803|NCT01899053|16334403|P1|Overall Study|Progressive Disease|4
4735804|NCT01898884|16334660|P9|Multiple Dose Period|Randomized Not Treated|1
4735805|NCT01898884|16334661|P8|Multiple Dose Period|Randomized Not Treated|0
4735806|NCT01898884|16334662|P7|Multiple Dose Period|Randomized Not Treated|0
4735807|NCT01898884|16334663|P6|Multiple Dose Period|Randomized Not Treated|0
4735808|NCT01898884|16334664|P5|Multiple Dose Period|Randomized Not Treated|0
4735809|NCT01898884|16334665|P4|Multiple Dose Period|Randomized Not Treated|0
4735810|NCT01898884|16334666|P3|Multiple Dose Period|Randomized Not Treated|0
4735811|NCT01898884|16334667|P2|Multiple Dose Period|Randomized Not Treated|0
4735812|NCT01898884|16334668|P1|Multiple Dose Period|Randomized Not Treated|0
4735813|NCT01898884|16334660|P9|Multiple Dose Period|Adverse Event|0
4735814|NCT01898884|16334661|P8|Multiple Dose Period|Adverse Event|0
4735815|NCT01898884|16334662|P7|Multiple Dose Period|Adverse Event|1
4735816|NCT01898884|16334663|P6|Multiple Dose Period|Adverse Event|0
4735817|NCT01898884|16334664|P5|Multiple Dose Period|Adverse Event|0
4735818|NCT01898884|16334665|P4|Multiple Dose Period|Adverse Event|0
4735819|NCT01898884|16334666|P3|Multiple Dose Period|Adverse Event|0
4735820|NCT01898884|16334667|P2|Multiple Dose Period|Adverse Event|0
4735821|NCT01898884|16334668|P1|Multiple Dose Period|Adverse Event|0
4735822|NCT01898806|16334818|P1|Overall Study|Physician Decision|1
4735823|NCT01898806|16334818|P1|Overall Study|Withdrawal by Subject|2
4735824|NCT01898598|16334848|P2|Overall Study|Other|1
4735825|NCT01898598|16334849|P1|Overall Study|Other|0
4735826|NCT01898598|16334848|P2|Overall Study|Lost to Follow-up|1
4735827|NCT01898598|16334849|P1|Overall Study|Lost to Follow-up|0
4735828|NCT01898598|16334848|P2|Overall Study|Withdrawal by Subject|0
4735829|NCT01898598|16334849|P1|Overall Study|Withdrawal by Subject|3
4735830|NCT01898598|16334848|P2|Overall Study|Adverse Event|0
4735831|NCT01898598|16334849|P1|Overall Study|Adverse Event|1
4735832|NCT01898442|16334868|P3|Overall Study|Patient vomited pills|1
4735833|NCT01898442|16334869|P2|Overall Study|Patient vomited pills|0
4735834|NCT01898442|16334870|P1|Overall Study|Patient vomited pills|0
4735835|NCT01898442|16334868|P3|Overall Study|Hemolysis/technical problems|2
4735836|NCT01898442|16334869|P2|Overall Study|Hemolysis/technical problems|2
4735837|NCT01898442|16334870|P1|Overall Study|Hemolysis/technical problems|1
4735838|NCT01898299|16334907|P2|Post Treatment (One Month)|Lost to Follow-up|4
4735839|NCT01898299|16334908|P1|Post Treatment (One Month)|Lost to Follow-up|3
4735840|NCT01898286|16334914|P1|Overall Study|Lost to Follow-up|1
4735841|NCT01898286|16334914|P1|Overall Study|Protocol Violation|1
4735842|NCT01898286|16334914|P1|Overall Study|Withdrawal by Subject|1
4735843|NCT01898208|16334924|P3|Overall Study|Lost to Follow-up|1
4735844|NCT01898208|16334925|P2|Overall Study|Lost to Follow-up|1
4735845|NCT01898208|16334926|P1|Overall Study|Lost to Follow-up|3
4735846|NCT01898208|16334924|P3|Overall Study|System/Technical Error|3
4735847|NCT01898208|16334925|P2|Overall Study|System/Technical Error|2
4735848|NCT01898208|16334926|P1|Overall Study|System/Technical Error|1
4735849|NCT01898208|16334924|P3|Overall Study|Non-Blood Specimens in Bottles|4
4735850|NCT01898208|16334925|P2|Overall Study|Non-Blood Specimens in Bottles|5
4735851|NCT01898208|16334926|P1|Overall Study|Non-Blood Specimens in Bottles|3
4735852|NCT01898208|16334924|P3|Overall Study|Negative Gram Stain|6
4735853|NCT01898208|16334925|P2|Overall Study|Negative Gram Stain|9
4735854|NCT01898208|16334926|P1|Overall Study|Negative Gram Stain|6
4735855|NCT01898208|16334924|P3|Overall Study|Death/comfort care within 24 hours|8
4735856|NCT01898208|16334925|P2|Overall Study|Death/comfort care within 24 hours|9
4735857|NCT01898208|16334926|P1|Overall Study|Death/comfort care within 24 hours|10
4735858|NCT01898208|16334924|P3|Overall Study|Positive blood culture|15
4735859|NCT01898208|16334925|P2|Overall Study|Positive blood culture|23
4735860|NCT01898208|16334926|P1|Overall Study|Positive blood culture|17
4735861|NCT01898195|16334973|P3|Smoking Abstinence|Did not have good measurements|36
4735862|NCT01898195|16334974|P2|Smoking Abstinence|Did not have good measurements|38
4735863|NCT01898195|16334975|P1|Smoking Abstinence|Did not have good measurements|35
4735864|NCT01898130|16334986|P1|Follow up Until PD or Death|Lost to Follow-up|1
4735865|NCT01898130|16334986|P1|Treatment|Progressive Disease|4
4735866|NCT01898130|16334986|P1|Treatment|Withdrawal by Subject|2
4735867|NCT01898091|16335001|P2|Overall Study|Withdrawal by Subject|5
4735868|NCT01898091|16335002|P1|Overall Study|Withdrawal by Subject|1
4735869|NCT01898091|16335001|P2|Overall Study|Lost to Follow-up|1
4735870|NCT01898091|16335002|P1|Overall Study|Lost to Follow-up|1
4735871|NCT01898078|16335010|P2|Overall Study|Reason not Specified|1
4735872|NCT01898078|16335011|P1|Overall Study|Reason not Specified|0
4735873|NCT01898078|16335010|P2|Overall Study|Symptomatic Deterioration|0
4735874|NCT01898078|16335011|P1|Overall Study|Symptomatic Deterioration|2
4735875|NCT01898078|16335010|P2|Overall Study|Withdrawal by Subject|1
4735876|NCT01898078|16335011|P1|Overall Study|Withdrawal by Subject|1
4735877|NCT01898078|16335010|P2|Overall Study|Adverse Event|1
4735878|NCT01898078|16335011|P1|Overall Study|Adverse Event|2
4735879|NCT01898078|16335010|P2|Overall Study|Progressive Disease|5
4735880|NCT01898078|16335011|P1|Overall Study|Progressive Disease|1
4735881|NCT01897896|16335048|P2|Overall Study|Other than specified|1
4735882|NCT01897896|16335049|P1|Overall Study|Other than specified|2
4735883|NCT01897896|16335048|P2|Overall Study|Caregiver can no longer participate|2
4735884|NCT01897896|16335049|P1|Overall Study|Caregiver can no longer participate|0
4735885|NCT01897896|16335048|P2|Overall Study|Withdrawal per Investigator's judgement|1
4735886|NCT01897896|16335049|P1|Overall Study|Withdrawal per Investigator's judgement|1
4735887|NCT01897896|16335048|P2|Overall Study|Protocol Violation|1
4735888|NCT01897896|16335049|P1|Overall Study|Protocol Violation|1
4735889|NCT01897896|16335048|P2|Overall Study|Require drug that interfere with study|4
4735890|NCT01897896|16335049|P1|Overall Study|Require drug that interfere with study|1
4735891|NCT01897896|16335048|P2|Overall Study|Withdrawal by Subject|1
4735892|NCT01897896|16335049|P1|Overall Study|Withdrawal by Subject|7
4735893|NCT01897896|16335048|P2|Overall Study|Non-compliance with study drug dosing|1
4735894|NCT01897896|16335049|P1|Overall Study|Non-compliance with study drug dosing|1
4735895|NCT01897896|16335048|P2|Overall Study|Lost to Follow-up|0
4735896|NCT01897896|16335049|P1|Overall Study|Lost to Follow-up|1
4735897|NCT01897896|16335048|P2|Overall Study|Adverse Event|1
4735898|NCT01897896|16335049|P1|Overall Study|Adverse Event|11
4735899|NCT01897896|16335048|P2|Overall Study|Death|0
4735900|NCT01897896|16335049|P1|Overall Study|Death|1
4735901|NCT01897727|16335181|P2|Overall Study|Exclusion: central sleep apnea|1
4735902|NCT01897727|16335182|P1|Overall Study|Exclusion: central sleep apnea|0
4735903|NCT01897714|16335194|P6|Phase II (MTD)|Other|0
4735904|NCT01897714|16335195|P5|Phase II (MTD)|Other|3
4735905|NCT01897714|16335196|P4|Phase II (MTD)|Other|0
4735906|NCT01897714|16335197|P3|Phase II (MTD)|Other|0
4735907|NCT01897714|16335198|P2|Phase II (MTD)|Other|0
4735908|NCT01897714|16335199|P1|Phase II (MTD)|Other|0
4735909|NCT01897714|16335194|P6|Phase II (MTD)|Study terminated with patient alive|0
4735910|NCT01897714|16335195|P5|Phase II (MTD)|Study terminated with patient alive|1
4735911|NCT01897714|16335196|P4|Phase II (MTD)|Study terminated with patient alive|0
4735912|NCT01897714|16335197|P3|Phase II (MTD)|Study terminated with patient alive|0
4735913|NCT01897714|16335198|P2|Phase II (MTD)|Study terminated with patient alive|0
4735914|NCT01897714|16335199|P1|Phase II (MTD)|Study terminated with patient alive|0
4735915|NCT01897714|16335194|P6|Phase II (MTD)|Death|10
4735916|NCT01897714|16335195|P5|Phase II (MTD)|Death|25
4735917|NCT01897714|16335196|P4|Phase II (MTD)|Death|0
4735918|NCT01897714|16335197|P3|Phase II (MTD)|Death|0
4735919|NCT01897714|16335198|P2|Phase II (MTD)|Death|0
4735920|NCT01897714|16335199|P1|Phase II (MTD)|Death|0
4735921|NCT01897714|16335194|P6|Phase II (MTD)|Lost to Follow-up|0
4735922|NCT01897714|16335195|P5|Phase II (MTD)|Lost to Follow-up|1
4735923|NCT01897714|16335196|P4|Phase II (MTD)|Lost to Follow-up|0
4735924|NCT01897714|16335197|P3|Phase II (MTD)|Lost to Follow-up|0
4735925|NCT01897714|16335198|P2|Phase II (MTD)|Lost to Follow-up|0
4735926|NCT01897714|16335199|P1|Phase II (MTD)|Lost to Follow-up|0
4735927|NCT01897714|16335194|P6|Phase II (MTD)|Withdrawal by Subject|1
4735928|NCT01897714|16335195|P5|Phase II (MTD)|Withdrawal by Subject|0
4735929|NCT01897714|16335196|P4|Phase II (MTD)|Withdrawal by Subject|0
4735930|NCT01897714|16335197|P3|Phase II (MTD)|Withdrawal by Subject|0
4735931|NCT01897714|16335198|P2|Phase II (MTD)|Withdrawal by Subject|0
4735932|NCT01897714|16335199|P1|Phase II (MTD)|Withdrawal by Subject|0
4735933|NCT01897714|16335194|P6|Phase I (Dose Escalation)|Other|0
4735934|NCT01897714|16335195|P5|Phase I (Dose Escalation)|Other|0
4735935|NCT01897714|16335196|P4|Phase I (Dose Escalation)|Other|0
4735936|NCT01897714|16335197|P3|Phase I (Dose Escalation)|Other|0
4735937|NCT01897714|16335198|P2|Phase I (Dose Escalation)|Other|1
4735938|NCT01897714|16335199|P1|Phase I (Dose Escalation)|Other|0
4735939|NCT01897714|16335194|P6|Phase I (Dose Escalation)|Adverse Event|0
4735940|NCT01897714|16335195|P5|Phase I (Dose Escalation)|Adverse Event|0
4735941|NCT01897714|16335196|P4|Phase I (Dose Escalation)|Adverse Event|3
4735942|NCT01897714|16335197|P3|Phase I (Dose Escalation)|Adverse Event|4
4735943|NCT01897714|16335198|P2|Phase I (Dose Escalation)|Adverse Event|1
4735944|NCT01897714|16335199|P1|Phase I (Dose Escalation)|Adverse Event|0
4735945|NCT01897714|16335194|P6|Phase I (Dose Escalation)|Disease progression|0
4735946|NCT01897714|16335195|P5|Phase I (Dose Escalation)|Disease progression|0
4735947|NCT01897714|16335196|P4|Phase I (Dose Escalation)|Disease progression|3
4735948|NCT01897714|16335197|P3|Phase I (Dose Escalation)|Disease progression|1
4735949|NCT01897714|16335198|P2|Phase I (Dose Escalation)|Disease progression|5
4735950|NCT01897714|16335199|P1|Phase I (Dose Escalation)|Disease progression|3
4735951|NCT01897532|16335245|P2|Discontinuation From Trial|Patient lost to follow-up for MACE|36
4735952|NCT01897532|16335246|P1|Discontinuation From Trial|Patient lost to follow-up for MACE|55
4735953|NCT01897532|16335245|P2|Discontinuation From Trial|Not Treated|5
4735954|NCT01897532|16335246|P1|Discontinuation From Trial|Not Treated|7
4735955|NCT01897532|16335245|P2|Discontinuation From Treatment|Adverse event/ CV outcome event|362
4735956|NCT01897532|16335246|P1|Discontinuation From Treatment|Adverse event/ CV outcome event|402
4735957|NCT01897532|16335245|P2|Discontinuation From Treatment|Non compliance|15
4735958|NCT01897532|16335246|P1|Discontinuation From Treatment|Non compliance|24
4735959|NCT01897532|16335245|P2|Discontinuation From Treatment|Withdrawal by Subject|281
4735960|NCT01897532|16335246|P1|Discontinuation From Treatment|Withdrawal by Subject|333
4735961|NCT01897532|16335245|P2|Discontinuation From Treatment|Other reason than specified|176
4735962|NCT01897532|16335246|P1|Discontinuation From Treatment|Other reason than specified|196
4735963|NCT01897532|16335245|P2|Discontinuation From Treatment|Not Treated|5
4735964|NCT01897532|16335246|P1|Discontinuation From Treatment|Not Treated|7
4735965|NCT01897493|16335254|P1|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1
4735966|NCT01897233|16335290|P1|Part B (24 Weeks)|Physician Decision|1
4735967|NCT01897233|16335290|P1|Part B (24 Weeks)|Withdrawal by Subject|2
4735968|NCT01897233|16335290|P1|Part B (24 Weeks)|Adverse Event|1
4735969|NCT01896986|16335342|P2|Overall Study|samples lost|23
4735970|NCT01896986|16335343|P1|Overall Study|samples lost|14
4735971|NCT01896934|16335349|P1|Overall Study|Withdrawal by Subject|1
4735972|NCT01896934|16335349|P1|Overall Study|Adverse Event|1
4735973|NCT01896895|16335362|P4|Double-blind MP|Lost to Follow-up|0
4735974|NCT01896895|16335363|P3|Double-blind MP|Lost to Follow-up|1
4735975|NCT01896895|16335364|P2|Double-blind MP|Lost to Follow-up|0
4735976|NCT01896895|16335365|P1|Double-blind MP|Lost to Follow-up|1
4735977|NCT01896895|16335362|P4|Double-blind MP|Withdrawal by Subject|0
4735978|NCT01896895|16335363|P3|Double-blind MP|Withdrawal by Subject|1
4735979|NCT01896895|16335364|P2|Double-blind MP|Withdrawal by Subject|2
4735980|NCT01896895|16335365|P1|Double-blind MP|Withdrawal by Subject|0
4735981|NCT01896895|16335362|P4|Double-blind MP|Physician Decision|0
4735982|NCT01896895|16335363|P3|Double-blind MP|Physician Decision|1
4735983|NCT01896895|16335364|P2|Double-blind MP|Physician Decision|0
4735984|NCT01896895|16335365|P1|Double-blind MP|Physician Decision|0
4735985|NCT01896869|16335382|P2|Overall Study|Lost to Follow-up|0
4735986|NCT01896869|16335383|P1|Overall Study|Lost to Follow-up|1
4735987|NCT01896869|16335382|P2|Overall Study|Withdrawal by Subject|6
4735988|NCT01896869|16335383|P1|Overall Study|Withdrawal by Subject|0
4735989|NCT01896856|16335408|P6|Overall Study|Transportation issues / Non-compliance|0
4735990|NCT01896856|16335409|P5|Overall Study|Transportation issues / Non-compliance|0
4735991|NCT01896856|16335410|P4|Overall Study|Transportation issues / Non-compliance|0
4735992|NCT01896856|16335411|P3|Overall Study|Transportation issues / Non-compliance|1
4735993|NCT01896856|16335412|P2|Overall Study|Transportation issues / Non-compliance|0
4735994|NCT01896856|16335413|P1|Overall Study|Transportation issues / Non-compliance|0
4735995|NCT01896726|16335432|P1|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1
4735996|NCT01896726|16335432|P1|Treatment Period 2 (Days 23-31)|Adverse Event|1
4735997|NCT01896700|16335447|P2|Overall Study|Withdrawal by Subject|1
4735998|NCT01896700|16335448|P1|Overall Study|Withdrawal by Subject|0
4735999|NCT01896700|16335447|P2|Overall Study|Adverse Event|5
4736000|NCT01896700|16335448|P1|Overall Study|Adverse Event|4
4736001|NCT01896557|16335479|P2|Clopidogrel + GI Protector|Reading error|3
4736002|NCT01896557|16335480|P1|Clopidogrel + GI Protector|Reading error|1
4736003|NCT01896557|16335479|P2|Clopidogrel + GI Protector|low adherence|1
4736004|NCT01896557|16335480|P1|Clopidogrel + GI Protector|low adherence|1
4736005|NCT01896557|16335479|P2|Clopidogrel Alone|Adverse Event|0
4736006|NCT01896557|16335480|P1|Clopidogrel Alone|Adverse Event|1
4736007|NCT01896297|16335517|P1|Overall Study|Died in post treatment phase|1
4736008|NCT01896232|16335524|P2|Overall Study|Lost to Follow-up|12
4736009|NCT01896232|16335525|P1|Overall Study|Lost to Follow-up|9
4736010|NCT01896232|16335524|P2|Overall Study|Sponsor Decision|0
4736011|NCT01896232|16335525|P1|Overall Study|Sponsor Decision|2
4736012|NCT01896232|16335524|P2|Overall Study|Withdrawal by Subject|31
4736013|NCT01896232|16335525|P1|Overall Study|Withdrawal by Subject|32
4736014|NCT01896232|16335524|P2|Overall Study|Death|10
4736015|NCT01896232|16335525|P1|Overall Study|Death|6
4736016|NCT01896193|16335553|P2|Overall Study|Withdrew Consent|0
4736017|NCT01896193|16335554|P1|Overall Study|Withdrew Consent|1
4736018|NCT01896193|16335553|P2|Overall Study|Protocol Violation|1
4736019|NCT01896193|16335554|P1|Overall Study|Protocol Violation|0
4736020|NCT01896193|16335553|P2|Overall Study|Lack of Efficacy|11
4736021|NCT01896193|16335554|P1|Overall Study|Lack of Efficacy|20
4736022|NCT01896128|16335580|P2|Overall Study|Withdrawal by Subject|3
4736023|NCT01896128|16335581|P1|Overall Study|Withdrawal by Subject|3
4736024|NCT01896050|16335623|P2|Overall Study|Death|0
4736025|NCT01896050|16335624|P1|Overall Study|Death|1
4736026|NCT01896050|16335623|P2|Overall Study|Adverse Event|2
4736027|NCT01896050|16335624|P1|Overall Study|Adverse Event|37
4736028|NCT01895777|16335662|P2|Overall Study|Non-compliance with the CTP|1
4736029|NCT01895777|16335663|P1|Overall Study|Non-compliance with the CTP|2
4736030|NCT01895777|16335662|P2|Overall Study|Other reasons|2
4736031|NCT01895777|16335663|P1|Overall Study|Other reasons|3
4736032|NCT01895777|16335662|P2|Overall Study|Not treated|0
4736033|NCT01895777|16335663|P1|Overall Study|Not treated|1
4736034|NCT01895777|16335662|P2|Overall Study|Lost to Follow-up|0
4736035|NCT01895777|16335663|P1|Overall Study|Lost to Follow-up|2
4736036|NCT01895777|16335662|P2|Overall Study|Adverse Event|2
4736037|NCT01895777|16335663|P1|Overall Study|Adverse Event|1
4736038|NCT01895608|16335719|P4|Overall Study|Withdrawal by Subject|0
4736039|NCT01895608|16335720|P3|Overall Study|Withdrawal by Subject|2
4736040|NCT01895608|16335721|P2|Overall Study|Withdrawal by Subject|0
4736041|NCT01895608|16335722|P1|Overall Study|Withdrawal by Subject|0
4736042|NCT01895608|16335719|P4|Overall Study|change in health status|0
4736043|NCT01895608|16335720|P3|Overall Study|change in health status|1
4736044|NCT01895608|16335721|P2|Overall Study|change in health status|1
4736045|NCT01895608|16335722|P1|Overall Study|change in health status|0
4736046|NCT01895543|16335752|P1|Overall Study|Other (Not fulfilling above criteria)|24
4736047|NCT01895543|16335752|P1|Overall Study|Physician Decision|2
4736048|NCT01895543|16335752|P1|Overall Study|Protocol Violation|1
4736049|NCT01895543|16335752|P1|Overall Study|Subject's substantial non-compliance|6
4736050|NCT01895543|16335752|P1|Overall Study|Adverse Event|28
4736051|NCT01895543|16335752|P1|Overall Study|Lost to Follow-up|25
4736052|NCT01895543|16335752|P1|Overall Study|Withdrawal by Subject|43
4736053|NCT01895452|16335768|P2|Overall Study|Noncompliance with study drug|1
4736054|NCT01895452|16335769|P1|Overall Study|Noncompliance with study drug|0
4736055|NCT01895452|16335768|P2|Overall Study|Underlying disease|3
4736056|NCT01895452|16335769|P1|Overall Study|Underlying disease|0
4736057|NCT01895452|16335768|P2|Overall Study|Withdrawal by Subject|14
4736058|NCT01895452|16335769|P1|Overall Study|Withdrawal by Subject|2
4736059|NCT01895452|16335768|P2|Overall Study|Pregnancy|1
4736060|NCT01895452|16335769|P1|Overall Study|Pregnancy|0
4736061|NCT01895452|16335768|P2|Overall Study|Lost to Follow-up|5
4736062|NCT01895452|16335769|P1|Overall Study|Lost to Follow-up|1
4736063|NCT01895452|16335768|P2|Overall Study|Adverse Event|4
4736064|NCT01895452|16335769|P1|Overall Study|Adverse Event|1
4736065|NCT01895361|16335782|P3|Overall Study|Reasons different from categories above|4
4736066|NCT01895361|16335783|P2|Overall Study|Reasons different from categories above|3
4736067|NCT01895361|16335784|P1|Overall Study|Reasons different from categories above|7
4736068|NCT01895361|16335782|P3|Overall Study|Lack of Efficacy|0
4736069|NCT01895361|16335783|P2|Overall Study|Lack of Efficacy|1
4736070|NCT01895361|16335784|P1|Overall Study|Lack of Efficacy|0
4736071|NCT01895361|16335782|P3|Overall Study|Withdrawal by Subject|6
4736072|NCT01895361|16335783|P2|Overall Study|Withdrawal by Subject|6
4736073|NCT01895361|16335784|P1|Overall Study|Withdrawal by Subject|7
4736074|NCT01895361|16335782|P3|Overall Study|Physician Decision|2
4736075|NCT01895361|16335783|P2|Overall Study|Physician Decision|2
4736076|NCT01895361|16335784|P1|Overall Study|Physician Decision|2
4736077|NCT01895361|16335782|P3|Overall Study|Non-compliance with study|1
4736078|NCT01895361|16335783|P2|Overall Study|Non-compliance with study|3
4736079|NCT01895361|16335784|P1|Overall Study|Non-compliance with study|1
4736080|NCT01895361|16335782|P3|Overall Study|Lost to Follow-up|6
4736081|NCT01895361|16335783|P2|Overall Study|Lost to Follow-up|4
4736082|NCT01895361|16335784|P1|Overall Study|Lost to Follow-up|4
4736083|NCT01895361|16335782|P3|Overall Study|Death|2
4736084|NCT01895361|16335783|P2|Overall Study|Death|1
4736085|NCT01895361|16335784|P1|Overall Study|Death|2
4736086|NCT01895361|16335782|P3|Overall Study|Adverse Event|3
4736087|NCT01895361|16335783|P2|Overall Study|Adverse Event|1
4736088|NCT01895361|16335784|P1|Overall Study|Adverse Event|1
4736089|NCT01895335|16335813|P1|Overall Study|Other than Specified Above|44
4736090|NCT01895335|16335813|P1|Overall Study|Included But Not treated|1
4736091|NCT01895335|16335813|P1|Overall Study|Poor Compliance to Protocol|11
4736092|NCT01895335|16335813|P1|Overall Study|Lack of Efficacy|53
4736093|NCT01895335|16335813|P1|Overall Study|Adverse Event|106
4736094|NCT01895322|16335830|P1|Overall Study|Protocol Violation|10
4736095|NCT01895322|16335830|P1|Overall Study|Withdrawal by Subject|2
4736096|NCT01895322|16335830|P1|Overall Study|Adverse Event|1
4736097|NCT01895309|16335839|P2|Overall Study|Withdrawal by Subject|18
4736098|NCT01895309|16335840|P1|Overall Study|Withdrawal by Subject|9
4736099|NCT01895309|16335839|P2|Overall Study|Physician Decision|10
4736100|NCT01895309|16335840|P1|Overall Study|Physician Decision|15
4736101|NCT01895309|16335839|P2|Overall Study|Lost to Follow-up|3
4736102|NCT01895309|16335840|P1|Overall Study|Lost to Follow-up|1
4736103|NCT01895309|16335839|P2|Overall Study|Lack of Efficacy|3
4736104|NCT01895309|16335840|P1|Overall Study|Lack of Efficacy|1
4736105|NCT01895309|16335839|P2|Overall Study|Protocol Violation|0
4736106|NCT01895309|16335840|P1|Overall Study|Protocol Violation|1
4736107|NCT01895309|16335839|P2|Overall Study|Adverse Event|17
4736108|NCT01895309|16335840|P1|Overall Study|Adverse Event|13
4736109|NCT01895270|16335854|P2|Isradipine Taper (W7-8)|Withdrawal by Subject|1
4736110|NCT01895270|16335855|P1|Isradipine Taper (W7-8)|Withdrawal by Subject|0
4736111|NCT01895270|16335854|P2|Isradipine Taper (W7-8)|Lost to Follow-up|1
4736112|NCT01895270|16335855|P1|Isradipine Taper (W7-8)|Lost to Follow-up|0
4736113|NCT01895270|16335854|P2|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5
4736114|NCT01895270|16335855|P1|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3
4736115|NCT01895270|16335854|P2|Study Medications Induction (W1-4)|Blood pressure issues|1
4736116|NCT01895270|16335855|P1|Study Medications Induction (W1-4)|Blood pressure issues|0
4736117|NCT01895270|16335854|P2|Study Medications Induction (W1-4)|noncompliance- missed medications|1
4736118|NCT01895270|16335855|P1|Study Medications Induction (W1-4)|noncompliance- missed medications|3
4736119|NCT01895270|16335854|P2|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2
4736120|NCT01895270|16335855|P1|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3
4736121|NCT01895270|16335854|P2|Study Medications Induction (W1-4)|Withdrawal by Subject|2
4736122|NCT01895270|16335855|P1|Study Medications Induction (W1-4)|Withdrawal by Subject|0
4736123|NCT01895101|16335874|P3|Overall Study|coagulation disorder|0
4736124|NCT01895101|16335875|P2|Overall Study|coagulation disorder|1
4736125|NCT01895101|16335876|P1|Overall Study|coagulation disorder|0
4736126|NCT01895101|16335874|P3|Overall Study|Death|0
4736127|NCT01895101|16335875|P2|Overall Study|Death|1
4736128|NCT01895101|16335876|P1|Overall Study|Death|0
4736129|NCT01895101|16335874|P3|Overall Study|another study, enrolled in other study|0
4736130|NCT01895101|16335875|P2|Overall Study|another study, enrolled in other study|1
4736131|NCT01895101|16335876|P1|Overall Study|another study, enrolled in other study|0
4736132|NCT01895101|16335874|P3|Overall Study|Withdrawal by Subject|2
4736133|NCT01895101|16335875|P2|Overall Study|Withdrawal by Subject|1
4736134|NCT01895101|16335876|P1|Overall Study|Withdrawal by Subject|0
4736135|NCT01895101|16335874|P3|Overall Study|OPCAB procedure|3
4736136|NCT01895101|16335875|P2|Overall Study|OPCAB procedure|1
4736137|NCT01895101|16335876|P1|Overall Study|OPCAB procedure|1
4736138|NCT01894984|16335911|P2|Overall Study|Other|175
4736139|NCT01894984|16335912|P1|Overall Study|Other|314
4736140|NCT01894919|16335941|P13|Overall Study|Lost to Follow-up|0
4736141|NCT01894919|16335942|P12|Overall Study|Lost to Follow-up|0
4736142|NCT01894919|16335943|P11|Overall Study|Lost to Follow-up|0
4736143|NCT01894919|16335944|P10|Overall Study|Lost to Follow-up|0
4736144|NCT01894919|16335945|P9|Overall Study|Lost to Follow-up|0
4736145|NCT01894919|16335946|P8|Overall Study|Lost to Follow-up|0
4736146|NCT01894919|16335947|P7|Overall Study|Lost to Follow-up|0
4736147|NCT01894919|16335948|P6|Overall Study|Lost to Follow-up|0
4736148|NCT01894919|16335949|P5|Overall Study|Lost to Follow-up|2
4736149|NCT01894919|16335950|P4|Overall Study|Lost to Follow-up|0
4736150|NCT01894919|16335951|P3|Overall Study|Lost to Follow-up|0
4736151|NCT01894919|16335952|P2|Overall Study|Lost to Follow-up|0
4736152|NCT01894919|16335953|P1|Overall Study|Lost to Follow-up|0
4736153|NCT01894919|16335941|P13|Overall Study|Other-Unspecified|0
4736154|NCT01894919|16335942|P12|Overall Study|Other-Unspecified|0
4736155|NCT01894919|16335943|P11|Overall Study|Other-Unspecified|0
4736156|NCT01894919|16335944|P10|Overall Study|Other-Unspecified|0
4736157|NCT01894919|16335945|P9|Overall Study|Other-Unspecified|0
4736158|NCT01894919|16335946|P8|Overall Study|Other-Unspecified|0
4736159|NCT01894919|16335947|P7|Overall Study|Other-Unspecified|0
4736160|NCT01894919|16335948|P6|Overall Study|Other-Unspecified|0
4736161|NCT01894919|16335949|P5|Overall Study|Other-Unspecified|0
4736162|NCT01894919|16335950|P4|Overall Study|Other-Unspecified|0
4736163|NCT01894919|16335951|P3|Overall Study|Other-Unspecified|0
4736164|NCT01894919|16335952|P2|Overall Study|Other-Unspecified|0
4736165|NCT01894919|16335953|P1|Overall Study|Other-Unspecified|1
4736166|NCT01894919|16335941|P13|Overall Study|Adverse Event|0
4736167|NCT01894919|16335942|P12|Overall Study|Adverse Event|0
4736168|NCT01894919|16335943|P11|Overall Study|Adverse Event|1
4736169|NCT01894919|16335944|P10|Overall Study|Adverse Event|0
4736170|NCT01894919|16335945|P9|Overall Study|Adverse Event|0
4736171|NCT01894919|16335946|P8|Overall Study|Adverse Event|0
4736172|NCT01894919|16335947|P7|Overall Study|Adverse Event|0
4736173|NCT01894919|16335948|P6|Overall Study|Adverse Event|0
4736174|NCT01894919|16335949|P5|Overall Study|Adverse Event|0
4736175|NCT01894919|16335950|P4|Overall Study|Adverse Event|0
4736176|NCT01894919|16335951|P3|Overall Study|Adverse Event|0
4736177|NCT01894919|16335952|P2|Overall Study|Adverse Event|0
4736178|NCT01894919|16335953|P1|Overall Study|Adverse Event|0
4736179|NCT01894919|16335941|P13|Overall Study|Withdrawal by Subject|0
4736180|NCT01894919|16335942|P12|Overall Study|Withdrawal by Subject|0
4736181|NCT01894919|16335943|P11|Overall Study|Withdrawal by Subject|1
4736182|NCT01894919|16335944|P10|Overall Study|Withdrawal by Subject|1
4736183|NCT01894919|16335945|P9|Overall Study|Withdrawal by Subject|0
4736184|NCT01894919|16335946|P8|Overall Study|Withdrawal by Subject|0
4736185|NCT01894919|16335947|P7|Overall Study|Withdrawal by Subject|0
4736186|NCT01894919|16335948|P6|Overall Study|Withdrawal by Subject|0
4736187|NCT01894919|16335949|P5|Overall Study|Withdrawal by Subject|1
4736188|NCT01894919|16335950|P4|Overall Study|Withdrawal by Subject|0
4736189|NCT01894919|16335951|P3|Overall Study|Withdrawal by Subject|0
4736190|NCT01894919|16335952|P2|Overall Study|Withdrawal by Subject|0
4736191|NCT01894919|16335953|P1|Overall Study|Withdrawal by Subject|1
4736192|NCT01894841|16336108|P2|Overall Study|Lost to Follow-up|3
4736193|NCT01894841|16336109|P1|Overall Study|Lost to Follow-up|7
4736194|NCT01894841|16336108|P2|Overall Study|Withdrawn by investigator|2
4736195|NCT01894841|16336109|P1|Overall Study|Withdrawn by investigator|2
4736196|NCT01894841|16336108|P2|Overall Study|Withdrawal by Subject|4
4736197|NCT01894841|16336109|P1|Overall Study|Withdrawal by Subject|9
4736198|NCT01894776|16336125|P1|Overall Study|Withdrawal by Subject|1
4736199|NCT01894620|16336139|P2|Overall Study|Withdrawal by Subject|1
4736200|NCT01894620|16336140|P1|Overall Study|Withdrawal by Subject|0
4736201|NCT01894607|16336148|P1|Overall Study|Ineligible|1
4736202|NCT01894581|16336155|P2|Overall Study|Screen Failure|4
4736203|NCT01894581|16336156|P1|Overall Study|Screen Failure|3
4736204|NCT01894581|16336155|P2|Overall Study|Withdrawal by Subject|3
4736205|NCT01894581|16336156|P1|Overall Study|Withdrawal by Subject|2
4736206|NCT01894568|16336164|P2|Overall Study|Lost to Follow-up|1
4736207|NCT01894568|16336165|P1|Overall Study|Lost to Follow-up|0
4736208|NCT01894568|16336164|P2|Overall Study|Physician Decision|0
4736209|NCT01894568|16336165|P1|Overall Study|Physician Decision|1
4736210|NCT01894568|16336164|P2|Overall Study|Withdrawal by Subject|5
4736211|NCT01894568|16336165|P1|Overall Study|Withdrawal by Subject|5
4736212|NCT01894568|16336164|P2|Overall Study|Protocol required discontinuation|1
4736213|NCT01894568|16336165|P1|Overall Study|Protocol required discontinuation|2
4736214|NCT01894568|16336164|P2|Overall Study|Adverse Event|3
4736215|NCT01894568|16336165|P1|Overall Study|Adverse Event|2
4736216|NCT01894477|16336216|P2|Overall Study|protocol changed due SC changed to cord|1
4736217|NCT01894477|16336217|P1|Overall Study|protocol changed due SC changed to cord|0
4736218|NCT01894477|16336216|P2|Overall Study|Protocol Violation|1
4736219|NCT01894477|16336217|P1|Overall Study|Protocol Violation|0
4736220|NCT01894256|16336228|P3|Part B|Lack of Efficacy|13
4736221|NCT01894256|16336229|P2|Part B|Lack of Efficacy|12
4736222|NCT01894256|16336230|P1|Part B|Lack of Efficacy|15
4736223|NCT01894256|16336228|P3|Part B|Withdrawal by Subject|0
4736224|NCT01894256|16336229|P2|Part B|Withdrawal by Subject|1
4736225|NCT01894256|16336230|P1|Part B|Withdrawal by Subject|0
4736226|NCT01894256|16336228|P3|Part B|Death|1
4736227|NCT01894256|16336229|P2|Part B|Death|1
4736228|NCT01894256|16336230|P1|Part B|Death|0
4736229|NCT01894256|16336228|P3|Part A|Adverse Event|0
4736230|NCT01894256|16336229|P2|Part A|Adverse Event|1
4736231|NCT01894256|16336230|P1|Part A|Adverse Event|0
4736232|NCT01894243|16336277|P3|Overall Study|Other|0
4736233|NCT01894243|16336278|P2|Overall Study|Other|0
4736234|NCT01894243|16336279|P1|Overall Study|Other|1
4736235|NCT01894243|16336277|P3|Overall Study|Subject decision|0
4736236|NCT01894243|16336278|P2|Overall Study|Subject decision|0
4736237|NCT01894243|16336279|P1|Overall Study|Subject decision|1
4736238|NCT01894243|16336277|P3|Overall Study|Condition under investigation worsened|2
4736239|NCT01894243|16336278|P2|Overall Study|Condition under investigation worsened|6
4736240|NCT01894243|16336279|P1|Overall Study|Condition under investigation worsened|8
4736241|NCT01894243|16336277|P3|Overall Study|Lack of Efficacy|1
4736242|NCT01894243|16336278|P2|Overall Study|Lack of Efficacy|3
4736243|NCT01894243|16336279|P1|Overall Study|Lack of Efficacy|3
4736244|NCT01894243|16336277|P3|Overall Study|Death|3
4736245|NCT01894243|16336278|P2|Overall Study|Death|0
4736246|NCT01894243|16336279|P1|Overall Study|Death|0
4736247|NCT01894243|16336277|P3|Overall Study|Adverse Event|2
4736248|NCT01894243|16336278|P2|Overall Study|Adverse Event|1
4736249|NCT01894243|16336279|P1|Overall Study|Adverse Event|0
4736250|NCT01894230|16336318|P2|Overall Study|Death|0
4736251|NCT01894230|16336319|P1|Overall Study|Death|1
4736252|NCT01894230|16336318|P2|Overall Study|Non-adherent|1
4736253|NCT01894230|16336319|P1|Overall Study|Non-adherent|0
4736254|NCT01894230|16336318|P2|Overall Study|Withdrawal by Subject|4
4736255|NCT01894230|16336319|P1|Overall Study|Withdrawal by Subject|4
4736256|NCT01894230|16336318|P2|Overall Study|Lost to Follow-up|2
4736257|NCT01894230|16336319|P1|Overall Study|Lost to Follow-up|2
4736258|NCT01894152|16336354|P1|Overall Study|No DMR and no Stent thrombosis|151
4736259|NCT01894100|16336397|P2|Overall Study|Withdrawal by Subject|0
4736260|NCT01894100|16336398|P1|Overall Study|Withdrawal by Subject|3
4736261|NCT01894100|16336397|P2|Overall Study|Lost to Follow-up|1
4736262|NCT01894100|16336398|P1|Overall Study|Lost to Follow-up|0
4736263|NCT01894022|16336423|P2|Overall Study|Study Closed/terminated|10
4736264|NCT01894022|16336424|P1|Overall Study|Study Closed/terminated|7
4736265|NCT01894022|16336423|P2|Overall Study|Adverse Event, non-fatal|0
4736266|NCT01894022|16336424|P1|Overall Study|Adverse Event, non-fatal|1
4736267|NCT01894022|16336423|P2|Overall Study|Death|0
4736268|NCT01894022|16336424|P1|Overall Study|Death|1
4736269|NCT01893905|16336493|P2|Overall Study|Other reason|3
4736270|NCT01893905|16336494|P1|Overall Study|Other reason|1
4736271|NCT01893905|16336493|P2|Overall Study|Lack of adherence to treatment|0
4736272|NCT01893905|16336494|P1|Overall Study|Lack of adherence to treatment|2
4736273|NCT01893905|16336493|P2|Overall Study|Protocol Violation|1
4736274|NCT01893905|16336494|P1|Overall Study|Protocol Violation|6
4736275|NCT01893905|16336493|P2|Overall Study|Lost to Follow-up|0
4736276|NCT01893905|16336494|P1|Overall Study|Lost to Follow-up|1
4736277|NCT01893905|16336493|P2|Overall Study|Lack of Efficacy|7
4736278|NCT01893905|16336494|P1|Overall Study|Lack of Efficacy|5
4736279|NCT01893905|16336493|P2|Overall Study|Adverse Event|3
4736280|NCT01893905|16336494|P1|Overall Study|Adverse Event|9
4736281|NCT01893905|16336493|P2|Overall Study|Withdrawal by Subject|0
4736282|NCT01893905|16336494|P1|Overall Study|Withdrawal by Subject|1
4736283|NCT01893827|16336511|P2|Overall Study|Lost to Follow-up|26
4736284|NCT01893827|16336512|P1|Overall Study|Lost to Follow-up|19
4736285|NCT01893411|16336542|P3|Overall Study|Lost to Follow-up|1
4736286|NCT01893411|16336543|P2|Overall Study|Lost to Follow-up|0
4736287|NCT01893411|16336544|P1|Overall Study|Lost to Follow-up|2
4736288|NCT01893411|16336542|P3|Overall Study|Withdrawal by Subject|3
4736289|NCT01893411|16336543|P2|Overall Study|Withdrawal by Subject|4
4736290|NCT01893411|16336544|P1|Overall Study|Withdrawal by Subject|7
4736291|NCT01893411|16336542|P3|Overall Study|Adverse Event|0
4736292|NCT01893411|16336543|P2|Overall Study|Adverse Event|0
4736293|NCT01893411|16336544|P1|Overall Study|Adverse Event|1
4736294|NCT01893411|16336542|P3|Overall Study|Other|3
4736295|NCT01893411|16336543|P2|Overall Study|Other|1
4736296|NCT01893411|16336544|P1|Overall Study|Other|3
4736297|NCT01893411|16336542|P3|Overall Study|Lack of Efficacy|0
4736298|NCT01893411|16336543|P2|Overall Study|Lack of Efficacy|1
4736299|NCT01893411|16336544|P1|Overall Study|Lack of Efficacy|2
4736300|NCT01893411|16336542|P3|Overall Study|Physician Decision|2
4736301|NCT01893411|16336543|P2|Overall Study|Physician Decision|1
4736302|NCT01893411|16336544|P1|Overall Study|Physician Decision|1
4736303|NCT01893411|16336542|P3|Overall Study|Protocol Violation|0
4736304|NCT01893411|16336543|P2|Overall Study|Protocol Violation|0
4736305|NCT01893411|16336544|P1|Overall Study|Protocol Violation|1
4736306|NCT01893346|16336641|P4|Overall Study|Withdrawal by Subject|0
4736307|NCT01893346|16336642|P3|Overall Study|Withdrawal by Subject|0
4736308|NCT01893346|16336643|P2|Overall Study|Withdrawal by Subject|0
4736309|NCT01893346|16336644|P1|Overall Study|Withdrawal by Subject|2
4736310|NCT01893346|16336641|P4|Overall Study|Protocol Violation|0
4736311|NCT01893346|16336642|P3|Overall Study|Protocol Violation|0
4736312|NCT01893346|16336643|P2|Overall Study|Protocol Violation|0
4736313|NCT01893346|16336644|P1|Overall Study|Protocol Violation|1
4736314|NCT01893346|16336641|P4|Overall Study|Lost to Follow-up|0
4736315|NCT01893346|16336642|P3|Overall Study|Lost to Follow-up|0
4736316|NCT01893346|16336643|P2|Overall Study|Lost to Follow-up|1
4736317|NCT01893346|16336644|P1|Overall Study|Lost to Follow-up|0
4736318|NCT01893281|16336658|P1|Overall Study|Withdrawal by Subject|1
4736319|NCT01893281|16336658|P1|Overall Study|Protocol Violation|1
4736320|NCT01893281|16336658|P1|Overall Study|Adverse Event|1
4736321|NCT01893203|16336665|P1|Overall Study|Withdrawal by Subject|1
4736322|NCT01892722|16336689|P2|Overall Study|Withdrawal by Subject|5
4736323|NCT01892722|16336690|P1|Overall Study|Withdrawal by Subject|3
4736324|NCT01892722|16336689|P2|Overall Study|Lack of Efficacy|7
4736325|NCT01892722|16336690|P1|Overall Study|Lack of Efficacy|0
4736326|NCT01892722|16336689|P2|Overall Study|Adverse Event|2
4736327|NCT01892722|16336690|P1|Overall Study|Adverse Event|3
4736328|NCT01892722|16336689|P2|Overall Study|Physician Decision|2
4736329|NCT01892722|16336690|P1|Overall Study|Physician Decision|1
4736330|NCT01892722|16336689|P2|Overall Study|Patient/guardian decision|2
4736331|NCT01892722|16336690|P1|Overall Study|Patient/guardian decision|0
4736332|NCT01892722|16336689|P2|Overall Study|Administrative problems|1
4736333|NCT01892722|16336690|P1|Overall Study|Administrative problems|0
4736334|NCT01892722|16336689|P2|Overall Study|Protocol deviation|1
4736335|NCT01892722|16336690|P1|Overall Study|Protocol deviation|0
4736336|NCT01892657|16336706|P1|Overall Study|Protocol Violation|12
4736337|NCT01892657|16336706|P1|Overall Study|Withdrawal by Subject|6
4736338|NCT01892540|16336725|P3|Overall Study|Did not fit in scanner|1
4736339|NCT01892540|16336726|P2|Overall Study|Did not fit in scanner|0
4736340|NCT01892540|16336727|P1|Overall Study|Did not fit in scanner|0
4736341|NCT01892540|16336725|P3|Overall Study|Did not complete PET/MRI|2
4736342|NCT01892540|16336726|P2|Overall Study|Did not complete PET/MRI|0
4736343|NCT01892540|16336727|P1|Overall Study|Did not complete PET/MRI|0
4736344|NCT01892436|16336748|P4|Overall Study|Adverse Event|3
4736345|NCT01892436|16336749|P3|Overall Study|Adverse Event|2
4736346|NCT01892436|16336750|P2|Overall Study|Adverse Event|6
4736347|NCT01892436|16336751|P1|Overall Study|Adverse Event|7
4736348|NCT01892436|16336748|P4|Overall Study|non-compliance with treatment|0
4736349|NCT01892436|16336749|P3|Overall Study|non-compliance with treatment|0
4736350|NCT01892436|16336750|P2|Overall Study|non-compliance with treatment|0
4736351|NCT01892436|16336751|P1|Overall Study|non-compliance with treatment|1
4736352|NCT01892436|16336748|P4|Overall Study|Lost to Follow-up|3
4736353|NCT01892436|16336749|P3|Overall Study|Lost to Follow-up|1
4736354|NCT01892436|16336750|P2|Overall Study|Lost to Follow-up|1
4736355|NCT01892436|16336751|P1|Overall Study|Lost to Follow-up|1
4736356|NCT01892436|16336748|P4|Overall Study|Lack of Efficacy|2
4736357|NCT01892436|16336749|P3|Overall Study|Lack of Efficacy|2
4736358|NCT01892436|16336750|P2|Overall Study|Lack of Efficacy|2
4736359|NCT01892436|16336751|P1|Overall Study|Lack of Efficacy|1
4736360|NCT01892436|16336748|P4|Overall Study|Technical problems|1
4736361|NCT01892436|16336749|P3|Overall Study|Technical problems|1
4736362|NCT01892436|16336750|P2|Overall Study|Technical problems|1
4736363|NCT01892436|16336751|P1|Overall Study|Technical problems|2
4736364|NCT01892436|16336748|P4|Overall Study|Pregnancy|0
4736365|NCT01892436|16336749|P3|Overall Study|Pregnancy|1
4736366|NCT01892436|16336750|P2|Overall Study|Pregnancy|2
4736367|NCT01892436|16336751|P1|Overall Study|Pregnancy|0
4736368|NCT01892436|16336748|P4|Overall Study|Physician Decision|1
4736369|NCT01892436|16336749|P3|Overall Study|Physician Decision|0
4736370|NCT01892436|16336750|P2|Overall Study|Physician Decision|1
4736371|NCT01892436|16336751|P1|Overall Study|Physician Decision|2
4736372|NCT01892436|16336748|P4|Overall Study|Death|0
4736373|NCT01892436|16336749|P3|Overall Study|Death|0
4736374|NCT01892436|16336750|P2|Overall Study|Death|1
4736375|NCT01892436|16336751|P1|Overall Study|Death|1
4736376|NCT01892436|16336748|P4|Overall Study|Withdrawal by Subject|4
4736377|NCT01892436|16336749|P3|Overall Study|Withdrawal by Subject|4
4736378|NCT01892436|16336750|P2|Overall Study|Withdrawal by Subject|15
4736379|NCT01892436|16336751|P1|Overall Study|Withdrawal by Subject|8
4736380|NCT01892345|16336791|P2|Overall Study|Withdrawal by Subject|1
4736381|NCT01892345|16336792|P1|Overall Study|Withdrawal by Subject|12
4736382|NCT01892345|16336791|P2|Overall Study|Lost to Follow-up|0
4736383|NCT01892345|16336792|P1|Overall Study|Lost to Follow-up|3
4736384|NCT01892345|16336791|P2|Overall Study|Death|0
4736385|NCT01892345|16336792|P1|Overall Study|Death|1
4736386|NCT01892345|16336791|P2|Overall Study|Adverse Event|2
4736387|NCT01892345|16336792|P1|Overall Study|Adverse Event|0
4736388|NCT01892293|16336833|P1|Overall Study|Apheresed but not treated|4
4736389|NCT01892189|16336877|P9|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736390|NCT01892189|16336878|P8|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736391|NCT01892189|16336879|P7|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736392|NCT01892189|16336880|P6|Washout Period 1 (7 Days)|Noncompliance, Irritability|1
4736393|NCT01892189|16336881|P5|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736394|NCT01892189|16336882|P4|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736395|NCT01892189|16336883|P3|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736396|NCT01892189|16336884|P2|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736397|NCT01892189|16336885|P1|Washout Period 1 (7 Days)|Noncompliance, Irritability|0
4736398|NCT01892189|16336877|P9|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4736399|NCT01892189|16336878|P8|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4736400|NCT01892189|16336879|P7|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4736401|NCT01892189|16336880|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4736402|NCT01892189|16336881|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4736403|NCT01892189|16336882|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4736404|NCT01892189|16336883|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|2
4736405|NCT01892189|16336884|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4736406|NCT01892189|16336885|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4736407|NCT01892189|16336877|P9|Washout Period 1 (7 Days)|Adverse Event|1
4736408|NCT01892189|16336878|P8|Washout Period 1 (7 Days)|Adverse Event|0
4736409|NCT01892189|16336879|P7|Washout Period 1 (7 Days)|Adverse Event|0
4736410|NCT01892189|16336880|P6|Washout Period 1 (7 Days)|Adverse Event|0
4736411|NCT01892189|16336881|P5|Washout Period 1 (7 Days)|Adverse Event|0
4736412|NCT01892189|16336882|P4|Washout Period 1 (7 Days)|Adverse Event|0
4736413|NCT01892189|16336883|P3|Washout Period 1 (7 Days)|Adverse Event|0
4736414|NCT01892189|16336884|P2|Washout Period 1 (7 Days)|Adverse Event|0
4736415|NCT01892189|16336885|P1|Washout Period 1 (7 Days)|Adverse Event|0
4736416|NCT01892163|16336927|P2|Overall Study|Lost to Follow-up|0
4736417|NCT01892163|16336928|P1|Overall Study|Lost to Follow-up|1
4736418|NCT01892163|16336927|P2|Overall Study|Death|1
4736419|NCT01892163|16336928|P1|Overall Study|Death|1
4736420|NCT01892020|16336940|P2|Period 2|Protocol Violation|0
4736421|NCT01892020|16336941|P1|Period 2|Protocol Violation|1
4736422|NCT01892020|16336940|P2|Period 1|Unclassified|1
4736423|NCT01892020|16336941|P1|Period 1|Unclassified|0
4736424|NCT01892020|16336940|P2|Period 1|Protocol Violation|4
4736425|NCT01892020|16336941|P1|Period 1|Protocol Violation|2
4736426|NCT01892020|16336940|P2|Period 1|Adverse Event|1
4736427|NCT01892020|16336941|P1|Period 1|Adverse Event|1
4736428|NCT01891890|16336999|P3|Overall Study|Study ended before endpoint reached|6
4736429|NCT01891890|16337000|P2|Overall Study|Study ended before endpoint reached|3
4736430|NCT01891890|16337001|P1|Overall Study|Study ended before endpoint reached|7
4736431|NCT01891890|16336999|P3|Overall Study|Lost to Follow-up|1
4736432|NCT01891890|16337000|P2|Overall Study|Lost to Follow-up|0
4736433|NCT01891890|16337001|P1|Overall Study|Lost to Follow-up|0
4736434|NCT01891864|16337044|P6|Extension Period|Lost to Follow-up|0
4736435|NCT01891864|16337045|P5|Extension Period|Lost to Follow-up|0
4736436|NCT01891864|16337046|P4|Extension Period|Lost to Follow-up|0
4736437|NCT01891864|16337047|P3|Extension Period|Lost to Follow-up|2
4736438|NCT01891864|16337048|P2|Extension Period|Lost to Follow-up|0
4736439|NCT01891864|16337049|P1|Extension Period|Lost to Follow-up|0
4736440|NCT01891864|16337044|P6|Extension Period|Withdrawal by Subject|0
4736441|NCT01891864|16337045|P5|Extension Period|Withdrawal by Subject|4
4736442|NCT01891864|16337046|P4|Extension Period|Withdrawal by Subject|2
4736443|NCT01891864|16337047|P3|Extension Period|Withdrawal by Subject|1
4736444|NCT01891864|16337048|P2|Extension Period|Withdrawal by Subject|0
4736445|NCT01891864|16337049|P1|Extension Period|Withdrawal by Subject|0
4736446|NCT01891864|16337044|P6|Extension Period|Adverse Event|0
4736447|NCT01891864|16337045|P5|Extension Period|Adverse Event|2
4736448|NCT01891864|16337046|P4|Extension Period|Adverse Event|2
4736449|NCT01891864|16337047|P3|Extension Period|Adverse Event|4
4736450|NCT01891864|16337048|P2|Extension Period|Adverse Event|0
4736451|NCT01891864|16337049|P1|Extension Period|Adverse Event|0
4736452|NCT01891864|16337044|P6|Extension Period|Pregnancy|0
4736453|NCT01891864|16337045|P5|Extension Period|Pregnancy|0
4736454|NCT01891864|16337046|P4|Extension Period|Pregnancy|0
4736455|NCT01891864|16337047|P3|Extension Period|Pregnancy|1
4736456|NCT01891864|16337048|P2|Extension Period|Pregnancy|0
4736457|NCT01891864|16337049|P1|Extension Period|Pregnancy|0
4736458|NCT01891864|16337044|P6|Extension Period|Lack of Efficacy|0
4736459|NCT01891864|16337045|P5|Extension Period|Lack of Efficacy|1
4736460|NCT01891864|16337046|P4|Extension Period|Lack of Efficacy|1
4736461|NCT01891864|16337047|P3|Extension Period|Lack of Efficacy|0
4736462|NCT01891864|16337048|P2|Extension Period|Lack of Efficacy|0
4736463|NCT01891864|16337049|P1|Extension Period|Lack of Efficacy|0
4736464|NCT01891864|16337044|P6|Treatment Period 2|Withdrawal by Subject|1
4736465|NCT01891864|16337045|P5|Treatment Period 2|Withdrawal by Subject|1
4736466|NCT01891864|16337046|P4|Treatment Period 2|Withdrawal by Subject|4
4736467|NCT01891864|16337047|P3|Treatment Period 2|Withdrawal by Subject|3
4736468|NCT01891864|16337048|P2|Treatment Period 2|Withdrawal by Subject|0
4736469|NCT01891864|16337049|P1|Treatment Period 2|Withdrawal by Subject|0
4736470|NCT01891864|16337044|P6|Treatment Period 2|Termination of Site|0
4736471|NCT01891864|16337045|P5|Treatment Period 2|Termination of Site|2
4736472|NCT01891864|16337046|P4|Treatment Period 2|Termination of Site|0
4736473|NCT01891864|16337047|P3|Treatment Period 2|Termination of Site|0
4736474|NCT01891864|16337048|P2|Treatment Period 2|Termination of Site|0
4736475|NCT01891864|16337049|P1|Treatment Period 2|Termination of Site|0
4736476|NCT01891864|16337044|P6|Treatment Period 2|Adverse Event|4
4736477|NCT01891864|16337045|P5|Treatment Period 2|Adverse Event|0
4736478|NCT01891864|16337046|P4|Treatment Period 2|Adverse Event|2
4736479|NCT01891864|16337047|P3|Treatment Period 2|Adverse Event|1
4736480|NCT01891864|16337048|P2|Treatment Period 2|Adverse Event|0
4736481|NCT01891864|16337049|P1|Treatment Period 2|Adverse Event|0
4736482|NCT01891864|16337044|P6|Treatment Period 2|Lack of Efficacy|0
4736483|NCT01891864|16337045|P5|Treatment Period 2|Lack of Efficacy|1
4736484|NCT01891864|16337046|P4|Treatment Period 2|Lack of Efficacy|0
4736485|NCT01891864|16337047|P3|Treatment Period 2|Lack of Efficacy|1
4736486|NCT01891864|16337048|P2|Treatment Period 2|Lack of Efficacy|0
4736487|NCT01891864|16337049|P1|Treatment Period 2|Lack of Efficacy|0
4736488|NCT01891864|16337044|P6|Treatment Period 2|Site Termination|0
4736489|NCT01891864|16337045|P5|Treatment Period 2|Site Termination|0
4736490|NCT01891864|16337046|P4|Treatment Period 2|Site Termination|2
4736491|NCT01891864|16337047|P3|Treatment Period 2|Site Termination|1
4736492|NCT01891864|16337048|P2|Treatment Period 2|Site Termination|0
4736493|NCT01891864|16337049|P1|Treatment Period 2|Site Termination|0
4736494|NCT01891864|16337044|P6|Treatment Period 2|Physician Decision|0
4736495|NCT01891864|16337045|P5|Treatment Period 2|Physician Decision|0
4736496|NCT01891864|16337046|P4|Treatment Period 2|Physician Decision|0
4736497|NCT01891864|16337047|P3|Treatment Period 2|Physician Decision|1
4736498|NCT01891864|16337048|P2|Treatment Period 2|Physician Decision|0
4736499|NCT01891864|16337049|P1|Treatment Period 2|Physician Decision|0
4736500|NCT01891864|16337044|P6|Treatment Period 2|Protocol Violation|0
4736501|NCT01891864|16337045|P5|Treatment Period 2|Protocol Violation|0
4736502|NCT01891864|16337046|P4|Treatment Period 2|Protocol Violation|1
4736503|NCT01891864|16337047|P3|Treatment Period 2|Protocol Violation|0
4736504|NCT01891864|16337048|P2|Treatment Period 2|Protocol Violation|0
4736505|NCT01891864|16337049|P1|Treatment Period 2|Protocol Violation|0
4736506|NCT01891864|16337044|P6|Treatment Period 1|Lost to Follow-up|0
4736507|NCT01891864|16337045|P5|Treatment Period 1|Lost to Follow-up|0
4736508|NCT01891864|16337046|P4|Treatment Period 1|Lost to Follow-up|0
4736509|NCT01891864|16337047|P3|Treatment Period 1|Lost to Follow-up|0
4736510|NCT01891864|16337048|P2|Treatment Period 1|Lost to Follow-up|0
4736511|NCT01891864|16337049|P1|Treatment Period 1|Lost to Follow-up|1
4736512|NCT01891864|16337044|P6|Treatment Period 1|Withdrawal by Subject|0
4736513|NCT01891864|16337045|P5|Treatment Period 1|Withdrawal by Subject|0
4736514|NCT01891864|16337046|P4|Treatment Period 1|Withdrawal by Subject|0
4736515|NCT01891864|16337047|P3|Treatment Period 1|Withdrawal by Subject|0
4736516|NCT01891864|16337048|P2|Treatment Period 1|Withdrawal by Subject|5
4736517|NCT01891864|16337049|P1|Treatment Period 1|Withdrawal by Subject|2
4736518|NCT01891864|16337044|P6|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4736519|NCT01891864|16337045|P5|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4736520|NCT01891864|16337046|P4|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4736521|NCT01891864|16337047|P3|Treatment Period 1|Adverse Event / Injection Site Reaction|0
4736522|NCT01891864|16337048|P2|Treatment Period 1|Adverse Event / Injection Site Reaction|4
4736523|NCT01891864|16337049|P1|Treatment Period 1|Adverse Event / Injection Site Reaction|4
4736524|NCT01891864|16337044|P6|Treatment Period 1|Adverse Event, Serious, Fatal|0
4736525|NCT01891864|16337045|P5|Treatment Period 1|Adverse Event, Serious, Fatal|0
4736526|NCT01891864|16337046|P4|Treatment Period 1|Adverse Event, Serious, Fatal|0
4736527|NCT01891864|16337047|P3|Treatment Period 1|Adverse Event, Serious, Fatal|0
4736528|NCT01891864|16337048|P2|Treatment Period 1|Adverse Event, Serious, Fatal|1
4736529|NCT01891864|16337049|P1|Treatment Period 1|Adverse Event, Serious, Fatal|0
4736530|NCT01891864|16337044|P6|Treatment Period 1|Physician Decision|0
4736531|NCT01891864|16337045|P5|Treatment Period 1|Physician Decision|0
4736532|NCT01891864|16337046|P4|Treatment Period 1|Physician Decision|0
4736533|NCT01891864|16337047|P3|Treatment Period 1|Physician Decision|0
4736534|NCT01891864|16337048|P2|Treatment Period 1|Physician Decision|1
4736535|NCT01891864|16337049|P1|Treatment Period 1|Physician Decision|0
4736536|NCT01891864|16337044|P6|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4736537|NCT01891864|16337045|P5|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4736538|NCT01891864|16337046|P4|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4736539|NCT01891864|16337047|P3|Treatment Period 1|Protocol Violation / IMP non-compliance|0
4736540|NCT01891864|16337048|P2|Treatment Period 1|Protocol Violation / IMP non-compliance|1
4736541|NCT01891864|16337049|P1|Treatment Period 1|Protocol Violation / IMP non-compliance|1
4736542|NCT01891721|16337085|P3|Overall Study|Lost to Follow-up|1
4736543|NCT01891721|16337086|P2|Overall Study|Lost to Follow-up|5
4736544|NCT01891721|16337087|P1|Overall Study|Lost to Follow-up|10
4736545|NCT01891669|16337111|P10|Overall Study|Other|0
4736546|NCT01891669|16337112|P9|Overall Study|Other|0
4736547|NCT01891669|16337113|P8|Overall Study|Other|1
4736548|NCT01891669|16337114|P7|Overall Study|Other|0
4736549|NCT01891669|16337115|P6|Overall Study|Other|0
4736550|NCT01891669|16337116|P5|Overall Study|Other|0
4736551|NCT01891669|16337117|P4|Overall Study|Other|0
4736552|NCT01891669|16337118|P3|Overall Study|Other|0
4736553|NCT01891669|16337119|P2|Overall Study|Other|0
4736554|NCT01891669|16337120|P1|Overall Study|Other|1
4736555|NCT01891669|16337111|P10|Overall Study|Withdrawal by Subject|1
4736556|NCT01891669|16337112|P9|Overall Study|Withdrawal by Subject|1
4736557|NCT01891669|16337113|P8|Overall Study|Withdrawal by Subject|2
4736558|NCT01891669|16337114|P7|Overall Study|Withdrawal by Subject|1
4736559|NCT01891669|16337115|P6|Overall Study|Withdrawal by Subject|0
4736560|NCT01891669|16337116|P5|Overall Study|Withdrawal by Subject|0
4736561|NCT01891669|16337117|P4|Overall Study|Withdrawal by Subject|0
4736562|NCT01891669|16337118|P3|Overall Study|Withdrawal by Subject|0
4736563|NCT01891669|16337119|P2|Overall Study|Withdrawal by Subject|1
4736564|NCT01891669|16337120|P1|Overall Study|Withdrawal by Subject|1
4736565|NCT01891669|16337111|P10|Overall Study|Death|1
4736566|NCT01891669|16337112|P9|Overall Study|Death|0
4736567|NCT01891669|16337113|P8|Overall Study|Death|1
4736568|NCT01891669|16337114|P7|Overall Study|Death|0
4736569|NCT01891669|16337115|P6|Overall Study|Death|0
4736570|NCT01891669|16337116|P5|Overall Study|Death|0
4736571|NCT01891669|16337117|P4|Overall Study|Death|0
4736572|NCT01891669|16337118|P3|Overall Study|Death|0
4736573|NCT01891669|16337119|P2|Overall Study|Death|0
4736574|NCT01891669|16337120|P1|Overall Study|Death|0
4736575|NCT01891357|16337271|P1|Overall Study|Protocol Violation|3
4736576|NCT01890967|16337318|P6|Overall Study|Withdrawal by Subject|1
4736577|NCT01890967|16337319|P5|Overall Study|Withdrawal by Subject|3
4736578|NCT01890967|16337320|P4|Overall Study|Withdrawal by Subject|3
4736579|NCT01890967|16337321|P3|Overall Study|Withdrawal by Subject|2
4736580|NCT01890967|16337322|P2|Overall Study|Withdrawal by Subject|4
4736581|NCT01890967|16337323|P1|Overall Study|Withdrawal by Subject|3
4736582|NCT01890967|16337318|P6|Overall Study|Sponsor Decision|3
4736583|NCT01890967|16337319|P5|Overall Study|Sponsor Decision|2
4736584|NCT01890967|16337320|P4|Overall Study|Sponsor Decision|3
4736585|NCT01890967|16337321|P3|Overall Study|Sponsor Decision|1
4736586|NCT01890967|16337322|P2|Overall Study|Sponsor Decision|0
4736587|NCT01890967|16337323|P1|Overall Study|Sponsor Decision|2
4736588|NCT01890967|16337318|P6|Overall Study|Protocol Violation|1
4736589|NCT01890967|16337319|P5|Overall Study|Protocol Violation|4
4736590|NCT01890967|16337320|P4|Overall Study|Protocol Violation|2
4736591|NCT01890967|16337321|P3|Overall Study|Protocol Violation|3
4736592|NCT01890967|16337322|P2|Overall Study|Protocol Violation|3
4736593|NCT01890967|16337323|P1|Overall Study|Protocol Violation|0
4736594|NCT01890967|16337318|P6|Overall Study|Lost to Follow-up|1
4736595|NCT01890967|16337319|P5|Overall Study|Lost to Follow-up|0
4736596|NCT01890967|16337320|P4|Overall Study|Lost to Follow-up|1
4736597|NCT01890967|16337321|P3|Overall Study|Lost to Follow-up|1
4736598|NCT01890967|16337322|P2|Overall Study|Lost to Follow-up|1
4736599|NCT01890967|16337323|P1|Overall Study|Lost to Follow-up|1
4736600|NCT01890967|16337318|P6|Overall Study|Death|0
4736601|NCT01890967|16337319|P5|Overall Study|Death|0
4736602|NCT01890967|16337320|P4|Overall Study|Death|0
4736603|NCT01890967|16337321|P3|Overall Study|Death|0
4736604|NCT01890967|16337322|P2|Overall Study|Death|0
4736605|NCT01890967|16337323|P1|Overall Study|Death|1
4736606|NCT01890967|16337318|P6|Overall Study|Adverse Event|7
4736607|NCT01890967|16337319|P5|Overall Study|Adverse Event|1
4736608|NCT01890967|16337320|P4|Overall Study|Adverse Event|2
4736609|NCT01890967|16337321|P3|Overall Study|Adverse Event|3
4736610|NCT01890967|16337322|P2|Overall Study|Adverse Event|3
4736611|NCT01890967|16337323|P1|Overall Study|Adverse Event|3
4736612|NCT01890915|16337401|P2|Overall Study|Equipment Malfunction|1
4736613|NCT01890915|16337402|P1|Overall Study|Equipment Malfunction|0
4736614|NCT01890915|16337401|P2|Overall Study|Protocol Violation|0
4736615|NCT01890915|16337402|P1|Overall Study|Protocol Violation|2
4736616|NCT01890915|16337401|P2|Overall Study|Adverse Event|0
4736617|NCT01890915|16337402|P1|Overall Study|Adverse Event|1
4736618|NCT01890785|16337418|P6|Third Intervention|Withdrawal by Subject|0
4736619|NCT01890785|16337419|P5|Third Intervention|Withdrawal by Subject|0
4736620|NCT01890785|16337420|P4|Third Intervention|Withdrawal by Subject|0
4736621|NCT01890785|16337421|P3|Third Intervention|Withdrawal by Subject|0
4736622|NCT01890785|16337422|P2|Third Intervention|Withdrawal by Subject|1
4736623|NCT01890785|16337423|P1|Third Intervention|Withdrawal by Subject|0
4736624|NCT01890759|16337442|P2|Overall Study|Withdrawal by Subject|8
4736625|NCT01890759|16337443|P1|Overall Study|Withdrawal by Subject|2
4736626|NCT01890759|16337442|P2|Overall Study|Lost to Follow-up|2
4736627|NCT01890759|16337443|P1|Overall Study|Lost to Follow-up|0
4736628|NCT01890759|16337442|P2|Overall Study|Protocol Violation|2
4736629|NCT01890759|16337443|P1|Overall Study|Protocol Violation|0
4736630|NCT01890746|16337477|P2|Overall Study|Withdrawal by Subject|8
4736631|NCT01890746|16337478|P1|Overall Study|Withdrawal by Subject|5
4736632|NCT01890746|16337477|P2|Overall Study|Physician Decision|2
4736633|NCT01890746|16337478|P1|Overall Study|Physician Decision|3
4736634|NCT01890746|16337477|P2|Overall Study|Lost to Follow-up|1
4736635|NCT01890746|16337478|P1|Overall Study|Lost to Follow-up|4
4736636|NCT01890746|16337477|P2|Overall Study|Adverse Event|0
4736637|NCT01890746|16337478|P1|Overall Study|Adverse Event|1
4736638|NCT01890746|16337477|P2|Overall Study|Death|30
4736639|NCT01890746|16337478|P1|Overall Study|Death|39
4736640|NCT01890707|16337564|P2|Overall Study|Lost to Follow-up|1
4736641|NCT01890707|16337565|P1|Overall Study|Lost to Follow-up|1
4736642|NCT01890512|16337644|P1|Overall Study|Protocol Violation|1
4736643|NCT01890512|16337644|P1|Overall Study|Withdrawal by Subject|1
4736644|NCT01890512|16337644|P1|Overall Study|Physician Decision|1
4736645|NCT01890473|16337650|P2|Overall Study|Poor/non-compliance|0
4736646|NCT01890473|16337651|P1|Overall Study|Poor/non-compliance|1
4736647|NCT01890473|16337650|P2|Overall Study|Lost to Follow-up|0
4736648|NCT01890473|16337651|P1|Overall Study|Lost to Follow-up|1
4736649|NCT01890434|16337677|P1|Overall Study|Withdrawal by PI for ICA not performed|2
4736650|NCT01890434|16337677|P1|Overall Study|Unable to contact|1
4736651|NCT01890434|16337677|P1|Overall Study|Moved out of position|1
4736652|NCT01890434|16337677|P1|Overall Study|Uncontactable by phone|1
4736653|NCT01890434|16337677|P1|Overall Study|Participant didn't complete MRI|1
4736654|NCT01890434|16337677|P1|Overall Study|GSPECT at rest was not done|1
4736655|NCT01890434|16337677|P1|Overall Study|Decline to return for GSPECT|1
4736656|NCT01890434|16337677|P1|Overall Study|Could not get whole set of images|1
4736657|NCT01890434|16337677|P1|Overall Study|CRC didn't contact participant for FU|1
4736658|NCT01890434|16337677|P1|Overall Study|Assessment discrepancy|1
4736659|NCT01890434|16337677|P1|Overall Study|PCI at external hospital|1
4736660|NCT01890434|16337677|P1|Overall Study|Adverse Event|8
4736661|NCT01890421|16337707|P1|Overall Study|Other reason|10
4736662|NCT01890421|16337707|P1|Overall Study|Adverse Event|1
4736663|NCT01890265|16337752|P6|Overall Study|Withdrawal by Subject|0
4736664|NCT01890265|16337753|P5|Overall Study|Withdrawal by Subject|2
4736665|NCT01890265|16337754|P4|Overall Study|Withdrawal by Subject|0
4736666|NCT01890265|16337755|P3|Overall Study|Withdrawal by Subject|3
4736667|NCT01890265|16337756|P2|Overall Study|Withdrawal by Subject|2
4736668|NCT01890265|16337757|P1|Overall Study|Withdrawal by Subject|0
4736669|NCT01890265|16337752|P6|Overall Study|Death|0
4736670|NCT01890265|16337753|P5|Overall Study|Death|0
4736671|NCT01890265|16337754|P4|Overall Study|Death|0
4736672|NCT01890265|16337755|P3|Overall Study|Death|1
4736673|NCT01890265|16337756|P2|Overall Study|Death|3
4736674|NCT01890265|16337757|P1|Overall Study|Death|2
4736675|NCT01890265|16337752|P6|Overall Study|Adverse Event|0
4736676|NCT01890265|16337753|P5|Overall Study|Adverse Event|0
4736677|NCT01890265|16337754|P4|Overall Study|Adverse Event|0
4736678|NCT01890265|16337755|P3|Overall Study|Adverse Event|0
4736679|NCT01890265|16337756|P2|Overall Study|Adverse Event|1
4736680|NCT01890265|16337757|P1|Overall Study|Adverse Event|2
4736681|NCT01890265|16337752|P6|Overall Study|Progressive disease|0
4736682|NCT01890265|16337753|P5|Overall Study|Progressive disease|0
4736683|NCT01890265|16337754|P4|Overall Study|Progressive disease|0
4736684|NCT01890265|16337755|P3|Overall Study|Progressive disease|0
4736685|NCT01890265|16337756|P2|Overall Study|Progressive disease|6
4736686|NCT01890265|16337757|P1|Overall Study|Progressive disease|6
4736687|NCT01890265|16337752|P6|Overall Study|Other (Unspecified reason)|0
4736688|NCT01890265|16337753|P5|Overall Study|Other (Unspecified reason)|0
4736689|NCT01890265|16337754|P4|Overall Study|Other (Unspecified reason)|0
4736690|NCT01890265|16337755|P3|Overall Study|Other (Unspecified reason)|0
4736691|NCT01890265|16337756|P2|Overall Study|Other (Unspecified reason)|1
4736692|NCT01890265|16337757|P1|Overall Study|Other (Unspecified reason)|0
4736693|NCT01890148|16337794|P1|Overall Study|Adverse Event|1
4736694|NCT01890122|16337814|P4|Overall Study|Randomized but not Treated|0
4736695|NCT01890122|16337815|P3|Overall Study|Randomized but not Treated|0
4736696|NCT01890122|16337816|P2|Overall Study|Randomized but not Treated|1
4736697|NCT01890122|16337817|P1|Overall Study|Randomized but not Treated|1
4736698|NCT01890122|16337814|P4|Overall Study|Reason not Specified|2
4736699|NCT01890122|16337815|P3|Overall Study|Reason not Specified|1
4736700|NCT01890122|16337816|P2|Overall Study|Reason not Specified|1
4736701|NCT01890122|16337817|P1|Overall Study|Reason not Specified|0
4736702|NCT01890122|16337814|P4|Overall Study|Lack of Efficacy|41
4736703|NCT01890122|16337815|P3|Overall Study|Lack of Efficacy|7
4736704|NCT01890122|16337816|P2|Overall Study|Lack of Efficacy|24
4736705|NCT01890122|16337817|P1|Overall Study|Lack of Efficacy|14
4736706|NCT01890122|16337814|P4|Overall Study|Voluntary Withdrawal|11
4736707|NCT01890122|16337815|P3|Overall Study|Voluntary Withdrawal|2
4736708|NCT01890122|16337816|P2|Overall Study|Voluntary Withdrawal|8
4736709|NCT01890122|16337817|P1|Overall Study|Voluntary Withdrawal|8
4736710|NCT01890122|16337814|P4|Overall Study|Lost to Follow-up|2
4736711|NCT01890122|16337815|P3|Overall Study|Lost to Follow-up|2
4736712|NCT01890122|16337816|P2|Overall Study|Lost to Follow-up|1
4736713|NCT01890122|16337817|P1|Overall Study|Lost to Follow-up|0
4736714|NCT01890122|16337814|P4|Overall Study|Major Protocol Deviation|1
4736715|NCT01890122|16337815|P3|Overall Study|Major Protocol Deviation|0
4736716|NCT01890122|16337816|P2|Overall Study|Major Protocol Deviation|1
4736717|NCT01890122|16337817|P1|Overall Study|Major Protocol Deviation|3
4736718|NCT01890122|16337814|P4|Overall Study|Adverse Event|2
4736719|NCT01890122|16337815|P3|Overall Study|Adverse Event|1
4736720|NCT01890122|16337816|P2|Overall Study|Adverse Event|1
4736721|NCT01890122|16337817|P1|Overall Study|Adverse Event|1
4736722|NCT01890109|16337881|P2|Overall Study|Lost to Follow-up|2
4736723|NCT01890109|16337882|P1|Overall Study|Lost to Follow-up|1
4736724|NCT01890109|16337881|P2|Overall Study|Withdrawal by Subject|3
4736725|NCT01890109|16337882|P1|Overall Study|Withdrawal by Subject|0
4736726|NCT01889602|16337987|P3|Third Intervention|Withdrawal by Subject|0
4736727|NCT01889602|16337988|P2|Third Intervention|Withdrawal by Subject|2
4736728|NCT01889602|16337989|P1|Third Intervention|Withdrawal by Subject|2
4736729|NCT01889602|16337987|P3|Third Intervention|Protocol Violation|0
4736730|NCT01889602|16337988|P2|Third Intervention|Protocol Violation|0
4736731|NCT01889602|16337989|P1|Third Intervention|Protocol Violation|1
4736732|NCT01889602|16337987|P3|Second Intervention|Withdrawal by Subject|1
4736733|NCT01889602|16337988|P2|Second Intervention|Withdrawal by Subject|0
4736734|NCT01889602|16337989|P1|Second Intervention|Withdrawal by Subject|0
4736735|NCT01889602|16337987|P3|Second Intervention|Study ending|0
4736736|NCT01889602|16337988|P2|Second Intervention|Study ending|0
4736737|NCT01889602|16337989|P1|Second Intervention|Study ending|1
4736738|NCT01889602|16337987|P3|Second Intervention|Adverse Event|1
4736739|NCT01889602|16337988|P2|Second Intervention|Adverse Event|0
4736740|NCT01889602|16337989|P1|Second Intervention|Adverse Event|0
4736741|NCT01889602|16337987|P3|First Intervention|Study ending|0
4736742|NCT01889602|16337988|P2|First Intervention|Study ending|1
4736743|NCT01889602|16337989|P1|First Intervention|Study ending|0
4736744|NCT01889602|16337987|P3|First Intervention|Protocol Violation|1
4736745|NCT01889602|16337988|P2|First Intervention|Protocol Violation|1
4736746|NCT01889602|16337989|P1|First Intervention|Protocol Violation|0
4736747|NCT01889602|16337987|P3|First Intervention|Adverse Event|1
4736748|NCT01889602|16337988|P2|First Intervention|Adverse Event|1
4736749|NCT01889602|16337989|P1|First Intervention|Adverse Event|1
4736750|NCT01889251|16338037|P2|Overall Study|Adverse Event|0
4736751|NCT01889251|16338038|P1|Overall Study|Adverse Event|1
4736752|NCT01889238|16338044|P1|Overall Study|Treatment ongoing|9
4736753|NCT01889069|16338063|P1|Overall Study|Consent Withdrawal|3
4736754|NCT01889069|16338063|P1|Overall Study|Other|4
4736755|NCT01889069|16338063|P1|Overall Study|Lost to Follow-up|6
4736756|NCT01889069|16338063|P1|Overall Study|Progression of Disease|14
4736757|NCT01889069|16338063|P1|Overall Study|Death|18
4736758|NCT01888965|16338108|P1|Overall Study|Lack of Efficacy|4
4736759|NCT01888965|16338108|P1|Overall Study|Adverse Event|5
4736760|NCT01888900|16338120|P2|Overall Study|failed treatment|2
4736761|NCT01888900|16338121|P1|Overall Study|failed treatment|0
4736762|NCT01888640|16338144|P3|Overall Study|Researcher Termination of Participant|1
4736763|NCT01888640|16338145|P2|Overall Study|Researcher Termination of Participant|1
4736764|NCT01888640|16338146|P1|Overall Study|Researcher Termination of Participant|0
4736765|NCT01888640|16338144|P3|Overall Study|Excluded for prior TENS|0
4736766|NCT01888640|16338145|P2|Overall Study|Excluded for prior TENS|1
4736767|NCT01888640|16338146|P1|Overall Study|Excluded for prior TENS|0
4736768|NCT01888640|16338144|P3|Overall Study|Given wrong unit (placebo)|0
4736769|NCT01888640|16338145|P2|Overall Study|Given wrong unit (placebo)|0
4736770|NCT01888640|16338146|P1|Overall Study|Given wrong unit (placebo)|1
4736771|NCT01888640|16338144|P3|Overall Study|Minimum dose not met|0
4736772|NCT01888640|16338145|P2|Overall Study|Minimum dose not met|16
4736773|NCT01888640|16338146|P1|Overall Study|Minimum dose not met|10
4736774|NCT01888640|16338144|P3|Overall Study|Withdrawal by Subject|4
4736775|NCT01888640|16338145|P2|Overall Study|Withdrawal by Subject|11
4736776|NCT01888640|16338146|P1|Overall Study|Withdrawal by Subject|15
4736777|NCT01888640|16338144|P3|Overall Study|Lost to Follow-up|0
4736778|NCT01888640|16338145|P2|Overall Study|Lost to Follow-up|2
4736779|NCT01888640|16338146|P1|Overall Study|Lost to Follow-up|1
4736780|NCT01888432|16338202|P2|36-month Analysis (Extension)|Death|0
4736781|NCT01888432|16338203|P1|36-month Analysis (Extension)|Death|1
4736782|NCT01888432|16338202|P2|24-month Analysis (FAS)|Death|4
4736783|NCT01888432|16338203|P1|24-month Analysis (FAS)|Death|8
4736784|NCT01888432|16338202|P2|24-month Analysis (FAS)|Withdrawal by Subject|6
4736785|NCT01888432|16338203|P1|24-month Analysis (FAS)|Withdrawal by Subject|7
4736786|NCT01888432|16338202|P2|24-month Analysis (FAS)|Physician Decision|4
4736787|NCT01888432|16338203|P1|24-month Analysis (FAS)|Physician Decision|2
4736788|NCT01888432|16338202|P2|24-month Analysis (FAS)|Lost to Follow-up|2
4736789|NCT01888432|16338203|P1|24-month Analysis (FAS)|Lost to Follow-up|0
4736790|NCT01888432|16338202|P2|24-month Analysis (FAS)|Graft loss|1
4736791|NCT01888432|16338203|P1|24-month Analysis (FAS)|Graft loss|0
4736792|NCT01888432|16338202|P2|12-month Analysis (FAS)|Death|3
4736793|NCT01888432|16338203|P1|12-month Analysis (FAS)|Death|4
4736794|NCT01888432|16338202|P2|12-month Analysis (FAS)|Withdrawal by Subject|3
4736795|NCT01888432|16338203|P1|12-month Analysis (FAS)|Withdrawal by Subject|6
4736796|NCT01888432|16338202|P2|12-month Analysis (FAS)|Physician Decision|1
4736797|NCT01888432|16338203|P1|12-month Analysis (FAS)|Physician Decision|1
4736798|NCT01888432|16338202|P2|12-month Analysis (FAS)|Lost to Follow-up|2
4736799|NCT01888432|16338203|P1|12-month Analysis (FAS)|Lost to Follow-up|0
4736800|NCT01888367|16338244|P3|Overall Study|30-Day Visit Too Early (< 28 Days)|0
4736801|NCT01888367|16338245|P2|Overall Study|30-Day Visit Too Early (< 28 Days)|0
4736802|NCT01888367|16338246|P1|Overall Study|30-Day Visit Too Early (< 28 Days)|1
4736803|NCT01888367|16338244|P3|Overall Study|Protocol Violation|1
4736804|NCT01888367|16338245|P2|Overall Study|Protocol Violation|0
4736805|NCT01888367|16338246|P1|Overall Study|Protocol Violation|0
4736806|NCT01888367|16338244|P3|Overall Study|Lost to Follow-up|0
4736807|NCT01888367|16338245|P2|Overall Study|Lost to Follow-up|1
4736808|NCT01888367|16338246|P1|Overall Study|Lost to Follow-up|1
4736809|NCT01888367|16338244|P3|Overall Study|Withdrawal by Subject|1
4736810|NCT01888367|16338245|P2|Overall Study|Withdrawal by Subject|0
4736811|NCT01888367|16338246|P1|Overall Study|Withdrawal by Subject|1
4736812|NCT01888367|16338244|P3|Overall Study|Death|1
4736813|NCT01888367|16338245|P2|Overall Study|Death|0
4736814|NCT01888367|16338246|P1|Overall Study|Death|2
4736815|NCT01888367|16338244|P3|Overall Study|Physician Decision|2
4736816|NCT01888367|16338245|P2|Overall Study|Physician Decision|4
4736817|NCT01888367|16338246|P1|Overall Study|Physician Decision|3
4736818|NCT01888003|16338266|P3|Overall Study|Study Terminated|40
4736819|NCT01888003|16338267|P2|Overall Study|Study Terminated|6
4736820|NCT01888003|16338268|P1|Overall Study|Study Terminated|5
4736821|NCT01887912|16338308|P2|Overall Study|Other|58
4736822|NCT01887912|16338309|P1|Overall Study|Other|122
4736823|NCT01887912|16338308|P2|Overall Study|Withdrawal by Subject|349
4736824|NCT01887912|16338309|P1|Overall Study|Withdrawal by Subject|606
4736825|NCT01887912|16338308|P2|Overall Study|Lost to Follow-up|74
4736826|NCT01887912|16338309|P1|Overall Study|Lost to Follow-up|163
4736827|NCT01887912|16338308|P2|Overall Study|Protocol Violation|37
4736828|NCT01887912|16338309|P1|Overall Study|Protocol Violation|67
4736829|NCT01887912|16338308|P2|Overall Study|Other Adverse Event|15
4736830|NCT01887912|16338309|P1|Overall Study|Other Adverse Event|34
4736831|NCT01887912|16338308|P2|Overall Study|Serious adverse event|198
4736832|NCT01887912|16338309|P1|Overall Study|Serious adverse event|400
4736833|NCT01887717|16338337|P2|Overall Study|Administrative reasons|2
4736834|NCT01887717|16338338|P1|Overall Study|Administrative reasons|5
4736835|NCT01887717|16338337|P2|Overall Study|Physician Decision|2
4736836|NCT01887717|16338338|P1|Overall Study|Physician Decision|0
4736837|NCT01887717|16338337|P2|Overall Study|Withdrawal by Subject|7
4736838|NCT01887717|16338338|P1|Overall Study|Withdrawal by Subject|1
4736839|NCT01887678|16338360|P2|Overall Study|Specified|2
4736840|NCT01887678|16338361|P1|Overall Study|Specified|1
4736841|NCT01887678|16338360|P2|Overall Study|Non-compliance|3
4736842|NCT01887678|16338361|P1|Overall Study|Non-compliance|0
4736843|NCT01887678|16338360|P2|Overall Study|Lack of Efficacy|2
4736844|NCT01887678|16338361|P1|Overall Study|Lack of Efficacy|1
4736934|NCT01884597|16338951|P3|Overall Study|Death|0
4736845|NCT01887678|16338360|P2|Overall Study|Deterioration of clinical condition|4
4736846|NCT01887678|16338361|P1|Overall Study|Deterioration of clinical condition|0
4736847|NCT01887678|16338360|P2|Overall Study|Lost to Follow-up|2
4736848|NCT01887678|16338361|P1|Overall Study|Lost to Follow-up|4
4736849|NCT01887678|16338360|P2|Overall Study|Withdrawal of consent|4
4736850|NCT01887678|16338361|P1|Overall Study|Withdrawal of consent|3
4736851|NCT01887678|16338360|P2|Overall Study|Exceeded rescue medication dosage|5
4736852|NCT01887678|16338361|P1|Overall Study|Exceeded rescue medication dosage|4
4736853|NCT01887678|16338360|P2|Overall Study|Adverse Event|6
4736854|NCT01887678|16338361|P1|Overall Study|Adverse Event|4
4736855|NCT01887418|16338434|P3|Overall Study|Travelling difficulties|1
4736856|NCT01887418|16338435|P2|Overall Study|Travelling difficulties|0
4736857|NCT01887418|16338436|P1|Overall Study|Travelling difficulties|0
4736858|NCT01887353|16338455|P2|Overall Study|Study stopped early|3
4736859|NCT01887353|16338456|P1|Overall Study|Study stopped early|4
4736860|NCT01887288|16338484|P1|Overall Study|The study was terminated and the PI has|16
4736861|NCT01887210|16338491|P2|Overall Study|Lost to Follow-up|1
4736862|NCT01887210|16338492|P1|Overall Study|Lost to Follow-up|0
4736863|NCT01887210|16338491|P2|Overall Study|Withdrawal by Subject|3
4736864|NCT01887210|16338492|P1|Overall Study|Withdrawal by Subject|1
4736865|NCT01886872|16338539|P3|Overall Study|Ineligible|12
4736866|NCT01886872|16338540|P2|Overall Study|Ineligible|4
4736867|NCT01886872|16338541|P1|Overall Study|Ineligible|7
4736868|NCT01886833|16338574|P1|Overall Study|IgA not available from both periods|204
4736869|NCT01886781|16338606|P2|Overall Study|Worsening of symptoms|1
4736870|NCT01886781|16338607|P1|Overall Study|Worsening of symptoms|1
4736871|NCT01886781|16338606|P2|Overall Study|Withdrawal by Subject|1
4736872|NCT01886781|16338607|P1|Overall Study|Withdrawal by Subject|2
4736873|NCT01886781|16338606|P2|Overall Study|Lost to Follow-up|0
4736874|NCT01886781|16338607|P1|Overall Study|Lost to Follow-up|5
4736875|NCT01886781|16338606|P2|Overall Study|Adverse Event|0
4736876|NCT01886781|16338607|P1|Overall Study|Adverse Event|1
4736877|NCT01886781|16338606|P2|Overall Study|Protocol Violation|0
4736878|NCT01886781|16338607|P1|Overall Study|Protocol Violation|5
4736879|NCT01886716|16338617|P4|Week 3|Lost to Follow-up|1
4736880|NCT01886716|16338618|P3|Week 3|Lost to Follow-up|0
4736881|NCT01886716|16338619|P2|Week 3|Lost to Follow-up|1
4736882|NCT01886716|16338620|P1|Week 3|Lost to Follow-up|1
4736883|NCT01886716|16338617|P4|Week 2|Lost to Follow-up|3
4736884|NCT01886716|16338618|P3|Week 2|Lost to Follow-up|1
4736885|NCT01886716|16338619|P2|Week 2|Lost to Follow-up|2
4736886|NCT01886716|16338620|P1|Week 2|Lost to Follow-up|3
4736887|NCT01886716|16338617|P4|Week 1|Lost to Follow-up|2
4736888|NCT01886716|16338618|P3|Week 1|Lost to Follow-up|2
4736889|NCT01886716|16338619|P2|Week 1|Lost to Follow-up|0
4736890|NCT01886716|16338620|P1|Week 1|Lost to Follow-up|0
4736891|NCT01886690|16338636|P2|Overall Study|Personal Reasons|1
4736892|NCT01886690|16338637|P1|Overall Study|Personal Reasons|0
4736893|NCT01886690|16338636|P2|Overall Study|Protocol Violation|1
4736894|NCT01886690|16338637|P1|Overall Study|Protocol Violation|0
4736895|NCT01886313|16338653|P2|Overall Study|Adverse Event|1
4736896|NCT01886313|16338654|P1|Overall Study|Adverse Event|1
4736897|NCT01886300|16338660|P1|Overall Study|Trial terminated by sponsor|16
4736898|NCT01886287|16338671|P1|Overall Study|Clinical progression due to disease|1
4736899|NCT01886287|16338671|P1|Overall Study|Radiographic disease progression|1
4736900|NCT01886105|16338687|P1|Overall Study|Lack of Efficacy|3
4736901|NCT01885936|16338694|P2|Overall Study|Withdrawal by Subject|0
4736902|NCT01885936|16338695|P1|Overall Study|Withdrawal by Subject|1
4736903|NCT01885559|16338778|P2|Overall Study|Protocol Violation|1
4736904|NCT01885559|16338779|P1|Overall Study|Protocol Violation|0
4736905|NCT01885559|16338778|P2|Overall Study|Less than full participation|19
4736906|NCT01885559|16338779|P1|Overall Study|Less than full participation|9
4736907|NCT01885559|16338778|P2|Overall Study|Lost to Follow-up|16
4736908|NCT01885559|16338779|P1|Overall Study|Lost to Follow-up|15
4736909|NCT01885208|16338801|P2|Overall Study|Unclassified|38
4736910|NCT01885208|16338802|P1|Overall Study|Unclassified|32
4736911|NCT01885182|16338820|P2|Overall Study|Lack of Efficacy|1
4736912|NCT01885182|16338821|P1|Overall Study|Lack of Efficacy|8
4736913|NCT01885182|16338820|P2|Overall Study|Lost to Follow-up|2
4736914|NCT01885182|16338821|P1|Overall Study|Lost to Follow-up|2
4736915|NCT01885182|16338820|P2|Overall Study|Withdrawal by Subject|6
4736916|NCT01885182|16338821|P1|Overall Study|Withdrawal by Subject|13
4736917|NCT01885182|16338820|P2|Overall Study|Adverse Event|13
4736918|NCT01885182|16338821|P1|Overall Study|Adverse Event|11
4736919|NCT01885104|16338868|P2|Overall Study|Physician Decision|0
4736920|NCT01885104|16338869|P1|Overall Study|Physician Decision|1
4736921|NCT01885104|16338868|P2|Overall Study|Lost to Follow-up|1
4736922|NCT01885104|16338869|P1|Overall Study|Lost to Follow-up|0
4736923|NCT01885104|16338868|P2|Overall Study|Withdrawal of Consent|0
4736924|NCT01885104|16338869|P1|Overall Study|Withdrawal of Consent|1
4736925|NCT01885000|16338879|P2|Overall Study|Protocol Violation|1
4736926|NCT01885000|16338880|P1|Overall Study|Protocol Violation|0
4736927|NCT01885000|16338879|P2|Overall Study|Withdrawal by Subject|1
4736928|NCT01885000|16338880|P1|Overall Study|Withdrawal by Subject|1
4736929|NCT01885000|16338879|P2|Overall Study|Adverse Event|0
4736930|NCT01885000|16338880|P1|Overall Study|Adverse Event|1
4736931|NCT01884688|16338901|P1|Overall Study|Screen Failure|2
4736932|NCT01884675|16338907|P2|Overall Study|Study closed/terminated|2
4736933|NCT01884675|16338908|P1|Overall Study|Study closed/terminated|3
4736935|NCT01884597|16338952|P2|Overall Study|Death|1
4736936|NCT01884597|16338953|P1|Overall Study|Death|0
4736937|NCT01884597|16338951|P3|Overall Study|Lack of Efficacy|0
4736938|NCT01884597|16338952|P2|Overall Study|Lack of Efficacy|0
4736939|NCT01884597|16338953|P1|Overall Study|Lack of Efficacy|1
4736940|NCT01884597|16338951|P3|Overall Study|Adverse Event|1
4736941|NCT01884597|16338952|P2|Overall Study|Adverse Event|0
4736942|NCT01884597|16338953|P1|Overall Study|Adverse Event|0
4736943|NCT01884571|16338982|P1|Overall Study|Disease progression|3
4736944|NCT01884571|16338982|P1|Overall Study|Withdrawal by Subject|2
4736945|NCT01884571|16338982|P1|Overall Study|Death|2
4736946|NCT01884571|16338982|P1|Overall Study|Adverse Event|1
4736947|NCT01884545|16338997|P4|Overall Study|Non-adherence|0
4736948|NCT01884545|16338998|P3|Overall Study|Non-adherence|0
4736949|NCT01884545|16338999|P2|Overall Study|Non-adherence|2
4736950|NCT01884545|16339000|P1|Overall Study|Non-adherence|0
4736951|NCT01884545|16338997|P4|Overall Study|Patient withdrawn|5
4736952|NCT01884545|16338998|P3|Overall Study|Patient withdrawn|5
4736953|NCT01884545|16338999|P2|Overall Study|Patient withdrawn|12
4736954|NCT01884545|16339000|P1|Overall Study|Patient withdrawn|7
4736955|NCT01884545|16338997|P4|Overall Study|Lost to Follow-up|4
4736956|NCT01884545|16338998|P3|Overall Study|Lost to Follow-up|9
4736957|NCT01884545|16338999|P2|Overall Study|Lost to Follow-up|4
4736958|NCT01884545|16339000|P1|Overall Study|Lost to Follow-up|6
4736959|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
4736960|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0
4736961|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2
4736962|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
4736963|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0
4736964|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1
4736965|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0
4736966|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1
4736967|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4
4736968|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
4736969|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0
4736970|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3
4736971|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
4736972|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0
4736973|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4
4736974|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2
4736975|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0
4736976|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3
4736977|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0
4736978|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3
4736979|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17
4736980|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3
4736981|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6
4736982|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17
4736983|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
4736984|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0
4736985|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1
4736986|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Death|3
4736987|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Death|3
4736988|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Death|7
4736989|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2
4736990|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0
4736991|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21
4736992|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0
4736993|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
4736994|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3
4736995|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0
4736996|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
4736997|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1
4736998|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0
4736999|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
4737000|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1
4737001|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
4737002|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0
4737003|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2
4737004|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0
4737005|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5
4737006|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2
4737007|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
4737008|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2
4737009|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0
4737010|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0
4737011|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11
4737012|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15
4737013|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0
4737014|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6
4737015|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7
4737016|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
4737017|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1
4737018|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0
4737019|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Death|0
4737020|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Death|4
4737021|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Death|6
4737022|NCT01884350|16339153|P3|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0
4737023|NCT01884350|16339154|P2|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20
4737024|NCT01884350|16339155|P1|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17
4737025|NCT01884337|16339178|P2|Follow-up Period|Lost to Follow-up|1
4737026|NCT01884337|16339179|P1|Follow-up Period|Lost to Follow-up|1
4737027|NCT01884337|16339178|P2|Treatment|Subj. request to discont. treatment|0
4737028|NCT01884337|16339179|P1|Treatment|Subj. request to discont. treatment|2
4737029|NCT01884337|16339178|P2|Treatment|Adverse Event|2
4737030|NCT01884337|16339179|P1|Treatment|Adverse Event|2
4737031|NCT01884311|16339187|P1|Overall Study|Precautionary measure|1
4737032|NCT01884311|16339187|P1|Overall Study|withdrew consent due to AEs|1
4737033|NCT01884311|16339187|P1|Overall Study|Withdrawal by Subject|3
4737034|NCT01884077|16339197|P2|Overall Study|study closed|4
4737035|NCT01884077|16339198|P1|Overall Study|study closed|6
4737036|NCT01884077|16339197|P2|Overall Study|Lost to Follow-up|4
4737037|NCT01884077|16339198|P1|Overall Study|Lost to Follow-up|0
4737038|NCT01884077|16339197|P2|Overall Study|canceled surgery|0
4737039|NCT01884077|16339198|P1|Overall Study|canceled surgery|2
4737040|NCT01884077|16339197|P2|Overall Study|screen fail|2
4737041|NCT01884077|16339198|P1|Overall Study|screen fail|0
4737042|NCT01884025|16339219|P2|Overall Study|Lost to Follow-up|4
4737043|NCT01884025|16339220|P1|Overall Study|Lost to Follow-up|3
4737044|NCT01883895|16339280|P1|Overall Study|Lost to Follow-up|2
4737045|NCT01883635|16339307|P2|Overall Study|Withdrawal by Subject|0
4737046|NCT01883635|16339308|P1|Overall Study|Withdrawal by Subject|4
4737047|NCT01883492|16339322|P2|Overall Study|bone anatomy did not meet study criteria|1
4737048|NCT01883492|16339323|P1|Overall Study|bone anatomy did not meet study criteria|1
4737049|NCT01883492|16339322|P2|Overall Study|inappropriate implant used|1
4737050|NCT01883492|16339323|P1|Overall Study|inappropriate implant used|1
4737051|NCT01883492|16339322|P2|Overall Study|Withdrawal by Subject|0
4737052|NCT01883492|16339323|P1|Overall Study|Withdrawal by Subject|1
4737053|NCT01883492|16339322|P2|Overall Study|Poor X-ray quality|4
4737054|NCT01883492|16339323|P1|Overall Study|Poor X-ray quality|7
4737055|NCT01883492|16339322|P2|Overall Study|Surgery on contra-lateral hip|1
4737056|NCT01883492|16339323|P1|Overall Study|Surgery on contra-lateral hip|0
4737057|NCT01883492|16339322|P2|Overall Study|Lost to Follow-up|4
4737058|NCT01883492|16339323|P1|Overall Study|Lost to Follow-up|3
4737059|NCT01883453|16339355|P2|Overall Study|No episode of common cold|23
4737060|NCT01883453|16339356|P1|Overall Study|No episode of common cold|25
4737061|NCT01882985|16339391|P1|Overall Study|Withdrawal by Subject|1
4737062|NCT01882985|16339391|P1|Overall Study|Lost to Follow-up|1
4737063|NCT01882907|16339400|P2|Overall Study|Withdrawal by Subject|6
4737064|NCT01882907|16339401|P1|Overall Study|Withdrawal by Subject|0
4737065|NCT01882907|16339400|P2|Overall Study|Protocol Violation|14
4737066|NCT01882907|16339401|P1|Overall Study|Protocol Violation|10
4737067|NCT01882907|16339400|P2|Overall Study|Lost to Follow-up|4
4737068|NCT01882907|16339401|P1|Overall Study|Lost to Follow-up|1
4737069|NCT01882907|16339400|P2|Overall Study|Lack of Efficacy|3
4737070|NCT01882907|16339401|P1|Overall Study|Lack of Efficacy|0
4737071|NCT01882907|16339400|P2|Overall Study|Adverse Event|1
4737072|NCT01882907|16339401|P1|Overall Study|Adverse Event|3
4737073|NCT01882829|16339447|P1|Overall Study|Withdrawal by Subject|1
4737074|NCT01882829|16339447|P1|Overall Study|Protocol Violation|1
4737075|NCT01882829|16339447|P1|Overall Study|Adverse Event|4
4737076|NCT01882803|16339461|P1|Overall Study|Withdrawal by Subject|4
4737077|NCT01882803|16339461|P1|Overall Study|Protocol Violation|1
4737078|NCT01882803|16339461|P1|Overall Study|Physician Decision|7
4737079|NCT01882803|16339461|P1|Overall Study|Death|7
4737080|NCT01882803|16339461|P1|Overall Study|Adverse Event|22
4737081|NCT01882803|16339461|P1|Overall Study|Disease Progression|53
4737082|NCT01882647|16339488|P2|Overall Study|Withdrawal by Subject|4
4737083|NCT01882647|16339489|P1|Overall Study|Withdrawal by Subject|0
4737084|NCT01882647|16339488|P2|Overall Study|Lost to Follow-up|2
4737085|NCT01882647|16339489|P1|Overall Study|Lost to Follow-up|2
4737086|NCT01882465|16339529|P7|Period 2|Protocol Violation|0
4737087|NCT01882465|16339530|P6|Period 2|Protocol Violation|0
4737088|NCT01882465|16339531|P5|Period 2|Protocol Violation|1
4737089|NCT01882465|16339532|P4|Period 2|Protocol Violation|0
4737090|NCT01882465|16339533|P3|Period 2|Protocol Violation|0
4737091|NCT01882465|16339534|P2|Period 2|Protocol Violation|0
4737092|NCT01882465|16339535|P1|Period 2|Protocol Violation|0
4737093|NCT01882465|16339529|P7|Period 1|Withdrawal by Subject|1
4737094|NCT01882465|16339530|P6|Period 1|Withdrawal by Subject|0
4737095|NCT01882465|16339531|P5|Period 1|Withdrawal by Subject|0
4737096|NCT01882465|16339532|P4|Period 1|Withdrawal by Subject|0
4737097|NCT01882465|16339533|P3|Period 1|Withdrawal by Subject|0
4737098|NCT01882465|16339534|P2|Period 1|Withdrawal by Subject|0
4737099|NCT01882465|16339535|P1|Period 1|Withdrawal by Subject|0
4737100|NCT01882465|16339529|P7|Period 1|Lens Discomfort|0
4737101|NCT01882465|16339530|P6|Period 1|Lens Discomfort|0
4737102|NCT01882465|16339531|P5|Period 1|Lens Discomfort|0
4737103|NCT01882465|16339532|P4|Period 1|Lens Discomfort|1
4737104|NCT01882465|16339533|P3|Period 1|Lens Discomfort|0
4737105|NCT01882465|16339534|P2|Period 1|Lens Discomfort|0
4737106|NCT01882465|16339535|P1|Period 1|Lens Discomfort|0
4737107|NCT01882439|16339547|P4|Overall Study|Adverse event unrelated to study drug|1
4737108|NCT01882439|16339548|P3|Overall Study|Adverse event unrelated to study drug|1
4737109|NCT01882439|16339549|P2|Overall Study|Adverse event unrelated to study drug|2
4737110|NCT01882439|16339550|P1|Overall Study|Adverse event unrelated to study drug|2
4737111|NCT01882439|16339547|P4|Overall Study|Insufficient clinical response|2
4737112|NCT01882439|16339548|P3|Overall Study|Insufficient clinical response|4
4737113|NCT01882439|16339549|P2|Overall Study|Insufficient clinical response|4
4737114|NCT01882439|16339550|P1|Overall Study|Insufficient clinical response|1
4737115|NCT01882439|16339547|P4|Overall Study|Medication error with no associated AE|0
4737116|NCT01882439|16339548|P3|Overall Study|Medication error with no associated AE|2
4737117|NCT01882439|16339549|P2|Overall Study|Medication error with no associated AE|0
4737118|NCT01882439|16339550|P1|Overall Study|Medication error with no associated AE|0
4737119|NCT01882439|16339547|P4|Overall Study|No longer willing to participate|3
4737120|NCT01882439|16339548|P3|Overall Study|No longer willing to participate|2
4737121|NCT01882439|16339549|P2|Overall Study|No longer willing to participate|4
4737122|NCT01882439|16339550|P1|Overall Study|No longer willing to participate|1
4737123|NCT01882439|16339547|P4|Overall Study|Protocol Violation|1
4737124|NCT01882439|16339548|P3|Overall Study|Protocol Violation|0
4737125|NCT01882439|16339549|P2|Overall Study|Protocol Violation|2
4737126|NCT01882439|16339550|P1|Overall Study|Protocol Violation|2
4737127|NCT01882439|16339547|P4|Overall Study|Pregnancy|0
4737128|NCT01882439|16339548|P3|Overall Study|Pregnancy|0
4737129|NCT01882439|16339549|P2|Overall Study|Pregnancy|1
4737130|NCT01882439|16339550|P1|Overall Study|Pregnancy|0
4737131|NCT01882439|16339547|P4|Overall Study|Adverse event related to study drug|2
4737132|NCT01882439|16339548|P3|Overall Study|Adverse event related to study drug|1
4737133|NCT01882439|16339549|P2|Overall Study|Adverse event related to study drug|8
4737134|NCT01882439|16339550|P1|Overall Study|Adverse event related to study drug|3
4737135|NCT01882257|16339747|P3|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4
4737136|NCT01882257|16339748|P2|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11
4737137|NCT01882257|16339749|P1|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0
4737138|NCT01882257|16339747|P3|Study Origination to Beginning Therapy|Withdrawal by Subject|1
4737139|NCT01882257|16339748|P2|Study Origination to Beginning Therapy|Withdrawal by Subject|2
4737140|NCT01882257|16339749|P1|Study Origination to Beginning Therapy|Withdrawal by Subject|0
4737141|NCT01882088|16339756|P1|Overall Study|inadequate pH-impedance tracings|2
4737142|NCT01882088|16339756|P1|Overall Study|Protocol Violation|1
4737143|NCT01882088|16339756|P1|Overall Study|no possibility to place the catheter|1
4737144|NCT01882088|16339756|P1|Overall Study|Intolerance of esophageal manometry|1
4737145|NCT01881776|16339838|P3|Overall Study|Protocol Violation|1
4737146|NCT01881776|16339839|P2|Overall Study|Protocol Violation|2
4737147|NCT01881776|16339840|P1|Overall Study|Protocol Violation|0
4737148|NCT01881776|16339838|P3|Overall Study|Lost to Follow-up|1
4737149|NCT01881776|16339839|P2|Overall Study|Lost to Follow-up|2
4737150|NCT01881776|16339840|P1|Overall Study|Lost to Follow-up|1
4737151|NCT01881750|16339868|P2|Overall Study|Lost to Follow-up|1
4737152|NCT01881750|16339869|P1|Overall Study|Lost to Follow-up|0
4737153|NCT01881750|16339868|P2|Overall Study|Changes in concomitant therapies|3
4737154|NCT01881750|16339869|P1|Overall Study|Changes in concomitant therapies|2
4737155|NCT01881737|16339887|P1|Overall Study|Worsening of baseline behavior|1
4737156|NCT01881737|16339887|P1|Overall Study|Withdrawal by Subject|1
4737157|NCT01881737|16339887|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
4737158|NCT01881620|16339896|P1|Overall Study|Protocol Violation|4
4737159|NCT01881230|16339976|P3|Overall Study|Untreated: Withdrawal Before Study Start|0
4737160|NCT01881230|16339977|P2|Overall Study|Untreated: Withdrawal Before Study Start|0
4737161|NCT01881230|16339978|P1|Overall Study|Untreated: Withdrawal Before Study Start|1
4737162|NCT01881230|16339976|P3|Overall Study|Untreated: Death|1
4737163|NCT01881230|16339977|P2|Overall Study|Untreated: Death|0
4737164|NCT01881230|16339978|P1|Overall Study|Untreated: Death|0
4737165|NCT01881230|16339976|P3|Overall Study|Untreated: Other|1
4737166|NCT01881230|16339977|P2|Overall Study|Untreated: Other|0
4737167|NCT01881230|16339978|P1|Overall Study|Untreated: Other|0
4737168|NCT01881230|16339976|P3|Overall Study|Miscellaneous|0
4737169|NCT01881230|16339977|P2|Overall Study|Miscellaneous|3
4737170|NCT01881230|16339978|P1|Overall Study|Miscellaneous|3
4737171|NCT01881230|16339976|P3|Overall Study|Protocol Violation|0
4737172|NCT01881230|16339977|P2|Overall Study|Protocol Violation|1
4737173|NCT01881230|16339978|P1|Overall Study|Protocol Violation|1
4737174|NCT01881230|16339976|P3|Overall Study|Given Commercially Available Drug|2
4737175|NCT01881230|16339977|P2|Overall Study|Given Commercially Available Drug|0
4737176|NCT01881230|16339978|P1|Overall Study|Given Commercially Available Drug|0
4737177|NCT01881230|16339976|P3|Overall Study|Non-Compliance with Study Drug|0
4737178|NCT01881230|16339977|P2|Overall Study|Non-Compliance with Study Drug|2
4737179|NCT01881230|16339978|P1|Overall Study|Non-Compliance with Study Drug|1
4737180|NCT01881230|16339976|P3|Overall Study|Physician Decision|6
4737181|NCT01881230|16339977|P2|Overall Study|Physician Decision|3
4737182|NCT01881230|16339978|P1|Overall Study|Physician Decision|4
4737183|NCT01881230|16339976|P3|Overall Study|Withdrawal by Subject|6
4737184|NCT01881230|16339977|P2|Overall Study|Withdrawal by Subject|4
4737185|NCT01881230|16339978|P1|Overall Study|Withdrawal by Subject|6
4737186|NCT01881230|16339976|P3|Overall Study|Symptomatic Deterioration|1
4737187|NCT01881230|16339977|P2|Overall Study|Symptomatic Deterioration|3
4737188|NCT01881230|16339978|P1|Overall Study|Symptomatic Deterioration|3
4737189|NCT01881230|16339976|P3|Overall Study|Progressive Disease|36
4737190|NCT01881230|16339977|P2|Overall Study|Progressive Disease|35
4737191|NCT01881230|16339978|P1|Overall Study|Progressive Disease|31
4737192|NCT01881230|16339976|P3|Overall Study|Adverse Event|12
4737193|NCT01881230|16339977|P2|Overall Study|Adverse Event|13
4737194|NCT01881230|16339978|P1|Overall Study|Adverse Event|9
4737195|NCT01881230|16339976|P3|Overall Study|Death|1
4737196|NCT01881230|16339977|P2|Overall Study|Death|0
4737197|NCT01881230|16339978|P1|Overall Study|Death|2
4737198|NCT01881126|16340006|P2|Overall Study|Adverse Event|1
4737199|NCT01881126|16340007|P1|Overall Study|Adverse Event|0
4737200|NCT01881126|16340006|P2|Overall Study|Non-compliance|1
4737201|NCT01881126|16340007|P1|Overall Study|Non-compliance|1
4737202|NCT01881009|16340088|P2|Summer Camp Session (6 Days)|Unable to wear device|1
4737203|NCT01881009|16340089|P1|Summer Camp Session (6 Days)|Unable to wear device|0
4737204|NCT01880736|16340111|P4|Overall Study|Withdrawal Criteria|5
4737205|NCT01880736|16340112|P3|Overall Study|Withdrawal Criteria|1
4737206|NCT01880736|16340113|P2|Overall Study|Withdrawal Criteria|2
4737207|NCT01880736|16340114|P1|Overall Study|Withdrawal Criteria|1
4737208|NCT01880736|16340111|P4|Overall Study|Adverse Event|1
4737209|NCT01880736|16340112|P3|Overall Study|Adverse Event|0
4737210|NCT01880736|16340113|P2|Overall Study|Adverse Event|0
4737211|NCT01880736|16340114|P1|Overall Study|Adverse Event|0
4737212|NCT01880593|16340198|P2|Overall Study|Withdrawal by Subject|1
4737213|NCT01880593|16340199|P1|Overall Study|Withdrawal by Subject|6
4737214|NCT01880593|16340198|P2|Overall Study|Lack of Efficacy|5
4737215|NCT01880593|16340199|P1|Overall Study|Lack of Efficacy|1
4737216|NCT01880593|16340198|P2|Overall Study|Adverse Event|0
4737217|NCT01880593|16340199|P1|Overall Study|Adverse Event|1
4737218|NCT01880528|16340219|P2|Overall Study|Other|1
4737219|NCT01880528|16340220|P1|Overall Study|Other|1
4737220|NCT01880515|16340236|P2|Overall Study|Disease Progression|7
4737221|NCT01880515|16340237|P1|Overall Study|Disease Progression|5
4737222|NCT01880515|16340236|P2|Overall Study|Lost to Follow-up|2
4737223|NCT01880515|16340237|P1|Overall Study|Lost to Follow-up|3
4737224|NCT01880437|16340248|P3|Overall Study|Study terminated by Sponsor|2
4737225|NCT01880437|16340249|P2|Overall Study|Study terminated by Sponsor|0
4737226|NCT01880437|16340250|P1|Overall Study|Study terminated by Sponsor|3
4737227|NCT01880437|16340248|P3|Overall Study|Death|17
4737228|NCT01880437|16340249|P2|Overall Study|Death|4
4737229|NCT01880437|16340250|P1|Overall Study|Death|12
4737230|NCT01880424|16340276|P2|Overall Study|Other|0
4737231|NCT01880424|16340277|P1|Overall Study|Other|1
4737232|NCT01880424|16340276|P2|Overall Study|Withdrawal by Subject|30
4737233|NCT01880424|16340277|P1|Overall Study|Withdrawal by Subject|10
4737234|NCT01880424|16340276|P2|Overall Study|Protocol Violation|13
4737235|NCT01880424|16340277|P1|Overall Study|Protocol Violation|11
4737236|NCT01880424|16340276|P2|Overall Study|Lost to Follow-up|2
4737237|NCT01880424|16340277|P1|Overall Study|Lost to Follow-up|3
4737238|NCT01880424|16340276|P2|Overall Study|Lack of Efficacy|4
4737239|NCT01880424|16340277|P1|Overall Study|Lack of Efficacy|1
4737240|NCT01880424|16340276|P2|Overall Study|Adverse Event|6
4737241|NCT01880424|16340277|P1|Overall Study|Adverse Event|7
4737242|NCT01880086|16340333|P2|Overall Study|Lost to Follow-up|1
4737243|NCT01880086|16340334|P1|Overall Study|Lost to Follow-up|1
4737244|NCT01879852|16340389|P2|Overall Study|Withdrawal by Subject|0
4737245|NCT01879852|16340390|P1|Overall Study|Withdrawal by Subject|2
4737246|NCT01879722|16340445|P10|Overall Study|Voluntary Withdrawal|0
4737247|NCT01879722|16340446|P9|Overall Study|Voluntary Withdrawal|1
4737248|NCT01879722|16340447|P8|Overall Study|Voluntary Withdrawal|0
4737249|NCT01879722|16340448|P7|Overall Study|Voluntary Withdrawal|0
4737250|NCT01879722|16340449|P6|Overall Study|Voluntary Withdrawal|0
4737251|NCT01879722|16340450|P5|Overall Study|Voluntary Withdrawal|0
4737252|NCT01879722|16340451|P4|Overall Study|Voluntary Withdrawal|0
4737253|NCT01879722|16340452|P3|Overall Study|Voluntary Withdrawal|0
4737254|NCT01879722|16340453|P2|Overall Study|Voluntary Withdrawal|0
4737255|NCT01879722|16340454|P1|Overall Study|Voluntary Withdrawal|0
4737256|NCT01879722|16340445|P10|Overall Study|Pretreatment Event/Adverse Event|0
4737257|NCT01879722|16340446|P9|Overall Study|Pretreatment Event/Adverse Event|1
4737258|NCT01879722|16340447|P8|Overall Study|Pretreatment Event/Adverse Event|1
4737259|NCT01879722|16340448|P7|Overall Study|Pretreatment Event/Adverse Event|0
4737260|NCT01879722|16340449|P6|Overall Study|Pretreatment Event/Adverse Event|0
4737261|NCT01879722|16340450|P5|Overall Study|Pretreatment Event/Adverse Event|1
4737262|NCT01879722|16340451|P4|Overall Study|Pretreatment Event/Adverse Event|1
4737263|NCT01879722|16340452|P3|Overall Study|Pretreatment Event/Adverse Event|0
4737264|NCT01879722|16340453|P2|Overall Study|Pretreatment Event/Adverse Event|1
4737265|NCT01879722|16340454|P1|Overall Study|Pretreatment Event/Adverse Event|0
4737266|NCT01879683|16340602|P1|Overall Study|Did not Complete 4-week Follow-up Visit|1
4737267|NCT01879618|16340609|P1|Overall Study|Adverse Event|5
4737268|NCT01879618|16340609|P1|Overall Study|Protocol Violation|6
4737269|NCT01879618|16340609|P1|Overall Study|Surgery;changed schedule; not available|8
4737270|NCT01879618|16340609|P1|Overall Study|Withdrawal by Subject|1
4737271|NCT01879618|16340609|P1|Overall Study|Does not meet entrance criteria|1
4737272|NCT01879579|16340616|P2|Overall Study|Discontinued insulin - possible allergy|1
4737273|NCT01879579|16340617|P1|Overall Study|Discontinued insulin - possible allergy|0
4737274|NCT01879579|16340616|P2|Overall Study|Phenotypic type 1 diabetes|1
4737275|NCT01879579|16340617|P1|Overall Study|Phenotypic type 1 diabetes|0
4737276|NCT01879579|16340616|P2|Overall Study|Did not initiate insulin treatment|0
4737277|NCT01879579|16340617|P1|Overall Study|Did not initiate insulin treatment|1
4737278|NCT01879579|16340616|P2|Overall Study|Did not enroll in texting platform|0
4737279|NCT01879579|16340617|P1|Overall Study|Did not enroll in texting platform|1
4737280|NCT01879579|16340616|P2|Overall Study|Phone incompatible with texting platform|0
4737281|NCT01879579|16340617|P1|Overall Study|Phone incompatible with texting platform|3
4737282|NCT01879553|16340647|P2|Overall Study|Withdrawal by Subject|0
4737283|NCT01879553|16340648|P1|Overall Study|Withdrawal by Subject|1
4737284|NCT01879410|16340682|P2|Overall Study|Randomised in Error|2
4737285|NCT01879410|16340683|P1|Overall Study|Randomised in Error|1
4737286|NCT01879410|16340682|P2|Overall Study|Withdrawal by Subject|8
4737287|NCT01879410|16340683|P1|Overall Study|Withdrawal by Subject|7
4737288|NCT01879410|16340682|P2|Overall Study|Lost to Follow-up|1
4737289|NCT01879410|16340683|P1|Overall Study|Lost to Follow-up|2
4737290|NCT01879410|16340682|P2|Overall Study|Protocol Violation|7
4737291|NCT01879410|16340683|P1|Overall Study|Protocol Violation|1
4737292|NCT01879410|16340682|P2|Overall Study|Lack of Efficacy|6
4737293|NCT01879410|16340683|P1|Overall Study|Lack of Efficacy|4
4737294|NCT01879410|16340682|P2|Overall Study|Adverse Event|14
4737295|NCT01879410|16340683|P1|Overall Study|Adverse Event|9
4737296|NCT01879319|16340750|P2|Overall Study|Lost to Follow-up|5
4737297|NCT01879319|16340751|P1|Overall Study|Lost to Follow-up|1
4737298|NCT01879319|16340750|P2|Overall Study|Withdrawal by Subject|0
4737299|NCT01879319|16340751|P1|Overall Study|Withdrawal by Subject|1
4737300|NCT01879072|16340768|P1|Overall Study|Not Transplanted|30
4737301|NCT01879072|16340768|P1|Overall Study|Withdrawal by Subject|121
4737302|NCT01878383|16340912|P2|Overall Study|Lost to Follow-up|1499
4737303|NCT01878383|16340913|P1|Overall Study|Lost to Follow-up|0
4737304|NCT01878292|16340923|P3|Double-blind Down-Taper Period|Withdrawal by Subject|4
4737305|NCT01878292|16340924|P2|Double-blind Down-Taper Period|Withdrawal by Subject|8
4737306|NCT01878292|16340925|P1|Double-blind Down-Taper Period|Withdrawal by Subject|5
4737307|NCT01878292|16340923|P3|Double-blind Treatment Period|Adverse Event|8
4737308|NCT01878292|16340924|P2|Double-blind Treatment Period|Adverse Event|9
4737309|NCT01878292|16340925|P1|Double-blind Treatment Period|Adverse Event|4
4737310|NCT01878292|16340923|P3|Double-blind Treatment Period|Lack of Efficacy|0
4737311|NCT01878292|16340924|P2|Double-blind Treatment Period|Lack of Efficacy|3
4737312|NCT01878292|16340925|P1|Double-blind Treatment Period|Lack of Efficacy|5
4737313|NCT01878292|16340923|P3|Double-blind Treatment Period|Protocol Violation|2
4737314|NCT01878292|16340924|P2|Double-blind Treatment Period|Protocol Violation|4
4737315|NCT01878292|16340925|P1|Double-blind Treatment Period|Protocol Violation|3
4737316|NCT01878292|16340923|P3|Double-blind Treatment Period|Withdrawal by Subject|8
4737317|NCT01878292|16340924|P2|Double-blind Treatment Period|Withdrawal by Subject|7
4737318|NCT01878292|16340925|P1|Double-blind Treatment Period|Withdrawal by Subject|9
4737319|NCT01878292|16340923|P3|Double-blind Treatment Period|Lost to Follow-up|1
4737320|NCT01878292|16340924|P2|Double-blind Treatment Period|Lost to Follow-up|3
4737321|NCT01878292|16340925|P1|Double-blind Treatment Period|Lost to Follow-up|6
4737322|NCT01878292|16340923|P3|Double-blind Treatment Period|Other Reasons|0
4737323|NCT01878292|16340924|P2|Double-blind Treatment Period|Other Reasons|0
4737324|NCT01878292|16340925|P1|Double-blind Treatment Period|Other Reasons|2
4737325|NCT01878292|16340923|P3|Randomized|Adverse Event|0
4737326|NCT01878292|16340924|P2|Randomized|Adverse Event|0
4737327|NCT01878292|16340925|P1|Randomized|Adverse Event|1
4737328|NCT01878292|16340923|P3|Randomized|Lost to Follow-up|0
4737329|NCT01878292|16340924|P2|Randomized|Lost to Follow-up|0
4737330|NCT01878292|16340925|P1|Randomized|Lost to Follow-up|1
4737331|NCT01878292|16340923|P3|Randomized|Protocol Violation|0
4737332|NCT01878292|16340924|P2|Randomized|Protocol Violation|0
4737333|NCT01878292|16340925|P1|Randomized|Protocol Violation|1
4737334|NCT01878253|16340936|P1|Overall Study|Completed Study w/o Follow-up Data|2
4737335|NCT01878253|16340936|P1|Overall Study|Lost to Follow-up|2
4737336|NCT01878253|16340936|P1|Overall Study|Withdrawal by Subject|1
4737337|NCT01878253|16340936|P1|Overall Study|SIdus System Removal|3
4737338|NCT01878253|16340936|P1|Overall Study|Death|1
4737339|NCT01878214|16340947|P2|Overall Study|Lost to Follow-up|36
4737340|NCT01878214|16340948|P1|Overall Study|Lost to Follow-up|35
4737341|NCT01878214|16340947|P2|Overall Study|Death|1
4737342|NCT01878214|16340948|P1|Overall Study|Death|0
4737343|NCT01878214|16340947|P2|Overall Study|Withdrawal by Subject|7
4737344|NCT01878214|16340948|P1|Overall Study|Withdrawal by Subject|18
4737345|NCT01878175|16340962|P1|Overall Study|Developed contraindicated health problem|2
4737346|NCT01878149|16340981|P2|Overall Study|Did Not Meet Eligibility Criteria|2
4737347|NCT01878149|16340982|P1|Overall Study|Did Not Meet Eligibility Criteria|2
4737348|NCT01878097|16340990|P2|Implementation Year 4|Surveys not fully completed|3007
4737349|NCT01878097|16340991|P1|Implementation Year 4|Surveys not fully completed|3604
4737350|NCT01878097|16340990|P2|Implementation Year 3|Surveys not fully completed|2980
4737351|NCT01878097|16340991|P1|Implementation Year 3|Surveys not fully completed|3494
4737352|NCT01878097|16340990|P2|Implementation Year 2|Surveys not fully completed|2841
4737353|NCT01878097|16340991|P1|Implementation Year 2|Surveys not fully completed|3281
4737354|NCT01878097|16340990|P2|Implementation Year 1|Surveys not fully completed|2549
4737355|NCT01878097|16340991|P1|Implementation Year 1|Surveys not fully completed|3202
4737356|NCT01878097|16340990|P2|Baseline|Surveys not fully completed|1800
4737357|NCT01878097|16340991|P1|Baseline|Surveys not fully completed|2497
4737358|NCT01878084|16340999|P1|Overall Study|Physician Decision|2
4737359|NCT01877915|16341033|P2|Overall Study|Other|4
4737360|NCT01877915|16341034|P1|Overall Study|Other|2
4737361|NCT01877915|16341033|P2|Overall Study|Withdrawal by Subject|55
4737362|NCT01877915|16341034|P1|Overall Study|Withdrawal by Subject|42
4737363|NCT01877915|16341033|P2|Overall Study|Lost to Follow-up|9
4737364|NCT01877915|16341034|P1|Overall Study|Lost to Follow-up|10
4737365|NCT01877720|16341056|P2|Overall Study|Adverse Event|0
4737366|NCT01877720|16341057|P1|Overall Study|Adverse Event|1
4737367|NCT01877668|16341086|P5|Overall Study|Adverse event unrelated to study drug|1
4737368|NCT01877668|16341087|P4|Overall Study|Adverse event unrelated to study drug|0
4737369|NCT01877668|16341088|P3|Overall Study|Adverse event unrelated to study drug|2
4737370|NCT01877668|16341089|P2|Overall Study|Adverse event unrelated to study drug|1
4737371|NCT01877668|16341090|P1|Overall Study|Adverse event unrelated to study drug|4
4737372|NCT01877668|16341086|P5|Overall Study|Adverse event related to study drug|1
4737373|NCT01877668|16341087|P4|Overall Study|Adverse event related to study drug|2
4737374|NCT01877668|16341088|P3|Overall Study|Adverse event related to study drug|2
4737375|NCT01877668|16341089|P2|Overall Study|Adverse event related to study drug|2
4737376|NCT01877668|16341090|P1|Overall Study|Adverse event related to study drug|2
4737377|NCT01877668|16341086|P5|Overall Study|Protocol Violation|3
4737378|NCT01877668|16341087|P4|Overall Study|Protocol Violation|0
4737379|NCT01877668|16341088|P3|Overall Study|Protocol Violation|0
4737380|NCT01877668|16341089|P2|Overall Study|Protocol Violation|1
4737381|NCT01877668|16341090|P1|Overall Study|Protocol Violation|1
4737382|NCT01877668|16341086|P5|Overall Study|Other|3
4737383|NCT01877668|16341087|P4|Overall Study|Other|1
4737384|NCT01877668|16341088|P3|Overall Study|Other|1
4737385|NCT01877668|16341089|P2|Overall Study|Other|1
4737386|NCT01877668|16341090|P1|Overall Study|Other|1
4737387|NCT01877668|16341086|P5|Overall Study|Withdrawal by Subject|2
4737388|NCT01877668|16341087|P4|Overall Study|Withdrawal by Subject|2
4737389|NCT01877668|16341088|P3|Overall Study|Withdrawal by Subject|3
4737390|NCT01877668|16341089|P2|Overall Study|Withdrawal by Subject|0
4737391|NCT01877668|16341090|P1|Overall Study|Withdrawal by Subject|2
4737392|NCT01877668|16341086|P5|Overall Study|Lost to Follow-up|0
4737393|NCT01877668|16341087|P4|Overall Study|Lost to Follow-up|0
4737394|NCT01877668|16341088|P3|Overall Study|Lost to Follow-up|1
4737395|NCT01877668|16341089|P2|Overall Study|Lost to Follow-up|2
4737396|NCT01877668|16341090|P1|Overall Study|Lost to Follow-up|0
4737397|NCT01877668|16341086|P5|Overall Study|Insufficient clinical response|0
4737398|NCT01877668|16341087|P4|Overall Study|Insufficient clinical response|2
4737399|NCT01877668|16341088|P3|Overall Study|Insufficient clinical response|2
4737400|NCT01877668|16341089|P2|Overall Study|Insufficient clinical response|1
4737401|NCT01877668|16341090|P1|Overall Study|Insufficient clinical response|0
4737402|NCT01877668|16341086|P5|Overall Study|No longer met study criteria|0
4737403|NCT01877668|16341087|P4|Overall Study|No longer met study criteria|0
4737404|NCT01877668|16341088|P3|Overall Study|No longer met study criteria|1
4737405|NCT01877668|16341089|P2|Overall Study|No longer met study criteria|0
4737406|NCT01877668|16341090|P1|Overall Study|No longer met study criteria|1
4737407|NCT01877668|16341086|P5|Overall Study|Death|0
4737408|NCT01877668|16341087|P4|Overall Study|Death|1
4737409|NCT01877668|16341088|P3|Overall Study|Death|0
4737410|NCT01877668|16341089|P2|Overall Study|Death|0
4737411|NCT01877668|16341090|P1|Overall Study|Death|0
4737412|NCT01877551|16341359|P2|Overall Study|Physician Decision|1
4737413|NCT01877551|16341360|P1|Overall Study|Physician Decision|0
4737414|NCT01877421|16341409|P18|Phase 2|Protocol Violation|0
4737415|NCT01877421|16341410|P17|Phase 2|Protocol Violation|0
4737416|NCT01877421|16341411|P16|Phase 2|Protocol Violation|0
4737417|NCT01877421|16341412|P15|Phase 2|Protocol Violation|0
4737418|NCT01877421|16341413|P14|Phase 2|Protocol Violation|0
4737419|NCT01877421|16341414|P13|Phase 2|Protocol Violation|0
4737420|NCT01877421|16341415|P12|Phase 2|Protocol Violation|0
4737421|NCT01877421|16341416|P11|Phase 2|Protocol Violation|1
4737422|NCT01877421|16341417|P10|Phase 2|Protocol Violation|0
4737423|NCT01877421|16341418|P9|Phase 2|Protocol Violation|0
4737424|NCT01877421|16341419|P8|Phase 2|Protocol Violation|0
4737425|NCT01877421|16341420|P7|Phase 2|Protocol Violation|0
4737426|NCT01877421|16341421|P6|Phase 2|Protocol Violation|0
4737427|NCT01877421|16341422|P5|Phase 2|Protocol Violation|0
4737428|NCT01877421|16341423|P4|Phase 2|Protocol Violation|0
4737429|NCT01877421|16341424|P3|Phase 2|Protocol Violation|0
4737430|NCT01877421|16341425|P2|Phase 2|Protocol Violation|0
4737431|NCT01877421|16341426|P1|Phase 2|Protocol Violation|0
4737432|NCT01877421|16341409|P18|Phase 2|Withdrawal by Subject|0
4737433|NCT01877421|16341410|P17|Phase 2|Withdrawal by Subject|0
4737434|NCT01877421|16341411|P16|Phase 2|Withdrawal by Subject|1
4737435|NCT01877421|16341412|P15|Phase 2|Withdrawal by Subject|0
4737436|NCT01877421|16341413|P14|Phase 2|Withdrawal by Subject|0
4737437|NCT01877421|16341414|P13|Phase 2|Withdrawal by Subject|1
4737438|NCT01877421|16341415|P12|Phase 2|Withdrawal by Subject|0
4737439|NCT01877421|16341416|P11|Phase 2|Withdrawal by Subject|1
4737440|NCT01877421|16341417|P10|Phase 2|Withdrawal by Subject|0
4737441|NCT01877421|16341418|P9|Phase 2|Withdrawal by Subject|1
4737442|NCT01877421|16341419|P8|Phase 2|Withdrawal by Subject|0
4737443|NCT01877421|16341420|P7|Phase 2|Withdrawal by Subject|0
4737444|NCT01877421|16341421|P6|Phase 2|Withdrawal by Subject|0
4737445|NCT01877421|16341422|P5|Phase 2|Withdrawal by Subject|0
4737446|NCT01877421|16341423|P4|Phase 2|Withdrawal by Subject|0
4737447|NCT01877421|16341424|P3|Phase 2|Withdrawal by Subject|0
4737448|NCT01877421|16341425|P2|Phase 2|Withdrawal by Subject|0
4737449|NCT01877421|16341426|P1|Phase 2|Withdrawal by Subject|0
4737450|NCT01877421|16341409|P18|Phase 2|Lost to Follow-up|0
4737451|NCT01877421|16341410|P17|Phase 2|Lost to Follow-up|0
4737452|NCT01877421|16341411|P16|Phase 2|Lost to Follow-up|0
4737453|NCT01877421|16341412|P15|Phase 2|Lost to Follow-up|0
4737454|NCT01877421|16341413|P14|Phase 2|Lost to Follow-up|0
4737455|NCT01877421|16341414|P13|Phase 2|Lost to Follow-up|0
4737456|NCT01877421|16341415|P12|Phase 2|Lost to Follow-up|0
4737457|NCT01877421|16341416|P11|Phase 2|Lost to Follow-up|0
4737458|NCT01877421|16341417|P10|Phase 2|Lost to Follow-up|0
4737459|NCT01877421|16341418|P9|Phase 2|Lost to Follow-up|0
4737460|NCT01877421|16341419|P8|Phase 2|Lost to Follow-up|0
4737461|NCT01877421|16341420|P7|Phase 2|Lost to Follow-up|1
4737462|NCT01877421|16341421|P6|Phase 2|Lost to Follow-up|0
4737463|NCT01877421|16341422|P5|Phase 2|Lost to Follow-up|0
4737464|NCT01877421|16341423|P4|Phase 2|Lost to Follow-up|0
4737465|NCT01877421|16341424|P3|Phase 2|Lost to Follow-up|0
4737466|NCT01877421|16341425|P2|Phase 2|Lost to Follow-up|0
4737467|NCT01877421|16341426|P1|Phase 2|Lost to Follow-up|0
4737468|NCT01877408|16341536|P2|Overall Study|Lost to Follow-up|2
4737469|NCT01877408|16341537|P1|Overall Study|Lost to Follow-up|0
4737470|NCT01877278|16341570|P2|Overall Study|Lost to Follow-up|3
4737471|NCT01877278|16341571|P1|Overall Study|Lost to Follow-up|3
4737472|NCT01877265|16341579|P6|Treatment Period 3|Lost to Follow-up|0
4737473|NCT01877265|16341580|P5|Treatment Period 3|Lost to Follow-up|0
4737474|NCT01877265|16341581|P4|Treatment Period 3|Lost to Follow-up|0
4737475|NCT01877265|16341582|P3|Treatment Period 3|Lost to Follow-up|0
4737476|NCT01877265|16341583|P2|Treatment Period 3|Lost to Follow-up|0
4737477|NCT01877265|16341584|P1|Treatment Period 3|Lost to Follow-up|1
4737478|NCT01877265|16341579|P6|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1
4737479|NCT01877265|16341580|P5|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4737480|NCT01877265|16341581|P4|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4737481|NCT01877265|16341582|P3|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4737482|NCT01877265|16341583|P2|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4737483|NCT01877265|16341584|P1|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0
4737484|NCT01877265|16341579|P6|Treatment Period 1|Sponsor Decision|0
4737485|NCT01877265|16341580|P5|Treatment Period 1|Sponsor Decision|0
4737486|NCT01877265|16341581|P4|Treatment Period 1|Sponsor Decision|0
4737487|NCT01877265|16341582|P3|Treatment Period 1|Sponsor Decision|1
4737488|NCT01877265|16341583|P2|Treatment Period 1|Sponsor Decision|0
4737489|NCT01877265|16341584|P1|Treatment Period 1|Sponsor Decision|0
4737490|NCT01877239|16341601|P1|Overall Study|Data not available|35
4737491|NCT01877239|16341601|P1|Overall Study|Lack of Efficacy|4
4737492|NCT01877239|16341601|P1|Overall Study|Other|2
4737493|NCT01877239|16341601|P1|Overall Study|Withdrawal by Subject|4
4737494|NCT01877239|16341601|P1|Overall Study|Disease Remission|1
4737495|NCT01877239|16341601|P1|Overall Study|Adverse Event|4
4737496|NCT01877187|16341607|P1|Overall Study|Liver transplant|2
4737497|NCT01877187|16341607|P1|Overall Study|Declining clinical status|11
4737498|NCT01877187|16341607|P1|Overall Study|Lost to Follow-up|3
4737499|NCT01877187|16341607|P1|Overall Study|Withdrawal by Subject|4
4737500|NCT01877187|16341607|P1|Overall Study|Death|2
4737501|NCT01877083|16341659|P1|Extension Phase|Adverse Event|2
4737502|NCT01877083|16341659|P1|Extension Phase|Disease Progression|3
4737503|NCT01877083|16341659|P1|Treatment Phase|Lost to Follow-up|1
4737504|NCT01877083|16341659|P1|Treatment Phase|Withdrawal by Subject|2
4737505|NCT01877083|16341659|P1|Treatment Phase|Adverse Event|6
4737506|NCT01877083|16341659|P1|Treatment Phase|Clinical Progression|1
4737507|NCT01877083|16341659|P1|Treatment Phase|Disease Progression|10
4737508|NCT01876979|16341683|P2|Overall Study|Physician Decision|3
4737509|NCT01876979|16341684|P1|Overall Study|Physician Decision|2
4737510|NCT01876823|16341690|P1|Overall Study|Patients moved|2
4737511|NCT01876823|16341690|P1|Overall Study|Physician Decision|2
4737512|NCT01876823|16341690|P1|Overall Study|Withdrawal by Subject|5
4737513|NCT01876810|16341703|P2|Overall Study|Physician Decision|1
4737514|NCT01876810|16341704|P1|Overall Study|Physician Decision|0
4737515|NCT01876784|16341716|P2|Overall Study|Ongoing|40
4737516|NCT01876784|16341717|P1|Overall Study|Ongoing|41
4737517|NCT01876784|16341716|P2|Overall Study|Other than specified above|6
4737518|NCT01876784|16341717|P1|Overall Study|Other than specified above|5
4737519|NCT01876784|16341716|P2|Overall Study|Randomized but not treated|1
4737520|NCT01876784|16341717|P1|Overall Study|Randomized but not treated|2
4737521|NCT01876784|16341716|P2|Overall Study|Death|0
4737522|NCT01876784|16341717|P1|Overall Study|Death|1
4737523|NCT01876784|16341716|P2|Overall Study|Lost to Follow-up|1
4737524|NCT01876784|16341717|P1|Overall Study|Lost to Follow-up|0
4737525|NCT01876784|16341716|P2|Overall Study|Disease progression|67
4737526|NCT01876784|16341717|P1|Overall Study|Disease progression|37
4737527|NCT01876784|16341716|P2|Overall Study|Protocol Violation|0
4737528|NCT01876784|16341717|P1|Overall Study|Protocol Violation|1
4737529|NCT01876784|16341716|P2|Overall Study|Adverse Event|2
4737530|NCT01876784|16341717|P1|Overall Study|Adverse Event|15
4737531|NCT01876784|16341716|P2|Overall Study|Withdrawal by Subject|2
4737532|NCT01876784|16341717|P1|Overall Study|Withdrawal by Subject|17
4737533|NCT01876732|16341723|P1|Overall Study|MMA was not over 800mg/dL|75
4737534|NCT01876706|16341728|P1|Overall Study|Death|3
4737535|NCT01876706|16341728|P1|Overall Study|Withdrawals|6
4737536|NCT01876706|16341728|P1|Overall Study|Lost to Follow-up|7
4737537|NCT01876706|16341728|P1|Overall Study|BPH Intervention|9
4737538|NCT01876511|16341748|P3|Overall Study|Physician Decision|1
4737539|NCT01876511|16341749|P2|Overall Study|Physician Decision|0
4737540|NCT01876511|16341750|P1|Overall Study|Physician Decision|1
4737541|NCT01876511|16341748|P3|Overall Study|Patient Decision|6
4737542|NCT01876511|16341749|P2|Overall Study|Patient Decision|0
4737543|NCT01876511|16341750|P1|Overall Study|Patient Decision|3
4737544|NCT01876511|16341748|P3|Overall Study|Drug-related Toxicity|6
4737545|NCT01876511|16341749|P2|Overall Study|Drug-related Toxicity|1
4737546|NCT01876511|16341750|P1|Overall Study|Drug-related Toxicity|5
4737547|NCT01876511|16341748|P3|Overall Study|Death (unrelated)|2
4737548|NCT01876511|16341749|P2|Overall Study|Death (unrelated)|0
4737549|NCT01876511|16341750|P1|Overall Study|Death (unrelated)|3
4737550|NCT01876511|16341748|P3|Overall Study|Disease Progression-clinical/radiologic|16
4737551|NCT01876511|16341749|P2|Overall Study|Disease Progression-clinical/radiologic|24
4737552|NCT01876511|16341750|P1|Overall Study|Disease Progression-clinical/radiologic|11
4737553|NCT01876446|16341798|P2|Overall Study|Physician Decision|3
4737554|NCT01876446|16341799|P1|Overall Study|Physician Decision|1
4737555|NCT01876446|16341798|P2|Overall Study|Withdrawal by Subject|2
4737556|NCT01876446|16341799|P1|Overall Study|Withdrawal by Subject|1
4737557|NCT01876446|16341798|P2|Overall Study|Death|1
4737558|NCT01876446|16341799|P1|Overall Study|Death|0
4737559|NCT01876420|16341815|P1|Overall Study|Missed 30 day visit|1
4737560|NCT01876381|16341827|P1|Overall Study|Withdrawal by Subject|1
4737561|NCT01876381|16341827|P1|Overall Study|Physician Decision|1
4737562|NCT01876381|16341827|P1|Overall Study|Lack of Efficacy|5
4737563|NCT01876368|16341834|P2|Overall Study|Subject/guardian decision|1
4737564|NCT01876368|16341835|P1|Overall Study|Subject/guardian decision|3
4737565|NCT01876368|16341834|P2|Overall Study|Protocol deviation|3
4737566|NCT01876368|16341835|P1|Overall Study|Protocol deviation|3
4737567|NCT01876368|16341834|P2|Overall Study|Physician Decision|2
4737568|NCT01876368|16341835|P1|Overall Study|Physician Decision|0
4737569|NCT01876368|16341834|P2|Overall Study|Non-compliance with study treatment|1
4737570|NCT01876368|16341835|P1|Overall Study|Non-compliance with study treatment|0
4737571|NCT01876368|16341834|P2|Overall Study|Lost to Follow-up|1
4737572|NCT01876368|16341835|P1|Overall Study|Lost to Follow-up|0
4737573|NCT01876368|16341834|P2|Overall Study|Lack of Efficacy|0
4737574|NCT01876368|16341835|P1|Overall Study|Lack of Efficacy|1
4737575|NCT01876368|16341834|P2|Overall Study|Adverse Event|5
4737576|NCT01876368|16341835|P1|Overall Study|Adverse Event|2
4737577|NCT01876251|16341880|P3|Overall Study|Objective progression or relapse|8
4737578|NCT01876251|16341881|P2|Overall Study|Objective progression or relapse|3
4737579|NCT01876251|16341882|P1|Overall Study|Objective progression or relapse|10
4737580|NCT01876251|16341880|P3|Overall Study|Study terminated|0
4737581|NCT01876251|16341881|P2|Overall Study|Study terminated|0
4737582|NCT01876251|16341882|P1|Overall Study|Study terminated|1
4737583|NCT01876251|16341880|P3|Overall Study|Participant refused further follow-up|1
4737584|NCT01876251|16341881|P2|Overall Study|Participant refused further follow-up|0
4737585|NCT01876251|16341882|P1|Overall Study|Participant refused further follow-up|0
4737586|NCT01876251|16341880|P3|Overall Study|Participant started new treatment|1
4737587|NCT01876251|16341881|P2|Overall Study|Participant started new treatment|0
4737588|NCT01876251|16341882|P1|Overall Study|Participant started new treatment|1
4737589|NCT01876251|16341880|P3|Overall Study|Death|1
4737590|NCT01876251|16341881|P2|Overall Study|Death|0
4737591|NCT01876251|16341882|P1|Overall Study|Death|2
4737592|NCT01876251|16341880|P3|Overall Study|Clinical progression|0
4737593|NCT01876251|16341881|P2|Overall Study|Clinical progression|0
4737594|NCT01876251|16341882|P1|Overall Study|Clinical progression|1
4737595|NCT01876043|16341986|P1|Overall Study|Withdrawal by Subject|1
4737596|NCT01876043|16341986|P1|Overall Study|Death|1
4737597|NCT01875991|16341998|P2|Overall Study|Sponsor Decision|0
4737598|NCT01875991|16341999|P1|Overall Study|Sponsor Decision|1
4737599|NCT01875991|16341998|P2|Overall Study|Withdrawal by Subject|6
4737600|NCT01875991|16341999|P1|Overall Study|Withdrawal by Subject|6
4737601|NCT01875874|16342035|P1|Overall Study|Death|3
4737602|NCT01875848|16342055|P2|Overall Study|Withdrawal by Subject|0
4737603|NCT01875848|16342056|P1|Overall Study|Withdrawal by Subject|2
4737604|NCT01875731|16342073|P2|Overall Study|Fail to obtain lab sample|0
4737605|NCT01875731|16342074|P1|Overall Study|Fail to obtain lab sample|1
4737606|NCT01875471|16342093|P2|Overall Study|Unsatisfactory Lens Fitting|0
4737607|NCT01875471|16342094|P1|Overall Study|Unsatisfactory Lens Fitting|1
4737608|NCT01875471|16342093|P2|Overall Study|Adverse Event|1
4737609|NCT01875471|16342094|P1|Overall Study|Adverse Event|0
4737610|NCT01875445|16342102|P2|Overall Study|Withdrawal by Subject|0
4737611|NCT01875445|16342103|P1|Overall Study|Withdrawal by Subject|2
4737612|NCT01875445|16342102|P2|Overall Study|Lost to Follow-up|0
4737613|NCT01875445|16342103|P1|Overall Study|Lost to Follow-up|5
4737614|NCT01875250|16342113|P2|Overall Study|Adverse Event|0
4737615|NCT01875250|16342114|P1|Overall Study|Adverse Event|2
4737616|NCT01875237|16342129|P2|Overall Study|DLI cells could not be produced|0
4737617|NCT01875237|16342130|P1|Overall Study|DLI cells could not be produced|1
4737618|NCT01875237|16342129|P2|Overall Study|GVDH before DLI|0
4737619|NCT01875237|16342130|P1|Overall Study|GVDH before DLI|1
4737620|NCT01875185|16342156|P2|Overall Study|study was terminated|48
4737621|NCT01875185|16342157|P1|Overall Study|study was terminated|52
4737622|NCT01874665|16342242|P2|Overall Study|Other|0
4737623|NCT01874665|16342243|P1|Overall Study|Other|2
4737624|NCT01874665|16342242|P2|Overall Study|Documented Progressive Disease|7
4737625|NCT01874665|16342243|P1|Overall Study|Documented Progressive Disease|11
4737626|NCT01874665|16342242|P2|Overall Study|Study Terminated by Sponsor|2
4737627|NCT01874665|16342243|P1|Overall Study|Study Terminated by Sponsor|0
4737628|NCT01874665|16342242|P2|Overall Study|Clinical Progressive Disease|3
4737629|NCT01874665|16342243|P1|Overall Study|Clinical Progressive Disease|4
4737630|NCT01874665|16342242|P2|Overall Study|Physician Decision|0
4737631|NCT01874665|16342243|P1|Overall Study|Physician Decision|3
4737632|NCT01874665|16342242|P2|Overall Study|Withdrawal by Subject|1
4737633|NCT01874665|16342243|P1|Overall Study|Withdrawal by Subject|4
4737634|NCT01874665|16342242|P2|Overall Study|Adverse Event|2
4737635|NCT01874665|16342243|P1|Overall Study|Adverse Event|6
4737636|NCT01874535|16342271|P2|Overall Study|incomplete symptom resolution|35
4737637|NCT01874535|16342272|P1|Overall Study|incomplete symptom resolution|45
4737638|NCT01874535|16342271|P2|Overall Study|Lost to Follow-up|9
4737639|NCT01874535|16342272|P1|Overall Study|Lost to Follow-up|10
4737640|NCT01874353|16342280|P2|Overall Study|Withdrawal by Subject|9
4737641|NCT01874353|16342281|P1|Overall Study|Withdrawal by Subject|7
4737642|NCT01874353|16342280|P2|Overall Study|Death|27
4737643|NCT01874353|16342281|P1|Overall Study|Death|45
4737644|NCT01874353|16342280|P2|Overall Study|Lost to Follow-up|1
4737645|NCT01874353|16342281|P1|Overall Study|Lost to Follow-up|1
4737646|NCT01874353|16342280|P2|Overall Study|Other|0
4737647|NCT01874353|16342281|P1|Overall Study|Other|2
4737648|NCT01874340|16342308|P4|Overall Study|Withdrawal by Subject|1
4737649|NCT01874340|16342309|P3|Overall Study|Withdrawal by Subject|0
4737650|NCT01874340|16342310|P2|Overall Study|Withdrawal by Subject|0
4737651|NCT01874340|16342311|P1|Overall Study|Withdrawal by Subject|0
4737652|NCT01874340|16342308|P4|Overall Study|Study terminated by Sponsor|4
4737653|NCT01874340|16342309|P3|Overall Study|Study terminated by Sponsor|8
4737654|NCT01874340|16342310|P2|Overall Study|Study terminated by Sponsor|8
4737655|NCT01874340|16342311|P1|Overall Study|Study terminated by Sponsor|6
4737656|NCT01874275|16342339|P2|Overall Study|Lost to Follow-up|0
4737657|NCT01874275|16342340|P1|Overall Study|Lost to Follow-up|1
4737658|NCT01874145|16342363|P2|Extension Period|Lost to Follow-up|1
4737659|NCT01874145|16342364|P1|Extension Period|Lost to Follow-up|1
4737660|NCT01874145|16342363|P2|Extension Period|Withdrawal by Subject|1
4737661|NCT01874145|16342364|P1|Extension Period|Withdrawal by Subject|2
4737662|NCT01874145|16342363|P2|Extension Period|Adverse Event|2
4737663|NCT01874145|16342364|P1|Extension Period|Adverse Event|3
4737664|NCT01874145|16342363|P2|Core Period|Withdrawal by Subject|4
4737665|NCT01874145|16342364|P1|Core Period|Withdrawal by Subject|0
4737666|NCT01874145|16342363|P2|Core Period|Adverse Event|1
4737667|NCT01874145|16342364|P1|Core Period|Adverse Event|0
4737668|NCT01874145|16342363|P2|Core Period|Physician Decision|1
4737669|NCT01874145|16342364|P1|Core Period|Physician Decision|1
4737670|NCT01874145|16342363|P2|Core Period|Protocol Violation|1
4737671|NCT01874145|16342364|P1|Core Period|Protocol Violation|1
4737672|NCT01874145|16342363|P2|Core Period|Non-compliance|0
4737673|NCT01874145|16342364|P1|Core Period|Non-compliance|1
4737674|NCT01874054|16342423|P1|Overall Study|Death|5
4737675|NCT01874054|16342423|P1|Overall Study|Lost to Follow-up|5
4737676|NCT01874054|16342423|P1|Overall Study|Study Termination by Sponsor|42
4737677|NCT01874054|16342423|P1|Overall Study|Withdrawal by Subject|3
4737678|NCT01873950|16342445|P5|Period 5|Withdrawal by Subject|0
4737679|NCT01873950|16342446|P4|Period 5|Withdrawal by Subject|1
4737680|NCT01873950|16342447|P3|Period 5|Withdrawal by Subject|0
4737681|NCT01873950|16342448|P2|Period 5|Withdrawal by Subject|0
4737682|NCT01873950|16342449|P1|Period 5|Withdrawal by Subject|0
4737683|NCT01873859|16342486|P2|Overall Study|Withdrawal by Subject|4
4737684|NCT01873859|16342487|P1|Overall Study|Withdrawal by Subject|0
4737685|NCT01873742|16342505|P2|Overall Study|Lost to Follow-up|76
4737686|NCT01873742|16342506|P1|Overall Study|Lost to Follow-up|68
4737687|NCT01873729|16342512|P1|Overall Study|Withdrawal by Subject|1
4737688|NCT01873586|16342517|P1|Overall Study|Lost to Follow-up|3
4737689|NCT01873495|16342530|P1|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1
4737690|NCT01873495|16342530|P1|Overall Study|Removed for Transplantation|1
4737691|NCT01873495|16342530|P1|Overall Study|Adverse Event|1
4737692|NCT01873495|16342530|P1|Overall Study|Physician Decision|3
4737693|NCT01873495|16342530|P1|Overall Study|Withdrawal by Subject|1
4737694|NCT01873417|16342538|P1|Overall Study|Physician Decision|3
4737695|NCT01873417|16342538|P1|Overall Study|Withdrawal by Subject|2
4737696|NCT01873417|16342538|P1|Overall Study|Lost to Follow-up|2
4737697|NCT01873417|16342538|P1|Overall Study|Adverse Event|24
4737698|NCT01873417|16342538|P1|Overall Study|Did Not Receive Any Study Drug|4
4737699|NCT01872910|16342566|P6|Overall Study|Lost to Follow-up|0
4737700|NCT01872910|16342567|P5|Overall Study|Lost to Follow-up|0
4737701|NCT01872910|16342568|P4|Overall Study|Lost to Follow-up|0
4737702|NCT01872910|16342569|P3|Overall Study|Lost to Follow-up|2
4737703|NCT01872910|16342570|P2|Overall Study|Lost to Follow-up|0
4737704|NCT01872910|16342571|P1|Overall Study|Lost to Follow-up|2
4737705|NCT01872715|16342616|P1|Overall Study|Withdrawal by Subject|2
4737706|NCT01872715|16342616|P1|Overall Study|Protocol Violation|1
4737707|NCT01872715|16342616|P1|Overall Study|Adverse Event|1
4737708|NCT01872689|16342635|P4|Open-Label Period (Only For Monotherapy)|Adverse Event|0
4737709|NCT01872689|16342636|P3|Open-Label Period (Only For Monotherapy)|Adverse Event|0
4737710|NCT01872689|16342637|P2|Open-Label Period (Only For Monotherapy)|Adverse Event|1
4737711|NCT01872689|16342638|P1|Open-Label Period (Only For Monotherapy)|Adverse Event|2
4737712|NCT01872689|16342635|P4|Open-Label Period (Only For Monotherapy)|Death|0
4737713|NCT01872689|16342636|P3|Open-Label Period (Only For Monotherapy)|Death|0
4737714|NCT01872689|16342637|P2|Open-Label Period (Only For Monotherapy)|Death|3
4737715|NCT01872689|16342638|P1|Open-Label Period (Only For Monotherapy)|Death|5
4737716|NCT01872689|16342635|P4|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
4737717|NCT01872689|16342636|P3|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0
4737718|NCT01872689|16342637|P2|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3
4737719|NCT01872689|16342638|P1|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1
4737720|NCT01872689|16342635|P4|Open-Label Period (Only For Monotherapy)|Physician Decision|0
4737721|NCT01872689|16342636|P3|Open-Label Period (Only For Monotherapy)|Physician Decision|0
4737722|NCT01872689|16342637|P2|Open-Label Period (Only For Monotherapy)|Physician Decision|1
4737723|NCT01872689|16342638|P1|Open-Label Period (Only For Monotherapy)|Physician Decision|0
4737724|NCT01872689|16342635|P4|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
4737725|NCT01872689|16342636|P3|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0
4737726|NCT01872689|16342637|P2|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12
4737727|NCT01872689|16342638|P1|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11
4737728|NCT01872689|16342635|P4|Open-Label Period (Only For Monotherapy)|Other|0
4737729|NCT01872689|16342636|P3|Open-Label Period (Only For Monotherapy)|Other|0
4737730|NCT01872689|16342637|P2|Open-Label Period (Only For Monotherapy)|Other|3
4737731|NCT01872689|16342638|P1|Open-Label Period (Only For Monotherapy)|Other|2
4737732|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Adverse Event|7
4737733|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Adverse Event|10
4737734|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Adverse Event|3
4737735|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Adverse Event|6
4737736|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Death|9
4737737|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Death|14
4737738|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Death|4
4737739|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Death|3
4737740|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
4737741|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
4737742|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0
4737743|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1
4737744|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Physician Decision|1
4737745|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Physician Decision|3
4737746|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Physician Decision|3
4737747|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Physician Decision|0
4737748|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
4737749|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Protocol Violation|1
4737750|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
4737751|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Protocol Violation|0
4737752|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16
4737753|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14
4737754|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8
4737755|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9
4737756|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Other|3
4737757|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Other|6
4737758|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Other|1
4737759|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Other|1
4737760|NCT01872689|16342635|P4|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
4737761|NCT01872689|16342636|P3|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
4737762|NCT01872689|16342637|P2|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1
4737763|NCT01872689|16342638|P1|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0
4737764|NCT01872611|16342714|P2|Overall Study|Reason not provided|6
4737765|NCT01872611|16342715|P1|Overall Study|Reason not provided|6
4737766|NCT01872611|16342714|P2|Overall Study|Withdrawal by Subject|1
4737767|NCT01872611|16342715|P1|Overall Study|Withdrawal by Subject|6
4737768|NCT01872611|16342714|P2|Overall Study|Physician Decision|0
4737769|NCT01872611|16342715|P1|Overall Study|Physician Decision|1
4737770|NCT01872611|16342714|P2|Overall Study|Lost to Follow-up|1
4737771|NCT01872611|16342715|P1|Overall Study|Lost to Follow-up|8
4737772|NCT01872611|16342714|P2|Overall Study|Death, prior to treatment|1
4737773|NCT01872611|16342715|P1|Overall Study|Death, prior to treatment|0
4737774|NCT01872611|16342714|P2|Overall Study|Death|1
4737775|NCT01872611|16342715|P1|Overall Study|Death|0
4737776|NCT01872611|16342714|P2|Overall Study|Adverse Event, prior to treatment|1
4737777|NCT01872611|16342715|P1|Overall Study|Adverse Event, prior to treatment|0
4737778|NCT01872611|16342714|P2|Overall Study|Adverse Event|1
4737779|NCT01872611|16342715|P1|Overall Study|Adverse Event|3
4737780|NCT01872078|16342752|P4|Overall Study|Patient met exclusion criterion 16.|1
4737781|NCT01872078|16342753|P3|Overall Study|Patient met exclusion criterion 16.|0
4737782|NCT01872078|16342754|P2|Overall Study|Patient met exclusion criterion 16.|0
4737783|NCT01872078|16342755|P1|Overall Study|Patient met exclusion criterion 16.|0
4737784|NCT01872078|16342752|P4|Overall Study|Withdrawal by Subject|0
4737785|NCT01872078|16342753|P3|Overall Study|Withdrawal by Subject|1
4737786|NCT01872078|16342754|P2|Overall Study|Withdrawal by Subject|0
4737787|NCT01872078|16342755|P1|Overall Study|Withdrawal by Subject|0
4737788|NCT01872078|16342752|P4|Overall Study|Protocol Violation|0
4737789|NCT01872078|16342753|P3|Overall Study|Protocol Violation|1
4737790|NCT01872078|16342754|P2|Overall Study|Protocol Violation|0
4737791|NCT01872078|16342755|P1|Overall Study|Protocol Violation|0
4737792|NCT01872078|16342752|P4|Overall Study|Dose administration non-compliance|1
4737793|NCT01872078|16342753|P3|Overall Study|Dose administration non-compliance|0
4737794|NCT01872078|16342754|P2|Overall Study|Dose administration non-compliance|0
4737795|NCT01872078|16342755|P1|Overall Study|Dose administration non-compliance|0
4737796|NCT01872078|16342752|P4|Overall Study|Adverse Event|0
4737797|NCT01872078|16342753|P3|Overall Study|Adverse Event|1
4737798|NCT01872078|16342754|P2|Overall Study|Adverse Event|0
4737799|NCT01872078|16342755|P1|Overall Study|Adverse Event|0
4737800|NCT01871870|16342765|P1|Overall Study|hyperglycemia|2
4737801|NCT01871870|16342765|P1|Overall Study|Hardware issues|7
4737802|NCT01871805|16342776|P6|Phase II|Lost to Follow-up|13
4737803|NCT01871805|16342777|P5|Phase II|Lost to Follow-up|0
4737804|NCT01871805|16342778|P4|Phase II|Lost to Follow-up|0
4737805|NCT01871805|16342779|P3|Phase II|Lost to Follow-up|0
4737806|NCT01871805|16342780|P2|Phase II|Lost to Follow-up|0
4737807|NCT01871805|16342781|P1|Phase II|Lost to Follow-up|0
4737808|NCT01871805|16342776|P6|Phase II|Alive in Survival Follow-up|29
4737809|NCT01871805|16342777|P5|Phase II|Alive in Survival Follow-up|0
4737810|NCT01871805|16342778|P4|Phase II|Alive in Survival Follow-up|0
4737811|NCT01871805|16342779|P3|Phase II|Alive in Survival Follow-up|0
4737812|NCT01871805|16342780|P2|Phase II|Alive in Survival Follow-up|0
4737813|NCT01871805|16342781|P1|Phase II|Alive in Survival Follow-up|0
4737814|NCT01871805|16342776|P6|Phase II|Death|45
4737815|NCT01871805|16342777|P5|Phase II|Death|0
4737816|NCT01871805|16342778|P4|Phase II|Death|0
4737817|NCT01871805|16342779|P3|Phase II|Death|0
4737818|NCT01871805|16342780|P2|Phase II|Death|0
4737819|NCT01871805|16342781|P1|Phase II|Death|0
4737820|NCT01871805|16342776|P6|Phase I|Lost to Follow-up|0
4737821|NCT01871805|16342777|P5|Phase I|Lost to Follow-up|0
4737822|NCT01871805|16342778|P4|Phase I|Lost to Follow-up|0
4737823|NCT01871805|16342779|P3|Phase I|Lost to Follow-up|3
4737824|NCT01871805|16342780|P2|Phase I|Lost to Follow-up|1
4737825|NCT01871805|16342781|P1|Phase I|Lost to Follow-up|0
4737826|NCT01871805|16342776|P6|Phase I|Alive in Survival Follow-up|0
4737827|NCT01871805|16342777|P5|Phase I|Alive in Survival Follow-up|4
4737828|NCT01871805|16342778|P4|Phase I|Alive in Survival Follow-up|5
4737829|NCT01871805|16342779|P3|Phase I|Alive in Survival Follow-up|4
4737830|NCT01871805|16342780|P2|Phase I|Alive in Survival Follow-up|2
4737831|NCT01871805|16342781|P1|Phase I|Alive in Survival Follow-up|0
4737832|NCT01871805|16342776|P6|Phase I|Death|0
4737833|NCT01871805|16342777|P5|Phase I|Death|9
4737834|NCT01871805|16342778|P4|Phase I|Death|2
4737835|NCT01871805|16342779|P3|Phase I|Death|6
4737836|NCT01871805|16342780|P2|Phase I|Death|4
4737837|NCT01871805|16342781|P1|Phase I|Death|7
4737838|NCT01871558|16342853|P2|Overall Study|Withdrawal by Subject|0
4737839|NCT01871558|16342854|P1|Overall Study|Withdrawal by Subject|2
4737840|NCT01871558|16342853|P2|Overall Study|antidiabetic drug prematurely stopped|1
4737841|NCT01871558|16342854|P1|Overall Study|antidiabetic drug prematurely stopped|1
4737842|NCT01871558|16342853|P2|Overall Study|Other reason|1
4737843|NCT01871558|16342854|P1|Overall Study|Other reason|0
4737844|NCT01871545|16342874|P2|Overall Study|Withdrawal by Subject|1
4737845|NCT01871545|16342875|P1|Overall Study|Withdrawal by Subject|0
4737846|NCT01871545|16342874|P2|Overall Study|Physician Decision|0
4737847|NCT01871545|16342875|P1|Overall Study|Physician Decision|4
4737848|NCT01871545|16342874|P2|Overall Study|Lack of Efficacy|2
4737849|NCT01871545|16342875|P1|Overall Study|Lack of Efficacy|11
4737850|NCT01871545|16342874|P2|Overall Study|Death|0
4737851|NCT01871545|16342875|P1|Overall Study|Death|2
4737852|NCT01871532|16342916|P2|Overall Study|Withdrawal by Subject|2
4737853|NCT01871532|16342917|P1|Overall Study|Withdrawal by Subject|1
4737854|NCT01871519|16342951|P1|Overall Study|Withdrawal by Subject|49
4737855|NCT01871519|16342951|P1|Overall Study|Lost to Follow-up|15
4737856|NCT01871519|16342951|P1|Overall Study|Death|26
4737857|NCT01871402|16343008|P2|Overall Study|Non-compliance|1
4737858|NCT01871402|16343009|P1|Overall Study|Non-compliance|0
4737859|NCT01871402|16343008|P2|Overall Study|Withdrawal by Subject|2
4737860|NCT01871402|16343009|P1|Overall Study|Withdrawal by Subject|0
4737861|NCT01871402|16343008|P2|Overall Study|Lost to Follow-up|0
4737862|NCT01871402|16343009|P1|Overall Study|Lost to Follow-up|1
4737863|NCT01871285|16343027|P4|First Intervention (1 Day)|Lost to Follow-up|0
4737864|NCT01871285|16343028|P3|First Intervention (1 Day)|Lost to Follow-up|1
4737865|NCT01871285|16343029|P2|First Intervention (1 Day)|Lost to Follow-up|1
4737866|NCT01871285|16343030|P1|First Intervention (1 Day)|Lost to Follow-up|0
4737867|NCT01871285|16343027|P4|First Intervention (1 Day)|Adverse Event|0
4737868|NCT01871285|16343028|P3|First Intervention (1 Day)|Adverse Event|0
4737869|NCT01871285|16343029|P2|First Intervention (1 Day)|Adverse Event|0
4737870|NCT01871285|16343030|P1|First Intervention (1 Day)|Adverse Event|1
4737871|NCT01871142|16343056|P1|Overall Study|Adverse Event|1
4737872|NCT01871090|16343072|P2|Overall Study|Subject Non-Compliance|1
4737873|NCT01871090|16343073|P1|Overall Study|Subject Non-Compliance|0
4737874|NCT01871090|16343072|P2|Overall Study|Interrogation not completed correctly|0
4737875|NCT01871090|16343073|P1|Overall Study|Interrogation not completed correctly|1
4737876|NCT01871090|16343072|P2|Overall Study|Interrogation not done in Emergency Room|22
4737877|NCT01871090|16343073|P1|Overall Study|Interrogation not done in Emergency Room|1
4737878|NCT01870999|16343093|P3|Overall Study|Protocol Violation|1
4737879|NCT01870999|16343094|P2|Overall Study|Protocol Violation|0
4737880|NCT01870999|16343095|P1|Overall Study|Protocol Violation|0
4737881|NCT01870999|16343093|P3|Overall Study|Withdrawal by Subject|5
4737882|NCT01870999|16343094|P2|Overall Study|Withdrawal by Subject|2
4737883|NCT01870999|16343095|P1|Overall Study|Withdrawal by Subject|0
4737884|NCT01870999|16343093|P3|Overall Study|Subject withdrawn by Investigator|0
4737885|NCT01870999|16343094|P2|Overall Study|Subject withdrawn by Investigator|0
4737886|NCT01870999|16343095|P1|Overall Study|Subject withdrawn by Investigator|1
4737887|NCT01870999|16343093|P3|Overall Study|Subject met withdrawal criteria|0
4737888|NCT01870999|16343094|P2|Overall Study|Subject met withdrawal criteria|2
4737889|NCT01870999|16343095|P1|Overall Study|Subject met withdrawal criteria|3
4737890|NCT01870999|16343093|P3|Overall Study|Adverse Event|1
4737891|NCT01870999|16343094|P2|Overall Study|Adverse Event|4
4737892|NCT01870999|16343095|P1|Overall Study|Adverse Event|0
4737893|NCT01870973|16343153|P2|Overall Study|Lost to Follow-up|3
4737894|NCT01870973|16343154|P1|Overall Study|Lost to Follow-up|10
4737895|NCT01870921|16343160|P1|Overall Study|Other|1
4737896|NCT01870921|16343160|P1|Overall Study|Subject Lost to Follow up|2
4737897|NCT01870921|16343160|P1|Overall Study|Severe non-compliance to protocol|7
4737898|NCT01870921|16343160|P1|Overall Study|Subject decision|80
4737899|NCT01870869|16343170|P4|Overall Study|Not evaluable|10
4737900|NCT01870869|16343171|P3|Overall Study|Not evaluable|42
4737901|NCT01870869|16343172|P2|Overall Study|Not evaluable|5
4737902|NCT01870869|16343173|P1|Overall Study|Not evaluable|10
4737903|NCT01870869|16343170|P4|Overall Study|Reason not Specified|4
4737904|NCT01870869|16343171|P3|Overall Study|Reason not Specified|20
4737905|NCT01870869|16343172|P2|Overall Study|Reason not Specified|2
4737906|NCT01870869|16343173|P1|Overall Study|Reason not Specified|1
4737907|NCT01870869|16343170|P4|Overall Study|Lost to Follow-up|3
4737908|NCT01870869|16343171|P3|Overall Study|Lost to Follow-up|25
4737909|NCT01870869|16343172|P2|Overall Study|Lost to Follow-up|2
4737910|NCT01870869|16343173|P1|Overall Study|Lost to Follow-up|10
4737911|NCT01870869|16343170|P4|Overall Study|Subject choice|8
4737912|NCT01870869|16343171|P3|Overall Study|Subject choice|22
4737913|NCT01870869|16343172|P2|Overall Study|Subject choice|2
4737914|NCT01870869|16343173|P1|Overall Study|Subject choice|6
4737915|NCT01870869|16343170|P4|Overall Study|Death|1
4737916|NCT01870869|16343171|P3|Overall Study|Death|7
4737917|NCT01870869|16343172|P2|Overall Study|Death|0
4737918|NCT01870869|16343173|P1|Overall Study|Death|0
4737919|NCT01870869|16343170|P4|Overall Study|Implanted with nonstudy device|4
4737920|NCT01870869|16343171|P3|Overall Study|Implanted with nonstudy device|14
4737921|NCT01870869|16343172|P2|Overall Study|Implanted with nonstudy device|3
4737922|NCT01870869|16343173|P1|Overall Study|Implanted with nonstudy device|1
4737923|NCT01870843|16343212|P1|Overall Study|Withdrawal by Subject|18
4737924|NCT01870843|16343212|P1|Overall Study|Death|1
4737925|NCT01870843|16343212|P1|Overall Study|Lost to Follow-up|24
4737926|NCT01870843|16343212|P1|Overall Study|Adverse Event|10
4737927|NCT01870778|16343227|P2|Overall Study|Lost to Follow-up|2
4737928|NCT01870778|16343228|P1|Overall Study|Lost to Follow-up|0
4737929|NCT01870778|16343227|P2|Overall Study|Withdrawal by Subject|7
4737930|NCT01870778|16343228|P1|Overall Study|Withdrawal by Subject|8
4737931|NCT01870739|16343254|P2|Add-on Period (40 Weeks)|Patient withdrew consent|0
4737932|NCT01870739|16343255|P1|Add-on Period (40 Weeks)|Patient withdrew consent|1
4737933|NCT01870739|16343254|P2|Add-on Period (40 Weeks)|Protocol deviation|1
4737934|NCT01870739|16343255|P1|Add-on Period (40 Weeks)|Protocol deviation|1
4737935|NCT01870739|16343254|P2|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0
4737936|NCT01870739|16343255|P1|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1
4737937|NCT01870739|16343254|P2|Add-on Period (40 Weeks)|Adverse Event|1
4737938|NCT01870739|16343255|P1|Add-on Period (40 Weeks)|Adverse Event|0
4737939|NCT01870739|16343254|P2|Single Drug Treatment (12 Weeks)|Administrative problems|2
4737940|NCT01870739|16343255|P1|Single Drug Treatment (12 Weeks)|Administrative problems|3
4737941|NCT01870739|16343254|P2|Single Drug Treatment (12 Weeks)|Adverse Event|1
4737942|NCT01870739|16343255|P1|Single Drug Treatment (12 Weeks)|Adverse Event|0
4737943|NCT01870739|16343254|P2|Single Drug Treatment (12 Weeks)|Protocol deviation|1
4737944|NCT01870739|16343255|P1|Single Drug Treatment (12 Weeks)|Protocol deviation|0
4737945|NCT01870726|16343294|P7|Overall Study|Progressive disease|10
4737946|NCT01870726|16343295|P6|Overall Study|Progressive disease|4
4737947|NCT01870726|16343296|P5|Overall Study|Progressive disease|6
4737948|NCT01870726|16343297|P4|Overall Study|Progressive disease|5
4737949|NCT01870726|16343298|P3|Overall Study|Progressive disease|4
4737950|NCT01870726|16343299|P2|Overall Study|Progressive disease|5
4737951|NCT01870726|16343300|P1|Overall Study|Progressive disease|5
4737952|NCT01870726|16343294|P7|Overall Study|Adverse Event|0
4737953|NCT01870726|16343295|P6|Overall Study|Adverse Event|1
4737954|NCT01870726|16343296|P5|Overall Study|Adverse Event|1
4737955|NCT01870726|16343297|P4|Overall Study|Adverse Event|0
4737956|NCT01870726|16343298|P3|Overall Study|Adverse Event|0
4737957|NCT01870726|16343299|P2|Overall Study|Adverse Event|0
4737958|NCT01870726|16343300|P1|Overall Study|Adverse Event|0
4737959|NCT01870726|16343294|P7|Overall Study|Withdrawal by Subject|0
4737960|NCT01870726|16343295|P6|Overall Study|Withdrawal by Subject|0
4737961|NCT01870726|16343296|P5|Overall Study|Withdrawal by Subject|0
4737962|NCT01870726|16343297|P4|Overall Study|Withdrawal by Subject|0
4737963|NCT01870726|16343298|P3|Overall Study|Withdrawal by Subject|0
4737964|NCT01870726|16343299|P2|Overall Study|Withdrawal by Subject|1
4737965|NCT01870726|16343300|P1|Overall Study|Withdrawal by Subject|0
4737966|NCT01870726|16343294|P7|Overall Study|Withdrawal of informed consent|0
4737967|NCT01870726|16343295|P6|Overall Study|Withdrawal of informed consent|0
4737968|NCT01870726|16343296|P5|Overall Study|Withdrawal of informed consent|0
4737969|NCT01870726|16343297|P4|Overall Study|Withdrawal of informed consent|1
4737970|NCT01870726|16343298|P3|Overall Study|Withdrawal of informed consent|0
4737971|NCT01870726|16343299|P2|Overall Study|Withdrawal of informed consent|0
4737972|NCT01870726|16343300|P1|Overall Study|Withdrawal of informed consent|0
4737973|NCT01870583|16343395|P3|Overall Study|Lost to Follow-up|5
4737974|NCT01870583|16343396|P2|Overall Study|Lost to Follow-up|13
4737975|NCT01870583|16343397|P1|Overall Study|Lost to Follow-up|11
4737976|NCT01870583|16343395|P3|Overall Study|Protocol Violation|3
4737977|NCT01870583|16343396|P2|Overall Study|Protocol Violation|5
4737978|NCT01870583|16343397|P1|Overall Study|Protocol Violation|0
4737979|NCT01870401|16343407|P2|Overall Study|On-going in the Study|25
4737980|NCT01870401|16343408|P1|Overall Study|On-going in the Study|35
4737981|NCT01870401|16343407|P2|Overall Study|Other|7
4737982|NCT01870401|16343408|P1|Overall Study|Other|9
4737983|NCT01870401|16343407|P2|Overall Study|Lost to Follow-up|14
4737984|NCT01870401|16343408|P1|Overall Study|Lost to Follow-up|19
4737985|NCT01870401|16343407|P2|Overall Study|Withdrawal by Subject|26
4737986|NCT01870401|16343408|P1|Overall Study|Withdrawal by Subject|39
4737987|NCT01870401|16343407|P2|Overall Study|Death|24
4737988|NCT01870401|16343408|P1|Overall Study|Death|48
4737989|NCT01870297|16343484|P7|Overall Study|Sponsor Decision|1
4737990|NCT01870297|16343485|P6|Overall Study|Sponsor Decision|0
4737991|NCT01870297|16343486|P5|Overall Study|Sponsor Decision|0
4737992|NCT01870297|16343487|P4|Overall Study|Sponsor Decision|0
4737993|NCT01870297|16343488|P3|Overall Study|Sponsor Decision|0
4737994|NCT01870297|16343489|P2|Overall Study|Sponsor Decision|6
4737995|NCT01870297|16343490|P1|Overall Study|Sponsor Decision|0
4737996|NCT01870297|16343484|P7|Overall Study|Withdrawal by Subject|1
4737997|NCT01870297|16343485|P6|Overall Study|Withdrawal by Subject|1
4737998|NCT01870297|16343486|P5|Overall Study|Withdrawal by Subject|1
4737999|NCT01870297|16343487|P4|Overall Study|Withdrawal by Subject|0
4738000|NCT01870297|16343488|P3|Overall Study|Withdrawal by Subject|0
4738001|NCT01870297|16343489|P2|Overall Study|Withdrawal by Subject|0
4738002|NCT01870297|16343490|P1|Overall Study|Withdrawal by Subject|0
4738003|NCT01870297|16343484|P7|Overall Study|Lost to Follow-up|0
4738004|NCT01870297|16343485|P6|Overall Study|Lost to Follow-up|0
4738005|NCT01870297|16343486|P5|Overall Study|Lost to Follow-up|0
4738006|NCT01870297|16343487|P4|Overall Study|Lost to Follow-up|0
4738007|NCT01870297|16343488|P3|Overall Study|Lost to Follow-up|1
4738008|NCT01870297|16343489|P2|Overall Study|Lost to Follow-up|1
4738009|NCT01870297|16343490|P1|Overall Study|Lost to Follow-up|0
4738010|NCT01870297|16343484|P7|Overall Study|Adverse Event|0
4738011|NCT01870297|16343485|P6|Overall Study|Adverse Event|0
4738012|NCT01870297|16343486|P5|Overall Study|Adverse Event|2
4738013|NCT01870297|16343487|P4|Overall Study|Adverse Event|0
4738014|NCT01870297|16343488|P3|Overall Study|Adverse Event|0
4738015|NCT01870297|16343489|P2|Overall Study|Adverse Event|0
4738016|NCT01870297|16343490|P1|Overall Study|Adverse Event|0
4738017|NCT01870076|16343534|P4|Overall Study|Withdrawal by Subject|0
4738018|NCT01870076|16343535|P3|Overall Study|Withdrawal by Subject|1
4738019|NCT01870076|16343536|P2|Overall Study|Withdrawal by Subject|0
4738020|NCT01870076|16343537|P1|Overall Study|Withdrawal by Subject|1
4738021|NCT01869959|16343555|P5|Treatment Period|Withdrawal by Subject|0
4738022|NCT01869959|16343556|P4|Treatment Period|Withdrawal by Subject|0
4738023|NCT01869959|16343557|P3|Treatment Period|Withdrawal by Subject|0
4738024|NCT01869959|16343558|P2|Treatment Period|Withdrawal by Subject|1
4738025|NCT01869959|16343559|P1|Treatment Period|Withdrawal by Subject|0
4738026|NCT01869959|16343555|P5|Treatment Period|Sponsor decision|0
4738027|NCT01869959|16343556|P4|Treatment Period|Sponsor decision|1
4738028|NCT01869959|16343557|P3|Treatment Period|Sponsor decision|0
4738029|NCT01869959|16343558|P2|Treatment Period|Sponsor decision|1
4738030|NCT01869959|16343559|P1|Treatment Period|Sponsor decision|0
4738031|NCT01869959|16343555|P5|Treatment Period|Adverse Event|0
4738032|NCT01869959|16343556|P4|Treatment Period|Adverse Event|1
4738033|NCT01869959|16343557|P3|Treatment Period|Adverse Event|3
4738034|NCT01869959|16343558|P2|Treatment Period|Adverse Event|0
4738035|NCT01869959|16343559|P1|Treatment Period|Adverse Event|1
4738036|NCT01869959|16343555|P5|Randomization Period|Physician Decision|1
4738037|NCT01869959|16343556|P4|Randomization Period|Physician Decision|0
4738038|NCT01869959|16343557|P3|Randomization Period|Physician Decision|0
4738039|NCT01869959|16343558|P2|Randomization Period|Physician Decision|0
4738040|NCT01869959|16343559|P1|Randomization Period|Physician Decision|0
4738041|NCT01869777|16343627|P1|Overall Study|Excluded from the analysis, ineligible|1
4738042|NCT01869764|16343640|P2|Overall Study|Withdrawal by Subject|2
4738043|NCT01869764|16343641|P1|Overall Study|Withdrawal by Subject|0
4738044|NCT01869699|16343659|P2|Overall Study|Withdrawal by Subject|0
4738045|NCT01869699|16343660|P1|Overall Study|Withdrawal by Subject|1
4738046|NCT01869348|16343745|P2|Overall Study|Withdrawal by Subject|1
4738047|NCT01869348|16343746|P1|Overall Study|Withdrawal by Subject|1
4738048|NCT01869192|16343754|P2|Postoperative Chemotherapy|Physician Decision|2
4738049|NCT01869192|16343755|P1|Postoperative Chemotherapy|Physician Decision|0
4738050|NCT01869192|16343754|P2|Preoperative Chemotherapy to Surgery|patient choice|1
4738051|NCT01869192|16343755|P1|Preoperative Chemotherapy to Surgery|patient choice|2
4738052|NCT01868997|16343790|P2|Overall Study|Other|1
4738053|NCT01868997|16343791|P1|Overall Study|Other|3
4738054|NCT01868997|16343790|P2|Overall Study|Lack of Efficacy|0
4738055|NCT01868997|16343791|P1|Overall Study|Lack of Efficacy|2
4738056|NCT01868997|16343790|P2|Overall Study|Adverse Event|5
4738057|NCT01868997|16343791|P1|Overall Study|Adverse Event|2
4738058|NCT01868893|16343807|P1|Overall Study|Neutropenia|1
4738059|NCT01868893|16343807|P1|Overall Study|Commercial availability of study drug|17
4738060|NCT01868893|16343807|P1|Overall Study|Adverse Event|2
4738061|NCT01868646|16343838|P2|Overall Study|Do not meet inclusion criteria|5
4738062|NCT01868646|16343839|P1|Overall Study|Do not meet inclusion criteria|3
4738063|NCT01868594|16343884|P2|Overall Study|Do not meet inclusion criteria|3
4738064|NCT01868594|16343885|P1|Overall Study|Do not meet inclusion criteria|4
4738065|NCT01868542|16343905|P2|Overall Study|Unclassified|1
4738066|NCT01868542|16343906|P1|Overall Study|Unclassified|0
4738067|NCT01868542|16343905|P2|Overall Study|Protocol Violation|1
4738068|NCT01868542|16343906|P1|Overall Study|Protocol Violation|0
4738069|NCT01868503|16343924|P1|Overall Study|Protocol Violation|1
4738070|NCT01868503|16343924|P1|Overall Study|Withdrawal by Subject|1
4738071|NCT01868477|16343934|P2|Overall Study|Withdrawal by Subject|0
4738072|NCT01868477|16343935|P1|Overall Study|Withdrawal by Subject|1
4738073|NCT01868477|16343934|P2|Overall Study|Disease progression|1
4738074|NCT01868477|16343935|P1|Overall Study|Disease progression|1
4738075|NCT01868477|16343934|P2|Overall Study|Adverse Event|4
4738076|NCT01868477|16343935|P1|Overall Study|Adverse Event|2
4738077|NCT01868243|16344039|P2|Overall Study|Death|1
4738078|NCT01868243|16344040|P1|Overall Study|Death|0
4738079|NCT01868165|16344048|P1|Overall Study|Death|4
4738080|NCT01868165|16344048|P1|Overall Study|Lost to Follow-up|3
4738081|NCT01868165|16344048|P1|Overall Study|Physician Decision|2
4738082|NCT01868165|16344048|P1|Overall Study|Withdrawal by Subject|36
4738083|NCT01868074|16344064|P2|Overall Study|Withdrawal by Subject|2
4738084|NCT01868074|16344065|P1|Overall Study|Withdrawal by Subject|4
4738085|NCT01868074|16344064|P2|Overall Study|Lost to Follow-up|2
4738086|NCT01868074|16344065|P1|Overall Study|Lost to Follow-up|3
4738087|NCT01868035|16344075|P1|Overall Study|Non-compliance|1
4738088|NCT01868035|16344075|P1|Overall Study|Progressive Disease|2
4738089|NCT01868035|16344075|P1|Overall Study|Withdrawal by Subject|1
4738090|NCT01868035|16344075|P1|Overall Study|Lost to Follow-up|3
4738091|NCT01868022|16344100|P9|Overall Study|Ongoing|0
4738092|NCT01868022|16344101|P8|Overall Study|Ongoing|3
4738093|NCT01868022|16344102|P7|Overall Study|Ongoing|0
4738094|NCT01868022|16344103|P6|Overall Study|Ongoing|0
4738095|NCT01868022|16344104|P5|Overall Study|Ongoing|0
4738096|NCT01868022|16344105|P4|Overall Study|Ongoing|0
4738097|NCT01868022|16344106|P3|Overall Study|Ongoing|0
4738098|NCT01868022|16344107|P2|Overall Study|Ongoing|0
4738099|NCT01868022|16344108|P1|Overall Study|Ongoing|0
4738100|NCT01868022|16344100|P9|Overall Study|Study closed/terminated|0
4738101|NCT01868022|16344101|P8|Overall Study|Study closed/terminated|1
4738102|NCT01868022|16344102|P7|Overall Study|Study closed/terminated|0
4738103|NCT01868022|16344103|P6|Overall Study|Study closed/terminated|0
4738104|NCT01868022|16344104|P5|Overall Study|Study closed/terminated|0
4738105|NCT01868022|16344105|P4|Overall Study|Study closed/terminated|0
4738106|NCT01868022|16344106|P3|Overall Study|Study closed/terminated|0
4738107|NCT01868022|16344107|P2|Overall Study|Study closed/terminated|0
4738108|NCT01868022|16344108|P1|Overall Study|Study closed/terminated|0
4738109|NCT01868022|16344100|P9|Overall Study|Physician Decision|0
4738110|NCT01868022|16344101|P8|Overall Study|Physician Decision|2
4738111|NCT01868022|16344102|P7|Overall Study|Physician Decision|0
4738112|NCT01868022|16344103|P6|Overall Study|Physician Decision|1
4738113|NCT01868022|16344104|P5|Overall Study|Physician Decision|0
4738114|NCT01868022|16344105|P4|Overall Study|Physician Decision|0
4738115|NCT01868022|16344106|P3|Overall Study|Physician Decision|0
4738116|NCT01868022|16344107|P2|Overall Study|Physician Decision|0
4738117|NCT01868022|16344108|P1|Overall Study|Physician Decision|0
4738118|NCT01868022|16344100|P9|Overall Study|Adverse Event|2
4738119|NCT01868022|16344101|P8|Overall Study|Adverse Event|2
4738120|NCT01868022|16344102|P7|Overall Study|Adverse Event|0
4738121|NCT01868022|16344103|P6|Overall Study|Adverse Event|0
4738122|NCT01868022|16344104|P5|Overall Study|Adverse Event|2
4738123|NCT01868022|16344105|P4|Overall Study|Adverse Event|0
4738124|NCT01868022|16344106|P3|Overall Study|Adverse Event|0
4738125|NCT01868022|16344107|P2|Overall Study|Adverse Event|0
4738126|NCT01868022|16344108|P1|Overall Study|Adverse Event|0
4738127|NCT01868022|16344100|P9|Overall Study|Withdrawal by Subject|0
4738128|NCT01868022|16344101|P8|Overall Study|Withdrawal by Subject|1
4738129|NCT01868022|16344102|P7|Overall Study|Withdrawal by Subject|0
4738130|NCT01868022|16344103|P6|Overall Study|Withdrawal by Subject|0
4738131|NCT01868022|16344104|P5|Overall Study|Withdrawal by Subject|0
4738132|NCT01868022|16344105|P4|Overall Study|Withdrawal by Subject|1
4738133|NCT01868022|16344106|P3|Overall Study|Withdrawal by Subject|1
4738134|NCT01868022|16344107|P2|Overall Study|Withdrawal by Subject|0
4738135|NCT01868022|16344108|P1|Overall Study|Withdrawal by Subject|0
4738136|NCT01868009|16344314|P2|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0
4738137|NCT01868009|16344315|P1|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1
4738138|NCT01868009|16344314|P2|Period 2 (5-9 Days)|Adverse Event|0
4738139|NCT01868009|16344315|P1|Period 2 (5-9 Days)|Adverse Event|1
4738140|NCT01868009|16344314|P2|Period 1 (5-9 Days)|Adverse Event|2
4738141|NCT01868009|16344315|P1|Period 1 (5-9 Days)|Adverse Event|0
4738142|NCT01867710|16344329|P4|Overall Study|Study medication no longer effective|0
4738143|NCT01867710|16344330|P3|Overall Study|Study medication no longer effective|0
4738144|NCT01867710|16344331|P2|Overall Study|Study medication no longer effective|1
4738145|NCT01867710|16344332|P1|Overall Study|Study medication no longer effective|0
4738146|NCT01867710|16344329|P4|Overall Study|PSA-progression|0
4738147|NCT01867710|16344330|P3|Overall Study|PSA-progression|0
4738148|NCT01867710|16344331|P2|Overall Study|PSA-progression|1
4738149|NCT01867710|16344332|P1|Overall Study|PSA-progression|0
4738150|NCT01867710|16344329|P4|Overall Study|Protocol Violation|1
4738151|NCT01867710|16344330|P3|Overall Study|Protocol Violation|0
4738152|NCT01867710|16344331|P2|Overall Study|Protocol Violation|0
4738153|NCT01867710|16344332|P1|Overall Study|Protocol Violation|0
4738154|NCT01867710|16344329|P4|Overall Study|Progressive disease|0
4738155|NCT01867710|16344330|P3|Overall Study|Progressive disease|0
4738156|NCT01867710|16344331|P2|Overall Study|Progressive disease|0
4738157|NCT01867710|16344332|P1|Overall Study|Progressive disease|1
4738158|NCT01867710|16344329|P4|Overall Study|Patient to follow subsequent treatment|0
4738159|NCT01867710|16344330|P3|Overall Study|Patient to follow subsequent treatment|0
4738160|NCT01867710|16344331|P2|Overall Study|Patient to follow subsequent treatment|1
4738161|NCT01867710|16344332|P1|Overall Study|Patient to follow subsequent treatment|0
4738162|NCT01867710|16344329|P4|Overall Study|Patient decision|1
4738163|NCT01867710|16344330|P3|Overall Study|Patient decision|0
4738164|NCT01867710|16344331|P2|Overall Study|Patient decision|0
4738165|NCT01867710|16344332|P1|Overall Study|Patient decision|0
4738166|NCT01867710|16344329|P4|Overall Study|Disease progression|0
4738167|NCT01867710|16344330|P3|Overall Study|Disease progression|0
4738168|NCT01867710|16344331|P2|Overall Study|Disease progression|0
4738169|NCT01867710|16344332|P1|Overall Study|Disease progression|1
4738170|NCT01867710|16344329|P4|Overall Study|Clinical progression|0
4738171|NCT01867710|16344330|P3|Overall Study|Clinical progression|1
4738172|NCT01867710|16344331|P2|Overall Study|Clinical progression|0
4738173|NCT01867710|16344332|P1|Overall Study|Clinical progression|0
4738174|NCT01867710|16344329|P4|Overall Study|Biochemical progression|0
4738175|NCT01867710|16344330|P3|Overall Study|Biochemical progression|0
4738176|NCT01867710|16344331|P2|Overall Study|Biochemical progression|1
4738177|NCT01867710|16344332|P1|Overall Study|Biochemical progression|0
4738178|NCT01867710|16344329|P4|Overall Study|Study Terminated by Sponsor|16
4738179|NCT01867710|16344330|P3|Overall Study|Study Terminated by Sponsor|8
4738180|NCT01867710|16344331|P2|Overall Study|Study Terminated by Sponsor|13
4738181|NCT01867710|16344332|P1|Overall Study|Study Terminated by Sponsor|9
4738182|NCT01867710|16344329|P4|Overall Study|Withdrawal of consent|2
4738183|NCT01867710|16344330|P3|Overall Study|Withdrawal of consent|1
4738184|NCT01867710|16344331|P2|Overall Study|Withdrawal of consent|5
4738185|NCT01867710|16344332|P1|Overall Study|Withdrawal of consent|2
4738186|NCT01867710|16344329|P4|Overall Study|Lost to Follow-up|2
4738187|NCT01867710|16344330|P3|Overall Study|Lost to Follow-up|3
4738188|NCT01867710|16344331|P2|Overall Study|Lost to Follow-up|4
4738189|NCT01867710|16344332|P1|Overall Study|Lost to Follow-up|3
4738190|NCT01867710|16344329|P4|Overall Study|Death|20
4738191|NCT01867710|16344330|P3|Overall Study|Death|27
4738192|NCT01867710|16344331|P2|Overall Study|Death|15
4738193|NCT01867710|16344332|P1|Overall Study|Death|25
4738194|NCT01867671|16344400|P2|Overall Study|Withdrawal by Subject|21
4738195|NCT01867671|16344401|P1|Overall Study|Withdrawal by Subject|21
4738196|NCT01867671|16344400|P2|Overall Study|Non-compliance with Study Drug|2
4738197|NCT01867671|16344401|P1|Overall Study|Non-compliance with Study Drug|1
4738198|NCT01867671|16344400|P2|Overall Study|Lost to Follow-up|1
4738199|NCT01867671|16344401|P1|Overall Study|Lost to Follow-up|0
4738200|NCT01867671|16344400|P2|Overall Study|Inability to reach 3 mg peanut/placebo|0
4738201|NCT01867671|16344401|P1|Overall Study|Inability to reach 3 mg peanut/placebo|2
4738202|NCT01867671|16344400|P2|Overall Study|Anaphylaxis|1
4738203|NCT01867671|16344401|P1|Overall Study|Anaphylaxis|0
4738204|NCT01867671|16344400|P2|Overall Study|Adverse Event|3
4738205|NCT01867671|16344401|P1|Overall Study|Adverse Event|5
4738206|NCT01867658|16344414|P1|Overall Study|Subject could not be contacted|1
4738207|NCT01867658|16344414|P1|Overall Study|Death|2
4738208|NCT01867658|16344414|P1|Overall Study|Withdrawal by Subject|6
4738209|NCT01867606|16344438|P2|Overall Study|Protocol Violation|1
4738210|NCT01867606|16344439|P1|Overall Study|Protocol Violation|0
4738211|NCT01867606|16344438|P2|Overall Study|Withdrawal by Subject|14
4738212|NCT01867606|16344439|P1|Overall Study|Withdrawal by Subject|10
4738213|NCT01867580|16344457|P2|Overall Study|Wound recurrence|1
4738214|NCT01867580|16344458|P1|Overall Study|Wound recurrence|0
4738215|NCT01867580|16344457|P2|Overall Study|Continuation of therapy|1
4738216|NCT01867580|16344458|P1|Overall Study|Continuation of therapy|0
4738217|NCT01867580|16344457|P2|Overall Study|Osteomyelitis|1
4738218|NCT01867580|16344458|P1|Overall Study|Osteomyelitis|0
4738219|NCT01867580|16344457|P2|Overall Study|Interruption to therapy|0
4738220|NCT01867580|16344458|P1|Overall Study|Interruption to therapy|3
4738221|NCT01867580|16344457|P2|Overall Study|Missed follow-up assessment|1
4738222|NCT01867580|16344458|P1|Overall Study|Missed follow-up assessment|2
4738223|NCT01867580|16344457|P2|Overall Study|Sponsor terminated study|0
4738224|NCT01867580|16344458|P1|Overall Study|Sponsor terminated study|1
4738225|NCT01867580|16344457|P2|Overall Study|Lost to Follow-up|5
4738226|NCT01867580|16344458|P1|Overall Study|Lost to Follow-up|3
4738227|NCT01867580|16344457|P2|Overall Study|Physician Decision|12
4738228|NCT01867580|16344458|P1|Overall Study|Physician Decision|17
4738229|NCT01867580|16344457|P2|Overall Study|Withdrawal by Subject|3
4738230|NCT01867580|16344458|P1|Overall Study|Withdrawal by Subject|2
4738231|NCT01867424|16344483|P2|Overall Study|Patient noncompliance|1
4738232|NCT01867424|16344484|P1|Overall Study|Patient noncompliance|2
4738233|NCT01867307|16344498|P2|Overall Study|Other Adverse Event|3
4738234|NCT01867307|16344499|P1|Overall Study|Other Adverse Event|1
4738235|NCT01867307|16344498|P2|Overall Study|Protocol Violation|0
4738236|NCT01867307|16344499|P1|Overall Study|Protocol Violation|2
4738237|NCT01867294|16344509|P4|Overall Study|Withdrawal by Subject|0
4738238|NCT01867294|16344510|P3|Overall Study|Withdrawal by Subject|0
4738239|NCT01867294|16344511|P2|Overall Study|Withdrawal by Subject|1
4738240|NCT01867294|16344512|P1|Overall Study|Withdrawal by Subject|1
4738241|NCT01867216|16344559|P7|Overall Study|Unable to Place Catheter for Blood Draws|0
4738242|NCT01867216|16344560|P6|Overall Study|Unable to Place Catheter for Blood Draws|0
4738243|NCT01867216|16344561|P5|Overall Study|Unable to Place Catheter for Blood Draws|0
4738244|NCT01867216|16344562|P4|Overall Study|Unable to Place Catheter for Blood Draws|0
4738245|NCT01867216|16344563|P3|Overall Study|Unable to Place Catheter for Blood Draws|0
4738246|NCT01867216|16344564|P2|Overall Study|Unable to Place Catheter for Blood Draws|0
4738247|NCT01867216|16344565|P1|Overall Study|Unable to Place Catheter for Blood Draws|1
4738248|NCT01867216|16344559|P7|Overall Study|Physician Decision|0
4738249|NCT01867216|16344560|P6|Overall Study|Physician Decision|0
4738250|NCT01867216|16344561|P5|Overall Study|Physician Decision|0
4738251|NCT01867216|16344562|P4|Overall Study|Physician Decision|0
4738252|NCT01867216|16344563|P3|Overall Study|Physician Decision|0
4738253|NCT01867216|16344564|P2|Overall Study|Physician Decision|0
4738254|NCT01867216|16344565|P1|Overall Study|Physician Decision|1
4738255|NCT01867216|16344559|P7|Overall Study|Withdrawal by Subject|1
4738256|NCT01867216|16344560|P6|Overall Study|Withdrawal by Subject|0
4738257|NCT01867216|16344561|P5|Overall Study|Withdrawal by Subject|1
4738258|NCT01867216|16344562|P4|Overall Study|Withdrawal by Subject|0
4738259|NCT01867216|16344563|P3|Overall Study|Withdrawal by Subject|0
4738260|NCT01867216|16344564|P2|Overall Study|Withdrawal by Subject|0
4738261|NCT01867216|16344565|P1|Overall Study|Withdrawal by Subject|2
4738262|NCT01867086|16344637|P1|Overall Study|Disease Progression|1
4738263|NCT01867047|16344646|P2|Overall Study|surgery not indicated in protocol|2
4738264|NCT01867047|16344647|P1|Overall Study|surgery not indicated in protocol|1
4738265|NCT01867047|16344646|P2|Overall Study|Physician Decision|0
4738266|NCT01867047|16344647|P1|Overall Study|Physician Decision|2
4738267|NCT01867047|16344646|P2|Overall Study|Withdrawal by Subject|0
4738268|NCT01867047|16344647|P1|Overall Study|Withdrawal by Subject|2
4738269|NCT01867047|16344646|P2|Overall Study|Lost to Follow-up|3
4738270|NCT01867047|16344647|P1|Overall Study|Lost to Follow-up|3
4738271|NCT01867021|16344667|P2|Overall Study|Withdrawal by Subject|6
4738272|NCT01867021|16344668|P1|Overall Study|Withdrawal by Subject|1
4738273|NCT01867021|16344667|P2|Overall Study|Lost to Follow-up|2
4738274|NCT01867021|16344668|P1|Overall Study|Lost to Follow-up|0
4738275|NCT01867021|16344667|P2|Overall Study|Death|0
4738276|NCT01867021|16344668|P1|Overall Study|Death|1
4738277|NCT01867021|16344667|P2|Overall Study|Not Eligible|1
4738278|NCT01867021|16344668|P1|Overall Study|Not Eligible|0
4738279|NCT01867021|16344667|P2|Overall Study|Adverse Event|1
4738280|NCT01867021|16344668|P1|Overall Study|Adverse Event|0
4738281|NCT01866917|16344699|P2|Overall Study|Pharmacist stopped dispensing treatment|6
4738282|NCT01866917|16344700|P1|Overall Study|Pharmacist stopped dispensing treatment|4
4738283|NCT01866826|16344724|P2|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1
4738284|NCT01866826|16344725|P1|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0
4738285|NCT01866826|16344724|P2|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2
4738286|NCT01866826|16344725|P1|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0
4738287|NCT01866826|16344724|P2|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0
4738288|NCT01866826|16344725|P1|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1
4738289|NCT01866709|16344741|P2|Overall Study|Adverse Event|0
4738290|NCT01866709|16344742|P1|Overall Study|Adverse Event|1
4738291|NCT01866423|16344783|P1|Overall Study|Sponsor Decision|1
4738292|NCT01866423|16344783|P1|Overall Study|Lack of Efficacy|3
4738293|NCT01866319|16344811|P3|Overall Study|Withdrawal by Subject|12
4738294|NCT01866319|16344812|P2|Overall Study|Withdrawal by Subject|14
4738295|NCT01866319|16344813|P1|Overall Study|Withdrawal by Subject|32
4738296|NCT01866319|16344811|P3|Overall Study|Protocol Violation|1
4738297|NCT01866319|16344812|P2|Overall Study|Protocol Violation|0
4738298|NCT01866319|16344813|P1|Overall Study|Protocol Violation|0
4738299|NCT01866319|16344811|P3|Overall Study|Physician Decision|1
4738300|NCT01866319|16344812|P2|Overall Study|Physician Decision|0
4738301|NCT01866319|16344813|P1|Overall Study|Physician Decision|1
4738302|NCT01866319|16344811|P3|Overall Study|Lost to Follow-up|8
4738303|NCT01866319|16344812|P2|Overall Study|Lost to Follow-up|3
4738304|NCT01866319|16344813|P1|Overall Study|Lost to Follow-up|6
4738305|NCT01866319|16344811|P3|Overall Study|Death|147
4738306|NCT01866319|16344812|P2|Overall Study|Death|154
4738307|NCT01866319|16344813|P1|Overall Study|Death|153
4738308|NCT01866319|16344811|P3|Overall Study|Clinical progression|2
4738309|NCT01866319|16344812|P2|Overall Study|Clinical progression|2
4738310|NCT01866319|16344813|P1|Overall Study|Clinical progression|3
4738311|NCT01866319|16344811|P3|Overall Study|Adverse Event|9
4738312|NCT01866319|16344812|P2|Overall Study|Adverse Event|5
4738313|NCT01866319|16344813|P1|Overall Study|Adverse Event|12
4738314|NCT01866293|16344912|P1|Overall Study|Adverse Event|2
4738315|NCT01866098|16344957|P3|Overall Study|Death|0
4738316|NCT01866098|16344958|P2|Overall Study|Death|1
4738317|NCT01866098|16344959|P1|Overall Study|Death|0
4738318|NCT01866098|16344957|P3|Overall Study|Pregnancy|0
4738319|NCT01866098|16344958|P2|Overall Study|Pregnancy|0
4738320|NCT01866098|16344959|P1|Overall Study|Pregnancy|2
4738321|NCT01866098|16344957|P3|Overall Study|Non-compliance|1
4738322|NCT01866098|16344958|P2|Overall Study|Non-compliance|0
4738323|NCT01866098|16344959|P1|Overall Study|Non-compliance|1
4738324|NCT01866098|16344957|P3|Overall Study|Unrelated Hospitalization|1
4738325|NCT01866098|16344958|P2|Overall Study|Unrelated Hospitalization|0
4738326|NCT01866098|16344959|P1|Overall Study|Unrelated Hospitalization|2
4738327|NCT01866098|16344957|P3|Overall Study|Withdrawal by Subject|0
4738328|NCT01866098|16344958|P2|Overall Study|Withdrawal by Subject|2
4738329|NCT01866098|16344959|P1|Overall Study|Withdrawal by Subject|1
4738330|NCT01866098|16344957|P3|Overall Study|Protocol Violation|0
4738331|NCT01866098|16344958|P2|Overall Study|Protocol Violation|0
4738332|NCT01866098|16344959|P1|Overall Study|Protocol Violation|1
4738333|NCT01866098|16344957|P3|Overall Study|Adverse Event|4
4738334|NCT01866098|16344958|P2|Overall Study|Adverse Event|5
4738335|NCT01866098|16344959|P1|Overall Study|Adverse Event|1
4738336|NCT01866098|16344957|P3|Overall Study|Physician Decision|2
4738337|NCT01866098|16344958|P2|Overall Study|Physician Decision|1
4738338|NCT01866098|16344959|P1|Overall Study|Physician Decision|0
4738339|NCT01866098|16344957|P3|Overall Study|Lost to Follow-up|13
4738340|NCT01866098|16344958|P2|Overall Study|Lost to Follow-up|18
4738341|NCT01866098|16344959|P1|Overall Study|Lost to Follow-up|11
4738342|NCT01865812|16344988|P1|Overall Study|Adverse Event|2
4738343|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Other|1
4738344|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Other|0
4738345|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Progressive Disease|92
4738346|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Progressive Disease|82
4738347|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Withdrawal by Subject|7
4738348|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Withdrawal by Subject|3
4738349|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Physician Decision|2
4738350|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Physician Decision|4
4738351|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Protocol Violation|1
4738352|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Protocol Violation|1
4738353|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Lack of Efficacy|0
4738354|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Lack of Efficacy|2
4738355|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Clinical Deterioration|29
4738356|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Clinical Deterioration|18
4738357|NCT01865747|16344996|P2|Primary Intent to Treat (PITT)|Adverse Event|20
4738358|NCT01865747|16344997|P1|Primary Intent to Treat (PITT)|Adverse Event|21
4738359|NCT01865747|16344996|P2|Overall Study (ITT)|Reason Not Provided|1
4738360|NCT01865747|16344997|P1|Overall Study (ITT)|Reason Not Provided|0
4738361|NCT01865747|16344996|P2|Overall Study (ITT)|Progressive Disease|158
4738362|NCT01865747|16344997|P1|Overall Study (ITT)|Progressive Disease|122
4738363|NCT01865747|16344996|P2|Overall Study (ITT)|Sponsor Decision|1
4738364|NCT01865747|16344997|P1|Overall Study (ITT)|Sponsor Decision|0
4738365|NCT01865747|16344996|P2|Overall Study (ITT)|Withdrawal by Subject|11
4738366|NCT01865747|16344997|P1|Overall Study (ITT)|Withdrawal by Subject|6
4738367|NCT01865747|16344996|P2|Overall Study (ITT)|Physician Decision|2
4738368|NCT01865747|16344997|P1|Overall Study (ITT)|Physician Decision|5
4738369|NCT01865747|16344996|P2|Overall Study (ITT)|Protocol Violation|1
4738370|NCT01865747|16344997|P1|Overall Study (ITT)|Protocol Violation|1
4738371|NCT01865747|16344996|P2|Overall Study (ITT)|Lack of Efficacy|0
4738372|NCT01865747|16344997|P1|Overall Study (ITT)|Lack of Efficacy|3
4738373|NCT01865747|16344996|P2|Overall Study (ITT)|Clinical Deterioration|50
4738374|NCT01865747|16344997|P1|Overall Study (ITT)|Clinical Deterioration|29
4738375|NCT01865747|16344996|P2|Overall Study (ITT)|Adverse Event|31
4738376|NCT01865747|16344997|P1|Overall Study (ITT)|Adverse Event|32
4738377|NCT01865552|16345018|P6|Period 1|Other|0
4738378|NCT01865552|16345019|P5|Period 1|Other|1
4738379|NCT01865552|16345020|P4|Period 1|Other|0
4738380|NCT01865552|16345021|P3|Period 1|Other|0
4738381|NCT01865552|16345022|P2|Period 1|Other|0
4738382|NCT01865552|16345023|P1|Period 1|Other|0
4738383|NCT01865552|16345018|P6|Period 1|Pathological lab|0
4738384|NCT01865552|16345019|P5|Period 1|Pathological lab|1
4738385|NCT01865552|16345020|P4|Period 1|Pathological lab|0
4738386|NCT01865552|16345021|P3|Period 1|Pathological lab|0
4738387|NCT01865552|16345022|P2|Period 1|Pathological lab|0
4738388|NCT01865552|16345023|P1|Period 1|Pathological lab|0
4738389|NCT01865552|16345018|P6|Period 1|Adverse Event|1
4738390|NCT01865552|16345019|P5|Period 1|Adverse Event|1
4738391|NCT01865552|16345020|P4|Period 1|Adverse Event|1
4738392|NCT01865552|16345021|P3|Period 1|Adverse Event|0
4738393|NCT01865552|16345022|P2|Period 1|Adverse Event|0
4738394|NCT01865552|16345023|P1|Period 1|Adverse Event|1
4738395|NCT01865487|16345061|P10|Overall Study|Withdrawal by Subject|0
4738396|NCT01865487|16345062|P9|Overall Study|Withdrawal by Subject|0
4738397|NCT01865487|16345063|P8|Overall Study|Withdrawal by Subject|0
4738398|NCT01865487|16345064|P7|Overall Study|Withdrawal by Subject|0
4738399|NCT01865487|16345065|P6|Overall Study|Withdrawal by Subject|0
4738400|NCT01865487|16345066|P5|Overall Study|Withdrawal by Subject|1
4738401|NCT01865487|16345067|P4|Overall Study|Withdrawal by Subject|0
4738402|NCT01865487|16345068|P3|Overall Study|Withdrawal by Subject|0
4738403|NCT01865487|16345069|P2|Overall Study|Withdrawal by Subject|0
4738404|NCT01865487|16345070|P1|Overall Study|Withdrawal by Subject|0
4738405|NCT01865487|16345061|P10|Overall Study|Lost to Follow-up|0
4738406|NCT01865487|16345062|P9|Overall Study|Lost to Follow-up|0
4738407|NCT01865487|16345063|P8|Overall Study|Lost to Follow-up|0
4738408|NCT01865487|16345064|P7|Overall Study|Lost to Follow-up|1
4738409|NCT01865487|16345065|P6|Overall Study|Lost to Follow-up|0
4738410|NCT01865487|16345066|P5|Overall Study|Lost to Follow-up|0
4738411|NCT01865487|16345067|P4|Overall Study|Lost to Follow-up|1
4738412|NCT01865487|16345068|P3|Overall Study|Lost to Follow-up|0
4738413|NCT01865487|16345069|P2|Overall Study|Lost to Follow-up|0
4738414|NCT01865487|16345070|P1|Overall Study|Lost to Follow-up|0
4738415|NCT01865448|16345109|P2|Overall Study|dropout unrelated to study|1
4738416|NCT01865448|16345110|P1|Overall Study|dropout unrelated to study|1
4738417|NCT01865448|16345109|P2|Overall Study|Pregnancy|1
4738418|NCT01865448|16345110|P1|Overall Study|Pregnancy|0
4738419|NCT01865448|16345109|P2|Overall Study|Adverse Event|1
4738420|NCT01865448|16345110|P1|Overall Study|Adverse Event|1
4738421|NCT01865084|16345221|P3|Open Label Extension (OLE) Period|Withdrawal by Subject|2
4738422|NCT01865084|16345222|P2|Open Label Extension (OLE) Period|Withdrawal by Subject|2
4738423|NCT01865084|16345223|P1|Open Label Extension (OLE) Period|Withdrawal by Subject|0
4738424|NCT01865084|16345221|P3|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2
4738425|NCT01865084|16345222|P2|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8
4738426|NCT01865084|16345223|P1|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0
4738427|NCT01865084|16345221|P3|Open Label Extension (OLE) Period|Lost to Follow-up|0
4738428|NCT01865084|16345222|P2|Open Label Extension (OLE) Period|Lost to Follow-up|1
4738429|NCT01865084|16345223|P1|Open Label Extension (OLE) Period|Lost to Follow-up|0
4738430|NCT01865084|16345221|P3|Open Label Extension (OLE) Period|Lack of Efficacy|2
4738431|NCT01865084|16345222|P2|Open Label Extension (OLE) Period|Lack of Efficacy|0
4738432|NCT01865084|16345223|P1|Open Label Extension (OLE) Period|Lack of Efficacy|0
4738433|NCT01865084|16345221|P3|Open Label Extension (OLE) Period|Adverse Event|1
4738434|NCT01865084|16345222|P2|Open Label Extension (OLE) Period|Adverse Event|0
4738435|NCT01865084|16345223|P1|Open Label Extension (OLE) Period|Adverse Event|0
4738436|NCT01865084|16345221|P3|Double Blind Period (DB)|Withdrawal by Subject|0
4738437|NCT01865084|16345222|P2|Double Blind Period (DB)|Withdrawal by Subject|0
4738438|NCT01865084|16345223|P1|Double Blind Period (DB)|Withdrawal by Subject|1
4738439|NCT01865084|16345221|P3|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4
4738440|NCT01865084|16345222|P2|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
4738441|NCT01865084|16345223|P1|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2
4738442|NCT01865084|16345221|P3|Double Blind Period (DB)|Protocol Violation|1
4738443|NCT01865084|16345222|P2|Double Blind Period (DB)|Protocol Violation|0
4738444|NCT01865084|16345223|P1|Double Blind Period (DB)|Protocol Violation|0
4738445|NCT01865084|16345221|P3|Double Blind Period (DB)|Adverse Event|1
4738446|NCT01865084|16345222|P2|Double Blind Period (DB)|Adverse Event|2
4738447|NCT01865084|16345223|P1|Double Blind Period (DB)|Adverse Event|2
4738448|NCT01864564|16345251|P2|Overall Study|not reported|34
4738449|NCT01864564|16345252|P1|Overall Study|not reported|0
4738450|NCT01864564|16345251|P2|Overall Study|Protocol Violation|27
4738451|NCT01864564|16345252|P1|Overall Study|Protocol Violation|0
4738452|NCT01864564|16345251|P2|Overall Study|Withdrawal by Subject|11
4738453|NCT01864564|16345252|P1|Overall Study|Withdrawal by Subject|20
4738454|NCT01864564|16345251|P2|Overall Study|Lost to Follow-up|23
4738455|NCT01864564|16345252|P1|Overall Study|Lost to Follow-up|17
4738456|NCT01864525|16345284|P2|Overall Study|Adverse Event|0
4738457|NCT01864525|16345285|P1|Overall Study|Adverse Event|1
4738458|NCT01864291|16345306|P1|Overall Study|need for revision surgery|2
4738459|NCT01864200|16345314|P2|Overall Study|Protocol Violation|0
4738460|NCT01864200|16345315|P1|Overall Study|Protocol Violation|1
4738461|NCT01864200|16345314|P2|Overall Study|Lost to Follow-up|3
4738462|NCT01864200|16345315|P1|Overall Study|Lost to Follow-up|1
4738463|NCT01864174|16345323|P2|Off Treatment Follow-Up|Subject Withdrew Consent|0
4738464|NCT01864174|16345324|P1|Off Treatment Follow-Up|Subject Withdrew Consent|1
4738465|NCT01864174|16345323|P2|Off Treatment Follow-Up|Other|0
4738466|NCT01864174|16345324|P1|Off Treatment Follow-Up|Other|2
4738467|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Other|10
4738468|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Other|6
4738469|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Poor/Non-compliance|0
4738470|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Poor/Non-compliance|1
4738471|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Lost to Follow-up|10
4738472|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Lost to Follow-up|3
4738473|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Death|0
4738474|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Death|1
4738475|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Subject Withdrew Consent|5
4738476|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Subject Withdrew Consent|4
4738477|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0
4738478|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2
4738479|NCT01864174|16345323|P2|Double Blind - Compliant Randomized|Adverse Event|1
4738480|NCT01864174|16345324|P1|Double Blind - Compliant Randomized|Adverse Event|6
4738481|NCT01864174|16345323|P2|Double Blind Treatment - All Treated|Removed due to site non-compliance|14
4738482|NCT01864174|16345324|P1|Double Blind Treatment - All Treated|Removed due to site non-compliance|15
4738483|NCT01864148|16345343|P5|Overall Study|Not Dosed|0
4738484|NCT01864148|16345344|P4|Overall Study|Not Dosed|1
4738485|NCT01864148|16345345|P3|Overall Study|Not Dosed|0
4738486|NCT01864148|16345346|P2|Overall Study|Not Dosed|0
4738487|NCT01864148|16345347|P1|Overall Study|Not Dosed|0
4738488|NCT01864148|16345343|P5|Overall Study|Adverse Event|7
4738489|NCT01864148|16345344|P4|Overall Study|Adverse Event|7
4738490|NCT01864148|16345345|P3|Overall Study|Adverse Event|4
4738491|NCT01864148|16345346|P2|Overall Study|Adverse Event|2
4738492|NCT01864148|16345347|P1|Overall Study|Adverse Event|4
4738493|NCT01864148|16345343|P5|Overall Study|Lost to Follow-up|1
4738494|NCT01864148|16345344|P4|Overall Study|Lost to Follow-up|2
4738495|NCT01864148|16345345|P3|Overall Study|Lost to Follow-up|0
4738496|NCT01864148|16345346|P2|Overall Study|Lost to Follow-up|0
4738497|NCT01864148|16345347|P1|Overall Study|Lost to Follow-up|0
4738498|NCT01864148|16345343|P5|Overall Study|Withdrawal by Subject|8
4738499|NCT01864148|16345344|P4|Overall Study|Withdrawal by Subject|8
4738500|NCT01864148|16345345|P3|Overall Study|Withdrawal by Subject|6
4738501|NCT01864148|16345346|P2|Overall Study|Withdrawal by Subject|2
4738502|NCT01864148|16345347|P1|Overall Study|Withdrawal by Subject|9
4738503|NCT01864148|16345343|P5|Overall Study|Investigator Decision|6
4738504|NCT01864148|16345344|P4|Overall Study|Investigator Decision|4
4738505|NCT01864148|16345345|P3|Overall Study|Investigator Decision|0
4738506|NCT01864148|16345346|P2|Overall Study|Investigator Decision|0
4738507|NCT01864148|16345347|P1|Overall Study|Investigator Decision|5
4738508|NCT01864148|16345343|P5|Overall Study|Death|0
4738509|NCT01864148|16345344|P4|Overall Study|Death|1
4738510|NCT01864148|16345345|P3|Overall Study|Death|0
4738511|NCT01864148|16345346|P2|Overall Study|Death|0
4738512|NCT01864148|16345347|P1|Overall Study|Death|0
4738513|NCT01864148|16345343|P5|Overall Study|Other|1
4738514|NCT01864148|16345344|P4|Overall Study|Other|3
4738515|NCT01864148|16345345|P3|Overall Study|Other|1
4738516|NCT01864148|16345346|P2|Overall Study|Other|1
4738517|NCT01864148|16345347|P1|Overall Study|Other|2
4738518|NCT01864005|16345376|P2|Overall Study|Need GP IIb/IIIa|3
4738519|NCT01864005|16345377|P1|Overall Study|Need GP IIb/IIIa|1
4738520|NCT01864005|16345376|P2|Overall Study|Disease need|1
4738521|NCT01864005|16345377|P1|Overall Study|Disease need|1
4738522|NCT01864005|16345376|P2|Overall Study|Incorrect enrolment|0
4738523|NCT01864005|16345377|P1|Overall Study|Incorrect enrolment|1
4738524|NCT01864005|16345376|P2|Overall Study|Withdrawal by Subject|1
4738525|NCT01864005|16345377|P1|Overall Study|Withdrawal by Subject|0
4738526|NCT01864005|16345376|P2|Overall Study|Protocol Violation|1
4738527|NCT01864005|16345377|P1|Overall Study|Protocol Violation|0
4738528|NCT01863953|16345394|P3|Overall Study|Adverse Event|1
4738529|NCT01863953|16345395|P2|Overall Study|Adverse Event|0
4738530|NCT01863953|16345396|P1|Overall Study|Adverse Event|0
4738531|NCT01863771|16345410|P4|Maintenance Phase|Withdrawal by Subject|3
4738532|NCT01863771|16345411|P3|Maintenance Phase|Withdrawal by Subject|2
4738533|NCT01863771|16345412|P2|Maintenance Phase|Withdrawal by Subject|1
4738534|NCT01863771|16345413|P1|Maintenance Phase|Withdrawal by Subject|0
4738535|NCT01863771|16345410|P4|Maintenance Phase|Pregnancy|0
4738536|NCT01863771|16345411|P3|Maintenance Phase|Pregnancy|0
4738537|NCT01863771|16345412|P2|Maintenance Phase|Pregnancy|1
4738538|NCT01863771|16345413|P1|Maintenance Phase|Pregnancy|0
4738539|NCT01863771|16345410|P4|Maintenance Phase|Physician Decision|1
4738540|NCT01863771|16345411|P3|Maintenance Phase|Physician Decision|2
4738541|NCT01863771|16345412|P2|Maintenance Phase|Physician Decision|0
4738542|NCT01863771|16345413|P1|Maintenance Phase|Physician Decision|0
4738543|NCT01863771|16345410|P4|Maintenance Phase|Lack of Efficacy|38
4738544|NCT01863771|16345411|P3|Maintenance Phase|Lack of Efficacy|7
4738545|NCT01863771|16345412|P2|Maintenance Phase|Lack of Efficacy|3
4738546|NCT01863771|16345413|P1|Maintenance Phase|Lack of Efficacy|0
4738547|NCT01863771|16345410|P4|Maintenance Phase|Adverse Event|1
4738548|NCT01863771|16345411|P3|Maintenance Phase|Adverse Event|1
4738549|NCT01863771|16345412|P2|Maintenance Phase|Adverse Event|0
4738550|NCT01863771|16345413|P1|Maintenance Phase|Adverse Event|0
4738551|NCT01863771|16345410|P4|Induction Phase|Withdrawal by Subject|0
4738552|NCT01863771|16345411|P3|Induction Phase|Withdrawal by Subject|0
4738553|NCT01863771|16345412|P2|Induction Phase|Withdrawal by Subject|0
4738554|NCT01863771|16345413|P1|Induction Phase|Withdrawal by Subject|2
4738555|NCT01863771|16345410|P4|Induction Phase|Lack of Efficacy|0
4738556|NCT01863771|16345411|P3|Induction Phase|Lack of Efficacy|0
4738557|NCT01863771|16345412|P2|Induction Phase|Lack of Efficacy|0
4738558|NCT01863771|16345413|P1|Induction Phase|Lack of Efficacy|10
4738559|NCT01863771|16345410|P4|Induction Phase|Adverse Event|0
4738560|NCT01863771|16345411|P3|Induction Phase|Adverse Event|0
4738561|NCT01863771|16345412|P2|Induction Phase|Adverse Event|0
4738562|NCT01863771|16345413|P1|Induction Phase|Adverse Event|9
4738563|NCT01863758|16345425|P1|Prophylactic Treatment-Phase II|Lost to Follow-up|1
4738564|NCT01863758|16345425|P1|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1
4738565|NCT01863732|16345437|P4|Overall Study|Death|1
4738566|NCT01863732|16345438|P3|Overall Study|Death|0
4738567|NCT01863732|16345439|P2|Overall Study|Death|0
4738568|NCT01863732|16345440|P1|Overall Study|Death|1
4738569|NCT01863732|16345437|P4|Overall Study|Subject/guardian decision|1
4738570|NCT01863732|16345438|P3|Overall Study|Subject/guardian decision|3
4738571|NCT01863732|16345439|P2|Overall Study|Subject/guardian decision|9
4738572|NCT01863732|16345440|P1|Overall Study|Subject/guardian decision|6
4738573|NCT01863732|16345437|P4|Overall Study|Technical problems|0
4738574|NCT01863732|16345438|P3|Overall Study|Technical problems|1
4738575|NCT01863732|16345439|P2|Overall Study|Technical problems|1
4738576|NCT01863732|16345440|P1|Overall Study|Technical problems|0
4738577|NCT01863732|16345437|P4|Overall Study|Pregnancy|1
4738578|NCT01863732|16345438|P3|Overall Study|Pregnancy|0
4738579|NCT01863732|16345439|P2|Overall Study|Pregnancy|0
4738580|NCT01863732|16345440|P1|Overall Study|Pregnancy|0
4738581|NCT01863732|16345437|P4|Overall Study|Physician Decision|0
4738582|NCT01863732|16345438|P3|Overall Study|Physician Decision|1
4738583|NCT01863732|16345439|P2|Overall Study|Physician Decision|0
4738584|NCT01863732|16345440|P1|Overall Study|Physician Decision|1
4738585|NCT01863732|16345437|P4|Overall Study|Lost to Follow-up|1
4738586|NCT01863732|16345438|P3|Overall Study|Lost to Follow-up|1
4738587|NCT01863732|16345439|P2|Overall Study|Lost to Follow-up|2
4738588|NCT01863732|16345440|P1|Overall Study|Lost to Follow-up|2
4738589|NCT01863732|16345437|P4|Overall Study|Lack of Efficacy|1
4738590|NCT01863732|16345438|P3|Overall Study|Lack of Efficacy|2
4738591|NCT01863732|16345439|P2|Overall Study|Lack of Efficacy|0
4738592|NCT01863732|16345440|P1|Overall Study|Lack of Efficacy|1
4738593|NCT01863732|16345437|P4|Overall Study|Adverse Event|3
4738594|NCT01863732|16345438|P3|Overall Study|Adverse Event|3
4738595|NCT01863732|16345439|P2|Overall Study|Adverse Event|0
4738596|NCT01863732|16345440|P1|Overall Study|Adverse Event|2
4738597|NCT01863680|16345453|P1|Overall Study|Other|6
4738598|NCT01863680|16345453|P1|Overall Study|Did not undergo IVF/ET|14
4738599|NCT01863680|16345453|P1|Overall Study|Withdrawal by Subject|1
4738600|NCT01863680|16345453|P1|Overall Study|Spontaneous pregnancy|2
4738601|NCT01863680|16345453|P1|Overall Study|Risk of OHSS|17
4738602|NCT01863680|16345453|P1|Overall Study|Adverse Event|17
4738603|NCT01863667|16345461|P2|Overall Study|Withdrawal by Subject|2
4738604|NCT01863667|16345462|P1|Overall Study|Withdrawal by Subject|2
4738605|NCT01863667|16345461|P2|Overall Study|Study terminated by Sponsor|30
4738606|NCT01863667|16345462|P1|Overall Study|Study terminated by Sponsor|30
4738607|NCT01863667|16345461|P2|Overall Study|Adverse Event|0
4738608|NCT01863667|16345462|P1|Overall Study|Adverse Event|1
4738609|NCT01863433|16345486|P1|Overall Study|Protocol Violation|1
4738610|NCT01863368|16345496|P2|Phase II, Day 35 to Day 90|Lost to Follow-up|0
4738611|NCT01863368|16345497|P1|Phase II, Day 35 to Day 90|Lost to Follow-up|1
4738612|NCT01863368|16345496|P2|Phase II, Day 35 to Day 90|Adverse Event|0
4738613|NCT01863368|16345497|P1|Phase II, Day 35 to Day 90|Adverse Event|1
4738614|NCT01863368|16345496|P2|Phase I, Day 0 to Day 35|Withdrawal by Subject|2
4738615|NCT01863368|16345497|P1|Phase I, Day 0 to Day 35|Withdrawal by Subject|0
4738616|NCT01863368|16345496|P2|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1
4738617|NCT01863368|16345497|P1|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0
4738618|NCT01863368|16345496|P2|Phase I, Day 0 to Day 35|Lost to Follow-up|0
4738619|NCT01863368|16345497|P1|Phase I, Day 0 to Day 35|Lost to Follow-up|1
4738620|NCT01863368|16345496|P2|Phase I, Day 0 to Day 35|Adverse Event|4
4738621|NCT01863368|16345497|P1|Phase I, Day 0 to Day 35|Adverse Event|2
4738622|NCT01862991|16345551|P3|Overall Study|Protocol Violation|0
4738623|NCT01862991|16345552|P2|Overall Study|Protocol Violation|0
4738624|NCT01862991|16345553|P1|Overall Study|Protocol Violation|1
4738625|NCT01862991|16345551|P3|Overall Study|Lost to Follow-up|1
4738626|NCT01862991|16345552|P2|Overall Study|Lost to Follow-up|1
4738627|NCT01862991|16345553|P1|Overall Study|Lost to Follow-up|2
4738628|NCT01862874|16345566|P2|Overall Study|Death|1
4738629|NCT01862874|16345567|P1|Overall Study|Death|0
4738630|NCT01862874|16345566|P2|Overall Study|Withdrawal by Subject|40
4738631|NCT01862874|16345567|P1|Overall Study|Withdrawal by Subject|46
4738632|NCT01862874|16345566|P2|Overall Study|Withdrawn by parent/guardian|1
4738633|NCT01862874|16345567|P1|Overall Study|Withdrawn by parent/guardian|1
4738634|NCT01862874|16345566|P2|Overall Study|Physician Decision|3
4738635|NCT01862874|16345567|P1|Overall Study|Physician Decision|5
4738636|NCT01862874|16345566|P2|Overall Study|Lost to Follow-up|29
4738637|NCT01862874|16345567|P1|Overall Study|Lost to Follow-up|26
4738638|NCT01862874|16345566|P2|Overall Study|Adverse Event|3
4738639|NCT01862874|16345567|P1|Overall Study|Adverse Event|0
4738640|NCT01862874|16345566|P2|Overall Study|Randomized not treated|0
4738641|NCT01862874|16345567|P1|Overall Study|Randomized not treated|1
4738642|NCT01862796|16345586|P3|Overall Study|Prohibited medications|1
4738643|NCT01862796|16345587|P2|Overall Study|Prohibited medications|0
4738644|NCT01862796|16345588|P1|Overall Study|Prohibited medications|0
4738645|NCT01862640|16345603|P4|Overall Study|Protocol Deviation|0
4738646|NCT01862640|16345604|P3|Overall Study|Protocol Deviation|1
4738647|NCT01862640|16345605|P2|Overall Study|Protocol Deviation|0
4738648|NCT01862640|16345606|P1|Overall Study|Protocol Deviation|0
4738649|NCT01862640|16345603|P4|Overall Study|Withdrawal by Subject|5
4738650|NCT01862640|16345604|P3|Overall Study|Withdrawal by Subject|8
4738651|NCT01862640|16345605|P2|Overall Study|Withdrawal by Subject|4
4738652|NCT01862640|16345606|P1|Overall Study|Withdrawal by Subject|2
4738653|NCT01862640|16345603|P4|Overall Study|Participant Withdrawn by Investigator|1
4738654|NCT01862640|16345604|P3|Overall Study|Participant Withdrawn by Investigator|1
4738655|NCT01862640|16345605|P2|Overall Study|Participant Withdrawn by Investigator|1
4738656|NCT01862640|16345606|P1|Overall Study|Participant Withdrawn by Investigator|0
4738657|NCT01862640|16345603|P4|Overall Study|Participant Met Withdrawal Criteria|1
4738658|NCT01862640|16345604|P3|Overall Study|Participant Met Withdrawal Criteria|2
4738659|NCT01862640|16345605|P2|Overall Study|Participant Met Withdrawal Criteria|1
4738660|NCT01862640|16345606|P1|Overall Study|Participant Met Withdrawal Criteria|1
4738661|NCT01862640|16345603|P4|Overall Study|Adverse Event|8
4738662|NCT01862640|16345604|P3|Overall Study|Adverse Event|6
4738663|NCT01862640|16345605|P2|Overall Study|Adverse Event|10
4738664|NCT01862640|16345606|P1|Overall Study|Adverse Event|4
4738665|NCT01862484|16345620|P2|Overall Study|Withdrawal by Subject|3
4738666|NCT01862484|16345621|P1|Overall Study|Withdrawal by Subject|0
4738667|NCT01862484|16345620|P2|Overall Study|Protocol Violation|2
4738668|NCT01862484|16345621|P1|Overall Study|Protocol Violation|0
4738669|NCT01862484|16345620|P2|Overall Study|Lost to Follow-up|2
4738670|NCT01862484|16345621|P1|Overall Study|Lost to Follow-up|1
4738671|NCT01862484|16345620|P2|Overall Study|Lack of Efficacy|1
4738672|NCT01862484|16345621|P1|Overall Study|Lack of Efficacy|1
4738673|NCT01862328|16345647|P7|Overall Study|Symptomatic Deterioration|1
4738674|NCT01862328|16345648|P6|Overall Study|Symptomatic Deterioration|0
4738675|NCT01862328|16345649|P5|Overall Study|Symptomatic Deterioration|0
4738676|NCT01862328|16345650|P4|Overall Study|Symptomatic Deterioration|0
4738677|NCT01862328|16345651|P3|Overall Study|Symptomatic Deterioration|0
4738678|NCT01862328|16345652|P2|Overall Study|Symptomatic Deterioration|0
4738679|NCT01862328|16345653|P1|Overall Study|Symptomatic Deterioration|0
4738680|NCT01862328|16345647|P7|Overall Study|Withdrawal by Subject|1
4738681|NCT01862328|16345648|P6|Overall Study|Withdrawal by Subject|1
4738682|NCT01862328|16345649|P5|Overall Study|Withdrawal by Subject|1
4738683|NCT01862328|16345650|P4|Overall Study|Withdrawal by Subject|0
4738684|NCT01862328|16345651|P3|Overall Study|Withdrawal by Subject|0
4738685|NCT01862328|16345652|P2|Overall Study|Withdrawal by Subject|1
4738686|NCT01862328|16345653|P1|Overall Study|Withdrawal by Subject|1
4738687|NCT01862328|16345647|P7|Overall Study|Other|1
4738688|NCT01862328|16345648|P6|Overall Study|Other|0
4738689|NCT01862328|16345649|P5|Overall Study|Other|4
4738690|NCT01862328|16345650|P4|Overall Study|Other|0
4738691|NCT01862328|16345651|P3|Overall Study|Other|1
4738692|NCT01862328|16345652|P2|Overall Study|Other|2
4738693|NCT01862328|16345653|P1|Overall Study|Other|0
4738694|NCT01862328|16345647|P7|Overall Study|Adverse Event|4
4738695|NCT01862328|16345648|P6|Overall Study|Adverse Event|2
4738696|NCT01862328|16345649|P5|Overall Study|Adverse Event|0
4738697|NCT01862328|16345650|P4|Overall Study|Adverse Event|1
4738698|NCT01862328|16345651|P3|Overall Study|Adverse Event|0
4738699|NCT01862328|16345652|P2|Overall Study|Adverse Event|4
4738700|NCT01862328|16345653|P1|Overall Study|Adverse Event|0
4738701|NCT01862328|16345647|P7|Overall Study|Progressive Disease|3
4738702|NCT01862328|16345648|P6|Overall Study|Progressive Disease|4
4738703|NCT01862328|16345649|P5|Overall Study|Progressive Disease|7
4738704|NCT01862328|16345650|P4|Overall Study|Progressive Disease|6
4738705|NCT01862328|16345651|P3|Overall Study|Progressive Disease|5
4738706|NCT01862328|16345652|P2|Overall Study|Progressive Disease|11
4738707|NCT01862328|16345653|P1|Overall Study|Progressive Disease|3
4738708|NCT01862250|16345705|P1|Overall Study|Adverse Event|4
4738709|NCT01862029|16345726|P1|Overall Study|Physician Decision|1
4738710|NCT01861522|16345829|P2|Overall Study|Withdrawal by Subject|0
4738711|NCT01861522|16345830|P1|Overall Study|Withdrawal by Subject|2
4738712|NCT01861522|16345829|P2|Overall Study|Adverse Event|0
4738713|NCT01861522|16345830|P1|Overall Study|Adverse Event|1
4738714|NCT01860989|16345854|P1|Overall Study|Unsatisfactory therapeutic|5
4738715|NCT01860976|16345860|P2|Long Term Extension|Ongoing treatment at time of analysis|100
4738716|NCT01860976|16345861|P1|Long Term Extension|Ongoing treatment at time of analysis|106
4738717|NCT01860976|16345860|P2|Long Term Extension|Withdrawal by Subject|0
4738718|NCT01860976|16345861|P1|Long Term Extension|Withdrawal by Subject|1
4738719|NCT01860976|16345860|P2|Long Term Extension|Subject request to discontinue treatment|0
4738720|NCT01860976|16345861|P1|Long Term Extension|Subject request to discontinue treatment|2
4738721|NCT01860976|16345860|P2|Long Term Extension|Lack of Efficacy|7
4738722|NCT01860976|16345861|P1|Long Term Extension|Lack of Efficacy|3
4738723|NCT01860976|16345860|P2|Long Term Extension|Adverse Event|0
4738724|NCT01860976|16345861|P1|Long Term Extension|Adverse Event|1
4738725|NCT01860976|16345860|P2|Open-Label|Ongoing OL treatment at time of analysis|45
4738726|NCT01860976|16345861|P1|Open-Label|Ongoing OL treatment at time of analysis|46
4738727|NCT01860976|16345860|P2|Open-Label|Other Reasons|1
4738728|NCT01860976|16345861|P1|Open-Label|Other Reasons|1
4738729|NCT01860976|16345860|P2|Open-Label|Withdrawal by Subject|1
4738730|NCT01860976|16345861|P1|Open-Label|Withdrawal by Subject|4
4738731|NCT01860976|16345860|P2|Open-Label|Subject request discontinue treatment|3
4738732|NCT01860976|16345861|P1|Open-Label|Subject request discontinue treatment|4
4738733|NCT01860976|16345860|P2|Open-Label|Lost to Follow-up|2
4738734|NCT01860976|16345861|P1|Open-Label|Lost to Follow-up|1
4738735|NCT01860976|16345860|P2|Open-Label|Lack of Efficacy|8
4738736|NCT01860976|16345861|P1|Open-Label|Lack of Efficacy|16
4738737|NCT01860976|16345860|P2|Open-Label|Adverse Event|4
4738738|NCT01860976|16345861|P1|Open-Label|Adverse Event|2
4738739|NCT01860976|16345860|P2|Blinded Treatment|Early Escape: Transitioned to OL period|89
4738740|NCT01860976|16345861|P1|Blinded Treatment|Early Escape: Transitioned to OL period|76
4738741|NCT01860976|16345860|P2|Blinded Treatment|Entered Open-Label in error|1
4738742|NCT01860976|16345861|P1|Blinded Treatment|Entered Open-Label in error|0
4738743|NCT01860976|16345860|P2|Blinded Treatment|Subject no longer met criteria|0
4738744|NCT01860976|16345861|P1|Blinded Treatment|Subject no longer met criteria|1
4738745|NCT01860976|16345860|P2|Blinded Treatment|Withdrawal by Subject|5
4738746|NCT01860976|16345861|P1|Blinded Treatment|Withdrawal by Subject|3
4738747|NCT01860976|16345860|P2|Blinded Treatment|Subject request to discontinue treatment|3
4738748|NCT01860976|16345861|P1|Blinded Treatment|Subject request to discontinue treatment|2
4738749|NCT01860976|16345860|P2|Blinded Treatment|Lack of Efficacy|12
4738750|NCT01860976|16345861|P1|Blinded Treatment|Lack of Efficacy|5
4738751|NCT01860976|16345860|P2|Blinded Treatment|Adverse Event|3
4738752|NCT01860976|16345861|P1|Blinded Treatment|Adverse Event|1
4738753|NCT01860846|16345915|P1|Overall Study|Lost to Follow-up|33
4738754|NCT01860703|16345935|P4|Overall Study|Personal reason|0
4738755|NCT01860703|16345936|P3|Overall Study|Personal reason|1
4738756|NCT01860703|16345937|P2|Overall Study|Personal reason|0
4738757|NCT01860703|16345938|P1|Overall Study|Personal reason|1
4738758|NCT01860703|16345935|P4|Overall Study|Withdrawal by Subject|0
4738759|NCT01860703|16345936|P3|Overall Study|Withdrawal by Subject|0
4738760|NCT01860703|16345937|P2|Overall Study|Withdrawal by Subject|1
4738761|NCT01860703|16345938|P1|Overall Study|Withdrawal by Subject|0
4738762|NCT01860703|16345935|P4|Overall Study|Adverse Event|2
4738763|NCT01860703|16345936|P3|Overall Study|Adverse Event|0
4738764|NCT01860703|16345937|P2|Overall Study|Adverse Event|4
4738765|NCT01860703|16345938|P1|Overall Study|Adverse Event|1
4738766|NCT01860677|16345970|P2|Second Intervention (1 Day)|Lost to Follow-up|0
4738767|NCT01860677|16345971|P1|Second Intervention (1 Day)|Lost to Follow-up|7
4738768|NCT01860534|16346028|P2|ROP #2|discharged prior to ROP #2|0
4738769|NCT01860534|16346029|P1|ROP #2|discharged prior to ROP #2|1
4738770|NCT01860534|16346028|P2|ROP #1|Needed treatment for ROP|1
4738771|NCT01860534|16346029|P1|ROP #1|Needed treatment for ROP|0
4738772|NCT01860079|16346090|P2|Overall Study|Physician Decision|22
4738773|NCT01860079|16346091|P1|Overall Study|Physician Decision|14
4738774|NCT01860040|16346099|P2|Overall Study|Withdrawal by Subject|0
4738775|NCT01860040|16346100|P1|Overall Study|Withdrawal by Subject|1
4738776|NCT01859988|16346111|P6|Overall Study|Other than specified above|3
4738777|NCT01859988|16346112|P5|Overall Study|Other than specified above|5
4738778|NCT01859988|16346113|P4|Overall Study|Other than specified above|3
4738779|NCT01859988|16346114|P3|Overall Study|Other than specified above|11
4738780|NCT01859988|16346115|P2|Overall Study|Other than specified above|2
4738781|NCT01859988|16346116|P1|Overall Study|Other than specified above|0
4738782|NCT01859988|16346111|P6|Overall Study|Protocol Violation|0
4738783|NCT01859988|16346112|P5|Overall Study|Protocol Violation|0
4738784|NCT01859988|16346113|P4|Overall Study|Protocol Violation|0
4738785|NCT01859988|16346114|P3|Overall Study|Protocol Violation|1
4738786|NCT01859988|16346115|P2|Overall Study|Protocol Violation|0
4738787|NCT01859988|16346116|P1|Overall Study|Protocol Violation|0
4738788|NCT01859988|16346111|P6|Overall Study|Lost to Follow-up|2
4738789|NCT01859988|16346112|P5|Overall Study|Lost to Follow-up|3
4738790|NCT01859988|16346113|P4|Overall Study|Lost to Follow-up|0
4738791|NCT01859988|16346114|P3|Overall Study|Lost to Follow-up|3
4738792|NCT01859988|16346115|P2|Overall Study|Lost to Follow-up|2
4738793|NCT01859988|16346116|P1|Overall Study|Lost to Follow-up|1
4738794|NCT01859988|16346111|P6|Overall Study|Adverse Event|2
4738795|NCT01859988|16346112|P5|Overall Study|Adverse Event|2
4738796|NCT01859988|16346113|P4|Overall Study|Adverse Event|1
4738797|NCT01859988|16346114|P3|Overall Study|Adverse Event|3
4738798|NCT01859988|16346115|P2|Overall Study|Adverse Event|1
4738799|NCT01859988|16346116|P1|Overall Study|Adverse Event|2
4738800|NCT01859988|16346111|P6|Overall Study|Physician Decision|1
4738801|NCT01859988|16346112|P5|Overall Study|Physician Decision|4
4738802|NCT01859988|16346113|P4|Overall Study|Physician Decision|3
4738803|NCT01859988|16346114|P3|Overall Study|Physician Decision|1
4738804|NCT01859988|16346115|P2|Overall Study|Physician Decision|3
4738805|NCT01859988|16346116|P1|Overall Study|Physician Decision|1
4738806|NCT01859988|16346111|P6|Overall Study|Lack of Efficacy|9
4738807|NCT01859988|16346112|P5|Overall Study|Lack of Efficacy|7
4738808|NCT01859988|16346113|P4|Overall Study|Lack of Efficacy|0
4738809|NCT01859988|16346114|P3|Overall Study|Lack of Efficacy|5
4738810|NCT01859988|16346115|P2|Overall Study|Lack of Efficacy|1
4738811|NCT01859988|16346116|P1|Overall Study|Lack of Efficacy|1
4738812|NCT01859988|16346111|P6|Overall Study|Withdrawal by Subject|2
4738813|NCT01859988|16346112|P5|Overall Study|Withdrawal by Subject|2
4738814|NCT01859988|16346113|P4|Overall Study|Withdrawal by Subject|3
4738815|NCT01859988|16346114|P3|Overall Study|Withdrawal by Subject|4
4738816|NCT01859988|16346115|P2|Overall Study|Withdrawal by Subject|3
4738817|NCT01859988|16346116|P1|Overall Study|Withdrawal by Subject|6
4738818|NCT01859949|16346210|P2|Overall Study|Adverse Event|1
4738819|NCT01859949|16346211|P1|Overall Study|Adverse Event|0
4738820|NCT01859949|16346210|P2|Overall Study|Protocol Violation|1
4738821|NCT01859949|16346211|P1|Overall Study|Protocol Violation|1
4738822|NCT01859949|16346210|P2|Overall Study|Withdrawal by Subject|10
4738823|NCT01859949|16346211|P1|Overall Study|Withdrawal by Subject|11
4738824|NCT01859949|16346210|P2|Overall Study|Physician Decision|4
4738825|NCT01859949|16346211|P1|Overall Study|Physician Decision|2
4738826|NCT01859949|16346210|P2|Overall Study|Family Matters|1
4738827|NCT01859949|16346211|P1|Overall Study|Family Matters|0
4738828|NCT01859793|16346229|P2|Washout Period (4 Weeks)|Lost to Follow-up|1
4738829|NCT01859793|16346230|P1|Washout Period (4 Weeks)|Lost to Follow-up|1
4738830|NCT01859793|16346229|P2|First Intervention (8 Weeks)|Withdrawal by Subject|1
4738831|NCT01859793|16346230|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
4738832|NCT01859793|16346229|P2|First Intervention (8 Weeks)|Adverse Event|0
4738833|NCT01859793|16346230|P1|First Intervention (8 Weeks)|Adverse Event|1
4738834|NCT01859793|16346229|P2|First Intervention (8 Weeks)|Protocol Violation|0
4738835|NCT01859793|16346230|P1|First Intervention (8 Weeks)|Protocol Violation|2
4738836|NCT01859741|16346248|P8|Overall Study|Other|0
4738837|NCT01859741|16346249|P7|Overall Study|Other|2
4738838|NCT01859741|16346250|P6|Overall Study|Other|0
4738839|NCT01859741|16346251|P5|Overall Study|Other|0
4738840|NCT01859741|16346252|P4|Overall Study|Other|0
4738841|NCT01859741|16346253|P3|Overall Study|Other|0
4738842|NCT01859741|16346254|P2|Overall Study|Other|0
4738843|NCT01859741|16346255|P1|Overall Study|Other|0
4738844|NCT01859741|16346248|P8|Overall Study|Study Terminated by Sponsor|14
4738845|NCT01859741|16346249|P7|Overall Study|Study Terminated by Sponsor|16
4738846|NCT01859741|16346250|P6|Overall Study|Study Terminated by Sponsor|0
4738847|NCT01859741|16346251|P5|Overall Study|Study Terminated by Sponsor|1
4738848|NCT01859741|16346252|P4|Overall Study|Study Terminated by Sponsor|0
4738849|NCT01859741|16346253|P3|Overall Study|Study Terminated by Sponsor|0
4738850|NCT01859741|16346254|P2|Overall Study|Study Terminated by Sponsor|0
4738851|NCT01859741|16346255|P1|Overall Study|Study Terminated by Sponsor|0
4738852|NCT01859741|16346248|P8|Overall Study|Withdrawal by Subject|1
4738853|NCT01859741|16346249|P7|Overall Study|Withdrawal by Subject|1
4738854|NCT01859741|16346250|P6|Overall Study|Withdrawal by Subject|1
4738855|NCT01859741|16346251|P5|Overall Study|Withdrawal by Subject|0
4738856|NCT01859741|16346252|P4|Overall Study|Withdrawal by Subject|0
4738857|NCT01859741|16346253|P3|Overall Study|Withdrawal by Subject|2
4738858|NCT01859741|16346254|P2|Overall Study|Withdrawal by Subject|1
4738859|NCT01859741|16346255|P1|Overall Study|Withdrawal by Subject|0
4738860|NCT01859741|16346248|P8|Overall Study|Lost to Follow-up|4
4738861|NCT01859741|16346249|P7|Overall Study|Lost to Follow-up|0
4738862|NCT01859741|16346250|P6|Overall Study|Lost to Follow-up|1
4738863|NCT01859741|16346251|P5|Overall Study|Lost to Follow-up|0
4738864|NCT01859741|16346252|P4|Overall Study|Lost to Follow-up|0
4738865|NCT01859741|16346253|P3|Overall Study|Lost to Follow-up|0
4738866|NCT01859741|16346254|P2|Overall Study|Lost to Follow-up|0
4738867|NCT01859741|16346255|P1|Overall Study|Lost to Follow-up|0
4738868|NCT01859741|16346248|P8|Overall Study|Death|51
4738869|NCT01859741|16346249|P7|Overall Study|Death|51
4738870|NCT01859741|16346250|P6|Overall Study|Death|4
4738871|NCT01859741|16346251|P5|Overall Study|Death|5
4738872|NCT01859741|16346252|P4|Overall Study|Death|3
4738873|NCT01859741|16346253|P3|Overall Study|Death|4
4738874|NCT01859741|16346254|P2|Overall Study|Death|2
4738875|NCT01859741|16346255|P1|Overall Study|Death|3
4738876|NCT01859715|16346284|P3|Overall Study|No 2nd VAS|23
4738877|NCT01859715|16346285|P2|Overall Study|No 2nd VAS|8
4738878|NCT01859715|16346286|P1|Overall Study|No 2nd VAS|16
4738879|NCT01859702|16346297|P1|Overall Study|Adverse Event|2
4738880|NCT01859702|16346297|P1|Overall Study|Protocol deviation|3
4738881|NCT01859598|16346311|P1|Visit 2 at 3 Months|Lost to Follow-up|1742
4738882|NCT01859507|16346319|P1|Overall Study|left the country|4
4738883|NCT01859494|16346324|P1|Overall Study|Adverse Event|1
4738884|NCT01859390|16346335|P2|Overall Study|Shipment Error|1
4738885|NCT01859390|16346336|P1|Overall Study|Shipment Error|0
4738886|NCT01859390|16346335|P2|Overall Study|Tube Cracked|2
4738887|NCT01859390|16346336|P1|Overall Study|Tube Cracked|0
4738888|NCT01859390|16346335|P2|Overall Study|Sample Missing Collection Date|1
4738889|NCT01859390|16346336|P1|Overall Study|Sample Missing Collection Date|0
4738890|NCT01859390|16346335|P2|Overall Study|Insufficient Sputum Collected|3
4738891|NCT01859390|16346336|P1|Overall Study|Insufficient Sputum Collected|1
4738892|NCT01859143|16346470|P2|Overall Study|Lost to Follow-up|0
4738893|NCT01859143|16346471|P1|Overall Study|Lost to Follow-up|2
4738894|NCT01858766|16346527|P19|Overall Study|Withdrew Consent|0
4738895|NCT01858766|16346528|P18|Overall Study|Withdrew Consent|0
4738896|NCT01858766|16346529|P17|Overall Study|Withdrew Consent|0
4738897|NCT01858766|16346530|P16|Overall Study|Withdrew Consent|0
4738898|NCT01858766|16346531|P15|Overall Study|Withdrew Consent|0
4738899|NCT01858766|16346532|P14|Overall Study|Withdrew Consent|0
4738900|NCT01858766|16346533|P13|Overall Study|Withdrew Consent|0
4738901|NCT01858766|16346534|P12|Overall Study|Withdrew Consent|1
4738902|NCT01858766|16346535|P11|Overall Study|Withdrew Consent|0
4738903|NCT01858766|16346536|P10|Overall Study|Withdrew Consent|0
4738904|NCT01858766|16346537|P9|Overall Study|Withdrew Consent|0
4738905|NCT01858766|16346538|P8|Overall Study|Withdrew Consent|0
4738906|NCT01858766|16346539|P7|Overall Study|Withdrew Consent|0
4738907|NCT01858766|16346540|P6|Overall Study|Withdrew Consent|0
4738908|NCT01858766|16346541|P5|Overall Study|Withdrew Consent|0
4738909|NCT01858766|16346542|P4|Overall Study|Withdrew Consent|0
4738910|NCT01858766|16346543|P3|Overall Study|Withdrew Consent|0
4738911|NCT01858766|16346544|P2|Overall Study|Withdrew Consent|0
4738912|NCT01858766|16346545|P1|Overall Study|Withdrew Consent|0
4738913|NCT01858766|16346527|P19|Overall Study|Lost to Follow-up|1
4738914|NCT01858766|16346528|P18|Overall Study|Lost to Follow-up|0
4738915|NCT01858766|16346529|P17|Overall Study|Lost to Follow-up|1
4738916|NCT01858766|16346530|P16|Overall Study|Lost to Follow-up|1
4738917|NCT01858766|16346531|P15|Overall Study|Lost to Follow-up|3
4738918|NCT01858766|16346532|P14|Overall Study|Lost to Follow-up|0
4738919|NCT01858766|16346533|P13|Overall Study|Lost to Follow-up|0
4738920|NCT01858766|16346534|P12|Overall Study|Lost to Follow-up|1
4738921|NCT01858766|16346535|P11|Overall Study|Lost to Follow-up|0
4738922|NCT01858766|16346536|P10|Overall Study|Lost to Follow-up|0
4738923|NCT01858766|16346537|P9|Overall Study|Lost to Follow-up|0
4738924|NCT01858766|16346538|P8|Overall Study|Lost to Follow-up|2
4738925|NCT01858766|16346539|P7|Overall Study|Lost to Follow-up|0
4738926|NCT01858766|16346540|P6|Overall Study|Lost to Follow-up|1
4738927|NCT01858766|16346541|P5|Overall Study|Lost to Follow-up|0
4738928|NCT01858766|16346542|P4|Overall Study|Lost to Follow-up|0
4738929|NCT01858766|16346543|P3|Overall Study|Lost to Follow-up|0
4738930|NCT01858766|16346544|P2|Overall Study|Lost to Follow-up|0
4738931|NCT01858766|16346545|P1|Overall Study|Lost to Follow-up|0
4738932|NCT01858766|16346527|P19|Overall Study|Lack of Efficacy|3
4738933|NCT01858766|16346528|P18|Overall Study|Lack of Efficacy|3
4738934|NCT01858766|16346529|P17|Overall Study|Lack of Efficacy|2
4738935|NCT01858766|16346530|P16|Overall Study|Lack of Efficacy|5
4738936|NCT01858766|16346531|P15|Overall Study|Lack of Efficacy|5
4738937|NCT01858766|16346532|P14|Overall Study|Lack of Efficacy|3
4738938|NCT01858766|16346533|P13|Overall Study|Lack of Efficacy|5
4738939|NCT01858766|16346534|P12|Overall Study|Lack of Efficacy|3
4738940|NCT01858766|16346535|P11|Overall Study|Lack of Efficacy|0
4738941|NCT01858766|16346536|P10|Overall Study|Lack of Efficacy|0
4738942|NCT01858766|16346537|P9|Overall Study|Lack of Efficacy|0
4738943|NCT01858766|16346538|P8|Overall Study|Lack of Efficacy|0
4738944|NCT01858766|16346539|P7|Overall Study|Lack of Efficacy|0
4738945|NCT01858766|16346540|P6|Overall Study|Lack of Efficacy|2
4738946|NCT01858766|16346541|P5|Overall Study|Lack of Efficacy|1
4738947|NCT01858766|16346542|P4|Overall Study|Lack of Efficacy|0
4738948|NCT01858766|16346543|P3|Overall Study|Lack of Efficacy|0
4738949|NCT01858766|16346544|P2|Overall Study|Lack of Efficacy|0
4738950|NCT01858766|16346545|P1|Overall Study|Lack of Efficacy|1
4738951|NCT01858766|16346527|P19|Overall Study|Death|0
4738952|NCT01858766|16346528|P18|Overall Study|Death|0
4738953|NCT01858766|16346529|P17|Overall Study|Death|0
4738954|NCT01858766|16346530|P16|Overall Study|Death|0
4738955|NCT01858766|16346531|P15|Overall Study|Death|0
4738956|NCT01858766|16346532|P14|Overall Study|Death|0
4738957|NCT01858766|16346533|P13|Overall Study|Death|0
4738958|NCT01858766|16346534|P12|Overall Study|Death|0
4738959|NCT01858766|16346535|P11|Overall Study|Death|0
4738960|NCT01858766|16346536|P10|Overall Study|Death|0
4738961|NCT01858766|16346537|P9|Overall Study|Death|0
4738962|NCT01858766|16346538|P8|Overall Study|Death|0
4738963|NCT01858766|16346539|P7|Overall Study|Death|0
4738964|NCT01858766|16346540|P6|Overall Study|Death|0
4738965|NCT01858766|16346541|P5|Overall Study|Death|0
4738966|NCT01858766|16346542|P4|Overall Study|Death|0
4738967|NCT01858766|16346543|P3|Overall Study|Death|1
4738968|NCT01858766|16346544|P2|Overall Study|Death|0
4738969|NCT01858766|16346545|P1|Overall Study|Death|0
4738970|NCT01858766|16346527|P19|Overall Study|Randomized but Never Treated|0
4738971|NCT01858766|16346528|P18|Overall Study|Randomized but Never Treated|1
4738972|NCT01858766|16346529|P17|Overall Study|Randomized but Never Treated|0
4738973|NCT01858766|16346530|P16|Overall Study|Randomized but Never Treated|0
4738974|NCT01858766|16346531|P15|Overall Study|Randomized but Never Treated|0
4738975|NCT01858766|16346532|P14|Overall Study|Randomized but Never Treated|0
4738976|NCT01858766|16346533|P13|Overall Study|Randomized but Never Treated|0
4738977|NCT01858766|16346534|P12|Overall Study|Randomized but Never Treated|0
4738978|NCT01858766|16346535|P11|Overall Study|Randomized but Never Treated|0
4738979|NCT01858766|16346536|P10|Overall Study|Randomized but Never Treated|0
4738980|NCT01858766|16346537|P9|Overall Study|Randomized but Never Treated|0
4738981|NCT01858766|16346538|P8|Overall Study|Randomized but Never Treated|0
4738982|NCT01858766|16346539|P7|Overall Study|Randomized but Never Treated|0
4738983|NCT01858766|16346540|P6|Overall Study|Randomized but Never Treated|1
4738984|NCT01858766|16346541|P5|Overall Study|Randomized but Never Treated|0
4738985|NCT01858766|16346542|P4|Overall Study|Randomized but Never Treated|0
4738986|NCT01858766|16346543|P3|Overall Study|Randomized but Never Treated|0
4738987|NCT01858766|16346544|P2|Overall Study|Randomized but Never Treated|0
4738988|NCT01858766|16346545|P1|Overall Study|Randomized but Never Treated|0
4738989|NCT01858701|16346616|P2|Period 2, Second 30 Days of Wear|Comfort|1
4738990|NCT01858701|16346617|P1|Period 2, Second 30 Days of Wear|Comfort|0
4738991|NCT01858701|16346616|P2|Washout Period, 1-13 Days|Withdrawal by Subject|2
4738992|NCT01858701|16346617|P1|Washout Period, 1-13 Days|Withdrawal by Subject|1
4738993|NCT01858701|16346616|P2|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0
4738994|NCT01858701|16346617|P1|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1
4738995|NCT01858701|16346616|P2|Period 1, First 30 Days of Wear|Withdrawal by Subject|1
4738996|NCT01858701|16346617|P1|Period 1, First 30 Days of Wear|Withdrawal by Subject|0
4738997|NCT01858636|16346623|P1|Overall Study|Withdrawal by Subject|1
4738998|NCT01858636|16346623|P1|Overall Study|Lost to Follow-up|1
4738999|NCT01858636|16346623|P1|Overall Study|Death|1
4739000|NCT01858636|16346623|P1|Overall Study|Physician Decision|1
4739001|NCT01858636|16346623|P1|Overall Study|No Device Deployment Attempted|24
4739002|NCT01858558|16346630|P2|Overall Study|Failed expansion of cell product|0
4739003|NCT01858558|16346631|P1|Overall Study|Failed expansion of cell product|2
4739004|NCT01858558|16346630|P2|Overall Study|Product contamination|0
4739005|NCT01858558|16346631|P1|Overall Study|Product contamination|2
4739006|NCT01858558|16346630|P2|Overall Study|Disease progression|1
4739007|NCT01858558|16346631|P1|Overall Study|Disease progression|3
4739008|NCT01858558|16346630|P2|Overall Study|Lost to Follow-up|0
4739009|NCT01858558|16346631|P1|Overall Study|Lost to Follow-up|1
4739010|NCT01858558|16346630|P2|Overall Study|Death|1
4739011|NCT01858558|16346631|P1|Overall Study|Death|1
4739012|NCT01858532|16346653|P4|Overall Study|Other, not specified|11
4739013|NCT01858532|16346654|P3|Overall Study|Other, not specified|13
4739014|NCT01858532|16346655|P2|Overall Study|Other, not specified|15
4739015|NCT01858532|16346656|P1|Overall Study|Other, not specified|29
4739016|NCT01858532|16346653|P4|Overall Study|Investigator request|6
4739017|NCT01858532|16346654|P3|Overall Study|Investigator request|2
4739018|NCT01858532|16346655|P2|Overall Study|Investigator request|4
4739019|NCT01858532|16346656|P1|Overall Study|Investigator request|3
4739020|NCT01858532|16346653|P4|Overall Study|Deterioration of medical status|7
4739021|NCT01858532|16346654|P3|Overall Study|Deterioration of medical status|3
4739022|NCT01858532|16346655|P2|Overall Study|Deterioration of medical status|4
4739023|NCT01858532|16346656|P1|Overall Study|Deterioration of medical status|3
4739024|NCT01858532|16346653|P4|Overall Study|Lost to Follow-up|14
4739025|NCT01858532|16346654|P3|Overall Study|Lost to Follow-up|11
4739026|NCT01858532|16346655|P2|Overall Study|Lost to Follow-up|26
4739027|NCT01858532|16346656|P1|Overall Study|Lost to Follow-up|17
4739028|NCT01858532|16346653|P4|Overall Study|Withdrew consent|27
4739029|NCT01858532|16346654|P3|Overall Study|Withdrew consent|46
4739030|NCT01858532|16346655|P2|Overall Study|Withdrew consent|93
4739031|NCT01858532|16346656|P1|Overall Study|Withdrew consent|71
4739032|NCT01858532|16346653|P4|Overall Study|Adverse Event|28
4739033|NCT01858532|16346654|P3|Overall Study|Adverse Event|23
4739034|NCT01858532|16346655|P2|Overall Study|Adverse Event|50
4739035|NCT01858532|16346656|P1|Overall Study|Adverse Event|58
4739036|NCT01858389|16346710|P2|Overall Study|Did not receive treatment|3
4739037|NCT01858389|16346711|P1|Overall Study|Did not receive treatment|0
4739038|NCT01858389|16346710|P2|Overall Study|Adverse Event|1
4739039|NCT01858389|16346711|P1|Overall Study|Adverse Event|3
4739040|NCT01858389|16346710|P2|Overall Study|Other|4
4739041|NCT01858389|16346711|P1|Overall Study|Other|2
4739042|NCT01858389|16346710|P2|Overall Study|Progressive disease|11
4739043|NCT01858389|16346711|P1|Overall Study|Progressive disease|10
4739044|NCT01858389|16346710|P2|Overall Study|Withdrawal by Subject|1
4739045|NCT01858389|16346711|P1|Overall Study|Withdrawal by Subject|0
4739046|NCT01858389|16346710|P2|Overall Study|Study terminated by sponsor|2
4739047|NCT01858389|16346711|P1|Overall Study|Study terminated by sponsor|0
4739048|NCT01858389|16346710|P2|Overall Study|Death|3
4739049|NCT01858389|16346711|P1|Overall Study|Death|1
4739050|NCT01858376|16346726|P1|Overall Study|Dropped d/t lab work not fitting criter|4
4739051|NCT01858194|16346735|P2|Overall Study|Lost to Follow-up|1
4739052|NCT01858194|16346736|P1|Overall Study|Lost to Follow-up|0
4739053|NCT01858194|16346735|P2|Overall Study|Total Artificial Heart Implant|1
4739054|NCT01858194|16346736|P1|Overall Study|Total Artificial Heart Implant|0
4739055|NCT01857973|16346789|P1|Overall Study|Physician Decision|1
4739056|NCT01857973|16346789|P1|Overall Study|drop out after 3 failed attempts|1
4739057|NCT01857973|16346789|P1|Overall Study|Subject did not meet required BG range|3
4739058|NCT01857869|16346819|P10|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739059|NCT01857869|16346820|P9|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739060|NCT01857869|16346821|P8|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739061|NCT01857869|16346822|P7|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739062|NCT01857869|16346823|P6|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739063|NCT01857869|16346824|P5|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739064|NCT01857869|16346825|P4|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1
4739065|NCT01857869|16346826|P3|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739066|NCT01857869|16346827|P2|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739067|NCT01857869|16346828|P1|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0
4739068|NCT01857869|16346819|P10|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739069|NCT01857869|16346820|P9|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739070|NCT01857869|16346821|P8|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739071|NCT01857869|16346822|P7|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739072|NCT01857869|16346823|P6|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739073|NCT01857869|16346824|P5|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739074|NCT01857869|16346825|P4|Booster/Rechallenge Phase|Withdrawal by Subject|1
4739075|NCT01857869|16346826|P3|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739076|NCT01857869|16346827|P2|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739077|NCT01857869|16346828|P1|Booster/Rechallenge Phase|Withdrawal by Subject|0
4739078|NCT01857869|16346819|P10|Primary/Challenge Phase|Other|0
4739079|NCT01857869|16346820|P9|Primary/Challenge Phase|Other|0
4739080|NCT01857869|16346821|P8|Primary/Challenge Phase|Other|0
4739081|NCT01857869|16346822|P7|Primary/Challenge Phase|Other|0
4739082|NCT01857869|16346823|P6|Primary/Challenge Phase|Other|0
4739083|NCT01857869|16346824|P5|Primary/Challenge Phase|Other|0
4739084|NCT01857869|16346825|P4|Primary/Challenge Phase|Other|0
4739085|NCT01857869|16346826|P3|Primary/Challenge Phase|Other|0
4739086|NCT01857869|16346827|P2|Primary/Challenge Phase|Other|1
4739087|NCT01857869|16346828|P1|Primary/Challenge Phase|Other|1
4739088|NCT01857869|16346819|P10|Primary/Challenge Phase|Protocol Violation|0
4739089|NCT01857869|16346820|P9|Primary/Challenge Phase|Protocol Violation|0
4739090|NCT01857869|16346821|P8|Primary/Challenge Phase|Protocol Violation|0
4739091|NCT01857869|16346822|P7|Primary/Challenge Phase|Protocol Violation|0
4739092|NCT01857869|16346823|P6|Primary/Challenge Phase|Protocol Violation|0
4739093|NCT01857869|16346824|P5|Primary/Challenge Phase|Protocol Violation|0
4739094|NCT01857869|16346825|P4|Primary/Challenge Phase|Protocol Violation|0
4739095|NCT01857869|16346826|P3|Primary/Challenge Phase|Protocol Violation|0
4739096|NCT01857869|16346827|P2|Primary/Challenge Phase|Protocol Violation|0
4739097|NCT01857869|16346828|P1|Primary/Challenge Phase|Protocol Violation|1
4739098|NCT01857869|16346819|P10|Primary/Challenge Phase|Pregnancy|0
4739099|NCT01857869|16346820|P9|Primary/Challenge Phase|Pregnancy|0
4739100|NCT01857869|16346821|P8|Primary/Challenge Phase|Pregnancy|0
4739101|NCT01857869|16346822|P7|Primary/Challenge Phase|Pregnancy|0
4739102|NCT01857869|16346823|P6|Primary/Challenge Phase|Pregnancy|0
4739103|NCT01857869|16346824|P5|Primary/Challenge Phase|Pregnancy|0
4739104|NCT01857869|16346825|P4|Primary/Challenge Phase|Pregnancy|0
4739105|NCT01857869|16346826|P3|Primary/Challenge Phase|Pregnancy|0
4739106|NCT01857869|16346827|P2|Primary/Challenge Phase|Pregnancy|0
4739107|NCT01857869|16346828|P1|Primary/Challenge Phase|Pregnancy|1
4739108|NCT01857869|16346819|P10|Primary/Challenge Phase|Lost to Follow-up|0
4739109|NCT01857869|16346820|P9|Primary/Challenge Phase|Lost to Follow-up|0
4739110|NCT01857869|16346821|P8|Primary/Challenge Phase|Lost to Follow-up|0
4739111|NCT01857869|16346822|P7|Primary/Challenge Phase|Lost to Follow-up|0
4739112|NCT01857869|16346823|P6|Primary/Challenge Phase|Lost to Follow-up|0
4739113|NCT01857869|16346824|P5|Primary/Challenge Phase|Lost to Follow-up|0
4739114|NCT01857869|16346825|P4|Primary/Challenge Phase|Lost to Follow-up|0
4739115|NCT01857869|16346826|P3|Primary/Challenge Phase|Lost to Follow-up|0
4739116|NCT01857869|16346827|P2|Primary/Challenge Phase|Lost to Follow-up|0
4739117|NCT01857869|16346828|P1|Primary/Challenge Phase|Lost to Follow-up|2
4739118|NCT01857622|16346918|P3|Overall Study|Withdrawal by Subject|0
4739119|NCT01857622|16346919|P2|Overall Study|Withdrawal by Subject|0
4739120|NCT01857622|16346920|P1|Overall Study|Withdrawal by Subject|1
4739121|NCT01857622|16346918|P3|Overall Study|Protocol Violation|0
4739122|NCT01857622|16346919|P2|Overall Study|Protocol Violation|1
4739123|NCT01857622|16346920|P1|Overall Study|Protocol Violation|4
4739124|NCT01857622|16346918|P3|Overall Study|Physician Decision|0
4739125|NCT01857622|16346919|P2|Overall Study|Physician Decision|0
4739126|NCT01857622|16346920|P1|Overall Study|Physician Decision|1
4739127|NCT01857622|16346918|P3|Overall Study|Adverse Event|2
4739128|NCT01857622|16346919|P2|Overall Study|Adverse Event|0
4739129|NCT01857622|16346920|P1|Overall Study|Adverse Event|5
4739130|NCT01857583|16346932|P4|Overall Study|Withdrawal by Subject|2
4739131|NCT01857583|16346933|P3|Overall Study|Withdrawal by Subject|1
4739132|NCT01857583|16346934|P2|Overall Study|Withdrawal by Subject|0
4739133|NCT01857583|16346935|P1|Overall Study|Withdrawal by Subject|1
4739134|NCT01857583|16346932|P4|Overall Study|Physician Decision|1
4739135|NCT01857583|16346933|P3|Overall Study|Physician Decision|0
4739136|NCT01857583|16346934|P2|Overall Study|Physician Decision|0
4739137|NCT01857583|16346935|P1|Overall Study|Physician Decision|0
4739138|NCT01857583|16346932|P4|Overall Study|Death|0
4739139|NCT01857583|16346933|P3|Overall Study|Death|1
4739140|NCT01857583|16346934|P2|Overall Study|Death|1
4739141|NCT01857583|16346935|P1|Overall Study|Death|0
4739142|NCT01857583|16346932|P4|Overall Study|Adverse Event|1
4739143|NCT01857583|16346933|P3|Overall Study|Adverse Event|1
4739144|NCT01857583|16346934|P2|Overall Study|Adverse Event|0
4739145|NCT01857583|16346935|P1|Overall Study|Adverse Event|0
4739146|NCT01857531|16346945|P1|Overall Study|Withdrawal by Subject|4
4739147|NCT01857323|16346963|P1|Overall Study|Did not complete 180 doses|48
4739148|NCT01857323|16346963|P1|Overall Study|Other|4
4739149|NCT01857323|16346963|P1|Overall Study|Lost to Follow-up|1
4739150|NCT01857323|16346963|P1|Overall Study|Protocol Violation|6
4739151|NCT01857323|16346963|P1|Overall Study|Non-compliance|1
4739152|NCT01857323|16346963|P1|Overall Study|Withdrawal by Subject|3
4739153|NCT01857323|16346963|P1|Overall Study|Adverse Event|1
4739154|NCT01857271|16346989|P1|Overall Study|Lost to Follow-up|1
4739155|NCT01857206|16347042|P2|Overall Study|Withdrawal by Subject|0
4739156|NCT01857206|16347043|P1|Overall Study|Withdrawal by Subject|1
4739157|NCT01857206|16347042|P2|Overall Study|Unclassified|3
4739158|NCT01857206|16347043|P1|Overall Study|Unclassified|3
4739159|NCT01857206|16347042|P2|Overall Study|Lost to Follow-up|6
4739160|NCT01857206|16347043|P1|Overall Study|Lost to Follow-up|9
4739161|NCT01857206|16347042|P2|Overall Study|ADMINISTRATIVE REASON|1
4739162|NCT01857206|16347043|P1|Overall Study|ADMINISTRATIVE REASON|0
4739163|NCT01857102|16347061|P2|Period 2|Unsatisfactory Lens Fit|0
4739164|NCT01857102|16347062|P1|Period 2|Unsatisfactory Lens Fit|1
4739165|NCT01857102|16347061|P2|Period 2|Lens Discomfort|0
4739166|NCT01857102|16347062|P1|Period 2|Lens Discomfort|1
4739167|NCT01857102|16347061|P2|Period 1|Physician Decision|0
4739168|NCT01857102|16347062|P1|Period 1|Physician Decision|1
4739169|NCT01857102|16347061|P2|Period 1|Unsatisfactory Visual Response|0
4739170|NCT01857102|16347062|P1|Period 1|Unsatisfactory Visual Response|1
4739171|NCT01857102|16347061|P2|Period 1|Unsatisfactory Lens Fit|0
4739172|NCT01857102|16347062|P1|Period 1|Unsatisfactory Lens Fit|1
4739173|NCT01857102|16347061|P2|Period 1|Lost to Follow-up|3
4739174|NCT01857102|16347062|P1|Period 1|Lost to Follow-up|0
4739175|NCT01857102|16347061|P2|Period 1|No longer meets Eligibility Criteria|2
4739176|NCT01857102|16347062|P1|Period 1|No longer meets Eligibility Criteria|0
4739177|NCT01857063|16347072|P2|Period 2 (7 Days)|Withdrawal by Subject|0
4739178|NCT01857063|16347073|P1|Period 2 (7 Days)|Withdrawal by Subject|1
4739179|NCT01857063|16347072|P2|Period 2 (7 Days)|Physician Decision|1
4739180|NCT01857063|16347073|P1|Period 2 (7 Days)|Physician Decision|1
4739181|NCT01857063|16347072|P2|Period 2 (7 Days)|Adverse Event|1
4739182|NCT01857063|16347073|P1|Period 2 (7 Days)|Adverse Event|2
4739183|NCT01857063|16347072|P2|Period 1 (7 Days)|Withdrawal by Subject|3
4739184|NCT01857063|16347073|P1|Period 1 (7 Days)|Withdrawal by Subject|1
4739185|NCT01857063|16347072|P2|Period 1 (7 Days)|Physician Decision|0
4739186|NCT01857063|16347073|P1|Period 1 (7 Days)|Physician Decision|1
4739187|NCT01857063|16347072|P2|Period 1 (7 Days)|Adverse Event|1
4739188|NCT01857063|16347073|P1|Period 1 (7 Days)|Adverse Event|0
4739189|NCT01856907|16347107|P3|Overall Study|Withdrawal by Subject|0
4739190|NCT01856907|16347108|P2|Overall Study|Withdrawal by Subject|1
4739191|NCT01856907|16347109|P1|Overall Study|Withdrawal by Subject|0
4739192|NCT01856907|16347107|P3|Overall Study|Pregnancy|0
4739193|NCT01856907|16347108|P2|Overall Study|Pregnancy|1
4739194|NCT01856907|16347109|P1|Overall Study|Pregnancy|0
4739195|NCT01856907|16347107|P3|Overall Study|Pregnancy|0
4739196|NCT01856907|16347108|P2|Overall Study|Pregnancy|1
4739197|NCT01856907|16347109|P1|Overall Study|Pregnancy|0
4739198|NCT01856790|16347147|P1|Closed Loop Control + Liraglutide|Withdrawal by Subject|2
4739199|NCT01856790|16347147|P1|Closed Loop Control|Withdrawal by Subject|2
4739200|NCT01856686|16347201|P2|Overall Study|Lost to Follow-up|11
4739201|NCT01856686|16347202|P1|Overall Study|Lost to Follow-up|5
4739202|NCT01856673|16347245|P3|Overall Study|Protocol Violation|1
4739203|NCT01856673|16347246|P2|Overall Study|Protocol Violation|0
4739204|NCT01856673|16347247|P1|Overall Study|Protocol Violation|1
4739205|NCT01856673|16347245|P3|Overall Study|Death|0
4739206|NCT01856673|16347246|P2|Overall Study|Death|1
4739207|NCT01856673|16347247|P1|Overall Study|Death|2
4739208|NCT01856673|16347245|P3|Overall Study|Paperwork errors|0
4739209|NCT01856673|16347246|P2|Overall Study|Paperwork errors|0
4739210|NCT01856673|16347247|P1|Overall Study|Paperwork errors|4
4739211|NCT01856673|16347245|P3|Overall Study|Psychologist decision|0
4739212|NCT01856673|16347246|P2|Overall Study|Psychologist decision|0
4739213|NCT01856673|16347247|P1|Overall Study|Psychologist decision|3
4739214|NCT01856673|16347245|P3|Overall Study|Unknown reasons|0
4739215|NCT01856673|16347246|P2|Overall Study|Unknown reasons|0
4739216|NCT01856673|16347247|P1|Overall Study|Unknown reasons|20
4739217|NCT01856673|16347245|P3|Overall Study|Lost to Follow-up|0
4739218|NCT01856673|16347246|P2|Overall Study|Lost to Follow-up|34
4739219|NCT01856673|16347247|P1|Overall Study|Lost to Follow-up|22
4739220|NCT01856673|16347245|P3|Overall Study|Withdrawal by Subject|33
4739221|NCT01856673|16347246|P2|Overall Study|Withdrawal by Subject|50
4739222|NCT01856673|16347247|P1|Overall Study|Withdrawal by Subject|46
4739223|NCT01856595|16347267|P9|Overall Study|Withdrawal by Subject|0
4739224|NCT01856595|16347268|P8|Overall Study|Withdrawal by Subject|0
4739225|NCT01856595|16347269|P7|Overall Study|Withdrawal by Subject|1
4739226|NCT01856595|16347270|P6|Overall Study|Withdrawal by Subject|0
4739227|NCT01856595|16347271|P5|Overall Study|Withdrawal by Subject|0
4739228|NCT01856595|16347272|P4|Overall Study|Withdrawal by Subject|0
4739229|NCT01856595|16347273|P3|Overall Study|Withdrawal by Subject|0
4739230|NCT01856595|16347274|P2|Overall Study|Withdrawal by Subject|1
4739231|NCT01856595|16347275|P1|Overall Study|Withdrawal by Subject|0
4739232|NCT01856582|16347508|P1|Overall Study|Died prior to Boost infusion|1
4739233|NCT01856569|16347512|P1|Overall Study|Did not met inclusion criteria|8
4739234|NCT01856569|16347512|P1|Overall Study|Lost to Follow-up|3
4739235|NCT01856569|16347512|P1|Overall Study|Changed Site/Structure|1
4739236|NCT01856569|16347512|P1|Overall Study|Other|1
4739237|NCT01856543|16347523|P2|Overall Study|Withdrawn before start|3
4739238|NCT01856543|16347524|P1|Overall Study|Withdrawn before start|7
4739239|NCT01856543|16347523|P2|Overall Study|Treatment discontinued|3
4739240|NCT01856543|16347524|P1|Overall Study|Treatment discontinued|6
4739241|NCT01856322|16347582|P3|Overall Study|off study due to lack of accrual|3
4739242|NCT01856322|16347583|P2|Overall Study|off study due to lack of accrual|0
4739243|NCT01856322|16347584|P1|Overall Study|off study due to lack of accrual|0
4739244|NCT01856309|16347595|P4|Overall Study|Noncompliance With Study Drug|1
4739245|NCT01856309|16347596|P3|Overall Study|Noncompliance With Study Drug|4
4739246|NCT01856309|16347597|P2|Overall Study|Noncompliance With Study Drug|1
4739247|NCT01856309|16347598|P1|Overall Study|Noncompliance With Study Drug|0
4739248|NCT01856309|16347595|P4|Overall Study|Physician Decision|8
4739249|NCT01856309|16347596|P3|Overall Study|Physician Decision|6
4739250|NCT01856309|16347597|P2|Overall Study|Physician Decision|1
4739251|NCT01856309|16347598|P1|Overall Study|Physician Decision|6
4739252|NCT01856309|16347595|P4|Overall Study|Pregnancy|1
4739253|NCT01856309|16347596|P3|Overall Study|Pregnancy|0
4739254|NCT01856309|16347597|P2|Overall Study|Pregnancy|0
4739255|NCT01856309|16347598|P1|Overall Study|Pregnancy|0
4739256|NCT01856309|16347595|P4|Overall Study|Adverse Event|65
4739257|NCT01856309|16347596|P3|Overall Study|Adverse Event|55
4739258|NCT01856309|16347597|P2|Overall Study|Adverse Event|31
4739259|NCT01856309|16347598|P1|Overall Study|Adverse Event|31
4739260|NCT01856309|16347595|P4|Overall Study|Lack of Efficacy|25
4739261|NCT01856309|16347596|P3|Overall Study|Lack of Efficacy|40
4739262|NCT01856309|16347597|P2|Overall Study|Lack of Efficacy|9
4739263|NCT01856309|16347598|P1|Overall Study|Lack of Efficacy|14
4739264|NCT01856309|16347595|P4|Overall Study|Other|469
4739265|NCT01856309|16347596|P3|Overall Study|Other|447
4739266|NCT01856309|16347597|P2|Overall Study|Other|225
4739267|NCT01856309|16347598|P1|Overall Study|Other|227
4739268|NCT01856309|16347595|P4|Overall Study|Withdrawal by Subject|26
4739269|NCT01856309|16347596|P3|Overall Study|Withdrawal by Subject|28
4739270|NCT01856309|16347597|P2|Overall Study|Withdrawal by Subject|13
4739271|NCT01856309|16347598|P1|Overall Study|Withdrawal by Subject|11
4739272|NCT01856309|16347595|P4|Overall Study|Lost to Follow-up|8
4739273|NCT01856309|16347596|P3|Overall Study|Lost to Follow-up|4
4739274|NCT01856309|16347597|P2|Overall Study|Lost to Follow-up|2
4739275|NCT01856309|16347598|P1|Overall Study|Lost to Follow-up|6
4739276|NCT01856309|16347595|P4|Overall Study|Death|6
4739277|NCT01856309|16347596|P3|Overall Study|Death|11
4739278|NCT01856309|16347597|P2|Overall Study|Death|6
4739279|NCT01856309|16347598|P1|Overall Study|Death|4
4739280|NCT01856257|16347722|P4|Overall Study|Donor complication|1
4739281|NCT01856257|16347723|P3|Overall Study|Donor complication|0
4739282|NCT01856257|16347724|P2|Overall Study|Donor complication|0
4739283|NCT01856257|16347725|P1|Overall Study|Donor complication|0
4739284|NCT01856257|16347722|P4|Overall Study|Withdrawal by Subject|0
4739285|NCT01856257|16347723|P3|Overall Study|Withdrawal by Subject|0
4739286|NCT01856257|16347724|P2|Overall Study|Withdrawal by Subject|1
4739287|NCT01856257|16347725|P1|Overall Study|Withdrawal by Subject|1
4739288|NCT01856257|16347722|P4|Overall Study|Physician Decision|1
4739289|NCT01856257|16347723|P3|Overall Study|Physician Decision|0
4739290|NCT01856257|16347724|P2|Overall Study|Physician Decision|0
4739291|NCT01856257|16347725|P1|Overall Study|Physician Decision|0
4739292|NCT01856257|16347722|P4|Overall Study|Death|0
4739293|NCT01856257|16347723|P3|Overall Study|Death|0
4739294|NCT01856257|16347724|P2|Overall Study|Death|0
4739295|NCT01856257|16347725|P1|Overall Study|Death|2
4739296|NCT01856114|16347840|P2|Overall Study|Adverse Event|0
4739297|NCT01856114|16347841|P1|Overall Study|Adverse Event|1
4739298|NCT01856114|16347840|P2|Overall Study|Withdrawal by Subject|0
4739299|NCT01856114|16347841|P1|Overall Study|Withdrawal by Subject|1
4739300|NCT01855958|16347906|P2|Overall Study|Withdrawal by Subject|0
4739301|NCT01855958|16347907|P1|Overall Study|Withdrawal by Subject|1
4739302|NCT01855945|16347937|P12|Overall Study|Withdrawal by Subject|1
4739303|NCT01855945|16347938|P11|Overall Study|Withdrawal by Subject|4
4739304|NCT01855945|16347939|P10|Overall Study|Withdrawal by Subject|2
4739305|NCT01855945|16347940|P9|Overall Study|Withdrawal by Subject|0
4739306|NCT01855945|16347941|P8|Overall Study|Withdrawal by Subject|0
4739307|NCT01855945|16347942|P7|Overall Study|Withdrawal by Subject|1
4739308|NCT01855945|16347943|P6|Overall Study|Withdrawal by Subject|0
4739309|NCT01855945|16347944|P5|Overall Study|Withdrawal by Subject|1
4739310|NCT01855945|16347945|P4|Overall Study|Withdrawal by Subject|1
4739311|NCT01855945|16347946|P3|Overall Study|Withdrawal by Subject|4
4739312|NCT01855945|16347947|P2|Overall Study|Withdrawal by Subject|0
4739313|NCT01855945|16347948|P1|Overall Study|Withdrawal by Subject|4
4739314|NCT01855945|16347937|P12|Overall Study|Other - Unclassified|0
4739315|NCT01855945|16347938|P11|Overall Study|Other - Unclassified|1
4739316|NCT01855945|16347939|P10|Overall Study|Other - Unclassified|0
4739317|NCT01855945|16347940|P9|Overall Study|Other - Unclassified|0
4739318|NCT01855945|16347941|P8|Overall Study|Other - Unclassified|1
4739319|NCT01855945|16347942|P7|Overall Study|Other - Unclassified|2
4739320|NCT01855945|16347943|P6|Overall Study|Other - Unclassified|0
4739321|NCT01855945|16347944|P5|Overall Study|Other - Unclassified|0
4739322|NCT01855945|16347945|P4|Overall Study|Other - Unclassified|0
4739323|NCT01855945|16347946|P3|Overall Study|Other - Unclassified|1
4739324|NCT01855945|16347947|P2|Overall Study|Other - Unclassified|1
4739325|NCT01855945|16347948|P1|Overall Study|Other - Unclassified|1
4739326|NCT01855945|16347937|P12|Overall Study|Lost to Follow-up|2
4739327|NCT01855945|16347938|P11|Overall Study|Lost to Follow-up|0
4739328|NCT01855945|16347939|P10|Overall Study|Lost to Follow-up|0
4739329|NCT01855945|16347940|P9|Overall Study|Lost to Follow-up|2
4739330|NCT01855945|16347941|P8|Overall Study|Lost to Follow-up|7
4739331|NCT01855945|16347942|P7|Overall Study|Lost to Follow-up|4
4739332|NCT01855945|16347943|P6|Overall Study|Lost to Follow-up|3
4739333|NCT01855945|16347944|P5|Overall Study|Lost to Follow-up|0
4739334|NCT01855945|16347945|P4|Overall Study|Lost to Follow-up|3
4739335|NCT01855945|16347946|P3|Overall Study|Lost to Follow-up|7
4739336|NCT01855945|16347947|P2|Overall Study|Lost to Follow-up|10
4739337|NCT01855945|16347948|P1|Overall Study|Lost to Follow-up|11
4739338|NCT01855945|16347937|P12|Overall Study|Death|0
4739339|NCT01855945|16347938|P11|Overall Study|Death|0
4739340|NCT01855945|16347939|P10|Overall Study|Death|0
4739341|NCT01855945|16347940|P9|Overall Study|Death|0
4739342|NCT01855945|16347941|P8|Overall Study|Death|0
4739343|NCT01855945|16347942|P7|Overall Study|Death|2
4739344|NCT01855945|16347943|P6|Overall Study|Death|0
4739345|NCT01855945|16347944|P5|Overall Study|Death|0
4739346|NCT01855945|16347945|P4|Overall Study|Death|0
4739347|NCT01855945|16347946|P3|Overall Study|Death|0
4739348|NCT01855945|16347947|P2|Overall Study|Death|0
4739349|NCT01855945|16347948|P1|Overall Study|Death|0
4739350|NCT01855945|16347937|P12|Overall Study|Adverse Event|0
4739351|NCT01855945|16347938|P11|Overall Study|Adverse Event|0
4739352|NCT01855945|16347939|P10|Overall Study|Adverse Event|0
4739353|NCT01855945|16347940|P9|Overall Study|Adverse Event|0
4739354|NCT01855945|16347941|P8|Overall Study|Adverse Event|0
4739355|NCT01855945|16347942|P7|Overall Study|Adverse Event|1
4739356|NCT01855945|16347943|P6|Overall Study|Adverse Event|0
4739357|NCT01855945|16347944|P5|Overall Study|Adverse Event|0
4739358|NCT01855945|16347945|P4|Overall Study|Adverse Event|0
4739359|NCT01855945|16347946|P3|Overall Study|Adverse Event|0
4739360|NCT01855945|16347947|P2|Overall Study|Adverse Event|0
4739361|NCT01855945|16347948|P1|Overall Study|Adverse Event|0
4739362|NCT01855919|16348084|P2|Overall Study|Protocol Violation|4
4739363|NCT01855919|16348085|P1|Overall Study|Protocol Violation|1
4739364|NCT01855919|16348084|P2|Overall Study|Entry Criteria Not Met|1
4739365|NCT01855919|16348085|P1|Overall Study|Entry Criteria Not Met|1
4739366|NCT01855919|16348084|P2|Overall Study|Withdrawal by Subject|10
4739367|NCT01855919|16348085|P1|Overall Study|Withdrawal by Subject|4
4739368|NCT01855919|16348084|P2|Overall Study|Lack of Efficacy|3
4739369|NCT01855919|16348085|P1|Overall Study|Lack of Efficacy|1
4739370|NCT01855919|16348084|P2|Overall Study|Adverse Event|8
4739371|NCT01855919|16348085|P1|Overall Study|Adverse Event|16
4739372|NCT01855828|16348117|P1|Overall Study|Withdrawal by Subject|1
4739373|NCT01855828|16348117|P1|Overall Study|Adverse Event|1
4739374|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Other|1
4739375|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Other|0
4739376|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Other|0
4739377|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Other|0
4739378|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Sponsor Decision|1
4739379|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Sponsor Decision|0
4739380|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Sponsor Decision|0
4739381|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Sponsor Decision|0
4739382|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Participant Non-compliance|1
4739383|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Participant Non-compliance|0
4739384|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Participant Non-compliance|1
4739385|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Participant Non-compliance|0
4739386|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Physician Decision|4
4739387|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Physician Decision|2
4739388|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Physician Decision|0
4739389|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Physician Decision|0
4739390|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Withdrawal by Subject|8
4739391|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Withdrawal by Subject|5
4739392|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Withdrawal by Subject|7
4739393|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Withdrawal by Subject|0
4739394|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Protocol Violation|1
4739395|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Protocol Violation|0
4739396|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Protocol Violation|0
4739397|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Protocol Violation|0
4739398|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Lost to Follow-up|4
4739399|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Lost to Follow-up|1
4739400|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Lost to Follow-up|1
4739401|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Lost to Follow-up|0
4739402|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Lack of Efficacy|16
4739403|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Lack of Efficacy|5
4739404|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Lack of Efficacy|2
4739405|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Lack of Efficacy|0
4739406|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1
4739407|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
4739408|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
4739409|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0
4739410|NCT01855789|16348127|P4|2) Week 24 up to End of Study|Adverse Event|21
4739411|NCT01855789|16348128|P3|2) Week 24 up to End of Study|Adverse Event|5
4739412|NCT01855789|16348129|P2|2) Week 24 up to End of Study|Adverse Event|4
4739413|NCT01855789|16348130|P1|2) Week 24 up to End of Study|Adverse Event|0
4739414|NCT01855789|16348127|P4|1) Baseline up to Week 24|Other|0
4739415|NCT01855789|16348128|P3|1) Baseline up to Week 24|Other|0
4739416|NCT01855789|16348129|P2|1) Baseline up to Week 24|Other|0
4739417|NCT01855789|16348130|P1|1) Baseline up to Week 24|Other|4
4739418|NCT01855789|16348127|P4|1) Baseline up to Week 24|Sponsor Decision|0
4739419|NCT01855789|16348128|P3|1) Baseline up to Week 24|Sponsor Decision|0
4739420|NCT01855789|16348129|P2|1) Baseline up to Week 24|Sponsor Decision|0
4739421|NCT01855789|16348130|P1|1) Baseline up to Week 24|Sponsor Decision|3
4739422|NCT01855789|16348127|P4|1) Baseline up to Week 24|Participant Non-compliance|0
4739423|NCT01855789|16348128|P3|1) Baseline up to Week 24|Participant Non-compliance|0
4739424|NCT01855789|16348129|P2|1) Baseline up to Week 24|Participant Non-compliance|0
4739425|NCT01855789|16348130|P1|1) Baseline up to Week 24|Participant Non-compliance|3
4739426|NCT01855789|16348127|P4|1) Baseline up to Week 24|Pregnancy|0
4739427|NCT01855789|16348128|P3|1) Baseline up to Week 24|Pregnancy|0
4739428|NCT01855789|16348129|P2|1) Baseline up to Week 24|Pregnancy|0
4739429|NCT01855789|16348130|P1|1) Baseline up to Week 24|Pregnancy|1
4739430|NCT01855789|16348127|P4|1) Baseline up to Week 24|Physician Decision|0
4739431|NCT01855789|16348128|P3|1) Baseline up to Week 24|Physician Decision|0
4739432|NCT01855789|16348129|P2|1) Baseline up to Week 24|Physician Decision|0
4739433|NCT01855789|16348130|P1|1) Baseline up to Week 24|Physician Decision|4
4739434|NCT01855789|16348127|P4|1) Baseline up to Week 24|Withdrawal by Subject|0
4739435|NCT01855789|16348128|P3|1) Baseline up to Week 24|Withdrawal by Subject|0
4739436|NCT01855789|16348129|P2|1) Baseline up to Week 24|Withdrawal by Subject|0
4739437|NCT01855789|16348130|P1|1) Baseline up to Week 24|Withdrawal by Subject|31
4739438|NCT01855789|16348127|P4|1) Baseline up to Week 24|Protocol Violation|0
4739439|NCT01855789|16348128|P3|1) Baseline up to Week 24|Protocol Violation|0
4739440|NCT01855789|16348129|P2|1) Baseline up to Week 24|Protocol Violation|0
4739441|NCT01855789|16348130|P1|1) Baseline up to Week 24|Protocol Violation|4
4739442|NCT01855789|16348127|P4|1) Baseline up to Week 24|Lost to Follow-up|0
4739443|NCT01855789|16348128|P3|1) Baseline up to Week 24|Lost to Follow-up|0
4739444|NCT01855789|16348129|P2|1) Baseline up to Week 24|Lost to Follow-up|0
4739445|NCT01855789|16348130|P1|1) Baseline up to Week 24|Lost to Follow-up|11
4739446|NCT01855789|16348127|P4|1) Baseline up to Week 24|Lack of Efficacy|0
4739447|NCT01855789|16348128|P3|1) Baseline up to Week 24|Lack of Efficacy|0
4739448|NCT01855789|16348129|P2|1) Baseline up to Week 24|Lack of Efficacy|0
4739449|NCT01855789|16348130|P1|1) Baseline up to Week 24|Lack of Efficacy|16
4739450|NCT01855789|16348127|P4|1) Baseline up to Week 24|Death|0
4739451|NCT01855789|16348128|P3|1) Baseline up to Week 24|Death|0
4739452|NCT01855789|16348129|P2|1) Baseline up to Week 24|Death|0
4739453|NCT01855789|16348130|P1|1) Baseline up to Week 24|Death|2
4739454|NCT01855789|16348127|P4|1) Baseline up to Week 24|Adverse Event|0
4739455|NCT01855789|16348128|P3|1) Baseline up to Week 24|Adverse Event|0
4739456|NCT01855789|16348129|P2|1) Baseline up to Week 24|Adverse Event|0
4739457|NCT01855789|16348130|P1|1) Baseline up to Week 24|Adverse Event|37
4739458|NCT01855750|16348154|P2|Overall Study|Sponsor ends the study|290
4739459|NCT01855750|16348155|P1|Overall Study|Sponsor ends the study|297
4739460|NCT01855750|16348154|P2|Overall Study|Withdrawal by Subject|28
4739461|NCT01855750|16348155|P1|Overall Study|Withdrawal by Subject|35
4739462|NCT01855750|16348154|P2|Overall Study|Lost to Follow-up|23
4739463|NCT01855750|16348155|P1|Overall Study|Lost to Follow-up|9
4739464|NCT01855750|16348154|P2|Overall Study|Death|78
4739465|NCT01855750|16348155|P1|Overall Study|Death|78
4739466|NCT01855425|16348171|P1|Overall Study|Physician Decision|20
4739467|NCT01855399|16348177|P2|12 Month|Lost to Follow-up|11
4739468|NCT01855399|16348178|P1|12 Month|Lost to Follow-up|7
4739469|NCT01855399|16348177|P2|6 Month|Withdrawal by Subject|6
4739470|NCT01855399|16348178|P1|6 Month|Withdrawal by Subject|8
4739471|NCT01855399|16348177|P2|6 Month|Lost to Follow-up|9
4739472|NCT01855399|16348178|P1|6 Month|Lost to Follow-up|12
4739473|NCT01855243|16348187|P3|Overall Study|develpoed diabetic ketoacidosis|0
4739474|NCT01855243|16348188|P2|Overall Study|develpoed diabetic ketoacidosis|0
4739475|NCT01855243|16348189|P1|Overall Study|develpoed diabetic ketoacidosis|1
4739476|NCT01855126|16348211|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|2
4739477|NCT01855126|16348212|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|2
4739478|NCT01855126|16348211|P2|First Intervention (8 Weeks)|Withdrawal by Subject|6
4739479|NCT01855126|16348212|P1|First Intervention (8 Weeks)|Withdrawal by Subject|4
4739480|NCT01855074|16348224|P1|Overall Study|Started but not treated|1
4739481|NCT01855074|16348224|P1|Overall Study|Withdrawal by Subject|8
4739482|NCT01855074|16348224|P1|Overall Study|Lost to Follow-up|4
4739483|NCT01855074|16348224|P1|Overall Study|Adverse Event|1
4739484|NCT01854944|16348236|P3|Overall Study|Withdrawal by Subject|1
4739485|NCT01854944|16348237|P2|Overall Study|Withdrawal by Subject|0
4739486|NCT01854944|16348238|P1|Overall Study|Withdrawal by Subject|0
4739487|NCT01854918|16348290|P2|All-IP Period (Years 2 and 3)|Death|16
4739488|NCT01854918|16348291|P1|All-IP Period (Years 2 and 3)|Death|5
4739489|NCT01854918|16348290|P2|All-IP Period (Years 2 and 3)|Lost to Follow-up|51
4739490|NCT01854918|16348291|P1|All-IP Period (Years 2 and 3)|Lost to Follow-up|27
4739491|NCT01854918|16348290|P2|All-IP Period (Years 2 and 3)|Decision by Sponsor|11
4739492|NCT01854918|16348291|P1|All-IP Period (Years 2 and 3)|Decision by Sponsor|8
4739493|NCT01854918|16348290|P2|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117
4739494|NCT01854918|16348291|P1|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78
4739495|NCT01854918|16348290|P2|SOC-controlled Period (Year 1)|Death|5
4739496|NCT01854918|16348291|P1|SOC-controlled Period (Year 1)|Death|5
4739497|NCT01854918|16348290|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|8
4739498|NCT01854918|16348291|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|3
4739499|NCT01854918|16348290|P2|SOC-controlled Period (Year 1)|Decision by Sponsor|1
4739500|NCT01854918|16348291|P1|SOC-controlled Period (Year 1)|Decision by Sponsor|2
4739501|NCT01854918|16348290|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|49
4739502|NCT01854918|16348291|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|20
4739503|NCT01854827|16348310|P1|Overall Study|Death|1
4739504|NCT01854710|16348322|P6|Overall Study|CRI procedural error|2
4739505|NCT01854710|16348323|P5|Overall Study|CRI procedural error|2
4739506|NCT01854710|16348324|P4|Overall Study|CRI procedural error|2
4739507|NCT01854710|16348325|P3|Overall Study|CRI procedural error|2
4739508|NCT01854710|16348326|P2|Overall Study|CRI procedural error|2
4739509|NCT01854710|16348327|P1|Overall Study|CRI procedural error|2
4739510|NCT01854710|16348322|P6|Overall Study|Withdrawal by Subject|0
4739511|NCT01854710|16348323|P5|Overall Study|Withdrawal by Subject|0
4739512|NCT01854710|16348324|P4|Overall Study|Withdrawal by Subject|0
4739513|NCT01854710|16348325|P3|Overall Study|Withdrawal by Subject|0
4739514|NCT01854710|16348326|P2|Overall Study|Withdrawal by Subject|1
4739515|NCT01854710|16348327|P1|Overall Study|Withdrawal by Subject|2
4739516|NCT01854697|16348348|P5|Overall Study|Other|0
4739517|NCT01854697|16348349|P4|Overall Study|Other|0
4739518|NCT01854697|16348350|P3|Overall Study|Other|1
4739519|NCT01854697|16348351|P2|Overall Study|Other|1
4739520|NCT01854697|16348352|P1|Overall Study|Other|0
4739521|NCT01854697|16348348|P5|Overall Study|Withdrew Consent|0
4739522|NCT01854697|16348349|P4|Overall Study|Withdrew Consent|1
4739523|NCT01854697|16348350|P3|Overall Study|Withdrew Consent|0
4739524|NCT01854697|16348351|P2|Overall Study|Withdrew Consent|1
4739525|NCT01854697|16348352|P1|Overall Study|Withdrew Consent|0
4739526|NCT01854697|16348348|P5|Overall Study|To enter another AbbVie study|1
4739527|NCT01854697|16348349|P4|Overall Study|To enter another AbbVie study|0
4739528|NCT01854697|16348350|P3|Overall Study|To enter another AbbVie study|0
4739529|NCT01854697|16348351|P2|Overall Study|To enter another AbbVie study|0
4739530|NCT01854697|16348352|P1|Overall Study|To enter another AbbVie study|1
4739531|NCT01854697|16348348|P5|Overall Study|Lost to Follow-up|0
4739532|NCT01854697|16348349|P4|Overall Study|Lost to Follow-up|2
4739533|NCT01854697|16348350|P3|Overall Study|Lost to Follow-up|1
4739534|NCT01854697|16348351|P2|Overall Study|Lost to Follow-up|1
4739535|NCT01854697|16348352|P1|Overall Study|Lost to Follow-up|4
4739536|NCT01854697|16348348|P5|Overall Study|Adverse Event|1
4739537|NCT01854697|16348349|P4|Overall Study|Adverse Event|0
4739538|NCT01854697|16348350|P3|Overall Study|Adverse Event|0
4739539|NCT01854697|16348351|P2|Overall Study|Adverse Event|0
4739540|NCT01854697|16348352|P1|Overall Study|Adverse Event|1
4739541|NCT01854658|16348396|P4|Overall Study|Administrative reasons|2
4739542|NCT01854658|16348397|P3|Overall Study|Administrative reasons|2
4739543|NCT01854658|16348398|P2|Overall Study|Administrative reasons|1
4739544|NCT01854658|16348399|P1|Overall Study|Administrative reasons|5
4739545|NCT01854658|16348396|P4|Overall Study|Adverse Event|19
4739546|NCT01854658|16348397|P3|Overall Study|Adverse Event|23
4739547|NCT01854658|16348398|P2|Overall Study|Adverse Event|14
4739548|NCT01854658|16348399|P1|Overall Study|Adverse Event|21
4739549|NCT01854658|16348396|P4|Overall Study|Lack of Efficacy|7
4739550|NCT01854658|16348397|P3|Overall Study|Lack of Efficacy|4
4739551|NCT01854658|16348398|P2|Overall Study|Lack of Efficacy|8
4739552|NCT01854658|16348399|P1|Overall Study|Lack of Efficacy|3
4739553|NCT01854658|16348396|P4|Overall Study|Protocol-specified criteria|7
4739554|NCT01854658|16348397|P3|Overall Study|Protocol-specified criteria|10
4739555|NCT01854658|16348398|P2|Overall Study|Protocol-specified criteria|15
4739556|NCT01854658|16348399|P1|Overall Study|Protocol-specified criteria|15
4739557|NCT01854658|16348396|P4|Overall Study|Withdrawal by Subject|15
4739558|NCT01854658|16348397|P3|Overall Study|Withdrawal by Subject|29
4739559|NCT01854658|16348398|P2|Overall Study|Withdrawal by Subject|21
4739560|NCT01854658|16348399|P1|Overall Study|Withdrawal by Subject|28
4739561|NCT01854658|16348396|P4|Overall Study|Lost to Follow-up|4
4739562|NCT01854658|16348397|P3|Overall Study|Lost to Follow-up|8
4739563|NCT01854658|16348398|P2|Overall Study|Lost to Follow-up|9
4739564|NCT01854658|16348399|P1|Overall Study|Lost to Follow-up|8
4739565|NCT01854658|16348396|P4|Overall Study|Physician Decision|4
4739566|NCT01854658|16348397|P3|Overall Study|Physician Decision|2
4739567|NCT01854658|16348398|P2|Overall Study|Physician Decision|5
4739568|NCT01854658|16348399|P1|Overall Study|Physician Decision|7
4739569|NCT01854658|16348396|P4|Overall Study|Protocol Violation|1
4739570|NCT01854658|16348397|P3|Overall Study|Protocol Violation|2
4739571|NCT01854658|16348398|P2|Overall Study|Protocol Violation|2
4739572|NCT01854658|16348399|P1|Overall Study|Protocol Violation|6
4739573|NCT01854645|16348434|P5|Overall Study|Adverse Event|11
4739574|NCT01854645|16348435|P4|Overall Study|Adverse Event|20
4739575|NCT01854645|16348436|P3|Overall Study|Adverse Event|19
4739576|NCT01854645|16348437|P2|Overall Study|Adverse Event|31
4739577|NCT01854645|16348438|P1|Overall Study|Adverse Event|33
4739578|NCT01854645|16348434|P5|Overall Study|Lack of Efficacy|9
4739579|NCT01854645|16348435|P4|Overall Study|Lack of Efficacy|3
4739580|NCT01854645|16348436|P3|Overall Study|Lack of Efficacy|9
4739581|NCT01854645|16348437|P2|Overall Study|Lack of Efficacy|12
4739582|NCT01854645|16348438|P1|Overall Study|Lack of Efficacy|7
4739583|NCT01854645|16348434|P5|Overall Study|Withdrawal by Subject|24
4739584|NCT01854645|16348435|P4|Overall Study|Withdrawal by Subject|21
4739585|NCT01854645|16348436|P3|Overall Study|Withdrawal by Subject|30
4739586|NCT01854645|16348437|P2|Overall Study|Withdrawal by Subject|41
4739587|NCT01854645|16348438|P1|Overall Study|Withdrawal by Subject|31
4739588|NCT01854645|16348434|P5|Overall Study|Physician Decision|7
4739589|NCT01854645|16348435|P4|Overall Study|Physician Decision|3
4739590|NCT01854645|16348436|P3|Overall Study|Physician Decision|3
4739591|NCT01854645|16348437|P2|Overall Study|Physician Decision|5
4739592|NCT01854645|16348438|P1|Overall Study|Physician Decision|1
4739593|NCT01854645|16348434|P5|Overall Study|Lost to Follow-up|0
4739594|NCT01854645|16348435|P4|Overall Study|Lost to Follow-up|5
4739595|NCT01854645|16348436|P3|Overall Study|Lost to Follow-up|8
4739596|NCT01854645|16348437|P2|Overall Study|Lost to Follow-up|7
4739597|NCT01854645|16348438|P1|Overall Study|Lost to Follow-up|10
4739598|NCT01854645|16348434|P5|Overall Study|Protocol Violation|1
4739599|NCT01854645|16348435|P4|Overall Study|Protocol Violation|4
4739600|NCT01854645|16348436|P3|Overall Study|Protocol Violation|5
4739601|NCT01854645|16348437|P2|Overall Study|Protocol Violation|0
4739602|NCT01854645|16348438|P1|Overall Study|Protocol Violation|3
4739603|NCT01854645|16348434|P5|Overall Study|Administrative Reasons / Missing|1
4739604|NCT01854645|16348435|P4|Overall Study|Administrative Reasons / Missing|1
4739605|NCT01854645|16348436|P3|Overall Study|Administrative Reasons / Missing|0
4739606|NCT01854645|16348437|P2|Overall Study|Administrative Reasons / Missing|0
4739607|NCT01854645|16348438|P1|Overall Study|Administrative Reasons / Missing|0
4739608|NCT01854645|16348434|P5|Overall Study|Protocol-Specified Criteria|7
4739609|NCT01854645|16348435|P4|Overall Study|Protocol-Specified Criteria|5
4739610|NCT01854645|16348436|P3|Overall Study|Protocol-Specified Criteria|8
4739611|NCT01854645|16348437|P2|Overall Study|Protocol-Specified Criteria|10
4739612|NCT01854645|16348438|P1|Overall Study|Protocol-Specified Criteria|13
4739613|NCT01854528|16348519|P2|Overall Study|Virologic Failure|9
4739614|NCT01854528|16348520|P1|Overall Study|Virologic Failure|0
4739615|NCT01854528|16348519|P2|Overall Study|Withdrawal by Subject|2
4739616|NCT01854528|16348520|P1|Overall Study|Withdrawal by Subject|0
4739617|NCT01854528|16348519|P2|Overall Study|Adverse Event|4
4739618|NCT01854528|16348520|P1|Overall Study|Adverse Event|0
4739619|NCT01854047|16348591|P5|Overall Study|Other than specified above|8
4739620|NCT01854047|16348592|P4|Overall Study|Other than specified above|5
4739621|NCT01854047|16348593|P3|Overall Study|Other than specified above|3
4739622|NCT01854047|16348594|P2|Overall Study|Other than specified above|3
4739623|NCT01854047|16348595|P1|Overall Study|Other than specified above|3
4739624|NCT01854047|16348591|P5|Overall Study|Randomized but not treated|4
4739625|NCT01854047|16348592|P4|Overall Study|Randomized but not treated|0
4739626|NCT01854047|16348593|P3|Overall Study|Randomized but not treated|2
4739627|NCT01854047|16348594|P2|Overall Study|Randomized but not treated|1
4739628|NCT01854047|16348595|P1|Overall Study|Randomized but not treated|0
4739629|NCT01854047|16348591|P5|Overall Study|Adverse Event|7
4739630|NCT01854047|16348592|P4|Overall Study|Adverse Event|10
4739631|NCT01854047|16348593|P3|Overall Study|Adverse Event|6
4739632|NCT01854047|16348594|P2|Overall Study|Adverse Event|4
4739633|NCT01854047|16348595|P1|Overall Study|Adverse Event|5
4739634|NCT01854047|16348591|P5|Overall Study|Poor compliance to protocol|0
4739635|NCT01854047|16348592|P4|Overall Study|Poor compliance to protocol|0
4739636|NCT01854047|16348593|P3|Overall Study|Poor compliance to protocol|2
4739637|NCT01854047|16348594|P2|Overall Study|Poor compliance to protocol|0
4739638|NCT01854047|16348595|P1|Overall Study|Poor compliance to protocol|3
4739639|NCT01854047|16348591|P5|Overall Study|Lack of Efficacy|0
4739640|NCT01854047|16348592|P4|Overall Study|Lack of Efficacy|0
4739641|NCT01854047|16348593|P3|Overall Study|Lack of Efficacy|0
4739642|NCT01854047|16348594|P2|Overall Study|Lack of Efficacy|0
4739643|NCT01854047|16348595|P1|Overall Study|Lack of Efficacy|1
4739644|NCT01853982|16348726|P2|Overall Study|Lost to Follow-up|1
4739645|NCT01853982|16348727|P1|Overall Study|Lost to Follow-up|0
4739646|NCT01853982|16348726|P2|Overall Study|Death|0
4739647|NCT01853982|16348727|P1|Overall Study|Death|1
4739648|NCT01853982|16348726|P2|Overall Study|Withdrawal by Subject|0
4739649|NCT01853982|16348727|P1|Overall Study|Withdrawal by Subject|1
4739650|NCT01853878|16348744|P2|Overall Study|Other|43
4739651|NCT01853878|16348745|P1|Overall Study|Other|55
4739652|NCT01853878|16348744|P2|Overall Study|Migrated/moved from the study area|0
4739653|NCT01853878|16348745|P1|Overall Study|Migrated/moved from the study area|1
4739654|NCT01853878|16348744|P2|Overall Study|Withdrawal by Subject|1
4739655|NCT01853878|16348745|P1|Overall Study|Withdrawal by Subject|3
4739656|NCT01853878|16348744|P2|Overall Study|Adverse Event|0
4739657|NCT01853878|16348745|P1|Overall Study|Adverse Event|2
4739658|NCT01853878|16348744|P2|Overall Study|Recurrence|0
4739659|NCT01853878|16348745|P1|Overall Study|Recurrence|2
4739660|NCT01853839|16348769|P1|Overall Study|Lost to follow-up or no valid BP measure|336
4739661|NCT01853839|16348769|P1|Overall Study|End of treatment visit too early|33
4739662|NCT01853839|16348769|P1|Overall Study|Not meet ITT population definition|58
4739663|NCT01853839|16348769|P1|Overall Study|Violated inclusion criteria|2
4739664|NCT01853696|16348802|P2|Overall Study|Lost to Follow-up|4
4739665|NCT01853696|16348803|P1|Overall Study|Lost to Follow-up|5
4739666|NCT01853696|16348802|P2|Overall Study|Withdrawal by Subject|1
4739667|NCT01853696|16348803|P1|Overall Study|Withdrawal by Subject|1
4739668|NCT01853644|16348811|P1|Follow up for 3 Years or Until Death|Still in the follow up period|3
4739669|NCT01853644|16348811|P1|Continued Treatment After First Response|Progressive Diseaes|10
4739670|NCT01853644|16348811|P1|Continued Treatment After First Response|Adverse Event|2
4739671|NCT01853644|16348811|P1|Reached First Response/Complete 2 Cycles|Progressive Disease|2
4739672|NCT01853644|16348811|P1|Reached First Response/Complete 2 Cycles|Other|1
4739673|NCT01853644|16348811|P1|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1
4739674|NCT01853644|16348811|P1|Reached First Response/Complete 2 Cycles|Adverse Event|2
4739675|NCT01853644|16348811|P1|Registration and Treatment Start|Did not start treatment|1
4739676|NCT01853618|16348825|P5|Overall Study|Refused further treatment|1
4739677|NCT01853618|16348826|P4|Overall Study|Refused further treatment|0
4739678|NCT01853618|16348827|P3|Overall Study|Refused further treatment|0
4739679|NCT01853618|16348828|P2|Overall Study|Refused further treatment|0
4739680|NCT01853618|16348829|P1|Overall Study|Refused further treatment|0
4739681|NCT01853618|16348825|P5|Overall Study|Physician Decision|0
4739682|NCT01853618|16348826|P4|Overall Study|Physician Decision|0
4739683|NCT01853618|16348827|P3|Overall Study|Physician Decision|1
4739684|NCT01853618|16348828|P2|Overall Study|Physician Decision|1
4739685|NCT01853618|16348829|P1|Overall Study|Physician Decision|0
4739686|NCT01853618|16348825|P5|Overall Study|Progressive disease|2
4739687|NCT01853618|16348826|P4|Overall Study|Progressive disease|1
4739688|NCT01853618|16348827|P3|Overall Study|Progressive disease|1
4739689|NCT01853618|16348828|P2|Overall Study|Progressive disease|1
4739690|NCT01853618|16348829|P1|Overall Study|Progressive disease|1
4739691|NCT01853618|16348825|P5|Overall Study|Bile duct stent blockage/progressive dis|0
4739692|NCT01853618|16348826|P4|Overall Study|Bile duct stent blockage/progressive dis|0
4739693|NCT01853618|16348827|P3|Overall Study|Bile duct stent blockage/progressive dis|0
4739694|NCT01853618|16348828|P2|Overall Study|Bile duct stent blockage/progressive dis|0
4739695|NCT01853618|16348829|P1|Overall Study|Bile duct stent blockage/progressive dis|1
4739696|NCT01853475|16348895|P3|Overall Study|Withdrawal by Subject|0
4739697|NCT01853475|16348896|P2|Overall Study|Withdrawal by Subject|1
4739698|NCT01853475|16348897|P1|Overall Study|Withdrawal by Subject|0
4739699|NCT01853462|16348916|P2|Overall Study|Withdrawal by Subject|1
4739700|NCT01853462|16348917|P1|Overall Study|Withdrawal by Subject|1
4739701|NCT01853397|16348987|P4|Overall Study|Subject Noncompliance|1
4739702|NCT01853397|16348988|P3|Overall Study|Subject Noncompliance|0
4739703|NCT01853397|16348989|P2|Overall Study|Subject Noncompliance|0
4739704|NCT01853397|16348990|P1|Overall Study|Subject Noncompliance|0
4739705|NCT01853397|16348987|P4|Overall Study|Withdrawal by Subject|1
4739706|NCT01853397|16348988|P3|Overall Study|Withdrawal by Subject|0
4739707|NCT01853397|16348989|P2|Overall Study|Withdrawal by Subject|0
4739708|NCT01853397|16348990|P1|Overall Study|Withdrawal by Subject|0
4739709|NCT01853384|16349018|P2|Completed Follow up Visit 2|Lost to Follow-up|1
4739710|NCT01853384|16349019|P1|Completed Follow up Visit 2|Lost to Follow-up|0
4739711|NCT01853384|16349018|P2|Completed Follow up Visit 2|Death|0
4739712|NCT01853384|16349019|P1|Completed Follow up Visit 2|Death|1
4739713|NCT01853384|16349018|P2|Completed Follow up Visit 2|Withdrawal by Subject|2
4739714|NCT01853384|16349019|P1|Completed Follow up Visit 2|Withdrawal by Subject|1
4739715|NCT01853384|16349018|P2|Completed Follow up Visit 2|Adverse Event|0
4739716|NCT01853384|16349019|P1|Completed Follow up Visit 2|Adverse Event|1
4739717|NCT01853384|16349018|P2|Completed Follow up Visit 1|Withdrawal by Subject|0
4739718|NCT01853384|16349019|P1|Completed Follow up Visit 1|Withdrawal by Subject|1
4739719|NCT01853384|16349018|P2|Completed Follow up Visit 1|Early Termination|9
4739720|NCT01853384|16349019|P1|Completed Follow up Visit 1|Early Termination|13
4739721|NCT01853384|16349018|P2|Randomized|Other|3
4739722|NCT01853384|16349019|P1|Randomized|Other|3
4739723|NCT01853384|16349018|P2|Randomized|Sponsor Decision|34
4739724|NCT01853384|16349019|P1|Randomized|Sponsor Decision|47
4739725|NCT01853384|16349018|P2|Randomized|Withdrawal by Subject|3
4739726|NCT01853384|16349019|P1|Randomized|Withdrawal by Subject|5
4739727|NCT01853384|16349018|P2|Randomized|Lost to Follow-up|1
4739728|NCT01853384|16349019|P1|Randomized|Lost to Follow-up|1
4739729|NCT01853384|16349018|P2|Randomized|Death|2
4739730|NCT01853384|16349019|P1|Randomized|Death|1
4739731|NCT01853384|16349018|P2|Randomized|Adverse Event|3
4739732|NCT01853384|16349019|P1|Randomized|Adverse Event|5
4739733|NCT01853280|16349059|P2|Overall Study|Ineligible|1
4739734|NCT01853280|16349060|P1|Overall Study|Ineligible|0
4739735|NCT01853280|16349059|P2|Overall Study|Withdrawal by Subject|1
4739736|NCT01853280|16349060|P1|Overall Study|Withdrawal by Subject|0
4739737|NCT01853280|16349059|P2|Overall Study|Physician Decision|1
4739738|NCT01853280|16349060|P1|Overall Study|Physician Decision|0
4739739|NCT01853280|16349059|P2|Overall Study|Lost to Follow-up|1
4739740|NCT01853280|16349060|P1|Overall Study|Lost to Follow-up|0
4739741|NCT01853280|16349059|P2|Overall Study|Lack of Efficacy|2
4739742|NCT01853280|16349060|P1|Overall Study|Lack of Efficacy|2
4739743|NCT01853254|16349066|P1|Overall Study|Administrative/Other|16
4739744|NCT01853254|16349066|P1|Overall Study|Withdrawal of Consent|16
4739745|NCT01853254|16349066|P1|Overall Study|Other Protocol Violation|1
4739746|NCT01853254|16349066|P1|Overall Study|Refusal of Treatment|1
4739747|NCT01853254|16349066|P1|Overall Study|Insufficient Therapeutic Response|22
4739748|NCT01853254|16349066|P1|Overall Study|Failure to Return|43
4739749|NCT01853254|16349066|P1|Overall Study|Death|1
4739750|NCT01853254|16349066|P1|Overall Study|Adverse Event/Intercurrent Illness|3
4739751|NCT01853254|16349066|P1|Overall Study|Abnormal Laboratory Test|1
4739752|NCT01853228|16349070|P2|Phase 2|Lack of Efficacy|4
4739753|NCT01853228|16349071|P1|Phase 2|Lack of Efficacy|0
4739754|NCT01853228|16349070|P2|Phase 2|Proceed To Transplant|3
4739755|NCT01853228|16349071|P1|Phase 2|Proceed To Transplant|0
4739756|NCT01853228|16349070|P2|Phase 2|Physician Decision|1
4739757|NCT01853228|16349071|P1|Phase 2|Physician Decision|0
4739758|NCT01853228|16349070|P2|Phase 1|Other|0
4739759|NCT01853228|16349071|P1|Phase 1|Other|1
4739760|NCT01853228|16349070|P2|Phase 1|Lack of Efficacy|0
4739761|NCT01853228|16349071|P1|Phase 1|Lack of Efficacy|8
4739762|NCT01853176|16349101|P2|Overall Study|Study terminated|0
4739763|NCT01853176|16349102|P1|Overall Study|Study terminated|4
4739764|NCT01853072|16349121|P2|Overall Study|Reason not specified|6
4739765|NCT01853072|16349122|P1|Overall Study|Reason not specified|9
4739766|NCT01853072|16349121|P2|Overall Study|Withdrawal by Subject|2
4739767|NCT01853072|16349122|P1|Overall Study|Withdrawal by Subject|1
4739768|NCT01853072|16349121|P2|Overall Study|Physician Decision|1
4739769|NCT01853072|16349122|P1|Overall Study|Physician Decision|1
4739770|NCT01853072|16349121|P2|Overall Study|Non-compliance with study drug|1
4739771|NCT01853072|16349122|P1|Overall Study|Non-compliance with study drug|0
4739772|NCT01853072|16349121|P2|Overall Study|Lost to Follow-up|3
4739773|NCT01853072|16349122|P1|Overall Study|Lost to Follow-up|0
4739774|NCT01853072|16349121|P2|Overall Study|Death|4
4739775|NCT01853072|16349122|P1|Overall Study|Death|1
4739776|NCT01853072|16349121|P2|Overall Study|Adverse Event|3
4739777|NCT01853072|16349122|P1|Overall Study|Adverse Event|0
4739778|NCT01853072|16349121|P2|Overall Study|Adverse event prior to treatment|1
4739779|NCT01853072|16349122|P1|Overall Study|Adverse event prior to treatment|0
4739780|NCT01853046|16349142|P2|Overall Study|Disease progression|3
4739781|NCT01853046|16349143|P1|Overall Study|Disease progression|13
4739782|NCT01853046|16349142|P2|Overall Study|Adverse Event|2
4739783|NCT01853046|16349143|P1|Overall Study|Adverse Event|4
4739784|NCT01853046|16349142|P2|Overall Study|Withdrawal by Subject|1
4739785|NCT01853046|16349143|P1|Overall Study|Withdrawal by Subject|1
4739786|NCT01852825|16349211|P3|Overall Study|Withdrawal by Subject|0
4739787|NCT01852825|16349212|P2|Overall Study|Withdrawal by Subject|0
4739788|NCT01852825|16349213|P1|Overall Study|Withdrawal by Subject|2
4739789|NCT01852812|16349239|P3|Overall Study|Non-compliance With Study Drug|0
4739790|NCT01852812|16349240|P2|Overall Study|Non-compliance With Study Drug|1
4739791|NCT01852812|16349241|P1|Overall Study|Non-compliance With Study Drug|0
4739792|NCT01852812|16349239|P3|Overall Study|Adverse Event|1
4739793|NCT01852812|16349240|P2|Overall Study|Adverse Event|0
4739794|NCT01852812|16349241|P1|Overall Study|Adverse Event|0
4739795|NCT01852591|16349279|P1|Overall Study|Not Evaluable at Time of Analysis|1
4739796|NCT01852591|16349279|P1|Overall Study|Withdrawal by Subject|2
4739797|NCT01852292|16349333|P2|Overall Study|Progressive disease|52
4739798|NCT01852292|16349334|P1|Overall Study|Progressive disease|42
4739799|NCT01852292|16349333|P2|Overall Study|Study terminated by Sponsor|1
4739800|NCT01852292|16349334|P1|Overall Study|Study terminated by Sponsor|0
4739801|NCT01852292|16349333|P2|Overall Study|Non-compliance with study treatment|0
4739802|NCT01852292|16349334|P1|Overall Study|Non-compliance with study treatment|1
4739803|NCT01852292|16349333|P2|Overall Study|Protocol Violation|0
4739804|NCT01852292|16349334|P1|Overall Study|Protocol Violation|2
4739805|NCT01852292|16349333|P2|Overall Study|Physician Decision|2
4739806|NCT01852292|16349334|P1|Overall Study|Physician Decision|6
4739807|NCT01852292|16349333|P2|Overall Study|Adverse Event|11
4739808|NCT01852292|16349334|P1|Overall Study|Adverse Event|8
4739809|NCT01852292|16349333|P2|Overall Study|Patient/guardian decision|4
4739810|NCT01852292|16349334|P1|Overall Study|Patient/guardian decision|8
4739811|NCT01852292|16349333|P2|Overall Study|Death|8
4739812|NCT01852292|16349334|P1|Overall Study|Death|9
4739813|NCT01852292|16349333|P2|Overall Study|Untreated - did not receive study drug|1
4739814|NCT01852292|16349334|P1|Overall Study|Untreated - did not receive study drug|3
4739815|NCT01852214|16349358|P2|Washout Period|Withdrawal by Subject|1
4739816|NCT01852214|16349359|P1|Washout Period|Withdrawal by Subject|0
4739817|NCT01852214|16349358|P2|Period 1|Withdrawal by Subject|1
4739818|NCT01852214|16349359|P1|Period 1|Withdrawal by Subject|0
4739819|NCT01852214|16349358|P2|Period 1|Adverse Event|2
4739820|NCT01852214|16349359|P1|Period 1|Adverse Event|1
4739821|NCT01852162|16349411|P2|Overall Study|Withdrawal by Subject|1
4739822|NCT01852162|16349412|P1|Overall Study|Withdrawal by Subject|3
4739823|NCT01852162|16349411|P2|Overall Study|Adverse Event|0
4739824|NCT01852162|16349412|P1|Overall Study|Adverse Event|1
4739825|NCT01852110|16349428|P6|Overall Study|Withdrawal by Subject|0
4739826|NCT01852110|16349429|P5|Overall Study|Withdrawal by Subject|0
4739827|NCT01852110|16349430|P4|Overall Study|Withdrawal by Subject|0
4739828|NCT01852110|16349431|P3|Overall Study|Withdrawal by Subject|0
4739829|NCT01852110|16349432|P2|Overall Study|Withdrawal by Subject|4
4739830|NCT01852110|16349433|P1|Overall Study|Withdrawal by Subject|4
4739831|NCT01852110|16349428|P6|Overall Study|Study Terminated by Sponsor|0
4739832|NCT01852110|16349429|P5|Overall Study|Study Terminated by Sponsor|0
4739833|NCT01852110|16349430|P4|Overall Study|Study Terminated by Sponsor|0
4739834|NCT01852110|16349431|P3|Overall Study|Study Terminated by Sponsor|0
4739835|NCT01852110|16349432|P2|Overall Study|Study Terminated by Sponsor|32
4739836|NCT01852110|16349433|P1|Overall Study|Study Terminated by Sponsor|30
4739837|NCT01852110|16349428|P6|Overall Study|Protocol Violation|0
4739838|NCT01852110|16349429|P5|Overall Study|Protocol Violation|0
4739839|NCT01852110|16349430|P4|Overall Study|Protocol Violation|0
4739840|NCT01852110|16349431|P3|Overall Study|Protocol Violation|0
4739841|NCT01852110|16349432|P2|Overall Study|Protocol Violation|1
4739842|NCT01852110|16349433|P1|Overall Study|Protocol Violation|0
4739843|NCT01852110|16349428|P6|Overall Study|Physician Decision|0
4739844|NCT01852110|16349429|P5|Overall Study|Physician Decision|0
4739845|NCT01852110|16349430|P4|Overall Study|Physician Decision|0
4739846|NCT01852110|16349431|P3|Overall Study|Physician Decision|0
4739847|NCT01852110|16349432|P2|Overall Study|Physician Decision|0
4739848|NCT01852110|16349433|P1|Overall Study|Physician Decision|1
4739849|NCT01852110|16349428|P6|Overall Study|Non-compliance with Study Drug|0
4739850|NCT01852110|16349429|P5|Overall Study|Non-compliance with Study Drug|0
4739851|NCT01852110|16349430|P4|Overall Study|Non-compliance with Study Drug|0
4739852|NCT01852110|16349431|P3|Overall Study|Non-compliance with Study Drug|0
4739853|NCT01852110|16349432|P2|Overall Study|Non-compliance with Study Drug|1
4739854|NCT01852110|16349433|P1|Overall Study|Non-compliance with Study Drug|2
4739855|NCT01852110|16349428|P6|Overall Study|Lost to Follow-up|0
4739856|NCT01852110|16349429|P5|Overall Study|Lost to Follow-up|0
4739857|NCT01852110|16349430|P4|Overall Study|Lost to Follow-up|0
4739858|NCT01852110|16349431|P3|Overall Study|Lost to Follow-up|0
4739859|NCT01852110|16349432|P2|Overall Study|Lost to Follow-up|3
4739860|NCT01852110|16349433|P1|Overall Study|Lost to Follow-up|1
4739861|NCT01852110|16349428|P6|Overall Study|Adverse Event|0
4739862|NCT01852110|16349429|P5|Overall Study|Adverse Event|0
4739863|NCT01852110|16349430|P4|Overall Study|Adverse Event|0
4739864|NCT01852110|16349431|P3|Overall Study|Adverse Event|0
4739865|NCT01852110|16349432|P2|Overall Study|Adverse Event|5
4739866|NCT01852110|16349433|P1|Overall Study|Adverse Event|12
4739867|NCT01852058|16349497|P12|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739868|NCT01852058|16349498|P11|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739869|NCT01852058|16349499|P10|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739870|NCT01852058|16349500|P9|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1
4739871|NCT01852058|16349501|P8|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739872|NCT01852058|16349502|P7|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739873|NCT01852058|16349503|P6|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739874|NCT01852058|16349504|P5|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739875|NCT01852058|16349505|P4|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739876|NCT01852058|16349506|P3|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739877|NCT01852058|16349507|P2|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739878|NCT01852058|16349508|P1|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0
4739879|NCT01852058|16349497|P12|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739880|NCT01852058|16349498|P11|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739881|NCT01852058|16349499|P10|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739882|NCT01852058|16349500|P9|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739883|NCT01852058|16349501|P8|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1
4739884|NCT01852058|16349502|P7|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739885|NCT01852058|16349503|P6|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739886|NCT01852058|16349504|P5|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739887|NCT01852058|16349505|P4|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739888|NCT01852058|16349506|P3|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739889|NCT01852058|16349507|P2|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739890|NCT01852058|16349508|P1|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0
4739891|NCT01852058|16349497|P12|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739892|NCT01852058|16349498|P11|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739893|NCT01852058|16349499|P10|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739894|NCT01852058|16349500|P9|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739895|NCT01852058|16349501|P8|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739896|NCT01852058|16349502|P7|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739897|NCT01852058|16349503|P6|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7
4739898|NCT01852058|16349504|P5|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1
4739899|NCT01852058|16349505|P4|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739900|NCT01852058|16349506|P3|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739901|NCT01852058|16349507|P2|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739902|NCT01852058|16349508|P1|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0
4739903|NCT01852058|16349497|P12|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739904|NCT01852058|16349498|P11|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739905|NCT01852058|16349499|P10|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739906|NCT01852058|16349500|P9|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739907|NCT01852058|16349501|P8|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739908|NCT01852058|16349502|P7|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739909|NCT01852058|16349503|P6|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739910|NCT01852058|16349504|P5|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739911|NCT01852058|16349505|P4|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1
4739912|NCT01852058|16349506|P3|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739913|NCT01852058|16349507|P2|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739914|NCT01852058|16349508|P1|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0
4739915|NCT01852058|16349497|P12|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739916|NCT01852058|16349498|P11|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739917|NCT01852058|16349499|P10|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739918|NCT01852058|16349500|P9|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739919|NCT01852058|16349501|P8|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739920|NCT01852058|16349502|P7|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739921|NCT01852058|16349503|P6|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1
4739922|NCT01852058|16349504|P5|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3
4739923|NCT01852058|16349505|P4|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739924|NCT01852058|16349506|P3|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739925|NCT01852058|16349507|P2|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739926|NCT01852058|16349508|P1|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0
4739927|NCT01852058|16349497|P12|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739928|NCT01852058|16349498|P11|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739929|NCT01852058|16349499|P10|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739930|NCT01852058|16349500|P9|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739931|NCT01852058|16349501|P8|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739932|NCT01852058|16349502|P7|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739933|NCT01852058|16349503|P6|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739934|NCT01852058|16349504|P5|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1
4739935|NCT01852058|16349505|P4|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739936|NCT01852058|16349506|P3|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739937|NCT01852058|16349507|P2|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739938|NCT01852058|16349508|P1|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0
4739939|NCT01852058|16349497|P12|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739940|NCT01852058|16349498|P11|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739941|NCT01852058|16349499|P10|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739942|NCT01852058|16349500|P9|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739943|NCT01852058|16349501|P8|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739944|NCT01852058|16349502|P7|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739945|NCT01852058|16349503|P6|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
4739946|NCT01852058|16349504|P5|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1
4739947|NCT01852058|16349505|P4|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739948|NCT01852058|16349506|P3|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739949|NCT01852058|16349507|P2|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739950|NCT01852058|16349508|P1|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0
4739951|NCT01852058|16349497|P12|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739952|NCT01852058|16349498|P11|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739953|NCT01852058|16349499|P10|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739954|NCT01852058|16349500|P9|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739955|NCT01852058|16349501|P8|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739956|NCT01852058|16349502|P7|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739957|NCT01852058|16349503|P6|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739958|NCT01852058|16349504|P5|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1
4739959|NCT01852058|16349505|P4|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739960|NCT01852058|16349506|P3|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739961|NCT01852058|16349507|P2|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739962|NCT01852058|16349508|P1|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0
4739963|NCT01852058|16349497|P12|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739964|NCT01852058|16349498|P11|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739965|NCT01852058|16349499|P10|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739966|NCT01852058|16349500|P9|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739967|NCT01852058|16349501|P8|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739968|NCT01852058|16349502|P7|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739969|NCT01852058|16349503|P6|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739970|NCT01852058|16349504|P5|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739971|NCT01852058|16349505|P4|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739972|NCT01852058|16349506|P3|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739973|NCT01852058|16349507|P2|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0
4739974|NCT01852058|16349508|P1|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1
4739975|NCT01852045|16349588|P3|Overall Study|Other Miscellaneous Reasons|2
4739976|NCT01852045|16349589|P2|Overall Study|Other Miscellaneous Reasons|3
4739977|NCT01852045|16349590|P1|Overall Study|Other Miscellaneous Reasons|1
4739978|NCT01852045|16349588|P3|Overall Study|Withdrawal by Subject|1
4739979|NCT01852045|16349589|P2|Overall Study|Withdrawal by Subject|0
4739980|NCT01852045|16349590|P1|Overall Study|Withdrawal by Subject|1
4739981|NCT01852045|16349588|P3|Overall Study|Lost to Follow-up|1
4739982|NCT01852045|16349589|P2|Overall Study|Lost to Follow-up|1
4739983|NCT01852045|16349590|P1|Overall Study|Lost to Follow-up|0
4739984|NCT01852045|16349588|P3|Overall Study|Lack of Efficacy|0
4739985|NCT01852045|16349589|P2|Overall Study|Lack of Efficacy|0
4739986|NCT01852045|16349590|P1|Overall Study|Lack of Efficacy|3
4739987|NCT01852045|16349588|P3|Overall Study|Adverse Event|0
4739988|NCT01852045|16349589|P2|Overall Study|Adverse Event|0
4739989|NCT01852045|16349590|P1|Overall Study|Adverse Event|1
4739990|NCT01851863|16349674|P4|Overall Study|Lost to Follow-up|3
4739991|NCT01851863|16349675|P3|Overall Study|Lost to Follow-up|2
4739992|NCT01851863|16349676|P2|Overall Study|Lost to Follow-up|4
4739993|NCT01851863|16349677|P1|Overall Study|Lost to Follow-up|3
4739994|NCT01851863|16349674|P4|Overall Study|Did not receive study medication|0
4739995|NCT01851863|16349675|P3|Overall Study|Did not receive study medication|3
4739996|NCT01851863|16349676|P2|Overall Study|Did not receive study medication|5
4739997|NCT01851863|16349677|P1|Overall Study|Did not receive study medication|2
4739998|NCT01851720|16349706|P2|Overall Study|Lost to Follow-up|1
4739999|NCT01851720|16349707|P1|Overall Study|Lost to Follow-up|0
4740000|NCT01851590|16349737|P3|Overall Study|Lack of Efficacy|0
4740001|NCT01851590|16349738|P2|Overall Study|Lack of Efficacy|1
4740002|NCT01851590|16349739|P1|Overall Study|Lack of Efficacy|0
4740003|NCT01851590|16349737|P3|Overall Study|Adverse Event|2
4740004|NCT01851590|16349738|P2|Overall Study|Adverse Event|0
4740005|NCT01851590|16349739|P1|Overall Study|Adverse Event|0
4740006|NCT01851590|16349737|P3|Overall Study|Withdrawal by Subject|1
4740007|NCT01851590|16349738|P2|Overall Study|Withdrawal by Subject|0
4740008|NCT01851590|16349739|P1|Overall Study|Withdrawal by Subject|0
4740009|NCT01851330|16349762|P3|Overall Study|Investigator's Discretion|1
4740010|NCT01851330|16349763|P2|Overall Study|Investigator's Discretion|0
4740011|NCT01851330|16349764|P1|Overall Study|Investigator's Discretion|0
4740012|NCT01851330|16349762|P3|Overall Study|Withdrew Consent|0
4740013|NCT01851330|16349763|P2|Overall Study|Withdrew Consent|1
4740014|NCT01851330|16349764|P1|Overall Study|Withdrew Consent|2
4740015|NCT01851330|16349762|P3|Overall Study|Lost to Follow-up|9
4740016|NCT01851330|16349763|P2|Overall Study|Lost to Follow-up|6
4740017|NCT01851330|16349764|P1|Overall Study|Lost to Follow-up|1
4740018|NCT01851330|16349762|P3|Overall Study|Lack of Efficacy|2
4740019|NCT01851330|16349763|P2|Overall Study|Lack of Efficacy|9
4740020|NCT01851330|16349764|P1|Overall Study|Lack of Efficacy|10
4740021|NCT01850823|16349807|P3|Overall Study|Withdrawal by Subject|1
4740022|NCT01850823|16349808|P2|Overall Study|Withdrawal by Subject|0
4740023|NCT01850823|16349809|P1|Overall Study|Withdrawal by Subject|2
4740024|NCT01850823|16349807|P3|Overall Study|Significant worstening of SAR|0
4740025|NCT01850823|16349808|P2|Overall Study|Significant worstening of SAR|1
4740026|NCT01850823|16349809|P1|Overall Study|Significant worstening of SAR|0
4740027|NCT01850823|16349807|P3|Overall Study|Restricted Medication|2
4740028|NCT01850823|16349808|P2|Overall Study|Restricted Medication|0
4740029|NCT01850823|16349809|P1|Overall Study|Restricted Medication|0
4740030|NCT01850823|16349807|P3|Overall Study|Lost to Follow-up|1
4740031|NCT01850823|16349808|P2|Overall Study|Lost to Follow-up|0
4740032|NCT01850823|16349809|P1|Overall Study|Lost to Follow-up|0
4740033|NCT01850823|16349807|P3|Overall Study|Lack of Efficacy|0
4740034|NCT01850823|16349808|P2|Overall Study|Lack of Efficacy|0
4740035|NCT01850823|16349809|P1|Overall Study|Lack of Efficacy|1
4740036|NCT01850823|16349807|P3|Overall Study|Enrolled in Error|2
4740037|NCT01850823|16349808|P2|Overall Study|Enrolled in Error|1
4740038|NCT01850823|16349809|P1|Overall Study|Enrolled in Error|0
4740039|NCT01850823|16349807|P3|Overall Study|Early Visit Window|4
4740040|NCT01850823|16349808|P2|Overall Study|Early Visit Window|1
4740041|NCT01850823|16349809|P1|Overall Study|Early Visit Window|0
4740042|NCT01850641|16349832|P1|Overall Study|Increase in serum ferritin|1
4740043|NCT01850641|16349832|P1|Overall Study|Decrease in serum calcium|2
4740044|NCT01850641|16349832|P1|Overall Study|Decrease in serum phosphorus|1
4740045|NCT01850641|16349832|P1|Overall Study|Physician Decision|1
4740046|NCT01850615|16349846|P2|Overall Study|Unclassified|1
4740047|NCT01850615|16349847|P1|Overall Study|Unclassified|0
4740048|NCT01850615|16349846|P2|Overall Study|Lost to Follow-up|1
4740049|NCT01850615|16349847|P1|Overall Study|Lost to Follow-up|0
4740050|NCT01850615|16349846|P2|Overall Study|Withdrawal by Subject|1
4740051|NCT01850615|16349847|P1|Overall Study|Withdrawal by Subject|3
4740052|NCT01850615|16349846|P2|Overall Study|Adverse Event|1
4740053|NCT01850615|16349847|P1|Overall Study|Adverse Event|2
4740054|NCT01850615|16349846|P2|Overall Study|Protocol Violation|1
4740055|NCT01850615|16349847|P1|Overall Study|Protocol Violation|4
4740056|NCT01850602|16349865|P2|Overall Study|Increase in serum ferritin|0
4740057|NCT01850602|16349866|P1|Overall Study|Increase in serum ferritin|1
4740058|NCT01850602|16349865|P2|Overall Study|Decrease in serum calcium|3
4740059|NCT01850602|16349866|P1|Overall Study|Decrease in serum calcium|2
4740060|NCT01850602|16349865|P2|Overall Study|Withdrawal by Subject|4
4740061|NCT01850602|16349866|P1|Overall Study|Withdrawal by Subject|2
4740062|NCT01850602|16349865|P2|Overall Study|Physician Decision|1
4740063|NCT01850602|16349866|P1|Overall Study|Physician Decision|2
4740064|NCT01850602|16349865|P2|Overall Study|Adverse Event|10
4740065|NCT01850602|16349866|P1|Overall Study|Adverse Event|7
4740066|NCT01850589|16349880|P2|Overall Study|Withdrawal by Subject|0
4740067|NCT01850589|16349881|P1|Overall Study|Withdrawal by Subject|8
4740068|NCT01850446|16349921|P2|Overall Study|Protocol Violation|2
4740069|NCT01850446|16349922|P1|Overall Study|Protocol Violation|0
4740070|NCT01850446|16349921|P2|Overall Study|Withdrawal by Subject|0
4740071|NCT01850446|16349922|P1|Overall Study|Withdrawal by Subject|4
4740072|NCT01850446|16349921|P2|Overall Study|Lack of Efficacy|0
4740073|NCT01850446|16349922|P1|Overall Study|Lack of Efficacy|1
4740074|NCT01850030|16349981|P2|Overall Study|pregnancy not confirmed at visit 4|249
4740075|NCT01850030|16349982|P1|Overall Study|pregnancy not confirmed at visit 4|248
4740076|NCT01850030|16349981|P2|Overall Study|Protocol Violation|28
4740077|NCT01850030|16349982|P1|Overall Study|Protocol Violation|24
4740078|NCT01850030|16349981|P2|Overall Study|Withdrawal by Subject|4
4740079|NCT01850030|16349982|P1|Overall Study|Withdrawal by Subject|3
4740080|NCT01850030|16349981|P2|Overall Study|Lost to Follow-up|5
4740081|NCT01850030|16349982|P1|Overall Study|Lost to Follow-up|5
4740082|NCT01850030|16349981|P2|Overall Study|Lack of Efficacy|1
4740083|NCT01850030|16349982|P1|Overall Study|Lack of Efficacy|3
4740084|NCT01850030|16349981|P2|Overall Study|Adverse Event|82
4740085|NCT01850030|16349982|P1|Overall Study|Adverse Event|64
4740086|NCT01850004|16349994|P1|Overall Study|AE Unrelated to Study Drug|1
4740087|NCT01850004|16349994|P1|Overall Study|Subject Request to Discontinue Treatment|1
4740088|NCT01850004|16349994|P1|Overall Study|Subject Withdrew Consent|4
4740089|NCT01850004|16349994|P1|Overall Study|Poor/Non-compliance|1
4740090|NCT01850004|16349994|P1|Overall Study|Subject Moved|1
4740091|NCT01849848|16350001|P1|Overall Study|Progression of the primary disease|3
4740092|NCT01849848|16350001|P1|Overall Study|Physician Decision|1
4740093|NCT01849588|16350099|P1|Overall Study|Lack of Efficacy|3
4740094|NCT01849562|16350118|P3|Overall Study|Non-compliance with Study Drug|0
4740095|NCT01849562|16350119|P2|Overall Study|Non-compliance with Study Drug|0
4740096|NCT01849562|16350120|P1|Overall Study|Non-compliance with Study Drug|1
4740097|NCT01849562|16350118|P3|Overall Study|Lost to Follow-up|0
4740098|NCT01849562|16350119|P2|Overall Study|Lost to Follow-up|0
4740099|NCT01849562|16350120|P1|Overall Study|Lost to Follow-up|1
4740100|NCT01849497|16350133|P2|Overall Study|Lost to Follow-up|1
4740101|NCT01849497|16350134|P1|Overall Study|Lost to Follow-up|0
4740102|NCT01849497|16350133|P2|Overall Study|Sponsor Decision|1
4740103|NCT01849497|16350134|P1|Overall Study|Sponsor Decision|0
4740104|NCT01849497|16350133|P2|Overall Study|Withdrawal by Subject|2
4740105|NCT01849497|16350134|P1|Overall Study|Withdrawal by Subject|1
4740106|NCT01849458|16350142|P1|Overall Study|Lost to Follow-up|4
4740107|NCT01849289|16350181|P2|Overall Study|Unclassified|18
4740108|NCT01849289|16350182|P1|Overall Study|Unclassified|25
4740109|NCT01849289|16350181|P2|Overall Study|Withdrawal criteria|0
4740110|NCT01849289|16350182|P1|Overall Study|Withdrawal criteria|1
4740111|NCT01849289|16350181|P2|Overall Study|Protocol Violation|3
4740112|NCT01849289|16350182|P1|Overall Study|Protocol Violation|3
4740113|NCT01849289|16350181|P2|Overall Study|Adverse Event|3
4740114|NCT01849289|16350182|P1|Overall Study|Adverse Event|3
4740115|NCT01849276|16350198|P1|Followed for Survival for 5 Years|Early termination of the study|1
4740116|NCT01849276|16350198|P1|Followed for Survival for 5 Years|Death|1
4740117|NCT01849055|16350280|P6|Overall Study|Withdrawal by Subject|0
4740118|NCT01849055|16350281|P5|Overall Study|Withdrawal by Subject|0
4740119|NCT01849055|16350282|P4|Overall Study|Withdrawal by Subject|0
4740120|NCT01849055|16350283|P3|Overall Study|Withdrawal by Subject|1
4740121|NCT01849055|16350284|P2|Overall Study|Withdrawal by Subject|0
4740122|NCT01849055|16350285|P1|Overall Study|Withdrawal by Subject|0
4740123|NCT01848990|16350320|P3|Overall Study|Other|2
4740124|NCT01848990|16350321|P2|Overall Study|Other|4
4740125|NCT01848990|16350322|P1|Overall Study|Other|1
4740126|NCT01848990|16350320|P3|Overall Study|Death|1
4740127|NCT01848990|16350321|P2|Overall Study|Death|0
4740128|NCT01848990|16350322|P1|Overall Study|Death|1
4740129|NCT01848990|16350320|P3|Overall Study|Non Compliance|0
4740130|NCT01848990|16350321|P2|Overall Study|Non Compliance|0
4740131|NCT01848990|16350322|P1|Overall Study|Non Compliance|1
4740132|NCT01848990|16350320|P3|Overall Study|Physician Decision|0
4740133|NCT01848990|16350321|P2|Overall Study|Physician Decision|1
4740134|NCT01848990|16350322|P1|Overall Study|Physician Decision|1
4740135|NCT01848990|16350320|P3|Overall Study|Withdrawal by Subject|11
4740136|NCT01848990|16350321|P2|Overall Study|Withdrawal by Subject|10
4740137|NCT01848990|16350322|P1|Overall Study|Withdrawal by Subject|29
4740138|NCT01848990|16350320|P3|Overall Study|Protocol Violation|0
4740139|NCT01848990|16350321|P2|Overall Study|Protocol Violation|1
4740140|NCT01848990|16350322|P1|Overall Study|Protocol Violation|1
4740141|NCT01848990|16350320|P3|Overall Study|Lost to Follow-up|2
4740142|NCT01848990|16350321|P2|Overall Study|Lost to Follow-up|2
4740143|NCT01848990|16350322|P1|Overall Study|Lost to Follow-up|6
4740144|NCT01848990|16350320|P3|Overall Study|Adverse Event|0
4740145|NCT01848990|16350321|P2|Overall Study|Adverse Event|2
4740146|NCT01848990|16350322|P1|Overall Study|Adverse Event|6
4740147|NCT01848938|16350392|P2|Overall Study|Lost to Follow-up|1
4740148|NCT01848938|16350393|P1|Overall Study|Lost to Follow-up|1
4740149|NCT01848834|16350442|P5|Overall Study|Not Treated|0
4740150|NCT01848834|16350443|P4|Overall Study|Not Treated|0
4740151|NCT01848834|16350444|P3|Overall Study|Not Treated|0
4740152|NCT01848834|16350445|P2|Overall Study|Not Treated|1
4740153|NCT01848834|16350446|P1|Overall Study|Not Treated|0
4740154|NCT01848834|16350442|P5|Overall Study|Withdrawal by Subject|7
4740155|NCT01848834|16350443|P4|Overall Study|Withdrawal by Subject|0
4740156|NCT01848834|16350444|P3|Overall Study|Withdrawal by Subject|3
4740157|NCT01848834|16350445|P2|Overall Study|Withdrawal by Subject|2
4740158|NCT01848834|16350446|P1|Overall Study|Withdrawal by Subject|0
4740159|NCT01848834|16350442|P5|Overall Study|Protocol Violation|2
4740160|NCT01848834|16350443|P4|Overall Study|Protocol Violation|0
4740161|NCT01848834|16350444|P3|Overall Study|Protocol Violation|1
4740162|NCT01848834|16350445|P2|Overall Study|Protocol Violation|0
4740163|NCT01848834|16350446|P1|Overall Study|Protocol Violation|0
4740164|NCT01848834|16350442|P5|Overall Study|Progressive Disease|78
4740165|NCT01848834|16350443|P4|Overall Study|Progressive Disease|36
4740166|NCT01848834|16350444|P3|Overall Study|Progressive Disease|21
4740167|NCT01848834|16350445|P2|Overall Study|Progressive Disease|41
4740168|NCT01848834|16350446|P1|Overall Study|Progressive Disease|27
4740169|NCT01848834|16350442|P5|Overall Study|Death|3
4740170|NCT01848834|16350443|P4|Overall Study|Death|0
4740171|NCT01848834|16350444|P3|Overall Study|Death|0
4740172|NCT01848834|16350445|P2|Overall Study|Death|1
4740173|NCT01848834|16350446|P1|Overall Study|Death|0
4740174|NCT01848834|16350442|P5|Overall Study|Complete Response|0
4740175|NCT01848834|16350443|P4|Overall Study|Complete Response|0
4740176|NCT01848834|16350444|P3|Overall Study|Complete Response|0
4740177|NCT01848834|16350445|P2|Overall Study|Complete Response|1
4740178|NCT01848834|16350446|P1|Overall Study|Complete Response|0
4740179|NCT01848834|16350442|P5|Overall Study|Adverse Event|15
4740180|NCT01848834|16350443|P4|Overall Study|Adverse Event|1
4740181|NCT01848834|16350444|P3|Overall Study|Adverse Event|6
4740182|NCT01848834|16350445|P2|Overall Study|Adverse Event|8
4740183|NCT01848834|16350446|P1|Overall Study|Adverse Event|3
4740184|NCT01848834|16350442|P5|Overall Study|Physician Decision|1
4740185|NCT01848834|16350443|P4|Overall Study|Physician Decision|0
4740186|NCT01848834|16350444|P3|Overall Study|Physician Decision|0
4740187|NCT01848834|16350445|P2|Overall Study|Physician Decision|0
4740188|NCT01848834|16350446|P1|Overall Study|Physician Decision|0
4740189|NCT01848834|16350442|P5|Overall Study|Ongoing in Study|26
4740190|NCT01848834|16350443|P4|Overall Study|Ongoing in Study|0
4740191|NCT01848834|16350444|P3|Overall Study|Ongoing in Study|1
4740192|NCT01848834|16350445|P2|Overall Study|Ongoing in Study|6
4740193|NCT01848834|16350446|P1|Overall Study|Ongoing in Study|0
4740194|NCT01848756|16350494|P1|Overall Study|Enrolled in Error|1
4740195|NCT01848756|16350494|P1|Overall Study|Withdrawal by Subject|1
4740196|NCT01848756|16350494|P1|Overall Study|Adverse Event|1
4740197|NCT01848483|16350506|P2|Overall Study|Incarceration|2
4740198|NCT01848483|16350507|P1|Overall Study|Incarceration|2
4740199|NCT01848483|16350506|P2|Overall Study|Withdrawal by Subject|0
4740200|NCT01848483|16350507|P1|Overall Study|Withdrawal by Subject|1
4740201|NCT01848483|16350506|P2|Overall Study|Lost to Follow-up|8
4740202|NCT01848483|16350507|P1|Overall Study|Lost to Follow-up|6
4740203|NCT01848483|16350506|P2|Overall Study|Death|1
4740204|NCT01848483|16350507|P1|Overall Study|Death|2
4740205|NCT01848457|16350525|P4|Overall Study|Death|0
4740206|NCT01848457|16350526|P3|Overall Study|Death|0
4740207|NCT01848457|16350527|P2|Overall Study|Death|0
4740208|NCT01848457|16350528|P1|Overall Study|Death|1
4740209|NCT01848353|16350560|P4|Phase 3|Withdrawal by Subject|0
4740210|NCT01848353|16350561|P3|Phase 3|Withdrawal by Subject|0
4740211|NCT01848353|16350562|P2|Phase 3|Withdrawal by Subject|1
4740212|NCT01848353|16350563|P1|Phase 3|Withdrawal by Subject|1
4740213|NCT01848353|16350560|P4|Phase 2|Withdrawal by Subject|0
4740214|NCT01848353|16350561|P3|Phase 2|Withdrawal by Subject|0
4740215|NCT01848353|16350562|P2|Phase 2|Withdrawal by Subject|2
4740216|NCT01848353|16350563|P1|Phase 2|Withdrawal by Subject|3
4740217|NCT01848353|16350560|P4|Phase 1|Withdrawal by Subject|0
4740218|NCT01848353|16350561|P3|Phase 1|Withdrawal by Subject|0
4740219|NCT01848353|16350562|P2|Phase 1|Withdrawal by Subject|1
4740220|NCT01848353|16350563|P1|Phase 1|Withdrawal by Subject|3
4740221|NCT01848288|16350619|P1|Overall Study|Withdrawal by Subject|1
4740222|NCT01848288|16350619|P1|Overall Study|Protocol Violation|1
4740223|NCT01848288|16350619|P1|Overall Study|Death|1
4740224|NCT01848210|16350630|P2|Overall Study|Administrative|0
4740225|NCT01848210|16350631|P1|Overall Study|Administrative|1
4740226|NCT01848210|16350630|P2|Overall Study|Chronic Venous Insufficiency Course|2
4740227|NCT01848210|16350631|P1|Overall Study|Chronic Venous Insufficiency Course|1
4740228|NCT01848210|16350630|P2|Overall Study|Hepatic Function Alteration|0
4740229|NCT01848210|16350631|P1|Overall Study|Hepatic Function Alteration|4
4740230|NCT01848210|16350630|P2|Overall Study|Hypesensitivity|0
4740231|NCT01848210|16350631|P1|Overall Study|Hypesensitivity|1
4740232|NCT01848210|16350630|P2|Overall Study|Discontinuation Criterion|7
4740233|NCT01848210|16350631|P1|Overall Study|Discontinuation Criterion|5
4740234|NCT01848210|16350630|P2|Overall Study|Adverse Event|9
4740235|NCT01848210|16350631|P1|Overall Study|Adverse Event|7
4740236|NCT01848210|16350630|P2|Overall Study|Impedition Condition|9
4740237|NCT01848210|16350631|P1|Overall Study|Impedition Condition|5
4740238|NCT01848210|16350630|P2|Overall Study|Use of Forbidden Drugs|10
4740239|NCT01848210|16350631|P1|Overall Study|Use of Forbidden Drugs|9
4740240|NCT01848210|16350630|P2|Overall Study|Protocol Violation|5
4740241|NCT01848210|16350631|P1|Overall Study|Protocol Violation|3
4740242|NCT01848210|16350630|P2|Overall Study|Lost to Follow-up|12
4740243|NCT01848210|16350631|P1|Overall Study|Lost to Follow-up|24
4740244|NCT01848210|16350630|P2|Overall Study|Informed Consent Form Withdrawal|24
4740245|NCT01848210|16350631|P1|Overall Study|Informed Consent Form Withdrawal|28
4740246|NCT01848145|16350680|P1|Subsequent Infusions: Weeks 3-8|Death|1
4740247|NCT01848145|16350680|P1|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3
4740248|NCT01848145|16350680|P1|Subsequent Infusions: Weeks 3-8|Disease Progression|6
4740249|NCT01848145|16350680|P1|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1
4740250|NCT01848145|16350680|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1
4740251|NCT01848145|16350680|P1|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1
4740252|NCT01848145|16350680|P1|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1
4740253|NCT01847885|16350720|P3|Randomization|Screen Failure|0
4740254|NCT01847885|16350721|P2|Randomization|Screen Failure|3
4740255|NCT01847885|16350722|P1|Randomization|Screen Failure|0
4740256|NCT01847885|16350720|P3|Randomization|Withdrawal by Subject|2
4740257|NCT01847885|16350721|P2|Randomization|Withdrawal by Subject|0
4740258|NCT01847885|16350722|P1|Randomization|Withdrawal by Subject|0
4740259|NCT01847885|16350720|P3|Randomization|Protocol Violation|0
4740260|NCT01847885|16350721|P2|Randomization|Protocol Violation|1
4740261|NCT01847885|16350722|P1|Randomization|Protocol Violation|0
4740262|NCT01847885|16350720|P3|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
4740263|NCT01847885|16350721|P2|Initial Enrollment (Consented)|Pending prior to enrollment stop|0
4740264|NCT01847885|16350722|P1|Initial Enrollment (Consented)|Pending prior to enrollment stop|6
4740265|NCT01847885|16350720|P3|Initial Enrollment (Consented)|Screen failure|0
4740266|NCT01847885|16350721|P2|Initial Enrollment (Consented)|Screen failure|0
4740351|NCT01846442|16351361|P2|Overall Study|Left the city/Lost medication|0
4740267|NCT01847885|16350722|P1|Initial Enrollment (Consented)|Screen failure|39
4740268|NCT01847885|16350720|P3|Initial Enrollment (Consented)|Withdrawal by Subject|0
4740269|NCT01847885|16350721|P2|Initial Enrollment (Consented)|Withdrawal by Subject|0
4740270|NCT01847885|16350722|P1|Initial Enrollment (Consented)|Withdrawal by Subject|2
4740271|NCT01847885|16350720|P3|Initial Enrollment (Consented)|Protocol Violation|0
4740272|NCT01847885|16350721|P2|Initial Enrollment (Consented)|Protocol Violation|0
4740273|NCT01847885|16350722|P1|Initial Enrollment (Consented)|Protocol Violation|1
4740274|NCT01847443|16350886|P4|Washout Period Before Study Period 4|Positive alcohol test|0
4740275|NCT01847443|16350887|P3|Washout Period Before Study Period 4|Positive alcohol test|0
4740276|NCT01847443|16350888|P2|Washout Period Before Study Period 4|Positive alcohol test|0
4740277|NCT01847443|16350889|P1|Washout Period Before Study Period 4|Positive alcohol test|1
4740278|NCT01847443|16350886|P4|Washout Period Before Study Period 4|Withdrawal by Subject|0
4740279|NCT01847443|16350887|P3|Washout Period Before Study Period 4|Withdrawal by Subject|0
4740280|NCT01847443|16350888|P2|Washout Period Before Study Period 4|Withdrawal by Subject|0
4740281|NCT01847443|16350889|P1|Washout Period Before Study Period 4|Withdrawal by Subject|1
4740282|NCT01847443|16350886|P4|Washout Period Before Study Period 3|Other reason|0
4740283|NCT01847443|16350887|P3|Washout Period Before Study Period 3|Other reason|0
4740284|NCT01847443|16350888|P2|Washout Period Before Study Period 3|Other reason|0
4740285|NCT01847443|16350889|P1|Washout Period Before Study Period 3|Other reason|1
4740286|NCT01847443|16350886|P4|Washout Period Before Study Period 2|Other reason|0
4740287|NCT01847443|16350887|P3|Washout Period Before Study Period 2|Other reason|0
4740288|NCT01847443|16350888|P2|Washout Period Before Study Period 2|Other reason|0
4740289|NCT01847443|16350889|P1|Washout Period Before Study Period 2|Other reason|1
4740290|NCT01847443|16350886|P4|Washout Period Before Study Period 2|Adverse Event|0
4740291|NCT01847443|16350887|P3|Washout Period Before Study Period 2|Adverse Event|0
4740292|NCT01847443|16350888|P2|Washout Period Before Study Period 2|Adverse Event|1
4740293|NCT01847443|16350889|P1|Washout Period Before Study Period 2|Adverse Event|1
4740294|NCT01847443|16350886|P4|Study Period 1|Withdrawal by Subject|0
4740295|NCT01847443|16350887|P3|Study Period 1|Withdrawal by Subject|0
4740296|NCT01847443|16350888|P2|Study Period 1|Withdrawal by Subject|1
4740297|NCT01847443|16350889|P1|Study Period 1|Withdrawal by Subject|0
4740298|NCT01847313|16350932|P2|Overall Study|Withdrawal by Subject|1
4740299|NCT01847313|16350933|P1|Overall Study|Withdrawal by Subject|0
4740300|NCT01847313|16350932|P2|Overall Study|Death|1
4740301|NCT01847313|16350933|P1|Overall Study|Death|0
4740302|NCT01847274|16350949|P4|Overall Study|Non Compliance|0
4740303|NCT01847274|16350950|P3|Overall Study|Non Compliance|2
4740304|NCT01847274|16350951|P2|Overall Study|Non Compliance|0
4740305|NCT01847274|16350952|P1|Overall Study|Non Compliance|0
4740306|NCT01847274|16350949|P4|Overall Study|Other Reasons|3
4740307|NCT01847274|16350950|P3|Overall Study|Other Reasons|11
4740308|NCT01847274|16350951|P2|Overall Study|Other Reasons|1
4740309|NCT01847274|16350952|P1|Overall Study|Other Reasons|3
4740310|NCT01847274|16350949|P4|Overall Study|Treatment Associated Risk|0
4740311|NCT01847274|16350950|P3|Overall Study|Treatment Associated Risk|2
4740312|NCT01847274|16350951|P2|Overall Study|Treatment Associated Risk|2
4740313|NCT01847274|16350952|P1|Overall Study|Treatment Associated Risk|0
4740314|NCT01847274|16350949|P4|Overall Study|Disease Progression|98
4740315|NCT01847274|16350950|P3|Overall Study|Disease Progression|129
4740316|NCT01847274|16350951|P2|Overall Study|Disease Progression|49
4740317|NCT01847274|16350952|P1|Overall Study|Disease Progression|63
4740318|NCT01847274|16350949|P4|Overall Study|Withdrawal by Subject|1
4740319|NCT01847274|16350950|P3|Overall Study|Withdrawal by Subject|11
4740320|NCT01847274|16350951|P2|Overall Study|Withdrawal by Subject|8
4740321|NCT01847274|16350952|P1|Overall Study|Withdrawal by Subject|8
4740322|NCT01847274|16350949|P4|Overall Study|Adverse Event|2
4740323|NCT01847274|16350950|P3|Overall Study|Adverse Event|33
4740324|NCT01847274|16350951|P2|Overall Study|Adverse Event|1
4740325|NCT01847274|16350952|P1|Overall Study|Adverse Event|17
4740326|NCT01847209|16351006|P1|Overall Study|No lung nodule found on intraop CT scan|1
4740327|NCT01847209|16351006|P1|Overall Study|Withdrawal by Subject|1
4740328|NCT01847092|16351029|P2|Overall Study|Protocol Violation|2
4740329|NCT01847092|16351030|P1|Overall Study|Protocol Violation|0
4740330|NCT01847092|16351029|P2|Overall Study|Physician Decision|1
4740331|NCT01847092|16351030|P1|Overall Study|Physician Decision|1
4740332|NCT01847092|16351029|P2|Overall Study|Protocol Specified|0
4740333|NCT01847092|16351030|P1|Overall Study|Protocol Specified|8
4740334|NCT01847092|16351029|P2|Overall Study|Withdrawal by Subject|5
4740335|NCT01847092|16351030|P1|Overall Study|Withdrawal by Subject|5
4740336|NCT01847092|16351029|P2|Overall Study|Adverse Event|3
4740337|NCT01847092|16351030|P1|Overall Study|Adverse Event|12
4740338|NCT01846741|16351084|P1|Baseline Visit|Subject did not meet entry criteria|2
4740339|NCT01846624|16351240|P1|Overall Study|Died during induction, no midostaurin|1
4740340|NCT01846611|16351250|P2|Overall Study|Other|18
4740341|NCT01846611|16351251|P1|Overall Study|Other|19
4740342|NCT01846611|16351250|P2|Overall Study|Withdrawal by Subject|19
4740343|NCT01846611|16351251|P1|Overall Study|Withdrawal by Subject|15
4740344|NCT01846611|16351250|P2|Overall Study|Lost to Follow-up|6
4740345|NCT01846611|16351251|P1|Overall Study|Lost to Follow-up|4
4740346|NCT01846507|16351261|P1|Overall Study|Missing data|2
4740347|NCT01846507|16351261|P1|Overall Study|Protocol Violation|1
4740348|NCT01846507|16351261|P1|Overall Study|Lost to Follow-up|4
4740349|NCT01846442|16351359|P4|Overall Study|Left the city/Lost medication|1
4740350|NCT01846442|16351360|P3|Overall Study|Left the city/Lost medication|1
4740352|NCT01846442|16351362|P1|Overall Study|Left the city/Lost medication|1
4740353|NCT01846442|16351359|P4|Overall Study|Withdrawal by Subject|1
4740354|NCT01846442|16351360|P3|Overall Study|Withdrawal by Subject|0
4740355|NCT01846442|16351361|P2|Overall Study|Withdrawal by Subject|2
4740356|NCT01846442|16351362|P1|Overall Study|Withdrawal by Subject|3
4740357|NCT01846442|16351359|P4|Overall Study|Lost to Follow-up|0
4740358|NCT01846442|16351360|P3|Overall Study|Lost to Follow-up|1
4740359|NCT01846442|16351361|P2|Overall Study|Lost to Follow-up|0
4740360|NCT01846442|16351362|P1|Overall Study|Lost to Follow-up|0
4740361|NCT01846442|16351359|P4|Overall Study|Adverse Event|1
4740362|NCT01846442|16351360|P3|Overall Study|Adverse Event|2
4740363|NCT01846442|16351361|P2|Overall Study|Adverse Event|4
4740364|NCT01846442|16351362|P1|Overall Study|Adverse Event|2
4740365|NCT01846416|16351403|P3|Survival Follow-up|Other|1
4740366|NCT01846416|16351404|P2|Survival Follow-up|Other|1
4740367|NCT01846416|16351405|P1|Survival Follow-up|Other|3
4740368|NCT01846416|16351403|P3|Survival Follow-up|Study Terminated by Sponsor|0
4740369|NCT01846416|16351404|P2|Survival Follow-up|Study Terminated by Sponsor|8
4740370|NCT01846416|16351405|P1|Survival Follow-up|Study Terminated by Sponsor|2
4740371|NCT01846416|16351403|P3|Survival Follow-up|Withdrawal by Subject|0
4740372|NCT01846416|16351404|P2|Survival Follow-up|Withdrawal by Subject|7
4740373|NCT01846416|16351405|P1|Survival Follow-up|Withdrawal by Subject|2
4740374|NCT01846416|16351403|P3|Survival Follow-up|Lost to Follow-up|2
4740375|NCT01846416|16351404|P2|Survival Follow-up|Lost to Follow-up|2
4740376|NCT01846416|16351405|P1|Survival Follow-up|Lost to Follow-up|0
4740377|NCT01846416|16351403|P3|Survival Follow-up|Death|9
4740378|NCT01846416|16351404|P2|Survival Follow-up|Death|62
4740379|NCT01846416|16351405|P1|Survival Follow-up|Death|21
4740380|NCT01846416|16351403|P3|Treatment Phase|Progressive Disease|9
4740381|NCT01846416|16351404|P2|Treatment Phase|Progressive Disease|63
4740382|NCT01846416|16351405|P1|Treatment Phase|Progressive Disease|21
4740383|NCT01846416|16351403|P3|Treatment Phase|Study Terminated by Sponsor|0
4740384|NCT01846416|16351404|P2|Treatment Phase|Study Terminated by Sponsor|4
4740385|NCT01846416|16351405|P1|Treatment Phase|Study Terminated by Sponsor|1
4740386|NCT01846416|16351403|P3|Treatment Phase|Non-compliance|0
4740387|NCT01846416|16351404|P2|Treatment Phase|Non-compliance|2
4740388|NCT01846416|16351405|P1|Treatment Phase|Non-compliance|0
4740389|NCT01846416|16351403|P3|Treatment Phase|Adverse Event|0
4740390|NCT01846416|16351404|P2|Treatment Phase|Adverse Event|4
4740391|NCT01846416|16351405|P1|Treatment Phase|Adverse Event|3
4740392|NCT01846416|16351403|P3|Treatment Phase|Physician Decision|0
4740393|NCT01846416|16351404|P2|Treatment Phase|Physician Decision|2
4740394|NCT01846416|16351405|P1|Treatment Phase|Physician Decision|1
4740395|NCT01846416|16351403|P3|Treatment Phase|Other|1
4740396|NCT01846416|16351404|P2|Treatment Phase|Other|5
4740397|NCT01846416|16351405|P1|Treatment Phase|Other|1
4740398|NCT01846416|16351403|P3|Treatment Phase|Withdrawal by Subject|2
4740399|NCT01846416|16351404|P2|Treatment Phase|Withdrawal by Subject|4
4740400|NCT01846416|16351405|P1|Treatment Phase|Withdrawal by Subject|2
4740401|NCT01846416|16351403|P3|Treatment Phase|Death|1
4740402|NCT01846416|16351404|P2|Treatment Phase|Death|9
4740403|NCT01846416|16351405|P1|Treatment Phase|Death|2
4740404|NCT01846299|16351450|P2|Overall Study|Adverse Event|0
4740405|NCT01846299|16351451|P1|Overall Study|Adverse Event|2
4740406|NCT01846299|16351450|P2|Overall Study|Withdrawal by Subject|6
4740407|NCT01846299|16351451|P1|Overall Study|Withdrawal by Subject|1
4740408|NCT01846299|16351450|P2|Overall Study|Lost to Follow-up|0
4740409|NCT01846299|16351451|P1|Overall Study|Lost to Follow-up|3
4740410|NCT01846299|16351450|P2|Overall Study|Death|2
4740411|NCT01846299|16351451|P1|Overall Study|Death|1
4740412|NCT01846299|16351450|P2|Overall Study|Protocol deviation|0
4740413|NCT01846299|16351451|P1|Overall Study|Protocol deviation|1
4740414|NCT01846299|16351450|P2|Overall Study|Physician Decision|2
4740415|NCT01846299|16351451|P1|Overall Study|Physician Decision|4
4740416|NCT01846273|16351490|P3|Overall Study|Physician Decision|0
4740417|NCT01846273|16351491|P2|Overall Study|Physician Decision|2
4740418|NCT01846273|16351492|P1|Overall Study|Physician Decision|1
4740419|NCT01846273|16351490|P3|Overall Study|Protocol Deviation|0
4740420|NCT01846273|16351491|P2|Overall Study|Protocol Deviation|3
4740421|NCT01846273|16351492|P1|Overall Study|Protocol Deviation|2
4740422|NCT01846273|16351490|P3|Overall Study|Disease Progression|0
4740423|NCT01846273|16351491|P2|Overall Study|Disease Progression|4
4740424|NCT01846273|16351492|P1|Overall Study|Disease Progression|0
4740425|NCT01846273|16351490|P3|Overall Study|Death|0
4740426|NCT01846273|16351491|P2|Overall Study|Death|1
4740427|NCT01846273|16351492|P1|Overall Study|Death|2
4740428|NCT01846273|16351490|P3|Overall Study|Administrative problems|0
4740429|NCT01846273|16351491|P2|Overall Study|Administrative problems|0
4740430|NCT01846273|16351492|P1|Overall Study|Administrative problems|1
4740431|NCT01846273|16351490|P3|Overall Study|Lost to Follow-up|0
4740432|NCT01846273|16351491|P2|Overall Study|Lost to Follow-up|1
4740433|NCT01846273|16351492|P1|Overall Study|Lost to Follow-up|2
4740434|NCT01846273|16351490|P3|Overall Study|Subject withdrew consent|0
4740435|NCT01846273|16351491|P2|Overall Study|Subject withdrew consent|8
4740436|NCT01846273|16351492|P1|Overall Study|Subject withdrew consent|5
4740437|NCT01846273|16351490|P3|Overall Study|Adverse Event|0
4740438|NCT01846273|16351491|P2|Overall Study|Adverse Event|7
4740439|NCT01846273|16351492|P1|Overall Study|Adverse Event|9
4740440|NCT01846221|16351548|P2|Overall Study|Age Exclusion|0
4740441|NCT01846221|16351549|P1|Overall Study|Age Exclusion|1
4740442|NCT01846221|16351548|P2|Overall Study|Catheter Failure|0
4740443|NCT01846221|16351549|P1|Overall Study|Catheter Failure|2
4740444|NCT01846208|16351566|P3|Overall Study|Refused SU OFC|1
4740445|NCT01846208|16351567|P2|Overall Study|Refused SU OFC|0
4740446|NCT01846208|16351568|P1|Overall Study|Refused SU OFC|0
4740447|NCT01846208|16351566|P3|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
4740448|NCT01846208|16351567|P2|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0
4740449|NCT01846208|16351568|P1|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1
4740450|NCT01846208|16351566|P3|Overall Study|Non-compliance|0
4740451|NCT01846208|16351567|P2|Overall Study|Non-compliance|1
4740452|NCT01846208|16351568|P1|Overall Study|Non-compliance|1
4740453|NCT01846208|16351566|P3|Overall Study|Withdrawal by Subject|0
4740454|NCT01846208|16351567|P2|Overall Study|Withdrawal by Subject|0
4740455|NCT01846208|16351568|P1|Overall Study|Withdrawal by Subject|5
4740456|NCT01846208|16351566|P3|Overall Study|Dosing Symptoms|6
4740457|NCT01846208|16351567|P2|Overall Study|Dosing Symptoms|2
4740458|NCT01846208|16351568|P1|Overall Study|Dosing Symptoms|1
4740459|NCT01846208|16351566|P3|Overall Study|Withdrew prior to treatment|1
4740460|NCT01846208|16351567|P2|Overall Study|Withdrew prior to treatment|1
4740461|NCT01846208|16351568|P1|Overall Study|Withdrew prior to treatment|1
4740462|NCT01846104|16351588|P1|Overall Study|Withdrawal by Subject|1
4740463|NCT01846039|16351594|P1|Overall Study|Subject Withdrew Consent|1
4740464|NCT01846039|16351594|P1|Overall Study|Protocol Violation|1
4740465|NCT01845974|16351606|P2|Overall Study|screen failure|0
4740466|NCT01845974|16351607|P1|Overall Study|screen failure|1
4740467|NCT01845831|16351615|P5|Inpatient Phase|Withdrawal by Subject|0
4740468|NCT01845831|16351616|P4|Inpatient Phase|Withdrawal by Subject|0
4740469|NCT01845831|16351617|P3|Inpatient Phase|Withdrawal by Subject|0
4740470|NCT01845831|16351618|P2|Inpatient Phase|Withdrawal by Subject|1
4740471|NCT01845831|16351619|P1|Inpatient Phase|Withdrawal by Subject|1
4740472|NCT01845818|16351648|P2|Overall Study|No Follow-Up Data Available|1
4740473|NCT01845818|16351649|P1|Overall Study|No Follow-Up Data Available|4
4740474|NCT01845818|16351648|P2|Overall Study|Did Not Receive Any Dose of Adalimumab|0
4740475|NCT01845818|16351649|P1|Overall Study|Did Not Receive Any Dose of Adalimumab|5
4740476|NCT01845818|16351648|P2|Overall Study|Other|8
4740477|NCT01845818|16351649|P1|Overall Study|Other|25
4740478|NCT01845818|16351648|P2|Overall Study|Serious Adverse Event|1
4740479|NCT01845818|16351649|P1|Overall Study|Serious Adverse Event|1
4740480|NCT01845818|16351648|P2|Overall Study|Administrative Reasons|1
4740481|NCT01845818|16351649|P1|Overall Study|Administrative Reasons|3
4740482|NCT01845818|16351648|P2|Overall Study|Lost to Follow-up|5
4740483|NCT01845818|16351649|P1|Overall Study|Lost to Follow-up|7
4740484|NCT01845818|16351648|P2|Overall Study|Withdrawal by Subject|1
4740485|NCT01845818|16351649|P1|Overall Study|Withdrawal by Subject|0
4740486|NCT01845077|16351733|P6|Washout Period|Protocol Violation|0
4740487|NCT01845077|16351734|P5|Washout Period|Protocol Violation|1
4740488|NCT01845077|16351735|P4|Washout Period|Protocol Violation|1
4740489|NCT01845077|16351736|P3|Washout Period|Protocol Violation|0
4740490|NCT01845077|16351737|P2|Washout Period|Protocol Violation|0
4740491|NCT01845077|16351738|P1|Washout Period|Protocol Violation|0
4740492|NCT01845077|16351733|P6|Washout Period|elevated lab values (not clinic. sign.)|0
4740493|NCT01845077|16351734|P5|Washout Period|elevated lab values (not clinic. sign.)|0
4740494|NCT01845077|16351735|P4|Washout Period|elevated lab values (not clinic. sign.)|0
4740495|NCT01845077|16351736|P3|Washout Period|elevated lab values (not clinic. sign.)|1
4740496|NCT01845077|16351737|P2|Washout Period|elevated lab values (not clinic. sign.)|0
4740497|NCT01845077|16351738|P1|Washout Period|elevated lab values (not clinic. sign.)|0
4740498|NCT01845077|16351733|P6|Washout Period|Adverse Event|0
4740499|NCT01845077|16351734|P5|Washout Period|Adverse Event|0
4740500|NCT01845077|16351735|P4|Washout Period|Adverse Event|0
4740501|NCT01845077|16351736|P3|Washout Period|Adverse Event|0
4740502|NCT01845077|16351737|P2|Washout Period|Adverse Event|0
4740503|NCT01845077|16351738|P1|Washout Period|Adverse Event|1
4740504|NCT01845077|16351733|P6|Washout Period|Lost to Follow-up|1
4740505|NCT01845077|16351734|P5|Washout Period|Lost to Follow-up|0
4740506|NCT01845077|16351735|P4|Washout Period|Lost to Follow-up|1
4740507|NCT01845077|16351736|P3|Washout Period|Lost to Follow-up|0
4740508|NCT01845077|16351737|P2|Washout Period|Lost to Follow-up|1
4740509|NCT01845077|16351738|P1|Washout Period|Lost to Follow-up|0
4740510|NCT01845025|16351784|P2|Overall Study|Missing|1
4740511|NCT01845025|16351785|P1|Overall Study|Missing|1
4740512|NCT01845025|16351784|P2|Overall Study|Protocol deviation|6
4740513|NCT01845025|16351785|P1|Overall Study|Protocol deviation|3
4740514|NCT01845025|16351784|P2|Overall Study|Death|0
4740515|NCT01845025|16351785|P1|Overall Study|Death|2
4740516|NCT01845025|16351784|P2|Overall Study|Administrative problems|8
4740517|NCT01845025|16351785|P1|Overall Study|Administrative problems|8
4740518|NCT01845025|16351784|P2|Overall Study|Lost to Follow-up|13
4740519|NCT01845025|16351785|P1|Overall Study|Lost to Follow-up|13
4740520|NCT01845025|16351784|P2|Overall Study|Withdrawal by Subject|44
4740521|NCT01845025|16351785|P1|Overall Study|Withdrawal by Subject|48
4740522|NCT01845025|16351784|P2|Overall Study|Unsatisfactory therapeutic effect|2
4740523|NCT01845025|16351785|P1|Overall Study|Unsatisfactory therapeutic effect|4
4740524|NCT01845025|16351784|P2|Overall Study|Adverse Event|3
4740525|NCT01845025|16351785|P1|Overall Study|Adverse Event|6
4740526|NCT01844986|16351809|P2|Overall Study|Death|26
4740527|NCT01844986|16351810|P1|Overall Study|Death|55
4740528|NCT01844986|16351809|P2|Overall Study|Withdrawal by Subject|14
4740529|NCT01844986|16351810|P1|Overall Study|Withdrawal by Subject|21
4740530|NCT01844986|16351809|P2|Overall Study|Severe non-compliance to protocol|0
4740531|NCT01844986|16351810|P1|Overall Study|Severe non-compliance to protocol|1
4740532|NCT01844895|16351832|P1|Day 29 - Day113 - Autoinjector|planned surgery|1
4740533|NCT01844895|16351832|P1|Day 29 - Day113 - Autoinjector|Difficulty using device|3
4740534|NCT01844895|16351832|P1|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1
4740535|NCT01844895|16351832|P1|Day 29 - Day113 - Autoinjector|Adverse Event|1
4740536|NCT01844895|16351832|P1|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1
4740537|NCT01844895|16351832|P1|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1
4740538|NCT01844895|16351832|P1|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1
4740539|NCT01844856|16351850|P2|Overall Study|Randomized but was a Screen Failure|1
4740540|NCT01844856|16351851|P1|Overall Study|Randomized but was a Screen Failure|0
4740541|NCT01844856|16351850|P2|Overall Study|Inadvertently Not Scheduled|0
4740542|NCT01844856|16351851|P1|Overall Study|Inadvertently Not Scheduled|1
4740543|NCT01844856|16351850|P2|Overall Study|Enterococcus Resistant|1
4740544|NCT01844856|16351851|P1|Overall Study|Enterococcus Resistant|0
4740545|NCT01844856|16351850|P2|Overall Study|Noncompliance|3
4740546|NCT01844856|16351851|P1|Overall Study|Noncompliance|2
4740547|NCT01844856|16351850|P2|Overall Study|Withdrawal by Subject|2
4740548|NCT01844856|16351851|P1|Overall Study|Withdrawal by Subject|3
4740549|NCT01844856|16351850|P2|Overall Study|Adverse Event|6
4740550|NCT01844856|16351851|P1|Overall Study|Adverse Event|3
4740551|NCT01844856|16351850|P2|Overall Study|Lost to Follow-up|3
4740552|NCT01844856|16351851|P1|Overall Study|Lost to Follow-up|15
4740553|NCT01844830|16351863|P2|Overall Study|Withdrawal by Subject|0
4740554|NCT01844830|16351864|P1|Overall Study|Withdrawal by Subject|1
4740555|NCT01844817|16351894|P2|Treatment|Other|3
4740556|NCT01844817|16351895|P1|Treatment|Other|0
4740557|NCT01844817|16351894|P2|Treatment|Lost to Follow-up|1
4740558|NCT01844817|16351895|P1|Treatment|Lost to Follow-up|0
4740559|NCT01844817|16351894|P2|Treatment|Death|8
4740560|NCT01844817|16351895|P1|Treatment|Death|10
4740561|NCT01844817|16351894|P2|Treatment|Withdrawal by Subject|6
4740562|NCT01844817|16351895|P1|Treatment|Withdrawal by Subject|10
4740563|NCT01844817|16351894|P2|Treatment|Adverse Event|9
4740564|NCT01844817|16351895|P1|Treatment|Adverse Event|17
4740565|NCT01844817|16351894|P2|Treatment|Progressive Disease|36
4740566|NCT01844817|16351895|P1|Treatment|Progressive Disease|27
4740567|NCT01844817|16351894|P2|Enrolled and Randomized|Withdrawal by Subject|3
4740568|NCT01844817|16351895|P1|Enrolled and Randomized|Withdrawal by Subject|2
4740569|NCT01844778|16351908|P3|Overall Study|Adverse Event|2
4740570|NCT01844778|16351909|P2|Overall Study|Adverse Event|2
4740571|NCT01844778|16351910|P1|Overall Study|Adverse Event|0
4740572|NCT01844778|16351908|P3|Overall Study|Withdrawal by Subject|0
4740573|NCT01844778|16351909|P2|Overall Study|Withdrawal by Subject|0
4740574|NCT01844778|16351910|P1|Overall Study|Withdrawal by Subject|2
4740575|NCT01844778|16351908|P3|Overall Study|Protocol deviation|2
4740576|NCT01844778|16351909|P2|Overall Study|Protocol deviation|1
4740577|NCT01844778|16351910|P1|Overall Study|Protocol deviation|0
4740578|NCT01844700|16351936|P2|Overall Study|stopped taking meds|1
4740579|NCT01844700|16351937|P1|Overall Study|stopped taking meds|0
4740580|NCT01844700|16351936|P2|Overall Study|Withdrawal by Subject|0
4740581|NCT01844700|16351937|P1|Overall Study|Withdrawal by Subject|1
4740582|NCT01844700|16351936|P2|Overall Study|refused medication switch|0
4740583|NCT01844700|16351937|P1|Overall Study|refused medication switch|1
4740584|NCT01844700|16351936|P2|Overall Study|Lack of Efficacy|0
4740585|NCT01844700|16351937|P1|Overall Study|Lack of Efficacy|1
4740586|NCT01844687|16351949|P1|Visit 4|Withdrawal by Subject|2
4740587|NCT01844687|16351949|P1|Visit 4|Lost to Follow-up|1
4740588|NCT01844687|16351949|P1|Visit 4|Pregnancy|1
4740589|NCT01844687|16351949|P1|Visit 3|child care problems|1
4740590|NCT01844687|16351949|P1|Visit 3|Withdrawal by Subject|3
4740591|NCT01844687|16351949|P1|Visit 3|Lost to Follow-up|1
4740592|NCT01844687|16351949|P1|Visit 2|Protocol Violation|1
4740593|NCT01844687|16351949|P1|Visit 2|Withdrawal by Subject|1
4740594|NCT01844687|16351949|P1|Visit 1|Lost to Follow-up|5
4740595|NCT01844687|16351949|P1|Visit 1|Protocol Violation|3
4740596|NCT01844583|16352010|P2|Overall Study|Didn't complete dosing;PK/ECG assessment|10
4740597|NCT01844583|16352011|P1|Overall Study|Didn't complete dosing;PK/ECG assessment|8
4740598|NCT01844531|16352043|P4|Overall Study|Withdrawal by Subject|0
4740599|NCT01844531|16352044|P3|Overall Study|Withdrawal by Subject|0
4740600|NCT01844531|16352045|P2|Overall Study|Withdrawal by Subject|1
4740601|NCT01844531|16352046|P1|Overall Study|Withdrawal by Subject|0
4740602|NCT01844518|16352076|P1|Long-Term Extension|Still in On-Going Study|149
4740603|NCT01844518|16352076|P1|Long-Term Extension|No Longer Met Study Criteria|1
4740604|NCT01844518|16352076|P1|Long-Term Extension|Adverse Event|1
4740605|NCT01844518|16352076|P1|Long-Term Extension|Lack of Efficacy|6
4740606|NCT01844518|16352076|P1|Short-Term (ST) Period|Poor/Non-Compliance|1
4740607|NCT01844518|16352076|P1|Short-Term (ST) Period|Withdrawal of Consent|2
4740608|NCT01844518|16352076|P1|Short-Term (ST) Period|Lack of Efficacy|3
4740609|NCT01844518|16352076|P1|Short-Term (ST) Period|Adverse Event|3
4740610|NCT01844505|16352093|P3|Overall Study|Not Reported|1
4740611|NCT01844505|16352094|P2|Overall Study|Not Reported|0
4740612|NCT01844505|16352095|P1|Overall Study|Not Reported|0
4740613|NCT01844505|16352093|P3|Overall Study|Other Reasons|2
4740614|NCT01844505|16352094|P2|Overall Study|Other Reasons|2
4740615|NCT01844505|16352095|P1|Overall Study|Other Reasons|4
4740616|NCT01844505|16352093|P3|Overall Study|Subject no longer meets criteria|0
4740617|NCT01844505|16352094|P2|Overall Study|Subject no longer meets criteria|1
4740618|NCT01844505|16352095|P1|Overall Study|Subject no longer meets criteria|0
4740619|NCT01844505|16352093|P3|Overall Study|Poor/non-compliance|1
4740620|NCT01844505|16352094|P2|Overall Study|Poor/non-compliance|1
4740621|NCT01844505|16352095|P1|Overall Study|Poor/non-compliance|1
4740622|NCT01844505|16352093|P3|Overall Study|Maximum clinical benefit|2
4740623|NCT01844505|16352094|P2|Overall Study|Maximum clinical benefit|11
4740624|NCT01844505|16352095|P1|Overall Study|Maximum clinical benefit|8
4740625|NCT01844505|16352093|P3|Overall Study|Lost to Follow-up|0
4740626|NCT01844505|16352094|P2|Overall Study|Lost to Follow-up|0
4740627|NCT01844505|16352095|P1|Overall Study|Lost to Follow-up|1
4740628|NCT01844505|16352093|P3|Overall Study|Withdrawal by Subject|0
4740629|NCT01844505|16352094|P2|Overall Study|Withdrawal by Subject|3
4740630|NCT01844505|16352095|P1|Overall Study|Withdrawal by Subject|0
4740631|NCT01844505|16352093|P3|Overall Study|Subject request discontinue treatment|8
4740632|NCT01844505|16352094|P2|Overall Study|Subject request discontinue treatment|14
4740633|NCT01844505|16352095|P1|Overall Study|Subject request discontinue treatment|17
4740634|NCT01844505|16352093|P3|Overall Study|Adverse event unrelated to study drug|6
4740635|NCT01844505|16352094|P2|Overall Study|Adverse event unrelated to study drug|15
4740636|NCT01844505|16352095|P1|Overall Study|Adverse event unrelated to study drug|7
4740637|NCT01844505|16352093|P3|Overall Study|Death|1
4740638|NCT01844505|16352094|P2|Overall Study|Death|3
4740639|NCT01844505|16352095|P1|Overall Study|Death|1
4740640|NCT01844505|16352093|P3|Overall Study|Study drug toxicity|50
4740641|NCT01844505|16352094|P2|Overall Study|Study drug toxicity|131
4740642|NCT01844505|16352095|P1|Overall Study|Study drug toxicity|40
4740643|NCT01844505|16352093|P3|Overall Study|Disease progression|224
4740644|NCT01844505|16352094|P2|Overall Study|Disease progression|88
4740645|NCT01844505|16352095|P1|Overall Study|Disease progression|170
4740646|NCT01844375|16352189|P2|Overall Study|Protocol Violation|1
4740647|NCT01844375|16352190|P1|Overall Study|Protocol Violation|1
4740648|NCT01844284|16352202|P2|Overall Study|Lost to Follow-up|7
4740649|NCT01844284|16352203|P1|Overall Study|Lost to Follow-up|12
4740650|NCT01844115|16352422|P2|Overall Study|Pregnancy|1
4740651|NCT01844115|16352423|P1|Overall Study|Pregnancy|0
4740652|NCT01844115|16352422|P2|Overall Study|Lost to Follow-up|10
4740653|NCT01844115|16352423|P1|Overall Study|Lost to Follow-up|11
4740654|NCT01844115|16352422|P2|Overall Study|Withdrawal by Subject|11
4740655|NCT01844115|16352423|P1|Overall Study|Withdrawal by Subject|11
4740656|NCT01844115|16352422|P2|Overall Study|Protocol Violation|10
4740657|NCT01844115|16352423|P1|Overall Study|Protocol Violation|12
4740658|NCT01844115|16352422|P2|Overall Study|Lack of Efficacy|4
4740659|NCT01844115|16352423|P1|Overall Study|Lack of Efficacy|1
4740660|NCT01844115|16352422|P2|Overall Study|Adverse Event|22
4740661|NCT01844115|16352423|P1|Overall Study|Adverse Event|4
4740662|NCT01843972|16352441|P10|Overall Study|Withdrawal by Subject|0
4740663|NCT01843972|16352442|P9|Overall Study|Withdrawal by Subject|0
4740664|NCT01843972|16352443|P8|Overall Study|Withdrawal by Subject|0
4740665|NCT01843972|16352444|P7|Overall Study|Withdrawal by Subject|0
4740666|NCT01843972|16352445|P6|Overall Study|Withdrawal by Subject|0
4740667|NCT01843972|16352446|P5|Overall Study|Withdrawal by Subject|1
4740668|NCT01843972|16352447|P4|Overall Study|Withdrawal by Subject|0
4740669|NCT01843972|16352448|P3|Overall Study|Withdrawal by Subject|0
4740670|NCT01843972|16352449|P2|Overall Study|Withdrawal by Subject|0
4740671|NCT01843972|16352450|P1|Overall Study|Withdrawal by Subject|0
4740672|NCT01843933|16352520|P2|Overall Study|Data lost|4
4740673|NCT01843933|16352521|P1|Overall Study|Data lost|6
4740674|NCT01843842|16352540|P2|Overall Study|Do not meet inclusion criteria|1
4740675|NCT01843842|16352541|P1|Overall Study|Do not meet inclusion criteria|1
4740676|NCT01843803|16352563|P2|Overall Study|not a Veteran, did not see provider|3
4740677|NCT01843803|16352564|P1|Overall Study|not a Veteran, did not see provider|1
4740678|NCT01843777|16352578|P2|Overall Study|Withdrawal by Subject|0
4740679|NCT01843777|16352579|P1|Overall Study|Withdrawal by Subject|1
4740680|NCT01843673|16352604|P1|Overall Study|Withdrawal by Subject|4
4740681|NCT01843673|16352604|P1|Overall Study|Lack of Efficacy|2
4740682|NCT01843660|16352616|P1|Overall Study|Other|30
4740683|NCT01843374|16352657|P2|Overall Study|Withdrawing due to Other reason|46
4740684|NCT01843374|16352658|P1|Overall Study|Withdrawing due to Other reason|20
4740685|NCT01843374|16352657|P2|Overall Study|Withdrawal by Subject|20
4740686|NCT01843374|16352658|P1|Overall Study|Withdrawal by Subject|14
4740687|NCT01843374|16352657|P2|Overall Study|Death|313
4740688|NCT01843374|16352658|P1|Overall Study|Death|155
4740689|NCT01843348|16352685|P3|Overall Study|Various reasons|6
4740690|NCT01843348|16352686|P2|Overall Study|Various reasons|9
4740691|NCT01843348|16352687|P1|Overall Study|Various reasons|4
4740692|NCT01843348|16352685|P3|Overall Study|Graft loss/retransplantation|11
4740693|NCT01843348|16352686|P2|Overall Study|Graft loss/retransplantation|8
4740694|NCT01843348|16352687|P1|Overall Study|Graft loss/retransplantation|5
4740695|NCT01843348|16352685|P3|Overall Study|Death|4
4740696|NCT01843348|16352686|P2|Overall Study|Death|3
4740697|NCT01843348|16352687|P1|Overall Study|Death|5
4740698|NCT01843348|16352685|P3|Overall Study|Lost to Follow-up|2
4740699|NCT01843348|16352686|P2|Overall Study|Lost to Follow-up|4
4740700|NCT01843348|16352687|P1|Overall Study|Lost to Follow-up|5
4740701|NCT01843348|16352685|P3|Overall Study|Withdrawal by Subject|18
4740702|NCT01843348|16352686|P2|Overall Study|Withdrawal by Subject|16
4740703|NCT01843348|16352687|P1|Overall Study|Withdrawal by Subject|4
4740704|NCT01843205|16352727|P2|First Treatment (11 Days)|Withdrawal by Subject|0
4740705|NCT01843205|16352728|P1|First Treatment (11 Days)|Withdrawal by Subject|1
4740706|NCT01843192|16352789|P3|Overall Study|Intra-operative exclusions per protocol|2
4740707|NCT01843192|16352790|P2|Overall Study|Intra-operative exclusions per protocol|6
4740708|NCT01843192|16352791|P1|Overall Study|Intra-operative exclusions per protocol|2
4740709|NCT01843062|16352822|P2|Overall Study|Lost to Follow-up|4
4740710|NCT01843062|16352823|P1|Overall Study|Lost to Follow-up|2
4740711|NCT01843062|16352822|P2|Overall Study|Death|2
4740712|NCT01843062|16352823|P1|Overall Study|Death|1
4740713|NCT01843062|16352822|P2|Overall Study|Withdrawal by Subject|3
4740714|NCT01843062|16352823|P1|Overall Study|Withdrawal by Subject|12
4740715|NCT01843062|16352822|P2|Overall Study|Incorrect randomisation|0
4740716|NCT01843062|16352823|P1|Overall Study|Incorrect randomisation|1
4740717|NCT01843062|16352822|P2|Overall Study|Adverse Event|0
4740718|NCT01843062|16352823|P1|Overall Study|Adverse Event|2
4740719|NCT01843062|16352822|P2|Overall Study|Pregnancy|0
4740720|NCT01843062|16352823|P1|Overall Study|Pregnancy|1
4740721|NCT01843062|16352822|P2|Overall Study|New treatment following progression|0
4740722|NCT01843062|16352823|P1|Overall Study|New treatment following progression|2
4740723|NCT01843062|16352822|P2|Overall Study|Protocol Violation|0
4740724|NCT01843062|16352823|P1|Overall Study|Protocol Violation|1
4740725|NCT01842958|16352837|P2|Overall Study|Lost to Follow-up|1
4740726|NCT01842958|16352838|P1|Overall Study|Lost to Follow-up|1
4740727|NCT01842633|16352913|P3|Overall Study|Technical issues|0
4740728|NCT01842633|16352914|P2|Overall Study|Technical issues|0
4740729|NCT01842633|16352915|P1|Overall Study|Technical issues|1
4740730|NCT01842633|16352913|P3|Overall Study|Withdrawal by Subject|0
4740731|NCT01842633|16352914|P2|Overall Study|Withdrawal by Subject|1
4740732|NCT01842633|16352915|P1|Overall Study|Withdrawal by Subject|0
4740733|NCT01842633|16352913|P3|Overall Study|Adverse Event|0
4740734|NCT01842633|16352914|P2|Overall Study|Adverse Event|1
4740735|NCT01842633|16352915|P1|Overall Study|Adverse Event|1
4740736|NCT01842633|16352913|P3|Overall Study|Screen Failure|0
4740737|NCT01842633|16352914|P2|Overall Study|Screen Failure|0
4740738|NCT01842633|16352915|P1|Overall Study|Screen Failure|1
4740739|NCT01842620|16352962|P2|Period 1|Withdrawal by Subject|0
4740740|NCT01842620|16352963|P1|Period 1|Withdrawal by Subject|1
4740741|NCT01842607|16352979|P1|Overall Study|Withdrawal by Subject|14
4740742|NCT01842607|16352979|P1|Overall Study|Physician Decision|9
4740743|NCT01842607|16352979|P1|Overall Study|Lost to Follow-up|3
4740744|NCT01842607|16352979|P1|Overall Study|Protocol defined stopping criteria|2
4740745|NCT01842607|16352979|P1|Overall Study|Protocol Violation|8
4740746|NCT01842607|16352979|P1|Overall Study|Lack of Efficacy|19
4740747|NCT01842607|16352979|P1|Overall Study|Adverse Event|11
4740748|NCT01842581|16353005|P2|Overall Study|Other than specified|1
4740749|NCT01842581|16353006|P1|Overall Study|Other than specified|3
4740750|NCT01842581|16353005|P2|Overall Study|Withdrawal by Subject|7
4740751|NCT01842581|16353006|P1|Overall Study|Withdrawal by Subject|5
4740752|NCT01842581|16353005|P2|Overall Study|Lost to Follow-up|5
4740753|NCT01842581|16353006|P1|Overall Study|Lost to Follow-up|2
4740754|NCT01842581|16353005|P2|Overall Study|Liver transplant|0
4740755|NCT01842581|16353006|P1|Overall Study|Liver transplant|2
4740756|NCT01842581|16353005|P2|Overall Study|HE breakthrough|13
4740757|NCT01842581|16353006|P1|Overall Study|HE breakthrough|26
4740758|NCT01842581|16353005|P2|Overall Study|Adverse Event|4
4740759|NCT01842581|16353006|P1|Overall Study|Adverse Event|6
4740760|NCT01842438|16353030|P2|T2: 6month Follow-up|Death|1
4740761|NCT01842438|16353031|P1|T2: 6month Follow-up|Death|0
4740762|NCT01842438|16353030|P2|T2: 6month Follow-up|Withdrawal by Subject|3
4740763|NCT01842438|16353031|P1|T2: 6month Follow-up|Withdrawal by Subject|4
4740764|NCT01842438|16353030|P2|T1: Immediately After the Intervention|Withdrawal by Subject|8
4740765|NCT01842438|16353031|P1|T1: Immediately After the Intervention|Withdrawal by Subject|6
4740766|NCT01842334|16353045|P2|Overall Study|Moved away mid-study|1
4740767|NCT01842334|16353046|P1|Overall Study|Moved away mid-study|0
4740768|NCT01842334|16353045|P2|Overall Study|Withdrawal by Subject|3
4740769|NCT01842334|16353046|P1|Overall Study|Withdrawal by Subject|3
4740770|NCT01842308|16353057|P5|Overall Study|Withdrawal by Subject|1
4740771|NCT01842308|16353058|P4|Overall Study|Withdrawal by Subject|0
4740772|NCT01842308|16353059|P3|Overall Study|Withdrawal by Subject|0
4740773|NCT01842308|16353060|P2|Overall Study|Withdrawal by Subject|0
4740774|NCT01842308|16353061|P1|Overall Study|Withdrawal by Subject|0
4740775|NCT01841970|16353080|P1|Overall Study|Lost to Follow-up|8
4740776|NCT01841970|16353080|P1|Overall Study|Physician Decision|2
4740777|NCT01841970|16353080|P1|Overall Study|Withdrawal by Subject|1
4740778|NCT01841762|16353104|P1|Post-Treatment Safety Follow-Up Period|Other, administrative error|1
4740779|NCT01841762|16353104|P1|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6
4740780|NCT01841762|16353104|P1|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7
4740781|NCT01841762|16353104|P1|Post-Treatment Safety Follow-Up Period|Death|1
4740782|NCT01841762|16353104|P1|Treatment Period|Other, including non-compliance|5
4740783|NCT01841762|16353104|P1|Treatment Period|Physician Decision|2
4740784|NCT01841762|16353104|P1|Treatment Period|Lost to Follow-up|1
4740785|NCT01841762|16353104|P1|Treatment Period|Withdrawal by Subject|7
4740786|NCT01841762|16353104|P1|Treatment Period|Death|1
4740787|NCT01841762|16353104|P1|Treatment Period|Adverse Event|16
4740788|NCT01841762|16353104|P1|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51
4740789|NCT01841697|16353128|P2|Overall Study|Withdrawal by Subject|16
4740790|NCT01841697|16353129|P1|Overall Study|Withdrawal by Subject|16
4740791|NCT01841697|16353128|P2|Overall Study|Lost to Follow-up|1
4740792|NCT01841697|16353129|P1|Overall Study|Lost to Follow-up|4
4740793|NCT01841697|16353128|P2|Overall Study|Death|1
4740794|NCT01841697|16353129|P1|Overall Study|Death|0
4740795|NCT01841593|16353169|P2|Second Intervention (Days 8 to 14)|Adverse Event|0
4740796|NCT01841593|16353170|P1|Second Intervention (Days 8 to 14)|Adverse Event|1
4740797|NCT01841593|16353169|P2|First Intervention (Days 1 to 7)|Protocol Violation|1
4740798|NCT01841593|16353170|P1|First Intervention (Days 1 to 7)|Protocol Violation|0
4740799|NCT01841567|16353186|P1|Overall Study|Adverse Event|3
4740800|NCT01841554|16353191|P1|Overall Study|Study exit due to secondary intervention|6
4740801|NCT01841554|16353191|P1|Overall Study|Discontinued Follow Up|5
4740802|NCT01841554|16353191|P1|Overall Study|No Implantation|1
4740803|NCT01841554|16353191|P1|Overall Study|Death|7
4740804|NCT01841073|16353240|P2|Overall Study|Lost to Follow-up|2
4740805|NCT01841073|16353241|P1|Overall Study|Lost to Follow-up|0
4740806|NCT01841073|16353240|P2|Overall Study|Physician Decision|0
4740807|NCT01841073|16353241|P1|Overall Study|Physician Decision|1
4740808|NCT01841073|16353240|P2|Overall Study|Adverse Event|1
4740809|NCT01841073|16353241|P1|Overall Study|Adverse Event|1
4740810|NCT01840943|16353263|P2|Overall Study|Lost to Follow-up|4
4740811|NCT01840943|16353264|P1|Overall Study|Lost to Follow-up|4
4740812|NCT01840943|16353263|P2|Overall Study|Physician Decision|2
4740813|NCT01840943|16353264|P1|Overall Study|Physician Decision|4
4740814|NCT01840943|16353263|P2|Overall Study|Withdrawal by Subject|6
4740815|NCT01840943|16353264|P1|Overall Study|Withdrawal by Subject|5
4740816|NCT01840605|16353313|P2|Overall Study|Physician Decision|1
4740817|NCT01840605|16353314|P1|Overall Study|Physician Decision|2
4740818|NCT01840605|16353313|P2|Overall Study|Adverse Event|1
4740819|NCT01840605|16353314|P1|Overall Study|Adverse Event|0
4740820|NCT01840410|16353328|P2|Overall Study|Adverse Event|1
4740821|NCT01840410|16353329|P1|Overall Study|Adverse Event|1
4740822|NCT01840410|16353328|P2|Overall Study|Withdrawal by Subject|1
4740823|NCT01840410|16353329|P1|Overall Study|Withdrawal by Subject|2
4740824|NCT01840410|16353328|P2|Overall Study|Lost to Follow-up|0
4740825|NCT01840410|16353329|P1|Overall Study|Lost to Follow-up|1
4740826|NCT01840410|16353328|P2|Overall Study|Protocol deviation|0
4740827|NCT01840410|16353329|P1|Overall Study|Protocol deviation|1
4740828|NCT01840410|16353328|P2|Overall Study|Pregnancy|0
4740829|NCT01840410|16353329|P1|Overall Study|Pregnancy|1
4740830|NCT01840410|16353328|P2|Overall Study|Physician Decision|2
4740831|NCT01840410|16353329|P1|Overall Study|Physician Decision|1
4740832|NCT01840228|16353378|P2|Overall Study|Lost to Follow-up|1
4740833|NCT01840228|16353379|P1|Overall Study|Lost to Follow-up|1
4740834|NCT01840163|16353407|P2|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35
4740835|NCT01840163|16353408|P1|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43
4740836|NCT01840163|16353407|P2|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40
4740837|NCT01840163|16353408|P1|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48
4740838|NCT01840163|16353407|P2|First Follow up -Primary Outcome|Lost to Follow-up|16
4740839|NCT01840163|16353408|P1|First Follow up -Primary Outcome|Lost to Follow-up|19
4740840|NCT01839916|16353453|P1|Overall Study|Graft Failure|1
4740841|NCT01839916|16353453|P1|Overall Study|GVHD|2
4740842|NCT01839916|16353453|P1|Overall Study|Relapse|12
4740843|NCT01839916|16353453|P1|Overall Study|Physician Decision|17
4740844|NCT01839916|16353453|P1|Overall Study|Death|9
4740845|NCT01839656|16353504|P2|Overall Study|Adverse Event|0
4740846|NCT01839656|16353505|P1|Overall Study|Adverse Event|1
4740847|NCT01839656|16353504|P2|Overall Study|Early study closure|11
4740848|NCT01839656|16353505|P1|Overall Study|Early study closure|0
4740849|NCT01839656|16353504|P2|Overall Study|Adverse event, serious fatal|4
4740850|NCT01839656|16353505|P1|Overall Study|Adverse event, serious fatal|1
4740851|NCT01839656|16353504|P2|Overall Study|Withdrawal by Subject|1
4740852|NCT01839656|16353505|P1|Overall Study|Withdrawal by Subject|1
4740853|NCT01839487|16353565|P6|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
4740854|NCT01839487|16353566|P5|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2
4740855|NCT01839487|16353567|P4|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3
4740856|NCT01839487|16353568|P3|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1
4740857|NCT01839487|16353569|P2|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
4740858|NCT01839487|16353570|P1|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0
4740859|NCT01839487|16353565|P6|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3
4740860|NCT01839487|16353566|P5|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10
4740861|NCT01839487|16353567|P4|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1
4740862|NCT01839487|16353568|P3|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
4740863|NCT01839487|16353569|P2|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
4740864|NCT01839487|16353570|P1|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0
4740865|NCT01839487|16353565|P6|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4740866|NCT01839487|16353566|P5|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1
4740867|NCT01839487|16353567|P4|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4740868|NCT01839487|16353568|P3|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2
4740869|NCT01839487|16353569|P2|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4740870|NCT01839487|16353570|P1|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0
4740871|NCT01839487|16353565|P6|Phase 2 (Maximum Exposure:935 Days)|Death|32
4740872|NCT01839487|16353566|P5|Phase 2 (Maximum Exposure:935 Days)|Death|71
4740873|NCT01839487|16353567|P4|Phase 2 (Maximum Exposure:935 Days)|Death|49
4740874|NCT01839487|16353568|P3|Phase 2 (Maximum Exposure:935 Days)|Death|46
4740875|NCT01839487|16353569|P2|Phase 2 (Maximum Exposure:935 Days)|Death|0
4740876|NCT01839487|16353570|P1|Phase 2 (Maximum Exposure:935 Days)|Death|0
4740877|NCT01839487|16353565|P6|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8
4740878|NCT01839487|16353566|P5|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4
4740879|NCT01839487|16353567|P4|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9
4740880|NCT01839487|16353568|P3|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12
4740881|NCT01839487|16353569|P2|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
4740882|NCT01839487|16353570|P1|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0
4740883|NCT01839487|16353565|P6|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4740884|NCT01839487|16353566|P5|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4740885|NCT01839487|16353567|P4|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4740886|NCT01839487|16353568|P3|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4740887|NCT01839487|16353569|P2|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0
4740888|NCT01839487|16353570|P1|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1
4740889|NCT01839487|16353565|P6|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4740890|NCT01839487|16353566|P5|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4740891|NCT01839487|16353567|P4|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4740892|NCT01839487|16353568|P3|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4740893|NCT01839487|16353569|P2|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1
4740894|NCT01839487|16353570|P1|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0
4740895|NCT01839487|16353565|P6|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4740896|NCT01839487|16353566|P5|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4740897|NCT01839487|16353567|P4|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4740898|NCT01839487|16353568|P3|Run-in Phase (Maximum Exposure:295 Days)|Death|0
4740899|NCT01839487|16353569|P2|Run-in Phase (Maximum Exposure:295 Days)|Death|6
4740900|NCT01839487|16353570|P1|Run-in Phase (Maximum Exposure:295 Days)|Death|14
4740901|NCT01839487|16353565|P6|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4740902|NCT01839487|16353566|P5|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4740903|NCT01839487|16353567|P4|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4740904|NCT01839487|16353568|P3|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4740905|NCT01839487|16353569|P2|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0
4740906|NCT01839487|16353570|P1|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1
4740907|NCT01839279|16353621|P3|Overall Study|Classified as 'Other'|0
4740908|NCT01839279|16353622|P2|Overall Study|Classified as 'Other'|0
4740909|NCT01839279|16353623|P1|Overall Study|Classified as 'Other'|5
4740910|NCT01839279|16353621|P3|Overall Study|Withdrawal by Subject|1
4740911|NCT01839279|16353622|P2|Overall Study|Withdrawal by Subject|1
4740912|NCT01839279|16353623|P1|Overall Study|Withdrawal by Subject|4
4740913|NCT01839279|16353621|P3|Overall Study|Adverse Event|1
4740914|NCT01839279|16353622|P2|Overall Study|Adverse Event|1
4740915|NCT01839279|16353623|P1|Overall Study|Adverse Event|4
4740916|NCT01839188|16353642|P1|Overall Study|Withdrawal by Subject|1
4740917|NCT01838941|16353714|P1|Overall Study|Withdrawal by Subject|1
4740918|NCT01838941|16353714|P1|Overall Study|Adverse Event|1
4740919|NCT01838876|16353719|P1|Overall Study|Did not meet eligibility criteria|78
4740920|NCT01838876|16353719|P1|Overall Study|Reason not Specified|7
4740921|NCT01838876|16353719|P1|Overall Study|Study or Site Terminated by Sponsor|1
4740922|NCT01838876|16353719|P1|Overall Study|Lost to Follow-up|21
4740923|NCT01838876|16353719|P1|Overall Study|Withdrawal of Consent|33
4740924|NCT01838876|16353719|P1|Overall Study|Protocol Violation|34
4740925|NCT01838876|16353719|P1|Overall Study|Insufficient Therapeutic Response|10
4740926|NCT01838876|16353719|P1|Overall Study|Adverse Event|49
4740927|NCT01838694|16353828|P2|Overall Study|Adverse Event|1
4740928|NCT01838694|16353829|P1|Overall Study|Adverse Event|0
4740929|NCT01838681|16353838|P4|Period B/A+|Administrative or other reasons|28
4740930|NCT01838681|16353839|P3|Period B/A+|Administrative or other reasons|10
4740931|NCT01838681|16353840|P2|Period B/A+|Administrative or other reasons|6
4740932|NCT01838681|16353841|P1|Period B/A+|Administrative or other reasons|0
4740933|NCT01838681|16353838|P4|Period B/A+|Withdrawal before treatment|0
4740934|NCT01838681|16353839|P3|Period B/A+|Withdrawal before treatment|0
4740935|NCT01838681|16353840|P2|Period B/A+|Withdrawal before treatment|1
4740936|NCT01838681|16353841|P1|Period B/A+|Withdrawal before treatment|0
4740937|NCT01838681|16353838|P4|Period B/A+|Lost to Follow-up|11
4740938|NCT01838681|16353839|P3|Period B/A+|Lost to Follow-up|5
4740939|NCT01838681|16353840|P2|Period B/A+|Lost to Follow-up|2
4740940|NCT01838681|16353841|P1|Period B/A+|Lost to Follow-up|0
4740941|NCT01838681|16353838|P4|Period B/A+|Non-compliance with IMP|3
4740942|NCT01838681|16353839|P3|Period B/A+|Non-compliance with IMP|3
4740943|NCT01838681|16353840|P2|Period B/A+|Non-compliance with IMP|2
4740944|NCT01838681|16353841|P1|Period B/A+|Non-compliance with IMP|0
4740945|NCT01838681|16353838|P4|Period B/A+|Protocol Violation|6
4740946|NCT01838681|16353839|P3|Period B/A+|Protocol Violation|4
4740947|NCT01838681|16353840|P2|Period B/A+|Protocol Violation|1
4740948|NCT01838681|16353841|P1|Period B/A+|Protocol Violation|0
4740949|NCT01838681|16353838|P4|Period B/A+|Withdrawal by Subject|47
4740950|NCT01838681|16353839|P3|Period B/A+|Withdrawal by Subject|35
4740951|NCT01838681|16353840|P2|Period B/A+|Withdrawal by Subject|28
4740952|NCT01838681|16353841|P1|Period B/A+|Withdrawal by Subject|0
4740953|NCT01838681|16353838|P4|Period B/A+|Lack of Efficacy|6
4740954|NCT01838681|16353839|P3|Period B/A+|Lack of Efficacy|11
4740955|NCT01838681|16353840|P2|Period B/A+|Lack of Efficacy|9
4740956|NCT01838681|16353841|P1|Period B/A+|Lack of Efficacy|0
4740957|NCT01838681|16353838|P4|Period B/A+|Adverse Event|16
4740958|NCT01838681|16353839|P3|Period B/A+|Adverse Event|27
4740959|NCT01838681|16353840|P2|Period B/A+|Adverse Event|13
4740960|NCT01838681|16353841|P1|Period B/A+|Adverse Event|0
4740961|NCT01838681|16353838|P4|Period A|Administrative or other reasons|0
4740962|NCT01838681|16353839|P3|Period A|Administrative or other reasons|0
4740963|NCT01838681|16353840|P2|Period A|Administrative or other reasons|0
4740964|NCT01838681|16353841|P1|Period A|Administrative or other reasons|17
4740965|NCT01838681|16353838|P4|Period A|Withdrawal before treatment|0
4740966|NCT01838681|16353839|P3|Period A|Withdrawal before treatment|0
4740967|NCT01838681|16353840|P2|Period A|Withdrawal before treatment|0
4740968|NCT01838681|16353841|P1|Period A|Withdrawal before treatment|4
4740969|NCT01838681|16353838|P4|Period A|Lost to Follow-up|0
4740970|NCT01838681|16353839|P3|Period A|Lost to Follow-up|0
4740971|NCT01838681|16353840|P2|Period A|Lost to Follow-up|0
4740972|NCT01838681|16353841|P1|Period A|Lost to Follow-up|4
4740973|NCT01838681|16353838|P4|Period A|Non-compliance with IMP|0
4740974|NCT01838681|16353839|P3|Period A|Non-compliance with IMP|0
4740975|NCT01838681|16353840|P2|Period A|Non-compliance with IMP|0
4740976|NCT01838681|16353841|P1|Period A|Non-compliance with IMP|6
4740977|NCT01838681|16353838|P4|Period A|Protocol Violation|0
4740978|NCT01838681|16353839|P3|Period A|Protocol Violation|0
4740979|NCT01838681|16353840|P2|Period A|Protocol Violation|0
4740980|NCT01838681|16353841|P1|Period A|Protocol Violation|16
4740981|NCT01838681|16353838|P4|Period A|Withdrawal by Subject|0
4740982|NCT01838681|16353839|P3|Period A|Withdrawal by Subject|0
4740983|NCT01838681|16353840|P2|Period A|Withdrawal by Subject|0
4740984|NCT01838681|16353841|P1|Period A|Withdrawal by Subject|70
4740985|NCT01838681|16353838|P4|Period A|Early response|0
4740986|NCT01838681|16353839|P3|Period A|Early response|0
4740987|NCT01838681|16353840|P2|Period A|Early response|0
4740988|NCT01838681|16353841|P1|Period A|Early response|148
4740989|NCT01838681|16353838|P4|Period A|Lack of Efficacy|0
4740990|NCT01838681|16353839|P3|Period A|Lack of Efficacy|0
4740991|NCT01838681|16353840|P2|Period A|Lack of Efficacy|0
4740992|NCT01838681|16353841|P1|Period A|Lack of Efficacy|21
4740993|NCT01838681|16353838|P4|Period A|Adverse Event|0
4740994|NCT01838681|16353839|P3|Period A|Adverse Event|0
4740995|NCT01838681|16353840|P2|Period A|Adverse Event|0
4740996|NCT01838681|16353841|P1|Period A|Adverse Event|39
4740997|NCT01838642|16353949|P1|Overall Study|Died on study|1
4740998|NCT01838616|16353962|P2|Pick-up Arm|Technical problems|0
4740999|NCT01838616|16353963|P1|Pick-up Arm|Technical problems|1
4741000|NCT01838616|16353962|P2|Pick-up Arm|Withdrawal by Subject|0
4741001|NCT01838616|16353963|P1|Pick-up Arm|Withdrawal by Subject|1
4741002|NCT01838616|16353962|P2|Pick-up Arm|Adverse Event|0
4741003|NCT01838616|16353963|P1|Pick-up Arm|Adverse Event|9
4741004|NCT01838616|16353962|P2|Pick-up Arm|Lack of Efficacy|0
4741005|NCT01838616|16353963|P1|Pick-up Arm|Lack of Efficacy|4
4741006|NCT01838616|16353962|P2|Continuation Period|Technical problems|1
4741007|NCT01838616|16353963|P1|Continuation Period|Technical problems|0
4741008|NCT01838616|16353962|P2|Continuation Period|Withdrawal by Subject|4
4741009|NCT01838616|16353963|P1|Continuation Period|Withdrawal by Subject|0
4741010|NCT01838616|16353962|P2|Continuation Period|Lost to Follow-up|0
4741011|NCT01838616|16353963|P1|Continuation Period|Lost to Follow-up|1
4741012|NCT01838616|16353962|P2|Continuation Period|Protocol Violation|0
4741013|NCT01838616|16353963|P1|Continuation Period|Protocol Violation|2
4741014|NCT01838616|16353962|P2|Continuation Period|Adverse Event|4
4741015|NCT01838616|16353963|P1|Continuation Period|Adverse Event|8
4741016|NCT01838616|16353962|P2|Continuation Period|Lack of Efficacy|5
4741017|NCT01838616|16353963|P1|Continuation Period|Lack of Efficacy|3
4741018|NCT01838616|16353962|P2|Titration Period|Protocol Violation|1
4741019|NCT01838616|16353963|P1|Titration Period|Protocol Violation|0
4741020|NCT01838616|16353962|P2|Titration Period|Other|0
4741021|NCT01838616|16353963|P1|Titration Period|Other|1
4741022|NCT01838616|16353962|P2|Titration Period|Technical problems|0
4741023|NCT01838616|16353963|P1|Titration Period|Technical problems|1
4741024|NCT01838616|16353962|P2|Titration Period|Withdrawal by Subject|5
4741025|NCT01838616|16353963|P1|Titration Period|Withdrawal by Subject|5
4741026|NCT01838616|16353962|P2|Titration Period|Lack of Efficacy|12
4741027|NCT01838616|16353963|P1|Titration Period|Lack of Efficacy|5
4741028|NCT01838616|16353962|P2|Titration Period|Adverse Event|48
4741029|NCT01838616|16353963|P1|Titration Period|Adverse Event|18
4741030|NCT01838590|16354034|P2|Overall Study|Lost to Follow-up|1
4741031|NCT01838590|16354035|P1|Overall Study|Lost to Follow-up|0
4741032|NCT01838590|16354034|P2|Overall Study|Lack of Efficacy|4
4741033|NCT01838590|16354035|P1|Overall Study|Lack of Efficacy|12
4741034|NCT01838499|16354059|P2|Overall Study|Withdrawal by Subject|9
4741035|NCT01838499|16354060|P1|Overall Study|Withdrawal by Subject|19
4741036|NCT01838499|16354059|P2|Overall Study|Adverse Event|1
4741037|NCT01838499|16354060|P1|Overall Study|Adverse Event|2
4741038|NCT01838499|16354059|P2|Overall Study|Lack of Efficacy|2
4741039|NCT01838499|16354060|P1|Overall Study|Lack of Efficacy|1
4741040|NCT01838499|16354059|P2|Overall Study|Lost to Follow-up|4
4741041|NCT01838499|16354060|P1|Overall Study|Lost to Follow-up|2
4741042|NCT01838499|16354059|P2|Overall Study|Protocol Violation|1
4741043|NCT01838499|16354060|P1|Overall Study|Protocol Violation|0
4741044|NCT01838447|16354072|P2|Overall Study|Withdrawal by Subject|1
4741045|NCT01838447|16354073|P1|Overall Study|Withdrawal by Subject|1
4741046|NCT01838447|16354072|P2|Overall Study|Change in surgical plan|2
4741047|NCT01838447|16354073|P1|Overall Study|Change in surgical plan|1
4741048|NCT01838213|16354121|P2|Overall Study|Ineligible|191
4741049|NCT01838213|16354122|P1|Overall Study|Ineligible|166
4741050|NCT01838200|16354130|P2|Overall Study|Progressive disease|0
4741051|NCT01838200|16354131|P1|Overall Study|Progressive disease|3
4741052|NCT01838200|16354130|P2|Overall Study|Adverse Event|2
4741053|NCT01838200|16354131|P1|Overall Study|Adverse Event|0
4741054|NCT01838044|16354143|P2|Overall Study|Lost to Follow-up|2
4741055|NCT01838044|16354144|P1|Overall Study|Lost to Follow-up|0
4741056|NCT01838044|16354143|P2|Overall Study|Medication error without associated AE|1
4741057|NCT01838044|16354144|P1|Overall Study|Medication error without associated AE|0
4741058|NCT01838044|16354143|P2|Overall Study|Insufficient clinical response|2
4741059|NCT01838044|16354144|P1|Overall Study|Insufficient clinical response|1
4741060|NCT01838044|16354143|P2|Overall Study|Withdrawal by Subject|2
4741061|NCT01838044|16354144|P1|Overall Study|Withdrawal by Subject|0
4741062|NCT01838044|16354143|P2|Overall Study|Protocol Violation|3
4741063|NCT01838044|16354144|P1|Overall Study|Protocol Violation|3
4741064|NCT01838044|16354143|P2|Overall Study|Adverse Event|6
4741065|NCT01838044|16354144|P1|Overall Study|Adverse Event|4
4741066|NCT01837966|16354177|P2|Overall Study|Withdrawal by Subject|1
4741067|NCT01837966|16354178|P1|Overall Study|Withdrawal by Subject|2
4741068|NCT01837823|16354184|P1|Overall Study|Lost to Follow-up|6
4741069|NCT01837797|16354215|P5|Period 3|Other|2
4741070|NCT01837797|16354216|P4|Period 3|Other|0
4741071|NCT01837797|16354217|P3|Period 3|Other|0
4741072|NCT01837797|16354218|P2|Period 3|Other|0
4741073|NCT01837797|16354219|P1|Period 3|Other|0
4741074|NCT01837797|16354215|P5|Period 3|Administrative reasons|20
4741075|NCT01837797|16354216|P4|Period 3|Administrative reasons|0
4741076|NCT01837797|16354217|P3|Period 3|Administrative reasons|0
4741077|NCT01837797|16354218|P2|Period 3|Administrative reasons|0
4741078|NCT01837797|16354219|P1|Period 3|Administrative reasons|0
4741079|NCT01837797|16354215|P5|Period 3|Adverse Event|1
4741080|NCT01837797|16354216|P4|Period 3|Adverse Event|0
4741081|NCT01837797|16354217|P3|Period 3|Adverse Event|0
4741082|NCT01837797|16354218|P2|Period 3|Adverse Event|0
4741083|NCT01837797|16354219|P1|Period 3|Adverse Event|0
4741084|NCT01837797|16354215|P5|Period 2|Adverse Event|0
4741085|NCT01837797|16354216|P4|Period 2|Adverse Event|1
4741086|NCT01837797|16354217|P3|Period 2|Adverse Event|0
4741087|NCT01837797|16354218|P2|Period 2|Adverse Event|0
4741088|NCT01837797|16354219|P1|Period 2|Adverse Event|0
4741089|NCT01837797|16354215|P5|Period 2|Administrative or other reasons|0
4741090|NCT01837797|16354216|P4|Period 2|Administrative or other reasons|4
4741091|NCT01837797|16354217|P3|Period 2|Administrative or other reasons|2
4741092|NCT01837797|16354218|P2|Period 2|Administrative or other reasons|5
4741093|NCT01837797|16354219|P1|Period 2|Administrative or other reasons|0
4741094|NCT01837797|16354215|P5|Period 1|Other|0
4741095|NCT01837797|16354216|P4|Period 1|Other|0
4741096|NCT01837797|16354217|P3|Period 1|Other|0
4741097|NCT01837797|16354218|P2|Period 1|Other|0
4741098|NCT01837797|16354219|P1|Period 1|Other|10
4741099|NCT01837797|16354215|P5|Period 1|Withdrawal of consent before treatment|0
4741100|NCT01837797|16354216|P4|Period 1|Withdrawal of consent before treatment|0
4741101|NCT01837797|16354217|P3|Period 1|Withdrawal of consent before treatment|0
4741102|NCT01837797|16354218|P2|Period 1|Withdrawal of consent before treatment|0
4741103|NCT01837797|16354219|P1|Period 1|Withdrawal of consent before treatment|1
4741104|NCT01837797|16354215|P5|Period 1|Administrative reasons|0
4741105|NCT01837797|16354216|P4|Period 1|Administrative reasons|0
4741106|NCT01837797|16354217|P3|Period 1|Administrative reasons|0
4741107|NCT01837797|16354218|P2|Period 1|Administrative reasons|0
4741108|NCT01837797|16354219|P1|Period 1|Administrative reasons|76
4741109|NCT01837797|16354215|P5|Period 1|Withdrawal by Subject|0
4741110|NCT01837797|16354216|P4|Period 1|Withdrawal by Subject|0
4741111|NCT01837797|16354217|P3|Period 1|Withdrawal by Subject|0
4741112|NCT01837797|16354218|P2|Period 1|Withdrawal by Subject|0
4741113|NCT01837797|16354219|P1|Period 1|Withdrawal by Subject|6
4741114|NCT01837797|16354215|P5|Period 1|Adverse Event|0
4741115|NCT01837797|16354216|P4|Period 1|Adverse Event|0
4741116|NCT01837797|16354217|P3|Period 1|Adverse Event|0
4741117|NCT01837797|16354218|P2|Period 1|Adverse Event|0
4741118|NCT01837797|16354219|P1|Period 1|Adverse Event|9
4741119|NCT01837719|16354254|P1|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1
4741120|NCT01837719|16354254|P1|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1
4741121|NCT01837680|16354323|P2|Overall Study|switched to oral hypoglycemic or diet|4
4741122|NCT01837680|16354324|P1|Overall Study|switched to oral hypoglycemic or diet|2
4741123|NCT01837680|16354323|P2|Overall Study|allergic reaction|0
4741124|NCT01837680|16354324|P1|Overall Study|allergic reaction|6
4741125|NCT01837680|16354323|P2|Overall Study|lack of insurance|2
4741126|NCT01837680|16354324|P1|Overall Study|lack of insurance|0
4741127|NCT01837680|16354323|P2|Overall Study|Lost to Follow-up|2
4741128|NCT01837680|16354324|P1|Overall Study|Lost to Follow-up|2
4741129|NCT01836549|16354458|P7|Overall Study|Patient inevaluable to start therapy|1
4741130|NCT01836549|16354459|P6|Overall Study|Patient inevaluable to start therapy|0
4741131|NCT01836549|16354460|P5|Overall Study|Patient inevaluable to start therapy|0
4741132|NCT01836549|16354461|P4|Overall Study|Patient inevaluable to start therapy|0
4741133|NCT01836549|16354462|P3|Overall Study|Patient inevaluable to start therapy|0
4741134|NCT01836549|16354463|P2|Overall Study|Patient inevaluable to start therapy|0
4741135|NCT01836549|16354464|P1|Overall Study|Patient inevaluable to start therapy|0
4741136|NCT01836549|16354458|P7|Overall Study|Patient declared ineligible|0
4741137|NCT01836549|16354459|P6|Overall Study|Patient declared ineligible|0
4741138|NCT01836549|16354460|P5|Overall Study|Patient declared ineligible|0
4741139|NCT01836549|16354461|P4|Overall Study|Patient declared ineligible|1
4741140|NCT01836549|16354462|P3|Overall Study|Patient declared ineligible|0
4741141|NCT01836549|16354463|P2|Overall Study|Patient declared ineligible|0
4741142|NCT01836549|16354464|P1|Overall Study|Patient declared ineligible|0
4741143|NCT01836549|16354458|P7|Overall Study|Did not receive study drug|0
4741144|NCT01836549|16354459|P6|Overall Study|Did not receive study drug|0
4741145|NCT01836549|16354460|P5|Overall Study|Did not receive study drug|0
4741146|NCT01836549|16354461|P4|Overall Study|Did not receive study drug|0
4741147|NCT01836549|16354462|P3|Overall Study|Did not receive study drug|1
4741148|NCT01836549|16354463|P2|Overall Study|Did not receive study drug|0
4741149|NCT01836549|16354464|P1|Overall Study|Did not receive study drug|0
4741150|NCT01836523|16354488|P4|Overall Study|Unclassified|29
4741151|NCT01836523|16354489|P3|Overall Study|Unclassified|19
4741152|NCT01836523|16354490|P2|Overall Study|Unclassified|28
4741153|NCT01836523|16354491|P1|Overall Study|Unclassified|17
4741154|NCT01836523|16354488|P4|Overall Study|Met Withdrawal Criteria|27
4741155|NCT01836523|16354489|P3|Overall Study|Met Withdrawal Criteria|21
4741156|NCT01836523|16354490|P2|Overall Study|Met Withdrawal Criteria|13
4741157|NCT01836523|16354491|P1|Overall Study|Met Withdrawal Criteria|13
4741158|NCT01836523|16354488|P4|Overall Study|Protocol Violation|4
4741159|NCT01836523|16354489|P3|Overall Study|Protocol Violation|2
4741160|NCT01836523|16354490|P2|Overall Study|Protocol Violation|3
4741161|NCT01836523|16354491|P1|Overall Study|Protocol Violation|6
4741162|NCT01836523|16354488|P4|Overall Study|Adverse Event|14
4741163|NCT01836523|16354489|P3|Overall Study|Adverse Event|49
4741164|NCT01836523|16354490|P2|Overall Study|Adverse Event|41
4741165|NCT01836523|16354491|P1|Overall Study|Adverse Event|15
4741166|NCT01836471|16354518|P5|Overall Study|Non compliance with tx|0
4741167|NCT01836471|16354519|P4|Overall Study|Non compliance with tx|0
4741168|NCT01836471|16354520|P3|Overall Study|Non compliance with tx|0
4741169|NCT01836471|16354521|P2|Overall Study|Non compliance with tx|1
4741170|NCT01836471|16354522|P1|Overall Study|Non compliance with tx|1
4741171|NCT01836471|16354518|P5|Overall Study|Adverse Event|2
4741172|NCT01836471|16354519|P4|Overall Study|Adverse Event|1
4741173|NCT01836471|16354520|P3|Overall Study|Adverse Event|1
4741174|NCT01836471|16354521|P2|Overall Study|Adverse Event|3
4741175|NCT01836471|16354522|P1|Overall Study|Adverse Event|6
4741176|NCT01836471|16354518|P5|Overall Study|Lost to Follow-up|1
4741177|NCT01836471|16354519|P4|Overall Study|Lost to Follow-up|1
4741178|NCT01836471|16354520|P3|Overall Study|Lost to Follow-up|0
4741179|NCT01836471|16354521|P2|Overall Study|Lost to Follow-up|0
4741180|NCT01836471|16354522|P1|Overall Study|Lost to Follow-up|0
4741181|NCT01836471|16354518|P5|Overall Study|Physician Decision|0
4741182|NCT01836471|16354519|P4|Overall Study|Physician Decision|0
4741183|NCT01836471|16354520|P3|Overall Study|Physician Decision|0
4741184|NCT01836471|16354521|P2|Overall Study|Physician Decision|1
4741185|NCT01836471|16354522|P1|Overall Study|Physician Decision|0
4741186|NCT01836471|16354518|P5|Overall Study|Withdrawal by Subject|2
4741187|NCT01836471|16354519|P4|Overall Study|Withdrawal by Subject|0
4741188|NCT01836471|16354520|P3|Overall Study|Withdrawal by Subject|1
4741189|NCT01836471|16354521|P2|Overall Study|Withdrawal by Subject|4
4741190|NCT01836471|16354522|P1|Overall Study|Withdrawal by Subject|3
4741191|NCT01836471|16354518|P5|Overall Study|Pregnancy|0
4741192|NCT01836471|16354519|P4|Overall Study|Pregnancy|0
4741193|NCT01836471|16354520|P3|Overall Study|Pregnancy|0
4741194|NCT01836471|16354521|P2|Overall Study|Pregnancy|0
4741195|NCT01836471|16354522|P1|Overall Study|Pregnancy|1
4741196|NCT01836458|16354551|P4|Overall Study|Unsatisfactory therapeutic effect|6
4741197|NCT01836458|16354552|P3|Overall Study|Unsatisfactory therapeutic effect|5
4741198|NCT01836458|16354553|P2|Overall Study|Unsatisfactory therapeutic effect|2
4741199|NCT01836458|16354554|P1|Overall Study|Unsatisfactory therapeutic effect|3
4741200|NCT01836276|16354639|P2|Overall Study|Lost to Follow-up|51
4741201|NCT01836276|16354640|P1|Overall Study|Lost to Follow-up|28
4741202|NCT01836198|16354648|P3|Part A, Period 2|Protocol Violation|0
4741203|NCT01836198|16354649|P2|Part A, Period 2|Protocol Violation|1
4741204|NCT01836198|16354650|P1|Part A, Period 2|Protocol Violation|0
4741205|NCT01835899|16354752|P3|Overall Study|Other than stated above|0
4741206|NCT01835899|16354753|P2|Overall Study|Other than stated above|1
4741207|NCT01835899|16354754|P1|Overall Study|Other than stated above|0
4741208|NCT01835899|16354752|P3|Overall Study|Adverse Event|1
4741209|NCT01835899|16354753|P2|Overall Study|Adverse Event|0
4741210|NCT01835899|16354754|P1|Overall Study|Adverse Event|0
4741211|NCT01835587|16354811|P4|Overall Study|Miscellaneous|0
4741212|NCT01835587|16354812|P3|Overall Study|Miscellaneous|0
4741213|NCT01835587|16354813|P2|Overall Study|Miscellaneous|1
4741214|NCT01835587|16354814|P1|Overall Study|Miscellaneous|0
4741215|NCT01835587|16354811|P4|Overall Study|Death|1
4741216|NCT01835587|16354812|P3|Overall Study|Death|0
4741217|NCT01835587|16354813|P2|Overall Study|Death|0
4741218|NCT01835587|16354814|P1|Overall Study|Death|0
4741219|NCT01835587|16354811|P4|Overall Study|Adverse Event|2
4741220|NCT01835587|16354812|P3|Overall Study|Adverse Event|2
4741221|NCT01835587|16354813|P2|Overall Study|Adverse Event|0
4741222|NCT01835587|16354814|P1|Overall Study|Adverse Event|0
4741223|NCT01835587|16354811|P4|Overall Study|Withdrawal by Subject|3
4741224|NCT01835587|16354812|P3|Overall Study|Withdrawal by Subject|0
4741225|NCT01835587|16354813|P2|Overall Study|Withdrawal by Subject|0
4741226|NCT01835587|16354814|P1|Overall Study|Withdrawal by Subject|2
4741227|NCT01835587|16354811|P4|Overall Study|Disease Recurrence or Relapse|3
4741228|NCT01835587|16354812|P3|Overall Study|Disease Recurrence or Relapse|0
4741229|NCT01835587|16354813|P2|Overall Study|Disease Recurrence or Relapse|3
4741230|NCT01835587|16354814|P1|Overall Study|Disease Recurrence or Relapse|0
4741231|NCT01835548|16354875|P3|Double-Blind Treatment Period|Withdrawal by Subject|0
4741232|NCT01835548|16354876|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
4741233|NCT01835548|16354877|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
4741234|NCT01835548|16354875|P3|Double-Blind Treatment Period|Adverse Event|0
4741235|NCT01835548|16354876|P2|Double-Blind Treatment Period|Adverse Event|1
4741236|NCT01835548|16354877|P1|Double-Blind Treatment Period|Adverse Event|0
4741237|NCT01835548|16354875|P3|Dose Optimization Period|Withdrawal by Subject|1
4741238|NCT01835548|16354876|P2|Dose Optimization Period|Withdrawal by Subject|0
4741239|NCT01835548|16354877|P1|Dose Optimization Period|Withdrawal by Subject|0
4741240|NCT01835548|16354875|P3|Dose Optimization Period|Adverse Event|1
4741241|NCT01835548|16354876|P2|Dose Optimization Period|Adverse Event|0
4741242|NCT01835548|16354877|P1|Dose Optimization Period|Adverse Event|0
4741243|NCT01835470|16354906|P1|Long Term Treatment Period|Lack of Efficacy|3
4741244|NCT01835470|16354906|P1|Long Term Treatment Period|Subject Request to Discontinue|1
4741245|NCT01835431|16354918|P2|Overall Study|Protocol Violation|0
4741246|NCT01835431|16354919|P1|Overall Study|Protocol Violation|1
4741247|NCT01835431|16354918|P2|Overall Study|Withdrawal by Subject|10
4741248|NCT01835431|16354919|P1|Overall Study|Withdrawal by Subject|6
4741249|NCT01835431|16354918|P2|Overall Study|other|2
4741250|NCT01835431|16354919|P1|Overall Study|other|0
4741251|NCT01835431|16354918|P2|Overall Study|Adverse Event|0
4741252|NCT01835431|16354919|P1|Overall Study|Adverse Event|1
4741253|NCT01835158|16354959|P2|Overall Study|Withdrawal by Subject|6
4741254|NCT01835158|16354960|P1|Overall Study|Withdrawal by Subject|1
4741255|NCT01835145|16354972|P2|Overall Study|Ineligible prior to treatment|0
4741256|NCT01835145|16354973|P1|Overall Study|Ineligible prior to treatment|1
4741257|NCT01835132|16354988|P1|Initial Phase|Insufficient Therapeutic Response|2
4741258|NCT01835015|16355033|P5|Overall Study|Adverse Event|0
4741259|NCT01835015|16355034|P4|Overall Study|Adverse Event|0
4741260|NCT01835015|16355035|P3|Overall Study|Adverse Event|1
4741261|NCT01835015|16355036|P2|Overall Study|Adverse Event|0
4741262|NCT01835015|16355037|P1|Overall Study|Adverse Event|0
4741263|NCT01834729|16355114|P4|Overall Study|Adverse Event|2
4741264|NCT01834729|16355115|P3|Overall Study|Adverse Event|0
4741265|NCT01834729|16355116|P2|Overall Study|Adverse Event|0
4741266|NCT01834729|16355117|P1|Overall Study|Adverse Event|0
4741267|NCT01834729|16355114|P4|Overall Study|Withdrawal by Subject|0
4741268|NCT01834729|16355115|P3|Overall Study|Withdrawal by Subject|0
4741269|NCT01834729|16355116|P2|Overall Study|Withdrawal by Subject|1
4741270|NCT01834729|16355117|P1|Overall Study|Withdrawal by Subject|1
4741271|NCT01834729|16355114|P4|Overall Study|Did not return bowel diaries|0
4741272|NCT01834729|16355115|P3|Overall Study|Did not return bowel diaries|3
4741273|NCT01834729|16355116|P2|Overall Study|Did not return bowel diaries|0
4741274|NCT01834729|16355117|P1|Overall Study|Did not return bowel diaries|0
4741275|NCT01834586|16355150|P1|Overall Study|Adverse Event|1
4741276|NCT01834274|16355190|P2|Overall Study|Other|1
4741277|NCT01834274|16355191|P1|Overall Study|Other|2
4741278|NCT01834274|16355190|P2|Overall Study|Lost to Follow-up|1
4741279|NCT01834274|16355191|P1|Overall Study|Lost to Follow-up|3
4741280|NCT01834274|16355190|P2|Overall Study|Withdrawal by Subject|1
4741281|NCT01834274|16355191|P1|Overall Study|Withdrawal by Subject|1
4741282|NCT01834274|16355190|P2|Overall Study|Study Termination|38
4741283|NCT01834274|16355191|P1|Overall Study|Study Termination|41
4741284|NCT01834222|16355214|P1|Overall Study|Not meet inclusion/exclusion criteria|1
4741285|NCT01833897|16355309|P1|Overall Study|Lack of Efficacy|1
4741286|NCT01833832|16355321|P1|Overall Study|Pt could not be cytoreduced for HIPEC|1
4741287|NCT01833533|16355476|P2|Overall Study|Other|7
4741288|NCT01833533|16355477|P1|Overall Study|Other|2
4741289|NCT01833533|16355476|P2|Overall Study|To Enter an Extension Study|4
4741290|NCT01833533|16355477|P1|Overall Study|To Enter an Extension Study|0
4741291|NCT01833533|16355476|P2|Overall Study|Lost to Follow-up|9
4741292|NCT01833533|16355477|P1|Overall Study|Lost to Follow-up|4
4741293|NCT01833533|16355476|P2|Overall Study|Adverse Event|1
4741294|NCT01833533|16355477|P1|Overall Study|Adverse Event|0
4741295|NCT01833494|16355491|P1|Overall Study|Increase in serum ferritin|1
4741296|NCT01833494|16355491|P1|Overall Study|Decrease in serum calcium|4
4741297|NCT01833494|16355491|P1|Overall Study|Decrease in serum phosphorus|4
4741298|NCT01833494|16355491|P1|Overall Study|Withdrawal by Subject|6
4741299|NCT01833494|16355491|P1|Overall Study|Physician Decision|6
4741300|NCT01833494|16355491|P1|Overall Study|Adverse Event|24
4741301|NCT01833455|16355519|P2|Overall Study|Withdrawal by Subject|0
4741302|NCT01833455|16355520|P1|Overall Study|Withdrawal by Subject|1
4741303|NCT01833169|16355549|P1|Overall Study|Physician Decision|2
4741304|NCT01833169|16355549|P1|Overall Study|Death|3
4741305|NCT01833169|16355549|P1|Overall Study|Withdrawal by Subject|9
4741306|NCT01833169|16355549|P1|Overall Study|Adverse Event|33
4741307|NCT01833169|16355549|P1|Overall Study|Disease Progression|99
4741308|NCT01833143|16355560|P1|Overall Study|Not Treated|1
4741309|NCT01833065|16355625|P5|Overall Study|Others|4
4741310|NCT01833065|16355626|P4|Overall Study|Others|1
4741311|NCT01833065|16355627|P3|Overall Study|Others|1
4741312|NCT01833065|16355628|P2|Overall Study|Others|1
4741313|NCT01833065|16355629|P1|Overall Study|Others|2
4741314|NCT01833065|16355625|P5|Overall Study|Trial terminated by sponsor|13
4741315|NCT01833065|16355626|P4|Overall Study|Trial terminated by sponsor|3
4741316|NCT01833065|16355627|P3|Overall Study|Trial terminated by sponsor|7
4741317|NCT01833065|16355628|P2|Overall Study|Trial terminated by sponsor|8
4741318|NCT01833065|16355629|P1|Overall Study|Trial terminated by sponsor|8
4741319|NCT01833065|16355625|P5|Overall Study|Subject's substantial non-compliance|0
4741320|NCT01833065|16355626|P4|Overall Study|Subject's substantial non-compliance|0
4741321|NCT01833065|16355627|P3|Overall Study|Subject's substantial non-compliance|0
4741322|NCT01833065|16355628|P2|Overall Study|Subject's substantial non-compliance|1
4741323|NCT01833065|16355629|P1|Overall Study|Subject's substantial non-compliance|0
4741324|NCT01833065|16355625|P5|Overall Study|Withdrawal by Subject|11
4741325|NCT01833065|16355626|P4|Overall Study|Withdrawal by Subject|3
4741326|NCT01833065|16355627|P3|Overall Study|Withdrawal by Subject|4
4741327|NCT01833065|16355628|P2|Overall Study|Withdrawal by Subject|2
4741328|NCT01833065|16355629|P1|Overall Study|Withdrawal by Subject|6
4741329|NCT01833065|16355625|P5|Overall Study|Lost to Follow-up|3
4741330|NCT01833065|16355626|P4|Overall Study|Lost to Follow-up|0
4741331|NCT01833065|16355627|P3|Overall Study|Lost to Follow-up|0
4741332|NCT01833065|16355628|P2|Overall Study|Lost to Follow-up|0
4741333|NCT01833065|16355629|P1|Overall Study|Lost to Follow-up|1
4741334|NCT01833065|16355625|P5|Overall Study|Protocol Violation|2
4741335|NCT01833065|16355626|P4|Overall Study|Protocol Violation|0
4741336|NCT01833065|16355627|P3|Overall Study|Protocol Violation|0
4741337|NCT01833065|16355628|P2|Overall Study|Protocol Violation|0
4741338|NCT01833065|16355629|P1|Overall Study|Protocol Violation|1
4741339|NCT01833065|16355625|P5|Overall Study|Adverse Event|3
4741340|NCT01833065|16355626|P4|Overall Study|Adverse Event|2
4741341|NCT01833065|16355627|P3|Overall Study|Adverse Event|0
4741342|NCT01833065|16355628|P2|Overall Study|Adverse Event|1
4741343|NCT01833065|16355629|P1|Overall Study|Adverse Event|6
4741344|NCT01832818|16355698|P1|Overall Study|Lost to Follow-up|6
4741345|NCT01832766|16355707|P2|Washout|Lost to Follow-up|1
4741346|NCT01832766|16355708|P1|Washout|Lost to Follow-up|0
4741347|NCT01832727|16355744|P9|Overall Study|Study terminated by sponsor|1
4741348|NCT01832727|16355745|P8|Overall Study|Study terminated by sponsor|1
4741349|NCT01832727|16355746|P7|Overall Study|Study terminated by sponsor|0
4741350|NCT01832727|16355747|P6|Overall Study|Study terminated by sponsor|0
4741351|NCT01832727|16355748|P5|Overall Study|Study terminated by sponsor|0
4741352|NCT01832727|16355749|P4|Overall Study|Study terminated by sponsor|0
4741353|NCT01832727|16355750|P3|Overall Study|Study terminated by sponsor|0
4741354|NCT01832727|16355751|P2|Overall Study|Study terminated by sponsor|0
4741355|NCT01832727|16355752|P1|Overall Study|Study terminated by sponsor|0
4741356|NCT01832727|16355744|P9|Overall Study|Withdrawal by Subject|1
4741357|NCT01832727|16355745|P8|Overall Study|Withdrawal by Subject|2
4741358|NCT01832727|16355746|P7|Overall Study|Withdrawal by Subject|0
4741359|NCT01832727|16355747|P6|Overall Study|Withdrawal by Subject|1
4741360|NCT01832727|16355748|P5|Overall Study|Withdrawal by Subject|0
4741361|NCT01832727|16355749|P4|Overall Study|Withdrawal by Subject|1
4741362|NCT01832727|16355750|P3|Overall Study|Withdrawal by Subject|0
4741363|NCT01832727|16355751|P2|Overall Study|Withdrawal by Subject|1
4741364|NCT01832727|16355752|P1|Overall Study|Withdrawal by Subject|1
4741365|NCT01832727|16355744|P9|Overall Study|Physician Decision|0
4741366|NCT01832727|16355745|P8|Overall Study|Physician Decision|0
4741367|NCT01832727|16355746|P7|Overall Study|Physician Decision|0
4741368|NCT01832727|16355747|P6|Overall Study|Physician Decision|1
4741369|NCT01832727|16355748|P5|Overall Study|Physician Decision|0
4741370|NCT01832727|16355749|P4|Overall Study|Physician Decision|1
4741371|NCT01832727|16355750|P3|Overall Study|Physician Decision|0
4741372|NCT01832727|16355751|P2|Overall Study|Physician Decision|0
4741373|NCT01832727|16355752|P1|Overall Study|Physician Decision|1
4741374|NCT01832727|16355744|P9|Overall Study|Lost to Follow-up|0
4741375|NCT01832727|16355745|P8|Overall Study|Lost to Follow-up|0
4741376|NCT01832727|16355746|P7|Overall Study|Lost to Follow-up|0
4741377|NCT01832727|16355747|P6|Overall Study|Lost to Follow-up|0
4741378|NCT01832727|16355748|P5|Overall Study|Lost to Follow-up|0
4741379|NCT01832727|16355749|P4|Overall Study|Lost to Follow-up|1
4741380|NCT01832727|16355750|P3|Overall Study|Lost to Follow-up|0
4741381|NCT01832727|16355751|P2|Overall Study|Lost to Follow-up|0
4741382|NCT01832727|16355752|P1|Overall Study|Lost to Follow-up|0
4741383|NCT01832727|16355744|P9|Overall Study|Disease progression|7
4741384|NCT01832727|16355745|P8|Overall Study|Disease progression|2
4741385|NCT01832727|16355746|P7|Overall Study|Disease progression|6
4741386|NCT01832727|16355747|P6|Overall Study|Disease progression|3
4741387|NCT01832727|16355748|P5|Overall Study|Disease progression|3
4741388|NCT01832727|16355749|P4|Overall Study|Disease progression|1
4741389|NCT01832727|16355750|P3|Overall Study|Disease progression|2
4741390|NCT01832727|16355751|P2|Overall Study|Disease progression|0
4741391|NCT01832727|16355752|P1|Overall Study|Disease progression|3
4741392|NCT01832727|16355744|P9|Overall Study|Adverse Event|9
4741393|NCT01832727|16355745|P8|Overall Study|Adverse Event|1
4741394|NCT01832727|16355746|P7|Overall Study|Adverse Event|2
4741395|NCT01832727|16355747|P6|Overall Study|Adverse Event|1
4741396|NCT01832727|16355748|P5|Overall Study|Adverse Event|1
4741397|NCT01832727|16355749|P4|Overall Study|Adverse Event|0
4741398|NCT01832727|16355750|P3|Overall Study|Adverse Event|1
4741399|NCT01832727|16355751|P2|Overall Study|Adverse Event|6
4741400|NCT01832727|16355752|P1|Overall Study|Adverse Event|4
4741401|NCT01832532|16355865|P2|Overall Study|Withdrawal by Subject|2
4741402|NCT01832532|16355866|P1|Overall Study|Withdrawal by Subject|5
4741403|NCT01832493|16355928|P1|Overall Study|Unable to place LV lead|2
4741404|NCT01832493|16355928|P1|Overall Study|Protocol Violation|4
4741405|NCT01832493|16355928|P1|Overall Study|Physician Decision|2
4741406|NCT01832480|16355937|P2|Overall Study|post randomization ineligible|10
4741407|NCT01832480|16355938|P1|Overall Study|post randomization ineligible|8
4741408|NCT01832480|16355937|P2|Overall Study|Withdrawal by Subject|2
4741409|NCT01832480|16355938|P1|Overall Study|Withdrawal by Subject|0
4741410|NCT01832480|16355937|P2|Overall Study|Lost to Follow-up|30
4741411|NCT01832480|16355938|P1|Overall Study|Lost to Follow-up|33
4741412|NCT01832402|16355946|P2|Overall Study|Declining Performance status|1
4741413|NCT01832402|16355947|P1|Overall Study|Declining Performance status|2
4741414|NCT01832402|16355946|P2|Overall Study|Withdrawal by Subject|3
4741415|NCT01832402|16355947|P1|Overall Study|Withdrawal by Subject|3
4741416|NCT01832402|16355946|P2|Overall Study|Lost to Follow-up|0
4741417|NCT01832402|16355947|P1|Overall Study|Lost to Follow-up|2
4741418|NCT01832155|16355974|P2|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0
4741419|NCT01832155|16355975|P1|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1
4741420|NCT01832155|16355974|P2|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0
4741421|NCT01832155|16355975|P1|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1
4741422|NCT01832038|16356042|P1|Overall Study|Subject considered the efficacy was poor|1
4741423|NCT01832038|16356042|P1|Overall Study|Pregnancy and abortion in EP0008 study|1
4741424|NCT01832038|16356042|P1|Overall Study|Prohibited concomitant medication|1
4741425|NCT01832038|16356042|P1|Overall Study|Bad mood and has suicidal thought|1
4741426|NCT01832038|16356042|P1|Overall Study|Plan to pregnancy|7
4741427|NCT01832038|16356042|P1|Overall Study|Changes of implementation system|3
4741428|NCT01832038|16356042|P1|Overall Study|Not possible to visit the hospital|1
4741429|NCT01832038|16356042|P1|Overall Study|Prohibit procedure|2
4741430|NCT01832038|16356042|P1|Overall Study|Low compliance|3
4741431|NCT01832038|16356042|P1|Overall Study|Pregnancy|1
4741432|NCT01832038|16356042|P1|Overall Study|Back home|1
4741433|NCT01832038|16356042|P1|Overall Study|Participant was asked to quit|5
4741434|NCT01832038|16356042|P1|Overall Study|Not convenient to come back to site|2
4741435|NCT01832038|16356042|P1|Overall Study|Subject refused to return visit|2
4741436|NCT01832038|16356042|P1|Overall Study|Visit non-compliance|2
4741437|NCT01832038|16356042|P1|Overall Study|Withdrawal by Subject|49
4741438|NCT01832038|16356042|P1|Overall Study|Lost to Follow-up|10
4741439|NCT01832038|16356042|P1|Overall Study|Protocol Violation|7
4741440|NCT01832038|16356042|P1|Overall Study|Lack of Efficacy|81
4741441|NCT01832038|16356042|P1|Overall Study|Adverse Event|50
4741442|NCT01832038|16356042|P1|Overall Study|Death|5
4741443|NCT01831856|16356085|P2|Overall Study|Unsuccessful Electrical Cardioversion|18
4741444|NCT01831856|16356086|P1|Overall Study|Unsuccessful Electrical Cardioversion|16
4741445|NCT01831856|16356085|P2|Overall Study|Lack of Efficacy|11
4741446|NCT01831856|16356086|P1|Overall Study|Lack of Efficacy|13
4741447|NCT01831856|16356085|P2|Overall Study|Adverse Event|8
4741448|NCT01831856|16356086|P1|Overall Study|Adverse Event|5
4741449|NCT01831817|16356096|P4|Overall Study|Withdrawl of Consent|0
4741450|NCT01831817|16356097|P3|Overall Study|Withdrawl of Consent|0
4741451|NCT01831817|16356098|P2|Overall Study|Withdrawl of Consent|0
4741452|NCT01831817|16356099|P1|Overall Study|Withdrawl of Consent|3
4741453|NCT01831817|16356096|P4|Overall Study|Lost to Follow-up|0
4741454|NCT01831817|16356097|P3|Overall Study|Lost to Follow-up|0
4741455|NCT01831817|16356098|P2|Overall Study|Lost to Follow-up|0
4741456|NCT01831817|16356099|P1|Overall Study|Lost to Follow-up|1
4741457|NCT01831804|16356146|P9|Overall Study|Withdrew Consent|0
4741458|NCT01831804|16356147|P8|Overall Study|Withdrew Consent|2
4741459|NCT01831804|16356148|P7|Overall Study|Withdrew Consent|0
4741460|NCT01831804|16356149|P6|Overall Study|Withdrew Consent|0
4741461|NCT01831804|16356150|P5|Overall Study|Withdrew Consent|0
4741462|NCT01831804|16356151|P4|Overall Study|Withdrew Consent|0
4741463|NCT01831804|16356152|P3|Overall Study|Withdrew Consent|0
4741464|NCT01831804|16356153|P2|Overall Study|Withdrew Consent|1
4741465|NCT01831804|16356154|P1|Overall Study|Withdrew Consent|0
4741466|NCT01831804|16356146|P9|Overall Study|Investigator discretion|0
4741467|NCT01831804|16356147|P8|Overall Study|Investigator discretion|1
4741468|NCT01831804|16356148|P7|Overall Study|Investigator discretion|0
4741469|NCT01831804|16356149|P6|Overall Study|Investigator discretion|0
4741470|NCT01831804|16356150|P5|Overall Study|Investigator discretion|1
4741471|NCT01831804|16356151|P4|Overall Study|Investigator discretion|0
4741472|NCT01831804|16356152|P3|Overall Study|Investigator discretion|0
4741473|NCT01831804|16356153|P2|Overall Study|Investigator discretion|0
4741474|NCT01831804|16356154|P1|Overall Study|Investigator discretion|0
4741475|NCT01831804|16356146|P9|Overall Study|Lost to Follow-up|1
4741476|NCT01831804|16356147|P8|Overall Study|Lost to Follow-up|0
4741477|NCT01831804|16356148|P7|Overall Study|Lost to Follow-up|0
4741478|NCT01831804|16356149|P6|Overall Study|Lost to Follow-up|0
4741479|NCT01831804|16356150|P5|Overall Study|Lost to Follow-up|0
4741480|NCT01831804|16356151|P4|Overall Study|Lost to Follow-up|0
4741481|NCT01831804|16356152|P3|Overall Study|Lost to Follow-up|1
4741482|NCT01831804|16356153|P2|Overall Study|Lost to Follow-up|0
4741483|NCT01831804|16356154|P1|Overall Study|Lost to Follow-up|0
4741484|NCT01831804|16356146|P9|Overall Study|Protocol defined stopping criteria|0
4741485|NCT01831804|16356147|P8|Overall Study|Protocol defined stopping criteria|0
4741486|NCT01831804|16356148|P7|Overall Study|Protocol defined stopping criteria|0
4741487|NCT01831804|16356149|P6|Overall Study|Protocol defined stopping criteria|0
4741488|NCT01831804|16356150|P5|Overall Study|Protocol defined stopping criteria|1
4741489|NCT01831804|16356151|P4|Overall Study|Protocol defined stopping criteria|0
4741490|NCT01831804|16356152|P3|Overall Study|Protocol defined stopping criteria|3
4741491|NCT01831804|16356153|P2|Overall Study|Protocol defined stopping criteria|1
4741492|NCT01831804|16356154|P1|Overall Study|Protocol defined stopping criteria|1
4741493|NCT01831804|16356146|P9|Overall Study|Protocol Violation|0
4741494|NCT01831804|16356147|P8|Overall Study|Protocol Violation|0
4741495|NCT01831804|16356148|P7|Overall Study|Protocol Violation|0
4741496|NCT01831804|16356149|P6|Overall Study|Protocol Violation|0
4741497|NCT01831804|16356150|P5|Overall Study|Protocol Violation|0
4741498|NCT01831804|16356151|P4|Overall Study|Protocol Violation|0
4741499|NCT01831804|16356152|P3|Overall Study|Protocol Violation|2
4741500|NCT01831804|16356153|P2|Overall Study|Protocol Violation|0
4741501|NCT01831804|16356154|P1|Overall Study|Protocol Violation|0
4741502|NCT01831804|16356146|P9|Overall Study|Adverse Event|1
4741503|NCT01831804|16356147|P8|Overall Study|Adverse Event|0
4741504|NCT01831804|16356148|P7|Overall Study|Adverse Event|1
4741505|NCT01831804|16356149|P6|Overall Study|Adverse Event|0
4741506|NCT01831804|16356150|P5|Overall Study|Adverse Event|0
4741507|NCT01831804|16356151|P4|Overall Study|Adverse Event|0
4741508|NCT01831804|16356152|P3|Overall Study|Adverse Event|0
4741509|NCT01831804|16356153|P2|Overall Study|Adverse Event|0
4741510|NCT01831804|16356154|P1|Overall Study|Adverse Event|0
4741511|NCT01831791|16356249|P1|Overall Study|Withdrawal by Subject|10
4741512|NCT01831765|16356278|P3|Overall Study|Lost to Follow-up|3
4741513|NCT01831765|16356279|P2|Overall Study|Lost to Follow-up|3
4741514|NCT01831765|16356280|P1|Overall Study|Lost to Follow-up|2
4741515|NCT01831765|16356278|P3|Overall Study|Withdrawal criteria|16
4741516|NCT01831765|16356279|P2|Overall Study|Withdrawal criteria|10
4741517|NCT01831765|16356280|P1|Overall Study|Withdrawal criteria|12
4741518|NCT01831765|16356278|P3|Overall Study|Withdrawal by Subject|17
4741519|NCT01831765|16356279|P2|Overall Study|Withdrawal by Subject|7
4741520|NCT01831765|16356280|P1|Overall Study|Withdrawal by Subject|22
4741521|NCT01831765|16356278|P3|Overall Study|Adverse Event|3
4741522|NCT01831765|16356279|P2|Overall Study|Adverse Event|3
4741523|NCT01831765|16356280|P1|Overall Study|Adverse Event|5
4741524|NCT01831765|16356278|P3|Overall Study|Other, site closed|0
4741525|NCT01831765|16356279|P2|Overall Study|Other, site closed|1
4741526|NCT01831765|16356280|P1|Overall Study|Other, site closed|1
4741527|NCT01831765|16356278|P3|Overall Study|Death|1
4741528|NCT01831765|16356279|P2|Overall Study|Death|1
4741529|NCT01831765|16356280|P1|Overall Study|Death|0
4741530|NCT01831765|16356278|P3|Overall Study|Pregnancy|2
4741531|NCT01831765|16356279|P2|Overall Study|Pregnancy|1
4741532|NCT01831765|16356280|P1|Overall Study|Pregnancy|1
4741533|NCT01831765|16356278|P3|Overall Study|Other, sponsor withdrew subject|0
4741534|NCT01831765|16356279|P2|Overall Study|Other, sponsor withdrew subject|1
4741535|NCT01831765|16356280|P1|Overall Study|Other, sponsor withdrew subject|0
4741536|NCT01831765|16356278|P3|Overall Study|Lack of Efficacy|0
4741537|NCT01831765|16356279|P2|Overall Study|Lack of Efficacy|0
4741538|NCT01831765|16356280|P1|Overall Study|Lack of Efficacy|1
4741539|NCT01831726|16356306|P1|Overall Study|Subject/guardian decision|7
4741540|NCT01831726|16356306|P1|Overall Study|Physician Decision|1
4741541|NCT01831726|16356306|P1|Overall Study|Disease Progression|49
4741542|NCT01831726|16356306|P1|Overall Study|Death|7
4741543|NCT01831726|16356306|P1|Overall Study|Adverse Event|16
4741544|NCT01831596|16356313|P1|Overall Study|Other|8
4741545|NCT01831544|16356317|P1|Overall Study|Still on original MVAD device|2
4741546|NCT01831544|16356317|P1|Overall Study|Death|1
4741547|NCT01831466|16356346|P12|Overall Study|Adverse Event|2
4741548|NCT01831466|16356347|P11|Overall Study|Adverse Event|0
4741549|NCT01831466|16356348|P10|Overall Study|Adverse Event|1
4741550|NCT01831466|16356349|P9|Overall Study|Adverse Event|1
4741551|NCT01831466|16356350|P8|Overall Study|Adverse Event|1
4741552|NCT01831466|16356351|P7|Overall Study|Adverse Event|0
4741553|NCT01831466|16356352|P6|Overall Study|Adverse Event|7
4741554|NCT01831466|16356353|P5|Overall Study|Adverse Event|3
4741555|NCT01831466|16356354|P4|Overall Study|Adverse Event|6
4741556|NCT01831466|16356355|P3|Overall Study|Adverse Event|4
4741557|NCT01831466|16356356|P2|Overall Study|Adverse Event|0
4741558|NCT01831466|16356357|P1|Overall Study|Adverse Event|0
4741559|NCT01831466|16356346|P12|Overall Study|Lack of Efficacy|0
4741560|NCT01831466|16356347|P11|Overall Study|Lack of Efficacy|2
4741561|NCT01831466|16356348|P10|Overall Study|Lack of Efficacy|2
4741562|NCT01831466|16356349|P9|Overall Study|Lack of Efficacy|2
4741563|NCT01831466|16356350|P8|Overall Study|Lack of Efficacy|1
4741564|NCT01831466|16356351|P7|Overall Study|Lack of Efficacy|1
4741565|NCT01831466|16356352|P6|Overall Study|Lack of Efficacy|8
4741566|NCT01831466|16356353|P5|Overall Study|Lack of Efficacy|9
4741567|NCT01831466|16356354|P4|Overall Study|Lack of Efficacy|6
4741568|NCT01831466|16356355|P3|Overall Study|Lack of Efficacy|7
4741569|NCT01831466|16356356|P2|Overall Study|Lack of Efficacy|8
4741570|NCT01831466|16356357|P1|Overall Study|Lack of Efficacy|5
4741571|NCT01831466|16356346|P12|Overall Study|Lost to Follow-up|1
4741572|NCT01831466|16356347|P11|Overall Study|Lost to Follow-up|0
4741573|NCT01831466|16356348|P10|Overall Study|Lost to Follow-up|1
4741574|NCT01831466|16356349|P9|Overall Study|Lost to Follow-up|0
4741575|NCT01831466|16356350|P8|Overall Study|Lost to Follow-up|0
4741576|NCT01831466|16356351|P7|Overall Study|Lost to Follow-up|0
4741577|NCT01831466|16356352|P6|Overall Study|Lost to Follow-up|3
4741578|NCT01831466|16356353|P5|Overall Study|Lost to Follow-up|0
4741579|NCT01831466|16356354|P4|Overall Study|Lost to Follow-up|2
4741580|NCT01831466|16356355|P3|Overall Study|Lost to Follow-up|4
4741581|NCT01831466|16356356|P2|Overall Study|Lost to Follow-up|1
4741582|NCT01831466|16356357|P1|Overall Study|Lost to Follow-up|0
4741583|NCT01831466|16356346|P12|Overall Study|Withdrawal by Subject|1
4741584|NCT01831466|16356347|P11|Overall Study|Withdrawal by Subject|0
4741585|NCT01831466|16356348|P10|Overall Study|Withdrawal by Subject|1
4741586|NCT01831466|16356349|P9|Overall Study|Withdrawal by Subject|0
4741587|NCT01831466|16356350|P8|Overall Study|Withdrawal by Subject|0
4741588|NCT01831466|16356351|P7|Overall Study|Withdrawal by Subject|0
4741589|NCT01831466|16356352|P6|Overall Study|Withdrawal by Subject|5
4741590|NCT01831466|16356353|P5|Overall Study|Withdrawal by Subject|3
4741591|NCT01831466|16356354|P4|Overall Study|Withdrawal by Subject|3
4741592|NCT01831466|16356355|P3|Overall Study|Withdrawal by Subject|3
4741593|NCT01831466|16356356|P2|Overall Study|Withdrawal by Subject|3
4741594|NCT01831466|16356357|P1|Overall Study|Withdrawal by Subject|6
4741595|NCT01831466|16356346|P12|Overall Study|Death|0
4741596|NCT01831466|16356347|P11|Overall Study|Death|0
4741597|NCT01831466|16356348|P10|Overall Study|Death|0
4741598|NCT01831466|16356349|P9|Overall Study|Death|0
4741599|NCT01831466|16356350|P8|Overall Study|Death|0
4741600|NCT01831466|16356351|P7|Overall Study|Death|0
4741601|NCT01831466|16356352|P6|Overall Study|Death|0
4741602|NCT01831466|16356353|P5|Overall Study|Death|0
4741603|NCT01831466|16356354|P4|Overall Study|Death|0
4741604|NCT01831466|16356355|P3|Overall Study|Death|0
4741605|NCT01831466|16356356|P2|Overall Study|Death|1
4741606|NCT01831466|16356357|P1|Overall Study|Death|0
4741607|NCT01831466|16356346|P12|Overall Study|Non-compliance with study treatment|0
4741608|NCT01831466|16356347|P11|Overall Study|Non-compliance with study treatment|0
4741609|NCT01831466|16356348|P10|Overall Study|Non-compliance with study treatment|0
4741610|NCT01831466|16356349|P9|Overall Study|Non-compliance with study treatment|0
4741611|NCT01831466|16356350|P8|Overall Study|Non-compliance with study treatment|0
4741612|NCT01831466|16356351|P7|Overall Study|Non-compliance with study treatment|0
4741613|NCT01831466|16356352|P6|Overall Study|Non-compliance with study treatment|1
4741614|NCT01831466|16356353|P5|Overall Study|Non-compliance with study treatment|0
4741615|NCT01831466|16356354|P4|Overall Study|Non-compliance with study treatment|0
4741616|NCT01831466|16356355|P3|Overall Study|Non-compliance with study treatment|1
4741617|NCT01831466|16356356|P2|Overall Study|Non-compliance with study treatment|1
4741618|NCT01831466|16356357|P1|Overall Study|Non-compliance with study treatment|2
4741619|NCT01831466|16356346|P12|Overall Study|Other|0
4741620|NCT01831466|16356347|P11|Overall Study|Other|0
4741621|NCT01831466|16356348|P10|Overall Study|Other|0
4741622|NCT01831466|16356349|P9|Overall Study|Other|0
4741623|NCT01831466|16356350|P8|Overall Study|Other|0
4741624|NCT01831466|16356351|P7|Overall Study|Other|0
4741625|NCT01831466|16356352|P6|Overall Study|Other|1
4741626|NCT01831466|16356353|P5|Overall Study|Other|2
4741627|NCT01831466|16356354|P4|Overall Study|Other|2
4741628|NCT01831466|16356355|P3|Overall Study|Other|2
4741629|NCT01831466|16356356|P2|Overall Study|Other|3
4741630|NCT01831466|16356357|P1|Overall Study|Other|2
4741631|NCT01831466|16356346|P12|Overall Study|Protocol Violation|0
4741632|NCT01831466|16356347|P11|Overall Study|Protocol Violation|0
4741633|NCT01831466|16356348|P10|Overall Study|Protocol Violation|0
4741634|NCT01831466|16356349|P9|Overall Study|Protocol Violation|0
4741635|NCT01831466|16356350|P8|Overall Study|Protocol Violation|0
4741636|NCT01831466|16356351|P7|Overall Study|Protocol Violation|0
4741637|NCT01831466|16356352|P6|Overall Study|Protocol Violation|1
4741638|NCT01831466|16356353|P5|Overall Study|Protocol Violation|0
4741639|NCT01831466|16356354|P4|Overall Study|Protocol Violation|0
4741640|NCT01831466|16356355|P3|Overall Study|Protocol Violation|2
4741641|NCT01831466|16356356|P2|Overall Study|Protocol Violation|1
4741642|NCT01831466|16356357|P1|Overall Study|Protocol Violation|1
4741643|NCT01831258|16356479|P2|Overall Study|Lost to Follow-up|2
4741644|NCT01831258|16356480|P1|Overall Study|Lost to Follow-up|3
4741645|NCT01831258|16356479|P2|Overall Study|Withdrawal by Subject|1
4741646|NCT01831258|16356480|P1|Overall Study|Withdrawal by Subject|2
4741647|NCT01831089|16356570|P6|Cohort B: Arm B|Global end of study|1
4741648|NCT01831089|16356571|P5|Cohort B: Arm B|Global end of study|0
4741649|NCT01831089|16356572|P4|Cohort B: Arm B|Global end of study|0
4741650|NCT01831089|16356573|P3|Cohort B: Arm B|Global end of study|0
4741651|NCT01831089|16356574|P2|Cohort B: Arm B|Global end of study|0
4741652|NCT01831089|16356575|P1|Cohort B: Arm B|Global end of study|0
4741653|NCT01831089|16356570|P6|Cohort B: Arm B|Adverse Event|1
4741654|NCT01831089|16356571|P5|Cohort B: Arm B|Adverse Event|0
4741655|NCT01831089|16356572|P4|Cohort B: Arm B|Adverse Event|0
4741656|NCT01831089|16356573|P3|Cohort B: Arm B|Adverse Event|0
4741657|NCT01831089|16356574|P2|Cohort B: Arm B|Adverse Event|0
4741658|NCT01831089|16356575|P1|Cohort B: Arm B|Adverse Event|0
4741659|NCT01831089|16356570|P6|Cohort B: Arm B|Never treated|2
4741660|NCT01831089|16356571|P5|Cohort B: Arm B|Never treated|0
4741661|NCT01831089|16356572|P4|Cohort B: Arm B|Never treated|0
4741662|NCT01831089|16356573|P3|Cohort B: Arm B|Never treated|0
4741663|NCT01831089|16356574|P2|Cohort B: Arm B|Never treated|0
4741664|NCT01831089|16356575|P1|Cohort B: Arm B|Never treated|0
4741665|NCT01831089|16356570|P6|Cohort B: Arm B|Physician Decision|2
4741666|NCT01831089|16356571|P5|Cohort B: Arm B|Physician Decision|0
4741667|NCT01831089|16356572|P4|Cohort B: Arm B|Physician Decision|0
4741668|NCT01831089|16356573|P3|Cohort B: Arm B|Physician Decision|0
4741669|NCT01831089|16356574|P2|Cohort B: Arm B|Physician Decision|0
4741670|NCT01831089|16356575|P1|Cohort B: Arm B|Physician Decision|0
4741671|NCT01831089|16356570|P6|Cohort B: Arm B|Progressive disease|8
4741672|NCT01831089|16356571|P5|Cohort B: Arm B|Progressive disease|0
4741673|NCT01831089|16356572|P4|Cohort B: Arm B|Progressive disease|0
4741674|NCT01831089|16356573|P3|Cohort B: Arm B|Progressive disease|0
4741675|NCT01831089|16356574|P2|Cohort B: Arm B|Progressive disease|0
4741676|NCT01831089|16356575|P1|Cohort B: Arm B|Progressive disease|0
4741677|NCT01831089|16356570|P6|Cohort V: Dose Level 5|Lost to Follow-up|0
4741678|NCT01831089|16356571|P5|Cohort V: Dose Level 5|Lost to Follow-up|1
4741679|NCT01831089|16356572|P4|Cohort V: Dose Level 5|Lost to Follow-up|0
4741680|NCT01831089|16356573|P3|Cohort V: Dose Level 5|Lost to Follow-up|0
4741681|NCT01831089|16356574|P2|Cohort V: Dose Level 5|Lost to Follow-up|0
4741682|NCT01831089|16356575|P1|Cohort V: Dose Level 5|Lost to Follow-up|0
4741683|NCT01831089|16356570|P6|Cohort V: Dose Level 5|Global end of study|0
4741684|NCT01831089|16356571|P5|Cohort V: Dose Level 5|Global end of study|2
4741685|NCT01831089|16356572|P4|Cohort V: Dose Level 5|Global end of study|0
4741686|NCT01831089|16356573|P3|Cohort V: Dose Level 5|Global end of study|0
4741687|NCT01831089|16356574|P2|Cohort V: Dose Level 5|Global end of study|0
4741688|NCT01831089|16356575|P1|Cohort V: Dose Level 5|Global end of study|0
4741689|NCT01831089|16356570|P6|Cohort V: Dose Level 5|Death|0
4741690|NCT01831089|16356571|P5|Cohort V: Dose Level 5|Death|1
4741691|NCT01831089|16356572|P4|Cohort V: Dose Level 5|Death|0
4741692|NCT01831089|16356573|P3|Cohort V: Dose Level 5|Death|0
4741693|NCT01831089|16356574|P2|Cohort V: Dose Level 5|Death|0
4741694|NCT01831089|16356575|P1|Cohort V: Dose Level 5|Death|0
4741695|NCT01831089|16356570|P6|Cohort V: Dose Level 5|Withdrawal by Subject|0
4741696|NCT01831089|16356571|P5|Cohort V: Dose Level 5|Withdrawal by Subject|3
4741697|NCT01831089|16356572|P4|Cohort V: Dose Level 5|Withdrawal by Subject|0
4741698|NCT01831089|16356573|P3|Cohort V: Dose Level 5|Withdrawal by Subject|0
4741699|NCT01831089|16356574|P2|Cohort V: Dose Level 5|Withdrawal by Subject|0
4741700|NCT01831089|16356575|P1|Cohort V: Dose Level 5|Withdrawal by Subject|0
4741701|NCT01831089|16356570|P6|Cohort V: Dose Level 5|Progressive disease|0
4741702|NCT01831089|16356571|P5|Cohort V: Dose Level 5|Progressive disease|30
4741703|NCT01831089|16356572|P4|Cohort V: Dose Level 5|Progressive disease|0
4741704|NCT01831089|16356573|P3|Cohort V: Dose Level 5|Progressive disease|0
4741705|NCT01831089|16356574|P2|Cohort V: Dose Level 5|Progressive disease|0
4741706|NCT01831089|16356575|P1|Cohort V: Dose Level 5|Progressive disease|0
4741707|NCT01831089|16356570|P6|Cohort IV: Dose Level 4|Progressive disease|0
4741708|NCT01831089|16356571|P5|Cohort IV: Dose Level 4|Progressive disease|0
4741709|NCT01831089|16356572|P4|Cohort IV: Dose Level 4|Progressive disease|6
4741710|NCT01831089|16356573|P3|Cohort IV: Dose Level 4|Progressive disease|0
4741711|NCT01831089|16356574|P2|Cohort IV: Dose Level 4|Progressive disease|0
4741712|NCT01831089|16356575|P1|Cohort IV: Dose Level 4|Progressive disease|0
4741713|NCT01831089|16356570|P6|Cohort III: Dose Level 3|Global end of study|0
4741714|NCT01831089|16356571|P5|Cohort III: Dose Level 3|Global end of study|0
4741715|NCT01831089|16356572|P4|Cohort III: Dose Level 3|Global end of study|0
4741716|NCT01831089|16356573|P3|Cohort III: Dose Level 3|Global end of study|1
4741717|NCT01831089|16356574|P2|Cohort III: Dose Level 3|Global end of study|0
4741718|NCT01831089|16356575|P1|Cohort III: Dose Level 3|Global end of study|0
4741719|NCT01831089|16356570|P6|Cohort III: Dose Level 3|Adverse Event|0
4741720|NCT01831089|16356571|P5|Cohort III: Dose Level 3|Adverse Event|0
4741721|NCT01831089|16356572|P4|Cohort III: Dose Level 3|Adverse Event|0
4741722|NCT01831089|16356573|P3|Cohort III: Dose Level 3|Adverse Event|1
4741723|NCT01831089|16356574|P2|Cohort III: Dose Level 3|Adverse Event|0
4741724|NCT01831089|16356575|P1|Cohort III: Dose Level 3|Adverse Event|0
4741725|NCT01831089|16356570|P6|Cohort III: Dose Level 3|Withdrawal by Subject|0
4741726|NCT01831089|16356571|P5|Cohort III: Dose Level 3|Withdrawal by Subject|0
4741727|NCT01831089|16356572|P4|Cohort III: Dose Level 3|Withdrawal by Subject|0
4741728|NCT01831089|16356573|P3|Cohort III: Dose Level 3|Withdrawal by Subject|1
4741729|NCT01831089|16356574|P2|Cohort III: Dose Level 3|Withdrawal by Subject|0
4741730|NCT01831089|16356575|P1|Cohort III: Dose Level 3|Withdrawal by Subject|0
4741731|NCT01831089|16356570|P6|Cohort III: Dose Level 3|Progressive disease|0
4741732|NCT01831089|16356571|P5|Cohort III: Dose Level 3|Progressive disease|0
4741733|NCT01831089|16356572|P4|Cohort III: Dose Level 3|Progressive disease|0
4741734|NCT01831089|16356573|P3|Cohort III: Dose Level 3|Progressive disease|3
4741735|NCT01831089|16356574|P2|Cohort III: Dose Level 3|Progressive disease|0
4741736|NCT01831089|16356575|P1|Cohort III: Dose Level 3|Progressive disease|0
4741737|NCT01831089|16356570|P6|Cohort II: Dose Level 2|Clinical progressive disease|0
4741738|NCT01831089|16356571|P5|Cohort II: Dose Level 2|Clinical progressive disease|0
4741739|NCT01831089|16356572|P4|Cohort II: Dose Level 2|Clinical progressive disease|0
4741740|NCT01831089|16356573|P3|Cohort II: Dose Level 2|Clinical progressive disease|0
4741741|NCT01831089|16356574|P2|Cohort II: Dose Level 2|Clinical progressive disease|1
4741742|NCT01831089|16356575|P1|Cohort II: Dose Level 2|Clinical progressive disease|0
4741743|NCT01831089|16356570|P6|Cohort II: Dose Level 2|Progressive disease|0
4741744|NCT01831089|16356571|P5|Cohort II: Dose Level 2|Progressive disease|0
4741745|NCT01831089|16356572|P4|Cohort II: Dose Level 2|Progressive disease|0
4741746|NCT01831089|16356573|P3|Cohort II: Dose Level 2|Progressive disease|0
4741747|NCT01831089|16356574|P2|Cohort II: Dose Level 2|Progressive disease|2
4741748|NCT01831089|16356575|P1|Cohort II: Dose Level 2|Progressive disease|0
4741749|NCT01831089|16356570|P6|Cohort I: Dose Level 1|Progressive disease|0
4741750|NCT01831089|16356571|P5|Cohort I: Dose Level 1|Progressive disease|0
4741751|NCT01831089|16356572|P4|Cohort I: Dose Level 1|Progressive disease|0
4741752|NCT01831089|16356573|P3|Cohort I: Dose Level 1|Progressive disease|0
4741753|NCT01831089|16356574|P2|Cohort I: Dose Level 1|Progressive disease|0
4741754|NCT01831089|16356575|P1|Cohort I: Dose Level 1|Progressive disease|3
4741755|NCT01830972|16356626|P2|Part IV|Non-Compliance|0
4741756|NCT01830972|16356627|P1|Part IV|Non-Compliance|1
4741757|NCT01830972|16356626|P2|Part IV|Withdrawal by Subject|1
4741758|NCT01830972|16356627|P1|Part IV|Withdrawal by Subject|2
4741759|NCT01830972|16356626|P2|Part III|Noncompliance|0
4741760|NCT01830972|16356627|P1|Part III|Noncompliance|1
4741761|NCT01830972|16356626|P2|Part III|Withdrawal by Subject|0
4741762|NCT01830972|16356627|P1|Part III|Withdrawal by Subject|1
4741763|NCT01830972|16356626|P2|Part II|Withdrawal by Subject|2
4741764|NCT01830972|16356627|P1|Part II|Withdrawal by Subject|2
4741765|NCT01830920|16356671|P5|Overall Study|Other|3
4741766|NCT01830920|16356672|P4|Overall Study|Other|5
4741767|NCT01830920|16356673|P3|Overall Study|Other|1
4741768|NCT01830920|16356674|P2|Overall Study|Other|1
4741769|NCT01830920|16356675|P1|Overall Study|Other|15
4741770|NCT01830920|16356671|P5|Overall Study|Death|4
4741771|NCT01830920|16356672|P4|Overall Study|Death|4
4741772|NCT01830920|16356673|P3|Overall Study|Death|5
4741773|NCT01830920|16356674|P2|Overall Study|Death|3
4741774|NCT01830920|16356675|P1|Overall Study|Death|3
4741775|NCT01830920|16356671|P5|Overall Study|Withdrawal by Subject|1
4741776|NCT01830920|16356672|P4|Overall Study|Withdrawal by Subject|7
4741777|NCT01830920|16356673|P3|Overall Study|Withdrawal by Subject|1
4741778|NCT01830920|16356674|P2|Overall Study|Withdrawal by Subject|2
4741779|NCT01830920|16356675|P1|Overall Study|Withdrawal by Subject|2
4741780|NCT01830920|16356671|P5|Overall Study|Adverse Event|0
4741781|NCT01830920|16356672|P4|Overall Study|Adverse Event|0
4741782|NCT01830920|16356673|P3|Overall Study|Adverse Event|1
4741783|NCT01830920|16356674|P2|Overall Study|Adverse Event|0
4741784|NCT01830920|16356675|P1|Overall Study|Adverse Event|1
4741785|NCT01830881|16356714|P2|Overall Study|Changed decision to have an abortion|1
4741786|NCT01830881|16356715|P1|Overall Study|Changed decision to have an abortion|0
4741787|NCT01830855|16356763|P4|Overall Study|Lost to Follow-up|33
4741788|NCT01830855|16356764|P3|Overall Study|Lost to Follow-up|23
4741789|NCT01830855|16356765|P2|Overall Study|Lost to Follow-up|20
4741790|NCT01830855|16356766|P1|Overall Study|Lost to Follow-up|47
4741791|NCT01830855|16356763|P4|Overall Study|No longer willing to participate|17
4741792|NCT01830855|16356764|P3|Overall Study|No longer willing to participate|12
4741793|NCT01830855|16356765|P2|Overall Study|No longer willing to participate|13
4741794|NCT01830855|16356766|P1|Overall Study|No longer willing to participate|32
4741795|NCT01830855|16356763|P4|Overall Study|Withdrawal by Subject|12
4741796|NCT01830855|16356764|P3|Overall Study|Withdrawal by Subject|10
4741797|NCT01830855|16356765|P2|Overall Study|Withdrawal by Subject|14
4741798|NCT01830855|16356766|P1|Overall Study|Withdrawal by Subject|33
4741799|NCT01830855|16356763|P4|Overall Study|Protocol deviation|6
4741800|NCT01830855|16356764|P3|Overall Study|Protocol deviation|6
4741801|NCT01830855|16356765|P2|Overall Study|Protocol deviation|5
4741802|NCT01830855|16356766|P1|Overall Study|Protocol deviation|10
4741803|NCT01830855|16356763|P4|Overall Study|Adverse Event|3
4741804|NCT01830855|16356764|P3|Overall Study|Adverse Event|6
4741805|NCT01830855|16356765|P2|Overall Study|Adverse Event|5
4741806|NCT01830855|16356766|P1|Overall Study|Adverse Event|11
4741807|NCT01830855|16356763|P4|Overall Study|No longer meets eligibility criteria|5
4741808|NCT01830855|16356764|P3|Overall Study|No longer meets eligibility criteria|3
4741809|NCT01830855|16356765|P2|Overall Study|No longer meets eligibility criteria|2
4741810|NCT01830855|16356766|P1|Overall Study|No longer meets eligibility criteria|11
4741811|NCT01830855|16356763|P4|Overall Study|Pregnancy|1
4741812|NCT01830855|16356764|P3|Overall Study|Pregnancy|2
4741813|NCT01830855|16356765|P2|Overall Study|Pregnancy|1
4741814|NCT01830855|16356766|P1|Overall Study|Pregnancy|3
4741815|NCT01830855|16356763|P4|Overall Study|Medication error without associated AE|1
4741816|NCT01830855|16356764|P3|Overall Study|Medication error without associated AE|0
4741817|NCT01830855|16356765|P2|Overall Study|Medication error without associated AE|0
4741818|NCT01830855|16356766|P1|Overall Study|Medication error without associated AE|1
4741819|NCT01830855|16356763|P4|Overall Study|Other|4
4741820|NCT01830855|16356764|P3|Overall Study|Other|4
4741821|NCT01830855|16356765|P2|Overall Study|Other|1
4741822|NCT01830855|16356766|P1|Overall Study|Other|7
4741823|NCT01830816|16356882|P3|Overall Study|Reason not Specified|0
4741824|NCT01830816|16356883|P2|Overall Study|Reason not Specified|0
4741825|NCT01830816|16356884|P1|Overall Study|Reason not Specified|2
4741826|NCT01830816|16356882|P3|Overall Study|Symptomatic Deterioration|0
4741827|NCT01830816|16356883|P2|Overall Study|Symptomatic Deterioration|0
4741828|NCT01830816|16356884|P1|Overall Study|Symptomatic Deterioration|1
4741829|NCT01830816|16356882|P3|Overall Study|Lost to Follow-up|0
4741830|NCT01830816|16356883|P2|Overall Study|Lost to Follow-up|1
4741831|NCT01830816|16356884|P1|Overall Study|Lost to Follow-up|0
4741832|NCT01830816|16356882|P3|Overall Study|Withdrawal by Subject|0
4741833|NCT01830816|16356883|P2|Overall Study|Withdrawal by Subject|1
4741834|NCT01830816|16356884|P1|Overall Study|Withdrawal by Subject|1
4741835|NCT01830816|16356882|P3|Overall Study|Study Terminated by Sponsor|0
4741836|NCT01830816|16356883|P2|Overall Study|Study Terminated by Sponsor|1
4741837|NCT01830816|16356884|P1|Overall Study|Study Terminated by Sponsor|1
4741838|NCT01830816|16356882|P3|Overall Study|Adverse Event|0
4741839|NCT01830816|16356883|P2|Overall Study|Adverse Event|4
4741840|NCT01830816|16356884|P1|Overall Study|Adverse Event|3
4741841|NCT01830816|16356882|P3|Overall Study|Progressive Disease|7
4741842|NCT01830816|16356883|P2|Overall Study|Progressive Disease|7
4741843|NCT01830816|16356884|P1|Overall Study|Progressive Disease|12
4741844|NCT01830595|16356948|P2|Washout|Withdrawal by Subject|2
4741845|NCT01830595|16356949|P1|Washout|Withdrawal by Subject|2
4741846|NCT01830595|16356948|P2|First Period|Withdrawal by Subject|3
4741847|NCT01830595|16356949|P1|First Period|Withdrawal by Subject|1
4741848|NCT01830543|16356966|P3|Overall Study|Other|37
4741849|NCT01830543|16356967|P2|Overall Study|Other|17
4741850|NCT01830543|16356968|P1|Overall Study|Other|12
4741851|NCT01830543|16356966|P3|Overall Study|Withdrawal by consent|3
4741852|NCT01830543|16356967|P2|Overall Study|Withdrawal by consent|3
4741853|NCT01830543|16356968|P1|Overall Study|Withdrawal by consent|3
4741854|NCT01830543|16356966|P3|Overall Study|Physician Decision|12
4741855|NCT01830543|16356967|P2|Overall Study|Physician Decision|5
4741856|NCT01830543|16356968|P1|Overall Study|Physician Decision|11
4741857|NCT01830543|16356966|P3|Overall Study|Protocol Violation|7
4741858|NCT01830543|16356967|P2|Overall Study|Protocol Violation|7
4741859|NCT01830543|16356968|P1|Overall Study|Protocol Violation|3
4741860|NCT01830543|16356966|P3|Overall Study|Death|22
4741861|NCT01830543|16356967|P2|Overall Study|Death|22
4741862|NCT01830543|16356968|P1|Overall Study|Death|20
4741863|NCT01830543|16356966|P3|Overall Study|Adverse Event|76
4741864|NCT01830543|16356967|P2|Overall Study|Adverse Event|77
4741865|NCT01830543|16356968|P1|Overall Study|Adverse Event|91
4741866|NCT01830543|16356966|P3|Overall Study|Subject Decision|57
4741867|NCT01830543|16356967|P2|Overall Study|Subject Decision|21
4741868|NCT01830543|16356968|P1|Overall Study|Subject Decision|19
4741869|NCT01830127|16357100|P2|Overall Study|Other reason not defined above|2
4741870|NCT01830127|16357101|P1|Overall Study|Other reason not defined above|0
4741871|NCT01830127|16357100|P2|Overall Study|Withdrawal by Subject|1
4741872|NCT01830127|16357101|P1|Overall Study|Withdrawal by Subject|1
4741873|NCT01830127|16357100|P2|Overall Study|Lack of Efficacy|0
4741874|NCT01830127|16357101|P1|Overall Study|Lack of Efficacy|3
4741875|NCT01830127|16357100|P2|Overall Study|Adverse Event|6
4741876|NCT01830127|16357101|P1|Overall Study|Adverse Event|1
4741877|NCT01829711|16357134|P1|Overall Study|Due to lack of response|1
4741878|NCT01829711|16357134|P1|Overall Study|Due to progression of disease|13
4741879|NCT01829711|16357134|P1|Overall Study|Adverse Event|3
4741880|NCT01829711|16357134|P1|Overall Study|Started new therapies|17
4741881|NCT01829711|16357134|P1|Overall Study|Death|4
4741882|NCT01829711|16357134|P1|Overall Study|Withdrawal by Subject|3
4741883|NCT01829711|16357134|P1|Overall Study|Lost to Follow-up|2
4741884|NCT01829477|16357191|P2|Overall Study|Withdrawal by Subject|0
4741885|NCT01829477|16357192|P1|Overall Study|Withdrawal by Subject|1
4741886|NCT01829477|16357191|P2|Overall Study|Study Terminated by Sponsor|15
4741887|NCT01829477|16357192|P1|Overall Study|Study Terminated by Sponsor|15
4741888|NCT01829464|16357205|P3|Overall Study|Lack of Efficacy|0
4741889|NCT01829464|16357206|P2|Overall Study|Lack of Efficacy|1
4741890|NCT01829464|16357207|P1|Overall Study|Lack of Efficacy|0
4741891|NCT01829464|16357205|P3|Overall Study|Study terminated by sponsor|25
4741892|NCT01829464|16357206|P2|Overall Study|Study terminated by sponsor|28
4741893|NCT01829464|16357207|P1|Overall Study|Study terminated by sponsor|25
4741894|NCT01829464|16357205|P3|Overall Study|Withdrawal by Subject|0
4741895|NCT01829464|16357206|P2|Overall Study|Withdrawal by Subject|0
4741896|NCT01829464|16357207|P1|Overall Study|Withdrawal by Subject|2
4741897|NCT01829464|16357205|P3|Overall Study|Lost to Follow-up|1
4741898|NCT01829464|16357206|P2|Overall Study|Lost to Follow-up|0
4741899|NCT01829464|16357207|P1|Overall Study|Lost to Follow-up|0
4741900|NCT01829464|16357205|P3|Overall Study|Adverse Event|0
4741901|NCT01829464|16357206|P2|Overall Study|Adverse Event|0
4741902|NCT01829464|16357207|P1|Overall Study|Adverse Event|1
4741903|NCT01829425|16357223|P2|Overall Study|Lost to Follow-up|1
4741904|NCT01829425|16357224|P1|Overall Study|Lost to Follow-up|2
4741905|NCT01829425|16357223|P2|Overall Study|Withdrawal by Subject|3
4741906|NCT01829425|16357224|P1|Overall Study|Withdrawal by Subject|4
4741907|NCT01829360|16357267|P4|Overall Study|Protocol Violation|0
4741908|NCT01829360|16357268|P3|Overall Study|Protocol Violation|1
4741909|NCT01829360|16357269|P2|Overall Study|Protocol Violation|0
4741910|NCT01829360|16357270|P1|Overall Study|Protocol Violation|0
4741911|NCT01829347|16357290|P2|VTI-210E|Study terminated prematurely|5
4741912|NCT01829347|16357291|P1|VTI-210E|Study terminated prematurely|1
4741913|NCT01829347|16357290|P2|VTI-210E|Death|1
4741914|NCT01829347|16357291|P1|VTI-210E|Death|2
4741915|NCT01829347|16357290|P2|VTI-210|Withdrawal by Subject|0
4741916|NCT01829347|16357291|P1|VTI-210|Withdrawal by Subject|1
4741917|NCT01829347|16357290|P2|VTI-210|Death|3
4741918|NCT01829347|16357291|P1|VTI-210|Death|5
4741919|NCT01829295|16357301|P4|6-12 Months|Withdrawal by Subject|0
4741920|NCT01829295|16357302|P3|6-12 Months|Withdrawal by Subject|0
4741921|NCT01829295|16357303|P2|6-12 Months|Withdrawal by Subject|2
4741922|NCT01829295|16357304|P1|6-12 Months|Withdrawal by Subject|2
4741923|NCT01829295|16357301|P4|6-12 Months|Lost to Follow-up|0
4741924|NCT01829295|16357302|P3|6-12 Months|Lost to Follow-up|0
4741925|NCT01829295|16357303|P2|6-12 Months|Lost to Follow-up|0
4741926|NCT01829295|16357304|P1|6-12 Months|Lost to Follow-up|2
4741927|NCT01829295|16357301|P4|6-12 Months|Adverse Event|2
4741928|NCT01829295|16357302|P3|6-12 Months|Adverse Event|3
4741929|NCT01829295|16357303|P2|6-12 Months|Adverse Event|0
4741930|NCT01829295|16357304|P1|6-12 Months|Adverse Event|0
4741931|NCT01829295|16357301|P4|6-12 Months|Did not want to switch antimetabolites|11
4741932|NCT01829295|16357302|P3|6-12 Months|Did not want to switch antimetabolites|9
4741933|NCT01829295|16357303|P2|6-12 Months|Did not want to switch antimetabolites|0
4741934|NCT01829295|16357304|P1|6-12 Months|Did not want to switch antimetabolites|0
4741935|NCT01829243|16357314|P2|First Intervention|Screen Failure|2
4741936|NCT01829243|16357315|P1|First Intervention|Screen Failure|4
4741937|NCT01829230|16357329|P2|Overall Study|Lost to Follow-up|1
4741938|NCT01829230|16357330|P1|Overall Study|Lost to Follow-up|1
4741939|NCT01829230|16357329|P2|Overall Study|Withdrawal by Subject|1
4741940|NCT01829230|16357330|P1|Overall Study|Withdrawal by Subject|0
4741941|NCT01829230|16357329|P2|Overall Study|Protocol Violation|2
4741942|NCT01829230|16357330|P1|Overall Study|Protocol Violation|0
4741943|NCT01829191|16357344|P2|Overall Study|Subject was fit for ortho - k|1
4741944|NCT01829191|16357345|P1|Overall Study|Subject was fit for ortho - k|0
4741945|NCT01829191|16357344|P2|Overall Study|Lost to Follow-up|1
4741946|NCT01829191|16357345|P1|Overall Study|Lost to Follow-up|0
4741947|NCT01829191|16357344|P2|Overall Study|Withdrawal by Subject|3
4741948|NCT01829191|16357345|P1|Overall Study|Withdrawal by Subject|2
4741949|NCT01829191|16357344|P2|Overall Study|Protocol Violation|1
4741950|NCT01829191|16357345|P1|Overall Study|Protocol Violation|4
4741951|NCT01829191|16357344|P2|Overall Study|Lens handling difficulty|4
4741952|NCT01829191|16357345|P1|Overall Study|Lens handling difficulty|1
4741953|NCT01829191|16357344|P2|Overall Study|Lens discomfort|3
4741954|NCT01829191|16357345|P1|Overall Study|Lens discomfort|0
4741955|NCT01829191|16357344|P2|Overall Study|Relocation|1
4741956|NCT01829191|16357345|P1|Overall Study|Relocation|0
4741957|NCT01829165|16357354|P2|Overall Study|Did not complete intervention|0
4741958|NCT01829165|16357355|P1|Overall Study|Did not complete intervention|2
4741959|NCT01829113|16357363|P2|Overall Study|Physician Decision|1
4741960|NCT01829113|16357364|P1|Overall Study|Physician Decision|1
4741961|NCT01829113|16357363|P2|Overall Study|No Study Treatment Received|2
4741962|NCT01829113|16357364|P1|Overall Study|No Study Treatment Received|3
4741963|NCT01829113|16357363|P2|Overall Study|Sponsor Decision|1
4741964|NCT01829113|16357364|P1|Overall Study|Sponsor Decision|1
4741965|NCT01829113|16357363|P2|Overall Study|Death|6
4741966|NCT01829113|16357364|P1|Overall Study|Death|4
4741967|NCT01829113|16357363|P2|Overall Study|Withdrawal by Subject|10
4741968|NCT01829113|16357364|P1|Overall Study|Withdrawal by Subject|17
4741969|NCT01829113|16357363|P2|Overall Study|Adverse Event|10
4741970|NCT01829113|16357364|P1|Overall Study|Adverse Event|14
4741971|NCT01829113|16357363|P2|Overall Study|Disease Progression|48
4741972|NCT01829113|16357364|P1|Overall Study|Disease Progression|37
4741973|NCT01829048|16357381|P5|Overall Study|Withdrawal by Subject|0
4741974|NCT01829048|16357382|P4|Overall Study|Withdrawal by Subject|2
4741975|NCT01829048|16357383|P3|Overall Study|Withdrawal by Subject|0
4741976|NCT01829048|16357384|P2|Overall Study|Withdrawal by Subject|0
4741977|NCT01829048|16357385|P1|Overall Study|Withdrawal by Subject|0
4741978|NCT01828567|16357498|P2|Overall Study|Excluded - did not meet criteria|1
4741979|NCT01828567|16357499|P1|Overall Study|Excluded - did not meet criteria|4
4741980|NCT01828567|16357498|P2|Overall Study|Lost to Follow-up|9
4741981|NCT01828567|16357499|P1|Overall Study|Lost to Follow-up|27
4741982|NCT01828281|16357554|P2|Overall Study|Withdrawal by Subject|0
4741983|NCT01828281|16357555|P1|Overall Study|Withdrawal by Subject|1
4741984|NCT01828112|16357605|P2|Overall Study|Subject/guardian decision|8
4741985|NCT01828112|16357606|P1|Overall Study|Subject/guardian decision|6
4741986|NCT01828112|16357605|P2|Overall Study|Progressive disease|82
4741987|NCT01828112|16357606|P1|Overall Study|Progressive disease|56
4741988|NCT01828112|16357605|P2|Overall Study|Physician Decision|5
4741989|NCT01828112|16357606|P1|Overall Study|Physician Decision|5
4741990|NCT01828112|16357605|P2|Overall Study|Death|5
4741991|NCT01828112|16357606|P1|Overall Study|Death|9
4741992|NCT01828112|16357605|P2|Overall Study|Adverse Event|8
4741993|NCT01828112|16357606|P1|Overall Study|Adverse Event|6
4741994|NCT01828099|16357614|P2|Overall Study|Subject/guardian decision|23
4741995|NCT01828099|16357615|P1|Overall Study|Subject/guardian decision|7
4741996|NCT01828099|16357614|P2|Overall Study|Protocol Violation|0
4741997|NCT01828099|16357615|P1|Overall Study|Protocol Violation|1
4741998|NCT01828099|16357614|P2|Overall Study|Progressive disease|94
4741999|NCT01828099|16357615|P1|Overall Study|Progressive disease|51
4742000|NCT01828099|16357614|P2|Overall Study|Physician Decision|11
4742001|NCT01828099|16357615|P1|Overall Study|Physician Decision|7
4742002|NCT01828099|16357614|P2|Overall Study|Non-compliance with study treatment|0
4742003|NCT01828099|16357615|P1|Overall Study|Non-compliance with study treatment|2
4742004|NCT01828099|16357614|P2|Overall Study|Lost to Follow-up|0
4742005|NCT01828099|16357615|P1|Overall Study|Lost to Follow-up|2
4742006|NCT01828099|16357614|P2|Overall Study|Death|11
4742007|NCT01828099|16357615|P1|Overall Study|Death|9
4742008|NCT01828099|16357614|P2|Overall Study|Adverse Event|18
4742009|NCT01828099|16357615|P1|Overall Study|Adverse Event|15
4742010|NCT01828073|16357623|P2|Overall Study|Lost to Follow-up|2
4742011|NCT01828073|16357624|P1|Overall Study|Lost to Follow-up|1
4742012|NCT01828021|16357644|P1|Overall Study|Ileal obstruction, unrelated|1
4742013|NCT01828021|16357644|P1|Overall Study|Withdrawal by Subject|2
4742014|NCT01828021|16357644|P1|Overall Study|Lack of Efficacy|17
4742015|NCT01828021|16357644|P1|Overall Study|Adverse Event|5
4742016|NCT01827839|16357649|P1|Overall Study|Consent Withdrawal|2
4742017|NCT01827839|16357649|P1|Overall Study|Adverse Event|1
4742018|NCT01827670|16357694|P2|Overall Study|Lost to Follow-up|1
4742019|NCT01827670|16357695|P1|Overall Study|Lost to Follow-up|0
4742020|NCT01827670|16357694|P2|Overall Study|Withdrawal of Consent|2
4742021|NCT01827670|16357695|P1|Overall Study|Withdrawal of Consent|3
4742022|NCT01827592|16357714|P3|Overall Study|Others|3
4742023|NCT01827592|16357715|P2|Overall Study|Others|1
4742024|NCT01827592|16357716|P1|Overall Study|Others|0
4742025|NCT01827592|16357714|P3|Overall Study|Trial terminated by Sponsor|51
4742026|NCT01827592|16357715|P2|Overall Study|Trial terminated by Sponsor|53
4742027|NCT01827592|16357716|P1|Overall Study|Trial terminated by Sponsor|47
4742028|NCT01827592|16357714|P3|Overall Study|Patient's substantial non-compliance|6
4742029|NCT01827592|16357715|P2|Overall Study|Patient's substantial non-compliance|1
4742030|NCT01827592|16357716|P1|Overall Study|Patient's substantial non-compliance|1
4742031|NCT01827592|16357714|P3|Overall Study|Withdrawal by Subject|11
4742032|NCT01827592|16357715|P2|Overall Study|Withdrawal by Subject|11
4742033|NCT01827592|16357716|P1|Overall Study|Withdrawal by Subject|12
4742034|NCT01827592|16357714|P3|Overall Study|Lost to Follow-up|2
4742035|NCT01827592|16357715|P2|Overall Study|Lost to Follow-up|2
4742036|NCT01827592|16357716|P1|Overall Study|Lost to Follow-up|1
4742037|NCT01827592|16357714|P3|Overall Study|Protocol Violation|0
4742038|NCT01827592|16357715|P2|Overall Study|Protocol Violation|1
4742039|NCT01827592|16357716|P1|Overall Study|Protocol Violation|2
4742040|NCT01827592|16357714|P3|Overall Study|Physician Decision|1
4742041|NCT01827592|16357715|P2|Overall Study|Physician Decision|2
4742042|NCT01827592|16357716|P1|Overall Study|Physician Decision|0
4742043|NCT01827592|16357714|P3|Overall Study|Adverse Event|2
4742044|NCT01827592|16357715|P2|Overall Study|Adverse Event|9
4742045|NCT01827592|16357716|P1|Overall Study|Adverse Event|11
4742046|NCT01827371|16357781|P4|Overall Study|Temporary study halt to vaccinations|13
4742047|NCT01827371|16357782|P3|Overall Study|Temporary study halt to vaccinations|5
4742048|NCT01827371|16357783|P2|Overall Study|Temporary study halt to vaccinations|2
4742049|NCT01827371|16357784|P1|Overall Study|Temporary study halt to vaccinations|11
4742050|NCT01827371|16357781|P4|Overall Study|Physician Decision|1
4742051|NCT01827371|16357782|P3|Overall Study|Physician Decision|0
4742052|NCT01827371|16357783|P2|Overall Study|Physician Decision|1
4742053|NCT01827371|16357784|P1|Overall Study|Physician Decision|0
4742054|NCT01827371|16357781|P4|Overall Study|Withdrawal by Subject|3
4742055|NCT01827371|16357782|P3|Overall Study|Withdrawal by Subject|2
4742056|NCT01827371|16357783|P2|Overall Study|Withdrawal by Subject|2
4742057|NCT01827371|16357784|P1|Overall Study|Withdrawal by Subject|1
4742058|NCT01827371|16357781|P4|Overall Study|Protocol Violation|0
4742059|NCT01827371|16357782|P3|Overall Study|Protocol Violation|0
4742060|NCT01827371|16357783|P2|Overall Study|Protocol Violation|0
4742061|NCT01827371|16357784|P1|Overall Study|Protocol Violation|1
4742062|NCT01827371|16357781|P4|Overall Study|Lost to Follow-up|4
4742063|NCT01827371|16357782|P3|Overall Study|Lost to Follow-up|0
4742064|NCT01827371|16357783|P2|Overall Study|Lost to Follow-up|2
4742065|NCT01827371|16357784|P1|Overall Study|Lost to Follow-up|0
4742066|NCT01827371|16357781|P4|Overall Study|Adverse Event|2
4742067|NCT01827371|16357782|P3|Overall Study|Adverse Event|4
4742068|NCT01827371|16357783|P2|Overall Study|Adverse Event|0
4742069|NCT01827371|16357784|P1|Overall Study|Adverse Event|0
4742070|NCT01827332|16357843|P2|Overall Study|Lost to Follow-up|1
4742071|NCT01827332|16357844|P1|Overall Study|Lost to Follow-up|2
4742072|NCT01827319|16357852|P1|Overall Study|Lost to Follow-up|3
4742073|NCT01827267|16357875|P2|Overall Study|Still on study|2
4742074|NCT01827267|16357876|P1|Overall Study|Still on study|0
4742075|NCT01827267|16357875|P2|Overall Study|Sponsor Discontinued Study|8
4742076|NCT01827267|16357876|P1|Overall Study|Sponsor Discontinued Study|2
4742077|NCT01827267|16357875|P2|Overall Study|Disease Progression|1
4742078|NCT01827267|16357876|P1|Overall Study|Disease Progression|1
4742079|NCT01827267|16357875|P2|Overall Study|Physician Decision|0
4742080|NCT01827267|16357876|P1|Overall Study|Physician Decision|1
4742081|NCT01827267|16357875|P2|Overall Study|Did not receive study drug|1
4742082|NCT01827267|16357876|P1|Overall Study|Did not receive study drug|1
4742083|NCT01827254|16357891|P1|Overall Study|Intolerance to treatment|4
4742084|NCT01827254|16357891|P1|Overall Study|Disease progression|36
4742085|NCT01827254|16357891|P1|Overall Study|Did not complete re-challenge|1
4742086|NCT01827254|16357891|P1|Overall Study|Discontinued prior initiation: sunitinib|1
4742087|NCT01827254|16357891|P1|Overall Study|Invalidated centre|3
4742088|NCT01827254|16357891|P1|Overall Study|Case report form not completed|4
4742089|NCT01827254|16357891|P1|Overall Study|Death|10
4742090|NCT01827163|16357901|P1|Overall Study|Adverse Event|9
4742091|NCT01827163|16357901|P1|Overall Study|Hypersensitivity reaction to Paclitaxel|2
4742092|NCT01827046|16357908|P2|Overall Study|Withdrawal by Subject|4
4742093|NCT01827046|16357909|P1|Overall Study|Withdrawal by Subject|0
4742094|NCT01827046|16357908|P2|Overall Study|Lost to Follow-up|5
4742095|NCT01827046|16357909|P1|Overall Study|Lost to Follow-up|1
4742096|NCT01826981|16357964|P15|Overall Study|Enrolled/Randomized but Not Treated|0
4742097|NCT01826981|16357965|P14|Overall Study|Enrolled/Randomized but Not Treated|0
4742098|NCT01826981|16357966|P13|Overall Study|Enrolled/Randomized but Not Treated|0
4742099|NCT01826981|16357967|P12|Overall Study|Enrolled/Randomized but Not Treated|0
4742100|NCT01826981|16357968|P11|Overall Study|Enrolled/Randomized but Not Treated|0
4742101|NCT01826981|16357969|P10|Overall Study|Enrolled/Randomized but Not Treated|0
4742102|NCT01826981|16357970|P9|Overall Study|Enrolled/Randomized but Not Treated|0
4742103|NCT01826981|16357971|P8|Overall Study|Enrolled/Randomized but Not Treated|1
4742104|NCT01826981|16357972|P7|Overall Study|Enrolled/Randomized but Not Treated|0
4742105|NCT01826981|16357973|P6|Overall Study|Enrolled/Randomized but Not Treated|0
4742106|NCT01826981|16357974|P5|Overall Study|Enrolled/Randomized but Not Treated|0
4742107|NCT01826981|16357975|P4|Overall Study|Enrolled/Randomized but Not Treated|0
4742108|NCT01826981|16357976|P3|Overall Study|Enrolled/Randomized but Not Treated|0
4742109|NCT01826981|16357977|P2|Overall Study|Enrolled/Randomized but Not Treated|0
4742110|NCT01826981|16357978|P1|Overall Study|Enrolled/Randomized but Not Treated|0
4742111|NCT01826981|16357964|P15|Overall Study|Upper G-I Haemorrhage|0
4742112|NCT01826981|16357965|P14|Overall Study|Upper G-I Haemorrhage|1
4742113|NCT01826981|16357966|P13|Overall Study|Upper G-I Haemorrhage|0
4742114|NCT01826981|16357967|P12|Overall Study|Upper G-I Haemorrhage|0
4742115|NCT01826981|16357968|P11|Overall Study|Upper G-I Haemorrhage|0
4742116|NCT01826981|16357969|P10|Overall Study|Upper G-I Haemorrhage|0
4742117|NCT01826981|16357970|P9|Overall Study|Upper G-I Haemorrhage|0
4742118|NCT01826981|16357971|P8|Overall Study|Upper G-I Haemorrhage|0
4742119|NCT01826981|16357972|P7|Overall Study|Upper G-I Haemorrhage|0
4742120|NCT01826981|16357973|P6|Overall Study|Upper G-I Haemorrhage|0
4742121|NCT01826981|16357974|P5|Overall Study|Upper G-I Haemorrhage|0
4742122|NCT01826981|16357975|P4|Overall Study|Upper G-I Haemorrhage|0
4742123|NCT01826981|16357976|P3|Overall Study|Upper G-I Haemorrhage|0
4742124|NCT01826981|16357977|P2|Overall Study|Upper G-I Haemorrhage|0
4742125|NCT01826981|16357978|P1|Overall Study|Upper G-I Haemorrhage|0
4742126|NCT01826981|16357964|P15|Overall Study|Adverse Event|0
4742127|NCT01826981|16357965|P14|Overall Study|Adverse Event|0
4742128|NCT01826981|16357966|P13|Overall Study|Adverse Event|0
4742129|NCT01826981|16357967|P12|Overall Study|Adverse Event|0
4742130|NCT01826981|16357968|P11|Overall Study|Adverse Event|0
4742131|NCT01826981|16357969|P10|Overall Study|Adverse Event|0
4742132|NCT01826981|16357970|P9|Overall Study|Adverse Event|0
4742133|NCT01826981|16357971|P8|Overall Study|Adverse Event|0
4742134|NCT01826981|16357972|P7|Overall Study|Adverse Event|0
4742135|NCT01826981|16357973|P6|Overall Study|Adverse Event|0
4742136|NCT01826981|16357974|P5|Overall Study|Adverse Event|1
4742137|NCT01826981|16357975|P4|Overall Study|Adverse Event|0
4742138|NCT01826981|16357976|P3|Overall Study|Adverse Event|0
4742139|NCT01826981|16357977|P2|Overall Study|Adverse Event|0
4742140|NCT01826981|16357978|P1|Overall Study|Adverse Event|0
4742141|NCT01826981|16357964|P15|Overall Study|Withdrew Consent|0
4742142|NCT01826981|16357965|P14|Overall Study|Withdrew Consent|1
4742143|NCT01826981|16357966|P13|Overall Study|Withdrew Consent|0
4742144|NCT01826981|16357967|P12|Overall Study|Withdrew Consent|1
4742145|NCT01826981|16357968|P11|Overall Study|Withdrew Consent|0
4742146|NCT01826981|16357969|P10|Overall Study|Withdrew Consent|0
4742147|NCT01826981|16357970|P9|Overall Study|Withdrew Consent|0
4742148|NCT01826981|16357971|P8|Overall Study|Withdrew Consent|1
4742149|NCT01826981|16357972|P7|Overall Study|Withdrew Consent|1
4742150|NCT01826981|16357973|P6|Overall Study|Withdrew Consent|0
4742151|NCT01826981|16357974|P5|Overall Study|Withdrew Consent|0
4742152|NCT01826981|16357975|P4|Overall Study|Withdrew Consent|0
4742153|NCT01826981|16357976|P3|Overall Study|Withdrew Consent|0
4742154|NCT01826981|16357977|P2|Overall Study|Withdrew Consent|0
4742155|NCT01826981|16357978|P1|Overall Study|Withdrew Consent|0
4742156|NCT01826981|16357964|P15|Overall Study|Lost to Follow-up|0
4742157|NCT01826981|16357965|P14|Overall Study|Lost to Follow-up|0
4742158|NCT01826981|16357966|P13|Overall Study|Lost to Follow-up|1
4742159|NCT01826981|16357967|P12|Overall Study|Lost to Follow-up|1
4742160|NCT01826981|16357968|P11|Overall Study|Lost to Follow-up|1
4742161|NCT01826981|16357969|P10|Overall Study|Lost to Follow-up|1
4742162|NCT01826981|16357970|P9|Overall Study|Lost to Follow-up|0
4742163|NCT01826981|16357971|P8|Overall Study|Lost to Follow-up|1
4742164|NCT01826981|16357972|P7|Overall Study|Lost to Follow-up|0
4742165|NCT01826981|16357973|P6|Overall Study|Lost to Follow-up|1
4742166|NCT01826981|16357974|P5|Overall Study|Lost to Follow-up|1
4742167|NCT01826981|16357975|P4|Overall Study|Lost to Follow-up|0
4742168|NCT01826981|16357976|P3|Overall Study|Lost to Follow-up|0
4742169|NCT01826981|16357977|P2|Overall Study|Lost to Follow-up|0
4742170|NCT01826981|16357978|P1|Overall Study|Lost to Follow-up|0
4742171|NCT01826981|16357964|P15|Overall Study|Lack of Efficacy|0
4742172|NCT01826981|16357965|P14|Overall Study|Lack of Efficacy|3
4742173|NCT01826981|16357966|P13|Overall Study|Lack of Efficacy|0
4742174|NCT01826981|16357967|P12|Overall Study|Lack of Efficacy|0
4742175|NCT01826981|16357968|P11|Overall Study|Lack of Efficacy|1
4742176|NCT01826981|16357969|P10|Overall Study|Lack of Efficacy|0
4742177|NCT01826981|16357970|P9|Overall Study|Lack of Efficacy|7
4742178|NCT01826981|16357971|P8|Overall Study|Lack of Efficacy|8
4742179|NCT01826981|16357972|P7|Overall Study|Lack of Efficacy|0
4742180|NCT01826981|16357973|P6|Overall Study|Lack of Efficacy|0
4742181|NCT01826981|16357974|P5|Overall Study|Lack of Efficacy|5
4742182|NCT01826981|16357975|P4|Overall Study|Lack of Efficacy|0
4742183|NCT01826981|16357976|P3|Overall Study|Lack of Efficacy|0
4742184|NCT01826981|16357977|P2|Overall Study|Lack of Efficacy|1
4742185|NCT01826981|16357978|P1|Overall Study|Lack of Efficacy|0
4742186|NCT01826604|16358164|P2|Overall Study|Lost to Follow-up|9
4742187|NCT01826604|16358165|P1|Overall Study|Lost to Follow-up|8
4742188|NCT01826487|16358209|P2|Overall Study|Protocol Violation|1
4742189|NCT01826487|16358210|P1|Overall Study|Protocol Violation|1
4742190|NCT01826487|16358209|P2|Overall Study|Withdrawal by Subject|3
4742191|NCT01826487|16358210|P1|Overall Study|Withdrawal by Subject|1
4742192|NCT01826487|16358209|P2|Overall Study|Lost to Follow-up|0
4742193|NCT01826487|16358210|P1|Overall Study|Lost to Follow-up|1
4742194|NCT01826487|16358209|P2|Overall Study|Adverse Event|1
4742195|NCT01826487|16358210|P1|Overall Study|Adverse Event|1
4742196|NCT01826448|16358237|P2|Overall Study|2 active cancers|1
4742197|NCT01826448|16358238|P1|Overall Study|2 active cancers|0
4742198|NCT01826448|16358237|P2|Overall Study|Physician Decision|1
4742199|NCT01826448|16358238|P1|Overall Study|Physician Decision|0
4742200|NCT01826448|16358237|P2|Overall Study|Withdrawal by Subject|0
4742201|NCT01826448|16358238|P1|Overall Study|Withdrawal by Subject|1
4742202|NCT01826448|16358237|P2|Overall Study|Disease progression|4
4742203|NCT01826448|16358238|P1|Overall Study|Disease progression|2
4742204|NCT01826448|16358237|P2|Overall Study|Adverse Event|3
4742205|NCT01826448|16358238|P1|Overall Study|Adverse Event|1
4742206|NCT01826422|16358246|P2|Overall Study|Withdrawal by Subject|3
4742207|NCT01826422|16358247|P1|Overall Study|Withdrawal by Subject|1
4742208|NCT01826370|16358291|P1|Overall Study|Other reason not defined above|2
4742209|NCT01826370|16358291|P1|Overall Study|Lost to Follow-up|12
4742210|NCT01826370|16358291|P1|Overall Study|Protocol Violation|6
4742211|NCT01826214|16358303|P2|Overall Study|Subject/guardian decision|3
4742212|NCT01826214|16358304|P1|Overall Study|Subject/guardian decision|2
4742213|NCT01826214|16358303|P2|Overall Study|Study terminated by Sponsor|1
4742214|NCT01826214|16358304|P1|Overall Study|Study terminated by Sponsor|0
4742215|NCT01826214|16358303|P2|Overall Study|Progressive disease|21
4742216|NCT01826214|16358304|P1|Overall Study|Progressive disease|22
4742217|NCT01826214|16358303|P2|Overall Study|Physician Decision|2
4742218|NCT01826214|16358304|P1|Overall Study|Physician Decision|0
4742219|NCT01826214|16358303|P2|Overall Study|Lost to Follow-up|0
4742220|NCT01826214|16358304|P1|Overall Study|Lost to Follow-up|1
4742221|NCT01826214|16358303|P2|Overall Study|Death|1
4742222|NCT01826214|16358304|P1|Overall Study|Death|3
4742223|NCT01826214|16358303|P2|Overall Study|Adverse Event|6
4742224|NCT01826214|16358304|P1|Overall Study|Adverse Event|7
4742225|NCT01826201|16358322|P1|Overall Study|Non compliance with protocol|4
4742226|NCT01825941|16358330|P2|Overall Study|Lost to Follow-up|1
4742227|NCT01825941|16358331|P1|Overall Study|Lost to Follow-up|4
4742228|NCT01825876|16358350|P2|Period 2|Withdrawal by Subject|1
4742229|NCT01825876|16358351|P1|Period 2|Withdrawal by Subject|0
4742230|NCT01825837|16358372|P4|PART II|reason unspecified|0
4742231|NCT01825837|16358373|P3|PART II|reason unspecified|2
4742232|NCT01825837|16358374|P2|PART II|reason unspecified|2
4742233|NCT01825837|16358375|P1|PART II|reason unspecified|2
4742234|NCT01825837|16358372|P4|PART II|Treatment failure|0
4742235|NCT01825837|16358373|P3|PART II|Treatment failure|5
4742236|NCT01825837|16358374|P2|PART II|Treatment failure|4
4742237|NCT01825837|16358375|P1|PART II|Treatment failure|6
4742238|NCT01825837|16358372|P4|PART II|Adverse Event|0
4742239|NCT01825837|16358373|P3|PART II|Adverse Event|1
4742240|NCT01825837|16358374|P2|PART II|Adverse Event|3
4742241|NCT01825837|16358375|P1|PART II|Adverse Event|3
4742242|NCT01825837|16358372|P4|PART II|Patient non-compliance|0
4742243|NCT01825837|16358373|P3|PART II|Patient non-compliance|4
4742244|NCT01825837|16358374|P2|PART II|Patient non-compliance|2
4742245|NCT01825837|16358375|P1|PART II|Patient non-compliance|5
4742246|NCT01825837|16358372|P4|PART II|Withdrawal by Subject|0
4742247|NCT01825837|16358373|P3|PART II|Withdrawal by Subject|7
4742248|NCT01825837|16358374|P2|PART II|Withdrawal by Subject|3
4742249|NCT01825837|16358375|P1|PART II|Withdrawal by Subject|3
4742250|NCT01825837|16358372|P4|PART I|reason unspecified|3
4742251|NCT01825837|16358373|P3|PART I|reason unspecified|0
4742252|NCT01825837|16358374|P2|PART I|reason unspecified|0
4742253|NCT01825837|16358375|P1|PART I|reason unspecified|0
4742254|NCT01825837|16358372|P4|PART I|Treatment failure|7
4742255|NCT01825837|16358373|P3|PART I|Treatment failure|0
4742256|NCT01825837|16358374|P2|PART I|Treatment failure|0
4742257|NCT01825837|16358375|P1|PART I|Treatment failure|0
4742258|NCT01825837|16358372|P4|PART I|Patient non-compliance|1
4742259|NCT01825837|16358373|P3|PART I|Patient non-compliance|0
4742260|NCT01825837|16358374|P2|PART I|Patient non-compliance|0
4742261|NCT01825837|16358375|P1|PART I|Patient non-compliance|0
4742262|NCT01825837|16358372|P4|PART I|Withdrawal by Subject|6
4742263|NCT01825837|16358373|P3|PART I|Withdrawal by Subject|0
4742264|NCT01825837|16358374|P2|PART I|Withdrawal by Subject|0
4742265|NCT01825837|16358375|P1|PART I|Withdrawal by Subject|0
4742266|NCT01825798|16358385|P2|Overall Study|Lost to Follow-up|0
4742267|NCT01825798|16358386|P1|Overall Study|Lost to Follow-up|1
4742268|NCT01825798|16358385|P2|Overall Study|Adverse Event|5
4742269|NCT01825798|16358386|P1|Overall Study|Adverse Event|1
4742270|NCT01825785|16358421|P7|Overall Study|Withdrawal by Subject|0
4742271|NCT01825785|16358422|P6|Overall Study|Withdrawal by Subject|1
4742272|NCT01825785|16358423|P5|Overall Study|Withdrawal by Subject|1
4742273|NCT01825785|16358424|P4|Overall Study|Withdrawal by Subject|0
4742274|NCT01825785|16358425|P3|Overall Study|Withdrawal by Subject|0
4742275|NCT01825785|16358426|P2|Overall Study|Withdrawal by Subject|0
4742276|NCT01825785|16358427|P1|Overall Study|Withdrawal by Subject|0
4742277|NCT01825785|16358421|P7|Overall Study|Adverse Event|0
4742278|NCT01825785|16358422|P6|Overall Study|Adverse Event|0
4742279|NCT01825785|16358423|P5|Overall Study|Adverse Event|1
4742280|NCT01825785|16358424|P4|Overall Study|Adverse Event|0
4742281|NCT01825785|16358425|P3|Overall Study|Adverse Event|0
4742282|NCT01825785|16358426|P2|Overall Study|Adverse Event|0
4742283|NCT01825785|16358427|P1|Overall Study|Adverse Event|0
4742284|NCT01825577|16358580|P1|Overall Study|Lack of Efficacy|3
4742285|NCT01825577|16358580|P1|Overall Study|Withdrawn by family members|2
4742286|NCT01825577|16358580|P1|Overall Study|Withdrawal by Subject|1
4742287|NCT01825577|16358580|P1|Overall Study|Physician Decision|2
4742288|NCT01825200|16358604|P2|Overall Study|Withdrawal by Subject|1
4742289|NCT01825200|16358605|P1|Overall Study|Withdrawal by Subject|0
4742290|NCT01825200|16358604|P2|Overall Study|Lost to Follow-up|6
4742291|NCT01825200|16358605|P1|Overall Study|Lost to Follow-up|5
4742292|NCT01824979|16358628|P2|Overall Study|Protocol Violation|13
4742293|NCT01824979|16358629|P1|Overall Study|Protocol Violation|6
4742294|NCT01824979|16358628|P2|Overall Study|Physician Decision|0
4742295|NCT01824979|16358629|P1|Overall Study|Physician Decision|2
4742296|NCT01824979|16358628|P2|Overall Study|Withdrawal by Subject|0
4742297|NCT01824979|16358629|P1|Overall Study|Withdrawal by Subject|5
4742298|NCT01824823|16358646|P2|Overall Study|Off-treatment reason not submitted|0
4742299|NCT01824823|16358647|P1|Overall Study|Off-treatment reason not submitted|1
4742300|NCT01824823|16358646|P2|Overall Study|Lack of Efficacy|1
4742301|NCT01824823|16358647|P1|Overall Study|Lack of Efficacy|1
4742302|NCT01824693|16358656|P3|Overall Study|No Transplant Planned|10
4742303|NCT01824693|16358657|P2|Overall Study|No Transplant Planned|0
4742304|NCT01824693|16358658|P1|Overall Study|No Transplant Planned|0
4742305|NCT01824693|16358656|P3|Overall Study|Ineligible|3
4742306|NCT01824693|16358657|P2|Overall Study|Ineligible|0
4742307|NCT01824693|16358658|P1|Overall Study|Ineligible|0
4742308|NCT01824693|16358656|P3|Overall Study|Progressive Disease|0
4742309|NCT01824693|16358657|P2|Overall Study|Progressive Disease|5
4742310|NCT01824693|16358658|P1|Overall Study|Progressive Disease|0
4742311|NCT01824693|16358656|P3|Overall Study|Withdrawal by Subject|1
4742312|NCT01824693|16358657|P2|Overall Study|Withdrawal by Subject|0
4742313|NCT01824693|16358658|P1|Overall Study|Withdrawal by Subject|0
4742314|NCT01824693|16358656|P3|Overall Study|Physician Decision|1
4742315|NCT01824693|16358657|P2|Overall Study|Physician Decision|1
4742316|NCT01824693|16358658|P1|Overall Study|Physician Decision|1
4742317|NCT01824693|16358656|P3|Overall Study|Death|0
4742318|NCT01824693|16358657|P2|Overall Study|Death|1
4742319|NCT01824693|16358658|P1|Overall Study|Death|0
4742320|NCT01824602|16358675|P4|Overall Study|Treatment failure|1
4742321|NCT01824602|16358676|P3|Overall Study|Treatment failure|0
4742322|NCT01824602|16358677|P2|Overall Study|Treatment failure|0
4742323|NCT01824602|16358678|P1|Overall Study|Treatment failure|0
4742324|NCT01824602|16358675|P4|Overall Study|Adverse Event|2
4742325|NCT01824602|16358676|P3|Overall Study|Adverse Event|2
4742326|NCT01824602|16358677|P2|Overall Study|Adverse Event|0
4742327|NCT01824602|16358678|P1|Overall Study|Adverse Event|1
4742328|NCT01824602|16358675|P4|Overall Study|Patient non-compliance|0
4742329|NCT01824602|16358676|P3|Overall Study|Patient non-compliance|1
4742330|NCT01824602|16358677|P2|Overall Study|Patient non-compliance|0
4742331|NCT01824602|16358678|P1|Overall Study|Patient non-compliance|0
4742332|NCT01824602|16358675|P4|Overall Study|Withdrawal by Subject|2
4742333|NCT01824602|16358676|P3|Overall Study|Withdrawal by Subject|1
4742334|NCT01824602|16358677|P2|Overall Study|Withdrawal by Subject|0
4742335|NCT01824602|16358678|P1|Overall Study|Withdrawal by Subject|0
4742336|NCT01824576|16358717|P1|Overall Study|Device deficiency|2
4742337|NCT01824498|16358735|P6|Washout (8 Weeks)|Withdrawal by Subject|0
4742338|NCT01824498|16358736|P5|Washout (8 Weeks)|Withdrawal by Subject|1
4742339|NCT01824498|16358737|P4|Washout (8 Weeks)|Withdrawal by Subject|1
4742340|NCT01824498|16358738|P3|Washout (8 Weeks)|Withdrawal by Subject|2
4742341|NCT01824498|16358739|P2|Washout (8 Weeks)|Withdrawal by Subject|0
4742342|NCT01824498|16358740|P1|Washout (8 Weeks)|Withdrawal by Subject|2
4742343|NCT01824472|16358751|P3|Overall Study|Ineligible post randomization&screening|0
4742344|NCT01824472|16358752|P2|Overall Study|Ineligible post randomization&screening|2
4742345|NCT01824472|16358753|P1|Overall Study|Ineligible post randomization&screening|0
4742346|NCT01824472|16358751|P3|Overall Study|Withdrawal by Subject|3
4742347|NCT01824472|16358752|P2|Overall Study|Withdrawal by Subject|5
4742348|NCT01824472|16358753|P1|Overall Study|Withdrawal by Subject|1
4742349|NCT01824472|16358751|P3|Overall Study|Lost to Follow-up|1
4742350|NCT01824472|16358752|P2|Overall Study|Lost to Follow-up|0
4742351|NCT01824472|16358753|P1|Overall Study|Lost to Follow-up|0
4742352|NCT01824394|16358787|P3|Overall Study|Excluded Subjects(No catheter inserted)|21
4742353|NCT01824394|16358788|P2|Overall Study|Excluded Subjects(No catheter inserted)|20
4742354|NCT01824394|16358789|P1|Overall Study|Excluded Subjects(No catheter inserted)|23
4742355|NCT01824394|16358787|P3|Overall Study|Discontinued Subjects|2
4742356|NCT01824394|16358788|P2|Overall Study|Discontinued Subjects|1
4742357|NCT01824394|16358789|P1|Overall Study|Discontinued Subjects|1
4742358|NCT01824394|16358787|P3|Overall Study|Death|4
4742359|NCT01824394|16358788|P2|Overall Study|Death|2
4742360|NCT01824394|16358789|P1|Overall Study|Death|3
4742361|NCT01824394|16358787|P3|Overall Study|Lost to Follow-up|3
4742362|NCT01824394|16358788|P2|Overall Study|Lost to Follow-up|9
4742363|NCT01824394|16358789|P1|Overall Study|Lost to Follow-up|0
4742364|NCT01824394|16358787|P3|Overall Study|Withdrawn due to Study Termination|41
4742365|NCT01824394|16358788|P2|Overall Study|Withdrawn due to Study Termination|83
4742366|NCT01824394|16358789|P1|Overall Study|Withdrawn due to Study Termination|91
4742367|NCT01824394|16358787|P3|Overall Study|Early Termination|3
4742368|NCT01824394|16358788|P2|Overall Study|Early Termination|1
4742369|NCT01824394|16358789|P1|Overall Study|Early Termination|1
4742370|NCT01824355|16358799|P1|Overall Study|unevaluable reference method results per|1
4742371|NCT01824355|16358799|P1|Overall Study|Adverse Event|2
4742372|NCT01824342|16358810|P2|Overall Study|Death|0
4742373|NCT01824342|16358811|P1|Overall Study|Death|2
4742374|NCT01824342|16358810|P2|Overall Study|Physician Decision|0
4742375|NCT01824342|16358811|P1|Overall Study|Physician Decision|5
4742376|NCT01824342|16358810|P2|Overall Study|Disease Progression|1
4742377|NCT01824342|16358811|P1|Overall Study|Disease Progression|1
4742378|NCT01824342|16358810|P2|Overall Study|Adverse Event|1
4742379|NCT01824342|16358811|P1|Overall Study|Adverse Event|1
4742380|NCT01824342|16358810|P2|Overall Study|Withdrawal by Subject|3
4742381|NCT01824342|16358811|P1|Overall Study|Withdrawal by Subject|0
4742382|NCT01824303|16358825|P2|Randomized Study|Other Miscellaneous Reasons|0
4742383|NCT01824303|16358826|P1|Randomized Study|Other Miscellaneous Reasons|1
4742384|NCT01824303|16358825|P2|Randomized Study|Withdrawal by Subject|1
4742385|NCT01824303|16358826|P1|Randomized Study|Withdrawal by Subject|1
4742386|NCT01823991|16358856|P2|Overall Study|Withdrawal by Subject|5
4742387|NCT01823991|16358857|P1|Overall Study|Withdrawal by Subject|8
4742388|NCT01823679|16358898|P1|Overall Study|Death|1
4742389|NCT01823536|16358951|P6|Overall Study|Subject moved out of the state|0
4742390|NCT01823536|16358952|P5|Overall Study|Subject moved out of the state|1
4742391|NCT01823536|16358953|P4|Overall Study|Subject moved out of the state|0
4742392|NCT01823536|16358954|P3|Overall Study|Subject moved out of the state|0
4742393|NCT01823536|16358955|P2|Overall Study|Subject moved out of the state|0
4742394|NCT01823536|16358956|P1|Overall Study|Subject moved out of the state|0
4742395|NCT01823536|16358951|P6|Overall Study|Met exclusion criterion No 6|0
4742396|NCT01823536|16358952|P5|Overall Study|Met exclusion criterion No 6|0
4742397|NCT01823536|16358953|P4|Overall Study|Met exclusion criterion No 6|1
4742398|NCT01823536|16358954|P3|Overall Study|Met exclusion criterion No 6|0
4742399|NCT01823536|16358955|P2|Overall Study|Met exclusion criterion No 6|0
4742400|NCT01823536|16358956|P1|Overall Study|Met exclusion criterion No 6|0
4742401|NCT01823536|16358951|P6|Overall Study|Visit 1 delayed, unable to reschedule|0
4742402|NCT01823536|16358952|P5|Overall Study|Visit 1 delayed, unable to reschedule|0
4742403|NCT01823536|16358953|P4|Overall Study|Visit 1 delayed, unable to reschedule|0
4742404|NCT01823536|16358954|P3|Overall Study|Visit 1 delayed, unable to reschedule|1
4742405|NCT01823536|16358955|P2|Overall Study|Visit 1 delayed, unable to reschedule|0
4742406|NCT01823536|16358956|P1|Overall Study|Visit 1 delayed, unable to reschedule|0
4742407|NCT01823536|16358951|P6|Overall Study|Withdrawal by Subject|0
4742408|NCT01823536|16358952|P5|Overall Study|Withdrawal by Subject|0
4742409|NCT01823536|16358953|P4|Overall Study|Withdrawal by Subject|0
4742410|NCT01823536|16358954|P3|Overall Study|Withdrawal by Subject|0
4742411|NCT01823536|16358955|P2|Overall Study|Withdrawal by Subject|1
4742412|NCT01823536|16358956|P1|Overall Study|Withdrawal by Subject|1
4742413|NCT01823536|16358951|P6|Overall Study|Protocol Violation|0
4742414|NCT01823536|16358952|P5|Overall Study|Protocol Violation|0
4742415|NCT01823536|16358953|P4|Overall Study|Protocol Violation|0
4742416|NCT01823536|16358954|P3|Overall Study|Protocol Violation|0
4742417|NCT01823536|16358955|P2|Overall Study|Protocol Violation|1
4742418|NCT01823536|16358956|P1|Overall Study|Protocol Violation|0
4742419|NCT01823536|16358951|P6|Overall Study|Lost to Follow-up|0
4742420|NCT01823536|16358952|P5|Overall Study|Lost to Follow-up|1
4742421|NCT01823536|16358953|P4|Overall Study|Lost to Follow-up|1
4742422|NCT01823536|16358954|P3|Overall Study|Lost to Follow-up|0
4742423|NCT01823536|16358955|P2|Overall Study|Lost to Follow-up|0
4742424|NCT01823536|16358956|P1|Overall Study|Lost to Follow-up|1
4742425|NCT01823341|16359018|P1|Overall Study|Adverse Event|1
4742426|NCT01823341|16359018|P1|Overall Study|Withdrawal by Subject|7
4742427|NCT01823341|16359018|P1|Overall Study|Failed run-in|7
4742428|NCT01823328|16359063|P2|Overall Study|Withdrawal by Subject|6
4742429|NCT01823328|16359064|P1|Overall Study|Withdrawal by Subject|8
4742430|NCT01823289|16359084|P1|Overall Study|Creatinine clearance<30milliliter/minute|1
4742431|NCT01823289|16359084|P1|Overall Study|Drug affected efficacy and safety|1
4742432|NCT01823289|16359084|P1|Overall Study|Transaminase increased more than 3 times|1
4742433|NCT01823289|16359084|P1|Overall Study|Administered contraindicated medicine|1
4742434|NCT01823289|16359084|P1|Overall Study|Physician Decision|9
4742435|NCT01823289|16359084|P1|Overall Study|Lack of Efficacy|1
4742436|NCT01823289|16359084|P1|Overall Study|Adverse Event|5
4742437|NCT01823289|16359084|P1|Overall Study|Lost to Follow-up|5
4742438|NCT01823224|16359092|P2|Overall Study|Withdrawal by Subject|1
4742439|NCT01823224|16359093|P1|Overall Study|Withdrawal by Subject|0
4742440|NCT01823224|16359092|P2|Overall Study|missed med dose|1
4742441|NCT01823224|16359093|P1|Overall Study|missed med dose|0
4742442|NCT01823224|16359092|P2|Overall Study|pharmacy error|1
4742443|NCT01823224|16359093|P1|Overall Study|pharmacy error|0
4742444|NCT01823224|16359092|P2|Overall Study|didn't qualify|2
4742445|NCT01823224|16359093|P1|Overall Study|didn't qualify|1
4742446|NCT01823224|16359092|P2|Overall Study|Lost to Follow-up|6
4742447|NCT01823224|16359093|P1|Overall Study|Lost to Follow-up|5
4742448|NCT01823146|16359103|P2|Overall Study|Lost to Follow-up|1
4742449|NCT01823146|16359104|P1|Overall Study|Lost to Follow-up|2
4742450|NCT01823146|16359103|P2|Overall Study|Withdrawal by Subject|1
4742451|NCT01823146|16359104|P1|Overall Study|Withdrawal by Subject|0
4742452|NCT01823107|16359114|P1|Overall Study|Withdrawal by Subject|1
4742453|NCT01822925|16359124|P4|Overall Study|Taking prohibited medication|1
4742454|NCT01822925|16359125|P3|Overall Study|Taking prohibited medication|0
4742455|NCT01822925|16359126|P2|Overall Study|Taking prohibited medication|0
4742456|NCT01822925|16359127|P1|Overall Study|Taking prohibited medication|2
4742457|NCT01822925|16359124|P4|Overall Study|Withdrawal by Subject|2
4742458|NCT01822925|16359125|P3|Overall Study|Withdrawal by Subject|2
4742459|NCT01822925|16359126|P2|Overall Study|Withdrawal by Subject|0
4742460|NCT01822925|16359127|P1|Overall Study|Withdrawal by Subject|2
4742461|NCT01822925|16359124|P4|Overall Study|Protocol Violation|1
4742462|NCT01822925|16359125|P3|Overall Study|Protocol Violation|0
4742463|NCT01822925|16359126|P2|Overall Study|Protocol Violation|0
4742464|NCT01822925|16359127|P1|Overall Study|Protocol Violation|1
4742465|NCT01822925|16359124|P4|Overall Study|Lost to Follow-up|0
4742466|NCT01822925|16359125|P3|Overall Study|Lost to Follow-up|0
4742467|NCT01822925|16359126|P2|Overall Study|Lost to Follow-up|1
4742468|NCT01822925|16359127|P1|Overall Study|Lost to Follow-up|0
4742469|NCT01822925|16359124|P4|Overall Study|Adverse Event|1
4742470|NCT01822925|16359125|P3|Overall Study|Adverse Event|1
4742471|NCT01822925|16359126|P2|Overall Study|Adverse Event|1
4742472|NCT01822925|16359127|P1|Overall Study|Adverse Event|1
4742473|NCT01822899|16359179|P2|Overall Study|Withdrawal by Subject|7
4742474|NCT01822899|16359180|P1|Overall Study|Withdrawal by Subject|5
4742475|NCT01822899|16359179|P2|Overall Study|Lost to Follow-up|0
4742476|NCT01822899|16359180|P1|Overall Study|Lost to Follow-up|1
4742477|NCT01822899|16359179|P2|Overall Study|Protocol Violation|3
4742478|NCT01822899|16359180|P1|Overall Study|Protocol Violation|6
4742479|NCT01822899|16359179|P2|Overall Study|Lack of Efficacy|3
4742480|NCT01822899|16359180|P1|Overall Study|Lack of Efficacy|6
4742481|NCT01822899|16359179|P2|Overall Study|Adverse Event|5
4742482|NCT01822899|16359180|P1|Overall Study|Adverse Event|6
4742483|NCT01822821|16359198|P2|Overall Study|Other reasons|0
4742484|NCT01822821|16359199|P1|Overall Study|Other reasons|1
4742485|NCT01822821|16359198|P2|Overall Study|Eligible surgery cancelled|1
4742486|NCT01822821|16359199|P1|Overall Study|Eligible surgery cancelled|1
4742487|NCT01822756|16359228|P5|Overall Study|disease progression & patient preference|0
4742488|NCT01822756|16359229|P4|Overall Study|disease progression & patient preference|0
4742489|NCT01822756|16359230|P3|Overall Study|disease progression & patient preference|1
4742490|NCT01822756|16359231|P2|Overall Study|disease progression & patient preference|0
4742491|NCT01822756|16359232|P1|Overall Study|disease progression & patient preference|2
4742492|NCT01822756|16359228|P5|Overall Study|Physician Decision|0
4742493|NCT01822756|16359229|P4|Overall Study|Physician Decision|0
4742494|NCT01822756|16359230|P3|Overall Study|Physician Decision|0
4742495|NCT01822756|16359231|P2|Overall Study|Physician Decision|1
4742496|NCT01822756|16359232|P1|Overall Study|Physician Decision|0
4742497|NCT01822756|16359228|P5|Overall Study|Lost to Follow-up|1
4742498|NCT01822756|16359229|P4|Overall Study|Lost to Follow-up|0
4742499|NCT01822756|16359230|P3|Overall Study|Lost to Follow-up|1
4742500|NCT01822756|16359231|P2|Overall Study|Lost to Follow-up|0
4742501|NCT01822756|16359232|P1|Overall Study|Lost to Follow-up|1
4742502|NCT01822756|16359228|P5|Overall Study|Death|0
4742503|NCT01822756|16359229|P4|Overall Study|Death|0
4742504|NCT01822756|16359230|P3|Overall Study|Death|1
4742505|NCT01822756|16359231|P2|Overall Study|Death|2
4742506|NCT01822756|16359232|P1|Overall Study|Death|2
4742507|NCT01822756|16359228|P5|Overall Study|Disease progression|6
4742508|NCT01822756|16359229|P4|Overall Study|Disease progression|2
4742509|NCT01822756|16359230|P3|Overall Study|Disease progression|7
4742510|NCT01822756|16359231|P2|Overall Study|Disease progression|1
4742511|NCT01822756|16359232|P1|Overall Study|Disease progression|11
4742512|NCT01822756|16359228|P5|Overall Study|Adverse Event|0
4742513|NCT01822756|16359229|P4|Overall Study|Adverse Event|2
4742514|NCT01822756|16359230|P3|Overall Study|Adverse Event|0
4742515|NCT01822756|16359231|P2|Overall Study|Adverse Event|0
4742516|NCT01822756|16359232|P1|Overall Study|Adverse Event|0
4742517|NCT01822691|16359274|P1|Overall Study|Withdrawal by Subject|2
4742518|NCT01822678|16359285|P3|Overall Study|Lost to Follow-up|1
4742519|NCT01822678|16359286|P2|Overall Study|Lost to Follow-up|2
4742520|NCT01822678|16359287|P1|Overall Study|Lost to Follow-up|0
4742521|NCT01822678|16359285|P3|Overall Study|Lack of Efficacy|5
4742522|NCT01822678|16359286|P2|Overall Study|Lack of Efficacy|6
4742523|NCT01822678|16359287|P1|Overall Study|Lack of Efficacy|3
4742524|NCT01822678|16359285|P3|Overall Study|Adverse Event|1
4742525|NCT01822678|16359286|P2|Overall Study|Adverse Event|3
4742526|NCT01822678|16359287|P1|Overall Study|Adverse Event|4
4742527|NCT01822678|16359285|P3|Overall Study|Withdrawal by Subject|4
4742528|NCT01822678|16359286|P2|Overall Study|Withdrawal by Subject|4
4742529|NCT01822678|16359287|P1|Overall Study|Withdrawal by Subject|5
4742530|NCT01822665|16359295|P1|Overall Study|Other Reason|5
4742531|NCT01822665|16359295|P1|Overall Study|Adverse Event|3
4742532|NCT01822587|16359322|P3|Overall Study|Physician Decision|6
4742533|NCT01822587|16359323|P2|Overall Study|Physician Decision|6
4742534|NCT01822587|16359324|P1|Overall Study|Physician Decision|9
4742535|NCT01822587|16359322|P3|Overall Study|Lost to Follow-up|12
4742536|NCT01822587|16359323|P2|Overall Study|Lost to Follow-up|9
4742537|NCT01822587|16359324|P1|Overall Study|Lost to Follow-up|7
4742538|NCT01822561|16359363|P1|Overall Study|Withdrawal by Subject|2
4742539|NCT01822535|16359384|P2|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0
4742540|NCT01822535|16359385|P1|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1
4742541|NCT01822535|16359384|P2|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2
4742542|NCT01822535|16359385|P1|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4
4742543|NCT01822535|16359384|P2|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0
4742544|NCT01822535|16359385|P1|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2
4742545|NCT01822496|16359401|P4|Overall Study|Withdrawal by Subject|3
4742546|NCT01822496|16359402|P3|Overall Study|Withdrawal by Subject|0
4742547|NCT01822496|16359403|P2|Overall Study|Withdrawal by Subject|0
4742548|NCT01822496|16359404|P1|Overall Study|Withdrawal by Subject|0
4742549|NCT01822496|16359401|P4|Overall Study|Protocol Violation|1
4742550|NCT01822496|16359402|P3|Overall Study|Protocol Violation|0
4742551|NCT01822496|16359403|P2|Overall Study|Protocol Violation|2
4742552|NCT01822496|16359404|P1|Overall Study|Protocol Violation|2
4742553|NCT01822366|16359457|P4|Overall Study|Partial Intervention Completion|15
4742554|NCT01822366|16359458|P3|Overall Study|Partial Intervention Completion|0
4742555|NCT01822366|16359459|P2|Overall Study|Partial Intervention Completion|15
4742556|NCT01822366|16359460|P1|Overall Study|Partial Intervention Completion|0
4742557|NCT01822366|16359457|P4|Overall Study|Withdrawal by Subject|6
4742558|NCT01822366|16359458|P3|Overall Study|Withdrawal by Subject|0
4742559|NCT01822366|16359459|P2|Overall Study|Withdrawal by Subject|6
4742560|NCT01822366|16359460|P1|Overall Study|Withdrawal by Subject|0
4742561|NCT01822366|16359457|P4|Overall Study|Lost to Follow-up|1
4742562|NCT01822366|16359458|P3|Overall Study|Lost to Follow-up|5
4742563|NCT01822366|16359459|P2|Overall Study|Lost to Follow-up|1
4742564|NCT01822366|16359460|P1|Overall Study|Lost to Follow-up|5
4742565|NCT01822353|16359491|P3|Overall Study|Withdrawal by Subject|0
4742566|NCT01822353|16359492|P2|Overall Study|Withdrawal by Subject|1
4742567|NCT01822353|16359493|P1|Overall Study|Withdrawal by Subject|3
4742568|NCT01822353|16359491|P3|Overall Study|Pregnancy|0
4742569|NCT01822353|16359492|P2|Overall Study|Pregnancy|1
4742570|NCT01822353|16359493|P1|Overall Study|Pregnancy|0
4742571|NCT01822353|16359491|P3|Overall Study|Adverse Event|1
4742572|NCT01822353|16359492|P2|Overall Study|Adverse Event|3
4742573|NCT01822353|16359493|P1|Overall Study|Adverse Event|1
4742574|NCT01822223|16359513|P2|Overall Study|Death|1
4742575|NCT01822223|16359514|P1|Overall Study|Death|0
4742576|NCT01822132|16359538|P2|Overall Study|Lost to Follow-up|2
4742577|NCT01822132|16359539|P1|Overall Study|Lost to Follow-up|4
4742578|NCT01821963|16359576|P1|Overall Study|Adverse Event|1
4742579|NCT01821937|16359582|P2|Overall Study|Adverse Event|3
4742580|NCT01821937|16359583|P1|Overall Study|Adverse Event|0
4742581|NCT01821807|16359607|P2|Overall Study|Lost to Follow-up|1
4742582|NCT01821807|16359608|P1|Overall Study|Lost to Follow-up|3
4742583|NCT01821729|16359616|P1|Overall Study|Withdrawal by Subject|1
4742584|NCT01821625|16359621|P1|Overall Study|Medical contraindication|1
4742585|NCT01821625|16359621|P1|Overall Study|Adverse Event|1
4742586|NCT01821625|16359621|P1|Overall Study|Lack of Efficacy|2
4742587|NCT01821625|16359621|P1|Overall Study|Withdrawal by Subject|2
4742588|NCT01821560|16359627|P2|Overall Study|Protocol Violation|1
4742589|NCT01821560|16359628|P1|Overall Study|Protocol Violation|0
4742590|NCT01821560|16359627|P2|Overall Study|Withdrawal by Subject|1
4742591|NCT01821560|16359628|P1|Overall Study|Withdrawal by Subject|1
4742592|NCT01821560|16359627|P2|Overall Study|Lost to Follow-up|5
4742593|NCT01821560|16359628|P1|Overall Study|Lost to Follow-up|5
4742594|NCT01821118|16359749|P2|Overall Study|Death|1
4742595|NCT01821118|16359750|P1|Overall Study|Death|0
4742596|NCT01820637|16359797|P1|Overall Study|Withdrawal by Subject|1
4742597|NCT01820637|16359797|P1|Overall Study|Death|2
4742598|NCT01820585|16359806|P4|Overall Study|Pregnancy|0
4742599|NCT01820585|16359807|P3|Overall Study|Pregnancy|0
4742600|NCT01820585|16359808|P2|Overall Study|Pregnancy|1
4742601|NCT01820585|16359809|P1|Overall Study|Pregnancy|0
4742602|NCT01820585|16359806|P4|Overall Study|at sponsor request|0
4742603|NCT01820585|16359807|P3|Overall Study|at sponsor request|1
4742604|NCT01820585|16359808|P2|Overall Study|at sponsor request|0
4742605|NCT01820585|16359809|P1|Overall Study|at sponsor request|0
4742606|NCT01820585|16359806|P4|Overall Study|Subject non-compliance|2
4742607|NCT01820585|16359807|P3|Overall Study|Subject non-compliance|1
4742608|NCT01820585|16359808|P2|Overall Study|Subject non-compliance|0
4742609|NCT01820585|16359809|P1|Overall Study|Subject non-compliance|0
4742610|NCT01820585|16359806|P4|Overall Study|Protocol Violation|1
4742611|NCT01820585|16359807|P3|Overall Study|Protocol Violation|1
4742612|NCT01820585|16359808|P2|Overall Study|Protocol Violation|1
4742613|NCT01820585|16359809|P1|Overall Study|Protocol Violation|3
4742614|NCT01820585|16359806|P4|Overall Study|Lost to Follow-up|3
4742615|NCT01820585|16359807|P3|Overall Study|Lost to Follow-up|0
4742616|NCT01820585|16359808|P2|Overall Study|Lost to Follow-up|3
4742617|NCT01820585|16359809|P1|Overall Study|Lost to Follow-up|3
4742618|NCT01820585|16359806|P4|Overall Study|Withdrawal by Subject|8
4742619|NCT01820585|16359807|P3|Overall Study|Withdrawal by Subject|3
4742620|NCT01820585|16359808|P2|Overall Study|Withdrawal by Subject|7
4742621|NCT01820585|16359809|P1|Overall Study|Withdrawal by Subject|3
4742622|NCT01820585|16359806|P4|Overall Study|Lack of Efficacy|1
4742623|NCT01820585|16359807|P3|Overall Study|Lack of Efficacy|5
4742624|NCT01820585|16359808|P2|Overall Study|Lack of Efficacy|7
4742625|NCT01820585|16359809|P1|Overall Study|Lack of Efficacy|9
4742626|NCT01820585|16359806|P4|Overall Study|Adverse Event|34
4742627|NCT01820585|16359807|P3|Overall Study|Adverse Event|23
4742628|NCT01820585|16359808|P2|Overall Study|Adverse Event|13
4742629|NCT01820585|16359809|P1|Overall Study|Adverse Event|9
4742630|NCT01820559|16359822|P3|Overall Study|Lack of Efficacy|3
4742631|NCT01820559|16359823|P2|Overall Study|Lack of Efficacy|2
4742632|NCT01820559|16359824|P1|Overall Study|Lack of Efficacy|3
4742633|NCT01820559|16359822|P3|Overall Study|At sponsor request|1
4742634|NCT01820559|16359823|P2|Overall Study|At sponsor request|0
4742635|NCT01820559|16359824|P1|Overall Study|At sponsor request|0
4742636|NCT01820559|16359822|P3|Overall Study|Lost to Follow-up|2
4742637|NCT01820559|16359823|P2|Overall Study|Lost to Follow-up|2
4742638|NCT01820559|16359824|P1|Overall Study|Lost to Follow-up|3
4742639|NCT01820559|16359822|P3|Overall Study|Subject's non-compliance|2
4742640|NCT01820559|16359823|P2|Overall Study|Subject's non-compliance|0
4742641|NCT01820559|16359824|P1|Overall Study|Subject's non-compliance|1
4742642|NCT01820559|16359822|P3|Overall Study|Protocol Violation|3
4742643|NCT01820559|16359823|P2|Overall Study|Protocol Violation|1
4742644|NCT01820559|16359824|P1|Overall Study|Protocol Violation|2
4742645|NCT01820559|16359822|P3|Overall Study|Withdrawal by Subject|5
4742646|NCT01820559|16359823|P2|Overall Study|Withdrawal by Subject|2
4742647|NCT01820559|16359824|P1|Overall Study|Withdrawal by Subject|1
4742648|NCT01820559|16359822|P3|Overall Study|Adverse Event|13
4742649|NCT01820559|16359823|P2|Overall Study|Adverse Event|6
4742650|NCT01820559|16359824|P1|Overall Study|Adverse Event|4
4742651|NCT01820364|16359845|P2|Part II: LGX818 + MEK162|Study Termination|1
4742652|NCT01820364|16359846|P1|Part II: LGX818 + MEK162|Study Termination|0
4742653|NCT01820364|16359845|P2|Part I: LGX818|Disease Progression|0
4742654|NCT01820364|16359846|P1|Part I: LGX818|Disease Progression|4
4742655|NCT01820364|16359845|P2|Part I: LGX818|Adverse Event|0
4742656|NCT01820364|16359846|P1|Part I: LGX818|Adverse Event|6
4742657|NCT01820364|16359845|P2|Part I: LGX818|Administrative Problems|0
4742658|NCT01820364|16359846|P1|Part I: LGX818|Administrative Problems|3
4742659|NCT01820364|16359845|P2|Part I: LGX818|Death|0
4742660|NCT01820364|16359846|P1|Part I: LGX818|Death|1
4742661|NCT01819727|16359990|P2|Overall Study|Quit due to lack of health benifits|1
4742662|NCT01819727|16359991|P1|Overall Study|Quit due to lack of health benifits|0
4742663|NCT01819727|16359990|P2|Overall Study|Unable to demostrate ability self-inject|1
4742664|NCT01819727|16359991|P1|Overall Study|Unable to demostrate ability self-inject|0
4742665|NCT01819727|16359990|P2|Overall Study|Withdrawal by Subject|11
4742666|NCT01819727|16359991|P1|Overall Study|Withdrawal by Subject|6
4742667|NCT01819727|16359990|P2|Overall Study|Study Terminated by Sponsor|1
4742668|NCT01819727|16359991|P1|Overall Study|Study Terminated by Sponsor|0
4742669|NCT01819727|16359990|P2|Overall Study|Protocol Violation|2
4742670|NCT01819727|16359991|P1|Overall Study|Protocol Violation|0
4742671|NCT01819727|16359990|P2|Overall Study|Pregnancy|0
4742672|NCT01819727|16359991|P1|Overall Study|Pregnancy|1
4742673|NCT01819727|16359990|P2|Overall Study|Physician Decision|2
4742674|NCT01819727|16359991|P1|Overall Study|Physician Decision|3
4742675|NCT01819727|16359990|P2|Overall Study|Lost to Follow-up|1
4742676|NCT01819727|16359991|P1|Overall Study|Lost to Follow-up|1
4742677|NCT01819727|16359990|P2|Overall Study|Death|0
4742678|NCT01819727|16359991|P1|Overall Study|Death|1
4742679|NCT01819727|16359990|P2|Overall Study|Adverse Event|9
4742680|NCT01819727|16359991|P1|Overall Study|Adverse Event|8
4742681|NCT01819506|16360013|P2|Overall Study|Withdrawal by Subject|3
4742682|NCT01819506|16360014|P1|Overall Study|Withdrawal by Subject|3
4742683|NCT01819506|16360013|P2|Overall Study|Physician Decision|2
4742684|NCT01819506|16360014|P1|Overall Study|Physician Decision|5
4742685|NCT01819272|16360066|P6|Overall Study|Loss of Glucose Control|0
4742686|NCT01819272|16360067|P5|Overall Study|Loss of Glucose Control|2
4742687|NCT01819272|16360068|P4|Overall Study|Loss of Glucose Control|1
4742688|NCT01819272|16360069|P3|Overall Study|Loss of Glucose Control|0
4742689|NCT01819272|16360070|P2|Overall Study|Loss of Glucose Control|1
4742690|NCT01819272|16360071|P1|Overall Study|Loss of Glucose Control|2
4742691|NCT01819272|16360066|P6|Overall Study|Withdrawal of Consent|1
4742692|NCT01819272|16360067|P5|Overall Study|Withdrawal of Consent|0
4742693|NCT01819272|16360068|P4|Overall Study|Withdrawal of Consent|1
4742694|NCT01819272|16360069|P3|Overall Study|Withdrawal of Consent|2
4742695|NCT01819272|16360070|P2|Overall Study|Withdrawal of Consent|1
4742696|NCT01819272|16360071|P1|Overall Study|Withdrawal of Consent|0
4742697|NCT01819272|16360066|P6|Overall Study|Physician Decision|0
4742698|NCT01819272|16360067|P5|Overall Study|Physician Decision|0
4742699|NCT01819272|16360068|P4|Overall Study|Physician Decision|0
4742700|NCT01819272|16360069|P3|Overall Study|Physician Decision|0
4742701|NCT01819272|16360070|P2|Overall Study|Physician Decision|1
4742702|NCT01819272|16360071|P1|Overall Study|Physician Decision|0
4742703|NCT01819272|16360066|P6|Overall Study|Protocol Violation|3
4742704|NCT01819272|16360067|P5|Overall Study|Protocol Violation|2
4742705|NCT01819272|16360068|P4|Overall Study|Protocol Violation|1
4742706|NCT01819272|16360069|P3|Overall Study|Protocol Violation|0
4742707|NCT01819272|16360070|P2|Overall Study|Protocol Violation|0
4742708|NCT01819272|16360071|P1|Overall Study|Protocol Violation|0
4742709|NCT01819272|16360066|P6|Overall Study|Lost to Follow-up|3
4742710|NCT01819272|16360067|P5|Overall Study|Lost to Follow-up|0
4742711|NCT01819272|16360068|P4|Overall Study|Lost to Follow-up|0
4742712|NCT01819272|16360069|P3|Overall Study|Lost to Follow-up|1
4742713|NCT01819272|16360070|P2|Overall Study|Lost to Follow-up|0
4742714|NCT01819272|16360071|P1|Overall Study|Lost to Follow-up|3
4742715|NCT01819272|16360066|P6|Overall Study|Adverse Event|0
4742716|NCT01819272|16360067|P5|Overall Study|Adverse Event|0
4742717|NCT01819272|16360068|P4|Overall Study|Adverse Event|2
4742718|NCT01819272|16360069|P3|Overall Study|Adverse Event|0
4742719|NCT01819272|16360070|P2|Overall Study|Adverse Event|0
4742720|NCT01819272|16360071|P1|Overall Study|Adverse Event|1
4742721|NCT01819194|16360109|P1|Overall Study|Loss of study articles|2
4742722|NCT01819129|16360116|P2|Overall Study|Withdrawal Criteria|15
4742723|NCT01819129|16360117|P1|Overall Study|Withdrawal Criteria|20
4742724|NCT01819129|16360116|P2|Overall Study|Death|1
4742725|NCT01819129|16360117|P1|Overall Study|Death|1
4742726|NCT01819129|16360116|P2|Overall Study|Adverse Event|4
4742727|NCT01819129|16360117|P1|Overall Study|Adverse Event|1
4742728|NCT01819129|16360116|P2|Overall Study|Lack of Efficacy|1
4742729|NCT01819129|16360117|P1|Overall Study|Lack of Efficacy|0
4742730|NCT01819129|16360116|P2|Overall Study|Lost to Follow-up|2
4742731|NCT01819129|16360117|P1|Overall Study|Lost to Follow-up|5
4742732|NCT01819129|16360116|P2|Overall Study|Withdrawal by Subject|15
4742733|NCT01819129|16360117|P1|Overall Study|Withdrawal by Subject|15
4742734|NCT01819129|16360116|P2|Overall Study|Other, Subject moved out of the country|1
4742735|NCT01819129|16360117|P1|Overall Study|Other, Subject moved out of the country|0
4742736|NCT01819129|16360116|P2|Overall Study|Other, weight gain, hypoglycaemic events|0
4742737|NCT01819129|16360117|P1|Overall Study|Other, weight gain, hypoglycaemic events|1
4742738|NCT01819129|16360116|P2|Overall Study|Other, Subject wanted HbA1c to be > 7%|0
4742739|NCT01819129|16360117|P1|Overall Study|Other, Subject wanted HbA1c to be > 7%|1
4742740|NCT01818765|16360142|P1|Overall Study|Death|2
4742741|NCT01818752|16360155|P2|Overall Study|Randomized but not Dosed|4
4742742|NCT01818752|16360156|P1|Overall Study|Randomized but not Dosed|7
4742743|NCT01818752|16360155|P2|Overall Study|Continuing Treatment|4
4742744|NCT01818752|16360156|P1|Overall Study|Continuing Treatment|1
4742745|NCT01818752|16360155|P2|Overall Study|Other|8
4742746|NCT01818752|16360156|P1|Overall Study|Other|7
4742747|NCT01818752|16360155|P2|Overall Study|Disease Progression|48
4742748|NCT01818752|16360156|P1|Overall Study|Disease Progression|54
4742749|NCT01818752|16360155|P2|Overall Study|Physician Decision|8
4742750|NCT01818752|16360156|P1|Overall Study|Physician Decision|9
4742751|NCT01818752|16360155|P2|Overall Study|Withdrawal by Subject|14
4742752|NCT01818752|16360156|P1|Overall Study|Withdrawal by Subject|15
4742753|NCT01818752|16360155|P2|Overall Study|Non-compliance|20
4742754|NCT01818752|16360156|P1|Overall Study|Non-compliance|16
4742755|NCT01818752|16360155|P2|Overall Study|Death|18
4742756|NCT01818752|16360156|P1|Overall Study|Death|14
4742757|NCT01818752|16360155|P2|Overall Study|Adverse Event|74
4742758|NCT01818752|16360156|P1|Overall Study|Adverse Event|64
4742759|NCT01818726|16360176|P2|Overall Study|Decision to perform 2nd course of trtmnt|0
4742760|NCT01818726|16360177|P1|Overall Study|Decision to perform 2nd course of trtmnt|1
4742761|NCT01818726|16360176|P2|Overall Study|Withdrawal by Subject|1
4742762|NCT01818726|16360177|P1|Overall Study|Withdrawal by Subject|0
4742763|NCT01818726|16360176|P2|Overall Study|Administrative reasons|1
4742764|NCT01818726|16360177|P1|Overall Study|Administrative reasons|5
4742765|NCT01818700|16360187|P1|Overall Study|Other|1
4742766|NCT01818700|16360187|P1|Overall Study|Protocol Violation|2
4742767|NCT01818700|16360187|P1|Overall Study|Withdrawal by Subject|27
4742768|NCT01818700|16360187|P1|Overall Study|Lost to Follow-up|5
4742769|NCT01818700|16360187|P1|Overall Study|Lack of Efficacy|2
4742770|NCT01818700|16360187|P1|Overall Study|Adverse Event|67
4742771|NCT01818596|16360198|P2|Overall Study|Lost to Follow-up|0
4742772|NCT01818596|16360199|P1|Overall Study|Lost to Follow-up|7
4742773|NCT01818596|16360198|P2|Overall Study|Withdrew Consent|0
4742774|NCT01818596|16360199|P1|Overall Study|Withdrew Consent|5
4742775|NCT01818596|16360198|P2|Overall Study|Protocol Violation|0
4742776|NCT01818596|16360199|P1|Overall Study|Protocol Violation|1
4742777|NCT01818596|16360198|P2|Overall Study|Investigator's Discretion|0
4742778|NCT01818596|16360199|P1|Overall Study|Investigator's Discretion|4
4742779|NCT01818596|16360198|P2|Overall Study|Death|0
4742780|NCT01818596|16360199|P1|Overall Study|Death|3
4742781|NCT01818596|16360198|P2|Overall Study|Adverse Event|0
4742782|NCT01818596|16360199|P1|Overall Study|Adverse Event|7
4742783|NCT01818596|16360198|P2|Overall Study|Enrolled but Not Treated|0
4742784|NCT01818596|16360199|P1|Overall Study|Enrolled but Not Treated|4
4742785|NCT01818531|16360238|P2|Overall Study|Withdrawn for failure to place block|1
4742786|NCT01818531|16360239|P1|Overall Study|Withdrawn for failure to place block|0
4742787|NCT01818531|16360238|P2|Overall Study|Withdrawn for long-acting opioid patch|1
4742788|NCT01818531|16360239|P1|Overall Study|Withdrawn for long-acting opioid patch|0
4742789|NCT01818531|16360238|P2|Overall Study|Withdrawn for case delay after block|0
4742790|NCT01818531|16360239|P1|Overall Study|Withdrawn for case delay after block|1
4742791|NCT01818336|16360312|P2|Overall Study|Lost to Follow-up|1
4742792|NCT01818336|16360313|P1|Overall Study|Lost to Follow-up|0
4742793|NCT01818336|16360312|P2|Overall Study|Declined retest visit|11
4742794|NCT01818336|16360313|P1|Overall Study|Declined retest visit|0
4742795|NCT01818297|16360321|P2|Open Label Phase (3-12 Months)|Early study closure|10
4742796|NCT01818297|16360322|P1|Open Label Phase (3-12 Months)|Early study closure|17
4742797|NCT01818297|16360321|P2|Open Label Phase (3-12 Months)|Physician Decision|0
4742798|NCT01818297|16360322|P1|Open Label Phase (3-12 Months)|Physician Decision|1
4742799|NCT01818297|16360321|P2|Blinded Phase (Randomization - 3 Months)|Adverse Event|1
4742800|NCT01818297|16360322|P1|Blinded Phase (Randomization - 3 Months)|Adverse Event|0
4742801|NCT01818284|16360340|P2|Overall Study|Death|2
4742802|NCT01818284|16360341|P1|Overall Study|Death|0
4742803|NCT01818284|16360340|P2|Overall Study|Not eligible due to White Blood Counts|4
4742804|NCT01818284|16360341|P1|Overall Study|Not eligible due to White Blood Counts|4
4742805|NCT01818141|16360374|P2|Overall Study|Lost to Follow-up|2
4742806|NCT01818141|16360375|P1|Overall Study|Lost to Follow-up|0
4742807|NCT01818141|16360374|P2|Overall Study|No baseline C.diff colonies|1
4742808|NCT01818141|16360375|P1|Overall Study|No baseline C.diff colonies|1
4742809|NCT01818141|16360374|P2|Overall Study|Withdrawal by Subject|0
4742810|NCT01818141|16360375|P1|Overall Study|Withdrawal by Subject|2
4742811|NCT01817959|16360398|P2|Overall Study|Patient didn't proceed to 1st Islet Inf|1
4742812|NCT01817959|16360399|P1|Overall Study|Patient didn't proceed to 1st Islet Inf|1
4742813|NCT01817959|16360398|P2|Overall Study|Adverse Event|0
4742814|NCT01817959|16360399|P1|Overall Study|Adverse Event|1
4742815|NCT01817959|16360398|P2|Overall Study|forbidden medication|1
4742816|NCT01817959|16360399|P1|Overall Study|forbidden medication|1
4742817|NCT01817959|16360398|P2|Overall Study|Graft loss|1
4742818|NCT01817959|16360399|P1|Overall Study|Graft loss|1
4742819|NCT01817790|16360491|P2|Overall Study|Other: Could not attend appointment|1
4742820|NCT01817790|16360492|P1|Overall Study|Other: Could not attend appointment|1
4742821|NCT01817790|16360491|P2|Overall Study|Withdrawal by Subject|3
4742822|NCT01817790|16360492|P1|Overall Study|Withdrawal by Subject|1
4742823|NCT01817790|16360491|P2|Overall Study|Protocol Violation|1
4742824|NCT01817790|16360492|P1|Overall Study|Protocol Violation|2
4742825|NCT01817790|16360491|P2|Overall Study|Lost to Follow-up|1
4742826|NCT01817790|16360492|P1|Overall Study|Lost to Follow-up|0
4742827|NCT01817790|16360491|P2|Overall Study|Adverse Event|2
4742828|NCT01817790|16360492|P1|Overall Study|Adverse Event|0
4742829|NCT01817777|16360536|P3|Interventional Phase (20 Weeks)|Early Study Termination|3
4742830|NCT01817777|16360537|P2|Interventional Phase (20 Weeks)|Early Study Termination|1
4742831|NCT01817777|16360538|P1|Interventional Phase (20 Weeks)|Early Study Termination|0
4742832|NCT01817777|16360536|P3|Interventional Phase (20 Weeks)|Lost to Follow-up|2
4742833|NCT01817777|16360537|P2|Interventional Phase (20 Weeks)|Lost to Follow-up|1
4742834|NCT01817777|16360538|P1|Interventional Phase (20 Weeks)|Lost to Follow-up|0
4742835|NCT01817777|16360536|P3|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
4742836|NCT01817777|16360537|P2|Interventional Phase (20 Weeks)|Withdrawal by Subject|3
4742837|NCT01817777|16360538|P1|Interventional Phase (20 Weeks)|Withdrawal by Subject|0
4742838|NCT01817777|16360536|P3|Observational Phase (8 Weeks)|Early Study Termination|0
4742839|NCT01817777|16360537|P2|Observational Phase (8 Weeks)|Early Study Termination|0
4742840|NCT01817777|16360538|P1|Observational Phase (8 Weeks)|Early Study Termination|2
4742841|NCT01817777|16360536|P3|Observational Phase (8 Weeks)|Lost to Follow-up|0
4742842|NCT01817777|16360537|P2|Observational Phase (8 Weeks)|Lost to Follow-up|0
4742843|NCT01817777|16360538|P1|Observational Phase (8 Weeks)|Lost to Follow-up|3
4742844|NCT01817764|16360562|P2|Overall Study|Withdrawal by Subject|12
4742845|NCT01817764|16360563|P1|Overall Study|Withdrawal by Subject|10
4742846|NCT01817764|16360562|P2|Overall Study|Lost to Follow-up|4
4742847|NCT01817764|16360563|P1|Overall Study|Lost to Follow-up|1
4742848|NCT01817764|16360562|P2|Overall Study|Protocol Violation|5
4742849|NCT01817764|16360563|P1|Overall Study|Protocol Violation|7
4742850|NCT01817764|16360562|P2|Overall Study|Lack of Efficacy|7
4742851|NCT01817764|16360563|P1|Overall Study|Lack of Efficacy|9
4742852|NCT01817764|16360562|P2|Overall Study|Adverse Event|10
4742853|NCT01817764|16360563|P1|Overall Study|Adverse Event|7
4742854|NCT01817725|16360571|P1|Overall Study|Withdrawal by Subject|1
4742855|NCT01817582|16360592|P3|Overall Study|Randomized but exclusion criteria met|0
4742856|NCT01817582|16360593|P2|Overall Study|Randomized but exclusion criteria met|0
4742857|NCT01817582|16360594|P1|Overall Study|Randomized but exclusion criteria met|1
4742858|NCT01817582|16360592|P3|Overall Study|Participant revealed masked treatment|0
4742859|NCT01817582|16360593|P2|Overall Study|Participant revealed masked treatment|0
4742860|NCT01817582|16360594|P1|Overall Study|Participant revealed masked treatment|1
4742861|NCT01817582|16360592|P3|Overall Study|Withdrawal by Subject|0
4742862|NCT01817582|16360593|P2|Overall Study|Withdrawal by Subject|1
4742863|NCT01817582|16360594|P1|Overall Study|Withdrawal by Subject|0
4742864|NCT01817530|16360664|P8|Overall Study|Lost to Follow-up|4
4742865|NCT01817530|16360665|P7|Overall Study|Lost to Follow-up|8
4742866|NCT01817530|16360666|P6|Overall Study|Lost to Follow-up|2
4742867|NCT01817530|16360667|P5|Overall Study|Lost to Follow-up|3
4742868|NCT01817530|16360668|P4|Overall Study|Lost to Follow-up|1
4742869|NCT01817530|16360669|P3|Overall Study|Lost to Follow-up|2
4742870|NCT01817530|16360670|P2|Overall Study|Lost to Follow-up|4
4742871|NCT01817530|16360671|P1|Overall Study|Lost to Follow-up|1
4742872|NCT01817530|16360664|P8|Overall Study|Consent Withdrawn by Subject|10
4742873|NCT01817530|16360665|P7|Overall Study|Consent Withdrawn by Subject|3
4742874|NCT01817530|16360666|P6|Overall Study|Consent Withdrawn by Subject|3
4742875|NCT01817530|16360667|P5|Overall Study|Consent Withdrawn by Subject|5
4742876|NCT01817530|16360668|P4|Overall Study|Consent Withdrawn by Subject|3
4742877|NCT01817530|16360669|P3|Overall Study|Consent Withdrawn by Subject|7
4742878|NCT01817530|16360670|P2|Overall Study|Consent Withdrawn by Subject|4
4742879|NCT01817530|16360671|P1|Overall Study|Consent Withdrawn by Subject|3
4742880|NCT01817530|16360664|P8|Overall Study|Surgery or Invasive Intervention|0
4742881|NCT01817530|16360665|P7|Overall Study|Surgery or Invasive Intervention|1
4742882|NCT01817530|16360666|P6|Overall Study|Surgery or Invasive Intervention|1
4742883|NCT01817530|16360667|P5|Overall Study|Surgery or Invasive Intervention|1
4742884|NCT01817530|16360668|P4|Overall Study|Surgery or Invasive Intervention|0
4742885|NCT01817530|16360669|P3|Overall Study|Surgery or Invasive Intervention|0
4742886|NCT01817530|16360670|P2|Overall Study|Surgery or Invasive Intervention|0
4742887|NCT01817530|16360671|P1|Overall Study|Surgery or Invasive Intervention|1
4742888|NCT01817530|16360664|P8|Overall Study|Other|0
4742889|NCT01817530|16360665|P7|Overall Study|Other|5
4742890|NCT01817530|16360666|P6|Overall Study|Other|0
4742891|NCT01817530|16360667|P5|Overall Study|Other|1
4742892|NCT01817530|16360668|P4|Overall Study|Other|0
4742893|NCT01817530|16360669|P3|Overall Study|Other|0
4742894|NCT01817530|16360670|P2|Overall Study|Other|1
4742895|NCT01817530|16360671|P1|Overall Study|Other|0
4742896|NCT01817530|16360664|P8|Overall Study|Pregnancy|0
4742897|NCT01817530|16360665|P7|Overall Study|Pregnancy|0
4742898|NCT01817530|16360666|P6|Overall Study|Pregnancy|1
4742899|NCT01817530|16360667|P5|Overall Study|Pregnancy|0
4742900|NCT01817530|16360668|P4|Overall Study|Pregnancy|0
4742901|NCT01817530|16360669|P3|Overall Study|Pregnancy|0
4742902|NCT01817530|16360670|P2|Overall Study|Pregnancy|0
4742903|NCT01817530|16360671|P1|Overall Study|Pregnancy|0
4742904|NCT01817530|16360664|P8|Overall Study|Lack of Efficacy|1
4742905|NCT01817530|16360665|P7|Overall Study|Lack of Efficacy|0
4742906|NCT01817530|16360666|P6|Overall Study|Lack of Efficacy|1
4742907|NCT01817530|16360667|P5|Overall Study|Lack of Efficacy|0
4742908|NCT01817530|16360668|P4|Overall Study|Lack of Efficacy|0
4742909|NCT01817530|16360669|P3|Overall Study|Lack of Efficacy|0
4742910|NCT01817530|16360670|P2|Overall Study|Lack of Efficacy|0
4742911|NCT01817530|16360671|P1|Overall Study|Lack of Efficacy|1
4742912|NCT01817530|16360664|P8|Overall Study|Subject Noncompliant|1
4742913|NCT01817530|16360665|P7|Overall Study|Subject Noncompliant|1
4742914|NCT01817530|16360666|P6|Overall Study|Subject Noncompliant|1
4742915|NCT01817530|16360667|P5|Overall Study|Subject Noncompliant|0
4742916|NCT01817530|16360668|P4|Overall Study|Subject Noncompliant|4
4742917|NCT01817530|16360669|P3|Overall Study|Subject Noncompliant|0
4742918|NCT01817530|16360670|P2|Overall Study|Subject Noncompliant|1
4742919|NCT01817530|16360671|P1|Overall Study|Subject Noncompliant|3
4742920|NCT01817530|16360664|P8|Overall Study|Adverse Event|8
4742921|NCT01817530|16360665|P7|Overall Study|Adverse Event|5
4742922|NCT01817530|16360666|P6|Overall Study|Adverse Event|10
4742923|NCT01817530|16360667|P5|Overall Study|Adverse Event|0
4742924|NCT01817530|16360668|P4|Overall Study|Adverse Event|5
4742925|NCT01817530|16360669|P3|Overall Study|Adverse Event|2
4742926|NCT01817530|16360670|P2|Overall Study|Adverse Event|3
4742927|NCT01817530|16360671|P1|Overall Study|Adverse Event|6
4742928|NCT01817530|16360664|P8|Overall Study|Exclusionary Medication Received|0
4742929|NCT01817530|16360665|P7|Overall Study|Exclusionary Medication Received|0
4742930|NCT01817530|16360666|P6|Overall Study|Exclusionary Medication Received|0
4742931|NCT01817530|16360667|P5|Overall Study|Exclusionary Medication Received|1
4742932|NCT01817530|16360668|P4|Overall Study|Exclusionary Medication Received|0
4742933|NCT01817530|16360669|P3|Overall Study|Exclusionary Medication Received|0
4742934|NCT01817530|16360670|P2|Overall Study|Exclusionary Medication Received|0
4742935|NCT01817530|16360671|P1|Overall Study|Exclusionary Medication Received|0
4742936|NCT01817075|16360896|P2|Overall Study|Ineligible|2
4742937|NCT01817075|16360897|P1|Overall Study|Ineligible|0
4742938|NCT01817075|16360896|P2|Overall Study|Received Sorafenib after enrollment|1
4742939|NCT01817075|16360897|P1|Overall Study|Received Sorafenib after enrollment|0
4742940|NCT01817075|16360896|P2|Overall Study|Withdrawal by Subject|15
4742941|NCT01817075|16360897|P1|Overall Study|Withdrawal by Subject|31
4742942|NCT01817075|16360896|P2|Overall Study|Physician Decision|12
4742943|NCT01817075|16360897|P1|Overall Study|Physician Decision|9
4742944|NCT01817075|16360896|P2|Overall Study|Adverse Event|5
4742945|NCT01817075|16360897|P1|Overall Study|Adverse Event|7
4742946|NCT01816984|16360909|P1|Overall Study|declining health status|1
4742947|NCT01816906|16360922|P2|12 Months|Lost to Follow-up|1
4742948|NCT01816906|16360923|P1|12 Months|Lost to Follow-up|2
4742949|NCT01816906|16360922|P2|12 Months|Death|2
4742950|NCT01816906|16360923|P1|12 Months|Death|0
4742951|NCT01816906|16360922|P2|12 Months|Adverse Event|2
4742952|NCT01816906|16360923|P1|12 Months|Adverse Event|2
4742953|NCT01816906|16360922|P2|Six Months|Lost to Follow-up|16
4742954|NCT01816906|16360923|P1|Six Months|Lost to Follow-up|14
4742955|NCT01816906|16360922|P2|Six Months|Did Not Show Up for Baseline Measurement|6
4742956|NCT01816906|16360923|P1|Six Months|Did Not Show Up for Baseline Measurement|7
4742957|NCT01816893|16360941|P2|Washout Period|Withdrawal by Subject|0
4742958|NCT01816893|16360942|P1|Washout Period|Withdrawal by Subject|2
4742959|NCT01816763|16360978|P3|Overall Study|The main reason for an incomplete survey|11
4742960|NCT01816763|16360979|P2|Overall Study|The main reason for an incomplete survey|15
4742961|NCT01816763|16360980|P1|Overall Study|The main reason for an incomplete survey|4
4742962|NCT01816685|16360996|P2|Overall Study|Surgery Cancelled|2
4742963|NCT01816685|16360997|P1|Overall Study|Surgery Cancelled|3
4742964|NCT01816685|16360996|P2|Overall Study|Lost to Follow-up|9
4742965|NCT01816685|16360997|P1|Overall Study|Lost to Follow-up|7
4742966|NCT01816594|16361007|P2|Overall Study|Physician Decision|0
4742967|NCT01816594|16361008|P1|Overall Study|Physician Decision|1
4742968|NCT01816594|16361007|P2|Overall Study|Withdrawal by Subject|0
4742969|NCT01816594|16361008|P1|Overall Study|Withdrawal by Subject|1
4742970|NCT01816594|16361007|P2|Overall Study|Adverse Event|0
4742971|NCT01816594|16361008|P1|Overall Study|Adverse Event|9
4742972|NCT01816594|16361007|P2|Overall Study|Local Progress|2
4742973|NCT01816594|16361008|P1|Overall Study|Local Progress|0
4742974|NCT01816477|16361046|P2|Overall Study|Unable to tolerate catheter placement|0
4742975|NCT01816477|16361047|P1|Overall Study|Unable to tolerate catheter placement|3
4742976|NCT01816477|16361046|P2|Overall Study|Withdrawal by Subject|1
4742977|NCT01816477|16361047|P1|Overall Study|Withdrawal by Subject|13
4742978|NCT01816295|16361101|P2|OLE Phase|Lack of Efficacy|7
4742979|NCT01816295|16361102|P1|OLE Phase|Lack of Efficacy|3
4742980|NCT01816295|16361101|P2|OLE Phase|Withdrawal by Subject|10
4742981|NCT01816295|16361102|P1|OLE Phase|Withdrawal by Subject|10
4742982|NCT01816295|16361101|P2|OLE Phase|Sponsor Decision|9
4742983|NCT01816295|16361102|P1|OLE Phase|Sponsor Decision|7
4742984|NCT01816295|16361101|P2|OLE Phase|Protocol Violation|4
4742985|NCT01816295|16361102|P1|OLE Phase|Protocol Violation|4
4742986|NCT01816295|16361101|P2|OLE Phase|Physician Decision|1
4742987|NCT01816295|16361102|P1|OLE Phase|Physician Decision|3
4742988|NCT01816295|16361101|P2|OLE Phase|Lost to Follow-up|5
4742989|NCT01816295|16361102|P1|OLE Phase|Lost to Follow-up|5
4742990|NCT01816295|16361101|P2|OLE Phase|Entry Criteria Not Met|5
4742991|NCT01816295|16361102|P1|OLE Phase|Entry Criteria Not Met|3
4742992|NCT01816295|16361101|P2|OLE Phase|Death|0
4742993|NCT01816295|16361102|P1|OLE Phase|Death|1
4742994|NCT01816295|16361101|P2|OLE Phase|Adverse Event|15
4742995|NCT01816295|16361102|P1|OLE Phase|Adverse Event|17
4742996|NCT01816295|16361101|P2|Double Blind Phase|Withdrawal by Subject|20
4742997|NCT01816295|16361102|P1|Double Blind Phase|Withdrawal by Subject|22
4742998|NCT01816295|16361101|P2|Double Blind Phase|Sponsor Decision|8
4742999|NCT01816295|16361102|P1|Double Blind Phase|Sponsor Decision|8
4743000|NCT01816295|16361101|P2|Double Blind Phase|Protocol Violation|11
4743001|NCT01816295|16361102|P1|Double Blind Phase|Protocol Violation|17
4743002|NCT01816295|16361101|P2|Double Blind Phase|Physician Decision|2
4743003|NCT01816295|16361102|P1|Double Blind Phase|Physician Decision|2
4743004|NCT01816295|16361101|P2|Double Blind Phase|Lost to Follow-up|5
4743005|NCT01816295|16361102|P1|Double Blind Phase|Lost to Follow-up|3
4743006|NCT01816295|16361101|P2|Double Blind Phase|Entry Criteria Not Met|2
4743007|NCT01816295|16361102|P1|Double Blind Phase|Entry Criteria Not Met|0
4743008|NCT01816295|16361101|P2|Double Blind Phase|Adverse Event|8
4743009|NCT01816295|16361102|P1|Double Blind Phase|Adverse Event|11
4743010|NCT01816243|16361117|P1|Overall Study|Amputation|3
4743011|NCT01816243|16361117|P1|Overall Study|Not eligible for the study|1
4743012|NCT01816243|16361117|P1|Overall Study|Lack of Efficacy|1
4743013|NCT01816243|16361117|P1|Overall Study|Lost to Follow-up|1
4743014|NCT01816243|16361117|P1|Overall Study|Adverse Event|6
4743015|NCT01816074|16361132|P4|Phase 2|Withdrawal by Subject|0
4743016|NCT01816074|16361133|P3|Phase 2|Withdrawal by Subject|0
4743017|NCT01816074|16361134|P2|Phase 2|Withdrawal by Subject|0
4743018|NCT01816074|16361135|P1|Phase 2|Withdrawal by Subject|1
4743019|NCT01816074|16361132|P4|Phase 2|Physician Decision|1
4743020|NCT01816074|16361133|P3|Phase 2|Physician Decision|0
4743021|NCT01816074|16361134|P2|Phase 2|Physician Decision|0
4743022|NCT01816074|16361135|P1|Phase 2|Physician Decision|0
4743023|NCT01816074|16361132|P4|Phase 2|Unsatisfied with Randomization assignmen|0
4743024|NCT01816074|16361133|P3|Phase 2|Unsatisfied with Randomization assignmen|0
4743025|NCT01816074|16361134|P2|Phase 2|Unsatisfied with Randomization assignmen|0
4743026|NCT01816074|16361135|P1|Phase 2|Unsatisfied with Randomization assignmen|1
4743027|NCT01816074|16361132|P4|Phase 2|Time commitment Issues|0
4743028|NCT01816074|16361133|P3|Phase 2|Time commitment Issues|0
4743029|NCT01816074|16361134|P2|Phase 2|Time commitment Issues|2
4743030|NCT01816074|16361135|P1|Phase 2|Time commitment Issues|0
4743031|NCT01816074|16361132|P4|Phase 1|Time commitment issues|0
4743032|NCT01816074|16361133|P3|Phase 1|Time commitment issues|1
4743033|NCT01816074|16361134|P2|Phase 1|Time commitment issues|0
4743034|NCT01816074|16361135|P1|Phase 1|Time commitment issues|0
4743035|NCT01816061|16361165|P2|Overall Study|Lost to Follow-up|24
4743036|NCT01816061|16361166|P1|Overall Study|Lost to Follow-up|13
4743037|NCT01816048|16361174|P1|Overall Study|Disease Progression|3
4743038|NCT01816048|16361174|P1|Overall Study|Withdrawal by Subject|1
4743039|NCT01816048|16361174|P1|Overall Study|Death|1
4743040|NCT01816048|16361174|P1|Overall Study|Adverse Event|1
4743041|NCT01815918|16361189|P2|Overall Study|Lack of Efficacy|15
4743042|NCT01815918|16361190|P1|Overall Study|Lack of Efficacy|15
4743043|NCT01815918|16361189|P2|Overall Study|Patient samples not analyzable|4
4743044|NCT01815918|16361190|P1|Overall Study|Patient samples not analyzable|3
4743045|NCT01815840|16361206|P2|Overall Study|Sponsor Termination Treatment|0
4743046|NCT01815840|16361207|P1|Overall Study|Sponsor Termination Treatment|1
4743047|NCT01815840|16361206|P2|Overall Study|Refused Treatment|1
4743048|NCT01815840|16361207|P1|Overall Study|Refused Treatment|5
4743049|NCT01815840|16361206|P2|Overall Study|Lost to Follow-up|6
4743050|NCT01815840|16361207|P1|Overall Study|Lost to Follow-up|3
4743051|NCT01815840|16361206|P2|Overall Study|Investigators Decision|3
4743052|NCT01815840|16361207|P1|Overall Study|Investigators Decision|2
4743053|NCT01815840|16361206|P2|Overall Study|Disease progression|2
4743054|NCT01815840|16361207|P1|Overall Study|Disease progression|3
4743055|NCT01815840|16361206|P2|Overall Study|Death|2
4743056|NCT01815840|16361207|P1|Overall Study|Death|2
4743057|NCT01815840|16361206|P2|Overall Study|Adverse Event|16
4743058|NCT01815840|16361207|P1|Overall Study|Adverse Event|10
4743059|NCT01815840|16361206|P2|Overall Study|Administrative/Other|3
4743060|NCT01815840|16361207|P1|Overall Study|Administrative/Other|1
4743061|NCT01815840|16361206|P2|Overall Study|Withdrew Consent|30
4743062|NCT01815840|16361207|P1|Overall Study|Withdrew Consent|31
4743063|NCT01815840|16361206|P2|Overall Study|Missing|0
4743064|NCT01815840|16361207|P1|Overall Study|Missing|1
4743065|NCT01815736|16361237|P2|Overall Study|Still on Study|449
4743066|NCT01815736|16361238|P1|Overall Study|Still on Study|929
4743067|NCT01815736|16361237|P2|Overall Study|Lost to Follow-up|7
4743068|NCT01815736|16361238|P1|Overall Study|Lost to Follow-up|6
4743069|NCT01815736|16361237|P2|Overall Study|Withdrew Consent|15
4743070|NCT01815736|16361238|P1|Overall Study|Withdrew Consent|7
4743071|NCT01815736|16361237|P2|Overall Study|Investigator's Discretion|0
4743072|NCT01815736|16361238|P1|Overall Study|Investigator's Discretion|4
4743073|NCT01815736|16361237|P2|Overall Study|Death|0
4743074|NCT01815736|16361238|P1|Overall Study|Death|4
4743075|NCT01815736|16361237|P2|Overall Study|Adverse Event|4
4743076|NCT01815736|16361238|P1|Overall Study|Adverse Event|7
4743077|NCT01815736|16361237|P2|Overall Study|Randomized but Not Treated|3
4743078|NCT01815736|16361238|P1|Overall Study|Randomized but Not Treated|4
4743079|NCT01815424|16361307|P5|Week 16 to 52|Withdrawal by Subject|0
4743080|NCT01815424|16361308|P4|Week 16 to 52|Withdrawal by Subject|0
4743081|NCT01815424|16361309|P3|Week 16 to 52|Withdrawal by Subject|0
4743082|NCT01815424|16361310|P2|Week 16 to 52|Withdrawal by Subject|2
4743083|NCT01815424|16361311|P1|Week 16 to 52|Withdrawal by Subject|1
4743084|NCT01815424|16361307|P5|Week 16 to 52|Lost to Follow-up|1
4743085|NCT01815424|16361308|P4|Week 16 to 52|Lost to Follow-up|2
4743086|NCT01815424|16361309|P3|Week 16 to 52|Lost to Follow-up|0
4743087|NCT01815424|16361310|P2|Week 16 to 52|Lost to Follow-up|2
4743088|NCT01815424|16361311|P1|Week 16 to 52|Lost to Follow-up|0
4743089|NCT01815424|16361307|P5|Week 16 to 52|Insufficient Clinical Response|1
4743090|NCT01815424|16361308|P4|Week 16 to 52|Insufficient Clinical Response|1
4743091|NCT01815424|16361309|P3|Week 16 to 52|Insufficient Clinical Response|0
4743092|NCT01815424|16361310|P2|Week 16 to 52|Insufficient Clinical Response|0
4743093|NCT01815424|16361311|P1|Week 16 to 52|Insufficient Clinical Response|1
4743094|NCT01815424|16361307|P5|Week 16 to 52|Adverse Event|1
4743095|NCT01815424|16361308|P4|Week 16 to 52|Adverse Event|0
4743096|NCT01815424|16361309|P3|Week 16 to 52|Adverse Event|0
4743097|NCT01815424|16361310|P2|Week 16 to 52|Adverse Event|0
4743098|NCT01815424|16361311|P1|Week 16 to 52|Adverse Event|0
4743099|NCT01815424|16361307|P5|Week 16 to 52|Other|0
4743100|NCT01815424|16361308|P4|Week 16 to 52|Other|0
4743101|NCT01815424|16361309|P3|Week 16 to 52|Other|0
4743102|NCT01815424|16361310|P2|Week 16 to 52|Other|1
4743103|NCT01815424|16361311|P1|Week 16 to 52|Other|0
4743104|NCT01815424|16361307|P5|Week 0 to 16|Insufficient Clinical Response|0
4743105|NCT01815424|16361308|P4|Week 0 to 16|Insufficient Clinical Response|0
4743106|NCT01815424|16361309|P3|Week 0 to 16|Insufficient Clinical Response|4
4743107|NCT01815424|16361310|P2|Week 0 to 16|Insufficient Clinical Response|0
4743108|NCT01815424|16361311|P1|Week 0 to 16|Insufficient Clinical Response|2
4743109|NCT01815424|16361307|P5|Week 0 to 16|Protocol Violation|0
4743110|NCT01815424|16361308|P4|Week 0 to 16|Protocol Violation|0
4743111|NCT01815424|16361309|P3|Week 0 to 16|Protocol Violation|0
4743112|NCT01815424|16361310|P2|Week 0 to 16|Protocol Violation|0
4743113|NCT01815424|16361311|P1|Week 0 to 16|Protocol Violation|1
4743114|NCT01815424|16361307|P5|Week 0 to 16|Other|0
4743115|NCT01815424|16361308|P4|Week 0 to 16|Other|0
4743116|NCT01815424|16361309|P3|Week 0 to 16|Other|3
4743117|NCT01815424|16361310|P2|Week 0 to 16|Other|0
4743118|NCT01815424|16361311|P1|Week 0 to 16|Other|1
4743119|NCT01815424|16361307|P5|Week 0 to 16|Withdrawal by Subject|0
4743120|NCT01815424|16361308|P4|Week 0 to 16|Withdrawal by Subject|0
4743121|NCT01815424|16361309|P3|Week 0 to 16|Withdrawal by Subject|1
4743122|NCT01815424|16361310|P2|Week 0 to 16|Withdrawal by Subject|0
4743123|NCT01815424|16361311|P1|Week 0 to 16|Withdrawal by Subject|0
4743124|NCT01815424|16361307|P5|Week 0 to 16|Lost to Follow-up|0
4743125|NCT01815424|16361308|P4|Week 0 to 16|Lost to Follow-up|0
4743126|NCT01815424|16361309|P3|Week 0 to 16|Lost to Follow-up|0
4743127|NCT01815424|16361310|P2|Week 0 to 16|Lost to Follow-up|1
4743128|NCT01815424|16361311|P1|Week 0 to 16|Lost to Follow-up|0
4743129|NCT01815424|16361307|P5|Week 0 to 16|Does Not Meet Entrance Criteria|0
4743130|NCT01815424|16361308|P4|Week 0 to 16|Does Not Meet Entrance Criteria|0
4743131|NCT01815424|16361309|P3|Week 0 to 16|Does Not Meet Entrance Criteria|0
4743132|NCT01815424|16361310|P2|Week 0 to 16|Does Not Meet Entrance Criteria|0
4743133|NCT01815424|16361311|P1|Week 0 to 16|Does Not Meet Entrance Criteria|2
4743134|NCT01815424|16361307|P5|Week 0 to 16|Adverse Event|0
4743135|NCT01815424|16361308|P4|Week 0 to 16|Adverse Event|0
4743136|NCT01815424|16361309|P3|Week 0 to 16|Adverse Event|3
4743137|NCT01815424|16361310|P2|Week 0 to 16|Adverse Event|3
4743138|NCT01815424|16361311|P1|Week 0 to 16|Adverse Event|1
4743139|NCT01815138|16361527|P2|Overall Study|Physician Decision|5
4743140|NCT01815138|16361528|P1|Overall Study|Physician Decision|8
4743141|NCT01815138|16361527|P2|Overall Study|Withdrawal by Subject|1
4743142|NCT01815138|16361528|P1|Overall Study|Withdrawal by Subject|0
4743143|NCT01815099|16361540|P1|Overall Study|unable to attend study visits|1
4743144|NCT01815099|16361540|P1|Overall Study|Lack of Efficacy|1
4743145|NCT01814878|16361554|P2|Overall Study|Other|0
4743146|NCT01814878|16361555|P1|Overall Study|Other|2
4743147|NCT01814878|16361554|P2|Overall Study|Screening failure (drop-out)|3
4743148|NCT01814878|16361555|P1|Overall Study|Screening failure (drop-out)|0
4743149|NCT01814878|16361554|P2|Overall Study|Physician Decision|1
4743150|NCT01814878|16361555|P1|Overall Study|Physician Decision|3
4743151|NCT01814878|16361554|P2|Overall Study|Protocol Violation|5
4743152|NCT01814878|16361555|P1|Overall Study|Protocol Violation|5
4743153|NCT01814878|16361554|P2|Overall Study|Withdrawal by Subject|16
4743154|NCT01814878|16361555|P1|Overall Study|Withdrawal by Subject|20
4743155|NCT01814878|16361554|P2|Overall Study|Adverse Event|5
4743156|NCT01814878|16361555|P1|Overall Study|Adverse Event|16
4743157|NCT01814826|16361578|P3|Overall Study|Death|3
4743158|NCT01814826|16361579|P2|Overall Study|Death|24
4743159|NCT01814826|16361580|P1|Overall Study|Death|29
4743160|NCT01814826|16361578|P3|Overall Study|Other|0
4743161|NCT01814826|16361579|P2|Overall Study|Other|5
4743162|NCT01814826|16361580|P1|Overall Study|Other|3
4743163|NCT01814800|16361672|P1|Overall Study|Subject relocation|1
4743164|NCT01814800|16361672|P1|Overall Study|Sponsor decision|1
4743165|NCT01814800|16361672|P1|Overall Study|Pregnancy|1
4743166|NCT01814800|16361672|P1|Overall Study|Adverse Event|2
4743167|NCT01814761|16361732|P2|Overall Study|Lost to Follow-up|5
4743168|NCT01814761|16361733|P1|Overall Study|Lost to Follow-up|1
4743169|NCT01814761|16361732|P2|Overall Study|Ocular Adverse Event|15
4743170|NCT01814761|16361733|P1|Overall Study|Ocular Adverse Event|6
4743171|NCT01814761|16361732|P2|Overall Study|Other Reasons|10
4743172|NCT01814761|16361733|P1|Overall Study|Other Reasons|1
4743173|NCT01814748|16361747|P2|Overall Study|Withdrawal by Subject|4
4743174|NCT01814748|16361748|P1|Overall Study|Withdrawal by Subject|6
4743175|NCT01814748|16361747|P2|Overall Study|Study site terminated by sponsor|1
4743176|NCT01814748|16361748|P1|Overall Study|Study site terminated by sponsor|1
4743177|NCT01814748|16361747|P2|Overall Study|Lost to Follow-up|2
4743178|NCT01814748|16361748|P1|Overall Study|Lost to Follow-up|1
4743179|NCT01814696|16361792|P2|Overall Study|Randomized to wrong group|0
4743180|NCT01814696|16361793|P1|Overall Study|Randomized to wrong group|1
4743181|NCT01814696|16361792|P2|Overall Study|Withdrawal by Subject|0
4743182|NCT01814696|16361793|P1|Overall Study|Withdrawal by Subject|1
4743183|NCT01814670|16361811|P1|Overall Study|Protocol Violation|12
4743184|NCT01814553|16361821|P2|Overall Study|Other than stated|8
4743185|NCT01814553|16361822|P1|Overall Study|Other than stated|7
4743186|NCT01814553|16361821|P2|Overall Study|Withdrawal by Subject|1
4743187|NCT01814553|16361822|P1|Overall Study|Withdrawal by Subject|1
4743188|NCT01814553|16361821|P2|Overall Study|Other Adverse Event|5
4743189|NCT01814553|16361822|P1|Overall Study|Other Adverse Event|4
4743190|NCT01814553|16361821|P2|Overall Study|PD per clinical progression|8
4743191|NCT01814553|16361822|P1|Overall Study|PD per clinical progression|6
4743192|NCT01814397|16361836|P1|Overall Study|Withdrawal by Subject|7
4743193|NCT01814397|16361836|P1|Overall Study|Adverse Event|7
4743194|NCT01814371|16361845|P2|Overall Study|Lost to Follow-up|27
4743195|NCT01814371|16361846|P1|Overall Study|Lost to Follow-up|30
4743196|NCT01814332|16361881|P2|Overall Study|Lost to Follow-up|1
4743197|NCT01814332|16361882|P1|Overall Study|Lost to Follow-up|5
4743198|NCT01814332|16361881|P2|Overall Study|Protocol Violation|4
4743199|NCT01814332|16361882|P1|Overall Study|Protocol Violation|0
4743200|NCT01814332|16361881|P2|Overall Study|Withdrawal by Subject|8
4743201|NCT01814332|16361882|P1|Overall Study|Withdrawal by Subject|3
4743202|NCT01814332|16361881|P2|Overall Study|Adverse Event|3
4743203|NCT01814332|16361882|P1|Overall Study|Adverse Event|8
4743204|NCT01814137|16361904|P2|Overall Study|Unclassified|1
4743205|NCT01814137|16361905|P1|Overall Study|Unclassified|2
4743206|NCT01814137|16361904|P2|Overall Study|Physician Decision|1
4743207|NCT01814137|16361905|P1|Overall Study|Physician Decision|1
4743208|NCT01814137|16361904|P2|Overall Study|Withdrawal by Subject|2
4743209|NCT01814137|16361905|P1|Overall Study|Withdrawal by Subject|2
4743210|NCT01814137|16361904|P2|Overall Study|Adverse Event|1
4743211|NCT01814137|16361905|P1|Overall Study|Adverse Event|0
4743212|NCT01814046|16361921|P3|Drug Administration|Death due to complications of RSV|0
4743213|NCT01814046|16361922|P2|Drug Administration|Death due to complications of RSV|0
4743214|NCT01814046|16361923|P1|Drug Administration|Death due to complications of RSV|1
4743215|NCT01813890|16361937|P3|Overall Study|Lack of Efficacy|2
4743216|NCT01813890|16361938|P2|Overall Study|Lack of Efficacy|1
4743217|NCT01813890|16361939|P1|Overall Study|Lack of Efficacy|9
4743218|NCT01813890|16361937|P3|Overall Study|Adverse Event|4
4743219|NCT01813890|16361938|P2|Overall Study|Adverse Event|3
4743220|NCT01813890|16361939|P1|Overall Study|Adverse Event|0
4743221|NCT01813721|16361976|P1|Overall Study|Withdrawal by Subject|1
4743222|NCT01813721|16361976|P1|Overall Study|Ineligibility determined|63
4743223|NCT01813474|16362031|P3|Overall Study|Death|1
4743224|NCT01813474|16362032|P2|Overall Study|Death|0
4743225|NCT01813474|16362033|P1|Overall Study|Death|0
4743226|NCT01813474|16362031|P3|Overall Study|Lack of Efficacy|9
4743227|NCT01813474|16362032|P2|Overall Study|Lack of Efficacy|6
4743228|NCT01813474|16362033|P1|Overall Study|Lack of Efficacy|2
4743229|NCT01813474|16362031|P3|Overall Study|Adverse Event|0
4743230|NCT01813474|16362032|P2|Overall Study|Adverse Event|1
4743231|NCT01813474|16362033|P1|Overall Study|Adverse Event|1
4743232|NCT01813474|16362031|P3|Overall Study|Withdrawal by Subject|1
4743233|NCT01813474|16362032|P2|Overall Study|Withdrawal by Subject|0
4743234|NCT01813474|16362033|P1|Overall Study|Withdrawal by Subject|0
4743235|NCT01813435|16362057|P2|Overall Study|Lost to Follow-up|237
4743236|NCT01813435|16362058|P1|Overall Study|Lost to Follow-up|268
4743237|NCT01813435|16362057|P2|Overall Study|did not finish experimental regimen|770
4743238|NCT01813435|16362058|P1|Overall Study|did not finish experimental regimen|1902
4743239|NCT01813422|16362082|P2|Overall Study|Lost to Follow-up|4
4743240|NCT01813422|16362083|P1|Overall Study|Lost to Follow-up|2
4743241|NCT01813422|16362082|P2|Overall Study|Sponsor Decision|1
4743242|NCT01813422|16362083|P1|Overall Study|Sponsor Decision|2
4743243|NCT01813422|16362082|P2|Overall Study|Death|3
4743244|NCT01813422|16362083|P1|Overall Study|Death|2
4743245|NCT01813422|16362082|P2|Overall Study|Withdrawal by Subject|8
4743246|NCT01813422|16362083|P1|Overall Study|Withdrawal by Subject|14
4743247|NCT01813357|16362097|P2|Overall Study|Lost to Follow-up|6
4743248|NCT01813357|16362098|P1|Overall Study|Lost to Follow-up|5
4743249|NCT01813071|16362139|P9|Overall Study|Met inc/exc criteria|1
4743250|NCT01813071|16362140|P8|Overall Study|Met inc/exc criteria|1
4743251|NCT01813071|16362141|P7|Overall Study|Met inc/exc criteria|0
4743252|NCT01813071|16362142|P6|Overall Study|Met inc/exc criteria|1
4743253|NCT01813071|16362143|P5|Overall Study|Met inc/exc criteria|0
4743254|NCT01813071|16362144|P4|Overall Study|Met inc/exc criteria|0
4743255|NCT01813071|16362145|P3|Overall Study|Met inc/exc criteria|0
4743256|NCT01813071|16362146|P2|Overall Study|Met inc/exc criteria|0
4743257|NCT01813071|16362147|P1|Overall Study|Met inc/exc criteria|0
4743258|NCT01813071|16362139|P9|Overall Study|Physician Decision|0
4743259|NCT01813071|16362140|P8|Overall Study|Physician Decision|0
4743260|NCT01813071|16362141|P7|Overall Study|Physician Decision|1
4743261|NCT01813071|16362142|P6|Overall Study|Physician Decision|0
4743262|NCT01813071|16362143|P5|Overall Study|Physician Decision|0
4743263|NCT01813071|16362144|P4|Overall Study|Physician Decision|0
4743264|NCT01813071|16362145|P3|Overall Study|Physician Decision|0
4743265|NCT01813071|16362146|P2|Overall Study|Physician Decision|0
4743266|NCT01813071|16362147|P1|Overall Study|Physician Decision|0
4743267|NCT01813071|16362139|P9|Overall Study|Adverse Event|0
4743268|NCT01813071|16362140|P8|Overall Study|Adverse Event|0
4743269|NCT01813071|16362141|P7|Overall Study|Adverse Event|0
4743270|NCT01813071|16362142|P6|Overall Study|Adverse Event|1
4743271|NCT01813071|16362143|P5|Overall Study|Adverse Event|0
4743272|NCT01813071|16362144|P4|Overall Study|Adverse Event|0
4743273|NCT01813071|16362145|P3|Overall Study|Adverse Event|0
4743274|NCT01813071|16362146|P2|Overall Study|Adverse Event|0
4743275|NCT01813071|16362147|P1|Overall Study|Adverse Event|0
4743276|NCT01813071|16362139|P9|Overall Study|Withdrawal by Subject|0
4743277|NCT01813071|16362140|P8|Overall Study|Withdrawal by Subject|0
4743278|NCT01813071|16362141|P7|Overall Study|Withdrawal by Subject|0
4743279|NCT01813071|16362142|P6|Overall Study|Withdrawal by Subject|1
4743280|NCT01813071|16362143|P5|Overall Study|Withdrawal by Subject|0
4743281|NCT01813071|16362144|P4|Overall Study|Withdrawal by Subject|0
4743282|NCT01813071|16362145|P3|Overall Study|Withdrawal by Subject|0
4743283|NCT01813071|16362146|P2|Overall Study|Withdrawal by Subject|0
4743284|NCT01813071|16362147|P1|Overall Study|Withdrawal by Subject|0
4743285|NCT01813071|16362139|P9|Overall Study|Protocol Violation|2
4743286|NCT01813071|16362140|P8|Overall Study|Protocol Violation|4
4743287|NCT01813071|16362141|P7|Overall Study|Protocol Violation|2
4743288|NCT01813071|16362142|P6|Overall Study|Protocol Violation|4
4743289|NCT01813071|16362143|P5|Overall Study|Protocol Violation|1
4743290|NCT01813071|16362144|P4|Overall Study|Protocol Violation|0
4743291|NCT01813071|16362145|P3|Overall Study|Protocol Violation|0
4743292|NCT01813071|16362146|P2|Overall Study|Protocol Violation|0
4743293|NCT01813071|16362147|P1|Overall Study|Protocol Violation|0
4743294|NCT01813058|16362614|P2|Overall Study|Withdrawal by Subject|4
4743295|NCT01813058|16362615|P1|Overall Study|Withdrawal by Subject|5
4743296|NCT01813019|16362623|P2|Overall Study|Protocol Deviation|1
4743297|NCT01813019|16362624|P1|Overall Study|Protocol Deviation|2
4743298|NCT01813019|16362623|P2|Overall Study|administrative problems|0
4743299|NCT01813019|16362624|P1|Overall Study|administrative problems|2
4743300|NCT01813019|16362623|P2|Overall Study|Withdrawal by Subject|2
4743301|NCT01813019|16362624|P1|Overall Study|Withdrawal by Subject|3
4743302|NCT01813019|16362623|P2|Overall Study|Adverse Event|3
4743303|NCT01813019|16362624|P1|Overall Study|Adverse Event|0
4743304|NCT01812837|16362635|P3|Overall Study|Protocol Violation|0
4743305|NCT01812837|16362636|P2|Overall Study|Protocol Violation|0
4743306|NCT01812837|16362637|P1|Overall Study|Protocol Violation|1
4743307|NCT01812837|16362635|P3|Overall Study|Lost to Follow-up|0
4743308|NCT01812837|16362636|P2|Overall Study|Lost to Follow-up|1
4743309|NCT01812837|16362637|P1|Overall Study|Lost to Follow-up|1
4743310|NCT01812759|16362648|P3|Overall Study|Physician Decision|1
4743311|NCT01812759|16362649|P2|Overall Study|Physician Decision|0
4743312|NCT01812759|16362650|P1|Overall Study|Physician Decision|0
4743313|NCT01812707|16362662|P4|Overall Study|Consent withdrawn by participant|0
4743314|NCT01812707|16362663|P3|Overall Study|Consent withdrawn by participant|0
4743315|NCT01812707|16362664|P2|Overall Study|Consent withdrawn by participant|0
4743316|NCT01812707|16362665|P1|Overall Study|Consent withdrawn by participant|1
4743317|NCT01812707|16362662|P4|Overall Study|Poor compliance to protocol|0
4743318|NCT01812707|16362663|P3|Overall Study|Poor compliance to protocol|0
4743319|NCT01812707|16362664|P2|Overall Study|Poor compliance to protocol|0
4743320|NCT01812707|16362665|P1|Overall Study|Poor compliance to protocol|1
4743321|NCT01812707|16362662|P4|Overall Study|Adverse Event|2
4743322|NCT01812707|16362663|P3|Overall Study|Adverse Event|0
4743323|NCT01812707|16362664|P2|Overall Study|Adverse Event|0
4743324|NCT01812707|16362665|P1|Overall Study|Adverse Event|0
4743325|NCT01812655|16362713|P3|Overall Study|Protocol Violation|0
4743326|NCT01812655|16362714|P2|Overall Study|Protocol Violation|1
4743327|NCT01812655|16362715|P1|Overall Study|Protocol Violation|1
4743328|NCT01812057|16362740|P2|Overall Study|Physician Decision|0
4743329|NCT01812057|16362741|P1|Overall Study|Physician Decision|1
4743330|NCT01812057|16362740|P2|Overall Study|Protocol Violation|0
4743331|NCT01812057|16362741|P1|Overall Study|Protocol Violation|1
4743332|NCT01811953|16362844|P6|Overall Study|Protocol Violation|0
4743333|NCT01811953|16362845|P5|Overall Study|Protocol Violation|1
4743334|NCT01811953|16362846|P4|Overall Study|Protocol Violation|0
4743335|NCT01811953|16362847|P3|Overall Study|Protocol Violation|0
4743336|NCT01811953|16362848|P2|Overall Study|Protocol Violation|0
4743337|NCT01811953|16362849|P1|Overall Study|Protocol Violation|0
4743338|NCT01811953|16362844|P6|Overall Study|Adverse Event|1
4743339|NCT01811953|16362845|P5|Overall Study|Adverse Event|0
4743340|NCT01811953|16362846|P4|Overall Study|Adverse Event|1
4743341|NCT01811953|16362847|P3|Overall Study|Adverse Event|0
4743342|NCT01811953|16362848|P2|Overall Study|Adverse Event|0
4743343|NCT01811953|16362849|P1|Overall Study|Adverse Event|0
4743344|NCT01811732|16362906|P2|Overall Study|Correct study drug not available on site|0
4743345|NCT01811732|16362907|P1|Overall Study|Correct study drug not available on site|1
4743346|NCT01811732|16362906|P2|Overall Study|Admitted to another facility|0
4743347|NCT01811732|16362907|P1|Overall Study|Admitted to another facility|1
4743348|NCT01811732|16362906|P2|Overall Study|Subject incarcerated|2
4743349|NCT01811732|16362907|P1|Overall Study|Subject incarcerated|1
4743350|NCT01811732|16362906|P2|Overall Study|Protocol Violation|1
4743351|NCT01811732|16362907|P1|Overall Study|Protocol Violation|0
4743352|NCT01811732|16362906|P2|Overall Study|Insufficient venous access|1
4743353|NCT01811732|16362907|P1|Overall Study|Insufficient venous access|0
4743354|NCT01811732|16362906|P2|Overall Study|Death|1
4743355|NCT01811732|16362907|P1|Overall Study|Death|1
4743356|NCT01811732|16362906|P2|Overall Study|Physician Decision|0
4743357|NCT01811732|16362907|P1|Overall Study|Physician Decision|2
4743358|NCT01811732|16362906|P2|Overall Study|Non-compliance with study drug/procedure|3
4743359|NCT01811732|16362907|P1|Overall Study|Non-compliance with study drug/procedure|3
4743360|NCT01811732|16362906|P2|Overall Study|Lack of Efficacy|1
4743361|NCT01811732|16362907|P1|Overall Study|Lack of Efficacy|3
4743362|NCT01811732|16362906|P2|Overall Study|Adverse Event|9
4743363|NCT01811732|16362907|P1|Overall Study|Adverse Event|3
4743364|NCT01811732|16362906|P2|Overall Study|Withdrawal by Subject|10
4743365|NCT01811732|16362907|P1|Overall Study|Withdrawal by Subject|16
4743366|NCT01811732|16362906|P2|Overall Study|Lost to Follow-up|30
4743367|NCT01811732|16362907|P1|Overall Study|Lost to Follow-up|24
4743368|NCT01811706|16362917|P2|First Intervention ( 4 Weeks)|Adverse Event|0
4743369|NCT01811706|16362918|P1|First Intervention ( 4 Weeks)|Adverse Event|1
4743370|NCT01811563|16362946|P2|Overall Study|Incorrect Randomization procedure|1
4743371|NCT01811563|16362947|P1|Overall Study|Incorrect Randomization procedure|0
4743372|NCT01811563|16362946|P2|Overall Study|Lost to Follow-up|2
4743373|NCT01811563|16362947|P1|Overall Study|Lost to Follow-up|5
4743374|NCT01811485|16362976|P3|Overall Study|Protocol Deviation|0
4743375|NCT01811485|16362977|P2|Overall Study|Protocol Deviation|1
4743376|NCT01811485|16362978|P1|Overall Study|Protocol Deviation|0
4743377|NCT01811485|16362976|P3|Overall Study|Administrative problems|0
4743378|NCT01811485|16362977|P2|Overall Study|Administrative problems|0
4743379|NCT01811485|16362978|P1|Overall Study|Administrative problems|1
4743380|NCT01811485|16362976|P3|Overall Study|Unsatisfactory therapeutic effect|3
4743381|NCT01811485|16362977|P2|Overall Study|Unsatisfactory therapeutic effect|0
4743382|NCT01811485|16362978|P1|Overall Study|Unsatisfactory therapeutic effect|0
4743383|NCT01811485|16362976|P3|Overall Study|Adverse Event|2
4743384|NCT01811485|16362977|P2|Overall Study|Adverse Event|3
4743385|NCT01811485|16362978|P1|Overall Study|Adverse Event|1
4743386|NCT01811472|16362998|P3|Overall Study|Subject/guardian decision|0
4743387|NCT01811472|16362999|P2|Overall Study|Subject/guardian decision|0
4743388|NCT01811472|16363000|P1|Overall Study|Subject/guardian decision|1
4743389|NCT01811472|16362998|P3|Overall Study|Lost to Follow-up|1
4743390|NCT01811472|16362999|P2|Overall Study|Lost to Follow-up|0
4743391|NCT01811472|16363000|P1|Overall Study|Lost to Follow-up|0
4743392|NCT01811472|16362998|P3|Overall Study|Adverse Event|4
4743393|NCT01811472|16362999|P2|Overall Study|Adverse Event|0
4743394|NCT01811472|16363000|P1|Overall Study|Adverse Event|1
4743395|NCT01811238|16363087|P1|Overall Study|subject refused study medication|6
4743396|NCT01811238|16363087|P1|Overall Study|Lack of Efficacy|4
4743397|NCT01811238|16363087|P1|Overall Study|Protocol Violation|4
4743398|NCT01811238|16363087|P1|Overall Study|Adverse Event|25
4743399|NCT01811238|16363087|P1|Overall Study|Withdrawal by Subject|42
4743400|NCT01811186|16363111|P2|Overall Study|Lost to Follow-up|2
4743401|NCT01811186|16363112|P1|Overall Study|Lost to Follow-up|4
4743402|NCT01811186|16363111|P2|Overall Study|Lack of Efficacy|6
4743403|NCT01811186|16363112|P1|Overall Study|Lack of Efficacy|3
4743404|NCT01811186|16363111|P2|Overall Study|Withdrawal by Subject|10
4743405|NCT01811186|16363112|P1|Overall Study|Withdrawal by Subject|5
4743406|NCT01811186|16363111|P2|Overall Study|Protocol Violation|6
4743407|NCT01811186|16363112|P1|Overall Study|Protocol Violation|5
4743408|NCT01811186|16363111|P2|Overall Study|Adverse Event|38
4743409|NCT01811186|16363112|P1|Overall Study|Adverse Event|54
4743410|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
4743488|NCT01810380|16363220|P3|Overall Study|Lack of Efficacy|11
4743411|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1
4743412|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0
4743413|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1
4743414|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2
4743415|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0
4743416|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14
4743417|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2
4743418|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0
4743419|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2
4743420|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1
4743421|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0
4743422|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
4743423|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1
4743424|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0
4743425|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1
4743426|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
4743427|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0
4743428|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Death|1
4743429|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Death|0
4743430|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Death|0
4743431|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Adverse Event|1
4743432|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Adverse Event|1
4743433|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Adverse Event|0
4743434|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
4743435|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1
4743436|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0
4743437|NCT01810939|16363166|P3|Part B Placebo-Controlled Withdrawal|Physician Decision|1
4743438|NCT01810939|16363167|P2|Part B Placebo-Controlled Withdrawal|Physician Decision|1
4743439|NCT01810939|16363168|P1|Part B Placebo-Controlled Withdrawal|Physician Decision|0
4743440|NCT01810939|16363166|P3|Part A Treatment Period|Protocol-specified (Low K+)|0
4743441|NCT01810939|16363167|P2|Part A Treatment Period|Protocol-specified (Low K+)|0
4743442|NCT01810939|16363168|P1|Part A Treatment Period|Protocol-specified (Low K+)|1
4743443|NCT01810939|16363166|P3|Part A Treatment Period|Protocol-specified (High K+)|0
4743444|NCT01810939|16363167|P2|Part A Treatment Period|Protocol-specified (High K+)|0
4743445|NCT01810939|16363168|P1|Part A Treatment Period|Protocol-specified (High K+)|3
4743446|NCT01810939|16363166|P3|Part A Treatment Period|Protocol-specified (eGFR)|0
4743447|NCT01810939|16363167|P2|Part A Treatment Period|Protocol-specified (eGFR)|0
4743448|NCT01810939|16363168|P1|Part A Treatment Period|Protocol-specified (eGFR)|2
4743449|NCT01810939|16363166|P3|Part A Treatment Period|Withdrawal by Subject|0
4743450|NCT01810939|16363167|P2|Part A Treatment Period|Withdrawal by Subject|0
4743451|NCT01810939|16363168|P1|Part A Treatment Period|Withdrawal by Subject|5
4743452|NCT01810939|16363166|P3|Part A Treatment Period|Adverse Event|0
4743453|NCT01810939|16363167|P2|Part A Treatment Period|Adverse Event|0
4743454|NCT01810939|16363168|P1|Part A Treatment Period|Adverse Event|10
4743455|NCT01810939|16363166|P3|Part A Treatment Period|Protocol Violation|0
4743456|NCT01810939|16363167|P2|Part A Treatment Period|Protocol Violation|0
4743457|NCT01810939|16363168|P1|Part A Treatment Period|Protocol Violation|2
4743458|NCT01810939|16363166|P3|Part A Treatment Period|Non-compliance with Study Drug|0
4743459|NCT01810939|16363167|P2|Part A Treatment Period|Non-compliance with Study Drug|0
4743460|NCT01810939|16363168|P1|Part A Treatment Period|Non-compliance with Study Drug|1
4743461|NCT01810783|16363181|P1|Overall Study|Enrolled, not treated|1
4743462|NCT01810783|16363181|P1|Overall Study|Adminstrative or other reason(s)|23
4743463|NCT01810783|16363181|P1|Overall Study|Non-compliance with IMP|4
4743464|NCT01810783|16363181|P1|Overall Study|Protocol Violation|5
4743465|NCT01810783|16363181|P1|Overall Study|Lost to Follow-up|10
4743466|NCT01810783|16363181|P1|Overall Study|Lack of Efficacy|12
4743467|NCT01810783|16363181|P1|Overall Study|Withdrawal by Subject|22
4743468|NCT01810783|16363181|P1|Overall Study|Adverse Event|32
4743469|NCT01810432|16363206|P2|Period 2|Lost to Follow-up|1
4743470|NCT01810432|16363207|P1|Period 2|Lost to Follow-up|1
4743471|NCT01810432|16363206|P2|Period 2|Physician Decision|0
4743472|NCT01810432|16363207|P1|Period 2|Physician Decision|1
4743473|NCT01810432|16363206|P2|Period 2|Withdrawal by Subject|1
4743474|NCT01810432|16363207|P1|Period 2|Withdrawal by Subject|2
4743475|NCT01810432|16363206|P2|Washout|Adverse Event|0
4743476|NCT01810432|16363207|P1|Washout|Adverse Event|1
4743477|NCT01810432|16363206|P2|Washout|Protocol Violation|1
4743478|NCT01810432|16363207|P1|Washout|Protocol Violation|0
4743479|NCT01810380|16363220|P3|Overall Study|Administrative or other reasons|9
4743480|NCT01810380|16363221|P2|Overall Study|Administrative or other reasons|13
4743481|NCT01810380|16363222|P1|Overall Study|Administrative or other reasons|11
4743482|NCT01810380|16363220|P3|Overall Study|Withdrawal by Subject|6
4743483|NCT01810380|16363221|P2|Overall Study|Withdrawal by Subject|0
4743484|NCT01810380|16363222|P1|Overall Study|Withdrawal by Subject|6
4743485|NCT01810380|16363220|P3|Overall Study|Protocol Violation|1
4743486|NCT01810380|16363221|P2|Overall Study|Protocol Violation|0
4743487|NCT01810380|16363222|P1|Overall Study|Protocol Violation|1
4743489|NCT01810380|16363221|P2|Overall Study|Lack of Efficacy|10
4743490|NCT01810380|16363222|P1|Overall Study|Lack of Efficacy|24
4743491|NCT01810380|16363220|P3|Overall Study|Adverse Event|4
4743492|NCT01810380|16363221|P2|Overall Study|Adverse Event|14
4743493|NCT01810380|16363222|P1|Overall Study|Adverse Event|11
4743494|NCT01810380|16363220|P3|Overall Study|Randomised not treated|1
4743495|NCT01810380|16363221|P2|Overall Study|Randomised not treated|1
4743496|NCT01810380|16363222|P1|Overall Study|Randomised not treated|2
4743497|NCT01810302|16363283|P2|Overall Study|Physician Decision|1
4743498|NCT01810302|16363284|P1|Overall Study|Physician Decision|0
4743499|NCT01810302|16363283|P2|Overall Study|Death|0
4743500|NCT01810302|16363284|P1|Overall Study|Death|1
4743501|NCT01810263|16363311|P2|Overall Study|Lost to Follow-up|7
4743502|NCT01810263|16363312|P1|Overall Study|Lost to Follow-up|8
4743503|NCT01810042|16363318|P1|Overall Study|Lost to Follow-up|10
4743504|NCT01810016|16363328|P3|Overall Study|Death|1
4743505|NCT01810016|16363329|P2|Overall Study|Death|0
4743506|NCT01810016|16363330|P1|Overall Study|Death|0
4743507|NCT01810016|16363328|P3|Overall Study|Progressive disease|0
4743508|NCT01810016|16363329|P2|Overall Study|Progressive disease|1
4743509|NCT01810016|16363330|P1|Overall Study|Progressive disease|1
4743510|NCT01809327|16363400|P5|Overall Study|Other|9
4743511|NCT01809327|16363401|P4|Overall Study|Other|4
4743512|NCT01809327|16363402|P3|Overall Study|Other|7
4743513|NCT01809327|16363403|P2|Overall Study|Other|15
4743514|NCT01809327|16363404|P1|Overall Study|Other|14
4743515|NCT01809327|16363400|P5|Overall Study|Pregnancy|0
4743516|NCT01809327|16363401|P4|Overall Study|Pregnancy|0
4743517|NCT01809327|16363402|P3|Overall Study|Pregnancy|0
4743518|NCT01809327|16363403|P2|Overall Study|Pregnancy|0
4743519|NCT01809327|16363404|P1|Overall Study|Pregnancy|1
4743520|NCT01809327|16363400|P5|Overall Study|Physician Decision|0
4743521|NCT01809327|16363401|P4|Overall Study|Physician Decision|0
4743522|NCT01809327|16363402|P3|Overall Study|Physician Decision|0
4743523|NCT01809327|16363403|P2|Overall Study|Physician Decision|1
4743524|NCT01809327|16363404|P1|Overall Study|Physician Decision|1
4743525|NCT01809327|16363400|P5|Overall Study|Protocol Violation|0
4743526|NCT01809327|16363401|P4|Overall Study|Protocol Violation|0
4743527|NCT01809327|16363402|P3|Overall Study|Protocol Violation|0
4743528|NCT01809327|16363403|P2|Overall Study|Protocol Violation|1
4743529|NCT01809327|16363404|P1|Overall Study|Protocol Violation|0
4743530|NCT01809327|16363400|P5|Overall Study|Death|0
4743531|NCT01809327|16363401|P4|Overall Study|Death|0
4743532|NCT01809327|16363402|P3|Overall Study|Death|0
4743533|NCT01809327|16363403|P2|Overall Study|Death|0
4743534|NCT01809327|16363404|P1|Overall Study|Death|1
4743535|NCT01809327|16363400|P5|Overall Study|Adverse Event|8
4743536|NCT01809327|16363401|P4|Overall Study|Adverse Event|4
4743537|NCT01809327|16363402|P3|Overall Study|Adverse Event|7
4743538|NCT01809327|16363403|P2|Overall Study|Adverse Event|3
4743539|NCT01809327|16363404|P1|Overall Study|Adverse Event|4
4743540|NCT01809327|16363400|P5|Overall Study|Withdrawal by Subject|5
4743541|NCT01809327|16363401|P4|Overall Study|Withdrawal by Subject|2
4743542|NCT01809327|16363402|P3|Overall Study|Withdrawal by Subject|4
4743543|NCT01809327|16363403|P2|Overall Study|Withdrawal by Subject|4
4743544|NCT01809327|16363404|P1|Overall Study|Withdrawal by Subject|6
4743545|NCT01809327|16363400|P5|Overall Study|Lost to Follow-up|3
4743546|NCT01809327|16363401|P4|Overall Study|Lost to Follow-up|2
4743547|NCT01809327|16363402|P3|Overall Study|Lost to Follow-up|4
4743548|NCT01809327|16363403|P2|Overall Study|Lost to Follow-up|2
4743549|NCT01809327|16363404|P1|Overall Study|Lost to Follow-up|5
4743550|NCT01809314|16363446|P1|Overall Study|Lost to Follow-up|724
4743551|NCT01809314|16363446|P1|Overall Study|Insufficient Therapeutic Response|14
4743552|NCT01809314|16363446|P1|Overall Study|Adverse Event|6
4743553|NCT01809314|16363446|P1|Overall Study|Withdrawal Prior to Treatment|1
4743554|NCT01809262|16363452|P10|Period 3 (Third Dose + Washout)|Adverse Event|0
4743555|NCT01809262|16363453|P9|Period 3 (Third Dose + Washout)|Adverse Event|0
4743556|NCT01809262|16363454|P8|Period 3 (Third Dose + Washout)|Adverse Event|0
4743557|NCT01809262|16363455|P7|Period 3 (Third Dose + Washout)|Adverse Event|0
4743558|NCT01809262|16363456|P6|Period 3 (Third Dose + Washout)|Adverse Event|0
4743559|NCT01809262|16363457|P5|Period 3 (Third Dose + Washout)|Adverse Event|0
4743560|NCT01809262|16363458|P4|Period 3 (Third Dose + Washout)|Adverse Event|0
4743561|NCT01809262|16363459|P3|Period 3 (Third Dose + Washout)|Adverse Event|0
4743562|NCT01809262|16363460|P2|Period 3 (Third Dose + Washout)|Adverse Event|1
4743563|NCT01809262|16363461|P1|Period 3 (Third Dose + Washout)|Adverse Event|0
4743564|NCT01809262|16363452|P10|Period 1 (First Dose + Washout)|Adverse Event|0
4743565|NCT01809262|16363453|P9|Period 1 (First Dose + Washout)|Adverse Event|0
4743566|NCT01809262|16363454|P8|Period 1 (First Dose + Washout)|Adverse Event|0
4743567|NCT01809262|16363455|P7|Period 1 (First Dose + Washout)|Adverse Event|0
4743568|NCT01809262|16363456|P6|Period 1 (First Dose + Washout)|Adverse Event|0
4743569|NCT01809262|16363457|P5|Period 1 (First Dose + Washout)|Adverse Event|1
4743570|NCT01809262|16363458|P4|Period 1 (First Dose + Washout)|Adverse Event|0
4743571|NCT01809262|16363459|P3|Period 1 (First Dose + Washout)|Adverse Event|0
4743572|NCT01809262|16363460|P2|Period 1 (First Dose + Washout)|Adverse Event|0
4743573|NCT01809262|16363461|P1|Period 1 (First Dose + Washout)|Adverse Event|0
4743574|NCT01809210|16363535|P7|Overall Study|Death|1
4743575|NCT01809210|16363536|P6|Overall Study|Death|3
4743576|NCT01809210|16363537|P5|Overall Study|Death|1
4743577|NCT01809210|16363538|P4|Overall Study|Death|0
4743578|NCT01809210|16363539|P3|Overall Study|Death|2
4743579|NCT01809210|16363540|P2|Overall Study|Death|1
4743580|NCT01809210|16363541|P1|Overall Study|Death|1
4743581|NCT01809210|16363535|P7|Overall Study|Withdrawal by Subject|4
4743582|NCT01809210|16363536|P6|Overall Study|Withdrawal by Subject|0
4743583|NCT01809210|16363537|P5|Overall Study|Withdrawal by Subject|1
4743584|NCT01809210|16363538|P4|Overall Study|Withdrawal by Subject|1
4743585|NCT01809210|16363539|P3|Overall Study|Withdrawal by Subject|1
4743586|NCT01809210|16363540|P2|Overall Study|Withdrawal by Subject|0
4743587|NCT01809210|16363541|P1|Overall Study|Withdrawal by Subject|0
4743588|NCT01809197|16363615|P2|Overall Study|Product not available|1
4743589|NCT01809197|16363616|P1|Overall Study|Product not available|0
4743590|NCT01809197|16363615|P2|Overall Study|Withdrawal by Subject|1
4743591|NCT01809197|16363616|P1|Overall Study|Withdrawal by Subject|1
4743592|NCT01809197|16363615|P2|Overall Study|Decision Unrelated to an Adverse Event|0
4743593|NCT01809197|16363616|P1|Overall Study|Decision Unrelated to an Adverse Event|1
4743594|NCT01809197|16363615|P2|Overall Study|Non-Compliance|1
4743595|NCT01809197|16363616|P1|Overall Study|Non-Compliance|1
4743596|NCT01809197|16363615|P2|Overall Study|Failed slit lamp exam|0
4743597|NCT01809197|16363616|P1|Overall Study|Failed slit lamp exam|1
4743598|NCT01809197|16363615|P2|Overall Study|Adverse Event|3
4743599|NCT01809197|16363616|P1|Overall Study|Adverse Event|2
4743600|NCT01809197|16363615|P2|Overall Study|Lost to Follow-up|2
4743601|NCT01809197|16363616|P1|Overall Study|Lost to Follow-up|4
4743602|NCT01808690|16363697|P2|Overall Study|Withdrawal by Subject|2
4743603|NCT01808690|16363698|P1|Overall Study|Withdrawal by Subject|1
4743604|NCT01808651|16363717|P3|Study Period 1|Participant Decision|3
4743605|NCT01808651|16363718|P2|Study Period 1|Participant Decision|7
4743606|NCT01808651|16363719|P1|Study Period 1|Participant Decision|9
4743607|NCT01808651|16363717|P3|Study Period 1|Adverse Event|1
4743608|NCT01808651|16363718|P2|Study Period 1|Adverse Event|4
4743609|NCT01808651|16363719|P1|Study Period 1|Adverse Event|10
4743610|NCT01808651|16363717|P3|Study Period 1|Lack of Efficacy|0
4743611|NCT01808651|16363718|P2|Study Period 1|Lack of Efficacy|1
4743612|NCT01808651|16363719|P1|Study Period 1|Lack of Efficacy|2
4743613|NCT01808651|16363717|P3|Study Period 1|Physician Decision|0
4743614|NCT01808651|16363718|P2|Study Period 1|Physician Decision|2
4743615|NCT01808651|16363719|P1|Study Period 1|Physician Decision|3
4743616|NCT01808651|16363717|P3|Study Period 1|Protocol Violation|1
4743617|NCT01808651|16363718|P2|Study Period 1|Protocol Violation|0
4743618|NCT01808651|16363719|P1|Study Period 1|Protocol Violation|1
4743619|NCT01808651|16363717|P3|Study Period 1|Lost to Follow-up|0
4743620|NCT01808651|16363718|P2|Study Period 1|Lost to Follow-up|3
4743621|NCT01808651|16363719|P1|Study Period 1|Lost to Follow-up|1
4743622|NCT01808612|16363754|P3|Discontinuation Period|Lost to Follow-up|0
4743623|NCT01808612|16363755|P2|Discontinuation Period|Lost to Follow-up|1
4743624|NCT01808612|16363756|P1|Discontinuation Period|Lost to Follow-up|0
4743625|NCT01808612|16363754|P3|Discontinuation Period|Physician Decision|0
4743626|NCT01808612|16363755|P2|Discontinuation Period|Physician Decision|0
4743627|NCT01808612|16363756|P1|Discontinuation Period|Physician Decision|1
4743628|NCT01808612|16363754|P3|Discontinuation Period|Adverse Event|0
4743629|NCT01808612|16363755|P2|Discontinuation Period|Adverse Event|0
4743630|NCT01808612|16363756|P1|Discontinuation Period|Adverse Event|1
4743631|NCT01808612|16363754|P3|Treatment Period|Lack of Efficacy|2
4743632|NCT01808612|16363755|P2|Treatment Period|Lack of Efficacy|1
4743633|NCT01808612|16363756|P1|Treatment Period|Lack of Efficacy|1
4743634|NCT01808612|16363754|P3|Treatment Period|Sponsor Decision|0
4743635|NCT01808612|16363755|P2|Treatment Period|Sponsor Decision|0
4743636|NCT01808612|16363756|P1|Treatment Period|Sponsor Decision|1
4743637|NCT01808612|16363754|P3|Treatment Period|Physician Decision|4
4743638|NCT01808612|16363755|P2|Treatment Period|Physician Decision|0
4743639|NCT01808612|16363756|P1|Treatment Period|Physician Decision|1
4743640|NCT01808612|16363754|P3|Treatment Period|Withdrawal by Subject|4
4743641|NCT01808612|16363755|P2|Treatment Period|Withdrawal by Subject|0
4743642|NCT01808612|16363756|P1|Treatment Period|Withdrawal by Subject|1
4743643|NCT01808612|16363754|P3|Treatment Period|Protocol Violation|0
4743644|NCT01808612|16363755|P2|Treatment Period|Protocol Violation|0
4743645|NCT01808612|16363756|P1|Treatment Period|Protocol Violation|1
4743646|NCT01808612|16363754|P3|Treatment Period|Lost to Follow-up|1
4743647|NCT01808612|16363755|P2|Treatment Period|Lost to Follow-up|2
4743648|NCT01808612|16363756|P1|Treatment Period|Lost to Follow-up|2
4743649|NCT01808612|16363754|P3|Treatment Period|Adverse Event|3
4743650|NCT01808612|16363755|P2|Treatment Period|Adverse Event|4
4743651|NCT01808612|16363756|P1|Treatment Period|Adverse Event|8
4743652|NCT01808573|16363787|P2|Overall Study|Randomized in Error|0
4743653|NCT01808573|16363788|P1|Overall Study|Randomized in Error|1
4743654|NCT01808573|16363787|P2|Overall Study|Discontinuation of study by sponsor|64
4743655|NCT01808573|16363788|P1|Overall Study|Discontinuation of study by sponsor|79
4743656|NCT01808573|16363787|P2|Overall Study|Lost to Follow-up|0
4743657|NCT01808573|16363788|P1|Overall Study|Lost to Follow-up|3
4743658|NCT01808573|16363787|P2|Overall Study|Withdrawal by Subject|10
4743659|NCT01808573|16363788|P1|Overall Study|Withdrawal by Subject|12
4743660|NCT01808573|16363787|P2|Overall Study|Death|240
4743661|NCT01808573|16363788|P1|Overall Study|Death|212
4743662|NCT01808534|16363843|P1|Overall Study|Physician Decision|1
4743663|NCT01808534|16363843|P1|Overall Study|Disease progression|3
4743664|NCT01808508|16363854|P3|Overall Study|Lost to Follow-up|0
4743665|NCT01808508|16363855|P2|Overall Study|Lost to Follow-up|0
4743666|NCT01808508|16363856|P1|Overall Study|Lost to Follow-up|1
4743667|NCT01808339|16363873|P6|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743668|NCT01808339|16363874|P5|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743669|NCT01808339|16363875|P4|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743670|NCT01808339|16363876|P3|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1
4743671|NCT01808339|16363877|P2|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743672|NCT01808339|16363878|P1|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743673|NCT01808339|16363873|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4743674|NCT01808339|16363874|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4743675|NCT01808339|16363875|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4743676|NCT01808339|16363876|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4743677|NCT01808339|16363877|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4743678|NCT01808339|16363878|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4743679|NCT01808339|16363873|P6|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
4743680|NCT01808339|16363874|P5|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2
4743681|NCT01808339|16363875|P4|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1
4743682|NCT01808339|16363876|P3|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743683|NCT01808339|16363877|P2|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743684|NCT01808339|16363878|P1|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0
4743685|NCT01808313|16363922|P1|Overall Study|Physician Decision|1
4743686|NCT01808313|16363922|P1|Overall Study|Lost to Follow-up|1
4743687|NCT01808313|16363922|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
4743688|NCT01808313|16363922|P1|Overall Study|Protocol Violation|2
4743689|NCT01808313|16363922|P1|Overall Study|Adverse Event|5
4743690|NCT01808261|16363952|P2|Overall Study|Lost to Follow-up|1
4743691|NCT01808261|16363953|P1|Overall Study|Lost to Follow-up|3
4743692|NCT01808261|16363952|P2|Overall Study|Consent withdrawn by subject|7
4743693|NCT01808261|16363953|P1|Overall Study|Consent withdrawn by subject|6
4743694|NCT01808261|16363952|P2|Overall Study|Adverse event, non-fatal|0
4743695|NCT01808261|16363953|P1|Overall Study|Adverse event, non-fatal|2
4743696|NCT01808261|16363952|P2|Overall Study|Study Closed/Terminated|23
4743697|NCT01808261|16363953|P1|Overall Study|Study Closed/Terminated|25
4743698|NCT01808261|16363952|P2|Overall Study|Physician Decision|2
4743699|NCT01808261|16363953|P1|Overall Study|Physician Decision|0
4743700|NCT01808248|16364009|P1|Overall Study|Lost to Follow-up|1
4743701|NCT01808248|16364009|P1|Overall Study|Withdrawal by Subject|1
4743702|NCT01808248|16364009|P1|Overall Study|Lack of Efficacy|3
4743703|NCT01808222|16364021|P1|Overall Study|mpMR scan was not performed|1
4743704|NCT01808209|16364028|P2|Overall Study|Lost to Follow-up|1
4743705|NCT01808209|16364029|P1|Overall Study|Lost to Follow-up|0
4743706|NCT01808196|16364071|P1|Overall Study|Lost to Follow-up|1
4743707|NCT01808144|16364079|P2|Overall Study|Adverse Event|15
4743708|NCT01808144|16364080|P1|Overall Study|Adverse Event|11
4743709|NCT01808144|16364079|P2|Overall Study|Gout flare|1
4743710|NCT01808144|16364080|P1|Overall Study|Gout flare|0
4743711|NCT01808144|16364079|P2|Overall Study|Protocol Violation|6
4743712|NCT01808144|16364080|P1|Overall Study|Protocol Violation|6
4743713|NCT01808144|16364079|P2|Overall Study|Lost to Follow-up|3
4743714|NCT01808144|16364080|P1|Overall Study|Lost to Follow-up|6
4743715|NCT01808144|16364079|P2|Overall Study|Withdrawal by Subject|23
4743716|NCT01808144|16364080|P1|Overall Study|Withdrawal by Subject|16
4743717|NCT01808144|16364079|P2|Overall Study|Death|0
4743718|NCT01808144|16364080|P1|Overall Study|Death|1
4743719|NCT01808118|16364088|P3|Period 2|Switched to other therapy|0
4743720|NCT01808118|16364089|P2|Period 2|Switched to other therapy|1
4743721|NCT01808118|16364090|P1|Period 2|Switched to other therapy|0
4743722|NCT01808118|16364088|P3|Period 2|Investigator no longer conducting trials|0
4743723|NCT01808118|16364089|P2|Period 2|Investigator no longer conducting trials|1
4743724|NCT01808118|16364090|P1|Period 2|Investigator no longer conducting trials|0
4743725|NCT01808118|16364088|P3|Period 2|Lost to Follow-up|2
4743726|NCT01808118|16364089|P2|Period 2|Lost to Follow-up|0
4743727|NCT01808118|16364090|P1|Period 2|Lost to Follow-up|0
4743728|NCT01808118|16364088|P3|Period 2|Withdrew consent|6
4743729|NCT01808118|16364089|P2|Period 2|Withdrew consent|7
4743730|NCT01808118|16364090|P1|Period 2|Withdrew consent|0
4743731|NCT01808118|16364088|P3|Period 2|Adverse Event|0
4743732|NCT01808118|16364089|P2|Period 2|Adverse Event|4
4743733|NCT01808118|16364090|P1|Period 2|Adverse Event|0
4743734|NCT01808118|16364088|P3|Period 1|Lack of Efficacy|0
4743735|NCT01808118|16364089|P2|Period 1|Lack of Efficacy|0
4743736|NCT01808118|16364090|P1|Period 1|Lack of Efficacy|1
4743737|NCT01808118|16364088|P3|Period 1|Non-compliance per sponsor|0
4743738|NCT01808118|16364089|P2|Period 1|Non-compliance per sponsor|0
4743739|NCT01808118|16364090|P1|Period 1|Non-compliance per sponsor|1
4743740|NCT01808118|16364088|P3|Period 1|Investigator decision: site closure|0
4743741|NCT01808118|16364089|P2|Period 1|Investigator decision: site closure|0
4743742|NCT01808118|16364090|P1|Period 1|Investigator decision: site closure|2
4743743|NCT01808118|16364088|P3|Period 1|Non-conformance with inclusion criteria|0
4743744|NCT01808118|16364089|P2|Period 1|Non-conformance with inclusion criteria|0
4743745|NCT01808118|16364090|P1|Period 1|Non-conformance with inclusion criteria|3
4743746|NCT01808118|16364088|P3|Period 1|Did not meet inclusion criteria|0
4743747|NCT01808118|16364089|P2|Period 1|Did not meet inclusion criteria|0
4743748|NCT01808118|16364090|P1|Period 1|Did not meet inclusion criteria|3
4743749|NCT01808118|16364088|P3|Period 1|Enrolled in error|0
4743750|NCT01808118|16364089|P2|Period 1|Enrolled in error|0
4743751|NCT01808118|16364090|P1|Period 1|Enrolled in error|7
4743752|NCT01808118|16364088|P3|Period 1|Did not meet criteria for remission|0
4743753|NCT01808118|16364089|P2|Period 1|Did not meet criteria for remission|0
4743754|NCT01808118|16364090|P1|Period 1|Did not meet criteria for remission|303
4743755|NCT01808118|16364088|P3|Period 1|Lost to Follow-up|0
4743756|NCT01808118|16364089|P2|Period 1|Lost to Follow-up|0
4743757|NCT01808118|16364090|P1|Period 1|Lost to Follow-up|9
4743758|NCT01808118|16364088|P3|Period 1|Withdrew consent|0
4743759|NCT01808118|16364089|P2|Period 1|Withdrew consent|0
4743760|NCT01808118|16364090|P1|Period 1|Withdrew consent|24
4743761|NCT01808118|16364088|P3|Period 1|Adverse Event|0
4743762|NCT01808118|16364089|P2|Period 1|Adverse Event|0
4743763|NCT01808118|16364090|P1|Period 1|Adverse Event|15
4743764|NCT01808092|16364153|P2|Overall Study|Other Eligibility criteria|5
4743765|NCT01808092|16364154|P1|Overall Study|Other Eligibility criteria|3
4743766|NCT01808092|16364153|P2|Overall Study|Withdrawal by Subject|4
4743767|NCT01808092|16364154|P1|Overall Study|Withdrawal by Subject|9
4743768|NCT01808092|16364153|P2|Overall Study|Lost to Follow-up|7
4743769|NCT01808092|16364154|P1|Overall Study|Lost to Follow-up|3
4743770|NCT01808092|16364153|P2|Overall Study|Death|29
4743771|NCT01808092|16364154|P1|Overall Study|Death|39
4743772|NCT01808066|16364256|P1|Overall Study|Withdrawal by Subject|15
4743773|NCT01807949|16364267|P3|Overall Study|Randomized But Not Treated|2
4743774|NCT01807949|16364268|P2|Overall Study|Randomized But Not Treated|2
4743775|NCT01807949|16364269|P1|Overall Study|Randomized But Not Treated|0
4743776|NCT01807949|16364267|P3|Overall Study|Undefined|2
4743777|NCT01807949|16364268|P2|Overall Study|Undefined|1
4743778|NCT01807949|16364269|P1|Overall Study|Undefined|0
4743779|NCT01807949|16364267|P3|Overall Study|Non-Compliance|1
4743780|NCT01807949|16364268|P2|Overall Study|Non-Compliance|0
4743781|NCT01807949|16364269|P1|Overall Study|Non-Compliance|0
4743782|NCT01807949|16364267|P3|Overall Study|Withdrawal by Subject|2
4743783|NCT01807949|16364268|P2|Overall Study|Withdrawal by Subject|2
4743784|NCT01807949|16364269|P1|Overall Study|Withdrawal by Subject|1
4743785|NCT01807949|16364267|P3|Overall Study|Adverse Event|2
4743786|NCT01807949|16364268|P2|Overall Study|Adverse Event|2
4743787|NCT01807949|16364269|P1|Overall Study|Adverse Event|1
4743788|NCT01807923|16364321|P3|Overall Study|Randomized But Not Treated|5
4743789|NCT01807923|16364322|P2|Overall Study|Randomized But Not Treated|2
4743790|NCT01807923|16364323|P1|Overall Study|Randomized But Not Treated|3
4743791|NCT01807923|16364321|P3|Overall Study|Not Eligible (Genotype)|1
4743792|NCT01807923|16364322|P2|Overall Study|Not Eligible (Genotype)|0
4743793|NCT01807923|16364323|P1|Overall Study|Not Eligible (Genotype)|0
4743794|NCT01807923|16364321|P3|Overall Study|Physician Decision|1
4743795|NCT01807923|16364322|P2|Overall Study|Physician Decision|0
4743796|NCT01807923|16364323|P1|Overall Study|Physician Decision|0
4743797|NCT01807923|16364321|P3|Overall Study|Withdrawal of Consent (not due to AE)|2
4743798|NCT01807923|16364322|P2|Overall Study|Withdrawal of Consent (not due to AE)|3
4743799|NCT01807923|16364323|P1|Overall Study|Withdrawal of Consent (not due to AE)|0
4743800|NCT01807923|16364321|P3|Overall Study|Adverse Event|2
4743801|NCT01807923|16364322|P2|Overall Study|Adverse Event|1
4743802|NCT01807923|16364323|P1|Overall Study|Adverse Event|2
4743803|NCT01807650|16364385|P1|Overall Study|Other|2
4743804|NCT01807650|16364385|P1|Overall Study|Adverse Event|5
4743805|NCT01807650|16364385|P1|Overall Study|Lack of Full Wound Closure at Day 28|13
4743806|NCT01807598|16364471|P1|Overall Study|Other Physician Decision|1
4743807|NCT01807598|16364471|P1|Overall Study|Adverse Event|1
4743808|NCT01807598|16364471|P1|Overall Study|Withdrawal by Subject|4
4743809|NCT01807520|16364503|P7|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1
4743810|NCT01807520|16364504|P6|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2
4743811|NCT01807520|16364505|P5|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4743812|NCT01807520|16364506|P4|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4743813|NCT01807520|16364507|P3|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4743814|NCT01807520|16364508|P2|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4743815|NCT01807520|16364509|P1|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0
4743816|NCT01807520|16364503|P7|Follow-up Period (132-140 Weeks)|Study terminated|0
4743817|NCT01807520|16364504|P6|Follow-up Period (132-140 Weeks)|Study terminated|1
4743818|NCT01807520|16364505|P5|Follow-up Period (132-140 Weeks)|Study terminated|0
4743819|NCT01807520|16364506|P4|Follow-up Period (132-140 Weeks)|Study terminated|0
4743820|NCT01807520|16364507|P3|Follow-up Period (132-140 Weeks)|Study terminated|0
4743821|NCT01807520|16364508|P2|Follow-up Period (132-140 Weeks)|Study terminated|0
4743822|NCT01807520|16364509|P1|Follow-up Period (132-140 Weeks)|Study terminated|0
4743823|NCT01807520|16364503|P7|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4743824|NCT01807520|16364504|P6|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1
4743825|NCT01807520|16364505|P5|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4743826|NCT01807520|16364506|P4|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4743827|NCT01807520|16364507|P3|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4743828|NCT01807520|16364508|P2|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4743829|NCT01807520|16364509|P1|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0
4743830|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
4743831|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
4743832|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
4744137|NCT01804946|16365205|P1|Overall Study|Insufficient data available|0
4743833|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2
4743834|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0
4743835|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6
4743836|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5
4743837|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4743838|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4743839|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4743840|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
4743841|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Adverse Event|0
4743842|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
4743843|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Adverse Event|3
4743844|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4743845|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4743846|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1
4743847|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4743848|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0
4743849|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3
4743850|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5
4743851|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4743852|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4743853|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4743854|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1
4743855|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4743856|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0
4743857|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4
4743858|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4743859|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4743860|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4743861|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4743862|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4743863|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2
4743864|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0
4743865|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4743866|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4743867|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4743868|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4743869|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4743870|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Pregnancy|0
4743871|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Pregnancy|1
4743872|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4743873|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4743874|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4743875|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1
4743876|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4743877|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4743878|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0
4743879|NCT01807520|16364503|P7|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4743880|NCT01807520|16364504|P6|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4743881|NCT01807520|16364505|P5|Treatment Period 2 (16-132 Weeks)|Study terminated|2
4743882|NCT01807520|16364506|P4|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4743883|NCT01807520|16364507|P3|Treatment Period 2 (16-132 Weeks)|Study terminated|0
4743884|NCT01807520|16364508|P2|Treatment Period 2 (16-132 Weeks)|Study terminated|4
4743885|NCT01807520|16364509|P1|Treatment Period 2 (16-132 Weeks)|Study terminated|7
4743886|NCT01807520|16364503|P7|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4743887|NCT01807520|16364504|P6|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4743888|NCT01807520|16364505|P5|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4743889|NCT01807520|16364506|P4|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4743890|NCT01807520|16364507|P3|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4743891|NCT01807520|16364508|P2|Treatment Period 1 (0-16 Weeks)|Adverse Event|0
4743892|NCT01807520|16364509|P1|Treatment Period 1 (0-16 Weeks)|Adverse Event|2
4743893|NCT01807520|16364503|P7|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4743894|NCT01807520|16364504|P6|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4743895|NCT01807520|16364505|P5|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4743896|NCT01807520|16364506|P4|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4743897|NCT01807520|16364507|P3|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2
4743898|NCT01807520|16364508|P2|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4743899|NCT01807520|16364509|P1|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0
4743900|NCT01807520|16364503|P7|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4743901|NCT01807520|16364504|P6|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4743902|NCT01807520|16364505|P5|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4743903|NCT01807520|16364506|P4|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4743904|NCT01807520|16364507|P3|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4743905|NCT01807520|16364508|P2|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0
4743906|NCT01807520|16364509|P1|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1
4743907|NCT01807520|16364503|P7|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4743908|NCT01807520|16364504|P6|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4743909|NCT01807520|16364505|P5|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4743910|NCT01807520|16364506|P4|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4743911|NCT01807520|16364507|P3|Treatment Period 1 (0-16 Weeks)|Physician Decision|1
4743912|NCT01807520|16364508|P2|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4743913|NCT01807520|16364509|P1|Treatment Period 1 (0-16 Weeks)|Physician Decision|0
4743914|NCT01807520|16364503|P7|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4743915|NCT01807520|16364504|P6|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4743916|NCT01807520|16364505|P5|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4743917|NCT01807520|16364506|P4|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4743918|NCT01807520|16364507|P3|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
4743919|NCT01807520|16364508|P2|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0
4743920|NCT01807520|16364509|P1|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1
4743921|NCT01807520|16364503|P7|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4743922|NCT01807520|16364504|P6|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4743923|NCT01807520|16364505|P5|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4743924|NCT01807520|16364506|P4|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4743925|NCT01807520|16364507|P3|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3
4743926|NCT01807520|16364508|P2|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1
4743927|NCT01807520|16364509|P1|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0
4743928|NCT01807299|16364540|P4|Overall Study|Protocol Violation|2
4743929|NCT01807299|16364541|P3|Overall Study|Protocol Violation|0
4743930|NCT01807299|16364542|P2|Overall Study|Protocol Violation|1
4743931|NCT01807299|16364543|P1|Overall Study|Protocol Violation|3
4743932|NCT01807234|16364559|P6|Overall Study|Lack of Efficacy|1
4743933|NCT01807234|16364560|P5|Overall Study|Lack of Efficacy|1
4743934|NCT01807234|16364561|P4|Overall Study|Lack of Efficacy|0
4743935|NCT01807234|16364562|P3|Overall Study|Lack of Efficacy|0
4743936|NCT01807234|16364563|P2|Overall Study|Lack of Efficacy|0
4743937|NCT01807234|16364564|P1|Overall Study|Lack of Efficacy|0
4743938|NCT01807234|16364559|P6|Overall Study|Withdrawal by Subject|1
4743939|NCT01807234|16364560|P5|Overall Study|Withdrawal by Subject|2
4743940|NCT01807234|16364561|P4|Overall Study|Withdrawal by Subject|1
4743941|NCT01807234|16364562|P3|Overall Study|Withdrawal by Subject|1
4743942|NCT01807234|16364563|P2|Overall Study|Withdrawal by Subject|1
4743943|NCT01807234|16364564|P1|Overall Study|Withdrawal by Subject|3
4743944|NCT01807234|16364559|P6|Overall Study|Lost to Follow-up|2
4743945|NCT01807234|16364560|P5|Overall Study|Lost to Follow-up|1
4743946|NCT01807234|16364561|P4|Overall Study|Lost to Follow-up|1
4743947|NCT01807234|16364562|P3|Overall Study|Lost to Follow-up|1
4743948|NCT01807234|16364563|P2|Overall Study|Lost to Follow-up|5
4743949|NCT01807234|16364564|P1|Overall Study|Lost to Follow-up|2
4743950|NCT01807156|16364599|P1|Overall Study|Physician Decision|1
4743951|NCT01807065|16364615|P2|Overall Study|Receive no sip-T due to IV access|1
4743952|NCT01807065|16364616|P1|Overall Study|Receive no sip-T due to IV access|1
4743953|NCT01806961|16364682|P1|Overall Study|sponsor decision|16
4743954|NCT01806896|16364688|P2|Overall Study|Other|0
4743955|NCT01806896|16364689|P1|Overall Study|Other|1
4743956|NCT01806896|16364688|P2|Overall Study|Adverse Event|0
4743957|NCT01806896|16364689|P1|Overall Study|Adverse Event|2
4743958|NCT01806779|16364756|P3|Overall Study|Withdrawal by Subject|22
4743959|NCT01806779|16364757|P2|Overall Study|Withdrawal by Subject|23
4743960|NCT01806779|16364758|P1|Overall Study|Withdrawal by Subject|20
4743961|NCT01806779|16364756|P3|Overall Study|Lost to Follow-up|0
4743962|NCT01806779|16364757|P2|Overall Study|Lost to Follow-up|20
4743963|NCT01806779|16364758|P1|Overall Study|Lost to Follow-up|19
4743964|NCT01806779|16364756|P3|Overall Study|Lack of Efficacy|0
4743965|NCT01806779|16364757|P2|Overall Study|Lack of Efficacy|1
4743966|NCT01806779|16364758|P1|Overall Study|Lack of Efficacy|1
4743967|NCT01806779|16364756|P3|Overall Study|Physician Decision|1
4743968|NCT01806779|16364757|P2|Overall Study|Physician Decision|0
4743969|NCT01806779|16364758|P1|Overall Study|Physician Decision|2
4743970|NCT01806740|16364771|P1|Overall Study|Patient's refusal of treatment|1
4743971|NCT01806740|16364771|P1|Overall Study|Physician Decision|1
4743972|NCT01806740|16364771|P1|Overall Study|Withdrawal by Subject|4
4743973|NCT01806714|16364782|P2|Overall Study|No functioning phone number|170
4743974|NCT01806714|16364783|P1|Overall Study|No functioning phone number|200
4743975|NCT01806662|16364818|P2|Second Intervention (Weeks 16-32)|Lost to Follow-up|1
4743976|NCT01806662|16364819|P1|Second Intervention (Weeks 16-32)|Lost to Follow-up|0
4743977|NCT01806662|16364818|P2|Second Intervention (Weeks 16-32)|Lack of Efficacy|3
4743978|NCT01806662|16364819|P1|Second Intervention (Weeks 16-32)|Lack of Efficacy|2
4743979|NCT01806662|16364818|P2|First Intervention (Weeks 0-16)|Adverse Event|1
4743980|NCT01806662|16364819|P1|First Intervention (Weeks 0-16)|Adverse Event|0
4743981|NCT01806662|16364818|P2|First Intervention (Weeks 0-16)|Withdrawal by Subject|0
4743982|NCT01806662|16364819|P1|First Intervention (Weeks 0-16)|Withdrawal by Subject|4
4743983|NCT01806623|16364825|P1|Overall Study|Did not meet the inclusion criteria|56
4743984|NCT01806623|16364825|P1|Overall Study|Adverse Event|1
4743985|NCT01806623|16364825|P1|Overall Study|Withdrawal by Subject|1
4743986|NCT01806597|16364845|P6|Follow-up Period (Week 132 to Week 140)|Physician Decision|1
4743987|NCT01806597|16364846|P5|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4743988|NCT01806597|16364847|P4|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4743989|NCT01806597|16364848|P3|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4743990|NCT01806597|16364849|P2|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4743991|NCT01806597|16364850|P1|Follow-up Period (Week 132 to Week 140)|Physician Decision|0
4743992|NCT01806597|16364845|P6|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2
4743993|NCT01806597|16364846|P5|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4743994|NCT01806597|16364847|P4|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4743995|NCT01806597|16364848|P3|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4743996|NCT01806597|16364849|P2|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4743997|NCT01806597|16364850|P1|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0
4743998|NCT01806597|16364845|P6|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2
4743999|NCT01806597|16364846|P5|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4744000|NCT01806597|16364847|P4|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4744001|NCT01806597|16364848|P3|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4744002|NCT01806597|16364849|P2|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4744003|NCT01806597|16364850|P1|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0
4744004|NCT01806597|16364845|P6|Follow-up Period (Week 132 to Week 140)|Adverse Event|2
4744005|NCT01806597|16364846|P5|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4744006|NCT01806597|16364847|P4|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4744007|NCT01806597|16364848|P3|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4744008|NCT01806597|16364849|P2|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4744009|NCT01806597|16364850|P1|Follow-up Period (Week 132 to Week 140)|Adverse Event|0
4744010|NCT01806597|16364845|P6|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5
4744011|NCT01806597|16364846|P5|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4744012|NCT01806597|16364847|P4|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4744013|NCT01806597|16364848|P3|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4744014|NCT01806597|16364849|P2|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4744015|NCT01806597|16364850|P1|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0
4744016|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Death|0
4744017|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Death|0
4744018|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Death|0
4744019|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Death|0
4744020|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Death|0
4744021|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Death|1
4744022|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
4744023|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0
4744024|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
4744025|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1
4744026|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
4744027|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2
4744028|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
4744029|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0
4744030|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
4744031|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6
4744032|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5
4744033|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10
4744034|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4744035|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4744036|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
4744037|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4744038|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1
4744039|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0
4744040|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4744041|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4744042|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4744043|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4744044|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0
4744045|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2
4744046|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4744047|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4744048|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4744049|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0
4744050|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
4744051|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1
4744052|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4744053|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4744054|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4744055|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4744056|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0
4744057|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2
4744058|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
4744059|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0
4744060|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1
4744061|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3
4744062|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5
4744063|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12
4744064|NCT01806597|16364845|P6|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0
4744065|NCT01806597|16364846|P5|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1
4744066|NCT01806597|16364847|P4|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3
4744067|NCT01806597|16364848|P3|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4
4744068|NCT01806597|16364849|P2|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6
4744069|NCT01806597|16364850|P1|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9
4744070|NCT01806597|16364845|P6|Period 1 (Baseline to Week 16)|Physician Decision|0
4744071|NCT01806597|16364846|P5|Period 1 (Baseline to Week 16)|Physician Decision|0
4744072|NCT01806597|16364847|P4|Period 1 (Baseline to Week 16)|Physician Decision|0
4744073|NCT01806597|16364848|P3|Period 1 (Baseline to Week 16)|Physician Decision|0
4744074|NCT01806597|16364849|P2|Period 1 (Baseline to Week 16)|Physician Decision|1
4744075|NCT01806597|16364850|P1|Period 1 (Baseline to Week 16)|Physician Decision|0
4744076|NCT01806597|16364845|P6|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
4744077|NCT01806597|16364846|P5|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
4744078|NCT01806597|16364847|P4|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
4744079|NCT01806597|16364848|P3|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0
4744080|NCT01806597|16364849|P2|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2
4744081|NCT01806597|16364850|P1|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3
4744082|NCT01806597|16364845|P6|Period 1 (Baseline to Week 16)|Protocol Violation|0
4744083|NCT01806597|16364846|P5|Period 1 (Baseline to Week 16)|Protocol Violation|0
4744084|NCT01806597|16364847|P4|Period 1 (Baseline to Week 16)|Protocol Violation|0
4744085|NCT01806597|16364848|P3|Period 1 (Baseline to Week 16)|Protocol Violation|0
4744086|NCT01806597|16364849|P2|Period 1 (Baseline to Week 16)|Protocol Violation|1
4744087|NCT01806597|16364850|P1|Period 1 (Baseline to Week 16)|Protocol Violation|0
4744088|NCT01806597|16364845|P6|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4744089|NCT01806597|16364846|P5|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
4744090|NCT01806597|16364847|P4|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4744091|NCT01806597|16364848|P3|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4744092|NCT01806597|16364849|P2|Period 1 (Baseline to Week 16)|Lack of Efficacy|0
4744093|NCT01806597|16364850|P1|Period 1 (Baseline to Week 16)|Lack of Efficacy|1
4744094|NCT01806597|16364845|P6|Period 1 (Baseline to Week 16)|Adverse Event|0
4744095|NCT01806597|16364846|P5|Period 1 (Baseline to Week 16)|Adverse Event|2
4744096|NCT01806597|16364847|P4|Period 1 (Baseline to Week 16)|Adverse Event|0
4744097|NCT01806597|16364848|P3|Period 1 (Baseline to Week 16)|Adverse Event|0
4744098|NCT01806597|16364849|P2|Period 1 (Baseline to Week 16)|Adverse Event|1
4744099|NCT01806597|16364850|P1|Period 1 (Baseline to Week 16)|Adverse Event|1
4744100|NCT01806584|16364886|P2|Overall Study|Other unspecified|0
4744101|NCT01806584|16364887|P1|Overall Study|Other unspecified|1
4744102|NCT01806584|16364886|P2|Overall Study|Withdrawal by Subject|1
4744103|NCT01806584|16364887|P1|Overall Study|Withdrawal by Subject|1
4744104|NCT01806584|16364886|P2|Overall Study|Study terminated by sponsor|14
4744105|NCT01806584|16364887|P1|Overall Study|Study terminated by sponsor|9
4744106|NCT01806584|16364886|P2|Overall Study|Lost to Follow-up|2
4744107|NCT01806584|16364887|P1|Overall Study|Lost to Follow-up|0
4744108|NCT01806584|16364886|P2|Overall Study|Death|0
4744109|NCT01806584|16364887|P1|Overall Study|Death|1
4744110|NCT01806584|16364886|P2|Overall Study|Adverse Event|1
4744111|NCT01806584|16364887|P1|Overall Study|Adverse Event|2
4744112|NCT01806545|16364909|P2|Overall Study|Withdrawal by Subject|2
4744113|NCT01806545|16364910|P1|Overall Study|Withdrawal by Subject|3
4744114|NCT01806545|16364909|P2|Overall Study|Lost to Follow-up|0
4744115|NCT01806545|16364910|P1|Overall Study|Lost to Follow-up|1
4744116|NCT01806545|16364909|P2|Overall Study|Adverse Event|3
4744117|NCT01806545|16364910|P1|Overall Study|Adverse Event|2
4744118|NCT01806506|16364934|P2|Overall Study|Lost to Follow-up|1
4744119|NCT01806506|16364935|P1|Overall Study|Lost to Follow-up|2
4744120|NCT01806389|16364941|P1|Overall Study|Withdrawal by Subject|4
4744121|NCT01806298|16364955|P1|Overall Study|Other|5
4744122|NCT01806298|16364955|P1|Overall Study|Withdrawal by Subject|1
4744123|NCT01806298|16364955|P1|Overall Study|Protocol Non-compliance|1
4744124|NCT01806298|16364955|P1|Overall Study|Adverse Event|3
4744125|NCT01806064|16364981|P5|Overall Study|Randomized Not Enrolled|2
4744126|NCT01806064|16364982|P4|Overall Study|Randomized Not Enrolled|1
4744127|NCT01806064|16364983|P3|Overall Study|Randomized Not Enrolled|0
4744128|NCT01806064|16364984|P2|Overall Study|Randomized Not Enrolled|0
4744129|NCT01806064|16364985|P1|Overall Study|Randomized Not Enrolled|0
4744130|NCT01806051|16365010|P1|Overall Study|Withdrawal by Subject|6
4744131|NCT01805180|16365127|P3|Lead-in Donor Phase|screen failure|0
4744132|NCT01805180|16365128|P2|Lead-in Donor Phase|screen failure|0
4744133|NCT01805180|16365129|P1|Lead-in Donor Phase|screen failure|1
4744134|NCT01804946|16365204|P2|Overall Study|Do not meet inclusion criteria|2
4744135|NCT01804946|16365205|P1|Overall Study|Do not meet inclusion criteria|1
4744136|NCT01804946|16365204|P2|Overall Study|Insufficient data available|1
4744138|NCT01804946|16365204|P2|Overall Study|Adverse Event|1
4744139|NCT01804946|16365205|P1|Overall Study|Adverse Event|0
4744140|NCT01804946|16365204|P2|Overall Study|Protocol Violation|0
4744141|NCT01804946|16365205|P1|Overall Study|Protocol Violation|1
4744142|NCT01804842|16365243|P3|Overall Study|Personal Reason|1
4744143|NCT01804842|16365244|P2|Overall Study|Personal Reason|0
4744144|NCT01804842|16365245|P1|Overall Study|Personal Reason|0
4744145|NCT01804842|16365243|P3|Overall Study|Non-Compliance|0
4744146|NCT01804842|16365244|P2|Overall Study|Non-Compliance|1
4744147|NCT01804842|16365245|P1|Overall Study|Non-Compliance|1
4744148|NCT01804842|16365243|P3|Overall Study|Lost to Follow-up|0
4744149|NCT01804842|16365244|P2|Overall Study|Lost to Follow-up|0
4744150|NCT01804842|16365245|P1|Overall Study|Lost to Follow-up|1
4744151|NCT01804842|16365243|P3|Overall Study|Adverse Event|0
4744152|NCT01804842|16365244|P2|Overall Study|Adverse Event|1
4744153|NCT01804842|16365245|P1|Overall Study|Adverse Event|1
4744154|NCT01804816|16365262|P1|Acupuncture (Second 5 Weeks)|Physician Decision|1
4744155|NCT01804816|16365262|P1|No Acupuncture (Initial 5 Weeks)|Withdrawal by Subject|3
4744156|NCT01804673|16365274|P1|Overall Study|Other|4
4744157|NCT01804673|16365274|P1|Overall Study|Use of Prohibited Medication|1
4744158|NCT01804673|16365274|P1|Overall Study|No Further Therapy Required|84
4744159|NCT01804673|16365274|P1|Overall Study|Change to Oral Therapy|37
4744160|NCT01804673|16365274|P1|Overall Study|Lack of Efficacy|9
4744161|NCT01804673|16365274|P1|Overall Study|Withdrawal by Subject|1
4744162|NCT01804673|16365274|P1|Overall Study|Adverse Event|4
4744163|NCT01804582|16365292|P2|Overall Study|Physician Decision|0
4744164|NCT01804582|16365293|P1|Overall Study|Physician Decision|2
4744165|NCT01804582|16365292|P2|Overall Study|Lost to Follow-up|56
4744166|NCT01804582|16365293|P1|Overall Study|Lost to Follow-up|47
4744167|NCT01804140|16365313|P1|Overall Study|No sampling or biopsy procedures done|114
4744168|NCT01804049|16365347|P2|Overall Study|Enrollment in dual studies|1
4744169|NCT01804049|16365348|P1|Overall Study|Enrollment in dual studies|0
4744170|NCT01804049|16365347|P2|Overall Study|other MD recommended|1
4744171|NCT01804049|16365348|P1|Overall Study|other MD recommended|1
4744172|NCT01804049|16365347|P2|Overall Study|Moved out of area|7
4744173|NCT01804049|16365348|P1|Overall Study|Moved out of area|0
4744174|NCT01804049|16365347|P2|Overall Study|Other health concerns|7
4744175|NCT01804049|16365348|P1|Overall Study|Other health concerns|2
4744176|NCT01804049|16365347|P2|Overall Study|Decreased interest/personal|5
4744177|NCT01804049|16365348|P1|Overall Study|Decreased interest/personal|4
4744178|NCT01804049|16365347|P2|Overall Study|Lost to Follow-up|1
4744179|NCT01804049|16365348|P1|Overall Study|Lost to Follow-up|2
4744180|NCT01804049|16365347|P2|Overall Study|Adverse Event|10
4744181|NCT01804049|16365348|P1|Overall Study|Adverse Event|2
4744182|NCT01803880|16365396|P3|Overall Study|Incomplete data entry by sites|0
4744183|NCT01803880|16365397|P2|Overall Study|Incomplete data entry by sites|0
4744184|NCT01803880|16365398|P1|Overall Study|Incomplete data entry by sites|2
4744185|NCT01803880|16365396|P3|Overall Study|Early study termination|5
4744186|NCT01803880|16365397|P2|Overall Study|Early study termination|6
4744187|NCT01803880|16365398|P1|Overall Study|Early study termination|0
4744188|NCT01803880|16365396|P3|Overall Study|Protocol Violation|0
4744189|NCT01803880|16365397|P2|Overall Study|Protocol Violation|0
4744190|NCT01803880|16365398|P1|Overall Study|Protocol Violation|1
4744191|NCT01803880|16365396|P3|Overall Study|Lost to Follow-up|3
4744192|NCT01803880|16365397|P2|Overall Study|Lost to Follow-up|2
4744193|NCT01803880|16365398|P1|Overall Study|Lost to Follow-up|1
4744194|NCT01803880|16365396|P3|Overall Study|Unable to return for follow-up visits|2
4744195|NCT01803880|16365397|P2|Overall Study|Unable to return for follow-up visits|1
4744196|NCT01803880|16365398|P1|Overall Study|Unable to return for follow-up visits|0
4744197|NCT01803880|16365396|P3|Overall Study|Physician Decision|1
4744198|NCT01803880|16365397|P2|Overall Study|Physician Decision|0
4744199|NCT01803880|16365398|P1|Overall Study|Physician Decision|0
4744200|NCT01803880|16365396|P3|Overall Study|Withdrawal by Subject|4
4744201|NCT01803880|16365397|P2|Overall Study|Withdrawal by Subject|1
4744202|NCT01803880|16365398|P1|Overall Study|Withdrawal by Subject|1
4744203|NCT01803880|16365396|P3|Overall Study|Adverse Event|0
4744204|NCT01803880|16365397|P2|Overall Study|Adverse Event|0
4744205|NCT01803880|16365398|P1|Overall Study|Adverse Event|1
4744206|NCT01803737|16365434|P2|Overall Study|Lost to Follow-up|2
4744207|NCT01803737|16365435|P1|Overall Study|Lost to Follow-up|0
4744208|NCT01803737|16365434|P2|Overall Study|Medical Reason|1
4744209|NCT01803737|16365435|P1|Overall Study|Medical Reason|0
4744210|NCT01803737|16365434|P2|Overall Study|Lack of Time|0
4744211|NCT01803737|16365435|P1|Overall Study|Lack of Time|1
4744212|NCT01803711|16365459|P2|Overall Study|Adverse Event|1
4744213|NCT01803711|16365460|P1|Overall Study|Adverse Event|1
4744214|NCT01803646|16365478|P2|Overall Study|Lost to Follow-up|1
4744215|NCT01803646|16365479|P1|Overall Study|Lost to Follow-up|5
4744216|NCT01803646|16365478|P2|Overall Study|Randomization error|2
4744217|NCT01803646|16365479|P1|Overall Study|Randomization error|1
4744218|NCT01803646|16365478|P2|Overall Study|Withdrawal by Subject|6
4744219|NCT01803646|16365479|P1|Overall Study|Withdrawal by Subject|9
4744220|NCT01803646|16365478|P2|Overall Study|Adverse Event|1
4744221|NCT01803646|16365479|P1|Overall Study|Adverse Event|1
4744222|NCT01803646|16365478|P2|Overall Study|Protocol Violation|0
4744223|NCT01803646|16365479|P1|Overall Study|Protocol Violation|1
4744224|NCT01803607|16365491|P2|Overall Study|Withdrawal by Subject|5
4744225|NCT01803607|16365492|P1|Overall Study|Withdrawal by Subject|6
4744226|NCT01803607|16365491|P2|Overall Study|Study terminated by sponsor|56
4744227|NCT01803607|16365492|P1|Overall Study|Study terminated by sponsor|54
4744228|NCT01803607|16365491|P2|Overall Study|Protocol Violation|2
4744229|NCT01803607|16365492|P1|Overall Study|Protocol Violation|3
4744230|NCT01803607|16365491|P2|Overall Study|Lack of Efficacy|1
4744231|NCT01803607|16365492|P1|Overall Study|Lack of Efficacy|0
4744232|NCT01803607|16365491|P2|Overall Study|Adverse Event|3
4744233|NCT01803607|16365492|P1|Overall Study|Adverse Event|5
4744234|NCT01803464|16365516|P4|Overall Study|Withdrawal by Subject|0
4744235|NCT01803464|16365517|P3|Overall Study|Withdrawal by Subject|0
4744236|NCT01803464|16365518|P2|Overall Study|Withdrawal by Subject|0
4744237|NCT01803464|16365519|P1|Overall Study|Withdrawal by Subject|1
4744238|NCT01803464|16365516|P4|Overall Study|Incomplete data|0
4744239|NCT01803464|16365517|P3|Overall Study|Incomplete data|4
4744240|NCT01803464|16365518|P2|Overall Study|Incomplete data|0
4744241|NCT01803464|16365519|P1|Overall Study|Incomplete data|0
4744242|NCT01803282|16365549|P12|Overall Study|Enrolled but Never Treated|0
4744243|NCT01803282|16365550|P11|Overall Study|Enrolled but Never Treated|0
4744244|NCT01803282|16365551|P10|Overall Study|Enrolled but Never Treated|1
4744245|NCT01803282|16365552|P9|Overall Study|Enrolled but Never Treated|0
4744246|NCT01803282|16365553|P8|Overall Study|Enrolled but Never Treated|1
4744247|NCT01803282|16365554|P7|Overall Study|Enrolled but Never Treated|1
4744248|NCT01803282|16365555|P6|Overall Study|Enrolled but Never Treated|0
4744249|NCT01803282|16365556|P5|Overall Study|Enrolled but Never Treated|1
4744250|NCT01803282|16365557|P4|Overall Study|Enrolled but Never Treated|0
4744251|NCT01803282|16365558|P3|Overall Study|Enrolled but Never Treated|0
4744252|NCT01803282|16365559|P2|Overall Study|Enrolled but Never Treated|0
4744253|NCT01803282|16365560|P1|Overall Study|Enrolled but Never Treated|0
4744254|NCT01803282|16365549|P12|Overall Study|Specified Criteria for Withdrawal|0
4744255|NCT01803282|16365550|P11|Overall Study|Specified Criteria for Withdrawal|1
4744256|NCT01803282|16365551|P10|Overall Study|Specified Criteria for Withdrawal|1
4744257|NCT01803282|16365552|P9|Overall Study|Specified Criteria for Withdrawal|0
4744258|NCT01803282|16365553|P8|Overall Study|Specified Criteria for Withdrawal|0
4744259|NCT01803282|16365554|P7|Overall Study|Specified Criteria for Withdrawal|0
4744260|NCT01803282|16365555|P6|Overall Study|Specified Criteria for Withdrawal|0
4744261|NCT01803282|16365556|P5|Overall Study|Specified Criteria for Withdrawal|0
4744262|NCT01803282|16365557|P4|Overall Study|Specified Criteria for Withdrawal|0
4744263|NCT01803282|16365558|P3|Overall Study|Specified Criteria for Withdrawal|0
4744264|NCT01803282|16365559|P2|Overall Study|Specified Criteria for Withdrawal|0
4744265|NCT01803282|16365560|P1|Overall Study|Specified Criteria for Withdrawal|0
4744266|NCT01803282|16365549|P12|Overall Study|Unknown Reason|0
4744267|NCT01803282|16365550|P11|Overall Study|Unknown Reason|0
4744268|NCT01803282|16365551|P10|Overall Study|Unknown Reason|0
4744269|NCT01803282|16365552|P9|Overall Study|Unknown Reason|0
4744270|NCT01803282|16365553|P8|Overall Study|Unknown Reason|1
4744271|NCT01803282|16365554|P7|Overall Study|Unknown Reason|0
4744272|NCT01803282|16365555|P6|Overall Study|Unknown Reason|0
4744273|NCT01803282|16365556|P5|Overall Study|Unknown Reason|0
4744274|NCT01803282|16365557|P4|Overall Study|Unknown Reason|0
4744275|NCT01803282|16365558|P3|Overall Study|Unknown Reason|0
4744276|NCT01803282|16365559|P2|Overall Study|Unknown Reason|0
4744277|NCT01803282|16365560|P1|Overall Study|Unknown Reason|0
4744278|NCT01803282|16365549|P12|Overall Study|Non-Compliance with Study Drug|0
4744279|NCT01803282|16365550|P11|Overall Study|Non-Compliance with Study Drug|0
4744280|NCT01803282|16365551|P10|Overall Study|Non-Compliance with Study Drug|0
4744281|NCT01803282|16365552|P9|Overall Study|Non-Compliance with Study Drug|0
4744282|NCT01803282|16365553|P8|Overall Study|Non-Compliance with Study Drug|0
4744283|NCT01803282|16365554|P7|Overall Study|Non-Compliance with Study Drug|0
4744284|NCT01803282|16365555|P6|Overall Study|Non-Compliance with Study Drug|0
4744285|NCT01803282|16365556|P5|Overall Study|Non-Compliance with Study Drug|0
4744286|NCT01803282|16365557|P4|Overall Study|Non-Compliance with Study Drug|1
4744287|NCT01803282|16365558|P3|Overall Study|Non-Compliance with Study Drug|0
4744288|NCT01803282|16365559|P2|Overall Study|Non-Compliance with Study Drug|0
4744289|NCT01803282|16365560|P1|Overall Study|Non-Compliance with Study Drug|0
4744290|NCT01803282|16365549|P12|Overall Study|Adverse Event|3
4744291|NCT01803282|16365550|P11|Overall Study|Adverse Event|0
4744292|NCT01803282|16365551|P10|Overall Study|Adverse Event|1
4744293|NCT01803282|16365552|P9|Overall Study|Adverse Event|0
4744294|NCT01803282|16365553|P8|Overall Study|Adverse Event|2
4744295|NCT01803282|16365554|P7|Overall Study|Adverse Event|1
4744296|NCT01803282|16365555|P6|Overall Study|Adverse Event|0
4744297|NCT01803282|16365556|P5|Overall Study|Adverse Event|0
4744298|NCT01803282|16365557|P4|Overall Study|Adverse Event|0
4744299|NCT01803282|16365558|P3|Overall Study|Adverse Event|0
4744300|NCT01803282|16365559|P2|Overall Study|Adverse Event|0
4744301|NCT01803282|16365560|P1|Overall Study|Adverse Event|0
4744302|NCT01803282|16365549|P12|Overall Study|Investigator's Discretion|0
4744303|NCT01803282|16365550|P11|Overall Study|Investigator's Discretion|1
4744304|NCT01803282|16365551|P10|Overall Study|Investigator's Discretion|7
4744305|NCT01803282|16365552|P9|Overall Study|Investigator's Discretion|6
4744306|NCT01803282|16365553|P8|Overall Study|Investigator's Discretion|10
4744307|NCT01803282|16365554|P7|Overall Study|Investigator's Discretion|7
4744308|NCT01803282|16365555|P6|Overall Study|Investigator's Discretion|1
4744309|NCT01803282|16365556|P5|Overall Study|Investigator's Discretion|2
4744310|NCT01803282|16365557|P4|Overall Study|Investigator's Discretion|7
4744311|NCT01803282|16365558|P3|Overall Study|Investigator's Discretion|0
4744312|NCT01803282|16365559|P2|Overall Study|Investigator's Discretion|0
4744313|NCT01803282|16365560|P1|Overall Study|Investigator's Discretion|0
4744314|NCT01803282|16365549|P12|Overall Study|Withdrew Consent|1
4744315|NCT01803282|16365550|P11|Overall Study|Withdrew Consent|0
4744316|NCT01803282|16365551|P10|Overall Study|Withdrew Consent|5
4744317|NCT01803282|16365552|P9|Overall Study|Withdrew Consent|1
4744318|NCT01803282|16365553|P8|Overall Study|Withdrew Consent|3
4744319|NCT01803282|16365554|P7|Overall Study|Withdrew Consent|8
4744320|NCT01803282|16365555|P6|Overall Study|Withdrew Consent|0
4744321|NCT01803282|16365556|P5|Overall Study|Withdrew Consent|1
4744322|NCT01803282|16365557|P4|Overall Study|Withdrew Consent|6
4744323|NCT01803282|16365558|P3|Overall Study|Withdrew Consent|0
4744324|NCT01803282|16365559|P2|Overall Study|Withdrew Consent|0
4744325|NCT01803282|16365560|P1|Overall Study|Withdrew Consent|0
4744326|NCT01803282|16365549|P12|Overall Study|Death|0
4744327|NCT01803282|16365550|P11|Overall Study|Death|0
4744328|NCT01803282|16365551|P10|Overall Study|Death|1
4744329|NCT01803282|16365552|P9|Overall Study|Death|1
4744330|NCT01803282|16365553|P8|Overall Study|Death|5
4744331|NCT01803282|16365554|P7|Overall Study|Death|1
4744332|NCT01803282|16365555|P6|Overall Study|Death|1
4744333|NCT01803282|16365556|P5|Overall Study|Death|2
4744334|NCT01803282|16365557|P4|Overall Study|Death|0
4744335|NCT01803282|16365558|P3|Overall Study|Death|0
4744336|NCT01803282|16365559|P2|Overall Study|Death|0
4744337|NCT01803282|16365560|P1|Overall Study|Death|0
4744338|NCT01803282|16365549|P12|Overall Study|Progressive Disease|11
4744339|NCT01803282|16365550|P11|Overall Study|Progressive Disease|6
4744340|NCT01803282|16365551|P10|Overall Study|Progressive Disease|29
4744341|NCT01803282|16365552|P9|Overall Study|Progressive Disease|3
4744342|NCT01803282|16365553|P8|Overall Study|Progressive Disease|24
4744343|NCT01803282|16365554|P7|Overall Study|Progressive Disease|23
4744344|NCT01803282|16365555|P6|Overall Study|Progressive Disease|8
4744345|NCT01803282|16365556|P5|Overall Study|Progressive Disease|5
4744346|NCT01803282|16365557|P4|Overall Study|Progressive Disease|22
4744347|NCT01803282|16365558|P3|Overall Study|Progressive Disease|6
4744348|NCT01803282|16365559|P2|Overall Study|Progressive Disease|3
4744349|NCT01803282|16365560|P1|Overall Study|Progressive Disease|4
4744350|NCT01803269|16365601|P3|Overall Study|Withdrawal by Subject|0
4744351|NCT01803269|16365602|P2|Overall Study|Withdrawal by Subject|0
4744352|NCT01803269|16365603|P1|Overall Study|Withdrawal by Subject|3
4744353|NCT01802879|16365917|P1|Overall Study|Disease progression|6
4744354|NCT01802879|16365917|P1|Overall Study|Administrative problems|2
4744355|NCT01802775|16365924|P2|Overall Study|Lost to Follow-up|2
4744356|NCT01802775|16365925|P1|Overall Study|Lost to Follow-up|1
4744357|NCT01802775|16365924|P2|Overall Study|Withdrawal by Subject|5
4744358|NCT01802775|16365925|P1|Overall Study|Withdrawal by Subject|3
4744359|NCT01802775|16365924|P2|Overall Study|Adverse Event|1
4744360|NCT01802775|16365925|P1|Overall Study|Adverse Event|1
4744361|NCT01802775|16365924|P2|Overall Study|Physician Decision|0
4744362|NCT01802775|16365925|P1|Overall Study|Physician Decision|1
4744363|NCT01802775|16365924|P2|Overall Study|Reason not provided|1
4744364|NCT01802775|16365925|P1|Overall Study|Reason not provided|0
4744365|NCT01802775|16365924|P2|Overall Study|Death|3
4744366|NCT01802775|16365925|P1|Overall Study|Death|0
4744367|NCT01802580|16365956|P2|Overall Study|Lack of Efficacy|2
4744368|NCT01802580|16365957|P1|Overall Study|Lack of Efficacy|0
4744369|NCT01802580|16365956|P2|Overall Study|Other|3
4744370|NCT01802580|16365957|P1|Overall Study|Other|1
4744371|NCT01802580|16365956|P2|Overall Study|Withdrawal by Subject|6
4744372|NCT01802580|16365957|P1|Overall Study|Withdrawal by Subject|5
4744373|NCT01802580|16365956|P2|Overall Study|Protocol Violation|0
4744374|NCT01802580|16365957|P1|Overall Study|Protocol Violation|2
4744375|NCT01802580|16365956|P2|Overall Study|Physician Decision|0
4744376|NCT01802580|16365957|P1|Overall Study|Physician Decision|1
4744377|NCT01802515|16365988|P3|Overall Study|Withdrawal by Subject|0
4744378|NCT01802515|16365989|P2|Overall Study|Withdrawal by Subject|0
4744379|NCT01802515|16365990|P1|Overall Study|Withdrawal by Subject|3
4744380|NCT01802437|16366003|P2|Overall Study|Withdrawal by Subject|4
4744381|NCT01802437|16366004|P1|Overall Study|Withdrawal by Subject|3
4744382|NCT01802437|16366003|P2|Overall Study|Lost to Follow-up|0
4744383|NCT01802437|16366004|P1|Overall Study|Lost to Follow-up|1
4744384|NCT01802385|16366016|P2|Overall Study|Death|120
4744385|NCT01802385|16366017|P1|Overall Study|Death|106
4744386|NCT01802333|16366040|P3|Overall Study|Did not start treatment|5
4744387|NCT01802333|16366041|P2|Overall Study|Did not start treatment|2
4744388|NCT01802333|16366042|P1|Overall Study|Did not start treatment|0
4744389|NCT01802333|16366040|P3|Overall Study|Other - not protocol specified|24
4744390|NCT01802333|16366041|P2|Overall Study|Other - not protocol specified|22
4744391|NCT01802333|16366042|P1|Overall Study|Other - not protocol specified|32
4744392|NCT01802333|16366040|P3|Overall Study|Death|13
4744393|NCT01802333|16366041|P2|Overall Study|Death|14
4744394|NCT01802333|16366042|P1|Overall Study|Death|7
4744395|NCT01802333|16366040|P3|Overall Study|Progression/relapse|0
4744396|NCT01802333|16366041|P2|Overall Study|Progression/relapse|3
4744397|NCT01802333|16366042|P1|Overall Study|Progression/relapse|1
4744398|NCT01802333|16366040|P3|Overall Study|Withdrawal by Subject|5
4744399|NCT01802333|16366041|P2|Overall Study|Withdrawal by Subject|6
4744400|NCT01802333|16366042|P1|Overall Study|Withdrawal by Subject|6
4744401|NCT01802333|16366040|P3|Overall Study|Adverse Event|8
4744402|NCT01802333|16366041|P2|Overall Study|Adverse Event|8
4744403|NCT01802333|16366042|P1|Overall Study|Adverse Event|1
4744404|NCT01802333|16366040|P3|Overall Study|Ineligible|8
4744405|NCT01802333|16366041|P2|Overall Study|Ineligible|6
4744406|NCT01802333|16366042|P1|Overall Study|Ineligible|2
4744407|NCT01802320|16366069|P1|Overall Study|Withdrawal by Subject|1
4744408|NCT01802320|16366069|P1|Overall Study|Death|1
4744409|NCT01802216|16366079|P2|12 Month Visit|Participant did not show to visit|4
4744410|NCT01802216|16366080|P1|12 Month Visit|Participant did not show to visit|3
4744411|NCT01802216|16366079|P2|8 Month Visit|Participant did not show to visit|5
4744412|NCT01802216|16366080|P1|8 Month Visit|Participant did not show to visit|3
4744413|NCT01802216|16366079|P2|4 Month Visit|Participant did not show to visit|4
4744414|NCT01802216|16366080|P1|4 Month Visit|Participant did not show to visit|3
4744415|NCT01802073|16366159|P2|Overall Study|Physician Decision|7
4744416|NCT01802073|16366160|P1|Overall Study|Physician Decision|0
4744417|NCT01802073|16366159|P2|Overall Study|Withdrawal by Subject|1
4744418|NCT01802073|16366160|P1|Overall Study|Withdrawal by Subject|1
4744419|NCT01802073|16366159|P2|Overall Study|Non-compliant|2
4744420|NCT01802073|16366160|P1|Overall Study|Non-compliant|4
4744421|NCT01802073|16366159|P2|Overall Study|Lost to Follow-up|1
4744422|NCT01802073|16366160|P1|Overall Study|Lost to Follow-up|0
4744423|NCT01801982|16366176|P1|Overall Study|Lost to Follow-up|1
4744424|NCT01801917|16366190|P4|Period 1 - Randomized|Adverse Event|0
4744425|NCT01801917|16366191|P3|Period 1 - Randomized|Adverse Event|1
4744426|NCT01801917|16366192|P2|Period 1 - Randomized|Adverse Event|0
4744427|NCT01801917|16366193|P1|Period 1 - Randomized|Adverse Event|1
4744428|NCT01801865|16366213|P1|Overall Study|Physician Decision|7
4744429|NCT01801865|16366213|P1|Overall Study|Patients scanned on another MRI scanner|35
4744430|NCT01801735|16366218|P1|Overall Study|Other, including site closure|19
4744431|NCT01801735|16366218|P1|Overall Study|Death|1
4744432|NCT01801735|16366218|P1|Overall Study|Physician Decision|3
4744433|NCT01801735|16366218|P1|Overall Study|Non-compliance with Trial Drug|13
4744434|NCT01801735|16366218|P1|Overall Study|Lost to Follow-up|15
4744435|NCT01801735|16366218|P1|Overall Study|Protocol Violation|25
4744436|NCT01801735|16366218|P1|Overall Study|Withdrawal by Subject|27
4744437|NCT01801735|16366218|P1|Overall Study|Lack of Efficacy|28
4744438|NCT01801735|16366218|P1|Overall Study|Adverse Event|79
4744439|NCT01801475|16366225|P5|Overall Study|Withdrawal by Subject|1
4744440|NCT01801475|16366226|P4|Overall Study|Withdrawal by Subject|0
4744441|NCT01801475|16366227|P3|Overall Study|Withdrawal by Subject|0
4744442|NCT01801475|16366228|P2|Overall Study|Withdrawal by Subject|0
4744443|NCT01801475|16366229|P1|Overall Study|Withdrawal by Subject|0
4744444|NCT01801436|16366254|P1|Overall Study|Progressive disease|4
4744445|NCT01801436|16366254|P1|Overall Study|Adverse Event|2
4744446|NCT01801436|16366254|P1|Overall Study|Withdrawal by Subject|3
4744447|NCT01801358|16366292|P6|Overall Study|Withdrawal by Subject|2
4744448|NCT01801358|16366293|P5|Overall Study|Withdrawal by Subject|0
4744449|NCT01801358|16366294|P4|Overall Study|Withdrawal by Subject|1
4744450|NCT01801358|16366295|P3|Overall Study|Withdrawal by Subject|0
4744451|NCT01801358|16366296|P2|Overall Study|Withdrawal by Subject|0
4744452|NCT01801358|16366297|P1|Overall Study|Withdrawal by Subject|0
4744453|NCT01801358|16366292|P6|Overall Study|Progressive Disease|5
4744454|NCT01801358|16366293|P5|Overall Study|Progressive Disease|6
4744455|NCT01801358|16366294|P4|Overall Study|Progressive Disease|5
4744456|NCT01801358|16366295|P3|Overall Study|Progressive Disease|4
4744457|NCT01801358|16366296|P2|Overall Study|Progressive Disease|4
4744458|NCT01801358|16366297|P1|Overall Study|Progressive Disease|6
4744459|NCT01801358|16366292|P6|Overall Study|Physician Decision|0
4744460|NCT01801358|16366293|P5|Overall Study|Physician Decision|0
4744461|NCT01801358|16366294|P4|Overall Study|Physician Decision|0
4744462|NCT01801358|16366295|P3|Overall Study|Physician Decision|1
4744463|NCT01801358|16366296|P2|Overall Study|Physician Decision|0
4744464|NCT01801358|16366297|P1|Overall Study|Physician Decision|0
4744465|NCT01801358|16366292|P6|Overall Study|Adverse Event|1
4744466|NCT01801358|16366293|P5|Overall Study|Adverse Event|0
4744467|NCT01801358|16366294|P4|Overall Study|Adverse Event|0
4744468|NCT01801358|16366295|P3|Overall Study|Adverse Event|1
4744469|NCT01801358|16366296|P2|Overall Study|Adverse Event|2
4744470|NCT01801358|16366297|P1|Overall Study|Adverse Event|0
4744471|NCT01801280|16366419|P4|Period 4|Protocol Violation|0
4744472|NCT01801280|16366420|P3|Period 4|Protocol Violation|1
4744473|NCT01801280|16366421|P2|Period 4|Protocol Violation|0
4744474|NCT01801280|16366422|P1|Period 4|Protocol Violation|0
4744475|NCT01801280|16366419|P4|Period 2|Withdrawal by Subject|0
4744476|NCT01801280|16366420|P3|Period 2|Withdrawal by Subject|0
4744477|NCT01801280|16366421|P2|Period 2|Withdrawal by Subject|0
4744478|NCT01801280|16366422|P1|Period 2|Withdrawal by Subject|1
4744479|NCT01801280|16366419|P4|Period 1|Withdrawal by Subject|0
4744480|NCT01801280|16366420|P3|Period 1|Withdrawal by Subject|0
4744481|NCT01801280|16366421|P2|Period 1|Withdrawal by Subject|1
4744482|NCT01801280|16366422|P1|Period 1|Withdrawal by Subject|0
4744483|NCT01801111|16366437|P1|Overall Study|Progressive Disease|81
4744484|NCT01801111|16366437|P1|Overall Study|Study Terminated by Sponsor|27
4744485|NCT01801111|16366437|P1|Overall Study|Withdrawal by Subject|4
4744486|NCT01801111|16366437|P1|Overall Study|Other|1
4744487|NCT01801111|16366437|P1|Overall Study|Physician Decision|5
4744488|NCT01801111|16366437|P1|Overall Study|Death|8
4744489|NCT01801111|16366437|P1|Overall Study|Adverse Event|12
4744490|NCT01801007|16366476|P1|Overall Study|Withdrawal by Subject|5
4744491|NCT01801007|16366476|P1|Overall Study|Lost to Follow-up|4
4744492|NCT01801007|16366476|P1|Overall Study|Adverse Event|2
4744493|NCT01800968|16366489|P2|Overall Study|Physician Decision|0
4744494|NCT01800968|16366490|P1|Overall Study|Physician Decision|1
4744495|NCT01800968|16366489|P2|Overall Study|Withdrawal by Subject|9
4744496|NCT01800968|16366490|P1|Overall Study|Withdrawal by Subject|7
4744497|NCT01800968|16366489|P2|Overall Study|Lost to Follow-up|7
4744498|NCT01800968|16366490|P1|Overall Study|Lost to Follow-up|5
4744499|NCT01800968|16366489|P2|Overall Study|Death|16
4744500|NCT01800968|16366490|P1|Overall Study|Death|23
4744501|NCT01800916|16366532|P9|Test Period 1 (1 Week)|Adverse Event|0
4744502|NCT01800916|16366533|P8|Test Period 1 (1 Week)|Adverse Event|0
4744503|NCT01800916|16366534|P7|Test Period 1 (1 Week)|Adverse Event|0
4744504|NCT01800916|16366535|P6|Test Period 1 (1 Week)|Adverse Event|0
4744505|NCT01800916|16366536|P5|Test Period 1 (1 Week)|Adverse Event|1
4744506|NCT01800916|16366537|P4|Test Period 1 (1 Week)|Adverse Event|0
4744507|NCT01800916|16366538|P3|Test Period 1 (1 Week)|Adverse Event|0
4744508|NCT01800916|16366539|P2|Test Period 1 (1 Week)|Adverse Event|0
4744509|NCT01800916|16366540|P1|Test Period 1 (1 Week)|Adverse Event|0
4744510|NCT01800916|16366532|P9|Test Period 1 (1 Week)|Convex product user|0
4744511|NCT01800916|16366533|P8|Test Period 1 (1 Week)|Convex product user|0
4744512|NCT01800916|16366534|P7|Test Period 1 (1 Week)|Convex product user|0
4744513|NCT01800916|16366535|P6|Test Period 1 (1 Week)|Convex product user|0
4744514|NCT01800916|16366536|P5|Test Period 1 (1 Week)|Convex product user|0
4744515|NCT01800916|16366537|P4|Test Period 1 (1 Week)|Convex product user|1
4744516|NCT01800916|16366538|P3|Test Period 1 (1 Week)|Convex product user|0
4744517|NCT01800916|16366539|P2|Test Period 1 (1 Week)|Convex product user|0
4744518|NCT01800916|16366540|P1|Test Period 1 (1 Week)|Convex product user|0
4744519|NCT01800903|16366550|P6|Second Test Period|unable to catheterise|0
4744520|NCT01800903|16366551|P5|Second Test Period|unable to catheterise|0
4744521|NCT01800903|16366552|P4|Second Test Period|unable to catheterise|0
4744522|NCT01800903|16366553|P3|Second Test Period|unable to catheterise|0
4744523|NCT01800903|16366554|P2|Second Test Period|unable to catheterise|0
4744524|NCT01800903|16366555|P1|Second Test Period|unable to catheterise|1
4744525|NCT01800201|16366644|P2|Overall Study|PI withdrawal, cognitive concerns|1
4744526|NCT01800201|16366645|P1|Overall Study|PI withdrawal, cognitive concerns|0
4744527|NCT01800201|16366644|P2|Overall Study|did not want to use device|1
4744528|NCT01800201|16366645|P1|Overall Study|did not want to use device|0
4744529|NCT01800201|16366644|P2|Overall Study|patient privacy concerns|1
4744530|NCT01800201|16366645|P1|Overall Study|patient privacy concerns|1
4744531|NCT01800201|16366644|P2|Overall Study|Withdrawal by Subject|0
4744532|NCT01800201|16366645|P1|Overall Study|Withdrawal by Subject|2
4744533|NCT01800058|16366686|P1|Overall Study|Lost to Follow-up|1
4744534|NCT01799993|16366699|P2|Overall Study|Subject didn't return for follow-up|1
4744535|NCT01799993|16366700|P1|Overall Study|Subject didn't return for follow-up|0
4744536|NCT01799993|16366699|P2|Overall Study|Other|0
4744537|NCT01799993|16366700|P1|Overall Study|Other|1
4744538|NCT01799993|16366699|P2|Overall Study|Withdrawal by parent/guardian|1
4744539|NCT01799993|16366700|P1|Overall Study|Withdrawal by parent/guardian|0
4744540|NCT01799993|16366699|P2|Overall Study|Non-compliance with medical device|0
4744541|NCT01799993|16366700|P1|Overall Study|Non-compliance with medical device|1
4744542|NCT01799993|16366699|P2|Overall Study|Protocol deviation|0
4744543|NCT01799993|16366700|P1|Overall Study|Protocol deviation|1
4744544|NCT01799993|16366699|P2|Overall Study|Logistical difficulties|0
4744545|NCT01799993|16366700|P1|Overall Study|Logistical difficulties|1
4744546|NCT01799993|16366699|P2|Overall Study|Recovery|1
4744547|NCT01799993|16366700|P1|Overall Study|Recovery|0
4744548|NCT01799993|16366699|P2|Overall Study|Lack of Efficacy|0
4744549|NCT01799993|16366700|P1|Overall Study|Lack of Efficacy|1
4744550|NCT01799993|16366699|P2|Overall Study|Adverse Event|0
4744551|NCT01799993|16366700|P1|Overall Study|Adverse Event|1
4744552|NCT01799993|16366699|P2|Overall Study|Screen failure|1
4744553|NCT01799993|16366700|P1|Overall Study|Screen failure|0
4744554|NCT01799993|16366699|P2|Overall Study|Deterioration of general conditions|0
4744555|NCT01799993|16366700|P1|Overall Study|Deterioration of general conditions|2
4744556|NCT01799993|16366699|P2|Overall Study|Protocol Violation|1
4744557|NCT01799993|16366700|P1|Overall Study|Protocol Violation|1
4744558|NCT01799993|16366699|P2|Overall Study|Protocol driven decision point|3
4744559|NCT01799993|16366700|P1|Overall Study|Protocol driven decision point|0
4744560|NCT01799993|16366699|P2|Overall Study|Withdrawal by parent/guardian/LAR|3
4744561|NCT01799993|16366700|P1|Overall Study|Withdrawal by parent/guardian/LAR|5
4744562|NCT01799993|16366699|P2|Overall Study|Lost to Follow-up|8
4744563|NCT01799993|16366700|P1|Overall Study|Lost to Follow-up|5
4744564|NCT01799993|16366699|P2|Overall Study|Withdrawal by Subject|24
4744565|NCT01799993|16366700|P1|Overall Study|Withdrawal by Subject|23
4744566|NCT01799993|16366699|P2|Overall Study|Death|45
4744567|NCT01799993|16366700|P1|Overall Study|Death|61
4744568|NCT01799993|16366699|P2|Overall Study|"Didn't complete CRF page End of FU"|40
4744569|NCT01799993|16366700|P1|Overall Study|"Didn't complete CRF page End of FU"|30
4744570|NCT01799941|16366732|P1|Overall Study|Other|15
4744571|NCT01799941|16366732|P1|Overall Study|Lost to Follow-up|17
4744572|NCT01799941|16366732|P1|Overall Study|Lack of Efficacy|3
4744573|NCT01799941|16366732|P1|Overall Study|Investigator Decision|4
4744574|NCT01799941|16366732|P1|Overall Study|Death|2
4744575|NCT01799941|16366732|P1|Overall Study|Withdrawal by Subject|21
4744576|NCT01799941|16366732|P1|Overall Study|Adverse Event|34
4744577|NCT01799889|16366798|P12|Overall Study|Non-Compliance With Study Drug|0
4744578|NCT01799889|16366799|P11|Overall Study|Non-Compliance With Study Drug|0
4744579|NCT01799889|16366800|P10|Overall Study|Non-Compliance With Study Drug|0
4744580|NCT01799889|16366801|P9|Overall Study|Non-Compliance With Study Drug|0
4744581|NCT01799889|16366802|P8|Overall Study|Non-Compliance With Study Drug|0
4744582|NCT01799889|16366803|P7|Overall Study|Non-Compliance With Study Drug|0
4744583|NCT01799889|16366804|P6|Overall Study|Non-Compliance With Study Drug|1
4744584|NCT01799889|16366805|P5|Overall Study|Non-Compliance With Study Drug|0
4744585|NCT01799889|16366806|P4|Overall Study|Non-Compliance With Study Drug|0
4744586|NCT01799889|16366807|P3|Overall Study|Non-Compliance With Study Drug|0
4744587|NCT01799889|16366808|P2|Overall Study|Non-Compliance With Study Drug|0
4744588|NCT01799889|16366809|P1|Overall Study|Non-Compliance With Study Drug|0
4744589|NCT01799889|16366798|P12|Overall Study|Withdrawal by Subject|1
4744590|NCT01799889|16366799|P11|Overall Study|Withdrawal by Subject|1
4744591|NCT01799889|16366800|P10|Overall Study|Withdrawal by Subject|1
4744592|NCT01799889|16366801|P9|Overall Study|Withdrawal by Subject|2
4744593|NCT01799889|16366802|P8|Overall Study|Withdrawal by Subject|1
4744594|NCT01799889|16366803|P7|Overall Study|Withdrawal by Subject|3
4744595|NCT01799889|16366804|P6|Overall Study|Withdrawal by Subject|1
4744596|NCT01799889|16366805|P5|Overall Study|Withdrawal by Subject|5
4744597|NCT01799889|16366806|P4|Overall Study|Withdrawal by Subject|0
4744598|NCT01799889|16366807|P3|Overall Study|Withdrawal by Subject|4
4744599|NCT01799889|16366808|P2|Overall Study|Withdrawal by Subject|6
4744600|NCT01799889|16366809|P1|Overall Study|Withdrawal by Subject|1
4744601|NCT01799889|16366798|P12|Overall Study|Study Terminated By Sponsor|0
4744602|NCT01799889|16366799|P11|Overall Study|Study Terminated By Sponsor|0
4744603|NCT01799889|16366800|P10|Overall Study|Study Terminated By Sponsor|1
4744604|NCT01799889|16366801|P9|Overall Study|Study Terminated By Sponsor|1
4744605|NCT01799889|16366802|P8|Overall Study|Study Terminated By Sponsor|2
4744606|NCT01799889|16366803|P7|Overall Study|Study Terminated By Sponsor|0
4744607|NCT01799889|16366804|P6|Overall Study|Study Terminated By Sponsor|1
4744608|NCT01799889|16366805|P5|Overall Study|Study Terminated By Sponsor|2
4744609|NCT01799889|16366806|P4|Overall Study|Study Terminated By Sponsor|0
4744610|NCT01799889|16366807|P3|Overall Study|Study Terminated By Sponsor|0
4744611|NCT01799889|16366808|P2|Overall Study|Study Terminated By Sponsor|0
4744612|NCT01799889|16366809|P1|Overall Study|Study Terminated By Sponsor|1
4744613|NCT01799889|16366798|P12|Overall Study|Specified Criteria for Withdrawal|0
4744614|NCT01799889|16366799|P11|Overall Study|Specified Criteria for Withdrawal|0
4744615|NCT01799889|16366800|P10|Overall Study|Specified Criteria for Withdrawal|0
4744616|NCT01799889|16366801|P9|Overall Study|Specified Criteria for Withdrawal|0
4744617|NCT01799889|16366802|P8|Overall Study|Specified Criteria for Withdrawal|0
4744618|NCT01799889|16366803|P7|Overall Study|Specified Criteria for Withdrawal|0
4744619|NCT01799889|16366804|P6|Overall Study|Specified Criteria for Withdrawal|0
4744620|NCT01799889|16366805|P5|Overall Study|Specified Criteria for Withdrawal|0
4744621|NCT01799889|16366806|P4|Overall Study|Specified Criteria for Withdrawal|0
4744622|NCT01799889|16366807|P3|Overall Study|Specified Criteria for Withdrawal|1
4744623|NCT01799889|16366808|P2|Overall Study|Specified Criteria for Withdrawal|1
4744624|NCT01799889|16366809|P1|Overall Study|Specified Criteria for Withdrawal|0
4744625|NCT01799889|16366798|P12|Overall Study|Progressive Disease|1
4744626|NCT01799889|16366799|P11|Overall Study|Progressive Disease|3
4744627|NCT01799889|16366800|P10|Overall Study|Progressive Disease|5
4744628|NCT01799889|16366801|P9|Overall Study|Progressive Disease|18
4744629|NCT01799889|16366802|P8|Overall Study|Progressive Disease|13
4744630|NCT01799889|16366803|P7|Overall Study|Progressive Disease|8
4744631|NCT01799889|16366804|P6|Overall Study|Progressive Disease|9
4744632|NCT01799889|16366805|P5|Overall Study|Progressive Disease|23
4744633|NCT01799889|16366806|P4|Overall Study|Progressive Disease|30
4744634|NCT01799889|16366807|P3|Overall Study|Progressive Disease|25
4744635|NCT01799889|16366808|P2|Overall Study|Progressive Disease|26
4744636|NCT01799889|16366809|P1|Overall Study|Progressive Disease|30
4744637|NCT01799889|16366798|P12|Overall Study|Physician Decision|1
4744638|NCT01799889|16366799|P11|Overall Study|Physician Decision|0
4744639|NCT01799889|16366800|P10|Overall Study|Physician Decision|0
4744640|NCT01799889|16366801|P9|Overall Study|Physician Decision|6
4744641|NCT01799889|16366802|P8|Overall Study|Physician Decision|2
4744642|NCT01799889|16366803|P7|Overall Study|Physician Decision|5
4744643|NCT01799889|16366804|P6|Overall Study|Physician Decision|5
4744644|NCT01799889|16366805|P5|Overall Study|Physician Decision|5
4744645|NCT01799889|16366806|P4|Overall Study|Physician Decision|4
4744646|NCT01799889|16366807|P3|Overall Study|Physician Decision|4
4744647|NCT01799889|16366808|P2|Overall Study|Physician Decision|2
4744648|NCT01799889|16366809|P1|Overall Study|Physician Decision|3
4744649|NCT01799889|16366798|P12|Overall Study|Lost to Follow-up|0
4744650|NCT01799889|16366799|P11|Overall Study|Lost to Follow-up|0
4744651|NCT01799889|16366800|P10|Overall Study|Lost to Follow-up|0
4744652|NCT01799889|16366801|P9|Overall Study|Lost to Follow-up|0
4744653|NCT01799889|16366802|P8|Overall Study|Lost to Follow-up|0
4744654|NCT01799889|16366803|P7|Overall Study|Lost to Follow-up|0
4744655|NCT01799889|16366804|P6|Overall Study|Lost to Follow-up|0
4744656|NCT01799889|16366805|P5|Overall Study|Lost to Follow-up|0
4744657|NCT01799889|16366806|P4|Overall Study|Lost to Follow-up|0
4744658|NCT01799889|16366807|P3|Overall Study|Lost to Follow-up|0
4744659|NCT01799889|16366808|P2|Overall Study|Lost to Follow-up|1
4744660|NCT01799889|16366809|P1|Overall Study|Lost to Follow-up|0
4744661|NCT01799889|16366798|P12|Overall Study|Lack of Efficacy|0
4744662|NCT01799889|16366799|P11|Overall Study|Lack of Efficacy|1
4744663|NCT01799889|16366800|P10|Overall Study|Lack of Efficacy|0
4744664|NCT01799889|16366801|P9|Overall Study|Lack of Efficacy|2
4744665|NCT01799889|16366802|P8|Overall Study|Lack of Efficacy|0
4744666|NCT01799889|16366803|P7|Overall Study|Lack of Efficacy|0
4744667|NCT01799889|16366804|P6|Overall Study|Lack of Efficacy|2
4744668|NCT01799889|16366805|P5|Overall Study|Lack of Efficacy|2
4744669|NCT01799889|16366806|P4|Overall Study|Lack of Efficacy|1
4744670|NCT01799889|16366807|P3|Overall Study|Lack of Efficacy|0
4744671|NCT01799889|16366808|P2|Overall Study|Lack of Efficacy|1
4744672|NCT01799889|16366809|P1|Overall Study|Lack of Efficacy|1
4744673|NCT01799889|16366798|P12|Overall Study|Death|0
4744674|NCT01799889|16366799|P11|Overall Study|Death|1
4744675|NCT01799889|16366800|P10|Overall Study|Death|0
4744676|NCT01799889|16366801|P9|Overall Study|Death|1
4744677|NCT01799889|16366802|P8|Overall Study|Death|0
4744678|NCT01799889|16366803|P7|Overall Study|Death|0
4744679|NCT01799889|16366804|P6|Overall Study|Death|0
4744680|NCT01799889|16366805|P5|Overall Study|Death|1
4744681|NCT01799889|16366806|P4|Overall Study|Death|3
4744682|NCT01799889|16366807|P3|Overall Study|Death|5
4744683|NCT01799889|16366808|P2|Overall Study|Death|0
4744684|NCT01799889|16366809|P1|Overall Study|Death|1
4744685|NCT01799889|16366798|P12|Overall Study|Adverse Event|0
4744686|NCT01799889|16366799|P11|Overall Study|Adverse Event|1
4744687|NCT01799889|16366800|P10|Overall Study|Adverse Event|1
4744688|NCT01799889|16366801|P9|Overall Study|Adverse Event|3
4744689|NCT01799889|16366802|P8|Overall Study|Adverse Event|2
4744690|NCT01799889|16366803|P7|Overall Study|Adverse Event|5
4744691|NCT01799889|16366804|P6|Overall Study|Adverse Event|1
4744692|NCT01799889|16366805|P5|Overall Study|Adverse Event|11
4744693|NCT01799889|16366806|P4|Overall Study|Adverse Event|1
4744694|NCT01799889|16366807|P3|Overall Study|Adverse Event|5
4744695|NCT01799889|16366808|P2|Overall Study|Adverse Event|4
4744696|NCT01799889|16366809|P1|Overall Study|Adverse Event|4
4744697|NCT01799720|16366910|P3|Overall Study|Pregnancy|1
4744698|NCT01799720|16366911|P2|Overall Study|Pregnancy|0
4744699|NCT01799720|16366912|P1|Overall Study|Pregnancy|0
4744700|NCT01799720|16366910|P3|Overall Study|Protocol Violation|0
4744701|NCT01799720|16366911|P2|Overall Study|Protocol Violation|1
4744702|NCT01799720|16366912|P1|Overall Study|Protocol Violation|0
4744703|NCT01799720|16366910|P3|Overall Study|Withdrawal by Subject|0
4744704|NCT01799720|16366911|P2|Overall Study|Withdrawal by Subject|0
4744705|NCT01799720|16366912|P1|Overall Study|Withdrawal by Subject|3
4744706|NCT01799590|16366950|P3|Overall Study|Other|1
4744707|NCT01799590|16366951|P2|Overall Study|Other|0
4744708|NCT01799590|16366952|P1|Overall Study|Other|3
4744709|NCT01799590|16366950|P3|Overall Study|Use of prohibited concomitant drugs|0
4744710|NCT01799590|16366951|P2|Overall Study|Use of prohibited concomitant drugs|0
4744711|NCT01799590|16366952|P1|Overall Study|Use of prohibited concomitant drugs|1
4744712|NCT01799590|16366950|P3|Overall Study|Using drugs with restricted days of use|2
4744713|NCT01799590|16366951|P2|Overall Study|Using drugs with restricted days of use|3
4744714|NCT01799590|16366952|P1|Overall Study|Using drugs with restricted days of use|0
4744715|NCT01799590|16366950|P3|Overall Study|Aggravation of complications|1
4744716|NCT01799590|16366951|P2|Overall Study|Aggravation of complications|1
4744717|NCT01799590|16366952|P1|Overall Study|Aggravation of complications|0
4744718|NCT01799590|16366950|P3|Overall Study|Participants convenience|2
4744719|NCT01799590|16366951|P2|Overall Study|Participants convenience|4
4744720|NCT01799590|16366952|P1|Overall Study|Participants convenience|4
4744721|NCT01799590|16366950|P3|Overall Study|Lack of Efficacy|3
4744722|NCT01799590|16366951|P2|Overall Study|Lack of Efficacy|1
4744723|NCT01799590|16366952|P1|Overall Study|Lack of Efficacy|3
4744724|NCT01799590|16366950|P3|Overall Study|Pregnancy|0
4744725|NCT01799590|16366951|P2|Overall Study|Pregnancy|0
4744726|NCT01799590|16366952|P1|Overall Study|Pregnancy|2
4744727|NCT01799590|16366950|P3|Overall Study|Adverse Event|5
4744728|NCT01799590|16366951|P2|Overall Study|Adverse Event|7
4744729|NCT01799590|16366952|P1|Overall Study|Adverse Event|13
4744730|NCT01799239|16366995|P2|Period 2 (7 Days)|Protocol Violation|0
4744731|NCT01799239|16366996|P1|Period 2 (7 Days)|Protocol Violation|1
4744732|NCT01799239|16366995|P2|Period 2 (7 Days)|Withdrawal by Subject|1
4744733|NCT01799239|16366996|P1|Period 2 (7 Days)|Withdrawal by Subject|1
4744734|NCT01799239|16366995|P2|Period 1 (7 Days)|Protocol Violation|1
4744735|NCT01799239|16366996|P1|Period 1 (7 Days)|Protocol Violation|0
4744736|NCT01799239|16366995|P2|Period 1 (7 Days)|Withdrawal by Subject|0
4744737|NCT01799239|16366996|P1|Period 1 (7 Days)|Withdrawal by Subject|2
4744738|NCT01799239|16366995|P2|Period 1 (7 Days)|Lack of Efficacy|0
4744739|NCT01799239|16366996|P1|Period 1 (7 Days)|Lack of Efficacy|1
4744740|NCT01799226|16367004|P2|Overall Study|Disqualified at Day 14|0
4744741|NCT01799226|16367005|P1|Overall Study|Disqualified at Day 14|1
4744742|NCT01799226|16367004|P2|Overall Study|Withdrawal by Subject|0
4744743|NCT01799226|16367005|P1|Overall Study|Withdrawal by Subject|1
4744744|NCT01798992|16367036|P4|Overall Study|Insufficient biopsy tissue|0
4744745|NCT01798992|16367037|P3|Overall Study|Insufficient biopsy tissue|1
4744746|NCT01798992|16367038|P2|Overall Study|Insufficient biopsy tissue|0
4744747|NCT01798992|16367039|P1|Overall Study|Insufficient biopsy tissue|0
4744748|NCT01798992|16367036|P4|Overall Study|Lost to Follow-up|0
4744749|NCT01798992|16367037|P3|Overall Study|Lost to Follow-up|1
4744750|NCT01798992|16367038|P2|Overall Study|Lost to Follow-up|1
4744751|NCT01798992|16367039|P1|Overall Study|Lost to Follow-up|0
4744752|NCT01798992|16367036|P4|Overall Study|Administrative withdrawal|1
4744753|NCT01798992|16367037|P3|Overall Study|Administrative withdrawal|0
4744754|NCT01798992|16367038|P2|Overall Study|Administrative withdrawal|1
4744755|NCT01798992|16367039|P1|Overall Study|Administrative withdrawal|0
4744756|NCT01798927|16367059|P1|Overall Study|Withdrawal by Subject|1
4744757|NCT01798849|16367068|P3|Overall Study|Physician Decision|1
4744758|NCT01798849|16367069|P2|Overall Study|Physician Decision|0
4744759|NCT01798849|16367070|P1|Overall Study|Physician Decision|0
4744760|NCT01798706|16367260|P2|Overall Study|Other than specified above|9
4744761|NCT01798706|16367261|P1|Overall Study|Other than specified above|5
4744762|NCT01798706|16367260|P2|Overall Study|Poor compliance to protocol|0
4744763|NCT01798706|16367261|P1|Overall Study|Poor compliance to protocol|1
4744764|NCT01798706|16367260|P2|Overall Study|Lack of Efficacy|2
4744765|NCT01798706|16367261|P1|Overall Study|Lack of Efficacy|0
4744766|NCT01798706|16367260|P2|Overall Study|Adverse Event|10
4744767|NCT01798706|16367261|P1|Overall Study|Adverse Event|15
4744768|NCT01798485|16367332|P2|Overall Study|Clinical Progression|24
4744769|NCT01798485|16367333|P1|Overall Study|Clinical Progression|35
4744770|NCT01798485|16367332|P2|Overall Study|Sponsor Decision|54
4744771|NCT01798485|16367333|P1|Overall Study|Sponsor Decision|61
4744772|NCT01798485|16367332|P2|Overall Study|Death|22
4744773|NCT01798485|16367333|P1|Overall Study|Death|25
4744774|NCT01798485|16367332|P2|Overall Study|Objective Disease Progression|106
4744775|NCT01798485|16367333|P1|Overall Study|Objective Disease Progression|152
4744776|NCT01798485|16367332|P2|Overall Study|Physician Decision|10
4744777|NCT01798485|16367333|P1|Overall Study|Physician Decision|14
4744778|NCT01798485|16367332|P2|Overall Study|Lost to Follow-up|3
4744779|NCT01798485|16367333|P1|Overall Study|Lost to Follow-up|0
4744780|NCT01798485|16367332|P2|Overall Study|Withdrawal by Subject|31
4744781|NCT01798485|16367333|P1|Overall Study|Withdrawal by Subject|27
4744782|NCT01798485|16367332|P2|Overall Study|Adverse Event|40
4744783|NCT01798485|16367333|P1|Overall Study|Adverse Event|32
4744784|NCT01798134|16367470|P1|Overall Study|Liver transplant/surgery|4
4744785|NCT01798134|16367470|P1|Overall Study|Physician Decision|3
4744786|NCT01798134|16367470|P1|Overall Study|Adverse Event|3
4744787|NCT01798134|16367470|P1|Overall Study|Death|2
4744788|NCT01798134|16367470|P1|Overall Study|Withdrawal by Subject|3
4744789|NCT01798134|16367470|P1|Overall Study|Lost to Follow-up|1
4744790|NCT01798056|16367479|P2|Overall Study|Other|2
4744791|NCT01798056|16367480|P1|Overall Study|Other|0
4744792|NCT01798056|16367479|P2|Overall Study|Lost to Follow-up|1
4744793|NCT01798056|16367480|P1|Overall Study|Lost to Follow-up|1
4744794|NCT01798056|16367479|P2|Overall Study|Migrated/moved from study area|1
4744795|NCT01798056|16367480|P1|Overall Study|Migrated/moved from study area|1
4744796|NCT01798056|16367479|P2|Overall Study|Withdrawal by Subject|9
4744797|NCT01798056|16367480|P1|Overall Study|Withdrawal by Subject|12
4744798|NCT01798056|16367479|P2|Overall Study|Serious Adverse Event|12
4744799|NCT01798056|16367480|P1|Overall Study|Serious Adverse Event|13
4744800|NCT01798004|16367514|P1|Overall Study|Enrollment another COG therapeutic trial|32
4744801|NCT01798004|16367514|P1|Overall Study|Initiation of other non-protocol therapy|5
4744802|NCT01798004|16367514|P1|Overall Study|Patient/parent refusal|7
4744803|NCT01798004|16367514|P1|Overall Study|Ineligible|4
4744804|NCT01798004|16367514|P1|Overall Study|Withdrawal by Subject|4
4744805|NCT01798004|16367514|P1|Overall Study|Physician Decision|25
4744806|NCT01798004|16367514|P1|Overall Study|Lack of Efficacy|8
4744807|NCT01798004|16367514|P1|Overall Study|Death|2
4744808|NCT01797965|16367522|P4|Overall Study|Reason Not Specified|15
4744809|NCT01797965|16367523|P3|Overall Study|Reason Not Specified|0
4744810|NCT01797965|16367524|P2|Overall Study|Reason Not Specified|295
4744811|NCT01797965|16367525|P1|Overall Study|Reason Not Specified|280
4744812|NCT01797965|16367522|P4|Overall Study|Disease progression, defined by protocol|0
4744813|NCT01797965|16367523|P3|Overall Study|Disease progression, defined by protocol|0
4744814|NCT01797965|16367524|P2|Overall Study|Disease progression, defined by protocol|1
4744815|NCT01797965|16367525|P1|Overall Study|Disease progression, defined by protocol|3
4744816|NCT01797965|16367522|P4|Overall Study|Death|0
4744817|NCT01797965|16367523|P3|Overall Study|Death|0
4744818|NCT01797965|16367524|P2|Overall Study|Death|4
4744819|NCT01797965|16367525|P1|Overall Study|Death|2
4744820|NCT01797965|16367522|P4|Overall Study|Investigator decision|0
4744821|NCT01797965|16367523|P3|Overall Study|Investigator decision|0
4744822|NCT01797965|16367524|P2|Overall Study|Investigator decision|15
4744823|NCT01797965|16367525|P1|Overall Study|Investigator decision|21
4744824|NCT01797965|16367522|P4|Overall Study|Consent withdrawn|35
4744825|NCT01797965|16367523|P3|Overall Study|Consent withdrawn|3
4744826|NCT01797965|16367524|P2|Overall Study|Consent withdrawn|117
4744827|NCT01797965|16367525|P1|Overall Study|Consent withdrawn|130
4744828|NCT01797965|16367522|P4|Overall Study|Lost to Follow-up|2
4744829|NCT01797965|16367523|P3|Overall Study|Lost to Follow-up|1
4744830|NCT01797965|16367524|P2|Overall Study|Lost to Follow-up|8
4744831|NCT01797965|16367525|P1|Overall Study|Lost to Follow-up|9
4744832|NCT01797965|16367522|P4|Overall Study|Adverse Event|21
4744833|NCT01797965|16367523|P3|Overall Study|Adverse Event|4
4744834|NCT01797965|16367524|P2|Overall Study|Adverse Event|129
4744835|NCT01797965|16367525|P1|Overall Study|Adverse Event|104
4744836|NCT01797835|16367659|P2|Overall Study|Lost to Follow-up|27
4744837|NCT01797835|16367660|P1|Overall Study|Lost to Follow-up|31
4744838|NCT01797783|16367676|P2|Overall Study|Withdrawal by Subject|0
4744839|NCT01797783|16367677|P1|Overall Study|Withdrawal by Subject|1
4744840|NCT01797783|16367676|P2|Overall Study|Adverse Event|1
4744841|NCT01797783|16367677|P1|Overall Study|Adverse Event|1
4744842|NCT01797731|16367701|P2|Overall Study|Didn't have proper radiographs required|3
4744843|NCT01797731|16367702|P1|Overall Study|Didn't have proper radiographs required|3
4744844|NCT01797705|16367710|P1|Overall Study|Withdrawal by Subject|1
4744845|NCT01797705|16367710|P1|Overall Study|Equipment anomalies during sleep studies|4
4744846|NCT01797562|16367771|P1|Overall Study|Protocol Violation|5
4744847|NCT01797536|16367780|P4|Overall Study|Adverse Event|0
4744848|NCT01797536|16367781|P3|Overall Study|Adverse Event|0
4744849|NCT01797536|16367782|P2|Overall Study|Adverse Event|1
4744850|NCT01797536|16367783|P1|Overall Study|Adverse Event|0
4744851|NCT01797445|16367855|P2|Open-Label Extension Phase|Investigator's Discretion|0
4744852|NCT01797445|16367856|P1|Open-Label Extension Phase|Investigator's Discretion|1
4744853|NCT01797445|16367855|P2|Double-Blind Phase|Lost to Follow-up|26
4744854|NCT01797445|16367856|P1|Double-Blind Phase|Lost to Follow-up|34
4744855|NCT01797445|16367855|P2|Double-Blind Phase|Withdrew Consent|35
4744856|NCT01797445|16367856|P1|Double-Blind Phase|Withdrew Consent|20
4744857|NCT01797445|16367855|P2|Double-Blind Phase|Protocol Violation|1
4744858|NCT01797445|16367856|P1|Double-Blind Phase|Protocol Violation|0
4744859|NCT01797445|16367855|P2|Double-Blind Phase|Noncompliance with Study Drug|1
4744860|NCT01797445|16367856|P1|Double-Blind Phase|Noncompliance with Study Drug|5
4744861|NCT01797445|16367855|P2|Double-Blind Phase|Investigator's Discretion|17
4744862|NCT01797445|16367856|P1|Double-Blind Phase|Investigator's Discretion|15
4744863|NCT01797445|16367855|P2|Double-Blind Phase|Lack of Efficacy|2
4744864|NCT01797445|16367856|P1|Double-Blind Phase|Lack of Efficacy|1
4744865|NCT01797445|16367855|P2|Double-Blind Phase|Pregnancy|1
4744866|NCT01797445|16367856|P1|Double-Blind Phase|Pregnancy|0
4744867|NCT01797445|16367855|P2|Double-Blind Phase|Death|4
4744868|NCT01797445|16367856|P1|Double-Blind Phase|Death|5
4744869|NCT01797445|16367855|P2|Double-Blind Phase|Adverse Event|0
4744870|NCT01797445|16367856|P1|Double-Blind Phase|Adverse Event|3
4744871|NCT01797445|16367855|P2|Double-Blind Phase|Randomized but Not Treated|2
4744872|NCT01797445|16367856|P1|Double-Blind Phase|Randomized but Not Treated|4
4744873|NCT01797302|16367917|P3|Overall Study|Withdrawal by Subject|4
4744874|NCT01797302|16367918|P2|Overall Study|Withdrawal by Subject|3
4744875|NCT01797302|16367919|P1|Overall Study|Withdrawal by Subject|1
4744876|NCT01797302|16367917|P3|Overall Study|Lost to Follow-up|22
4744877|NCT01797302|16367918|P2|Overall Study|Lost to Follow-up|23
4744878|NCT01797302|16367919|P1|Overall Study|Lost to Follow-up|16
4744879|NCT01797263|16367956|P2|Overall Study|Lost to Follow-up|15
4744880|NCT01797263|16367957|P1|Overall Study|Lost to Follow-up|15
4744881|NCT01797263|16367956|P2|Overall Study|Death|0
4744882|NCT01797263|16367957|P1|Overall Study|Death|1
4744883|NCT01797263|16367956|P2|Overall Study|Withdrawal by Subject|25
4744884|NCT01797263|16367957|P1|Overall Study|Withdrawal by Subject|21
4744885|NCT01797185|16367992|P3|Overall Study|Protocol Violation|0
4744886|NCT01797185|16367993|P2|Overall Study|Protocol Violation|1
4744887|NCT01797185|16367994|P1|Overall Study|Protocol Violation|1
4744888|NCT01797185|16367992|P3|Overall Study|Physician Decision|0
4744889|NCT01797185|16367993|P2|Overall Study|Physician Decision|3
4744890|NCT01797185|16367994|P1|Overall Study|Physician Decision|1
4744891|NCT01797185|16367992|P3|Overall Study|Withdrawn per sponsor|0
4744892|NCT01797185|16367993|P2|Overall Study|Withdrawn per sponsor|0
4744893|NCT01797185|16367994|P1|Overall Study|Withdrawn per sponsor|5
4744894|NCT01797185|16367992|P3|Overall Study|Lost to Follow-up|1
4744895|NCT01797185|16367993|P2|Overall Study|Lost to Follow-up|6
4744896|NCT01797185|16367994|P1|Overall Study|Lost to Follow-up|2
4744897|NCT01797185|16367992|P3|Overall Study|Site terminated|0
4744898|NCT01797185|16367993|P2|Overall Study|Site terminated|4
4744899|NCT01797185|16367994|P1|Overall Study|Site terminated|8
4744900|NCT01797185|16367992|P3|Overall Study|Withdrawal by Subject|5
4744901|NCT01797185|16367993|P2|Overall Study|Withdrawal by Subject|9
4744902|NCT01797185|16367994|P1|Overall Study|Withdrawal by Subject|6
4744903|NCT01797185|16367992|P3|Overall Study|Adverse Event|6
4744904|NCT01797185|16367993|P2|Overall Study|Adverse Event|15
4744905|NCT01797185|16367994|P1|Overall Study|Adverse Event|5
4744906|NCT01797120|16368018|P2|Overall Study|never start protocol therapy|0
4744907|NCT01797120|16368019|P1|Overall Study|never start protocol therapy|2
4744908|NCT01797120|16368018|P2|Overall Study|still on treatment|4
4744909|NCT01797120|16368019|P1|Overall Study|still on treatment|2
4744910|NCT01797120|16368018|P2|Overall Study|Physician Decision|0
4744911|NCT01797120|16368019|P1|Overall Study|Physician Decision|3
4744912|NCT01797120|16368018|P2|Overall Study|Non-compliance|0
4744913|NCT01797120|16368019|P1|Overall Study|Non-compliance|1
4744914|NCT01797120|16368018|P2|Overall Study|Symptomatic progression|1
4744915|NCT01797120|16368019|P1|Overall Study|Symptomatic progression|2
4744916|NCT01797120|16368018|P2|Overall Study|Withdrawal by Subject|6
4744917|NCT01797120|16368019|P1|Overall Study|Withdrawal by Subject|6
4744918|NCT01797120|16368018|P2|Overall Study|Adverse Event|5
4744919|NCT01797120|16368019|P1|Overall Study|Adverse Event|13
4744920|NCT01797120|16368018|P2|Overall Study|Disesae progression|49
4744921|NCT01797120|16368019|P1|Overall Study|Disesae progression|37
4744922|NCT01797094|16368033|P2|Overall Study|Other Miscellaneous Reasons|0
4744923|NCT01797094|16368034|P1|Overall Study|Other Miscellaneous Reasons|1
4744924|NCT01797094|16368033|P2|Overall Study|Protocol Violation|1
4744925|NCT01797094|16368034|P1|Overall Study|Protocol Violation|0
4744926|NCT01797094|16368033|P2|Overall Study|Personal Reasons|0
4744927|NCT01797094|16368034|P1|Overall Study|Personal Reasons|4
4744928|NCT01797094|16368033|P2|Overall Study|Adverse Event|1
4744929|NCT01797094|16368034|P1|Overall Study|Adverse Event|1
4744930|NCT01797081|16368056|P4|Overall Study|Protocol Violation|1
4744931|NCT01797081|16368057|P3|Overall Study|Protocol Violation|0
4744932|NCT01797081|16368058|P2|Overall Study|Protocol Violation|0
4744933|NCT01797081|16368059|P1|Overall Study|Protocol Violation|0
4744934|NCT01797081|16368056|P4|Overall Study|Personal Reasons|8
4744935|NCT01797081|16368057|P3|Overall Study|Personal Reasons|4
4744936|NCT01797081|16368058|P2|Overall Study|Personal Reasons|4
4744937|NCT01797081|16368059|P1|Overall Study|Personal Reasons|12
4744938|NCT01797081|16368056|P4|Overall Study|Pregnancy|0
4744939|NCT01797081|16368057|P3|Overall Study|Pregnancy|0
4744940|NCT01797081|16368058|P2|Overall Study|Pregnancy|0
4744941|NCT01797081|16368059|P1|Overall Study|Pregnancy|1
4744942|NCT01797081|16368056|P4|Overall Study|Adverse Event|0
4744943|NCT01797081|16368057|P3|Overall Study|Adverse Event|1
4744944|NCT01797081|16368058|P2|Overall Study|Adverse Event|0
4744945|NCT01797081|16368059|P1|Overall Study|Adverse Event|1
4744946|NCT01796964|16368100|P2|Overall Study|Withdrawal by Subject|1
4744947|NCT01796964|16368101|P1|Overall Study|Withdrawal by Subject|1
4744948|NCT01796964|16368100|P2|Overall Study|Protocol Violation|1
4744949|NCT01796964|16368101|P1|Overall Study|Protocol Violation|0
4744950|NCT01796964|16368100|P2|Overall Study|Death|0
4744951|NCT01796964|16368101|P1|Overall Study|Death|1
4744952|NCT01796964|16368100|P2|Overall Study|Adverse Event|1
4744953|NCT01796964|16368101|P1|Overall Study|Adverse Event|1
4744954|NCT01796860|16368142|P1|Overall Study|Withdrawal by Subject|3
4744955|NCT01796548|16368148|P1|Overall Study|Other|2
4744956|NCT01796548|16368148|P1|Overall Study|Lost to Follow-up|1
4744957|NCT01796470|16368165|P5|Overall Study|Withdrawal by Subject|1
4744958|NCT01796470|16368166|P4|Overall Study|Withdrawal by Subject|0
4744959|NCT01796470|16368167|P3|Overall Study|Withdrawal by Subject|0
4744960|NCT01796470|16368168|P2|Overall Study|Withdrawal by Subject|0
4744961|NCT01796470|16368169|P1|Overall Study|Withdrawal by Subject|7
4744962|NCT01796470|16368165|P5|Overall Study|Protocol Criteria for Withdrawal|0
4744963|NCT01796470|16368166|P4|Overall Study|Protocol Criteria for Withdrawal|0
4744964|NCT01796470|16368167|P3|Overall Study|Protocol Criteria for Withdrawal|0
4744965|NCT01796470|16368168|P2|Overall Study|Protocol Criteria for Withdrawal|0
4744966|NCT01796470|16368169|P1|Overall Study|Protocol Criteria for Withdrawal|1
4744967|NCT01796470|16368165|P5|Overall Study|Progressive Disease|0
4744968|NCT01796470|16368166|P4|Overall Study|Progressive Disease|2
4744969|NCT01796470|16368167|P3|Overall Study|Progressive Disease|3
4744970|NCT01796470|16368168|P2|Overall Study|Progressive Disease|7
4744971|NCT01796470|16368169|P1|Overall Study|Progressive Disease|7
4744972|NCT01796470|16368165|P5|Overall Study|Physician Decision|1
4744973|NCT01796470|16368166|P4|Overall Study|Physician Decision|0
4744974|NCT01796470|16368167|P3|Overall Study|Physician Decision|1
4744975|NCT01796470|16368168|P2|Overall Study|Physician Decision|4
4744976|NCT01796470|16368169|P1|Overall Study|Physician Decision|5
4744977|NCT01796470|16368165|P5|Overall Study|Lost to Follow-up|0
4744978|NCT01796470|16368166|P4|Overall Study|Lost to Follow-up|0
4744979|NCT01796470|16368167|P3|Overall Study|Lost to Follow-up|0
4744980|NCT01796470|16368168|P2|Overall Study|Lost to Follow-up|1
4744981|NCT01796470|16368169|P1|Overall Study|Lost to Follow-up|0
4744982|NCT01796470|16368165|P5|Overall Study|Initiated New Therapy|2
4744983|NCT01796470|16368166|P4|Overall Study|Initiated New Therapy|0
4744984|NCT01796470|16368167|P3|Overall Study|Initiated New Therapy|0
4744985|NCT01796470|16368168|P2|Overall Study|Initiated New Therapy|0
4744986|NCT01796470|16368169|P1|Overall Study|Initiated New Therapy|9
4744987|NCT01796470|16368165|P5|Overall Study|Death|1
4744988|NCT01796470|16368166|P4|Overall Study|Death|0
4744989|NCT01796470|16368167|P3|Overall Study|Death|0
4744990|NCT01796470|16368168|P2|Overall Study|Death|0
4744991|NCT01796470|16368169|P1|Overall Study|Death|2
4744992|NCT01796470|16368165|P5|Overall Study|Adverse Event|3
4744993|NCT01796470|16368166|P4|Overall Study|Adverse Event|1
4744994|NCT01796470|16368167|P3|Overall Study|Adverse Event|2
4744995|NCT01796470|16368168|P2|Overall Study|Adverse Event|2
4744996|NCT01796470|16368169|P1|Overall Study|Adverse Event|4
4744997|NCT01796392|16368213|P2|Overall Study|Lost to Follow-up|0
4744998|NCT01796392|16368214|P1|Overall Study|Lost to Follow-up|1
4744999|NCT01796392|16368213|P2|Overall Study|Excluded for medical reasons|2
4745000|NCT01796392|16368214|P1|Overall Study|Excluded for medical reasons|1
4745001|NCT01796392|16368213|P2|Overall Study|Death|1
4745002|NCT01796392|16368214|P1|Overall Study|Death|5
4745003|NCT01796392|16368213|P2|Overall Study|Withdrawal by Subject|0
4745004|NCT01796392|16368214|P1|Overall Study|Withdrawal by Subject|2
4745005|NCT01796301|16368228|P2|Overall Study|Decision by Sponsor|1
4745006|NCT01796301|16368229|P1|Overall Study|Decision by Sponsor|0
4745007|NCT01796301|16368228|P2|Overall Study|Death|1
4745008|NCT01796301|16368229|P1|Overall Study|Death|0
4745009|NCT01796301|16368228|P2|Overall Study|Lost to Follow-up|3
4745010|NCT01796301|16368229|P1|Overall Study|Lost to Follow-up|3
4745011|NCT01796301|16368228|P2|Overall Study|Withdrawal by Subject|15
4745012|NCT01796301|16368229|P1|Overall Study|Withdrawal by Subject|15
4745013|NCT01795937|16368315|P3|Overall Study|Physician Decision|0
4745014|NCT01795937|16368316|P2|Overall Study|Physician Decision|1
4745015|NCT01795937|16368317|P1|Overall Study|Physician Decision|0
4745016|NCT01795937|16368315|P3|Overall Study|Withdrawal by Subject|0
4745017|NCT01795937|16368316|P2|Overall Study|Withdrawal by Subject|0
4745018|NCT01795937|16368317|P1|Overall Study|Withdrawal by Subject|1
4745019|NCT01795898|16368346|P1|Overall Study|Physician Decision|1
4745020|NCT01795898|16368346|P1|Overall Study|Withdrew consent & had adverse events|3
4745021|NCT01795898|16368346|P1|Overall Study|Death|1
4745022|NCT01795898|16368346|P1|Overall Study|No pain|1
4745023|NCT01795898|16368346|P1|Overall Study|Diagnosed with metastasis|1
4745024|NCT01795898|16368346|P1|Overall Study|Withdrawal of consent|6
4745025|NCT01795898|16368346|P1|Overall Study|Lost to Follow-up|20
4745026|NCT01795898|16368346|P1|Overall Study|Adverse Event|27
4745027|NCT01795638|16368382|P2|Overall Study|Withdrawal by Subject|0
4745028|NCT01795638|16368383|P1|Overall Study|Withdrawal by Subject|1
4745029|NCT01795638|16368382|P2|Overall Study|discharged from hospital|5
4745030|NCT01795638|16368383|P1|Overall Study|discharged from hospital|7
4745031|NCT01795638|16368382|P2|Overall Study|Protocol Violation|0
4745032|NCT01795638|16368383|P1|Overall Study|Protocol Violation|3
4745033|NCT01795638|16368382|P2|Overall Study|transferred to quaternary hospital|3
4745034|NCT01795638|16368383|P1|Overall Study|transferred to quaternary hospital|2
4745035|NCT01795638|16368382|P2|Overall Study|Death|3
4745036|NCT01795638|16368383|P1|Overall Study|Death|0
4745037|NCT01795547|16368409|P2|Overall Study|Not stated|1
4745038|NCT01795547|16368410|P1|Overall Study|Not stated|0
4745039|NCT01795547|16368409|P2|Overall Study|Others|1
4745040|NCT01795547|16368410|P1|Overall Study|Others|4
4745041|NCT01795547|16368409|P2|Overall Study|Non-compliance with IMP|1
4745042|NCT01795547|16368410|P1|Overall Study|Non-compliance with IMP|1
4745043|NCT01795547|16368409|P2|Overall Study|Not Treated|10
4745044|NCT01795547|16368410|P1|Overall Study|Not Treated|4
4745045|NCT01795547|16368409|P2|Overall Study|Withdrawal of consent|12
4745046|NCT01795547|16368410|P1|Overall Study|Withdrawal of consent|7
4745047|NCT01795547|16368409|P2|Overall Study|Lost to Follow-up|5
4745048|NCT01795547|16368410|P1|Overall Study|Lost to Follow-up|2
4745049|NCT01795547|16368409|P2|Overall Study|Protocol Violation|4
4745050|NCT01795547|16368410|P1|Overall Study|Protocol Violation|6
4745051|NCT01795547|16368409|P2|Overall Study|Lack of Efficacy|3
4745052|NCT01795547|16368410|P1|Overall Study|Lack of Efficacy|8
4745053|NCT01795547|16368409|P2|Overall Study|Adverse Event|27
4745054|NCT01795547|16368410|P1|Overall Study|Adverse Event|16
4745055|NCT01795495|16368442|P3|Overall Study|Physician Decision|1
4745056|NCT01795495|16368443|P2|Overall Study|Physician Decision|0
4745057|NCT01795495|16368444|P1|Overall Study|Physician Decision|0
4745058|NCT01795495|16368442|P3|Overall Study|Protocol Violation|1
4745059|NCT01795495|16368443|P2|Overall Study|Protocol Violation|0
4745060|NCT01795495|16368444|P1|Overall Study|Protocol Violation|1
4745061|NCT01794949|16368464|P2|Overall Study|Lost to Follow-up|0
4745062|NCT01794949|16368465|P1|Overall Study|Lost to Follow-up|1
4745063|NCT01794845|16368476|P1|Overall Study|Withdrawal by Subject|1
4745064|NCT01794780|16368504|P8|Overall Study|Other|1
4745065|NCT01794780|16368505|P7|Overall Study|Other|4
4745066|NCT01794780|16368506|P6|Overall Study|Other|24
4745067|NCT01794780|16368507|P5|Overall Study|Other|1
4745068|NCT01794780|16368508|P4|Overall Study|Other|20
4745069|NCT01794780|16368509|P3|Overall Study|Other|25
4745070|NCT01794780|16368510|P2|Overall Study|Other|12
4745071|NCT01794780|16368511|P1|Overall Study|Other|0
4745072|NCT01794780|16368504|P8|Overall Study|Withdrew informed consent|3
4745073|NCT01794780|16368505|P7|Overall Study|Withdrew informed consent|4
4745074|NCT01794780|16368506|P6|Overall Study|Withdrew informed consent|48
4745075|NCT01794780|16368507|P5|Overall Study|Withdrew informed consent|0
4745076|NCT01794780|16368508|P4|Overall Study|Withdrew informed consent|9
4745077|NCT01794780|16368509|P3|Overall Study|Withdrew informed consent|36
4745078|NCT01794780|16368510|P2|Overall Study|Withdrew informed consent|17
4745079|NCT01794780|16368511|P1|Overall Study|Withdrew informed consent|7
4745080|NCT01794780|16368504|P8|Overall Study|Lost to Follow-up|5
4745081|NCT01794780|16368505|P7|Overall Study|Lost to Follow-up|30
4745082|NCT01794780|16368506|P6|Overall Study|Lost to Follow-up|99
4745083|NCT01794780|16368507|P5|Overall Study|Lost to Follow-up|2
4745084|NCT01794780|16368508|P4|Overall Study|Lost to Follow-up|53
4745085|NCT01794780|16368509|P3|Overall Study|Lost to Follow-up|165
4745086|NCT01794780|16368510|P2|Overall Study|Lost to Follow-up|64
4745087|NCT01794780|16368511|P1|Overall Study|Lost to Follow-up|10
4745088|NCT01794780|16368504|P8|Overall Study|Death|0
4745089|NCT01794780|16368505|P7|Overall Study|Death|4
4745090|NCT01794780|16368506|P6|Overall Study|Death|9
4745091|NCT01794780|16368507|P5|Overall Study|Death|0
4745092|NCT01794780|16368508|P4|Overall Study|Death|1
4745093|NCT01794780|16368509|P3|Overall Study|Death|14
4745094|NCT01794780|16368510|P2|Overall Study|Death|2
4745095|NCT01794780|16368511|P1|Overall Study|Death|0
4745096|NCT01794780|16368504|P8|Overall Study|Adverse Event|0
4745097|NCT01794780|16368505|P7|Overall Study|Adverse Event|0
4745098|NCT01794780|16368506|P6|Overall Study|Adverse Event|0
4745099|NCT01794780|16368507|P5|Overall Study|Adverse Event|0
4745100|NCT01794780|16368508|P4|Overall Study|Adverse Event|0
4745101|NCT01794780|16368509|P3|Overall Study|Adverse Event|2
4745102|NCT01794780|16368510|P2|Overall Study|Adverse Event|1
4745103|NCT01794780|16368511|P1|Overall Study|Adverse Event|0
4745104|NCT01794689|16368587|P4|Intervention 1 (2 Nights)|Adverse Event|0
4745105|NCT01794689|16368588|P3|Intervention 1 (2 Nights)|Adverse Event|0
4745106|NCT01794689|16368589|P2|Intervention 1 (2 Nights)|Adverse Event|1
4745107|NCT01794689|16368590|P1|Intervention 1 (2 Nights)|Adverse Event|0
4745108|NCT01794689|16368587|P4|Intervention 1 (2 Nights)|Physician Decision|0
4745109|NCT01794689|16368588|P3|Intervention 1 (2 Nights)|Physician Decision|0
4745110|NCT01794689|16368589|P2|Intervention 1 (2 Nights)|Physician Decision|1
4745111|NCT01794689|16368590|P1|Intervention 1 (2 Nights)|Physician Decision|1
4745112|NCT01794689|16368587|P4|Intervention 1 (2 Nights)|Protocol Violation|0
4745113|NCT01794689|16368588|P3|Intervention 1 (2 Nights)|Protocol Violation|1
4745114|NCT01794689|16368589|P2|Intervention 1 (2 Nights)|Protocol Violation|0
4745115|NCT01794689|16368590|P1|Intervention 1 (2 Nights)|Protocol Violation|1
4745116|NCT01794689|16368587|P4|Intervention 1 (2 Nights)|Withdrawal by Subject|4
4745117|NCT01794689|16368588|P3|Intervention 1 (2 Nights)|Withdrawal by Subject|2
4745118|NCT01794689|16368589|P2|Intervention 1 (2 Nights)|Withdrawal by Subject|0
4745119|NCT01794689|16368590|P1|Intervention 1 (2 Nights)|Withdrawal by Subject|3
4745120|NCT01794000|16368659|P2|Open-Label Extension Phase (OLE)|Sponsor Decision|0
4745121|NCT01794000|16368660|P1|Open-Label Extension Phase (OLE)|Sponsor Decision|3
4745122|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Withdrawal by Subject|11
4745123|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Withdrawal by Subject|6
4745124|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Sponsor Decision|149
4745125|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Sponsor Decision|148
4745126|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Physician Decision|0
4745127|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Physician Decision|2
4745128|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2
4745129|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5
4745130|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Entry Criteria Not Met|0
4745131|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Entry Criteria Not Met|2
4745132|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Death|2
4745133|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Death|1
4745134|NCT01794000|16368659|P2|Double-Blind Phase (DBP)|Adverse Event|2
4745135|NCT01794000|16368660|P1|Double-Blind Phase (DBP)|Adverse Event|5
4745136|NCT01793935|16368693|P2|Overall Study|Lost to Follow-up|1
4745137|NCT01793935|16368694|P1|Overall Study|Lost to Follow-up|0
4745138|NCT01793935|16368693|P2|Overall Study|Patient did not take study medication|1
4745139|NCT01793935|16368694|P1|Overall Study|Patient did not take study medication|1
4745140|NCT01793935|16368693|P2|Overall Study|Adverse Event|0
4745141|NCT01793935|16368694|P1|Overall Study|Adverse Event|2
4745142|NCT01793935|16368693|P2|Overall Study|Protocol Violation|1
4745143|NCT01793935|16368694|P1|Overall Study|Protocol Violation|2
4745144|NCT01793935|16368693|P2|Overall Study|Pregnancy|0
4745145|NCT01793935|16368694|P1|Overall Study|Pregnancy|1
4745146|NCT01793883|16368740|P3|Overall Study|Respiratory distress during spirometry|1
4745147|NCT01793883|16368741|P2|Overall Study|Respiratory distress during spirometry|0
4745148|NCT01793883|16368742|P1|Overall Study|Respiratory distress during spirometry|0
4745149|NCT01793883|16368740|P3|Overall Study|Dosing error|0
4745150|NCT01793883|16368741|P2|Overall Study|Dosing error|1
4745151|NCT01793883|16368742|P1|Overall Study|Dosing error|0
4745152|NCT01793883|16368740|P3|Overall Study|Met exclusion criteria|0
4745153|NCT01793883|16368741|P2|Overall Study|Met exclusion criteria|0
4745154|NCT01793883|16368742|P1|Overall Study|Met exclusion criteria|1
4745155|NCT01793883|16368740|P3|Overall Study|Unable to complete measurements|0
4745156|NCT01793883|16368741|P2|Overall Study|Unable to complete measurements|0
4745157|NCT01793883|16368742|P1|Overall Study|Unable to complete measurements|1
4745158|NCT01793883|16368740|P3|Overall Study|Unable to complete spriometry|0
4745159|NCT01793883|16368741|P2|Overall Study|Unable to complete spriometry|0
4745160|NCT01793883|16368742|P1|Overall Study|Unable to complete spriometry|1
4745161|NCT01793883|16368740|P3|Overall Study|Randomized in error|0
4745162|NCT01793883|16368741|P2|Overall Study|Randomized in error|0
4745163|NCT01793883|16368742|P1|Overall Study|Randomized in error|1
4745164|NCT01793883|16368740|P3|Overall Study|Lost to Follow-up|3
4745165|NCT01793883|16368741|P2|Overall Study|Lost to Follow-up|1
4745166|NCT01793883|16368742|P1|Overall Study|Lost to Follow-up|5
4745167|NCT01793883|16368740|P3|Overall Study|Subject noncompliance|1
4745168|NCT01793883|16368741|P2|Overall Study|Subject noncompliance|1
4745169|NCT01793883|16368742|P1|Overall Study|Subject noncompliance|0
4745170|NCT01793883|16368740|P3|Overall Study|Withdrawal by Subject|3
4745171|NCT01793883|16368741|P2|Overall Study|Withdrawal by Subject|7
4745172|NCT01793883|16368742|P1|Overall Study|Withdrawal by Subject|3
4745173|NCT01793792|16368750|P1|Overall Study|Device Not Implanted|1
4745174|NCT01793792|16368750|P1|Overall Study|Withdrawal by Subject|1
4745175|NCT01793792|16368750|P1|Overall Study|Lost to Follow-up|5
4745176|NCT01793792|16368750|P1|Overall Study|Death|5
4745177|NCT01793688|16368755|P1|Overall Study|Protocol Violation|2
4745178|NCT01793610|16368765|P3|Overall Study|Withdrawal by Subject|1
4745179|NCT01793610|16368766|P2|Overall Study|Withdrawal by Subject|0
4745180|NCT01793610|16368767|P1|Overall Study|Withdrawal by Subject|1
4745181|NCT01793142|16368810|P1|Overall Study|Randomized not treated|7
4745182|NCT01792830|16368840|P11|Overall Study|Adverse Event|0
4745183|NCT01792830|16368841|P10|Overall Study|Adverse Event|0
4745184|NCT01792830|16368842|P9|Overall Study|Adverse Event|1
4745185|NCT01792830|16368843|P8|Overall Study|Adverse Event|0
4745186|NCT01792830|16368844|P7|Overall Study|Adverse Event|0
4745187|NCT01792830|16368845|P6|Overall Study|Adverse Event|0
4745188|NCT01792830|16368846|P5|Overall Study|Adverse Event|0
4745189|NCT01792830|16368847|P4|Overall Study|Adverse Event|0
4745190|NCT01792830|16368848|P3|Overall Study|Adverse Event|0
4745191|NCT01792830|16368849|P2|Overall Study|Adverse Event|0
4745192|NCT01792830|16368850|P1|Overall Study|Adverse Event|0
4745193|NCT01792830|16368840|P11|Overall Study|Death|1
4745194|NCT01792830|16368841|P10|Overall Study|Death|0
4745195|NCT01792830|16368842|P9|Overall Study|Death|1
4745196|NCT01792830|16368843|P8|Overall Study|Death|0
4745197|NCT01792830|16368844|P7|Overall Study|Death|1
4745198|NCT01792830|16368845|P6|Overall Study|Death|0
4745199|NCT01792830|16368846|P5|Overall Study|Death|0
4745200|NCT01792830|16368847|P4|Overall Study|Death|1
4745201|NCT01792830|16368848|P3|Overall Study|Death|0
4745202|NCT01792830|16368849|P2|Overall Study|Death|0
4745203|NCT01792830|16368850|P1|Overall Study|Death|3
4745204|NCT01792830|16368840|P11|Overall Study|Withdrawal by Subject|2
4745205|NCT01792830|16368841|P10|Overall Study|Withdrawal by Subject|0
4745206|NCT01792830|16368842|P9|Overall Study|Withdrawal by Subject|7
4745207|NCT01792830|16368843|P8|Overall Study|Withdrawal by Subject|1
4745208|NCT01792830|16368844|P7|Overall Study|Withdrawal by Subject|1
4745209|NCT01792830|16368845|P6|Overall Study|Withdrawal by Subject|1
4745210|NCT01792830|16368846|P5|Overall Study|Withdrawal by Subject|1
4745211|NCT01792830|16368847|P4|Overall Study|Withdrawal by Subject|2
4745212|NCT01792830|16368848|P3|Overall Study|Withdrawal by Subject|0
4745213|NCT01792830|16368849|P2|Overall Study|Withdrawal by Subject|0
4745214|NCT01792830|16368850|P1|Overall Study|Withdrawal by Subject|22
4745215|NCT01792635|16368937|P3|Part B|Study terminated|3
4745216|NCT01792635|16368938|P2|Part B|Study terminated|4
4745217|NCT01792635|16368939|P1|Part B|Study terminated|0
4745218|NCT01792635|16368937|P3|Part B|Adverse Event|1
4745219|NCT01792635|16368938|P2|Part B|Adverse Event|0
4745220|NCT01792635|16368939|P1|Part B|Adverse Event|0
4745221|NCT01792518|16368967|P2|Overall Study|Other Reason|1
4745222|NCT01792518|16368968|P1|Overall Study|Other Reason|0
4745223|NCT01792518|16368967|P2|Overall Study|Withdrawal by Subject|0
4745224|NCT01792518|16368968|P1|Overall Study|Withdrawal by Subject|2
4745225|NCT01792518|16368967|P2|Overall Study|Lost to Follow-up|1
4745226|NCT01792518|16368968|P1|Overall Study|Lost to Follow-up|3
4745227|NCT01792518|16368967|P2|Overall Study|Protocol Violation|1
4745228|NCT01792518|16368968|P1|Overall Study|Protocol Violation|0
4745229|NCT01792518|16368967|P2|Overall Study|Adverse Event|4
4745230|NCT01792518|16368968|P1|Overall Study|Adverse Event|3
4745231|NCT01792284|16368978|P3|Randomization Period 2|Withdrawal by Subject|0
4745232|NCT01792284|16368979|P2|Randomization Period 2|Withdrawal by Subject|2
4745233|NCT01792284|16368980|P1|Randomization Period 2|Withdrawal by Subject|0
4745234|NCT01792284|16368978|P3|Randomization Period 2|Protocol Violation|0
4745235|NCT01792284|16368979|P2|Randomization Period 2|Protocol Violation|1
4745236|NCT01792284|16368980|P1|Randomization Period 2|Protocol Violation|0
4745237|NCT01792284|16368978|P3|Randomization Period 1|Lost to Follow-up|1
4745238|NCT01792284|16368979|P2|Randomization Period 1|Lost to Follow-up|0
4745239|NCT01792284|16368980|P1|Randomization Period 1|Lost to Follow-up|0
4745240|NCT01792284|16368978|P3|Randomization Period 1|Adverse Event|2
4745241|NCT01792284|16368979|P2|Randomization Period 1|Adverse Event|0
4745242|NCT01792284|16368980|P1|Randomization Period 1|Adverse Event|0
4745243|NCT01792284|16368978|P3|Randomization Period 1|Physician Decision|1
4745244|NCT01792284|16368979|P2|Randomization Period 1|Physician Decision|1
4745245|NCT01792284|16368980|P1|Randomization Period 1|Physician Decision|0
4745246|NCT01792284|16368978|P3|Randomization Period 1|Withdrawal by Subject|1
4745247|NCT01792284|16368979|P2|Randomization Period 1|Withdrawal by Subject|1
4745248|NCT01792284|16368980|P1|Randomization Period 1|Withdrawal by Subject|0
4745249|NCT01792284|16368978|P3|Lead-in Period|Protocol Required Discontinuation|0
4745250|NCT01792284|16368979|P2|Lead-in Period|Protocol Required Discontinuation|0
4745251|NCT01792284|16368980|P1|Lead-in Period|Protocol Required Discontinuation|1
4745252|NCT01792284|16368978|P3|Lead-in Period|Physician Decision|0
4745253|NCT01792284|16368979|P2|Lead-in Period|Physician Decision|0
4745254|NCT01792284|16368980|P1|Lead-in Period|Physician Decision|1
4745255|NCT01792284|16368978|P3|Lead-in Period|Withdrawal by Subject|0
4745256|NCT01792284|16368979|P2|Lead-in Period|Withdrawal by Subject|0
4745257|NCT01792284|16368980|P1|Lead-in Period|Withdrawal by Subject|10
4745258|NCT01792284|16368978|P3|Lead-in Period|Protocol Violation|0
4745259|NCT01792284|16368979|P2|Lead-in Period|Protocol Violation|0
4745260|NCT01792284|16368980|P1|Lead-in Period|Protocol Violation|1
4745261|NCT01792284|16368978|P3|Lead-in Period|Lost to Follow-up|0
4745262|NCT01792284|16368979|P2|Lead-in Period|Lost to Follow-up|0
4745263|NCT01792284|16368980|P1|Lead-in Period|Lost to Follow-up|2
4745264|NCT01792284|16368978|P3|Lead-in Period|Adverse Event|0
4745265|NCT01792284|16368979|P2|Lead-in Period|Adverse Event|0
4745266|NCT01792284|16368980|P1|Lead-in Period|Adverse Event|15
4745267|NCT01792115|16369021|P3|Overall Study|Lost to Follow-up|0
4745268|NCT01792115|16369022|P2|Overall Study|Lost to Follow-up|1
4745269|NCT01792115|16369023|P1|Overall Study|Lost to Follow-up|0
4745270|NCT01791894|16369073|P1|Overall Study|Adverse Event|1
4745271|NCT01791803|16369084|P4|Overall Study|Death|2
4745272|NCT01791803|16369085|P3|Overall Study|Death|2
4745273|NCT01791803|16369086|P2|Overall Study|Death|0
4745274|NCT01791803|16369087|P1|Overall Study|Death|0
4745275|NCT01791803|16369084|P4|Overall Study|Physician Decision|1
4745276|NCT01791803|16369085|P3|Overall Study|Physician Decision|0
4745277|NCT01791803|16369086|P2|Overall Study|Physician Decision|2
4745278|NCT01791803|16369087|P1|Overall Study|Physician Decision|0
4745279|NCT01791803|16369084|P4|Overall Study|Withdrawal by Subject|2
4745280|NCT01791803|16369085|P3|Overall Study|Withdrawal by Subject|0
4745281|NCT01791803|16369086|P2|Overall Study|Withdrawal by Subject|0
4745282|NCT01791803|16369087|P1|Overall Study|Withdrawal by Subject|0
4745283|NCT01791725|16369105|P3|Overall Study|Withdrawal by Subject|0
4745284|NCT01791725|16369106|P2|Overall Study|Withdrawal by Subject|1
4745285|NCT01791725|16369107|P1|Overall Study|Withdrawal by Subject|0
4745286|NCT01791517|16369130|P12|Phase II|Pre-Existing Ocular Issue|1
4745287|NCT01791517|16369131|P11|Phase II|Pre-Existing Ocular Issue|0
4745288|NCT01791517|16369132|P10|Phase II|Pre-Existing Ocular Issue|0
4745289|NCT01791517|16369133|P9|Phase II|Pre-Existing Ocular Issue|0
4745290|NCT01791517|16369134|P8|Phase II|Pre-Existing Ocular Issue|0
4745291|NCT01791517|16369135|P7|Phase II|Pre-Existing Ocular Issue|0
4745292|NCT01791517|16369136|P6|Phase II|Pre-Existing Ocular Issue|0
4745293|NCT01791517|16369137|P5|Phase II|Pre-Existing Ocular Issue|0
4745294|NCT01791517|16369138|P4|Phase II|Pre-Existing Ocular Issue|0
4745295|NCT01791517|16369139|P3|Phase II|Pre-Existing Ocular Issue|0
4745296|NCT01791517|16369140|P2|Phase II|Pre-Existing Ocular Issue|0
4745297|NCT01791517|16369141|P1|Phase II|Pre-Existing Ocular Issue|0
4745298|NCT01791517|16369130|P12|Phase II|Unsatisfactory Lens Fitting|0
4745299|NCT01791517|16369131|P11|Phase II|Unsatisfactory Lens Fitting|0
4745300|NCT01791517|16369132|P10|Phase II|Unsatisfactory Lens Fitting|1
4745301|NCT01791517|16369133|P9|Phase II|Unsatisfactory Lens Fitting|0
4745302|NCT01791517|16369134|P8|Phase II|Unsatisfactory Lens Fitting|0
4745303|NCT01791517|16369135|P7|Phase II|Unsatisfactory Lens Fitting|0
4745304|NCT01791517|16369136|P6|Phase II|Unsatisfactory Lens Fitting|0
4745305|NCT01791517|16369137|P5|Phase II|Unsatisfactory Lens Fitting|0
4745306|NCT01791517|16369138|P4|Phase II|Unsatisfactory Lens Fitting|0
4745307|NCT01791517|16369139|P3|Phase II|Unsatisfactory Lens Fitting|0
4745308|NCT01791517|16369140|P2|Phase II|Unsatisfactory Lens Fitting|0
4745309|NCT01791517|16369141|P1|Phase II|Unsatisfactory Lens Fitting|0
4745310|NCT01791517|16369130|P12|Phase II|Lens Handling Difficulties|0
4745311|NCT01791517|16369131|P11|Phase II|Lens Handling Difficulties|0
4745312|NCT01791517|16369132|P10|Phase II|Lens Handling Difficulties|0
4745313|NCT01791517|16369133|P9|Phase II|Lens Handling Difficulties|1
4745314|NCT01791517|16369134|P8|Phase II|Lens Handling Difficulties|0
4745315|NCT01791517|16369135|P7|Phase II|Lens Handling Difficulties|0
4745316|NCT01791517|16369136|P6|Phase II|Lens Handling Difficulties|0
4745317|NCT01791517|16369137|P5|Phase II|Lens Handling Difficulties|0
4745318|NCT01791517|16369138|P4|Phase II|Lens Handling Difficulties|0
4745319|NCT01791517|16369139|P3|Phase II|Lens Handling Difficulties|0
4745320|NCT01791517|16369140|P2|Phase II|Lens Handling Difficulties|0
4745321|NCT01791517|16369141|P1|Phase II|Lens Handling Difficulties|0
4745322|NCT01791517|16369130|P12|Phase II|Adverse Event|0
4745323|NCT01791517|16369131|P11|Phase II|Adverse Event|0
4745324|NCT01791517|16369132|P10|Phase II|Adverse Event|1
4745325|NCT01791517|16369133|P9|Phase II|Adverse Event|0
4745326|NCT01791517|16369134|P8|Phase II|Adverse Event|1
4745327|NCT01791517|16369135|P7|Phase II|Adverse Event|2
4745328|NCT01791517|16369136|P6|Phase II|Adverse Event|0
4745329|NCT01791517|16369137|P5|Phase II|Adverse Event|0
4745330|NCT01791517|16369138|P4|Phase II|Adverse Event|0
4745331|NCT01791517|16369139|P3|Phase II|Adverse Event|0
4745332|NCT01791517|16369140|P2|Phase II|Adverse Event|0
4745333|NCT01791517|16369141|P1|Phase II|Adverse Event|0
4745334|NCT01791517|16369130|P12|Phase II|Lack of Efficacy|0
4745335|NCT01791517|16369131|P11|Phase II|Lack of Efficacy|0
4745336|NCT01791517|16369132|P10|Phase II|Lack of Efficacy|0
4745337|NCT01791517|16369133|P9|Phase II|Lack of Efficacy|0
4745338|NCT01791517|16369134|P8|Phase II|Lack of Efficacy|0
4745339|NCT01791517|16369135|P7|Phase II|Lack of Efficacy|0
4745340|NCT01791517|16369136|P6|Phase II|Lack of Efficacy|0
4745341|NCT01791517|16369137|P5|Phase II|Lack of Efficacy|1
4745342|NCT01791517|16369138|P4|Phase II|Lack of Efficacy|0
4745343|NCT01791517|16369139|P3|Phase II|Lack of Efficacy|0
4745344|NCT01791517|16369140|P2|Phase II|Lack of Efficacy|0
4745345|NCT01791517|16369141|P1|Phase II|Lack of Efficacy|0
4745346|NCT01791517|16369130|P12|Phase II|Withdrawal by Subject|0
4745347|NCT01791517|16369131|P11|Phase II|Withdrawal by Subject|1
4745348|NCT01791517|16369132|P10|Phase II|Withdrawal by Subject|0
4745349|NCT01791517|16369133|P9|Phase II|Withdrawal by Subject|0
4745350|NCT01791517|16369134|P8|Phase II|Withdrawal by Subject|1
4745351|NCT01791517|16369135|P7|Phase II|Withdrawal by Subject|0
4745352|NCT01791517|16369136|P6|Phase II|Withdrawal by Subject|2
4745353|NCT01791517|16369137|P5|Phase II|Withdrawal by Subject|0
4745354|NCT01791517|16369138|P4|Phase II|Withdrawal by Subject|0
4745355|NCT01791517|16369139|P3|Phase II|Withdrawal by Subject|0
4745356|NCT01791517|16369140|P2|Phase II|Withdrawal by Subject|0
4745357|NCT01791517|16369141|P1|Phase II|Withdrawal by Subject|1
4745358|NCT01791517|16369130|P12|Phase II|Lost to Follow-up|0
4745359|NCT01791517|16369131|P11|Phase II|Lost to Follow-up|0
4745360|NCT01791517|16369132|P10|Phase II|Lost to Follow-up|1
4745361|NCT01791517|16369133|P9|Phase II|Lost to Follow-up|1
4745362|NCT01791517|16369134|P8|Phase II|Lost to Follow-up|1
4745363|NCT01791517|16369135|P7|Phase II|Lost to Follow-up|0
4745364|NCT01791517|16369136|P6|Phase II|Lost to Follow-up|2
4745365|NCT01791517|16369137|P5|Phase II|Lost to Follow-up|1
4745366|NCT01791517|16369138|P4|Phase II|Lost to Follow-up|0
4745367|NCT01791517|16369139|P3|Phase II|Lost to Follow-up|1
4745368|NCT01791517|16369140|P2|Phase II|Lost to Follow-up|0
4745369|NCT01791517|16369141|P1|Phase II|Lost to Follow-up|1
4745370|NCT01791517|16369130|P12|Phase I: Period 3|Adverse Event|0
4745371|NCT01791517|16369131|P11|Phase I: Period 3|Adverse Event|0
4745372|NCT01791517|16369132|P10|Phase I: Period 3|Adverse Event|0
4745373|NCT01791517|16369133|P9|Phase I: Period 3|Adverse Event|0
4745374|NCT01791517|16369134|P8|Phase I: Period 3|Adverse Event|0
4745375|NCT01791517|16369135|P7|Phase I: Period 3|Adverse Event|0
4745376|NCT01791517|16369136|P6|Phase I: Period 3|Adverse Event|0
4745377|NCT01791517|16369137|P5|Phase I: Period 3|Adverse Event|0
4745378|NCT01791517|16369138|P4|Phase I: Period 3|Adverse Event|1
4745379|NCT01791517|16369139|P3|Phase I: Period 3|Adverse Event|0
4745380|NCT01791517|16369140|P2|Phase I: Period 3|Adverse Event|0
4745381|NCT01791517|16369141|P1|Phase I: Period 3|Adverse Event|0
4745382|NCT01791517|16369130|P12|Phase I: Period 3|Lost to Follow-up|0
4745383|NCT01791517|16369131|P11|Phase I: Period 3|Lost to Follow-up|0
4745384|NCT01791517|16369132|P10|Phase I: Period 3|Lost to Follow-up|0
4745385|NCT01791517|16369133|P9|Phase I: Period 3|Lost to Follow-up|0
4745386|NCT01791517|16369134|P8|Phase I: Period 3|Lost to Follow-up|0
4745387|NCT01791517|16369135|P7|Phase I: Period 3|Lost to Follow-up|0
4745388|NCT01791517|16369136|P6|Phase I: Period 3|Lost to Follow-up|0
4745389|NCT01791517|16369137|P5|Phase I: Period 3|Lost to Follow-up|1
4745390|NCT01791517|16369138|P4|Phase I: Period 3|Lost to Follow-up|0
4745391|NCT01791517|16369139|P3|Phase I: Period 3|Lost to Follow-up|0
4745392|NCT01791517|16369140|P2|Phase I: Period 3|Lost to Follow-up|1
4745393|NCT01791517|16369141|P1|Phase I: Period 3|Lost to Follow-up|0
4745394|NCT01791517|16369130|P12|Phase I: Period 3|Lens Discomfort|1
4745395|NCT01791517|16369131|P11|Phase I: Period 3|Lens Discomfort|0
4745396|NCT01791517|16369132|P10|Phase I: Period 3|Lens Discomfort|0
4745397|NCT01791517|16369133|P9|Phase I: Period 3|Lens Discomfort|0
4745398|NCT01791517|16369134|P8|Phase I: Period 3|Lens Discomfort|0
4745399|NCT01791517|16369135|P7|Phase I: Period 3|Lens Discomfort|0
4745400|NCT01791517|16369136|P6|Phase I: Period 3|Lens Discomfort|0
4745401|NCT01791517|16369137|P5|Phase I: Period 3|Lens Discomfort|0
4745402|NCT01791517|16369138|P4|Phase I: Period 3|Lens Discomfort|0
4745403|NCT01791517|16369139|P3|Phase I: Period 3|Lens Discomfort|0
4745404|NCT01791517|16369140|P2|Phase I: Period 3|Lens Discomfort|0
4745405|NCT01791517|16369141|P1|Phase I: Period 3|Lens Discomfort|0
4745406|NCT01791517|16369130|P12|Phase I: Period 2|Lost to Follow-up|0
4745407|NCT01791517|16369131|P11|Phase I: Period 2|Lost to Follow-up|0
4745408|NCT01791517|16369132|P10|Phase I: Period 2|Lost to Follow-up|0
4745409|NCT01791517|16369133|P9|Phase I: Period 2|Lost to Follow-up|0
4745410|NCT01791517|16369134|P8|Phase I: Period 2|Lost to Follow-up|0
4745411|NCT01791517|16369135|P7|Phase I: Period 2|Lost to Follow-up|0
4745412|NCT01791517|16369136|P6|Phase I: Period 2|Lost to Follow-up|0
4745413|NCT01791517|16369137|P5|Phase I: Period 2|Lost to Follow-up|0
4745414|NCT01791517|16369138|P4|Phase I: Period 2|Lost to Follow-up|0
4745415|NCT01791517|16369139|P3|Phase I: Period 2|Lost to Follow-up|2
4745416|NCT01791517|16369140|P2|Phase I: Period 2|Lost to Follow-up|3
4745417|NCT01791517|16369141|P1|Phase I: Period 2|Lost to Follow-up|0
4745418|NCT01791517|16369130|P12|Phase I: Period 2|Lens Discomfort|0
4745419|NCT01791517|16369131|P11|Phase I: Period 2|Lens Discomfort|0
4745420|NCT01791517|16369132|P10|Phase I: Period 2|Lens Discomfort|0
4745421|NCT01791517|16369133|P9|Phase I: Period 2|Lens Discomfort|0
4745422|NCT01791517|16369134|P8|Phase I: Period 2|Lens Discomfort|0
4745423|NCT01791517|16369135|P7|Phase I: Period 2|Lens Discomfort|0
4745424|NCT01791517|16369136|P6|Phase I: Period 2|Lens Discomfort|1
4745425|NCT01791517|16369137|P5|Phase I: Period 2|Lens Discomfort|0
4745426|NCT01791517|16369138|P4|Phase I: Period 2|Lens Discomfort|0
4745427|NCT01791517|16369139|P3|Phase I: Period 2|Lens Discomfort|0
4745428|NCT01791517|16369140|P2|Phase I: Period 2|Lens Discomfort|0
4745429|NCT01791517|16369141|P1|Phase I: Period 2|Lens Discomfort|0
4745430|NCT01791517|16369130|P12|Phase I: Period 2|Unsatisfactory Visual Response|0
4745431|NCT01791517|16369131|P11|Phase I: Period 2|Unsatisfactory Visual Response|1
4745432|NCT01791517|16369132|P10|Phase I: Period 2|Unsatisfactory Visual Response|0
4745433|NCT01791517|16369133|P9|Phase I: Period 2|Unsatisfactory Visual Response|0
4745434|NCT01791517|16369134|P8|Phase I: Period 2|Unsatisfactory Visual Response|0
4745435|NCT01791517|16369135|P7|Phase I: Period 2|Unsatisfactory Visual Response|0
4745436|NCT01791517|16369136|P6|Phase I: Period 2|Unsatisfactory Visual Response|0
4745437|NCT01791517|16369137|P5|Phase I: Period 2|Unsatisfactory Visual Response|0
4745438|NCT01791517|16369138|P4|Phase I: Period 2|Unsatisfactory Visual Response|0
4745439|NCT01791517|16369139|P3|Phase I: Period 2|Unsatisfactory Visual Response|0
4745440|NCT01791517|16369140|P2|Phase I: Period 2|Unsatisfactory Visual Response|0
4745441|NCT01791517|16369141|P1|Phase I: Period 2|Unsatisfactory Visual Response|0
4745442|NCT01791517|16369130|P12|Phase I: Period 2|Withdrawal by Subject|0
4745443|NCT01791517|16369131|P11|Phase I: Period 2|Withdrawal by Subject|1
4745444|NCT01791517|16369132|P10|Phase I: Period 2|Withdrawal by Subject|1
4745445|NCT01791517|16369133|P9|Phase I: Period 2|Withdrawal by Subject|0
4745446|NCT01791517|16369134|P8|Phase I: Period 2|Withdrawal by Subject|0
4745447|NCT01791517|16369135|P7|Phase I: Period 2|Withdrawal by Subject|0
4745448|NCT01791517|16369136|P6|Phase I: Period 2|Withdrawal by Subject|0
4745449|NCT01791517|16369137|P5|Phase I: Period 2|Withdrawal by Subject|0
4745450|NCT01791517|16369138|P4|Phase I: Period 2|Withdrawal by Subject|0
4745451|NCT01791517|16369139|P3|Phase I: Period 2|Withdrawal by Subject|0
4745452|NCT01791517|16369140|P2|Phase I: Period 2|Withdrawal by Subject|0
4745453|NCT01791517|16369141|P1|Phase I: Period 2|Withdrawal by Subject|0
4745454|NCT01791517|16369130|P12|Phase I: Period 2|Protocol Violation|0
4745455|NCT01791517|16369131|P11|Phase I: Period 2|Protocol Violation|0
4745456|NCT01791517|16369132|P10|Phase I: Period 2|Protocol Violation|0
4745457|NCT01791517|16369133|P9|Phase I: Period 2|Protocol Violation|0
4745458|NCT01791517|16369134|P8|Phase I: Period 2|Protocol Violation|0
4745459|NCT01791517|16369135|P7|Phase I: Period 2|Protocol Violation|0
4745460|NCT01791517|16369136|P6|Phase I: Period 2|Protocol Violation|0
4745461|NCT01791517|16369137|P5|Phase I: Period 2|Protocol Violation|0
4745462|NCT01791517|16369138|P4|Phase I: Period 2|Protocol Violation|1
4745463|NCT01791517|16369139|P3|Phase I: Period 2|Protocol Violation|0
4745464|NCT01791517|16369140|P2|Phase I: Period 2|Protocol Violation|0
4745465|NCT01791517|16369141|P1|Phase I: Period 2|Protocol Violation|0
4745466|NCT01791517|16369130|P12|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745467|NCT01791517|16369131|P11|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745468|NCT01791517|16369132|P10|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745469|NCT01791517|16369133|P9|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745470|NCT01791517|16369134|P8|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745471|NCT01791517|16369135|P7|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745472|NCT01791517|16369136|P6|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745473|NCT01791517|16369137|P5|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745474|NCT01791517|16369138|P4|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745475|NCT01791517|16369139|P3|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745476|NCT01791517|16369140|P2|Phase I: Period 2|Unsatisfactory Lens Fit|0
4745477|NCT01791517|16369141|P1|Phase I: Period 2|Unsatisfactory Lens Fit|1
4745478|NCT01791517|16369130|P12|Phase I: Period 1|Lens Handling DIfficulties|1
4745479|NCT01791517|16369131|P11|Phase I: Period 1|Lens Handling DIfficulties|0
4745480|NCT01791517|16369132|P10|Phase I: Period 1|Lens Handling DIfficulties|0
4745481|NCT01791517|16369133|P9|Phase I: Period 1|Lens Handling DIfficulties|0
4745482|NCT01791517|16369134|P8|Phase I: Period 1|Lens Handling DIfficulties|0
4745483|NCT01791517|16369135|P7|Phase I: Period 1|Lens Handling DIfficulties|0
4745484|NCT01791517|16369136|P6|Phase I: Period 1|Lens Handling DIfficulties|0
4745485|NCT01791517|16369137|P5|Phase I: Period 1|Lens Handling DIfficulties|0
4745486|NCT01791517|16369138|P4|Phase I: Period 1|Lens Handling DIfficulties|0
4745487|NCT01791517|16369139|P3|Phase I: Period 1|Lens Handling DIfficulties|0
4745488|NCT01791517|16369140|P2|Phase I: Period 1|Lens Handling DIfficulties|0
4745489|NCT01791517|16369141|P1|Phase I: Period 1|Lens Handling DIfficulties|0
4745490|NCT01791517|16369130|P12|Phase I: Period 1|Lost to Follow-up|0
4745491|NCT01791517|16369131|P11|Phase I: Period 1|Lost to Follow-up|0
4745492|NCT01791517|16369132|P10|Phase I: Period 1|Lost to Follow-up|1
4745493|NCT01791517|16369133|P9|Phase I: Period 1|Lost to Follow-up|1
4745494|NCT01791517|16369134|P8|Phase I: Period 1|Lost to Follow-up|0
4745495|NCT01791517|16369135|P7|Phase I: Period 1|Lost to Follow-up|1
4745496|NCT01791517|16369136|P6|Phase I: Period 1|Lost to Follow-up|0
4745497|NCT01791517|16369137|P5|Phase I: Period 1|Lost to Follow-up|0
4745498|NCT01791517|16369138|P4|Phase I: Period 1|Lost to Follow-up|1
4745499|NCT01791517|16369139|P3|Phase I: Period 1|Lost to Follow-up|0
4745500|NCT01791517|16369140|P2|Phase I: Period 1|Lost to Follow-up|0
4745501|NCT01791517|16369141|P1|Phase I: Period 1|Lost to Follow-up|0
4745502|NCT01791517|16369130|P12|Phase I: Period 1|Protocol Violation|0
4745503|NCT01791517|16369131|P11|Phase I: Period 1|Protocol Violation|0
4745504|NCT01791517|16369132|P10|Phase I: Period 1|Protocol Violation|0
4745505|NCT01791517|16369133|P9|Phase I: Period 1|Protocol Violation|0
4745506|NCT01791517|16369134|P8|Phase I: Period 1|Protocol Violation|0
4745507|NCT01791517|16369135|P7|Phase I: Period 1|Protocol Violation|0
4745508|NCT01791517|16369136|P6|Phase I: Period 1|Protocol Violation|0
4745509|NCT01791517|16369137|P5|Phase I: Period 1|Protocol Violation|0
4745510|NCT01791517|16369138|P4|Phase I: Period 1|Protocol Violation|0
4745511|NCT01791517|16369139|P3|Phase I: Period 1|Protocol Violation|0
4745512|NCT01791517|16369140|P2|Phase I: Period 1|Protocol Violation|1
4745513|NCT01791517|16369141|P1|Phase I: Period 1|Protocol Violation|0
4745514|NCT01791517|16369130|P12|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745515|NCT01791517|16369131|P11|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745516|NCT01791517|16369132|P10|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745517|NCT01791517|16369133|P9|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745518|NCT01791517|16369134|P8|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745519|NCT01791517|16369135|P7|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745520|NCT01791517|16369136|P6|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745521|NCT01791517|16369137|P5|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745522|NCT01791517|16369138|P4|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745523|NCT01791517|16369139|P3|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745524|NCT01791517|16369140|P2|Phase I: Period 1|Unsatisfactory Lens Fitting|0
4745525|NCT01791517|16369141|P1|Phase I: Period 1|Unsatisfactory Lens Fitting|1
4745526|NCT01791517|16369130|P12|Phase I: Period 1|Adverse Event|0
4745527|NCT01791517|16369131|P11|Phase I: Period 1|Adverse Event|0
4745528|NCT01791517|16369132|P10|Phase I: Period 1|Adverse Event|0
4745529|NCT01791517|16369133|P9|Phase I: Period 1|Adverse Event|0
4745530|NCT01791517|16369134|P8|Phase I: Period 1|Adverse Event|0
4745531|NCT01791517|16369135|P7|Phase I: Period 1|Adverse Event|0
4745532|NCT01791517|16369136|P6|Phase I: Period 1|Adverse Event|0
4745533|NCT01791517|16369137|P5|Phase I: Period 1|Adverse Event|0
4745534|NCT01791517|16369138|P4|Phase I: Period 1|Adverse Event|1
4745535|NCT01791517|16369139|P3|Phase I: Period 1|Adverse Event|1
4745536|NCT01791517|16369140|P2|Phase I: Period 1|Adverse Event|0
4745537|NCT01791517|16369141|P1|Phase I: Period 1|Adverse Event|0
4745538|NCT01791517|16369130|P12|Phase I: Period 1|Withdrawal by Subject|0
4745539|NCT01791517|16369131|P11|Phase I: Period 1|Withdrawal by Subject|0
4745540|NCT01791517|16369132|P10|Phase I: Period 1|Withdrawal by Subject|0
4745541|NCT01791517|16369133|P9|Phase I: Period 1|Withdrawal by Subject|0
4745542|NCT01791517|16369134|P8|Phase I: Period 1|Withdrawal by Subject|0
4745543|NCT01791517|16369135|P7|Phase I: Period 1|Withdrawal by Subject|0
4745544|NCT01791517|16369136|P6|Phase I: Period 1|Withdrawal by Subject|1
4745545|NCT01791517|16369137|P5|Phase I: Period 1|Withdrawal by Subject|1
4745546|NCT01791517|16369138|P4|Phase I: Period 1|Withdrawal by Subject|0
4745547|NCT01791517|16369139|P3|Phase I: Period 1|Withdrawal by Subject|1
4745548|NCT01791517|16369140|P2|Phase I: Period 1|Withdrawal by Subject|1
4745549|NCT01791517|16369141|P1|Phase I: Period 1|Withdrawal by Subject|0
4745550|NCT01791413|16369205|P2|Overall Study|Lost to Follow-up|1
4745551|NCT01791413|16369206|P1|Overall Study|Lost to Follow-up|5
4745552|NCT01791244|16369215|P2|Overall Study|Laboratory Abnormality|1
4745553|NCT01791244|16369216|P1|Overall Study|Laboratory Abnormality|0
4745554|NCT01791244|16369215|P2|Overall Study|Insufficient clinical response|10
4745555|NCT01791244|16369216|P1|Overall Study|Insufficient clinical response|10
4745556|NCT01791244|16369215|P2|Overall Study|Adverse Event|7
4745557|NCT01791244|16369216|P1|Overall Study|Adverse Event|5
4745558|NCT01791205|16369252|P2|Phase II|Physician's decision|0
4745559|NCT01791205|16369253|P1|Phase II|Physician's decision|1
4745560|NCT01791205|16369252|P2|Phase II|Remission of disease|0
4745561|NCT01791205|16369253|P1|Phase II|Remission of disease|1
4745562|NCT01791205|16369252|P2|Phase II|Lost to Follow-up|0
4745563|NCT01791205|16369253|P1|Phase II|Lost to Follow-up|1
4745564|NCT01791205|16369252|P2|Phase II|Safety|0
4745565|NCT01791205|16369253|P1|Phase II|Safety|1
4745566|NCT01791205|16369252|P2|Phase II|Adverse Event|0
4745567|NCT01791205|16369253|P1|Phase II|Adverse Event|2
4745568|NCT01791205|16369252|P2|Phase II|Lack of Efficacy|0
4745569|NCT01791205|16369253|P1|Phase II|Lack of Efficacy|6
4745570|NCT01791153|16369337|P8|Part 2: Open-label Period|Physician Decision|0
4745571|NCT01791153|16369338|P7|Part 2: Open-label Period|Physician Decision|0
4745572|NCT01791153|16369339|P6|Part 2: Open-label Period|Physician Decision|1
4745573|NCT01791153|16369340|P5|Part 2: Open-label Period|Physician Decision|1
4745574|NCT01791153|16369341|P4|Part 2: Open-label Period|Physician Decision|0
4745575|NCT01791153|16369342|P3|Part 2: Open-label Period|Physician Decision|0
4745576|NCT01791153|16369343|P2|Part 2: Open-label Period|Physician Decision|0
4745577|NCT01791153|16369344|P1|Part 2: Open-label Period|Physician Decision|0
4745578|NCT01791153|16369337|P8|Part 2: Open-label Period|Withdrawal by Subject|2
4745579|NCT01791153|16369338|P7|Part 2: Open-label Period|Withdrawal by Subject|3
4745580|NCT01791153|16369339|P6|Part 2: Open-label Period|Withdrawal by Subject|1
4745581|NCT01791153|16369340|P5|Part 2: Open-label Period|Withdrawal by Subject|1
4745582|NCT01791153|16369341|P4|Part 2: Open-label Period|Withdrawal by Subject|0
4745583|NCT01791153|16369342|P3|Part 2: Open-label Period|Withdrawal by Subject|0
4745584|NCT01791153|16369343|P2|Part 2: Open-label Period|Withdrawal by Subject|0
4745585|NCT01791153|16369344|P1|Part 2: Open-label Period|Withdrawal by Subject|0
4745586|NCT01791153|16369337|P8|Part 2: Open-label Period|Lack of Efficacy|1
4745587|NCT01791153|16369338|P7|Part 2: Open-label Period|Lack of Efficacy|0
4745588|NCT01791153|16369339|P6|Part 2: Open-label Period|Lack of Efficacy|0
4745589|NCT01791153|16369340|P5|Part 2: Open-label Period|Lack of Efficacy|0
4745590|NCT01791153|16369341|P4|Part 2: Open-label Period|Lack of Efficacy|0
4745591|NCT01791153|16369342|P3|Part 2: Open-label Period|Lack of Efficacy|0
4745592|NCT01791153|16369343|P2|Part 2: Open-label Period|Lack of Efficacy|0
4745593|NCT01791153|16369344|P1|Part 2: Open-label Period|Lack of Efficacy|0
4745594|NCT01791153|16369337|P8|Part 2: Open-label Period|Lost to Follow-up|0
4745595|NCT01791153|16369338|P7|Part 2: Open-label Period|Lost to Follow-up|1
4745596|NCT01791153|16369339|P6|Part 2: Open-label Period|Lost to Follow-up|0
4745597|NCT01791153|16369340|P5|Part 2: Open-label Period|Lost to Follow-up|0
4745598|NCT01791153|16369341|P4|Part 2: Open-label Period|Lost to Follow-up|0
4745599|NCT01791153|16369342|P3|Part 2: Open-label Period|Lost to Follow-up|0
4745600|NCT01791153|16369343|P2|Part 2: Open-label Period|Lost to Follow-up|0
4745601|NCT01791153|16369344|P1|Part 2: Open-label Period|Lost to Follow-up|0
4745602|NCT01791153|16369337|P8|Part 2: Open-label Period|Death|1
4745603|NCT01791153|16369338|P7|Part 2: Open-label Period|Death|1
4745604|NCT01791153|16369339|P6|Part 2: Open-label Period|Death|1
4745605|NCT01791153|16369340|P5|Part 2: Open-label Period|Death|0
4745606|NCT01791153|16369341|P4|Part 2: Open-label Period|Death|0
4745607|NCT01791153|16369342|P3|Part 2: Open-label Period|Death|0
4745608|NCT01791153|16369343|P2|Part 2: Open-label Period|Death|0
4745609|NCT01791153|16369344|P1|Part 2: Open-label Period|Death|0
4745610|NCT01791153|16369337|P8|Part 2: Open-label Period|Adverse Event|2
4745611|NCT01791153|16369338|P7|Part 2: Open-label Period|Adverse Event|1
4745612|NCT01791153|16369339|P6|Part 2: Open-label Period|Adverse Event|1
4745613|NCT01791153|16369340|P5|Part 2: Open-label Period|Adverse Event|0
4745614|NCT01791153|16369341|P4|Part 2: Open-label Period|Adverse Event|0
4745615|NCT01791153|16369342|P3|Part 2: Open-label Period|Adverse Event|0
4745616|NCT01791153|16369343|P2|Part 2: Open-label Period|Adverse Event|0
4745617|NCT01791153|16369344|P1|Part 2: Open-label Period|Adverse Event|0
4745618|NCT01791153|16369337|P8|Part 1: Blinded Period|Withdrawal by Subject|0
4745619|NCT01791153|16369338|P7|Part 1: Blinded Period|Withdrawal by Subject|0
4745620|NCT01791153|16369339|P6|Part 1: Blinded Period|Withdrawal by Subject|0
4745621|NCT01791153|16369340|P5|Part 1: Blinded Period|Withdrawal by Subject|0
4745622|NCT01791153|16369341|P4|Part 1: Blinded Period|Withdrawal by Subject|1
4745623|NCT01791153|16369342|P3|Part 1: Blinded Period|Withdrawal by Subject|2
4745624|NCT01791153|16369343|P2|Part 1: Blinded Period|Withdrawal by Subject|2
4745625|NCT01791153|16369344|P1|Part 1: Blinded Period|Withdrawal by Subject|6
4745626|NCT01791153|16369337|P8|Part 1: Blinded Period|Protocol Violation|0
4745627|NCT01791153|16369338|P7|Part 1: Blinded Period|Protocol Violation|0
4745628|NCT01791153|16369339|P6|Part 1: Blinded Period|Protocol Violation|0
4745629|NCT01791153|16369340|P5|Part 1: Blinded Period|Protocol Violation|0
4745630|NCT01791153|16369341|P4|Part 1: Blinded Period|Protocol Violation|1
4745631|NCT01791153|16369342|P3|Part 1: Blinded Period|Protocol Violation|0
4745632|NCT01791153|16369343|P2|Part 1: Blinded Period|Protocol Violation|0
4745633|NCT01791153|16369344|P1|Part 1: Blinded Period|Protocol Violation|0
4745634|NCT01791153|16369337|P8|Part 1: Blinded Period|Physician Decision|0
4745635|NCT01791153|16369338|P7|Part 1: Blinded Period|Physician Decision|0
4745636|NCT01791153|16369339|P6|Part 1: Blinded Period|Physician Decision|0
4745637|NCT01791153|16369340|P5|Part 1: Blinded Period|Physician Decision|0
4745638|NCT01791153|16369341|P4|Part 1: Blinded Period|Physician Decision|1
4745639|NCT01791153|16369342|P3|Part 1: Blinded Period|Physician Decision|0
4745640|NCT01791153|16369343|P2|Part 1: Blinded Period|Physician Decision|0
4745641|NCT01791153|16369344|P1|Part 1: Blinded Period|Physician Decision|0
4745642|NCT01791153|16369337|P8|Part 1: Blinded Period|Non-Compliance|0
4745643|NCT01791153|16369338|P7|Part 1: Blinded Period|Non-Compliance|0
4745644|NCT01791153|16369339|P6|Part 1: Blinded Period|Non-Compliance|0
4745645|NCT01791153|16369340|P5|Part 1: Blinded Period|Non-Compliance|0
4745646|NCT01791153|16369341|P4|Part 1: Blinded Period|Non-Compliance|0
4745647|NCT01791153|16369342|P3|Part 1: Blinded Period|Non-Compliance|0
4745648|NCT01791153|16369343|P2|Part 1: Blinded Period|Non-Compliance|0
4745649|NCT01791153|16369344|P1|Part 1: Blinded Period|Non-Compliance|1
4745650|NCT01791153|16369337|P8|Part 1: Blinded Period|Lack of Efficacy|0
4745651|NCT01791153|16369338|P7|Part 1: Blinded Period|Lack of Efficacy|0
4745652|NCT01791153|16369339|P6|Part 1: Blinded Period|Lack of Efficacy|0
4745653|NCT01791153|16369340|P5|Part 1: Blinded Period|Lack of Efficacy|0
4745654|NCT01791153|16369341|P4|Part 1: Blinded Period|Lack of Efficacy|2
4745655|NCT01791153|16369342|P3|Part 1: Blinded Period|Lack of Efficacy|2
4745656|NCT01791153|16369343|P2|Part 1: Blinded Period|Lack of Efficacy|3
4745657|NCT01791153|16369344|P1|Part 1: Blinded Period|Lack of Efficacy|1
4745658|NCT01791153|16369337|P8|Part 1: Blinded Period|Adverse Event|0
4745659|NCT01791153|16369338|P7|Part 1: Blinded Period|Adverse Event|0
4745660|NCT01791153|16369339|P6|Part 1: Blinded Period|Adverse Event|0
4745661|NCT01791153|16369340|P5|Part 1: Blinded Period|Adverse Event|0
4745662|NCT01791153|16369341|P4|Part 1: Blinded Period|Adverse Event|0
4745663|NCT01791153|16369342|P3|Part 1: Blinded Period|Adverse Event|2
4745664|NCT01791153|16369343|P2|Part 1: Blinded Period|Adverse Event|3
4745665|NCT01791153|16369344|P1|Part 1: Blinded Period|Adverse Event|7
4745666|NCT01791127|16369404|P1|Overall Study|Study terminated for EP Passion|749
4745667|NCT01791127|16369404|P1|Overall Study|Completion of 30 day safety registry|1
4745668|NCT01791127|16369404|P1|Overall Study|All Siello leads are explanted|31
4745669|NCT01791127|16369404|P1|Overall Study|Lost to Follow-up|42
4745670|NCT01791127|16369404|P1|Overall Study|Patient has withdrawn from study|293
4745671|NCT01791127|16369404|P1|Overall Study|Death|356
4745672|NCT01790932|16369428|P1|Overall Study|Withdrawal by Subject|1
4745673|NCT01790932|16369428|P1|Overall Study|Physician Decision|1
4745674|NCT01790932|16369428|P1|Overall Study|Adverse Event|7
4745675|NCT01790932|16369428|P1|Overall Study|Disease Progression|41
4745676|NCT01790828|16369434|P1|Overall Study|Other|34
4745677|NCT01790633|16369492|P2|Overall Study|RT failure and no follow-up ELISA|3
4745678|NCT01790633|16369493|P1|Overall Study|RT failure and no follow-up ELISA|0
4745679|NCT01790633|16369492|P2|Overall Study|Did not have serology performed|0
4745680|NCT01790633|16369493|P1|Overall Study|Did not have serology performed|47
4745681|NCT01790633|16369492|P2|Overall Study|Protocol Violation|2
4745682|NCT01790633|16369493|P1|Overall Study|Protocol Violation|1
4745683|NCT01790594|16369506|P3|Overall Study|Terminated prior to week 76|0
4745684|NCT01790594|16369507|P2|Overall Study|Terminated prior to week 76|2
4745685|NCT01790594|16369508|P1|Overall Study|Terminated prior to week 76|0
4745686|NCT01790594|16369506|P3|Overall Study|Transplant was not done|3
4745687|NCT01790594|16369507|P2|Overall Study|Transplant was not done|0
4745688|NCT01790594|16369508|P1|Overall Study|Transplant was not done|0
4745689|NCT01790594|16369506|P3|Overall Study|Withdrawal by Subject|0
4745690|NCT01790594|16369507|P2|Overall Study|Withdrawal by Subject|0
4745691|NCT01790594|16369508|P1|Overall Study|Withdrawal by Subject|2
4745692|NCT01790594|16369506|P3|Overall Study|Physician Decision|0
4745693|NCT01790594|16369507|P2|Overall Study|Physician Decision|1
4745694|NCT01790594|16369508|P1|Overall Study|Physician Decision|2
4745695|NCT01790594|16369506|P3|Overall Study|Death|0
4745696|NCT01790594|16369507|P2|Overall Study|Death|0
4745697|NCT01790594|16369508|P1|Overall Study|Death|1
4745698|NCT01790568|16369585|P2|Overall Study|Progression prior to transplant|1
4745699|NCT01790568|16369586|P1|Overall Study|Progression prior to transplant|0
4745700|NCT01790516|16369594|P2|Overall Study|Physician Decision|0
4745701|NCT01790516|16369595|P1|Overall Study|Physician Decision|1
4745702|NCT01790503|16369612|P11|Overall Study|Other|0
4745703|NCT01790503|16369613|P10|Overall Study|Other|2
4745704|NCT01790503|16369614|P9|Overall Study|Other|1
4745705|NCT01790503|16369615|P8|Overall Study|Other|0
4745706|NCT01790503|16369616|P7|Overall Study|Other|0
4745707|NCT01790503|16369617|P6|Overall Study|Other|0
4745708|NCT01790503|16369618|P5|Overall Study|Other|1
4745709|NCT01790503|16369619|P4|Overall Study|Other|0
4745710|NCT01790503|16369620|P3|Overall Study|Other|0
4745711|NCT01790503|16369621|P2|Overall Study|Other|0
4745712|NCT01790503|16369622|P1|Overall Study|Other|0
4745713|NCT01790503|16369612|P11|Overall Study|Non Compliance|0
4745714|NCT01790503|16369613|P10|Overall Study|Non Compliance|0
4745715|NCT01790503|16369614|P9|Overall Study|Non Compliance|0
4745716|NCT01790503|16369615|P8|Overall Study|Non Compliance|0
4745717|NCT01790503|16369616|P7|Overall Study|Non Compliance|0
4745718|NCT01790503|16369617|P6|Overall Study|Non Compliance|0
4745719|NCT01790503|16369618|P5|Overall Study|Non Compliance|1
4745720|NCT01790503|16369619|P4|Overall Study|Non Compliance|0
4745721|NCT01790503|16369620|P3|Overall Study|Non Compliance|0
4745722|NCT01790503|16369621|P2|Overall Study|Non Compliance|0
4745723|NCT01790503|16369622|P1|Overall Study|Non Compliance|0
4745724|NCT01790503|16369612|P11|Overall Study|Death|0
4745725|NCT01790503|16369613|P10|Overall Study|Death|1
4745726|NCT01790503|16369614|P9|Overall Study|Death|0
4745727|NCT01790503|16369615|P8|Overall Study|Death|0
4745728|NCT01790503|16369616|P7|Overall Study|Death|0
4745729|NCT01790503|16369617|P6|Overall Study|Death|0
4745730|NCT01790503|16369618|P5|Overall Study|Death|0
4745731|NCT01790503|16369619|P4|Overall Study|Death|0
4745732|NCT01790503|16369620|P3|Overall Study|Death|0
4745733|NCT01790503|16369621|P2|Overall Study|Death|0
4745734|NCT01790503|16369622|P1|Overall Study|Death|0
4745735|NCT01790503|16369612|P11|Overall Study|Physician Decision|1
4745736|NCT01790503|16369613|P10|Overall Study|Physician Decision|1
4745737|NCT01790503|16369614|P9|Overall Study|Physician Decision|0
4745738|NCT01790503|16369615|P8|Overall Study|Physician Decision|0
4745739|NCT01790503|16369616|P7|Overall Study|Physician Decision|0
4745740|NCT01790503|16369617|P6|Overall Study|Physician Decision|0
4745741|NCT01790503|16369618|P5|Overall Study|Physician Decision|0
4745742|NCT01790503|16369619|P4|Overall Study|Physician Decision|0
4745743|NCT01790503|16369620|P3|Overall Study|Physician Decision|0
4745744|NCT01790503|16369621|P2|Overall Study|Physician Decision|0
4745745|NCT01790503|16369622|P1|Overall Study|Physician Decision|0
4745746|NCT01790503|16369612|P11|Overall Study|Protocol Violation|0
4745747|NCT01790503|16369613|P10|Overall Study|Protocol Violation|1
4745748|NCT01790503|16369614|P9|Overall Study|Protocol Violation|0
4745749|NCT01790503|16369615|P8|Overall Study|Protocol Violation|0
4745750|NCT01790503|16369616|P7|Overall Study|Protocol Violation|0
4745751|NCT01790503|16369617|P6|Overall Study|Protocol Violation|0
4745752|NCT01790503|16369618|P5|Overall Study|Protocol Violation|0
4745753|NCT01790503|16369619|P4|Overall Study|Protocol Violation|0
4745754|NCT01790503|16369620|P3|Overall Study|Protocol Violation|0
4745755|NCT01790503|16369621|P2|Overall Study|Protocol Violation|0
4745756|NCT01790503|16369622|P1|Overall Study|Protocol Violation|0
4745757|NCT01790503|16369612|P11|Overall Study|Disease progression|7
4745758|NCT01790503|16369613|P10|Overall Study|Disease progression|17
4745759|NCT01790503|16369614|P9|Overall Study|Disease progression|0
4745760|NCT01790503|16369615|P8|Overall Study|Disease progression|1
4745761|NCT01790503|16369616|P7|Overall Study|Disease progression|0
4745762|NCT01790503|16369617|P6|Overall Study|Disease progression|1
4745763|NCT01790503|16369618|P5|Overall Study|Disease progression|2
4745764|NCT01790503|16369619|P4|Overall Study|Disease progression|1
4745765|NCT01790503|16369620|P3|Overall Study|Disease progression|0
4745766|NCT01790503|16369621|P2|Overall Study|Disease progression|1
4745767|NCT01790503|16369622|P1|Overall Study|Disease progression|2
4745768|NCT01790503|16369612|P11|Overall Study|Withdrawal by Subject|1
4745769|NCT01790503|16369613|P10|Overall Study|Withdrawal by Subject|0
4745770|NCT01790503|16369614|P9|Overall Study|Withdrawal by Subject|0
4745771|NCT01790503|16369615|P8|Overall Study|Withdrawal by Subject|0
4745772|NCT01790503|16369616|P7|Overall Study|Withdrawal by Subject|1
4745773|NCT01790503|16369617|P6|Overall Study|Withdrawal by Subject|2
4745774|NCT01790503|16369618|P5|Overall Study|Withdrawal by Subject|1
4745775|NCT01790503|16369619|P4|Overall Study|Withdrawal by Subject|1
4745776|NCT01790503|16369620|P3|Overall Study|Withdrawal by Subject|1
4745777|NCT01790503|16369621|P2|Overall Study|Withdrawal by Subject|0
4745778|NCT01790503|16369622|P1|Overall Study|Withdrawal by Subject|0
4745779|NCT01790503|16369612|P11|Overall Study|Adverse Event|7
4745780|NCT01790503|16369613|P10|Overall Study|Adverse Event|4
4745781|NCT01790503|16369614|P9|Overall Study|Adverse Event|2
4745782|NCT01790503|16369615|P8|Overall Study|Adverse Event|0
4745783|NCT01790503|16369616|P7|Overall Study|Adverse Event|0
4745784|NCT01790503|16369617|P6|Overall Study|Adverse Event|2
4745785|NCT01790503|16369618|P5|Overall Study|Adverse Event|0
4745786|NCT01790503|16369619|P4|Overall Study|Adverse Event|0
4745787|NCT01790503|16369620|P3|Overall Study|Adverse Event|0
4745788|NCT01790503|16369621|P2|Overall Study|Adverse Event|0
4745789|NCT01790503|16369622|P1|Overall Study|Adverse Event|1
4745790|NCT01790438|16369692|P2|Overall Study|Protocol Required Discontinuation|1
4745791|NCT01790438|16369693|P1|Overall Study|Protocol Required Discontinuation|7
4745792|NCT01790438|16369692|P2|Overall Study|Sponsor Decision|3
4745793|NCT01790438|16369693|P1|Overall Study|Sponsor Decision|0
4745794|NCT01790438|16369692|P2|Overall Study|Physician Decision|1
4745795|NCT01790438|16369693|P1|Overall Study|Physician Decision|3
4745796|NCT01790438|16369692|P2|Overall Study|Withdrawal by Subject|2
4745797|NCT01790438|16369693|P1|Overall Study|Withdrawal by Subject|13
4745798|NCT01790438|16369692|P2|Overall Study|Lost to Follow-up|2
4745799|NCT01790438|16369693|P1|Overall Study|Lost to Follow-up|5
4745800|NCT01790438|16369692|P2|Overall Study|Death|0
4745801|NCT01790438|16369693|P1|Overall Study|Death|4
4745802|NCT01790438|16369692|P2|Overall Study|Adverse Event|2
4745803|NCT01790438|16369693|P1|Overall Study|Adverse Event|3
4745804|NCT01790295|16369743|P1|Overall Study|Study closure|4
4745805|NCT01790295|16369743|P1|Overall Study|Lack of Efficacy|2
4745806|NCT01790295|16369743|P1|Overall Study|Death|4
4745807|NCT01790295|16369743|P1|Overall Study|Adverse Event|1
4745808|NCT01790126|16369813|P3|Overall Study|Radiographic Progression|0
4745809|NCT01790126|16369814|P2|Overall Study|Radiographic Progression|1
4745810|NCT01790126|16369815|P1|Overall Study|Radiographic Progression|3
4745811|NCT01790126|16369813|P3|Overall Study|Death|0
4745812|NCT01790126|16369814|P2|Overall Study|Death|0
4745813|NCT01790126|16369815|P1|Overall Study|Death|2
4745814|NCT01790126|16369813|P3|Overall Study|Adverse Event|0
4745815|NCT01790126|16369814|P2|Overall Study|Adverse Event|2
4745816|NCT01790126|16369815|P1|Overall Study|Adverse Event|0
4745817|NCT01790126|16369813|P3|Overall Study|Lost to Follow-up|1
4745818|NCT01790126|16369814|P2|Overall Study|Lost to Follow-up|0
4745819|NCT01790126|16369815|P1|Overall Study|Lost to Follow-up|1
4745820|NCT01790126|16369813|P3|Overall Study|Withdrawal by Subject|2
4745821|NCT01790126|16369814|P2|Overall Study|Withdrawal by Subject|1
4745822|NCT01790126|16369815|P1|Overall Study|Withdrawal by Subject|3
4745823|NCT01790126|16369813|P3|Overall Study|Withdrawal by Physician|2
4745824|NCT01790126|16369814|P2|Overall Study|Withdrawal by Physician|1
4745825|NCT01790126|16369815|P1|Overall Study|Withdrawal by Physician|1
4745826|NCT01790126|16369813|P3|Overall Study|Initiation of Non-Protocol Therapy|2
4745827|NCT01790126|16369814|P2|Overall Study|Initiation of Non-Protocol Therapy|4
4745828|NCT01790126|16369815|P1|Overall Study|Initiation of Non-Protocol Therapy|3
4745829|NCT01790126|16369813|P3|Overall Study|Other|8
4745830|NCT01790126|16369814|P2|Overall Study|Other|4
4745831|NCT01790126|16369815|P1|Overall Study|Other|5
4745832|NCT01790126|16369813|P3|Overall Study|PSA Progression|16
4745833|NCT01790126|16369814|P2|Overall Study|PSA Progression|16
4745834|NCT01790126|16369815|P1|Overall Study|PSA Progression|12
4745835|NCT01790048|16369872|P2|Overall Study|Measurement error|0
4745836|NCT01790048|16369873|P1|Overall Study|Measurement error|1
4745837|NCT01790048|16369872|P2|Overall Study|SAM at Enrollment|0
4745838|NCT01790048|16369873|P1|Overall Study|SAM at Enrollment|2
4745839|NCT01790048|16369872|P2|Overall Study|Other|2
4745840|NCT01790048|16369873|P1|Overall Study|Other|0
4745841|NCT01790048|16369872|P2|Overall Study|data entry error|1
4745842|NCT01790048|16369873|P1|Overall Study|data entry error|0
4745843|NCT01790048|16369872|P2|Overall Study|Incorrect Age|14
4745844|NCT01790048|16369873|P1|Overall Study|Incorrect Age|9
4745845|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
4745846|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1
4745847|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0
4745848|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Other|3
4745849|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Other|1
4745850|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Other|0
4745851|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
4745852|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Pregnancy|1
4745853|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Pregnancy|0
4745854|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2
4745855|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1
4745856|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0
4745857|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1
4745858|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2
4745859|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0
4745860|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
4745861|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2
4745862|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
4745863|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7
4745864|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
4745865|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
4745866|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9
4745867|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7
4745868|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4745869|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
4745870|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
4745871|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4745872|NCT01789970|16369891|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|15
4745873|NCT01789970|16369892|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|9
4745874|NCT01789970|16369893|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
4745875|NCT01789970|16369891|P3|Open-label Titration Period|Dropped out prior to dosing|0
4745876|NCT01789970|16369892|P2|Open-label Titration Period|Dropped out prior to dosing|0
4745877|NCT01789970|16369893|P1|Open-label Titration Period|Dropped out prior to dosing|2
4745878|NCT01789970|16369891|P3|Open-label Titration Period|Other|0
4745879|NCT01789970|16369892|P2|Open-label Titration Period|Other|0
4745880|NCT01789970|16369893|P1|Open-label Titration Period|Other|76
4745881|NCT01789970|16369891|P3|Open-label Titration Period|Pregnancy|0
4745882|NCT01789970|16369892|P2|Open-label Titration Period|Pregnancy|0
4745883|NCT01789970|16369893|P1|Open-label Titration Period|Pregnancy|2
4745884|NCT01789970|16369891|P3|Open-label Titration Period|Noncompliance with study procedures|0
4745885|NCT01789970|16369892|P2|Open-label Titration Period|Noncompliance with study procedures|0
4745886|NCT01789970|16369893|P1|Open-label Titration Period|Noncompliance with study procedures|8
4745887|NCT01789970|16369891|P3|Open-label Titration Period|Noncompliance with study rescue meds|0
4745888|NCT01789970|16369892|P2|Open-label Titration Period|Noncompliance with study rescue meds|0
4745889|NCT01789970|16369893|P1|Open-label Titration Period|Noncompliance with study rescue meds|2
4745890|NCT01789970|16369891|P3|Open-label Titration Period|Noncompliance to study drug admin|0
4745891|NCT01789970|16369892|P2|Open-label Titration Period|Noncompliance to study drug admin|0
4745892|NCT01789970|16369893|P1|Open-label Titration Period|Noncompliance to study drug admin|11
4745893|NCT01789970|16369891|P3|Open-label Titration Period|Lost to Follow-up|0
4745894|NCT01789970|16369892|P2|Open-label Titration Period|Lost to Follow-up|0
4745895|NCT01789970|16369893|P1|Open-label Titration Period|Lost to Follow-up|5
4745896|NCT01789970|16369891|P3|Open-label Titration Period|Protocol Violation|0
4745897|NCT01789970|16369892|P2|Open-label Titration Period|Protocol Violation|0
4745898|NCT01789970|16369893|P1|Open-label Titration Period|Protocol Violation|18
4745899|NCT01789970|16369891|P3|Open-label Titration Period|Withdrawal by Subject|0
4745900|NCT01789970|16369892|P2|Open-label Titration Period|Withdrawal by Subject|0
4745901|NCT01789970|16369893|P1|Open-label Titration Period|Withdrawal by Subject|31
4745902|NCT01789970|16369891|P3|Open-label Titration Period|Lack of Efficacy|0
4745903|NCT01789970|16369892|P2|Open-label Titration Period|Lack of Efficacy|0
4745904|NCT01789970|16369893|P1|Open-label Titration Period|Lack of Efficacy|31
4745905|NCT01789970|16369891|P3|Open-label Titration Period|Adverse Event|0
4745906|NCT01789970|16369892|P2|Open-label Titration Period|Adverse Event|0
4745907|NCT01789970|16369893|P1|Open-label Titration Period|Adverse Event|68
4745908|NCT01789606|16369951|P2|Overall Study|Ineligible or not Willing to Continue|348
4745909|NCT01789606|16369952|P1|Overall Study|Ineligible or not Willing to Continue|0
4745910|NCT01789606|16369951|P2|Overall Study|Lost to Follow-up|14
4745911|NCT01789606|16369952|P1|Overall Study|Lost to Follow-up|0
4745912|NCT01789606|16369951|P2|Overall Study|Adverse Event|3
4745913|NCT01789606|16369952|P1|Overall Study|Adverse Event|0
4745914|NCT01789606|16369951|P2|Overall Study|Protocol Violation|55
4745915|NCT01789606|16369952|P1|Overall Study|Protocol Violation|0
4745916|NCT01789606|16369951|P2|Overall Study|No Study Medication Taken|1
4745917|NCT01789606|16369952|P1|Overall Study|No Study Medication Taken|0
4745918|NCT01789606|16369951|P2|Overall Study|Administrative Reasons|6
4745919|NCT01789606|16369952|P1|Overall Study|Administrative Reasons|17
4745920|NCT01789606|16369951|P2|Overall Study|Ineligible|2
4745921|NCT01789606|16369952|P1|Overall Study|Ineligible|6
4745922|NCT01789606|16369951|P2|Overall Study|Withdrawal by Subject|1
4745923|NCT01789606|16369952|P1|Overall Study|Withdrawal by Subject|0
4745924|NCT01789606|16369951|P2|Overall Study|Participant not Purchased the Product|20
4745925|NCT01789606|16369952|P1|Overall Study|Participant not Purchased the Product|0
4745926|NCT01789567|16369970|P1|Overall Study|Death|6
4745927|NCT01789476|16369979|P2|Overall Study|Unable to get IV access|0
4745928|NCT01789476|16369980|P1|Overall Study|Unable to get IV access|1
4745929|NCT01789476|16369979|P2|Overall Study|Adverse Event|0
4745930|NCT01789476|16369980|P1|Overall Study|Adverse Event|1
4745931|NCT01789476|16369979|P2|Overall Study|Lack of Efficacy|2
4745932|NCT01789476|16369980|P1|Overall Study|Lack of Efficacy|6
4745933|NCT01789203|16370002|P2|Overall Study|patient non-adherent|0
4745934|NCT01789203|16370003|P1|Overall Study|patient non-adherent|2
4745935|NCT01789203|16370002|P2|Overall Study|Other|1
4745936|NCT01789203|16370003|P1|Overall Study|Other|1
4745937|NCT01789203|16370002|P2|Overall Study|Protocol Violation|1
4745938|NCT01789203|16370003|P1|Overall Study|Protocol Violation|2
4745939|NCT01789203|16370002|P2|Overall Study|Death|0
4745940|NCT01789203|16370003|P1|Overall Study|Death|1
4745941|NCT01789203|16370002|P2|Overall Study|Withdrawal by Subject|0
4745942|NCT01789203|16370003|P1|Overall Study|Withdrawal by Subject|1
4745943|NCT01789203|16370002|P2|Overall Study|Adverse Event|2
4745944|NCT01789203|16370003|P1|Overall Study|Adverse Event|2
4745945|NCT01789047|16370044|P2|Overall Study|Withdrawal by Subject|2
4745946|NCT01789047|16370045|P1|Overall Study|Withdrawal by Subject|1
4745947|NCT01789047|16370044|P2|Overall Study|Adverse Event|2
4745948|NCT01789047|16370045|P1|Overall Study|Adverse Event|3
4745949|NCT01788943|16370053|P2|Overall Study|Withdrawal by Subject|0
4745950|NCT01788943|16370054|P1|Overall Study|Withdrawal by Subject|1
4745951|NCT01788566|16370083|P1|Overall Study|Clinical Progressive Disease|3
4745952|NCT01788566|16370083|P1|Overall Study|Adverse Event|1
4745953|NCT01788566|16370083|P1|Overall Study|Death|4
4745954|NCT01788423|16370121|P3|Overall Study|See Comments in Completed (above)|5
4745955|NCT01788423|16370122|P2|Overall Study|See Comments in Completed (above)|4
4745956|NCT01788423|16370123|P1|Overall Study|See Comments in Completed (above)|0
4745957|NCT01788358|16370134|P1|Overall Study|Adverse Event|51
4745958|NCT01788358|16370134|P1|Overall Study|Lack of Efficacy|1
4745959|NCT01788358|16370134|P1|Overall Study|Withdrawal by Subject|26
4745960|NCT01788358|16370134|P1|Overall Study|Protocol Violation|3
4745961|NCT01788358|16370134|P1|Overall Study|Lost to Follow-up|5
4745962|NCT01788358|16370134|P1|Overall Study|Logistical difficulties|1
4745963|NCT01788358|16370134|P1|Overall Study|Other|11
4745964|NCT01788228|16370148|P2|Overall Study|Migrated/moved from study area|0
4745965|NCT01788228|16370149|P1|Overall Study|Migrated/moved from study area|1
4745966|NCT01788215|16370182|P2|Overall Study|Lost to Follow-up|0
4745967|NCT01788215|16370183|P1|Overall Study|Lost to Follow-up|2
4745968|NCT01788215|16370182|P2|Overall Study|Withdrawal by Subject|1
4745969|NCT01788215|16370183|P1|Overall Study|Withdrawal by Subject|0
4745970|NCT01788163|16370212|P9|Overall Study|Withdrawal by Subject|1
4745971|NCT01788163|16370213|P8|Overall Study|Withdrawal by Subject|0
4745972|NCT01788163|16370214|P7|Overall Study|Withdrawal by Subject|0
4745973|NCT01788163|16370215|P6|Overall Study|Withdrawal by Subject|0
4745974|NCT01788163|16370216|P5|Overall Study|Withdrawal by Subject|0
4745975|NCT01788163|16370217|P4|Overall Study|Withdrawal by Subject|0
4745976|NCT01788163|16370218|P3|Overall Study|Withdrawal by Subject|0
4745977|NCT01788163|16370219|P2|Overall Study|Withdrawal by Subject|0
4745978|NCT01788163|16370220|P1|Overall Study|Withdrawal by Subject|2
4745979|NCT01788163|16370212|P9|Overall Study|Other|15
4745980|NCT01788163|16370213|P8|Overall Study|Other|48
4745981|NCT01788163|16370214|P7|Overall Study|Other|1
4745982|NCT01788163|16370215|P6|Overall Study|Other|7
4745983|NCT01788163|16370216|P5|Overall Study|Other|0
4745984|NCT01788163|16370217|P4|Overall Study|Other|0
4745985|NCT01788163|16370218|P3|Overall Study|Other|0
4745986|NCT01788163|16370219|P2|Overall Study|Other|0
4745987|NCT01788163|16370220|P1|Overall Study|Other|53
4745988|NCT01788046|16370383|P2|Overall Study|Protocol Specified Criteria|1
4745989|NCT01788046|16370384|P1|Overall Study|Protocol Specified Criteria|25
4745990|NCT01788046|16370383|P2|Overall Study|Death|5
4745991|NCT01788046|16370384|P1|Overall Study|Death|7
4745992|NCT01788046|16370383|P2|Overall Study|Lost to Follow-up|19
4745993|NCT01788046|16370384|P1|Overall Study|Lost to Follow-up|12
4745994|NCT01788046|16370383|P2|Overall Study|Withdrawal by Subject|12
4745995|NCT01788046|16370384|P1|Overall Study|Withdrawal by Subject|12
4745996|NCT01787838|16370407|P1|Overall Study|refused|1413
4745997|NCT01787825|16370411|P2|Overall Study|Data Not Analyzable|1
4745998|NCT01787825|16370412|P1|Overall Study|Data Not Analyzable|5
4745999|NCT01787825|16370411|P2|Overall Study|Subject Did Not Ingest Capsules|0
4746000|NCT01787825|16370412|P1|Overall Study|Subject Did Not Ingest Capsules|1
4746001|NCT01787760|16370430|P3|Overall Study|Near vision blur|0
4746002|NCT01787760|16370431|P2|Overall Study|Near vision blur|0
4746003|NCT01787760|16370432|P1|Overall Study|Near vision blur|1
4746004|NCT01787760|16370430|P3|Overall Study|Unsatisfactory visual response|0
4746005|NCT01787760|16370431|P2|Overall Study|Unsatisfactory visual response|1
4746006|NCT01787760|16370432|P1|Overall Study|Unsatisfactory visual response|1
4746007|NCT01787760|16370430|P3|Overall Study|Unsatisfactory physiological response|0
4746008|NCT01787760|16370431|P2|Overall Study|Unsatisfactory physiological response|4
4746009|NCT01787760|16370432|P1|Overall Study|Unsatisfactory physiological response|2
4746010|NCT01787760|16370430|P3|Overall Study|Unsatisfactory lens fitting performance|0
4746011|NCT01787760|16370431|P2|Overall Study|Unsatisfactory lens fitting performance|6
4746012|NCT01787760|16370432|P1|Overall Study|Unsatisfactory lens fitting performance|3
4746013|NCT01787760|16370430|P3|Overall Study|Stroke|0
4746014|NCT01787760|16370431|P2|Overall Study|Stroke|0
4746015|NCT01787760|16370432|P1|Overall Study|Stroke|1
4746016|NCT01787760|16370430|P3|Overall Study|Lost to Follow-up|1
4746017|NCT01787760|16370431|P2|Overall Study|Lost to Follow-up|0
4746018|NCT01787760|16370432|P1|Overall Study|Lost to Follow-up|1
4746019|NCT01787760|16370430|P3|Overall Study|Withdrawal by Subject|2
4746020|NCT01787760|16370431|P2|Overall Study|Withdrawal by Subject|1
4746021|NCT01787760|16370432|P1|Overall Study|Withdrawal by Subject|5
4746022|NCT01787760|16370430|P3|Overall Study|Protocol Violation|1
4746023|NCT01787760|16370431|P2|Overall Study|Protocol Violation|0
4746024|NCT01787760|16370432|P1|Overall Study|Protocol Violation|6
4746025|NCT01787760|16370430|P3|Overall Study|Lens handling difficulty|0
4746026|NCT01787760|16370431|P2|Overall Study|Lens handling difficulty|2
4746027|NCT01787760|16370432|P1|Overall Study|Lens handling difficulty|1
4746028|NCT01787760|16370430|P3|Overall Study|Lens discomfort|0
4746029|NCT01787760|16370431|P2|Overall Study|Lens discomfort|0
4746030|NCT01787760|16370432|P1|Overall Study|Lens discomfort|3
4746031|NCT01787760|16370430|P3|Overall Study|Relocation|0
4746032|NCT01787760|16370431|P2|Overall Study|Relocation|1
4746033|NCT01787760|16370432|P1|Overall Study|Relocation|1
4746034|NCT01787760|16370430|P3|Overall Study|Dryness|0
4746035|NCT01787760|16370431|P2|Overall Study|Dryness|1
4746036|NCT01787760|16370432|P1|Overall Study|Dryness|0
4746037|NCT01787760|16370430|P3|Overall Study|Decompensated on left exotropia|1
4746038|NCT01787760|16370431|P2|Overall Study|Decompensated on left exotropia|0
4746039|NCT01787760|16370432|P1|Overall Study|Decompensated on left exotropia|0
4746040|NCT01787760|16370430|P3|Overall Study|Anisometropia > -1.00D in spherical equi|0
4746041|NCT01787760|16370431|P2|Overall Study|Anisometropia > -1.00D in spherical equi|0
4746042|NCT01787760|16370432|P1|Overall Study|Anisometropia > -1.00D in spherical equi|1
4746043|NCT01787591|16370457|P4|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1
4746044|NCT01787591|16370458|P3|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
4746045|NCT01787591|16370459|P2|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
4746046|NCT01787591|16370460|P1|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0
4746047|NCT01787552|16370490|P4|Overall Study|Progressive Disease|1
4746048|NCT01787552|16370491|P3|Overall Study|Progressive Disease|1
4746049|NCT01787552|16370492|P2|Overall Study|Progressive Disease|2
4746050|NCT01787552|16370493|P1|Overall Study|Progressive Disease|2
4746051|NCT01787552|16370490|P4|Overall Study|Study terminated by Sponsor|3
4746052|NCT01787552|16370491|P3|Overall Study|Study terminated by Sponsor|1
4746053|NCT01787552|16370492|P2|Overall Study|Study terminated by Sponsor|0
4746054|NCT01787552|16370493|P1|Overall Study|Study terminated by Sponsor|0
4746055|NCT01787552|16370490|P4|Overall Study|Adverse Event|16
4746056|NCT01787552|16370491|P3|Overall Study|Adverse Event|2
4746057|NCT01787552|16370492|P2|Overall Study|Adverse Event|5
4746058|NCT01787552|16370493|P1|Overall Study|Adverse Event|2
4746059|NCT01787552|16370490|P4|Overall Study|Death|1
4746060|NCT01787552|16370491|P3|Overall Study|Death|0
4746061|NCT01787552|16370492|P2|Overall Study|Death|0
4746062|NCT01787552|16370493|P1|Overall Study|Death|0
4746063|NCT01787552|16370490|P4|Overall Study|Physician Decision|2
4746064|NCT01787552|16370491|P3|Overall Study|Physician Decision|1
4746065|NCT01787552|16370492|P2|Overall Study|Physician Decision|2
4746066|NCT01787552|16370493|P1|Overall Study|Physician Decision|2
4746067|NCT01787552|16370490|P4|Overall Study|Withdrawal by Subject|4
4746068|NCT01787552|16370491|P3|Overall Study|Withdrawal by Subject|0
4746069|NCT01787552|16370492|P2|Overall Study|Withdrawal by Subject|0
4746070|NCT01787552|16370493|P1|Overall Study|Withdrawal by Subject|2
4746071|NCT01787461|16370563|P2|Overall Study|Protocol Violation|0
4746072|NCT01787461|16370564|P1|Overall Study|Protocol Violation|3
4746073|NCT01787461|16370563|P2|Overall Study|Withdrawal by Subject|4
4746074|NCT01787461|16370564|P1|Overall Study|Withdrawal by Subject|3
4746075|NCT01787461|16370563|P2|Overall Study|No longer met eligibility criteria|0
4746076|NCT01787461|16370564|P1|Overall Study|No longer met eligibility criteria|1
4746077|NCT01787461|16370563|P2|Overall Study|Lost to Follow-up|2
4746078|NCT01787461|16370564|P1|Overall Study|Lost to Follow-up|3
4746079|NCT01787461|16370563|P2|Overall Study|Adverse Event|3
4746080|NCT01787461|16370564|P1|Overall Study|Adverse Event|4
4746081|NCT01787331|16370613|P1|Overall Study|Withdrawal by Subject|1
4746082|NCT01787331|16370613|P1|Overall Study|Physician Decision|1
4746083|NCT01787292|16370625|P2|Home Based Exercise Program|Withdrawal by Subject|1
4746084|NCT01787292|16370626|P1|Home Based Exercise Program|Withdrawal by Subject|3
4746085|NCT01787292|16370625|P2|Crossover Exercise Interventions|Withdrawal by Subject|2
4746086|NCT01787292|16370626|P1|Crossover Exercise Interventions|Withdrawal by Subject|2
4746087|NCT01787279|16370643|P1|Overall Study|Lack of Efficacy|1
4746088|NCT01787279|16370643|P1|Overall Study|Lost to Follow-up|2
4746089|NCT01787188|16370669|P3|Overall Study|Other, including patient moved|0
4746090|NCT01787188|16370670|P2|Overall Study|Other, including patient moved|3
4746091|NCT01787188|16370671|P1|Overall Study|Other, including patient moved|0
4746092|NCT01787188|16370669|P3|Overall Study|Lost to Follow-up|2
4746093|NCT01787188|16370670|P2|Overall Study|Lost to Follow-up|2
4746094|NCT01787188|16370671|P1|Overall Study|Lost to Follow-up|1
4746095|NCT01787188|16370669|P3|Overall Study|Protocol Violation|3
4746096|NCT01787188|16370670|P2|Overall Study|Protocol Violation|2
4746097|NCT01787188|16370671|P1|Overall Study|Protocol Violation|3
4746098|NCT01787188|16370669|P3|Overall Study|Withdrawal by Subject|2
4746099|NCT01787188|16370670|P2|Overall Study|Withdrawal by Subject|3
4746100|NCT01787188|16370671|P1|Overall Study|Withdrawal by Subject|4
4746101|NCT01787188|16370669|P3|Overall Study|Non-compliance with Study Drug|0
4746102|NCT01787188|16370670|P2|Overall Study|Non-compliance with Study Drug|1
4746103|NCT01787188|16370671|P1|Overall Study|Non-compliance with Study Drug|0
4746104|NCT01787188|16370669|P3|Overall Study|Lack of Efficacy|5
4746105|NCT01787188|16370670|P2|Overall Study|Lack of Efficacy|3
4746106|NCT01787188|16370671|P1|Overall Study|Lack of Efficacy|7
4746107|NCT01787188|16370669|P3|Overall Study|Adverse Event|6
4746108|NCT01787188|16370670|P2|Overall Study|Adverse Event|4
4746109|NCT01787188|16370671|P1|Overall Study|Adverse Event|2
4746110|NCT01787032|16370743|P6|Overall Study|Protocol Violation|1
4746111|NCT01787032|16370744|P5|Overall Study|Protocol Violation|1
4746112|NCT01787032|16370745|P4|Overall Study|Protocol Violation|0
4746113|NCT01787032|16370746|P3|Overall Study|Protocol Violation|0
4746114|NCT01787032|16370747|P2|Overall Study|Protocol Violation|0
4746115|NCT01787032|16370748|P1|Overall Study|Protocol Violation|0
4746116|NCT01786993|16370801|P2|Overall Study|Hospice Admission|0
4746117|NCT01786993|16370802|P1|Overall Study|Hospice Admission|1
4746118|NCT01786993|16370801|P2|Overall Study|System Explant|0
4746119|NCT01786993|16370802|P1|Overall Study|System Explant|1
4746120|NCT01786993|16370801|P2|Overall Study|Subject Non-Compliance|0
4746121|NCT01786993|16370802|P1|Overall Study|Subject Non-Compliance|1
4746122|NCT01786993|16370801|P2|Overall Study|Lost to Follow-up|1
4746123|NCT01786993|16370802|P1|Overall Study|Lost to Follow-up|0
4746124|NCT01786993|16370801|P2|Overall Study|Withdrawal by Subject|2
4746125|NCT01786993|16370802|P1|Overall Study|Withdrawal by Subject|3
4746126|NCT01786993|16370801|P2|Overall Study|Death|7
4746127|NCT01786993|16370802|P1|Overall Study|Death|6
4746128|NCT01786707|16370861|P2|Overall Study|Lost to Follow-up|1
4746129|NCT01786707|16370862|P1|Overall Study|Lost to Follow-up|1
4746130|NCT01786668|16370874|P4|Overall Study|Lost to Follow-up|0
4746131|NCT01786668|16370875|P3|Overall Study|Lost to Follow-up|1
4746132|NCT01786668|16370876|P2|Overall Study|Lost to Follow-up|0
4746133|NCT01786668|16370877|P1|Overall Study|Lost to Follow-up|1
4746134|NCT01786668|16370874|P4|Overall Study|Pregnancy|1
4746135|NCT01786668|16370875|P3|Overall Study|Pregnancy|0
4746136|NCT01786668|16370876|P2|Overall Study|Pregnancy|0
4746137|NCT01786668|16370877|P1|Overall Study|Pregnancy|0
4746138|NCT01786668|16370874|P4|Overall Study|Withdrawal by Subject|1
4746139|NCT01786668|16370875|P3|Overall Study|Withdrawal by Subject|3
4746140|NCT01786668|16370876|P2|Overall Study|Withdrawal by Subject|0
4746141|NCT01786668|16370877|P1|Overall Study|Withdrawal by Subject|0
4746142|NCT01786668|16370874|P4|Overall Study|Adverse Event|2
4746143|NCT01786668|16370875|P3|Overall Study|Adverse Event|1
4746144|NCT01786668|16370876|P2|Overall Study|Adverse Event|1
4746145|NCT01786668|16370877|P1|Overall Study|Adverse Event|0
4746146|NCT01786629|16370977|P2|Overall Study|Adverse Event|1
4746147|NCT01786629|16370978|P1|Overall Study|Adverse Event|0
4746148|NCT01786629|16370977|P2|Overall Study|Lack of Efficacy|4
4746149|NCT01786629|16370978|P1|Overall Study|Lack of Efficacy|0
4746150|NCT01786603|16370986|P2|Overall Study|Lost to Follow-up|2
4746151|NCT01786603|16370987|P1|Overall Study|Lost to Follow-up|1
4746152|NCT01786603|16370986|P2|Overall Study|Physician decision to withdraw|7
4746153|NCT01786603|16370987|P1|Overall Study|Physician decision to withdraw|6
4746154|NCT01786603|16370986|P2|Overall Study|Adverse Event|2
4746155|NCT01786603|16370987|P1|Overall Study|Adverse Event|6
4746156|NCT01786603|16370986|P2|Overall Study|Death|1
4746157|NCT01786603|16370987|P1|Overall Study|Death|5
4746158|NCT01786564|16371005|P1|Overall Study|Ineligible|17
4746159|NCT01786564|16371005|P1|Overall Study|Lost to Follow-up|47
4746160|NCT01786551|16371009|P1|Overall Study|Participant withdrew consent|2
4746161|NCT01786330|16371030|P2|Overall Study|Protocol Violation|0
4746162|NCT01786330|16371031|P1|Overall Study|Protocol Violation|1
4746163|NCT01786330|16371030|P2|Overall Study|Excluded intraoperatively|1
4746164|NCT01786330|16371031|P1|Overall Study|Excluded intraoperatively|0
4746165|NCT01786330|16371030|P2|Overall Study|Lost to Follow-up|1
4746166|NCT01786330|16371031|P1|Overall Study|Lost to Follow-up|0
4746167|NCT01786330|16371030|P2|Overall Study|Withdrawal by Subject|1
4746168|NCT01786330|16371031|P1|Overall Study|Withdrawal by Subject|0
4746169|NCT01786174|16371083|P2|Overall Study|Discontinued Study Drug|0
4746170|NCT01786174|16371084|P1|Overall Study|Discontinued Study Drug|2
4746171|NCT01786148|16371113|P2|Overall Study|Incarceration|1
4746172|NCT01786148|16371114|P1|Overall Study|Incarceration|1
4746173|NCT01786148|16371113|P2|Overall Study|Withdrawal by Subject|7
4746174|NCT01786148|16371114|P1|Overall Study|Withdrawal by Subject|0
4746175|NCT01786148|16371113|P2|Overall Study|Death|1
4746176|NCT01786148|16371114|P1|Overall Study|Death|0
4746177|NCT01786148|16371113|P2|Overall Study|Lost to Follow-up|13
4746178|NCT01786148|16371114|P1|Overall Study|Lost to Follow-up|21
4746179|NCT01786109|16371129|P3|Overall Study|adverse effects colon preparation|1
4746180|NCT01786109|16371130|P2|Overall Study|adverse effects colon preparation|0
4746181|NCT01786109|16371131|P1|Overall Study|adverse effects colon preparation|0
4746182|NCT01786109|16371129|P3|Overall Study|unrelated illness|1
4746183|NCT01786109|16371130|P2|Overall Study|unrelated illness|0
4746184|NCT01786109|16371131|P1|Overall Study|unrelated illness|0
4746185|NCT01786109|16371129|P3|Overall Study|fail manometry barostat tube placement|0
4746186|NCT01786109|16371130|P2|Overall Study|fail manometry barostat tube placement|0
4746187|NCT01786109|16371131|P1|Overall Study|fail manometry barostat tube placement|1
4746188|NCT01785875|16371160|P3|Overall Study|Missing|3
4746189|NCT01785875|16371161|P2|Overall Study|Missing|1
4746190|NCT01785875|16371162|P1|Overall Study|Missing|0
4746191|NCT01785875|16371160|P3|Overall Study|Protocol Specified Criteria|55
4746192|NCT01785875|16371161|P2|Overall Study|Protocol Specified Criteria|214
4746193|NCT01785875|16371162|P1|Overall Study|Protocol Specified Criteria|207
4746194|NCT01785875|16371160|P3|Overall Study|Sponsor Decision|0
4746195|NCT01785875|16371161|P2|Overall Study|Sponsor Decision|2
4746196|NCT01785875|16371162|P1|Overall Study|Sponsor Decision|0
4746197|NCT01785875|16371160|P3|Overall Study|Death|7
4746198|NCT01785875|16371161|P2|Overall Study|Death|16
4746199|NCT01785875|16371162|P1|Overall Study|Death|27
4746200|NCT01785875|16371160|P3|Overall Study|Lost to Follow-up|6
4746201|NCT01785875|16371161|P2|Overall Study|Lost to Follow-up|22
4746202|NCT01785875|16371162|P1|Overall Study|Lost to Follow-up|19
4746203|NCT01785875|16371160|P3|Overall Study|Withdrawal by Subject|36
4746204|NCT01785875|16371161|P2|Overall Study|Withdrawal by Subject|34
4746205|NCT01785875|16371162|P1|Overall Study|Withdrawal by Subject|41
4746206|NCT01785849|16371231|P2|Overall Study|Lost to Follow-up|11
4746207|NCT01785849|16371232|P1|Overall Study|Lost to Follow-up|10
4746208|NCT01785849|16371231|P2|Overall Study|Sponsor Decision|1
4746209|NCT01785849|16371232|P1|Overall Study|Sponsor Decision|0
4746210|NCT01785849|16371231|P2|Overall Study|Withdrawal by Subject|12
4746211|NCT01785849|16371232|P1|Overall Study|Withdrawal by Subject|15
4746212|NCT01785849|16371231|P2|Overall Study|Protocol Specified Criteria|1
4746213|NCT01785849|16371232|P1|Overall Study|Protocol Specified Criteria|29
4746214|NCT01785849|16371231|P2|Overall Study|Death|9
4746215|NCT01785849|16371232|P1|Overall Study|Death|7
4746216|NCT01785628|16371265|P2|Overall Study|Lost to Follow-up|3
4746217|NCT01785628|16371266|P1|Overall Study|Lost to Follow-up|2
4746218|NCT01785615|16371289|P4|Dietary Phase|Lost to Follow-up|24
4746219|NCT01785615|16371290|P3|Dietary Phase|Lost to Follow-up|0
4746220|NCT01785615|16371291|P2|Dietary Phase|Lost to Follow-up|0
4746221|NCT01785615|16371292|P1|Dietary Phase|Lost to Follow-up|0
4746222|NCT01785602|16371364|P2|Overall Study|Administrative problems|3
4746223|NCT01785602|16371365|P1|Overall Study|Administrative problems|7
4746224|NCT01785602|16371364|P2|Overall Study|Adverse Event|5
4746225|NCT01785602|16371365|P1|Overall Study|Adverse Event|3
4746226|NCT01785602|16371364|P2|Overall Study|Lost to Follow-up|1
4746227|NCT01785602|16371365|P1|Overall Study|Lost to Follow-up|1
4746228|NCT01785602|16371364|P2|Overall Study|Withdrawal by Subject|0
4746229|NCT01785602|16371365|P1|Overall Study|Withdrawal by Subject|2
4746230|NCT01785524|16371375|P2|Overall Study|Withdrawal by Subject|2
4746231|NCT01785524|16371376|P1|Overall Study|Withdrawal by Subject|2
4746232|NCT01785472|16371395|P3|Overall Study|Technical problems|1
4746233|NCT01785472|16371396|P2|Overall Study|Technical problems|0
4746234|NCT01785472|16371397|P1|Overall Study|Technical problems|0
4746235|NCT01785472|16371395|P3|Overall Study|Subject/guardian decision|11
4746236|NCT01785472|16371396|P2|Overall Study|Subject/guardian decision|10
4746237|NCT01785472|16371397|P1|Overall Study|Subject/guardian decision|15
4746238|NCT01785472|16371395|P3|Overall Study|Protocol deviation|2
4746239|NCT01785472|16371396|P2|Overall Study|Protocol deviation|2
4746240|NCT01785472|16371397|P1|Overall Study|Protocol deviation|0
4746241|NCT01785472|16371395|P3|Overall Study|Physician Decision|1
4746242|NCT01785472|16371396|P2|Overall Study|Physician Decision|1
4746243|NCT01785472|16371397|P1|Overall Study|Physician Decision|1
4746244|NCT01785472|16371395|P3|Overall Study|Lost to Follow-up|0
4746245|NCT01785472|16371396|P2|Overall Study|Lost to Follow-up|2
4746246|NCT01785472|16371397|P1|Overall Study|Lost to Follow-up|1
4746247|NCT01785472|16371395|P3|Overall Study|Lack of Efficacy|1
4746248|NCT01785472|16371396|P2|Overall Study|Lack of Efficacy|0
4746249|NCT01785472|16371397|P1|Overall Study|Lack of Efficacy|2
4746250|NCT01785472|16371395|P3|Overall Study|Adverse Event|6
4746251|NCT01785472|16371396|P2|Overall Study|Adverse Event|4
4746252|NCT01785472|16371397|P1|Overall Study|Adverse Event|5
4746253|NCT01785160|16371483|P1|Washout Period of at Least 7 Days|Consent withdrawn|1
4746254|NCT01785160|16371483|P1|Treatment Period 1: Raltegravir|Not treated|1
4746255|NCT01785069|16371520|P4|Overall Study|Not evaluable|8
4746256|NCT01785069|16371521|P3|Overall Study|Not evaluable|5
4746257|NCT01785069|16371522|P2|Overall Study|Not evaluable|4
4746258|NCT01785069|16371523|P1|Overall Study|Not evaluable|7
4746259|NCT01785069|16371520|P4|Overall Study|Reason not Specified|4
4746260|NCT01785069|16371521|P3|Overall Study|Reason not Specified|1
4746261|NCT01785069|16371522|P2|Overall Study|Reason not Specified|2
4746262|NCT01785069|16371523|P1|Overall Study|Reason not Specified|1
4746263|NCT01785069|16371520|P4|Overall Study|Lost to Follow-up|1
4746264|NCT01785069|16371521|P3|Overall Study|Lost to Follow-up|4
4746265|NCT01785069|16371522|P2|Overall Study|Lost to Follow-up|2
4746266|NCT01785069|16371523|P1|Overall Study|Lost to Follow-up|1
4746267|NCT01785069|16371520|P4|Overall Study|Subject choice|1
4746268|NCT01785069|16371521|P3|Overall Study|Subject choice|0
4746269|NCT01785069|16371522|P2|Overall Study|Subject choice|2
4746270|NCT01785069|16371523|P1|Overall Study|Subject choice|2
4746271|NCT01785069|16371520|P4|Overall Study|Death|0
4746272|NCT01785069|16371521|P3|Overall Study|Death|2
4746273|NCT01785069|16371522|P2|Overall Study|Death|0
4746274|NCT01785069|16371523|P1|Overall Study|Death|0
4746275|NCT01785069|16371520|P4|Overall Study|Implanted with nonstudy device|0
4746276|NCT01785069|16371521|P3|Overall Study|Implanted with nonstudy device|1
4746277|NCT01785069|16371522|P2|Overall Study|Implanted with nonstudy device|2
4746278|NCT01785069|16371523|P1|Overall Study|Implanted with nonstudy device|1
4746279|NCT01784965|16371572|P2|Overall Study|Adverse Event|8
4746280|NCT01784965|16371573|P1|Overall Study|Adverse Event|0
4746281|NCT01784965|16371572|P2|Overall Study|Withdrawal by Subject|3
4746282|NCT01784965|16371573|P1|Overall Study|Withdrawal by Subject|6
4746283|NCT01784419|16371694|P1|Overall Study|Adverse Event|3
4746284|NCT01784211|16371702|P6|Part A (Days 1-15)|Withdrawal by Subject|0
4746285|NCT01784211|16371703|P5|Part A (Days 1-15)|Withdrawal by Subject|0
4746286|NCT01784211|16371704|P4|Part A (Days 1-15)|Withdrawal by Subject|0
4746287|NCT01784211|16371705|P3|Part A (Days 1-15)|Withdrawal by Subject|0
4746288|NCT01784211|16371706|P2|Part A (Days 1-15)|Withdrawal by Subject|1
4746289|NCT01784211|16371707|P1|Part A (Days 1-15)|Withdrawal by Subject|2
4746290|NCT01784211|16371702|P6|Part A (Days 1-15)|Adverse Event|0
4746291|NCT01784211|16371703|P5|Part A (Days 1-15)|Adverse Event|0
4746292|NCT01784211|16371704|P4|Part A (Days 1-15)|Adverse Event|0
4746293|NCT01784211|16371705|P3|Part A (Days 1-15)|Adverse Event|0
4746294|NCT01784211|16371706|P2|Part A (Days 1-15)|Adverse Event|1
4746295|NCT01784211|16371707|P1|Part A (Days 1-15)|Adverse Event|1
4746296|NCT01784029|16371732|P3|Overall Study|Lost to Follow-up|22
4746297|NCT01784029|16371733|P2|Overall Study|Lost to Follow-up|20
4746298|NCT01784029|16371734|P1|Overall Study|Lost to Follow-up|19
4746299|NCT01783938|16371763|P2|Overall Study|Other|0
4746300|NCT01783938|16371764|P1|Overall Study|Other|1
4746301|NCT01783938|16371763|P2|Overall Study|Withdrew Consent|0
4746302|NCT01783938|16371764|P1|Overall Study|Withdrew Consent|3
4746303|NCT01783938|16371763|P2|Overall Study|Request to Discontinue Study Treatment|2
4746304|NCT01783938|16371764|P1|Overall Study|Request to Discontinue Study Treatment|1
4746305|NCT01783938|16371763|P2|Overall Study|Adverse Event Unrelated to Study Drug|2
4746306|NCT01783938|16371764|P1|Overall Study|Adverse Event Unrelated to Study Drug|2
4746307|NCT01783938|16371763|P2|Overall Study|Study Drug Toxicity|10
4746308|NCT01783938|16371764|P1|Overall Study|Study Drug Toxicity|22
4746309|NCT01783938|16371763|P2|Overall Study|Disease Progression|39
4746310|NCT01783938|16371764|P1|Overall Study|Disease Progression|18
4746311|NCT01783886|16371792|P3|Overall Study|Adverse Event|4
4746312|NCT01783886|16371793|P2|Overall Study|Adverse Event|5
4746313|NCT01783886|16371794|P1|Overall Study|Adverse Event|4
4746314|NCT01783886|16371792|P3|Overall Study|Withdrawal of consent by participant|4
4746315|NCT01783886|16371793|P2|Overall Study|Withdrawal of consent by participant|3
4746316|NCT01783886|16371794|P1|Overall Study|Withdrawal of consent by participant|1
4746317|NCT01783886|16371792|P3|Overall Study|Protocol deviation|2
4746318|NCT01783886|16371793|P2|Overall Study|Protocol deviation|0
4746319|NCT01783886|16371794|P1|Overall Study|Protocol deviation|0
4746320|NCT01783886|16371792|P3|Overall Study|Lost to Follow-up|0
4746321|NCT01783886|16371793|P2|Overall Study|Lost to Follow-up|3
4746322|NCT01783886|16371794|P1|Overall Study|Lost to Follow-up|0
4746323|NCT01783821|16371857|P2|Overall Study|Screen Failure|1
4746324|NCT01783821|16371858|P1|Overall Study|Screen Failure|1
4746325|NCT01783743|16371876|P2|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236
4746326|NCT01783743|16371877|P1|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305
4746327|NCT01783743|16371876|P2|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684
4746328|NCT01783743|16371877|P1|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591
4746329|NCT01783743|16371876|P2|Screening of Subjects by CTA During MDA|Absent at MDA|4439
4746330|NCT01783743|16371877|P1|Screening of Subjects by CTA During MDA|Absent at MDA|3427
4746331|NCT01783730|16371891|P1|Overall Study|Failed to meet inclusion criteria|6
4746332|NCT01783678|16371916|P6|Overall Study|Withdrew Consent|0
4746333|NCT01783678|16371917|P5|Overall Study|Withdrew Consent|0
4746334|NCT01783678|16371918|P4|Overall Study|Withdrew Consent|2
4746335|NCT01783678|16371919|P3|Overall Study|Withdrew Consent|0
4746336|NCT01783678|16371920|P2|Overall Study|Withdrew Consent|1
4746337|NCT01783678|16371921|P1|Overall Study|Withdrew Consent|1
4746338|NCT01783678|16371916|P6|Overall Study|Lost to Follow-up|0
4746339|NCT01783678|16371917|P5|Overall Study|Lost to Follow-up|1
4746340|NCT01783678|16371918|P4|Overall Study|Lost to Follow-up|2
4746341|NCT01783678|16371919|P3|Overall Study|Lost to Follow-up|0
4746342|NCT01783678|16371920|P2|Overall Study|Lost to Follow-up|4
4746343|NCT01783678|16371921|P1|Overall Study|Lost to Follow-up|0
4746344|NCT01783678|16371916|P6|Overall Study|Lack of Efficacy|5
4746345|NCT01783678|16371917|P5|Overall Study|Lack of Efficacy|6
4746346|NCT01783678|16371918|P4|Overall Study|Lack of Efficacy|3
4746347|NCT01783678|16371919|P3|Overall Study|Lack of Efficacy|1
4746348|NCT01783678|16371920|P2|Overall Study|Lack of Efficacy|13
4746349|NCT01783678|16371921|P1|Overall Study|Lack of Efficacy|1
4746350|NCT01783678|16371916|P6|Overall Study|Randomized but Not Treated|0
4746351|NCT01783678|16371917|P5|Overall Study|Randomized but Not Treated|0
4746352|NCT01783678|16371918|P4|Overall Study|Randomized but Not Treated|1
4746353|NCT01783678|16371919|P3|Overall Study|Randomized but Not Treated|0
4746354|NCT01783678|16371920|P2|Overall Study|Randomized but Not Treated|0
4746355|NCT01783678|16371921|P1|Overall Study|Randomized but Not Treated|0
4746356|NCT01783548|16372025|P2|Overall Study|Lack of Efficacy|1
4746357|NCT01783548|16372026|P1|Overall Study|Lack of Efficacy|1
4746358|NCT01783548|16372025|P2|Overall Study|Lost to Follow-up|3
4746359|NCT01783548|16372026|P1|Overall Study|Lost to Follow-up|8
4746360|NCT01783548|16372025|P2|Overall Study|Protocol Violation|2
4746361|NCT01783548|16372026|P1|Overall Study|Protocol Violation|2
4746362|NCT01783548|16372025|P2|Overall Study|Non-compliance|0
4746363|NCT01783548|16372026|P1|Overall Study|Non-compliance|4
4746364|NCT01783548|16372025|P2|Overall Study|Withdrawal by Subject|8
4746365|NCT01783548|16372026|P1|Overall Study|Withdrawal by Subject|11
4746366|NCT01783548|16372025|P2|Overall Study|Adverse Event|4
4746367|NCT01783548|16372026|P1|Overall Study|Adverse Event|8
4746368|NCT01783496|16372059|P6|Overall Study|Withdrawal by Subject|0
4746369|NCT01783496|16372060|P5|Overall Study|Withdrawal by Subject|0
4746370|NCT01783496|16372061|P4|Overall Study|Withdrawal by Subject|0
4746371|NCT01783496|16372062|P3|Overall Study|Withdrawal by Subject|0
4746372|NCT01783496|16372063|P2|Overall Study|Withdrawal by Subject|0
4746373|NCT01783496|16372064|P1|Overall Study|Withdrawal by Subject|1
4746374|NCT01783496|16372059|P6|Overall Study|Lost to Follow-up|1
4746375|NCT01783496|16372060|P5|Overall Study|Lost to Follow-up|0
4746376|NCT01783496|16372061|P4|Overall Study|Lost to Follow-up|2
4746377|NCT01783496|16372062|P3|Overall Study|Lost to Follow-up|0
4746378|NCT01783496|16372063|P2|Overall Study|Lost to Follow-up|0
4746379|NCT01783496|16372064|P1|Overall Study|Lost to Follow-up|0
4746380|NCT01783483|16372092|P2|Overall Study|Physician Decision|1
4746381|NCT01783483|16372093|P1|Overall Study|Physician Decision|1
4746382|NCT01783483|16372092|P2|Overall Study|Withdrawal by Subject|1
4746383|NCT01783483|16372093|P1|Overall Study|Withdrawal by Subject|2
4746384|NCT01783483|16372092|P2|Overall Study|Lost to Follow-up|10
4746385|NCT01783483|16372093|P1|Overall Study|Lost to Follow-up|14
4746386|NCT01783483|16372092|P2|Overall Study|Death|3
4746387|NCT01783483|16372093|P1|Overall Study|Death|3
4746388|NCT01783418|16372131|P2|Overall Study|Withdrawal by Subject|0
4746389|NCT01783418|16372132|P1|Overall Study|Withdrawal by Subject|1
4746390|NCT01783015|16372185|P3|Open Label Treatment|Study Terminated by Sponsor|6
4746391|NCT01783015|16372186|P2|Open Label Treatment|Study Terminated by Sponsor|0
4746392|NCT01783015|16372187|P1|Open Label Treatment|Study Terminated by Sponsor|0
4746393|NCT01783015|16372185|P3|Blinded Treatment|Study Terminated by Sponsor|0
4746394|NCT01783015|16372186|P2|Blinded Treatment|Study Terminated by Sponsor|0
4746395|NCT01783015|16372187|P1|Blinded Treatment|Study Terminated by Sponsor|2
4746396|NCT01783015|16372185|P3|Blinded Treatment|Withdrawal by Subject|0
4746397|NCT01783015|16372186|P2|Blinded Treatment|Withdrawal by Subject|1
4746398|NCT01783015|16372187|P1|Blinded Treatment|Withdrawal by Subject|0
4746399|NCT01783015|16372185|P3|Blinded Treatment|Protocol Violation|0
4746400|NCT01783015|16372186|P2|Blinded Treatment|Protocol Violation|1
4746401|NCT01783015|16372187|P1|Blinded Treatment|Protocol Violation|0
4746402|NCT01783015|16372185|P3|Blinded Treatment|Adverse Event|0
4746403|NCT01783015|16372186|P2|Blinded Treatment|Adverse Event|1
4746404|NCT01783015|16372187|P1|Blinded Treatment|Adverse Event|0
4746405|NCT01782885|16372300|P2|Overall Study|Lost to Follow-up|6
4746406|NCT01782885|16372301|P1|Overall Study|Lost to Follow-up|4
4746407|NCT01782872|16372327|P4|Overall Study|Withdrawal by Subject|0
4746408|NCT01782872|16372328|P3|Overall Study|Withdrawal by Subject|0
4746409|NCT01782872|16372329|P2|Overall Study|Withdrawal by Subject|1
4746410|NCT01782872|16372330|P1|Overall Study|Withdrawal by Subject|0
4746411|NCT01782872|16372327|P4|Overall Study|Protocol Violation|1
4746412|NCT01782872|16372328|P3|Overall Study|Protocol Violation|0
4746413|NCT01782872|16372329|P2|Overall Study|Protocol Violation|0
4746414|NCT01782872|16372330|P1|Overall Study|Protocol Violation|0
4746415|NCT01782859|16372354|P2|Overall Study|Withdrawal by Subject|1
4746416|NCT01782859|16372355|P1|Overall Study|Withdrawal by Subject|0
4746417|NCT01782859|16372354|P2|Overall Study|Protocol Violation|6
4746418|NCT01782859|16372355|P1|Overall Study|Protocol Violation|6
4746419|NCT01782742|16372377|P2|Double-blind Treatment Phase|Adverse Event|0
4746420|NCT01782742|16372378|P1|Double-blind Treatment Phase|Adverse Event|1
4746421|NCT01782690|16372411|P1|Overall Study|Study completion unknown|7
4746422|NCT01782690|16372411|P1|Overall Study|Death|133
4746423|NCT01782690|16372411|P1|Overall Study|Tumor progression|74
4746424|NCT01782690|16372411|P1|Overall Study|Patient's wish|21
4746425|NCT01782690|16372411|P1|Overall Study|Physician Decision|13
4746426|NCT01782690|16372411|P1|Overall Study|Absent rash|9
4746427|NCT01782690|16372411|P1|Overall Study|Withdrawal of informed consent|2
4746428|NCT01782690|16372411|P1|Overall Study|Lost to Follow-up|31
4746429|NCT01782690|16372411|P1|Overall Study|Toxicity of erlotinib|1
4746430|NCT01782690|16372411|P1|Overall Study|Toxicity of gemcitabine|1
4746431|NCT01782690|16372411|P1|Overall Study|Not reported|7
4746432|NCT01782664|16372433|P6|Overall Study|Withdrawal by Subject|0
4746433|NCT01782664|16372434|P5|Overall Study|Withdrawal by Subject|0
4746434|NCT01782664|16372435|P4|Overall Study|Withdrawal by Subject|0
4746435|NCT01782664|16372436|P3|Overall Study|Withdrawal by Subject|0
4746436|NCT01782664|16372437|P2|Overall Study|Withdrawal by Subject|2
4746437|NCT01782664|16372438|P1|Overall Study|Withdrawal by Subject|2
4746438|NCT01782664|16372433|P6|Overall Study|Protocol Violation|0
4746439|NCT01782664|16372434|P5|Overall Study|Protocol Violation|0
4746440|NCT01782664|16372435|P4|Overall Study|Protocol Violation|1
4746441|NCT01782664|16372436|P3|Overall Study|Protocol Violation|0
4746442|NCT01782664|16372437|P2|Overall Study|Protocol Violation|1
4746443|NCT01782664|16372438|P1|Overall Study|Protocol Violation|0
4746444|NCT01782664|16372433|P6|Overall Study|Lack of Efficacy|0
4746445|NCT01782664|16372434|P5|Overall Study|Lack of Efficacy|0
4746446|NCT01782664|16372435|P4|Overall Study|Lack of Efficacy|2
4746447|NCT01782664|16372436|P3|Overall Study|Lack of Efficacy|2
4746448|NCT01782664|16372437|P2|Overall Study|Lack of Efficacy|0
4746449|NCT01782664|16372438|P1|Overall Study|Lack of Efficacy|2
4746450|NCT01782664|16372433|P6|Overall Study|Adverse Event|0
4746451|NCT01782664|16372434|P5|Overall Study|Adverse Event|0
4746452|NCT01782664|16372435|P4|Overall Study|Adverse Event|2
4746453|NCT01782664|16372436|P3|Overall Study|Adverse Event|2
4746454|NCT01782664|16372437|P2|Overall Study|Adverse Event|2
4746455|NCT01782664|16372438|P1|Overall Study|Adverse Event|2
4746456|NCT01782495|16372595|P11|Overall Study|Withdrew Consent|0
4746457|NCT01782495|16372596|P10|Overall Study|Withdrew Consent|0
4746458|NCT01782495|16372597|P9|Overall Study|Withdrew Consent|0
4746459|NCT01782495|16372598|P8|Overall Study|Withdrew Consent|1
4746460|NCT01782495|16372599|P7|Overall Study|Withdrew Consent|0
4746461|NCT01782495|16372600|P6|Overall Study|Withdrew Consent|0
4746462|NCT01782495|16372601|P5|Overall Study|Withdrew Consent|0
4746463|NCT01782495|16372602|P4|Overall Study|Withdrew Consent|0
4746464|NCT01782495|16372603|P3|Overall Study|Withdrew Consent|0
4746465|NCT01782495|16372604|P2|Overall Study|Withdrew Consent|1
4746466|NCT01782495|16372605|P1|Overall Study|Withdrew Consent|0
4746467|NCT01782495|16372595|P11|Overall Study|Adverse Event|0
4746468|NCT01782495|16372596|P10|Overall Study|Adverse Event|0
4746469|NCT01782495|16372597|P9|Overall Study|Adverse Event|0
4746470|NCT01782495|16372598|P8|Overall Study|Adverse Event|2
4746471|NCT01782495|16372599|P7|Overall Study|Adverse Event|0
4746472|NCT01782495|16372600|P6|Overall Study|Adverse Event|0
4746473|NCT01782495|16372601|P5|Overall Study|Adverse Event|0
4746474|NCT01782495|16372602|P4|Overall Study|Adverse Event|0
4746475|NCT01782495|16372603|P3|Overall Study|Adverse Event|0
4746476|NCT01782495|16372604|P2|Overall Study|Adverse Event|0
4746477|NCT01782495|16372605|P1|Overall Study|Adverse Event|0
4746478|NCT01782482|16372664|P2|Overall Study|Habitually wearing toric lens OS|1
4746479|NCT01782482|16372665|P1|Overall Study|Habitually wearing toric lens OS|0
4746480|NCT01782482|16372664|P2|Overall Study|Randomized in Error|2
4746481|NCT01782482|16372665|P1|Overall Study|Randomized in Error|2
4746482|NCT01782482|16372664|P2|Overall Study|Withdrawal by Subject|3
4746483|NCT01782482|16372665|P1|Overall Study|Withdrawal by Subject|2
4746484|NCT01782482|16372664|P2|Overall Study|Protocol Violation|0
4746485|NCT01782482|16372665|P1|Overall Study|Protocol Violation|1
4746486|NCT01782482|16372664|P2|Overall Study|Physician Decision|0
4746487|NCT01782482|16372665|P1|Overall Study|Physician Decision|1
4746488|NCT01782482|16372664|P2|Overall Study|Lost to Follow-up|3
4746489|NCT01782482|16372665|P1|Overall Study|Lost to Follow-up|2
4746490|NCT01782482|16372664|P2|Overall Study|Adverse Event|1
4746491|NCT01782482|16372665|P1|Overall Study|Adverse Event|2
4746492|NCT01782469|16372673|P1|Overall Study|Lost to Follow-up|1
4746493|NCT01782378|16372683|P2|Second Series|Did not choose to complete S2 Optional|0
4746494|NCT01782378|16372684|P1|Second Series|Did not choose to complete S2 Optional|18
4746495|NCT01782378|16372683|P2|Second Series|Lost to Follow-up|7
4746496|NCT01782378|16372684|P1|Second Series|Lost to Follow-up|8
4746497|NCT01782378|16372683|P2|Second Series|Partial Crossover Design- no Sham 2nd|25
4746498|NCT01782378|16372684|P1|Second Series|Partial Crossover Design- no Sham 2nd|0
4746499|NCT01782378|16372683|P2|First Series|Lost to Follow-up|8
4746500|NCT01782378|16372684|P1|First Series|Lost to Follow-up|7
4746501|NCT01782326|16372750|P2|Double-blind Treatment|Technical problems|5
4746502|NCT01782326|16372751|P1|Double-blind Treatment|Technical problems|0
4746503|NCT01782326|16372750|P2|Double-blind Treatment|Protocol deviation|7
4746504|NCT01782326|16372751|P1|Double-blind Treatment|Protocol deviation|8
4746505|NCT01782326|16372750|P2|Double-blind Treatment|Physician Decision|16
4746506|NCT01782326|16372751|P1|Double-blind Treatment|Physician Decision|13
4746507|NCT01782326|16372750|P2|Double-blind Treatment|Lack of Efficacy|22
4746508|NCT01782326|16372751|P1|Double-blind Treatment|Lack of Efficacy|17
4746509|NCT01782326|16372750|P2|Double-blind Treatment|Subject/guardian decision|125
4746510|NCT01782326|16372751|P1|Double-blind Treatment|Subject/guardian decision|111
4746511|NCT01782326|16372750|P2|Double-blind Treatment|Adverse Event|145
4746512|NCT01782326|16372751|P1|Double-blind Treatment|Adverse Event|129
4746513|NCT01782326|16372750|P2|Planned Treatment Epoch|Technical problems|4
4746514|NCT01782326|16372751|P1|Planned Treatment Epoch|Technical problems|0
4746515|NCT01782326|16372750|P2|Planned Treatment Epoch|Lost to Follow-up|4
4746516|NCT01782326|16372751|P1|Planned Treatment Epoch|Lost to Follow-up|4
4746517|NCT01782326|16372750|P2|Planned Treatment Epoch|Protocol deviation|3
4746518|NCT01782326|16372751|P1|Planned Treatment Epoch|Protocol deviation|2
4746519|NCT01782326|16372750|P2|Planned Treatment Epoch|Physician Decision|16
4746520|NCT01782326|16372751|P1|Planned Treatment Epoch|Physician Decision|18
4746521|NCT01782326|16372750|P2|Planned Treatment Epoch|Death|30
4746522|NCT01782326|16372751|P1|Planned Treatment Epoch|Death|29
4746523|NCT01782326|16372750|P2|Planned Treatment Epoch|Subject/guardian decision|151
4746524|NCT01782326|16372751|P1|Planned Treatment Epoch|Subject/guardian decision|149
4746525|NCT01782313|16372811|P1|Survival Follow up|Lost to Follow-up|1
4746526|NCT01782313|16372811|P1|Continued Treatment After 16 Weeks|Withdrawal by Subject|1
4746527|NCT01782313|16372811|P1|Continued Treatment After 16 Weeks|Progressive Disease|6
4746528|NCT01782313|16372811|P1|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1
4746529|NCT01782313|16372811|P1|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5
4746530|NCT01782313|16372811|P1|Treated Cycle 3|Progressive Disease|21
4746531|NCT01782313|16372811|P1|Reached First Response/Completed 2 Cycle|Progressive Disease|3
4746532|NCT01782313|16372811|P1|Reached First Response/Completed 2 Cycle|Adverse Event|3
4746533|NCT01782222|16372825|P3|Overall Study|Moved to other state|0
4746534|NCT01782222|16372826|P2|Overall Study|Moved to other state|1
4746535|NCT01782222|16372827|P1|Overall Study|Moved to other state|0
4746536|NCT01782222|16372825|P3|Overall Study|Withdrawal by Subject|1
4746537|NCT01782222|16372826|P2|Overall Study|Withdrawal by Subject|4
4746538|NCT01782222|16372827|P1|Overall Study|Withdrawal by Subject|1
4746539|NCT01782222|16372825|P3|Overall Study|Protocol Violation|0
4746540|NCT01782222|16372826|P2|Overall Study|Protocol Violation|0
4746541|NCT01782222|16372827|P1|Overall Study|Protocol Violation|1
4746542|NCT01782222|16372825|P3|Overall Study|Lack of Efficacy|0
4746543|NCT01782222|16372826|P2|Overall Study|Lack of Efficacy|1
4746544|NCT01782222|16372827|P1|Overall Study|Lack of Efficacy|2
4746545|NCT01782222|16372825|P3|Overall Study|Adverse Event|3
4746546|NCT01782222|16372826|P2|Overall Study|Adverse Event|5
4746547|NCT01782222|16372827|P1|Overall Study|Adverse Event|4
4746548|NCT01782131|16372865|P2|Overall Study|Reason not provided|1
4746549|NCT01782131|16372866|P1|Overall Study|Reason not provided|0
4746550|NCT01782131|16372865|P2|Overall Study|Randomized but not treated|5
4746551|NCT01782131|16372866|P1|Overall Study|Randomized but not treated|5
4746552|NCT01782131|16372865|P2|Overall Study|Withdrawal by Subject|10
4746553|NCT01782131|16372866|P1|Overall Study|Withdrawal by Subject|10
4746554|NCT01782131|16372865|P2|Overall Study|Lost to Follow-up|3
4746555|NCT01782131|16372866|P1|Overall Study|Lost to Follow-up|1
4746556|NCT01782131|16372865|P2|Overall Study|Death|96
4746557|NCT01782131|16372866|P1|Overall Study|Death|93
4746558|NCT01781975|16372903|P2|Overall Study|Withdrawal by Subject|1
4746559|NCT01781975|16372904|P1|Overall Study|Withdrawal by Subject|1
4746560|NCT01781975|16372903|P2|Overall Study|Death|0
4746561|NCT01781975|16372904|P1|Overall Study|Death|1
4746562|NCT01781962|16372920|P1|Overall Study|Other Miscellaneous Reasons|5
4746563|NCT01781832|16372926|P1|Overall Study|Withdrawal by Subject|1
4746564|NCT01781637|16372946|P2|Overall Study|Withdrawal by Subject|0
4746565|NCT01781637|16372947|P1|Overall Study|Withdrawal by Subject|1
4746566|NCT01781637|16372946|P2|Overall Study|Lack of Efficacy|6
4746567|NCT01781637|16372947|P1|Overall Study|Lack of Efficacy|2
4746568|NCT01781637|16372946|P2|Overall Study|Adverse Event|0
4746569|NCT01781637|16372947|P1|Overall Study|Adverse Event|1
4746570|NCT01781572|16372966|P3|MEK162 45mg LEE011 600mg|Progressive Disease|0
4746571|NCT01781572|16372967|P2|MEK162 45mg LEE011 600mg|Progressive Disease|5
4746572|NCT01781572|16372968|P1|MEK162 45mg LEE011 600mg|Progressive Disease|0
4746573|NCT01781572|16372966|P3|MEK162 45mg LEE011 600mg|Adverse Event|0
4746574|NCT01781572|16372967|P2|MEK162 45mg LEE011 600mg|Adverse Event|1
4746575|NCT01781572|16372968|P1|MEK162 45mg LEE011 600mg|Adverse Event|0
4746576|NCT01781572|16372966|P3|MEK162 45mg LEE011 450mg|Progressive Disease|0
4746577|NCT01781572|16372967|P2|MEK162 45mg LEE011 450mg|Progressive Disease|6
4746578|NCT01781572|16372968|P1|MEK162 45mg LEE011 450mg|Progressive Disease|0
4746579|NCT01781572|16372966|P3|MEK162 45mg LEE011 450mg|Physician Decision|0
4746580|NCT01781572|16372967|P2|MEK162 45mg LEE011 450mg|Physician Decision|2
4746581|NCT01781572|16372968|P1|MEK162 45mg LEE011 450mg|Physician Decision|0
4746582|NCT01781572|16372966|P3|MEK162 45mg LEE011 450mg|Adverse Event|0
4746583|NCT01781572|16372967|P2|MEK162 45mg LEE011 450mg|Adverse Event|1
4746584|NCT01781572|16372968|P1|MEK162 45mg LEE011 450mg|Adverse Event|0
4746585|NCT01781572|16372966|P3|MEK162 30mg LEE011 200mg|Progressive Disease|0
4746586|NCT01781572|16372967|P2|MEK162 30mg LEE011 200mg|Progressive Disease|5
4746587|NCT01781572|16372968|P1|MEK162 30mg LEE011 200mg|Progressive Disease|0
4746588|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 300mg|Death|0
4746589|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 300mg|Death|0
4746590|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 300mg|Death|1
4746591|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0
4746592|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3
4746593|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4
4746594|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 300mg|Adverse Event|0
4746595|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
4746596|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 300mg|Adverse Event|1
4746597|NCT01781572|16372966|P3|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0
4746598|NCT01781572|16372967|P2|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2
4746599|NCT01781572|16372968|P1|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3
4746600|NCT01781572|16372966|P3|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
4746601|NCT01781572|16372967|P2|MEK162 30mg BID+LEE011 300mg|Adverse Event|0
4746602|NCT01781572|16372968|P1|MEK162 30mg BID+LEE011 300mg|Adverse Event|1
4746603|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
4746604|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0
4746605|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1
4746606|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
4746607|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0
4746608|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2
4746609|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 200mg|Death|1
4746610|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 200mg|Death|0
4746611|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 200mg|Death|0
4746612|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 200mg|Physician Decision|4
4746613|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
4746614|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 200mg|Physician Decision|0
4746615|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2
4746616|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0
4746617|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1
4746618|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 200mg|Progressive disease|23
4746619|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 200mg|Progressive disease|6
4746620|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 200mg|Progressive disease|8
4746621|NCT01781572|16372966|P3|MEK162 45mg BID+LEE011 200mg|Adverse Event|11
4746622|NCT01781572|16372967|P2|MEK162 45mg BID+LEE011 200mg|Adverse Event|0
4746623|NCT01781572|16372968|P1|MEK162 45mg BID+LEE011 200mg|Adverse Event|7
4746624|NCT01781429|16373309|P16|Overall Study|Enrolled, but not treated|0
4746625|NCT01781429|16373310|P15|Overall Study|Enrolled, but not treated|0
4746626|NCT01781429|16373311|P14|Overall Study|Enrolled, but not treated|0
4746627|NCT01781429|16373312|P13|Overall Study|Enrolled, but not treated|0
4746628|NCT01781429|16373313|P12|Overall Study|Enrolled, but not treated|0
4746629|NCT01781429|16373314|P11|Overall Study|Enrolled, but not treated|1
4746630|NCT01781429|16373315|P10|Overall Study|Enrolled, but not treated|0
4746631|NCT01781429|16373316|P9|Overall Study|Enrolled, but not treated|0
4746632|NCT01781429|16373317|P8|Overall Study|Enrolled, but not treated|0
4746633|NCT01781429|16373318|P7|Overall Study|Enrolled, but not treated|0
4746634|NCT01781429|16373319|P6|Overall Study|Enrolled, but not treated|0
4746635|NCT01781429|16373320|P5|Overall Study|Enrolled, but not treated|0
4746636|NCT01781429|16373321|P4|Overall Study|Enrolled, but not treated|0
4746637|NCT01781429|16373322|P3|Overall Study|Enrolled, but not treated|0
4746638|NCT01781429|16373323|P2|Overall Study|Enrolled, but not treated|0
4746639|NCT01781429|16373324|P1|Overall Study|Enrolled, but not treated|0
4746640|NCT01781429|16373309|P16|Overall Study|Other - as entered by PI in eCRF|0
4746641|NCT01781429|16373310|P15|Overall Study|Other - as entered by PI in eCRF|1
4746642|NCT01781429|16373311|P14|Overall Study|Other - as entered by PI in eCRF|1
4746643|NCT01781429|16373312|P13|Overall Study|Other - as entered by PI in eCRF|1
4746644|NCT01781429|16373313|P12|Overall Study|Other - as entered by PI in eCRF|2
4746645|NCT01781429|16373314|P11|Overall Study|Other - as entered by PI in eCRF|1
4746646|NCT01781429|16373315|P10|Overall Study|Other - as entered by PI in eCRF|1
4746647|NCT01781429|16373316|P9|Overall Study|Other - as entered by PI in eCRF|0
4746648|NCT01781429|16373317|P8|Overall Study|Other - as entered by PI in eCRF|0
4746649|NCT01781429|16373318|P7|Overall Study|Other - as entered by PI in eCRF|0
4746650|NCT01781429|16373319|P6|Overall Study|Other - as entered by PI in eCRF|0
4746651|NCT01781429|16373320|P5|Overall Study|Other - as entered by PI in eCRF|0
4746652|NCT01781429|16373321|P4|Overall Study|Other - as entered by PI in eCRF|0
4746653|NCT01781429|16373322|P3|Overall Study|Other - as entered by PI in eCRF|0
4746654|NCT01781429|16373323|P2|Overall Study|Other - as entered by PI in eCRF|1
4746655|NCT01781429|16373324|P1|Overall Study|Other - as entered by PI in eCRF|0
4746656|NCT01781429|16373309|P16|Overall Study|Patient Condition Changed|0
4746657|NCT01781429|16373310|P15|Overall Study|Patient Condition Changed|0
4746658|NCT01781429|16373311|P14|Overall Study|Patient Condition Changed|1
4746659|NCT01781429|16373312|P13|Overall Study|Patient Condition Changed|0
4746660|NCT01781429|16373313|P12|Overall Study|Patient Condition Changed|1
4746661|NCT01781429|16373314|P11|Overall Study|Patient Condition Changed|0
4746662|NCT01781429|16373315|P10|Overall Study|Patient Condition Changed|4
4746663|NCT01781429|16373316|P9|Overall Study|Patient Condition Changed|0
4746664|NCT01781429|16373317|P8|Overall Study|Patient Condition Changed|0
4746665|NCT01781429|16373318|P7|Overall Study|Patient Condition Changed|0
4746666|NCT01781429|16373319|P6|Overall Study|Patient Condition Changed|0
4746667|NCT01781429|16373320|P5|Overall Study|Patient Condition Changed|0
4746668|NCT01781429|16373321|P4|Overall Study|Patient Condition Changed|0
4746669|NCT01781429|16373322|P3|Overall Study|Patient Condition Changed|0
4746670|NCT01781429|16373323|P2|Overall Study|Patient Condition Changed|0
4746671|NCT01781429|16373324|P1|Overall Study|Patient Condition Changed|0
4746672|NCT01781429|16373309|P16|Overall Study|Unacceptable Toxicity|0
4746673|NCT01781429|16373310|P15|Overall Study|Unacceptable Toxicity|0
4746674|NCT01781429|16373311|P14|Overall Study|Unacceptable Toxicity|0
4746675|NCT01781429|16373312|P13|Overall Study|Unacceptable Toxicity|0
4746676|NCT01781429|16373313|P12|Overall Study|Unacceptable Toxicity|2
4746677|NCT01781429|16373314|P11|Overall Study|Unacceptable Toxicity|0
4746678|NCT01781429|16373315|P10|Overall Study|Unacceptable Toxicity|0
4746679|NCT01781429|16373316|P9|Overall Study|Unacceptable Toxicity|0
4746680|NCT01781429|16373317|P8|Overall Study|Unacceptable Toxicity|0
4746681|NCT01781429|16373318|P7|Overall Study|Unacceptable Toxicity|0
4746682|NCT01781429|16373319|P6|Overall Study|Unacceptable Toxicity|0
4746683|NCT01781429|16373320|P5|Overall Study|Unacceptable Toxicity|0
4746684|NCT01781429|16373321|P4|Overall Study|Unacceptable Toxicity|0
4746685|NCT01781429|16373322|P3|Overall Study|Unacceptable Toxicity|0
4746686|NCT01781429|16373323|P2|Overall Study|Unacceptable Toxicity|0
4746687|NCT01781429|16373324|P1|Overall Study|Unacceptable Toxicity|0
4746688|NCT01781429|16373309|P16|Overall Study|Disease Progression|0
4746689|NCT01781429|16373310|P15|Overall Study|Disease Progression|11
4746690|NCT01781429|16373311|P14|Overall Study|Disease Progression|4
4746691|NCT01781429|16373312|P13|Overall Study|Disease Progression|15
4746692|NCT01781429|16373313|P12|Overall Study|Disease Progression|15
4746693|NCT01781429|16373314|P11|Overall Study|Disease Progression|15
4746694|NCT01781429|16373315|P10|Overall Study|Disease Progression|15
4746695|NCT01781429|16373316|P9|Overall Study|Disease Progression|6
4746696|NCT01781429|16373317|P8|Overall Study|Disease Progression|4
4746697|NCT01781429|16373318|P7|Overall Study|Disease Progression|7
4746698|NCT01781429|16373319|P6|Overall Study|Disease Progression|4
4746699|NCT01781429|16373320|P5|Overall Study|Disease Progression|1
4746700|NCT01781429|16373321|P4|Overall Study|Disease Progression|1
4746701|NCT01781429|16373322|P3|Overall Study|Disease Progression|1
4746702|NCT01781429|16373323|P2|Overall Study|Disease Progression|0
4746703|NCT01781429|16373324|P1|Overall Study|Disease Progression|1
4746704|NCT01781429|16373309|P16|Overall Study|Withdrawal by Subject|0
4746705|NCT01781429|16373310|P15|Overall Study|Withdrawal by Subject|3
4746706|NCT01781429|16373311|P14|Overall Study|Withdrawal by Subject|2
4746707|NCT01781429|16373312|P13|Overall Study|Withdrawal by Subject|5
4746708|NCT01781429|16373313|P12|Overall Study|Withdrawal by Subject|1
4746709|NCT01781429|16373314|P11|Overall Study|Withdrawal by Subject|1
4746710|NCT01781429|16373315|P10|Overall Study|Withdrawal by Subject|3
4746711|NCT01781429|16373316|P9|Overall Study|Withdrawal by Subject|1
4746712|NCT01781429|16373317|P8|Overall Study|Withdrawal by Subject|0
4746713|NCT01781429|16373318|P7|Overall Study|Withdrawal by Subject|0
4746714|NCT01781429|16373319|P6|Overall Study|Withdrawal by Subject|0
4746715|NCT01781429|16373320|P5|Overall Study|Withdrawal by Subject|0
4746716|NCT01781429|16373321|P4|Overall Study|Withdrawal by Subject|0
4746717|NCT01781429|16373322|P3|Overall Study|Withdrawal by Subject|0
4746718|NCT01781429|16373323|P2|Overall Study|Withdrawal by Subject|0
4746719|NCT01781429|16373324|P1|Overall Study|Withdrawal by Subject|0
4746720|NCT01781429|16373309|P16|Overall Study|Death|0
4746721|NCT01781429|16373310|P15|Overall Study|Death|1
4746722|NCT01781429|16373311|P14|Overall Study|Death|0
4746723|NCT01781429|16373312|P13|Overall Study|Death|1
4746724|NCT01781429|16373313|P12|Overall Study|Death|0
4746725|NCT01781429|16373314|P11|Overall Study|Death|0
4746726|NCT01781429|16373315|P10|Overall Study|Death|1
4746727|NCT01781429|16373316|P9|Overall Study|Death|0
4746728|NCT01781429|16373317|P8|Overall Study|Death|0
4746729|NCT01781429|16373318|P7|Overall Study|Death|0
4746730|NCT01781429|16373319|P6|Overall Study|Death|0
4746731|NCT01781429|16373320|P5|Overall Study|Death|0
4746732|NCT01781429|16373321|P4|Overall Study|Death|0
4746733|NCT01781429|16373322|P3|Overall Study|Death|0
4746734|NCT01781429|16373323|P2|Overall Study|Death|0
4746735|NCT01781429|16373324|P1|Overall Study|Death|0
4746736|NCT01781299|16373401|P2|Overall Study|Withdrawal by Subject|1
4746737|NCT01781299|16373402|P1|Overall Study|Withdrawal by Subject|0
4746738|NCT01781286|16373410|P6|Overall Study|Noncompliance|0
4746739|NCT01781286|16373411|P5|Overall Study|Noncompliance|0
4746740|NCT01781286|16373412|P4|Overall Study|Noncompliance|1
4746741|NCT01781286|16373413|P3|Overall Study|Noncompliance|0
4746742|NCT01781286|16373414|P2|Overall Study|Noncompliance|0
4746743|NCT01781286|16373415|P1|Overall Study|Noncompliance|0
4746744|NCT01781286|16373410|P6|Overall Study|Time Constraints|0
4746745|NCT01781286|16373411|P5|Overall Study|Time Constraints|0
4746746|NCT01781286|16373412|P4|Overall Study|Time Constraints|0
4746747|NCT01781286|16373413|P3|Overall Study|Time Constraints|2
4746748|NCT01781286|16373414|P2|Overall Study|Time Constraints|0
4746749|NCT01781286|16373415|P1|Overall Study|Time Constraints|2
4746750|NCT01781286|16373410|P6|Overall Study|Lost to Follow-up|1
4746751|NCT01781286|16373411|P5|Overall Study|Lost to Follow-up|0
4746752|NCT01781286|16373412|P4|Overall Study|Lost to Follow-up|0
4746753|NCT01781286|16373413|P3|Overall Study|Lost to Follow-up|0
4746754|NCT01781286|16373414|P2|Overall Study|Lost to Follow-up|0
4746755|NCT01781286|16373415|P1|Overall Study|Lost to Follow-up|0
4746756|NCT01781234|16373440|P2|Overall Study|Withdrawal by Subject|3
4746757|NCT01781234|16373441|P1|Overall Study|Withdrawal by Subject|4
4746758|NCT01781234|16373440|P2|Overall Study|Protocol Violation|0
4746759|NCT01781234|16373441|P1|Overall Study|Protocol Violation|3
4746760|NCT01781234|16373440|P2|Overall Study|Adverse Event|0
4746761|NCT01781234|16373441|P1|Overall Study|Adverse Event|2
4746762|NCT01781026|16373479|P1|Overall Study|Lack of Efficacy|2
4746763|NCT01780987|16373485|P2|Overall Study|Not Receiving any Study Medication|1
4746764|NCT01780987|16373486|P1|Overall Study|Not Receiving any Study Medication|0
4746765|NCT01780987|16373485|P2|Overall Study|Changing Residence|0
4746766|NCT01780987|16373486|P1|Overall Study|Changing Residence|1
4746767|NCT01780987|16373485|P2|Overall Study|Request of Changing Hospital|1
4746768|NCT01780987|16373486|P1|Overall Study|Request of Changing Hospital|0
4746769|NCT01780987|16373485|P2|Overall Study|Withdrawal by Subject|0
4746770|NCT01780987|16373486|P1|Overall Study|Withdrawal by Subject|2
4746771|NCT01780987|16373485|P2|Overall Study|Adverse Event|4
4746772|NCT01780987|16373486|P1|Overall Study|Adverse Event|0
4746773|NCT01780974|16373504|P2|Overall Study|Adverse Event|3
4746774|NCT01780974|16373505|P1|Overall Study|Adverse Event|1
4746775|NCT01780974|16373504|P2|Overall Study|Death|0
4746776|NCT01780974|16373505|P1|Overall Study|Death|1
4746777|NCT01780935|16373515|P2|Overall Study|Patient withdrew consent|9
4746778|NCT01780935|16373516|P1|Overall Study|Patient withdrew consent|8
4746779|NCT01780935|16373515|P2|Overall Study|Protocol deviation|1
4746780|NCT01780935|16373516|P1|Overall Study|Protocol deviation|0
4746781|NCT01780935|16373515|P2|Overall Study|Physician Decision|1
4746782|NCT01780935|16373516|P1|Overall Study|Physician Decision|1
4746783|NCT01780935|16373515|P2|Overall Study|Lost to Follow-up|6
4746784|NCT01780935|16373516|P1|Overall Study|Lost to Follow-up|2
4746785|NCT01780935|16373515|P2|Overall Study|Death|6
4746786|NCT01780935|16373516|P1|Overall Study|Death|1
4746787|NCT01780935|16373515|P2|Overall Study|Adverse Event|4
4746788|NCT01780935|16373516|P1|Overall Study|Adverse Event|2
4746789|NCT01780935|16373515|P2|Overall Study|Admin problems due to early termination|309
4746790|NCT01780935|16373516|P1|Overall Study|Admin problems due to early termination|321
4746791|NCT01780831|16373621|P4|Overall Study|Lost to Follow-up|1
4746792|NCT01780831|16373622|P3|Overall Study|Lost to Follow-up|0
4746793|NCT01780831|16373623|P2|Overall Study|Lost to Follow-up|0
4746794|NCT01780831|16373624|P1|Overall Study|Lost to Follow-up|0
4746795|NCT01780831|16373621|P4|Overall Study|Withdrawal by Subject|0
4746796|NCT01780831|16373622|P3|Overall Study|Withdrawal by Subject|4
4746797|NCT01780831|16373623|P2|Overall Study|Withdrawal by Subject|0
4746798|NCT01780831|16373624|P1|Overall Study|Withdrawal by Subject|0
4746799|NCT01780662|16373692|P3|Overall Study|Ineligible|1
4746800|NCT01780662|16373693|P2|Overall Study|Ineligible|0
4746801|NCT01780662|16373694|P1|Overall Study|Ineligible|0
4746802|NCT01780662|16373692|P3|Overall Study|Protocol Violation|0
4746803|NCT01780662|16373693|P2|Overall Study|Protocol Violation|1
4746804|NCT01780662|16373694|P1|Overall Study|Protocol Violation|0
4746805|NCT01780662|16373692|P3|Overall Study|Physician Decision|7
4746806|NCT01780662|16373693|P2|Overall Study|Physician Decision|5
4746807|NCT01780662|16373694|P1|Overall Study|Physician Decision|0
4746808|NCT01780662|16373692|P3|Overall Study|Adverse Event|2
4746809|NCT01780662|16373693|P2|Overall Study|Adverse Event|0
4746810|NCT01780662|16373694|P1|Overall Study|Adverse Event|1
4746811|NCT01780584|16373711|P3|Overall Study|Protocol Violation|1
4746812|NCT01780584|16373712|P2|Overall Study|Protocol Violation|0
4746813|NCT01780584|16373713|P1|Overall Study|Protocol Violation|0
4746814|NCT01780584|16373711|P3|Overall Study|Adverse Event|0
4746815|NCT01780584|16373712|P2|Overall Study|Adverse Event|1
4746816|NCT01780584|16373713|P1|Overall Study|Adverse Event|0
4746817|NCT01780584|16373711|P3|Overall Study|Death|1
4746818|NCT01780584|16373712|P2|Overall Study|Death|0
4746819|NCT01780584|16373713|P1|Overall Study|Death|1
4746820|NCT01780545|16373735|P2|Overall Study|Lost to Follow-up|1
4746821|NCT01780545|16373736|P1|Overall Study|Lost to Follow-up|1
4746822|NCT01780545|16373735|P2|Overall Study|Withdrawal by Subject|1
4746823|NCT01780545|16373736|P1|Overall Study|Withdrawal by Subject|3
4746824|NCT01780506|16373754|P2|Open-Label Extension Phase|Enrolled but not Treated|1
4746825|NCT01780506|16373755|P1|Open-Label Extension Phase|Enrolled but not Treated|0
4746826|NCT01780506|16373754|P2|Double-Blind Phase|Lost to Follow-up|26
4746827|NCT01780506|16373755|P1|Double-Blind Phase|Lost to Follow-up|23
4746828|NCT01780506|16373754|P2|Double-Blind Phase|Withdrew Consent|24
4746829|NCT01780506|16373755|P1|Double-Blind Phase|Withdrew Consent|23
4746830|NCT01780506|16373754|P2|Double-Blind Phase|Protocol Violation|3
4746831|NCT01780506|16373755|P1|Double-Blind Phase|Protocol Violation|4
4746832|NCT01780506|16373754|P2|Double-Blind Phase|Non-Compliance with Study Drug|3
4746833|NCT01780506|16373755|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
4746834|NCT01780506|16373754|P2|Double-Blind Phase|Investigator's Discretion|2
4746835|NCT01780506|16373755|P1|Double-Blind Phase|Investigator's Discretion|5
4746836|NCT01780506|16373754|P2|Double-Blind Phase|Lack of Efficacy|1
4746837|NCT01780506|16373755|P1|Double-Blind Phase|Lack of Efficacy|1
4746838|NCT01780506|16373754|P2|Double-Blind Phase|Pregnancy|1
4746839|NCT01780506|16373755|P1|Double-Blind Phase|Pregnancy|2
4746840|NCT01780506|16373754|P2|Double-Blind Phase|Death|2
4746841|NCT01780506|16373755|P1|Double-Blind Phase|Death|1
4746842|NCT01780506|16373754|P2|Double-Blind Phase|Adverse Event|14
4746843|NCT01780506|16373755|P1|Double-Blind Phase|Adverse Event|4
4746844|NCT01780506|16373754|P2|Double-Blind Phase|Randomized but not Treated|2
4746845|NCT01780506|16373755|P1|Double-Blind Phase|Randomized but not Treated|3
4746846|NCT01780389|16373813|P1|Overall Study|Adverse Event|1
4746847|NCT01779869|16373851|P1|Overall Study|Physician Decision|2
4746848|NCT01779700|16373857|P2|Overall Study|Withdrawal by Subject|2
4746849|NCT01779700|16373858|P1|Overall Study|Withdrawal by Subject|0
4746850|NCT01779700|16373857|P2|Overall Study|Adverse Event|3
4746851|NCT01779700|16373858|P1|Overall Study|Adverse Event|4
4746852|NCT01779648|16373898|P2|Overall Study|Protocol Violation|0
4746853|NCT01779648|16373899|P1|Overall Study|Protocol Violation|1
4746854|NCT01779440|16373929|P2|Overall Study|Withdrawal by Subject|5
4746855|NCT01779440|16373930|P1|Overall Study|Withdrawal by Subject|3
4746856|NCT01778985|16373995|P2|Overall Study|Protocol Violation|1
4746857|NCT01778985|16373996|P1|Overall Study|Protocol Violation|4
4746858|NCT01778985|16373995|P2|Overall Study|Physician Decision|2
4746859|NCT01778985|16373996|P1|Overall Study|Physician Decision|2
4746860|NCT01778985|16373995|P2|Overall Study|Lost to Follow-up|0
4746861|NCT01778985|16373996|P1|Overall Study|Lost to Follow-up|1
4746862|NCT01778855|16374042|P2|Overall Study|Death|1
4746863|NCT01778855|16374043|P1|Overall Study|Death|0
4746864|NCT01778751|16374051|P2|Overall Study|Transfered care|0
4746865|NCT01778751|16374052|P1|Overall Study|Transfered care|1
4746866|NCT01778751|16374051|P2|Overall Study|Withdrawal by Subject|2
4746867|NCT01778751|16374052|P1|Overall Study|Withdrawal by Subject|0
4746868|NCT01778751|16374051|P2|Overall Study|Lost to Follow-up|0
4746869|NCT01778751|16374052|P1|Overall Study|Lost to Follow-up|1
4746870|NCT01778556|16374105|P2|Long-term Follow-up|noncompliance with metreleptin|0
4746871|NCT01778556|16374106|P1|Long-term Follow-up|noncompliance with metreleptin|1
4746872|NCT01778556|16374105|P2|Intervention 2 (14 Days)|Protocol Violation|0
4746873|NCT01778556|16374106|P1|Intervention 2 (14 Days)|Protocol Violation|1
4746874|NCT01778556|16374105|P2|Intervention 1 (5 Days)|Withdrawal by Subject|1
4746875|NCT01778556|16374106|P1|Intervention 1 (5 Days)|Withdrawal by Subject|0
4746876|NCT01778556|16374105|P2|Intervention 1 (5 Days)|Protocol Violation|1
4746877|NCT01778556|16374106|P1|Intervention 1 (5 Days)|Protocol Violation|0
4746878|NCT01778530|16374119|P1|Overall Study|Adverse event/side effect|1
4746879|NCT01778530|16374119|P1|Overall Study|Progression on study|1
4746880|NCT01778127|16374161|P3|Overall Study|Withdrawal by Subject|4
4746881|NCT01778127|16374162|P2|Overall Study|Withdrawal by Subject|1
4746882|NCT01778127|16374163|P1|Overall Study|Withdrawal by Subject|3
4746883|NCT01778127|16374161|P3|Overall Study|Lost to Follow-up|2
4746884|NCT01778127|16374162|P2|Overall Study|Lost to Follow-up|1
4746885|NCT01778127|16374163|P1|Overall Study|Lost to Follow-up|5
4746886|NCT01778062|16374206|P2|Overall Study|major protocol deviation|3
4746887|NCT01778062|16374207|P1|Overall Study|major protocol deviation|4
4746888|NCT01778062|16374206|P2|Overall Study|Consent Withdrawal|5
4746889|NCT01778062|16374207|P1|Overall Study|Consent Withdrawal|1
4746890|NCT01778062|16374206|P2|Overall Study|Adverse Event|3
4746891|NCT01778062|16374207|P1|Overall Study|Adverse Event|1
4746892|NCT01778049|16374221|P6|Double Blind Treatment Period|Other reason not defined above|1
4746893|NCT01778049|16374222|P5|Double Blind Treatment Period|Other reason not defined above|2
4746894|NCT01778049|16374223|P4|Double Blind Treatment Period|Other reason not defined above|2
4746895|NCT01778049|16374224|P3|Double Blind Treatment Period|Other reason not defined above|4
4746896|NCT01778049|16374225|P2|Double Blind Treatment Period|Other reason not defined above|0
4746897|NCT01778049|16374226|P1|Double Blind Treatment Period|Other reason not defined above|0
4746898|NCT01778049|16374221|P6|Double Blind Treatment Period|Not treated|0
4746899|NCT01778049|16374222|P5|Double Blind Treatment Period|Not treated|2
4746900|NCT01778049|16374223|P4|Double Blind Treatment Period|Not treated|2
4746901|NCT01778049|16374224|P3|Double Blind Treatment Period|Not treated|0
4746902|NCT01778049|16374225|P2|Double Blind Treatment Period|Not treated|0
4746903|NCT01778049|16374226|P1|Double Blind Treatment Period|Not treated|0
4746904|NCT01778049|16374221|P6|Double Blind Treatment Period|Withdrawal by Subject|1
4746905|NCT01778049|16374222|P5|Double Blind Treatment Period|Withdrawal by Subject|0
4746906|NCT01778049|16374223|P4|Double Blind Treatment Period|Withdrawal by Subject|2
4746907|NCT01778049|16374224|P3|Double Blind Treatment Period|Withdrawal by Subject|1
4746908|NCT01778049|16374225|P2|Double Blind Treatment Period|Withdrawal by Subject|0
4746909|NCT01778049|16374226|P1|Double Blind Treatment Period|Withdrawal by Subject|0
4746910|NCT01778049|16374221|P6|Double Blind Treatment Period|Lost to Follow-up|2
4746911|NCT01778049|16374222|P5|Double Blind Treatment Period|Lost to Follow-up|5
4746912|NCT01778049|16374223|P4|Double Blind Treatment Period|Lost to Follow-up|1
4746913|NCT01778049|16374224|P3|Double Blind Treatment Period|Lost to Follow-up|4
4746914|NCT01778049|16374225|P2|Double Blind Treatment Period|Lost to Follow-up|0
4746915|NCT01778049|16374226|P1|Double Blind Treatment Period|Lost to Follow-up|0
4746916|NCT01778049|16374221|P6|Double Blind Treatment Period|Protocol Violation|0
4746917|NCT01778049|16374222|P5|Double Blind Treatment Period|Protocol Violation|0
4746918|NCT01778049|16374223|P4|Double Blind Treatment Period|Protocol Violation|0
4746919|NCT01778049|16374224|P3|Double Blind Treatment Period|Protocol Violation|2
4746920|NCT01778049|16374225|P2|Double Blind Treatment Period|Protocol Violation|0
4746921|NCT01778049|16374226|P1|Double Blind Treatment Period|Protocol Violation|0
4746922|NCT01778049|16374221|P6|Double Blind Treatment Period|Lack of Efficacy|1
4746923|NCT01778049|16374222|P5|Double Blind Treatment Period|Lack of Efficacy|0
4746924|NCT01778049|16374223|P4|Double Blind Treatment Period|Lack of Efficacy|0
4746925|NCT01778049|16374224|P3|Double Blind Treatment Period|Lack of Efficacy|0
4746926|NCT01778049|16374225|P2|Double Blind Treatment Period|Lack of Efficacy|0
4746927|NCT01778049|16374226|P1|Double Blind Treatment Period|Lack of Efficacy|0
4746928|NCT01778049|16374221|P6|Double Blind Treatment Period|Adverse Event|2
4746929|NCT01778049|16374222|P5|Double Blind Treatment Period|Adverse Event|3
4746930|NCT01778049|16374223|P4|Double Blind Treatment Period|Adverse Event|5
4746931|NCT01778049|16374224|P3|Double Blind Treatment Period|Adverse Event|4
4746932|NCT01778049|16374225|P2|Double Blind Treatment Period|Adverse Event|0
4746933|NCT01778049|16374226|P1|Double Blind Treatment Period|Adverse Event|0
4746934|NCT01778049|16374221|P6|Open Label Treatment Period|Other reason not defined above|0
4746935|NCT01778049|16374222|P5|Open Label Treatment Period|Other reason not defined above|0
4746936|NCT01778049|16374223|P4|Open Label Treatment Period|Other reason not defined above|0
4746937|NCT01778049|16374224|P3|Open Label Treatment Period|Other reason not defined above|0
4746938|NCT01778049|16374225|P2|Open Label Treatment Period|Other reason not defined above|94
4746939|NCT01778049|16374226|P1|Open Label Treatment Period|Other reason not defined above|77
4746940|NCT01778049|16374221|P6|Open Label Treatment Period|Not treated|0
4746941|NCT01778049|16374222|P5|Open Label Treatment Period|Not treated|0
4746942|NCT01778049|16374223|P4|Open Label Treatment Period|Not treated|0
4746943|NCT01778049|16374224|P3|Open Label Treatment Period|Not treated|0
4746944|NCT01778049|16374225|P2|Open Label Treatment Period|Not treated|1
4746945|NCT01778049|16374226|P1|Open Label Treatment Period|Not treated|2
4746946|NCT01778049|16374221|P6|Open Label Treatment Period|Withdrawal by Subject|0
4746947|NCT01778049|16374222|P5|Open Label Treatment Period|Withdrawal by Subject|0
4746948|NCT01778049|16374223|P4|Open Label Treatment Period|Withdrawal by Subject|0
4746949|NCT01778049|16374224|P3|Open Label Treatment Period|Withdrawal by Subject|0
4746950|NCT01778049|16374225|P2|Open Label Treatment Period|Withdrawal by Subject|10
4746951|NCT01778049|16374226|P1|Open Label Treatment Period|Withdrawal by Subject|4
4746952|NCT01778049|16374221|P6|Open Label Treatment Period|Lost to Follow-up|0
4746953|NCT01778049|16374222|P5|Open Label Treatment Period|Lost to Follow-up|0
4746954|NCT01778049|16374223|P4|Open Label Treatment Period|Lost to Follow-up|0
4746955|NCT01778049|16374224|P3|Open Label Treatment Period|Lost to Follow-up|0
4746956|NCT01778049|16374225|P2|Open Label Treatment Period|Lost to Follow-up|3
4746957|NCT01778049|16374226|P1|Open Label Treatment Period|Lost to Follow-up|4
4746958|NCT01778049|16374221|P6|Open Label Treatment Period|Protocol Violation|0
4746959|NCT01778049|16374222|P5|Open Label Treatment Period|Protocol Violation|0
4746960|NCT01778049|16374223|P4|Open Label Treatment Period|Protocol Violation|0
4746961|NCT01778049|16374224|P3|Open Label Treatment Period|Protocol Violation|0
4746962|NCT01778049|16374225|P2|Open Label Treatment Period|Protocol Violation|5
4746963|NCT01778049|16374226|P1|Open Label Treatment Period|Protocol Violation|5
4746964|NCT01778049|16374221|P6|Open Label Treatment Period|Lack of Efficacy|0
4746965|NCT01778049|16374222|P5|Open Label Treatment Period|Lack of Efficacy|0
4746966|NCT01778049|16374223|P4|Open Label Treatment Period|Lack of Efficacy|0
4746967|NCT01778049|16374224|P3|Open Label Treatment Period|Lack of Efficacy|0
4746968|NCT01778049|16374225|P2|Open Label Treatment Period|Lack of Efficacy|1
4746969|NCT01778049|16374226|P1|Open Label Treatment Period|Lack of Efficacy|1
4746970|NCT01778049|16374221|P6|Open Label Treatment Period|Adverse Event|0
4746971|NCT01778049|16374222|P5|Open Label Treatment Period|Adverse Event|0
4746972|NCT01778049|16374223|P4|Open Label Treatment Period|Adverse Event|0
4746973|NCT01778049|16374224|P3|Open Label Treatment Period|Adverse Event|0
4746974|NCT01778049|16374225|P2|Open Label Treatment Period|Adverse Event|15
4746975|NCT01778049|16374226|P1|Open Label Treatment Period|Adverse Event|5
4746976|NCT01778023|16374244|P2|Overall Study|Withdrawal by Subject|3
4746977|NCT01778023|16374245|P1|Overall Study|Withdrawal by Subject|0
4746978|NCT01778010|16374262|P1|Overall Study|rash while on placebo|1
4746979|NCT01778010|16374262|P1|Overall Study|Arrested|1
4746980|NCT01778010|16374262|P1|Overall Study|abnormal ECG before meds|1
4746981|NCT01778010|16374262|P1|Overall Study|Withdrawal by Subject|2
4746982|NCT01777997|16374303|P1|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1
4746983|NCT01777997|16374303|P1|Weeks 48 to 72/96 on ART|Death|1
4746984|NCT01777997|16374303|P1|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1
4746985|NCT01777997|16374303|P1|12 Week lead-in of no ART|Severe debilitation|2
4746986|NCT01777932|16374325|P1|Overall Study|Patient refused further treatment|10
4746987|NCT01777932|16374325|P1|Overall Study|Reimbursement limit|9
4746988|NCT01777932|16374325|P1|Overall Study|Investigator decision|10
4746989|NCT01777932|16374325|P1|Overall Study|Lost to Follow-up|3
4746990|NCT01777932|16374325|P1|Overall Study|Adverse Event|34
4746991|NCT01777932|16374325|P1|Overall Study|Death|3
4746992|NCT01777932|16374325|P1|Overall Study|Disease progression|136
4746993|NCT01777854|16374339|P2|Overall Study|Physician Decision|3
4746994|NCT01777854|16374340|P1|Overall Study|Physician Decision|3
4746995|NCT01777776|16374348|P4|Overall Study|Withdrawal by Subject|1
4746996|NCT01777776|16374349|P3|Overall Study|Withdrawal by Subject|0
4746997|NCT01777776|16374350|P2|Overall Study|Withdrawal by Subject|0
4746998|NCT01777776|16374351|P1|Overall Study|Withdrawal by Subject|0
4746999|NCT01777776|16374348|P4|Overall Study|Disease Progression|3
4747000|NCT01777776|16374349|P3|Overall Study|Disease Progression|6
4747001|NCT01777776|16374350|P2|Overall Study|Disease Progression|8
4747002|NCT01777776|16374351|P1|Overall Study|Disease Progression|4
4747003|NCT01777776|16374348|P4|Overall Study|Adverse Event|0
4747004|NCT01777776|16374349|P3|Overall Study|Adverse Event|0
4747005|NCT01777776|16374350|P2|Overall Study|Adverse Event|4
4747006|NCT01777776|16374351|P1|Overall Study|Adverse Event|2
4747007|NCT01777763|16374410|P2|Overall Study|Treatment Failure|6
4747008|NCT01777763|16374411|P1|Overall Study|Treatment Failure|1
4747009|NCT01777763|16374410|P2|Overall Study|Withdrawal by Subject|2
4747010|NCT01777763|16374411|P1|Overall Study|Withdrawal by Subject|0
4747011|NCT01777763|16374410|P2|Overall Study|Protocol Violation|7
4747012|NCT01777763|16374411|P1|Overall Study|Protocol Violation|1
4747013|NCT01777763|16374410|P2|Overall Study|Adverse Event|32
4747014|NCT01777763|16374411|P1|Overall Study|Adverse Event|2
4747015|NCT01777620|16374435|P2|Overall Study|Subject Withdrawal|0
4747016|NCT01777620|16374436|P1|Overall Study|Subject Withdrawal|1
4747017|NCT01777581|16374462|P2|Overall Study|Lack of Efficacy|1
4747018|NCT01777581|16374463|P1|Overall Study|Lack of Efficacy|0
4747019|NCT01777581|16374462|P2|Overall Study|Adverse Event|0
4747020|NCT01777581|16374463|P1|Overall Study|Adverse Event|2
4747021|NCT01777581|16374462|P2|Overall Study|Lost to Follow-up|1
4747022|NCT01777581|16374463|P1|Overall Study|Lost to Follow-up|1
4747023|NCT01777542|16374492|P2|Second Intervention (20 Weeks)|Adverse Event|1
4747024|NCT01777542|16374493|P1|Second Intervention (20 Weeks)|Adverse Event|0
4747025|NCT01777490|16374536|P4|Overall Study|Dyad withdrew with data use prohibition|1
4747026|NCT01777490|16374537|P3|Overall Study|Dyad withdrew with data use prohibition|1
4747027|NCT01777490|16374538|P2|Overall Study|Dyad withdrew with data use prohibition|0
4747028|NCT01777490|16374539|P1|Overall Study|Dyad withdrew with data use prohibition|0
4747029|NCT01777334|16374584|P2|Overall Study|Withdrawal by Subject|11
4747030|NCT01777334|16374585|P1|Overall Study|Withdrawal by Subject|14
4747031|NCT01777334|16374584|P2|Overall Study|Lost to Follow-up|2
4747032|NCT01777334|16374585|P1|Overall Study|Lost to Follow-up|3
4747033|NCT01777334|16374584|P2|Overall Study|Protocol Violation|7
4747034|NCT01777334|16374585|P1|Overall Study|Protocol Violation|3
4747035|NCT01777334|16374584|P2|Overall Study|Lack of Efficacy|29
4747036|NCT01777334|16374585|P1|Overall Study|Lack of Efficacy|15
4747037|NCT01777334|16374584|P2|Overall Study|Adverse Event|14
4747038|NCT01777334|16374585|P1|Overall Study|Adverse Event|18
4747039|NCT01777321|16374595|P2|Overall Study|Withdrawal by Subject|1
4747040|NCT01777321|16374596|P1|Overall Study|Withdrawal by Subject|0
4747041|NCT01777308|16374634|P2|Overall Study|Blood draw refusal at Visit 3|0
4747042|NCT01777308|16374635|P1|Overall Study|Blood draw refusal at Visit 3|1
4747043|NCT01777308|16374634|P2|Overall Study|Lost to Follow-up|2
4747044|NCT01777308|16374635|P1|Overall Study|Lost to Follow-up|7
4747045|NCT01777308|16374634|P2|Overall Study|Migrated/moved from study area|0
4747046|NCT01777308|16374635|P1|Overall Study|Migrated/moved from study area|1
4747047|NCT01777308|16374634|P2|Overall Study|Withdrawal by Subject|1
4747048|NCT01777308|16374635|P1|Overall Study|Withdrawal by Subject|5
4747049|NCT01777295|16374667|P2|Overall Study|Investigator call for AEs check|0
4747050|NCT01777295|16374668|P1|Overall Study|Investigator call for AEs check|1
4747051|NCT01777295|16374667|P2|Overall Study|Personal problem|0
4747052|NCT01777295|16374668|P1|Overall Study|Personal problem|1
4747053|NCT01777295|16374667|P2|Overall Study|Pregnancy|1
4747054|NCT01777295|16374668|P1|Overall Study|Pregnancy|0
4747055|NCT01777295|16374667|P2|Overall Study|Withdrawal by Subject|2
4747056|NCT01777295|16374668|P1|Overall Study|Withdrawal by Subject|2
4747057|NCT01777282|16374875|P5|Overall Study|Moved, transfer abroad, did not enter FU|0
4747058|NCT01777282|16374876|P4|Overall Study|Moved, transfer abroad, did not enter FU|0
4747059|NCT01777282|16374877|P3|Overall Study|Moved, transfer abroad, did not enter FU|1
4747060|NCT01777282|16374878|P2|Overall Study|Moved, transfer abroad, did not enter FU|0
4747061|NCT01777282|16374879|P1|Overall Study|Moved, transfer abroad, did not enter FU|1
4747062|NCT01777282|16374875|P5|Overall Study|Protocol Violation|2
4747063|NCT01777282|16374876|P4|Overall Study|Protocol Violation|0
4747064|NCT01777282|16374877|P3|Overall Study|Protocol Violation|1
4747065|NCT01777282|16374878|P2|Overall Study|Protocol Violation|0
4747066|NCT01777282|16374879|P1|Overall Study|Protocol Violation|2
4747067|NCT01777282|16374875|P5|Overall Study|Withdrawal by Subject|2
4747068|NCT01777282|16374876|P4|Overall Study|Withdrawal by Subject|1
4747069|NCT01777282|16374877|P3|Overall Study|Withdrawal by Subject|0
4747070|NCT01777282|16374878|P2|Overall Study|Withdrawal by Subject|0
4747071|NCT01777282|16374879|P1|Overall Study|Withdrawal by Subject|4
4747072|NCT01777282|16374875|P5|Overall Study|Adverse Event|3
4747073|NCT01777282|16374876|P4|Overall Study|Adverse Event|1
4747074|NCT01777282|16374877|P3|Overall Study|Adverse Event|2
4747075|NCT01777282|16374878|P2|Overall Study|Adverse Event|4
4747076|NCT01777282|16374879|P1|Overall Study|Adverse Event|4
4747077|NCT01777282|16374875|P5|Overall Study|New Antidiabetic Medication|0
4747078|NCT01777282|16374876|P4|Overall Study|New Antidiabetic Medication|0
4747079|NCT01777282|16374877|P3|Overall Study|New Antidiabetic Medication|1
4747080|NCT01777282|16374878|P2|Overall Study|New Antidiabetic Medication|0
4747081|NCT01777282|16374879|P1|Overall Study|New Antidiabetic Medication|0
4747082|NCT01777282|16374875|P5|Overall Study|Persistent Hyperglycemia|0
4747083|NCT01777282|16374876|P4|Overall Study|Persistent Hyperglycemia|0
4747084|NCT01777282|16374877|P3|Overall Study|Persistent Hyperglycemia|1
4747085|NCT01777282|16374878|P2|Overall Study|Persistent Hyperglycemia|0
4747086|NCT01777282|16374879|P1|Overall Study|Persistent Hyperglycemia|0
4747087|NCT01777269|16374923|P2|Overall Study|Withdrawal by Subject|9
4747088|NCT01777269|16374924|P1|Overall Study|Withdrawal by Subject|9
4747089|NCT01777269|16374923|P2|Overall Study|Physician Decision|2
4747090|NCT01777269|16374924|P1|Overall Study|Physician Decision|5
4747091|NCT01777269|16374923|P2|Overall Study|Lost to Follow-up|0
4747092|NCT01777269|16374924|P1|Overall Study|Lost to Follow-up|4
4747093|NCT01777269|16374923|P2|Overall Study|Participants reached stopping criteria|1
4747094|NCT01777269|16374924|P1|Overall Study|Participants reached stopping criteria|1
4747095|NCT01777269|16374923|P2|Overall Study|Protocol Violation|4
4747096|NCT01777269|16374924|P1|Overall Study|Protocol Violation|4
4747097|NCT01777269|16374923|P2|Overall Study|Lack of Efficacy|10
4747098|NCT01777269|16374924|P1|Overall Study|Lack of Efficacy|8
4747099|NCT01777269|16374923|P2|Overall Study|Adverse Event|33
4747100|NCT01777269|16374924|P1|Overall Study|Adverse Event|24
4747101|NCT01777191|16374961|P2|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3
4747102|NCT01777191|16374962|P1|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1
4747103|NCT01777191|16374961|P2|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2
4747104|NCT01777191|16374962|P1|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1
4747105|NCT01777191|16374961|P2|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
4747106|NCT01777191|16374962|P1|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4
4747107|NCT01777191|16374961|P2|Safety Extension Per (Week 12-Week 48)|Death|1
4747108|NCT01777191|16374962|P1|Safety Extension Per (Week 12-Week 48)|Death|0
4747109|NCT01777191|16374961|P2|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
4747110|NCT01777191|16374962|P1|Safety Extension Per (Week 12-Week 48)|Adverse Event|3
4747111|NCT01777191|16374961|P2|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0
4747112|NCT01777191|16374962|P1|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1
4747113|NCT01777191|16374961|P2|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
4747114|NCT01777191|16374962|P1|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1
4747115|NCT01777191|16374961|P2|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3
4747116|NCT01777191|16374962|P1|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0
4747117|NCT01777191|16374961|P2|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2
4747118|NCT01777191|16374962|P1|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1
4747119|NCT01777191|16374961|P2|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
4747120|NCT01777191|16374962|P1|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1
4747121|NCT01777191|16374961|P2|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1
4747122|NCT01777191|16374962|P1|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2
4747123|NCT01777152|16374992|P2|Overall Study|Change of diagnosis|0
4747124|NCT01777152|16374993|P1|Overall Study|Change of diagnosis|1
4747125|NCT01777152|16374992|P2|Overall Study|Not eligible, no study drug received|0
4747126|NCT01777152|16374993|P1|Overall Study|Not eligible, no study drug received|1
4747127|NCT01777152|16374992|P2|Overall Study|Death|73
4747128|NCT01777152|16374993|P1|Overall Study|Death|51
4747129|NCT01777152|16374992|P2|Overall Study|Lost to Follow-up|4
4747130|NCT01777152|16374993|P1|Overall Study|Lost to Follow-up|0
4747131|NCT01777152|16374992|P2|Overall Study|Withdrawal by Subject|10
4747132|NCT01777152|16374993|P1|Overall Study|Withdrawal by Subject|16
4747133|NCT01777152|16374992|P2|Overall Study|In Follow Up|139
4747134|NCT01777152|16374993|P1|Overall Study|In Follow Up|157
4747135|NCT01777139|16375009|P2|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3
4747136|NCT01777139|16375010|P1|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0
4747137|NCT01777139|16375009|P2|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1
4747138|NCT01777139|16375010|P1|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0
4747139|NCT01777139|16375009|P2|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0
4747140|NCT01777139|16375010|P1|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4
4747141|NCT01777139|16375009|P2|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0
4747142|NCT01777139|16375010|P1|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2
4747143|NCT01777139|16375009|P2|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0
4747144|NCT01777139|16375010|P1|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3
4747145|NCT01777139|16375009|P2|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0
4747146|NCT01777139|16375010|P1|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8
4747147|NCT01777139|16375009|P2|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0
4747148|NCT01777139|16375010|P1|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6
4747149|NCT01777139|16375009|P2|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0
4747150|NCT01777139|16375010|P1|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7
4747151|NCT01776554|16375124|P2|Overall Study|Unclassified|1
4747152|NCT01776554|16375125|P1|Overall Study|Unclassified|4
4747153|NCT01776554|16375124|P2|Overall Study|Protocol Violation|0
4747154|NCT01776554|16375125|P1|Overall Study|Protocol Violation|1
4747155|NCT01776554|16375124|P2|Overall Study|Administrative Reason|5
4747156|NCT01776554|16375125|P1|Overall Study|Administrative Reason|2
4747157|NCT01776554|16375124|P2|Overall Study|Lost to Follow-up|9
4747158|NCT01776554|16375125|P1|Overall Study|Lost to Follow-up|6
4747159|NCT01776554|16375124|P2|Overall Study|Withdrawal by Subject|8
4747160|NCT01776554|16375125|P1|Overall Study|Withdrawal by Subject|3
4747161|NCT01776554|16375124|P2|Overall Study|Adverse Event|0
4747162|NCT01776554|16375125|P1|Overall Study|Adverse Event|1
4747163|NCT01776541|16375168|P2|Overall Study|Withdrawal by Subject|20
4747164|NCT01776541|16375169|P1|Overall Study|Withdrawal by Subject|12
4747165|NCT01776541|16375168|P2|Overall Study|Protocol Violation|1
4747166|NCT01776541|16375169|P1|Overall Study|Protocol Violation|2
4747167|NCT01776541|16375168|P2|Overall Study|Unclassified|4
4747168|NCT01776541|16375169|P1|Overall Study|Unclassified|5
4747169|NCT01776541|16375168|P2|Overall Study|Lost to Follow-up|48
4747170|NCT01776541|16375169|P1|Overall Study|Lost to Follow-up|27
4747171|NCT01776541|16375168|P2|Overall Study|Death|0
4747172|NCT01776541|16375169|P1|Overall Study|Death|4
4747173|NCT01776541|16375168|P2|Overall Study|Administrative Reason|2
4747174|NCT01776541|16375169|P1|Overall Study|Administrative Reason|6
4747175|NCT01776424|16375191|P3|Overall Study|Withdrawal by Subject|15
4747176|NCT01776424|16375192|P2|Overall Study|Withdrawal by Subject|11
4747177|NCT01776424|16375193|P1|Overall Study|Withdrawal by Subject|10
4747178|NCT01776424|16375191|P3|Overall Study|Lost to Follow-up|9
4747179|NCT01776424|16375192|P2|Overall Study|Lost to Follow-up|8
4747180|NCT01776424|16375193|P1|Overall Study|Lost to Follow-up|10
4747181|NCT01776008|16375224|P1|Overall Study|ineligible|2
4747182|NCT01775995|16375238|P2|Overall Study|Lost to Follow-up|1
4747183|NCT01775995|16375239|P1|Overall Study|Lost to Follow-up|1
4747184|NCT01775930|16375299|P1|Overall Study|Futility stopping boundary met|1
4747185|NCT01775904|16375307|P1|LY2886721 ODT (Water, Fasting)|Adverse Event|1
4747186|NCT01775904|16375307|P1|LY2886721 Capsule (Water, Fasting)|Adverse Event|1
4747187|NCT01775787|16375373|P2|Second 7-10 Days|concerns with using IV|1
4747188|NCT01775787|16375374|P1|Second 7-10 Days|concerns with using IV|0
4747189|NCT01775787|16375373|P2|Second 7-10 Days|time commitment|1
4747190|NCT01775787|16375374|P1|Second 7-10 Days|time commitment|0
4747191|NCT01775787|16375373|P2|First 7-10 Days|concerns with using IV|2
4747192|NCT01775787|16375374|P1|First 7-10 Days|concerns with using IV|1
4747193|NCT01775787|16375373|P2|First 7-10 Days|time commitment|2
4747194|NCT01775787|16375374|P1|First 7-10 Days|time commitment|0
4747195|NCT01775787|16375373|P2|First 7-10 Days|family emergency|1
4747196|NCT01775787|16375374|P1|First 7-10 Days|family emergency|0
4747197|NCT01775787|16375373|P2|First 7-10 Days|Adverse Event|1
4747198|NCT01775787|16375374|P1|First 7-10 Days|Adverse Event|0
4747199|NCT01775670|16375430|P2|Overall Study|Lost to Follow-up|1
4747200|NCT01775670|16375431|P1|Overall Study|Lost to Follow-up|1
4747201|NCT01775553|16375457|P1|Overall Study|Disease Progression|12
4747202|NCT01775553|16375457|P1|Overall Study|Adverse Event|1
4747203|NCT01775501|16375465|P1|Overall Study|Discontinued prior to treatment|1
4747204|NCT01775189|16375474|P7|Treatment Phase: Washout Period 3|Protocol Violation|1
4747205|NCT01775189|16375475|P6|Treatment Phase: Washout Period 3|Protocol Violation|0
4747206|NCT01775189|16375476|P5|Treatment Phase: Washout Period 3|Protocol Violation|0
4747207|NCT01775189|16375477|P4|Treatment Phase: Washout Period 3|Protocol Violation|1
4747208|NCT01775189|16375478|P3|Treatment Phase: Washout Period 3|Protocol Violation|0
4747209|NCT01775189|16375479|P2|Treatment Phase: Washout Period 3|Protocol Violation|0
4747210|NCT01775189|16375480|P1|Treatment Phase: Washout Period 3|Protocol Violation|0
4747211|NCT01775189|16375474|P7|Treatment Phase: Washout Period 2|Protocol Violation|0
4747212|NCT01775189|16375475|P6|Treatment Phase: Washout Period 2|Protocol Violation|0
4747213|NCT01775189|16375476|P5|Treatment Phase: Washout Period 2|Protocol Violation|0
4747214|NCT01775189|16375477|P4|Treatment Phase: Washout Period 2|Protocol Violation|1
4747215|NCT01775189|16375478|P3|Treatment Phase: Washout Period 2|Protocol Violation|0
4747216|NCT01775189|16375479|P2|Treatment Phase: Washout Period 2|Protocol Violation|0
4747217|NCT01775189|16375480|P1|Treatment Phase: Washout Period 2|Protocol Violation|0
4747218|NCT01775189|16375474|P7|Treatment Phase: Washout Period 1|Protocol Violation|0
4747219|NCT01775189|16375475|P6|Treatment Phase: Washout Period 1|Protocol Violation|1
4747220|NCT01775189|16375476|P5|Treatment Phase: Washout Period 1|Protocol Violation|0
4747221|NCT01775189|16375477|P4|Treatment Phase: Washout Period 1|Protocol Violation|0
4747222|NCT01775189|16375478|P3|Treatment Phase: Washout Period 1|Protocol Violation|0
4747223|NCT01775189|16375479|P2|Treatment Phase: Washout Period 1|Protocol Violation|0
4747224|NCT01775189|16375480|P1|Treatment Phase: Washout Period 1|Protocol Violation|0
4747225|NCT01775189|16375474|P7|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4747226|NCT01775189|16375475|P6|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4747227|NCT01775189|16375476|P5|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4747228|NCT01775189|16375477|P4|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4747229|NCT01775189|16375478|P3|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7
4747230|NCT01775189|16375479|P2|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2
4747231|NCT01775189|16375480|P1|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0
4747232|NCT01775189|16375474|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
4747233|NCT01775189|16375475|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
4747234|NCT01775189|16375476|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
4747235|NCT01775189|16375477|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
4747236|NCT01775189|16375478|P3|Drug Discrimination Phase: Day 2|Protocol Violation|0
4747237|NCT01775189|16375479|P2|Drug Discrimination Phase: Day 2|Protocol Violation|1
4747238|NCT01775189|16375480|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
4747239|NCT01775189|16375474|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
4747240|NCT01775189|16375475|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
4747241|NCT01775189|16375476|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
4747242|NCT01775189|16375477|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
4747243|NCT01775189|16375478|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
4747244|NCT01775189|16375479|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
4747245|NCT01775189|16375480|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
4747246|NCT01775137|16375699|P1|Overall Study|Withdrawal by participants|5
4747247|NCT01775137|16375699|P1|Overall Study|Adverse Event|1
4747248|NCT01775137|16375699|P1|Overall Study|Unsatisfactory therapeutic effect|2
4747249|NCT01775137|16375699|P1|Overall Study|Protocol deviation|2
4747250|NCT01775137|16375699|P1|Overall Study|Death|1
4747251|NCT01775124|16375726|P2|Extension Period|Withdrawal by Subject|12
4747252|NCT01775124|16375727|P1|Extension Period|Withdrawal by Subject|9
4747253|NCT01775124|16375726|P2|Extension Period|Lost to Follow-up|1
4747254|NCT01775124|16375727|P1|Extension Period|Lost to Follow-up|0
4747255|NCT01775124|16375726|P2|Extension Period|Administrative problems|1
4747256|NCT01775124|16375727|P1|Extension Period|Administrative problems|0
4747257|NCT01775124|16375726|P2|Extension Period|Physician Decision|2
4747258|NCT01775124|16375727|P1|Extension Period|Physician Decision|0
4747259|NCT01775124|16375726|P2|Extension Period|Adverse Event|2
4747260|NCT01775124|16375727|P1|Extension Period|Adverse Event|3
4747261|NCT01775124|16375726|P2|Core Period|Adverse Event|5
4747262|NCT01775124|16375727|P1|Core Period|Adverse Event|5
4747263|NCT01775124|16375726|P2|Core Period|Withdrawal by Subject|2
4747264|NCT01775124|16375727|P1|Core Period|Withdrawal by Subject|4
4747265|NCT01775124|16375726|P2|Core Period|Administrative problems|0
4747266|NCT01775124|16375727|P1|Core Period|Administrative problems|1
4747267|NCT01775124|16375726|P2|Core Period|Death|1
4747268|NCT01775124|16375727|P1|Core Period|Death|0
4747269|NCT01775124|16375726|P2|Core Period|Physician Decision|1
4747270|NCT01775124|16375727|P1|Core Period|Physician Decision|1
4747271|NCT01775124|16375726|P2|Core Period|Disease Progression|1
4747272|NCT01775124|16375727|P1|Core Period|Disease Progression|0
4747273|NCT01774981|16375762|P8|Overall Study|Death|0
4747274|NCT01774981|16375763|P7|Overall Study|Death|0
4747275|NCT01774981|16375764|P6|Overall Study|Death|0
4747276|NCT01774981|16375765|P5|Overall Study|Death|1
4747277|NCT01774981|16375766|P4|Overall Study|Death|0
4747278|NCT01774981|16375767|P3|Overall Study|Death|0
4747279|NCT01774981|16375768|P2|Overall Study|Death|0
4747280|NCT01774981|16375769|P1|Overall Study|Death|0
4747281|NCT01774981|16375762|P8|Overall Study|Withdrawal by Subject|1
4747282|NCT01774981|16375763|P7|Overall Study|Withdrawal by Subject|0
4747283|NCT01774981|16375764|P6|Overall Study|Withdrawal by Subject|0
4747284|NCT01774981|16375765|P5|Overall Study|Withdrawal by Subject|0
4747285|NCT01774981|16375766|P4|Overall Study|Withdrawal by Subject|0
4747286|NCT01774981|16375767|P3|Overall Study|Withdrawal by Subject|0
4747287|NCT01774981|16375768|P2|Overall Study|Withdrawal by Subject|0
4747288|NCT01774981|16375769|P1|Overall Study|Withdrawal by Subject|0
4747289|NCT01774981|16375762|P8|Overall Study|Adverse Event|0
4747290|NCT01774981|16375763|P7|Overall Study|Adverse Event|0
4747291|NCT01774981|16375764|P6|Overall Study|Adverse Event|1
4747292|NCT01774981|16375765|P5|Overall Study|Adverse Event|0
4747293|NCT01774981|16375766|P4|Overall Study|Adverse Event|0
4747294|NCT01774981|16375767|P3|Overall Study|Adverse Event|0
4747295|NCT01774981|16375768|P2|Overall Study|Adverse Event|0
4747296|NCT01774981|16375769|P1|Overall Study|Adverse Event|0
4747297|NCT01774968|16375801|P2|Overall Study|Withdrawal by Subject|11
4747298|NCT01774968|16375802|P1|Overall Study|Withdrawal by Subject|6
4747299|NCT01774968|16375801|P2|Overall Study|Sponsor Decision|2
4747300|NCT01774968|16375802|P1|Overall Study|Sponsor Decision|0
4747301|NCT01774968|16375801|P2|Overall Study|Protocol Violation|13
4747302|NCT01774968|16375802|P1|Overall Study|Protocol Violation|14
4747303|NCT01774968|16375801|P2|Overall Study|Physician Decision|1
4747304|NCT01774968|16375802|P1|Overall Study|Physician Decision|5
4747305|NCT01774968|16375801|P2|Overall Study|Lost to Follow-up|3
4747306|NCT01774968|16375802|P1|Overall Study|Lost to Follow-up|1
4747307|NCT01774968|16375801|P2|Overall Study|Death|1
4747308|NCT01774968|16375802|P1|Overall Study|Death|0
4747309|NCT01774968|16375801|P2|Overall Study|Adverse Event|4
4747310|NCT01774968|16375802|P1|Overall Study|Adverse Event|4
4747311|NCT01774929|16375836|P1|Overall Study|Adverse Event|3
4747312|NCT01774903|16375842|P1|Overall Study|Ineligible to continue the trial|1
4747313|NCT01774903|16375842|P1|Overall Study|Lack of Efficacy|1
4747314|NCT01774903|16375842|P1|Overall Study|Withdrawal by Subject|2
4747315|NCT01774903|16375842|P1|Overall Study|Adverse Event|7
4747316|NCT01774799|16375862|P4|Overall Study|Lost to Follow-up|0
4747317|NCT01774799|16375863|P3|Overall Study|Lost to Follow-up|0
4747318|NCT01774799|16375864|P2|Overall Study|Lost to Follow-up|1
4747319|NCT01774799|16375865|P1|Overall Study|Lost to Follow-up|1
4747320|NCT01774786|16375881|P2|Overall Study|Ineligible for Study|3
4747321|NCT01774786|16375882|P1|Overall Study|Ineligible for Study|1
4747322|NCT01774786|16375881|P2|Overall Study|Physician Decision|0
4747323|NCT01774786|16375882|P1|Overall Study|Physician Decision|1
4747324|NCT01774786|16375881|P2|Overall Study|Withdrawal by Subject|12
4747325|NCT01774786|16375882|P1|Overall Study|Withdrawal by Subject|15
4747326|NCT01774786|16375881|P2|Overall Study|Lost to Follow-up|4
4747327|NCT01774786|16375882|P1|Overall Study|Lost to Follow-up|3
4747328|NCT01774786|16375881|P2|Overall Study|Death|262
4747329|NCT01774786|16375882|P1|Overall Study|Death|242
4747330|NCT01774786|16375881|P2|Overall Study|In Follow-up|62
4747331|NCT01774786|16375882|P1|Overall Study|In Follow-up|65
4747332|NCT01774786|16375881|P2|Overall Study|Between Treatment and Follow-up|2
4747333|NCT01774786|16375882|P1|Overall Study|Between Treatment and Follow-up|6
4747334|NCT01774786|16375881|P2|Overall Study|On Treatment|47
4747335|NCT01774786|16375882|P1|Overall Study|On Treatment|55
4747336|NCT01774721|16375916|P2|Overall Study|Ongoing in study|120
4747337|NCT01774721|16375917|P1|Overall Study|Ongoing in study|136
4747338|NCT01774721|16375916|P2|Overall Study|Did not meet eligibility criteria|3
4747339|NCT01774721|16375917|P1|Overall Study|Did not meet eligibility criteria|0
4747340|NCT01774721|16375916|P2|Overall Study|Lost to Follow-up|1
4747341|NCT01774721|16375917|P1|Overall Study|Lost to Follow-up|1
4747342|NCT01774721|16375916|P2|Overall Study|Withdrawal by Subject|10
4747343|NCT01774721|16375917|P1|Overall Study|Withdrawal by Subject|14
4747344|NCT01774721|16375916|P2|Overall Study|Death|91
4747345|NCT01774721|16375917|P1|Overall Study|Death|76
4747346|NCT01774591|16375982|P2|Overall Study|Adverse Event|2
4747347|NCT01774591|16375983|P1|Overall Study|Adverse Event|0
4747348|NCT01774591|16375982|P2|Overall Study|Withdrawal by Subject|1
4747349|NCT01774591|16375983|P1|Overall Study|Withdrawal by Subject|0
4747350|NCT01774591|16375982|P2|Overall Study|Physician Decision|1
4747351|NCT01774591|16375983|P1|Overall Study|Physician Decision|1
4747352|NCT01774370|16375993|P1|Overall Study|Follow-up failure|34
4747353|NCT01774370|16375993|P1|Overall Study|Violated inclusion/exclusion criteria|53
4747354|NCT01774370|16375993|P1|Overall Study|Subjects of contraindications|34
4747355|NCT01774370|16375993|P1|Overall Study|Administered prior to the contract date|4
4747356|NCT01774370|16375993|P1|Overall Study|Never taken the PRADAXA during the study|4
4747357|NCT01774344|16376001|P2|Overall Study|Did not enter Survival Follow up|83
4747358|NCT01774344|16376002|P1|Overall Study|Did not enter Survival Follow up|49
4747359|NCT01774344|16376001|P2|Overall Study|Other|1
4747360|NCT01774344|16376002|P1|Overall Study|Other|0
4747361|NCT01774344|16376001|P2|Overall Study|Data collection finished|14
4747362|NCT01774344|16376002|P1|Overall Study|Data collection finished|4
4747363|NCT01774344|16376001|P2|Overall Study|End of survival follow-up not available|2
4747364|NCT01774344|16376002|P1|Overall Study|End of survival follow-up not available|2
4747365|NCT01774344|16376001|P2|Overall Study|Lost to Follow-up|10
4747366|NCT01774344|16376002|P1|Overall Study|Lost to Follow-up|4
4747367|NCT01774344|16376001|P2|Overall Study|Protocol Violation|1
4747368|NCT01774344|16376002|P1|Overall Study|Protocol Violation|0
4747369|NCT01774344|16376001|P2|Overall Study|Withdrawal by Subject|10
4747370|NCT01774344|16376002|P1|Overall Study|Withdrawal by Subject|3
4747371|NCT01774305|16376020|P2|Overall Study|Physician Decision|0
4747372|NCT01774305|16376021|P1|Overall Study|Physician Decision|1
4747373|NCT01774253|16376029|P1|Overall Study|Death|1
4747374|NCT01774253|16376029|P1|Overall Study|Withdrawal by Subject|2
4747375|NCT01774253|16376029|P1|Overall Study|Physician Decision|2
4747376|NCT01774253|16376029|P1|Overall Study|Lack of Efficacy|4
4747377|NCT01774110|16376048|P1|Overall Study|Lost to Follow-up|7
4747378|NCT01774097|16376056|P2|Overall Study|Adverse Event|1
4747379|NCT01774097|16376057|P1|Overall Study|Adverse Event|1
4747380|NCT01774097|16376056|P2|Overall Study|Withdrawal by Subject|1
4747381|NCT01774097|16376057|P1|Overall Study|Withdrawal by Subject|1
4747382|NCT01774084|16376087|P2|Overall Study|Personal reasons|0
4747383|NCT01774084|16376088|P1|Overall Study|Personal reasons|1
4747384|NCT01773993|16376113|P1|Overall Study|No Visit After Treatment|35
4747385|NCT01773967|16376132|P2|Overall Study|Lost to Follow-up|13
4747386|NCT01773967|16376133|P1|Overall Study|Lost to Follow-up|15
4747387|NCT01773889|16376148|P1|Overall Study|lack of funding|2
4747388|NCT01773473|16376154|P2|Overall Study|Lost to Follow-up|0
4747389|NCT01773473|16376155|P1|Overall Study|Lost to Follow-up|2
4747390|NCT01773473|16376154|P2|Overall Study|Withdrawal by Subject|3
4747391|NCT01773473|16376155|P1|Overall Study|Withdrawal by Subject|5
4747392|NCT01773473|16376154|P2|Overall Study|Non-Compliance with study drug|4
4747393|NCT01773473|16376155|P1|Overall Study|Non-Compliance with study drug|1
4747394|NCT01773473|16376154|P2|Overall Study|Lack of Efficacy|1
4747395|NCT01773473|16376155|P1|Overall Study|Lack of Efficacy|0
4747396|NCT01773473|16376154|P2|Overall Study|Sponsor Decision|0
4747397|NCT01773473|16376155|P1|Overall Study|Sponsor Decision|2
4747398|NCT01773473|16376154|P2|Overall Study|Physician Decision|5
4747399|NCT01773473|16376155|P1|Overall Study|Physician Decision|3
4747400|NCT01773473|16376154|P2|Overall Study|Protocol Violation|4
4747401|NCT01773473|16376155|P1|Overall Study|Protocol Violation|0
4747402|NCT01773473|16376154|P2|Overall Study|Adverse Event|2
4747403|NCT01773473|16376155|P1|Overall Study|Adverse Event|3
4747404|NCT01773421|16376177|P7|Extension Phase|Adverse Event|0
4747405|NCT01773421|16376178|P6|Extension Phase|Adverse Event|0
4747406|NCT01773421|16376179|P5|Extension Phase|Adverse Event|2
4747407|NCT01773421|16376180|P4|Extension Phase|Adverse Event|0
4747408|NCT01773421|16376181|P3|Extension Phase|Adverse Event|0
4747409|NCT01773421|16376182|P2|Extension Phase|Adverse Event|0
4747410|NCT01773421|16376183|P1|Extension Phase|Adverse Event|0
4747411|NCT01773421|16376177|P7|Extension Phase|Other|0
4747412|NCT01773421|16376178|P6|Extension Phase|Other|2
4747413|NCT01773421|16376179|P5|Extension Phase|Other|1
4747414|NCT01773421|16376180|P4|Extension Phase|Other|0
4747415|NCT01773421|16376181|P3|Extension Phase|Other|0
4747416|NCT01773421|16376182|P2|Extension Phase|Other|0
4747417|NCT01773421|16376183|P1|Extension Phase|Other|0
4747418|NCT01773421|16376177|P7|Treatment Phase|Withdrawal by Subject|0
4747419|NCT01773421|16376178|P6|Treatment Phase|Withdrawal by Subject|0
4747420|NCT01773421|16376179|P5|Treatment Phase|Withdrawal by Subject|0
4747421|NCT01773421|16376180|P4|Treatment Phase|Withdrawal by Subject|1
4747422|NCT01773421|16376181|P3|Treatment Phase|Withdrawal by Subject|1
4747423|NCT01773421|16376182|P2|Treatment Phase|Withdrawal by Subject|0
4747424|NCT01773421|16376183|P1|Treatment Phase|Withdrawal by Subject|0
4747425|NCT01773421|16376177|P7|Treatment Phase|Adverse Event|0
4747426|NCT01773421|16376178|P6|Treatment Phase|Adverse Event|0
4747427|NCT01773421|16376179|P5|Treatment Phase|Adverse Event|0
4747428|NCT01773421|16376180|P4|Treatment Phase|Adverse Event|1
4747429|NCT01773421|16376181|P3|Treatment Phase|Adverse Event|3
4747430|NCT01773421|16376182|P2|Treatment Phase|Adverse Event|0
4747431|NCT01773421|16376183|P1|Treatment Phase|Adverse Event|0
4747432|NCT01773421|16376177|P7|Treatment Phase|Other|0
4747433|NCT01773421|16376178|P6|Treatment Phase|Other|0
4747434|NCT01773421|16376179|P5|Treatment Phase|Other|0
4747435|NCT01773421|16376180|P4|Treatment Phase|Other|0
4747436|NCT01773421|16376181|P3|Treatment Phase|Other|2
4747437|NCT01773421|16376182|P2|Treatment Phase|Other|0
4747438|NCT01773421|16376183|P1|Treatment Phase|Other|0
4747439|NCT01773291|16376214|P3|Overall Study|Withdrawal by Subject|1
4747440|NCT01773291|16376215|P2|Overall Study|Withdrawal by Subject|0
4747441|NCT01773291|16376216|P1|Overall Study|Withdrawal by Subject|0
4747442|NCT01773291|16376214|P3|Overall Study|Protocol Violation|0
4747443|NCT01773291|16376215|P2|Overall Study|Protocol Violation|0
4747444|NCT01773291|16376216|P1|Overall Study|Protocol Violation|1
4747445|NCT01773226|16376227|P1|Overall Study|Withdrawal by Subject|1
4747446|NCT01773122|16376257|P4|Overall Study|Due to amended age eligibility criteria|1
4747447|NCT01773122|16376258|P3|Overall Study|Due to amended age eligibility criteria|0
4747448|NCT01773122|16376259|P2|Overall Study|Due to amended age eligibility criteria|1
4747449|NCT01773122|16376260|P1|Overall Study|Due to amended age eligibility criteria|3
4747450|NCT01773109|16376274|P1|Overall Study|Death|1
4747451|NCT01773109|16376274|P1|Overall Study|Symptomatic Progression|2
4747452|NCT01773070|16376278|P1|Overall Study|Death (unrelated to study procedures)|3
4747453|NCT01773070|16376278|P1|Overall Study|Other|15
4747454|NCT01773070|16376278|P1|Overall Study|Lost to Follow-up|39
4747455|NCT01773070|16376278|P1|Overall Study|Withdrawal by Subject|24
4747456|NCT01772823|16376288|P2|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0
4747457|NCT01772823|16376289|P1|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1
4747458|NCT01772823|16376288|P2|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
4747459|NCT01772823|16376289|P1|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2
4747460|NCT01772823|16376288|P2|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2
4747461|NCT01772823|16376289|P1|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1
4747462|NCT01772823|16376288|P2|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5
4747463|NCT01772823|16376289|P1|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6
4747464|NCT01772823|16376288|P2|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
4747465|NCT01772823|16376289|P1|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1
4747466|NCT01772823|16376288|P2|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0
4747467|NCT01772823|16376289|P1|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1
4747468|NCT01772823|16376288|P2|Treatment Phase (Week 0- Week 48)|Incarcerated|0
4747469|NCT01772823|16376289|P1|Treatment Phase (Week 0- Week 48)|Incarcerated|1
4747470|NCT01772823|16376288|P2|Treatment Phase (Week 0- Week 48)|Moved out of area|3
4747471|NCT01772823|16376289|P1|Treatment Phase (Week 0- Week 48)|Moved out of area|4
4747472|NCT01772823|16376288|P2|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1
4747473|NCT01772823|16376289|P1|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6
4747474|NCT01772823|16376288|P2|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13
4747475|NCT01772823|16376289|P1|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15
4747476|NCT01772823|16376288|P2|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0
4747477|NCT01772823|16376289|P1|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1
4747478|NCT01772823|16376288|P2|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0
4747479|NCT01772823|16376289|P1|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6
4747480|NCT01772823|16376288|P2|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1
4747481|NCT01772823|16376289|P1|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2
4747482|NCT01772823|16376288|P2|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0
4747483|NCT01772823|16376289|P1|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1
4747484|NCT01772823|16376288|P2|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
4747485|NCT01772823|16376289|P1|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1
4747486|NCT01772823|16376288|P2|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0
4747487|NCT01772823|16376289|P1|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1
4747488|NCT01772719|16376402|P1|Overall Study|Lost to Follow-up|1
4747489|NCT01772719|16376402|P1|Overall Study|Protocol Violation|1
4747490|NCT01772719|16376402|P1|Overall Study|Adverse Event|2
4747491|NCT01772719|16376402|P1|Overall Study|Withdrawal by Subject|3
4747492|NCT01772693|16376415|P2|Overall Study|Alternative Treatment|0
4747493|NCT01772693|16376416|P1|Overall Study|Alternative Treatment|2
4747494|NCT01772693|16376415|P2|Overall Study|Withdrawal by Subject|0
4747495|NCT01772693|16376416|P1|Overall Study|Withdrawal by Subject|2
4747496|NCT01772693|16376415|P2|Overall Study|Health Concerns Unrelated to Study|1
4747497|NCT01772693|16376416|P1|Overall Study|Health Concerns Unrelated to Study|2
4747498|NCT01772576|16376437|P1|Overall Study|Withdrawal by Subject|6
4747499|NCT01772576|16376437|P1|Overall Study|Adverse Event|6
4747500|NCT01772576|16376437|P1|Overall Study|Study device not used|3
4747501|NCT01772576|16376437|P1|Overall Study|Lost to Follow-up|3
4747502|NCT01772576|16376437|P1|Overall Study|Protocol Violation|1
4747503|NCT01772576|16376437|P1|Overall Study|Death|15
4747504|NCT01772550|16376449|P3|Overall Study|Adverse Event|1
4747505|NCT01772550|16376450|P2|Overall Study|Adverse Event|0
4747506|NCT01772550|16376451|P1|Overall Study|Adverse Event|0
4747507|NCT01772550|16376449|P3|Overall Study|Unable to insert IV in antecubital vein|5
4747508|NCT01772550|16376450|P2|Overall Study|Unable to insert IV in antecubital vein|1
4747509|NCT01772550|16376451|P1|Overall Study|Unable to insert IV in antecubital vein|1
4747510|NCT01772537|16376492|P3|Overall Study|unsuccessful lumbar drain placement|0
4747511|NCT01772537|16376493|P2|Overall Study|unsuccessful lumbar drain placement|0
4747512|NCT01772537|16376494|P1|Overall Study|unsuccessful lumbar drain placement|1
4747513|NCT01772472|16376510|P2|Overall Study|Ongoing|635
4747514|NCT01772472|16376511|P1|Overall Study|Ongoing|597
4747515|NCT01772472|16376510|P2|Overall Study|Withdrawal by Subject|50
4747516|NCT01772472|16376511|P1|Overall Study|Withdrawal by Subject|72
4747517|NCT01772472|16376510|P2|Overall Study|Lost to Follow-up|8
4747518|NCT01772472|16376511|P1|Overall Study|Lost to Follow-up|12
4747519|NCT01772472|16376510|P2|Overall Study|Other|5
4747520|NCT01772472|16376511|P1|Overall Study|Other|5
4747521|NCT01772472|16376510|P2|Overall Study|Physician Decision|3
4747522|NCT01772472|16376511|P1|Overall Study|Physician Decision|1
4747523|NCT01772472|16376510|P2|Overall Study|Death|42
4747524|NCT01772472|16376511|P1|Overall Study|Death|56
4747525|NCT01772368|16376523|P1|Overall Study|Other|1
4747526|NCT01772368|16376523|P1|Overall Study|Protocol Violation|2
4747527|NCT01772368|16376523|P1|Overall Study|Withdrawal by Subject|3
4747528|NCT01772368|16376523|P1|Overall Study|Adverse Event|1
4747529|NCT01772316|16376569|P1|Overall Study|Withdrawn by sponsor decision|5
4747530|NCT01772316|16376569|P1|Overall Study|Inform consent withdrawn|1
4747531|NCT01772316|16376569|P1|Overall Study|Serious adverse event|1
4747532|NCT01772160|16376587|P1|Overall Study|Other|5
4747533|NCT01772160|16376587|P1|Overall Study|Lost to Follow-up|30
4747534|NCT01772160|16376587|P1|Overall Study|Migrated / moved from the study area|4
4747535|NCT01772160|16376587|P1|Overall Study|Consent withdrawal|3
4747536|NCT01772160|16376587|P1|Overall Study|Eligibility criteria not fulfilled|3
4747537|NCT01772160|16376587|P1|Overall Study|Death|3
4747538|NCT01772147|16376610|P3|Overall Study|Lack of Efficacy|6
4747539|NCT01772147|16376611|P2|Overall Study|Lack of Efficacy|6
4747540|NCT01772147|16376612|P1|Overall Study|Lack of Efficacy|8
4747541|NCT01772147|16376610|P3|Overall Study|Protocol Deviation|1
4747542|NCT01772147|16376611|P2|Overall Study|Protocol Deviation|1
4747543|NCT01772147|16376612|P1|Overall Study|Protocol Deviation|2
4747544|NCT01772147|16376610|P3|Overall Study|Lost to Follow-up|1
4747545|NCT01772147|16376611|P2|Overall Study|Lost to Follow-up|0
4747546|NCT01772147|16376612|P1|Overall Study|Lost to Follow-up|1
4747547|NCT01772147|16376610|P3|Overall Study|Withdrew Consent|4
4747548|NCT01772147|16376611|P2|Overall Study|Withdrew Consent|8
4747549|NCT01772147|16376612|P1|Overall Study|Withdrew Consent|7
4747550|NCT01772147|16376610|P3|Overall Study|Adverse Event|6
4747551|NCT01772147|16376611|P2|Overall Study|Adverse Event|10
4747552|NCT01772147|16376612|P1|Overall Study|Adverse Event|13
4747553|NCT01772134|16376632|P3|Overall Study|Randomized Study Medication Not Received|1
4747554|NCT01772134|16376633|P2|Overall Study|Randomized Study Medication Not Received|0
4747555|NCT01772134|16376634|P1|Overall Study|Randomized Study Medication Not Received|2
4747556|NCT01772134|16376632|P3|Overall Study|Protocol-defined Stopping Criteria|0
4747557|NCT01772134|16376633|P2|Overall Study|Protocol-defined Stopping Criteria|0
4747558|NCT01772134|16376634|P1|Overall Study|Protocol-defined Stopping Criteria|1
4747559|NCT01772134|16376632|P3|Overall Study|Lack of Efficacy|3
4747560|NCT01772134|16376633|P2|Overall Study|Lack of Efficacy|5
4747561|NCT01772134|16376634|P1|Overall Study|Lack of Efficacy|11
4747562|NCT01772134|16376632|P3|Overall Study|Protocol Deviation|3
4747563|NCT01772134|16376633|P2|Overall Study|Protocol Deviation|3
4747564|NCT01772134|16376634|P1|Overall Study|Protocol Deviation|4
4747565|NCT01772134|16376632|P3|Overall Study|Lost to Follow-up|0
4747566|NCT01772134|16376633|P2|Overall Study|Lost to Follow-up|0
4747567|NCT01772134|16376634|P1|Overall Study|Lost to Follow-up|2
4747568|NCT01772134|16376632|P3|Overall Study|Withdrew Consent|5
4747569|NCT01772134|16376633|P2|Overall Study|Withdrew Consent|1
4747570|NCT01772134|16376634|P1|Overall Study|Withdrew Consent|3
4747571|NCT01772134|16376632|P3|Overall Study|Adverse Event|10
4747572|NCT01772134|16376633|P2|Overall Study|Adverse Event|5
4747573|NCT01772134|16376634|P1|Overall Study|Adverse Event|6
4747574|NCT01771913|16376690|P2|Overall Study|Withdrawal by Subject|0
4747575|NCT01771913|16376691|P1|Overall Study|Withdrawal by Subject|1
4747576|NCT01771809|16376703|P2|Overall Study|Other (other)|5
4747577|NCT01771809|16376704|P1|Overall Study|Other (other)|9
4747578|NCT01771809|16376703|P2|Overall Study|Death|0
4747579|NCT01771809|16376704|P1|Overall Study|Death|1
4747580|NCT01771809|16376703|P2|Overall Study|Other (Insufficient clinical response)|20
4747581|NCT01771809|16376704|P1|Overall Study|Other (Insufficient clinical response)|22
4747582|NCT01771809|16376703|P2|Overall Study|Lost to Follow-up|3
4747583|NCT01771809|16376704|P1|Overall Study|Lost to Follow-up|1
4747584|NCT01771809|16376703|P2|Overall Study|Withdrawal by Subject|42
4747585|NCT01771809|16376704|P1|Overall Study|Withdrawal by Subject|34
4747586|NCT01771809|16376703|P2|Overall Study|Protocol Violation|1
4747587|NCT01771809|16376704|P1|Overall Study|Protocol Violation|0
4747588|NCT01771809|16376703|P2|Overall Study|Adverse Event|12
4747589|NCT01771809|16376704|P1|Overall Study|Adverse Event|4
4747590|NCT01771731|16376720|P2|Overall Study|Adverse event: Pain Crisis|1
4747591|NCT01771731|16376721|P1|Overall Study|Adverse event: Pain Crisis|1
4747592|NCT01771731|16376720|P2|Overall Study|Protocol Violation|1
4747593|NCT01771731|16376721|P1|Overall Study|Protocol Violation|0
4747594|NCT01771731|16376720|P2|Overall Study|Physician Decision|0
4747595|NCT01771731|16376721|P1|Overall Study|Physician Decision|1
4747596|NCT01771250|16376741|P2|Period 1|Met exclusion criteria|0
4747597|NCT01771250|16376742|P1|Period 1|Met exclusion criteria|1
4747598|NCT01770912|16376760|P2|Overall Study|Lost to Follow-up|0
4747599|NCT01770912|16376761|P1|Overall Study|Lost to Follow-up|2
4747600|NCT01770860|16376795|P1|Overall Study|Administrative decision made by the PI|1
4747601|NCT01770860|16376795|P1|Overall Study|Lost to Follow-up|1
4747602|NCT01770860|16376795|P1|Overall Study|Withdrawal by Subject|4
4747603|NCT01770743|16376843|P5|Overall Study|Moving Out of State|0
4747604|NCT01770743|16376844|P4|Overall Study|Moving Out of State|0
4747605|NCT01770743|16376845|P3|Overall Study|Moving Out of State|0
4747606|NCT01770743|16376846|P2|Overall Study|Moving Out of State|1
4747607|NCT01770743|16376847|P1|Overall Study|Moving Out of State|0
4747608|NCT01770743|16376843|P5|Overall Study|Sponsor Terminated Subject|0
4747609|NCT01770743|16376844|P4|Overall Study|Sponsor Terminated Subject|1
4747610|NCT01770743|16376845|P3|Overall Study|Sponsor Terminated Subject|0
4747611|NCT01770743|16376846|P2|Overall Study|Sponsor Terminated Subject|0
4747612|NCT01770743|16376847|P1|Overall Study|Sponsor Terminated Subject|1
4747613|NCT01770743|16376843|P5|Overall Study|Lost to Follow-up|1
4747614|NCT01770743|16376844|P4|Overall Study|Lost to Follow-up|0
4747615|NCT01770743|16376845|P3|Overall Study|Lost to Follow-up|0
4747616|NCT01770743|16376846|P2|Overall Study|Lost to Follow-up|2
4747617|NCT01770743|16376847|P1|Overall Study|Lost to Follow-up|0
4747618|NCT01770743|16376843|P5|Overall Study|Withdrawal by Subject|1
4747619|NCT01770743|16376844|P4|Overall Study|Withdrawal by Subject|1
4747620|NCT01770743|16376845|P3|Overall Study|Withdrawal by Subject|1
4747621|NCT01770743|16376846|P2|Overall Study|Withdrawal by Subject|0
4747622|NCT01770743|16376847|P1|Overall Study|Withdrawal by Subject|0
4747623|NCT01770743|16376843|P5|Overall Study|Adverse Event|0
4747624|NCT01770743|16376844|P4|Overall Study|Adverse Event|0
4747625|NCT01770743|16376845|P3|Overall Study|Adverse Event|0
4747626|NCT01770743|16376846|P2|Overall Study|Adverse Event|0
4747627|NCT01770743|16376847|P1|Overall Study|Adverse Event|1
4747628|NCT01770509|16376949|P2|Overall Study|Lost to Follow-up|2
4747629|NCT01770509|16376950|P1|Overall Study|Lost to Follow-up|1
4747630|NCT01770509|16376949|P2|Overall Study|Injury|1
4747631|NCT01770509|16376950|P1|Overall Study|Injury|0
4747632|NCT01770392|16376986|P1|Washout Period of at Least 14 Days|Adverse Event|1
4747633|NCT01770379|16377001|P3|Overall Study|Adverse Event|2
4747634|NCT01770379|16377002|P2|Overall Study|Adverse Event|3
4747635|NCT01770379|16377003|P1|Overall Study|Adverse Event|1
4747636|NCT01770379|16377001|P3|Overall Study|Lack of Efficacy|6
4747637|NCT01770379|16377002|P2|Overall Study|Lack of Efficacy|6
4747638|NCT01770379|16377003|P1|Overall Study|Lack of Efficacy|8
4747639|NCT01770379|16377001|P3|Overall Study|Lost to Follow-up|2
4747640|NCT01770379|16377002|P2|Overall Study|Lost to Follow-up|0
4747641|NCT01770379|16377003|P1|Overall Study|Lost to Follow-up|0
4747642|NCT01770379|16377001|P3|Overall Study|Physician Decision|2
4747643|NCT01770379|16377002|P2|Overall Study|Physician Decision|1
4747644|NCT01770379|16377003|P1|Overall Study|Physician Decision|0
4747645|NCT01770379|16377001|P3|Overall Study|Protocol Violation|1
4747646|NCT01770379|16377002|P2|Overall Study|Protocol Violation|1
4747647|NCT01770379|16377003|P1|Overall Study|Protocol Violation|0
4747648|NCT01770379|16377001|P3|Overall Study|study terminated by sponsor|22
4747649|NCT01770379|16377002|P2|Overall Study|study terminated by sponsor|23
4747650|NCT01770379|16377003|P1|Overall Study|study terminated by sponsor|22
4747651|NCT01770379|16377001|P3|Overall Study|Withdrawal by Subject|7
4747652|NCT01770379|16377002|P2|Overall Study|Withdrawal by Subject|10
4747653|NCT01770379|16377003|P1|Overall Study|Withdrawal by Subject|7
4747654|NCT01770379|16377001|P3|Overall Study|Technical issues|0
4747655|NCT01770379|16377002|P2|Overall Study|Technical issues|0
4747656|NCT01770379|16377003|P1|Overall Study|Technical issues|1
4747657|NCT01770353|16377031|P2|Overall Study|Toxicity related diarrhoea + progression|1
4747658|NCT01770353|16377032|P1|Overall Study|Toxicity related diarrhoea + progression|0
4747659|NCT01770353|16377031|P2|Overall Study|Clinical deterioration|6
4747660|NCT01770353|16377032|P1|Overall Study|Clinical deterioration|3
4747661|NCT01770353|16377031|P2|Overall Study|Physician Decision|3
4747662|NCT01770353|16377032|P1|Overall Study|Physician Decision|0
4747663|NCT01770353|16377031|P2|Overall Study|Protocol Violation|0
4747664|NCT01770353|16377032|P1|Overall Study|Protocol Violation|1
4747665|NCT01770353|16377031|P2|Overall Study|Adverse Event|1
4747666|NCT01770353|16377032|P1|Overall Study|Adverse Event|0
4747667|NCT01770353|16377031|P2|Overall Study|Progressive disease|1
4747668|NCT01770353|16377032|P1|Overall Study|Progressive disease|2
4747669|NCT01770145|16377091|P1|Treatment|Withdrawal by Subject|1
4747670|NCT01770145|16377091|P1|Treatment|Adverse Event|3
4747671|NCT01770145|16377091|P1|Baseline|Unable to define optimal dose|4
4747672|NCT01770145|16377091|P1|Baseline|Lost to Follow-up|1
4747673|NCT01770145|16377091|P1|Baseline|Withdrawal by Subject|1
4747674|NCT01770145|16377091|P1|Baseline|Adverse Event|20
4747675|NCT01769508|16377147|P1|Overall Study|Lost to Follow-up|1
4747676|NCT01769508|16377147|P1|Overall Study|Adverse Event|1
4747677|NCT01769508|16377147|P1|Overall Study|Withdrawal by Subject|1
4747678|NCT01769508|16377147|P1|Overall Study|Death|3
4747679|NCT01769469|16377156|P1|Overall Study|Subject Confirmed HIV Positive|3
4747680|NCT01769469|16377156|P1|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7
4747681|NCT01769469|16377156|P1|Overall Study|Lost to Follow-up|17
4747682|NCT01769469|16377156|P1|Overall Study|Moved Out Of Area|3
4747683|NCT01769469|16377156|P1|Overall Study|Consent Withdrawn|5
4747684|NCT01769456|16377316|P1|Overall Study|Parental request to youth to withdraw|1
4747685|NCT01769456|16377316|P1|Overall Study|No wk 0 visit w/in 30 days of screening|5
4747686|NCT01769456|16377316|P1|Overall Study|Moved out of the area|3
4747687|NCT01769456|16377316|P1|Overall Study|Did not receive PCC intervention|6
4747688|NCT01769456|16377316|P1|Overall Study|Withdrawal by Subject|3
4747689|NCT01769456|16377316|P1|Overall Study|Lost to Follow-up|19
4747690|NCT01769443|16377337|P2|Overall Study|Study closure|0
4747691|NCT01769443|16377338|P1|Overall Study|Study closure|1
4747692|NCT01769404|16377380|P2|Treatment Period 2|Sponsor decision|0
4747693|NCT01769404|16377381|P1|Treatment Period 2|Sponsor decision|7
4747694|NCT01769404|16377380|P2|Treatment Period 1|Sponsor decision|0
4747695|NCT01769404|16377381|P1|Treatment Period 1|Sponsor decision|1
4747696|NCT01769404|16377380|P2|Treatment Period 1|Withdrawal by Subject|0
4747697|NCT01769404|16377381|P1|Treatment Period 1|Withdrawal by Subject|3
4747698|NCT01769404|16377380|P2|Treatment Period 1|Did not meet eligibility criteria|0
4747699|NCT01769404|16377381|P1|Treatment Period 1|Did not meet eligibility criteria|1
4747700|NCT01769391|16377403|P2|Overall Study|Investigator Decision|0
4747701|NCT01769391|16377404|P1|Overall Study|Investigator Decision|2
4747702|NCT01769391|16377403|P2|Overall Study|Withdrawal by Subject|3
4747703|NCT01769391|16377404|P1|Overall Study|Withdrawal by Subject|4
4747704|NCT01769391|16377403|P2|Overall Study|Progressive Disease|2
4747705|NCT01769391|16377404|P1|Overall Study|Progressive Disease|1
4747706|NCT01769391|16377403|P2|Overall Study|Adverse Event|3
4747707|NCT01769391|16377404|P1|Overall Study|Adverse Event|0
4747708|NCT01769391|16377403|P2|Overall Study|Death|1
4747709|NCT01769391|16377404|P1|Overall Study|Death|10
4747710|NCT01769378|16377423|P2|Overall Study|Lost to Follow-up|0
4747711|NCT01769378|16377424|P1|Overall Study|Lost to Follow-up|2
4747712|NCT01769378|16377423|P2|Overall Study|Sponsor Decision|0
4747713|NCT01769378|16377424|P1|Overall Study|Sponsor Decision|1
4747714|NCT01769378|16377423|P2|Overall Study|Withdrawal by Subject|3
4747715|NCT01769378|16377424|P1|Overall Study|Withdrawal by Subject|10
4747716|NCT01769378|16377423|P2|Overall Study|Protocol Violation|1
4747717|NCT01769378|16377424|P1|Overall Study|Protocol Violation|1
4747718|NCT01769378|16377423|P2|Overall Study|Entry criteria not met|0
4747719|NCT01769378|16377424|P1|Overall Study|Entry criteria not met|1
4747720|NCT01769378|16377423|P2|Overall Study|Adverse Event|0
4747721|NCT01769378|16377424|P1|Overall Study|Adverse Event|10
4747722|NCT01769339|16377504|P1|Overall Study|Adverse Event|1
4747723|NCT01769339|16377504|P1|Overall Study|Lost to Follow-up|42
4747724|NCT01769326|16377515|P4|Overall Study|Got sick and could not complete study|0
4747725|NCT01769326|16377516|P3|Overall Study|Got sick and could not complete study|1
4747726|NCT01769326|16377517|P2|Overall Study|Got sick and could not complete study|0
4747727|NCT01769326|16377518|P1|Overall Study|Got sick and could not complete study|0
4747728|NCT01769326|16377515|P4|Overall Study|got a job|0
4747729|NCT01769326|16377516|P3|Overall Study|got a job|0
4747730|NCT01769326|16377517|P2|Overall Study|got a job|1
4747731|NCT01769326|16377518|P1|Overall Study|got a job|0
4747732|NCT01769326|16377515|P4|Overall Study|unrelated injry|0
4747733|NCT01769326|16377516|P3|Overall Study|unrelated injry|0
4747734|NCT01769326|16377517|P2|Overall Study|unrelated injry|1
4747735|NCT01769326|16377518|P1|Overall Study|unrelated injry|1
4747736|NCT01769326|16377515|P4|Overall Study|Lost to Follow-up|0
4747737|NCT01769326|16377516|P3|Overall Study|Lost to Follow-up|0
4747738|NCT01769326|16377517|P2|Overall Study|Lost to Follow-up|2
4747739|NCT01769326|16377518|P1|Overall Study|Lost to Follow-up|1
4747740|NCT01769196|16377663|P2|Overall Study|Withdrew consent|40
4747741|NCT01769196|16377664|P1|Overall Study|Withdrew consent|36
4747742|NCT01769196|16377663|P2|Overall Study|Participant never dosed with study drug|0
4747743|NCT01769196|16377664|P1|Overall Study|Participant never dosed with study drug|1
4747744|NCT01769196|16377663|P2|Overall Study|Study terminated by sponsor|161
4747745|NCT01769196|16377664|P1|Overall Study|Study terminated by sponsor|160
4747746|NCT01769196|16377663|P2|Overall Study|Protocol Violation|3
4747747|NCT01769196|16377664|P1|Overall Study|Protocol Violation|0
4747748|NCT01769196|16377663|P2|Overall Study|Protocol defined criteria for withdrawal|11
4747749|NCT01769196|16377664|P1|Overall Study|Protocol defined criteria for withdrawal|9
4747750|NCT01769196|16377663|P2|Overall Study|Progressive disease|6
4747751|NCT01769196|16377664|P1|Overall Study|Progressive disease|11
4747752|NCT01769196|16377663|P2|Overall Study|Lack of Efficacy|2
4747753|NCT01769196|16377664|P1|Overall Study|Lack of Efficacy|3
4747754|NCT01769196|16377663|P2|Overall Study|Investigator Discretion|3
4747755|NCT01769196|16377664|P1|Overall Study|Investigator Discretion|7
4747756|NCT01769196|16377663|P2|Overall Study|Death|26
4747757|NCT01769196|16377664|P1|Overall Study|Death|21
4747758|NCT01769196|16377663|P2|Overall Study|Adverse Event|20
4747759|NCT01769196|16377664|P1|Overall Study|Adverse Event|24
4747760|NCT01769105|16377694|P2|Cross-over|Lost to Follow-up|0
4747761|NCT01769105|16377695|P1|Cross-over|Lost to Follow-up|5
4747762|NCT01769105|16377694|P2|First Intervention|Protocol Violation|2
4747763|NCT01769105|16377695|P1|First Intervention|Protocol Violation|2
4747764|NCT01768858|16377714|P1|Overall Study|Withdrawal by Subject|1
4747765|NCT01768858|16377714|P1|Overall Study|Exanthema|1
4747766|NCT01768858|16377714|P1|Overall Study|Aggravation of NY Heart Assoc 3 status|1
4747767|NCT01768858|16377714|P1|Overall Study|Participant moved to Germany|1
4747768|NCT01768858|16377714|P1|Overall Study|Serious Adverse Event|1
4747769|NCT01768858|16377714|P1|Overall Study|Lack of Efficacy|8
4747770|NCT01768858|16377714|P1|Overall Study|Lost to Follow-up|9
4747771|NCT01768676|16377765|P2|Overall Study|Withdrawal by Subject|10
4747772|NCT01768676|16377766|P1|Overall Study|Withdrawal by Subject|3
4747773|NCT01768676|16377765|P2|Overall Study|Physician Decision|1
4747774|NCT01768676|16377766|P1|Overall Study|Physician Decision|4
4747775|NCT01768676|16377765|P2|Overall Study|Protocol Violation|1
4747776|NCT01768676|16377766|P1|Overall Study|Protocol Violation|1
4747777|NCT01768676|16377765|P2|Overall Study|Lost to Follow-up|16
4747778|NCT01768676|16377766|P1|Overall Study|Lost to Follow-up|13
4747779|NCT01768676|16377765|P2|Overall Study|Adverse Event|3
4747780|NCT01768676|16377766|P1|Overall Study|Adverse Event|3
4747781|NCT01768637|16377782|P2|Overall Study|Difficult blood draw|0
4747782|NCT01768637|16377783|P1|Overall Study|Difficult blood draw|1
4747783|NCT01768637|16377782|P2|Overall Study|Lost to Follow-up|7
4747784|NCT01768637|16377783|P1|Overall Study|Lost to Follow-up|2
4747785|NCT01768572|16377796|P3|Overall Study|Other, Not due to an adverse event|1
4747786|NCT01768572|16377797|P2|Overall Study|Other, Not due to an adverse event|1
4747787|NCT01768572|16377798|P1|Overall Study|Other, Not due to an adverse event|1
4747788|NCT01768572|16377796|P3|Overall Study|Lack of Efficacy|1
4747789|NCT01768572|16377797|P2|Overall Study|Lack of Efficacy|3
4747790|NCT01768572|16377798|P1|Overall Study|Lack of Efficacy|1
4747791|NCT01768572|16377796|P3|Overall Study|Adverse Event|4
4747792|NCT01768572|16377797|P2|Overall Study|Adverse Event|8
4747793|NCT01768572|16377798|P1|Overall Study|Adverse Event|7
4747794|NCT01768559|16377809|P3|Overall Study|Other than specified|5
4747795|NCT01768559|16377810|P2|Overall Study|Other than specified|8
4747796|NCT01768559|16377811|P1|Overall Study|Other than specified|9
4747797|NCT01768559|16377809|P3|Overall Study|Poor compliance to protocol|2
4747798|NCT01768559|16377810|P2|Overall Study|Poor compliance to protocol|3
4747799|NCT01768559|16377811|P1|Overall Study|Poor compliance to protocol|0
4747800|NCT01768559|16377809|P3|Overall Study|Lack of Efficacy|0
4747801|NCT01768559|16377810|P2|Overall Study|Lack of Efficacy|4
4747802|NCT01768559|16377811|P1|Overall Study|Lack of Efficacy|6
4747803|NCT01768559|16377809|P3|Overall Study|Adverse Event|5
4747804|NCT01768559|16377810|P2|Overall Study|Adverse Event|2
4747805|NCT01768559|16377811|P1|Overall Study|Adverse Event|15
4747806|NCT01768559|16377809|P3|Overall Study|Randomized but not treated|1
4747807|NCT01768559|16377810|P2|Overall Study|Randomized but not treated|0
4747808|NCT01768559|16377811|P1|Overall Study|Randomized but not treated|0
4747809|NCT01768286|16377892|P4|Overall Study|Withdrew Consent|0
4747810|NCT01768286|16377893|P3|Overall Study|Withdrew Consent|1
4747811|NCT01768286|16377894|P2|Overall Study|Withdrew Consent|0
4747812|NCT01768286|16377895|P1|Overall Study|Withdrew Consent|0
4747813|NCT01768286|16377892|P4|Overall Study|Lack of Efficacy|1
4747814|NCT01768286|16377893|P3|Overall Study|Lack of Efficacy|0
4747815|NCT01768286|16377894|P2|Overall Study|Lack of Efficacy|4
4747816|NCT01768286|16377895|P1|Overall Study|Lack of Efficacy|7
4747817|NCT01768286|16377892|P4|Overall Study|Randomized But Not Treated|0
4747818|NCT01768286|16377893|P3|Overall Study|Randomized But Not Treated|1
4747819|NCT01768286|16377894|P2|Overall Study|Randomized But Not Treated|0
4747820|NCT01768286|16377895|P1|Overall Study|Randomized But Not Treated|0
4747821|NCT01768117|16377957|P1|Overall Study|Protocol Violation|3
4747822|NCT01768117|16377957|P1|Overall Study|Withdrawal by Subject|2
4747823|NCT01768117|16377957|P1|Overall Study|Lost to Follow-up|1
4747824|NCT01767987|16378021|P2|Overall Study|Physician Decision|1
4747825|NCT01767987|16378022|P1|Overall Study|Physician Decision|4
4747826|NCT01767909|16378054|P2|Overall Study|LP uncessessful|1
4747827|NCT01767909|16378055|P1|Overall Study|LP uncessessful|0
4747828|NCT01767909|16378054|P2|Overall Study|Lost to Follow-up|1
4747829|NCT01767909|16378055|P1|Overall Study|Lost to Follow-up|0
4747830|NCT01767909|16378054|P2|Overall Study|Investigator Recommendation|1
4747831|NCT01767909|16378055|P1|Overall Study|Investigator Recommendation|0
4747832|NCT01767909|16378054|P2|Overall Study|Perceived Lack of Efficacy|0
4747833|NCT01767909|16378055|P1|Overall Study|Perceived Lack of Efficacy|1
4747834|NCT01767909|16378054|P2|Overall Study|Non-Compliance|0
4747835|NCT01767909|16378055|P1|Overall Study|Non-Compliance|2
4747836|NCT01767909|16378054|P2|Overall Study|Withdrawal by Study Partner|1
4747837|NCT01767909|16378055|P1|Overall Study|Withdrawal by Study Partner|3
4747838|NCT01767909|16378054|P2|Overall Study|Adverse Event|1
4747839|NCT01767909|16378055|P1|Overall Study|Adverse Event|3
4747840|NCT01767909|16378054|P2|Overall Study|Withdrawal by Subject|7
4747841|NCT01767909|16378055|P1|Overall Study|Withdrawal by Subject|4
4747842|NCT01767597|16378125|P2|Overall Study|Withdrawal by Subject|0
4747843|NCT01767597|16378126|P1|Overall Study|Withdrawal by Subject|1
4747844|NCT01767597|16378125|P2|Overall Study|Incomplete intervention|1
4747845|NCT01767597|16378126|P1|Overall Study|Incomplete intervention|3
4747846|NCT01767519|16378135|P3|Overall Study|Adverse Event|1
4747847|NCT01767519|16378136|P2|Overall Study|Adverse Event|5
4747848|NCT01767519|16378137|P1|Overall Study|Adverse Event|5
4747849|NCT01767519|16378135|P3|Overall Study|Lack of Efficacy|0
4747850|NCT01767519|16378136|P2|Overall Study|Lack of Efficacy|0
4747851|NCT01767519|16378137|P1|Overall Study|Lack of Efficacy|1
4747852|NCT01767519|16378135|P3|Overall Study|Lost to Follow-up|2
4747853|NCT01767519|16378136|P2|Overall Study|Lost to Follow-up|1
4747854|NCT01767519|16378137|P1|Overall Study|Lost to Follow-up|3
4747855|NCT01767519|16378135|P3|Overall Study|Personal Reasons|0
4747856|NCT01767519|16378136|P2|Overall Study|Personal Reasons|0
4747857|NCT01767519|16378137|P1|Overall Study|Personal Reasons|1
4747858|NCT01767519|16378135|P3|Overall Study|Protocol Violation|0
4747859|NCT01767519|16378136|P2|Overall Study|Protocol Violation|3
4747860|NCT01767519|16378137|P1|Overall Study|Protocol Violation|0
4747861|NCT01767519|16378135|P3|Overall Study|Other Reasons|2
4747862|NCT01767519|16378136|P2|Overall Study|Other Reasons|4
4747863|NCT01767519|16378137|P1|Overall Study|Other Reasons|4
4747864|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Subject Unavailable|2
4747865|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Subject Unavailable|0
4747866|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Physician Decision|0
4747867|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Physician Decision|1
4747868|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1
4747869|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0
4747870|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Lost to Follow-up|4
4747871|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Lost to Follow-up|6
4747872|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3
4747873|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0
4747874|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Withdrawal by Subject|14
4747875|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Withdrawal by Subject|9
4747876|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Protocol Violation|0
4747877|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Protocol Violation|2
4747878|NCT01767467|16378178|P2|End of Study Phase (up to Month 13)|Adverse Event|39
4747879|NCT01767467|16378179|P1|End of Study Phase (up to Month 13)|Adverse Event|29
4747880|NCT01767467|16378178|P2|Vaccination Phase (up to Month 2)|Subject unavailable|1
4747881|NCT01767467|16378179|P1|Vaccination Phase (up to Month 2)|Subject unavailable|0
4747882|NCT01767467|16378178|P2|Vaccination Phase (up to Month 2)|Physician Decision|0
4747883|NCT01767467|16378179|P1|Vaccination Phase (up to Month 2)|Physician Decision|1
4747884|NCT01767467|16378178|P2|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1
4747885|NCT01767467|16378179|P1|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0
4747886|NCT01767467|16378178|P2|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10
4747887|NCT01767467|16378179|P1|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7
4747888|NCT01767467|16378178|P2|Vaccination Phase (up to Month 2)|Protocol Violation|0
4747889|NCT01767467|16378179|P1|Vaccination Phase (up to Month 2)|Protocol Violation|1
4747890|NCT01767467|16378178|P2|Vaccination Phase (up to Month 2)|Adverse Event|8
4747891|NCT01767467|16378179|P1|Vaccination Phase (up to Month 2)|Adverse Event|8
4747892|NCT01767376|16378235|P3|Overall Study|Withdrawal by Subject|0
4747893|NCT01767376|16378236|P2|Overall Study|Withdrawal by Subject|1
4747894|NCT01767376|16378237|P1|Overall Study|Withdrawal by Subject|1
4747895|NCT01767376|16378235|P3|Overall Study|Lost to Follow-up|0
4747896|NCT01767376|16378236|P2|Overall Study|Lost to Follow-up|2
4747897|NCT01767376|16378237|P1|Overall Study|Lost to Follow-up|3
4747898|NCT01767194|16378303|P2|Overall Study|Criteria not met on time for next cycle|1
4747899|NCT01767194|16378304|P1|Overall Study|Criteria not met on time for next cycle|0
4747900|NCT01767194|16378303|P2|Overall Study|Refusal by patient/parent|4
4747901|NCT01767194|16378304|P1|Overall Study|Refusal by patient/parent|2
4747902|NCT01767194|16378303|P2|Overall Study|Ineligible|1
4747903|NCT01767194|16378304|P1|Overall Study|Ineligible|1
4747904|NCT01767194|16378303|P2|Overall Study|Withdrawal by Subject|1
4747905|NCT01767194|16378304|P1|Overall Study|Withdrawal by Subject|0
4747906|NCT01767194|16378303|P2|Overall Study|Physician Decision|23
4747907|NCT01767194|16378304|P1|Overall Study|Physician Decision|2
4747908|NCT01767194|16378303|P2|Overall Study|Lack of Efficacy|11
4747909|NCT01767194|16378304|P1|Overall Study|Lack of Efficacy|12
4747910|NCT01767194|16378303|P2|Overall Study|Death|1
4747911|NCT01767194|16378304|P1|Overall Study|Death|0
4747912|NCT01767194|16378303|P2|Overall Study|Adverse Event|1
4747913|NCT01767194|16378304|P1|Overall Study|Adverse Event|1
4747914|NCT01767142|16378326|P1|Overall Study|Lost to Follow-up|3
4747915|NCT01767116|16378335|P2|Overall Study|Lost to Follow-up|2
4747916|NCT01767116|16378336|P1|Overall Study|Lost to Follow-up|2
4747917|NCT01766921|16378394|P2|Overall Study|Withdrawal by Subject|5
4747918|NCT01766921|16378395|P1|Overall Study|Withdrawal by Subject|14
4747919|NCT01766921|16378394|P2|Overall Study|Protocol Violation|1
4747920|NCT01766921|16378395|P1|Overall Study|Protocol Violation|1
4747921|NCT01766921|16378394|P2|Overall Study|Unclassified|2
4747922|NCT01766921|16378395|P1|Overall Study|Unclassified|2
4747923|NCT01766921|16378394|P2|Overall Study|Lost to Follow-up|3
4747924|NCT01766921|16378395|P1|Overall Study|Lost to Follow-up|1
4747925|NCT01766921|16378394|P2|Overall Study|Death|1
4747926|NCT01766921|16378395|P1|Overall Study|Death|1
4747927|NCT01766921|16378394|P2|Overall Study|Administrative Reason|5
4747928|NCT01766921|16378395|P1|Overall Study|Administrative Reason|5
4747929|NCT01766817|16378417|P3|Overall Study|Other|0
4747930|NCT01766817|16378418|P2|Overall Study|Other|0
4747931|NCT01766817|16378419|P1|Overall Study|Other|1
4747932|NCT01766817|16378417|P3|Overall Study|Physician Decision|4
4747933|NCT01766817|16378418|P2|Overall Study|Physician Decision|3
4747934|NCT01766817|16378419|P1|Overall Study|Physician Decision|3
4747935|NCT01766817|16378417|P3|Overall Study|Subject non-compliance|2
4747936|NCT01766817|16378418|P2|Overall Study|Subject non-compliance|1
4747937|NCT01766817|16378419|P1|Overall Study|Subject non-compliance|0
4747938|NCT01766817|16378417|P3|Overall Study|Withdrawal by Subject|3
4747939|NCT01766817|16378418|P2|Overall Study|Withdrawal by Subject|0
4747940|NCT01766817|16378419|P1|Overall Study|Withdrawal by Subject|2
4747941|NCT01766817|16378417|P3|Overall Study|Unable to take study drug|0
4747942|NCT01766817|16378418|P2|Overall Study|Unable to take study drug|1
4747943|NCT01766817|16378419|P1|Overall Study|Unable to take study drug|0
4747944|NCT01766817|16378417|P3|Overall Study|Death|0
4747945|NCT01766817|16378418|P2|Overall Study|Death|1
4747946|NCT01766817|16378419|P1|Overall Study|Death|1
4747947|NCT01766817|16378417|P3|Overall Study|Drug-unrelated adverse event|3
4747948|NCT01766817|16378418|P2|Overall Study|Drug-unrelated adverse event|3
4747949|NCT01766817|16378419|P1|Overall Study|Drug-unrelated adverse event|3
4747950|NCT01766817|16378417|P3|Overall Study|Drug-related adverse event|1
4747951|NCT01766817|16378418|P2|Overall Study|Drug-related adverse event|2
4747952|NCT01766817|16378419|P1|Overall Study|Drug-related adverse event|1
4747953|NCT01766778|16378470|P2|Overall Study|Withdrawal by Subject|0
4747954|NCT01766778|16378471|P1|Overall Study|Withdrawal by Subject|1
4747955|NCT01766778|16378470|P2|Overall Study|Adverse Event|4
4747956|NCT01766778|16378471|P1|Overall Study|Adverse Event|4
4747957|NCT01766401|16378525|P2|Overall Study|Pregnancy|1
4747958|NCT01766401|16378526|P1|Overall Study|Pregnancy|1
4747959|NCT01766401|16378525|P2|Overall Study|Lost to Follow-up|11
4747960|NCT01766401|16378526|P1|Overall Study|Lost to Follow-up|10
4747961|NCT01766401|16378525|P2|Overall Study|Withdrawal by Subject|12
4747962|NCT01766401|16378526|P1|Overall Study|Withdrawal by Subject|15
4747963|NCT01766401|16378525|P2|Overall Study|Protocol Violation|8
4747964|NCT01766401|16378526|P1|Overall Study|Protocol Violation|3
4747965|NCT01766401|16378525|P2|Overall Study|Lack of Efficacy|2
4747966|NCT01766401|16378526|P1|Overall Study|Lack of Efficacy|1
4747967|NCT01766401|16378525|P2|Overall Study|Adverse Event|22
4747968|NCT01766401|16378526|P1|Overall Study|Adverse Event|7
4747969|NCT01766336|16378536|P2|Overall Study|Withdrawal by Subject|15
4747970|NCT01766336|16378537|P1|Overall Study|Withdrawal by Subject|18
4747971|NCT01766336|16378536|P2|Overall Study|Sponsor Decision|43
4747972|NCT01766336|16378537|P1|Overall Study|Sponsor Decision|52
4747973|NCT01766336|16378536|P2|Overall Study|Protocol Violation|1
4747974|NCT01766336|16378537|P1|Overall Study|Protocol Violation|0
4747975|NCT01766336|16378536|P2|Overall Study|Physician Decision|2
4747976|NCT01766336|16378537|P1|Overall Study|Physician Decision|4
4747977|NCT01766336|16378536|P2|Overall Study|Lost to Follow-up|3
4747978|NCT01766336|16378537|P1|Overall Study|Lost to Follow-up|1
4747979|NCT01766336|16378536|P2|Overall Study|Death|3
4747980|NCT01766336|16378537|P1|Overall Study|Death|4
4747981|NCT01766336|16378536|P2|Overall Study|Adverse Event|8
4747982|NCT01766336|16378537|P1|Overall Study|Adverse Event|11
4747983|NCT01766310|16378545|P2|Overall Study|Lost to Follow-up|3
4747984|NCT01766310|16378546|P1|Overall Study|Lost to Follow-up|1
4747985|NCT01766206|16378576|P1|Overall Study|Withdrawal and inappropriate enrollment|1
4747986|NCT01766206|16378576|P1|Overall Study|Inappropriate enrollment|18
4747987|NCT01766206|16378576|P1|Overall Study|Lost to Follow-up|10
4747988|NCT01766206|16378576|P1|Overall Study|Withdrawal by Subject|22
4747989|NCT01766050|16378603|P1|Overall Study|Withdrawal by Subject|2
4747990|NCT01766050|16378603|P1|Overall Study|Lost to Follow-up|1
4747991|NCT01766050|16378603|P1|Overall Study|Adverse Event|1
4747992|NCT01766037|16378738|P2|Overall Study|nausea / discomfort|0
4747993|NCT01766037|16378739|P1|Overall Study|nausea / discomfort|3
4747994|NCT01766037|16378738|P2|Overall Study|medical - unrelated|2
4747995|NCT01766037|16378739|P1|Overall Study|medical - unrelated|1
4747996|NCT01766037|16378738|P2|Overall Study|Moved from area|0
4747997|NCT01766037|16378739|P1|Overall Study|Moved from area|5
4747998|NCT01766037|16378738|P2|Overall Study|Withdrawal by Subject|16
4747999|NCT01766037|16378739|P1|Overall Study|Withdrawal by Subject|18
4748000|NCT01766037|16378738|P2|Overall Study|Physician Decision|1
4748001|NCT01766037|16378739|P1|Overall Study|Physician Decision|0
4748002|NCT01766037|16378738|P2|Overall Study|Lost to Follow-up|10
4748003|NCT01766037|16378739|P1|Overall Study|Lost to Follow-up|0
4748004|NCT01766037|16378738|P2|Overall Study|Lack of Efficacy|0
4748005|NCT01766037|16378739|P1|Overall Study|Lack of Efficacy|1
4748006|NCT01766037|16378738|P2|Overall Study|Adverse Event|0
4748007|NCT01766037|16378739|P1|Overall Study|Adverse Event|1
4748008|NCT01765764|16378808|P3|Treatment Period|Other Miscellaneous Reasons|2
4748009|NCT01765764|16378809|P2|Treatment Period|Other Miscellaneous Reasons|2
4748010|NCT01765764|16378810|P1|Treatment Period|Other Miscellaneous Reasons|1
4748011|NCT01765764|16378808|P3|Treatment Period|Personal Reasons|1
4748012|NCT01765764|16378809|P2|Treatment Period|Personal Reasons|2
4748013|NCT01765764|16378810|P1|Treatment Period|Personal Reasons|1
4748014|NCT01765764|16378808|P3|Treatment Period|Lost to Follow-up|2
4748015|NCT01765764|16378809|P2|Treatment Period|Lost to Follow-up|3
4748016|NCT01765764|16378810|P1|Treatment Period|Lost to Follow-up|0
4748017|NCT01765764|16378808|P3|Treatment Period|Adverse Event|1
4748018|NCT01765764|16378809|P2|Treatment Period|Adverse Event|2
4748019|NCT01765764|16378810|P1|Treatment Period|Adverse Event|1
4748020|NCT01765751|16378830|P3|Overall Study|Lost to Follow-up|1
4748021|NCT01765751|16378831|P2|Overall Study|Lost to Follow-up|2
4748022|NCT01765751|16378832|P1|Overall Study|Lost to Follow-up|0
4748023|NCT01765673|16378864|P1|Overall Study|No transportation for 2nd/3rd visits|1
4748024|NCT01765582|16378897|P3|Overall Study|Withdrawal of Consent|10
4748025|NCT01765582|16378898|P2|Overall Study|Withdrawal of Consent|6
4748026|NCT01765582|16378899|P1|Overall Study|Withdrawal of Consent|11
4748027|NCT01765582|16378897|P3|Overall Study|Sponsor Decision|42
4748028|NCT01765582|16378898|P2|Overall Study|Sponsor Decision|42
4748029|NCT01765582|16378899|P1|Overall Study|Sponsor Decision|46
4748030|NCT01765582|16378897|P3|Overall Study|Death|33
4748031|NCT01765582|16378898|P2|Overall Study|Death|36
4748032|NCT01765582|16378899|P1|Overall Study|Death|31
4748033|NCT01765582|16378897|P3|Overall Study|Lost to Follow-up|1
4748034|NCT01765582|16378898|P2|Overall Study|Lost to Follow-up|2
4748035|NCT01765582|16378899|P1|Overall Study|Lost to Follow-up|2
4748036|NCT01765582|16378897|P3|Overall Study|Other|9
4748037|NCT01765582|16378898|P2|Overall Study|Other|6
4748038|NCT01765582|16378899|P1|Overall Study|Other|3
4748039|NCT01765569|16378932|P1|Period C|Death|1
4748040|NCT01765569|16378932|P1|Period B|Withdrawal by Subject|1
4748041|NCT01765543|16378953|P1|Overall Study|Withdrawal by Subject|2
4748042|NCT01765543|16378953|P1|Overall Study|Death|1
4748043|NCT01765426|16379005|P4|Overall Study|Lost to Follow-up|0
4748044|NCT01765426|16379006|P3|Overall Study|Lost to Follow-up|0
4748045|NCT01765426|16379007|P2|Overall Study|Lost to Follow-up|1
4748046|NCT01765426|16379008|P1|Overall Study|Lost to Follow-up|0
4748047|NCT01765270|16379064|P2|Overall Study|Withdrawal by Subject|1
4748048|NCT01765270|16379065|P1|Overall Study|Withdrawal by Subject|0
4748049|NCT01765270|16379064|P2|Overall Study|Physician Decision|0
4748050|NCT01765270|16379065|P1|Overall Study|Physician Decision|1
4748051|NCT01765192|16379087|P2|End of Treatment Period 2 to Final Visit|Adverse Event|1
4748052|NCT01765192|16379088|P1|End of Treatment Period 2 to Final Visit|Adverse Event|0
4748053|NCT01765192|16379087|P2|Treatment Period 2|Reason not specified|2
4748054|NCT01765192|16379088|P1|Treatment Period 2|Reason not specified|0
4748055|NCT01765192|16379087|P2|Washout Period|Reason not specified|0
4748056|NCT01765192|16379088|P1|Washout Period|Reason not specified|1
4748057|NCT01765192|16379087|P2|Washout Period|Voluntary Withdrawal|1
4748058|NCT01765192|16379088|P1|Washout Period|Voluntary Withdrawal|1
4748059|NCT01765192|16379087|P2|Treatment Period 1|Adverse Event|1
4748060|NCT01765192|16379088|P1|Treatment Period 1|Adverse Event|0
4748061|NCT01765179|16379106|P1|Overall Study|Ca elevated 10.6|1
4748062|NCT01765179|16379106|P1|Overall Study|work conflict|1
4748063|NCT01765179|16379106|P1|Overall Study|lack of venous access|1
4748064|NCT01765179|16379106|P1|Overall Study|Out of country unable to finish study|1
4748065|NCT01765179|16379106|P1|Overall Study|prohibited med|1
4748066|NCT01765179|16379106|P1|Overall Study|Hematocrit >54%|3
4748067|NCT01765179|16379106|P1|Overall Study|Withdrawal by Subject|8
4748068|NCT01765179|16379106|P1|Overall Study|Protocol Violation|1
4748069|NCT01765179|16379106|P1|Overall Study|Non-compliance with study drug|2
4748070|NCT01765179|16379106|P1|Overall Study|Lost to Follow-up|5
4748071|NCT01765179|16379106|P1|Overall Study|Adverse Event|3
4748072|NCT01765153|16379113|P2|Rest Phase 2|Lost to Follow-up|1
4748073|NCT01765153|16379114|P1|Rest Phase 2|Lost to Follow-up|2
4748074|NCT01765153|16379113|P2|Training Phase 2|Withdrawal by Subject|1
4748075|NCT01765153|16379114|P1|Training Phase 2|Withdrawal by Subject|0
4748076|NCT01765153|16379113|P2|Rest Phase 1|Withdrawal by Subject|1
4748077|NCT01765153|16379114|P1|Rest Phase 1|Withdrawal by Subject|0
4748078|NCT01765153|16379113|P2|Training Phase 1|Poor participation in intervention|1
4748079|NCT01765153|16379114|P1|Training Phase 1|Poor participation in intervention|0
4748080|NCT01765153|16379113|P2|Training Phase 1|Format of intervention differed|0
4748081|NCT01765153|16379114|P1|Training Phase 1|Format of intervention differed|1
4748082|NCT01764997|16379221|P5|Study Drug Treatment Period|Other than specified above|10
4748083|NCT01764997|16379222|P4|Study Drug Treatment Period|Other than specified above|0
4748084|NCT01764997|16379223|P3|Study Drug Treatment Period|Other than specified above|0
4748085|NCT01764997|16379224|P2|Study Drug Treatment Period|Other than specified above|0
4748086|NCT01764997|16379225|P1|Study Drug Treatment Period|Other than specified above|0
4748087|NCT01764997|16379221|P5|Study Drug Treatment Period|Lack of Efficacy|2
4748088|NCT01764997|16379222|P4|Study Drug Treatment Period|Lack of Efficacy|0
4748089|NCT01764997|16379223|P3|Study Drug Treatment Period|Lack of Efficacy|0
4748090|NCT01764997|16379224|P2|Study Drug Treatment Period|Lack of Efficacy|0
4748091|NCT01764997|16379225|P1|Study Drug Treatment Period|Lack of Efficacy|0
4748092|NCT01764997|16379221|P5|Study Drug Treatment Period|Adverse Event|24
4748093|NCT01764997|16379222|P4|Study Drug Treatment Period|Adverse Event|0
4748094|NCT01764997|16379223|P3|Study Drug Treatment Period|Adverse Event|0
4748095|NCT01764997|16379224|P2|Study Drug Treatment Period|Adverse Event|1
4748096|NCT01764997|16379225|P1|Study Drug Treatment Period|Adverse Event|0
4748097|NCT01764997|16379221|P5|Run-in Period|Other than specified above|0
4748098|NCT01764997|16379222|P4|Run-in Period|Other than specified above|0
4748099|NCT01764997|16379223|P3|Run-in Period|Other than specified above|0
4748100|NCT01764997|16379224|P2|Run-in Period|Other than specified above|0
4748101|NCT01764997|16379225|P1|Run-in Period|Other than specified above|17
4748102|NCT01764997|16379221|P5|Run-in Period|Poor compliance to protocol|0
4748103|NCT01764997|16379222|P4|Run-in Period|Poor compliance to protocol|0
4748104|NCT01764997|16379223|P3|Run-in Period|Poor compliance to protocol|0
4748105|NCT01764997|16379224|P2|Run-in Period|Poor compliance to protocol|0
4748106|NCT01764997|16379225|P1|Run-in Period|Poor compliance to protocol|1
4748107|NCT01764997|16379221|P5|Run-in Period|Lack of Efficacy|0
4748108|NCT01764997|16379222|P4|Run-in Period|Lack of Efficacy|0
4748109|NCT01764997|16379223|P3|Run-in Period|Lack of Efficacy|0
4748110|NCT01764997|16379224|P2|Run-in Period|Lack of Efficacy|0
4748111|NCT01764997|16379225|P1|Run-in Period|Lack of Efficacy|5
4748112|NCT01764997|16379221|P5|Run-in Period|Adverse Event|0
4748113|NCT01764997|16379222|P4|Run-in Period|Adverse Event|0
4748114|NCT01764997|16379223|P3|Run-in Period|Adverse Event|0
4748115|NCT01764997|16379224|P2|Run-in Period|Adverse Event|0
4748116|NCT01764997|16379225|P1|Run-in Period|Adverse Event|15
4748117|NCT01764945|16379252|P8|Overall Study|Adverse Event|0
4748118|NCT01764945|16379253|P7|Overall Study|Adverse Event|1
4748119|NCT01764945|16379254|P6|Overall Study|Adverse Event|0
4748120|NCT01764945|16379255|P5|Overall Study|Adverse Event|0
4748121|NCT01764945|16379256|P4|Overall Study|Adverse Event|0
4748122|NCT01764945|16379257|P3|Overall Study|Adverse Event|0
4748123|NCT01764945|16379258|P2|Overall Study|Adverse Event|1
4748124|NCT01764945|16379259|P1|Overall Study|Adverse Event|0
4748125|NCT01764854|16379305|P4|Overall Study|Protocol Violation|2
4748126|NCT01764854|16379306|P3|Overall Study|Protocol Violation|1
4748127|NCT01764854|16379307|P2|Overall Study|Protocol Violation|0
4748128|NCT01764854|16379308|P1|Overall Study|Protocol Violation|0
4748129|NCT01764854|16379305|P4|Overall Study|relocation|0
4748130|NCT01764854|16379306|P3|Overall Study|relocation|2
4748131|NCT01764854|16379307|P2|Overall Study|relocation|0
4748132|NCT01764854|16379308|P1|Overall Study|relocation|0
4748133|NCT01764854|16379305|P4|Overall Study|Withdrawal by Subject|0
4748134|NCT01764854|16379306|P3|Overall Study|Withdrawal by Subject|1
4748135|NCT01764854|16379307|P2|Overall Study|Withdrawal by Subject|0
4748136|NCT01764854|16379308|P1|Overall Study|Withdrawal by Subject|0
4748137|NCT01764854|16379305|P4|Overall Study|Adverse Event|0
4748138|NCT01764854|16379306|P3|Overall Study|Adverse Event|2
4748139|NCT01764854|16379307|P2|Overall Study|Adverse Event|0
4748140|NCT01764854|16379308|P1|Overall Study|Adverse Event|0
4748141|NCT01764841|16379322|P4|Overall Study|Lost to Follow-up|0
4748142|NCT01764841|16379323|P3|Overall Study|Lost to Follow-up|1
4748143|NCT01764841|16379324|P2|Overall Study|Lost to Follow-up|0
4748144|NCT01764841|16379325|P1|Overall Study|Lost to Follow-up|3
4748145|NCT01764841|16379322|P4|Overall Study|Withdrawal by Subject|15
4748146|NCT01764841|16379323|P3|Overall Study|Withdrawal by Subject|11
4748147|NCT01764841|16379324|P2|Overall Study|Withdrawal by Subject|24
4748148|NCT01764841|16379325|P1|Overall Study|Withdrawal by Subject|16
4748149|NCT01764841|16379322|P4|Overall Study|Protocol Violation|0
4748150|NCT01764841|16379323|P3|Overall Study|Protocol Violation|0
4748151|NCT01764841|16379324|P2|Overall Study|Protocol Violation|1
4748152|NCT01764841|16379325|P1|Overall Study|Protocol Violation|0
4748153|NCT01764841|16379322|P4|Overall Study|No Follow Up|0
4748154|NCT01764841|16379323|P3|Overall Study|No Follow Up|1
4748155|NCT01764841|16379324|P2|Overall Study|No Follow Up|0
4748156|NCT01764841|16379325|P1|Overall Study|No Follow Up|1
4748157|NCT01764841|16379322|P4|Overall Study|Death|4
4748158|NCT01764841|16379323|P3|Overall Study|Death|1
4748159|NCT01764841|16379324|P2|Overall Study|Death|0
4748160|NCT01764841|16379325|P1|Overall Study|Death|3
4748161|NCT01764841|16379322|P4|Overall Study|Logistical Difficulties|0
4748162|NCT01764841|16379323|P3|Overall Study|Logistical Difficulties|0
4748163|NCT01764841|16379324|P2|Overall Study|Logistical Difficulties|1
4748164|NCT01764841|16379325|P1|Overall Study|Logistical Difficulties|0
4748165|NCT01764659|16379366|P1|Overall Study|Physician Decision|1
4748166|NCT01764659|16379366|P1|Overall Study|Death|1
4748167|NCT01764633|16379380|P2|Overall Study|Lost to Follow-up|5
4748168|NCT01764633|16379381|P1|Overall Study|Lost to Follow-up|13
4748169|NCT01764633|16379380|P2|Overall Study|Withdrawal by Subject|88
4748170|NCT01764633|16379381|P1|Overall Study|Withdrawal by Subject|105
4748171|NCT01764464|16379410|P2|Second Intervention (Cross-over)|Adverse Event|0
4748172|NCT01764464|16379411|P1|Second Intervention (Cross-over)|Adverse Event|2
4748173|NCT01764464|16379410|P2|First Intervention|did not receive study drug|1
4748174|NCT01764464|16379411|P1|First Intervention|did not receive study drug|0
4748175|NCT01764464|16379410|P2|First Intervention|Adverse Event|2
4748176|NCT01764464|16379411|P1|First Intervention|Adverse Event|0
4748177|NCT01764464|16379410|P2|First Intervention|Lost to Follow-up|0
4748178|NCT01764464|16379411|P1|First Intervention|Lost to Follow-up|1
4748179|NCT01764464|16379410|P2|First Intervention|Withdrawal by Subject|0
4748180|NCT01764464|16379411|P1|First Intervention|Withdrawal by Subject|1
4748181|NCT01764386|16379429|P2|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
4748182|NCT01764386|16379430|P1|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5
4748183|NCT01764386|16379429|P2|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
4748184|NCT01764386|16379430|P1|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9
4748185|NCT01764386|16379429|P2|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26
4748186|NCT01764386|16379430|P1|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0
4748187|NCT01764386|16379429|P2|Uncontrolled Treatment Period (UTP)|Adverse Event|13
4748188|NCT01764386|16379430|P1|Uncontrolled Treatment Period (UTP)|Adverse Event|2
4748189|NCT01764386|16379429|P2|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2
4748190|NCT01764386|16379430|P1|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6
4748191|NCT01764386|16379429|P2|Controlled Treatment Period (CTP)|Lost to Follow-up|5
4748192|NCT01764386|16379430|P1|Controlled Treatment Period (CTP)|Lost to Follow-up|9
4748193|NCT01764386|16379429|P2|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0
4748194|NCT01764386|16379430|P1|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32
4748195|NCT01764386|16379429|P2|Controlled Treatment Period (CTP)|Adverse Event|0
4748196|NCT01764386|16379430|P1|Controlled Treatment Period (CTP)|Adverse Event|35
4748197|NCT01764256|16379475|P4|Completed Study|Lost to Follow-up|1
4748198|NCT01764256|16379476|P3|Completed Study|Lost to Follow-up|0
4748199|NCT01764256|16379477|P2|Completed Study|Lost to Follow-up|0
4748200|NCT01764256|16379478|P1|Completed Study|Lost to Follow-up|0
4748201|NCT01764256|16379475|P4|Received All Vaccinations|Lost to Follow-up|0
4748202|NCT01764256|16379476|P3|Received All Vaccinations|Lost to Follow-up|0
4748203|NCT01764256|16379477|P2|Received All Vaccinations|Lost to Follow-up|0
4748204|NCT01764256|16379478|P1|Received All Vaccinations|Lost to Follow-up|1
4748205|NCT01764256|16379475|P4|Received All Vaccinations|Did not meet inclusion criteria|0
4748206|NCT01764256|16379476|P3|Received All Vaccinations|Did not meet inclusion criteria|1
4748207|NCT01764256|16379477|P2|Received All Vaccinations|Did not meet inclusion criteria|0
4748208|NCT01764256|16379478|P1|Received All Vaccinations|Did not meet inclusion criteria|0
4748209|NCT01764256|16379475|P4|Received All Vaccinations|Adverse Event|0
4748210|NCT01764256|16379476|P3|Received All Vaccinations|Adverse Event|0
4748211|NCT01764256|16379477|P2|Received All Vaccinations|Adverse Event|1
4748212|NCT01764256|16379478|P1|Received All Vaccinations|Adverse Event|1
4748213|NCT01764022|16379521|P2|Overall Study|Protocol Violation|0
4748214|NCT01764022|16379522|P1|Overall Study|Protocol Violation|1
4748215|NCT01764022|16379521|P2|Overall Study|Lost to Follow-up|0
4748216|NCT01764022|16379522|P1|Overall Study|Lost to Follow-up|2
4748217|NCT01764022|16379521|P2|Overall Study|Physician Decision|2
4748218|NCT01764022|16379522|P1|Overall Study|Physician Decision|0
4748219|NCT01764022|16379521|P2|Overall Study|Lack of Efficacy|1
4748220|NCT01764022|16379522|P1|Overall Study|Lack of Efficacy|0
4748221|NCT01764022|16379521|P2|Overall Study|Withdrawal by Subject|6
4748222|NCT01764022|16379522|P1|Overall Study|Withdrawal by Subject|2
4748223|NCT01764022|16379521|P2|Overall Study|Death|5
4748224|NCT01764022|16379522|P1|Overall Study|Death|3
4748225|NCT01763996|16379554|P2|Treatment Period 2|Adverse Event|1
4748226|NCT01763996|16379555|P1|Treatment Period 2|Adverse Event|0
4748227|NCT01763918|16379609|P4|Overall Study|Sponsor Decision|0
4748228|NCT01763918|16379610|P3|Overall Study|Sponsor Decision|9
4748229|NCT01763918|16379611|P2|Overall Study|Sponsor Decision|0
4748230|NCT01763918|16379612|P1|Overall Study|Sponsor Decision|4
4748231|NCT01763918|16379609|P4|Overall Study|Withdrawal by Subject|2
4748232|NCT01763918|16379610|P3|Overall Study|Withdrawal by Subject|1
4748233|NCT01763918|16379611|P2|Overall Study|Withdrawal by Subject|1
4748234|NCT01763918|16379612|P1|Overall Study|Withdrawal by Subject|2
4748235|NCT01763905|16379710|P4|Overall Study|Lost to Follow-up|0
4748236|NCT01763905|16379711|P3|Overall Study|Lost to Follow-up|1
4748237|NCT01763905|16379712|P2|Overall Study|Lost to Follow-up|0
4748238|NCT01763905|16379713|P1|Overall Study|Lost to Follow-up|0
4748239|NCT01763905|16379710|P4|Overall Study|Decision by sponsor|0
4748240|NCT01763905|16379711|P3|Overall Study|Decision by sponsor|8
4748241|NCT01763905|16379712|P2|Overall Study|Decision by sponsor|0
4748242|NCT01763905|16379713|P1|Overall Study|Decision by sponsor|5
4748243|NCT01763905|16379710|P4|Overall Study|Withdrawal by Subject|1
4748244|NCT01763905|16379711|P3|Overall Study|Withdrawal by Subject|0
4748245|NCT01763905|16379712|P2|Overall Study|Withdrawal by Subject|1
4748246|NCT01763905|16379713|P1|Overall Study|Withdrawal by Subject|1
4748247|NCT01763866|16379831|P24|Overall Study|Death|0
4748248|NCT01763866|16379832|P23|Overall Study|Death|0
4748249|NCT01763866|16379833|P22|Overall Study|Death|0
4748250|NCT01763866|16379834|P21|Overall Study|Death|0
4748251|NCT01763866|16379835|P20|Overall Study|Death|0
4748252|NCT01763866|16379836|P19|Overall Study|Death|0
4748253|NCT01763866|16379837|P18|Overall Study|Death|0
4748254|NCT01763866|16379838|P17|Overall Study|Death|1
4748255|NCT01763866|16379839|P16|Overall Study|Death|0
4748256|NCT01763866|16379840|P15|Overall Study|Death|0
4748257|NCT01763866|16379841|P14|Overall Study|Death|0
4748258|NCT01763866|16379842|P13|Overall Study|Death|0
4748259|NCT01763866|16379843|P12|Overall Study|Death|0
4748260|NCT01763866|16379844|P11|Overall Study|Death|0
4748261|NCT01763866|16379845|P10|Overall Study|Death|0
4748262|NCT01763866|16379846|P9|Overall Study|Death|0
4748263|NCT01763866|16379847|P8|Overall Study|Death|0
4748264|NCT01763866|16379848|P7|Overall Study|Death|0
4748265|NCT01763866|16379849|P6|Overall Study|Death|0
4748266|NCT01763866|16379850|P5|Overall Study|Death|0
4748267|NCT01763866|16379851|P4|Overall Study|Death|0
4748268|NCT01763866|16379852|P3|Overall Study|Death|0
4748269|NCT01763866|16379853|P2|Overall Study|Death|0
4748270|NCT01763866|16379854|P1|Overall Study|Death|0
4748271|NCT01763866|16379831|P24|Overall Study|Lost to Follow-up|1
4748272|NCT01763866|16379832|P23|Overall Study|Lost to Follow-up|0
4748273|NCT01763866|16379833|P22|Overall Study|Lost to Follow-up|0
4748274|NCT01763866|16379834|P21|Overall Study|Lost to Follow-up|0
4748275|NCT01763866|16379835|P20|Overall Study|Lost to Follow-up|1
4748276|NCT01763866|16379836|P19|Overall Study|Lost to Follow-up|1
4748277|NCT01763866|16379837|P18|Overall Study|Lost to Follow-up|0
4748278|NCT01763866|16379838|P17|Overall Study|Lost to Follow-up|0
4748279|NCT01763866|16379839|P16|Overall Study|Lost to Follow-up|0
4748280|NCT01763866|16379840|P15|Overall Study|Lost to Follow-up|1
4748281|NCT01763866|16379841|P14|Overall Study|Lost to Follow-up|0
4748282|NCT01763866|16379842|P13|Overall Study|Lost to Follow-up|1
4748283|NCT01763866|16379843|P12|Overall Study|Lost to Follow-up|0
4748284|NCT01763866|16379844|P11|Overall Study|Lost to Follow-up|0
4748285|NCT01763866|16379845|P10|Overall Study|Lost to Follow-up|0
4748286|NCT01763866|16379846|P9|Overall Study|Lost to Follow-up|0
4748287|NCT01763866|16379847|P8|Overall Study|Lost to Follow-up|0
4748288|NCT01763866|16379848|P7|Overall Study|Lost to Follow-up|1
4748289|NCT01763866|16379849|P6|Overall Study|Lost to Follow-up|0
4748290|NCT01763866|16379850|P5|Overall Study|Lost to Follow-up|0
4748291|NCT01763866|16379851|P4|Overall Study|Lost to Follow-up|0
4748292|NCT01763866|16379852|P3|Overall Study|Lost to Follow-up|0
4748293|NCT01763866|16379853|P2|Overall Study|Lost to Follow-up|0
4748294|NCT01763866|16379854|P1|Overall Study|Lost to Follow-up|0
4748295|NCT01763866|16379831|P24|Overall Study|Decision by sponsor|0
4748296|NCT01763866|16379832|P23|Overall Study|Decision by sponsor|1
4748297|NCT01763866|16379833|P22|Overall Study|Decision by sponsor|0
4748298|NCT01763866|16379834|P21|Overall Study|Decision by sponsor|2
4748299|NCT01763866|16379835|P20|Overall Study|Decision by sponsor|0
4748300|NCT01763866|16379836|P19|Overall Study|Decision by sponsor|4
4748301|NCT01763866|16379837|P18|Overall Study|Decision by sponsor|0
4748302|NCT01763866|16379838|P17|Overall Study|Decision by sponsor|0
4748303|NCT01763866|16379839|P16|Overall Study|Decision by sponsor|0
4748304|NCT01763866|16379840|P15|Overall Study|Decision by sponsor|5
4748305|NCT01763866|16379841|P14|Overall Study|Decision by sponsor|0
4748306|NCT01763866|16379842|P13|Overall Study|Decision by sponsor|1
4748307|NCT01763866|16379843|P12|Overall Study|Decision by sponsor|0
4748308|NCT01763866|16379844|P11|Overall Study|Decision by sponsor|6
4748309|NCT01763866|16379845|P10|Overall Study|Decision by sponsor|0
4748310|NCT01763866|16379846|P9|Overall Study|Decision by sponsor|2
4748311|NCT01763866|16379847|P8|Overall Study|Decision by sponsor|0
4748312|NCT01763866|16379848|P7|Overall Study|Decision by sponsor|2
4748313|NCT01763866|16379849|P6|Overall Study|Decision by sponsor|0
4748314|NCT01763866|16379850|P5|Overall Study|Decision by sponsor|2
4748315|NCT01763866|16379851|P4|Overall Study|Decision by sponsor|0
4748316|NCT01763866|16379852|P3|Overall Study|Decision by sponsor|1
4748317|NCT01763866|16379853|P2|Overall Study|Decision by sponsor|0
4748318|NCT01763866|16379854|P1|Overall Study|Decision by sponsor|0
4748319|NCT01763866|16379831|P24|Overall Study|Withdrawal by Subject|1
4748320|NCT01763866|16379832|P23|Overall Study|Withdrawal by Subject|2
4748321|NCT01763866|16379833|P22|Overall Study|Withdrawal by Subject|1
4748322|NCT01763866|16379834|P21|Overall Study|Withdrawal by Subject|2
4748323|NCT01763866|16379835|P20|Overall Study|Withdrawal by Subject|1
4748324|NCT01763866|16379836|P19|Overall Study|Withdrawal by Subject|1
4748325|NCT01763866|16379837|P18|Overall Study|Withdrawal by Subject|1
4748326|NCT01763866|16379838|P17|Overall Study|Withdrawal by Subject|0
4748327|NCT01763866|16379839|P16|Overall Study|Withdrawal by Subject|3
4748328|NCT01763866|16379840|P15|Overall Study|Withdrawal by Subject|6
4748329|NCT01763866|16379841|P14|Overall Study|Withdrawal by Subject|0
4748330|NCT01763866|16379842|P13|Overall Study|Withdrawal by Subject|2
4748331|NCT01763866|16379843|P12|Overall Study|Withdrawal by Subject|2
4748332|NCT01763866|16379844|P11|Overall Study|Withdrawal by Subject|2
4748333|NCT01763866|16379845|P10|Overall Study|Withdrawal by Subject|1
4748334|NCT01763866|16379846|P9|Overall Study|Withdrawal by Subject|1
4748335|NCT01763866|16379847|P8|Overall Study|Withdrawal by Subject|0
4748336|NCT01763866|16379848|P7|Overall Study|Withdrawal by Subject|4
4748337|NCT01763866|16379849|P6|Overall Study|Withdrawal by Subject|3
4748338|NCT01763866|16379850|P5|Overall Study|Withdrawal by Subject|0
4748339|NCT01763866|16379851|P4|Overall Study|Withdrawal by Subject|0
4748340|NCT01763866|16379852|P3|Overall Study|Withdrawal by Subject|4
4748341|NCT01763866|16379853|P2|Overall Study|Withdrawal by Subject|1
4748342|NCT01763866|16379854|P1|Overall Study|Withdrawal by Subject|2
4748343|NCT01763827|16380414|P6|Overall Study|Lost to Follow-up|1
4748344|NCT01763827|16380415|P5|Overall Study|Lost to Follow-up|2
4748345|NCT01763827|16380416|P4|Overall Study|Lost to Follow-up|1
4748346|NCT01763827|16380417|P3|Overall Study|Lost to Follow-up|1
4748347|NCT01763827|16380418|P2|Overall Study|Lost to Follow-up|1
4748348|NCT01763827|16380419|P1|Overall Study|Lost to Follow-up|0
4748349|NCT01763827|16380414|P6|Overall Study|Decision by sponsor|1
4748350|NCT01763827|16380415|P5|Overall Study|Decision by sponsor|2
4748351|NCT01763827|16380416|P4|Overall Study|Decision by sponsor|0
4748352|NCT01763827|16380417|P3|Overall Study|Decision by sponsor|3
4748353|NCT01763827|16380418|P2|Overall Study|Decision by sponsor|0
4748354|NCT01763827|16380419|P1|Overall Study|Decision by sponsor|2
4748355|NCT01763827|16380414|P6|Overall Study|Withdrawal by Subject|0
4748356|NCT01763827|16380415|P5|Overall Study|Withdrawal by Subject|2
4748357|NCT01763827|16380416|P4|Overall Study|Withdrawal by Subject|0
4748358|NCT01763827|16380417|P3|Overall Study|Withdrawal by Subject|0
4748359|NCT01763827|16380418|P2|Overall Study|Withdrawal by Subject|0
4748360|NCT01763827|16380419|P1|Overall Study|Withdrawal by Subject|1
4748361|NCT01763788|16380563|P4|Overall Study|Lost to Follow-up|0
4748362|NCT01763788|16380564|P3|Overall Study|Lost to Follow-up|1
4748363|NCT01763788|16380565|P2|Overall Study|Lost to Follow-up|0
4748364|NCT01763788|16380566|P1|Overall Study|Lost to Follow-up|0
4748365|NCT01763203|16380787|P2|Overall Study|Physician Decision|1
4748366|NCT01763203|16380788|P1|Overall Study|Physician Decision|2
4748367|NCT01763203|16380787|P2|Overall Study|Moved out of study region|10
4748368|NCT01763203|16380788|P1|Overall Study|Moved out of study region|7
4748369|NCT01763203|16380787|P2|Overall Study|Withdrawal by Subject|12
4748370|NCT01763203|16380788|P1|Overall Study|Withdrawal by Subject|8
4748371|NCT01763203|16380787|P2|Overall Study|Lost to Follow-up|12
4748372|NCT01763203|16380788|P1|Overall Study|Lost to Follow-up|12
4748373|NCT01763203|16380787|P2|Overall Study|Death|7
4748374|NCT01763203|16380788|P1|Overall Study|Death|4
4748375|NCT01763047|16380834|P2|Period 2|Unsatisfactory lens Fitting|1
4748376|NCT01763047|16380835|P1|Period 2|Unsatisfactory lens Fitting|0
4748377|NCT01763047|16380834|P2|Period 2|Protocol Violation|2
4748378|NCT01763047|16380835|P1|Period 2|Protocol Violation|0
4748379|NCT01763047|16380834|P2|Period 2|Unsatisfactory Visual Response|1
4748380|NCT01763047|16380835|P1|Period 2|Unsatisfactory Visual Response|1
4748381|NCT01763047|16380834|P2|Period 2|Study Site office Closed|1
4748382|NCT01763047|16380835|P1|Period 2|Study Site office Closed|1
4748383|NCT01763047|16380834|P2|Period 2|No longer meets Eligibility Criteria|0
4748384|NCT01763047|16380835|P1|Period 2|No longer meets Eligibility Criteria|1
4748385|NCT01763047|16380834|P2|Period 2|Lens Discomfort|0
4748386|NCT01763047|16380835|P1|Period 2|Lens Discomfort|1
4748387|NCT01763047|16380834|P2|Period 1|Study Site office Closed|1
4748388|NCT01763047|16380835|P1|Period 1|Study Site office Closed|0
4748389|NCT01763047|16380834|P2|Period 1|Lens Power Not Available|1
4748390|NCT01763047|16380835|P1|Period 1|Lens Power Not Available|0
4748391|NCT01763047|16380834|P2|Period 1|Unsatisfactory Visual Response|3
4748392|NCT01763047|16380835|P1|Period 1|Unsatisfactory Visual Response|0
4748393|NCT01763047|16380834|P2|Period 1|Adverse Event|1
4748394|NCT01763047|16380835|P1|Period 1|Adverse Event|0
4748395|NCT01763047|16380834|P2|Period 1|No Longer Meets Eligibility criteria|0
4748396|NCT01763047|16380835|P1|Period 1|No Longer Meets Eligibility criteria|1
4748397|NCT01763047|16380834|P2|Period 1|Protocol Violation|4
4748398|NCT01763047|16380835|P1|Period 1|Protocol Violation|4
4748399|NCT01763047|16380834|P2|Period 1|Test Article Not Available|1
4748400|NCT01763047|16380835|P1|Period 1|Test Article Not Available|4
4748401|NCT01762943|16380874|P2|Overall Study|Withdrawal by Subject|1
4748402|NCT01762943|16380875|P1|Overall Study|Withdrawal by Subject|2
4748403|NCT01762943|16380874|P2|Overall Study|Protocol Violation|0
4748404|NCT01762943|16380875|P1|Overall Study|Protocol Violation|1
4748405|NCT01762943|16380874|P2|Overall Study|Physician Decision|1
4748406|NCT01762943|16380875|P1|Overall Study|Physician Decision|1
4748407|NCT01762800|16380892|P2|Overall Study|Withdrawal by Subject|4
4748408|NCT01762800|16380893|P1|Overall Study|Withdrawal by Subject|7
4748409|NCT01762800|16380892|P2|Overall Study|Physician Decision|1
4748410|NCT01762800|16380893|P1|Overall Study|Physician Decision|1
4748411|NCT01762800|16380892|P2|Overall Study|Study Closed/Terminated|1
4748412|NCT01762800|16380893|P1|Overall Study|Study Closed/Terminated|0
4748413|NCT01762800|16380892|P2|Overall Study|Lack of Efficacy|2
4748414|NCT01762800|16380893|P1|Overall Study|Lack of Efficacy|3
4748415|NCT01762800|16380892|P2|Overall Study|Adverse Event|13
4748416|NCT01762800|16380893|P1|Overall Study|Adverse Event|8
4748417|NCT01762761|16380967|P2|Overall Study|Withdrawal by Subject|8
4748418|NCT01762761|16380968|P1|Overall Study|Withdrawal by Subject|7
4748419|NCT01762761|16380967|P2|Overall Study|Physician Decision|6
4748420|NCT01762761|16380968|P1|Overall Study|Physician Decision|4
4748421|NCT01762761|16380967|P2|Overall Study|Lost to Follow-up|6
4748422|NCT01762761|16380968|P1|Overall Study|Lost to Follow-up|3
4748423|NCT01762761|16380967|P2|Overall Study|Study closed/terminated|2
4748424|NCT01762761|16380968|P1|Overall Study|Study closed/terminated|0
4748425|NCT01762761|16380967|P2|Overall Study|Protocol Violation|1
4748426|NCT01762761|16380968|P1|Overall Study|Protocol Violation|1
4748427|NCT01762761|16380967|P2|Overall Study|Lack of Efficacy|25
4748428|NCT01762761|16380968|P1|Overall Study|Lack of Efficacy|9
4748429|NCT01762761|16380967|P2|Overall Study|Adverse Event|17
4748430|NCT01762761|16380968|P1|Overall Study|Adverse Event|15
4748431|NCT01762345|16381067|P1|Overall Study|Protocol Violation|2
4748432|NCT01762345|16381067|P1|Overall Study|Adverse Event|5
4748433|NCT01761565|16381128|P1|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1
4748434|NCT01761292|16381140|P1|Extension 1|Withdrawal by Subject|1
4748435|NCT01761292|16381140|P1|Part 1|not receiving treatment in Part 1|1
4748436|NCT01761292|16381140|P1|Part 1|Adverse Event|1
4748437|NCT01761266|16381174|P2|Overall Study|Ongoing as of data-cut off|107
4748438|NCT01761266|16381175|P1|Overall Study|Ongoing as of data-cut off|109
4748439|NCT01761266|16381174|P2|Overall Study|Withdrawal by Subject|8
4748440|NCT01761266|16381175|P1|Overall Study|Withdrawal by Subject|13
4748441|NCT01761266|16381174|P2|Overall Study|Lost to Follow-up|11
4748442|NCT01761266|16381175|P1|Overall Study|Lost to Follow-up|5
4748443|NCT01761266|16381174|P2|Overall Study|Death|350
4748444|NCT01761266|16381175|P1|Overall Study|Death|351
4748445|NCT01761162|16381232|P1|Overall Study|Withdrawal by Subject|3
4748446|NCT01760954|16381321|P4|Post-treatment Follow-up (12 Months)|Other|6
4748447|NCT01760954|16381322|P3|Post-treatment Follow-up (12 Months)|Other|9
4748448|NCT01760954|16381323|P2|Post-treatment Follow-up (12 Months)|Other|8
4748449|NCT01760954|16381324|P1|Post-treatment Follow-up (12 Months)|Other|13
4748450|NCT01760954|16381321|P4|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
4748451|NCT01760954|16381322|P3|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1
4748452|NCT01760954|16381323|P2|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
4748453|NCT01760954|16381324|P1|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0
4748454|NCT01760954|16381321|P4|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
4748455|NCT01760954|16381322|P3|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0
4748456|NCT01760954|16381323|P2|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4
4748457|NCT01760954|16381324|P1|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1
4748458|NCT01760954|16381321|P4|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
4748459|NCT01760954|16381322|P3|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5
4748460|NCT01760954|16381323|P2|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10
4748461|NCT01760954|16381324|P1|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6
4748462|NCT01760954|16381321|P4|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0
4748463|NCT01760954|16381322|P3|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2
4748464|NCT01760954|16381323|P2|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7
4748465|NCT01760954|16381324|P1|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4
4748466|NCT01760954|16381321|P4|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9
4748467|NCT01760954|16381322|P3|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4
4748468|NCT01760954|16381323|P2|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
4748469|NCT01760954|16381324|P1|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6
4748470|NCT01760954|16381321|P4|Treatment Period (6 Months)|Exclusionary Medication|0
4748471|NCT01760954|16381322|P3|Treatment Period (6 Months)|Exclusionary Medication|0
4748472|NCT01760954|16381323|P2|Treatment Period (6 Months)|Exclusionary Medication|0
4748473|NCT01760954|16381324|P1|Treatment Period (6 Months)|Exclusionary Medication|1
4748474|NCT01760954|16381321|P4|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
4748475|NCT01760954|16381322|P3|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0
4748476|NCT01760954|16381323|P2|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6
4748477|NCT01760954|16381324|P1|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1
4748478|NCT01760954|16381321|P4|Treatment Period (6 Months)|Other|1
4748479|NCT01760954|16381322|P3|Treatment Period (6 Months)|Other|3
4748480|NCT01760954|16381323|P2|Treatment Period (6 Months)|Other|3
4748481|NCT01760954|16381324|P1|Treatment Period (6 Months)|Other|0
4748482|NCT01760954|16381321|P4|Treatment Period (6 Months)|Non-compliance|3
4748483|NCT01760954|16381322|P3|Treatment Period (6 Months)|Non-compliance|0
4748484|NCT01760954|16381323|P2|Treatment Period (6 Months)|Non-compliance|4
4748485|NCT01760954|16381324|P1|Treatment Period (6 Months)|Non-compliance|1
4748486|NCT01760954|16381321|P4|Treatment Period (6 Months)|Pregnancy|2
4748487|NCT01760954|16381322|P3|Treatment Period (6 Months)|Pregnancy|3
4748488|NCT01760954|16381323|P2|Treatment Period (6 Months)|Pregnancy|0
4748489|NCT01760954|16381324|P1|Treatment Period (6 Months)|Pregnancy|5
4748490|NCT01760954|16381321|P4|Treatment Period (6 Months)|Surgery or invasive intervention for end|2
4748491|NCT01760954|16381322|P3|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
4748492|NCT01760954|16381323|P2|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
4748493|NCT01760954|16381324|P1|Treatment Period (6 Months)|Surgery or invasive intervention for end|3
4748494|NCT01760954|16381321|P4|Treatment Period (6 Months)|Lost to Follow-up|3
4748495|NCT01760954|16381322|P3|Treatment Period (6 Months)|Lost to Follow-up|4
4748496|NCT01760954|16381323|P2|Treatment Period (6 Months)|Lost to Follow-up|1
4748497|NCT01760954|16381324|P1|Treatment Period (6 Months)|Lost to Follow-up|9
4748498|NCT01760954|16381321|P4|Treatment Period (6 Months)|Adverse Event|10
4748499|NCT01760954|16381322|P3|Treatment Period (6 Months)|Adverse Event|4
4748500|NCT01760954|16381323|P2|Treatment Period (6 Months)|Adverse Event|3
4748501|NCT01760954|16381324|P1|Treatment Period (6 Months)|Adverse Event|5
4748502|NCT01760954|16381321|P4|Treatment Period (6 Months)|Withdrawal by Subject|5
4748503|NCT01760954|16381322|P3|Treatment Period (6 Months)|Withdrawal by Subject|4
4748504|NCT01760954|16381323|P2|Treatment Period (6 Months)|Withdrawal by Subject|8
4748505|NCT01760954|16381324|P1|Treatment Period (6 Months)|Withdrawal by Subject|8
4748506|NCT01760876|16381461|P1|Overall Study|Very poor baseline OCT quality|2
4748507|NCT01760876|16381461|P1|Overall Study|Major depression|1
4748508|NCT01760876|16381461|P1|Overall Study|Impaired renal function|1
4748509|NCT01760876|16381461|P1|Overall Study|Carcinoma of prostate|1
4748510|NCT01760876|16381461|P1|Overall Study|Non-cardiac death (head injury)|1
4748511|NCT01760733|16381476|P1|Transplanted|Graft loss|7
4748512|NCT01760733|16381476|P1|Transplanted|Death|26
4748513|NCT01760733|16381476|P1|Transplanted|Not reached 10 years post transplant|184
4748514|NCT01760733|16381476|P1|Waiting List|Not received a transplant yet|13
4748515|NCT01760733|16381476|P1|Waiting List|Removed from waiting list|41
4748516|NCT01760733|16381476|P1|Waiting List|Death|18
4748517|NCT01760447|16381506|P4|Weeks 20-54|Lost to Follow-up|2
4748518|NCT01760447|16381507|P3|Weeks 20-54|Lost to Follow-up|1
4748519|NCT01760447|16381508|P2|Weeks 20-54|Lost to Follow-up|0
4748520|NCT01760447|16381509|P1|Weeks 20-54|Lost to Follow-up|0
4748521|NCT01760447|16381506|P4|Weeks 20-54|Withdrawal by Subject|2
4748522|NCT01760447|16381507|P3|Weeks 20-54|Withdrawal by Subject|1
4748523|NCT01760447|16381508|P2|Weeks 20-54|Withdrawal by Subject|1
4748524|NCT01760447|16381509|P1|Weeks 20-54|Withdrawal by Subject|2
4748525|NCT01760447|16381506|P4|Weeks 20-54|Consent withdrawn by Parent/Guardian|0
4748526|NCT01760447|16381507|P3|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
4748527|NCT01760447|16381508|P2|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
4748528|NCT01760447|16381509|P1|Weeks 20-54|Consent withdrawn by Parent/Guardian|1
4748529|NCT01760447|16381506|P4|Weeks 0-20|Randomized but not treated|0
4748530|NCT01760447|16381507|P3|Weeks 0-20|Randomized but not treated|2
4748531|NCT01760447|16381508|P2|Weeks 0-20|Randomized but not treated|0
4748532|NCT01760447|16381509|P1|Weeks 0-20|Randomized but not treated|0
4748533|NCT01760447|16381506|P4|Weeks 0-20|Lost to Follow-up|1
4748534|NCT01760447|16381507|P3|Weeks 0-20|Lost to Follow-up|1
4748535|NCT01760447|16381508|P2|Weeks 0-20|Lost to Follow-up|0
4748536|NCT01760447|16381509|P1|Weeks 0-20|Lost to Follow-up|1
4748537|NCT01760447|16381506|P4|Weeks 0-20|Withdrawal by Subject|0
4748538|NCT01760447|16381507|P3|Weeks 0-20|Withdrawal by Subject|1
4748539|NCT01760447|16381508|P2|Weeks 0-20|Withdrawal by Subject|0
4748540|NCT01760447|16381509|P1|Weeks 0-20|Withdrawal by Subject|2
4748541|NCT01760447|16381506|P4|Weeks 0-20|Consent withdrawn by Parent/Guardian|3
4748542|NCT01760447|16381507|P3|Weeks 0-20|Consent withdrawn by Parent/Guardian|1
4748543|NCT01760447|16381508|P2|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
4748544|NCT01760447|16381509|P1|Weeks 0-20|Consent withdrawn by Parent/Guardian|0
4748545|NCT01759862|16381837|P2|Overall Study|Adverse Event|1
4748546|NCT01759862|16381838|P1|Overall Study|Adverse Event|0
4748547|NCT01759862|16381837|P2|Overall Study|Physician Decision|1
4748548|NCT01759862|16381838|P1|Overall Study|Physician Decision|3
4748549|NCT01759511|16381856|P1|Overall Study|Withdrawal by Subject|3
4748550|NCT01759511|16381856|P1|Overall Study|Study Terminated by Sponsor|13
4748551|NCT01759511|16381856|P1|Overall Study|Protocol-Specified Criteria for Withdraw|4
4748552|NCT01759511|16381856|P1|Overall Study|Progressive Disease|5
4748553|NCT01759511|16381856|P1|Overall Study|Physician Decision|1
4748554|NCT01759511|16381856|P1|Overall Study|Lack of Efficacy|2
4748555|NCT01759511|16381856|P1|Overall Study|Death|2
4748556|NCT01759511|16381856|P1|Overall Study|Adverse Event|4
4748557|NCT01759446|16381869|P5|Overall Study|Withdrawal by Subject|0
4748558|NCT01759446|16381870|P4|Overall Study|Withdrawal by Subject|1
4748559|NCT01759446|16381871|P3|Overall Study|Withdrawal by Subject|0
4748560|NCT01759446|16381872|P2|Overall Study|Withdrawal by Subject|1
4748561|NCT01759446|16381873|P1|Overall Study|Withdrawal by Subject|0
4748562|NCT01759446|16381869|P5|Overall Study|Protocol Violation|0
4748563|NCT01759446|16381870|P4|Overall Study|Protocol Violation|0
4748564|NCT01759446|16381871|P3|Overall Study|Protocol Violation|1
4748565|NCT01759446|16381872|P2|Overall Study|Protocol Violation|0
4748566|NCT01759446|16381873|P1|Overall Study|Protocol Violation|1
4748567|NCT01759420|16381885|P1|Overall Study|Inaccurate EKG machine readings|1
4748568|NCT01759420|16381885|P1|Overall Study|Screen failure|5
4748569|NCT01759407|16381892|P2|Overall Study|Protocol Violation|2
4748570|NCT01759407|16381893|P1|Overall Study|Protocol Violation|0
4748571|NCT01759381|16381905|P2|Overall Study|Death|0
4748572|NCT01759381|16381906|P1|Overall Study|Death|1
4748573|NCT01759368|16381914|P2|Overall Study|Lost to Follow-up|0
4748574|NCT01759368|16381915|P1|Overall Study|Lost to Follow-up|1
4748575|NCT01759290|16381933|P1|Overall Study|Unknown reason|4
4748576|NCT01759290|16381933|P1|Overall Study|Lost to Follow-up|53
4748577|NCT01759290|16381933|P1|Overall Study|Death|17
4748578|NCT01759290|16381933|P1|Overall Study|Physician Decision|2
4748579|NCT01759290|16381933|P1|Overall Study|Subjects withdrawn consent|5
4748580|NCT01759264|16382002|P1|Overall Study|Discontinued Humira Due to Business Trip|1
4748581|NCT01759264|16382002|P1|Overall Study|Withdrawal by Subject|3
4748582|NCT01759264|16382002|P1|Overall Study|Lost to Follow-up|2
4748583|NCT01759264|16382002|P1|Overall Study|Other|2
4748584|NCT01759264|16382002|P1|Overall Study|Adverse Event|1
4748585|NCT01759264|16382002|P1|Overall Study|Serious Adverse Events (SAEs)|1
4748586|NCT01758900|16382030|P2|Overall Study|difficulty for further intubation|8
4748587|NCT01758900|16382031|P1|Overall Study|difficulty for further intubation|7
4748588|NCT01758731|16382049|P1|Overall Study|Physician Decision|1
4748589|NCT01758523|16382068|P2|Overall Study|Withdrawal by Subject|7
4748590|NCT01758523|16382069|P1|Overall Study|Withdrawal by Subject|12
4748591|NCT01758523|16382068|P2|Overall Study|Lost to Follow-up|4
4748592|NCT01758523|16382069|P1|Overall Study|Lost to Follow-up|3
4748593|NCT01758523|16382068|P2|Overall Study|Lack of Efficacy|2
4748594|NCT01758523|16382069|P1|Overall Study|Lack of Efficacy|4
4748595|NCT01758523|16382068|P2|Overall Study|Adverse Event|1
4748596|NCT01758523|16382069|P1|Overall Study|Adverse Event|2
4748597|NCT01758289|16382172|P1|Overall Study|Adverse Event|9
4748598|NCT01758289|16382172|P1|Overall Study|Premature Study Termination|44
4748599|NCT01757847|16382198|P2|Overall Study|Withdrawal by Subject|4
4748600|NCT01757847|16382199|P1|Overall Study|Withdrawal by Subject|3
4748601|NCT01757821|16382207|P1|Overall Study|Adverse Event|1
4748602|NCT01757704|16382222|P2|Overall Study|Protocol Violation|3
4748603|NCT01757704|16382223|P1|Overall Study|Protocol Violation|1
4748604|NCT01757691|16382241|P2|Overall Study|Administrative problems|0
4748605|NCT01757691|16382242|P1|Overall Study|Administrative problems|2
4748606|NCT01757665|16382269|P2|Overall Study|Not Implanted with Device|1
4748607|NCT01757665|16382270|P1|Overall Study|Not Implanted with Device|5
4748608|NCT01757665|16382269|P2|Overall Study|Lost to Follow-up|1
4748609|NCT01757665|16382270|P1|Overall Study|Lost to Follow-up|1
4748610|NCT01757665|16382269|P2|Overall Study|Withdrawal by Subject|0
4748611|NCT01757665|16382270|P1|Overall Study|Withdrawal by Subject|10
4748612|NCT01757665|16382269|P2|Overall Study|Explant|2
4748613|NCT01757665|16382270|P1|Overall Study|Explant|1
4748614|NCT01757665|16382269|P2|Overall Study|Death|8
4748615|NCT01757665|16382270|P1|Overall Study|Death|25
4748616|NCT01757665|16382269|P2|Overall Study|Still on Study - Missed Visit|1
4748617|NCT01757665|16382270|P1|Overall Study|Still on Study - Missed Visit|14
4748618|NCT01757665|16382269|P2|Overall Study|Still on Study - Visit Pending|40
4748619|NCT01757665|16382270|P1|Overall Study|Still on Study - Visit Pending|398
4748620|NCT01757665|16382269|P2|Overall Study|Still on Study - Visit Completed|30
4748621|NCT01757665|16382270|P1|Overall Study|Still on Study - Visit Completed|240
4748622|NCT01757405|16382442|P2|Overall Study|Withdrawal by Subject|1
4748623|NCT01757405|16382443|P1|Overall Study|Withdrawal by Subject|0
4748624|NCT01757405|16382442|P2|Overall Study|Lost to Follow-up|1
4748625|NCT01757405|16382443|P1|Overall Study|Lost to Follow-up|1
4748626|NCT01757275|16382478|P2|Overall Study|Not treated|4
4748627|NCT01757275|16382479|P1|Overall Study|Not treated|3
4748628|NCT01757275|16382478|P2|Overall Study|Withdrawal by Subject|4
4748629|NCT01757275|16382479|P1|Overall Study|Withdrawal by Subject|2
4748630|NCT01757275|16382478|P2|Overall Study|Adverse Event|3
4748631|NCT01757275|16382479|P1|Overall Study|Adverse Event|3
4748632|NCT01757275|16382478|P2|Overall Study|Lost to Follow-up|2
4748633|NCT01757275|16382479|P1|Overall Study|Lost to Follow-up|1
4748634|NCT01757197|16382501|P1|Overall Study|Death|2
4748635|NCT01757184|16382510|P4|Open-label Period|Discontinued by Sponsor|2
4748636|NCT01757184|16382511|P3|Open-label Period|Discontinued by Sponsor|1
4748637|NCT01757184|16382512|P2|Open-label Period|Discontinued by Sponsor|0
4748638|NCT01757184|16382513|P1|Open-label Period|Discontinued by Sponsor|0
4748639|NCT01757184|16382510|P4|Open-label Period|Withdrawal by Subject|1
4748640|NCT01757184|16382511|P3|Open-label Period|Withdrawal by Subject|1
4748641|NCT01757184|16382512|P2|Open-label Period|Withdrawal by Subject|0
4748642|NCT01757184|16382513|P1|Open-label Period|Withdrawal by Subject|0
4748643|NCT01757184|16382510|P4|Open-label Period|Lost to Follow-up|0
4748644|NCT01757184|16382511|P3|Open-label Period|Lost to Follow-up|2
4748645|NCT01757184|16382512|P2|Open-label Period|Lost to Follow-up|0
4748646|NCT01757184|16382513|P1|Open-label Period|Lost to Follow-up|0
4748647|NCT01757184|16382510|P4|Double-blind Period|Adverse Event|0
4748648|NCT01757184|16382511|P3|Double-blind Period|Adverse Event|0
4748649|NCT01757184|16382512|P2|Double-blind Period|Adverse Event|0
4748650|NCT01757184|16382513|P1|Double-blind Period|Adverse Event|1
4748651|NCT01757171|16382557|P2|Overall Study|ECOG decline|0
4748652|NCT01757171|16382558|P1|Overall Study|ECOG decline|1
4748653|NCT01757171|16382557|P2|Overall Study|Hospitalization|0
4748654|NCT01757171|16382558|P1|Overall Study|Hospitalization|1
4748655|NCT01757171|16382557|P2|Overall Study|Disease Progression|0
4748656|NCT01757171|16382558|P1|Overall Study|Disease Progression|1
4748657|NCT01757171|16382557|P2|Overall Study|Adverse Event|1
4748658|NCT01757171|16382558|P1|Overall Study|Adverse Event|5
4748659|NCT01756846|16382594|P2|Overall Study|Withdrawal by Subject|2
4748660|NCT01756846|16382595|P1|Overall Study|Withdrawal by Subject|1
4748661|NCT01756846|16382594|P2|Overall Study|Lost to Follow-up|10
4748662|NCT01756846|16382595|P1|Overall Study|Lost to Follow-up|5
4748663|NCT01756456|16382640|P6|Follow Up Period Phase I/II|Other causes|5
4748664|NCT01756456|16382641|P5|Follow Up Period Phase I/II|Other causes|3
4748665|NCT01756456|16382642|P4|Follow Up Period Phase I/II|Other causes|1
4748666|NCT01756456|16382643|P3|Follow Up Period Phase I/II|Other causes|0
4748667|NCT01756456|16382644|P2|Follow Up Period Phase I/II|Other causes|0
4748668|NCT01756456|16382645|P1|Follow Up Period Phase I/II|Other causes|0
4748669|NCT01756456|16382640|P6|Follow Up Period Phase I/II|Lost to Follow-up|1
4748670|NCT01756456|16382641|P5|Follow Up Period Phase I/II|Lost to Follow-up|0
4748671|NCT01756456|16382642|P4|Follow Up Period Phase I/II|Lost to Follow-up|2
4748672|NCT01756456|16382643|P3|Follow Up Period Phase I/II|Lost to Follow-up|1
4748673|NCT01756456|16382644|P2|Follow Up Period Phase I/II|Lost to Follow-up|0
4748674|NCT01756456|16382645|P1|Follow Up Period Phase I/II|Lost to Follow-up|0
4748675|NCT01756456|16382640|P6|Follow Up Period Phase I/II|Adverse Event|1
4748676|NCT01756456|16382641|P5|Follow Up Period Phase I/II|Adverse Event|0
4748677|NCT01756456|16382642|P4|Follow Up Period Phase I/II|Adverse Event|5
4748678|NCT01756456|16382643|P3|Follow Up Period Phase I/II|Adverse Event|0
4748679|NCT01756456|16382644|P2|Follow Up Period Phase I/II|Adverse Event|0
4748680|NCT01756456|16382645|P1|Follow Up Period Phase I/II|Adverse Event|1
4748681|NCT01756456|16382640|P6|Follow Up Period Phase I/II|Lack of Efficacy|1
4748682|NCT01756456|16382641|P5|Follow Up Period Phase I/II|Lack of Efficacy|0
4748683|NCT01756456|16382642|P4|Follow Up Period Phase I/II|Lack of Efficacy|0
4748684|NCT01756456|16382643|P3|Follow Up Period Phase I/II|Lack of Efficacy|0
4748685|NCT01756456|16382644|P2|Follow Up Period Phase I/II|Lack of Efficacy|0
4748686|NCT01756456|16382645|P1|Follow Up Period Phase I/II|Lack of Efficacy|0
4748687|NCT01756456|16382640|P6|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4748688|NCT01756456|16382641|P5|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4748689|NCT01756456|16382642|P4|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4748690|NCT01756456|16382643|P3|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4748691|NCT01756456|16382644|P2|Follow Up Period Phase I/II|parent withdrew the consent to continue|1
4748692|NCT01756456|16382645|P1|Follow Up Period Phase I/II|parent withdrew the consent to continue|0
4748693|NCT01756456|16382640|P6|Follow Up Period Phase I/II|still in study after week 20|25
4748694|NCT01756456|16382641|P5|Follow Up Period Phase I/II|still in study after week 20|23
4748695|NCT01756456|16382642|P4|Follow Up Period Phase I/II|still in study after week 20|25
4748696|NCT01756456|16382643|P3|Follow Up Period Phase I/II|still in study after week 20|0
4748697|NCT01756456|16382644|P2|Follow Up Period Phase I/II|still in study after week 20|0
4748698|NCT01756456|16382645|P1|Follow Up Period Phase I/II|still in study after week 20|0
4748699|NCT01756456|16382640|P6|Treatment Period: Phase I/II|Other causes|2
4748700|NCT01756456|16382641|P5|Treatment Period: Phase I/II|Other causes|2
4748701|NCT01756456|16382642|P4|Treatment Period: Phase I/II|Other causes|1
4748702|NCT01756456|16382643|P3|Treatment Period: Phase I/II|Other causes|0
4748703|NCT01756456|16382644|P2|Treatment Period: Phase I/II|Other causes|0
4748704|NCT01756456|16382645|P1|Treatment Period: Phase I/II|Other causes|0
4748705|NCT01756456|16382640|P6|Treatment Period: Phase I/II|Adverse Event|1
4748706|NCT01756456|16382641|P5|Treatment Period: Phase I/II|Adverse Event|9
4748707|NCT01756456|16382642|P4|Treatment Period: Phase I/II|Adverse Event|3
4748708|NCT01756456|16382643|P3|Treatment Period: Phase I/II|Adverse Event|2
4748709|NCT01756456|16382644|P2|Treatment Period: Phase I/II|Adverse Event|0
4748710|NCT01756456|16382645|P1|Treatment Period: Phase I/II|Adverse Event|1
4748711|NCT01756456|16382640|P6|Treatment Period: Phase I/II|Withdrawal by Subject|0
4748712|NCT01756456|16382641|P5|Treatment Period: Phase I/II|Withdrawal by Subject|0
4748713|NCT01756456|16382642|P4|Treatment Period: Phase I/II|Withdrawal by Subject|0
4748714|NCT01756456|16382643|P3|Treatment Period: Phase I/II|Withdrawal by Subject|0
4748715|NCT01756456|16382644|P2|Treatment Period: Phase I/II|Withdrawal by Subject|1
4748716|NCT01756456|16382645|P1|Treatment Period: Phase I/II|Withdrawal by Subject|0
4748717|NCT01756456|16382640|P6|Treatment Period: Phase I/II|Lack of Efficacy|0
4748718|NCT01756456|16382641|P5|Treatment Period: Phase I/II|Lack of Efficacy|1
4748719|NCT01756456|16382642|P4|Treatment Period: Phase I/II|Lack of Efficacy|2
4748720|NCT01756456|16382643|P3|Treatment Period: Phase I/II|Lack of Efficacy|0
4748721|NCT01756456|16382644|P2|Treatment Period: Phase I/II|Lack of Efficacy|0
4748722|NCT01756456|16382645|P1|Treatment Period: Phase I/II|Lack of Efficacy|0
4748723|NCT01756456|16382640|P6|Treatment Period: Phase I/II|decision unrelated to adverse event|1
4748724|NCT01756456|16382641|P5|Treatment Period: Phase I/II|decision unrelated to adverse event|1
4748725|NCT01756456|16382642|P4|Treatment Period: Phase I/II|decision unrelated to adverse event|1
4748726|NCT01756456|16382643|P3|Treatment Period: Phase I/II|decision unrelated to adverse event|0
4748727|NCT01756456|16382644|P2|Treatment Period: Phase I/II|decision unrelated to adverse event|0
4748728|NCT01756456|16382645|P1|Treatment Period: Phase I/II|decision unrelated to adverse event|0
4748729|NCT01756352|16382747|P1|Overall Study|moved away and lost to followup|1
4748730|NCT01756300|16382752|P1|Overall Study|Withdrawal by Subject|1
4748731|NCT01756300|16382752|P1|Overall Study|Death|1
4748732|NCT01756274|16382774|P1|Overall Study|Laboratory error|1
4748733|NCT01756274|16382774|P1|Overall Study|Protocol Violation|2
4748734|NCT01756235|16382781|P1|Overall Study|Adalimumab Treatment was not Documented|2
4748735|NCT01756157|16382819|P2|First Intervention Period|Lost to Follow-up|2
4748736|NCT01756157|16382820|P1|First Intervention Period|Lost to Follow-up|0
4748737|NCT01756157|16382819|P2|First Intervention Period|Withdrawal by Subject|0
4748738|NCT01756157|16382820|P1|First Intervention Period|Withdrawal by Subject|1
4748739|NCT01756079|16382834|P1|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4
4748740|NCT01756079|16382834|P1|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20
4748741|NCT01756079|16382834|P1|Treatment / Follow-up: Week 4 to Week 72|No information available|2
4748742|NCT01756079|16382834|P1|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5
4748743|NCT01756079|16382834|P1|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4
4748744|NCT01756053|16382840|P2|Period 2 (10 Days)|Protocol Violation|2
4748745|NCT01756053|16382841|P1|Period 2 (10 Days)|Protocol Violation|0
4748746|NCT01756053|16382840|P2|Period 1 (10 Days)|Protocol Violation|1
4748747|NCT01756053|16382841|P1|Period 1 (10 Days)|Protocol Violation|1
4748748|NCT01755858|16382900|P2|Overall Study|Adverse Event|1
4748749|NCT01755858|16382901|P1|Overall Study|Adverse Event|1
4748750|NCT01755767|16382927|P4|Overall Study|Ongoing Treatment as of 06 Jan 2017|2
4748751|NCT01755767|16382928|P3|Overall Study|Ongoing Treatment as of 06 Jan 2017|5
4748752|NCT01755767|16382929|P2|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
4748753|NCT01755767|16382930|P1|Overall Study|Ongoing Treatment as of 06 Jan 2017|0
4748754|NCT01755767|16382927|P4|Overall Study|Other|3
4748755|NCT01755767|16382928|P3|Overall Study|Other|2
4748756|NCT01755767|16382929|P2|Overall Study|Other|0
4748757|NCT01755767|16382930|P1|Overall Study|Other|0
4748758|NCT01755767|16382927|P4|Overall Study|Withdrawal by Subject|1
4748759|NCT01755767|16382928|P3|Overall Study|Withdrawal by Subject|2
4748760|NCT01755767|16382929|P2|Overall Study|Withdrawal by Subject|0
4748761|NCT01755767|16382930|P1|Overall Study|Withdrawal by Subject|0
4748762|NCT01755767|16382927|P4|Overall Study|Subject Decision|3
4748763|NCT01755767|16382928|P3|Overall Study|Subject Decision|10
4748764|NCT01755767|16382929|P2|Overall Study|Subject Decision|0
4748765|NCT01755767|16382930|P1|Overall Study|Subject Decision|0
4748766|NCT01755767|16382927|P4|Overall Study|Death|4
4748767|NCT01755767|16382928|P3|Overall Study|Death|15
4748768|NCT01755767|16382929|P2|Overall Study|Death|2
4748769|NCT01755767|16382930|P1|Overall Study|Death|1
4748770|NCT01755767|16382927|P4|Overall Study|Adverse Event|11
4748771|NCT01755767|16382928|P3|Overall Study|Adverse Event|28
4748772|NCT01755767|16382929|P2|Overall Study|Adverse Event|0
4748773|NCT01755767|16382930|P1|Overall Study|Adverse Event|6
4748774|NCT01755767|16382927|P4|Overall Study|Radiographic Disease Progression|27
4748775|NCT01755767|16382928|P3|Overall Study|Radiographic Disease Progression|44
4748776|NCT01755767|16382929|P2|Overall Study|Radiographic Disease Progression|4
4748777|NCT01755767|16382930|P1|Overall Study|Radiographic Disease Progression|9
4748778|NCT01755767|16382927|P4|Overall Study|Clinical Disease Progression|20
4748779|NCT01755767|16382928|P3|Overall Study|Clinical Disease Progression|29
4748780|NCT01755767|16382929|P2|Overall Study|Clinical Disease Progression|2
4748781|NCT01755767|16382930|P1|Overall Study|Clinical Disease Progression|4
4748782|NCT01755767|16382927|P4|Overall Study|Progressive Disease|43
4748783|NCT01755767|16382928|P3|Overall Study|Progressive Disease|91
4748784|NCT01755767|16382929|P2|Overall Study|Progressive Disease|7
4748785|NCT01755767|16382930|P1|Overall Study|Progressive Disease|8
4748786|NCT01755702|16382946|P1|Washout Period II|Other Reason|5
4748787|NCT01755702|16382946|P1|Wash Out Period I|Other Reason|3
4748788|NCT01755689|16382993|P5|Overall Study|Pregnancy|2
4748789|NCT01755689|16382994|P4|Overall Study|Pregnancy|4
4748790|NCT01755689|16382995|P3|Overall Study|Pregnancy|2
4748791|NCT01755689|16382996|P2|Overall Study|Pregnancy|1
4748792|NCT01755689|16382997|P1|Overall Study|Pregnancy|1
4748793|NCT01755689|16382993|P5|Overall Study|Lost to Follow-up|2
4748794|NCT01755689|16382994|P4|Overall Study|Lost to Follow-up|0
4748795|NCT01755689|16382995|P3|Overall Study|Lost to Follow-up|1
4748796|NCT01755689|16382996|P2|Overall Study|Lost to Follow-up|0
4748797|NCT01755689|16382997|P1|Overall Study|Lost to Follow-up|1
4748798|NCT01755689|16382993|P5|Overall Study|Migrated/moved from study area|1
4748799|NCT01755689|16382994|P4|Overall Study|Migrated/moved from study area|1
4748800|NCT01755689|16382995|P3|Overall Study|Migrated/moved from study area|1
4748801|NCT01755689|16382996|P2|Overall Study|Migrated/moved from study area|1
4748802|NCT01755689|16382997|P1|Overall Study|Migrated/moved from study area|0
4748803|NCT01755689|16382993|P5|Overall Study|Withdrawal by Subject|1
4748804|NCT01755689|16382994|P4|Overall Study|Withdrawal by Subject|1
4748805|NCT01755689|16382995|P3|Overall Study|Withdrawal by Subject|2
4748806|NCT01755689|16382996|P2|Overall Study|Withdrawal by Subject|3
4748807|NCT01755689|16382997|P1|Overall Study|Withdrawal by Subject|1
4748808|NCT01755637|16383072|P2|Period 1|Adverse Event|1
4748809|NCT01755637|16383073|P1|Period 1|Adverse Event|0
4748810|NCT01755598|16383093|P2|Overall Study|Adverse Event|28
4748811|NCT01755598|16383094|P1|Overall Study|Adverse Event|19
4748812|NCT01755598|16383093|P2|Overall Study|Protocol Violation|7
4748813|NCT01755598|16383094|P1|Overall Study|Protocol Violation|7
4748814|NCT01755598|16383093|P2|Overall Study|Withdrawal by Subject|31
4748815|NCT01755598|16383094|P1|Overall Study|Withdrawal by Subject|22
4748816|NCT01755598|16383093|P2|Overall Study|Migrated/moved from study area|65
4748817|NCT01755598|16383094|P1|Overall Study|Migrated/moved from study area|76
4748818|NCT01755598|16383093|P2|Overall Study|Lost to Follow-up|43
4748819|NCT01755598|16383094|P1|Overall Study|Lost to Follow-up|32
4748820|NCT01755598|16383093|P2|Overall Study|Other|109
4748821|NCT01755598|16383094|P1|Overall Study|Other|109
4748822|NCT01755546|16383128|P1|Long Term Treatment|other and ongoing|41
4748823|NCT01755546|16383128|P1|Long Term Treatment|Lost to Follow-up|17
4748824|NCT01755546|16383128|P1|Long Term Treatment|Withdrawal by Subject|35
4748825|NCT01755546|16383128|P1|Long Term Treatment|Protocol Violation|10
4748826|NCT01755546|16383128|P1|Long Term Treatment|Lack of Efficacy|6
4748827|NCT01755546|16383128|P1|Long Term Treatment|Adverse Event|12
4748828|NCT01755546|16383128|P1|Titration Phase|Withdrawal by Subject|8
4748829|NCT01755546|16383128|P1|Titration Phase|Other and Continuing|22
4748830|NCT01755546|16383128|P1|Titration Phase|Lost to Follow-up|2
4748831|NCT01755546|16383128|P1|Titration Phase|Protocol Violation|9
4748832|NCT01755546|16383128|P1|Titration Phase|Lack of Efficacy|18
4748833|NCT01755546|16383128|P1|Titration Phase|Adverse Event|11
4748834|NCT01755546|16383128|P1|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5
4748835|NCT01755546|16383128|P1|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1
4748836|NCT01755546|16383128|P1|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3
4748837|NCT01755546|16383128|P1|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1
4748838|NCT01755416|16383145|P2|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2
4748839|NCT01755416|16383146|P1|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1
4748840|NCT01755234|16383154|P2|Overall Study|unblinded|0
4748841|NCT01755234|16383155|P1|Overall Study|unblinded|1
4748842|NCT01755234|16383154|P2|Overall Study|Withdrawal by Subject|1
4748843|NCT01755234|16383155|P1|Overall Study|Withdrawal by Subject|0
4748844|NCT01755234|16383154|P2|Overall Study|case cancelled|0
4748845|NCT01755234|16383155|P1|Overall Study|case cancelled|1
4748846|NCT01755234|16383154|P2|Overall Study|Change in surgical case|1
4748847|NCT01755234|16383155|P1|Overall Study|Change in surgical case|2
4748848|NCT01755234|16383154|P2|Overall Study|Lost to Follow-up|6
4748849|NCT01755234|16383155|P1|Overall Study|Lost to Follow-up|11
4748850|NCT01755156|16383186|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|31
4748851|NCT01755156|16383187|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|27
4748852|NCT01755156|16383186|P2|Phase B (Weeks 24-104)|Lost to Follow-up|5
4748853|NCT01755156|16383187|P1|Phase B (Weeks 24-104)|Lost to Follow-up|12
4748854|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
4748855|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1
4748856|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2
4748857|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0
4748858|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|13
4748859|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|6
4748860|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Protocol Violation|1
4748861|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Protocol Violation|1
4748862|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Physician Decision|1
4748863|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Physician Decision|0
4748864|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Non-compliance with study drug|0
4748865|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Non-compliance with study drug|1
4748866|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Lost to Follow-up|3
4748867|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Lost to Follow-up|5
4748868|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Lack of Efficacy|0
4748869|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Lack of Efficacy|1
4748870|NCT01755156|16383186|P2|Phase A (Weeks 0-24)|Adverse Event|3
4748871|NCT01755156|16383187|P1|Phase A (Weeks 0-24)|Adverse Event|2
4748872|NCT01755091|16383251|P3|Overall Study|Physician Decision|2
4748873|NCT01755091|16383252|P2|Overall Study|Physician Decision|1
4748874|NCT01755091|16383253|P1|Overall Study|Physician Decision|1
4748875|NCT01755091|16383251|P3|Overall Study|Lost to Follow-up|1
4748876|NCT01755091|16383252|P2|Overall Study|Lost to Follow-up|0
4748877|NCT01755091|16383253|P1|Overall Study|Lost to Follow-up|1
4748878|NCT01755091|16383251|P3|Overall Study|Adverse Event|1
4748879|NCT01755091|16383252|P2|Overall Study|Adverse Event|1
4748880|NCT01755091|16383253|P1|Overall Study|Adverse Event|1
4748881|NCT01755091|16383251|P3|Overall Study|Withdrawal by Subject|3
4748882|NCT01755091|16383252|P2|Overall Study|Withdrawal by Subject|1
4748883|NCT01755091|16383253|P1|Overall Study|Withdrawal by Subject|6
4748884|NCT01755026|16383278|P2|Overall Study|Withdrawal by Subject|1
4748885|NCT01755026|16383279|P1|Overall Study|Withdrawal by Subject|1
4748886|NCT01755026|16383278|P2|Overall Study|Adverse Event|0
4748887|NCT01755026|16383279|P1|Overall Study|Adverse Event|1
4748888|NCT01754922|16383302|P2|Overall Study|Adverse Event|1
4748889|NCT01754922|16383303|P1|Overall Study|Adverse Event|0
4748890|NCT01754766|16383329|P3|Overall Study|Personal reasons|0
4748891|NCT01754766|16383330|P2|Overall Study|Personal reasons|1
4748892|NCT01754766|16383331|P1|Overall Study|Personal reasons|1
4748893|NCT01754727|16383345|P1|Overall Study|Adalimumab Treatment was not Documented|2
4748894|NCT01754493|16383477|P1|Overall Study|Scheduling conflict|1
4748895|NCT01754493|16383477|P1|Overall Study|Moved out of town|1
4748896|NCT01754493|16383477|P1|Overall Study|Withdrawal by Subject|1
4748897|NCT01754493|16383477|P1|Overall Study|Lost to Follow-up|3
4748898|NCT01754493|16383477|P1|Overall Study|Adverse Event|1
4748899|NCT01754467|16383502|P1|Overall Study|Lost to Follow-up|1
4748900|NCT01754402|16383512|P3|Overall Study|Lack of Efficacy|1
4748901|NCT01754402|16383513|P2|Overall Study|Lack of Efficacy|0
4748902|NCT01754402|16383514|P1|Overall Study|Lack of Efficacy|0
4748903|NCT01754402|16383512|P3|Overall Study|Withdrawal by Subject|1
4748904|NCT01754402|16383513|P2|Overall Study|Withdrawal by Subject|0
4748905|NCT01754402|16383514|P1|Overall Study|Withdrawal by Subject|0
4748906|NCT01754402|16383512|P3|Overall Study|Adverse Event|1
4748907|NCT01754402|16383513|P2|Overall Study|Adverse Event|2
4748908|NCT01754402|16383514|P1|Overall Study|Adverse Event|2
4748909|NCT01754402|16383512|P3|Overall Study|Death|1
4748910|NCT01754402|16383513|P2|Overall Study|Death|0
4748911|NCT01754402|16383514|P1|Overall Study|Death|0
4748912|NCT01754376|16383548|P1|Overall Study|Lack of Efficacy|2
4748913|NCT01754376|16383548|P1|Overall Study|Adverse Event|1
4748914|NCT01754259|16383559|P2|Overall Study|Lost to Follow-up|1
4748915|NCT01754259|16383560|P1|Overall Study|Lost to Follow-up|0
4748916|NCT01754259|16383559|P2|Overall Study|Adverse Event|1
4748917|NCT01754259|16383560|P1|Overall Study|Adverse Event|3
4748918|NCT01754259|16383559|P2|Overall Study|Withdrawal by Subject|4
4748919|NCT01754259|16383560|P1|Overall Study|Withdrawal by Subject|2
4748920|NCT01754194|16383570|P2|Overall Study|Other|8
4748921|NCT01754194|16383571|P1|Overall Study|Other|9
4748922|NCT01754194|16383570|P2|Overall Study|Withdrawal by Subject|5
4748923|NCT01754194|16383571|P1|Overall Study|Withdrawal by Subject|4
4748924|NCT01754194|16383570|P2|Overall Study|Lost to Follow-up|14
4748925|NCT01754194|16383571|P1|Overall Study|Lost to Follow-up|39
4748926|NCT01754129|16383591|P1|Overall Study|Inclusion/exclusion criteria violation|3
4748927|NCT01754129|16383591|P1|Overall Study|Withdrew consent|1
4748928|NCT01754129|16383591|P1|Overall Study|Lost to Follow-up|7
4748929|NCT01754129|16383591|P1|Overall Study|Duodopa discontinuation|9
4748930|NCT01754129|16383591|P1|Overall Study|Death|13
4748931|NCT01753999|16383614|P2|Period 2 -Cross to Alternate Arm|Physician Decision|1
4748932|NCT01753999|16383615|P1|Period 2 -Cross to Alternate Arm|Physician Decision|1
4748933|NCT01753999|16383614|P2|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5
4748934|NCT01753999|16383615|P1|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3
4748935|NCT01753999|16383614|P2|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17
4748936|NCT01753999|16383615|P1|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13
4748937|NCT01753999|16383614|P2|Period 1 - Initial Assignment|Lost to Follow-up|27
4748938|NCT01753999|16383615|P1|Period 1 - Initial Assignment|Lost to Follow-up|18
4748939|NCT01753999|16383614|P2|Period 1 - Initial Assignment|Withdrawal by Subject|20
4748940|NCT01753999|16383615|P1|Period 1 - Initial Assignment|Withdrawal by Subject|19
4748941|NCT01753999|16383614|P2|Period 1 - Initial Assignment|Physician Decision|3
4748942|NCT01753999|16383615|P1|Period 1 - Initial Assignment|Physician Decision|2
4748943|NCT01753856|16383629|P2|Overall Study|Sponsor Decision|0
4748944|NCT01753856|16383630|P1|Overall Study|Sponsor Decision|2
4748945|NCT01753856|16383629|P2|Overall Study|Withdrawal by Subject|2
4748946|NCT01753856|16383630|P1|Overall Study|Withdrawal by Subject|0
4748947|NCT01753856|16383629|P2|Overall Study|Adverse Event|0
4748948|NCT01753856|16383630|P1|Overall Study|Adverse Event|1
4748949|NCT01753570|16383742|P3|Overall Study|Withdrawal by Subject|0
4748950|NCT01753570|16383743|P2|Overall Study|Withdrawal by Subject|4
4748951|NCT01753570|16383744|P1|Overall Study|Withdrawal by Subject|1
4748952|NCT01753570|16383742|P3|Overall Study|Physician Decision|0
4748953|NCT01753570|16383743|P2|Overall Study|Physician Decision|1
4748954|NCT01753570|16383744|P1|Overall Study|Physician Decision|0
4748955|NCT01753570|16383742|P3|Overall Study|Adverse Event|1
4748956|NCT01753570|16383743|P2|Overall Study|Adverse Event|0
4748957|NCT01753570|16383744|P1|Overall Study|Adverse Event|1
4748958|NCT01753518|16383787|P2|Postpartum Follow-up|Lost to Follow-up|15
4748959|NCT01753518|16383788|P1|Postpartum Follow-up|Lost to Follow-up|22
4748960|NCT01753518|16383787|P2|Intention-to-Treat Analysis|Body Mass Index>50|1
4748961|NCT01753518|16383788|P1|Intention-to-Treat Analysis|Body Mass Index>50|0
4748962|NCT01753518|16383787|P2|Intention-to-Treat Analysis|Multifetal gestation|3
4748963|NCT01753518|16383788|P1|Intention-to-Treat Analysis|Multifetal gestation|2
4748964|NCT01753518|16383787|P2|Intention-to-Treat Analysis|Missing consent form|3
4748965|NCT01753518|16383788|P1|Intention-to-Treat Analysis|Missing consent form|5
4748966|NCT01753401|16383812|P4|Open Label Period (44 Weeks)|Reason not provided|2
4748967|NCT01753401|16383813|P3|Open Label Period (44 Weeks)|Reason not provided|0
4748968|NCT01753401|16383814|P2|Open Label Period (44 Weeks)|Reason not provided|0
4748969|NCT01753401|16383815|P1|Open Label Period (44 Weeks)|Reason not provided|0
4748970|NCT01753401|16383812|P4|Open Label Period (44 Weeks)|Lack of Efficacy|1
4748971|NCT01753401|16383813|P3|Open Label Period (44 Weeks)|Lack of Efficacy|1
4748972|NCT01753401|16383814|P2|Open Label Period (44 Weeks)|Lack of Efficacy|0
4748973|NCT01753401|16383815|P1|Open Label Period (44 Weeks)|Lack of Efficacy|0
4748974|NCT01753401|16383812|P4|Open Label Period (44 Weeks)|Withdrawal by Subject|2
4748975|NCT01753401|16383813|P3|Open Label Period (44 Weeks)|Withdrawal by Subject|0
4748976|NCT01753401|16383814|P2|Open Label Period (44 Weeks)|Withdrawal by Subject|0
4748977|NCT01753401|16383815|P1|Open Label Period (44 Weeks)|Withdrawal by Subject|0
4748978|NCT01753401|16383812|P4|Open Label Period (44 Weeks)|Adverse Event|4
4748979|NCT01753401|16383813|P3|Open Label Period (44 Weeks)|Adverse Event|3
4748980|NCT01753401|16383814|P2|Open Label Period (44 Weeks)|Adverse Event|0
4748981|NCT01753401|16383815|P1|Open Label Period (44 Weeks)|Adverse Event|0
4748982|NCT01753401|16383812|P4|Double-blind Period (8 Weeks)|Protocol Violation|0
4748983|NCT01753401|16383813|P3|Double-blind Period (8 Weeks)|Protocol Violation|0
4748984|NCT01753401|16383814|P2|Double-blind Period (8 Weeks)|Protocol Violation|1
4748985|NCT01753401|16383815|P1|Double-blind Period (8 Weeks)|Protocol Violation|0
4748986|NCT01753401|16383812|P4|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
4748987|NCT01753401|16383813|P3|Double-blind Period (8 Weeks)|Withdrawal by Subject|0
4748988|NCT01753401|16383814|P2|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
4748989|NCT01753401|16383815|P1|Double-blind Period (8 Weeks)|Withdrawal by Subject|1
4748990|NCT01753401|16383812|P4|Double-blind Period (8 Weeks)|Adverse Event|0
4748991|NCT01753401|16383813|P3|Double-blind Period (8 Weeks)|Adverse Event|0
4748992|NCT01753401|16383814|P2|Double-blind Period (8 Weeks)|Adverse Event|2
4748993|NCT01753401|16383815|P1|Double-blind Period (8 Weeks)|Adverse Event|0
4748994|NCT01753336|16383874|P1|Overall Study|Withdrawal by Subject|1
4748995|NCT01753336|16383874|P1|Overall Study|Sponsor's decision|2
4748996|NCT01753336|16383874|P1|Overall Study|Physician Decision|2
4748997|NCT01753336|16383874|P1|Overall Study|Lost to Follow-up|3
4748998|NCT01753336|16383874|P1|Overall Study|Patient decision|12
4748999|NCT01753323|16383886|P3|Overall Study|Adverse Event|1
4749000|NCT01753323|16383887|P2|Overall Study|Adverse Event|0
4749001|NCT01753323|16383888|P1|Overall Study|Adverse Event|0
4749002|NCT01753323|16383886|P3|Overall Study|Protocol deviation|0
4749003|NCT01753323|16383887|P2|Overall Study|Protocol deviation|0
4749004|NCT01753323|16383888|P1|Overall Study|Protocol deviation|1
4749005|NCT01753323|16383886|P3|Overall Study|Lack of Efficacy|8
4749006|NCT01753323|16383887|P2|Overall Study|Lack of Efficacy|0
4749007|NCT01753323|16383888|P1|Overall Study|Lack of Efficacy|0
4749008|NCT01753310|16383926|P2|Overall Study|Withdrawal by Subject|0
4749009|NCT01753310|16383927|P1|Overall Study|Withdrawal by Subject|1
4749010|NCT01753310|16383926|P2|Overall Study|Sponsor decision|0
4749011|NCT01753310|16383927|P1|Overall Study|Sponsor decision|1
4749012|NCT01753310|16383926|P2|Overall Study|Subject decision|2
4749013|NCT01753310|16383927|P1|Overall Study|Subject decision|2
4749014|NCT01753310|16383926|P2|Overall Study|Lost to Follow-up|0
4749015|NCT01753310|16383927|P1|Overall Study|Lost to Follow-up|2
4749016|NCT01753310|16383926|P2|Overall Study|Adverse Event|0
4749017|NCT01753310|16383927|P1|Overall Study|Adverse Event|1
4749018|NCT01753310|16383926|P2|Overall Study|Entered into open label extension study|22
4749019|NCT01753310|16383927|P1|Overall Study|Entered into open label extension study|25
4749020|NCT01753193|16383947|P1|Overall Study|Other|16
4749021|NCT01753193|16383947|P1|Overall Study|Death|1
4749022|NCT01753193|16383947|P1|Overall Study|Lost to Follow-up|6
4749023|NCT01753193|16383947|P1|Overall Study|Withdrawal by Subject|23
4749024|NCT01753115|16383962|P3|Overall Study|Used excluded drug|0
4749025|NCT01753115|16383963|P2|Overall Study|Used excluded drug|1
4749026|NCT01753115|16383964|P1|Overall Study|Used excluded drug|0
4749027|NCT01753115|16383962|P3|Overall Study|Subject non-compliant|0
4749028|NCT01753115|16383963|P2|Overall Study|Subject non-compliant|3
4749029|NCT01753115|16383964|P1|Overall Study|Subject non-compliant|3
4749030|NCT01753115|16383962|P3|Overall Study|Withdrawal by Subject|6
4749031|NCT01753115|16383963|P2|Overall Study|Withdrawal by Subject|5
4749032|NCT01753115|16383964|P1|Overall Study|Withdrawal by Subject|6
4749033|NCT01753115|16383962|P3|Overall Study|Lost to Follow-up|8
4749034|NCT01753115|16383963|P2|Overall Study|Lost to Follow-up|6
4749035|NCT01753115|16383964|P1|Overall Study|Lost to Follow-up|3
4749036|NCT01753076|16383974|P2|Overall Study|Other-Reached Protocol-defined Stopping|0
4749037|NCT01753076|16383975|P1|Overall Study|Other-Reached Protocol-defined Stopping|1
4749038|NCT01753076|16383974|P2|Overall Study|Withdrawal by Subject|24
4749039|NCT01753076|16383975|P1|Overall Study|Withdrawal by Subject|14
4749040|NCT01753076|16383974|P2|Overall Study|Physician Decision|2
4749041|NCT01753076|16383975|P1|Overall Study|Physician Decision|4
4749042|NCT01753076|16383974|P2|Overall Study|Lost to Follow-up|1
4749043|NCT01753076|16383975|P1|Overall Study|Lost to Follow-up|2
4749044|NCT01753076|16383974|P2|Overall Study|Lack of Efficacy|1
4749045|NCT01753076|16383975|P1|Overall Study|Lack of Efficacy|3
4749046|NCT01753076|16383974|P2|Overall Study|Adverse Event|18
4749047|NCT01753076|16383975|P1|Overall Study|Adverse Event|17
4749048|NCT01752985|16384002|P3|Treatment Period|Lost to Follow-up|1
4749049|NCT01752985|16384003|P2|Treatment Period|Lost to Follow-up|0
4749050|NCT01752985|16384004|P1|Treatment Period|Lost to Follow-up|0
4749051|NCT01752985|16384002|P3|Treatment Period|Withdrawal by Subject|0
4749052|NCT01752985|16384003|P2|Treatment Period|Withdrawal by Subject|1
4749053|NCT01752985|16384004|P1|Treatment Period|Withdrawal by Subject|1
4749054|NCT01752985|16384002|P3|Treatment Period|Adverse Event|2
4749055|NCT01752985|16384003|P2|Treatment Period|Adverse Event|1
4749056|NCT01752985|16384004|P1|Treatment Period|Adverse Event|2
4749057|NCT01752985|16384002|P3|Treatment Period|Subject no longer meets study criteria|1
4749058|NCT01752985|16384003|P2|Treatment Period|Subject no longer meets study criteria|1
4749059|NCT01752985|16384004|P1|Treatment Period|Subject no longer meets study criteria|0
4749060|NCT01752985|16384002|P3|Treatment Period|Subject request to discontinue treatment|1
4749061|NCT01752985|16384003|P2|Treatment Period|Subject request to discontinue treatment|0
4749062|NCT01752985|16384004|P1|Treatment Period|Subject request to discontinue treatment|1
4749063|NCT01752933|16384032|P2|Overall Study and Follow-up|Lost to Follow-up|2
4749064|NCT01752933|16384033|P1|Overall Study and Follow-up|Lost to Follow-up|0
4749065|NCT01752933|16384032|P2|Overall Study and Follow-up|Withdrawal by Subject|3
4749066|NCT01752933|16384033|P1|Overall Study and Follow-up|Withdrawal by Subject|0
4749067|NCT01752933|16384032|P2|Overall Study and Follow-up|Sponsor terminated study/Database lock|7
4749068|NCT01752933|16384033|P1|Overall Study and Follow-up|Sponsor terminated study/Database lock|0
4749069|NCT01752933|16384032|P2|Overall Study and Follow-up|Death|34
4749070|NCT01752933|16384033|P1|Overall Study and Follow-up|Death|4
4749071|NCT01752933|16384032|P2|Treatment|Patient unable to travel to appointments|1
4749072|NCT01752933|16384033|P1|Treatment|Patient unable to travel to appointments|0
4749073|NCT01752933|16384032|P2|Treatment|Patient noncompliant|1
4749074|NCT01752933|16384033|P1|Treatment|Patient noncompliant|0
4749075|NCT01752933|16384032|P2|Treatment|Hepatocellular carcinoma not confirmed|1
4749076|NCT01752933|16384033|P1|Treatment|Hepatocellular carcinoma not confirmed|0
4749077|NCT01752933|16384032|P2|Treatment|Death|2
4749078|NCT01752933|16384033|P1|Treatment|Death|0
4749079|NCT01752933|16384032|P2|Treatment|Physician Decision|3
4749080|NCT01752933|16384033|P1|Treatment|Physician Decision|0
4749081|NCT01752933|16384032|P2|Treatment|Adverse Event|4
4749082|NCT01752933|16384033|P1|Treatment|Adverse Event|1
4749083|NCT01752933|16384032|P2|Treatment|Withdrawal by Subject|5
4749084|NCT01752933|16384033|P1|Treatment|Withdrawal by Subject|0
4749085|NCT01752933|16384032|P2|Treatment|Disease Progression|29
4749086|NCT01752933|16384033|P1|Treatment|Disease Progression|3
4749087|NCT01752907|16384051|P2|Overall Study|Decision by Sponsor|9
4749088|NCT01752907|16384052|P1|Overall Study|Decision by Sponsor|6
4749089|NCT01752907|16384051|P2|Overall Study|Lost to Follow-up|1
4749090|NCT01752907|16384052|P1|Overall Study|Lost to Follow-up|2
4749091|NCT01752907|16384051|P2|Overall Study|Withdrawal by Subject|10
4749092|NCT01752907|16384052|P1|Overall Study|Withdrawal by Subject|4
4749093|NCT01752855|16384072|P2|Overall Study|Lack of Efficacy|2
4749094|NCT01752855|16384073|P1|Overall Study|Lack of Efficacy|0
4749095|NCT01752855|16384072|P2|Overall Study|Withdrew Consent|2
4749096|NCT01752855|16384073|P1|Overall Study|Withdrew Consent|0
4749097|NCT01752855|16384072|P2|Overall Study|Adverse Event|0
4749098|NCT01752855|16384073|P1|Overall Study|Adverse Event|1
4749099|NCT01752842|16384089|P2|Overall Study|Withdrawal by Subject|2
4749100|NCT01752842|16384090|P1|Overall Study|Withdrawal by Subject|0
4749101|NCT01752842|16384089|P2|Overall Study|Adverse Event|0
4749102|NCT01752842|16384090|P1|Overall Study|Adverse Event|3
4749103|NCT01752634|16384125|P6|Week 24 to Week 260|Adverse Event|0
4749104|NCT01752634|16384126|P5|Week 24 to Week 260|Adverse Event|2
4749105|NCT01752634|16384127|P4|Week 24 to Week 260|Adverse Event|4
4749106|NCT01752634|16384128|P3|Week 24 to Week 260|Adverse Event|8
4749107|NCT01752634|16384129|P2|Week 24 to Week 260|Adverse Event|8
4749108|NCT01752634|16384130|P1|Week 24 to Week 260|Adverse Event|4
4749109|NCT01752634|16384125|P6|Week 24 to Week 260|Lost to Follow-up|0
4749110|NCT01752634|16384126|P5|Week 24 to Week 260|Lost to Follow-up|2
4749111|NCT01752634|16384127|P4|Week 24 to Week 260|Lost to Follow-up|0
4749112|NCT01752634|16384128|P3|Week 24 to Week 260|Lost to Follow-up|3
4749113|NCT01752634|16384129|P2|Week 24 to Week 260|Lost to Follow-up|2
4749114|NCT01752634|16384130|P1|Week 24 to Week 260|Lost to Follow-up|2
4749115|NCT01752634|16384125|P6|Week 24 to Week 260|Noncompliance with study treatment|0
4749116|NCT01752634|16384126|P5|Week 24 to Week 260|Noncompliance with study treatment|0
4749117|NCT01752634|16384127|P4|Week 24 to Week 260|Noncompliance with study treatment|0
4749118|NCT01752634|16384128|P3|Week 24 to Week 260|Noncompliance with study treatment|1
4749119|NCT01752634|16384129|P2|Week 24 to Week 260|Noncompliance with study treatment|0
4749120|NCT01752634|16384130|P1|Week 24 to Week 260|Noncompliance with study treatment|0
4749121|NCT01752634|16384125|P6|Week 24 to Week 260|Pregnancy|0
4749122|NCT01752634|16384126|P5|Week 24 to Week 260|Pregnancy|0
4749123|NCT01752634|16384127|P4|Week 24 to Week 260|Pregnancy|0
4749124|NCT01752634|16384128|P3|Week 24 to Week 260|Pregnancy|1
4749125|NCT01752634|16384129|P2|Week 24 to Week 260|Pregnancy|0
4749126|NCT01752634|16384130|P1|Week 24 to Week 260|Pregnancy|0
4749127|NCT01752634|16384125|P6|Week 24 to Week 260|Death|0
4749128|NCT01752634|16384126|P5|Week 24 to Week 260|Death|0
4749129|NCT01752634|16384127|P4|Week 24 to Week 260|Death|0
4749130|NCT01752634|16384128|P3|Week 24 to Week 260|Death|0
4749131|NCT01752634|16384129|P2|Week 24 to Week 260|Death|1
4749132|NCT01752634|16384130|P1|Week 24 to Week 260|Death|0
4749133|NCT01752634|16384125|P6|Week 24 to Week 260|Physician Decision|0
4749134|NCT01752634|16384126|P5|Week 24 to Week 260|Physician Decision|1
4749135|NCT01752634|16384127|P4|Week 24 to Week 260|Physician Decision|2
4749136|NCT01752634|16384128|P3|Week 24 to Week 260|Physician Decision|4
4749137|NCT01752634|16384129|P2|Week 24 to Week 260|Physician Decision|2
4749138|NCT01752634|16384130|P1|Week 24 to Week 260|Physician Decision|1
4749139|NCT01752634|16384125|P6|Week 24 to Week 260|Subject/guardian decision|0
4749140|NCT01752634|16384126|P5|Week 24 to Week 260|Subject/guardian decision|5
4749141|NCT01752634|16384127|P4|Week 24 to Week 260|Subject/guardian decision|5
4749142|NCT01752634|16384128|P3|Week 24 to Week 260|Subject/guardian decision|9
4749143|NCT01752634|16384129|P2|Week 24 to Week 260|Subject/guardian decision|10
4749144|NCT01752634|16384130|P1|Week 24 to Week 260|Subject/guardian decision|12
4749145|NCT01752634|16384125|P6|Week 24 to Week 260|Lack of Efficacy|0
4749146|NCT01752634|16384126|P5|Week 24 to Week 260|Lack of Efficacy|4
4749147|NCT01752634|16384127|P4|Week 24 to Week 260|Lack of Efficacy|3
4749148|NCT01752634|16384128|P3|Week 24 to Week 260|Lack of Efficacy|7
4749149|NCT01752634|16384129|P2|Week 24 to Week 260|Lack of Efficacy|7
4749150|NCT01752634|16384130|P1|Week 24 to Week 260|Lack of Efficacy|15
4749151|NCT01752634|16384125|P6|Up to Week 24 (Primary Analysis)|Adverse Event|4
4749152|NCT01752634|16384126|P5|Up to Week 24 (Primary Analysis)|Adverse Event|0
4749153|NCT01752634|16384127|P4|Up to Week 24 (Primary Analysis)|Adverse Event|0
4749154|NCT01752634|16384128|P3|Up to Week 24 (Primary Analysis)|Adverse Event|2
4749155|NCT01752634|16384129|P2|Up to Week 24 (Primary Analysis)|Adverse Event|0
4749156|NCT01752634|16384130|P1|Up to Week 24 (Primary Analysis)|Adverse Event|3
4749157|NCT01752634|16384125|P6|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
4749158|NCT01752634|16384126|P5|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
4749159|NCT01752634|16384127|P4|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
4749160|NCT01752634|16384128|P3|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0
4749161|NCT01752634|16384129|P2|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3
4749162|NCT01752634|16384130|P1|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2
4749163|NCT01752634|16384125|P6|Up to Week 24 (Primary Analysis)|Physician Decision|0
4749164|NCT01752634|16384126|P5|Up to Week 24 (Primary Analysis)|Physician Decision|0
4749165|NCT01752634|16384127|P4|Up to Week 24 (Primary Analysis)|Physician Decision|0
4749166|NCT01752634|16384128|P3|Up to Week 24 (Primary Analysis)|Physician Decision|0
4749167|NCT01752634|16384129|P2|Up to Week 24 (Primary Analysis)|Physician Decision|1
4749168|NCT01752634|16384130|P1|Up to Week 24 (Primary Analysis)|Physician Decision|0
4749169|NCT01752634|16384125|P6|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3
4749170|NCT01752634|16384126|P5|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
4749171|NCT01752634|16384127|P4|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0
4749172|NCT01752634|16384128|P3|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
4749173|NCT01752634|16384129|P2|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
4749174|NCT01752634|16384130|P1|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1
4749175|NCT01752036|16384188|P1|Overall Study|Death|2
4749176|NCT01752023|16384201|P2|Overall Study|Physician Decision|1
4749177|NCT01752023|16384202|P1|Overall Study|Physician Decision|2
4749178|NCT01751906|16384238|P2|Overall Study|Other|0
4749179|NCT01751906|16384239|P1|Overall Study|Other|1
4749180|NCT01751906|16384238|P2|Overall Study|Death|22
4749181|NCT01751906|16384239|P1|Overall Study|Death|38
4749182|NCT01751906|16384238|P2|Overall Study|Physician Decision|1
4749183|NCT01751906|16384239|P1|Overall Study|Physician Decision|3
4749184|NCT01751906|16384238|P2|Overall Study|Withdrawal by Subject|6
4749185|NCT01751906|16384239|P1|Overall Study|Withdrawal by Subject|14
4749186|NCT01751906|16384238|P2|Overall Study|Lost to Follow-up|18
4749187|NCT01751906|16384239|P1|Overall Study|Lost to Follow-up|28
4749188|NCT01751867|16384443|P2|Overall Study|Randomized but not treated.|1
4749189|NCT01751867|16384444|P1|Overall Study|Randomized but not treated.|2
4749190|NCT01751867|16384443|P2|Overall Study|Other|37
4749191|NCT01751867|16384444|P1|Overall Study|Other|11
4749192|NCT01751867|16384443|P2|Overall Study|Death|5
4749193|NCT01751867|16384444|P1|Overall Study|Death|0
4749194|NCT01751867|16384443|P2|Overall Study|Protocol Violation|2
4749195|NCT01751867|16384444|P1|Overall Study|Protocol Violation|0
4749196|NCT01751867|16384443|P2|Overall Study|Physician Decision|7
4749197|NCT01751867|16384444|P1|Overall Study|Physician Decision|4
4749198|NCT01751867|16384443|P2|Overall Study|Withdrawal by Subject|1
4749199|NCT01751867|16384444|P1|Overall Study|Withdrawal by Subject|3
4749200|NCT01751867|16384443|P2|Overall Study|Poor Compliance|5
4749201|NCT01751867|16384444|P1|Overall Study|Poor Compliance|0
4749202|NCT01751867|16384443|P2|Overall Study|Adverse Event|15
4749203|NCT01751867|16384444|P1|Overall Study|Adverse Event|8
4749204|NCT01751867|16384443|P2|Overall Study|Diease Progression|18
4749205|NCT01751867|16384444|P1|Overall Study|Diease Progression|4
4749206|NCT01751867|16384443|P2|Overall Study|Completed treatment,dropped in follow-up|8
4749207|NCT01751867|16384444|P1|Overall Study|Completed treatment,dropped in follow-up|4
4749208|NCT01751802|16384464|P2|Overall Study|Adverse Event|2
4749209|NCT01751802|16384465|P1|Overall Study|Adverse Event|4
4749210|NCT01751724|16384479|P2|Overall Study|withdrawn by parent|2
4749211|NCT01751724|16384480|P1|Overall Study|withdrawn by parent|0
4749212|NCT01751724|16384479|P2|Overall Study|extubated bef.start assigned treatment|0
4749213|NCT01751724|16384480|P1|Overall Study|extubated bef.start assigned treatment|1
4749214|NCT01751646|16384508|P2|Overall Study|Childcare issues|1
4749215|NCT01751646|16384509|P1|Overall Study|Childcare issues|1
4749216|NCT01751646|16384508|P2|Overall Study|Fails to comply with study requirements|1
4749217|NCT01751646|16384509|P1|Overall Study|Fails to comply with study requirements|0
4749218|NCT01751646|16384508|P2|Overall Study|Off study due to multiple obligations|1
4749219|NCT01751646|16384509|P1|Overall Study|Off study due to multiple obligations|0
4749220|NCT01751646|16384508|P2|Overall Study|Inability to attend required visits|1
4749221|NCT01751646|16384509|P1|Overall Study|Inability to attend required visits|0
4749222|NCT01751646|16384508|P2|Overall Study|Moved out of the area|5
4749223|NCT01751646|16384509|P1|Overall Study|Moved out of the area|1
4749224|NCT01751646|16384508|P2|Overall Study|Inadvertent enrollment|1
4749225|NCT01751646|16384509|P1|Overall Study|Inadvertent enrollment|1
4749226|NCT01751646|16384508|P2|Overall Study|Missed 4 or more consecutive DOT visits|3
4749227|NCT01751646|16384509|P1|Overall Study|Missed 4 or more consecutive DOT visits|2
4749228|NCT01751646|16384508|P2|Overall Study|Starting hormone therapy|0
4749229|NCT01751646|16384509|P1|Overall Study|Starting hormone therapy|1
4749230|NCT01751646|16384508|P2|Overall Study|Withdrawal by Subject|4
4749231|NCT01751646|16384509|P1|Overall Study|Withdrawal by Subject|0
4749232|NCT01751646|16384508|P2|Overall Study|Lost to Follow-up|1
4749233|NCT01751646|16384509|P1|Overall Study|Lost to Follow-up|5
4749234|NCT01751412|16384657|P1|Overall Study|Disease Progression Before Treatment|1
4749235|NCT01751178|16384767|P3|Overall Study|Other Reason (unknown)|2
4749236|NCT01751178|16384768|P2|Overall Study|Other Reason (unknown)|0
4749237|NCT01751178|16384769|P1|Overall Study|Other Reason (unknown)|1
4749238|NCT01751178|16384767|P3|Overall Study|Adverse Event|0
4749239|NCT01751178|16384768|P2|Overall Study|Adverse Event|0
4749240|NCT01751178|16384769|P1|Overall Study|Adverse Event|2
4749241|NCT01751165|16384789|P3|Overall Study|Lost to Follow-up|1
4749242|NCT01751165|16384790|P2|Overall Study|Lost to Follow-up|1
4749243|NCT01751165|16384791|P1|Overall Study|Lost to Follow-up|1
4749244|NCT01751165|16384789|P3|Overall Study|Serious adverse event|0
4749245|NCT01751165|16384790|P2|Overall Study|Serious adverse event|2
4749246|NCT01751165|16384791|P1|Overall Study|Serious adverse event|0
4749247|NCT01751165|16384789|P3|Overall Study|Withdrawal by Subject|1
4749248|NCT01751165|16384790|P2|Overall Study|Withdrawal by Subject|0
4749249|NCT01751165|16384791|P1|Overall Study|Withdrawal by Subject|0
4749250|NCT01751165|16384789|P3|Overall Study|Adverse event, serious fatal|1
4749251|NCT01751165|16384790|P2|Overall Study|Adverse event, serious fatal|0
4749252|NCT01751165|16384791|P1|Overall Study|Adverse event, serious fatal|1
4749253|NCT01751139|16384831|P1|Overall Study|Death|31
4749254|NCT01751139|16384831|P1|Overall Study|Adverse Event|1
4749255|NCT01751139|16384831|P1|Overall Study|Withdrawal by Subject|251
4749256|NCT01751139|16384831|P1|Overall Study|Lost to Follow-up|240
4749257|NCT01751139|16384831|P1|Overall Study|Sponsor study termination|1609
4749258|NCT01751139|16384831|P1|Overall Study|Other|135
4749259|NCT01751113|16384849|P6|Treatment Period 3 (4 Weeks)|Adverse Event|1
4749260|NCT01751113|16384850|P5|Treatment Period 3 (4 Weeks)|Adverse Event|0
4749261|NCT01751113|16384851|P4|Treatment Period 3 (4 Weeks)|Adverse Event|0
4749262|NCT01751113|16384852|P3|Treatment Period 3 (4 Weeks)|Adverse Event|0
4749263|NCT01751113|16384853|P2|Treatment Period 3 (4 Weeks)|Adverse Event|0
4749264|NCT01751113|16384854|P1|Treatment Period 3 (4 Weeks)|Adverse Event|0
4749265|NCT01751113|16384849|P6|Treatment Period 1 (4 Weeks)|Adverse Event|0
4749266|NCT01751113|16384850|P5|Treatment Period 1 (4 Weeks)|Adverse Event|1
4749267|NCT01751113|16384851|P4|Treatment Period 1 (4 Weeks)|Adverse Event|1
4749268|NCT01751113|16384852|P3|Treatment Period 1 (4 Weeks)|Adverse Event|0
4749269|NCT01751113|16384853|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
4749270|NCT01751113|16384854|P1|Treatment Period 1 (4 Weeks)|Adverse Event|0
4749271|NCT01751087|16384895|P3|Overall Study|Physician Decision|1
4749272|NCT01751087|16384896|P2|Overall Study|Physician Decision|0
4749273|NCT01751087|16384897|P1|Overall Study|Physician Decision|0
4749274|NCT01751087|16384895|P3|Overall Study|Withdrawal by Subject|0
4749275|NCT01751087|16384896|P2|Overall Study|Withdrawal by Subject|0
4749276|NCT01751087|16384897|P1|Overall Study|Withdrawal by Subject|1
4749277|NCT01751061|16384931|P2|Overall Study|Physician Decision|0
4749278|NCT01751061|16384932|P1|Overall Study|Physician Decision|2
4749279|NCT01751061|16384931|P2|Overall Study|Withdrawal by Subject|1
4749280|NCT01751061|16384932|P1|Overall Study|Withdrawal by Subject|4
4749281|NCT01751061|16384931|P2|Overall Study|patient regained decisional capacity|8
4749282|NCT01751061|16384932|P1|Overall Study|patient regained decisional capacity|4
4749283|NCT01751061|16384931|P2|Overall Study|Lost to Follow-up|25
4749284|NCT01751061|16384932|P1|Overall Study|Lost to Follow-up|40
4749285|NCT01751061|16384931|P2|Overall Study|patient death|0
4749286|NCT01751061|16384932|P1|Overall Study|patient death|5
4749287|NCT01751061|16384931|P2|Overall Study|Death|0
4749288|NCT01751061|16384932|P1|Overall Study|Death|1
4749289|NCT01750840|16385006|P1|Overall Study|Lost to Follow-up|4
4749290|NCT01750697|16385011|P1|Overall Study|Withdrawal by Subject|1
4749291|NCT01750697|16385011|P1|Overall Study|Physician Decision|1
4749292|NCT01750697|16385011|P1|Overall Study|Transferred to Adult Services|5
4749293|NCT01750697|16385011|P1|Overall Study|Physician and Family Decision|1
4749294|NCT01750697|16385011|P1|Overall Study|Transferred Back to Local Hospital|1
4749295|NCT01750684|16385023|P2|Overall Study|Protocol Violation|0
4749296|NCT01750684|16385024|P1|Overall Study|Protocol Violation|1
4749297|NCT01750684|16385023|P2|Overall Study|Withdrawn by Sponsor|1
4749298|NCT01750684|16385024|P1|Overall Study|Withdrawn by Sponsor|0
4749299|NCT01750684|16385023|P2|Overall Study|Non-compliance with Study Drug|1
4749300|NCT01750684|16385024|P1|Overall Study|Non-compliance with Study Drug|0
4749301|NCT01750684|16385023|P2|Overall Study|Death|0
4749302|NCT01750684|16385024|P1|Overall Study|Death|1
4749303|NCT01750346|16385061|P3|Overall Study|Adverse Event|0
4749304|NCT01750346|16385062|P2|Overall Study|Adverse Event|0
4749305|NCT01750346|16385063|P1|Overall Study|Adverse Event|1
4749306|NCT01750294|16385089|P1|Overall Study|Safety Endpoint|1
4749307|NCT01750294|16385089|P1|Overall Study|Withdrawal by Subject|1
4749308|NCT01750281|16385096|P3|Overall Study|Did not receive treatment|0
4749309|NCT01750281|16385097|P2|Overall Study|Did not receive treatment|1
4749310|NCT01750281|16385098|P1|Overall Study|Did not receive treatment|0
4749311|NCT01750281|16385096|P3|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9
4749312|NCT01750281|16385097|P2|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7
4749313|NCT01750281|16385098|P1|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6
4749314|NCT01750281|16385096|P3|Overall Study|Discontinued Selumetinib/Placebo|75
4749315|NCT01750281|16385097|P2|Overall Study|Discontinued Selumetinib/Placebo|77
4749316|NCT01750281|16385098|P1|Overall Study|Discontinued Selumetinib/Placebo|37
4749317|NCT01750268|16385111|P2|Overall Study|Withdrawal by Subject|0
4749318|NCT01750268|16385112|P1|Overall Study|Withdrawal by Subject|2
4749319|NCT01750268|16385111|P2|Overall Study|Physician Decision|3
4749320|NCT01750268|16385112|P1|Overall Study|Physician Decision|0
4749321|NCT01750268|16385111|P2|Overall Study|Lost to Follow-up|2
4749322|NCT01750268|16385112|P1|Overall Study|Lost to Follow-up|0
4749323|NCT01750242|16385139|P1|Overall Study|Unreadable Images|3
4749324|NCT01750229|16385144|P1|Long-term Follow-up Phase|Withdrawal by Subject|1
4749325|NCT01750229|16385144|P1|Long-term Follow-up Phase|Adverse Event|2
4749326|NCT01750229|16385144|P1|Randomized Crossover Phase|Withdrawal by Subject|1
4749327|NCT01750229|16385144|P1|Randomized Crossover Phase|Adverse Event|1
4749328|NCT01749982|16385171|P4|Overall Study|Withdrawal by Subject|1
4749329|NCT01749982|16385172|P3|Overall Study|Withdrawal by Subject|0
4749330|NCT01749982|16385173|P2|Overall Study|Withdrawal by Subject|0
4749331|NCT01749982|16385174|P1|Overall Study|Withdrawal by Subject|0
4749332|NCT01749982|16385171|P4|Overall Study|Lost to Follow-up|1
4749333|NCT01749982|16385172|P3|Overall Study|Lost to Follow-up|0
4749334|NCT01749982|16385173|P2|Overall Study|Lost to Follow-up|0
4749335|NCT01749982|16385174|P1|Overall Study|Lost to Follow-up|0
4749336|NCT01749982|16385171|P4|Overall Study|Physician Decision|1
4749337|NCT01749982|16385172|P3|Overall Study|Physician Decision|0
4749338|NCT01749982|16385173|P2|Overall Study|Physician Decision|0
4749339|NCT01749982|16385174|P1|Overall Study|Physician Decision|0
4749340|NCT01749826|16385238|P2|Overall Study|Study Terminated|0
4749341|NCT01749826|16385239|P1|Overall Study|Study Terminated|20
4749342|NCT01749800|16385254|P3|Overall Study|Withdrawal by Subject|0
4749343|NCT01749800|16385255|P2|Overall Study|Withdrawal by Subject|1
4749344|NCT01749800|16385256|P1|Overall Study|Withdrawal by Subject|0
4749345|NCT01749800|16385254|P3|Overall Study|not meeting inclusion criteria|0
4749346|NCT01749800|16385255|P2|Overall Study|not meeting inclusion criteria|0
4749347|NCT01749800|16385256|P1|Overall Study|not meeting inclusion criteria|3
4749348|NCT01749735|16385266|P2|Overall Study|Withdrawal by Subject|0
4749349|NCT01749735|16385267|P1|Overall Study|Withdrawal by Subject|1
4749350|NCT01749033|16385318|P3|Overall Study|Lost to Follow-up|1
4749351|NCT01749033|16385319|P2|Overall Study|Lost to Follow-up|2
4749352|NCT01749033|16385320|P1|Overall Study|Lost to Follow-up|0
4749353|NCT01749033|16385318|P3|Overall Study|Did not receive allocated intervention|0
4749354|NCT01749033|16385319|P2|Overall Study|Did not receive allocated intervention|3
4749355|NCT01749033|16385320|P1|Overall Study|Did not receive allocated intervention|3
4749356|NCT01748890|16385390|P1|Overall Study|Insufficient recruitment for analysis|4
4749357|NCT01748760|16385445|P2|Overall Study|Lost to Follow-up|1
4749358|NCT01748760|16385446|P1|Overall Study|Lost to Follow-up|5
4749359|NCT01748760|16385445|P2|Overall Study|Withdrawal by Subject|1
4749360|NCT01748760|16385446|P1|Overall Study|Withdrawal by Subject|1
4749361|NCT01748552|16385492|P12|Intervention Period 2 and Washout|Contingency dose not tested|0
4749362|NCT01748552|16385493|P11|Intervention Period 2 and Washout|Contingency dose not tested|0
4749363|NCT01748552|16385494|P10|Intervention Period 2 and Washout|Contingency dose not tested|0
4749364|NCT01748552|16385495|P9|Intervention Period 2 and Washout|Contingency dose not tested|3
4749365|NCT01748552|16385496|P8|Intervention Period 2 and Washout|Contingency dose not tested|3
4749366|NCT01748552|16385497|P7|Intervention Period 2 and Washout|Contingency dose not tested|3
4749367|NCT01748552|16385498|P6|Intervention Period 2 and Washout|Contingency dose not tested|0
4749368|NCT01748552|16385499|P5|Intervention Period 2 and Washout|Contingency dose not tested|0
4749369|NCT01748552|16385500|P4|Intervention Period 2 and Washout|Contingency dose not tested|0
4749370|NCT01748552|16385501|P3|Intervention Period 2 and Washout|Contingency dose not tested|0
4749371|NCT01748552|16385502|P2|Intervention Period 2 and Washout|Contingency dose not tested|0
4749372|NCT01748552|16385503|P1|Intervention Period 2 and Washout|Contingency dose not tested|0
4749373|NCT01748552|16385492|P12|Intervention Period 2 and Washout|Physician Decision|0
4749374|NCT01748552|16385493|P11|Intervention Period 2 and Washout|Physician Decision|0
4749375|NCT01748552|16385494|P10|Intervention Period 2 and Washout|Physician Decision|0
4749376|NCT01748552|16385495|P9|Intervention Period 2 and Washout|Physician Decision|0
4749377|NCT01748552|16385496|P8|Intervention Period 2 and Washout|Physician Decision|0
4749378|NCT01748552|16385497|P7|Intervention Period 2 and Washout|Physician Decision|0
4749379|NCT01748552|16385498|P6|Intervention Period 2 and Washout|Physician Decision|0
4749380|NCT01748552|16385499|P5|Intervention Period 2 and Washout|Physician Decision|0
4749381|NCT01748552|16385500|P4|Intervention Period 2 and Washout|Physician Decision|0
4749382|NCT01748552|16385501|P3|Intervention Period 2 and Washout|Physician Decision|1
4749383|NCT01748552|16385502|P2|Intervention Period 2 and Washout|Physician Decision|0
4749384|NCT01748552|16385503|P1|Intervention Period 2 and Washout|Physician Decision|0
4749385|NCT01748292|16385573|P2|Overall Study|Withdrawal by Subject|2
4749386|NCT01748292|16385574|P1|Overall Study|Withdrawal by Subject|0
4749387|NCT01748292|16385573|P2|Overall Study|Death|3
4749388|NCT01748292|16385574|P1|Overall Study|Death|0
4749389|NCT01748292|16385573|P2|Overall Study|Lost to Follow-up|3
4749390|NCT01748292|16385574|P1|Overall Study|Lost to Follow-up|0
4749391|NCT01748292|16385573|P2|Overall Study|Adverse Event|4
4749392|NCT01748292|16385574|P1|Overall Study|Adverse Event|2
4749393|NCT01748162|16385608|P2|Overall Study|reasons not available|2
4749394|NCT01748162|16385609|P1|Overall Study|reasons not available|3
4749395|NCT01748162|16385608|P2|Overall Study|participant consented but did not begin|1
4749396|NCT01748162|16385609|P1|Overall Study|participant consented but did not begin|0
4749397|NCT01748162|16385608|P2|Overall Study|no additional croup episodes to evaluate|2
4749398|NCT01748162|16385609|P1|Overall Study|no additional croup episodes to evaluate|2
4749399|NCT01748071|16385620|P3|Overall Study|Adverse Event|0
4749400|NCT01748071|16385621|P2|Overall Study|Adverse Event|2
4749401|NCT01748071|16385622|P1|Overall Study|Adverse Event|2
4749402|NCT01747915|16385885|P3|Overall Study|Pregnancy|1
4749403|NCT01747915|16385886|P2|Overall Study|Pregnancy|0
4749404|NCT01747915|16385887|P1|Overall Study|Pregnancy|0
4749405|NCT01747915|16385885|P3|Overall Study|Protocol Violation|0
4749406|NCT01747915|16385886|P2|Overall Study|Protocol Violation|0
4749407|NCT01747915|16385887|P1|Overall Study|Protocol Violation|1
4749408|NCT01747915|16385885|P3|Overall Study|Withdrawal by Subject|1
4749409|NCT01747915|16385886|P2|Overall Study|Withdrawal by Subject|4
4749410|NCT01747915|16385887|P1|Overall Study|Withdrawal by Subject|4
4749411|NCT01747915|16385885|P3|Overall Study|Lost to Follow-up|0
4749412|NCT01747915|16385886|P2|Overall Study|Lost to Follow-up|0
4749413|NCT01747915|16385887|P1|Overall Study|Lost to Follow-up|1
4749414|NCT01747915|16385885|P3|Overall Study|Lack of Efficacy|0
4749415|NCT01747915|16385886|P2|Overall Study|Lack of Efficacy|1
4749416|NCT01747915|16385887|P1|Overall Study|Lack of Efficacy|0
4749417|NCT01747915|16385885|P3|Overall Study|Death|1
4749418|NCT01747915|16385886|P2|Overall Study|Death|0
4749419|NCT01747915|16385887|P1|Overall Study|Death|0
4749420|NCT01747915|16385885|P3|Overall Study|Adverse Event|2
4749421|NCT01747915|16385886|P2|Overall Study|Adverse Event|5
4749422|NCT01747915|16385887|P1|Overall Study|Adverse Event|8
4749423|NCT01747915|16385885|P3|Overall Study|Other|1
4749424|NCT01747915|16385886|P2|Overall Study|Other|1
4749425|NCT01747915|16385887|P1|Overall Study|Other|1
4749426|NCT01747876|16385901|P3|Overall Study|Trtment duration compl. as per protocol|1
4749427|NCT01747876|16385902|P2|Overall Study|Trtment duration compl. as per protocol|1
4749428|NCT01747876|16385903|P1|Overall Study|Trtment duration compl. as per protocol|0
4749429|NCT01747876|16385901|P3|Overall Study|Disease progression|8
4749430|NCT01747876|16385902|P2|Overall Study|Disease progression|13
4749431|NCT01747876|16385903|P1|Overall Study|Disease progression|4
4749432|NCT01747876|16385901|P3|Overall Study|Withdrawal by Subject|1
4749433|NCT01747876|16385902|P2|Overall Study|Withdrawal by Subject|1
4749434|NCT01747876|16385903|P1|Overall Study|Withdrawal by Subject|0
4749435|NCT01747876|16385901|P3|Overall Study|Adverse Event|2
4749436|NCT01747876|16385902|P2|Overall Study|Adverse Event|0
4749437|NCT01747876|16385903|P1|Overall Study|Adverse Event|1
4749438|NCT01747837|16385956|P2|Overall Study|Death|4
4749439|NCT01747837|16385957|P1|Overall Study|Death|4
4749440|NCT01747837|16385956|P2|Overall Study|Lost to Follow-up|2
4749441|NCT01747837|16385957|P1|Overall Study|Lost to Follow-up|5
4749442|NCT01747811|16385987|P2|Overall Study|Lack of Efficacy|4
4749443|NCT01747811|16385988|P1|Overall Study|Lack of Efficacy|2
4749444|NCT01747772|16386004|P1|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9
4749445|NCT01747655|16386012|P2|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0
4749446|NCT01747655|16386013|P1|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1
4749447|NCT01747655|16386012|P2|PEG-J Period (Duodopa Treatment)|Patient Decision|0
4749448|NCT01747655|16386013|P1|PEG-J Period (Duodopa Treatment)|Patient Decision|8
4749449|NCT01747655|16386012|P2|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0
4749450|NCT01747655|16386013|P1|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5
4749451|NCT01747629|16386043|P2|Overall Study|Other|1
4749452|NCT01747629|16386044|P1|Overall Study|Other|2
4749453|NCT01747629|16386043|P2|Overall Study|Not treated|0
4749454|NCT01747629|16386044|P1|Overall Study|Not treated|1
4749455|NCT01747629|16386043|P2|Overall Study|Inclusion criteria not met|0
4749456|NCT01747629|16386044|P1|Overall Study|Inclusion criteria not met|1
4749457|NCT01747629|16386043|P2|Overall Study|Noncompliance|1
4749458|NCT01747629|16386044|P1|Overall Study|Noncompliance|1
4749459|NCT01747629|16386043|P2|Overall Study|Withdrawal by Subject|2
4749460|NCT01747629|16386044|P1|Overall Study|Withdrawal by Subject|2
4749461|NCT01747629|16386043|P2|Overall Study|Adverse Event|2
4749462|NCT01747629|16386044|P1|Overall Study|Adverse Event|1
4749463|NCT01747551|16386078|P2|Overall Study|Other|0
4749464|NCT01747551|16386079|P1|Overall Study|Other|2
4749465|NCT01747551|16386078|P2|Overall Study|Physician Decision|1
4749466|NCT01747551|16386079|P1|Overall Study|Physician Decision|2
4749467|NCT01747551|16386078|P2|Overall Study|Withdrawal by Subject|1
4749468|NCT01747551|16386079|P1|Overall Study|Withdrawal by Subject|3
4749469|NCT01747551|16386078|P2|Overall Study|Prolonged Treatment Delay|0
4749470|NCT01747551|16386079|P1|Overall Study|Prolonged Treatment Delay|2
4749471|NCT01747551|16386078|P2|Overall Study|Adverse Event|1
4749472|NCT01747551|16386079|P1|Overall Study|Adverse Event|7
4749473|NCT01747551|16386078|P2|Overall Study|Death|1
4749474|NCT01747551|16386079|P1|Overall Study|Death|3
4749475|NCT01747551|16386078|P2|Overall Study|Progressive Disease|17
4749476|NCT01747551|16386079|P1|Overall Study|Progressive Disease|24
4749477|NCT01747499|16386096|P5|Overall Study|Determined not to be eligible|1
4749478|NCT01747499|16386097|P4|Overall Study|Determined not to be eligible|0
4749479|NCT01747499|16386098|P3|Overall Study|Determined not to be eligible|0
4749480|NCT01747499|16386099|P2|Overall Study|Determined not to be eligible|0
4749481|NCT01747499|16386100|P1|Overall Study|Determined not to be eligible|0
4749482|NCT01747499|16386096|P5|Overall Study|Developed AML and death|1
4749483|NCT01747499|16386097|P4|Overall Study|Developed AML and death|0
4749484|NCT01747499|16386098|P3|Overall Study|Developed AML and death|0
4749485|NCT01747499|16386099|P2|Overall Study|Developed AML and death|0
4749486|NCT01747499|16386100|P1|Overall Study|Developed AML and death|0
4749487|NCT01747499|16386096|P5|Overall Study|Withdrawal by Subject|6
4749488|NCT01747499|16386097|P4|Overall Study|Withdrawal by Subject|0
4749489|NCT01747499|16386098|P3|Overall Study|Withdrawal by Subject|0
4749490|NCT01747499|16386099|P2|Overall Study|Withdrawal by Subject|0
4749491|NCT01747499|16386100|P1|Overall Study|Withdrawal by Subject|0
4749492|NCT01747499|16386096|P5|Overall Study|Death|1
4749493|NCT01747499|16386097|P4|Overall Study|Death|1
4749494|NCT01747499|16386098|P3|Overall Study|Death|0
4749495|NCT01747499|16386099|P2|Overall Study|Death|0
4749496|NCT01747499|16386100|P1|Overall Study|Death|0
4749497|NCT01747499|16386096|P5|Overall Study|Physician Decision|2
4749498|NCT01747499|16386097|P4|Overall Study|Physician Decision|0
4749499|NCT01747499|16386098|P3|Overall Study|Physician Decision|0
4749500|NCT01747499|16386099|P2|Overall Study|Physician Decision|1
4749501|NCT01747499|16386100|P1|Overall Study|Physician Decision|0
4749502|NCT01747499|16386096|P5|Overall Study|Steroid refractory aGvHD|4
4749503|NCT01747499|16386097|P4|Overall Study|Steroid refractory aGvHD|1
4749504|NCT01747499|16386098|P3|Overall Study|Steroid refractory aGvHD|0
4749505|NCT01747499|16386099|P2|Overall Study|Steroid refractory aGvHD|0
4749506|NCT01747499|16386100|P1|Overall Study|Steroid refractory aGvHD|1
4749507|NCT01747486|16386136|P2|Stage 2|Disease Progression|0
4749508|NCT01747486|16386137|P1|Stage 2|Disease Progression|3
4749509|NCT01747486|16386136|P2|Stage 2|New Cancer Therapy|0
4749510|NCT01747486|16386137|P1|Stage 2|New Cancer Therapy|3
4749511|NCT01747486|16386136|P2|Stage 2|Withdrawal by Subject|0
4749512|NCT01747486|16386137|P1|Stage 2|Withdrawal by Subject|1
4749513|NCT01747486|16386136|P2|Stage 2|Physician Decision|0
4749514|NCT01747486|16386137|P1|Stage 2|Physician Decision|2
4749515|NCT01747486|16386136|P2|Stage 1|Death|1
4749516|NCT01747486|16386137|P1|Stage 1|Death|1
4749517|NCT01747486|16386136|P2|Stage 1|Disease progression|9
4749518|NCT01747486|16386137|P1|Stage 1|Disease progression|4
4749519|NCT01747486|16386136|P2|Stage 1|Withdrawal by Subject|3
4749520|NCT01747486|16386137|P1|Stage 1|Withdrawal by Subject|4
4749521|NCT01747486|16386136|P2|Stage 1|Physician Decision|0
4749522|NCT01747486|16386137|P1|Stage 1|Physician Decision|3
4749523|NCT01746901|16386187|P9|Treatment Phase: Fourth Intervention|Protocol Violation|1
4749524|NCT01746901|16386188|P8|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749525|NCT01746901|16386189|P7|Treatment Phase: Fourth Intervention|Protocol Violation|1
4749526|NCT01746901|16386190|P6|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749527|NCT01746901|16386191|P5|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749528|NCT01746901|16386192|P4|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749529|NCT01746901|16386193|P3|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749530|NCT01746901|16386194|P2|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749531|NCT01746901|16386195|P1|Treatment Phase: Fourth Intervention|Protocol Violation|0
4749532|NCT01746901|16386187|P9|Treatment Phase: Fourth Intervention|Adverse Event|1
4749533|NCT01746901|16386188|P8|Treatment Phase: Fourth Intervention|Adverse Event|0
4749534|NCT01746901|16386189|P7|Treatment Phase: Fourth Intervention|Adverse Event|0
4749535|NCT01746901|16386190|P6|Treatment Phase: Fourth Intervention|Adverse Event|1
4749536|NCT01746901|16386191|P5|Treatment Phase: Fourth Intervention|Adverse Event|0
4749537|NCT01746901|16386192|P4|Treatment Phase: Fourth Intervention|Adverse Event|0
4749538|NCT01746901|16386193|P3|Treatment Phase: Fourth Intervention|Adverse Event|0
4749539|NCT01746901|16386194|P2|Treatment Phase: Fourth Intervention|Adverse Event|0
4749540|NCT01746901|16386195|P1|Treatment Phase: Fourth Intervention|Adverse Event|0
4749541|NCT01746901|16386187|P9|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749542|NCT01746901|16386188|P8|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749543|NCT01746901|16386189|P7|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749544|NCT01746901|16386190|P6|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749545|NCT01746901|16386191|P5|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749546|NCT01746901|16386192|P4|Treatment Phase: Fourth Intervention|Lost to Follow-up|1
4749547|NCT01746901|16386193|P3|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749548|NCT01746901|16386194|P2|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749549|NCT01746901|16386195|P1|Treatment Phase: Fourth Intervention|Lost to Follow-up|0
4749550|NCT01746901|16386187|P9|Treatment Phase: Third Intervention|Protocol Violation|0
4749551|NCT01746901|16386188|P8|Treatment Phase: Third Intervention|Protocol Violation|0
4749552|NCT01746901|16386189|P7|Treatment Phase: Third Intervention|Protocol Violation|1
4749553|NCT01746901|16386190|P6|Treatment Phase: Third Intervention|Protocol Violation|1
4749554|NCT01746901|16386191|P5|Treatment Phase: Third Intervention|Protocol Violation|0
4749555|NCT01746901|16386192|P4|Treatment Phase: Third Intervention|Protocol Violation|0
4749556|NCT01746901|16386193|P3|Treatment Phase: Third Intervention|Protocol Violation|0
4749557|NCT01746901|16386194|P2|Treatment Phase: Third Intervention|Protocol Violation|0
4749558|NCT01746901|16386195|P1|Treatment Phase: Third Intervention|Protocol Violation|0
4749559|NCT01746901|16386187|P9|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749560|NCT01746901|16386188|P8|Treatment Phase: Second Intervention|Withdrawal by Subject|1
4749561|NCT01746901|16386189|P7|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749562|NCT01746901|16386190|P6|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749563|NCT01746901|16386191|P5|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749564|NCT01746901|16386192|P4|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749565|NCT01746901|16386193|P3|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749566|NCT01746901|16386194|P2|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749567|NCT01746901|16386195|P1|Treatment Phase: Second Intervention|Withdrawal by Subject|0
4749568|NCT01746901|16386187|P9|Treatment Phase: First Intervention|Protocol Violation|0
4749569|NCT01746901|16386188|P8|Treatment Phase: First Intervention|Protocol Violation|0
4749570|NCT01746901|16386189|P7|Treatment Phase: First Intervention|Protocol Violation|1
4749571|NCT01746901|16386190|P6|Treatment Phase: First Intervention|Protocol Violation|0
4749572|NCT01746901|16386191|P5|Treatment Phase: First Intervention|Protocol Violation|0
4749573|NCT01746901|16386192|P4|Treatment Phase: First Intervention|Protocol Violation|0
4749574|NCT01746901|16386193|P3|Treatment Phase: First Intervention|Protocol Violation|0
4749575|NCT01746901|16386194|P2|Treatment Phase: First Intervention|Protocol Violation|0
4749576|NCT01746901|16386195|P1|Treatment Phase: First Intervention|Protocol Violation|0
4749577|NCT01746901|16386187|P9|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749578|NCT01746901|16386188|P8|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749579|NCT01746901|16386189|P7|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749580|NCT01746901|16386190|P6|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749581|NCT01746901|16386191|P5|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749582|NCT01746901|16386192|P4|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749583|NCT01746901|16386193|P3|Drug Discrimination Phase: Day 2|Protocol Violation|3
4749584|NCT01746901|16386194|P2|Drug Discrimination Phase: Day 2|Protocol Violation|3
4749585|NCT01746901|16386195|P1|Drug Discrimination Phase: Day 2|Protocol Violation|0
4749586|NCT01746901|16386187|P9|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749587|NCT01746901|16386188|P8|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749588|NCT01746901|16386189|P7|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749589|NCT01746901|16386190|P6|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749590|NCT01746901|16386191|P5|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749591|NCT01746901|16386192|P4|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749592|NCT01746901|16386193|P3|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10
4749593|NCT01746901|16386194|P2|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9
4749594|NCT01746901|16386195|P1|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0
4749595|NCT01746901|16386187|P9|Drug Discrimination Phase: Day 2|Adverse Event|0
4749596|NCT01746901|16386188|P8|Drug Discrimination Phase: Day 2|Adverse Event|0
4749597|NCT01746901|16386189|P7|Drug Discrimination Phase: Day 2|Adverse Event|0
4749598|NCT01746901|16386190|P6|Drug Discrimination Phase: Day 2|Adverse Event|0
4749599|NCT01746901|16386191|P5|Drug Discrimination Phase: Day 2|Adverse Event|0
4749600|NCT01746901|16386192|P4|Drug Discrimination Phase: Day 2|Adverse Event|0
4749601|NCT01746901|16386193|P3|Drug Discrimination Phase: Day 2|Adverse Event|1
4749602|NCT01746901|16386194|P2|Drug Discrimination Phase: Day 2|Adverse Event|2
4749603|NCT01746901|16386195|P1|Drug Discrimination Phase: Day 2|Adverse Event|0
4749604|NCT01746901|16386187|P9|Drug Discrimination Phase: Day 1|Adverse Event|0
4749605|NCT01746901|16386188|P8|Drug Discrimination Phase: Day 1|Adverse Event|0
4749606|NCT01746901|16386189|P7|Drug Discrimination Phase: Day 1|Adverse Event|0
4749607|NCT01746901|16386190|P6|Drug Discrimination Phase: Day 1|Adverse Event|0
4749608|NCT01746901|16386191|P5|Drug Discrimination Phase: Day 1|Adverse Event|0
4749609|NCT01746901|16386192|P4|Drug Discrimination Phase: Day 1|Adverse Event|0
4749610|NCT01746901|16386193|P3|Drug Discrimination Phase: Day 1|Adverse Event|0
4749611|NCT01746901|16386194|P2|Drug Discrimination Phase: Day 1|Adverse Event|3
4749612|NCT01746901|16386195|P1|Drug Discrimination Phase: Day 1|Adverse Event|0
4749613|NCT01746901|16386187|P9|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749614|NCT01746901|16386188|P8|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749615|NCT01746901|16386189|P7|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749616|NCT01746901|16386190|P6|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749617|NCT01746901|16386191|P5|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749618|NCT01746901|16386192|P4|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749619|NCT01746901|16386193|P3|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749620|NCT01746901|16386194|P2|Naloxone Challenge Phase|Did not meet entrance criteria|0
4749621|NCT01746901|16386195|P1|Naloxone Challenge Phase|Did not meet entrance criteria|1
4749622|NCT01746901|16386187|P9|Naloxone Challenge Phase|Adverse Event|0
4749623|NCT01746901|16386188|P8|Naloxone Challenge Phase|Adverse Event|0
4749624|NCT01746901|16386189|P7|Naloxone Challenge Phase|Adverse Event|0
4749625|NCT01746901|16386190|P6|Naloxone Challenge Phase|Adverse Event|0
4749626|NCT01746901|16386191|P5|Naloxone Challenge Phase|Adverse Event|0
4749627|NCT01746901|16386192|P4|Naloxone Challenge Phase|Adverse Event|0
4749628|NCT01746901|16386193|P3|Naloxone Challenge Phase|Adverse Event|0
4749629|NCT01746901|16386194|P2|Naloxone Challenge Phase|Adverse Event|0
4749630|NCT01746901|16386195|P1|Naloxone Challenge Phase|Adverse Event|2
4749631|NCT01746862|16386518|P2|Overall Study|Entered puberty during the study|0
4749632|NCT01746862|16386519|P1|Overall Study|Entered puberty during the study|1
4749633|NCT01746862|16386518|P2|Overall Study|Consent withdrawal by parent's guardian|2
4749634|NCT01746862|16386519|P1|Overall Study|Consent withdrawal by parent's guardian|5
4749635|NCT01746862|16386518|P2|Overall Study|Protocol Violation|0
4749636|NCT01746862|16386519|P1|Overall Study|Protocol Violation|1
4749637|NCT01746862|16386518|P2|Overall Study|Withdrawal by Subject|1
4749638|NCT01746862|16386519|P1|Overall Study|Withdrawal by Subject|1
4749639|NCT01746732|16386583|P3|Period 2|Lost to Follow-up|1
4749640|NCT01746732|16386584|P2|Period 2|Lost to Follow-up|0
4749641|NCT01746732|16386585|P1|Period 2|Lost to Follow-up|0
4749642|NCT01746732|16386583|P3|Period 2|Adverse Event|1
4749643|NCT01746732|16386584|P2|Period 2|Adverse Event|0
4749644|NCT01746732|16386585|P1|Period 2|Adverse Event|0
4749645|NCT01746732|16386583|P3|Period 2|Withdrawal by Subject|2
4749646|NCT01746732|16386584|P2|Period 2|Withdrawal by Subject|0
4749647|NCT01746732|16386585|P1|Period 2|Withdrawal by Subject|0
4749648|NCT01746732|16386583|P3|Period 1|Physician Decision|0
4749649|NCT01746732|16386584|P2|Period 1|Physician Decision|1
4749650|NCT01746732|16386585|P1|Period 1|Physician Decision|0
4749651|NCT01746732|16386583|P3|Lead-In Period|Withdrawal by Subject|0
4749652|NCT01746732|16386584|P2|Lead-In Period|Withdrawal by Subject|0
4749653|NCT01746732|16386585|P1|Lead-In Period|Withdrawal by Subject|1
4749654|NCT01746368|16386666|P2|Overall Study|Withdrawal by Subject|1
4749655|NCT01746368|16386667|P1|Overall Study|Withdrawal by Subject|0
4749656|NCT01746368|16386666|P2|Overall Study|Lost to Follow-up|0
4749657|NCT01746368|16386667|P1|Overall Study|Lost to Follow-up|2
4749658|NCT01746225|16386697|P3|Overall Study|Continuing Treatment|3
4749659|NCT01746225|16386698|P2|Overall Study|Continuing Treatment|8
4749660|NCT01746225|16386699|P1|Overall Study|Continuing Treatment|5
4749661|NCT01746225|16386697|P3|Overall Study|Adverse Event|17
4749662|NCT01746225|16386698|P2|Overall Study|Adverse Event|12
4749663|NCT01746225|16386699|P1|Overall Study|Adverse Event|15
4749664|NCT01746225|16386697|P3|Overall Study|Physician Decision|3
4749665|NCT01746225|16386698|P2|Overall Study|Physician Decision|11
4749666|NCT01746225|16386699|P1|Overall Study|Physician Decision|14
4749667|NCT01746225|16386697|P3|Overall Study|Withdrawal by Subject|19
4749668|NCT01746225|16386698|P2|Overall Study|Withdrawal by Subject|15
4749669|NCT01746225|16386699|P1|Overall Study|Withdrawal by Subject|5
4749670|NCT01746225|16386697|P3|Overall Study|Death|1
4749671|NCT01746225|16386698|P2|Overall Study|Death|0
4749672|NCT01746225|16386699|P1|Overall Study|Death|1
4749673|NCT01746173|16386722|P1|Overall Study|Disease Progression|2
4749674|NCT01746108|16386730|P3|Overall Study|Lost to Follow-up|0
4749675|NCT01746108|16386731|P2|Overall Study|Lost to Follow-up|1
4749676|NCT01746108|16386732|P1|Overall Study|Lost to Follow-up|0
4749677|NCT01746108|16386730|P3|Overall Study|Withdrawal by Subject|0
4749678|NCT01746108|16386731|P2|Overall Study|Withdrawal by Subject|1
4749679|NCT01746108|16386732|P1|Overall Study|Withdrawal by Subject|0
4749680|NCT01746108|16386730|P3|Overall Study|Adverse event, non-fatal|0
4749681|NCT01746108|16386731|P2|Overall Study|Adverse event, non-fatal|1
4749682|NCT01746108|16386732|P1|Overall Study|Adverse event, non-fatal|0
4749683|NCT01746108|16386730|P3|Overall Study|Migrated /moved from study area|0
4749684|NCT01746108|16386731|P2|Overall Study|Migrated /moved from study area|1
4749685|NCT01746108|16386732|P1|Overall Study|Migrated /moved from study area|0
4749686|NCT01746017|16386849|P11|Period 3|Withdrawal by Subject|0
4749687|NCT01746017|16386850|P10|Period 3|Withdrawal by Subject|0
4749688|NCT01746017|16386851|P9|Period 3|Withdrawal by Subject|0
4749689|NCT01746017|16386852|P8|Period 3|Withdrawal by Subject|0
4749690|NCT01746017|16386853|P7|Period 3|Withdrawal by Subject|0
4749691|NCT01746017|16386854|P6|Period 3|Withdrawal by Subject|1
4749692|NCT01746017|16386855|P5|Period 3|Withdrawal by Subject|0
4749693|NCT01746017|16386856|P4|Period 3|Withdrawal by Subject|0
4749694|NCT01746017|16386857|P3|Period 3|Withdrawal by Subject|0
4749695|NCT01746017|16386858|P2|Period 3|Withdrawal by Subject|0
4749696|NCT01746017|16386859|P1|Period 3|Withdrawal by Subject|0
4749697|NCT01746017|16386849|P11|Period 1|Withdrawal by Subject|0
4749698|NCT01746017|16386850|P10|Period 1|Withdrawal by Subject|0
4749699|NCT01746017|16386851|P9|Period 1|Withdrawal by Subject|0
4749700|NCT01746017|16386852|P8|Period 1|Withdrawal by Subject|0
4749701|NCT01746017|16386853|P7|Period 1|Withdrawal by Subject|1
4749702|NCT01746017|16386854|P6|Period 1|Withdrawal by Subject|0
4749703|NCT01746017|16386855|P5|Period 1|Withdrawal by Subject|0
4749704|NCT01746017|16386856|P4|Period 1|Withdrawal by Subject|0
4749705|NCT01746017|16386857|P3|Period 1|Withdrawal by Subject|0
4749706|NCT01746017|16386858|P2|Period 1|Withdrawal by Subject|0
4749707|NCT01746017|16386859|P1|Period 1|Withdrawal by Subject|0
4749708|NCT01745848|16386980|P1|Overall Study|Adverse Event|6
4749709|NCT01745393|16386987|P2|12-month Follow-up|Lost to Follow-up|5
4749710|NCT01745393|16386988|P1|12-month Follow-up|Lost to Follow-up|6
4749711|NCT01745393|16386987|P2|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0
4749712|NCT01745393|16386988|P1|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1
4749713|NCT01745393|16386987|P2|Treatment to End-of-treatment Assessment|Lost to Follow-up|8
4749714|NCT01745393|16386988|P1|Treatment to End-of-treatment Assessment|Lost to Follow-up|20
4749715|NCT01745380|16387000|P2|Overall Study|Lack of Efficacy|1
4749716|NCT01745380|16387001|P1|Overall Study|Lack of Efficacy|0
4749717|NCT01745380|16387000|P2|Overall Study|Lost to Follow-up|0
4749718|NCT01745380|16387001|P1|Overall Study|Lost to Follow-up|1
4749719|NCT01745367|16387039|P2|Overall Study|Other Reasons Unspecified|2
4749720|NCT01745367|16387040|P1|Overall Study|Other Reasons Unspecified|0
4749721|NCT01745367|16387039|P2|Overall Study|Termination of The Study by The Sponsor|18
4749722|NCT01745367|16387040|P1|Overall Study|Termination of The Study by The Sponsor|6
4749723|NCT01745367|16387039|P2|Overall Study|Withdrawal by Subject|2
4749724|NCT01745367|16387040|P1|Overall Study|Withdrawal by Subject|1
4749725|NCT01745367|16387039|P2|Overall Study|Death|0
4749726|NCT01745367|16387040|P1|Overall Study|Death|1
4749727|NCT01745146|16387060|P2|Overall Study|Lost to Follow-up|0
4749728|NCT01745146|16387061|P1|Overall Study|Lost to Follow-up|2
4749729|NCT01745146|16387060|P2|Overall Study|Withdrawal by Subject|3
4749730|NCT01745146|16387061|P1|Overall Study|Withdrawal by Subject|1
4749731|NCT01745120|16387083|P2|Overall Study|Investigator decision|0
4749732|NCT01745120|16387084|P1|Overall Study|Investigator decision|1
4749733|NCT01745094|16387142|P4|Overall Study|Untenable Due to Recurrent Cystitis|0
4749734|NCT01745094|16387143|P3|Overall Study|Untenable Due to Recurrent Cystitis|0
4749735|NCT01745094|16387144|P2|Overall Study|Untenable Due to Recurrent Cystitis|0
4749736|NCT01745094|16387145|P1|Overall Study|Untenable Due to Recurrent Cystitis|1
4749737|NCT01745094|16387142|P4|Overall Study|Show no Stable Solifenacin Intake|0
4749738|NCT01745094|16387143|P3|Overall Study|Show no Stable Solifenacin Intake|1
4749739|NCT01745094|16387144|P2|Overall Study|Show no Stable Solifenacin Intake|0
4749740|NCT01745094|16387145|P1|Overall Study|Show no Stable Solifenacin Intake|0
4749741|NCT01745094|16387142|P4|Overall Study|Need Further Examinations Due to Biopsy|0
4749742|NCT01745094|16387143|P3|Overall Study|Need Further Examinations Due to Biopsy|1
4749743|NCT01745094|16387144|P2|Overall Study|Need Further Examinations Due to Biopsy|0
4749744|NCT01745094|16387145|P1|Overall Study|Need Further Examinations Due to Biopsy|0
4749745|NCT01745094|16387142|P4|Overall Study|Protocol Violation|1
4749746|NCT01745094|16387143|P3|Overall Study|Protocol Violation|3
4749747|NCT01745094|16387144|P2|Overall Study|Protocol Violation|0
4749748|NCT01745094|16387145|P1|Overall Study|Protocol Violation|1
4749749|NCT01745094|16387142|P4|Overall Study|Withdrawal by Subject|2
4749750|NCT01745094|16387143|P3|Overall Study|Withdrawal by Subject|1
4749751|NCT01745094|16387144|P2|Overall Study|Withdrawal by Subject|0
4749752|NCT01745094|16387145|P1|Overall Study|Withdrawal by Subject|2
4749753|NCT01745094|16387142|P4|Overall Study|Adverse Event|0
4749754|NCT01745094|16387143|P3|Overall Study|Adverse Event|3
4749755|NCT01745094|16387144|P2|Overall Study|Adverse Event|0
4749756|NCT01745094|16387145|P1|Overall Study|Adverse Event|0
4749757|NCT01745094|16387142|P4|Overall Study|Not Meeting the Eligibility Criteria|0
4749758|NCT01745094|16387143|P3|Overall Study|Not Meeting the Eligibility Criteria|3
4749759|NCT01745094|16387144|P2|Overall Study|Not Meeting the Eligibility Criteria|0
4749760|NCT01745094|16387145|P1|Overall Study|Not Meeting the Eligibility Criteria|1
4749761|NCT01744977|16387246|P2|Overall Study|No longer meets inclusion|0
4749762|NCT01744977|16387247|P1|Overall Study|No longer meets inclusion|6
4749763|NCT01744977|16387246|P2|Overall Study|Lost to Follow-up|0
4749764|NCT01744977|16387247|P1|Overall Study|Lost to Follow-up|2
4749765|NCT01744977|16387246|P2|Overall Study|Death|3
4749766|NCT01744977|16387247|P1|Overall Study|Death|2
4749767|NCT01744977|16387246|P2|Overall Study|Withdrawal by Subject|2
4749768|NCT01744977|16387247|P1|Overall Study|Withdrawal by Subject|1
4749769|NCT01744782|16387318|P1|Overall Study|Death|1
4749770|NCT01744691|16387479|P1|Overall Study|Physician Decision|4
4749771|NCT01744691|16387479|P1|Overall Study|Withdrawal of consent for treatment|3
4749772|NCT01744691|16387479|P1|Overall Study|Unacceptable toxicity, AE or death|18
4749773|NCT01744691|16387479|P1|Overall Study|Progressive Disease|18
4749774|NCT01744665|16387484|P1|Re-initiation Phase|Withdrawal by Subject|1
4749775|NCT01744665|16387484|P1|Re-initiation Phase|No longer required treatment|1
4749776|NCT01744665|16387484|P1|Re-initiation Phase|Adverse Event|1
4749777|NCT01744665|16387484|P1|Re-initiation Phase|Administrative problems|10
4749778|NCT01744665|16387484|P1|Consolidation Phase|Administrative problems|9
4749779|NCT01744665|16387484|P1|Consolidation Phase|Withdrawal by Subject|4
4749780|NCT01744665|16387484|P1|Consolidation Phase|Unsatisfactory therapeutic effect|4
4749781|NCT01744665|16387484|P1|Consolidation Phase|Adverse Event|2
4749782|NCT01744665|16387484|P1|Monitoring Phase|Did not achieve MR4.5|1
4749783|NCT01744665|16387484|P1|Monitoring Phase|Withdrawal by Subject|5
4749784|NCT01744665|16387484|P1|Monitoring Phase|Unsatisfactory therapeutic effect|7
4749785|NCT01744665|16387484|P1|Monitoring Phase|Abnormal laboratory value(s)|1
4749786|NCT01744665|16387484|P1|Monitoring Phase|Adverse Event|4
4749787|NCT01744496|16387554|P2|Maintenance Period|Subject left town|0
4749788|NCT01744496|16387555|P1|Maintenance Period|Subject left town|1
4749789|NCT01744496|16387554|P2|Maintenance Period|Withdrawal by Subject|1
4749790|NCT01744496|16387555|P1|Maintenance Period|Withdrawal by Subject|1
4749791|NCT01744496|16387554|P2|Maintenance Period|Protocol Violation|0
4749792|NCT01744496|16387555|P1|Maintenance Period|Protocol Violation|1
4749793|NCT01744496|16387554|P2|Maintenance Period|Adverse Event|3
4749794|NCT01744496|16387555|P1|Maintenance Period|Adverse Event|1
4749795|NCT01744496|16387554|P2|Titration Period|Personal reasons|1
4749796|NCT01744496|16387555|P1|Titration Period|Personal reasons|0
4749797|NCT01744496|16387554|P2|Titration Period|Adverse Event|1
4749798|NCT01744496|16387555|P1|Titration Period|Adverse Event|2
4749799|NCT01744483|16387576|P3|Overall Study|Routed to OSH|1
4749800|NCT01744483|16387577|P2|Overall Study|Routed to OSH|0
4749801|NCT01744483|16387578|P1|Overall Study|Routed to OSH|2
4749802|NCT01744483|16387576|P3|Overall Study|No ICU Admit|2
4749803|NCT01744483|16387577|P2|Overall Study|No ICU Admit|1
4749804|NCT01744483|16387578|P1|Overall Study|No ICU Admit|5
4749805|NCT01744483|16387576|P3|Overall Study|Withdrawal by Subject|2
4749806|NCT01744483|16387577|P2|Overall Study|Withdrawal by Subject|6
4749807|NCT01744483|16387578|P1|Overall Study|Withdrawal by Subject|4
4749808|NCT01744483|16387576|P3|Overall Study|Protocol Violation|1
4749809|NCT01744483|16387577|P2|Overall Study|Protocol Violation|2
4749810|NCT01744483|16387578|P1|Overall Study|Protocol Violation|1
4749811|NCT01744483|16387576|P3|Overall Study|Lost to Follow-up|11
4749812|NCT01744483|16387577|P2|Overall Study|Lost to Follow-up|9
4749813|NCT01744483|16387578|P1|Overall Study|Lost to Follow-up|8
4749814|NCT01744483|16387576|P3|Overall Study|Death|11
4749815|NCT01744483|16387577|P2|Overall Study|Death|4
4749816|NCT01744483|16387578|P1|Overall Study|Death|9
4749817|NCT01744392|16387586|P1|Overall Study|Physician Decision|1
4749818|NCT01744197|16387626|P2|Overall Study|No patch received|2
4749819|NCT01744197|16387627|P1|Overall Study|No patch received|2
4749820|NCT01744197|16387626|P2|Overall Study|Received 1 patch|1
4749821|NCT01744197|16387627|P1|Overall Study|Received 1 patch|2
4749822|NCT01743560|16387720|P1|Overall Study|>1 dose of study drug|3
4749823|NCT01743560|16387720|P1|Overall Study|Protocol Violation|1
4749824|NCT01743560|16387720|P1|Overall Study|Withdrawal by Subject|2
4749825|NCT01743560|16387720|P1|Overall Study|Death|3
4749826|NCT01743560|16387720|P1|Overall Study|Adverse Event|8
4749827|NCT01743560|16387720|P1|Overall Study|Disease progression|26
4749828|NCT01743469|16387804|P4|Follow-up Period - Post-Treatment|Lost to Follow-up|0
4749829|NCT01743469|16387805|P3|Follow-up Period - Post-Treatment|Lost to Follow-up|0
4749830|NCT01743469|16387806|P2|Follow-up Period - Post-Treatment|Lost to Follow-up|1
4749831|NCT01743469|16387807|P1|Follow-up Period - Post-Treatment|Lost to Follow-up|1
4749832|NCT01743469|16387804|P4|Follow-up Period - Post-Treatment|Death|16
4749833|NCT01743469|16387805|P3|Follow-up Period - Post-Treatment|Death|22
4749834|NCT01743469|16387806|P2|Follow-up Period - Post-Treatment|Death|47
4749835|NCT01743469|16387807|P1|Follow-up Period - Post-Treatment|Death|43
4749836|NCT01743469|16387804|P4|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
4749837|NCT01743469|16387805|P3|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
4749838|NCT01743469|16387806|P2|Follow-up Period - Post-Treatment|Withdrawal by Subject|0
4749839|NCT01743469|16387807|P1|Follow-up Period - Post-Treatment|Withdrawal by Subject|1
4749840|NCT01743469|16387804|P4|Active Treatment Phase|Missing|0
4749841|NCT01743469|16387805|P3|Active Treatment Phase|Missing|0
4749842|NCT01743469|16387806|P2|Active Treatment Phase|Missing|0
4749843|NCT01743469|16387807|P1|Active Treatment Phase|Missing|1
4749844|NCT01743469|16387804|P4|Active Treatment Phase|Withdrawal by Subject|0
4749845|NCT01743469|16387805|P3|Active Treatment Phase|Withdrawal by Subject|0
4749846|NCT01743469|16387806|P2|Active Treatment Phase|Withdrawal by Subject|3
4749847|NCT01743469|16387807|P1|Active Treatment Phase|Withdrawal by Subject|2
4749848|NCT01743469|16387804|P4|Active Treatment Phase|Disease Progression|20
4749849|NCT01743469|16387805|P3|Active Treatment Phase|Disease Progression|30
4749850|NCT01743469|16387806|P2|Active Treatment Phase|Disease Progression|47
4749851|NCT01743469|16387807|P1|Active Treatment Phase|Disease Progression|40
4749852|NCT01743469|16387804|P4|Active Treatment Phase|Adverse Event|1
4749853|NCT01743469|16387805|P3|Active Treatment Phase|Adverse Event|8
4749854|NCT01743469|16387806|P2|Active Treatment Phase|Adverse Event|5
4749855|NCT01743469|16387807|P1|Active Treatment Phase|Adverse Event|10
4749856|NCT01743092|16387872|P2|Overall Study|Lost to Follow-up|15
4749857|NCT01743092|16387873|P1|Overall Study|Lost to Follow-up|14
4749858|NCT01743040|16387881|P1|Overall Study|Withdrawal by Subject|121
4749859|NCT01743040|16387881|P1|Overall Study|Protocol Violation|1
4749860|NCT01743040|16387881|P1|Overall Study|Physician Decision|40
4749861|NCT01743040|16387881|P1|Overall Study|Lost to Follow-up|66
4749862|NCT01743040|16387881|P1|Overall Study|Death|1
4749863|NCT01743027|16387889|P4|Overall Study|Withdrawal by Subject|1
4749864|NCT01743027|16387890|P3|Overall Study|Withdrawal by Subject|3
4749865|NCT01743027|16387891|P2|Overall Study|Withdrawal by Subject|0
4749866|NCT01743027|16387892|P1|Overall Study|Withdrawal by Subject|1
4749867|NCT01743027|16387889|P4|Overall Study|Protocol Violation|0
4749868|NCT01743027|16387890|P3|Overall Study|Protocol Violation|1
4749869|NCT01743027|16387891|P2|Overall Study|Protocol Violation|1
4749870|NCT01743027|16387892|P1|Overall Study|Protocol Violation|1
4749871|NCT01743027|16387889|P4|Overall Study|Progressive Disease|0
4749872|NCT01743027|16387890|P3|Overall Study|Progressive Disease|3
4749873|NCT01743027|16387891|P2|Overall Study|Progressive Disease|4
4749874|NCT01743027|16387892|P1|Overall Study|Progressive Disease|1
4749875|NCT01743027|16387889|P4|Overall Study|Lost to Follow-up|0
4749876|NCT01743027|16387890|P3|Overall Study|Lost to Follow-up|2
4749877|NCT01743027|16387891|P2|Overall Study|Lost to Follow-up|0
4749878|NCT01743027|16387892|P1|Overall Study|Lost to Follow-up|0
4749879|NCT01743027|16387889|P4|Overall Study|Adverse Event|0
4749880|NCT01743027|16387890|P3|Overall Study|Adverse Event|0
4749881|NCT01743027|16387891|P2|Overall Study|Adverse Event|0
4749882|NCT01743027|16387892|P1|Overall Study|Adverse Event|2
4749883|NCT01743001|16387932|P2|Overall Study|Death|0
4749884|NCT01743001|16387933|P1|Overall Study|Death|1
4749885|NCT01743001|16387932|P2|Overall Study|Pregnancy|0
4749886|NCT01743001|16387933|P1|Overall Study|Pregnancy|1
4749887|NCT01743001|16387932|P2|Overall Study|Physician Decision|0
4749888|NCT01743001|16387933|P1|Overall Study|Physician Decision|1
4749889|NCT01742897|16387976|P1|Overall Study|Other|1
4749890|NCT01742897|16387976|P1|Overall Study|Withdrawal by Subject|1
4749891|NCT01742897|16387976|P1|Overall Study|Adverse Event|3
4749892|NCT01742286|16388029|P7|Expansion Phase|Withdrawal by Subject|1
4749893|NCT01742286|16388030|P6|Expansion Phase|Withdrawal by Subject|0
4749894|NCT01742286|16388031|P5|Expansion Phase|Withdrawal by Subject|0
4749895|NCT01742286|16388032|P4|Expansion Phase|Withdrawal by Subject|0
4749896|NCT01742286|16388033|P3|Expansion Phase|Withdrawal by Subject|0
4749897|NCT01742286|16388034|P2|Expansion Phase|Withdrawal by Subject|0
4749898|NCT01742286|16388035|P1|Expansion Phase|Withdrawal by Subject|0
4749899|NCT01742286|16388029|P7|Expansion Phase|Disease progression|15
4749900|NCT01742286|16388030|P6|Expansion Phase|Disease progression|0
4749901|NCT01742286|16388031|P5|Expansion Phase|Disease progression|0
4749902|NCT01742286|16388032|P4|Expansion Phase|Disease progression|0
4749903|NCT01742286|16388033|P3|Expansion Phase|Disease progression|3
4749904|NCT01742286|16388034|P2|Expansion Phase|Disease progression|0
4749905|NCT01742286|16388035|P1|Expansion Phase|Disease progression|0
4749906|NCT01742286|16388029|P7|Expansion Phase|Adverse Event|6
4749907|NCT01742286|16388030|P6|Expansion Phase|Adverse Event|0
4749908|NCT01742286|16388031|P5|Expansion Phase|Adverse Event|0
4749909|NCT01742286|16388032|P4|Expansion Phase|Adverse Event|0
4749910|NCT01742286|16388033|P3|Expansion Phase|Adverse Event|0
4749911|NCT01742286|16388034|P2|Expansion Phase|Adverse Event|0
4749912|NCT01742286|16388035|P1|Expansion Phase|Adverse Event|0
4749913|NCT01742286|16388029|P7|Expansion Phase|Physician Decision|9
4749914|NCT01742286|16388030|P6|Expansion Phase|Physician Decision|0
4749915|NCT01742286|16388031|P5|Expansion Phase|Physician Decision|0
4749916|NCT01742286|16388032|P4|Expansion Phase|Physician Decision|0
4749917|NCT01742286|16388033|P3|Expansion Phase|Physician Decision|4
4749918|NCT01742286|16388034|P2|Expansion Phase|Physician Decision|0
4749919|NCT01742286|16388035|P1|Expansion Phase|Physician Decision|0
4749920|NCT01742286|16388029|P7|Expansion Phase|Administrative problems|5
4749921|NCT01742286|16388030|P6|Expansion Phase|Administrative problems|0
4749922|NCT01742286|16388031|P5|Expansion Phase|Administrative problems|0
4749923|NCT01742286|16388032|P4|Expansion Phase|Administrative problems|0
4749924|NCT01742286|16388033|P3|Expansion Phase|Administrative problems|0
4749925|NCT01742286|16388034|P2|Expansion Phase|Administrative problems|0
4749926|NCT01742286|16388035|P1|Expansion Phase|Administrative problems|0
4749927|NCT01742286|16388029|P7|Escalation Phase|Subject/guardian decision|0
4749928|NCT01742286|16388030|P6|Escalation Phase|Subject/guardian decision|0
4749929|NCT01742286|16388031|P5|Escalation Phase|Subject/guardian decision|0
4749930|NCT01742286|16388032|P4|Escalation Phase|Subject/guardian decision|0
4749931|NCT01742286|16388033|P3|Escalation Phase|Subject/guardian decision|0
4749932|NCT01742286|16388034|P2|Escalation Phase|Subject/guardian decision|0
4749933|NCT01742286|16388035|P1|Escalation Phase|Subject/guardian decision|1
4749934|NCT01742286|16388029|P7|Escalation Phase|Physician Decision|2
4749935|NCT01742286|16388030|P6|Escalation Phase|Physician Decision|0
4749936|NCT01742286|16388031|P5|Escalation Phase|Physician Decision|0
4749937|NCT01742286|16388032|P4|Escalation Phase|Physician Decision|1
4749938|NCT01742286|16388033|P3|Escalation Phase|Physician Decision|0
4749939|NCT01742286|16388034|P2|Escalation Phase|Physician Decision|3
4749940|NCT01742286|16388035|P1|Escalation Phase|Physician Decision|0
4749941|NCT01742286|16388029|P7|Escalation Phase|Death|0
4749942|NCT01742286|16388030|P6|Escalation Phase|Death|1
4749943|NCT01742286|16388031|P5|Escalation Phase|Death|0
4749944|NCT01742286|16388032|P4|Escalation Phase|Death|0
4749945|NCT01742286|16388033|P3|Escalation Phase|Death|0
4749946|NCT01742286|16388034|P2|Escalation Phase|Death|0
4749947|NCT01742286|16388035|P1|Escalation Phase|Death|0
4749948|NCT01742286|16388029|P7|Escalation Phase|Disease progression|2
4749949|NCT01742286|16388030|P6|Escalation Phase|Disease progression|3
4749950|NCT01742286|16388031|P5|Escalation Phase|Disease progression|4
4749951|NCT01742286|16388032|P4|Escalation Phase|Disease progression|1
4749952|NCT01742286|16388033|P3|Escalation Phase|Disease progression|4
4749953|NCT01742286|16388034|P2|Escalation Phase|Disease progression|7
4749954|NCT01742286|16388035|P1|Escalation Phase|Disease progression|3
4749955|NCT01742286|16388029|P7|Escalation Phase|Adverse Event|0
4749956|NCT01742286|16388030|P6|Escalation Phase|Adverse Event|1
4749957|NCT01742286|16388031|P5|Escalation Phase|Adverse Event|0
4749958|NCT01742286|16388032|P4|Escalation Phase|Adverse Event|0
4749959|NCT01742286|16388033|P3|Escalation Phase|Adverse Event|2
4749960|NCT01742286|16388034|P2|Escalation Phase|Adverse Event|1
4749961|NCT01742286|16388035|P1|Escalation Phase|Adverse Event|0
4749962|NCT01742286|16388029|P7|Escalation Phase|Administrative problems|2
4749963|NCT01742286|16388030|P6|Escalation Phase|Administrative problems|0
4749964|NCT01742286|16388031|P5|Escalation Phase|Administrative problems|0
4749965|NCT01742286|16388032|P4|Escalation Phase|Administrative problems|0
4749966|NCT01742286|16388033|P3|Escalation Phase|Administrative problems|0
4749967|NCT01742286|16388034|P2|Escalation Phase|Administrative problems|1
4749968|NCT01742286|16388035|P1|Escalation Phase|Administrative problems|1
4749969|NCT01742091|16388168|P6|Overall Study|Lost to Follow-up|1
4749970|NCT01742091|16388169|P5|Overall Study|Lost to Follow-up|0
4749971|NCT01742091|16388170|P4|Overall Study|Lost to Follow-up|0
4749972|NCT01742091|16388171|P3|Overall Study|Lost to Follow-up|0
4749973|NCT01742091|16388172|P2|Overall Study|Lost to Follow-up|0
4749974|NCT01742091|16388173|P1|Overall Study|Lost to Follow-up|0
4749975|NCT01742091|16388168|P6|Overall Study|Withdrawal by Subject|0
4749976|NCT01742091|16388169|P5|Overall Study|Withdrawal by Subject|0
4749977|NCT01742091|16388170|P4|Overall Study|Withdrawal by Subject|1
4749978|NCT01742091|16388171|P3|Overall Study|Withdrawal by Subject|0
4749979|NCT01742091|16388172|P2|Overall Study|Withdrawal by Subject|0
4749980|NCT01742091|16388173|P1|Overall Study|Withdrawal by Subject|0
4749981|NCT01742091|16388168|P6|Overall Study|Physician Decision|1
4749982|NCT01742091|16388169|P5|Overall Study|Physician Decision|0
4749983|NCT01742091|16388170|P4|Overall Study|Physician Decision|0
4749984|NCT01742091|16388171|P3|Overall Study|Physician Decision|0
4749985|NCT01742091|16388172|P2|Overall Study|Physician Decision|0
4749986|NCT01742091|16388173|P1|Overall Study|Physician Decision|0
4749987|NCT01742091|16388168|P6|Overall Study|Adverse Event|0
4749988|NCT01742091|16388169|P5|Overall Study|Adverse Event|1
4749989|NCT01742091|16388170|P4|Overall Study|Adverse Event|0
4749990|NCT01742091|16388171|P3|Overall Study|Adverse Event|0
4749991|NCT01742091|16388172|P2|Overall Study|Adverse Event|0
4749992|NCT01742091|16388173|P1|Overall Study|Adverse Event|0
4749993|NCT01742078|16388219|P9|Overall Study|Withdrawal by Subject|0
4749994|NCT01742078|16388220|P8|Overall Study|Withdrawal by Subject|0
4749995|NCT01742078|16388221|P7|Overall Study|Withdrawal by Subject|0
4749996|NCT01742078|16388222|P6|Overall Study|Withdrawal by Subject|0
4749997|NCT01742078|16388223|P5|Overall Study|Withdrawal by Subject|0
4749998|NCT01742078|16388224|P4|Overall Study|Withdrawal by Subject|1
4749999|NCT01742078|16388225|P3|Overall Study|Withdrawal by Subject|0
4750000|NCT01742078|16388226|P2|Overall Study|Withdrawal by Subject|0
4750001|NCT01742078|16388227|P1|Overall Study|Withdrawal by Subject|0
4750002|NCT01741792|16388296|P3|Overall Study|Death|12
4750003|NCT01741792|16388297|P2|Overall Study|Death|1
4750004|NCT01741792|16388298|P1|Overall Study|Death|6
4750005|NCT01741701|16388365|P2|Overall Study|Withdrawal by Subject|1
4750006|NCT01741701|16388366|P1|Overall Study|Withdrawal by Subject|0
4750007|NCT01741701|16388365|P2|Overall Study|Adverse Event|1
4750008|NCT01741701|16388366|P1|Overall Study|Adverse Event|5
4750009|NCT01741688|16388382|P1|Overall Study|Withdrawal by Subject|1
4750010|NCT01741688|16388382|P1|Overall Study|Lack of insurance coverage|2
4750011|NCT01741545|16388401|P2|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
4750012|NCT01741545|16388402|P1|Follow-up Period (24 Weeks)|Withdrawal by Subject|1
4750013|NCT01741545|16388401|P2|Follow-up Period (24 Weeks)|Other than specified|1
4750014|NCT01741545|16388402|P1|Follow-up Period (24 Weeks)|Other than specified|0
4750015|NCT01741545|16388401|P2|Treatment Period|Adverse event, non-fatal|3
4750016|NCT01741545|16388402|P1|Treatment Period|Adverse event, non-fatal|1
4750017|NCT01741545|16388401|P2|Treatment Period|Lack of Efficacy|1
4750018|NCT01741545|16388402|P1|Treatment Period|Lack of Efficacy|0
4750019|NCT01741532|16388426|P2|Overall Study|Medical event|0
4750020|NCT01741532|16388427|P1|Overall Study|Medical event|1
4750021|NCT01741532|16388426|P2|Overall Study|Sponsor decision|0
4750022|NCT01741532|16388427|P1|Overall Study|Sponsor decision|1
4750023|NCT01741532|16388426|P2|Overall Study|Worsening of the disease|1
4750024|NCT01741532|16388427|P1|Overall Study|Worsening of the disease|3
4750025|NCT01741532|16388426|P2|Overall Study|Protocol Violation|1
4750026|NCT01741532|16388427|P1|Overall Study|Protocol Violation|0
4750027|NCT01741532|16388426|P2|Overall Study|Withdrawal by Subject|1
4750028|NCT01741532|16388427|P1|Overall Study|Withdrawal by Subject|1
4750029|NCT01741532|16388426|P2|Overall Study|Adverse Event|0
4750030|NCT01741532|16388427|P1|Overall Study|Adverse Event|4
4750031|NCT01741259|16388641|P2|Overall Study|Withdrawal by Subject|2
4750032|NCT01741259|16388642|P1|Overall Study|Withdrawal by Subject|0
4750033|NCT01741259|16388641|P2|Overall Study|Protocol Violation|4
4750034|NCT01741259|16388642|P1|Overall Study|Protocol Violation|6
4750035|NCT01741012|16388696|P1|Overall Study|Withdrawal by Subject|2
4750036|NCT01741012|16388696|P1|Overall Study|Lost to Follow-up|1
4750037|NCT01740440|16388768|P1|Overall Study|Lost to Follow-up|3
4750038|NCT01740427|16388776|P2|Overall Study|Study terminated by Sponsor|0
4750039|NCT01740427|16388777|P1|Overall Study|Study terminated by Sponsor|1
4750040|NCT01740427|16388776|P2|Overall Study|Lost to Follow-up|0
4750041|NCT01740427|16388777|P1|Overall Study|Lost to Follow-up|1
4750042|NCT01740427|16388776|P2|Overall Study|Protocol Violation|3
4750043|NCT01740427|16388777|P1|Overall Study|Protocol Violation|5
4750044|NCT01740427|16388776|P2|Overall Study|Death|2
4750045|NCT01740427|16388777|P1|Overall Study|Death|6
4750046|NCT01740427|16388776|P2|Overall Study|Unspecified reasons|4
4750047|NCT01740427|16388777|P1|Overall Study|Unspecified reasons|6
4750048|NCT01740427|16388776|P2|Overall Study|Subject refused continued treatment|9
4750049|NCT01740427|16388777|P1|Overall Study|Subject refused continued treatment|12
4750050|NCT01740427|16388776|P2|Overall Study|Global deterioration of health status|9
4750051|NCT01740427|16388777|P1|Overall Study|Global deterioration of health status|16
4750052|NCT01740427|16388776|P2|Overall Study|Adverse Event|9
4750053|NCT01740427|16388777|P1|Overall Study|Adverse Event|20
4750054|NCT01740427|16388776|P2|Overall Study|Objective progression or relapse|125
4750055|NCT01740427|16388777|P1|Overall Study|Objective progression or relapse|172
4750056|NCT01740427|16388776|P2|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|61
4750057|NCT01740427|16388777|P1|Overall Study|Ongoing at date of cutoff (26 Feb 2016)|205
4750058|NCT01740401|16388829|P1|Overall Study|Did not reach primary endpoint|2
4750059|NCT01740401|16388829|P1|Overall Study|Adverse Event|2
4750060|NCT01740401|16388829|P1|Overall Study|Progression of disease|6
4750061|NCT01740388|16388838|P2|Overall Study|Subjects missing data, completed|36
4750062|NCT01740388|16388839|P1|Overall Study|Subjects missing data, completed|41
4750063|NCT01740388|16388838|P2|Overall Study|Physician Decision|6
4750064|NCT01740388|16388839|P1|Overall Study|Physician Decision|2
4750065|NCT01740388|16388838|P2|Overall Study|Lost to Follow-up|0
4750066|NCT01740388|16388839|P1|Overall Study|Lost to Follow-up|2
4750067|NCT01740388|16388838|P2|Overall Study|Withdrawal by Subject|2
4750068|NCT01740388|16388839|P1|Overall Study|Withdrawal by Subject|1
4750069|NCT01740323|16388890|P2|Overall Study|Randomized but did not take study drug|0
4750070|NCT01740323|16388891|P1|Overall Study|Randomized but did not take study drug|1
4750071|NCT01740323|16388890|P2|Overall Study|Adverse Event|0
4750072|NCT01740323|16388891|P1|Overall Study|Adverse Event|1
4750073|NCT01740297|16388912|P3|Overall Study|Sponsor Decision|0
4750074|NCT01740297|16388913|P2|Overall Study|Sponsor Decision|1
4750075|NCT01740297|16388914|P1|Overall Study|Sponsor Decision|0
4750076|NCT01740297|16388912|P3|Overall Study|Death|19
4750077|NCT01740297|16388913|P2|Overall Study|Death|23
4750078|NCT01740297|16388914|P1|Overall Study|Death|8
4750079|NCT01740297|16388912|P3|Overall Study|Withdrawal by Subject|11
4750080|NCT01740297|16388913|P2|Overall Study|Withdrawal by Subject|9
4750081|NCT01740297|16388914|P1|Overall Study|Withdrawal by Subject|1
4750082|NCT01740297|16388912|P3|Overall Study|Continuing Study|68
4750083|NCT01740297|16388913|P2|Overall Study|Continuing Study|67
4750084|NCT01740297|16388914|P1|Overall Study|Continuing Study|10
4750085|NCT01740154|16388963|P1|Overall Study|Adverse Event|1
4750086|NCT01740128|16388971|P2|Overall Study|Insufficient protocol compliance|2
4750087|NCT01740128|16388972|P1|Overall Study|Insufficient protocol compliance|2
4750088|NCT01740128|16388971|P2|Overall Study|Withdrawal by Subject|0
4750089|NCT01740128|16388972|P1|Overall Study|Withdrawal by Subject|1
4750090|NCT01740128|16388971|P2|Overall Study|Lost to Follow-up|2
4750091|NCT01740128|16388972|P1|Overall Study|Lost to Follow-up|2
4750092|NCT01740128|16388971|P2|Overall Study|Protocol Violation|2
4750093|NCT01740128|16388972|P1|Overall Study|Protocol Violation|1
4750094|NCT01740128|16388971|P2|Overall Study|Pregnancy|1
4750095|NCT01740128|16388972|P1|Overall Study|Pregnancy|0
4750096|NCT01740089|16389001|P3|After 12 Weeks|Withdrawal by Subject|1
4750097|NCT01740089|16389002|P2|After 12 Weeks|Withdrawal by Subject|1
4750098|NCT01740089|16389003|P1|After 12 Weeks|Withdrawal by Subject|1
4750099|NCT01740089|16389001|P3|After 12 Weeks|Protocol Violation|1
4750100|NCT01740089|16389002|P2|After 12 Weeks|Protocol Violation|1
4750101|NCT01740089|16389003|P1|After 12 Weeks|Protocol Violation|1
4750102|NCT01740089|16389001|P3|After 12 Weeks|Adverse Event|5
4750103|NCT01740089|16389002|P2|After 12 Weeks|Adverse Event|0
4750104|NCT01740089|16389003|P1|After 12 Weeks|Adverse Event|2
4750105|NCT01740089|16389001|P3|After 12 Weeks|Lack of Efficacy|4
4750106|NCT01740089|16389002|P2|After 12 Weeks|Lack of Efficacy|1
4750107|NCT01740089|16389003|P1|After 12 Weeks|Lack of Efficacy|3
4750108|NCT01740089|16389001|P3|First 12 Weeks of Treatment|Withdrawal by Subject|0
4750109|NCT01740089|16389002|P2|First 12 Weeks of Treatment|Withdrawal by Subject|1
4750110|NCT01740089|16389003|P1|First 12 Weeks of Treatment|Withdrawal by Subject|0
4750111|NCT01740089|16389001|P3|First 12 Weeks of Treatment|Adverse Event|2
4750112|NCT01740089|16389002|P2|First 12 Weeks of Treatment|Adverse Event|1
4750113|NCT01740089|16389003|P1|First 12 Weeks of Treatment|Adverse Event|0
4750114|NCT01739803|16389021|P2|Overall Study|Lost to Follow-up|6
4750115|NCT01739803|16389022|P1|Overall Study|Lost to Follow-up|9
4750116|NCT01739790|16389034|P2|Overall Study|Early Trial Termination|4
4750117|NCT01739790|16389035|P1|Overall Study|Early Trial Termination|2
4750118|NCT01739595|16389044|P3|Overall Study|Drug discrepancy|0
4750119|NCT01739595|16389045|P2|Overall Study|Drug discrepancy|0
4750120|NCT01739595|16389046|P1|Overall Study|Drug discrepancy|1
4750121|NCT01739595|16389044|P3|Overall Study|Lab assessment|0
4750122|NCT01739595|16389045|P2|Overall Study|Lab assessment|0
4750123|NCT01739595|16389046|P1|Overall Study|Lab assessment|1
4750124|NCT01739595|16389044|P3|Overall Study|Protocol Violation|0
4750125|NCT01739595|16389045|P2|Overall Study|Protocol Violation|0
4750126|NCT01739595|16389046|P1|Overall Study|Protocol Violation|1
4750127|NCT01739595|16389044|P3|Overall Study|Eligibility issue|0
4750128|NCT01739595|16389045|P2|Overall Study|Eligibility issue|0
4750129|NCT01739595|16389046|P1|Overall Study|Eligibility issue|3
4750130|NCT01739595|16389044|P3|Overall Study|Withdrawal by Subject|2
4750131|NCT01739595|16389045|P2|Overall Study|Withdrawal by Subject|1
4750132|NCT01739595|16389046|P1|Overall Study|Withdrawal by Subject|2
4750133|NCT01739595|16389044|P3|Overall Study|Lost to Follow-up|0
4750134|NCT01739595|16389045|P2|Overall Study|Lost to Follow-up|0
4750135|NCT01739595|16389046|P1|Overall Study|Lost to Follow-up|2
4750136|NCT01739595|16389044|P3|Overall Study|Adverse Event|0
4750137|NCT01739595|16389045|P2|Overall Study|Adverse Event|0
4750138|NCT01739595|16389046|P1|Overall Study|Adverse Event|3
4750139|NCT01739400|16389056|P2|Overall Study|Withdrawal by Subject|7
4750140|NCT01739400|16389057|P1|Overall Study|Withdrawal by Subject|7
4750141|NCT01739400|16389056|P2|Overall Study|Death|2
4750142|NCT01739400|16389057|P1|Overall Study|Death|5
4750143|NCT01739400|16389056|P2|Overall Study|Lost to Follow-up|0
4750144|NCT01739400|16389057|P1|Overall Study|Lost to Follow-up|2
4750145|NCT01739400|16389056|P2|Overall Study|Physician Decision|0
4750146|NCT01739400|16389057|P1|Overall Study|Physician Decision|3
4750147|NCT01739348|16389085|P4|Part II (Extension Study)|Withdrawal by Subject|7
4750148|NCT01739348|16389086|P3|Part II (Extension Study)|Withdrawal by Subject|4
4750149|NCT01739348|16389087|P2|Part II (Extension Study)|Withdrawal by Subject|2
4750150|NCT01739348|16389088|P1|Part II (Extension Study)|Withdrawal by Subject|5
4750151|NCT01739348|16389085|P4|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16
4750152|NCT01739348|16389086|P3|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8
4750153|NCT01739348|16389087|P2|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12
4750154|NCT01739348|16389088|P1|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18
4750155|NCT01739348|16389085|P4|Part II (Extension Study)|Participant Moved|3
4750156|NCT01739348|16389086|P3|Part II (Extension Study)|Participant Moved|0
4750157|NCT01739348|16389087|P2|Part II (Extension Study)|Participant Moved|3
4750158|NCT01739348|16389088|P1|Part II (Extension Study)|Participant Moved|3
4750159|NCT01739348|16389085|P4|Part II (Extension Study)|Study Terminated by Sponsor|323
4750160|NCT01739348|16389086|P3|Part II (Extension Study)|Study Terminated by Sponsor|34
4750161|NCT01739348|16389087|P2|Part II (Extension Study)|Study Terminated by Sponsor|315
4750162|NCT01739348|16389088|P1|Part II (Extension Study)|Study Terminated by Sponsor|329
4750163|NCT01739348|16389085|P4|Part II (Extension Study)|Physician Decision|12
4750164|NCT01739348|16389086|P3|Part II (Extension Study)|Physician Decision|6
4750165|NCT01739348|16389087|P2|Part II (Extension Study)|Physician Decision|11
4750166|NCT01739348|16389088|P1|Part II (Extension Study)|Physician Decision|7
4750167|NCT01739348|16389085|P4|Part II (Extension Study)|Non-Compliance with Study Drug|1
4750168|NCT01739348|16389086|P3|Part II (Extension Study)|Non-Compliance with Study Drug|0
4750169|NCT01739348|16389087|P2|Part II (Extension Study)|Non-Compliance with Study Drug|0
4750170|NCT01739348|16389088|P1|Part II (Extension Study)|Non-Compliance with Study Drug|0
4750171|NCT01739348|16389085|P4|Part II (Extension Study)|Lost to Follow-up|1
4750172|NCT01739348|16389086|P3|Part II (Extension Study)|Lost to Follow-up|0
4750173|NCT01739348|16389087|P2|Part II (Extension Study)|Lost to Follow-up|4
4750174|NCT01739348|16389088|P1|Part II (Extension Study)|Lost to Follow-up|3
4750175|NCT01739348|16389085|P4|Part II (Extension Study)|Lack of Efficacy|1
4750176|NCT01739348|16389086|P3|Part II (Extension Study)|Lack of Efficacy|0
4750177|NCT01739348|16389087|P2|Part II (Extension Study)|Lack of Efficacy|5
4750178|NCT01739348|16389088|P1|Part II (Extension Study)|Lack of Efficacy|1
4750179|NCT01739348|16389085|P4|Part II (Extension Study)|Death|6
4750180|NCT01739348|16389086|P3|Part II (Extension Study)|Death|2
4750181|NCT01739348|16389087|P2|Part II (Extension Study)|Death|3
4750182|NCT01739348|16389088|P1|Part II (Extension Study)|Death|3
4750183|NCT01739348|16389085|P4|Part II (Extension Study)|Adverse Event|26
4750184|NCT01739348|16389086|P3|Part II (Extension Study)|Adverse Event|7
4750185|NCT01739348|16389087|P2|Part II (Extension Study)|Adverse Event|11
4750186|NCT01739348|16389088|P1|Part II (Extension Study)|Adverse Event|10
4750187|NCT01739348|16389085|P4|Part I (Base Study)|Withdrawal by Subject|20
4750188|NCT01739348|16389086|P3|Part I (Base Study)|Withdrawal by Subject|7
4750189|NCT01739348|16389087|P2|Part I (Base Study)|Withdrawal by Subject|21
4750190|NCT01739348|16389088|P1|Part I (Base Study)|Withdrawal by Subject|23
4750191|NCT01739348|16389085|P4|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18
4750192|NCT01739348|16389086|P3|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2
4750193|NCT01739348|16389087|P2|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25
4750194|NCT01739348|16389088|P1|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27
4750195|NCT01739348|16389085|P4|Part I (Base Study)|Participant Moved|7
4750196|NCT01739348|16389086|P3|Part I (Base Study)|Participant Moved|1
4750197|NCT01739348|16389087|P2|Part I (Base Study)|Participant Moved|3
4750198|NCT01739348|16389088|P1|Part I (Base Study)|Participant Moved|4
4750199|NCT01739348|16389085|P4|Part I (Base Study)|Study Terminated by Sponsor|86
4750200|NCT01739348|16389086|P3|Part I (Base Study)|Study Terminated by Sponsor|0
4750201|NCT01739348|16389087|P2|Part I (Base Study)|Study Terminated by Sponsor|73
4750202|NCT01739348|16389088|P1|Part I (Base Study)|Study Terminated by Sponsor|72
4750203|NCT01739348|16389085|P4|Part I (Base Study)|Site Discontinued Study Participation|0
4750204|NCT01739348|16389086|P3|Part I (Base Study)|Site Discontinued Study Participation|0
4750205|NCT01739348|16389087|P2|Part I (Base Study)|Site Discontinued Study Participation|3
4750206|NCT01739348|16389088|P1|Part I (Base Study)|Site Discontinued Study Participation|1
4750207|NCT01739348|16389085|P4|Part I (Base Study)|Screen Failure|0
4750208|NCT01739348|16389086|P3|Part I (Base Study)|Screen Failure|0
4750209|NCT01739348|16389087|P2|Part I (Base Study)|Screen Failure|0
4750210|NCT01739348|16389088|P1|Part I (Base Study)|Screen Failure|2
4750211|NCT01739348|16389085|P4|Part I (Base Study)|Protocol Violation|2
4750212|NCT01739348|16389086|P3|Part I (Base Study)|Protocol Violation|1
4750213|NCT01739348|16389087|P2|Part I (Base Study)|Protocol Violation|0
4750214|NCT01739348|16389088|P1|Part I (Base Study)|Protocol Violation|2
4750215|NCT01739348|16389085|P4|Part I (Base Study)|Physician Decision|4
4750216|NCT01739348|16389086|P3|Part I (Base Study)|Physician Decision|1
4750217|NCT01739348|16389087|P2|Part I (Base Study)|Physician Decision|7
4750218|NCT01739348|16389088|P1|Part I (Base Study)|Physician Decision|10
4750219|NCT01739348|16389085|P4|Part I (Base Study)|Non-Compliance with Study Drug|0
4750220|NCT01739348|16389086|P3|Part I (Base Study)|Non-Compliance with Study Drug|0
4750221|NCT01739348|16389087|P2|Part I (Base Study)|Non-Compliance with Study Drug|2
4750222|NCT01739348|16389088|P1|Part I (Base Study)|Non-Compliance with Study Drug|3
4750223|NCT01739348|16389085|P4|Part I (Base Study)|Lost to Follow-up|4
4750224|NCT01739348|16389086|P3|Part I (Base Study)|Lost to Follow-up|4
4750225|NCT01739348|16389087|P2|Part I (Base Study)|Lost to Follow-up|2
4750226|NCT01739348|16389088|P1|Part I (Base Study)|Lost to Follow-up|4
4750227|NCT01739348|16389085|P4|Part I (Base Study)|Lack of Efficacy|7
4750228|NCT01739348|16389086|P3|Part I (Base Study)|Lack of Efficacy|0
4750229|NCT01739348|16389087|P2|Part I (Base Study)|Lack of Efficacy|8
4750230|NCT01739348|16389088|P1|Part I (Base Study)|Lack of Efficacy|3
4750231|NCT01739348|16389085|P4|Part I (Base Study)|Death|8
4750232|NCT01739348|16389086|P3|Part I (Base Study)|Death|2
4750233|NCT01739348|16389087|P2|Part I (Base Study)|Death|7
4750234|NCT01739348|16389088|P1|Part I (Base Study)|Death|10
4750235|NCT01739348|16389085|P4|Part I (Base Study)|Adverse Event|33
4750236|NCT01739348|16389086|P3|Part I (Base Study)|Adverse Event|8
4750237|NCT01739348|16389087|P2|Part I (Base Study)|Adverse Event|52
4750238|NCT01739348|16389088|P1|Part I (Base Study)|Adverse Event|41
4750239|NCT01739335|16389160|P2|Overall Study|Ineligible patient randomized|1
4750240|NCT01739335|16389161|P1|Overall Study|Ineligible patient randomized|0
4750241|NCT01739335|16389160|P2|Overall Study|Lost to Follow-up|4
4750242|NCT01739335|16389161|P1|Overall Study|Lost to Follow-up|7
4750243|NCT01739309|16389193|P1|Overall Study|On study treatment|3
4750244|NCT01738984|16389388|P2|Overall Study|Lost to Follow-up|39
4750245|NCT01738984|16389389|P1|Overall Study|Lost to Follow-up|59
4750246|NCT01738984|16389388|P2|Overall Study|Withdrawal by Subject|0
4750247|NCT01738984|16389389|P1|Overall Study|Withdrawal by Subject|1
4750248|NCT01738984|16389388|P2|Overall Study|Pregnancy|0
4750249|NCT01738984|16389389|P1|Overall Study|Pregnancy|4
4750250|NCT01738971|16389402|P3|Overall Study|Lost to Follow-up|17
4750251|NCT01738971|16389403|P2|Overall Study|Lost to Follow-up|30
4750252|NCT01738971|16389404|P1|Overall Study|Lost to Follow-up|19
4750253|NCT01738919|16389420|P2|Overall Study|Not treated in accordance to guidelines|1
4750254|NCT01738919|16389421|P1|Overall Study|Not treated in accordance to guidelines|0
4750255|NCT01738919|16389420|P2|Overall Study|Withdrawal by Subject|1
4750256|NCT01738919|16389421|P1|Overall Study|Withdrawal by Subject|0
4750257|NCT01738919|16389420|P2|Overall Study|Immigrated|1
4750258|NCT01738919|16389421|P1|Overall Study|Immigrated|0
4750259|NCT01738919|16389420|P2|Overall Study|Lost to Follow-up|0
4750260|NCT01738919|16389421|P1|Overall Study|Lost to Follow-up|1
4750261|NCT01738646|16389571|P1|Overall Study|Still Receiving Treatment|2
4750262|NCT01738594|16389582|P8|Follow up for 1 Year|Other|0
4750263|NCT01738594|16389583|P7|Follow up for 1 Year|Other|0
4750264|NCT01738594|16389584|P6|Follow up for 1 Year|Other|2
4750265|NCT01738594|16389585|P5|Follow up for 1 Year|Other|0
4750266|NCT01738594|16389586|P4|Follow up for 1 Year|Other|0
4750267|NCT01738594|16389587|P3|Follow up for 1 Year|Other|0
4750268|NCT01738594|16389588|P2|Follow up for 1 Year|Other|0
4750269|NCT01738594|16389589|P1|Follow up for 1 Year|Other|0
4750270|NCT01738594|16389582|P8|Follow up for 1 Year|Death|0
4750271|NCT01738594|16389583|P7|Follow up for 1 Year|Death|0
4750272|NCT01738594|16389584|P6|Follow up for 1 Year|Death|1
4750273|NCT01738594|16389585|P5|Follow up for 1 Year|Death|0
4750274|NCT01738594|16389586|P4|Follow up for 1 Year|Death|0
4750275|NCT01738594|16389587|P3|Follow up for 1 Year|Death|0
4750276|NCT01738594|16389588|P2|Follow up for 1 Year|Death|0
4750277|NCT01738594|16389589|P1|Follow up for 1 Year|Death|0
4750278|NCT01738594|16389582|P8|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750279|NCT01738594|16389583|P7|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750280|NCT01738594|16389584|P6|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750281|NCT01738594|16389585|P5|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1
4750282|NCT01738594|16389586|P4|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750283|NCT01738594|16389587|P3|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750284|NCT01738594|16389588|P2|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750285|NCT01738594|16389589|P1|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0
4750286|NCT01738594|16389582|P8|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750287|NCT01738594|16389583|P7|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750288|NCT01738594|16389584|P6|Went on to Continue Treatment Cycle 5|Progressive Disease|1
4750289|NCT01738594|16389585|P5|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750290|NCT01738594|16389586|P4|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750291|NCT01738594|16389587|P3|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750292|NCT01738594|16389588|P2|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750293|NCT01738594|16389589|P1|Went on to Continue Treatment Cycle 5|Progressive Disease|0
4750294|NCT01738594|16389582|P8|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750295|NCT01738594|16389583|P7|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750296|NCT01738594|16389584|P6|Completed 4 Cycles of Treatment|No response/patient benefit|1
4750297|NCT01738594|16389585|P5|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750298|NCT01738594|16389586|P4|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750299|NCT01738594|16389587|P3|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750300|NCT01738594|16389588|P2|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750301|NCT01738594|16389589|P1|Completed 4 Cycles of Treatment|No response/patient benefit|0
4750302|NCT01738594|16389582|P8|Completed 4 Cycles of Treatment|Progressive disease|0
4750303|NCT01738594|16389583|P7|Completed 4 Cycles of Treatment|Progressive disease|0
4750304|NCT01738594|16389584|P6|Completed 4 Cycles of Treatment|Progressive disease|0
4750305|NCT01738594|16389585|P5|Completed 4 Cycles of Treatment|Progressive disease|0
4750306|NCT01738594|16389586|P4|Completed 4 Cycles of Treatment|Progressive disease|0
4750307|NCT01738594|16389587|P3|Completed 4 Cycles of Treatment|Progressive disease|0
4750308|NCT01738594|16389588|P2|Completed 4 Cycles of Treatment|Progressive disease|2
4750309|NCT01738594|16389589|P1|Completed 4 Cycles of Treatment|Progressive disease|0
4750310|NCT01738594|16389582|P8|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750311|NCT01738594|16389583|P7|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750312|NCT01738594|16389584|P6|Completed 2 Cycles/Reached 1st Response|Physician Decision|1
4750313|NCT01738594|16389585|P5|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750314|NCT01738594|16389586|P4|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750315|NCT01738594|16389587|P3|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750316|NCT01738594|16389588|P2|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750317|NCT01738594|16389589|P1|Completed 2 Cycles/Reached 1st Response|Physician Decision|0
4750318|NCT01738594|16389582|P8|Registration and Treatment Start|Adverse Event|0
4750319|NCT01738594|16389583|P7|Registration and Treatment Start|Adverse Event|0
4750320|NCT01738594|16389584|P6|Registration and Treatment Start|Adverse Event|0
4750321|NCT01738594|16389585|P5|Registration and Treatment Start|Adverse Event|0
4750322|NCT01738594|16389586|P4|Registration and Treatment Start|Adverse Event|0
4750323|NCT01738594|16389587|P3|Registration and Treatment Start|Adverse Event|0
4750324|NCT01738594|16389588|P2|Registration and Treatment Start|Adverse Event|1
4750325|NCT01738594|16389589|P1|Registration and Treatment Start|Adverse Event|0
4750326|NCT01738581|16389607|P2|Overall Study|Lost to Follow-up|0
4750327|NCT01738581|16389608|P1|Overall Study|Lost to Follow-up|1
4750328|NCT01738503|16389632|P7|PET Imaging Sub-study|Scheduling issues with imaging facility|1
4750329|NCT01738503|16389633|P6|PET Imaging Sub-study|Scheduling issues with imaging facility|1
4750330|NCT01738503|16389634|P5|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4750331|NCT01738503|16389635|P4|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4750332|NCT01738503|16389636|P3|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4750333|NCT01738503|16389637|P2|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4750334|NCT01738503|16389638|P1|PET Imaging Sub-study|Scheduling issues with imaging facility|0
4750335|NCT01738503|16389632|P7|PET Imaging Sub-study|Adverse Event|0
4750336|NCT01738503|16389633|P6|PET Imaging Sub-study|Adverse Event|1
4750337|NCT01738503|16389634|P5|PET Imaging Sub-study|Adverse Event|0
4750338|NCT01738503|16389635|P4|PET Imaging Sub-study|Adverse Event|0
4750339|NCT01738503|16389636|P3|PET Imaging Sub-study|Adverse Event|0
4750340|NCT01738503|16389637|P2|PET Imaging Sub-study|Adverse Event|0
4750341|NCT01738503|16389638|P1|PET Imaging Sub-study|Adverse Event|0
4750342|NCT01738503|16389632|P7|Treatment Period|Other|0
4750343|NCT01738503|16389633|P6|Treatment Period|Other|0
4750344|NCT01738503|16389634|P5|Treatment Period|Other|0
4750345|NCT01738503|16389635|P4|Treatment Period|Other|0
4750346|NCT01738503|16389636|P3|Treatment Period|Other|1
4750347|NCT01738503|16389637|P2|Treatment Period|Other|0
4750348|NCT01738503|16389638|P1|Treatment Period|Other|0
4750349|NCT01738503|16389632|P7|Treatment Period|Protocol Violation|0
4750350|NCT01738503|16389633|P6|Treatment Period|Protocol Violation|2
4750351|NCT01738503|16389634|P5|Treatment Period|Protocol Violation|4
4750352|NCT01738503|16389635|P4|Treatment Period|Protocol Violation|0
4750353|NCT01738503|16389636|P3|Treatment Period|Protocol Violation|1
4750354|NCT01738503|16389637|P2|Treatment Period|Protocol Violation|3
4750355|NCT01738503|16389638|P1|Treatment Period|Protocol Violation|0
4750356|NCT01738503|16389632|P7|Treatment Period|Withdrawal by Subject|1
4750357|NCT01738503|16389633|P6|Treatment Period|Withdrawal by Subject|1
4750358|NCT01738503|16389634|P5|Treatment Period|Withdrawal by Subject|1
4750359|NCT01738503|16389635|P4|Treatment Period|Withdrawal by Subject|1
4750360|NCT01738503|16389636|P3|Treatment Period|Withdrawal by Subject|0
4750361|NCT01738503|16389637|P2|Treatment Period|Withdrawal by Subject|1
4750362|NCT01738503|16389638|P1|Treatment Period|Withdrawal by Subject|0
4750363|NCT01738503|16389632|P7|Treatment Period|Lost to Follow-up|5
4750364|NCT01738503|16389633|P6|Treatment Period|Lost to Follow-up|1
4750365|NCT01738503|16389634|P5|Treatment Period|Lost to Follow-up|1
4750366|NCT01738503|16389635|P4|Treatment Period|Lost to Follow-up|4
4750367|NCT01738503|16389636|P3|Treatment Period|Lost to Follow-up|3
4750368|NCT01738503|16389637|P2|Treatment Period|Lost to Follow-up|0
4750369|NCT01738503|16389638|P1|Treatment Period|Lost to Follow-up|0
4750370|NCT01738503|16389632|P7|Treatment Period|Adverse Event|2
4750371|NCT01738503|16389633|P6|Treatment Period|Adverse Event|2
4750372|NCT01738503|16389634|P5|Treatment Period|Adverse Event|2
4750373|NCT01738503|16389635|P4|Treatment Period|Adverse Event|1
4750374|NCT01738503|16389636|P3|Treatment Period|Adverse Event|0
4750375|NCT01738503|16389637|P2|Treatment Period|Adverse Event|1
4750376|NCT01738503|16389638|P1|Treatment Period|Adverse Event|0
4750377|NCT01738503|16389632|P7|Induction/Stabilization (Days -14 to -1)|Other|0
4750378|NCT01738503|16389633|P6|Induction/Stabilization (Days -14 to -1)|Other|0
4750379|NCT01738503|16389634|P5|Induction/Stabilization (Days -14 to -1)|Other|0
4750380|NCT01738503|16389635|P4|Induction/Stabilization (Days -14 to -1)|Other|0
4750381|NCT01738503|16389636|P3|Induction/Stabilization (Days -14 to -1)|Other|0
4750382|NCT01738503|16389637|P2|Induction/Stabilization (Days -14 to -1)|Other|0
4750383|NCT01738503|16389638|P1|Induction/Stabilization (Days -14 to -1)|Other|35
4750384|NCT01738477|16389836|P2|Overall Study|Lost to Follow-up|4
4750385|NCT01738477|16389837|P1|Overall Study|Lost to Follow-up|1
4750386|NCT01738438|16389865|P1|Overall Study|Adverse Event|3
4750387|NCT01738438|16389865|P1|Overall Study|Disease Progression|32
4750388|NCT01738191|16389882|P2|Overall Study|Withdrawal by Subject|1
4750389|NCT01738191|16389883|P1|Overall Study|Withdrawal by Subject|4
4750390|NCT01737996|16389906|P3|Overall Study|Withdrawal by Subject|1
4750391|NCT01737996|16389907|P2|Overall Study|Withdrawal by Subject|0
4750392|NCT01737996|16389908|P1|Overall Study|Withdrawal by Subject|0
4750393|NCT01737996|16389906|P3|Overall Study|Adverse Event|1
4750394|NCT01737996|16389907|P2|Overall Study|Adverse Event|1
4750395|NCT01737996|16389908|P1|Overall Study|Adverse Event|0
4750396|NCT01737931|16389970|P3|Overall Study|Physician Decision|0
4750397|NCT01737931|16389971|P2|Overall Study|Physician Decision|1
4750398|NCT01737931|16389972|P1|Overall Study|Physician Decision|0
4750399|NCT01737931|16389970|P3|Overall Study|Withdrawal by Subject|1
4750400|NCT01737931|16389971|P2|Overall Study|Withdrawal by Subject|1
4750401|NCT01737931|16389972|P1|Overall Study|Withdrawal by Subject|0
4750402|NCT01737879|16389987|P1|Overall Study|Sponsor decision|40
4750403|NCT01737879|16389987|P1|Overall Study|Death|1
4750404|NCT01737840|16389996|P2|Overall Study|Diagnosed with an other pathology|2
4750405|NCT01737840|16389997|P1|Overall Study|Diagnosed with an other pathology|2
4750406|NCT01737762|16390007|P2|Overall Study|Trial termination|9
4750407|NCT01737762|16390008|P1|Overall Study|Trial termination|11
4750408|NCT01737762|16390007|P2|Overall Study|Moved from area|1
4750409|NCT01737762|16390008|P1|Overall Study|Moved from area|2
4750410|NCT01737762|16390007|P2|Overall Study|Physician Decision|1
4750411|NCT01737762|16390008|P1|Overall Study|Physician Decision|1
4750412|NCT01737762|16390007|P2|Overall Study|Progressive disease|2
4750413|NCT01737762|16390008|P1|Overall Study|Progressive disease|1
4750414|NCT01737762|16390007|P2|Overall Study|Withdrawal by Subject|2
4750415|NCT01737762|16390008|P1|Overall Study|Withdrawal by Subject|2
4750416|NCT01737762|16390007|P2|Overall Study|Lost to Follow-up|0
4750417|NCT01737762|16390008|P1|Overall Study|Lost to Follow-up|1
4750418|NCT01737762|16390007|P2|Overall Study|Adverse Event|2
4750419|NCT01737762|16390008|P1|Overall Study|Adverse Event|2
4750420|NCT01737710|16390021|P5|Overall Study|Vaccinated in Error/Ineligible|0
4750421|NCT01737710|16390022|P4|Overall Study|Vaccinated in Error/Ineligible|0
4750422|NCT01737710|16390023|P3|Overall Study|Vaccinated in Error/Ineligible|0
4750423|NCT01737710|16390024|P2|Overall Study|Vaccinated in Error/Ineligible|1
4750424|NCT01737710|16390025|P1|Overall Study|Vaccinated in Error/Ineligible|1
4750425|NCT01737710|16390021|P5|Overall Study|Withdrawal by Subject|0
4750426|NCT01737710|16390022|P4|Overall Study|Withdrawal by Subject|0
4750427|NCT01737710|16390023|P3|Overall Study|Withdrawal by Subject|1
4750428|NCT01737710|16390024|P2|Overall Study|Withdrawal by Subject|1
4750429|NCT01737710|16390025|P1|Overall Study|Withdrawal by Subject|1
4750430|NCT01737710|16390021|P5|Overall Study|Lost to Follow-up|0
4750431|NCT01737710|16390022|P4|Overall Study|Lost to Follow-up|0
4750432|NCT01737710|16390023|P3|Overall Study|Lost to Follow-up|2
4750433|NCT01737710|16390024|P2|Overall Study|Lost to Follow-up|2
4750434|NCT01737710|16390025|P1|Overall Study|Lost to Follow-up|0
4750435|NCT01737697|16390067|P15|Subacute Phase|Death|0
4750436|NCT01737697|16390068|P14|Subacute Phase|Death|0
4750437|NCT01737697|16390069|P13|Subacute Phase|Death|0
4750438|NCT01737697|16390070|P12|Subacute Phase|Death|0
4750439|NCT01737697|16390071|P11|Subacute Phase|Death|1
4750440|NCT01737697|16390072|P10|Subacute Phase|Death|0
4750441|NCT01737697|16390073|P9|Subacute Phase|Death|0
4750442|NCT01737697|16390074|P8|Subacute Phase|Death|0
4750443|NCT01737697|16390075|P7|Subacute Phase|Death|0
4750444|NCT01737697|16390076|P6|Subacute Phase|Death|0
4750445|NCT01737697|16390077|P5|Subacute Phase|Death|0
4750446|NCT01737697|16390078|P4|Subacute Phase|Death|0
4750447|NCT01737697|16390079|P3|Subacute Phase|Death|0
4750448|NCT01737697|16390080|P2|Subacute Phase|Death|0
4750449|NCT01737697|16390081|P1|Subacute Phase|Death|0
4750450|NCT01737697|16390067|P15|Subacute Phase|Physician Decision|0
4750451|NCT01737697|16390068|P14|Subacute Phase|Physician Decision|0
4750452|NCT01737697|16390069|P13|Subacute Phase|Physician Decision|0
4750453|NCT01737697|16390070|P12|Subacute Phase|Physician Decision|0
4750454|NCT01737697|16390071|P11|Subacute Phase|Physician Decision|0
4750455|NCT01737697|16390072|P10|Subacute Phase|Physician Decision|0
4750456|NCT01737697|16390073|P9|Subacute Phase|Physician Decision|1
4750457|NCT01737697|16390074|P8|Subacute Phase|Physician Decision|0
4750458|NCT01737697|16390075|P7|Subacute Phase|Physician Decision|0
4750459|NCT01737697|16390076|P6|Subacute Phase|Physician Decision|0
4750460|NCT01737697|16390077|P5|Subacute Phase|Physician Decision|0
4750461|NCT01737697|16390078|P4|Subacute Phase|Physician Decision|0
4750462|NCT01737697|16390079|P3|Subacute Phase|Physician Decision|0
4750463|NCT01737697|16390080|P2|Subacute Phase|Physician Decision|0
4750464|NCT01737697|16390081|P1|Subacute Phase|Physician Decision|0
4750465|NCT01737697|16390067|P15|Subacute Phase|Protocol Violation|0
4750466|NCT01737697|16390068|P14|Subacute Phase|Protocol Violation|0
4750467|NCT01737697|16390069|P13|Subacute Phase|Protocol Violation|0
4750468|NCT01737697|16390070|P12|Subacute Phase|Protocol Violation|0
4750469|NCT01737697|16390071|P11|Subacute Phase|Protocol Violation|1
4750470|NCT01737697|16390072|P10|Subacute Phase|Protocol Violation|0
4750471|NCT01737697|16390073|P9|Subacute Phase|Protocol Violation|0
4750472|NCT01737697|16390074|P8|Subacute Phase|Protocol Violation|0
4750473|NCT01737697|16390075|P7|Subacute Phase|Protocol Violation|0
4750474|NCT01737697|16390076|P6|Subacute Phase|Protocol Violation|1
4750475|NCT01737697|16390077|P5|Subacute Phase|Protocol Violation|0
4750476|NCT01737697|16390078|P4|Subacute Phase|Protocol Violation|0
4750477|NCT01737697|16390079|P3|Subacute Phase|Protocol Violation|0
4750478|NCT01737697|16390080|P2|Subacute Phase|Protocol Violation|0
4750479|NCT01737697|16390081|P1|Subacute Phase|Protocol Violation|0
4750480|NCT01737697|16390067|P15|Subacute Phase|Hypo-or hyperkalemia|0
4750481|NCT01737697|16390068|P14|Subacute Phase|Hypo-or hyperkalemia|1
4750482|NCT01737697|16390069|P13|Subacute Phase|Hypo-or hyperkalemia|0
4750483|NCT01737697|16390070|P12|Subacute Phase|Hypo-or hyperkalemia|1
4750484|NCT01737697|16390071|P11|Subacute Phase|Hypo-or hyperkalemia|0
4750485|NCT01737697|16390072|P10|Subacute Phase|Hypo-or hyperkalemia|0
4750486|NCT01737697|16390073|P9|Subacute Phase|Hypo-or hyperkalemia|0
4750487|NCT01737697|16390074|P8|Subacute Phase|Hypo-or hyperkalemia|0
4750488|NCT01737697|16390075|P7|Subacute Phase|Hypo-or hyperkalemia|0
4750489|NCT01737697|16390076|P6|Subacute Phase|Hypo-or hyperkalemia|0
4750490|NCT01737697|16390077|P5|Subacute Phase|Hypo-or hyperkalemia|0
4750491|NCT01737697|16390078|P4|Subacute Phase|Hypo-or hyperkalemia|0
4750492|NCT01737697|16390079|P3|Subacute Phase|Hypo-or hyperkalemia|0
4750493|NCT01737697|16390080|P2|Subacute Phase|Hypo-or hyperkalemia|0
4750494|NCT01737697|16390081|P1|Subacute Phase|Hypo-or hyperkalemia|0
4750495|NCT01737697|16390067|P15|Subacute Phase|Lost to Follow-up|1
4750496|NCT01737697|16390068|P14|Subacute Phase|Lost to Follow-up|0
4750497|NCT01737697|16390069|P13|Subacute Phase|Lost to Follow-up|0
4750498|NCT01737697|16390070|P12|Subacute Phase|Lost to Follow-up|0
4750499|NCT01737697|16390071|P11|Subacute Phase|Lost to Follow-up|0
4750500|NCT01737697|16390072|P10|Subacute Phase|Lost to Follow-up|0
4750501|NCT01737697|16390073|P9|Subacute Phase|Lost to Follow-up|0
4750502|NCT01737697|16390074|P8|Subacute Phase|Lost to Follow-up|0
4750503|NCT01737697|16390075|P7|Subacute Phase|Lost to Follow-up|0
4750504|NCT01737697|16390076|P6|Subacute Phase|Lost to Follow-up|0
4750505|NCT01737697|16390077|P5|Subacute Phase|Lost to Follow-up|0
4750506|NCT01737697|16390078|P4|Subacute Phase|Lost to Follow-up|0
4750507|NCT01737697|16390079|P3|Subacute Phase|Lost to Follow-up|0
4750508|NCT01737697|16390080|P2|Subacute Phase|Lost to Follow-up|0
4750509|NCT01737697|16390081|P1|Subacute Phase|Lost to Follow-up|0
4750510|NCT01737697|16390067|P15|Subacute Phase|Withdrawal by Subject|0
4750511|NCT01737697|16390068|P14|Subacute Phase|Withdrawal by Subject|1
4750512|NCT01737697|16390069|P13|Subacute Phase|Withdrawal by Subject|1
4750513|NCT01737697|16390070|P12|Subacute Phase|Withdrawal by Subject|1
4750514|NCT01737697|16390071|P11|Subacute Phase|Withdrawal by Subject|0
4750515|NCT01737697|16390072|P10|Subacute Phase|Withdrawal by Subject|1
4750516|NCT01737697|16390073|P9|Subacute Phase|Withdrawal by Subject|0
4750517|NCT01737697|16390074|P8|Subacute Phase|Withdrawal by Subject|2
4750518|NCT01737697|16390075|P7|Subacute Phase|Withdrawal by Subject|0
4750519|NCT01737697|16390076|P6|Subacute Phase|Withdrawal by Subject|1
4750520|NCT01737697|16390077|P5|Subacute Phase|Withdrawal by Subject|0
4750521|NCT01737697|16390078|P4|Subacute Phase|Withdrawal by Subject|0
4750522|NCT01737697|16390079|P3|Subacute Phase|Withdrawal by Subject|0
4750523|NCT01737697|16390080|P2|Subacute Phase|Withdrawal by Subject|0
4750524|NCT01737697|16390081|P1|Subacute Phase|Withdrawal by Subject|0
4750525|NCT01737697|16390067|P15|Subacute Phase|Adverse Event|0
4750526|NCT01737697|16390068|P14|Subacute Phase|Adverse Event|0
4750527|NCT01737697|16390069|P13|Subacute Phase|Adverse Event|1
4750528|NCT01737697|16390070|P12|Subacute Phase|Adverse Event|1
4750529|NCT01737697|16390071|P11|Subacute Phase|Adverse Event|4
4750530|NCT01737697|16390072|P10|Subacute Phase|Adverse Event|1
4750531|NCT01737697|16390073|P9|Subacute Phase|Adverse Event|1
4750532|NCT01737697|16390074|P8|Subacute Phase|Adverse Event|1
4750533|NCT01737697|16390075|P7|Subacute Phase|Adverse Event|1
4750534|NCT01737697|16390076|P6|Subacute Phase|Adverse Event|1
4750535|NCT01737697|16390077|P5|Subacute Phase|Adverse Event|0
4750536|NCT01737697|16390078|P4|Subacute Phase|Adverse Event|0
4750537|NCT01737697|16390079|P3|Subacute Phase|Adverse Event|0
4750538|NCT01737697|16390080|P2|Subacute Phase|Adverse Event|0
4750539|NCT01737697|16390081|P1|Subacute Phase|Adverse Event|0
4750540|NCT01737697|16390067|P15|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750541|NCT01737697|16390068|P14|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750542|NCT01737697|16390069|P13|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750543|NCT01737697|16390070|P12|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750544|NCT01737697|16390071|P11|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750545|NCT01737697|16390072|P10|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750546|NCT01737697|16390073|P9|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750547|NCT01737697|16390074|P8|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750548|NCT01737697|16390075|P7|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750549|NCT01737697|16390076|P6|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750550|NCT01737697|16390077|P5|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
4750551|NCT01737697|16390078|P4|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4
4750552|NCT01737697|16390079|P3|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
4750553|NCT01737697|16390080|P2|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1
4750554|NCT01737697|16390081|P1|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0
4750555|NCT01737697|16390067|P15|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750556|NCT01737697|16390068|P14|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750557|NCT01737697|16390069|P13|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750558|NCT01737697|16390070|P12|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750559|NCT01737697|16390071|P11|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750560|NCT01737697|16390072|P10|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750561|NCT01737697|16390073|P9|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750562|NCT01737697|16390074|P8|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750563|NCT01737697|16390075|P7|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750564|NCT01737697|16390076|P6|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750565|NCT01737697|16390077|P5|Acute Phase-Initial 48 Hours|Lost to Follow-up|1
4750566|NCT01737697|16390078|P4|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750567|NCT01737697|16390079|P3|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750568|NCT01737697|16390080|P2|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750569|NCT01737697|16390081|P1|Acute Phase-Initial 48 Hours|Lost to Follow-up|0
4750570|NCT01737697|16390067|P15|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750571|NCT01737697|16390068|P14|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750572|NCT01737697|16390069|P13|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750573|NCT01737697|16390070|P12|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750574|NCT01737697|16390071|P11|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750575|NCT01737697|16390072|P10|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750576|NCT01737697|16390073|P9|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750577|NCT01737697|16390074|P8|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750578|NCT01737697|16390075|P7|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750579|NCT01737697|16390076|P6|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750580|NCT01737697|16390077|P5|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750581|NCT01737697|16390078|P4|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750582|NCT01737697|16390079|P3|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750583|NCT01737697|16390080|P2|Acute Phase-Initial 48 Hours|Sponsor's decision|1
4750584|NCT01737697|16390081|P1|Acute Phase-Initial 48 Hours|Sponsor's decision|0
4750585|NCT01737697|16390067|P15|Acute Phase-Initial 48 Hours|Family emergency|0
4750586|NCT01737697|16390068|P14|Acute Phase-Initial 48 Hours|Family emergency|0
4750587|NCT01737697|16390069|P13|Acute Phase-Initial 48 Hours|Family emergency|0
4750588|NCT01737697|16390070|P12|Acute Phase-Initial 48 Hours|Family emergency|0
4750589|NCT01737697|16390071|P11|Acute Phase-Initial 48 Hours|Family emergency|0
4750590|NCT01737697|16390072|P10|Acute Phase-Initial 48 Hours|Family emergency|0
4750591|NCT01737697|16390073|P9|Acute Phase-Initial 48 Hours|Family emergency|0
4750592|NCT01737697|16390074|P8|Acute Phase-Initial 48 Hours|Family emergency|0
4750593|NCT01737697|16390075|P7|Acute Phase-Initial 48 Hours|Family emergency|0
4750594|NCT01737697|16390076|P6|Acute Phase-Initial 48 Hours|Family emergency|0
4750595|NCT01737697|16390077|P5|Acute Phase-Initial 48 Hours|Family emergency|0
4750596|NCT01737697|16390078|P4|Acute Phase-Initial 48 Hours|Family emergency|1
4750597|NCT01737697|16390079|P3|Acute Phase-Initial 48 Hours|Family emergency|0
4750598|NCT01737697|16390080|P2|Acute Phase-Initial 48 Hours|Family emergency|0
4750599|NCT01737697|16390081|P1|Acute Phase-Initial 48 Hours|Family emergency|0
4750600|NCT01737697|16390067|P15|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750601|NCT01737697|16390068|P14|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750602|NCT01737697|16390069|P13|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750603|NCT01737697|16390070|P12|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750604|NCT01737697|16390071|P11|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750605|NCT01737697|16390072|P10|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750606|NCT01737697|16390073|P9|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750607|NCT01737697|16390074|P8|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750608|NCT01737697|16390075|P7|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750609|NCT01737697|16390076|P6|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750610|NCT01737697|16390077|P5|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750611|NCT01737697|16390078|P4|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0
4750612|NCT01737697|16390079|P3|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3
4750613|NCT01737697|16390080|P2|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
4750614|NCT01737697|16390081|P1|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1
4750615|NCT01737697|16390067|P15|Acute Phase-Initial 48 Hours|Adverse Event|0
4750616|NCT01737697|16390068|P14|Acute Phase-Initial 48 Hours|Adverse Event|0
4750617|NCT01737697|16390069|P13|Acute Phase-Initial 48 Hours|Adverse Event|0
4750618|NCT01737697|16390070|P12|Acute Phase-Initial 48 Hours|Adverse Event|0
4750619|NCT01737697|16390071|P11|Acute Phase-Initial 48 Hours|Adverse Event|0
4750620|NCT01737697|16390072|P10|Acute Phase-Initial 48 Hours|Adverse Event|0
4750621|NCT01737697|16390073|P9|Acute Phase-Initial 48 Hours|Adverse Event|0
4750622|NCT01737697|16390074|P8|Acute Phase-Initial 48 Hours|Adverse Event|0
4750623|NCT01737697|16390075|P7|Acute Phase-Initial 48 Hours|Adverse Event|0
4750624|NCT01737697|16390076|P6|Acute Phase-Initial 48 Hours|Adverse Event|0
4750625|NCT01737697|16390077|P5|Acute Phase-Initial 48 Hours|Adverse Event|1
4750626|NCT01737697|16390078|P4|Acute Phase-Initial 48 Hours|Adverse Event|1
4750627|NCT01737697|16390079|P3|Acute Phase-Initial 48 Hours|Adverse Event|0
4750628|NCT01737697|16390080|P2|Acute Phase-Initial 48 Hours|Adverse Event|1
4750629|NCT01737697|16390081|P1|Acute Phase-Initial 48 Hours|Adverse Event|0
4750630|NCT01737398|16390224|P2|Overall Study|Sponsor's decision|0
4750631|NCT01737398|16390225|P1|Overall Study|Sponsor's decision|2
4750632|NCT01737398|16390224|P2|Overall Study|Disease progression|3
4750633|NCT01737398|16390225|P1|Overall Study|Disease progression|2
4750634|NCT01737398|16390224|P2|Overall Study|Liver transplant|0
4750635|NCT01737398|16390225|P1|Overall Study|Liver transplant|1
4750636|NCT01737398|16390224|P2|Overall Study|Ineligibility|0
4750637|NCT01737398|16390225|P1|Overall Study|Ineligibility|1
4750638|NCT01737398|16390224|P2|Overall Study|Voluntary withdrawal|3
4750639|NCT01737398|16390225|P1|Overall Study|Voluntary withdrawal|2
4750640|NCT01737398|16390224|P2|Overall Study|Stopping rule met|1
4750641|NCT01737398|16390225|P1|Overall Study|Stopping rule met|2
4750642|NCT01737398|16390224|P2|Overall Study|Adverse event or SAE|1
4750643|NCT01737398|16390225|P1|Overall Study|Adverse event or SAE|16
4750644|NCT01737268|16390278|P1|Overall Study|In consideration of the patient's safety|1
4750645|NCT01737268|16390278|P1|Overall Study|Worsening of Target Disease|2
4750646|NCT01737268|16390278|P1|Overall Study|Adverse Event|6
4750647|NCT01737021|16390292|P2|Overall Study|Lost to Follow-up|3
4750648|NCT01737021|16390293|P1|Overall Study|Lost to Follow-up|5
4750649|NCT01736917|16390339|P1|Overall Study|Protocol Violation|10
4750650|NCT01736917|16390339|P1|Overall Study|Adverse Event|1
4750651|NCT01736696|16390379|P7|Overall Study|Withdrawal by Subject|0
4750652|NCT01736696|16390380|P6|Overall Study|Withdrawal by Subject|0
4750653|NCT01736696|16390381|P5|Overall Study|Withdrawal by Subject|0
4750654|NCT01736696|16390382|P4|Overall Study|Withdrawal by Subject|0
4750655|NCT01736696|16390383|P3|Overall Study|Withdrawal by Subject|1
4750656|NCT01736696|16390384|P2|Overall Study|Withdrawal by Subject|0
4750657|NCT01736696|16390385|P1|Overall Study|Withdrawal by Subject|0
4750658|NCT01736683|16390707|P5|Overall Study|Other|1
4750659|NCT01736683|16390708|P4|Overall Study|Other|9
4750660|NCT01736683|16390709|P3|Overall Study|Other|1
4750661|NCT01736683|16390710|P2|Overall Study|Other|0
4750662|NCT01736683|16390711|P1|Overall Study|Other|0
4750663|NCT01736683|16390707|P5|Overall Study|Progressive Disease|0
4750664|NCT01736683|16390708|P4|Overall Study|Progressive Disease|1
4750665|NCT01736683|16390709|P3|Overall Study|Progressive Disease|0
4750666|NCT01736683|16390710|P2|Overall Study|Progressive Disease|0
4750667|NCT01736683|16390711|P1|Overall Study|Progressive Disease|0
4750668|NCT01736683|16390707|P5|Overall Study|Lack of Therapeutic Effect|1
4750669|NCT01736683|16390708|P4|Overall Study|Lack of Therapeutic Effect|20
4750670|NCT01736683|16390709|P3|Overall Study|Lack of Therapeutic Effect|13
4750671|NCT01736683|16390710|P2|Overall Study|Lack of Therapeutic Effect|4
4750672|NCT01736683|16390711|P1|Overall Study|Lack of Therapeutic Effect|7
4750673|NCT01736683|16390707|P5|Overall Study|Withdrawal by Subject|1
4750674|NCT01736683|16390708|P4|Overall Study|Withdrawal by Subject|1
4750675|NCT01736683|16390709|P3|Overall Study|Withdrawal by Subject|3
4750676|NCT01736683|16390710|P2|Overall Study|Withdrawal by Subject|0
4750677|NCT01736683|16390711|P1|Overall Study|Withdrawal by Subject|0
4750678|NCT01736683|16390707|P5|Overall Study|Adverse Event|2
4750679|NCT01736683|16390708|P4|Overall Study|Adverse Event|3
4750680|NCT01736683|16390709|P3|Overall Study|Adverse Event|2
4750681|NCT01736683|16390710|P2|Overall Study|Adverse Event|2
4750682|NCT01736683|16390711|P1|Overall Study|Adverse Event|0
4750683|NCT01736683|16390707|P5|Overall Study|Disease Relapse|0
4750684|NCT01736683|16390708|P4|Overall Study|Disease Relapse|1
4750685|NCT01736683|16390709|P3|Overall Study|Disease Relapse|2
4750686|NCT01736683|16390710|P2|Overall Study|Disease Relapse|0
4750687|NCT01736683|16390711|P1|Overall Study|Disease Relapse|0
4750688|NCT01736657|16390773|P1|Overall Study|insufficient vascular access|1
4750689|NCT01736579|16390782|P2|Overall Study|Termination of Study by Sponsor|2
4750690|NCT01736579|16390783|P1|Overall Study|Termination of Study by Sponsor|2
4750691|NCT01736566|16390822|P5|Long Term Follow-up|Still collecting data|1
4750692|NCT01736566|16390823|P4|Long Term Follow-up|Still collecting data|0
4750693|NCT01736566|16390824|P3|Long Term Follow-up|Still collecting data|49
4750694|NCT01736566|16390825|P2|Long Term Follow-up|Still collecting data|0
4750695|NCT01736566|16390826|P1|Long Term Follow-up|Still collecting data|42
4750696|NCT01736553|16390911|P2|Overall Study|Lost to Follow-up|2
4750697|NCT01736553|16390912|P1|Overall Study|Lost to Follow-up|2
4750698|NCT01736553|16390911|P2|Overall Study|Withdrawal by Subject|2
4750699|NCT01736553|16390912|P1|Overall Study|Withdrawal by Subject|5
4750700|NCT01736553|16390911|P2|Overall Study|Death|0
4750701|NCT01736553|16390912|P1|Overall Study|Death|12
4750702|NCT01736540|16390963|P1|Overall Study|Unable to make MRI appointment|3
4750703|NCT01736540|16390963|P1|Overall Study|No show for MRI appointment|1
4750704|NCT01736540|16390963|P1|Overall Study|Unable to tolerate MRI; claustrophobic|1
4750705|NCT01736540|16390963|P1|Overall Study|Protocol Violation|1
4750706|NCT01736540|16390963|P1|Overall Study|Withdrawal by Subject|5
4750707|NCT01736540|16390963|P1|Overall Study|Abnormal test procedure|1
4750708|NCT01736540|16390963|P1|Overall Study|Death|1
4750709|NCT01736540|16390963|P1|Overall Study|Did not complete scan within 45 days|2
4750710|NCT01736475|16391029|P2|Overall Study|Other - Surgical procedure|0
4750711|NCT01736475|16391030|P1|Overall Study|Other - Surgical procedure|1
4750712|NCT01736475|16391029|P2|Overall Study|Other - Screen failure|0
4750713|NCT01736475|16391030|P1|Overall Study|Other - Screen failure|1
4750714|NCT01736475|16391029|P2|Overall Study|Protocol Violation|0
4750715|NCT01736475|16391030|P1|Overall Study|Protocol Violation|4
4750716|NCT01736475|16391029|P2|Overall Study|Withdrawal by Subject|0
4750717|NCT01736475|16391030|P1|Overall Study|Withdrawal by Subject|2
4750718|NCT01736475|16391029|P2|Overall Study|Adverse Event|0
4750719|NCT01736475|16391030|P1|Overall Study|Adverse Event|4
4750720|NCT01736397|16391085|P2|Overall Study|Not stated|4
4750721|NCT01736397|16391086|P1|Overall Study|Not stated|1
4750722|NCT01736397|16391085|P2|Overall Study|Adverse Event|3
4750723|NCT01736397|16391086|P1|Overall Study|Adverse Event|6
4750724|NCT01736397|16391085|P2|Overall Study|Lost to Follow-up|1
4750725|NCT01736397|16391086|P1|Overall Study|Lost to Follow-up|0
4750726|NCT01736397|16391085|P2|Overall Study|Withdrawal by Subject|5
4750727|NCT01736397|16391086|P1|Overall Study|Withdrawal by Subject|6
4750728|NCT01736397|16391085|P2|Overall Study|Lack of Efficacy|11
4750729|NCT01736397|16391086|P1|Overall Study|Lack of Efficacy|1
4750730|NCT01736254|16391119|P1|Period 3 (Days 13 to 23)|Adverse Event|1
4750731|NCT01736254|16391119|P1|Period 2 (Days 2 to 12)|Adverse Event|3
4750732|NCT01736215|16391184|P1|Overall Study|Insufficient data to perform analysis|8
4750733|NCT01736215|16391184|P1|Overall Study|Progressive disease stop chemotherapy|1
4750734|NCT01736215|16391184|P1|Overall Study|Adverse Event|4
4750735|NCT01736215|16391184|P1|Overall Study|Early termination of erythropoietin use|1
4750736|NCT01736189|16391196|P1|Overall Study|Criteria and protocol violations|1
4750737|NCT01736189|16391196|P1|Overall Study|Protocol Violation|4
4750738|NCT01736189|16391196|P1|Overall Study|Violation of registration criteria|41
4750739|NCT01736176|16391205|P1|Overall Study|Unable to Complete PEG Placement|1
4750740|NCT01736176|16391205|P1|Overall Study|Lack of Efficacy|3
4750741|NCT01736176|16391205|P1|Overall Study|Withdrawal by Subject|4
4750742|NCT01736176|16391205|P1|Overall Study|Adverse Event|3
4750743|NCT01735994|16391276|P2|Overall Study|Lost to Follow-up|62
4750744|NCT01735994|16391277|P1|Overall Study|Lost to Follow-up|50
4750745|NCT01735994|16391276|P2|Overall Study|Kicked off team|0
4750746|NCT01735994|16391277|P1|Overall Study|Kicked off team|5
4750747|NCT01735994|16391276|P2|Overall Study|Injury|0
4750748|NCT01735994|16391277|P1|Overall Study|Injury|2
4750749|NCT01735994|16391276|P2|Overall Study|Withdrawal by Subject|4
4750750|NCT01735994|16391277|P1|Overall Study|Withdrawal by Subject|6
4750751|NCT01735916|16391292|P3|Overall Study|Withdrawal by Subject|0
4750752|NCT01735916|16391293|P2|Overall Study|Withdrawal by Subject|0
4750753|NCT01735916|16391294|P1|Overall Study|Withdrawal by Subject|3
4750754|NCT01735916|16391292|P3|Overall Study|Early termination of study by sponsor|7
4750755|NCT01735916|16391293|P2|Overall Study|Early termination of study by sponsor|19
4750756|NCT01735916|16391294|P1|Overall Study|Early termination of study by sponsor|4
4750757|NCT01735916|16391292|P3|Overall Study|Subject not eligible to be randomized|0
4750758|NCT01735916|16391293|P2|Overall Study|Subject not eligible to be randomized|0
4750759|NCT01735916|16391294|P1|Overall Study|Subject not eligible to be randomized|11
4750760|NCT01735630|16391332|P2|Overall Study|Withdrawal by Subject|9
4750761|NCT01735630|16391333|P1|Overall Study|Withdrawal by Subject|7
4750762|NCT01735630|16391332|P2|Overall Study|Sponsor Decision|1
4750763|NCT01735630|16391333|P1|Overall Study|Sponsor Decision|2
4750764|NCT01735630|16391332|P2|Overall Study|Physician Decision|1
4750765|NCT01735630|16391333|P1|Overall Study|Physician Decision|0
4750766|NCT01735630|16391332|P2|Overall Study|Lost to Follow-up|0
4750767|NCT01735630|16391333|P1|Overall Study|Lost to Follow-up|1
4750768|NCT01735630|16391332|P2|Overall Study|Adverse Event|7
4750769|NCT01735630|16391333|P1|Overall Study|Adverse Event|8
4750770|NCT01735396|16391360|P1|Overall Study|not evaluable|1
4750771|NCT01735279|16391371|P2|Overall Study|Lost to Follow-up|8
4750772|NCT01735279|16391372|P1|Overall Study|Lost to Follow-up|11
4750773|NCT01735201|16391404|P8|Overall Study|Other Miscellaneous Reasons|1
4750774|NCT01735201|16391405|P7|Overall Study|Other Miscellaneous Reasons|1
4750775|NCT01735201|16391406|P6|Overall Study|Other Miscellaneous Reasons|2
4750776|NCT01735201|16391407|P5|Overall Study|Other Miscellaneous Reasons|0
4750777|NCT01735201|16391408|P4|Overall Study|Other Miscellaneous Reasons|1
4750778|NCT01735201|16391409|P3|Overall Study|Other Miscellaneous Reasons|0
4750779|NCT01735201|16391410|P2|Overall Study|Other Miscellaneous Reasons|0
4750780|NCT01735201|16391411|P1|Overall Study|Other Miscellaneous Reasons|0
4750781|NCT01735201|16391404|P8|Overall Study|Protocol Violation|0
4750782|NCT01735201|16391405|P7|Overall Study|Protocol Violation|0
4750783|NCT01735201|16391406|P6|Overall Study|Protocol Violation|0
4750784|NCT01735201|16391407|P5|Overall Study|Protocol Violation|0
4750785|NCT01735201|16391408|P4|Overall Study|Protocol Violation|0
4750786|NCT01735201|16391409|P3|Overall Study|Protocol Violation|0
4750787|NCT01735201|16391410|P2|Overall Study|Protocol Violation|0
4750788|NCT01735201|16391411|P1|Overall Study|Protocol Violation|1
4750789|NCT01735201|16391404|P8|Overall Study|Personal Reasons|0
4750790|NCT01735201|16391405|P7|Overall Study|Personal Reasons|0
4750791|NCT01735201|16391406|P6|Overall Study|Personal Reasons|0
4750792|NCT01735201|16391407|P5|Overall Study|Personal Reasons|0
4750793|NCT01735201|16391408|P4|Overall Study|Personal Reasons|0
4750794|NCT01735201|16391409|P3|Overall Study|Personal Reasons|0
4750795|NCT01735201|16391410|P2|Overall Study|Personal Reasons|0
4750796|NCT01735201|16391411|P1|Overall Study|Personal Reasons|1
4750797|NCT01735201|16391404|P8|Overall Study|Adverse Event|1
4750798|NCT01735201|16391405|P7|Overall Study|Adverse Event|2
4750799|NCT01735201|16391406|P6|Overall Study|Adverse Event|3
4750800|NCT01735201|16391407|P5|Overall Study|Adverse Event|1
4750801|NCT01735201|16391408|P4|Overall Study|Adverse Event|1
4750802|NCT01735201|16391409|P3|Overall Study|Adverse Event|0
4750803|NCT01735201|16391410|P2|Overall Study|Adverse Event|1
4750804|NCT01735201|16391411|P1|Overall Study|Adverse Event|1
4750805|NCT01735175|16391447|P2|Overall Study|Other (mostly EOS/EOT visit missing)|7
4750806|NCT01735175|16391448|P1|Overall Study|Other (mostly EOS/EOT visit missing)|13
4750807|NCT01735175|16391447|P2|Overall Study|Death|2
4750808|NCT01735175|16391448|P1|Overall Study|Death|3
4750809|NCT01735175|16391447|P2|Overall Study|Lost to Follow-up|2
4750810|NCT01735175|16391448|P1|Overall Study|Lost to Follow-up|4
4750811|NCT01735175|16391447|P2|Overall Study|Withdrawal by Subject|2
4750812|NCT01735175|16391448|P1|Overall Study|Withdrawal by Subject|9
4750813|NCT01734993|16391468|P1|Overall Study|Lack of Efficacy|1
4750814|NCT01734993|16391468|P1|Overall Study|Adverse Event|1
4750815|NCT01734902|16391496|P2|Overall Study|Other than listed|2
4750816|NCT01734902|16391497|P1|Overall Study|Other than listed|0
4750817|NCT01734850|16391518|P3|Overall Study|Not infused due to manufacturing failure|1
4750818|NCT01734850|16391519|P2|Overall Study|Not infused due to manufacturing failure|0
4750819|NCT01734850|16391520|P1|Overall Study|Not infused due to manufacturing failure|0
4750820|NCT01734850|16391518|P3|Overall Study|Continued to Week 48 but recommenced ART|3
4750821|NCT01734850|16391519|P2|Overall Study|Continued to Week 48 but recommenced ART|2
4750822|NCT01734850|16391520|P1|Overall Study|Continued to Week 48 but recommenced ART|3
4750823|NCT01734811|16391577|P2|Overall Study|Withdrawal by Subject|0
4750824|NCT01734811|16391578|P1|Overall Study|Withdrawal by Subject|2
4750825|NCT01734811|16391577|P2|Overall Study|Lost to Follow-up|3
4750826|NCT01734811|16391578|P1|Overall Study|Lost to Follow-up|2
4750827|NCT01734785|16391605|P4|Double-Blind Period|Not treated|0
4750828|NCT01734785|16391606|P3|Double-Blind Period|Not treated|0
4750829|NCT01734785|16391607|P2|Double-Blind Period|Not treated|0
4750830|NCT01734785|16391608|P1|Double-Blind Period|Not treated|1
4750831|NCT01734785|16391605|P4|Double-Blind Period|Withdrawal by Subject|0
4750832|NCT01734785|16391606|P3|Double-Blind Period|Withdrawal by Subject|0
4750833|NCT01734785|16391607|P2|Double-Blind Period|Withdrawal by Subject|0
4750834|NCT01734785|16391608|P1|Double-Blind Period|Withdrawal by Subject|2
4750835|NCT01734785|16391605|P4|Double-Blind Period|Lost to Follow-up|0
4750836|NCT01734785|16391606|P3|Double-Blind Period|Lost to Follow-up|2
4750837|NCT01734785|16391607|P2|Double-Blind Period|Lost to Follow-up|4
4750838|NCT01734785|16391608|P1|Double-Blind Period|Lost to Follow-up|2
4750839|NCT01734785|16391605|P4|Double-Blind Period|Protocol Violation|0
4750840|NCT01734785|16391606|P3|Double-Blind Period|Protocol Violation|1
4750841|NCT01734785|16391607|P2|Double-Blind Period|Protocol Violation|1
4750842|NCT01734785|16391608|P1|Double-Blind Period|Protocol Violation|0
4750843|NCT01734785|16391605|P4|Double-Blind Period|Lack of Efficacy|0
4750844|NCT01734785|16391606|P3|Double-Blind Period|Lack of Efficacy|0
4750845|NCT01734785|16391607|P2|Double-Blind Period|Lack of Efficacy|1
4750846|NCT01734785|16391608|P1|Double-Blind Period|Lack of Efficacy|0
4750847|NCT01734785|16391605|P4|Double-Blind Period|Adverse Event|0
4750848|NCT01734785|16391606|P3|Double-Blind Period|Adverse Event|2
4750849|NCT01734785|16391607|P2|Double-Blind Period|Adverse Event|3
4750850|NCT01734785|16391608|P1|Double-Blind Period|Adverse Event|0
4750851|NCT01734785|16391605|P4|Open-Label Period|Other Reasons|224
4750852|NCT01734785|16391606|P3|Open-Label Period|Other Reasons|0
4750853|NCT01734785|16391607|P2|Open-Label Period|Other Reasons|0
4750854|NCT01734785|16391608|P1|Open-Label Period|Other Reasons|0
4750855|NCT01734785|16391605|P4|Open-Label Period|Withdrawal by Subject|12
4750856|NCT01734785|16391606|P3|Open-Label Period|Withdrawal by Subject|0
4750857|NCT01734785|16391607|P2|Open-Label Period|Withdrawal by Subject|0
4750858|NCT01734785|16391608|P1|Open-Label Period|Withdrawal by Subject|0
4750859|NCT01734785|16391605|P4|Open-Label Period|Lost to Follow-up|14
4750860|NCT01734785|16391606|P3|Open-Label Period|Lost to Follow-up|0
4750861|NCT01734785|16391607|P2|Open-Label Period|Lost to Follow-up|0
4750862|NCT01734785|16391608|P1|Open-Label Period|Lost to Follow-up|0
4750863|NCT01734785|16391605|P4|Open-Label Period|Protocol Violation|13
4750864|NCT01734785|16391606|P3|Open-Label Period|Protocol Violation|0
4750865|NCT01734785|16391607|P2|Open-Label Period|Protocol Violation|0
4750866|NCT01734785|16391608|P1|Open-Label Period|Protocol Violation|0
4750867|NCT01734785|16391605|P4|Open-Label Period|Lack of Efficacy|1
4750868|NCT01734785|16391606|P3|Open-Label Period|Lack of Efficacy|0
4750869|NCT01734785|16391607|P2|Open-Label Period|Lack of Efficacy|0
4750870|NCT01734785|16391608|P1|Open-Label Period|Lack of Efficacy|0
4750871|NCT01734785|16391605|P4|Open-Label Period|Adverse Event|9
4750872|NCT01734785|16391606|P3|Open-Label Period|Adverse Event|0
4750873|NCT01734785|16391607|P2|Open-Label Period|Adverse Event|0
4750874|NCT01734785|16391608|P1|Open-Label Period|Adverse Event|0
4750875|NCT01734772|16391625|P2|Overall Study|Withdrawal by Subject|1
4750876|NCT01734772|16391626|P1|Overall Study|Withdrawal by Subject|0
4750877|NCT01734772|16391625|P2|Overall Study|Adverse Event|2
4750878|NCT01734772|16391626|P1|Overall Study|Adverse Event|1
4750879|NCT01734434|16391681|P4|Overall Study|17 Yr Old Subject Signed Consent form|0
4750880|NCT01734434|16391682|P3|Overall Study|17 Yr Old Subject Signed Consent form|1
4750881|NCT01734434|16391683|P2|Overall Study|17 Yr Old Subject Signed Consent form|0
4750882|NCT01734434|16391684|P1|Overall Study|17 Yr Old Subject Signed Consent form|0
4750883|NCT01734434|16391681|P4|Overall Study|Wrong Version of Consent Form Signed|0
4750884|NCT01734434|16391682|P3|Overall Study|Wrong Version of Consent Form Signed|1
4750885|NCT01734434|16391683|P2|Overall Study|Wrong Version of Consent Form Signed|0
4750886|NCT01734434|16391684|P1|Overall Study|Wrong Version of Consent Form Signed|0
4750887|NCT01734434|16391681|P4|Overall Study|Treatment Defaulter|0
4750888|NCT01734434|16391682|P3|Overall Study|Treatment Defaulter|1
4750889|NCT01734434|16391683|P2|Overall Study|Treatment Defaulter|0
4750890|NCT01734434|16391684|P1|Overall Study|Treatment Defaulter|0
4750891|NCT01734434|16391681|P4|Overall Study|Subject Not Reachable|0
4750892|NCT01734434|16391682|P3|Overall Study|Subject Not Reachable|1
4750893|NCT01734434|16391683|P2|Overall Study|Subject Not Reachable|0
4750894|NCT01734434|16391684|P1|Overall Study|Subject Not Reachable|0
4750895|NCT01734434|16391681|P4|Overall Study|Signed Adult Version of Consent Form|0
4750896|NCT01734434|16391682|P3|Overall Study|Signed Adult Version of Consent Form|1
4750897|NCT01734434|16391683|P2|Overall Study|Signed Adult Version of Consent Form|0
4750898|NCT01734434|16391684|P1|Overall Study|Signed Adult Version of Consent Form|0
4750899|NCT01734434|16391681|P4|Overall Study|Withdrawal by Subject|1
4750900|NCT01734434|16391682|P3|Overall Study|Withdrawal by Subject|8
4750901|NCT01734434|16391683|P2|Overall Study|Withdrawal by Subject|0
4750902|NCT01734434|16391684|P1|Overall Study|Withdrawal by Subject|4
4750903|NCT01734434|16391681|P4|Overall Study|No Live Birth|6
4750904|NCT01734434|16391682|P3|Overall Study|No Live Birth|32
4750905|NCT01734434|16391683|P2|Overall Study|No Live Birth|2
4750906|NCT01734434|16391684|P1|Overall Study|No Live Birth|1
4750907|NCT01734434|16391681|P4|Overall Study|Lost to Follow-up|11
4750908|NCT01734434|16391682|P3|Overall Study|Lost to Follow-up|67
4750909|NCT01734434|16391683|P2|Overall Study|Lost to Follow-up|9
4750910|NCT01734434|16391684|P1|Overall Study|Lost to Follow-up|2
4750911|NCT01734434|16391681|P4|Overall Study|Death Infant|5
4750912|NCT01734434|16391682|P3|Overall Study|Death Infant|17
4750913|NCT01734434|16391683|P2|Overall Study|Death Infant|1
4750914|NCT01734434|16391684|P1|Overall Study|Death Infant|3
4750915|NCT01734395|16391706|P1|Overall Study|Missing the reasons for not completed|3
4750916|NCT01734395|16391706|P1|Overall Study|Withdrawal by Subject|10
4750917|NCT01734395|16391706|P1|Overall Study|Adverse Event|40
4750918|NCT01734395|16391706|P1|Overall Study|Lack of Efficacy|5
4750919|NCT01734395|16391706|P1|Overall Study|Lost to Follow-up|287
4750920|NCT01734395|16391706|P1|Overall Study|Other|65
4750921|NCT01734382|16391715|P3|Part 2|Withdrawal by Subject|1
4750922|NCT01734382|16391716|P2|Part 2|Withdrawal by Subject|0
4750923|NCT01734382|16391717|P1|Part 2|Withdrawal by Subject|0
4750924|NCT01734382|16391715|P3|Part 2|Protocol Violation|0
4750925|NCT01734382|16391716|P2|Part 2|Protocol Violation|1
4750926|NCT01734382|16391717|P1|Part 2|Protocol Violation|0
4750927|NCT01734382|16391715|P3|Part 2|Physician Decision|3
4750928|NCT01734382|16391716|P2|Part 2|Physician Decision|0
4750929|NCT01734382|16391717|P1|Part 2|Physician Decision|0
4750930|NCT01734382|16391715|P3|Part 2|Other|1
4750931|NCT01734382|16391716|P2|Part 2|Other|0
4750932|NCT01734382|16391717|P1|Part 2|Other|0
4750933|NCT01734382|16391715|P3|Part 2|Lack of Efficacy|1
4750934|NCT01734382|16391716|P2|Part 2|Lack of Efficacy|1
4750935|NCT01734382|16391717|P1|Part 2|Lack of Efficacy|0
4750936|NCT01734382|16391715|P3|Part 2|Adverse Event|1
4750937|NCT01734382|16391716|P2|Part 2|Adverse Event|0
4750938|NCT01734382|16391717|P1|Part 2|Adverse Event|0
4750939|NCT01734382|16391715|P3|Part 1|Adverse Event|0
4750940|NCT01734382|16391716|P2|Part 1|Adverse Event|0
4750941|NCT01734382|16391717|P1|Part 1|Adverse Event|2
4750942|NCT01733758|16391830|P4|Overall Study|Inv Decision, HbA1c not controlled|1
4750943|NCT01733758|16391831|P3|Overall Study|Inv Decision, HbA1c not controlled|0
4750944|NCT01733758|16391832|P2|Overall Study|Inv Decision, HbA1c not controlled|1
4750945|NCT01733758|16391833|P1|Overall Study|Inv Decision, HbA1c not controlled|1
4750946|NCT01733758|16391830|P4|Overall Study|Intro of New Anti-Diabetic Medication|1
4750947|NCT01733758|16391831|P3|Overall Study|Intro of New Anti-Diabetic Medication|0
4750948|NCT01733758|16391832|P2|Overall Study|Intro of New Anti-Diabetic Medication|0
4750949|NCT01733758|16391833|P1|Overall Study|Intro of New Anti-Diabetic Medication|4
4750950|NCT01733758|16391830|P4|Overall Study|Non-compliance|0
4750951|NCT01733758|16391831|P3|Overall Study|Non-compliance|0
4750952|NCT01733758|16391832|P2|Overall Study|Non-compliance|0
4750953|NCT01733758|16391833|P1|Overall Study|Non-compliance|1
4750954|NCT01733758|16391830|P4|Overall Study|Protocol Violation|2
4750955|NCT01733758|16391831|P3|Overall Study|Protocol Violation|2
4750956|NCT01733758|16391832|P2|Overall Study|Protocol Violation|1
4750957|NCT01733758|16391833|P1|Overall Study|Protocol Violation|0
4750958|NCT01733758|16391830|P4|Overall Study|Persistent Hyperglycemia|0
4750959|NCT01733758|16391831|P3|Overall Study|Persistent Hyperglycemia|0
4750960|NCT01733758|16391832|P2|Overall Study|Persistent Hyperglycemia|2
4750961|NCT01733758|16391833|P1|Overall Study|Persistent Hyperglycemia|3
4750962|NCT01733758|16391830|P4|Overall Study|Withdrawal by Subject|3
4750963|NCT01733758|16391831|P3|Overall Study|Withdrawal by Subject|5
4750964|NCT01733758|16391832|P2|Overall Study|Withdrawal by Subject|1
4750965|NCT01733758|16391833|P1|Overall Study|Withdrawal by Subject|1
4750966|NCT01733758|16391830|P4|Overall Study|Adverse Event|1
4750967|NCT01733758|16391831|P3|Overall Study|Adverse Event|8
4750968|NCT01733758|16391832|P2|Overall Study|Adverse Event|7
4750969|NCT01733758|16391833|P1|Overall Study|Adverse Event|5
4750970|NCT01733732|16391899|P2|Overall Study|Did not attend all study visits|0
4750971|NCT01733732|16391900|P1|Overall Study|Did not attend all study visits|1
4750972|NCT01733732|16391899|P2|Overall Study|Adverse Event|0
4750973|NCT01733732|16391900|P1|Overall Study|Adverse Event|1
4750974|NCT01733680|16391936|P2|Overall Study|Withdrawal by Subject|1
4750975|NCT01733680|16391937|P1|Overall Study|Withdrawal by Subject|0
4750976|NCT01733329|16391996|P2|Overall Study|Uterine artery injury|0
4750977|NCT01733329|16391997|P1|Overall Study|Uterine artery injury|1
4750978|NCT01733329|16391996|P2|Overall Study|Protocol Violation|1
4750979|NCT01733329|16391997|P1|Overall Study|Protocol Violation|1
4750980|NCT01733316|16392009|P1|Long Term Extension Phase|Sponsor Decision|2
4750981|NCT01733316|16392009|P1|Long Term Extension Phase|Consent Withdrawn by Subject|2
4750982|NCT01733316|16392009|P1|Long Term Extension Phase|Adverse Event|1
4750983|NCT01733316|16392009|P1|RP103 Phase|Non-compliance|1
4750984|NCT01733121|16392052|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
4750985|NCT01733121|16392053|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
4750986|NCT01733121|16392052|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3
4750987|NCT01733121|16392053|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
4750988|NCT01733121|16392052|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
4750989|NCT01733121|16392053|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|3
4750990|NCT01733121|16392052|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
4750991|NCT01733121|16392053|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|2
4750992|NCT01732926|16392095|P2|Overall Study|Blind Broken by Subject or Study Site|1
4750993|NCT01732926|16392096|P1|Overall Study|Blind Broken by Subject or Study Site|1
4750994|NCT01732926|16392095|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|6
4750995|NCT01732926|16392096|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|7
4750996|NCT01732926|16392095|P2|Overall Study|Other Reason|4
4750997|NCT01732926|16392096|P1|Overall Study|Other Reason|21
4750998|NCT01732926|16392095|P2|Overall Study|Physician Decision|11
4750999|NCT01732926|16392096|P1|Overall Study|Physician Decision|24
4751000|NCT01732926|16392095|P2|Overall Study|Withdrawal by Subject|8
4751001|NCT01732926|16392096|P1|Overall Study|Withdrawal by Subject|46
4751002|NCT01732926|16392095|P2|Overall Study|Study Terminated by Sponsor|80
4751003|NCT01732926|16392096|P1|Overall Study|Study Terminated by Sponsor|168
4751004|NCT01732913|16392112|P2|Overall Study|Initiation of Other Anti-Cancer Therapy|2
4751005|NCT01732913|16392113|P1|Overall Study|Initiation of Other Anti-Cancer Therapy|3
4751006|NCT01732913|16392112|P2|Overall Study|Other|1
4751007|NCT01732913|16392113|P1|Overall Study|Other|7
4751008|NCT01732913|16392112|P2|Overall Study|Physician Decision|7
4751009|NCT01732913|16392113|P1|Overall Study|Physician Decision|14
4751010|NCT01732913|16392112|P2|Overall Study|Withdrawal by Subject|4
4751011|NCT01732913|16392113|P1|Overall Study|Withdrawal by Subject|27
4751012|NCT01732913|16392112|P2|Overall Study|Study Terminated by Sponsor|55
4751013|NCT01732913|16392113|P1|Overall Study|Study Terminated by Sponsor|105
4751014|NCT01732835|16392127|P1|2-year Extended Follow-up|Death|1
4751015|NCT01732835|16392127|P1|2-year Extended Follow-up|Adverse Event|3
4751016|NCT01732835|16392127|P1|2-year Extended Follow-up|Withdrawal by Subject|1
4751017|NCT01732835|16392127|P1|6-month Primary Endpoint|Adverse Event|3
4751018|NCT01732835|16392127|P1|6-month Primary Endpoint|Withdrawal by Subject|2
4751019|NCT01732835|16392127|P1|6-month Primary Endpoint|Did not receive device|19
4751020|NCT01732822|16392160|P2|Overall Study|Withdrawal by Subject|113
4751021|NCT01732822|16392161|P1|Overall Study|Withdrawal by Subject|123
4751022|NCT01732796|16392234|P3|Overall Study|Other reason not defined above|2
4751023|NCT01732796|16392235|P2|Overall Study|Other reason not defined above|0
4751024|NCT01732796|16392236|P1|Overall Study|Other reason not defined above|1
4751025|NCT01732796|16392234|P3|Overall Study|Withdrawal by Subject|2
4751026|NCT01732796|16392235|P2|Overall Study|Withdrawal by Subject|8
4751027|NCT01732796|16392236|P1|Overall Study|Withdrawal by Subject|6
4751028|NCT01732796|16392234|P3|Overall Study|Lost to Follow-up|0
4751029|NCT01732796|16392235|P2|Overall Study|Lost to Follow-up|0
4751030|NCT01732796|16392236|P1|Overall Study|Lost to Follow-up|2
4751031|NCT01732796|16392234|P3|Overall Study|Lack of Efficacy|5
4751032|NCT01732796|16392235|P2|Overall Study|Lack of Efficacy|18
4751033|NCT01732796|16392236|P1|Overall Study|Lack of Efficacy|21
4751034|NCT01732796|16392234|P3|Overall Study|Adverse Event|4
4751035|NCT01732796|16392235|P2|Overall Study|Adverse Event|16
4751036|NCT01732796|16392236|P1|Overall Study|Adverse Event|16
4751037|NCT01732783|16392255|P3|Overall Study|Withdrawal by Subject|0
4751038|NCT01732783|16392256|P2|Overall Study|Withdrawal by Subject|0
4751039|NCT01732783|16392257|P1|Overall Study|Withdrawal by Subject|1
4751040|NCT01732783|16392255|P3|Overall Study|Administrative Decision|1
4751041|NCT01732783|16392256|P2|Overall Study|Administrative Decision|2
4751042|NCT01732783|16392257|P1|Overall Study|Administrative Decision|8
4751043|NCT01732783|16392255|P3|Overall Study|Lost to Follow-up|1
4751044|NCT01732783|16392256|P2|Overall Study|Lost to Follow-up|1
4751045|NCT01732783|16392257|P1|Overall Study|Lost to Follow-up|7
4751046|NCT01732783|16392255|P3|Overall Study|Death|1
4751047|NCT01732783|16392256|P2|Overall Study|Death|4
4751048|NCT01732783|16392257|P1|Overall Study|Death|13
4751049|NCT01732783|16392255|P3|Overall Study|Discontinued Panitumumab Treatment|7
4751050|NCT01732783|16392256|P2|Overall Study|Discontinued Panitumumab Treatment|25
4751051|NCT01732783|16392257|P1|Overall Study|Discontinued Panitumumab Treatment|106
4751052|NCT01732770|16392321|P2|Overall Study|Death|0
4751053|NCT01732770|16392322|P1|Overall Study|Death|1
4751054|NCT01732770|16392321|P2|Overall Study|Decision by Sponsor|2
4751055|NCT01732770|16392322|P1|Overall Study|Decision by Sponsor|2
4751056|NCT01732770|16392321|P2|Overall Study|Withdrawal by Subject|3
4751057|NCT01732770|16392322|P1|Overall Study|Withdrawal by Subject|5
4751058|NCT01732770|16392321|P2|Overall Study|Lost to Follow-up|3
4751059|NCT01732770|16392322|P1|Overall Study|Lost to Follow-up|2
4751060|NCT01732757|16392337|P3|Overall Study|Lost to Follow-up|0
4751061|NCT01732757|16392338|P2|Overall Study|Lost to Follow-up|0
4751062|NCT01732757|16392339|P1|Overall Study|Lost to Follow-up|1
4751063|NCT01732692|16392416|P2|Overall Study|Adverse Event|1
4751064|NCT01732692|16392417|P1|Overall Study|Adverse Event|0
4751065|NCT01732640|16392431|P2|Overall Study|Death|1
4751066|NCT01732640|16392432|P1|Overall Study|Death|0
4751067|NCT01732640|16392431|P2|Overall Study|Adverse Event|1
4751068|NCT01732640|16392432|P1|Overall Study|Adverse Event|0
4751069|NCT01732627|16392449|P2|Overall Study|Withdrawal by Subject|0
4751070|NCT01732627|16392450|P1|Overall Study|Withdrawal by Subject|1
4751071|NCT01732588|16392483|P3|First Intervention (7 Days)|Adverse Event|0
4751072|NCT01732588|16392484|P2|First Intervention (7 Days)|Adverse Event|1
4751073|NCT01732588|16392485|P1|First Intervention (7 Days)|Adverse Event|0
4751074|NCT01732549|16392501|P2|Overall Study|Other|14
4751075|NCT01732549|16392502|P1|Overall Study|Other|8
4751076|NCT01732549|16392501|P2|Overall Study|Disease progression|50
4751077|NCT01732549|16392502|P1|Overall Study|Disease progression|37
4751078|NCT01732549|16392501|P2|Overall Study|Consent withdrawn|6
4751079|NCT01732549|16392502|P1|Overall Study|Consent withdrawn|13
4751080|NCT01732549|16392501|P2|Overall Study|Adverse Event|3
4751081|NCT01732549|16392502|P1|Overall Study|Adverse Event|13
4751082|NCT01732536|16392524|P2|Overall Study|Withdrawal by Subject|1
4751083|NCT01732536|16392525|P1|Overall Study|Withdrawal by Subject|1
4751084|NCT01732510|16392548|P7|Overall Study|Study Terminated By Sponsor|6
4751085|NCT01732510|16392549|P6|Overall Study|Study Terminated By Sponsor|12
4751086|NCT01732510|16392550|P5|Overall Study|Study Terminated By Sponsor|0
4751087|NCT01732510|16392551|P4|Overall Study|Study Terminated By Sponsor|1
4751088|NCT01732510|16392552|P3|Overall Study|Study Terminated By Sponsor|0
4751089|NCT01732510|16392553|P2|Overall Study|Study Terminated By Sponsor|0
4751090|NCT01732510|16392554|P1|Overall Study|Study Terminated By Sponsor|0
4751091|NCT01732510|16392548|P7|Overall Study|Pregnancy|0
4751092|NCT01732510|16392549|P6|Overall Study|Pregnancy|0
4751093|NCT01732510|16392550|P5|Overall Study|Pregnancy|0
4751094|NCT01732510|16392551|P4|Overall Study|Pregnancy|1
4751095|NCT01732510|16392552|P3|Overall Study|Pregnancy|0
4751096|NCT01732510|16392553|P2|Overall Study|Pregnancy|0
4751097|NCT01732510|16392554|P1|Overall Study|Pregnancy|0
4751098|NCT01732510|16392548|P7|Overall Study|Physician Decision|0
4751099|NCT01732510|16392549|P6|Overall Study|Physician Decision|0
4751100|NCT01732510|16392550|P5|Overall Study|Physician Decision|0
4751101|NCT01732510|16392551|P4|Overall Study|Physician Decision|0
4751102|NCT01732510|16392552|P3|Overall Study|Physician Decision|0
4751103|NCT01732510|16392553|P2|Overall Study|Physician Decision|1
4751104|NCT01732510|16392554|P1|Overall Study|Physician Decision|0
4751105|NCT01732510|16392548|P7|Overall Study|Lost to Follow-up|0
4751106|NCT01732510|16392549|P6|Overall Study|Lost to Follow-up|1
4751107|NCT01732510|16392550|P5|Overall Study|Lost to Follow-up|0
4751108|NCT01732510|16392551|P4|Overall Study|Lost to Follow-up|1
4751109|NCT01732510|16392552|P3|Overall Study|Lost to Follow-up|1
4751110|NCT01732510|16392553|P2|Overall Study|Lost to Follow-up|0
4751111|NCT01732510|16392554|P1|Overall Study|Lost to Follow-up|0
4751112|NCT01732510|16392548|P7|Overall Study|Withdrawal by Subject|1
4751113|NCT01732510|16392549|P6|Overall Study|Withdrawal by Subject|0
4751114|NCT01732510|16392550|P5|Overall Study|Withdrawal by Subject|5
4751115|NCT01732510|16392551|P4|Overall Study|Withdrawal by Subject|1
4751116|NCT01732510|16392552|P3|Overall Study|Withdrawal by Subject|2
4751117|NCT01732510|16392553|P2|Overall Study|Withdrawal by Subject|3
4751118|NCT01732510|16392554|P1|Overall Study|Withdrawal by Subject|1
4751119|NCT01732510|16392548|P7|Overall Study|Protocol Violation|0
4751120|NCT01732510|16392549|P6|Overall Study|Protocol Violation|0
4751121|NCT01732510|16392550|P5|Overall Study|Protocol Violation|0
4751122|NCT01732510|16392551|P4|Overall Study|Protocol Violation|1
4751123|NCT01732510|16392552|P3|Overall Study|Protocol Violation|0
4751124|NCT01732510|16392553|P2|Overall Study|Protocol Violation|0
4751125|NCT01732510|16392554|P1|Overall Study|Protocol Violation|0
4751126|NCT01732510|16392548|P7|Overall Study|Adverse Event|1
4751127|NCT01732510|16392549|P6|Overall Study|Adverse Event|0
4751128|NCT01732510|16392550|P5|Overall Study|Adverse Event|0
4751129|NCT01732510|16392551|P4|Overall Study|Adverse Event|0
4751130|NCT01732510|16392552|P3|Overall Study|Adverse Event|1
4751131|NCT01732510|16392553|P2|Overall Study|Adverse Event|1
4751132|NCT01732510|16392554|P1|Overall Study|Adverse Event|0
4751133|NCT01732484|16392633|P1|Overall Study|chronical illness|5
4751134|NCT01732484|16392633|P1|Overall Study|Lost to Follow-up|14
4751135|NCT01732484|16392633|P1|Overall Study|Death|7
4751136|NCT01732471|16392641|P1|Overall Study|Withdrawal by Subject|1
4751137|NCT01732458|16392652|P4|Overall Study|Screen Failure|0
4751138|NCT01732458|16392653|P3|Overall Study|Screen Failure|0
4751139|NCT01732458|16392654|P2|Overall Study|Screen Failure|1
4751140|NCT01732458|16392655|P1|Overall Study|Screen Failure|0
4751141|NCT01732458|16392652|P4|Overall Study|Protocol Violation|2
4751142|NCT01732458|16392653|P3|Overall Study|Protocol Violation|0
4751143|NCT01732458|16392654|P2|Overall Study|Protocol Violation|0
4751144|NCT01732458|16392655|P1|Overall Study|Protocol Violation|2
4751145|NCT01732458|16392652|P4|Overall Study|Physician Decision|0
4751146|NCT01732458|16392653|P3|Overall Study|Physician Decision|2
4751147|NCT01732458|16392654|P2|Overall Study|Physician Decision|2
4751148|NCT01732458|16392655|P1|Overall Study|Physician Decision|1
4751149|NCT01732458|16392652|P4|Overall Study|Non-Compliance With Study Drug|0
4751150|NCT01732458|16392653|P3|Overall Study|Non-Compliance With Study Drug|1
4751151|NCT01732458|16392654|P2|Overall Study|Non-Compliance With Study Drug|0
4751152|NCT01732458|16392655|P1|Overall Study|Non-Compliance With Study Drug|0
4751153|NCT01732458|16392652|P4|Overall Study|Lost to Follow-up|0
4751154|NCT01732458|16392653|P3|Overall Study|Lost to Follow-up|0
4751155|NCT01732458|16392654|P2|Overall Study|Lost to Follow-up|2
4751156|NCT01732458|16392655|P1|Overall Study|Lost to Follow-up|0
4751157|NCT01732107|16392817|P1|Overall Study|Withdrawal by Subject|2
4751158|NCT01732107|16392817|P1|Overall Study|Physician Decision|1
4751159|NCT01732107|16392817|P1|Overall Study|Disease Progression|8
4751160|NCT01732107|16392817|P1|Overall Study|Adverse Event|2
4751161|NCT01731990|16392834|P2|Overall Study|Death|0
4751162|NCT01731990|16392835|P1|Overall Study|Death|1
4751163|NCT01731990|16392834|P2|Overall Study|Protocol deviation|2
4751164|NCT01731990|16392835|P1|Overall Study|Protocol deviation|1
4751165|NCT01731990|16392834|P2|Overall Study|Withdrawal by Subject|1
4751166|NCT01731990|16392835|P1|Overall Study|Withdrawal by Subject|1
4751167|NCT01731990|16392834|P2|Overall Study|Adverse Event|5
4751168|NCT01731990|16392835|P1|Overall Study|Adverse Event|1
4751169|NCT01731938|16392851|P2|Primary Part II|Missed Week 6 visit|3
4751170|NCT01731938|16392852|P1|Primary Part II|Missed Week 6 visit|2
4751171|NCT01731938|16392851|P2|Primary Part II|Death|1
4751172|NCT01731938|16392852|P1|Primary Part II|Death|2
4751173|NCT01731938|16392851|P2|Primary Part II|Lost to Follow-up|5
4751174|NCT01731938|16392852|P1|Primary Part II|Lost to Follow-up|4
4751175|NCT01731938|16392851|P2|Primary Part II|Withdrawal by Subject|4
4751176|NCT01731938|16392852|P1|Primary Part II|Withdrawal by Subject|5
4751177|NCT01731938|16392851|P2|Preliminary Part I|Missed Week 6 visit|3
4751178|NCT01731938|16392852|P1|Preliminary Part I|Missed Week 6 visit|0
4751179|NCT01731938|16392851|P2|Preliminary Part I|Lost to Follow-up|3
4751180|NCT01731938|16392852|P1|Preliminary Part I|Lost to Follow-up|0
4751181|NCT01731938|16392851|P2|Preliminary Part I|Physician Decision|0
4751182|NCT01731938|16392852|P1|Preliminary Part I|Physician Decision|1
4751183|NCT01731938|16392851|P2|Preliminary Part I|Withdrawal by Subject|2
4751184|NCT01731938|16392852|P1|Preliminary Part I|Withdrawal by Subject|2
4751185|NCT01731912|16392864|P1|Overall Study|noncompliance|2
4751186|NCT01731886|16392871|P2|Overall Study|Non-compliant|0
4751187|NCT01731886|16392872|P1|Overall Study|Non-compliant|1
4751188|NCT01731886|16392871|P2|Overall Study|Never started treatment|1
4751189|NCT01731886|16392872|P1|Overall Study|Never started treatment|0
4751190|NCT01731886|16392871|P2|Overall Study|Death|0
4751191|NCT01731886|16392872|P1|Overall Study|Death|1
4751192|NCT01731678|16392917|P1|Overall Study|RMT too high, making TMS difficult|3
4751193|NCT01731678|16392917|P1|Overall Study|Did not meet inclusion criteria|1
4751194|NCT01731678|16392917|P1|Overall Study|Withdrawal by Subject|3
4751195|NCT01731600|16392923|P2|Overall Study|Other reasons|0
4751196|NCT01731600|16392924|P1|Overall Study|Other reasons|3
4751197|NCT01731600|16392923|P2|Overall Study|Withdrawal criteria|0
4751198|NCT01731600|16392924|P1|Overall Study|Withdrawal criteria|1
4751199|NCT01731600|16392923|P2|Overall Study|Adverse Event|0
4751200|NCT01731600|16392924|P1|Overall Study|Adverse Event|2
4751201|NCT01731470|16392978|P1|Overall Study|Did not meet study criteria|1
4751202|NCT01731470|16392978|P1|Overall Study|Withdrawal by Subject|1
4751203|NCT01731171|16392985|P2|Overall Study|Terminated for Safety Reasons|1
4751204|NCT01731171|16392986|P1|Overall Study|Terminated for Safety Reasons|0
4751205|NCT01731171|16392985|P2|Overall Study|Terminated for Lack of Adherence|1
4751206|NCT01731171|16392986|P1|Overall Study|Terminated for Lack of Adherence|0
4751207|NCT01731171|16392985|P2|Overall Study|Moved out of Area|2
4751208|NCT01731171|16392986|P1|Overall Study|Moved out of Area|0
4751209|NCT01731171|16392985|P2|Overall Study|Lost to Follow-up|2
4751210|NCT01731171|16392986|P1|Overall Study|Lost to Follow-up|3
4751211|NCT01731171|16392985|P2|Overall Study|Withdrawal by Subject|1
4751212|NCT01731171|16392986|P1|Overall Study|Withdrawal by Subject|4
4751213|NCT01731002|16393020|P3|Overall Study|Inappropriate use of study medications|1
4751214|NCT01731002|16393021|P2|Overall Study|Inappropriate use of study medications|0
4751215|NCT01731002|16393022|P1|Overall Study|Inappropriate use of study medications|0
4751216|NCT01731002|16393020|P3|Overall Study|Elevated IOP|0
4751217|NCT01731002|16393021|P2|Overall Study|Elevated IOP|0
4751218|NCT01731002|16393022|P1|Overall Study|Elevated IOP|1
4751219|NCT01731002|16393020|P3|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
4751220|NCT01731002|16393021|P2|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0
4751221|NCT01731002|16393022|P1|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2
4751222|NCT01731002|16393020|P3|Overall Study|Test Agent Discontinuation|0
4751223|NCT01731002|16393021|P2|Overall Study|Test Agent Discontinuation|1
4751224|NCT01731002|16393022|P1|Overall Study|Test Agent Discontinuation|0
4751225|NCT01731002|16393020|P3|Overall Study|Lost to Follow-up|0
4751226|NCT01731002|16393021|P2|Overall Study|Lost to Follow-up|0
4751227|NCT01731002|16393022|P1|Overall Study|Lost to Follow-up|1
4751228|NCT01731002|16393020|P3|Overall Study|Non-Compliant|0
4751229|NCT01731002|16393021|P2|Overall Study|Non-Compliant|1
4751230|NCT01731002|16393022|P1|Overall Study|Non-Compliant|0
4751231|NCT01731002|16393020|P3|Overall Study|Adverse Event|2
4751232|NCT01731002|16393021|P2|Overall Study|Adverse Event|2
4751233|NCT01731002|16393022|P1|Overall Study|Adverse Event|0
4751234|NCT01730950|16393035|P2|Overall Study|Protocol Violation|6
4751235|NCT01730950|16393036|P1|Overall Study|Protocol Violation|6
4751236|NCT01730729|16393082|P1|Overall Study|Progressive Disease|12
4751237|NCT01730729|16393082|P1|Overall Study|Death|1
4751238|NCT01730729|16393082|P1|Overall Study|Adverse Event|1
4751239|NCT01730586|16393096|P1|Overall Study|Hospice|1
4751240|NCT01730586|16393096|P1|Overall Study|Adverse Event|2
4751241|NCT01730586|16393096|P1|Overall Study|Inadequate Trial|8
4751242|NCT01730586|16393096|P1|Overall Study|Progressive Disease|2
4751243|NCT01730534|16393105|P2|Overall Study|Lost to Follow-up|18
4751244|NCT01730534|16393106|P1|Overall Study|Lost to Follow-up|12
4751245|NCT01730534|16393105|P2|Overall Study|Withdrawal by Subject|127
4751246|NCT01730534|16393106|P1|Overall Study|Withdrawal by Subject|97
4751247|NCT01730378|16393120|P2|Overall Study|Lost to Follow-up|0
4751248|NCT01730378|16393121|P1|Overall Study|Lost to Follow-up|1
4751249|NCT01730339|16393152|P2|Overall Study|Un-specified|0
4751250|NCT01730339|16393153|P1|Overall Study|Un-specified|1
4751251|NCT01730339|16393152|P2|Overall Study|Lost to Follow-up|1
4751252|NCT01730339|16393153|P1|Overall Study|Lost to Follow-up|1
4751253|NCT01730339|16393152|P2|Overall Study|Withdrawal by Subject|2
4751254|NCT01730339|16393153|P1|Overall Study|Withdrawal by Subject|3
4751255|NCT01730053|16393193|P6|Overall Study|Other than specified|9
4751256|NCT01730053|16393194|P5|Overall Study|Other than specified|7
4751257|NCT01730053|16393195|P4|Overall Study|Other than specified|4
4751258|NCT01730053|16393196|P3|Overall Study|Other than specified|5
4751259|NCT01730053|16393197|P2|Overall Study|Other than specified|6
4751260|NCT01730053|16393198|P1|Overall Study|Other than specified|2
4751261|NCT01730053|16393193|P6|Overall Study|Poor compliance to protocol|2
4751262|NCT01730053|16393194|P5|Overall Study|Poor compliance to protocol|0
4751263|NCT01730053|16393195|P4|Overall Study|Poor compliance to protocol|0
4751264|NCT01730053|16393196|P3|Overall Study|Poor compliance to protocol|2
4751265|NCT01730053|16393197|P2|Overall Study|Poor compliance to protocol|2
4751266|NCT01730053|16393198|P1|Overall Study|Poor compliance to protocol|1
4751267|NCT01730053|16393193|P6|Overall Study|Adverse Event|2
4751268|NCT01730053|16393194|P5|Overall Study|Adverse Event|2
4751269|NCT01730053|16393195|P4|Overall Study|Adverse Event|3
4751270|NCT01730053|16393196|P3|Overall Study|Adverse Event|3
4751271|NCT01730053|16393197|P2|Overall Study|Adverse Event|6
4751272|NCT01730053|16393198|P1|Overall Study|Adverse Event|2
4751273|NCT01730053|16393193|P6|Overall Study|Physician Decision|0
4751274|NCT01730053|16393194|P5|Overall Study|Physician Decision|0
4751275|NCT01730053|16393195|P4|Overall Study|Physician Decision|1
4751276|NCT01730053|16393196|P3|Overall Study|Physician Decision|0
4751277|NCT01730053|16393197|P2|Overall Study|Physician Decision|0
4751278|NCT01730053|16393198|P1|Overall Study|Physician Decision|0
4751279|NCT01730053|16393193|P6|Overall Study|Participant moved|0
4751280|NCT01730053|16393194|P5|Overall Study|Participant moved|0
4751281|NCT01730053|16393195|P4|Overall Study|Participant moved|0
4751282|NCT01730053|16393196|P3|Overall Study|Participant moved|1
4751283|NCT01730053|16393197|P2|Overall Study|Participant moved|0
4751284|NCT01730053|16393198|P1|Overall Study|Participant moved|0
4751285|NCT01730040|16393357|P7|Overall Study|Poor compliance to protocol|1
4751286|NCT01730040|16393358|P6|Overall Study|Poor compliance to protocol|0
4751287|NCT01730040|16393359|P5|Overall Study|Poor compliance to protocol|0
4751288|NCT01730040|16393360|P4|Overall Study|Poor compliance to protocol|0
4751289|NCT01730040|16393361|P3|Overall Study|Poor compliance to protocol|0
4751290|NCT01730040|16393362|P2|Overall Study|Poor compliance to protocol|4
4751291|NCT01730040|16393363|P1|Overall Study|Poor compliance to protocol|2
4751292|NCT01730040|16393357|P7|Overall Study|Adverse Event|2
4751293|NCT01730040|16393358|P6|Overall Study|Adverse Event|1
4751294|NCT01730040|16393359|P5|Overall Study|Adverse Event|1
4751295|NCT01730040|16393360|P4|Overall Study|Adverse Event|3
4751296|NCT01730040|16393361|P3|Overall Study|Adverse Event|5
4751297|NCT01730040|16393362|P2|Overall Study|Adverse Event|3
4751298|NCT01730040|16393363|P1|Overall Study|Adverse Event|4
4751299|NCT01730040|16393357|P7|Overall Study|Other than specified|4
4751300|NCT01730040|16393358|P6|Overall Study|Other than specified|4
4751301|NCT01730040|16393359|P5|Overall Study|Other than specified|5
4751302|NCT01730040|16393360|P4|Overall Study|Other than specified|5
4751303|NCT01730040|16393361|P3|Overall Study|Other than specified|5
4751304|NCT01730040|16393362|P2|Overall Study|Other than specified|8
4751305|NCT01730040|16393363|P1|Overall Study|Other than specified|7
4751306|NCT01730040|16393357|P7|Overall Study|Physician Decision|1
4751307|NCT01730040|16393358|P6|Overall Study|Physician Decision|1
4751308|NCT01730040|16393359|P5|Overall Study|Physician Decision|0
4751309|NCT01730040|16393360|P4|Overall Study|Physician Decision|0
4751310|NCT01730040|16393361|P3|Overall Study|Physician Decision|0
4751311|NCT01730040|16393362|P2|Overall Study|Physician Decision|0
4751312|NCT01730040|16393363|P1|Overall Study|Physician Decision|0
4751313|NCT01730040|16393357|P7|Overall Study|Subject moved|1
4751314|NCT01730040|16393358|P6|Overall Study|Subject moved|0
4751315|NCT01730040|16393359|P5|Overall Study|Subject moved|0
4751316|NCT01730040|16393360|P4|Overall Study|Subject moved|0
4751317|NCT01730040|16393361|P3|Overall Study|Subject moved|1
4751318|NCT01730040|16393362|P2|Overall Study|Subject moved|0
4751319|NCT01730040|16393363|P1|Overall Study|Subject moved|0
4751320|NCT01730040|16393357|P7|Overall Study|Randomized but not treated|0
4751321|NCT01730040|16393358|P6|Overall Study|Randomized but not treated|1
4751322|NCT01730040|16393359|P5|Overall Study|Randomized but not treated|0
4751323|NCT01730040|16393360|P4|Overall Study|Randomized but not treated|0
4751324|NCT01730040|16393361|P3|Overall Study|Randomized but not treated|0
4751325|NCT01730040|16393362|P2|Overall Study|Randomized but not treated|0
4751326|NCT01730040|16393363|P1|Overall Study|Randomized but not treated|0
4751327|NCT01729871|16393552|P2|Overall Study|Other|9
4751328|NCT01729871|16393553|P1|Overall Study|Other|4
4751329|NCT01729871|16393552|P2|Overall Study|Withdrawal by Subject|3
4751330|NCT01729871|16393553|P1|Overall Study|Withdrawal by Subject|0
4751331|NCT01729871|16393552|P2|Overall Study|Protocol Violation|0
4751332|NCT01729871|16393553|P1|Overall Study|Protocol Violation|1
4751333|NCT01729871|16393552|P2|Overall Study|Physician Decision|2
4751334|NCT01729871|16393553|P1|Overall Study|Physician Decision|0
4751335|NCT01729871|16393552|P2|Overall Study|Lack of Efficacy|1
4751336|NCT01729871|16393553|P1|Overall Study|Lack of Efficacy|0
4751337|NCT01729871|16393552|P2|Overall Study|Death|1
4751338|NCT01729871|16393553|P1|Overall Study|Death|0
4751339|NCT01729871|16393552|P2|Overall Study|Adverse Event|7
4751340|NCT01729871|16393553|P1|Overall Study|Adverse Event|7
4751341|NCT01729819|16393587|P2|Overall Study|Withdrawal by Subject|2
4751342|NCT01729819|16393588|P1|Overall Study|Withdrawal by Subject|0
4751343|NCT01729819|16393587|P2|Overall Study|Protocol Violation|1
4751344|NCT01729819|16393588|P1|Overall Study|Protocol Violation|0
4751345|NCT01729819|16393587|P2|Overall Study|Other reason|0
4751346|NCT01729819|16393588|P1|Overall Study|Other reason|1
4751347|NCT01729819|16393587|P2|Overall Study|Lost to Follow-up|0
4751348|NCT01729819|16393588|P1|Overall Study|Lost to Follow-up|2
4751349|NCT01729819|16393587|P2|Overall Study|Lack of Efficacy|0
4751350|NCT01729819|16393588|P1|Overall Study|Lack of Efficacy|1
4751351|NCT01729819|16393587|P2|Overall Study|Adverse Event|4
4751352|NCT01729819|16393588|P1|Overall Study|Adverse Event|2
4751353|NCT01729754|16393607|P10|Part 3|Other Protocol Specified Criteria|0
4751354|NCT01729754|16393608|P9|Part 3|Other Protocol Specified Criteria|0
4751355|NCT01729754|16393609|P8|Part 3|Other Protocol Specified Criteria|1
4751356|NCT01729754|16393610|P7|Part 3|Other Protocol Specified Criteria|0
4751357|NCT01729754|16393611|P6|Part 3|Other Protocol Specified Criteria|2
4751358|NCT01729754|16393612|P5|Part 3|Other Protocol Specified Criteria|0
4751359|NCT01729754|16393613|P4|Part 3|Other Protocol Specified Criteria|0
4751360|NCT01729754|16393614|P3|Part 3|Other Protocol Specified Criteria|0
4751361|NCT01729754|16393615|P2|Part 3|Other Protocol Specified Criteria|0
4751362|NCT01729754|16393616|P1|Part 3|Other Protocol Specified Criteria|0
4751363|NCT01729754|16393607|P10|Part 3|Withdrawal by Subject|0
4751364|NCT01729754|16393608|P9|Part 3|Withdrawal by Subject|0
4751365|NCT01729754|16393609|P8|Part 3|Withdrawal by Subject|2
4751366|NCT01729754|16393610|P7|Part 3|Withdrawal by Subject|0
4751367|NCT01729754|16393611|P6|Part 3|Withdrawal by Subject|1
4751368|NCT01729754|16393612|P5|Part 3|Withdrawal by Subject|2
4751369|NCT01729754|16393613|P4|Part 3|Withdrawal by Subject|0
4751370|NCT01729754|16393614|P3|Part 3|Withdrawal by Subject|1
4751371|NCT01729754|16393615|P2|Part 3|Withdrawal by Subject|4
4751372|NCT01729754|16393616|P1|Part 3|Withdrawal by Subject|0
4751373|NCT01729754|16393607|P10|Part 3|Physician Decision|0
4751374|NCT01729754|16393608|P9|Part 3|Physician Decision|0
4751375|NCT01729754|16393609|P8|Part 3|Physician Decision|0
4751376|NCT01729754|16393610|P7|Part 3|Physician Decision|0
4751377|NCT01729754|16393611|P6|Part 3|Physician Decision|0
4751378|NCT01729754|16393612|P5|Part 3|Physician Decision|0
4751379|NCT01729754|16393613|P4|Part 3|Physician Decision|0
4751380|NCT01729754|16393614|P3|Part 3|Physician Decision|1
4751381|NCT01729754|16393615|P2|Part 3|Physician Decision|0
4751382|NCT01729754|16393616|P1|Part 3|Physician Decision|0
4751383|NCT01729754|16393607|P10|Part 3|Lost to Follow-up|0
4751384|NCT01729754|16393608|P9|Part 3|Lost to Follow-up|1
4751385|NCT01729754|16393609|P8|Part 3|Lost to Follow-up|0
4751386|NCT01729754|16393610|P7|Part 3|Lost to Follow-up|0
4751387|NCT01729754|16393611|P6|Part 3|Lost to Follow-up|3
4751388|NCT01729754|16393612|P5|Part 3|Lost to Follow-up|0
4751389|NCT01729754|16393613|P4|Part 3|Lost to Follow-up|0
4751390|NCT01729754|16393614|P3|Part 3|Lost to Follow-up|2
4751391|NCT01729754|16393615|P2|Part 3|Lost to Follow-up|1
4751392|NCT01729754|16393616|P1|Part 3|Lost to Follow-up|0
4751393|NCT01729754|16393607|P10|Part 3|Lack of Efficacy|4
4751394|NCT01729754|16393608|P9|Part 3|Lack of Efficacy|0
4751395|NCT01729754|16393609|P8|Part 3|Lack of Efficacy|0
4751396|NCT01729754|16393610|P7|Part 3|Lack of Efficacy|0
4751397|NCT01729754|16393611|P6|Part 3|Lack of Efficacy|0
4751398|NCT01729754|16393612|P5|Part 3|Lack of Efficacy|2
4751399|NCT01729754|16393613|P4|Part 3|Lack of Efficacy|0
4751400|NCT01729754|16393614|P3|Part 3|Lack of Efficacy|0
4751401|NCT01729754|16393615|P2|Part 3|Lack of Efficacy|0
4751402|NCT01729754|16393616|P1|Part 3|Lack of Efficacy|0
4751403|NCT01729754|16393607|P10|Part 3|Death|0
4751404|NCT01729754|16393608|P9|Part 3|Death|0
4751405|NCT01729754|16393609|P8|Part 3|Death|0
4751406|NCT01729754|16393610|P7|Part 3|Death|0
4751407|NCT01729754|16393611|P6|Part 3|Death|2
4751408|NCT01729754|16393612|P5|Part 3|Death|0
4751409|NCT01729754|16393613|P4|Part 3|Death|0
4751410|NCT01729754|16393614|P3|Part 3|Death|0
4751411|NCT01729754|16393615|P2|Part 3|Death|0
4751412|NCT01729754|16393616|P1|Part 3|Death|0
4751413|NCT01729754|16393607|P10|Part 3|Adverse Event|3
4751414|NCT01729754|16393608|P9|Part 3|Adverse Event|0
4751415|NCT01729754|16393609|P8|Part 3|Adverse Event|0
4751416|NCT01729754|16393610|P7|Part 3|Adverse Event|0
4751417|NCT01729754|16393611|P6|Part 3|Adverse Event|5
4751418|NCT01729754|16393612|P5|Part 3|Adverse Event|0
4751419|NCT01729754|16393613|P4|Part 3|Adverse Event|0
4751420|NCT01729754|16393614|P3|Part 3|Adverse Event|1
4751421|NCT01729754|16393615|P2|Part 3|Adverse Event|0
4751422|NCT01729754|16393616|P1|Part 3|Adverse Event|0
4751423|NCT01729754|16393607|P10|Part 2|Other Protocol Specified Criteria|0
4751424|NCT01729754|16393608|P9|Part 2|Other Protocol Specified Criteria|0
4751425|NCT01729754|16393609|P8|Part 2|Other Protocol Specified Criteria|1
4751426|NCT01729754|16393610|P7|Part 2|Other Protocol Specified Criteria|0
4751427|NCT01729754|16393611|P6|Part 2|Other Protocol Specified Criteria|0
4751428|NCT01729754|16393612|P5|Part 2|Other Protocol Specified Criteria|0
4751429|NCT01729754|16393613|P4|Part 2|Other Protocol Specified Criteria|0
4751430|NCT01729754|16393614|P3|Part 2|Other Protocol Specified Criteria|0
4751431|NCT01729754|16393615|P2|Part 2|Other Protocol Specified Criteria|0
4751432|NCT01729754|16393616|P1|Part 2|Other Protocol Specified Criteria|1
4751433|NCT01729754|16393607|P10|Part 2|Withdrawal by Subject|4
4751434|NCT01729754|16393608|P9|Part 2|Withdrawal by Subject|1
4751435|NCT01729754|16393609|P8|Part 2|Withdrawal by Subject|1
4751436|NCT01729754|16393610|P7|Part 2|Withdrawal by Subject|0
4751437|NCT01729754|16393611|P6|Part 2|Withdrawal by Subject|0
4751438|NCT01729754|16393612|P5|Part 2|Withdrawal by Subject|0
4751439|NCT01729754|16393613|P4|Part 2|Withdrawal by Subject|2
4751440|NCT01729754|16393614|P3|Part 2|Withdrawal by Subject|0
4751441|NCT01729754|16393615|P2|Part 2|Withdrawal by Subject|0
4751442|NCT01729754|16393616|P1|Part 2|Withdrawal by Subject|3
4751443|NCT01729754|16393607|P10|Part 2|Pregnancy|1
4751444|NCT01729754|16393608|P9|Part 2|Pregnancy|0
4751445|NCT01729754|16393609|P8|Part 2|Pregnancy|0
4751446|NCT01729754|16393610|P7|Part 2|Pregnancy|0
4751447|NCT01729754|16393611|P6|Part 2|Pregnancy|0
4751448|NCT01729754|16393612|P5|Part 2|Pregnancy|0
4751449|NCT01729754|16393613|P4|Part 2|Pregnancy|1
4751450|NCT01729754|16393614|P3|Part 2|Pregnancy|0
4751451|NCT01729754|16393615|P2|Part 2|Pregnancy|0
4751452|NCT01729754|16393616|P1|Part 2|Pregnancy|0
4751453|NCT01729754|16393607|P10|Part 2|Non-Compliance with Study Drug|1
4751454|NCT01729754|16393608|P9|Part 2|Non-Compliance with Study Drug|0
4751455|NCT01729754|16393609|P8|Part 2|Non-Compliance with Study Drug|0
4751456|NCT01729754|16393610|P7|Part 2|Non-Compliance with Study Drug|0
4751457|NCT01729754|16393611|P6|Part 2|Non-Compliance with Study Drug|0
4751458|NCT01729754|16393612|P5|Part 2|Non-Compliance with Study Drug|0
4751459|NCT01729754|16393613|P4|Part 2|Non-Compliance with Study Drug|0
4751460|NCT01729754|16393614|P3|Part 2|Non-Compliance with Study Drug|0
4751461|NCT01729754|16393615|P2|Part 2|Non-Compliance with Study Drug|0
4751462|NCT01729754|16393616|P1|Part 2|Non-Compliance with Study Drug|0
4751463|NCT01729754|16393607|P10|Part 2|Lost to Follow-up|2
4751464|NCT01729754|16393608|P9|Part 2|Lost to Follow-up|0
4751465|NCT01729754|16393609|P8|Part 2|Lost to Follow-up|1
4751466|NCT01729754|16393610|P7|Part 2|Lost to Follow-up|0
4751467|NCT01729754|16393611|P6|Part 2|Lost to Follow-up|0
4751468|NCT01729754|16393612|P5|Part 2|Lost to Follow-up|0
4751469|NCT01729754|16393613|P4|Part 2|Lost to Follow-up|2
4751470|NCT01729754|16393614|P3|Part 2|Lost to Follow-up|0
4751471|NCT01729754|16393615|P2|Part 2|Lost to Follow-up|0
4751472|NCT01729754|16393616|P1|Part 2|Lost to Follow-up|0
4751473|NCT01729754|16393607|P10|Part 2|Lack of Efficacy|2
4751474|NCT01729754|16393608|P9|Part 2|Lack of Efficacy|2
4751475|NCT01729754|16393609|P8|Part 2|Lack of Efficacy|0
4751476|NCT01729754|16393610|P7|Part 2|Lack of Efficacy|0
4751477|NCT01729754|16393611|P6|Part 2|Lack of Efficacy|0
4751478|NCT01729754|16393612|P5|Part 2|Lack of Efficacy|0
4751479|NCT01729754|16393613|P4|Part 2|Lack of Efficacy|0
4751480|NCT01729754|16393614|P3|Part 2|Lack of Efficacy|0
4751481|NCT01729754|16393615|P2|Part 2|Lack of Efficacy|0
4751482|NCT01729754|16393616|P1|Part 2|Lack of Efficacy|0
4751483|NCT01729754|16393607|P10|Part 2|Adverse Event|2
4751484|NCT01729754|16393608|P9|Part 2|Adverse Event|1
4751485|NCT01729754|16393609|P8|Part 2|Adverse Event|0
4751486|NCT01729754|16393610|P7|Part 2|Adverse Event|0
4751487|NCT01729754|16393611|P6|Part 2|Adverse Event|0
4751488|NCT01729754|16393612|P5|Part 2|Adverse Event|0
4751489|NCT01729754|16393613|P4|Part 2|Adverse Event|0
4751490|NCT01729754|16393614|P3|Part 2|Adverse Event|0
4751491|NCT01729754|16393615|P2|Part 2|Adverse Event|0
4751492|NCT01729754|16393616|P1|Part 2|Adverse Event|2
4751493|NCT01729754|16393607|P10|Part 1|Other Protocol Specified Criteria|4
4751494|NCT01729754|16393608|P9|Part 1|Other Protocol Specified Criteria|0
4751495|NCT01729754|16393609|P8|Part 1|Other Protocol Specified Criteria|0
4751496|NCT01729754|16393610|P7|Part 1|Other Protocol Specified Criteria|1
4751497|NCT01729754|16393611|P6|Part 1|Other Protocol Specified Criteria|0
4751498|NCT01729754|16393612|P5|Part 1|Other Protocol Specified Criteria|0
4751499|NCT01729754|16393613|P4|Part 1|Other Protocol Specified Criteria|0
4751500|NCT01729754|16393614|P3|Part 1|Other Protocol Specified Criteria|0
4751501|NCT01729754|16393615|P2|Part 1|Other Protocol Specified Criteria|0
4751502|NCT01729754|16393616|P1|Part 1|Other Protocol Specified Criteria|2
4751503|NCT01729754|16393607|P10|Part 1|Withdrawal by Subject|6
4751504|NCT01729754|16393608|P9|Part 1|Withdrawal by Subject|0
4751505|NCT01729754|16393609|P8|Part 1|Withdrawal by Subject|0
4751506|NCT01729754|16393610|P7|Part 1|Withdrawal by Subject|5
4751507|NCT01729754|16393611|P6|Part 1|Withdrawal by Subject|0
4751508|NCT01729754|16393612|P5|Part 1|Withdrawal by Subject|0
4751509|NCT01729754|16393613|P4|Part 1|Withdrawal by Subject|7
4751510|NCT01729754|16393614|P3|Part 1|Withdrawal by Subject|0
4751511|NCT01729754|16393615|P2|Part 1|Withdrawal by Subject|0
4751512|NCT01729754|16393616|P1|Part 1|Withdrawal by Subject|5
4751513|NCT01729754|16393607|P10|Part 1|Protocol Violation|0
4751514|NCT01729754|16393608|P9|Part 1|Protocol Violation|0
4751515|NCT01729754|16393609|P8|Part 1|Protocol Violation|0
4751516|NCT01729754|16393610|P7|Part 1|Protocol Violation|1
4751517|NCT01729754|16393611|P6|Part 1|Protocol Violation|0
4751518|NCT01729754|16393612|P5|Part 1|Protocol Violation|0
4751519|NCT01729754|16393613|P4|Part 1|Protocol Violation|1
4751520|NCT01729754|16393614|P3|Part 1|Protocol Violation|0
4751521|NCT01729754|16393615|P2|Part 1|Protocol Violation|0
4751522|NCT01729754|16393616|P1|Part 1|Protocol Violation|2
4751523|NCT01729754|16393607|P10|Part 1|Progressive Disease|1
4751524|NCT01729754|16393608|P9|Part 1|Progressive Disease|0
4751525|NCT01729754|16393609|P8|Part 1|Progressive Disease|0
4751526|NCT01729754|16393610|P7|Part 1|Progressive Disease|0
4751527|NCT01729754|16393611|P6|Part 1|Progressive Disease|0
4751528|NCT01729754|16393612|P5|Part 1|Progressive Disease|0
4751529|NCT01729754|16393613|P4|Part 1|Progressive Disease|0
4751530|NCT01729754|16393614|P3|Part 1|Progressive Disease|0
4751531|NCT01729754|16393615|P2|Part 1|Progressive Disease|0
4751532|NCT01729754|16393616|P1|Part 1|Progressive Disease|0
4751533|NCT01729754|16393607|P10|Part 1|Pregnancy|1
4751534|NCT01729754|16393608|P9|Part 1|Pregnancy|0
4751535|NCT01729754|16393609|P8|Part 1|Pregnancy|0
4751536|NCT01729754|16393610|P7|Part 1|Pregnancy|0
4751537|NCT01729754|16393611|P6|Part 1|Pregnancy|0
4751538|NCT01729754|16393612|P5|Part 1|Pregnancy|0
4751539|NCT01729754|16393613|P4|Part 1|Pregnancy|1
4751540|NCT01729754|16393614|P3|Part 1|Pregnancy|0
4751541|NCT01729754|16393615|P2|Part 1|Pregnancy|0
4751542|NCT01729754|16393616|P1|Part 1|Pregnancy|0
4751543|NCT01729754|16393607|P10|Part 1|Physician Decision|4
4751544|NCT01729754|16393608|P9|Part 1|Physician Decision|0
4751545|NCT01729754|16393609|P8|Part 1|Physician Decision|0
4751546|NCT01729754|16393610|P7|Part 1|Physician Decision|0
4751547|NCT01729754|16393611|P6|Part 1|Physician Decision|0
4751548|NCT01729754|16393612|P5|Part 1|Physician Decision|0
4751549|NCT01729754|16393613|P4|Part 1|Physician Decision|0
4751550|NCT01729754|16393614|P3|Part 1|Physician Decision|0
4751551|NCT01729754|16393615|P2|Part 1|Physician Decision|0
4751552|NCT01729754|16393616|P1|Part 1|Physician Decision|0
4751553|NCT01729754|16393607|P10|Part 1|Non-compliance with Study Drug|0
4751554|NCT01729754|16393608|P9|Part 1|Non-compliance with Study Drug|0
4751555|NCT01729754|16393609|P8|Part 1|Non-compliance with Study Drug|0
4751556|NCT01729754|16393610|P7|Part 1|Non-compliance with Study Drug|0
4751557|NCT01729754|16393611|P6|Part 1|Non-compliance with Study Drug|0
4751558|NCT01729754|16393612|P5|Part 1|Non-compliance with Study Drug|0
4751559|NCT01729754|16393613|P4|Part 1|Non-compliance with Study Drug|0
4751560|NCT01729754|16393614|P3|Part 1|Non-compliance with Study Drug|0
4751561|NCT01729754|16393615|P2|Part 1|Non-compliance with Study Drug|0
4751562|NCT01729754|16393616|P1|Part 1|Non-compliance with Study Drug|1
4751563|NCT01729754|16393607|P10|Part 1|Lost to Follow-up|3
4751564|NCT01729754|16393608|P9|Part 1|Lost to Follow-up|0
4751565|NCT01729754|16393609|P8|Part 1|Lost to Follow-up|0
4751566|NCT01729754|16393610|P7|Part 1|Lost to Follow-up|3
4751567|NCT01729754|16393611|P6|Part 1|Lost to Follow-up|0
4751568|NCT01729754|16393612|P5|Part 1|Lost to Follow-up|0
4751569|NCT01729754|16393613|P4|Part 1|Lost to Follow-up|2
4751570|NCT01729754|16393614|P3|Part 1|Lost to Follow-up|0
4751571|NCT01729754|16393615|P2|Part 1|Lost to Follow-up|0
4751572|NCT01729754|16393616|P1|Part 1|Lost to Follow-up|1
4751573|NCT01729754|16393607|P10|Part 1|Lack of Efficacy|0
4751574|NCT01729754|16393608|P9|Part 1|Lack of Efficacy|0
4751575|NCT01729754|16393609|P8|Part 1|Lack of Efficacy|0
4751576|NCT01729754|16393610|P7|Part 1|Lack of Efficacy|2
4751577|NCT01729754|16393611|P6|Part 1|Lack of Efficacy|0
4751578|NCT01729754|16393612|P5|Part 1|Lack of Efficacy|0
4751579|NCT01729754|16393613|P4|Part 1|Lack of Efficacy|0
4751580|NCT01729754|16393614|P3|Part 1|Lack of Efficacy|0
4751581|NCT01729754|16393615|P2|Part 1|Lack of Efficacy|0
4751582|NCT01729754|16393616|P1|Part 1|Lack of Efficacy|1
4751583|NCT01729754|16393607|P10|Part 1|Adverse Event|5
4751584|NCT01729754|16393608|P9|Part 1|Adverse Event|0
4751585|NCT01729754|16393609|P8|Part 1|Adverse Event|0
4751586|NCT01729754|16393610|P7|Part 1|Adverse Event|2
4751587|NCT01729754|16393611|P6|Part 1|Adverse Event|0
4751588|NCT01729754|16393612|P5|Part 1|Adverse Event|0
4751589|NCT01729754|16393613|P4|Part 1|Adverse Event|1
4751590|NCT01729754|16393614|P3|Part 1|Adverse Event|0
4751591|NCT01729754|16393615|P2|Part 1|Adverse Event|0
4751592|NCT01729754|16393616|P1|Part 1|Adverse Event|2
4751593|NCT01729728|16393823|P3|Overall Study|Protocol Violation|1
4751594|NCT01729728|16393824|P2|Overall Study|Protocol Violation|0
4751595|NCT01729728|16393825|P1|Overall Study|Protocol Violation|1
4751596|NCT01729728|16393823|P3|Overall Study|Adverse Event|0
4751597|NCT01729728|16393824|P2|Overall Study|Adverse Event|6
4751598|NCT01729728|16393825|P1|Overall Study|Adverse Event|0
4751599|NCT01729559|16393975|P2|Overall Study|Protocol Violation|28
4751600|NCT01729559|16393976|P1|Overall Study|Protocol Violation|31
4751601|NCT01729208|16394019|P2|36 Months Follow-up|Withdrawal by Subject|4
4751602|NCT01729208|16394020|P1|36 Months Follow-up|Withdrawal by Subject|2
4751603|NCT01729208|16394019|P2|36 Months Follow-up|Physician Decision|0
4751604|NCT01729208|16394020|P1|36 Months Follow-up|Physician Decision|1
4751605|NCT01729208|16394019|P2|24 Months Follow-up|Lost to Follow-up|0
4751606|NCT01729208|16394020|P1|24 Months Follow-up|Lost to Follow-up|3
4751607|NCT01729208|16394019|P2|12 Months Follow-up|Lost to Follow-up|3
4751608|NCT01729208|16394020|P1|12 Months Follow-up|Lost to Follow-up|3
4751609|NCT01729208|16394019|P2|12 Months Follow-up|Withdrawal by Subject|7
4751610|NCT01729208|16394020|P1|12 Months Follow-up|Withdrawal by Subject|4
4751611|NCT01729208|16394019|P2|Baseline|Physician Decision|4
4751612|NCT01729208|16394020|P1|Baseline|Physician Decision|5
4751613|NCT01729156|16394053|P3|Overall Study|Withdrawal by Subject|0
4751614|NCT01729156|16394054|P2|Overall Study|Withdrawal by Subject|0
4751615|NCT01729156|16394055|P1|Overall Study|Withdrawal by Subject|1
4751616|NCT01729039|16394083|P2|Overall Study|Withdrawal by Subject|7
4751617|NCT01729039|16394084|P1|Overall Study|Withdrawal by Subject|8
4751618|NCT01729039|16394083|P2|Overall Study|disqualified|5
4751619|NCT01729039|16394084|P1|Overall Study|disqualified|2
4751620|NCT01729026|16394100|P2|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2
4751621|NCT01729026|16394101|P1|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1
4751622|NCT01729026|16394100|P2|Randomization to 3-month Follow-up|Lost to Follow-up|2
4751623|NCT01729026|16394101|P1|Randomization to 3-month Follow-up|Lost to Follow-up|2
4751624|NCT01728792|16394204|P5|Overall Study|Lost to Follow-up|0
4751625|NCT01728792|16394205|P4|Overall Study|Lost to Follow-up|2
4751626|NCT01728792|16394206|P3|Overall Study|Lost to Follow-up|4
4751627|NCT01728792|16394207|P2|Overall Study|Lost to Follow-up|1
4751628|NCT01728792|16394208|P1|Overall Study|Lost to Follow-up|2
4751629|NCT01728792|16394204|P5|Overall Study|Withdrawal of Consent|0
4751630|NCT01728792|16394205|P4|Overall Study|Withdrawal of Consent|1
4751631|NCT01728792|16394206|P3|Overall Study|Withdrawal of Consent|0
4751632|NCT01728792|16394207|P2|Overall Study|Withdrawal of Consent|1
4751633|NCT01728792|16394208|P1|Overall Study|Withdrawal of Consent|1
4751634|NCT01728623|16394258|P1|Overall Study|Withdrawal by Subject|1
4751635|NCT01728623|16394258|P1|Overall Study|Adverse Event|1
4751636|NCT01728623|16394258|P1|Overall Study|Disease progression|26
4751637|NCT01728584|16394284|P4|Overall Study|Other reason (not specified)|1
4751638|NCT01728584|16394285|P3|Overall Study|Other reason (not specified)|0
4751639|NCT01728584|16394286|P2|Overall Study|Other reason (not specified)|0
4751640|NCT01728584|16394287|P1|Overall Study|Other reason (not specified)|1
4751641|NCT01728584|16394284|P4|Overall Study|Screen failure|0
4751642|NCT01728584|16394285|P3|Overall Study|Screen failure|0
4751643|NCT01728584|16394286|P2|Overall Study|Screen failure|0
4751644|NCT01728584|16394287|P1|Overall Study|Screen failure|1
4751645|NCT01728584|16394284|P4|Overall Study|Withdrawal by Subject|0
4751646|NCT01728584|16394285|P3|Overall Study|Withdrawal by Subject|0
4751647|NCT01728584|16394286|P2|Overall Study|Withdrawal by Subject|0
4751648|NCT01728584|16394287|P1|Overall Study|Withdrawal by Subject|1
4751649|NCT01728584|16394284|P4|Overall Study|Physician Decision|0
4751650|NCT01728584|16394285|P3|Overall Study|Physician Decision|1
4751651|NCT01728584|16394286|P2|Overall Study|Physician Decision|0
4751652|NCT01728584|16394287|P1|Overall Study|Physician Decision|4
4751653|NCT01728584|16394284|P4|Overall Study|Adverse Event|0
4751654|NCT01728584|16394285|P3|Overall Study|Adverse Event|0
4751655|NCT01728584|16394286|P2|Overall Study|Adverse Event|0
4751656|NCT01728584|16394287|P1|Overall Study|Adverse Event|1
4751657|NCT01728454|16394342|P3|Stage 3|Withdrew due to Adverse Events/Toxicity|0
4751658|NCT01728454|16394343|P2|Stage 3|Withdrew due to Adverse Events/Toxicity|0
4751659|NCT01728454|16394344|P1|Stage 3|Withdrew due to Adverse Events/Toxicity|1
4751660|NCT01728454|16394342|P3|Stage 3|Lost to Follow-up|1
4751661|NCT01728454|16394343|P2|Stage 3|Lost to Follow-up|3
4751662|NCT01728454|16394344|P1|Stage 3|Lost to Follow-up|0
4751663|NCT01728454|16394342|P3|Stage 3|Non-compliance with Protocol|1
4751664|NCT01728454|16394343|P2|Stage 3|Non-compliance with Protocol|0
4751665|NCT01728454|16394344|P1|Stage 3|Non-compliance with Protocol|0
4751666|NCT01728454|16394342|P3|Stage 3|Withdrew Consent|1
4751667|NCT01728454|16394343|P2|Stage 3|Withdrew Consent|0
4751668|NCT01728454|16394344|P1|Stage 3|Withdrew Consent|1
4751669|NCT01728454|16394342|P3|Stage 3|Pregnancy|0
4751670|NCT01728454|16394343|P2|Stage 3|Pregnancy|0
4751671|NCT01728454|16394344|P1|Stage 3|Pregnancy|1
4751672|NCT01728454|16394342|P3|Stage 3|Subject Required Other Treatment|0
4751673|NCT01728454|16394343|P2|Stage 3|Subject Required Other Treatment|1
4751674|NCT01728454|16394344|P1|Stage 3|Subject Required Other Treatment|0
4751675|NCT01728454|16394342|P3|Stage 3|Reason Missing|1
4751676|NCT01728454|16394343|P2|Stage 3|Reason Missing|0
4751677|NCT01728454|16394344|P1|Stage 3|Reason Missing|0
4751678|NCT01728454|16394342|P3|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
4751679|NCT01728454|16394343|P2|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3
4751680|NCT01728454|16394344|P1|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2
4751681|NCT01728454|16394342|P3|Stage 1 and 2|Lost to Follow-up|0
4751682|NCT01728454|16394343|P2|Stage 1 and 2|Lost to Follow-up|1
4751683|NCT01728454|16394344|P1|Stage 1 and 2|Lost to Follow-up|1
4751684|NCT01728454|16394342|P3|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
4751685|NCT01728454|16394343|P2|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0
4751686|NCT01728454|16394344|P1|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1
4751687|NCT01728454|16394342|P3|Stage 1 and 2|Non-compliance with Protocol|1
4751688|NCT01728454|16394343|P2|Stage 1 and 2|Non-compliance with Protocol|0
4751689|NCT01728454|16394344|P1|Stage 1 and 2|Non-compliance with Protocol|0
4751690|NCT01728454|16394342|P3|Stage 1 and 2|Pregnancy|0
4751691|NCT01728454|16394343|P2|Stage 1 and 2|Pregnancy|0
4751692|NCT01728454|16394344|P1|Stage 1 and 2|Pregnancy|1
4751693|NCT01728376|16394394|P6|Overall Study|Subject/Parent/Legal Guardian Decision|1
4751694|NCT01728376|16394395|P5|Overall Study|Subject/Parent/Legal Guardian Decision|0
4751695|NCT01728376|16394396|P4|Overall Study|Subject/Parent/Legal Guardian Decision|1
4751696|NCT01728376|16394397|P3|Overall Study|Subject/Parent/Legal Guardian Decision|0
4751697|NCT01728376|16394398|P2|Overall Study|Subject/Parent/Legal Guardian Decision|0
4751698|NCT01728376|16394399|P1|Overall Study|Subject/Parent/Legal Guardian Decision|0
4751699|NCT01728376|16394394|P6|Overall Study|Did not receive treatment|0
4751700|NCT01728376|16394395|P5|Overall Study|Did not receive treatment|0
4751701|NCT01728376|16394396|P4|Overall Study|Did not receive treatment|0
4751702|NCT01728376|16394397|P3|Overall Study|Did not receive treatment|0
4751703|NCT01728376|16394398|P2|Overall Study|Did not receive treatment|1
4751704|NCT01728376|16394399|P1|Overall Study|Did not receive treatment|0
4751705|NCT01728376|16394394|P6|Overall Study|No relevant bacteria|1
4751706|NCT01728376|16394395|P5|Overall Study|No relevant bacteria|1
4751707|NCT01728376|16394396|P4|Overall Study|No relevant bacteria|0
4751708|NCT01728376|16394397|P3|Overall Study|No relevant bacteria|0
4751709|NCT01728376|16394398|P2|Overall Study|No relevant bacteria|0
4751710|NCT01728376|16394399|P1|Overall Study|No relevant bacteria|2
4751711|NCT01728376|16394394|P6|Overall Study|Persistent Positive Blood Cultures|0
4751712|NCT01728376|16394395|P5|Overall Study|Persistent Positive Blood Cultures|0
4751713|NCT01728376|16394396|P4|Overall Study|Persistent Positive Blood Cultures|0
4751714|NCT01728376|16394397|P3|Overall Study|Persistent Positive Blood Cultures|1
4751715|NCT01728376|16394398|P2|Overall Study|Persistent Positive Blood Cultures|0
4751716|NCT01728376|16394399|P1|Overall Study|Persistent Positive Blood Cultures|1
4751717|NCT01728376|16394394|P6|Overall Study|Adverse Event|0
4751718|NCT01728376|16394395|P5|Overall Study|Adverse Event|1
4751719|NCT01728376|16394396|P4|Overall Study|Adverse Event|1
4751720|NCT01728376|16394397|P3|Overall Study|Adverse Event|1
4751721|NCT01728376|16394398|P2|Overall Study|Adverse Event|1
4751722|NCT01728376|16394399|P1|Overall Study|Adverse Event|1
4751723|NCT01728324|16394472|P3|Termination of RBV|Protocol Violation (Placebo Period)|0
4751724|NCT01728324|16394473|P2|Termination of RBV|Protocol Violation (Placebo Period)|1
4751725|NCT01728324|16394474|P1|Termination of RBV|Protocol Violation (Placebo Period)|0
4751726|NCT01728324|16394472|P3|Termination of RBV|Adverse Event (Placebo Period)|0
4751727|NCT01728324|16394473|P2|Termination of RBV|Adverse Event (Placebo Period)|1
4751728|NCT01728324|16394474|P1|Termination of RBV|Adverse Event (Placebo Period)|0
4751729|NCT01728324|16394472|P3|Termination of RBV|Other than stated|1
4751730|NCT01728324|16394473|P2|Termination of RBV|Other than stated|3
4751731|NCT01728324|16394474|P1|Termination of RBV|Other than stated|1
4751732|NCT01728324|16394472|P3|Termination of RBV|Withdrawal by Subject|2
4751733|NCT01728324|16394473|P2|Termination of RBV|Withdrawal by Subject|5
4751734|NCT01728324|16394474|P1|Termination of RBV|Withdrawal by Subject|9
4751735|NCT01728324|16394472|P3|Termination of RBV|Lack of Efficacy|7
4751736|NCT01728324|16394473|P2|Termination of RBV|Lack of Efficacy|11
4751737|NCT01728324|16394474|P1|Termination of RBV|Lack of Efficacy|14
4751738|NCT01728324|16394472|P3|Termination of RBV|Adverse Event|5
4751739|NCT01728324|16394473|P2|Termination of RBV|Adverse Event|16
4751740|NCT01728324|16394474|P1|Termination of RBV|Adverse Event|15
4751741|NCT01728324|16394472|P3|Termination of FDV|Protocol Violation (Placebo Period)|0
4751742|NCT01728324|16394473|P2|Termination of FDV|Protocol Violation (Placebo Period)|1
4751743|NCT01728324|16394474|P1|Termination of FDV|Protocol Violation (Placebo Period)|0
4751744|NCT01728324|16394472|P3|Termination of FDV|Adverse Event (Placebo Period)|0
4751745|NCT01728324|16394473|P2|Termination of FDV|Adverse Event (Placebo Period)|1
4751746|NCT01728324|16394474|P1|Termination of FDV|Adverse Event (Placebo Period)|0
4751747|NCT01728324|16394472|P3|Termination of FDV|Other than stated|0
4751748|NCT01728324|16394473|P2|Termination of FDV|Other than stated|3
4751749|NCT01728324|16394474|P1|Termination of FDV|Other than stated|1
4751750|NCT01728324|16394472|P3|Termination of FDV|Withdrawal by Subject|2
4751751|NCT01728324|16394473|P2|Termination of FDV|Withdrawal by Subject|6
4751752|NCT01728324|16394474|P1|Termination of FDV|Withdrawal by Subject|9
4751753|NCT01728324|16394472|P3|Termination of FDV|Lack of Efficacy|8
4751754|NCT01728324|16394473|P2|Termination of FDV|Lack of Efficacy|12
4751755|NCT01728324|16394474|P1|Termination of FDV|Lack of Efficacy|14
4751756|NCT01728324|16394472|P3|Termination of FDV|Adverse Event|4
4751757|NCT01728324|16394473|P2|Termination of FDV|Adverse Event|13
4751758|NCT01728324|16394474|P1|Termination of FDV|Adverse Event|14
4751759|NCT01728324|16394472|P3|Termination of DBV|Protocol Violation (Placebo Period)|0
4751760|NCT01728324|16394473|P2|Termination of DBV|Protocol Violation (Placebo Period)|1
4751761|NCT01728324|16394474|P1|Termination of DBV|Protocol Violation (Placebo Period)|0
4751762|NCT01728324|16394472|P3|Termination of DBV|Adverse Event (Placebo Period)|0
4751763|NCT01728324|16394473|P2|Termination of DBV|Adverse Event (Placebo Period)|1
4751764|NCT01728324|16394474|P1|Termination of DBV|Adverse Event (Placebo Period)|0
4751765|NCT01728324|16394472|P3|Termination of DBV|Other than stated|0
4751766|NCT01728324|16394473|P2|Termination of DBV|Other than stated|3
4751767|NCT01728324|16394474|P1|Termination of DBV|Other than stated|1
4751768|NCT01728324|16394472|P3|Termination of DBV|Withdrawal by Subject|2
4751769|NCT01728324|16394473|P2|Termination of DBV|Withdrawal by Subject|6
4751770|NCT01728324|16394474|P1|Termination of DBV|Withdrawal by Subject|9
4751771|NCT01728324|16394472|P3|Termination of DBV|Lack of Efficacy|8
4751772|NCT01728324|16394473|P2|Termination of DBV|Lack of Efficacy|12
4751773|NCT01728324|16394474|P1|Termination of DBV|Lack of Efficacy|14
4751774|NCT01728324|16394472|P3|Termination of DBV|Adverse Event|4
4751775|NCT01728324|16394473|P2|Termination of DBV|Adverse Event|13
4751776|NCT01728324|16394474|P1|Termination of DBV|Adverse Event|14
4751777|NCT01728246|16394495|P2|Overall Study|Adverse Event|5
4751778|NCT01728246|16394496|P1|Overall Study|Adverse Event|8
4751779|NCT01728246|16394495|P2|Overall Study|Lack of Efficacy|1
4751780|NCT01728246|16394496|P1|Overall Study|Lack of Efficacy|1
4751781|NCT01728246|16394495|P2|Overall Study|Lost to Follow-up|22
4751782|NCT01728246|16394496|P1|Overall Study|Lost to Follow-up|23
4751783|NCT01728246|16394495|P2|Overall Study|Withdrawal by Subject|3
4751784|NCT01728246|16394496|P1|Overall Study|Withdrawal by Subject|2
4751785|NCT01728246|16394495|P2|Overall Study|Protocol Violation|0
4751786|NCT01728246|16394496|P1|Overall Study|Protocol Violation|1
4751787|NCT01728246|16394495|P2|Overall Study|Participant needed rescue medication|5
4751788|NCT01728246|16394496|P1|Overall Study|Participant needed rescue medication|1
4751789|NCT01728194|16394514|P2|Overall Study|Family Member Request|0
4751790|NCT01728194|16394515|P1|Overall Study|Family Member Request|1
4751791|NCT01728194|16394514|P2|Overall Study|Perceived Medication Side Effects|0
4751792|NCT01728194|16394515|P1|Overall Study|Perceived Medication Side Effects|4
4751793|NCT01728194|16394514|P2|Overall Study|Withdrawal by Subject|3
4751794|NCT01728194|16394515|P1|Overall Study|Withdrawal by Subject|7
4751795|NCT01728194|16394514|P2|Overall Study|Physician Decision|0
4751796|NCT01728194|16394515|P1|Overall Study|Physician Decision|4
4751797|NCT01728194|16394514|P2|Overall Study|Lost to Follow-up|3
4751798|NCT01728194|16394515|P1|Overall Study|Lost to Follow-up|4
4751799|NCT01728116|16394525|P2|Overall Study|various not noted previously|0
4751800|NCT01728116|16394526|P1|Overall Study|various not noted previously|5
4751801|NCT01728116|16394525|P2|Overall Study|Incorrectly enrolled in Study|1
4751802|NCT01728116|16394526|P1|Overall Study|Incorrectly enrolled in Study|0
4751803|NCT01728116|16394525|P2|Overall Study|Inter-current finding at procedure|0
4751804|NCT01728116|16394526|P1|Overall Study|Inter-current finding at procedure|1
4751805|NCT01728116|16394525|P2|Overall Study|Subject Non-Compliance|0
4751806|NCT01728116|16394526|P1|Overall Study|Subject Non-Compliance|2
4751807|NCT01728116|16394525|P2|Overall Study|Physician Decision|0
4751808|NCT01728116|16394526|P1|Overall Study|Physician Decision|2
4751809|NCT01728116|16394525|P2|Overall Study|Lost to Follow-up|2
4751810|NCT01728116|16394526|P1|Overall Study|Lost to Follow-up|9
4751811|NCT01728116|16394525|P2|Overall Study|Procedure/device failure|0
4751812|NCT01728116|16394526|P1|Overall Study|Procedure/device failure|7
4751813|NCT01728116|16394525|P2|Overall Study|Adverse Event|0
4751814|NCT01728116|16394526|P1|Overall Study|Adverse Event|13
4751815|NCT01728116|16394525|P2|Overall Study|Withdrawal by Subject|9
4751816|NCT01728116|16394526|P1|Overall Study|Withdrawal by Subject|16
4751817|NCT01728116|16394525|P2|Overall Study|Sponsor Terminated Study|35
4751818|NCT01728116|16394526|P1|Overall Study|Sponsor Terminated Study|106
4751819|NCT01728077|16394551|P2|Overall Study|Non compliance|0
4751820|NCT01728077|16394552|P1|Overall Study|Non compliance|1
4751821|NCT01728077|16394551|P2|Overall Study|Patient moving|0
4751822|NCT01728077|16394552|P1|Overall Study|Patient moving|1
4751823|NCT01728077|16394551|P2|Overall Study|Death|1
4751824|NCT01728077|16394552|P1|Overall Study|Death|0
4751825|NCT01728077|16394551|P2|Overall Study|Subject choice|3
4751826|NCT01728077|16394552|P1|Overall Study|Subject choice|2
4751827|NCT01728077|16394551|P2|Overall Study|Lost to Follow-up|0
4751828|NCT01728077|16394552|P1|Overall Study|Lost to Follow-up|1
4751829|NCT01728077|16394551|P2|Overall Study|Lack of Efficacy|1
4751830|NCT01728077|16394552|P1|Overall Study|Lack of Efficacy|3
4751831|NCT01727713|16394650|P1|Overall Study|Protocol Deviation|2
4751832|NCT01727713|16394650|P1|Overall Study|Withdrawal by Subject|13
4751833|NCT01727713|16394650|P1|Overall Study|Participant Met Withdrawal Criteria|5
4751834|NCT01727713|16394650|P1|Overall Study|Adverse Event|10
4751835|NCT01727713|16394650|P1|Overall Study|Lost to Follow-up|5
4751836|NCT01727700|16394677|P3|Overall Study|Protocol Violation|0
4751837|NCT01727700|16394678|P2|Overall Study|Protocol Violation|0
4751838|NCT01727700|16394679|P1|Overall Study|Protocol Violation|2
4751839|NCT01727700|16394677|P3|Overall Study|Particpant withdrew consent|1
4751840|NCT01727700|16394678|P2|Overall Study|Particpant withdrew consent|3
4751841|NCT01727700|16394679|P1|Overall Study|Particpant withdrew consent|0
4751842|NCT01727700|16394677|P3|Overall Study|Adverse Event|1
4751843|NCT01727700|16394678|P2|Overall Study|Adverse Event|7
4751844|NCT01727700|16394679|P1|Overall Study|Adverse Event|0
4751845|NCT01727505|16394702|P2|Second 24 Hours|Missing data|1
4751846|NCT01727505|16394703|P1|Second 24 Hours|Missing data|0
4751847|NCT01727505|16394702|P2|First 24 Hours|Adverse Event|1
4751848|NCT01727505|16394703|P1|First 24 Hours|Adverse Event|0
4751849|NCT01727297|16394728|P2|Overall Study|Other (e.g. AF detection pre-implant)|8
4751850|NCT01727297|16394729|P1|Overall Study|Other (e.g. AF detection pre-implant)|29
4751851|NCT01727297|16394728|P2|Overall Study|Physician Decision|5
4751852|NCT01727297|16394729|P1|Overall Study|Physician Decision|19
4751853|NCT01727297|16394728|P2|Overall Study|Withdrawal by Subject|27
4751854|NCT01727297|16394729|P1|Overall Study|Withdrawal by Subject|26
4751855|NCT01727297|16394728|P2|Overall Study|Lost to Follow-up|0
4751856|NCT01727297|16394729|P1|Overall Study|Lost to Follow-up|11
4751857|NCT01727297|16394728|P2|Overall Study|Adverse Event|1
4751858|NCT01727297|16394729|P1|Overall Study|Adverse Event|3
4751859|NCT01727297|16394728|P2|Overall Study|Protocol Violation|10
4751860|NCT01727297|16394729|P1|Overall Study|Protocol Violation|1
4751861|NCT01727297|16394728|P2|Overall Study|Death|0
4751862|NCT01727297|16394729|P1|Overall Study|Death|13
4751863|NCT01727258|16394745|P3|Overall Study|Lost to Follow-up|0
4751864|NCT01727258|16394746|P2|Overall Study|Lost to Follow-up|0
4751865|NCT01727258|16394747|P1|Overall Study|Lost to Follow-up|1
4751866|NCT01727258|16394745|P3|Overall Study|Withdrawal by Subject|0
4751867|NCT01727258|16394746|P2|Overall Study|Withdrawal by Subject|1
4751868|NCT01727258|16394747|P1|Overall Study|Withdrawal by Subject|1
4751869|NCT01727258|16394745|P3|Overall Study|Noncompliance with Study Drug|1
4751870|NCT01727258|16394746|P2|Overall Study|Noncompliance with Study Drug|0
4751871|NCT01727258|16394747|P1|Overall Study|Noncompliance with Study Drug|0
4751872|NCT01727258|16394745|P3|Overall Study|Adverse Event|0
4751873|NCT01727258|16394746|P2|Overall Study|Adverse Event|2
4751874|NCT01727258|16394747|P1|Overall Study|Adverse Event|0
4751875|NCT01727154|16394785|P1|Overall Study|No Discontinuation Documentation|4
4751876|NCT01727154|16394785|P1|Overall Study|Study Terminated|6
4751877|NCT01727154|16394785|P1|Overall Study|Subject Withdrew Consent|18
4751878|NCT01727154|16394785|P1|Overall Study|Withdrawal by Subject|14
4751879|NCT01727154|16394785|P1|Overall Study|Death|17
4751880|NCT01727141|16394793|P4|Overall Study|Withdrawal by Subject|11
4751881|NCT01727141|16394794|P3|Overall Study|Withdrawal by Subject|2
4751882|NCT01727141|16394795|P2|Overall Study|Withdrawal by Subject|4
4751883|NCT01727141|16394796|P1|Overall Study|Withdrawal by Subject|4
4751884|NCT01727141|16394793|P4|Overall Study|Protocol deviation|1
4751885|NCT01727141|16394794|P3|Overall Study|Protocol deviation|0
4751886|NCT01727141|16394795|P2|Overall Study|Protocol deviation|1
4751887|NCT01727141|16394796|P1|Overall Study|Protocol deviation|1
4751888|NCT01727141|16394793|P4|Overall Study|Death|1
4751889|NCT01727141|16394794|P3|Overall Study|Death|1
4751890|NCT01727141|16394795|P2|Overall Study|Death|1
4751891|NCT01727141|16394796|P1|Overall Study|Death|0
4751892|NCT01727141|16394793|P4|Overall Study|Lost to Follow-up|0
4751893|NCT01727141|16394794|P3|Overall Study|Lost to Follow-up|0
4751894|NCT01727141|16394795|P2|Overall Study|Lost to Follow-up|2
4751895|NCT01727141|16394796|P1|Overall Study|Lost to Follow-up|0
4751896|NCT01727141|16394793|P4|Overall Study|Physician Decision|2
4751897|NCT01727141|16394794|P3|Overall Study|Physician Decision|0
4751898|NCT01727141|16394795|P2|Overall Study|Physician Decision|1
4751899|NCT01727141|16394796|P1|Overall Study|Physician Decision|0
4751900|NCT01727024|16394861|P2|Period 1|Withdrawal by Subject|3
4751901|NCT01727024|16394862|P1|Period 1|Withdrawal by Subject|2
4751902|NCT01727024|16394861|P2|Period 1|Lost to Follow-up|1
4751903|NCT01727024|16394862|P1|Period 1|Lost to Follow-up|1
4751904|NCT01726803|16394877|P2|Overall Study|Withdrawal by Subject|0
4751905|NCT01726803|16394878|P1|Overall Study|Withdrawal by Subject|1
4751906|NCT01726803|16394877|P2|Overall Study|Lost to Follow-up|1
4751907|NCT01726803|16394878|P1|Overall Study|Lost to Follow-up|6
4751908|NCT01726517|16394930|P5|Overall Study|Withdrawal by Subject|0
4751909|NCT01726517|16394931|P4|Overall Study|Withdrawal by Subject|0
4751910|NCT01726517|16394932|P3|Overall Study|Withdrawal by Subject|1
4751911|NCT01726517|16394933|P2|Overall Study|Withdrawal by Subject|0
4751912|NCT01726517|16394934|P1|Overall Study|Withdrawal by Subject|0
4751913|NCT01726335|16394990|P1|Overall Study|Exacerbation of psychotic symptoms|1
4751914|NCT01726335|16394990|P1|Overall Study|Lost to Follow-up|2
4751915|NCT01726335|16394990|P1|Overall Study|Adverse Event|4
4751916|NCT01726335|16394990|P1|Overall Study|Withdrawal by Subject|15
4751917|NCT01726335|16394990|P1|Overall Study|Lost to Follow-up|2
4751918|NCT01726270|16395006|P1|Part 2, Actual-Use Phase|Other than reason specified above|7
4751919|NCT01726270|16395006|P1|Part 2, Actual-Use Phase|Lost to Follow-up|5
4751920|NCT01726270|16395006|P1|Part 2, Actual-Use Phase|Adverse Event|6
4751921|NCT01726270|16395006|P1|Part 2, Actual-Use Phase|Withdrawal by Subject|21
4751922|NCT01726270|16395006|P1|Eligibility for Part 2|Eligible but did not enter Part 2|20
4751923|NCT01726270|16395006|P1|Part 1, Self-Selection Phase|Withdrawal by Subject|10
4751924|NCT01726049|16395019|P2|Overall Study|refused second HC|2
4751925|NCT01726049|16395020|P1|Overall Study|refused second HC|0
4751926|NCT01726049|16395019|P2|Overall Study|Adverse Event|1
4751927|NCT01726049|16395020|P1|Overall Study|Adverse Event|4
4751928|NCT01726049|16395019|P2|Overall Study|Death|1
4751929|NCT01726049|16395020|P1|Overall Study|Death|1
4751930|NCT01726023|16395045|P2|Overall Study|Withdrawal by Subject|8
4751931|NCT01726023|16395046|P1|Overall Study|Withdrawal by Subject|16
4751932|NCT01726023|16395045|P2|Overall Study|Other Eligibility criteria|7
4751933|NCT01726023|16395046|P1|Overall Study|Other Eligibility criteria|7
4751934|NCT01726023|16395045|P2|Overall Study|Lost to Follow-up|10
4751935|NCT01726023|16395046|P1|Overall Study|Lost to Follow-up|5
4751936|NCT01726023|16395045|P2|Overall Study|Death|1
4751937|NCT01726023|16395046|P1|Overall Study|Death|1
4751938|NCT01725750|16395180|P2|Overall Study|Withdrawal by Subject|9
4751939|NCT01725750|16395181|P1|Overall Study|Withdrawal by Subject|0
4751940|NCT01725750|16395180|P2|Overall Study|Lost to Follow-up|1
4751941|NCT01725750|16395181|P1|Overall Study|Lost to Follow-up|1
4751942|NCT01725750|16395180|P2|Overall Study|Adverse Event|0
4751943|NCT01725750|16395181|P1|Overall Study|Adverse Event|1
4751944|NCT01725529|16395214|P3|Overall Study|Withdrawal by Subject|8
4751945|NCT01725529|16395215|P2|Overall Study|Withdrawal by Subject|14
4751946|NCT01725529|16395216|P1|Overall Study|Withdrawal by Subject|12
4751947|NCT01725529|16395214|P3|Overall Study|Protocol Violation|1
4751948|NCT01725529|16395215|P2|Overall Study|Protocol Violation|1
4751949|NCT01725529|16395216|P1|Overall Study|Protocol Violation|0
4751950|NCT01725529|16395214|P3|Overall Study|Lost to Follow-up|1
4751951|NCT01725529|16395215|P2|Overall Study|Lost to Follow-up|1
4751952|NCT01725529|16395216|P1|Overall Study|Lost to Follow-up|2
4751953|NCT01725529|16395214|P3|Overall Study|Adverse Event|0
4751954|NCT01725529|16395215|P2|Overall Study|Adverse Event|0
4751955|NCT01725529|16395216|P1|Overall Study|Adverse Event|1
4751956|NCT01725451|16395242|P4|Period 4|Adverse Event|0
4751957|NCT01725451|16395243|P3|Period 4|Adverse Event|1
4751958|NCT01725451|16395244|P2|Period 4|Adverse Event|0
4751959|NCT01725451|16395245|P1|Period 4|Adverse Event|0
4751960|NCT01725451|16395242|P4|Washout From Period 3|Adverse Event|0
4751961|NCT01725451|16395243|P3|Washout From Period 3|Adverse Event|0
4751962|NCT01725451|16395244|P2|Washout From Period 3|Adverse Event|1
4751963|NCT01725451|16395245|P1|Washout From Period 3|Adverse Event|0
4751964|NCT01725451|16395242|P4|Washout From Period 3|Protocol Violation|0
4751965|NCT01725451|16395243|P3|Washout From Period 3|Protocol Violation|1
4751966|NCT01725451|16395244|P2|Washout From Period 3|Protocol Violation|0
4751967|NCT01725451|16395245|P1|Washout From Period 3|Protocol Violation|0
4751968|NCT01725451|16395242|P4|Period 1|Withdrawal by Subject|0
4751969|NCT01725451|16395243|P3|Period 1|Withdrawal by Subject|0
4751970|NCT01725451|16395244|P2|Period 1|Withdrawal by Subject|0
4751971|NCT01725451|16395245|P1|Period 1|Withdrawal by Subject|1
4751972|NCT01725386|16395267|P2|Overall Study|Withdrawal by Subject|0
4751973|NCT01725386|16395268|P1|Overall Study|Withdrawal by Subject|10
4751974|NCT01725386|16395267|P2|Overall Study|Lost to Follow-up|6
4751975|NCT01725386|16395268|P1|Overall Study|Lost to Follow-up|81
4751976|NCT01725386|16395267|P2|Overall Study|Death|40
4751977|NCT01725386|16395268|P1|Overall Study|Death|84
4751978|NCT01725308|16395287|P3|Treatment Period II|Miscellaneous|7
4751979|NCT01725308|16395288|P2|Treatment Period II|Miscellaneous|3
4751980|NCT01725308|16395289|P1|Treatment Period II|Miscellaneous|5
4751981|NCT01725308|16395287|P3|Treatment Period II|Protocol Deviations|1
4751982|NCT01725308|16395288|P2|Treatment Period II|Protocol Deviations|0
4751983|NCT01725308|16395289|P1|Treatment Period II|Protocol Deviations|0
4751984|NCT01725308|16395287|P3|Treatment Period II|Lost to Follow-up|3
4751985|NCT01725308|16395288|P2|Treatment Period II|Lost to Follow-up|5
4751986|NCT01725308|16395289|P1|Treatment Period II|Lost to Follow-up|1
4751987|NCT01725308|16395287|P3|Treatment Period II|Withdrawal of Consent|16
4751988|NCT01725308|16395288|P2|Treatment Period II|Withdrawal of Consent|2
4751989|NCT01725308|16395289|P1|Treatment Period II|Withdrawal of Consent|28
4751990|NCT01725308|16395287|P3|Treatment Period II|Changes in the Episodes|5
4751991|NCT01725308|16395288|P2|Treatment Period II|Changes in the Episodes|0
4751992|NCT01725308|16395289|P1|Treatment Period II|Changes in the Episodes|1
4751993|NCT01725308|16395287|P3|Treatment Period II|Worsening of the Target Disease|2
4751994|NCT01725308|16395288|P2|Treatment Period II|Worsening of the Target Disease|4
4751995|NCT01725308|16395289|P1|Treatment Period II|Worsening of the Target Disease|1
4751996|NCT01725308|16395287|P3|Treatment Period II|Insufficient Response|6
4751997|NCT01725308|16395288|P2|Treatment Period II|Insufficient Response|4
4751998|NCT01725308|16395289|P1|Treatment Period II|Insufficient Response|2
4751999|NCT01725308|16395287|P3|Treatment Period II|Adverse Event|20
4752000|NCT01725308|16395288|P2|Treatment Period II|Adverse Event|8
4752001|NCT01725308|16395289|P1|Treatment Period II|Adverse Event|13
4752002|NCT01725308|16395287|P3|Treatment Period II|Did Not Receive Drug|0
4752003|NCT01725308|16395288|P2|Treatment Period II|Did Not Receive Drug|0
4752004|NCT01725308|16395289|P1|Treatment Period II|Did Not Receive Drug|4
4752005|NCT01725308|16395287|P3|Treatment Period II|Did Not Meet Transition Criteria|4
4752006|NCT01725308|16395288|P2|Treatment Period II|Did Not Meet Transition Criteria|3
4752007|NCT01725308|16395289|P1|Treatment Period II|Did Not Meet Transition Criteria|0
4752008|NCT01725308|16395287|P3|Treatment Period I|Miscellaneous|3
4752009|NCT01725308|16395288|P2|Treatment Period I|Miscellaneous|0
4752010|NCT01725308|16395289|P1|Treatment Period I|Miscellaneous|2
4752011|NCT01725308|16395287|P3|Treatment Period I|Protocol Deviations|1
4752012|NCT01725308|16395288|P2|Treatment Period I|Protocol Deviations|1
4752013|NCT01725308|16395289|P1|Treatment Period I|Protocol Deviations|3
4752014|NCT01725308|16395287|P3|Treatment Period I|Lost to Follow-up|2
4752015|NCT01725308|16395288|P2|Treatment Period I|Lost to Follow-up|2
4752016|NCT01725308|16395289|P1|Treatment Period I|Lost to Follow-up|3
4752017|NCT01725308|16395287|P3|Treatment Period I|Withdrawal of Consent|5
4752018|NCT01725308|16395288|P2|Treatment Period I|Withdrawal of Consent|7
4752019|NCT01725308|16395289|P1|Treatment Period I|Withdrawal of Consent|12
4752020|NCT01725308|16395287|P3|Treatment Period I|Changes in the Episodes|2
4752021|NCT01725308|16395288|P2|Treatment Period I|Changes in the Episodes|0
4752022|NCT01725308|16395289|P1|Treatment Period I|Changes in the Episodes|3
4752023|NCT01725308|16395287|P3|Treatment Period I|Worsening of the Target Disease|2
4752024|NCT01725308|16395288|P2|Treatment Period I|Worsening of the Target Disease|0
4752025|NCT01725308|16395289|P1|Treatment Period I|Worsening of the Target Disease|8
4752026|NCT01725308|16395287|P3|Treatment Period I|Insufficient Response|5
4752027|NCT01725308|16395288|P2|Treatment Period I|Insufficient Response|0
4752028|NCT01725308|16395289|P1|Treatment Period I|Insufficient Response|7
4752029|NCT01725308|16395287|P3|Treatment Period I|Adverse Event|21
4752030|NCT01725308|16395288|P2|Treatment Period I|Adverse Event|4
4752031|NCT01725308|16395289|P1|Treatment Period I|Adverse Event|5
4752032|NCT01725308|16395287|P3|Treatment Period I|Did Not Receive Drug|0
4752033|NCT01725308|16395288|P2|Treatment Period I|Did Not Receive Drug|0
4752034|NCT01725308|16395289|P1|Treatment Period I|Did Not Receive Drug|1
4752035|NCT01725282|16395436|P4|Overall Study|Lack of Efficacy|1
4752036|NCT01725282|16395437|P3|Overall Study|Lack of Efficacy|0
4752037|NCT01725282|16395438|P2|Overall Study|Lack of Efficacy|1
4752038|NCT01725282|16395439|P1|Overall Study|Lack of Efficacy|0
4752039|NCT01725282|16395436|P4|Overall Study|Withdrawal by Subject|1
4752040|NCT01725282|16395437|P3|Overall Study|Withdrawal by Subject|1
4752041|NCT01725282|16395438|P2|Overall Study|Withdrawal by Subject|0
4752042|NCT01725282|16395439|P1|Overall Study|Withdrawal by Subject|0
4752043|NCT01725282|16395436|P4|Overall Study|Study Site Withdrawal|0
4752044|NCT01725282|16395437|P3|Overall Study|Study Site Withdrawal|0
4752045|NCT01725282|16395438|P2|Overall Study|Study Site Withdrawal|1
4752046|NCT01725282|16395439|P1|Overall Study|Study Site Withdrawal|0
4752047|NCT01725282|16395436|P4|Overall Study|Met Exclusion Criteria|0
4752048|NCT01725282|16395437|P3|Overall Study|Met Exclusion Criteria|1
4752049|NCT01725282|16395438|P2|Overall Study|Met Exclusion Criteria|0
4752050|NCT01725282|16395439|P1|Overall Study|Met Exclusion Criteria|0
4752051|NCT01725282|16395436|P4|Overall Study|Exacerbation of Target Disease|1
4752052|NCT01725282|16395437|P3|Overall Study|Exacerbation of Target Disease|0
4752053|NCT01725282|16395438|P2|Overall Study|Exacerbation of Target Disease|0
4752054|NCT01725282|16395439|P1|Overall Study|Exacerbation of Target Disease|1
4752055|NCT01725282|16395436|P4|Overall Study|Adverse Event|4
4752056|NCT01725282|16395437|P3|Overall Study|Adverse Event|6
4752057|NCT01725282|16395438|P2|Overall Study|Adverse Event|3
4752058|NCT01725282|16395439|P1|Overall Study|Adverse Event|1
4752059|NCT01725217|16395472|P3|Overall Study|Withdrawal by Subject|0
4752060|NCT01725217|16395473|P2|Overall Study|Withdrawal by Subject|0
4752061|NCT01725217|16395474|P1|Overall Study|Withdrawal by Subject|1
4752062|NCT01725126|16395508|P6|Overall Study|Withdrawal by Subject|0
4752063|NCT01725126|16395509|P5|Overall Study|Withdrawal by Subject|0
4752064|NCT01725126|16395510|P4|Overall Study|Withdrawal by Subject|1
4752065|NCT01725126|16395511|P3|Overall Study|Withdrawal by Subject|0
4752066|NCT01725126|16395512|P2|Overall Study|Withdrawal by Subject|0
4752067|NCT01725126|16395513|P1|Overall Study|Withdrawal by Subject|0
4752068|NCT01725126|16395508|P6|Overall Study|Protocol Violation|0
4752069|NCT01725126|16395509|P5|Overall Study|Protocol Violation|0
4752070|NCT01725126|16395510|P4|Overall Study|Protocol Violation|0
4752071|NCT01725126|16395511|P3|Overall Study|Protocol Violation|0
4752072|NCT01725126|16395512|P2|Overall Study|Protocol Violation|1
4752073|NCT01725126|16395513|P1|Overall Study|Protocol Violation|0
4752074|NCT01724528|16395711|P2|Overall Study|Patient refused to attend last visit|0
4752075|NCT01724528|16395712|P1|Overall Study|Patient refused to attend last visit|1
4752076|NCT01724528|16395711|P2|Overall Study|Protocol Violation|1
4752077|NCT01724528|16395712|P1|Overall Study|Protocol Violation|0
4752078|NCT01724528|16395711|P2|Overall Study|Withdrawal by Subject|2
4752079|NCT01724528|16395712|P1|Overall Study|Withdrawal by Subject|0
4752080|NCT01724528|16395711|P2|Overall Study|Death|0
4752081|NCT01724528|16395712|P1|Overall Study|Death|3
4752082|NCT01724489|16395728|P2|Overall Study|Withdrawal by Subject|6
4752083|NCT01724489|16395729|P1|Overall Study|Withdrawal by Subject|6
4752084|NCT01724489|16395728|P2|Overall Study|Lost to Follow-up|2
4752085|NCT01724489|16395729|P1|Overall Study|Lost to Follow-up|1
4752086|NCT01724489|16395728|P2|Overall Study|Surgery, medication|1
4752087|NCT01724489|16395729|P1|Overall Study|Surgery, medication|1
4752088|NCT01724489|16395728|P2|Overall Study|Adverse Event|3
4752089|NCT01724489|16395729|P1|Overall Study|Adverse Event|8
4752090|NCT01724359|16395735|P1|Overall Study|Other|20
4752091|NCT01724359|16395735|P1|Overall Study|Death|1
4752092|NCT01724359|16395735|P1|Overall Study|Adverse Event|10
4752093|NCT01724216|16395748|P1|Overall Study|Scan was not completed|1
4752094|NCT01724177|16395752|P1|Overall Study|Serious Adverse Event Related|1
4752095|NCT01724177|16395752|P1|Overall Study|Nervous participant|1
4752096|NCT01724177|16395752|P1|Overall Study|Progressive disease or Relapsed Disease|16
4752097|NCT01724177|16395752|P1|Overall Study|Adverse Event|8
4752098|NCT01724021|16395798|P2|Overall Study|Missing|1
4752099|NCT01724021|16395799|P1|Overall Study|Missing|1
4752100|NCT01724021|16395798|P2|Overall Study|Reason Not Specified|39
4752101|NCT01724021|16395799|P1|Overall Study|Reason Not Specified|36
4752102|NCT01724021|16395798|P2|Overall Study|Lost to Follow-up|15
4752103|NCT01724021|16395799|P1|Overall Study|Lost to Follow-up|15
4752104|NCT01724021|16395798|P2|Overall Study|Participant request/ Withdrew consent|14
4752105|NCT01724021|16395799|P1|Overall Study|Participant request/ Withdrew consent|18
4752106|NCT01724021|16395798|P2|Overall Study|Death|58
4752107|NCT01724021|16395799|P1|Overall Study|Death|46
4752108|NCT01724021|16395798|P2|Overall Study|Adverse Event|6
4752109|NCT01724021|16395799|P1|Overall Study|Adverse Event|11
4752110|NCT01723904|16395831|P1|Overall Study|Unable to follow protocol/ judged by inv|3
4752111|NCT01723904|16395831|P1|Overall Study|Adverse Event|5
4752112|NCT01723904|16395831|P1|Overall Study|Noncompliant|3
4752113|NCT01723826|16395845|P4|Overall Study|Withdrawal by Subject|48
4752114|NCT01723826|16395846|P3|Overall Study|Withdrawal by Subject|27
4752115|NCT01723826|16395847|P2|Overall Study|Withdrawal by Subject|17
4752116|NCT01723826|16395848|P1|Overall Study|Withdrawal by Subject|10
4752117|NCT01723826|16395845|P4|Overall Study|Protocol Violation|1
4752118|NCT01723826|16395846|P3|Overall Study|Protocol Violation|3
4752119|NCT01723826|16395847|P2|Overall Study|Protocol Violation|1
4752120|NCT01723826|16395848|P1|Overall Study|Protocol Violation|1
4752121|NCT01723826|16395845|P4|Overall Study|Physician Decision|11
4752122|NCT01723826|16395846|P3|Overall Study|Physician Decision|4
4752123|NCT01723826|16395847|P2|Overall Study|Physician Decision|3
4752124|NCT01723826|16395848|P1|Overall Study|Physician Decision|1
4752125|NCT01723826|16395845|P4|Overall Study|Other Reason|14
4752126|NCT01723826|16395846|P3|Overall Study|Other Reason|12
4752127|NCT01723826|16395847|P2|Overall Study|Other Reason|6
4752128|NCT01723826|16395848|P1|Overall Study|Other Reason|8
4752129|NCT01723826|16395845|P4|Overall Study|Non-compliance With Study Drug|0
4752130|NCT01723826|16395846|P3|Overall Study|Non-compliance With Study Drug|0
4752131|NCT01723826|16395847|P2|Overall Study|Non-compliance With Study Drug|1
4752132|NCT01723826|16395848|P1|Overall Study|Non-compliance With Study Drug|0
4752133|NCT01723826|16395845|P4|Overall Study|Non-compliance|3
4752134|NCT01723826|16395846|P3|Overall Study|Non-compliance|3
4752135|NCT01723826|16395847|P2|Overall Study|Non-compliance|1
4752136|NCT01723826|16395848|P1|Overall Study|Non-compliance|0
4752137|NCT01723826|16395845|P4|Overall Study|Lost to Follow-up|1
4752138|NCT01723826|16395846|P3|Overall Study|Lost to Follow-up|1
4752139|NCT01723826|16395847|P2|Overall Study|Lost to Follow-up|3
4752140|NCT01723826|16395848|P1|Overall Study|Lost to Follow-up|1
4752141|NCT01723826|16395845|P4|Overall Study|Death according to AE eCRF|7
4752142|NCT01723826|16395846|P3|Overall Study|Death according to AE eCRF|3
4752143|NCT01723826|16395847|P2|Overall Study|Death according to AE eCRF|3
4752144|NCT01723826|16395848|P1|Overall Study|Death according to AE eCRF|2
4752145|NCT01723826|16395845|P4|Overall Study|Adverse Event|5
4752146|NCT01723826|16395846|P3|Overall Study|Adverse Event|4
4752147|NCT01723826|16395847|P2|Overall Study|Adverse Event|1
4752148|NCT01723826|16395848|P1|Overall Study|Adverse Event|4
4752149|NCT01723397|16395993|P2|Study Period 2|Protocol Violation|1
4752150|NCT01723397|16395994|P1|Study Period 2|Protocol Violation|0
4752151|NCT01723397|16395993|P2|Study Period 1|Protocol Violation|1
4752152|NCT01723397|16395994|P1|Study Period 1|Protocol Violation|0
4752153|NCT01723254|16396021|P8|Overall Study|Withdrawal by Subject|2
4752154|NCT01723254|16396022|P7|Overall Study|Withdrawal by Subject|1
4752155|NCT01723254|16396023|P6|Overall Study|Withdrawal by Subject|1
4752156|NCT01723254|16396024|P5|Overall Study|Withdrawal by Subject|1
4752157|NCT01723254|16396025|P4|Overall Study|Withdrawal by Subject|0
4752158|NCT01723254|16396026|P3|Overall Study|Withdrawal by Subject|1
4752159|NCT01723254|16396027|P2|Overall Study|Withdrawal by Subject|2
4752160|NCT01723254|16396028|P1|Overall Study|Withdrawal by Subject|1
4752161|NCT01723254|16396021|P8|Overall Study|Protocol Violation|0
4752162|NCT01723254|16396022|P7|Overall Study|Protocol Violation|0
4752163|NCT01723254|16396023|P6|Overall Study|Protocol Violation|0
4752164|NCT01723254|16396024|P5|Overall Study|Protocol Violation|0
4752165|NCT01723254|16396025|P4|Overall Study|Protocol Violation|0
4752166|NCT01723254|16396026|P3|Overall Study|Protocol Violation|0
4752167|NCT01723254|16396027|P2|Overall Study|Protocol Violation|1
4752168|NCT01723254|16396028|P1|Overall Study|Protocol Violation|0
4752169|NCT01723254|16396021|P8|Overall Study|Move/Left to another country/city|0
4752170|NCT01723254|16396022|P7|Overall Study|Move/Left to another country/city|0
4752171|NCT01723254|16396023|P6|Overall Study|Move/Left to another country/city|0
4752172|NCT01723254|16396024|P5|Overall Study|Move/Left to another country/city|1
4752173|NCT01723254|16396025|P4|Overall Study|Move/Left to another country/city|1
4752174|NCT01723254|16396026|P3|Overall Study|Move/Left to another country/city|2
4752175|NCT01723254|16396027|P2|Overall Study|Move/Left to another country/city|0
4752176|NCT01723254|16396028|P1|Overall Study|Move/Left to another country/city|0
4752177|NCT01723254|16396021|P8|Overall Study|No longer have time to participate|0
4752178|NCT01723254|16396022|P7|Overall Study|No longer have time to participate|0
4752179|NCT01723254|16396023|P6|Overall Study|No longer have time to participate|0
4752180|NCT01723254|16396024|P5|Overall Study|No longer have time to participate|0
4752181|NCT01723254|16396025|P4|Overall Study|No longer have time to participate|1
4752182|NCT01723254|16396026|P3|Overall Study|No longer have time to participate|0
4752183|NCT01723254|16396027|P2|Overall Study|No longer have time to participate|0
4752184|NCT01723254|16396028|P1|Overall Study|No longer have time to participate|0
4752185|NCT01723254|16396021|P8|Overall Study|Personal issues|0
4752186|NCT01723254|16396022|P7|Overall Study|Personal issues|0
4752187|NCT01723254|16396023|P6|Overall Study|Personal issues|1
4752188|NCT01723254|16396024|P5|Overall Study|Personal issues|0
4752189|NCT01723254|16396025|P4|Overall Study|Personal issues|0
4752190|NCT01723254|16396026|P3|Overall Study|Personal issues|0
4752191|NCT01723254|16396027|P2|Overall Study|Personal issues|0
4752192|NCT01723254|16396028|P1|Overall Study|Personal issues|0
4752193|NCT01723254|16396021|P8|Overall Study|Conflict with work schedule|1
4752194|NCT01723254|16396022|P7|Overall Study|Conflict with work schedule|0
4752195|NCT01723254|16396023|P6|Overall Study|Conflict with work schedule|0
4752196|NCT01723254|16396024|P5|Overall Study|Conflict with work schedule|0
4752197|NCT01723254|16396025|P4|Overall Study|Conflict with work schedule|0
4752198|NCT01723254|16396026|P3|Overall Study|Conflict with work schedule|0
4752199|NCT01723254|16396027|P2|Overall Study|Conflict with work schedule|0
4752200|NCT01723254|16396028|P1|Overall Study|Conflict with work schedule|0
4752201|NCT01723228|16396080|P2|Overall Study|Other|1
4752202|NCT01723228|16396081|P1|Overall Study|Other|2
4752203|NCT01723228|16396080|P2|Overall Study|Lost to Follow-up|1
4752204|NCT01723228|16396081|P1|Overall Study|Lost to Follow-up|2
4752205|NCT01723228|16396080|P2|Overall Study|Protocol Violation|2
4752206|NCT01723228|16396081|P1|Overall Study|Protocol Violation|0
4752207|NCT01723228|16396080|P2|Overall Study|Withdrawal by Subject|1
4752208|NCT01723228|16396081|P1|Overall Study|Withdrawal by Subject|2
4752209|NCT01723228|16396080|P2|Overall Study|Adverse Event|6
4752210|NCT01723228|16396081|P1|Overall Study|Adverse Event|2
4752211|NCT01723163|16396099|P2|12-Month Follow-up|Unable to Contact|28
4752212|NCT01723163|16396100|P1|12-Month Follow-up|Unable to Contact|23
4752213|NCT01723163|16396099|P2|12-Month Follow-up|Death|0
4752214|NCT01723163|16396100|P1|12-Month Follow-up|Death|1
4752215|NCT01723163|16396099|P2|6-Month Follow-up|Unable to Contact|15
4752216|NCT01723163|16396100|P1|6-Month Follow-up|Unable to Contact|17
4752217|NCT01723163|16396099|P2|6-Month Follow-up|Death|0
4752218|NCT01723163|16396100|P1|6-Month Follow-up|Death|1
4752219|NCT01723163|16396099|P2|3-Month Follow-up|Unable to Contact|19
4752220|NCT01723163|16396100|P1|3-Month Follow-up|Unable to Contact|12
4752221|NCT01723163|16396099|P2|3-Month Follow-up|Withdrawal by Subject|0
4752222|NCT01723163|16396100|P1|3-Month Follow-up|Withdrawal by Subject|1
4752223|NCT01723163|16396099|P2|Treatment Phase|Withdrawal by PI|1
4752224|NCT01723163|16396100|P1|Treatment Phase|Withdrawal by PI|5
4752225|NCT01723163|16396099|P2|Treatment Phase|Withdrawal by Subject|6
4752226|NCT01723163|16396100|P1|Treatment Phase|Withdrawal by Subject|14
4752227|NCT01723072|16396108|P2|Overall Study|Other|3
4752228|NCT01723072|16396109|P1|Overall Study|Other|4
4752229|NCT01723072|16396108|P2|Overall Study|Discon for rescue medication after wk 24|5
4752230|NCT01723072|16396109|P1|Overall Study|Discon for rescue medication after wk 24|0
4752231|NCT01723072|16396108|P2|Overall Study|Withdrawal by Subject|13
4752232|NCT01723072|16396109|P1|Overall Study|Withdrawal by Subject|7
4752233|NCT01722994|16396147|P2|Overall Study|Missing data|17
4752234|NCT01722994|16396148|P1|Overall Study|Missing data|25
4752235|NCT01722877|16396167|P1|Overall Study|Lost to Follow-up|1
4752236|NCT01722877|16396167|P1|Overall Study|Death|1
4752237|NCT01722669|16396193|P6|Overall Study|Withdrawal by Subject|2
4752238|NCT01722669|16396194|P5|Overall Study|Withdrawal by Subject|0
4752239|NCT01722669|16396195|P4|Overall Study|Withdrawal by Subject|0
4752240|NCT01722669|16396196|P3|Overall Study|Withdrawal by Subject|0
4752241|NCT01722669|16396197|P2|Overall Study|Withdrawal by Subject|0
4752242|NCT01722669|16396198|P1|Overall Study|Withdrawal by Subject|0
4752243|NCT01722331|16396269|P7|Part 3|Other Protocol Specified Criteria|0
4752244|NCT01722331|16396270|P6|Part 3|Other Protocol Specified Criteria|0
4752245|NCT01722331|16396271|P5|Part 3|Other Protocol Specified Criteria|0
4752246|NCT01722331|16396272|P4|Part 3|Other Protocol Specified Criteria|0
4752247|NCT01722331|16396273|P3|Part 3|Other Protocol Specified Criteria|0
4752248|NCT01722331|16396274|P2|Part 3|Other Protocol Specified Criteria|1
4752249|NCT01722331|16396275|P1|Part 3|Other Protocol Specified Criteria|1
4752250|NCT01722331|16396269|P7|Part 3|Withdrawal by Subject|1
4752251|NCT01722331|16396270|P6|Part 3|Withdrawal by Subject|2
4752252|NCT01722331|16396271|P5|Part 3|Withdrawal by Subject|0
4752253|NCT01722331|16396272|P4|Part 3|Withdrawal by Subject|0
4752254|NCT01722331|16396273|P3|Part 3|Withdrawal by Subject|0
4752255|NCT01722331|16396274|P2|Part 3|Withdrawal by Subject|7
4752256|NCT01722331|16396275|P1|Part 3|Withdrawal by Subject|4
4752257|NCT01722331|16396269|P7|Part 3|Protocol Violation|0
4752258|NCT01722331|16396270|P6|Part 3|Protocol Violation|0
4752259|NCT01722331|16396271|P5|Part 3|Protocol Violation|0
4752260|NCT01722331|16396272|P4|Part 3|Protocol Violation|0
4752261|NCT01722331|16396273|P3|Part 3|Protocol Violation|0
4752262|NCT01722331|16396274|P2|Part 3|Protocol Violation|1
4752263|NCT01722331|16396275|P1|Part 3|Protocol Violation|2
4752264|NCT01722331|16396269|P7|Part 3|Physician Decision|1
4752265|NCT01722331|16396270|P6|Part 3|Physician Decision|0
4752266|NCT01722331|16396271|P5|Part 3|Physician Decision|0
4752267|NCT01722331|16396272|P4|Part 3|Physician Decision|0
4752268|NCT01722331|16396273|P3|Part 3|Physician Decision|0
4752269|NCT01722331|16396274|P2|Part 3|Physician Decision|1
4752270|NCT01722331|16396275|P1|Part 3|Physician Decision|1
4752271|NCT01722331|16396269|P7|Part 3|Non-Compliance with Study Drug|0
4752272|NCT01722331|16396270|P6|Part 3|Non-Compliance with Study Drug|0
4752273|NCT01722331|16396271|P5|Part 3|Non-Compliance with Study Drug|0
4752274|NCT01722331|16396272|P4|Part 3|Non-Compliance with Study Drug|0
4752275|NCT01722331|16396273|P3|Part 3|Non-Compliance with Study Drug|0
4752276|NCT01722331|16396274|P2|Part 3|Non-Compliance with Study Drug|1
4752277|NCT01722331|16396275|P1|Part 3|Non-Compliance with Study Drug|0
4752278|NCT01722331|16396269|P7|Part 3|Lost to Follow-up|0
4752279|NCT01722331|16396270|P6|Part 3|Lost to Follow-up|1
4752280|NCT01722331|16396271|P5|Part 3|Lost to Follow-up|0
4752281|NCT01722331|16396272|P4|Part 3|Lost to Follow-up|0
4752282|NCT01722331|16396273|P3|Part 3|Lost to Follow-up|0
4752283|NCT01722331|16396274|P2|Part 3|Lost to Follow-up|4
4752284|NCT01722331|16396275|P1|Part 3|Lost to Follow-up|3
4752285|NCT01722331|16396269|P7|Part 3|Lack of Efficacy|0
4752286|NCT01722331|16396270|P6|Part 3|Lack of Efficacy|0
4752287|NCT01722331|16396271|P5|Part 3|Lack of Efficacy|0
4752288|NCT01722331|16396272|P4|Part 3|Lack of Efficacy|0
4752289|NCT01722331|16396273|P3|Part 3|Lack of Efficacy|0
4752290|NCT01722331|16396274|P2|Part 3|Lack of Efficacy|0
4752291|NCT01722331|16396275|P1|Part 3|Lack of Efficacy|1
4752292|NCT01722331|16396269|P7|Part 3|Death|0
4752293|NCT01722331|16396270|P6|Part 3|Death|0
4752294|NCT01722331|16396271|P5|Part 3|Death|0
4752295|NCT01722331|16396272|P4|Part 3|Death|0
4752296|NCT01722331|16396273|P3|Part 3|Death|0
4752297|NCT01722331|16396274|P2|Part 3|Death|0
4752298|NCT01722331|16396275|P1|Part 3|Death|1
4752299|NCT01722331|16396269|P7|Part 3|Adverse Event|0
4752300|NCT01722331|16396270|P6|Part 3|Adverse Event|0
4752301|NCT01722331|16396271|P5|Part 3|Adverse Event|0
4752302|NCT01722331|16396272|P4|Part 3|Adverse Event|1
4752303|NCT01722331|16396273|P3|Part 3|Adverse Event|0
4752304|NCT01722331|16396274|P2|Part 3|Adverse Event|2
4752305|NCT01722331|16396275|P1|Part 3|Adverse Event|2
4752306|NCT01722331|16396269|P7|Part 2|Other Protocol Specified Criteria|1
4752307|NCT01722331|16396270|P6|Part 2|Other Protocol Specified Criteria|2
4752308|NCT01722331|16396271|P5|Part 2|Other Protocol Specified Criteria|0
4752309|NCT01722331|16396272|P4|Part 2|Other Protocol Specified Criteria|0
4752310|NCT01722331|16396273|P3|Part 2|Other Protocol Specified Criteria|10
4752311|NCT01722331|16396274|P2|Part 2|Other Protocol Specified Criteria|0
4752312|NCT01722331|16396275|P1|Part 2|Other Protocol Specified Criteria|6
4752313|NCT01722331|16396269|P7|Part 2|Withdrawal by Subject|2
4752314|NCT01722331|16396270|P6|Part 2|Withdrawal by Subject|2
4752315|NCT01722331|16396271|P5|Part 2|Withdrawal by Subject|0
4752316|NCT01722331|16396272|P4|Part 2|Withdrawal by Subject|0
4752317|NCT01722331|16396273|P3|Part 2|Withdrawal by Subject|3
4752318|NCT01722331|16396274|P2|Part 2|Withdrawal by Subject|0
4752319|NCT01722331|16396275|P1|Part 2|Withdrawal by Subject|5
4752320|NCT01722331|16396269|P7|Part 2|Protocol Violation|0
4752321|NCT01722331|16396270|P6|Part 2|Protocol Violation|0
4752322|NCT01722331|16396271|P5|Part 2|Protocol Violation|0
4752323|NCT01722331|16396272|P4|Part 2|Protocol Violation|0
4752324|NCT01722331|16396273|P3|Part 2|Protocol Violation|0
4752325|NCT01722331|16396274|P2|Part 2|Protocol Violation|0
4752326|NCT01722331|16396275|P1|Part 2|Protocol Violation|1
4752327|NCT01722331|16396269|P7|Part 2|Progressive Disease|0
4752328|NCT01722331|16396270|P6|Part 2|Progressive Disease|0
4752329|NCT01722331|16396271|P5|Part 2|Progressive Disease|0
4752330|NCT01722331|16396272|P4|Part 2|Progressive Disease|0
4752331|NCT01722331|16396273|P3|Part 2|Progressive Disease|1
4752332|NCT01722331|16396274|P2|Part 2|Progressive Disease|0
4752333|NCT01722331|16396275|P1|Part 2|Progressive Disease|0
4752334|NCT01722331|16396269|P7|Part 2|Pregnancy|0
4752335|NCT01722331|16396270|P6|Part 2|Pregnancy|1
4752336|NCT01722331|16396271|P5|Part 2|Pregnancy|0
4752337|NCT01722331|16396272|P4|Part 2|Pregnancy|0
4752338|NCT01722331|16396273|P3|Part 2|Pregnancy|0
4752339|NCT01722331|16396274|P2|Part 2|Pregnancy|0
4752340|NCT01722331|16396275|P1|Part 2|Pregnancy|0
4752341|NCT01722331|16396269|P7|Part 2|Physician Decision|0
4752342|NCT01722331|16396270|P6|Part 2|Physician Decision|0
4752343|NCT01722331|16396271|P5|Part 2|Physician Decision|0
4752344|NCT01722331|16396272|P4|Part 2|Physician Decision|0
4752345|NCT01722331|16396273|P3|Part 2|Physician Decision|2
4752346|NCT01722331|16396274|P2|Part 2|Physician Decision|0
4752347|NCT01722331|16396275|P1|Part 2|Physician Decision|0
4752348|NCT01722331|16396269|P7|Part 2|Non-Compliance with Study Drug|0
4752349|NCT01722331|16396270|P6|Part 2|Non-Compliance with Study Drug|0
4752350|NCT01722331|16396271|P5|Part 2|Non-Compliance with Study Drug|0
4752351|NCT01722331|16396272|P4|Part 2|Non-Compliance with Study Drug|0
4752352|NCT01722331|16396273|P3|Part 2|Non-Compliance with Study Drug|1
4752353|NCT01722331|16396274|P2|Part 2|Non-Compliance with Study Drug|0
4752354|NCT01722331|16396275|P1|Part 2|Non-Compliance with Study Drug|1
4752355|NCT01722331|16396269|P7|Part 2|Lost to Follow-up|1
4752356|NCT01722331|16396270|P6|Part 2|Lost to Follow-up|1
4752357|NCT01722331|16396271|P5|Part 2|Lost to Follow-up|0
4752358|NCT01722331|16396272|P4|Part 2|Lost to Follow-up|0
4752359|NCT01722331|16396273|P3|Part 2|Lost to Follow-up|3
4752360|NCT01722331|16396274|P2|Part 2|Lost to Follow-up|0
4752361|NCT01722331|16396275|P1|Part 2|Lost to Follow-up|0
4752362|NCT01722331|16396269|P7|Part 2|Lack of Efficacy|3
4752363|NCT01722331|16396270|P6|Part 2|Lack of Efficacy|3
4752364|NCT01722331|16396271|P5|Part 2|Lack of Efficacy|0
4752365|NCT01722331|16396272|P4|Part 2|Lack of Efficacy|0
4752366|NCT01722331|16396273|P3|Part 2|Lack of Efficacy|11
4752367|NCT01722331|16396274|P2|Part 2|Lack of Efficacy|0
4752368|NCT01722331|16396275|P1|Part 2|Lack of Efficacy|3
4752369|NCT01722331|16396269|P7|Part 2|Adverse Event|0
4752370|NCT01722331|16396270|P6|Part 2|Adverse Event|1
4752371|NCT01722331|16396271|P5|Part 2|Adverse Event|0
4752372|NCT01722331|16396272|P4|Part 2|Adverse Event|0
4752373|NCT01722331|16396273|P3|Part 2|Adverse Event|0
4752374|NCT01722331|16396274|P2|Part 2|Adverse Event|0
4752375|NCT01722331|16396275|P1|Part 2|Adverse Event|3
4752376|NCT01722331|16396269|P7|Part 1|Withdrawal by Subject|0
4752377|NCT01722331|16396270|P6|Part 1|Withdrawal by Subject|0
4752378|NCT01722331|16396271|P5|Part 1|Withdrawal by Subject|3
4752379|NCT01722331|16396272|P4|Part 1|Withdrawal by Subject|0
4752380|NCT01722331|16396273|P3|Part 1|Withdrawal by Subject|3
4752381|NCT01722331|16396274|P2|Part 1|Withdrawal by Subject|0
4752382|NCT01722331|16396275|P1|Part 1|Withdrawal by Subject|2
4752383|NCT01722331|16396269|P7|Part 1|Protocol Violation|0
4752384|NCT01722331|16396270|P6|Part 1|Protocol Violation|0
4752385|NCT01722331|16396271|P5|Part 1|Protocol Violation|1
4752386|NCT01722331|16396272|P4|Part 1|Protocol Violation|0
4752387|NCT01722331|16396273|P3|Part 1|Protocol Violation|0
4752388|NCT01722331|16396274|P2|Part 1|Protocol Violation|0
4752389|NCT01722331|16396275|P1|Part 1|Protocol Violation|1
4752390|NCT01722331|16396269|P7|Part 1|Progressive Disease|0
4752391|NCT01722331|16396270|P6|Part 1|Progressive Disease|0
4752392|NCT01722331|16396271|P5|Part 1|Progressive Disease|1
4752393|NCT01722331|16396272|P4|Part 1|Progressive Disease|0
4752394|NCT01722331|16396273|P3|Part 1|Progressive Disease|0
4752395|NCT01722331|16396274|P2|Part 1|Progressive Disease|0
4752396|NCT01722331|16396275|P1|Part 1|Progressive Disease|0
4752397|NCT01722331|16396269|P7|Part 1|Pregnancy|0
4752398|NCT01722331|16396270|P6|Part 1|Pregnancy|0
4752399|NCT01722331|16396271|P5|Part 1|Pregnancy|0
4752400|NCT01722331|16396272|P4|Part 1|Pregnancy|0
4752401|NCT01722331|16396273|P3|Part 1|Pregnancy|0
4752402|NCT01722331|16396274|P2|Part 1|Pregnancy|0
4752403|NCT01722331|16396275|P1|Part 1|Pregnancy|1
4752404|NCT01722331|16396269|P7|Part 1|Physician Decision|0
4752405|NCT01722331|16396270|P6|Part 1|Physician Decision|0
4752406|NCT01722331|16396271|P5|Part 1|Physician Decision|1
4752407|NCT01722331|16396272|P4|Part 1|Physician Decision|0
4752408|NCT01722331|16396273|P3|Part 1|Physician Decision|3
4752409|NCT01722331|16396274|P2|Part 1|Physician Decision|0
4752410|NCT01722331|16396275|P1|Part 1|Physician Decision|0
4752411|NCT01722331|16396269|P7|Part 1|Lost to Follow-up|0
4752412|NCT01722331|16396270|P6|Part 1|Lost to Follow-up|0
4752413|NCT01722331|16396271|P5|Part 1|Lost to Follow-up|1
4752414|NCT01722331|16396272|P4|Part 1|Lost to Follow-up|0
4752415|NCT01722331|16396273|P3|Part 1|Lost to Follow-up|2
4752416|NCT01722331|16396274|P2|Part 1|Lost to Follow-up|0
4752417|NCT01722331|16396275|P1|Part 1|Lost to Follow-up|1
4752418|NCT01722331|16396269|P7|Part 1|Lack of Efficacy|0
4752419|NCT01722331|16396270|P6|Part 1|Lack of Efficacy|0
4752420|NCT01722331|16396271|P5|Part 1|Lack of Efficacy|2
4752421|NCT01722331|16396272|P4|Part 1|Lack of Efficacy|0
4752422|NCT01722331|16396273|P3|Part 1|Lack of Efficacy|1
4752423|NCT01722331|16396274|P2|Part 1|Lack of Efficacy|0
4752424|NCT01722331|16396275|P1|Part 1|Lack of Efficacy|0
4752425|NCT01722331|16396269|P7|Part 1|Adverse Event|0
4752426|NCT01722331|16396270|P6|Part 1|Adverse Event|0
4752427|NCT01722331|16396271|P5|Part 1|Adverse Event|0
4752428|NCT01722331|16396272|P4|Part 1|Adverse Event|0
4752429|NCT01722331|16396273|P3|Part 1|Adverse Event|0
4752430|NCT01722331|16396274|P2|Part 1|Adverse Event|0
4752431|NCT01722331|16396275|P1|Part 1|Adverse Event|5
4752432|NCT01722266|16396391|P4|Overall Study|Dropped out due to Nausea|0
4752433|NCT01722266|16396392|P3|Overall Study|Dropped out due to Nausea|2
4752434|NCT01722266|16396393|P2|Overall Study|Dropped out due to Nausea|0
4752435|NCT01722266|16396394|P1|Overall Study|Dropped out due to Nausea|0
4752436|NCT01722266|16396391|P4|Overall Study|Tolerated only 0.6 mg liraglutide|0
4752437|NCT01722266|16396392|P3|Overall Study|Tolerated only 0.6 mg liraglutide|3
4752438|NCT01722266|16396393|P2|Overall Study|Tolerated only 0.6 mg liraglutide|1
4752439|NCT01722266|16396394|P1|Overall Study|Tolerated only 0.6 mg liraglutide|0
4752440|NCT01722266|16396391|P4|Overall Study|Withdrawal by Subject|0
4752441|NCT01722266|16396392|P3|Overall Study|Withdrawal by Subject|0
4752442|NCT01722266|16396393|P2|Overall Study|Withdrawal by Subject|2
4752443|NCT01722266|16396394|P1|Overall Study|Withdrawal by Subject|1
4752444|NCT01722162|16396422|P2|Overall Study|Noncompliance|1
4752445|NCT01722162|16396423|P1|Overall Study|Noncompliance|0
4752446|NCT01722162|16396422|P2|Overall Study|Insurance denial post enrollment|1
4752447|NCT01722162|16396423|P1|Overall Study|Insurance denial post enrollment|0
4752448|NCT01722162|16396422|P2|Overall Study|Adverse Event|1
4752449|NCT01722162|16396423|P1|Overall Study|Adverse Event|1
4752450|NCT01722162|16396422|P2|Overall Study|Unrelated to study adverse event|2
4752451|NCT01722162|16396423|P1|Overall Study|Unrelated to study adverse event|2
4752452|NCT01722162|16396422|P2|Overall Study|Found ineligible|0
4752453|NCT01722162|16396423|P1|Overall Study|Found ineligible|1
4752454|NCT01722162|16396422|P2|Overall Study|Withdrawal by Subject|1
4752455|NCT01722162|16396423|P1|Overall Study|Withdrawal by Subject|1
4752456|NCT01722097|16396433|P2|Overall Study|Patient sheets not returned|5
4752457|NCT01722097|16396434|P1|Overall Study|Patient sheets not returned|6
4752458|NCT01722071|16396442|P2|Overall Study|Protocol Violation|0
4752459|NCT01722071|16396443|P1|Overall Study|Protocol Violation|1
4752460|NCT01722045|16396449|P1|Overall Study|Relocation (did not wish to transfer)|1
4752461|NCT01722045|16396449|P1|Overall Study|Physician Decision|3
4752462|NCT01722045|16396449|P1|Overall Study|Protocol Deviation|1
4752463|NCT01722045|16396449|P1|Overall Study|Lost to Follow-up|4
4752464|NCT01722045|16396449|P1|Overall Study|Withdrawal by Subject|8
4752465|NCT01722045|16396449|P1|Overall Study|Death|3
4752466|NCT01722045|16396449|P1|Overall Study|Adverse Event|8
4752467|NCT01721954|16396470|P2|Overall Study|Lost to Follow-up|1
4752468|NCT01721954|16396471|P1|Overall Study|Lost to Follow-up|2
4752469|NCT01721954|16396470|P2|Overall Study|Adverse Event|0
4752470|NCT01721954|16396471|P1|Overall Study|Adverse Event|2
4752471|NCT01721954|16396470|P2|Overall Study|Withdrawal by Subject|4
4752472|NCT01721954|16396471|P1|Overall Study|Withdrawal by Subject|8
4752473|NCT01721954|16396470|P2|Overall Study|Death|64
4752474|NCT01721954|16396471|P1|Overall Study|Death|58
4752475|NCT01721772|16396485|P2|Overall Study|Other|1
4752476|NCT01721772|16396486|P1|Overall Study|Other|0
4752477|NCT01721772|16396485|P2|Overall Study|Maximum clinical benefit|1
4752478|NCT01721772|16396486|P1|Overall Study|Maximum clinical benefit|1
4752479|NCT01721772|16396485|P2|Overall Study|Withdrawal by Subject|5
4752480|NCT01721772|16396486|P1|Overall Study|Withdrawal by Subject|7
4752481|NCT01721772|16396485|P2|Overall Study|Unrelated adverse event|3
4752482|NCT01721772|16396486|P1|Overall Study|Unrelated adverse event|2
4752483|NCT01721772|16396485|P2|Overall Study|Study drug toxicity|7
4752484|NCT01721772|16396486|P1|Overall Study|Study drug toxicity|5
4752485|NCT01721772|16396485|P2|Overall Study|Disease progression|175
4752486|NCT01721772|16396486|P1|Overall Study|Disease progression|96
4752487|NCT01721759|16396506|P1|Overall Study|Withdrawal by Subject|1
4752488|NCT01721759|16396506|P1|Overall Study|Adverse event unrelated to study drug|9
4752489|NCT01721759|16396506|P1|Overall Study|Study drug toxicity|14
4752490|NCT01721759|16396506|P1|Overall Study|Disease progression|78
4752491|NCT01721746|16396514|P3|Treatment Period|Other|1
4752492|NCT01721746|16396515|P2|Treatment Period|Other|1
4752493|NCT01721746|16396516|P1|Treatment Period|Other|2
4752494|NCT01721746|16396514|P3|Treatment Period|Subject No Longer Met Study Criteria|0
4752495|NCT01721746|16396515|P2|Treatment Period|Subject No Longer Met Study Criteria|0
4752496|NCT01721746|16396516|P1|Treatment Period|Subject No Longer Met Study Criteria|4
4752497|NCT01721746|16396514|P3|Treatment Period|Poor/Non-compliance|0
4752498|NCT01721746|16396515|P2|Treatment Period|Poor/Non-compliance|0
4752499|NCT01721746|16396516|P1|Treatment Period|Poor/Non-compliance|1
4752500|NCT01721746|16396514|P3|Treatment Period|Maximum Clinical Benefit|3
4752501|NCT01721746|16396515|P2|Treatment Period|Maximum Clinical Benefit|0
4752502|NCT01721746|16396516|P1|Treatment Period|Maximum Clinical Benefit|1
4752503|NCT01721746|16396514|P3|Treatment Period|Subject Withdrew Consent|2
4752504|NCT01721746|16396515|P2|Treatment Period|Subject Withdrew Consent|0
4752505|NCT01721746|16396516|P1|Treatment Period|Subject Withdrew Consent|3
4752506|NCT01721746|16396514|P3|Treatment Period|Subject Request to Discontinue Treatment|6
4752507|NCT01721746|16396515|P2|Treatment Period|Subject Request to Discontinue Treatment|1
4752508|NCT01721746|16396516|P1|Treatment Period|Subject Request to Discontinue Treatment|19
4752509|NCT01721746|16396514|P3|Treatment Period|Adverse Event Unrelated to Study Drug|2
4752510|NCT01721746|16396515|P2|Treatment Period|Adverse Event Unrelated to Study Drug|1
4752511|NCT01721746|16396516|P1|Treatment Period|Adverse Event Unrelated to Study Drug|6
4752512|NCT01721746|16396514|P3|Treatment Period|Study Drug Toxicity|9
4752513|NCT01721746|16396515|P2|Treatment Period|Study Drug Toxicity|2
4752514|NCT01721746|16396516|P1|Treatment Period|Study Drug Toxicity|15
4752515|NCT01721746|16396514|P3|Treatment Period|Disease Progression|34
4752516|NCT01721746|16396515|P2|Treatment Period|Disease Progression|40
4752517|NCT01721746|16396516|P1|Treatment Period|Disease Progression|182
4752518|NCT01721486|16396556|P2|Overall Study|Physician Decision|1
4752519|NCT01721486|16396557|P1|Overall Study|Physician Decision|0
4752520|NCT01721486|16396556|P2|Overall Study|Protocol Violation|0
4752521|NCT01721486|16396557|P1|Overall Study|Protocol Violation|1
4752522|NCT01721408|16396605|P2|Overall Study|Does not meet entrance criteria|0
4752523|NCT01721408|16396606|P1|Overall Study|Does not meet entrance criteria|1
4752524|NCT01721408|16396605|P2|Overall Study|Lost to Follow-up|2
4752525|NCT01721408|16396606|P1|Overall Study|Lost to Follow-up|1
4752526|NCT01721408|16396605|P2|Overall Study|Other|3
4752527|NCT01721408|16396606|P1|Overall Study|Other|3
4752528|NCT01721408|16396605|P2|Overall Study|Protocol Violation|2
4752529|NCT01721408|16396606|P1|Overall Study|Protocol Violation|0
4752530|NCT01721408|16396605|P2|Overall Study|No longer willing to participate study|10
4752531|NCT01721408|16396606|P1|Overall Study|No longer willing to participate study|9
4752532|NCT01721408|16396605|P2|Overall Study|Insufficient clinical response|6
4752533|NCT01721408|16396606|P1|Overall Study|Insufficient clinical response|15
4752534|NCT01721408|16396605|P2|Overall Study|Death|0
4752535|NCT01721408|16396606|P1|Overall Study|Death|1
4752536|NCT01721408|16396605|P2|Overall Study|Adverse Event|1
4752537|NCT01721408|16396606|P1|Overall Study|Adverse Event|6
4752538|NCT01721369|16396620|P1|Overall Study|Not initial etiological diagnosis|12
4752539|NCT01721330|16396626|P2|Overall Study|Withdrawal by Subject|1
4752540|NCT01721330|16396627|P1|Overall Study|Withdrawal by Subject|0
4752541|NCT01721317|16396635|P2|Overall Study|Withdrawal by Subject|1
4752542|NCT01721317|16396636|P1|Overall Study|Withdrawal by Subject|0
4752543|NCT01721317|16396635|P2|Overall Study|Physician Decision|1
4752544|NCT01721317|16396636|P1|Overall Study|Physician Decision|0
4752545|NCT01721317|16396635|P2|Overall Study|Study Closed / Terminated|2
4752546|NCT01721317|16396636|P1|Overall Study|Study Closed / Terminated|2
4752547|NCT01721200|16396715|P2|Overall Study|Lost to Follow-up|5
4752548|NCT01721200|16396716|P1|Overall Study|Lost to Follow-up|3
4752549|NCT01721161|16396741|P2|Overall Study|Other|1
4752550|NCT01721161|16396742|P1|Overall Study|Other|0
4752551|NCT01721161|16396741|P2|Overall Study|Withdrawal by Subject|1
4752552|NCT01721161|16396742|P1|Overall Study|Withdrawal by Subject|1
4752553|NCT01721161|16396741|P2|Overall Study|Lost to Follow-up|2
4752554|NCT01721161|16396742|P1|Overall Study|Lost to Follow-up|1
4752555|NCT01721161|16396741|P2|Overall Study|Adverse Event|3
4752556|NCT01721161|16396742|P1|Overall Study|Adverse Event|2
4752557|NCT01721109|16396765|P1|Overall Study|Lost to Follow-up|2
4752558|NCT01721109|16396765|P1|Overall Study|Withdrew Consent|1
4752559|NCT01721109|16396765|P1|Overall Study|Non- Compliance with Study Drug|3
4752560|NCT01721109|16396765|P1|Overall Study|Lack of Efficacy|1
4752561|NCT01721070|16396960|P1|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1
4752562|NCT01721057|16396971|P7|Rescue Period|Lack of Efficacy|0
4752563|NCT01721057|16396972|P6|Rescue Period|Lack of Efficacy|0
4752564|NCT01721057|16396973|P5|Rescue Period|Lack of Efficacy|0
4752565|NCT01721057|16396974|P4|Rescue Period|Lack of Efficacy|2
4752566|NCT01721057|16396975|P3|Rescue Period|Lack of Efficacy|0
4752567|NCT01721057|16396976|P2|Rescue Period|Lack of Efficacy|0
4752568|NCT01721057|16396977|P1|Rescue Period|Lack of Efficacy|0
4752569|NCT01721057|16396971|P7|Rescue Period|Adverse Event|0
4752570|NCT01721057|16396972|P6|Rescue Period|Adverse Event|0
4752571|NCT01721057|16396973|P5|Rescue Period|Adverse Event|0
4752572|NCT01721057|16396974|P4|Rescue Period|Adverse Event|1
4752573|NCT01721057|16396975|P3|Rescue Period|Adverse Event|0
4752574|NCT01721057|16396976|P2|Rescue Period|Adverse Event|0
4752575|NCT01721057|16396977|P1|Rescue Period|Adverse Event|0
4752576|NCT01721057|16396971|P7|Treatment Period|Death|0
4752577|NCT01721057|16396972|P6|Treatment Period|Death|0
4752578|NCT01721057|16396973|P5|Treatment Period|Death|0
4752579|NCT01721057|16396974|P4|Treatment Period|Death|0
4752580|NCT01721057|16396975|P3|Treatment Period|Death|0
4752581|NCT01721057|16396976|P2|Treatment Period|Death|0
4752582|NCT01721057|16396977|P1|Treatment Period|Death|2
4752583|NCT01721057|16396971|P7|Treatment Period|Physician Decision|0
4752584|NCT01721057|16396972|P6|Treatment Period|Physician Decision|0
4752585|NCT01721057|16396973|P5|Treatment Period|Physician Decision|0
4752586|NCT01721057|16396974|P4|Treatment Period|Physician Decision|0
4752587|NCT01721057|16396975|P3|Treatment Period|Physician Decision|3
4752588|NCT01721057|16396976|P2|Treatment Period|Physician Decision|1
4752589|NCT01721057|16396977|P1|Treatment Period|Physician Decision|0
4752590|NCT01721057|16396971|P7|Treatment Period|Lost to Follow-up|0
4752591|NCT01721057|16396972|P6|Treatment Period|Lost to Follow-up|0
4752592|NCT01721057|16396973|P5|Treatment Period|Lost to Follow-up|0
4752593|NCT01721057|16396974|P4|Treatment Period|Lost to Follow-up|0
4752594|NCT01721057|16396975|P3|Treatment Period|Lost to Follow-up|0
4752595|NCT01721057|16396976|P2|Treatment Period|Lost to Follow-up|0
4752596|NCT01721057|16396977|P1|Treatment Period|Lost to Follow-up|1
4752597|NCT01721057|16396971|P7|Treatment Period|Lack of Efficacy|0
4752598|NCT01721057|16396972|P6|Treatment Period|Lack of Efficacy|0
4752599|NCT01721057|16396973|P5|Treatment Period|Lack of Efficacy|0
4752600|NCT01721057|16396974|P4|Treatment Period|Lack of Efficacy|0
4752601|NCT01721057|16396975|P3|Treatment Period|Lack of Efficacy|0
4752602|NCT01721057|16396976|P2|Treatment Period|Lack of Efficacy|3
4752603|NCT01721057|16396977|P1|Treatment Period|Lack of Efficacy|7
4752604|NCT01721057|16396971|P7|Treatment Period|Adverse Event|0
4752605|NCT01721057|16396972|P6|Treatment Period|Adverse Event|0
4752606|NCT01721057|16396973|P5|Treatment Period|Adverse Event|0
4752607|NCT01721057|16396974|P4|Treatment Period|Adverse Event|0
4752608|NCT01721057|16396975|P3|Treatment Period|Adverse Event|12
4752609|NCT01721057|16396976|P2|Treatment Period|Adverse Event|10
4752610|NCT01721057|16396977|P1|Treatment Period|Adverse Event|7
4752611|NCT01721057|16396971|P7|Treatment Period|Withdrawal by Subject|0
4752612|NCT01721057|16396972|P6|Treatment Period|Withdrawal by Subject|0
4752613|NCT01721057|16396973|P5|Treatment Period|Withdrawal by Subject|0
4752614|NCT01721057|16396974|P4|Treatment Period|Withdrawal by Subject|0
4752615|NCT01721057|16396975|P3|Treatment Period|Withdrawal by Subject|8
4752616|NCT01721057|16396976|P2|Treatment Period|Withdrawal by Subject|5
4752617|NCT01721057|16396977|P1|Treatment Period|Withdrawal by Subject|11
4752618|NCT01721044|16397050|P3|Treatment Period|Withdrawal by Subject|1
4752619|NCT01721044|16397051|P2|Treatment Period|Withdrawal by Subject|6
4752620|NCT01721044|16397052|P1|Treatment Period|Withdrawal by Subject|7
4752621|NCT01721044|16397050|P3|Treatment Period|Protocol Violation|0
4752622|NCT01721044|16397051|P2|Treatment Period|Protocol Violation|0
4752623|NCT01721044|16397052|P1|Treatment Period|Protocol Violation|1
4752624|NCT01721044|16397050|P3|Treatment Period|Physician Decision|2
4752625|NCT01721044|16397051|P2|Treatment Period|Physician Decision|0
4752626|NCT01721044|16397052|P1|Treatment Period|Physician Decision|1
4752627|NCT01721044|16397050|P3|Treatment Period|Lost to Follow-up|1
4752628|NCT01721044|16397051|P2|Treatment Period|Lost to Follow-up|0
4752629|NCT01721044|16397052|P1|Treatment Period|Lost to Follow-up|0
4752630|NCT01721044|16397050|P3|Treatment Period|Lack of Efficacy|4
4752631|NCT01721044|16397051|P2|Treatment Period|Lack of Efficacy|4
4752632|NCT01721044|16397052|P1|Treatment Period|Lack of Efficacy|16
4752633|NCT01721044|16397050|P3|Treatment Period|Death|1
4752634|NCT01721044|16397051|P2|Treatment Period|Death|0
4752635|NCT01721044|16397052|P1|Treatment Period|Death|0
4752636|NCT01721044|16397050|P3|Treatment Period|Adverse Event|10
4752637|NCT01721044|16397051|P2|Treatment Period|Adverse Event|7
4752638|NCT01721044|16397052|P1|Treatment Period|Adverse Event|7
4752639|NCT01720797|16397125|P2|Overall Study|Withdrawal by Subject|0
4752640|NCT01720797|16397126|P1|Overall Study|Withdrawal by Subject|3
4752641|NCT01720667|16397134|P2|Overall Study|Withdrawal by Subject|0
4752642|NCT01720667|16397135|P1|Overall Study|Withdrawal by Subject|3
4752643|NCT01720667|16397134|P2|Overall Study|Adverse Event|1
4752644|NCT01720667|16397135|P1|Overall Study|Adverse Event|1
4752645|NCT01720602|16397149|P1|Overall Study|Progressive disease on therapy|2
4752646|NCT01720602|16397149|P1|Overall Study|Adverse Event|3
4752647|NCT01720524|16397159|P2|Part B|Death|2
4752648|NCT01720524|16397160|P1|Part B|Death|0
4752649|NCT01720524|16397159|P2|Part B|Lost to Follow-up|3
4752650|NCT01720524|16397160|P1|Part B|Lost to Follow-up|1
4752651|NCT01720524|16397159|P2|Part B|Other|0
4752652|NCT01720524|16397160|P1|Part B|Other|2
4752653|NCT01720524|16397159|P2|Part B|Withdrawal by Subject|4
4752654|NCT01720524|16397160|P1|Part B|Withdrawal by Subject|1
4752655|NCT01720524|16397159|P2|Part B|Ongoing|5
4752656|NCT01720524|16397160|P1|Part B|Ongoing|3
4752657|NCT01720524|16397159|P2|Part A|Lost to Follow-up|1
4752658|NCT01720524|16397160|P1|Part A|Lost to Follow-up|0
4752659|NCT01720524|16397159|P2|Part A|Other|1
4752660|NCT01720524|16397160|P1|Part A|Other|0
4752661|NCT01720524|16397159|P2|Part A|Withdrawal by Subject|1
4752662|NCT01720524|16397160|P1|Part A|Withdrawal by Subject|0
4752663|NCT01720524|16397159|P2|Part A|Missed 28 day follow-up visit|1
4752664|NCT01720524|16397160|P1|Part A|Missed 28 day follow-up visit|1
4752665|NCT01720524|16397159|P2|Part A|Lost to Follow-up|1
4752666|NCT01720524|16397160|P1|Part A|Lost to Follow-up|0
4752667|NCT01720524|16397159|P2|Part A|Death|1
4752668|NCT01720524|16397160|P1|Part A|Death|2
4752669|NCT01720524|16397159|P2|Part A|Adverse Event|2
4752670|NCT01720524|16397160|P1|Part A|Adverse Event|2
4752671|NCT01720524|16397159|P2|Part A|Insufficient Clinical Response|4
4752672|NCT01720524|16397160|P1|Part A|Insufficient Clinical Response|2
4752673|NCT01720446|16397193|P4|Overall Study|Withdrawal by Subject|4
4752674|NCT01720446|16397194|P3|Overall Study|Withdrawal by Subject|4
4752675|NCT01720446|16397195|P2|Overall Study|Withdrawal by Subject|5
4752676|NCT01720446|16397196|P1|Overall Study|Withdrawal by Subject|2
4752677|NCT01720446|16397193|P4|Overall Study|Lost to Follow-up|16
4752678|NCT01720446|16397194|P3|Overall Study|Lost to Follow-up|16
4752679|NCT01720446|16397195|P2|Overall Study|Lost to Follow-up|6
4752680|NCT01720446|16397196|P1|Overall Study|Lost to Follow-up|12
4752681|NCT01720264|16397317|P1|Post-transplant (Day 16) to 1 Year|Disease Progression|4
4752682|NCT01720264|16397317|P1|Post-transplant (Day 16) to 1 Year|Death|8
4752683|NCT01720264|16397317|P1|Transplant With Sitagliptin for 15 Days|Adverse Event|1
4752684|NCT01720069|16397348|P3|Overall Study|Lost to Follow-up|1
4752685|NCT01720069|16397349|P2|Overall Study|Lost to Follow-up|0
4752686|NCT01720069|16397350|P1|Overall Study|Lost to Follow-up|0
4752687|NCT01720069|16397348|P3|Overall Study|Non-compliance on using e-diary|1
4752688|NCT01720069|16397349|P2|Overall Study|Non-compliance on using e-diary|0
4752689|NCT01720069|16397350|P1|Overall Study|Non-compliance on using e-diary|0
4752690|NCT01720069|16397348|P3|Overall Study|OCS bursts occured, discontinued in line|0
4752691|NCT01720069|16397349|P2|Overall Study|OCS bursts occured, discontinued in line|0
4752692|NCT01720069|16397350|P1|Overall Study|OCS bursts occured, discontinued in line|1
4752693|NCT01720069|16397348|P3|Overall Study|Withdrawal by Subject|1
4752694|NCT01720069|16397349|P2|Overall Study|Withdrawal by Subject|2
4752695|NCT01720069|16397350|P1|Overall Study|Withdrawal by Subject|0
4752696|NCT01720069|16397348|P3|Overall Study|Treatment period withdrawal criteria met|9
4752697|NCT01720069|16397349|P2|Overall Study|Treatment period withdrawal criteria met|8
4752698|NCT01720069|16397350|P1|Overall Study|Treatment period withdrawal criteria met|4
4752699|NCT01720069|16397348|P3|Overall Study|Lack of Efficacy|0
4752700|NCT01720069|16397349|P2|Overall Study|Lack of Efficacy|4
4752701|NCT01720069|16397350|P1|Overall Study|Lack of Efficacy|0
4752702|NCT01720069|16397348|P3|Overall Study|Adverse Event|1
4752703|NCT01720069|16397349|P2|Overall Study|Adverse Event|0
4752704|NCT01720069|16397350|P1|Overall Study|Adverse Event|0
4752705|NCT01720069|16397348|P3|Overall Study|Randomised without baseline values|1
4752706|NCT01720069|16397349|P2|Overall Study|Randomised without baseline values|0
4752707|NCT01720069|16397350|P1|Overall Study|Randomised without baseline values|0
4752708|NCT01720069|16397348|P3|Overall Study|Could not use e-diary correctly|1
4752709|NCT01720069|16397349|P2|Overall Study|Could not use e-diary correctly|1
4752710|NCT01720069|16397350|P1|Overall Study|Could not use e-diary correctly|0
4752711|NCT01720043|16397376|P1|Overall Study|Withdrawal by Subject|1
4752712|NCT01719861|16397405|P1|Cycle 2|Death|1
4752713|NCT01719861|16397405|P1|Cycle 1|Death|4
4752714|NCT01719783|16397415|P2|Dose 2|Physician Decision|0
4752715|NCT01719783|16397416|P1|Dose 2|Physician Decision|1
4752716|NCT01719757|16397502|P1|Overall Study|well controlled pain|27
4752717|NCT01719757|16397502|P1|Overall Study|Protocol Violation|1
4752718|NCT01719757|16397502|P1|Overall Study|Lost to Follow-up|20
4752719|NCT01719757|16397502|P1|Overall Study|Withdrawal by Subject|15
4752720|NCT01719757|16397502|P1|Overall Study|Adverse Event|38
4752721|NCT01719224|16397556|P2|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2
4752722|NCT01719224|16397557|P1|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4
4752723|NCT01719172|16397566|P1|Overall Study|Death|1
4752724|NCT01719172|16397566|P1|Overall Study|Lost to Follow-up|1
4752725|NCT01719003|16397580|P9|Overall Study|Lack of Efficacy|0
4752726|NCT01719003|16397581|P8|Overall Study|Lack of Efficacy|0
4752727|NCT01719003|16397582|P7|Overall Study|Lack of Efficacy|1
4752728|NCT01719003|16397583|P6|Overall Study|Lack of Efficacy|0
4752729|NCT01719003|16397584|P5|Overall Study|Lack of Efficacy|0
4752730|NCT01719003|16397585|P4|Overall Study|Lack of Efficacy|0
4752731|NCT01719003|16397586|P3|Overall Study|Lack of Efficacy|0
4752732|NCT01719003|16397587|P2|Overall Study|Lack of Efficacy|0
4752733|NCT01719003|16397588|P1|Overall Study|Lack of Efficacy|0
4752734|NCT01719003|16397580|P9|Overall Study|Reason other than those specified|1
4752735|NCT01719003|16397581|P8|Overall Study|Reason other than those specified|3
4752736|NCT01719003|16397582|P7|Overall Study|Reason other than those specified|0
4752737|NCT01719003|16397583|P6|Overall Study|Reason other than those specified|1
4752738|NCT01719003|16397584|P5|Overall Study|Reason other than those specified|4
4752739|NCT01719003|16397585|P4|Overall Study|Reason other than those specified|3
4752740|NCT01719003|16397586|P3|Overall Study|Reason other than those specified|2
4752741|NCT01719003|16397587|P2|Overall Study|Reason other than those specified|0
4752742|NCT01719003|16397588|P1|Overall Study|Reason other than those specified|0
4752743|NCT01719003|16397580|P9|Overall Study|Refusal to continue, not due to AE|1
4752744|NCT01719003|16397581|P8|Overall Study|Refusal to continue, not due to AE|7
4752745|NCT01719003|16397582|P7|Overall Study|Refusal to continue, not due to AE|8
4752746|NCT01719003|16397583|P6|Overall Study|Refusal to continue, not due to AE|3
4752747|NCT01719003|16397584|P5|Overall Study|Refusal to continue, not due to AE|4
4752748|NCT01719003|16397585|P4|Overall Study|Refusal to continue, not due to AE|4
4752749|NCT01719003|16397586|P3|Overall Study|Refusal to continue, not due to AE|4
4752750|NCT01719003|16397587|P2|Overall Study|Refusal to continue, not due to AE|5
4752751|NCT01719003|16397588|P1|Overall Study|Refusal to continue, not due to AE|2
4752752|NCT01719003|16397580|P9|Overall Study|Lost to Follow-up|2
4752753|NCT01719003|16397581|P8|Overall Study|Lost to Follow-up|2
4752754|NCT01719003|16397582|P7|Overall Study|Lost to Follow-up|3
4752755|NCT01719003|16397583|P6|Overall Study|Lost to Follow-up|4
4752756|NCT01719003|16397584|P5|Overall Study|Lost to Follow-up|3
4752757|NCT01719003|16397585|P4|Overall Study|Lost to Follow-up|2
4752758|NCT01719003|16397586|P3|Overall Study|Lost to Follow-up|7
4752759|NCT01719003|16397587|P2|Overall Study|Lost to Follow-up|6
4752760|NCT01719003|16397588|P1|Overall Study|Lost to Follow-up|0
4752761|NCT01719003|16397580|P9|Overall Study|Adverse Event|0
4752762|NCT01719003|16397581|P8|Overall Study|Adverse Event|5
4752763|NCT01719003|16397582|P7|Overall Study|Adverse Event|6
4752764|NCT01719003|16397583|P6|Overall Study|Adverse Event|3
4752765|NCT01719003|16397584|P5|Overall Study|Adverse Event|4
4752766|NCT01719003|16397585|P4|Overall Study|Adverse Event|3
4752767|NCT01719003|16397586|P3|Overall Study|Adverse Event|4
4752768|NCT01719003|16397587|P2|Overall Study|Adverse Event|5
4752769|NCT01719003|16397588|P1|Overall Study|Adverse Event|6
4752770|NCT01719003|16397580|P9|Overall Study|Non compliant with protocol|0
4752771|NCT01719003|16397581|P8|Overall Study|Non compliant with protocol|3
4752772|NCT01719003|16397582|P7|Overall Study|Non compliant with protocol|2
4752773|NCT01719003|16397583|P6|Overall Study|Non compliant with protocol|1
4752774|NCT01719003|16397584|P5|Overall Study|Non compliant with protocol|2
4752775|NCT01719003|16397585|P4|Overall Study|Non compliant with protocol|1
4752776|NCT01719003|16397586|P3|Overall Study|Non compliant with protocol|0
4752777|NCT01719003|16397587|P2|Overall Study|Non compliant with protocol|1
4752778|NCT01719003|16397588|P1|Overall Study|Non compliant with protocol|1
4752779|NCT01718535|16397669|P10|Overall Study|Bidirectional Sequencing not possible|0
4752780|NCT01718535|16397670|P9|Overall Study|Bidirectional Sequencing not possible|0
4752781|NCT01718535|16397671|P8|Overall Study|Bidirectional Sequencing not possible|0
4752782|NCT01718535|16397672|P7|Overall Study|Bidirectional Sequencing not possible|0
4752783|NCT01718535|16397673|P6|Overall Study|Bidirectional Sequencing not possible|0
4752784|NCT01718535|16397674|P5|Overall Study|Bidirectional Sequencing not possible|0
4752785|NCT01718535|16397675|P4|Overall Study|Bidirectional Sequencing not possible|1
4752786|NCT01718535|16397676|P3|Overall Study|Bidirectional Sequencing not possible|0
4752787|NCT01718535|16397677|P2|Overall Study|Bidirectional Sequencing not possible|0
4752788|NCT01718535|16397678|P1|Overall Study|Bidirectional Sequencing not possible|1
4752789|NCT01718509|16397716|P2|Overall Study|Lack of Efficacy|0
4752790|NCT01718509|16397717|P1|Overall Study|Lack of Efficacy|1
4752791|NCT01718509|16397716|P2|Overall Study|Protocol Violation|2
4752792|NCT01718509|16397717|P1|Overall Study|Protocol Violation|4
4752793|NCT01718509|16397716|P2|Overall Study|Other|11
4752794|NCT01718509|16397717|P1|Overall Study|Other|13
4752795|NCT01718509|16397716|P2|Overall Study|Adverse Event|7
4752796|NCT01718509|16397717|P1|Overall Study|Adverse Event|5
4752797|NCT01718509|16397716|P2|Overall Study|Withdrawal by Subject|13
4752798|NCT01718509|16397717|P1|Overall Study|Withdrawal by Subject|7
4752799|NCT01718509|16397716|P2|Overall Study|Lost to Follow-up|15
4752800|NCT01718509|16397717|P1|Overall Study|Lost to Follow-up|18
4752801|NCT01718483|16397763|P2|Overall Study|Lack of Efficacy|0
4752802|NCT01718483|16397764|P1|Overall Study|Lack of Efficacy|1
4752803|NCT01718483|16397763|P2|Overall Study|Pregnancy|1
4752804|NCT01718483|16397764|P1|Overall Study|Pregnancy|1
4752805|NCT01718483|16397763|P2|Overall Study|Other|4
4752806|NCT01718483|16397764|P1|Overall Study|Other|1
4752807|NCT01718483|16397763|P2|Overall Study|Protocol Violation|2
4752808|NCT01718483|16397764|P1|Overall Study|Protocol Violation|4
4752809|NCT01718483|16397763|P2|Overall Study|Lost to Follow-up|3
4752810|NCT01718483|16397764|P1|Overall Study|Lost to Follow-up|8
4752811|NCT01718483|16397763|P2|Overall Study|Adverse Event|12
4752812|NCT01718483|16397764|P1|Overall Study|Adverse Event|5
4752813|NCT01718483|16397763|P2|Overall Study|Withdrawal by Subject|12
4752814|NCT01718483|16397764|P1|Overall Study|Withdrawal by Subject|14
4752815|NCT01718353|16397819|P2|Overall Study|Randomized but not treated|0
4752816|NCT01718353|16397820|P1|Overall Study|Randomized but not treated|2
4752817|NCT01718353|16397819|P2|Overall Study|Principal Investigator's Decision|4
4752818|NCT01718353|16397820|P1|Overall Study|Principal Investigator's Decision|10
4752819|NCT01718353|16397819|P2|Overall Study|Lost to Follow-up|1
4752820|NCT01718353|16397820|P1|Overall Study|Lost to Follow-up|0
4752821|NCT01717989|16397851|P1|Overall Study|Other|40
4752822|NCT01717989|16397851|P1|Overall Study|Protocol-specified criteria|551
4752823|NCT01717989|16397851|P1|Overall Study|Death|439
4752824|NCT01717989|16397851|P1|Overall Study|Lost to Follow-up|11
4752825|NCT01717989|16397851|P1|Overall Study|Physician Decision|2
4752826|NCT01717989|16397851|P1|Overall Study|Withdrawal by Subject|11
4752827|NCT01717989|16397851|P1|Overall Study|Protocol deviation|6
4752828|NCT01717989|16397851|P1|Overall Study|Ineligibility determined|6
4752829|NCT01717976|16397919|P2|Overall Study|Protocol Violation|1
4752830|NCT01717976|16397920|P1|Overall Study|Protocol Violation|0
4752831|NCT01717859|16397975|P1|Overall Study|Withdrawal by Subject|2
4752832|NCT01717859|16397975|P1|Overall Study|Lost to Follow-up|1
4752833|NCT01717859|16397975|P1|Overall Study|Patient concerned about mental health|1
4752834|NCT01717859|16397975|P1|Overall Study|Moved out of state|1
4752835|NCT01717859|16397975|P1|Overall Study|Adverse Event|5
4752836|NCT01717768|16397996|P12|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752837|NCT01717768|16397997|P11|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752838|NCT01717768|16397998|P10|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1
4752839|NCT01717768|16397999|P9|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752840|NCT01717768|16398000|P8|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752841|NCT01717768|16398001|P7|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752842|NCT01717768|16398002|P6|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752843|NCT01717768|16398003|P5|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752844|NCT01717768|16398004|P4|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752845|NCT01717768|16398005|P3|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752846|NCT01717768|16398006|P2|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752847|NCT01717768|16398007|P1|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0
4752848|NCT01717768|16397996|P12|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752849|NCT01717768|16397997|P11|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752850|NCT01717768|16397998|P10|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752851|NCT01717768|16397999|P9|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752852|NCT01717768|16398000|P8|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2
4752853|NCT01717768|16398001|P7|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752854|NCT01717768|16398002|P6|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752855|NCT01717768|16398003|P5|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752856|NCT01717768|16398004|P4|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752857|NCT01717768|16398005|P3|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752858|NCT01717768|16398006|P2|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752859|NCT01717768|16398007|P1|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0
4752860|NCT01717768|16397996|P12|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1
4752861|NCT01717768|16397997|P11|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752862|NCT01717768|16397998|P10|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752863|NCT01717768|16397999|P9|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752864|NCT01717768|16398000|P8|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752865|NCT01717768|16398001|P7|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752866|NCT01717768|16398002|P6|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752867|NCT01717768|16398003|P5|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752868|NCT01717768|16398004|P4|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752869|NCT01717768|16398005|P3|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752870|NCT01717768|16398006|P2|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752871|NCT01717768|16398007|P1|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0
4752872|NCT01717768|16397996|P12|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752873|NCT01717768|16397997|P11|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752874|NCT01717768|16397998|P10|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752875|NCT01717768|16397999|P9|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752876|NCT01717768|16398000|P8|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752877|NCT01717768|16398001|P7|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752878|NCT01717768|16398002|P6|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752879|NCT01717768|16398003|P5|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752880|NCT01717768|16398004|P4|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752881|NCT01717768|16398005|P3|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752882|NCT01717768|16398006|P2|Part 1 (Duration of 15 Days)|Lost to Follow-up|1
4752883|NCT01717768|16398007|P1|Part 1 (Duration of 15 Days)|Lost to Follow-up|0
4752884|NCT01717638|16398087|P13|Overall Study|Withdrawal by Subject|18
4752885|NCT01717638|16398088|P12|Overall Study|Withdrawal by Subject|0
4752886|NCT01717638|16398089|P11|Overall Study|Withdrawal by Subject|0
4752887|NCT01717638|16398090|P10|Overall Study|Withdrawal by Subject|1
4752888|NCT01717638|16398091|P9|Overall Study|Withdrawal by Subject|2
4752889|NCT01717638|16398092|P8|Overall Study|Withdrawal by Subject|1
4752890|NCT01717638|16398093|P7|Overall Study|Withdrawal by Subject|2
4752891|NCT01717638|16398094|P6|Overall Study|Withdrawal by Subject|0
4752892|NCT01717638|16398095|P5|Overall Study|Withdrawal by Subject|1
4752893|NCT01717638|16398096|P4|Overall Study|Withdrawal by Subject|0
4752894|NCT01717638|16398097|P3|Overall Study|Withdrawal by Subject|1
4752895|NCT01717638|16398098|P2|Overall Study|Withdrawal by Subject|1
4752896|NCT01717638|16398099|P1|Overall Study|Withdrawal by Subject|0
4752897|NCT01717638|16398087|P13|Overall Study|Father in hospital|1
4752898|NCT01717638|16398088|P12|Overall Study|Father in hospital|0
4752899|NCT01717638|16398089|P11|Overall Study|Father in hospital|0
4752900|NCT01717638|16398090|P10|Overall Study|Father in hospital|0
4752901|NCT01717638|16398091|P9|Overall Study|Father in hospital|0
4752902|NCT01717638|16398092|P8|Overall Study|Father in hospital|0
4752903|NCT01717638|16398093|P7|Overall Study|Father in hospital|0
4752904|NCT01717638|16398094|P6|Overall Study|Father in hospital|0
4752905|NCT01717638|16398095|P5|Overall Study|Father in hospital|0
4752906|NCT01717638|16398096|P4|Overall Study|Father in hospital|0
4752907|NCT01717638|16398097|P3|Overall Study|Father in hospital|0
4752908|NCT01717638|16398098|P2|Overall Study|Father in hospital|0
4752909|NCT01717638|16398099|P1|Overall Study|Father in hospital|0
4752910|NCT01717638|16398087|P13|Overall Study|Lost to Follow-up|0
4752911|NCT01717638|16398088|P12|Overall Study|Lost to Follow-up|0
4752912|NCT01717638|16398089|P11|Overall Study|Lost to Follow-up|0
4752913|NCT01717638|16398090|P10|Overall Study|Lost to Follow-up|0
4752914|NCT01717638|16398091|P9|Overall Study|Lost to Follow-up|0
4752915|NCT01717638|16398092|P8|Overall Study|Lost to Follow-up|0
4752916|NCT01717638|16398093|P7|Overall Study|Lost to Follow-up|0
4752917|NCT01717638|16398094|P6|Overall Study|Lost to Follow-up|1
4752918|NCT01717638|16398095|P5|Overall Study|Lost to Follow-up|0
4752919|NCT01717638|16398096|P4|Overall Study|Lost to Follow-up|0
4752920|NCT01717638|16398097|P3|Overall Study|Lost to Follow-up|0
4752921|NCT01717638|16398098|P2|Overall Study|Lost to Follow-up|0
4752922|NCT01717638|16398099|P1|Overall Study|Lost to Follow-up|0
4752923|NCT01717456|16398275|P2|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
4752924|NCT01717456|16398276|P1|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4
4752925|NCT01717456|16398275|P2|End of Treatment|Lost to Follow-up|1
4752926|NCT01717456|16398276|P1|End of Treatment|Lost to Follow-up|0
4752927|NCT01717456|16398275|P2|End of Treatment|Physician Decision|1
4752928|NCT01717456|16398276|P1|End of Treatment|Physician Decision|0
4752929|NCT01717391|16398344|P1|Overall Study|FLT technical failure|3
4752930|NCT01717391|16398344|P1|Overall Study|Physician Decision|1
4752931|NCT01717391|16398344|P1|Overall Study|Withdrawal by Subject|5
4752932|NCT01717326|16398373|P20|Overall Study|Withdrawal by Subject|3
4752933|NCT01717326|16398374|P19|Overall Study|Withdrawal by Subject|2
4752934|NCT01717326|16398375|P18|Overall Study|Withdrawal by Subject|0
4752935|NCT01717326|16398376|P17|Overall Study|Withdrawal by Subject|0
4752936|NCT01717326|16398377|P16|Overall Study|Withdrawal by Subject|1
4752937|NCT01717326|16398378|P15|Overall Study|Withdrawal by Subject|0
4752938|NCT01717326|16398379|P14|Overall Study|Withdrawal by Subject|0
4752939|NCT01717326|16398380|P13|Overall Study|Withdrawal by Subject|1
4752940|NCT01717326|16398381|P12|Overall Study|Withdrawal by Subject|0
4752941|NCT01717326|16398382|P11|Overall Study|Withdrawal by Subject|0
4752942|NCT01717326|16398383|P10|Overall Study|Withdrawal by Subject|1
4752943|NCT01717326|16398384|P9|Overall Study|Withdrawal by Subject|0
4752944|NCT01717326|16398385|P8|Overall Study|Withdrawal by Subject|0
4752945|NCT01717326|16398386|P7|Overall Study|Withdrawal by Subject|0
4752946|NCT01717326|16398387|P6|Overall Study|Withdrawal by Subject|0
4752947|NCT01717326|16398388|P5|Overall Study|Withdrawal by Subject|0
4752948|NCT01717326|16398389|P4|Overall Study|Withdrawal by Subject|0
4752949|NCT01717326|16398390|P3|Overall Study|Withdrawal by Subject|0
4752950|NCT01717326|16398391|P2|Overall Study|Withdrawal by Subject|1
4752951|NCT01717326|16398392|P1|Overall Study|Withdrawal by Subject|0
4752952|NCT01717326|16398373|P20|Overall Study|Protocol Violation|0
4752953|NCT01717326|16398374|P19|Overall Study|Protocol Violation|0
4752954|NCT01717326|16398375|P18|Overall Study|Protocol Violation|0
4752955|NCT01717326|16398376|P17|Overall Study|Protocol Violation|0
4752956|NCT01717326|16398377|P16|Overall Study|Protocol Violation|0
4752957|NCT01717326|16398378|P15|Overall Study|Protocol Violation|0
4752958|NCT01717326|16398379|P14|Overall Study|Protocol Violation|0
4752959|NCT01717326|16398380|P13|Overall Study|Protocol Violation|0
4752960|NCT01717326|16398381|P12|Overall Study|Protocol Violation|0
4752961|NCT01717326|16398382|P11|Overall Study|Protocol Violation|0
4752962|NCT01717326|16398383|P10|Overall Study|Protocol Violation|0
4752963|NCT01717326|16398384|P9|Overall Study|Protocol Violation|0
4752964|NCT01717326|16398385|P8|Overall Study|Protocol Violation|0
4752965|NCT01717326|16398386|P7|Overall Study|Protocol Violation|0
4752966|NCT01717326|16398387|P6|Overall Study|Protocol Violation|0
4752967|NCT01717326|16398388|P5|Overall Study|Protocol Violation|1
4752968|NCT01717326|16398389|P4|Overall Study|Protocol Violation|0
4752969|NCT01717326|16398390|P3|Overall Study|Protocol Violation|0
4752970|NCT01717326|16398391|P2|Overall Study|Protocol Violation|0
4752971|NCT01717326|16398392|P1|Overall Study|Protocol Violation|0
4752972|NCT01717326|16398373|P20|Overall Study|Physician Decision|0
4752973|NCT01717326|16398374|P19|Overall Study|Physician Decision|0
4752974|NCT01717326|16398375|P18|Overall Study|Physician Decision|0
4752975|NCT01717326|16398376|P17|Overall Study|Physician Decision|0
4752976|NCT01717326|16398377|P16|Overall Study|Physician Decision|0
4752977|NCT01717326|16398378|P15|Overall Study|Physician Decision|0
4752978|NCT01717326|16398379|P14|Overall Study|Physician Decision|0
4752979|NCT01717326|16398380|P13|Overall Study|Physician Decision|0
4752980|NCT01717326|16398381|P12|Overall Study|Physician Decision|0
4752981|NCT01717326|16398382|P11|Overall Study|Physician Decision|0
4752982|NCT01717326|16398383|P10|Overall Study|Physician Decision|1
4752983|NCT01717326|16398384|P9|Overall Study|Physician Decision|0
4752984|NCT01717326|16398385|P8|Overall Study|Physician Decision|0
4752985|NCT01717326|16398386|P7|Overall Study|Physician Decision|0
4752986|NCT01717326|16398387|P6|Overall Study|Physician Decision|0
4752987|NCT01717326|16398388|P5|Overall Study|Physician Decision|0
4752988|NCT01717326|16398389|P4|Overall Study|Physician Decision|0
4752989|NCT01717326|16398390|P3|Overall Study|Physician Decision|0
4752990|NCT01717326|16398391|P2|Overall Study|Physician Decision|0
4752991|NCT01717326|16398392|P1|Overall Study|Physician Decision|0
4752992|NCT01717326|16398373|P20|Overall Study|Lost to Follow-up|3
4752993|NCT01717326|16398374|P19|Overall Study|Lost to Follow-up|2
4752994|NCT01717326|16398375|P18|Overall Study|Lost to Follow-up|0
4752995|NCT01717326|16398376|P17|Overall Study|Lost to Follow-up|1
4752996|NCT01717326|16398377|P16|Overall Study|Lost to Follow-up|2
4752997|NCT01717326|16398378|P15|Overall Study|Lost to Follow-up|0
4752998|NCT01717326|16398379|P14|Overall Study|Lost to Follow-up|0
4752999|NCT01717326|16398380|P13|Overall Study|Lost to Follow-up|0
4753000|NCT01717326|16398381|P12|Overall Study|Lost to Follow-up|0
4753001|NCT01717326|16398382|P11|Overall Study|Lost to Follow-up|1
4753002|NCT01717326|16398383|P10|Overall Study|Lost to Follow-up|0
4753003|NCT01717326|16398384|P9|Overall Study|Lost to Follow-up|0
4753004|NCT01717326|16398385|P8|Overall Study|Lost to Follow-up|0
4753005|NCT01717326|16398386|P7|Overall Study|Lost to Follow-up|1
4753006|NCT01717326|16398387|P6|Overall Study|Lost to Follow-up|0
4753007|NCT01717326|16398388|P5|Overall Study|Lost to Follow-up|1
4753008|NCT01717326|16398389|P4|Overall Study|Lost to Follow-up|2
4753009|NCT01717326|16398390|P3|Overall Study|Lost to Follow-up|0
4753010|NCT01717326|16398391|P2|Overall Study|Lost to Follow-up|0
4753011|NCT01717326|16398392|P1|Overall Study|Lost to Follow-up|3
4753012|NCT01717326|16398373|P20|Overall Study|Death|0
4753013|NCT01717326|16398374|P19|Overall Study|Death|0
4753014|NCT01717326|16398375|P18|Overall Study|Death|0
4753015|NCT01717326|16398376|P17|Overall Study|Death|0
4753016|NCT01717326|16398377|P16|Overall Study|Death|0
4753017|NCT01717326|16398378|P15|Overall Study|Death|0
4753018|NCT01717326|16398379|P14|Overall Study|Death|0
4753019|NCT01717326|16398380|P13|Overall Study|Death|0
4753020|NCT01717326|16398381|P12|Overall Study|Death|0
4753021|NCT01717326|16398382|P11|Overall Study|Death|1
4753022|NCT01717326|16398383|P10|Overall Study|Death|0
4753023|NCT01717326|16398384|P9|Overall Study|Death|0
4753024|NCT01717326|16398385|P8|Overall Study|Death|0
4753025|NCT01717326|16398386|P7|Overall Study|Death|0
4753026|NCT01717326|16398387|P6|Overall Study|Death|0
4753027|NCT01717326|16398388|P5|Overall Study|Death|0
4753028|NCT01717326|16398389|P4|Overall Study|Death|0
4753029|NCT01717326|16398390|P3|Overall Study|Death|0
4753030|NCT01717326|16398391|P2|Overall Study|Death|0
4753031|NCT01717326|16398392|P1|Overall Study|Death|0
4753032|NCT01717313|16398656|P2|Phase B (Weeks 24 to 54)|Lost to Follow-up|3
4753033|NCT01717313|16398657|P1|Phase B (Weeks 24 to 54)|Lost to Follow-up|1
4753034|NCT01717313|16398656|P2|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9
4753035|NCT01717313|16398657|P1|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7
4753036|NCT01717313|16398656|P2|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
4753037|NCT01717313|16398657|P1|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4
4753038|NCT01717313|16398656|P2|Interphase|Completed Phase A Did Not Enter Phase B|0
4753039|NCT01717313|16398657|P1|Interphase|Completed Phase A Did Not Enter Phase B|1
4753040|NCT01717313|16398656|P2|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
4753041|NCT01717313|16398657|P1|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1
4753042|NCT01717313|16398656|P2|Phase A (Weeks 0 to 24)|Adverse Event|2
4753043|NCT01717313|16398657|P1|Phase A (Weeks 0 to 24)|Adverse Event|4
4753044|NCT01717313|16398656|P2|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6
4753045|NCT01717313|16398657|P1|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12
4753046|NCT01717313|16398656|P2|Phase A (Weeks 0 to 24)|Lost to Follow-up|3
4753047|NCT01717313|16398657|P1|Phase A (Weeks 0 to 24)|Lost to Follow-up|1
4753048|NCT01717313|16398656|P2|Phase A (Weeks 0 to 24)|Death|1
4753049|NCT01717313|16398657|P1|Phase A (Weeks 0 to 24)|Death|0
4753050|NCT01717287|16398695|P2|Overall Study|Protocol Violation|1
4753051|NCT01717287|16398696|P1|Overall Study|Protocol Violation|0
4753052|NCT01717287|16398695|P2|Overall Study|Lost to Follow-up|2
4753053|NCT01717287|16398696|P1|Overall Study|Lost to Follow-up|0
4753054|NCT01717040|16398736|P2|Overall Study|New Substance Use Disorder|0
4753055|NCT01717040|16398737|P1|Overall Study|New Substance Use Disorder|1
4753056|NCT01717040|16398736|P2|Overall Study|Required Medication Change|1
4753057|NCT01717040|16398737|P1|Overall Study|Required Medication Change|0
4753058|NCT01717040|16398736|P2|Overall Study|Adverse Event|0
4753059|NCT01717040|16398737|P1|Overall Study|Adverse Event|1
4753060|NCT01717040|16398736|P2|Overall Study|Lack of Efficacy|1
4753061|NCT01717040|16398737|P1|Overall Study|Lack of Efficacy|1
4753062|NCT01717040|16398736|P2|Overall Study|Lost to Follow-up|3
4753063|NCT01717040|16398737|P1|Overall Study|Lost to Follow-up|2
4753064|NCT01716754|16398755|P4|Overall Study|Withdrawal by Subject|3
4753065|NCT01716754|16398756|P3|Overall Study|Withdrawal by Subject|4
4753066|NCT01716754|16398757|P2|Overall Study|Withdrawal by Subject|0
4753067|NCT01716754|16398758|P1|Overall Study|Withdrawal by Subject|5
4753068|NCT01716754|16398755|P4|Overall Study|Adverse Event|1
4753069|NCT01716754|16398756|P3|Overall Study|Adverse Event|2
4753070|NCT01716754|16398757|P2|Overall Study|Adverse Event|2
4753071|NCT01716754|16398758|P1|Overall Study|Adverse Event|4
4753072|NCT01716754|16398755|P4|Overall Study|Lost to Follow-up|1
4753073|NCT01716754|16398756|P3|Overall Study|Lost to Follow-up|0
4753074|NCT01716754|16398757|P2|Overall Study|Lost to Follow-up|0
4753075|NCT01716754|16398758|P1|Overall Study|Lost to Follow-up|1
4753076|NCT01716754|16398755|P4|Overall Study|Physician Decision|0
4753077|NCT01716754|16398756|P3|Overall Study|Physician Decision|0
4753078|NCT01716754|16398757|P2|Overall Study|Physician Decision|0
4753079|NCT01716754|16398758|P1|Overall Study|Physician Decision|1
4753080|NCT01716754|16398755|P4|Overall Study|Non-compliance with study treatment|0
4753081|NCT01716754|16398756|P3|Overall Study|Non-compliance with study treatment|1
4753082|NCT01716754|16398757|P2|Overall Study|Non-compliance with study treatment|0
4753083|NCT01716754|16398758|P1|Overall Study|Non-compliance with study treatment|0
4753084|NCT01716754|16398755|P4|Overall Study|Protocol deviation|2
4753085|NCT01716754|16398756|P3|Overall Study|Protocol deviation|7
4753086|NCT01716754|16398757|P2|Overall Study|Protocol deviation|2
4753087|NCT01716754|16398758|P1|Overall Study|Protocol deviation|0
4753088|NCT01716754|16398755|P4|Overall Study|Death|1
4753089|NCT01716754|16398756|P3|Overall Study|Death|0
4753090|NCT01716754|16398757|P2|Overall Study|Death|0
4753091|NCT01716754|16398758|P1|Overall Study|Death|0
4753092|NCT01716715|16398781|P2|Overall Study|Never Treated|4
4753093|NCT01716715|16398782|P1|Overall Study|Never Treated|2
4753094|NCT01716663|16398798|P1|Overall Study|Treated with non-study catheter|2
4753095|NCT01716663|16398798|P1|Overall Study|Withdrawn prior to procedure|4
4753096|NCT01716585|16398808|P2|Open-label Treatment|Withdrawal by Subject|3
4753097|NCT01716585|16398809|P1|Open-label Treatment|Withdrawal by Subject|0
4753098|NCT01716585|16398808|P2|Open-label Treatment|Virologic Failure|2
4753099|NCT01716585|16398809|P1|Open-label Treatment|Virologic Failure|0
4753100|NCT01716585|16398808|P2|Open-label Treatment|Adverse Event|2
4753101|NCT01716585|16398809|P1|Open-label Treatment|Adverse Event|0
4753102|NCT01716585|16398808|P2|Double-blind Treatment|Other|0
4753103|NCT01716585|16398809|P1|Double-blind Treatment|Other|1
4753104|NCT01716585|16398808|P2|Double-blind Treatment|Subject Noncompliant|0
4753105|NCT01716585|16398809|P1|Double-blind Treatment|Subject Noncompliant|1
4753106|NCT01716585|16398808|P2|Double-blind Treatment|Lost to Follow-up|0
4753107|NCT01716585|16398809|P1|Double-blind Treatment|Lost to Follow-up|2
4753108|NCT01716585|16398808|P2|Double-blind Treatment|Withdrawal by Subject|0
4753109|NCT01716585|16398809|P1|Double-blind Treatment|Withdrawal by Subject|3
4753110|NCT01716585|16398808|P2|Double-blind Treatment|Adverse Event|1
4753111|NCT01716585|16398809|P1|Double-blind Treatment|Adverse Event|2
4753112|NCT01716585|16398808|P2|Double-blind Treatment|Did Not Receive Study Drug|1
4753113|NCT01716585|16398809|P1|Double-blind Treatment|Did Not Receive Study Drug|4
4753114|NCT01716559|16398821|P1|Overall Study|Other withdrawal reason|75
4753115|NCT01716559|16398821|P1|Overall Study|Withdrawal by Subject|4
4753116|NCT01716559|16398821|P1|Overall Study|Death|21
4753117|NCT01716559|16398821|P1|Overall Study|Adverse Event|11
4753118|NCT01716533|16398833|P4|Overall Study|Immunosuppressants>14days past 6months|1
4753119|NCT01716533|16398834|P3|Overall Study|Immunosuppressants>14days past 6months|0
4753120|NCT01716533|16398835|P2|Overall Study|Immunosuppressants>14days past 6months|0
4753121|NCT01716533|16398836|P1|Overall Study|Immunosuppressants>14days past 6months|0
4753122|NCT01716533|16398833|P4|Overall Study|Death|2
4753123|NCT01716533|16398834|P3|Overall Study|Death|0
4753124|NCT01716533|16398835|P2|Overall Study|Death|0
4753125|NCT01716533|16398836|P1|Overall Study|Death|0
4753126|NCT01716533|16398833|P4|Overall Study|Withdrawal by Subject|5
4753127|NCT01716533|16398834|P3|Overall Study|Withdrawal by Subject|0
4753128|NCT01716533|16398835|P2|Overall Study|Withdrawal by Subject|0
4753129|NCT01716533|16398836|P1|Overall Study|Withdrawal by Subject|0
4753130|NCT01716533|16398833|P4|Overall Study|Failure of antibiotic treatment to treat|0
4753131|NCT01716533|16398834|P3|Overall Study|Failure of antibiotic treatment to treat|5
4753132|NCT01716533|16398835|P2|Overall Study|Failure of antibiotic treatment to treat|0
4753133|NCT01716533|16398836|P1|Overall Study|Failure of antibiotic treatment to treat|0
4753134|NCT01716520|16398890|P6|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4753135|NCT01716520|16398891|P5|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4753136|NCT01716520|16398892|P4|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4753137|NCT01716520|16398893|P3|Treatment Period 3 (14 Days)|Withdrawal by Subject|1
4753138|NCT01716520|16398894|P2|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4753139|NCT01716520|16398895|P1|Treatment Period 3 (14 Days)|Withdrawal by Subject|0
4753140|NCT01716520|16398890|P6|Treatment Period 3 (14 Days)|Lack of Efficacy|2
4753141|NCT01716520|16398891|P5|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4753142|NCT01716520|16398892|P4|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4753143|NCT01716520|16398893|P3|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4753144|NCT01716520|16398894|P2|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4753145|NCT01716520|16398895|P1|Treatment Period 3 (14 Days)|Lack of Efficacy|0
4753146|NCT01716520|16398890|P6|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4753147|NCT01716520|16398891|P5|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4753148|NCT01716520|16398892|P4|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4753149|NCT01716520|16398893|P3|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4753150|NCT01716520|16398894|P2|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1
4753151|NCT01716520|16398895|P1|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0
4753152|NCT01716520|16398890|P6|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1
4753153|NCT01716520|16398891|P5|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4753154|NCT01716520|16398892|P4|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4753155|NCT01716520|16398893|P3|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4753156|NCT01716520|16398894|P2|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4753157|NCT01716520|16398895|P1|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0
4753158|NCT01716520|16398890|P6|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4753159|NCT01716520|16398891|P5|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4753160|NCT01716520|16398892|P4|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4753161|NCT01716520|16398893|P3|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4753162|NCT01716520|16398894|P2|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0
4753163|NCT01716520|16398895|P1|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1
4753164|NCT01716520|16398890|P6|Washout Period 2 (10 to 14 Days)|Adverse Event|1
4753165|NCT01716520|16398891|P5|Washout Period 2 (10 to 14 Days)|Adverse Event|0
4753166|NCT01716520|16398892|P4|Washout Period 2 (10 to 14 Days)|Adverse Event|0
4753167|NCT01716520|16398893|P3|Washout Period 2 (10 to 14 Days)|Adverse Event|1
4753168|NCT01716520|16398894|P2|Washout Period 2 (10 to 14 Days)|Adverse Event|0
4753169|NCT01716520|16398895|P1|Washout Period 2 (10 to 14 Days)|Adverse Event|1
4753170|NCT01716520|16398890|P6|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4753171|NCT01716520|16398891|P5|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4753249|NCT01716234|16398954|P3|Overall Study|Lack of Efficacy|0
4753172|NCT01716520|16398892|P4|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1
4753173|NCT01716520|16398893|P3|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4753174|NCT01716520|16398894|P2|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4753175|NCT01716520|16398895|P1|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0
4753176|NCT01716520|16398890|P6|Treatment Period 2 (14 Days)|Protocol Violation|0
4753177|NCT01716520|16398891|P5|Treatment Period 2 (14 Days)|Protocol Violation|1
4753178|NCT01716520|16398892|P4|Treatment Period 2 (14 Days)|Protocol Violation|0
4753179|NCT01716520|16398893|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
4753180|NCT01716520|16398894|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
4753181|NCT01716520|16398895|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
4753182|NCT01716520|16398890|P6|Treatment Period 2 (14 Days)|Adverse Event|0
4753183|NCT01716520|16398891|P5|Treatment Period 2 (14 Days)|Adverse Event|1
4753184|NCT01716520|16398892|P4|Treatment Period 2 (14 Days)|Adverse Event|0
4753185|NCT01716520|16398893|P3|Treatment Period 2 (14 Days)|Adverse Event|0
4753186|NCT01716520|16398894|P2|Treatment Period 2 (14 Days)|Adverse Event|0
4753187|NCT01716520|16398895|P1|Treatment Period 2 (14 Days)|Adverse Event|0
4753188|NCT01716520|16398890|P6|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
4753189|NCT01716520|16398891|P5|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4753190|NCT01716520|16398892|P4|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4753191|NCT01716520|16398893|P3|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1
4753192|NCT01716520|16398894|P2|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4753193|NCT01716520|16398895|P1|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0
4753194|NCT01716520|16398890|P6|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1
4753195|NCT01716520|16398891|P5|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4753196|NCT01716520|16398892|P4|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4753197|NCT01716520|16398893|P3|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4753198|NCT01716520|16398894|P2|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4753199|NCT01716520|16398895|P1|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0
4753200|NCT01716520|16398890|P6|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4753201|NCT01716520|16398891|P5|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4753202|NCT01716520|16398892|P4|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4753203|NCT01716520|16398893|P3|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4753204|NCT01716520|16398894|P2|Washout Period 1 (10 to 14 Days)|Adverse Event|1
4753205|NCT01716520|16398895|P1|Washout Period 1 (10 to 14 Days)|Adverse Event|0
4753206|NCT01716520|16398890|P6|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4753207|NCT01716520|16398891|P5|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4753208|NCT01716520|16398892|P4|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4753209|NCT01716520|16398893|P3|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4753210|NCT01716520|16398894|P2|Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4753211|NCT01716520|16398895|P1|Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4753212|NCT01716520|16398890|P6|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
4753213|NCT01716520|16398891|P5|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
4753214|NCT01716520|16398892|P4|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
4753215|NCT01716520|16398893|P3|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2
4753216|NCT01716520|16398894|P2|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0
4753217|NCT01716520|16398895|P1|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1
4753218|NCT01716520|16398890|P6|Treatment Period 1 (14 Days)|Adverse Event|0
4753219|NCT01716520|16398891|P5|Treatment Period 1 (14 Days)|Adverse Event|0
4753220|NCT01716520|16398892|P4|Treatment Period 1 (14 Days)|Adverse Event|0
4753221|NCT01716520|16398893|P3|Treatment Period 1 (14 Days)|Adverse Event|0
4753222|NCT01716520|16398894|P2|Treatment Period 1 (14 Days)|Adverse Event|0
4753223|NCT01716520|16398895|P1|Treatment Period 1 (14 Days)|Adverse Event|1
4753224|NCT01716234|16398950|P7|Overall Study|Withdrawal by Subject|0
4753225|NCT01716234|16398951|P6|Overall Study|Withdrawal by Subject|3
4753226|NCT01716234|16398952|P5|Overall Study|Withdrawal by Subject|1
4753227|NCT01716234|16398953|P4|Overall Study|Withdrawal by Subject|2
4753228|NCT01716234|16398954|P3|Overall Study|Withdrawal by Subject|2
4753229|NCT01716234|16398955|P2|Overall Study|Withdrawal by Subject|0
4753230|NCT01716234|16398956|P1|Overall Study|Withdrawal by Subject|3
4753231|NCT01716234|16398950|P7|Overall Study|Adverse Event|0
4753232|NCT01716234|16398951|P6|Overall Study|Adverse Event|6
4753233|NCT01716234|16398952|P5|Overall Study|Adverse Event|3
4753234|NCT01716234|16398953|P4|Overall Study|Adverse Event|8
4753235|NCT01716234|16398954|P3|Overall Study|Adverse Event|2
4753236|NCT01716234|16398955|P2|Overall Study|Adverse Event|10
4753237|NCT01716234|16398956|P1|Overall Study|Adverse Event|7
4753238|NCT01716234|16398950|P7|Overall Study|Did not meet protocol eligibility|0
4753239|NCT01716234|16398951|P6|Overall Study|Did not meet protocol eligibility|4
4753240|NCT01716234|16398952|P5|Overall Study|Did not meet protocol eligibility|0
4753241|NCT01716234|16398953|P4|Overall Study|Did not meet protocol eligibility|0
4753242|NCT01716234|16398954|P3|Overall Study|Did not meet protocol eligibility|1
4753243|NCT01716234|16398955|P2|Overall Study|Did not meet protocol eligibility|0
4753244|NCT01716234|16398956|P1|Overall Study|Did not meet protocol eligibility|0
4753245|NCT01716234|16398950|P7|Overall Study|Lack of Efficacy|0
4753246|NCT01716234|16398951|P6|Overall Study|Lack of Efficacy|0
4753247|NCT01716234|16398952|P5|Overall Study|Lack of Efficacy|0
4753248|NCT01716234|16398953|P4|Overall Study|Lack of Efficacy|1
4753250|NCT01716234|16398955|P2|Overall Study|Lack of Efficacy|0
4753251|NCT01716234|16398956|P1|Overall Study|Lack of Efficacy|0
4753252|NCT01716234|16398950|P7|Overall Study|Protocol Violation|0
4753253|NCT01716234|16398951|P6|Overall Study|Protocol Violation|1
4753254|NCT01716234|16398952|P5|Overall Study|Protocol Violation|1
4753255|NCT01716234|16398953|P4|Overall Study|Protocol Violation|1
4753256|NCT01716234|16398954|P3|Overall Study|Protocol Violation|0
4753257|NCT01716234|16398955|P2|Overall Study|Protocol Violation|0
4753258|NCT01716234|16398956|P1|Overall Study|Protocol Violation|0
4753259|NCT01716169|16399019|P1|Overall Study|inconsistent dressing application|1
4753260|NCT01716169|16399019|P1|Overall Study|Withdrawal by Subject|1
4753261|NCT01716169|16399019|P1|Overall Study|Lost to Follow-up|1
4753262|NCT01716169|16399019|P1|Overall Study|Adverse Event|1
4753263|NCT01716156|16399028|P3|Overall Study|Lost to Follow-up|0
4753264|NCT01716156|16399029|P2|Overall Study|Lost to Follow-up|0
4753265|NCT01716156|16399030|P1|Overall Study|Lost to Follow-up|1
4753266|NCT01716156|16399028|P3|Overall Study|Withdrawal by Subject|2
4753267|NCT01716156|16399029|P2|Overall Study|Withdrawal by Subject|1
4753268|NCT01716156|16399030|P1|Overall Study|Withdrawal by Subject|0
4753269|NCT01716156|16399028|P3|Overall Study|Protocol Violation|0
4753270|NCT01716156|16399029|P2|Overall Study|Protocol Violation|0
4753271|NCT01716156|16399030|P1|Overall Study|Protocol Violation|1
4753272|NCT01716117|16399056|P2|Overall Study|Withdrawal by Subject|0
4753273|NCT01716117|16399057|P1|Overall Study|Withdrawal by Subject|2
4753274|NCT01716117|16399056|P2|Overall Study|Death|2
4753275|NCT01716117|16399057|P1|Overall Study|Death|5
4753276|NCT01716104|16399076|P2|Overall Study|Do not meet inclusion criteria|7
4753277|NCT01716104|16399077|P1|Overall Study|Do not meet inclusion criteria|6
4753278|NCT01716052|16399103|P2|Overall Study|Withdrawal of funding|1
4753279|NCT01716052|16399104|P1|Overall Study|Withdrawal of funding|1
4753280|NCT01715896|16399146|P2|Overall Study|Other|5
4753281|NCT01715896|16399147|P1|Overall Study|Other|2
4753282|NCT01715896|16399146|P2|Overall Study|Withdrawal by Subject|4
4753283|NCT01715896|16399147|P1|Overall Study|Withdrawal by Subject|1
4753284|NCT01715896|16399146|P2|Overall Study|Lost to Follow-up|2
4753285|NCT01715896|16399147|P1|Overall Study|Lost to Follow-up|0
4753286|NCT01715857|16399220|P1|Overall Study|Did Not Meet Eligibility Criteria|96
4753287|NCT01715831|16399230|P1|Overall Study|Adverse Event|1
4753288|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
4753289|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
4753290|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3
4753291|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0
4753292|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Other Reason Not Specified|3
4753293|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Other Reason Not Specified|0
4753294|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Other Reason Not Specified|1
4753295|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Other Reason Not Specified|0
4753296|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Lost to Follow-up|10
4753297|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Lost to Follow-up|10
4753298|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Lost to Follow-up|7
4753299|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Lost to Follow-up|0
4753300|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Withdrawal of consent|13
4753301|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Withdrawal of consent|11
4753302|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Withdrawal of consent|11
4753303|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Withdrawal of consent|0
4753304|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Protocol Violation|19
4753305|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Protocol Violation|12
4753306|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Protocol Violation|14
4753307|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Protocol Violation|0
4753308|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Adverse Event|2
4753309|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Adverse Event|23
4753310|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Adverse Event|3
4753311|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Adverse Event|0
4753312|NCT01715805|16399246|P4|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1
4753313|NCT01715805|16399247|P3|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
4753314|NCT01715805|16399248|P2|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
4753315|NCT01715805|16399249|P1|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0
4753316|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
4753317|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
4753318|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Other Reason Not Specified|0
4753319|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Other Reason Not Specified|10
4753320|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
4753321|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
4753322|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0
4753323|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1
4753324|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Lost to Follow-up|0
4753325|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Lost to Follow-up|0
4753326|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Lost to Follow-up|0
4753327|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Lost to Follow-up|34
4753328|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
4753329|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
4753330|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Withdrawal of Consent|0
4753331|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Withdrawal of Consent|49
4753332|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Protocol Violation|0
4753333|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Protocol Violation|0
4753334|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Protocol Violation|0
4753335|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Protocol Violation|74
4753336|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
4753337|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
4753338|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0
4753339|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6
4753340|NCT01715805|16399246|P4|Placebo + ADT Lead-in Period|Adverse Event|0
4753341|NCT01715805|16399247|P3|Placebo + ADT Lead-in Period|Adverse Event|0
4753342|NCT01715805|16399248|P2|Placebo + ADT Lead-in Period|Adverse Event|0
4753343|NCT01715805|16399249|P1|Placebo + ADT Lead-in Period|Adverse Event|41
4753344|NCT01715415|16399263|P2|Open-label Treatment|Subject Noncompliant|1
4753345|NCT01715415|16399264|P1|Open-label Treatment|Subject Noncompliant|0
4753346|NCT01715415|16399263|P2|Open-label Treatment|Adverse Event|1
4753347|NCT01715415|16399264|P1|Open-label Treatment|Adverse Event|0
4753348|NCT01715415|16399263|P2|Double-blind Treatment|Other|0
4753349|NCT01715415|16399264|P1|Double-blind Treatment|Other|1
4753350|NCT01715415|16399263|P2|Double-blind Treatment|Withdrawal by Subject|1
4753351|NCT01715415|16399264|P1|Double-blind Treatment|Withdrawal by Subject|1
4753352|NCT01715415|16399263|P2|Double-blind Treatment|Adverse Event|0
4753353|NCT01715415|16399264|P1|Double-blind Treatment|Adverse Event|3
4753354|NCT01715415|16399263|P2|Double-blind Treatment|Did Not Receive Study Drug|1
4753355|NCT01715415|16399264|P1|Double-blind Treatment|Did Not Receive Study Drug|0
4753356|NCT01715298|16399278|P2|Overall Study|Patient/guardian decision|9
4753357|NCT01715298|16399279|P1|Overall Study|Patient/guardian decision|7
4753358|NCT01715298|16399278|P2|Overall Study|Lost to Follow-up|2
4753359|NCT01715298|16399279|P1|Overall Study|Lost to Follow-up|0
4753360|NCT01715285|16399317|P3|Open-label (OL) Extension Phase|Ongoing|72
4753361|NCT01715285|16399318|P2|Open-label (OL) Extension Phase|Ongoing|0
4753362|NCT01715285|16399319|P1|Open-label (OL) Extension Phase|Ongoing|157
4753363|NCT01715285|16399317|P3|Treatment Period|Placebo Cross-over|0
4753364|NCT01715285|16399318|P2|Treatment Period|Placebo Cross-over|72
4753365|NCT01715285|16399319|P1|Treatment Period|Placebo Cross-over|0
4753366|NCT01715285|16399317|P3|Treatment Period|Other|0
4753367|NCT01715285|16399318|P2|Treatment Period|Other|12
4753368|NCT01715285|16399319|P1|Treatment Period|Other|10
4753369|NCT01715285|16399317|P3|Treatment Period|Ongoing|0
4753370|NCT01715285|16399318|P2|Treatment Period|Ongoing|0
4753371|NCT01715285|16399319|P1|Treatment Period|Ongoing|157
4753372|NCT01715285|16399317|P3|Treatment Period|Physician Decision|0
4753373|NCT01715285|16399318|P2|Treatment Period|Physician Decision|23
4753374|NCT01715285|16399319|P1|Treatment Period|Physician Decision|21
4753375|NCT01715285|16399317|P3|Treatment Period|Withdrawal Of Consent|0
4753376|NCT01715285|16399318|P2|Treatment Period|Withdrawal Of Consent|47
4753377|NCT01715285|16399319|P1|Treatment Period|Withdrawal Of Consent|52
4753378|NCT01715285|16399317|P3|Treatment Period|Progressive Disease|0
4753379|NCT01715285|16399318|P2|Treatment Period|Progressive Disease|388
4753380|NCT01715285|16399319|P1|Treatment Period|Progressive Disease|254
4753381|NCT01715285|16399317|P3|Treatment Period|Noncompliance With Study Drug|0
4753382|NCT01715285|16399318|P2|Treatment Period|Noncompliance With Study Drug|2
4753383|NCT01715285|16399319|P1|Treatment Period|Noncompliance With Study Drug|4
4753384|NCT01715285|16399317|P3|Treatment Period|Death|0
4753385|NCT01715285|16399318|P2|Treatment Period|Death|23
4753386|NCT01715285|16399319|P1|Treatment Period|Death|36
4753387|NCT01715285|16399317|P3|Treatment Period|Lost to Follow-up|0
4753388|NCT01715285|16399318|P2|Treatment Period|Lost to Follow-up|2
4753389|NCT01715285|16399319|P1|Treatment Period|Lost to Follow-up|3
4753390|NCT01715285|16399317|P3|Treatment Period|Adverse Event|0
4753391|NCT01715285|16399318|P2|Treatment Period|Adverse Event|33
4753392|NCT01715285|16399319|P1|Treatment Period|Adverse Event|60
4753393|NCT01715129|16399355|P1|Overall Study|Other|1
4753394|NCT01715129|16399355|P1|Overall Study|Lost to Follow-up|1
4753395|NCT01715129|16399355|P1|Overall Study|Consent Withdrawn|2
4753396|NCT01715129|16399355|P1|Overall Study|Protocol Violation|1
4753397|NCT01715129|16399355|P1|Overall Study|Lack of Efficacy|3
4753398|NCT01715129|16399355|P1|Overall Study|Adverse Event, fatal|1
4753399|NCT01714947|16399381|P1|Part B|Progressive Disease|3
4753400|NCT01714817|16399422|P2|Overall Study|Hypersensitivity to the medication|1
4753401|NCT01714817|16399423|P1|Overall Study|Hypersensitivity to the medication|0
4753402|NCT01714817|16399422|P2|Overall Study|Antiproteinuric changed/dose increased|1
4753403|NCT01714817|16399423|P1|Overall Study|Antiproteinuric changed/dose increased|0
4753404|NCT01714817|16399422|P2|Overall Study|Need of use of Prohibited Medications|0
4753405|NCT01714817|16399423|P1|Overall Study|Need of use of Prohibited Medications|1
4753406|NCT01714817|16399422|P2|Overall Study|Change in Concomitant Medication|1
4753407|NCT01714817|16399423|P1|Overall Study|Change in Concomitant Medication|0
4753408|NCT01714817|16399422|P2|Overall Study|Not treated- received ACE inhibition|0
4753409|NCT01714817|16399423|P1|Overall Study|Not treated- received ACE inhibition|1
4753410|NCT01714817|16399422|P2|Overall Study|Participant no longer meets criteria|2
4753411|NCT01714817|16399423|P1|Overall Study|Participant no longer meets criteria|6
4753412|NCT01714817|16399422|P2|Overall Study|Pregnancy|0
4753413|NCT01714817|16399423|P1|Overall Study|Pregnancy|2
4753414|NCT01714817|16399422|P2|Overall Study|Poor / non-compliance|1
4753415|NCT01714817|16399423|P1|Overall Study|Poor / non-compliance|0
4753416|NCT01714817|16399422|P2|Overall Study|Lost to Follow-up|2
4753417|NCT01714817|16399423|P1|Overall Study|Lost to Follow-up|0
4753418|NCT01714817|16399422|P2|Overall Study|Death|1
4753419|NCT01714817|16399423|P1|Overall Study|Death|1
4753420|NCT01714817|16399422|P2|Overall Study|Withdrawal by Subject|7
4753421|NCT01714817|16399423|P1|Overall Study|Withdrawal by Subject|6
4753422|NCT01714817|16399422|P2|Overall Study|Adverse Event|17
4753423|NCT01714817|16399423|P1|Overall Study|Adverse Event|20
4753424|NCT01714817|16399422|P2|Overall Study|Lack of Efficacy|9
4753425|NCT01714817|16399423|P1|Overall Study|Lack of Efficacy|11
4753426|NCT01714726|16399455|P4|Open-Label Period|Lost to Follow-up|4
4753427|NCT01714726|16399456|P3|Open-Label Period|Lost to Follow-up|3
4753428|NCT01714726|16399457|P2|Open-Label Period|Lost to Follow-up|0
4753429|NCT01714726|16399458|P1|Open-Label Period|Lost to Follow-up|0
4753430|NCT01714726|16399455|P4|Open-Label Period|Developed specific withdrawal criteria|2
4753431|NCT01714726|16399456|P3|Open-Label Period|Developed specific withdrawal criteria|5
4753432|NCT01714726|16399457|P2|Open-Label Period|Developed specific withdrawal criteria|0
4753433|NCT01714726|16399458|P1|Open-Label Period|Developed specific withdrawal criteria|0
4753434|NCT01714726|16399455|P4|Open-Label Period|Withdrawal by Subject|19
4753435|NCT01714726|16399456|P3|Open-Label Period|Withdrawal by Subject|9
4753436|NCT01714726|16399457|P2|Open-Label Period|Withdrawal by Subject|0
4753437|NCT01714726|16399458|P1|Open-Label Period|Withdrawal by Subject|0
4753438|NCT01714726|16399455|P4|Open-Label Period|Adverse Event|0
4753439|NCT01714726|16399456|P3|Open-Label Period|Adverse Event|1
4753440|NCT01714726|16399457|P2|Open-Label Period|Adverse Event|0
4753441|NCT01714726|16399458|P1|Open-Label Period|Adverse Event|0
4753442|NCT01714726|16399455|P4|Open-Label Period|Other|3
4753443|NCT01714726|16399456|P3|Open-Label Period|Other|1
4753444|NCT01714726|16399457|P2|Open-Label Period|Other|0
4753445|NCT01714726|16399458|P1|Open-Label Period|Other|0
4753446|NCT01714726|16399455|P4|Double-Blinded Induction Period|Lost to Follow-up|0
4753447|NCT01714726|16399456|P3|Double-Blinded Induction Period|Lost to Follow-up|0
4753448|NCT01714726|16399457|P2|Double-Blinded Induction Period|Lost to Follow-up|2
4753449|NCT01714726|16399458|P1|Double-Blinded Induction Period|Lost to Follow-up|0
4753450|NCT01714726|16399455|P4|Double-Blinded Induction Period|Withdrawal by Subject|0
4753451|NCT01714726|16399456|P3|Double-Blinded Induction Period|Withdrawal by Subject|0
4753452|NCT01714726|16399457|P2|Double-Blinded Induction Period|Withdrawal by Subject|3
4753453|NCT01714726|16399458|P1|Double-Blinded Induction Period|Withdrawal by Subject|5
4753454|NCT01714726|16399455|P4|Double-Blinded Induction Period|Adverse Event|0
4753455|NCT01714726|16399456|P3|Double-Blinded Induction Period|Adverse Event|0
4753456|NCT01714726|16399457|P2|Double-Blinded Induction Period|Adverse Event|1
4753457|NCT01714726|16399458|P1|Double-Blinded Induction Period|Adverse Event|0
4753458|NCT01714726|16399455|P4|Double-Blinded Induction Period|Subject not in open label period|0
4753459|NCT01714726|16399456|P3|Double-Blinded Induction Period|Subject not in open label period|0
4753460|NCT01714726|16399457|P2|Double-Blinded Induction Period|Subject not in open label period|1
4753461|NCT01714726|16399458|P1|Double-Blinded Induction Period|Subject not in open label period|3
4753462|NCT01714687|16399538|P2|Overall Study|Lost to Follow-up|4
4753463|NCT01714687|16399539|P1|Overall Study|Lost to Follow-up|2
4753464|NCT01714687|16399538|P2|Overall Study|Withdrawal by Subject|0
4753465|NCT01714687|16399539|P1|Overall Study|Withdrawal by Subject|1
4753466|NCT01714635|16399563|P3|Overall Study|Missed 6-month exam|0
4753467|NCT01714635|16399564|P2|Overall Study|Missed 6-month exam|0
4753468|NCT01714635|16399565|P1|Overall Study|Missed 6-month exam|1
4753469|NCT01714635|16399563|P3|Overall Study|Discontinued|2
4753470|NCT01714635|16399564|P2|Overall Study|Discontinued|0
4753471|NCT01714635|16399565|P1|Overall Study|Discontinued|1
4753472|NCT01714609|16399581|P2|Overall Study|Protocol Violation|0
4753473|NCT01714609|16399582|P1|Overall Study|Protocol Violation|1
4753474|NCT01714544|16399588|P1|Overall Study|Withdrawal by Subject|1
4753475|NCT01714544|16399588|P1|Overall Study|Physician Decision|1
4753476|NCT01714544|16399588|P1|Overall Study|Lost to Follow-up|1
4753477|NCT01714310|16399659|P3|Double Blind Adjunctive Treatment|Protocol Violation|0
4753478|NCT01714310|16399660|P2|Double Blind Adjunctive Treatment|Protocol Violation|2
4753479|NCT01714310|16399661|P1|Double Blind Adjunctive Treatment|Protocol Violation|1
4753480|NCT01714310|16399659|P3|Double Blind Adjunctive Treatment|Adverse Event|0
4753481|NCT01714310|16399660|P2|Double Blind Adjunctive Treatment|Adverse Event|1
4753482|NCT01714310|16399661|P1|Double Blind Adjunctive Treatment|Adverse Event|1
4753483|NCT01714310|16399659|P3|Open Lisdexamfetamine Titration|Adverse Event|3
4753484|NCT01714310|16399660|P2|Open Lisdexamfetamine Titration|Adverse Event|0
4753485|NCT01714310|16399661|P1|Open Lisdexamfetamine Titration|Adverse Event|0
4753486|NCT01714310|16399659|P3|Open Lisdexamfetamine Titration|Protocol Violation|1
4753487|NCT01714310|16399660|P2|Open Lisdexamfetamine Titration|Protocol Violation|0
4753488|NCT01714310|16399661|P1|Open Lisdexamfetamine Titration|Protocol Violation|0
4753489|NCT01714063|16399714|P1|Overall Study|Equipment malfunction|2
4753490|NCT01713998|16399751|P3|Overall Study|Withdrawal by Subject|0
4753491|NCT01713998|16399752|P2|Overall Study|Withdrawal by Subject|0
4753492|NCT01713998|16399753|P1|Overall Study|Withdrawal by Subject|1
4753493|NCT01713998|16399751|P3|Overall Study|Lost to Follow-up|2
4753494|NCT01713998|16399752|P2|Overall Study|Lost to Follow-up|0
4753495|NCT01713998|16399753|P1|Overall Study|Lost to Follow-up|2
4753496|NCT01713946|16399774|P3|Overall Study|Patients never switched to everolimus|5
4753497|NCT01713946|16399775|P2|Overall Study|Patients never switched to everolimus|0
4753498|NCT01713946|16399776|P1|Overall Study|Patients never switched to everolimus|0
4753499|NCT01713946|16399774|P3|Overall Study|Did not continue in Post-Ext. Phase|0
4753500|NCT01713946|16399775|P2|Overall Study|Did not continue in Post-Ext. Phase|2
4753501|NCT01713946|16399776|P1|Overall Study|Did not continue in Post-Ext. Phase|1
4753502|NCT01713946|16399774|P3|Overall Study|Did not continue in Ext|0
4753503|NCT01713946|16399775|P2|Overall Study|Did not continue in Ext|3
4753504|NCT01713946|16399776|P1|Overall Study|Did not continue in Ext|0
4753505|NCT01713946|16399774|P3|Overall Study|Administrative problems|0
4753506|NCT01713946|16399775|P2|Overall Study|Administrative problems|0
4753507|NCT01713946|16399776|P1|Overall Study|Administrative problems|1
4753508|NCT01713946|16399774|P3|Overall Study|Lost to Follow-up|1
4753509|NCT01713946|16399775|P2|Overall Study|Lost to Follow-up|0
4753510|NCT01713946|16399776|P1|Overall Study|Lost to Follow-up|0
4753511|NCT01713946|16399774|P3|Overall Study|Protocol Violation|1
4753512|NCT01713946|16399775|P2|Overall Study|Protocol Violation|4
4753513|NCT01713946|16399776|P1|Overall Study|Protocol Violation|2
4753514|NCT01713946|16399774|P3|Overall Study|Lack of Efficacy|14
4753515|NCT01713946|16399775|P2|Overall Study|Lack of Efficacy|8
4753516|NCT01713946|16399776|P1|Overall Study|Lack of Efficacy|8
4753517|NCT01713946|16399774|P3|Overall Study|Withdrawal by Subject|8
4753518|NCT01713946|16399775|P2|Overall Study|Withdrawal by Subject|12
4753519|NCT01713946|16399776|P1|Overall Study|Withdrawal by Subject|12
4753520|NCT01713946|16399774|P3|Overall Study|Adverse Event|13
4753521|NCT01713946|16399775|P2|Overall Study|Adverse Event|14
4753522|NCT01713946|16399776|P1|Overall Study|Adverse Event|19
4753523|NCT01713946|16399774|P3|Overall Study|Death|2
4753524|NCT01713946|16399775|P2|Overall Study|Death|2
4753525|NCT01713946|16399776|P1|Overall Study|Death|0
4753526|NCT01713933|16399867|P1|Overall Study|Excluded from analysis as a BMI outlier|1
4753527|NCT01713933|16399867|P1|Overall Study|Withdrawal by Subject|3
4753528|NCT01713933|16399867|P1|Overall Study|Lost to Follow-up|2
4753529|NCT01713686|16399916|P1|Overall Study|Withdrawal by Subject|6
4753530|NCT01713686|16399916|P1|Overall Study|Lost to Follow-up|9
4753531|NCT01713582|16399986|P21|Overall Study|Disease progression and adverse event|0
4753532|NCT01713582|16399987|P20|Overall Study|Disease progression and adverse event|0
4753533|NCT01713582|16399988|P19|Overall Study|Disease progression and adverse event|0
4753534|NCT01713582|16399989|P18|Overall Study|Disease progression and adverse event|0
4753535|NCT01713582|16399990|P17|Overall Study|Disease progression and adverse event|1
4753536|NCT01713582|16399991|P16|Overall Study|Disease progression and adverse event|0
4753537|NCT01713582|16399992|P15|Overall Study|Disease progression and adverse event|0
4753538|NCT01713582|16399993|P14|Overall Study|Disease progression and adverse event|0
4753539|NCT01713582|16399994|P13|Overall Study|Disease progression and adverse event|0
4753540|NCT01713582|16399995|P12|Overall Study|Disease progression and adverse event|0
4753541|NCT01713582|16399996|P11|Overall Study|Disease progression and adverse event|0
4753542|NCT01713582|16399997|P10|Overall Study|Disease progression and adverse event|0
4753543|NCT01713582|16399998|P9|Overall Study|Disease progression and adverse event|0
4753544|NCT01713582|16399999|P8|Overall Study|Disease progression and adverse event|0
4753545|NCT01713582|16400000|P7|Overall Study|Disease progression and adverse event|0
4753546|NCT01713582|16400001|P6|Overall Study|Disease progression and adverse event|0
4753547|NCT01713582|16400002|P5|Overall Study|Disease progression and adverse event|0
4753548|NCT01713582|16400003|P4|Overall Study|Disease progression and adverse event|0
4753549|NCT01713582|16400004|P3|Overall Study|Disease progression and adverse event|0
4753550|NCT01713582|16400005|P2|Overall Study|Disease progression and adverse event|0
4753551|NCT01713582|16400006|P1|Overall Study|Disease progression and adverse event|0
4753552|NCT01713582|16399986|P21|Overall Study|Stopped to receive bone marrow graft|0
4753553|NCT01713582|16399987|P20|Overall Study|Stopped to receive bone marrow graft|0
4753554|NCT01713582|16399988|P19|Overall Study|Stopped to receive bone marrow graft|0
4753555|NCT01713582|16399989|P18|Overall Study|Stopped to receive bone marrow graft|0
4753556|NCT01713582|16399990|P17|Overall Study|Stopped to receive bone marrow graft|1
4753557|NCT01713582|16399991|P16|Overall Study|Stopped to receive bone marrow graft|0
4753558|NCT01713582|16399992|P15|Overall Study|Stopped to receive bone marrow graft|0
4753559|NCT01713582|16399993|P14|Overall Study|Stopped to receive bone marrow graft|0
4753560|NCT01713582|16399994|P13|Overall Study|Stopped to receive bone marrow graft|0
4753561|NCT01713582|16399995|P12|Overall Study|Stopped to receive bone marrow graft|0
4753562|NCT01713582|16399996|P11|Overall Study|Stopped to receive bone marrow graft|0
4753563|NCT01713582|16399997|P10|Overall Study|Stopped to receive bone marrow graft|0
4753564|NCT01713582|16399998|P9|Overall Study|Stopped to receive bone marrow graft|0
4753565|NCT01713582|16399999|P8|Overall Study|Stopped to receive bone marrow graft|0
4753566|NCT01713582|16400000|P7|Overall Study|Stopped to receive bone marrow graft|0
4753567|NCT01713582|16400001|P6|Overall Study|Stopped to receive bone marrow graft|0
4753568|NCT01713582|16400002|P5|Overall Study|Stopped to receive bone marrow graft|0
4753569|NCT01713582|16400003|P4|Overall Study|Stopped to receive bone marrow graft|0
4753570|NCT01713582|16400004|P3|Overall Study|Stopped to receive bone marrow graft|0
4753571|NCT01713582|16400005|P2|Overall Study|Stopped to receive bone marrow graft|0
4753572|NCT01713582|16400006|P1|Overall Study|Stopped to receive bone marrow graft|0
4753573|NCT01713582|16399986|P21|Overall Study|Withdrawal by Subject|0
4753574|NCT01713582|16399987|P20|Overall Study|Withdrawal by Subject|0
4753575|NCT01713582|16399988|P19|Overall Study|Withdrawal by Subject|0
4753576|NCT01713582|16399989|P18|Overall Study|Withdrawal by Subject|1
4753577|NCT01713582|16399990|P17|Overall Study|Withdrawal by Subject|0
4753578|NCT01713582|16399991|P16|Overall Study|Withdrawal by Subject|0
4753579|NCT01713582|16399992|P15|Overall Study|Withdrawal by Subject|0
4753580|NCT01713582|16399993|P14|Overall Study|Withdrawal by Subject|0
4753581|NCT01713582|16399994|P13|Overall Study|Withdrawal by Subject|0
4753582|NCT01713582|16399995|P12|Overall Study|Withdrawal by Subject|0
4753583|NCT01713582|16399996|P11|Overall Study|Withdrawal by Subject|0
4753584|NCT01713582|16399997|P10|Overall Study|Withdrawal by Subject|0
4753585|NCT01713582|16399998|P9|Overall Study|Withdrawal by Subject|0
4753586|NCT01713582|16399999|P8|Overall Study|Withdrawal by Subject|0
4753587|NCT01713582|16400000|P7|Overall Study|Withdrawal by Subject|0
4753588|NCT01713582|16400001|P6|Overall Study|Withdrawal by Subject|0
4753589|NCT01713582|16400002|P5|Overall Study|Withdrawal by Subject|0
4753590|NCT01713582|16400003|P4|Overall Study|Withdrawal by Subject|0
4753591|NCT01713582|16400004|P3|Overall Study|Withdrawal by Subject|0
4753592|NCT01713582|16400005|P2|Overall Study|Withdrawal by Subject|0
4753593|NCT01713582|16400006|P1|Overall Study|Withdrawal by Subject|0
4753594|NCT01713582|16399986|P21|Overall Study|Lack of Efficacy|0
4753595|NCT01713582|16399987|P20|Overall Study|Lack of Efficacy|0
4753596|NCT01713582|16399988|P19|Overall Study|Lack of Efficacy|0
4753597|NCT01713582|16399989|P18|Overall Study|Lack of Efficacy|0
4753598|NCT01713582|16399990|P17|Overall Study|Lack of Efficacy|0
4753599|NCT01713582|16399991|P16|Overall Study|Lack of Efficacy|0
4753600|NCT01713582|16399992|P15|Overall Study|Lack of Efficacy|0
4753601|NCT01713582|16399993|P14|Overall Study|Lack of Efficacy|0
4753602|NCT01713582|16399994|P13|Overall Study|Lack of Efficacy|0
4753603|NCT01713582|16399995|P12|Overall Study|Lack of Efficacy|0
4753604|NCT01713582|16399996|P11|Overall Study|Lack of Efficacy|2
4753605|NCT01713582|16399997|P10|Overall Study|Lack of Efficacy|1
4753606|NCT01713582|16399998|P9|Overall Study|Lack of Efficacy|0
4753607|NCT01713582|16399999|P8|Overall Study|Lack of Efficacy|0
4753608|NCT01713582|16400000|P7|Overall Study|Lack of Efficacy|0
4753609|NCT01713582|16400001|P6|Overall Study|Lack of Efficacy|0
4753610|NCT01713582|16400002|P5|Overall Study|Lack of Efficacy|0
4753611|NCT01713582|16400003|P4|Overall Study|Lack of Efficacy|0
4753612|NCT01713582|16400004|P3|Overall Study|Lack of Efficacy|0
4753613|NCT01713582|16400005|P2|Overall Study|Lack of Efficacy|0
4753614|NCT01713582|16400006|P1|Overall Study|Lack of Efficacy|0
4753615|NCT01713582|16399986|P21|Overall Study|Withdrawal of consent|0
4753616|NCT01713582|16399987|P20|Overall Study|Withdrawal of consent|0
4753617|NCT01713582|16399988|P19|Overall Study|Withdrawal of consent|1
4753618|NCT01713582|16399989|P18|Overall Study|Withdrawal of consent|0
4753619|NCT01713582|16399990|P17|Overall Study|Withdrawal of consent|0
4753620|NCT01713582|16399991|P16|Overall Study|Withdrawal of consent|0
4753621|NCT01713582|16399992|P15|Overall Study|Withdrawal of consent|0
4753622|NCT01713582|16399993|P14|Overall Study|Withdrawal of consent|0
4753623|NCT01713582|16399994|P13|Overall Study|Withdrawal of consent|0
4753624|NCT01713582|16399995|P12|Overall Study|Withdrawal of consent|0
4753625|NCT01713582|16399996|P11|Overall Study|Withdrawal of consent|0
4753626|NCT01713582|16399997|P10|Overall Study|Withdrawal of consent|1
4753627|NCT01713582|16399998|P9|Overall Study|Withdrawal of consent|0
4753628|NCT01713582|16399999|P8|Overall Study|Withdrawal of consent|0
4753629|NCT01713582|16400000|P7|Overall Study|Withdrawal of consent|0
4753630|NCT01713582|16400001|P6|Overall Study|Withdrawal of consent|1
4753631|NCT01713582|16400002|P5|Overall Study|Withdrawal of consent|0
4753632|NCT01713582|16400003|P4|Overall Study|Withdrawal of consent|0
4753633|NCT01713582|16400004|P3|Overall Study|Withdrawal of consent|1
4753634|NCT01713582|16400005|P2|Overall Study|Withdrawal of consent|0
4753635|NCT01713582|16400006|P1|Overall Study|Withdrawal of consent|0
4753636|NCT01713582|16399986|P21|Overall Study|Adverse event-unrelated|0
4753637|NCT01713582|16399987|P20|Overall Study|Adverse event-unrelated|0
4753638|NCT01713582|16399988|P19|Overall Study|Adverse event-unrelated|0
4753639|NCT01713582|16399989|P18|Overall Study|Adverse event-unrelated|0
4753640|NCT01713582|16399990|P17|Overall Study|Adverse event-unrelated|0
4753641|NCT01713582|16399991|P16|Overall Study|Adverse event-unrelated|0
4753642|NCT01713582|16399992|P15|Overall Study|Adverse event-unrelated|1
4753643|NCT01713582|16399993|P14|Overall Study|Adverse event-unrelated|1
4753644|NCT01713582|16399994|P13|Overall Study|Adverse event-unrelated|0
4753645|NCT01713582|16399995|P12|Overall Study|Adverse event-unrelated|0
4753646|NCT01713582|16399996|P11|Overall Study|Adverse event-unrelated|0
4753647|NCT01713582|16399997|P10|Overall Study|Adverse event-unrelated|0
4753648|NCT01713582|16399998|P9|Overall Study|Adverse event-unrelated|0
4753649|NCT01713582|16399999|P8|Overall Study|Adverse event-unrelated|1
4753650|NCT01713582|16400000|P7|Overall Study|Adverse event-unrelated|1
4753651|NCT01713582|16400001|P6|Overall Study|Adverse event-unrelated|1
4753652|NCT01713582|16400002|P5|Overall Study|Adverse event-unrelated|0
4753653|NCT01713582|16400003|P4|Overall Study|Adverse event-unrelated|0
4753654|NCT01713582|16400004|P3|Overall Study|Adverse event-unrelated|0
4753655|NCT01713582|16400005|P2|Overall Study|Adverse event-unrelated|0
4753656|NCT01713582|16400006|P1|Overall Study|Adverse event-unrelated|0
4753657|NCT01713582|16399986|P21|Overall Study|Adverse event-related|0
4753658|NCT01713582|16399987|P20|Overall Study|Adverse event-related|0
4753659|NCT01713582|16399988|P19|Overall Study|Adverse event-related|1
4753660|NCT01713582|16399989|P18|Overall Study|Adverse event-related|0
4753661|NCT01713582|16399990|P17|Overall Study|Adverse event-related|0
4753662|NCT01713582|16399991|P16|Overall Study|Adverse event-related|0
4753663|NCT01713582|16399992|P15|Overall Study|Adverse event-related|0
4753664|NCT01713582|16399993|P14|Overall Study|Adverse event-related|0
4753665|NCT01713582|16399994|P13|Overall Study|Adverse event-related|0
4753666|NCT01713582|16399995|P12|Overall Study|Adverse event-related|0
4753667|NCT01713582|16399996|P11|Overall Study|Adverse event-related|1
4753668|NCT01713582|16399997|P10|Overall Study|Adverse event-related|1
4753669|NCT01713582|16399998|P9|Overall Study|Adverse event-related|0
4753670|NCT01713582|16399999|P8|Overall Study|Adverse event-related|0
4753671|NCT01713582|16400000|P7|Overall Study|Adverse event-related|0
4753672|NCT01713582|16400001|P6|Overall Study|Adverse event-related|0
4753673|NCT01713582|16400002|P5|Overall Study|Adverse event-related|0
4753674|NCT01713582|16400003|P4|Overall Study|Adverse event-related|0
4753675|NCT01713582|16400004|P3|Overall Study|Adverse event-related|0
4753676|NCT01713582|16400005|P2|Overall Study|Adverse event-related|0
4753677|NCT01713582|16400006|P1|Overall Study|Adverse event-related|0
4753678|NCT01713582|16399986|P21|Overall Study|Death|0
4753679|NCT01713582|16399987|P20|Overall Study|Death|0
4753680|NCT01713582|16399988|P19|Overall Study|Death|0
4753681|NCT01713582|16399989|P18|Overall Study|Death|0
4753682|NCT01713582|16399990|P17|Overall Study|Death|0
4753683|NCT01713582|16399991|P16|Overall Study|Death|0
4753684|NCT01713582|16399992|P15|Overall Study|Death|0
4753685|NCT01713582|16399993|P14|Overall Study|Death|0
4753686|NCT01713582|16399994|P13|Overall Study|Death|0
4753687|NCT01713582|16399995|P12|Overall Study|Death|0
4753688|NCT01713582|16399996|P11|Overall Study|Death|3
4753689|NCT01713582|16399997|P10|Overall Study|Death|4
4753690|NCT01713582|16399998|P9|Overall Study|Death|3
4753691|NCT01713582|16399999|P8|Overall Study|Death|2
4753692|NCT01713582|16400000|P7|Overall Study|Death|3
4753693|NCT01713582|16400001|P6|Overall Study|Death|3
4753694|NCT01713582|16400002|P5|Overall Study|Death|1
4753695|NCT01713582|16400003|P4|Overall Study|Death|1
4753696|NCT01713582|16400004|P3|Overall Study|Death|0
4753697|NCT01713582|16400005|P2|Overall Study|Death|0
4753698|NCT01713582|16400006|P1|Overall Study|Death|0
4753699|NCT01713582|16399986|P21|Overall Study|Disease progression|15
4753700|NCT01713582|16399987|P20|Overall Study|Disease progression|5
4753701|NCT01713582|16399988|P19|Overall Study|Disease progression|3
4753702|NCT01713582|16399989|P18|Overall Study|Disease progression|2
4753703|NCT01713582|16399990|P17|Overall Study|Disease progression|5
4753704|NCT01713582|16399991|P16|Overall Study|Disease progression|6
4753705|NCT01713582|16399992|P15|Overall Study|Disease progression|6
4753706|NCT01713582|16399993|P14|Overall Study|Disease progression|3
4753707|NCT01713582|16399994|P13|Overall Study|Disease progression|3
4753708|NCT01713582|16399995|P12|Overall Study|Disease progression|5
4753709|NCT01713582|16399996|P11|Overall Study|Disease progression|10
4753710|NCT01713582|16399997|P10|Overall Study|Disease progression|11
4753711|NCT01713582|16399998|P9|Overall Study|Disease progression|3
4753712|NCT01713582|16399999|P8|Overall Study|Disease progression|3
4753713|NCT01713582|16400000|P7|Overall Study|Disease progression|3
4753714|NCT01713582|16400001|P6|Overall Study|Disease progression|3
4753715|NCT01713582|16400002|P5|Overall Study|Disease progression|3
4753716|NCT01713582|16400003|P4|Overall Study|Disease progression|2
4753717|NCT01713582|16400004|P3|Overall Study|Disease progression|3
4753718|NCT01713582|16400005|P2|Overall Study|Disease progression|3
4753719|NCT01713582|16400006|P1|Overall Study|Disease progression|3
4753720|NCT01713530|16400169|P2|Overall Study|Unclassified|2
4753721|NCT01713530|16400170|P1|Overall Study|Unclassified|4
4753722|NCT01713530|16400169|P2|Overall Study|Withdrawal criteria|12
4753723|NCT01713530|16400170|P1|Overall Study|Withdrawal criteria|21
4753724|NCT01713530|16400169|P2|Overall Study|Adverse Event|5
4753725|NCT01713530|16400170|P1|Overall Study|Adverse Event|0
4753726|NCT01713348|16400201|P4|Overall Study|Lost to Follow-up|0
4753727|NCT01713348|16400202|P3|Overall Study|Lost to Follow-up|0
4753728|NCT01713348|16400203|P2|Overall Study|Lost to Follow-up|0
4753729|NCT01713348|16400204|P1|Overall Study|Lost to Follow-up|1
4753730|NCT01713348|16400201|P4|Overall Study|Withdrawal by Subject|0
4753731|NCT01713348|16400202|P3|Overall Study|Withdrawal by Subject|2
4753732|NCT01713348|16400203|P2|Overall Study|Withdrawal by Subject|2
4753733|NCT01713348|16400204|P1|Overall Study|Withdrawal by Subject|3
4753734|NCT01713283|16400234|P2|Overall Study|Lost to Follow-up|1
4753735|NCT01713283|16400235|P1|Overall Study|Lost to Follow-up|1
4753736|NCT01713283|16400234|P2|Overall Study|Lack of Efficacy|2
4753737|NCT01713283|16400235|P1|Overall Study|Lack of Efficacy|10
4753738|NCT01713036|16400257|P1|Overall Study|Death|1
4753739|NCT01712984|16400297|P3|Overall Study|Withdrawal by Subject|7
4753740|NCT01712984|16400298|P2|Overall Study|Withdrawal by Subject|6
4753741|NCT01712984|16400299|P1|Overall Study|Withdrawal by Subject|6
4753742|NCT01712984|16400297|P3|Overall Study|Lost to Follow-up|1
4753743|NCT01712984|16400298|P2|Overall Study|Lost to Follow-up|10
4753744|NCT01712984|16400299|P1|Overall Study|Lost to Follow-up|8
4753745|NCT01712984|16400297|P3|Overall Study|Protocol Violation|1
4753746|NCT01712984|16400298|P2|Overall Study|Protocol Violation|0
4753747|NCT01712984|16400299|P1|Overall Study|Protocol Violation|2
4753748|NCT01712984|16400297|P3|Overall Study|Adverse Event|1
4753749|NCT01712984|16400298|P2|Overall Study|Adverse Event|0
4753750|NCT01712984|16400299|P1|Overall Study|Adverse Event|0
4753751|NCT01712854|16400319|P1|Overall Study|Physician Decision|1
4753752|NCT01712685|16400342|P1|Overall Study|pt declined to participate before trmt|1
4753753|NCT01712516|16400358|P4|Overall Study|Withdrawal by Subject|9
4753754|NCT01712516|16400359|P3|Overall Study|Withdrawal by Subject|3
4753755|NCT01712516|16400360|P2|Overall Study|Withdrawal by Subject|9
4753756|NCT01712516|16400361|P1|Overall Study|Withdrawal by Subject|3
4753757|NCT01712516|16400358|P4|Overall Study|Physician Decision|1
4753758|NCT01712516|16400359|P3|Overall Study|Physician Decision|0
4753759|NCT01712516|16400360|P2|Overall Study|Physician Decision|0
4753760|NCT01712516|16400361|P1|Overall Study|Physician Decision|2
4753761|NCT01712516|16400358|P4|Overall Study|Protocol deviation|0
4753762|NCT01712516|16400359|P3|Overall Study|Protocol deviation|1
4753763|NCT01712516|16400360|P2|Overall Study|Protocol deviation|0
4753764|NCT01712516|16400361|P1|Overall Study|Protocol deviation|1
4753765|NCT01712516|16400358|P4|Overall Study|Death|0
4753766|NCT01712516|16400359|P3|Overall Study|Death|0
4753767|NCT01712516|16400360|P2|Overall Study|Death|1
4753768|NCT01712516|16400361|P1|Overall Study|Death|0
4753769|NCT01712516|16400358|P4|Overall Study|Lost to Follow-up|1
4753770|NCT01712516|16400359|P3|Overall Study|Lost to Follow-up|2
4753771|NCT01712516|16400360|P2|Overall Study|Lost to Follow-up|0
4753772|NCT01712516|16400361|P1|Overall Study|Lost to Follow-up|0
4753773|NCT01712516|16400358|P4|Overall Study|Technical problems|2
4753774|NCT01712516|16400359|P3|Overall Study|Technical problems|0
4753775|NCT01712516|16400360|P2|Overall Study|Technical problems|0
4753776|NCT01712516|16400361|P1|Overall Study|Technical problems|0
4753777|NCT01712490|16400413|P2|Overall Study|Lost to Follow-up|29
4753778|NCT01712490|16400414|P1|Overall Study|Lost to Follow-up|16
4753779|NCT01712490|16400413|P2|Overall Study|Withdrawal by Subject|44
4753780|NCT01712490|16400414|P1|Overall Study|Withdrawal by Subject|36
4753781|NCT01712490|16400413|P2|Overall Study|Other|11
4753782|NCT01712490|16400414|P1|Overall Study|Other|11
4753783|NCT01712490|16400413|P2|Overall Study|Ongoing|586
4753784|NCT01712490|16400414|P1|Overall Study|Ongoing|601
4753785|NCT01712438|16400451|P1|Overall Study|Prematurely Discontinued|25
4753786|NCT01712438|16400451|P1|Overall Study|Violated inclusion & exclusion criteria|4
4753787|NCT01712438|16400451|P1|Overall Study|Ongoing ITI treatment|6
4753788|NCT01712438|16400451|P1|Overall Study|Not treated with Human-cl rhFVIII|2
4753789|NCT01712399|16400461|P1|Overall Study|Study closure|345
4753790|NCT01712399|16400461|P1|Overall Study|Adverse Event|11
4753791|NCT01712399|16400461|P1|Overall Study|Death|1
4753792|NCT01712399|16400461|P1|Overall Study|Withdrawal by Subject|39
4753793|NCT01712399|16400461|P1|Overall Study|Lost to Follow-up|1
4753794|NCT01712334|16400507|P2|Treatment Period 1|Randomized in Error|2
4753795|NCT01712334|16400508|P1|Treatment Period 1|Randomized in Error|0
4753796|NCT01712256|16400516|P1|Overall Study|Lost to Follow-up|1
4753797|NCT01712204|16400546|P2|Overall Study|Protocol Violation|1
4753798|NCT01712204|16400547|P1|Overall Study|Protocol Violation|1
4753799|NCT01712204|16400546|P2|Overall Study|Lost to Follow-up|0
4753800|NCT01712204|16400547|P1|Overall Study|Lost to Follow-up|1
4753801|NCT01712204|16400546|P2|Overall Study|Withdrawal by Subject|3
4753802|NCT01712204|16400547|P1|Overall Study|Withdrawal by Subject|3
4753803|NCT01712204|16400546|P2|Overall Study|Adverse Event|1
4753804|NCT01712204|16400547|P1|Overall Study|Adverse Event|3
4753805|NCT01712178|16400555|P2|Overall Study|Lost to Follow-up|1
4753806|NCT01712178|16400556|P1|Overall Study|Lost to Follow-up|0
4753807|NCT01712178|16400555|P2|Overall Study|Serious adverse event/withdrew consent|1
4753808|NCT01712178|16400556|P1|Overall Study|Serious adverse event/withdrew consent|0
4753809|NCT01712178|16400555|P2|Overall Study|Withdrew consent due to an adverse event|1
4753810|NCT01712178|16400556|P1|Overall Study|Withdrew consent due to an adverse event|1
4753811|NCT01712074|16400581|P3|Double Blind Period|No longer met eligibility criteria|0
4753812|NCT01712074|16400582|P2|Double Blind Period|No longer met eligibility criteria|3
4753813|NCT01712074|16400583|P1|Double Blind Period|No longer met eligibility criteria|0
4753814|NCT01712074|16400581|P3|Double Blind Period|Protocol Violation|1
4753815|NCT01712074|16400582|P2|Double Blind Period|Protocol Violation|0
4753816|NCT01712074|16400583|P1|Double Blind Period|Protocol Violation|0
4753817|NCT01712074|16400581|P3|Double Blind Period|Other|1
4753818|NCT01712074|16400582|P2|Double Blind Period|Other|4
4753819|NCT01712074|16400583|P1|Double Blind Period|Other|0
4753820|NCT01712074|16400581|P3|Double Blind Period|Lost to Follow-up|1
4753821|NCT01712074|16400582|P2|Double Blind Period|Lost to Follow-up|2
4753822|NCT01712074|16400583|P1|Double Blind Period|Lost to Follow-up|0
4753823|NCT01712074|16400581|P3|Double Blind Period|Death|0
4753824|NCT01712074|16400582|P2|Double Blind Period|Death|1
4753825|NCT01712074|16400583|P1|Double Blind Period|Death|0
4753826|NCT01712074|16400581|P3|Double Blind Period|No longer willing to participate|4
4753827|NCT01712074|16400582|P2|Double Blind Period|No longer willing to participate|2
4753828|NCT01712074|16400583|P1|Double Blind Period|No longer willing to participate|0
4753829|NCT01712074|16400581|P3|Double Blind Period|Adverse Event|1
4753830|NCT01712074|16400582|P2|Double Blind Period|Adverse Event|2
4753831|NCT01712074|16400583|P1|Double Blind Period|Adverse Event|0
4753832|NCT01712074|16400581|P3|Placebo Run-in Period|No longer willing to participate|0
4753833|NCT01712074|16400582|P2|Placebo Run-in Period|No longer willing to participate|0
4753834|NCT01712074|16400583|P1|Placebo Run-in Period|No longer willing to participate|1
4753835|NCT01712074|16400581|P3|Placebo Run-in Period|Other|0
4753836|NCT01712074|16400582|P2|Placebo Run-in Period|Other|0
4753837|NCT01712074|16400583|P1|Placebo Run-in Period|Other|1
4753838|NCT01712074|16400581|P3|Placebo Run-in Period|No longer meets eligibility criteria|0
4753839|NCT01712074|16400582|P2|Placebo Run-in Period|No longer meets eligibility criteria|0
4753840|NCT01712074|16400583|P1|Placebo Run-in Period|No longer meets eligibility criteria|5
4753841|NCT01712074|16400581|P3|Placebo Run-in Period|Lost to Follow-up|0
4753842|NCT01712074|16400582|P2|Placebo Run-in Period|Lost to Follow-up|0
4753843|NCT01712074|16400583|P1|Placebo Run-in Period|Lost to Follow-up|1
4753844|NCT01712074|16400581|P3|Placebo Run-in Period|Adverse Event|0
4753845|NCT01712074|16400582|P2|Placebo Run-in Period|Adverse Event|0
4753846|NCT01712074|16400583|P1|Placebo Run-in Period|Adverse Event|2
4753847|NCT01712061|16400639|P3|Overall Study|Other|0
4753848|NCT01712061|16400640|P2|Overall Study|Other|3
4753849|NCT01712061|16400641|P1|Overall Study|Other|0
4753850|NCT01712061|16400639|P3|Overall Study|Withdrawal by Subject|1
4753851|NCT01712061|16400640|P2|Overall Study|Withdrawal by Subject|7
4753852|NCT01712061|16400641|P1|Overall Study|Withdrawal by Subject|1
4753853|NCT01712061|16400639|P3|Overall Study|Medication Error Without Associated AE|0
4753854|NCT01712061|16400640|P2|Overall Study|Medication Error Without Associated AE|1
4753855|NCT01712061|16400641|P1|Overall Study|Medication Error Without Associated AE|0
4753856|NCT01712061|16400639|P3|Overall Study|Did Not Meet Entrance Criteria|3
4753857|NCT01712061|16400640|P2|Overall Study|Did Not Meet Entrance Criteria|6
4753858|NCT01712061|16400641|P1|Overall Study|Did Not Meet Entrance Criteria|4
4753859|NCT01712061|16400639|P3|Overall Study|Lost to Follow-up|1
4753860|NCT01712061|16400640|P2|Overall Study|Lost to Follow-up|0
4753861|NCT01712061|16400641|P1|Overall Study|Lost to Follow-up|1
4753862|NCT01712061|16400639|P3|Overall Study|Death|1
4753863|NCT01712061|16400640|P2|Overall Study|Death|0
4753864|NCT01712061|16400641|P1|Overall Study|Death|0
4753865|NCT01712061|16400639|P3|Overall Study|Adverse Event|5
4753866|NCT01712061|16400640|P2|Overall Study|Adverse Event|9
4753867|NCT01712061|16400641|P1|Overall Study|Adverse Event|4
4753868|NCT01712009|16400681|P3|Overall Study|Decision by Sponsor|12
4753869|NCT01712009|16400682|P2|Overall Study|Decision by Sponsor|14
4753870|NCT01712009|16400683|P1|Overall Study|Decision by Sponsor|12
4753871|NCT01712009|16400681|P3|Overall Study|Lost to Follow-up|1
4753872|NCT01712009|16400682|P2|Overall Study|Lost to Follow-up|0
4753873|NCT01712009|16400683|P1|Overall Study|Lost to Follow-up|2
4753874|NCT01712009|16400681|P3|Overall Study|Withdrawal by Subject|8
4753875|NCT01712009|16400682|P2|Overall Study|Withdrawal by Subject|15
4753876|NCT01712009|16400683|P1|Overall Study|Withdrawal by Subject|24
4753877|NCT01711983|16400709|P1|36-Month Closure Evaluation|Missed Echocardiograph|62
4753878|NCT01711983|16400709|P1|36-Month Closure Evaluation|Test Device Removal|2
4753879|NCT01711983|16400709|P1|6-Month Closure Evaluation|Technical Failure (No Test Device)|26
4753880|NCT01711983|16400709|P1|6-Month Clinical Success Evaluation|Missed Echocardiograph|32
4753881|NCT01711866|16400727|P1|Overall Study|Adverse Event|2
4753882|NCT01711866|16400727|P1|Overall Study|Withdrawal by Subject|3
4753883|NCT01711866|16400727|P1|Overall Study|Noncompliant|3
4753884|NCT01711853|16400732|P1|Overall Study|Not treated|3
4753885|NCT01711736|16400739|P2|Overall Study|Migrated/moved from study area|1
4753886|NCT01711736|16400740|P1|Overall Study|Migrated/moved from study area|2
4753887|NCT01711736|16400739|P2|Overall Study|Withdrawal by Subject|6
4753888|NCT01711736|16400740|P1|Overall Study|Withdrawal by Subject|6
4753889|NCT01711736|16400739|P2|Overall Study|Lost to Follow-up|1
4753890|NCT01711736|16400740|P1|Overall Study|Lost to Follow-up|4
4753891|NCT01711645|16400768|P1|Overall Study|Physician Decision|5
4753892|NCT01711645|16400768|P1|Overall Study|Lost to Follow-up|6
4753893|NCT01711645|16400768|P1|Overall Study|Withdrawal by Subject|8
4753894|NCT01711619|16400805|P2|Overall Study|Lost to Follow-up|0
4753895|NCT01711619|16400806|P1|Overall Study|Lost to Follow-up|1
4753896|NCT01711619|16400805|P2|Overall Study|Adverse Event|0
4753897|NCT01711619|16400806|P1|Overall Study|Adverse Event|2
4753898|NCT01711619|16400805|P2|Overall Study|Protocol Violation|3
4753899|NCT01711619|16400806|P1|Overall Study|Protocol Violation|2
4753900|NCT01711619|16400805|P2|Overall Study|Withdrawal by Subject|7
4753901|NCT01711619|16400806|P1|Overall Study|Withdrawal by Subject|3
4753902|NCT01711619|16400805|P2|Overall Study|Early study termination|14
4753903|NCT01711619|16400806|P1|Overall Study|Early study termination|10
4753904|NCT01711541|16400823|P5|Overall Study|Ineligible|0
4753905|NCT01711541|16400824|P4|Overall Study|Ineligible|0
4753906|NCT01711541|16400825|P3|Overall Study|Ineligible|0
4753907|NCT01711541|16400826|P2|Overall Study|Ineligible|1
4753908|NCT01711541|16400827|P1|Overall Study|Ineligible|0
4753909|NCT01711541|16400823|P5|Overall Study|Cancel prior to treatment|0
4753910|NCT01711541|16400824|P4|Overall Study|Cancel prior to treatment|1
4753911|NCT01711541|16400825|P3|Overall Study|Cancel prior to treatment|0
4753912|NCT01711541|16400826|P2|Overall Study|Cancel prior to treatment|0
4753913|NCT01711541|16400827|P1|Overall Study|Cancel prior to treatment|0
4753914|NCT01711359|16400876|P3|Treatment Period|Randomized, Not Treated|0
4753915|NCT01711359|16400877|P2|Treatment Period|Randomized, Not Treated|1
4753916|NCT01711359|16400878|P1|Treatment Period|Randomized, Not Treated|3
4753917|NCT01711359|16400876|P3|Treatment Period|Lost to Follow-up|1
4753918|NCT01711359|16400877|P2|Treatment Period|Lost to Follow-up|1
4753919|NCT01711359|16400878|P1|Treatment Period|Lost to Follow-up|1
4753920|NCT01711359|16400876|P3|Treatment Period|Sponsor Decision|0
4753921|NCT01711359|16400877|P2|Treatment Period|Sponsor Decision|0
4753922|NCT01711359|16400878|P1|Treatment Period|Sponsor Decision|1
4753923|NCT01711359|16400876|P3|Treatment Period|Entry Criteria Not Met|0
4753924|NCT01711359|16400877|P2|Treatment Period|Entry Criteria Not Met|0
4753925|NCT01711359|16400878|P1|Treatment Period|Entry Criteria Not Met|1
4753926|NCT01711359|16400876|P3|Treatment Period|Death|0
4753927|NCT01711359|16400877|P2|Treatment Period|Death|0
4753928|NCT01711359|16400878|P1|Treatment Period|Death|3
4753929|NCT01711359|16400876|P3|Treatment Period|Physician Decision|2
4753930|NCT01711359|16400877|P2|Treatment Period|Physician Decision|3
4753931|NCT01711359|16400878|P1|Treatment Period|Physician Decision|4
4753932|NCT01711359|16400876|P3|Treatment Period|Adverse Event|24
4753933|NCT01711359|16400877|P2|Treatment Period|Adverse Event|10
4753934|NCT01711359|16400878|P1|Treatment Period|Adverse Event|8
4753935|NCT01711359|16400876|P3|Treatment Period|Lack of Efficacy|2
4753936|NCT01711359|16400877|P2|Treatment Period|Lack of Efficacy|2
4753937|NCT01711359|16400878|P1|Treatment Period|Lack of Efficacy|13
4753938|NCT01711359|16400876|P3|Treatment Period|Withdrawal by Subject|13
4753939|NCT01711359|16400877|P2|Treatment Period|Withdrawal by Subject|7
4753940|NCT01711359|16400878|P1|Treatment Period|Withdrawal by Subject|18
4753941|NCT01711216|16400949|P1|Overall Study|no reason specified|22
4753942|NCT01711216|16400949|P1|Overall Study|variety of other minor reasons|83
4753943|NCT01711216|16400949|P1|Overall Study|Lost to Follow-up|46
4753944|NCT01711216|16400949|P1|Overall Study|Withdrawal by Subject|6
4753945|NCT01711216|16400949|P1|Overall Study|Pregnancy|56
4753946|NCT01711216|16400949|P1|Overall Study|Adverse Event|4
4753947|NCT01710800|16401027|P1|Overall Study|Protocol Violation|1
4753948|NCT01710800|16401027|P1|Overall Study|Withdrawal by Subject|21
4753949|NCT01710709|16401091|P1|Overall Study|Lack of Efficacy|3
4753950|NCT01710709|16401091|P1|Overall Study|Protocol Violation|5
4753951|NCT01710709|16401091|P1|Overall Study|Withdrawal by Subject|53
4753952|NCT01710709|16401091|P1|Overall Study|Participant withdrawn by investigator|2
4753953|NCT01710709|16401091|P1|Overall Study|Participant met withdrawal criteria|33
4753954|NCT01710709|16401091|P1|Overall Study|Adverse Event|48
4753955|NCT01710709|16401091|P1|Overall Study|Lost to Follow-up|29
4753956|NCT01710657|16401106|P3|Overall Study|Lack of Efficacy|1
4753957|NCT01710657|16401107|P2|Overall Study|Lack of Efficacy|1
4753958|NCT01710657|16401108|P1|Overall Study|Lack of Efficacy|0
4753959|NCT01710657|16401106|P3|Overall Study|Withdrawal by Subject|2
4753960|NCT01710657|16401107|P2|Overall Study|Withdrawal by Subject|1
4753961|NCT01710657|16401108|P1|Overall Study|Withdrawal by Subject|0
4753962|NCT01710657|16401106|P3|Overall Study|Adverse Event|28
4753963|NCT01710657|16401107|P2|Overall Study|Adverse Event|8
4753964|NCT01710657|16401108|P1|Overall Study|Adverse Event|14
4753965|NCT01710657|16401106|P3|Overall Study|Protocol Violation|0
4753966|NCT01710657|16401107|P2|Overall Study|Protocol Violation|2
4753967|NCT01710657|16401108|P1|Overall Study|Protocol Violation|2
4753968|NCT01710657|16401106|P3|Overall Study|Lost to Follow-up|1
4753969|NCT01710657|16401107|P2|Overall Study|Lost to Follow-up|0
4753970|NCT01710657|16401108|P1|Overall Study|Lost to Follow-up|2
4753971|NCT01710527|16401125|P2|Period 2: Washout Period (7 Days)|Personal reasons|1
4753972|NCT01710527|16401126|P1|Period 2: Washout Period (7 Days)|Personal reasons|0
4753973|NCT01710514|16401152|P2|Overall Study|Withdrawal by Subject|0
4753974|NCT01710514|16401153|P1|Overall Study|Withdrawal by Subject|1
4753975|NCT01710514|16401152|P2|Overall Study|Adverse Event|7
4753976|NCT01710514|16401153|P1|Overall Study|Adverse Event|6
4753977|NCT01710501|16401174|P3|Overall Study|Lost to Follow-up|0
4753978|NCT01710501|16401175|P2|Overall Study|Lost to Follow-up|0
4753979|NCT01710501|16401176|P1|Overall Study|Lost to Follow-up|2
4753980|NCT01710358|16401208|P3|Rescue Period|Withdrawal by Subject|0
4753981|NCT01710358|16401209|P2|Rescue Period|Withdrawal by Subject|8
4753982|NCT01710358|16401210|P1|Rescue Period|Withdrawal by Subject|0
4753983|NCT01710358|16401208|P3|Rescue Period|Lack of Efficacy|0
4753984|NCT01710358|16401209|P2|Rescue Period|Lack of Efficacy|7
4753985|NCT01710358|16401210|P1|Rescue Period|Lack of Efficacy|0
4753986|NCT01710358|16401208|P3|Rescue Period|Death|0
4753987|NCT01710358|16401209|P2|Rescue Period|Death|1
4753988|NCT01710358|16401210|P1|Rescue Period|Death|0
4753989|NCT01710358|16401208|P3|Rescue Period|Adverse Event|0
4753990|NCT01710358|16401209|P2|Rescue Period|Adverse Event|15
4753991|NCT01710358|16401210|P1|Rescue Period|Adverse Event|0
4753992|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7
4753993|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3
4753994|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4
4753995|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0
4753996|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2
4753997|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1
4753998|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
4753999|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1
4754000|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0
4754001|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1
4754002|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
4754003|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0
4754004|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1
4754005|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
4754006|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0
4754007|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Death|1
4754008|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Death|0
4754009|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Death|1
4754010|NCT01710358|16401208|P3|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5
4754011|NCT01710358|16401209|P2|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16
4754012|NCT01710358|16401210|P1|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10
4754013|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0
4754014|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
4754015|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1
4754016|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12
4754017|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5
4754018|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15
4754019|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
4754020|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0
4754021|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4
4754022|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
4754023|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0
4754024|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1
4754025|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
4754026|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1
4754027|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0
4754028|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3
4754029|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1
4754030|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15
4754031|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
4754032|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1
4754033|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0
4754034|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Death|0
4754035|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Death|2
4754036|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Death|0
4754037|NCT01710358|16401208|P3|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7
4754038|NCT01710358|16401209|P2|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18
4754039|NCT01710358|16401210|P1|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15
4754040|NCT01710345|16401281|P3|Overall Study|Drug Dosing Error|0
4754041|NCT01710345|16401282|P2|Overall Study|Drug Dosing Error|0
4754042|NCT01710345|16401283|P1|Overall Study|Drug Dosing Error|1
4754043|NCT01710345|16401281|P3|Overall Study|Lack of Efficacy|1
4754044|NCT01710345|16401282|P2|Overall Study|Lack of Efficacy|3
4754045|NCT01710345|16401283|P1|Overall Study|Lack of Efficacy|2
4754046|NCT01710345|16401281|P3|Overall Study|Adverse Event|0
4754047|NCT01710345|16401282|P2|Overall Study|Adverse Event|2
4754048|NCT01710345|16401283|P1|Overall Study|Adverse Event|0
4754049|NCT01710046|16401342|P2|Overall Study|Lost to Follow-up|0
4754050|NCT01710046|16401343|P1|Overall Study|Lost to Follow-up|1
4754051|NCT01710033|16401383|P5|Stage 2|Adverse Event|1
4754052|NCT01710033|16401384|P4|Stage 2|Adverse Event|0
4754053|NCT01710033|16401385|P3|Stage 2|Adverse Event|0
4754054|NCT01710033|16401386|P2|Stage 2|Adverse Event|0
4754055|NCT01710033|16401387|P1|Stage 2|Adverse Event|0
4754056|NCT01710020|16401468|P1|Period 1|Protocol Violation|1
4754057|NCT01709903|16401504|P2|Overall Study|Adverse Event|18
4754058|NCT01709903|16401505|P1|Overall Study|Adverse Event|11
4754059|NCT01709903|16401504|P2|Overall Study|Withdrawal by Subject|6
4754060|NCT01709903|16401505|P1|Overall Study|Withdrawal by Subject|6
4754061|NCT01709903|16401504|P2|Overall Study|Lack of Efficacy|3
4754062|NCT01709903|16401505|P1|Overall Study|Lack of Efficacy|3
4754063|NCT01709903|16401504|P2|Overall Study|Protocol Violation|2
4754064|NCT01709903|16401505|P1|Overall Study|Protocol Violation|3
4754065|NCT01709903|16401504|P2|Overall Study|Death|0
4754066|NCT01709903|16401505|P1|Overall Study|Death|2
4754067|NCT01709903|16401504|P2|Overall Study|Lost to Follow-up|2
4754068|NCT01709903|16401505|P1|Overall Study|Lost to Follow-up|0
4754069|NCT01709903|16401504|P2|Overall Study|no longer needed study drug|1
4754070|NCT01709903|16401505|P1|Overall Study|no longer needed study drug|0
4754071|NCT01709903|16401504|P2|Overall Study|In ability to use device|1
4754072|NCT01709903|16401505|P1|Overall Study|In ability to use device|1
4754073|NCT01709903|16401504|P2|Overall Study|Abnormal test procedure results|0
4754074|NCT01709903|16401505|P1|Overall Study|Abnormal test procedure results|1
4754075|NCT01709903|16401504|P2|Overall Study|administrative problems|6
4754076|NCT01709903|16401505|P1|Overall Study|administrative problems|2
4754077|NCT01709864|16401529|P2|Overall Study|Death|1
4754078|NCT01709864|16401530|P1|Overall Study|Death|0
4754079|NCT01709864|16401529|P2|Overall Study|Adverse Event|2
4754080|NCT01709864|16401530|P1|Overall Study|Adverse Event|0
4754081|NCT01709864|16401529|P2|Overall Study|non-compliance with study treatment|1
4754082|NCT01709864|16401530|P1|Overall Study|non-compliance with study treatment|1
4754083|NCT01709864|16401529|P2|Overall Study|Lost to Follow-up|0
4754084|NCT01709864|16401530|P1|Overall Study|Lost to Follow-up|1
4754085|NCT01709864|16401529|P2|Overall Study|subject/guardian decision|6
4754086|NCT01709864|16401530|P1|Overall Study|subject/guardian decision|5
4754087|NCT01709864|16401529|P2|Overall Study|Physician Decision|1
4754088|NCT01709864|16401530|P1|Overall Study|Physician Decision|0
4754089|NCT01709838|16401564|P1|Overall Study|Protocol Violation|1
4754090|NCT01709838|16401564|P1|Overall Study|Death|3
4754091|NCT01709838|16401564|P1|Overall Study|Physician Decision|4
4754092|NCT01709838|16401564|P1|Overall Study|Adverse Event|4
4754093|NCT01709838|16401564|P1|Overall Study|Subject/guardian decision|8
4754094|NCT01709838|16401564|P1|Overall Study|Pregnancy|10
4754095|NCT01709838|16401564|P1|Overall Study|Lost to Follow-up|16
4754096|NCT01709838|16401564|P1|Overall Study|Withdrawal by Subject|21
4754097|NCT01709708|16401621|P2|Overall Study|Protocol Violation|2
4754098|NCT01709708|16401622|P1|Overall Study|Protocol Violation|1
4754099|NCT01709695|16401646|P2|Overall Study|Withdrawal by Subject|1
4754100|NCT01709695|16401647|P1|Overall Study|Withdrawal by Subject|1
4754101|NCT01709578|16401672|P3|Overall Study|Other, not related to safety or efficacy|5
4754102|NCT01709578|16401673|P2|Overall Study|Other, not related to safety or efficacy|7
4754103|NCT01709578|16401674|P1|Overall Study|Other, not related to safety or efficacy|2
4754104|NCT01709578|16401672|P3|Overall Study|Poor compliance to protocol|1
4754105|NCT01709578|16401673|P2|Overall Study|Poor compliance to protocol|2
4754106|NCT01709578|16401674|P1|Overall Study|Poor compliance to protocol|1
4754107|NCT01709578|16401672|P3|Overall Study|Lack of Efficacy|2
4754108|NCT01709578|16401673|P2|Overall Study|Lack of Efficacy|4
4754109|NCT01709578|16401674|P1|Overall Study|Lack of Efficacy|5
4754110|NCT01709578|16401672|P3|Overall Study|Adverse Event|17
4754111|NCT01709578|16401673|P2|Overall Study|Adverse Event|18
4754112|NCT01709578|16401674|P1|Overall Study|Adverse Event|9
4754113|NCT01709578|16401672|P3|Overall Study|Rescued and entered in long term safety|26
4754114|NCT01709578|16401673|P2|Overall Study|Rescued and entered in long term safety|25
4754115|NCT01709578|16401674|P1|Overall Study|Rescued and entered in long term safety|63
4754116|NCT01709513|16401805|P3|Overall Study|Other|7
4754117|NCT01709513|16401806|P2|Overall Study|Other|11
4754118|NCT01709513|16401807|P1|Overall Study|Other|3
4754119|NCT01709513|16401805|P3|Overall Study|Poor compliance to protocol|0
4754120|NCT01709513|16401806|P2|Overall Study|Poor compliance to protocol|0
4754121|NCT01709513|16401807|P1|Overall Study|Poor compliance to protocol|2
4754122|NCT01709513|16401805|P3|Overall Study|Adverse Event|23
4754123|NCT01709513|16401806|P2|Overall Study|Adverse Event|31
4754124|NCT01709513|16401807|P1|Overall Study|Adverse Event|16
4754125|NCT01709513|16401805|P3|Overall Study|Randomized but not treated|0
4754126|NCT01709513|16401806|P2|Overall Study|Randomized but not treated|1
4754127|NCT01709513|16401807|P1|Overall Study|Randomized but not treated|0
4754128|NCT01709500|16401868|P2|Overall Study|Treatment ongoing|78
4754129|NCT01709500|16401869|P1|Overall Study|Treatment ongoing|156
4754130|NCT01709500|16401868|P2|Overall Study|Related to IMP administration|0
4754131|NCT01709500|16401869|P1|Overall Study|Related to IMP administration|1
4754132|NCT01709500|16401868|P2|Overall Study|Other|1
4754133|NCT01709500|16401869|P1|Overall Study|Other|3
4754134|NCT01709500|16401868|P2|Overall Study|Poor compliance to protocol|1
4754135|NCT01709500|16401869|P1|Overall Study|Poor compliance to protocol|2
4754136|NCT01709500|16401868|P2|Overall Study|Adverse Event|1
4754137|NCT01709500|16401869|P1|Overall Study|Adverse Event|5
4754138|NCT01709500|16401868|P2|Overall Study|Randomized but not treated|1
4754139|NCT01709500|16401869|P1|Overall Study|Randomized but not treated|0
4754140|NCT01709409|16401947|P2|Overall Study|Protocol Violation|0
4754141|NCT01709409|16401948|P1|Overall Study|Protocol Violation|1
4754142|NCT01709383|16401956|P2|Overall Study|Lost to Follow-up|0
4754143|NCT01709383|16401957|P1|Overall Study|Lost to Follow-up|1
4754144|NCT01709331|16401975|P1|Overall Study|Adverse Event|1
4754145|NCT01709318|16401988|P7|Overall Study|Other Protocol Specified Criteria|0
4754146|NCT01709318|16401989|P6|Overall Study|Other Protocol Specified Criteria|0
4754147|NCT01709318|16401990|P5|Overall Study|Other Protocol Specified Criteria|0
4754148|NCT01709318|16401991|P4|Overall Study|Other Protocol Specified Criteria|0
4754149|NCT01709318|16401992|P3|Overall Study|Other Protocol Specified Criteria|0
4754150|NCT01709318|16401993|P2|Overall Study|Other Protocol Specified Criteria|1
4754151|NCT01709318|16401994|P1|Overall Study|Other Protocol Specified Criteria|0
4754152|NCT01709318|16401988|P7|Overall Study|Withdrawal by Subject|4
4754153|NCT01709318|16401989|P6|Overall Study|Withdrawal by Subject|2
4754154|NCT01709318|16401990|P5|Overall Study|Withdrawal by Subject|0
4754155|NCT01709318|16401991|P4|Overall Study|Withdrawal by Subject|3
4754156|NCT01709318|16401992|P3|Overall Study|Withdrawal by Subject|3
4754157|NCT01709318|16401993|P2|Overall Study|Withdrawal by Subject|0
4754158|NCT01709318|16401994|P1|Overall Study|Withdrawal by Subject|3
4754159|NCT01709318|16401988|P7|Overall Study|Technical Problems|0
4754160|NCT01709318|16401989|P6|Overall Study|Technical Problems|0
4754161|NCT01709318|16401990|P5|Overall Study|Technical Problems|0
4754162|NCT01709318|16401991|P4|Overall Study|Technical Problems|0
4754163|NCT01709318|16401992|P3|Overall Study|Technical Problems|0
4754164|NCT01709318|16401993|P2|Overall Study|Technical Problems|0
4754165|NCT01709318|16401994|P1|Overall Study|Technical Problems|1
4754166|NCT01709318|16401988|P7|Overall Study|Protocol Violation|1
4754167|NCT01709318|16401989|P6|Overall Study|Protocol Violation|0
4754168|NCT01709318|16401990|P5|Overall Study|Protocol Violation|2
4754169|NCT01709318|16401991|P4|Overall Study|Protocol Violation|0
4754170|NCT01709318|16401992|P3|Overall Study|Protocol Violation|0
4754171|NCT01709318|16401993|P2|Overall Study|Protocol Violation|0
4754172|NCT01709318|16401994|P1|Overall Study|Protocol Violation|0
4754173|NCT01709318|16401988|P7|Overall Study|Pregnancy|0
4754174|NCT01709318|16401989|P6|Overall Study|Pregnancy|0
4754175|NCT01709318|16401990|P5|Overall Study|Pregnancy|1
4754176|NCT01709318|16401991|P4|Overall Study|Pregnancy|0
4754177|NCT01709318|16401992|P3|Overall Study|Pregnancy|0
4754178|NCT01709318|16401993|P2|Overall Study|Pregnancy|0
4754179|NCT01709318|16401994|P1|Overall Study|Pregnancy|0
4754180|NCT01709318|16401988|P7|Overall Study|Physician Decision|1
4754181|NCT01709318|16401989|P6|Overall Study|Physician Decision|0
4754182|NCT01709318|16401990|P5|Overall Study|Physician Decision|0
4754183|NCT01709318|16401991|P4|Overall Study|Physician Decision|0
4754184|NCT01709318|16401992|P3|Overall Study|Physician Decision|0
4754185|NCT01709318|16401993|P2|Overall Study|Physician Decision|0
4754186|NCT01709318|16401994|P1|Overall Study|Physician Decision|0
4754187|NCT01709318|16401988|P7|Overall Study|Non-compliance with Study Drug|2
4754188|NCT01709318|16401989|P6|Overall Study|Non-compliance with Study Drug|0
4754189|NCT01709318|16401990|P5|Overall Study|Non-compliance with Study Drug|0
4754190|NCT01709318|16401991|P4|Overall Study|Non-compliance with Study Drug|1
4754191|NCT01709318|16401992|P3|Overall Study|Non-compliance with Study Drug|1
4754192|NCT01709318|16401993|P2|Overall Study|Non-compliance with Study Drug|2
4754193|NCT01709318|16401994|P1|Overall Study|Non-compliance with Study Drug|0
4754194|NCT01709318|16401988|P7|Overall Study|Lost to Follow-up|1
4754195|NCT01709318|16401989|P6|Overall Study|Lost to Follow-up|1
4754196|NCT01709318|16401990|P5|Overall Study|Lost to Follow-up|1
4754197|NCT01709318|16401991|P4|Overall Study|Lost to Follow-up|0
4754198|NCT01709318|16401992|P3|Overall Study|Lost to Follow-up|0
4754199|NCT01709318|16401993|P2|Overall Study|Lost to Follow-up|0
4754200|NCT01709318|16401994|P1|Overall Study|Lost to Follow-up|2
4754201|NCT01709318|16401988|P7|Overall Study|Adverse Event|2
4754202|NCT01709318|16401989|P6|Overall Study|Adverse Event|1
4754203|NCT01709318|16401990|P5|Overall Study|Adverse Event|0
4754204|NCT01709318|16401991|P4|Overall Study|Adverse Event|2
4754205|NCT01709318|16401992|P3|Overall Study|Adverse Event|2
4754206|NCT01709318|16401993|P2|Overall Study|Adverse Event|4
4754207|NCT01709318|16401994|P1|Overall Study|Adverse Event|3
4754208|NCT01709305|16402087|P5|Phase 2|Withdrawal by Subject|12
4754209|NCT01709305|16402088|P4|Phase 2|Withdrawal by Subject|15
4754210|NCT01709305|16402089|P3|Phase 2|Withdrawal by Subject|6
4754211|NCT01709305|16402090|P2|Phase 2|Withdrawal by Subject|8
4754212|NCT01709305|16402091|P1|Phase 2|Withdrawal by Subject|0
4754213|NCT01709305|16402087|P5|Phase 2|Protocol Violation|9
4754214|NCT01709305|16402088|P4|Phase 2|Protocol Violation|13
4754215|NCT01709305|16402089|P3|Phase 2|Protocol Violation|19
4754216|NCT01709305|16402090|P2|Phase 2|Protocol Violation|19
4754217|NCT01709305|16402091|P1|Phase 2|Protocol Violation|0
4754218|NCT01709305|16402087|P5|Phase 2|Physician Decision|2
4754219|NCT01709305|16402088|P4|Phase 2|Physician Decision|1
4754220|NCT01709305|16402089|P3|Phase 2|Physician Decision|0
4754221|NCT01709305|16402090|P2|Phase 2|Physician Decision|2
4754222|NCT01709305|16402091|P1|Phase 2|Physician Decision|0
4754223|NCT01709305|16402087|P5|Phase 2|Travel, moving, etc.|5
4754224|NCT01709305|16402088|P4|Phase 2|Travel, moving, etc.|3
4754225|NCT01709305|16402089|P3|Phase 2|Travel, moving, etc.|3
4754226|NCT01709305|16402090|P2|Phase 2|Travel, moving, etc.|2
4754227|NCT01709305|16402091|P1|Phase 2|Travel, moving, etc.|0
4754228|NCT01709305|16402087|P5|Phase 2|Lost to Follow-up|5
4754229|NCT01709305|16402088|P4|Phase 2|Lost to Follow-up|9
4754230|NCT01709305|16402089|P3|Phase 2|Lost to Follow-up|6
4754231|NCT01709305|16402090|P2|Phase 2|Lost to Follow-up|10
4754232|NCT01709305|16402091|P1|Phase 2|Lost to Follow-up|0
4754233|NCT01709305|16402087|P5|Phase 2|Laboratory Adverse Event|1
4754234|NCT01709305|16402088|P4|Phase 2|Laboratory Adverse Event|1
4754235|NCT01709305|16402089|P3|Phase 2|Laboratory Adverse Event|0
4754236|NCT01709305|16402090|P2|Phase 2|Laboratory Adverse Event|1
4754237|NCT01709305|16402091|P1|Phase 2|Laboratory Adverse Event|0
4754238|NCT01709305|16402087|P5|Phase 2|Hyperglycemia (lack of efficacy)|2
4754239|NCT01709305|16402088|P4|Phase 2|Hyperglycemia (lack of efficacy)|0
4754240|NCT01709305|16402089|P3|Phase 2|Hyperglycemia (lack of efficacy)|0
4754241|NCT01709305|16402090|P2|Phase 2|Hyperglycemia (lack of efficacy)|0
4754242|NCT01709305|16402091|P1|Phase 2|Hyperglycemia (lack of efficacy)|0
4754243|NCT01709305|16402087|P5|Phase 2|Death|0
4754244|NCT01709305|16402088|P4|Phase 2|Death|0
4754245|NCT01709305|16402089|P3|Phase 2|Death|1
4754246|NCT01709305|16402090|P2|Phase 2|Death|0
4754247|NCT01709305|16402091|P1|Phase 2|Death|0
4754248|NCT01709305|16402087|P5|Phase 2|Clinical Adverse Event|11
4754249|NCT01709305|16402088|P4|Phase 2|Clinical Adverse Event|6
4754250|NCT01709305|16402089|P3|Phase 2|Clinical Adverse Event|10
4754251|NCT01709305|16402090|P2|Phase 2|Clinical Adverse Event|10
4754252|NCT01709305|16402091|P1|Phase 2|Clinical Adverse Event|0
4754253|NCT01709305|16402087|P5|Phase 1|Withdrawal by Subject|0
4754254|NCT01709305|16402088|P4|Phase 1|Withdrawal by Subject|0
4754255|NCT01709305|16402089|P3|Phase 1|Withdrawal by Subject|0
4754256|NCT01709305|16402090|P2|Phase 1|Withdrawal by Subject|0
4754257|NCT01709305|16402091|P1|Phase 1|Withdrawal by Subject|218
4754258|NCT01709305|16402087|P5|Phase 1|Protocol Violation|0
4754259|NCT01709305|16402088|P4|Phase 1|Protocol Violation|0
4754260|NCT01709305|16402089|P3|Phase 1|Protocol Violation|0
4754261|NCT01709305|16402090|P2|Phase 1|Protocol Violation|0
4754262|NCT01709305|16402091|P1|Phase 1|Protocol Violation|118
4754263|NCT01709305|16402087|P5|Phase 1|Physician Decision|0
4754264|NCT01709305|16402088|P4|Phase 1|Physician Decision|0
4754265|NCT01709305|16402089|P3|Phase 1|Physician Decision|0
4754266|NCT01709305|16402090|P2|Phase 1|Physician Decision|0
4754267|NCT01709305|16402091|P1|Phase 1|Physician Decision|13
4754268|NCT01709305|16402087|P5|Phase 1|Travel, moving, etc.|0
4754269|NCT01709305|16402088|P4|Phase 1|Travel, moving, etc.|0
4754270|NCT01709305|16402089|P3|Phase 1|Travel, moving, etc.|0
4754271|NCT01709305|16402090|P2|Phase 1|Travel, moving, etc.|0
4754272|NCT01709305|16402091|P1|Phase 1|Travel, moving, etc.|30
4754273|NCT01709305|16402087|P5|Phase 1|Lost to Follow-up|0
4754274|NCT01709305|16402088|P4|Phase 1|Lost to Follow-up|0
4754275|NCT01709305|16402089|P3|Phase 1|Lost to Follow-up|0
4754276|NCT01709305|16402090|P2|Phase 1|Lost to Follow-up|0
4754277|NCT01709305|16402091|P1|Phase 1|Lost to Follow-up|147
4754278|NCT01709305|16402087|P5|Phase 1|Laboratory Adverse Event|0
4754279|NCT01709305|16402088|P4|Phase 1|Laboratory Adverse Event|0
4754280|NCT01709305|16402089|P3|Phase 1|Laboratory Adverse Event|0
4754281|NCT01709305|16402090|P2|Phase 1|Laboratory Adverse Event|0
4754282|NCT01709305|16402091|P1|Phase 1|Laboratory Adverse Event|16
4754283|NCT01709305|16402087|P5|Phase 1|Hyperglycemia (lack of efficacy)|0
4754284|NCT01709305|16402088|P4|Phase 1|Hyperglycemia (lack of efficacy)|0
4754285|NCT01709305|16402089|P3|Phase 1|Hyperglycemia (lack of efficacy)|0
4754286|NCT01709305|16402090|P2|Phase 1|Hyperglycemia (lack of efficacy)|0
4754287|NCT01709305|16402091|P1|Phase 1|Hyperglycemia (lack of efficacy)|13
4754288|NCT01709305|16402087|P5|Phase 1|Death|0
4754289|NCT01709305|16402088|P4|Phase 1|Death|0
4754290|NCT01709305|16402089|P3|Phase 1|Death|0
4754291|NCT01709305|16402090|P2|Phase 1|Death|0
4754292|NCT01709305|16402091|P1|Phase 1|Death|2
4754293|NCT01709305|16402087|P5|Phase 1|Clinical Adverse Event|0
4754294|NCT01709305|16402088|P4|Phase 1|Clinical Adverse Event|0
4754295|NCT01709305|16402089|P3|Phase 1|Clinical Adverse Event|0
4754296|NCT01709305|16402090|P2|Phase 1|Clinical Adverse Event|0
4754297|NCT01709305|16402091|P1|Phase 1|Clinical Adverse Event|80
4754298|NCT01709227|16402128|P2|Overall Study|Pleural Peritoneal communication|9
4754299|NCT01709227|16402129|P1|Overall Study|Pleural Peritoneal communication|0
4754300|NCT01709227|16402128|P2|Overall Study|Physician Decision|0
4754301|NCT01709227|16402129|P1|Overall Study|Physician Decision|1
4754302|NCT01709162|16402155|P2|Overall Study|Withdrawal by Subject|1
4754303|NCT01709162|16402156|P1|Overall Study|Withdrawal by Subject|0
4754304|NCT01709162|16402155|P2|Overall Study|Other|0
4754305|NCT01709162|16402156|P1|Overall Study|Other|1
4754306|NCT01709162|16402155|P2|Overall Study|Administrative reason by sponsor|1
4754307|NCT01709162|16402156|P1|Overall Study|Administrative reason by sponsor|0
4754308|NCT01709162|16402155|P2|Overall Study|Study drug toxicity|0
4754309|NCT01709162|16402156|P1|Overall Study|Study drug toxicity|2
4754310|NCT01709162|16402155|P2|Overall Study|Disease progression|3
4754311|NCT01709162|16402156|P1|Overall Study|Disease progression|3
4754312|NCT01709149|16402171|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4754313|NCT01709149|16402172|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2
4754314|NCT01709149|16402173|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4754315|NCT01709149|16402171|P3|Double-blind, Placebo-controlled Phase|not defined|2
4754316|NCT01709149|16402172|P2|Double-blind, Placebo-controlled Phase|not defined|1
4754317|NCT01709149|16402173|P1|Double-blind, Placebo-controlled Phase|not defined|0
4754318|NCT01709149|16402171|P3|Double-blind, Placebo-controlled Phase|Death|0
4754319|NCT01709149|16402172|P2|Double-blind, Placebo-controlled Phase|Death|2
4754320|NCT01709149|16402173|P1|Double-blind, Placebo-controlled Phase|Death|0
4754321|NCT01709149|16402171|P3|Double-blind, Placebo-controlled Phase|Physician Decision|5
4754322|NCT01709149|16402172|P2|Double-blind, Placebo-controlled Phase|Physician Decision|2
4754323|NCT01709149|16402173|P1|Double-blind, Placebo-controlled Phase|Physician Decision|0
4754324|NCT01709149|16402171|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12
4754325|NCT01709149|16402172|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7
4754326|NCT01709149|16402173|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4754327|NCT01709149|16402171|P3|Double-blind, Placebo-controlled Phase|Adverse Event|78
4754328|NCT01709149|16402172|P2|Double-blind, Placebo-controlled Phase|Adverse Event|12
4754329|NCT01709149|16402173|P1|Double-blind, Placebo-controlled Phase|Adverse Event|0
4754330|NCT01709149|16402171|P3|Open-label Lead-in Phase|Protocol Violation|0
4754331|NCT01709149|16402172|P2|Open-label Lead-in Phase|Protocol Violation|0
4754332|NCT01709149|16402173|P1|Open-label Lead-in Phase|Protocol Violation|3
4754333|NCT01709149|16402171|P3|Open-label Lead-in Phase|Death|0
4754334|NCT01709149|16402172|P2|Open-label Lead-in Phase|Death|0
4754335|NCT01709149|16402173|P1|Open-label Lead-in Phase|Death|1
4754336|NCT01709149|16402171|P3|Open-label Lead-in Phase|Withdrawal by Subject|0
4754337|NCT01709149|16402172|P2|Open-label Lead-in Phase|Withdrawal by Subject|0
4754338|NCT01709149|16402173|P1|Open-label Lead-in Phase|Withdrawal by Subject|2
4754339|NCT01709149|16402171|P3|Open-label Lead-in Phase|Adverse Event|0
4754340|NCT01709149|16402172|P2|Open-label Lead-in Phase|Adverse Event|0
4754341|NCT01709149|16402173|P1|Open-label Lead-in Phase|Adverse Event|109
4754342|NCT01709110|16402201|P2|Overall Study|Caregiver Decision|1
4754343|NCT01709110|16402202|P1|Overall Study|Caregiver Decision|1
4754344|NCT01709110|16402201|P2|Overall Study|Lack of Efficacy|1
4754345|NCT01709110|16402202|P1|Overall Study|Lack of Efficacy|1
4754346|NCT01709110|16402201|P2|Overall Study|Sponsor Decision|2
4754347|NCT01709110|16402202|P1|Overall Study|Sponsor Decision|2
4754348|NCT01709110|16402201|P2|Overall Study|Physician Decision|10
4754349|NCT01709110|16402202|P1|Overall Study|Physician Decision|4
4754350|NCT01709110|16402201|P2|Overall Study|Withdrawal by Subject|89
4754351|NCT01709110|16402202|P1|Overall Study|Withdrawal by Subject|96
4754352|NCT01709110|16402201|P2|Overall Study|Protocol Violation|6
4754353|NCT01709110|16402202|P1|Overall Study|Protocol Violation|4
4754354|NCT01709110|16402201|P2|Overall Study|Lost to Follow-up|5
4754355|NCT01709110|16402202|P1|Overall Study|Lost to Follow-up|7
4754356|NCT01709110|16402201|P2|Overall Study|Death|6
4754357|NCT01709110|16402202|P1|Overall Study|Death|14
4754358|NCT01709110|16402201|P2|Overall Study|Adverse Event|48
4754359|NCT01709110|16402202|P1|Overall Study|Adverse Event|56
4754360|NCT01709084|16402232|P2|Overall Study|Not Treated|2
4754361|NCT01709084|16402233|P1|Overall Study|Not Treated|0
4754362|NCT01709084|16402232|P2|Overall Study|Participant Reached a Virologic Endpoint|1
4754363|NCT01709084|16402233|P1|Overall Study|Participant Reached a Virologic Endpoint|0
4754364|NCT01709084|16402232|P2|Overall Study|Other|3
4754365|NCT01709084|16402233|P1|Overall Study|Other|5
4754366|NCT01709084|16402232|P2|Overall Study|Adverse Event|0
4754367|NCT01709084|16402233|P1|Overall Study|Adverse Event|5
4754368|NCT01709084|16402232|P2|Overall Study|Withdrawal by Subject|2
4754369|NCT01709084|16402233|P1|Overall Study|Withdrawal by Subject|2
4754370|NCT01709084|16402232|P2|Overall Study|Lost to Follow-up|7
4754371|NCT01709084|16402233|P1|Overall Study|Lost to Follow-up|4
4754372|NCT01708954|16402266|P3|Step 2|Withdrawal by Subject|0
4754373|NCT01708954|16402267|P2|Step 2|Withdrawal by Subject|1
4754374|NCT01708954|16402268|P1|Step 2|Withdrawal by Subject|1
4754375|NCT01708954|16402266|P3|Step 2|Adverse Event|0
4754376|NCT01708954|16402267|P2|Step 2|Adverse Event|2
4754377|NCT01708954|16402268|P1|Step 2|Adverse Event|3
4754378|NCT01708954|16402266|P3|Step 2|Disease progression|0
4754379|NCT01708954|16402267|P2|Step 2|Disease progression|4
4754380|NCT01708954|16402268|P1|Step 2|Disease progression|9
4754381|NCT01708954|16402266|P3|Step 1|Ineligible or never received treatment|8
4754382|NCT01708954|16402267|P2|Step 1|Ineligible or never received treatment|2
4754383|NCT01708954|16402268|P1|Step 1|Ineligible or never received treatment|4
4754384|NCT01708954|16402266|P3|Step 1|Off-treatment reason not submitted|1
4754385|NCT01708954|16402267|P2|Step 1|Off-treatment reason not submitted|1
4754386|NCT01708954|16402268|P1|Step 1|Off-treatment reason not submitted|1
4754387|NCT01708954|16402266|P3|Step 1|Symptomatic deterioration|1
4754388|NCT01708954|16402267|P2|Step 1|Symptomatic deterioration|0
4754389|NCT01708954|16402268|P1|Step 1|Symptomatic deterioration|1
4754390|NCT01708954|16402266|P3|Step 1|Crossed over to Step 2|0
4754391|NCT01708954|16402267|P2|Step 1|Crossed over to Step 2|0
4754392|NCT01708954|16402268|P1|Step 1|Crossed over to Step 2|2
4754393|NCT01708954|16402266|P3|Step 1|Other complicating disease|0
4754394|NCT01708954|16402267|P2|Step 1|Other complicating disease|2
4754395|NCT01708954|16402268|P1|Step 1|Other complicating disease|0
4754396|NCT01708954|16402266|P3|Step 1|Withdrawal by Subject|3
4754397|NCT01708954|16402267|P2|Step 1|Withdrawal by Subject|5
4754398|NCT01708954|16402268|P1|Step 1|Withdrawal by Subject|2
4754399|NCT01708954|16402266|P3|Step 1|Death|3
4754400|NCT01708954|16402267|P2|Step 1|Death|2
4754401|NCT01708954|16402268|P1|Step 1|Death|3
4754402|NCT01708954|16402266|P3|Step 1|Adverse Event|13
4754403|NCT01708954|16402267|P2|Step 1|Adverse Event|11
4754404|NCT01708954|16402268|P1|Step 1|Adverse Event|3
4754405|NCT01708954|16402266|P3|Step 1|Disease progression|14
4754406|NCT01708954|16402267|P2|Step 1|Disease progression|17
4754407|NCT01708954|16402268|P1|Step 1|Disease progression|26
4754408|NCT01708941|16402293|P4|Overall Study|Ineligible|0
4754409|NCT01708941|16402294|P3|Overall Study|Ineligible|2
4754410|NCT01708941|16402295|P2|Overall Study|Ineligible|0
4754411|NCT01708941|16402296|P1|Overall Study|Ineligible|0
4754412|NCT01708941|16402293|P4|Overall Study|Never started treatment|0
4754413|NCT01708941|16402294|P3|Overall Study|Never started treatment|0
4754414|NCT01708941|16402295|P2|Overall Study|Never started treatment|1
4754415|NCT01708941|16402296|P1|Overall Study|Never started treatment|2
4754416|NCT01708941|16402293|P4|Overall Study|Ineligible and never started treatment|0
4754417|NCT01708941|16402294|P3|Overall Study|Ineligible and never started treatment|1
4754418|NCT01708941|16402295|P2|Overall Study|Ineligible and never started treatment|0
4754419|NCT01708941|16402296|P1|Overall Study|Ineligible and never started treatment|1
4754420|NCT01708941|16402293|P4|Overall Study|Alternative therapy|0
4754421|NCT01708941|16402294|P3|Overall Study|Alternative therapy|2
4754422|NCT01708941|16402295|P2|Overall Study|Alternative therapy|0
4754423|NCT01708941|16402296|P1|Overall Study|Alternative therapy|0
4754424|NCT01708941|16402293|P4|Overall Study|Disease progression|0
4754425|NCT01708941|16402294|P3|Overall Study|Disease progression|8
4754426|NCT01708941|16402295|P2|Overall Study|Disease progression|10
4754427|NCT01708941|16402296|P1|Overall Study|Disease progression|9
4754428|NCT01708941|16402293|P4|Overall Study|Withdrawal by Subject|4
4754429|NCT01708941|16402294|P3|Overall Study|Withdrawal by Subject|3
4754430|NCT01708941|16402295|P2|Overall Study|Withdrawal by Subject|0
4754431|NCT01708941|16402296|P1|Overall Study|Withdrawal by Subject|1
4754432|NCT01708941|16402293|P4|Overall Study|Death|14
4754433|NCT01708941|16402294|P3|Overall Study|Death|2
4754434|NCT01708941|16402295|P2|Overall Study|Death|1
4754435|NCT01708941|16402296|P1|Overall Study|Death|1
4754436|NCT01708941|16402293|P4|Overall Study|Adverse Event|0
4754437|NCT01708941|16402294|P3|Overall Study|Adverse Event|1
4754438|NCT01708941|16402295|P2|Overall Study|Adverse Event|6
4754439|NCT01708941|16402296|P1|Overall Study|Adverse Event|4
4754440|NCT01708915|16402314|P4|Overall Study|Other reasons than stated above|2
4754441|NCT01708915|16402315|P3|Overall Study|Other reasons than stated above|0
4754442|NCT01708915|16402316|P2|Overall Study|Other reasons than stated above|1
4754443|NCT01708915|16402317|P1|Overall Study|Other reasons than stated above|1
4754444|NCT01708915|16402314|P4|Overall Study|Withdrawal by Subject|2
4754445|NCT01708915|16402315|P3|Overall Study|Withdrawal by Subject|2
4754446|NCT01708915|16402316|P2|Overall Study|Withdrawal by Subject|1
4754447|NCT01708915|16402317|P1|Overall Study|Withdrawal by Subject|0
4754448|NCT01708915|16402314|P4|Overall Study|Protocol Violation|1
4754449|NCT01708915|16402315|P3|Overall Study|Protocol Violation|0
4754450|NCT01708915|16402316|P2|Overall Study|Protocol Violation|0
4754451|NCT01708915|16402317|P1|Overall Study|Protocol Violation|0
4754452|NCT01708915|16402314|P4|Overall Study|Lack of Efficacy|15
4754453|NCT01708915|16402315|P3|Overall Study|Lack of Efficacy|35
4754454|NCT01708915|16402316|P2|Overall Study|Lack of Efficacy|60
4754455|NCT01708915|16402317|P1|Overall Study|Lack of Efficacy|84
4754456|NCT01708915|16402314|P4|Overall Study|Adverse Event|13
4754457|NCT01708915|16402315|P3|Overall Study|Adverse Event|9
4754458|NCT01708915|16402316|P2|Overall Study|Adverse Event|0
4754459|NCT01708915|16402317|P1|Overall Study|Adverse Event|1
4754460|NCT01708902|16402346|P7|Overall Study|Other Reason|0
4754461|NCT01708902|16402347|P6|Overall Study|Other Reason|2
4754462|NCT01708902|16402348|P5|Overall Study|Other Reason|1
4754463|NCT01708902|16402349|P4|Overall Study|Other Reason|1
4754464|NCT01708902|16402350|P3|Overall Study|Other Reason|1
4754465|NCT01708902|16402351|P2|Overall Study|Other Reason|0
4754466|NCT01708902|16402352|P1|Overall Study|Other Reason|1
4754467|NCT01708902|16402346|P7|Overall Study|Refused to continue trial medication|1
4754468|NCT01708902|16402347|P6|Overall Study|Refused to continue trial medication|1
4754469|NCT01708902|16402348|P5|Overall Study|Refused to continue trial medication|8
4754470|NCT01708902|16402349|P4|Overall Study|Refused to continue trial medication|2
4754471|NCT01708902|16402350|P3|Overall Study|Refused to continue trial medication|4
4754472|NCT01708902|16402351|P2|Overall Study|Refused to continue trial medication|0
4754473|NCT01708902|16402352|P1|Overall Study|Refused to continue trial medication|8
4754474|NCT01708902|16402346|P7|Overall Study|Lost to Follow-up|1
4754475|NCT01708902|16402347|P6|Overall Study|Lost to Follow-up|0
4754476|NCT01708902|16402348|P5|Overall Study|Lost to Follow-up|0
4754477|NCT01708902|16402349|P4|Overall Study|Lost to Follow-up|2
4754478|NCT01708902|16402350|P3|Overall Study|Lost to Follow-up|2
4754479|NCT01708902|16402351|P2|Overall Study|Lost to Follow-up|1
4754480|NCT01708902|16402352|P1|Overall Study|Lost to Follow-up|2
4754481|NCT01708902|16402346|P7|Overall Study|Non compliance with protocol|0
4754482|NCT01708902|16402347|P6|Overall Study|Non compliance with protocol|0
4754483|NCT01708902|16402348|P5|Overall Study|Non compliance with protocol|0
4754484|NCT01708902|16402349|P4|Overall Study|Non compliance with protocol|3
4754485|NCT01708902|16402350|P3|Overall Study|Non compliance with protocol|1
4754486|NCT01708902|16402351|P2|Overall Study|Non compliance with protocol|2
4754487|NCT01708902|16402352|P1|Overall Study|Non compliance with protocol|0
4754488|NCT01708902|16402346|P7|Overall Study|Lack of Efficacy|0
4754489|NCT01708902|16402347|P6|Overall Study|Lack of Efficacy|1
4754490|NCT01708902|16402348|P5|Overall Study|Lack of Efficacy|0
4754491|NCT01708902|16402349|P4|Overall Study|Lack of Efficacy|0
4754492|NCT01708902|16402350|P3|Overall Study|Lack of Efficacy|0
4754493|NCT01708902|16402351|P2|Overall Study|Lack of Efficacy|1
4754494|NCT01708902|16402352|P1|Overall Study|Lack of Efficacy|3
4754495|NCT01708902|16402346|P7|Overall Study|Adverse Event|5
4754496|NCT01708902|16402347|P6|Overall Study|Adverse Event|3
4754497|NCT01708902|16402348|P5|Overall Study|Adverse Event|7
4754498|NCT01708902|16402349|P4|Overall Study|Adverse Event|2
4754499|NCT01708902|16402350|P3|Overall Study|Adverse Event|9
4754500|NCT01708902|16402351|P2|Overall Study|Adverse Event|4
4754501|NCT01708902|16402352|P1|Overall Study|Adverse Event|3
4754502|NCT01708291|16402494|P2|Overall Study|fighting|1
4754503|NCT01708291|16402495|P1|Overall Study|fighting|2
4754504|NCT01708187|16402534|P2|Overall Study|Lost to Follow-up|1
4754505|NCT01708187|16402535|P1|Overall Study|Lost to Follow-up|0
4754506|NCT01708174|16402544|P3|Treatment Period|Adverse Event|0
4754507|NCT01708174|16402545|P2|Treatment Period|Adverse Event|1
4754508|NCT01708174|16402546|P1|Treatment Period|Adverse Event|0
4754509|NCT01708174|16402544|P3|Treatment Period|Death|1
4754510|NCT01708174|16402545|P2|Treatment Period|Death|0
4754511|NCT01708174|16402546|P1|Treatment Period|Death|0
4754512|NCT01708174|16402544|P3|Treatment Period|Progressive disease|0
4754513|NCT01708174|16402545|P2|Treatment Period|Progressive disease|1
4754514|NCT01708174|16402546|P1|Treatment Period|Progressive disease|0
4754515|NCT01708174|16402544|P3|Treatment Period|Withdrawal by Subject|0
4754516|NCT01708174|16402545|P2|Treatment Period|Withdrawal by Subject|0
4754517|NCT01708174|16402546|P1|Treatment Period|Withdrawal by Subject|1
4754518|NCT01708161|16402578|P6|Overall Study|Disease progression|0
4754519|NCT01708161|16402579|P5|Overall Study|Disease progression|3
4754520|NCT01708161|16402580|P4|Overall Study|Disease progression|13
4754521|NCT01708161|16402581|P3|Overall Study|Disease progression|5
4754522|NCT01708161|16402582|P2|Overall Study|Disease progression|5
4754523|NCT01708161|16402583|P1|Overall Study|Disease progression|3
4754524|NCT01708161|16402578|P6|Overall Study|Administrative problems|0
4754525|NCT01708161|16402579|P5|Overall Study|Administrative problems|0
4754526|NCT01708161|16402580|P4|Overall Study|Administrative problems|0
4754527|NCT01708161|16402581|P3|Overall Study|Administrative problems|0
4754528|NCT01708161|16402582|P2|Overall Study|Administrative problems|1
4754529|NCT01708161|16402583|P1|Overall Study|Administrative problems|0
4754530|NCT01708161|16402578|P6|Overall Study|Withdrawal by Subject|0
4754531|NCT01708161|16402579|P5|Overall Study|Withdrawal by Subject|0
4754532|NCT01708161|16402580|P4|Overall Study|Withdrawal by Subject|0
4754533|NCT01708161|16402581|P3|Overall Study|Withdrawal by Subject|1
4754534|NCT01708161|16402582|P2|Overall Study|Withdrawal by Subject|1
4754535|NCT01708161|16402583|P1|Overall Study|Withdrawal by Subject|0
4754536|NCT01708161|16402578|P6|Overall Study|Death|1
4754537|NCT01708161|16402579|P5|Overall Study|Death|0
4754538|NCT01708161|16402580|P4|Overall Study|Death|1
4754539|NCT01708161|16402581|P3|Overall Study|Death|0
4754540|NCT01708161|16402582|P2|Overall Study|Death|0
4754541|NCT01708161|16402583|P1|Overall Study|Death|0
4754542|NCT01708161|16402578|P6|Overall Study|Adverse Event|0
4754543|NCT01708161|16402579|P5|Overall Study|Adverse Event|3
4754544|NCT01708161|16402580|P4|Overall Study|Adverse Event|2
4754545|NCT01708161|16402581|P3|Overall Study|Adverse Event|4
4754546|NCT01708161|16402582|P2|Overall Study|Adverse Event|3
4754547|NCT01708161|16402583|P1|Overall Study|Adverse Event|1
4754548|NCT01708057|16402634|P3|Overall Study|Withdrawal due to study termination.|1
4754549|NCT01708057|16402635|P2|Overall Study|Withdrawal due to study termination.|1
4754550|NCT01708057|16402636|P1|Overall Study|Withdrawal due to study termination.|1
4754551|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4754552|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4
4754553|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4754554|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4754555|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4754556|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0
4754557|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Study terminated by sponsor|174
4754558|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Study terminated by sponsor|243
4754559|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Study terminated by sponsor|809
4754560|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
4754561|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
4754562|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Study terminated by sponsor|0
4754563|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Noncompliance|2
4754564|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Noncompliance|4
4754565|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Noncompliance|0
4754566|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Noncompliance|0
4754567|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Noncompliance|0
4754568|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Noncompliance|0
4754569|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Other than specified|2
4754570|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Other than specified|5
4754571|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Other than specified|1
4754572|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Other than specified|0
4754573|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Other than specified|0
4754574|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Other than specified|0
4754575|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Death|0
4754576|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Death|0
4754577|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Death|2
4754578|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Death|0
4754579|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Death|0
4754580|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Death|0
4754581|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Lost to Follow-up|1
4754582|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Lost to Follow-up|11
4754583|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Lost to Follow-up|5
4754584|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Lost to Follow-up|0
4754585|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Lost to Follow-up|0
4754586|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Lost to Follow-up|0
4754587|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Pregnancy|2
4754588|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Pregnancy|5
4754589|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Pregnancy|2
4754590|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Pregnancy|0
4754591|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Pregnancy|0
4754592|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Pregnancy|0
4754593|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Withdrawal by Subject|32
4754594|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Withdrawal by Subject|220
4754595|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Withdrawal by Subject|58
4754596|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
4754597|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
4754598|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Withdrawal by Subject|0
4754599|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Lack of Efficacy|2
4754600|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Lack of Efficacy|1
4754601|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Lack of Efficacy|3
4754602|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Lack of Efficacy|0
4754603|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Lack of Efficacy|0
4754604|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Lack of Efficacy|0
4754605|NCT01707992|16402695|P6|Active Treatment Phase (24 Months)|Adverse Event|0
4754606|NCT01707992|16402696|P5|Active Treatment Phase (24 Months)|Adverse Event|1
4754607|NCT01707992|16402697|P4|Active Treatment Phase (24 Months)|Adverse Event|4
4754608|NCT01707992|16402698|P3|Active Treatment Phase (24 Months)|Adverse Event|0
4754609|NCT01707992|16402699|P2|Active Treatment Phase (24 Months)|Adverse Event|0
4754610|NCT01707992|16402700|P1|Active Treatment Phase (24 Months)|Adverse Event|0
4754611|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Other than specified|0
4754612|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Other than specified|0
4754613|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Other than specified|0
4754614|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Other than specified|10
4754615|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Other than specified|9
4754616|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Other than specified|11
4754617|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
4754618|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
4754619|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0
4754620|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6
4754621|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1
4754622|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2
4754623|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Death|0
4754624|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Death|0
4754625|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Death|0
4754626|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Death|1
4754627|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Death|1
4754628|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Death|2
4754629|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
4754630|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
4754631|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0
4754632|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9
4754633|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4
4754634|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10
4754635|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Pregnancy|0
4754636|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Pregnancy|0
4754637|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Pregnancy|0
4754638|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Pregnancy|9
4754639|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Pregnancy|5
4754640|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Pregnancy|12
4754641|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4754642|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4754643|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4754644|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4754645|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Protocol Violation|0
4754646|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Protocol Violation|1
4754647|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
4754648|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
4754649|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0
4754650|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154
4754651|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68
4754652|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88
4754653|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
4754654|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
4754655|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0
4754656|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2
4754657|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3
4754658|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10
4754659|NCT01707992|16402695|P6|Placebo-Controlled Phase (24 Months)|Adverse Event|0
4754660|NCT01707992|16402696|P5|Placebo-Controlled Phase (24 Months)|Adverse Event|0
4754661|NCT01707992|16402697|P4|Placebo-Controlled Phase (24 Months)|Adverse Event|0
4754662|NCT01707992|16402698|P3|Placebo-Controlled Phase (24 Months)|Adverse Event|9
4754663|NCT01707992|16402699|P2|Placebo-Controlled Phase (24 Months)|Adverse Event|13
4754664|NCT01707992|16402700|P1|Placebo-Controlled Phase (24 Months)|Adverse Event|8
4754665|NCT01707693|16402752|P2|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2
4754666|NCT01707693|16402753|P1|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0
4754667|NCT01707693|16402752|P2|Time 3 Measures @ 6 Mth|Lost to Follow-up|3
4754668|NCT01707693|16402753|P1|Time 3 Measures @ 6 Mth|Lost to Follow-up|0
4754669|NCT01707693|16402752|P2|Overall Study Allocation|Protocol Violation|3
4754670|NCT01707693|16402753|P1|Overall Study Allocation|Protocol Violation|4
4754671|NCT01707693|16402752|P2|Overall Study Allocation|Withdrawal by Subject|5
4754672|NCT01707693|16402753|P1|Overall Study Allocation|Withdrawal by Subject|9
4754673|NCT01707667|16402767|P2|Period 1|expulsion of colonic sensor catheter|0
4754674|NCT01707667|16402768|P1|Period 1|expulsion of colonic sensor catheter|1
4754675|NCT01707290|16402838|P2|Overall Study|Other unspecified|0
4754676|NCT01707290|16402839|P1|Overall Study|Other unspecified|17
4754677|NCT01707290|16402838|P2|Overall Study|Commercial drug available|1
4754678|NCT01707290|16402839|P1|Overall Study|Commercial drug available|60
4754679|NCT01707290|16402838|P2|Overall Study|Withdrawal of Consent (Not Due to AE)|0
4754680|NCT01707290|16402839|P1|Overall Study|Withdrawal of Consent (Not Due to AE)|4
4754681|NCT01707290|16402838|P2|Overall Study|Lost to Follow-up|0
4754682|NCT01707290|16402839|P1|Overall Study|Lost to Follow-up|3
4754683|NCT01707290|16402838|P2|Overall Study|Physician Decision|0
4754684|NCT01707290|16402839|P1|Overall Study|Physician Decision|1
4754685|NCT01707290|16402838|P2|Overall Study|Adverse event (AE)|0
4754686|NCT01707290|16402839|P1|Overall Study|Adverse event (AE)|1
4754687|NCT01707147|16402884|P1|Overall Study|Violated inclusion/exclusion criteria|77
4754688|NCT01707147|16402884|P1|Overall Study|Follow-up failure|17
4754689|NCT01707147|16402884|P1|Overall Study|Patients who have not taken Trajenta|1
4754690|NCT01707147|16402884|P1|Overall Study|Administered Trajenta prior to contract|5
4754691|NCT01707030|16402916|P2|Overall Study|Lost to Follow-up|13
4754692|NCT01707030|16402917|P1|Overall Study|Lost to Follow-up|8
4754693|NCT01707030|16402916|P2|Overall Study|Withdrawal by Subject|3
4754694|NCT01707030|16402917|P1|Overall Study|Withdrawal by Subject|2
4754695|NCT01707030|16402916|P2|Overall Study|Death|1
4754696|NCT01707030|16402917|P1|Overall Study|Death|1
4754697|NCT01707004|16402935|P1|Overall Study|Physician Decision|3
4754698|NCT01706926|16402989|P4|Overall Study|Other|3
4754699|NCT01706926|16402990|P3|Overall Study|Other|4
4754700|NCT01706926|16402991|P2|Overall Study|Other|4
4754701|NCT01706926|16402992|P1|Overall Study|Other|4
4754702|NCT01706926|16402989|P4|Overall Study|Withdrawal by Subject|2
4754703|NCT01706926|16402990|P3|Overall Study|Withdrawal by Subject|1
4754704|NCT01706926|16402991|P2|Overall Study|Withdrawal by Subject|0
4754705|NCT01706926|16402992|P1|Overall Study|Withdrawal by Subject|2
4754706|NCT01706926|16402989|P4|Overall Study|Lost to Follow-up|0
4754707|NCT01706926|16402990|P3|Overall Study|Lost to Follow-up|1
4754708|NCT01706926|16402991|P2|Overall Study|Lost to Follow-up|0
4754709|NCT01706926|16402992|P1|Overall Study|Lost to Follow-up|0
4754710|NCT01706770|16403111|P2|Overall Study|Physician Decision|0
4754711|NCT01706770|16403112|P1|Overall Study|Physician Decision|1
4754712|NCT01706770|16403111|P2|Overall Study|Lost to Follow-up|0
4754713|NCT01706770|16403112|P1|Overall Study|Lost to Follow-up|1
4754714|NCT01706575|16403160|P1|Overall Study|Started but not Treated|6
4754715|NCT01706575|16403160|P1|Overall Study|Lost to Follow-up|2
4754716|NCT01706575|16403160|P1|Overall Study|Participant Withdrew Consent|4
4754717|NCT01706536|16403181|P5|Overall Study|non compliance|0
4754718|NCT01706536|16403182|P4|Overall Study|non compliance|0
4754719|NCT01706536|16403183|P3|Overall Study|non compliance|0
4754720|NCT01706536|16403184|P2|Overall Study|non compliance|1
4754721|NCT01706536|16403185|P1|Overall Study|non compliance|0
4754722|NCT01706536|16403181|P5|Overall Study|Lack of Efficacy|0
4754723|NCT01706536|16403182|P4|Overall Study|Lack of Efficacy|1
4754724|NCT01706536|16403183|P3|Overall Study|Lack of Efficacy|0
4754725|NCT01706536|16403184|P2|Overall Study|Lack of Efficacy|0
4754726|NCT01706536|16403185|P1|Overall Study|Lack of Efficacy|1
4754727|NCT01706536|16403181|P5|Overall Study|Adverse Event|2
4754728|NCT01706536|16403182|P4|Overall Study|Adverse Event|3
4754729|NCT01706536|16403183|P3|Overall Study|Adverse Event|4
4754730|NCT01706536|16403184|P2|Overall Study|Adverse Event|3
4754731|NCT01706536|16403185|P1|Overall Study|Adverse Event|2
4754732|NCT01706536|16403181|P5|Overall Study|Withdrawal by Subject|0
4754733|NCT01706536|16403182|P4|Overall Study|Withdrawal by Subject|0
4754734|NCT01706536|16403183|P3|Overall Study|Withdrawal by Subject|1
4754735|NCT01706536|16403184|P2|Overall Study|Withdrawal by Subject|0
4754736|NCT01706536|16403185|P1|Overall Study|Withdrawal by Subject|1
4754737|NCT01706458|16403252|P2|Overall Study|Physician Decision|4
4754738|NCT01706458|16403253|P1|Overall Study|Physician Decision|3
4754739|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Withdrawal by Subject|11
4754740|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Withdrawal by Subject|8
4754741|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Withdrawal by Subject|0
4754742|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Physician Decision|2
4754743|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Physician Decision|2
4754744|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Physician Decision|0
4754745|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Lost to Follow-up|1
4754746|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Lost to Follow-up|3
4754747|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Lost to Follow-up|0
4754748|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9
4754749|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11
4754750|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0
4754751|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Protocol Violation|2
4754752|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Protocol Violation|4
4754753|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Protocol Violation|0
4754754|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Lack of Efficacy|4
4754755|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Lack of Efficacy|4
4754756|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Lack of Efficacy|0
4754757|NCT01706328|16403277|P3|12-week Double-blind Treatment Period|Adverse Event|16
4754758|NCT01706328|16403278|P2|12-week Double-blind Treatment Period|Adverse Event|14
4754759|NCT01706328|16403279|P1|12-week Double-blind Treatment Period|Adverse Event|0
4754760|NCT01706328|16403277|P3|2-week Run-in Period|Lost to Follow-up|0
4754761|NCT01706328|16403278|P2|2-week Run-in Period|Lost to Follow-up|0
4754762|NCT01706328|16403279|P1|2-week Run-in Period|Lost to Follow-up|2
4754763|NCT01706328|16403277|P3|2-week Run-in Period|Adverse Event|0
4754764|NCT01706328|16403278|P2|2-week Run-in Period|Adverse Event|0
4754765|NCT01706328|16403279|P1|2-week Run-in Period|Adverse Event|4
4754766|NCT01706328|16403277|P3|2-week Run-in Period|Physician Decision|0
4754767|NCT01706328|16403278|P2|2-week Run-in Period|Physician Decision|0
4754768|NCT01706328|16403279|P1|2-week Run-in Period|Physician Decision|4
4754769|NCT01706328|16403277|P3|2-week Run-in Period|Withdrawal by Subject|0
4754770|NCT01706328|16403278|P2|2-week Run-in Period|Withdrawal by Subject|0
4754771|NCT01706328|16403279|P1|2-week Run-in Period|Withdrawal by Subject|15
4754772|NCT01706328|16403277|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4754773|NCT01706328|16403278|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4754774|NCT01706328|16403279|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140
4754775|NCT01706250|16403298|P1|Overall Study|Lost to Follow-up|2
4754776|NCT01706198|16403329|P2|Overall Study|Withdrawal by Subject|31
4754777|NCT01706198|16403330|P1|Overall Study|Withdrawal by Subject|23
4754778|NCT01706198|16403329|P2|Overall Study|Physician Decision|37
4754779|NCT01706198|16403330|P1|Overall Study|Physician Decision|23
4754780|NCT01706198|16403329|P2|Overall Study|Lost to Follow-up|93
4754781|NCT01706198|16403330|P1|Overall Study|Lost to Follow-up|97
4754782|NCT01706198|16403329|P2|Overall Study|Other: Subject reached stopping criteria|13
4754783|NCT01706198|16403330|P1|Overall Study|Other: Subject reached stopping criteria|11
4754784|NCT01706198|16403329|P2|Overall Study|Protocol Violation|5
4754785|NCT01706198|16403330|P1|Overall Study|Protocol Violation|7
4754786|NCT01706198|16403329|P2|Overall Study|Adverse Event|15
4754787|NCT01706198|16403330|P1|Overall Study|Adverse Event|12
4754788|NCT01706159|16403382|P2|Overall Study|Unclassified|1
4754789|NCT01706159|16403383|P1|Overall Study|Unclassified|6
4754790|NCT01706159|16403382|P2|Overall Study|Withdrawal Criteria|1
4754791|NCT01706159|16403383|P1|Overall Study|Withdrawal Criteria|2
4754792|NCT01706146|16403397|P1|Overall Study|Developed AF and need for antiplatelets|2
4754793|NCT01706146|16403397|P1|Overall Study|Adverse Event|3
4754794|NCT01706146|16403397|P1|Overall Study|Withdrawal by Subject|1
4754795|NCT01706003|16403417|P2|Overall Study|Lost to Follow-up|4
4754796|NCT01706003|16403418|P1|Overall Study|Lost to Follow-up|6
4754797|NCT01706003|16403417|P2|Overall Study|Not scheduled|0
4754798|NCT01706003|16403418|P1|Overall Study|Not scheduled|3
4754799|NCT01706003|16403417|P2|Overall Study|Withdrawal by Subject|0
4754800|NCT01706003|16403418|P1|Overall Study|Withdrawal by Subject|2
4754801|NCT01705977|16403426|P2|Overall Study|Missing study conclusion form|2
4754802|NCT01705977|16403427|P1|Overall Study|Missing study conclusion form|2
4754803|NCT01705977|16403426|P2|Overall Study|Physician Decision|38
4754804|NCT01705977|16403427|P1|Overall Study|Physician Decision|48
4754805|NCT01705977|16403426|P2|Overall Study|Lost to Follow-up|37
4754806|NCT01705977|16403427|P1|Overall Study|Lost to Follow-up|33
4754807|NCT01705977|16403426|P2|Overall Study|Site closure|2
4754808|NCT01705977|16403427|P1|Overall Study|Site closure|3
4754809|NCT01705977|16403426|P2|Overall Study|Protocol Violation|4
4754810|NCT01705977|16403427|P1|Overall Study|Protocol Violation|2
4754811|NCT01705977|16403426|P2|Overall Study|Adverse Event|49
4754812|NCT01705977|16403427|P1|Overall Study|Adverse Event|57
4754813|NCT01705977|16403426|P2|Overall Study|Withdrawal by Subject|128
4754814|NCT01705977|16403427|P1|Overall Study|Withdrawal by Subject|128
4754815|NCT01705730|16403445|P1|Overall Study|Reason not Specified|4
4754816|NCT01705730|16403445|P1|Overall Study|Lost to Follow-up|1
4754817|NCT01705730|16403445|P1|Overall Study|Adverse Event|3
4754818|NCT01705730|16403445|P1|Overall Study|Lack of Efficacy|1
4754819|NCT01705717|16403485|P2|Overall Study|Other|2
4754820|NCT01705717|16403486|P1|Overall Study|Other|0
4754821|NCT01705717|16403485|P2|Overall Study|Lack of Efficacy|1
4754822|NCT01705717|16403486|P1|Overall Study|Lack of Efficacy|0
4754823|NCT01705717|16403485|P2|Overall Study|Adverse Event|2
4754824|NCT01705717|16403486|P1|Overall Study|Adverse Event|2
4754825|NCT01705691|16403503|P2|Overall Study|Other|1
4754826|NCT01705691|16403504|P1|Overall Study|Other|0
4754827|NCT01705691|16403503|P2|Overall Study|Lost to Follow-up|1
4754828|NCT01705691|16403504|P1|Overall Study|Lost to Follow-up|1
4754829|NCT01705691|16403503|P2|Overall Study|Withdrawal by Subject|2
4754830|NCT01705691|16403504|P1|Overall Study|Withdrawal by Subject|1
4754831|NCT01705691|16403503|P2|Overall Study|Death|2
4754832|NCT01705691|16403504|P1|Overall Study|Death|1
4754833|NCT01705652|16403524|P2|Overall Study|non-compliance|1
4754834|NCT01705652|16403525|P1|Overall Study|non-compliance|1
4754835|NCT01705652|16403524|P2|Overall Study|Withdrawal by Subject|2
4754836|NCT01705652|16403525|P1|Overall Study|Withdrawal by Subject|1
4754837|NCT01705652|16403524|P2|Overall Study|Adverse Event|0
4754838|NCT01705652|16403525|P1|Overall Study|Adverse Event|1
4754839|NCT01705587|16403533|P2|Overall Study|Withdrawal by Subject|1
4754840|NCT01705587|16403534|P1|Overall Study|Withdrawal by Subject|0
4754841|NCT01705574|16403552|P4|Open-Label Extension Phase|Pregnancy|1
4754842|NCT01705574|16403553|P3|Open-Label Extension Phase|Pregnancy|1
4754843|NCT01705574|16403554|P2|Open-Label Extension Phase|Pregnancy|0
4754844|NCT01705574|16403555|P1|Open-Label Extension Phase|Pregnancy|0
4754845|NCT01705574|16403552|P4|Open-Label Extension Phase|Physician Decision|0
4754846|NCT01705574|16403553|P3|Open-Label Extension Phase|Physician Decision|2
4754847|NCT01705574|16403554|P2|Open-Label Extension Phase|Physician Decision|0
4754848|NCT01705574|16403555|P1|Open-Label Extension Phase|Physician Decision|0
4754849|NCT01705574|16403552|P4|Open-Label Extension Phase|Non-Compliance with Study Drug|0
4754850|NCT01705574|16403553|P3|Open-Label Extension Phase|Non-Compliance with Study Drug|1
4754851|NCT01705574|16403554|P2|Open-Label Extension Phase|Non-Compliance with Study Drug|0
4754852|NCT01705574|16403555|P1|Open-Label Extension Phase|Non-Compliance with Study Drug|0
4754853|NCT01705574|16403552|P4|Open-Label Extension Phase|Death|0
4754854|NCT01705574|16403553|P3|Open-Label Extension Phase|Death|1
4754855|NCT01705574|16403554|P2|Open-Label Extension Phase|Death|0
4754856|NCT01705574|16403555|P1|Open-Label Extension Phase|Death|2
4754857|NCT01705574|16403552|P4|Open-Label Extension Phase|Adverse Event|1
4754858|NCT01705574|16403553|P3|Open-Label Extension Phase|Adverse Event|0
4754859|NCT01705574|16403554|P2|Open-Label Extension Phase|Adverse Event|0
4754860|NCT01705574|16403555|P1|Open-Label Extension Phase|Adverse Event|3
4754861|NCT01705574|16403552|P4|Open-Label Extension Phase|Withdrew Consent|1
4754862|NCT01705574|16403553|P3|Open-Label Extension Phase|Withdrew Consent|4
4754863|NCT01705574|16403554|P2|Open-Label Extension Phase|Withdrew Consent|0
4754864|NCT01705574|16403555|P1|Open-Label Extension Phase|Withdrew Consent|4
4754865|NCT01705574|16403552|P4|Open-Label Extension Phase|Lost to Follow-up|2
4754866|NCT01705574|16403553|P3|Open-Label Extension Phase|Lost to Follow-up|2
4754867|NCT01705574|16403554|P2|Open-Label Extension Phase|Lost to Follow-up|0
4754868|NCT01705574|16403555|P1|Open-Label Extension Phase|Lost to Follow-up|6
4754869|NCT01705574|16403552|P4|Double-Blind Phase|Randomized but Not Treated|0
4754870|NCT01705574|16403553|P3|Double-Blind Phase|Randomized but Not Treated|0
4754871|NCT01705574|16403554|P2|Double-Blind Phase|Randomized but Not Treated|4
4754872|NCT01705574|16403555|P1|Double-Blind Phase|Randomized but Not Treated|4
4754873|NCT01705574|16403552|P4|Double-Blind Phase|Protocol Violation|0
4754874|NCT01705574|16403553|P3|Double-Blind Phase|Protocol Violation|0
4754875|NCT01705574|16403554|P2|Double-Blind Phase|Protocol Violation|0
4754876|NCT01705574|16403555|P1|Double-Blind Phase|Protocol Violation|1
4754877|NCT01705574|16403552|P4|Double-Blind Phase|Pregnancy|0
4754878|NCT01705574|16403553|P3|Double-Blind Phase|Pregnancy|0
4754879|NCT01705574|16403554|P2|Double-Blind Phase|Pregnancy|1
4754880|NCT01705574|16403555|P1|Double-Blind Phase|Pregnancy|1
4754881|NCT01705574|16403552|P4|Double-Blind Phase|Non-Compliance with Study Drug|0
4754882|NCT01705574|16403553|P3|Double-Blind Phase|Non-Compliance with Study Drug|0
4754883|NCT01705574|16403554|P2|Double-Blind Phase|Non-Compliance with Study Drug|5
4754884|NCT01705574|16403555|P1|Double-Blind Phase|Non-Compliance with Study Drug|4
4754885|NCT01705574|16403552|P4|Double-Blind Phase|Withdrew Consent|0
4754886|NCT01705574|16403553|P3|Double-Blind Phase|Withdrew Consent|0
4754887|NCT01705574|16403554|P2|Double-Blind Phase|Withdrew Consent|5
4754888|NCT01705574|16403555|P1|Double-Blind Phase|Withdrew Consent|8
4754889|NCT01705574|16403552|P4|Double-Blind Phase|Adverse Event|0
4754890|NCT01705574|16403553|P3|Double-Blind Phase|Adverse Event|0
4754891|NCT01705574|16403554|P2|Double-Blind Phase|Adverse Event|10
4754892|NCT01705574|16403555|P1|Double-Blind Phase|Adverse Event|3
4754893|NCT01705574|16403552|P4|Double-Blind Phase|Lost to Follow-up|0
4754894|NCT01705574|16403553|P3|Double-Blind Phase|Lost to Follow-up|0
4754895|NCT01705574|16403554|P2|Double-Blind Phase|Lost to Follow-up|16
4754896|NCT01705574|16403555|P1|Double-Blind Phase|Lost to Follow-up|12
4754897|NCT01705509|16403572|P1|CPET w/ Ranexa|Screen Failure|2
4754898|NCT01705509|16403572|P1|Inclusion CPET|Withdrawal by Subject|2
4754899|NCT01705509|16403572|P1|Inclusion CPET|Screen Failure|5
4754900|NCT01705236|16403599|P1|Overall Study|Adverse Event|5
4754901|NCT01705236|16403599|P1|Overall Study|Withdrawal by Subject|5
4754902|NCT01705236|16403599|P1|Overall Study|Abnormal laboratory value(s)|4
4754903|NCT01705236|16403599|P1|Overall Study|Abnormal test procedure result(s)|4
4754904|NCT01705236|16403599|P1|Overall Study|Protocol Violation|3
4754905|NCT01705236|16403599|P1|Overall Study|Unsatisfactory therapeutic effect|3
4754906|NCT01705236|16403599|P1|Overall Study|Administrative problems|2
4754907|NCT01705236|16403599|P1|Overall Study|Lost to Follow-up|1
4754908|NCT01705145|16403608|P1|Part B|Adverse Event|1
4754909|NCT01705080|16403648|P4|Overall Study|Missed 6 Month Visit|0
4754910|NCT01705080|16403649|P3|Overall Study|Missed 6 Month Visit|1
4754911|NCT01705080|16403650|P2|Overall Study|Missed 6 Month Visit|1
4754912|NCT01705080|16403651|P1|Overall Study|Missed 6 Month Visit|3
4754913|NCT01705080|16403648|P4|Overall Study|Protocol Violation|0
4754914|NCT01705080|16403649|P3|Overall Study|Protocol Violation|0
4754915|NCT01705080|16403650|P2|Overall Study|Protocol Violation|0
4754916|NCT01705080|16403651|P1|Overall Study|Protocol Violation|2
4754917|NCT01705080|16403648|P4|Overall Study|Lost to Follow-up|2
4754918|NCT01705080|16403649|P3|Overall Study|Lost to Follow-up|0
4754919|NCT01705080|16403650|P2|Overall Study|Lost to Follow-up|0
4754920|NCT01705080|16403651|P1|Overall Study|Lost to Follow-up|0
4754921|NCT01705080|16403648|P4|Overall Study|Physician Decision|8
4754922|NCT01705080|16403649|P3|Overall Study|Physician Decision|1
4754923|NCT01705080|16403650|P2|Overall Study|Physician Decision|2
4754924|NCT01705080|16403651|P1|Overall Study|Physician Decision|1
4754925|NCT01705080|16403648|P4|Overall Study|Withdrawal by Subject|12
4754926|NCT01705080|16403649|P3|Overall Study|Withdrawal by Subject|0
4754927|NCT01705080|16403650|P2|Overall Study|Withdrawal by Subject|1
4754928|NCT01705080|16403651|P1|Overall Study|Withdrawal by Subject|1
4754929|NCT01705080|16403648|P4|Overall Study|Death|0
4754930|NCT01705080|16403649|P3|Overall Study|Death|0
4754931|NCT01705080|16403650|P2|Overall Study|Death|1
4754932|NCT01705080|16403651|P1|Overall Study|Death|0
4754933|NCT01705080|16403648|P4|Overall Study|Failed Procedure|0
4754934|NCT01705080|16403649|P3|Overall Study|Failed Procedure|0
4754935|NCT01705080|16403650|P2|Overall Study|Failed Procedure|2
4754936|NCT01705080|16403651|P1|Overall Study|Failed Procedure|0
4754937|NCT01705080|16403648|P4|Overall Study|Screen Failure Post Consent|20
4754938|NCT01705080|16403649|P3|Overall Study|Screen Failure Post Consent|3
4754939|NCT01705080|16403650|P2|Overall Study|Screen Failure Post Consent|9
4754940|NCT01705080|16403651|P1|Overall Study|Screen Failure Post Consent|8
4754941|NCT01704846|16403780|P2|Treatment Period 2|Withdrawal by Subject|1
4754942|NCT01704846|16403781|P1|Treatment Period 2|Withdrawal by Subject|0
4754943|NCT01704755|16403836|P2|Overall Study|Withdrew consent and personal issues|0
4754944|NCT01704755|16403837|P1|Overall Study|Withdrew consent and personal issues|1
4754945|NCT01704755|16403836|P2|Overall Study|Other (not specified)|1
4754946|NCT01704755|16403837|P1|Overall Study|Other (not specified)|3
4754947|NCT01704755|16403836|P2|Overall Study|Withdrew consent|1
4754948|NCT01704755|16403837|P1|Overall Study|Withdrew consent|1
4754949|NCT01704755|16403836|P2|Overall Study|Lost to Follow-up|4
4754950|NCT01704755|16403837|P1|Overall Study|Lost to Follow-up|3
4754951|NCT01704755|16403836|P2|Overall Study|Adverse Event|1
4754952|NCT01704755|16403837|P1|Overall Study|Adverse Event|4
4754953|NCT01704651|16403851|P2|Overall Study|Post-op did not have laparotomy|1
4754954|NCT01704651|16403852|P1|Overall Study|Post-op did not have laparotomy|2
4754955|NCT01704651|16403851|P2|Overall Study|Nasogastric tube placement in surgery|1
4754956|NCT01704651|16403852|P1|Overall Study|Nasogastric tube placement in surgery|1
4754957|NCT01704651|16403851|P2|Overall Study|Pre-op change in treatment plan|4
4754958|NCT01704651|16403852|P1|Overall Study|Pre-op change in treatment plan|1
4754959|NCT01704651|16403851|P2|Overall Study|Pre-op withdrawal by subject|1
4754960|NCT01704651|16403852|P1|Overall Study|Pre-op withdrawal by subject|1
4754961|NCT01704599|16403860|P1|Overall Study|Adverse Event|1
4754962|NCT01704495|16403900|P4|Optional Safety Extension|Withdrawal by Subject|2
4754963|NCT01704495|16403901|P3|Optional Safety Extension|Withdrawal by Subject|1
4754964|NCT01704495|16403902|P2|Optional Safety Extension|Withdrawal by Subject|0
4754965|NCT01704495|16403903|P1|Optional Safety Extension|Withdrawal by Subject|2
4754966|NCT01704495|16403900|P4|Optional Safety Extension|Other reason|28
4754967|NCT01704495|16403901|P3|Optional Safety Extension|Other reason|30
4754968|NCT01704495|16403902|P2|Optional Safety Extension|Other reason|29
4754969|NCT01704495|16403903|P1|Optional Safety Extension|Other reason|27
4754970|NCT01704495|16403900|P4|Optional Safety Extension|Adverse Event|1
4754971|NCT01704495|16403901|P3|Optional Safety Extension|Adverse Event|0
4754972|NCT01704495|16403902|P2|Optional Safety Extension|Adverse Event|4
4754973|NCT01704495|16403903|P1|Optional Safety Extension|Adverse Event|0
4754974|NCT01704495|16403900|P4|Subjects Randomized|Eligibility criteria not fulfilled|3
4754975|NCT01704495|16403901|P3|Subjects Randomized|Eligibility criteria not fulfilled|4
4754976|NCT01704495|16403902|P2|Subjects Randomized|Eligibility criteria not fulfilled|3
4754977|NCT01704495|16403903|P1|Subjects Randomized|Eligibility criteria not fulfilled|1
4754978|NCT01704495|16403900|P4|Subjects Randomized|Protocol Violation|0
4754979|NCT01704495|16403901|P3|Subjects Randomized|Protocol Violation|2
4754980|NCT01704495|16403902|P2|Subjects Randomized|Protocol Violation|1
4754981|NCT01704495|16403903|P1|Subjects Randomized|Protocol Violation|1
4754982|NCT01704495|16403900|P4|Subjects Randomized|Withdrawal by Subject|5
4754983|NCT01704495|16403901|P3|Subjects Randomized|Withdrawal by Subject|5
4754984|NCT01704495|16403902|P2|Subjects Randomized|Withdrawal by Subject|5
4754985|NCT01704495|16403903|P1|Subjects Randomized|Withdrawal by Subject|5
4754986|NCT01704495|16403900|P4|Subjects Randomized|Adverse Event|7
4754987|NCT01704495|16403901|P3|Subjects Randomized|Adverse Event|0
4754988|NCT01704495|16403902|P2|Subjects Randomized|Adverse Event|2
4754989|NCT01704495|16403903|P1|Subjects Randomized|Adverse Event|8
4754990|NCT01704495|16403900|P4|Subjects Randomized|Discontinuation criteria met|0
4754991|NCT01704495|16403901|P3|Subjects Randomized|Discontinuation criteria met|2
4754992|NCT01704495|16403902|P2|Subjects Randomized|Discontinuation criteria met|2
4754993|NCT01704495|16403903|P1|Subjects Randomized|Discontinuation criteria met|4
4754994|NCT01704495|16403900|P4|Subjects Randomized|Other Reason|2
4754995|NCT01704495|16403901|P3|Subjects Randomized|Other Reason|3
4754996|NCT01704495|16403902|P2|Subjects Randomized|Other Reason|2
4754997|NCT01704495|16403903|P1|Subjects Randomized|Other Reason|3
4754998|NCT01704456|16404079|P2|Overall Study|Lost to Follow-up|14
4754999|NCT01704456|16404080|P1|Overall Study|Lost to Follow-up|8
4755000|NCT01704287|16404142|P5|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4755001|NCT01704287|16404143|P4|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1
4755002|NCT01704287|16404144|P3|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4755003|NCT01704287|16404145|P2|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4755004|NCT01704287|16404146|P1|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0
4755005|NCT01704287|16404142|P5|Switch to Pembrolizumab Treatment Period|Death|37
4755006|NCT01704287|16404143|P4|Switch to Pembrolizumab Treatment Period|Death|35
4755007|NCT01704287|16404144|P3|Switch to Pembrolizumab Treatment Period|Death|0
4755008|NCT01704287|16404145|P2|Switch to Pembrolizumab Treatment Period|Death|0
4755009|NCT01704287|16404146|P1|Switch to Pembrolizumab Treatment Period|Death|0
4755010|NCT01704287|16404142|P5|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1
4755011|NCT01704287|16404143|P4|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2
4755012|NCT01704287|16404144|P3|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
4755013|NCT01704287|16404145|P2|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
4755014|NCT01704287|16404146|P1|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0
4755015|NCT01704287|16404142|P5|Initial Treatment Period|Switched to Pembrolizumab|0
4755016|NCT01704287|16404143|P4|Initial Treatment Period|Switched to Pembrolizumab|0
4755017|NCT01704287|16404144|P3|Initial Treatment Period|Switched to Pembrolizumab|98
4755018|NCT01704287|16404145|P2|Initial Treatment Period|Switched to Pembrolizumab|0
4755019|NCT01704287|16404146|P1|Initial Treatment Period|Switched to Pembrolizumab|0
4755020|NCT01704287|16404142|P5|Initial Treatment Period|Lost to Follow-up|0
4755021|NCT01704287|16404143|P4|Initial Treatment Period|Lost to Follow-up|0
4755022|NCT01704287|16404144|P3|Initial Treatment Period|Lost to Follow-up|0
4755023|NCT01704287|16404145|P2|Initial Treatment Period|Lost to Follow-up|3
4755024|NCT01704287|16404146|P1|Initial Treatment Period|Lost to Follow-up|5
4755025|NCT01704287|16404142|P5|Initial Treatment Period|Withdrawal by Subject|0
4755026|NCT01704287|16404143|P4|Initial Treatment Period|Withdrawal by Subject|0
4755027|NCT01704287|16404144|P3|Initial Treatment Period|Withdrawal by Subject|4
4755028|NCT01704287|16404145|P2|Initial Treatment Period|Withdrawal by Subject|2
4755029|NCT01704287|16404146|P1|Initial Treatment Period|Withdrawal by Subject|3
4755030|NCT01704287|16404142|P5|Initial Treatment Period|Death|0
4755031|NCT01704287|16404143|P4|Initial Treatment Period|Death|0
4755032|NCT01704287|16404144|P3|Initial Treatment Period|Death|71
4755033|NCT01704287|16404145|P2|Initial Treatment Period|Death|129
4755034|NCT01704287|16404146|P1|Initial Treatment Period|Death|139
4755035|NCT01704261|16404194|P2|Overall Study|Lost to Follow-up|0
4755036|NCT01704261|16404195|P1|Overall Study|Lost to Follow-up|1
4755037|NCT01704261|16404194|P2|Overall Study|Withdrawal by Subject|15
4755038|NCT01704261|16404195|P1|Overall Study|Withdrawal by Subject|12
4755039|NCT01704079|16404222|P2|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1
4755040|NCT01704079|16404223|P1|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0
4755041|NCT01704079|16404222|P2|Overall Study|Subject noncompliance|3
4755042|NCT01704079|16404223|P1|Overall Study|Subject noncompliance|2
4755043|NCT01704079|16404222|P2|Overall Study|Protocol Violation|0
4755044|NCT01704079|16404223|P1|Overall Study|Protocol Violation|1
4755045|NCT01704079|16404222|P2|Overall Study|Adverse Event|7
4755046|NCT01704079|16404223|P1|Overall Study|Adverse Event|4
4755047|NCT01704079|16404222|P2|Overall Study|Lost to Follow-up|5
4755048|NCT01704079|16404223|P1|Overall Study|Lost to Follow-up|2
4755049|NCT01704079|16404222|P2|Overall Study|Withdrawal by Subject|7
4755050|NCT01704079|16404223|P1|Overall Study|Withdrawal by Subject|5
4755051|NCT01703988|16404239|P4|Overall Study|Investigator Judgment|1
4755052|NCT01703988|16404240|P3|Overall Study|Investigator Judgment|0
4755053|NCT01703988|16404241|P2|Overall Study|Investigator Judgment|0
4755054|NCT01703988|16404242|P1|Overall Study|Investigator Judgment|0
4755055|NCT01703858|16404272|P3|Overall Study|Withdrawal by Subject|0
4755056|NCT01703858|16404273|P2|Overall Study|Withdrawal by Subject|1
4755057|NCT01703858|16404274|P1|Overall Study|Withdrawal by Subject|0
4755058|NCT01703845|16404299|P2|Overall Study|other than stated above|0
4755059|NCT01703845|16404300|P1|Overall Study|other than stated above|1
4755060|NCT01703845|16404299|P2|Overall Study|Protocol Violation|0
4755061|NCT01703845|16404300|P1|Overall Study|Protocol Violation|1
4755062|NCT01703845|16404299|P2|Overall Study|Adverse Event|0
4755063|NCT01703845|16404300|P1|Overall Study|Adverse Event|1
4755064|NCT01703832|16404337|P2|Overall Study|Withdrawal by Subject|0
4755065|NCT01703832|16404338|P1|Overall Study|Withdrawal by Subject|1
4755066|NCT01703819|16404370|P2|Overall Study|Withdrawal by Subject|1
4755067|NCT01703819|16404371|P1|Overall Study|Withdrawal by Subject|0
4755068|NCT01703819|16404370|P2|Overall Study|Adverse Event|1
4755069|NCT01703819|16404371|P1|Overall Study|Adverse Event|0
4755070|NCT01703741|16404401|P1|Overall Study|Subject started testosterone injections|1
4755071|NCT01703741|16404401|P1|Overall Study|Subject cannot comply with study visits|1
4755072|NCT01703741|16404401|P1|Overall Study|Subject did not want to continue|2
4755073|NCT01703741|16404401|P1|Overall Study|Lost to Follow-up|3
4755074|NCT01703741|16404401|P1|Overall Study|Protocol Violation|1
4755075|NCT01703741|16404401|P1|Overall Study|Physician Decision|2
4755076|NCT01703741|16404401|P1|Overall Study|Adverse Event|2
4755077|NCT01703741|16404401|P1|Overall Study|Withdrawal by Subject|6
4755078|NCT01703286|16404467|P6|Period 2 Including Washout|Adverse Event|0
4755079|NCT01703286|16404468|P5|Period 2 Including Washout|Adverse Event|0
4755080|NCT01703286|16404469|P4|Period 2 Including Washout|Adverse Event|1
4755081|NCT01703286|16404470|P3|Period 2 Including Washout|Adverse Event|0
4755082|NCT01703286|16404471|P2|Period 2 Including Washout|Adverse Event|0
4755083|NCT01703286|16404472|P1|Period 2 Including Washout|Adverse Event|0
4755084|NCT01703286|16404467|P6|Period 1 Including Washout|Withdrawal by Subject|1
4755085|NCT01703286|16404468|P5|Period 1 Including Washout|Withdrawal by Subject|0
4755086|NCT01703286|16404469|P4|Period 1 Including Washout|Withdrawal by Subject|1
4755087|NCT01703286|16404470|P3|Period 1 Including Washout|Withdrawal by Subject|0
4755088|NCT01703286|16404471|P2|Period 1 Including Washout|Withdrawal by Subject|0
4755089|NCT01703286|16404472|P1|Period 1 Including Washout|Withdrawal by Subject|0
4755090|NCT01703260|16404495|P3|Overall Study|Study Termination|0
4755091|NCT01703260|16404496|P2|Overall Study|Study Termination|2
4755092|NCT01703260|16404497|P1|Overall Study|Study Termination|1
4755093|NCT01703260|16404495|P3|Overall Study|Withdrawal by Subject|1
4755094|NCT01703260|16404496|P2|Overall Study|Withdrawal by Subject|0
4755095|NCT01703260|16404497|P1|Overall Study|Withdrawal by Subject|0
4755096|NCT01703260|16404495|P3|Overall Study|Lost to Follow-up|0
4755097|NCT01703260|16404496|P2|Overall Study|Lost to Follow-up|0
4755098|NCT01703260|16404497|P1|Overall Study|Lost to Follow-up|1
4755099|NCT01703260|16404495|P3|Overall Study|Adverse Event|2
4755100|NCT01703260|16404496|P2|Overall Study|Adverse Event|2
4755101|NCT01703260|16404497|P1|Overall Study|Adverse Event|1
4755102|NCT01703221|16404523|P3|Phase B - (Week 25 to 52)|Lack of Efficacy|3
4755103|NCT01703221|16404524|P2|Phase B - (Week 25 to 52)|Lack of Efficacy|10
4755104|NCT01703221|16404525|P1|Phase B - (Week 25 to 52)|Lack of Efficacy|12
4755105|NCT01703221|16404523|P3|Phase B - (Week 25 to 52)|Adverse Event|2
4755106|NCT01703221|16404524|P2|Phase B - (Week 25 to 52)|Adverse Event|3
4755107|NCT01703221|16404525|P1|Phase B - (Week 25 to 52)|Adverse Event|2
4755108|NCT01703221|16404523|P3|Phase B - (Week 25 to 52)|Withdrawal by Subject|0
4755109|NCT01703221|16404524|P2|Phase B - (Week 25 to 52)|Withdrawal by Subject|1
4755110|NCT01703221|16404525|P1|Phase B - (Week 25 to 52)|Withdrawal by Subject|2
4755111|NCT01703221|16404523|P3|Phase A (Up to 24 Weeks)|Protocol Violation|1
4755112|NCT01703221|16404524|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755113|NCT01703221|16404525|P1|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755114|NCT01703221|16404523|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4755115|NCT01703221|16404524|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755116|NCT01703221|16404525|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2
4755117|NCT01703221|16404523|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
4755118|NCT01703221|16404524|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
4755119|NCT01703221|16404525|P1|Phase A (Up to 24 Weeks)|Physician Decision|1
4755120|NCT01703221|16404523|P3|Phase A (Up to 24 Weeks)|Lack of Efficacy|1
4755121|NCT01703221|16404524|P2|Phase A (Up to 24 Weeks)|Lack of Efficacy|0
4755122|NCT01703221|16404525|P1|Phase A (Up to 24 Weeks)|Lack of Efficacy|2
4755123|NCT01703221|16404523|P3|Phase A (Up to 24 Weeks)|Adverse Event|0
4755124|NCT01703221|16404524|P2|Phase A (Up to 24 Weeks)|Adverse Event|4
4755125|NCT01703221|16404525|P1|Phase A (Up to 24 Weeks)|Adverse Event|2
4755126|NCT01703208|16404556|P2|Overall Study|Protocol Deviation|0
4755127|NCT01703208|16404557|P1|Overall Study|Protocol Deviation|2
4755128|NCT01703208|16404556|P2|Overall Study|Technical Problems|1
4755129|NCT01703208|16404557|P1|Overall Study|Technical Problems|0
4755130|NCT01703208|16404556|P2|Overall Study|Adverse Event|19
4755131|NCT01703208|16404557|P1|Overall Study|Adverse Event|14
4755132|NCT01703208|16404556|P2|Overall Study|Withdrawal by Subject|209
4755133|NCT01703208|16404557|P1|Overall Study|Withdrawal by Subject|205
4755134|NCT01703208|16404556|P2|Overall Study|Study Terminated by Sponsor|1716
4755135|NCT01703208|16404557|P1|Overall Study|Study Terminated by Sponsor|1710
4755136|NCT01703208|16404556|P2|Overall Study|Protocol Violation|1
4755137|NCT01703208|16404557|P1|Overall Study|Protocol Violation|1
4755138|NCT01703208|16404556|P2|Overall Study|Progressive disease|2
4755139|NCT01703208|16404557|P1|Overall Study|Progressive disease|2
4755140|NCT01703208|16404556|P2|Overall Study|Physician Decision|13
4755141|NCT01703208|16404557|P1|Overall Study|Physician Decision|11
4755142|NCT01703208|16404556|P2|Overall Study|Site Discontinued Study Participation|27
4755143|NCT01703208|16404557|P1|Overall Study|Site Discontinued Study Participation|23
4755144|NCT01703208|16404556|P2|Overall Study|Excluded Medication|2
4755145|NCT01703208|16404557|P1|Overall Study|Excluded Medication|1
4755146|NCT01703208|16404556|P2|Overall Study|Non-Compliance with Study Drug|0
4755147|NCT01703208|16404557|P1|Overall Study|Non-Compliance with Study Drug|1
4755148|NCT01703208|16404556|P2|Overall Study|Lost to Follow-up|62
4755149|NCT01703208|16404557|P1|Overall Study|Lost to Follow-up|68
4755150|NCT01703208|16404556|P2|Overall Study|Lack of Efficacy|2
4755151|NCT01703208|16404557|P1|Overall Study|Lack of Efficacy|1
4755152|NCT01703208|16404556|P2|Overall Study|Death|48
4755153|NCT01703208|16404557|P1|Overall Study|Death|61
4755154|NCT01703091|16404621|P2|Overall Study|Sponsor Decision|0
4755155|NCT01703091|16404622|P1|Overall Study|Sponsor Decision|1
4755156|NCT01703091|16404621|P2|Overall Study|Withdrawal by Subject|0
4755157|NCT01703091|16404622|P1|Overall Study|Withdrawal by Subject|1
4755158|NCT01703091|16404621|P2|Overall Study|Physician Decision|1
4755159|NCT01703091|16404622|P1|Overall Study|Physician Decision|2
4755160|NCT01703091|16404621|P2|Overall Study|Adverse Event|3
4755161|NCT01703091|16404622|P1|Overall Study|Adverse Event|5
4755162|NCT01703065|16404640|P2|Overall Study|Lack of Efficacy|0
4755163|NCT01703065|16404641|P1|Overall Study|Lack of Efficacy|1
4755164|NCT01703000|16404671|P1|Overall Study|Death|1
4755165|NCT01702987|16404704|P2|Overall Study|Withdrawal by Subject|0
4755166|NCT01702987|16404705|P1|Overall Study|Withdrawal by Subject|1
4755167|NCT01702961|16404711|P1|Overall Study|Ongoing|11
4755168|NCT01702961|16404711|P1|Overall Study|Lost to Follow-up|2
4755169|NCT01702961|16404711|P1|Overall Study|Death|6
4755170|NCT01702961|16404711|P1|Overall Study|Relapse|20
4755171|NCT01702961|16404711|P1|Overall Study|Progressive disease|5
4755172|NCT01702961|16404711|P1|Overall Study|Additional treatment|3
4755173|NCT01702844|16404729|P1|Overall Study|Physician Decision|6
4755174|NCT01702844|16404729|P1|Overall Study|Withdrawal by Subject|3
4755175|NCT01702844|16404729|P1|Overall Study|Death|1
4755176|NCT01702844|16404729|P1|Overall Study|Adverse Event|9
4755177|NCT01702558|16404741|P5|Overall Study|Other|17
4755178|NCT01702558|16404742|P4|Overall Study|Other|16
4755179|NCT01702558|16404743|P3|Overall Study|Other|0
4755180|NCT01702558|16404744|P2|Overall Study|Other|0
4755181|NCT01702558|16404745|P1|Overall Study|Other|0
4755182|NCT01702558|16404741|P5|Overall Study|Study Terminated by Sponsor|1
4755183|NCT01702558|16404742|P4|Overall Study|Study Terminated by Sponsor|0
4755184|NCT01702558|16404743|P3|Overall Study|Study Terminated by Sponsor|0
4755185|NCT01702558|16404744|P2|Overall Study|Study Terminated by Sponsor|1
4755186|NCT01702558|16404745|P1|Overall Study|Study Terminated by Sponsor|0
4755187|NCT01702558|16404741|P5|Overall Study|Safety Follow-Up less than 3 Months|0
4755188|NCT01702558|16404742|P4|Overall Study|Safety Follow-Up less than 3 Months|0
4755189|NCT01702558|16404743|P3|Overall Study|Safety Follow-Up less than 3 Months|2
4755190|NCT01702558|16404744|P2|Overall Study|Safety Follow-Up less than 3 Months|0
4755191|NCT01702558|16404745|P1|Overall Study|Safety Follow-Up less than 3 Months|0
4755192|NCT01702558|16404741|P5|Overall Study|Death|20
4755193|NCT01702558|16404742|P4|Overall Study|Death|16
4755194|NCT01702558|16404743|P3|Overall Study|Death|3
4755195|NCT01702558|16404744|P2|Overall Study|Death|3
4755196|NCT01702558|16404745|P1|Overall Study|Death|4
4755197|NCT01702558|16404741|P5|Overall Study|Lost to Follow-up|0
4755198|NCT01702558|16404742|P4|Overall Study|Lost to Follow-up|3
4755199|NCT01702558|16404743|P3|Overall Study|Lost to Follow-up|0
4755200|NCT01702558|16404744|P2|Overall Study|Lost to Follow-up|0
4755201|NCT01702558|16404745|P1|Overall Study|Lost to Follow-up|0
4755202|NCT01702558|16404741|P5|Overall Study|Withdrawal by Subject|4
4755203|NCT01702558|16404742|P4|Overall Study|Withdrawal by Subject|12
4755204|NCT01702558|16404743|P3|Overall Study|Withdrawal by Subject|0
4755205|NCT01702558|16404744|P2|Overall Study|Withdrawal by Subject|0
4755206|NCT01702558|16404745|P1|Overall Study|Withdrawal by Subject|0
4755207|NCT01702532|16404810|P2|Overall Study|Adverse Event|1
4755208|NCT01702532|16404811|P1|Overall Study|Adverse Event|0
4755209|NCT01702519|16404821|P2|Washout Period|Withdrawal by Subject|2
4755210|NCT01702519|16404822|P1|Washout Period|Withdrawal by Subject|0
4755211|NCT01702519|16404821|P2|Washout Period|Lost to Follow-up|0
4755212|NCT01702519|16404822|P1|Washout Period|Lost to Follow-up|1
4755213|NCT01702454|16404840|P2|Overall Study|Lost to Follow-up|6
4755214|NCT01702454|16404841|P1|Overall Study|Lost to Follow-up|3
4755215|NCT01702454|16404840|P2|Overall Study|Migrated/moved from study area|1
4755216|NCT01702454|16404841|P1|Overall Study|Migrated/moved from study area|0
4755217|NCT01702454|16404840|P2|Overall Study|Consent withdrawal|1
4755218|NCT01702454|16404841|P1|Overall Study|Consent withdrawal|0
4755219|NCT01702428|16404923|P4|Overall Study|Withdrawal by Subject|10
4755220|NCT01702428|16404924|P3|Overall Study|Withdrawal by Subject|14
4755221|NCT01702428|16404925|P2|Overall Study|Withdrawal by Subject|23
4755222|NCT01702428|16404926|P1|Overall Study|Withdrawal by Subject|21
4755223|NCT01702428|16404923|P4|Overall Study|Protocol Violation|0
4755224|NCT01702428|16404924|P3|Overall Study|Protocol Violation|1
4755225|NCT01702428|16404925|P2|Overall Study|Protocol Violation|0
4755226|NCT01702428|16404926|P1|Overall Study|Protocol Violation|3
4755227|NCT01702428|16404923|P4|Overall Study|Parents too busy|0
4755228|NCT01702428|16404924|P3|Overall Study|Parents too busy|0
4755229|NCT01702428|16404925|P2|Overall Study|Parents too busy|0
4755230|NCT01702428|16404926|P1|Overall Study|Parents too busy|1
4755231|NCT01702428|16404923|P4|Overall Study|Mother transferred care|0
4755232|NCT01702428|16404924|P3|Overall Study|Mother transferred care|0
4755233|NCT01702428|16404925|P2|Overall Study|Mother transferred care|1
4755234|NCT01702428|16404926|P1|Overall Study|Mother transferred care|0
4755235|NCT01702428|16404923|P4|Overall Study|Lost Health Plan|2
4755236|NCT01702428|16404924|P3|Overall Study|Lost Health Plan|0
4755237|NCT01702428|16404925|P2|Overall Study|Lost Health Plan|5
4755238|NCT01702428|16404926|P1|Overall Study|Lost Health Plan|3
4755239|NCT01702428|16404923|P4|Overall Study|Lost Coverage|1
4755240|NCT01702428|16404924|P3|Overall Study|Lost Coverage|0
4755241|NCT01702428|16404925|P2|Overall Study|Lost Coverage|0
4755242|NCT01702428|16404926|P1|Overall Study|Lost Coverage|0
4755243|NCT01702428|16404923|P4|Overall Study|Parents cannot assist to site|0
4755244|NCT01702428|16404924|P3|Overall Study|Parents cannot assist to site|1
4755245|NCT01702428|16404925|P2|Overall Study|Parents cannot assist to site|0
4755246|NCT01702428|16404926|P1|Overall Study|Parents cannot assist to site|1
4755247|NCT01702428|16404923|P4|Overall Study|Lost to Follow-up|44
4755248|NCT01702428|16404924|P3|Overall Study|Lost to Follow-up|37
4755249|NCT01702428|16404925|P2|Overall Study|Lost to Follow-up|41
4755250|NCT01702428|16404926|P1|Overall Study|Lost to Follow-up|33
4755251|NCT01702428|16404923|P4|Overall Study|Adverse Event|0
4755252|NCT01702428|16404924|P3|Overall Study|Adverse Event|0
4755253|NCT01702428|16404925|P2|Overall Study|Adverse Event|0
4755254|NCT01702428|16404926|P1|Overall Study|Adverse Event|2
4755255|NCT01702363|16405013|P1|Overall Study|Withdrawal by Subject|2
4755256|NCT01702363|16405013|P1|Overall Study|Lack of Efficacy|4
4755257|NCT01702363|16405013|P1|Overall Study|Adverse Event|14
4755258|NCT01702311|16405030|P2|Overall Study|Physician Decision|4
4755259|NCT01702311|16405031|P1|Overall Study|Physician Decision|3
4755260|NCT01702311|16405030|P2|Overall Study|Discharge less than 24 hours|7
4755261|NCT01702311|16405031|P1|Overall Study|Discharge less than 24 hours|10
4755262|NCT01702311|16405030|P2|Overall Study|Withdrawal by Subject|2
4755263|NCT01702311|16405031|P1|Overall Study|Withdrawal by Subject|3
4755264|NCT01702298|16405061|P1|Overall Study|Withdrawal by Subject|1
4755265|NCT01702246|16405089|P1|Overall Study|Physician Decision|1
4755266|NCT01702246|16405089|P1|Overall Study|Withdrawal by Subject|2
4755267|NCT01702246|16405089|P1|Overall Study|Lost to Follow-up|2
4755268|NCT01702025|16405143|P4|Overall Study|Adverse Event|0
4755269|NCT01702025|16405144|P3|Overall Study|Adverse Event|1
4755270|NCT01702025|16405145|P2|Overall Study|Adverse Event|1
4755271|NCT01702025|16405146|P1|Overall Study|Adverse Event|1
4755272|NCT01702025|16405143|P4|Overall Study|Equipment failure|0
4755273|NCT01702025|16405144|P3|Overall Study|Equipment failure|0
4755274|NCT01702025|16405145|P2|Overall Study|Equipment failure|0
4755275|NCT01702025|16405146|P1|Overall Study|Equipment failure|1
4755276|NCT01701973|16405175|P8|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755277|NCT01701973|16405176|P7|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755278|NCT01701973|16405177|P6|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755279|NCT01701973|16405178|P5|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755280|NCT01701973|16405179|P4|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755281|NCT01701973|16405180|P3|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755282|NCT01701973|16405181|P2|Aim 1: First Intervention (1 Day)|Adverse Event|1
4755283|NCT01701973|16405182|P1|Aim 1: First Intervention (1 Day)|Adverse Event|0
4755284|NCT01701401|16405308|P4|Overall Study|Protocol Violation|0
4755285|NCT01701401|16405309|P3|Overall Study|Protocol Violation|1
4755286|NCT01701401|16405310|P2|Overall Study|Protocol Violation|0
4755287|NCT01701401|16405311|P1|Overall Study|Protocol Violation|0
4755288|NCT01701401|16405308|P4|Overall Study|Adverse Event|0
4755289|NCT01701401|16405309|P3|Overall Study|Adverse Event|0
4755290|NCT01701401|16405310|P2|Overall Study|Adverse Event|0
4755291|NCT01701401|16405311|P1|Overall Study|Adverse Event|1
4755292|NCT01701401|16405308|P4|Overall Study|Lack of Efficacy|0
4755293|NCT01701401|16405309|P3|Overall Study|Lack of Efficacy|2
4755294|NCT01701401|16405310|P2|Overall Study|Lack of Efficacy|0
4755295|NCT01701401|16405311|P1|Overall Study|Lack of Efficacy|1
4755296|NCT01701401|16405308|P4|Overall Study|Withdrew Consent|2
4755297|NCT01701401|16405309|P3|Overall Study|Withdrew Consent|1
4755298|NCT01701401|16405310|P2|Overall Study|Withdrew Consent|3
4755299|NCT01701401|16405311|P1|Overall Study|Withdrew Consent|0
4755300|NCT01701401|16405308|P4|Overall Study|Lost to Follow-up|3
4755301|NCT01701401|16405309|P3|Overall Study|Lost to Follow-up|1
4755302|NCT01701401|16405310|P2|Overall Study|Lost to Follow-up|5
4755303|NCT01701401|16405311|P1|Overall Study|Lost to Follow-up|5
4755304|NCT01701401|16405308|P4|Overall Study|Randomized But Not Treated|1
4755305|NCT01701401|16405309|P3|Overall Study|Randomized But Not Treated|0
4755306|NCT01701401|16405310|P2|Overall Study|Randomized But Not Treated|1
4755307|NCT01701401|16405311|P1|Overall Study|Randomized But Not Treated|3
4755308|NCT01701362|16405363|P2|Overall Study|Reasons other than those mentioned above|5
4755309|NCT01701362|16405364|P1|Overall Study|Reasons other than those mentioned above|3
4755310|NCT01701362|16405363|P2|Overall Study|Randomized but not treated|2
4755311|NCT01701362|16405364|P1|Overall Study|Randomized but not treated|1
4755312|NCT01701362|16405363|P2|Overall Study|Death|1
4755313|NCT01701362|16405364|P1|Overall Study|Death|0
4755314|NCT01701362|16405363|P2|Overall Study|Insufficient clinical response|6
4755315|NCT01701362|16405364|P1|Overall Study|Insufficient clinical response|6
4755316|NCT01701362|16405363|P2|Overall Study|Lost to Follow-up|9
4755317|NCT01701362|16405364|P1|Overall Study|Lost to Follow-up|6
4755318|NCT01701362|16405363|P2|Overall Study|No longer willing to participate|14
4755319|NCT01701362|16405364|P1|Overall Study|No longer willing to participate|8
4755320|NCT01701362|16405363|P2|Overall Study|Protocol Violation|3
4755321|NCT01701362|16405364|P1|Overall Study|Protocol Violation|5
4755322|NCT01701362|16405363|P2|Overall Study|Adverse events related to study drug|10
4755323|NCT01701362|16405364|P1|Overall Study|Adverse events related to study drug|12
4755324|NCT01701362|16405363|P2|Overall Study|Adverse events not related to study drug|6
4755325|NCT01701362|16405364|P1|Overall Study|Adverse events not related to study drug|1
4755326|NCT01701258|16405402|P13|Assessment and Scheduling|Investigator Terminated|0
4755327|NCT01701258|16405403|P12|Assessment and Scheduling|Investigator Terminated|0
4755328|NCT01701258|16405404|P11|Assessment and Scheduling|Investigator Terminated|0
4755329|NCT01701258|16405405|P10|Assessment and Scheduling|Investigator Terminated|0
4755330|NCT01701258|16405406|P9|Assessment and Scheduling|Investigator Terminated|0
4755331|NCT01701258|16405407|P8|Assessment and Scheduling|Investigator Terminated|0
4755332|NCT01701258|16405408|P7|Assessment and Scheduling|Investigator Terminated|0
4755333|NCT01701258|16405409|P6|Assessment and Scheduling|Investigator Terminated|0
4755334|NCT01701258|16405410|P5|Assessment and Scheduling|Investigator Terminated|0
4755335|NCT01701258|16405411|P4|Assessment and Scheduling|Investigator Terminated|0
4755336|NCT01701258|16405412|P3|Assessment and Scheduling|Investigator Terminated|0
4755337|NCT01701258|16405413|P2|Assessment and Scheduling|Investigator Terminated|0
4755338|NCT01701258|16405414|P1|Assessment and Scheduling|Investigator Terminated|2
4755339|NCT01701258|16405402|P13|Assessment and Scheduling|Withdrawal by Subject|0
4755340|NCT01701258|16405403|P12|Assessment and Scheduling|Withdrawal by Subject|0
4755341|NCT01701258|16405404|P11|Assessment and Scheduling|Withdrawal by Subject|0
4755342|NCT01701258|16405405|P10|Assessment and Scheduling|Withdrawal by Subject|0
4755343|NCT01701258|16405406|P9|Assessment and Scheduling|Withdrawal by Subject|0
4755344|NCT01701258|16405407|P8|Assessment and Scheduling|Withdrawal by Subject|0
4755345|NCT01701258|16405408|P7|Assessment and Scheduling|Withdrawal by Subject|0
4755346|NCT01701258|16405409|P6|Assessment and Scheduling|Withdrawal by Subject|0
4755347|NCT01701258|16405410|P5|Assessment and Scheduling|Withdrawal by Subject|0
4755348|NCT01701258|16405411|P4|Assessment and Scheduling|Withdrawal by Subject|0
4755349|NCT01701258|16405412|P3|Assessment and Scheduling|Withdrawal by Subject|0
4755350|NCT01701258|16405413|P2|Assessment and Scheduling|Withdrawal by Subject|0
4755351|NCT01701258|16405414|P1|Assessment and Scheduling|Withdrawal by Subject|14
4755352|NCT01701258|16405402|P13|Assessment and Scheduling|Lost to Follow-up|0
4755353|NCT01701258|16405403|P12|Assessment and Scheduling|Lost to Follow-up|0
4755354|NCT01701258|16405404|P11|Assessment and Scheduling|Lost to Follow-up|0
4755355|NCT01701258|16405405|P10|Assessment and Scheduling|Lost to Follow-up|0
4755356|NCT01701258|16405406|P9|Assessment and Scheduling|Lost to Follow-up|0
4755357|NCT01701258|16405407|P8|Assessment and Scheduling|Lost to Follow-up|0
4755358|NCT01701258|16405408|P7|Assessment and Scheduling|Lost to Follow-up|0
4755359|NCT01701258|16405409|P6|Assessment and Scheduling|Lost to Follow-up|0
4755360|NCT01701258|16405410|P5|Assessment and Scheduling|Lost to Follow-up|0
4755361|NCT01701258|16405411|P4|Assessment and Scheduling|Lost to Follow-up|0
4755362|NCT01701258|16405412|P3|Assessment and Scheduling|Lost to Follow-up|0
4755363|NCT01701258|16405413|P2|Assessment and Scheduling|Lost to Follow-up|0
4755364|NCT01701258|16405414|P1|Assessment and Scheduling|Lost to Follow-up|10
4755365|NCT01701258|16405402|P13|Assessment and Scheduling|Found to be Ineligible|0
4755366|NCT01701258|16405403|P12|Assessment and Scheduling|Found to be Ineligible|0
4755367|NCT01701258|16405404|P11|Assessment and Scheduling|Found to be Ineligible|0
4755368|NCT01701258|16405405|P10|Assessment and Scheduling|Found to be Ineligible|0
4755369|NCT01701258|16405406|P9|Assessment and Scheduling|Found to be Ineligible|0
4755370|NCT01701258|16405407|P8|Assessment and Scheduling|Found to be Ineligible|0
4755371|NCT01701258|16405408|P7|Assessment and Scheduling|Found to be Ineligible|0
4755372|NCT01701258|16405409|P6|Assessment and Scheduling|Found to be Ineligible|0
4755373|NCT01701258|16405410|P5|Assessment and Scheduling|Found to be Ineligible|0
4755374|NCT01701258|16405411|P4|Assessment and Scheduling|Found to be Ineligible|0
4755375|NCT01701258|16405412|P3|Assessment and Scheduling|Found to be Ineligible|0
4755376|NCT01701258|16405413|P2|Assessment and Scheduling|Found to be Ineligible|0
4755377|NCT01701258|16405414|P1|Assessment and Scheduling|Found to be Ineligible|57
4755378|NCT01701245|16405468|P2|Overall Study|Did not complete the open label period|12
4755379|NCT01701245|16405469|P1|Overall Study|Did not complete the open label period|11
4755380|NCT01701245|16405468|P2|Overall Study|Protocol Violation|3
4755381|NCT01701245|16405469|P1|Overall Study|Protocol Violation|1
4755382|NCT01701063|16405516|P3|Overall Study|Other|1
4755383|NCT01701063|16405517|P2|Overall Study|Other|0
4755384|NCT01701063|16405518|P1|Overall Study|Other|0
4755385|NCT01701063|16405516|P3|Overall Study|Withdrawal by Subject|1
4755386|NCT01701063|16405517|P2|Overall Study|Withdrawal by Subject|0
4755387|NCT01701063|16405518|P1|Overall Study|Withdrawal by Subject|0
4755388|NCT01701063|16405516|P3|Overall Study|Lost to Follow-up|0
4755389|NCT01701063|16405517|P2|Overall Study|Lost to Follow-up|1
4755390|NCT01701063|16405518|P1|Overall Study|Lost to Follow-up|0
4755391|NCT01700985|16405602|P2|Overall Study|Incarcerated|1
4755392|NCT01700985|16405603|P1|Overall Study|Incarcerated|0
4755393|NCT01700959|16405625|P6|Overall Study|Side effects|1
4755394|NCT01700959|16405626|P5|Overall Study|Side effects|4
4755395|NCT01700959|16405627|P4|Overall Study|Side effects|4
4755396|NCT01700959|16405628|P3|Overall Study|Side effects|8
4755397|NCT01700959|16405629|P2|Overall Study|Side effects|4
4755398|NCT01700959|16405630|P1|Overall Study|Side effects|1
4755399|NCT01700959|16405625|P6|Overall Study|Noncompliant|9
4755400|NCT01700959|16405626|P5|Overall Study|Noncompliant|15
4755401|NCT01700959|16405627|P4|Overall Study|Noncompliant|18
4755402|NCT01700959|16405628|P3|Overall Study|Noncompliant|17
4755403|NCT01700959|16405629|P2|Overall Study|Noncompliant|9
4755404|NCT01700959|16405630|P1|Overall Study|Noncompliant|9
4755405|NCT01700959|16405625|P6|Overall Study|Ineligible|1
4755406|NCT01700959|16405626|P5|Overall Study|Ineligible|0
4755407|NCT01700959|16405627|P4|Overall Study|Ineligible|0
4755408|NCT01700959|16405628|P3|Overall Study|Ineligible|2
4755409|NCT01700959|16405629|P2|Overall Study|Ineligible|1
4755410|NCT01700959|16405630|P1|Overall Study|Ineligible|2
4755411|NCT01700959|16405625|P6|Overall Study|Withdrawal by Subject|12
4755412|NCT01700959|16405626|P5|Overall Study|Withdrawal by Subject|8
4755413|NCT01700959|16405627|P4|Overall Study|Withdrawal by Subject|11
4755414|NCT01700959|16405628|P3|Overall Study|Withdrawal by Subject|12
4755415|NCT01700959|16405629|P2|Overall Study|Withdrawal by Subject|9
4755416|NCT01700959|16405630|P1|Overall Study|Withdrawal by Subject|15
4755417|NCT01700959|16405625|P6|Overall Study|Adverse Event|2
4755418|NCT01700959|16405626|P5|Overall Study|Adverse Event|0
4755419|NCT01700959|16405627|P4|Overall Study|Adverse Event|2
4755420|NCT01700959|16405628|P3|Overall Study|Adverse Event|1
4755421|NCT01700959|16405629|P2|Overall Study|Adverse Event|1
4755422|NCT01700959|16405630|P1|Overall Study|Adverse Event|0
4755423|NCT01700829|16405671|P2|Overall Study|Withdrawal by Subject|1
4755424|NCT01700829|16405672|P1|Overall Study|Withdrawal by Subject|1
4755425|NCT01700621|16405732|P2|Analyzed for Immunogenicity|Baseline measles measure high|2
4755426|NCT01700621|16405733|P1|Analyzed for Immunogenicity|Baseline measles measure high|1
4755427|NCT01700621|16405732|P2|Analyzed for Immunogenicity|Protocol Violation|1
4755428|NCT01700621|16405733|P1|Analyzed for Immunogenicity|Protocol Violation|5
4755429|NCT01700621|16405732|P2|Analyzed for Immunogenicity|Lost to Follow-up|4
4755430|NCT01700621|16405733|P1|Analyzed for Immunogenicity|Lost to Follow-up|7
4755431|NCT01700530|16405771|P3|Overall Study|Withdrawal by Subject|1
4755432|NCT01700530|16405772|P2|Overall Study|Withdrawal by Subject|3
4755433|NCT01700530|16405773|P1|Overall Study|Withdrawal by Subject|0
4755434|NCT01700387|16405822|P2|Overall Study|Lost to Follow-up|1
4755435|NCT01700387|16405823|P1|Overall Study|Lost to Follow-up|2
4755436|NCT01700387|16405822|P2|Overall Study|Adverse Event|1
4755437|NCT01700387|16405823|P1|Overall Study|Adverse Event|1
4755438|NCT01700387|16405822|P2|Overall Study|Withdrawal by Subject|2
4755439|NCT01700387|16405823|P1|Overall Study|Withdrawal by Subject|1
4755440|NCT01700348|16405853|P1|Overall Study|Lost to Follow-up|1
4755441|NCT01700348|16405853|P1|Overall Study|Withdrawal by Subject|22
4755442|NCT01700205|16405876|P2|Overall Study|Protocol Violation|2
4755443|NCT01700205|16405877|P1|Overall Study|Protocol Violation|2
4755444|NCT01700205|16405876|P2|Overall Study|Withdrawal by Subject|13
4755445|NCT01700205|16405877|P1|Overall Study|Withdrawal by Subject|13
4755446|NCT01700192|16405899|P2|Overall Study|Never received study drug|0
4755447|NCT01700192|16405900|P1|Overall Study|Never received study drug|1
4755448|NCT01700192|16405899|P2|Overall Study|Withdrawal by Subject|64
4755449|NCT01700192|16405900|P1|Overall Study|Withdrawal by Subject|56
4755450|NCT01700192|16405899|P2|Overall Study|Technical problems|1
4755451|NCT01700192|16405900|P1|Overall Study|Technical problems|0
4755452|NCT01700192|16405899|P2|Overall Study|Protocol Violation|4
4755453|NCT01700192|16405900|P1|Overall Study|Protocol Violation|3
4755454|NCT01700192|16405899|P2|Overall Study|Progressive disease|0
4755455|NCT01700192|16405900|P1|Overall Study|Progressive disease|1
4755456|NCT01700192|16405899|P2|Overall Study|Pregnancy|4
4755457|NCT01700192|16405900|P1|Overall Study|Pregnancy|1
4755458|NCT01700192|16405899|P2|Overall Study|Physician Decision|3
4755459|NCT01700192|16405900|P1|Overall Study|Physician Decision|2
4755460|NCT01700192|16405899|P2|Overall Study|Noncompliance with study drug|5
4755461|NCT01700192|16405900|P1|Overall Study|Noncompliance with study drug|0
4755462|NCT01700192|16405899|P2|Overall Study|Lost to Follow-up|29
4755463|NCT01700192|16405900|P1|Overall Study|Lost to Follow-up|42
4755464|NCT01700192|16405899|P2|Overall Study|Lack of Efficacy|0
4755465|NCT01700192|16405900|P1|Overall Study|Lack of Efficacy|1
4755466|NCT01700192|16405899|P2|Overall Study|Adverse Event|18
4755467|NCT01700192|16405900|P1|Overall Study|Adverse Event|73
4755468|NCT01700179|16405918|P1|Overall Study|Physician Decision|2
4755469|NCT01700140|16405925|P3|Overall Study|Inclusion/exclusion criteria deviation|0
4755470|NCT01700140|16405926|P2|Overall Study|Inclusion/exclusion criteria deviation|4
4755471|NCT01700140|16405927|P1|Overall Study|Inclusion/exclusion criteria deviation|1
4755472|NCT01700140|16405925|P3|Overall Study|Adverse Event|0
4755473|NCT01700140|16405926|P2|Overall Study|Adverse Event|1
4755474|NCT01700140|16405927|P1|Overall Study|Adverse Event|0
4755475|NCT01700140|16405925|P3|Overall Study|Aggravation of symptoms|0
4755476|NCT01700140|16405926|P2|Overall Study|Aggravation of symptoms|0
4755477|NCT01700140|16405927|P1|Overall Study|Aggravation of symptoms|1
4755478|NCT01700140|16405925|P3|Overall Study|Use of chemotherapy or surgical therapy|0
4755479|NCT01700140|16405926|P2|Overall Study|Use of chemotherapy or surgical therapy|1
4755480|NCT01700140|16405927|P1|Overall Study|Use of chemotherapy or surgical therapy|0
4755481|NCT01700140|16405925|P3|Overall Study|Discontinuation of radiotherapy|0
4755482|NCT01700140|16405926|P2|Overall Study|Discontinuation of radiotherapy|0
4755483|NCT01700140|16405927|P1|Overall Study|Discontinuation of radiotherapy|1
4755484|NCT01700140|16405925|P3|Overall Study|Use of rescue drugs|1
4755485|NCT01700140|16405926|P2|Overall Study|Use of rescue drugs|3
4755486|NCT01700140|16405927|P1|Overall Study|Use of rescue drugs|3
4755487|NCT01700049|16405959|P1|Overall Study|Withdrawal by Subject|1
4755488|NCT01699867|16405974|P1|Overall Study|Screening Failure|3
4755489|NCT01699815|16405981|P2|Overall Study|Adverse Event|1
4755490|NCT01699815|16405982|P1|Overall Study|Adverse Event|0
4755491|NCT01699815|16405981|P2|Overall Study|record could not be located|0
4755492|NCT01699815|16405982|P1|Overall Study|record could not be located|1
4755493|NCT01699815|16405981|P2|Overall Study|Protocol Violation|7
4755494|NCT01699815|16405982|P1|Overall Study|Protocol Violation|4
4755495|NCT01699789|16405994|P2|Overall Study|Lost to Follow-up|101
4755496|NCT01699789|16405995|P1|Overall Study|Lost to Follow-up|83
4755497|NCT01699789|16405994|P2|Overall Study|Death|2
4755498|NCT01699789|16405995|P1|Overall Study|Death|1
4755499|NCT01699789|16405994|P2|Overall Study|Withdrawal by Subject|23
4755500|NCT01699789|16405995|P1|Overall Study|Withdrawal by Subject|18
4755501|NCT01699750|16406065|P2|Overall Study|Other|2
4755502|NCT01699750|16406066|P1|Overall Study|Other|0
4755503|NCT01699750|16406065|P2|Overall Study|Withdrew Consent|1
4755504|NCT01699750|16406066|P1|Overall Study|Withdrew Consent|0
4755505|NCT01699685|16406101|P2|Period 2|Lost to Follow-up|0
4755506|NCT01699685|16406102|P1|Period 2|Lost to Follow-up|1
4755507|NCT01699685|16406101|P2|Period 1|Patient request|1
4755508|NCT01699685|16406102|P1|Period 1|Patient request|0
4755509|NCT01699685|16406101|P2|Period 1|Other|1
4755510|NCT01699685|16406102|P1|Period 1|Other|0
4755511|NCT01699685|16406101|P2|Period 1|Medical or ethical, noncompliance|0
4755512|NCT01699685|16406102|P1|Period 1|Medical or ethical, noncompliance|2
4755513|NCT01699685|16406101|P2|Period 1|Adverse Event|1
4755514|NCT01699685|16406102|P1|Period 1|Adverse Event|1
4755515|NCT01699503|16406128|P2|Overall Study|Excluded due to quality|791
4755516|NCT01699503|16406129|P1|Overall Study|Excluded due to quality|783
4755517|NCT01699503|16406128|P2|Overall Study|Lost to Follow-up|117
4755518|NCT01699503|16406129|P1|Overall Study|Lost to Follow-up|121
4755519|NCT01699503|16406128|P2|Overall Study|Withdrawal by Subject|57
4755520|NCT01699503|16406129|P1|Overall Study|Withdrawal by Subject|65
4755521|NCT01699503|16406128|P2|Overall Study|Death|40
4755522|NCT01699503|16406129|P1|Overall Study|Death|31
4755523|NCT01699178|16406154|P2|Overall Study|ineligible/noncompliant/ subject reason|4
4755524|NCT01699178|16406155|P1|Overall Study|ineligible/noncompliant/ subject reason|4
4755525|NCT01699178|16406154|P2|Overall Study|PSA increase of >1.4 ng/mL|3
4755526|NCT01699178|16406155|P1|Overall Study|PSA increase of >1.4 ng/mL|4
4755527|NCT01699178|16406154|P2|Overall Study|Hematocrit >54%|1
4755528|NCT01699178|16406155|P1|Overall Study|Hematocrit >54%|1
4755529|NCT01699178|16406154|P2|Overall Study|Withdrawal by Subject|12
4755530|NCT01699178|16406155|P1|Overall Study|Withdrawal by Subject|4
4755531|NCT01699178|16406154|P2|Overall Study|Physician Decision|0
4755532|NCT01699178|16406155|P1|Overall Study|Physician Decision|1
4755533|NCT01699178|16406154|P2|Overall Study|Non-compliance with Study Drug|1
4755534|NCT01699178|16406155|P1|Overall Study|Non-compliance with Study Drug|3
4755535|NCT01699178|16406154|P2|Overall Study|Lost to Follow-up|6
4755536|NCT01699178|16406155|P1|Overall Study|Lost to Follow-up|1
4755537|NCT01699178|16406154|P2|Overall Study|Adverse Event|5
4755538|NCT01699178|16406155|P1|Overall Study|Adverse Event|1
4755539|NCT01699087|16406171|P1|Overall Study|Unable to make future visits|2
4755540|NCT01699087|16406171|P1|Overall Study|Screen failure (prior to treatment)|15
4755541|NCT01699087|16406171|P1|Overall Study|Lost to Follow-up|7
4755542|NCT01699022|16406185|P1|Overall Study|Early discontinuation from the study|3
4755543|NCT01698814|16406200|P2|Overall Study|Randomized in error|0
4755544|NCT01698814|16406201|P1|Overall Study|Randomized in error|1
4755545|NCT01698814|16406200|P2|Overall Study|Pregnancy|0
4755546|NCT01698814|16406201|P1|Overall Study|Pregnancy|1
4755547|NCT01698814|16406200|P2|Overall Study|Lost to Follow-up|1
4755548|NCT01698814|16406201|P1|Overall Study|Lost to Follow-up|0
4755549|NCT01698814|16406200|P2|Overall Study|Adverse Event|2
4755550|NCT01698814|16406201|P1|Overall Study|Adverse Event|0
4755551|NCT01698801|16406207|P1|Follow Up Phase|Death|4
4755552|NCT01698801|16406207|P1|Follow Up Phase|Withdrawal by Subject|1
4755553|NCT01698801|16406207|P1|Treatment Phase|Disease progression|1
4755554|NCT01698801|16406207|P1|Treatment Phase|Withdrawal by Subject|1
4755555|NCT01698801|16406207|P1|Treatment Phase|Other|4
4755556|NCT01698801|16406207|P1|Treatment Phase|Protocol Violation|1
4755557|NCT01698801|16406207|P1|Treatment Phase|Adverse Event|4
4755558|NCT01698775|16406218|P2|Phase B|Withdrawal by Subject|2
4755559|NCT01698775|16406219|P1|Phase B|Withdrawal by Subject|6
4755560|NCT01698775|16406218|P2|Phase B|Protocol Violation|1
4755561|NCT01698775|16406219|P1|Phase B|Protocol Violation|1
4755562|NCT01698775|16406218|P2|Phase B|Physician Decision|1
4755563|NCT01698775|16406219|P1|Phase B|Physician Decision|1
4755564|NCT01698775|16406218|P2|Phase B|Lost to Follow-up|1
4755565|NCT01698775|16406219|P1|Phase B|Lost to Follow-up|0
4755566|NCT01698775|16406218|P2|Phase B|Lack of Efficacy|1
4755567|NCT01698775|16406219|P1|Phase B|Lack of Efficacy|0
4755568|NCT01698775|16406218|P2|Phase B|Death|1
4755569|NCT01698775|16406219|P1|Phase B|Death|0
4755570|NCT01698775|16406218|P2|Phase B|Adverse Event|3
4755571|NCT01698775|16406219|P1|Phase B|Adverse Event|6
4755572|NCT01698775|16406218|P2|Phase B|Hyperglycemia Discontinuation Criteria|1
4755573|NCT01698775|16406219|P1|Phase B|Hyperglycemia Discontinuation Criteria|0
4755574|NCT01698775|16406218|P2|Phase A|Kidney [transplant]|1
4755575|NCT01698775|16406219|P1|Phase A|Kidney [transplant]|0
4755576|NCT01698775|16406218|P2|Phase A|Withdrawal by Subject|4
4755577|NCT01698775|16406219|P1|Phase A|Withdrawal by Subject|3
4755578|NCT01698775|16406218|P2|Phase A|Protocol Violation|0
4755579|NCT01698775|16406219|P1|Phase A|Protocol Violation|1
4755580|NCT01698775|16406218|P2|Phase A|Lost to Follow-up|2
4755581|NCT01698775|16406219|P1|Phase A|Lost to Follow-up|1
4755582|NCT01698775|16406218|P2|Phase A|Lack of Efficacy|0
4755583|NCT01698775|16406219|P1|Phase A|Lack of Efficacy|1
4755584|NCT01698775|16406218|P2|Phase A|Death|1
4755585|NCT01698775|16406219|P1|Phase A|Death|1
4755586|NCT01698775|16406218|P2|Phase A|Adverse Event|1
4755587|NCT01698775|16406219|P1|Phase A|Adverse Event|2
4755588|NCT01698554|16406268|P4|Overall Study|Other Miscellaneous Reasons|0
4755589|NCT01698554|16406269|P3|Overall Study|Other Miscellaneous Reasons|0
4755590|NCT01698554|16406270|P2|Overall Study|Other Miscellaneous Reasons|0
4755591|NCT01698554|16406271|P1|Overall Study|Other Miscellaneous Reasons|1
4755592|NCT01698554|16406268|P4|Overall Study|Protocol Violation|0
4755593|NCT01698554|16406269|P3|Overall Study|Protocol Violation|1
4755594|NCT01698554|16406270|P2|Overall Study|Protocol Violation|0
4755595|NCT01698554|16406271|P1|Overall Study|Protocol Violation|2
4755596|NCT01698554|16406268|P4|Overall Study|Personal Reasons|1
4755597|NCT01698554|16406269|P3|Overall Study|Personal Reasons|1
4755598|NCT01698554|16406270|P2|Overall Study|Personal Reasons|5
4755599|NCT01698554|16406271|P1|Overall Study|Personal Reasons|0
4755600|NCT01698554|16406268|P4|Overall Study|Lost to Follow-up|0
4755601|NCT01698554|16406269|P3|Overall Study|Lost to Follow-up|0
4755602|NCT01698554|16406270|P2|Overall Study|Lost to Follow-up|0
4755603|NCT01698554|16406271|P1|Overall Study|Lost to Follow-up|1
4755604|NCT01698554|16406268|P4|Overall Study|Adverse Event|1
4755605|NCT01698554|16406269|P3|Overall Study|Adverse Event|0
4755606|NCT01698554|16406270|P2|Overall Study|Adverse Event|5
4755607|NCT01698554|16406271|P1|Overall Study|Adverse Event|2
4755608|NCT01698320|16406341|P3|40-Week Open-Label Period|Lost to Follow-up|0
4755609|NCT01698320|16406342|P2|40-Week Open-Label Period|Lost to Follow-up|2
4755610|NCT01698320|16406343|P1|40-Week Open-Label Period|Lost to Follow-up|0
4755611|NCT01698320|16406341|P3|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
4755612|NCT01698320|16406342|P2|40-Week Open-Label Period|Sponsor requested subject withdrawal|1
4755613|NCT01698320|16406343|P1|40-Week Open-Label Period|Sponsor requested subject withdrawal|0
4755614|NCT01698320|16406341|P3|40-Week Open-Label Period|Pregnancy|1
4755615|NCT01698320|16406342|P2|40-Week Open-Label Period|Pregnancy|2
4755616|NCT01698320|16406343|P1|40-Week Open-Label Period|Pregnancy|0
4755617|NCT01698320|16406341|P3|40-Week Open-Label Period|Withdrawal by Subject|7
4755618|NCT01698320|16406342|P2|40-Week Open-Label Period|Withdrawal by Subject|11
4755619|NCT01698320|16406343|P1|40-Week Open-Label Period|Withdrawal by Subject|0
4755620|NCT01698320|16406341|P3|40-Week Open-Label Period|Adverse Event|2
4755621|NCT01698320|16406342|P2|40-Week Open-Label Period|Adverse Event|3
4755622|NCT01698320|16406343|P1|40-Week Open-Label Period|Adverse Event|0
4755623|NCT01698320|16406341|P3|12-Week Double-Blind Period|Lost to Follow-up|4
4755624|NCT01698320|16406342|P2|12-Week Double-Blind Period|Lost to Follow-up|0
4755625|NCT01698320|16406343|P1|12-Week Double-Blind Period|Lost to Follow-up|0
4755626|NCT01698320|16406341|P3|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2
4755627|NCT01698320|16406342|P2|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
4755628|NCT01698320|16406343|P1|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0
4755629|NCT01698320|16406341|P3|12-Week Double-Blind Period|Pregnancy|1
4755630|NCT01698320|16406342|P2|12-Week Double-Blind Period|Pregnancy|1
4755631|NCT01698320|16406343|P1|12-Week Double-Blind Period|Pregnancy|0
4755632|NCT01698320|16406341|P3|12-Week Double-Blind Period|Protocol Violation|2
4755633|NCT01698320|16406342|P2|12-Week Double-Blind Period|Protocol Violation|0
4755634|NCT01698320|16406343|P1|12-Week Double-Blind Period|Protocol Violation|0
4755635|NCT01698320|16406341|P3|12-Week Double-Blind Period|Withdrawal by Subject|2
4755636|NCT01698320|16406342|P2|12-Week Double-Blind Period|Withdrawal by Subject|2
4755637|NCT01698320|16406343|P1|12-Week Double-Blind Period|Withdrawal by Subject|0
4755638|NCT01698320|16406341|P3|12-Week Double-Blind Period|Adverse Event|1
4755639|NCT01698320|16406342|P2|12-Week Double-Blind Period|Adverse Event|1
4755640|NCT01698320|16406343|P1|12-Week Double-Blind Period|Adverse Event|0
4755641|NCT01698320|16406341|P3|Run-In Period (Week -1 to Day 0)|Other|0
4755642|NCT01698320|16406342|P2|Run-In Period (Week -1 to Day 0)|Other|0
4755643|NCT01698320|16406343|P1|Run-In Period (Week -1 to Day 0)|Other|1
4755644|NCT01698320|16406341|P3|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
4755645|NCT01698320|16406342|P2|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0
4755646|NCT01698320|16406343|P1|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1
4755647|NCT01698320|16406341|P3|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
4755648|NCT01698320|16406342|P2|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0
4755649|NCT01698320|16406343|P1|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1
4755650|NCT01698320|16406341|P3|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
4755651|NCT01698320|16406342|P2|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0
4755652|NCT01698320|16406343|P1|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24
4755653|NCT01698268|16406363|P2|Overall Study|Physician Decision|1
4755654|NCT01698268|16406364|P1|Overall Study|Physician Decision|2
4755655|NCT01698008|16406372|P2|Overall Study|Withdrawal by Subject|2
4755656|NCT01698008|16406373|P1|Overall Study|Withdrawal by Subject|1
4755657|NCT01697969|16406379|P1|Overall Study|Did not meet inc/exc criteria|3
4755658|NCT01697956|16406386|P2|Overall Study|Protocol Violation|1
4755659|NCT01697956|16406387|P1|Overall Study|Protocol Violation|1
4755660|NCT01697800|16406417|P2|Overall Study|Death|1
4755661|NCT01697800|16406418|P1|Overall Study|Death|0
4755662|NCT01697748|16406426|P2|Overall Study|Lost to Follow-up|65
4755663|NCT01697748|16406427|P1|Overall Study|Lost to Follow-up|53
4755664|NCT01697748|16406426|P2|Overall Study|ineligible uterine incision|1
4755665|NCT01697748|16406427|P1|Overall Study|ineligible uterine incision|4
4755666|NCT01697748|16406426|P2|Overall Study|ineligible skin incision|2
4755667|NCT01697748|16406427|P1|Overall Study|ineligible skin incision|1
4755668|NCT01697696|16406456|P2|Overall Study|Subject/guardian decision|35
4755669|NCT01697696|16406457|P1|Overall Study|Subject/guardian decision|31
4755670|NCT01697696|16406456|P2|Overall Study|Lost to Follow-up|7
4755671|NCT01697696|16406457|P1|Overall Study|Lost to Follow-up|10
4755672|NCT01697696|16406456|P2|Overall Study|Death|2
4755673|NCT01697696|16406457|P1|Overall Study|Death|4
4755674|NCT01697696|16406456|P2|Overall Study|Physician Decision|0
4755675|NCT01697696|16406457|P1|Overall Study|Physician Decision|1
4755676|NCT01697696|16406456|P2|Overall Study|Protocol deviation|0
4755677|NCT01697696|16406457|P1|Overall Study|Protocol deviation|1
4755678|NCT01697696|16406456|P2|Overall Study|Study terminated by sponsor|3
4755679|NCT01697696|16406457|P1|Overall Study|Study terminated by sponsor|0
4755680|NCT01697592|16406489|P10|Phase B (Week 25 to Week 52)|Adverse Event|0
4755681|NCT01697592|16406490|P9|Phase B (Week 25 to Week 52)|Adverse Event|2
4755682|NCT01697592|16406491|P8|Phase B (Week 25 to Week 52)|Adverse Event|0
4755683|NCT01697592|16406492|P7|Phase B (Week 25 to Week 52)|Adverse Event|1
4755684|NCT01697592|16406493|P6|Phase B (Week 25 to Week 52)|Adverse Event|1
4755685|NCT01697592|16406494|P5|Phase B (Week 25 to Week 52)|Adverse Event|0
4755686|NCT01697592|16406495|P4|Phase B (Week 25 to Week 52)|Adverse Event|2
4755687|NCT01697592|16406496|P3|Phase B (Week 25 to Week 52)|Adverse Event|1
4755688|NCT01697592|16406497|P2|Phase B (Week 25 to Week 52)|Adverse Event|1
4755689|NCT01697592|16406498|P1|Phase B (Week 25 to Week 52)|Adverse Event|2
4755690|NCT01697592|16406489|P10|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755691|NCT01697592|16406490|P9|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755692|NCT01697592|16406491|P8|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
4755693|NCT01697592|16406492|P7|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755694|NCT01697592|16406493|P6|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1
4755695|NCT01697592|16406494|P5|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755696|NCT01697592|16406495|P4|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755697|NCT01697592|16406496|P3|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755698|NCT01697592|16406497|P2|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0
4755699|NCT01697592|16406498|P1|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2
4755700|NCT01697592|16406489|P10|Phase B (Week 25 to Week 52)|Physician Decision|0
4755701|NCT01697592|16406490|P9|Phase B (Week 25 to Week 52)|Physician Decision|0
4755702|NCT01697592|16406491|P8|Phase B (Week 25 to Week 52)|Physician Decision|0
4755703|NCT01697592|16406492|P7|Phase B (Week 25 to Week 52)|Physician Decision|0
4755704|NCT01697592|16406493|P6|Phase B (Week 25 to Week 52)|Physician Decision|0
4755705|NCT01697592|16406494|P5|Phase B (Week 25 to Week 52)|Physician Decision|0
4755706|NCT01697592|16406495|P4|Phase B (Week 25 to Week 52)|Physician Decision|1
4755707|NCT01697592|16406496|P3|Phase B (Week 25 to Week 52)|Physician Decision|0
4755708|NCT01697592|16406497|P2|Phase B (Week 25 to Week 52)|Physician Decision|0
4755709|NCT01697592|16406498|P1|Phase B (Week 25 to Week 52)|Physician Decision|1
4755710|NCT01697592|16406489|P10|Phase A (Up to 24 Weeks)|Adverse Event|1
4755711|NCT01697592|16406490|P9|Phase A (Up to 24 Weeks)|Adverse Event|0
4755712|NCT01697592|16406491|P8|Phase A (Up to 24 Weeks)|Adverse Event|0
4755713|NCT01697592|16406492|P7|Phase A (Up to 24 Weeks)|Adverse Event|1
4755714|NCT01697592|16406493|P6|Phase A (Up to 24 Weeks)|Adverse Event|0
4755715|NCT01697592|16406494|P5|Phase A (Up to 24 Weeks)|Adverse Event|0
4755716|NCT01697592|16406495|P4|Phase A (Up to 24 Weeks)|Adverse Event|2
4755717|NCT01697592|16406496|P3|Phase A (Up to 24 Weeks)|Adverse Event|1
4755718|NCT01697592|16406497|P2|Phase A (Up to 24 Weeks)|Adverse Event|2
4755719|NCT01697592|16406498|P1|Phase A (Up to 24 Weeks)|Adverse Event|0
4755720|NCT01697592|16406489|P10|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4755721|NCT01697592|16406490|P9|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755722|NCT01697592|16406491|P8|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755723|NCT01697592|16406492|P7|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4755724|NCT01697592|16406493|P6|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755725|NCT01697592|16406494|P5|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755726|NCT01697592|16406495|P4|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755727|NCT01697592|16406496|P3|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0
4755728|NCT01697592|16406497|P2|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4755729|NCT01697592|16406498|P1|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1
4755730|NCT01697592|16406489|P10|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755731|NCT01697592|16406490|P9|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755732|NCT01697592|16406491|P8|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755733|NCT01697592|16406492|P7|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755734|NCT01697592|16406493|P6|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755735|NCT01697592|16406494|P5|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755736|NCT01697592|16406495|P4|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755737|NCT01697592|16406496|P3|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755738|NCT01697592|16406497|P2|Phase A (Up to 24 Weeks)|Protocol Violation|0
4755739|NCT01697592|16406498|P1|Phase A (Up to 24 Weeks)|Protocol Violation|1
4755740|NCT01697592|16406489|P10|Phase A (Up to 24 Weeks)|Physician Decision|0
4755741|NCT01697592|16406490|P9|Phase A (Up to 24 Weeks)|Physician Decision|0
4755742|NCT01697592|16406491|P8|Phase A (Up to 24 Weeks)|Physician Decision|0
4755743|NCT01697592|16406492|P7|Phase A (Up to 24 Weeks)|Physician Decision|0
4755744|NCT01697592|16406493|P6|Phase A (Up to 24 Weeks)|Physician Decision|1
4755745|NCT01697592|16406494|P5|Phase A (Up to 24 Weeks)|Physician Decision|0
4755746|NCT01697592|16406495|P4|Phase A (Up to 24 Weeks)|Physician Decision|0
4755747|NCT01697592|16406496|P3|Phase A (Up to 24 Weeks)|Physician Decision|0
4755748|NCT01697592|16406497|P2|Phase A (Up to 24 Weeks)|Physician Decision|0
4755749|NCT01697592|16406498|P1|Phase A (Up to 24 Weeks)|Physician Decision|0
4755750|NCT01697592|16406489|P10|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755751|NCT01697592|16406490|P9|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755752|NCT01697592|16406491|P8|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755753|NCT01697592|16406492|P7|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755754|NCT01697592|16406493|P6|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755755|NCT01697592|16406494|P5|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755756|NCT01697592|16406495|P4|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755757|NCT01697592|16406496|P3|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755758|NCT01697592|16406497|P2|Phase A (Up to 24 Weeks)|Lost to Follow-up|0
4755759|NCT01697592|16406498|P1|Phase A (Up to 24 Weeks)|Lost to Follow-up|1
4755760|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Lost to Follow-up|1
4755761|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4755762|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4755763|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4755764|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4755765|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4755766|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Lost to Follow-up|0
4755767|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4
4755768|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6
4755769|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4755770|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4755771|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4755772|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4755773|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0
4755774|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Participant Moved|2
4755775|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Participant Moved|0
4755776|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Participant Moved|0
4755777|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Participant Moved|0
4755778|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Participant Moved|0
4755779|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Participant Moved|0
4755780|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Participant Moved|0
4755781|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Technical Problems|1
4755782|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Technical Problems|0
4755783|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Technical Problems|0
4755784|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Technical Problems|0
4755785|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Technical Problems|0
4755786|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Technical Problems|0
4755787|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Technical Problems|0
4755788|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2
4755789|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4755790|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4755791|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4755792|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4755793|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4755794|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0
4755795|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11
4755796|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4
4755797|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4755798|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4755799|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4755800|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4755801|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0
4755802|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24
4755803|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15
4755804|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4755805|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4755806|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4755807|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4755808|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0
4755809|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4755810|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1
4755811|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4755812|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4755813|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4755814|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4755815|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0
4755816|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Excluded Medication|2
4755817|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Excluded Medication|1
4755818|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Excluded Medication|0
4755819|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Excluded Medication|0
4755820|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Excluded Medication|0
4755821|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Excluded Medication|0
4755822|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Excluded Medication|0
4755823|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Protocol Violation|4
4755824|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Protocol Violation|0
4755825|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Protocol Violation|0
4755826|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Protocol Violation|0
4755827|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Protocol Violation|0
4755828|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Protocol Violation|0
4755829|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Protocol Violation|0
4755830|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Physician Decision|11
4755831|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Physician Decision|7
4755832|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Physician Decision|0
4755833|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Physician Decision|0
4755834|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Physician Decision|0
4755835|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Physician Decision|0
4755836|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Physician Decision|0
4755837|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5
4755838|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1
4755839|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4755840|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4755841|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4755842|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4755843|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0
4755844|NCT01697579|16406567|P7|Optional Extension-Cycles 2-6|Death|2
4755845|NCT01697579|16406568|P6|Optional Extension-Cycles 2-6|Death|0
4755846|NCT01697579|16406569|P5|Optional Extension-Cycles 2-6|Death|0
4755847|NCT01697579|16406570|P4|Optional Extension-Cycles 2-6|Death|0
4755848|NCT01697579|16406571|P3|Optional Extension-Cycles 2-6|Death|0
4755849|NCT01697579|16406572|P2|Optional Extension-Cycles 2-6|Death|0
4755850|NCT01697579|16406573|P1|Optional Extension-Cycles 2-6|Death|0
4755851|NCT01697579|16406567|P7|Base Study-Cycle 1|Technical Problems|0
4755852|NCT01697579|16406568|P6|Base Study-Cycle 1|Technical Problems|0
4755853|NCT01697579|16406569|P5|Base Study-Cycle 1|Technical Problems|0
4755854|NCT01697579|16406570|P4|Base Study-Cycle 1|Technical Problems|1
4755855|NCT01697579|16406571|P3|Base Study-Cycle 1|Technical Problems|1
4755856|NCT01697579|16406572|P2|Base Study-Cycle 1|Technical Problems|0
4755857|NCT01697579|16406573|P1|Base Study-Cycle 1|Technical Problems|0
4755858|NCT01697579|16406567|P7|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4755859|NCT01697579|16406568|P6|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4755860|NCT01697579|16406569|P5|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4755861|NCT01697579|16406570|P4|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4755862|NCT01697579|16406571|P3|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4755863|NCT01697579|16406572|P2|Base Study-Cycle 1|Consent Withdrawn by Participant|1
4755864|NCT01697579|16406573|P1|Base Study-Cycle 1|Consent Withdrawn by Participant|0
4755865|NCT01697579|16406567|P7|Base Study-Cycle 1|Protocol Violation|0
4755866|NCT01697579|16406568|P6|Base Study-Cycle 1|Protocol Violation|0
4755867|NCT01697579|16406569|P5|Base Study-Cycle 1|Protocol Violation|3
4755868|NCT01697579|16406570|P4|Base Study-Cycle 1|Protocol Violation|0
4755869|NCT01697579|16406571|P3|Base Study-Cycle 1|Protocol Violation|0
4755870|NCT01697579|16406572|P2|Base Study-Cycle 1|Protocol Violation|0
4755871|NCT01697579|16406573|P1|Base Study-Cycle 1|Protocol Violation|0
4755872|NCT01697579|16406567|P7|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4755873|NCT01697579|16406568|P6|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4755874|NCT01697579|16406569|P5|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4755875|NCT01697579|16406570|P4|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4755876|NCT01697579|16406571|P3|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4755877|NCT01697579|16406572|P2|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0
4755878|NCT01697579|16406573|P1|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1
4755879|NCT01697579|16406567|P7|Base Study-Cycle 1|Adverse Event|0
4755880|NCT01697579|16406568|P6|Base Study-Cycle 1|Adverse Event|0
4755881|NCT01697579|16406569|P5|Base Study-Cycle 1|Adverse Event|0
4755882|NCT01697579|16406570|P4|Base Study-Cycle 1|Adverse Event|0
4755883|NCT01697579|16406571|P3|Base Study-Cycle 1|Adverse Event|0
4755884|NCT01697579|16406572|P2|Base Study-Cycle 1|Adverse Event|0
4755885|NCT01697579|16406573|P1|Base Study-Cycle 1|Adverse Event|1
4755886|NCT01697501|16406685|P1|Overall Study|Protocol Violation|2
4755887|NCT01697462|16406728|P1|Overall Study|Missing|5
4755888|NCT01697462|16406728|P1|Overall Study|Other|10
4755889|NCT01697462|16406728|P1|Overall Study|Death|1
4755890|NCT01697462|16406728|P1|Overall Study|Investigator Decision|21
4755891|NCT01697462|16406728|P1|Overall Study|Withdrawal by Subject|12
4755892|NCT01697462|16406728|P1|Overall Study|Lost to Follow-up|21
4755893|NCT01697462|16406728|P1|Overall Study|Adverse Event|6
4755894|NCT01697462|16406728|P1|Overall Study|Disease Progression|1
4755895|NCT01697449|16406735|P1|Overall Study|Missing|25
4755896|NCT01697449|16406735|P1|Overall Study|Other|1
4755897|NCT01697449|16406735|P1|Overall Study|Death|2
4755898|NCT01697449|16406735|P1|Overall Study|Physician Decision|1
4755899|NCT01697449|16406735|P1|Overall Study|Withdrawal by Subject|2
4755900|NCT01697449|16406735|P1|Overall Study|Lost to Follow-up|5
4755901|NCT01697449|16406735|P1|Overall Study|Adverse Event|7
4755902|NCT01697449|16406735|P1|Overall Study|Disease progression|47
4755903|NCT01697358|16406746|P2|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26
4755904|NCT01697358|16406747|P1|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34
4755905|NCT01697358|16406746|P2|Period II: 6-24M Long-term Follow-up|Adverse Event|3
4755906|NCT01697358|16406747|P1|Period II: 6-24M Long-term Follow-up|Adverse Event|0
4755907|NCT01697358|16406746|P2|Period II: 6-24M Long-term Follow-up|Death|1
4755908|NCT01697358|16406747|P1|Period II: 6-24M Long-term Follow-up|Death|1
4755909|NCT01697358|16406746|P2|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
4755910|NCT01697358|16406747|P1|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3
4755911|NCT01697358|16406746|P2|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10
4755912|NCT01697358|16406747|P1|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8
4755913|NCT01697358|16406746|P2|Period II: 6-24M Long-term Follow-up|Physician Decision|12
4755914|NCT01697358|16406747|P1|Period II: 6-24M Long-term Follow-up|Physician Decision|3
4755915|NCT01697358|16406746|P2|Period I: Randomization to 6 Months|Lost to Follow-up|0
4755916|NCT01697358|16406747|P1|Period I: Randomization to 6 Months|Lost to Follow-up|2
4755917|NCT01697358|16406746|P2|Period I: Randomization to 6 Months|Adverse Event|1
4755918|NCT01697358|16406747|P1|Period I: Randomization to 6 Months|Adverse Event|1
4755919|NCT01697358|16406746|P2|Period I: Randomization to 6 Months|Physician Decision|0
4755920|NCT01697358|16406747|P1|Period I: Randomization to 6 Months|Physician Decision|4
4755921|NCT01697358|16406746|P2|Period I: Randomization to 6 Months|Withdrawal by Subject|0
4755922|NCT01697358|16406747|P1|Period I: Randomization to 6 Months|Withdrawal by Subject|6
4755923|NCT01697345|16406763|P1|Overall Study|Withdrawal by Subject|1
4755924|NCT01697319|16406788|P1|Extension Phase|Terminated by Sponsor|15
4755925|NCT01697319|16406788|P1|Primary Phase|Withdrawal by Subject|1
4755926|NCT01696994|16406797|P2|Overall Study|Refused Screen (Ovarian Screening)|3582
4755927|NCT01696994|16406798|P1|Overall Study|Refused Screen (Ovarian Screening)|0
4755928|NCT01696994|16406797|P2|Overall Study|Refused ASU (Control)|0
4755929|NCT01696994|16406798|P1|Overall Study|Refused ASU (Control)|311
4755930|NCT01696994|16406797|P2|Overall Study|No Ovaries at Baseline|4851
4755931|NCT01696994|16406798|P1|Overall Study|No Ovaries at Baseline|4807
4755932|NCT01696994|16406797|P2|Overall Study|Died Before ASU (Control)|0
4755933|NCT01696994|16406798|P1|Overall Study|Died Before ASU (Control)|73
4755934|NCT01696994|16406797|P2|Overall Study|Died Before Randomization|2
4755935|NCT01696994|16406798|P1|Overall Study|Died Before Randomization|1
4755936|NCT01696994|16406797|P2|Overall Study|Cancer Before Rand. (Ovarian Screening)|2
4755937|NCT01696994|16406798|P1|Overall Study|Cancer Before Rand. (Ovarian Screening)|0
4755938|NCT01696981|16406826|P2|Overall Study|Refused Screen (Colorectal Screening)|10346
4755939|NCT01696981|16406827|P1|Overall Study|Refused Screen (Colorectal Screening)|0
4755940|NCT01696981|16406826|P2|Overall Study|Refused ASU (Control)|0
4755941|NCT01696981|16406827|P1|Overall Study|Refused ASU (Control)|920
4755942|NCT01696981|16406826|P2|Overall Study|Died Before ASU (Control)|0
4755943|NCT01696981|16406827|P1|Overall Study|Died Before ASU (Control)|278
4755944|NCT01696981|16406826|P2|Overall Study|Died Before Randomization|8
4755945|NCT01696981|16406827|P1|Overall Study|Died Before Randomization|3
4755946|NCT01696981|16406826|P2|Overall Study|Cancer Before Rand. (Colo. Screening)|20
4755947|NCT01696981|16406827|P1|Overall Study|Cancer Before Rand. (Colo. Screening)|0
4755948|NCT01696968|16406847|P2|Overall Study|Refused Screen (Lung Screening)|6796
4755949|NCT01696968|16406848|P1|Overall Study|Refused Screen (Lung Screening)|0
4755950|NCT01696968|16406847|P2|Overall Study|Refused ASU (Control)|0
4755951|NCT01696968|16406848|P1|Overall Study|Refused ASU (Control)|920
4755952|NCT01696968|16406847|P2|Overall Study|Died Before ASU (Control)|0
4755953|NCT01696968|16406848|P1|Overall Study|Died Before ASU (Control)|278
4755954|NCT01696968|16406847|P2|Overall Study|Died Before Randomization|8
4755955|NCT01696968|16406848|P1|Overall Study|Died Before Randomization|3
4755956|NCT01696968|16406847|P2|Overall Study|Cancer Before Rand. (Lung Screening)|8
4755957|NCT01696968|16406848|P1|Overall Study|Cancer Before Rand. (Lung Screening)|0
4755958|NCT01696955|16406870|P2|Main Study|Withdrawal by Subject|1
4755959|NCT01696955|16406871|P1|Main Study|Withdrawal by Subject|1
4755960|NCT01696955|16406870|P2|Main Study|Protocol Violation|0
4755961|NCT01696955|16406871|P1|Main Study|Protocol Violation|1
4755962|NCT01696942|16406896|P2|Overall Study|screen failure|1
4755963|NCT01696942|16406897|P1|Overall Study|screen failure|0
4755964|NCT01696942|16406896|P2|Overall Study|Protocol Violation|2
4755965|NCT01696942|16406897|P1|Overall Study|Protocol Violation|1
4755966|NCT01696942|16406896|P2|Overall Study|Withdrawal by Subject|0
4755967|NCT01696942|16406897|P1|Overall Study|Withdrawal by Subject|1
4755968|NCT01696929|16406905|P1|Overall Study|Physician Decision|1
4755969|NCT01696877|16406912|P2|Overall Study|Adverse Event|1
4755970|NCT01696877|16406913|P1|Overall Study|Adverse Event|0
4755971|NCT01696773|16406935|P2|Days 15-27, Washout|Adverse Event|0
4755972|NCT01696773|16406936|P1|Days 15-27, Washout|Adverse Event|1
4755973|NCT01696695|16406963|P1|Overall Study|Major Protocol Violation|192
4755974|NCT01696695|16406963|P1|Overall Study|Other|74
4755975|NCT01696695|16406963|P1|Overall Study|Lost to Follow-up|48
4755976|NCT01696695|16406963|P1|Overall Study|Withdrawal by Subject|92
4755977|NCT01696695|16406963|P1|Overall Study|Adverse Event|74
4755978|NCT01696695|16406963|P1|Overall Study|Death|29
4755979|NCT01696695|16406963|P1|Overall Study|Disease progression|373
4755980|NCT01696643|16406975|P2|Overall Study|Participant Did Not Receive Study Drug|2
4755981|NCT01696643|16406976|P1|Overall Study|Participant Did Not Receive Study Drug|2
4755982|NCT01696643|16406975|P2|Overall Study|Medical Monitor Decision|2
4755983|NCT01696643|16406976|P1|Overall Study|Medical Monitor Decision|0
4755984|NCT01696643|16406975|P2|Overall Study|Participant Incarcerated|1
4755985|NCT01696643|16406976|P1|Overall Study|Participant Incarcerated|0
4755986|NCT01696643|16406975|P2|Overall Study|Site Error|1
4755987|NCT01696643|16406976|P1|Overall Study|Site Error|2
4755988|NCT01696643|16406975|P2|Overall Study|Participant on Restricted Bed Rest|0
4755989|NCT01696643|16406976|P1|Overall Study|Participant on Restricted Bed Rest|1
4755990|NCT01696643|16406975|P2|Overall Study|Withdrawal by Subject|149
4755991|NCT01696643|16406976|P1|Overall Study|Withdrawal by Subject|142
4755992|NCT01696643|16406975|P2|Overall Study|Study Terminated by Sponsor|294
4755993|NCT01696643|16406976|P1|Overall Study|Study Terminated by Sponsor|286
4755994|NCT01696643|16406975|P2|Overall Study|Protocol Violation|7
4755995|NCT01696643|16406976|P1|Overall Study|Protocol Violation|7
4755996|NCT01696643|16406975|P2|Overall Study|Pregnancy|1
4755997|NCT01696643|16406976|P1|Overall Study|Pregnancy|0
4755998|NCT01696643|16406975|P2|Overall Study|Physician Decision|2
4755999|NCT01696643|16406976|P1|Overall Study|Physician Decision|3
4756000|NCT01696643|16406975|P2|Overall Study|Lost to Follow-up|67
4756001|NCT01696643|16406976|P1|Overall Study|Lost to Follow-up|67
4756002|NCT01696643|16406975|P2|Overall Study|Lack of Efficacy|0
4756003|NCT01696643|16406976|P1|Overall Study|Lack of Efficacy|3
4756004|NCT01696643|16406975|P2|Overall Study|Death|2
4756005|NCT01696643|16406976|P1|Overall Study|Death|1
4756006|NCT01696643|16406975|P2|Overall Study|Adverse Event|7
4756007|NCT01696643|16406976|P1|Overall Study|Adverse Event|15
4756008|NCT01696396|16406995|P4|Overall Study|Death|0
4756009|NCT01696396|16406996|P3|Overall Study|Death|1
4756010|NCT01696396|16406997|P2|Overall Study|Death|0
4756011|NCT01696396|16406998|P1|Overall Study|Death|0
4756012|NCT01696396|16406995|P4|Overall Study|Lost to Follow-up|1
4756013|NCT01696396|16406996|P3|Overall Study|Lost to Follow-up|4
4756014|NCT01696396|16406997|P2|Overall Study|Lost to Follow-up|1
4756015|NCT01696396|16406998|P1|Overall Study|Lost to Follow-up|9
4756016|NCT01696396|16406995|P4|Overall Study|Decision by Sponsor|2
4756017|NCT01696396|16406996|P3|Overall Study|Decision by Sponsor|2
4756018|NCT01696396|16406997|P2|Overall Study|Decision by Sponsor|1
4756019|NCT01696396|16406998|P1|Overall Study|Decision by Sponsor|3
4756020|NCT01696396|16406995|P4|Overall Study|Withdrawal by Subject|11
4756021|NCT01696396|16406996|P3|Overall Study|Withdrawal by Subject|19
4756022|NCT01696396|16406997|P2|Overall Study|Withdrawal by Subject|5
4756023|NCT01696396|16406998|P1|Overall Study|Withdrawal by Subject|19
4756024|NCT01696279|16407049|P4|Part 3: Lanthanum Carbonate (6 Months)|Missing|1
4756025|NCT01696279|16407050|P3|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
4756026|NCT01696279|16407051|P2|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
4756027|NCT01696279|16407052|P1|Part 3: Lanthanum Carbonate (6 Months)|Missing|0
4756028|NCT01696279|16407049|P4|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1
4756029|NCT01696279|16407050|P3|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
4756030|NCT01696279|16407051|P2|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
4756031|NCT01696279|16407052|P1|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0
4756032|NCT01696279|16407049|P4|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6
4756033|NCT01696279|16407050|P3|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
4756034|NCT01696279|16407051|P2|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
4756035|NCT01696279|16407052|P1|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0
4756036|NCT01696279|16407049|P4|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
4756037|NCT01696279|16407050|P3|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1
4756038|NCT01696279|16407051|P2|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
4756039|NCT01696279|16407052|P1|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0
4756040|NCT01696279|16407049|P4|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
4756041|NCT01696279|16407050|P3|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
4756042|NCT01696279|16407051|P2|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2
4756043|NCT01696279|16407052|P1|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0
4756044|NCT01696279|16407049|P4|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
4756045|NCT01696279|16407050|P3|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
4756046|NCT01696279|16407051|P2|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7
4756047|NCT01696279|16407052|P1|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0
4756048|NCT01696279|16407049|P4|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
4756049|NCT01696279|16407050|P3|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
4756050|NCT01696279|16407051|P2|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3
4756051|NCT01696279|16407052|P1|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0
4756052|NCT01696279|16407049|P4|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
4756053|NCT01696279|16407050|P3|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
4756054|NCT01696279|16407051|P2|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1
4756055|NCT01696279|16407052|P1|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0
4756056|NCT01696279|16407049|P4|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
4756057|NCT01696279|16407050|P3|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
4756058|NCT01696279|16407051|P2|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1
4756059|NCT01696279|16407052|P1|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0
4756060|NCT01696279|16407049|P4|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
4756061|NCT01696279|16407050|P3|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
4756062|NCT01696279|16407051|P2|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5
4756063|NCT01696279|16407052|P1|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0
4756064|NCT01696279|16407049|P4|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
4756065|NCT01696279|16407050|P3|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
4756066|NCT01696279|16407051|P2|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0
4756067|NCT01696279|16407052|P1|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1
4756068|NCT01696214|16407090|P4|Overall Study|Lost to Follow-up|0
4756069|NCT01696214|16407091|P3|Overall Study|Lost to Follow-up|0
4756070|NCT01696214|16407092|P2|Overall Study|Lost to Follow-up|0
4756071|NCT01696214|16407093|P1|Overall Study|Lost to Follow-up|1
4756072|NCT01696188|16407113|P2|Overall Study|Protocol Violation|1
4756073|NCT01696188|16407114|P1|Overall Study|Protocol Violation|1
4756074|NCT01696071|16407145|P2|Treatment Period 2: 4 Weeks|Adverse Event|0
4756075|NCT01696071|16407146|P1|Treatment Period 2: 4 Weeks|Adverse Event|1
4756076|NCT01696058|16407174|P2|Overall Study|Other reason prematurely discontinued|3
4756077|NCT01696058|16407175|P1|Overall Study|Other reason prematurely discontinued|5
4756078|NCT01696058|16407174|P2|Overall Study|Withdrawal by Subject|6
4756079|NCT01696058|16407175|P1|Overall Study|Withdrawal by Subject|4
4756080|NCT01696058|16407174|P2|Overall Study|Lost to Follow-up|5
4756081|NCT01696058|16407175|P1|Overall Study|Lost to Follow-up|2
4756082|NCT01696058|16407174|P2|Overall Study|Protocol Violation|3
4756083|NCT01696058|16407175|P1|Overall Study|Protocol Violation|9
4756084|NCT01696058|16407174|P2|Overall Study|Lack of Efficacy|3
4756085|NCT01696058|16407175|P1|Overall Study|Lack of Efficacy|2
4756086|NCT01696058|16407174|P2|Overall Study|Adverse Event|11
4756087|NCT01696058|16407175|P1|Overall Study|Adverse Event|21
4756088|NCT01696045|16407203|P2|Overall Study|Disease progression|2
4756089|NCT01696045|16407204|P1|Overall Study|Disease progression|2
4756090|NCT01696045|16407203|P2|Overall Study|Study drug toxicity|5
4756091|NCT01696045|16407204|P1|Overall Study|Study drug toxicity|1
4756092|NCT01695993|16407223|P3|Overall Study|Changed Medical Facility|1
4756093|NCT01695993|16407224|P2|Overall Study|Changed Medical Facility|0
4756094|NCT01695993|16407225|P1|Overall Study|Changed Medical Facility|0
4756095|NCT01695993|16407223|P3|Overall Study|To ill to continue|0
4756096|NCT01695993|16407224|P2|Overall Study|To ill to continue|2
4756097|NCT01695993|16407225|P1|Overall Study|To ill to continue|1
4756098|NCT01695993|16407223|P3|Overall Study|Withdrawal by Subject|2
4756099|NCT01695993|16407224|P2|Overall Study|Withdrawal by Subject|2
4756100|NCT01695993|16407225|P1|Overall Study|Withdrawal by Subject|2
4756101|NCT01695993|16407223|P3|Overall Study|Lost to Follow-up|3
4756102|NCT01695993|16407224|P2|Overall Study|Lost to Follow-up|1
4756103|NCT01695993|16407225|P1|Overall Study|Lost to Follow-up|2
4756104|NCT01695954|16407235|P2|Overall Study|Adverse Event|2
4756105|NCT01695954|16407236|P1|Overall Study|Adverse Event|0
4756106|NCT01695954|16407235|P2|Overall Study|Withdrawal by Subject|0
4756107|NCT01695954|16407236|P1|Overall Study|Withdrawal by Subject|4
4756108|NCT01695772|16407246|P1|Overall Study|Unspecified Reason|1
4756109|NCT01695772|16407246|P1|Overall Study|Protocol Violation|2
4756110|NCT01695772|16407246|P1|Overall Study|Lost to Follow-up|4
4756111|NCT01695772|16407246|P1|Overall Study|Investigator Decision|5
4756112|NCT01695772|16407246|P1|Overall Study|Progressive Disease|8
4756113|NCT01695772|16407246|P1|Overall Study|Withdrawal by Subject|18
4756114|NCT01695746|16407258|P1|Overall Study|Participant not willing to participate|3
4756115|NCT01695746|16407258|P1|Overall Study|Protocol Violation|5
4756116|NCT01695746|16407258|P1|Overall Study|Non-compliance by the participant|3
4756117|NCT01695746|16407258|P1|Overall Study|Adverse Event|1
4756118|NCT01695239|16407318|P14|Post-Treatment Follow-Up Period|Protocol Violation|1
4756119|NCT01695239|16407319|P13|Post-Treatment Follow-Up Period|Protocol Violation|0
4756120|NCT01695239|16407320|P12|Post-Treatment Follow-Up Period|Protocol Violation|0
4756121|NCT01695239|16407321|P11|Post-Treatment Follow-Up Period|Protocol Violation|0
4756122|NCT01695239|16407322|P10|Post-Treatment Follow-Up Period|Protocol Violation|0
4756123|NCT01695239|16407323|P9|Post-Treatment Follow-Up Period|Protocol Violation|0
4756124|NCT01695239|16407324|P8|Post-Treatment Follow-Up Period|Protocol Violation|0
4756125|NCT01695239|16407325|P7|Post-Treatment Follow-Up Period|Protocol Violation|0
4756126|NCT01695239|16407326|P6|Post-Treatment Follow-Up Period|Protocol Violation|0
4756127|NCT01695239|16407327|P5|Post-Treatment Follow-Up Period|Protocol Violation|0
4756128|NCT01695239|16407328|P4|Post-Treatment Follow-Up Period|Protocol Violation|0
4756129|NCT01695239|16407329|P3|Post-Treatment Follow-Up Period|Protocol Violation|0
4756130|NCT01695239|16407330|P2|Post-Treatment Follow-Up Period|Protocol Violation|0
4756131|NCT01695239|16407331|P1|Post-Treatment Follow-Up Period|Protocol Violation|0
4756132|NCT01695239|16407318|P14|Post-Treatment Follow-Up Period|Physician Decision|0
4756133|NCT01695239|16407319|P13|Post-Treatment Follow-Up Period|Physician Decision|2
4756134|NCT01695239|16407320|P12|Post-Treatment Follow-Up Period|Physician Decision|0
4756135|NCT01695239|16407321|P11|Post-Treatment Follow-Up Period|Physician Decision|0
4756136|NCT01695239|16407322|P10|Post-Treatment Follow-Up Period|Physician Decision|0
4756137|NCT01695239|16407323|P9|Post-Treatment Follow-Up Period|Physician Decision|0
4756138|NCT01695239|16407324|P8|Post-Treatment Follow-Up Period|Physician Decision|0
4756139|NCT01695239|16407325|P7|Post-Treatment Follow-Up Period|Physician Decision|0
4756140|NCT01695239|16407326|P6|Post-Treatment Follow-Up Period|Physician Decision|0
4756141|NCT01695239|16407327|P5|Post-Treatment Follow-Up Period|Physician Decision|0
4756142|NCT01695239|16407328|P4|Post-Treatment Follow-Up Period|Physician Decision|0
4756143|NCT01695239|16407329|P3|Post-Treatment Follow-Up Period|Physician Decision|0
4756144|NCT01695239|16407330|P2|Post-Treatment Follow-Up Period|Physician Decision|0
4756145|NCT01695239|16407331|P1|Post-Treatment Follow-Up Period|Physician Decision|0
4756146|NCT01695239|16407318|P14|Post-Treatment Follow-Up Period|Lost to Follow-up|1
4756147|NCT01695239|16407319|P13|Post-Treatment Follow-Up Period|Lost to Follow-up|1
4756148|NCT01695239|16407320|P12|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756149|NCT01695239|16407321|P11|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756150|NCT01695239|16407322|P10|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756151|NCT01695239|16407323|P9|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756152|NCT01695239|16407324|P8|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756153|NCT01695239|16407325|P7|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756154|NCT01695239|16407326|P6|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756155|NCT01695239|16407327|P5|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756156|NCT01695239|16407328|P4|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756157|NCT01695239|16407329|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756158|NCT01695239|16407330|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756159|NCT01695239|16407331|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|0
4756160|NCT01695239|16407318|P14|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
4756161|NCT01695239|16407319|P13|Post-Treatment Follow-Up Period|Withdrawal by Subject|6
4756162|NCT01695239|16407320|P12|Post-Treatment Follow-Up Period|Withdrawal by Subject|1
4756163|NCT01695239|16407321|P11|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756164|NCT01695239|16407322|P10|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756165|NCT01695239|16407323|P9|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756166|NCT01695239|16407324|P8|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756167|NCT01695239|16407325|P7|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756168|NCT01695239|16407326|P6|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756169|NCT01695239|16407327|P5|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756170|NCT01695239|16407328|P4|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756171|NCT01695239|16407329|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756172|NCT01695239|16407330|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756173|NCT01695239|16407331|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|0
4756174|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Death|0
4756175|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Death|0
4756176|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Death|0
4756177|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Death|0
4756178|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Death|0
4756179|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Death|1
4756180|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Death|0
4756181|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Death|0
4756182|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Death|0
4756183|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Death|0
4756184|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Death|0
4756185|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Death|0
4756186|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Death|0
4756187|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Death|0
4756188|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Sponsor Decision|0
4756189|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Sponsor Decision|0
4756190|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Sponsor Decision|0
4756191|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Sponsor Decision|0
4756192|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Sponsor Decision|1
4756193|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Sponsor Decision|2
4756194|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Sponsor Decision|0
4756195|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Sponsor Decision|0
4756196|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Sponsor Decision|0
4756197|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Sponsor Decision|0
4756198|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Sponsor Decision|0
4756199|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Sponsor Decision|0
4756200|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Sponsor Decision|0
4756201|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Sponsor Decision|0
4756202|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756203|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756204|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756205|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756206|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Lost to Follow-up|1
4756207|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Lost to Follow-up|2
4756208|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756209|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756210|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756211|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756212|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756213|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756214|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756215|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Lost to Follow-up|0
4756216|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Physician Decision|0
4756217|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Physician Decision|0
4756218|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Physician Decision|0
4756219|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Physician Decision|0
4756220|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Physician Decision|0
4756221|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Physician Decision|3
4756222|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Physician Decision|0
4756223|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Physician Decision|0
4756224|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Physician Decision|0
4756225|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Physician Decision|0
4756226|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Physician Decision|0
4756227|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Physician Decision|0
4756228|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Physician Decision|0
4756229|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Physician Decision|0
4756230|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756231|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756232|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756233|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756234|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Withdrawal by Subject|7
4756235|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Withdrawal by Subject|6
4756236|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756237|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756238|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756239|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756240|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756241|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756242|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756243|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Withdrawal by Subject|0
4756244|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Adverse Event|0
4756245|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Adverse Event|0
4756246|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Adverse Event|0
4756247|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Adverse Event|0
4756248|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Adverse Event|21
4756249|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Adverse Event|15
4756250|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Adverse Event|0
4756251|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Adverse Event|0
4756252|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Adverse Event|0
4756253|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Adverse Event|0
4756254|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Adverse Event|0
4756255|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Adverse Event|0
4756256|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Adverse Event|0
4756257|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Adverse Event|0
4756258|NCT01695239|16407318|P14|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756259|NCT01695239|16407319|P13|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756260|NCT01695239|16407320|P12|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756261|NCT01695239|16407321|P11|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756262|NCT01695239|16407322|P10|Extension Long-Term Extension Periods|Lack of Efficacy|31
4756263|NCT01695239|16407323|P9|Extension Long-Term Extension Periods|Lack of Efficacy|37
4756264|NCT01695239|16407324|P8|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756265|NCT01695239|16407325|P7|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756266|NCT01695239|16407326|P6|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756267|NCT01695239|16407327|P5|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756268|NCT01695239|16407328|P4|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756269|NCT01695239|16407329|P3|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756270|NCT01695239|16407330|P2|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756271|NCT01695239|16407331|P1|Extension Long-Term Extension Periods|Lack of Efficacy|0
4756272|NCT01695239|16407318|P14|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756273|NCT01695239|16407319|P13|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756274|NCT01695239|16407320|P12|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756275|NCT01695239|16407321|P11|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756276|NCT01695239|16407322|P10|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756277|NCT01695239|16407323|P9|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756278|NCT01695239|16407324|P8|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1
4756279|NCT01695239|16407325|P7|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756280|NCT01695239|16407326|P6|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756281|NCT01695239|16407327|P5|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756282|NCT01695239|16407328|P4|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756283|NCT01695239|16407329|P3|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756284|NCT01695239|16407330|P2|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756285|NCT01695239|16407331|P1|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0
4756286|NCT01695239|16407318|P14|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756287|NCT01695239|16407319|P13|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756288|NCT01695239|16407320|P12|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756289|NCT01695239|16407321|P11|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756290|NCT01695239|16407322|P10|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756291|NCT01695239|16407323|P9|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756292|NCT01695239|16407324|P8|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1
4756293|NCT01695239|16407325|P7|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756294|NCT01695239|16407326|P6|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756295|NCT01695239|16407327|P5|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756296|NCT01695239|16407328|P4|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756297|NCT01695239|16407329|P3|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756298|NCT01695239|16407330|P2|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756299|NCT01695239|16407331|P1|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0
4756300|NCT01695239|16407318|P14|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756301|NCT01695239|16407319|P13|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756302|NCT01695239|16407320|P12|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756303|NCT01695239|16407321|P11|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756304|NCT01695239|16407322|P10|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756305|NCT01695239|16407323|P9|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756306|NCT01695239|16407324|P8|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9
4756307|NCT01695239|16407325|P7|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756308|NCT01695239|16407326|P6|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756309|NCT01695239|16407327|P5|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756310|NCT01695239|16407328|P4|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756311|NCT01695239|16407329|P3|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756312|NCT01695239|16407330|P2|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756313|NCT01695239|16407331|P1|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0
4756314|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756315|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756316|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756317|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756318|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756319|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756320|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756321|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756322|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756323|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756324|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756325|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756326|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Protocol Violation|0
4756327|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Protocol Violation|1
4756328|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756329|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756330|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756331|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756332|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756333|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756334|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756335|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756336|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756337|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756338|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756339|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4756340|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4756341|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4756342|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756343|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756344|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756345|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756346|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756347|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756348|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756349|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756350|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756351|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756352|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756353|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Sponsor Decision|1
4756354|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Sponsor Decision|0
4756355|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Sponsor Decision|3
4756356|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756357|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756358|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756359|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756360|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756361|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756362|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756363|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756364|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756365|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756366|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4756367|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
4756368|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1
4756369|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3
4756370|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756371|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756372|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756373|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756374|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756375|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756376|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756377|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756378|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756379|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756380|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756381|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
4756382|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4756383|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|4
4756384|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Adverse Event|0
4756385|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Adverse Event|0
4756386|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Adverse Event|0
4756387|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Adverse Event|0
4756388|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Adverse Event|0
4756389|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Adverse Event|0
4756390|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Adverse Event|0
4756391|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Adverse Event|0
4756392|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Adverse Event|0
4756393|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Adverse Event|0
4756394|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Adverse Event|3
4756395|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Adverse Event|2
4756396|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Adverse Event|2
4756397|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Adverse Event|2
4756398|NCT01695239|16407318|P14|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756399|NCT01695239|16407319|P13|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756400|NCT01695239|16407320|P12|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756401|NCT01695239|16407321|P11|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756402|NCT01695239|16407322|P10|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756403|NCT01695239|16407323|P9|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756404|NCT01695239|16407324|P8|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756405|NCT01695239|16407325|P7|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756406|NCT01695239|16407326|P6|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756407|NCT01695239|16407327|P5|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0
4756408|NCT01695239|16407328|P4|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4
4756409|NCT01695239|16407329|P3|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3
4756410|NCT01695239|16407330|P2|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
4756411|NCT01695239|16407331|P1|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1
4756412|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Noncompliance with study drug|1
4756413|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Noncompliance with study drug|0
4756414|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Noncompliance with study drug|0
4756415|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Noncompliance with study drug|0
4756416|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Death|7
4756417|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Death|2
4756418|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Death|0
4756419|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Death|0
4756420|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Physician Decision|1
4756421|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Physician Decision|4
4756422|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Physician Decision|0
4756423|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Physician Decision|0
4756424|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Other|7
4756425|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Other|4
4756426|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Other|0
4756427|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Other|0
4756428|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Adverse Event|16
4756429|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Adverse Event|11
4756430|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Adverse Event|0
4756431|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Adverse Event|0
4756432|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Withdrawal by Subject|16
4756433|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Withdrawal by Subject|6
4756434|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Withdrawal by Subject|0
4756435|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Withdrawal by Subject|0
4756436|NCT01695135|16407472|P4|Open Label Extension Treatment Phase|Progressive disease|22
4756437|NCT01695135|16407473|P3|Open Label Extension Treatment Phase|Progressive disease|13
4756438|NCT01695135|16407474|P2|Open Label Extension Treatment Phase|Progressive disease|0
4756439|NCT01695135|16407475|P1|Open Label Extension Treatment Phase|Progressive disease|0
4756440|NCT01695135|16407472|P4|Double-blind Treatment Phase|Noncompliance with study drug|0
4756441|NCT01695135|16407473|P3|Double-blind Treatment Phase|Noncompliance with study drug|0
4756442|NCT01695135|16407474|P2|Double-blind Treatment Phase|Noncompliance with study drug|1
4756443|NCT01695135|16407475|P1|Double-blind Treatment Phase|Noncompliance with study drug|0
4756444|NCT01695135|16407472|P4|Double-blind Treatment Phase|Death|0
4756445|NCT01695135|16407473|P3|Double-blind Treatment Phase|Death|0
4756446|NCT01695135|16407474|P2|Double-blind Treatment Phase|Death|1
4756447|NCT01695135|16407475|P1|Double-blind Treatment Phase|Death|1
4756448|NCT01695135|16407472|P4|Double-blind Treatment Phase|Physician Decision|0
4756449|NCT01695135|16407473|P3|Double-blind Treatment Phase|Physician Decision|0
4756450|NCT01695135|16407474|P2|Double-blind Treatment Phase|Physician Decision|3
4756451|NCT01695135|16407475|P1|Double-blind Treatment Phase|Physician Decision|6
4756452|NCT01695135|16407472|P4|Double-blind Treatment Phase|Other|0
4756453|NCT01695135|16407473|P3|Double-blind Treatment Phase|Other|0
4756454|NCT01695135|16407474|P2|Double-blind Treatment Phase|Other|3
4756455|NCT01695135|16407475|P1|Double-blind Treatment Phase|Other|1
4756456|NCT01695135|16407472|P4|Double-blind Treatment Phase|Adverse Event|0
4756457|NCT01695135|16407473|P3|Double-blind Treatment Phase|Adverse Event|0
4756458|NCT01695135|16407474|P2|Double-blind Treatment Phase|Adverse Event|7
4756459|NCT01695135|16407475|P1|Double-blind Treatment Phase|Adverse Event|7
4756460|NCT01695135|16407472|P4|Double-blind Treatment Phase|Withdrawal by Subject|0
4756461|NCT01695135|16407473|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
4756462|NCT01695135|16407474|P2|Double-blind Treatment Phase|Withdrawal by Subject|14
4756463|NCT01695135|16407475|P1|Double-blind Treatment Phase|Withdrawal by Subject|6
4756464|NCT01695135|16407472|P4|Double-blind Treatment Phase|Progressive disease|0
4756465|NCT01695135|16407473|P3|Double-blind Treatment Phase|Progressive disease|0
4756466|NCT01695135|16407474|P2|Double-blind Treatment Phase|Progressive disease|110
4756467|NCT01695135|16407475|P1|Double-blind Treatment Phase|Progressive disease|50
4756468|NCT01694771|16407524|P2|Overall Study|Other reasons|6
4756469|NCT01694771|16407525|P1|Overall Study|Other reasons|5
4756470|NCT01694771|16407524|P2|Overall Study|Consent withdrawn|9
4756471|NCT01694771|16407525|P1|Overall Study|Consent withdrawn|7
4756472|NCT01694771|16407524|P2|Overall Study|Lost to Follow-up|3
4756473|NCT01694771|16407525|P1|Overall Study|Lost to Follow-up|2
4756474|NCT01694771|16407524|P2|Overall Study|Non compliance protocol|6
4756475|NCT01694771|16407525|P1|Overall Study|Non compliance protocol|7
4756476|NCT01694771|16407524|P2|Overall Study|Lack of Efficacy|0
4756477|NCT01694771|16407525|P1|Overall Study|Lack of Efficacy|1
4756478|NCT01694771|16407524|P2|Overall Study|Adverse Event|16
4756479|NCT01694771|16407525|P1|Overall Study|Adverse Event|18
4756480|NCT01694706|16407549|P3|Overall Study|other reason not defined above|0
4756481|NCT01694706|16407550|P2|Overall Study|other reason not defined above|0
4756482|NCT01694706|16407551|P1|Overall Study|other reason not defined above|1
4756483|NCT01694706|16407549|P3|Overall Study|Adverse Event|0
4756484|NCT01694706|16407550|P2|Overall Study|Adverse Event|1
4756485|NCT01694706|16407551|P1|Overall Study|Adverse Event|0
4756486|NCT01694485|16407610|P5|Overall Study|Death|0
4756487|NCT01694485|16407611|P4|Overall Study|Death|1
4756488|NCT01694485|16407612|P3|Overall Study|Death|0
4756489|NCT01694485|16407613|P2|Overall Study|Death|0
4756490|NCT01694485|16407614|P1|Overall Study|Death|1
4756491|NCT01694485|16407610|P5|Overall Study|Lost to Follow-up|7
4756492|NCT01694485|16407611|P4|Overall Study|Lost to Follow-up|10
4756493|NCT01694485|16407612|P3|Overall Study|Lost to Follow-up|6
4756494|NCT01694485|16407613|P2|Overall Study|Lost to Follow-up|1
4756495|NCT01694485|16407614|P1|Overall Study|Lost to Follow-up|9
4756496|NCT01694485|16407610|P5|Overall Study|Sponsor Decision|0
4756497|NCT01694485|16407611|P4|Overall Study|Sponsor Decision|2
4756498|NCT01694485|16407612|P3|Overall Study|Sponsor Decision|0
4756499|NCT01694485|16407613|P2|Overall Study|Sponsor Decision|0
4756500|NCT01694485|16407614|P1|Overall Study|Sponsor Decision|3
4756501|NCT01694485|16407610|P5|Overall Study|Withdrawal by Subject|18
4756502|NCT01694485|16407611|P4|Overall Study|Withdrawal by Subject|25
4756503|NCT01694485|16407612|P3|Overall Study|Withdrawal by Subject|7
4756504|NCT01694485|16407613|P2|Overall Study|Withdrawal by Subject|6
4756505|NCT01694485|16407614|P1|Overall Study|Withdrawal by Subject|20
4756506|NCT01694433|16407648|P2|Overall Study|Withdrawal by Subject|4
4756507|NCT01694433|16407649|P1|Overall Study|Withdrawal by Subject|3
4756508|NCT01694433|16407648|P2|Overall Study|Physician Decision|0
4756509|NCT01694433|16407649|P1|Overall Study|Physician Decision|1
4756510|NCT01694433|16407648|P2|Overall Study|Adverse Event|0
4756511|NCT01694433|16407649|P1|Overall Study|Adverse Event|7
4756512|NCT01694420|16407657|P1|Overall Study|Lost to Follow-up|3
4756513|NCT01694121|16407694|P2|Overall Study|Participant used false ID, was withdrawn|0
4756514|NCT01694121|16407695|P1|Overall Study|Participant used false ID, was withdrawn|1
4756515|NCT01693614|16407809|P3|Overall Study|Withdrawal by Subject|5
4756516|NCT01693614|16407810|P2|Overall Study|Withdrawal by Subject|0
4756517|NCT01693614|16407811|P1|Overall Study|Withdrawal by Subject|1
4756518|NCT01693614|16407809|P3|Overall Study|Withdrawal by subject/guardian|2
4756519|NCT01693614|16407810|P2|Overall Study|Withdrawal by subject/guardian|0
4756520|NCT01693614|16407811|P1|Overall Study|Withdrawal by subject/guardian|0
4756521|NCT01693614|16407809|P3|Overall Study|Physician Decision|4
4756522|NCT01693614|16407810|P2|Overall Study|Physician Decision|1
4756523|NCT01693614|16407811|P1|Overall Study|Physician Decision|1
4756524|NCT01693614|16407809|P3|Overall Study|Death|0
4756525|NCT01693614|16407810|P2|Overall Study|Death|0
4756526|NCT01693614|16407811|P1|Overall Study|Death|1
4756527|NCT01693614|16407809|P3|Overall Study|Protocol Violation|1
4756528|NCT01693614|16407810|P2|Overall Study|Protocol Violation|2
4756529|NCT01693614|16407811|P1|Overall Study|Protocol Violation|5
4756530|NCT01693614|16407809|P3|Overall Study|Disease progression|7
4756531|NCT01693614|16407810|P2|Overall Study|Disease progression|8
4756532|NCT01693614|16407811|P1|Overall Study|Disease progression|11
4756533|NCT01693614|16407809|P3|Overall Study|Adverse Event|5
4756534|NCT01693614|16407810|P2|Overall Study|Adverse Event|11
4756535|NCT01693614|16407811|P1|Overall Study|Adverse Event|7
4756536|NCT01693523|16407836|P3|Overall Study|Chemotherapy was held|0
4756537|NCT01693523|16407837|P2|Overall Study|Chemotherapy was held|2
4756538|NCT01693523|16407838|P1|Overall Study|Chemotherapy was held|1
4756539|NCT01693523|16407836|P3|Overall Study|Lack of compliance study medication|0
4756540|NCT01693523|16407837|P2|Overall Study|Lack of compliance study medication|2
4756541|NCT01693523|16407838|P1|Overall Study|Lack of compliance study medication|1
4756542|NCT01693523|16407836|P3|Overall Study|Withdrawal by Subject|2
4756543|NCT01693523|16407837|P2|Overall Study|Withdrawal by Subject|2
4756544|NCT01693523|16407838|P1|Overall Study|Withdrawal by Subject|1
4756545|NCT01693523|16407836|P3|Overall Study|Physician Decision|1
4756546|NCT01693523|16407837|P2|Overall Study|Physician Decision|0
4756547|NCT01693523|16407838|P1|Overall Study|Physician Decision|0
4756548|NCT01693523|16407836|P3|Overall Study|Lost to Follow-up|4
4756549|NCT01693523|16407837|P2|Overall Study|Lost to Follow-up|0
4756550|NCT01693523|16407838|P1|Overall Study|Lost to Follow-up|0
4756551|NCT01693523|16407836|P3|Overall Study|Death|1
4756552|NCT01693523|16407837|P2|Overall Study|Death|1
4756553|NCT01693523|16407838|P1|Overall Study|Death|0
4756554|NCT01693523|16407836|P3|Overall Study|Adverse Event|0
4756555|NCT01693523|16407837|P2|Overall Study|Adverse Event|1
4756556|NCT01693523|16407838|P1|Overall Study|Adverse Event|2
4756557|NCT01693367|16407854|P2|Overall Study|Physician Decision|1
4756558|NCT01693367|16407855|P1|Overall Study|Physician Decision|0
4756559|NCT01693367|16407854|P2|Overall Study|Withdrawal by Subject|1
4756560|NCT01693367|16407855|P1|Overall Study|Withdrawal by Subject|1
4756561|NCT01693250|16407873|P2|Overall Study|Lost to Follow-up|2
4756562|NCT01693250|16407874|P1|Overall Study|Lost to Follow-up|2
4756563|NCT01693185|16407884|P2|Overall Study|diagnostic procedure after colonoscopy|6
4756564|NCT01693185|16407885|P1|Overall Study|diagnostic procedure after colonoscopy|0
4756565|NCT01693120|16407901|P1|Phased RF Study Procedure and Follow-up|Other reasons|7
4756566|NCT01693120|16407901|P1|Phased RF Study Procedure and Follow-up|Protocol Violation|1
4756567|NCT01693120|16407901|P1|Phased RF Study Procedure and Follow-up|Physician Decision|3
4756568|NCT01693120|16407901|P1|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5
4756569|NCT01693120|16407901|P1|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1
4756570|NCT01693120|16407901|P1|Enrollment|Other|1
4756571|NCT01693120|16407901|P1|Enrollment|Study closed|8
4756572|NCT01693120|16407901|P1|Enrollment|Adverse Event|1
4756573|NCT01693120|16407901|P1|Enrollment|Physician Decision|3
4756574|NCT01693120|16407901|P1|Enrollment|Protocol Violation|46
4756575|NCT01693120|16407901|P1|Enrollment|Withdrawal by Subject|10
4756576|NCT01693120|16407901|P1|Enrollment|Lost to Follow-up|1
4756577|NCT01693068|16407910|P3|Cross-over (Dacarbazine To Pimasertib)|On-study|1
4756578|NCT01693068|16407911|P2|Cross-over (Dacarbazine To Pimasertib)|On-study|0
4756579|NCT01693068|16407912|P1|Cross-over (Dacarbazine To Pimasertib)|On-study|0
4756580|NCT01693068|16407910|P3|Randomization Period|On-study|0
4756581|NCT01693068|16407911|P2|Randomization Period|On-study|5
4756582|NCT01693068|16407912|P1|Randomization Period|On-study|2
4756583|NCT01693029|16407944|P2|Overall Study|Non-compliance|1
4756584|NCT01693029|16407945|P1|Overall Study|Non-compliance|2
4756585|NCT01693029|16407944|P2|Overall Study|Death|8
4756586|NCT01693029|16407945|P1|Overall Study|Death|5
4756587|NCT01693029|16407944|P2|Overall Study|Adverse Event|6
4756588|NCT01693029|16407945|P1|Overall Study|Adverse Event|1
4756589|NCT01693029|16407944|P2|Overall Study|Lost to Follow-up|1
4756590|NCT01693029|16407945|P1|Overall Study|Lost to Follow-up|0
4756591|NCT01693029|16407944|P2|Overall Study|Physician Decision|2
4756592|NCT01693029|16407945|P1|Overall Study|Physician Decision|0
4756593|NCT01693029|16407944|P2|Overall Study|Change in dialysis modality|1
4756594|NCT01693029|16407945|P1|Overall Study|Change in dialysis modality|2
4756595|NCT01693029|16407944|P2|Overall Study|Protocol Violation|7
4756596|NCT01693029|16407945|P1|Overall Study|Protocol Violation|6
4756597|NCT01693029|16407944|P2|Overall Study|Bindinging anti-EPO antibodies|2
4756598|NCT01693029|16407945|P1|Overall Study|Bindinging anti-EPO antibodies|6
4756599|NCT01693029|16407944|P2|Overall Study|Kidney transplantation|7
4756600|NCT01693029|16407945|P1|Overall Study|Kidney transplantation|7
4756601|NCT01693029|16407944|P2|Overall Study|Withdrawal by Subject|22
4756602|NCT01693029|16407945|P1|Overall Study|Withdrawal by Subject|15
4756603|NCT01692938|16407981|P2|Overall Study|Study completed prior to site completion|3
4756604|NCT01692938|16407982|P1|Overall Study|Study completed prior to site completion|3
4756605|NCT01692938|16407981|P2|Overall Study|Protocol Deviation|1
4756606|NCT01692938|16407982|P1|Overall Study|Protocol Deviation|1
4756607|NCT01692782|16407993|P3|Overall Study|Withdrawal by Subject|3
4756608|NCT01692782|16407994|P2|Overall Study|Withdrawal by Subject|10
4756609|NCT01692782|16407995|P1|Overall Study|Withdrawal by Subject|3
4756610|NCT01692782|16407993|P3|Overall Study|SAE not related to study drug|0
4756611|NCT01692782|16407994|P2|Overall Study|SAE not related to study drug|1
4756612|NCT01692782|16407995|P1|Overall Study|SAE not related to study drug|0
4756613|NCT01692782|16407993|P3|Overall Study|Non-compliant with study visits|1
4756614|NCT01692782|16407994|P2|Overall Study|Non-compliant with study visits|0
4756615|NCT01692782|16407995|P1|Overall Study|Non-compliant with study visits|0
4756616|NCT01692782|16407993|P3|Overall Study|Non-complance with study drug|1
4756617|NCT01692782|16407994|P2|Overall Study|Non-complance with study drug|4
4756618|NCT01692782|16407995|P1|Overall Study|Non-complance with study drug|0
4756619|NCT01692782|16407993|P3|Overall Study|Protocol Violation|2
4756620|NCT01692782|16407994|P2|Overall Study|Protocol Violation|0
4756621|NCT01692782|16407995|P1|Overall Study|Protocol Violation|1
4756622|NCT01692782|16407993|P3|Overall Study|Pregnancy|0
4756623|NCT01692782|16407994|P2|Overall Study|Pregnancy|0
4756624|NCT01692782|16407995|P1|Overall Study|Pregnancy|1
4756625|NCT01692782|16407993|P3|Overall Study|Lost to Follow-up|1
4756626|NCT01692782|16407994|P2|Overall Study|Lost to Follow-up|7
4756627|NCT01692782|16407995|P1|Overall Study|Lost to Follow-up|2
4756628|NCT01692782|16407993|P3|Overall Study|Lack of Efficacy|0
4756629|NCT01692782|16407994|P2|Overall Study|Lack of Efficacy|2
4756630|NCT01692782|16407995|P1|Overall Study|Lack of Efficacy|1
4756631|NCT01692782|16407993|P3|Overall Study|Adverse Event|2
4756632|NCT01692782|16407994|P2|Overall Study|Adverse Event|32
4756633|NCT01692782|16407995|P1|Overall Study|Adverse Event|12
4756634|NCT01692730|16408104|P2|Overall Study|Lost to Follow-up|227
4756635|NCT01692730|16408105|P1|Overall Study|Lost to Follow-up|225
4756636|NCT01692626|16408119|P2|Overall Study|Withdrawal by Subject|0
4756637|NCT01692626|16408120|P1|Overall Study|Withdrawal by Subject|1
4756638|NCT01692626|16408119|P2|Overall Study|Protocol Violation|2
4756639|NCT01692626|16408120|P1|Overall Study|Protocol Violation|1
4756640|NCT01692626|16408119|P2|Overall Study|Adverse Event|3
4756641|NCT01692626|16408120|P1|Overall Study|Adverse Event|2
4756642|NCT01692626|16408119|P2|Overall Study|Death|1
4756643|NCT01692626|16408120|P1|Overall Study|Death|0
4756644|NCT01692301|16408155|P2|Overall Study|Lost to Follow-up|1
4756645|NCT01692301|16408156|P1|Overall Study|Lost to Follow-up|1
4756646|NCT01692301|16408155|P2|Overall Study|Physician Decision|2
4756647|NCT01692301|16408156|P1|Overall Study|Physician Decision|2
4756648|NCT01692301|16408155|P2|Overall Study|Technical problems|1
4756649|NCT01692301|16408156|P1|Overall Study|Technical problems|0
4756650|NCT01692301|16408155|P2|Overall Study|Patient/guardian decision|15
4756651|NCT01692301|16408156|P1|Overall Study|Patient/guardian decision|16
4756652|NCT01692301|16408155|P2|Overall Study|Protocol deviation|2
4756653|NCT01692301|16408156|P1|Overall Study|Protocol deviation|9
4756654|NCT01692301|16408155|P2|Overall Study|Non-compliance with study treatment|2
4756655|NCT01692301|16408156|P1|Overall Study|Non-compliance with study treatment|1
4756656|NCT01692301|16408155|P2|Overall Study|Lack of Efficacy|5
4756657|NCT01692301|16408156|P1|Overall Study|Lack of Efficacy|0
4756658|NCT01692301|16408155|P2|Overall Study|Death|2
4756659|NCT01692301|16408156|P1|Overall Study|Death|1
4756660|NCT01692301|16408155|P2|Overall Study|Adverse Event|12
4756661|NCT01692301|16408156|P1|Overall Study|Adverse Event|15
4756662|NCT01692275|16408188|P2|Overall Study|Withdrawal by Subject|11
4756663|NCT01692275|16408189|P1|Overall Study|Withdrawal by Subject|9
4756664|NCT01692275|16408188|P2|Overall Study|Lost to Follow-up|48
4756665|NCT01692275|16408189|P1|Overall Study|Lost to Follow-up|57
4756666|NCT01692197|16408249|P1|Overall Study|Failed Screening|3
4756667|NCT01691898|16408271|P6|Overall Study|Non-Compliance|0
4756668|NCT01691898|16408272|P5|Overall Study|Non-Compliance|1
4756669|NCT01691898|16408273|P4|Overall Study|Non-Compliance|0
4756670|NCT01691898|16408274|P3|Overall Study|Non-Compliance|0
4756671|NCT01691898|16408275|P2|Overall Study|Non-Compliance|0
4756672|NCT01691898|16408276|P1|Overall Study|Non-Compliance|0
4756673|NCT01691898|16408271|P6|Overall Study|Withdrawal by Subject|3
4756674|NCT01691898|16408272|P5|Overall Study|Withdrawal by Subject|3
4756675|NCT01691898|16408273|P4|Overall Study|Withdrawal by Subject|1
4756676|NCT01691898|16408274|P3|Overall Study|Withdrawal by Subject|2
4756677|NCT01691898|16408275|P2|Overall Study|Withdrawal by Subject|8
4756678|NCT01691898|16408276|P1|Overall Study|Withdrawal by Subject|9
4756679|NCT01691898|16408271|P6|Overall Study|Lost to Follow-up|0
4756680|NCT01691898|16408272|P5|Overall Study|Lost to Follow-up|1
4756681|NCT01691898|16408273|P4|Overall Study|Lost to Follow-up|0
4756682|NCT01691898|16408274|P3|Overall Study|Lost to Follow-up|0
4756683|NCT01691898|16408275|P2|Overall Study|Lost to Follow-up|1
4756684|NCT01691898|16408276|P1|Overall Study|Lost to Follow-up|3
4756685|NCT01691898|16408271|P6|Overall Study|Progression of Disease|1
4756686|NCT01691898|16408272|P5|Overall Study|Progression of Disease|0
4756687|NCT01691898|16408273|P4|Overall Study|Progression of Disease|0
4756688|NCT01691898|16408274|P3|Overall Study|Progression of Disease|1
4756689|NCT01691898|16408275|P2|Overall Study|Progression of Disease|2
4756690|NCT01691898|16408276|P1|Overall Study|Progression of Disease|1
4756691|NCT01691898|16408271|P6|Overall Study|Adverse Event|0
4756692|NCT01691898|16408272|P5|Overall Study|Adverse Event|1
4756693|NCT01691898|16408273|P4|Overall Study|Adverse Event|1
4756694|NCT01691898|16408274|P3|Overall Study|Adverse Event|0
4756695|NCT01691898|16408275|P2|Overall Study|Adverse Event|1
4756696|NCT01691898|16408276|P1|Overall Study|Adverse Event|0
4756697|NCT01691898|16408271|P6|Overall Study|Death|31
4756698|NCT01691898|16408272|P5|Overall Study|Death|8
4756699|NCT01691898|16408273|P4|Overall Study|Death|3
4756700|NCT01691898|16408274|P3|Overall Study|Death|6
4756701|NCT01691898|16408275|P2|Overall Study|Death|32
4756702|NCT01691898|16408276|P1|Overall Study|Death|34
4756703|NCT01691885|16408430|P2|Washout Period (7-9 Days)|Adverse Event|1
4756704|NCT01691885|16408431|P1|Washout Period (7-9 Days)|Adverse Event|0
4756705|NCT01691885|16408430|P2|Treatment Period 1(7-14 Days)|Adverse Event|1
4756706|NCT01691885|16408431|P1|Treatment Period 1(7-14 Days)|Adverse Event|1
4756707|NCT01691859|16408437|P1|Overall Study|Withdrawal by Subject|31
4756708|NCT01691859|16408437|P1|Overall Study|Physician Decision|6
4756709|NCT01691859|16408437|P1|Overall Study|Lost to Follow-up|5
4756710|NCT01691859|16408437|P1|Overall Study|Study closed/terminated|50
4756711|NCT01691859|16408437|P1|Overall Study|Product commercially available|221
4756712|NCT01691859|16408437|P1|Overall Study|Protocol Violation|4
4756713|NCT01691859|16408437|P1|Overall Study|Lack of Efficacy|11
4756714|NCT01691859|16408437|P1|Overall Study|Adverse Event|19
4756715|NCT01691820|16408484|P3|Overall Study|Other (unspecified)|1
4756716|NCT01691820|16408485|P2|Overall Study|Other (unspecified)|0
4756717|NCT01691820|16408486|P1|Overall Study|Other (unspecified)|5
4756718|NCT01691820|16408484|P3|Overall Study|Lost to Follow-up|0
4756719|NCT01691820|16408485|P2|Overall Study|Lost to Follow-up|15
4756720|NCT01691820|16408486|P1|Overall Study|Lost to Follow-up|8
4756721|NCT01691820|16408484|P3|Overall Study|Migrated/moved from study area|0
4756722|NCT01691820|16408485|P2|Overall Study|Migrated/moved from study area|4
4756723|NCT01691820|16408486|P1|Overall Study|Migrated/moved from study area|7
4756724|NCT01691820|16408484|P3|Overall Study|Consent withdrawal (not due to an AE)|0
4756725|NCT01691820|16408485|P2|Overall Study|Consent withdrawal (not due to an AE)|15
4756726|NCT01691820|16408486|P1|Overall Study|Consent withdrawal (not due to an AE)|9
4756727|NCT01691794|16408524|P3|Overall Study|Did not complete first 24 weeks of study|3
4756728|NCT01691794|16408525|P2|Overall Study|Did not complete first 24 weeks of study|3
4756729|NCT01691794|16408526|P1|Overall Study|Did not complete first 24 weeks of study|0
4756730|NCT01691794|16408524|P3|Overall Study|Completed Only first 24 weeks of study|3
4756731|NCT01691794|16408525|P2|Overall Study|Completed Only first 24 weeks of study|2
4756732|NCT01691794|16408526|P1|Overall Study|Completed Only first 24 weeks of study|0
4756733|NCT01691794|16408524|P3|Overall Study|Adverse Event|1
4756734|NCT01691794|16408525|P2|Overall Study|Adverse Event|1
4756735|NCT01691794|16408526|P1|Overall Study|Adverse Event|0
4756736|NCT01691794|16408524|P3|Overall Study|Participant request to discontinue|0
4756737|NCT01691794|16408525|P2|Overall Study|Participant request to discontinue|1
4756738|NCT01691794|16408526|P1|Overall Study|Participant request to discontinue|0
4756739|NCT01691794|16408524|P3|Overall Study|Lack of Efficacy|1
4756740|NCT01691794|16408525|P2|Overall Study|Lack of Efficacy|7
4756741|NCT01691794|16408526|P1|Overall Study|Lack of Efficacy|0
4756742|NCT01691794|16408524|P3|Overall Study|Death|1
4756743|NCT01691794|16408525|P2|Overall Study|Death|0
4756744|NCT01691794|16408526|P1|Overall Study|Death|0
4756745|NCT01691794|16408524|P3|Overall Study|Poor/Non-Compliance|1
4756746|NCT01691794|16408525|P2|Overall Study|Poor/Non-Compliance|4
4756747|NCT01691794|16408526|P1|Overall Study|Poor/Non-Compliance|1
4756748|NCT01691781|16408542|P2|Overall Study|Adverse Event|1
4756749|NCT01691781|16408543|P1|Overall Study|Adverse Event|0
4756750|NCT01691781|16408542|P2|Overall Study|Protocol Violation|2
4756751|NCT01691781|16408543|P1|Overall Study|Protocol Violation|2
4756752|NCT01691781|16408542|P2|Overall Study|Physician Decision|1
4756753|NCT01691781|16408543|P1|Overall Study|Physician Decision|1
4756754|NCT01691781|16408542|P2|Overall Study|Withdrawal by Subject|3
4756755|NCT01691781|16408543|P1|Overall Study|Withdrawal by Subject|4
4756756|NCT01691768|16408555|P2|Overall Study|Investigator decision|1
4756757|NCT01691768|16408556|P1|Overall Study|Investigator decision|1
4756758|NCT01691768|16408555|P2|Overall Study|Relocated|1
4756759|NCT01691768|16408556|P1|Overall Study|Relocated|0
4756760|NCT01691768|16408555|P2|Overall Study|Withdrawal by Subject|9
4756761|NCT01691768|16408556|P1|Overall Study|Withdrawal by Subject|10
4756762|NCT01691768|16408555|P2|Overall Study|Lost to Follow-up|3
4756763|NCT01691768|16408556|P1|Overall Study|Lost to Follow-up|4
4756764|NCT01691768|16408555|P2|Overall Study|Death|2
4756765|NCT01691768|16408556|P1|Overall Study|Death|0
4756766|NCT01691612|16408591|P1|Overall Study|Adverse Event|1
4756767|NCT01691612|16408591|P1|Overall Study|deemed ineligible after 1st visit|6
4756768|NCT01691521|16408702|P3|Overall Study|Withdrawal by Subject|4
4756769|NCT01691521|16408703|P2|Overall Study|Withdrawal by Subject|9
4756770|NCT01691521|16408704|P1|Overall Study|Withdrawal by Subject|5
4756771|NCT01691521|16408702|P3|Overall Study|Physician Decision|0
4756772|NCT01691521|16408703|P2|Overall Study|Physician Decision|1
4756773|NCT01691521|16408704|P1|Overall Study|Physician Decision|2
4756774|NCT01691521|16408702|P3|Overall Study|Lost to Follow-up|2
4756775|NCT01691521|16408703|P2|Overall Study|Lost to Follow-up|2
4756776|NCT01691521|16408704|P1|Overall Study|Lost to Follow-up|0
4756777|NCT01691521|16408702|P3|Overall Study|Protocol Violation|0
4756778|NCT01691521|16408703|P2|Overall Study|Protocol Violation|3
4756779|NCT01691521|16408704|P1|Overall Study|Protocol Violation|0
4756780|NCT01691521|16408702|P3|Overall Study|Lack of Efficacy|2
4756781|NCT01691521|16408703|P2|Overall Study|Lack of Efficacy|1
4756782|NCT01691521|16408704|P1|Overall Study|Lack of Efficacy|1
4756783|NCT01691521|16408702|P3|Overall Study|Adverse Event|1
4756784|NCT01691521|16408703|P2|Overall Study|Adverse Event|0
4756785|NCT01691521|16408704|P1|Overall Study|Adverse Event|4
4756786|NCT01691508|16408726|P2|Overall Study|Withdrawal by Subject|0
4756787|NCT01691508|16408727|P1|Overall Study|Withdrawal by Subject|1
4756788|NCT01691508|16408726|P2|Overall Study|Adverse Event|3
4756789|NCT01691508|16408727|P1|Overall Study|Adverse Event|3
4756790|NCT01691482|16408741|P2|Treatment Period 2|Protocol Violation|1
4756791|NCT01691482|16408742|P1|Treatment Period 2|Protocol Violation|1
4756792|NCT01691482|16408741|P2|Treatment Period 2|Adverse Event|1
4756793|NCT01691482|16408742|P1|Treatment Period 2|Adverse Event|0
4756794|NCT01691430|16408760|P2|Overall Study|Lost to Follow-up|3
4756795|NCT01691430|16408761|P1|Overall Study|Lost to Follow-up|0
4756796|NCT01691430|16408760|P2|Overall Study|Withdrawal by Subject|1
4756797|NCT01691430|16408761|P1|Overall Study|Withdrawal by Subject|5
4756798|NCT01691430|16408760|P2|Overall Study|Death|16
4756799|NCT01691430|16408761|P1|Overall Study|Death|17
4756800|NCT01691378|16408787|P2|Overall Study|Lost to Follow-up|2
4756801|NCT01691378|16408788|P1|Overall Study|Lost to Follow-up|5
4756802|NCT01691378|16408787|P2|Overall Study|Withdrawal by Subject|0
4756803|NCT01691378|16408788|P1|Overall Study|Withdrawal by Subject|2
4756804|NCT01691248|16408871|P2|Overall Study|Not Treated|7
4756805|NCT01691248|16408872|P1|Overall Study|Not Treated|4
4756806|NCT01691248|16408871|P2|Overall Study|Reason not provided|4
4756807|NCT01691248|16408872|P1|Overall Study|Reason not provided|4
4756808|NCT01691248|16408871|P2|Overall Study|Lost to Follow-up|5
4756809|NCT01691248|16408872|P1|Overall Study|Lost to Follow-up|2
4756810|NCT01691248|16408871|P2|Overall Study|Confirmed CDAD|31
4756811|NCT01691248|16408872|P1|Overall Study|Confirmed CDAD|14
4756812|NCT01691248|16408871|P2|Overall Study|Withdrawal by Subject|18
4756813|NCT01691248|16408872|P1|Overall Study|Withdrawal by Subject|20
4756814|NCT01691248|16408871|P2|Overall Study|Adverse Event|22
4756815|NCT01691248|16408872|P1|Overall Study|Adverse Event|24
4756816|NCT01691248|16408871|P2|Overall Study|Protocol Violation|27
4756817|NCT01691248|16408872|P1|Overall Study|Protocol Violation|43
4756818|NCT01691105|16408884|P2|12 Month Biochemical Verification|subject did not self-report abstinence|401
4756819|NCT01691105|16408885|P1|12 Month Biochemical Verification|subject did not self-report abstinence|352
4756820|NCT01691105|16408884|P2|12 Month Biochemical Verification|Lost to Follow-up|71
4756821|NCT01691105|16408885|P1|12 Month Biochemical Verification|Lost to Follow-up|50
4756822|NCT01691105|16408884|P2|12 Month Biochemical Verification|Death|30
4756823|NCT01691105|16408885|P1|12 Month Biochemical Verification|Death|22
4756824|NCT01691105|16408884|P2|12 Month Follow-up|Death|30
4756825|NCT01691105|16408885|P1|12 Month Follow-up|Death|22
4756826|NCT01691105|16408884|P2|12 Month Follow-up|Lost to Follow-up|71
4756827|NCT01691105|16408885|P1|12 Month Follow-up|Lost to Follow-up|50
4756828|NCT01691105|16408884|P2|6 Month Follow-up|Death|13
4756829|NCT01691105|16408885|P1|6 Month Follow-up|Death|13
4756830|NCT01691105|16408884|P2|6 Month Follow-up|Lost to Follow-up|58
4756831|NCT01691105|16408885|P1|6 Month Follow-up|Lost to Follow-up|39
4756832|NCT01691105|16408884|P2|1 Month Follow-up|Death|3
4756833|NCT01691105|16408885|P1|1 Month Follow-up|Death|2
4756834|NCT01691105|16408884|P2|1 Month Follow-up|Lost to Follow-up|38
4756835|NCT01691105|16408885|P1|1 Month Follow-up|Lost to Follow-up|41
4756836|NCT01691092|16408905|P1|Overall Study|screen fail|19
4756837|NCT01691092|16408905|P1|Overall Study|used for different study|2
4756838|NCT01691092|16408905|P1|Overall Study|non-compliance|3
4756839|NCT01691092|16408905|P1|Overall Study|Withdrawal by Subject|3
4756840|NCT01691092|16408905|P1|Overall Study|Physician Decision|4
4756841|NCT01691092|16408905|P1|Overall Study|Lost to Follow-up|10
4756842|NCT01691014|16408929|P4|Overall Study|Lack of Efficacy|0
4756843|NCT01691014|16408930|P3|Overall Study|Lack of Efficacy|7
4756844|NCT01691014|16408931|P2|Overall Study|Lack of Efficacy|3
4756845|NCT01691014|16408932|P1|Overall Study|Lack of Efficacy|2
4756846|NCT01691014|16408929|P4|Overall Study|Adverse Event|1
4756847|NCT01691014|16408930|P3|Overall Study|Adverse Event|1
4756848|NCT01691014|16408931|P2|Overall Study|Adverse Event|5
4756849|NCT01691014|16408932|P1|Overall Study|Adverse Event|0
4756850|NCT01691014|16408929|P4|Overall Study|Withdrawal by Subject|1
4756851|NCT01691014|16408930|P3|Overall Study|Withdrawal by Subject|1
4756852|NCT01691014|16408931|P2|Overall Study|Withdrawal by Subject|1
4756853|NCT01691014|16408932|P1|Overall Study|Withdrawal by Subject|0
4756854|NCT01691014|16408929|P4|Overall Study|Other|0
4756855|NCT01691014|16408930|P3|Overall Study|Other|2
4756856|NCT01691014|16408931|P2|Overall Study|Other|0
4756857|NCT01691014|16408932|P1|Overall Study|Other|0
4756858|NCT01691014|16408929|P4|Overall Study|Premature Termination|3
4756859|NCT01691014|16408930|P3|Overall Study|Premature Termination|0
4756860|NCT01691014|16408931|P2|Overall Study|Premature Termination|6
4756861|NCT01691014|16408932|P1|Overall Study|Premature Termination|1
4756862|NCT01690988|16408977|P3|Overall Study|Sedated|2
4756863|NCT01690988|16408978|P2|Overall Study|Sedated|1
4756864|NCT01690988|16408979|P1|Overall Study|Sedated|1
4756865|NCT01690988|16408977|P3|Overall Study|Death|1
4756866|NCT01690988|16408978|P2|Overall Study|Death|1
4756867|NCT01690988|16408979|P1|Overall Study|Death|1
4756868|NCT01690988|16408977|P3|Overall Study|Determined ineligible|0
4756869|NCT01690988|16408978|P2|Overall Study|Determined ineligible|0
4756870|NCT01690988|16408979|P1|Overall Study|Determined ineligible|1
4756871|NCT01690988|16408977|P3|Overall Study|Operation Cancelled|0
4756872|NCT01690988|16408978|P2|Overall Study|Operation Cancelled|1
4756873|NCT01690988|16408979|P1|Overall Study|Operation Cancelled|1
4756874|NCT01690988|16408977|P3|Overall Study|Physician Decision|1
4756875|NCT01690988|16408978|P2|Overall Study|Physician Decision|0
4756876|NCT01690988|16408979|P1|Overall Study|Physician Decision|0
4756877|NCT01690988|16408977|P3|Overall Study|Withdrawal by Subject|3
4756878|NCT01690988|16408978|P2|Overall Study|Withdrawal by Subject|2
4756879|NCT01690988|16408979|P1|Overall Study|Withdrawal by Subject|2
4756880|NCT01690299|16409047|P6|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1
4756881|NCT01690299|16409048|P5|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4756882|NCT01690299|16409049|P4|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4756883|NCT01690299|16409050|P3|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4756884|NCT01690299|16409051|P2|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4756885|NCT01690299|16409052|P1|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0
4756886|NCT01690299|16409047|P6|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
4756887|NCT01690299|16409048|P5|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13
4756888|NCT01690299|16409049|P4|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6
4756889|NCT01690299|16409050|P3|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
4756890|NCT01690299|16409051|P2|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
4756891|NCT01690299|16409052|P1|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0
4756892|NCT01690299|16409047|P6|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11
4756893|NCT01690299|16409048|P5|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5
4756894|NCT01690299|16409049|P4|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8
4756895|NCT01690299|16409050|P3|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
4756896|NCT01690299|16409051|P2|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
4756897|NCT01690299|16409052|P1|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0
4756898|NCT01690299|16409047|P6|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
4756899|NCT01690299|16409048|P5|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1
4756900|NCT01690299|16409049|P4|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4756901|NCT01690299|16409050|P3|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4756902|NCT01690299|16409051|P2|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4756903|NCT01690299|16409052|P1|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0
4756904|NCT01690299|16409047|P6|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8
4756905|NCT01690299|16409048|P5|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10
4756906|NCT01690299|16409049|P4|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9
4756907|NCT01690299|16409050|P3|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
4756908|NCT01690299|16409051|P2|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
4756909|NCT01690299|16409052|P1|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0
4756910|NCT01690299|16409047|P6|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
4756911|NCT01690299|16409048|P5|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4
4756912|NCT01690299|16409049|P4|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3
4756913|NCT01690299|16409050|P3|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
4756914|NCT01690299|16409051|P2|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
4756915|NCT01690299|16409052|P1|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0
4756916|NCT01690299|16409047|P6|Placebo-controlled Phase (Weeks 0-16)|Other|0
4756917|NCT01690299|16409048|P5|Placebo-controlled Phase (Weeks 0-16)|Other|0
4756918|NCT01690299|16409049|P4|Placebo-controlled Phase (Weeks 0-16)|Other|0
4756919|NCT01690299|16409050|P3|Placebo-controlled Phase (Weeks 0-16)|Other|1
4756920|NCT01690299|16409051|P2|Placebo-controlled Phase (Weeks 0-16)|Other|1
4756921|NCT01690299|16409052|P1|Placebo-controlled Phase (Weeks 0-16)|Other|2
4756922|NCT01690299|16409047|P6|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4756923|NCT01690299|16409048|P5|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4756924|NCT01690299|16409049|P4|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4756925|NCT01690299|16409050|P3|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4756926|NCT01690299|16409051|P2|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3
4756927|NCT01690299|16409052|P1|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1
4756928|NCT01690299|16409047|P6|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4756929|NCT01690299|16409048|P5|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4756930|NCT01690299|16409049|P4|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4756931|NCT01690299|16409050|P3|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4756932|NCT01690299|16409051|P2|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4756933|NCT01690299|16409052|P1|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4
4756934|NCT01690299|16409047|P6|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
4756935|NCT01690299|16409048|P5|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
4756936|NCT01690299|16409049|P4|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0
4756937|NCT01690299|16409050|P3|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1
4756938|NCT01690299|16409051|P2|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
4756939|NCT01690299|16409052|P1|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2
4756940|NCT01690143|16409149|P1|Overall Study|Withdrawal by Subject|1
4756941|NCT01690130|16409159|P2|Overall Study|Subject have cancelled visit.|0
4756942|NCT01690130|16409160|P1|Overall Study|Subject have cancelled visit.|1
4756943|NCT01690052|16409207|P2|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2
4756944|NCT01690052|16409208|P1|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1
4756945|NCT01689974|16409225|P2|Overall Study|Termination of Study|5
4756946|NCT01689974|16409226|P1|Overall Study|Termination of Study|5
4756947|NCT01689857|16409257|P2|Overall Study|Lost to Follow-up|2
4756948|NCT01689857|16409258|P1|Overall Study|Lost to Follow-up|5
4756949|NCT01689649|16409306|P1|Overall Study|Lost to Follow-up|5
4756950|NCT01689649|16409306|P1|Overall Study|Protocol Violation|3
4756951|NCT01689649|16409306|P1|Overall Study|Non-compliance|11
4756952|NCT01689649|16409306|P1|Overall Study|Lack of Efficacy|3
4756953|NCT01689532|16409318|P2|Overall Study|Physician Decision|0
4756954|NCT01689532|16409319|P1|Overall Study|Physician Decision|2
4756955|NCT01689532|16409318|P2|Overall Study|Withdrawal by Subject|2
4756956|NCT01689532|16409319|P1|Overall Study|Withdrawal by Subject|1
4756957|NCT01689532|16409318|P2|Overall Study|Lack of Efficacy|2
4756958|NCT01689532|16409319|P1|Overall Study|Lack of Efficacy|2
4756959|NCT01689532|16409318|P2|Overall Study|Adverse Event|5
4756960|NCT01689532|16409319|P1|Overall Study|Adverse Event|9
4756961|NCT01689519|16409383|P2|Safety Population|Withdrawal by Subject|20
4756962|NCT01689519|16409384|P1|Safety Population|Withdrawal by Subject|20
4756963|NCT01689519|16409383|P2|Safety Population|Study Terminated By Sponsor|47
4756964|NCT01689519|16409384|P1|Safety Population|Study Terminated By Sponsor|60
4756965|NCT01689519|16409383|P2|Safety Population|Physician Decision|1
4756966|NCT01689519|16409384|P1|Safety Population|Physician Decision|4
4756967|NCT01689519|16409383|P2|Safety Population|Other|4
4756968|NCT01689519|16409384|P1|Safety Population|Other|2
4756969|NCT01689519|16409383|P2|Safety Population|Lost to Follow-up|8
4756970|NCT01689519|16409384|P1|Safety Population|Lost to Follow-up|4
4756971|NCT01689519|16409383|P2|Safety Population|Death|165
4756972|NCT01689519|16409384|P1|Safety Population|Death|158
4756973|NCT01689519|16409383|P2|Intent to Treat|Withdrawal by Subject|20
4756974|NCT01689519|16409384|P1|Intent to Treat|Withdrawal by Subject|21
4756975|NCT01689519|16409383|P2|Intent to Treat|Study terminated by Spon6sor|48
4756976|NCT01689519|16409384|P1|Intent to Treat|Study terminated by Spon6sor|59
4756977|NCT01689519|16409383|P2|Intent to Treat|Physician Decision|1
4756978|NCT01689519|16409384|P1|Intent to Treat|Physician Decision|4
4756979|NCT01689519|16409383|P2|Intent to Treat|Other|4
4756980|NCT01689519|16409384|P1|Intent to Treat|Other|2
4756981|NCT01689519|16409383|P2|Intent to Treat|Lost to Follow-up|8
4756982|NCT01689519|16409384|P1|Intent to Treat|Lost to Follow-up|4
4756983|NCT01689519|16409383|P2|Intent to Treat|Death|167
4756984|NCT01689519|16409384|P1|Intent to Treat|Death|157
4756985|NCT01689363|16409409|P8|Overall Study|Protocol Violation|0
4756986|NCT01689363|16409410|P7|Overall Study|Protocol Violation|0
4756987|NCT01689363|16409411|P6|Overall Study|Protocol Violation|0
4756988|NCT01689363|16409412|P5|Overall Study|Protocol Violation|0
4756989|NCT01689363|16409413|P4|Overall Study|Protocol Violation|0
4756990|NCT01689363|16409414|P3|Overall Study|Protocol Violation|0
4756991|NCT01689363|16409415|P2|Overall Study|Protocol Violation|1
4756992|NCT01689363|16409416|P1|Overall Study|Protocol Violation|0
4756993|NCT01689337|16409471|P1|Overall Study|Study Discontinuation|1
4756994|NCT01689207|16409510|P11|Overall Study|Adverse Event|0
4756995|NCT01689207|16409511|P10|Overall Study|Adverse Event|0
4756996|NCT01689207|16409512|P9|Overall Study|Adverse Event|1
4756997|NCT01689207|16409513|P8|Overall Study|Adverse Event|0
4756998|NCT01689207|16409514|P7|Overall Study|Adverse Event|0
4756999|NCT01689207|16409515|P6|Overall Study|Adverse Event|1
4757000|NCT01689207|16409516|P5|Overall Study|Adverse Event|2
4757001|NCT01689207|16409517|P4|Overall Study|Adverse Event|0
4757002|NCT01689207|16409518|P3|Overall Study|Adverse Event|0
4757003|NCT01689207|16409519|P2|Overall Study|Adverse Event|1
4757004|NCT01689207|16409520|P1|Overall Study|Adverse Event|0
4757005|NCT01688999|16409628|P3|Overall Study|Ineligible/Not treated|0
4757006|NCT01688999|16409629|P2|Overall Study|Ineligible/Not treated|0
4757007|NCT01688999|16409630|P1|Overall Study|Ineligible/Not treated|1
4757008|NCT01688999|16409628|P3|Overall Study|Adverse Event|2
4757009|NCT01688999|16409629|P2|Overall Study|Adverse Event|0
4757010|NCT01688999|16409630|P1|Overall Study|Adverse Event|2
4757011|NCT01688999|16409628|P3|Overall Study|Withdrawal by Subject|1
4757012|NCT01688999|16409629|P2|Overall Study|Withdrawal by Subject|1
4757013|NCT01688999|16409630|P1|Overall Study|Withdrawal by Subject|5
4757014|NCT01688973|16409646|P2|Overall Study|Ineligible|3
4757015|NCT01688973|16409647|P1|Overall Study|Ineligible|2
4757016|NCT01688921|16409661|P2|Overall Study|informed consent|0
4757017|NCT01688921|16409662|P1|Overall Study|informed consent|3
4757018|NCT01688921|16409661|P2|Overall Study|Protocol Violation|1
4757019|NCT01688921|16409662|P1|Overall Study|Protocol Violation|0
4757020|NCT01688921|16409661|P2|Overall Study|Physician Decision|1
4757021|NCT01688921|16409662|P1|Overall Study|Physician Decision|6
4757022|NCT01688921|16409661|P2|Overall Study|Lost to Follow-up|13
4757023|NCT01688921|16409662|P1|Overall Study|Lost to Follow-up|7
4757024|NCT01688882|16409694|P2|Overall Study|Administrative problems|0
4757025|NCT01688882|16409695|P1|Overall Study|Administrative problems|1
4757026|NCT01688882|16409694|P2|Overall Study|Unsatisfactory therapeutic effect|1
4757027|NCT01688882|16409695|P1|Overall Study|Unsatisfactory therapeutic effect|1
4757028|NCT01688882|16409694|P2|Overall Study|Adverse Event|0
4757029|NCT01688882|16409695|P1|Overall Study|Adverse Event|1
4757030|NCT01688830|16409766|P21|Overall Study|Lost to Follow-up|0
4757031|NCT01688830|16409767|P20|Overall Study|Lost to Follow-up|0
4757032|NCT01688830|16409768|P19|Overall Study|Lost to Follow-up|0
4757033|NCT01688830|16409769|P18|Overall Study|Lost to Follow-up|0
4757034|NCT01688830|16409770|P17|Overall Study|Lost to Follow-up|0
4757035|NCT01688830|16409771|P16|Overall Study|Lost to Follow-up|0
4757036|NCT01688830|16409772|P15|Overall Study|Lost to Follow-up|0
4757037|NCT01688830|16409773|P14|Overall Study|Lost to Follow-up|0
4757038|NCT01688830|16409774|P13|Overall Study|Lost to Follow-up|0
4757039|NCT01688830|16409775|P12|Overall Study|Lost to Follow-up|0
4757040|NCT01688830|16409776|P11|Overall Study|Lost to Follow-up|1
4757041|NCT01688830|16409777|P10|Overall Study|Lost to Follow-up|0
4757042|NCT01688830|16409778|P9|Overall Study|Lost to Follow-up|0
4757043|NCT01688830|16409779|P8|Overall Study|Lost to Follow-up|0
4757044|NCT01688830|16409780|P7|Overall Study|Lost to Follow-up|0
4757045|NCT01688830|16409781|P6|Overall Study|Lost to Follow-up|0
4757046|NCT01688830|16409782|P5|Overall Study|Lost to Follow-up|0
4757047|NCT01688830|16409783|P4|Overall Study|Lost to Follow-up|0
4757048|NCT01688830|16409784|P3|Overall Study|Lost to Follow-up|0
4757049|NCT01688830|16409785|P2|Overall Study|Lost to Follow-up|0
4757050|NCT01688830|16409786|P1|Overall Study|Lost to Follow-up|0
4757051|NCT01688739|16409940|P10|Overall Study|Administrative Decision|0
4757052|NCT01688739|16409941|P9|Overall Study|Administrative Decision|0
4757053|NCT01688739|16409942|P8|Overall Study|Administrative Decision|0
4757054|NCT01688739|16409943|P7|Overall Study|Administrative Decision|0
4757055|NCT01688739|16409944|P6|Overall Study|Administrative Decision|0
4757056|NCT01688739|16409945|P5|Overall Study|Administrative Decision|0
4757057|NCT01688739|16409946|P4|Overall Study|Administrative Decision|0
4757058|NCT01688739|16409947|P3|Overall Study|Administrative Decision|0
4757059|NCT01688739|16409948|P2|Overall Study|Administrative Decision|0
4757060|NCT01688739|16409949|P1|Overall Study|Administrative Decision|1
4757061|NCT01688726|16410025|P2|Overall Study|Relocated abroad|1
4757062|NCT01688726|16410026|P1|Overall Study|Relocated abroad|0
4757063|NCT01688726|16410025|P2|Overall Study|Adverse Event|0
4757064|NCT01688726|16410026|P1|Overall Study|Adverse Event|1
4757065|NCT01688635|16410038|P2|Washout 3|Withdrawal by Subject|0
4757066|NCT01688635|16410039|P1|Washout 3|Withdrawal by Subject|1
4757067|NCT01688635|16410038|P2|Washout 2|Sponsor Decision|2
4757068|NCT01688635|16410039|P1|Washout 2|Sponsor Decision|1
4757069|NCT01688635|16410038|P2|Washout 2|Withdrawal by Subject|0
4757070|NCT01688635|16410039|P1|Washout 2|Withdrawal by Subject|1
4757071|NCT01688635|16410038|P2|Washout 2|Physician Decision|0
4757072|NCT01688635|16410039|P1|Washout 2|Physician Decision|1
4757073|NCT01688635|16410038|P2|Washout 1|Physician Decision|1
4757074|NCT01688635|16410039|P1|Washout 1|Physician Decision|0
4757075|NCT01688635|16410038|P2|Washout 1|Adverse Event|1
4757076|NCT01688635|16410039|P1|Washout 1|Adverse Event|0
4757077|NCT01688635|16410038|P2|Washout 1|Withdrawal by Subject|0
4757078|NCT01688635|16410039|P1|Washout 1|Withdrawal by Subject|1
4757079|NCT01688466|16410086|P2|Overall Study|Not evaluable|1
4757080|NCT01688466|16410087|P1|Overall Study|Not evaluable|0
4757081|NCT01688466|16410086|P2|Overall Study|Adverse Event|4
4757082|NCT01688466|16410087|P1|Overall Study|Adverse Event|0
4757083|NCT01688466|16410086|P2|Overall Study|Death|1
4757084|NCT01688466|16410087|P1|Overall Study|Death|0
4757085|NCT01688466|16410086|P2|Overall Study|Withdrawal by Subject|1
4757086|NCT01688466|16410087|P1|Overall Study|Withdrawal by Subject|2
4757087|NCT01688050|16410178|P1|Overall Study|Withdrawal by Subject|10
4757088|NCT01688050|16410178|P1|Overall Study|Lost to Follow-up|13
4757089|NCT01688050|16410178|P1|Overall Study|Conversion to open repair|1
4757090|NCT01688050|16410178|P1|Overall Study|Death|7
4757091|NCT01688037|16410187|P3|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
4757092|NCT01688037|16410188|P2|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1
4757093|NCT01688037|16410189|P1|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0
4757094|NCT01688037|16410187|P3|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1
4757095|NCT01688037|16410188|P2|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
4757096|NCT01688037|16410189|P1|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0
4757097|NCT01688037|16410187|P3|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0
4757098|NCT01688037|16410188|P2|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2
4757099|NCT01688037|16410189|P1|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1
4757100|NCT01688037|16410187|P3|Open-Label Period (Week 6 to 12)|Non-compliance|2
4757101|NCT01688037|16410188|P2|Open-Label Period (Week 6 to 12)|Non-compliance|0
4757102|NCT01688037|16410189|P1|Open-Label Period (Week 6 to 12)|Non-compliance|0
4757103|NCT01688037|16410187|P3|Open-Label Period (Week 6 to 12)|Adverse Event|1
4757104|NCT01688037|16410188|P2|Open-Label Period (Week 6 to 12)|Adverse Event|1
4757105|NCT01688037|16410189|P1|Open-Label Period (Week 6 to 12)|Adverse Event|4
4757106|NCT01688037|16410187|P3|Double-Blind Period (Week 0 to 6)|Physician Decision|0
4757107|NCT01688037|16410188|P2|Double-Blind Period (Week 0 to 6)|Physician Decision|1
4757108|NCT01688037|16410189|P1|Double-Blind Period (Week 0 to 6)|Physician Decision|0
4757109|NCT01688037|16410187|P3|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
4757110|NCT01688037|16410188|P2|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0
4757111|NCT01688037|16410189|P1|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1
4757112|NCT01688037|16410187|P3|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1
4757113|NCT01688037|16410188|P2|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0
4757114|NCT01688037|16410189|P1|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4
4757115|NCT01688037|16410187|P3|Double-Blind Period (Week 0 to 6)|Non-compliance|3
4757116|NCT01688037|16410188|P2|Double-Blind Period (Week 0 to 6)|Non-compliance|2
4757117|NCT01688037|16410189|P1|Double-Blind Period (Week 0 to 6)|Non-compliance|1
4757118|NCT01688037|16410187|P3|Double-Blind Period (Week 0 to 6)|Adverse Event|1
4757119|NCT01688037|16410188|P2|Double-Blind Period (Week 0 to 6)|Adverse Event|0
4757120|NCT01688037|16410189|P1|Double-Blind Period (Week 0 to 6)|Adverse Event|1
4757121|NCT01687998|16410205|P2|Overall Study|Lost to Follow-up|7
4757122|NCT01687998|16410206|P1|Overall Study|Lost to Follow-up|9
4757123|NCT01687998|16410205|P2|Overall Study|Known to be Alive at Study End|62
4757124|NCT01687998|16410206|P1|Overall Study|Known to be Alive at Study End|54
4757125|NCT01687998|16410205|P2|Overall Study|Withdrawal by Subject|51
4757126|NCT01687998|16410206|P1|Overall Study|Withdrawal by Subject|49
4757127|NCT01687712|16410242|P2|Cycle 3|Miscarriage/Spontaneous Abortion|0
4757128|NCT01687712|16410243|P1|Cycle 3|Miscarriage/Spontaneous Abortion|1
4757129|NCT01687712|16410242|P2|Cycle 3|Ectopic Pregnancy|0
4757130|NCT01687712|16410243|P1|Cycle 3|Ectopic Pregnancy|1
4757131|NCT01687712|16410242|P2|Cycle 3|Early Pregnancy Loss|2
4757132|NCT01687712|16410243|P1|Cycle 3|Early Pregnancy Loss|1
4757133|NCT01687712|16410242|P2|Cycle 3|Not Biochemically Pregnant|22
4757134|NCT01687712|16410243|P1|Cycle 3|Not Biochemically Pregnant|21
4757135|NCT01687712|16410242|P2|Cycle 2|Miscarriage/Spontaneous Abortion|1
4757136|NCT01687712|16410243|P1|Cycle 2|Miscarriage/Spontaneous Abortion|0
4757137|NCT01687712|16410242|P2|Cycle 2|Still Birth|0
4757138|NCT01687712|16410243|P1|Cycle 2|Still Birth|1
4757139|NCT01687712|16410242|P2|Cycle 2|Ectopic Pregnancy|1
4757140|NCT01687712|16410243|P1|Cycle 2|Ectopic Pregnancy|0
4757141|NCT01687712|16410242|P2|Cycle 2|Early Pregnancy Loss|16
4757142|NCT01687712|16410243|P1|Cycle 2|Early Pregnancy Loss|18
4757143|NCT01687712|16410242|P2|Cycle 2|Not Biochemically Pregnant|77
4757144|NCT01687712|16410243|P1|Cycle 2|Not Biochemically Pregnant|74
4757145|NCT01687712|16410242|P2|Cycle 1|Lost to Follow-up|1
4757146|NCT01687712|16410243|P1|Cycle 1|Lost to Follow-up|1
4757147|NCT01687712|16410242|P2|Cycle 1|Intrauterine Fetal Death|1
4757148|NCT01687712|16410243|P1|Cycle 1|Intrauterine Fetal Death|0
4757149|NCT01687712|16410242|P2|Cycle 1|Abortion|0
4757150|NCT01687712|16410243|P1|Cycle 1|Abortion|3
4757151|NCT01687712|16410242|P2|Cycle 1|Miscarriage/Spontaneous Abortion|14
4757152|NCT01687712|16410243|P1|Cycle 1|Miscarriage/Spontaneous Abortion|9
4757153|NCT01687712|16410242|P2|Cycle 1|Heterotropic Pregnancy|0
4757154|NCT01687712|16410243|P1|Cycle 1|Heterotropic Pregnancy|1
4757155|NCT01687712|16410242|P2|Cycle 1|Ectopic Pregnancy|5
4757156|NCT01687712|16410243|P1|Cycle 1|Ectopic Pregnancy|5
4757157|NCT01687712|16410242|P2|Cycle 1|Early Pregnancy Loss|60
4757158|NCT01687712|16410243|P1|Cycle 1|Early Pregnancy Loss|43
4757159|NCT01687712|16410242|P2|Cycle 1|Not Biochemically Pregnant|348
4757160|NCT01687712|16410243|P1|Cycle 1|Not Biochemically Pregnant|386
4757161|NCT01687478|16410283|P2|Overall Study|Entry Criteria Not Met|2
4757162|NCT01687478|16410284|P1|Overall Study|Entry Criteria Not Met|6
4757163|NCT01687478|16410283|P2|Overall Study|Physician Decision|3
4757164|NCT01687478|16410284|P1|Overall Study|Physician Decision|1
4757165|NCT01687478|16410283|P2|Overall Study|Withdrawal by Subject|19
4757166|NCT01687478|16410284|P1|Overall Study|Withdrawal by Subject|21
4757167|NCT01687478|16410283|P2|Overall Study|Protocol Violation|2
4757168|NCT01687478|16410284|P1|Overall Study|Protocol Violation|0
4757169|NCT01687478|16410283|P2|Overall Study|Lost to Follow-up|3
4757170|NCT01687478|16410284|P1|Overall Study|Lost to Follow-up|1
4757171|NCT01687478|16410283|P2|Overall Study|Adverse Event|10
4757172|NCT01687478|16410284|P1|Overall Study|Adverse Event|3
4757173|NCT01687296|16410335|P2|Overall Study|Withdrawal by Subject|3
4757174|NCT01687296|16410336|P1|Overall Study|Withdrawal by Subject|6
4757175|NCT01687296|16410335|P2|Overall Study|Protocol Violation|1
4757176|NCT01687296|16410336|P1|Overall Study|Protocol Violation|0
4757177|NCT01687296|16410335|P2|Overall Study|Lack of Efficacy|1
4757178|NCT01687296|16410336|P1|Overall Study|Lack of Efficacy|1
4757179|NCT01687283|16410358|P2|Overall Study|Withdrawal by Subject|8
4757180|NCT01687283|16410359|P1|Overall Study|Withdrawal by Subject|9
4757181|NCT01687283|16410358|P2|Overall Study|Investigator discretion|0
4757182|NCT01687283|16410359|P1|Overall Study|Investigator discretion|2
4757183|NCT01687283|16410358|P2|Overall Study|Lost to Follow-up|1
4757184|NCT01687283|16410359|P1|Overall Study|Lost to Follow-up|1
4757185|NCT01687283|16410358|P2|Overall Study|protocol defined stopping criteria|10
4757186|NCT01687283|16410359|P1|Overall Study|protocol defined stopping criteria|8
4757187|NCT01687283|16410358|P2|Overall Study|Protocol Violation|3
4757188|NCT01687283|16410359|P1|Overall Study|Protocol Violation|1
4757189|NCT01687283|16410358|P2|Overall Study|Lack of Efficacy|1
4757190|NCT01687283|16410359|P1|Overall Study|Lack of Efficacy|3
4757191|NCT01687283|16410358|P2|Overall Study|Adverse Event|4
4757192|NCT01687283|16410359|P1|Overall Study|Adverse Event|11
4757193|NCT01687270|16410382|P1|Overall Study|Lost to Follow-up|1
4757194|NCT01687270|16410382|P1|Overall Study|Lack of Efficacy|11
4757195|NCT01687257|16410393|P3|Overall Study|Investigator's Discretion|0
4757196|NCT01687257|16410394|P2|Overall Study|Investigator's Discretion|3
4757197|NCT01687257|16410395|P1|Overall Study|Investigator's Discretion|0
4757198|NCT01687257|16410393|P3|Overall Study|Adverse Event|0
4757199|NCT01687257|16410394|P2|Overall Study|Adverse Event|0
4757200|NCT01687257|16410395|P1|Overall Study|Adverse Event|1
4757201|NCT01687257|16410393|P3|Overall Study|Subject Withdrew Consent|1
4757202|NCT01687257|16410394|P2|Overall Study|Subject Withdrew Consent|1
4757203|NCT01687257|16410395|P1|Overall Study|Subject Withdrew Consent|1
4757204|NCT01687257|16410393|P3|Overall Study|Efficacy Failure|5
4757205|NCT01687257|16410394|P2|Overall Study|Efficacy Failure|0
4757206|NCT01687257|16410395|P1|Overall Study|Efficacy Failure|6
4757207|NCT01687218|16410460|P6|Overall Study|Relocated, no follow-up planned|0
4757208|NCT01687218|16410461|P5|Overall Study|Relocated, no follow-up planned|0
4757209|NCT01687218|16410462|P4|Overall Study|Relocated, no follow-up planned|1
4757210|NCT01687218|16410463|P3|Overall Study|Relocated, no follow-up planned|1
4757211|NCT01687218|16410464|P2|Overall Study|Relocated, no follow-up planned|0
4757212|NCT01687218|16410465|P1|Overall Study|Relocated, no follow-up planned|1
4757213|NCT01687218|16410460|P6|Overall Study|Withdrawal by Subject|0
4757214|NCT01687218|16410461|P5|Overall Study|Withdrawal by Subject|1
4757215|NCT01687218|16410462|P4|Overall Study|Withdrawal by Subject|1
4757216|NCT01687218|16410463|P3|Overall Study|Withdrawal by Subject|0
4757217|NCT01687218|16410464|P2|Overall Study|Withdrawal by Subject|3
4757218|NCT01687218|16410465|P1|Overall Study|Withdrawal by Subject|2
4757219|NCT01687166|16410517|P4|Overall Study|Insurance|1
4757220|NCT01687166|16410518|P3|Overall Study|Insurance|1
4757221|NCT01687166|16410519|P2|Overall Study|Insurance|0
4757222|NCT01687166|16410520|P1|Overall Study|Insurance|0
4757223|NCT01687166|16410517|P4|Overall Study|Physician choice to use different device|0
4757224|NCT01687166|16410518|P3|Overall Study|Physician choice to use different device|4
4757225|NCT01687166|16410519|P2|Overall Study|Physician choice to use different device|2
4757226|NCT01687166|16410520|P1|Overall Study|Physician choice to use different device|1
4757227|NCT01687166|16410517|P4|Overall Study|Patient unable to be compliant|0
4757228|NCT01687166|16410518|P3|Overall Study|Patient unable to be compliant|0
4757229|NCT01687166|16410519|P2|Overall Study|Patient unable to be compliant|0
4757230|NCT01687166|16410520|P1|Overall Study|Patient unable to be compliant|1
4757231|NCT01687166|16410517|P4|Overall Study|Subject moved out of state|0
4757232|NCT01687166|16410518|P3|Overall Study|Subject moved out of state|0
4757233|NCT01687166|16410519|P2|Overall Study|Subject moved out of state|1
4757234|NCT01687166|16410520|P1|Overall Study|Subject moved out of state|0
4757235|NCT01687166|16410517|P4|Overall Study|Protocol Violation|0
4757236|NCT01687166|16410518|P3|Overall Study|Protocol Violation|1
4757237|NCT01687166|16410519|P2|Overall Study|Protocol Violation|1
4757238|NCT01687166|16410520|P1|Overall Study|Protocol Violation|1
4757239|NCT01687166|16410517|P4|Overall Study|Death|0
4757240|NCT01687166|16410518|P3|Overall Study|Death|0
4757241|NCT01687166|16410519|P2|Overall Study|Death|1
4757242|NCT01687166|16410520|P1|Overall Study|Death|1
4757243|NCT01687166|16410517|P4|Overall Study|Equipment/Device Availability|0
4757244|NCT01687166|16410518|P3|Overall Study|Equipment/Device Availability|0
4757245|NCT01687166|16410519|P2|Overall Study|Equipment/Device Availability|1
4757246|NCT01687166|16410520|P1|Overall Study|Equipment/Device Availability|0
4757247|NCT01687166|16410517|P4|Overall Study|Lost to Follow-up|0
4757248|NCT01687166|16410518|P3|Overall Study|Lost to Follow-up|1
4757249|NCT01687166|16410519|P2|Overall Study|Lost to Follow-up|5
4757250|NCT01687166|16410520|P1|Overall Study|Lost to Follow-up|2
4757251|NCT01687166|16410517|P4|Overall Study|Withdrawal by Subject|0
4757252|NCT01687166|16410518|P3|Overall Study|Withdrawal by Subject|3
4757253|NCT01687166|16410519|P2|Overall Study|Withdrawal by Subject|4
4757254|NCT01687166|16410520|P1|Overall Study|Withdrawal by Subject|11
4757255|NCT01687166|16410517|P4|Overall Study|Physician Decision|0
4757256|NCT01687166|16410518|P3|Overall Study|Physician Decision|1
4757257|NCT01687166|16410519|P2|Overall Study|Physician Decision|2
4757258|NCT01687166|16410520|P1|Overall Study|Physician Decision|3
4757259|NCT01687166|16410517|P4|Overall Study|Adverse Event|0
4757260|NCT01687166|16410518|P3|Overall Study|Adverse Event|0
4757261|NCT01687166|16410519|P2|Overall Study|Adverse Event|1
4757262|NCT01687166|16410520|P1|Overall Study|Adverse Event|2
4757263|NCT01687166|16410517|P4|Overall Study|Did not meet eligibility criteria|1
4757264|NCT01687166|16410518|P3|Overall Study|Did not meet eligibility criteria|1
4757265|NCT01687166|16410519|P2|Overall Study|Did not meet eligibility criteria|6
4757266|NCT01687166|16410520|P1|Overall Study|Did not meet eligibility criteria|4
4757267|NCT01687166|16410517|P4|Overall Study|Attempt subject|0
4757268|NCT01687166|16410518|P3|Overall Study|Attempt subject|2
4757269|NCT01687166|16410519|P2|Overall Study|Attempt subject|3
4757270|NCT01687166|16410520|P1|Overall Study|Attempt subject|2
4757271|NCT01687101|16410536|P1|Overall Study|Lost to Follow-up|7
4757272|NCT01686958|16410561|P1|Overall Study|Withdrawal by Subject|1
4757273|NCT01686932|16410574|P2|Period 1|Adverse Event|1
4757274|NCT01686932|16410575|P1|Period 1|Adverse Event|1
4757275|NCT01686828|16410605|P4|Overall Study|Weight Loss|0
4757276|NCT01686828|16410606|P3|Overall Study|Weight Loss|1
4757277|NCT01686828|16410607|P2|Overall Study|Weight Loss|0
4757278|NCT01686828|16410608|P1|Overall Study|Weight Loss|0
4757279|NCT01686828|16410605|P4|Overall Study|New Job|0
4757280|NCT01686828|16410606|P3|Overall Study|New Job|0
4757281|NCT01686828|16410607|P2|Overall Study|New Job|1
4757282|NCT01686828|16410608|P1|Overall Study|New Job|0
4757283|NCT01686828|16410605|P4|Overall Study|Physician Decision|0
4757284|NCT01686828|16410606|P3|Overall Study|Physician Decision|0
4757285|NCT01686828|16410607|P2|Overall Study|Physician Decision|0
4757286|NCT01686828|16410608|P1|Overall Study|Physician Decision|1
4757287|NCT01686633|16410721|P3|Overall Study|Lost to Follow-up|1
4757288|NCT01686633|16410722|P2|Overall Study|Lost to Follow-up|1
4757289|NCT01686633|16410723|P1|Overall Study|Lost to Follow-up|0
4757290|NCT01686633|16410721|P3|Overall Study|Protocol-defined Stopping Criteria|1
4757291|NCT01686633|16410722|P2|Overall Study|Protocol-defined Stopping Criteria|0
4757292|NCT01686633|16410723|P1|Overall Study|Protocol-defined Stopping Criteria|1
4757293|NCT01686633|16410721|P3|Overall Study|Protocol Violation|0
4757294|NCT01686633|16410722|P2|Overall Study|Protocol Violation|3
4757295|NCT01686633|16410723|P1|Overall Study|Protocol Violation|2
4757296|NCT01686633|16410721|P3|Overall Study|Adverse Event|3
4757297|NCT01686633|16410722|P2|Overall Study|Adverse Event|3
4757298|NCT01686633|16410723|P1|Overall Study|Adverse Event|4
4757299|NCT01686633|16410721|P3|Overall Study|Physician Decision|4
4757300|NCT01686633|16410722|P2|Overall Study|Physician Decision|4
4757301|NCT01686633|16410723|P1|Overall Study|Physician Decision|3
4757302|NCT01686633|16410721|P3|Overall Study|Withdrawal by Subject|5
4757303|NCT01686633|16410722|P2|Overall Study|Withdrawal by Subject|8
4757304|NCT01686633|16410723|P1|Overall Study|Withdrawal by Subject|8
4757305|NCT01686633|16410721|P3|Overall Study|Lack of Efficacy|11
4757306|NCT01686633|16410722|P2|Overall Study|Lack of Efficacy|13
4757307|NCT01686633|16410723|P1|Overall Study|Lack of Efficacy|33
4757308|NCT01686581|16410746|P1|Overall Study|Reason Missing|1
4757309|NCT01686581|16410746|P1|Overall Study|Other Miscellaneous Reasons|36
4757310|NCT01686581|16410746|P1|Overall Study|Thinks it is Inconvenient|17
4757311|NCT01686581|16410746|P1|Overall Study|Trying to get Pregnant or Nursing|2
4757312|NCT01686581|16410746|P1|Overall Study|Thinks Injections Take Too Much Time|2
4757313|NCT01686581|16410746|P1|Overall Study|Thinks Injections Too Painful|8
4757314|NCT01686581|16410746|P1|Overall Study|Participant Concerned about Risks|6
4757315|NCT01686581|16410746|P1|Overall Study|Lack of Efficacy|90
4757316|NCT01686581|16410746|P1|Overall Study|Side-effects or Health Problems|15
4757317|NCT01686568|16410759|P2|Sub-Study|Not consented for sub-study|2
4757318|NCT01686568|16410760|P1|Sub-Study|Not consented for sub-study|2
4757319|NCT01686568|16410759|P2|Main Study|Liver enzymes above range of exclusion|0
4757320|NCT01686568|16410760|P1|Main Study|Liver enzymes above range of exclusion|1
4757321|NCT01686568|16410759|P2|Main Study|Noncompliance with protocol|1
4757322|NCT01686568|16410760|P1|Main Study|Noncompliance with protocol|0
4757323|NCT01686568|16410759|P2|Main Study|Withdrawal by Subject|3
4757324|NCT01686568|16410760|P1|Main Study|Withdrawal by Subject|1
4757325|NCT01686438|16410837|P3|Overall Study|Withdrawal by Subject|1
4757326|NCT01686438|16410838|P2|Overall Study|Withdrawal by Subject|0
4757327|NCT01686438|16410839|P1|Overall Study|Withdrawal by Subject|0
4757328|NCT01686438|16410837|P3|Overall Study|Protocol Violation|1
4757329|NCT01686438|16410838|P2|Overall Study|Protocol Violation|0
4757330|NCT01686438|16410839|P1|Overall Study|Protocol Violation|0
4757331|NCT01686438|16410837|P3|Overall Study|Adverse Event|1
4757332|NCT01686438|16410838|P2|Overall Study|Adverse Event|0
4757333|NCT01686438|16410839|P1|Overall Study|Adverse Event|0
4757334|NCT01686438|16410837|P3|Overall Study|Lost to Follow-up|10
4757335|NCT01686438|16410838|P2|Overall Study|Lost to Follow-up|9
4757336|NCT01686438|16410839|P1|Overall Study|Lost to Follow-up|8
4757337|NCT01686373|16410887|P2|Overall Study|Adverse Event|1
4757338|NCT01686373|16410888|P1|Overall Study|Adverse Event|0
4757339|NCT01686373|16410887|P2|Overall Study|Withdrawal by Subject|1
4757340|NCT01686373|16410888|P1|Overall Study|Withdrawal by Subject|0
4757341|NCT01686373|16410887|P2|Overall Study|Lost to Follow-up|0
4757342|NCT01686373|16410888|P1|Overall Study|Lost to Follow-up|3
4757343|NCT01685983|16410912|P1|Overall Study|Noncompliance with Study Drug|1
4757344|NCT01685983|16410912|P1|Overall Study|Progressive Disease|32
4757345|NCT01685983|16410912|P1|Overall Study|Other|7
4757346|NCT01685983|16410912|P1|Overall Study|Physician Decision|13
4757347|NCT01685983|16410912|P1|Overall Study|Protocol Violation|2
4757348|NCT01685983|16410912|P1|Overall Study|Withdrawal by Subject|19
4757349|NCT01685983|16410912|P1|Overall Study|Death|1
4757350|NCT01685983|16410912|P1|Overall Study|Adverse Event|7
4757351|NCT01685840|16410924|P2|Overall Study|Had VAD, Dialysis or Transplant|17
4757352|NCT01685840|16410925|P1|Overall Study|Had VAD, Dialysis or Transplant|11
4757353|NCT01685840|16410924|P2|Overall Study|Futility|200
4757354|NCT01685840|16410925|P1|Overall Study|Futility|197
4757355|NCT01685840|16410924|P2|Overall Study|Withdrawal by Subject|17
4757356|NCT01685840|16410925|P1|Overall Study|Withdrawal by Subject|14
4757357|NCT01685840|16410924|P2|Overall Study|Physician Decision|7
4757358|NCT01685840|16410925|P1|Overall Study|Physician Decision|3
4757359|NCT01685840|16410924|P2|Overall Study|Lost to Follow-up|25
4757360|NCT01685840|16410925|P1|Overall Study|Lost to Follow-up|27
4757361|NCT01685840|16410924|P2|Overall Study|Death|66
4757362|NCT01685840|16410925|P1|Overall Study|Death|77
4757363|NCT01685801|16410969|P4|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
4757364|NCT01685801|16410970|P3|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
4757365|NCT01685801|16410971|P2|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1
4757366|NCT01685801|16410972|P1|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0
4757367|NCT01685801|16410969|P4|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1
4757368|NCT01685801|16410970|P3|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
4757369|NCT01685801|16410971|P2|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
4757370|NCT01685801|16410972|P1|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0
4757371|NCT01685697|16410994|P2|Overall Study|Protocol Violation|3
4757372|NCT01685697|16410995|P1|Overall Study|Protocol Violation|3
4757373|NCT01685606|16411029|P1|Overall Study|Withdrawal by Subject|1
4757374|NCT01685437|16411057|P1|Overall Study|Unable to make visits due to work|1
4757375|NCT01685437|16411057|P1|Overall Study|Protocol Violation|4
4757376|NCT01685437|16411057|P1|Overall Study|Adverse Event|1
4757377|NCT01685437|16411057|P1|Overall Study|Lost to Follow-up|3
4757378|NCT01685437|16411057|P1|Overall Study|Withdrawal by Subject|22
4757379|NCT01685372|16411071|P2|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4
4757380|NCT01685372|16411072|P1|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3
4757381|NCT01685229|16411162|P2|Overall Study|Death|0
4757382|NCT01685229|16411163|P1|Overall Study|Death|1
4757383|NCT01685229|16411162|P2|Overall Study|Withdrawal by Subject|5
4757384|NCT01685229|16411163|P1|Overall Study|Withdrawal by Subject|6
4757385|NCT01685229|16411162|P2|Overall Study|Lost to Follow-up|10
4757386|NCT01685229|16411163|P1|Overall Study|Lost to Follow-up|16
4757387|NCT01685229|16411162|P2|Overall Study|Subjects missing Study Exit form|1
4757388|NCT01685229|16411163|P1|Overall Study|Subjects missing Study Exit form|3
4757389|NCT01685216|16411189|P1|Overall Study|Did not receive study drug|1
4757390|NCT01685203|16411206|P7|Overall Study|Patient's decision|0
4757391|NCT01685203|16411207|P6|Overall Study|Patient's decision|1
4757392|NCT01685203|16411208|P5|Overall Study|Patient's decision|0
4757393|NCT01685203|16411209|P4|Overall Study|Patient's decision|0
4757394|NCT01685203|16411210|P3|Overall Study|Patient's decision|0
4757395|NCT01685203|16411211|P2|Overall Study|Patient's decision|0
4757396|NCT01685203|16411212|P1|Overall Study|Patient's decision|0
4757397|NCT01685203|16411206|P7|Overall Study|Adverse event and withdrew consent|0
4757398|NCT01685203|16411207|P6|Overall Study|Adverse event and withdrew consent|0
4757399|NCT01685203|16411208|P5|Overall Study|Adverse event and withdrew consent|0
4757400|NCT01685203|16411209|P4|Overall Study|Adverse event and withdrew consent|0
4757401|NCT01685203|16411210|P3|Overall Study|Adverse event and withdrew consent|0
4757402|NCT01685203|16411211|P2|Overall Study|Adverse event and withdrew consent|0
4757403|NCT01685203|16411212|P1|Overall Study|Adverse event and withdrew consent|1
4757404|NCT01685203|16411206|P7|Overall Study|Adverse Event|0
4757405|NCT01685203|16411207|P6|Overall Study|Adverse Event|2
4757406|NCT01685203|16411208|P5|Overall Study|Adverse Event|0
4757407|NCT01685203|16411209|P4|Overall Study|Adverse Event|0
4757408|NCT01685203|16411210|P3|Overall Study|Adverse Event|0
4757409|NCT01685203|16411211|P2|Overall Study|Adverse Event|0
4757410|NCT01685203|16411212|P1|Overall Study|Adverse Event|0
4757411|NCT01685203|16411206|P7|Overall Study|Lost to Follow-up|0
4757412|NCT01685203|16411207|P6|Overall Study|Lost to Follow-up|0
4757413|NCT01685203|16411208|P5|Overall Study|Lost to Follow-up|0
4757414|NCT01685203|16411209|P4|Overall Study|Lost to Follow-up|1
4757415|NCT01685203|16411210|P3|Overall Study|Lost to Follow-up|0
4757416|NCT01685203|16411211|P2|Overall Study|Lost to Follow-up|3
4757417|NCT01685203|16411212|P1|Overall Study|Lost to Follow-up|3
4757418|NCT01685138|16411256|P1|Overall Study|Progressive disease|53
4757419|NCT01685138|16411256|P1|Overall Study|Adverse Event|18
4757420|NCT01685138|16411256|P1|Overall Study|Death|10
4757421|NCT01685138|16411256|P1|Overall Study|Physician Decision|6
4757422|NCT01685138|16411256|P1|Overall Study|Subject/guardian decision|2
4757423|NCT01685138|16411256|P1|Overall Study|No longer requires treatment|1
4757424|NCT01685138|16411256|P1|Overall Study|Protocol Violation|1
4757425|NCT01685138|16411256|P1|Overall Study|Lost to Follow-up|1
4757426|NCT01685073|16411272|P2|Overall Study|Withdrawal by Subject|24
4757427|NCT01685073|16411273|P1|Overall Study|Withdrawal by Subject|24
4757428|NCT01685073|16411272|P2|Overall Study|Lost to Follow-up|8
4757429|NCT01685073|16411273|P1|Overall Study|Lost to Follow-up|6
4757430|NCT01685060|16411281|P1|Overall Study|Death|8
4757431|NCT01685060|16411281|P1|Overall Study|Lost to Follow-up|1
4757432|NCT01685060|16411281|P1|Overall Study|Subject/guardian decision|20
4757433|NCT01685060|16411281|P1|Overall Study|Physician Decision|14
4757434|NCT01685060|16411281|P1|Overall Study|Progressive disease|69
4757435|NCT01685060|16411281|P1|Overall Study|Adverse Event|12
4757436|NCT01685060|16411281|P1|Overall Study|Rollover patients|16
4757437|NCT01685047|16411296|P1|Overall Study|patient withdrawn by sponsor|1
4757438|NCT01685047|16411296|P1|Overall Study|Adverse Event|5
4757439|NCT01685047|16411296|P1|Overall Study|Physician Decision|25
4757440|NCT01685047|16411296|P1|Overall Study|Lost to Follow-up|8
4757441|NCT01685047|16411296|P1|Overall Study|Death|26
4757442|NCT01685047|16411296|P1|Overall Study|Withdrawal by Subject|20
4757443|NCT01684943|16411312|P3|Overall Study|Planning Pregnancy|0
4757444|NCT01684943|16411313|P2|Overall Study|Planning Pregnancy|0
4757445|NCT01684943|16411314|P1|Overall Study|Planning Pregnancy|1
4757446|NCT01684943|16411312|P3|Overall Study|Lost to Follow-up|0
4757447|NCT01684943|16411313|P2|Overall Study|Lost to Follow-up|0
4757448|NCT01684943|16411314|P1|Overall Study|Lost to Follow-up|3
4757449|NCT01684943|16411312|P3|Overall Study|Excluded from Analysis|1
4757450|NCT01684943|16411313|P2|Overall Study|Excluded from Analysis|1
4757451|NCT01684943|16411314|P1|Overall Study|Excluded from Analysis|1
4757452|NCT01684943|16411312|P3|Overall Study|Principal Investigator Determination|0
4757453|NCT01684943|16411313|P2|Overall Study|Principal Investigator Determination|0
4757454|NCT01684943|16411314|P1|Overall Study|Principal Investigator Determination|1
4757455|NCT01684943|16411312|P3|Overall Study|Inadequate Venous Access|0
4757456|NCT01684943|16411313|P2|Overall Study|Inadequate Venous Access|0
4757457|NCT01684943|16411314|P1|Overall Study|Inadequate Venous Access|3
4757458|NCT01684930|16411333|P2|Overall Study|Withdrawal by Subject|1
4757459|NCT01684930|16411334|P1|Overall Study|Withdrawal by Subject|3
4757460|NCT01684878|16411391|P4|Part 2: Randomized Phase|Participant noncompliance|1
4757461|NCT01684878|16411392|P3|Part 2: Randomized Phase|Participant noncompliance|0
4757462|NCT01684878|16411393|P2|Part 2: Randomized Phase|Participant noncompliance|0
4757463|NCT01684878|16411394|P1|Part 2: Randomized Phase|Participant noncompliance|0
4757464|NCT01684878|16411391|P4|Part 2: Randomized Phase|Alive at data-cut|7
4757465|NCT01684878|16411392|P3|Part 2: Randomized Phase|Alive at data-cut|13
4757466|NCT01684878|16411393|P2|Part 2: Randomized Phase|Alive at data-cut|0
4757467|NCT01684878|16411394|P1|Part 2: Randomized Phase|Alive at data-cut|0
4757468|NCT01684878|16411391|P4|Part 2: Randomized Phase|Death|68
4757469|NCT01684878|16411392|P3|Part 2: Randomized Phase|Death|62
4757470|NCT01684878|16411393|P2|Part 2: Randomized Phase|Death|0
4757471|NCT01684878|16411394|P1|Part 2: Randomized Phase|Death|0
4757472|NCT01684878|16411391|P4|Part 2: Randomized Phase|Lost to Follow-up|0
4757473|NCT01684878|16411392|P3|Part 2: Randomized Phase|Lost to Follow-up|2
4757474|NCT01684878|16411393|P2|Part 2: Randomized Phase|Lost to Follow-up|0
4757475|NCT01684878|16411394|P1|Part 2: Randomized Phase|Lost to Follow-up|0
4757476|NCT01684878|16411391|P4|Part 2: Randomized Phase|Participant withdrew consent|2
4757477|NCT01684878|16411392|P3|Part 2: Randomized Phase|Participant withdrew consent|1
4757478|NCT01684878|16411393|P2|Part 2: Randomized Phase|Participant withdrew consent|0
4757479|NCT01684878|16411394|P1|Part 2: Randomized Phase|Participant withdrew consent|0
4757480|NCT01684878|16411391|P4|Part 1: Safety Run in Phase|Lost to Follow-up|0
4757481|NCT01684878|16411392|P3|Part 1: Safety Run in Phase|Lost to Follow-up|0
4757482|NCT01684878|16411393|P2|Part 1: Safety Run in Phase|Lost to Follow-up|2
4757483|NCT01684878|16411394|P1|Part 1: Safety Run in Phase|Lost to Follow-up|0
4757484|NCT01684878|16411391|P4|Part 1: Safety Run in Phase|Death|0
4757485|NCT01684878|16411392|P3|Part 1: Safety Run in Phase|Death|0
4757486|NCT01684878|16411393|P2|Part 1: Safety Run in Phase|Death|20
4757487|NCT01684878|16411394|P1|Part 1: Safety Run in Phase|Death|15
4757488|NCT01684878|16411391|P4|Part 1: Safety Run in Phase|Participants withdrawn consent|0
4757489|NCT01684878|16411392|P3|Part 1: Safety Run in Phase|Participants withdrawn consent|0
4757490|NCT01684878|16411393|P2|Part 1: Safety Run in Phase|Participants withdrawn consent|1
4757491|NCT01684878|16411394|P1|Part 1: Safety Run in Phase|Participants withdrawn consent|1
4757492|NCT01684722|16411442|P4|Overall Study|Death|21
4757493|NCT01684722|16411443|P3|Overall Study|Death|19
4757494|NCT01684722|16411444|P2|Overall Study|Death|21
4757495|NCT01684722|16411445|P1|Overall Study|Death|19
4757496|NCT01684722|16411442|P4|Overall Study|Lost to Follow-up|89
4757497|NCT01684722|16411443|P3|Overall Study|Lost to Follow-up|75
4757498|NCT01684722|16411444|P2|Overall Study|Lost to Follow-up|56
4757499|NCT01684722|16411445|P1|Overall Study|Lost to Follow-up|78
4757500|NCT01684423|16411519|P5|Overall Study|Withdrawal by Subject|0
4757501|NCT01684423|16411520|P4|Overall Study|Withdrawal by Subject|0
4757502|NCT01684423|16411521|P3|Overall Study|Withdrawal by Subject|1
4757503|NCT01684423|16411522|P2|Overall Study|Withdrawal by Subject|0
4757504|NCT01684423|16411523|P1|Overall Study|Withdrawal by Subject|0
4757505|NCT01684215|16411580|P4|Phase 2|Lost to Follow-up|4
4757506|NCT01684215|16411581|P3|Phase 2|Lost to Follow-up|0
4757507|NCT01684215|16411582|P2|Phase 2|Lost to Follow-up|0
4757508|NCT01684215|16411583|P1|Phase 2|Lost to Follow-up|0
4757509|NCT01684215|16411580|P4|Phase 2|Enrolled but not treated|1
4757510|NCT01684215|16411581|P3|Phase 2|Enrolled but not treated|0
4757511|NCT01684215|16411582|P2|Phase 2|Enrolled but not treated|0
4757512|NCT01684215|16411583|P1|Phase 2|Enrolled but not treated|0
4757513|NCT01684215|16411580|P4|Phase 2|Study terminated by sponsor|30
4757514|NCT01684215|16411581|P3|Phase 2|Study terminated by sponsor|0
4757515|NCT01684215|16411582|P2|Phase 2|Study terminated by sponsor|0
4757516|NCT01684215|16411583|P1|Phase 2|Study terminated by sponsor|0
4757517|NCT01684215|16411580|P4|Phase 2|Death|8
4757518|NCT01684215|16411581|P3|Phase 2|Death|0
4757519|NCT01684215|16411582|P2|Phase 2|Death|0
4757520|NCT01684215|16411583|P1|Phase 2|Death|0
4757521|NCT01684215|16411580|P4|Phase 1, Part 2|Withdrawal by Subject|0
4757522|NCT01684215|16411581|P3|Phase 1, Part 2|Withdrawal by Subject|1
4757523|NCT01684215|16411582|P2|Phase 1, Part 2|Withdrawal by Subject|0
4757524|NCT01684215|16411583|P1|Phase 1, Part 2|Withdrawal by Subject|0
4757525|NCT01684215|16411580|P4|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
4757526|NCT01684215|16411581|P3|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4
4757527|NCT01684215|16411582|P2|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
4757528|NCT01684215|16411583|P1|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0
4757529|NCT01684215|16411580|P4|Phase 1, Part 2|Adverse Event|0
4757530|NCT01684215|16411581|P3|Phase 1, Part 2|Adverse Event|1
4757531|NCT01684215|16411582|P2|Phase 1, Part 2|Adverse Event|0
4757532|NCT01684215|16411583|P1|Phase 1, Part 2|Adverse Event|0
4757533|NCT01684215|16411580|P4|Phase 1, Part 1|Objective progression or relapse|0
4757534|NCT01684215|16411581|P3|Phase 1, Part 1|Objective progression or relapse|0
4757535|NCT01684215|16411582|P2|Phase 1, Part 1|Objective progression or relapse|6
4757536|NCT01684215|16411583|P1|Phase 1, Part 1|Objective progression or relapse|5
4757537|NCT01684215|16411580|P4|Phase 1, Part 1|Adverse Event|0
4757538|NCT01684215|16411581|P3|Phase 1, Part 1|Adverse Event|0
4757539|NCT01684215|16411582|P2|Phase 1, Part 1|Adverse Event|0
4757540|NCT01684215|16411583|P1|Phase 1, Part 1|Adverse Event|1
4757541|NCT01684046|16411657|P2|Period 1, First 30 Days|Adverse Event|2
4757542|NCT01684046|16411658|P1|Period 1, First 30 Days|Adverse Event|0
4757543|NCT01684033|16411664|P2|Period 2, Second 30 Days|Adverse Event|0
4757544|NCT01684033|16411665|P1|Period 2, Second 30 Days|Adverse Event|1
4757545|NCT01684033|16411664|P2|Period 1, First 30 Days|Lost to Follow-up|0
4757546|NCT01684033|16411665|P1|Period 1, First 30 Days|Lost to Follow-up|1
4757547|NCT01684033|16411664|P2|Period 1, First 30 Days|Withdrawal by Subject|0
4757548|NCT01684033|16411665|P1|Period 1, First 30 Days|Withdrawal by Subject|1
4757549|NCT01684033|16411664|P2|Period 1, First 30 Days|Noncompliance|0
4757550|NCT01684033|16411665|P1|Period 1, First 30 Days|Noncompliance|1
4757551|NCT01684033|16411664|P2|Period 1, First 30 Days|Adverse Event|1
4757552|NCT01684033|16411665|P1|Period 1, First 30 Days|Adverse Event|1
4757553|NCT01683994|16411714|P5|Overall Study|Intercurrent illness|1
4757554|NCT01683994|16411715|P4|Overall Study|Intercurrent illness|2
4757555|NCT01683994|16411716|P3|Overall Study|Intercurrent illness|0
4757556|NCT01683994|16411717|P2|Overall Study|Intercurrent illness|0
4757557|NCT01683994|16411718|P1|Overall Study|Intercurrent illness|0
4757558|NCT01683994|16411714|P5|Overall Study|Withdrawal by Subject|0
4757559|NCT01683994|16411715|P4|Overall Study|Withdrawal by Subject|1
4757560|NCT01683994|16411716|P3|Overall Study|Withdrawal by Subject|0
4757561|NCT01683994|16411717|P2|Overall Study|Withdrawal by Subject|0
4757562|NCT01683994|16411718|P1|Overall Study|Withdrawal by Subject|1
4757563|NCT01683838|16411759|P2|Overall Study|Other|3
4757564|NCT01683838|16411760|P1|Overall Study|Other|4
4757565|NCT01683838|16411759|P2|Overall Study|Lost to Follow-up|1
4757566|NCT01683838|16411760|P1|Overall Study|Lost to Follow-up|1
4757567|NCT01683838|16411759|P2|Overall Study|Withdrawal by Subject|5
4757568|NCT01683838|16411760|P1|Overall Study|Withdrawal by Subject|6
4757569|NCT01683838|16411759|P2|Overall Study|Protocol Violation|1
4757570|NCT01683838|16411760|P1|Overall Study|Protocol Violation|3
4757571|NCT01683838|16411759|P2|Overall Study|Adverse Event|2
4757572|NCT01683838|16411760|P1|Overall Study|Adverse Event|12
4757573|NCT01683604|16411800|P1|Overall Study|Other|2
4757574|NCT01683604|16411800|P1|Overall Study|Lack of Efficacy|1
4757575|NCT01683604|16411800|P1|Overall Study|Adverse Event|2
4757576|NCT01683565|16411965|P2|Overall Study|Discontinued Intervention|1
4757577|NCT01683565|16411966|P1|Overall Study|Discontinued Intervention|1
4757578|NCT01683565|16411965|P2|Overall Study|Lost to Follow-up|0
4757579|NCT01683565|16411966|P1|Overall Study|Lost to Follow-up|2
4757580|NCT01683409|16412000|P5|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4757581|NCT01683409|16412001|P4|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4757582|NCT01683409|16412002|P3|Washout Period 2 (Weeks 29-32)|Physician Decision|1
4757583|NCT01683409|16412003|P2|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4757584|NCT01683409|16412004|P1|Washout Period 2 (Weeks 29-32)|Physician Decision|0
4757585|NCT01683409|16412000|P5|Washout Period 2 (Weeks 29-32)|Adverse Event|3
4757586|NCT01683409|16412001|P4|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4757587|NCT01683409|16412002|P3|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4757588|NCT01683409|16412003|P2|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4757589|NCT01683409|16412004|P1|Washout Period 2 (Weeks 29-32)|Adverse Event|0
4757590|NCT01683409|16412000|P5|Washout Period 1 (Weeks 25-28)|Adverse Event|2
4757591|NCT01683409|16412001|P4|Washout Period 1 (Weeks 25-28)|Adverse Event|1
4757592|NCT01683409|16412002|P3|Washout Period 1 (Weeks 25-28)|Adverse Event|0
4757593|NCT01683409|16412003|P2|Washout Period 1 (Weeks 25-28)|Adverse Event|4
4757594|NCT01683409|16412004|P1|Washout Period 1 (Weeks 25-28)|Adverse Event|0
4757595|NCT01683409|16412000|P5|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4757596|NCT01683409|16412001|P4|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4757597|NCT01683409|16412002|P3|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4757598|NCT01683409|16412003|P2|Washout Period 1 (Weeks 25-28)|Physician Decision|0
4757599|NCT01683409|16412004|P1|Washout Period 1 (Weeks 25-28)|Physician Decision|1
4757600|NCT01683409|16412000|P5|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
4757601|NCT01683409|16412001|P4|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
4757602|NCT01683409|16412002|P3|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
4757603|NCT01683409|16412003|P2|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0
4757604|NCT01683409|16412004|P1|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1
4757605|NCT01683409|16412000|P5|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
4757606|NCT01683409|16412001|P4|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
4757607|NCT01683409|16412002|P3|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
4757608|NCT01683409|16412003|P2|Washout Period 1 (Weeks 25-28)|Protocol Violation|0
4757609|NCT01683409|16412004|P1|Washout Period 1 (Weeks 25-28)|Protocol Violation|1
4757610|NCT01683409|16412000|P5|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4757611|NCT01683409|16412001|P4|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4757612|NCT01683409|16412002|P3|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1
4757613|NCT01683409|16412003|P2|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4757614|NCT01683409|16412004|P1|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0
4757615|NCT01683409|16412000|P5|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
4757616|NCT01683409|16412001|P4|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1
4757617|NCT01683409|16412002|P3|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
4757618|NCT01683409|16412003|P2|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
4757619|NCT01683409|16412004|P1|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0
4757620|NCT01683409|16412000|P5|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4757621|NCT01683409|16412001|P4|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4757622|NCT01683409|16412002|P3|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4757623|NCT01683409|16412003|P2|Treatment Period (Weeks 1-24)|Lost to Follow-up|1
4757624|NCT01683409|16412004|P1|Treatment Period (Weeks 1-24)|Lost to Follow-up|0
4757625|NCT01683409|16412000|P5|Treatment Period (Weeks 1-24)|Adverse Event|1
4757626|NCT01683409|16412001|P4|Treatment Period (Weeks 1-24)|Adverse Event|1
4757627|NCT01683409|16412002|P3|Treatment Period (Weeks 1-24)|Adverse Event|0
4757628|NCT01683409|16412003|P2|Treatment Period (Weeks 1-24)|Adverse Event|3
4757629|NCT01683409|16412004|P1|Treatment Period (Weeks 1-24)|Adverse Event|0
4757630|NCT01683409|16412000|P5|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4757631|NCT01683409|16412001|P4|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4757632|NCT01683409|16412002|P3|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1
4757633|NCT01683409|16412003|P2|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4757634|NCT01683409|16412004|P1|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0
4757635|NCT01683383|16412047|P2|Overall Study|Infant was not transported|0
4757636|NCT01683383|16412048|P1|Overall Study|Infant was not transported|1
4757637|NCT01683266|16412075|P2|Overall Study|Serious Adverse Event of Hypoglycemia|1
4757638|NCT01683266|16412076|P1|Overall Study|Serious Adverse Event of Hypoglycemia|0
4757639|NCT01683266|16412075|P2|Overall Study|Possibly Hypoglycemia|0
4757640|NCT01683266|16412076|P1|Overall Study|Possibly Hypoglycemia|1
4757641|NCT01683266|16412075|P2|Overall Study|Perceived Lack of Efficacy|1
4757642|NCT01683266|16412076|P1|Overall Study|Perceived Lack of Efficacy|1
4757643|NCT01683266|16412075|P2|Overall Study|Nonserious Hypoglycemia|3
4757644|NCT01683266|16412076|P1|Overall Study|Nonserious Hypoglycemia|0
4757645|NCT01683266|16412075|P2|Overall Study|Site Closure / Site Withdrawal|3
4757646|NCT01683266|16412076|P1|Overall Study|Site Closure / Site Withdrawal|1
4757647|NCT01683266|16412075|P2|Overall Study|Lost to Follow-up|0
4757648|NCT01683266|16412076|P1|Overall Study|Lost to Follow-up|5
4757649|NCT01683266|16412075|P2|Overall Study|Selection Criterion / Protocol Violation|5
4757650|NCT01683266|16412076|P1|Overall Study|Selection Criterion / Protocol Violation|7
4757651|NCT01683266|16412075|P2|Overall Study|Personal Reason|25
4757652|NCT01683266|16412076|P1|Overall Study|Personal Reason|17
4757653|NCT01683266|16412075|P2|Overall Study|Protocol Violation|6
4757654|NCT01683266|16412076|P1|Overall Study|Protocol Violation|13
4757655|NCT01683266|16412075|P2|Overall Study|Lack of Efficacy|2
4757656|NCT01683266|16412076|P1|Overall Study|Lack of Efficacy|5
4757657|NCT01683266|16412075|P2|Overall Study|Adverse Event|4
4757658|NCT01683266|16412076|P1|Overall Study|Adverse Event|5
4757659|NCT01683058|16412104|P1|Overall Study|Lack of Efficacy|2
4757660|NCT01683058|16412104|P1|Overall Study|Withdrawal by Subject|7
4757661|NCT01683058|16412104|P1|Overall Study|Subject Met Withdrawal Criteria|5
4757662|NCT01683058|16412104|P1|Overall Study|Adverse Event|6
4757663|NCT01683058|16412104|P1|Overall Study|Lost to Follow-up|9
4757664|NCT01683019|16412135|P3|Overall Study|Withdrawal by Subject|4
4757665|NCT01683019|16412136|P2|Overall Study|Withdrawal by Subject|1
4757666|NCT01683019|16412137|P1|Overall Study|Withdrawal by Subject|2
4757667|NCT01682876|16412171|P4|Overall Study|Other|1
4757668|NCT01682876|16412172|P3|Overall Study|Other|1
4757669|NCT01682876|16412173|P2|Overall Study|Other|0
4757670|NCT01682876|16412174|P1|Overall Study|Other|1
4757671|NCT01682876|16412171|P4|Overall Study|Withdrawal by Subject|2
4757672|NCT01682876|16412172|P3|Overall Study|Withdrawal by Subject|0
4757673|NCT01682876|16412173|P2|Overall Study|Withdrawal by Subject|0
4757674|NCT01682876|16412174|P1|Overall Study|Withdrawal by Subject|4
4757675|NCT01682876|16412171|P4|Overall Study|Protocol Violation|1
4757676|NCT01682876|16412172|P3|Overall Study|Protocol Violation|1
4757677|NCT01682876|16412173|P2|Overall Study|Protocol Violation|1
4757678|NCT01682876|16412174|P1|Overall Study|Protocol Violation|1
4757679|NCT01682876|16412171|P4|Overall Study|Lost to Follow-up|11
4757680|NCT01682876|16412172|P3|Overall Study|Lost to Follow-up|9
4757681|NCT01682876|16412173|P2|Overall Study|Lost to Follow-up|15
4757682|NCT01682876|16412174|P1|Overall Study|Lost to Follow-up|11
4757683|NCT01682876|16412171|P4|Overall Study|Adverse Event|1
4757684|NCT01682876|16412172|P3|Overall Study|Adverse Event|0
4757685|NCT01682876|16412173|P2|Overall Study|Adverse Event|0
4757686|NCT01682876|16412174|P1|Overall Study|Adverse Event|0
4757687|NCT01682876|16412171|P4|Overall Study|Administrative reason|3
4757688|NCT01682876|16412172|P3|Overall Study|Administrative reason|0
4757689|NCT01682876|16412173|P2|Overall Study|Administrative reason|4
4757690|NCT01682876|16412174|P1|Overall Study|Administrative reason|4
4757691|NCT01682863|16412220|P3|Overall Study|Physician Decision|1
4757692|NCT01682863|16412221|P2|Overall Study|Physician Decision|0
4757693|NCT01682863|16412222|P1|Overall Study|Physician Decision|0
4757694|NCT01682863|16412220|P3|Overall Study|Adverse Event|2
4757695|NCT01682863|16412221|P2|Overall Study|Adverse Event|1
4757696|NCT01682863|16412222|P1|Overall Study|Adverse Event|0
4757697|NCT01682863|16412220|P3|Overall Study|Technical problems|0
4757698|NCT01682863|16412221|P2|Overall Study|Technical problems|0
4757699|NCT01682863|16412222|P1|Overall Study|Technical problems|1
4757700|NCT01682863|16412220|P3|Overall Study|Protocol deviation|1
4757701|NCT01682863|16412221|P2|Overall Study|Protocol deviation|0
4757702|NCT01682863|16412222|P1|Overall Study|Protocol deviation|1
4757703|NCT01682863|16412220|P3|Overall Study|Death|4
4757704|NCT01682863|16412221|P2|Overall Study|Death|3
4757705|NCT01682863|16412222|P1|Overall Study|Death|1
4757706|NCT01682863|16412220|P3|Overall Study|Lost to Follow-up|6
4757707|NCT01682863|16412221|P2|Overall Study|Lost to Follow-up|1
4757708|NCT01682863|16412222|P1|Overall Study|Lost to Follow-up|5
4757709|NCT01682863|16412220|P3|Overall Study|Subject/guardian decision|10
4757710|NCT01682863|16412221|P2|Overall Study|Subject/guardian decision|12
4757711|NCT01682863|16412222|P1|Overall Study|Subject/guardian decision|19
4757712|NCT01682837|16412251|P1|Baseline|Withdrawal by Subject|5
4757713|NCT01682759|16412295|P2|Overall Study|Withdrawal by Subject|55
4757714|NCT01682759|16412296|P1|Overall Study|Withdrawal by Subject|56
4757715|NCT01682759|16412295|P2|Overall Study|Physician Decision|1
4757716|NCT01682759|16412296|P1|Overall Study|Physician Decision|1
4757717|NCT01682759|16412295|P2|Overall Study|Lost to Follow-up|13
4757718|NCT01682759|16412296|P1|Overall Study|Lost to Follow-up|10
4757719|NCT01682759|16412295|P2|Overall Study|Death|1
4757720|NCT01682759|16412296|P1|Overall Study|Death|2
4757721|NCT01682720|16412320|P4|Overall Study|Adverse Event|1
4757722|NCT01682720|16412321|P3|Overall Study|Adverse Event|1
4757723|NCT01682720|16412322|P2|Overall Study|Adverse Event|0
4757724|NCT01682720|16412323|P1|Overall Study|Adverse Event|1
4757725|NCT01682720|16412320|P4|Overall Study|Subject Withdrew Consent|2
4757726|NCT01682720|16412321|P3|Overall Study|Subject Withdrew Consent|2
4757727|NCT01682720|16412322|P2|Overall Study|Subject Withdrew Consent|0
4757728|NCT01682720|16412323|P1|Overall Study|Subject Withdrew Consent|0
4757729|NCT01682720|16412320|P4|Overall Study|Lost to Follow-up|6
4757730|NCT01682720|16412321|P3|Overall Study|Lost to Follow-up|0
4757731|NCT01682720|16412322|P2|Overall Study|Lost to Follow-up|1
4757732|NCT01682720|16412323|P1|Overall Study|Lost to Follow-up|1
4757733|NCT01682720|16412320|P4|Overall Study|Efficacy Failure|30
4757734|NCT01682720|16412321|P3|Overall Study|Efficacy Failure|3
4757735|NCT01682720|16412322|P2|Overall Study|Efficacy Failure|3
4757736|NCT01682720|16412323|P1|Overall Study|Efficacy Failure|0
4757737|NCT01682720|16412320|P4|Overall Study|Terminated by Sponsor|0
4757738|NCT01682720|16412321|P3|Overall Study|Terminated by Sponsor|0
4757739|NCT01682720|16412322|P2|Overall Study|Terminated by Sponsor|0
4757740|NCT01682720|16412323|P1|Overall Study|Terminated by Sponsor|83
4757741|NCT01682720|16412320|P4|Overall Study|Randomized but Not Treated|0
4757742|NCT01682720|16412321|P3|Overall Study|Randomized but Not Treated|1
4757743|NCT01682720|16412322|P2|Overall Study|Randomized but Not Treated|1
4757744|NCT01682720|16412323|P1|Overall Study|Randomized but Not Treated|0
4757745|NCT01682681|16412340|P1|Overall Study|Low compliance|13
4757746|NCT01682681|16412340|P1|Overall Study|Other|21
4757747|NCT01682681|16412340|P1|Overall Study|tapering of topiramate|5
4757748|NCT01682681|16412340|P1|Overall Study|Adverse Event|46
4757749|NCT01682681|16412340|P1|Overall Study|Lost to Follow-up|174
4757750|NCT01682681|16412340|P1|Overall Study|Moved to other hospital|10
4757751|NCT01682681|16412340|P1|Overall Study|Withdrawal by Subject|1
4757752|NCT01682681|16412340|P1|Overall Study|Lack of Efficacy|62
4757753|NCT01682603|16412369|P1|Overall Study|Lost to Follow-up|3
4757754|NCT01682512|16412414|P3|Overall Study|Other than stated above|2
4757755|NCT01682512|16412415|P2|Overall Study|Other than stated above|4
4757756|NCT01682512|16412416|P1|Overall Study|Other than stated above|2
4757757|NCT01682512|16412414|P3|Overall Study|Secondary lack of efficacy|0
4757758|NCT01682512|16412415|P2|Overall Study|Secondary lack of efficacy|1
4757759|NCT01682512|16412416|P1|Overall Study|Secondary lack of efficacy|1
4757760|NCT01682512|16412414|P3|Overall Study|Primary lack of efficacy|7
4757761|NCT01682512|16412415|P2|Overall Study|Primary lack of efficacy|7
4757762|NCT01682512|16412416|P1|Overall Study|Primary lack of efficacy|10
4757763|NCT01682512|16412414|P3|Overall Study|Protocol Violation|2
4757764|NCT01682512|16412415|P2|Overall Study|Protocol Violation|3
4757765|NCT01682512|16412416|P1|Overall Study|Protocol Violation|2
4757766|NCT01682512|16412414|P3|Overall Study|Lost to Follow-up|2
4757767|NCT01682512|16412415|P2|Overall Study|Lost to Follow-up|0
4757768|NCT01682512|16412416|P1|Overall Study|Lost to Follow-up|3
4757769|NCT01682512|16412414|P3|Overall Study|Study terminated by sponsor|0
4757770|NCT01682512|16412415|P2|Overall Study|Study terminated by sponsor|43
4757771|NCT01682512|16412416|P1|Overall Study|Study terminated by sponsor|46
4757772|NCT01682512|16412414|P3|Overall Study|Physician Decision|0
4757773|NCT01682512|16412415|P2|Overall Study|Physician Decision|2
4757774|NCT01682512|16412416|P1|Overall Study|Physician Decision|0
4757775|NCT01682512|16412414|P3|Overall Study|Withdrawal by Subject|3
4757776|NCT01682512|16412415|P2|Overall Study|Withdrawal by Subject|6
4757777|NCT01682512|16412416|P1|Overall Study|Withdrawal by Subject|2
4757778|NCT01682512|16412414|P3|Overall Study|Adverse Event|2
4757779|NCT01682512|16412415|P2|Overall Study|Adverse Event|5
4757780|NCT01682512|16412416|P1|Overall Study|Adverse Event|6
4757781|NCT01682460|16412441|P1|Overall Study|Did not meet inclusion criteria|2
4757782|NCT01682460|16412441|P1|Overall Study|Withdrawal by Subject|2
4757783|NCT01682213|16412456|P1|Overall Study|Withdrawal by Subject|2
4757784|NCT01682148|16412464|P2|Overall Study|Protocol Violation|1
4757785|NCT01682148|16412465|P1|Overall Study|Protocol Violation|1
4757786|NCT01682148|16412464|P2|Overall Study|Lost to Follow-up|2
4757787|NCT01682148|16412465|P1|Overall Study|Lost to Follow-up|1
4757788|NCT01682148|16412464|P2|Overall Study|Withdrawal by Subject|0
4757789|NCT01682148|16412465|P1|Overall Study|Withdrawal by Subject|2
4757790|NCT01682083|16412525|P2|Overall Study|Physician Decision|4
4757791|NCT01682083|16412526|P1|Overall Study|Physician Decision|5
4757792|NCT01682083|16412525|P2|Overall Study|Death|93
4757793|NCT01682083|16412526|P1|Overall Study|Death|60
4757794|NCT01682083|16412525|P2|Overall Study|Withdrawal by Subject|40
4757795|NCT01682083|16412526|P1|Overall Study|Withdrawal by Subject|31
4757796|NCT01682083|16412525|P2|Overall Study|Lost to Follow-up|18
4757797|NCT01682083|16412526|P1|Overall Study|Lost to Follow-up|11
4757798|NCT01682044|16412538|P1|Overall Study|Progression|3
4757799|NCT01682044|16412538|P1|Overall Study|Death|1
4757800|NCT01682031|16412550|P2|Overall Study|Patient stopped selenium on his own|1
4757801|NCT01682031|16412551|P1|Overall Study|Patient stopped selenium on his own|0
4757802|NCT01682031|16412550|P2|Overall Study|Patient could not swallow tablets|0
4757803|NCT01682031|16412551|P1|Overall Study|Patient could not swallow tablets|1
4757804|NCT01682031|16412550|P2|Overall Study|MRI results indicate increased nodul|1
4757805|NCT01682031|16412551|P1|Overall Study|MRI results indicate increased nodul|0
4757806|NCT01682031|16412550|P2|Overall Study|Adverse Event|2
4757807|NCT01682031|16412551|P1|Overall Study|Adverse Event|0
4757808|NCT01682031|16412550|P2|Overall Study|Withdrawal by Subject|1
4757809|NCT01682031|16412551|P1|Overall Study|Withdrawal by Subject|0
4757810|NCT01681992|16412574|P3|Overall Study|Withdrawal by Subject|25
4757811|NCT01681992|16412575|P2|Overall Study|Withdrawal by Subject|30
4757812|NCT01681992|16412576|P1|Overall Study|Withdrawal by Subject|27
4757813|NCT01681992|16412574|P3|Overall Study|Protocol Violation|1
4757814|NCT01681992|16412575|P2|Overall Study|Protocol Violation|0
4757815|NCT01681992|16412576|P1|Overall Study|Protocol Violation|0
4757816|NCT01681992|16412574|P3|Overall Study|As Per Sponsor Decision|1
4757817|NCT01681992|16412575|P2|Overall Study|As Per Sponsor Decision|0
4757818|NCT01681992|16412576|P1|Overall Study|As Per Sponsor Decision|0
4757819|NCT01681992|16412574|P3|Overall Study|Lost to Follow-up|53
4757820|NCT01681992|16412575|P2|Overall Study|Lost to Follow-up|38
4757821|NCT01681992|16412576|P1|Overall Study|Lost to Follow-up|36
4757822|NCT01681992|16412574|P3|Overall Study|Adverse Event|3
4757823|NCT01681992|16412575|P2|Overall Study|Adverse Event|2
4757824|NCT01681992|16412576|P1|Overall Study|Adverse Event|3
4757825|NCT01681849|16412665|P3|Overall Study|Lost to Follow-up|6
4757826|NCT01681849|16412666|P2|Overall Study|Lost to Follow-up|2
4757827|NCT01681849|16412667|P1|Overall Study|Lost to Follow-up|3
4757828|NCT01681849|16412665|P3|Overall Study|Withdrawal by Subject|33
4757829|NCT01681849|16412666|P2|Overall Study|Withdrawal by Subject|5
4757830|NCT01681849|16412667|P1|Overall Study|Withdrawal by Subject|3
4757831|NCT01681849|16412665|P3|Overall Study|Protocol Violation|0
4757832|NCT01681849|16412666|P2|Overall Study|Protocol Violation|0
4757833|NCT01681849|16412667|P1|Overall Study|Protocol Violation|2
4757834|NCT01681836|16412676|P2|Second Intervention|Withdrawal by Subject|1
4757835|NCT01681836|16412677|P1|Second Intervention|Withdrawal by Subject|0
4757836|NCT01681771|16412711|P2|Overall Study|Lost to Follow-up|2
4757837|NCT01681771|16412712|P1|Overall Study|Lost to Follow-up|4
4757838|NCT01681628|16412720|P2|19 Months Follow-up|Lost to Follow-up|43
4757839|NCT01681628|16412721|P1|19 Months Follow-up|Lost to Follow-up|61
4757840|NCT01681628|16412720|P2|19 Months Follow-up|Death|0
4757841|NCT01681628|16412721|P1|19 Months Follow-up|Death|1
4757842|NCT01681628|16412720|P2|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15
4757843|NCT01681628|16412721|P1|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0
4757844|NCT01681628|16412720|P2|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6
4757845|NCT01681628|16412721|P1|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14
4757846|NCT01681576|16412750|P2|Period 2|Non-compliance with study treatment|0
4757847|NCT01681576|16412751|P1|Period 2|Non-compliance with study treatment|1
4757848|NCT01681576|16412750|P2|Period 2|subject/guardian decision|1
4757849|NCT01681576|16412751|P1|Period 2|subject/guardian decision|3
4757850|NCT01681576|16412750|P2|Period 1|Protocol Deviation|0
4757851|NCT01681576|16412751|P1|Period 1|Protocol Deviation|1
4757852|NCT01681576|16412750|P2|Period 1|Adverse Event|0
4757853|NCT01681576|16412751|P1|Period 1|Adverse Event|1
4757854|NCT01681511|16412767|P2|Overall Study|No post-catheter sample collected|4
4757855|NCT01681511|16412768|P1|Overall Study|No post-catheter sample collected|11
4757856|NCT01681511|16412767|P2|Overall Study|No Daily Urine Sample Collected|1
4757857|NCT01681511|16412768|P1|Overall Study|No Daily Urine Sample Collected|0
4757858|NCT01681511|16412767|P2|Overall Study|No Baseline Dips Stick & Urine Culture|6
4757859|NCT01681511|16412768|P1|Overall Study|No Baseline Dips Stick & Urine Culture|3
4757860|NCT01681511|16412767|P2|Overall Study|Failed Inclusion/Exclusion|0
4757861|NCT01681511|16412768|P1|Overall Study|Failed Inclusion/Exclusion|3
4757862|NCT01681511|16412767|P2|Overall Study|No Treatment Received|3
4757863|NCT01681511|16412768|P1|Overall Study|No Treatment Received|1
4757864|NCT01681472|16412786|P4|Overall Study|Adverse Event|0
4757865|NCT01681472|16412787|P3|Overall Study|Adverse Event|0
4757866|NCT01681472|16412788|P2|Overall Study|Adverse Event|1
4757867|NCT01681472|16412789|P1|Overall Study|Adverse Event|0
4757868|NCT01681433|16412969|P2|Overall Study|Lost to Follow-up|1
4757869|NCT01681433|16412970|P1|Overall Study|Lost to Follow-up|0
4757870|NCT01681433|16412969|P2|Overall Study|Adverse Event|4
4757871|NCT01681433|16412970|P1|Overall Study|Adverse Event|2
4757872|NCT01681433|16412969|P2|Overall Study|Protocol Violation|0
4757873|NCT01681433|16412970|P1|Overall Study|Protocol Violation|2
4757874|NCT01681433|16412969|P2|Overall Study|Withdrawal by Subject|5
4757875|NCT01681433|16412970|P1|Overall Study|Withdrawal by Subject|5
4757876|NCT01681433|16412969|P2|Overall Study|Lack of Efficacy|23
4757877|NCT01681433|16412970|P1|Overall Study|Lack of Efficacy|23
4757878|NCT01681368|16412988|P1|Overall Study|Refused further follow up|1
4757879|NCT01681368|16412988|P1|Overall Study|Refused further treatment|1
4757880|NCT01681277|16413005|P5|Overall Study|Adverse Event|0
4757881|NCT01681277|16413006|P4|Overall Study|Adverse Event|0
4757882|NCT01681277|16413007|P3|Overall Study|Adverse Event|0
4757883|NCT01681277|16413008|P2|Overall Study|Adverse Event|0
4757884|NCT01681277|16413009|P1|Overall Study|Adverse Event|1
4757885|NCT01681212|16413050|P1|Overall Study|Administrative reason by sponsor|1
4757886|NCT01681212|16413050|P1|Overall Study|No longer met study criteria|5
4757887|NCT01681186|16413064|P8|Fourth Intervention|Protocol Violation|1
4757888|NCT01681186|16413065|P7|Fourth Intervention|Protocol Violation|0
4757889|NCT01681186|16413066|P6|Fourth Intervention|Protocol Violation|0
4757890|NCT01681186|16413067|P5|Fourth Intervention|Protocol Violation|0
4757891|NCT01681186|16413068|P4|Fourth Intervention|Protocol Violation|0
4757892|NCT01681186|16413069|P3|Fourth Intervention|Protocol Violation|0
4757893|NCT01681186|16413070|P2|Fourth Intervention|Protocol Violation|0
4757894|NCT01681186|16413071|P1|Fourth Intervention|Protocol Violation|0
4757895|NCT01681186|16413064|P8|Washout Period From Third Intervention|Lost to Follow-up|0
4757896|NCT01681186|16413065|P7|Washout Period From Third Intervention|Lost to Follow-up|1
4757897|NCT01681186|16413066|P6|Washout Period From Third Intervention|Lost to Follow-up|0
4757898|NCT01681186|16413067|P5|Washout Period From Third Intervention|Lost to Follow-up|0
4757899|NCT01681186|16413068|P4|Washout Period From Third Intervention|Lost to Follow-up|0
4757900|NCT01681186|16413069|P3|Washout Period From Third Intervention|Lost to Follow-up|0
4757901|NCT01681186|16413070|P2|Washout Period From Third Intervention|Lost to Follow-up|0
4757902|NCT01681186|16413071|P1|Washout Period From Third Intervention|Lost to Follow-up|0
4757903|NCT01681186|16413064|P8|Washout Period From Second Intervention|Protocol Violation|1
4757904|NCT01681186|16413065|P7|Washout Period From Second Intervention|Protocol Violation|0
4757905|NCT01681186|16413066|P6|Washout Period From Second Intervention|Protocol Violation|0
4757906|NCT01681186|16413067|P5|Washout Period From Second Intervention|Protocol Violation|0
4757907|NCT01681186|16413068|P4|Washout Period From Second Intervention|Protocol Violation|0
4757908|NCT01681186|16413069|P3|Washout Period From Second Intervention|Protocol Violation|0
4757909|NCT01681186|16413070|P2|Washout Period From Second Intervention|Protocol Violation|0
4757910|NCT01681186|16413071|P1|Washout Period From Second Intervention|Protocol Violation|0
4757911|NCT01681186|16413064|P8|Washout Period From Second Intervention|Adverse Event|0
4757912|NCT01681186|16413065|P7|Washout Period From Second Intervention|Adverse Event|1
4757913|NCT01681186|16413066|P6|Washout Period From Second Intervention|Adverse Event|0
4757914|NCT01681186|16413067|P5|Washout Period From Second Intervention|Adverse Event|0
4757915|NCT01681186|16413068|P4|Washout Period From Second Intervention|Adverse Event|0
4757916|NCT01681186|16413069|P3|Washout Period From Second Intervention|Adverse Event|0
4757917|NCT01681186|16413070|P2|Washout Period From Second Intervention|Adverse Event|0
4757918|NCT01681186|16413071|P1|Washout Period From Second Intervention|Adverse Event|0
4757919|NCT01681069|16413174|P2|Overall Study|Adverse Event|1
4757920|NCT01681069|16413175|P1|Overall Study|Adverse Event|0
4757921|NCT01681069|16413174|P2|Overall Study|Protocol Violation|1
4757922|NCT01681069|16413175|P1|Overall Study|Protocol Violation|1
4757923|NCT01681069|16413174|P2|Overall Study|Withdrawal by Subject|5
4757924|NCT01681069|16413175|P1|Overall Study|Withdrawal by Subject|4
4757925|NCT01681004|16413212|P2|Study Completion|Death|1
4757926|NCT01681004|16413213|P1|Study Completion|Death|1
4757927|NCT01681004|16413212|P2|Study Completion|Site Termination|1
4757928|NCT01681004|16413213|P1|Study Completion|Site Termination|2
4757929|NCT01681004|16413212|P2|Study Completion|Physician Decision|3
4757930|NCT01681004|16413213|P1|Study Completion|Physician Decision|1
4757931|NCT01681004|16413212|P2|Study Completion|Lost to Follow-up|3
4757932|NCT01681004|16413213|P1|Study Completion|Lost to Follow-up|8
4757933|NCT01681004|16413212|P2|Primary Endpoint: 6 Months|Withdrawal by Subject|2
4757934|NCT01681004|16413213|P1|Primary Endpoint: 6 Months|Withdrawal by Subject|1
4757935|NCT01680991|16413270|P3|Overall Study|PD confirmed in other hospital|0
4757936|NCT01680991|16413271|P2|Overall Study|PD confirmed in other hospital|0
4757937|NCT01680991|16413272|P1|Overall Study|PD confirmed in other hospital|1
4757938|NCT01680991|16413270|P3|Overall Study|Bad physical condition|1
4757939|NCT01680991|16413271|P2|Overall Study|Bad physical condition|0
4757940|NCT01680991|16413272|P1|Overall Study|Bad physical condition|0
4757941|NCT01680991|16413270|P3|Overall Study|Physician Decision|2
4757942|NCT01680991|16413271|P2|Overall Study|Physician Decision|7
4757943|NCT01680991|16413272|P1|Overall Study|Physician Decision|0
4757944|NCT01680991|16413270|P3|Overall Study|Progressive disease (PD)|0
4757945|NCT01680991|16413271|P2|Overall Study|Progressive disease (PD)|10
4757946|NCT01680991|16413272|P1|Overall Study|Progressive disease (PD)|0
4757947|NCT01680991|16413270|P3|Overall Study|Withdrawal by Subject|0
4757948|NCT01680991|16413271|P2|Overall Study|Withdrawal by Subject|1
4757949|NCT01680991|16413272|P1|Overall Study|Withdrawal by Subject|5
4757950|NCT01680991|16413270|P3|Overall Study|Protocol Violation|0
4757951|NCT01680991|16413271|P2|Overall Study|Protocol Violation|1
4757952|NCT01680991|16413272|P1|Overall Study|Protocol Violation|0
4757953|NCT01680991|16413270|P3|Overall Study|Death|1
4757954|NCT01680991|16413271|P2|Overall Study|Death|0
4757955|NCT01680991|16413272|P1|Overall Study|Death|1
4757956|NCT01680991|16413270|P3|Overall Study|Adverse Event|0
4757957|NCT01680991|16413271|P2|Overall Study|Adverse Event|0
4757958|NCT01680991|16413272|P1|Overall Study|Adverse Event|1
4757959|NCT01680861|16413363|P2|Early Post-transplant Period|Protocol Violation|1
4757960|NCT01680861|16413364|P1|Early Post-transplant Period|Protocol Violation|1
4757961|NCT01680497|16413461|P1|Overall Study|Lost to Follow-up|2
4757962|NCT01680458|16413471|P1|Overall Study|Protocol Violation|3
4757963|NCT01680341|16413482|P2|Overall Study|Unclassified|15
4757964|NCT01680341|16413483|P1|Overall Study|Unclassified|18
4757965|NCT01680341|16413482|P2|Overall Study|Adverse Event|2
4757966|NCT01680341|16413483|P1|Overall Study|Adverse Event|3
4757967|NCT01680159|16413554|P1|Increased Dose Period|Withdrawal by Subject|2
4757968|NCT01680159|16413554|P1|Increased Dose Period|Adverse Event|6
4757969|NCT01680159|16413554|P1|Screening Period|Not meet criteria for dose-up period|7
4757970|NCT01680016|16413581|P4|Overall Study|Withdrawal by Subject|1
4757971|NCT01680016|16413582|P3|Overall Study|Withdrawal by Subject|1
4757972|NCT01680016|16413583|P2|Overall Study|Withdrawal by Subject|7
4757973|NCT01680016|16413584|P1|Overall Study|Withdrawal by Subject|5
4757974|NCT01680016|16413581|P4|Overall Study|Protocol Violation|0
4757975|NCT01680016|16413582|P3|Overall Study|Protocol Violation|0
4757976|NCT01680016|16413583|P2|Overall Study|Protocol Violation|1
4757977|NCT01680016|16413584|P1|Overall Study|Protocol Violation|0
4757978|NCT01680016|16413581|P4|Overall Study|The Subject went out of The Trial|0
4757979|NCT01680016|16413582|P3|Overall Study|The Subject went out of The Trial|3
4757980|NCT01680016|16413583|P2|Overall Study|The Subject went out of The Trial|0
4757981|NCT01680016|16413584|P1|Overall Study|The Subject went out of The Trial|1
4757982|NCT01680016|16413581|P4|Overall Study|Adverse Event|4
4757983|NCT01680016|16413582|P3|Overall Study|Adverse Event|1
4757984|NCT01680016|16413583|P2|Overall Study|Adverse Event|0
4757985|NCT01680016|16413584|P1|Overall Study|Adverse Event|0
4757986|NCT01679613|16413646|P4|Overall Study|other than stated above|2
4757987|NCT01679613|16413647|P3|Overall Study|other than stated above|2
4757988|NCT01679613|16413648|P2|Overall Study|other than stated above|1
4757989|NCT01679613|16413649|P1|Overall Study|other than stated above|0
4757990|NCT01679405|16413671|P2|Overall Study|Death|5
4757991|NCT01679405|16413672|P1|Overall Study|Death|2
4757992|NCT01679301|16413707|P3|Screening Period|screen failure|0
4757993|NCT01679301|16413708|P2|Screening Period|screen failure|0
4757994|NCT01679301|16413709|P1|Screening Period|screen failure|3
4757995|NCT01679236|16413717|P2|Overall Study|Lost to Follow-up|15
4757996|NCT01679236|16413718|P1|Overall Study|Lost to Follow-up|15
4757997|NCT01679002|16413765|P3|Overall Study|Adverse Event|0
4757998|NCT01679002|16413766|P2|Overall Study|Adverse Event|1
4757999|NCT01679002|16413767|P1|Overall Study|Adverse Event|1
4758000|NCT01678924|16413798|P4|Overall Study|Unable to attend scheduled visits|1
4758001|NCT01678924|16413799|P3|Overall Study|Unable to attend scheduled visits|0
4758002|NCT01678924|16413800|P2|Overall Study|Unable to attend scheduled visits|0
4758003|NCT01678924|16413801|P1|Overall Study|Unable to attend scheduled visits|0
4758004|NCT01678924|16413798|P4|Overall Study|Withdrawal by Subject|2
4758005|NCT01678924|16413799|P3|Overall Study|Withdrawal by Subject|0
4758006|NCT01678924|16413800|P2|Overall Study|Withdrawal by Subject|3
4758007|NCT01678924|16413801|P1|Overall Study|Withdrawal by Subject|0
4758008|NCT01678924|16413798|P4|Overall Study|Personal Reasons|7
4758009|NCT01678924|16413799|P3|Overall Study|Personal Reasons|2
4758010|NCT01678924|16413800|P2|Overall Study|Personal Reasons|2
4758011|NCT01678924|16413801|P1|Overall Study|Personal Reasons|2
4758012|NCT01678924|16413798|P4|Overall Study|Lost to Follow-up|2
4758013|NCT01678924|16413799|P3|Overall Study|Lost to Follow-up|0
4758014|NCT01678924|16413800|P2|Overall Study|Lost to Follow-up|4
4758015|NCT01678924|16413801|P1|Overall Study|Lost to Follow-up|0
4758016|NCT01678924|16413798|P4|Overall Study|Lack of Efficacy|5
4758017|NCT01678924|16413799|P3|Overall Study|Lack of Efficacy|0
4758018|NCT01678924|16413800|P2|Overall Study|Lack of Efficacy|2
4758019|NCT01678924|16413801|P1|Overall Study|Lack of Efficacy|7
4758020|NCT01678924|16413798|P4|Overall Study|Adverse Event|1
4758021|NCT01678924|16413799|P3|Overall Study|Adverse Event|0
4758022|NCT01678924|16413800|P2|Overall Study|Adverse Event|1
4758023|NCT01678924|16413801|P1|Overall Study|Adverse Event|1
4758024|NCT01678911|16413932|P2|Second Intervention|Lost to Follow-up|0
4758025|NCT01678911|16413933|P1|Second Intervention|Lost to Follow-up|2
4758026|NCT01678898|16413950|P3|PB-102-F01|Physician Decision|0
4758027|NCT01678898|16413951|P2|PB-102-F01|Physician Decision|1
4758028|NCT01678898|16413952|P1|PB-102-F01|Physician Decision|0
4758029|NCT01678898|16413950|P3|PB-102-F01|Adverse Event|0
4758030|NCT01678898|16413951|P2|PB-102-F01|Adverse Event|1
4758031|NCT01678898|16413952|P1|PB-102-F01|Adverse Event|0
4758032|NCT01678820|16414062|P3|Overall Study|Not treated with double-blind study drug|2
4758033|NCT01678820|16414063|P2|Overall Study|Not treated with double-blind study drug|2
4758034|NCT01678820|16414064|P1|Overall Study|Not treated with double-blind study drug|0
4758035|NCT01678820|16414062|P3|Overall Study|Protocol Violation|4
4758036|NCT01678820|16414063|P2|Overall Study|Protocol Violation|5
4758037|NCT01678820|16414064|P1|Overall Study|Protocol Violation|4
4758038|NCT01678820|16414062|P3|Overall Study|Physician Decision|1
4758039|NCT01678820|16414063|P2|Overall Study|Physician Decision|0
4758040|NCT01678820|16414064|P1|Overall Study|Physician Decision|0
4758041|NCT01678820|16414062|P3|Overall Study|Non-compliance with study drug|0
4758042|NCT01678820|16414063|P2|Overall Study|Non-compliance with study drug|1
4758043|NCT01678820|16414064|P1|Overall Study|Non-compliance with study drug|0
4758044|NCT01678820|16414062|P3|Overall Study|Lost to Follow-up|2
4758045|NCT01678820|16414063|P2|Overall Study|Lost to Follow-up|2
4758046|NCT01678820|16414064|P1|Overall Study|Lost to Follow-up|7
4758047|NCT01678820|16414062|P3|Overall Study|Adverse Event|2
4758048|NCT01678820|16414063|P2|Overall Study|Adverse Event|2
4758049|NCT01678820|16414064|P1|Overall Study|Adverse Event|2
4758050|NCT01678820|16414062|P3|Overall Study|Protocol Specified Criteria|1
4758051|NCT01678820|16414063|P2|Overall Study|Protocol Specified Criteria|3
4758052|NCT01678820|16414064|P1|Overall Study|Protocol Specified Criteria|2
4758053|NCT01678820|16414062|P3|Overall Study|Withdrawal by Subject|2
4758054|NCT01678820|16414063|P2|Overall Study|Withdrawal by Subject|5
4758055|NCT01678820|16414064|P1|Overall Study|Withdrawal by Subject|2
4758056|NCT01678820|16414062|P3|Overall Study|Study Terminated by Sponsor|43
4758057|NCT01678820|16414063|P2|Overall Study|Study Terminated by Sponsor|43
4758058|NCT01678820|16414064|P1|Overall Study|Study Terminated by Sponsor|45
4758059|NCT01678807|16414109|P3|Overall Study|Withdrawn by Parent/Guardian|0
4758060|NCT01678807|16414110|P2|Overall Study|Withdrawn by Parent/Guardian|1
4758061|NCT01678807|16414111|P1|Overall Study|Withdrawn by Parent/Guardian|0
4758062|NCT01678807|16414109|P3|Overall Study|Adverse Event|0
4758063|NCT01678807|16414110|P2|Overall Study|Adverse Event|4
4758064|NCT01678807|16414111|P1|Overall Study|Adverse Event|4
4758065|NCT01678560|16414124|P2|Overall Study|Withdrawal by Subject|1
4758066|NCT01678560|16414125|P1|Overall Study|Withdrawal by Subject|0
4758067|NCT01678560|16414124|P2|Overall Study|Death|1
4758068|NCT01678560|16414125|P1|Overall Study|Death|0
4758069|NCT01678560|16414124|P2|Overall Study|Physician Decision|4
4758070|NCT01678560|16414125|P1|Overall Study|Physician Decision|4
4758071|NCT01678313|16414146|P2|Prostate Biopsy at 3 Months|Not received prostate biopsy|12
4758072|NCT01678313|16414147|P1|Prostate Biopsy at 3 Months|Not received prostate biopsy|11
4758073|NCT01678313|16414146|P2|PSA >4 ng/dL at 3 Months|PSA≦4|9
4758074|NCT01678313|16414147|P1|PSA >4 ng/dL at 3 Months|PSA≦4|8
4758075|NCT01678313|16414146|P2|Completed the 3-month Therapy|Physician Decision|4
4758076|NCT01678313|16414147|P1|Completed the 3-month Therapy|Physician Decision|3
4758077|NCT01678313|16414146|P2|Completed the 3-month Therapy|Lost to Follow-up|8
4758078|NCT01678313|16414147|P1|Completed the 3-month Therapy|Lost to Follow-up|3
4758079|NCT01678209|16414166|P3|Overall Study|screen fail|16
4758080|NCT01678209|16414167|P2|Overall Study|screen fail|17
4758081|NCT01678209|16414168|P1|Overall Study|screen fail|16
4758082|NCT01678209|16414166|P3|Overall Study|scheduling conflicts|1
4758083|NCT01678209|16414167|P2|Overall Study|scheduling conflicts|0
4758084|NCT01678209|16414168|P1|Overall Study|scheduling conflicts|0
4758085|NCT01678209|16414166|P3|Overall Study|could not scan twice|1
4758086|NCT01678209|16414167|P2|Overall Study|could not scan twice|1
4758087|NCT01678209|16414168|P1|Overall Study|could not scan twice|1
4758088|NCT01678144|16414209|P1|Stage 1: MAR Classic|Adverse Event|1
4758089|NCT01678131|16414228|P3|Overall Study|Withdrawal by Subject|2
4758090|NCT01678131|16414229|P2|Overall Study|Withdrawal by Subject|0
4758091|NCT01678131|16414230|P1|Overall Study|Withdrawal by Subject|0
4758092|NCT01678131|16414228|P3|Overall Study|Adverse Event|0
4758093|NCT01678131|16414229|P2|Overall Study|Adverse Event|1
4758094|NCT01678131|16414230|P1|Overall Study|Adverse Event|0
4758095|NCT01677988|16414238|P1|Overall Study|Lack of Efficacy|2
4758096|NCT01677936|16414251|P2|Overall Study|Protocol Violation|4
4758097|NCT01677936|16414252|P1|Overall Study|Protocol Violation|0
4758098|NCT01677936|16414251|P2|Overall Study|Lost to Follow-up|0
4758099|NCT01677936|16414252|P1|Overall Study|Lost to Follow-up|1
4758100|NCT01677936|16414251|P2|Overall Study|Adverse Event|0
4758101|NCT01677936|16414252|P1|Overall Study|Adverse Event|1
4758102|NCT01677936|16414251|P2|Overall Study|Protocol Violation|0
4758103|NCT01677936|16414252|P1|Overall Study|Protocol Violation|3
4758104|NCT01677936|16414251|P2|Overall Study|Lost to Follow-up|1
4758105|NCT01677936|16414252|P1|Overall Study|Lost to Follow-up|4
4758106|NCT01677910|16414263|P4|Open-Label Extension Period (OLE)|Lost to Follow-up|1
4758107|NCT01677910|16414264|P3|Open-Label Extension Period (OLE)|Lost to Follow-up|0
4758108|NCT01677910|16414265|P2|Open-Label Extension Period (OLE)|Lost to Follow-up|0
4758109|NCT01677910|16414266|P1|Open-Label Extension Period (OLE)|Lost to Follow-up|0
4758110|NCT01677910|16414263|P4|Open-Label Extension Period (OLE)|Adverse Event|15
4758111|NCT01677910|16414264|P3|Open-Label Extension Period (OLE)|Adverse Event|0
4758112|NCT01677910|16414265|P2|Open-Label Extension Period (OLE)|Adverse Event|0
4758113|NCT01677910|16414266|P1|Open-Label Extension Period (OLE)|Adverse Event|0
4758114|NCT01677910|16414263|P4|Open-Label Extension Period (OLE)|Lack of Efficacy|5
4758115|NCT01677910|16414264|P3|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4758116|NCT01677910|16414265|P2|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4758117|NCT01677910|16414266|P1|Open-Label Extension Period (OLE)|Lack of Efficacy|0
4758118|NCT01677910|16414263|P4|Open-Label Extension Period (OLE)|Withdrawal of Consent|9
4758119|NCT01677910|16414264|P3|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4758120|NCT01677910|16414265|P2|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4758121|NCT01677910|16414266|P1|Open-Label Extension Period (OLE)|Withdrawal of Consent|0
4758122|NCT01677910|16414263|P4|Open-Label Extension Period (OLE)|Reason not Specified|2
4758123|NCT01677910|16414264|P3|Open-Label Extension Period (OLE)|Reason not Specified|0
4758124|NCT01677910|16414265|P2|Open-Label Extension Period (OLE)|Reason not Specified|0
4758125|NCT01677910|16414266|P1|Open-Label Extension Period (OLE)|Reason not Specified|0
4758126|NCT01677910|16414263|P4|Open-Label Extension Period (OLE)|Physician Decision|4
4758127|NCT01677910|16414264|P3|Open-Label Extension Period (OLE)|Physician Decision|0
4758128|NCT01677910|16414265|P2|Open-Label Extension Period (OLE)|Physician Decision|0
4758129|NCT01677910|16414266|P1|Open-Label Extension Period (OLE)|Physician Decision|0
4758130|NCT01677910|16414263|P4|Double-Blind Treatment Period|Reason Not Specified|0
4758131|NCT01677910|16414264|P3|Double-Blind Treatment Period|Reason Not Specified|0
4758132|NCT01677910|16414265|P2|Double-Blind Treatment Period|Reason Not Specified|1
4758133|NCT01677910|16414266|P1|Double-Blind Treatment Period|Reason Not Specified|0
4758134|NCT01677910|16414263|P4|Double-Blind Treatment Period|Withdrawal of consent|0
4758135|NCT01677910|16414264|P3|Double-Blind Treatment Period|Withdrawal of consent|3
4758136|NCT01677910|16414265|P2|Double-Blind Treatment Period|Withdrawal of consent|0
4758137|NCT01677910|16414266|P1|Double-Blind Treatment Period|Withdrawal of consent|1
4758138|NCT01677910|16414263|P4|Double-Blind Treatment Period|Physician Decision|0
4758139|NCT01677910|16414264|P3|Double-Blind Treatment Period|Physician Decision|1
4758140|NCT01677910|16414265|P2|Double-Blind Treatment Period|Physician Decision|0
4758141|NCT01677910|16414266|P1|Double-Blind Treatment Period|Physician Decision|0
4758142|NCT01677910|16414263|P4|Double-Blind Treatment Period|Adverse Event|0
4758143|NCT01677910|16414264|P3|Double-Blind Treatment Period|Adverse Event|3
4758144|NCT01677910|16414265|P2|Double-Blind Treatment Period|Adverse Event|2
4758145|NCT01677910|16414266|P1|Double-Blind Treatment Period|Adverse Event|6
4758146|NCT01677858|16414293|P5|Overall Study|Lost to Follow-up|1
4758147|NCT01677858|16414294|P4|Overall Study|Lost to Follow-up|0
4758148|NCT01677858|16414295|P3|Overall Study|Lost to Follow-up|0
4758149|NCT01677858|16414296|P2|Overall Study|Lost to Follow-up|0
4758150|NCT01677858|16414297|P1|Overall Study|Lost to Follow-up|0
4758151|NCT01677858|16414293|P5|Overall Study|Withdrawal by Subject|15
4758152|NCT01677858|16414294|P4|Overall Study|Withdrawal by Subject|0
4758153|NCT01677858|16414295|P3|Overall Study|Withdrawal by Subject|1
4758154|NCT01677858|16414296|P2|Overall Study|Withdrawal by Subject|1
4758155|NCT01677858|16414297|P1|Overall Study|Withdrawal by Subject|0
4758156|NCT01677858|16414293|P5|Overall Study|Progressive Disease|43
4758157|NCT01677858|16414294|P4|Overall Study|Progressive Disease|3
4758158|NCT01677858|16414295|P3|Overall Study|Progressive Disease|9
4758159|NCT01677858|16414296|P2|Overall Study|Progressive Disease|1
4758160|NCT01677858|16414297|P1|Overall Study|Progressive Disease|2
4758161|NCT01677858|16414293|P5|Overall Study|Physician Decision|12
4758162|NCT01677858|16414294|P4|Overall Study|Physician Decision|0
4758163|NCT01677858|16414295|P3|Overall Study|Physician Decision|2
4758164|NCT01677858|16414296|P2|Overall Study|Physician Decision|0
4758165|NCT01677858|16414297|P1|Overall Study|Physician Decision|1
4758166|NCT01677858|16414293|P5|Overall Study|Death|1
4758167|NCT01677858|16414294|P4|Overall Study|Death|0
4758168|NCT01677858|16414295|P3|Overall Study|Death|0
4758169|NCT01677858|16414296|P2|Overall Study|Death|0
4758170|NCT01677858|16414297|P1|Overall Study|Death|0
4758171|NCT01677858|16414293|P5|Overall Study|Adverse Event|13
4758172|NCT01677858|16414294|P4|Overall Study|Adverse Event|3
4758173|NCT01677858|16414295|P3|Overall Study|Adverse Event|2
4758174|NCT01677858|16414296|P2|Overall Study|Adverse Event|0
4758175|NCT01677858|16414297|P1|Overall Study|Adverse Event|0
4758176|NCT01677767|16414370|P1|Overall Study|Non-compliance by the participants|3
4758177|NCT01677767|16414370|P1|Overall Study|Withdrawal by Subject|10
4758178|NCT01677767|16414370|P1|Overall Study|Protocol Violation|4
4758179|NCT01677767|16414370|P1|Overall Study|Death|4
4758180|NCT01677767|16414370|P1|Overall Study|Adverse Event|1
4758181|NCT01677624|16414384|P1|Overall Study|Insuf Resp: intra-articular hemorrhage|1
4758182|NCT01677507|16414389|P2|Second Assigment|Adverse Event|3
4758183|NCT01677507|16414390|P1|Second Assigment|Adverse Event|1
4758184|NCT01677507|16414389|P2|Second Assigment|Withdrawal by Subject|2
4758185|NCT01677507|16414390|P1|Second Assigment|Withdrawal by Subject|2
4758186|NCT01677507|16414389|P2|Initial Assignment|Protocol Violation|1
4758187|NCT01677507|16414390|P1|Initial Assignment|Protocol Violation|0
4758188|NCT01677507|16414389|P2|Initial Assignment|Adverse Event|1
4758189|NCT01677507|16414390|P1|Initial Assignment|Adverse Event|0
4758190|NCT01677377|16414403|P3|Overall Study|Pregnancy|1
4758191|NCT01677377|16414404|P2|Overall Study|Pregnancy|0
4758192|NCT01677377|16414405|P1|Overall Study|Pregnancy|0
4758193|NCT01677377|16414403|P3|Overall Study|Lack of Efficacy|1
4758194|NCT01677377|16414404|P2|Overall Study|Lack of Efficacy|0
4758195|NCT01677377|16414405|P1|Overall Study|Lack of Efficacy|0
4758196|NCT01677377|16414403|P3|Overall Study|Withdrawal by Subject|3
4758197|NCT01677377|16414404|P2|Overall Study|Withdrawal by Subject|0
4758198|NCT01677377|16414405|P1|Overall Study|Withdrawal by Subject|0
4758199|NCT01677377|16414403|P3|Overall Study|Lost to Follow-up|1
4758200|NCT01677377|16414404|P2|Overall Study|Lost to Follow-up|1
4758201|NCT01677377|16414405|P1|Overall Study|Lost to Follow-up|0
4758202|NCT01677377|16414403|P3|Overall Study|Protocol Violation|0
4758203|NCT01677377|16414404|P2|Overall Study|Protocol Violation|0
4758204|NCT01677377|16414405|P1|Overall Study|Protocol Violation|1
4758205|NCT01677299|16414621|P4|Overall Study|Withdrawal by Subject|1
4758206|NCT01677299|16414622|P3|Overall Study|Withdrawal by Subject|0
4758207|NCT01677299|16414623|P2|Overall Study|Withdrawal by Subject|1
4758208|NCT01677299|16414624|P1|Overall Study|Withdrawal by Subject|0
4758209|NCT01677299|16414621|P4|Overall Study|Adverse Event|0
4758210|NCT01677299|16414622|P3|Overall Study|Adverse Event|1
4758211|NCT01677299|16414623|P2|Overall Study|Adverse Event|2
4758212|NCT01677299|16414624|P1|Overall Study|Adverse Event|0
4758213|NCT01677195|16414656|P3|Overall Study|Protocol Violation|4
4758214|NCT01677195|16414657|P2|Overall Study|Protocol Violation|3
4758215|NCT01677195|16414658|P1|Overall Study|Protocol Violation|7
4758216|NCT01677195|16414656|P3|Overall Study|Pregnancy|0
4758217|NCT01677195|16414657|P2|Overall Study|Pregnancy|1
4758218|NCT01677195|16414658|P1|Overall Study|Pregnancy|0
4758219|NCT01677195|16414656|P3|Overall Study|Physician Decision|2
4758220|NCT01677195|16414657|P2|Overall Study|Physician Decision|2
4758221|NCT01677195|16414658|P1|Overall Study|Physician Decision|1
4758222|NCT01677195|16414656|P3|Overall Study|Adverse Event|1
4758223|NCT01677195|16414657|P2|Overall Study|Adverse Event|4
4758224|NCT01677195|16414658|P1|Overall Study|Adverse Event|6
4758225|NCT01677195|16414656|P3|Overall Study|Withdrawal by Subject|1
4758226|NCT01677195|16414657|P2|Overall Study|Withdrawal by Subject|0
4758227|NCT01677195|16414658|P1|Overall Study|Withdrawal by Subject|1
4758228|NCT01677195|16414656|P3|Overall Study|Lost to Follow-up|22
4758229|NCT01677195|16414657|P2|Overall Study|Lost to Follow-up|22
4758230|NCT01677195|16414658|P1|Overall Study|Lost to Follow-up|14
4758231|NCT01677182|16414669|P3|Overall Study|Other reasons|2
4758232|NCT01677182|16414670|P2|Overall Study|Other reasons|5
4758233|NCT01677182|16414671|P1|Overall Study|Other reasons|1
4758234|NCT01677182|16414669|P3|Overall Study|Lack of Efficacy|1
4758235|NCT01677182|16414670|P2|Overall Study|Lack of Efficacy|0
4758236|NCT01677182|16414671|P1|Overall Study|Lack of Efficacy|3
4758237|NCT01677182|16414669|P3|Overall Study|Study termination|11
4758238|NCT01677182|16414670|P2|Overall Study|Study termination|9
4758239|NCT01677182|16414671|P1|Overall Study|Study termination|12
4758240|NCT01677182|16414669|P3|Overall Study|Withdrawal by Subject|10
4758241|NCT01677182|16414670|P2|Overall Study|Withdrawal by Subject|12
4758242|NCT01677182|16414671|P1|Overall Study|Withdrawal by Subject|7
4758243|NCT01677182|16414669|P3|Overall Study|Lost to Follow-up|3
4758244|NCT01677182|16414670|P2|Overall Study|Lost to Follow-up|0
4758245|NCT01677182|16414671|P1|Overall Study|Lost to Follow-up|4
4758246|NCT01677182|16414669|P3|Overall Study|Protocol Violation|4
4758247|NCT01677182|16414670|P2|Overall Study|Protocol Violation|1
4758248|NCT01677182|16414671|P1|Overall Study|Protocol Violation|5
4758249|NCT01677182|16414669|P3|Overall Study|Adverse Event|8
4758250|NCT01677182|16414670|P2|Overall Study|Adverse Event|1
4758251|NCT01677182|16414671|P1|Overall Study|Adverse Event|2
4758252|NCT01676961|16414703|P1|Overall Study|Withdrawal by Subject|1
4758253|NCT01676961|16414703|P1|Overall Study|Lost to Follow-up|1
4758254|NCT01676961|16414703|P1|Overall Study|Death|3
4758255|NCT01676909|16414710|P2|Overall Study|Lost to Follow-up|9
4758256|NCT01676909|16414711|P1|Overall Study|Lost to Follow-up|15
4758257|NCT01676909|16414710|P2|Overall Study|Withdrawal by Subject|5
4758258|NCT01676909|16414711|P1|Overall Study|Withdrawal by Subject|3
4758259|NCT01676896|16414776|P3|Overall Study|Withdrawal by Subject|19
4758260|NCT01676896|16414777|P2|Overall Study|Withdrawal by Subject|7
4758261|NCT01676896|16414778|P1|Overall Study|Withdrawal by Subject|12
4758262|NCT01676727|16414886|P1|Overall Study|Valve explanted|1
4758263|NCT01676727|16414886|P1|Overall Study|Not willing to attend 1-year visit|2
4758264|NCT01676727|16414886|P1|Overall Study|Screening failure|5
4758265|NCT01676727|16414886|P1|Overall Study|Withdrawal by Subject|6
4758266|NCT01676727|16414886|P1|Overall Study|Death|18
4758267|NCT01676701|16414900|P2|Overall Study|Sponsor Decision|4
4758268|NCT01676701|16414901|P1|Overall Study|Sponsor Decision|3
4758269|NCT01676701|16414900|P2|Overall Study|Protocol Violation|0
4758270|NCT01676701|16414901|P1|Overall Study|Protocol Violation|1
4758271|NCT01676220|16415003|P2|Overall Study|No More Need of Insulin|0
4758272|NCT01676220|16415004|P1|Overall Study|No More Need of Insulin|1
4758273|NCT01676220|16415003|P2|Overall Study|Non Serious Hypoglycemia|0
4758274|NCT01676220|16415004|P1|Overall Study|Non Serious Hypoglycemia|2
4758275|NCT01676220|16415003|P2|Overall Study|Perceived Lack of Efficacy|1
4758276|NCT01676220|16415004|P1|Overall Study|Perceived Lack of Efficacy|3
4758277|NCT01676220|16415003|P2|Overall Study|Site Closure/Site Withdrawal|4
4758278|NCT01676220|16415004|P1|Overall Study|Site Closure/Site Withdrawal|1
4758279|NCT01676220|16415003|P2|Overall Study|Selection Criterion/Protocol Violation|9
4758280|NCT01676220|16415004|P1|Overall Study|Selection Criterion/Protocol Violation|9
4758281|NCT01676220|16415003|P2|Overall Study|Lost to Follow-up|18
4758282|NCT01676220|16415004|P1|Overall Study|Lost to Follow-up|11
4758283|NCT01676220|16415003|P2|Overall Study|Personal Reason|45
4758284|NCT01676220|16415004|P1|Overall Study|Personal Reason|34
4758285|NCT01676220|16415003|P2|Overall Study|Received Rescue Therapy|22
4758286|NCT01676220|16415004|P1|Overall Study|Received Rescue Therapy|14
4758287|NCT01676220|16415003|P2|Overall Study|Protocol Violation|12
4758288|NCT01676220|16415004|P1|Overall Study|Protocol Violation|11
4758289|NCT01676220|16415003|P2|Overall Study|Lack of Efficacy|5
4758290|NCT01676220|16415004|P1|Overall Study|Lack of Efficacy|2
4758291|NCT01676220|16415003|P2|Overall Study|Adverse Event|8
4758292|NCT01676220|16415004|P1|Overall Study|Adverse Event|10
4758293|NCT01676220|16415003|P2|Overall Study|Randomized But Not Treated|1
4758294|NCT01676220|16415004|P1|Overall Study|Randomized But Not Treated|4
4758295|NCT01676116|16415036|P2|Overall Study|Protocol Violation|3
4758296|NCT01676116|16415037|P1|Overall Study|Protocol Violation|9
4758297|NCT01676116|16415036|P2|Overall Study|Unclassified|10
4758298|NCT01676116|16415037|P1|Overall Study|Unclassified|4
4758299|NCT01676116|16415036|P2|Overall Study|Adverse Event|2
4758300|NCT01676116|16415037|P1|Overall Study|Adverse Event|1
4758301|NCT01676116|16415036|P2|Overall Study|Withdrawal criteria|14
4758302|NCT01676116|16415037|P1|Overall Study|Withdrawal criteria|2
4758303|NCT01676012|16415059|P1|Overall Study|incomplete set of videos|1
4758304|NCT01676012|16415059|P1|Overall Study|Adverse Event|2
4758305|NCT01675765|16415103|P2|Overall Study|Clinical progression|2
4758306|NCT01675765|16415104|P1|Overall Study|Clinical progression|3
4758307|NCT01675765|16415103|P2|Overall Study|Death|0
4758308|NCT01675765|16415104|P1|Overall Study|Death|1
4758309|NCT01675765|16415103|P2|Overall Study|Withdrawal by Subject|0
4758310|NCT01675765|16415104|P1|Overall Study|Withdrawal by Subject|2
4758311|NCT01675765|16415103|P2|Overall Study|Adverse Event|2
4758312|NCT01675765|16415104|P1|Overall Study|Adverse Event|1
4758313|NCT01675765|16415103|P2|Overall Study|Progressive disease|4
4758314|NCT01675765|16415104|P1|Overall Study|Progressive disease|4
4758315|NCT01675661|16415120|P2|Overall Study|Other reason|2
4758316|NCT01675661|16415121|P1|Overall Study|Other reason|1
4758317|NCT01675661|16415120|P2|Overall Study|Death|1
4758318|NCT01675661|16415121|P1|Overall Study|Death|0
4758319|NCT01675661|16415120|P2|Overall Study|Physician Decision|2
4758320|NCT01675661|16415121|P1|Overall Study|Physician Decision|0
4758321|NCT01675661|16415120|P2|Overall Study|Withdrawal by Subject|7
4758322|NCT01675661|16415121|P1|Overall Study|Withdrawal by Subject|3
4758323|NCT01675661|16415120|P2|Overall Study|Moved away|6
4758324|NCT01675661|16415121|P1|Overall Study|Moved away|5
4758325|NCT01675661|16415120|P2|Overall Study|Practical problems|5
4758326|NCT01675661|16415121|P1|Overall Study|Practical problems|9
4758327|NCT01675661|16415120|P2|Overall Study|Lost to Follow-up|23
4758328|NCT01675661|16415121|P1|Overall Study|Lost to Follow-up|22
4758329|NCT01675622|16415150|P2|Overall Study|Other|4
4758330|NCT01675622|16415151|P1|Overall Study|Other|5
4758331|NCT01675622|16415150|P2|Overall Study|Lost to Follow-up|3
4758332|NCT01675622|16415151|P1|Overall Study|Lost to Follow-up|1
4758333|NCT01675622|16415150|P2|Overall Study|Lack of Efficacy|4
4758334|NCT01675622|16415151|P1|Overall Study|Lack of Efficacy|2
4758335|NCT01675622|16415150|P2|Overall Study|Protocol Violation|1
4758336|NCT01675622|16415151|P1|Overall Study|Protocol Violation|4
4758337|NCT01675622|16415150|P2|Overall Study|Adverse Event|10
4758338|NCT01675622|16415151|P1|Overall Study|Adverse Event|12
4758339|NCT01675622|16415150|P2|Overall Study|Withdrawal by Subject|2
4758340|NCT01675622|16415151|P1|Overall Study|Withdrawal by Subject|2
4758341|NCT01675596|16415175|P1|Overall Study|Missed Visit|1
4758342|NCT01675596|16415175|P1|Overall Study|Exit with other reason|1
4758343|NCT01675596|16415175|P1|Overall Study|Death|6
4758344|NCT01675544|16415181|P1|Overall Study|Withdrawal by Subject|2
4758345|NCT01675531|16415186|P1|Overall Study|Protocol Violation|8
4758346|NCT01675531|16415186|P1|Overall Study|Lack of Efficacy|1
4758347|NCT01675531|16415186|P1|Overall Study|Withdrawal by Subject|7
4758348|NCT01675531|16415186|P1|Overall Study|Adverse Event|9
4758349|NCT01675492|16415193|P1|Overall Study|study completed early - product approval|42
4758350|NCT01675479|16415198|P1|Overall Study|Lost to Follow-up|11
4758351|NCT01675427|16415212|P1|Overall Study|Other|2
4758352|NCT01675427|16415212|P1|Overall Study|Lost to Follow-up|5
4758353|NCT01675427|16415212|P1|Overall Study|Sample not Collected by Mistake|2
4758354|NCT01675427|16415212|P1|Overall Study|Participant Refused Sample Collection|18
4758355|NCT01675427|16415212|P1|Overall Study|Withdrawal by Subject|7
4758356|NCT01675167|16415512|P3|Double-blind Treatment Phase|Other|5
4758357|NCT01675167|16415513|P2|Double-blind Treatment Phase|Other|7
4758358|NCT01675167|16415514|P1|Double-blind Treatment Phase|Other|0
4758359|NCT01675167|16415512|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9
4758360|NCT01675167|16415513|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
4758361|NCT01675167|16415514|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
4758362|NCT01675167|16415512|P3|Double-blind Treatment Phase|Lost to Follow-up|5
4758363|NCT01675167|16415513|P2|Double-blind Treatment Phase|Lost to Follow-up|1
4758364|NCT01675167|16415514|P1|Double-blind Treatment Phase|Lost to Follow-up|0
4758365|NCT01675167|16415512|P3|Double-blind Treatment Phase|Protocol Violation|11
4758366|NCT01675167|16415513|P2|Double-blind Treatment Phase|Protocol Violation|4
4758367|NCT01675167|16415514|P1|Double-blind Treatment Phase|Protocol Violation|0
4758368|NCT01675167|16415512|P3|Double-blind Treatment Phase|Adverse Event|13
4758369|NCT01675167|16415513|P2|Double-blind Treatment Phase|Adverse Event|5
4758370|NCT01675167|16415514|P1|Double-blind Treatment Phase|Adverse Event|0
4758371|NCT01675167|16415512|P3|Double-blind Treatment Phase|Withdrawal by Subject|6
4758372|NCT01675167|16415513|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
4758373|NCT01675167|16415514|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
4758374|NCT01675167|16415512|P3|Double-blind Treatment Phase|Lack of Efficacy|61
4758375|NCT01675167|16415513|P2|Double-blind Treatment Phase|Lack of Efficacy|19
4758376|NCT01675167|16415514|P1|Double-blind Treatment Phase|Lack of Efficacy|0
4758377|NCT01675167|16415512|P3|Open-label Titration Phase|Other|0
4758378|NCT01675167|16415513|P2|Open-label Titration Phase|Other|0
4758379|NCT01675167|16415514|P1|Open-label Titration Phase|Other|55
4758380|NCT01675167|16415512|P3|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
4758381|NCT01675167|16415513|P2|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0
4758382|NCT01675167|16415514|P1|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1
4758383|NCT01675167|16415512|P3|Open-label Titration Phase|Lost to Follow-up|0
4758384|NCT01675167|16415513|P2|Open-label Titration Phase|Lost to Follow-up|0
4758385|NCT01675167|16415514|P1|Open-label Titration Phase|Lost to Follow-up|15
4758386|NCT01675167|16415512|P3|Open-label Titration Phase|Protocol Violation|0
4758387|NCT01675167|16415513|P2|Open-label Titration Phase|Protocol Violation|0
4758388|NCT01675167|16415514|P1|Open-label Titration Phase|Protocol Violation|43
4758389|NCT01675167|16415512|P3|Open-label Titration Phase|Withdrawal by Subject|0
4758390|NCT01675167|16415513|P2|Open-label Titration Phase|Withdrawal by Subject|0
4758391|NCT01675167|16415514|P1|Open-label Titration Phase|Withdrawal by Subject|46
4758392|NCT01675167|16415512|P3|Open-label Titration Phase|Lack of Efficacy|0
4758393|NCT01675167|16415513|P2|Open-label Titration Phase|Lack of Efficacy|0
4758394|NCT01675167|16415514|P1|Open-label Titration Phase|Lack of Efficacy|63
4758395|NCT01675167|16415512|P3|Open-label Titration Phase|Adverse Event|0
4758396|NCT01675167|16415513|P2|Open-label Titration Phase|Adverse Event|0
4758397|NCT01675167|16415514|P1|Open-label Titration Phase|Adverse Event|81
4758398|NCT01675141|16415536|P1|Overall Study|No treatment, per protocol|1
4758399|NCT01675141|16415536|P1|Overall Study|Physician Decision|4
4758400|NCT01675141|16415536|P1|Overall Study|Withdrawal by Subject|3
4758401|NCT01675141|16415536|P1|Overall Study|Lenalidomide outside NIH|3
4758402|NCT01675128|16415549|P3|Overall Study|Pulmonary complication; off study|0
4758403|NCT01675128|16415550|P2|Overall Study|Pulmonary complication; off study|1
4758404|NCT01675128|16415551|P1|Overall Study|Pulmonary complication; off study|0
4758405|NCT01675128|16415549|P3|Overall Study|Refused further treatment|0
4758406|NCT01675128|16415550|P2|Overall Study|Refused further treatment|0
4758407|NCT01675128|16415551|P1|Overall Study|Refused further treatment|1
4758408|NCT01675128|16415549|P3|Overall Study|Disease progression on study|1
4758409|NCT01675128|16415550|P2|Overall Study|Disease progression on study|1
4758410|NCT01675128|16415551|P1|Overall Study|Disease progression on study|1
4758411|NCT01675050|16415579|P2|Period One Treatment|Withdrawal by Subject|0
4758412|NCT01675050|16415580|P1|Period One Treatment|Withdrawal by Subject|1
4758413|NCT01675011|16415590|P2|Overall Study|Trial terminated by Sponsor|1
4758414|NCT01675011|16415591|P1|Overall Study|Trial terminated by Sponsor|3
4758415|NCT01674725|16415599|P2|Overall Study|Lost to Follow-up|1
4758416|NCT01674725|16415600|P1|Overall Study|Lost to Follow-up|0
4758417|NCT01674725|16415599|P2|Overall Study|Withdrawal by Subject|0
4758418|NCT01674725|16415600|P1|Overall Study|Withdrawal by Subject|1
4758419|NCT01674725|16415599|P2|Overall Study|Did not receive study drug|0
4758420|NCT01674725|16415600|P1|Overall Study|Did not receive study drug|1
4758421|NCT01674725|16415599|P2|Overall Study|Adverse Event|0
4758422|NCT01674725|16415600|P1|Overall Study|Adverse Event|1
4758423|NCT01674712|16415619|P5|Overall Study|Lack of Efficacy|1
4758424|NCT01674712|16415620|P4|Overall Study|Lack of Efficacy|0
4758425|NCT01674712|16415621|P3|Overall Study|Lack of Efficacy|1
4758426|NCT01674712|16415622|P2|Overall Study|Lack of Efficacy|0
4758427|NCT01674712|16415623|P1|Overall Study|Lack of Efficacy|0
4758428|NCT01674712|16415619|P5|Overall Study|Administrative|1
4758429|NCT01674712|16415620|P4|Overall Study|Administrative|0
4758430|NCT01674712|16415621|P3|Overall Study|Administrative|0
4758431|NCT01674712|16415622|P2|Overall Study|Administrative|1
4758432|NCT01674712|16415623|P1|Overall Study|Administrative|0
4758433|NCT01674712|16415619|P5|Overall Study|Withdrawal by Subject|3
4758434|NCT01674712|16415620|P4|Overall Study|Withdrawal by Subject|4
4758435|NCT01674712|16415621|P3|Overall Study|Withdrawal by Subject|5
4758436|NCT01674712|16415622|P2|Overall Study|Withdrawal by Subject|2
4758437|NCT01674712|16415623|P1|Overall Study|Withdrawal by Subject|2
4758438|NCT01674712|16415619|P5|Overall Study|Protocol Violation|0
4758439|NCT01674712|16415620|P4|Overall Study|Protocol Violation|0
4758440|NCT01674712|16415621|P3|Overall Study|Protocol Violation|0
4758441|NCT01674712|16415622|P2|Overall Study|Protocol Violation|0
4758442|NCT01674712|16415623|P1|Overall Study|Protocol Violation|2
4758443|NCT01674712|16415619|P5|Overall Study|Lost to Follow-up|0
4758444|NCT01674712|16415620|P4|Overall Study|Lost to Follow-up|0
4758445|NCT01674712|16415621|P3|Overall Study|Lost to Follow-up|0
4758446|NCT01674712|16415622|P2|Overall Study|Lost to Follow-up|0
4758447|NCT01674712|16415623|P1|Overall Study|Lost to Follow-up|1
4758448|NCT01674712|16415619|P5|Overall Study|Adverse Event|6
4758449|NCT01674712|16415620|P4|Overall Study|Adverse Event|4
4758450|NCT01674712|16415621|P3|Overall Study|Adverse Event|3
4758451|NCT01674712|16415622|P2|Overall Study|Adverse Event|6
4758452|NCT01674712|16415623|P1|Overall Study|Adverse Event|5
4758453|NCT01674647|16415647|P2|30-day Safety Follow-up Period|Lost to Follow-up|5
4758454|NCT01674647|16415648|P1|30-day Safety Follow-up Period|Lost to Follow-up|8
4758455|NCT01674647|16415647|P2|30-day Safety Follow-up Period|Withdrawal by Subject|8
4758456|NCT01674647|16415648|P1|30-day Safety Follow-up Period|Withdrawal by Subject|7
4758457|NCT01674647|16415647|P2|30-day Safety Follow-up Period|Logistical difficulties|3
4758458|NCT01674647|16415648|P1|30-day Safety Follow-up Period|Logistical difficulties|1
4758459|NCT01674647|16415647|P2|30-day Safety Follow-up Period|Protocol Violation|22
4758460|NCT01674647|16415648|P1|30-day Safety Follow-up Period|Protocol Violation|39
4758461|NCT01674647|16415647|P2|30-day Safety Follow-up Period|Non-compliance with study drug|1
4758462|NCT01674647|16415648|P1|30-day Safety Follow-up Period|Non-compliance with study drug|0
4758463|NCT01674647|16415647|P2|30-day Safety Follow-up Period|Death|2
4758464|NCT01674647|16415648|P1|30-day Safety Follow-up Period|Death|3
4758465|NCT01674647|16415647|P2|Treatment Period|Protocol Violation|36
4758466|NCT01674647|16415648|P1|Treatment Period|Protocol Violation|56
4758467|NCT01674647|16415647|P2|Treatment Period|Treatment failure|14
4758468|NCT01674647|16415648|P1|Treatment Period|Treatment failure|0
4758469|NCT01674647|16415647|P2|Treatment Period|Logistical difficulties|8
4758470|NCT01674647|16415648|P1|Treatment Period|Logistical difficulties|5
4758471|NCT01674647|16415647|P2|Treatment Period|Switching to other therapy|2
4758472|NCT01674647|16415648|P1|Treatment Period|Switching to other therapy|5
4758473|NCT01674647|16415647|P2|Treatment Period|Withdrawal by Subject|16
4758474|NCT01674647|16415648|P1|Treatment Period|Withdrawal by Subject|19
4758475|NCT01674647|16415647|P2|Treatment Period|Lost to Follow-up|1
4758476|NCT01674647|16415648|P1|Treatment Period|Lost to Follow-up|1
4758477|NCT01674647|16415647|P2|Treatment Period|Non-compliance with study drug|0
4758478|NCT01674647|16415648|P1|Treatment Period|Non-compliance with study drug|3
4758479|NCT01674647|16415647|P2|Treatment Period|Adverse Event|22
4758480|NCT01674647|16415648|P1|Treatment Period|Adverse Event|60
4758481|NCT01674647|16415647|P2|Treatment Period|Physician Decision|1
4758482|NCT01674647|16415648|P1|Treatment Period|Physician Decision|3
4758483|NCT01674647|16415647|P2|Treatment Period|Efficacy outcome reached|1
4758484|NCT01674647|16415648|P1|Treatment Period|Efficacy outcome reached|0
4758485|NCT01674647|16415647|P2|Treatment Period|Death|1
4758486|NCT01674647|16415648|P1|Treatment Period|Death|4
4758487|NCT01674634|16415674|P1|Overall Study|Lost to Follow-up|3
4758488|NCT01674634|16415674|P1|Overall Study|Withdrawal by Subject|3
4758489|NCT01674621|16415694|P5|Overall Study|Other than specified|2
4758490|NCT01674621|16415695|P4|Overall Study|Other than specified|0
4758491|NCT01674621|16415696|P3|Overall Study|Other than specified|0
4758492|NCT01674621|16415697|P2|Overall Study|Other than specified|1
4758493|NCT01674621|16415698|P1|Overall Study|Other than specified|0
4758494|NCT01674621|16415694|P5|Overall Study|Withdrawal by Subject|1
4758495|NCT01674621|16415695|P4|Overall Study|Withdrawal by Subject|0
4758496|NCT01674621|16415696|P3|Overall Study|Withdrawal by Subject|2
4758497|NCT01674621|16415697|P2|Overall Study|Withdrawal by Subject|5
4758498|NCT01674621|16415698|P1|Overall Study|Withdrawal by Subject|2
4758499|NCT01674621|16415694|P5|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4758500|NCT01674621|16415695|P4|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1
4758501|NCT01674621|16415696|P3|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4758502|NCT01674621|16415697|P2|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4758503|NCT01674621|16415698|P1|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0
4758504|NCT01674621|16415694|P5|Overall Study|Inability to Complete Study Procedures|2
4758505|NCT01674621|16415695|P4|Overall Study|Inability to Complete Study Procedures|0
4758506|NCT01674621|16415696|P3|Overall Study|Inability to Complete Study Procedures|0
4758507|NCT01674621|16415697|P2|Overall Study|Inability to Complete Study Procedures|0
4758508|NCT01674621|16415698|P1|Overall Study|Inability to Complete Study Procedures|0
4758509|NCT01674621|16415694|P5|Overall Study|Adverse Event|1
4758510|NCT01674621|16415695|P4|Overall Study|Adverse Event|5
4758511|NCT01674621|16415696|P3|Overall Study|Adverse Event|5
4758512|NCT01674621|16415697|P2|Overall Study|Adverse Event|2
4758513|NCT01674621|16415698|P1|Overall Study|Adverse Event|3
4758514|NCT01674569|16415775|P6|Overall Study|Withdrawal by Subject|0
4758515|NCT01674569|16415776|P5|Overall Study|Withdrawal by Subject|0
4758516|NCT01674569|16415777|P4|Overall Study|Withdrawal by Subject|0
4758517|NCT01674569|16415778|P3|Overall Study|Withdrawal by Subject|1
4758518|NCT01674569|16415779|P2|Overall Study|Withdrawal by Subject|0
4758519|NCT01674569|16415780|P1|Overall Study|Withdrawal by Subject|0
4758520|NCT01674569|16415775|P6|Overall Study|Protocol Violation|0
4758521|NCT01674569|16415776|P5|Overall Study|Protocol Violation|0
4758522|NCT01674569|16415777|P4|Overall Study|Protocol Violation|0
4758523|NCT01674569|16415778|P3|Overall Study|Protocol Violation|1
4758524|NCT01674569|16415779|P2|Overall Study|Protocol Violation|1
4758525|NCT01674569|16415780|P1|Overall Study|Protocol Violation|0
4758526|NCT01674569|16415775|P6|Overall Study|Adverse Event|2
4758527|NCT01674569|16415776|P5|Overall Study|Adverse Event|2
4758528|NCT01674569|16415777|P4|Overall Study|Adverse Event|1
4758529|NCT01674569|16415778|P3|Overall Study|Adverse Event|0
4758530|NCT01674569|16415779|P2|Overall Study|Adverse Event|2
4758531|NCT01674569|16415780|P1|Overall Study|Adverse Event|0
4758532|NCT01674062|16415801|P2|Overall Study|Programming Error|0
4758533|NCT01674062|16415802|P1|Overall Study|Programming Error|1
4758534|NCT01674062|16415801|P2|Overall Study|Death|1
4758535|NCT01674062|16415802|P1|Overall Study|Death|0
4758536|NCT01674062|16415801|P2|Overall Study|Adverse Event|1
4758537|NCT01674062|16415802|P1|Overall Study|Adverse Event|1
4758538|NCT01674062|16415801|P2|Overall Study|Other|1
4758539|NCT01674062|16415802|P1|Overall Study|Other|8
4758540|NCT01674062|16415801|P2|Overall Study|Insufficient Therapeutic Response|26
4758541|NCT01674062|16415802|P1|Overall Study|Insufficient Therapeutic Response|56
4758542|NCT01674010|16415817|P3|Randomization Phase 2|Withdrawal by Subject|7
4758543|NCT01674010|16415818|P2|Randomization Phase 2|Withdrawal by Subject|8
4758544|NCT01674010|16415819|P1|Randomization Phase 2|Withdrawal by Subject|0
4758545|NCT01674010|16415817|P3|Randomization Phase 2|Sponsor Decision|45
4758546|NCT01674010|16415818|P2|Randomization Phase 2|Sponsor Decision|42
4758547|NCT01674010|16415819|P1|Randomization Phase 2|Sponsor Decision|0
4758548|NCT01674010|16415817|P3|Randomization Phase 2|Protocol Violation|1
4758549|NCT01674010|16415818|P2|Randomization Phase 2|Protocol Violation|1
4758550|NCT01674010|16415819|P1|Randomization Phase 2|Protocol Violation|0
4758551|NCT01674010|16415817|P3|Randomization Phase 2|Pregnancy|1
4758552|NCT01674010|16415818|P2|Randomization Phase 2|Pregnancy|1
4758553|NCT01674010|16415819|P1|Randomization Phase 2|Pregnancy|0
4758554|NCT01674010|16415817|P3|Randomization Phase 2|Physician Decision|2
4758555|NCT01674010|16415818|P2|Randomization Phase 2|Physician Decision|0
4758556|NCT01674010|16415819|P1|Randomization Phase 2|Physician Decision|0
4758557|NCT01674010|16415817|P3|Randomization Phase 2|Mood episode recurrence|2
4758558|NCT01674010|16415818|P2|Randomization Phase 2|Mood episode recurrence|8
4758559|NCT01674010|16415819|P1|Randomization Phase 2|Mood episode recurrence|0
4758560|NCT01674010|16415817|P3|Randomization Phase 2|Lost to Follow-up|2
4758561|NCT01674010|16415818|P2|Randomization Phase 2|Lost to Follow-up|1
4758562|NCT01674010|16415819|P1|Randomization Phase 2|Lost to Follow-up|0
4758563|NCT01674010|16415817|P3|Randomization Phase 2|Adverse Event|1
4758564|NCT01674010|16415818|P2|Randomization Phase 2|Adverse Event|1
4758565|NCT01674010|16415819|P1|Randomization Phase 2|Adverse Event|0
4758566|NCT01674010|16415817|P3|Open Treatment Phase 1|Withdrawal by Subject|0
4758567|NCT01674010|16415818|P2|Open Treatment Phase 1|Withdrawal by Subject|0
4758568|NCT01674010|16415819|P1|Open Treatment Phase 1|Withdrawal by Subject|25
4758569|NCT01674010|16415817|P3|Open Treatment Phase 1|Did not remain in a stable remission|0
4758570|NCT01674010|16415818|P2|Open Treatment Phase 1|Did not remain in a stable remission|0
4758571|NCT01674010|16415819|P1|Open Treatment Phase 1|Did not remain in a stable remission|30
4758572|NCT01674010|16415817|P3|Open Treatment Phase 1|Sponsor Decision|0
4758573|NCT01674010|16415818|P2|Open Treatment Phase 1|Sponsor Decision|0
4758574|NCT01674010|16415819|P1|Open Treatment Phase 1|Sponsor Decision|79
4758575|NCT01674010|16415817|P3|Open Treatment Phase 1|Protocol Violation|0
4758576|NCT01674010|16415818|P2|Open Treatment Phase 1|Protocol Violation|0
4758577|NCT01674010|16415819|P1|Open Treatment Phase 1|Protocol Violation|7
4758578|NCT01674010|16415817|P3|Open Treatment Phase 1|Physician Decision|0
4758579|NCT01674010|16415818|P2|Open Treatment Phase 1|Physician Decision|0
4758580|NCT01674010|16415819|P1|Open Treatment Phase 1|Physician Decision|9
4758581|NCT01674010|16415817|P3|Open Treatment Phase 1|Lost to Follow-up|0
4758582|NCT01674010|16415818|P2|Open Treatment Phase 1|Lost to Follow-up|0
4758583|NCT01674010|16415819|P1|Open Treatment Phase 1|Lost to Follow-up|19
4758584|NCT01674010|16415817|P3|Open Treatment Phase 1|Death|0
4758585|NCT01674010|16415818|P2|Open Treatment Phase 1|Death|0
4758586|NCT01674010|16415819|P1|Open Treatment Phase 1|Death|1
4758587|NCT01674010|16415817|P3|Open Treatment Phase 1|Adverse Event|0
4758588|NCT01674010|16415818|P2|Open Treatment Phase 1|Adverse Event|0
4758589|NCT01674010|16415819|P1|Open Treatment Phase 1|Adverse Event|10
4758590|NCT01673984|16415838|P2|Overall Study|Study termination|6
4758591|NCT01673984|16415839|P1|Overall Study|Study termination|9
4758592|NCT01673984|16415838|P2|Overall Study|Adverse Event|0
4758593|NCT01673984|16415839|P1|Overall Study|Adverse Event|1
4758594|NCT01673867|16415889|P2|Treatment|Physician Decision|1
4758595|NCT01673867|16415890|P1|Treatment|Physician Decision|0
4758596|NCT01673867|16415889|P2|Treatment|Symptomatic deterioration|1
4758597|NCT01673867|16415890|P1|Treatment|Symptomatic deterioration|0
4758598|NCT01673867|16415889|P2|Treatment|Required prolonged hospitalization|1
4758599|NCT01673867|16415890|P1|Treatment|Required prolonged hospitalization|0
4758600|NCT01673867|16415889|P2|Treatment|Health status not improved|0
4758601|NCT01673867|16415890|P1|Treatment|Health status not improved|1
4758602|NCT01673867|16415889|P2|Treatment|Required steroid therapy|0
4758603|NCT01673867|16415890|P1|Treatment|Required steroid therapy|1
4758604|NCT01673867|16415889|P2|Treatment|No longer meets criteria|0
4758605|NCT01673867|16415890|P1|Treatment|No longer meets criteria|2
4758606|NCT01673867|16415889|P2|Treatment|Maximum clinical benefit|10
4758607|NCT01673867|16415890|P1|Treatment|Maximum clinical benefit|0
4758608|NCT01673867|16415889|P2|Treatment|Withdrawal by Subject|6
4758609|NCT01673867|16415890|P1|Treatment|Withdrawal by Subject|4
4758610|NCT01673867|16415889|P2|Treatment|Requested treatment discontinuation|16
4758611|NCT01673867|16415890|P1|Treatment|Requested treatment discontinuation|5
4758612|NCT01673867|16415889|P2|Treatment|AE unrelated to study drug|11
4758613|NCT01673867|16415890|P1|Treatment|AE unrelated to study drug|19
4758614|NCT01673867|16415889|P2|Treatment|Death|1
4758615|NCT01673867|16415890|P1|Treatment|Death|1
4758616|NCT01673867|16415889|P2|Treatment|Study Drug Toxicity|42
4758617|NCT01673867|16415890|P1|Treatment|Study Drug Toxicity|17
4758618|NCT01673867|16415889|P2|Treatment|Disease Progression|179
4758619|NCT01673867|16415890|P1|Treatment|Disease Progression|194
4758620|NCT01673867|16415889|P2|Randomization|No longer meets criteria|5
4758621|NCT01673867|16415890|P1|Randomization|No longer meets criteria|4
4758622|NCT01673867|16415889|P2|Randomization|Lost to Follow-up|1
4758623|NCT01673867|16415890|P1|Randomization|Lost to Follow-up|0
4758624|NCT01673867|16415889|P2|Randomization|Withdrawal by Subject|12
4758625|NCT01673867|16415890|P1|Randomization|Withdrawal by Subject|0
4758626|NCT01673867|16415889|P2|Randomization|Requested treatment discontinuation|4
4758627|NCT01673867|16415890|P1|Randomization|Requested treatment discontinuation|0
4758628|NCT01673867|16415889|P2|Randomization|AE unrelated to study drug|0
4758629|NCT01673867|16415890|P1|Randomization|AE unrelated to study drug|1
4758630|NCT01673854|16415916|P1|Vem 2 Phase (Vemurafenib Retreatment)|Death|1
4758631|NCT01673854|16415916|P1|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1
4758632|NCT01673854|16415916|P1|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5
4758633|NCT01673854|16415916|P1|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12
4758634|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7
4758635|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2
4758636|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1
4758637|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1
4758638|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1
4758639|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2
4758640|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6
4758641|NCT01673854|16415916|P1|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7
4758642|NCT01673698|16415939|P2|Overall Study|Lost to Follow-up|13
4758643|NCT01673698|16415940|P1|Overall Study|Lost to Follow-up|51
4758644|NCT01673646|16415951|P3|Overall Study|Completed Core/did not enter Ext.|1
4758645|NCT01673646|16415952|P2|Overall Study|Completed Core/did not enter Ext.|1
4758646|NCT01673646|16415953|P1|Overall Study|Completed Core/did not enter Ext.|2
4758647|NCT01673646|16415951|P3|Overall Study|Withdrawal by Subject|2
4758648|NCT01673646|16415952|P2|Overall Study|Withdrawal by Subject|2
4758649|NCT01673646|16415953|P1|Overall Study|Withdrawal by Subject|0
4758650|NCT01673646|16415951|P3|Overall Study|Condition no longer requires study drug|0
4758651|NCT01673646|16415952|P2|Overall Study|Condition no longer requires study drug|1
4758652|NCT01673646|16415953|P1|Overall Study|Condition no longer requires study drug|0
4758653|NCT01673646|16415951|P3|Overall Study|Unsatisfactory therapeutic effect|0
4758654|NCT01673646|16415952|P2|Overall Study|Unsatisfactory therapeutic effect|2
4758655|NCT01673646|16415953|P1|Overall Study|Unsatisfactory therapeutic effect|0
4758656|NCT01673646|16415951|P3|Overall Study|Adverse Event|1
4758657|NCT01673646|16415952|P2|Overall Study|Adverse Event|1
4758658|NCT01673646|16415953|P1|Overall Study|Adverse Event|2
4758659|NCT01673620|16415992|P2|Overall Study|Adverse Event|0
4758660|NCT01673620|16415993|P1|Overall Study|Adverse Event|1
4758661|NCT01673594|16416003|P2|Overall Study|Withdrawal by Subject|1
4758662|NCT01673594|16416004|P1|Overall Study|Withdrawal by Subject|0
4758663|NCT01673594|16416003|P2|Overall Study|Physician Decision|4
4758664|NCT01673594|16416004|P1|Overall Study|Physician Decision|2
4758665|NCT01673594|16416003|P2|Overall Study|Lost to Follow-up|0
4758666|NCT01673594|16416004|P1|Overall Study|Lost to Follow-up|1
4758667|NCT01673594|16416003|P2|Overall Study|Adverse Event|1
4758668|NCT01673594|16416004|P1|Overall Study|Adverse Event|3
4758669|NCT01673490|16416023|P1|Overall Study|Withdrawal by Subject|3
4758670|NCT01673490|16416023|P1|Overall Study|Adverse Event|3
4758671|NCT01673490|16416023|P1|Overall Study|Lost to Follow-up|1
4758672|NCT01673386|16416040|P2|Overall Study|Withdrawal by Subject|2
4758673|NCT01673386|16416041|P1|Overall Study|Withdrawal by Subject|0
4758674|NCT01673386|16416040|P2|Overall Study|Progressive disease|1
4758675|NCT01673386|16416041|P1|Overall Study|Progressive disease|4
4758676|NCT01673386|16416040|P2|Overall Study|Adverse Event|2
4758677|NCT01673386|16416041|P1|Overall Study|Adverse Event|5
4758678|NCT01673386|16416040|P2|Overall Study|Study terminated by sponsor|22
4758679|NCT01673386|16416041|P1|Overall Study|Study terminated by sponsor|16
4758680|NCT01673373|16416071|P1|Overall Study|Death|2
4758681|NCT01673347|16416087|P1|Overall Study|failure of allograft|7
4758682|NCT01673282|16416096|P2|Overall Study|Other|6
4758683|NCT01673282|16416097|P1|Overall Study|Other|1
4758684|NCT01673282|16416096|P2|Overall Study|Withdrawal by Subject|3
4758685|NCT01673282|16416097|P1|Overall Study|Withdrawal by Subject|3
4758686|NCT01673282|16416096|P2|Overall Study|Lost to Follow-up|10
4758687|NCT01673282|16416097|P1|Overall Study|Lost to Follow-up|11
4758688|NCT01673282|16416096|P2|Overall Study|Lack of Efficacy|2
4758689|NCT01673282|16416097|P1|Overall Study|Lack of Efficacy|9
4758690|NCT01673282|16416096|P2|Overall Study|Adverse Drug Reaction - Vimpat|5
4758691|NCT01673282|16416097|P1|Overall Study|Adverse Drug Reaction - Vimpat|9
4758692|NCT01673178|16416133|P5|Overall Study|Other|0
4758693|NCT01673178|16416134|P4|Overall Study|Other|1
4758694|NCT01673178|16416135|P3|Overall Study|Other|2
4758695|NCT01673178|16416136|P2|Overall Study|Other|0
4758696|NCT01673178|16416137|P1|Overall Study|Other|1
4758697|NCT01673178|16416133|P5|Overall Study|Adverse Event|0
4758698|NCT01673178|16416134|P4|Overall Study|Adverse Event|2
4758699|NCT01673178|16416135|P3|Overall Study|Adverse Event|0
4758700|NCT01673178|16416136|P2|Overall Study|Adverse Event|0
4758701|NCT01673178|16416137|P1|Overall Study|Adverse Event|1
4758702|NCT01673178|16416133|P5|Overall Study|Protocol Violation|0
4758703|NCT01673178|16416134|P4|Overall Study|Protocol Violation|1
4758704|NCT01673178|16416135|P3|Overall Study|Protocol Violation|0
4758705|NCT01673178|16416136|P2|Overall Study|Protocol Violation|1
4758706|NCT01673178|16416137|P1|Overall Study|Protocol Violation|1
4758707|NCT01673178|16416133|P5|Overall Study|Withdrawal by Subject|2
4758708|NCT01673178|16416134|P4|Overall Study|Withdrawal by Subject|4
4758709|NCT01673178|16416135|P3|Overall Study|Withdrawal by Subject|1
4758710|NCT01673178|16416136|P2|Overall Study|Withdrawal by Subject|0
4758711|NCT01673178|16416137|P1|Overall Study|Withdrawal by Subject|0
4758712|NCT01673178|16416133|P5|Overall Study|Lost to Follow-up|0
4758713|NCT01673178|16416134|P4|Overall Study|Lost to Follow-up|0
4758714|NCT01673178|16416135|P3|Overall Study|Lost to Follow-up|0
4758715|NCT01673178|16416136|P2|Overall Study|Lost to Follow-up|1
4758716|NCT01673178|16416137|P1|Overall Study|Lost to Follow-up|0
4758717|NCT01673126|16416376|P2|Overall Study|change of diagnosis|3
4758718|NCT01673126|16416377|P1|Overall Study|change of diagnosis|4
4758719|NCT01673009|16416416|P1|Overall Study|Withdrawal by Subject|8
4758720|NCT01673009|16416416|P1|Overall Study|Physician Decision|5
4758721|NCT01672970|16416501|P1|Overall Study|Enrolled but not treated|1
4758722|NCT01672970|16416501|P1|Overall Study|Other|9
4758723|NCT01672970|16416501|P1|Overall Study|Lost to Follow-up|5
4758724|NCT01672970|16416501|P1|Overall Study|Withdrawal by Subject|2
4758725|NCT01672970|16416501|P1|Overall Study|Adverse Event|18
4758726|NCT01672970|16416501|P1|Overall Study|Lack of Efficacy|12
4758727|NCT01672957|16416537|P1|Overall Study|ICF Signed After Transplantation|5
4758728|NCT01672957|16416537|P1|Overall Study|Death|2
4758729|NCT01672957|16416537|P1|Overall Study|Protocol Violation|48
4758730|NCT01672892|16416552|P2|Overall Study|Protocol Violation|3
4758731|NCT01672892|16416553|P1|Overall Study|Protocol Violation|7
4758732|NCT01672879|16416582|P3|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
4758733|NCT01672879|16416583|P2|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0
4758734|NCT01672879|16416584|P1|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1
4758735|NCT01672879|16416582|P3|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
4758736|NCT01672879|16416583|P2|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0
4758737|NCT01672879|16416584|P1|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1
4758738|NCT01672879|16416582|P3|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
4758739|NCT01672879|16416583|P2|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1
4758740|NCT01672879|16416584|P1|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5
4758741|NCT01672879|16416582|P3|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6
4758742|NCT01672879|16416583|P2|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16
4758743|NCT01672879|16416584|P1|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8
4758744|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8
4758745|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17
4758746|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15
4758747|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1
4758748|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
4758749|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0
4758750|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Missing|0
4758751|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Missing|0
4758752|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Missing|1
4758753|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Death|0
4758754|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Death|2
4758755|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Death|0
4758756|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2
4758757|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0
4758758|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5
4758759|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1
4758760|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3
4758761|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4
4758762|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Adverse Event|7
4758763|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Adverse Event|2
4758764|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Adverse Event|5
4758765|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6
4758766|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7
4758767|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14
4758768|NCT01672879|16416582|P3|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61
4758769|NCT01672879|16416583|P2|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55
4758770|NCT01672879|16416584|P1|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43
4758771|NCT01672866|16416599|P3|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
4758772|NCT01672866|16416600|P2|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0
4758773|NCT01672866|16416601|P1|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1
4758774|NCT01672866|16416599|P3|Open-Label Phase (up to 240 Weeks)|Death|0
4758775|NCT01672866|16416600|P2|Open-Label Phase (up to 240 Weeks)|Death|0
4758776|NCT01672866|16416601|P1|Open-Label Phase (up to 240 Weeks)|Death|1
4758777|NCT01672866|16416599|P3|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
4758778|NCT01672866|16416600|P2|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0
4758779|NCT01672866|16416601|P1|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1
4758780|NCT01672866|16416599|P3|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
4758781|NCT01672866|16416600|P2|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15
4758782|NCT01672866|16416601|P1|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8
4758783|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16
4758784|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15
4758785|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11
4758786|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
4758787|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0
4758788|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3
4758789|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Death|1
4758790|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Death|0
4758791|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Death|0
4758792|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
4758793|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Protocol Violation|0
4758794|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Protocol Violation|2
4758795|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2
4758796|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
4758797|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3
4758798|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Adverse Event|3
4758799|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Adverse Event|3
4758800|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Adverse Event|3
4758801|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5
4758802|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
4758803|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3
4758804|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12
4758805|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8
4758806|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9
4758807|NCT01672866|16416599|P3|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35
4758808|NCT01672866|16416600|P2|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42
4758809|NCT01672866|16416601|P1|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40
4758810|NCT01672853|16416616|P3|Overall Study|Randomized but Never Treated|1
4758811|NCT01672853|16416617|P2|Overall Study|Randomized but Never Treated|0
4758812|NCT01672853|16416618|P1|Overall Study|Randomized but Never Treated|0
4758813|NCT01672853|16416616|P3|Overall Study|Lost to Follow-up|0
4758814|NCT01672853|16416617|P2|Overall Study|Lost to Follow-up|1
4758815|NCT01672853|16416618|P1|Overall Study|Lost to Follow-up|0
4758816|NCT01672853|16416616|P3|Overall Study|Adverse Event|8
4758817|NCT01672853|16416617|P2|Overall Study|Adverse Event|6
4758818|NCT01672853|16416618|P1|Overall Study|Adverse Event|4
4758819|NCT01672853|16416616|P3|Overall Study|Withdrew Consent|5
4758820|NCT01672853|16416617|P2|Overall Study|Withdrew Consent|5
4758821|NCT01672853|16416618|P1|Overall Study|Withdrew Consent|5
4758822|NCT01672853|16416616|P3|Overall Study|Investigator's Discretion|0
4758823|NCT01672853|16416617|P2|Overall Study|Investigator's Discretion|0
4758824|NCT01672853|16416618|P1|Overall Study|Investigator's Discretion|1
4758825|NCT01672853|16416616|P3|Overall Study|Pregnancy|0
4758826|NCT01672853|16416617|P2|Overall Study|Pregnancy|1
4758827|NCT01672853|16416618|P1|Overall Study|Pregnancy|0
4758828|NCT01672853|16416616|P3|Overall Study|Protocol Specified Criteria for Withdraw|0
4758829|NCT01672853|16416617|P2|Overall Study|Protocol Specified Criteria for Withdraw|4
4758830|NCT01672853|16416618|P1|Overall Study|Protocol Specified Criteria for Withdraw|0
4758831|NCT01672801|16416643|P2|Overall Study|Screen Failure|1
4758832|NCT01672801|16416644|P1|Overall Study|Screen Failure|0
4758833|NCT01672788|16416652|P4|Washout Period 2 (7 Days)|Adverse Event|1
4758834|NCT01672788|16416653|P3|Washout Period 2 (7 Days)|Adverse Event|0
4758835|NCT01672788|16416654|P2|Washout Period 2 (7 Days)|Adverse Event|0
4758836|NCT01672788|16416655|P1|Washout Period 2 (7 Days)|Adverse Event|0
4758837|NCT01672736|16416685|P1|Overall Study|Available drug expired on 31 May 16|3
4758838|NCT01672723|16416689|P2|First Intervention|Adverse Event|0
4758839|NCT01672723|16416690|P1|First Intervention|Adverse Event|3
4758840|NCT01672710|16416702|P2|3 Month Follow up|follow up due after termination date|1
4758841|NCT01672710|16416703|P1|3 Month Follow up|follow up due after termination date|4
4758842|NCT01672710|16416702|P2|3 Month Follow up|Lost to Follow-up|3
4758843|NCT01672710|16416703|P1|3 Month Follow up|Lost to Follow-up|2
4758844|NCT01672710|16416702|P2|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1
4758845|NCT01672710|16416703|P1|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0
4758846|NCT01672294|16416738|P4|Overall Study|Lost to Follow-up|9
4758847|NCT01672294|16416739|P3|Overall Study|Lost to Follow-up|7
4758848|NCT01672294|16416740|P2|Overall Study|Lost to Follow-up|16
4758849|NCT01672294|16416741|P1|Overall Study|Lost to Follow-up|1
4758850|NCT01672294|16416738|P4|Overall Study|Excluded by study|0
4758851|NCT01672294|16416739|P3|Overall Study|Excluded by study|0
4758852|NCT01672294|16416740|P2|Overall Study|Excluded by study|1
4758853|NCT01672294|16416741|P1|Overall Study|Excluded by study|1
4758854|NCT01672294|16416738|P4|Overall Study|Withdrawal by Subject|4
4758855|NCT01672294|16416739|P3|Overall Study|Withdrawal by Subject|4
4758856|NCT01672294|16416740|P2|Overall Study|Withdrawal by Subject|4
4758857|NCT01672294|16416741|P1|Overall Study|Withdrawal by Subject|4
4758858|NCT01671748|16416786|P2|4 Week run-in Phase|Not eligible|0
4758859|NCT01671748|16416787|P1|4 Week run-in Phase|Not eligible|9
4758860|NCT01671748|16416786|P2|4 Week run-in Phase|Adverse Event|0
4758861|NCT01671748|16416787|P1|4 Week run-in Phase|Adverse Event|1
4758862|NCT01671748|16416786|P2|4 Week run-in Phase|Withdrawal by Subject|0
4758863|NCT01671748|16416787|P1|4 Week run-in Phase|Withdrawal by Subject|1
4758864|NCT01671488|16416814|P1|Overall Study|Withdrawal by Subject|1
4758865|NCT01671345|16416822|P2|Overall Study|visit with non-participating physician|3
4758866|NCT01671345|16416823|P1|Overall Study|visit with non-participating physician|3
4758867|NCT01671345|16416822|P2|Overall Study|Lost to Follow-up|6
4758868|NCT01671345|16416823|P1|Overall Study|Lost to Follow-up|10
4758869|NCT01671332|16416837|P2|Overall Study|Withdrawal by Subject|1
4758870|NCT01671332|16416838|P1|Overall Study|Withdrawal by Subject|1
4758871|NCT01671319|16416852|P1|Overall Study|Withdrawal by Subject|1
4758872|NCT01671280|16416867|P1|Overall Study|Withdrawal by Subject|2
4758873|NCT01671111|16416878|P1|Overall Study|Other|24
4758874|NCT01671111|16416878|P1|Overall Study|Physician Decision|1
4758875|NCT01671111|16416878|P1|Overall Study|Withdrawal by Subject|2
4758876|NCT01671111|16416878|P1|Overall Study|Lack of Efficacy|1
4758877|NCT01671111|16416878|P1|Overall Study|Adverse Event|2
4758878|NCT01671085|16416890|P2|Overall Study|Withdrawal by Subject|0
4758879|NCT01671085|16416891|P1|Overall Study|Withdrawal by Subject|1
4758880|NCT01671059|16416902|P1|Overall Study|Lack of Efficacy|1
4758881|NCT01671059|16416902|P1|Overall Study|Adverse Event|4
4758882|NCT01670721|16416998|P1|Overall Study|Other than specified above|38
4758883|NCT01670721|16416998|P1|Overall Study|Participant's decision|15
4758884|NCT01670656|16417010|P5|Overall Study|Subject moved|0
4758885|NCT01670656|16417011|P4|Overall Study|Subject moved|1
4758886|NCT01670656|16417012|P3|Overall Study|Subject moved|0
4758887|NCT01670656|16417013|P2|Overall Study|Subject moved|0
4758888|NCT01670656|16417014|P1|Overall Study|Subject moved|0
4758889|NCT01670656|16417010|P5|Overall Study|Lost to Follow-up|3
4758890|NCT01670656|16417011|P4|Overall Study|Lost to Follow-up|0
4758891|NCT01670656|16417012|P3|Overall Study|Lost to Follow-up|0
4758892|NCT01670656|16417013|P2|Overall Study|Lost to Follow-up|0
4758893|NCT01670656|16417014|P1|Overall Study|Lost to Follow-up|0
4758894|NCT01670656|16417010|P5|Overall Study|Subject withdrew consent|1
4758895|NCT01670656|16417011|P4|Overall Study|Subject withdrew consent|1
4758896|NCT01670656|16417012|P3|Overall Study|Subject withdrew consent|2
4758897|NCT01670656|16417013|P2|Overall Study|Subject withdrew consent|1
4758898|NCT01670656|16417014|P1|Overall Study|Subject withdrew consent|0
4758899|NCT01670656|16417010|P5|Overall Study|Adverse Event|3
4758900|NCT01670656|16417011|P4|Overall Study|Adverse Event|3
4758901|NCT01670656|16417012|P3|Overall Study|Adverse Event|2
4758902|NCT01670656|16417013|P2|Overall Study|Adverse Event|2
4758903|NCT01670656|16417014|P1|Overall Study|Adverse Event|2
4758904|NCT01670656|16417010|P5|Overall Study|Non-compliance with protocol|2
4758905|NCT01670656|16417011|P4|Overall Study|Non-compliance with protocol|1
4758906|NCT01670656|16417012|P3|Overall Study|Non-compliance with protocol|1
4758907|NCT01670656|16417013|P2|Overall Study|Non-compliance with protocol|3
4758908|NCT01670656|16417014|P1|Overall Study|Non-compliance with protocol|0
4758909|NCT01670656|16417010|P5|Overall Study|Withdrawal by Subject|0
4758910|NCT01670656|16417011|P4|Overall Study|Withdrawal by Subject|0
4758911|NCT01670656|16417012|P3|Overall Study|Withdrawal by Subject|0
4758912|NCT01670656|16417013|P2|Overall Study|Withdrawal by Subject|1
4758913|NCT01670656|16417014|P1|Overall Study|Withdrawal by Subject|1
4758914|NCT01670656|16417010|P5|Overall Study|Pregnancy|1
4758915|NCT01670656|16417011|P4|Overall Study|Pregnancy|0
4758916|NCT01670656|16417012|P3|Overall Study|Pregnancy|0
4758917|NCT01670656|16417013|P2|Overall Study|Pregnancy|0
4758918|NCT01670656|16417014|P1|Overall Study|Pregnancy|0
4758919|NCT01670656|16417010|P5|Overall Study|Non-compliance with study drug|1
4758920|NCT01670656|16417011|P4|Overall Study|Non-compliance with study drug|0
4758921|NCT01670656|16417012|P3|Overall Study|Non-compliance with study drug|3
4758922|NCT01670656|16417013|P2|Overall Study|Non-compliance with study drug|0
4758923|NCT01670656|16417014|P1|Overall Study|Non-compliance with study drug|0
4758924|NCT01670526|16417043|P2|Overall Study|Lost to Follow-up|5
4758925|NCT01670526|16417044|P1|Overall Study|Lost to Follow-up|9
4758926|NCT01670526|16417043|P2|Overall Study|Withdrawal by Subject|1
4758927|NCT01670526|16417044|P1|Overall Study|Withdrawal by Subject|3
4758928|NCT01670500|16417058|P2|Overall Study|Withdrawal by Subject|0
4758929|NCT01670500|16417059|P1|Overall Study|Withdrawal by Subject|1
4758930|NCT01670292|16417082|P1|Overall Study|Lost to Follow-up|14
4758931|NCT01670279|16417123|P4|Overall Study|Participant met withdrawal criteria|1
4758932|NCT01670279|16417124|P3|Overall Study|Participant met withdrawal criteria|0
4758933|NCT01670279|16417125|P2|Overall Study|Participant met withdrawal criteria|0
4758934|NCT01670279|16417126|P1|Overall Study|Participant met withdrawal criteria|0
4758935|NCT01670279|16417123|P4|Overall Study|Physician Decision|0
4758936|NCT01670279|16417124|P3|Overall Study|Physician Decision|0
4758937|NCT01670279|16417125|P2|Overall Study|Physician Decision|1
4758938|NCT01670279|16417126|P1|Overall Study|Physician Decision|0
4758939|NCT01670279|16417123|P4|Overall Study|Adverse Event|0
4758940|NCT01670279|16417124|P3|Overall Study|Adverse Event|0
4758941|NCT01670279|16417125|P2|Overall Study|Adverse Event|1
4758942|NCT01670279|16417126|P1|Overall Study|Adverse Event|0
4758943|NCT01670188|16417168|P2|Overall Study|Death|1
4758944|NCT01670188|16417169|P1|Overall Study|Death|0
4758945|NCT01670045|16417198|P1|Overall Study|Lost to Follow-up|11
4758946|NCT01670045|16417198|P1|Overall Study|Death|1
4758947|NCT01670045|16417198|P1|Overall Study|Adverse Event|1
4758948|NCT01670045|16417198|P1|Overall Study|Withdrawal by Subject|3
4758949|NCT01670019|16417216|P2|Overall Study|Withdrawal by Subject|0
4758950|NCT01670019|16417217|P1|Overall Study|Withdrawal by Subject|6
4758951|NCT01670019|16417216|P2|Overall Study|Adverse Event|0
4758952|NCT01670019|16417217|P1|Overall Study|Adverse Event|3
4758953|NCT01669902|16417231|P1|Overall Study|Other|8
4758954|NCT01669902|16417231|P1|Overall Study|Lack of Efficacy|10
4758955|NCT01669902|16417231|P1|Overall Study|Adverse Event|11
4758956|NCT01669811|16417266|P2|Overall Study|Eligibility Criteria Not Fulfilled|2
4758957|NCT01669811|16417267|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
4758958|NCT01669811|16417266|P2|Overall Study|Adverse Event|6
4758959|NCT01669811|16417267|P1|Overall Study|Adverse Event|2
4758960|NCT01669811|16417266|P2|Overall Study|Withdrawal by Subject|2
4758961|NCT01669811|16417267|P1|Overall Study|Withdrawal by Subject|1
4758962|NCT01669811|16417266|P2|Overall Study|Investigator decision|1
4758963|NCT01669811|16417267|P1|Overall Study|Investigator decision|0
4758964|NCT01669798|16417285|P1|Overall Study|Physician Decision|5
4758965|NCT01669629|16417391|P2|Period 1|protocol deviation|2
4758966|NCT01669629|16417392|P1|Period 1|protocol deviation|1
4758967|NCT01669577|16417415|P1|Overall Study|Physician Decision|34
4758968|NCT01669577|16417415|P1|Overall Study|Lost to Follow-up|78
4758969|NCT01669577|16417415|P1|Overall Study|Death|22
4758970|NCT01669421|16417453|P1|Phase 1: Standard Dose Therapy|Physician Decision|1
4758971|NCT01669421|16417453|P1|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1
4758972|NCT01669174|16417472|P2|Overall Study|Administrative problems|2
4758973|NCT01669174|16417473|P1|Overall Study|Administrative problems|1
4758974|NCT01669174|16417472|P2|Overall Study|Adverse Event|2
4758975|NCT01669174|16417473|P1|Overall Study|Adverse Event|2
4758976|NCT01669174|16417472|P2|Overall Study|Lost to Follow-up|0
4758977|NCT01669174|16417473|P1|Overall Study|Lost to Follow-up|1
4758978|NCT01669174|16417472|P2|Overall Study|Subject withdrew consent|2
4758979|NCT01669174|16417473|P1|Overall Study|Subject withdrew consent|2
4758980|NCT01669122|16417489|P1|Washout Period II|Protocol Violation|2
4758981|NCT01669122|16417489|P1|Period I|Lost to Follow-up|1
4758982|NCT01668966|16417556|P1|Overall Study|Not treated|2
4758983|NCT01668966|16417556|P1|Overall Study|Death|1
4758984|NCT01668966|16417556|P1|Overall Study|Withdrawal by Subject|1
4758985|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38
4758986|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49
4758987|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
4758988|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0
4758989|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2
4758990|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4
4758991|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
4758992|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0
4758993|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30
4758994|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11
4758995|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
4758996|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0
4758997|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10
4758998|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2
4758999|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
4759000|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0
4759001|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
4759002|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2
4759003|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
4759004|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0
4759005|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5
4759006|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3
4759007|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
4759008|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0
4759009|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2
4759010|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5
4759011|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
4759012|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0
4759013|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
4759014|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3
4759015|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
4759016|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0
4759017|NCT01668797|16417652|P4|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6
4759018|NCT01668797|16417653|P3|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4
4759019|NCT01668797|16417654|P2|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
4759020|NCT01668797|16417655|P1|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0
4759021|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
4759022|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
4759023|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86
4759024|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0
4759025|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
4759026|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
4759027|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43
4759028|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0
4759029|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Lack of Efficacy|0
4759030|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Lack of Efficacy|0
4759031|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Lack of Efficacy|21
4759032|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Lack of Efficacy|0
4759033|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Protocol Violation|0
4759034|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Protocol Violation|0
4759035|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Protocol Violation|3
4759036|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Protocol Violation|0
4759037|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Withdrawal by Subject|0
4759038|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Withdrawal by Subject|0
4759039|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Withdrawal by Subject|60
4759040|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Withdrawal by Subject|0
4759041|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Physician Decision|0
4759042|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Physician Decision|0
4759043|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Physician Decision|11
4759044|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Physician Decision|0
4759045|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
4759046|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
4759047|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22
4759048|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0
4759049|NCT01668797|16417652|P4|Phase B (Stabilization Phase)|Lost to Follow-up|0
4759050|NCT01668797|16417653|P3|Phase B (Stabilization Phase)|Lost to Follow-up|0
4759051|NCT01668797|16417654|P2|Phase B (Stabilization Phase)|Lost to Follow-up|16
4759052|NCT01668797|16417655|P1|Phase B (Stabilization Phase)|Lost to Follow-up|0
4759053|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
4759054|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
4759055|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0
4759056|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19
4759057|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
4759058|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
4759059|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0
4759060|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8
4759061|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Lack of Efficacy|0
4759062|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Lack of Efficacy|0
4759063|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Lack of Efficacy|0
4759064|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Lack of Efficacy|7
4759065|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Protocol Violation|0
4759066|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Protocol Violation|0
4759067|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Protocol Violation|0
4759068|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Protocol Violation|2
4759069|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Withdrawal by Subject|0
4759070|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Withdrawal by Subject|0
4759071|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Withdrawal by Subject|0
4759072|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Withdrawal by Subject|16
4759073|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Physician Decision|0
4759074|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Physician Decision|0
4759075|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Physician Decision|0
4759076|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Physician Decision|2
4759077|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
4759078|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
4759079|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Met Withdrawal Criteria|0
4759080|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Met Withdrawal Criteria|3
4759081|NCT01668797|16417652|P4|Phase A (Conversion Phase)|Lost to Follow-up|0
4759082|NCT01668797|16417653|P3|Phase A (Conversion Phase)|Lost to Follow-up|0
4759083|NCT01668797|16417654|P2|Phase A (Conversion Phase)|Lost to Follow-up|0
4759084|NCT01668797|16417655|P1|Phase A (Conversion Phase)|Lost to Follow-up|3
4759085|NCT01668784|16417720|P2|Treated (Overall)|Other|4
4759086|NCT01668784|16417721|P1|Treated (Overall)|Other|0
4759087|NCT01668784|16417720|P2|Treated (Overall)|Maximal Clinical Benefit|3
4759088|NCT01668784|16417721|P1|Treated (Overall)|Maximal Clinical Benefit|2
4759089|NCT01668784|16417720|P2|Treated (Overall)|Withdrawal by Subject|3
4759090|NCT01668784|16417721|P1|Treated (Overall)|Withdrawal by Subject|2
4759091|NCT01668784|16417720|P2|Treated (Overall)|Request to Discontinue Study Treatment|18
4759092|NCT01668784|16417721|P1|Treated (Overall)|Request to Discontinue Study Treatment|5
4759093|NCT01668784|16417720|P2|Treated (Overall)|Adverse Event Unrelated to Study Drug|14
4759094|NCT01668784|16417721|P1|Treated (Overall)|Adverse Event Unrelated to Study Drug|9
4759095|NCT01668784|16417720|P2|Treated (Overall)|Death|1
4759096|NCT01668784|16417721|P1|Treated (Overall)|Death|1
4759097|NCT01668784|16417720|P2|Treated (Overall)|Study Drug Toxicity|53
4759098|NCT01668784|16417721|P1|Treated (Overall)|Study Drug Toxicity|35
4759099|NCT01668784|16417720|P2|Treated (Overall)|Disease Progression|273
4759100|NCT01668784|16417721|P1|Treated (Overall)|Disease Progression|285
4759101|NCT01668784|16417720|P2|Randomized (Pre-treatment)|Other|1
4759102|NCT01668784|16417721|P1|Randomized (Pre-treatment)|Other|0
4759103|NCT01668784|16417720|P2|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1
4759104|NCT01668784|16417721|P1|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2
4759105|NCT01668784|16417720|P2|Randomized (Pre-treatment)|Poor/Non-Compliance|0
4759106|NCT01668784|16417721|P1|Randomized (Pre-treatment)|Poor/Non-Compliance|1
4759107|NCT01668784|16417720|P2|Randomized (Pre-treatment)|Withdrawal by Subject|8
4759108|NCT01668784|16417721|P1|Randomized (Pre-treatment)|Withdrawal by Subject|1
4759109|NCT01668784|16417720|P2|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3
4759110|NCT01668784|16417721|P1|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0
4759111|NCT01668784|16417720|P2|Randomized (Pre-treatment)|Disease Progression|1
4759112|NCT01668784|16417721|P1|Randomized (Pre-treatment)|Disease Progression|0
4759113|NCT01668667|16417749|P4|Overall Study|Withdrawal by Subject|5
4759114|NCT01668667|16417750|P3|Overall Study|Withdrawal by Subject|5
4759115|NCT01668667|16417751|P2|Overall Study|Withdrawal by Subject|4
4759116|NCT01668667|16417752|P1|Overall Study|Withdrawal by Subject|7
4759117|NCT01668667|16417749|P4|Overall Study|Physician Decision|0
4759118|NCT01668667|16417750|P3|Overall Study|Physician Decision|1
4759119|NCT01668667|16417751|P2|Overall Study|Physician Decision|0
4759120|NCT01668667|16417752|P1|Overall Study|Physician Decision|3
4759121|NCT01668667|16417749|P4|Overall Study|Lost to Follow-up|6
4759122|NCT01668667|16417750|P3|Overall Study|Lost to Follow-up|7
4759123|NCT01668667|16417751|P2|Overall Study|Lost to Follow-up|4
4759124|NCT01668667|16417752|P1|Overall Study|Lost to Follow-up|9
4759125|NCT01668667|16417749|P4|Overall Study|Protocol Violation|5
4759126|NCT01668667|16417750|P3|Overall Study|Protocol Violation|12
4759127|NCT01668667|16417751|P2|Overall Study|Protocol Violation|10
4759128|NCT01668667|16417752|P1|Overall Study|Protocol Violation|6
4759129|NCT01668667|16417749|P4|Overall Study|Lack of Efficacy|3
4759130|NCT01668667|16417750|P3|Overall Study|Lack of Efficacy|2
4759131|NCT01668667|16417751|P2|Overall Study|Lack of Efficacy|2
4759132|NCT01668667|16417752|P1|Overall Study|Lack of Efficacy|3
4759133|NCT01668667|16417749|P4|Overall Study|Adverse Event|4
4759134|NCT01668667|16417750|P3|Overall Study|Adverse Event|4
4759135|NCT01668667|16417751|P2|Overall Study|Adverse Event|6
4759136|NCT01668667|16417752|P1|Overall Study|Adverse Event|3
4759137|NCT01668589|16417795|P4|Overall Study|Other|15
4759138|NCT01668589|16417796|P3|Overall Study|Other|7
4759139|NCT01668589|16417797|P2|Overall Study|Other|10
4759140|NCT01668589|16417798|P1|Overall Study|Other|44
4759141|NCT01668589|16417795|P4|Overall Study|Death|11
4759142|NCT01668589|16417796|P3|Overall Study|Death|2
4759143|NCT01668589|16417797|P2|Overall Study|Death|3
4759144|NCT01668589|16417798|P1|Overall Study|Death|12
4759145|NCT01668589|16417795|P4|Overall Study|Full Consent/Agreement Withdrawn|4
4759146|NCT01668589|16417796|P3|Overall Study|Full Consent/Agreement Withdrawn|11
4759147|NCT01668589|16417797|P2|Overall Study|Full Consent/Agreement Withdrawn|8
4759148|NCT01668589|16417798|P1|Overall Study|Full Consent/Agreement Withdrawn|54
4759149|NCT01668589|16417795|P4|Overall Study|Lost to Follow-up|5
4759150|NCT01668589|16417796|P3|Overall Study|Lost to Follow-up|15
4759151|NCT01668589|16417797|P2|Overall Study|Lost to Follow-up|37
4759152|NCT01668589|16417798|P1|Overall Study|Lost to Follow-up|29
4759153|NCT01668537|16417838|P2|Overall Study|Other|3
4759154|NCT01668537|16417839|P1|Overall Study|Other|2
4759155|NCT01668537|16417838|P2|Overall Study|Lost to Follow-up|6
4759156|NCT01668537|16417839|P1|Overall Study|Lost to Follow-up|13
4759157|NCT01668537|16417838|P2|Overall Study|Reason Precludes Participation|0
4759158|NCT01668537|16417839|P1|Overall Study|Reason Precludes Participation|1
4759159|NCT01668537|16417838|P2|Overall Study|Subject unwilling/unable to comply|0
4759160|NCT01668537|16417839|P1|Overall Study|Subject unwilling/unable to comply|5
4759161|NCT01668537|16417838|P2|Overall Study|Request to Discontinue Prematurely|1
4759162|NCT01668537|16417839|P1|Overall Study|Request to Discontinue Prematurely|1
4759163|NCT01668355|16417881|P2|Overall Study|Withdrawal by Subject|1
4759164|NCT01668355|16417882|P1|Overall Study|Withdrawal by Subject|6
4759165|NCT01668355|16417881|P2|Overall Study|Death|1
4759166|NCT01668355|16417882|P1|Overall Study|Death|3
4759167|NCT01668173|16417902|P1|Overall Study|Trial suspension|4
4759168|NCT01668173|16417902|P1|Overall Study|Adverse Event|3
4759169|NCT01668147|16417906|P1|Overall Study|Withdrawal by Subject|6
4759170|NCT01668004|16418036|P1|Overall Study|Non-compliance with treatment|2
4759171|NCT01668004|16418036|P1|Overall Study|Lack of Efficacy|9
4759172|NCT01668004|16418036|P1|Overall Study|Lost to Follow-up|5
4759173|NCT01668004|16418036|P1|Overall Study|Withdrawal by Subject|2
4759174|NCT01668004|16418036|P1|Overall Study|Adverse Event|7
4759175|NCT01667926|16418058|P3|Overall Study|Side effects|0
4759176|NCT01667926|16418059|P2|Overall Study|Side effects|0
4759177|NCT01667926|16418060|P1|Overall Study|Side effects|3
4759178|NCT01667926|16418058|P3|Overall Study|Lost to Follow-up|1
4759179|NCT01667926|16418059|P2|Overall Study|Lost to Follow-up|2
4759180|NCT01667926|16418060|P1|Overall Study|Lost to Follow-up|1
4759181|NCT01667926|16418058|P3|Overall Study|Inclusion/Exclusion Criteria|5
4759182|NCT01667926|16418059|P2|Overall Study|Inclusion/Exclusion Criteria|0
4759183|NCT01667926|16418060|P1|Overall Study|Inclusion/Exclusion Criteria|0
4759184|NCT01667926|16418058|P3|Overall Study|Time committment|2
4759185|NCT01667926|16418059|P2|Overall Study|Time committment|0
4759186|NCT01667926|16418060|P1|Overall Study|Time committment|0
4759187|NCT01667926|16418058|P3|Overall Study|Physician Decision|1
4759188|NCT01667926|16418059|P2|Overall Study|Physician Decision|0
4759189|NCT01667926|16418060|P1|Overall Study|Physician Decision|0
4759190|NCT01667926|16418058|P3|Overall Study|Withdrawal by Subject|2
4759191|NCT01667926|16418059|P2|Overall Study|Withdrawal by Subject|2
4759192|NCT01667926|16418060|P1|Overall Study|Withdrawal by Subject|1
4759193|NCT01667900|16418073|P20|Part B|Death|0
4759194|NCT01667900|16418074|P19|Part B|Death|0
4759195|NCT01667900|16418075|P18|Part B|Death|0
4759196|NCT01667900|16418076|P17|Part B|Death|1
4759197|NCT01667900|16418077|P16|Part B|Death|0
4759198|NCT01667900|16418078|P15|Part B|Death|0
4759199|NCT01667900|16418079|P14|Part B|Death|0
4759200|NCT01667900|16418080|P13|Part B|Death|0
4759201|NCT01667900|16418081|P12|Part B|Death|0
4759202|NCT01667900|16418082|P11|Part B|Death|0
4759203|NCT01667900|16418083|P10|Part B|Death|0
4759204|NCT01667900|16418084|P9|Part B|Death|0
4759205|NCT01667900|16418085|P8|Part B|Death|0
4759206|NCT01667900|16418086|P7|Part B|Death|0
4759207|NCT01667900|16418087|P6|Part B|Death|0
4759208|NCT01667900|16418088|P5|Part B|Death|0
4759209|NCT01667900|16418089|P4|Part B|Death|0
4759210|NCT01667900|16418090|P3|Part B|Death|0
4759211|NCT01667900|16418091|P2|Part B|Death|0
4759212|NCT01667900|16418092|P1|Part B|Death|0
4759213|NCT01667731|16418162|P5|Overall Study|Death|0
4759214|NCT01667731|16418163|P4|Overall Study|Death|0
4759215|NCT01667731|16418164|P3|Overall Study|Death|0
4759216|NCT01667731|16418165|P2|Overall Study|Death|1
4759217|NCT01667731|16418166|P1|Overall Study|Death|0
4759218|NCT01667731|16418162|P5|Overall Study|Subject Withdrew Consent|1
4759219|NCT01667731|16418163|P4|Overall Study|Subject Withdrew Consent|0
4759220|NCT01667731|16418164|P3|Overall Study|Subject Withdrew Consent|1
4759221|NCT01667731|16418165|P2|Overall Study|Subject Withdrew Consent|0
4759222|NCT01667731|16418166|P1|Overall Study|Subject Withdrew Consent|2
4759223|NCT01667731|16418162|P5|Overall Study|Lost to Follow-up|2
4759224|NCT01667731|16418163|P4|Overall Study|Lost to Follow-up|1
4759225|NCT01667731|16418164|P3|Overall Study|Lost to Follow-up|1
4759226|NCT01667731|16418165|P2|Overall Study|Lost to Follow-up|3
4759227|NCT01667731|16418166|P1|Overall Study|Lost to Follow-up|2
4759228|NCT01667731|16418162|P5|Overall Study|Efficacy Failure|24
4759229|NCT01667731|16418163|P4|Overall Study|Efficacy Failure|1
4759230|NCT01667731|16418164|P3|Overall Study|Efficacy Failure|0
4759231|NCT01667731|16418165|P2|Overall Study|Efficacy Failure|12
4759232|NCT01667731|16418166|P1|Overall Study|Efficacy Failure|1
4759233|NCT01667731|16418162|P5|Overall Study|Enrolled but not treated|1
4759234|NCT01667731|16418163|P4|Overall Study|Enrolled but not treated|0
4759235|NCT01667731|16418164|P3|Overall Study|Enrolled but not treated|0
4759236|NCT01667731|16418165|P2|Overall Study|Enrolled but not treated|0
4759237|NCT01667731|16418166|P1|Overall Study|Enrolled but not treated|0
4759238|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1
4759239|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0
4759240|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1
4759241|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0
4759242|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1
4759243|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0
4759244|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1
4759245|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0
4759246|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Adverse Event|0
4759247|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Adverse Event|1
4759248|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0
4759249|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1
4759250|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0
4759251|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1
4759252|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance|4
4759253|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance|3
4759254|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10
4759255|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8
4759256|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0
4759257|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2
4759258|NCT01667679|16418221|P2|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4
4759259|NCT01667679|16418222|P1|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6
4759260|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1
4759261|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0
4759262|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Non-compliance|3
4759263|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Non-compliance|0
4759264|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2
4759265|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0
4759266|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2
4759267|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0
4759268|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
4759269|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Adverse Event|3
4759270|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13
4759271|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6
4759272|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0
4759273|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1
4759274|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0
4759275|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2
4759276|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0
4759277|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2
4759278|NCT01667679|16418221|P2|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6
4759279|NCT01667679|16418222|P1|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2
4759280|NCT01667562|16418280|P2|Erlotinib Phase|Switch to Commercial Drug|1
4759281|NCT01667562|16418281|P1|Erlotinib Phase|Switch to Commercial Drug|0
4759282|NCT01667562|16418280|P2|Erlotinib Phase|Adverse Event|1
4759283|NCT01667562|16418281|P1|Erlotinib Phase|Adverse Event|0
4759284|NCT01667562|16418280|P2|Erlotinib Phase|Lost to Follow-up|1
4759285|NCT01667562|16418281|P1|Erlotinib Phase|Lost to Follow-up|0
4759286|NCT01667562|16418280|P2|Diagnostic Phase|Started Erlotinib in Treatment Period|0
4759287|NCT01667562|16418281|P1|Diagnostic Phase|Started Erlotinib in Treatment Period|30
4759288|NCT01667549|16418295|P5|Overall Study|Withdrawal by Subject|1
4759289|NCT01667549|16418296|P4|Overall Study|Withdrawal by Subject|6
4759290|NCT01667549|16418297|P3|Overall Study|Withdrawal by Subject|7
4759291|NCT01667549|16418298|P2|Overall Study|Withdrawal by Subject|5
4759292|NCT01667549|16418299|P1|Overall Study|Withdrawal by Subject|3
4759293|NCT01667432|16418358|P1|Overall Study|Missing Information|4
4759294|NCT01667432|16418358|P1|Overall Study|Reason Not Specified|2
4759295|NCT01667432|16418358|P1|Overall Study|Principal Investigator Decision|1
4759296|NCT01667432|16418358|P1|Overall Study|Protocol Deviation|2
4759297|NCT01667432|16418358|P1|Overall Study|Adverse Event|1
4759298|NCT01667432|16418358|P1|Overall Study|Insufficient Therapeutic Response|4
4759299|NCT01667432|16418358|P1|Overall Study|Refused Treatment/Withdrew Consent|1
4759300|NCT01667432|16418358|P1|Overall Study|Lost to Follow-up|3
4759301|NCT01667432|16418358|P1|Overall Study|Moved to Another Center|3
4759302|NCT01667432|16418358|P1|Overall Study|Failure to Return|10
4759303|NCT01667432|16418358|P1|Overall Study|Premature Study Termination|26
4759304|NCT01667419|16418367|P4|Overall Study|Death|26
4759305|NCT01667419|16418368|P3|Overall Study|Death|25
4759306|NCT01667419|16418369|P2|Overall Study|Death|33
4759307|NCT01667419|16418370|P1|Overall Study|Death|18
4759308|NCT01667419|16418367|P4|Overall Study|Lost to Follow-up|4
4759309|NCT01667419|16418368|P3|Overall Study|Lost to Follow-up|2
4759310|NCT01667419|16418369|P2|Overall Study|Lost to Follow-up|6
4759311|NCT01667419|16418370|P1|Overall Study|Lost to Follow-up|7
4759312|NCT01667419|16418367|P4|Overall Study|Protocol Violation|0
4759313|NCT01667419|16418368|P3|Overall Study|Protocol Violation|0
4759314|NCT01667419|16418369|P2|Overall Study|Protocol Violation|0
4759315|NCT01667419|16418370|P1|Overall Study|Protocol Violation|1
4759316|NCT01667419|16418367|P4|Overall Study|Non-compliance|1
4759317|NCT01667419|16418368|P3|Overall Study|Non-compliance|0
4759318|NCT01667419|16418369|P2|Overall Study|Non-compliance|0
4759319|NCT01667419|16418370|P1|Overall Study|Non-compliance|0
4759320|NCT01667419|16418367|P4|Overall Study|Withdrawal by Subject|8
4759321|NCT01667419|16418368|P3|Overall Study|Withdrawal by Subject|9
4759322|NCT01667419|16418369|P2|Overall Study|Withdrawal by Subject|8
4759323|NCT01667419|16418370|P1|Overall Study|Withdrawal by Subject|16
4759324|NCT01667419|16418367|P4|Overall Study|Reason Not Specified|0
4759325|NCT01667419|16418368|P3|Overall Study|Reason Not Specified|0
4759326|NCT01667419|16418369|P2|Overall Study|Reason Not Specified|0
4759327|NCT01667419|16418370|P1|Overall Study|Reason Not Specified|1
4759328|NCT01667224|16418418|P2|Overall Study|Protocol Violation|1
4759329|NCT01667224|16418419|P1|Overall Study|Protocol Violation|1
4759330|NCT01667224|16418418|P2|Overall Study|Withdrawal by Subject|1
4759331|NCT01667224|16418419|P1|Overall Study|Withdrawal by Subject|3
4759332|NCT01667107|16418433|P2|Overall Study|Lack of Efficacy|1
4759333|NCT01667107|16418434|P1|Overall Study|Lack of Efficacy|0
4759334|NCT01667107|16418433|P2|Overall Study|Protocol Violation|1
4759335|NCT01667107|16418434|P1|Overall Study|Protocol Violation|0
4759336|NCT01667107|16418433|P2|Overall Study|Tolerability issues|2
4759337|NCT01667107|16418434|P1|Overall Study|Tolerability issues|0
4759338|NCT01667107|16418433|P2|Overall Study|Adverse Event|3
4759339|NCT01667107|16418434|P1|Overall Study|Adverse Event|4
4759340|NCT01666951|16418493|P2|Overall Study|Not dosed|1
4759341|NCT01666951|16418494|P1|Overall Study|Not dosed|1
4759342|NCT01666782|16418545|P2|Overall Study|Enrolled both years; year 1 data used|0
4759343|NCT01666782|16418546|P1|Overall Study|Enrolled both years; year 1 data used|4
4759344|NCT01666782|16418545|P2|Overall Study|Received 2 doses of vaccine|1
4759345|NCT01666782|16418546|P1|Overall Study|Received 2 doses of vaccine|0
4759346|NCT01666652|16418567|P5|Overall Study|Lost to Follow-up|0
4759347|NCT01666652|16418568|P4|Overall Study|Lost to Follow-up|1
4759348|NCT01666652|16418569|P3|Overall Study|Lost to Follow-up|1
4759349|NCT01666652|16418570|P2|Overall Study|Lost to Follow-up|1
4759350|NCT01666652|16418571|P1|Overall Study|Lost to Follow-up|1
4759351|NCT01666652|16418567|P5|Overall Study|Moved from study area|0
4759352|NCT01666652|16418568|P4|Overall Study|Moved from study area|2
4759353|NCT01666652|16418569|P3|Overall Study|Moved from study area|0
4759354|NCT01666652|16418570|P2|Overall Study|Moved from study area|0
4759355|NCT01666652|16418571|P1|Overall Study|Moved from study area|1
4759356|NCT01666652|16418567|P5|Overall Study|Withdrawal by Subject|1
4759357|NCT01666652|16418568|P4|Overall Study|Withdrawal by Subject|0
4759358|NCT01666652|16418569|P3|Overall Study|Withdrawal by Subject|0
4759359|NCT01666652|16418570|P2|Overall Study|Withdrawal by Subject|0
4759360|NCT01666652|16418571|P1|Overall Study|Withdrawal by Subject|0
4759361|NCT01666652|16418567|P5|Overall Study|Serious Adverse Event|0
4759362|NCT01666652|16418568|P4|Overall Study|Serious Adverse Event|1
4759363|NCT01666652|16418569|P3|Overall Study|Serious Adverse Event|0
4759364|NCT01666652|16418570|P2|Overall Study|Serious Adverse Event|0
4759365|NCT01666652|16418571|P1|Overall Study|Serious Adverse Event|0
4759366|NCT01666444|16418620|P2|Overall Study|Did not initiate treatment|1
4759367|NCT01666444|16418621|P1|Overall Study|Did not initiate treatment|2
4759368|NCT01666314|16418639|P4|Overall Study|Reason not Specified|5
4759369|NCT01666314|16418640|P3|Overall Study|Reason not Specified|5
4759370|NCT01666314|16418641|P2|Overall Study|Reason not Specified|7
4759371|NCT01666314|16418642|P1|Overall Study|Reason not Specified|10
4759372|NCT01666314|16418639|P4|Overall Study|Withdrawal by Subject|3
4759373|NCT01666314|16418640|P3|Overall Study|Withdrawal by Subject|2
4759374|NCT01666314|16418641|P2|Overall Study|Withdrawal by Subject|1
4759375|NCT01666314|16418642|P1|Overall Study|Withdrawal by Subject|1
4759376|NCT01666314|16418639|P4|Overall Study|Unsatisfactory Therapeutic Response|1
4759377|NCT01666314|16418640|P3|Overall Study|Unsatisfactory Therapeutic Response|1
4759378|NCT01666314|16418641|P2|Overall Study|Unsatisfactory Therapeutic Response|2
4759379|NCT01666314|16418642|P1|Overall Study|Unsatisfactory Therapeutic Response|7
4759380|NCT01666314|16418639|P4|Overall Study|Symptomatic Deterioration|0
4759381|NCT01666314|16418640|P3|Overall Study|Symptomatic Deterioration|2
4759382|NCT01666314|16418641|P2|Overall Study|Symptomatic Deterioration|0
4759383|NCT01666314|16418642|P1|Overall Study|Symptomatic Deterioration|1
4759384|NCT01666314|16418639|P4|Overall Study|Progressive Disease|20
4759385|NCT01666314|16418640|P3|Overall Study|Progressive Disease|19
4759386|NCT01666314|16418641|P2|Overall Study|Progressive Disease|9
4759387|NCT01666314|16418642|P1|Overall Study|Progressive Disease|11
4759388|NCT01666314|16418639|P4|Overall Study|Adverse Event|7
4759389|NCT01666314|16418640|P3|Overall Study|Adverse Event|7
4759390|NCT01666314|16418641|P2|Overall Study|Adverse Event|13
4759391|NCT01666314|16418642|P1|Overall Study|Adverse Event|3
4759392|NCT01666119|16418778|P1|Overall Study|Subject experiencing withdrawal symptoms|5
4759393|NCT01666119|16418778|P1|Overall Study|non compliance with study medication, pa|18
4759394|NCT01666119|16418778|P1|Overall Study|Lost to Follow-up|7
4759395|NCT01666119|16418778|P1|Overall Study|Withdrawal by Subject|16
4759396|NCT01666119|16418778|P1|Overall Study|Adverse Event|6
4759397|NCT01666002|16418785|P2|Overall Study|Lost to Follow-up|0
4759398|NCT01666002|16418786|P1|Overall Study|Lost to Follow-up|5
4759399|NCT01665911|16418807|P1|Overall Study|Adverse Event|1
4759400|NCT01665911|16418807|P1|Overall Study|Withdrawal by Subject|1
4759401|NCT01665911|16418807|P1|Overall Study|Protocol Violation|4
4759402|NCT01665807|16418833|P3|Overall Study|Withdrawal by Subject|1
4759403|NCT01665807|16418834|P2|Overall Study|Withdrawal by Subject|0
4759404|NCT01665807|16418835|P1|Overall Study|Withdrawal by Subject|2
4759405|NCT01665768|16418846|P1|Overall Study|Withdrawal by Subject|1
4759406|NCT01665768|16418846|P1|Overall Study|Lack of Efficacy|19
4759407|NCT01665768|16418846|P1|Overall Study|Adverse Event|3
4759408|NCT01665599|16418851|P1|Overall Study|Could Not Continue Due to Time Constrain|1
4759409|NCT01665599|16418851|P1|Overall Study|Participant Left for More Than 3 Months|1
4759410|NCT01665599|16418851|P1|Overall Study|Lost to Follow-up|2
4759411|NCT01665599|16418851|P1|Overall Study|Death|1
4759412|NCT01665599|16418851|P1|Overall Study|Investigator/Sponsor decision|1
4759413|NCT01665599|16418851|P1|Overall Study|Consent Withdrawn|1
4759414|NCT01665599|16418851|P1|Overall Study|Adverse Event|1
4759415|NCT01665430|16418887|P1|Overall Study|Other Unspecified|2
4759416|NCT01665430|16418887|P1|Overall Study|Withdrawal by Subject|6
4759417|NCT01665430|16418887|P1|Overall Study|Adverse Event|1
4759418|NCT01665144|16418985|P2|Overall Study|Withdrawal by Subject|77
4759419|NCT01665144|16418986|P1|Overall Study|Withdrawal by Subject|96
4759420|NCT01665144|16418985|P2|Overall Study|Adverse Event|18
4759421|NCT01665144|16418986|P1|Overall Study|Adverse Event|45
4759422|NCT01665144|16418985|P2|Overall Study|Lack of Efficacy|11
4759423|NCT01665144|16418986|P1|Overall Study|Lack of Efficacy|16
4759424|NCT01665144|16418985|P2|Overall Study|Physician Decision|1
4759425|NCT01665144|16418986|P1|Overall Study|Physician Decision|13
4759426|NCT01665144|16418985|P2|Overall Study|Lost to Follow-up|8
4759427|NCT01665144|16418986|P1|Overall Study|Lost to Follow-up|9
4759428|NCT01665144|16418985|P2|Overall Study|Progressive disease|4
4759429|NCT01665144|16418986|P1|Overall Study|Progressive disease|8
4759430|NCT01665144|16418985|P2|Overall Study|Non-compliance w/study treatment|0
4759431|NCT01665144|16418986|P1|Overall Study|Non-compliance w/study treatment|5
4759432|NCT01665144|16418985|P2|Overall Study|Protocol deviation|1
4759433|NCT01665144|16418986|P1|Overall Study|Protocol deviation|3
4759434|NCT01665144|16418985|P2|Overall Study|Death|1
4759435|NCT01665144|16418986|P1|Overall Study|Death|3
4759436|NCT01665144|16418985|P2|Overall Study|Technical problems|0
4759437|NCT01665144|16418986|P1|Overall Study|Technical problems|2
4759438|NCT01665144|16418985|P2|Overall Study|New therapy for study indication|1
4759439|NCT01665144|16418986|P1|Overall Study|New therapy for study indication|2
4759440|NCT01664949|16419066|P2|Overall Study|Other Miscellaneous Reasons|1
4759441|NCT01664949|16419067|P1|Overall Study|Other Miscellaneous Reasons|3
4759442|NCT01664949|16419066|P2|Overall Study|Protocol Violation|5
4759443|NCT01664949|16419067|P1|Overall Study|Protocol Violation|5
4759444|NCT01664949|16419066|P2|Overall Study|Personal Reasons|4
4759445|NCT01664949|16419067|P1|Overall Study|Personal Reasons|3
4759446|NCT01664949|16419066|P2|Overall Study|Lost to Follow-up|2
4759447|NCT01664949|16419067|P1|Overall Study|Lost to Follow-up|1
4759448|NCT01664949|16419066|P2|Overall Study|Lack of Efficacy|1
4759449|NCT01664949|16419067|P1|Overall Study|Lack of Efficacy|1
4759450|NCT01664949|16419066|P2|Overall Study|Adverse Event|12
4759451|NCT01664949|16419067|P1|Overall Study|Adverse Event|11
4759452|NCT01664923|16419083|P2|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4
4759453|NCT01664923|16419084|P1|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2
4759454|NCT01664923|16419083|P2|Period 2: Open-label Phase-36 Months|Adverse Event|7
4759455|NCT01664923|16419084|P1|Period 2: Open-label Phase-36 Months|Adverse Event|4
4759456|NCT01664923|16419083|P2|Period 2: Open-label Phase-36 Months|Other|1
4759457|NCT01664923|16419084|P1|Period 2: Open-label Phase-36 Months|Other|3
4759458|NCT01664923|16419083|P2|Period 2: Open-label Phase-36 Months|Disease progression|9
4759459|NCT01664923|16419084|P1|Period 2: Open-label Phase-36 Months|Disease progression|28
4759460|NCT01664923|16419083|P2|Period 2: Open-label Phase-36 Months|On Treatment|1
4759461|NCT01664923|16419084|P1|Period 2: Open-label Phase-36 Months|On Treatment|1
4759462|NCT01664923|16419083|P2|Period 2: Open-label Phase-36 Months|Death|1
4759463|NCT01664923|16419084|P1|Period 2: Open-label Phase-36 Months|Death|3
4759464|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0
4759465|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1
4759466|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Other|4
4759467|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Other|3
4759468|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Adverse Event|9
4759469|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Adverse Event|14
4759470|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Disease Progression|132
4759471|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Disease Progression|65
4759472|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8
4759473|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12
4759474|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Protocol Violation|0
4759475|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Protocol Violation|2
4759476|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1
4759477|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0
4759478|NCT01664923|16419083|P2|Period1:Double Blind Phase-29 Months|Death|6
4759479|NCT01664923|16419084|P1|Period1:Double Blind Phase-29 Months|Death|8
4759480|NCT01664624|16419175|P4|Overall Study|Adverse Event|0
4759481|NCT01664624|16419176|P3|Overall Study|Adverse Event|0
4759482|NCT01664624|16419177|P2|Overall Study|Adverse Event|1
4759483|NCT01664624|16419178|P1|Overall Study|Adverse Event|0
4759484|NCT01664533|16419225|P1|Overall Study|Protocol Violation|3
4759485|NCT01664533|16419225|P1|Overall Study|Study termination|9
4759486|NCT01664533|16419225|P1|Overall Study|Lost to Follow-up|3
4759487|NCT01664533|16419225|P1|Overall Study|Death|42
4759488|NCT01664494|16419233|P1|Overall Study|Lost to Follow-up|99
4759489|NCT01664494|16419233|P1|Overall Study|Other|49
4759490|NCT01664494|16419233|P1|Overall Study|Death|18
4759491|NCT01664494|16419233|P1|Overall Study|Withdrawal by Subject|27
4759492|NCT01664247|16419240|P2|Overall Study|Unclassified|29
4759493|NCT01664247|16419241|P1|Overall Study|Unclassified|5
4759494|NCT01664247|16419240|P2|Overall Study|Withdrawal Criteria|4
4759495|NCT01664247|16419241|P1|Overall Study|Withdrawal Criteria|1
4759496|NCT01664247|16419240|P2|Overall Study|Protocol Violation|5
4759497|NCT01664247|16419241|P1|Overall Study|Protocol Violation|3
4759498|NCT01664247|16419240|P2|Overall Study|Adverse Event|3
4759499|NCT01664247|16419241|P1|Overall Study|Adverse Event|5
4759500|NCT01664130|16419263|P1|Overall Study|competing secondary disease|2
4759501|NCT01664104|16419341|P1|Overall Study|Unknown: Reason Unrelated to TCZ|2
4759502|NCT01664104|16419341|P1|Overall Study|Other|1
4759503|NCT01664104|16419341|P1|Overall Study|Lost to Follow-up|4
4759504|NCT01664104|16419341|P1|Overall Study|Withdrawal by Subject|1
4759505|NCT01664104|16419341|P1|Overall Study|Lack of Efficacy|2
4759506|NCT01664104|16419341|P1|Overall Study|Adverse Event|6
4759507|NCT01664091|16419408|P1|Overall Study|Withdrawal by Subject|1
4759508|NCT01664091|16419408|P1|Overall Study|Lost to Follow-up|2
4759509|NCT01664091|16419408|P1|Overall Study|Disease Progression|2
4759510|NCT01664091|16419408|P1|Overall Study|Death|1
4759511|NCT01664078|16419416|P1|Overall Study|Other|53
4759512|NCT01664078|16419416|P1|Overall Study|missed 5 year visit|1
4759513|NCT01664078|16419416|P1|Overall Study|Lost to Follow-up|2
4759514|NCT01664078|16419416|P1|Overall Study|Withdrawal by Subject|4
4759515|NCT01664078|16419416|P1|Overall Study|Death|9
4759516|NCT01664052|16419469|P2|Phase 2|No device placement|4
4759517|NCT01664052|16419470|P1|Phase 2|No device placement|0
4759518|NCT01664052|16419469|P2|Phase 1|No HSG 1 hr post placement|0
4759519|NCT01664052|16419470|P1|Phase 1|No HSG 1 hr post placement|1
4759520|NCT01664052|16419469|P2|Phase 1|No device placement|0
4759521|NCT01664052|16419470|P1|Phase 1|No device placement|6
4759522|NCT01664039|16419488|P2|Overall Study|Noncompliance|1
4759523|NCT01664039|16419489|P1|Overall Study|Noncompliance|1
4759524|NCT01664039|16419488|P2|Overall Study|Withdrawal by Subject|3
4759525|NCT01664039|16419489|P1|Overall Study|Withdrawal by Subject|1
4759526|NCT01664039|16419488|P2|Overall Study|Lost to Follow-up|1
4759527|NCT01664039|16419489|P1|Overall Study|Lost to Follow-up|1
4759528|NCT01664039|16419488|P2|Overall Study|Adverse Event|4
4759529|NCT01664039|16419489|P1|Overall Study|Adverse Event|3
4759530|NCT01663987|16419511|P2|Overall Study|Other reason not defined above|0
4759531|NCT01663987|16419512|P1|Overall Study|Other reason not defined above|3
4759532|NCT01663987|16419511|P2|Overall Study|Withdrawal by Subject|3
4759533|NCT01663987|16419512|P1|Overall Study|Withdrawal by Subject|2
4759534|NCT01663987|16419511|P2|Overall Study|Lost to Follow-up|1
4759535|NCT01663987|16419512|P1|Overall Study|Lost to Follow-up|1
4759536|NCT01663987|16419511|P2|Overall Study|Adverse Event|2
4759537|NCT01663987|16419512|P1|Overall Study|Adverse Event|7
4759538|NCT01663896|16419551|P1|Overall Study|Various reasons|43
4759539|NCT01663857|16419562|P4|Overall Study|Lost to Follow-up|1
4759540|NCT01663857|16419563|P3|Overall Study|Lost to Follow-up|3
4759541|NCT01663857|16419564|P2|Overall Study|Lost to Follow-up|0
4759542|NCT01663857|16419565|P1|Overall Study|Lost to Follow-up|0
4759543|NCT01663857|16419562|P4|Overall Study|Withdrew Consent to Study Participation|3
4759544|NCT01663857|16419563|P3|Overall Study|Withdrew Consent to Study Participation|7
4759545|NCT01663857|16419564|P2|Overall Study|Withdrew Consent to Study Participation|1
4759546|NCT01663857|16419565|P1|Overall Study|Withdrew Consent to Study Participation|0
4759547|NCT01663740|16419593|P2|Overall Study|No end of study status|0
4759548|NCT01663740|16419594|P1|Overall Study|No end of study status|3
4759549|NCT01663740|16419593|P2|Overall Study|Withdrawal by Subject|1
4759550|NCT01663740|16419594|P1|Overall Study|Withdrawal by Subject|2
4759551|NCT01663740|16419593|P2|Overall Study|Death|1
4759552|NCT01663740|16419594|P1|Overall Study|Death|0
4759553|NCT01663740|16419593|P2|Overall Study|Inclusion/Exclusion not met|0
4759554|NCT01663740|16419594|P1|Overall Study|Inclusion/Exclusion not met|1
4759555|NCT01663740|16419593|P2|Overall Study|Other|2
4759556|NCT01663740|16419594|P1|Overall Study|Other|9
4759557|NCT01663740|16419593|P2|Overall Study|Lost to Follow-up|4
4759558|NCT01663740|16419594|P1|Overall Study|Lost to Follow-up|1
4759559|NCT01663727|16419654|P2|Overall Study|Withdrawal prior to dosing.|0
4759560|NCT01663727|16419655|P1|Overall Study|Withdrawal prior to dosing.|1
4759561|NCT01663727|16419654|P2|Overall Study|Withdrawal by subject and Adverse Event.|0
4759562|NCT01663727|16419655|P1|Overall Study|Withdrawal by subject and Adverse Event.|1
4759563|NCT01663727|16419654|P2|Overall Study|Study Terminated|50
4759564|NCT01663727|16419655|P1|Overall Study|Study Terminated|51
4759565|NCT01663727|16419654|P2|Overall Study|Withdrawal by Subject|25
4759566|NCT01663727|16419655|P1|Overall Study|Withdrawal by Subject|18
4759567|NCT01663727|16419654|P2|Overall Study|Lost to Follow-up|8
4759568|NCT01663727|16419655|P1|Overall Study|Lost to Follow-up|10
4759569|NCT01663727|16419654|P2|Overall Study|Death|155
4759570|NCT01663727|16419655|P1|Overall Study|Death|161
4759571|NCT01663714|16419687|P1|Long-Term Follow-Up|Non-compliance|1
4759572|NCT01663714|16419687|P1|Long-Term Follow-Up|Death|4
4759573|NCT01663714|16419687|P1|Long-Term Follow-Up|Lost to Follow-up|1
4759574|NCT01663714|16419687|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16
4759575|NCT01663714|16419687|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|11
4759576|NCT01663714|16419687|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
4759577|NCT01663636|16419716|P2|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31
4759578|NCT01663636|16419717|P1|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25
4759579|NCT01663623|16419725|P2|Overall Study|Withdrawal by Subject|1
4759580|NCT01663623|16419726|P1|Overall Study|Withdrawal by Subject|2
4759581|NCT01663623|16419725|P2|Overall Study|Physician Decision|4
4759582|NCT01663623|16419726|P1|Overall Study|Physician Decision|1
4759583|NCT01663623|16419725|P2|Overall Study|Other-Study closed/terminated|1
4759584|NCT01663623|16419726|P1|Overall Study|Other-Study closed/terminated|1
4759585|NCT01663623|16419725|P2|Overall Study|Protocol Violation|1
4759586|NCT01663623|16419726|P1|Overall Study|Protocol Violation|0
4759587|NCT01663623|16419725|P2|Overall Study|Lack of Efficacy|6
4759588|NCT01663623|16419726|P1|Overall Study|Lack of Efficacy|5
4759589|NCT01663623|16419725|P2|Overall Study|Adverse Event|7
4759590|NCT01663623|16419726|P1|Overall Study|Adverse Event|3
4759591|NCT01663532|16419736|P2|Overall Study|Lack of Efficacy|60
4759592|NCT01663532|16419737|P1|Overall Study|Lack of Efficacy|15
4759593|NCT01663532|16419736|P2|Overall Study|Withdrawal by Subject|17
4759594|NCT01663532|16419737|P1|Overall Study|Withdrawal by Subject|35
4759595|NCT01663532|16419736|P2|Overall Study|Physician Decision|1
4759596|NCT01663532|16419737|P1|Overall Study|Physician Decision|1
4759597|NCT01663532|16419736|P2|Overall Study|Met Withdrawal Criteria|6
4759598|NCT01663532|16419737|P1|Overall Study|Met Withdrawal Criteria|7
4759599|NCT01663532|16419736|P2|Overall Study|Adverse Event|13
4759600|NCT01663532|16419737|P1|Overall Study|Adverse Event|7
4759601|NCT01663532|16419736|P2|Overall Study|Lost to Follow-up|10
4759602|NCT01663532|16419737|P1|Overall Study|Lost to Follow-up|9
4759603|NCT01663506|16419755|P1|Overall Study|Switched to Subcutaneous Tocilizumab|2
4759604|NCT01663506|16419755|P1|Overall Study|Adverse Event|1
4759605|NCT01663506|16419755|P1|Overall Study|Lost to Follow-up|1
4759606|NCT01663506|16419755|P1|Overall Study|Consent Withdrawal by Subject|1
4759607|NCT01663506|16419755|P1|Overall Study|Lack of Efficacy|3
4759608|NCT01663402|16419786|P2|Overall Study|Other than specified above|147
4759609|NCT01663402|16419787|P1|Overall Study|Other than specified above|172
4759610|NCT01663402|16419786|P2|Overall Study|Lost to Follow-up|15
4759611|NCT01663402|16419787|P1|Overall Study|Lost to Follow-up|17
4759612|NCT01663402|16419786|P2|Overall Study|Related to study drug administration|105
4759613|NCT01663402|16419787|P1|Overall Study|Related to study drug administration|96
4759614|NCT01663402|16419786|P2|Overall Study|Withdrawal by Subject|91
4759615|NCT01663402|16419787|P1|Overall Study|Withdrawal by Subject|118
4759616|NCT01663402|16419786|P2|Overall Study|Participant moved|104
4759617|NCT01663402|16419787|P1|Overall Study|Participant moved|139
4759618|NCT01663402|16419786|P2|Overall Study|Site terminated by sponsor|3
4759619|NCT01663402|16419787|P1|Overall Study|Site terminated by sponsor|1
4759620|NCT01663402|16419786|P2|Overall Study|Physician Decision|62
4759621|NCT01663402|16419787|P1|Overall Study|Physician Decision|77
4759622|NCT01663402|16419786|P2|Overall Study|Poor compliance to protocol|454
4759623|NCT01663402|16419787|P1|Overall Study|Poor compliance to protocol|529
4759624|NCT01663402|16419786|P2|Overall Study|Two consecutive LDL-C <15 mg/dL|730
4759625|NCT01663402|16419787|P1|Overall Study|Two consecutive LDL-C <15 mg/dL|0
4759626|NCT01663402|16419786|P2|Overall Study|Adverse Event|362
4759627|NCT01663402|16419787|P1|Overall Study|Adverse Event|347
4759628|NCT01663402|16419786|P2|Overall Study|Randomized but not treated|11
4759629|NCT01663402|16419787|P1|Overall Study|Randomized but not treated|19
4759630|NCT01663233|16419850|P2|Overall Study|Lost to Follow-up|1
4759631|NCT01663233|16419851|P1|Overall Study|Lost to Follow-up|0
4759632|NCT01663233|16419850|P2|Overall Study|Protocol Deviation|4
4759633|NCT01663233|16419851|P1|Overall Study|Protocol Deviation|1
4759634|NCT01663233|16419850|P2|Overall Study|Withdrawal by Subject|2
4759635|NCT01663233|16419851|P1|Overall Study|Withdrawal by Subject|3
4759636|NCT01663103|16419875|P2|Overall Study|dog bite|0
4759637|NCT01663103|16419876|P1|Overall Study|dog bite|1
4759638|NCT01663103|16419875|P2|Overall Study|Adverse Event|0
4759639|NCT01663103|16419876|P1|Overall Study|Adverse Event|1
4759640|NCT01663103|16419875|P2|Overall Study|Withdrawal by Subject|2
4759641|NCT01663103|16419876|P1|Overall Study|Withdrawal by Subject|1
4759642|NCT01662999|16419904|P6|Period 3|Withdrawal by Subject|0
4759643|NCT01662999|16419905|P5|Period 3|Withdrawal by Subject|0
4759644|NCT01662999|16419906|P4|Period 3|Withdrawal by Subject|0
4759645|NCT01662999|16419907|P3|Period 3|Withdrawal by Subject|0
4759646|NCT01662999|16419908|P2|Period 3|Withdrawal by Subject|1
4759647|NCT01662999|16419909|P1|Period 3|Withdrawal by Subject|0
4759648|NCT01662986|16419980|P2|Overall Study|Other than stated above|0
4759649|NCT01662986|16419981|P1|Overall Study|Other than stated above|3
4759650|NCT01662986|16419980|P2|Overall Study|Not Treated|0
4759651|NCT01662986|16419981|P1|Overall Study|Not Treated|1
4759652|NCT01662986|16419980|P2|Overall Study|Withdrawal by Subject|2
4759653|NCT01662986|16419981|P1|Overall Study|Withdrawal by Subject|2
4759654|NCT01662986|16419980|P2|Overall Study|Lost to Follow-up|4
4759655|NCT01662986|16419981|P1|Overall Study|Lost to Follow-up|5
4759656|NCT01662986|16419980|P2|Overall Study|Protocol Violation|3
4759657|NCT01662986|16419981|P1|Overall Study|Protocol Violation|2
4759658|NCT01662986|16419980|P2|Overall Study|Adverse Event|4
4759659|NCT01662986|16419981|P1|Overall Study|Adverse Event|5
4759660|NCT01662895|16420069|P2|Overall Study|Lost to Follow-up|1
4759661|NCT01662895|16420070|P1|Overall Study|Lost to Follow-up|0
4759662|NCT01662648|16420194|P2|Overall Study|LOE and Participant non-compliant|1
4759663|NCT01662648|16420195|P1|Overall Study|LOE and Participant non-compliant|0
4759664|NCT01662648|16420194|P2|Overall Study|LOE and other reason unspecified|0
4759665|NCT01662648|16420195|P1|Overall Study|LOE and other reason unspecified|1
4759666|NCT01662648|16420194|P2|Overall Study|Adverse event and lack of efficacy (LOE)|0
4759667|NCT01662648|16420195|P1|Overall Study|Adverse event and lack of efficacy (LOE)|3
4759668|NCT01662648|16420194|P2|Overall Study|Other|11
4759669|NCT01662648|16420195|P1|Overall Study|Other|8
4759670|NCT01662648|16420194|P2|Overall Study|Participant non-compliant|20
4759671|NCT01662648|16420195|P1|Overall Study|Participant non-compliant|16
4759672|NCT01662648|16420194|P2|Overall Study|Withdrawal by Subject|53
4759673|NCT01662648|16420195|P1|Overall Study|Withdrawal by Subject|36
4759674|NCT01662648|16420194|P2|Overall Study|Lost to Follow-up|36
4759675|NCT01662648|16420195|P1|Overall Study|Lost to Follow-up|24
4759676|NCT01662648|16420194|P2|Overall Study|Participant ineligible to continue trial|1
4759677|NCT01662648|16420195|P1|Overall Study|Participant ineligible to continue trial|1
4759678|NCT01662648|16420194|P2|Overall Study|Lack of Efficacy|16
4759679|NCT01662648|16420195|P1|Overall Study|Lack of Efficacy|17
4759680|NCT01662648|16420194|P2|Overall Study|Adverse Event|37
4759681|NCT01662648|16420195|P1|Overall Study|Adverse Event|40
4759682|NCT01662648|16420194|P2|Overall Study|Death|3
4759683|NCT01662648|16420195|P1|Overall Study|Death|1
4759684|NCT01662635|16420217|P1|Overall Study|scarce samples for evaluation|30
4759685|NCT01662505|16420268|P3|Overall Study|Not specified above|2
4759686|NCT01662505|16420269|P2|Overall Study|Not specified above|3
4759687|NCT01662505|16420270|P1|Overall Study|Not specified above|1
4759688|NCT01662505|16420268|P3|Overall Study|Refused cont. medication|1
4759689|NCT01662505|16420269|P2|Overall Study|Refused cont. medication|0
4759690|NCT01662505|16420270|P1|Overall Study|Refused cont. medication|0
4759691|NCT01662505|16420268|P3|Overall Study|Progressive disease|5
4759692|NCT01662505|16420269|P2|Overall Study|Progressive disease|1
4759693|NCT01662505|16420270|P1|Overall Study|Progressive disease|6
4759694|NCT01662492|16420294|P3|Overall Study|Lack of Efficacy|2
4759695|NCT01662492|16420295|P2|Overall Study|Lack of Efficacy|1
4759696|NCT01662492|16420296|P1|Overall Study|Lack of Efficacy|1
4759697|NCT01662492|16420294|P3|Overall Study|Lost to Follow-up|2
4759698|NCT01662492|16420295|P2|Overall Study|Lost to Follow-up|0
4759699|NCT01662492|16420296|P1|Overall Study|Lost to Follow-up|0
4759700|NCT01662492|16420294|P3|Overall Study|Protocol Violation|0
4759701|NCT01662492|16420295|P2|Overall Study|Protocol Violation|0
4759702|NCT01662492|16420296|P1|Overall Study|Protocol Violation|1
4759703|NCT01662492|16420294|P3|Overall Study|Withdrawal by Subject|1
4759704|NCT01662492|16420295|P2|Overall Study|Withdrawal by Subject|0
4759705|NCT01662492|16420296|P1|Overall Study|Withdrawal by Subject|0
4759706|NCT01662492|16420294|P3|Overall Study|Other miscellaneous reasons.|1
4759707|NCT01662492|16420295|P2|Overall Study|Other miscellaneous reasons.|0
4759708|NCT01662492|16420296|P1|Overall Study|Other miscellaneous reasons.|1
4759709|NCT01662440|16420320|P4|Overall Study|Withdrawal by Subject|2
4759710|NCT01662440|16420321|P3|Overall Study|Withdrawal by Subject|2
4759711|NCT01662440|16420322|P2|Overall Study|Withdrawal by Subject|2
4759712|NCT01662440|16420323|P1|Overall Study|Withdrawal by Subject|5
4759713|NCT01662440|16420320|P4|Overall Study|Protocol Violation|0
4759714|NCT01662440|16420321|P3|Overall Study|Protocol Violation|0
4759715|NCT01662440|16420322|P2|Overall Study|Protocol Violation|0
4759716|NCT01662440|16420323|P1|Overall Study|Protocol Violation|1
4759717|NCT01662440|16420320|P4|Overall Study|Subject moved to another country.|0
4759718|NCT01662440|16420321|P3|Overall Study|Subject moved to another country.|0
4759719|NCT01662440|16420322|P2|Overall Study|Subject moved to another country.|1
4759720|NCT01662440|16420323|P1|Overall Study|Subject moved to another country.|0
4759721|NCT01662440|16420320|P4|Overall Study|Lost to Follow-up|1
4759722|NCT01662440|16420321|P3|Overall Study|Lost to Follow-up|4
4759723|NCT01662440|16420322|P2|Overall Study|Lost to Follow-up|2
4759724|NCT01662440|16420323|P1|Overall Study|Lost to Follow-up|2
4759725|NCT01662440|16420320|P4|Overall Study|Death|0
4759726|NCT01662440|16420321|P3|Overall Study|Death|0
4759727|NCT01662440|16420322|P2|Overall Study|Death|1
4759728|NCT01662440|16420323|P1|Overall Study|Death|0
4759729|NCT01662440|16420320|P4|Overall Study|Adverse Event|1
4759730|NCT01662440|16420321|P3|Overall Study|Adverse Event|0
4759731|NCT01662440|16420322|P2|Overall Study|Adverse Event|0
4759732|NCT01662440|16420323|P1|Overall Study|Adverse Event|1
4759733|NCT01662362|16420371|P1|Overall Study|Lost to Follow-up|38
4759734|NCT01662336|16420376|P1|Overall Study|Withdrawal by Subject|6
4759735|NCT01662336|16420376|P1|Overall Study|Other|29
4759736|NCT01662336|16420376|P1|Overall Study|No longer on LPV/r|30
4759737|NCT01662336|16420376|P1|Overall Study|Adverse Event|1
4759738|NCT01662310|16420402|P5|Open-Label Extension Phase|Withdrawal by Subject|7
4759739|NCT01662310|16420403|P4|Open-Label Extension Phase|Withdrawal by Subject|2
4759740|NCT01662310|16420404|P3|Open-Label Extension Phase|Withdrawal by Subject|0
4759741|NCT01662310|16420405|P2|Open-Label Extension Phase|Withdrawal by Subject|0
4759742|NCT01662310|16420406|P1|Open-Label Extension Phase|Withdrawal by Subject|0
4759743|NCT01662310|16420402|P5|Open-Label Extension Phase|Pregnancy|0
4759744|NCT01662310|16420403|P4|Open-Label Extension Phase|Pregnancy|1
4759745|NCT01662310|16420404|P3|Open-Label Extension Phase|Pregnancy|0
4759746|NCT01662310|16420405|P2|Open-Label Extension Phase|Pregnancy|0
4759747|NCT01662310|16420406|P1|Open-Label Extension Phase|Pregnancy|0
4759748|NCT01662310|16420402|P5|Open-Label Extension Phase|Lost to Follow-up|1
4759749|NCT01662310|16420403|P4|Open-Label Extension Phase|Lost to Follow-up|2
4759750|NCT01662310|16420404|P3|Open-Label Extension Phase|Lost to Follow-up|0
4759751|NCT01662310|16420405|P2|Open-Label Extension Phase|Lost to Follow-up|0
4759752|NCT01662310|16420406|P1|Open-Label Extension Phase|Lost to Follow-up|0
4759753|NCT01662310|16420402|P5|Open-Label Extension Phase|Lack of Efficacy|2
4759754|NCT01662310|16420403|P4|Open-Label Extension Phase|Lack of Efficacy|2
4759755|NCT01662310|16420404|P3|Open-Label Extension Phase|Lack of Efficacy|0
4759756|NCT01662310|16420405|P2|Open-Label Extension Phase|Lack of Efficacy|0
4759757|NCT01662310|16420406|P1|Open-Label Extension Phase|Lack of Efficacy|0
4759758|NCT01662310|16420402|P5|Open-Label Extension Phase|Death|0
4759759|NCT01662310|16420403|P4|Open-Label Extension Phase|Death|1
4759760|NCT01662310|16420404|P3|Open-Label Extension Phase|Death|0
4759761|NCT01662310|16420405|P2|Open-Label Extension Phase|Death|0
4759762|NCT01662310|16420406|P1|Open-Label Extension Phase|Death|0
4759763|NCT01662310|16420402|P5|Open-Label Extension Phase|Adverse Event|0
4759764|NCT01662310|16420403|P4|Open-Label Extension Phase|Adverse Event|3
4759765|NCT01662310|16420404|P3|Open-Label Extension Phase|Adverse Event|0
4759766|NCT01662310|16420405|P2|Open-Label Extension Phase|Adverse Event|0
4759767|NCT01662310|16420406|P1|Open-Label Extension Phase|Adverse Event|0
4759768|NCT01662310|16420402|P5|Double-Blind Phase|Randomized but not treated|0
4759769|NCT01662310|16420403|P4|Double-Blind Phase|Randomized but not treated|0
4759770|NCT01662310|16420404|P3|Double-Blind Phase|Randomized but not treated|0
4759771|NCT01662310|16420405|P2|Double-Blind Phase|Randomized but not treated|1
4759772|NCT01662310|16420406|P1|Double-Blind Phase|Randomized but not treated|0
4759773|NCT01662310|16420402|P5|Double-Blind Phase|Other|0
4759774|NCT01662310|16420403|P4|Double-Blind Phase|Other|0
4759775|NCT01662310|16420404|P3|Double-Blind Phase|Other|1
4759776|NCT01662310|16420405|P2|Double-Blind Phase|Other|0
4759777|NCT01662310|16420406|P1|Double-Blind Phase|Other|0
4759778|NCT01662310|16420402|P5|Double-Blind Phase|Withdrawal by Subject|0
4759779|NCT01662310|16420403|P4|Double-Blind Phase|Withdrawal by Subject|0
4759780|NCT01662310|16420404|P3|Double-Blind Phase|Withdrawal by Subject|3
4759781|NCT01662310|16420405|P2|Double-Blind Phase|Withdrawal by Subject|9
4759782|NCT01662310|16420406|P1|Double-Blind Phase|Withdrawal by Subject|0
4759783|NCT01662310|16420402|P5|Double-Blind Phase|Pregnancy|0
4759784|NCT01662310|16420403|P4|Double-Blind Phase|Pregnancy|0
4759785|NCT01662310|16420404|P3|Double-Blind Phase|Pregnancy|0
4759786|NCT01662310|16420405|P2|Double-Blind Phase|Pregnancy|2
4759787|NCT01662310|16420406|P1|Double-Blind Phase|Pregnancy|0
4759788|NCT01662310|16420402|P5|Double-Blind Phase|Lost to Follow-up|0
4759789|NCT01662310|16420403|P4|Double-Blind Phase|Lost to Follow-up|0
4759790|NCT01662310|16420404|P3|Double-Blind Phase|Lost to Follow-up|0
4759791|NCT01662310|16420405|P2|Double-Blind Phase|Lost to Follow-up|3
4759792|NCT01662310|16420406|P1|Double-Blind Phase|Lost to Follow-up|0
4759793|NCT01662310|16420402|P5|Double-Blind Phase|Adverse Event|0
4759794|NCT01662310|16420403|P4|Double-Blind Phase|Adverse Event|0
4759795|NCT01662310|16420404|P3|Double-Blind Phase|Adverse Event|1
4759796|NCT01662310|16420405|P2|Double-Blind Phase|Adverse Event|0
4759797|NCT01662310|16420406|P1|Double-Blind Phase|Adverse Event|0
4759798|NCT01662310|16420402|P5|Run-In or Stabilization Phase|Other|0
4759799|NCT01662310|16420403|P4|Run-In or Stabilization Phase|Other|0
4759800|NCT01662310|16420404|P3|Run-In or Stabilization Phase|Other|0
4759801|NCT01662310|16420405|P2|Run-In or Stabilization Phase|Other|0
4759802|NCT01662310|16420406|P1|Run-In or Stabilization Phase|Other|1
4759803|NCT01662310|16420402|P5|Run-In or Stabilization Phase|Withdrawal by Subject|0
4759804|NCT01662310|16420403|P4|Run-In or Stabilization Phase|Withdrawal by Subject|0
4759805|NCT01662310|16420404|P3|Run-In or Stabilization Phase|Withdrawal by Subject|0
4759806|NCT01662310|16420405|P2|Run-In or Stabilization Phase|Withdrawal by Subject|0
4759807|NCT01662310|16420406|P1|Run-In or Stabilization Phase|Withdrawal by Subject|25
4759808|NCT01662310|16420402|P5|Run-In or Stabilization Phase|Protocol Violation|0
4759809|NCT01662310|16420403|P4|Run-In or Stabilization Phase|Protocol Violation|0
4759810|NCT01662310|16420404|P3|Run-In or Stabilization Phase|Protocol Violation|0
4759811|NCT01662310|16420405|P2|Run-In or Stabilization Phase|Protocol Violation|0
4759812|NCT01662310|16420406|P1|Run-In or Stabilization Phase|Protocol Violation|15
4759813|NCT01662310|16420402|P5|Run-In or Stabilization Phase|Lost to Follow-up|0
4759814|NCT01662310|16420403|P4|Run-In or Stabilization Phase|Lost to Follow-up|0
4759815|NCT01662310|16420404|P3|Run-In or Stabilization Phase|Lost to Follow-up|0
4759816|NCT01662310|16420405|P2|Run-In or Stabilization Phase|Lost to Follow-up|0
4759817|NCT01662310|16420406|P1|Run-In or Stabilization Phase|Lost to Follow-up|4
4759818|NCT01662310|16420402|P5|Run-In or Stabilization Phase|Lack of Efficacy|0
4759819|NCT01662310|16420403|P4|Run-In or Stabilization Phase|Lack of Efficacy|0
4759820|NCT01662310|16420404|P3|Run-In or Stabilization Phase|Lack of Efficacy|0
4759821|NCT01662310|16420405|P2|Run-In or Stabilization Phase|Lack of Efficacy|0
4759822|NCT01662310|16420406|P1|Run-In or Stabilization Phase|Lack of Efficacy|9
4759823|NCT01662310|16420402|P5|Run-In or Stabilization Phase|Adverse Event|0
4759824|NCT01662310|16420403|P4|Run-In or Stabilization Phase|Adverse Event|0
4759825|NCT01662310|16420404|P3|Run-In or Stabilization Phase|Adverse Event|0
4759826|NCT01662310|16420405|P2|Run-In or Stabilization Phase|Adverse Event|0
4759827|NCT01662310|16420406|P1|Run-In or Stabilization Phase|Adverse Event|11
4759828|NCT01662102|16420487|P2|Overall Study|Sponsor's decision|0
4759829|NCT01662102|16420488|P1|Overall Study|Sponsor's decision|1
4759830|NCT01662063|16420496|P3|Overall Study|Other|0
4759831|NCT01662063|16420497|P2|Overall Study|Other|1
4759832|NCT01662063|16420498|P1|Overall Study|Other|0
4759833|NCT01662063|16420496|P3|Overall Study|Physician Decision|0
4759834|NCT01662063|16420497|P2|Overall Study|Physician Decision|2
4759835|NCT01662063|16420498|P1|Overall Study|Physician Decision|0
4759836|NCT01662063|16420496|P3|Overall Study|Withdrawal by Subject|1
4759837|NCT01662063|16420497|P2|Overall Study|Withdrawal by Subject|4
4759838|NCT01662063|16420498|P1|Overall Study|Withdrawal by Subject|2
4759839|NCT01662063|16420496|P3|Overall Study|Protocol Violation|0
4759840|NCT01662063|16420497|P2|Overall Study|Protocol Violation|0
4759841|NCT01662063|16420498|P1|Overall Study|Protocol Violation|1
4759842|NCT01662063|16420496|P3|Overall Study|Lost to Follow-up|0
4759843|NCT01662063|16420497|P2|Overall Study|Lost to Follow-up|4
4759844|NCT01662063|16420498|P1|Overall Study|Lost to Follow-up|0
4759845|NCT01662063|16420496|P3|Overall Study|Lack of Efficacy|0
4759846|NCT01662063|16420497|P2|Overall Study|Lack of Efficacy|6
4759847|NCT01662063|16420498|P1|Overall Study|Lack of Efficacy|1
4759848|NCT01662063|16420496|P3|Overall Study|Adverse Event or Intercurrent Illness|0
4759849|NCT01662063|16420497|P2|Overall Study|Adverse Event or Intercurrent Illness|12
4759850|NCT01662063|16420498|P1|Overall Study|Adverse Event or Intercurrent Illness|1
4759851|NCT01662024|16420577|P1|Overall Study|Withdrawal by Subject|3
4759852|NCT01662024|16420577|P1|Overall Study|Pregnancy|2
4759853|NCT01661972|16420589|P2|Overall Study|Withdrawal by Subject|1
4759854|NCT01661972|16420590|P1|Overall Study|Withdrawal by Subject|0
4759855|NCT01661972|16420589|P2|Overall Study|Death during Treatment period|1
4759856|NCT01661972|16420590|P1|Overall Study|Death during Treatment period|1
4759857|NCT01661972|16420589|P2|Overall Study|Adverse Event|2
4759858|NCT01661972|16420590|P1|Overall Study|Adverse Event|1
4759859|NCT01661933|16420609|P1|High-dose Gluten Challenge|Withdrawal by Subject|2
4759860|NCT01661933|16420609|P1|Low-dose Gluten Challenge|Physician Decision|2
4759861|NCT01661881|16420616|P1|Overall Study|Disease Progression|1
4759862|NCT01661790|16420624|P2|Overall Study|Lost to Follow-up|2
4759863|NCT01661790|16420625|P1|Overall Study|Lost to Follow-up|0
4759864|NCT01661686|16420725|P2|Overall Study|did not receive allocated intervention|1
4759865|NCT01661686|16420726|P1|Overall Study|did not receive allocated intervention|0
4759866|NCT01661686|16420725|P2|Overall Study|Lost to Follow-up|1
4759867|NCT01661686|16420726|P1|Overall Study|Lost to Follow-up|2
4759868|NCT01661595|16420767|P4|Phase 2: Week 5-8.|Protocol Violation|0
4759869|NCT01661595|16420768|P3|Phase 2: Week 5-8.|Protocol Violation|1
4759870|NCT01661595|16420769|P2|Phase 2: Week 5-8.|Protocol Violation|0
4759871|NCT01661595|16420770|P1|Phase 2: Week 5-8.|Protocol Violation|0
4759872|NCT01661595|16420767|P4|Phase 1: Week 0-4|Adverse Event|0
4759873|NCT01661595|16420768|P3|Phase 1: Week 0-4|Adverse Event|0
4759874|NCT01661595|16420769|P2|Phase 1: Week 0-4|Adverse Event|0
4759875|NCT01661595|16420770|P1|Phase 1: Week 0-4|Adverse Event|1
4759876|NCT01661205|16420898|P1|Overall Study|Physician Decision|2
4759877|NCT01661179|16420909|P1|Overall Study|Other Eligibility criteria|4
4759878|NCT01661179|16420909|P1|Overall Study|Withdrawal by Subject|1
4759879|NCT01661179|16420909|P1|Overall Study|Death|1
4759880|NCT01661140|16420913|P3|Double-Blind Period|Administrative/Other|6
4759881|NCT01661140|16420914|P2|Double-Blind Period|Administrative/Other|7
4759882|NCT01661140|16420915|P1|Double-Blind Period|Administrative/Other|0
4759883|NCT01661140|16420913|P3|Double-Blind Period|Sponsor Termination|17
4759884|NCT01661140|16420914|P2|Double-Blind Period|Sponsor Termination|14
4759885|NCT01661140|16420915|P1|Double-Blind Period|Sponsor Termination|0
4759886|NCT01661140|16420913|P3|Double-Blind Period|Investigator's Decision|2
4759887|NCT01661140|16420914|P2|Double-Blind Period|Investigator's Decision|1
4759888|NCT01661140|16420915|P1|Double-Blind Period|Investigator's Decision|0
4759889|NCT01661140|16420913|P3|Double-Blind Period|Withdrawal by Subject|3
4759890|NCT01661140|16420914|P2|Double-Blind Period|Withdrawal by Subject|1
4759891|NCT01661140|16420915|P1|Double-Blind Period|Withdrawal by Subject|0
4759892|NCT01661140|16420913|P3|Double-Blind Period|Protocol Violation|3
4759893|NCT01661140|16420914|P2|Double-Blind Period|Protocol Violation|2
4759894|NCT01661140|16420915|P1|Double-Blind Period|Protocol Violation|0
4759895|NCT01661140|16420913|P3|Double-Blind Period|Adverse Event|18
4759896|NCT01661140|16420914|P2|Double-Blind Period|Adverse Event|16
4759897|NCT01661140|16420915|P1|Double-Blind Period|Adverse Event|0
4759898|NCT01661140|16420913|P3|Double-Blind Period|Refused Treatment|1
4759899|NCT01661140|16420914|P2|Double-Blind Period|Refused Treatment|0
4759900|NCT01661140|16420915|P1|Double-Blind Period|Refused Treatment|0
4759901|NCT01661140|16420913|P3|Open-Label Period|Lost to Follow-up|0
4759902|NCT01661140|16420914|P2|Open-Label Period|Lost to Follow-up|0
4759903|NCT01661140|16420915|P1|Open-Label Period|Lost to Follow-up|2
4759904|NCT01661140|16420913|P3|Open-Label Period|Did not meet EULAR criteria|0
4759905|NCT01661140|16420914|P2|Open-Label Period|Did not meet EULAR criteria|0
4759906|NCT01661140|16420915|P1|Open-Label Period|Did not meet EULAR criteria|1
4759907|NCT01661140|16420913|P3|Open-Label Period|Sponsor termination|0
4759908|NCT01661140|16420914|P2|Open-Label Period|Sponsor termination|0
4759909|NCT01661140|16420915|P1|Open-Label Period|Sponsor termination|16
4759910|NCT01661140|16420913|P3|Open-Label Period|Administrative/Other|0
4759911|NCT01661140|16420914|P2|Open-Label Period|Administrative/Other|0
4759912|NCT01661140|16420915|P1|Open-Label Period|Administrative/Other|1
4759913|NCT01661140|16420913|P3|Open-Label Period|Death|0
4759914|NCT01661140|16420914|P2|Open-Label Period|Death|0
4759915|NCT01661140|16420915|P1|Open-Label Period|Death|1
4759916|NCT01661140|16420913|P3|Open-Label Period|Investigator Decision|0
4759917|NCT01661140|16420914|P2|Open-Label Period|Investigator Decision|0
4759918|NCT01661140|16420915|P1|Open-Label Period|Investigator Decision|3
4759919|NCT01661140|16420913|P3|Open-Label Period|Withdrawal by Subject|0
4759920|NCT01661140|16420914|P2|Open-Label Period|Withdrawal by Subject|0
4759921|NCT01661140|16420915|P1|Open-Label Period|Withdrawal by Subject|5
4759922|NCT01661140|16420913|P3|Open-Label Period|Protocol Violation|0
4759923|NCT01661140|16420914|P2|Open-Label Period|Protocol Violation|0
4759924|NCT01661140|16420915|P1|Open-Label Period|Protocol Violation|3
4759925|NCT01661140|16420913|P3|Open-Label Period|Adverse Event|0
4759926|NCT01661140|16420914|P2|Open-Label Period|Adverse Event|0
4759927|NCT01661140|16420915|P1|Open-Label Period|Adverse Event|44
4759928|NCT01661062|16420967|P1|Overall Study|Withdrawal by Subject|2
4759929|NCT01661062|16420967|P1|Overall Study|Completed Treatment Off Study|3
4759930|NCT01660906|16420972|P1|Overall Study|Discontinued due to study drug toxicity|3
4759931|NCT01660763|16421055|P2|Overall Study|Patient ready for early discharge|4
4759932|NCT01660763|16421056|P1|Overall Study|Patient ready for early discharge|28
4759933|NCT01660763|16421055|P2|Overall Study|Withdrawal by Subject|0
4759934|NCT01660763|16421056|P1|Overall Study|Withdrawal by Subject|4
4759935|NCT01660763|16421055|P2|Overall Study|Protocol Violation|0
4759936|NCT01660763|16421056|P1|Overall Study|Protocol Violation|1
4759937|NCT01660763|16421055|P2|Overall Study|Adverse Event|7
4759938|NCT01660763|16421056|P1|Overall Study|Adverse Event|22
4759939|NCT01660763|16421055|P2|Overall Study|Lack of Efficacy|50
4759940|NCT01660763|16421056|P1|Overall Study|Lack of Efficacy|45
4759941|NCT01660451|16421104|P3|Overall Study|Ongoing with treatment|46
4759942|NCT01660451|16421105|P2|Overall Study|Ongoing with treatment|3
4759943|NCT01660451|16421106|P1|Overall Study|Ongoing with treatment|3
4759944|NCT01660451|16421104|P3|Overall Study|Withdrawal by Subject|16
4759945|NCT01660451|16421105|P2|Overall Study|Withdrawal by Subject|0
4759946|NCT01660451|16421106|P1|Overall Study|Withdrawal by Subject|1
4759947|NCT01660451|16421104|P3|Overall Study|Physician Decision|5
4759948|NCT01660451|16421105|P2|Overall Study|Physician Decision|2
4759949|NCT01660451|16421106|P1|Overall Study|Physician Decision|1
4759950|NCT01660451|16421104|P3|Overall Study|Protocol Deviation|1
4759951|NCT01660451|16421105|P2|Overall Study|Protocol Deviation|0
4759952|NCT01660451|16421106|P1|Overall Study|Protocol Deviation|0
4759953|NCT01660451|16421104|P3|Overall Study|Sponsor Decision|1
4759954|NCT01660451|16421105|P2|Overall Study|Sponsor Decision|0
4759955|NCT01660451|16421106|P1|Overall Study|Sponsor Decision|0
4759956|NCT01660451|16421104|P3|Overall Study|AE with Clinical PD|9
4759957|NCT01660451|16421105|P2|Overall Study|AE with Clinical PD|3
4759958|NCT01660451|16421106|P1|Overall Study|AE with Clinical PD|1
4759959|NCT01660451|16421104|P3|Overall Study|Adverse Event (AE) without Clinical PD|26
4759960|NCT01660451|16421105|P2|Overall Study|Adverse Event (AE) without Clinical PD|8
4759961|NCT01660451|16421106|P1|Overall Study|Adverse Event (AE) without Clinical PD|11
4759962|NCT01660451|16421104|P3|Overall Study|Protocol Violation|1
4759963|NCT01660451|16421105|P2|Overall Study|Protocol Violation|1
4759964|NCT01660451|16421106|P1|Overall Study|Protocol Violation|0
4759965|NCT01660412|16421134|P2|Overall Study|Protocol Violation|3
4759966|NCT01660412|16421135|P1|Overall Study|Protocol Violation|0
4759967|NCT01660334|16421141|P1|Overall Study|Lost to Follow-up|1
4759968|NCT01660022|16421384|P6|First Sequence (7 Days)|Protocol Violation|1
4759969|NCT01660022|16421385|P5|First Sequence (7 Days)|Protocol Violation|0
4759970|NCT01660022|16421386|P4|First Sequence (7 Days)|Protocol Violation|0
4759971|NCT01660022|16421387|P3|First Sequence (7 Days)|Protocol Violation|0
4759972|NCT01660022|16421388|P2|First Sequence (7 Days)|Protocol Violation|0
4759973|NCT01660022|16421389|P1|First Sequence (7 Days)|Protocol Violation|0
4759974|NCT01660022|16421384|P6|First Sequence (7 Days)|Adverse Event|3
4759975|NCT01660022|16421385|P5|First Sequence (7 Days)|Adverse Event|1
4759976|NCT01660022|16421386|P4|First Sequence (7 Days)|Adverse Event|0
4759977|NCT01660022|16421387|P3|First Sequence (7 Days)|Adverse Event|0
4759978|NCT01660022|16421388|P2|First Sequence (7 Days)|Adverse Event|0
4759979|NCT01660022|16421389|P1|First Sequence (7 Days)|Adverse Event|0
4759980|NCT01660022|16421384|P6|First Sequence (7 Days)|Withdrawal by Subject|0
4759981|NCT01660022|16421385|P5|First Sequence (7 Days)|Withdrawal by Subject|0
4759982|NCT01660022|16421386|P4|First Sequence (7 Days)|Withdrawal by Subject|1
4759983|NCT01660022|16421387|P3|First Sequence (7 Days)|Withdrawal by Subject|0
4759984|NCT01660022|16421388|P2|First Sequence (7 Days)|Withdrawal by Subject|1
4759985|NCT01660022|16421389|P1|First Sequence (7 Days)|Withdrawal by Subject|0
4759986|NCT01659996|16421448|P3|Overall Study|Withdrawal by Subject|5
4759987|NCT01659996|16421449|P2|Overall Study|Withdrawal by Subject|1
4759988|NCT01659996|16421450|P1|Overall Study|Withdrawal by Subject|4
4759989|NCT01659996|16421448|P3|Overall Study|Adverse Event|1
4759990|NCT01659996|16421449|P2|Overall Study|Adverse Event|0
4759991|NCT01659996|16421450|P1|Overall Study|Adverse Event|0
4759992|NCT01659996|16421448|P3|Overall Study|Lost to Follow-up|2
4759993|NCT01659996|16421449|P2|Overall Study|Lost to Follow-up|3
4759994|NCT01659996|16421450|P1|Overall Study|Lost to Follow-up|1
4759995|NCT01659996|16421448|P3|Overall Study|Protocol Violation|3
4759996|NCT01659996|16421449|P2|Overall Study|Protocol Violation|3
4759997|NCT01659996|16421450|P1|Overall Study|Protocol Violation|3
4759998|NCT01659853|16421491|P2|Washout , 3 to 7 Days|Protocol Violation|0
4759999|NCT01659853|16421492|P1|Washout , 3 to 7 Days|Protocol Violation|1
4760000|NCT01659853|16421491|P2|Washout , 3 to 7 Days|Adverse Event|0
4760001|NCT01659853|16421492|P1|Washout , 3 to 7 Days|Adverse Event|1
4760002|NCT01659736|16421502|P2|3-month Follow-up|Lost to Follow-up|1
4760003|NCT01659736|16421503|P1|3-month Follow-up|Lost to Follow-up|0
4760004|NCT01659736|16421502|P2|Treatment Period|Withdrawal by Subject|0
4760005|NCT01659736|16421503|P1|Treatment Period|Withdrawal by Subject|1
4760006|NCT01659736|16421502|P2|Treatment Period|Protocol Violation|1
4760007|NCT01659736|16421503|P1|Treatment Period|Protocol Violation|3
4760008|NCT01659736|16421502|P2|Treatment Period|Adverse Event|1
4760009|NCT01659736|16421503|P1|Treatment Period|Adverse Event|1
4760010|NCT01659567|16421517|P1|Overall Study|Other|13
4760011|NCT01659567|16421517|P1|Overall Study|Progression of the main disease|1
4760012|NCT01659567|16421517|P1|Overall Study|Withdrawal by Subject|64
4760013|NCT01659567|16421517|P1|Overall Study|Good result at early stage of treatment|5
4760014|NCT01659567|16421517|P1|Overall Study|Adverse Event|12
4760015|NCT01659567|16421517|P1|Overall Study|Switched to Pegferon|6
4760016|NCT01659567|16421517|P1|Overall Study|Lack of Efficacy|22
4760017|NCT01659554|16421534|P1|Overall Study|Study Termination|4
4760018|NCT01659320|16421541|P1|Overall Study|Physician Decision|1
4760019|NCT01659320|16421541|P1|Overall Study|Withdrawal by Subject|2
4760020|NCT01659125|16421560|P1|Overall Study|Failed to Start Treatment|2
4760021|NCT01659125|16421560|P1|Overall Study|Time Constraints|2
4760022|NCT01659125|16421560|P1|Overall Study|Technical Problem|1
4760023|NCT01659125|16421560|P1|Overall Study|Lost to Follow-up|7
4760024|NCT01659125|16421560|P1|Overall Study|Withdrawal by Subject|2
4760025|NCT01659021|16421567|P2|Long-Term Follow Up|Withdrawal by Subject|1
4760026|NCT01659021|16421568|P1|Long-Term Follow Up|Withdrawal by Subject|2
4760027|NCT01659021|16421567|P2|Long-Term Follow Up|Lost to Follow-up|3
4760028|NCT01659021|16421568|P1|Long-Term Follow Up|Lost to Follow-up|3
4760029|NCT01659021|16421567|P2|Main Study|Study Terminated by Sponsor|1
4760030|NCT01659021|16421568|P1|Main Study|Study Terminated by Sponsor|16
4760031|NCT01659021|16421567|P2|Main Study|Withdrawal by Subject|16
4760032|NCT01659021|16421568|P1|Main Study|Withdrawal by Subject|19
4760033|NCT01659021|16421567|P2|Main Study|Physician Decision|16
4760034|NCT01659021|16421568|P1|Main Study|Physician Decision|34
4760035|NCT01659021|16421567|P2|Main Study|Unknown Reasons|1
4760036|NCT01659021|16421568|P1|Main Study|Unknown Reasons|2
4760037|NCT01659021|16421567|P2|Main Study|Lost to Follow-up|0
4760038|NCT01659021|16421568|P1|Main Study|Lost to Follow-up|1
4760039|NCT01659021|16421567|P2|Main Study|Adverse Event|3
4760040|NCT01659021|16421568|P1|Main Study|Adverse Event|2
4760041|NCT01658943|16421586|P2|Overall Study|Withdrew prior to beginning protocol Tx|0
4760042|NCT01658943|16421587|P1|Overall Study|Withdrew prior to beginning protocol Tx|1
4760043|NCT01658943|16421586|P2|Overall Study|Not eligible|9
4760044|NCT01658943|16421587|P1|Overall Study|Not eligible|7
4760045|NCT01658943|16421586|P2|Overall Study|not protocol specified|1
4760046|NCT01658943|16421587|P1|Overall Study|not protocol specified|4
4760047|NCT01658943|16421586|P2|Overall Study|Death|2
4760048|NCT01658943|16421587|P1|Overall Study|Death|4
4760049|NCT01658943|16421586|P2|Overall Study|Progression/Relapse|40
4760050|NCT01658943|16421587|P1|Overall Study|Progression/Relapse|39
4760051|NCT01658943|16421586|P2|Overall Study|Withdrawal by Subject|2
4760052|NCT01658943|16421587|P1|Overall Study|Withdrawal by Subject|9
4760053|NCT01658943|16421586|P2|Overall Study|Adverse Event|13
4760054|NCT01658943|16421587|P1|Overall Study|Adverse Event|6
4760055|NCT01658904|16421602|P3|Overall Study|Principal Investigator discretion|0
4760056|NCT01658904|16421603|P2|Overall Study|Principal Investigator discretion|0
4760057|NCT01658904|16421604|P1|Overall Study|Principal Investigator discretion|2
4760058|NCT01658813|16421630|P1|Overall Study|Disease progression|3
4760059|NCT01658735|16421641|P3|Overall Study|Withdrawal by Subject|3
4760060|NCT01658735|16421642|P2|Overall Study|Withdrawal by Subject|5
4760061|NCT01658735|16421643|P1|Overall Study|Withdrawal by Subject|3
4760062|NCT01658735|16421641|P3|Overall Study|Protocol Violation|0
4760063|NCT01658735|16421642|P2|Overall Study|Protocol Violation|1
4760064|NCT01658735|16421643|P1|Overall Study|Protocol Violation|0
4760065|NCT01658735|16421641|P3|Overall Study|Lost to Follow-up|0
4760066|NCT01658735|16421642|P2|Overall Study|Lost to Follow-up|1
4760067|NCT01658735|16421643|P1|Overall Study|Lost to Follow-up|1
4760068|NCT01658735|16421641|P3|Overall Study|Lack of Efficacy|1
4760069|NCT01658735|16421642|P2|Overall Study|Lack of Efficacy|0
4760070|NCT01658735|16421643|P1|Overall Study|Lack of Efficacy|1
4760071|NCT01658579|16421685|P4|Treatment Period B|Other|1
4760072|NCT01658579|16421686|P3|Treatment Period B|Other|0
4760073|NCT01658579|16421687|P2|Treatment Period B|Other|0
4760074|NCT01658579|16421688|P1|Treatment Period B|Other|0
4760075|NCT01658579|16421685|P4|Treatment Period A|Adverse Event|0
4760076|NCT01658579|16421686|P3|Treatment Period A|Adverse Event|0
4760077|NCT01658579|16421687|P2|Treatment Period A|Adverse Event|0
4760078|NCT01658579|16421688|P1|Treatment Period A|Adverse Event|1
4760079|NCT01658579|16421685|P4|Treatment Period A|Other|1
4760080|NCT01658579|16421686|P3|Treatment Period A|Other|1
4760081|NCT01658579|16421687|P2|Treatment Period A|Other|0
4760082|NCT01658579|16421688|P1|Treatment Period A|Other|0
4760083|NCT01658514|16421716|P3|Overall Study|Protocol Violation|2
4760084|NCT01658514|16421717|P2|Overall Study|Protocol Violation|0
4760085|NCT01658514|16421718|P1|Overall Study|Protocol Violation|1
4760086|NCT01658436|16421729|P2|Overall Study|Death|0
4760087|NCT01658436|16421730|P1|Overall Study|Death|1
4760088|NCT01658436|16421729|P2|Overall Study|Subject/guardian decision|1
4760089|NCT01658436|16421730|P1|Overall Study|Subject/guardian decision|0
4760090|NCT01658436|16421729|P2|Overall Study|Study terminated by sponsor|1
4760091|NCT01658436|16421730|P1|Overall Study|Study terminated by sponsor|0
4760092|NCT01658436|16421729|P2|Overall Study|Progressive disease|4
4760093|NCT01658436|16421730|P1|Overall Study|Progressive disease|12
4760094|NCT01658436|16421729|P2|Overall Study|Physician Decision|0
4760095|NCT01658436|16421730|P1|Overall Study|Physician Decision|1
4760096|NCT01658436|16421729|P2|Overall Study|Adverse Event|5
4760097|NCT01658436|16421730|P1|Overall Study|Adverse Event|6
4760098|NCT01658150|16421750|P1|Overall Study|Withdrawal by Subject|1
4760099|NCT01658072|16421772|P2|Overall Study|Protocol Violation|2
4760100|NCT01658072|16421773|P1|Overall Study|Protocol Violation|4
4760101|NCT01658020|16421788|P2|Overall Study|Protocol Violation|1
4760102|NCT01658020|16421789|P1|Overall Study|Protocol Violation|0
4760103|NCT01658020|16421788|P2|Overall Study|Withdrawal by Subject|5
4760104|NCT01658020|16421789|P1|Overall Study|Withdrawal by Subject|4
4760105|NCT01658020|16421788|P2|Overall Study|Lost to Follow-up|0
4760106|NCT01658020|16421789|P1|Overall Study|Lost to Follow-up|1
4760107|NCT01658020|16421788|P2|Overall Study|Adverse Event|3
4760108|NCT01658020|16421789|P1|Overall Study|Adverse Event|3
4760109|NCT01657903|16421805|P1|Overall Study|Withdrawal by Subject|1
4760110|NCT01657903|16421805|P1|Overall Study|Lost to Follow-up|1
4760111|NCT01657877|16421827|P1|Overall Study|Other Reason|2
4760112|NCT01657877|16421827|P1|Overall Study|Adverse Event|2
4760113|NCT01657877|16421827|P1|Overall Study|Protocol Violation|6
4760114|NCT01657877|16421827|P1|Overall Study|Withdrawal by Subject|4
4760115|NCT01657799|16421847|P3|Overall Study|Other|49
4760116|NCT01657799|16421848|P2|Overall Study|Other|62
4760117|NCT01657799|16421849|P1|Overall Study|Other|52
4760118|NCT01657799|16421847|P3|Overall Study|Radiographic & Clinical Progression|15
4760119|NCT01657799|16421848|P2|Overall Study|Radiographic & Clinical Progression|11
4760120|NCT01657799|16421849|P1|Overall Study|Radiographic & Clinical Progression|16
4760121|NCT01657799|16421847|P3|Overall Study|Progressive Disease Clinical|7
4760122|NCT01657799|16421848|P2|Overall Study|Progressive Disease Clinical|4
4760123|NCT01657799|16421849|P1|Overall Study|Progressive Disease Clinical|7
4760124|NCT01657799|16421847|P3|Overall Study|Disease Progression|4
4760125|NCT01657799|16421848|P2|Overall Study|Disease Progression|4
4760126|NCT01657799|16421849|P1|Overall Study|Disease Progression|2
4760127|NCT01657799|16421847|P3|Overall Study|Lost to Follow-up|1
4760128|NCT01657799|16421848|P2|Overall Study|Lost to Follow-up|0
4760129|NCT01657799|16421849|P1|Overall Study|Lost to Follow-up|1
4760130|NCT01657799|16421847|P3|Overall Study|Withdrawal by Subject|10
4760131|NCT01657799|16421848|P2|Overall Study|Withdrawal by Subject|10
4760132|NCT01657799|16421849|P1|Overall Study|Withdrawal by Subject|13
4760133|NCT01657799|16421847|P3|Overall Study|Adverse Event Not Related to Progression|4
4760134|NCT01657799|16421848|P2|Overall Study|Adverse Event Not Related to Progression|4
4760135|NCT01657799|16421849|P1|Overall Study|Adverse Event Not Related to Progression|5
4760136|NCT01657799|16421847|P3|Overall Study|Adverse Event Related to progression|12
4760137|NCT01657799|16421848|P2|Overall Study|Adverse Event Related to progression|8
4760138|NCT01657799|16421849|P1|Overall Study|Adverse Event Related to progression|6
4760139|NCT01657760|16421868|P4|Overall Study|Physician Decision|2
4760140|NCT01657760|16421869|P3|Overall Study|Physician Decision|1
4760141|NCT01657760|16421870|P2|Overall Study|Physician Decision|1
4760142|NCT01657760|16421871|P1|Overall Study|Physician Decision|1
4760143|NCT01657760|16421868|P4|Overall Study|Withdrawal by Subject|1
4760144|NCT01657760|16421869|P3|Overall Study|Withdrawal by Subject|0
4760145|NCT01657760|16421870|P2|Overall Study|Withdrawal by Subject|0
4760146|NCT01657760|16421871|P1|Overall Study|Withdrawal by Subject|0
4760147|NCT01657461|16421890|P2|Overall Study|Withdrawal by Subject|3
4760148|NCT01657461|16421891|P1|Overall Study|Withdrawal by Subject|1
4760149|NCT01657461|16421890|P2|Overall Study|Physician Decision|2
4760150|NCT01657461|16421891|P1|Overall Study|Physician Decision|0
4760151|NCT01657461|16421890|P2|Overall Study|Lost to Follow-up|3
4760152|NCT01657461|16421891|P1|Overall Study|Lost to Follow-up|0
4760153|NCT01657461|16421890|P2|Overall Study|Death|12
4760154|NCT01657461|16421891|P1|Overall Study|Death|9
4760155|NCT01657370|16421921|P6|Overall Study|Lost to Follow-up|1
4760156|NCT01657370|16421922|P5|Overall Study|Lost to Follow-up|0
4760157|NCT01657370|16421923|P4|Overall Study|Lost to Follow-up|0
4760158|NCT01657370|16421924|P3|Overall Study|Lost to Follow-up|1
4760159|NCT01657370|16421925|P2|Overall Study|Lost to Follow-up|0
4760160|NCT01657370|16421926|P1|Overall Study|Lost to Follow-up|2
4760161|NCT01657370|16421921|P6|Overall Study|Protocol Violation|0
4760162|NCT01657370|16421922|P5|Overall Study|Protocol Violation|0
4760163|NCT01657370|16421923|P4|Overall Study|Protocol Violation|1
4760164|NCT01657370|16421924|P3|Overall Study|Protocol Violation|1
4760165|NCT01657370|16421925|P2|Overall Study|Protocol Violation|1
4760166|NCT01657370|16421926|P1|Overall Study|Protocol Violation|1
4760167|NCT01657370|16421921|P6|Overall Study|Adverse Event|0
4760168|NCT01657370|16421922|P5|Overall Study|Adverse Event|1
4760169|NCT01657370|16421923|P4|Overall Study|Adverse Event|0
4760170|NCT01657370|16421924|P3|Overall Study|Adverse Event|0
4760171|NCT01657370|16421925|P2|Overall Study|Adverse Event|0
4760172|NCT01657370|16421926|P1|Overall Study|Adverse Event|0
4760173|NCT01657370|16421921|P6|Overall Study|Lack of Qualifying Event|2
4760174|NCT01657370|16421922|P5|Overall Study|Lack of Qualifying Event|1
4760175|NCT01657370|16421923|P4|Overall Study|Lack of Qualifying Event|2
4760176|NCT01657370|16421924|P3|Overall Study|Lack of Qualifying Event|3
4760177|NCT01657370|16421925|P2|Overall Study|Lack of Qualifying Event|0
4760178|NCT01657370|16421926|P1|Overall Study|Lack of Qualifying Event|1
4760179|NCT01657370|16421921|P6|Overall Study|Physician Decision|0
4760180|NCT01657370|16421922|P5|Overall Study|Physician Decision|5
4760181|NCT01657370|16421923|P4|Overall Study|Physician Decision|2
4760182|NCT01657370|16421924|P3|Overall Study|Physician Decision|1
4760183|NCT01657370|16421925|P2|Overall Study|Physician Decision|3
4760184|NCT01657370|16421926|P1|Overall Study|Physician Decision|2
4760185|NCT01657370|16421921|P6|Overall Study|Withdrawal by Subject|1
4760186|NCT01657370|16421922|P5|Overall Study|Withdrawal by Subject|0
4760187|NCT01657370|16421923|P4|Overall Study|Withdrawal by Subject|0
4760188|NCT01657370|16421924|P3|Overall Study|Withdrawal by Subject|1
4760189|NCT01657370|16421925|P2|Overall Study|Withdrawal by Subject|0
4760190|NCT01657370|16421926|P1|Overall Study|Withdrawal by Subject|0
4760191|NCT01657305|16422024|P1|Overall Study|Did not Adhere to Protocol/Procedures|4
4760192|NCT01657305|16422024|P1|Overall Study|Lost to Follow-up|1
4760193|NCT01657305|16422024|P1|Overall Study|Adverse Event|1
4760194|NCT01657305|16422024|P1|Overall Study|Withdrawal by Subject|4
4760195|NCT01657305|16422024|P1|Overall Study|Lack of Wound Closure at Day 28|15
4760196|NCT01657292|16422074|P1|Overall Study|Change of therapy|1
4760197|NCT01657292|16422074|P1|Overall Study|Violation of eligibility criteria|1
4760198|NCT01657292|16422074|P1|Overall Study|Withdrawal by Subject|2
4760199|NCT01657292|16422074|P1|Overall Study|Adverse Event|6
4760200|NCT01657266|16422083|P2|Overall Study|Adverse Event|3
4760201|NCT01657266|16422084|P1|Overall Study|Adverse Event|2
4760202|NCT01657266|16422083|P2|Overall Study|Lost to Follow-up|2
4760203|NCT01657266|16422084|P1|Overall Study|Lost to Follow-up|2
4760204|NCT01657253|16422106|P2|Overall Study|Adverse Event|1
4760205|NCT01657253|16422107|P1|Overall Study|Adverse Event|0
4760206|NCT01657253|16422106|P2|Overall Study|Withdrawal by Subject|12
4760207|NCT01657253|16422107|P1|Overall Study|Withdrawal by Subject|11
4760208|NCT01657253|16422106|P2|Overall Study|Lost to Follow-up|5
4760209|NCT01657253|16422107|P1|Overall Study|Lost to Follow-up|6
4760210|NCT01657032|16422119|P2|Overall Study|Lost to Follow-up|7
4760211|NCT01657032|16422120|P1|Overall Study|Lost to Follow-up|0
4760212|NCT01657019|16422146|P1|Overall Study|Other|58
4760213|NCT01657019|16422146|P1|Overall Study|Lack of Efficacy|3
4760214|NCT01657019|16422146|P1|Overall Study|Protocol Violation|6
4760215|NCT01657019|16422146|P1|Overall Study|Lost to Follow-up|48
4760216|NCT01657019|16422146|P1|Overall Study|Adverse Event|55
4760217|NCT01657019|16422146|P1|Overall Study|Withdrawal by Subject|65
4760218|NCT01656967|16422160|P2|Overall Study|unsuccessful ETT insertion|2
4760219|NCT01656967|16422161|P1|Overall Study|unsuccessful ETT insertion|3
4760220|NCT01656967|16422160|P2|Overall Study|faulty monitor|0
4760221|NCT01656967|16422161|P1|Overall Study|faulty monitor|1
4760222|NCT01656889|16422187|P2|Post Treatment Follow-Up, 3 Months|Site Closure|1
4760223|NCT01656889|16422188|P1|Post Treatment Follow-Up, 3 Months|Site Closure|0
4760224|NCT01656889|16422187|P2|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1
4760225|NCT01656889|16422188|P1|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2
4760226|NCT01656889|16422187|P2|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2
4760227|NCT01656889|16422188|P1|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1
4760228|NCT01656889|16422187|P2|Post Treatment Follow-Up, 3 Months|Death|5
4760229|NCT01656889|16422188|P1|Post Treatment Follow-Up, 3 Months|Death|1
4760230|NCT01656889|16422187|P2|Treatment Period, 12 Weeks|Moved out of the area|2
4760231|NCT01656889|16422188|P1|Treatment Period, 12 Weeks|Moved out of the area|0
4760232|NCT01656889|16422187|P2|Treatment Period, 12 Weeks|Protocol Violation|1
4760233|NCT01656889|16422188|P1|Treatment Period, 12 Weeks|Protocol Violation|0
4760234|NCT01656889|16422187|P2|Treatment Period, 12 Weeks|Withdrawal by Subject|2
4760235|NCT01656889|16422188|P1|Treatment Period, 12 Weeks|Withdrawal by Subject|1
4760236|NCT01656889|16422187|P2|Treatment Period, 12 Weeks|Lost to Follow-up|1
4760237|NCT01656889|16422188|P1|Treatment Period, 12 Weeks|Lost to Follow-up|1
4760238|NCT01656889|16422187|P2|Treatment Period, 12 Weeks|Death|1
4760239|NCT01656889|16422188|P1|Treatment Period, 12 Weeks|Death|0
4760240|NCT01656889|16422187|P2|Treatment Period, 12 Weeks|Adverse Event|4
4760241|NCT01656889|16422188|P1|Treatment Period, 12 Weeks|Adverse Event|10
4760242|NCT01656850|16422208|P2|First Intervention (3 Months)|Withdrawal by Subject|4
4760243|NCT01656850|16422209|P1|First Intervention (3 Months)|Withdrawal by Subject|3
4760244|NCT01656759|16422300|P2|Overall Study|Protocol Violation|3
4760245|NCT01656759|16422301|P1|Overall Study|Protocol Violation|2
4760246|NCT01656733|16422315|P2|Overall Study|Spontaneous abortion|1
4760247|NCT01656733|16422316|P1|Overall Study|Spontaneous abortion|0
4760248|NCT01656733|16422315|P2|Overall Study|Delivery at another hospital|2
4760249|NCT01656733|16422316|P1|Overall Study|Delivery at another hospital|0
4760250|NCT01656733|16422315|P2|Overall Study|No permission to collect birth outcomes|1
4760251|NCT01656733|16422316|P1|Overall Study|No permission to collect birth outcomes|0
4760252|NCT01656434|16422366|P2|Overall Study|Withdrawal by Subject|7
4760253|NCT01656434|16422367|P1|Overall Study|Withdrawal by Subject|64
4760254|NCT01656434|16422366|P2|Overall Study|Participant withdrew consent|9
4760255|NCT01656434|16422367|P1|Overall Study|Participant withdrew consent|28
4760256|NCT01656434|16422366|P2|Overall Study|Participant moved|12
4760257|NCT01656434|16422367|P1|Overall Study|Participant moved|40
4760258|NCT01656434|16422366|P2|Overall Study|Non-compliance with protocol|15
4760259|NCT01656434|16422367|P1|Overall Study|Non-compliance with protocol|39
4760260|NCT01656434|16422366|P2|Overall Study|Part. discontinued; unrelated to drug|10
4760261|NCT01656434|16422367|P1|Overall Study|Part. discontinued; unrelated to drug|55
4760262|NCT01656434|16422366|P2|Overall Study|Participant discontinued; drug related|4
4760263|NCT01656434|16422367|P1|Overall Study|Participant discontinued; drug related|13
4760264|NCT01656434|16422366|P2|Overall Study|Study terminated by sponsor|348
4760265|NCT01656434|16422367|P1|Overall Study|Study terminated by sponsor|1501
4760266|NCT01656434|16422366|P2|Overall Study|Non-compliance with study drug|9
4760267|NCT01656434|16422367|P1|Overall Study|Non-compliance with study drug|48
4760268|NCT01656434|16422366|P2|Overall Study|Physician Decision|2
4760269|NCT01656434|16422367|P1|Overall Study|Physician Decision|7
4760270|NCT01656434|16422366|P2|Overall Study|Pregnancy|10
4760271|NCT01656434|16422367|P1|Overall Study|Pregnancy|45
4760272|NCT01656434|16422366|P2|Overall Study|Pregnancy wish|6
4760273|NCT01656434|16422367|P1|Overall Study|Pregnancy wish|18
4760274|NCT01656434|16422366|P2|Overall Study|Protocol Violation|0
4760275|NCT01656434|16422367|P1|Overall Study|Protocol Violation|7
4760276|NCT01656434|16422366|P2|Overall Study|Screen failure|0
4760277|NCT01656434|16422367|P1|Overall Study|Screen failure|2
4760278|NCT01656434|16422366|P2|Overall Study|Site discontinued study participation|9
4760279|NCT01656434|16422367|P1|Overall Study|Site discontinued study participation|24
4760280|NCT01656434|16422366|P2|Overall Study|Lost to Follow-up|76
4760281|NCT01656434|16422367|P1|Overall Study|Lost to Follow-up|309
4760282|NCT01656434|16422366|P2|Overall Study|Enrollment terminated at trial site|0
4760283|NCT01656434|16422367|P1|Overall Study|Enrollment terminated at trial site|2
4760284|NCT01656434|16422366|P2|Overall Study|Adverse Event|63
4760285|NCT01656434|16422367|P1|Overall Study|Adverse Event|199
4760286|NCT01656408|16422393|P10|Overall Study|Physician Decision|3
4760287|NCT01656408|16422394|P9|Overall Study|Physician Decision|1
4760288|NCT01656408|16422395|P8|Overall Study|Physician Decision|1
4760289|NCT01656408|16422396|P7|Overall Study|Physician Decision|0
4760290|NCT01656408|16422397|P6|Overall Study|Physician Decision|1
4760291|NCT01656408|16422398|P5|Overall Study|Physician Decision|1
4760292|NCT01656408|16422399|P4|Overall Study|Physician Decision|0
4760293|NCT01656408|16422400|P3|Overall Study|Physician Decision|1
4760294|NCT01656408|16422401|P2|Overall Study|Physician Decision|0
4760295|NCT01656408|16422402|P1|Overall Study|Physician Decision|1
4760296|NCT01656408|16422393|P10|Overall Study|Adverse Event|0
4760297|NCT01656408|16422394|P9|Overall Study|Adverse Event|1
4760298|NCT01656408|16422395|P8|Overall Study|Adverse Event|0
4760299|NCT01656408|16422396|P7|Overall Study|Adverse Event|1
4760300|NCT01656408|16422397|P6|Overall Study|Adverse Event|1
4760301|NCT01656408|16422398|P5|Overall Study|Adverse Event|0
4760302|NCT01656408|16422399|P4|Overall Study|Adverse Event|0
4760303|NCT01656408|16422400|P3|Overall Study|Adverse Event|1
4760304|NCT01656408|16422401|P2|Overall Study|Adverse Event|0
4760305|NCT01656408|16422402|P1|Overall Study|Adverse Event|0
4760306|NCT01656395|16422597|P8|Overall Study|Withdrawal by Subject|0
4760307|NCT01656395|16422598|P7|Overall Study|Withdrawal by Subject|0
4760308|NCT01656395|16422599|P6|Overall Study|Withdrawal by Subject|3
4760309|NCT01656395|16422600|P5|Overall Study|Withdrawal by Subject|0
4760310|NCT01656395|16422601|P4|Overall Study|Withdrawal by Subject|2
4760311|NCT01656395|16422602|P3|Overall Study|Withdrawal by Subject|4
4760312|NCT01656395|16422603|P2|Overall Study|Withdrawal by Subject|1
4760313|NCT01656395|16422604|P1|Overall Study|Withdrawal by Subject|3
4760314|NCT01656395|16422597|P8|Overall Study|Screen Failure|0
4760315|NCT01656395|16422598|P7|Overall Study|Screen Failure|0
4760316|NCT01656395|16422599|P6|Overall Study|Screen Failure|8
4760317|NCT01656395|16422600|P5|Overall Study|Screen Failure|0
4760318|NCT01656395|16422601|P4|Overall Study|Screen Failure|1
4760319|NCT01656395|16422602|P3|Overall Study|Screen Failure|7
4760320|NCT01656395|16422603|P2|Overall Study|Screen Failure|1
4760321|NCT01656395|16422604|P1|Overall Study|Screen Failure|2
4760322|NCT01656395|16422597|P8|Overall Study|Protocol Violation|0
4760323|NCT01656395|16422598|P7|Overall Study|Protocol Violation|0
4760324|NCT01656395|16422599|P6|Overall Study|Protocol Violation|10
4760325|NCT01656395|16422600|P5|Overall Study|Protocol Violation|4
4760326|NCT01656395|16422601|P4|Overall Study|Protocol Violation|2
4760327|NCT01656395|16422602|P3|Overall Study|Protocol Violation|9
4760328|NCT01656395|16422603|P2|Overall Study|Protocol Violation|6
4760329|NCT01656395|16422604|P1|Overall Study|Protocol Violation|6
4760330|NCT01656395|16422597|P8|Overall Study|Progressive Disease|0
4760331|NCT01656395|16422598|P7|Overall Study|Progressive Disease|0
4760332|NCT01656395|16422599|P6|Overall Study|Progressive Disease|1
4760333|NCT01656395|16422600|P5|Overall Study|Progressive Disease|0
4760334|NCT01656395|16422601|P4|Overall Study|Progressive Disease|0
4760335|NCT01656395|16422602|P3|Overall Study|Progressive Disease|0
4760336|NCT01656395|16422603|P2|Overall Study|Progressive Disease|0
4760337|NCT01656395|16422604|P1|Overall Study|Progressive Disease|0
4760338|NCT01656395|16422597|P8|Overall Study|Pregnancy|0
4760339|NCT01656395|16422598|P7|Overall Study|Pregnancy|0
4760340|NCT01656395|16422599|P6|Overall Study|Pregnancy|0
4760341|NCT01656395|16422600|P5|Overall Study|Pregnancy|0
4760342|NCT01656395|16422601|P4|Overall Study|Pregnancy|0
4760343|NCT01656395|16422602|P3|Overall Study|Pregnancy|1
4760344|NCT01656395|16422603|P2|Overall Study|Pregnancy|0
4760345|NCT01656395|16422604|P1|Overall Study|Pregnancy|0
4760346|NCT01656395|16422597|P8|Overall Study|Physician Decision|0
4760347|NCT01656395|16422598|P7|Overall Study|Physician Decision|0
4760348|NCT01656395|16422599|P6|Overall Study|Physician Decision|3
4760349|NCT01656395|16422600|P5|Overall Study|Physician Decision|3
4760350|NCT01656395|16422601|P4|Overall Study|Physician Decision|2
4760351|NCT01656395|16422602|P3|Overall Study|Physician Decision|3
4760352|NCT01656395|16422603|P2|Overall Study|Physician Decision|3
4760353|NCT01656395|16422604|P1|Overall Study|Physician Decision|2
4760354|NCT01656395|16422597|P8|Overall Study|Other|0
4760355|NCT01656395|16422598|P7|Overall Study|Other|0
4760356|NCT01656395|16422599|P6|Overall Study|Other|1
4760357|NCT01656395|16422600|P5|Overall Study|Other|0
4760358|NCT01656395|16422601|P4|Overall Study|Other|0
4760359|NCT01656395|16422602|P3|Overall Study|Other|1
4760360|NCT01656395|16422603|P2|Overall Study|Other|0
4760361|NCT01656395|16422604|P1|Overall Study|Other|0
4760362|NCT01656395|16422597|P8|Overall Study|Non-Compliance with Study Drug|0
4760363|NCT01656395|16422598|P7|Overall Study|Non-Compliance with Study Drug|0
4760364|NCT01656395|16422599|P6|Overall Study|Non-Compliance with Study Drug|1
4760365|NCT01656395|16422600|P5|Overall Study|Non-Compliance with Study Drug|1
4760366|NCT01656395|16422601|P4|Overall Study|Non-Compliance with Study Drug|0
4760367|NCT01656395|16422602|P3|Overall Study|Non-Compliance with Study Drug|0
4760368|NCT01656395|16422603|P2|Overall Study|Non-Compliance with Study Drug|1
4760369|NCT01656395|16422604|P1|Overall Study|Non-Compliance with Study Drug|1
4760370|NCT01656395|16422597|P8|Overall Study|Lost to Follow-up|0
4760371|NCT01656395|16422598|P7|Overall Study|Lost to Follow-up|0
4760372|NCT01656395|16422599|P6|Overall Study|Lost to Follow-up|0
4760373|NCT01656395|16422600|P5|Overall Study|Lost to Follow-up|0
4760374|NCT01656395|16422601|P4|Overall Study|Lost to Follow-up|0
4760375|NCT01656395|16422602|P3|Overall Study|Lost to Follow-up|0
4760376|NCT01656395|16422603|P2|Overall Study|Lost to Follow-up|0
4760377|NCT01656395|16422604|P1|Overall Study|Lost to Follow-up|1
4760378|NCT01656395|16422597|P8|Overall Study|Lack of Efficacy|0
4760379|NCT01656395|16422598|P7|Overall Study|Lack of Efficacy|0
4760380|NCT01656395|16422599|P6|Overall Study|Lack of Efficacy|6
4760381|NCT01656395|16422600|P5|Overall Study|Lack of Efficacy|1
4760382|NCT01656395|16422601|P4|Overall Study|Lack of Efficacy|1
4760383|NCT01656395|16422602|P3|Overall Study|Lack of Efficacy|6
4760384|NCT01656395|16422603|P2|Overall Study|Lack of Efficacy|8
4760385|NCT01656395|16422604|P1|Overall Study|Lack of Efficacy|1
4760386|NCT01656395|16422597|P8|Overall Study|Adverse Event|0
4760387|NCT01656395|16422598|P7|Overall Study|Adverse Event|0
4760388|NCT01656395|16422599|P6|Overall Study|Adverse Event|7
4760389|NCT01656395|16422600|P5|Overall Study|Adverse Event|5
4760390|NCT01656395|16422601|P4|Overall Study|Adverse Event|4
4760391|NCT01656395|16422602|P3|Overall Study|Adverse Event|5
4760392|NCT01656395|16422603|P2|Overall Study|Adverse Event|14
4760393|NCT01656395|16422604|P1|Overall Study|Adverse Event|1
4760394|NCT01656304|16422690|P1|Overall Study|Ineligible, uncontrolled hypertension|1
4760395|NCT01656200|16422731|P1|Overall Study|Withdrawal by Subject|1
4760396|NCT01656161|16422746|P1|Overall Study|Withdrawal by Subject|1
4760397|NCT01656161|16422746|P1|Overall Study|Protocol Violation|1
4760398|NCT01656161|16422746|P1|Overall Study|Adverse Event|2
4760399|NCT01656161|16422746|P1|Overall Study|Death|3
4760400|NCT01655901|16422764|P6|Third Intervention (Hour 3)|Lost to Follow-up|0
4760401|NCT01655901|16422765|P5|Third Intervention (Hour 3)|Lost to Follow-up|1
4760402|NCT01655901|16422766|P4|Third Intervention (Hour 3)|Lost to Follow-up|0
4760403|NCT01655901|16422767|P3|Third Intervention (Hour 3)|Lost to Follow-up|1
4760404|NCT01655901|16422768|P2|Third Intervention (Hour 3)|Lost to Follow-up|1
4760405|NCT01655901|16422769|P1|Third Intervention (Hour 3)|Lost to Follow-up|1
4760406|NCT01655823|16422783|P5|Overall Study|Withdrawal by Subject|0
4760407|NCT01655823|16422784|P4|Overall Study|Withdrawal by Subject|1
4760408|NCT01655823|16422785|P3|Overall Study|Withdrawal by Subject|0
4760409|NCT01655823|16422786|P2|Overall Study|Withdrawal by Subject|1
4760410|NCT01655823|16422787|P1|Overall Study|Withdrawal by Subject|0
4760411|NCT01655823|16422783|P5|Overall Study|Lost to Follow-up|1
4760412|NCT01655823|16422784|P4|Overall Study|Lost to Follow-up|0
4760413|NCT01655823|16422785|P3|Overall Study|Lost to Follow-up|0
4760414|NCT01655823|16422786|P2|Overall Study|Lost to Follow-up|1
4760415|NCT01655823|16422787|P1|Overall Study|Lost to Follow-up|0
4760416|NCT01655498|16422818|P1|Overall Study|Withdrawal by Subject|1
4760417|NCT01655498|16422818|P1|Overall Study|Protocol Violation|2
4760418|NCT01655498|16422818|P1|Overall Study|Unrelated health issue|2
4760419|NCT01655381|16422825|P1|Overall Study|Insufficient Treatment Response|1
4760420|NCT01655381|16422825|P1|Overall Study|Moved to Another City|1
4760421|NCT01655381|16422825|P1|Overall Study|Investigator Decision|1
4760422|NCT01655069|16422865|P4|Overall Study|Withdrawal by Subject|0
4760423|NCT01655069|16422866|P3|Overall Study|Withdrawal by Subject|0
4760424|NCT01655069|16422867|P2|Overall Study|Withdrawal by Subject|3
4760425|NCT01655069|16422868|P1|Overall Study|Withdrawal by Subject|2
4760426|NCT01655069|16422865|P4|Overall Study|No Treatment Needed|0
4760427|NCT01655069|16422866|P3|Overall Study|No Treatment Needed|0
4760428|NCT01655069|16422867|P2|Overall Study|No Treatment Needed|1
4760429|NCT01655069|16422868|P1|Overall Study|No Treatment Needed|0
4760430|NCT01655069|16422865|P4|Overall Study|Lack of Efficacy|0
4760431|NCT01655069|16422866|P3|Overall Study|Lack of Efficacy|0
4760432|NCT01655069|16422867|P2|Overall Study|Lack of Efficacy|1
4760433|NCT01655069|16422868|P1|Overall Study|Lack of Efficacy|0
4760434|NCT01655069|16422865|P4|Overall Study|Adverse Event|3
4760435|NCT01655069|16422866|P3|Overall Study|Adverse Event|2
4760436|NCT01655069|16422867|P2|Overall Study|Adverse Event|7
4760437|NCT01655069|16422868|P1|Overall Study|Adverse Event|6
4760438|NCT01655069|16422865|P4|Overall Study|Physician Decision|1
4760439|NCT01655069|16422866|P3|Overall Study|Physician Decision|0
4760440|NCT01655069|16422867|P2|Overall Study|Physician Decision|0
4760441|NCT01655069|16422868|P1|Overall Study|Physician Decision|0
4760442|NCT01654666|16422928|P3|Overall Study|Withdrawal by Subject|1
4760443|NCT01654666|16422929|P2|Overall Study|Withdrawal by Subject|4
4760444|NCT01654666|16422930|P1|Overall Study|Withdrawal by Subject|4
4760445|NCT01654666|16422928|P3|Overall Study|Lost to Follow-up|5
4760446|NCT01654666|16422929|P2|Overall Study|Lost to Follow-up|5
4760447|NCT01654666|16422930|P1|Overall Study|Lost to Follow-up|4
4760448|NCT01654666|16422928|P3|Overall Study|Protocol Violation|8
4760449|NCT01654666|16422929|P2|Overall Study|Protocol Violation|4
4760450|NCT01654666|16422930|P1|Overall Study|Protocol Violation|7
4760451|NCT01654601|16422955|P2|2nd Administration|Protocol Violation|1
4760452|NCT01654601|16422956|P1|2nd Administration|Protocol Violation|0
4760453|NCT01654601|16422955|P2|2nd Administration|Adverse Event|0
4760454|NCT01654601|16422956|P1|2nd Administration|Adverse Event|1
4760455|NCT01654601|16422955|P2|1st Administration|Protocol Violation|2
4760456|NCT01654601|16422956|P1|1st Administration|Protocol Violation|0
4760457|NCT01654601|16422955|P2|1st Administration|Withdrawal by Subject|0
4760458|NCT01654601|16422956|P1|1st Administration|Withdrawal by Subject|2
4760459|NCT01654549|16422970|P2|Overall Study|H.pylori eradication not successful|1
4760460|NCT01654549|16422971|P1|Overall Study|H.pylori eradication not successful|0
4760461|NCT01654536|16422983|P2|Overall Study|Withdrawal by Subject|25
4760462|NCT01654536|16422984|P1|Overall Study|Withdrawal by Subject|27
4760463|NCT01654536|16422983|P2|Overall Study|Physician Decision|8
4760464|NCT01654536|16422984|P1|Overall Study|Physician Decision|12
4760465|NCT01654536|16422983|P2|Overall Study|Lost to Follow-up|5
4760466|NCT01654536|16422984|P1|Overall Study|Lost to Follow-up|5
4760467|NCT01654523|16423020|P1|Overall Study|Withdrawal by Subject|1
4760468|NCT01654380|16423026|P4|Part B, Period 1|Physician Decision|0
4760469|NCT01654380|16423027|P3|Part B, Period 1|Physician Decision|1
4760470|NCT01654380|16423028|P2|Part B, Period 1|Physician Decision|0
4760471|NCT01654380|16423029|P1|Part B, Period 1|Physician Decision|0
4760472|NCT01654302|16423072|P2|Second Intervention (Day 7)|Lost to Follow-up|1
4760473|NCT01654302|16423073|P1|Second Intervention (Day 7)|Lost to Follow-up|1
4760474|NCT01654289|16423082|P3|Overall Study|Withdrew from intervention only|0
4760475|NCT01654289|16423083|P2|Overall Study|Withdrew from intervention only|20
4760476|NCT01654289|16423084|P1|Overall Study|Withdrew from intervention only|17
4760477|NCT01654289|16423082|P3|Overall Study|Withdrawal by Subject|5
4760478|NCT01654289|16423083|P2|Overall Study|Withdrawal by Subject|8
4760479|NCT01654289|16423084|P1|Overall Study|Withdrawal by Subject|10
4760480|NCT01654276|16423122|P1|Overall Study|Withdrawal by Subject|1
4760481|NCT01654276|16423122|P1|Overall Study|Lost to Follow-up|4
4760482|NCT01654276|16423122|P1|Overall Study|Lack of Efficacy|1
4760483|NCT01654250|16423176|P2|Overall Study|Lost to Follow-up|0
4760484|NCT01654250|16423177|P1|Overall Study|Lost to Follow-up|1
4760485|NCT01654224|16423194|P2|Overall Study|Insufficient blood sample|2
4760486|NCT01654224|16423195|P1|Overall Study|Insufficient blood sample|3
4760487|NCT01654224|16423194|P2|Overall Study|Did not receive allocation|8
4760488|NCT01654224|16423195|P1|Overall Study|Did not receive allocation|1
4760489|NCT01654224|16423194|P2|Overall Study|Lost to Follow-up|2
4760490|NCT01654224|16423195|P1|Overall Study|Lost to Follow-up|2
4760491|NCT01653912|16423226|P6|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1
4760492|NCT01653912|16423227|P5|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4760493|NCT01653912|16423228|P4|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4760494|NCT01653912|16423229|P3|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4760495|NCT01653912|16423230|P2|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4760496|NCT01653912|16423231|P1|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0
4760497|NCT01653912|16423226|P6|Phase 2: GSK2110183 125 mg|Clinical Progression|6
4760498|NCT01653912|16423227|P5|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4760499|NCT01653912|16423228|P4|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4760500|NCT01653912|16423229|P3|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4760501|NCT01653912|16423230|P2|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4760502|NCT01653912|16423231|P1|Phase 2: GSK2110183 125 mg|Clinical Progression|0
4760503|NCT01653912|16423226|P6|Phase 2: GSK2110183 125 mg|Adverse Event|1
4760504|NCT01653912|16423227|P5|Phase 2: GSK2110183 125 mg|Adverse Event|0
4760505|NCT01653912|16423228|P4|Phase 2: GSK2110183 125 mg|Adverse Event|0
4760506|NCT01653912|16423229|P3|Phase 2: GSK2110183 125 mg|Adverse Event|0
4760507|NCT01653912|16423230|P2|Phase 2: GSK2110183 125 mg|Adverse Event|0
4760508|NCT01653912|16423231|P1|Phase 2: GSK2110183 125 mg|Adverse Event|0
4760509|NCT01653912|16423226|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4760510|NCT01653912|16423227|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4760511|NCT01653912|16423228|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1
4760512|NCT01653912|16423229|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4760513|NCT01653912|16423230|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4760514|NCT01653912|16423231|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0
4760515|NCT01653912|16423226|P6|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4760516|NCT01653912|16423227|P5|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4760517|NCT01653912|16423228|P4|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1
4760518|NCT01653912|16423229|P3|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4760519|NCT01653912|16423230|P2|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4760520|NCT01653912|16423231|P1|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0
4760521|NCT01653912|16423226|P6|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4760522|NCT01653912|16423227|P5|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4760523|NCT01653912|16423228|P4|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4760524|NCT01653912|16423229|P3|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2
4760525|NCT01653912|16423230|P2|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4760526|NCT01653912|16423231|P1|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0
4760527|NCT01653912|16423226|P6|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4760528|NCT01653912|16423227|P5|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4760529|NCT01653912|16423228|P4|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4760530|NCT01653912|16423229|P3|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4760531|NCT01653912|16423230|P2|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1
4760532|NCT01653912|16423231|P1|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0
4760533|NCT01653782|16423249|P3|Overall Study|Lost to Follow-up|2
4760534|NCT01653782|16423250|P2|Overall Study|Lost to Follow-up|3
4760535|NCT01653782|16423251|P1|Overall Study|Lost to Follow-up|7
4760536|NCT01653782|16423249|P3|Overall Study|Withdrawal by Subject|4
4760537|NCT01653782|16423250|P2|Overall Study|Withdrawal by Subject|15
4760538|NCT01653782|16423251|P1|Overall Study|Withdrawal by Subject|9
4760539|NCT01653743|16423261|P2|Overall Study|Investigator discretion|0
4760540|NCT01653743|16423262|P1|Overall Study|Investigator discretion|3
4760541|NCT01653743|16423261|P2|Overall Study|Withdrawal by Subject|0
4760542|NCT01653743|16423262|P1|Overall Study|Withdrawal by Subject|1
4760543|NCT01653704|16423278|P2|Overall Study|Performance not reflective of training|0
4760544|NCT01653704|16423279|P1|Overall Study|Performance not reflective of training|1
4760545|NCT01653704|16423278|P2|Overall Study|Technical failure during recording|1
4760546|NCT01653704|16423279|P1|Overall Study|Technical failure during recording|1
4760547|NCT01653327|16423348|P1|Overall Study|Withdrawal by Subject|1
4760548|NCT01653262|16423373|P1|Overall Study|AE, non-serious non-fatal|1
4760549|NCT01653262|16423373|P1|Overall Study|SAE, non-fatal|1
4760550|NCT01653262|16423373|P1|Overall Study|Lack of Efficacy|1
4760551|NCT01653158|16423391|P8|Overall Study|Withdrawal by Subject|0
4760552|NCT01653158|16423392|P7|Overall Study|Withdrawal by Subject|0
4760553|NCT01653158|16423393|P6|Overall Study|Withdrawal by Subject|0
4760554|NCT01653158|16423394|P5|Overall Study|Withdrawal by Subject|0
4760555|NCT01653158|16423395|P4|Overall Study|Withdrawal by Subject|0
4760556|NCT01653158|16423396|P3|Overall Study|Withdrawal by Subject|0
4760557|NCT01653158|16423397|P2|Overall Study|Withdrawal by Subject|0
4760558|NCT01653158|16423398|P1|Overall Study|Withdrawal by Subject|1
4760559|NCT01653158|16423391|P8|Overall Study|Progressive disease|9
4760560|NCT01653158|16423392|P7|Overall Study|Progressive disease|2
4760561|NCT01653158|16423393|P6|Overall Study|Progressive disease|1
4760562|NCT01653158|16423394|P5|Overall Study|Progressive disease|1
4760563|NCT01653158|16423395|P4|Overall Study|Progressive disease|0
4760564|NCT01653158|16423396|P3|Overall Study|Progressive disease|0
4760565|NCT01653158|16423397|P2|Overall Study|Progressive disease|0
4760566|NCT01653158|16423398|P1|Overall Study|Progressive disease|0
4760567|NCT01653158|16423391|P8|Overall Study|Other|1
4760568|NCT01653158|16423392|P7|Overall Study|Other|0
4760569|NCT01653158|16423393|P6|Overall Study|Other|0
4760570|NCT01653158|16423394|P5|Overall Study|Other|0
4760571|NCT01653158|16423395|P4|Overall Study|Other|0
4760572|NCT01653158|16423396|P3|Overall Study|Other|0
4760573|NCT01653158|16423397|P2|Overall Study|Other|0
4760574|NCT01653158|16423398|P1|Overall Study|Other|0
4760575|NCT01653158|16423391|P8|Overall Study|Adverse Event|3
4760576|NCT01653158|16423392|P7|Overall Study|Adverse Event|0
4760577|NCT01653158|16423393|P6|Overall Study|Adverse Event|0
4760578|NCT01653158|16423394|P5|Overall Study|Adverse Event|0
4760579|NCT01653158|16423395|P4|Overall Study|Adverse Event|1
4760580|NCT01653158|16423396|P3|Overall Study|Adverse Event|0
4760581|NCT01653158|16423397|P2|Overall Study|Adverse Event|0
4760582|NCT01653158|16423398|P1|Overall Study|Adverse Event|0
4760583|NCT01653158|16423391|P8|Overall Study|Death|2
4760584|NCT01653158|16423392|P7|Overall Study|Death|0
4760585|NCT01653158|16423393|P6|Overall Study|Death|0
4760586|NCT01653158|16423394|P5|Overall Study|Death|0
4760587|NCT01653158|16423395|P4|Overall Study|Death|1
4760588|NCT01653158|16423396|P3|Overall Study|Death|0
4760589|NCT01653158|16423397|P2|Overall Study|Death|0
4760590|NCT01653158|16423398|P1|Overall Study|Death|0
4760591|NCT01653132|16423670|P2|First Intervention|Protocol Violation|0
4760592|NCT01653132|16423671|P1|First Intervention|Protocol Violation|1
4760593|NCT01652885|16423735|P1|Overall Study|Adverse Event|1
4760594|NCT01652872|16423762|P2|Overall Study|Withdrawal by Subject|84
4760595|NCT01652872|16423763|P1|Overall Study|Withdrawal by Subject|76
4760596|NCT01652872|16423762|P2|Overall Study|Decision by sponsor|7
4760597|NCT01652872|16423763|P1|Overall Study|Decision by sponsor|5
4760598|NCT01652872|16423762|P2|Overall Study|Lost to Follow-up|23
4760599|NCT01652872|16423763|P1|Overall Study|Lost to Follow-up|28
4760600|NCT01652872|16423762|P2|Overall Study|Death|39
4760601|NCT01652872|16423763|P1|Overall Study|Death|36
4760602|NCT01652729|16423780|P3|Overall Study|Administrative|0
4760603|NCT01652729|16423781|P2|Overall Study|Administrative|0
4760604|NCT01652729|16423782|P1|Overall Study|Administrative|1
4760605|NCT01652729|16423780|P3|Overall Study|Lost to Follow-up|3
4760606|NCT01652729|16423781|P2|Overall Study|Lost to Follow-up|6
4760607|NCT01652729|16423782|P1|Overall Study|Lost to Follow-up|6
4760608|NCT01652729|16423780|P3|Overall Study|Protocol Violation|0
4760609|NCT01652729|16423781|P2|Overall Study|Protocol Violation|0
4760610|NCT01652729|16423782|P1|Overall Study|Protocol Violation|1
4760611|NCT01652729|16423780|P3|Overall Study|Physician Decision|1
4760612|NCT01652729|16423781|P2|Overall Study|Physician Decision|0
4760613|NCT01652729|16423782|P1|Overall Study|Physician Decision|1
4760614|NCT01652729|16423780|P3|Overall Study|Adverse Event|3
4760615|NCT01652729|16423781|P2|Overall Study|Adverse Event|0
4760616|NCT01652729|16423782|P1|Overall Study|Adverse Event|4
4760617|NCT01652729|16423780|P3|Overall Study|Withdrawal by Subject|7
4760618|NCT01652729|16423781|P2|Overall Study|Withdrawal by Subject|7
4760619|NCT01652729|16423782|P1|Overall Study|Withdrawal by Subject|14
4760620|NCT01652716|16423804|P2|Overall Study|Withdrawal by Subject|18
4760621|NCT01652716|16423805|P1|Overall Study|Withdrawal by Subject|33
4760622|NCT01652716|16423804|P2|Overall Study|Adverse Event|10
4760623|NCT01652716|16423805|P1|Overall Study|Adverse Event|7
4760624|NCT01652716|16423804|P2|Overall Study|Protocol Violation|1
4760625|NCT01652716|16423805|P1|Overall Study|Protocol Violation|2
4760626|NCT01652716|16423804|P2|Overall Study|Lost to Follow-up|11
4760627|NCT01652716|16423805|P1|Overall Study|Lost to Follow-up|12
4760628|NCT01652716|16423804|P2|Overall Study|Investigator decision|4
4760629|NCT01652716|16423805|P1|Overall Study|Investigator decision|1
4760630|NCT01652716|16423804|P2|Overall Study|Administrative|2
4760631|NCT01652716|16423805|P1|Overall Study|Administrative|0
4760632|NCT01652716|16423804|P2|Overall Study|Loss of glucose control|0
4760633|NCT01652716|16423805|P1|Overall Study|Loss of glucose control|1
4760634|NCT01652703|16423825|P6|Overall Study|Other|1
4760635|NCT01652703|16423826|P5|Overall Study|Other|1
4760636|NCT01652703|16423827|P4|Overall Study|Other|1
4760637|NCT01652703|16423828|P3|Overall Study|Other|0
4760638|NCT01652703|16423829|P2|Overall Study|Other|0
4760639|NCT01652703|16423830|P1|Overall Study|Other|0
4760640|NCT01652703|16423825|P6|Overall Study|Withdrawal by Subject|1
4760641|NCT01652703|16423826|P5|Overall Study|Withdrawal by Subject|0
4760642|NCT01652703|16423827|P4|Overall Study|Withdrawal by Subject|1
4760643|NCT01652703|16423828|P3|Overall Study|Withdrawal by Subject|3
4760644|NCT01652703|16423829|P2|Overall Study|Withdrawal by Subject|1
4760645|NCT01652703|16423830|P1|Overall Study|Withdrawal by Subject|0
4760646|NCT01652690|16423888|P2|Overall Study|Death|2
4760647|NCT01652690|16423889|P1|Overall Study|Death|5
4760648|NCT01652690|16423888|P2|Overall Study|Lost to Follow-up|6
4760649|NCT01652690|16423889|P1|Overall Study|Lost to Follow-up|6
4760650|NCT01652690|16423888|P2|Overall Study|Other|9
4760651|NCT01652690|16423889|P1|Overall Study|Other|8
4760652|NCT01652690|16423888|P2|Overall Study|Withdrawal by Subject|4
4760653|NCT01652690|16423889|P1|Overall Study|Withdrawal by Subject|16
4760654|NCT01652664|16423923|P2|Overall Study|Inadequate IOP control|0
4760655|NCT01652664|16423924|P1|Overall Study|Inadequate IOP control|1
4760656|NCT01652664|16423923|P2|Overall Study|Treatment Failure|1
4760657|NCT01652664|16423924|P1|Overall Study|Treatment Failure|5
4760658|NCT01652573|16423933|P2|Overall Study|Adverse Event|1
4760659|NCT01652573|16423934|P1|Overall Study|Adverse Event|0
4760660|NCT01652534|16423976|P2|Overall Study|Lack of Efficacy|0
4760661|NCT01652534|16423977|P1|Overall Study|Lack of Efficacy|1
4760662|NCT01652469|16424018|P2|Overall Study|Lost to Follow-up|2
4760663|NCT01652469|16424019|P1|Overall Study|Lost to Follow-up|0
4760664|NCT01652469|16424018|P2|Overall Study|Withdrawal by Subject|4
4760665|NCT01652469|16424019|P1|Overall Study|Withdrawal by Subject|1
4760666|NCT01652287|16424035|P2|Overall Study|Withdrawal by Subject|0
4760667|NCT01652287|16424036|P1|Overall Study|Withdrawal by Subject|2
4760668|NCT01651949|16424067|P3|Overall Study|Withdrawal by Subject|9
4760669|NCT01651949|16424068|P2|Overall Study|Withdrawal by Subject|18
4760670|NCT01651949|16424069|P1|Overall Study|Withdrawal by Subject|17
4760671|NCT01651949|16424067|P3|Overall Study|Screen failure|0
4760672|NCT01651949|16424068|P2|Overall Study|Screen failure|2
4760673|NCT01651949|16424069|P1|Overall Study|Screen failure|2
4760674|NCT01651949|16424067|P3|Overall Study|Adverse Event|1
4760675|NCT01651949|16424068|P2|Overall Study|Adverse Event|2
4760676|NCT01651949|16424069|P1|Overall Study|Adverse Event|0
4760677|NCT01651949|16424067|P3|Overall Study|Physician Decision|0
4760678|NCT01651949|16424068|P2|Overall Study|Physician Decision|2
4760679|NCT01651949|16424069|P1|Overall Study|Physician Decision|0
4760680|NCT01651949|16424067|P3|Overall Study|Protocol Violation|1
4760681|NCT01651949|16424068|P2|Overall Study|Protocol Violation|2
4760682|NCT01651949|16424069|P1|Overall Study|Protocol Violation|0
4760683|NCT01651949|16424067|P3|Overall Study|Lost to Follow-up|20
4760684|NCT01651949|16424068|P2|Overall Study|Lost to Follow-up|56
4760685|NCT01651949|16424069|P1|Overall Study|Lost to Follow-up|30
4760686|NCT01651949|16424067|P3|Overall Study|Unknown status|0
4760687|NCT01651949|16424068|P2|Overall Study|Unknown status|4
4760688|NCT01651949|16424069|P1|Overall Study|Unknown status|4
4760689|NCT01651936|16424089|P3|Extension Study|Study terminated by sponsor|13
4760690|NCT01651936|16424090|P2|Extension Study|Study terminated by sponsor|0
4760691|NCT01651936|16424091|P1|Extension Study|Study terminated by sponsor|0
4760692|NCT01651936|16424089|P3|Extension Study|Lack of Efficacy|1
4760693|NCT01651936|16424090|P2|Extension Study|Lack of Efficacy|0
4760694|NCT01651936|16424091|P1|Extension Study|Lack of Efficacy|0
4760695|NCT01651936|16424089|P3|Base Study|Study terminated by sponsor|0
4760696|NCT01651936|16424090|P2|Base Study|Study terminated by sponsor|16
4760697|NCT01651936|16424091|P1|Base Study|Study terminated by sponsor|21
4760698|NCT01651936|16424089|P3|Base Study|Early Escape|0
4760699|NCT01651936|16424090|P2|Base Study|Early Escape|8
4760700|NCT01651936|16424091|P1|Base Study|Early Escape|2
4760701|NCT01651936|16424089|P3|Base Study|Withdrawal by Subject|0
4760702|NCT01651936|16424090|P2|Base Study|Withdrawal by Subject|1
4760703|NCT01651936|16424091|P1|Base Study|Withdrawal by Subject|1
4760704|NCT01651936|16424089|P3|Base Study|Adverse Event|0
4760705|NCT01651936|16424090|P2|Base Study|Adverse Event|0
4760706|NCT01651936|16424091|P1|Base Study|Adverse Event|3
4760707|NCT01651780|16424161|P2|Overall Study|Physician decision: Day 30 visit <23 day|5
4760708|NCT01651780|16424162|P1|Overall Study|Physician decision: Day 30 visit <23 day|1
4760709|NCT01651780|16424161|P2|Overall Study|Lost to Follow-up|2
4760710|NCT01651780|16424162|P1|Overall Study|Lost to Follow-up|1
4760711|NCT01651780|16424161|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4760712|NCT01651780|16424162|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|3
4760713|NCT01651780|16424161|P2|Overall Study|Withdrawal by Subject|0
4760714|NCT01651780|16424162|P1|Overall Study|Withdrawal by Subject|2
4760715|NCT01651780|16424161|P2|Overall Study|Reason Not Specified: No 30-day visit|2
4760716|NCT01651780|16424162|P1|Overall Study|Reason Not Specified: No 30-day visit|2
4760717|NCT01651780|16424161|P2|Overall Study|Physician decision: No 30-day visit|1
4760718|NCT01651780|16424162|P1|Overall Study|Physician decision: No 30-day visit|2
4760719|NCT01651403|16424213|P2|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|2
4760720|NCT01651403|16424214|P1|Open-Label Phase (Weeks 49/73-120/144)|Withdrew consent/assent|1
4760721|NCT01651403|16424213|P2|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
4760722|NCT01651403|16424214|P1|Open-Label Phase (Weeks 49/73-120/144)|Investigator decision|1
4760723|NCT01651403|16424213|P2|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|13
4760724|NCT01651403|16424214|P1|Open-Label Phase (Weeks 49/73-120/144)|Continuing Study|25
4760725|NCT01651403|16424213|P2|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|1
4760726|NCT01651403|16424214|P1|Double-Blind Period (Through Week 48/72)|Enrolled but not Treated|0
4760727|NCT01651403|16424213|P2|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
4760728|NCT01651403|16424214|P1|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3
4760729|NCT01651403|16424213|P2|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|0
4760730|NCT01651403|16424214|P1|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1
4760731|NCT01651260|16424264|P1|Overall Study|unable to apply product|3
4760732|NCT01651208|16424271|P2|Overall Study|Lost to Follow-up|16
4760733|NCT01651208|16424272|P1|Overall Study|Lost to Follow-up|14
4760734|NCT01651117|16424284|P4|Overall Study|Death|2
4760735|NCT01651117|16424285|P3|Overall Study|Death|2
4760736|NCT01651117|16424286|P2|Overall Study|Death|3
4760737|NCT01651117|16424287|P1|Overall Study|Death|2
4760738|NCT01651052|16424367|P1|Overall Study|Lost to Follow-up|3
4760739|NCT01651052|16424367|P1|Overall Study|Withdrawal by Subject|1
4760740|NCT01651052|16424367|P1|Overall Study|Explant|1
4760741|NCT01651052|16424367|P1|Overall Study|Death|21
4760742|NCT01651039|16424387|P1|Overall Study|Progressive Disease|22
4760743|NCT01651039|16424387|P1|Overall Study|Withdrawal by Subject|1
4760744|NCT01651039|16424387|P1|Overall Study|Physician Decision|2
4760745|NCT01651039|16424387|P1|Overall Study|Non-evaluables|5
4760746|NCT01651000|16424400|P2|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1
4760747|NCT01651000|16424401|P1|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0
4760748|NCT01651000|16424400|P2|Overall Study|Administrative reason|0
4760749|NCT01651000|16424401|P1|Overall Study|Administrative reason|1
4760750|NCT01651000|16424400|P2|Overall Study|Physician Decision|0
4760751|NCT01651000|16424401|P1|Overall Study|Physician Decision|1
4760752|NCT01651000|16424400|P2|Overall Study|Lack of Efficacy|1
4760753|NCT01651000|16424401|P1|Overall Study|Lack of Efficacy|1
4760754|NCT01651000|16424400|P2|Overall Study|Subject noncompliance|3
4760755|NCT01651000|16424401|P1|Overall Study|Subject noncompliance|0
4760756|NCT01651000|16424400|P2|Overall Study|Withdrawal by Subject|10
4760757|NCT01651000|16424401|P1|Overall Study|Withdrawal by Subject|2
4760758|NCT01651000|16424400|P2|Overall Study|Protocol Violation|3
4760759|NCT01651000|16424401|P1|Overall Study|Protocol Violation|0
4760760|NCT01651000|16424400|P2|Overall Study|Lost to Follow-up|2
4760761|NCT01651000|16424401|P1|Overall Study|Lost to Follow-up|3
4760762|NCT01651000|16424400|P2|Overall Study|Adverse Event|8
4760763|NCT01651000|16424401|P1|Overall Study|Adverse Event|2
4760764|NCT01650831|16424422|P1|Overall Study|Screen failure|1
4760765|NCT01650805|16424432|P2|Overall Study|Withdrawal by Subject|0
4760766|NCT01650805|16424433|P1|Overall Study|Withdrawal by Subject|1
4760767|NCT01650779|16424443|P1|Overall Study|Withdrawal by Subject|1
4760768|NCT01650636|16424452|P2|Washout up to 9 Months|Lost to Follow-up|1
4760769|NCT01650636|16424453|P1|Washout up to 9 Months|Lost to Follow-up|2
4760770|NCT01650636|16424452|P2|Washout up to 9 Months|Withdrawal by Subject|2
4760771|NCT01650636|16424453|P1|Washout up to 9 Months|Withdrawal by Subject|4
4760772|NCT01650636|16424452|P2|Washout up to 5 Months|Lost to Follow-up|8
4760773|NCT01650636|16424453|P1|Washout up to 5 Months|Lost to Follow-up|2
4760774|NCT01650636|16424452|P2|Washout up to 5 Months|Death|0
4760775|NCT01650636|16424453|P1|Washout up to 5 Months|Death|1
4760776|NCT01650636|16424452|P2|Washout up to 5 Months|Physician Decision|2
4760777|NCT01650636|16424453|P1|Washout up to 5 Months|Physician Decision|2
4760778|NCT01650636|16424452|P2|Washout up to 5 Months|Withdrawal by Subject|8
4760779|NCT01650636|16424453|P1|Washout up to 5 Months|Withdrawal by Subject|4
4760780|NCT01650519|16424493|P2|Overall Study|Withdrawal by Subject|0
4760781|NCT01650519|16424494|P1|Overall Study|Withdrawal by Subject|1
4760782|NCT01650285|16424565|P1|Overall Study|Adverse Event|1
4760783|NCT01650259|16424572|P2|Overall Study|Other than listed|146
4760784|NCT01650259|16424573|P1|Overall Study|Other than listed|64
4760785|NCT01650259|16424572|P2|Overall Study|Not treated|7
4760786|NCT01650259|16424573|P1|Overall Study|Not treated|1
4760787|NCT01650259|16424572|P2|Overall Study|CRF not collected|82
4760788|NCT01650259|16424573|P1|Overall Study|CRF not collected|98
4760789|NCT01650259|16424572|P2|Overall Study|Patients had no visit after entry|0
4760790|NCT01650259|16424573|P1|Overall Study|Patients had no visit after entry|70
4760791|NCT01650259|16424572|P2|Overall Study|Lost to Follow-up|0
4760792|NCT01650259|16424573|P1|Overall Study|Lost to Follow-up|435
4760793|NCT01650259|16424572|P2|Overall Study|Lack of Efficacy|0
4760794|NCT01650259|16424573|P1|Overall Study|Lack of Efficacy|143
4760795|NCT01650259|16424572|P2|Overall Study|Adverse Event|0
4760796|NCT01650259|16424573|P1|Overall Study|Adverse Event|127
4760797|NCT01650259|16424572|P2|Overall Study|Improvement|0
4760798|NCT01650259|16424573|P1|Overall Study|Improvement|105
4760799|NCT01650246|16424578|P1|Overall Study|Lack of Efficacy|30
4760800|NCT01650246|16424578|P1|Overall Study|Death|1
4760801|NCT01650246|16424578|P1|Overall Study|Withdrawal by Subject|26
4760802|NCT01650246|16424578|P1|Overall Study|Lost to Follow-up|5
4760803|NCT01650246|16424578|P1|Overall Study|Sponsor terminated study|53
4760804|NCT01650246|16424578|P1|Overall Study|Protocol Violation|5
4760805|NCT01650246|16424578|P1|Overall Study|Adverse Event|23
4760806|NCT01650194|16424583|P1|Overall Study|Miscellaneous|10
4760807|NCT01650194|16424583|P1|Overall Study|Withdrawal by Subject|2
4760808|NCT01650194|16424583|P1|Overall Study|Progressive Disease (PD)|35
4760809|NCT01649856|16424619|P2|Overall Study|Other|5
4760810|NCT01649856|16424620|P1|Overall Study|Other|20
4760811|NCT01649856|16424619|P2|Overall Study|Lack of Compliance|1
4760812|NCT01649856|16424620|P1|Overall Study|Lack of Compliance|6
4760813|NCT01649856|16424619|P2|Overall Study|Lost to Follow-up|16
4760814|NCT01649856|16424620|P1|Overall Study|Lost to Follow-up|20
4760815|NCT01649856|16424619|P2|Overall Study|Stable or Progressed Disease|3
4760816|NCT01649856|16424620|P1|Overall Study|Stable or Progressed Disease|5
4760817|NCT01649856|16424619|P2|Overall Study|Death|34
4760818|NCT01649856|16424620|P1|Overall Study|Death|69
4760819|NCT01649856|16424619|P2|Overall Study|Treatment Failure|1
4760820|NCT01649856|16424620|P1|Overall Study|Treatment Failure|1
4760821|NCT01649856|16424619|P2|Overall Study|Protocol Violation|4
4760822|NCT01649856|16424620|P1|Overall Study|Protocol Violation|4
4760823|NCT01649856|16424619|P2|Overall Study|Withdrawal by Subject|14
4760824|NCT01649856|16424620|P1|Overall Study|Withdrawal by Subject|14
4760825|NCT01649804|16424652|P1|Overall Study|Administrative/Other|8
4760826|NCT01649791|16424664|P1|Overall Study|Adverse Event|1
4760827|NCT01649791|16424664|P1|Overall Study|Disease Progression|2
4760828|NCT01649765|16424673|P2|Overall Study|Withdrawal by Subject|1
4760829|NCT01649765|16424674|P1|Overall Study|Withdrawal by Subject|2
4760830|NCT01649765|16424673|P2|Overall Study|Protocol Violation|0
4760831|NCT01649765|16424674|P1|Overall Study|Protocol Violation|1
4760832|NCT01649765|16424673|P2|Overall Study|Physician Decision|3
4760833|NCT01649765|16424674|P1|Overall Study|Physician Decision|0
4760834|NCT01649765|16424673|P2|Overall Study|Lack of Efficacy|1
4760835|NCT01649765|16424674|P1|Overall Study|Lack of Efficacy|1
4760836|NCT01649765|16424673|P2|Overall Study|Adverse Event|3
4760837|NCT01649765|16424674|P1|Overall Study|Adverse Event|5
4760838|NCT01649557|16424725|P3|Overall Study|Lack of Efficacy|0
4760839|NCT01649557|16424726|P2|Overall Study|Lack of Efficacy|0
4760840|NCT01649557|16424727|P1|Overall Study|Lack of Efficacy|5
4760841|NCT01649557|16424725|P3|Overall Study|Protocol deviation|0
4760842|NCT01649557|16424726|P2|Overall Study|Protocol deviation|2
4760843|NCT01649557|16424727|P1|Overall Study|Protocol deviation|0
4760844|NCT01649557|16424725|P3|Overall Study|Withdrawal by Subject|4
4760845|NCT01649557|16424726|P2|Overall Study|Withdrawal by Subject|5
4760846|NCT01649557|16424727|P1|Overall Study|Withdrawal by Subject|15
4760847|NCT01649557|16424725|P3|Overall Study|Physician Decision|1
4760848|NCT01649557|16424726|P2|Overall Study|Physician Decision|2
4760849|NCT01649557|16424727|P1|Overall Study|Physician Decision|8
4760850|NCT01649557|16424725|P3|Overall Study|Met withdrawal criteria|0
4760851|NCT01649557|16424726|P2|Overall Study|Met withdrawal criteria|0
4760852|NCT01649557|16424727|P1|Overall Study|Met withdrawal criteria|4
4760853|NCT01649557|16424725|P3|Overall Study|Adverse Event|1
4760854|NCT01649557|16424726|P2|Overall Study|Adverse Event|5
4760855|NCT01649557|16424727|P1|Overall Study|Adverse Event|7
4760856|NCT01649557|16424725|P3|Overall Study|Lost to Follow-up|3
4760857|NCT01649557|16424726|P2|Overall Study|Lost to Follow-up|0
4760858|NCT01649557|16424727|P1|Overall Study|Lost to Follow-up|5
4760859|NCT01649427|16424773|P2|Overall Study|Surgical problems during nephrectomy|2
4760860|NCT01649427|16424774|P1|Overall Study|Surgical problems during nephrectomy|2
4760861|NCT01649427|16424773|P2|Overall Study|Graft loss|1
4760862|NCT01649427|16424774|P1|Overall Study|Graft loss|0
4760863|NCT01649427|16424773|P2|Overall Study|Lost to Follow-up|1
4760864|NCT01649427|16424774|P1|Overall Study|Lost to Follow-up|0
4760865|NCT01649427|16424773|P2|Overall Study|Withdrawal by Subject|7
4760866|NCT01649427|16424774|P1|Overall Study|Withdrawal by Subject|8
4760867|NCT01649427|16424773|P2|Overall Study|Adverse Event|1
4760868|NCT01649427|16424774|P1|Overall Study|Adverse Event|1
4760869|NCT01649375|16424793|P5|Week 16 up to Week 260|Adverse Event|2
4760870|NCT01649375|16424794|P4|Week 16 up to Week 260|Adverse Event|3
4760871|NCT01649375|16424795|P3|Week 16 up to Week 260|Adverse Event|0
4760872|NCT01649375|16424796|P2|Week 16 up to Week 260|Adverse Event|2
4760873|NCT01649375|16424797|P1|Week 16 up to Week 260|Adverse Event|5
4760874|NCT01649375|16424793|P5|Week 16 up to Week 260|Death|0
4760875|NCT01649375|16424794|P4|Week 16 up to Week 260|Death|0
4760876|NCT01649375|16424795|P3|Week 16 up to Week 260|Death|0
4760877|NCT01649375|16424796|P2|Week 16 up to Week 260|Death|1
4760878|NCT01649375|16424797|P1|Week 16 up to Week 260|Death|1
4760879|NCT01649375|16424793|P5|Week 16 up to Week 260|Withdrawal by Subject|1
4760880|NCT01649375|16424794|P4|Week 16 up to Week 260|Withdrawal by Subject|3
4760881|NCT01649375|16424795|P3|Week 16 up to Week 260|Withdrawal by Subject|0
4760882|NCT01649375|16424796|P2|Week 16 up to Week 260|Withdrawal by Subject|2
4760883|NCT01649375|16424797|P1|Week 16 up to Week 260|Withdrawal by Subject|7
4760884|NCT01649375|16424793|P5|Week 16 up to Week 260|Technical issues|0
4760885|NCT01649375|16424794|P4|Week 16 up to Week 260|Technical issues|1
4760886|NCT01649375|16424795|P3|Week 16 up to Week 260|Technical issues|0
4760887|NCT01649375|16424796|P2|Week 16 up to Week 260|Technical issues|1
4760888|NCT01649375|16424797|P1|Week 16 up to Week 260|Technical issues|0
4760889|NCT01649375|16424793|P5|Week 16 up to Week 260|Physician Decision|0
4760890|NCT01649375|16424794|P4|Week 16 up to Week 260|Physician Decision|0
4760891|NCT01649375|16424795|P3|Week 16 up to Week 260|Physician Decision|0
4760892|NCT01649375|16424796|P2|Week 16 up to Week 260|Physician Decision|2
4760893|NCT01649375|16424797|P1|Week 16 up to Week 260|Physician Decision|0
4760894|NCT01649375|16424793|P5|Week 16 up to Week 260|Non-compliance|0
4760895|NCT01649375|16424794|P4|Week 16 up to Week 260|Non-compliance|1
4760896|NCT01649375|16424795|P3|Week 16 up to Week 260|Non-compliance|0
4760897|NCT01649375|16424796|P2|Week 16 up to Week 260|Non-compliance|1
4760898|NCT01649375|16424797|P1|Week 16 up to Week 260|Non-compliance|0
4760899|NCT01649375|16424793|P5|Week 16 up to Week 260|Lack of Efficacy|2
4760900|NCT01649375|16424794|P4|Week 16 up to Week 260|Lack of Efficacy|4
4760901|NCT01649375|16424795|P3|Week 16 up to Week 260|Lack of Efficacy|0
4760902|NCT01649375|16424796|P2|Week 16 up to Week 260|Lack of Efficacy|4
4760903|NCT01649375|16424797|P1|Week 16 up to Week 260|Lack of Efficacy|7
4760904|NCT01649375|16424793|P5|Up to Week 16|Death|0
4760905|NCT01649375|16424794|P4|Up to Week 16|Death|0
4760906|NCT01649375|16424795|P3|Up to Week 16|Death|0
4760907|NCT01649375|16424796|P2|Up to Week 16|Death|0
4760908|NCT01649375|16424797|P1|Up to Week 16|Death|1
4760909|NCT01649375|16424793|P5|Up to Week 16|Withdrawal by Subject|0
4760910|NCT01649375|16424794|P4|Up to Week 16|Withdrawal by Subject|0
4760911|NCT01649375|16424795|P3|Up to Week 16|Withdrawal by Subject|2
4760912|NCT01649375|16424796|P2|Up to Week 16|Withdrawal by Subject|1
4760913|NCT01649375|16424797|P1|Up to Week 16|Withdrawal by Subject|2
4760914|NCT01649375|16424793|P5|Up to Week 16|Physician Decision|0
4760915|NCT01649375|16424794|P4|Up to Week 16|Physician Decision|0
4760916|NCT01649375|16424795|P3|Up to Week 16|Physician Decision|1
4760917|NCT01649375|16424796|P2|Up to Week 16|Physician Decision|0
4760918|NCT01649375|16424797|P1|Up to Week 16|Physician Decision|0
4760919|NCT01649375|16424793|P5|Up to Week 16|Lack of Efficacy|0
4760920|NCT01649375|16424794|P4|Up to Week 16|Lack of Efficacy|0
4760921|NCT01649375|16424795|P3|Up to Week 16|Lack of Efficacy|1
4760922|NCT01649375|16424796|P2|Up to Week 16|Lack of Efficacy|0
4760923|NCT01649375|16424797|P1|Up to Week 16|Lack of Efficacy|0
4760924|NCT01649375|16424793|P5|Up to Week 16|Adverse Event|0
4760925|NCT01649375|16424794|P4|Up to Week 16|Adverse Event|0
4760926|NCT01649375|16424795|P3|Up to Week 16|Adverse Event|4
4760927|NCT01649375|16424796|P2|Up to Week 16|Adverse Event|5
4760928|NCT01649375|16424797|P1|Up to Week 16|Adverse Event|2
4760929|NCT01649297|16424844|P5|Overall Study|For other reason|0
4760930|NCT01649297|16424845|P4|Overall Study|For other reason|0
4760931|NCT01649297|16424846|P3|Overall Study|For other reason|2
4760932|NCT01649297|16424847|P2|Overall Study|For other reason|1
4760933|NCT01649297|16424848|P1|Overall Study|For other reason|4
4760934|NCT01649297|16424844|P5|Overall Study|Patient withdrawal (not due to AE)|1
4760935|NCT01649297|16424845|P4|Overall Study|Patient withdrawal (not due to AE)|1
4760936|NCT01649297|16424846|P3|Overall Study|Patient withdrawal (not due to AE)|4
4760937|NCT01649297|16424847|P2|Overall Study|Patient withdrawal (not due to AE)|6
4760938|NCT01649297|16424848|P1|Overall Study|Patient withdrawal (not due to AE)|3
4760939|NCT01649297|16424844|P5|Overall Study|Lost to Follow-up|0
4760940|NCT01649297|16424845|P4|Overall Study|Lost to Follow-up|3
4760941|NCT01649297|16424846|P3|Overall Study|Lost to Follow-up|4
4760942|NCT01649297|16424847|P2|Overall Study|Lost to Follow-up|1
4760943|NCT01649297|16424848|P1|Overall Study|Lost to Follow-up|1
4760944|NCT01649297|16424844|P5|Overall Study|Non compliant with Protocol|1
4760945|NCT01649297|16424845|P4|Overall Study|Non compliant with Protocol|2
4760946|NCT01649297|16424846|P3|Overall Study|Non compliant with Protocol|3
4760947|NCT01649297|16424847|P2|Overall Study|Non compliant with Protocol|0
4760948|NCT01649297|16424848|P1|Overall Study|Non compliant with Protocol|1
4760949|NCT01649297|16424844|P5|Overall Study|Lack of Efficacy|1
4760950|NCT01649297|16424845|P4|Overall Study|Lack of Efficacy|0
4760951|NCT01649297|16424846|P3|Overall Study|Lack of Efficacy|0
4760952|NCT01649297|16424847|P2|Overall Study|Lack of Efficacy|0
4760953|NCT01649297|16424848|P1|Overall Study|Lack of Efficacy|0
4760954|NCT01649297|16424844|P5|Overall Study|Adverse Event|1
4760955|NCT01649297|16424845|P4|Overall Study|Adverse Event|13
4760956|NCT01649297|16424846|P3|Overall Study|Adverse Event|4
4760957|NCT01649297|16424847|P2|Overall Study|Adverse Event|5
4760958|NCT01649297|16424848|P1|Overall Study|Adverse Event|5
4760959|NCT01649271|16424867|P2|Overall Study|Other than stated above|0
4760960|NCT01649271|16424868|P1|Overall Study|Other than stated above|1
4760961|NCT01649271|16424867|P2|Overall Study|Withdrawal by Subject|0
4760962|NCT01649271|16424868|P1|Overall Study|Withdrawal by Subject|1
4760963|NCT01649271|16424867|P2|Overall Study|Other Adverse Event|2
4760964|NCT01649271|16424868|P1|Overall Study|Other Adverse Event|0
4760965|NCT01649271|16424867|P2|Overall Study|Progressive disease|5
4760966|NCT01649271|16424868|P1|Overall Study|Progressive disease|4
4760967|NCT01649232|16424883|P2|Overall Study|Physician Decision|0
4760968|NCT01649232|16424884|P1|Overall Study|Physician Decision|2
4760969|NCT01648790|16424936|P5|Treatment 3|Withdrawal by Subject|0
4760970|NCT01648790|16424937|P4|Treatment 3|Withdrawal by Subject|1
4760971|NCT01648790|16424938|P3|Treatment 3|Withdrawal by Subject|0
4760972|NCT01648790|16424939|P2|Treatment 3|Withdrawal by Subject|0
4760973|NCT01648790|16424940|P1|Treatment 3|Withdrawal by Subject|0
4760974|NCT01648764|16424975|P14|Overall Study|Investigator Decision|0
4760975|NCT01648764|16424976|P13|Overall Study|Investigator Decision|0
4760976|NCT01648764|16424977|P12|Overall Study|Investigator Decision|1
4760977|NCT01648764|16424978|P11|Overall Study|Investigator Decision|0
4760978|NCT01648764|16424979|P10|Overall Study|Investigator Decision|0
4760979|NCT01648764|16424980|P9|Overall Study|Investigator Decision|0
4760980|NCT01648764|16424981|P8|Overall Study|Investigator Decision|0
4760981|NCT01648764|16424982|P7|Overall Study|Investigator Decision|1
4760982|NCT01648764|16424983|P6|Overall Study|Investigator Decision|0
4760983|NCT01648764|16424984|P5|Overall Study|Investigator Decision|0
4760984|NCT01648764|16424985|P4|Overall Study|Investigator Decision|0
4760985|NCT01648764|16424986|P3|Overall Study|Investigator Decision|0
4760986|NCT01648764|16424987|P2|Overall Study|Investigator Decision|0
4760987|NCT01648764|16424988|P1|Overall Study|Investigator Decision|0
4760988|NCT01648764|16424975|P14|Overall Study|Withdrawal by Subject|0
4760989|NCT01648764|16424976|P13|Overall Study|Withdrawal by Subject|1
4760990|NCT01648764|16424977|P12|Overall Study|Withdrawal by Subject|0
4760991|NCT01648764|16424978|P11|Overall Study|Withdrawal by Subject|0
4760992|NCT01648764|16424979|P10|Overall Study|Withdrawal by Subject|0
4760993|NCT01648764|16424980|P9|Overall Study|Withdrawal by Subject|0
4760994|NCT01648764|16424981|P8|Overall Study|Withdrawal by Subject|0
4760995|NCT01648764|16424982|P7|Overall Study|Withdrawal by Subject|2
4760996|NCT01648764|16424983|P6|Overall Study|Withdrawal by Subject|0
4760997|NCT01648764|16424984|P5|Overall Study|Withdrawal by Subject|0
4760998|NCT01648764|16424985|P4|Overall Study|Withdrawal by Subject|0
4760999|NCT01648764|16424986|P3|Overall Study|Withdrawal by Subject|0
4761000|NCT01648764|16424987|P2|Overall Study|Withdrawal by Subject|0
4761001|NCT01648764|16424988|P1|Overall Study|Withdrawal by Subject|0
4761002|NCT01648764|16424975|P14|Overall Study|Death|1
4761003|NCT01648764|16424976|P13|Overall Study|Death|0
4761004|NCT01648764|16424977|P12|Overall Study|Death|0
4761005|NCT01648764|16424978|P11|Overall Study|Death|0
4761006|NCT01648764|16424979|P10|Overall Study|Death|0
4761007|NCT01648764|16424980|P9|Overall Study|Death|0
4761008|NCT01648764|16424981|P8|Overall Study|Death|0
4761009|NCT01648764|16424982|P7|Overall Study|Death|1
4761010|NCT01648764|16424983|P6|Overall Study|Death|0
4761011|NCT01648764|16424984|P5|Overall Study|Death|0
4761012|NCT01648764|16424985|P4|Overall Study|Death|0
4761013|NCT01648764|16424986|P3|Overall Study|Death|0
4761014|NCT01648764|16424987|P2|Overall Study|Death|0
4761015|NCT01648764|16424988|P1|Overall Study|Death|0
4761016|NCT01648764|16424975|P14|Overall Study|Adverse Event|1
4761017|NCT01648764|16424976|P13|Overall Study|Adverse Event|1
4761018|NCT01648764|16424977|P12|Overall Study|Adverse Event|3
4761019|NCT01648764|16424978|P11|Overall Study|Adverse Event|0
4761020|NCT01648764|16424979|P10|Overall Study|Adverse Event|1
4761021|NCT01648764|16424980|P9|Overall Study|Adverse Event|0
4761022|NCT01648764|16424981|P8|Overall Study|Adverse Event|0
4761023|NCT01648764|16424982|P7|Overall Study|Adverse Event|0
4761024|NCT01648764|16424983|P6|Overall Study|Adverse Event|1
4761025|NCT01648764|16424984|P5|Overall Study|Adverse Event|0
4761026|NCT01648764|16424985|P4|Overall Study|Adverse Event|0
4761027|NCT01648764|16424986|P3|Overall Study|Adverse Event|0
4761028|NCT01648764|16424987|P2|Overall Study|Adverse Event|0
4761029|NCT01648764|16424988|P1|Overall Study|Adverse Event|0
4761030|NCT01648764|16424975|P14|Overall Study|Progressive Disease|1
4761031|NCT01648764|16424976|P13|Overall Study|Progressive Disease|2
4761032|NCT01648764|16424977|P12|Overall Study|Progressive Disease|1
4761033|NCT01648764|16424978|P11|Overall Study|Progressive Disease|0
4761034|NCT01648764|16424979|P10|Overall Study|Progressive Disease|2
4761035|NCT01648764|16424980|P9|Overall Study|Progressive Disease|0
4761036|NCT01648764|16424981|P8|Overall Study|Progressive Disease|0
4761037|NCT01648764|16424982|P7|Overall Study|Progressive Disease|1
4761038|NCT01648764|16424983|P6|Overall Study|Progressive Disease|1
4761039|NCT01648764|16424984|P5|Overall Study|Progressive Disease|0
4761040|NCT01648764|16424985|P4|Overall Study|Progressive Disease|0
4761041|NCT01648764|16424986|P3|Overall Study|Progressive Disease|0
4761042|NCT01648764|16424987|P2|Overall Study|Progressive Disease|1
4761043|NCT01648764|16424988|P1|Overall Study|Progressive Disease|0
4761044|NCT01648699|16425140|P1|Overall Study|Unspecified/unable to complete 4 visits|2
4761045|NCT01648699|16425140|P1|Overall Study|Lost to Follow-up|2
4761046|NCT01648699|16425140|P1|Overall Study|Death|1
4761047|NCT01648582|16425169|P3|Overall Study|Sponsor Decision|1
4761048|NCT01648582|16425170|P2|Overall Study|Sponsor Decision|1
4761049|NCT01648582|16425171|P1|Overall Study|Sponsor Decision|0
4761050|NCT01648582|16425169|P3|Overall Study|Death|0
4761051|NCT01648582|16425170|P2|Overall Study|Death|0
4761052|NCT01648582|16425171|P1|Overall Study|Death|1
4761053|NCT01648582|16425169|P3|Overall Study|Physician Decision|3
4761054|NCT01648582|16425170|P2|Overall Study|Physician Decision|1
4761055|NCT01648582|16425171|P1|Overall Study|Physician Decision|0
4761056|NCT01648582|16425169|P3|Overall Study|Withdrawal by Subject|17
4761057|NCT01648582|16425170|P2|Overall Study|Withdrawal by Subject|17
4761058|NCT01648582|16425171|P1|Overall Study|Withdrawal by Subject|15
4761059|NCT01648582|16425169|P3|Overall Study|Protocol Violation|1
4761060|NCT01648582|16425170|P2|Overall Study|Protocol Violation|2
4761061|NCT01648582|16425171|P1|Overall Study|Protocol Violation|1
4761062|NCT01648582|16425169|P3|Overall Study|Lost to Follow-up|8
4761063|NCT01648582|16425170|P2|Overall Study|Lost to Follow-up|6
4761064|NCT01648582|16425171|P1|Overall Study|Lost to Follow-up|9
4761065|NCT01648582|16425169|P3|Overall Study|Adverse Event|2
4761066|NCT01648582|16425170|P2|Overall Study|Adverse Event|11
4761067|NCT01648582|16425171|P1|Overall Study|Adverse Event|6
4761068|NCT01648348|16425274|P6|Overall Study|Replaced for MTD analysis|0
4761069|NCT01648348|16425275|P5|Overall Study|Replaced for MTD analysis|0
4761070|NCT01648348|16425276|P4|Overall Study|Replaced for MTD analysis|0
4761071|NCT01648348|16425277|P3|Overall Study|Replaced for MTD analysis|1
4761072|NCT01648348|16425278|P2|Overall Study|Replaced for MTD analysis|0
4761073|NCT01648348|16425279|P1|Overall Study|Replaced for MTD analysis|1
4761074|NCT01648348|16425274|P6|Overall Study|Cancel|6
4761075|NCT01648348|16425275|P5|Overall Study|Cancel|3
4761076|NCT01648348|16425276|P4|Overall Study|Cancel|0
4761077|NCT01648348|16425277|P3|Overall Study|Cancel|0
4761078|NCT01648348|16425278|P2|Overall Study|Cancel|0
4761079|NCT01648348|16425279|P1|Overall Study|Cancel|1
4761080|NCT01648283|16425366|P1|Overall Study|Withdrawal by Subject|14
4761081|NCT01648270|16425372|P1|Intravenous Buprenorphine|Withdrawal by Subject|12
4761082|NCT01648166|16425384|P2|Overall Study|inadequate toenail samples|100
4761083|NCT01648166|16425385|P1|Overall Study|inadequate toenail samples|53
4761084|NCT01648140|16425395|P4|Overall Study|Lost to Follow-up|0
4761085|NCT01648140|16425396|P3|Overall Study|Lost to Follow-up|2
4761086|NCT01648140|16425397|P2|Overall Study|Lost to Follow-up|1
4761087|NCT01648140|16425398|P1|Overall Study|Lost to Follow-up|2
4761088|NCT01648140|16425395|P4|Overall Study|Withdrawal by Subject|2
4761089|NCT01648140|16425396|P3|Overall Study|Withdrawal by Subject|3
4761090|NCT01648140|16425397|P2|Overall Study|Withdrawal by Subject|3
4761091|NCT01648140|16425398|P1|Overall Study|Withdrawal by Subject|2
4761092|NCT01648140|16425395|P4|Overall Study|Adverse Event|0
4761093|NCT01648140|16425396|P3|Overall Study|Adverse Event|2
4761094|NCT01648140|16425397|P2|Overall Study|Adverse Event|1
4761095|NCT01648140|16425398|P1|Overall Study|Adverse Event|3
4761096|NCT01648140|16425395|P4|Overall Study|Lack of Efficacy|0
4761097|NCT01648140|16425396|P3|Overall Study|Lack of Efficacy|1
4761098|NCT01648140|16425397|P2|Overall Study|Lack of Efficacy|7
4761099|NCT01648140|16425398|P1|Overall Study|Lack of Efficacy|4
4761100|NCT01648140|16425395|P4|Overall Study|Physician Decision|0
4761101|NCT01648140|16425396|P3|Overall Study|Physician Decision|0
4761102|NCT01648140|16425397|P2|Overall Study|Physician Decision|0
4761103|NCT01648140|16425398|P1|Overall Study|Physician Decision|1
4761104|NCT01648101|16425563|P3|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
4761105|NCT01648101|16425564|P2|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1
4761106|NCT01648101|16425565|P1|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0
4761107|NCT01648101|16425563|P3|Transition Phase (4 Weeks)|Study Terminated|0
4761108|NCT01648101|16425564|P2|Transition Phase (4 Weeks)|Study Terminated|0
4761109|NCT01648101|16425565|P1|Transition Phase (4 Weeks)|Study Terminated|1
4761110|NCT01648101|16425563|P3|Transition Phase (4 Weeks)|Withdrawal by Subject|2
4761111|NCT01648101|16425564|P2|Transition Phase (4 Weeks)|Withdrawal by Subject|0
4761112|NCT01648101|16425565|P1|Transition Phase (4 Weeks)|Withdrawal by Subject|0
4761113|NCT01648101|16425563|P3|Transition Phase (4 Weeks)|Lack of Efficacy|0
4761114|NCT01648101|16425564|P2|Transition Phase (4 Weeks)|Lack of Efficacy|2
4761115|NCT01648101|16425565|P1|Transition Phase (4 Weeks)|Lack of Efficacy|0
4761116|NCT01648101|16425563|P3|Transition Phase (4 Weeks)|Adverse Event|2
4761117|NCT01648101|16425564|P2|Transition Phase (4 Weeks)|Adverse Event|3
4761118|NCT01648101|16425565|P1|Transition Phase (4 Weeks)|Adverse Event|4
4761119|NCT01648101|16425563|P3|Maintenance Phase (12 Weeks)|Adverse Event|4
4761120|NCT01648101|16425564|P2|Maintenance Phase (12 Weeks)|Adverse Event|3
4761121|NCT01648101|16425565|P1|Maintenance Phase (12 Weeks)|Adverse Event|1
4761122|NCT01648101|16425563|P3|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
4761123|NCT01648101|16425564|P2|Maintenance Phase (12 Weeks)|Lack of Efficacy|0
4761124|NCT01648101|16425565|P1|Maintenance Phase (12 Weeks)|Lack of Efficacy|1
4761125|NCT01648101|16425563|P3|Maintenance Phase (12 Weeks)|Withdrew Consent|1
4761126|NCT01648101|16425564|P2|Maintenance Phase (12 Weeks)|Withdrew Consent|0
4761127|NCT01648101|16425565|P1|Maintenance Phase (12 Weeks)|Withdrew Consent|1
4761128|NCT01648101|16425563|P3|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1
4761129|NCT01648101|16425564|P2|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
4761130|NCT01648101|16425565|P1|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0
4761131|NCT01648101|16425563|P3|Titration Phase (4 Weeks)|Adverse Event|3
4761132|NCT01648101|16425564|P2|Titration Phase (4 Weeks)|Adverse Event|2
4761133|NCT01648101|16425565|P1|Titration Phase (4 Weeks)|Adverse Event|0
4761134|NCT01648101|16425563|P3|Titration Phase (4 Weeks)|Protocol Violation|2
4761135|NCT01648101|16425564|P2|Titration Phase (4 Weeks)|Protocol Violation|1
4761136|NCT01648101|16425565|P1|Titration Phase (4 Weeks)|Protocol Violation|2
4761137|NCT01647711|16425652|P5|Overall Study|Other reason not defined|0
4761138|NCT01647711|16425653|P4|Overall Study|Other reason not defined|1
4761139|NCT01647711|16425654|P3|Overall Study|Other reason not defined|1
4761140|NCT01647711|16425655|P2|Overall Study|Other reason not defined|1
4761141|NCT01647711|16425656|P1|Overall Study|Other reason not defined|0
4761142|NCT01647711|16425652|P5|Overall Study|Refused to continue taking medication|1
4761143|NCT01647711|16425653|P4|Overall Study|Refused to continue taking medication|2
4761144|NCT01647711|16425654|P3|Overall Study|Refused to continue taking medication|0
4761145|NCT01647711|16425655|P2|Overall Study|Refused to continue taking medication|0
4761146|NCT01647711|16425656|P1|Overall Study|Refused to continue taking medication|0
4761147|NCT01647711|16425652|P5|Overall Study|Protocol Violation|1
4761148|NCT01647711|16425653|P4|Overall Study|Protocol Violation|0
4761149|NCT01647711|16425654|P3|Overall Study|Protocol Violation|0
4761150|NCT01647711|16425655|P2|Overall Study|Protocol Violation|0
4761151|NCT01647711|16425656|P1|Overall Study|Protocol Violation|0
4761152|NCT01647711|16425652|P5|Overall Study|Other adverse event|2
4761153|NCT01647711|16425653|P4|Overall Study|Other adverse event|0
4761154|NCT01647711|16425654|P3|Overall Study|Other adverse event|2
4761155|NCT01647711|16425655|P2|Overall Study|Other adverse event|0
4761156|NCT01647711|16425656|P1|Overall Study|Other adverse event|0
4761157|NCT01647711|16425652|P5|Overall Study|Progressive disease|2
4761158|NCT01647711|16425653|P4|Overall Study|Progressive disease|8
4761159|NCT01647711|16425654|P3|Overall Study|Progressive disease|6
4761160|NCT01647711|16425655|P2|Overall Study|Progressive disease|2
4761161|NCT01647711|16425656|P1|Overall Study|Progressive disease|6
4761162|NCT01647542|16425693|P3|Overall Study|Death|1
4761163|NCT01647542|16425694|P2|Overall Study|Death|0
4761164|NCT01647542|16425695|P1|Overall Study|Death|0
4761165|NCT01647542|16425693|P3|Overall Study|Lack of Efficacy|0
4761166|NCT01647542|16425694|P2|Overall Study|Lack of Efficacy|1
4761167|NCT01647542|16425695|P1|Overall Study|Lack of Efficacy|1
4761168|NCT01647542|16425693|P3|Overall Study|Study Termination|65
4761169|NCT01647542|16425694|P2|Overall Study|Study Termination|61
4761170|NCT01647542|16425695|P1|Overall Study|Study Termination|64
4761171|NCT01647542|16425693|P3|Overall Study|Withdrawal by Subject|0
4761172|NCT01647542|16425694|P2|Overall Study|Withdrawal by Subject|4
4761173|NCT01647542|16425695|P1|Overall Study|Withdrawal by Subject|6
4761174|NCT01647542|16425693|P3|Overall Study|Lost to Follow-up|2
4761175|NCT01647542|16425694|P2|Overall Study|Lost to Follow-up|2
4761176|NCT01647542|16425695|P1|Overall Study|Lost to Follow-up|0
4761177|NCT01647542|16425693|P3|Overall Study|Adverse Event|4
4761178|NCT01647542|16425694|P2|Overall Study|Adverse Event|5
4761179|NCT01647542|16425695|P1|Overall Study|Adverse Event|4
4761180|NCT01647542|16425693|P3|Overall Study|Major Protocol Deviation|0
4761181|NCT01647542|16425694|P2|Overall Study|Major Protocol Deviation|0
4761182|NCT01647542|16425695|P1|Overall Study|Major Protocol Deviation|1
4761183|NCT01647516|16425715|P6|Open-Label Period|No completion / discontinuation visit|1
4761184|NCT01647516|16425716|P5|Open-Label Period|No completion / discontinuation visit|2
4761185|NCT01647516|16425717|P4|Open-Label Period|No completion / discontinuation visit|0
4761186|NCT01647516|16425718|P3|Open-Label Period|No completion / discontinuation visit|0
4761187|NCT01647516|16425719|P2|Open-Label Period|No completion / discontinuation visit|0
4761188|NCT01647516|16425720|P1|Open-Label Period|No completion / discontinuation visit|0
4761189|NCT01647516|16425715|P6|Open-Label Period|Participant Choice to Stop Study Drug|10
4761190|NCT01647516|16425716|P5|Open-Label Period|Participant Choice to Stop Study Drug|9
4761191|NCT01647516|16425717|P4|Open-Label Period|Participant Choice to Stop Study Drug|7
4761192|NCT01647516|16425718|P3|Open-Label Period|Participant Choice to Stop Study Drug|0
4761193|NCT01647516|16425719|P2|Open-Label Period|Participant Choice to Stop Study Drug|0
4761194|NCT01647516|16425720|P1|Open-Label Period|Participant Choice to Stop Study Drug|0
4761195|NCT01647516|16425715|P6|Open-Label Period|Lack of Efficacy|10
4761196|NCT01647516|16425716|P5|Open-Label Period|Lack of Efficacy|9
4761197|NCT01647516|16425717|P4|Open-Label Period|Lack of Efficacy|7
4761198|NCT01647516|16425718|P3|Open-Label Period|Lack of Efficacy|0
4761199|NCT01647516|16425719|P2|Open-Label Period|Lack of Efficacy|0
4761200|NCT01647516|16425720|P1|Open-Label Period|Lack of Efficacy|0
4761201|NCT01647516|16425715|P6|Open-Label Period|Sponsor Termination; moved to 3102 study|23
4761202|NCT01647516|16425716|P5|Open-Label Period|Sponsor Termination; moved to 3102 study|13
4761203|NCT01647516|16425717|P4|Open-Label Period|Sponsor Termination; moved to 3102 study|18
4761204|NCT01647516|16425718|P3|Open-Label Period|Sponsor Termination; moved to 3102 study|0
4761205|NCT01647516|16425719|P2|Open-Label Period|Sponsor Termination; moved to 3102 study|0
4761206|NCT01647516|16425720|P1|Open-Label Period|Sponsor Termination; moved to 3102 study|0
4761207|NCT01647516|16425715|P6|Open-Label Period|Lost to Follow-up|1
4761208|NCT01647516|16425716|P5|Open-Label Period|Lost to Follow-up|0
4761209|NCT01647516|16425717|P4|Open-Label Period|Lost to Follow-up|1
4761210|NCT01647516|16425718|P3|Open-Label Period|Lost to Follow-up|0
4761211|NCT01647516|16425719|P2|Open-Label Period|Lost to Follow-up|0
4761212|NCT01647516|16425720|P1|Open-Label Period|Lost to Follow-up|0
4761213|NCT01647516|16425715|P6|Open-Label Period|Withdrawal by Subject|6
4761214|NCT01647516|16425716|P5|Open-Label Period|Withdrawal by Subject|11
4761215|NCT01647516|16425717|P4|Open-Label Period|Withdrawal by Subject|9
4761216|NCT01647516|16425718|P3|Open-Label Period|Withdrawal by Subject|0
4761217|NCT01647516|16425719|P2|Open-Label Period|Withdrawal by Subject|0
4761218|NCT01647516|16425720|P1|Open-Label Period|Withdrawal by Subject|0
4761219|NCT01647516|16425715|P6|Open-Label Period|Physician Decision|0
4761220|NCT01647516|16425716|P5|Open-Label Period|Physician Decision|1
4761221|NCT01647516|16425717|P4|Open-Label Period|Physician Decision|1
4761222|NCT01647516|16425718|P3|Open-Label Period|Physician Decision|0
4761223|NCT01647516|16425719|P2|Open-Label Period|Physician Decision|0
4761224|NCT01647516|16425720|P1|Open-Label Period|Physician Decision|0
4761225|NCT01647516|16425715|P6|Open-Label Period|Non-compliance|1
4761226|NCT01647516|16425716|P5|Open-Label Period|Non-compliance|0
4761227|NCT01647516|16425717|P4|Open-Label Period|Non-compliance|1
4761228|NCT01647516|16425718|P3|Open-Label Period|Non-compliance|0
4761229|NCT01647516|16425719|P2|Open-Label Period|Non-compliance|0
4761230|NCT01647516|16425720|P1|Open-Label Period|Non-compliance|0
4761231|NCT01647516|16425715|P6|Open-Label Period|Pregnancy|1
4761232|NCT01647516|16425716|P5|Open-Label Period|Pregnancy|0
4761233|NCT01647516|16425717|P4|Open-Label Period|Pregnancy|0
4761234|NCT01647516|16425718|P3|Open-Label Period|Pregnancy|0
4761235|NCT01647516|16425719|P2|Open-Label Period|Pregnancy|0
4761236|NCT01647516|16425720|P1|Open-Label Period|Pregnancy|0
4761237|NCT01647516|16425715|P6|Open-Label Period|Adverse Event|3
4761238|NCT01647516|16425716|P5|Open-Label Period|Adverse Event|6
4761239|NCT01647516|16425717|P4|Open-Label Period|Adverse Event|5
4761240|NCT01647516|16425718|P3|Open-Label Period|Adverse Event|0
4761241|NCT01647516|16425719|P2|Open-Label Period|Adverse Event|0
4761242|NCT01647516|16425720|P1|Open-Label Period|Adverse Event|0
4761243|NCT01647516|16425715|P6|Maintenance Period (MP)|Lack of Efficacy|0
4761244|NCT01647516|16425716|P5|Maintenance Period (MP)|Lack of Efficacy|0
4761245|NCT01647516|16425717|P4|Maintenance Period (MP)|Lack of Efficacy|0
4761246|NCT01647516|16425718|P3|Maintenance Period (MP)|Lack of Efficacy|1
4761247|NCT01647516|16425719|P2|Maintenance Period (MP)|Lack of Efficacy|4
4761248|NCT01647516|16425720|P1|Maintenance Period (MP)|Lack of Efficacy|1
4761249|NCT01647516|16425715|P6|Maintenance Period (MP)|Withdrawal by Subject|0
4761250|NCT01647516|16425716|P5|Maintenance Period (MP)|Withdrawal by Subject|0
4761251|NCT01647516|16425717|P4|Maintenance Period (MP)|Withdrawal by Subject|0
4761252|NCT01647516|16425718|P3|Maintenance Period (MP)|Withdrawal by Subject|1
4761253|NCT01647516|16425719|P2|Maintenance Period (MP)|Withdrawal by Subject|1
4761254|NCT01647516|16425720|P1|Maintenance Period (MP)|Withdrawal by Subject|0
4761255|NCT01647516|16425715|P6|Maintenance Period (MP)|Non-compliance|0
4761256|NCT01647516|16425716|P5|Maintenance Period (MP)|Non-compliance|0
4761257|NCT01647516|16425717|P4|Maintenance Period (MP)|Non-compliance|0
4761258|NCT01647516|16425718|P3|Maintenance Period (MP)|Non-compliance|0
4761259|NCT01647516|16425719|P2|Maintenance Period (MP)|Non-compliance|0
4761260|NCT01647516|16425720|P1|Maintenance Period (MP)|Non-compliance|1
4761261|NCT01647516|16425715|P6|Maintenance Period (MP)|Adverse Event|0
4761262|NCT01647516|16425716|P5|Maintenance Period (MP)|Adverse Event|0
4761263|NCT01647516|16425717|P4|Maintenance Period (MP)|Adverse Event|0
4761264|NCT01647516|16425718|P3|Maintenance Period (MP)|Adverse Event|0
4761265|NCT01647516|16425719|P2|Maintenance Period (MP)|Adverse Event|1
4761266|NCT01647516|16425720|P1|Maintenance Period (MP)|Adverse Event|2
4761267|NCT01647516|16425715|P6|Induction Period (IP)|No study drug received|0
4761268|NCT01647516|16425716|P5|Induction Period (IP)|No study drug received|0
4761269|NCT01647516|16425717|P4|Induction Period (IP)|No study drug received|0
4761270|NCT01647516|16425718|P3|Induction Period (IP)|No study drug received|0
4761271|NCT01647516|16425719|P2|Induction Period (IP)|No study drug received|1
4761272|NCT01647516|16425720|P1|Induction Period (IP)|No study drug received|1
4761273|NCT01647516|16425715|P6|Induction Period (IP)|Lack of Efficacy|0
4761274|NCT01647516|16425716|P5|Induction Period (IP)|Lack of Efficacy|0
4761275|NCT01647516|16425717|P4|Induction Period (IP)|Lack of Efficacy|0
4761276|NCT01647516|16425718|P3|Induction Period (IP)|Lack of Efficacy|0
4761277|NCT01647516|16425719|P2|Induction Period (IP)|Lack of Efficacy|0
4761278|NCT01647516|16425720|P1|Induction Period (IP)|Lack of Efficacy|1
4761279|NCT01647516|16425715|P6|Induction Period (IP)|Participant Choice|0
4761280|NCT01647516|16425716|P5|Induction Period (IP)|Participant Choice|0
4761281|NCT01647516|16425717|P4|Induction Period (IP)|Participant Choice|0
4761282|NCT01647516|16425718|P3|Induction Period (IP)|Participant Choice|1
4761283|NCT01647516|16425719|P2|Induction Period (IP)|Participant Choice|0
4761284|NCT01647516|16425720|P1|Induction Period (IP)|Participant Choice|0
4761285|NCT01647516|16425715|P6|Induction Period (IP)|Withdrawal by Subject|0
4761286|NCT01647516|16425716|P5|Induction Period (IP)|Withdrawal by Subject|0
4761287|NCT01647516|16425717|P4|Induction Period (IP)|Withdrawal by Subject|0
4761288|NCT01647516|16425718|P3|Induction Period (IP)|Withdrawal by Subject|3
4761289|NCT01647516|16425719|P2|Induction Period (IP)|Withdrawal by Subject|0
4761290|NCT01647516|16425720|P1|Induction Period (IP)|Withdrawal by Subject|1
4761291|NCT01647516|16425715|P6|Induction Period (IP)|Adverse Event|0
4761292|NCT01647516|16425716|P5|Induction Period (IP)|Adverse Event|0
4761293|NCT01647516|16425717|P4|Induction Period (IP)|Adverse Event|0
4761294|NCT01647516|16425718|P3|Induction Period (IP)|Adverse Event|0
4761295|NCT01647516|16425719|P2|Induction Period (IP)|Adverse Event|2
4761296|NCT01647516|16425720|P1|Induction Period (IP)|Adverse Event|1
4761297|NCT01647516|16425715|P6|Induction Period (IP)|Physician Decision|0
4761298|NCT01647516|16425716|P5|Induction Period (IP)|Physician Decision|0
4761299|NCT01647516|16425717|P4|Induction Period (IP)|Physician Decision|0
4761300|NCT01647516|16425718|P3|Induction Period (IP)|Physician Decision|0
4761301|NCT01647516|16425719|P2|Induction Period (IP)|Physician Decision|0
4761302|NCT01647516|16425720|P1|Induction Period (IP)|Physician Decision|2
4761303|NCT01647282|16425776|P2|Overall Study|Physician Decision|5
4761304|NCT01647282|16425777|P1|Overall Study|Physician Decision|7
4761305|NCT01646827|16425798|P2|Overall Study|Withdrawal by Subject|0
4761306|NCT01646827|16425799|P1|Overall Study|Withdrawal by Subject|1
4761307|NCT01646827|16425798|P2|Overall Study|Physician Decision|2
4761308|NCT01646827|16425799|P1|Overall Study|Physician Decision|1
4761309|NCT01646827|16425798|P2|Overall Study|Lost to Follow-up|3
4761310|NCT01646827|16425799|P1|Overall Study|Lost to Follow-up|0
4761311|NCT01646398|16425886|P2|Overall Study|Withdrawal by Subject|0
4761312|NCT01646398|16425887|P1|Overall Study|Withdrawal by Subject|1
4761313|NCT01646385|16425903|P2|Overall Study|Switched to alternate biologic|649
4761314|NCT01646385|16425904|P1|Overall Study|Switched to alternate biologic|636
4761315|NCT01646385|16425903|P2|Overall Study|Death|222
4761316|NCT01646385|16425904|P1|Overall Study|Death|202
4761317|NCT01646320|16425947|P2|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2
4761318|NCT01646320|16425948|P1|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0
4761319|NCT01646320|16425947|P2|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1
4761320|NCT01646320|16425948|P1|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0
4761321|NCT01646320|16425947|P2|Long-term Period (Weeks 24 to 52)|Adverse Event|2
4761322|NCT01646320|16425948|P1|Long-term Period (Weeks 24 to 52)|Adverse Event|4
4761323|NCT01646320|16425947|P2|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2
4761324|NCT01646320|16425948|P1|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0
4761325|NCT01646320|16425947|P2|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0
4761326|NCT01646320|16425948|P1|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2
4761327|NCT01646320|16425947|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0
4761328|NCT01646320|16425948|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2
4761329|NCT01646320|16425947|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4761330|NCT01646320|16425948|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4761331|NCT01646320|16425947|P2|Short-term Period (Day 1 to Week 24)|Other|0
4761332|NCT01646320|16425948|P1|Short-term Period (Day 1 to Week 24)|Other|1
4761333|NCT01646320|16425947|P2|Short-term Period (Day 1 to Week 24)|Not reported|2
4761334|NCT01646320|16425948|P1|Short-term Period (Day 1 to Week 24)|Not reported|2
4761335|NCT01646320|16425947|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1
4761336|NCT01646320|16425948|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
4761337|NCT01646320|16425947|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|0
4761338|NCT01646320|16425948|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|3
4761339|NCT01646268|16425964|P2|Overall Study|Other|0
4761340|NCT01646268|16425965|P1|Overall Study|Other|2
4761341|NCT01646268|16425964|P2|Overall Study|Withdrawal by Subject|5
4761342|NCT01646268|16425965|P1|Overall Study|Withdrawal by Subject|2
4761343|NCT01646268|16425964|P2|Overall Study|Protocol Violation|1
4761344|NCT01646268|16425965|P1|Overall Study|Protocol Violation|0
4761345|NCT01646268|16425964|P2|Overall Study|Lack of Efficacy|3
4761346|NCT01646268|16425965|P1|Overall Study|Lack of Efficacy|1
4761347|NCT01646268|16425964|P2|Overall Study|Adverse Event|7
4761348|NCT01646268|16425965|P1|Overall Study|Adverse Event|6
4761349|NCT01646255|16425979|P2|Overall Study|Inclusion Criteria Deviation|0
4761350|NCT01646255|16425980|P1|Overall Study|Inclusion Criteria Deviation|1
4761351|NCT01646255|16425979|P2|Overall Study|Compliance is not well|0
4761352|NCT01646255|16425980|P1|Overall Study|Compliance is not well|1
4761353|NCT01646255|16425979|P2|Overall Study|Withdrawal by Subject|6
4761354|NCT01646255|16425980|P1|Overall Study|Withdrawal by Subject|10
4761355|NCT01646255|16425979|P2|Overall Study|Lack of Efficacy|0
4761356|NCT01646255|16425980|P1|Overall Study|Lack of Efficacy|2
4761357|NCT01646255|16425979|P2|Overall Study|Adverse Event|8
4761358|NCT01646255|16425980|P1|Overall Study|Adverse Event|7
4761359|NCT01646216|16426012|P2|Overall Study|Investigator decision|1
4761360|NCT01646216|16426013|P1|Overall Study|Investigator decision|1
4761361|NCT01646216|16426012|P2|Overall Study|Did not complete training|2
4761362|NCT01646216|16426013|P1|Overall Study|Did not complete training|0
4761363|NCT01646216|16426012|P2|Overall Study|Baseline step length difference (<5cm)|10
4761364|NCT01646216|16426013|P1|Overall Study|Baseline step length difference (<5cm)|10
4761365|NCT01646203|16426035|P3|Overall Study|Physician's Decision|0
4761366|NCT01646203|16426036|P2|Overall Study|Physician's Decision|1
4761367|NCT01646203|16426037|P1|Overall Study|Physician's Decision|0
4761368|NCT01646203|16426035|P3|Overall Study|Withdrawal by Subject|0
4761369|NCT01646203|16426036|P2|Overall Study|Withdrawal by Subject|1
4761370|NCT01646203|16426037|P1|Overall Study|Withdrawal by Subject|0
4761371|NCT01646203|16426035|P3|Overall Study|Adverse Event|1
4761372|NCT01646203|16426036|P2|Overall Study|Adverse Event|0
4761373|NCT01646203|16426037|P1|Overall Study|Adverse Event|2
4761374|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
4761375|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1
4761376|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761377|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761378|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761379|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761380|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761381|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761382|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761383|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761384|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761385|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0
4761386|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Death|1
4761387|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Death|1
4761388|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761389|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Death|1
4761390|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761391|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761392|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761393|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761394|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761395|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761396|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761397|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Death|0
4761398|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
4761399|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
4761400|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1
4761401|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761402|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761403|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761404|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761405|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761406|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761407|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761408|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761409|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0
4761410|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3
4761411|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
4761412|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1
4761413|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761414|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761415|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761416|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761417|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761418|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761419|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761420|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761421|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0
4761422|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3
4761423|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
4761424|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2
4761425|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1
4761426|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761427|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761428|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761429|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761430|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761431|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761432|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761433|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0
4761434|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7
4761435|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4
4761436|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6
4761437|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1
4761438|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761439|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761440|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761441|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761442|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761443|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761444|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761445|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0
4761446|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
4761447|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8
4761448|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9
4761449|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4
4761450|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761451|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761452|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761453|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761454|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761455|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761456|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761457|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0
4761458|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
4761459|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9
4761460|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8
4761461|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4
4761462|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761463|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761464|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761465|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761466|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761467|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761468|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761469|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0
4761470|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
4761471|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19
4761472|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21
4761473|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7
4761474|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761475|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761476|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761477|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761478|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761479|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761480|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761481|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0
4761482|NCT01646177|16426066|P12|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30
4761483|NCT01646177|16426067|P11|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34
4761484|NCT01646177|16426068|P10|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28
4761485|NCT01646177|16426069|P9|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13
4761486|NCT01646177|16426070|P8|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761487|NCT01646177|16426071|P7|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761488|NCT01646177|16426072|P6|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761489|NCT01646177|16426073|P5|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761490|NCT01646177|16426074|P4|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761491|NCT01646177|16426075|P3|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761492|NCT01646177|16426076|P2|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761493|NCT01646177|16426077|P1|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0
4761494|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761495|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761496|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761497|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761498|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1
4761499|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2
4761500|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3
4761501|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761502|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761503|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761504|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761505|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0
4761506|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761507|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761508|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761509|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761510|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1
4761511|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761512|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761513|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761514|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761515|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761516|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761517|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0
4761518|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761519|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761520|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761521|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761522|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4
4761523|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
4761524|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
4761525|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1
4761526|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761527|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761528|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761529|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0
4761530|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Death|0
4761531|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Death|0
4761532|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Death|0
4761533|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Death|0
4761534|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Death|3
4761535|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Death|1
4761536|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Death|3
4761537|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Death|1
4761538|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Death|0
4761539|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Death|0
4761540|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Death|0
4761541|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Death|0
4761542|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761543|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761544|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761545|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761546|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
4761547|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
4761548|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2
4761549|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3
4761550|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761551|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761552|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761553|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0
4761554|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761555|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761556|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761557|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761558|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Protocol Violation|5
4761559|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761560|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Protocol Violation|4
4761561|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Protocol Violation|1
4761562|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761563|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761564|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761565|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Protocol Violation|0
4761566|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761567|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761568|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761569|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761570|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Physician Decision|5
4761571|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Physician Decision|5
4761572|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Physician Decision|5
4761573|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Physician Decision|3
4761574|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761575|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761576|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761577|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Physician Decision|0
4761578|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761579|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761580|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761581|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761582|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11
4761583|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10
4761584|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14
4761585|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6
4761586|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761587|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761588|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761589|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0
4761590|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761591|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761592|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761593|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761594|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18
4761595|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23
4761596|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17
4761597|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6
4761598|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761599|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761600|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761601|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0
4761602|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761603|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761604|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761605|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761606|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27
4761607|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29
4761608|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30
4761609|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11
4761610|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761611|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761612|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761613|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0
4761614|NCT01646177|16426066|P12|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761615|NCT01646177|16426067|P11|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761616|NCT01646177|16426068|P10|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761617|NCT01646177|16426069|P9|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761618|NCT01646177|16426070|P8|Long-Term Extension Period (Week 12-264)|Adverse Event|30
4761619|NCT01646177|16426071|P7|Long-Term Extension Period (Week 12-264)|Adverse Event|43
4761620|NCT01646177|16426072|P6|Long-Term Extension Period (Week 12-264)|Adverse Event|34
4761621|NCT01646177|16426073|P5|Long-Term Extension Period (Week 12-264)|Adverse Event|16
4761622|NCT01646177|16426074|P4|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761623|NCT01646177|16426075|P3|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761624|NCT01646177|16426076|P2|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761625|NCT01646177|16426077|P1|Long-Term Extension Period (Week 12-264)|Adverse Event|0
4761626|NCT01646177|16426066|P12|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761627|NCT01646177|16426067|P11|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761628|NCT01646177|16426068|P10|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761629|NCT01646177|16426069|P9|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761630|NCT01646177|16426070|P8|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761631|NCT01646177|16426071|P7|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761632|NCT01646177|16426072|P6|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761633|NCT01646177|16426073|P5|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761634|NCT01646177|16426074|P4|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0
4761635|NCT01646177|16426075|P3|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
4761636|NCT01646177|16426076|P2|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2
4761637|NCT01646177|16426077|P1|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3
4761638|NCT01646177|16426066|P12|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761639|NCT01646177|16426067|P11|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761640|NCT01646177|16426068|P10|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761641|NCT01646177|16426069|P9|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761642|NCT01646177|16426070|P8|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761643|NCT01646177|16426071|P7|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761644|NCT01646177|16426072|P6|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761645|NCT01646177|16426073|P5|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761646|NCT01646177|16426074|P4|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1
4761647|NCT01646177|16426075|P3|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2
4761648|NCT01646177|16426076|P2|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761649|NCT01646177|16426077|P1|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0
4761650|NCT01646177|16426066|P12|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761651|NCT01646177|16426067|P11|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761652|NCT01646177|16426068|P10|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761653|NCT01646177|16426069|P9|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761654|NCT01646177|16426070|P8|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761655|NCT01646177|16426071|P7|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761656|NCT01646177|16426072|P6|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761657|NCT01646177|16426073|P5|Blinded Induction Dosing (Week 0-12)|Physician Decision|0
4761658|NCT01646177|16426074|P4|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
4761659|NCT01646177|16426075|P3|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
4761660|NCT01646177|16426076|P2|Blinded Induction Dosing (Week 0-12)|Physician Decision|2
4761661|NCT01646177|16426077|P1|Blinded Induction Dosing (Week 0-12)|Physician Decision|1
4761662|NCT01646177|16426066|P12|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761663|NCT01646177|16426067|P11|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761664|NCT01646177|16426068|P10|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761665|NCT01646177|16426069|P9|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761666|NCT01646177|16426070|P8|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761667|NCT01646177|16426071|P7|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761668|NCT01646177|16426072|P6|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761669|NCT01646177|16426073|P5|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0
4761670|NCT01646177|16426074|P4|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
4761671|NCT01646177|16426075|P3|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4
4761672|NCT01646177|16426076|P2|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2
4761673|NCT01646177|16426077|P1|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3
4761674|NCT01646177|16426066|P12|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761675|NCT01646177|16426067|P11|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761676|NCT01646177|16426068|P10|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761677|NCT01646177|16426069|P9|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761678|NCT01646177|16426070|P8|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761679|NCT01646177|16426071|P7|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761680|NCT01646177|16426072|P6|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761681|NCT01646177|16426073|P5|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0
4761682|NCT01646177|16426074|P4|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7
4761683|NCT01646177|16426075|P3|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8
4761684|NCT01646177|16426076|P2|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3
4761685|NCT01646177|16426077|P1|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1
4761686|NCT01646177|16426066|P12|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761687|NCT01646177|16426067|P11|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761688|NCT01646177|16426068|P10|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761689|NCT01646177|16426069|P9|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761690|NCT01646177|16426070|P8|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761691|NCT01646177|16426071|P7|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761692|NCT01646177|16426072|P6|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761693|NCT01646177|16426073|P5|Blinded Induction Dosing (Week 0-12)|Adverse Event|0
4761694|NCT01646177|16426074|P4|Blinded Induction Dosing (Week 0-12)|Adverse Event|8
4761695|NCT01646177|16426075|P3|Blinded Induction Dosing (Week 0-12)|Adverse Event|9
4761696|NCT01646177|16426076|P2|Blinded Induction Dosing (Week 0-12)|Adverse Event|4
4761697|NCT01646177|16426077|P1|Blinded Induction Dosing (Week 0-12)|Adverse Event|2
4761698|NCT01646138|16426179|P5|Overall Study|Lost to Follow-up|2
4761699|NCT01646138|16426180|P4|Overall Study|Lost to Follow-up|0
4761700|NCT01646138|16426181|P3|Overall Study|Lost to Follow-up|0
4761701|NCT01646138|16426182|P2|Overall Study|Lost to Follow-up|0
4761702|NCT01646138|16426183|P1|Overall Study|Lost to Follow-up|0
4761703|NCT01646125|16426197|P2|Overall Study|Subject/Guardian decision|1
4761704|NCT01646125|16426198|P1|Overall Study|Subject/Guardian decision|1
4761705|NCT01646125|16426197|P2|Overall Study|Study terminated by sponsor|1
4761706|NCT01646125|16426198|P1|Overall Study|Study terminated by sponsor|2
4761707|NCT01646125|16426197|P2|Overall Study|Progressive disease|16
4761708|NCT01646125|16426198|P1|Overall Study|Progressive disease|22
4761709|NCT01646125|16426197|P2|Overall Study|Physician Decision|3
4761710|NCT01646125|16426198|P1|Overall Study|Physician Decision|1
4761711|NCT01646125|16426197|P2|Overall Study|Death|1
4761712|NCT01646125|16426198|P1|Overall Study|Death|1
4761713|NCT01646125|16426197|P2|Overall Study|Adverse Event|1
4761714|NCT01646125|16426198|P1|Overall Study|Adverse Event|2
4761715|NCT01646125|16426197|P2|Overall Study|Untreated|5
4761716|NCT01646125|16426198|P1|Overall Study|Untreated|2
4761717|NCT01646073|16426223|P2|Period B (12 Weeks)|Lost to Follow-up|1
4761718|NCT01646073|16426224|P1|Period B (12 Weeks)|Lost to Follow-up|0
4761719|NCT01646073|16426223|P2|Period B (12 Weeks)|Withdrawal by Subject|5
4761720|NCT01646073|16426224|P1|Period B (12 Weeks)|Withdrawal by Subject|1
4761721|NCT01646073|16426223|P2|Period B (12 Weeks)|Adverse Event|7
4761722|NCT01646073|16426224|P1|Period B (12 Weeks)|Adverse Event|0
4761723|NCT01646073|16426223|P2|Period A (12 Weeks)|Other|1
4761724|NCT01646073|16426224|P1|Period A (12 Weeks)|Other|0
4761725|NCT01646073|16426223|P2|Period A (12 Weeks)|Protocol Violation|1
4761726|NCT01646073|16426224|P1|Period A (12 Weeks)|Protocol Violation|0
4761727|NCT01646073|16426223|P2|Period A (12 Weeks)|Lack of Efficacy|0
4761728|NCT01646073|16426224|P1|Period A (12 Weeks)|Lack of Efficacy|1
4761729|NCT01646073|16426223|P2|Period A (12 Weeks)|Withdrawal by Subject|1
4761730|NCT01646073|16426224|P1|Period A (12 Weeks)|Withdrawal by Subject|1
4761731|NCT01646073|16426223|P2|Period A (12 Weeks)|Adverse Event|2
4761732|NCT01646073|16426224|P1|Period A (12 Weeks)|Adverse Event|0
4761733|NCT01646021|16426265|P2|Overall Study|Withdrawal by Subject|15
4761734|NCT01646021|16426266|P1|Overall Study|Withdrawal by Subject|10
4761735|NCT01646021|16426265|P2|Overall Study|Lost to Follow-up|2
4761736|NCT01646021|16426266|P1|Overall Study|Lost to Follow-up|2
4761737|NCT01646021|16426265|P2|Overall Study|Study Terminated by Sponsor|41
4761738|NCT01646021|16426266|P1|Overall Study|Study Terminated by Sponsor|50
4761739|NCT01646021|16426265|P2|Overall Study|Death|83
4761740|NCT01646021|16426266|P1|Overall Study|Death|77
4761741|NCT01645930|16426303|P1|Overall Study|Reason not Defined|1
4761742|NCT01645930|16426303|P1|Overall Study|Withdrawal by Participant|2
4761743|NCT01645930|16426303|P1|Overall Study|Unsatisfactory Therapeutic Response|2
4761744|NCT01645930|16426303|P1|Overall Study|Adverse Event|4
4761745|NCT01645930|16426303|P1|Overall Study|Progressive Disease|12
4761746|NCT01645930|16426303|P1|Overall Study|Participants Ongoing on Study Treatment|22
4761747|NCT01645735|16426320|P2|Overall Study|Adverse Event|1
4761748|NCT01645735|16426321|P1|Overall Study|Adverse Event|0
4761749|NCT01645735|16426320|P2|Overall Study|Protocol Violation|0
4761750|NCT01645735|16426321|P1|Overall Study|Protocol Violation|1
4761751|NCT01645735|16426320|P2|Overall Study|Withdrawal by Subject|0
4761752|NCT01645735|16426321|P1|Overall Study|Withdrawal by Subject|1
4761753|NCT01645735|16426320|P2|Overall Study|Physician Decision|0
4761754|NCT01645735|16426321|P1|Overall Study|Physician Decision|2
4761755|NCT01645280|16426363|P5|Overall Study|Treatment not completed/Completed f/u|2
4761847|NCT01644565|16426693|P1|Overall Study|Family emergency|0
4761756|NCT01645280|16426364|P4|Overall Study|Treatment not completed/Completed f/u|0
4761757|NCT01645280|16426365|P3|Overall Study|Treatment not completed/Completed f/u|2
4761758|NCT01645280|16426366|P2|Overall Study|Treatment not completed/Completed f/u|1
4761759|NCT01645280|16426367|P1|Overall Study|Treatment not completed/Completed f/u|1
4761760|NCT01645280|16426363|P5|Overall Study|Other|0
4761761|NCT01645280|16426364|P4|Overall Study|Other|0
4761762|NCT01645280|16426365|P3|Overall Study|Other|2
4761763|NCT01645280|16426366|P2|Overall Study|Other|1
4761764|NCT01645280|16426367|P1|Overall Study|Other|1
4761765|NCT01645280|16426363|P5|Overall Study|Lost to Follow-up|1
4761766|NCT01645280|16426364|P4|Overall Study|Lost to Follow-up|2
4761767|NCT01645280|16426365|P3|Overall Study|Lost to Follow-up|0
4761768|NCT01645280|16426366|P2|Overall Study|Lost to Follow-up|0
4761769|NCT01645280|16426367|P1|Overall Study|Lost to Follow-up|0
4761770|NCT01645280|16426363|P5|Overall Study|Withdrawal by Subject|5
4761771|NCT01645280|16426364|P4|Overall Study|Withdrawal by Subject|4
4761772|NCT01645280|16426365|P3|Overall Study|Withdrawal by Subject|2
4761773|NCT01645280|16426366|P2|Overall Study|Withdrawal by Subject|0
4761774|NCT01645280|16426367|P1|Overall Study|Withdrawal by Subject|4
4761775|NCT01645280|16426363|P5|Overall Study|Death|0
4761776|NCT01645280|16426364|P4|Overall Study|Death|0
4761777|NCT01645280|16426365|P3|Overall Study|Death|0
4761778|NCT01645280|16426366|P2|Overall Study|Death|1
4761779|NCT01645280|16426367|P1|Overall Study|Death|0
4761780|NCT01645176|16426395|P1|Overall Study|did not complete final MRI|1
4761781|NCT01645176|16426395|P1|Overall Study|Lack of Efficacy|4
4761782|NCT01645111|16426399|P1|Overall Study|Did not require Clevidipine|15
4761783|NCT01644890|16426440|P2|Overall Study|Other|9
4761784|NCT01644890|16426441|P1|Overall Study|Other|8
4761785|NCT01644890|16426440|P2|Overall Study|> 28 days since last dose of study drug|3
4761786|NCT01644890|16426441|P1|Overall Study|> 28 days since last dose of study drug|6
4761787|NCT01644890|16426440|P2|Overall Study|Clinical Progression|6
4761788|NCT01644890|16426441|P1|Overall Study|Clinical Progression|6
4761789|NCT01644890|16426440|P2|Overall Study|Progression Disease|131
4761790|NCT01644890|16426441|P1|Overall Study|Progression Disease|160
4761791|NCT01644890|16426440|P2|Overall Study|Withdrawal by Subject|27
4761792|NCT01644890|16426441|P1|Overall Study|Withdrawal by Subject|19
4761793|NCT01644890|16426440|P2|Overall Study|Protocol Violation|7
4761794|NCT01644890|16426441|P1|Overall Study|Protocol Violation|6
4761795|NCT01644890|16426440|P2|Overall Study|Physician Decision|9
4761796|NCT01644890|16426441|P1|Overall Study|Physician Decision|3
4761797|NCT01644890|16426440|P2|Overall Study|Death|3
4761798|NCT01644890|16426441|P1|Overall Study|Death|1
4761799|NCT01644890|16426440|P2|Overall Study|Adverse Event|20
4761800|NCT01644890|16426441|P1|Overall Study|Adverse Event|7
4761801|NCT01644734|16426451|P1|Overall Study|Missing documentation|238
4761802|NCT01644734|16426451|P1|Overall Study|Reasons other than stated above|7
4761803|NCT01644734|16426451|P1|Overall Study|Lost to Follow-up|17
4761804|NCT01644734|16426451|P1|Overall Study|Adverse Event|4
4761805|NCT01644643|16426465|P4|Overall Study|Other Eligibility criteria|2
4761806|NCT01644643|16426466|P3|Overall Study|Other Eligibility criteria|0
4761807|NCT01644643|16426467|P2|Overall Study|Other Eligibility criteria|0
4761808|NCT01644643|16426468|P1|Overall Study|Other Eligibility criteria|0
4761809|NCT01644643|16426465|P4|Overall Study|Withdrawal by Subject|1
4761810|NCT01644643|16426466|P3|Overall Study|Withdrawal by Subject|2
4761811|NCT01644643|16426467|P2|Overall Study|Withdrawal by Subject|0
4761812|NCT01644643|16426468|P1|Overall Study|Withdrawal by Subject|1
4761813|NCT01644643|16426465|P4|Overall Study|Lost to Follow-up|4
4761814|NCT01644643|16426466|P3|Overall Study|Lost to Follow-up|0
4761815|NCT01644643|16426467|P2|Overall Study|Lost to Follow-up|0
4761816|NCT01644643|16426468|P1|Overall Study|Lost to Follow-up|0
4761817|NCT01644643|16426465|P4|Overall Study|Death|3
4761818|NCT01644643|16426466|P3|Overall Study|Death|3
4761819|NCT01644643|16426467|P2|Overall Study|Death|0
4761820|NCT01644643|16426468|P1|Overall Study|Death|1
4761821|NCT01644617|16426633|P3|Overall Study|Adverse Event|6
4761822|NCT01644617|16426634|P2|Overall Study|Adverse Event|0
4761823|NCT01644617|16426635|P1|Overall Study|Adverse Event|3
4761824|NCT01644617|16426633|P3|Overall Study|Lost to Follow-up|0
4761825|NCT01644617|16426634|P2|Overall Study|Lost to Follow-up|1
4761826|NCT01644617|16426635|P1|Overall Study|Lost to Follow-up|0
4761827|NCT01644617|16426633|P3|Overall Study|Withdrawal by Subject|1
4761828|NCT01644617|16426634|P2|Overall Study|Withdrawal by Subject|4
4761829|NCT01644617|16426635|P1|Overall Study|Withdrawal by Subject|3
4761830|NCT01644565|16426685|P9|Overall Study|Relocation|1
4761831|NCT01644565|16426686|P8|Overall Study|Relocation|0
4761832|NCT01644565|16426687|P7|Overall Study|Relocation|0
4761833|NCT01644565|16426688|P6|Overall Study|Relocation|0
4761834|NCT01644565|16426689|P5|Overall Study|Relocation|0
4761835|NCT01644565|16426690|P4|Overall Study|Relocation|0
4761836|NCT01644565|16426691|P3|Overall Study|Relocation|0
4761837|NCT01644565|16426692|P2|Overall Study|Relocation|0
4761838|NCT01644565|16426693|P1|Overall Study|Relocation|0
4761839|NCT01644565|16426685|P9|Overall Study|Family emergency|0
4761840|NCT01644565|16426686|P8|Overall Study|Family emergency|0
4761841|NCT01644565|16426687|P7|Overall Study|Family emergency|0
4761842|NCT01644565|16426688|P6|Overall Study|Family emergency|0
4761843|NCT01644565|16426689|P5|Overall Study|Family emergency|1
4761844|NCT01644565|16426690|P4|Overall Study|Family emergency|0
4761845|NCT01644565|16426691|P3|Overall Study|Family emergency|0
4761846|NCT01644565|16426692|P2|Overall Study|Family emergency|0
4761848|NCT01644565|16426685|P9|Overall Study|Lost to Follow-up|0
4761849|NCT01644565|16426686|P8|Overall Study|Lost to Follow-up|2
4761850|NCT01644565|16426687|P7|Overall Study|Lost to Follow-up|0
4761851|NCT01644565|16426688|P6|Overall Study|Lost to Follow-up|0
4761852|NCT01644565|16426689|P5|Overall Study|Lost to Follow-up|0
4761853|NCT01644565|16426690|P4|Overall Study|Lost to Follow-up|1
4761854|NCT01644565|16426691|P3|Overall Study|Lost to Follow-up|0
4761855|NCT01644565|16426692|P2|Overall Study|Lost to Follow-up|0
4761856|NCT01644565|16426693|P1|Overall Study|Lost to Follow-up|0
4761857|NCT01644565|16426685|P9|Overall Study|Undisclosed Medical History|0
4761858|NCT01644565|16426686|P8|Overall Study|Undisclosed Medical History|0
4761859|NCT01644565|16426687|P7|Overall Study|Undisclosed Medical History|0
4761860|NCT01644565|16426688|P6|Overall Study|Undisclosed Medical History|0
4761861|NCT01644565|16426689|P5|Overall Study|Undisclosed Medical History|0
4761862|NCT01644565|16426690|P4|Overall Study|Undisclosed Medical History|0
4761863|NCT01644565|16426691|P3|Overall Study|Undisclosed Medical History|0
4761864|NCT01644565|16426692|P2|Overall Study|Undisclosed Medical History|0
4761865|NCT01644565|16426693|P1|Overall Study|Undisclosed Medical History|1
4761866|NCT01644500|16426734|P3|Overall Study|Physician Decision|1
4761867|NCT01644500|16426735|P2|Overall Study|Physician Decision|1
4761868|NCT01644500|16426736|P1|Overall Study|Physician Decision|1
4761869|NCT01644500|16426734|P3|Overall Study|Withdrawal by Subject|12
4761870|NCT01644500|16426735|P2|Overall Study|Withdrawal by Subject|12
4761871|NCT01644500|16426736|P1|Overall Study|Withdrawal by Subject|11
4761872|NCT01644500|16426734|P3|Overall Study|Protocol Violation|0
4761873|NCT01644500|16426735|P2|Overall Study|Protocol Violation|1
4761874|NCT01644500|16426736|P1|Overall Study|Protocol Violation|1
4761875|NCT01644500|16426734|P3|Overall Study|Lost to Follow-up|0
4761876|NCT01644500|16426735|P2|Overall Study|Lost to Follow-up|8
4761877|NCT01644500|16426736|P1|Overall Study|Lost to Follow-up|3
4761878|NCT01644500|16426734|P3|Overall Study|Death|0
4761879|NCT01644500|16426735|P2|Overall Study|Death|1
4761880|NCT01644500|16426736|P1|Overall Study|Death|0
4761881|NCT01644500|16426734|P3|Overall Study|Adverse Event|2
4761882|NCT01644500|16426735|P2|Overall Study|Adverse Event|1
4761883|NCT01644500|16426736|P1|Overall Study|Adverse Event|6
4761884|NCT01644474|16426806|P2|Overall Study|Protocol Violation|0
4761885|NCT01644474|16426807|P1|Overall Study|Protocol Violation|1
4761886|NCT01644474|16426806|P2|Overall Study|Site scheduling error|1
4761887|NCT01644474|16426807|P1|Overall Study|Site scheduling error|1
4761888|NCT01644474|16426806|P2|Overall Study|Adverse Event|5
4761889|NCT01644474|16426807|P1|Overall Study|Adverse Event|4
4761890|NCT01644474|16426806|P2|Overall Study|Participant moved|1
4761891|NCT01644474|16426807|P1|Overall Study|Participant moved|0
4761892|NCT01644474|16426806|P2|Overall Study|Consent withdrawn by participant|1
4761893|NCT01644474|16426807|P1|Overall Study|Consent withdrawn by participant|0
4761894|NCT01644474|16426806|P2|Overall Study|Poor compliance to protocol|0
4761895|NCT01644474|16426807|P1|Overall Study|Poor compliance to protocol|1
4761896|NCT01644188|16426991|P2|Overall Study|Other than specified above|7
4761897|NCT01644188|16426992|P1|Overall Study|Other than specified above|6
4761898|NCT01644188|16426991|P2|Overall Study|Site closure|1
4761899|NCT01644188|16426992|P1|Overall Study|Site closure|1
4761900|NCT01644188|16426991|P2|Overall Study|Last visit outside protocol visit window|16
4761901|NCT01644188|16426992|P1|Overall Study|Last visit outside protocol visit window|14
4761902|NCT01644188|16426991|P2|Overall Study|Death|3
4761903|NCT01644188|16426992|P1|Overall Study|Death|4
4761904|NCT01644188|16426991|P2|Overall Study|Lost to Follow-up|0
4761905|NCT01644188|16426992|P1|Overall Study|Lost to Follow-up|1
4761906|NCT01644188|16426991|P2|Overall Study|Selection criteria finally not met|0
4761907|NCT01644188|16426992|P1|Overall Study|Selection criteria finally not met|2
4761908|NCT01644188|16426991|P2|Overall Study|Consent withdrawn by participant|7
4761909|NCT01644188|16426992|P1|Overall Study|Consent withdrawn by participant|14
4761910|NCT01644188|16426991|P2|Overall Study|Related to auto-injector administration|2
4761911|NCT01644188|16426992|P1|Overall Study|Related to auto-injector administration|2
4761912|NCT01644188|16426991|P2|Overall Study|Participant moved|2
4761913|NCT01644188|16426992|P1|Overall Study|Participant moved|7
4761914|NCT01644188|16426991|P2|Overall Study|Physician Decision|3
4761915|NCT01644188|16426992|P1|Overall Study|Physician Decision|1
4761916|NCT01644188|16426991|P2|Overall Study|Poor compliance to protocol|14
4761917|NCT01644188|16426992|P1|Overall Study|Poor compliance to protocol|26
4761918|NCT01644188|16426991|P2|Overall Study|Adverse Event|20
4761919|NCT01644188|16426992|P1|Overall Study|Adverse Event|44
4761920|NCT01644175|16427050|P2|Overall Study|Other than specified above|3
4761921|NCT01644175|16427051|P1|Overall Study|Other than specified above|0
4761922|NCT01644175|16427050|P2|Overall Study|Lost to Follow-up|0
4761923|NCT01644175|16427051|P1|Overall Study|Lost to Follow-up|1
4761924|NCT01644175|16427050|P2|Overall Study|Site closure|2
4761925|NCT01644175|16427051|P1|Overall Study|Site closure|2
4761926|NCT01644175|16427050|P2|Overall Study|Selection criteria finally not met|1
4761927|NCT01644175|16427051|P1|Overall Study|Selection criteria finally not met|0
4761928|NCT01644175|16427050|P2|Overall Study|Last visit outside protocol visit window|11
4761929|NCT01644175|16427051|P1|Overall Study|Last visit outside protocol visit window|4
4761930|NCT01644175|16427050|P2|Overall Study|Related to Autoinjector Administration|1
4761931|NCT01644175|16427051|P1|Overall Study|Related to Autoinjector Administration|2
4761932|NCT01644175|16427050|P2|Overall Study|Consent withdrawn by participant|4
4761933|NCT01644175|16427051|P1|Overall Study|Consent withdrawn by participant|3
4761934|NCT01644175|16427050|P2|Overall Study|Participant Moved|2
4761935|NCT01644175|16427051|P1|Overall Study|Participant Moved|1
4761936|NCT01644175|16427050|P2|Overall Study|Physician Decision|2
4761937|NCT01644175|16427051|P1|Overall Study|Physician Decision|1
4761938|NCT01644175|16427050|P2|Overall Study|Poor compliance to protocol|10
4761939|NCT01644175|16427051|P1|Overall Study|Poor compliance to protocol|9
4761940|NCT01644175|16427050|P2|Overall Study|Death|2
4761941|NCT01644175|16427051|P1|Overall Study|Death|1
4761942|NCT01644175|16427050|P2|Overall Study|Adverse Event|13
4761943|NCT01644175|16427051|P1|Overall Study|Adverse Event|8
4761944|NCT01644175|16427050|P2|Overall Study|Randomized But Not Treated|2
4761945|NCT01644175|16427051|P1|Overall Study|Randomized But Not Treated|0
4761946|NCT01644149|16427103|P2|Overall Study|Lost to Follow-up|1
4761947|NCT01644149|16427104|P1|Overall Study|Lost to Follow-up|3
4761948|NCT01644149|16427103|P2|Overall Study|Withdrawal by Subject|0
4761949|NCT01644149|16427104|P1|Overall Study|Withdrawal by Subject|1
4761950|NCT01643928|16427124|P5|Overall Study|Adverse Event|2
4761951|NCT01643928|16427125|P4|Overall Study|Adverse Event|1
4761952|NCT01643928|16427126|P3|Overall Study|Adverse Event|0
4761953|NCT01643928|16427127|P2|Overall Study|Adverse Event|1
4761954|NCT01643928|16427128|P1|Overall Study|Adverse Event|2
4761955|NCT01643928|16427124|P5|Overall Study|Other|0
4761956|NCT01643928|16427125|P4|Overall Study|Other|0
4761957|NCT01643928|16427126|P3|Overall Study|Other|1
4761958|NCT01643928|16427127|P2|Overall Study|Other|1
4761959|NCT01643928|16427128|P1|Overall Study|Other|5
4761960|NCT01643928|16427124|P5|Overall Study|Pregnancy|0
4761961|NCT01643928|16427125|P4|Overall Study|Pregnancy|1
4761962|NCT01643928|16427126|P3|Overall Study|Pregnancy|0
4761963|NCT01643928|16427127|P2|Overall Study|Pregnancy|0
4761964|NCT01643928|16427128|P1|Overall Study|Pregnancy|0
4761965|NCT01643928|16427124|P5|Overall Study|Withdrawal by Subject|0
4761966|NCT01643928|16427125|P4|Overall Study|Withdrawal by Subject|1
4761967|NCT01643928|16427126|P3|Overall Study|Withdrawal by Subject|0
4761968|NCT01643928|16427127|P2|Overall Study|Withdrawal by Subject|0
4761969|NCT01643928|16427128|P1|Overall Study|Withdrawal by Subject|2
4761970|NCT01643928|16427124|P5|Overall Study|Lost to Follow-up|0
4761971|NCT01643928|16427125|P4|Overall Study|Lost to Follow-up|0
4761972|NCT01643928|16427126|P3|Overall Study|Lost to Follow-up|2
4761973|NCT01643928|16427127|P2|Overall Study|Lost to Follow-up|0
4761974|NCT01643928|16427128|P1|Overall Study|Lost to Follow-up|1
4761975|NCT01643850|16427432|P9|Overall Study|Administrative Problems|0
4761976|NCT01643850|16427433|P8|Overall Study|Administrative Problems|0
4761977|NCT01643850|16427434|P7|Overall Study|Administrative Problems|0
4761978|NCT01643850|16427435|P6|Overall Study|Administrative Problems|0
4761979|NCT01643850|16427436|P5|Overall Study|Administrative Problems|1
4761980|NCT01643850|16427437|P4|Overall Study|Administrative Problems|0
4761981|NCT01643850|16427438|P3|Overall Study|Administrative Problems|1
4761982|NCT01643850|16427439|P2|Overall Study|Administrative Problems|0
4761983|NCT01643850|16427440|P1|Overall Study|Administrative Problems|0
4761984|NCT01643850|16427432|P9|Overall Study|Adverse Event|0
4761985|NCT01643850|16427433|P8|Overall Study|Adverse Event|0
4761986|NCT01643850|16427434|P7|Overall Study|Adverse Event|0
4761987|NCT01643850|16427435|P6|Overall Study|Adverse Event|0
4761988|NCT01643850|16427436|P5|Overall Study|Adverse Event|1
4761989|NCT01643850|16427437|P4|Overall Study|Adverse Event|0
4761990|NCT01643850|16427438|P3|Overall Study|Adverse Event|0
4761991|NCT01643850|16427439|P2|Overall Study|Adverse Event|0
4761992|NCT01643850|16427440|P1|Overall Study|Adverse Event|0
4761993|NCT01643850|16427432|P9|Overall Study|Lost to Follow-up|1
4761994|NCT01643850|16427433|P8|Overall Study|Lost to Follow-up|0
4761995|NCT01643850|16427434|P7|Overall Study|Lost to Follow-up|1
4761996|NCT01643850|16427435|P6|Overall Study|Lost to Follow-up|0
4761997|NCT01643850|16427436|P5|Overall Study|Lost to Follow-up|0
4761998|NCT01643850|16427437|P4|Overall Study|Lost to Follow-up|0
4761999|NCT01643850|16427438|P3|Overall Study|Lost to Follow-up|0
4762000|NCT01643850|16427439|P2|Overall Study|Lost to Follow-up|0
4762001|NCT01643850|16427440|P1|Overall Study|Lost to Follow-up|0
4762002|NCT01643850|16427432|P9|Overall Study|Withdrawal by Subject|0
4762003|NCT01643850|16427433|P8|Overall Study|Withdrawal by Subject|0
4762004|NCT01643850|16427434|P7|Overall Study|Withdrawal by Subject|0
4762005|NCT01643850|16427435|P6|Overall Study|Withdrawal by Subject|0
4762006|NCT01643850|16427436|P5|Overall Study|Withdrawal by Subject|1
4762007|NCT01643850|16427437|P4|Overall Study|Withdrawal by Subject|0
4762008|NCT01643850|16427438|P3|Overall Study|Withdrawal by Subject|0
4762009|NCT01643850|16427439|P2|Overall Study|Withdrawal by Subject|0
4762010|NCT01643850|16427440|P1|Overall Study|Withdrawal by Subject|0
4762011|NCT01643798|16427579|P2|Pretreatment 1 and Stimulation|Withdrawal by Subject|0
4762012|NCT01643798|16427580|P1|Pretreatment 1 and Stimulation|Withdrawal by Subject|1
4762013|NCT01643772|16427595|P4|Overall Study|Adverse Event|1
4762014|NCT01643772|16427596|P3|Overall Study|Adverse Event|0
4762015|NCT01643772|16427597|P2|Overall Study|Adverse Event|0
4762016|NCT01643772|16427598|P1|Overall Study|Adverse Event|0
4762017|NCT01643772|16427595|P4|Overall Study|Protocol Violation|1
4762018|NCT01643772|16427596|P3|Overall Study|Protocol Violation|0
4762019|NCT01643772|16427597|P2|Overall Study|Protocol Violation|0
4762020|NCT01643772|16427598|P1|Overall Study|Protocol Violation|0
4762021|NCT01643668|16427638|P1|Overall Study|Death|1
4762022|NCT01643473|16427669|P2|Overall Study|Lost to Follow-up|0
4762023|NCT01643473|16427670|P1|Overall Study|Lost to Follow-up|1
4762024|NCT01643044|16427693|P2|Overall Study|Delivered outside of hospital|2
4762025|NCT01643044|16427694|P1|Overall Study|Delivered outside of hospital|1
4762026|NCT01643044|16427693|P2|Overall Study|Miscarried baby|2
4762027|NCT01643044|16427694|P1|Overall Study|Miscarried baby|2
4762028|NCT01643044|16427693|P2|Overall Study|Lost to Follow-up|1
4762029|NCT01643044|16427694|P1|Overall Study|Lost to Follow-up|1
4762030|NCT01642914|16427703|P3|Overall Study|Other Reason|0
4762031|NCT01642914|16427704|P2|Overall Study|Other Reason|0
4762032|NCT01642914|16427705|P1|Overall Study|Other Reason|1
4762033|NCT01642914|16427703|P3|Overall Study|Lost to Follow-up|7
4762034|NCT01642914|16427704|P2|Overall Study|Lost to Follow-up|3
4762035|NCT01642914|16427705|P1|Overall Study|Lost to Follow-up|5
4762036|NCT01642914|16427703|P3|Overall Study|Withdrawal by Subject|10
4762037|NCT01642914|16427704|P2|Overall Study|Withdrawal by Subject|5
4762038|NCT01642914|16427705|P1|Overall Study|Withdrawal by Subject|5
4762039|NCT01642914|16427703|P3|Overall Study|Protocol Violation|6
4762040|NCT01642914|16427704|P2|Overall Study|Protocol Violation|13
4762041|NCT01642914|16427705|P1|Overall Study|Protocol Violation|15
4762042|NCT01642914|16427703|P3|Overall Study|Lack of Efficacy|2
4762043|NCT01642914|16427704|P2|Overall Study|Lack of Efficacy|4
4762044|NCT01642914|16427705|P1|Overall Study|Lack of Efficacy|9
4762045|NCT01642914|16427703|P3|Overall Study|Adverse Event|15
4762046|NCT01642914|16427704|P2|Overall Study|Adverse Event|7
4762047|NCT01642914|16427705|P1|Overall Study|Adverse Event|11
4762048|NCT01642732|16427780|P1|Overall Study|Withdrawal by Subject|1
4762049|NCT01642615|16427785|P3|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1
4762050|NCT01642615|16427786|P2|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
4762051|NCT01642615|16427787|P1|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0
4762052|NCT01642615|16427785|P3|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
4762053|NCT01642615|16427786|P2|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1
4762054|NCT01642615|16427787|P1|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0
4762055|NCT01642615|16427785|P3|Double Blind Maintenance Phase|Voluntary Withdrawal|2
4762056|NCT01642615|16427786|P2|Double Blind Maintenance Phase|Voluntary Withdrawal|5
4762057|NCT01642615|16427787|P1|Double Blind Maintenance Phase|Voluntary Withdrawal|0
4762058|NCT01642615|16427785|P3|Double Blind Maintenance Phase|Lack of Efficacy|3
4762059|NCT01642615|16427786|P2|Double Blind Maintenance Phase|Lack of Efficacy|1
4762060|NCT01642615|16427787|P1|Double Blind Maintenance Phase|Lack of Efficacy|0
4762061|NCT01642615|16427785|P3|Open Label Maintenance Phase|Did not receive treatment|0
4762062|NCT01642615|16427786|P2|Open Label Maintenance Phase|Did not receive treatment|0
4762063|NCT01642615|16427787|P1|Open Label Maintenance Phase|Did not receive treatment|1
4762064|NCT01642615|16427785|P3|Open Label Maintenance Phase|Voluntary Withdrawal|0
4762065|NCT01642615|16427786|P2|Open Label Maintenance Phase|Voluntary Withdrawal|0
4762066|NCT01642615|16427787|P1|Open Label Maintenance Phase|Voluntary Withdrawal|1
4762067|NCT01642615|16427785|P3|Open Label Maintenance Phase|Lost to Follow-up|0
4762068|NCT01642615|16427786|P2|Open Label Maintenance Phase|Lost to Follow-up|0
4762069|NCT01642615|16427787|P1|Open Label Maintenance Phase|Lost to Follow-up|1
4762070|NCT01642615|16427785|P3|Open Label Maintenance Phase|Major Protocol Deviation|0
4762071|NCT01642615|16427786|P2|Open Label Maintenance Phase|Major Protocol Deviation|0
4762072|NCT01642615|16427787|P1|Open Label Maintenance Phase|Major Protocol Deviation|1
4762073|NCT01642615|16427785|P3|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
4762074|NCT01642615|16427786|P2|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0
4762075|NCT01642615|16427787|P1|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1
4762076|NCT01642602|16427801|P1|Overall Study|Adverse Event|2
4762077|NCT01642589|16427808|P2|Overall Study|Withdrawal by Subject|1
4762078|NCT01642589|16427809|P1|Overall Study|Withdrawal by Subject|1
4762079|NCT01642407|16427848|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1
4762080|NCT01642407|16427848|P1|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1
4762081|NCT01642407|16427848|P1|Part 1 (Screening Till Week 16)|Insufficient clinical response|3
4762082|NCT01642277|16427895|P2|Overall Study|Withdrawal by Subject|0
4762083|NCT01642277|16427896|P1|Overall Study|Withdrawal by Subject|11
4762084|NCT01642277|16427895|P2|Overall Study|Protocol Violation|0
4762085|NCT01642277|16427896|P1|Overall Study|Protocol Violation|1
4762086|NCT01642277|16427895|P2|Overall Study|Physician Decision|0
4762087|NCT01642277|16427896|P1|Overall Study|Physician Decision|2
4762088|NCT01642277|16427895|P2|Overall Study|Adverse Event|0
4762089|NCT01642277|16427896|P1|Overall Study|Adverse Event|10
4762090|NCT01642251|16427908|P4|Overall Study|Ineligible/never start protocol therapy|8
4762091|NCT01642251|16427909|P3|Overall Study|Ineligible/never start protocol therapy|11
4762092|NCT01642251|16427910|P2|Overall Study|Ineligible/never start protocol therapy|0
4762093|NCT01642251|16427911|P1|Overall Study|Ineligible/never start protocol therapy|0
4762094|NCT01642251|16427908|P4|Overall Study|Other complicating disease|0
4762095|NCT01642251|16427909|P3|Overall Study|Other complicating disease|1
4762096|NCT01642251|16427910|P2|Overall Study|Other complicating disease|0
4762097|NCT01642251|16427911|P1|Overall Study|Other complicating disease|0
4762098|NCT01642251|16427908|P4|Overall Study|Alternative therapy|2
4762099|NCT01642251|16427909|P3|Overall Study|Alternative therapy|0
4762100|NCT01642251|16427910|P2|Overall Study|Alternative therapy|0
4762101|NCT01642251|16427911|P1|Overall Study|Alternative therapy|0
4762102|NCT01642251|16427908|P4|Overall Study|Withdrawal by Subject|3
4762103|NCT01642251|16427909|P3|Overall Study|Withdrawal by Subject|1
4762104|NCT01642251|16427910|P2|Overall Study|Withdrawal by Subject|0
4762105|NCT01642251|16427911|P1|Overall Study|Withdrawal by Subject|0
4762106|NCT01642251|16427908|P4|Overall Study|Death|3
4762107|NCT01642251|16427909|P3|Overall Study|Death|1
4762108|NCT01642251|16427910|P2|Overall Study|Death|0
4762109|NCT01642251|16427911|P1|Overall Study|Death|0
4762110|NCT01642251|16427908|P4|Overall Study|Adverse Event|4
4762111|NCT01642251|16427909|P3|Overall Study|Adverse Event|5
4762112|NCT01642251|16427910|P2|Overall Study|Adverse Event|0
4762113|NCT01642251|16427911|P1|Overall Study|Adverse Event|0
4762114|NCT01642251|16427908|P4|Overall Study|Progressive disease|3
4762115|NCT01642251|16427909|P3|Overall Study|Progressive disease|3
4762116|NCT01642251|16427910|P2|Overall Study|Progressive disease|0
4762117|NCT01642251|16427911|P1|Overall Study|Progressive disease|0
4762118|NCT01642212|16427949|P5|Open-label Extension|Other|1
4762119|NCT01642212|16427950|P4|Open-label Extension|Other|0
4762120|NCT01642212|16427951|P3|Open-label Extension|Other|0
4762121|NCT01642212|16427952|P2|Open-label Extension|Other|0
4762122|NCT01642212|16427953|P1|Open-label Extension|Other|0
4762123|NCT01642212|16427949|P5|Open-label Extension|Lost to Follow-up|1
4762124|NCT01642212|16427950|P4|Open-label Extension|Lost to Follow-up|0
4762125|NCT01642212|16427951|P3|Open-label Extension|Lost to Follow-up|0
4762126|NCT01642212|16427952|P2|Open-label Extension|Lost to Follow-up|0
4762127|NCT01642212|16427953|P1|Open-label Extension|Lost to Follow-up|0
4762128|NCT01642212|16427949|P5|Open-label Extension|Consent Withdrawn|2
4762129|NCT01642212|16427950|P4|Open-label Extension|Consent Withdrawn|0
4762130|NCT01642212|16427951|P3|Open-label Extension|Consent Withdrawn|0
4762131|NCT01642212|16427952|P2|Open-label Extension|Consent Withdrawn|0
4762132|NCT01642212|16427953|P1|Open-label Extension|Consent Withdrawn|0
4762133|NCT01642212|16427949|P5|Open-label Extension|Sponsor Decision|4
4762134|NCT01642212|16427950|P4|Open-label Extension|Sponsor Decision|7
4762135|NCT01642212|16427951|P3|Open-label Extension|Sponsor Decision|0
4762136|NCT01642212|16427952|P2|Open-label Extension|Sponsor Decision|0
4762137|NCT01642212|16427953|P1|Open-label Extension|Sponsor Decision|0
4762138|NCT01642212|16427949|P5|Open-label Extension|Adverse Event|0
4762139|NCT01642212|16427950|P4|Open-label Extension|Adverse Event|3
4762140|NCT01642212|16427951|P3|Open-label Extension|Adverse Event|0
4762141|NCT01642212|16427952|P2|Open-label Extension|Adverse Event|0
4762142|NCT01642212|16427953|P1|Open-label Extension|Adverse Event|0
4762143|NCT01642212|16427949|P5|Double-blind Treatment|Adverse Event|0
4762144|NCT01642212|16427950|P4|Double-blind Treatment|Adverse Event|0
4762145|NCT01642212|16427951|P3|Double-blind Treatment|Adverse Event|1
4762146|NCT01642212|16427952|P2|Double-blind Treatment|Adverse Event|0
4762147|NCT01642212|16427953|P1|Double-blind Treatment|Adverse Event|0
4762148|NCT01642212|16427949|P5|Double-blind Treatment|Non-compliance|0
4762149|NCT01642212|16427950|P4|Double-blind Treatment|Non-compliance|0
4762150|NCT01642212|16427951|P3|Double-blind Treatment|Non-compliance|0
4762151|NCT01642212|16427952|P2|Double-blind Treatment|Non-compliance|1
4762152|NCT01642212|16427953|P1|Double-blind Treatment|Non-compliance|0
4762153|NCT01642212|16427949|P5|Double-blind Treatment|Other|0
4762154|NCT01642212|16427950|P4|Double-blind Treatment|Other|0
4762155|NCT01642212|16427951|P3|Double-blind Treatment|Other|1
4762156|NCT01642212|16427952|P2|Double-blind Treatment|Other|2
4762157|NCT01642212|16427953|P1|Double-blind Treatment|Other|0
4762158|NCT01642212|16427949|P5|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4762159|NCT01642212|16427950|P4|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4762160|NCT01642212|16427951|P3|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4762161|NCT01642212|16427952|P2|Single-blind Baseline|Did Not Meet Eligibility Criteria|0
4762162|NCT01642212|16427953|P1|Single-blind Baseline|Did Not Meet Eligibility Criteria|26
4762163|NCT01642004|16428048|P2|Treatment|Missing from data|1
4762164|NCT01642004|16428049|P1|Treatment|Missing from data|0
4762165|NCT01642004|16428048|P2|Treatment|Other|2
4762166|NCT01642004|16428049|P1|Treatment|Other|1
4762167|NCT01642004|16428048|P2|Treatment|No longer meets study criteria|2
4762168|NCT01642004|16428049|P1|Treatment|No longer meets study criteria|1
4762169|NCT01642004|16428048|P2|Treatment|Poor/non-compliance|0
4762170|NCT01642004|16428049|P1|Treatment|Poor/non-compliance|1
4762171|NCT01642004|16428048|P2|Treatment|Maximum clinical benefit|7
4762172|NCT01642004|16428049|P1|Treatment|Maximum clinical benefit|2
4762173|NCT01642004|16428048|P2|Treatment|Withdrawal by Subject|9
4762174|NCT01642004|16428049|P1|Treatment|Withdrawal by Subject|5
4762175|NCT01642004|16428048|P2|Treatment|Adverse event unrelated to study drug|13
4762176|NCT01642004|16428049|P1|Treatment|Adverse event unrelated to study drug|6
4762177|NCT01642004|16428048|P2|Treatment|Death|0
4762178|NCT01642004|16428049|P1|Treatment|Death|1
4762179|NCT01642004|16428048|P2|Treatment|Study drug toxicity|13
4762180|NCT01642004|16428049|P1|Treatment|Study drug toxicity|5
4762181|NCT01642004|16428048|P2|Treatment|Disease progression|80
4762182|NCT01642004|16428049|P1|Treatment|Disease progression|88
4762183|NCT01642004|16428048|P2|Randomization|No longer meets study criteria|2
4762184|NCT01642004|16428049|P1|Randomization|No longer meets study criteria|2
4762185|NCT01642004|16428048|P2|Randomization|Withdrawal by Subject|6
4762186|NCT01642004|16428049|P1|Randomization|Withdrawal by Subject|1
4762187|NCT01642004|16428048|P2|Randomization|Adverse Event unrelated to study drug|0
4762188|NCT01642004|16428049|P1|Randomization|Adverse Event unrelated to study drug|1
4762189|NCT01641991|16428083|P4|Overall Study|no longer eligible|4
4762190|NCT01641991|16428084|P3|Overall Study|no longer eligible|0
4762191|NCT01641991|16428085|P2|Overall Study|no longer eligible|1
4762192|NCT01641991|16428086|P1|Overall Study|no longer eligible|2
4762193|NCT01641991|16428083|P4|Overall Study|Pregnancy|0
4762194|NCT01641991|16428084|P3|Overall Study|Pregnancy|1
4762195|NCT01641991|16428085|P2|Overall Study|Pregnancy|0
4762196|NCT01641991|16428086|P1|Overall Study|Pregnancy|0
4762197|NCT01641991|16428083|P4|Overall Study|Protocol Violation|0
4762198|NCT01641991|16428084|P3|Overall Study|Protocol Violation|3
4762199|NCT01641991|16428085|P2|Overall Study|Protocol Violation|1
4762200|NCT01641991|16428086|P1|Overall Study|Protocol Violation|1
4762201|NCT01641991|16428083|P4|Overall Study|Lost to Follow-up|1
4762202|NCT01641991|16428084|P3|Overall Study|Lost to Follow-up|3
4762203|NCT01641991|16428085|P2|Overall Study|Lost to Follow-up|2
4762204|NCT01641991|16428086|P1|Overall Study|Lost to Follow-up|0
4762205|NCT01641991|16428083|P4|Overall Study|Adverse Event|1
4762206|NCT01641991|16428084|P3|Overall Study|Adverse Event|2
4762207|NCT01641991|16428085|P2|Overall Study|Adverse Event|1
4762208|NCT01641991|16428086|P1|Overall Study|Adverse Event|2
4762209|NCT01641991|16428083|P4|Overall Study|Withdrawal by Subject|5
4762210|NCT01641991|16428084|P3|Overall Study|Withdrawal by Subject|1
4762211|NCT01641991|16428085|P2|Overall Study|Withdrawal by Subject|2
4762212|NCT01641991|16428086|P1|Overall Study|Withdrawal by Subject|4
4762213|NCT01641991|16428083|P4|Overall Study|Physician Decision|5
4762214|NCT01641991|16428084|P3|Overall Study|Physician Decision|7
4762215|NCT01641991|16428085|P2|Overall Study|Physician Decision|1
4762216|NCT01641991|16428086|P1|Overall Study|Physician Decision|0
4762217|NCT01641952|16428170|P1|Overall Study|Adverse Event|6
4762218|NCT01641952|16428170|P1|Overall Study|Lost to Follow-up|28
4762219|NCT01641939|16428186|P3|Overall Study|Study Terminated by Sponsor|3
4762220|NCT01641939|16428187|P2|Overall Study|Study Terminated by Sponsor|28
4762221|NCT01641939|16428188|P1|Overall Study|Study Terminated by Sponsor|10
4762222|NCT01641939|16428186|P3|Overall Study|Withdrawal by Subject|5
4762223|NCT01641939|16428187|P2|Overall Study|Withdrawal by Subject|11
4762224|NCT01641939|16428188|P1|Overall Study|Withdrawal by Subject|14
4762225|NCT01641939|16428186|P3|Overall Study|Lost to Follow-up|1
4762226|NCT01641939|16428187|P2|Overall Study|Lost to Follow-up|2
4762227|NCT01641939|16428188|P1|Overall Study|Lost to Follow-up|3
4762228|NCT01641939|16428186|P3|Overall Study|Death|61
4762229|NCT01641939|16428187|P2|Overall Study|Death|187
4762230|NCT01641939|16428188|P1|Overall Study|Death|90
4762231|NCT01641926|16428231|P4|Overall Study|Not Treated|0
4762232|NCT01641926|16428232|P3|Overall Study|Not Treated|1
4762233|NCT01641926|16428233|P2|Overall Study|Not Treated|1
4762234|NCT01641926|16428234|P1|Overall Study|Not Treated|1
4762235|NCT01641926|16428231|P4|Overall Study|Withdrawal by Subject|1
4762236|NCT01641926|16428232|P3|Overall Study|Withdrawal by Subject|6
4762237|NCT01641926|16428233|P2|Overall Study|Withdrawal by Subject|5
4762238|NCT01641926|16428234|P1|Overall Study|Withdrawal by Subject|13
4762239|NCT01641926|16428231|P4|Overall Study|Protocol Violation|1
4762240|NCT01641926|16428232|P3|Overall Study|Protocol Violation|0
4762241|NCT01641926|16428233|P2|Overall Study|Protocol Violation|0
4762242|NCT01641926|16428234|P1|Overall Study|Protocol Violation|1
4762243|NCT01641926|16428231|P4|Overall Study|Physician Decision|1
4762244|NCT01641926|16428232|P3|Overall Study|Physician Decision|0
4762245|NCT01641926|16428233|P2|Overall Study|Physician Decision|5
4762246|NCT01641926|16428234|P1|Overall Study|Physician Decision|6
4762247|NCT01641926|16428231|P4|Overall Study|Lost to Follow-up|0
4762248|NCT01641926|16428232|P3|Overall Study|Lost to Follow-up|1
4762249|NCT01641926|16428233|P2|Overall Study|Lost to Follow-up|2
4762250|NCT01641926|16428234|P1|Overall Study|Lost to Follow-up|2
4762251|NCT01641926|16428231|P4|Overall Study|Adverse Event|1
4762252|NCT01641926|16428232|P3|Overall Study|Adverse Event|3
4762253|NCT01641926|16428233|P2|Overall Study|Adverse Event|2
4762254|NCT01641926|16428234|P1|Overall Study|Adverse Event|5
4762255|NCT01641900|16428262|P2|Overall Study|Withdrawal by Subject|2
4762256|NCT01641900|16428263|P1|Overall Study|Withdrawal by Subject|2
4762257|NCT01641861|16428275|P2|Overall Study|Died due to drowning|1
4762258|NCT01641861|16428276|P1|Overall Study|Died due to drowning|0
4762259|NCT01641861|16428275|P2|Overall Study|Lost the tooth due to normal exfoliation|8
4762260|NCT01641861|16428276|P1|Overall Study|Lost the tooth due to normal exfoliation|14
4762261|NCT01641861|16428275|P2|Overall Study|Lost to Follow-up|16
4762262|NCT01641861|16428276|P1|Overall Study|Lost to Follow-up|21
4762263|NCT01641822|16428297|P3|Comparative Phase|Protocol-specified criteria for withdraw|1
4762264|NCT01641822|16428298|P2|Comparative Phase|Protocol-specified criteria for withdraw|1
4762265|NCT01641822|16428299|P1|Comparative Phase|Protocol-specified criteria for withdraw|0
4762266|NCT01641822|16428297|P3|Comparative Phase|Withdrew consent|7
4762267|NCT01641822|16428298|P2|Comparative Phase|Withdrew consent|3
4762268|NCT01641822|16428299|P1|Comparative Phase|Withdrew consent|0
4762269|NCT01641822|16428297|P3|Comparative Phase|Adverse event, serious fatal|0
4762270|NCT01641822|16428298|P2|Comparative Phase|Adverse event, serious fatal|1
4762271|NCT01641822|16428299|P1|Comparative Phase|Adverse event, serious fatal|0
4762272|NCT01641822|16428297|P3|Comparative Phase|Pregnancy|1
4762273|NCT01641822|16428298|P2|Comparative Phase|Pregnancy|0
4762274|NCT01641822|16428299|P1|Comparative Phase|Pregnancy|0
4762275|NCT01641822|16428297|P3|Comparative Phase|Investigator's discretion|1
4762276|NCT01641822|16428298|P2|Comparative Phase|Investigator's discretion|0
4762277|NCT01641822|16428299|P1|Comparative Phase|Investigator's discretion|0
4762278|NCT01641822|16428297|P3|Comparative Phase|Noncompliance with study drug|0
4762279|NCT01641822|16428298|P2|Comparative Phase|Noncompliance with study drug|1
4762280|NCT01641822|16428299|P1|Comparative Phase|Noncompliance with study drug|0
4762281|NCT01641822|16428297|P3|Run-in Phase|Protocol-specified criteria for withdraw|0
4762282|NCT01641822|16428298|P2|Run-in Phase|Protocol-specified criteria for withdraw|0
4762283|NCT01641822|16428299|P1|Run-in Phase|Protocol-specified criteria for withdraw|9
4762284|NCT01641822|16428297|P3|Run-in Phase|Withdrew consent|0
4762285|NCT01641822|16428298|P2|Run-in Phase|Withdrew consent|0
4762286|NCT01641822|16428299|P1|Run-in Phase|Withdrew consent|1
4762287|NCT01641822|16428297|P3|Run-in Phase|Adverse Event|0
4762288|NCT01641822|16428298|P2|Run-in Phase|Adverse Event|0
4762289|NCT01641822|16428299|P1|Run-in Phase|Adverse Event|3
4762290|NCT01641822|16428297|P3|Run-in Phase|Noncompliance with study drug|0
4762291|NCT01641822|16428298|P2|Run-in Phase|Noncompliance with study drug|0
4762292|NCT01641822|16428299|P1|Run-in Phase|Noncompliance with study drug|1
4762293|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Adverse Event|0
4762294|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Adverse Event|1
4762295|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Adverse Event|2
4762296|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Adverse Event|3
4762297|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
4762298|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Lack of Efficacy|0
4762299|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Lack of Efficacy|1
4762300|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Lack of Efficacy|4
4762301|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Protocol Violation|0
4762302|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Protocol Violation|0
4762303|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Protocol Violation|1
4762304|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Protocol Violation|1
4762305|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Site closed|0
4762306|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Site closed|0
4762307|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Site closed|0
4762308|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Site closed|1
4762309|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Lost to Follow-up|0
4762310|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
4762311|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Lost to Follow-up|4
4762312|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Lost to Follow-up|5
4762313|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Physician Decision|0
4762314|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Physician Decision|1
4762315|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Physician Decision|1
4762316|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Physician Decision|0
4762317|NCT01641809|16428320|P4|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0
4762318|NCT01641809|16428321|P3|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1
4762319|NCT01641809|16428322|P2|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3
4762320|NCT01641809|16428323|P1|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2
4762321|NCT01641809|16428320|P4|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2
4762322|NCT01641809|16428321|P3|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
4762323|NCT01641809|16428322|P2|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0
4762324|NCT01641809|16428323|P1|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1
4762325|NCT01641809|16428320|P4|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2
4762326|NCT01641809|16428321|P3|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0
4762327|NCT01641809|16428322|P2|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
4762328|NCT01641809|16428323|P1|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1
4762329|NCT01641809|16428320|P4|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
4762330|NCT01641809|16428321|P3|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1
4762331|NCT01641809|16428322|P2|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0
4762332|NCT01641809|16428323|P1|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2
4762333|NCT01641809|16428320|P4|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
4762334|NCT01641809|16428321|P3|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
4762335|NCT01641809|16428322|P2|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1
4762336|NCT01641809|16428323|P1|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0
4762337|NCT01641809|16428320|P4|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0
4762338|NCT01641809|16428321|P3|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1
4762339|NCT01641809|16428322|P2|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3
4762340|NCT01641809|16428323|P1|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2
4762341|NCT01641809|16428320|P4|Induction Phase (Day 1 to Week 24)|Adverse Event|7
4762342|NCT01641809|16428321|P3|Induction Phase (Day 1 to Week 24)|Adverse Event|3
4762343|NCT01641809|16428322|P2|Induction Phase (Day 1 to Week 24)|Adverse Event|1
4762344|NCT01641809|16428323|P1|Induction Phase (Day 1 to Week 24)|Adverse Event|0
4762345|NCT01641809|16428320|P4|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3
4762346|NCT01641809|16428321|P3|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2
4762347|NCT01641809|16428322|P2|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1
4762348|NCT01641809|16428323|P1|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4
4762349|NCT01641809|16428320|P4|Induction Phase (Day 1 to Week 24)|Protocol Violation|0
4762350|NCT01641809|16428321|P3|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
4762351|NCT01641809|16428322|P2|Induction Phase (Day 1 to Week 24)|Protocol Violation|1
4762352|NCT01641809|16428323|P1|Induction Phase (Day 1 to Week 24)|Protocol Violation|2
4762353|NCT01641809|16428320|P4|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3
4762354|NCT01641809|16428321|P3|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0
4762355|NCT01641809|16428322|P2|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2
4762356|NCT01641809|16428323|P1|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1
4762357|NCT01641809|16428320|P4|Induction Phase (Day 1 to Week 24)|Physician Decision|1
4762358|NCT01641809|16428321|P3|Induction Phase (Day 1 to Week 24)|Physician Decision|0
4762359|NCT01641809|16428322|P2|Induction Phase (Day 1 to Week 24)|Physician Decision|1
4762360|NCT01641809|16428323|P1|Induction Phase (Day 1 to Week 24)|Physician Decision|0
4762361|NCT01641809|16428320|P4|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
4762362|NCT01641809|16428321|P3|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0
4762363|NCT01641809|16428322|P2|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
4762364|NCT01641809|16428323|P1|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1
4762365|NCT01641692|16428507|P8|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
4762366|NCT01641692|16428508|P7|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4762367|NCT01641692|16428509|P6|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4762368|NCT01641692|16428510|P5|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
4762369|NCT01641692|16428511|P4|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4762370|NCT01641692|16428512|P3|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4762371|NCT01641692|16428513|P2|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0
4762372|NCT01641692|16428514|P1|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1
4762373|NCT01641692|16428507|P8|Washout Period 3 or Follow-up|Protocol Violation|0
4762374|NCT01641692|16428508|P7|Washout Period 3 or Follow-up|Protocol Violation|0
4762375|NCT01641692|16428509|P6|Washout Period 3 or Follow-up|Protocol Violation|1
4762376|NCT01641692|16428510|P5|Washout Period 3 or Follow-up|Protocol Violation|0
4762377|NCT01641692|16428511|P4|Washout Period 3 or Follow-up|Protocol Violation|0
4762378|NCT01641692|16428512|P3|Washout Period 3 or Follow-up|Protocol Violation|0
4762379|NCT01641692|16428513|P2|Washout Period 3 or Follow-up|Protocol Violation|0
4762380|NCT01641692|16428514|P1|Washout Period 3 or Follow-up|Protocol Violation|0
4762381|NCT01641692|16428507|P8|Treatment Period 3|Lost to Follow-up|0
4762382|NCT01641692|16428508|P7|Treatment Period 3|Lost to Follow-up|0
4762383|NCT01641692|16428509|P6|Treatment Period 3|Lost to Follow-up|0
4762384|NCT01641692|16428510|P5|Treatment Period 3|Lost to Follow-up|0
4762385|NCT01641692|16428511|P4|Treatment Period 3|Lost to Follow-up|0
4762386|NCT01641692|16428512|P3|Treatment Period 3|Lost to Follow-up|0
4762387|NCT01641692|16428513|P2|Treatment Period 3|Lost to Follow-up|1
4762388|NCT01641692|16428514|P1|Treatment Period 3|Lost to Follow-up|0
4762389|NCT01641692|16428507|P8|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762390|NCT01641692|16428508|P7|Treatment Period 3|Protocol-defined Stopping Criteria|1
4762391|NCT01641692|16428509|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762392|NCT01641692|16428510|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762393|NCT01641692|16428511|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762394|NCT01641692|16428512|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762395|NCT01641692|16428513|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762396|NCT01641692|16428514|P1|Treatment Period 3|Protocol-defined Stopping Criteria|0
4762397|NCT01641692|16428507|P8|Treatment Period 3|Protocol Violation|0
4762398|NCT01641692|16428508|P7|Treatment Period 3|Protocol Violation|0
4762399|NCT01641692|16428509|P6|Treatment Period 3|Protocol Violation|0
4762400|NCT01641692|16428510|P5|Treatment Period 3|Protocol Violation|0
4762401|NCT01641692|16428511|P4|Treatment Period 3|Protocol Violation|0
4762402|NCT01641692|16428512|P3|Treatment Period 3|Protocol Violation|1
4762403|NCT01641692|16428513|P2|Treatment Period 3|Protocol Violation|0
4762404|NCT01641692|16428514|P1|Treatment Period 3|Protocol Violation|0
4762405|NCT01641692|16428507|P8|Treatment Period 3|Adverse Event|0
4762406|NCT01641692|16428508|P7|Treatment Period 3|Adverse Event|1
4762407|NCT01641692|16428509|P6|Treatment Period 3|Adverse Event|0
4762408|NCT01641692|16428510|P5|Treatment Period 3|Adverse Event|0
4762409|NCT01641692|16428511|P4|Treatment Period 3|Adverse Event|0
4762410|NCT01641692|16428512|P3|Treatment Period 3|Adverse Event|0
4762411|NCT01641692|16428513|P2|Treatment Period 3|Adverse Event|0
4762412|NCT01641692|16428514|P1|Treatment Period 3|Adverse Event|0
4762413|NCT01641692|16428507|P8|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4762414|NCT01641692|16428508|P7|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4762415|NCT01641692|16428509|P6|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4762416|NCT01641692|16428510|P5|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4762417|NCT01641692|16428511|P4|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4762418|NCT01641692|16428512|P3|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4762419|NCT01641692|16428513|P2|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4762420|NCT01641692|16428514|P1|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4762421|NCT01641692|16428507|P8|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762422|NCT01641692|16428508|P7|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1
4762423|NCT01641692|16428509|P6|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762424|NCT01641692|16428510|P5|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3
4762425|NCT01641692|16428511|P4|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762426|NCT01641692|16428512|P3|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762427|NCT01641692|16428513|P2|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762428|NCT01641692|16428514|P1|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762429|NCT01641692|16428507|P8|Treatment Period 2|Withdrawal by Subject|1
4762430|NCT01641692|16428508|P7|Treatment Period 2|Withdrawal by Subject|0
4762431|NCT01641692|16428509|P6|Treatment Period 2|Withdrawal by Subject|1
4762432|NCT01641692|16428510|P5|Treatment Period 2|Withdrawal by Subject|0
4762433|NCT01641692|16428511|P4|Treatment Period 2|Withdrawal by Subject|0
4762434|NCT01641692|16428512|P3|Treatment Period 2|Withdrawal by Subject|0
4762435|NCT01641692|16428513|P2|Treatment Period 2|Withdrawal by Subject|0
4762436|NCT01641692|16428514|P1|Treatment Period 2|Withdrawal by Subject|1
4762437|NCT01641692|16428507|P8|Treatment Period 2|Lost to Follow-up|0
4762438|NCT01641692|16428508|P7|Treatment Period 2|Lost to Follow-up|0
4762439|NCT01641692|16428509|P6|Treatment Period 2|Lost to Follow-up|1
4762440|NCT01641692|16428510|P5|Treatment Period 2|Lost to Follow-up|0
4762441|NCT01641692|16428511|P4|Treatment Period 2|Lost to Follow-up|0
4762442|NCT01641692|16428512|P3|Treatment Period 2|Lost to Follow-up|0
4762443|NCT01641692|16428513|P2|Treatment Period 2|Lost to Follow-up|0
4762444|NCT01641692|16428514|P1|Treatment Period 2|Lost to Follow-up|0
4762445|NCT01641692|16428507|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762446|NCT01641692|16428508|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762447|NCT01641692|16428509|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762448|NCT01641692|16428510|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762449|NCT01641692|16428511|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762450|NCT01641692|16428512|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762451|NCT01641692|16428513|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
4762452|NCT01641692|16428514|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
4762453|NCT01641692|16428507|P8|Treatment Period 2|Lack of Efficacy|0
4762454|NCT01641692|16428508|P7|Treatment Period 2|Lack of Efficacy|0
4762455|NCT01641692|16428509|P6|Treatment Period 2|Lack of Efficacy|0
4762456|NCT01641692|16428510|P5|Treatment Period 2|Lack of Efficacy|0
4762457|NCT01641692|16428511|P4|Treatment Period 2|Lack of Efficacy|0
4762458|NCT01641692|16428512|P3|Treatment Period 2|Lack of Efficacy|0
4762459|NCT01641692|16428513|P2|Treatment Period 2|Lack of Efficacy|0
4762460|NCT01641692|16428514|P1|Treatment Period 2|Lack of Efficacy|1
4762461|NCT01641692|16428507|P8|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4762462|NCT01641692|16428508|P7|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4762463|NCT01641692|16428509|P6|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4762464|NCT01641692|16428510|P5|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4762465|NCT01641692|16428511|P4|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4762466|NCT01641692|16428512|P3|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4762467|NCT01641692|16428513|P2|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4762468|NCT01641692|16428514|P1|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4762469|NCT01641692|16428507|P8|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
4762470|NCT01641692|16428508|P7|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762471|NCT01641692|16428509|P6|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762472|NCT01641692|16428510|P5|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
4762473|NCT01641692|16428511|P4|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
4762474|NCT01641692|16428512|P3|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3
4762475|NCT01641692|16428513|P2|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0
4762476|NCT01641692|16428514|P1|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1
4762477|NCT01641692|16428507|P8|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762478|NCT01641692|16428508|P7|Washout Period 1 (12-14 Days)|Protocol Violation|1
4762479|NCT01641692|16428509|P6|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762480|NCT01641692|16428510|P5|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762481|NCT01641692|16428511|P4|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762482|NCT01641692|16428512|P3|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762483|NCT01641692|16428513|P2|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762484|NCT01641692|16428514|P1|Washout Period 1 (12-14 Days)|Protocol Violation|0
4762485|NCT01641692|16428507|P8|Washout Period 1 (12-14 Days)|Adverse Event|0
4762486|NCT01641692|16428508|P7|Washout Period 1 (12-14 Days)|Adverse Event|0
4762487|NCT01641692|16428509|P6|Washout Period 1 (12-14 Days)|Adverse Event|0
4762488|NCT01641692|16428510|P5|Washout Period 1 (12-14 Days)|Adverse Event|0
4762489|NCT01641692|16428511|P4|Washout Period 1 (12-14 Days)|Adverse Event|0
4762490|NCT01641692|16428512|P3|Washout Period 1 (12-14 Days)|Adverse Event|0
4762491|NCT01641692|16428513|P2|Washout Period 1 (12-14 Days)|Adverse Event|0
4762492|NCT01641692|16428514|P1|Washout Period 1 (12-14 Days)|Adverse Event|2
4762493|NCT01641692|16428507|P8|Treatment Period 1|Withdrawal by Subject|1
4762494|NCT01641692|16428508|P7|Treatment Period 1|Withdrawal by Subject|0
4762495|NCT01641692|16428509|P6|Treatment Period 1|Withdrawal by Subject|2
4762496|NCT01641692|16428510|P5|Treatment Period 1|Withdrawal by Subject|0
4762497|NCT01641692|16428511|P4|Treatment Period 1|Withdrawal by Subject|0
4762498|NCT01641692|16428512|P3|Treatment Period 1|Withdrawal by Subject|0
4762499|NCT01641692|16428513|P2|Treatment Period 1|Withdrawal by Subject|0
4762500|NCT01641692|16428514|P1|Treatment Period 1|Withdrawal by Subject|0
4762501|NCT01641692|16428507|P8|Treatment Period 1|Physician Decision|0
4762502|NCT01641692|16428508|P7|Treatment Period 1|Physician Decision|0
4762503|NCT01641692|16428509|P6|Treatment Period 1|Physician Decision|0
4762504|NCT01641692|16428510|P5|Treatment Period 1|Physician Decision|1
4762505|NCT01641692|16428511|P4|Treatment Period 1|Physician Decision|0
4762506|NCT01641692|16428512|P3|Treatment Period 1|Physician Decision|0
4762507|NCT01641692|16428513|P2|Treatment Period 1|Physician Decision|0
4762508|NCT01641692|16428514|P1|Treatment Period 1|Physician Decision|0
4762509|NCT01641692|16428507|P8|Treatment Period 1|Lost to Follow-up|0
4762510|NCT01641692|16428508|P7|Treatment Period 1|Lost to Follow-up|0
4762511|NCT01641692|16428509|P6|Treatment Period 1|Lost to Follow-up|0
4762512|NCT01641692|16428510|P5|Treatment Period 1|Lost to Follow-up|0
4762513|NCT01641692|16428511|P4|Treatment Period 1|Lost to Follow-up|0
4762514|NCT01641692|16428512|P3|Treatment Period 1|Lost to Follow-up|1
4762515|NCT01641692|16428513|P2|Treatment Period 1|Lost to Follow-up|0
4762516|NCT01641692|16428514|P1|Treatment Period 1|Lost to Follow-up|0
4762517|NCT01641692|16428507|P8|Treatment Period 1|Protocol-defined Stopping Criteria|1
4762518|NCT01641692|16428508|P7|Treatment Period 1|Protocol-defined Stopping Criteria|0
4762519|NCT01641692|16428509|P6|Treatment Period 1|Protocol-defined Stopping Criteria|0
4762520|NCT01641692|16428510|P5|Treatment Period 1|Protocol-defined Stopping Criteria|1
4762521|NCT01641692|16428511|P4|Treatment Period 1|Protocol-defined Stopping Criteria|0
4762522|NCT01641692|16428512|P3|Treatment Period 1|Protocol-defined Stopping Criteria|0
4762523|NCT01641692|16428513|P2|Treatment Period 1|Protocol-defined Stopping Criteria|0
4762524|NCT01641692|16428514|P1|Treatment Period 1|Protocol-defined Stopping Criteria|0
4762525|NCT01641692|16428507|P8|Treatment Period 1|Protocol Violation|0
4762526|NCT01641692|16428508|P7|Treatment Period 1|Protocol Violation|0
4762527|NCT01641692|16428509|P6|Treatment Period 1|Protocol Violation|0
4762528|NCT01641692|16428510|P5|Treatment Period 1|Protocol Violation|2
4762529|NCT01641692|16428511|P4|Treatment Period 1|Protocol Violation|0
4762530|NCT01641692|16428512|P3|Treatment Period 1|Protocol Violation|0
4762531|NCT01641692|16428513|P2|Treatment Period 1|Protocol Violation|0
4762532|NCT01641692|16428514|P1|Treatment Period 1|Protocol Violation|1
4762533|NCT01641692|16428507|P8|Treatment Period 1|Lack of Efficacy|1
4762534|NCT01641692|16428508|P7|Treatment Period 1|Lack of Efficacy|0
4762535|NCT01641692|16428509|P6|Treatment Period 1|Lack of Efficacy|0
4762536|NCT01641692|16428510|P5|Treatment Period 1|Lack of Efficacy|0
4762537|NCT01641692|16428511|P4|Treatment Period 1|Lack of Efficacy|0
4762538|NCT01641692|16428512|P3|Treatment Period 1|Lack of Efficacy|0
4762539|NCT01641692|16428513|P2|Treatment Period 1|Lack of Efficacy|0
4762540|NCT01641692|16428514|P1|Treatment Period 1|Lack of Efficacy|0
4762541|NCT01641692|16428507|P8|Treatment Period 1|Adverse Event|0
4762542|NCT01641692|16428508|P7|Treatment Period 1|Adverse Event|0
4762543|NCT01641692|16428509|P6|Treatment Period 1|Adverse Event|0
4762544|NCT01641692|16428510|P5|Treatment Period 1|Adverse Event|0
4762545|NCT01641692|16428511|P4|Treatment Period 1|Adverse Event|0
4762546|NCT01641692|16428512|P3|Treatment Period 1|Adverse Event|0
4762547|NCT01641692|16428513|P2|Treatment Period 1|Adverse Event|0
4762548|NCT01641692|16428514|P1|Treatment Period 1|Adverse Event|1
4762549|NCT01641640|16428714|P1|Overall Study|Adverse Event|1
4762550|NCT01641640|16428714|P1|Overall Study|Withdrawal by Subject|2
4762551|NCT01641640|16428714|P1|Overall Study|Lost to Follow-up|3
4762552|NCT01641640|16428714|P1|Overall Study|Efficacy failure|29
4762553|NCT01641640|16428714|P1|Overall Study|Enrolled but not treated|1
4762554|NCT01641601|16428725|P2|Overall Study|Study discontinued.|5
4762555|NCT01641601|16428726|P1|Overall Study|Study discontinued.|3
4762556|NCT01641471|16428736|P2|Overall Study|Protocol Violation|4
4762557|NCT01641471|16428737|P1|Overall Study|Protocol Violation|2
4762558|NCT01641471|16428736|P2|Overall Study|Lost to Follow-up|4
4762559|NCT01641471|16428737|P1|Overall Study|Lost to Follow-up|2
4762560|NCT01641471|16428736|P2|Overall Study|Withdrawal by Subject|19
4762561|NCT01641471|16428737|P1|Overall Study|Withdrawal by Subject|19
4762562|NCT01641367|16428784|P8|Randomized Adherence Intervention|Lost to Follow-up|12
4762563|NCT01641367|16428785|P7|Randomized Adherence Intervention|Lost to Follow-up|8
4762564|NCT01641367|16428786|P6|Randomized Adherence Intervention|Lost to Follow-up|0
4762565|NCT01641367|16428787|P5|Randomized Adherence Intervention|Lost to Follow-up|0
4762566|NCT01641367|16428788|P4|Randomized Adherence Intervention|Lost to Follow-up|0
4762567|NCT01641367|16428789|P3|Randomized Adherence Intervention|Lost to Follow-up|0
4762568|NCT01641367|16428790|P2|Randomized Adherence Intervention|Lost to Follow-up|0
4762569|NCT01641367|16428791|P1|Randomized Adherence Intervention|Lost to Follow-up|0
4762570|NCT01641367|16428784|P8|Randomized Adherence Intervention|Death|12
4762571|NCT01641367|16428785|P7|Randomized Adherence Intervention|Death|11
4762572|NCT01641367|16428786|P6|Randomized Adherence Intervention|Death|0
4762573|NCT01641367|16428787|P5|Randomized Adherence Intervention|Death|0
4762574|NCT01641367|16428788|P4|Randomized Adherence Intervention|Death|0
4762575|NCT01641367|16428789|P3|Randomized Adherence Intervention|Death|0
4762576|NCT01641367|16428790|P2|Randomized Adherence Intervention|Death|0
4762577|NCT01641367|16428791|P1|Randomized Adherence Intervention|Death|0
4762578|NCT01641367|16428784|P8|Cohorts|Lost to Follow-up|0
4762579|NCT01641367|16428785|P7|Cohorts|Lost to Follow-up|0
4762580|NCT01641367|16428786|P6|Cohorts|Lost to Follow-up|0
4762581|NCT01641367|16428787|P5|Cohorts|Lost to Follow-up|2
4762582|NCT01641367|16428788|P4|Cohorts|Lost to Follow-up|0
4762583|NCT01641367|16428789|P3|Cohorts|Lost to Follow-up|2
4762584|NCT01641367|16428790|P2|Cohorts|Lost to Follow-up|0
4762585|NCT01641367|16428791|P1|Cohorts|Lost to Follow-up|16
4762586|NCT01641367|16428784|P8|Cohorts|Death|0
4762587|NCT01641367|16428785|P7|Cohorts|Death|0
4762588|NCT01641367|16428786|P6|Cohorts|Death|1
4762589|NCT01641367|16428787|P5|Cohorts|Death|1
4762590|NCT01641367|16428788|P4|Cohorts|Death|0
4762591|NCT01641367|16428789|P3|Cohorts|Death|2
4762592|NCT01641367|16428790|P2|Cohorts|Death|1
4762593|NCT01641367|16428791|P1|Cohorts|Death|18
4762594|NCT01641237|16429042|P4|Period III|Lost to Follow-up|0
4762595|NCT01641237|16429043|P3|Period III|Lost to Follow-up|0
4762596|NCT01641237|16429044|P2|Period III|Lost to Follow-up|0
4762597|NCT01641237|16429045|P1|Period III|Lost to Follow-up|1
4762598|NCT01641237|16429042|P4|Period II|Withdrawal by Subject|0
4762599|NCT01641237|16429043|P3|Period II|Withdrawal by Subject|0
4762600|NCT01641237|16429044|P2|Period II|Withdrawal by Subject|0
4762601|NCT01641237|16429045|P1|Period II|Withdrawal by Subject|1
4762602|NCT01641198|16429070|P3|At 15-20 Years of Function|Death|1
4762603|NCT01641198|16429071|P2|At 15-20 Years of Function|Death|0
4762604|NCT01641198|16429072|P1|At 15-20 Years of Function|Death|1
4762605|NCT01641198|16429070|P3|At 15-20 Years of Function|Lost to Follow-up|1
4762606|NCT01641198|16429071|P2|At 15-20 Years of Function|Lost to Follow-up|1
4762607|NCT01641198|16429072|P1|At 15-20 Years of Function|Lost to Follow-up|5
4762608|NCT01641198|16429070|P3|After 24 Months of Function|Lost to Follow-up|6
4762609|NCT01641198|16429071|P2|After 24 Months of Function|Lost to Follow-up|9
4762610|NCT01641198|16429072|P1|After 24 Months of Function|Lost to Follow-up|4
4762611|NCT01641198|16429070|P3|After 12 Months of Function|Adverse Event|0
4762612|NCT01641198|16429071|P2|After 12 Months of Function|Adverse Event|1
4762613|NCT01641198|16429072|P1|After 12 Months of Function|Adverse Event|0
4762614|NCT01641198|16429070|P3|After 12 Months of Function|Protocol Violation|0
4762615|NCT01641198|16429071|P2|After 12 Months of Function|Protocol Violation|0
4762616|NCT01641198|16429072|P1|After 12 Months of Function|Protocol Violation|1
4762617|NCT01641198|16429070|P3|After 12 Months of Function|Lost to Follow-up|2
4762618|NCT01641198|16429071|P2|After 12 Months of Function|Lost to Follow-up|2
4762619|NCT01641198|16429072|P1|After 12 Months of Function|Lost to Follow-up|3
4762620|NCT01641159|16429088|P2|Overall Study|Withdrawal by Subject|1
4762621|NCT01641159|16429089|P1|Overall Study|Withdrawal by Subject|0
4762622|NCT01641159|16429088|P2|Overall Study|Lost to Follow-up|1
4762623|NCT01641159|16429089|P1|Overall Study|Lost to Follow-up|2
4762624|NCT01641133|16429100|P3|Overall Study|Lost to Follow-up|2
4762625|NCT01641133|16429101|P2|Overall Study|Lost to Follow-up|2
4762626|NCT01641133|16429102|P1|Overall Study|Lost to Follow-up|0
4762627|NCT01641133|16429100|P3|Overall Study|Withdrawal by Subject|3
4762628|NCT01641133|16429101|P2|Overall Study|Withdrawal by Subject|3
4762629|NCT01641133|16429102|P1|Overall Study|Withdrawal by Subject|5
4762630|NCT01641133|16429100|P3|Overall Study|Adverse Event|1
4762631|NCT01641133|16429101|P2|Overall Study|Adverse Event|0
4762632|NCT01641133|16429102|P1|Overall Study|Adverse Event|0
4762633|NCT01641133|16429100|P3|Overall Study|Migrated/moved from study area|1
4762634|NCT01641133|16429101|P2|Overall Study|Migrated/moved from study area|3
4762635|NCT01641133|16429102|P1|Overall Study|Migrated/moved from study area|5
4762636|NCT01641133|16429100|P3|Overall Study|Protocol Violation|1
4762637|NCT01641133|16429101|P2|Overall Study|Protocol Violation|1
4762638|NCT01641133|16429102|P1|Overall Study|Protocol Violation|0
4762639|NCT01641081|16429155|P10|Period 5|Adverse Event|0
4762640|NCT01641081|16429156|P9|Period 5|Adverse Event|0
4762641|NCT01641081|16429157|P8|Period 5|Adverse Event|0
4762642|NCT01641081|16429158|P7|Period 5|Adverse Event|0
4762643|NCT01641081|16429159|P6|Period 5|Adverse Event|0
4762644|NCT01641081|16429160|P5|Period 5|Adverse Event|0
4762645|NCT01641081|16429161|P4|Period 5|Adverse Event|0
4762646|NCT01641081|16429162|P3|Period 5|Adverse Event|2
4762647|NCT01641081|16429163|P2|Period 5|Adverse Event|0
4762648|NCT01641081|16429164|P1|Period 5|Adverse Event|0
4762649|NCT01641081|16429155|P10|Period 4|Adverse Event|0
4762650|NCT01641081|16429156|P9|Period 4|Adverse Event|0
4762651|NCT01641081|16429157|P8|Period 4|Adverse Event|0
4762652|NCT01641081|16429158|P7|Period 4|Adverse Event|0
4762653|NCT01641081|16429159|P6|Period 4|Adverse Event|0
4762654|NCT01641081|16429160|P5|Period 4|Adverse Event|0
4762655|NCT01641081|16429161|P4|Period 4|Adverse Event|1
4762656|NCT01641081|16429162|P3|Period 4|Adverse Event|0
4762657|NCT01641081|16429163|P2|Period 4|Adverse Event|1
4762658|NCT01641081|16429164|P1|Period 4|Adverse Event|0
4762659|NCT01641081|16429155|P10|Period 3|Withdrawal by Subject|0
4762660|NCT01641081|16429156|P9|Period 3|Withdrawal by Subject|1
4762661|NCT01641081|16429157|P8|Period 3|Withdrawal by Subject|0
4762662|NCT01641081|16429158|P7|Period 3|Withdrawal by Subject|0
4762663|NCT01641081|16429159|P6|Period 3|Withdrawal by Subject|0
4762664|NCT01641081|16429160|P5|Period 3|Withdrawal by Subject|0
4762665|NCT01641081|16429161|P4|Period 3|Withdrawal by Subject|0
4762666|NCT01641081|16429162|P3|Period 3|Withdrawal by Subject|0
4762667|NCT01641081|16429163|P2|Period 3|Withdrawal by Subject|0
4762668|NCT01641081|16429164|P1|Period 3|Withdrawal by Subject|0
4762669|NCT01641081|16429155|P10|Period 3|Adverse Event|0
4762670|NCT01641081|16429156|P9|Period 3|Adverse Event|0
4762671|NCT01641081|16429157|P8|Period 3|Adverse Event|0
4762672|NCT01641081|16429158|P7|Period 3|Adverse Event|0
4762673|NCT01641081|16429159|P6|Period 3|Adverse Event|0
4762674|NCT01641081|16429160|P5|Period 3|Adverse Event|0
4762675|NCT01641081|16429161|P4|Period 3|Adverse Event|0
4762676|NCT01641081|16429162|P3|Period 3|Adverse Event|1
4762677|NCT01641081|16429163|P2|Period 3|Adverse Event|0
4762678|NCT01641081|16429164|P1|Period 3|Adverse Event|0
4762679|NCT01641081|16429155|P10|Period 2|Protocol Violation|0
4762680|NCT01641081|16429156|P9|Period 2|Protocol Violation|0
4762681|NCT01641081|16429157|P8|Period 2|Protocol Violation|0
4762682|NCT01641081|16429158|P7|Period 2|Protocol Violation|0
4762683|NCT01641081|16429159|P6|Period 2|Protocol Violation|0
4762684|NCT01641081|16429160|P5|Period 2|Protocol Violation|0
4762685|NCT01641081|16429161|P4|Period 2|Protocol Violation|0
4762686|NCT01641081|16429162|P3|Period 2|Protocol Violation|0
4762687|NCT01641081|16429163|P2|Period 2|Protocol Violation|0
4762688|NCT01641081|16429164|P1|Period 2|Protocol Violation|1
4762689|NCT01641081|16429155|P10|Period 2|Withdrawal by Subject|0
4762690|NCT01641081|16429156|P9|Period 2|Withdrawal by Subject|0
4762691|NCT01641081|16429157|P8|Period 2|Withdrawal by Subject|0
4762692|NCT01641081|16429158|P7|Period 2|Withdrawal by Subject|2
4762693|NCT01641081|16429159|P6|Period 2|Withdrawal by Subject|0
4762694|NCT01641081|16429160|P5|Period 2|Withdrawal by Subject|0
4762695|NCT01641081|16429161|P4|Period 2|Withdrawal by Subject|1
4762696|NCT01641081|16429162|P3|Period 2|Withdrawal by Subject|0
4762697|NCT01641081|16429163|P2|Period 2|Withdrawal by Subject|0
4762698|NCT01641081|16429164|P1|Period 2|Withdrawal by Subject|0
4762699|NCT01641081|16429155|P10|Period 2|Adverse Event|0
4762700|NCT01641081|16429156|P9|Period 2|Adverse Event|0
4762701|NCT01641081|16429157|P8|Period 2|Adverse Event|0
4762702|NCT01641081|16429158|P7|Period 2|Adverse Event|0
4762703|NCT01641081|16429159|P6|Period 2|Adverse Event|1
4762704|NCT01641081|16429160|P5|Period 2|Adverse Event|0
4762705|NCT01641081|16429161|P4|Period 2|Adverse Event|0
4762706|NCT01641081|16429162|P3|Period 2|Adverse Event|0
4762707|NCT01641081|16429163|P2|Period 2|Adverse Event|0
4762708|NCT01641081|16429164|P1|Period 2|Adverse Event|0
4762709|NCT01641081|16429155|P10|Period 1|Adverse Event|0
4762710|NCT01641081|16429156|P9|Period 1|Adverse Event|0
4762711|NCT01641081|16429157|P8|Period 1|Adverse Event|2
4762712|NCT01641081|16429158|P7|Period 1|Adverse Event|0
4762713|NCT01641081|16429159|P6|Period 1|Adverse Event|0
4762714|NCT01641081|16429160|P5|Period 1|Adverse Event|0
4762715|NCT01641081|16429161|P4|Period 1|Adverse Event|0
4762716|NCT01641081|16429162|P3|Period 1|Adverse Event|0
4762717|NCT01641081|16429163|P2|Period 1|Adverse Event|0
4762718|NCT01641081|16429164|P1|Period 1|Adverse Event|1
4762719|NCT01641081|16429155|P10|Period 1|Protocol Violation|0
4762720|NCT01641081|16429156|P9|Period 1|Protocol Violation|0
4762721|NCT01641081|16429157|P8|Period 1|Protocol Violation|1
4762722|NCT01641081|16429158|P7|Period 1|Protocol Violation|0
4762723|NCT01641081|16429159|P6|Period 1|Protocol Violation|0
4762724|NCT01641081|16429160|P5|Period 1|Protocol Violation|1
4762725|NCT01641081|16429161|P4|Period 1|Protocol Violation|0
4762726|NCT01641081|16429162|P3|Period 1|Protocol Violation|0
4762727|NCT01641081|16429163|P2|Period 1|Protocol Violation|0
4762728|NCT01641081|16429164|P1|Period 1|Protocol Violation|0
4762729|NCT01641081|16429155|P10|Period 1|Sponsor request (potential unblinding)|0
4762730|NCT01641081|16429156|P9|Period 1|Sponsor request (potential unblinding)|0
4762731|NCT01641081|16429157|P8|Period 1|Sponsor request (potential unblinding)|0
4762732|NCT01641081|16429158|P7|Period 1|Sponsor request (potential unblinding)|1
4762733|NCT01641081|16429159|P6|Period 1|Sponsor request (potential unblinding)|0
4762734|NCT01641081|16429160|P5|Period 1|Sponsor request (potential unblinding)|0
4762735|NCT01641081|16429161|P4|Period 1|Sponsor request (potential unblinding)|0
4762736|NCT01641081|16429162|P3|Period 1|Sponsor request (potential unblinding)|0
4762737|NCT01641081|16429163|P2|Period 1|Sponsor request (potential unblinding)|0
4762738|NCT01641081|16429164|P1|Period 1|Sponsor request (potential unblinding)|0
4762739|NCT01640964|16429233|P3|Overall Study|Protocol Deviation|2
4762740|NCT01640964|16429234|P2|Overall Study|Protocol Deviation|1
4762741|NCT01640964|16429235|P1|Overall Study|Protocol Deviation|1
4762742|NCT01640964|16429233|P3|Overall Study|Lost to Follow-up|1
4762743|NCT01640964|16429234|P2|Overall Study|Lost to Follow-up|0
4762744|NCT01640964|16429235|P1|Overall Study|Lost to Follow-up|0
4762745|NCT01640951|16429258|P8|Overall Study|Death|2
4762746|NCT01640951|16429259|P7|Overall Study|Death|0
4762747|NCT01640951|16429260|P6|Overall Study|Death|0
4762748|NCT01640951|16429261|P5|Overall Study|Death|0
4762749|NCT01640951|16429262|P4|Overall Study|Death|0
4762750|NCT01640951|16429263|P3|Overall Study|Death|1
4762751|NCT01640951|16429264|P2|Overall Study|Death|1
4762752|NCT01640951|16429265|P1|Overall Study|Death|0
4762753|NCT01640951|16429258|P8|Overall Study|Subject/Guardian decision|4
4762754|NCT01640951|16429259|P7|Overall Study|Subject/Guardian decision|5
4762755|NCT01640951|16429260|P6|Overall Study|Subject/Guardian decision|19
4762756|NCT01640951|16429261|P5|Overall Study|Subject/Guardian decision|7
4762757|NCT01640951|16429262|P4|Overall Study|Subject/Guardian decision|15
4762758|NCT01640951|16429263|P3|Overall Study|Subject/Guardian decision|13
4762759|NCT01640951|16429264|P2|Overall Study|Subject/Guardian decision|4
4762760|NCT01640951|16429265|P1|Overall Study|Subject/Guardian decision|12
4762761|NCT01640951|16429258|P8|Overall Study|Protocol Deviation|0
4762762|NCT01640951|16429259|P7|Overall Study|Protocol Deviation|0
4762763|NCT01640951|16429260|P6|Overall Study|Protocol Deviation|1
4762764|NCT01640951|16429261|P5|Overall Study|Protocol Deviation|0
4762765|NCT01640951|16429262|P4|Overall Study|Protocol Deviation|1
4762766|NCT01640951|16429263|P3|Overall Study|Protocol Deviation|2
4762767|NCT01640951|16429264|P2|Overall Study|Protocol Deviation|1
4762768|NCT01640951|16429265|P1|Overall Study|Protocol Deviation|0
4762769|NCT01640951|16429258|P8|Overall Study|Pregnancy|0
4762770|NCT01640951|16429259|P7|Overall Study|Pregnancy|2
4762771|NCT01640951|16429260|P6|Overall Study|Pregnancy|0
4762772|NCT01640951|16429261|P5|Overall Study|Pregnancy|0
4762773|NCT01640951|16429262|P4|Overall Study|Pregnancy|4
4762774|NCT01640951|16429263|P3|Overall Study|Pregnancy|0
4762775|NCT01640951|16429264|P2|Overall Study|Pregnancy|0
4762776|NCT01640951|16429265|P1|Overall Study|Pregnancy|3
4762777|NCT01640951|16429258|P8|Overall Study|Physician Decision|0
4762778|NCT01640951|16429259|P7|Overall Study|Physician Decision|3
4762779|NCT01640951|16429260|P6|Overall Study|Physician Decision|3
4762780|NCT01640951|16429261|P5|Overall Study|Physician Decision|2
4762781|NCT01640951|16429262|P4|Overall Study|Physician Decision|2
4762782|NCT01640951|16429263|P3|Overall Study|Physician Decision|2
4762783|NCT01640951|16429264|P2|Overall Study|Physician Decision|5
4762784|NCT01640951|16429265|P1|Overall Study|Physician Decision|2
4762785|NCT01640951|16429258|P8|Overall Study|Non-compliance with study treatment|0
4762786|NCT01640951|16429259|P7|Overall Study|Non-compliance with study treatment|1
4762787|NCT01640951|16429260|P6|Overall Study|Non-compliance with study treatment|4
4762788|NCT01640951|16429261|P5|Overall Study|Non-compliance with study treatment|1
4762789|NCT01640951|16429262|P4|Overall Study|Non-compliance with study treatment|1
4762790|NCT01640951|16429263|P3|Overall Study|Non-compliance with study treatment|1
4762791|NCT01640951|16429264|P2|Overall Study|Non-compliance with study treatment|0
4762792|NCT01640951|16429265|P1|Overall Study|Non-compliance with study treatment|0
4762793|NCT01640951|16429258|P8|Overall Study|Lost to Follow-up|1
4762794|NCT01640951|16429259|P7|Overall Study|Lost to Follow-up|1
4762795|NCT01640951|16429260|P6|Overall Study|Lost to Follow-up|3
4762796|NCT01640951|16429261|P5|Overall Study|Lost to Follow-up|2
4762797|NCT01640951|16429262|P4|Overall Study|Lost to Follow-up|2
4762798|NCT01640951|16429263|P3|Overall Study|Lost to Follow-up|6
4762799|NCT01640951|16429264|P2|Overall Study|Lost to Follow-up|0
4762800|NCT01640951|16429265|P1|Overall Study|Lost to Follow-up|1
4762801|NCT01640951|16429258|P8|Overall Study|Lack of Efficacy|6
4762802|NCT01640951|16429259|P7|Overall Study|Lack of Efficacy|5
4762803|NCT01640951|16429260|P6|Overall Study|Lack of Efficacy|6
4762804|NCT01640951|16429261|P5|Overall Study|Lack of Efficacy|0
4762805|NCT01640951|16429262|P4|Overall Study|Lack of Efficacy|14
4762806|NCT01640951|16429263|P3|Overall Study|Lack of Efficacy|7
4762807|NCT01640951|16429264|P2|Overall Study|Lack of Efficacy|1
4762808|NCT01640951|16429265|P1|Overall Study|Lack of Efficacy|20
4762809|NCT01640951|16429258|P8|Overall Study|Adverse Event|3
4762810|NCT01640951|16429259|P7|Overall Study|Adverse Event|1
4762811|NCT01640951|16429260|P6|Overall Study|Adverse Event|11
4762812|NCT01640951|16429261|P5|Overall Study|Adverse Event|1
4762813|NCT01640951|16429262|P4|Overall Study|Adverse Event|6
4762814|NCT01640951|16429263|P3|Overall Study|Adverse Event|10
4762815|NCT01640951|16429264|P2|Overall Study|Adverse Event|3
4762816|NCT01640951|16429265|P1|Overall Study|Adverse Event|8
4762817|NCT01640925|16429367|P2|Overall Study|Previously enrolled in this trial|11
4762818|NCT01640925|16429368|P1|Overall Study|Previously enrolled in this trial|13
4762819|NCT01640925|16429367|P2|Overall Study|Withdrawal by Subject|0
4762820|NCT01640925|16429368|P1|Overall Study|Withdrawal by Subject|1
4762821|NCT01640873|16429382|P2|Overall Study|Protocol Violation|1
4762822|NCT01640873|16429383|P1|Overall Study|Protocol Violation|2
4762823|NCT01640366|16429456|P1|Overall Study|Lost to Follow-up|5
4762824|NCT01640366|16429456|P1|Overall Study|Protocol Violation|16
4762825|NCT01640366|16429456|P1|Overall Study|Withdrawal by Subject|1
4762826|NCT01640353|16429469|P1|Overall Study|Physician Decision|1
4762827|NCT01640353|16429469|P1|Overall Study|Lost to Follow-up|12
4762828|NCT01640353|16429469|P1|Overall Study|Early site termination|3
4762829|NCT01640353|16429469|P1|Overall Study|Death|2
4762830|NCT01640353|16429469|P1|Overall Study|Withdrawal by Subject|5
4762831|NCT01640353|16429469|P1|Overall Study|Withdrawn from analysis at term site|12
4762832|NCT01640353|16429469|P1|Overall Study|Withdrew prior to treatment|10
4762833|NCT01640314|16429517|P2|Overall Study|Protocol Violation|1
4762834|NCT01640314|16429518|P1|Overall Study|Protocol Violation|0
4762835|NCT01640288|16429534|P2|Overall Study|Withdrawal by Subject|0
4762836|NCT01640288|16429535|P1|Overall Study|Withdrawal by Subject|1
4762837|NCT01640288|16429534|P2|Overall Study|Withdrawn by PI|0
4762838|NCT01640288|16429535|P1|Overall Study|Withdrawn by PI|5
4762839|NCT01640288|16429534|P2|Overall Study|Screen Failure|18
4762840|NCT01640288|16429535|P1|Overall Study|Screen Failure|20
4762841|NCT01640288|16429534|P2|Overall Study|Equipment Failure or Poor Image Quality|5
4762842|NCT01640288|16429535|P1|Overall Study|Equipment Failure or Poor Image Quality|4
4762843|NCT01640249|16429552|P7|Period 1|Withdrawal by Subject|0
4762844|NCT01640249|16429553|P6|Period 1|Withdrawal by Subject|1
4762845|NCT01640249|16429554|P5|Period 1|Withdrawal by Subject|0
4762846|NCT01640249|16429555|P4|Period 1|Withdrawal by Subject|0
4762847|NCT01640249|16429556|P3|Period 1|Withdrawal by Subject|0
4762848|NCT01640249|16429557|P2|Period 1|Withdrawal by Subject|0
4762849|NCT01640249|16429558|P1|Period 1|Withdrawal by Subject|1
4762850|NCT01640184|16429606|P3|Overall Study|Protocol Violation|1
4762851|NCT01640184|16429607|P2|Overall Study|Protocol Violation|0
4762852|NCT01640184|16429608|P1|Overall Study|Protocol Violation|0
4762853|NCT01640184|16429606|P3|Overall Study|Withdrawal by Subject|1
4762854|NCT01640184|16429607|P2|Overall Study|Withdrawal by Subject|1
4762855|NCT01640184|16429608|P1|Overall Study|Withdrawal by Subject|0
4762856|NCT01640184|16429606|P3|Overall Study|Physician Decision|0
4762857|NCT01640184|16429607|P2|Overall Study|Physician Decision|0
4762858|NCT01640184|16429608|P1|Overall Study|Physician Decision|3
4762859|NCT01640184|16429606|P3|Overall Study|Lost to Follow-up|0
4762860|NCT01640184|16429607|P2|Overall Study|Lost to Follow-up|1
4762861|NCT01640184|16429608|P1|Overall Study|Lost to Follow-up|4
4762862|NCT01640184|16429606|P3|Overall Study|Death|0
4762863|NCT01640184|16429607|P2|Overall Study|Death|0
4762864|NCT01640184|16429608|P1|Overall Study|Death|1
4762865|NCT01640054|16429637|P1|Overall Study|Adverse Event|2
4762866|NCT01640054|16429637|P1|Overall Study|Lack of Efficacy|3
4762867|NCT01640054|16429637|P1|Overall Study|Study-specific disc criteria|1
4762868|NCT01639833|16429658|P2|Overall Study|Withdrawal by Subject|2
4762869|NCT01639833|16429659|P1|Overall Study|Withdrawal by Subject|2
4762870|NCT01639833|16429658|P2|Overall Study|Death|2
4762871|NCT01639833|16429659|P1|Overall Study|Death|4
4762872|NCT01639755|16429667|P1|Overall Study|Patient had device explantation|4
4762873|NCT01639755|16429667|P1|Overall Study|Study Ongoing|15
4762874|NCT01639742|16429675|P1|Overall Study|Lost to Follow-up|1
4762875|NCT01639742|16429675|P1|Overall Study|Study Ongoing|17
4762876|NCT01639729|16429683|P6|Overall Study|Withdrawal by Subject|0
4762877|NCT01639729|16429684|P5|Overall Study|Withdrawal by Subject|0
4762878|NCT01639729|16429685|P4|Overall Study|Withdrawal by Subject|1
4762879|NCT01639729|16429686|P3|Overall Study|Withdrawal by Subject|1
4762880|NCT01639729|16429687|P2|Overall Study|Withdrawal by Subject|0
4762881|NCT01639729|16429688|P1|Overall Study|Withdrawal by Subject|1
4762882|NCT01639703|16429710|P1|Overall Study|Other reason|7
4762883|NCT01639703|16429710|P1|Overall Study|Withdrawal by Subject|5
4762884|NCT01639560|16429775|P2|Overall Study|Adverse Event|2
4762885|NCT01639560|16429776|P1|Overall Study|Adverse Event|0
4762886|NCT01639560|16429775|P2|Overall Study|Lost to Follow-up|11
4762887|NCT01639560|16429776|P1|Overall Study|Lost to Follow-up|9
4762888|NCT01639560|16429775|P2|Overall Study|Lack of Efficacy|2
4762889|NCT01639560|16429776|P1|Overall Study|Lack of Efficacy|1
4762890|NCT01639560|16429775|P2|Overall Study|Withdrawal by Subject|14
4762891|NCT01639560|16429776|P1|Overall Study|Withdrawal by Subject|9
4762892|NCT01639495|16429788|P1|Overall Study|No radiofrequency energy applied|2
4762893|NCT01639495|16429788|P1|Overall Study|Not meeting inclusion/exclusion criteria|4
4762894|NCT01639495|16429788|P1|Overall Study|Consented but didn't have study catheter|4
4762895|NCT01639495|16429788|P1|Overall Study|Lost to Follow-up|6
4762896|NCT01639469|16429798|P2|Overall Study|Lost to Follow-up|1
4762897|NCT01639469|16429799|P1|Overall Study|Lost to Follow-up|1
4762898|NCT01639469|16429798|P2|Overall Study|Death|2
4762899|NCT01639469|16429799|P1|Overall Study|Death|4
4762900|NCT01639339|16429835|P2|Overall Study|Adverse Event|7
4762901|NCT01639339|16429836|P1|Overall Study|Adverse Event|10
4762902|NCT01639339|16429835|P2|Overall Study|Lack of Efficacy|1
4762903|NCT01639339|16429836|P1|Overall Study|Lack of Efficacy|2
4762904|NCT01639339|16429835|P2|Overall Study|Protocol Violation|2
4762905|NCT01639339|16429836|P1|Overall Study|Protocol Violation|0
4762906|NCT01639339|16429835|P2|Overall Study|Lost to Follow-up|4
4762907|NCT01639339|16429836|P1|Overall Study|Lost to Follow-up|5
4762908|NCT01639339|16429835|P2|Overall Study|Physician Decision|5
4762909|NCT01639339|16429836|P1|Overall Study|Physician Decision|11
4762910|NCT01639339|16429835|P2|Overall Study|Withdrawal by Subject|19
4762911|NCT01639339|16429836|P1|Overall Study|Withdrawal by Subject|26
4762912|NCT01639144|16429925|P2|Overall Study|Met postoperative exclusion criteria|3
4762913|NCT01639144|16429926|P1|Overall Study|Met postoperative exclusion criteria|4
4762914|NCT01639144|16429925|P2|Overall Study|Physician Decision|0
4762915|NCT01639144|16429926|P1|Overall Study|Physician Decision|2
4762916|NCT01639144|16429925|P2|Overall Study|Withdrawal by Subject|2
4762917|NCT01639144|16429926|P1|Overall Study|Withdrawal by Subject|4
4762918|NCT01639040|16429934|P2|Overall Study|Adverse Event|0
4762919|NCT01639040|16429935|P1|Overall Study|Adverse Event|1
4762920|NCT01639001|16429953|P2|Overall Study|Death|35
4762921|NCT01639001|16429954|P1|Overall Study|Death|35
4762922|NCT01639001|16429953|P2|Overall Study|Lost to Follow-up|0
4762923|NCT01639001|16429954|P1|Overall Study|Lost to Follow-up|1
4762924|NCT01639001|16429953|P2|Overall Study|Refused further follow-up|6
4762925|NCT01639001|16429954|P1|Overall Study|Refused further follow-up|3
4762926|NCT01639001|16429953|P2|Overall Study|Ongoing at date of cutoff|60
4762927|NCT01639001|16429954|P1|Overall Study|Ongoing at date of cutoff|65
4762928|NCT01639001|16429953|P2|Overall Study|Randomized but not treated|2
4762929|NCT01639001|16429954|P1|Overall Study|Randomized but not treated|0
4762930|NCT01638819|16430000|P2|Overall Study|Lost to Follow-up|0
4762931|NCT01638819|16430001|P1|Overall Study|Lost to Follow-up|1
4762932|NCT01638559|16430010|P1|Overall Study|Subject declined to travel for biopsy|1
4762933|NCT01638559|16430010|P1|Overall Study|Withdrawal by Subject|1
4762934|NCT01638559|16430010|P1|Overall Study|Lost to Follow-up|1
4762935|NCT01638546|16430028|P2|Overall Study|Adverse Event|3
4762936|NCT01638546|16430029|P1|Overall Study|Adverse Event|1
4762937|NCT01638429|16430068|P1|Overall Study|Withdrawal by Subject|1
4762938|NCT01638390|16430119|P1|Overall Study|screening failures|21
4762939|NCT01638013|16430143|P3|Overall Study|Not met inclusion or exclusion criteria|1
4762940|NCT01638013|16430144|P2|Overall Study|Not met inclusion or exclusion criteria|0
4762941|NCT01638013|16430145|P1|Overall Study|Not met inclusion or exclusion criteria|0
4762942|NCT01638013|16430143|P3|Overall Study|Withdrawal of Consent|16
4762943|NCT01638013|16430144|P2|Overall Study|Withdrawal of Consent|12
4762944|NCT01638013|16430145|P1|Overall Study|Withdrawal of Consent|16
4762945|NCT01638013|16430143|P3|Overall Study|Miscellaneous|23
4762946|NCT01638013|16430144|P2|Overall Study|Miscellaneous|19
4762947|NCT01638013|16430145|P1|Overall Study|Miscellaneous|25
4762948|NCT01638013|16430143|P3|Overall Study|Subject Lost to Follow up|1
4762949|NCT01638013|16430144|P2|Overall Study|Subject Lost to Follow up|0
4762950|NCT01638013|16430145|P1|Overall Study|Subject Lost to Follow up|1
4762951|NCT01638013|16430143|P3|Overall Study|Met discontinuation criteria|7
4762952|NCT01638013|16430144|P2|Overall Study|Met discontinuation criteria|0
4762953|NCT01638013|16430145|P1|Overall Study|Met discontinuation criteria|4
4762954|NCT01638013|16430143|P3|Overall Study|Protocol Violation|11
4762955|NCT01638013|16430144|P2|Overall Study|Protocol Violation|7
4762956|NCT01638013|16430145|P1|Overall Study|Protocol Violation|10
4762957|NCT01638013|16430143|P3|Overall Study|Lack of Efficacy|14
4762958|NCT01638013|16430144|P2|Overall Study|Lack of Efficacy|11
4762959|NCT01638013|16430145|P1|Overall Study|Lack of Efficacy|39
4762960|NCT01638013|16430143|P3|Overall Study|Adverse Event|48
4762961|NCT01638013|16430144|P2|Overall Study|Adverse Event|29
4762962|NCT01638013|16430145|P1|Overall Study|Adverse Event|36
4762963|NCT01638000|16430278|P2|Overall Study|Miscellaneous|2
4762964|NCT01638000|16430279|P1|Overall Study|Miscellaneous|2
4762965|NCT01638000|16430278|P2|Overall Study|Withdrawal by Subject|24
4762966|NCT01638000|16430279|P1|Overall Study|Withdrawal by Subject|21
4762967|NCT01638000|16430278|P2|Overall Study|Protocol Violation|13
4762968|NCT01638000|16430279|P1|Overall Study|Protocol Violation|11
4762969|NCT01638000|16430278|P2|Overall Study|Lack of Efficacy|6
4762970|NCT01638000|16430279|P1|Overall Study|Lack of Efficacy|5
4762971|NCT01638000|16430278|P2|Overall Study|Adverse Event|16
4762972|NCT01638000|16430279|P1|Overall Study|Adverse Event|14
4762973|NCT01638000|16430278|P2|Overall Study|Randomized but Never Received Drug|10
4762974|NCT01638000|16430279|P1|Overall Study|Randomized but Never Received Drug|7
4762975|NCT01637961|16430377|P1|Overall Study|Ineligible: inadequate pathology|1
4762976|NCT01637961|16430377|P1|Overall Study|Ineligible: wrong primary|1
4762977|NCT01637922|16430409|P2|Overall Study|Lost to Follow-up|0
4762978|NCT01637922|16430410|P1|Overall Study|Lost to Follow-up|2
4762979|NCT01637922|16430409|P2|Overall Study|Withdrawal by Subject|3
4762980|NCT01637922|16430410|P1|Overall Study|Withdrawal by Subject|0
4762981|NCT01637922|16430409|P2|Overall Study|Protocol Violation|1
4762982|NCT01637922|16430410|P1|Overall Study|Protocol Violation|0
4762983|NCT01637922|16430409|P2|Overall Study|Adverse Event|1
4762984|NCT01637922|16430410|P1|Overall Study|Adverse Event|0
4762985|NCT01637623|16430440|P3|Overall Study|Physician Decision|1
4762986|NCT01637623|16430441|P2|Overall Study|Physician Decision|0
4762987|NCT01637623|16430442|P1|Overall Study|Physician Decision|1
4762988|NCT01637623|16430440|P3|Overall Study|Lost to Follow-up|2
4762989|NCT01637623|16430441|P2|Overall Study|Lost to Follow-up|0
4762990|NCT01637623|16430442|P1|Overall Study|Lost to Follow-up|0
4762991|NCT01637584|16430482|P2|Overall Study|Withdrawal by Subject|3
4762992|NCT01637584|16430483|P1|Overall Study|Withdrawal by Subject|1
4762993|NCT01637402|16430490|P2|Treatment Regiments Post Week 12|Progression after escalation arm closed|0
4762994|NCT01637402|16430491|P1|Treatment Regiments Post Week 12|Progression after escalation arm closed|5
4762995|NCT01637402|16430490|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
4762996|NCT01637402|16430491|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|4
4762997|NCT01637402|16430490|P2|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4
4762998|NCT01637402|16430491|P1|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0
4762999|NCT01637402|16430490|P2|Week 12 Evaluation|Lack of Efficacy|0
4763000|NCT01637402|16430491|P1|Week 12 Evaluation|Lack of Efficacy|6
4763001|NCT01637402|16430490|P2|Standard Dose Regimen|Adverse Event|0
4763002|NCT01637402|16430491|P1|Standard Dose Regimen|Adverse Event|1
4763003|NCT01637402|16430490|P2|Standard Dose Regimen|Lack of Efficacy|0
4763004|NCT01637402|16430491|P1|Standard Dose Regimen|Lack of Efficacy|2
4763005|NCT01637272|16430522|P1|Overall Study|Protocol Violation|2
4763006|NCT01637272|16430522|P1|Overall Study|Administrative problems|1
4763007|NCT01637272|16430522|P1|Overall Study|completed core, did not enter ext. phase|4
4763008|NCT01637272|16430522|P1|Overall Study|Lost to Follow-up|2
4763009|NCT01637272|16430522|P1|Overall Study|Withdrawal by Subject|3
4763010|NCT01637272|16430522|P1|Overall Study|Unsatisfactory therapeutic effect|2
4763011|NCT01637272|16430522|P1|Overall Study|Adverse Event|6
4763012|NCT01637077|16430602|P2|Overall Study|No cycle 1 questionnaire data|0
4763013|NCT01637077|16430603|P1|Overall Study|No cycle 1 questionnaire data|2
4763014|NCT01637077|16430602|P2|Overall Study|Withdrawal by Subject|0
4763015|NCT01637077|16430603|P1|Overall Study|Withdrawal by Subject|1
4763016|NCT01637077|16430602|P2|Overall Study|Cancel|1
4763017|NCT01637077|16430603|P1|Overall Study|Cancel|1
4763018|NCT01636986|16430631|P2|Overall Study|Corneal Staining|1
4763019|NCT01636986|16430632|P1|Overall Study|Corneal Staining|0
4763020|NCT01636986|16430631|P2|Overall Study|Withdrawal by Subject|1
4763021|NCT01636986|16430632|P1|Overall Study|Withdrawal by Subject|0
4763022|NCT01636960|16430638|P1|Maintenance Phase|Progressive disease|1
4763023|NCT01636960|16430638|P1|Maintenance Phase|Adverse Event|3
4763024|NCT01636960|16430638|P1|Maintenance Phase|Continued drug after regulatory approval|3
4763025|NCT01636960|16430638|P1|Induction Phase|Adverse Event|2
4763026|NCT01636947|16430646|P2|Overall Study|Did Not Meet Eligibility Criteria|4
4763027|NCT01636947|16430647|P1|Overall Study|Did Not Meet Eligibility Criteria|1
4763028|NCT01636947|16430646|P2|Overall Study|Adverse Event|1
4763029|NCT01636947|16430647|P1|Overall Study|Adverse Event|1
4763030|NCT01636947|16430646|P2|Overall Study|Withdrawal by Subject|3
4763031|NCT01636947|16430647|P1|Overall Study|Withdrawal by Subject|3
4763032|NCT01636947|16430646|P2|Overall Study|Protocol Violation|1
4763033|NCT01636947|16430647|P1|Overall Study|Protocol Violation|1
4763034|NCT01636947|16430646|P2|Overall Study|Lost to Follow-up|0
4763035|NCT01636947|16430647|P1|Overall Study|Lost to Follow-up|4
4763036|NCT01636947|16430646|P2|Overall Study|Not Treated|2
4763037|NCT01636947|16430647|P1|Overall Study|Not Treated|2
4763038|NCT01636934|16430669|P2|Overall Study|Never started study medication|1
4763039|NCT01636934|16430670|P1|Overall Study|Never started study medication|1
4763040|NCT01636934|16430669|P2|Overall Study|Too ill to continue|0
4763041|NCT01636934|16430670|P1|Overall Study|Too ill to continue|1
4763042|NCT01636934|16430669|P2|Overall Study|Chemo cancel|0
4763043|NCT01636934|16430670|P1|Overall Study|Chemo cancel|1
4763044|NCT01636934|16430669|P2|Overall Study|Withdrawal by Subject|2
4763045|NCT01636934|16430670|P1|Overall Study|Withdrawal by Subject|3
4763046|NCT01636778|16430682|P3|Follow-up Period After Part 2|Withdrawal by Subject|2
4763047|NCT01636778|16430683|P2|Follow-up Period After Part 2|Withdrawal by Subject|0
4763048|NCT01636778|16430684|P1|Follow-up Period After Part 2|Withdrawal by Subject|0
4763049|NCT01636778|16430682|P3|Follow-up Period After Part 2|Not entered FU period after withdrawal|1
4763050|NCT01636778|16430683|P2|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
4763051|NCT01636778|16430684|P1|Follow-up Period After Part 2|Not entered FU period after withdrawal|0
4763052|NCT01636778|16430682|P3|Follow-up Period After Part 2|Other|1
4763053|NCT01636778|16430683|P2|Follow-up Period After Part 2|Other|0
4763054|NCT01636778|16430684|P1|Follow-up Period After Part 2|Other|0
4763055|NCT01636778|16430682|P3|Antiviral Treatment Period (Part 2)|Physician Decision|0
4763056|NCT01636778|16430683|P2|Antiviral Treatment Period (Part 2)|Physician Decision|2
4763057|NCT01636778|16430684|P1|Antiviral Treatment Period (Part 2)|Physician Decision|0
4763058|NCT01636778|16430682|P3|Antiviral Treatment Period (Part 2)|Protocol Violation|0
4763059|NCT01636778|16430683|P2|Antiviral Treatment Period (Part 2)|Protocol Violation|1
4763060|NCT01636778|16430684|P1|Antiviral Treatment Period (Part 2)|Protocol Violation|0
4763061|NCT01636778|16430682|P3|Antiviral Treatment Period (Part 2)|Adverse Event|0
4763062|NCT01636778|16430683|P2|Antiviral Treatment Period (Part 2)|Adverse Event|7
4763063|NCT01636778|16430684|P1|Antiviral Treatment Period (Part 2)|Adverse Event|0
4763064|NCT01636778|16430682|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
4763065|NCT01636778|16430683|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0
4763066|NCT01636778|16430684|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1
4763067|NCT01636778|16430682|P3|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
4763068|NCT01636778|16430683|P2|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0
4763069|NCT01636778|16430684|P1|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3
4763070|NCT01636713|16430755|P3|Overall Study|Met Protocol-defined Stopping Criteria|4
4763071|NCT01636713|16430756|P2|Overall Study|Met Protocol-defined Stopping Criteria|2
4763072|NCT01636713|16430757|P1|Overall Study|Met Protocol-defined Stopping Criteria|2
4763073|NCT01636713|16430755|P3|Overall Study|Withdrawal by Subject|8
4763074|NCT01636713|16430756|P2|Overall Study|Withdrawal by Subject|4
4763075|NCT01636713|16430757|P1|Overall Study|Withdrawal by Subject|5
4763076|NCT01636713|16430755|P3|Overall Study|Lost to Follow-up|1
4763077|NCT01636713|16430756|P2|Overall Study|Lost to Follow-up|0
4763078|NCT01636713|16430757|P1|Overall Study|Lost to Follow-up|0
4763079|NCT01636713|16430755|P3|Overall Study|Protocol Violation|1
4763080|NCT01636713|16430756|P2|Overall Study|Protocol Violation|0
4763081|NCT01636713|16430757|P1|Overall Study|Protocol Violation|3
4763082|NCT01636713|16430755|P3|Overall Study|Lack of Efficacy|2
4763083|NCT01636713|16430756|P2|Overall Study|Lack of Efficacy|6
4763084|NCT01636713|16430757|P1|Overall Study|Lack of Efficacy|6
4763085|NCT01636713|16430755|P3|Overall Study|Adverse Event|7
4763086|NCT01636713|16430756|P2|Overall Study|Adverse Event|16
4763087|NCT01636713|16430757|P1|Overall Study|Adverse Event|16
4763088|NCT01636687|16430774|P5|Follow-up Period|Withdrawal by Subject|1
4763089|NCT01636687|16430775|P4|Follow-up Period|Withdrawal by Subject|0
4763090|NCT01636687|16430776|P3|Follow-up Period|Withdrawal by Subject|0
4763091|NCT01636687|16430777|P2|Follow-up Period|Withdrawal by Subject|0
4763092|NCT01636687|16430778|P1|Follow-up Period|Withdrawal by Subject|1
4763093|NCT01636687|16430774|P5|Extension Period|Withdrawal by Subject|0
4763094|NCT01636687|16430775|P4|Extension Period|Withdrawal by Subject|1
4763095|NCT01636687|16430776|P3|Extension Period|Withdrawal by Subject|1
4763096|NCT01636687|16430777|P2|Extension Period|Withdrawal by Subject|0
4763097|NCT01636687|16430778|P1|Extension Period|Withdrawal by Subject|1
4763098|NCT01636687|16430774|P5|Extension Period|study terminated by sponsor|0
4763099|NCT01636687|16430775|P4|Extension Period|study terminated by sponsor|23
4763100|NCT01636687|16430776|P3|Extension Period|study terminated by sponsor|17
4763101|NCT01636687|16430777|P2|Extension Period|study terminated by sponsor|50
4763102|NCT01636687|16430778|P1|Extension Period|study terminated by sponsor|33
4763103|NCT01636687|16430774|P5|Extension Period|Physician Decision|0
4763104|NCT01636687|16430775|P4|Extension Period|Physician Decision|1
4763105|NCT01636687|16430776|P3|Extension Period|Physician Decision|0
4763106|NCT01636687|16430777|P2|Extension Period|Physician Decision|0
4763107|NCT01636687|16430778|P1|Extension Period|Physician Decision|1
4763108|NCT01636687|16430774|P5|Extension Period|Lost to Follow-up|0
4763109|NCT01636687|16430775|P4|Extension Period|Lost to Follow-up|0
4763110|NCT01636687|16430776|P3|Extension Period|Lost to Follow-up|1
4763111|NCT01636687|16430777|P2|Extension Period|Lost to Follow-up|0
4763112|NCT01636687|16430778|P1|Extension Period|Lost to Follow-up|1
4763113|NCT01636687|16430774|P5|Extension Period|Lack of Efficacy|0
4763114|NCT01636687|16430775|P4|Extension Period|Lack of Efficacy|1
4763115|NCT01636687|16430776|P3|Extension Period|Lack of Efficacy|2
4763116|NCT01636687|16430777|P2|Extension Period|Lack of Efficacy|0
4763117|NCT01636687|16430778|P1|Extension Period|Lack of Efficacy|7
4763118|NCT01636687|16430774|P5|Extension Period|Adverse Event|0
4763119|NCT01636687|16430775|P4|Extension Period|Adverse Event|1
4763120|NCT01636687|16430776|P3|Extension Period|Adverse Event|2
4763121|NCT01636687|16430777|P2|Extension Period|Adverse Event|3
4763122|NCT01636687|16430778|P1|Extension Period|Adverse Event|4
4763123|NCT01636687|16430774|P5|Extension Period|technical problems|0
4763124|NCT01636687|16430775|P4|Extension Period|technical problems|1
4763125|NCT01636687|16430776|P3|Extension Period|technical problems|2
4763126|NCT01636687|16430777|P2|Extension Period|technical problems|1
4763127|NCT01636687|16430778|P1|Extension Period|technical problems|0
4763128|NCT01636687|16430774|P5|Maintenance Period|Physician Decision|1
4763129|NCT01636687|16430775|P4|Maintenance Period|Physician Decision|0
4763130|NCT01636687|16430776|P3|Maintenance Period|Physician Decision|0
4763131|NCT01636687|16430777|P2|Maintenance Period|Physician Decision|0
4763132|NCT01636687|16430778|P1|Maintenance Period|Physician Decision|0
4763133|NCT01636687|16430774|P5|Maintenance Period|Lost to Follow-up|1
4763134|NCT01636687|16430775|P4|Maintenance Period|Lost to Follow-up|0
4763135|NCT01636687|16430776|P3|Maintenance Period|Lost to Follow-up|0
4763136|NCT01636687|16430777|P2|Maintenance Period|Lost to Follow-up|1
4763137|NCT01636687|16430778|P1|Maintenance Period|Lost to Follow-up|1
4763138|NCT01636687|16430774|P5|Maintenance Period|Lack of Efficacy|0
4763139|NCT01636687|16430775|P4|Maintenance Period|Lack of Efficacy|0
4763140|NCT01636687|16430776|P3|Maintenance Period|Lack of Efficacy|0
4763141|NCT01636687|16430777|P2|Maintenance Period|Lack of Efficacy|1
4763142|NCT01636687|16430778|P1|Maintenance Period|Lack of Efficacy|4
4763143|NCT01636687|16430774|P5|Maintenance Period|Adverse Event|0
4763144|NCT01636687|16430775|P4|Maintenance Period|Adverse Event|0
4763145|NCT01636687|16430776|P3|Maintenance Period|Adverse Event|0
4763146|NCT01636687|16430777|P2|Maintenance Period|Adverse Event|0
4763147|NCT01636687|16430778|P1|Maintenance Period|Adverse Event|1
4763148|NCT01636687|16430774|P5|Maintenance Period|Withdrawal by Subject|0
4763149|NCT01636687|16430775|P4|Maintenance Period|Withdrawal by Subject|0
4763150|NCT01636687|16430776|P3|Maintenance Period|Withdrawal by Subject|2
4763151|NCT01636687|16430777|P2|Maintenance Period|Withdrawal by Subject|0
4763152|NCT01636687|16430778|P1|Maintenance Period|Withdrawal by Subject|2
4763153|NCT01636687|16430774|P5|Induction Period|Physician Decision|0
4763154|NCT01636687|16430775|P4|Induction Period|Physician Decision|0
4763155|NCT01636687|16430776|P3|Induction Period|Physician Decision|0
4763156|NCT01636687|16430777|P2|Induction Period|Physician Decision|0
4763157|NCT01636687|16430778|P1|Induction Period|Physician Decision|1
4763158|NCT01636687|16430774|P5|Induction Period|Lack of Efficacy|1
4763159|NCT01636687|16430775|P4|Induction Period|Lack of Efficacy|0
4763160|NCT01636687|16430776|P3|Induction Period|Lack of Efficacy|0
4763161|NCT01636687|16430777|P2|Induction Period|Lack of Efficacy|0
4763162|NCT01636687|16430778|P1|Induction Period|Lack of Efficacy|0
4763163|NCT01636687|16430774|P5|Induction Period|Adverse Event|1
4763164|NCT01636687|16430775|P4|Induction Period|Adverse Event|0
4763165|NCT01636687|16430776|P3|Induction Period|Adverse Event|0
4763166|NCT01636687|16430777|P2|Induction Period|Adverse Event|0
4763167|NCT01636687|16430778|P1|Induction Period|Adverse Event|1
4763168|NCT01636687|16430774|P5|Induction Period|Withdrawal by Subject|0
4763169|NCT01636687|16430775|P4|Induction Period|Withdrawal by Subject|0
4763170|NCT01636687|16430776|P3|Induction Period|Withdrawal by Subject|0
4763171|NCT01636687|16430777|P2|Induction Period|Withdrawal by Subject|0
4763172|NCT01636687|16430778|P1|Induction Period|Withdrawal by Subject|1
4763173|NCT01636362|16430919|P1|Overall Study|Withdrawal by Subject|1
4763174|NCT01636362|16430919|P1|Overall Study|Subject healed, not returning|1
4763175|NCT01636362|16430919|P1|Overall Study|Physician Decision|6
4763176|NCT01636258|16430946|P2|Overall Study|Lost to Follow-up|0
4763177|NCT01636258|16430947|P1|Overall Study|Lost to Follow-up|1
4763178|NCT01636076|16430987|P2|Overall Study|Withdrawal by Subject|10
4763179|NCT01636076|16430988|P1|Overall Study|Withdrawal by Subject|7
4763180|NCT01636076|16430987|P2|Overall Study|Adverse Event|11
4763181|NCT01636076|16430988|P1|Overall Study|Adverse Event|6
4763182|NCT01636076|16430987|P2|Overall Study|Non-compliance with study treatment|1
4763183|NCT01636076|16430988|P1|Overall Study|Non-compliance with study treatment|1
4763184|NCT01636076|16430987|P2|Overall Study|Physician Decision|1
4763185|NCT01636076|16430988|P1|Overall Study|Physician Decision|1
4763186|NCT01636076|16430987|P2|Overall Study|Lost to Follow-up|0
4763187|NCT01636076|16430988|P1|Overall Study|Lost to Follow-up|1
4763188|NCT01636076|16430987|P2|Overall Study|Lack of Efficacy|1
4763189|NCT01636076|16430988|P1|Overall Study|Lack of Efficacy|0
4763190|NCT01636076|16430987|P2|Overall Study|Terminated by sponsor|1
4763191|NCT01636076|16430988|P1|Overall Study|Terminated by sponsor|1
4763192|NCT01635933|16431059|P2|Overall Study|No longer had transportation|1
4763193|NCT01635933|16431060|P1|Overall Study|No longer had transportation|0
4763194|NCT01635933|16431059|P2|Overall Study|Noncompliance|1
4763195|NCT01635933|16431060|P1|Overall Study|Noncompliance|0
4763196|NCT01635933|16431059|P2|Overall Study|Subject decision|1
4763197|NCT01635933|16431060|P1|Overall Study|Subject decision|1
4763198|NCT01635933|16431059|P2|Overall Study|Lost to Follow-up|5
4763199|NCT01635933|16431060|P1|Overall Study|Lost to Follow-up|0
4763200|NCT01635933|16431059|P2|Overall Study|Adverse Event|0
4763201|NCT01635933|16431060|P1|Overall Study|Adverse Event|1
4763202|NCT01635920|16431072|P2|Overall Study|Subject decision|0
4763203|NCT01635920|16431073|P1|Overall Study|Subject decision|2
4763204|NCT01635920|16431072|P2|Overall Study|Lost to Follow-up|1
4763205|NCT01635920|16431073|P1|Overall Study|Lost to Follow-up|0
4763206|NCT01635920|16431072|P2|Overall Study|Adverse Event|0
4763207|NCT01635920|16431073|P1|Overall Study|Adverse Event|1
4763208|NCT01635855|16431086|P1|Overall Study|Withdrawal by Subject|4
4763209|NCT01635764|16431095|P1|Overall Study|Other|28
4763210|NCT01635764|16431095|P1|Overall Study|Lost to Follow-up|53
4763211|NCT01635764|16431095|P1|Overall Study|Withdrew Consent|67
4763212|NCT01635764|16431095|P1|Overall Study|Protocol Deviation|1
4763213|NCT01635764|16431095|P1|Overall Study|Exceed Protocol-specified Interventions|2
4763214|NCT01635764|16431095|P1|Overall Study|Lack of Efficacy|76
4763215|NCT01635764|16431095|P1|Overall Study|Adverse Event|46
4763216|NCT01635218|16431161|P3|Overall Study|Lost to Follow-up|6
4763217|NCT01635218|16431162|P2|Overall Study|Lost to Follow-up|7
4763218|NCT01635218|16431163|P1|Overall Study|Lost to Follow-up|3
4763219|NCT01635153|16431185|P2|Overall Study|Lost to Follow-up|43
4763220|NCT01635153|16431186|P1|Overall Study|Lost to Follow-up|40
4763221|NCT01634854|16431239|P2|Overall Study|Cesarean delivery|7
4763222|NCT01634854|16431240|P1|Overall Study|Cesarean delivery|2
4763223|NCT01634659|16431260|P2|Period 2 - Second 8 Days of Wear|Physician Decision|0
4763224|NCT01634659|16431261|P1|Period 2 - Second 8 Days of Wear|Physician Decision|1
4763225|NCT01634659|16431260|P2|Period 2 - Second 8 Days of Wear|Adverse Event|0
4763226|NCT01634659|16431261|P1|Period 2 - Second 8 Days of Wear|Adverse Event|2
4763227|NCT01634555|16431291|P1|Overall Study|Physician Decision|1
4763228|NCT01634555|16431291|P1|Overall Study|Adverse Event|3
4763229|NCT01634360|16431302|P2|Overall Study|Study termination by sponsor|44
4763230|NCT01634360|16431303|P1|Overall Study|Study termination by sponsor|18
4763231|NCT01634360|16431302|P2|Overall Study|Other|20
4763232|NCT01634360|16431303|P1|Overall Study|Other|3
4763233|NCT01634360|16431302|P2|Overall Study|Lack of Efficacy|14
4763234|NCT01634360|16431303|P1|Overall Study|Lack of Efficacy|4
4763235|NCT01634360|16431302|P2|Overall Study|Protocol Violation|1
4763236|NCT01634360|16431303|P1|Overall Study|Protocol Violation|1
4763237|NCT01634360|16431302|P2|Overall Study|subject withdrew consent|23
4763238|NCT01634360|16431303|P1|Overall Study|subject withdrew consent|13
4763239|NCT01634360|16431302|P2|Overall Study|Adverse Event|34
4763240|NCT01634360|16431303|P1|Overall Study|Adverse Event|10
4763241|NCT01634243|16431377|P2|Overall Study|Lack of Efficacy|0
4763242|NCT01634243|16431378|P1|Overall Study|Lack of Efficacy|1
4763243|NCT01634243|16431377|P2|Overall Study|Adverse Event|5
4763244|NCT01634243|16431378|P1|Overall Study|Adverse Event|5
4763245|NCT01634165|16431404|P4|Period 2|Adverse Event|0
4763246|NCT01634165|16431405|P3|Period 2|Adverse Event|0
4763247|NCT01634165|16431406|P2|Period 2|Adverse Event|1
4763248|NCT01634165|16431407|P1|Period 2|Adverse Event|0
4763249|NCT01634152|16431440|P3|Overall Study|Other reason not defined above|1
4763250|NCT01634152|16431441|P2|Overall Study|Other reason not defined above|0
4763251|NCT01634152|16431442|P1|Overall Study|Other reason not defined above|1
4763252|NCT01634152|16431440|P3|Overall Study|Not treated|0
4763253|NCT01634152|16431441|P2|Overall Study|Not treated|1
4763254|NCT01634152|16431442|P1|Overall Study|Not treated|0
4763255|NCT01634152|16431440|P3|Overall Study|Consent withdrawn not due to AE|1
4763256|NCT01634152|16431441|P2|Overall Study|Consent withdrawn not due to AE|0
4763257|NCT01634152|16431442|P1|Overall Study|Consent withdrawn not due to AE|1
4763258|NCT01634152|16431440|P3|Overall Study|Adverse Event|2
4763259|NCT01634152|16431441|P2|Overall Study|Adverse Event|0
4763260|NCT01634152|16431442|P1|Overall Study|Adverse Event|2
4763261|NCT01634139|16431525|P3|Overall Study|Not treated|0
4763262|NCT01634139|16431526|P2|Overall Study|Not treated|1
4763263|NCT01634139|16431527|P1|Overall Study|Not treated|1
4763264|NCT01634139|16431525|P3|Overall Study|Lost to Follow-up|0
4763265|NCT01634139|16431526|P2|Overall Study|Lost to Follow-up|2
4763266|NCT01634139|16431527|P1|Overall Study|Lost to Follow-up|0
4763267|NCT01634139|16431525|P3|Overall Study|Other|3
4763268|NCT01634139|16431526|P2|Overall Study|Other|0
4763269|NCT01634139|16431527|P1|Overall Study|Other|4
4763270|NCT01634139|16431525|P3|Overall Study|Consent withdrawn not due to AE|2
4763271|NCT01634139|16431526|P2|Overall Study|Consent withdrawn not due to AE|3
4763272|NCT01634139|16431527|P1|Overall Study|Consent withdrawn not due to AE|4
4763273|NCT01634139|16431525|P3|Overall Study|Non compliant with protocol|0
4763274|NCT01634139|16431526|P2|Overall Study|Non compliant with protocol|0
4763275|NCT01634139|16431527|P1|Overall Study|Non compliant with protocol|1
4763276|NCT01634113|16431628|P3|Overall Study|Not treated|1
4763277|NCT01634113|16431629|P2|Overall Study|Not treated|0
4763278|NCT01634113|16431630|P1|Overall Study|Not treated|0
4763279|NCT01634100|16431674|P6|Overall Study|Withdrawal by Subject|0
4763280|NCT01634100|16431675|P5|Overall Study|Withdrawal by Subject|0
4763281|NCT01634100|16431676|P4|Overall Study|Withdrawal by Subject|0
4763282|NCT01634100|16431677|P3|Overall Study|Withdrawal by Subject|1
4763283|NCT01634100|16431678|P2|Overall Study|Withdrawal by Subject|0
4763284|NCT01634100|16431679|P1|Overall Study|Withdrawal by Subject|1
4763285|NCT01633944|16431695|P3|Double-blind Treatment Phase|Other|0
4763286|NCT01633944|16431696|P2|Double-blind Treatment Phase|Other|7
4763287|NCT01633944|16431697|P1|Double-blind Treatment Phase|Other|0
4763454|NCT01632566|16432062|P4|Overall Study|Withdrawal by Subject|0
4763288|NCT01633944|16431695|P3|Double-blind Treatment Phase|Not exposed to DB study medication|0
4763289|NCT01633944|16431696|P2|Double-blind Treatment Phase|Not exposed to DB study medication|1
4763290|NCT01633944|16431697|P1|Double-blind Treatment Phase|Not exposed to DB study medication|0
4763291|NCT01633944|16431695|P3|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1
4763292|NCT01633944|16431696|P2|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3
4763293|NCT01633944|16431697|P1|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0
4763294|NCT01633944|16431695|P3|Double-blind Treatment Phase|Lost to Follow-up|9
4763295|NCT01633944|16431696|P2|Double-blind Treatment Phase|Lost to Follow-up|4
4763296|NCT01633944|16431697|P1|Double-blind Treatment Phase|Lost to Follow-up|0
4763297|NCT01633944|16431695|P3|Double-blind Treatment Phase|Protocol Violation|10
4763298|NCT01633944|16431696|P2|Double-blind Treatment Phase|Protocol Violation|7
4763299|NCT01633944|16431697|P1|Double-blind Treatment Phase|Protocol Violation|0
4763300|NCT01633944|16431695|P3|Double-blind Treatment Phase|Withdrawal by Subject|8
4763301|NCT01633944|16431696|P2|Double-blind Treatment Phase|Withdrawal by Subject|11
4763302|NCT01633944|16431697|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
4763303|NCT01633944|16431695|P3|Double-blind Treatment Phase|Lack of Efficacy|23
4763304|NCT01633944|16431696|P2|Double-blind Treatment Phase|Lack of Efficacy|8
4763305|NCT01633944|16431697|P1|Double-blind Treatment Phase|Lack of Efficacy|0
4763306|NCT01633944|16431695|P3|Double-blind Treatment Phase|Adverse Event|7
4763307|NCT01633944|16431696|P2|Double-blind Treatment Phase|Adverse Event|13
4763308|NCT01633944|16431697|P1|Double-blind Treatment Phase|Adverse Event|0
4763309|NCT01633944|16431695|P3|Open-label Titration Phase|Other|0
4763310|NCT01633944|16431696|P2|Open-label Titration Phase|Other|0
4763311|NCT01633944|16431697|P1|Open-label Titration Phase|Other|68
4763312|NCT01633944|16431695|P3|Open-label Titration Phase|Lost to Follow-up|0
4763313|NCT01633944|16431696|P2|Open-label Titration Phase|Lost to Follow-up|0
4763314|NCT01633944|16431697|P1|Open-label Titration Phase|Lost to Follow-up|22
4763315|NCT01633944|16431695|P3|Open-label Titration Phase|Protocol Violation|0
4763316|NCT01633944|16431696|P2|Open-label Titration Phase|Protocol Violation|0
4763317|NCT01633944|16431697|P1|Open-label Titration Phase|Protocol Violation|24
4763318|NCT01633944|16431695|P3|Open-label Titration Phase|Withdrawal by Subject|0
4763319|NCT01633944|16431696|P2|Open-label Titration Phase|Withdrawal by Subject|0
4763320|NCT01633944|16431697|P1|Open-label Titration Phase|Withdrawal by Subject|34
4763321|NCT01633944|16431695|P3|Open-label Titration Phase|Lack of Efficacy|0
4763322|NCT01633944|16431696|P2|Open-label Titration Phase|Lack of Efficacy|0
4763323|NCT01633944|16431697|P1|Open-label Titration Phase|Lack of Efficacy|33
4763324|NCT01633944|16431695|P3|Open-label Titration Phase|Adverse Event|0
4763325|NCT01633944|16431696|P2|Open-label Titration Phase|Adverse Event|0
4763326|NCT01633944|16431697|P1|Open-label Titration Phase|Adverse Event|109
4763327|NCT01633788|16431765|P4|Overall Study|Other Reasons|7
4763328|NCT01633788|16431766|P3|Overall Study|Other Reasons|3
4763329|NCT01633788|16431767|P2|Overall Study|Other Reasons|2
4763330|NCT01633788|16431768|P1|Overall Study|Other Reasons|0
4763331|NCT01633788|16431765|P4|Overall Study|Protocol Violation|0
4763332|NCT01633788|16431766|P3|Overall Study|Protocol Violation|1
4763333|NCT01633788|16431767|P2|Overall Study|Protocol Violation|0
4763334|NCT01633788|16431768|P1|Overall Study|Protocol Violation|1
4763335|NCT01633788|16431765|P4|Overall Study|Personal Reasons|3
4763336|NCT01633788|16431766|P3|Overall Study|Personal Reasons|1
4763337|NCT01633788|16431767|P2|Overall Study|Personal Reasons|1
4763338|NCT01633788|16431768|P1|Overall Study|Personal Reasons|3
4763339|NCT01633788|16431765|P4|Overall Study|Lost to Follow-up|0
4763340|NCT01633788|16431766|P3|Overall Study|Lost to Follow-up|2
4763341|NCT01633788|16431767|P2|Overall Study|Lost to Follow-up|2
4763342|NCT01633788|16431768|P1|Overall Study|Lost to Follow-up|2
4763343|NCT01633788|16431765|P4|Overall Study|Adverse Event|3
4763344|NCT01633788|16431766|P3|Overall Study|Adverse Event|3
4763345|NCT01633788|16431767|P2|Overall Study|Adverse Event|3
4763346|NCT01633788|16431768|P1|Overall Study|Adverse Event|1
4763347|NCT01633112|16431800|P3|Overall Study|missing Study Completion CRF|4
4763348|NCT01633112|16431801|P2|Overall Study|missing Study Completion CRF|1
4763349|NCT01633112|16431802|P1|Overall Study|missing Study Completion CRF|1
4763350|NCT01633112|16431800|P3|Overall Study|Withdrawal by Subject|41
4763351|NCT01633112|16431801|P2|Overall Study|Withdrawal by Subject|12
4763352|NCT01633112|16431802|P1|Overall Study|Withdrawal by Subject|20
4763353|NCT01633112|16431800|P3|Overall Study|Subject no longer requires study drug|1
4763354|NCT01633112|16431801|P2|Overall Study|Subject no longer requires study drug|0
4763355|NCT01633112|16431802|P1|Overall Study|Subject no longer requires study drug|0
4763356|NCT01633112|16431800|P3|Overall Study|Protocol Violation|2
4763357|NCT01633112|16431801|P2|Overall Study|Protocol Violation|0
4763358|NCT01633112|16431802|P1|Overall Study|Protocol Violation|4
4763359|NCT01633112|16431800|P3|Overall Study|Lost to Follow-up|6
4763360|NCT01633112|16431801|P2|Overall Study|Lost to Follow-up|19
4763361|NCT01633112|16431802|P1|Overall Study|Lost to Follow-up|7
4763362|NCT01633112|16431800|P3|Overall Study|Adverse Event|20
4763363|NCT01633112|16431801|P2|Overall Study|Adverse Event|18
4763364|NCT01633112|16431802|P1|Overall Study|Adverse Event|16
4763365|NCT01633112|16431800|P3|Overall Study|Administrative problems|5
4763366|NCT01633112|16431801|P2|Overall Study|Administrative problems|2
4763367|NCT01633112|16431802|P1|Overall Study|Administrative problems|1
4763368|NCT01633112|16431800|P3|Overall Study|Abnormal test procedure result(s)|0
4763369|NCT01633112|16431801|P2|Overall Study|Abnormal test procedure result(s)|1
4763370|NCT01633112|16431802|P1|Overall Study|Abnormal test procedure result(s)|0
4763371|NCT01633112|16431800|P3|Overall Study|Abnormal laboratory value(s)|0
4763372|NCT01633112|16431801|P2|Overall Study|Abnormal laboratory value(s)|1
4763373|NCT01633112|16431802|P1|Overall Study|Abnormal laboratory value(s)|3
4763374|NCT01633112|16431800|P3|Overall Study|Lack of Efficacy|13
4763375|NCT01633112|16431801|P2|Overall Study|Lack of Efficacy|6
4763376|NCT01633112|16431802|P1|Overall Study|Lack of Efficacy|1
4763377|NCT01633060|16431837|P2|Post-Treatment Efficacy Follow-Up Phase|Death|0
4763378|NCT01633060|16431838|P1|Post-Treatment Efficacy Follow-Up Phase|Death|1
4763379|NCT01633060|16431837|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
4763380|NCT01633060|16431838|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
4763381|NCT01633060|16431837|P2|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0
4763382|NCT01633060|16431838|P1|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1
4763383|NCT01633060|16431837|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1
4763384|NCT01633060|16431838|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10
4763385|NCT01633060|16431837|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0
4763386|NCT01633060|16431838|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1
4763387|NCT01633060|16431837|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4763388|NCT01633060|16431838|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
4763389|NCT01633060|16431837|P2|Treatment Phase|Death|3
4763390|NCT01633060|16431838|P1|Treatment Phase|Death|4
4763391|NCT01633060|16431837|P2|Treatment Phase|Subject/guardian decision|4
4763392|NCT01633060|16431838|P1|Treatment Phase|Subject/guardian decision|25
4763393|NCT01633060|16431837|P2|Treatment Phase|Study Terminated by sponsor|3
4763394|NCT01633060|16431838|P1|Treatment Phase|Study Terminated by sponsor|7
4763395|NCT01633060|16431837|P2|Treatment Phase|Protocol Deviation|0
4763396|NCT01633060|16431838|P1|Treatment Phase|Protocol Deviation|1
4763397|NCT01633060|16431837|P2|Treatment Phase|Progressive Disease|120
4763398|NCT01633060|16431838|P1|Treatment Phase|Progressive Disease|210
4763399|NCT01633060|16431837|P2|Treatment Phase|Physician Decision|7
4763400|NCT01633060|16431838|P1|Treatment Phase|Physician Decision|16
4763401|NCT01633060|16431837|P2|Treatment Phase|Lost to Follow-up|0
4763402|NCT01633060|16431838|P1|Treatment Phase|Lost to Follow-up|1
4763403|NCT01633060|16431837|P2|Treatment Phase|Adverse Event|3
4763404|NCT01633060|16431838|P1|Treatment Phase|Adverse Event|24
4763405|NCT01633060|16431837|P2|Randomization Phase|Technical problem|1
4763406|NCT01633060|16431838|P1|Randomization Phase|Technical problem|0
4763407|NCT01633060|16431837|P2|Randomization Phase|Protocol deviation|2
4763408|NCT01633060|16431838|P1|Randomization Phase|Protocol deviation|1
4763409|NCT01632904|16431878|P2|Overall Study|Reason for discontinuation not available|1
4763410|NCT01632904|16431879|P1|Overall Study|Reason for discontinuation not available|0
4763411|NCT01632904|16431878|P2|Overall Study|Disease Progression|1
4763412|NCT01632904|16431879|P1|Overall Study|Disease Progression|0
4763413|NCT01632904|16431878|P2|Overall Study|Subject decision|2
4763414|NCT01632904|16431879|P1|Overall Study|Subject decision|3
4763415|NCT01632904|16431878|P2|Overall Study|Physician Decision|1
4763416|NCT01632904|16431879|P1|Overall Study|Physician Decision|0
4763417|NCT01632904|16431878|P2|Overall Study|Adverse Event|1
4763418|NCT01632904|16431879|P1|Overall Study|Adverse Event|4
4763419|NCT01632891|16431890|P2|Overall Study|Withdrawal by Subject|0
4763420|NCT01632891|16431891|P1|Overall Study|Withdrawal by Subject|1
4763421|NCT01632891|16431890|P2|Overall Study|Lost to Follow-up|1
4763422|NCT01632891|16431891|P1|Overall Study|Lost to Follow-up|0
4763423|NCT01632878|16431915|P1|Treatment|no information on study completion|43
4763424|NCT01632878|16431915|P1|Treatment|missing information|4
4763425|NCT01632878|16431915|P1|Treatment|Physician Decision|34
4763426|NCT01632878|16431915|P1|Treatment|Withdrawal by Subject|36
4763427|NCT01632878|16431915|P1|Treatment|Lost to Follow-up|41
4763428|NCT01632878|16431915|P1|Screening|Physician Decision|268
4763429|NCT01632800|16431919|P1|Overall Study|Subject did not fit in apparatus|1
4763430|NCT01632579|16431986|P9|Period 2 (Second Intervention)|Adverse Event|0
4763431|NCT01632579|16431987|P8|Period 2 (Second Intervention)|Adverse Event|0
4763432|NCT01632579|16431988|P7|Period 2 (Second Intervention)|Adverse Event|0
4763433|NCT01632579|16431989|P6|Period 2 (Second Intervention)|Adverse Event|0
4763434|NCT01632579|16431990|P5|Period 2 (Second Intervention)|Adverse Event|0
4763435|NCT01632579|16431991|P4|Period 2 (Second Intervention)|Adverse Event|0
4763436|NCT01632579|16431992|P3|Period 2 (Second Intervention)|Adverse Event|0
4763437|NCT01632579|16431993|P2|Period 2 (Second Intervention)|Adverse Event|0
4763438|NCT01632579|16431994|P1|Period 2 (Second Intervention)|Adverse Event|1
4763439|NCT01632579|16431986|P9|Washout Period|Adverse Event|0
4763440|NCT01632579|16431987|P8|Washout Period|Adverse Event|0
4763441|NCT01632579|16431988|P7|Washout Period|Adverse Event|0
4763442|NCT01632579|16431989|P6|Washout Period|Adverse Event|0
4763443|NCT01632579|16431990|P5|Washout Period|Adverse Event|0
4763444|NCT01632579|16431991|P4|Washout Period|Adverse Event|0
4763445|NCT01632579|16431992|P3|Washout Period|Adverse Event|0
4763446|NCT01632579|16431993|P2|Washout Period|Adverse Event|0
4763447|NCT01632579|16431994|P1|Washout Period|Adverse Event|1
4763448|NCT01632566|16432061|P5|Overall Study|Sponsor Decision|2
4763449|NCT01632566|16432062|P4|Overall Study|Sponsor Decision|2
4763450|NCT01632566|16432063|P3|Overall Study|Sponsor Decision|9
4763451|NCT01632566|16432064|P2|Overall Study|Sponsor Decision|2
4763452|NCT01632566|16432065|P1|Overall Study|Sponsor Decision|0
4763453|NCT01632566|16432061|P5|Overall Study|Withdrawal by Subject|0
4763455|NCT01632566|16432063|P3|Overall Study|Withdrawal by Subject|0
4763456|NCT01632566|16432064|P2|Overall Study|Withdrawal by Subject|1
4763457|NCT01632566|16432065|P1|Overall Study|Withdrawal by Subject|0
4763458|NCT01632345|16432116|P7|Treatment: Part II|Withdrawal by Subject|2
4763459|NCT01632345|16432117|P6|Treatment: Part II|Withdrawal by Subject|2
4763460|NCT01632345|16432118|P5|Treatment: Part II|Withdrawal by Subject|0
4763461|NCT01632345|16432119|P4|Treatment: Part II|Withdrawal by Subject|0
4763462|NCT01632345|16432120|P3|Treatment: Part II|Withdrawal by Subject|0
4763463|NCT01632345|16432121|P2|Treatment: Part II|Withdrawal by Subject|0
4763464|NCT01632345|16432122|P1|Treatment: Part II|Withdrawal by Subject|0
4763465|NCT01632345|16432116|P7|Treatment: Part II|Non-Compliance with Study Drug|0
4763466|NCT01632345|16432117|P6|Treatment: Part II|Non-Compliance with Study Drug|3
4763467|NCT01632345|16432118|P5|Treatment: Part II|Non-Compliance with Study Drug|0
4763468|NCT01632345|16432119|P4|Treatment: Part II|Non-Compliance with Study Drug|0
4763469|NCT01632345|16432120|P3|Treatment: Part II|Non-Compliance with Study Drug|0
4763470|NCT01632345|16432121|P2|Treatment: Part II|Non-Compliance with Study Drug|0
4763471|NCT01632345|16432122|P1|Treatment: Part II|Non-Compliance with Study Drug|0
4763472|NCT01632345|16432116|P7|Treatment: Part II|Lost to Follow-up|1
4763473|NCT01632345|16432117|P6|Treatment: Part II|Lost to Follow-up|3
4763474|NCT01632345|16432118|P5|Treatment: Part II|Lost to Follow-up|0
4763475|NCT01632345|16432119|P4|Treatment: Part II|Lost to Follow-up|0
4763476|NCT01632345|16432120|P3|Treatment: Part II|Lost to Follow-up|0
4763477|NCT01632345|16432121|P2|Treatment: Part II|Lost to Follow-up|0
4763478|NCT01632345|16432122|P1|Treatment: Part II|Lost to Follow-up|0
4763479|NCT01632345|16432116|P7|Treatment: Part II|Adverse Event|8
4763480|NCT01632345|16432117|P6|Treatment: Part II|Adverse Event|3
4763481|NCT01632345|16432118|P5|Treatment: Part II|Adverse Event|0
4763482|NCT01632345|16432119|P4|Treatment: Part II|Adverse Event|0
4763483|NCT01632345|16432120|P3|Treatment: Part II|Adverse Event|0
4763484|NCT01632345|16432121|P2|Treatment: Part II|Adverse Event|0
4763485|NCT01632345|16432122|P1|Treatment: Part II|Adverse Event|0
4763486|NCT01632345|16432116|P7|Treatment: Part I|Withdrawal by Subject|0
4763487|NCT01632345|16432117|P6|Treatment: Part I|Withdrawal by Subject|0
4763488|NCT01632345|16432118|P5|Treatment: Part I|Withdrawal by Subject|4
4763489|NCT01632345|16432119|P4|Treatment: Part I|Withdrawal by Subject|1
4763490|NCT01632345|16432120|P3|Treatment: Part I|Withdrawal by Subject|4
4763491|NCT01632345|16432121|P2|Treatment: Part I|Withdrawal by Subject|4
4763492|NCT01632345|16432122|P1|Treatment: Part I|Withdrawal by Subject|3
4763493|NCT01632345|16432116|P7|Treatment: Part I|Protocol Deviation|0
4763494|NCT01632345|16432117|P6|Treatment: Part I|Protocol Deviation|0
4763495|NCT01632345|16432118|P5|Treatment: Part I|Protocol Deviation|0
4763496|NCT01632345|16432119|P4|Treatment: Part I|Protocol Deviation|1
4763497|NCT01632345|16432120|P3|Treatment: Part I|Protocol Deviation|1
4763498|NCT01632345|16432121|P2|Treatment: Part I|Protocol Deviation|0
4763499|NCT01632345|16432122|P1|Treatment: Part I|Protocol Deviation|0
4763500|NCT01632345|16432116|P7|Treatment: Part I|Pregnancy|0
4763501|NCT01632345|16432117|P6|Treatment: Part I|Pregnancy|0
4763502|NCT01632345|16432118|P5|Treatment: Part I|Pregnancy|0
4763503|NCT01632345|16432119|P4|Treatment: Part I|Pregnancy|0
4763504|NCT01632345|16432120|P3|Treatment: Part I|Pregnancy|0
4763505|NCT01632345|16432121|P2|Treatment: Part I|Pregnancy|1
4763506|NCT01632345|16432122|P1|Treatment: Part I|Pregnancy|0
4763507|NCT01632345|16432116|P7|Treatment: Part I|Physician Decision|0
4763508|NCT01632345|16432117|P6|Treatment: Part I|Physician Decision|0
4763509|NCT01632345|16432118|P5|Treatment: Part I|Physician Decision|1
4763510|NCT01632345|16432119|P4|Treatment: Part I|Physician Decision|0
4763511|NCT01632345|16432120|P3|Treatment: Part I|Physician Decision|0
4763512|NCT01632345|16432121|P2|Treatment: Part I|Physician Decision|1
4763513|NCT01632345|16432122|P1|Treatment: Part I|Physician Decision|2
4763514|NCT01632345|16432116|P7|Treatment: Part I|Non-Compliance with Study Drug|0
4763515|NCT01632345|16432117|P6|Treatment: Part I|Non-Compliance with Study Drug|0
4763516|NCT01632345|16432118|P5|Treatment: Part I|Non-Compliance with Study Drug|0
4763517|NCT01632345|16432119|P4|Treatment: Part I|Non-Compliance with Study Drug|1
4763518|NCT01632345|16432120|P3|Treatment: Part I|Non-Compliance with Study Drug|2
4763519|NCT01632345|16432121|P2|Treatment: Part I|Non-Compliance with Study Drug|2
4763520|NCT01632345|16432122|P1|Treatment: Part I|Non-Compliance with Study Drug|3
4763521|NCT01632345|16432116|P7|Treatment: Part I|Lost to Follow-up|0
4763522|NCT01632345|16432117|P6|Treatment: Part I|Lost to Follow-up|0
4763523|NCT01632345|16432118|P5|Treatment: Part I|Lost to Follow-up|4
4763524|NCT01632345|16432119|P4|Treatment: Part I|Lost to Follow-up|3
4763525|NCT01632345|16432120|P3|Treatment: Part I|Lost to Follow-up|1
4763526|NCT01632345|16432121|P2|Treatment: Part I|Lost to Follow-up|2
4763527|NCT01632345|16432122|P1|Treatment: Part I|Lost to Follow-up|3
4763528|NCT01632345|16432116|P7|Treatment: Part I|Lack of Efficacy|0
4763529|NCT01632345|16432117|P6|Treatment: Part I|Lack of Efficacy|0
4763530|NCT01632345|16432118|P5|Treatment: Part I|Lack of Efficacy|1
4763531|NCT01632345|16432119|P4|Treatment: Part I|Lack of Efficacy|1
4763532|NCT01632345|16432120|P3|Treatment: Part I|Lack of Efficacy|0
4763533|NCT01632345|16432121|P2|Treatment: Part I|Lack of Efficacy|1
4763534|NCT01632345|16432122|P1|Treatment: Part I|Lack of Efficacy|0
4763535|NCT01632345|16432116|P7|Treatment: Part I|Adverse Event|0
4763536|NCT01632345|16432117|P6|Treatment: Part I|Adverse Event|0
4763537|NCT01632345|16432118|P5|Treatment: Part I|Adverse Event|3
4763538|NCT01632345|16432119|P4|Treatment: Part I|Adverse Event|1
4763539|NCT01632345|16432120|P3|Treatment: Part I|Adverse Event|2
4763540|NCT01632345|16432121|P2|Treatment: Part I|Adverse Event|4
4763541|NCT01632345|16432122|P1|Treatment: Part I|Adverse Event|1
4763542|NCT01632306|16432184|P3|Overall Study|Protocol Violation|0
4763543|NCT01632306|16432185|P2|Overall Study|Protocol Violation|0
4763544|NCT01632306|16432186|P1|Overall Study|Protocol Violation|1
4763545|NCT01632280|16432202|P2|Overall Study|Withdrawal by Subject|0
4763546|NCT01632280|16432203|P1|Overall Study|Withdrawal by Subject|1
4763547|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Adverse Event|0
4763548|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Adverse Event|1
4763549|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Lack of Efficacy|2
4763550|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Lack of Efficacy|0
4763551|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Protocol Violation|2
4763552|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Protocol Violation|0
4763553|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Site Closed|8
4763554|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Site Closed|2
4763555|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Lost to Follow-up|4
4763556|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Lost to Follow-up|1
4763557|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Physician Decision|4
4763558|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Physician Decision|1
4763559|NCT01632241|16432219|P2|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2
4763560|NCT01632241|16432220|P1|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5
4763561|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Adverse Event|19
4763562|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Adverse Event|10
4763563|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Withdrawal by Subject|14
4763564|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Withdrawal by Subject|10
4763565|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Lack of Efficacy|15
4763566|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Lack of Efficacy|9
4763567|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Physician Decision|12
4763568|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Physician Decision|9
4763569|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Lost to Follow-up|8
4763570|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Lost to Follow-up|1
4763571|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Protocol Violation|6
4763572|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Protocol Violation|2
4763573|NCT01632241|16432219|P2|Double-blinded (Up to Week 52)|Site Closed|5
4763574|NCT01632241|16432220|P1|Double-blinded (Up to Week 52)|Site Closed|3
4763575|NCT01632150|16432279|P1|Overall Study|Moved to compassionate program|2
4763576|NCT01632150|16432279|P1|Overall Study|Patient underwent autologous transplant|1
4763577|NCT01632150|16432279|P1|Overall Study|Withdrawal by Subject|2
4763578|NCT01632150|16432279|P1|Overall Study|Unrelated adverse event|7
4763579|NCT01632150|16432279|P1|Overall Study|Study drug toxicity|1
4763580|NCT01632150|16432279|P1|Overall Study|Disease progression|27
4763581|NCT01632020|16432288|P2|Overall Study|Adverse Event|0
4763582|NCT01632020|16432289|P1|Overall Study|Adverse Event|1
4763583|NCT01632020|16432288|P2|Overall Study|Withdrawal by Subject|0
4763584|NCT01632020|16432289|P1|Overall Study|Withdrawal by Subject|1
4763585|NCT01631864|16432308|P2|Overall Study|Adverse Event|3
4763586|NCT01631864|16432309|P1|Overall Study|Adverse Event|2
4763587|NCT01631864|16432308|P2|Overall Study|Withdrawal by Subject|1
4763588|NCT01631864|16432309|P1|Overall Study|Withdrawal by Subject|0
4763589|NCT01631825|16432321|P1|Overall Study|Physician Decision|2
4763590|NCT01631825|16432321|P1|Overall Study|Discontinuation criteria|1
4763591|NCT01631825|16432321|P1|Overall Study|Protocol Violation|4
4763592|NCT01631825|16432321|P1|Overall Study|Withdrawal by Subject|9
4763593|NCT01631825|16432321|P1|Overall Study|Lack of Efficacy|7
4763594|NCT01631825|16432321|P1|Overall Study|Adverse Event|42
4763595|NCT01631812|16432341|P1|Overall Study|Physician Decision|3
4763596|NCT01631812|16432341|P1|Overall Study|Withdrawal by Subject|4
4763597|NCT01631812|16432341|P1|Overall Study|Lack of Efficacy|5
4763598|NCT01631812|16432341|P1|Overall Study|Adverse Event|25
4763599|NCT01631747|16432351|P2|One Year Infant Outcomes|Patient Refused|9
4763600|NCT01631747|16432352|P1|One Year Infant Outcomes|Patient Refused|13
4763601|NCT01631747|16432351|P2|Live Birth|Stillbirth|1
4763602|NCT01631747|16432352|P1|Live Birth|Stillbirth|1
4763603|NCT01631747|16432351|P2|Live Birth|MIscarriage|0
4763604|NCT01631747|16432352|P1|Live Birth|MIscarriage|2
4763605|NCT01631747|16432351|P2|Live Birth|Pregnancy Termination|0
4763606|NCT01631747|16432352|P1|Live Birth|Pregnancy Termination|1
4763607|NCT01631747|16432351|P2|Randomization Through End of Pregnancy|Lost to Follow-up|0
4763608|NCT01631747|16432352|P1|Randomization Through End of Pregnancy|Lost to Follow-up|1
4763609|NCT01631435|16432529|P1|Overall Study|incomplete study procedure|5
4763610|NCT01631435|16432529|P1|Overall Study|Withdrawal by Subject|2
4763611|NCT01631435|16432529|P1|Overall Study|Adverse Event|2
4763612|NCT01631227|16432543|P2|Overall Study|administrative|1
4763613|NCT01631227|16432544|P1|Overall Study|administrative|2
4763614|NCT01631227|16432543|P2|Overall Study|Adverse Event|0
4763615|NCT01631227|16432544|P1|Overall Study|Adverse Event|1
4763616|NCT01631227|16432543|P2|Overall Study|withdrawn consent|21
4763617|NCT01631227|16432544|P1|Overall Study|withdrawn consent|27
4763618|NCT01631214|16432552|P2|Overall Study|Administrative Decision|0
4763619|NCT01631214|16432553|P1|Overall Study|Administrative Decision|1
4763620|NCT01631214|16432552|P2|Overall Study|Ineligibility determined|2
4763621|NCT01631214|16432553|P1|Overall Study|Ineligibility determined|5
4763622|NCT01631214|16432552|P2|Overall Study|Protocol Deviation|3
4763623|NCT01631214|16432553|P1|Overall Study|Protocol Deviation|4
4763624|NCT01631214|16432552|P2|Overall Study|Requirement for Alternative Therapy|3
4763625|NCT01631214|16432553|P1|Overall Study|Requirement for Alternative Therapy|8
4763626|NCT01631214|16432552|P2|Overall Study|Noncompliance|15
4763627|NCT01631214|16432553|P1|Overall Study|Noncompliance|16
4763628|NCT01631214|16432552|P2|Overall Study|Other|19
4763629|NCT01631214|16432553|P1|Overall Study|Other|22
4763630|NCT01631214|16432552|P2|Overall Study|Adverse Event|45
4763631|NCT01631214|16432553|P1|Overall Study|Adverse Event|45
4763632|NCT01631214|16432552|P2|Overall Study|Lost to Follow-up|40
4763633|NCT01631214|16432553|P1|Overall Study|Lost to Follow-up|54
4763634|NCT01631214|16432552|P2|Overall Study|Death|106
4763635|NCT01631214|16432553|P1|Overall Study|Death|113
4763636|NCT01631214|16432552|P2|Overall Study|Withdrawal by Subject|290
4763637|NCT01631214|16432553|P1|Overall Study|Withdrawal by Subject|276
4763638|NCT01630811|16432662|P2|Second Intervention (8 Weeks)|Withdrawal by Subject|0
4763639|NCT01630811|16432663|P1|Second Intervention (8 Weeks)|Withdrawal by Subject|1
4763640|NCT01630616|16432690|P6|Overall Study|Withdrawal by Subject|0
4763641|NCT01630616|16432691|P5|Overall Study|Withdrawal by Subject|0
4763642|NCT01630616|16432692|P4|Overall Study|Withdrawal by Subject|2
4763643|NCT01630616|16432693|P3|Overall Study|Withdrawal by Subject|0
4763644|NCT01630616|16432694|P2|Overall Study|Withdrawal by Subject|0
4763645|NCT01630616|16432695|P1|Overall Study|Withdrawal by Subject|0
4763646|NCT01630616|16432690|P6|Overall Study|Adverse Event|0
4763647|NCT01630616|16432691|P5|Overall Study|Adverse Event|0
4763648|NCT01630616|16432692|P4|Overall Study|Adverse Event|1
4763649|NCT01630616|16432693|P3|Overall Study|Adverse Event|0
4763650|NCT01630616|16432694|P2|Overall Study|Adverse Event|0
4763651|NCT01630616|16432695|P1|Overall Study|Adverse Event|0
4763652|NCT01630135|16432795|P2|Overall Study|Protocol-defined Stopping Criteria Met|2
4763653|NCT01630135|16432796|P1|Overall Study|Protocol-defined Stopping Criteria Met|0
4763654|NCT01629966|16432860|P3|Overall Study|Adverse Event|30
4763655|NCT01629966|16432861|P2|Overall Study|Adverse Event|18
4763656|NCT01629966|16432862|P1|Overall Study|Adverse Event|11
4763657|NCT01629966|16432860|P3|Overall Study|Lack of Efficacy|4
4763658|NCT01629966|16432861|P2|Overall Study|Lack of Efficacy|2
4763659|NCT01629966|16432862|P1|Overall Study|Lack of Efficacy|5
4763660|NCT01629966|16432860|P3|Overall Study|Protocol Violation|7
4763661|NCT01629966|16432861|P2|Overall Study|Protocol Violation|9
4763662|NCT01629966|16432862|P1|Overall Study|Protocol Violation|7
4763663|NCT01629966|16432860|P3|Overall Study|Withdrawal by Subject|16
4763664|NCT01629966|16432861|P2|Overall Study|Withdrawal by Subject|9
4763665|NCT01629966|16432862|P1|Overall Study|Withdrawal by Subject|8
4763666|NCT01629966|16432860|P3|Overall Study|Lost to Follow-up|9
4763667|NCT01629966|16432861|P2|Overall Study|Lost to Follow-up|13
4763668|NCT01629966|16432862|P1|Overall Study|Lost to Follow-up|10
4763669|NCT01629966|16432860|P3|Overall Study|Pregnancy|0
4763670|NCT01629966|16432861|P2|Overall Study|Pregnancy|1
4763671|NCT01629966|16432862|P1|Overall Study|Pregnancy|0
4763672|NCT01629953|16432875|P2|Overall Study|Lost to Follow-up|14
4763673|NCT01629953|16432876|P1|Overall Study|Lost to Follow-up|10
4763674|NCT01629953|16432875|P2|Overall Study|Death|1
4763675|NCT01629953|16432876|P1|Overall Study|Death|3
4763676|NCT01629823|16432896|P3|Washout Period|Protocol Violation|0
4763677|NCT01629823|16432897|P2|Washout Period|Protocol Violation|1
4763678|NCT01629823|16432898|P1|Washout Period|Protocol Violation|0
4763679|NCT01629823|16432896|P3|Washout Period|Pregnancy|0
4763680|NCT01629823|16432897|P2|Washout Period|Pregnancy|0
4763681|NCT01629823|16432898|P1|Washout Period|Pregnancy|1
4763682|NCT01629823|16432896|P3|Washout Period|Safety|0
4763683|NCT01629823|16432897|P2|Washout Period|Safety|5
4763684|NCT01629823|16432898|P1|Washout Period|Safety|2
4763685|NCT01629823|16432896|P3|Trial Period|Failed to hold medication|1
4763686|NCT01629823|16432897|P2|Trial Period|Failed to hold medication|0
4763687|NCT01629823|16432898|P1|Trial Period|Failed to hold medication|0
4763688|NCT01629823|16432896|P3|Trial Period|Out-of-window visit|0
4763689|NCT01629823|16432897|P2|Trial Period|Out-of-window visit|2
4763690|NCT01629823|16432898|P1|Trial Period|Out-of-window visit|0
4763691|NCT01629823|16432896|P3|Trial Period|Adverse Event|0
4763692|NCT01629823|16432897|P2|Trial Period|Adverse Event|1
4763693|NCT01629823|16432898|P1|Trial Period|Adverse Event|0
4763694|NCT01629823|16432896|P3|Trial Period|Pregnancy|0
4763695|NCT01629823|16432897|P2|Trial Period|Pregnancy|0
4763696|NCT01629823|16432898|P1|Trial Period|Pregnancy|1
4763697|NCT01629823|16432896|P3|Trial Period|Pre-diluent FEV₁ predicted <70%|1
4763698|NCT01629823|16432897|P2|Trial Period|Pre-diluent FEV₁ predicted <70%|1
4763699|NCT01629823|16432898|P1|Trial Period|Pre-diluent FEV₁ predicted <70%|1
4763700|NCT01629823|16432896|P3|Trial Period|Missed visit|8
4763701|NCT01629823|16432897|P2|Trial Period|Missed visit|9
4763702|NCT01629823|16432898|P1|Trial Period|Missed visit|11
4763703|NCT01629706|16432933|P1|Phase 2 Habitual|Lost to Follow Up after Dispense|1
4763704|NCT01629706|16432933|P1|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1
4763705|NCT01629706|16432933|P1|Phase 2 Habitual|Relocation prior to Dispense|1
4763706|NCT01629706|16432933|P1|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1
4763707|NCT01629706|16432933|P1|Phase 2 Habitual|Screen Failure|6
4763708|NCT01629706|16432933|P1|Phase 1 PureVision|No Solution-Induced Corneal Staining|3
4763709|NCT01629706|16432933|P1|Phase 1 PureVision|Inconvenience prior to Dispense|1
4763710|NCT01629706|16432933|P1|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1
4763711|NCT01629706|16432933|P1|Phase 1 PureVision|Screen Failure|4
4763712|NCT01629693|16432961|P2|Overall Study|Subject decision unrelated to AE|1
4763713|NCT01629693|16432962|P1|Overall Study|Subject decision unrelated to AE|0
4763714|NCT01629693|16432961|P2|Overall Study|Poor comfort of study lenses|2
4763715|NCT01629693|16432962|P1|Overall Study|Poor comfort of study lenses|0
4763716|NCT01629693|16432961|P2|Overall Study|Investigator decision|1
4763717|NCT01629693|16432962|P1|Overall Study|Investigator decision|0
4763718|NCT01629693|16432961|P2|Overall Study|Adverse Event|0
4763719|NCT01629693|16432962|P1|Overall Study|Adverse Event|1
4763720|NCT01629693|16432961|P2|Overall Study|Withdrawal by Subject|2
4763721|NCT01629693|16432962|P1|Overall Study|Withdrawal by Subject|2
4763722|NCT01629693|16432961|P2|Overall Study|Lost to Follow-up|4
4763723|NCT01629693|16432962|P1|Overall Study|Lost to Follow-up|2
4763724|NCT01629667|16432971|P3|Overall Study|Code break|0
4763725|NCT01629667|16432972|P2|Overall Study|Code break|0
4763726|NCT01629667|16432973|P1|Overall Study|Code break|1
4763727|NCT01629667|16432971|P3|Overall Study|Enrolled in another clinical study|0
4763728|NCT01629667|16432972|P2|Overall Study|Enrolled in another clinical study|1
4763729|NCT01629667|16432973|P1|Overall Study|Enrolled in another clinical study|0
4763730|NCT01629667|16432971|P3|Overall Study|Site error in safety follow-up|1
4763731|NCT01629667|16432972|P2|Overall Study|Site error in safety follow-up|0
4763732|NCT01629667|16432973|P1|Overall Study|Site error in safety follow-up|0
4763733|NCT01629667|16432971|P3|Overall Study|Started other medicine|1
4763734|NCT01629667|16432972|P2|Overall Study|Started other medicine|0
4763735|NCT01629667|16432973|P1|Overall Study|Started other medicine|1
4763736|NCT01629667|16432971|P3|Overall Study|Early tretmt termntd, cmpltd safety f-up|8
4763737|NCT01629667|16432972|P2|Overall Study|Early tretmt termntd, cmpltd safety f-up|11
4763738|NCT01629667|16432973|P1|Overall Study|Early tretmt termntd, cmpltd safety f-up|9
4763739|NCT01629667|16432971|P3|Overall Study|Requiring lung transplant|3
4763740|NCT01629667|16432972|P2|Overall Study|Requiring lung transplant|1
4763741|NCT01629667|16432973|P1|Overall Study|Requiring lung transplant|2
4763742|NCT01629667|16432971|P3|Overall Study|Ongoing AE worsening right heart failure|0
4763743|NCT01629667|16432972|P2|Overall Study|Ongoing AE worsening right heart failure|1
4763744|NCT01629667|16432973|P1|Overall Study|Ongoing AE worsening right heart failure|0
4763745|NCT01629667|16432971|P3|Overall Study|Randomized, not treated|0
4763746|NCT01629667|16432972|P2|Overall Study|Randomized, not treated|1
4763747|NCT01629667|16432973|P1|Overall Study|Randomized, not treated|2
4763748|NCT01629667|16432971|P3|Overall Study|Death|3
4763749|NCT01629667|16432972|P2|Overall Study|Death|5
4763750|NCT01629667|16432973|P1|Overall Study|Death|1
4763751|NCT01629667|16432971|P3|Overall Study|Withdrawal by Subject|28
4763752|NCT01629667|16432972|P2|Overall Study|Withdrawal by Subject|20
4763753|NCT01629667|16432973|P1|Overall Study|Withdrawal by Subject|31
4763754|NCT01629667|16432971|P3|Overall Study|Lost to Follow-up|1
4763755|NCT01629667|16432972|P2|Overall Study|Lost to Follow-up|1
4763756|NCT01629667|16432973|P1|Overall Study|Lost to Follow-up|0
4763757|NCT01629589|16433057|P2|Overall Study|Did not receive study vaccine|1
4763758|NCT01629589|16433058|P1|Overall Study|Did not receive study vaccine|0
4763759|NCT01629589|16433057|P2|Overall Study|Withdrawal by Subject|3
4763760|NCT01629589|16433058|P1|Overall Study|Withdrawal by Subject|2
4763761|NCT01629589|16433057|P2|Overall Study|Lost to Follow-up|1
4763762|NCT01629589|16433058|P1|Overall Study|Lost to Follow-up|2
4763763|NCT01629589|16433057|P2|Overall Study|Protocol Violation|2
4763764|NCT01629589|16433058|P1|Overall Study|Protocol Violation|4
4763765|NCT01629563|16433076|P2|Overall Study|Protocol Violation|1
4763766|NCT01629563|16433077|P1|Overall Study|Protocol Violation|0
4763767|NCT01629563|16433076|P2|Overall Study|Lack of return of menses|7
4763768|NCT01629563|16433077|P1|Overall Study|Lack of return of menses|12
4763769|NCT01629563|16433076|P2|Overall Study|surgery|3
4763770|NCT01629563|16433077|P1|Overall Study|surgery|0
4763771|NCT01629563|16433076|P2|Overall Study|Withdrawal by Subject|20
4763772|NCT01629563|16433077|P1|Overall Study|Withdrawal by Subject|27
4763773|NCT01629563|16433076|P2|Overall Study|Protocol Violation|1
4763774|NCT01629563|16433077|P1|Overall Study|Protocol Violation|0
4763775|NCT01629563|16433076|P2|Overall Study|Pregnancy|2
4763776|NCT01629563|16433077|P1|Overall Study|Pregnancy|1
4763777|NCT01629563|16433076|P2|Overall Study|Lost to Follow-up|0
4763778|NCT01629563|16433077|P1|Overall Study|Lost to Follow-up|1
4763779|NCT01629563|16433076|P2|Overall Study|Lack of Efficacy|3
4763780|NCT01629563|16433077|P1|Overall Study|Lack of Efficacy|2
4763781|NCT01629563|16433076|P2|Overall Study|Death|0
4763782|NCT01629563|16433077|P1|Overall Study|Death|2
4763783|NCT01629563|16433076|P2|Overall Study|Adverse Event|16
4763784|NCT01629563|16433077|P1|Overall Study|Adverse Event|16
4763785|NCT01628965|16433166|P1|Overall Study|Discontinuation criteria|8
4763786|NCT01628965|16433166|P1|Overall Study|Lost to Follow-up|1
4763787|NCT01628965|16433166|P1|Overall Study|Withdrawal by Subject|3
4763788|NCT01628965|16433166|P1|Overall Study|Lack of Efficacy|7
4763789|NCT01628965|16433166|P1|Overall Study|Adverse Event|30
4763790|NCT01628926|16433175|P3|Overall Study|Physician Decision|1
4763791|NCT01628926|16433176|P2|Overall Study|Physician Decision|2
4763792|NCT01628926|16433177|P1|Overall Study|Physician Decision|2
4763793|NCT01628926|16433175|P3|Overall Study|Discontinuation criteria|0
4763794|NCT01628926|16433176|P2|Overall Study|Discontinuation criteria|4
4763795|NCT01628926|16433177|P1|Overall Study|Discontinuation criteria|3
4763796|NCT01628926|16433175|P3|Overall Study|Protocol Violation|0
4763797|NCT01628926|16433176|P2|Overall Study|Protocol Violation|1
4763798|NCT01628926|16433177|P1|Overall Study|Protocol Violation|0
4763799|NCT01628926|16433175|P3|Overall Study|Withdrawal by Subject|2
4763800|NCT01628926|16433176|P2|Overall Study|Withdrawal by Subject|4
4763801|NCT01628926|16433177|P1|Overall Study|Withdrawal by Subject|6
4763802|NCT01628926|16433175|P3|Overall Study|Lack of Efficacy|5
4763803|NCT01628926|16433176|P2|Overall Study|Lack of Efficacy|1
4763804|NCT01628926|16433177|P1|Overall Study|Lack of Efficacy|2
4763805|NCT01628926|16433175|P3|Overall Study|Adverse Event|9
4763806|NCT01628926|16433176|P2|Overall Study|Adverse Event|11
4763807|NCT01628926|16433177|P1|Overall Study|Adverse Event|13
4763808|NCT01628913|16433226|P2|Overall Study|Physician Decision|3
4763809|NCT01628913|16433227|P1|Overall Study|Physician Decision|1
4763810|NCT01628913|16433226|P2|Overall Study|Withdrawal by Subject|0
4763811|NCT01628913|16433227|P1|Overall Study|Withdrawal by Subject|1
4763812|NCT01628913|16433226|P2|Overall Study|study terminated by Sponsor|9
4763813|NCT01628913|16433227|P1|Overall Study|study terminated by Sponsor|4
4763814|NCT01628913|16433226|P2|Overall Study|Death|0
4763815|NCT01628913|16433227|P1|Overall Study|Death|1
4763816|NCT01628913|16433226|P2|Overall Study|Protocol Violation|0
4763817|NCT01628913|16433227|P1|Overall Study|Protocol Violation|1
4763818|NCT01628913|16433226|P2|Overall Study|Disease Progression|14
4763819|NCT01628913|16433227|P1|Overall Study|Disease Progression|11
4763820|NCT01628913|16433226|P2|Overall Study|Adverse Event|5
4763821|NCT01628913|16433227|P1|Overall Study|Adverse Event|12
4763822|NCT01628874|16433241|P2|Overall Study|Age >4 months|2
4763823|NCT01628874|16433242|P1|Overall Study|Age >4 months|4
4763824|NCT01628874|16433241|P2|Overall Study|Physician Decision|1
4763825|NCT01628874|16433242|P1|Overall Study|Physician Decision|1
4763826|NCT01628848|16433258|P2|Overall Study|Physician Decision|1
4763827|NCT01628848|16433259|P1|Overall Study|Physician Decision|3
4763828|NCT01628848|16433258|P2|Overall Study|Withdrawal by Subject|2
4763829|NCT01628848|16433259|P1|Overall Study|Withdrawal by Subject|0
4763830|NCT01628848|16433258|P2|Overall Study|Lack of Efficacy|4
4763831|NCT01628848|16433259|P1|Overall Study|Lack of Efficacy|0
4763832|NCT01628848|16433258|P2|Overall Study|Adverse Event|7
4763833|NCT01628848|16433259|P1|Overall Study|Adverse Event|9
4763834|NCT01628692|16433302|P6|Overall Study|Completed 12 Week only|1
4763835|NCT01628692|16433303|P5|Overall Study|Completed 12 Week only|0
4763836|NCT01628692|16433304|P4|Overall Study|Completed 12 Week only|0
4763837|NCT01628692|16433305|P3|Overall Study|Completed 12 Week only|0
4763838|NCT01628692|16433306|P2|Overall Study|Completed 12 Week only|0
4763839|NCT01628692|16433307|P1|Overall Study|Completed 12 Week only|0
4763840|NCT01628692|16433302|P6|Overall Study|Administrative reason by sponsor|1
4763841|NCT01628692|16433303|P5|Overall Study|Administrative reason by sponsor|0
4763842|NCT01628692|16433304|P4|Overall Study|Administrative reason by sponsor|0
4763843|NCT01628692|16433305|P3|Overall Study|Administrative reason by sponsor|0
4763844|NCT01628692|16433306|P2|Overall Study|Administrative reason by sponsor|0
4763845|NCT01628692|16433307|P1|Overall Study|Administrative reason by sponsor|0
4763846|NCT01628692|16433302|P6|Overall Study|Poor compliance/noncompliance|0
4763847|NCT01628692|16433303|P5|Overall Study|Poor compliance/noncompliance|0
4763848|NCT01628692|16433304|P4|Overall Study|Poor compliance/noncompliance|0
4763849|NCT01628692|16433305|P3|Overall Study|Poor compliance/noncompliance|0
4763850|NCT01628692|16433306|P2|Overall Study|Poor compliance/noncompliance|0
4763851|NCT01628692|16433307|P1|Overall Study|Poor compliance/noncompliance|1
4763852|NCT01628692|16433302|P6|Overall Study|Death|0
4763853|NCT01628692|16433303|P5|Overall Study|Death|0
4763854|NCT01628692|16433304|P4|Overall Study|Death|0
4763855|NCT01628692|16433305|P3|Overall Study|Death|0
4763856|NCT01628692|16433306|P2|Overall Study|Death|1
4763857|NCT01628692|16433307|P1|Overall Study|Death|0
4763858|NCT01628692|16433302|P6|Overall Study|Withdrawal by Subject|0
4763859|NCT01628692|16433303|P5|Overall Study|Withdrawal by Subject|0
4763860|NCT01628692|16433304|P4|Overall Study|Withdrawal by Subject|0
4763861|NCT01628692|16433305|P3|Overall Study|Withdrawal by Subject|1
4763862|NCT01628692|16433306|P2|Overall Study|Withdrawal by Subject|1
4763863|NCT01628692|16433307|P1|Overall Study|Withdrawal by Subject|0
4763864|NCT01628692|16433302|P6|Overall Study|Adverse Event|0
4763865|NCT01628692|16433303|P5|Overall Study|Adverse Event|0
4763866|NCT01628692|16433304|P4|Overall Study|Adverse Event|0
4763867|NCT01628692|16433305|P3|Overall Study|Adverse Event|2
4763868|NCT01628692|16433306|P2|Overall Study|Adverse Event|0
4763869|NCT01628692|16433307|P1|Overall Study|Adverse Event|2
4763870|NCT01628692|16433302|P6|Overall Study|Lack of Efficacy|7
4763871|NCT01628692|16433303|P5|Overall Study|Lack of Efficacy|4
4763872|NCT01628692|16433304|P4|Overall Study|Lack of Efficacy|1
4763873|NCT01628692|16433305|P3|Overall Study|Lack of Efficacy|5
4763874|NCT01628692|16433306|P2|Overall Study|Lack of Efficacy|4
4763875|NCT01628692|16433307|P1|Overall Study|Lack of Efficacy|4
4763876|NCT01628549|16433377|P4|Overall Study|positive pregnancy test|1
4763877|NCT01628549|16433378|P3|Overall Study|positive pregnancy test|0
4763878|NCT01628549|16433379|P2|Overall Study|positive pregnancy test|0
4763879|NCT01628549|16433380|P1|Overall Study|positive pregnancy test|0
4763880|NCT01628549|16433377|P4|Overall Study|abnormal laboratory test results|0
4763881|NCT01628549|16433378|P3|Overall Study|abnormal laboratory test results|1
4763882|NCT01628549|16433379|P2|Overall Study|abnormal laboratory test results|0
4763883|NCT01628549|16433380|P1|Overall Study|abnormal laboratory test results|0
4763884|NCT01628549|16433377|P4|Overall Study|withdrawn for noncompliance|0
4763885|NCT01628549|16433378|P3|Overall Study|withdrawn for noncompliance|1
4763886|NCT01628549|16433379|P2|Overall Study|withdrawn for noncompliance|2
4763887|NCT01628549|16433380|P1|Overall Study|withdrawn for noncompliance|0
4763888|NCT01628549|16433377|P4|Overall Study|Protocol Violation|0
4763889|NCT01628549|16433378|P3|Overall Study|Protocol Violation|1
4763890|NCT01628549|16433379|P2|Overall Study|Protocol Violation|1
4763891|NCT01628549|16433380|P1|Overall Study|Protocol Violation|2
4763892|NCT01628549|16433377|P4|Overall Study|Withdrawal by Subject|1
4763893|NCT01628549|16433378|P3|Overall Study|Withdrawal by Subject|4
4763894|NCT01628549|16433379|P2|Overall Study|Withdrawal by Subject|4
4763895|NCT01628549|16433380|P1|Overall Study|Withdrawal by Subject|3
4763896|NCT01628549|16433377|P4|Overall Study|Lost to Follow-up|3
4763897|NCT01628549|16433378|P3|Overall Study|Lost to Follow-up|3
4763898|NCT01628549|16433379|P2|Overall Study|Lost to Follow-up|4
4763899|NCT01628549|16433380|P1|Overall Study|Lost to Follow-up|3
4763900|NCT01628549|16433377|P4|Overall Study|Adverse Event|4
4763901|NCT01628549|16433378|P3|Overall Study|Adverse Event|0
4763902|NCT01628549|16433379|P2|Overall Study|Adverse Event|1
4763903|NCT01628549|16433380|P1|Overall Study|Adverse Event|1
4763904|NCT01628510|16433421|P2|Overall Study|Death|1
4763905|NCT01628510|16433422|P1|Overall Study|Death|3
4763906|NCT01628510|16433421|P2|Overall Study|Withdrawal by Subject|4
4763907|NCT01628510|16433422|P1|Overall Study|Withdrawal by Subject|0
4763908|NCT01628367|16433432|P2|Overall Study|Adverse Event|0
4763909|NCT01628367|16433433|P1|Overall Study|Adverse Event|1
4763910|NCT01628198|16433452|P1|Overall Study|Screen failure|1
4763911|NCT01628198|16433452|P1|Overall Study|Withdrawal by Subject|10
4763912|NCT01628198|16433452|P1|Overall Study|Lost to Follow-up|7
4763913|NCT01628120|16433479|P1|Overall Study|Use of Standard of Care|1
4763914|NCT01628120|16433479|P1|Overall Study|Kidney Transplant|2
4763915|NCT01628120|16433479|P1|Overall Study|Moved or Relocated|5
4763916|NCT01628120|16433479|P1|Overall Study|Missed Study Drug More than 2 Weeks|3
4763917|NCT01628120|16433479|P1|Overall Study|Switched Dialysis Method|2
4763918|NCT01628120|16433479|P1|Overall Study|Sponsor Decision|5
4763919|NCT01628120|16433479|P1|Overall Study|Not Treated|3
4763920|NCT01628120|16433479|P1|Overall Study|Non-compliant with Study Procedures|1
4763921|NCT01628120|16433479|P1|Overall Study|Not met Inclusion/Exclusion Criteria|2
4763922|NCT01628120|16433479|P1|Overall Study|Lost to Follow-up|1
4763923|NCT01628120|16433479|P1|Overall Study|Adverse Event|12
4763924|NCT01628120|16433479|P1|Overall Study|Withdrawal by Subject|7
4763925|NCT01628107|16433504|P1|Overall Study|Use of Standard of Care|9
4763926|NCT01628107|16433504|P1|Overall Study|Kidney Transplant|9
4763927|NCT01628107|16433504|P1|Overall Study|Relocated|8
4763928|NCT01628107|16433504|P1|Overall Study|Missed Study Drug More than 2 Weeks|7
4763929|NCT01628107|16433504|P1|Overall Study|Sponsor Decision|11
4763930|NCT01628107|16433504|P1|Overall Study|Not Treated|8
4763931|NCT01628107|16433504|P1|Overall Study|Non-compliant with Study Procedures|10
4763932|NCT01628107|16433504|P1|Overall Study|Not met Inclusion/Exclusion Criteria|1
4763933|NCT01628107|16433504|P1|Overall Study|Physician Decision|2
4763934|NCT01628107|16433504|P1|Overall Study|Adverse Event|33
4763935|NCT01628107|16433504|P1|Overall Study|Lost to Follow-up|4
4763936|NCT01628107|16433504|P1|Overall Study|Withdrawal by Subject|17
4763937|NCT01627899|16433570|P1|Overall Study|Study terminated early by sponsor.|5
4763938|NCT01627860|16433580|P2|Overall Study|Protocol Violation|0
4763939|NCT01627860|16433581|P1|Overall Study|Protocol Violation|1
4763940|NCT01627860|16433580|P2|Overall Study|Seizure frequency doubled|1
4763941|NCT01627860|16433581|P1|Overall Study|Seizure frequency doubled|0
4763942|NCT01627860|16433580|P2|Overall Study|Withdrawal by Subject|1
4763943|NCT01627860|16433581|P1|Overall Study|Withdrawal by Subject|2
4763944|NCT01627860|16433580|P2|Overall Study|Adverse Event|4
4763945|NCT01627860|16433581|P1|Overall Study|Adverse Event|9
4763946|NCT01627782|16433595|P4|Overall Study|Randomized But Not Treated|0
4763947|NCT01627782|16433596|P3|Overall Study|Randomized But Not Treated|0
4763948|NCT01627782|16433597|P2|Overall Study|Randomized But Not Treated|0
4763949|NCT01627782|16433598|P1|Overall Study|Randomized But Not Treated|1
4763950|NCT01627782|16433595|P4|Overall Study|Other|3
4763951|NCT01627782|16433596|P3|Overall Study|Other|0
4763952|NCT01627782|16433597|P2|Overall Study|Other|2
4763953|NCT01627782|16433598|P1|Overall Study|Other|0
4763954|NCT01627782|16433595|P4|Overall Study|Withdrawal by Subject|0
4763955|NCT01627782|16433596|P3|Overall Study|Withdrawal by Subject|0
4763956|NCT01627782|16433597|P2|Overall Study|Withdrawal by Subject|1
4763957|NCT01627782|16433598|P1|Overall Study|Withdrawal by Subject|2
4763958|NCT01627782|16433595|P4|Overall Study|Protocol Violation|0
4763959|NCT01627782|16433596|P3|Overall Study|Protocol Violation|0
4763960|NCT01627782|16433597|P2|Overall Study|Protocol Violation|0
4763961|NCT01627782|16433598|P1|Overall Study|Protocol Violation|1
4763962|NCT01627782|16433595|P4|Overall Study|Lack of Efficacy|2
4763963|NCT01627782|16433596|P3|Overall Study|Lack of Efficacy|15
4763964|NCT01627782|16433597|P2|Overall Study|Lack of Efficacy|1
4763965|NCT01627782|16433598|P1|Overall Study|Lack of Efficacy|11
4763966|NCT01627782|16433595|P4|Overall Study|Adverse Event|1
4763967|NCT01627782|16433596|P3|Overall Study|Adverse Event|0
4763968|NCT01627782|16433597|P2|Overall Study|Adverse Event|2
4763969|NCT01627782|16433598|P1|Overall Study|Adverse Event|1
4763970|NCT01627691|16433654|P1|Overall Study|Missed the visit|3
4763971|NCT01627691|16433654|P1|Overall Study|Withdrawal by Subject|1
4763972|NCT01627691|16433654|P1|Overall Study|Lost to Follow-up|3
4763973|NCT01627691|16433654|P1|Overall Study|Death|11
4763974|NCT01627561|16433667|P2|Overall Study|Migrated/moved from study area|2
4763975|NCT01627561|16433668|P1|Overall Study|Migrated/moved from study area|0
4763976|NCT01627561|16433667|P2|Overall Study|Withdrawal by Subject|1
4763977|NCT01627561|16433668|P1|Overall Study|Withdrawal by Subject|0
4763978|NCT01627561|16433667|P2|Overall Study|Lost to Follow-up|0
4763979|NCT01627561|16433668|P1|Overall Study|Lost to Follow-up|1
4763980|NCT01627340|16433734|P2|Overall Study|Withdrawal by Subject|0
4763981|NCT01627340|16433735|P1|Overall Study|Withdrawal by Subject|2
4763982|NCT01627340|16433734|P2|Overall Study|Pregnancy|0
4763983|NCT01627340|16433735|P1|Overall Study|Pregnancy|1
4763984|NCT01627340|16433734|P2|Overall Study|Lost to Follow-up|4
4763985|NCT01627340|16433735|P1|Overall Study|Lost to Follow-up|8
4763986|NCT01627340|16433734|P2|Overall Study|Adverse Event|0
4763987|NCT01627340|16433735|P1|Overall Study|Adverse Event|1
4763988|NCT01627327|16433753|P2|Overall Study|Withdrawal by Subject|3
4763989|NCT01627327|16433754|P1|Overall Study|Withdrawal by Subject|3
4763990|NCT01627327|16433753|P2|Overall Study|Physician Decision|0
4763991|NCT01627327|16433754|P1|Overall Study|Physician Decision|1
4763992|NCT01627327|16433753|P2|Overall Study|Lost to Follow-up|3
4763993|NCT01627327|16433754|P1|Overall Study|Lost to Follow-up|1
4763994|NCT01627327|16433753|P2|Overall Study|Protocol Violation|10
4763995|NCT01627327|16433754|P1|Overall Study|Protocol Violation|4
4763996|NCT01627327|16433753|P2|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9
4763997|NCT01627327|16433754|P1|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4
4763998|NCT01627327|16433753|P2|Overall Study|Lack of Efficacy-No Sub-Reason|2
4763999|NCT01627327|16433754|P1|Overall Study|Lack of Efficacy-No Sub-Reason|0
4764000|NCT01627327|16433753|P2|Overall Study|Adverse Event|12
4764001|NCT01627327|16433754|P1|Overall Study|Adverse Event|6
4764002|NCT01627249|16433804|P3|Overall Study|Missed Visit|0
4764003|NCT01627249|16433805|P2|Overall Study|Missed Visit|1
4764004|NCT01627249|16433806|P1|Overall Study|Missed Visit|1
4764005|NCT01627249|16433804|P3|Overall Study|Withdrawal by Subject|9
4764006|NCT01627249|16433805|P2|Overall Study|Withdrawal by Subject|6
4764007|NCT01627249|16433806|P1|Overall Study|Withdrawal by Subject|12
4764008|NCT01627249|16433804|P3|Overall Study|Death|3
4764009|NCT01627249|16433805|P2|Overall Study|Death|5
4764010|NCT01627249|16433806|P1|Overall Study|Death|3
4764011|NCT01627067|16433841|P1|Overall Study|Screen Failure|1
4764012|NCT01626989|16433910|P3|Screening Period|Withdrawal by Subject|0
4764013|NCT01626989|16433911|P2|Screening Period|Withdrawal by Subject|0
4764014|NCT01626989|16433912|P1|Screening Period|Withdrawal by Subject|2
4764015|NCT01626989|16433910|P3|Screening Period|Screen Failure|0
4764016|NCT01626989|16433911|P2|Screening Period|Screen Failure|0
4764017|NCT01626989|16433912|P1|Screening Period|Screen Failure|15
4764018|NCT01626690|16433984|P2|Overall Study|Adverse Event|0
4764019|NCT01626690|16433985|P1|Overall Study|Adverse Event|1
4764020|NCT01626690|16433984|P2|Overall Study|Protocol Violation|0
4764021|NCT01626690|16433985|P1|Overall Study|Protocol Violation|1
4764022|NCT01626495|16434022|P1|Overall Study|Manufacturing failure|1
4764023|NCT01626495|16434022|P1|Overall Study|New cancer therapy|16
4764024|NCT01626495|16434022|P1|Overall Study|Physician Decision|1
4764025|NCT01626495|16434022|P1|Overall Study|Death|2
4764026|NCT01626495|16434022|P1|Overall Study|Administrative problem|1
4764027|NCT01626495|16434022|P1|Overall Study|Withdrawal by Subject|1
4764028|NCT01626495|16434022|P1|Overall Study|Disease progression|27
4764029|NCT01626495|16434022|P1|Overall Study|Adverse Event|3
4764030|NCT01626456|16434031|P2|Overall Study|Incarceration|2
4764031|NCT01626456|16434032|P1|Overall Study|Incarceration|0
4764032|NCT01626456|16434031|P2|Overall Study|Site Closure|3
4764033|NCT01626456|16434032|P1|Overall Study|Site Closure|2
4764034|NCT01626456|16434031|P2|Overall Study|Protocol Violation|1
4764035|NCT01626456|16434032|P1|Overall Study|Protocol Violation|1
4764036|NCT01626456|16434031|P2|Overall Study|Physician Decision|4
4764037|NCT01626456|16434032|P1|Overall Study|Physician Decision|1
4764038|NCT01626456|16434031|P2|Overall Study|Lack of Efficacy|7
4764039|NCT01626456|16434032|P1|Overall Study|Lack of Efficacy|6
4764040|NCT01626456|16434031|P2|Overall Study|Lost to Follow-up|27
4764041|NCT01626456|16434032|P1|Overall Study|Lost to Follow-up|2
4764042|NCT01626456|16434031|P2|Overall Study|Adverse Event|27
4764043|NCT01626456|16434032|P1|Overall Study|Adverse Event|2
4764044|NCT01626456|16434031|P2|Overall Study|Withdrawal by Subject|46
4764045|NCT01626456|16434032|P1|Overall Study|Withdrawal by Subject|21
4764046|NCT01626391|16434062|P2|Overall Study|Withdrawal by Subject|0
4764047|NCT01626391|16434063|P1|Overall Study|Withdrawal by Subject|1
4764048|NCT01626391|16434062|P2|Overall Study|Physician Decision|0
4764049|NCT01626391|16434063|P1|Overall Study|Physician Decision|1
4764050|NCT01626352|16434069|P1|Overall Study|Never Treated|1
4764051|NCT01626352|16434069|P1|Overall Study|Non-Compliance|1
4764052|NCT01626352|16434069|P1|Overall Study|Withdrawal by Subject|1
4764053|NCT01626352|16434069|P1|Overall Study|Death|2
4764054|NCT01626352|16434069|P1|Overall Study|Intercurrent Illness|2
4764055|NCT01626352|16434069|P1|Overall Study|Disease Progression|3
4764056|NCT01626118|16434083|P4|Overall Study|Investigator Decision|0
4764057|NCT01626118|16434084|P3|Overall Study|Investigator Decision|0
4764058|NCT01626118|16434085|P2|Overall Study|Investigator Decision|1
4764059|NCT01626118|16434086|P1|Overall Study|Investigator Decision|0
4764060|NCT01626118|16434083|P4|Overall Study|Adverse Event|0
4764061|NCT01626118|16434084|P3|Overall Study|Adverse Event|1
4764062|NCT01626118|16434085|P2|Overall Study|Adverse Event|1
4764063|NCT01626118|16434086|P1|Overall Study|Adverse Event|0
4764064|NCT01626118|16434083|P4|Overall Study|Lost to Follow-up|0
4764065|NCT01626118|16434084|P3|Overall Study|Lost to Follow-up|0
4764066|NCT01626118|16434085|P2|Overall Study|Lost to Follow-up|0
4764067|NCT01626118|16434086|P1|Overall Study|Lost to Follow-up|1
4764068|NCT01626118|16434083|P4|Overall Study|Lack of Efficacy|3
4764069|NCT01626118|16434084|P3|Overall Study|Lack of Efficacy|1
4764070|NCT01626118|16434085|P2|Overall Study|Lack of Efficacy|0
4764071|NCT01626118|16434086|P1|Overall Study|Lack of Efficacy|1
4764072|NCT01626079|16434132|P2|Overall Study|Visits Expected or Not Due|69
4764073|NCT01626079|16434133|P1|Overall Study|Visits Expected or Not Due|74
4764074|NCT01626079|16434132|P2|Overall Study|Lost to Follow-up|3
4764075|NCT01626079|16434133|P1|Overall Study|Lost to Follow-up|3
4764076|NCT01626079|16434132|P2|Overall Study|Withdrawal by Subject|29
4764077|NCT01626079|16434133|P1|Overall Study|Withdrawal by Subject|12
4764078|NCT01626079|16434132|P2|Overall Study|Death|115
4764079|NCT01626079|16434133|P1|Overall Study|Death|78
4764080|NCT01625988|16434506|P2|Overall Study|Protocol Violation|2
4764081|NCT01625988|16434507|P1|Overall Study|Protocol Violation|0
4764082|NCT01625988|16434506|P2|Overall Study|Randomized Inappropriately|0
4764083|NCT01625988|16434507|P1|Overall Study|Randomized Inappropriately|1
4764084|NCT01625988|16434506|P2|Overall Study|Lack of Efficacy|1
4764085|NCT01625988|16434507|P1|Overall Study|Lack of Efficacy|0
4764086|NCT01625988|16434506|P2|Overall Study|Adverse Event|1
4764087|NCT01625988|16434507|P1|Overall Study|Adverse Event|0
4764088|NCT01625988|16434506|P2|Overall Study|Withdrawal by Subject|3
4764089|NCT01625988|16434507|P1|Overall Study|Withdrawal by Subject|8
4764090|NCT01625988|16434506|P2|Overall Study|Lost to Follow-up|6
4764091|NCT01625988|16434507|P1|Overall Study|Lost to Follow-up|5
4764092|NCT01625910|16434531|P2|Overall Study|Lost to Follow-up|4
4764093|NCT01625910|16434532|P1|Overall Study|Lost to Follow-up|3
4764094|NCT01625845|16434542|P2|Overall Study|Withdrawal by Subject|0
4764095|NCT01625845|16434543|P1|Overall Study|Withdrawal by Subject|2
4764096|NCT01625845|16434542|P2|Overall Study|Lost to Follow-up|1
4764097|NCT01625845|16434543|P1|Overall Study|Lost to Follow-up|2
4764098|NCT01625845|16434542|P2|Overall Study|Adverse Event|2
4764099|NCT01625845|16434543|P1|Overall Study|Adverse Event|1
4764100|NCT01625689|16434563|P2|Overall Study|Migration|1
4764101|NCT01625689|16434564|P1|Overall Study|Migration|2
4764102|NCT01625377|16434619|P2|Overall Study|Abnormal laboratory values|0
4764103|NCT01625377|16434620|P1|Overall Study|Abnormal laboratory values|1
4764104|NCT01625377|16434619|P2|Overall Study|Unsatisfactory therapeutic effect|1
4764105|NCT01625377|16434620|P1|Overall Study|Unsatisfactory therapeutic effect|0
4764106|NCT01625377|16434619|P2|Overall Study|Graft loss|0
4764107|NCT01625377|16434620|P1|Overall Study|Graft loss|1
4764108|NCT01625377|16434619|P2|Overall Study|Adverse Event|16
4764109|NCT01625377|16434620|P1|Overall Study|Adverse Event|3
4764110|NCT01625377|16434619|P2|Overall Study|Protocol Violation|3
4764111|NCT01625377|16434620|P1|Overall Study|Protocol Violation|0
4764112|NCT01625377|16434619|P2|Overall Study|Administrative Problem|1
4764113|NCT01625377|16434620|P1|Overall Study|Administrative Problem|1
4764114|NCT01625377|16434619|P2|Overall Study|Death|1
4764115|NCT01625377|16434620|P1|Overall Study|Death|1
4764116|NCT01625338|16434653|P3|Overall Study|Study Discontinued by Sponsor|1
4764117|NCT01625338|16434654|P2|Overall Study|Study Discontinued by Sponsor|0
4764118|NCT01625338|16434655|P1|Overall Study|Study Discontinued by Sponsor|0
4764119|NCT01625338|16434653|P3|Overall Study|Adverse Event|1
4764120|NCT01625338|16434654|P2|Overall Study|Adverse Event|0
4764121|NCT01625338|16434655|P1|Overall Study|Adverse Event|1
4764122|NCT01625338|16434653|P3|Overall Study|Subject Withdrew Consent|2
4764123|NCT01625338|16434654|P2|Overall Study|Subject Withdrew Consent|0
4764124|NCT01625338|16434655|P1|Overall Study|Subject Withdrew Consent|1
4764125|NCT01625338|16434653|P3|Overall Study|Investigator Decision|1
4764126|NCT01625338|16434654|P2|Overall Study|Investigator Decision|2
4764127|NCT01625338|16434655|P1|Overall Study|Investigator Decision|0
4764128|NCT01625338|16434653|P3|Overall Study|Lost to Follow-up|2
4764129|NCT01625338|16434654|P2|Overall Study|Lost to Follow-up|3
4764130|NCT01625338|16434655|P1|Overall Study|Lost to Follow-up|3
4764131|NCT01625338|16434653|P3|Overall Study|Efficacy Failure|31
4764132|NCT01625338|16434654|P2|Overall Study|Efficacy Failure|39
4764133|NCT01625338|16434655|P1|Overall Study|Efficacy Failure|27
4764134|NCT01625338|16434653|P3|Overall Study|Enrolled but not Treated|1
4764135|NCT01625338|16434654|P2|Overall Study|Enrolled but not Treated|0
4764136|NCT01625338|16434655|P1|Overall Study|Enrolled but not Treated|0
4764137|NCT01625286|16434682|P7|Overall Study|Ongoing on-treatment at DCO|6
4764138|NCT01625286|16434683|P6|Overall Study|Ongoing on-treatment at DCO|8
4764139|NCT01625286|16434684|P5|Overall Study|Ongoing on-treatment at DCO|0
4764140|NCT01625286|16434685|P4|Overall Study|Ongoing on-treatment at DCO|0
4764141|NCT01625286|16434686|P3|Overall Study|Ongoing on-treatment at DCO|0
4764142|NCT01625286|16434687|P2|Overall Study|Ongoing on-treatment at DCO|4
4764143|NCT01625286|16434688|P1|Overall Study|Ongoing on-treatment at DCO|6
4764144|NCT01625286|16434682|P7|Overall Study|Ongoing off-treatment at DCO|31
4764145|NCT01625286|16434683|P6|Overall Study|Ongoing off-treatment at DCO|32
4764146|NCT01625286|16434684|P5|Overall Study|Ongoing off-treatment at DCO|0
4764147|NCT01625286|16434685|P4|Overall Study|Ongoing off-treatment at DCO|0
4764148|NCT01625286|16434686|P3|Overall Study|Ongoing off-treatment at DCO|0
4764149|NCT01625286|16434687|P2|Overall Study|Ongoing off-treatment at DCO|0
4764150|NCT01625286|16434688|P1|Overall Study|Ongoing off-treatment at DCO|0
4764151|NCT01625286|16434682|P7|Overall Study|Lost to Follow-up|1
4764152|NCT01625286|16434683|P6|Overall Study|Lost to Follow-up|0
4764153|NCT01625286|16434684|P5|Overall Study|Lost to Follow-up|0
4764154|NCT01625286|16434685|P4|Overall Study|Lost to Follow-up|0
4764155|NCT01625286|16434686|P3|Overall Study|Lost to Follow-up|0
4764156|NCT01625286|16434687|P2|Overall Study|Lost to Follow-up|0
4764157|NCT01625286|16434688|P1|Overall Study|Lost to Follow-up|0
4764158|NCT01625286|16434682|P7|Overall Study|Progressive disease|0
4764159|NCT01625286|16434683|P6|Overall Study|Progressive disease|0
4764160|NCT01625286|16434684|P5|Overall Study|Progressive disease|5
4764161|NCT01625286|16434685|P4|Overall Study|Progressive disease|5
4764162|NCT01625286|16434686|P3|Overall Study|Progressive disease|4
4764163|NCT01625286|16434687|P2|Overall Study|Progressive disease|3
4764164|NCT01625286|16434688|P1|Overall Study|Progressive disease|6
4764165|NCT01625286|16434682|P7|Overall Study|Any reason not specifically recorded|0
4764166|NCT01625286|16434683|P6|Overall Study|Any reason not specifically recorded|1
4764167|NCT01625286|16434684|P5|Overall Study|Any reason not specifically recorded|0
4764168|NCT01625286|16434685|P4|Overall Study|Any reason not specifically recorded|0
4764169|NCT01625286|16434686|P3|Overall Study|Any reason not specifically recorded|0
4764170|NCT01625286|16434687|P2|Overall Study|Any reason not specifically recorded|0
4764171|NCT01625286|16434688|P1|Overall Study|Any reason not specifically recorded|0
4764172|NCT01625286|16434682|P7|Overall Study|Withdrawal by Subject|1
4764173|NCT01625286|16434683|P6|Overall Study|Withdrawal by Subject|0
4764174|NCT01625286|16434684|P5|Overall Study|Withdrawal by Subject|0
4764175|NCT01625286|16434685|P4|Overall Study|Withdrawal by Subject|1
4764176|NCT01625286|16434686|P3|Overall Study|Withdrawal by Subject|0
4764177|NCT01625286|16434687|P2|Overall Study|Withdrawal by Subject|1
4764178|NCT01625286|16434688|P1|Overall Study|Withdrawal by Subject|0
4764179|NCT01625286|16434682|P7|Overall Study|Death|16
4764180|NCT01625286|16434683|P6|Overall Study|Death|11
4764181|NCT01625286|16434684|P5|Overall Study|Death|0
4764182|NCT01625286|16434685|P4|Overall Study|Death|1
4764183|NCT01625286|16434686|P3|Overall Study|Death|1
4764184|NCT01625286|16434687|P2|Overall Study|Death|0
4764185|NCT01625286|16434688|P1|Overall Study|Death|0
4764186|NCT01625286|16434682|P7|Overall Study|Adverse Event|1
4764187|NCT01625286|16434683|P6|Overall Study|Adverse Event|2
4764188|NCT01625286|16434684|P5|Overall Study|Adverse Event|1
4764189|NCT01625286|16434685|P4|Overall Study|Adverse Event|0
4764190|NCT01625286|16434686|P3|Overall Study|Adverse Event|0
4764191|NCT01625286|16434687|P2|Overall Study|Adverse Event|0
4764192|NCT01625286|16434688|P1|Overall Study|Adverse Event|0
4764193|NCT01625182|16434774|P2|Overall Study|Lack of Efficacy|8
4764194|NCT01625182|16434775|P1|Overall Study|Lack of Efficacy|12
4764195|NCT01625182|16434774|P2|Overall Study|Withdrawal by Subject|1
4764196|NCT01625182|16434775|P1|Overall Study|Withdrawal by Subject|5
4764197|NCT01625182|16434774|P2|Overall Study|Adverse Event|0
4764198|NCT01625182|16434775|P1|Overall Study|Adverse Event|2
4764199|NCT01625182|16434774|P2|Overall Study|Protocol deviation|2
4764200|NCT01625182|16434775|P1|Overall Study|Protocol deviation|0
4764201|NCT01625182|16434774|P2|Overall Study|Administrative problems|0
4764202|NCT01625182|16434775|P1|Overall Study|Administrative problems|1
4764203|NCT01625091|16434812|P2|Post-intervention|Study termination|1
4764204|NCT01625091|16434813|P1|Post-intervention|Study termination|2
4764205|NCT01625091|16434812|P2|Post-intervention|Lost to Follow-up|0
4764206|NCT01625091|16434813|P1|Post-intervention|Lost to Follow-up|2
4764207|NCT01625091|16434812|P2|Post-intervention|Death|1
4764208|NCT01625091|16434813|P1|Post-intervention|Death|0
4764209|NCT01625091|16434812|P2|Intervention|Study termination|3
4764210|NCT01625091|16434813|P1|Intervention|Study termination|2
4764211|NCT01625091|16434812|P2|Intervention|Lost to Follow-up|4
4764212|NCT01625091|16434813|P1|Intervention|Lost to Follow-up|4
4764213|NCT01625091|16434812|P2|Intervention|Adverse Event|2
4764214|NCT01625091|16434813|P1|Intervention|Adverse Event|0
4764215|NCT01625091|16434812|P2|Intervention|Withdrawal by Subject|1
4764216|NCT01625091|16434813|P1|Intervention|Withdrawal by Subject|4
4764217|NCT01625091|16434812|P2|Intervention|Death|1
4764218|NCT01625091|16434813|P1|Intervention|Death|1
4764219|NCT01624974|16434831|P2|Period V of Treatment (4 Weeks)|Adverse Event|0
4764220|NCT01624974|16434832|P1|Period V of Treatment (4 Weeks)|Adverse Event|1
4764221|NCT01624974|16434831|P2|Period V of Treatment (4 Weeks)|Physician Decision|0
4764222|NCT01624974|16434832|P1|Period V of Treatment (4 Weeks)|Physician Decision|3
4764223|NCT01624974|16434831|P2|Period V of Treatment (4 Weeks)|Lack of Efficacy|0
4764224|NCT01624974|16434832|P1|Period V of Treatment (4 Weeks)|Lack of Efficacy|1
4764225|NCT01624974|16434831|P2|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1
4764226|NCT01624974|16434832|P1|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0
4764227|NCT01624974|16434831|P2|Period IV Washout (4 Weeks)|Adverse Event|0
4764228|NCT01624974|16434832|P1|Period IV Washout (4 Weeks)|Adverse Event|2
4764229|NCT01624974|16434831|P2|Period IV Washout (4 Weeks)|Withdrawal by Subject|1
4764230|NCT01624974|16434832|P1|Period IV Washout (4 Weeks)|Withdrawal by Subject|0
4764231|NCT01624974|16434831|P2|Period IV Washout (4 Weeks)|Lack of Efficacy|1
4764232|NCT01624974|16434832|P1|Period IV Washout (4 Weeks)|Lack of Efficacy|1
4764233|NCT01624974|16434831|P2|Period III of Treatment (4 Weeks)|Adverse Event|1
4764234|NCT01624974|16434832|P1|Period III of Treatment (4 Weeks)|Adverse Event|0
4764235|NCT01624974|16434831|P2|Period III of Treatment (4 Weeks)|Protocol Violation|0
4764236|NCT01624974|16434832|P1|Period III of Treatment (4 Weeks)|Protocol Violation|1
4764237|NCT01624974|16434831|P2|Period III of Treatment (4 Weeks)|Physician Decision|3
4764238|NCT01624974|16434832|P1|Period III of Treatment (4 Weeks)|Physician Decision|5
4764239|NCT01624974|16434831|P2|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2
4764240|NCT01624974|16434832|P1|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1
4764241|NCT01624974|16434831|P2|Period III of Treatment (4 Weeks)|Lack of Efficacy|2
4764242|NCT01624974|16434832|P1|Period III of Treatment (4 Weeks)|Lack of Efficacy|0
4764243|NCT01624870|16434873|P1|Overall Study|Lost to follow up|1
4764244|NCT01624870|16434873|P1|Overall Study|CoreValve not implanted|6
4764245|NCT01624870|16434873|P1|Overall Study|Withdrawal by Subject|1
4764246|NCT01624870|16434873|P1|Overall Study|Death|19
4764247|NCT01624662|16434893|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4764248|NCT01624662|16434894|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
4764249|NCT01624662|16434895|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4764250|NCT01624662|16434896|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4764251|NCT01624662|16434893|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4764252|NCT01624662|16434894|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4764253|NCT01624662|16434895|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
4764254|NCT01624662|16434896|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4764255|NCT01624662|16434893|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4764256|NCT01624662|16434894|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
4764257|NCT01624662|16434895|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4764258|NCT01624662|16434896|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4764259|NCT01624662|16434893|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
4764260|NCT01624662|16434894|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
4764261|NCT01624662|16434895|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
4764262|NCT01624662|16434896|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3
4764263|NCT01624662|16434893|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4764264|NCT01624662|16434894|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4764265|NCT01624662|16434895|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
4764266|NCT01624662|16434896|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4764267|NCT01624662|16434893|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
4764268|NCT01624662|16434894|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
4764269|NCT01624662|16434895|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1
4764270|NCT01624662|16434896|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5
4764271|NCT01624662|16434893|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0
4764272|NCT01624662|16434894|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
4764273|NCT01624662|16434895|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
4764274|NCT01624662|16434896|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
4764275|NCT01624467|16434967|P1|Overall Study|Subject Withdrew from Treatment|1
4764276|NCT01624467|16434967|P1|Overall Study|Per Sponsor Requirement|1
4764277|NCT01624467|16434967|P1|Overall Study|Progressive Disease|19
4764278|NCT01624467|16434967|P1|Overall Study|Adverse Event|7
4764279|NCT01624467|16434967|P1|Overall Study|Lost to Follow-up|1
4764280|NCT01624467|16434967|P1|Overall Study|Withdrawal by Subject|2
4764281|NCT01624259|16435006|P2|Overall Study|Abnormal laboratory measure|0
4764282|NCT01624259|16435007|P1|Overall Study|Abnormal laboratory measure|3
4764283|NCT01624259|16435006|P2|Overall Study|Lost to Follow-up|3
4764284|NCT01624259|16435007|P1|Overall Study|Lost to Follow-up|2
4764285|NCT01624259|16435006|P2|Overall Study|Physician Decision|1
4764286|NCT01624259|16435007|P1|Overall Study|Physician Decision|1
4764287|NCT01624259|16435006|P2|Overall Study|Withdrawal by Subject|7
4764288|NCT01624259|16435007|P1|Overall Study|Withdrawal by Subject|5
4764289|NCT01624259|16435006|P2|Overall Study|Protocol Violation|2
4764290|NCT01624259|16435007|P1|Overall Study|Protocol Violation|1
4764291|NCT01624259|16435006|P2|Overall Study|Adverse Event|18
4764292|NCT01624259|16435007|P1|Overall Study|Adverse Event|18
4764293|NCT01624233|16435056|P1|Period 6: Follow-up|Withdrawal by Subject|3
4764294|NCT01624233|16435056|P1|Period 6: Follow-up|Physician Decision|1
4764295|NCT01624233|16435056|P1|Period 6: Follow-up|Lack of Efficacy|2
4764296|NCT01624233|16435056|P1|Period 6: Follow-up|Adverse Event|3
4764297|NCT01624233|16435056|P1|Period 5 - Retreatment Period|Withdrawal by Subject|3
4764298|NCT01624233|16435056|P1|Period 5 - Retreatment Period|Physician Decision|1
4764299|NCT01624233|16435056|P1|Period 5 - Retreatment Period|Lack of Efficacy|1
4764300|NCT01624233|16435056|P1|Period 5 - Retreatment Period|Adverse Event|5
4764301|NCT01624233|16435056|P1|Period 4 - Drug Free Period|Relapsed|61
4764302|NCT01624233|16435056|P1|Period 3 - Maintenance|Withdrawal by Subject|2
4764303|NCT01624233|16435056|P1|Period 3 - Maintenance|Physician Decision|2
4764304|NCT01624233|16435056|P1|Period 3 - Maintenance|Lack of Efficacy|1
4764305|NCT01624233|16435056|P1|Period 3 - Maintenance|Adverse Event|2
4764306|NCT01624233|16435056|P1|Period 2 - Induction|Adverse Event|1
4764307|NCT01624194|16435088|P2|Overall Study|Withdrawal by Subject|0
4764308|NCT01624194|16435089|P1|Overall Study|Withdrawal by Subject|1
4764309|NCT01624194|16435088|P2|Overall Study|Lost to Follow-up|0
4764310|NCT01624194|16435089|P1|Overall Study|Lost to Follow-up|1
4764311|NCT01624142|16435157|P2|Overall Study|Other|0
4764312|NCT01624142|16435158|P1|Overall Study|Other|1
4764313|NCT01624142|16435157|P2|Overall Study|Lost to Follow-up|0
4764314|NCT01624142|16435158|P1|Overall Study|Lost to Follow-up|2
4764315|NCT01624142|16435157|P2|Overall Study|Study Closure|6
4764316|NCT01624142|16435158|P1|Overall Study|Study Closure|12
4764317|NCT01624142|16435157|P2|Overall Study|Death|6
4764318|NCT01624142|16435158|P1|Overall Study|Death|3
4764319|NCT01624142|16435157|P2|Overall Study|Withdrawal by Subject|4
4764320|NCT01624142|16435158|P1|Overall Study|Withdrawal by Subject|14
4764321|NCT01624090|16435183|P4|Overall Study|Dose escalated|0
4764322|NCT01624090|16435184|P3|Overall Study|Dose escalated|3
4764323|NCT01624090|16435185|P2|Overall Study|Dose escalated|0
4764324|NCT01624090|16435186|P1|Overall Study|Dose escalated|0
4764325|NCT01624090|16435183|P4|Overall Study|Did not complete 1 crse of therapy|0
4764326|NCT01624090|16435184|P3|Overall Study|Did not complete 1 crse of therapy|2
4764327|NCT01624090|16435185|P2|Overall Study|Did not complete 1 crse of therapy|0
4764328|NCT01624090|16435186|P1|Overall Study|Did not complete 1 crse of therapy|0
4764329|NCT01624090|16435183|P4|Overall Study|Died on study|0
4764330|NCT01624090|16435184|P3|Overall Study|Died on study|2
4764331|NCT01624090|16435185|P2|Overall Study|Died on study|0
4764332|NCT01624090|16435186|P1|Overall Study|Died on study|0
4764333|NCT01624090|16435183|P4|Overall Study|Withdrew prior to treatment|0
4764334|NCT01624090|16435184|P3|Overall Study|Withdrew prior to treatment|0
4764335|NCT01624090|16435185|P2|Overall Study|Withdrew prior to treatment|1
4764336|NCT01624090|16435186|P1|Overall Study|Withdrew prior to treatment|0
4764337|NCT01624090|16435183|P4|Overall Study|DLT, taken off therapy|0
4764338|NCT01624090|16435184|P3|Overall Study|DLT, taken off therapy|0
4764339|NCT01624090|16435185|P2|Overall Study|DLT, taken off therapy|1
4764340|NCT01624090|16435186|P1|Overall Study|DLT, taken off therapy|0
4764341|NCT01623830|16435208|P2|Overall Study|Exclusion from Study|2
4764342|NCT01623830|16435209|P1|Overall Study|Exclusion from Study|1
4764343|NCT01623830|16435208|P2|Overall Study|Withdrawal by Subject|7
4764344|NCT01623830|16435209|P1|Overall Study|Withdrawal by Subject|6
4764345|NCT01623752|16435226|P3|Phase 2 (78 Weeks)|Adverse Event|0
4764346|NCT01623752|16435227|P2|Phase 2 (78 Weeks)|Adverse Event|4
4764347|NCT01623752|16435228|P1|Phase 2 (78 Weeks)|Adverse Event|4
4764348|NCT01623752|16435226|P3|Phase 2 (78 Weeks)|No Data|0
4764349|NCT01623752|16435227|P2|Phase 2 (78 Weeks)|No Data|11
4764350|NCT01623752|16435228|P1|Phase 2 (78 Weeks)|No Data|43
4764351|NCT01623752|16435226|P3|Phase 2 (78 Weeks)|Other|0
4764352|NCT01623752|16435227|P2|Phase 2 (78 Weeks)|Other|1
4764353|NCT01623752|16435228|P1|Phase 2 (78 Weeks)|Other|5
4764354|NCT01623752|16435226|P3|Phase 2 (78 Weeks)|Lack of Efficacy|0
4764355|NCT01623752|16435227|P2|Phase 2 (78 Weeks)|Lack of Efficacy|2
4764356|NCT01623752|16435228|P1|Phase 2 (78 Weeks)|Lack of Efficacy|14
4764357|NCT01623752|16435226|P3|Phase 1 (78 Weeks)|Lack of Efficacy|0
4764358|NCT01623752|16435227|P2|Phase 1 (78 Weeks)|Lack of Efficacy|82
4764359|NCT01623752|16435228|P1|Phase 1 (78 Weeks)|Lack of Efficacy|227
4764360|NCT01623752|16435226|P3|Phase 1 (78 Weeks)|Adverse Event|0
4764361|NCT01623752|16435227|P2|Phase 1 (78 Weeks)|Adverse Event|39
4764362|NCT01623752|16435228|P1|Phase 1 (78 Weeks)|Adverse Event|122
4764363|NCT01623752|16435226|P3|Phase 1 (78 Weeks)|Other|0
4764364|NCT01623752|16435227|P2|Phase 1 (78 Weeks)|Other|20
4764365|NCT01623752|16435228|P1|Phase 1 (78 Weeks)|Other|33
4764366|NCT01623752|16435226|P3|Phase 1 (78 Weeks)|No Data|2
4764367|NCT01623752|16435227|P2|Phase 1 (78 Weeks)|No Data|66
4764368|NCT01623752|16435228|P1|Phase 1 (78 Weeks)|No Data|249
4764369|NCT01623596|16435331|P2|Overall Study|Lack of Efficacy|3
4764370|NCT01623596|16435332|P1|Overall Study|Lack of Efficacy|5
4764371|NCT01623596|16435331|P2|Overall Study|Protocol Violation|6
4764372|NCT01623596|16435332|P1|Overall Study|Protocol Violation|0
4764373|NCT01623596|16435331|P2|Overall Study|Patient no longer requires study drug|0
4764374|NCT01623596|16435332|P1|Overall Study|Patient no longer requires study drug|1
4764375|NCT01623596|16435331|P2|Overall Study|Withdrawal by Subject|31
4764376|NCT01623596|16435332|P1|Overall Study|Withdrawal by Subject|13
4764377|NCT01623596|16435331|P2|Overall Study|Lost to Follow-up|16
4764378|NCT01623596|16435332|P1|Overall Study|Lost to Follow-up|12
4764379|NCT01623596|16435331|P2|Overall Study|Death|2
4764380|NCT01623596|16435332|P1|Overall Study|Death|0
4764381|NCT01623596|16435331|P2|Overall Study|Adverse Event|29
4764382|NCT01623596|16435332|P1|Overall Study|Adverse Event|20
4764383|NCT01623596|16435331|P2|Overall Study|Administrative problems|13
4764384|NCT01623596|16435332|P1|Overall Study|Administrative problems|9
4764385|NCT01623596|16435331|P2|Overall Study|Abnormal laboratory values|0
4764386|NCT01623596|16435332|P1|Overall Study|Abnormal laboratory values|2
4764387|NCT01623531|16435350|P2|Overall Study|Missing data at primary outcome time poi|1
4764388|NCT01623531|16435351|P1|Overall Study|Missing data at primary outcome time poi|1
4764389|NCT01623531|16435350|P2|Overall Study|Protocol Violation|1
4764390|NCT01623531|16435351|P1|Overall Study|Protocol Violation|2
4764391|NCT01623531|16435350|P2|Overall Study|Death|0
4764392|NCT01623531|16435351|P1|Overall Study|Death|1
4764393|NCT01623310|16435418|P1|Overall Study|Investigators Discretion-Noncompliant|1
4764394|NCT01623310|16435418|P1|Overall Study|Diagnoses of bilateral cateracts|1
4764395|NCT01623310|16435418|P1|Overall Study|Became potentially child-bearing|1
4764396|NCT01623310|16435418|P1|Overall Study|Withdrawal by Subject|25
4764397|NCT01623310|16435418|P1|Overall Study|Protocol Violation|6
4764398|NCT01623310|16435418|P1|Overall Study|Lack of Efficacy|6
4764399|NCT01623310|16435418|P1|Overall Study|Lost to Follow-up|18
4764400|NCT01623310|16435418|P1|Overall Study|Adverse Event|21
4764401|NCT01623271|16435427|P1|Overall Study|Withdrawal by Subject|2
4764402|NCT01623154|16435444|P1|Overall Study|Did not drink Pranactin Citric|4
4764403|NCT01623115|16435452|P2|Overall Study|Other than specified above|3
4764404|NCT01623115|16435453|P1|Overall Study|Other than specified above|0
4764405|NCT01623115|16435452|P2|Overall Study|Death|4
4764406|NCT01623115|16435453|P1|Overall Study|Death|0
4764407|NCT01623115|16435452|P2|Overall Study|Site closure|7
4764408|NCT01623115|16435453|P1|Overall Study|Site closure|1
4764409|NCT01623115|16435452|P2|Overall Study|Last visit outside protocol visit window|26
4764410|NCT01623115|16435453|P1|Overall Study|Last visit outside protocol visit window|14
4764411|NCT01623115|16435452|P2|Overall Study|Related to study drug administration|2
4764412|NCT01623115|16435453|P1|Overall Study|Related to study drug administration|0
4764413|NCT01623115|16435452|P2|Overall Study|Consent withdrawn by participant|6
4764414|NCT01623115|16435453|P1|Overall Study|Consent withdrawn by participant|2
4764415|NCT01623115|16435452|P2|Overall Study|Poor compliance to protocol|10
4764416|NCT01623115|16435453|P1|Overall Study|Poor compliance to protocol|4
4764417|NCT01623115|16435452|P2|Overall Study|Adverse Event|13
4764418|NCT01623115|16435453|P1|Overall Study|Adverse Event|10
4764419|NCT01623115|16435452|P2|Overall Study|Participants moved|5
4764420|NCT01623115|16435453|P1|Overall Study|Participants moved|1
4764421|NCT01623115|16435452|P2|Overall Study|Physician Decision|0
4764422|NCT01623115|16435453|P1|Overall Study|Physician Decision|1
4764423|NCT01623115|16435452|P2|Overall Study|Randomized but not treated|1
4764424|NCT01623115|16435453|P1|Overall Study|Randomized but not treated|0
4764425|NCT01623050|16435513|P1|Overall Study|Lost to Follow-up|9
4764426|NCT01622673|16435542|P6|Treatment Period 3|Protocol Violation|0
4764427|NCT01622673|16435543|P5|Treatment Period 3|Protocol Violation|0
4764428|NCT01622673|16435544|P4|Treatment Period 3|Protocol Violation|0
4764429|NCT01622673|16435545|P3|Treatment Period 3|Protocol Violation|0
4764430|NCT01622673|16435546|P2|Treatment Period 3|Protocol Violation|1
4764431|NCT01622673|16435547|P1|Treatment Period 3|Protocol Violation|0
4764432|NCT01622673|16435542|P6|Treatment Period 2|Withdrawal by Subject|0
4764433|NCT01622673|16435543|P5|Treatment Period 2|Withdrawal by Subject|0
4764434|NCT01622673|16435544|P4|Treatment Period 2|Withdrawal by Subject|1
4764435|NCT01622673|16435545|P3|Treatment Period 2|Withdrawal by Subject|0
4764436|NCT01622673|16435546|P2|Treatment Period 2|Withdrawal by Subject|0
4764437|NCT01622673|16435547|P1|Treatment Period 2|Withdrawal by Subject|0
4764438|NCT01622673|16435542|P6|Treatment Period 1|Protocol Violation|0
4764439|NCT01622673|16435543|P5|Treatment Period 1|Protocol Violation|0
4764440|NCT01622673|16435544|P4|Treatment Period 1|Protocol Violation|0
4764441|NCT01622673|16435545|P3|Treatment Period 1|Protocol Violation|0
4764442|NCT01622673|16435546|P2|Treatment Period 1|Protocol Violation|1
4764443|NCT01622673|16435547|P1|Treatment Period 1|Protocol Violation|0
4764444|NCT01622673|16435542|P6|Treatment Period 1|Withdrawal by Subject|0
4764445|NCT01622673|16435543|P5|Treatment Period 1|Withdrawal by Subject|0
4764446|NCT01622673|16435544|P4|Treatment Period 1|Withdrawal by Subject|1
4764447|NCT01622673|16435545|P3|Treatment Period 1|Withdrawal by Subject|0
4764448|NCT01622673|16435546|P2|Treatment Period 1|Withdrawal by Subject|0
4764449|NCT01622673|16435547|P1|Treatment Period 1|Withdrawal by Subject|0
4764450|NCT01622660|16435582|P1|Overall Study|Adverse Event|1
4764451|NCT01622569|16435590|P4|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1
4764452|NCT01622569|16435591|P3|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4764453|NCT01622569|16435592|P2|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4764454|NCT01622569|16435593|P1|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0
4764455|NCT01622569|16435590|P4|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
4764456|NCT01622569|16435591|P3|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2
4764457|NCT01622569|16435592|P2|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0
4764458|NCT01622569|16435593|P1|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1
4764459|NCT01622569|16435590|P4|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
4764460|NCT01622569|16435591|P3|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1
4764461|NCT01622569|16435592|P2|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2
4764462|NCT01622569|16435593|P1|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0
4764463|NCT01622569|16435590|P4|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0
4764464|NCT01622569|16435591|P3|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
4764465|NCT01622569|16435592|P2|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
4764466|NCT01622569|16435593|P1|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2
4764467|NCT01622569|16435590|P4|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1
4764468|NCT01622569|16435591|P3|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4764469|NCT01622569|16435592|P2|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2
4764470|NCT01622569|16435593|P1|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0
4764471|NCT01622569|16435590|P4|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2
4764472|NCT01622569|16435591|P3|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3
4764473|NCT01622569|16435592|P2|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0
4764474|NCT01622569|16435593|P1|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6
4764475|NCT01622569|16435590|P4|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
4764476|NCT01622569|16435591|P3|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1
4764477|NCT01622569|16435592|P2|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
4764478|NCT01622569|16435593|P1|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0
4764479|NCT01622569|16435590|P4|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1
4764480|NCT01622569|16435591|P3|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3
4764481|NCT01622569|16435592|P2|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2
4764482|NCT01622569|16435593|P1|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4
4764483|NCT01622348|16435678|P3|Overall Study|Withdrawal by Subject|1
4764484|NCT01622348|16435679|P2|Overall Study|Withdrawal by Subject|0
4764485|NCT01622348|16435680|P1|Overall Study|Withdrawal by Subject|1
4764486|NCT01622231|16435719|P1|Overall Study|Withdrawal by Subject|1
4764487|NCT01622231|16435719|P1|Overall Study|Physician Decision|1
4764488|NCT01621880|16435749|P2|Overall Study|Withdrawal by Subject|4
4764489|NCT01621880|16435750|P1|Overall Study|Withdrawal by Subject|5
4764490|NCT01621880|16435749|P2|Overall Study|Adverse Event|1
4764491|NCT01621880|16435750|P1|Overall Study|Adverse Event|5
4764492|NCT01621802|16435764|P6|Overall Study|Lost to Follow-up|11
4764493|NCT01621802|16435765|P5|Overall Study|Lost to Follow-up|31
4764494|NCT01621802|16435766|P4|Overall Study|Lost to Follow-up|7
4764495|NCT01621802|16435767|P3|Overall Study|Lost to Follow-up|24
4764496|NCT01621802|16435768|P2|Overall Study|Lost to Follow-up|16
4764497|NCT01621802|16435769|P1|Overall Study|Lost to Follow-up|36
4764498|NCT01621802|16435764|P6|Overall Study|Others|0
4764499|NCT01621802|16435765|P5|Overall Study|Others|1
4764500|NCT01621802|16435766|P4|Overall Study|Others|2
4764501|NCT01621802|16435767|P3|Overall Study|Others|3
4764502|NCT01621802|16435768|P2|Overall Study|Others|3
4764503|NCT01621802|16435769|P1|Overall Study|Others|3
4764504|NCT01621802|16435764|P6|Overall Study|Migrated/moved from study area|0
4764505|NCT01621802|16435765|P5|Overall Study|Migrated/moved from study area|1
4764506|NCT01621802|16435766|P4|Overall Study|Migrated/moved from study area|0
4764507|NCT01621802|16435767|P3|Overall Study|Migrated/moved from study area|2
4764508|NCT01621802|16435768|P2|Overall Study|Migrated/moved from study area|0
4764509|NCT01621802|16435769|P1|Overall Study|Migrated/moved from study area|0
4764510|NCT01621802|16435764|P6|Overall Study|Withdrawal by Subject|0
4764511|NCT01621802|16435765|P5|Overall Study|Withdrawal by Subject|2
4764512|NCT01621802|16435766|P4|Overall Study|Withdrawal by Subject|2
4764513|NCT01621802|16435767|P3|Overall Study|Withdrawal by Subject|4
4764514|NCT01621802|16435768|P2|Overall Study|Withdrawal by Subject|4
4764515|NCT01621802|16435769|P1|Overall Study|Withdrawal by Subject|8
4764516|NCT01621802|16435764|P6|Overall Study|Protocol Violation|1
4764517|NCT01621802|16435765|P5|Overall Study|Protocol Violation|0
4764518|NCT01621802|16435766|P4|Overall Study|Protocol Violation|0
4764519|NCT01621802|16435767|P3|Overall Study|Protocol Violation|0
4764520|NCT01621802|16435768|P2|Overall Study|Protocol Violation|0
4764521|NCT01621802|16435769|P1|Overall Study|Protocol Violation|0
4764522|NCT01621542|16435954|P6|Overall Study|study stopped by sponsor|0
4764523|NCT01621542|16435955|P5|Overall Study|study stopped by sponsor|0
4764524|NCT01621542|16435956|P4|Overall Study|study stopped by sponsor|1
4764525|NCT01621542|16435957|P3|Overall Study|study stopped by sponsor|0
4764526|NCT01621542|16435958|P2|Overall Study|study stopped by sponsor|0
4764527|NCT01621542|16435959|P1|Overall Study|study stopped by sponsor|0
4764528|NCT01621542|16435954|P6|Overall Study|Protocol Violation|0
4764529|NCT01621542|16435955|P5|Overall Study|Protocol Violation|0
4764530|NCT01621542|16435956|P4|Overall Study|Protocol Violation|1
4764531|NCT01621542|16435957|P3|Overall Study|Protocol Violation|0
4764532|NCT01621542|16435958|P2|Overall Study|Protocol Violation|0
4764533|NCT01621542|16435959|P1|Overall Study|Protocol Violation|0
4764534|NCT01621542|16435954|P6|Overall Study|progression/treatment failure|5
4764535|NCT01621542|16435955|P5|Overall Study|progression/treatment failure|3
4764536|NCT01621542|16435956|P4|Overall Study|progression/treatment failure|7
4764537|NCT01621542|16435957|P3|Overall Study|progression/treatment failure|3
4764538|NCT01621542|16435958|P2|Overall Study|progression/treatment failure|4
4764539|NCT01621542|16435959|P1|Overall Study|progression/treatment failure|2
4764540|NCT01621542|16435954|P6|Overall Study|Withdrawal by Subject|3
4764541|NCT01621542|16435955|P5|Overall Study|Withdrawal by Subject|3
4764542|NCT01621542|16435956|P4|Overall Study|Withdrawal by Subject|3
4764543|NCT01621542|16435957|P3|Overall Study|Withdrawal by Subject|1
4764544|NCT01621542|16435958|P2|Overall Study|Withdrawal by Subject|0
4764545|NCT01621542|16435959|P1|Overall Study|Withdrawal by Subject|2
4764546|NCT01621542|16435954|P6|Overall Study|Physician Decision|1
4764547|NCT01621542|16435955|P5|Overall Study|Physician Decision|3
4764548|NCT01621542|16435956|P4|Overall Study|Physician Decision|13
4764549|NCT01621542|16435957|P3|Overall Study|Physician Decision|1
4764550|NCT01621542|16435958|P2|Overall Study|Physician Decision|0
4764551|NCT01621542|16435959|P1|Overall Study|Physician Decision|1
4764552|NCT01621542|16435954|P6|Overall Study|Death|0
4764553|NCT01621542|16435955|P5|Overall Study|Death|0
4764554|NCT01621542|16435956|P4|Overall Study|Death|0
4764555|NCT01621542|16435957|P3|Overall Study|Death|0
4764556|NCT01621542|16435958|P2|Overall Study|Death|1
4764557|NCT01621542|16435959|P1|Overall Study|Death|0
4764558|NCT01621542|16435954|P6|Overall Study|Adverse Event|0
4764559|NCT01621542|16435955|P5|Overall Study|Adverse Event|0
4764560|NCT01621542|16435956|P4|Overall Study|Adverse Event|3
4764561|NCT01621542|16435957|P3|Overall Study|Adverse Event|1
4764562|NCT01621542|16435958|P2|Overall Study|Adverse Event|0
4764563|NCT01621542|16435959|P1|Overall Study|Adverse Event|0
4764564|NCT01621490|16436000|P9|Overall Study|Patient delayed due to toxicity|0
4764565|NCT01621490|16436001|P8|Overall Study|Patient delayed due to toxicity|0
4764566|NCT01621490|16436002|P7|Overall Study|Patient delayed due to toxicity|0
4764567|NCT01621490|16436003|P6|Overall Study|Patient delayed due to toxicity|1
4764568|NCT01621490|16436004|P5|Overall Study|Patient delayed due to toxicity|0
4764569|NCT01621490|16436005|P4|Overall Study|Patient delayed due to toxicity|0
4764570|NCT01621490|16436006|P3|Overall Study|Patient delayed due to toxicity|0
4764571|NCT01621490|16436007|P2|Overall Study|Patient delayed due to toxicity|0
4764572|NCT01621490|16436008|P1|Overall Study|Patient delayed due to toxicity|0
4764573|NCT01621490|16436000|P9|Overall Study|Complete response|1
4764574|NCT01621490|16436001|P8|Overall Study|Complete response|0
4764575|NCT01621490|16436002|P7|Overall Study|Complete response|0
4764576|NCT01621490|16436003|P6|Overall Study|Complete response|0
4764577|NCT01621490|16436004|P5|Overall Study|Complete response|0
4764578|NCT01621490|16436005|P4|Overall Study|Complete response|0
4764579|NCT01621490|16436006|P3|Overall Study|Complete response|0
4764580|NCT01621490|16436007|P2|Overall Study|Complete response|0
4764581|NCT01621490|16436008|P1|Overall Study|Complete response|0
4764582|NCT01621490|16436000|P9|Overall Study|Clinical deterioration|0
4764583|NCT01621490|16436001|P8|Overall Study|Clinical deterioration|0
4764584|NCT01621490|16436002|P7|Overall Study|Clinical deterioration|0
4764585|NCT01621490|16436003|P6|Overall Study|Clinical deterioration|0
4764586|NCT01621490|16436004|P5|Overall Study|Clinical deterioration|0
4764587|NCT01621490|16436005|P4|Overall Study|Clinical deterioration|0
4764588|NCT01621490|16436006|P3|Overall Study|Clinical deterioration|0
4764589|NCT01621490|16436007|P2|Overall Study|Clinical deterioration|1
4764590|NCT01621490|16436008|P1|Overall Study|Clinical deterioration|0
4764591|NCT01621490|16436000|P9|Overall Study|Patient reached treatment 2 yr limit|0
4764592|NCT01621490|16436001|P8|Overall Study|Patient reached treatment 2 yr limit|0
4764593|NCT01621490|16436002|P7|Overall Study|Patient reached treatment 2 yr limit|0
4764594|NCT01621490|16436003|P6|Overall Study|Patient reached treatment 2 yr limit|0
4764595|NCT01621490|16436004|P5|Overall Study|Patient reached treatment 2 yr limit|0
4764596|NCT01621490|16436005|P4|Overall Study|Patient reached treatment 2 yr limit|0
4764597|NCT01621490|16436006|P3|Overall Study|Patient reached treatment 2 yr limit|0
4764598|NCT01621490|16436007|P2|Overall Study|Patient reached treatment 2 yr limit|1
4764599|NCT01621490|16436008|P1|Overall Study|Patient reached treatment 2 yr limit|0
4764600|NCT01621490|16436000|P9|Overall Study|Documented disease progression|0
4764601|NCT01621490|16436001|P8|Overall Study|Documented disease progression|0
4764602|NCT01621490|16436002|P7|Overall Study|Documented disease progression|0
4764603|NCT01621490|16436003|P6|Overall Study|Documented disease progression|0
4764604|NCT01621490|16436004|P5|Overall Study|Documented disease progression|0
4764605|NCT01621490|16436005|P4|Overall Study|Documented disease progression|0
4764606|NCT01621490|16436006|P3|Overall Study|Documented disease progression|1
4764607|NCT01621490|16436007|P2|Overall Study|Documented disease progression|0
4764608|NCT01621490|16436008|P1|Overall Study|Documented disease progression|0
4764609|NCT01621490|16436000|P9|Overall Study|Investigator decision|0
4764610|NCT01621490|16436001|P8|Overall Study|Investigator decision|0
4764611|NCT01621490|16436002|P7|Overall Study|Investigator decision|1
4764612|NCT01621490|16436003|P6|Overall Study|Investigator decision|0
4764613|NCT01621490|16436004|P5|Overall Study|Investigator decision|1
4764614|NCT01621490|16436005|P4|Overall Study|Investigator decision|0
4764615|NCT01621490|16436006|P3|Overall Study|Investigator decision|1
4764616|NCT01621490|16436007|P2|Overall Study|Investigator decision|0
4764617|NCT01621490|16436008|P1|Overall Study|Investigator decision|0
4764618|NCT01621490|16436000|P9|Overall Study|BMS informed of patient status|0
4764619|NCT01621490|16436001|P8|Overall Study|BMS informed of patient status|0
4764620|NCT01621490|16436002|P7|Overall Study|BMS informed of patient status|0
4764621|NCT01621490|16436003|P6|Overall Study|BMS informed of patient status|0
4764622|NCT01621490|16436004|P5|Overall Study|BMS informed of patient status|0
4764623|NCT01621490|16436005|P4|Overall Study|BMS informed of patient status|0
4764624|NCT01621490|16436006|P3|Overall Study|BMS informed of patient status|1
4764625|NCT01621490|16436007|P2|Overall Study|BMS informed of patient status|0
4764626|NCT01621490|16436008|P1|Overall Study|BMS informed of patient status|0
4764627|NCT01621490|16436000|P9|Overall Study|Grade 4 Lipase elevation|0
4764628|NCT01621490|16436001|P8|Overall Study|Grade 4 Lipase elevation|0
4764629|NCT01621490|16436002|P7|Overall Study|Grade 4 Lipase elevation|0
4764630|NCT01621490|16436003|P6|Overall Study|Grade 4 Lipase elevation|0
4764631|NCT01621490|16436004|P5|Overall Study|Grade 4 Lipase elevation|0
4764632|NCT01621490|16436005|P4|Overall Study|Grade 4 Lipase elevation|0
4764633|NCT01621490|16436006|P3|Overall Study|Grade 4 Lipase elevation|0
4764634|NCT01621490|16436007|P2|Overall Study|Grade 4 Lipase elevation|0
4764635|NCT01621490|16436008|P1|Overall Study|Grade 4 Lipase elevation|1
4764636|NCT01621490|16436000|P9|Overall Study|Death|0
4764637|NCT01621490|16436001|P8|Overall Study|Death|1
4764638|NCT01621490|16436002|P7|Overall Study|Death|0
4764639|NCT01621490|16436003|P6|Overall Study|Death|0
4764640|NCT01621490|16436004|P5|Overall Study|Death|0
4764641|NCT01621490|16436005|P4|Overall Study|Death|0
4764642|NCT01621490|16436006|P3|Overall Study|Death|0
4764643|NCT01621490|16436007|P2|Overall Study|Death|0
4764644|NCT01621490|16436008|P1|Overall Study|Death|0
4764645|NCT01621490|16436000|P9|Overall Study|Study drug toxicity|1
4764646|NCT01621490|16436001|P8|Overall Study|Study drug toxicity|4
4764647|NCT01621490|16436002|P7|Overall Study|Study drug toxicity|1
4764648|NCT01621490|16436003|P6|Overall Study|Study drug toxicity|10
4764649|NCT01621490|16436004|P5|Overall Study|Study drug toxicity|1
4764650|NCT01621490|16436005|P4|Overall Study|Study drug toxicity|3
4764651|NCT01621490|16436006|P3|Overall Study|Study drug toxicity|5
4764652|NCT01621490|16436007|P2|Overall Study|Study drug toxicity|4
4764653|NCT01621490|16436008|P1|Overall Study|Study drug toxicity|1
4764654|NCT01621490|16436000|P9|Overall Study|Disease progression|4
4764655|NCT01621490|16436001|P8|Overall Study|Disease progression|0
4764656|NCT01621490|16436002|P7|Overall Study|Disease progression|7
4764657|NCT01621490|16436003|P6|Overall Study|Disease progression|8
4764658|NCT01621490|16436004|P5|Overall Study|Disease progression|3
4764659|NCT01621490|16436005|P4|Overall Study|Disease progression|5
4764660|NCT01621490|16436006|P3|Overall Study|Disease progression|1
4764661|NCT01621490|16436007|P2|Overall Study|Disease progression|28
4764662|NCT01621490|16436008|P1|Overall Study|Disease progression|27
4764663|NCT01621490|16436000|P9|Overall Study|Adverse event unrelated to study drug|1
4764664|NCT01621490|16436001|P8|Overall Study|Adverse event unrelated to study drug|2
4764665|NCT01621490|16436002|P7|Overall Study|Adverse event unrelated to study drug|0
4764666|NCT01621490|16436003|P6|Overall Study|Adverse event unrelated to study drug|0
4764667|NCT01621490|16436004|P5|Overall Study|Adverse event unrelated to study drug|0
4764668|NCT01621490|16436005|P4|Overall Study|Adverse event unrelated to study drug|0
4764669|NCT01621490|16436006|P3|Overall Study|Adverse event unrelated to study drug|0
4764670|NCT01621490|16436007|P2|Overall Study|Adverse event unrelated to study drug|1
4764671|NCT01621490|16436008|P1|Overall Study|Adverse event unrelated to study drug|2
4764672|NCT01621490|16436000|P9|Overall Study|Subject request to discontinue study|1
4764673|NCT01621490|16436001|P8|Overall Study|Subject request to discontinue study|0
4764674|NCT01621490|16436002|P7|Overall Study|Subject request to discontinue study|1
4764675|NCT01621490|16436003|P6|Overall Study|Subject request to discontinue study|2
4764676|NCT01621490|16436004|P5|Overall Study|Subject request to discontinue study|0
4764677|NCT01621490|16436005|P4|Overall Study|Subject request to discontinue study|1
4764678|NCT01621490|16436006|P3|Overall Study|Subject request to discontinue study|1
4764679|NCT01621490|16436007|P2|Overall Study|Subject request to discontinue study|3
4764680|NCT01621490|16436008|P1|Overall Study|Subject request to discontinue study|1
4764681|NCT01621490|16436000|P9|Overall Study|Withdrawal by Subject|0
4764682|NCT01621490|16436001|P8|Overall Study|Withdrawal by Subject|0
4764683|NCT01621490|16436002|P7|Overall Study|Withdrawal by Subject|0
4764684|NCT01621490|16436003|P6|Overall Study|Withdrawal by Subject|3
4764685|NCT01621490|16436004|P5|Overall Study|Withdrawal by Subject|0
4764686|NCT01621490|16436005|P4|Overall Study|Withdrawal by Subject|0
4764687|NCT01621490|16436006|P3|Overall Study|Withdrawal by Subject|0
4764688|NCT01621490|16436007|P2|Overall Study|Withdrawal by Subject|0
4764689|NCT01621490|16436008|P1|Overall Study|Withdrawal by Subject|1
4764690|NCT01621490|16436000|P9|Overall Study|Maximum clinical benefit|0
4764691|NCT01621490|16436001|P8|Overall Study|Maximum clinical benefit|2
4764692|NCT01621490|16436002|P7|Overall Study|Maximum clinical benefit|1
4764693|NCT01621490|16436003|P6|Overall Study|Maximum clinical benefit|0
4764694|NCT01621490|16436004|P5|Overall Study|Maximum clinical benefit|0
4764695|NCT01621490|16436005|P4|Overall Study|Maximum clinical benefit|0
4764696|NCT01621490|16436006|P3|Overall Study|Maximum clinical benefit|0
4764697|NCT01621490|16436007|P2|Overall Study|Maximum clinical benefit|2
4764698|NCT01621490|16436008|P1|Overall Study|Maximum clinical benefit|3
4764699|NCT01621490|16436000|P9|Overall Study|Subject no longer meets study criteria|0
4764700|NCT01621490|16436001|P8|Overall Study|Subject no longer meets study criteria|0
4764701|NCT01621490|16436002|P7|Overall Study|Subject no longer meets study criteria|0
4764702|NCT01621490|16436003|P6|Overall Study|Subject no longer meets study criteria|0
4764703|NCT01621490|16436004|P5|Overall Study|Subject no longer meets study criteria|1
4764704|NCT01621490|16436005|P4|Overall Study|Subject no longer meets study criteria|0
4764705|NCT01621490|16436006|P3|Overall Study|Subject no longer meets study criteria|0
4764706|NCT01621490|16436007|P2|Overall Study|Subject no longer meets study criteria|0
4764707|NCT01621490|16436008|P1|Overall Study|Subject no longer meets study criteria|0
4764708|NCT01621490|16436000|P9|Overall Study|Patient could not travel|0
4764709|NCT01621490|16436001|P8|Overall Study|Patient could not travel|0
4764710|NCT01621490|16436002|P7|Overall Study|Patient could not travel|0
4764711|NCT01621490|16436003|P6|Overall Study|Patient could not travel|0
4764712|NCT01621490|16436004|P5|Overall Study|Patient could not travel|0
4764713|NCT01621490|16436005|P4|Overall Study|Patient could not travel|0
4764714|NCT01621490|16436006|P3|Overall Study|Patient could not travel|0
4764715|NCT01621490|16436007|P2|Overall Study|Patient could not travel|0
4764716|NCT01621490|16436008|P1|Overall Study|Patient could not travel|1
4764717|NCT01621490|16436000|P9|Overall Study|Participant completed treatment|0
4764718|NCT01621490|16436001|P8|Overall Study|Participant completed treatment|1
4764719|NCT01621490|16436002|P7|Overall Study|Participant completed treatment|0
4764720|NCT01621490|16436003|P6|Overall Study|Participant completed treatment|0
4764721|NCT01621490|16436004|P5|Overall Study|Participant completed treatment|0
4764722|NCT01621490|16436005|P4|Overall Study|Participant completed treatment|0
4764723|NCT01621490|16436006|P3|Overall Study|Participant completed treatment|1
4764724|NCT01621490|16436007|P2|Overall Study|Participant completed treatment|4
4764725|NCT01621490|16436008|P1|Overall Study|Participant completed treatment|4
4764726|NCT01621191|16436260|P1|Overall Study|Site Removed From Study|1
4764727|NCT01621191|16436260|P1|Overall Study|Lost to Follow-up|1
4764728|NCT01621191|16436260|P1|Overall Study|Lack of Efficacy|6
4764729|NCT01621191|16436260|P1|Overall Study|Withdrawal by Subject|8
4764730|NCT01621191|16436260|P1|Overall Study|Adverse Event|9
4764731|NCT01621178|16436274|P3|Overall Study|Physician Decision|7
4764732|NCT01621178|16436275|P2|Overall Study|Physician Decision|2
4764733|NCT01621178|16436276|P1|Overall Study|Physician Decision|5
4764734|NCT01621178|16436274|P3|Overall Study|Withdrawal by Subject|18
4764735|NCT01621178|16436275|P2|Overall Study|Withdrawal by Subject|17
4764736|NCT01621178|16436276|P1|Overall Study|Withdrawal by Subject|14
4764737|NCT01621178|16436274|P3|Overall Study|Lost to Follow-up|1
4764738|NCT01621178|16436275|P2|Overall Study|Lost to Follow-up|2
4764739|NCT01621178|16436276|P1|Overall Study|Lost to Follow-up|1
4764740|NCT01621178|16436274|P3|Overall Study|Death|2
4764741|NCT01621178|16436275|P2|Overall Study|Death|7
4764742|NCT01621178|16436276|P1|Overall Study|Death|6
4764743|NCT01621178|16436274|P3|Overall Study|Adverse Event|8
4764744|NCT01621178|16436275|P2|Overall Study|Adverse Event|2
4764745|NCT01621178|16436276|P1|Overall Study|Adverse Event|5
4764746|NCT01621126|16436368|P1|Overall Study|Physician Decision|6
4764747|NCT01620983|16436390|P3|Overall Study|Physician Decision|5
4764748|NCT01620983|16436391|P2|Overall Study|Physician Decision|10
4764749|NCT01620983|16436392|P1|Overall Study|Physician Decision|3
4764750|NCT01620983|16436390|P3|Overall Study|Death|0
4764751|NCT01620983|16436391|P2|Overall Study|Death|0
4764752|NCT01620983|16436392|P1|Overall Study|Death|2
4764753|NCT01620983|16436390|P3|Overall Study|Withdrawal by Subject|1
4764754|NCT01620983|16436391|P2|Overall Study|Withdrawal by Subject|8
4764755|NCT01620983|16436392|P1|Overall Study|Withdrawal by Subject|6
4764756|NCT01620983|16436390|P3|Overall Study|Lost to Follow-up|9
4764757|NCT01620983|16436391|P2|Overall Study|Lost to Follow-up|4
4764758|NCT01620983|16436392|P1|Overall Study|Lost to Follow-up|8
4764759|NCT01620762|16436421|P3|Overall Study|Use of prohibted therapies|1
4764760|NCT01620762|16436422|P2|Overall Study|Use of prohibted therapies|1
4764761|NCT01620762|16436423|P1|Overall Study|Use of prohibted therapies|0
4764762|NCT01620762|16436421|P3|Overall Study|Non-specified|5
4764763|NCT01620762|16436422|P2|Overall Study|Non-specified|6
4764764|NCT01620762|16436423|P1|Overall Study|Non-specified|3
4764765|NCT01620762|16436421|P3|Overall Study|Subject deterioration|1
4764766|NCT01620762|16436422|P2|Overall Study|Subject deterioration|1
4764767|NCT01620762|16436423|P1|Overall Study|Subject deterioration|0
4764768|NCT01620762|16436421|P3|Overall Study|Protocol deviation|6
4764769|NCT01620762|16436422|P2|Overall Study|Protocol deviation|1
4764770|NCT01620762|16436423|P1|Overall Study|Protocol deviation|1
4764771|NCT01620762|16436421|P3|Overall Study|Lost to Follow-up|10
4764772|NCT01620762|16436422|P2|Overall Study|Lost to Follow-up|17
4764773|NCT01620762|16436423|P1|Overall Study|Lost to Follow-up|11
4764774|NCT01620762|16436421|P3|Overall Study|Withdrawal by Subject|27
4764775|NCT01620762|16436422|P2|Overall Study|Withdrawal by Subject|26
4764776|NCT01620762|16436423|P1|Overall Study|Withdrawal by Subject|23
4764777|NCT01620762|16436421|P3|Overall Study|Adverse Event|2
4764778|NCT01620762|16436422|P2|Overall Study|Adverse Event|5
4764779|NCT01620762|16436423|P1|Overall Study|Adverse Event|9
4764780|NCT01620762|16436421|P3|Overall Study|Protocol Violation|1
4764781|NCT01620762|16436422|P2|Overall Study|Protocol Violation|1
4764782|NCT01620762|16436423|P1|Overall Study|Protocol Violation|1
4764783|NCT01620528|16436484|P3|Post-Treatment Follow-Up Period|Other|2
4764784|NCT01620528|16436485|P2|Post-Treatment Follow-Up Period|Other|4
4764785|NCT01620528|16436486|P1|Post-Treatment Follow-Up Period|Other|6
4764786|NCT01620528|16436484|P3|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4
4764787|NCT01620528|16436485|P2|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3
4764788|NCT01620528|16436486|P1|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8
4764789|NCT01620528|16436484|P3|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
4764790|NCT01620528|16436485|P2|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1
4764791|NCT01620528|16436486|P1|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0
4764792|NCT01620528|16436484|P3|Post-Treatment Follow-Up Period|Lost to Follow-up|4
4764793|NCT01620528|16436485|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|2
4764794|NCT01620528|16436486|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|3
4764795|NCT01620528|16436484|P3|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
4764796|NCT01620528|16436485|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|7
4764797|NCT01620528|16436486|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|3
4764798|NCT01620528|16436484|P3|Treatment Period|Exclusionary Medication Received|0
4764799|NCT01620528|16436485|P2|Treatment Period|Exclusionary Medication Received|1
4764800|NCT01620528|16436486|P1|Treatment Period|Exclusionary Medication Received|0
4764801|NCT01620528|16436484|P3|Treatment Period|Surgery/Invasive Intervention|3
4764802|NCT01620528|16436485|P2|Treatment Period|Surgery/Invasive Intervention|1
4764803|NCT01620528|16436486|P1|Treatment Period|Surgery/Invasive Intervention|5
4764804|NCT01620528|16436484|P3|Treatment Period|Pregnancy|2
4764805|NCT01620528|16436485|P2|Treatment Period|Pregnancy|2
4764806|NCT01620528|16436486|P1|Treatment Period|Pregnancy|7
4764807|NCT01620528|16436484|P3|Treatment Period|Subject Noncompliant|2
4764808|NCT01620528|16436485|P2|Treatment Period|Subject Noncompliant|2
4764809|NCT01620528|16436486|P1|Treatment Period|Subject Noncompliant|11
4764810|NCT01620528|16436484|P3|Treatment Period|Other|7
4764811|NCT01620528|16436485|P2|Treatment Period|Other|5
4764812|NCT01620528|16436486|P1|Treatment Period|Other|9
4764813|NCT01620528|16436484|P3|Treatment Period|Lost to Follow-up|14
4764814|NCT01620528|16436485|P2|Treatment Period|Lost to Follow-up|8
4764815|NCT01620528|16436486|P1|Treatment Period|Lost to Follow-up|16
4764816|NCT01620528|16436484|P3|Treatment Period|Adverse Event|21
4764817|NCT01620528|16436485|P2|Treatment Period|Adverse Event|13
4764818|NCT01620528|16436486|P1|Treatment Period|Adverse Event|17
4764819|NCT01620528|16436484|P3|Treatment Period|Withdrawal by Subject|16
4764820|NCT01620528|16436485|P2|Treatment Period|Withdrawal by Subject|21
4764821|NCT01620528|16436486|P1|Treatment Period|Withdrawal by Subject|35
4764822|NCT01620528|16436484|P3|Treatment Period|Did Not Receive Study Drug|1
4764823|NCT01620528|16436485|P2|Treatment Period|Did Not Receive Study Drug|0
4764824|NCT01620528|16436486|P1|Treatment Period|Did Not Receive Study Drug|0
4764825|NCT01620489|16436826|P2|Overall Study|Unclassified|2
4764826|NCT01620489|16436827|P1|Overall Study|Unclassified|1
4764827|NCT01620489|16436826|P2|Overall Study|Withdrawal Criteria|25
4764828|NCT01620489|16436827|P1|Overall Study|Withdrawal Criteria|17
4764829|NCT01620489|16436826|P2|Overall Study|Protocol Violation|3
4764830|NCT01620489|16436827|P1|Overall Study|Protocol Violation|0
4764831|NCT01620489|16436826|P2|Overall Study|Adverse Event|4
4764832|NCT01620489|16436827|P1|Overall Study|Adverse Event|17
4764833|NCT01620255|16436848|P5|Overall Study|Withdrawn at discretion of investigator|1
4764834|NCT01620255|16436849|P4|Overall Study|Withdrawn at discretion of investigator|0
4764835|NCT01620255|16436850|P3|Overall Study|Withdrawn at discretion of investigator|0
4764836|NCT01620255|16436851|P2|Overall Study|Withdrawn at discretion of investigator|0
4764837|NCT01620255|16436852|P1|Overall Study|Withdrawn at discretion of investigator|0
4764838|NCT01620255|16436848|P5|Overall Study|Adverse Event|1
4764839|NCT01620255|16436849|P4|Overall Study|Adverse Event|1
4764840|NCT01620255|16436850|P3|Overall Study|Adverse Event|0
4764841|NCT01620255|16436851|P2|Overall Study|Adverse Event|4
4764842|NCT01620255|16436852|P1|Overall Study|Adverse Event|0
4764843|NCT01620255|16436848|P5|Overall Study|Non-compliance|0
4764844|NCT01620255|16436849|P4|Overall Study|Non-compliance|0
4764845|NCT01620255|16436850|P3|Overall Study|Non-compliance|0
4764846|NCT01620255|16436851|P2|Overall Study|Non-compliance|1
4764847|NCT01620255|16436852|P1|Overall Study|Non-compliance|0
4764848|NCT01620255|16436848|P5|Overall Study|Participant underwent fecal transplant|0
4764849|NCT01620255|16436849|P4|Overall Study|Participant underwent fecal transplant|0
4764850|NCT01620255|16436850|P3|Overall Study|Participant underwent fecal transplant|1
4764851|NCT01620255|16436851|P2|Overall Study|Participant underwent fecal transplant|0
4764852|NCT01620255|16436852|P1|Overall Study|Participant underwent fecal transplant|0
4764853|NCT01620255|16436848|P5|Overall Study|Withdrawal by Subject|4
4764854|NCT01620255|16436849|P4|Overall Study|Withdrawal by Subject|2
4764855|NCT01620255|16436850|P3|Overall Study|Withdrawal by Subject|1
4764856|NCT01620255|16436851|P2|Overall Study|Withdrawal by Subject|1
4764857|NCT01620255|16436852|P1|Overall Study|Withdrawal by Subject|4
4764858|NCT01620177|16436929|P1|Overall Study|Randomized, Not Active due to Scheduling|1
4764859|NCT01620177|16436929|P1|Overall Study|Physician Decision|2
4764860|NCT01620177|16436929|P1|Overall Study|Lost to Follow-up|7
4764861|NCT01620177|16436929|P1|Overall Study|Withdrawal by Subject|26
4764862|NCT01620177|16436929|P1|Overall Study|Failure at Screening Visit|43
4764863|NCT01620138|16436954|P2|Overall Study|Adverse Event|0
4764864|NCT01620138|16436955|P1|Overall Study|Adverse Event|2
4764865|NCT01620138|16436954|P2|Overall Study|Lack of Efficacy|0
4764866|NCT01620138|16436955|P1|Overall Study|Lack of Efficacy|1
4764867|NCT01620138|16436954|P2|Overall Study|Withdrawal by Subject|0
4764868|NCT01620138|16436955|P1|Overall Study|Withdrawal by Subject|3
4764869|NCT01620086|16436963|P3|Overall Study|Physician Decision|0
4764870|NCT01620086|16436964|P2|Overall Study|Physician Decision|0
4764871|NCT01620086|16436965|P1|Overall Study|Physician Decision|1
4764872|NCT01620086|16436963|P3|Overall Study|failed study criteria|0
4764873|NCT01620086|16436964|P2|Overall Study|failed study criteria|4
4764874|NCT01620086|16436965|P1|Overall Study|failed study criteria|1
4764875|NCT01620086|16436963|P3|Overall Study|Withdrawal by Subject|0
4764876|NCT01620086|16436964|P2|Overall Study|Withdrawal by Subject|3
4764877|NCT01620086|16436965|P1|Overall Study|Withdrawal by Subject|3
4764878|NCT01620060|16436984|P1|Overall Study|Per Sponsor Decision|2
4764879|NCT01620060|16436984|P1|Overall Study|Family emergency|1
4764880|NCT01620060|16436984|P1|Overall Study|Did not comply with Study Produre|1
4764881|NCT01620060|16436984|P1|Overall Study|Withdrawal by Subject|1
4764882|NCT01620060|16436984|P1|Overall Study|Protocol Violation|1
4764883|NCT01620060|16436984|P1|Overall Study|Adverse Event|9
4764884|NCT01619878|16437022|P1|Follow-up at 12 Months of Age|Death|2
4764885|NCT01619878|16437022|P1|Follow-up at 12 Months of Age|Lost to Follow-up|1
4764886|NCT01619878|16437022|P1|6 Week Follow-up Phase|Adverse Event|1
4764887|NCT01619852|16437036|P2|3 Month Follow up|Lost to Follow-up|34
4764888|NCT01619852|16437037|P1|3 Month Follow up|Lost to Follow-up|31
4764889|NCT01619852|16437036|P2|24 Hour Assessment|Withdrawal by Subject|1
4764890|NCT01619852|16437037|P1|24 Hour Assessment|Withdrawal by Subject|1
4764891|NCT01619800|16437053|P2|Overall Study|study terminated|0
4764892|NCT01619800|16437054|P1|Overall Study|study terminated|2
4764893|NCT01619787|16437062|P1|Overall Study|Lost to Follow-up|5
4764894|NCT01619579|16437079|P2|Overall Study|Withdrawal by Subject|3
4764895|NCT01619579|16437080|P1|Overall Study|Withdrawal by Subject|0
4764896|NCT01619423|16437094|P4|Part 1 (Dose Escalation)|High basal Mn|0
4764897|NCT01619423|16437095|P3|Part 1 (Dose Escalation)|High basal Mn|0
4764898|NCT01619423|16437096|P2|Part 1 (Dose Escalation)|High basal Mn|2
4764899|NCT01619423|16437097|P1|Part 1 (Dose Escalation)|High basal Mn|0
4764900|NCT01619410|16437110|P2|Overall Study|Lost to Follow-up|4
4764901|NCT01619410|16437111|P1|Overall Study|Lost to Follow-up|7
4764902|NCT01619085|16437123|P1|Overall Study|Ongoing on trial|27
4764903|NCT01619085|16437123|P1|Overall Study|Not treated|1
4764904|NCT01619085|16437123|P1|Overall Study|Other than specified|94
4764905|NCT01619085|16437123|P1|Overall Study|Withdrawal by Subject|15
4764906|NCT01619085|16437123|P1|Overall Study|Lost to Follow-up|10
4764907|NCT01619085|16437123|P1|Overall Study|Protocol Violation|10
4764908|NCT01619085|16437123|P1|Overall Study|Adverse Event|212
4764909|NCT01619059|16437129|P2|Long-Term (LT) Treatment Period|Not Met Study Criteria|1
4764910|NCT01619059|16437130|P1|Long-Term (LT) Treatment Period|Not Met Study Criteria|0
4764911|NCT01619059|16437129|P2|Long-Term (LT) Treatment Period|Lost to Follow-up|2
4764912|NCT01619059|16437130|P1|Long-Term (LT) Treatment Period|Lost to Follow-up|2
4764913|NCT01619059|16437129|P2|Long-Term (LT) Treatment Period|Death|0
4764914|NCT01619059|16437130|P1|Long-Term (LT) Treatment Period|Death|1
4764915|NCT01619059|16437129|P2|Long-Term (LT) Treatment Period|Withdrawal by Subject|2
4764916|NCT01619059|16437130|P1|Long-Term (LT) Treatment Period|Withdrawal by Subject|3
4764917|NCT01619059|16437129|P2|Long-Term (LT) Treatment Period|Adverse Event|3
4764918|NCT01619059|16437130|P1|Long-Term (LT) Treatment Period|Adverse Event|2
4764919|NCT01619059|16437129|P2|Long-Term (LT) Treatment Period|Lack of Efficacy|1
4764920|NCT01619059|16437130|P1|Long-Term (LT) Treatment Period|Lack of Efficacy|0
4764921|NCT01619059|16437129|P2|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2
4764922|NCT01619059|16437130|P1|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1
4764923|NCT01619059|16437129|P2|Short-Term (ST) Treatment Period|Lost to Follow-up|4
4764924|NCT01619059|16437130|P1|Short-Term (ST) Treatment Period|Lost to Follow-up|2
4764925|NCT01619059|16437129|P2|Short-Term (ST) Treatment Period|Withdrawal by Subject|5
4764926|NCT01619059|16437130|P1|Short-Term (ST) Treatment Period|Withdrawal by Subject|2
4764927|NCT01619059|16437129|P2|Short-Term (ST) Treatment Period|Adverse Event|0
4764928|NCT01619059|16437130|P1|Short-Term (ST) Treatment Period|Adverse Event|1
4764929|NCT01618968|16437146|P4|Overall Study|Death|1
4764930|NCT01618968|16437147|P3|Overall Study|Death|0
4764931|NCT01618968|16437148|P2|Overall Study|Death|0
4764932|NCT01618968|16437149|P1|Overall Study|Death|0
4764933|NCT01618968|16437146|P4|Overall Study|Adverse Event|0
4764934|NCT01618968|16437147|P3|Overall Study|Adverse Event|0
4764935|NCT01618968|16437148|P2|Overall Study|Adverse Event|0
4764936|NCT01618968|16437149|P1|Overall Study|Adverse Event|1
4764937|NCT01618916|16437222|P6|Overall Study|Lost to Follow-up|0
4764938|NCT01618916|16437223|P5|Overall Study|Lost to Follow-up|0
4764939|NCT01618916|16437224|P4|Overall Study|Lost to Follow-up|2
4764940|NCT01618916|16437225|P3|Overall Study|Lost to Follow-up|0
4764941|NCT01618916|16437226|P2|Overall Study|Lost to Follow-up|0
4764942|NCT01618916|16437227|P1|Overall Study|Lost to Follow-up|1
4764943|NCT01618916|16437222|P6|Overall Study|Withdrawal by Subject|0
4764944|NCT01618916|16437223|P5|Overall Study|Withdrawal by Subject|1
4764945|NCT01618916|16437224|P4|Overall Study|Withdrawal by Subject|0
4764946|NCT01618916|16437225|P3|Overall Study|Withdrawal by Subject|1
4764947|NCT01618916|16437226|P2|Overall Study|Withdrawal by Subject|1
4764948|NCT01618916|16437227|P1|Overall Study|Withdrawal by Subject|0
4764949|NCT01618916|16437222|P6|Overall Study|Adverse Event|0
4764950|NCT01618916|16437223|P5|Overall Study|Adverse Event|0
4764951|NCT01618916|16437224|P4|Overall Study|Adverse Event|0
4764952|NCT01618916|16437225|P3|Overall Study|Adverse Event|0
4764953|NCT01618916|16437226|P2|Overall Study|Adverse Event|0
4764954|NCT01618916|16437227|P1|Overall Study|Adverse Event|1
4764955|NCT01618864|16437257|P1|Overall Study|Lost to Follow-up|2
4764956|NCT01618864|16437257|P1|Overall Study|Withdrawal by Subject|2
4764957|NCT01618838|16437266|P1|Overall Study|slow accrual, trial closed prematurely.|4
4764958|NCT01618708|16437274|P2|Overall Study|Randomized but not treated|2
4764959|NCT01618708|16437275|P1|Overall Study|Randomized but not treated|3
4764960|NCT01618708|16437274|P2|Overall Study|Other than specified above|1
4764961|NCT01618708|16437275|P1|Overall Study|Other than specified above|1
4764962|NCT01618708|16437274|P2|Overall Study|Technical problems|0
4764963|NCT01618708|16437275|P1|Overall Study|Technical problems|2
4764964|NCT01618708|16437274|P2|Overall Study|Lack of Efficacy|8
4764965|NCT01618708|16437275|P1|Overall Study|Lack of Efficacy|8
4764966|NCT01618708|16437274|P2|Overall Study|Withdrawal by Subject|22
4764967|NCT01618708|16437275|P1|Overall Study|Withdrawal by Subject|17
4764968|NCT01618708|16437274|P2|Overall Study|Lost to Follow-up|3
4764969|NCT01618708|16437275|P1|Overall Study|Lost to Follow-up|3
4764970|NCT01618708|16437274|P2|Overall Study|Adverse Event|10
4764971|NCT01618708|16437275|P1|Overall Study|Adverse Event|10
4764972|NCT01618695|16437291|P4|Overall Study|Not treated|0
4764973|NCT01618695|16437292|P3|Overall Study|Not treated|2
4764974|NCT01618695|16437293|P2|Overall Study|Not treated|0
4764975|NCT01618695|16437294|P1|Overall Study|Not treated|1
4764976|NCT01618695|16437291|P4|Overall Study|Other than specified|2
4764977|NCT01618695|16437292|P3|Overall Study|Other than specified|2
4764978|NCT01618695|16437293|P2|Overall Study|Other than specified|2
4764979|NCT01618695|16437294|P1|Overall Study|Other than specified|1
4764980|NCT01618695|16437291|P4|Overall Study|Lack of Efficacy|1
4764981|NCT01618695|16437292|P3|Overall Study|Lack of Efficacy|1
4764982|NCT01618695|16437293|P2|Overall Study|Lack of Efficacy|2
4764983|NCT01618695|16437294|P1|Overall Study|Lack of Efficacy|1
4764984|NCT01618695|16437291|P4|Overall Study|Pregnancy|0
4764985|NCT01618695|16437292|P3|Overall Study|Pregnancy|0
4764986|NCT01618695|16437293|P2|Overall Study|Pregnancy|0
4764987|NCT01618695|16437294|P1|Overall Study|Pregnancy|2
4764988|NCT01618695|16437291|P4|Overall Study|Withdrawal by Subject|13
4764989|NCT01618695|16437292|P3|Overall Study|Withdrawal by Subject|9
4764990|NCT01618695|16437293|P2|Overall Study|Withdrawal by Subject|11
4764991|NCT01618695|16437294|P1|Overall Study|Withdrawal by Subject|16
4764992|NCT01618695|16437291|P4|Overall Study|Lost to Follow-up|0
4764993|NCT01618695|16437292|P3|Overall Study|Lost to Follow-up|1
4764994|NCT01618695|16437293|P2|Overall Study|Lost to Follow-up|0
4764995|NCT01618695|16437294|P1|Overall Study|Lost to Follow-up|0
4764996|NCT01618695|16437291|P4|Overall Study|Adverse Event|20
4764997|NCT01618695|16437292|P3|Overall Study|Adverse Event|15
4764998|NCT01618695|16437293|P2|Overall Study|Adverse Event|5
4764999|NCT01618695|16437294|P1|Overall Study|Adverse Event|4
4765000|NCT01618669|16437318|P2|Overall Study|Miscellaneous Reason|1
4765001|NCT01618669|16437319|P1|Overall Study|Miscellaneous Reason|0
4765002|NCT01618669|16437318|P2|Overall Study|Withdrawal by Subject|9
4765003|NCT01618669|16437319|P1|Overall Study|Withdrawal by Subject|9
4765004|NCT01618669|16437318|P2|Overall Study|Protocol Violation|3
4765005|NCT01618669|16437319|P1|Overall Study|Protocol Violation|5
4765006|NCT01618669|16437318|P2|Overall Study|Adverse Event|7
4765007|NCT01618669|16437319|P1|Overall Study|Adverse Event|16
4765008|NCT01618669|16437318|P2|Overall Study|Randomized but Never Received Study Drug|2
4765009|NCT01618669|16437319|P1|Overall Study|Randomized but Never Received Study Drug|3
4765010|NCT01618669|16437318|P2|Overall Study|Lost to Follow-up|1
4765011|NCT01618669|16437319|P1|Overall Study|Lost to Follow-up|1
4765012|NCT01618305|16437378|P2|Overall Study|Withdrawal by Subject|2
4765013|NCT01618305|16437379|P1|Overall Study|Withdrawal by Subject|3
4765014|NCT01618305|16437378|P2|Overall Study|Protocol Violation|0
4765015|NCT01618305|16437379|P1|Overall Study|Protocol Violation|1
4765016|NCT01618305|16437378|P2|Overall Study|Lost to Follow-up|7
4765017|NCT01618305|16437379|P1|Overall Study|Lost to Follow-up|11
4765018|NCT01618305|16437378|P2|Overall Study|Death|1
4765019|NCT01618305|16437379|P1|Overall Study|Death|0
4765020|NCT01618266|16437421|P1|Overall Study|Protocol Violation|43
4765021|NCT01618266|16437421|P1|Overall Study|Lack of Efficacy|23
4765022|NCT01618266|16437421|P1|Overall Study|Other reasons|11
4765023|NCT01618266|16437421|P1|Overall Study|Treatment satisfaction|10
4765024|NCT01618266|16437421|P1|Overall Study|Lost to Follow-up|9
4765025|NCT01618214|16437458|P2|Overall Study|Unclassified|5
4765026|NCT01618214|16437459|P1|Overall Study|Unclassified|4
4765027|NCT01618214|16437458|P2|Overall Study|Withdrawal Criteria|2
4765028|NCT01618214|16437459|P1|Overall Study|Withdrawal Criteria|1
4765029|NCT01618214|16437458|P2|Overall Study|Protocol Violation|4
4765030|NCT01618214|16437459|P1|Overall Study|Protocol Violation|1
4765031|NCT01618214|16437458|P2|Overall Study|Lack of Efficacy|1
4765032|NCT01618214|16437459|P1|Overall Study|Lack of Efficacy|1
4765033|NCT01618214|16437458|P2|Overall Study|Adverse Event|1
4765034|NCT01618214|16437459|P1|Overall Study|Adverse Event|3
4765035|NCT01618162|16437475|P2|Overall Study|Unclassified|13
4765036|NCT01618162|16437476|P1|Overall Study|Unclassified|14
4765037|NCT01618162|16437475|P2|Overall Study|Withdrawal Criteria|10
4765038|NCT01618162|16437476|P1|Overall Study|Withdrawal Criteria|2
4765039|NCT01618162|16437475|P2|Overall Study|Adverse Event|2
4765040|NCT01618162|16437476|P1|Overall Study|Adverse Event|9
4765041|NCT01618162|16437475|P2|Overall Study|Protocol Violation|10
4765042|NCT01618162|16437476|P1|Overall Study|Protocol Violation|13
4765043|NCT01618019|16437496|P2|Overall Study|Withdrawal by Subject|14
4765044|NCT01618019|16437497|P1|Overall Study|Withdrawal by Subject|14
4765045|NCT01617967|16437523|P6|Overall Study|Dosing Suspended by Sponsor|0
4765046|NCT01617967|16437524|P5|Overall Study|Dosing Suspended by Sponsor|0
4765047|NCT01617967|16437525|P4|Overall Study|Dosing Suspended by Sponsor|0
4765048|NCT01617967|16437526|P3|Overall Study|Dosing Suspended by Sponsor|0
4765049|NCT01617967|16437527|P2|Overall Study|Dosing Suspended by Sponsor|0
4765050|NCT01617967|16437528|P1|Overall Study|Dosing Suspended by Sponsor|1
4765051|NCT01617967|16437523|P6|Overall Study|Withdrawal by Subject|1
4765052|NCT01617967|16437524|P5|Overall Study|Withdrawal by Subject|0
4765053|NCT01617967|16437525|P4|Overall Study|Withdrawal by Subject|0
4765054|NCT01617967|16437526|P3|Overall Study|Withdrawal by Subject|0
4765055|NCT01617967|16437527|P2|Overall Study|Withdrawal by Subject|0
4765056|NCT01617967|16437528|P1|Overall Study|Withdrawal by Subject|0
4765057|NCT01617967|16437523|P6|Overall Study|Protocol Violation|0
4765058|NCT01617967|16437524|P5|Overall Study|Protocol Violation|0
4765059|NCT01617967|16437525|P4|Overall Study|Protocol Violation|1
4765060|NCT01617967|16437526|P3|Overall Study|Protocol Violation|0
4765061|NCT01617967|16437527|P2|Overall Study|Protocol Violation|0
4765062|NCT01617967|16437528|P1|Overall Study|Protocol Violation|0
4765063|NCT01617681|16437582|P5|Period 2 Open Label|Withdrawal by Subject|3
4765064|NCT01617681|16437583|P4|Period 2 Open Label|Withdrawal by Subject|0
4765065|NCT01617681|16437584|P3|Period 2 Open Label|Withdrawal by Subject|0
4765066|NCT01617681|16437585|P2|Period 2 Open Label|Withdrawal by Subject|0
4765067|NCT01617681|16437586|P1|Period 2 Open Label|Withdrawal by Subject|0
4765068|NCT01617681|16437582|P5|Period 2 Open Label|Adverse Event|3
4765069|NCT01617681|16437583|P4|Period 2 Open Label|Adverse Event|0
4765070|NCT01617681|16437584|P3|Period 2 Open Label|Adverse Event|0
4765071|NCT01617681|16437585|P2|Period 2 Open Label|Adverse Event|0
4765072|NCT01617681|16437586|P1|Period 2 Open Label|Adverse Event|0
4765073|NCT01617681|16437582|P5|Period 1 Double Blind|Withdrawal by Subject|0
4765074|NCT01617681|16437583|P4|Period 1 Double Blind|Withdrawal by Subject|0
4765075|NCT01617681|16437584|P3|Period 1 Double Blind|Withdrawal by Subject|1
4765076|NCT01617681|16437585|P2|Period 1 Double Blind|Withdrawal by Subject|1
4765077|NCT01617681|16437586|P1|Period 1 Double Blind|Withdrawal by Subject|1
4765078|NCT01617681|16437582|P5|Period 1 Double Blind|Adverse Event|0
4765079|NCT01617681|16437583|P4|Period 1 Double Blind|Adverse Event|2
4765080|NCT01617681|16437584|P3|Period 1 Double Blind|Adverse Event|0
4765081|NCT01617681|16437585|P2|Period 1 Double Blind|Adverse Event|0
4765082|NCT01617681|16437586|P1|Period 1 Double Blind|Adverse Event|2
4765083|NCT01617668|16437607|P4|Overall Study|Subject/guardian decision|1
4765084|NCT01617668|16437608|P3|Overall Study|Subject/guardian decision|2
4765085|NCT01617668|16437609|P2|Overall Study|Subject/guardian decision|3
4765086|NCT01617668|16437610|P1|Overall Study|Subject/guardian decision|1
4765087|NCT01617668|16437607|P4|Overall Study|Progressive Disease|9
4765088|NCT01617668|16437608|P3|Overall Study|Progressive Disease|6
4765089|NCT01617668|16437609|P2|Overall Study|Progressive Disease|4
4765090|NCT01617668|16437610|P1|Overall Study|Progressive Disease|4
4765091|NCT01617668|16437607|P4|Overall Study|Physician Decision|0
4765092|NCT01617668|16437608|P3|Overall Study|Physician Decision|3
4765093|NCT01617668|16437609|P2|Overall Study|Physician Decision|2
4765094|NCT01617668|16437610|P1|Overall Study|Physician Decision|1
4765095|NCT01617668|16437607|P4|Overall Study|Adverse Event|5
4765096|NCT01617668|16437608|P3|Overall Study|Adverse Event|12
4765097|NCT01617668|16437609|P2|Overall Study|Adverse Event|0
4765098|NCT01617668|16437610|P1|Overall Study|Adverse Event|7
4765099|NCT01617655|16437651|P2|Overall Study|Other than specified above|2
4765100|NCT01617655|16437652|P1|Overall Study|Other than specified above|1
4765101|NCT01617655|16437651|P2|Overall Study|Site closure|5
4765102|NCT01617655|16437652|P1|Overall Study|Site closure|3
4765103|NCT01617655|16437651|P2|Overall Study|Last visit outside protocol visit window|10
4765104|NCT01617655|16437652|P1|Overall Study|Last visit outside protocol visit window|1
4765105|NCT01617655|16437651|P2|Overall Study|Consent withdrawn by participant|1
4765106|NCT01617655|16437652|P1|Overall Study|Consent withdrawn by participant|1
4765107|NCT01617655|16437651|P2|Overall Study|Participants moved|4
4765108|NCT01617655|16437652|P1|Overall Study|Participants moved|0
4765109|NCT01617655|16437651|P2|Overall Study|Poor compliance to protocol|4
4765110|NCT01617655|16437652|P1|Overall Study|Poor compliance to protocol|1
4765111|NCT01617655|16437651|P2|Overall Study|Adverse Event|3
4765112|NCT01617655|16437652|P1|Overall Study|Adverse Event|2
4765113|NCT01617629|16437712|P1|Overall Study|Participant Withdrew Consent|2
4765114|NCT01617629|16437712|P1|Overall Study|Reason Not Specified|1
4765115|NCT01617629|16437712|P1|Overall Study|Investigator's Clinical Judgement|1
4765116|NCT01617629|16437712|P1|Overall Study|Death|2
4765117|NCT01617460|16437740|P1|Overall Study|Withdrawal by Subject|9
4765118|NCT01617460|16437740|P1|Overall Study|Protocol Violation|5
4765119|NCT01617460|16437740|P1|Overall Study|Physician Decision|16
4765120|NCT01617460|16437740|P1|Overall Study|Adverse Event|10
4765121|NCT01617447|16437746|P2|Overall Study|Physician Decision|2
4765122|NCT01617447|16437747|P1|Overall Study|Physician Decision|0
4765123|NCT01617447|16437746|P2|Overall Study|Adverse Event|1
4765124|NCT01617447|16437747|P1|Overall Study|Adverse Event|0
4765125|NCT01617434|16437755|P2|Overall Study|Unclassified|4
4765126|NCT01617434|16437756|P1|Overall Study|Unclassified|3
4765127|NCT01617434|16437755|P2|Overall Study|Withdrawal Criteria|37
4765128|NCT01617434|16437756|P1|Overall Study|Withdrawal Criteria|12
4765129|NCT01617434|16437755|P2|Overall Study|Protocol Violation|7
4765130|NCT01617434|16437756|P1|Overall Study|Protocol Violation|8
4765131|NCT01617434|16437755|P2|Overall Study|Adverse Event|3
4765132|NCT01617434|16437756|P1|Overall Study|Adverse Event|12
4765133|NCT01617187|16437795|P4|Treatment Through Study Completion|Protocol Violation|1
4765134|NCT01617187|16437796|P3|Treatment Through Study Completion|Protocol Violation|0
4765135|NCT01617187|16437797|P2|Treatment Through Study Completion|Protocol Violation|0
4765136|NCT01617187|16437798|P1|Treatment Through Study Completion|Protocol Violation|1
4765137|NCT01617187|16437795|P4|Treatment Through Study Completion|Withdrawal by Subject|6
4765138|NCT01617187|16437796|P3|Treatment Through Study Completion|Withdrawal by Subject|3
4765139|NCT01617187|16437797|P2|Treatment Through Study Completion|Withdrawal by Subject|8
4765140|NCT01617187|16437798|P1|Treatment Through Study Completion|Withdrawal by Subject|5
4765141|NCT01617187|16437795|P4|Treatment Through Study Completion|Lost to Follow-up|2
4765142|NCT01617187|16437796|P3|Treatment Through Study Completion|Lost to Follow-up|2
4765143|NCT01617187|16437797|P2|Treatment Through Study Completion|Lost to Follow-up|2
4765144|NCT01617187|16437798|P1|Treatment Through Study Completion|Lost to Follow-up|4
4765145|NCT01617187|16437795|P4|Treatment Through Study Completion|Adverse Event|1
4765146|NCT01617187|16437796|P3|Treatment Through Study Completion|Adverse Event|0
4765147|NCT01617187|16437797|P2|Treatment Through Study Completion|Adverse Event|1
4765148|NCT01617187|16437798|P1|Treatment Through Study Completion|Adverse Event|1
4765149|NCT01617187|16437795|P4|Randomization Through Start Treatment|Not Treated: Completed study in database|0
4765150|NCT01617187|16437796|P3|Randomization Through Start Treatment|Not Treated: Completed study in database|0
4765151|NCT01617187|16437797|P2|Randomization Through Start Treatment|Not Treated: Completed study in database|0
4765152|NCT01617187|16437798|P1|Randomization Through Start Treatment|Not Treated: Completed study in database|1
4765153|NCT01617187|16437795|P4|Randomization Through Start Treatment|Not Treated: Adverse Event|1
4765154|NCT01617187|16437796|P3|Randomization Through Start Treatment|Not Treated: Adverse Event|0
4765155|NCT01617187|16437797|P2|Randomization Through Start Treatment|Not Treated: Adverse Event|0
4765156|NCT01617187|16437798|P1|Randomization Through Start Treatment|Not Treated: Adverse Event|0
4765157|NCT01617187|16437795|P4|Randomization Through Start Treatment|Not Treated: Administrative Reason|1
4765158|NCT01617187|16437796|P3|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
4765159|NCT01617187|16437797|P2|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
4765160|NCT01617187|16437798|P1|Randomization Through Start Treatment|Not Treated: Administrative Reason|0
4765161|NCT01617070|16437895|P1|BH4 and LNAA (4 Weeks)|started medication interfere with study|1
4765162|NCT01617005|16437913|P1|Overall Study|Lack of motivation for treatment|1
4765163|NCT01617005|16437913|P1|Overall Study|Pregnancy|1
4765164|NCT01616953|16437922|P2|Overall Study|lack of bone and soft tissue|0
4765165|NCT01616953|16437923|P1|Overall Study|lack of bone and soft tissue|1
4765166|NCT01616953|16437922|P2|Overall Study|Lost to Follow-up|0
4765167|NCT01616953|16437923|P1|Overall Study|Lost to Follow-up|1
4765168|NCT01616771|16437931|P1|Smaller Sized GVL for 5 Sec|lack of GVL size|4
4765169|NCT01616693|16437944|P4|Blood Analyzed for Immunogenicity|Protocol Violation|1
4765170|NCT01616693|16437945|P3|Blood Analyzed for Immunogenicity|Protocol Violation|6
4765171|NCT01616693|16437946|P2|Blood Analyzed for Immunogenicity|Protocol Violation|2
4765172|NCT01616693|16437947|P1|Blood Analyzed for Immunogenicity|Protocol Violation|4
4765173|NCT01616693|16437944|P4|Received Both Vaccines|Lost to Follow-up|4
4765174|NCT01616693|16437945|P3|Received Both Vaccines|Lost to Follow-up|4
4765175|NCT01616693|16437946|P2|Received Both Vaccines|Lost to Follow-up|3
4765176|NCT01616693|16437947|P1|Received Both Vaccines|Lost to Follow-up|4
4765177|NCT01616693|16437944|P4|Received Both Vaccines|Withdrawal by Subject|15
4765178|NCT01616693|16437945|P3|Received Both Vaccines|Withdrawal by Subject|8
4765179|NCT01616693|16437946|P2|Received Both Vaccines|Withdrawal by Subject|7
4765180|NCT01616693|16437947|P1|Received Both Vaccines|Withdrawal by Subject|7
4765181|NCT01616693|16437944|P4|Received Both Vaccines|Adverse Event|0
4765182|NCT01616693|16437945|P3|Received Both Vaccines|Adverse Event|0
4765183|NCT01616693|16437946|P2|Received Both Vaccines|Adverse Event|0
4765184|NCT01616693|16437947|P1|Received Both Vaccines|Adverse Event|2
4765185|NCT01616693|16437944|P4|Evaluated for Safety|Physician Decision|0
4765186|NCT01616693|16437945|P3|Evaluated for Safety|Physician Decision|1
4765187|NCT01616693|16437946|P2|Evaluated for Safety|Physician Decision|0
4765188|NCT01616693|16437947|P1|Evaluated for Safety|Physician Decision|1
4765189|NCT01616459|16438013|P4|Overall Study|Other reason|0
4765190|NCT01616459|16438014|P3|Overall Study|Other reason|1
4765191|NCT01616459|16438015|P2|Overall Study|Other reason|1
4765192|NCT01616459|16438016|P1|Overall Study|Other reason|0
4765193|NCT01616459|16438013|P4|Overall Study|Withdrawal by Subject|4
4765194|NCT01616459|16438014|P3|Overall Study|Withdrawal by Subject|4
4765195|NCT01616459|16438015|P2|Overall Study|Withdrawal by Subject|4
4765196|NCT01616459|16438016|P1|Overall Study|Withdrawal by Subject|2
4765197|NCT01616459|16438013|P4|Overall Study|Protocol Violation|2
4765198|NCT01616459|16438014|P3|Overall Study|Protocol Violation|0
4765199|NCT01616459|16438015|P2|Overall Study|Protocol Violation|0
4765200|NCT01616459|16438016|P1|Overall Study|Protocol Violation|0
4765201|NCT01616459|16438013|P4|Overall Study|Lost to Follow-up|2
4765202|NCT01616459|16438014|P3|Overall Study|Lost to Follow-up|3
4765203|NCT01616459|16438015|P2|Overall Study|Lost to Follow-up|11
4765204|NCT01616459|16438016|P1|Overall Study|Lost to Follow-up|1
4765205|NCT01616459|16438013|P4|Overall Study|Adverse Event|0
4765206|NCT01616459|16438014|P3|Overall Study|Adverse Event|2
4765207|NCT01616459|16438015|P2|Overall Study|Adverse Event|1
4765208|NCT01616459|16438016|P1|Overall Study|Adverse Event|1
4765209|NCT01616173|16438117|P3|Overall Study|Lost to Follow-up|0
4765210|NCT01616173|16438118|P2|Overall Study|Lost to Follow-up|2
4765211|NCT01616173|16438119|P1|Overall Study|Lost to Follow-up|0
4765212|NCT01615939|16438152|P2|Overall Study|Lost to Follow-up|0
4765213|NCT01615939|16438153|P1|Overall Study|Lost to Follow-up|5
4765214|NCT01615822|16438166|P3|Period 2|Lost to Follow-up|2
4765215|NCT01615822|16438167|P2|Period 2|Lost to Follow-up|1
4765216|NCT01615822|16438168|P1|Period 2|Lost to Follow-up|0
4765217|NCT01615822|16438166|P3|Period 1|Adverse Event|0
4765218|NCT01615822|16438167|P2|Period 1|Adverse Event|1
4765219|NCT01615822|16438168|P1|Period 1|Adverse Event|1
4765220|NCT01615822|16438166|P3|Period 1|Withdrawal by Subject|0
4765221|NCT01615822|16438167|P2|Period 1|Withdrawal by Subject|1
4765222|NCT01615822|16438168|P1|Period 1|Withdrawal by Subject|0
4765223|NCT01615328|16438256|P2|Overall Study|Lost to Follow-up|5
4765224|NCT01615328|16438257|P1|Overall Study|Lost to Follow-up|3
4765225|NCT01615263|16438269|P2|Overall Study|Post-randomization exclusion|2
4765226|NCT01615263|16438270|P1|Overall Study|Post-randomization exclusion|0
4765227|NCT01615198|16438284|P2|Overall Study|Adverse Event|5
4765228|NCT01615198|16438285|P1|Overall Study|Adverse Event|11
4765229|NCT01615198|16438284|P2|Overall Study|Lack of Efficacy|6
4765230|NCT01615198|16438285|P1|Overall Study|Lack of Efficacy|1
4765231|NCT01615198|16438284|P2|Overall Study|Lost to Follow-up|1
4765232|NCT01615198|16438285|P1|Overall Study|Lost to Follow-up|1
4765233|NCT01615198|16438284|P2|Overall Study|Physician Decision|1
4765234|NCT01615198|16438285|P1|Overall Study|Physician Decision|5
4765235|NCT01615198|16438284|P2|Overall Study|Protocol deviation|1
4765236|NCT01615198|16438285|P1|Overall Study|Protocol deviation|1
4765237|NCT01615198|16438284|P2|Overall Study|Withdrawal by Subject|5
4765238|NCT01615198|16438285|P1|Overall Study|Withdrawal by Subject|5
4765239|NCT01614886|16438360|P2|Overall Study|Protocol deviation|2
4765240|NCT01614886|16438361|P1|Overall Study|Protocol deviation|0
4765241|NCT01614886|16438360|P2|Overall Study|Death|0
4765242|NCT01614886|16438361|P1|Overall Study|Death|1
4765243|NCT01614886|16438360|P2|Overall Study|Withdrawal by Subject|4
4765244|NCT01614886|16438361|P1|Overall Study|Withdrawal by Subject|4
4765245|NCT01614886|16438360|P2|Overall Study|Adverse Event|20
4765246|NCT01614886|16438361|P1|Overall Study|Adverse Event|15
4765247|NCT01614795|16438402|P4|Overall Study|Ineligible|0
4765248|NCT01614795|16438403|P3|Overall Study|Ineligible|0
4765249|NCT01614795|16438404|P2|Overall Study|Ineligible|1
4765250|NCT01614795|16438405|P1|Overall Study|Ineligible|0
4765251|NCT01614795|16438402|P4|Overall Study|Withdrawal by Subject|2
4765252|NCT01614795|16438403|P3|Overall Study|Withdrawal by Subject|0
4765253|NCT01614795|16438404|P2|Overall Study|Withdrawal by Subject|1
4765254|NCT01614795|16438405|P1|Overall Study|Withdrawal by Subject|0
4765255|NCT01614795|16438402|P4|Overall Study|Physician Decision|1
4765256|NCT01614795|16438403|P3|Overall Study|Physician Decision|1
4765257|NCT01614795|16438404|P2|Overall Study|Physician Decision|0
4765258|NCT01614795|16438405|P1|Overall Study|Physician Decision|1
4765259|NCT01614795|16438402|P4|Overall Study|Lack of Efficacy|8
4765260|NCT01614795|16438403|P3|Overall Study|Lack of Efficacy|9
4765261|NCT01614795|16438404|P2|Overall Study|Lack of Efficacy|10
4765262|NCT01614795|16438405|P1|Overall Study|Lack of Efficacy|10
4765263|NCT01614795|16438402|P4|Overall Study|Adverse Event|1
4765264|NCT01614795|16438403|P3|Overall Study|Adverse Event|1
4765265|NCT01614795|16438404|P2|Overall Study|Adverse Event|0
4765266|NCT01614795|16438405|P1|Overall Study|Adverse Event|0
4765267|NCT01614769|16438425|P6|Period 3|Withdrawal by Subject|0
4765268|NCT01614769|16438426|P5|Period 3|Withdrawal by Subject|0
4765269|NCT01614769|16438427|P4|Period 3|Withdrawal by Subject|0
4765270|NCT01614769|16438428|P3|Period 3|Withdrawal by Subject|1
4765271|NCT01614769|16438429|P2|Period 3|Withdrawal by Subject|0
4765272|NCT01614769|16438430|P1|Period 3|Withdrawal by Subject|0
4765273|NCT01614769|16438425|P6|Period 1|Withdrawal by Subject|0
4765274|NCT01614769|16438426|P5|Period 1|Withdrawal by Subject|0
4765275|NCT01614769|16438427|P4|Period 1|Withdrawal by Subject|0
4765276|NCT01614769|16438428|P3|Period 1|Withdrawal by Subject|0
4765277|NCT01614769|16438429|P2|Period 1|Withdrawal by Subject|0
4765278|NCT01614769|16438430|P1|Period 1|Withdrawal by Subject|1
4765279|NCT01614769|16438425|P6|Period 1|Protocol Violation|0
4765280|NCT01614769|16438426|P5|Period 1|Protocol Violation|0
4765281|NCT01614769|16438427|P4|Period 1|Protocol Violation|1
4765282|NCT01614769|16438428|P3|Period 1|Protocol Violation|0
4765283|NCT01614769|16438429|P2|Period 1|Protocol Violation|0
4765284|NCT01614769|16438430|P1|Period 1|Protocol Violation|0
4765285|NCT01614769|16438425|P6|Period 1|Discontinued due to Hypoglycemia|1
4765286|NCT01614769|16438426|P5|Period 1|Discontinued due to Hypoglycemia|0
4765287|NCT01614769|16438427|P4|Period 1|Discontinued due to Hypoglycemia|1
4765288|NCT01614769|16438428|P3|Period 1|Discontinued due to Hypoglycemia|0
4765289|NCT01614769|16438429|P2|Period 1|Discontinued due to Hypoglycemia|0
4765290|NCT01614769|16438430|P1|Period 1|Discontinued due to Hypoglycemia|0
4765291|NCT01614600|16438467|P1|Overall Study|Protocol deviation|1
4765292|NCT01614600|16438467|P1|Overall Study|Unable to remove lens at the end of day|1
4765293|NCT01614600|16438467|P1|Overall Study|Discomfort|1
4765294|NCT01614600|16438467|P1|Overall Study|Unacceptable fit|1
4765295|NCT01614470|16438498|P3|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0
4765296|NCT01614470|16438499|P2|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
4765297|NCT01614470|16438500|P1|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1
4765298|NCT01614470|16438498|P3|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4765299|NCT01614470|16438499|P2|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0
4765300|NCT01614470|16438500|P1|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1
4765301|NCT01614457|16438522|P2|Overall Study|Pregnancy (Self or Partner)|0
4765302|NCT01614457|16438523|P1|Overall Study|Pregnancy (Self or Partner)|1
4765303|NCT01614457|16438522|P2|Overall Study|Non-Compliance|0
4765304|NCT01614457|16438523|P1|Overall Study|Non-Compliance|1
4765305|NCT01614249|16438550|P2|Overall Study|Lost to Follow-up|23
4765306|NCT01614249|16438551|P1|Overall Study|Lost to Follow-up|11
4765307|NCT01614093|16438565|P1|Overall Study|Withdrawal by Subject|1
4765308|NCT01613716|16438578|P1|Overall Study|Lost to Follow-up|4
4765309|NCT01613716|16438578|P1|Overall Study|screen failures|3
4765310|NCT01613599|16438583|P1|Overall Study|Reason not specified|3
4765311|NCT01613599|16438583|P1|Overall Study|Withdrawal by Subject|8
4765312|NCT01613599|16438583|P1|Overall Study|Lost to Follow-up|5
4765313|NCT01613599|16438583|P1|Overall Study|Death|9
4765314|NCT01613417|16438598|P2|Washout (no Second Injection/MRI)|Withdrawal by Subject|7
4765315|NCT01613417|16438599|P1|Washout (no Second Injection/MRI)|Withdrawal by Subject|13
4765316|NCT01613378|16438636|P1|Overall Study|Other Reason|4
4765317|NCT01613378|16438636|P1|Overall Study|Lost to Follow-up|1
4765318|NCT01613378|16438636|P1|Overall Study|Death|2
4765319|NCT01613378|16438636|P1|Overall Study|Withdrawal by Subject|8
4765320|NCT01613378|16438636|P1|Overall Study|Adverse Event|11
4765321|NCT01613378|16438636|P1|Overall Study|Lack of Efficacy|13
4765322|NCT01613326|16438666|P2|Overall Study|Protocol Violation|1
4765323|NCT01613326|16438667|P1|Overall Study|Protocol Violation|0
4765324|NCT01613326|16438666|P2|Overall Study|Administrative|2
4765325|NCT01613326|16438667|P1|Overall Study|Administrative|0
4765326|NCT01613326|16438666|P2|Overall Study|Lost to Follow-up|1
4765327|NCT01613326|16438667|P1|Overall Study|Lost to Follow-up|0
4765328|NCT01613326|16438666|P2|Overall Study|Lack of Efficacy|1
4765329|NCT01613326|16438667|P1|Overall Study|Lack of Efficacy|0
4765330|NCT01613326|16438666|P2|Overall Study|inability to use device|0
4765331|NCT01613326|16438667|P1|Overall Study|inability to use device|1
4765332|NCT01613326|16438666|P2|Overall Study|Abnormal test procedure result(s)|0
4765333|NCT01613326|16438667|P1|Overall Study|Abnormal test procedure result(s)|2
4765334|NCT01613326|16438666|P2|Overall Study|Withdrawal by Subject|4
4765335|NCT01613326|16438667|P1|Overall Study|Withdrawal by Subject|3
4765336|NCT01613326|16438666|P2|Overall Study|Adverse Event|5
4765337|NCT01613326|16438667|P1|Overall Study|Adverse Event|7
4765338|NCT01613248|16438724|P6|Overall Study|Pregnancy|0
4765339|NCT01613248|16438725|P5|Overall Study|Pregnancy|0
4765340|NCT01613248|16438726|P4|Overall Study|Pregnancy|1
4765341|NCT01613248|16438727|P3|Overall Study|Pregnancy|0
4765342|NCT01613248|16438728|P2|Overall Study|Pregnancy|0
4765343|NCT01613248|16438729|P1|Overall Study|Pregnancy|0
4765344|NCT01613248|16438724|P6|Overall Study|Lack of Qualifying Event|18
4765345|NCT01613248|16438725|P5|Overall Study|Lack of Qualifying Event|15
4765346|NCT01613248|16438726|P4|Overall Study|Lack of Qualifying Event|11
4765347|NCT01613248|16438727|P3|Overall Study|Lack of Qualifying Event|10
4765348|NCT01613248|16438728|P2|Overall Study|Lack of Qualifying Event|11
4765349|NCT01613248|16438729|P1|Overall Study|Lack of Qualifying Event|9
4765350|NCT01613248|16438724|P6|Overall Study|Physician Decision|6
4765351|NCT01613248|16438725|P5|Overall Study|Physician Decision|7
4765352|NCT01613248|16438726|P4|Overall Study|Physician Decision|4
4765353|NCT01613248|16438727|P3|Overall Study|Physician Decision|9
4765354|NCT01613248|16438728|P2|Overall Study|Physician Decision|8
4765355|NCT01613248|16438729|P1|Overall Study|Physician Decision|8
4765356|NCT01613248|16438724|P6|Overall Study|Study Terminated by Sponsor|11
4765357|NCT01613248|16438725|P5|Overall Study|Study Terminated by Sponsor|9
4765358|NCT01613248|16438726|P4|Overall Study|Study Terminated by Sponsor|8
4765359|NCT01613248|16438727|P3|Overall Study|Study Terminated by Sponsor|8
4765360|NCT01613248|16438728|P2|Overall Study|Study Terminated by Sponsor|6
4765361|NCT01613248|16438729|P1|Overall Study|Study Terminated by Sponsor|4
4765362|NCT01613248|16438724|P6|Overall Study|Lost to Follow-up|2
4765363|NCT01613248|16438725|P5|Overall Study|Lost to Follow-up|4
4765364|NCT01613248|16438726|P4|Overall Study|Lost to Follow-up|8
4765365|NCT01613248|16438727|P3|Overall Study|Lost to Follow-up|4
4765366|NCT01613248|16438728|P2|Overall Study|Lost to Follow-up|7
4765367|NCT01613248|16438729|P1|Overall Study|Lost to Follow-up|5
4765368|NCT01613248|16438724|P6|Overall Study|Withdrawal by Subject|1
4765369|NCT01613248|16438725|P5|Overall Study|Withdrawal by Subject|0
4765370|NCT01613248|16438726|P4|Overall Study|Withdrawal by Subject|5
4765371|NCT01613248|16438727|P3|Overall Study|Withdrawal by Subject|2
4765372|NCT01613248|16438728|P2|Overall Study|Withdrawal by Subject|2
4765373|NCT01613248|16438729|P1|Overall Study|Withdrawal by Subject|3
4765374|NCT01613248|16438724|P6|Overall Study|Adverse Event|0
4765375|NCT01613248|16438725|P5|Overall Study|Adverse Event|0
4765376|NCT01613248|16438726|P4|Overall Study|Adverse Event|1
4765377|NCT01613248|16438727|P3|Overall Study|Adverse Event|0
4765378|NCT01613248|16438728|P2|Overall Study|Adverse Event|0
4765379|NCT01613248|16438729|P1|Overall Study|Adverse Event|0
4765380|NCT01613222|16438827|P1|Overall Study|Reused disposable sensors|10
4765381|NCT01613222|16438827|P1|Overall Study|Unable to place arterial line|1
4765382|NCT01613222|16438827|P1|Overall Study|Physician Decision|1
4765383|NCT01613131|16438842|P2|Overall Study|Withdrawal by Subject|5
4765384|NCT01613131|16438843|P1|Overall Study|Withdrawal by Subject|3
4765385|NCT01613027|16438871|P1|Overall Study|Patient's Decision Due to Adverse Event|1
4765386|NCT01613027|16438871|P1|Overall Study|Lack of Efficacy|1
4765387|NCT01613027|16438871|P1|Overall Study|Switched Physician|1
4765388|NCT01613027|16438871|P1|Overall Study|Lost to Follow-up|5
4765389|NCT01612858|16438914|P2|Overall Study|Withdrawal by Subject|1
4765390|NCT01612858|16438915|P1|Overall Study|Withdrawal by Subject|5
4765391|NCT01612780|16438932|P1|Overall Study|Withdrawal by Subject|5
4765392|NCT01612780|16438932|P1|Overall Study|Treatment not completed|1
4765393|NCT01612702|16438994|P2|Overall Study|Protocol Violation|11
4765394|NCT01612702|16438995|P1|Overall Study|Protocol Violation|11
4765395|NCT01612676|16439009|P4|Overall Study|Protocol Violation|0
4765396|NCT01612676|16439010|P3|Overall Study|Protocol Violation|0
4765397|NCT01612676|16439011|P2|Overall Study|Protocol Violation|1
4765398|NCT01612676|16439012|P1|Overall Study|Protocol Violation|0
4765399|NCT01612676|16439009|P4|Overall Study|Adverse Event|3
4765400|NCT01612676|16439010|P3|Overall Study|Adverse Event|1
4765401|NCT01612676|16439011|P2|Overall Study|Adverse Event|3
4765402|NCT01612676|16439012|P1|Overall Study|Adverse Event|2
4765403|NCT01612156|16439110|P2|Overall Study|Protocol Violation|0
4765404|NCT01612156|16439111|P1|Overall Study|Protocol Violation|2
4765405|NCT01612000|16439123|P4|Overall Study|Withdrawal by Subject|2
4765406|NCT01612000|16439124|P3|Overall Study|Withdrawal by Subject|2
4765407|NCT01612000|16439125|P2|Overall Study|Withdrawal by Subject|1
4765408|NCT01612000|16439126|P1|Overall Study|Withdrawal by Subject|3
4765409|NCT01612000|16439123|P4|Overall Study|Physician Decision|0
4765410|NCT01612000|16439124|P3|Overall Study|Physician Decision|1
4765411|NCT01612000|16439125|P2|Overall Study|Physician Decision|0
4765412|NCT01612000|16439126|P1|Overall Study|Physician Decision|0
4765413|NCT01612000|16439123|P4|Overall Study|Lost to Follow-up|8
4765414|NCT01612000|16439124|P3|Overall Study|Lost to Follow-up|4
4765415|NCT01612000|16439125|P2|Overall Study|Lost to Follow-up|4
4765416|NCT01612000|16439126|P1|Overall Study|Lost to Follow-up|6
4765417|NCT01611974|16439151|P3|Overall Study|Withdrawal by Subject|4
4765418|NCT01611974|16439152|P2|Overall Study|Withdrawal by Subject|1
4765419|NCT01611974|16439153|P1|Overall Study|Withdrawal by Subject|0
4765420|NCT01611974|16439151|P3|Overall Study|Physician Decision|2
4765421|NCT01611974|16439152|P2|Overall Study|Physician Decision|1
4765422|NCT01611974|16439153|P1|Overall Study|Physician Decision|5
4765423|NCT01611974|16439151|P3|Overall Study|Lost to Follow-up|0
4765424|NCT01611974|16439152|P2|Overall Study|Lost to Follow-up|1
4765425|NCT01611974|16439153|P1|Overall Study|Lost to Follow-up|0
4765426|NCT01611974|16439151|P3|Overall Study|Death|10
4765427|NCT01611974|16439152|P2|Overall Study|Death|12
4765428|NCT01611974|16439153|P1|Overall Study|Death|10
4765429|NCT01611935|16439199|P2|Overall Study|Family Declined Participation|0
4765430|NCT01611935|16439200|P1|Overall Study|Family Declined Participation|1
4765431|NCT01611883|16439212|P2|Overall Study|Adverse Event|1
4765432|NCT01611883|16439213|P1|Overall Study|Adverse Event|1
4765433|NCT01611857|16439239|P2|Overall Study|Withdrawal by Subject|2
4765434|NCT01611857|16439240|P1|Overall Study|Withdrawal by Subject|0
4765435|NCT01611792|16439252|P2|Followup: at 6 Months|Lost to Follow-up|13
4765436|NCT01611792|16439253|P1|Followup: at 6 Months|Lost to Follow-up|6
4765437|NCT01611792|16439252|P2|Initial Period: Time 0|unable to schedule 10 consecutive appts|9
4765438|NCT01611792|16439253|P1|Initial Period: Time 0|unable to schedule 10 consecutive appts|12
4765439|NCT01611558|16439307|P1|Maintenance Phase|Elevated Uric acid|1
4765440|NCT01611558|16439307|P1|Maintenance Phase|Withdrawal by Subject|1
4765441|NCT01611558|16439307|P1|Induction Phase|Death|1
4765442|NCT01611558|16439307|P1|Induction Phase|Adverse event unrelated to study drug|3
4765443|NCT01611558|16439307|P1|Induction Phase|Heart arrest,urosepsis,respiratory fail|1
4765444|NCT01611558|16439307|P1|Induction Phase|Disease progression|18
4765445|NCT01611558|16439307|P1|Induction Phase|Study drug toxicity|15
4765446|NCT01611298|16439313|P1|Overall Study|Relapsed|2
4765447|NCT01611259|16439318|P1|Overall Study|Withdrawal by Subject|7
4765448|NCT01611259|16439318|P1|Overall Study|Adverse Event|4
4765449|NCT01611259|16439318|P1|Overall Study|Lack of Efficacy|2
4765450|NCT01611259|16439318|P1|Overall Study|Physician Decision|1
4765451|NCT01611194|16439324|P2|Overall Study|drug use|1
4765452|NCT01611194|16439325|P1|Overall Study|drug use|0
4765453|NCT01611194|16439324|P2|Overall Study|Withdrawal by Subject|1
4765454|NCT01611194|16439325|P1|Overall Study|Withdrawal by Subject|0
4765455|NCT01611194|16439324|P2|Overall Study|Lost to Follow-up|1
4765456|NCT01611194|16439325|P1|Overall Study|Lost to Follow-up|0
4765457|NCT01611155|16439363|P2|Overall Study|Ineligible patient|1
4765458|NCT01611155|16439364|P1|Overall Study|Ineligible patient|0
4765459|NCT01611155|16439363|P2|Overall Study|Alternative treatment|1
4765460|NCT01611155|16439364|P1|Overall Study|Alternative treatment|0
4765461|NCT01611155|16439363|P2|Overall Study|Withdrawal by Subject|0
4765462|NCT01611155|16439364|P1|Overall Study|Withdrawal by Subject|1
4765463|NCT01611155|16439363|P2|Overall Study|Disease progression|0
4765464|NCT01611155|16439364|P1|Overall Study|Disease progression|1
4765465|NCT01611155|16439363|P2|Overall Study|Refused further treatment|4
4765466|NCT01611155|16439364|P1|Overall Study|Refused further treatment|6
4765467|NCT01611155|16439363|P2|Overall Study|Adverse Event|1
4765468|NCT01611155|16439364|P1|Overall Study|Adverse Event|1
4765469|NCT01611090|16439374|P3|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1
4765470|NCT01611090|16439375|P2|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
4765471|NCT01611090|16439376|P1|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0
4765472|NCT01611090|16439374|P3|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4
4765473|NCT01611090|16439375|P2|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
4765474|NCT01611090|16439376|P1|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0
4765475|NCT01611090|16439374|P3|Randomized Period|Withdrawal by Subject|0
4765476|NCT01611090|16439375|P2|Randomized Period|Withdrawal by Subject|26
4765477|NCT01611090|16439376|P1|Randomized Period|Withdrawal by Subject|22
4765478|NCT01611090|16439374|P3|Randomized Period|Lost to Follow-up|0
4765479|NCT01611090|16439375|P2|Randomized Period|Lost to Follow-up|3
4765480|NCT01611090|16439376|P1|Randomized Period|Lost to Follow-up|8
4765481|NCT01610791|16439409|P1|Overall Study|Not determined|5
4765482|NCT01610791|16439409|P1|Overall Study|Death|1
4765483|NCT01610791|16439409|P1|Overall Study|Adverse event and Investigator decision|1
4765484|NCT01610791|16439409|P1|Overall Study|Physician Decision|1
4765485|NCT01610791|16439409|P1|Overall Study|Adverse Event|6
4765486|NCT01610791|16439409|P1|Overall Study|Lost to Follow-up|7
4765487|NCT01610752|16439433|P3|Overall Study|Miscarriage/Pregnancy loss|4
4765488|NCT01610752|16439434|P2|Overall Study|Miscarriage/Pregnancy loss|0
4765489|NCT01610752|16439435|P1|Overall Study|Miscarriage/Pregnancy loss|0
4765490|NCT01610713|16439457|P2|Overall Study|Lost to Follow-up|1
4765491|NCT01610713|16439458|P1|Overall Study|Lost to Follow-up|0
4765492|NCT01610713|16439457|P2|Overall Study|adv. to use original dose/amitriptyline|0
4765493|NCT01610713|16439458|P1|Overall Study|adv. to use original dose/amitriptyline|1
4765494|NCT01610713|16439457|P2|Overall Study|low mood and poor motivation|0
4765495|NCT01610713|16439458|P1|Overall Study|low mood and poor motivation|1
4765496|NCT01610713|16439457|P2|Overall Study|Lack of Efficacy|0
4765497|NCT01610713|16439458|P1|Overall Study|Lack of Efficacy|1
4765498|NCT01610713|16439457|P2|Overall Study|Adverse Event|0
4765499|NCT01610713|16439458|P1|Overall Study|Adverse Event|3
4765500|NCT01610700|16439516|P2|Overall Study|subject took one dose of street cannabis|1
4765501|NCT01610700|16439517|P1|Overall Study|subject took one dose of street cannabis|0
4765502|NCT01610700|16439516|P2|Overall Study|Withdrawal by Subject|1
4765503|NCT01610700|16439517|P1|Overall Study|Withdrawal by Subject|0
4765504|NCT01610700|16439516|P2|Overall Study|Adverse Event|1
4765505|NCT01610700|16439517|P1|Overall Study|Adverse Event|3
4765506|NCT01610687|16439571|P1|Overall Study|Felt more alter without study medication|1
4765507|NCT01610687|16439571|P1|Overall Study|Cannabis affecting job|1
4765508|NCT01610687|16439571|P1|Overall Study|Death|1
4765509|NCT01610687|16439571|P1|Overall Study|Unable to make journey|1
4765510|NCT01610687|16439571|P1|Overall Study|Symptom control without study medication|2
4765511|NCT01610687|16439571|P1|Overall Study|Lost to Follow-up|4
4765512|NCT01610687|16439571|P1|Overall Study|Withdrawal by Subject|7
4765513|NCT01610687|16439571|P1|Overall Study|Moved out of area|6
4765514|NCT01610687|16439571|P1|Overall Study|Adverse Event|18
4765515|NCT01610687|16439571|P1|Overall Study|Lack of Efficacy|26
4765516|NCT01610596|16439584|P2|Overall Study|Lost to Follow-up|1
4765517|NCT01610596|16439585|P1|Overall Study|Lost to Follow-up|0
4765518|NCT01610557|16439643|P5|Post-36-Week Extension Phase|Withdrawal by Subject|3
4765519|NCT01610557|16439644|P4|Post-36-Week Extension Phase|Withdrawal by Subject|0
4765520|NCT01610557|16439645|P3|Post-36-Week Extension Phase|Withdrawal by Subject|0
4765521|NCT01610557|16439646|P2|Post-36-Week Extension Phase|Withdrawal by Subject|0
4765522|NCT01610557|16439647|P1|Post-36-Week Extension Phase|Withdrawal by Subject|0
4765523|NCT01610557|16439643|P5|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4765524|NCT01610557|16439644|P4|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4765525|NCT01610557|16439645|P3|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4765526|NCT01610557|16439646|P2|36-Week Randomized Crossover Phase|Withdrawal by Subject|1
4765527|NCT01610557|16439647|P1|36-Week Randomized Crossover Phase|Withdrawal by Subject|0
4765528|NCT01610492|16439660|P1|Overall Study|Other:Treatment stopped due to remission|1
4765529|NCT01610492|16439660|P1|Overall Study|Other: Reached stopping criteria|1
4765530|NCT01610492|16439660|P1|Overall Study|Lack of Efficacy|3
4765531|NCT01610492|16439660|P1|Overall Study|Adverse Event|1
4765532|NCT01610414|16439726|P2|After Month 25|Study end not reached|53
4765533|NCT01610414|16439727|P1|After Month 25|Study end not reached|48
4765534|NCT01610414|16439726|P2|Month 13 - Month 25|Other reasons for withdrawal|7
4765535|NCT01610414|16439727|P1|Month 13 - Month 25|Other reasons for withdrawal|6
4765536|NCT01610414|16439726|P2|Month 13 - Month 25|Lost to Follow-up|9
4765537|NCT01610414|16439727|P1|Month 13 - Month 25|Lost to Follow-up|5
4765538|NCT01610414|16439726|P2|Month 13 - Month 25|Protocol Violation|2
4765539|NCT01610414|16439727|P1|Month 13 - Month 25|Protocol Violation|0
4765540|NCT01610414|16439726|P2|Month 13 - Month 25|Migrated/moved from study area|2
4765541|NCT01610414|16439727|P1|Month 13 - Month 25|Migrated/moved from study area|4
4765542|NCT01610414|16439726|P2|Month 13 - Month 25|Withdrawal by Subject|8
4765543|NCT01610414|16439727|P1|Month 13 - Month 25|Withdrawal by Subject|7
4765544|NCT01610414|16439726|P2|Month 13 - Month 25|Adverse Event|4
4765545|NCT01610414|16439727|P1|Month 13 - Month 25|Adverse Event|8
4765546|NCT01610414|16439726|P2|Month 13 - Month 25|Serious Adverse Event|38
4765547|NCT01610414|16439727|P1|Month 13 - Month 25|Serious Adverse Event|35
4765548|NCT01610414|16439726|P2|Study Start - Month 13|Other reasons for withdrawal|4
4765549|NCT01610414|16439727|P1|Study Start - Month 13|Other reasons for withdrawal|3
4765550|NCT01610414|16439726|P2|Study Start - Month 13|Suspected HZ episode|3
4765551|NCT01610414|16439727|P1|Study Start - Month 13|Suspected HZ episode|1
4765552|NCT01610414|16439726|P2|Study Start - Month 13|Lost to Follow-up|6
4765553|NCT01610414|16439727|P1|Study Start - Month 13|Lost to Follow-up|4
4765554|NCT01610414|16439726|P2|Study Start - Month 13|Migrated/moved from study area|4
4765555|NCT01610414|16439727|P1|Study Start - Month 13|Migrated/moved from study area|2
4765556|NCT01610414|16439726|P2|Study Start - Month 13|Withdrawal by Subject|30
4765557|NCT01610414|16439727|P1|Study Start - Month 13|Withdrawal by Subject|23
4765558|NCT01610414|16439726|P2|Study Start - Month 13|Protocol Violation|1
4765559|NCT01610414|16439727|P1|Study Start - Month 13|Protocol Violation|3
4765560|NCT01610414|16439726|P2|Study Start - Month 13|Adverse Event|14
4765561|NCT01610414|16439727|P1|Study Start - Month 13|Adverse Event|14
4765562|NCT01610414|16439726|P2|Study Start - Month 13|Serious Adverse Event|67
4765563|NCT01610414|16439727|P1|Study Start - Month 13|Serious Adverse Event|65
4765564|NCT01610297|16439756|P1|Overall Study|Lost to Follow-up|1
4765565|NCT01610284|16439766|P2|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13
4765566|NCT01610284|16439767|P1|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38
4765567|NCT01610284|16439766|P2|Post-Treatment Efficacy Follow-Up Phase|Death|4
4765568|NCT01610284|16439767|P1|Post-Treatment Efficacy Follow-Up Phase|Death|4
4765569|NCT01610284|16439766|P2|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1
4765570|NCT01610284|16439767|P1|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11
4765571|NCT01610284|16439766|P2|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8
4765572|NCT01610284|16439767|P1|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24
4765573|NCT01610284|16439766|P2|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3
4765574|NCT01610284|16439767|P1|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10
4765575|NCT01610284|16439766|P2|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0
4765576|NCT01610284|16439767|P1|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2
4765577|NCT01610284|16439766|P2|Treatment Phase|Death|5
4765578|NCT01610284|16439767|P1|Treatment Phase|Death|6
4765579|NCT01610284|16439766|P2|Treatment Phase|Subject/Guardian Decision|23
4765580|NCT01610284|16439767|P1|Treatment Phase|Subject/Guardian Decision|55
4765581|NCT01610284|16439766|P2|Treatment Phase|Study terminated by Sponsor|15
4765582|NCT01610284|16439767|P1|Treatment Phase|Study terminated by Sponsor|18
4765583|NCT01610284|16439766|P2|Treatment Phase|Protocol Deviation|3
4765584|NCT01610284|16439767|P1|Treatment Phase|Protocol Deviation|2
4765585|NCT01610284|16439766|P2|Treatment Phase|Progressive Disease|486
4765586|NCT01610284|16439767|P1|Treatment Phase|Progressive Disease|377
4765587|NCT01610284|16439766|P2|Treatment Phase|Physician Decision|24
4765588|NCT01610284|16439767|P1|Treatment Phase|Physician Decision|27
4765589|NCT01610284|16439766|P2|Treatment Phase|Non-compliance with Study Treatment|1
4765590|NCT01610284|16439767|P1|Treatment Phase|Non-compliance with Study Treatment|8
4765591|NCT01610284|16439766|P2|Treatment Phase|Lost to Follow-up|0
4765592|NCT01610284|16439767|P1|Treatment Phase|Lost to Follow-up|1
4765593|NCT01610284|16439766|P2|Treatment Phase|Adverse Event|12
4765594|NCT01610284|16439767|P1|Treatment Phase|Adverse Event|80
4765595|NCT01610284|16439766|P2|Randomization Phase|Death|1
4765596|NCT01610284|16439767|P1|Randomization Phase|Death|0
4765597|NCT01610284|16439766|P2|Randomization Phase|Physician Decision|1
4765598|NCT01610284|16439767|P1|Randomization Phase|Physician Decision|1
4765599|NCT01610284|16439766|P2|Randomization Phase|Adverse Event|0
4765600|NCT01610284|16439767|P1|Randomization Phase|Adverse Event|1
4765601|NCT01610271|16439789|P2|Overall Study|Prosthesis not implanted|3
4765602|NCT01610271|16439790|P1|Overall Study|Prosthesis not implanted|2
4765603|NCT01610271|16439789|P2|Overall Study|Surgery not complete|1
4765604|NCT01610271|16439790|P1|Overall Study|Surgery not complete|0
4765605|NCT01610167|16439805|P3|Overall Study|Scheduling conflict.|2
4765606|NCT01610167|16439806|P2|Overall Study|Scheduling conflict.|0
4765607|NCT01610167|16439807|P1|Overall Study|Scheduling conflict.|0
4765608|NCT01610076|16439844|P2|Overall Study|Lost to Follow-up|4
4765609|NCT01610076|16439845|P1|Overall Study|Lost to Follow-up|3
4765610|NCT01610076|16439844|P2|Overall Study|Technical issue with video|1
4765611|NCT01610076|16439845|P1|Overall Study|Technical issue with video|0
4765612|NCT01610063|16439856|P2|Overall Study|Lost to Follow-up|20
4765613|NCT01610063|16439857|P1|Overall Study|Lost to Follow-up|42
4765614|NCT01610037|16439880|P3|Treatment and Follow up Period|Lost to Follow-up|4
4765615|NCT01610037|16439881|P2|Treatment and Follow up Period|Lost to Follow-up|6
4765616|NCT01610037|16439882|P1|Treatment and Follow up Period|Lost to Follow-up|1
4765617|NCT01610037|16439880|P3|Treatment and Follow up Period|Administrative problems|2
4765618|NCT01610037|16439881|P2|Treatment and Follow up Period|Administrative problems|3
4765619|NCT01610037|16439882|P1|Treatment and Follow up Period|Administrative problems|1
4765620|NCT01610037|16439880|P3|Treatment and Follow up Period|Death|4
4765621|NCT01610037|16439881|P2|Treatment and Follow up Period|Death|5
4765622|NCT01610037|16439882|P1|Treatment and Follow up Period|Death|10
4765623|NCT01610037|16439880|P3|Treatment and Follow up Period|Subject withdrew consent|16
4765624|NCT01610037|16439881|P2|Treatment and Follow up Period|Subject withdrew consent|14
4765625|NCT01610037|16439882|P1|Treatment and Follow up Period|Subject withdrew consent|13
4765626|NCT01610037|16439880|P3|All Patients|Abnormal test procedure result(s)|3
4765627|NCT01610037|16439881|P2|All Patients|Abnormal test procedure result(s)|1
4765628|NCT01610037|16439882|P1|All Patients|Abnormal test procedure result(s)|0
4765629|NCT01610037|16439880|P3|All Patients|Lost to Follow-up|0
4765630|NCT01610037|16439881|P2|All Patients|Lost to Follow-up|0
4765631|NCT01610037|16439882|P1|All Patients|Lost to Follow-up|1
4765632|NCT01610037|16439880|P3|All Patients|Administrative problems|4
4765633|NCT01610037|16439881|P2|All Patients|Administrative problems|4
4765634|NCT01610037|16439882|P1|All Patients|Administrative problems|1
4765635|NCT01610037|16439880|P3|All Patients|Abnormal laboratory value|0
4765636|NCT01610037|16439881|P2|All Patients|Abnormal laboratory value|1
4765637|NCT01610037|16439882|P1|All Patients|Abnormal laboratory value|1
4765638|NCT01610037|16439880|P3|All Patients|Protocol deviation|3
4765639|NCT01610037|16439881|P2|All Patients|Protocol deviation|3
4765640|NCT01610037|16439882|P1|All Patients|Protocol deviation|4
4765641|NCT01610037|16439880|P3|All Patients|Death|1
4765642|NCT01610037|16439881|P2|All Patients|Death|2
4765643|NCT01610037|16439882|P1|All Patients|Death|4
4765644|NCT01610037|16439880|P3|All Patients|Unsatisfactory therapeutic effect|27
4765645|NCT01610037|16439881|P2|All Patients|Unsatisfactory therapeutic effect|8
4765646|NCT01610037|16439882|P1|All Patients|Unsatisfactory therapeutic effect|9
4765647|NCT01610037|16439880|P3|All Patients|Withdrawal by Subject|20
4765648|NCT01610037|16439881|P2|All Patients|Withdrawal by Subject|10
4765649|NCT01610037|16439882|P1|All Patients|Withdrawal by Subject|12
4765650|NCT01610037|16439880|P3|All Patients|Adverse Event|26
4765651|NCT01610037|16439881|P2|All Patients|Adverse Event|22
4765652|NCT01610037|16439882|P1|All Patients|Adverse Event|27
4765653|NCT01609933|16439932|P1|Overall Study|Withdrawal by Subject|3
4765654|NCT01609933|16439932|P1|Overall Study|Adverse Event|1
4765655|NCT01609842|16439943|P2|Concurrent Intervention Control|pharmacy data not available|0
4765656|NCT01609842|16439944|P1|Concurrent Intervention Control|pharmacy data not available|2
4765657|NCT01609790|16439971|P3|Overall Study|Protocol Violation|8
4765658|NCT01609790|16439972|P2|Overall Study|Protocol Violation|7
4765659|NCT01609790|16439973|P1|Overall Study|Protocol Violation|1
4765660|NCT01609582|16439992|P2|Overall Study|Randomized, but not treated|3
4765661|NCT01609582|16439993|P1|Overall Study|Randomized, but not treated|0
4765662|NCT01609582|16439992|P2|Overall Study|Other|10
4765663|NCT01609582|16439993|P1|Overall Study|Other|9
4765664|NCT01609582|16439992|P2|Overall Study|Study Terminated by Sponsor|1548
4765665|NCT01609582|16439993|P1|Overall Study|Study Terminated by Sponsor|1543
4765666|NCT01609582|16439992|P2|Overall Study|Withdrawal by Subject|15
4765667|NCT01609582|16439993|P1|Overall Study|Withdrawal by Subject|21
4765668|NCT01609582|16439992|P2|Overall Study|Lost to Follow-up|10
4765669|NCT01609582|16439993|P1|Overall Study|Lost to Follow-up|10
4765670|NCT01609582|16439992|P2|Overall Study|Adverse Event|18
4765671|NCT01609582|16439993|P1|Overall Study|Adverse Event|20
4765672|NCT01609543|16440001|P1|Overall Study|Death|7
4765673|NCT01609543|16440001|P1|Overall Study|Protocol Violation|1
4765674|NCT01609543|16440001|P1|Overall Study|Withdrawal by Subject|1
4765675|NCT01609543|16440001|P1|Overall Study|Adverse Event|5
4765676|NCT01609543|16440001|P1|Overall Study|Disease Progression|28
4765677|NCT01609478|16440010|P3|Overall Study|Withdrawal by Subject|2
4765678|NCT01609478|16440011|P2|Overall Study|Withdrawal by Subject|0
4765679|NCT01609478|16440012|P1|Overall Study|Withdrawal by Subject|2
4765680|NCT01609478|16440010|P3|Overall Study|Physician Decision|1
4765681|NCT01609478|16440011|P2|Overall Study|Physician Decision|0
4765682|NCT01609478|16440012|P1|Overall Study|Physician Decision|1
4765683|NCT01609478|16440010|P3|Overall Study|Non-Compliance with study treatment|0
4765684|NCT01609478|16440011|P2|Overall Study|Non-Compliance with study treatment|0
4765685|NCT01609478|16440012|P1|Overall Study|Non-Compliance with study treatment|1
4765686|NCT01609478|16440010|P3|Overall Study|Protocol Deviation|1
4765687|NCT01609478|16440011|P2|Overall Study|Protocol Deviation|1
4765688|NCT01609478|16440012|P1|Overall Study|Protocol Deviation|0
4765689|NCT01609478|16440010|P3|Overall Study|Adverse Event|5
4765690|NCT01609478|16440011|P2|Overall Study|Adverse Event|1
4765691|NCT01609478|16440012|P1|Overall Study|Adverse Event|3
4765692|NCT01609296|16440085|P1|Overall Study|Withdrawal by Subject|71
4765693|NCT01609296|16440085|P1|Overall Study|Death|49
4765694|NCT01609257|16440098|P2|Overall Study|Non-compliance/Protocol deviation|6
4765695|NCT01609257|16440099|P1|Overall Study|Non-compliance/Protocol deviation|4
4765696|NCT01609257|16440098|P2|Overall Study|Voluntary Withdrawal by Subject|1
4765697|NCT01609257|16440099|P1|Overall Study|Voluntary Withdrawal by Subject|0
4765698|NCT01609257|16440098|P2|Overall Study|Lost to Follow-up|1
4765699|NCT01609257|16440099|P1|Overall Study|Lost to Follow-up|2
4765700|NCT01609231|16440171|P2|Overall Study|Withdrawal by Subject|0
4765701|NCT01609231|16440172|P1|Overall Study|Withdrawal by Subject|1
4765702|NCT01609231|16440171|P2|Overall Study|Physician Decision|0
4765703|NCT01609231|16440172|P1|Overall Study|Physician Decision|1
4765704|NCT01609231|16440171|P2|Overall Study|Adverse Event|3
4765705|NCT01609231|16440172|P1|Overall Study|Adverse Event|1
4765706|NCT01609062|16440182|P2|Extension Phase|Anticipated surgery & transition to EAP|1
4765707|NCT01609062|16440183|P1|Extension Phase|Anticipated surgery & transition to EAP|0
4765708|NCT01609062|16440182|P2|Extension Phase|Discontinued drug and then was pregnant|0
4765709|NCT01609062|16440183|P1|Extension Phase|Discontinued drug and then was pregnant|1
4765710|NCT01609062|16440182|P2|Extension Phase|Terminated by Sponsor|9
4765711|NCT01609062|16440183|P1|Extension Phase|Terminated by Sponsor|14
4765712|NCT01609023|16440226|P1|Overall Study|Personal reasons|1
4765713|NCT01609023|16440226|P1|Overall Study|Death|2
4765714|NCT01609023|16440226|P1|Overall Study|Physician Decision|2
4765715|NCT01609023|16440226|P1|Overall Study|Disease progression|10
4765716|NCT01609023|16440226|P1|Overall Study|Toxicity|3
4765717|NCT01609023|16440226|P1|Overall Study|Lost to Follow-up|8
4765718|NCT01609023|16440226|P1|Overall Study|Withdrawal by Subject|4
4765719|NCT01609023|16440226|P1|Overall Study|Lack of Efficacy|3
4765720|NCT01609010|16440238|P2|Overall Study|Lost to Follow-up|1
4765721|NCT01609010|16440239|P1|Overall Study|Lost to Follow-up|1
4765722|NCT01609010|16440238|P2|Overall Study|New cancer|0
4765723|NCT01609010|16440239|P1|Overall Study|New cancer|1
4765724|NCT01609010|16440238|P2|Overall Study|Protocol Violation|1
4765725|NCT01609010|16440239|P1|Overall Study|Protocol Violation|1
4765726|NCT01609010|16440238|P2|Overall Study|Pathology review|1
4765727|NCT01609010|16440239|P1|Overall Study|Pathology review|2
4765728|NCT01609010|16440238|P2|Overall Study|Other malignancy|0
4765729|NCT01609010|16440239|P1|Overall Study|Other malignancy|1
4765730|NCT01609010|16440238|P2|Overall Study|Other|0
4765731|NCT01609010|16440239|P1|Overall Study|Other|2
4765732|NCT01609010|16440238|P2|Overall Study|Withdrawal by Subject|2
4765733|NCT01609010|16440239|P1|Overall Study|Withdrawal by Subject|2
4765734|NCT01609010|16440238|P2|Overall Study|Adverse Event|6
4765735|NCT01609010|16440239|P1|Overall Study|Adverse Event|3
4765736|NCT01609010|16440238|P2|Overall Study|Progressive disease (PD)|10
4765737|NCT01609010|16440239|P1|Overall Study|Progressive disease (PD)|8
4765738|NCT01609010|16440238|P2|Overall Study|Stable disease (SD)|16
4765739|NCT01609010|16440239|P1|Overall Study|Stable disease (SD)|22
4765740|NCT01608724|16440300|P1|Overall Study|Safety reasons|1
4765741|NCT01608724|16440300|P1|Overall Study|bood sugar too high, etc.|3
4765742|NCT01608724|16440300|P1|Overall Study|Protocol Violation|6
4765743|NCT01608724|16440300|P1|Overall Study|Adverse Event|29
4765744|NCT01608724|16440300|P1|Overall Study|Study-specific discontinuation criteria|32
4765745|NCT01608724|16440300|P1|Overall Study|Lost to Follow-up|41
4765746|NCT01608724|16440300|P1|Overall Study|Withdrawal by Subject|131
4765747|NCT01608321|16440332|P2|Overall Study|Withdrawal by Subject|0
4765748|NCT01608321|16440333|P1|Overall Study|Withdrawal by Subject|1
4765749|NCT01608308|16440341|P2|Overall Study|pretreatment medical and billing reasons|2
4765750|NCT01608308|16440342|P1|Overall Study|pretreatment medical and billing reasons|0
4765751|NCT01608087|16440405|P3|Overall Study|Other Reason|0
4765752|NCT01608087|16440406|P2|Overall Study|Other Reason|1
4765753|NCT01608087|16440407|P1|Overall Study|Other Reason|0
4765754|NCT01608087|16440405|P3|Overall Study|Lost to Follow-up|0
4765755|NCT01608087|16440406|P2|Overall Study|Lost to Follow-up|1
4765756|NCT01608087|16440407|P1|Overall Study|Lost to Follow-up|0
4765757|NCT01607957|16440437|P2|Overall Study|Participant refusal|0
4765758|NCT01607957|16440438|P1|Overall Study|Participant refusal|1
4765759|NCT01607957|16440437|P2|Overall Study|Lost to Follow-up|3
4765760|NCT01607957|16440438|P1|Overall Study|Lost to Follow-up|3
4765761|NCT01607957|16440437|P2|Overall Study|Death|211
4765762|NCT01607957|16440438|P1|Overall Study|Death|367
4765763|NCT01607957|16440437|P2|Overall Study|Not treated|1
4765764|NCT01607957|16440438|P1|Overall Study|Not treated|1
4765765|NCT01607593|16440617|P1|Overall Study|Other|4
4765766|NCT01607593|16440617|P1|Overall Study|Continuation|33
4765767|NCT01607593|16440617|P1|Overall Study|Lost to Follow-up|25
4765768|NCT01607593|16440617|P1|Overall Study|Lack of Efficacy|16
4765769|NCT01607593|16440617|P1|Overall Study|Adverse Event|15
4765770|NCT01607554|16440623|P1|Overall Study|Disease progression|2
4765771|NCT01607476|16440636|P3|Overall Study|Lost to Follow-up|2
4765772|NCT01607476|16440637|P2|Overall Study|Lost to Follow-up|0
4765773|NCT01607476|16440638|P1|Overall Study|Lost to Follow-up|0
4765774|NCT01607476|16440636|P3|Overall Study|Withdrawal by Subject|1
4765775|NCT01607476|16440637|P2|Overall Study|Withdrawal by Subject|0
4765776|NCT01607476|16440638|P1|Overall Study|Withdrawal by Subject|1
4765777|NCT01607398|16440732|P2|Overall Study|Severe COPD|0
4765778|NCT01607398|16440733|P1|Overall Study|Severe COPD|2
4765779|NCT01607398|16440732|P2|Overall Study|Adverse Event|2
4765780|NCT01607398|16440733|P1|Overall Study|Adverse Event|0
4765781|NCT01607346|16440777|P1|Overall Study|Adverse Event|3
4765782|NCT01606800|16440875|P2|Overall Study|Missing completion status|0
4765783|NCT01606800|16440876|P1|Overall Study|Missing completion status|2
4765784|NCT01606800|16440875|P2|Overall Study|Participant withdrew consent|1
4765785|NCT01606800|16440876|P1|Overall Study|Participant withdrew consent|0
4765786|NCT01606800|16440875|P2|Overall Study|Adverse Event|1
4765787|NCT01606800|16440876|P1|Overall Study|Adverse Event|3
4765788|NCT01606787|16440884|P2|Overall Study|Surgery canceled|2
4765789|NCT01606787|16440885|P1|Overall Study|Surgery canceled|0
4765790|NCT01606787|16440884|P2|Overall Study|Withdrawal by Subject|5
4765791|NCT01606787|16440885|P1|Overall Study|Withdrawal by Subject|4
4765792|NCT01606761|16440896|P5|Safety Follow-up Period (Week 52-68)|Other|3
4765793|NCT01606761|16440897|P4|Safety Follow-up Period (Week 52-68)|Other|1
4765794|NCT01606761|16440898|P3|Safety Follow-up Period (Week 52-68)|Other|9
4765795|NCT01606761|16440899|P2|Safety Follow-up Period (Week 52-68)|Other|3
4765796|NCT01606761|16440900|P1|Safety Follow-up Period (Week 52-68)|Other|0
4765797|NCT01606761|16440896|P5|Safety Follow-up Period (Week 52-68)|Death|1
4765798|NCT01606761|16440897|P4|Safety Follow-up Period (Week 52-68)|Death|0
4765799|NCT01606761|16440898|P3|Safety Follow-up Period (Week 52-68)|Death|0
4765800|NCT01606761|16440899|P2|Safety Follow-up Period (Week 52-68)|Death|0
4765801|NCT01606761|16440900|P1|Safety Follow-up Period (Week 52-68)|Death|0
4765802|NCT01606761|16440896|P5|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3
4765803|NCT01606761|16440897|P4|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1
4765804|NCT01606761|16440898|P3|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
4765805|NCT01606761|16440899|P2|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6
4765806|NCT01606761|16440900|P1|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4
4765807|NCT01606761|16440896|P5|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
4765808|NCT01606761|16440897|P4|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
4765809|NCT01606761|16440898|P3|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2
4765810|NCT01606761|16440899|P2|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1
4765811|NCT01606761|16440900|P1|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0
4765812|NCT01606761|16440896|P5|Week 24 to Week 52|Other|2
4765813|NCT01606761|16440897|P4|Week 24 to Week 52|Other|2
4765814|NCT01606761|16440898|P3|Week 24 to Week 52|Other|5
4765815|NCT01606761|16440899|P2|Week 24 to Week 52|Other|1
4765816|NCT01606761|16440900|P1|Week 24 to Week 52|Other|0
4765817|NCT01606761|16440896|P5|Week 24 to Week 52|Physician Decision|0
4765818|NCT01606761|16440897|P4|Week 24 to Week 52|Physician Decision|0
4765819|NCT01606761|16440898|P3|Week 24 to Week 52|Physician Decision|1
4765820|NCT01606761|16440899|P2|Week 24 to Week 52|Physician Decision|1
4765821|NCT01606761|16440900|P1|Week 24 to Week 52|Physician Decision|0
4765822|NCT01606761|16440896|P5|Week 24 to Week 52|Lack of Efficacy|3
4765823|NCT01606761|16440897|P4|Week 24 to Week 52|Lack of Efficacy|10
4765824|NCT01606761|16440898|P3|Week 24 to Week 52|Lack of Efficacy|7
4765825|NCT01606761|16440899|P2|Week 24 to Week 52|Lack of Efficacy|13
4765826|NCT01606761|16440900|P1|Week 24 to Week 52|Lack of Efficacy|0
4765827|NCT01606761|16440896|P5|Week 24 to Week 52|Death|0
4765828|NCT01606761|16440897|P4|Week 24 to Week 52|Death|1
4765829|NCT01606761|16440898|P3|Week 24 to Week 52|Death|2
4765830|NCT01606761|16440899|P2|Week 24 to Week 52|Death|0
4765831|NCT01606761|16440900|P1|Week 24 to Week 52|Death|0
4765832|NCT01606761|16440896|P5|Week 24 to Week 52|Adverse Event|15
4765833|NCT01606761|16440897|P4|Week 24 to Week 52|Adverse Event|3
4765834|NCT01606761|16440898|P3|Week 24 to Week 52|Adverse Event|14
4765835|NCT01606761|16440899|P2|Week 24 to Week 52|Adverse Event|11
4765836|NCT01606761|16440900|P1|Week 24 to Week 52|Adverse Event|0
4765837|NCT01606761|16440896|P5|Week 24 to Week 52|Withdrawal by Subject|0
4765838|NCT01606761|16440897|P4|Week 24 to Week 52|Withdrawal by Subject|0
4765839|NCT01606761|16440898|P3|Week 24 to Week 52|Withdrawal by Subject|3
4765840|NCT01606761|16440899|P2|Week 24 to Week 52|Withdrawal by Subject|6
4765841|NCT01606761|16440900|P1|Week 24 to Week 52|Withdrawal by Subject|0
4765842|NCT01606761|16440896|P5|Week 24 to Week 52|Lost to Follow-up|0
4765843|NCT01606761|16440897|P4|Week 24 to Week 52|Lost to Follow-up|1
4765844|NCT01606761|16440898|P3|Week 24 to Week 52|Lost to Follow-up|1
4765845|NCT01606761|16440899|P2|Week 24 to Week 52|Lost to Follow-up|1
4765846|NCT01606761|16440900|P1|Week 24 to Week 52|Lost to Follow-up|0
4765847|NCT01606761|16440896|P5|Prior to Week 24|Other|0
4765848|NCT01606761|16440897|P4|Prior to Week 24|Other|0
4765849|NCT01606761|16440898|P3|Prior to Week 24|Other|5
4765850|NCT01606761|16440899|P2|Prior to Week 24|Other|7
4765851|NCT01606761|16440900|P1|Prior to Week 24|Other|4
4765852|NCT01606761|16440896|P5|Prior to Week 24|Physician Decision|0
4765853|NCT01606761|16440897|P4|Prior to Week 24|Physician Decision|0
4765854|NCT01606761|16440898|P3|Prior to Week 24|Physician Decision|1
4765855|NCT01606761|16440899|P2|Prior to Week 24|Physician Decision|3
4765856|NCT01606761|16440900|P1|Prior to Week 24|Physician Decision|0
4765857|NCT01606761|16440896|P5|Prior to Week 24|Lack of Efficacy|0
4765858|NCT01606761|16440897|P4|Prior to Week 24|Lack of Efficacy|0
4765859|NCT01606761|16440898|P3|Prior to Week 24|Lack of Efficacy|8
4765860|NCT01606761|16440899|P2|Prior to Week 24|Lack of Efficacy|14
4765861|NCT01606761|16440900|P1|Prior to Week 24|Lack of Efficacy|15
4765862|NCT01606761|16440896|P5|Prior to Week 24|Adverse Event|0
4765863|NCT01606761|16440897|P4|Prior to Week 24|Adverse Event|0
4765864|NCT01606761|16440898|P3|Prior to Week 24|Adverse Event|22
4765865|NCT01606761|16440899|P2|Prior to Week 24|Adverse Event|18
4765866|NCT01606761|16440900|P1|Prior to Week 24|Adverse Event|11
4765867|NCT01606761|16440896|P5|Prior to Week 24|Withdrawal by Subject|0
4765868|NCT01606761|16440897|P4|Prior to Week 24|Withdrawal by Subject|0
4765869|NCT01606761|16440898|P3|Prior to Week 24|Withdrawal by Subject|9
4765870|NCT01606761|16440899|P2|Prior to Week 24|Withdrawal by Subject|10
4765871|NCT01606761|16440900|P1|Prior to Week 24|Withdrawal by Subject|12
4765872|NCT01606761|16440896|P5|Prior to Week 24|Lost to Follow-up|0
4765873|NCT01606761|16440897|P4|Prior to Week 24|Lost to Follow-up|0
4765874|NCT01606761|16440898|P3|Prior to Week 24|Lost to Follow-up|2
4765875|NCT01606761|16440899|P2|Prior to Week 24|Lost to Follow-up|3
4765876|NCT01606761|16440900|P1|Prior to Week 24|Lost to Follow-up|0
4765877|NCT01606748|16440926|P2|Overall Study|Withdrawal by Subject|0
4765878|NCT01606748|16440927|P1|Overall Study|Withdrawal by Subject|1
4765879|NCT01606748|16440926|P2|Overall Study|Progressive Disease|0
4765880|NCT01606748|16440927|P1|Overall Study|Progressive Disease|1
4765881|NCT01606748|16440926|P2|Overall Study|Adverse Event|0
4765882|NCT01606748|16440927|P1|Overall Study|Adverse Event|1
4765883|NCT01606670|16440979|P1|Overall Study|Other Reason|2
4765884|NCT01606670|16440979|P1|Overall Study|Withdrawal by Subject|3
4765885|NCT01606670|16440979|P1|Overall Study|Lost to Follow-up|3
4765886|NCT01606670|16440979|P1|Overall Study|Lack of Efficacy|2
4765887|NCT01606670|16440979|P1|Overall Study|Adverse Event|6
4765888|NCT01606319|16440989|P2|Overall Study|Adverse Event|4
4765889|NCT01606319|16440990|P1|Overall Study|Adverse Event|1
4765890|NCT01606319|16440989|P2|Overall Study|Lack of Efficacy|8
4765891|NCT01606319|16440990|P1|Overall Study|Lack of Efficacy|6
4765892|NCT01606319|16440989|P2|Overall Study|Physician Decision|2
4765893|NCT01606319|16440990|P1|Overall Study|Physician Decision|1
4765894|NCT01606319|16440989|P2|Overall Study|Withdrawal by Subject|12
4765895|NCT01606319|16440990|P1|Overall Study|Withdrawal by Subject|9
4765896|NCT01606319|16440989|P2|Overall Study|Lost to Follow-up|14
4765897|NCT01606319|16440990|P1|Overall Study|Lost to Follow-up|17
4765898|NCT01606306|16441008|P6|Overall Study|Physician Decision|0
4765899|NCT01606306|16441009|P5|Overall Study|Physician Decision|0
4765900|NCT01606306|16441010|P4|Overall Study|Physician Decision|0
4765901|NCT01606306|16441011|P3|Overall Study|Physician Decision|0
4765902|NCT01606306|16441012|P2|Overall Study|Physician Decision|2
4765903|NCT01606306|16441013|P1|Overall Study|Physician Decision|1
4765904|NCT01606306|16441008|P6|Overall Study|Withdrawal by Subject|4
4765905|NCT01606306|16441009|P5|Overall Study|Withdrawal by Subject|5
4765906|NCT01606306|16441010|P4|Overall Study|Withdrawal by Subject|4
4765907|NCT01606306|16441011|P3|Overall Study|Withdrawal by Subject|4
4765908|NCT01606306|16441012|P2|Overall Study|Withdrawal by Subject|3
4765909|NCT01606306|16441013|P1|Overall Study|Withdrawal by Subject|4
4765910|NCT01606306|16441008|P6|Overall Study|Lost to Follow-up|5
4765911|NCT01606306|16441009|P5|Overall Study|Lost to Follow-up|3
4765912|NCT01606306|16441010|P4|Overall Study|Lost to Follow-up|4
4765913|NCT01606306|16441011|P3|Overall Study|Lost to Follow-up|5
4765914|NCT01606306|16441012|P2|Overall Study|Lost to Follow-up|4
4765915|NCT01606306|16441013|P1|Overall Study|Lost to Follow-up|7
4765916|NCT01606306|16441008|P6|Overall Study|Adverse Event|0
4765917|NCT01606306|16441009|P5|Overall Study|Adverse Event|2
4765918|NCT01606306|16441010|P4|Overall Study|Adverse Event|1
4765919|NCT01606306|16441011|P3|Overall Study|Adverse Event|1
4765920|NCT01606306|16441012|P2|Overall Study|Adverse Event|0
4765921|NCT01606306|16441013|P1|Overall Study|Adverse Event|1
4765922|NCT01606306|16441008|P6|Overall Study|Lack of Efficacy|2
4765923|NCT01606306|16441009|P5|Overall Study|Lack of Efficacy|1
4765924|NCT01606306|16441010|P4|Overall Study|Lack of Efficacy|4
4765925|NCT01606306|16441011|P3|Overall Study|Lack of Efficacy|4
4765926|NCT01606306|16441012|P2|Overall Study|Lack of Efficacy|1
4765927|NCT01606306|16441013|P1|Overall Study|Lack of Efficacy|2
4765928|NCT01606254|16441023|P4|Overall Study|Adverse Event|1
4765929|NCT01606254|16441024|P3|Overall Study|Adverse Event|0
4765930|NCT01606254|16441025|P2|Overall Study|Adverse Event|1
4765931|NCT01606254|16441026|P1|Overall Study|Adverse Event|1
4765932|NCT01606254|16441023|P4|Overall Study|Withdrawal by Subject|2
4765933|NCT01606254|16441024|P3|Overall Study|Withdrawal by Subject|0
4765934|NCT01606254|16441025|P2|Overall Study|Withdrawal by Subject|3
4765935|NCT01606254|16441026|P1|Overall Study|Withdrawal by Subject|1
4765936|NCT01606228|16441108|P1|Overall Study|Adverse Event|1
4765937|NCT01606228|16441108|P1|Overall Study|Lack of Efficacy|2
4765938|NCT01606228|16441108|P1|Overall Study|Non-compliant|3
4765939|NCT01606228|16441108|P1|Overall Study|Withdrawal by Subject|3
4765940|NCT01606228|16441108|P1|Overall Study|Lost to Follow-up|20
4765941|NCT01606202|16441125|P2|Overall Study|Problems with administration|1
4765942|NCT01606202|16441126|P1|Overall Study|Problems with administration|0
4765943|NCT01606202|16441125|P2|Overall Study|Personal problems|1
4765944|NCT01606202|16441126|P1|Overall Study|Personal problems|0
4765945|NCT01606202|16441125|P2|Overall Study|Withdrawal by Subject|1
4765946|NCT01606202|16441126|P1|Overall Study|Withdrawal by Subject|2
4765947|NCT01606202|16441125|P2|Overall Study|Adverse Event|0
4765948|NCT01606202|16441126|P1|Overall Study|Adverse Event|5
4765949|NCT01606189|16441158|P6|Third Intenvention (14-20 Days)|Withdrawal by Subject|1
4765950|NCT01606189|16441159|P5|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4765951|NCT01606189|16441160|P4|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4765952|NCT01606189|16441161|P3|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4765953|NCT01606189|16441162|P2|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4765954|NCT01606189|16441163|P1|Third Intenvention (14-20 Days)|Withdrawal by Subject|0
4765955|NCT01606189|16441158|P6|Second Intenvention (14-20 Days)|Adverse Event|1
4765956|NCT01606189|16441159|P5|Second Intenvention (14-20 Days)|Adverse Event|0
4765957|NCT01606189|16441160|P4|Second Intenvention (14-20 Days)|Adverse Event|0
4765958|NCT01606189|16441161|P3|Second Intenvention (14-20 Days)|Adverse Event|0
4765959|NCT01606189|16441162|P2|Second Intenvention (14-20 Days)|Adverse Event|0
4765960|NCT01606189|16441163|P1|Second Intenvention (14-20 Days)|Adverse Event|0
4765961|NCT01606176|16441197|P2|Overall Study|Withdrawal by Subject|0
4765962|NCT01606176|16441198|P1|Overall Study|Withdrawal by Subject|1
4765963|NCT01606176|16441197|P2|Overall Study|Disease progression|0
4765964|NCT01606176|16441198|P1|Overall Study|Disease progression|1
4765965|NCT01606176|16441197|P2|Overall Study|Adverse Event|3
4765966|NCT01606176|16441198|P1|Overall Study|Adverse Event|2
4765967|NCT01606137|16441243|P1|Overall Study|Unable to collect consistent data|1
4765968|NCT01606137|16441243|P1|Overall Study|Patient moving|1
4765969|NCT01606137|16441243|P1|Overall Study|Unable to tolerate study med. taste|1
4765970|NCT01606137|16441243|P1|Overall Study|Personal reasons|1
4765971|NCT01606137|16441243|P1|Overall Study|Patient leaving country|1
4765972|NCT01606137|16441243|P1|Overall Study|Wanted to try another treatment|1
4765973|NCT01606137|16441243|P1|Overall Study|Not enough improvement|4
4765974|NCT01606137|16441243|P1|Overall Study|Spray causes nausea|1
4765975|NCT01606137|16441243|P1|Overall Study|Increased bilirubin|1
4765976|NCT01606137|16441243|P1|Overall Study|multiple sclerosis less stable|1
4765977|NCT01606137|16441243|P1|Overall Study|Issues with driving|4
4765978|NCT01606137|16441243|P1|Overall Study|Decreased/no pain|4
4765979|NCT01606137|16441243|P1|Overall Study|Death|1
4765980|NCT01606137|16441243|P1|Overall Study|Patient non-compliance|9
4765981|NCT01606137|16441243|P1|Overall Study|Protocol Violation|1
4765982|NCT01606137|16441243|P1|Overall Study|Lost to Follow-up|15
4765983|NCT01606137|16441243|P1|Overall Study|Lack of Efficacy|56
4765984|NCT01606137|16441243|P1|Overall Study|Withdrawal by Subject|74
4765985|NCT01606137|16441243|P1|Overall Study|Adverse Event|85
4765986|NCT01606007|16441277|P3|Overall Study|Poor/Non-compliance|0
4765987|NCT01606007|16441278|P2|Overall Study|Poor/Non-compliance|0
4765988|NCT01606007|16441279|P1|Overall Study|Poor/Non-compliance|1
4765989|NCT01606007|16441277|P3|Overall Study|Lost to Follow-up|5
4765990|NCT01606007|16441278|P2|Overall Study|Lost to Follow-up|8
4765991|NCT01606007|16441279|P1|Overall Study|Lost to Follow-up|6
4765992|NCT01606007|16441277|P3|Overall Study|discontinue study treatment|1
4765993|NCT01606007|16441278|P2|Overall Study|discontinue study treatment|2
4765994|NCT01606007|16441279|P1|Overall Study|discontinue study treatment|0
4765995|NCT01606007|16441277|P3|Overall Study|Adverse Event|1
4765996|NCT01606007|16441278|P2|Overall Study|Adverse Event|1
4765997|NCT01606007|16441279|P1|Overall Study|Adverse Event|0
4765998|NCT01606007|16441277|P3|Overall Study|Withdrawal by Subject|1
4765999|NCT01606007|16441278|P2|Overall Study|Withdrawal by Subject|6
4766000|NCT01606007|16441279|P1|Overall Study|Withdrawal by Subject|8
4766001|NCT01606007|16441277|P3|Overall Study|Pregnancy|1
4766002|NCT01606007|16441278|P2|Overall Study|Pregnancy|1
4766003|NCT01606007|16441279|P1|Overall Study|Pregnancy|0
4766004|NCT01606007|16441277|P3|Overall Study|Reason 'Other' in the protocol|1
4766005|NCT01606007|16441278|P2|Overall Study|Reason 'Other' in the protocol|1
4766006|NCT01606007|16441279|P1|Overall Study|Reason 'Other' in the protocol|0
4766007|NCT01605916|16441314|P5|Overall Study|Withdrawal by Subject|2
4766008|NCT01605916|16441315|P4|Overall Study|Withdrawal by Subject|0
4766009|NCT01605916|16441316|P3|Overall Study|Withdrawal by Subject|0
4766010|NCT01605916|16441317|P2|Overall Study|Withdrawal by Subject|1
4766011|NCT01605916|16441318|P1|Overall Study|Withdrawal by Subject|1
4766012|NCT01605916|16441314|P5|Overall Study|Lack of Efficacy|4
4766013|NCT01605916|16441315|P4|Overall Study|Lack of Efficacy|5
4766014|NCT01605916|16441316|P3|Overall Study|Lack of Efficacy|3
4766015|NCT01605916|16441317|P2|Overall Study|Lack of Efficacy|3
4766016|NCT01605916|16441318|P1|Overall Study|Lack of Efficacy|2
4766017|NCT01605916|16441314|P5|Overall Study|Adverse Event|0
4766018|NCT01605916|16441315|P4|Overall Study|Adverse Event|1
4766019|NCT01605916|16441316|P3|Overall Study|Adverse Event|0
4766020|NCT01605916|16441317|P2|Overall Study|Adverse Event|0
4766021|NCT01605916|16441318|P1|Overall Study|Adverse Event|1
4766022|NCT01605877|16441415|P1|Overall Study|Withdrawal by Subject|1
4766023|NCT01605825|16441479|P2|Overall Study|Non-Compliance with Protocol|0
4766024|NCT01605825|16441480|P1|Overall Study|Non-Compliance with Protocol|3
4766025|NCT01605825|16441479|P2|Overall Study|Non-Compliance -Investigational Drug|0
4766026|NCT01605825|16441480|P1|Overall Study|Non-Compliance -Investigational Drug|3
4766027|NCT01605825|16441479|P2|Overall Study|Withdrawal by Subject|1
4766028|NCT01605825|16441480|P1|Overall Study|Withdrawal by Subject|0
4766029|NCT01605825|16441479|P2|Overall Study|Adverse Event|2
4766030|NCT01605825|16441480|P1|Overall Study|Adverse Event|4
4766031|NCT01605799|16441488|P2|Overall Study|Withdrawal by Subject|1
4766032|NCT01605799|16441489|P1|Overall Study|Withdrawal by Subject|2
4766033|NCT01605617|16441504|P2|Washout Period of 4 Weeks|Study Terminated|1
4766034|NCT01605617|16441505|P1|Washout Period of 4 Weeks|Study Terminated|2
4766035|NCT01605617|16441504|P2|First Intervention|Adverse Event|1
4766036|NCT01605617|16441505|P1|First Intervention|Adverse Event|0
4766037|NCT01605461|16441564|P1|Overall Study|Withdrawal by Subject|1
4766038|NCT01605461|16441564|P1|Overall Study|Lost to Follow-up|3
4766039|NCT01605396|16441623|P2|Overall Study|Transfer Off Study|5
4766040|NCT01605396|16441624|P1|Overall Study|Transfer Off Study|4
4766041|NCT01605396|16441623|P2|Overall Study|Withdrawal by Subject|2
4766042|NCT01605396|16441624|P1|Overall Study|Withdrawal by Subject|4
4766043|NCT01605396|16441623|P2|Overall Study|Progressive Disease|27
4766044|NCT01605396|16441624|P1|Overall Study|Progressive Disease|23
4766045|NCT01605396|16441623|P2|Overall Study|Physician Decision|2
4766046|NCT01605396|16441624|P1|Overall Study|Physician Decision|2
4766047|NCT01605396|16441623|P2|Overall Study|Non-Compliance With Study Drug|1
4766048|NCT01605396|16441624|P1|Overall Study|Non-Compliance With Study Drug|1
4766049|NCT01605396|16441623|P2|Overall Study|Lost to Follow-up|0
4766050|NCT01605396|16441624|P1|Overall Study|Lost to Follow-up|1
4766051|NCT01605396|16441623|P2|Overall Study|Adverse Event|3
4766052|NCT01605396|16441624|P1|Overall Study|Adverse Event|5
4766053|NCT01605370|16441638|P2|Overall Study|Adverse Event|0
4766054|NCT01605370|16441639|P1|Overall Study|Adverse Event|1
4766055|NCT01605227|16441674|P2|Overall Study|Dose Held >6 weeks|1
4766056|NCT01605227|16441675|P1|Overall Study|Dose Held >6 weeks|0
4766057|NCT01605227|16441674|P2|Overall Study|Subject Decision|1
4766058|NCT01605227|16441675|P1|Overall Study|Subject Decision|0
4766059|NCT01605227|16441674|P2|Overall Study|Started New Therapy|0
4766060|NCT01605227|16441675|P1|Overall Study|Started New Therapy|1
4766061|NCT01605227|16441674|P2|Overall Study|Sponsor Decision|0
4766062|NCT01605227|16441675|P1|Overall Study|Sponsor Decision|2
4766063|NCT01605227|16441674|P2|Overall Study|Withdrawal by Subject|14
4766064|NCT01605227|16441675|P1|Overall Study|Withdrawal by Subject|18
4766065|NCT01605227|16441674|P2|Overall Study|Physician Decision|7
4766066|NCT01605227|16441675|P1|Overall Study|Physician Decision|9
4766067|NCT01605227|16441674|P2|Overall Study|Protocol Violation|0
4766068|NCT01605227|16441675|P1|Overall Study|Protocol Violation|1
4766069|NCT01605227|16441674|P2|Overall Study|Lost to Follow-up|0
4766070|NCT01605227|16441675|P1|Overall Study|Lost to Follow-up|1
4766071|NCT01605227|16441674|P2|Overall Study|Clinical Deterioration|133
4766072|NCT01605227|16441675|P1|Overall Study|Clinical Deterioration|227
4766073|NCT01605227|16441674|P2|Overall Study|Progressive Disease|128
4766074|NCT01605227|16441675|P1|Overall Study|Progressive Disease|132
4766075|NCT01605227|16441674|P2|Overall Study|Adverse Event|42
4766076|NCT01605227|16441675|P1|Overall Study|Adverse Event|228
4766077|NCT01605227|16441674|P2|Overall Study|Did not receive study treatment|3
4766078|NCT01605227|16441675|P1|Overall Study|Did not receive study treatment|2
4766079|NCT01605136|16441687|P2|Safety Follow-Up Period|Withdrawal by Subject|2
4766080|NCT01605136|16441688|P1|Safety Follow-Up Period|Withdrawal by Subject|1
4766081|NCT01605136|16441687|P2|Study Period|Lost to Follow-up|2
4766082|NCT01605136|16441688|P1|Study Period|Lost to Follow-up|0
4766083|NCT01605136|16441687|P2|Study Period|Physician Decision|1
4766084|NCT01605136|16441688|P1|Study Period|Physician Decision|1
4766085|NCT01605136|16441687|P2|Study Period|Withdrawal by Subject|0
4766086|NCT01605136|16441688|P1|Study Period|Withdrawal by Subject|2
4766087|NCT01605019|16441717|P2|Overall Study|pt did not meet transplant endpoint|0
4766088|NCT01605019|16441718|P1|Overall Study|pt did not meet transplant endpoint|3
4766089|NCT01604941|16441728|P6|Overall Study|Early Study Termination|0
4766090|NCT01604941|16441729|P5|Overall Study|Early Study Termination|0
4766091|NCT01604941|16441730|P4|Overall Study|Early Study Termination|3
4766092|NCT01604941|16441731|P3|Overall Study|Early Study Termination|3
4766093|NCT01604941|16441732|P2|Overall Study|Early Study Termination|2
4766094|NCT01604941|16441733|P1|Overall Study|Early Study Termination|9
4766095|NCT01604941|16441728|P6|Overall Study|Participant Decision|2
4766096|NCT01604941|16441729|P5|Overall Study|Participant Decision|0
4766097|NCT01604941|16441730|P4|Overall Study|Participant Decision|0
4766098|NCT01604941|16441731|P3|Overall Study|Participant Decision|0
4766099|NCT01604941|16441732|P2|Overall Study|Participant Decision|0
4766100|NCT01604941|16441733|P1|Overall Study|Participant Decision|0
4766101|NCT01604941|16441728|P6|Overall Study|Non-compliance|0
4766102|NCT01604941|16441729|P5|Overall Study|Non-compliance|0
4766103|NCT01604941|16441730|P4|Overall Study|Non-compliance|0
4766104|NCT01604941|16441731|P3|Overall Study|Non-compliance|0
4766105|NCT01604941|16441732|P2|Overall Study|Non-compliance|0
4766106|NCT01604941|16441733|P1|Overall Study|Non-compliance|1
4766107|NCT01604941|16441728|P6|Overall Study|Adverse Event|5
4766108|NCT01604941|16441729|P5|Overall Study|Adverse Event|1
4766109|NCT01604941|16441730|P4|Overall Study|Adverse Event|0
4766110|NCT01604941|16441731|P3|Overall Study|Adverse Event|0
4766111|NCT01604941|16441732|P2|Overall Study|Adverse Event|2
4766112|NCT01604941|16441733|P1|Overall Study|Adverse Event|1
4766113|NCT01604850|16441761|P2|Overall Study|Subject withdrew consent|0
4766114|NCT01604850|16441762|P1|Overall Study|Subject withdrew consent|1
4766115|NCT01604850|16441761|P2|Overall Study|Lost to Follow-up|0
4766116|NCT01604850|16441762|P1|Overall Study|Lost to Follow-up|1
4766117|NCT01604850|16441761|P2|Overall Study|Efficacy Failure|29
4766118|NCT01604850|16441762|P1|Overall Study|Efficacy Failure|50
4766119|NCT01604850|16441761|P2|Overall Study|Enrolled but never treated|1
4766120|NCT01604850|16441762|P1|Overall Study|Enrolled but never treated|0
4766121|NCT01604824|16441782|P6|Open-label Extension (OLE) Period|Refused to come into office|0
4766122|NCT01604824|16441783|P5|Open-label Extension (OLE) Period|Refused to come into office|1
4766123|NCT01604824|16441784|P4|Open-label Extension (OLE) Period|Refused to come into office|0
4766124|NCT01604824|16441785|P3|Open-label Extension (OLE) Period|Refused to come into office|0
4766125|NCT01604824|16441786|P2|Open-label Extension (OLE) Period|Refused to come into office|0
4766126|NCT01604824|16441787|P1|Open-label Extension (OLE) Period|Refused to come into office|0
4766127|NCT01604824|16441782|P6|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4766128|NCT01604824|16441783|P5|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2
4766129|NCT01604824|16441784|P4|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4766130|NCT01604824|16441785|P3|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4766131|NCT01604824|16441786|P2|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4766132|NCT01604824|16441787|P1|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0
4766133|NCT01604785|16441817|P2|Overall Study|Repeat Visits Not Included in Analysis|1
4766134|NCT01604785|16441818|P1|Overall Study|Repeat Visits Not Included in Analysis|7
4766135|NCT01604408|16441837|P2|Observation Period|Withdrawal by Subject|2
4766136|NCT01604408|16441838|P1|Observation Period|Withdrawal by Subject|0
4766137|NCT01604408|16441837|P2|Observation Period|Adverse Event|1
4766138|NCT01604408|16441838|P1|Observation Period|Adverse Event|1
4766139|NCT01604408|16441837|P2|Treatment Period 6|Sponsor decision|1
4766140|NCT01604408|16441838|P1|Treatment Period 6|Sponsor decision|0
4766141|NCT01604408|16441837|P2|Treatment Period 6|Adverse Event|0
4766142|NCT01604408|16441838|P1|Treatment Period 6|Adverse Event|2
4766143|NCT01604408|16441837|P2|Treatment Period 6|Lost to Follow-up|1
4766144|NCT01604408|16441838|P1|Treatment Period 6|Lost to Follow-up|0
4766145|NCT01604408|16441837|P2|Treatment Period 5|Adverse Event|0
4766146|NCT01604408|16441838|P1|Treatment Period 5|Adverse Event|4
4766147|NCT01604408|16441837|P2|Treatment Period 4|Adverse Event|1
4766148|NCT01604408|16441838|P1|Treatment Period 4|Adverse Event|0
4766149|NCT01604408|16441837|P2|Treatment Period 4|Withdrawal by Subject|1
4766150|NCT01604408|16441838|P1|Treatment Period 4|Withdrawal by Subject|2
4766151|NCT01604408|16441837|P2|Treatment Period 4|Death|0
4766152|NCT01604408|16441838|P1|Treatment Period 4|Death|1
4766153|NCT01604408|16441837|P2|Treatment Period 3|Sponsor Decision|0
4766154|NCT01604408|16441838|P1|Treatment Period 3|Sponsor Decision|1
4766155|NCT01604408|16441837|P2|Treatment Period 3|Withdrawal by Subject|1
4766156|NCT01604408|16441838|P1|Treatment Period 3|Withdrawal by Subject|3
4766157|NCT01604408|16441837|P2|Treatment Period 3|Adverse Event|3
4766158|NCT01604408|16441838|P1|Treatment Period 3|Adverse Event|0
4766159|NCT01604408|16441837|P2|Treatment Period 3|Protocol Violation|1
4766160|NCT01604408|16441838|P1|Treatment Period 3|Protocol Violation|1
4766161|NCT01604408|16441837|P2|Treatment Period 2|Adverse Event|1
4766162|NCT01604408|16441838|P1|Treatment Period 2|Adverse Event|0
4766163|NCT01604408|16441837|P2|Treatment Period 2|Protocol Violation|0
4766164|NCT01604408|16441838|P1|Treatment Period 2|Protocol Violation|1
4766165|NCT01604408|16441837|P2|Treatment Period 2|Withdrawal by Subject|1
4766166|NCT01604408|16441838|P1|Treatment Period 2|Withdrawal by Subject|1
4766167|NCT01604408|16441837|P2|Treatment Period 1|Protocol Violation|1
4766168|NCT01604408|16441838|P1|Treatment Period 1|Protocol Violation|0
4766169|NCT01604343|16441853|P5|Safety Follow-up Period (Week 104-120)|Other|14
4766170|NCT01604343|16441854|P4|Safety Follow-up Period (Week 104-120)|Other|6
4766171|NCT01604343|16441855|P3|Safety Follow-up Period (Week 104-120)|Other|20
4766172|NCT01604343|16441856|P2|Safety Follow-up Period (Week 104-120)|Other|2
4766173|NCT01604343|16441857|P1|Safety Follow-up Period (Week 104-120)|Other|15
4766174|NCT01604343|16441853|P5|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14
4766175|NCT01604343|16441854|P4|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3
4766176|NCT01604343|16441855|P3|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11
4766177|NCT01604343|16441856|P2|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4
4766178|NCT01604343|16441857|P1|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12
4766179|NCT01604343|16441853|P5|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
4766180|NCT01604343|16441854|P4|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
4766181|NCT01604343|16441855|P3|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2
4766182|NCT01604343|16441856|P2|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1
4766183|NCT01604343|16441857|P1|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3
4766184|NCT01604343|16441853|P5|Week 52 to Week 104|Other|3
4766185|NCT01604343|16441854|P4|Week 52 to Week 104|Other|6
4766186|NCT01604343|16441855|P3|Week 52 to Week 104|Other|11
4766187|NCT01604343|16441856|P2|Week 52 to Week 104|Other|11
4766188|NCT01604343|16441857|P1|Week 52 to Week 104|Other|0
4766189|NCT01604343|16441853|P5|Week 52 to Week 104|Pregnancy|1
4766190|NCT01604343|16441854|P4|Week 52 to Week 104|Pregnancy|2
4766191|NCT01604343|16441855|P3|Week 52 to Week 104|Pregnancy|1
4766192|NCT01604343|16441856|P2|Week 52 to Week 104|Pregnancy|0
4766193|NCT01604343|16441857|P1|Week 52 to Week 104|Pregnancy|0
4766194|NCT01604343|16441853|P5|Week 52 to Week 104|Physician Decision|2
4766195|NCT01604343|16441854|P4|Week 52 to Week 104|Physician Decision|0
4766196|NCT01604343|16441855|P3|Week 52 to Week 104|Physician Decision|0
4766197|NCT01604343|16441856|P2|Week 52 to Week 104|Physician Decision|1
4766198|NCT01604343|16441857|P1|Week 52 to Week 104|Physician Decision|0
4766199|NCT01604343|16441853|P5|Week 52 to Week 104|Lack of Efficacy|3
4766200|NCT01604343|16441854|P4|Week 52 to Week 104|Lack of Efficacy|2
4766201|NCT01604343|16441855|P3|Week 52 to Week 104|Lack of Efficacy|11
4766202|NCT01604343|16441856|P2|Week 52 to Week 104|Lack of Efficacy|6
4766203|NCT01604343|16441857|P1|Week 52 to Week 104|Lack of Efficacy|0
4766204|NCT01604343|16441853|P5|Week 52 to Week 104|Death|0
4766205|NCT01604343|16441854|P4|Week 52 to Week 104|Death|5
4766206|NCT01604343|16441855|P3|Week 52 to Week 104|Death|2
4766207|NCT01604343|16441856|P2|Week 52 to Week 104|Death|4
4766208|NCT01604343|16441857|P1|Week 52 to Week 104|Death|0
4766209|NCT01604343|16441853|P5|Week 52 to Week 104|Adverse Event|27
4766210|NCT01604343|16441854|P4|Week 52 to Week 104|Adverse Event|21
4766211|NCT01604343|16441855|P3|Week 52 to Week 104|Adverse Event|26
4766212|NCT01604343|16441856|P2|Week 52 to Week 104|Adverse Event|12
4766213|NCT01604343|16441857|P1|Week 52 to Week 104|Adverse Event|0
4766214|NCT01604343|16441853|P5|Week 52 to Week 104|Withdrawal by Subject|4
4766215|NCT01604343|16441854|P4|Week 52 to Week 104|Withdrawal by Subject|8
4766216|NCT01604343|16441855|P3|Week 52 to Week 104|Withdrawal by Subject|12
4766217|NCT01604343|16441856|P2|Week 52 to Week 104|Withdrawal by Subject|7
4766218|NCT01604343|16441857|P1|Week 52 to Week 104|Withdrawal by Subject|0
4766219|NCT01604343|16441853|P5|Week 52 to Week 104|Lost to Follow-up|1
4766220|NCT01604343|16441854|P4|Week 52 to Week 104|Lost to Follow-up|2
4766221|NCT01604343|16441855|P3|Week 52 to Week 104|Lost to Follow-up|4
4766222|NCT01604343|16441856|P2|Week 52 to Week 104|Lost to Follow-up|2
4766223|NCT01604343|16441857|P1|Week 52 to Week 104|Lost to Follow-up|0
4766224|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Other|6
4766225|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Other|0
4766226|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Other|10
4766227|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Other|0
4766228|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Other|15
4766229|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Pregnancy|0
4766230|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Pregnancy|0
4766231|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Pregnancy|1
4766232|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Pregnancy|0
4766233|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Pregnancy|1
4766234|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Physician Decision|2
4766235|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Physician Decision|0
4766236|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Physician Decision|1
4766237|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Physician Decision|0
4766238|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Physician Decision|4
4766239|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Lack of Efficacy|14
4766240|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
4766241|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Lack of Efficacy|5
4766242|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Lack of Efficacy|0
4766243|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Lack of Efficacy|24
4766244|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Death|4
4766245|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Death|0
4766246|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Death|2
4766247|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Death|0
4766248|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Death|5
4766249|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Adverse Event|42
4766250|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Adverse Event|0
4766251|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Adverse Event|41
4766252|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Adverse Event|0
4766253|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Adverse Event|25
4766254|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16
4766255|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
4766256|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12
4766257|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0
4766258|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19
4766259|NCT01604343|16441853|P5|Prior to W52 Administration(Through W52)|Lost to Follow-up|3
4766260|NCT01604343|16441854|P4|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
4766261|NCT01604343|16441855|P3|Prior to W52 Administration(Through W52)|Lost to Follow-up|4
4766262|NCT01604343|16441856|P2|Prior to W52 Administration(Through W52)|Lost to Follow-up|0
4766263|NCT01604343|16441857|P1|Prior to W52 Administration(Through W52)|Lost to Follow-up|5
4766264|NCT01604278|16442022|P2|Overall Study|Protocol Deviation|3
4766265|NCT01604278|16442023|P1|Overall Study|Protocol Deviation|5
4766266|NCT01604278|16442022|P2|Overall Study|Adverse Event|5
4766267|NCT01604278|16442023|P1|Overall Study|Adverse Event|3
4766268|NCT01604278|16442022|P2|Overall Study|Withdrawal by Subject|3
4766269|NCT01604278|16442023|P1|Overall Study|Withdrawal by Subject|3
4766270|NCT01604278|16442022|P2|Overall Study|Administrative problems|1
4766271|NCT01604278|16442023|P1|Overall Study|Administrative problems|2
4766272|NCT01604278|16442022|P2|Overall Study|Lost to Follow-up|0
4766273|NCT01604278|16442023|P1|Overall Study|Lost to Follow-up|1
4766274|NCT01604278|16442022|P2|Overall Study|Lack of Efficacy|1
4766275|NCT01604278|16442023|P1|Overall Study|Lack of Efficacy|0
4766276|NCT01604265|16442049|P2|Overall Study|Withdrawal by Subject|0
4766277|NCT01604265|16442050|P1|Overall Study|Withdrawal by Subject|1
4766278|NCT01604265|16442049|P2|Overall Study|Adverse Event|0
4766279|NCT01604265|16442050|P1|Overall Study|Adverse Event|1
4766280|NCT01603875|16442161|P3|Overall Study|Protocol Violation|0
4766281|NCT01603875|16442162|P2|Overall Study|Protocol Violation|1
4766282|NCT01603875|16442163|P1|Overall Study|Protocol Violation|0
4766283|NCT01603875|16442161|P3|Overall Study|Lost to Follow-up|6
4766284|NCT01603875|16442162|P2|Overall Study|Lost to Follow-up|3
4766285|NCT01603875|16442163|P1|Overall Study|Lost to Follow-up|4
4766286|NCT01603875|16442161|P3|Overall Study|Preexisting rabies antibody|3
4766287|NCT01603875|16442162|P2|Overall Study|Preexisting rabies antibody|4
4766288|NCT01603875|16442163|P1|Overall Study|Preexisting rabies antibody|3
4766289|NCT01603641|16442183|P1|Overall Study|Other Miscellaneous Reasons|6
4766290|NCT01603641|16442183|P1|Overall Study|Personal Reasons|18
4766291|NCT01603641|16442183|P1|Overall Study|Lost to Follow-up|6
4766292|NCT01603641|16442183|P1|Overall Study|Lack of Efficacy|1
4766293|NCT01603641|16442183|P1|Overall Study|Adverse Event|1
4766294|NCT01603641|16442183|P1|Overall Study|Did not Receive Treatment|3
4766295|NCT01603628|16442190|P3|Overall Study|Other Miscellaneous Reason|0
4766296|NCT01603628|16442191|P2|Overall Study|Other Miscellaneous Reason|0
4766297|NCT01603628|16442192|P1|Overall Study|Other Miscellaneous Reason|1
4766298|NCT01603628|16442190|P3|Overall Study|Lost to Follow-up|0
4766299|NCT01603628|16442191|P2|Overall Study|Lost to Follow-up|1
4766300|NCT01603628|16442192|P1|Overall Study|Lost to Follow-up|0
4766301|NCT01603628|16442190|P3|Overall Study|Protocol Violation|0
4766302|NCT01603628|16442191|P2|Overall Study|Protocol Violation|1
4766303|NCT01603628|16442192|P1|Overall Study|Protocol Violation|1
4766304|NCT01603628|16442190|P3|Overall Study|Personal Reasons|2
4766305|NCT01603628|16442191|P2|Overall Study|Personal Reasons|1
4766306|NCT01603628|16442192|P1|Overall Study|Personal Reasons|1
4766307|NCT01603615|16442209|P1|Overall Study|Other Miscellaneous|1
4766308|NCT01603615|16442209|P1|Overall Study|Personal Reasons|17
4766309|NCT01603615|16442209|P1|Overall Study|Lost to Follow-up|9
4766310|NCT01603615|16442209|P1|Overall Study|Did not Receive Treatment|7
4766311|NCT01603602|16442216|P3|Overall Study|Personal Reasons|1
4766312|NCT01603602|16442217|P2|Overall Study|Personal Reasons|0
4766313|NCT01603602|16442218|P1|Overall Study|Personal Reasons|1
4766314|NCT01603602|16442216|P3|Overall Study|Adverse Event|0
4766315|NCT01603602|16442217|P2|Overall Study|Adverse Event|0
4766316|NCT01603602|16442218|P1|Overall Study|Adverse Event|1
4766317|NCT01603459|16442238|P1|Overall Study|Administrative reason|1
4766318|NCT01603459|16442238|P1|Overall Study|Non-compliance|1
4766319|NCT01603459|16442238|P1|Overall Study|Predefined discontinuation criteria|3
4766320|NCT01603459|16442238|P1|Overall Study|Lost to Follow-up|3
4766321|NCT01603459|16442238|P1|Overall Study|Withdrawal by Subject|5
4766322|NCT01603459|16442238|P1|Overall Study|Adverse Event|5
4766323|NCT01603394|16442389|P1|Overall Study|Adverse Event|1
4766324|NCT01603355|16442443|P1|Overall Study|Lack of Efficacy|2
4766325|NCT01603277|16442449|P2|Overall Study|Non-Compliance|1
4766326|NCT01603277|16442450|P1|Overall Study|Non-Compliance|2
4766327|NCT01603277|16442449|P2|Overall Study|Withdrawal by Subject|4
4766328|NCT01603277|16442450|P1|Overall Study|Withdrawal by Subject|5
4766329|NCT01603277|16442449|P2|Overall Study|Protocol Violation|10
4766330|NCT01603277|16442450|P1|Overall Study|Protocol Violation|6
4766331|NCT01603277|16442449|P2|Overall Study|Physician Decision|1
4766332|NCT01603277|16442450|P1|Overall Study|Physician Decision|0
4766333|NCT01603277|16442449|P2|Overall Study|Adverse Event|2
4766334|NCT01603277|16442450|P1|Overall Study|Adverse Event|1
4766335|NCT01603121|16442456|P2|Second Intervention, 10 Hours|Adverse Event|0
4766336|NCT01603121|16442457|P1|Second Intervention, 10 Hours|Adverse Event|1
4766337|NCT01603082|16442469|P2|Overall Study|Failed inclusion criterion after dosed|0
4766338|NCT01603082|16442470|P1|Overall Study|Failed inclusion criterion after dosed|1
4766339|NCT01603082|16442469|P2|Overall Study|Withdrawal by Subject|0
4766340|NCT01603082|16442470|P1|Overall Study|Withdrawal by Subject|1
4766341|NCT01603082|16442469|P2|Overall Study|Adverse Event|1
4766342|NCT01603082|16442470|P1|Overall Study|Adverse Event|0
4766343|NCT01603043|16442511|P2|Overall Study|Study Futility|3
4766344|NCT01603043|16442512|P1|Overall Study|Study Futility|7
4766345|NCT01602965|16442524|P2|Overall Study|Lost to Follow-up|2
4766346|NCT01602965|16442525|P1|Overall Study|Lost to Follow-up|4
4766347|NCT01602744|16442533|P2|Overall Study|Lost to Follow-up|8
4766348|NCT01602744|16442534|P1|Overall Study|Lost to Follow-up|13
4766349|NCT01602744|16442533|P2|Overall Study|Death|15
4766350|NCT01602744|16442534|P1|Overall Study|Death|17
4766351|NCT01602562|16442665|P2|Overall Study|Withdrawal by Subject|1
4766352|NCT01602562|16442666|P1|Overall Study|Withdrawal by Subject|1
4766353|NCT01602562|16442665|P2|Overall Study|Physician Decision|1
4766354|NCT01602562|16442666|P1|Overall Study|Physician Decision|1
4766355|NCT01602562|16442665|P2|Overall Study|Adverse Event|1
4766356|NCT01602562|16442666|P1|Overall Study|Adverse Event|3
4766357|NCT01602549|16442702|P2|Overall Study|Withdrawal by Subject|0
4766358|NCT01602549|16442703|P1|Overall Study|Withdrawal by Subject|1
4766359|NCT01602549|16442702|P2|Overall Study|Protocol Violation|1
4766360|NCT01602549|16442703|P1|Overall Study|Protocol Violation|0
4766361|NCT01602510|16442782|P3|Randomized Phase|Withdrawal by Subject|7
4766362|NCT01602510|16442783|P2|Randomized Phase|Withdrawal by Subject|6
4766363|NCT01602510|16442784|P1|Randomized Phase|Withdrawal by Subject|0
4766364|NCT01602510|16442782|P3|Randomized Phase|Physician Decision|2
4766365|NCT01602510|16442783|P2|Randomized Phase|Physician Decision|0
4766366|NCT01602510|16442784|P1|Randomized Phase|Physician Decision|0
4766367|NCT01602510|16442782|P3|Randomized Phase|Lost to Follow-up|3
4766368|NCT01602510|16442783|P2|Randomized Phase|Lost to Follow-up|1
4766369|NCT01602510|16442784|P1|Randomized Phase|Lost to Follow-up|0
4766370|NCT01602510|16442782|P3|Randomized Phase|Met protocol-defined stopping criteria|48
4766371|NCT01602510|16442783|P2|Randomized Phase|Met protocol-defined stopping criteria|58
4766372|NCT01602510|16442784|P1|Randomized Phase|Met protocol-defined stopping criteria|0
4766373|NCT01602510|16442782|P3|Randomized Phase|Protocol Violation|3
4766374|NCT01602510|16442783|P2|Randomized Phase|Protocol Violation|3
4766375|NCT01602510|16442784|P1|Randomized Phase|Protocol Violation|0
4766376|NCT01602510|16442782|P3|Randomized Phase|Lack of Efficacy|4
4766377|NCT01602510|16442783|P2|Randomized Phase|Lack of Efficacy|4
4766378|NCT01602510|16442784|P1|Randomized Phase|Lack of Efficacy|0
4766379|NCT01602510|16442782|P3|Randomized Phase|Adverse Event|6
4766380|NCT01602510|16442783|P2|Randomized Phase|Adverse Event|2
4766381|NCT01602510|16442784|P1|Randomized Phase|Adverse Event|0
4766382|NCT01602510|16442782|P3|Open Label Phase|Withdrawal by Subject|0
4766383|NCT01602510|16442783|P2|Open Label Phase|Withdrawal by Subject|0
4766384|NCT01602510|16442784|P1|Open Label Phase|Withdrawal by Subject|57
4766385|NCT01602510|16442782|P3|Open Label Phase|Physician Decision|0
4766386|NCT01602510|16442783|P2|Open Label Phase|Physician Decision|0
4766387|NCT01602510|16442784|P1|Open Label Phase|Physician Decision|19
4766388|NCT01602510|16442782|P3|Open Label Phase|Lost to Follow-up|0
4766389|NCT01602510|16442783|P2|Open Label Phase|Lost to Follow-up|0
4766390|NCT01602510|16442784|P1|Open Label Phase|Lost to Follow-up|22
4766391|NCT01602510|16442782|P3|Open Label Phase|Met protocol-defined stopping criteria|0
4766392|NCT01602510|16442783|P2|Open Label Phase|Met protocol-defined stopping criteria|0
4766393|NCT01602510|16442784|P1|Open Label Phase|Met protocol-defined stopping criteria|122
4766394|NCT01602510|16442782|P3|Open Label Phase|Protocol Violation|0
4766395|NCT01602510|16442783|P2|Open Label Phase|Protocol Violation|0
4766396|NCT01602510|16442784|P1|Open Label Phase|Protocol Violation|15
4766397|NCT01602510|16442782|P3|Open Label Phase|Lack of Efficacy|0
4766398|NCT01602510|16442783|P2|Open Label Phase|Lack of Efficacy|0
4766399|NCT01602510|16442784|P1|Open Label Phase|Lack of Efficacy|22
4766400|NCT01602510|16442782|P3|Open Label Phase|Adverse Event|0
4766401|NCT01602510|16442783|P2|Open Label Phase|Adverse Event|0
4766402|NCT01602510|16442784|P1|Open Label Phase|Adverse Event|46
4766403|NCT01602484|16442810|P2|Overall Study|Airway issues unrelated to study|1
4766404|NCT01602484|16442811|P1|Overall Study|Airway issues unrelated to study|0
4766405|NCT01602419|16442827|P1|Overall Study|Lost to Follow-up|6
4766406|NCT01602419|16442827|P1|Overall Study|Withdrawal by Subject|5
4766407|NCT01602419|16442827|P1|Overall Study|Treatment centre closed|1
4766408|NCT01602419|16442827|P1|Overall Study|Changed treatment centre|1
4766409|NCT01602419|16442827|P1|Overall Study|Insurance issues|3
4766410|NCT01602419|16442827|P1|Overall Study|Adverse Drug Reaction|4
4766411|NCT01602419|16442827|P1|Overall Study|Not treated with Wilate|9
4766412|NCT01602380|16442882|P2|Overall Study|Eligibility criteria not fulfilled|3
4766413|NCT01602380|16442883|P1|Overall Study|Eligibility criteria not fulfilled|2
4766414|NCT01602380|16442882|P2|Overall Study|Lost to Follow-up|1
4766415|NCT01602380|16442883|P1|Overall Study|Lost to Follow-up|6
4766416|NCT01602380|16442882|P2|Overall Study|Withdrawal by Subject|29
4766417|NCT01602380|16442883|P1|Overall Study|Withdrawal by Subject|22
4766418|NCT01602380|16442882|P2|Overall Study|Death|68
4766419|NCT01602380|16442883|P1|Overall Study|Death|63
4766420|NCT01602341|16442907|P2|Overall Study|Adverse Event|1
4766421|NCT01602341|16442908|P1|Overall Study|Adverse Event|0
4766422|NCT01602315|16442949|P7|Overall Study|Cross-over patients to combo treatment|0
4766423|NCT01602315|16442950|P6|Overall Study|Cross-over patients to combo treatment|16
4766424|NCT01602315|16442951|P5|Overall Study|Cross-over patients to combo treatment|0
4766425|NCT01602315|16442952|P4|Overall Study|Cross-over patients to combo treatment|0
4766426|NCT01602315|16442953|P3|Overall Study|Cross-over patients to combo treatment|0
4766427|NCT01602315|16442954|P2|Overall Study|Cross-over patients to combo treatment|0
4766428|NCT01602315|16442955|P1|Overall Study|Cross-over patients to combo treatment|0
4766429|NCT01602315|16442949|P7|Overall Study|Subject/guardian decision|1
4766430|NCT01602315|16442950|P6|Overall Study|Subject/guardian decision|0
4766431|NCT01602315|16442951|P5|Overall Study|Subject/guardian decision|0
4766432|NCT01602315|16442952|P4|Overall Study|Subject/guardian decision|0
4766433|NCT01602315|16442953|P3|Overall Study|Subject/guardian decision|0
4766434|NCT01602315|16442954|P2|Overall Study|Subject/guardian decision|0
4766435|NCT01602315|16442955|P1|Overall Study|Subject/guardian decision|0
4766436|NCT01602315|16442949|P7|Overall Study|Adverse Event|9
4766437|NCT01602315|16442950|P6|Overall Study|Adverse Event|3
4766438|NCT01602315|16442951|P5|Overall Study|Adverse Event|15
4766439|NCT01602315|16442952|P4|Overall Study|Adverse Event|4
4766440|NCT01602315|16442953|P3|Overall Study|Adverse Event|5
4766441|NCT01602315|16442954|P2|Overall Study|Adverse Event|1
4766442|NCT01602315|16442955|P1|Overall Study|Adverse Event|5
4766443|NCT01602315|16442949|P7|Overall Study|Withdrawal by Subject|1
4766444|NCT01602315|16442950|P6|Overall Study|Withdrawal by Subject|0
4766445|NCT01602315|16442951|P5|Overall Study|Withdrawal by Subject|6
4766446|NCT01602315|16442952|P4|Overall Study|Withdrawal by Subject|0
4766447|NCT01602315|16442953|P3|Overall Study|Withdrawal by Subject|2
4766448|NCT01602315|16442954|P2|Overall Study|Withdrawal by Subject|0
4766449|NCT01602315|16442955|P1|Overall Study|Withdrawal by Subject|2
4766450|NCT01602315|16442949|P7|Overall Study|Death|2
4766451|NCT01602315|16442950|P6|Overall Study|Death|2
4766452|NCT01602315|16442951|P5|Overall Study|Death|7
4766453|NCT01602315|16442952|P4|Overall Study|Death|1
4766454|NCT01602315|16442953|P3|Overall Study|Death|1
4766455|NCT01602315|16442954|P2|Overall Study|Death|1
4766456|NCT01602315|16442955|P1|Overall Study|Death|1
4766457|NCT01602315|16442949|P7|Overall Study|Disease progression|15
4766458|NCT01602315|16442950|P6|Overall Study|Disease progression|12
4766459|NCT01602315|16442951|P5|Overall Study|Disease progression|41
4766460|NCT01602315|16442952|P4|Overall Study|Disease progression|1
4766461|NCT01602315|16442953|P3|Overall Study|Disease progression|10
4766462|NCT01602315|16442954|P2|Overall Study|Disease progression|3
4766463|NCT01602315|16442955|P1|Overall Study|Disease progression|6
4766464|NCT01602315|16442949|P7|Overall Study|Physician Decision|1
4766465|NCT01602315|16442950|P6|Overall Study|Physician Decision|1
4766466|NCT01602315|16442951|P5|Overall Study|Physician Decision|2
4766467|NCT01602315|16442952|P4|Overall Study|Physician Decision|0
4766468|NCT01602315|16442953|P3|Overall Study|Physician Decision|0
4766469|NCT01602315|16442954|P2|Overall Study|Physician Decision|0
4766470|NCT01602315|16442955|P1|Overall Study|Physician Decision|2
4766471|NCT01602315|16442949|P7|Overall Study|Protocol Violation|0
4766472|NCT01602315|16442950|P6|Overall Study|Protocol Violation|1
4766473|NCT01602315|16442951|P5|Overall Study|Protocol Violation|0
4766474|NCT01602315|16442952|P4|Overall Study|Protocol Violation|0
4766475|NCT01602315|16442953|P3|Overall Study|Protocol Violation|0
4766476|NCT01602315|16442954|P2|Overall Study|Protocol Violation|0
4766477|NCT01602315|16442955|P1|Overall Study|Protocol Violation|0
4766478|NCT01602224|16443044|P3|Overall Study|Withdrawal by Subject|3
4766479|NCT01602224|16443045|P2|Overall Study|Withdrawal by Subject|3
4766480|NCT01602224|16443046|P1|Overall Study|Withdrawal by Subject|5
4766481|NCT01602224|16443044|P3|Overall Study|Sponsor Decision|2
4766482|NCT01602224|16443045|P2|Overall Study|Sponsor Decision|3
4766483|NCT01602224|16443046|P1|Overall Study|Sponsor Decision|2
4766484|NCT01602224|16443044|P3|Overall Study|Protocol Violation|0
4766485|NCT01602224|16443045|P2|Overall Study|Protocol Violation|1
4766486|NCT01602224|16443046|P1|Overall Study|Protocol Violation|0
4766487|NCT01602224|16443044|P3|Overall Study|Lost to Follow-up|1
4766488|NCT01602224|16443045|P2|Overall Study|Lost to Follow-up|0
4766489|NCT01602224|16443046|P1|Overall Study|Lost to Follow-up|0
4766490|NCT01602224|16443044|P3|Overall Study|Investigator Decison|0
4766491|NCT01602224|16443045|P2|Overall Study|Investigator Decison|0
4766492|NCT01602224|16443046|P1|Overall Study|Investigator Decison|1
4766493|NCT01602224|16443044|P3|Overall Study|Adverse Event|0
4766494|NCT01602224|16443045|P2|Overall Study|Adverse Event|1
4766495|NCT01602224|16443046|P1|Overall Study|Adverse Event|0
4766496|NCT01602120|16443131|P4|Overall Study|Unspecified Reason|2
4766497|NCT01602120|16443132|P3|Overall Study|Unspecified Reason|0
4766498|NCT01602120|16443133|P2|Overall Study|Unspecified Reason|1
4766499|NCT01602120|16443134|P1|Overall Study|Unspecified Reason|3
4766500|NCT01602120|16443131|P4|Overall Study|Physician Decision|0
4766501|NCT01602120|16443132|P3|Overall Study|Physician Decision|0
4766502|NCT01602120|16443133|P2|Overall Study|Physician Decision|3
4766503|NCT01602120|16443134|P1|Overall Study|Physician Decision|2
4766504|NCT01602120|16443131|P4|Overall Study|Study Terminated by Sponsor|44
4766505|NCT01602120|16443132|P3|Overall Study|Study Terminated by Sponsor|17
4766506|NCT01602120|16443133|P2|Overall Study|Study Terminated by Sponsor|24
4766507|NCT01602120|16443134|P1|Overall Study|Study Terminated by Sponsor|12
4766508|NCT01602120|16443131|P4|Overall Study|Withdrawal by Subject|3
4766509|NCT01602120|16443132|P3|Overall Study|Withdrawal by Subject|0
4766510|NCT01602120|16443133|P2|Overall Study|Withdrawal by Subject|17
4766511|NCT01602120|16443134|P1|Overall Study|Withdrawal by Subject|8
4766512|NCT01602120|16443131|P4|Overall Study|Non-compliance|1
4766513|NCT01602120|16443132|P3|Overall Study|Non-compliance|0
4766514|NCT01602120|16443133|P2|Overall Study|Non-compliance|3
4766515|NCT01602120|16443134|P1|Overall Study|Non-compliance|0
4766516|NCT01602120|16443131|P4|Overall Study|Protocol Violation|0
4766517|NCT01602120|16443132|P3|Overall Study|Protocol Violation|0
4766518|NCT01602120|16443133|P2|Overall Study|Protocol Violation|1
4766519|NCT01602120|16443134|P1|Overall Study|Protocol Violation|1
4766520|NCT01602120|16443131|P4|Overall Study|Lost to Follow-up|1
4766521|NCT01602120|16443132|P3|Overall Study|Lost to Follow-up|0
4766522|NCT01602120|16443133|P2|Overall Study|Lost to Follow-up|1
4766523|NCT01602120|16443134|P1|Overall Study|Lost to Follow-up|0
4766524|NCT01602120|16443131|P4|Overall Study|Death|0
4766525|NCT01602120|16443132|P3|Overall Study|Death|0
4766526|NCT01602120|16443133|P2|Overall Study|Death|4
4766527|NCT01602120|16443134|P1|Overall Study|Death|0
4766528|NCT01602120|16443131|P4|Overall Study|Adverse Event|2
4766529|NCT01602120|16443132|P3|Overall Study|Adverse Event|0
4766530|NCT01602120|16443133|P2|Overall Study|Adverse Event|6
4766531|NCT01602120|16443134|P1|Overall Study|Adverse Event|3
4766532|NCT01601873|16443182|P2|Overall Study|Lost to Follow-up|3
4766533|NCT01601873|16443183|P1|Overall Study|Lost to Follow-up|2
4766534|NCT01601847|16443209|P2|Overall Study|Lost to Follow-up|3
4766535|NCT01601847|16443210|P1|Overall Study|Lost to Follow-up|1
4766536|NCT01601847|16443209|P2|Overall Study|Withdrawal by Subject|7
4766537|NCT01601847|16443210|P1|Overall Study|Withdrawal by Subject|11
4766538|NCT01601847|16443209|P2|Overall Study|Death|0
4766539|NCT01601847|16443210|P1|Overall Study|Death|1
4766540|NCT01601821|16443222|P2|Overall Study|Other|1
4766541|NCT01601821|16443223|P1|Overall Study|Other|5
4766542|NCT01601821|16443222|P2|Overall Study|Study Events|1
4766543|NCT01601821|16443223|P1|Overall Study|Study Events|7
4766544|NCT01601821|16443222|P2|Overall Study|Graft Loss|6
4766545|NCT01601821|16443223|P1|Overall Study|Graft Loss|6
4766546|NCT01601821|16443222|P2|Overall Study|Withdrawal by Subject|0
4766547|NCT01601821|16443223|P1|Overall Study|Withdrawal by Subject|1
4766548|NCT01601821|16443222|P2|Overall Study|Lost to Follow-up|14
4766549|NCT01601821|16443223|P1|Overall Study|Lost to Follow-up|6
4766550|NCT01601821|16443222|P2|Overall Study|Protocol Violation|2
4766551|NCT01601821|16443223|P1|Overall Study|Protocol Violation|2
4766552|NCT01601821|16443222|P2|Overall Study|Death|5
4766553|NCT01601821|16443223|P1|Overall Study|Death|2
4766554|NCT01601704|16443259|P2|Overall Study|Randomized but not dispensed study med|4
4766555|NCT01601704|16443260|P1|Overall Study|Randomized but not dispensed study med|1
4766556|NCT01601626|16443281|P3|Overall Study|Not Willing to Adhere to Requirements|0
4766557|NCT01601626|16443282|P2|Overall Study|Not Willing to Adhere to Requirements|0
4766558|NCT01601626|16443283|P1|Overall Study|Not Willing to Adhere to Requirements|1
4766559|NCT01601626|16443281|P3|Overall Study|Withdrawal by Subject|1
4766560|NCT01601626|16443282|P2|Overall Study|Withdrawal by Subject|1
4766561|NCT01601626|16443283|P1|Overall Study|Withdrawal by Subject|0
4766562|NCT01601626|16443281|P3|Overall Study|Unable to Get to Clinic|0
4766563|NCT01601626|16443282|P2|Overall Study|Unable to Get to Clinic|1
4766564|NCT01601626|16443283|P1|Overall Study|Unable to Get to Clinic|0
4766565|NCT01601626|16443281|P3|Overall Study|Lost to Follow-up|0
4766566|NCT01601626|16443282|P2|Overall Study|Lost to Follow-up|2
4766567|NCT01601626|16443283|P1|Overall Study|Lost to Follow-up|1
4766568|NCT01601626|16443281|P3|Overall Study|Death|1
4766569|NCT01601626|16443282|P2|Overall Study|Death|1
4766570|NCT01601626|16443283|P1|Overall Study|Death|1
4766571|NCT01601535|16443372|P6|Phase 2|Started Another Treatment|2
4766572|NCT01601535|16443373|P5|Phase 2|Started Another Treatment|1
4766573|NCT01601535|16443374|P4|Phase 2|Started Another Treatment|0
4766574|NCT01601535|16443375|P3|Phase 2|Started Another Treatment|0
4766575|NCT01601535|16443376|P2|Phase 2|Started Another Treatment|0
4766576|NCT01601535|16443377|P1|Phase 2|Started Another Treatment|0
4766577|NCT01601535|16443372|P6|Phase 2|Progressive Disease|7
4766578|NCT01601535|16443373|P5|Phase 2|Progressive Disease|5
4766579|NCT01601535|16443374|P4|Phase 2|Progressive Disease|0
4766580|NCT01601535|16443375|P3|Phase 2|Progressive Disease|0
4766581|NCT01601535|16443376|P2|Phase 2|Progressive Disease|0
4766582|NCT01601535|16443377|P1|Phase 2|Progressive Disease|0
4766583|NCT01601535|16443372|P6|Phase 2|Withdrawal by Subject|2
4766584|NCT01601535|16443373|P5|Phase 2|Withdrawal by Subject|8
4766585|NCT01601535|16443374|P4|Phase 2|Withdrawal by Subject|0
4766586|NCT01601535|16443375|P3|Phase 2|Withdrawal by Subject|0
4766587|NCT01601535|16443376|P2|Phase 2|Withdrawal by Subject|0
4766588|NCT01601535|16443377|P1|Phase 2|Withdrawal by Subject|0
4766589|NCT01601535|16443372|P6|Phase 2|Adverse Event|1
4766590|NCT01601535|16443373|P5|Phase 2|Adverse Event|5
4766591|NCT01601535|16443374|P4|Phase 2|Adverse Event|0
4766592|NCT01601535|16443375|P3|Phase 2|Adverse Event|0
4766593|NCT01601535|16443376|P2|Phase 2|Adverse Event|0
4766594|NCT01601535|16443377|P1|Phase 2|Adverse Event|0
4766595|NCT01601535|16443372|P6|Phase 1|Started Another Treatment|0
4766596|NCT01601535|16443373|P5|Phase 1|Started Another Treatment|0
4766597|NCT01601535|16443374|P4|Phase 1|Started Another Treatment|0
4766598|NCT01601535|16443375|P3|Phase 1|Started Another Treatment|0
4766599|NCT01601535|16443376|P2|Phase 1|Started Another Treatment|2
4766600|NCT01601535|16443377|P1|Phase 1|Started Another Treatment|1
4766601|NCT01601535|16443372|P6|Phase 1|Progressive Disease|0
4766602|NCT01601535|16443373|P5|Phase 1|Progressive Disease|0
4766603|NCT01601535|16443374|P4|Phase 1|Progressive Disease|1
4766604|NCT01601535|16443375|P3|Phase 1|Progressive Disease|2
4766605|NCT01601535|16443376|P2|Phase 1|Progressive Disease|3
4766606|NCT01601535|16443377|P1|Phase 1|Progressive Disease|2
4766607|NCT01601535|16443372|P6|Phase 1|Withdrawal by Subject|0
4766608|NCT01601535|16443373|P5|Phase 1|Withdrawal by Subject|0
4766609|NCT01601535|16443374|P4|Phase 1|Withdrawal by Subject|2
4766610|NCT01601535|16443375|P3|Phase 1|Withdrawal by Subject|1
4766611|NCT01601535|16443376|P2|Phase 1|Withdrawal by Subject|1
4766612|NCT01601535|16443377|P1|Phase 1|Withdrawal by Subject|2
4766613|NCT01601535|16443372|P6|Phase 1|Adverse Event|0
4766614|NCT01601535|16443373|P5|Phase 1|Adverse Event|0
4766615|NCT01601535|16443374|P4|Phase 1|Adverse Event|1
4766616|NCT01601535|16443375|P3|Phase 1|Adverse Event|2
4766617|NCT01601535|16443376|P2|Phase 1|Adverse Event|0
4766618|NCT01601535|16443377|P1|Phase 1|Adverse Event|1
4766619|NCT01601496|16443433|P1|Overall Study|Other: patient refusal to continue|3
4766620|NCT01601496|16443433|P1|Overall Study|Death|4
4766621|NCT01601496|16443433|P1|Overall Study|Lost to Follow-up|6
4766622|NCT01601496|16443433|P1|Overall Study|Withdrawal by Subject|1
4766623|NCT01601496|16443433|P1|Overall Study|Physician Decision|1
4766624|NCT01601470|16443441|P1|Period 2 - LCZ696|Physician Decision|1
4766625|NCT01601132|16443512|P1|Overall Study|Protocol deviation|1
4766626|NCT01601132|16443512|P1|Overall Study|Patient withdrew consent|1
4766627|NCT01600885|16443557|P2|First Period|moved out of area|0
4766628|NCT01600885|16443558|P1|First Period|moved out of area|1
4766629|NCT01600885|16443557|P2|First Period|Adverse Event|1
4766630|NCT01600885|16443558|P1|First Period|Adverse Event|1
4766631|NCT01600716|16443575|P2|Overall Study|Adverse Event|1
4766632|NCT01600716|16443576|P1|Overall Study|Adverse Event|1
4766633|NCT01600716|16443575|P2|Overall Study|Lack of Efficacy|1
4766634|NCT01600716|16443576|P1|Overall Study|Lack of Efficacy|2
4766635|NCT01600716|16443575|P2|Overall Study|Pregnancy|0
4766636|NCT01600716|16443576|P1|Overall Study|Pregnancy|1
4766637|NCT01600716|16443575|P2|Overall Study|Lost to Follow-up|2
4766638|NCT01600716|16443576|P1|Overall Study|Lost to Follow-up|0
4766639|NCT01600716|16443575|P2|Overall Study|Personal Reasons|2
4766640|NCT01600716|16443576|P1|Overall Study|Personal Reasons|0
4766641|NCT01600716|16443575|P2|Overall Study|Other Reasons|1
4766642|NCT01600716|16443576|P1|Overall Study|Other Reasons|3
4766643|NCT01600586|16443624|P2|Overall Study|Physician Decision|3
4766644|NCT01600586|16443625|P1|Overall Study|Physician Decision|3
4766645|NCT01600326|16443677|P2|Overall Study|Lost to Follow-up|1
4766646|NCT01600326|16443678|P1|Overall Study|Lost to Follow-up|1
4766647|NCT01600105|16443754|P2|Sub Study V|Poor Image Quality|0
4766648|NCT01600105|16443755|P1|Sub Study V|Poor Image Quality|2
4766649|NCT01600105|16443754|P2|Sub Study III|Insufficient image quality|0
4766650|NCT01600105|16443755|P1|Sub Study III|Insufficient image quality|5
4766651|NCT01600105|16443754|P2|Sub Study II|Insufficient image quality|0
4766652|NCT01600105|16443755|P1|Sub Study II|Insufficient image quality|3
4766653|NCT01600105|16443754|P2|Sub Study II|No images in PACS|0
4766654|NCT01600105|16443755|P1|Sub Study II|No images in PACS|1
4766655|NCT01600105|16443754|P2|Sub Study II|Withdrawal by Subject|0
4766656|NCT01600105|16443755|P1|Sub Study II|Withdrawal by Subject|1
4766657|NCT01600105|16443754|P2|Sub Study I|Insufficient image quality|10
4766658|NCT01600105|16443755|P1|Sub Study I|Insufficient image quality|0
4766659|NCT01600105|16443754|P2|Total Participants|Insufficient image quality|10
4766660|NCT01600105|16443755|P1|Total Participants|Insufficient image quality|30
4766661|NCT01600105|16443754|P2|Total Participants|No images in PACS|0
4766662|NCT01600105|16443755|P1|Total Participants|No images in PACS|10
4766663|NCT01600105|16443754|P2|Total Participants|Withdrawal by Subject|0
4766664|NCT01600105|16443755|P1|Total Participants|Withdrawal by Subject|1
4766665|NCT01600092|16443783|P2|Overall Study|Randomized but not vaccinated|3
4766666|NCT01600092|16443784|P1|Overall Study|Randomized but not vaccinated|3
4766667|NCT01600092|16443783|P2|Overall Study|Physician Decision|1
4766668|NCT01600092|16443784|P1|Overall Study|Physician Decision|1
4766669|NCT01600092|16443783|P2|Overall Study|Withdrawal by parent/guardian|6
4766670|NCT01600092|16443784|P1|Overall Study|Withdrawal by parent/guardian|8
4766671|NCT01600092|16443783|P2|Overall Study|Lost to Follow-up|6
4766672|NCT01600092|16443784|P1|Overall Study|Lost to Follow-up|4
4766673|NCT01600092|16443783|P2|Overall Study|Adverse Event|0
4766674|NCT01600092|16443784|P1|Overall Study|Adverse Event|2
4766675|NCT01600053|16443798|P1|Overall Study|trial will not meet the interim endpoint|9
4766676|NCT01600053|16443798|P1|Overall Study|Adverse Event|2
4766677|NCT01600014|16443803|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0
4766678|NCT01600014|16443804|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1
4766679|NCT01600014|16443803|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0
4766680|NCT01600014|16443804|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1
4766681|NCT01600014|16443803|P2|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0
4766682|NCT01600014|16443804|P1|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1
4766683|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3
4766684|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1
4766685|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
4766686|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1
4766687|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0
4766688|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5
4766689|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0
4766690|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1
4766691|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1
4766692|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2
4766693|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3
4766694|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1
4766695|NCT01600014|16443803|P2|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2
4766696|NCT01600014|16443804|P1|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1
4766697|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0
4766698|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8
4766699|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Protocol Violation|0
4766700|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Protocol Violation|6
4766701|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0
4766702|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14
4766703|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Other|0
4766704|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Other|27
4766705|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Adverse Event|0
4766706|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Adverse Event|6
4766707|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0
4766708|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203
4766709|NCT01600014|16443803|P2|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0
4766710|NCT01600014|16443804|P1|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24
4766711|NCT01599806|16443832|P2|Overall Study|Other Eligibility criteria|9
4766712|NCT01599806|16443833|P1|Overall Study|Other Eligibility criteria|11
4766713|NCT01599806|16443832|P2|Overall Study|Withdrawal by Subject|12
4766714|NCT01599806|16443833|P1|Overall Study|Withdrawal by Subject|12
4766715|NCT01599806|16443832|P2|Overall Study|Lost to Follow-up|20
4766716|NCT01599806|16443833|P1|Overall Study|Lost to Follow-up|20
4766717|NCT01599793|16443957|P1|Overall Study|Adverse Event|2
4766718|NCT01599754|16443969|P2|Overall Study|Study terminated by sponsor|285
4766719|NCT01599754|16443970|P1|Overall Study|Study terminated by sponsor|282
4766720|NCT01599754|16443969|P2|Overall Study|Withdrawal by Subject|25
4766721|NCT01599754|16443970|P1|Overall Study|Withdrawal by Subject|24
4766722|NCT01599754|16443969|P2|Overall Study|Investigator decision|3
4766723|NCT01599754|16443970|P1|Overall Study|Investigator decision|1
4766724|NCT01599754|16443969|P2|Overall Study|Adverse Event|2
4766725|NCT01599754|16443970|P1|Overall Study|Adverse Event|3
4766726|NCT01599754|16443969|P2|Overall Study|Death|33
4766727|NCT01599754|16443970|P1|Overall Study|Death|31
4766728|NCT01599754|16443969|P2|Overall Study|Lost to Follow-up|6
4766729|NCT01599754|16443970|P1|Overall Study|Lost to Follow-up|13
4766730|NCT01599754|16443969|P2|Overall Study|Participant noncompliance|4
4766731|NCT01599754|16443970|P1|Overall Study|Participant noncompliance|4
4766732|NCT01599754|16443969|P2|Overall Study|Anticancer therapy need not in protocol|2
4766733|NCT01599754|16443970|P1|Overall Study|Anticancer therapy need not in protocol|5
4766734|NCT01599650|16444001|P3|Overall Study|Adverse Event|4
4766735|NCT01599650|16444002|P2|Overall Study|Adverse Event|8
4766736|NCT01599650|16444003|P1|Overall Study|Adverse Event|3
4766737|NCT01599650|16444001|P3|Overall Study|Withdrawal by Subject|10
4766738|NCT01599650|16444002|P2|Overall Study|Withdrawal by Subject|11
4766739|NCT01599650|16444003|P1|Overall Study|Withdrawal by Subject|11
4766740|NCT01599650|16444001|P3|Overall Study|Lost to Follow-up|3
4766741|NCT01599650|16444002|P2|Overall Study|Lost to Follow-up|3
4766742|NCT01599650|16444003|P1|Overall Study|Lost to Follow-up|3
4766743|NCT01599650|16444001|P3|Overall Study|Death|2
4766744|NCT01599650|16444002|P2|Overall Study|Death|1
4766745|NCT01599650|16444003|P1|Overall Study|Death|2
4766746|NCT01599650|16444001|P3|Overall Study|Protocol Violation|0
4766747|NCT01599650|16444002|P2|Overall Study|Protocol Violation|3
4766748|NCT01599650|16444003|P1|Overall Study|Protocol Violation|0
4766749|NCT01599650|16444001|P3|Overall Study|Physician Decision|7
4766750|NCT01599650|16444002|P2|Overall Study|Physician Decision|0
4766751|NCT01599650|16444003|P1|Overall Study|Physician Decision|2
4766752|NCT01599650|16444001|P3|Overall Study|Administrative issue|1
4766753|NCT01599650|16444002|P2|Overall Study|Administrative issue|0
4766754|NCT01599650|16444003|P1|Overall Study|Administrative issue|1
4766755|NCT01599637|16444042|P3|Overall Study|Adverse Event|0
4766756|NCT01599637|16444043|P2|Overall Study|Adverse Event|0
4766757|NCT01599637|16444044|P1|Overall Study|Adverse Event|1
4766758|NCT01599637|16444042|P3|Overall Study|administrative problems|0
4766759|NCT01599637|16444043|P2|Overall Study|administrative problems|2
4766760|NCT01599637|16444044|P1|Overall Study|administrative problems|0
4766761|NCT01599585|16444091|P2|Overall Study|randomized did not start treatment|3
4766762|NCT01599585|16444092|P1|Overall Study|randomized did not start treatment|3
4766763|NCT01599585|16444091|P2|Overall Study|Lost to Follow-up|5
4766764|NCT01599585|16444092|P1|Overall Study|Lost to Follow-up|3
4766765|NCT01599585|16444091|P2|Overall Study|Withdrawal by Subject|9
4766766|NCT01599585|16444092|P1|Overall Study|Withdrawal by Subject|16
4766767|NCT01599325|16444130|P1|Extension Phase|Withdrawal by Subject|8
4766768|NCT01599325|16444130|P1|Extension Phase|Disease Progression|1
4766769|NCT01599325|16444130|P1|Extension Phase|Lack of Therapeutic Effect|4
4766770|NCT01599325|16444130|P1|Extension Phase|Stopped to Receive Stem Cell Transplant|1
4766771|NCT01599325|16444130|P1|Extension Phase|Study Closure|1
4766772|NCT01599325|16444130|P1|Primary Parent Phase|Other|2
4766773|NCT01599325|16444130|P1|Primary Parent Phase|Lack of Therapeutic Effect|9
4766774|NCT01599325|16444130|P1|Primary Parent Phase|Protocol Violation|1
4766775|NCT01599325|16444130|P1|Primary Parent Phase|Death|13
4766776|NCT01599325|16444130|P1|Primary Parent Phase|Withdrawal by Subject|20
4766777|NCT01599325|16444130|P1|Primary Parent Phase|Disease Progression|7
4766778|NCT01599325|16444130|P1|Primary Parent Phase|Adverse Event|5
4766779|NCT01599234|16444154|P2|Overall Study|Pregnancy|1
4766780|NCT01599234|16444155|P1|Overall Study|Pregnancy|0
4766781|NCT01599234|16444154|P2|Overall Study|Contra-indication discovered|1
4766782|NCT01599234|16444155|P1|Overall Study|Contra-indication discovered|0
4766783|NCT01599234|16444154|P2|Overall Study|Patient would not stop driving|0
4766784|NCT01599234|16444155|P1|Overall Study|Patient would not stop driving|1
4766785|NCT01599234|16444154|P2|Overall Study|Death|0
4766786|NCT01599234|16444155|P1|Overall Study|Death|1
4766787|NCT01599234|16444154|P2|Overall Study|Sponsor request as creatinine levels <50|1
4766788|NCT01599234|16444155|P1|Overall Study|Sponsor request as creatinine levels <50|0
4766789|NCT01599234|16444154|P2|Overall Study|Unable to operate spray|0
4766790|NCT01599234|16444155|P1|Overall Study|Unable to operate spray|1
4766791|NCT01599234|16444154|P2|Overall Study|Lack of Efficacy|4
4766792|NCT01599234|16444155|P1|Overall Study|Lack of Efficacy|2
4766793|NCT01599234|16444154|P2|Overall Study|Lost to Follow-up|2
4766794|NCT01599234|16444155|P1|Overall Study|Lost to Follow-up|1
4766795|NCT01599234|16444154|P2|Overall Study|Withdrawal by Subject|1
4766796|NCT01599234|16444155|P1|Overall Study|Withdrawal by Subject|2
4766797|NCT01599234|16444154|P2|Overall Study|Adverse Event|5
4766798|NCT01599234|16444155|P1|Overall Study|Adverse Event|9
4766799|NCT01599104|16444180|P3|Overall Study|Adverse Event|12
4766800|NCT01599104|16444181|P2|Overall Study|Adverse Event|6
4766801|NCT01599104|16444182|P1|Overall Study|Adverse Event|7
4766802|NCT01599104|16444180|P3|Overall Study|Lack of Efficacy|10
4766803|NCT01599104|16444181|P2|Overall Study|Lack of Efficacy|4
4766804|NCT01599104|16444182|P1|Overall Study|Lack of Efficacy|4
4766805|NCT01599104|16444180|P3|Overall Study|Non-compliance with study treatment|0
4766806|NCT01599104|16444181|P2|Overall Study|Non-compliance with study treatment|1
4766807|NCT01599104|16444182|P1|Overall Study|Non-compliance with study treatment|0
4766808|NCT01599104|16444180|P3|Overall Study|Physician Decision|2
4766809|NCT01599104|16444181|P2|Overall Study|Physician Decision|2
4766810|NCT01599104|16444182|P1|Overall Study|Physician Decision|3
4766811|NCT01599104|16444180|P3|Overall Study|Technical Problems|0
4766812|NCT01599104|16444181|P2|Overall Study|Technical Problems|0
4766813|NCT01599104|16444182|P1|Overall Study|Technical Problems|1
4766814|NCT01599104|16444180|P3|Overall Study|Withdrawal by Subject|2
4766815|NCT01599104|16444181|P2|Overall Study|Withdrawal by Subject|1
4766816|NCT01599104|16444182|P1|Overall Study|Withdrawal by Subject|1
4766817|NCT01598987|16444220|P1|Baseline to 24 Month|Lost to Follow-up|1
4766818|NCT01598987|16444220|P1|Baseline to 24 Month|Administrative problems|2
4766819|NCT01598987|16444220|P1|Baseline to 24 Month|Withdrawal by Subject|5
4766820|NCT01598987|16444220|P1|Baseline to Month 12|Withdrawal by Subject|4
4766821|NCT01598987|16444220|P1|Baseline to Month 12|Administrative problems|2
4766822|NCT01598896|16444256|P2|Overall Study|Lack of Efficacy|1
4766823|NCT01598896|16444257|P1|Overall Study|Lack of Efficacy|0
4766824|NCT01598896|16444256|P2|Overall Study|Withdrawal by Subject|1
4766825|NCT01598896|16444257|P1|Overall Study|Withdrawal by Subject|0
4766826|NCT01598753|16444296|P4|Overall Study|Withdrawal by Subject|1
4766827|NCT01598753|16444297|P3|Overall Study|Withdrawal by Subject|0
4766828|NCT01598753|16444298|P2|Overall Study|Withdrawal by Subject|2
4766829|NCT01598753|16444299|P1|Overall Study|Withdrawal by Subject|7
4766830|NCT01598753|16444296|P4|Overall Study|Physician Decision|2
4766831|NCT01598753|16444297|P3|Overall Study|Physician Decision|0
4766832|NCT01598753|16444298|P2|Overall Study|Physician Decision|1
4766833|NCT01598753|16444299|P1|Overall Study|Physician Decision|0
4766834|NCT01598753|16444296|P4|Overall Study|Lost to Follow-up|5
4766835|NCT01598753|16444297|P3|Overall Study|Lost to Follow-up|7
4766836|NCT01598753|16444298|P2|Overall Study|Lost to Follow-up|3
4766837|NCT01598753|16444299|P1|Overall Study|Lost to Follow-up|4
4766838|NCT01598753|16444296|P4|Overall Study|Adverse Event|7
4766839|NCT01598753|16444297|P3|Overall Study|Adverse Event|1
4766840|NCT01598753|16444298|P2|Overall Study|Adverse Event|9
4766841|NCT01598753|16444299|P1|Overall Study|Adverse Event|1
4766842|NCT01598662|16444339|P2|Overall Study|IUD expelled before month 6|2
4766843|NCT01598662|16444340|P1|Overall Study|IUD expelled before month 6|0
4766844|NCT01598662|16444339|P2|Overall Study|Physician Decision|2
4766845|NCT01598662|16444340|P1|Overall Study|Physician Decision|1
4766846|NCT01598662|16444339|P2|Overall Study|Lost to Follow-up|17
4766847|NCT01598662|16444340|P1|Overall Study|Lost to Follow-up|10
4766848|NCT01598610|16444346|P1|Overall Study|Adverse Event|1
4766849|NCT01598532|16444363|P1|Overall Study|Did not meet inclusion criteria|8
4766850|NCT01598532|16444363|P1|Overall Study|Lost to Follow-up|3
4766851|NCT01598506|16444372|P1|Overall Study|Withdrawal by Subject|2
4766852|NCT01598311|16444392|P2|Overall Study|Assigned to CB but received vancomycin|0
4766853|NCT01598311|16444393|P1|Overall Study|Assigned to CB but received vancomycin|1
4766854|NCT01598311|16444392|P2|Overall Study|Treated but no confirmed CDAD|8
4766855|NCT01598311|16444393|P1|Overall Study|Treated but no confirmed CDAD|9
4766856|NCT01598311|16444392|P2|Overall Study|Randomized but never treated|5
4766857|NCT01598311|16444393|P1|Overall Study|Randomized but never treated|8
4766858|NCT01598311|16444392|P2|Overall Study|No reason provided.|5
4766859|NCT01598311|16444393|P1|Overall Study|No reason provided.|0
4766860|NCT01598311|16444392|P2|Overall Study|Withdrawal by Subject|13
4766861|NCT01598311|16444393|P1|Overall Study|Withdrawal by Subject|9
4766862|NCT01598311|16444392|P2|Overall Study|Lost to Follow-up|12
4766863|NCT01598311|16444393|P1|Overall Study|Lost to Follow-up|7
4766864|NCT01598311|16444392|P2|Overall Study|Adverse Event|13
4766865|NCT01598311|16444393|P1|Overall Study|Adverse Event|9
4766866|NCT01598311|16444392|P2|Overall Study|Physician Decision|5
4766867|NCT01598311|16444393|P1|Overall Study|Physician Decision|4
4766868|NCT01598298|16444409|P2|Overall Study|Other reason (not protocol specified)|0
4766869|NCT01598298|16444410|P1|Overall Study|Other reason (not protocol specified)|4
4766870|NCT01598298|16444409|P2|Overall Study|Withdrawal by Subject|15
4766871|NCT01598298|16444410|P1|Overall Study|Withdrawal by Subject|10
4766872|NCT01598298|16444409|P2|Overall Study|Progression/relapse|2
4766873|NCT01598298|16444410|P1|Overall Study|Progression/relapse|0
4766874|NCT01598298|16444409|P2|Overall Study|Adverse Event|19
4766875|NCT01598298|16444410|P1|Overall Study|Adverse Event|21
4766876|NCT01598298|16444409|P2|Overall Study|Not eligible|5
4766877|NCT01598298|16444410|P1|Overall Study|Not eligible|5
4766878|NCT01598129|16444454|P1|Overall Study|Withdrawal by Subject|1
4766879|NCT01598129|16444454|P1|Overall Study|Deterioration of WHO status to WHO 4|2
4766880|NCT01598129|16444454|P1|Overall Study|Disease progression|6
4766881|NCT01598090|16444466|P3|Follow-up Period|Lost to Follow-up|12
4766882|NCT01598090|16444467|P2|Follow-up Period|Lost to Follow-up|10
4766883|NCT01598090|16444468|P1|Follow-up Period|Lost to Follow-up|2
4766884|NCT01598090|16444466|P3|Follow-up Period|Other reasons|8
4766885|NCT01598090|16444467|P2|Follow-up Period|Other reasons|8
4766886|NCT01598090|16444468|P1|Follow-up Period|Other reasons|2
4766887|NCT01598090|16444466|P3|Follow-up Period|Withdrawal by Subject|2
4766888|NCT01598090|16444467|P2|Follow-up Period|Withdrawal by Subject|3
4766889|NCT01598090|16444468|P1|Follow-up Period|Withdrawal by Subject|0
4766890|NCT01598090|16444466|P3|Follow-up Period|Not reported|4
4766891|NCT01598090|16444467|P2|Follow-up Period|Not reported|10
4766892|NCT01598090|16444468|P1|Follow-up Period|Not reported|0
4766893|NCT01598090|16444466|P3|Follow-up Period|No longer required per protocol|2
4766894|NCT01598090|16444467|P2|Follow-up Period|No longer required per protocol|3
4766895|NCT01598090|16444468|P1|Follow-up Period|No longer required per protocol|1
4766896|NCT01598090|16444466|P3|Follow-up Period|Death|0
4766897|NCT01598090|16444467|P2|Follow-up Period|Death|1
4766898|NCT01598090|16444468|P1|Follow-up Period|Death|0
4766899|NCT01598090|16444466|P3|Treatment Period|Lost to Follow-up|1
4766900|NCT01598090|16444467|P2|Treatment Period|Lost to Follow-up|5
4766901|NCT01598090|16444468|P1|Treatment Period|Lost to Follow-up|1
4766902|NCT01598090|16444466|P3|Treatment Period|Withdrawal by Subject|10
4766903|NCT01598090|16444467|P2|Treatment Period|Withdrawal by Subject|13
4766904|NCT01598090|16444468|P1|Treatment Period|Withdrawal by Subject|3
4766905|NCT01598090|16444466|P3|Treatment Period|Other reasons|1
4766906|NCT01598090|16444467|P2|Treatment Period|Other reasons|4
4766907|NCT01598090|16444468|P1|Treatment Period|Other reasons|0
4766908|NCT01598090|16444466|P3|Treatment Period|Adverse Event|17
4766909|NCT01598090|16444467|P2|Treatment Period|Adverse Event|33
4766910|NCT01598090|16444468|P1|Treatment Period|Adverse Event|2
4766911|NCT01598090|16444466|P3|Treatment Period|Lack of Efficacy|6
4766912|NCT01598090|16444467|P2|Treatment Period|Lack of Efficacy|14
4766913|NCT01598090|16444468|P1|Treatment Period|Lack of Efficacy|5
4766914|NCT01598090|16444466|P3|Treatment Period|No longer meet study criteria|0
4766915|NCT01598090|16444467|P2|Treatment Period|No longer meet study criteria|1
4766916|NCT01598090|16444468|P1|Treatment Period|No longer meet study criteria|0
4766917|NCT01598090|16444466|P3|Treatment Period|Poor/non-compliance|0
4766918|NCT01598090|16444467|P2|Treatment Period|Poor/non-compliance|2
4766919|NCT01598090|16444468|P1|Treatment Period|Poor/non-compliance|0
4766920|NCT01597908|16444515|P2|Overall Study|Ongoing|202
4766921|NCT01597908|16444516|P1|Overall Study|Ongoing|236
4766922|NCT01597908|16444515|P2|Overall Study|Withdrawal by Subject|18
4766923|NCT01597908|16444516|P1|Overall Study|Withdrawal by Subject|10
4766924|NCT01597908|16444515|P2|Overall Study|Physician Decision|1
4766925|NCT01597908|16444516|P1|Overall Study|Physician Decision|2
4766926|NCT01597908|16444515|P2|Overall Study|Lost to Follow-up|9
4766927|NCT01597908|16444516|P1|Overall Study|Lost to Follow-up|4
4766928|NCT01597908|16444515|P2|Overall Study|Death|122
4766929|NCT01597908|16444516|P1|Overall Study|Death|100
4766930|NCT01597791|16444562|P2|Overall Study|Protocol Violation|1
4766931|NCT01597791|16444563|P1|Overall Study|Protocol Violation|0
4766932|NCT01597791|16444562|P2|Overall Study|Subject withdrawal|1
4766933|NCT01597791|16444563|P1|Overall Study|Subject withdrawal|0
4766934|NCT01597791|16444562|P2|Overall Study|Cesarean Section|7
4766935|NCT01597791|16444563|P1|Overall Study|Cesarean Section|6
4766936|NCT01597791|16444562|P2|Overall Study|Physician Decision|1
4766937|NCT01597791|16444563|P1|Overall Study|Physician Decision|2
4766938|NCT01597635|16444650|P3|Part B|Withdrawal by Subject|0
4766939|NCT01597635|16444651|P2|Part B|Withdrawal by Subject|1
4766940|NCT01597635|16444652|P1|Part B|Withdrawal by Subject|0
4766941|NCT01597635|16444650|P3|Part B|Protocol-defined stopping criteria|3
4766942|NCT01597635|16444651|P2|Part B|Protocol-defined stopping criteria|4
4766943|NCT01597635|16444652|P1|Part B|Protocol-defined stopping criteria|0
4766944|NCT01597635|16444650|P3|Part B|Protocol Violation|0
4766945|NCT01597635|16444651|P2|Part B|Protocol Violation|1
4766946|NCT01597635|16444652|P1|Part B|Protocol Violation|0
4766947|NCT01597635|16444650|P3|Part B|Adverse Event|1
4766948|NCT01597635|16444651|P2|Part B|Adverse Event|0
4766949|NCT01597635|16444652|P1|Part B|Adverse Event|0
4766950|NCT01597635|16444650|P3|Part A|Adverse Event|0
4766951|NCT01597635|16444651|P2|Part A|Adverse Event|0
4766952|NCT01597635|16444652|P1|Part A|Adverse Event|3
4766953|NCT01597622|16444715|P1|Overall Study|Death|1
4766954|NCT01597622|16444715|P1|Overall Study|Withdrawal by Subject|20
4766955|NCT01597622|16444715|P1|Overall Study|Investigator Discretion|5
4766956|NCT01597622|16444715|P1|Overall Study|Lost to Follow-up|1
4766957|NCT01597622|16444715|P1|Overall Study|Protocol Violation|1
4766958|NCT01597622|16444715|P1|Overall Study|Lack of Efficacy|3
4766959|NCT01597622|16444715|P1|Overall Study|Adverse Event|7
4766960|NCT01597596|16444722|P2|Overall Study|Physician Decision|1
4766961|NCT01597596|16444723|P1|Overall Study|Physician Decision|0
4766962|NCT01597596|16444722|P2|Overall Study|Study terminated by sponsor|0
4766963|NCT01597596|16444723|P1|Overall Study|Study terminated by sponsor|1
4766964|NCT01597557|16444737|P2|Overall Study|Did not undergo cardioversion procedure|3
4766965|NCT01597557|16444738|P1|Overall Study|Did not undergo cardioversion procedure|4
4766966|NCT01597505|16444750|P2|Overall Study|Missing|0
4766967|NCT01597505|16444751|P1|Overall Study|Missing|1
4766968|NCT01597505|16444750|P2|Overall Study|Other|6
4766969|NCT01597505|16444751|P1|Overall Study|Other|5
4766970|NCT01597505|16444750|P2|Overall Study|Withdrawal by Subject|18
4766971|NCT01597505|16444751|P1|Overall Study|Withdrawal by Subject|10
4766972|NCT01597505|16444750|P2|Overall Study|Lost to Follow-up|2
4766973|NCT01597505|16444751|P1|Overall Study|Lost to Follow-up|4
4766974|NCT01597505|16444750|P2|Overall Study|Adverse Event|7
4766975|NCT01597505|16444751|P1|Overall Study|Adverse Event|19
4766976|NCT01597505|16444750|P2|Overall Study|Physician Decision|0
4766977|NCT01597505|16444751|P1|Overall Study|Physician Decision|5
4766978|NCT01597492|16444785|P2|Overall Study|Other Reason|0
4766979|NCT01597492|16444786|P1|Overall Study|Other Reason|2
4766980|NCT01597492|16444785|P2|Overall Study|Lost to Follow-up|2
4766981|NCT01597492|16444786|P1|Overall Study|Lost to Follow-up|0
4766982|NCT01597492|16444785|P2|Overall Study|Adverse Event|0
4766983|NCT01597492|16444786|P1|Overall Study|Adverse Event|3
4766984|NCT01597492|16444785|P2|Overall Study|Withdrawal by Subject|2
4766985|NCT01597492|16444786|P1|Overall Study|Withdrawal by Subject|1
4766986|NCT01597479|16444794|P2|Overall Study|Lost to Follow-up|0
4766987|NCT01597479|16444795|P1|Overall Study|Lost to Follow-up|1
4766988|NCT01597479|16444794|P2|Overall Study|Protocol Violation|0
4766989|NCT01597479|16444795|P1|Overall Study|Protocol Violation|1
4766990|NCT01597375|16445081|P2|Second Intervention|Failed to react at both Aspirin|1
4766991|NCT01597375|16445082|P1|Second Intervention|Failed to react at both Aspirin|1
4766992|NCT01597375|16445081|P2|Washout (2 Weeks)|Adverse Event|0
4766993|NCT01597375|16445082|P1|Washout (2 Weeks)|Adverse Event|1
4766994|NCT01597375|16445081|P2|First Intervention (4 Weeks)|Lost to Follow-up|1
4766995|NCT01597375|16445082|P1|First Intervention (4 Weeks)|Lost to Follow-up|0
4766996|NCT01597375|16445081|P2|First Intervention (4 Weeks)|Needed surgery|0
4766997|NCT01597375|16445082|P1|First Intervention (4 Weeks)|Needed surgery|1
4766998|NCT01597375|16445081|P2|First Intervention (4 Weeks)|Uncontrolled Asthma|0
4766999|NCT01597375|16445082|P1|First Intervention (4 Weeks)|Uncontrolled Asthma|1
4767000|NCT01597258|16445099|P1|Overall Study|No Drug Administration|1
4767001|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767002|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1
4767003|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767004|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767005|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767006|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767007|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767008|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767009|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767010|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767011|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767012|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767013|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767014|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767015|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767016|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767017|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767018|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767019|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767020|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767021|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0
4767022|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767023|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
4767024|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767025|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767026|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1
4767027|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767028|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767029|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767030|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767031|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767032|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767033|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767034|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767035|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767036|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767037|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767038|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767039|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767040|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767041|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767042|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0
4767043|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767044|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3
4767045|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767046|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767047|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2
4767048|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767049|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767050|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767051|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767052|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767053|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767054|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767055|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767056|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767057|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767058|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767059|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767060|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767061|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767062|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767063|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0
4767064|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2
4767065|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6
4767066|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767067|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767068|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1
4767069|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767070|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767071|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767072|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767073|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767074|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767075|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767076|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767077|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767078|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767079|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767080|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767081|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767082|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767083|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767084|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0
4767085|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
4767086|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9
4767087|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767088|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767089|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1
4767090|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767091|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767092|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767093|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767094|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767095|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767096|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767097|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767098|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767099|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767100|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767101|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767102|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767103|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767104|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767105|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0
4767106|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4
4767817|NCT01595009|16445893|P4|Extension|Administrative problems|1
4767107|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14
4767108|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1
4767109|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767110|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767111|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767112|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767113|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767114|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767115|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767116|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767117|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767118|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767119|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767120|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767121|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767122|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767123|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767124|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767125|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767126|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0
4767127|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3
4767128|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29
4767129|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767130|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767131|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2
4767132|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767133|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767134|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767135|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767136|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767137|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767138|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767139|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767140|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767141|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767142|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767143|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767144|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767145|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767146|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767147|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0
4767148|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13
4767149|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41
4767150|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
4767151|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1
4767152|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767153|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767154|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767155|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767156|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767157|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767158|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767159|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767160|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767161|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767162|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767163|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767164|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767165|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767166|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767167|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767168|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0
4767169|NCT01597245|16445108|P21|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13
4767170|NCT01597245|16445109|P20|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63
4767171|NCT01597245|16445110|P19|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8
4767172|NCT01597245|16445111|P18|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5
4767173|NCT01597245|16445112|P17|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9
4767174|NCT01597245|16445113|P16|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767818|NCT01595009|16445894|P3|Extension|Administrative problems|0
4767175|NCT01597245|16445114|P15|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767176|NCT01597245|16445115|P14|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767177|NCT01597245|16445116|P13|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767178|NCT01597245|16445117|P12|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767179|NCT01597245|16445118|P11|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767180|NCT01597245|16445119|P10|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767181|NCT01597245|16445120|P9|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767182|NCT01597245|16445121|P8|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767183|NCT01597245|16445122|P7|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767184|NCT01597245|16445123|P6|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767185|NCT01597245|16445124|P5|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767186|NCT01597245|16445125|P4|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767187|NCT01597245|16445126|P3|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767188|NCT01597245|16445127|P2|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767189|NCT01597245|16445128|P1|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0
4767190|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767191|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767192|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767193|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767194|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767195|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767196|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767197|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23
4767198|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767199|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767200|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767201|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767202|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767203|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767204|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767205|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767206|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767207|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767208|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767209|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767210|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0
4767211|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767212|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767213|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767214|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767215|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767216|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
4767217|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1
4767218|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767219|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767220|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767221|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767222|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767223|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767224|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767225|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767226|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767227|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767228|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767229|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767230|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767231|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0
4767232|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767233|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767234|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767235|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767236|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767237|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
4767238|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4
4767239|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767240|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767241|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767242|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767819|NCT01595009|16445895|P2|Extension|Administrative problems|0
4767243|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767244|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767245|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767246|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767247|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767248|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767249|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767250|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767251|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767252|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0
4767253|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767254|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767255|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767256|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767257|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767258|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
4767259|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6
4767260|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767261|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767262|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767263|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767264|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767265|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767266|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767267|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767268|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767269|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767270|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767271|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767272|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767273|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0
4767274|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Death|0
4767275|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Death|0
4767276|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Death|0
4767277|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Death|0
4767278|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Death|0
4767279|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Death|8
4767280|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Death|8
4767281|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Death|0
4767282|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Death|0
4767283|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Death|0
4767284|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Death|0
4767285|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Death|0
4767286|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Death|0
4767287|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Death|0
4767288|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Death|0
4767289|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Death|0
4767290|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Death|0
4767291|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Death|0
4767292|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Death|0
4767293|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Death|0
4767294|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Death|0
4767295|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767296|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767297|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767298|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767299|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767300|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Physician Decision|12
4767301|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Physician Decision|11
4767302|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Physician Decision|1
4767303|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767304|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767305|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767306|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767307|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767308|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767309|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767310|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767311|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767312|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767313|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767820|NCT01595009|16445896|P1|Extension|Administrative problems|0
4767314|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767315|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Physician Decision|0
4767316|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767317|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767318|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767319|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767320|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767321|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
4767322|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26
4767323|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767324|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767325|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767326|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767327|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767328|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767329|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767330|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767331|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767332|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767333|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767334|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767335|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767336|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0
4767337|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767338|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767339|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767340|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767341|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767342|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
4767343|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38
4767344|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767345|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767346|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767347|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767348|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767349|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767350|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767351|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767352|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767353|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767354|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767355|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767356|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767357|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0
4767358|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767359|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767360|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767361|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767362|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767363|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63
4767364|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62
4767365|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1
4767366|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767367|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767368|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767369|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767370|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767371|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767372|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767373|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767374|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767375|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767376|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767377|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767378|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0
4767379|NCT01597245|16445108|P21|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767380|NCT01597245|16445109|P20|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767381|NCT01597245|16445110|P19|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767821|NCT01595009|16445893|P4|Core|Administrative problems|0
4767382|NCT01597245|16445111|P18|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767383|NCT01597245|16445112|P17|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767384|NCT01597245|16445113|P16|Long Term Extension (Week 60 - Week 264)|Adverse Event|70
4767385|NCT01597245|16445114|P15|Long Term Extension (Week 60 - Week 264)|Adverse Event|69
4767386|NCT01597245|16445115|P14|Long Term Extension (Week 60 - Week 264)|Adverse Event|1
4767387|NCT01597245|16445116|P13|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767388|NCT01597245|16445117|P12|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767389|NCT01597245|16445118|P11|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767390|NCT01597245|16445119|P10|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767391|NCT01597245|16445120|P9|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767392|NCT01597245|16445121|P8|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767393|NCT01597245|16445122|P7|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767394|NCT01597245|16445123|P6|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767395|NCT01597245|16445124|P5|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767396|NCT01597245|16445125|P4|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767397|NCT01597245|16445126|P3|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767398|NCT01597245|16445127|P2|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767399|NCT01597245|16445128|P1|Long Term Extension (Week 60 - Week 264)|Adverse Event|0
4767400|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767401|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767402|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767403|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767404|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767405|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767406|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767407|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767408|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767409|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767410|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1
4767411|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767412|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767413|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767414|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767415|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767416|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767417|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767418|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767419|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767420|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0
4767421|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767422|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767423|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767424|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767425|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767426|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767427|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767428|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767429|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767430|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4767431|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4767432|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4767433|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4767434|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767435|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767436|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Physician Decision|1
4767437|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767438|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767439|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767440|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767441|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Physician Decision|0
4767442|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767443|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767444|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767445|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767446|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767447|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767448|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767449|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767450|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
4767451|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
4767452|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
4767453|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2
4767454|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
4767455|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767456|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1
4767457|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4
4767458|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3
4767459|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767460|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767461|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767462|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0
4767463|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767464|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767465|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767466|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767467|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767468|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767469|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767470|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767471|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
4767472|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767473|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2
4767474|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
4767475|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3
4767476|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767477|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767478|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767479|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1
4767480|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767481|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767482|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767483|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0
4767484|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767485|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767486|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767487|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767488|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767489|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767490|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767491|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767492|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
4767493|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5
4767494|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6
4767495|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
4767496|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4
4767497|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767498|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1
4767499|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
4767500|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3
4767501|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767502|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767503|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767504|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0
4767505|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767506|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767507|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767508|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767509|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767510|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767511|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767512|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767513|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
4767514|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
4767515|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
4767516|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Adverse Event|2
4767517|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Adverse Event|8
4767518|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Adverse Event|1
4767519|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
4767822|NCT01595009|16445894|P3|Core|Administrative problems|0
4767520|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Adverse Event|6
4767521|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Adverse Event|4
4767522|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767523|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767524|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767525|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Adverse Event|0
4767526|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767527|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767528|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767529|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767530|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767531|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767532|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767533|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767534|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4
4767535|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10
4767536|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2
4767537|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767538|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3
4767539|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767540|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767541|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1
4767542|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767543|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767544|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767545|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767546|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0
4767547|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767548|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767549|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767550|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767551|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767552|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767553|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767554|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767555|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767556|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767557|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767558|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|Relapsed|114
4767559|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767560|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|Relapsed|2
4767561|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|Relapsed|80
4767562|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|Relapsed|22
4767563|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|Relapsed|150
4767564|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767565|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767566|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767567|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|Relapsed|0
4767568|NCT01597245|16445108|P21|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767569|NCT01597245|16445109|P20|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767570|NCT01597245|16445110|P19|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767571|NCT01597245|16445111|P18|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767572|NCT01597245|16445112|P17|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767573|NCT01597245|16445113|P16|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767574|NCT01597245|16445114|P15|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767575|NCT01597245|16445115|P14|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767576|NCT01597245|16445116|P13|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767577|NCT01597245|16445117|P12|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767578|NCT01597245|16445118|P11|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767579|NCT01597245|16445119|P10|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767580|NCT01597245|16445120|P9|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767581|NCT01597245|16445121|P8|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767582|NCT01597245|16445122|P7|Maintenance Period (Week 12 to Week 60)|On study treatment|1
4767583|NCT01597245|16445123|P6|Maintenance Period (Week 12 to Week 60)|On study treatment|1
4767584|NCT01597245|16445124|P5|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767585|NCT01597245|16445125|P4|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767586|NCT01597245|16445126|P3|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767587|NCT01597245|16445127|P2|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767588|NCT01597245|16445128|P1|Maintenance Period (Week 12 to Week 60)|On study treatment|0
4767589|NCT01597245|16445108|P21|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767590|NCT01597245|16445109|P20|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767823|NCT01595009|16445895|P2|Core|Administrative problems|1
4767591|NCT01597245|16445110|P19|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767592|NCT01597245|16445111|P18|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767593|NCT01597245|16445112|P17|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767594|NCT01597245|16445113|P16|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767595|NCT01597245|16445114|P15|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767596|NCT01597245|16445115|P14|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767597|NCT01597245|16445116|P13|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767598|NCT01597245|16445117|P12|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767599|NCT01597245|16445118|P11|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767600|NCT01597245|16445119|P10|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767601|NCT01597245|16445120|P9|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767602|NCT01597245|16445121|P8|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767603|NCT01597245|16445122|P7|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767604|NCT01597245|16445123|P6|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767605|NCT01597245|16445124|P5|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767606|NCT01597245|16445125|P4|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0
4767607|NCT01597245|16445126|P3|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1
4767608|NCT01597245|16445127|P2|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
4767609|NCT01597245|16445128|P1|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3
4767610|NCT01597245|16445108|P21|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767611|NCT01597245|16445109|P20|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767612|NCT01597245|16445110|P19|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767613|NCT01597245|16445111|P18|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767614|NCT01597245|16445112|P17|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767615|NCT01597245|16445113|P16|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767616|NCT01597245|16445114|P15|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767617|NCT01597245|16445115|P14|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767618|NCT01597245|16445116|P13|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767619|NCT01597245|16445117|P12|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767620|NCT01597245|16445118|P11|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767621|NCT01597245|16445119|P10|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767622|NCT01597245|16445120|P9|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767623|NCT01597245|16445121|P8|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767624|NCT01597245|16445122|P7|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767625|NCT01597245|16445123|P6|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767626|NCT01597245|16445124|P5|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767627|NCT01597245|16445125|P4|Induction Period (Week 0 - Week 12)|Physician Decision|1
4767628|NCT01597245|16445126|P3|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767629|NCT01597245|16445127|P2|Induction Period (Week 0 - Week 12)|Physician Decision|0
4767630|NCT01597245|16445128|P1|Induction Period (Week 0 - Week 12)|Physician Decision|1
4767631|NCT01597245|16445108|P21|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767632|NCT01597245|16445109|P20|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767633|NCT01597245|16445110|P19|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767634|NCT01597245|16445111|P18|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767635|NCT01597245|16445112|P17|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767636|NCT01597245|16445113|P16|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767637|NCT01597245|16445114|P15|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767638|NCT01597245|16445115|P14|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767639|NCT01597245|16445116|P13|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767640|NCT01597245|16445117|P12|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767641|NCT01597245|16445118|P11|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767642|NCT01597245|16445119|P10|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767643|NCT01597245|16445120|P9|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767644|NCT01597245|16445121|P8|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767645|NCT01597245|16445122|P7|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767646|NCT01597245|16445123|P6|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767647|NCT01597245|16445124|P5|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767648|NCT01597245|16445125|P4|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0
4767649|NCT01597245|16445126|P3|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2
4767650|NCT01597245|16445127|P2|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5
4767651|NCT01597245|16445128|P1|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1
4767652|NCT01597245|16445108|P21|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767653|NCT01597245|16445109|P20|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767654|NCT01597245|16445110|P19|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767655|NCT01597245|16445111|P18|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767656|NCT01597245|16445112|P17|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767657|NCT01597245|16445113|P16|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767658|NCT01597245|16445114|P15|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767659|NCT01597245|16445115|P14|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767660|NCT01597245|16445116|P13|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767661|NCT01597245|16445117|P12|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767662|NCT01597245|16445118|P11|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767663|NCT01597245|16445119|P10|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767664|NCT01597245|16445120|P9|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767665|NCT01597245|16445121|P8|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767666|NCT01597245|16445122|P7|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767667|NCT01597245|16445123|P6|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767668|NCT01597245|16445124|P5|Induction Period (Week 0 - Week 12)|Protocol Violation|0
4767669|NCT01597245|16445125|P4|Induction Period (Week 0 - Week 12)|Protocol Violation|2
4767670|NCT01597245|16445126|P3|Induction Period (Week 0 - Week 12)|Protocol Violation|5
4767671|NCT01597245|16445127|P2|Induction Period (Week 0 - Week 12)|Protocol Violation|4
4767672|NCT01597245|16445128|P1|Induction Period (Week 0 - Week 12)|Protocol Violation|2
4767673|NCT01597245|16445108|P21|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767674|NCT01597245|16445109|P20|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767675|NCT01597245|16445110|P19|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767676|NCT01597245|16445111|P18|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767677|NCT01597245|16445112|P17|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767678|NCT01597245|16445113|P16|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767679|NCT01597245|16445114|P15|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767680|NCT01597245|16445115|P14|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767681|NCT01597245|16445116|P13|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767682|NCT01597245|16445117|P12|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767683|NCT01597245|16445118|P11|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767684|NCT01597245|16445119|P10|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767685|NCT01597245|16445120|P9|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767686|NCT01597245|16445121|P8|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767687|NCT01597245|16445122|P7|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767688|NCT01597245|16445123|P6|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767689|NCT01597245|16445124|P5|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0
4767690|NCT01597245|16445125|P4|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
4767691|NCT01597245|16445126|P3|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6
4767692|NCT01597245|16445127|P2|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8
4767693|NCT01597245|16445128|P1|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2
4767694|NCT01597245|16445108|P21|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767695|NCT01597245|16445109|P20|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767696|NCT01597245|16445110|P19|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767697|NCT01597245|16445111|P18|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767698|NCT01597245|16445112|P17|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767699|NCT01597245|16445113|P16|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767700|NCT01597245|16445114|P15|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767701|NCT01597245|16445115|P14|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767702|NCT01597245|16445116|P13|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767703|NCT01597245|16445117|P12|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767704|NCT01597245|16445118|P11|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767705|NCT01597245|16445119|P10|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767706|NCT01597245|16445120|P9|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767707|NCT01597245|16445121|P8|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767708|NCT01597245|16445122|P7|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767709|NCT01597245|16445123|P6|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767710|NCT01597245|16445124|P5|Induction Period (Week 0 - Week 12)|Adverse Event|0
4767711|NCT01597245|16445125|P4|Induction Period (Week 0 - Week 12)|Adverse Event|4
4767712|NCT01597245|16445126|P3|Induction Period (Week 0 - Week 12)|Adverse Event|5
4767713|NCT01597245|16445127|P2|Induction Period (Week 0 - Week 12)|Adverse Event|5
4767714|NCT01597245|16445128|P1|Induction Period (Week 0 - Week 12)|Adverse Event|1
4767715|NCT01597193|16445226|P7|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4767716|NCT01597193|16445227|P6|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
4767717|NCT01597193|16445228|P5|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4767718|NCT01597193|16445229|P4|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1
4767719|NCT01597193|16445230|P3|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4767720|NCT01597193|16445231|P2|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4767721|NCT01597193|16445232|P1|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0
4767722|NCT01597193|16445226|P7|Stage 2: Dose Expansion (1067 Days)|Other|0
4767723|NCT01597193|16445227|P6|Stage 2: Dose Expansion (1067 Days)|Other|1
4767724|NCT01597193|16445228|P5|Stage 2: Dose Expansion (1067 Days)|Other|0
4767725|NCT01597193|16445229|P4|Stage 2: Dose Expansion (1067 Days)|Other|0
4767726|NCT01597193|16445230|P3|Stage 2: Dose Expansion (1067 Days)|Other|0
4767727|NCT01597193|16445231|P2|Stage 2: Dose Expansion (1067 Days)|Other|0
4767728|NCT01597193|16445232|P1|Stage 2: Dose Expansion (1067 Days)|Other|0
4767729|NCT01597193|16445226|P7|Stage 2: Dose Expansion (1067 Days)|Disease progression|11
4767730|NCT01597193|16445227|P6|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
4767731|NCT01597193|16445228|P5|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
4767732|NCT01597193|16445229|P4|Stage 2: Dose Expansion (1067 Days)|Disease progression|18
4767733|NCT01597193|16445230|P3|Stage 2: Dose Expansion (1067 Days)|Disease progression|14
4767734|NCT01597193|16445231|P2|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
4767735|NCT01597193|16445232|P1|Stage 2: Dose Expansion (1067 Days)|Disease progression|0
4767736|NCT01597193|16445226|P7|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4767737|NCT01597193|16445227|P6|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3
4767738|NCT01597193|16445228|P5|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2
4767739|NCT01597193|16445229|P4|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1
4767740|NCT01597193|16445230|P3|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4767741|NCT01597193|16445231|P2|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4767742|NCT01597193|16445232|P1|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0
4767743|NCT01597193|16445226|P7|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4767744|NCT01597193|16445227|P6|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4767745|NCT01597193|16445228|P5|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4767746|NCT01597193|16445229|P4|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4767747|NCT01597193|16445230|P3|Stage 1: Dose Escalation (141 Days)|Disease progression|0
4767748|NCT01597193|16445231|P2|Stage 1: Dose Escalation (141 Days)|Disease progression|8
4767749|NCT01597193|16445232|P1|Stage 1: Dose Escalation (141 Days)|Disease progression|7
4767750|NCT01597050|16445351|P2|Overall Study|Withdrawal by Subject|0
4767751|NCT01597050|16445352|P1|Overall Study|Withdrawal by Subject|1
4767752|NCT01596972|16445360|P2|Overall Study|Withdrawal by Subject|1
4767753|NCT01596972|16445361|P1|Overall Study|Withdrawal by Subject|0
4767754|NCT01596972|16445360|P2|Overall Study|Lost to Follow-up|4
4767755|NCT01596972|16445361|P1|Overall Study|Lost to Follow-up|0
4767756|NCT01596972|16445360|P2|Overall Study|Physician Decision|9
4767757|NCT01596972|16445361|P1|Overall Study|Physician Decision|1
4767758|NCT01596582|16445433|P2|Overall Study|Missing all outcome data|1
4767759|NCT01596582|16445434|P1|Overall Study|Missing all outcome data|1
4767760|NCT01596582|16445433|P2|Overall Study|Deemed ineligible after study visit|6
4767761|NCT01596582|16445434|P1|Overall Study|Deemed ineligible after study visit|3
4767762|NCT01596504|16445461|P3|Overall Study|Withdrawal by Subject|0
4767763|NCT01596504|16445462|P2|Overall Study|Withdrawal by Subject|0
4767764|NCT01596504|16445463|P1|Overall Study|Withdrawal by Subject|1
4767765|NCT01596504|16445461|P3|Overall Study|Adverse Event|1
4767766|NCT01596504|16445462|P2|Overall Study|Adverse Event|2
4767767|NCT01596504|16445463|P1|Overall Study|Adverse Event|1
4767768|NCT01596504|16445461|P3|Overall Study|Participant's Private Reason|0
4767769|NCT01596504|16445462|P2|Overall Study|Participant's Private Reason|1
4767770|NCT01596504|16445463|P1|Overall Study|Participant's Private Reason|0
4767771|NCT01596335|16445521|P2|Overall Study|exacerbation of primary disease|9
4767772|NCT01596335|16445522|P1|Overall Study|exacerbation of primary disease|5
4767773|NCT01596127|16445558|P1|Overall Study|Patient Ineligible|1
4767774|NCT01596062|16445570|P3|Overall Study|Lack of Efficacy|1
4767775|NCT01596062|16445571|P2|Overall Study|Lack of Efficacy|0
4767776|NCT01596062|16445572|P1|Overall Study|Lack of Efficacy|0
4767777|NCT01596062|16445570|P3|Overall Study|Adverse Event|2
4767778|NCT01596062|16445571|P2|Overall Study|Adverse Event|0
4767779|NCT01596062|16445572|P1|Overall Study|Adverse Event|1
4767780|NCT01595646|16445636|P3|Overall Study|Withdrawal by Subject|0
4767781|NCT01595646|16445637|P2|Overall Study|Withdrawal by Subject|0
4767782|NCT01595646|16445638|P1|Overall Study|Withdrawal by Subject|1
4767783|NCT01595529|16445660|P2|Overall Study|Entry Failure/Screening Failure|1
4767784|NCT01595529|16445661|P1|Overall Study|Entry Failure/Screening Failure|6
4767785|NCT01595529|16445660|P2|Overall Study|Administrative Decision|0
4767786|NCT01595529|16445661|P1|Overall Study|Administrative Decision|1
4767787|NCT01595529|16445660|P2|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
4767788|NCT01595529|16445661|P1|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3
4767789|NCT01595529|16445660|P2|Overall Study|Physician Decision|0
4767790|NCT01595529|16445661|P1|Overall Study|Physician Decision|1
4767791|NCT01595529|16445660|P2|Overall Study|Protocol Violation|2
4767792|NCT01595529|16445661|P1|Overall Study|Protocol Violation|1
4767793|NCT01595529|16445660|P2|Overall Study|Lost to Follow-up|14
4767794|NCT01595529|16445661|P1|Overall Study|Lost to Follow-up|8
4767795|NCT01595529|16445660|P2|Overall Study|Subject Non-Compliant|0
4767796|NCT01595529|16445661|P1|Overall Study|Subject Non-Compliant|2
4767797|NCT01595529|16445660|P2|Overall Study|Adverse Event|0
4767798|NCT01595529|16445661|P1|Overall Study|Adverse Event|2
4767799|NCT01595438|16445724|P2|Overall Study|Other Eligibility criteria|9
4767800|NCT01595438|16445725|P1|Overall Study|Other Eligibility criteria|11
4767801|NCT01595438|16445724|P2|Overall Study|Withdrawal by Subject|12
4767802|NCT01595438|16445725|P1|Overall Study|Withdrawal by Subject|12
4767803|NCT01595438|16445724|P2|Overall Study|Lost to Follow-up|20
4767804|NCT01595438|16445725|P1|Overall Study|Lost to Follow-up|20
4767805|NCT01595009|16445893|P4|Extension|Adverse Event|1
4767806|NCT01595009|16445894|P3|Extension|Adverse Event|0
4767807|NCT01595009|16445895|P2|Extension|Adverse Event|0
4767808|NCT01595009|16445896|P1|Extension|Adverse Event|0
4767809|NCT01595009|16445893|P4|Extension|Disease progression|7
4767810|NCT01595009|16445894|P3|Extension|Disease progression|4
4767811|NCT01595009|16445895|P2|Extension|Disease progression|0
4767812|NCT01595009|16445896|P1|Extension|Disease progression|0
4767813|NCT01595009|16445893|P4|Extension|Patients completed per protocol|2
4767814|NCT01595009|16445894|P3|Extension|Patients completed per protocol|0
4767815|NCT01595009|16445895|P2|Extension|Patients completed per protocol|0
4767816|NCT01595009|16445896|P1|Extension|Patients completed per protocol|0
4767824|NCT01595009|16445896|P1|Core|Administrative problems|0
4767825|NCT01595009|16445893|P4|Core|Protocol deviation|0
4767826|NCT01595009|16445894|P3|Core|Protocol deviation|0
4767827|NCT01595009|16445895|P2|Core|Protocol deviation|1
4767828|NCT01595009|16445896|P1|Core|Protocol deviation|0
4767829|NCT01595009|16445893|P4|Core|Lost to Follow-up|0
4767830|NCT01595009|16445894|P3|Core|Lost to Follow-up|0
4767831|NCT01595009|16445895|P2|Core|Lost to Follow-up|2
4767832|NCT01595009|16445896|P1|Core|Lost to Follow-up|1
4767833|NCT01595009|16445893|P4|Core|Death|0
4767834|NCT01595009|16445894|P3|Core|Death|0
4767835|NCT01595009|16445895|P2|Core|Death|6
4767836|NCT01595009|16445896|P1|Core|Death|3
4767837|NCT01595009|16445893|P4|Core|Withdrawal by Subject|0
4767838|NCT01595009|16445894|P3|Core|Withdrawal by Subject|0
4767839|NCT01595009|16445895|P2|Core|Withdrawal by Subject|17
4767840|NCT01595009|16445896|P1|Core|Withdrawal by Subject|4
4767841|NCT01595009|16445893|P4|Core|Disease progression|0
4767842|NCT01595009|16445894|P3|Core|Disease progression|0
4767843|NCT01595009|16445895|P2|Core|Disease progression|26
4767844|NCT01595009|16445896|P1|Core|Disease progression|14
4767845|NCT01595009|16445893|P4|Core|Adverse Event|0
4767846|NCT01595009|16445894|P3|Core|Adverse Event|0
4767847|NCT01595009|16445895|P2|Core|Adverse Event|23
4767848|NCT01595009|16445896|P1|Core|Adverse Event|19
4767849|NCT01595009|16445893|P4|Core|Patients completed per protocol|0
4767850|NCT01595009|16445894|P3|Core|Patients completed per protocol|0
4767851|NCT01595009|16445895|P2|Core|Patients completed per protocol|44
4767852|NCT01595009|16445896|P1|Core|Patients completed per protocol|85
4767853|NCT01594970|16445931|P3|Overall Study|Lost to Follow-up|37
4767854|NCT01594970|16445932|P2|Overall Study|Lost to Follow-up|54
4767855|NCT01594970|16445933|P1|Overall Study|Lost to Follow-up|54
4767856|NCT01594970|16445931|P3|Overall Study|Adverse Event|23
4767857|NCT01594970|16445932|P2|Overall Study|Adverse Event|23
4767858|NCT01594970|16445933|P1|Overall Study|Adverse Event|17
4767859|NCT01594970|16445931|P3|Overall Study|Non-Adverse Event Related|6
4767860|NCT01594970|16445932|P2|Overall Study|Non-Adverse Event Related|5
4767861|NCT01594970|16445933|P1|Overall Study|Non-Adverse Event Related|4
4767862|NCT01594853|16445952|P2|Overall Study|noncompliance with exercise|1
4767863|NCT01594853|16445953|P1|Overall Study|noncompliance with exercise|0
4767864|NCT01594853|16445952|P2|Overall Study|Lost to Follow-up|1
4767865|NCT01594853|16445953|P1|Overall Study|Lost to Follow-up|1
4767866|NCT01594853|16445952|P2|Overall Study|Withdrawal by Subject|1
4767867|NCT01594853|16445953|P1|Overall Study|Withdrawal by Subject|1
4767868|NCT01594827|16445961|P2|Overall Study|Physician Decision|0
4767869|NCT01594827|16445962|P1|Overall Study|Physician Decision|3
4767870|NCT01594827|16445961|P2|Overall Study|Adverse Event|0
4767871|NCT01594827|16445962|P1|Overall Study|Adverse Event|1
4767872|NCT01594762|16445986|P2|Overall Study|Lost to Follow-up|10
4767873|NCT01594762|16445987|P1|Overall Study|Lost to Follow-up|10
4767874|NCT01594762|16445986|P2|Overall Study|Withdrawal by Subject|0
4767875|NCT01594762|16445987|P1|Overall Study|Withdrawal by Subject|1
4767876|NCT01594749|16445999|P2|Overall Study|Lost Source Documentation|0
4767877|NCT01594749|16446000|P1|Overall Study|Lost Source Documentation|1
4767878|NCT01594749|16445999|P2|Overall Study|Not Treated|10
4767879|NCT01594749|16446000|P1|Overall Study|Not Treated|4
4767880|NCT01594749|16445999|P2|Overall Study|Death|3
4767881|NCT01594749|16446000|P1|Overall Study|Death|9
4767882|NCT01594749|16445999|P2|Overall Study|Lost to Follow-up|0
4767883|NCT01594749|16446000|P1|Overall Study|Lost to Follow-up|1
4767884|NCT01594749|16445999|P2|Overall Study|Non-compliance with Protocol|1
4767885|NCT01594749|16446000|P1|Overall Study|Non-compliance with Protocol|0
4767886|NCT01594749|16445999|P2|Overall Study|Physician Decision|1
4767887|NCT01594749|16446000|P1|Overall Study|Physician Decision|1
4767888|NCT01594749|16445999|P2|Overall Study|Protocol Violation|0
4767889|NCT01594749|16446000|P1|Overall Study|Protocol Violation|2
4767890|NCT01594749|16445999|P2|Overall Study|Withdrawal by Subject|2
4767891|NCT01594749|16446000|P1|Overall Study|Withdrawal by Subject|2
4767892|NCT01594749|16445999|P2|Overall Study|Adverse Event|1
4767893|NCT01594749|16446000|P1|Overall Study|Adverse Event|2
4767894|NCT01594476|16446138|P2|Overall Study|Protocol Violation|3
4767895|NCT01594476|16446139|P1|Overall Study|Protocol Violation|1
4767896|NCT01594411|16446161|P1|Overall Study|Lost to Follow-up|2
4767897|NCT01594333|16446195|P2|Overall Study|Withdrawal by Subject|63
4767898|NCT01594333|16446196|P1|Overall Study|Withdrawal by Subject|60
4767899|NCT01594333|16446195|P2|Overall Study|Lost to Follow-up|5
4767900|NCT01594333|16446196|P1|Overall Study|Lost to Follow-up|5
4767901|NCT01594333|16446195|P2|Overall Study|Death|83
4767902|NCT01594333|16446196|P1|Overall Study|Death|96
4767903|NCT01594281|16446242|P3|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
4767904|NCT01594281|16446243|P2|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0
4767905|NCT01594281|16446244|P1|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1
4767906|NCT01594281|16446242|P3|Non-Interventional Follow Up Phase|Administrative Problems|1
4767907|NCT01594281|16446243|P2|Non-Interventional Follow Up Phase|Administrative Problems|0
4767908|NCT01594281|16446244|P1|Non-Interventional Follow Up Phase|Administrative Problems|0
4767909|NCT01594281|16446242|P3|Non-Interventional Follow Up Phase|Lost to Follow-up|0
4767910|NCT01594281|16446243|P2|Non-Interventional Follow Up Phase|Lost to Follow-up|2
4767911|NCT01594281|16446244|P1|Non-Interventional Follow Up Phase|Lost to Follow-up|2
4767912|NCT01594281|16446242|P3|Interventional Core Phase|Adverse Event|4
4767913|NCT01594281|16446243|P2|Interventional Core Phase|Adverse Event|4
4767914|NCT01594281|16446244|P1|Interventional Core Phase|Adverse Event|4
4767915|NCT01594281|16446242|P3|Interventional Core Phase|Lost to Follow-up|1
4767916|NCT01594281|16446243|P2|Interventional Core Phase|Lost to Follow-up|4
4767917|NCT01594281|16446244|P1|Interventional Core Phase|Lost to Follow-up|1
4767918|NCT01594281|16446242|P3|Interventional Core Phase|Death|2
4767919|NCT01594281|16446243|P2|Interventional Core Phase|Death|1
4767920|NCT01594281|16446244|P1|Interventional Core Phase|Death|1
4767921|NCT01594281|16446242|P3|Interventional Core Phase|Subject Withdrew Consent|1
4767922|NCT01594281|16446243|P2|Interventional Core Phase|Subject Withdrew Consent|1
4767923|NCT01594281|16446244|P1|Interventional Core Phase|Subject Withdrew Consent|0
4767924|NCT01594281|16446242|P3|Interventional Core Phase|Protocol Deviation|0
4767925|NCT01594281|16446243|P2|Interventional Core Phase|Protocol Deviation|0
4767926|NCT01594281|16446244|P1|Interventional Core Phase|Protocol Deviation|1
4767927|NCT01594125|16446284|P5|Overall Study|Progressive Disease|7
4767928|NCT01594125|16446285|P4|Overall Study|Progressive Disease|3
4767929|NCT01594125|16446286|P3|Overall Study|Progressive Disease|3
4767930|NCT01594125|16446287|P2|Overall Study|Progressive Disease|12
4767931|NCT01594125|16446288|P1|Overall Study|Progressive Disease|3
4767932|NCT01594125|16446284|P5|Overall Study|Withdrawal by Subject|0
4767933|NCT01594125|16446285|P4|Overall Study|Withdrawal by Subject|1
4767934|NCT01594125|16446286|P3|Overall Study|Withdrawal by Subject|0
4767935|NCT01594125|16446287|P2|Overall Study|Withdrawal by Subject|0
4767936|NCT01594125|16446288|P1|Overall Study|Withdrawal by Subject|1
4767937|NCT01593787|16446348|P3|Overall Study|Adverse Event|0
4767938|NCT01593787|16446349|P2|Overall Study|Adverse Event|0
4767939|NCT01593787|16446350|P1|Overall Study|Adverse Event|1
4767940|NCT01593696|16446426|P4|Dose Expansion|Fungal infection|0
4767941|NCT01593696|16446427|P3|Dose Expansion|Fungal infection|1
4767942|NCT01593696|16446428|P2|Dose Expansion|Fungal infection|0
4767943|NCT01593696|16446429|P1|Dose Expansion|Fungal infection|0
4767944|NCT01593696|16446426|P4|Dose Escalation|Progressive Disease|0
4767945|NCT01593696|16446427|P3|Dose Escalation|Progressive Disease|0
4767946|NCT01593696|16446428|P2|Dose Escalation|Progressive Disease|0
4767947|NCT01593696|16446429|P1|Dose Escalation|Progressive Disease|2
4767948|NCT01593254|16446486|P2|Follow-Up Period|Study Drug Side Effects|1
4767949|NCT01593254|16446487|P1|Follow-Up Period|Study Drug Side Effects|0
4767950|NCT01593254|16446486|P2|Follow-Up Period|Disease Progression|1
4767951|NCT01593254|16446487|P1|Follow-Up Period|Disease Progression|0
4767952|NCT01593254|16446486|P2|Follow-Up Period|Fundus Hemorrhage|1
4767953|NCT01593254|16446487|P1|Follow-Up Period|Fundus Hemorrhage|0
4767954|NCT01593254|16446486|P2|Follow-Up Period|Patient refused to return|1
4767955|NCT01593254|16446487|P1|Follow-Up Period|Patient refused to return|0
4767956|NCT01593254|16446486|P2|Follow-Up Period|Study Drug Toxicity|1
4767957|NCT01593254|16446487|P1|Follow-Up Period|Study Drug Toxicity|0
4767958|NCT01593254|16446486|P2|Follow-Up Period|Pregnancy|1
4767959|NCT01593254|16446487|P1|Follow-Up Period|Pregnancy|0
4767960|NCT01593254|16446486|P2|Follow-Up Period|Subject request to Discontinue|1
4767961|NCT01593254|16446487|P1|Follow-Up Period|Subject request to Discontinue|0
4767962|NCT01593254|16446486|P2|Follow-Up Period|Death|2
4767963|NCT01593254|16446487|P1|Follow-Up Period|Death|2
4767964|NCT01593254|16446486|P2|Follow-Up Period|Non-Compliance|0
4767965|NCT01593254|16446487|P1|Follow-Up Period|Non-Compliance|1
4767966|NCT01593254|16446486|P2|Follow-Up Period|Withdrawal by Subject|2
4767967|NCT01593254|16446487|P1|Follow-Up Period|Withdrawal by Subject|0
4767968|NCT01593254|16446486|P2|Treatment Period|Investigator Decision|1
4767969|NCT01593254|16446487|P1|Treatment Period|Investigator Decision|2
4767970|NCT01593254|16446486|P2|Treatment Period|T315I MUTATION|1
4767971|NCT01593254|16446487|P1|Treatment Period|T315I MUTATION|0
4767972|NCT01593254|16446486|P2|Treatment Period|No Response|0
4767973|NCT01593254|16446487|P1|Treatment Period|No Response|1
4767974|NCT01593254|16446486|P2|Treatment Period|Patient Refused to Return|1
4767975|NCT01593254|16446487|P1|Treatment Period|Patient Refused to Return|0
4767976|NCT01593254|16446486|P2|Treatment Period|Did Not Achieve RCC|1
4767977|NCT01593254|16446487|P1|Treatment Period|Did Not Achieve RCC|0
4767978|NCT01593254|16446486|P2|Treatment Period|Disease Progression|6
4767979|NCT01593254|16446487|P1|Treatment Period|Disease Progression|1
4767980|NCT01593254|16446486|P2|Treatment Period|Study Drug Toxicity|9
4767981|NCT01593254|16446487|P1|Treatment Period|Study Drug Toxicity|3
4767982|NCT01593254|16446486|P2|Treatment Period|Death|1
4767983|NCT01593254|16446487|P1|Treatment Period|Death|2
4767984|NCT01593254|16446486|P2|Treatment Period|AE unrelated to Study Drug|1
4767985|NCT01593254|16446487|P1|Treatment Period|AE unrelated to Study Drug|0
4767986|NCT01593254|16446486|P2|Treatment Period|Subject Request to Discontinue|1
4767987|NCT01593254|16446487|P1|Treatment Period|Subject Request to Discontinue|1
4767988|NCT01593254|16446486|P2|Treatment Period|Subject withdrew consent|5
4767989|NCT01593254|16446487|P1|Treatment Period|Subject withdrew consent|0
4767990|NCT01593254|16446486|P2|Treatment Period|Maximum clinical benefit|0
4767991|NCT01593254|16446487|P1|Treatment Period|Maximum clinical benefit|1
4767992|NCT01593254|16446486|P2|Treatment Period|Poor/Non-Compliance|1
4767993|NCT01593254|16446487|P1|Treatment Period|Poor/Non-Compliance|2
4767994|NCT01593254|16446486|P2|Treatment Period|Pregnancy|1
4767995|NCT01593254|16446487|P1|Treatment Period|Pregnancy|0
4767996|NCT01593254|16446486|P2|Treatment Period|Treatment Failure|2
4767997|NCT01593254|16446487|P1|Treatment Period|Treatment Failure|1
4767998|NCT01592864|16446505|P2|Overall Study|Withdrawal by Subject|1
4767999|NCT01592864|16446506|P1|Overall Study|Withdrawal by Subject|0
4768000|NCT01592786|16446567|P1|Overall Study|Other|3
4768001|NCT01592786|16446567|P1|Overall Study|Lost to Follow-up|19
4768002|NCT01592786|16446567|P1|Overall Study|Withdrawal by Subject|23
4768003|NCT01592786|16446567|P1|Overall Study|Protocol Violation|14
4768004|NCT01592786|16446567|P1|Overall Study|Lack of Efficacy|19
4768005|NCT01592786|16446567|P1|Overall Study|Adverse Event|60
4768006|NCT01592773|16446571|P1|Overall Study|Other Reason|1
4768007|NCT01592773|16446571|P1|Overall Study|Inclusion/exclusion not meet|1
4768008|NCT01592773|16446571|P1|Overall Study|Protocol Violation|2
4768009|NCT01592773|16446571|P1|Overall Study|Lack of Efficacy|9
4768010|NCT01592773|16446571|P1|Overall Study|Adverse Event|17
4768011|NCT01592773|16446571|P1|Overall Study|Lost to Follow-up|19
4768012|NCT01592773|16446571|P1|Overall Study|Withdrawal by Subject|35
4768013|NCT01592773|16446571|P1|Overall Study|Study Terminated by Sponsor|582
4768014|NCT01592760|16446578|P3|24-hour Follow-Up|Lost to Follow-up|2
4768015|NCT01592760|16446579|P2|24-hour Follow-Up|Lost to Follow-up|3
4768016|NCT01592760|16446580|P1|24-hour Follow-Up|Lost to Follow-up|4
4768017|NCT01592747|16446624|P3|Overall Study|Other Reasons|0
4768018|NCT01592747|16446625|P2|Overall Study|Other Reasons|1
4768019|NCT01592747|16446626|P1|Overall Study|Other Reasons|1
4768020|NCT01592747|16446624|P3|Overall Study|Lost to Follow-up|1
4768021|NCT01592747|16446625|P2|Overall Study|Lost to Follow-up|0
4768022|NCT01592747|16446626|P1|Overall Study|Lost to Follow-up|1
4768023|NCT01592747|16446624|P3|Overall Study|Withdrawal by Subject|2
4768024|NCT01592747|16446625|P2|Overall Study|Withdrawal by Subject|0
4768025|NCT01592747|16446626|P1|Overall Study|Withdrawal by Subject|2
4768026|NCT01592747|16446624|P3|Overall Study|Lack of Efficacy|0
4768027|NCT01592747|16446625|P2|Overall Study|Lack of Efficacy|1
4768028|NCT01592747|16446626|P1|Overall Study|Lack of Efficacy|0
4768029|NCT01592747|16446624|P3|Overall Study|Protocol Violation|4
4768030|NCT01592747|16446625|P2|Overall Study|Protocol Violation|0
4768031|NCT01592747|16446626|P1|Overall Study|Protocol Violation|4
4768032|NCT01592747|16446624|P3|Overall Study|Adverse Event|0
4768033|NCT01592747|16446625|P2|Overall Study|Adverse Event|0
4768034|NCT01592747|16446626|P1|Overall Study|Adverse Event|1
4768035|NCT01592747|16446624|P3|Overall Study|Inclusion/Exclusion criteria not met|1
4768036|NCT01592747|16446625|P2|Overall Study|Inclusion/Exclusion criteria not met|1
4768037|NCT01592747|16446626|P1|Overall Study|Inclusion/Exclusion criteria not met|0
4768038|NCT01592747|16446624|P3|Overall Study|Loss of Therapeutic Response|100
4768039|NCT01592747|16446625|P2|Overall Study|Loss of Therapeutic Response|108
4768040|NCT01592747|16446626|P1|Overall Study|Loss of Therapeutic Response|107
4768041|NCT01592708|16446669|P2|Overall Study|Protocol Violation|0
4768042|NCT01592708|16446670|P1|Overall Study|Protocol Violation|3
4768043|NCT01592695|16446686|P2|Overall Study|Lost to Follow-up|4
4768044|NCT01592695|16446687|P1|Overall Study|Lost to Follow-up|8
4768045|NCT01592409|16446742|P2|Overall Study|Withdrawal by Subject|1
4768046|NCT01592409|16446743|P1|Overall Study|Withdrawal by Subject|0
4768047|NCT01592383|16446767|P1|Overall Study|Adverse Event|1
4768048|NCT01592344|16446778|P2|Overall Study|not available at primary outcome visit|4
4768049|NCT01592344|16446779|P1|Overall Study|not available at primary outcome visit|2
4768050|NCT01592344|16446778|P2|Overall Study|Lack of Efficacy|0
4768051|NCT01592344|16446779|P1|Overall Study|Lack of Efficacy|1
4768052|NCT01592344|16446778|P2|Overall Study|Adverse Event|1
4768053|NCT01592344|16446779|P1|Overall Study|Adverse Event|1
4768054|NCT01592292|16446793|P4|Overall Study|Other|1
4768055|NCT01592292|16446794|P3|Overall Study|Other|2
4768056|NCT01592292|16446795|P2|Overall Study|Other|1
4768057|NCT01592292|16446796|P1|Overall Study|Other|1
4768058|NCT01592292|16446793|P4|Overall Study|Withdrew consent|0
4768059|NCT01592292|16446794|P3|Overall Study|Withdrew consent|0
4768060|NCT01592292|16446795|P2|Overall Study|Withdrew consent|1
4768061|NCT01592292|16446796|P1|Overall Study|Withdrew consent|2
4768062|NCT01592292|16446793|P4|Overall Study|Follow-up loss|0
4768063|NCT01592292|16446794|P3|Overall Study|Follow-up loss|1
4768064|NCT01592292|16446795|P2|Overall Study|Follow-up loss|3
4768065|NCT01592292|16446796|P1|Overall Study|Follow-up loss|3
4768066|NCT01592240|16446835|P7|Overall Study|Did Not Meet Entrance Criteria|0
4768067|NCT01592240|16446836|P6|Overall Study|Did Not Meet Entrance Criteria|0
4768068|NCT01592240|16446837|P5|Overall Study|Did Not Meet Entrance Criteria|0
4768069|NCT01592240|16446838|P4|Overall Study|Did Not Meet Entrance Criteria|0
4768070|NCT01592240|16446839|P3|Overall Study|Did Not Meet Entrance Criteria|1
4768071|NCT01592240|16446840|P2|Overall Study|Did Not Meet Entrance Criteria|0
4768072|NCT01592240|16446841|P1|Overall Study|Did Not Meet Entrance Criteria|1
4768073|NCT01592240|16446835|P7|Overall Study|Other|1
4768074|NCT01592240|16446836|P6|Overall Study|Other|0
4768075|NCT01592240|16446837|P5|Overall Study|Other|0
4768076|NCT01592240|16446838|P4|Overall Study|Other|1
4768077|NCT01592240|16446839|P3|Overall Study|Other|1
4768078|NCT01592240|16446840|P2|Overall Study|Other|3
4768079|NCT01592240|16446841|P1|Overall Study|Other|0
4768080|NCT01592240|16446835|P7|Overall Study|Withdrawal by Subject|2
4768081|NCT01592240|16446836|P6|Overall Study|Withdrawal by Subject|0
4768082|NCT01592240|16446837|P5|Overall Study|Withdrawal by Subject|3
4768083|NCT01592240|16446838|P4|Overall Study|Withdrawal by Subject|1
4768084|NCT01592240|16446839|P3|Overall Study|Withdrawal by Subject|4
4768085|NCT01592240|16446840|P2|Overall Study|Withdrawal by Subject|4
4768086|NCT01592240|16446841|P1|Overall Study|Withdrawal by Subject|0
4768087|NCT01592240|16446835|P7|Overall Study|Protocol Violation|0
4768088|NCT01592240|16446836|P6|Overall Study|Protocol Violation|1
4768089|NCT01592240|16446837|P5|Overall Study|Protocol Violation|0
4768090|NCT01592240|16446838|P4|Overall Study|Protocol Violation|0
4768091|NCT01592240|16446839|P3|Overall Study|Protocol Violation|0
4768092|NCT01592240|16446840|P2|Overall Study|Protocol Violation|0
4768093|NCT01592240|16446841|P1|Overall Study|Protocol Violation|0
4768094|NCT01592240|16446835|P7|Overall Study|Lost to Follow-up|0
4768095|NCT01592240|16446836|P6|Overall Study|Lost to Follow-up|2
4768096|NCT01592240|16446837|P5|Overall Study|Lost to Follow-up|3
4768097|NCT01592240|16446838|P4|Overall Study|Lost to Follow-up|0
4768098|NCT01592240|16446839|P3|Overall Study|Lost to Follow-up|1
4768099|NCT01592240|16446840|P2|Overall Study|Lost to Follow-up|3
4768100|NCT01592240|16446841|P1|Overall Study|Lost to Follow-up|1
4768101|NCT01592240|16446835|P7|Overall Study|Death|0
4768102|NCT01592240|16446836|P6|Overall Study|Death|0
4768103|NCT01592240|16446837|P5|Overall Study|Death|0
4768104|NCT01592240|16446838|P4|Overall Study|Death|0
4768105|NCT01592240|16446839|P3|Overall Study|Death|0
4768106|NCT01592240|16446840|P2|Overall Study|Death|1
4768107|NCT01592240|16446841|P1|Overall Study|Death|0
4768108|NCT01592240|16446835|P7|Overall Study|Adverse Event|0
4768109|NCT01592240|16446836|P6|Overall Study|Adverse Event|0
4768110|NCT01592240|16446837|P5|Overall Study|Adverse Event|1
4768111|NCT01592240|16446838|P4|Overall Study|Adverse Event|1
4768112|NCT01592240|16446839|P3|Overall Study|Adverse Event|0
4768113|NCT01592240|16446840|P2|Overall Study|Adverse Event|0
4768114|NCT01592240|16446841|P1|Overall Study|Adverse Event|1
4768115|NCT01592045|16447034|P2|Overall Study|Moved out of country|0
4768116|NCT01592045|16447035|P1|Overall Study|Moved out of country|2
4768117|NCT01592045|16447034|P2|Overall Study|Withdrawal by Subject|0
4768118|NCT01592045|16447035|P1|Overall Study|Withdrawal by Subject|1
4768119|NCT01592045|16447034|P2|Overall Study|Adverse Event|1
4768120|NCT01592045|16447035|P1|Overall Study|Adverse Event|1
4768121|NCT01592045|16447034|P2|Overall Study|Disease Progression|1
4768122|NCT01592045|16447035|P1|Overall Study|Disease Progression|1
4768123|NCT01591863|16447053|P1|Overall Study|Lack of Efficacy|1
4768124|NCT01591863|16447053|P1|Overall Study|recurrence|9
4768125|NCT01591863|16447053|P1|Overall Study|Withdrawal by Subject|1
4768126|NCT01591863|16447053|P1|Overall Study|Adverse Event|3
4768127|NCT01591681|16447110|P1|Overall Study|Failed to use system during run-in|1
4768128|NCT01591681|16447110|P1|Overall Study|Didn't meet min hypoglycemia requirement|3
4768129|NCT01591616|16447157|P1|Overall Study|Withdrawal by Subject|1
4768130|NCT01591499|16447298|P4|Second Intervention (up to 24 Days)|Lost to Follow-up|3
4768131|NCT01591499|16447299|P3|Second Intervention (up to 24 Days)|Lost to Follow-up|1
4768132|NCT01591499|16447300|P2|Second Intervention (up to 24 Days)|Lost to Follow-up|3
4768133|NCT01591499|16447301|P1|Second Intervention (up to 24 Days)|Lost to Follow-up|4
4768134|NCT01591499|16447298|P4|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
4768135|NCT01591499|16447299|P3|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
4768136|NCT01591499|16447300|P2|Second Intervention (up to 24 Days)|Withdrawal by Subject|0
4768137|NCT01591499|16447301|P1|Second Intervention (up to 24 Days)|Withdrawal by Subject|2
4768138|NCT01591499|16447298|P4|Baseline Visit|Withdrawal by Subject|2
4768139|NCT01591499|16447299|P3|Baseline Visit|Withdrawal by Subject|0
4768140|NCT01591499|16447300|P2|Baseline Visit|Withdrawal by Subject|2
4768141|NCT01591499|16447301|P1|Baseline Visit|Withdrawal by Subject|0
4768142|NCT01591460|16447367|P1|Overall Study|Protocol Violation|1
4768143|NCT01591460|16447367|P1|Overall Study|Withdrawal by Subject|1
4768144|NCT01591460|16447367|P1|Overall Study|Participant Refusal|3
4768145|NCT01591460|16447367|P1|Overall Study|Noncompliance|1
4768146|NCT01591460|16447367|P1|Overall Study|Lost to Follow-up|1
4768147|NCT01591460|16447367|P1|Overall Study|Treatment Discontinued by Error|1
4768148|NCT01591460|16447367|P1|Overall Study|Rebound or Breakthrough|3
4768149|NCT01591460|16447367|P1|Overall Study|Futility Rule (Week 24)|3
4768150|NCT01591460|16447367|P1|Overall Study|Futility Rule (Week 12)|7
4768151|NCT01591460|16447367|P1|Overall Study|Adverse Event or Intercurrent Illness|5
4768152|NCT01591382|16447458|P2|Overall Study|Participant Opted for Morphine PCA|1
4768153|NCT01591382|16447459|P1|Overall Study|Participant Opted for Morphine PCA|1
4768154|NCT01591382|16447458|P2|Overall Study|Discharged Prior to Study Completion|1
4768155|NCT01591382|16447459|P1|Overall Study|Discharged Prior to Study Completion|2
4768156|NCT01591096|16447527|P1|Overall Study|Adverse Event|1
4768157|NCT01590888|16447599|P3|Overall Study|Lost to Follow-up|0
4768158|NCT01590888|16447600|P2|Overall Study|Lost to Follow-up|0
4768159|NCT01590888|16447601|P1|Overall Study|Lost to Follow-up|1
4768160|NCT01590888|16447599|P3|Overall Study|Adverse Event|1
4768161|NCT01590888|16447600|P2|Overall Study|Adverse Event|0
4768162|NCT01590888|16447601|P1|Overall Study|Adverse Event|3
4768163|NCT01590810|16447661|P5|Overall Study|Physician Decision|0
4768164|NCT01590810|16447662|P4|Overall Study|Physician Decision|0
4768165|NCT01590810|16447663|P3|Overall Study|Physician Decision|1
4768166|NCT01590810|16447664|P2|Overall Study|Physician Decision|1
4768167|NCT01590810|16447665|P1|Overall Study|Physician Decision|0
4768168|NCT01590797|16447810|P2|Overall Study|Other Protocol Specified Criteria|4
4768169|NCT01590797|16447811|P1|Overall Study|Other Protocol Specified Criteria|2
4768170|NCT01590797|16447810|P2|Overall Study|Withdrawal by Subject|5
4768171|NCT01590797|16447811|P1|Overall Study|Withdrawal by Subject|7
4768172|NCT01590797|16447810|P2|Overall Study|Protocol Violation|1
4768173|NCT01590797|16447811|P1|Overall Study|Protocol Violation|4
4768174|NCT01590797|16447810|P2|Overall Study|Lost to Follow-up|1
4768175|NCT01590797|16447811|P1|Overall Study|Lost to Follow-up|0
4768176|NCT01590797|16447810|P2|Overall Study|Lack of Efficacy|2
4768177|NCT01590797|16447811|P1|Overall Study|Lack of Efficacy|0
4768178|NCT01590797|16447810|P2|Overall Study|Adverse Event|3
4768179|NCT01590797|16447811|P1|Overall Study|Adverse Event|4
4768180|NCT01590771|16447827|P2|Overall Study|Adverse Event|7
4768181|NCT01590771|16447828|P1|Overall Study|Adverse Event|3
4768182|NCT01590771|16447827|P2|Overall Study|Lack of Efficacy|0
4768183|NCT01590771|16447828|P1|Overall Study|Lack of Efficacy|1
4768184|NCT01590771|16447827|P2|Overall Study|Lost to Follow-up|1
4768185|NCT01590771|16447828|P1|Overall Study|Lost to Follow-up|1
4768186|NCT01590771|16447827|P2|Overall Study|Protocol Violation|2
4768187|NCT01590771|16447828|P1|Overall Study|Protocol Violation|1
4768188|NCT01590771|16447827|P2|Overall Study|Withdrawal by Subject|15
4768189|NCT01590771|16447828|P1|Overall Study|Withdrawal by Subject|8
4768190|NCT01590771|16447827|P2|Overall Study|Other Protocol Specified Criteria|14
4768191|NCT01590771|16447828|P1|Overall Study|Other Protocol Specified Criteria|5
4768192|NCT01590758|16447856|P2|Overall Study|Lost to Follow-up|2
4768193|NCT01590758|16447857|P1|Overall Study|Lost to Follow-up|4
4768194|NCT01590758|16447856|P2|Overall Study|Physician Decision|2
4768195|NCT01590758|16447857|P1|Overall Study|Physician Decision|1
4768196|NCT01590758|16447856|P2|Overall Study|Withdrawal by Subject|3
4768197|NCT01590758|16447857|P1|Overall Study|Withdrawal by Subject|0
4768198|NCT01590563|16447867|P1|Overall Study|simple uterine hyperplasia - not related|1
4768199|NCT01590433|16447881|P2|Overall Study|Adverse Event|3
4768200|NCT01590433|16447882|P1|Overall Study|Adverse Event|11
4768201|NCT01590433|16447881|P2|Overall Study|Withdrawal by Subject|11
4768202|NCT01590433|16447882|P1|Overall Study|Withdrawal by Subject|21
4768203|NCT01590433|16447881|P2|Overall Study|Lost to Follow-up|8
4768204|NCT01590433|16447882|P1|Overall Study|Lost to Follow-up|20
4768205|NCT01590212|16447904|P3|Overall Study|Lost to Follow-up|3
4768206|NCT01590212|16447905|P2|Overall Study|Lost to Follow-up|2
4768207|NCT01590212|16447906|P1|Overall Study|Lost to Follow-up|1
4768208|NCT01590212|16447904|P3|Overall Study|Withdrawal by Subject|2
4768209|NCT01590212|16447905|P2|Overall Study|Withdrawal by Subject|2
4768210|NCT01590212|16447906|P1|Overall Study|Withdrawal by Subject|2
4768211|NCT01590082|16447925|P2|Overall Study|Ineligible|0
4768212|NCT01590082|16447926|P1|Overall Study|Ineligible|1
4768213|NCT01590082|16447925|P2|Overall Study|Withdrawal by Subject|0
4768214|NCT01590082|16447926|P1|Overall Study|Withdrawal by Subject|1
4768215|NCT01590017|16447932|P1|Overall Study|Physician Decision|1
4768216|NCT01590017|16447932|P1|Overall Study|Lack of Efficacy|1
4768217|NCT01590017|16447932|P1|Overall Study|Withdrawal by Subject|1
4768218|NCT01590017|16447932|P1|Overall Study|Adverse Event|1
4768219|NCT01589822|16447985|P3|Overall Study|Missed 90 day visit|1
4768220|NCT01589822|16447986|P2|Overall Study|Missed 90 day visit|1
4768221|NCT01589822|16447987|P1|Overall Study|Missed 90 day visit|2
4768222|NCT01589822|16447985|P3|Overall Study|Death|0
4768223|NCT01589822|16447986|P2|Overall Study|Death|0
4768224|NCT01589822|16447987|P1|Overall Study|Death|1
4768225|NCT01589822|16447985|P3|Overall Study|Withdrawal by Subject|0
4768226|NCT01589822|16447986|P2|Overall Study|Withdrawal by Subject|2
4768227|NCT01589822|16447987|P1|Overall Study|Withdrawal by Subject|1
4768228|NCT01589770|16448006|P2|Overall Study|claustrophobic when entering cardiac MRI|1
4768229|NCT01589770|16448007|P1|Overall Study|claustrophobic when entering cardiac MRI|2
4768230|NCT01589770|16448006|P2|Overall Study|EGFR <60ml/min|4
4768231|NCT01589770|16448007|P1|Overall Study|EGFR <60ml/min|6
4768232|NCT01589653|16448017|P2|Overall Study|Unclassified|3
4768233|NCT01589653|16448018|P1|Overall Study|Unclassified|0
4768234|NCT01589653|16448017|P2|Overall Study|Withdrawal criteria|7
4768235|NCT01589653|16448018|P1|Overall Study|Withdrawal criteria|4
4768236|NCT01589653|16448017|P2|Overall Study|Protocol Violation|1
4768237|NCT01589653|16448018|P1|Overall Study|Protocol Violation|3
4768238|NCT01589497|16448068|P4|Overall Study|Pre-entry overnight sputum< 10ML|0
4768239|NCT01589497|16448069|P3|Overall Study|Pre-entry overnight sputum< 10ML|1
4768240|NCT01589497|16448070|P2|Overall Study|Pre-entry overnight sputum< 10ML|0
4768241|NCT01589497|16448071|P1|Overall Study|Pre-entry overnight sputum< 10ML|0
4768242|NCT01589497|16448068|P4|Overall Study|Death|0
4768243|NCT01589497|16448069|P3|Overall Study|Death|0
4768244|NCT01589497|16448070|P2|Overall Study|Death|0
4768245|NCT01589497|16448071|P1|Overall Study|Death|1
4768246|NCT01589497|16448068|P4|Overall Study|Withdrawal by Subject|1
4768247|NCT01589497|16448069|P3|Overall Study|Withdrawal by Subject|0
4768248|NCT01589497|16448070|P2|Overall Study|Withdrawal by Subject|1
4768249|NCT01589497|16448071|P1|Overall Study|Withdrawal by Subject|0
4768250|NCT01589445|16448177|P1|002 (Metformin)-3 Months|Husbands of female patients refrained|2
4768251|NCT01589445|16448177|P1|002 (Metformin)-3 Months|Adverse Event|2
4768252|NCT01589445|16448177|P1|002 (Metformin)-3 Months|Protocol Violation|2
4768253|NCT01589445|16448177|P1|002 (Metformin)-3 Months|Lost to Follow-up|2
4768254|NCT01589445|16448177|P1|002 (Metformin)-3 Months|Lack of Efficacy|1
4768255|NCT01589445|16448177|P1|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2
4768256|NCT01589445|16448177|P1|001 (Pioglitazone) -3 Months|Lack of Efficacy|1
4768257|NCT01589445|16448177|P1|001 (Pioglitazone) -3 Months|Lost to Follow-up|2
4768258|NCT01589445|16448177|P1|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1
4768259|NCT01589445|16448177|P1|001 (Pioglitazone) -3 Months|Protocol Violation|1
4768260|NCT01589237|16448220|P4|Part B (Planned for 78 Week-terminated)|Physician Decision|1
4768261|NCT01589237|16448221|P3|Part B (Planned for 78 Week-terminated)|Physician Decision|0
4768262|NCT01589237|16448222|P2|Part B (Planned for 78 Week-terminated)|Physician Decision|0
4768263|NCT01589237|16448223|P1|Part B (Planned for 78 Week-terminated)|Physician Decision|0
4768264|NCT01589237|16448220|P4|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3
4768265|NCT01589237|16448221|P3|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4
4768266|NCT01589237|16448222|P2|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
4768267|NCT01589237|16448223|P1|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5
4768268|NCT01589237|16448220|P4|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
4768269|NCT01589237|16448221|P3|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
4768270|NCT01589237|16448222|P2|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1
4768271|NCT01589237|16448223|P1|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0
4768272|NCT01589237|16448220|P4|Part A (52 Weeks)|Subject/guardian decision|0
4768273|NCT01589237|16448221|P3|Part A (52 Weeks)|Subject/guardian decision|2
4768274|NCT01589237|16448222|P2|Part A (52 Weeks)|Subject/guardian decision|3
4768275|NCT01589237|16448223|P1|Part A (52 Weeks)|Subject/guardian decision|2
4768276|NCT01589185|16448274|P5|Overall Study|Lost to Follow-up|0
4768277|NCT01589185|16448275|P4|Overall Study|Lost to Follow-up|3
4768278|NCT01589185|16448276|P3|Overall Study|Lost to Follow-up|2
4768279|NCT01589185|16448277|P2|Overall Study|Lost to Follow-up|0
4768280|NCT01589185|16448278|P1|Overall Study|Lost to Follow-up|1
4768281|NCT01589185|16448274|P5|Overall Study|Death|1
4768282|NCT01589185|16448275|P4|Overall Study|Death|0
4768283|NCT01589185|16448276|P3|Overall Study|Death|2
4768284|NCT01589185|16448277|P2|Overall Study|Death|2
4768285|NCT01589185|16448278|P1|Overall Study|Death|1
4768286|NCT01589094|16448311|P1|Overall Study|Did not receive treatment|2
4768287|NCT01588990|16448318|P1|Phase B|Other|2
4768288|NCT01588990|16448318|P1|Phase B|Physician Decision|4
4768289|NCT01588990|16448318|P1|Phase B|Withdrawal by Subject|3
4768290|NCT01588990|16448318|P1|Phase B|Still on therapy at end of study|5
4768291|NCT01588990|16448318|P1|Phase B|Adverse Event|2
4768292|NCT01588990|16448318|P1|Phase A|Still on therapy at end of study|6
4768293|NCT01588990|16448318|P1|Phase A|Adverse Event|28
4768294|NCT01588990|16448318|P1|Phase A|Death|5
4768295|NCT01588990|16448318|P1|Phase A|Lost to Follow-up|1
4768296|NCT01588990|16448318|P1|Phase A|Other|14
4768297|NCT01588990|16448318|P1|Phase A|Physician Decision|11
4768298|NCT01588990|16448318|P1|Phase A|Withdrawal by Subject|5
4768299|NCT01588951|16448346|P3|Overall Study|Ineligible in retrospect|1
4768300|NCT01588951|16448347|P2|Overall Study|Ineligible in retrospect|0
4768301|NCT01588951|16448348|P1|Overall Study|Ineligible in retrospect|0
4768302|NCT01588548|16448384|P6|Overall Study|Condition Under Investigation Worsened|3
4768303|NCT01588548|16448385|P5|Overall Study|Condition Under Investigation Worsened|3
4768304|NCT01588548|16448386|P4|Overall Study|Condition Under Investigation Worsened|4
4768305|NCT01588548|16448387|P3|Overall Study|Condition Under Investigation Worsened|4
4768306|NCT01588548|16448388|P2|Overall Study|Condition Under Investigation Worsened|6
4768307|NCT01588548|16448389|P1|Overall Study|Condition Under Investigation Worsened|3
4768308|NCT01588548|16448384|P6|Overall Study|Adverse Event|0
4768309|NCT01588548|16448385|P5|Overall Study|Adverse Event|1
4768310|NCT01588548|16448386|P4|Overall Study|Adverse Event|2
4768311|NCT01588548|16448387|P3|Overall Study|Adverse Event|1
4768312|NCT01588548|16448388|P2|Overall Study|Adverse Event|0
4768313|NCT01588548|16448389|P1|Overall Study|Adverse Event|0
4768314|NCT01588548|16448384|P6|Overall Study|Withdrawal by Subject|3
4768315|NCT01588548|16448385|P5|Overall Study|Withdrawal by Subject|2
4768316|NCT01588548|16448386|P4|Overall Study|Withdrawal by Subject|1
4768317|NCT01588548|16448387|P3|Overall Study|Withdrawal by Subject|1
4768318|NCT01588548|16448388|P2|Overall Study|Withdrawal by Subject|1
4768319|NCT01588548|16448389|P1|Overall Study|Withdrawal by Subject|0
4768320|NCT01588509|16448405|P2|Overall Study|Lost to Follow-up|0
4768321|NCT01588509|16448406|P1|Overall Study|Lost to Follow-up|1
4768322|NCT01588496|16448429|P3|Overall Study|Withdrawal by Subject|0
4768323|NCT01588496|16448430|P2|Overall Study|Withdrawal by Subject|1
4768324|NCT01588496|16448431|P1|Overall Study|Withdrawal by Subject|0
4768325|NCT01588405|16448506|P1|Overall Study|Clinical Worsening|1
4768326|NCT01588405|16448506|P1|Overall Study|Adverse Event|1
4768327|NCT01588366|16448535|P6|Overall Study|Adverse Event|2
4768328|NCT01588366|16448536|P5|Overall Study|Adverse Event|0
4768329|NCT01588366|16448537|P4|Overall Study|Adverse Event|1
4768330|NCT01588366|16448538|P3|Overall Study|Adverse Event|0
4768331|NCT01588366|16448539|P2|Overall Study|Adverse Event|1
4768332|NCT01588366|16448540|P1|Overall Study|Adverse Event|0
4768333|NCT01588353|16448568|P3|Step3|Adverse Event|2
4768334|NCT01588353|16448569|P2|Step3|Adverse Event|0
4768335|NCT01588353|16448570|P1|Step3|Adverse Event|0
4768336|NCT01588353|16448568|P3|Step2|Withdrawal by Subject|0
4768337|NCT01588353|16448569|P2|Step2|Withdrawal by Subject|1
4768338|NCT01588353|16448570|P1|Step2|Withdrawal by Subject|0
4768339|NCT01588197|16448619|P2|Overall Study|No MRI|0
4768340|NCT01588197|16448620|P1|Overall Study|No MRI|1
4768341|NCT01588197|16448619|P2|Overall Study|Lack of Efficacy|1
4768342|NCT01588197|16448620|P1|Overall Study|Lack of Efficacy|0
4768343|NCT01588106|16448657|P2|Overall Study|Withdrawal by Subject|4
4768344|NCT01588106|16448658|P1|Overall Study|Withdrawal by Subject|5
4768345|NCT01587989|16448666|P3|Randomized Study Treatment|Physician Decision|1
4768346|NCT01587989|16448667|P2|Randomized Study Treatment|Physician Decision|0
4768347|NCT01587989|16448668|P1|Randomized Study Treatment|Physician Decision|0
4768348|NCT01587989|16448666|P3|Randomized Study Treatment|Screening failure|0
4768349|NCT01587989|16448667|P2|Randomized Study Treatment|Screening failure|1
4768350|NCT01587989|16448668|P1|Randomized Study Treatment|Screening failure|0
4768351|NCT01587989|16448666|P3|Randomized Study Treatment|Withdrawal by Subject|0
4768352|NCT01587989|16448667|P2|Randomized Study Treatment|Withdrawal by Subject|1
4768353|NCT01587989|16448668|P1|Randomized Study Treatment|Withdrawal by Subject|0
4768354|NCT01587989|16448666|P3|12-Week Open-Label Run-In Period|No EULAR Response|0
4768355|NCT01587989|16448667|P2|12-Week Open-Label Run-In Period|No EULAR Response|0
4768356|NCT01587989|16448668|P1|12-Week Open-Label Run-In Period|No EULAR Response|4
4768357|NCT01587989|16448666|P3|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
4768358|NCT01587989|16448667|P2|12-Week Open-Label Run-In Period|Withdrawal by Subject|0
4768359|NCT01587989|16448668|P1|12-Week Open-Label Run-In Period|Withdrawal by Subject|1
4768360|NCT01587989|16448666|P3|12-Week Open-Label Run-In Period|Physician Decision|0
4768361|NCT01587989|16448667|P2|12-Week Open-Label Run-In Period|Physician Decision|0
4768362|NCT01587989|16448668|P1|12-Week Open-Label Run-In Period|Physician Decision|7
4768363|NCT01587924|16448733|P4|Overall Study|Withdrawal by Subject|0
4768364|NCT01587924|16448734|P3|Overall Study|Withdrawal by Subject|1
4768365|NCT01587924|16448735|P2|Overall Study|Withdrawal by Subject|1
4768366|NCT01587924|16448736|P1|Overall Study|Withdrawal by Subject|0
4768367|NCT01587924|16448733|P4|Overall Study|Met Hemoglobin stopping criteria|0
4768368|NCT01587924|16448734|P3|Overall Study|Met Hemoglobin stopping criteria|1
4768369|NCT01587924|16448735|P2|Overall Study|Met Hemoglobin stopping criteria|0
4768370|NCT01587924|16448736|P1|Overall Study|Met Hemoglobin stopping criteria|2
4768371|NCT01587924|16448733|P4|Overall Study|Protocol Violation|1
4768372|NCT01587924|16448734|P3|Overall Study|Protocol Violation|2
4768373|NCT01587924|16448735|P2|Overall Study|Protocol Violation|1
4768374|NCT01587924|16448736|P1|Overall Study|Protocol Violation|2
4768375|NCT01587924|16448733|P4|Overall Study|Adverse Event|0
4768376|NCT01587924|16448734|P3|Overall Study|Adverse Event|0
4768377|NCT01587924|16448735|P2|Overall Study|Adverse Event|2
4768378|NCT01587924|16448736|P1|Overall Study|Adverse Event|0
4768379|NCT01587898|16448837|P4|Overall Study|Met haemoglobin stopping criteria|0
4768380|NCT01587898|16448838|P3|Overall Study|Met haemoglobin stopping criteria|1
4768381|NCT01587898|16448839|P2|Overall Study|Met haemoglobin stopping criteria|1
4768382|NCT01587898|16448840|P1|Overall Study|Met haemoglobin stopping criteria|1
4768383|NCT01587898|16448837|P4|Overall Study|Withdrawal by Subject|0
4768384|NCT01587898|16448838|P3|Overall Study|Withdrawal by Subject|0
4768385|NCT01587898|16448839|P2|Overall Study|Withdrawal by Subject|1
4768386|NCT01587898|16448840|P1|Overall Study|Withdrawal by Subject|2
4768387|NCT01587898|16448837|P4|Overall Study|Lost to Follow-up|1
4768388|NCT01587898|16448838|P3|Overall Study|Lost to Follow-up|0
4768389|NCT01587898|16448839|P2|Overall Study|Lost to Follow-up|0
4768390|NCT01587898|16448840|P1|Overall Study|Lost to Follow-up|0
4768391|NCT01587898|16448837|P4|Overall Study|Protocol Violation|1
4768392|NCT01587898|16448838|P3|Overall Study|Protocol Violation|1
4768393|NCT01587898|16448839|P2|Overall Study|Protocol Violation|2
4768394|NCT01587898|16448840|P1|Overall Study|Protocol Violation|0
4768395|NCT01587898|16448837|P4|Overall Study|Adverse Event|0
4768396|NCT01587898|16448838|P3|Overall Study|Adverse Event|0
4768397|NCT01587898|16448839|P2|Overall Study|Adverse Event|1
4768398|NCT01587898|16448840|P1|Overall Study|Adverse Event|1
4768399|NCT01587885|16449016|P2|Treatment Period 1|Protocol Violation|2
4768400|NCT01587885|16449017|P1|Treatment Period 1|Protocol Violation|0
4768401|NCT01587885|16449016|P2|Treatment Period 1|Failure to Return|1
4768402|NCT01587885|16449017|P1|Treatment Period 1|Failure to Return|0
4768403|NCT01587703|16449048|P19|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768404|NCT01587703|16449049|P18|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768405|NCT01587703|16449050|P17|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768406|NCT01587703|16449051|P16|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768407|NCT01587703|16449052|P15|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768408|NCT01587703|16449053|P14|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768409|NCT01587703|16449054|P13|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768410|NCT01587703|16449055|P12|Part2(Median Exposure of 1.41 Months)|Physician Decision|1
4768411|NCT01587703|16449056|P11|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768412|NCT01587703|16449057|P10|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768413|NCT01587703|16449058|P9|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768414|NCT01587703|16449059|P8|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768415|NCT01587703|16449060|P7|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768416|NCT01587703|16449061|P6|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768417|NCT01587703|16449062|P5|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768418|NCT01587703|16449063|P4|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768419|NCT01587703|16449064|P3|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768420|NCT01587703|16449065|P2|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768421|NCT01587703|16449066|P1|Part2(Median Exposure of 1.41 Months)|Physician Decision|0
4768422|NCT01587703|16449048|P19|Part2(Median Exposure of 1.41 Months)|Death|0
4768423|NCT01587703|16449049|P18|Part2(Median Exposure of 1.41 Months)|Death|0
4768424|NCT01587703|16449050|P17|Part2(Median Exposure of 1.41 Months)|Death|5
4768425|NCT01587703|16449051|P16|Part2(Median Exposure of 1.41 Months)|Death|17
4768426|NCT01587703|16449052|P15|Part2(Median Exposure of 1.41 Months)|Death|16
4768427|NCT01587703|16449053|P14|Part2(Median Exposure of 1.41 Months)|Death|21
4768428|NCT01587703|16449054|P13|Part2(Median Exposure of 1.41 Months)|Death|12
4768429|NCT01587703|16449055|P12|Part2(Median Exposure of 1.41 Months)|Death|8
4768430|NCT01587703|16449056|P11|Part2(Median Exposure of 1.41 Months)|Death|0
4768431|NCT01587703|16449057|P10|Part2(Median Exposure of 1.41 Months)|Death|0
4768432|NCT01587703|16449058|P9|Part2(Median Exposure of 1.41 Months)|Death|0
4768433|NCT01587703|16449059|P8|Part2(Median Exposure of 1.41 Months)|Death|0
4768434|NCT01587703|16449060|P7|Part2(Median Exposure of 1.41 Months)|Death|0
4768435|NCT01587703|16449061|P6|Part2(Median Exposure of 1.41 Months)|Death|0
4768436|NCT01587703|16449062|P5|Part2(Median Exposure of 1.41 Months)|Death|0
4768437|NCT01587703|16449063|P4|Part2(Median Exposure of 1.41 Months)|Death|0
4768438|NCT01587703|16449064|P3|Part2(Median Exposure of 1.41 Months)|Death|0
4768439|NCT01587703|16449065|P2|Part2(Median Exposure of 1.41 Months)|Death|0
4768440|NCT01587703|16449066|P1|Part2(Median Exposure of 1.41 Months)|Death|0
4768441|NCT01587703|16449048|P19|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768442|NCT01587703|16449049|P18|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768443|NCT01587703|16449050|P17|Part2(Median Exposure of 1.41 Months)|Site closed|8
4768444|NCT01587703|16449051|P16|Part2(Median Exposure of 1.41 Months)|Site closed|3
4768445|NCT01587703|16449052|P15|Part2(Median Exposure of 1.41 Months)|Site closed|1
4768446|NCT01587703|16449053|P14|Part2(Median Exposure of 1.41 Months)|Site closed|1
4768447|NCT01587703|16449054|P13|Part2(Median Exposure of 1.41 Months)|Site closed|2
4768448|NCT01587703|16449055|P12|Part2(Median Exposure of 1.41 Months)|Site closed|2
4768449|NCT01587703|16449056|P11|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768450|NCT01587703|16449057|P10|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768451|NCT01587703|16449058|P9|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768452|NCT01587703|16449059|P8|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768453|NCT01587703|16449060|P7|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768454|NCT01587703|16449061|P6|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768455|NCT01587703|16449062|P5|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768456|NCT01587703|16449063|P4|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768457|NCT01587703|16449064|P3|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768458|NCT01587703|16449065|P2|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768459|NCT01587703|16449066|P1|Part2(Median Exposure of 1.41 Months)|Site closed|0
4768460|NCT01587703|16449048|P19|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768461|NCT01587703|16449049|P18|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768462|NCT01587703|16449050|P17|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768463|NCT01587703|16449051|P16|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768464|NCT01587703|16449052|P15|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2
4768465|NCT01587703|16449053|P14|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768466|NCT01587703|16449054|P13|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768467|NCT01587703|16449055|P12|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1
4768468|NCT01587703|16449056|P11|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768469|NCT01587703|16449057|P10|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768470|NCT01587703|16449058|P9|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768471|NCT01587703|16449059|P8|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768472|NCT01587703|16449060|P7|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768473|NCT01587703|16449061|P6|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768474|NCT01587703|16449062|P5|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768475|NCT01587703|16449063|P4|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768476|NCT01587703|16449064|P3|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768477|NCT01587703|16449065|P2|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768478|NCT01587703|16449066|P1|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0
4768479|NCT01587703|16449048|P19|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768480|NCT01587703|16449049|P18|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768481|NCT01587703|16449050|P17|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768482|NCT01587703|16449051|P16|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1
4768483|NCT01587703|16449052|P15|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768484|NCT01587703|16449053|P14|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768485|NCT01587703|16449054|P13|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768486|NCT01587703|16449055|P12|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768487|NCT01587703|16449056|P11|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768488|NCT01587703|16449057|P10|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768489|NCT01587703|16449058|P9|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768490|NCT01587703|16449059|P8|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768491|NCT01587703|16449060|P7|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768492|NCT01587703|16449061|P6|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768493|NCT01587703|16449062|P5|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768494|NCT01587703|16449063|P4|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768495|NCT01587703|16449064|P3|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768496|NCT01587703|16449065|P2|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768497|NCT01587703|16449066|P1|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0
4768498|NCT01587703|16449048|P19|Substudy-P4,Maximum Exposure of 5.5month|Death|4
4768499|NCT01587703|16449049|P18|Substudy-P4,Maximum Exposure of 5.5month|Death|5
4768500|NCT01587703|16449050|P17|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768501|NCT01587703|16449051|P16|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768502|NCT01587703|16449052|P15|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768503|NCT01587703|16449053|P14|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768504|NCT01587703|16449054|P13|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768505|NCT01587703|16449055|P12|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768506|NCT01587703|16449056|P11|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768507|NCT01587703|16449057|P10|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768508|NCT01587703|16449058|P9|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768509|NCT01587703|16449059|P8|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768510|NCT01587703|16449060|P7|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768511|NCT01587703|16449061|P6|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768512|NCT01587703|16449062|P5|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768513|NCT01587703|16449063|P4|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768514|NCT01587703|16449064|P3|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768515|NCT01587703|16449065|P2|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768516|NCT01587703|16449066|P1|Substudy-P4,Maximum Exposure of 5.5month|Death|0
4768517|NCT01587703|16449048|P19|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1
4768518|NCT01587703|16449049|P18|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768519|NCT01587703|16449050|P17|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768520|NCT01587703|16449051|P16|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768521|NCT01587703|16449052|P15|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768522|NCT01587703|16449053|P14|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768523|NCT01587703|16449054|P13|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768524|NCT01587703|16449055|P12|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768525|NCT01587703|16449056|P11|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768526|NCT01587703|16449057|P10|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768527|NCT01587703|16449058|P9|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768528|NCT01587703|16449059|P8|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768529|NCT01587703|16449060|P7|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768530|NCT01587703|16449061|P6|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768531|NCT01587703|16449062|P5|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768532|NCT01587703|16449063|P4|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768533|NCT01587703|16449064|P3|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768534|NCT01587703|16449065|P2|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768535|NCT01587703|16449066|P1|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0
4768536|NCT01587703|16449048|P19|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768537|NCT01587703|16449049|P18|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768538|NCT01587703|16449050|P17|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768539|NCT01587703|16449051|P16|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768540|NCT01587703|16449052|P15|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768541|NCT01587703|16449053|P14|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768542|NCT01587703|16449054|P13|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768543|NCT01587703|16449055|P12|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768544|NCT01587703|16449056|P11|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768545|NCT01587703|16449057|P10|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768546|NCT01587703|16449058|P9|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1
4768547|NCT01587703|16449059|P8|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768548|NCT01587703|16449060|P7|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768549|NCT01587703|16449061|P6|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768550|NCT01587703|16449062|P5|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768551|NCT01587703|16449063|P4|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768552|NCT01587703|16449064|P3|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768553|NCT01587703|16449065|P2|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768554|NCT01587703|16449066|P1|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0
4768555|NCT01587703|16449048|P19|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768556|NCT01587703|16449049|P18|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768557|NCT01587703|16449050|P17|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768558|NCT01587703|16449051|P16|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768559|NCT01587703|16449052|P15|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768560|NCT01587703|16449053|P14|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768561|NCT01587703|16449054|P13|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768562|NCT01587703|16449055|P12|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768563|NCT01587703|16449056|P11|Part1 BID(Median Exposure of 1.41months)|Site closed|1
4768564|NCT01587703|16449057|P10|Part1 BID(Median Exposure of 1.41months)|Site closed|1
4768565|NCT01587703|16449058|P9|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768566|NCT01587703|16449059|P8|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768567|NCT01587703|16449060|P7|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768568|NCT01587703|16449061|P6|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768569|NCT01587703|16449062|P5|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768570|NCT01587703|16449063|P4|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768571|NCT01587703|16449064|P3|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768572|NCT01587703|16449065|P2|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768573|NCT01587703|16449066|P1|Part1 BID(Median Exposure of 1.41months)|Site closed|0
4768574|NCT01587703|16449048|P19|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768575|NCT01587703|16449049|P18|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768576|NCT01587703|16449050|P17|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768577|NCT01587703|16449051|P16|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768578|NCT01587703|16449052|P15|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768579|NCT01587703|16449053|P14|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768580|NCT01587703|16449054|P13|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768581|NCT01587703|16449055|P12|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768582|NCT01587703|16449056|P11|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
4768583|NCT01587703|16449057|P10|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768584|NCT01587703|16449058|P9|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1
4768585|NCT01587703|16449059|P8|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768586|NCT01587703|16449060|P7|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768587|NCT01587703|16449061|P6|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768588|NCT01587703|16449062|P5|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768589|NCT01587703|16449063|P4|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768590|NCT01587703|16449064|P3|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768591|NCT01587703|16449065|P2|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768592|NCT01587703|16449066|P1|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0
4768593|NCT01587703|16449048|P19|Part1 BID(Median Exposure of 1.41months)|Death|0
4768594|NCT01587703|16449049|P18|Part1 BID(Median Exposure of 1.41months)|Death|0
4768595|NCT01587703|16449050|P17|Part1 BID(Median Exposure of 1.41months)|Death|0
4768596|NCT01587703|16449051|P16|Part1 BID(Median Exposure of 1.41months)|Death|0
4768597|NCT01587703|16449052|P15|Part1 BID(Median Exposure of 1.41months)|Death|0
4768598|NCT01587703|16449053|P14|Part1 BID(Median Exposure of 1.41months)|Death|0
4768599|NCT01587703|16449054|P13|Part1 BID(Median Exposure of 1.41months)|Death|0
4768600|NCT01587703|16449055|P12|Part1 BID(Median Exposure of 1.41months)|Death|0
4768601|NCT01587703|16449056|P11|Part1 BID(Median Exposure of 1.41months)|Death|3
4768602|NCT01587703|16449057|P10|Part1 BID(Median Exposure of 1.41months)|Death|9
4768603|NCT01587703|16449058|P9|Part1 BID(Median Exposure of 1.41months)|Death|1
4768604|NCT01587703|16449059|P8|Part1 BID(Median Exposure of 1.41months)|Death|0
4768605|NCT01587703|16449060|P7|Part1 BID(Median Exposure of 1.41months)|Death|0
4768606|NCT01587703|16449061|P6|Part1 BID(Median Exposure of 1.41months)|Death|0
4768607|NCT01587703|16449062|P5|Part1 BID(Median Exposure of 1.41months)|Death|0
4768608|NCT01587703|16449063|P4|Part1 BID(Median Exposure of 1.41months)|Death|0
4768609|NCT01587703|16449064|P3|Part1 BID(Median Exposure of 1.41months)|Death|0
4768610|NCT01587703|16449065|P2|Part1 BID(Median Exposure of 1.41months)|Death|0
4768611|NCT01587703|16449066|P1|Part1 BID(Median Exposure of 1.41months)|Death|0
4768612|NCT01587703|16449048|P19|Part1 QD(Median Exposure of 1.38months)|Death|0
4768613|NCT01587703|16449049|P18|Part1 QD(Median Exposure of 1.38months)|Death|0
4768614|NCT01587703|16449050|P17|Part1 QD(Median Exposure of 1.38months)|Death|0
4768615|NCT01587703|16449051|P16|Part1 QD(Median Exposure of 1.38months)|Death|0
4768616|NCT01587703|16449052|P15|Part1 QD(Median Exposure of 1.38months)|Death|0
4768617|NCT01587703|16449053|P14|Part1 QD(Median Exposure of 1.38months)|Death|0
4768618|NCT01587703|16449054|P13|Part1 QD(Median Exposure of 1.38months)|Death|0
4768619|NCT01587703|16449055|P12|Part1 QD(Median Exposure of 1.38months)|Death|0
4768620|NCT01587703|16449056|P11|Part1 QD(Median Exposure of 1.38months)|Death|0
4768621|NCT01587703|16449057|P10|Part1 QD(Median Exposure of 1.38months)|Death|0
4768622|NCT01587703|16449058|P9|Part1 QD(Median Exposure of 1.38months)|Death|0
4768623|NCT01587703|16449059|P8|Part1 QD(Median Exposure of 1.38months)|Death|7
4768624|NCT01587703|16449060|P7|Part1 QD(Median Exposure of 1.38months)|Death|30
4768625|NCT01587703|16449061|P6|Part1 QD(Median Exposure of 1.38months)|Death|7
4768626|NCT01587703|16449062|P5|Part1 QD(Median Exposure of 1.38months)|Death|4
4768627|NCT01587703|16449063|P4|Part1 QD(Median Exposure of 1.38months)|Death|3
4768628|NCT01587703|16449064|P3|Part1 QD(Median Exposure of 1.38months)|Death|1
4768629|NCT01587703|16449065|P2|Part1 QD(Median Exposure of 1.38months)|Death|4
4768630|NCT01587703|16449066|P1|Part1 QD(Median Exposure of 1.38months)|Death|2
4768631|NCT01587703|16449048|P19|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768632|NCT01587703|16449049|P18|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768633|NCT01587703|16449050|P17|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768634|NCT01587703|16449051|P16|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768635|NCT01587703|16449052|P15|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768636|NCT01587703|16449053|P14|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768637|NCT01587703|16449054|P13|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768638|NCT01587703|16449055|P12|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768639|NCT01587703|16449056|P11|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768640|NCT01587703|16449057|P10|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768641|NCT01587703|16449058|P9|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768642|NCT01587703|16449059|P8|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768643|NCT01587703|16449060|P7|Part1 QD(Median Exposure of 1.38months)|Site closed|2
4768644|NCT01587703|16449061|P6|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768645|NCT01587703|16449062|P5|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768646|NCT01587703|16449063|P4|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768647|NCT01587703|16449064|P3|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768648|NCT01587703|16449065|P2|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768649|NCT01587703|16449066|P1|Part1 QD(Median Exposure of 1.38months)|Site closed|0
4768650|NCT01587703|16449048|P19|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768651|NCT01587703|16449049|P18|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768652|NCT01587703|16449050|P17|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768653|NCT01587703|16449051|P16|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768654|NCT01587703|16449052|P15|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768655|NCT01587703|16449053|P14|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768656|NCT01587703|16449054|P13|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768657|NCT01587703|16449055|P12|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768658|NCT01587703|16449056|P11|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768659|NCT01587703|16449057|P10|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768660|NCT01587703|16449058|P9|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768661|NCT01587703|16449059|P8|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2
4768662|NCT01587703|16449060|P7|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768663|NCT01587703|16449061|P6|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1
4768664|NCT01587703|16449062|P5|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768665|NCT01587703|16449063|P4|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768666|NCT01587703|16449064|P3|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768667|NCT01587703|16449065|P2|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768668|NCT01587703|16449066|P1|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0
4768669|NCT01587703|16449048|P19|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768670|NCT01587703|16449049|P18|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768671|NCT01587703|16449050|P17|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768672|NCT01587703|16449051|P16|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768673|NCT01587703|16449052|P15|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768674|NCT01587703|16449053|P14|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768675|NCT01587703|16449054|P13|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768676|NCT01587703|16449055|P12|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768677|NCT01587703|16449056|P11|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768678|NCT01587703|16449057|P10|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768679|NCT01587703|16449058|P9|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768680|NCT01587703|16449059|P8|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768681|NCT01587703|16449060|P7|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768682|NCT01587703|16449061|P6|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768683|NCT01587703|16449062|P5|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768684|NCT01587703|16449063|P4|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768685|NCT01587703|16449064|P3|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768686|NCT01587703|16449065|P2|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0
4768687|NCT01587703|16449066|P1|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1
4768688|NCT01587651|16449473|P3|Overall Study|Withdrawal by Subject|0
4768689|NCT01587651|16449474|P2|Overall Study|Withdrawal by Subject|1
4768690|NCT01587651|16449475|P1|Overall Study|Withdrawal by Subject|0
4768691|NCT01587651|16449473|P3|Overall Study|Protocol Violation|1
4768692|NCT01587651|16449474|P2|Overall Study|Protocol Violation|1
4768693|NCT01587651|16449475|P1|Overall Study|Protocol Violation|0
4768694|NCT01587651|16449473|P3|Overall Study|Adverse Event|0
4768695|NCT01587651|16449474|P2|Overall Study|Adverse Event|1
4768696|NCT01587651|16449475|P1|Overall Study|Adverse Event|0
4768697|NCT01587274|16449505|P3|Overall Study|Lost to Follow-up|3
4768698|NCT01587274|16449506|P2|Overall Study|Lost to Follow-up|5
4768699|NCT01587274|16449507|P1|Overall Study|Lost to Follow-up|4
4768700|NCT01587118|16449515|P1|Overall Study|nonresponse|1
4768701|NCT01587118|16449515|P1|Overall Study|Relocation|1
4768702|NCT01587118|16449515|P1|Overall Study|Lost to Follow-up|2
4768703|NCT01587118|16449515|P1|Overall Study|Adverse Event|3
4768704|NCT01587079|16449539|P1|Overall Study|Adverse Event|14
4768705|NCT01587079|16449539|P1|Overall Study|Withdrawal by Subject|7
4768706|NCT01587079|16449539|P1|Overall Study|Physician Decision|2
4768707|NCT01587079|16449539|P1|Overall Study|Lost to Follow-up|2
4768708|NCT01587079|16449539|P1|Overall Study|Protocol Violation|5
4768709|NCT01587079|16449539|P1|Overall Study|Protocol-specified criteria|9
4768710|NCT01587040|16449665|P4|Overall Study|Other than specified|1
4768711|NCT01587040|16449666|P3|Overall Study|Other than specified|11
4768712|NCT01587040|16449667|P2|Overall Study|Other than specified|1
4768713|NCT01587040|16449668|P1|Overall Study|Other than specified|5
4768714|NCT01587040|16449665|P4|Overall Study|Disease progression|3
4768715|NCT01587040|16449666|P3|Overall Study|Disease progression|15
4768716|NCT01587040|16449667|P2|Overall Study|Disease progression|1
4768717|NCT01587040|16449668|P1|Overall Study|Disease progression|12
4768718|NCT01587040|16449665|P4|Overall Study|Adverse Event|0
4768719|NCT01587040|16449666|P3|Overall Study|Adverse Event|10
4768720|NCT01587040|16449667|P2|Overall Study|Adverse Event|1
4768721|NCT01587040|16449668|P1|Overall Study|Adverse Event|0
4768722|NCT01587040|16449665|P4|Overall Study|Protocol Violation|0
4768723|NCT01587040|16449666|P3|Overall Study|Protocol Violation|1
4768724|NCT01587040|16449667|P2|Overall Study|Protocol Violation|0
4768725|NCT01587040|16449668|P1|Overall Study|Protocol Violation|0
4768726|NCT01587014|16449695|P1|Overall Study|Death|2
4768727|NCT01587001|16449702|P2|Overall Study|Insufficient samples to complete testing|1
4768728|NCT01587001|16449703|P1|Overall Study|Insufficient samples to complete testing|4
4768729|NCT01587001|16449702|P2|Overall Study|Lost to Follow-up|0
4768730|NCT01587001|16449703|P1|Overall Study|Lost to Follow-up|2
4768731|NCT01586910|16449732|P2|Overall Study|Physician withdrew Subject|24
4768732|NCT01586910|16449733|P1|Overall Study|Physician withdrew Subject|5
4768733|NCT01586910|16449732|P2|Overall Study|Withdrawal by Subject|43
4768734|NCT01586910|16449733|P1|Overall Study|Withdrawal by Subject|6
4768735|NCT01586910|16449732|P2|Overall Study|Death|4
4768736|NCT01586910|16449733|P1|Overall Study|Death|4
4768737|NCT01586819|16449807|P2|Overall Study|Withdrawal by Subject|0
4768738|NCT01586819|16449808|P1|Overall Study|Withdrawal by Subject|1
4768739|NCT01586806|16449819|P3|Overall Study|Lost to Follow-up|2
4768740|NCT01586806|16449820|P2|Overall Study|Lost to Follow-up|3
4768741|NCT01586806|16449821|P1|Overall Study|Lost to Follow-up|2
4768742|NCT01586806|16449819|P3|Overall Study|Withdrawal by Subject|0
4768743|NCT01586806|16449820|P2|Overall Study|Withdrawal by Subject|0
4768744|NCT01586806|16449821|P1|Overall Study|Withdrawal by Subject|1
4768745|NCT01586806|16449819|P3|Overall Study|Protocol Violation|0
4768746|NCT01586806|16449820|P2|Overall Study|Protocol Violation|1
4768747|NCT01586806|16449821|P1|Overall Study|Protocol Violation|0
4768748|NCT01586364|16449841|P1|Overall Study|Other-Not specified|1
4768749|NCT01586364|16449841|P1|Overall Study|Other-PI discretion, site closing|2
4768750|NCT01586364|16449841|P1|Overall Study|Other-Site closure due to PI illness|1
4768751|NCT01586364|16449841|P1|Overall Study|Other-Subject wasn't getting much relief|1
4768752|NCT01586364|16449841|P1|Overall Study|Other-Did not feel better post-treatment|1
4768753|NCT01586364|16449841|P1|Overall Study|Lack of Efficacy|1
4768754|NCT01586364|16449841|P1|Overall Study|Protocol Violation|16
4768755|NCT01586364|16449841|P1|Overall Study|Lost to Follow-up|17
4768756|NCT01586364|16449841|P1|Overall Study|Adverse Event|37
4768757|NCT01586364|16449841|P1|Overall Study|Withdrawal by Subject|40
4768758|NCT01586338|16449894|P1|Overall Study|Other|1
4768759|NCT01586338|16449894|P1|Overall Study|Withdrawal by participant|3
4768760|NCT01586338|16449894|P1|Overall Study|Lost to Follow-up|1
4768761|NCT01586338|16449894|P1|Overall Study|Adverse Event|3
4768762|NCT01586195|16449917|P1|Overall Study|Reason not specified|9
4768763|NCT01586195|16449917|P1|Overall Study|Started new anti-melanoma therapy|1
4768764|NCT01586195|16449917|P1|Overall Study|Withdrawal of Consent|5
4768765|NCT01586195|16449917|P1|Overall Study|Death|11
4768766|NCT01586156|16449931|P3|Overall Study|Pregnancy|0
4768767|NCT01586156|16449932|P2|Overall Study|Pregnancy|1
4768768|NCT01586156|16449933|P1|Overall Study|Pregnancy|0
4768769|NCT01585987|16449990|P2|Treated|Poor/Non-Compliance|1
4768770|NCT01585987|16449991|P1|Treated|Poor/Non-Compliance|0
4768771|NCT01585987|16449990|P2|Treated|Subject Request|1
4768772|NCT01585987|16449991|P1|Treated|Subject Request|0
4768773|NCT01585987|16449990|P2|Treated|Non-Specified|2
4768774|NCT01585987|16449991|P1|Treated|Non-Specified|1
4768775|NCT01585987|16449990|P2|Treated|Maximum Clinical Benefit|1
4768776|NCT01585987|16449991|P1|Treated|Maximum Clinical Benefit|0
4768777|NCT01585987|16449990|P2|Treated|Lost to Follow-up|1
4768778|NCT01585987|16449991|P1|Treated|Lost to Follow-up|0
4768779|NCT01585987|16449990|P2|Treated|Death|0
4768780|NCT01585987|16449991|P1|Treated|Death|1
4768781|NCT01585987|16449990|P2|Treated|Withdrawal by Subject|2
4768782|NCT01585987|16449991|P1|Treated|Withdrawal by Subject|1
4768783|NCT01585987|16449990|P2|Treated|Adverse Event|0
4768784|NCT01585987|16449991|P1|Treated|Adverse Event|3
4768785|NCT01585987|16449990|P2|Treated|Study Drug Toxicity|5
4768786|NCT01585987|16449991|P1|Treated|Study Drug Toxicity|9
4768787|NCT01585987|16449990|P2|Treated|Disease Progression|36
4768788|NCT01585987|16449991|P1|Treated|Disease Progression|39
4768789|NCT01585987|16449990|P2|Randomized|No longer met criteria|2
4768790|NCT01585987|16449991|P1|Randomized|No longer met criteria|0
4768791|NCT01585987|16449990|P2|Randomized|Withdrawal by Subject|4
4768792|NCT01585987|16449991|P1|Randomized|Withdrawal by Subject|0
4768793|NCT01585961|16450006|P1|Overall Study|Ablation cancelled for slow-heal wound|1
4768794|NCT01585961|16450006|P1|Overall Study|Lost to Follow-up|23
4768795|NCT01585961|16450006|P1|Overall Study|Withdrawal by Subject|1
4768796|NCT01585961|16450006|P1|Overall Study|Decision to use non-study catheter|1
4768797|NCT01585961|16450006|P1|Overall Study|Physician Decision|1
4768798|NCT01585961|16450006|P1|Overall Study|Death|6
4768799|NCT01585766|16450084|P6|Overall Study|Physician Decision|0
4768800|NCT01585766|16450085|P5|Overall Study|Physician Decision|0
4768801|NCT01585766|16450086|P4|Overall Study|Physician Decision|0
4768802|NCT01585766|16450087|P3|Overall Study|Physician Decision|1
4768803|NCT01585766|16450088|P2|Overall Study|Physician Decision|0
4768804|NCT01585766|16450089|P1|Overall Study|Physician Decision|0
4768805|NCT01585766|16450084|P6|Overall Study|Death|0
4768806|NCT01585766|16450085|P5|Overall Study|Death|0
4768807|NCT01585766|16450086|P4|Overall Study|Death|0
4768808|NCT01585766|16450087|P3|Overall Study|Death|0
4768809|NCT01585766|16450088|P2|Overall Study|Death|1
4768810|NCT01585766|16450089|P1|Overall Study|Death|0
4768811|NCT01585766|16450084|P6|Overall Study|Withdrawal by Subject|0
4768812|NCT01585766|16450085|P5|Overall Study|Withdrawal by Subject|0
4768813|NCT01585766|16450086|P4|Overall Study|Withdrawal by Subject|0
4768814|NCT01585766|16450087|P3|Overall Study|Withdrawal by Subject|1
4768815|NCT01585766|16450088|P2|Overall Study|Withdrawal by Subject|1
4768816|NCT01585766|16450089|P1|Overall Study|Withdrawal by Subject|0
4768817|NCT01585584|16450193|P1|Overall Study|Physician Decision|2
4768818|NCT01585584|16450193|P1|Overall Study|Withdrawal by Subject|1
4768819|NCT01585584|16450193|P1|Overall Study|Lack of Efficacy|1
4768820|NCT01585558|16450200|P3|Overall Study|Lack of Efficacy|1
4768821|NCT01585558|16450201|P2|Overall Study|Lack of Efficacy|0
4768822|NCT01585558|16450202|P1|Overall Study|Lack of Efficacy|0
4768823|NCT01585558|16450200|P3|Overall Study|Protocol Violation|2
4768824|NCT01585558|16450201|P2|Overall Study|Protocol Violation|3
4768825|NCT01585558|16450202|P1|Overall Study|Protocol Violation|4
4768826|NCT01585558|16450200|P3|Overall Study|Adverse Event|1
4768827|NCT01585558|16450201|P2|Overall Study|Adverse Event|4
4768828|NCT01585558|16450202|P1|Overall Study|Adverse Event|3
4768829|NCT01585558|16450200|P3|Overall Study|Lost to Follow-up|3
4768830|NCT01585558|16450201|P2|Overall Study|Lost to Follow-up|0
4768831|NCT01585558|16450202|P1|Overall Study|Lost to Follow-up|2
4768832|NCT01585558|16450200|P3|Overall Study|Withdrawal by Subject|8
4768833|NCT01585558|16450201|P2|Overall Study|Withdrawal by Subject|5
4768834|NCT01585558|16450202|P1|Overall Study|Withdrawal by Subject|4
4768835|NCT01585428|16450436|P2|Overall Study|Death during treatment|0
4768836|NCT01585428|16450437|P1|Overall Study|Death during treatment|1
4768837|NCT01585298|16450461|P1|Overall Study|Adverse Event|24
4768838|NCT01585298|16450461|P1|Overall Study|Abnormal test procedure results|1
4768839|NCT01585298|16450461|P1|Overall Study|Withdrawal by Subject|4
4768840|NCT01585298|16450461|P1|Overall Study|Lost to Follow-up|2
4768841|NCT01585298|16450461|P1|Overall Study|Administrative problems|4
4768842|NCT01585298|16450461|P1|Overall Study|Protocol deviation|1
4768843|NCT01585298|16450461|P1|Overall Study|Study completion was not documented.|1
4768844|NCT01585272|16450469|P1|Overall Study|Withdrawal by Subject|10
4768845|NCT01585272|16450469|P1|Overall Study|Protocol Violation|7
4768846|NCT01585272|16450469|P1|Overall Study|Adverse Event|22
4768847|NCT01585246|16450482|P5|Overall Study|Other|0
4768848|NCT01585246|16450483|P4|Overall Study|Other|1
4768849|NCT01585246|16450484|P3|Overall Study|Other|1
4768850|NCT01585246|16450485|P2|Overall Study|Other|1
4768851|NCT01585246|16450486|P1|Overall Study|Other|0
4768852|NCT01585246|16450482|P5|Overall Study|Withdrawal by Subject|1
4768853|NCT01585246|16450483|P4|Overall Study|Withdrawal by Subject|2
4768854|NCT01585246|16450484|P3|Overall Study|Withdrawal by Subject|1
4768855|NCT01585246|16450485|P2|Overall Study|Withdrawal by Subject|0
4768856|NCT01585246|16450486|P1|Overall Study|Withdrawal by Subject|0
4768857|NCT01585246|16450482|P5|Overall Study|Protocol Violation|1
4768858|NCT01585246|16450483|P4|Overall Study|Protocol Violation|0
4768859|NCT01585246|16450484|P3|Overall Study|Protocol Violation|0
4768860|NCT01585246|16450485|P2|Overall Study|Protocol Violation|0
4768861|NCT01585246|16450486|P1|Overall Study|Protocol Violation|0
4768862|NCT01585246|16450482|P5|Overall Study|Lost to Follow-up|0
4768863|NCT01585246|16450483|P4|Overall Study|Lost to Follow-up|1
4768864|NCT01585246|16450484|P3|Overall Study|Lost to Follow-up|2
4768865|NCT01585246|16450485|P2|Overall Study|Lost to Follow-up|0
4768866|NCT01585246|16450486|P1|Overall Study|Lost to Follow-up|0
4768867|NCT01585168|16450507|P4|Overall Study|Lost to Follow-up|1
4768868|NCT01585168|16450508|P3|Overall Study|Lost to Follow-up|1
4768869|NCT01585168|16450509|P2|Overall Study|Lost to Follow-up|1
4768870|NCT01585168|16450510|P1|Overall Study|Lost to Follow-up|3
4768871|NCT01585155|16450530|P1|Overall Study|Worsening ulcerative colitis|2
4768872|NCT01585155|16450530|P1|Overall Study|Lack of Efficacy|2
4768873|NCT01585155|16450530|P1|Overall Study|Adverse Event|1
4768874|NCT01585038|16450552|P2|Overall Study|Adverse Event|2
4768875|NCT01585038|16450553|P1|Overall Study|Adverse Event|2
4768876|NCT01585025|16450568|P3|Overall Study|Withdrawal by Subject|4
4768877|NCT01585025|16450569|P2|Overall Study|Withdrawal by Subject|3
4768878|NCT01585025|16450570|P1|Overall Study|Withdrawal by Subject|0
4768879|NCT01584843|16450600|P6|Second Treatment Period|Withdrawal by Subject|1
4768880|NCT01584843|16450601|P5|Second Treatment Period|Withdrawal by Subject|0
4768881|NCT01584843|16450602|P4|Second Treatment Period|Withdrawal by Subject|0
4768882|NCT01584843|16450603|P3|Second Treatment Period|Withdrawal by Subject|0
4768883|NCT01584843|16450604|P2|Second Treatment Period|Withdrawal by Subject|0
4768884|NCT01584843|16450605|P1|Second Treatment Period|Withdrawal by Subject|0
4768885|NCT01584843|16450600|P6|First Treatment Period|Met Protocol-defined Stopping Criteria|1
4768886|NCT01584843|16450601|P5|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4768887|NCT01584843|16450602|P4|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4768888|NCT01584843|16450603|P3|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4768889|NCT01584843|16450604|P2|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4768890|NCT01584843|16450605|P1|First Treatment Period|Met Protocol-defined Stopping Criteria|0
4768891|NCT01584843|16450600|P6|First Treatment Period|Protocol Violation|1
4768892|NCT01584843|16450601|P5|First Treatment Period|Protocol Violation|0
4768893|NCT01584843|16450602|P4|First Treatment Period|Protocol Violation|0
4768894|NCT01584843|16450603|P3|First Treatment Period|Protocol Violation|0
4768895|NCT01584843|16450604|P2|First Treatment Period|Protocol Violation|0
4768896|NCT01584843|16450605|P1|First Treatment Period|Protocol Violation|0
4768897|NCT01584843|16450600|P6|First Treatment Period|Adverse Event|0
4768898|NCT01584843|16450601|P5|First Treatment Period|Adverse Event|0
4768899|NCT01584843|16450602|P4|First Treatment Period|Adverse Event|0
4768900|NCT01584843|16450603|P3|First Treatment Period|Adverse Event|1
4768901|NCT01584843|16450604|P2|First Treatment Period|Adverse Event|0
4768902|NCT01584843|16450605|P1|First Treatment Period|Adverse Event|0
4768903|NCT01584648|16450716|P2|Overall Study|Ongoing|147
4768904|NCT01584648|16450717|P1|Overall Study|Ongoing|154
4768905|NCT01584648|16450716|P2|Overall Study|Death|55
4768906|NCT01584648|16450717|P1|Overall Study|Death|40
4768907|NCT01584648|16450716|P2|Overall Study|Withdrawal by Subject|5
4768908|NCT01584648|16450717|P1|Overall Study|Withdrawal by Subject|11
4768909|NCT01584648|16450716|P2|Overall Study|Physician Decision|2
4768910|NCT01584648|16450717|P1|Overall Study|Physician Decision|2
4768911|NCT01584648|16450716|P2|Overall Study|Lost to Follow-up|3
4768912|NCT01584648|16450717|P1|Overall Study|Lost to Follow-up|4
4768913|NCT01584232|16450845|P2|Overall Study|Lost to Follow-up|0
4768914|NCT01584232|16450846|P1|Overall Study|Lost to Follow-up|1
4768915|NCT01584232|16450845|P2|Overall Study|Physician Decision|1
4768916|NCT01584232|16450846|P1|Overall Study|Physician Decision|2
4768917|NCT01584232|16450845|P2|Overall Study|Withdrawal by Subject|1
4768918|NCT01584232|16450846|P1|Overall Study|Withdrawal by Subject|2
4768919|NCT01584232|16450845|P2|Overall Study|Adverse Event|1
4768920|NCT01584232|16450846|P1|Overall Study|Adverse Event|3
4768921|NCT01584024|16450862|P1|Overall Study|Withdrawal by Subject|3
4768922|NCT01584024|16450862|P1|Overall Study|Lost to Follow-up|10
4768923|NCT01583530|16450959|P6|Overall Study|Lack of compliance|0
4768924|NCT01583530|16450960|P5|Overall Study|Lack of compliance|1
4768925|NCT01583530|16450961|P4|Overall Study|Lack of compliance|0
4768926|NCT01583530|16450962|P3|Overall Study|Lack of compliance|0
4768927|NCT01583530|16450963|P2|Overall Study|Lack of compliance|0
4768928|NCT01583530|16450964|P1|Overall Study|Lack of compliance|0
4768929|NCT01583530|16450959|P6|Overall Study|Lost to Follow-up|0
4768930|NCT01583530|16450960|P5|Overall Study|Lost to Follow-up|3
4768931|NCT01583530|16450961|P4|Overall Study|Lost to Follow-up|0
4768932|NCT01583530|16450962|P3|Overall Study|Lost to Follow-up|0
4768933|NCT01583530|16450963|P2|Overall Study|Lost to Follow-up|0
4768934|NCT01583530|16450964|P1|Overall Study|Lost to Follow-up|0
4768935|NCT01583530|16450959|P6|Overall Study|Withdrawal by Subject|2
4768936|NCT01583530|16450960|P5|Overall Study|Withdrawal by Subject|1
4768937|NCT01583530|16450961|P4|Overall Study|Withdrawal by Subject|1
4768938|NCT01583530|16450962|P3|Overall Study|Withdrawal by Subject|0
4768939|NCT01583530|16450963|P2|Overall Study|Withdrawal by Subject|3
4768940|NCT01583530|16450964|P1|Overall Study|Withdrawal by Subject|0
4768941|NCT01583530|16450959|P6|Overall Study|Adverse Event|1
4768942|NCT01583530|16450960|P5|Overall Study|Adverse Event|0
4768943|NCT01583530|16450961|P4|Overall Study|Adverse Event|0
4768944|NCT01583530|16450962|P3|Overall Study|Adverse Event|0
4768945|NCT01583530|16450963|P2|Overall Study|Adverse Event|0
4768946|NCT01583530|16450964|P1|Overall Study|Adverse Event|0
4768947|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
4768948|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
4768949|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
4768950|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
4768951|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
4768952|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2
4768953|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1
4768954|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5
4768955|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0
4768956|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4768957|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4768958|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4768959|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4768960|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4768961|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4768962|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4768963|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1
4768964|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0
4768965|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Death|0
4768966|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Death|0
4768967|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Death|1
4768968|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Death|0
4768969|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Death|1
4768970|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Death|0
4768971|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Death|0
4768972|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Death|0
4768973|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Death|0
4768974|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
4768975|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3
4768976|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5
4768977|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7
4768978|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12
4768979|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1
4768980|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
4768981|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11
4768982|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0
4768983|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
4768984|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
4768985|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4768986|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4768987|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1
4768988|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4768989|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4768990|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4768991|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0
4768992|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
4768993|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2
4768994|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
4768995|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
4768996|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10
4768997|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7
4768998|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6
4768999|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4
4769000|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0
4769001|NCT01583374|16451026|P9|Long-Term Extension Phase Weeks 52-260|Adverse Event|1
4769002|NCT01583374|16451027|P8|Long-Term Extension Phase Weeks 52-260|Adverse Event|3
4769003|NCT01583374|16451028|P7|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4769004|NCT01583374|16451029|P6|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4769005|NCT01583374|16451030|P5|Long-Term Extension Phase Weeks 52-260|Adverse Event|6
4769006|NCT01583374|16451031|P4|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4769007|NCT01583374|16451032|P3|Long-Term Extension Phase Weeks 52-260|Adverse Event|2
4769008|NCT01583374|16451033|P2|Long-Term Extension Phase Weeks 52-260|Adverse Event|5
4769009|NCT01583374|16451034|P1|Long-Term Extension Phase Weeks 52-260|Adverse Event|0
4769010|NCT01583374|16451026|P9|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4769011|NCT01583374|16451027|P8|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4769012|NCT01583374|16451028|P7|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4769013|NCT01583374|16451029|P6|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2
4769014|NCT01583374|16451030|P5|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
4769015|NCT01583374|16451031|P4|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4769016|NCT01583374|16451032|P3|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
4769017|NCT01583374|16451033|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4769018|NCT01583374|16451034|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4769019|NCT01583374|16451026|P9|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4769020|NCT01583374|16451027|P8|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4769021|NCT01583374|16451028|P7|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4769022|NCT01583374|16451029|P6|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4769023|NCT01583374|16451030|P5|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
4769024|NCT01583374|16451031|P4|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4769025|NCT01583374|16451032|P3|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1
4769026|NCT01583374|16451033|P2|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2
4769027|NCT01583374|16451034|P1|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0
4769028|NCT01583374|16451026|P9|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
4769029|NCT01583374|16451027|P8|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
4769030|NCT01583374|16451028|P7|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5
4769031|NCT01583374|16451029|P6|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
4769032|NCT01583374|16451030|P5|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3
4769033|NCT01583374|16451031|P4|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6
4769034|NCT01583374|16451032|P3|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
4769035|NCT01583374|16451033|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2
4769036|NCT01583374|16451034|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
4769037|NCT01583374|16451026|P9|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4769038|NCT01583374|16451027|P8|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4769039|NCT01583374|16451028|P7|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4769040|NCT01583374|16451029|P6|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4769041|NCT01583374|16451030|P5|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4769042|NCT01583374|16451031|P4|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4769043|NCT01583374|16451032|P3|Extension Phase (Weeks 24 to 52)|Adverse Event|2
4769044|NCT01583374|16451033|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4769045|NCT01583374|16451034|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|0
4769046|NCT01583374|16451026|P9|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769047|NCT01583374|16451027|P8|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
4769048|NCT01583374|16451028|P7|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769049|NCT01583374|16451029|P6|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769050|NCT01583374|16451030|P5|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769051|NCT01583374|16451031|P4|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769052|NCT01583374|16451032|P3|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769053|NCT01583374|16451033|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769054|NCT01583374|16451034|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4769055|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Other|0
4769056|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Other|0
4769057|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Other|0
4769058|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Other|0
4769059|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Other|0
4769060|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Other|0
4769061|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Other|0
4769062|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Other|1
4769063|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Other|0
4769064|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769065|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769066|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769067|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769068|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769069|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769070|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3
4769071|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769072|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4769073|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769074|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769075|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769076|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769077|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769078|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769079|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0
4769080|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2
4769081|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1
4769082|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4769083|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4769084|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4769085|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4769086|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4769087|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4769088|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
4769089|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
4769090|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8
4769091|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769092|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769093|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769094|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769095|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769096|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769097|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4769098|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
4769099|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
4769100|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4769101|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4769102|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4769103|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4769104|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4769105|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4769106|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
4769107|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2
4769108|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3
4769109|NCT01583374|16451026|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4769110|NCT01583374|16451027|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4769111|NCT01583374|16451028|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4769112|NCT01583374|16451029|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4769113|NCT01583374|16451030|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4769114|NCT01583374|16451031|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4769115|NCT01583374|16451032|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|12
4769116|NCT01583374|16451033|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|7
4769117|NCT01583374|16451034|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|6
4769118|NCT01583218|16451076|P2|Overall Study|Withdraw of consent on day of random|0
4769119|NCT01583218|16451077|P1|Overall Study|Withdraw of consent on day of random|1
4769120|NCT01583218|16451076|P2|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1
4769121|NCT01583218|16451077|P1|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0
4769122|NCT01583218|16451076|P2|Overall Study|Patient was randomized due to mistake|0
4769123|NCT01583218|16451077|P1|Overall Study|Patient was randomized due to mistake|1
4769124|NCT01583218|16451076|P2|Overall Study|Patient was early terminated from study|1
4769125|NCT01583218|16451077|P1|Overall Study|Patient was early terminated from study|0
4769126|NCT01583218|16451076|P2|Overall Study|Patient deemed ineligible after random|0
4769127|NCT01583218|16451077|P1|Overall Study|Patient deemed ineligible after random|2
4769128|NCT01583218|16451076|P2|Overall Study|Patient was assessed via phone in person|0
4769129|NCT01583218|16451077|P1|Overall Study|Patient was assessed via phone in person|1
4769130|NCT01583218|16451076|P2|Overall Study|Patient randomized but not dosed|16
4769131|NCT01583218|16451077|P1|Overall Study|Patient randomized but not dosed|17
4769132|NCT01583218|16451076|P2|Overall Study|Patient did not wish to attend visits|1
4769133|NCT01583218|16451077|P1|Overall Study|Patient did not wish to attend visits|0
4769134|NCT01583218|16451076|P2|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2
4769135|NCT01583218|16451077|P1|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0
4769136|NCT01583218|16451076|P2|Overall Study|Cannot contact patient directly|2
4769137|NCT01583218|16451077|P1|Overall Study|Cannot contact patient directly|1
4769138|NCT01583218|16451076|P2|Overall Study|Patient /Family decision|0
4769139|NCT01583218|16451077|P1|Overall Study|Patient /Family decision|3
4769140|NCT01583218|16451076|P2|Overall Study|Adverse event or serious adverse event|3
4769141|NCT01583218|16451077|P1|Overall Study|Adverse event or serious adverse event|3
4769142|NCT01583218|16451076|P2|Overall Study|Lost to Follow-up|17
4769143|NCT01583218|16451077|P1|Overall Study|Lost to Follow-up|11
4769144|NCT01583218|16451076|P2|Overall Study|Death|211
4769145|NCT01583218|16451077|P1|Overall Study|Death|206
4769146|NCT01583218|16451076|P2|Overall Study|Withdrawal by Subject|29
4769147|NCT01583218|16451077|P1|Overall Study|Withdrawal by Subject|43
4769148|NCT01583179|16451097|P2|Overall Study|Screen failure|2
4769149|NCT01583179|16451098|P1|Overall Study|Screen failure|1
4769150|NCT01583166|16451108|P2|Overall Study|Withdrawal by Subject|6
4769151|NCT01583166|16451109|P1|Overall Study|Withdrawal by Subject|4
4769152|NCT01582971|16451132|P2|Overall Study|Other|13
4769153|NCT01582971|16451133|P1|Overall Study|Other|15
4769154|NCT01582971|16451132|P2|Overall Study|Withdrawal by Subject|2
4769155|NCT01582971|16451133|P1|Overall Study|Withdrawal by Subject|4
4769156|NCT01582971|16451132|P2|Overall Study|Lost to Follow-up|21
4769157|NCT01582971|16451133|P1|Overall Study|Lost to Follow-up|18
4769158|NCT01582971|16451132|P2|Overall Study|Death|1
4769159|NCT01582971|16451133|P1|Overall Study|Death|2
4769160|NCT01582945|16451151|P1|Overall Study|Scheduling conflicts|1
4769161|NCT01582945|16451151|P1|Overall Study|Intolerable side-effects|1
4769162|NCT01582854|16451165|P2|Overall Study|Other Miscellaneous Reason|0
4769163|NCT01582854|16451166|P1|Overall Study|Other Miscellaneous Reason|1
4769164|NCT01582854|16451165|P2|Overall Study|General Anaesthesia|1
4769165|NCT01582854|16451166|P1|Overall Study|General Anaesthesia|0
4769166|NCT01582854|16451165|P2|Overall Study|Carotid or Neurosurgery|1
4769167|NCT01582854|16451166|P1|Overall Study|Carotid or Neurosurgery|0
4769168|NCT01582854|16451165|P2|Overall Study|Disallowed Concomitant Medication|2
4769169|NCT01582854|16451166|P1|Overall Study|Disallowed Concomitant Medication|3
4769170|NCT01582854|16451165|P2|Overall Study|Recurrent Stroke|8
4769171|NCT01582854|16451166|P1|Overall Study|Recurrent Stroke|13
4769172|NCT01582854|16451165|P2|Overall Study|Physician Decision|1
4769173|NCT01582854|16451166|P1|Overall Study|Physician Decision|0
4769174|NCT01582854|16451165|P2|Overall Study|Lost to Follow-up|2
4769175|NCT01582854|16451166|P1|Overall Study|Lost to Follow-up|1
4769176|NCT01582854|16451165|P2|Overall Study|Withdrawal by Participant|11
4769177|NCT01582854|16451166|P1|Overall Study|Withdrawal by Participant|8
4769178|NCT01582854|16451165|P2|Overall Study|Adverse Event|3
4769179|NCT01582854|16451166|P1|Overall Study|Adverse Event|2
4769180|NCT01582854|16451165|P2|Overall Study|Death|5
4769181|NCT01582854|16451166|P1|Overall Study|Death|8
4769182|NCT01582789|16451194|P2|Second Intervention (14 Days)|Withdrawal by Subject|0
4769183|NCT01582789|16451195|P1|Second Intervention (14 Days)|Withdrawal by Subject|1
4769184|NCT01582451|16451255|P2|Overall Study|Sponsor Decision|0
4769185|NCT01582451|16451256|P1|Overall Study|Sponsor Decision|1
4769186|NCT01582451|16451255|P2|Overall Study|Physician Decision|0
4769187|NCT01582451|16451256|P1|Overall Study|Physician Decision|3
4769188|NCT01582451|16451255|P2|Overall Study|Withdrawal by Subject|9
4769189|NCT01582451|16451256|P1|Overall Study|Withdrawal by Subject|13
4769190|NCT01582451|16451255|P2|Overall Study|Protocol Violation|3
4769191|NCT01582451|16451256|P1|Overall Study|Protocol Violation|11
4769192|NCT01582451|16451255|P2|Overall Study|Lost to Follow-up|2
4769193|NCT01582451|16451256|P1|Overall Study|Lost to Follow-up|0
4769194|NCT01582451|16451255|P2|Overall Study|Death|3
4769195|NCT01582451|16451256|P1|Overall Study|Death|3
4769196|NCT01582451|16451255|P2|Overall Study|Adverse Event|3
4769197|NCT01582451|16451256|P1|Overall Study|Adverse Event|1
4769198|NCT01582308|16451298|P10|Period 4|Physician Decision|1
4769199|NCT01582308|16451299|P9|Period 4|Physician Decision|0
4769200|NCT01582308|16451300|P8|Period 4|Physician Decision|0
4769201|NCT01582308|16451301|P7|Period 4|Physician Decision|0
4769202|NCT01582308|16451302|P6|Period 4|Physician Decision|1
4769203|NCT01582308|16451303|P5|Period 4|Physician Decision|0
4769204|NCT01582308|16451304|P4|Period 4|Physician Decision|0
4769205|NCT01582308|16451305|P3|Period 4|Physician Decision|0
4769206|NCT01582308|16451306|P2|Period 4|Physician Decision|0
4769207|NCT01582308|16451307|P1|Period 4|Physician Decision|1
4769208|NCT01582308|16451298|P10|10-day Washout Following Period 1|Physician Decision|0
4769209|NCT01582308|16451299|P9|10-day Washout Following Period 1|Physician Decision|0
4769210|NCT01582308|16451300|P8|10-day Washout Following Period 1|Physician Decision|0
4769211|NCT01582308|16451301|P7|10-day Washout Following Period 1|Physician Decision|0
4769212|NCT01582308|16451302|P6|10-day Washout Following Period 1|Physician Decision|0
4769213|NCT01582308|16451303|P5|10-day Washout Following Period 1|Physician Decision|1
4769214|NCT01582308|16451304|P4|10-day Washout Following Period 1|Physician Decision|0
4769215|NCT01582308|16451305|P3|10-day Washout Following Period 1|Physician Decision|0
4769216|NCT01582308|16451306|P2|10-day Washout Following Period 1|Physician Decision|0
4769217|NCT01582308|16451307|P1|10-day Washout Following Period 1|Physician Decision|0
4769218|NCT01582308|16451298|P10|Period 1|Withdrawal by Subject|0
4769219|NCT01582308|16451299|P9|Period 1|Withdrawal by Subject|0
4769220|NCT01582308|16451300|P8|Period 1|Withdrawal by Subject|0
4769221|NCT01582308|16451301|P7|Period 1|Withdrawal by Subject|1
4769222|NCT01582308|16451302|P6|Period 1|Withdrawal by Subject|0
4769223|NCT01582308|16451303|P5|Period 1|Withdrawal by Subject|0
4769224|NCT01582308|16451304|P4|Period 1|Withdrawal by Subject|0
4769225|NCT01582308|16451305|P3|Period 1|Withdrawal by Subject|0
4769226|NCT01582308|16451306|P2|Period 1|Withdrawal by Subject|0
4769227|NCT01582308|16451307|P1|Period 1|Withdrawal by Subject|0
4769228|NCT01582282|16451335|P3|Overall Study|fasting blood glucose outside Protocol|0
4769229|NCT01582282|16451336|P2|Overall Study|fasting blood glucose outside Protocol|1
4769230|NCT01582282|16451337|P1|Overall Study|fasting blood glucose outside Protocol|0
4769231|NCT01582282|16451335|P3|Overall Study|Lost to Follow-up|0
4769232|NCT01582282|16451336|P2|Overall Study|Lost to Follow-up|0
4769233|NCT01582282|16451337|P1|Overall Study|Lost to Follow-up|1
4769234|NCT01582282|16451335|P3|Overall Study|Adverse Event|0
4769235|NCT01582282|16451336|P2|Overall Study|Adverse Event|1
4769236|NCT01582282|16451337|P1|Overall Study|Adverse Event|1
4769237|NCT01582243|16451360|P1|Overall Study|Lost to Follow-up|1
4769238|NCT01582243|16451360|P1|Overall Study|Adverse Event|1
4769239|NCT01582243|16451360|P1|Overall Study|Withdrawal by Subject|1
4769240|NCT01582178|16451371|P2|Overall Study|Physician Decision|5
4769241|NCT01582178|16451372|P1|Overall Study|Physician Decision|6
4769242|NCT01582152|16451380|P2|Overall Study|Adverse Event|1
4769243|NCT01582152|16451381|P1|Overall Study|Adverse Event|2
4769244|NCT01582152|16451380|P2|Overall Study|Disease Progression|5
4769245|NCT01582152|16451381|P1|Overall Study|Disease Progression|4
4769246|NCT01582100|16451404|P1|Overall Study|Withdrawal by Subject|1
4769247|NCT01582100|16451404|P1|Overall Study|Adverse Event|1
4769248|NCT01582061|16451410|P2|Overall Study|Lost to Follow-up|0
4769249|NCT01582061|16451411|P1|Overall Study|Lost to Follow-up|1
4769250|NCT01582061|16451410|P2|Overall Study|condition no longer requires study drug|0
4769251|NCT01582061|16451411|P1|Overall Study|condition no longer requires study drug|1
4769252|NCT01582061|16451410|P2|Overall Study|Death|1
4769253|NCT01582061|16451411|P1|Overall Study|Death|0
4769254|NCT01582061|16451410|P2|Overall Study|Abnormal laboratory value(s)|0
4769255|NCT01582061|16451411|P1|Overall Study|Abnormal laboratory value(s)|1
4769256|NCT01582061|16451410|P2|Overall Study|Withdrawal by Subject|4
4769257|NCT01582061|16451411|P1|Overall Study|Withdrawal by Subject|10
4769258|NCT01582061|16451410|P2|Overall Study|Adverse Event|8
4769259|NCT01582061|16451411|P1|Overall Study|Adverse Event|12
4769260|NCT01582061|16451410|P2|Overall Study|Lack of Efficacy|23
4769261|NCT01582061|16451411|P1|Overall Study|Lack of Efficacy|3
4769262|NCT01582009|16451461|P1|Overall Study|Physician Decision|1
4769263|NCT01582009|16451461|P1|Overall Study|Withdrawal by Subject|1
4769264|NCT01581931|16451478|P2|Washout|Adverse Event|1
4769265|NCT01581931|16451479|P1|Washout|Adverse Event|0
4769266|NCT01581684|16451532|P10|Overall Study|Other reason not defined|0
4769267|NCT01581684|16451533|P9|Overall Study|Other reason not defined|1
4769268|NCT01581684|16451534|P8|Overall Study|Other reason not defined|0
4769269|NCT01581684|16451535|P7|Overall Study|Other reason not defined|0
4769270|NCT01581684|16451536|P6|Overall Study|Other reason not defined|0
4769271|NCT01581684|16451537|P5|Overall Study|Other reason not defined|0
4769272|NCT01581684|16451538|P4|Overall Study|Other reason not defined|0
4769273|NCT01581684|16451539|P3|Overall Study|Other reason not defined|0
4769274|NCT01581684|16451540|P2|Overall Study|Other reason not defined|0
4769275|NCT01581684|16451541|P1|Overall Study|Other reason not defined|0
4769276|NCT01581619|16451637|P1|Overall Study|Lost to Follow-up|1
4769277|NCT01581619|16451637|P1|Overall Study|Withdrawal by Subject|1
4769278|NCT01581307|16451790|P1|Overall Study|Withdrawal by Subject|1
4769279|NCT01581281|16451799|P3|Overall Study|Early Study Closure|12
4769280|NCT01581281|16451800|P2|Overall Study|Early Study Closure|6
4769281|NCT01581281|16451801|P1|Overall Study|Early Study Closure|15
4769282|NCT01581021|16451823|P2|Overall Study|Lack of Efficacy|1
4769283|NCT01581021|16451824|P1|Overall Study|Lack of Efficacy|0
4769284|NCT01581021|16451823|P2|Overall Study|Lenke 6 Classification|1
4769285|NCT01581021|16451824|P1|Overall Study|Lenke 6 Classification|0
4769286|NCT01581021|16451823|P2|Overall Study|Not Randomized|2
4769287|NCT01581021|16451824|P1|Overall Study|Not Randomized|1
4769288|NCT01581021|16451823|P2|Overall Study|Neuromuscular|1
4769289|NCT01581021|16451824|P1|Overall Study|Neuromuscular|2
4769290|NCT01581021|16451823|P2|Overall Study|More than 2 hooks in thoracic|0
4769291|NCT01581021|16451824|P1|Overall Study|More than 2 hooks in thoracic|3
4769292|NCT01581021|16451823|P2|Overall Study|Lost to Follow-up|6
4769293|NCT01581021|16451824|P1|Overall Study|Lost to Follow-up|4
4769294|NCT01580995|16451851|P2|Overall Study|Lost to Follow-up|2
4769295|NCT01580995|16451852|P1|Overall Study|Lost to Follow-up|2
4769296|NCT01580969|16451861|P3|Overall Study|Physician Decision|0
4769297|NCT01580969|16451862|P2|Overall Study|Physician Decision|0
4769298|NCT01580969|16451863|P1|Overall Study|Physician Decision|3
4769299|NCT01580670|16451910|P1|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1
4769300|NCT01580670|16451910|P1|Maintenance Period (Week 14 to 54)|Adverse Event|1
4769301|NCT01580488|16451951|P1|Overall Study|Withdrawal by Subject|1
4769302|NCT01580293|16452057|P3|Part B|Part B ongoing|1
4769303|NCT01580293|16452058|P2|Part B|Part B ongoing|0
4769304|NCT01580293|16452059|P1|Part B|Part B ongoing|0
4769305|NCT01580293|16452057|P3|Part B|Other reason|1
4769306|NCT01580293|16452058|P2|Part B|Other reason|0
4769307|NCT01580293|16452059|P1|Part B|Other reason|0
4769308|NCT01580293|16452057|P3|Part B|Withdrawal by Subject|1
4769309|NCT01580293|16452058|P2|Part B|Withdrawal by Subject|0
4769310|NCT01580293|16452059|P1|Part B|Withdrawal by Subject|0
4769311|NCT01580293|16452057|P3|Part A_Extension|Extension ongoing|0
4769312|NCT01580293|16452058|P2|Part A_Extension|Extension ongoing|69
4769313|NCT01580293|16452059|P1|Part A_Extension|Extension ongoing|9
4769314|NCT01580293|16452057|P3|Part A_Extension|Other Reason|0
4769315|NCT01580293|16452058|P2|Part A_Extension|Other Reason|1
4769316|NCT01580293|16452059|P1|Part A_Extension|Other Reason|0
4769317|NCT01580293|16452057|P3|Part A_Extension|Lost to Follow-up|0
4769318|NCT01580293|16452058|P2|Part A_Extension|Lost to Follow-up|1
4769319|NCT01580293|16452059|P1|Part A_Extension|Lost to Follow-up|0
4769320|NCT01580293|16452057|P3|Part A_Extension|Withdrawal by Subject|0
4769321|NCT01580293|16452058|P2|Part A_Extension|Withdrawal by Subject|2
4769322|NCT01580293|16452059|P1|Part A_Extension|Withdrawal by Subject|0
4769323|NCT01580293|16452057|P3|Part A_Extension|Adverse Event|0
4769324|NCT01580293|16452058|P2|Part A_Extension|Adverse Event|2
4769325|NCT01580293|16452059|P1|Part A_Extension|Adverse Event|0
4769326|NCT01580293|16452057|P3|Part A_Main Trial|Non-adherence to the protocol|0
4769327|NCT01580293|16452058|P2|Part A_Main Trial|Non-adherence to the protocol|0
4769328|NCT01580293|16452059|P1|Part A_Main Trial|Non-adherence to the protocol|1
4769329|NCT01580293|16452057|P3|Part A_Main Trial|Withdrawal by Subject|0
4769330|NCT01580293|16452058|P2|Part A_Main Trial|Withdrawal by Subject|4
4769331|NCT01580293|16452059|P1|Part A_Main Trial|Withdrawal by Subject|1
4769332|NCT01580293|16452057|P3|Part A_Main Trial|Adverse Event|0
4769333|NCT01580293|16452058|P2|Part A_Main Trial|Adverse Event|2
4769334|NCT01580293|16452059|P1|Part A_Main Trial|Adverse Event|0
4769335|NCT01580020|16452199|P4|Overall Study|Lost to Follow-up|0
4769336|NCT01580020|16452200|P3|Overall Study|Lost to Follow-up|1
4769337|NCT01580020|16452201|P2|Overall Study|Lost to Follow-up|0
4769338|NCT01580020|16452202|P1|Overall Study|Lost to Follow-up|0
4769339|NCT01580020|16452199|P4|Overall Study|Administrative Problems|0
4769340|NCT01580020|16452200|P3|Overall Study|Administrative Problems|1
4769341|NCT01580020|16452201|P2|Overall Study|Administrative Problems|0
4769342|NCT01580020|16452202|P1|Overall Study|Administrative Problems|0
4769343|NCT01580020|16452199|P4|Overall Study|Adverse Event|1
4769344|NCT01580020|16452200|P3|Overall Study|Adverse Event|1
4769345|NCT01580020|16452201|P2|Overall Study|Adverse Event|1
4769346|NCT01580020|16452202|P1|Overall Study|Adverse Event|1
4769347|NCT01580020|16452199|P4|Overall Study|Withdrawal by Subject|0
4769348|NCT01580020|16452200|P3|Overall Study|Withdrawal by Subject|1
4769349|NCT01580020|16452201|P2|Overall Study|Withdrawal by Subject|1
4769350|NCT01580020|16452202|P1|Overall Study|Withdrawal by Subject|0
4769351|NCT01580020|16452199|P4|Overall Study|Lack of Efficacy|1
4769352|NCT01580020|16452200|P3|Overall Study|Lack of Efficacy|0
4769353|NCT01580020|16452201|P2|Overall Study|Lack of Efficacy|5
4769354|NCT01580020|16452202|P1|Overall Study|Lack of Efficacy|0
4769355|NCT01579916|16452246|P2|Overall Study|Death|0
4769356|NCT01579916|16452247|P1|Overall Study|Death|1
4769357|NCT01579916|16452246|P2|Overall Study|Withdrawal by Subject|1
4769358|NCT01579916|16452247|P1|Overall Study|Withdrawal by Subject|1
4769359|NCT01579916|16452246|P2|Overall Study|Lost to Follow-up|1
4769360|NCT01579916|16452247|P1|Overall Study|Lost to Follow-up|6
4769361|NCT01579812|16452273|P1|Overall Study|Withdrawal by Subject|6
4769362|NCT01579812|16452273|P1|Overall Study|Noncompliance|3
4769363|NCT01579812|16452273|P1|Overall Study|Patient choice|3
4769364|NCT01579812|16452273|P1|Overall Study|Ineligible after treatment start|40
4769365|NCT01579578|16452307|P2|Overall Study|Ongoing|0
4769366|NCT01579578|16452308|P1|Overall Study|Ongoing|3
4769367|NCT01579578|16452307|P2|Overall Study|Eligibility criteria|9
4769368|NCT01579578|16452308|P1|Overall Study|Eligibility criteria|3
4769369|NCT01579578|16452307|P2|Overall Study|Withdrawal by Subject|1
4769370|NCT01579578|16452308|P1|Overall Study|Withdrawal by Subject|2
4769371|NCT01579578|16452307|P2|Overall Study|Lost to Follow-up|1
4769372|NCT01579578|16452308|P1|Overall Study|Lost to Follow-up|1
4769373|NCT01579578|16452307|P2|Overall Study|Death|1
4769374|NCT01579578|16452308|P1|Overall Study|Death|4
4769375|NCT01579565|16452320|P2|Treated|declined to return for final visit|1
4769376|NCT01579565|16452321|P1|Treated|declined to return for final visit|0
4769377|NCT01579565|16452320|P2|Treated|Lost to Follow-up|1
4769378|NCT01579565|16452321|P1|Treated|Lost to Follow-up|2
4769379|NCT01579565|16452320|P2|Treated|Physician Decision|1
4769380|NCT01579565|16452321|P1|Treated|Physician Decision|0
4769381|NCT01579565|16452320|P2|Randomized|prohibited preoperative medication|1
4769382|NCT01579565|16452321|P1|Randomized|prohibited preoperative medication|0
4769383|NCT01579565|16452320|P2|Randomized|prohibited preoperative eating|0
4769384|NCT01579565|16452321|P1|Randomized|prohibited preoperative eating|1
4769385|NCT01579565|16452320|P2|Randomized|inadequate preoperative pupil dilation|1
4769386|NCT01579565|16452321|P1|Randomized|inadequate preoperative pupil dilation|0
4769387|NCT01579565|16452320|P2|Randomized|Withdrawal by Subject|0
4769388|NCT01579565|16452321|P1|Randomized|Withdrawal by Subject|3
4769389|NCT01579565|16452320|P2|Randomized|Adverse Event|3
4769390|NCT01579565|16452321|P1|Randomized|Adverse Event|1
4769391|NCT01579474|16452372|P6|Overall Study|Withdrawal by Subject|0
4769392|NCT01579474|16452373|P5|Overall Study|Withdrawal by Subject|0
4769393|NCT01579474|16452374|P4|Overall Study|Withdrawal by Subject|0
4769394|NCT01579474|16452375|P3|Overall Study|Withdrawal by Subject|0
4769395|NCT01579474|16452376|P2|Overall Study|Withdrawal by Subject|0
4769396|NCT01579474|16452377|P1|Overall Study|Withdrawal by Subject|1
4769397|NCT01579474|16452372|P6|Overall Study|Lack of Efficacy|0
4769398|NCT01579474|16452373|P5|Overall Study|Lack of Efficacy|1
4769399|NCT01579474|16452374|P4|Overall Study|Lack of Efficacy|0
4769400|NCT01579474|16452375|P3|Overall Study|Lack of Efficacy|0
4769401|NCT01579474|16452376|P2|Overall Study|Lack of Efficacy|0
4769402|NCT01579474|16452377|P1|Overall Study|Lack of Efficacy|1
4769403|NCT01579474|16452372|P6|Overall Study|Adverse Event|1
4769404|NCT01579474|16452373|P5|Overall Study|Adverse Event|0
4769405|NCT01579474|16452374|P4|Overall Study|Adverse Event|0
4769406|NCT01579474|16452375|P3|Overall Study|Adverse Event|2
4769407|NCT01579474|16452376|P2|Overall Study|Adverse Event|13
4769408|NCT01579474|16452377|P1|Overall Study|Adverse Event|1
4769409|NCT01579318|16452451|P1|Overall Study|Disease Progression|1
4769410|NCT01579006|16452546|P1|Overall Study|Scheduled surgery|1
4769411|NCT01579006|16452546|P1|Overall Study|Due to participant's health fund|1
4769412|NCT01579006|16452546|P1|Overall Study|Non-compliance|3
4769413|NCT01579006|16452546|P1|Overall Study|Withdrawal by Subject|5
4769414|NCT01579006|16452546|P1|Overall Study|Adverse Event|13
4769415|NCT01579006|16452546|P1|Overall Study|Lack of Efficacy|10
4769416|NCT01578850|16452605|P3|Period 2|Unspecified Reasons|0
4769417|NCT01578850|16452606|P2|Period 2|Unspecified Reasons|1
4769418|NCT01578850|16452607|P1|Period 2|Unspecified Reasons|0
4769419|NCT01578850|16452605|P3|Period 2|Study Terminated by Sponsor|4
4769420|NCT01578850|16452606|P2|Period 2|Study Terminated by Sponsor|5
4769421|NCT01578850|16452607|P1|Period 2|Study Terminated by Sponsor|0
4769422|NCT01578850|16452605|P3|Period 2|Withdrawal by Subject|2
4769423|NCT01578850|16452606|P2|Period 2|Withdrawal by Subject|2
4769424|NCT01578850|16452607|P1|Period 2|Withdrawal by Subject|0
4769425|NCT01578850|16452605|P3|Period 2|Lost to Follow-up|2
4769426|NCT01578850|16452606|P2|Period 2|Lost to Follow-up|1
4769427|NCT01578850|16452607|P1|Period 2|Lost to Follow-up|0
4769428|NCT01578850|16452605|P3|Period 2|Adverse Event|6
4769429|NCT01578850|16452606|P2|Period 2|Adverse Event|3
4769430|NCT01578850|16452607|P1|Period 2|Adverse Event|0
4769431|NCT01578850|16452605|P3|Period 2|Insufficient Clinical Response|0
4769432|NCT01578850|16452606|P2|Period 2|Insufficient Clinical Response|1
4769433|NCT01578850|16452607|P1|Period 2|Insufficient Clinical Response|0
4769434|NCT01578850|16452605|P3|Period 1|Study Terminated by Sponsor|0
4769435|NCT01578850|16452606|P2|Period 1|Study Terminated by Sponsor|0
4769436|NCT01578850|16452607|P1|Period 1|Study Terminated by Sponsor|3
4769437|NCT01578850|16452605|P3|Period 1|Withdrawal by Subject|0
4769438|NCT01578850|16452606|P2|Period 1|Withdrawal by Subject|0
4769439|NCT01578850|16452607|P1|Period 1|Withdrawal by Subject|9
4769440|NCT01578850|16452605|P3|Period 1|Does Not Meet Entrance Criteria|0
4769441|NCT01578850|16452606|P2|Period 1|Does Not Meet Entrance Criteria|0
4769442|NCT01578850|16452607|P1|Period 1|Does Not Meet Entrance Criteria|12
4769443|NCT01578850|16452605|P3|Period 1|Death|0
4769444|NCT01578850|16452606|P2|Period 1|Death|0
4769445|NCT01578850|16452607|P1|Period 1|Death|1
4769446|NCT01578850|16452605|P3|Period 1|Adverse Event|0
4769447|NCT01578850|16452606|P2|Period 1|Adverse Event|0
4769448|NCT01578850|16452607|P1|Period 1|Adverse Event|11
4769449|NCT01578850|16452605|P3|Period 1|Insufficient Clinical Response|0
4769450|NCT01578850|16452606|P2|Period 1|Insufficient Clinical Response|0
4769451|NCT01578850|16452607|P1|Period 1|Insufficient Clinical Response|1
4769452|NCT01578785|16452659|P2|Overall Study|Study terminated by sponsor|118
4769453|NCT01578785|16452660|P1|Overall Study|Study terminated by sponsor|59
4769454|NCT01578785|16452659|P2|Overall Study|Withdrawal by Subject|1
4769455|NCT01578785|16452660|P1|Overall Study|Withdrawal by Subject|0
4769456|NCT01578551|16452725|P2|Overall Study|Adverse Event|0
4769457|NCT01578551|16452726|P1|Overall Study|Adverse Event|1
4769458|NCT01578499|16452738|P2|Overall Study|Died and End of Study Page not Completed|0
4769459|NCT01578499|16452739|P1|Overall Study|Died and End of Study Page not Completed|2
4769460|NCT01578499|16452738|P2|Overall Study|Death|25
4769461|NCT01578499|16452739|P1|Overall Study|Death|20
4769462|NCT01578499|16452738|P2|Overall Study|Withdrawal by Subject|16
4769463|NCT01578499|16452739|P1|Overall Study|Withdrawal by Subject|10
4769464|NCT01578499|16452738|P2|Overall Study|Lost to Follow-up|1
4769465|NCT01578499|16452739|P1|Overall Study|Lost to Follow-up|2
4769466|NCT01578499|16452738|P2|Overall Study|Reason not Specified|1
4769467|NCT01578499|16452739|P1|Overall Study|Reason not Specified|0
4769468|NCT01578486|16452773|P1|Overall Study|Withdrawal by Subject|2
4769469|NCT01578486|16452773|P1|Overall Study|Physician Decision|3
4769470|NCT01578330|16452784|P1|Overall Study|Protocol Violation|5
4769471|NCT01578330|16452784|P1|Overall Study|Adverse Event|2
4769472|NCT01578187|16452826|P1|Usability Phase|Withdrawal by Subject|1
4769473|NCT01577758|16452868|P8|mCRC Expansion Phase|Progression Disease|19
4769474|NCT01577758|16452869|P7|mCRC Expansion Phase|Progression Disease|0
4769475|NCT01577758|16452870|P6|mCRC Expansion Phase|Progression Disease|0
4769476|NCT01577758|16452871|P5|mCRC Expansion Phase|Progression Disease|0
4769477|NCT01577758|16452872|P4|mCRC Expansion Phase|Progression Disease|0
4769478|NCT01577758|16452873|P3|mCRC Expansion Phase|Progression Disease|0
4769479|NCT01577758|16452874|P2|mCRC Expansion Phase|Progression Disease|0
4769480|NCT01577758|16452875|P1|mCRC Expansion Phase|Progression Disease|0
4769481|NCT01577758|16452868|P8|mCRC Expansion Phase|Withdrawal by Subject|2
4769482|NCT01577758|16452869|P7|mCRC Expansion Phase|Withdrawal by Subject|0
4769483|NCT01577758|16452870|P6|mCRC Expansion Phase|Withdrawal by Subject|0
4769484|NCT01577758|16452871|P5|mCRC Expansion Phase|Withdrawal by Subject|0
4769485|NCT01577758|16452872|P4|mCRC Expansion Phase|Withdrawal by Subject|0
4769486|NCT01577758|16452873|P3|mCRC Expansion Phase|Withdrawal by Subject|0
4769487|NCT01577758|16452874|P2|mCRC Expansion Phase|Withdrawal by Subject|0
4769488|NCT01577758|16452875|P1|mCRC Expansion Phase|Withdrawal by Subject|0
4769489|NCT01577758|16452868|P8|mCRC Expansion Phase|Symptomatic Deterioration|4
4769490|NCT01577758|16452869|P7|mCRC Expansion Phase|Symptomatic Deterioration|0
4769491|NCT01577758|16452870|P6|mCRC Expansion Phase|Symptomatic Deterioration|0
4769492|NCT01577758|16452871|P5|mCRC Expansion Phase|Symptomatic Deterioration|0
4769493|NCT01577758|16452872|P4|mCRC Expansion Phase|Symptomatic Deterioration|0
4769494|NCT01577758|16452873|P3|mCRC Expansion Phase|Symptomatic Deterioration|0
4769495|NCT01577758|16452874|P2|mCRC Expansion Phase|Symptomatic Deterioration|0
4769496|NCT01577758|16452875|P1|mCRC Expansion Phase|Symptomatic Deterioration|0
4769497|NCT01577758|16452868|P8|Dose Escalation Phase|Progression Disease|0
4769498|NCT01577758|16452869|P7|Dose Escalation Phase|Progression Disease|0
4769499|NCT01577758|16452870|P6|Dose Escalation Phase|Progression Disease|0
4769500|NCT01577758|16452871|P5|Dose Escalation Phase|Progression Disease|5
4769501|NCT01577758|16452872|P4|Dose Escalation Phase|Progression Disease|2
4769502|NCT01577758|16452873|P3|Dose Escalation Phase|Progression Disease|1
4769503|NCT01577758|16452874|P2|Dose Escalation Phase|Progression Disease|2
4769504|NCT01577758|16452875|P1|Dose Escalation Phase|Progression Disease|2
4769505|NCT01577758|16452868|P8|Dose Escalation Phase|Withdrawal by Subject|0
4769506|NCT01577758|16452869|P7|Dose Escalation Phase|Withdrawal by Subject|0
4769507|NCT01577758|16452870|P6|Dose Escalation Phase|Withdrawal by Subject|1
4769508|NCT01577758|16452871|P5|Dose Escalation Phase|Withdrawal by Subject|0
4769509|NCT01577758|16452872|P4|Dose Escalation Phase|Withdrawal by Subject|0
4769510|NCT01577758|16452873|P3|Dose Escalation Phase|Withdrawal by Subject|0
4769511|NCT01577758|16452874|P2|Dose Escalation Phase|Withdrawal by Subject|0
4769512|NCT01577758|16452875|P1|Dose Escalation Phase|Withdrawal by Subject|0
4769513|NCT01577758|16452868|P8|Dose Escalation Phase|Symptomatic Deterioration|0
4769514|NCT01577758|16452869|P7|Dose Escalation Phase|Symptomatic Deterioration|0
4769515|NCT01577758|16452870|P6|Dose Escalation Phase|Symptomatic Deterioration|1
4769516|NCT01577758|16452871|P5|Dose Escalation Phase|Symptomatic Deterioration|1
4769517|NCT01577758|16452872|P4|Dose Escalation Phase|Symptomatic Deterioration|0
4769518|NCT01577758|16452873|P3|Dose Escalation Phase|Symptomatic Deterioration|1
4769519|NCT01577758|16452874|P2|Dose Escalation Phase|Symptomatic Deterioration|0
4769520|NCT01577758|16452875|P1|Dose Escalation Phase|Symptomatic Deterioration|0
4769521|NCT01577758|16452868|P8|Dose Escalation Phase|Adverse Event|0
4769522|NCT01577758|16452869|P7|Dose Escalation Phase|Adverse Event|1
4769523|NCT01577758|16452870|P6|Dose Escalation Phase|Adverse Event|2
4769524|NCT01577758|16452871|P5|Dose Escalation Phase|Adverse Event|0
4769525|NCT01577758|16452872|P4|Dose Escalation Phase|Adverse Event|0
4769526|NCT01577758|16452873|P3|Dose Escalation Phase|Adverse Event|0
4769527|NCT01577758|16452874|P2|Dose Escalation Phase|Adverse Event|0
4769528|NCT01577758|16452875|P1|Dose Escalation Phase|Adverse Event|0
4769529|NCT01577745|16452914|P6|Overall Study|Alternative Therapy|0
4769530|NCT01577745|16452915|P5|Overall Study|Alternative Therapy|1
4769531|NCT01577745|16452916|P4|Overall Study|Alternative Therapy|1
4769532|NCT01577745|16452917|P3|Overall Study|Alternative Therapy|0
4769533|NCT01577745|16452918|P2|Overall Study|Alternative Therapy|0
4769534|NCT01577745|16452919|P1|Overall Study|Alternative Therapy|0
4769535|NCT01577745|16452914|P6|Overall Study|Lost to Follow-up|1
4769536|NCT01577745|16452915|P5|Overall Study|Lost to Follow-up|0
4769537|NCT01577745|16452916|P4|Overall Study|Lost to Follow-up|0
4769538|NCT01577745|16452917|P3|Overall Study|Lost to Follow-up|0
4769539|NCT01577745|16452918|P2|Overall Study|Lost to Follow-up|0
4769540|NCT01577745|16452919|P1|Overall Study|Lost to Follow-up|0
4769541|NCT01577745|16452914|P6|Overall Study|Physician Decision|0
4769542|NCT01577745|16452915|P5|Overall Study|Physician Decision|1
4769543|NCT01577745|16452916|P4|Overall Study|Physician Decision|1
4769544|NCT01577745|16452917|P3|Overall Study|Physician Decision|0
4769545|NCT01577745|16452918|P2|Overall Study|Physician Decision|0
4769546|NCT01577745|16452919|P1|Overall Study|Physician Decision|0
4769547|NCT01577745|16452914|P6|Overall Study|Death|3
4769548|NCT01577745|16452915|P5|Overall Study|Death|1
4769549|NCT01577745|16452916|P4|Overall Study|Death|1
4769550|NCT01577745|16452917|P3|Overall Study|Death|2
4769551|NCT01577745|16452918|P2|Overall Study|Death|2
4769552|NCT01577745|16452919|P1|Overall Study|Death|3
4769553|NCT01577745|16452914|P6|Overall Study|Withdrawal by Subject|0
4769554|NCT01577745|16452915|P5|Overall Study|Withdrawal by Subject|2
4769555|NCT01577745|16452916|P4|Overall Study|Withdrawal by Subject|3
4769556|NCT01577745|16452917|P3|Overall Study|Withdrawal by Subject|0
4769557|NCT01577745|16452918|P2|Overall Study|Withdrawal by Subject|1
4769558|NCT01577745|16452919|P1|Overall Study|Withdrawal by Subject|0
4769559|NCT01577381|16453120|P4|Overall Study|Ongoing at Date of Cut-Off|0
4769560|NCT01577381|16453121|P3|Overall Study|Ongoing at Date of Cut-Off|1
4769561|NCT01577381|16453122|P2|Overall Study|Ongoing at Date of Cut-Off|2
4769562|NCT01577381|16453123|P1|Overall Study|Ongoing at Date of Cut-Off|0
4769563|NCT01577381|16453120|P4|Overall Study|Discontinued|2
4769564|NCT01577381|16453121|P3|Overall Study|Discontinued|2
4769565|NCT01577381|16453122|P2|Overall Study|Discontinued|1
4769566|NCT01577381|16453123|P1|Overall Study|Discontinued|2
4769567|NCT01577186|16453278|P1|Overall Study|Other|2
4769568|NCT01577186|16453278|P1|Overall Study|Non-Compliant|8
4769569|NCT01577186|16453278|P1|Overall Study|Ineligible to Continue|15
4769570|NCT01577186|16453278|P1|Overall Study|Insufficient Response|18
4769571|NCT01577186|16453278|P1|Overall Study|Withdrawal by Subject|35
4769572|NCT01577186|16453278|P1|Overall Study|Lost to Follow-up|28
4769573|NCT01577186|16453278|P1|Overall Study|Death|1
4769574|NCT01577186|16453278|P1|Overall Study|Adverse Event|23
4769575|NCT01577160|16453286|P1|Overall Study|Other|9
4769576|NCT01577160|16453286|P1|Overall Study|Subject Uncooperative|7
4769577|NCT01577160|16453286|P1|Overall Study|Withdrawal by Subject|18
4769578|NCT01577160|16453286|P1|Overall Study|Lost to Follow-up|40
4769579|NCT01577160|16453286|P1|Overall Study|Lack of Efficacy|15
4769580|NCT01577160|16453286|P1|Overall Study|Adverse Event|9
4769581|NCT01576783|16453341|P2|Overall Study|Withdrawal by Subject|1
4769582|NCT01576783|16453342|P1|Overall Study|Withdrawal by Subject|5
4769583|NCT01576783|16453341|P2|Overall Study|Lost to Follow-up|16
4769584|NCT01576783|16453342|P1|Overall Study|Lost to Follow-up|14
4769585|NCT01576783|16453341|P2|Overall Study|Change in Medical Care|0
4769586|NCT01576783|16453342|P1|Overall Study|Change in Medical Care|1
4769587|NCT01576718|16453368|P7|Treatment Period|Noncompliance to study medication|1
4769588|NCT01576718|16453369|P6|Treatment Period|Noncompliance to study medication|1
4769589|NCT01576718|16453370|P5|Treatment Period|Noncompliance to study medication|0
4769590|NCT01576718|16453371|P4|Treatment Period|Noncompliance to study medication|0
4769591|NCT01576718|16453372|P3|Treatment Period|Noncompliance to study medication|0
4769592|NCT01576718|16453373|P2|Treatment Period|Noncompliance to study medication|0
4769593|NCT01576718|16453374|P1|Treatment Period|Noncompliance to study medication|0
4769594|NCT01576718|16453368|P7|Treatment Period|Lost to Follow-up|0
4769595|NCT01576718|16453369|P6|Treatment Period|Lost to Follow-up|0
4769596|NCT01576718|16453370|P5|Treatment Period|Lost to Follow-up|1
4769597|NCT01576718|16453371|P4|Treatment Period|Lost to Follow-up|0
4769598|NCT01576718|16453372|P3|Treatment Period|Lost to Follow-up|0
4769599|NCT01576718|16453373|P2|Treatment Period|Lost to Follow-up|0
4769600|NCT01576718|16453374|P1|Treatment Period|Lost to Follow-up|0
4769601|NCT01576718|16453368|P7|Treatment Period|Met stopping criteria|15
4769602|NCT01576718|16453369|P6|Treatment Period|Met stopping criteria|33
4769603|NCT01576718|16453370|P5|Treatment Period|Met stopping criteria|16
4769604|NCT01576718|16453371|P4|Treatment Period|Met stopping criteria|19
4769605|NCT01576718|16453372|P3|Treatment Period|Met stopping criteria|13
4769606|NCT01576718|16453373|P2|Treatment Period|Met stopping criteria|16
4769607|NCT01576718|16453374|P1|Treatment Period|Met stopping criteria|0
4769608|NCT01576718|16453368|P7|Treatment Period|Sponsor request|0
4769609|NCT01576718|16453369|P6|Treatment Period|Sponsor request|1
4769610|NCT01576718|16453370|P5|Treatment Period|Sponsor request|0
4769611|NCT01576718|16453371|P4|Treatment Period|Sponsor request|0
4769612|NCT01576718|16453372|P3|Treatment Period|Sponsor request|0
4769613|NCT01576718|16453373|P2|Treatment Period|Sponsor request|1
4769614|NCT01576718|16453374|P1|Treatment Period|Sponsor request|0
4769615|NCT01576718|16453368|P7|Treatment Period|Protocol Violation|12
4769616|NCT01576718|16453369|P6|Treatment Period|Protocol Violation|8
4769617|NCT01576718|16453370|P5|Treatment Period|Protocol Violation|6
4769618|NCT01576718|16453371|P4|Treatment Period|Protocol Violation|10
4769619|NCT01576718|16453372|P3|Treatment Period|Protocol Violation|4
4769620|NCT01576718|16453373|P2|Treatment Period|Protocol Violation|5
4769621|NCT01576718|16453374|P1|Treatment Period|Protocol Violation|0
4769622|NCT01576718|16453368|P7|Treatment Period|Physician Decision|0
4769623|NCT01576718|16453369|P6|Treatment Period|Physician Decision|0
4769624|NCT01576718|16453370|P5|Treatment Period|Physician Decision|1
4769625|NCT01576718|16453371|P4|Treatment Period|Physician Decision|1
4769626|NCT01576718|16453372|P3|Treatment Period|Physician Decision|1
4769627|NCT01576718|16453373|P2|Treatment Period|Physician Decision|1
4769628|NCT01576718|16453374|P1|Treatment Period|Physician Decision|0
4769629|NCT01576718|16453368|P7|Treatment Period|Withdrawal by Subject|2
4769630|NCT01576718|16453369|P6|Treatment Period|Withdrawal by Subject|4
4769631|NCT01576718|16453370|P5|Treatment Period|Withdrawal by Subject|2
4769632|NCT01576718|16453371|P4|Treatment Period|Withdrawal by Subject|0
4769633|NCT01576718|16453372|P3|Treatment Period|Withdrawal by Subject|1
4769634|NCT01576718|16453373|P2|Treatment Period|Withdrawal by Subject|1
4769635|NCT01576718|16453374|P1|Treatment Period|Withdrawal by Subject|0
4769636|NCT01576718|16453368|P7|Treatment Period|Adverse Event|0
4769637|NCT01576718|16453369|P6|Treatment Period|Adverse Event|1
4769638|NCT01576718|16453370|P5|Treatment Period|Adverse Event|1
4769639|NCT01576718|16453371|P4|Treatment Period|Adverse Event|1
4769640|NCT01576718|16453372|P3|Treatment Period|Adverse Event|1
4769641|NCT01576718|16453373|P2|Treatment Period|Adverse Event|1
4769642|NCT01576718|16453374|P1|Treatment Period|Adverse Event|0
4769643|NCT01576718|16453368|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
4769644|NCT01576718|16453369|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
4769645|NCT01576718|16453370|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
4769646|NCT01576718|16453371|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
4769647|NCT01576718|16453372|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
4769648|NCT01576718|16453373|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
4769649|NCT01576718|16453374|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
4769650|NCT01576718|16453368|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4769651|NCT01576718|16453369|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4769652|NCT01576718|16453370|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4769653|NCT01576718|16453371|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4769654|NCT01576718|16453372|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4769655|NCT01576718|16453373|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4769656|NCT01576718|16453374|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2
4769657|NCT01576718|16453368|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4769658|NCT01576718|16453369|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4769659|NCT01576718|16453370|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4769660|NCT01576718|16453371|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4769661|NCT01576718|16453372|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4769662|NCT01576718|16453373|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4769663|NCT01576718|16453374|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166
4769664|NCT01576718|16453368|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4769665|NCT01576718|16453369|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4769666|NCT01576718|16453370|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4769667|NCT01576718|16453371|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4769668|NCT01576718|16453372|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4769669|NCT01576718|16453373|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4769670|NCT01576718|16453374|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17
4769671|NCT01576718|16453368|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4769672|NCT01576718|16453369|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4769673|NCT01576718|16453370|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4769674|NCT01576718|16453371|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4769675|NCT01576718|16453372|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4769676|NCT01576718|16453373|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4769677|NCT01576718|16453374|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49
4769678|NCT01576705|16453470|P4|Overall Study|invalid ICF|0
4769679|NCT01576705|16453471|P3|Overall Study|invalid ICF|0
4769680|NCT01576705|16453472|P2|Overall Study|invalid ICF|1
4769681|NCT01576705|16453473|P1|Overall Study|invalid ICF|0
4769682|NCT01576705|16453470|P4|Overall Study|TSH > 7 mIU/L at baseline|3
4769683|NCT01576705|16453471|P3|Overall Study|TSH > 7 mIU/L at baseline|5
4769684|NCT01576705|16453472|P2|Overall Study|TSH > 7 mIU/L at baseline|7
4769685|NCT01576705|16453473|P1|Overall Study|TSH > 7 mIU/L at baseline|3
4769686|NCT01576575|16453494|P1|Buprenorphine + Grapefruit|Withdrawal by Subject|1
4769687|NCT01576575|16453494|P1|Buprenorphine + Rifampin|Withdrawal by Subject|3
4769688|NCT01576575|16453494|P1|Buprenorphine Control|Withdrawal by Subject|3
4769689|NCT01576549|16453504|P1|Overall Study|Sponsor Decision|2
4769690|NCT01576484|16453520|P2|Overall Study|Other|5
4769691|NCT01576484|16453521|P1|Overall Study|Other|2
4769692|NCT01576484|16453520|P2|Overall Study|Withdrawal by Subject|3
4769693|NCT01576484|16453521|P1|Overall Study|Withdrawal by Subject|0
4769694|NCT01576484|16453520|P2|Overall Study|Sponsor Decision|8
4769695|NCT01576484|16453521|P1|Overall Study|Sponsor Decision|2
4769696|NCT01576484|16453520|P2|Overall Study|Protocol Violation|2
4769697|NCT01576484|16453521|P1|Overall Study|Protocol Violation|0
4769698|NCT01576484|16453520|P2|Overall Study|Adverse Event|1
4769699|NCT01576484|16453521|P1|Overall Study|Adverse Event|1
4769700|NCT01576406|16453600|P6|Overall Study|Other|0
4769701|NCT01576406|16453601|P5|Overall Study|Other|0
4769702|NCT01576406|16453602|P4|Overall Study|Other|2
4769703|NCT01576406|16453603|P3|Overall Study|Other|2
4769704|NCT01576406|16453604|P2|Overall Study|Other|0
4769705|NCT01576406|16453605|P1|Overall Study|Other|0
4769706|NCT01576406|16453600|P6|Overall Study|Withdrawal the consent|3
4769707|NCT01576406|16453601|P5|Overall Study|Withdrawal the consent|1
4769708|NCT01576406|16453602|P4|Overall Study|Withdrawal the consent|1
4769709|NCT01576406|16453603|P3|Overall Study|Withdrawal the consent|5
4769710|NCT01576406|16453604|P2|Overall Study|Withdrawal the consent|2
4769711|NCT01576406|16453605|P1|Overall Study|Withdrawal the consent|2
4769712|NCT01576406|16453600|P6|Overall Study|Non-clinical trial supply of Crizotinib|0
4769713|NCT01576406|16453601|P5|Overall Study|Non-clinical trial supply of Crizotinib|0
4769714|NCT01576406|16453602|P4|Overall Study|Non-clinical trial supply of Crizotinib|1
4769715|NCT01576406|16453603|P3|Overall Study|Non-clinical trial supply of Crizotinib|1
4769716|NCT01576406|16453604|P2|Overall Study|Non-clinical trial supply of Crizotinib|0
4769717|NCT01576406|16453605|P1|Overall Study|Non-clinical trial supply of Crizotinib|0
4769718|NCT01576406|16453600|P6|Overall Study|Death|9
4769719|NCT01576406|16453601|P5|Overall Study|Death|7
4769720|NCT01576406|16453602|P4|Overall Study|Death|5
4769721|NCT01576406|16453603|P3|Overall Study|Death|8
4769722|NCT01576406|16453604|P2|Overall Study|Death|4
4769723|NCT01576406|16453605|P1|Overall Study|Death|3
4769724|NCT01576406|16453600|P6|Overall Study|Lost to Follow-up|0
4769725|NCT01576406|16453601|P5|Overall Study|Lost to Follow-up|0
4769726|NCT01576406|16453602|P4|Overall Study|Lost to Follow-up|0
4769727|NCT01576406|16453603|P3|Overall Study|Lost to Follow-up|0
4769728|NCT01576406|16453604|P2|Overall Study|Lost to Follow-up|2
4769729|NCT01576406|16453605|P1|Overall Study|Lost to Follow-up|1
4769730|NCT01576367|16453853|P1|Overall Study|Moved to commercial use after 6 months|1
4769731|NCT01576367|16453853|P1|Overall Study|Unsatisfactory therapeutic effect|2
4769732|NCT01576341|16453861|P1|Overall Study|Other|12
4769733|NCT01576341|16453861|P1|Overall Study|Protocol Violation|12
4769734|NCT01576341|16453861|P1|Overall Study|Kidney transplantation|10
4769735|NCT01576341|16453861|P1|Overall Study|Lost to Follow-up|2
4769736|NCT01576341|16453861|P1|Overall Study|Physician Decision|2
4769737|NCT01576341|16453861|P1|Overall Study|Death|21
4769738|NCT01576341|16453861|P1|Overall Study|Adverse Event|10
4769739|NCT01576341|16453861|P1|Overall Study|Withdrawal by Subject|24
4769740|NCT01576159|16453882|P4|Overall Study|Protocol Violation|0
4769741|NCT01576159|16453883|P3|Overall Study|Protocol Violation|0
4769742|NCT01576159|16453884|P2|Overall Study|Protocol Violation|0
4769743|NCT01576159|16453885|P1|Overall Study|Protocol Violation|1
4769744|NCT01576159|16453882|P4|Overall Study|Lost to Follow-up|1
4769745|NCT01576159|16453883|P3|Overall Study|Lost to Follow-up|0
4769746|NCT01576159|16453884|P2|Overall Study|Lost to Follow-up|0
4769747|NCT01576159|16453885|P1|Overall Study|Lost to Follow-up|0
4769748|NCT01576159|16453882|P4|Overall Study|Physician Decision|0
4769749|NCT01576159|16453883|P3|Overall Study|Physician Decision|1
4769750|NCT01576159|16453884|P2|Overall Study|Physician Decision|0
4769751|NCT01576159|16453885|P1|Overall Study|Physician Decision|0
4769752|NCT01576159|16453882|P4|Overall Study|Withdrawal by Subject|0
4769753|NCT01576159|16453883|P3|Overall Study|Withdrawal by Subject|0
4769754|NCT01576159|16453884|P2|Overall Study|Withdrawal by Subject|1
4769755|NCT01576159|16453885|P1|Overall Study|Withdrawal by Subject|0
4769756|NCT01576146|16453903|P1|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1
4769757|NCT01576146|16453903|P1|Extension Period 2|Renal Transplant|1
4769758|NCT01576146|16453903|P1|Extension Period 2|Adverse Event|1
4769759|NCT01576146|16453903|P1|Extension Period 2|Death|1
4769760|NCT01576146|16453903|P1|Extension Period 2|Sponsor Decision|13
4769761|NCT01576146|16453903|P1|Extension Period 1|Renal Transplant|1
4769762|NCT01576146|16453903|P1|Extension Period 1|Parathyroidectomy|1
4769763|NCT01576146|16453903|P1|Extension Period 1|Lost to Follow-up|1
4769764|NCT01576146|16453903|P1|Extension Period 1|Withdrawal by Subject|1
4769765|NCT01576146|16453903|P1|Extension Period 1|Physician Decision|2
4769766|NCT01576146|16453903|P1|Extension Period 1|Death|2
4769767|NCT01576146|16453903|P1|Extension Period 1|Adverse Event|2
4769768|NCT01576042|16453936|P2|Overall Study|Physician Decision|0
4769769|NCT01576042|16453937|P1|Overall Study|Physician Decision|2
4769770|NCT01575899|16453993|P3|Overall Study|Protocol Violation|0
4769771|NCT01575899|16453994|P2|Overall Study|Protocol Violation|1
4769772|NCT01575899|16453995|P1|Overall Study|Protocol Violation|2
4769773|NCT01575899|16453993|P3|Overall Study|Lost to Follow-up|2
4769774|NCT01575899|16453994|P2|Overall Study|Lost to Follow-up|4
4769775|NCT01575899|16453995|P1|Overall Study|Lost to Follow-up|3
4769776|NCT01575873|16454009|P4|Overall Study|Other|2
4769777|NCT01575873|16454010|P3|Overall Study|Other|4
4769778|NCT01575873|16454011|P2|Overall Study|Other|0
4769779|NCT01575873|16454012|P1|Overall Study|Other|0
4769780|NCT01575873|16454009|P4|Overall Study|Requirement for Alternative Therapy|1
4769781|NCT01575873|16454010|P3|Overall Study|Requirement for Alternative Therapy|1
4769782|NCT01575873|16454011|P2|Overall Study|Requirement for Alternative Therapy|0
4769783|NCT01575873|16454012|P1|Overall Study|Requirement for Alternative Therapy|0
4769784|NCT01575873|16454009|P4|Overall Study|Protocol deviation|1
4769785|NCT01575873|16454010|P3|Overall Study|Protocol deviation|0
4769786|NCT01575873|16454011|P2|Overall Study|Protocol deviation|1
4769787|NCT01575873|16454012|P1|Overall Study|Protocol deviation|0
4769788|NCT01575873|16454009|P4|Overall Study|Administrative decision|0
4769789|NCT01575873|16454010|P3|Overall Study|Administrative decision|1
4769790|NCT01575873|16454011|P2|Overall Study|Administrative decision|1
4769791|NCT01575873|16454012|P1|Overall Study|Administrative decision|1
4769792|NCT01575873|16454009|P4|Overall Study|Noncompliance|3
4769793|NCT01575873|16454010|P3|Overall Study|Noncompliance|4
4769794|NCT01575873|16454011|P2|Overall Study|Noncompliance|2
4769795|NCT01575873|16454012|P1|Overall Study|Noncompliance|1
4769796|NCT01575873|16454009|P4|Overall Study|Death|9
4769797|NCT01575873|16454010|P3|Overall Study|Death|8
4769798|NCT01575873|16454011|P2|Overall Study|Death|2
4769799|NCT01575873|16454012|P1|Overall Study|Death|3
4769800|NCT01575873|16454009|P4|Overall Study|Lost to Follow-up|5
4769801|NCT01575873|16454010|P3|Overall Study|Lost to Follow-up|13
4769802|NCT01575873|16454011|P2|Overall Study|Lost to Follow-up|3
4769803|NCT01575873|16454012|P1|Overall Study|Lost to Follow-up|1
4769804|NCT01575873|16454009|P4|Overall Study|Adverse Event|12
4769805|NCT01575873|16454010|P3|Overall Study|Adverse Event|9
4769806|NCT01575873|16454011|P2|Overall Study|Adverse Event|7
4769807|NCT01575873|16454012|P1|Overall Study|Adverse Event|7
4769808|NCT01575873|16454009|P4|Overall Study|Withdrawal by Subject|34
4769809|NCT01575873|16454010|P3|Overall Study|Withdrawal by Subject|34
4769810|NCT01575873|16454011|P2|Overall Study|Withdrawal by Subject|20
4769811|NCT01575873|16454012|P1|Overall Study|Withdrawal by Subject|15
4769812|NCT01575860|16454036|P1|Overall Study|Progression Prior to Lenalidomide Maint.|1
4769813|NCT01575860|16454036|P1|Overall Study|Withdrawal by Subject|1
4769814|NCT01575834|16454044|P2|Overall Study|Requirement for Alternative Therapy|4
4769815|NCT01575834|16454045|P1|Overall Study|Requirement for Alternative Therapy|2
4769816|NCT01575834|16454044|P2|Overall Study|Protocol Deviation|3
4769817|NCT01575834|16454045|P1|Overall Study|Protocol Deviation|4
4769818|NCT01575834|16454044|P2|Overall Study|Ineligibility Determined|8
4769819|NCT01575834|16454045|P1|Overall Study|Ineligibility Determined|5
4769820|NCT01575834|16454044|P2|Overall Study|Administrative decision|33
4769821|NCT01575834|16454045|P1|Overall Study|Administrative decision|15
4769822|NCT01575834|16454044|P2|Overall Study|Noncompliance|27
4769823|NCT01575834|16454045|P1|Overall Study|Noncompliance|52
4769824|NCT01575834|16454044|P2|Overall Study|Lost to Follow-up|68
4769825|NCT01575834|16454045|P1|Overall Study|Lost to Follow-up|55
4769826|NCT01575834|16454044|P2|Overall Study|Adverse Event|61
4769827|NCT01575834|16454045|P1|Overall Study|Adverse Event|63
4769828|NCT01575834|16454044|P2|Overall Study|Other|70
4769829|NCT01575834|16454045|P1|Overall Study|Other|70
4769830|NCT01575834|16454044|P2|Overall Study|Death|74
4769831|NCT01575834|16454045|P1|Overall Study|Death|81
4769832|NCT01575834|16454044|P2|Overall Study|Withdrawal by Subject|390
4769833|NCT01575834|16454045|P1|Overall Study|Withdrawal by Subject|352
4769834|NCT01575808|16454097|P2|Overall Study|Withdrawal by Subject|0
4769835|NCT01575808|16454098|P1|Overall Study|Withdrawal by Subject|1
4769836|NCT01575808|16454097|P2|Overall Study|Death|0
4769837|NCT01575808|16454098|P1|Overall Study|Death|2
4769838|NCT01575769|16454145|P1|Overall Study|Study terminated by sponsor|40
4769839|NCT01575769|16454145|P1|Overall Study|Adverse Event|1
4769840|NCT01575561|16454203|P1|Overall Study|administration|1
4769841|NCT01575561|16454203|P1|Overall Study|Withdrawal by Subject|11
4769842|NCT01575561|16454203|P1|Overall Study|Protocol Violation|4
4769843|NCT01575561|16454203|P1|Overall Study|Lost to Follow-up|6
4769844|NCT01575561|16454203|P1|Overall Study|Lack of Efficacy|8
4769845|NCT01575561|16454203|P1|Overall Study|Adverse Event|9
4769846|NCT01575197|16454233|P3|Overall Study|Protocol Violation|1
4769847|NCT01575197|16454234|P2|Overall Study|Protocol Violation|1
4769848|NCT01575197|16454235|P1|Overall Study|Protocol Violation|2
4769849|NCT01575197|16454233|P3|Overall Study|Withdrawal by Subject|1
4769850|NCT01575197|16454234|P2|Overall Study|Withdrawal by Subject|1
4769851|NCT01575197|16454235|P1|Overall Study|Withdrawal by Subject|0
4769852|NCT01575197|16454233|P3|Overall Study|Lost to Follow-up|0
4769853|NCT01575197|16454234|P2|Overall Study|Lost to Follow-up|1
4769854|NCT01575197|16454235|P1|Overall Study|Lost to Follow-up|0
4769855|NCT01575197|16454233|P3|Overall Study|SAE|0
4769856|NCT01575197|16454234|P2|Overall Study|SAE|1
4769857|NCT01575197|16454235|P1|Overall Study|SAE|0
4769858|NCT01575197|16454233|P3|Overall Study|Migration out of study area|4
4769859|NCT01575197|16454234|P2|Overall Study|Migration out of study area|5
4769860|NCT01575197|16454235|P1|Overall Study|Migration out of study area|1
4769861|NCT01575054|16454263|P2|Overall Study|Adverse Event|8
4769862|NCT01575054|16454264|P1|Overall Study|Adverse Event|9
4769863|NCT01575054|16454263|P2|Overall Study|Lost to Follow-up|3
4769864|NCT01575054|16454264|P1|Overall Study|Lost to Follow-up|3
4769865|NCT01575054|16454263|P2|Overall Study|Personal Reasons|11
4769866|NCT01575054|16454264|P1|Overall Study|Personal Reasons|10
4769867|NCT01575054|16454263|P2|Overall Study|Protocol Violation|1
4769868|NCT01575054|16454264|P1|Overall Study|Protocol Violation|2
4769869|NCT01575054|16454263|P2|Overall Study|Other Reasons|3
4769870|NCT01575054|16454264|P1|Overall Study|Other Reasons|5
4769871|NCT01575028|16454280|P2|Overall Study|Physician Decision|1
4769872|NCT01575028|16454281|P1|Overall Study|Physician Decision|0
4769873|NCT01574716|16454292|P5|Part 2|Lost to Follow-up|0
4769874|NCT01574716|16454293|P4|Part 2|Lost to Follow-up|3
4769875|NCT01574716|16454294|P3|Part 2|Lost to Follow-up|0
4769876|NCT01574716|16454295|P2|Part 2|Lost to Follow-up|0
4769877|NCT01574716|16454296|P1|Part 2|Lost to Follow-up|0
4769878|NCT01574716|16454292|P5|Part 2|Brain metastases|0
4769879|NCT01574716|16454293|P4|Part 2|Brain metastases|1
4769880|NCT01574716|16454294|P3|Part 2|Brain metastases|0
4769881|NCT01574716|16454295|P2|Part 2|Brain metastases|0
4769882|NCT01574716|16454296|P1|Part 2|Brain metastases|0
4769883|NCT01574716|16454292|P5|Part 2|Withdrawal by Subject|4
4769884|NCT01574716|16454293|P4|Part 2|Withdrawal by Subject|5
4769885|NCT01574716|16454294|P3|Part 2|Withdrawal by Subject|0
4769886|NCT01574716|16454295|P2|Part 2|Withdrawal by Subject|0
4769887|NCT01574716|16454296|P1|Part 2|Withdrawal by Subject|0
4769888|NCT01574716|16454292|P5|Part 2|Discontinuation of study by sponsor|31
4769889|NCT01574716|16454293|P4|Part 2|Discontinuation of study by sponsor|51
4769890|NCT01574716|16454294|P3|Part 2|Discontinuation of study by sponsor|0
4769891|NCT01574716|16454295|P2|Part 2|Discontinuation of study by sponsor|0
4769892|NCT01574716|16454296|P1|Part 2|Discontinuation of study by sponsor|0
4769893|NCT01574716|16454292|P5|Part 2|Death|35
4769894|NCT01574716|16454293|P4|Part 2|Death|76
4769895|NCT01574716|16454294|P3|Part 2|Death|0
4769896|NCT01574716|16454295|P2|Part 2|Death|0
4769897|NCT01574716|16454296|P1|Part 2|Death|0
4769898|NCT01574716|16454292|P5|Part 2|Progressive disease|0
4769899|NCT01574716|16454293|P4|Part 2|Progressive disease|1
4769900|NCT01574716|16454294|P3|Part 2|Progressive disease|0
4769901|NCT01574716|16454295|P2|Part 2|Progressive disease|0
4769902|NCT01574716|16454296|P1|Part 2|Progressive disease|0
4769903|NCT01574716|16454292|P5|Part 1|Lost to Follow-up|0
4769904|NCT01574716|16454293|P4|Part 1|Lost to Follow-up|0
4769905|NCT01574716|16454294|P3|Part 1|Lost to Follow-up|0
4769906|NCT01574716|16454295|P2|Part 1|Lost to Follow-up|1
4769907|NCT01574716|16454296|P1|Part 1|Lost to Follow-up|0
4769908|NCT01574716|16454292|P5|Part 1|Withdrawal by Subject|0
4769909|NCT01574716|16454293|P4|Part 1|Withdrawal by Subject|0
4769910|NCT01574716|16454294|P3|Part 1|Withdrawal by Subject|0
4769911|NCT01574716|16454295|P2|Part 1|Withdrawal by Subject|2
4769912|NCT01574716|16454296|P1|Part 1|Withdrawal by Subject|0
4769913|NCT01574716|16454292|P5|Part 1|Discontinuation of study by sponsor|0
4769914|NCT01574716|16454293|P4|Part 1|Discontinuation of study by sponsor|0
4769915|NCT01574716|16454294|P3|Part 1|Discontinuation of study by sponsor|1
4769916|NCT01574716|16454295|P2|Part 1|Discontinuation of study by sponsor|0
4769917|NCT01574716|16454296|P1|Part 1|Discontinuation of study by sponsor|0
4769918|NCT01574716|16454292|P5|Part 1|Death|0
4769919|NCT01574716|16454293|P4|Part 1|Death|0
4769920|NCT01574716|16454294|P3|Part 1|Death|8
4769921|NCT01574716|16454295|P2|Part 1|Death|1
4769922|NCT01574716|16454296|P1|Part 1|Death|3
4769923|NCT01574703|16454319|P4|Overall Study|Death|0
4769924|NCT01574703|16454320|P3|Overall Study|Death|1
4769925|NCT01574703|16454321|P2|Overall Study|Death|1
4769926|NCT01574703|16454322|P1|Overall Study|Death|2
4769927|NCT01574703|16454319|P4|Overall Study|Lost to Follow-up|35
4769928|NCT01574703|16454320|P3|Overall Study|Lost to Follow-up|46
4769929|NCT01574703|16454321|P2|Overall Study|Lost to Follow-up|41
4769930|NCT01574703|16454322|P1|Overall Study|Lost to Follow-up|43
4769931|NCT01574703|16454319|P4|Overall Study|Met Withdrawal Criteria|0
4769932|NCT01574703|16454320|P3|Overall Study|Met Withdrawal Criteria|1
4769933|NCT01574703|16454321|P2|Overall Study|Met Withdrawal Criteria|1
4769934|NCT01574703|16454322|P1|Overall Study|Met Withdrawal Criteria|0
4769935|NCT01574703|16454319|P4|Overall Study|Withdrawal by Subject|61
4769936|NCT01574703|16454320|P3|Overall Study|Withdrawal by Subject|36
4769937|NCT01574703|16454321|P2|Overall Study|Withdrawal by Subject|52
4769938|NCT01574703|16454322|P1|Overall Study|Withdrawal by Subject|53
4769939|NCT01574703|16454319|P4|Overall Study|Unspecified Reason|16
4769940|NCT01574703|16454320|P3|Overall Study|Unspecified Reason|20
4769941|NCT01574703|16454321|P2|Overall Study|Unspecified Reason|15
4769942|NCT01574703|16454322|P1|Overall Study|Unspecified Reason|27
4769943|NCT01574703|16454319|P4|Overall Study|Protocol Violation|1
4769944|NCT01574703|16454320|P3|Overall Study|Protocol Violation|0
4769945|NCT01574703|16454321|P2|Overall Study|Protocol Violation|0
4769946|NCT01574703|16454322|P1|Overall Study|Protocol Violation|0
4769947|NCT01574703|16454319|P4|Overall Study|Adverse Event|1
4769948|NCT01574703|16454320|P3|Overall Study|Adverse Event|1
4769949|NCT01574703|16454321|P2|Overall Study|Adverse Event|2
4769950|NCT01574703|16454322|P1|Overall Study|Adverse Event|0
4769951|NCT01574651|16454366|P2|Overall Study|Withdrawal by Subject|10
4769952|NCT01574651|16454367|P1|Overall Study|Withdrawal by Subject|9
4769953|NCT01574651|16454366|P2|Overall Study|Protocol Violation|5
4769954|NCT01574651|16454367|P1|Overall Study|Protocol Violation|3
4769955|NCT01574651|16454366|P2|Overall Study|Unsatisfactory therapeutic effect|0
4769956|NCT01574651|16454367|P1|Overall Study|Unsatisfactory therapeutic effect|6
4769957|NCT01574651|16454366|P2|Overall Study|Abnormal test procedure result(s)|1
4769958|NCT01574651|16454367|P1|Overall Study|Abnormal test procedure result(s)|1
4769959|NCT01574651|16454366|P2|Overall Study|Abnormal laboratory value(s)|0
4769960|NCT01574651|16454367|P1|Overall Study|Abnormal laboratory value(s)|1
4769961|NCT01574651|16454366|P2|Overall Study|Adverse Event|27
4769962|NCT01574651|16454367|P1|Overall Study|Adverse Event|36
4769963|NCT01574651|16454366|P2|Overall Study|Patient's inability to use the device|1
4769964|NCT01574651|16454367|P1|Overall Study|Patient's inability to use the device|0
4769965|NCT01574651|16454366|P2|Overall Study|Death|3
4769966|NCT01574651|16454367|P1|Overall Study|Death|3
4769967|NCT01574651|16454366|P2|Overall Study|Administrative problems|1
4769968|NCT01574651|16454367|P1|Overall Study|Administrative problems|0
4769969|NCT01574651|16454366|P2|Overall Study|Lost to Follow-up|4
4769970|NCT01574651|16454367|P1|Overall Study|Lost to Follow-up|2
4769971|NCT01574612|16454389|P1|Overall Study|Lost to Follow-up|2
4769972|NCT01574612|16454389|P1|Overall Study|Withdrawal by Subject|1
4769973|NCT01574612|16454389|P1|Overall Study|non compliant with drug|2
4769974|NCT01574612|16454389|P1|Overall Study|Adverse Event|3
4769975|NCT01574326|16454395|P2|Overall Study|Other: Mainly kidney transplant|8
4769976|NCT01574326|16454396|P1|Overall Study|Other: Mainly kidney transplant|8
4769977|NCT01574326|16454395|P2|Overall Study|Adverse Event|3
4769978|NCT01574326|16454396|P1|Overall Study|Adverse Event|1
4769979|NCT01574326|16454395|P2|Overall Study|Physician Decision|3
4769980|NCT01574326|16454396|P1|Overall Study|Physician Decision|5
4769981|NCT01574326|16454395|P2|Overall Study|Withdrawal by Participant|4
4769982|NCT01574326|16454396|P1|Overall Study|Withdrawal by Participant|2
4769983|NCT01574326|16454395|P2|Overall Study|Randomized but not treated|1
4769984|NCT01574326|16454396|P1|Overall Study|Randomized but not treated|0
4769985|NCT01574248|16454414|P2|Overall Study|Missing primary endpoint data|0
4769986|NCT01574248|16454415|P1|Overall Study|Missing primary endpoint data|1
4769987|NCT01574248|16454414|P2|Overall Study|Withdrawal by Subject|0
4769988|NCT01574248|16454415|P1|Overall Study|Withdrawal by Subject|2
4769989|NCT01574157|16454448|P2|Overall Study|Lost to Follow-up|3
4769990|NCT01574157|16454449|P1|Overall Study|Lost to Follow-up|0
4769991|NCT01574157|16454448|P2|Overall Study|Withdrawal by Subject|5
4769992|NCT01574157|16454449|P1|Overall Study|Withdrawal by Subject|4
4769993|NCT01574079|16454483|P2|Overall Study|Lost to Follow-up|0
4769994|NCT01574079|16454484|P1|Overall Study|Lost to Follow-up|1
4769995|NCT01574079|16454483|P2|Overall Study|Physician Decision|2
4769996|NCT01574079|16454484|P1|Overall Study|Physician Decision|0
4769997|NCT01573910|16454503|P2|Overall Study|Patient decision unrelated to Advs Event|11
4769998|NCT01573910|16454504|P1|Overall Study|Patient decision unrelated to Advs Event|11
4769999|NCT01573910|16454503|P2|Overall Study|Protocol Violation|0
4770000|NCT01573910|16454504|P1|Overall Study|Protocol Violation|3
4770001|NCT01573910|16454503|P2|Overall Study|Withdrawal by Subject|1
4770002|NCT01573910|16454504|P1|Overall Study|Withdrawal by Subject|0
4770003|NCT01573910|16454503|P2|Overall Study|Lost to Follow-up|1
4770004|NCT01573910|16454504|P1|Overall Study|Lost to Follow-up|2
4770005|NCT01573910|16454503|P2|Overall Study|Adverse Event|4
4770006|NCT01573910|16454504|P1|Overall Study|Adverse Event|4
4770007|NCT01573767|16454516|P4|Overall Study|Withdrawal by Subject|0
4770008|NCT01573767|16454517|P3|Overall Study|Withdrawal by Subject|0
4770009|NCT01573767|16454518|P2|Overall Study|Withdrawal by Subject|1
4770010|NCT01573767|16454519|P1|Overall Study|Withdrawal by Subject|0
4770011|NCT01573767|16454516|P4|Overall Study|Physician Decision|2
4770012|NCT01573767|16454517|P3|Overall Study|Physician Decision|0
4770013|NCT01573767|16454518|P2|Overall Study|Physician Decision|2
4770014|NCT01573767|16454519|P1|Overall Study|Physician Decision|1
4770015|NCT01573767|16454516|P4|Overall Study|Lost to Follow-up|1
4770016|NCT01573767|16454517|P3|Overall Study|Lost to Follow-up|1
4770017|NCT01573767|16454518|P2|Overall Study|Lost to Follow-up|1
4770018|NCT01573767|16454519|P1|Overall Study|Lost to Follow-up|0
4770019|NCT01573767|16454516|P4|Overall Study|Protocol Violation|3
4770020|NCT01573767|16454517|P3|Overall Study|Protocol Violation|1
4770021|NCT01573767|16454518|P2|Overall Study|Protocol Violation|1
4770022|NCT01573767|16454519|P1|Overall Study|Protocol Violation|3
4770023|NCT01573767|16454516|P4|Overall Study|Lack of Efficacy|17
4770024|NCT01573767|16454517|P3|Overall Study|Lack of Efficacy|12
4770025|NCT01573767|16454518|P2|Overall Study|Lack of Efficacy|15
4770026|NCT01573767|16454519|P1|Overall Study|Lack of Efficacy|18
4770027|NCT01573767|16454516|P4|Overall Study|Adverse Event|1
4770028|NCT01573767|16454517|P3|Overall Study|Adverse Event|0
4770029|NCT01573767|16454518|P2|Overall Study|Adverse Event|1
4770030|NCT01573767|16454519|P1|Overall Study|Adverse Event|0
4770031|NCT01573624|16454553|P7|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4770032|NCT01573624|16454554|P6|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4770033|NCT01573624|16454555|P5|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4770034|NCT01573624|16454556|P4|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4770035|NCT01573624|16454557|P3|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4770036|NCT01573624|16454558|P2|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0
4770037|NCT01573624|16454559|P1|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1
4770038|NCT01573624|16454553|P7|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4770039|NCT01573624|16454554|P6|Period 6 : Follow-up Period (7 Days)|Adverse Event|1
4770040|NCT01573624|16454555|P5|Period 6 : Follow-up Period (7 Days)|Adverse Event|2
4770041|NCT01573624|16454556|P4|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4770042|NCT01573624|16454557|P3|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4770043|NCT01573624|16454558|P2|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4770044|NCT01573624|16454559|P1|Period 6 : Follow-up Period (7 Days)|Adverse Event|0
4770045|NCT01573624|16454553|P7|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4770046|NCT01573624|16454554|P6|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4770047|NCT01573624|16454555|P5|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4770048|NCT01573624|16454556|P4|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4770049|NCT01573624|16454557|P3|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4770050|NCT01573624|16454558|P2|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0
4770051|NCT01573624|16454559|P1|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1
4770052|NCT01573624|16454553|P7|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4770053|NCT01573624|16454554|P6|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
4770054|NCT01573624|16454555|P5|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4770055|NCT01573624|16454556|P4|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4770056|NCT01573624|16454557|P3|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4770057|NCT01573624|16454558|P2|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1
4770058|NCT01573624|16454559|P1|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0
4770059|NCT01573624|16454553|P7|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4
4770060|NCT01573624|16454554|P6|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
4770061|NCT01573624|16454555|P5|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1
4770062|NCT01573624|16454556|P4|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
4770063|NCT01573624|16454557|P3|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
4770064|NCT01573624|16454558|P2|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0
4770065|NCT01573624|16454559|P1|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2
4770066|NCT01573624|16454553|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
4770067|NCT01573624|16454554|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4770068|NCT01573624|16454555|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
4770069|NCT01573624|16454556|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4770070|NCT01573624|16454557|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4770071|NCT01573624|16454558|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1
4770072|NCT01573624|16454559|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0
4770073|NCT01573624|16454553|P7|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4770074|NCT01573624|16454554|P6|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1
4770075|NCT01573624|16454555|P5|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4770076|NCT01573624|16454556|P4|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4770077|NCT01573624|16454557|P3|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4770078|NCT01573624|16454558|P2|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4770079|NCT01573624|16454559|P1|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0
4770080|NCT01573624|16454553|P7|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4770081|NCT01573624|16454554|P6|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4770082|NCT01573624|16454555|P5|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4770083|NCT01573624|16454556|P4|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4770084|NCT01573624|16454557|P3|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4770085|NCT01573624|16454558|P2|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1
4770086|NCT01573624|16454559|P1|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0
4770087|NCT01573624|16454553|P7|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4770088|NCT01573624|16454554|P6|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4770089|NCT01573624|16454555|P5|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4770090|NCT01573624|16454556|P4|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4770091|NCT01573624|16454557|P3|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4770092|NCT01573624|16454558|P2|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1
4770093|NCT01573624|16454559|P1|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0
4770094|NCT01573624|16454553|P7|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4770095|NCT01573624|16454554|P6|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
4770096|NCT01573624|16454555|P5|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4770097|NCT01573624|16454556|P4|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4770098|NCT01573624|16454557|P3|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4770099|NCT01573624|16454558|P2|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1
4770100|NCT01573624|16454559|P1|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0
4770101|NCT01573624|16454553|P7|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
4770102|NCT01573624|16454554|P6|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4770103|NCT01573624|16454555|P5|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4770104|NCT01573624|16454556|P4|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4770105|NCT01573624|16454557|P3|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4770106|NCT01573624|16454558|P2|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0
4770107|NCT01573624|16454559|P1|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1
4770108|NCT01573624|16454553|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4770109|NCT01573624|16454554|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4770110|NCT01573624|16454555|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4770111|NCT01573624|16454556|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4770112|NCT01573624|16454557|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4770113|NCT01573624|16454558|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0
4770114|NCT01573624|16454559|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1
4770115|NCT01573624|16454553|P7|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4770116|NCT01573624|16454554|P6|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4770117|NCT01573624|16454555|P5|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4770118|NCT01573624|16454556|P4|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4770119|NCT01573624|16454557|P3|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4770120|NCT01573624|16454558|P2|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4770121|NCT01573624|16454559|P1|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4770122|NCT01573624|16454553|P7|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4770123|NCT01573624|16454554|P6|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4770124|NCT01573624|16454555|P5|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4770125|NCT01573624|16454556|P4|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4770126|NCT01573624|16454557|P3|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4770127|NCT01573624|16454558|P2|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0
4770128|NCT01573624|16454559|P1|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1
4770129|NCT01573624|16454553|P7|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4770130|NCT01573624|16454554|P6|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2
4770131|NCT01573624|16454555|P5|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4770132|NCT01573624|16454556|P4|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4770133|NCT01573624|16454557|P3|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4770134|NCT01573624|16454558|P2|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1
4770135|NCT01573624|16454559|P1|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0
4770136|NCT01573624|16454553|P7|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0
4770137|NCT01573624|16454554|P6|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
4770138|NCT01573624|16454555|P5|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3
4770139|NCT01573624|16454556|P4|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1
4770140|NCT01573624|16454557|P3|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2
4770141|NCT01573624|16454558|P2|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4
4770142|NCT01573624|16454559|P1|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5
4770143|NCT01573624|16454553|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4770144|NCT01573624|16454554|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
4770145|NCT01573624|16454555|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4770146|NCT01573624|16454556|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
4770147|NCT01573624|16454557|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1
4770148|NCT01573624|16454558|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4770149|NCT01573624|16454559|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0
4770150|NCT01573624|16454553|P7|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1
4770151|NCT01573624|16454554|P6|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4770152|NCT01573624|16454555|P5|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4770153|NCT01573624|16454556|P4|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2
4770154|NCT01573624|16454557|P3|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4770155|NCT01573624|16454558|P2|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4770156|NCT01573624|16454559|P1|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0
4770157|NCT01573624|16454553|P7|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4770158|NCT01573624|16454554|P6|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1
4770159|NCT01573624|16454555|P5|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4770160|NCT01573624|16454556|P4|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4770161|NCT01573624|16454557|P3|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4770162|NCT01573624|16454558|P2|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4770163|NCT01573624|16454559|P1|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0
4770164|NCT01573624|16454553|P7|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4770165|NCT01573624|16454554|P6|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4770166|NCT01573624|16454555|P5|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4770167|NCT01573624|16454556|P4|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
4770168|NCT01573624|16454557|P3|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2
4770169|NCT01573624|16454558|P2|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0
4770170|NCT01573624|16454559|P1|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1
4770171|NCT01573624|16454553|P7|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
4770172|NCT01573624|16454554|P6|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4770173|NCT01573624|16454555|P5|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4770174|NCT01573624|16454556|P4|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
4770175|NCT01573624|16454557|P3|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4770176|NCT01573624|16454558|P2|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1
4770177|NCT01573624|16454559|P1|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0
4770178|NCT01573624|16454553|P7|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4770179|NCT01573624|16454554|P6|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1
4770180|NCT01573624|16454555|P5|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4770181|NCT01573624|16454556|P4|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4770182|NCT01573624|16454557|P3|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4770183|NCT01573624|16454558|P2|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4770184|NCT01573624|16454559|P1|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0
4770185|NCT01573624|16454553|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4770186|NCT01573624|16454554|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4770187|NCT01573624|16454555|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
4770188|NCT01573624|16454556|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4770189|NCT01573624|16454557|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1
4770190|NCT01573624|16454558|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
4770191|NCT01573624|16454559|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0
4770192|NCT01573624|16454553|P7|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4770193|NCT01573624|16454554|P6|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2
4770194|NCT01573624|16454555|P5|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4770195|NCT01573624|16454556|P4|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4770196|NCT01573624|16454557|P3|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4770197|NCT01573624|16454558|P2|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0
4770198|NCT01573624|16454559|P1|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1
4770199|NCT01573624|16454553|P7|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4770200|NCT01573624|16454554|P6|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4770201|NCT01573624|16454555|P5|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4770202|NCT01573624|16454556|P4|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4770203|NCT01573624|16454557|P3|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4770204|NCT01573624|16454558|P2|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0
4770205|NCT01573624|16454559|P1|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1
4770206|NCT01573624|16454553|P7|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
4770207|NCT01573624|16454554|P6|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0
4770208|NCT01573624|16454555|P5|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2
4770209|NCT01573624|16454556|P4|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1
4770210|NCT01573624|16454557|P3|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6
4770211|NCT01573624|16454558|P2|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3
4770212|NCT01573624|16454559|P1|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4
4770213|NCT01573624|16454553|P7|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4770214|NCT01573624|16454554|P6|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
4770215|NCT01573624|16454555|P5|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4770216|NCT01573624|16454556|P4|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4770217|NCT01573624|16454557|P3|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1
4770218|NCT01573624|16454558|P2|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4770219|NCT01573624|16454559|P1|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0
4770220|NCT01573442|16454619|P2|Overall Study|Cancels|10
4770221|NCT01573442|16454620|P1|Overall Study|Cancels|9
4770222|NCT01573000|16454764|P2|Long-Term Follow-Up|Lost to Follow-up|1
4770223|NCT01573000|16454765|P1|Long-Term Follow-Up|Lost to Follow-up|0
4770224|NCT01573000|16454764|P2|Long-Term Follow-Up|Death|0
4770225|NCT01573000|16454765|P1|Long-Term Follow-Up|Death|3
4770226|NCT01573000|16454764|P2|Crossover Phase|Death|3
4770227|NCT01573000|16454765|P1|Crossover Phase|Death|0
4770228|NCT01573000|16454764|P2|Crossover Phase|Lost to Follow-up|2
4770229|NCT01573000|16454765|P1|Crossover Phase|Lost to Follow-up|0
4770230|NCT01573000|16454764|P2|Crossover Phase|Lack of Efficacy|13
4770231|NCT01573000|16454765|P1|Crossover Phase|Lack of Efficacy|0
4770232|NCT01573000|16454764|P2|Dosimetric and Therapeutic Treatment|Received Other Treatment|0
4770233|NCT01573000|16454765|P1|Dosimetric and Therapeutic Treatment|Received Other Treatment|2
4770234|NCT01573000|16454764|P2|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0
4770235|NCT01573000|16454765|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2
4770236|NCT01573000|16454764|P2|Dosimetric and Therapeutic Treatment|Death|1
4770237|NCT01573000|16454765|P1|Dosimetric and Therapeutic Treatment|Death|0
4770238|NCT01573000|16454764|P2|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
4770239|NCT01573000|16454765|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4
4770240|NCT01573000|16454764|P2|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32
4770241|NCT01573000|16454765|P1|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27
4770242|NCT01572948|16454861|P2|Overall Study|unable to contact|1
4770243|NCT01572948|16454862|P1|Overall Study|unable to contact|0
4770244|NCT01572948|16454861|P2|Overall Study|Lost to Follow-up|0
4770245|NCT01572948|16454862|P1|Overall Study|Lost to Follow-up|1
4770246|NCT01572922|16454878|P1|Overall Study|Death|1
4770247|NCT01572922|16454878|P1|Overall Study|Protocol Violation|1
4770248|NCT01572922|16454878|P1|Overall Study|Adverse Event|1
4770249|NCT01572909|16454890|P2|Overall Study|Infarct, comorbidity, Pt refusal of exam|3
4770250|NCT01572909|16454891|P1|Overall Study|Infarct, comorbidity, Pt refusal of exam|0
4770251|NCT01572909|16454890|P2|Overall Study|Withdrawal by Subject|11
4770252|NCT01572909|16454891|P1|Overall Study|Withdrawal by Subject|12
4770253|NCT01572909|16454890|P2|Overall Study|Technical Issues|0
4770254|NCT01572909|16454891|P1|Overall Study|Technical Issues|1
4770255|NCT01572909|16454890|P2|Overall Study|Physician Decision|1
4770256|NCT01572909|16454891|P1|Overall Study|Physician Decision|1
4770257|NCT01572909|16454890|P2|Overall Study|Lost to Follow-up|7
4770258|NCT01572909|16454891|P1|Overall Study|Lost to Follow-up|8
4770259|NCT01572909|16454890|P2|Overall Study|Death|1
4770260|NCT01572909|16454891|P1|Overall Study|Death|3
4770261|NCT01572909|16454890|P2|Overall Study|Adverse Event|2
4770262|NCT01572909|16454891|P1|Overall Study|Adverse Event|7
4770263|NCT01572844|16454935|P2|Overall Study|Physician Decision|1
4770264|NCT01572844|16454936|P1|Overall Study|Physician Decision|1
4770265|NCT01572792|16454954|P5|Extension Study|Site termination/COPD exacerbation/other|6
4770266|NCT01572792|16454955|P4|Extension Study|Site termination/COPD exacerbation/other|6
4770267|NCT01572792|16454956|P3|Extension Study|Site termination/COPD exacerbation/other|4
4770268|NCT01572792|16454957|P2|Extension Study|Site termination/COPD exacerbation/other|8
4770269|NCT01572792|16454958|P1|Extension Study|Site termination/COPD exacerbation/other|3
4770270|NCT01572792|16454954|P5|Extension Study|Adverse Event|4
4770271|NCT01572792|16454955|P4|Extension Study|Adverse Event|6
4770272|NCT01572792|16454956|P3|Extension Study|Adverse Event|5
4770273|NCT01572792|16454957|P2|Extension Study|Adverse Event|6
4770274|NCT01572792|16454958|P1|Extension Study|Adverse Event|7
4770275|NCT01572792|16454954|P5|Extension Study|Lack of Efficacy|2
4770276|NCT01572792|16454955|P4|Extension Study|Lack of Efficacy|2
4770277|NCT01572792|16454956|P3|Extension Study|Lack of Efficacy|3
4770278|NCT01572792|16454957|P2|Extension Study|Lack of Efficacy|3
4770279|NCT01572792|16454958|P1|Extension Study|Lack of Efficacy|2
4770280|NCT01572792|16454954|P5|Extension Study|Protocol Violation|3
4770281|NCT01572792|16454955|P4|Extension Study|Protocol Violation|4
4770282|NCT01572792|16454956|P3|Extension Study|Protocol Violation|3
4770283|NCT01572792|16454957|P2|Extension Study|Protocol Violation|4
4770284|NCT01572792|16454958|P1|Extension Study|Protocol Violation|0
4770285|NCT01572792|16454954|P5|Extension Study|Withdrawal by Subject|14
4770286|NCT01572792|16454955|P4|Extension Study|Withdrawal by Subject|8
4770287|NCT01572792|16454956|P3|Extension Study|Withdrawal by Subject|11
4770288|NCT01572792|16454957|P2|Extension Study|Withdrawal by Subject|6
4770289|NCT01572792|16454958|P1|Extension Study|Withdrawal by Subject|7
4770290|NCT01572792|16454954|P5|Extension Study|Lost to Follow-up|3
4770291|NCT01572792|16454955|P4|Extension Study|Lost to Follow-up|3
4770292|NCT01572792|16454956|P3|Extension Study|Lost to Follow-up|0
4770293|NCT01572792|16454957|P2|Extension Study|Lost to Follow-up|2
4770294|NCT01572792|16454958|P1|Extension Study|Lost to Follow-up|6
4770295|NCT01572792|16454954|P5|Lead-in Study|Site termination/COPD exacerbation/other|9
4770296|NCT01572792|16454955|P4|Lead-in Study|Site termination/COPD exacerbation/other|9
4770297|NCT01572792|16454956|P3|Lead-in Study|Site termination/COPD exacerbation/other|8
4770298|NCT01572792|16454957|P2|Lead-in Study|Site termination/COPD exacerbation/other|10
4770299|NCT01572792|16454958|P1|Lead-in Study|Site termination/COPD exacerbation/other|14
4770300|NCT01572792|16454954|P5|Lead-in Study|Adverse Event|14
4770301|NCT01572792|16454955|P4|Lead-in Study|Adverse Event|16
4770302|NCT01572792|16454956|P3|Lead-in Study|Adverse Event|22
4770303|NCT01572792|16454957|P2|Lead-in Study|Adverse Event|21
4770304|NCT01572792|16454958|P1|Lead-in Study|Adverse Event|21
4770305|NCT01572792|16454954|P5|Lead-in Study|Lack of Efficacy|10
4770306|NCT01572792|16454955|P4|Lead-in Study|Lack of Efficacy|8
4770307|NCT01572792|16454956|P3|Lead-in Study|Lack of Efficacy|4
4770308|NCT01572792|16454957|P2|Lead-in Study|Lack of Efficacy|5
4770309|NCT01572792|16454958|P1|Lead-in Study|Lack of Efficacy|20
4770310|NCT01572792|16454954|P5|Lead-in Study|Protocol Violation|21
4770311|NCT01572792|16454955|P4|Lead-in Study|Protocol Violation|13
4770312|NCT01572792|16454956|P3|Lead-in Study|Protocol Violation|12
4770313|NCT01572792|16454957|P2|Lead-in Study|Protocol Violation|10
4770314|NCT01572792|16454958|P1|Lead-in Study|Protocol Violation|19
4770315|NCT01572792|16454954|P5|Lead-in Study|Withdrawal by Subject|11
4770316|NCT01572792|16454955|P4|Lead-in Study|Withdrawal by Subject|24
4770317|NCT01572792|16454956|P3|Lead-in Study|Withdrawal by Subject|12
4770318|NCT01572792|16454957|P2|Lead-in Study|Withdrawal by Subject|11
4770319|NCT01572792|16454958|P1|Lead-in Study|Withdrawal by Subject|22
4770320|NCT01572792|16454954|P5|Lead-in Study|Lost to Follow-up|4
4770321|NCT01572792|16454955|P4|Lead-in Study|Lost to Follow-up|2
4770322|NCT01572792|16454956|P3|Lead-in Study|Lost to Follow-up|4
4770323|NCT01572792|16454957|P2|Lead-in Study|Lost to Follow-up|9
4770324|NCT01572792|16454958|P1|Lead-in Study|Lost to Follow-up|5
4770325|NCT01572740|16455007|P2|Overall Study|unclassified|3
4770326|NCT01572740|16455008|P1|Overall Study|unclassified|4
4770327|NCT01572740|16455007|P2|Overall Study|Withdrawal by Subject|1
4770328|NCT01572740|16455008|P1|Overall Study|Withdrawal by Subject|1
4770329|NCT01572740|16455007|P2|Overall Study|Adverse Event|1
4770330|NCT01572740|16455008|P1|Overall Study|Adverse Event|1
4770331|NCT01572727|16455038|P2|Overall Study|Untreated|7
4770332|NCT01572727|16455039|P1|Overall Study|Untreated|4
4770333|NCT01572727|16455038|P2|Overall Study|Death|2
4770334|NCT01572727|16455039|P1|Overall Study|Death|2
4770335|NCT01572727|16455038|P2|Overall Study|Parent/guardian decision|9
4770336|NCT01572727|16455039|P1|Overall Study|Parent/guardian decision|14
4770337|NCT01572727|16455038|P2|Overall Study|Study terminated by sponsor|83
4770338|NCT01572727|16455039|P1|Overall Study|Study terminated by sponsor|61
4770339|NCT01572727|16455038|P2|Overall Study|Protocol Violation|1
4770340|NCT01572727|16455039|P1|Overall Study|Protocol Violation|0
4770341|NCT01572727|16455038|P2|Overall Study|Progressive disease|82
4770342|NCT01572727|16455039|P1|Overall Study|Progressive disease|59
4770343|NCT01572727|16455038|P2|Overall Study|Physician Decision|9
4770344|NCT01572727|16455039|P1|Overall Study|Physician Decision|23
4770345|NCT01572727|16455038|P2|Overall Study|Lost to Follow-up|1
4770346|NCT01572727|16455039|P1|Overall Study|Lost to Follow-up|1
4770347|NCT01572727|16455038|P2|Overall Study|Adverse Event|15
4770348|NCT01572727|16455039|P1|Overall Study|Adverse Event|43
4770349|NCT01572675|16455061|P2|Overall Study|Lost to Follow-up|27
4770350|NCT01572675|16455062|P1|Overall Study|Lost to Follow-up|22
4770351|NCT01572675|16455061|P2|Overall Study|Missing data|4
4770352|NCT01572675|16455062|P1|Overall Study|Missing data|1
4770353|NCT01572675|16455061|P2|Overall Study|Rheumatologist new evaluation|1
4770354|NCT01572675|16455062|P1|Overall Study|Rheumatologist new evaluation|0
4770355|NCT01572675|16455061|P2|Overall Study|Unknown reason|1
4770356|NCT01572675|16455062|P1|Overall Study|Unknown reason|1
4770357|NCT01572675|16455061|P2|Overall Study|Other disease detected|1
4770358|NCT01572675|16455062|P1|Overall Study|Other disease detected|1
4770359|NCT01572675|16455061|P2|Overall Study|Death unrelated to coxibs|1
4770360|NCT01572675|16455062|P1|Overall Study|Death unrelated to coxibs|1
4770361|NCT01572675|16455061|P2|Overall Study|Physician Decision|2
4770362|NCT01572675|16455062|P1|Overall Study|Physician Decision|2
4770363|NCT01572675|16455061|P2|Overall Study|Withdrawal by Subject|1
4770364|NCT01572675|16455062|P1|Overall Study|Withdrawal by Subject|5
4770365|NCT01572675|16455061|P2|Overall Study|Surgical intervention|6
4770366|NCT01572675|16455062|P1|Overall Study|Surgical intervention|3
4770367|NCT01572675|16455061|P2|Overall Study|Improved symptoms|2
4770368|NCT01572675|16455062|P1|Overall Study|Improved symptoms|8
4770369|NCT01572675|16455061|P2|Overall Study|Intolerance|5
4770370|NCT01572675|16455062|P1|Overall Study|Intolerance|6
4770371|NCT01572675|16455061|P2|Overall Study|Lack of Efficacy|31
4770372|NCT01572675|16455062|P1|Overall Study|Lack of Efficacy|31
4770373|NCT01572675|16455061|P2|Overall Study|Recovery|23
4770374|NCT01572675|16455062|P1|Overall Study|Recovery|16
4770375|NCT01572675|16455061|P2|Overall Study|End of prescribed treatment|118
4770376|NCT01572675|16455062|P1|Overall Study|End of prescribed treatment|140
4770377|NCT01572389|16455180|P2|Overall Study|Only A1C or Assessment was Collected|2
4770378|NCT01572389|16455181|P1|Overall Study|Only A1C or Assessment was Collected|6
4770379|NCT01572389|16455180|P2|Overall Study|Lost to Follow-up|14
4770380|NCT01572389|16455181|P1|Overall Study|Lost to Follow-up|25
4770381|NCT01572389|16455180|P2|Overall Study|Withdrawal by Subject|2
4770382|NCT01572389|16455181|P1|Overall Study|Withdrawal by Subject|14
4770383|NCT01572389|16455180|P2|Overall Study|Death|3
4770384|NCT01572389|16455181|P1|Overall Study|Death|1
4770385|NCT01572038|16455213|P1|Overall Study|Sponsor Decision|1
4770386|NCT01572038|16455213|P1|Overall Study|Patient Deterioration|1
4770387|NCT01572038|16455213|P1|Overall Study|Termination by Sponsor|2
4770388|NCT01572038|16455213|P1|Overall Study|Participated in Another Trial|3
4770389|NCT01572038|16455213|P1|Overall Study|Enrolled into Another Trial|3
4770390|NCT01572038|16455213|P1|Overall Study|Site Closed Before Completing Form|6
4770391|NCT01572038|16455213|P1|Overall Study|Progressive Disease|8
4770392|NCT01572038|16455213|P1|Overall Study|Patient Decision|14
4770393|NCT01572038|16455213|P1|Overall Study|Physician Decision|20
4770394|NCT01572038|16455213|P1|Overall Study|Lost to Follow-up|81
4770395|NCT01572038|16455213|P1|Overall Study|Withdrawal by Subject|204
4770396|NCT01572038|16455213|P1|Overall Study|Death|648
4770397|NCT01571453|16455328|P2|Overall Study|Administrative or other reason(s)|3
4770398|NCT01571453|16455329|P1|Overall Study|Administrative or other reason(s)|4
4770399|NCT01571453|16455328|P2|Overall Study|Lost to Follow-up|2
4770400|NCT01571453|16455329|P1|Overall Study|Lost to Follow-up|4
4770401|NCT01571453|16455328|P2|Overall Study|Withdrawal of consent|13
4770402|NCT01571453|16455329|P1|Overall Study|Withdrawal of consent|5
4770403|NCT01571453|16455328|P2|Overall Study|Protocol Violation|5
4770404|NCT01571453|16455329|P1|Overall Study|Protocol Violation|1
4770405|NCT01571453|16455328|P2|Overall Study|Non-compliance|4
4770406|NCT01571453|16455329|P1|Overall Study|Non-compliance|2
4770407|NCT01571453|16455328|P2|Overall Study|Lack of Efficacy|3
4770408|NCT01571453|16455329|P1|Overall Study|Lack of Efficacy|8
4770409|NCT01571453|16455328|P2|Overall Study|Adverse Event|32
4770410|NCT01571453|16455329|P1|Overall Study|Adverse Event|14
4770411|NCT01571362|16455376|P3|Double-Blind Treatment Period|Other - unspecified|1
4770412|NCT01571362|16455377|P2|Double-Blind Treatment Period|Other - unspecified|6
4770413|NCT01571362|16455378|P1|Double-Blind Treatment Period|Other - unspecified|0
4770414|NCT01571362|16455376|P3|Double-Blind Treatment Period|Insufficient clinical response|4
4770415|NCT01571362|16455377|P2|Double-Blind Treatment Period|Insufficient clinical response|16
4770416|NCT01571362|16455378|P1|Double-Blind Treatment Period|Insufficient clinical response|0
4770417|NCT01571362|16455376|P3|Double-Blind Treatment Period|Lost to Follow-up|6
4770418|NCT01571362|16455377|P2|Double-Blind Treatment Period|Lost to Follow-up|3
4770419|NCT01571362|16455378|P1|Double-Blind Treatment Period|Lost to Follow-up|0
4770420|NCT01571362|16455376|P3|Double-Blind Treatment Period|Adverse Event|14
4770421|NCT01571362|16455377|P2|Double-Blind Treatment Period|Adverse Event|9
4770422|NCT01571362|16455378|P1|Double-Blind Treatment Period|Adverse Event|0
4770423|NCT01571362|16455376|P3|Double-Blind Treatment Period|Protocol Violation|9
4770424|NCT01571362|16455377|P2|Double-Blind Treatment Period|Protocol Violation|8
4770425|NCT01571362|16455378|P1|Double-Blind Treatment Period|Protocol Violation|0
4770426|NCT01571362|16455376|P3|Double-Blind Treatment Period|Withdrawal by Subject|5
4770427|NCT01571362|16455377|P2|Double-Blind Treatment Period|Withdrawal by Subject|11
4770428|NCT01571362|16455378|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
4770429|NCT01571362|16455376|P3|Open-Label Conversion + Titration Period|Other - unspecified|0
4770430|NCT01571362|16455377|P2|Open-Label Conversion + Titration Period|Other - unspecified|0
4770431|NCT01571362|16455378|P1|Open-Label Conversion + Titration Period|Other - unspecified|3
4770432|NCT01571362|16455376|P3|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
4770433|NCT01571362|16455377|P2|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0
4770434|NCT01571362|16455378|P1|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41
4770435|NCT01571362|16455376|P3|Open-Label Conversion + Titration Period|Lost to Follow-up|0
4770436|NCT01571362|16455377|P2|Open-Label Conversion + Titration Period|Lost to Follow-up|0
4770437|NCT01571362|16455378|P1|Open-Label Conversion + Titration Period|Lost to Follow-up|10
4770438|NCT01571362|16455376|P3|Open-Label Conversion + Titration Period|Adverse Event|0
4770439|NCT01571362|16455377|P2|Open-Label Conversion + Titration Period|Adverse Event|0
4770440|NCT01571362|16455378|P1|Open-Label Conversion + Titration Period|Adverse Event|57
4770441|NCT01571362|16455376|P3|Open-Label Conversion + Titration Period|Protocol Violation|0
4770442|NCT01571362|16455377|P2|Open-Label Conversion + Titration Period|Protocol Violation|0
4770443|NCT01571362|16455378|P1|Open-Label Conversion + Titration Period|Protocol Violation|7
4770444|NCT01571362|16455376|P3|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
4770445|NCT01571362|16455377|P2|Open-Label Conversion + Titration Period|Withdrawal by Subject|0
4770446|NCT01571362|16455378|P1|Open-Label Conversion + Titration Period|Withdrawal by Subject|11
4770447|NCT01571284|16455548|P1|Overall Study|Other than specified above|80
4770448|NCT01571284|16455548|P1|Overall Study|Enrolled but not treated|2
4770449|NCT01571284|16455548|P1|Overall Study|Lost to Follow-up|3
4770450|NCT01571284|16455548|P1|Overall Study|Participant's decision|84
4770451|NCT01571232|16455571|P2|Overall Study|Withdrawal by Subject|0
4770452|NCT01571232|16455572|P1|Overall Study|Withdrawal by Subject|1
4770453|NCT01571232|16455571|P2|Overall Study|Lost to Follow-up|1
4770454|NCT01571232|16455572|P1|Overall Study|Lost to Follow-up|0
4770455|NCT01570868|16455584|P2|Overall Study|Withdrawal by Subject|0
4770456|NCT01570868|16455585|P1|Overall Study|Withdrawal by Subject|1
4770457|NCT01570868|16455584|P2|Overall Study|Lost to Follow-up|0
4770458|NCT01570868|16455585|P1|Overall Study|Lost to Follow-up|1
4770459|NCT01570868|16455584|P2|Overall Study|Physician Decision|4
4770460|NCT01570868|16455585|P1|Overall Study|Physician Decision|10
4770461|NCT01570868|16455584|P2|Overall Study|FDA Recommendation|3
4770462|NCT01570868|16455585|P1|Overall Study|FDA Recommendation|23
4770463|NCT01570868|16455584|P2|Overall Study|Adverse Event|1
4770464|NCT01570868|16455585|P1|Overall Study|Adverse Event|8
4770465|NCT01570751|16455597|P2|Period B (16 Weeks)|Protocol Violation|1
4770466|NCT01570751|16455598|P1|Period B (16 Weeks)|Protocol Violation|0
4770467|NCT01570751|16455597|P2|Period B (16 Weeks)|Adverse Event|0
4770468|NCT01570751|16455598|P1|Period B (16 Weeks)|Adverse Event|1
4770469|NCT01570751|16455597|P2|Period A (16 Weeks)|Unclassified|3
4770470|NCT01570751|16455598|P1|Period A (16 Weeks)|Unclassified|2
4770471|NCT01570751|16455597|P2|Period A (16 Weeks)|Withdrawal criteria|1
4770472|NCT01570751|16455598|P1|Period A (16 Weeks)|Withdrawal criteria|0
4770473|NCT01570751|16455597|P2|Period A (16 Weeks)|Protocol Violation|1
4770474|NCT01570751|16455598|P1|Period A (16 Weeks)|Protocol Violation|1
4770475|NCT01570686|16455616|P2|Overall Study|Unsatisfactory therapeutic effect|1
4770476|NCT01570686|16455617|P1|Overall Study|Unsatisfactory therapeutic effect|2
4770477|NCT01570686|16455616|P2|Overall Study|Withdrawal by Subject|4
4770478|NCT01570686|16455617|P1|Overall Study|Withdrawal by Subject|4
4770479|NCT01570686|16455616|P2|Overall Study|Protocol Deviation|0
4770480|NCT01570686|16455617|P1|Overall Study|Protocol Deviation|3
4770481|NCT01570686|16455616|P2|Overall Study|Lost to Follow-up|3
4770482|NCT01570686|16455617|P1|Overall Study|Lost to Follow-up|4
4770483|NCT01570686|16455616|P2|Overall Study|Adverse Event|6
4770484|NCT01570686|16455617|P1|Overall Study|Adverse Event|8
4770485|NCT01570686|16455616|P2|Overall Study|Administrative problems|1
4770486|NCT01570686|16455617|P1|Overall Study|Administrative problems|0
4770487|NCT01570686|16455616|P2|Overall Study|Abnormal test procedure result(s)|1
4770488|NCT01570686|16455617|P1|Overall Study|Abnormal test procedure result(s)|1
4770489|NCT01570491|16455653|P2|Overall Study|treatment: not given or discontinued|0
4770490|NCT01570491|16455654|P1|Overall Study|treatment: not given or discontinued|2
4770491|NCT01570491|16455653|P2|Overall Study|Lost to Follow-up|1
4770492|NCT01570491|16455654|P1|Overall Study|Lost to Follow-up|3
4770493|NCT01570387|16455670|P4|Overall Study|Withdrawal by Subject|1
4770494|NCT01570387|16455671|P3|Overall Study|Withdrawal by Subject|0
4770495|NCT01570387|16455672|P2|Overall Study|Withdrawal by Subject|0
4770496|NCT01570387|16455673|P1|Overall Study|Withdrawal by Subject|0
4770497|NCT01570387|16455670|P4|Overall Study|Death|1
4770498|NCT01570387|16455671|P3|Overall Study|Death|0
4770499|NCT01570387|16455672|P2|Overall Study|Death|0
4770500|NCT01570387|16455673|P1|Overall Study|Death|0
4770501|NCT01570387|16455670|P4|Overall Study|Adverse Event|0
4770502|NCT01570387|16455671|P3|Overall Study|Adverse Event|0
4770503|NCT01570387|16455672|P2|Overall Study|Adverse Event|0
4770504|NCT01570387|16455673|P1|Overall Study|Adverse Event|1
4770505|NCT01570361|16455685|P2|Overall Study|Other|2
4770506|NCT01570361|16455686|P1|Overall Study|Other|0
4770507|NCT01570361|16455685|P2|Overall Study|Death|4
4770508|NCT01570361|16455686|P1|Overall Study|Death|5
4770509|NCT01570361|16455685|P2|Overall Study|Lost to Follow-up|4
4770510|NCT01570361|16455686|P1|Overall Study|Lost to Follow-up|4
4770511|NCT01570361|16455685|P2|Overall Study|Adverse Event|1
4770512|NCT01570361|16455686|P1|Overall Study|Adverse Event|2
4770513|NCT01570361|16455685|P2|Overall Study|Subject withdrew consent|9
4770514|NCT01570361|16455686|P1|Overall Study|Subject withdrew consent|14
4770515|NCT01570361|16455685|P2|Overall Study|Subject excluded|3
4770516|NCT01570361|16455686|P1|Overall Study|Subject excluded|5
4770517|NCT01570361|16455685|P2|Overall Study|Sponsor closing the study|50
4770518|NCT01570361|16455686|P1|Overall Study|Sponsor closing the study|51
4770519|NCT01570361|16455685|P2|Overall Study|Subject discontinued|2
4770520|NCT01570361|16455686|P1|Overall Study|Subject discontinued|1
4770521|NCT01570309|16455729|P2|Overall Study|Withdrawal by Subject|3
4770522|NCT01570309|16455730|P1|Overall Study|Withdrawal by Subject|3
4770523|NCT01570283|16455747|P6|Cohort 3: Dose Level 3|Received other hematopoietic cells|1
4770524|NCT01570283|16455748|P5|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4770525|NCT01570283|16455749|P4|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4770526|NCT01570283|16455750|P3|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4770527|NCT01570283|16455751|P2|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4770528|NCT01570283|16455752|P1|Cohort 3: Dose Level 3|Received other hematopoietic cells|0
4770529|NCT01570283|16455747|P6|Cohort 3: Dose Level 3|Death|1
4770530|NCT01570283|16455748|P5|Cohort 3: Dose Level 3|Death|0
4770531|NCT01570283|16455749|P4|Cohort 3: Dose Level 3|Death|0
4770532|NCT01570283|16455750|P3|Cohort 3: Dose Level 3|Death|0
4770533|NCT01570283|16455751|P2|Cohort 3: Dose Level 3|Death|0
4770534|NCT01570283|16455752|P1|Cohort 3: Dose Level 3|Death|0
4770535|NCT01570283|16455747|P6|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4770536|NCT01570283|16455748|P5|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4770537|NCT01570283|16455749|P4|Cohort 2: Dose Level 2|Received other hematopoietic cells|1
4770538|NCT01570283|16455750|P3|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4770539|NCT01570283|16455751|P2|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4770540|NCT01570283|16455752|P1|Cohort 2: Dose Level 2|Received other hematopoietic cells|0
4770541|NCT01570283|16455747|P6|Cohort 2: Dose Level 2|Death|0
4770542|NCT01570283|16455748|P5|Cohort 2: Dose Level 2|Death|0
4770543|NCT01570283|16455749|P4|Cohort 2: Dose Level 2|Death|0
4770544|NCT01570283|16455750|P3|Cohort 2: Dose Level 2|Death|1
4770545|NCT01570283|16455751|P2|Cohort 2: Dose Level 2|Death|0
4770546|NCT01570283|16455752|P1|Cohort 2: Dose Level 2|Death|0
4770547|NCT01570283|16455747|P6|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4770548|NCT01570283|16455748|P5|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4770549|NCT01570283|16455749|P4|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4770550|NCT01570283|16455750|P3|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4770551|NCT01570283|16455751|P2|Cohort 1: Dose Level 1|Received other hematopoietic cells|1
4770552|NCT01570283|16455752|P1|Cohort 1: Dose Level 1|Received other hematopoietic cells|0
4770553|NCT01570283|16455747|P6|Cohort 1: Dose Level 1|Death|0
4770554|NCT01570283|16455748|P5|Cohort 1: Dose Level 1|Death|0
4770555|NCT01570283|16455749|P4|Cohort 1: Dose Level 1|Death|0
4770556|NCT01570283|16455750|P3|Cohort 1: Dose Level 1|Death|0
4770557|NCT01570283|16455751|P2|Cohort 1: Dose Level 1|Death|1
4770558|NCT01570283|16455752|P1|Cohort 1: Dose Level 1|Death|0
4770559|NCT01570244|16455769|P1|Microgynon+Faldaprevir|Adverse Event|1
4770560|NCT01570192|16455791|P2|Overall Study|Physician Decision|1
4770561|NCT01570192|16455792|P1|Overall Study|Physician Decision|0
4770562|NCT01570192|16455791|P2|Overall Study|changed to palliative care|0
4770563|NCT01570192|16455792|P1|Overall Study|changed to palliative care|1
4770564|NCT01570192|16455791|P2|Overall Study|no qualifying organism|12
4770565|NCT01570192|16455792|P1|Overall Study|no qualifying organism|6
4770566|NCT01569841|16455830|P2|Period A (6 Weeks)|Withdrawal by Subject|1
4770567|NCT01569841|16455831|P1|Period A (6 Weeks)|Withdrawal by Subject|0
4770568|NCT01569763|16455920|P2|Overall Study|Adverse Event|0
4770569|NCT01569763|16455921|P1|Overall Study|Adverse Event|1
4770570|NCT01569763|16455920|P2|Overall Study|Lack of Efficacy|7
4770571|NCT01569763|16455921|P1|Overall Study|Lack of Efficacy|2
4770572|NCT01569594|16455960|P1|Overall Study|No ECM used|9
4770573|NCT01569594|16455960|P1|Overall Study|Other|4
4770574|NCT01569594|16455960|P1|Overall Study|Withdrawal by Subject|13
4770575|NCT01569594|16455960|P1|Overall Study|Adverse Event|2
4770576|NCT01569594|16455960|P1|Overall Study|Lost to Follow-up|22
4770577|NCT01569594|16455960|P1|Overall Study|Death|13
4770578|NCT01569594|16455960|P1|Overall Study|Physician Decision|4
4770579|NCT01569568|16455966|P2|Overall Study|Physician Decision|2
4770580|NCT01569568|16455967|P1|Overall Study|Physician Decision|0
4770581|NCT01569464|16455990|P2|Overall Study|Other|1
4770582|NCT01569464|16455991|P1|Overall Study|Other|1
4770583|NCT01569464|16455990|P2|Overall Study|Withdrawal by Subject|1
4770584|NCT01569464|16455991|P1|Overall Study|Withdrawal by Subject|1
4770585|NCT01569464|16455990|P2|Overall Study|Lost to Follow-up|3
4770586|NCT01569464|16455991|P1|Overall Study|Lost to Follow-up|2
4770587|NCT01569464|16455990|P2|Overall Study|Protocol Violation|0
4770588|NCT01569464|16455991|P1|Overall Study|Protocol Violation|1
4770589|NCT01569464|16455990|P2|Overall Study|Lack of Efficacy|0
4770590|NCT01569464|16455991|P1|Overall Study|Lack of Efficacy|1
4770591|NCT01569464|16455990|P2|Overall Study|Adverse Event|0
4770592|NCT01569464|16455991|P1|Overall Study|Adverse Event|4
4770593|NCT01569438|16456058|P2|Overall Study|Unable to adhere to study schedule|1
4770594|NCT01569438|16456059|P1|Overall Study|Unable to adhere to study schedule|0
4770595|NCT01569438|16456058|P2|Overall Study|Sponsor/Physician decision|1
4770596|NCT01569438|16456059|P1|Overall Study|Sponsor/Physician decision|1
4770597|NCT01569438|16456058|P2|Overall Study|Decrease of GFR greater than 30 ml/min|0
4770598|NCT01569438|16456059|P1|Overall Study|Decrease of GFR greater than 30 ml/min|1
4770599|NCT01569438|16456058|P2|Overall Study|Protocol Violation|0
4770600|NCT01569438|16456059|P1|Overall Study|Protocol Violation|2
4770601|NCT01569438|16456058|P2|Overall Study|Adverse Event|15
4770602|NCT01569438|16456059|P1|Overall Study|Adverse Event|2
4770603|NCT01569438|16456058|P2|Overall Study|Withdrawal by Subject|3
4770604|NCT01569438|16456059|P1|Overall Study|Withdrawal by Subject|0
4770605|NCT01569438|16456058|P2|Overall Study|Lack of Efficacy|2
4770606|NCT01569438|16456059|P1|Overall Study|Lack of Efficacy|1
4770607|NCT01569295|16456073|P2|Overall Study|Lost to Follow-up|1
4770608|NCT01569295|16456074|P1|Overall Study|Lost to Follow-up|1
4770609|NCT01569295|16456073|P2|Overall Study|Other Anticancer/Experimental Therapy|2
4770610|NCT01569295|16456074|P1|Overall Study|Other Anticancer/Experimental Therapy|2
4770611|NCT01569295|16456073|P2|Overall Study|Non-Compliance with Study Drug|1
4770612|NCT01569295|16456074|P1|Overall Study|Non-Compliance with Study Drug|6
4770613|NCT01569295|16456073|P2|Overall Study|Other Reason not Specified|5
4770614|NCT01569295|16456074|P1|Overall Study|Other Reason not Specified|3
4770615|NCT01569295|16456073|P2|Overall Study|Study Terminated by Sponsor|2
4770616|NCT01569295|16456074|P1|Overall Study|Study Terminated by Sponsor|24
4770617|NCT01569295|16456073|P2|Overall Study|Physician Decision|18
4770618|NCT01569295|16456074|P1|Overall Study|Physician Decision|13
4770619|NCT01569295|16456073|P2|Overall Study|Death|15
4770620|NCT01569295|16456074|P1|Overall Study|Death|19
4770621|NCT01569295|16456073|P2|Overall Study|Withdrawal by Subject|12
4770622|NCT01569295|16456074|P1|Overall Study|Withdrawal by Subject|25
4770623|NCT01569295|16456073|P2|Overall Study|Adverse Event|14
4770624|NCT01569295|16456074|P1|Overall Study|Adverse Event|39
4770625|NCT01569295|16456073|P2|Overall Study|Progressive Disease|139
4770626|NCT01569295|16456074|P1|Overall Study|Progressive Disease|75
4770627|NCT01569152|16456111|P3|Safety Extension, Period 3|Study terminated by Sponsor|47
4770628|NCT01569152|16456112|P2|Safety Extension, Period 3|Study terminated by Sponsor|0
4770629|NCT01569152|16456113|P1|Safety Extension, Period 3|Study terminated by Sponsor|0
4770630|NCT01569152|16456111|P3|Safety Extension, Period 3|Physician Decision|2
4770631|NCT01569152|16456112|P2|Safety Extension, Period 3|Physician Decision|0
4770632|NCT01569152|16456113|P1|Safety Extension, Period 3|Physician Decision|0
4770633|NCT01569152|16456111|P3|Safety Extension, Period 3|Withdrawal by Subject|2
4770634|NCT01569152|16456112|P2|Safety Extension, Period 3|Withdrawal by Subject|0
4770635|NCT01569152|16456113|P1|Safety Extension, Period 3|Withdrawal by Subject|0
4770636|NCT01569152|16456111|P3|Safety Extension, Period 3|Adverse Event|4
4770637|NCT01569152|16456112|P2|Safety Extension, Period 3|Adverse Event|0
4770638|NCT01569152|16456113|P1|Safety Extension, Period 3|Adverse Event|0
4770639|NCT01569152|16456111|P3|Phase IIa, Period 1|Withdrawal by Subject|0
4770640|NCT01569152|16456112|P2|Phase IIa, Period 1|Withdrawal by Subject|1
4770641|NCT01569152|16456113|P1|Phase IIa, Period 1|Withdrawal by Subject|2
4770642|NCT01569152|16456111|P3|Phase IIa, Period 1|Protocol Violation|0
4770643|NCT01569152|16456112|P2|Phase IIa, Period 1|Protocol Violation|1
4770644|NCT01569152|16456113|P1|Phase IIa, Period 1|Protocol Violation|0
4770645|NCT01569152|16456111|P3|Phase IIa, Period 1|Study Terminated by Sponsor|0
4770646|NCT01569152|16456112|P2|Phase IIa, Period 1|Study Terminated by Sponsor|8
4770647|NCT01569152|16456113|P1|Phase IIa, Period 1|Study Terminated by Sponsor|9
4770648|NCT01569152|16456111|P3|Phase IIa, Period 1|Lost to Follow-up|0
4770649|NCT01569152|16456112|P2|Phase IIa, Period 1|Lost to Follow-up|0
4770650|NCT01569152|16456113|P1|Phase IIa, Period 1|Lost to Follow-up|1
4770651|NCT01569152|16456111|P3|Phase IIa, Period 1|Adverse Event|0
4770652|NCT01569152|16456112|P2|Phase IIa, Period 1|Adverse Event|0
4770653|NCT01569152|16456113|P1|Phase IIa, Period 1|Adverse Event|4
4770654|NCT01569152|16456111|P3|Phase IIa, Period 1|Early Escape|0
4770655|NCT01569152|16456112|P2|Phase IIa, Period 1|Early Escape|22
4770656|NCT01569152|16456113|P1|Phase IIa, Period 1|Early Escape|5
4770657|NCT01569074|16456249|P5|Overall Study|Adverse Event|0
4770658|NCT01569074|16456250|P4|Overall Study|Adverse Event|0
4770659|NCT01569074|16456251|P3|Overall Study|Adverse Event|3
4770660|NCT01569074|16456252|P2|Overall Study|Adverse Event|0
4770661|NCT01569074|16456253|P1|Overall Study|Adverse Event|1
4770662|NCT01569074|16456249|P5|Overall Study|eg change in circumstances|1
4770663|NCT01569074|16456250|P4|Overall Study|eg change in circumstances|1
4770664|NCT01569074|16456251|P3|Overall Study|eg change in circumstances|0
4770665|NCT01569074|16456252|P2|Overall Study|eg change in circumstances|2
4770666|NCT01569074|16456253|P1|Overall Study|eg change in circumstances|0
4770667|NCT01569074|16456249|P5|Overall Study|Severe non-compliance to protocol|0
4770668|NCT01569074|16456250|P4|Overall Study|Severe non-compliance to protocol|0
4770669|NCT01569074|16456251|P3|Overall Study|Severe non-compliance to protocol|1
4770670|NCT01569074|16456252|P2|Overall Study|Severe non-compliance to protocol|0
4770671|NCT01569074|16456253|P1|Overall Study|Severe non-compliance to protocol|0
4770672|NCT01569074|16456249|P5|Overall Study|Study-specific discontinuation criteria|0
4770673|NCT01569074|16456250|P4|Overall Study|Study-specific discontinuation criteria|0
4770674|NCT01569074|16456251|P3|Overall Study|Study-specific discontinuation criteria|0
4770675|NCT01569074|16456252|P2|Overall Study|Study-specific discontinuation criteria|1
4770676|NCT01569074|16456253|P1|Overall Study|Study-specific discontinuation criteria|0
4770677|NCT01569074|16456249|P5|Overall Study|Study stopped|7
4770678|NCT01569074|16456250|P4|Overall Study|Study stopped|7
4770679|NCT01569074|16456251|P3|Overall Study|Study stopped|8
4770680|NCT01569074|16456252|P2|Overall Study|Study stopped|6
4770681|NCT01569074|16456253|P1|Overall Study|Study stopped|6
4770682|NCT01569022|16456309|P2|Second Intervention|Lost to Follow-up|2
4770683|NCT01569022|16456310|P1|Second Intervention|Lost to Follow-up|2
4770684|NCT01569022|16456309|P2|First Intervention|Lost to Follow-up|1
4770685|NCT01569022|16456310|P1|First Intervention|Lost to Follow-up|2
4770686|NCT01568892|16456365|P2|Open-label Phase|Lost to Follow-up|1
4770687|NCT01568892|16456366|P1|Open-label Phase|Lost to Follow-up|0
4770688|NCT01568892|16456365|P2|Open-label Phase|Lack of Efficacy|2
4770689|NCT01568892|16456366|P1|Open-label Phase|Lack of Efficacy|4
4770690|NCT01568892|16456365|P2|Open-label Phase|Adverse Event|0
4770691|NCT01568892|16456366|P1|Open-label Phase|Adverse Event|2
4770692|NCT01568866|16456436|P2|Overall Study|Randomized but Not Dosed|1
4770693|NCT01568866|16456437|P1|Overall Study|Randomized but Not Dosed|9
4770694|NCT01568866|16456436|P2|Overall Study|Lost to Follow-up|0
4770695|NCT01568866|16456437|P1|Overall Study|Lost to Follow-up|1
4770696|NCT01568866|16456436|P2|Overall Study|Protocol Non-compliance|4
4770697|NCT01568866|16456437|P1|Overall Study|Protocol Non-compliance|2
4770698|NCT01568866|16456436|P2|Overall Study|Death|18
4770699|NCT01568866|16456437|P1|Overall Study|Death|10
4770700|NCT01568866|16456436|P2|Overall Study|Withdrawal by Subject|11
4770701|NCT01568866|16456437|P1|Overall Study|Withdrawal by Subject|19
4770702|NCT01568866|16456436|P2|Overall Study|Physician Decision|32
4770703|NCT01568866|16456437|P1|Overall Study|Physician Decision|40
4770704|NCT01568866|16456436|P2|Overall Study|Patient Request|71
4770705|NCT01568866|16456437|P1|Overall Study|Patient Request|55
4770706|NCT01568866|16456436|P2|Overall Study|Adverse Event|96
4770707|NCT01568866|16456437|P1|Overall Study|Adverse Event|94
4770708|NCT01568866|16456436|P2|Overall Study|Disease Progression|183
4770709|NCT01568866|16456437|P1|Overall Study|Disease Progression|208
4770710|NCT01568593|16456472|P2|Overall Study|Adverse Event|2
4770711|NCT01568593|16456473|P1|Overall Study|Adverse Event|3
4770712|NCT01568593|16456472|P2|Overall Study|Lack of Efficacy|1
4770713|NCT01568593|16456473|P1|Overall Study|Lack of Efficacy|4
4770714|NCT01568112|16456518|P4|Overall Study|Withdrawal by Physician|1
4770715|NCT01568112|16456519|P3|Overall Study|Withdrawal by Physician|1
4770716|NCT01568112|16456520|P2|Overall Study|Withdrawal by Physician|0
4770717|NCT01568112|16456521|P1|Overall Study|Withdrawal by Physician|1
4770718|NCT01568112|16456518|P4|Overall Study|Withdrawal by Subject|7
4770719|NCT01568112|16456519|P3|Overall Study|Withdrawal by Subject|0
4770720|NCT01568112|16456520|P2|Overall Study|Withdrawal by Subject|3
4770721|NCT01568112|16456521|P1|Overall Study|Withdrawal by Subject|2
4770722|NCT01568112|16456518|P4|Overall Study|Lost to Follow-up|1
4770723|NCT01568112|16456519|P3|Overall Study|Lost to Follow-up|0
4770724|NCT01568112|16456520|P2|Overall Study|Lost to Follow-up|0
4770725|NCT01568112|16456521|P1|Overall Study|Lost to Follow-up|0
4770726|NCT01568112|16456518|P4|Overall Study|Withdrew due to Adverse Event|3
4770727|NCT01568112|16456519|P3|Overall Study|Withdrew due to Adverse Event|6
4770728|NCT01568112|16456520|P2|Overall Study|Withdrew due to Adverse Event|4
4770729|NCT01568112|16456521|P1|Overall Study|Withdrew due to Adverse Event|2
4770730|NCT01568112|16456518|P4|Overall Study|Randomized But Not Treated|0
4770731|NCT01568112|16456519|P3|Overall Study|Randomized But Not Treated|0
4770732|NCT01568112|16456520|P2|Overall Study|Randomized But Not Treated|1
4770733|NCT01568112|16456521|P1|Overall Study|Randomized But Not Treated|0
4770734|NCT01568047|16456679|P4|Overall Study|Adverse Event|1
4770735|NCT01568047|16456680|P3|Overall Study|Adverse Event|1
4770736|NCT01568047|16456681|P2|Overall Study|Adverse Event|0
4770737|NCT01568047|16456682|P1|Overall Study|Adverse Event|0
4770738|NCT01568047|16456679|P4|Overall Study|Withdrawal by Subject|0
4770739|NCT01568047|16456680|P3|Overall Study|Withdrawal by Subject|0
4770740|NCT01568047|16456681|P2|Overall Study|Withdrawal by Subject|1
4770741|NCT01568047|16456682|P1|Overall Study|Withdrawal by Subject|0
4770742|NCT01568047|16456679|P4|Overall Study|Ineligibility|0
4770743|NCT01568047|16456680|P3|Overall Study|Ineligibility|0
4770744|NCT01568047|16456681|P2|Overall Study|Ineligibility|0
4770745|NCT01568047|16456682|P1|Overall Study|Ineligibility|1
4770746|NCT01568034|16456700|P4|Overall Study|Withdrawal by Subject|0
4770747|NCT01568034|16456701|P3|Overall Study|Withdrawal by Subject|0
4770748|NCT01568034|16456702|P2|Overall Study|Withdrawal by Subject|0
4770749|NCT01568034|16456703|P1|Overall Study|Withdrawal by Subject|1
4770750|NCT01567865|16456766|P4|Evaluated for Immunogenicity|Missing blood sample|28
4770751|NCT01567865|16456767|P3|Evaluated for Immunogenicity|Missing blood sample|16
4770752|NCT01567865|16456768|P2|Evaluated for Immunogenicity|Missing blood sample|24
4770753|NCT01567865|16456769|P1|Evaluated for Immunogenicity|Missing blood sample|17
4770754|NCT01567865|16456766|P4|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2
4770755|NCT01567865|16456767|P3|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3
4770756|NCT01567865|16456768|P2|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1
4770757|NCT01567865|16456769|P1|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0
4770758|NCT01567852|16456799|P2|Overall Study|ECT discontinued|1
4770759|NCT01567852|16456800|P1|Overall Study|ECT discontinued|1
4770760|NCT01567852|16456799|P2|Overall Study|Withdrawal by Subject|6
4770761|NCT01567852|16456800|P1|Overall Study|Withdrawal by Subject|3
4770762|NCT01567826|16456818|P2|Overall Study|Lost to Follow-up|2
4770763|NCT01567826|16456819|P1|Overall Study|Lost to Follow-up|3
4770764|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5
4770765|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8
4770766|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4770767|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4770768|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0
4770769|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35
4770770|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19
4770771|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
4770772|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
4770773|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0
4770774|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3
4770775|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1
4770776|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
4770777|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
4770778|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0
4770779|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10
4770780|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13
4770781|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4770782|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4770783|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0
4770784|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1
4770785|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7
4770786|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
4770942|NCT01567163|16456909|P1|Overall Study|Progressive Disease|2
4770787|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
4770788|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0
4770789|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7
4770790|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4
4770791|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
4770792|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
4770793|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0
4770794|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33
4770795|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16
4770796|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
4770797|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
4770798|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0
4770799|NCT01567527|16456845|P5|Double-blind, Placebo-controlled Phase|Protocol deviation|1
4770800|NCT01567527|16456846|P4|Double-blind, Placebo-controlled Phase|Protocol deviation|1
4770801|NCT01567527|16456847|P3|Double-blind, Placebo-controlled Phase|Protocol deviation|0
4770802|NCT01567527|16456848|P2|Double-blind, Placebo-controlled Phase|Protocol deviation|0
4770803|NCT01567527|16456849|P1|Double-blind, Placebo-controlled Phase|Protocol deviation|0
4770804|NCT01567527|16456845|P5|IM Depot Stabilization.|Withdrawn by the investigator|0
4770805|NCT01567527|16456846|P4|IM Depot Stabilization.|Withdrawn by the investigator|0
4770806|NCT01567527|16456847|P3|IM Depot Stabilization.|Withdrawn by the investigator|6
4770807|NCT01567527|16456848|P2|IM Depot Stabilization.|Withdrawn by the investigator|0
4770808|NCT01567527|16456849|P1|IM Depot Stabilization.|Withdrawn by the investigator|0
4770809|NCT01567527|16456845|P5|IM Depot Stabilization.|Adverse Event|0
4770810|NCT01567527|16456846|P4|IM Depot Stabilization.|Adverse Event|0
4770811|NCT01567527|16456847|P3|IM Depot Stabilization.|Adverse Event|37
4770812|NCT01567527|16456848|P2|IM Depot Stabilization.|Adverse Event|0
4770813|NCT01567527|16456849|P1|IM Depot Stabilization.|Adverse Event|0
4770814|NCT01567527|16456845|P5|IM Depot Stabilization.|Lack of Efficacy|0
4770815|NCT01567527|16456846|P4|IM Depot Stabilization.|Lack of Efficacy|0
4770816|NCT01567527|16456847|P3|IM Depot Stabilization.|Lack of Efficacy|7
4770817|NCT01567527|16456848|P2|IM Depot Stabilization.|Lack of Efficacy|0
4770818|NCT01567527|16456849|P1|IM Depot Stabilization.|Lack of Efficacy|0
4770819|NCT01567527|16456845|P5|IM Depot Stabilization.|Lost to Follow-up|0
4770820|NCT01567527|16456846|P4|IM Depot Stabilization.|Lost to Follow-up|0
4770821|NCT01567527|16456847|P3|IM Depot Stabilization.|Lost to Follow-up|21
4770822|NCT01567527|16456848|P2|IM Depot Stabilization.|Lost to Follow-up|0
4770823|NCT01567527|16456849|P1|IM Depot Stabilization.|Lost to Follow-up|0
4770824|NCT01567527|16456845|P5|IM Depot Stabilization.|Sponsor discontinued study|0
4770825|NCT01567527|16456846|P4|IM Depot Stabilization.|Sponsor discontinued study|0
4770826|NCT01567527|16456847|P3|IM Depot Stabilization.|Sponsor discontinued study|1
4770827|NCT01567527|16456848|P2|IM Depot Stabilization.|Sponsor discontinued study|0
4770828|NCT01567527|16456849|P1|IM Depot Stabilization.|Sponsor discontinued study|0
4770829|NCT01567527|16456845|P5|IM Depot Stabilization.|Withdrawal by Subject|0
4770830|NCT01567527|16456846|P4|IM Depot Stabilization.|Withdrawal by Subject|0
4770831|NCT01567527|16456847|P3|IM Depot Stabilization.|Withdrawal by Subject|56
4770832|NCT01567527|16456848|P2|IM Depot Stabilization.|Withdrawal by Subject|0
4770833|NCT01567527|16456849|P1|IM Depot Stabilization.|Withdrawal by Subject|0
4770834|NCT01567527|16456845|P5|IM Depot Stabilization.|Met withdrawal criteria|0
4770835|NCT01567527|16456846|P4|IM Depot Stabilization.|Met withdrawal criteria|0
4770836|NCT01567527|16456847|P3|IM Depot Stabilization.|Met withdrawal criteria|26
4770837|NCT01567527|16456848|P2|IM Depot Stabilization.|Met withdrawal criteria|0
4770838|NCT01567527|16456849|P1|IM Depot Stabilization.|Met withdrawal criteria|0
4770839|NCT01567527|16456845|P5|IM Depot Stabilization.|Protocol deviation|0
4770840|NCT01567527|16456846|P4|IM Depot Stabilization.|Protocol deviation|0
4770841|NCT01567527|16456847|P3|IM Depot Stabilization.|Protocol deviation|5
4770842|NCT01567527|16456848|P2|IM Depot Stabilization.|Protocol deviation|0
4770843|NCT01567527|16456849|P1|IM Depot Stabilization.|Protocol deviation|0
4770844|NCT01567527|16456845|P5|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4770845|NCT01567527|16456846|P4|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4770846|NCT01567527|16456847|P3|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4770847|NCT01567527|16456848|P2|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2
4770848|NCT01567527|16456849|P1|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0
4770849|NCT01567527|16456845|P5|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4770850|NCT01567527|16456846|P4|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4770851|NCT01567527|16456847|P3|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4770852|NCT01567527|16456848|P2|Oral Aripiprazole Stabilization Phase.|Adverse Event|63
4770853|NCT01567527|16456849|P1|Oral Aripiprazole Stabilization Phase.|Adverse Event|0
4770854|NCT01567527|16456845|P5|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4770855|NCT01567527|16456846|P4|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4770856|NCT01567527|16456847|P3|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4770857|NCT01567527|16456848|P2|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12
4770858|NCT01567527|16456849|P1|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0
4770859|NCT01567527|16456845|P5|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4770860|NCT01567527|16456846|P4|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4770861|NCT01567527|16456847|P3|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4770862|NCT01567527|16456848|P2|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44
4770863|NCT01567527|16456849|P1|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0
4770864|NCT01567527|16456845|P5|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4770865|NCT01567527|16456846|P4|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4770866|NCT01567527|16456847|P3|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4770867|NCT01567527|16456848|P2|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45
4770868|NCT01567527|16456849|P1|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0
4770869|NCT01567527|16456845|P5|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4770870|NCT01567527|16456846|P4|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4770871|NCT01567527|16456847|P3|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4770872|NCT01567527|16456848|P2|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41
4770873|NCT01567527|16456849|P1|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0
4770874|NCT01567527|16456845|P5|Conversion Phase.|Withdrawn by the investigator|0
4770875|NCT01567527|16456846|P4|Conversion Phase.|Withdrawn by the investigator|0
4770876|NCT01567527|16456847|P3|Conversion Phase.|Withdrawn by the investigator|0
4770877|NCT01567527|16456848|P2|Conversion Phase.|Withdrawn by the investigator|0
4770878|NCT01567527|16456849|P1|Conversion Phase.|Withdrawn by the investigator|3
4770879|NCT01567527|16456845|P5|Conversion Phase.|Adverse Event|0
4770880|NCT01567527|16456846|P4|Conversion Phase.|Adverse Event|0
4770881|NCT01567527|16456847|P3|Conversion Phase.|Adverse Event|0
4770882|NCT01567527|16456848|P2|Conversion Phase.|Adverse Event|0
4770883|NCT01567527|16456849|P1|Conversion Phase.|Adverse Event|33
4770884|NCT01567527|16456845|P5|Conversion Phase.|Lack of Efficacy|0
4770885|NCT01567527|16456846|P4|Conversion Phase.|Lack of Efficacy|0
4770886|NCT01567527|16456847|P3|Conversion Phase.|Lack of Efficacy|0
4770887|NCT01567527|16456848|P2|Conversion Phase.|Lack of Efficacy|0
4770888|NCT01567527|16456849|P1|Conversion Phase.|Lack of Efficacy|2
4770889|NCT01567527|16456845|P5|Conversion Phase.|Lost to Follow-up|0
4770890|NCT01567527|16456846|P4|Conversion Phase.|Lost to Follow-up|0
4770891|NCT01567527|16456847|P3|Conversion Phase.|Lost to Follow-up|0
4770892|NCT01567527|16456848|P2|Conversion Phase.|Lost to Follow-up|0
4770893|NCT01567527|16456849|P1|Conversion Phase.|Lost to Follow-up|16
4770894|NCT01567527|16456845|P5|Conversion Phase.|Withdrawal by Subject|0
4770895|NCT01567527|16456846|P4|Conversion Phase.|Withdrawal by Subject|0
4770896|NCT01567527|16456847|P3|Conversion Phase.|Withdrawal by Subject|0
4770897|NCT01567527|16456848|P2|Conversion Phase.|Withdrawal by Subject|0
4770898|NCT01567527|16456849|P1|Conversion Phase.|Withdrawal by Subject|32
4770899|NCT01567527|16456845|P5|Conversion Phase.|Met withdrawal criteria|0
4770900|NCT01567527|16456846|P4|Conversion Phase.|Met withdrawal criteria|0
4770901|NCT01567527|16456847|P3|Conversion Phase.|Met withdrawal criteria|0
4770902|NCT01567527|16456848|P2|Conversion Phase.|Met withdrawal criteria|0
4770903|NCT01567527|16456849|P1|Conversion Phase.|Met withdrawal criteria|10
4770904|NCT01567527|16456845|P5|Conversion Phase.|Protocol deviation|0
4770905|NCT01567527|16456846|P4|Conversion Phase.|Protocol deviation|0
4770906|NCT01567527|16456847|P3|Conversion Phase.|Protocol deviation|0
4770907|NCT01567527|16456848|P2|Conversion Phase.|Protocol deviation|0
4770908|NCT01567527|16456849|P1|Conversion Phase.|Protocol deviation|3
4770909|NCT01567462|16456866|P2|Overall Study|Withdrawal by Subject|7
4770910|NCT01567462|16456867|P1|Overall Study|Withdrawal by Subject|4
4770911|NCT01567306|16456890|P6|Overall Study|Withdrawal by Subject|1
4770912|NCT01567306|16456891|P5|Overall Study|Withdrawal by Subject|0
4770913|NCT01567306|16456892|P4|Overall Study|Withdrawal by Subject|0
4770914|NCT01567306|16456893|P3|Overall Study|Withdrawal by Subject|0
4770915|NCT01567306|16456894|P2|Overall Study|Withdrawal by Subject|0
4770916|NCT01567306|16456895|P1|Overall Study|Withdrawal by Subject|0
4770917|NCT01567306|16456890|P6|Overall Study|Lost to Follow-up|0
4770918|NCT01567306|16456891|P5|Overall Study|Lost to Follow-up|2
4770919|NCT01567306|16456892|P4|Overall Study|Lost to Follow-up|0
4770920|NCT01567306|16456893|P3|Overall Study|Lost to Follow-up|0
4770921|NCT01567306|16456894|P2|Overall Study|Lost to Follow-up|0
4770922|NCT01567306|16456895|P1|Overall Study|Lost to Follow-up|0
4770923|NCT01567306|16456890|P6|Overall Study|Adverse Event|1
4770924|NCT01567306|16456891|P5|Overall Study|Adverse Event|4
4770925|NCT01567306|16456892|P4|Overall Study|Adverse Event|2
4770926|NCT01567306|16456893|P3|Overall Study|Adverse Event|0
4770927|NCT01567306|16456894|P2|Overall Study|Adverse Event|0
4770928|NCT01567306|16456895|P1|Overall Study|Adverse Event|0
4770929|NCT01567306|16456890|P6|Overall Study|Change site living|0
4770930|NCT01567306|16456891|P5|Overall Study|Change site living|0
4770931|NCT01567306|16456892|P4|Overall Study|Change site living|0
4770932|NCT01567306|16456893|P3|Overall Study|Change site living|0
4770933|NCT01567306|16456894|P2|Overall Study|Change site living|0
4770934|NCT01567306|16456895|P1|Overall Study|Change site living|1
4770935|NCT01567306|16456890|P6|Overall Study|Protocol Violation|1
4770936|NCT01567306|16456891|P5|Overall Study|Protocol Violation|1
4770937|NCT01567306|16456892|P4|Overall Study|Protocol Violation|3
4770938|NCT01567306|16456893|P3|Overall Study|Protocol Violation|0
4770939|NCT01567306|16456894|P2|Overall Study|Protocol Violation|2
4770940|NCT01567306|16456895|P1|Overall Study|Protocol Violation|2
4770941|NCT01567163|16456909|P1|Overall Study|Lost to Follow-up|2
4770943|NCT01567085|16456930|P1|Overall Study|Terminal chronic kidney dysfunction|1
4770944|NCT01567085|16456930|P1|Overall Study|Returned to chronic dialysis|1
4770945|NCT01567085|16456930|P1|Overall Study|Renal transplantectomy|1
4770946|NCT01567085|16456930|P1|Overall Study|Graft loss|2
4770947|NCT01567085|16456930|P1|Overall Study|Lost to Follow-up|3
4770948|NCT01567085|16456930|P1|Overall Study|Adverse Event|6
4770949|NCT01567085|16456930|P1|Overall Study|Death|6
4770950|NCT01566981|16456967|P2|Overall Study|Lost to Follow-up|8
4770951|NCT01566981|16456968|P1|Overall Study|Lost to Follow-up|5
4770952|NCT01566773|16456997|P1|Overall Study|Physician Decision|2
4770953|NCT01566773|16456997|P1|Overall Study|Adverse Event|10
4770954|NCT01566773|16456997|P1|Overall Study|Administrative reason|1
4770955|NCT01566773|16456997|P1|Overall Study|Withdrawal by Subject|9
4770956|NCT01566773|16456997|P1|Overall Study|Protocol Violation|4
4770957|NCT01566773|16456997|P1|Overall Study|Protocol specified criteria|4
4770958|NCT01566721|16457206|P2|Overall Study|Withdrew Prior to Treatment|1
4770959|NCT01566721|16457207|P1|Overall Study|Withdrew Prior to Treatment|3
4770960|NCT01566721|16457206|P2|Overall Study|Other|4
4770961|NCT01566721|16457207|P1|Overall Study|Other|10
4770962|NCT01566721|16457206|P2|Overall Study|Death|3
4770963|NCT01566721|16457207|P1|Overall Study|Death|6
4770964|NCT01566721|16457206|P2|Overall Study|Lost to Follow-up|0
4770965|NCT01566721|16457207|P1|Overall Study|Lost to Follow-up|18
4770966|NCT01566721|16457206|P2|Overall Study|Disease Progression/Recurrence|28
4770967|NCT01566721|16457207|P1|Overall Study|Disease Progression/Recurrence|123
4770968|NCT01566721|16457206|P2|Overall Study|Withdrawal by Subject|15
4770969|NCT01566721|16457207|P1|Overall Study|Withdrawal by Subject|58
4770970|NCT01566721|16457206|P2|Overall Study|Ongoing Study|659
4770971|NCT01566721|16457207|P1|Overall Study|Ongoing Study|1649
4770972|NCT01566695|16457232|P2|Overall Study|Miscellaneous|6
4770973|NCT01566695|16457233|P1|Overall Study|Miscellaneous|4
4770974|NCT01566695|16457232|P2|Overall Study|Progressive Disease|6
4770975|NCT01566695|16457233|P1|Overall Study|Progressive Disease|11
4770976|NCT01566695|16457232|P2|Overall Study|Withdrawal by Subject|7
4770977|NCT01566695|16457233|P1|Overall Study|Withdrawal by Subject|14
4770978|NCT01566695|16457232|P2|Overall Study|Death|8
4770979|NCT01566695|16457233|P1|Overall Study|Death|20
4770980|NCT01566695|16457232|P2|Overall Study|Adverse Event|27
4770981|NCT01566695|16457233|P1|Overall Study|Adverse Event|28
4770982|NCT01566695|16457232|P2|Overall Study|Lack of Efficacy|45
4770983|NCT01566695|16457233|P1|Overall Study|Lack of Efficacy|18
4770984|NCT01566604|16457398|P2|Overall Study|Withdrawal by Subject|6
4770985|NCT01566604|16457399|P1|Overall Study|Withdrawal by Subject|9
4770986|NCT01566604|16457398|P2|Overall Study|Adverse Event|2
4770987|NCT01566604|16457399|P1|Overall Study|Adverse Event|4
4770988|NCT01566604|16457398|P2|Overall Study|Death|1
4770989|NCT01566604|16457399|P1|Overall Study|Death|4
4770990|NCT01566604|16457398|P2|Overall Study|Abnormal laboratory value|0
4770991|NCT01566604|16457399|P1|Overall Study|Abnormal laboratory value|2
4770992|NCT01566604|16457398|P2|Overall Study|Protocol deviation|0
4770993|NCT01566604|16457399|P1|Overall Study|Protocol deviation|2
4770994|NCT01566604|16457398|P2|Overall Study|Lack of Efficacy|2
4770995|NCT01566604|16457399|P1|Overall Study|Lack of Efficacy|1
4770996|NCT01566604|16457398|P2|Overall Study|Administrative problems|0
4770997|NCT01566604|16457399|P1|Overall Study|Administrative problems|1
4770998|NCT01566604|16457398|P2|Overall Study|Patient's inability to use the device|0
4770999|NCT01566604|16457399|P1|Overall Study|Patient's inability to use the device|1
4771000|NCT01566435|16457555|P1|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1
4771001|NCT01566214|16457621|P2|Overall Study|Lost to Follow-up|0
4771002|NCT01566214|16457622|P1|Overall Study|Lost to Follow-up|3
4771003|NCT01566149|16457666|P2|Overall Study|Withdrawal by Subject|0
4771004|NCT01566149|16457667|P1|Overall Study|Withdrawal by Subject|1
4771005|NCT01566149|16457666|P2|Overall Study|Protocol Violation|1
4771006|NCT01566149|16457667|P1|Overall Study|Protocol Violation|0
4771007|NCT01566149|16457666|P2|Overall Study|Non-compliance with study medication|0
4771008|NCT01566149|16457667|P1|Overall Study|Non-compliance with study medication|2
4771009|NCT01566149|16457666|P2|Overall Study|Adverse Event|1
4771010|NCT01566149|16457667|P1|Overall Study|Adverse Event|0
4771011|NCT01565993|16457700|P2|Overall Study|Physician Decision|3
4771012|NCT01565993|16457701|P1|Overall Study|Physician Decision|0
4771013|NCT01565980|16457709|P2|Overall Study|Withdrawal by Subject|3
4771014|NCT01565980|16457710|P1|Overall Study|Withdrawal by Subject|0
4771015|NCT01565980|16457709|P2|Overall Study|stopped medical treatment|0
4771016|NCT01565980|16457710|P1|Overall Study|stopped medical treatment|1
4771017|NCT01565980|16457709|P2|Overall Study|health complications|1
4771018|NCT01565980|16457710|P1|Overall Study|health complications|1
4771019|NCT01565980|16457709|P2|Overall Study|Lost to Follow-up|0
4771020|NCT01565980|16457710|P1|Overall Study|Lost to Follow-up|1
4771021|NCT01565980|16457709|P2|Overall Study|Death|0
4771022|NCT01565980|16457710|P1|Overall Study|Death|1
4771023|NCT01565941|16457730|P2|Overall Study|Randomized; did not receive intevention|2
4771024|NCT01565941|16457731|P1|Overall Study|Randomized; did not receive intevention|8
4771025|NCT01565941|16457730|P2|Overall Study|Withdrawn by parent/guardian|2
4771026|NCT01565941|16457731|P1|Overall Study|Withdrawn by parent/guardian|3
4771027|NCT01565928|16457773|P1|Overall Study|Death|2
4771028|NCT01565928|16457773|P1|Overall Study|Withdrawal by Subject|1
4771029|NCT01565928|16457773|P1|Overall Study|Progressive Disease|13
4771030|NCT01565928|16457773|P1|Overall Study|Other|3
4771031|NCT01565928|16457773|P1|Overall Study|Adverse Event|3
4771032|NCT01565889|16457827|P6|Part B|Lost to Follow-up|1
4771033|NCT01565889|16457828|P5|Part B|Lost to Follow-up|0
4771034|NCT01565889|16457829|P4|Part B|Lost to Follow-up|0
4771035|NCT01565889|16457830|P3|Part B|Lost to Follow-up|0
4771036|NCT01565889|16457831|P2|Part B|Lost to Follow-up|0
4771037|NCT01565889|16457832|P1|Part B|Lost to Follow-up|0
4771038|NCT01565889|16457827|P6|Part B|Lack of Efficacy|2
4771039|NCT01565889|16457828|P5|Part B|Lack of Efficacy|0
4771040|NCT01565889|16457829|P4|Part B|Lack of Efficacy|0
4771041|NCT01565889|16457830|P3|Part B|Lack of Efficacy|0
4771042|NCT01565889|16457831|P2|Part B|Lack of Efficacy|0
4771043|NCT01565889|16457832|P1|Part B|Lack of Efficacy|0
4771044|NCT01565889|16457827|P6|Part B|Withdrawal by Subject|1
4771045|NCT01565889|16457828|P5|Part B|Withdrawal by Subject|0
4771046|NCT01565889|16457829|P4|Part B|Withdrawal by Subject|0
4771047|NCT01565889|16457830|P3|Part B|Withdrawal by Subject|0
4771048|NCT01565889|16457831|P2|Part B|Withdrawal by Subject|0
4771049|NCT01565889|16457832|P1|Part B|Withdrawal by Subject|0
4771050|NCT01565889|16457827|P6|Part A|Withdrawal by Subject|0
4771051|NCT01565889|16457828|P5|Part A|Withdrawal by Subject|0
4771052|NCT01565889|16457829|P4|Part A|Withdrawal by Subject|0
4771053|NCT01565889|16457830|P3|Part A|Withdrawal by Subject|0
4771054|NCT01565889|16457831|P2|Part A|Withdrawal by Subject|0
4771055|NCT01565889|16457832|P1|Part A|Withdrawal by Subject|1
4771056|NCT01565850|16457863|P2|Overall Study|Withdrew Consent|2
4771057|NCT01565850|16457864|P1|Overall Study|Withdrew Consent|4
4771058|NCT01565850|16457863|P2|Overall Study|Participant noncompliance|0
4771059|NCT01565850|16457864|P1|Overall Study|Participant noncompliance|2
4771060|NCT01565850|16457863|P2|Overall Study|Investigator's Discretion|1
4771061|NCT01565850|16457864|P1|Overall Study|Investigator's Discretion|2
4771062|NCT01565850|16457863|P2|Overall Study|Lost to Follow-up|4
4771063|NCT01565850|16457864|P1|Overall Study|Lost to Follow-up|12
4771064|NCT01565850|16457863|P2|Overall Study|Adverse Event|1
4771065|NCT01565850|16457864|P1|Overall Study|Adverse Event|0
4771066|NCT01565707|16457884|P4|Overall Study|Miscellaneous|2
4771067|NCT01565707|16457885|P3|Overall Study|Miscellaneous|0
4771068|NCT01565707|16457886|P2|Overall Study|Miscellaneous|1
4771069|NCT01565707|16457887|P1|Overall Study|Miscellaneous|1
4771070|NCT01565707|16457884|P4|Overall Study|Randomized but not evaluable|0
4771071|NCT01565707|16457885|P3|Overall Study|Randomized but not evaluable|0
4771072|NCT01565707|16457886|P2|Overall Study|Randomized but not evaluable|0
4771073|NCT01565707|16457887|P1|Overall Study|Randomized but not evaluable|2
4771074|NCT01565707|16457884|P4|Overall Study|Withdrawal by Subject|1
4771075|NCT01565707|16457885|P3|Overall Study|Withdrawal by Subject|1
4771076|NCT01565707|16457886|P2|Overall Study|Withdrawal by Subject|1
4771077|NCT01565707|16457887|P1|Overall Study|Withdrawal by Subject|3
4771078|NCT01565707|16457884|P4|Overall Study|Protocol Violation|1
4771079|NCT01565707|16457885|P3|Overall Study|Protocol Violation|0
4771080|NCT01565707|16457886|P2|Overall Study|Protocol Violation|0
4771081|NCT01565707|16457887|P1|Overall Study|Protocol Violation|1
4771082|NCT01565707|16457884|P4|Overall Study|Lost to Follow-up|0
4771083|NCT01565707|16457885|P3|Overall Study|Lost to Follow-up|0
4771084|NCT01565707|16457886|P2|Overall Study|Lost to Follow-up|0
4771085|NCT01565707|16457887|P1|Overall Study|Lost to Follow-up|1
4771086|NCT01565707|16457884|P4|Overall Study|Adverse Event|1
4771087|NCT01565707|16457885|P3|Overall Study|Adverse Event|2
4771088|NCT01565707|16457886|P2|Overall Study|Adverse Event|6
4771089|NCT01565707|16457887|P1|Overall Study|Adverse Event|1
4771090|NCT01565694|16457978|P1|Fixed-Dose Assessment Period|Withdrawal by Subject|4
4771091|NCT01565694|16457978|P1|Dose-Titration Period|Protocol Violation|10
4771092|NCT01565694|16457978|P1|Dose-Titration Period|Adverse Event|4
4771093|NCT01565668|16457999|P2|Overall Study|HSCT Transplant|15
4771094|NCT01565668|16458000|P1|Overall Study|HSCT Transplant|11
4771095|NCT01565668|16457999|P2|Overall Study|Withdrawal by Subject|3
4771096|NCT01565668|16458000|P1|Overall Study|Withdrawal by Subject|1
4771097|NCT01565668|16457999|P2|Overall Study|Progressive disease|14
4771098|NCT01565668|16458000|P1|Overall Study|Progressive disease|13
4771099|NCT01565668|16457999|P2|Overall Study|Randomized, but never received drug|2
4771100|NCT01565668|16458000|P1|Overall Study|Randomized, but never received drug|0
4771101|NCT01565668|16457999|P2|Overall Study|Adverse Event|1
4771102|NCT01565668|16458000|P1|Overall Study|Adverse Event|6
4771103|NCT01565668|16457999|P2|Overall Study|Participant went on Hospice Care|0
4771104|NCT01565668|16458000|P1|Overall Study|Participant went on Hospice Care|1
4771105|NCT01565668|16457999|P2|Overall Study|Lack of Efficacy|2
4771106|NCT01565668|16458000|P1|Overall Study|Lack of Efficacy|4
4771107|NCT01565668|16457999|P2|Overall Study|Death|1
4771108|NCT01565668|16458000|P1|Overall Study|Death|2
4771109|NCT01565642|16458024|P2|Overall Study|Withdrawal by Subject|1
4771110|NCT01565642|16458025|P1|Overall Study|Withdrawal by Subject|2
4771111|NCT01565564|16458060|P2|Overall Study|Lost to Follow-up|1
4771112|NCT01565564|16458061|P1|Overall Study|Lost to Follow-up|5
4771113|NCT01565343|16458111|P3|Overall Study|Administrative decision/technical issues|0
4771114|NCT01565343|16458112|P2|Overall Study|Administrative decision/technical issues|0
4771115|NCT01565343|16458113|P1|Overall Study|Administrative decision/technical issues|1
4771116|NCT01565291|16458143|P2|Overall Study|Withdrawal by Subject|0
4771117|NCT01565291|16458144|P1|Overall Study|Withdrawal by Subject|1
4771118|NCT01565148|16458156|P4|Overall Study|Physician Decision|0
4771119|NCT01565148|16458157|P3|Overall Study|Physician Decision|0
4771120|NCT01565148|16458158|P2|Overall Study|Physician Decision|5
4771121|NCT01565148|16458159|P1|Overall Study|Physician Decision|2
4771122|NCT01565148|16458156|P4|Overall Study|Death|0
4771123|NCT01565148|16458157|P3|Overall Study|Death|1
4771124|NCT01565148|16458158|P2|Overall Study|Death|0
4771125|NCT01565148|16458159|P1|Overall Study|Death|0
4771126|NCT01565148|16458156|P4|Overall Study|Rescue Therapy|8
4771127|NCT01565148|16458157|P3|Overall Study|Rescue Therapy|5
4771128|NCT01565148|16458158|P2|Overall Study|Rescue Therapy|5
4771129|NCT01565148|16458159|P1|Overall Study|Rescue Therapy|8
4771130|NCT01565148|16458156|P4|Overall Study|Lost to Follow-up|3
4771131|NCT01565148|16458157|P3|Overall Study|Lost to Follow-up|0
4771132|NCT01565148|16458158|P2|Overall Study|Lost to Follow-up|4
4771133|NCT01565148|16458159|P1|Overall Study|Lost to Follow-up|4
4771134|NCT01565148|16458156|P4|Overall Study|Withdrawal by Subject|2
4771135|NCT01565148|16458157|P3|Overall Study|Withdrawal by Subject|1
4771136|NCT01565148|16458158|P2|Overall Study|Withdrawal by Subject|1
4771137|NCT01565148|16458159|P1|Overall Study|Withdrawal by Subject|1
4771138|NCT01565083|16458195|P2|Overall Study|Other|5
4771139|NCT01565083|16458196|P1|Overall Study|Other|3
4771140|NCT01565083|16458195|P2|Overall Study|Death|23
4771141|NCT01565083|16458196|P1|Overall Study|Death|22
4771142|NCT01565083|16458195|P2|Overall Study|Lost to Follow-up|7
4771143|NCT01565083|16458196|P1|Overall Study|Lost to Follow-up|2
4771144|NCT01565083|16458195|P2|Overall Study|Withdrawal by Subject|4
4771145|NCT01565083|16458196|P1|Overall Study|Withdrawal by Subject|6
4771146|NCT01564862|16458247|P3|Overall Study|Other reason(s)|0
4771147|NCT01564862|16458248|P2|Overall Study|Other reason(s)|0
4771148|NCT01564862|16458249|P1|Overall Study|Other reason(s)|1
4771149|NCT01564862|16458247|P3|Overall Study|Lack of Efficacy|6
4771150|NCT01564862|16458248|P2|Overall Study|Lack of Efficacy|5
4771151|NCT01564862|16458249|P1|Overall Study|Lack of Efficacy|1
4771152|NCT01564862|16458247|P3|Overall Study|Voluntary Withdrawal|8
4771153|NCT01564862|16458248|P2|Overall Study|Voluntary Withdrawal|6
4771154|NCT01564862|16458249|P1|Overall Study|Voluntary Withdrawal|9
4771155|NCT01564862|16458247|P3|Overall Study|Lost to Follow-up|6
4771156|NCT01564862|16458248|P2|Overall Study|Lost to Follow-up|8
4771157|NCT01564862|16458249|P1|Overall Study|Lost to Follow-up|10
4771158|NCT01564862|16458247|P3|Overall Study|Major Protocol Deviation|4
4771159|NCT01564862|16458248|P2|Overall Study|Major Protocol Deviation|3
4771160|NCT01564862|16458249|P1|Overall Study|Major Protocol Deviation|3
4771161|NCT01564862|16458247|P3|Overall Study|Pretreatment Event or Adverse Event|6
4771162|NCT01564862|16458248|P2|Overall Study|Pretreatment Event or Adverse Event|12
4771163|NCT01564862|16458249|P1|Overall Study|Pretreatment Event or Adverse Event|6
4771164|NCT01564784|16458300|P2|Overall Study|Death|126
4771165|NCT01564784|16458301|P1|Overall Study|Death|131
4771166|NCT01564784|16458300|P2|Overall Study|Lost to Follow-up|1
4771167|NCT01564784|16458301|P1|Overall Study|Lost to Follow-up|1
4771168|NCT01564784|16458300|P2|Overall Study|Subject refused further follow-up|6
4771169|NCT01564784|16458301|P1|Overall Study|Subject refused further follow-up|1
4771170|NCT01564784|16458300|P2|Overall Study|Other|0
4771171|NCT01564784|16458301|P1|Overall Study|Other|1
4771172|NCT01564758|16458328|P1|Overall Study|Other|3
4771173|NCT01564758|16458328|P1|Overall Study|Adverse Event|3
4771174|NCT01564758|16458328|P1|Overall Study|Death|8
4771175|NCT01564732|16458335|P2|Overall Study|Early termination by the study sponsor|5
4771176|NCT01564732|16458336|P1|Overall Study|Early termination by the study sponsor|6
4771177|NCT01564537|16458377|P2|Overall Study|Other Miscellaneous Reasons|2
4771178|NCT01564537|16458378|P1|Overall Study|Other Miscellaneous Reasons|1
4771179|NCT01564537|16458377|P2|Overall Study|Lost to Follow-up|0
4771180|NCT01564537|16458378|P1|Overall Study|Lost to Follow-up|1
4771181|NCT01564537|16458377|P2|Overall Study|Withdrawal by Participant|4
4771182|NCT01564537|16458378|P1|Overall Study|Withdrawal by Participant|4
4771183|NCT01564459|16458401|P3|Double-blind Treatment|Adverse Event|1
4771184|NCT01564459|16458402|P2|Double-blind Treatment|Adverse Event|0
4771185|NCT01564459|16458403|P1|Double-blind Treatment|Adverse Event|0
4771186|NCT01564459|16458401|P3|Run-In|Withdrawal by Subject|0
4771187|NCT01564459|16458402|P2|Run-In|Withdrawal by Subject|0
4771188|NCT01564459|16458403|P1|Run-In|Withdrawal by Subject|1
4771189|NCT01564459|16458401|P3|Run-In|Protocol Violation|0
4771190|NCT01564459|16458402|P2|Run-In|Protocol Violation|0
4771191|NCT01564459|16458403|P1|Run-In|Protocol Violation|1
4771192|NCT01564459|16458401|P3|Run-In|Non-compliance with study drug|0
4771193|NCT01564459|16458402|P2|Run-In|Non-compliance with study drug|0
4771194|NCT01564459|16458403|P1|Run-In|Non-compliance with study drug|2
4771195|NCT01564459|16458401|P3|Run-In|Lost to Follow-up|0
4771196|NCT01564459|16458402|P2|Run-In|Lost to Follow-up|0
4771197|NCT01564459|16458403|P1|Run-In|Lost to Follow-up|1
4771198|NCT01564459|16458401|P3|Run-In|Adverse Event|0
4771199|NCT01564459|16458402|P2|Run-In|Adverse Event|0
4771200|NCT01564459|16458403|P1|Run-In|Adverse Event|7
4771201|NCT01564407|16458427|P5|Overall Study|funding lost, study ended|0
4771202|NCT01564407|16458428|P4|Overall Study|funding lost, study ended|1
4771203|NCT01564407|16458429|P3|Overall Study|funding lost, study ended|0
4771204|NCT01564407|16458430|P2|Overall Study|funding lost, study ended|0
4771205|NCT01564407|16458431|P1|Overall Study|funding lost, study ended|0
4771206|NCT01564407|16458427|P5|Overall Study|Withdrawal by Subject|0
4771207|NCT01564407|16458428|P4|Overall Study|Withdrawal by Subject|0
4771208|NCT01564407|16458429|P3|Overall Study|Withdrawal by Subject|0
4771209|NCT01564407|16458430|P2|Overall Study|Withdrawal by Subject|1
4771210|NCT01564407|16458431|P1|Overall Study|Withdrawal by Subject|0
4771211|NCT01564407|16458427|P5|Overall Study|Lost to Follow-up|0
4771212|NCT01564407|16458428|P4|Overall Study|Lost to Follow-up|0
4771213|NCT01564407|16458429|P3|Overall Study|Lost to Follow-up|0
4771214|NCT01564407|16458430|P2|Overall Study|Lost to Follow-up|1
4771215|NCT01564407|16458431|P1|Overall Study|Lost to Follow-up|0
4771216|NCT01564394|16458472|P2|Overall Study|Withdrawal by Subject|10
4771217|NCT01564394|16458473|P1|Overall Study|Withdrawal by Subject|6
4771218|NCT01564277|16458487|P2|Overall Study|Physician Decision|0
4771219|NCT01564277|16458488|P1|Overall Study|Physician Decision|1
4771220|NCT01564277|16458487|P2|Overall Study|Protocol Violation|1
4771221|NCT01564277|16458488|P1|Overall Study|Protocol Violation|0
4771222|NCT01563978|16458506|P2|Overall Study|Adverse Event|2
4771223|NCT01563978|16458507|P1|Overall Study|Adverse Event|1
4771224|NCT01563978|16458506|P2|Overall Study|Dev. of study specific discont. criteria|0
4771225|NCT01563978|16458507|P1|Overall Study|Dev. of study specific discont. criteria|1
4771226|NCT01563978|16458506|P2|Overall Study|Lost to Follow-up|0
4771227|NCT01563978|16458507|P1|Overall Study|Lost to Follow-up|1
4771228|NCT01563978|16458506|P2|Overall Study|Physician Decision|0
4771229|NCT01563978|16458507|P1|Overall Study|Physician Decision|1
4771230|NCT01563913|16458533|P2|Overall Study|Spouse Passed Away|0
4771231|NCT01563913|16458534|P1|Overall Study|Spouse Passed Away|1
4771232|NCT01563913|16458533|P2|Overall Study|Physician Decision|0
4771233|NCT01563913|16458534|P1|Overall Study|Physician Decision|1
4771234|NCT01563536|16458546|P2|Overall Study|Lost to Follow-up|0
4771235|NCT01563536|16458547|P1|Overall Study|Lost to Follow-up|1
4771236|NCT01563536|16458546|P2|Overall Study|Withdrawal by Subject|2
4771237|NCT01563536|16458547|P1|Overall Study|Withdrawal by Subject|0
4771238|NCT01563185|16458606|P1|Overall Study|Non-Compliance with study drug|1
4771239|NCT01563185|16458606|P1|Overall Study|Withdrawal by Subject|1
4771240|NCT01563172|16458620|P1|Overall Study|Other (Not specified)|1
4771241|NCT01563172|16458620|P1|Overall Study|Other (Protocol deviation)|5
4771242|NCT01563172|16458620|P1|Overall Study|Lost to Follow-up|2
4771243|NCT01563172|16458620|P1|Overall Study|Adverse Event|5
4771244|NCT01563029|16458726|P5|Overall Study|Withdrawal by Subject|3
4771245|NCT01563029|16458727|P4|Overall Study|Withdrawal by Subject|4
4771246|NCT01563029|16458728|P3|Overall Study|Withdrawal by Subject|3
4771247|NCT01563029|16458729|P2|Overall Study|Withdrawal by Subject|1
4771248|NCT01563029|16458730|P1|Overall Study|Withdrawal by Subject|4
4771249|NCT01563029|16458726|P5|Overall Study|Physician Decision|2
4771250|NCT01563029|16458727|P4|Overall Study|Physician Decision|4
4771251|NCT01563029|16458728|P3|Overall Study|Physician Decision|2
4771252|NCT01563029|16458729|P2|Overall Study|Physician Decision|5
4771253|NCT01563029|16458730|P1|Overall Study|Physician Decision|3
4771254|NCT01563029|16458726|P5|Overall Study|Lost to Follow-up|1
4771255|NCT01563029|16458727|P4|Overall Study|Lost to Follow-up|1
4771256|NCT01563029|16458728|P3|Overall Study|Lost to Follow-up|1
4771257|NCT01563029|16458729|P2|Overall Study|Lost to Follow-up|0
4771258|NCT01563029|16458730|P1|Overall Study|Lost to Follow-up|1
4771259|NCT01563029|16458726|P5|Overall Study|Protocol defined stopping criteria|0
4771260|NCT01563029|16458727|P4|Overall Study|Protocol defined stopping criteria|0
4771261|NCT01563029|16458728|P3|Overall Study|Protocol defined stopping criteria|0
4771262|NCT01563029|16458729|P2|Overall Study|Protocol defined stopping criteria|0
4771263|NCT01563029|16458730|P1|Overall Study|Protocol defined stopping criteria|1
4771264|NCT01563029|16458726|P5|Overall Study|Protocol Violation|3
4771265|NCT01563029|16458727|P4|Overall Study|Protocol Violation|1
4771266|NCT01563029|16458728|P3|Overall Study|Protocol Violation|3
4771267|NCT01563029|16458729|P2|Overall Study|Protocol Violation|2
4771268|NCT01563029|16458730|P1|Overall Study|Protocol Violation|1
4771269|NCT01563029|16458726|P5|Overall Study|Lack of Efficacy|19
4771270|NCT01563029|16458727|P4|Overall Study|Lack of Efficacy|21
4771271|NCT01563029|16458728|P3|Overall Study|Lack of Efficacy|23
4771272|NCT01563029|16458729|P2|Overall Study|Lack of Efficacy|16
4771273|NCT01563029|16458730|P1|Overall Study|Lack of Efficacy|42
4771274|NCT01563029|16458726|P5|Overall Study|Adverse Event|1
4771275|NCT01563029|16458727|P4|Overall Study|Adverse Event|2
4771276|NCT01563029|16458728|P3|Overall Study|Adverse Event|1
4771277|NCT01563029|16458729|P2|Overall Study|Adverse Event|0
4771278|NCT01563029|16458730|P1|Overall Study|Adverse Event|1
4771279|NCT01562873|16458796|P2|Overall Study|Clinical PD and adverse event|0
4771280|NCT01562873|16458797|P1|Overall Study|Clinical PD and adverse event|1
4771281|NCT01562873|16458796|P2|Overall Study|Clinical Disease Progression|0
4771282|NCT01562873|16458797|P1|Overall Study|Clinical Disease Progression|9
4771283|NCT01562873|16458796|P2|Overall Study|Adverse Event|0
4771284|NCT01562873|16458797|P1|Overall Study|Adverse Event|1
4771285|NCT01562873|16458796|P2|Overall Study|Disease Progression per RECIST|0
4771286|NCT01562873|16458797|P1|Overall Study|Disease Progression per RECIST|10
4771287|NCT01562782|16458806|P2|Overall Study|screen failure|2
4771288|NCT01562782|16458807|P1|Overall Study|screen failure|1
4771289|NCT01562782|16458806|P2|Overall Study|Withdrawal by Subject|3
4771290|NCT01562782|16458807|P1|Overall Study|Withdrawal by Subject|3
4771291|NCT01562743|16458836|P1|Overall Study|Physician Decision|2
4771292|NCT01562743|16458836|P1|Overall Study|Lost to Follow-up|2
4771293|NCT01562743|16458836|P1|Overall Study|Discontinuation criteria|2
4771294|NCT01562743|16458836|P1|Overall Study|Protocol Violation|1
4771295|NCT01562743|16458836|P1|Overall Study|Withdrawal by Subject|13
4771296|NCT01562743|16458836|P1|Overall Study|Lack of Efficacy|3
4771297|NCT01562743|16458836|P1|Overall Study|Adverse Event|29
4771298|NCT01562613|16458855|P1|Overall Study|Withdrawal by Subject|2
4771299|NCT01562613|16458855|P1|Overall Study|Lost to Follow-up|2
4771300|NCT01562548|16458865|P4|Overall Study|Lost to Follow-up|0
4771301|NCT01562548|16458866|P3|Overall Study|Lost to Follow-up|1
4771302|NCT01562548|16458867|P2|Overall Study|Lost to Follow-up|0
4771303|NCT01562548|16458868|P1|Overall Study|Lost to Follow-up|0
4771304|NCT01562444|16458921|P3|Overall Study|Protocol forbidden medication|0
4771305|NCT01562444|16458922|P2|Overall Study|Protocol forbidden medication|0
4771306|NCT01562444|16458923|P1|Overall Study|Protocol forbidden medication|1
4771307|NCT01562444|16458921|P3|Overall Study|Protocol forbidden concomitant vaccine|1
4771308|NCT01562444|16458922|P2|Overall Study|Protocol forbidden concomitant vaccine|0
4771309|NCT01562444|16458923|P1|Overall Study|Protocol forbidden concomitant vaccine|1
4771310|NCT01562444|16458921|P3|Overall Study|Unavailable serological results|2
4771311|NCT01562444|16458922|P2|Overall Study|Unavailable serological results|2
4771312|NCT01562444|16458923|P1|Overall Study|Unavailable serological results|0
4771313|NCT01562444|16458921|P3|Overall Study|Did not comply with blood draw schedule|1
4771314|NCT01562444|16458922|P2|Overall Study|Did not comply with blood draw schedule|0
4771315|NCT01562444|16458923|P1|Overall Study|Did not comply with blood draw schedule|1
4771316|NCT01562444|16458921|P3|Overall Study|Did not meet entry criteria|3
4771317|NCT01562444|16458922|P2|Overall Study|Did not meet entry criteria|0
4771318|NCT01562444|16458923|P1|Overall Study|Did not meet entry criteria|2
4771319|NCT01562327|16459189|P1|Overall Study|Infusion not received at 6 month window|4
4771320|NCT01562327|16459189|P1|Overall Study|Participant drop-out|1
4771321|NCT01562327|16459189|P1|Overall Study|Lack of Efficacy|1
4771322|NCT01562327|16459189|P1|Overall Study|Adverse Event|2
4771323|NCT01562314|16459219|P2|Overall Study|Withdrawal by Subject|1
4771324|NCT01562314|16459220|P1|Overall Study|Withdrawal by Subject|0
4771325|NCT01562314|16459219|P2|Overall Study|Met Withdrawal Criteria|2
4771326|NCT01562314|16459220|P1|Overall Study|Met Withdrawal Criteria|3
4771327|NCT01562314|16459219|P2|Overall Study|Adverse Event|5
4771328|NCT01562314|16459220|P1|Overall Study|Adverse Event|10
4771329|NCT01562275|16459277|P13|Stage 2|Progression of Disease|4
4771330|NCT01562275|16459278|P12|Stage 2|Progression of Disease|12
4771331|NCT01562275|16459279|P11|Stage 2|Progression of Disease|0
4771332|NCT01562275|16459280|P10|Stage 2|Progression of Disease|0
4771333|NCT01562275|16459281|P9|Stage 2|Progression of Disease|0
4771334|NCT01562275|16459282|P8|Stage 2|Progression of Disease|0
4771335|NCT01562275|16459283|P7|Stage 2|Progression of Disease|0
4771336|NCT01562275|16459284|P6|Stage 2|Progression of Disease|0
4771337|NCT01562275|16459285|P5|Stage 2|Progression of Disease|0
4771338|NCT01562275|16459286|P4|Stage 2|Progression of Disease|0
4771339|NCT01562275|16459287|P3|Stage 2|Progression of Disease|0
4771340|NCT01562275|16459288|P2|Stage 2|Progression of Disease|0
4771341|NCT01562275|16459289|P1|Stage 2|Progression of Disease|0
4771342|NCT01562275|16459277|P13|Stage 2|Death|1
4771343|NCT01562275|16459278|P12|Stage 2|Death|2
4771344|NCT01562275|16459279|P11|Stage 2|Death|0
4771345|NCT01562275|16459280|P10|Stage 2|Death|0
4771346|NCT01562275|16459281|P9|Stage 2|Death|0
4771347|NCT01562275|16459282|P8|Stage 2|Death|0
4771348|NCT01562275|16459283|P7|Stage 2|Death|0
4771349|NCT01562275|16459284|P6|Stage 2|Death|0
4771350|NCT01562275|16459285|P5|Stage 2|Death|0
4771351|NCT01562275|16459286|P4|Stage 2|Death|0
4771352|NCT01562275|16459287|P3|Stage 2|Death|0
4771353|NCT01562275|16459288|P2|Stage 2|Death|0
4771354|NCT01562275|16459289|P1|Stage 2|Death|0
4771355|NCT01562275|16459277|P13|Stage 1|Withdrawal by Subject|0
4771356|NCT01562275|16459278|P12|Stage 1|Withdrawal by Subject|0
4771357|NCT01562275|16459279|P11|Stage 1|Withdrawal by Subject|0
4771358|NCT01562275|16459280|P10|Stage 1|Withdrawal by Subject|1
4771359|NCT01562275|16459281|P9|Stage 1|Withdrawal by Subject|0
4771360|NCT01562275|16459282|P8|Stage 1|Withdrawal by Subject|0
4771361|NCT01562275|16459283|P7|Stage 1|Withdrawal by Subject|1
4771362|NCT01562275|16459284|P6|Stage 1|Withdrawal by Subject|0
4771363|NCT01562275|16459285|P5|Stage 1|Withdrawal by Subject|0
4771364|NCT01562275|16459286|P4|Stage 1|Withdrawal by Subject|2
4771365|NCT01562275|16459287|P3|Stage 1|Withdrawal by Subject|0
4771366|NCT01562275|16459288|P2|Stage 1|Withdrawal by Subject|1
4771367|NCT01562275|16459289|P1|Stage 1|Withdrawal by Subject|0
4771368|NCT01562275|16459277|P13|Stage 1|Progression of Disease|0
4771369|NCT01562275|16459278|P12|Stage 1|Progression of Disease|0
4771370|NCT01562275|16459279|P11|Stage 1|Progression of Disease|3
4771371|NCT01562275|16459280|P10|Stage 1|Progression of Disease|5
4771372|NCT01562275|16459281|P9|Stage 1|Progression of Disease|2
4771373|NCT01562275|16459282|P8|Stage 1|Progression of Disease|7
4771374|NCT01562275|16459283|P7|Stage 1|Progression of Disease|1
4771375|NCT01562275|16459284|P6|Stage 1|Progression of Disease|4
4771376|NCT01562275|16459285|P5|Stage 1|Progression of Disease|2
4771377|NCT01562275|16459286|P4|Stage 1|Progression of Disease|1
4771378|NCT01562275|16459287|P3|Stage 1|Progression of Disease|2
4771379|NCT01562275|16459288|P2|Stage 1|Progression of Disease|6
4771380|NCT01562275|16459289|P1|Stage 1|Progression of Disease|2
4771381|NCT01562275|16459277|P13|Stage 1|Physician Decision|0
4771382|NCT01562275|16459278|P12|Stage 1|Physician Decision|0
4771383|NCT01562275|16459279|P11|Stage 1|Physician Decision|0
4771384|NCT01562275|16459280|P10|Stage 1|Physician Decision|0
4771385|NCT01562275|16459281|P9|Stage 1|Physician Decision|1
4771386|NCT01562275|16459282|P8|Stage 1|Physician Decision|0
4771387|NCT01562275|16459283|P7|Stage 1|Physician Decision|1
4771388|NCT01562275|16459284|P6|Stage 1|Physician Decision|0
4771389|NCT01562275|16459285|P5|Stage 1|Physician Decision|1
4771390|NCT01562275|16459286|P4|Stage 1|Physician Decision|0
4771391|NCT01562275|16459287|P3|Stage 1|Physician Decision|0
4771392|NCT01562275|16459288|P2|Stage 1|Physician Decision|0
4771393|NCT01562275|16459289|P1|Stage 1|Physician Decision|0
4771394|NCT01562275|16459277|P13|Stage 1|Non Compliance|0
4771395|NCT01562275|16459278|P12|Stage 1|Non Compliance|0
4771396|NCT01562275|16459279|P11|Stage 1|Non Compliance|0
4771397|NCT01562275|16459280|P10|Stage 1|Non Compliance|0
4771398|NCT01562275|16459281|P9|Stage 1|Non Compliance|0
4771399|NCT01562275|16459282|P8|Stage 1|Non Compliance|0
4771400|NCT01562275|16459283|P7|Stage 1|Non Compliance|0
4771401|NCT01562275|16459284|P6|Stage 1|Non Compliance|0
4771402|NCT01562275|16459285|P5|Stage 1|Non Compliance|0
4771403|NCT01562275|16459286|P4|Stage 1|Non Compliance|0
4771404|NCT01562275|16459287|P3|Stage 1|Non Compliance|1
4771405|NCT01562275|16459288|P2|Stage 1|Non Compliance|0
4771406|NCT01562275|16459289|P1|Stage 1|Non Compliance|0
4771407|NCT01562275|16459277|P13|Stage 1|Death|0
4771408|NCT01562275|16459278|P12|Stage 1|Death|0
4771409|NCT01562275|16459279|P11|Stage 1|Death|0
4771410|NCT01562275|16459280|P10|Stage 1|Death|0
4771411|NCT01562275|16459281|P9|Stage 1|Death|0
4771412|NCT01562275|16459282|P8|Stage 1|Death|0
4771413|NCT01562275|16459283|P7|Stage 1|Death|0
4771414|NCT01562275|16459284|P6|Stage 1|Death|0
4771415|NCT01562275|16459285|P5|Stage 1|Death|0
4771416|NCT01562275|16459286|P4|Stage 1|Death|0
4771417|NCT01562275|16459287|P3|Stage 1|Death|0
4771418|NCT01562275|16459288|P2|Stage 1|Death|0
4771419|NCT01562275|16459289|P1|Stage 1|Death|1
4771420|NCT01562275|16459277|P13|Stage 1|Adverse Event|0
4771421|NCT01562275|16459278|P12|Stage 1|Adverse Event|0
4771422|NCT01562275|16459279|P11|Stage 1|Adverse Event|0
4771423|NCT01562275|16459280|P10|Stage 1|Adverse Event|1
4771424|NCT01562275|16459281|P9|Stage 1|Adverse Event|0
4771425|NCT01562275|16459282|P8|Stage 1|Adverse Event|0
4771426|NCT01562275|16459283|P7|Stage 1|Adverse Event|0
4771427|NCT01562275|16459284|P6|Stage 1|Adverse Event|0
4771428|NCT01562275|16459285|P5|Stage 1|Adverse Event|1
4771429|NCT01562275|16459286|P4|Stage 1|Adverse Event|1
4771430|NCT01562275|16459287|P3|Stage 1|Adverse Event|0
4771431|NCT01562275|16459288|P2|Stage 1|Adverse Event|0
4771432|NCT01562275|16459289|P1|Stage 1|Adverse Event|0
4771433|NCT01562028|16459430|P2|Overall Study|Lost to Follow-up|1
4771434|NCT01562028|16459431|P1|Overall Study|Lost to Follow-up|2
4771435|NCT01562028|16459430|P2|Overall Study|Withdrawal by Subject|1
4771436|NCT01562028|16459431|P1|Overall Study|Withdrawal by Subject|1
4771437|NCT01561989|16459451|P2|Overall Study|accural target not met.|6
4771438|NCT01561989|16459452|P1|Overall Study|accural target not met.|5
4771439|NCT01561976|16459474|P6|Washout Period 2 (7 Days)|Non-compliance|0
4771440|NCT01561976|16459475|P5|Washout Period 2 (7 Days)|Non-compliance|0
4771441|NCT01561976|16459476|P4|Washout Period 2 (7 Days)|Non-compliance|0
4771442|NCT01561976|16459477|P3|Washout Period 2 (7 Days)|Non-compliance|1
4771443|NCT01561976|16459478|P2|Washout Period 2 (7 Days)|Non-compliance|0
4771444|NCT01561976|16459479|P1|Washout Period 2 (7 Days)|Non-compliance|1
4771445|NCT01561976|16459474|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4771446|NCT01561976|16459475|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4771447|NCT01561976|16459476|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4771448|NCT01561976|16459477|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4771449|NCT01561976|16459478|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4771450|NCT01561976|16459479|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4771451|NCT01561976|16459474|P6|Washout Period 1 (7 Days)|Adverse Event|0
4771452|NCT01561976|16459475|P5|Washout Period 1 (7 Days)|Adverse Event|0
4771453|NCT01561976|16459476|P4|Washout Period 1 (7 Days)|Adverse Event|1
4771454|NCT01561976|16459477|P3|Washout Period 1 (7 Days)|Adverse Event|0
4771455|NCT01561976|16459478|P2|Washout Period 1 (7 Days)|Adverse Event|0
4771456|NCT01561976|16459479|P1|Washout Period 1 (7 Days)|Adverse Event|0
4771457|NCT01561976|16459474|P6|Period 1|Adverse Event|0
4771458|NCT01561976|16459475|P5|Period 1|Adverse Event|0
4771459|NCT01561976|16459476|P4|Period 1|Adverse Event|0
4771460|NCT01561976|16459477|P3|Period 1|Adverse Event|1
4771461|NCT01561976|16459478|P2|Period 1|Adverse Event|0
4771462|NCT01561976|16459479|P1|Period 1|Adverse Event|0
4771463|NCT01561898|16459512|P4|Overall Study|Physician Decision|1
4771464|NCT01561898|16459513|P3|Overall Study|Physician Decision|7
4771465|NCT01561898|16459514|P2|Overall Study|Physician Decision|5
4771466|NCT01561898|16459515|P1|Overall Study|Physician Decision|1
4771467|NCT01561898|16459512|P4|Overall Study|Adverse Event|9
4771468|NCT01561898|16459513|P3|Overall Study|Adverse Event|14
4771469|NCT01561898|16459514|P2|Overall Study|Adverse Event|19
4771470|NCT01561898|16459515|P1|Overall Study|Adverse Event|1
4771471|NCT01561898|16459512|P4|Overall Study|Lost to Follow-up|0
4771472|NCT01561898|16459513|P3|Overall Study|Lost to Follow-up|1
4771473|NCT01561898|16459514|P2|Overall Study|Lost to Follow-up|0
4771474|NCT01561898|16459515|P1|Overall Study|Lost to Follow-up|0
4771475|NCT01561898|16459512|P4|Overall Study|Worsening of complications|0
4771476|NCT01561898|16459513|P3|Overall Study|Worsening of complications|0
4771477|NCT01561898|16459514|P2|Overall Study|Worsening of complications|1
4771478|NCT01561898|16459515|P1|Overall Study|Worsening of complications|0
4771479|NCT01561898|16459512|P4|Overall Study|Lack of Efficacy|5
4771480|NCT01561898|16459513|P3|Overall Study|Lack of Efficacy|10
4771481|NCT01561898|16459514|P2|Overall Study|Lack of Efficacy|8
4771482|NCT01561898|16459515|P1|Overall Study|Lack of Efficacy|0
4771483|NCT01561898|16459512|P4|Overall Study|Withdrawal by Subject|5
4771484|NCT01561898|16459513|P3|Overall Study|Withdrawal by Subject|12
4771485|NCT01561898|16459514|P2|Overall Study|Withdrawal by Subject|8
4771486|NCT01561898|16459515|P1|Overall Study|Withdrawal by Subject|0
4771487|NCT01561755|16459533|P2|Overall Study|Lost to Follow-up|1
4771488|NCT01561755|16459534|P1|Overall Study|Lost to Follow-up|0
4771489|NCT01561560|16459586|P2|Second Two Weeks of Wear|Adverse Event|1
4771490|NCT01561560|16459587|P1|Second Two Weeks of Wear|Adverse Event|0
4771491|NCT01561560|16459586|P2|First Two Weeks of Wear|Adverse Event|1
4771492|NCT01561560|16459587|P1|First Two Weeks of Wear|Adverse Event|0
4771493|NCT01561560|16459586|P2|First Two Weeks of Wear|Time/job conflict|1
4771494|NCT01561560|16459587|P1|First Two Weeks of Wear|Time/job conflict|0
4771495|NCT01561430|16459622|P4|Overall Study|Sponsor Decision|12
4771496|NCT01561430|16459623|P3|Overall Study|Sponsor Decision|13
4771497|NCT01561430|16459624|P2|Overall Study|Sponsor Decision|14
4771498|NCT01561430|16459625|P1|Overall Study|Sponsor Decision|1
4771499|NCT01561430|16459622|P4|Overall Study|Physician Decision|0
4771500|NCT01561430|16459623|P3|Overall Study|Physician Decision|0
4771501|NCT01561430|16459624|P2|Overall Study|Physician Decision|1
4771502|NCT01561430|16459625|P1|Overall Study|Physician Decision|0
4771503|NCT01561430|16459622|P4|Overall Study|Withdrawal by Subject|0
4771504|NCT01561430|16459623|P3|Overall Study|Withdrawal by Subject|1
4771505|NCT01561430|16459624|P2|Overall Study|Withdrawal by Subject|0
4771506|NCT01561430|16459625|P1|Overall Study|Withdrawal by Subject|0
4771507|NCT01561430|16459622|P4|Overall Study|Adverse Event|1
4771508|NCT01561430|16459623|P3|Overall Study|Adverse Event|3
4771509|NCT01561430|16459624|P2|Overall Study|Adverse Event|0
4771510|NCT01561430|16459625|P1|Overall Study|Adverse Event|0
4771511|NCT01561313|16459688|P2|Overall Study|Adverse event and withdrawal by subject|0
4771512|NCT01561313|16459689|P1|Overall Study|Adverse event and withdrawal by subject|1
4771513|NCT01561313|16459688|P2|Overall Study|Withdrawal by Subject|0
4771514|NCT01561313|16459689|P1|Overall Study|Withdrawal by Subject|1
4771515|NCT01561300|16459707|P2|Run in on Placebo|Adverse Event|0
4771516|NCT01561300|16459708|P1|Run in on Placebo|Adverse Event|1
4771517|NCT01561079|16459719|P1|Overall Study|Protocol Violation|2
4771518|NCT01561079|16459719|P1|Overall Study|Withdrawal by Subject|59
4771519|NCT01561079|16459719|P1|Overall Study|Physician Decision|17
4771520|NCT01560988|16459805|P2|Washout (Six Weeks)|Lost to Follow-up|2
4771521|NCT01560988|16459806|P1|Washout (Six Weeks)|Lost to Follow-up|2
4771522|NCT01560988|16459805|P2|First Intervention (Six Weeks)|Withdrawal by Subject|0
4771523|NCT01560988|16459806|P1|First Intervention (Six Weeks)|Withdrawal by Subject|3
4771524|NCT01560988|16459805|P2|First Intervention (Six Weeks)|Lost to Follow-up|4
4771525|NCT01560988|16459806|P1|First Intervention (Six Weeks)|Lost to Follow-up|7
4771526|NCT01560949|16459842|P1|Surgery Phase|Physician Decision|3
4771527|NCT01560949|16459842|P1|Systemic Phase: mFOLFIRINOX|Adverse Event|6
4771528|NCT01560871|16459876|P2|Overall Study|Lost to Follow-up|0
4771529|NCT01560871|16459877|P1|Overall Study|Lost to Follow-up|1
4771530|NCT01560871|16459876|P2|Overall Study|readmission to a hospital|1
4771531|NCT01560871|16459877|P1|Overall Study|readmission to a hospital|2
4771532|NCT01560871|16459876|P2|Overall Study|relocation|0
4771533|NCT01560871|16459877|P1|Overall Study|relocation|1
4771534|NCT01560871|16459876|P2|Overall Study|transportation issues|1
4771535|NCT01560871|16459877|P1|Overall Study|transportation issues|2
4771536|NCT01560819|16459893|P2|Overall Study|Physician Decision|0
4771537|NCT01560819|16459894|P1|Overall Study|Physician Decision|1
4771538|NCT01560780|16459900|P2|Overall Study|Patient Preference|11
4771539|NCT01560780|16459901|P1|Overall Study|Patient Preference|11
4771540|NCT01560780|16459900|P2|Overall Study|Death|1
4771541|NCT01560780|16459901|P1|Overall Study|Death|2
4771542|NCT01560507|16459937|P3|Overall Study|Withdrawal by Subject|0
4771543|NCT01560507|16459938|P2|Overall Study|Withdrawal by Subject|1
4771544|NCT01560507|16459939|P1|Overall Study|Withdrawal by Subject|1
4771545|NCT01560507|16459937|P3|Overall Study|Lost to Follow-up|2
4771546|NCT01560507|16459938|P2|Overall Study|Lost to Follow-up|1
4771547|NCT01560507|16459939|P1|Overall Study|Lost to Follow-up|3
4771548|NCT01560429|16459952|P2|Overall Study|Protocol Violation|6
4771549|NCT01560429|16459953|P1|Overall Study|Protocol Violation|3
4771550|NCT01560416|16459963|P2|Randomized Phase|Crossover Participants|0
4771551|NCT01560416|16459964|P1|Randomized Phase|Crossover Participants|7
4771552|NCT01560403|16459982|P2|Overall Study|Lost to Follow-up|1
4771553|NCT01560403|16459983|P1|Overall Study|Lost to Follow-up|0
4771554|NCT01560234|16460031|P8|Overall Study|Lost to Follow-up|2
4771555|NCT01560234|16460032|P7|Overall Study|Lost to Follow-up|0
4771556|NCT01560234|16460033|P6|Overall Study|Lost to Follow-up|2
4771557|NCT01560234|16460034|P5|Overall Study|Lost to Follow-up|0
4771558|NCT01560234|16460035|P4|Overall Study|Lost to Follow-up|0
4771559|NCT01560234|16460036|P3|Overall Study|Lost to Follow-up|1
4771560|NCT01560234|16460037|P2|Overall Study|Lost to Follow-up|0
4771561|NCT01560234|16460038|P1|Overall Study|Lost to Follow-up|3
4771562|NCT01559935|16460133|P1|Maintenance Phase|Non-compliance|2
4771563|NCT01559935|16460133|P1|Maintenance Phase|Withdrawal by Subject|5
4771564|NCT01559935|16460133|P1|Maintenance Phase|Lack of Efficacy|18
4771565|NCT01559935|16460133|P1|Maintenance Phase|Toxicity|1
4771566|NCT01559935|16460133|P1|Maintenance Phase|Remains on study|28
4771567|NCT01559935|16460133|P1|BiRD Phase|Withdrawal by Subject|2
4771568|NCT01559935|16460133|P1|BiRD Phase|Lack of Efficacy|1
4771569|NCT01559935|16460133|P1|BiRD Phase|Toxicity|1
4771570|NCT01559935|16460133|P1|Car Phase|non-compliance|1
4771571|NCT01559935|16460133|P1|Car Phase|Insurance|1
4771572|NCT01559935|16460133|P1|Car Phase|Per protocol|1
4771573|NCT01559935|16460133|P1|Car Phase|Withdrawal by Subject|2
4771574|NCT01559935|16460133|P1|Car Phase|Physician Decision|1
4771575|NCT01559935|16460133|P1|Car Phase|Lost to Follow-up|1
4771576|NCT01559935|16460133|P1|Car Phase|Lack of Efficacy|2
4771577|NCT01559935|16460133|P1|Car Phase|Death|1
4771578|NCT01559935|16460133|P1|Car Phase|Toxicity|4
4771579|NCT01559844|16460169|P1|Overall Study|No Longer A Transplant Candidate|3
4771580|NCT01559844|16460169|P1|Overall Study|Efficacy Failure|10
4771581|NCT01559844|16460169|P1|Overall Study|Death|5
4771582|NCT01559844|16460169|P1|Overall Study|Consent Withdrawn|7
4771583|NCT01559675|16460182|P2|Overall Study|2nd operation on same patient excluded|12
4771584|NCT01559675|16460183|P1|Overall Study|2nd operation on same patient excluded|14
4771585|NCT01559675|16460182|P2|Overall Study|Protocol Violation|2
4771586|NCT01559675|16460183|P1|Overall Study|Protocol Violation|1
4771587|NCT01559454|16460214|P2|Overall Study|Lack of Efficacy|1
4771588|NCT01559454|16460215|P1|Overall Study|Lack of Efficacy|0
4771589|NCT01559454|16460214|P2|Overall Study|Protocol Violation|1
4771590|NCT01559454|16460215|P1|Overall Study|Protocol Violation|0
4771591|NCT01559454|16460214|P2|Overall Study|Physician Decision|1
4771592|NCT01559454|16460215|P1|Overall Study|Physician Decision|0
4771593|NCT01559454|16460214|P2|Overall Study|Withdrawal by Subject|1
4771594|NCT01559454|16460215|P1|Overall Study|Withdrawal by Subject|0
4771595|NCT01559454|16460214|P2|Overall Study|Lost to Follow-up|2
4771596|NCT01559454|16460215|P1|Overall Study|Lost to Follow-up|3
4771597|NCT01559389|16460233|P2|Overall Study|Withdrawal by Subject|20
4771598|NCT01559389|16460234|P1|Overall Study|Withdrawal by Subject|20
4771599|NCT01559311|16460247|P3|Overall Study|Adverse Event|1
4771600|NCT01559311|16460248|P2|Overall Study|Adverse Event|0
4771601|NCT01559311|16460249|P1|Overall Study|Adverse Event|0
4771602|NCT01559311|16460247|P3|Overall Study|Lost to Follow-up|2
4771603|NCT01559311|16460248|P2|Overall Study|Lost to Follow-up|3
4771604|NCT01559311|16460249|P1|Overall Study|Lost to Follow-up|0
4771605|NCT01559311|16460247|P3|Overall Study|Death|3
4771606|NCT01559311|16460248|P2|Overall Study|Death|2
4771607|NCT01559311|16460249|P1|Overall Study|Death|0
4771608|NCT01559311|16460247|P3|Overall Study|Withdrawal by Subject|0
4771609|NCT01559311|16460248|P2|Overall Study|Withdrawal by Subject|1
4771610|NCT01559311|16460249|P1|Overall Study|Withdrawal by Subject|2
4771611|NCT01559311|16460247|P3|Overall Study|Difficulty in cannulating the lateral ve|0
4771612|NCT01559311|16460248|P2|Overall Study|Difficulty in cannulating the lateral ve|0
4771613|NCT01559311|16460249|P1|Overall Study|Difficulty in cannulating the lateral ve|1
4771614|NCT01559311|16460247|P3|Overall Study|Protocol Violation|2
4771615|NCT01559311|16460248|P2|Overall Study|Protocol Violation|0
4771616|NCT01559311|16460249|P1|Overall Study|Protocol Violation|0
4771617|NCT01559259|16460265|P5|Overall Study|Adverse Event|0
4771618|NCT01559259|16460266|P4|Overall Study|Adverse Event|0
4771619|NCT01559259|16460267|P3|Overall Study|Adverse Event|1
4771620|NCT01559259|16460268|P2|Overall Study|Adverse Event|1
4771621|NCT01559259|16460269|P1|Overall Study|Adverse Event|0
4771622|NCT01559259|16460265|P5|Overall Study|Withdrawal by Subject|0
4771623|NCT01559259|16460266|P4|Overall Study|Withdrawal by Subject|1
4771624|NCT01559259|16460267|P3|Overall Study|Withdrawal by Subject|0
4771625|NCT01559259|16460268|P2|Overall Study|Withdrawal by Subject|0
4771626|NCT01559259|16460269|P1|Overall Study|Withdrawal by Subject|0
4771627|NCT01559129|16460358|P2|Open-label Extension Period|Study Terminated by Sponsor|2
4771628|NCT01559129|16460359|P1|Open-label Extension Period|Study Terminated by Sponsor|5
4771629|NCT01559129|16460358|P2|Open-label Extension Period|Adverse Event|0
4771630|NCT01559129|16460359|P1|Open-label Extension Period|Adverse Event|1
4771631|NCT01559129|16460358|P2|Treatment Phase|Did Not Receive Study Drug|1
4771632|NCT01559129|16460359|P1|Treatment Phase|Did Not Receive Study Drug|0
4771633|NCT01559129|16460358|P2|Treatment Phase|Protocol Exclusion Criteria|0
4771634|NCT01559129|16460359|P1|Treatment Phase|Protocol Exclusion Criteria|1
4771635|NCT01559129|16460358|P2|Treatment Phase|Study Terminated by Sponsor|2
4771636|NCT01559129|16460359|P1|Treatment Phase|Study Terminated by Sponsor|3
4771637|NCT01559129|16460358|P2|Treatment Phase|Lack of Efficacy|1
4771638|NCT01559129|16460359|P1|Treatment Phase|Lack of Efficacy|0
4771639|NCT01559129|16460358|P2|Treatment Phase|Progressive Disease|1
4771640|NCT01559129|16460359|P1|Treatment Phase|Progressive Disease|1
4771641|NCT01559129|16460358|P2|Treatment Phase|Adverse Event|2
4771642|NCT01559129|16460359|P1|Treatment Phase|Adverse Event|0
4771643|NCT01559116|16460435|P1|Overall Study|other than stated above|9
4771644|NCT01559116|16460435|P1|Overall Study|Withdrawal by Subject|4
4771645|NCT01559116|16460435|P1|Overall Study|Protocol Violation|1
4771646|NCT01559116|16460435|P1|Overall Study|Lost to Follow-up|1
4771647|NCT01559116|16460435|P1|Overall Study|Lack of Efficacy|1
4771648|NCT01559116|16460435|P1|Overall Study|Adverse Event|10
4771649|NCT01559090|16460506|P3|Stage II|Withdrawal by Subject|0
4771650|NCT01559090|16460507|P2|Stage II|Withdrawal by Subject|0
4771651|NCT01559090|16460508|P1|Stage II|Withdrawal by Subject|1
4771652|NCT01559090|16460506|P3|Stage I|Withdrawal by Subject|3
4771653|NCT01559090|16460507|P2|Stage I|Withdrawal by Subject|2
4771654|NCT01559090|16460508|P1|Stage I|Withdrawal by Subject|2
4771655|NCT01559012|16460540|P2|Overall Study|Withdrawal by Subject|1
4771656|NCT01559012|16460541|P1|Overall Study|Withdrawal by Subject|0
4771657|NCT01558739|16460579|P1|Overall Study|Protocol Violation|1
4771658|NCT01558739|16460579|P1|Overall Study|Disease Progression|4
4771659|NCT01558739|16460579|P1|Overall Study|Death|3
4771660|NCT01558739|16460579|P1|Overall Study|Withdrawal by Subject|2
4771661|NCT01558739|16460579|P1|Overall Study|Adverse Event|7
4771662|NCT01558674|16460604|P2|Part 1|Withdrawal by Subject|0
4771663|NCT01558674|16460605|P1|Part 1|Withdrawal by Subject|1
4771664|NCT01558674|16460604|P2|Part 1|Study Terminated by Sponsor|0
4771665|NCT01558674|16460605|P1|Part 1|Study Terminated by Sponsor|10
4771666|NCT01558635|16460656|P1|Overall Study|Reveal XT was explanted|1
4771667|NCT01558635|16460656|P1|Overall Study|Subject received other treatment|1
4771668|NCT01558635|16460656|P1|Overall Study|Physician Decision|1
4771669|NCT01558635|16460656|P1|Overall Study|Withdrawal by Subject|2
4771670|NCT01558635|16460656|P1|Overall Study|Death|1
4771671|NCT01558596|16460673|P2|Overall Study|Protocol Violation|0
4771672|NCT01558596|16460674|P1|Overall Study|Protocol Violation|1
4771673|NCT01558596|16460673|P2|Overall Study|surgery elsewhere or cancelled|1
4771674|NCT01558596|16460674|P1|Overall Study|surgery elsewhere or cancelled|1
4771675|NCT01558596|16460673|P2|Overall Study|Withdrawal by Subject|0
4771676|NCT01558596|16460674|P1|Overall Study|Withdrawal by Subject|1
4771677|NCT01558297|16460689|P3|Overall Study|Withdrawal by Subject|1
4771678|NCT01558297|16460690|P2|Overall Study|Withdrawal by Subject|2
4771679|NCT01558297|16460691|P1|Overall Study|Withdrawal by Subject|2
4771680|NCT01558271|16460708|P3|Overall Study|Physician Decision|1
4771681|NCT01558271|16460709|P2|Overall Study|Physician Decision|2
4771682|NCT01558271|16460710|P1|Overall Study|Physician Decision|0
4771683|NCT01558271|16460708|P3|Overall Study|Withdrawal by Subject|12
4771684|NCT01558271|16460709|P2|Overall Study|Withdrawal by Subject|6
4771685|NCT01558271|16460710|P1|Overall Study|Withdrawal by Subject|10
4771686|NCT01558271|16460708|P3|Overall Study|Protocol Violation|0
4771687|NCT01558271|16460709|P2|Overall Study|Protocol Violation|0
4771688|NCT01558271|16460710|P1|Overall Study|Protocol Violation|1
4771689|NCT01558271|16460708|P3|Overall Study|Lost to Follow-up|0
4771690|NCT01558271|16460709|P2|Overall Study|Lost to Follow-up|0
4771691|NCT01558271|16460710|P1|Overall Study|Lost to Follow-up|1
4771692|NCT01558271|16460708|P3|Overall Study|Adverse Event|4
4771693|NCT01558271|16460709|P2|Overall Study|Adverse Event|3
4771694|NCT01558271|16460710|P1|Overall Study|Adverse Event|6
4771695|NCT01558089|16460776|P1|Overall Study|Withdrawal by Subject|6
4771696|NCT01558089|16460776|P1|Overall Study|Lost to Follow-up|5
4771697|NCT01558089|16460776|P1|Overall Study|Lack of Efficacy|1
4771698|NCT01558089|16460776|P1|Overall Study|Adverse Event|1
4771699|NCT01557946|16460829|P2|Overall Study|Adverse Event|0
4771700|NCT01557946|16460830|P1|Overall Study|Adverse Event|3
4771701|NCT01557920|16460836|P2|Overall Study|Lack of Efficacy|0
4771702|NCT01557920|16460837|P1|Overall Study|Lack of Efficacy|1
4771703|NCT01557920|16460836|P2|Overall Study|Withdrawal by Subject|3
4771704|NCT01557920|16460837|P1|Overall Study|Withdrawal by Subject|2
4771705|NCT01557842|16460906|P2|Overall Study|Not Ablated|0
4771706|NCT01557842|16460907|P1|Overall Study|Not Ablated|2
4771707|NCT01557842|16460906|P2|Overall Study|Study Terminated by Sponsor|4
4771708|NCT01557842|16460907|P1|Overall Study|Study Terminated by Sponsor|3
4771709|NCT01557842|16460906|P2|Overall Study|Not Meet Inclusion/Exclusion Criteria|0
4771710|NCT01557842|16460907|P1|Overall Study|Not Meet Inclusion/Exclusion Criteria|3
4771711|NCT01557842|16460906|P2|Overall Study|Lack of Efficacy|1
4771712|NCT01557842|16460907|P1|Overall Study|Lack of Efficacy|0
4771713|NCT01557842|16460906|P2|Overall Study|Death|0
4771714|NCT01557842|16460907|P1|Overall Study|Death|1
4771715|NCT01557842|16460906|P2|Overall Study|Lost to Follow-up|1
4771716|NCT01557842|16460907|P1|Overall Study|Lost to Follow-up|0
4771717|NCT01557751|16460919|P1|Overall Study|Physician Decision|3
4771718|NCT01557582|16460964|P1|Overall Study|Operator error|2
4771719|NCT01557582|16460964|P1|Overall Study|Protocol Violation|4
4771720|NCT01557569|16460972|P2|Overall Study|noncompliance with rules of residential|1
4771721|NCT01557569|16460973|P1|Overall Study|noncompliance with rules of residential|0
4771722|NCT01557569|16460972|P2|Overall Study|Withdrawal by Subject|5
4771723|NCT01557569|16460973|P1|Overall Study|Withdrawal by Subject|3
4771724|NCT01557569|16460972|P2|Overall Study|high blood pressure|1
4771725|NCT01557569|16460973|P1|Overall Study|high blood pressure|0
4771726|NCT01557569|16460972|P2|Overall Study|Adverse Event|0
4771727|NCT01557569|16460973|P1|Overall Study|Adverse Event|2
4771728|NCT01557517|16460981|P2|Overall Study|Pt declined before treatment started|0
4771729|NCT01557517|16460982|P1|Overall Study|Pt declined before treatment started|1
4771730|NCT01557517|16460981|P2|Overall Study|Adverse Event|2
4771731|NCT01557517|16460982|P1|Overall Study|Adverse Event|0
4771732|NCT01557517|16460981|P2|Overall Study|Refused further treatment|2
4771733|NCT01557517|16460982|P1|Overall Study|Refused further treatment|0
4771734|NCT01557517|16460981|P2|Overall Study|Death|0
4771735|NCT01557517|16460982|P1|Overall Study|Death|1
4771736|NCT01557348|16461008|P2|Overall Study|Administrative|11
4771737|NCT01557348|16461009|P1|Overall Study|Administrative|18
4771738|NCT01557348|16461008|P2|Overall Study|Lost to Follow-up|22
4771739|NCT01557348|16461009|P1|Overall Study|Lost to Follow-up|26
4771740|NCT01557348|16461008|P2|Overall Study|Withdrawal by Subject|4
4771741|NCT01557348|16461009|P1|Overall Study|Withdrawal by Subject|5
4771742|NCT01557348|16461008|P2|Overall Study|Insufficient Therapeutic Response|28
4771743|NCT01557348|16461009|P1|Overall Study|Insufficient Therapeutic Response|13
4771744|NCT01557348|16461008|P2|Overall Study|Death|4
4771745|NCT01557348|16461009|P1|Overall Study|Death|7
4771746|NCT01557348|16461008|P2|Overall Study|Infusion reaction event|5
4771747|NCT01557348|16461009|P1|Overall Study|Infusion reaction event|5
4771748|NCT01557348|16461008|P2|Overall Study|Adverse Event|16
4771749|NCT01557348|16461009|P1|Overall Study|Adverse Event|6
4771750|NCT01557283|16461126|P1|Overall Study|Other|6
4771751|NCT01557283|16461126|P1|Overall Study|Worsening of psoriasis|1
4771752|NCT01557283|16461126|P1|Overall Study|Participant's weight too high for dose|1
4771753|NCT01557283|16461126|P1|Overall Study|Withdrawal by Subject|1
4771754|NCT01557283|16461126|P1|Overall Study|Non-compliance|1
4771755|NCT01557283|16461126|P1|Overall Study|Lack of Efficacy|1
4771756|NCT01557283|16461126|P1|Overall Study|Adverse Event|7
4771757|NCT01557283|16461126|P1|Overall Study|Non-responder|19
4771758|NCT01557283|16461126|P1|Overall Study|Lost to Follow-up|7
4771759|NCT01557166|16461138|P2|Overall Study|Unclassified|5
4771760|NCT01557166|16461139|P1|Overall Study|Unclassified|2
4771761|NCT01557166|16461138|P2|Overall Study|Psychiatric disorder|0
4771762|NCT01557166|16461139|P1|Overall Study|Psychiatric disorder|1
4771763|NCT01557166|16461138|P2|Overall Study|Target dose not tolerated|0
4771764|NCT01557166|16461139|P1|Overall Study|Target dose not tolerated|1
4771765|NCT01557166|16461138|P2|Overall Study|Withdrawn consent|20
4771766|NCT01557166|16461139|P1|Overall Study|Withdrawn consent|12
4771767|NCT01557166|16461138|P2|Overall Study|Protocol Violation|5
4771768|NCT01557166|16461139|P1|Overall Study|Protocol Violation|8
4771769|NCT01557166|16461138|P2|Overall Study|Lack of Efficacy|1
4771770|NCT01557166|16461139|P1|Overall Study|Lack of Efficacy|2
4771771|NCT01557166|16461138|P2|Overall Study|Adverse Event|6
4771772|NCT01557166|16461139|P1|Overall Study|Adverse Event|20
4771773|NCT01556997|16461154|P3|Overall Study|Other|7
4771774|NCT01556997|16461155|P2|Overall Study|Other|3
4771775|NCT01556997|16461156|P1|Overall Study|Other|2
4771776|NCT01556997|16461154|P3|Overall Study|Withdrawal by Subject|8
4771777|NCT01556997|16461155|P2|Overall Study|Withdrawal by Subject|6
4771778|NCT01556997|16461156|P1|Overall Study|Withdrawal by Subject|7
4771779|NCT01556997|16461154|P3|Overall Study|Physician Decision|1
4771780|NCT01556997|16461155|P2|Overall Study|Physician Decision|1
4771781|NCT01556997|16461156|P1|Overall Study|Physician Decision|1
4771782|NCT01556997|16461154|P3|Overall Study|Lost to Follow-up|4
4771783|NCT01556997|16461155|P2|Overall Study|Lost to Follow-up|6
4771784|NCT01556997|16461156|P1|Overall Study|Lost to Follow-up|6
4771785|NCT01556997|16461154|P3|Overall Study|Adverse Event|12
4771786|NCT01556997|16461155|P2|Overall Study|Adverse Event|12
4771787|NCT01556997|16461156|P1|Overall Study|Adverse Event|10
4771788|NCT01556932|16461167|P2|Time Point 60 Minutes|Withdrawal by Subject|1
4771789|NCT01556932|16461168|P1|Time Point 60 Minutes|Withdrawal by Subject|1
4771790|NCT01556763|16461194|P3|Overall Study|Withdrawal by Subject|0
4771791|NCT01556763|16461195|P2|Overall Study|Withdrawal by Subject|1
4771792|NCT01556763|16461196|P1|Overall Study|Withdrawal by Subject|0
4771793|NCT01556438|16461335|P2|Overall Study|Death|1
4771794|NCT01556438|16461336|P1|Overall Study|Death|0
4771795|NCT01556438|16461335|P2|Overall Study|Progressive Disease|6
4771796|NCT01556438|16461336|P1|Overall Study|Progressive Disease|0
4771797|NCT01556438|16461335|P2|Overall Study|Sponsor Decision|2
4771798|NCT01556438|16461336|P1|Overall Study|Sponsor Decision|0
4771799|NCT01556438|16461335|P2|Overall Study|Adverse Event|2
4771800|NCT01556438|16461336|P1|Overall Study|Adverse Event|4
4771801|NCT01556165|16461423|P2|Overall Study|Withdrawal of Consent|1
4771802|NCT01556165|16461424|P1|Overall Study|Withdrawal of Consent|7
4771803|NCT01556165|16461423|P2|Overall Study|Protocol Violation|3
4771804|NCT01556165|16461424|P1|Overall Study|Protocol Violation|0
4771805|NCT01556165|16461423|P2|Overall Study|Adverse Event|3
4771806|NCT01556165|16461424|P1|Overall Study|Adverse Event|5
4771807|NCT01555983|16461454|P6|Overall Study|Withdrawal by Subject|1
4771808|NCT01555983|16461455|P5|Overall Study|Withdrawal by Subject|1
4771809|NCT01555983|16461456|P4|Overall Study|Withdrawal by Subject|0
4771810|NCT01555983|16461457|P3|Overall Study|Withdrawal by Subject|0
4771811|NCT01555983|16461458|P2|Overall Study|Withdrawal by Subject|0
4771812|NCT01555983|16461459|P1|Overall Study|Withdrawal by Subject|1
4771813|NCT01555931|16461469|P2|Overall Study|Lost to Follow-up|5
4771814|NCT01555931|16461470|P1|Overall Study|Lost to Follow-up|2
4771815|NCT01555762|16461478|P1|Overall Study|Death linked to an adverse event|14
4771816|NCT01555762|16461478|P1|Overall Study|Missing data|1
4771817|NCT01555762|16461478|P1|Overall Study|Participant not wishing to continue|5
4771818|NCT01555762|16461478|P1|Overall Study|Investigator's decision|10
4771819|NCT01555762|16461478|P1|Overall Study|Lost follow-up/moved house/changed team|35
4771820|NCT01555762|16461478|P1|Overall Study|Death linked to progression of disease|165
4771821|NCT01555762|16461478|P1|Overall Study|Treatment with Bevacizumab ticked No|24
4771822|NCT01555762|16461478|P1|Overall Study|75 years old or more ticked No|1
4771823|NCT01555762|16461478|P1|Overall Study|Missing start date of infusion|8
4771824|NCT01555762|16461478|P1|Overall Study|No information on Bevacizumab intake|11
4771825|NCT01555463|16461558|P2|Follow up|Other reason|3
4771826|NCT01555463|16461559|P1|Follow up|Other reason|3
4771827|NCT01555463|16461558|P2|Follow up|Protocol Violation|4
4771828|NCT01555463|16461559|P1|Follow up|Protocol Violation|2
4771829|NCT01555463|16461558|P2|Follow up|Lost to Follow-up|10
4771830|NCT01555463|16461559|P1|Follow up|Lost to Follow-up|9
4771831|NCT01555463|16461558|P2|Follow up|Withdrawal by Subject|22
4771832|NCT01555463|16461559|P1|Follow up|Withdrawal by Subject|22
4771833|NCT01555463|16461558|P2|Follow up|Death|1
4771834|NCT01555463|16461559|P1|Follow up|Death|0
4771835|NCT01555463|16461558|P2|Follow up|Adverse Event|5
4771836|NCT01555463|16461559|P1|Follow up|Adverse Event|2
4771837|NCT01555463|16461558|P2|Treatment|Other reason|3
4771838|NCT01555463|16461559|P1|Treatment|Other reason|2
4771839|NCT01555463|16461558|P2|Treatment|Protocol Violation|5
4771840|NCT01555463|16461559|P1|Treatment|Protocol Violation|4
4771841|NCT01555463|16461558|P2|Treatment|Lost to Follow-up|23
4771842|NCT01555463|16461559|P1|Treatment|Lost to Follow-up|28
4771843|NCT01555463|16461558|P2|Treatment|Withdrawal by Subject|36
4771844|NCT01555463|16461559|P1|Treatment|Withdrawal by Subject|24
4771845|NCT01555463|16461558|P2|Treatment|Adverse Event|12
4771846|NCT01555463|16461559|P1|Treatment|Adverse Event|6
4771847|NCT01555164|16461601|P2|Overall Study|Subject Withdrew Consent|11
4771848|NCT01555164|16461602|P1|Overall Study|Subject Withdrew Consent|6
4771849|NCT01555164|16461601|P2|Overall Study|Subject Non-compliance|6
4771850|NCT01555164|16461602|P1|Overall Study|Subject Non-compliance|14
4771851|NCT01555164|16461601|P2|Overall Study|Protocol Violation|5
4771852|NCT01555164|16461602|P1|Overall Study|Protocol Violation|9
4771853|NCT01555164|16461601|P2|Overall Study|Lost to Follow-up|3
4771854|NCT01555164|16461602|P1|Overall Study|Lost to Follow-up|4
4771855|NCT01555164|16461601|P2|Overall Study|Investigator's Discretion|2
4771856|NCT01555164|16461602|P1|Overall Study|Investigator's Discretion|2
4771857|NCT01555164|16461601|P2|Overall Study|Hyperglycemia|1
4771858|NCT01555164|16461602|P1|Overall Study|Hyperglycemia|0
4771859|NCT01555164|16461601|P2|Overall Study|Adverse Event|7
4771860|NCT01555164|16461602|P1|Overall Study|Adverse Event|5
4771861|NCT01555151|16461616|P4|Overall Study|Lost to Follow-up|1
4771862|NCT01555151|16461617|P3|Overall Study|Lost to Follow-up|0
4771863|NCT01555151|16461618|P2|Overall Study|Lost to Follow-up|0
4771864|NCT01555151|16461619|P1|Overall Study|Lost to Follow-up|0
4771865|NCT01555151|16461616|P4|Overall Study|Adverse Event|2
4771866|NCT01555151|16461617|P3|Overall Study|Adverse Event|1
4771867|NCT01555151|16461618|P2|Overall Study|Adverse Event|2
4771868|NCT01555151|16461619|P1|Overall Study|Adverse Event|1
4771869|NCT01555151|16461616|P4|Overall Study|Protocol Violation|5
4771870|NCT01555151|16461617|P3|Overall Study|Protocol Violation|3
4771871|NCT01555151|16461618|P2|Overall Study|Protocol Violation|3
4771872|NCT01555151|16461619|P1|Overall Study|Protocol Violation|3
4771873|NCT01555151|16461616|P4|Overall Study|Administrative|0
4771874|NCT01555151|16461617|P3|Overall Study|Administrative|2
4771875|NCT01555151|16461618|P2|Overall Study|Administrative|1
4771876|NCT01555151|16461619|P1|Overall Study|Administrative|3
4771877|NCT01555151|16461616|P4|Overall Study|Withdrawal by Subject|2
4771878|NCT01555151|16461617|P3|Overall Study|Withdrawal by Subject|0
4771879|NCT01555151|16461618|P2|Overall Study|Withdrawal by Subject|2
4771880|NCT01555151|16461619|P1|Overall Study|Withdrawal by Subject|6
4771881|NCT01555138|16461672|P2|Overall Study|Adverse Event|14
4771882|NCT01555138|16461673|P1|Overall Study|Adverse Event|14
4771883|NCT01555138|16461672|P2|Overall Study|Withdrawal by Subject|15
4771884|NCT01555138|16461673|P1|Overall Study|Withdrawal by Subject|16
4771885|NCT01555138|16461672|P2|Overall Study|Administrative problems|0
4771886|NCT01555138|16461673|P1|Overall Study|Administrative problems|8
4771887|NCT01555138|16461672|P2|Overall Study|Protocol Violation|3
4771888|NCT01555138|16461673|P1|Overall Study|Protocol Violation|5
4771889|NCT01555138|16461672|P2|Overall Study|Lack of Efficacy|2
4771890|NCT01555138|16461673|P1|Overall Study|Lack of Efficacy|2
4771891|NCT01555138|16461672|P2|Overall Study|Abnormal Lab reults|3
4771892|NCT01555138|16461673|P1|Overall Study|Abnormal Lab reults|1
4771893|NCT01555138|16461672|P2|Overall Study|Lost to Follow-up|0
4771894|NCT01555138|16461673|P1|Overall Study|Lost to Follow-up|1
4771895|NCT01555138|16461672|P2|Overall Study|Death|1
4771896|NCT01555138|16461673|P1|Overall Study|Death|0
4771897|NCT01555125|16461702|P5|Follow-Up Period|Subject / guardian decision|0
4771898|NCT01555125|16461703|P4|Follow-Up Period|Subject / guardian decision|1
4771899|NCT01555125|16461704|P3|Follow-Up Period|Subject / guardian decision|1
4771900|NCT01555125|16461705|P2|Follow-Up Period|Subject / guardian decision|1
4771901|NCT01555125|16461706|P1|Follow-Up Period|Subject / guardian decision|3
4771902|NCT01555125|16461702|P5|Follow-Up Period|Lost to Follow-up|0
4771903|NCT01555125|16461703|P4|Follow-Up Period|Lost to Follow-up|0
4771904|NCT01555125|16461704|P3|Follow-Up Period|Lost to Follow-up|0
4771905|NCT01555125|16461705|P2|Follow-Up Period|Lost to Follow-up|0
4771906|NCT01555125|16461706|P1|Follow-Up Period|Lost to Follow-up|1
4771907|NCT01555125|16461702|P5|Extension|Technical Problems|0
4771908|NCT01555125|16461703|P4|Extension|Technical Problems|1
4771909|NCT01555125|16461704|P3|Extension|Technical Problems|0
4771910|NCT01555125|16461705|P2|Extension|Technical Problems|0
4771911|NCT01555125|16461706|P1|Extension|Technical Problems|1
4771912|NCT01555125|16461702|P5|Extension|Subject/guardian decision|0
4771913|NCT01555125|16461703|P4|Extension|Subject/guardian decision|0
4771914|NCT01555125|16461704|P3|Extension|Subject/guardian decision|1
4771915|NCT01555125|16461705|P2|Extension|Subject/guardian decision|9
4771916|NCT01555125|16461706|P1|Extension|Subject/guardian decision|1
4771917|NCT01555125|16461702|P5|Extension|Study terminated by sponsor|0
4771918|NCT01555125|16461703|P4|Extension|Study terminated by sponsor|20
4771919|NCT01555125|16461704|P3|Extension|Study terminated by sponsor|16
4771920|NCT01555125|16461705|P2|Extension|Study terminated by sponsor|33
4771921|NCT01555125|16461706|P1|Extension|Study terminated by sponsor|32
4771922|NCT01555125|16461702|P5|Extension|Lost to Follow-up|0
4771923|NCT01555125|16461703|P4|Extension|Lost to Follow-up|0
4771924|NCT01555125|16461704|P3|Extension|Lost to Follow-up|2
4771925|NCT01555125|16461705|P2|Extension|Lost to Follow-up|1
4771926|NCT01555125|16461706|P1|Extension|Lost to Follow-up|2
4771927|NCT01555125|16461702|P5|Extension|Lack of Efficacy|0
4771928|NCT01555125|16461703|P4|Extension|Lack of Efficacy|0
4771929|NCT01555125|16461704|P3|Extension|Lack of Efficacy|3
4771930|NCT01555125|16461705|P2|Extension|Lack of Efficacy|6
4771931|NCT01555125|16461706|P1|Extension|Lack of Efficacy|7
4771932|NCT01555125|16461702|P5|Extension|Protocol deviation|0
4771933|NCT01555125|16461703|P4|Extension|Protocol deviation|0
4771934|NCT01555125|16461704|P3|Extension|Protocol deviation|0
4771935|NCT01555125|16461705|P2|Extension|Protocol deviation|0
4771936|NCT01555125|16461706|P1|Extension|Protocol deviation|1
4771937|NCT01555125|16461702|P5|Extension|Adverse Event|0
4771938|NCT01555125|16461703|P4|Extension|Adverse Event|1
4771939|NCT01555125|16461704|P3|Extension|Adverse Event|1
4771940|NCT01555125|16461705|P2|Extension|Adverse Event|2
4771941|NCT01555125|16461706|P1|Extension|Adverse Event|1
4771942|NCT01555125|16461702|P5|Maintenance Period|Death|0
4771943|NCT01555125|16461703|P4|Maintenance Period|Death|1
4771944|NCT01555125|16461704|P3|Maintenance Period|Death|0
4771945|NCT01555125|16461705|P2|Maintenance Period|Death|0
4771946|NCT01555125|16461706|P1|Maintenance Period|Death|0
4771947|NCT01555125|16461702|P5|Maintenance Period|Physician Decision|0
4771948|NCT01555125|16461703|P4|Maintenance Period|Physician Decision|0
4771949|NCT01555125|16461704|P3|Maintenance Period|Physician Decision|1
4771950|NCT01555125|16461705|P2|Maintenance Period|Physician Decision|0
4771951|NCT01555125|16461706|P1|Maintenance Period|Physician Decision|0
4771952|NCT01555125|16461702|P5|Maintenance Period|Lack of Efficacy|0
4771953|NCT01555125|16461703|P4|Maintenance Period|Lack of Efficacy|0
4771954|NCT01555125|16461704|P3|Maintenance Period|Lack of Efficacy|3
4771955|NCT01555125|16461705|P2|Maintenance Period|Lack of Efficacy|1
4771956|NCT01555125|16461706|P1|Maintenance Period|Lack of Efficacy|6
4771957|NCT01555125|16461702|P5|Maintenance Period|Lost to Follow-up|0
4771958|NCT01555125|16461703|P4|Maintenance Period|Lost to Follow-up|1
4771959|NCT01555125|16461704|P3|Maintenance Period|Lost to Follow-up|0
4771960|NCT01555125|16461705|P2|Maintenance Period|Lost to Follow-up|0
4771961|NCT01555125|16461706|P1|Maintenance Period|Lost to Follow-up|2
4771962|NCT01555125|16461702|P5|Maintenance Period|Subject / guardian decision|0
4771963|NCT01555125|16461703|P4|Maintenance Period|Subject / guardian decision|0
4771964|NCT01555125|16461704|P3|Maintenance Period|Subject / guardian decision|0
4771965|NCT01555125|16461705|P2|Maintenance Period|Subject / guardian decision|2
4771966|NCT01555125|16461706|P1|Maintenance Period|Subject / guardian decision|1
4771967|NCT01555125|16461702|P5|Maintenance Period|Adverse Event|0
4771968|NCT01555125|16461703|P4|Maintenance Period|Adverse Event|0
4771969|NCT01555125|16461704|P3|Maintenance Period|Adverse Event|0
4771970|NCT01555125|16461705|P2|Maintenance Period|Adverse Event|1
4771971|NCT01555125|16461706|P1|Maintenance Period|Adverse Event|1
4771972|NCT01555125|16461702|P5|Induction Period|Death|0
4771973|NCT01555125|16461703|P4|Induction Period|Death|0
4771974|NCT01555125|16461704|P3|Induction Period|Death|0
4771975|NCT01555125|16461705|P2|Induction Period|Death|0
4771976|NCT01555125|16461706|P1|Induction Period|Death|1
4771977|NCT01555125|16461702|P5|Induction Period|Subject / guardian decision|2
4771978|NCT01555125|16461703|P4|Induction Period|Subject / guardian decision|0
4771979|NCT01555125|16461704|P3|Induction Period|Subject / guardian decision|0
4771980|NCT01555125|16461705|P2|Induction Period|Subject / guardian decision|0
4771981|NCT01555125|16461706|P1|Induction Period|Subject / guardian decision|0
4771982|NCT01555125|16461702|P5|Induction Period|Adverse Event|1
4771983|NCT01555125|16461703|P4|Induction Period|Adverse Event|0
4771984|NCT01555125|16461704|P3|Induction Period|Adverse Event|0
4771985|NCT01555125|16461705|P2|Induction Period|Adverse Event|1
4771986|NCT01555125|16461706|P1|Induction Period|Adverse Event|0
4771987|NCT01555125|16461702|P5|Induction Period|Lost to Follow-up|0
4771988|NCT01555125|16461703|P4|Induction Period|Lost to Follow-up|0
4771989|NCT01555125|16461704|P3|Induction Period|Lost to Follow-up|0
4771990|NCT01555125|16461705|P2|Induction Period|Lost to Follow-up|2
4771991|NCT01555125|16461706|P1|Induction Period|Lost to Follow-up|0
4771992|NCT01555073|16461799|P4|Overall Study|Lost to Follow-up|5
4771993|NCT01555073|16461800|P3|Overall Study|Lost to Follow-up|0
4771994|NCT01555073|16461801|P2|Overall Study|Lost to Follow-up|2
4771995|NCT01555073|16461802|P1|Overall Study|Lost to Follow-up|1
4771996|NCT01555021|16461818|P2|Overall Study|Lost to Follow-up|2
4771997|NCT01555021|16461819|P1|Overall Study|Lost to Follow-up|1
4771998|NCT01554904|16461844|P1|Overall Study|Had sleep apnea on Home Study 1|1
4771999|NCT01554904|16461844|P1|Overall Study|Withdrawal by Subject|3
4772000|NCT01554579|16461889|P2|Overall Study|Withdrawal by Subject|1
4772001|NCT01554579|16461890|P1|Overall Study|Withdrawal by Subject|2
4772002|NCT01554579|16461889|P2|Overall Study|Lack of Efficacy|1
4772003|NCT01554579|16461890|P1|Overall Study|Lack of Efficacy|2
4772004|NCT01554579|16461889|P2|Overall Study|Adverse Event|25
4772005|NCT01554579|16461890|P1|Overall Study|Adverse Event|6
4772006|NCT01554527|16461903|P3|Overall Study|Physician Decision|1
4772007|NCT01554527|16461904|P2|Overall Study|Physician Decision|0
4772008|NCT01554527|16461905|P1|Overall Study|Physician Decision|0
4772009|NCT01554527|16461903|P3|Overall Study|Lost to Follow-up|4
4772010|NCT01554527|16461904|P2|Overall Study|Lost to Follow-up|0
4772011|NCT01554527|16461905|P1|Overall Study|Lost to Follow-up|0
4772012|NCT01554527|16461903|P3|Overall Study|Withdrawal by Subject|3
4772013|NCT01554527|16461904|P2|Overall Study|Withdrawal by Subject|0
4772014|NCT01554527|16461905|P1|Overall Study|Withdrawal by Subject|1
4772015|NCT01554241|16461961|P4|Overall Study|Withdrawal by Subject|0
4772016|NCT01554241|16461962|P3|Overall Study|Withdrawal by Subject|2
4772017|NCT01554241|16461963|P2|Overall Study|Withdrawal by Subject|0
4772018|NCT01554241|16461964|P1|Overall Study|Withdrawal by Subject|0
4772019|NCT01554241|16461961|P4|Overall Study|protocol specified change in eGFR|0
4772020|NCT01554241|16461962|P3|Overall Study|protocol specified change in eGFR|1
4772021|NCT01554241|16461963|P2|Overall Study|protocol specified change in eGFR|0
4772022|NCT01554241|16461964|P1|Overall Study|protocol specified change in eGFR|0
4772023|NCT01554241|16461961|P4|Overall Study|protocol specified renal stone|1
4772024|NCT01554241|16461962|P3|Overall Study|protocol specified renal stone|0
4772025|NCT01554241|16461963|P2|Overall Study|protocol specified renal stone|0
4772026|NCT01554241|16461964|P1|Overall Study|protocol specified renal stone|0
4772027|NCT01554241|16461961|P4|Overall Study|Death|0
4772028|NCT01554241|16461962|P3|Overall Study|Death|1
4772029|NCT01554241|16461963|P2|Overall Study|Death|1
4772030|NCT01554241|16461964|P1|Overall Study|Death|3
4772031|NCT01554176|16461980|P5|Run-out Phase|Protocol Violation|0
4772032|NCT01554176|16461981|P4|Run-out Phase|Protocol Violation|1
4772033|NCT01554176|16461982|P3|Run-out Phase|Protocol Violation|0
4772034|NCT01554176|16461983|P2|Run-out Phase|Protocol Violation|0
4772035|NCT01554176|16461984|P1|Run-out Phase|Protocol Violation|0
4772036|NCT01554176|16461980|P5|Treatment Phase|Lost to Follow-up|0
4772037|NCT01554176|16461981|P4|Treatment Phase|Lost to Follow-up|0
4772038|NCT01554176|16461982|P3|Treatment Phase|Lost to Follow-up|0
4772039|NCT01554176|16461983|P2|Treatment Phase|Lost to Follow-up|0
4772040|NCT01554176|16461984|P1|Treatment Phase|Lost to Follow-up|3
4772041|NCT01554176|16461980|P5|Treatment Phase|Withdrawal by Subject|0
4772042|NCT01554176|16461981|P4|Treatment Phase|Withdrawal by Subject|0
4772043|NCT01554176|16461982|P3|Treatment Phase|Withdrawal by Subject|0
4772044|NCT01554176|16461983|P2|Treatment Phase|Withdrawal by Subject|0
4772045|NCT01554176|16461984|P1|Treatment Phase|Withdrawal by Subject|1
4772046|NCT01554176|16461980|P5|Treatment Phase|Non-compliance with study drug|0
4772047|NCT01554176|16461981|P4|Treatment Phase|Non-compliance with study drug|0
4772048|NCT01554176|16461982|P3|Treatment Phase|Non-compliance with study drug|0
4772049|NCT01554176|16461983|P2|Treatment Phase|Non-compliance with study drug|0
4772050|NCT01554176|16461984|P1|Treatment Phase|Non-compliance with study drug|1
4772051|NCT01554176|16461980|P5|Treatment Phase|Adverse event, non-fatal|0
4772052|NCT01554176|16461981|P4|Treatment Phase|Adverse event, non-fatal|0
4772053|NCT01554176|16461982|P3|Treatment Phase|Adverse event, non-fatal|0
4772054|NCT01554176|16461983|P2|Treatment Phase|Adverse event, non-fatal|1
4772055|NCT01554176|16461984|P1|Treatment Phase|Adverse event, non-fatal|1
4772056|NCT01554176|16461980|P5|Treatment Phase|Lack of Efficacy|0
4772057|NCT01554176|16461981|P4|Treatment Phase|Lack of Efficacy|0
4772058|NCT01554176|16461982|P3|Treatment Phase|Lack of Efficacy|0
4772059|NCT01554176|16461983|P2|Treatment Phase|Lack of Efficacy|1
4772060|NCT01554176|16461984|P1|Treatment Phase|Lack of Efficacy|0
4772061|NCT01554176|16461980|P5|Treatment Phase|Physician Decision|0
4772062|NCT01554176|16461981|P4|Treatment Phase|Physician Decision|0
4772063|NCT01554176|16461982|P3|Treatment Phase|Physician Decision|0
4772064|NCT01554176|16461983|P2|Treatment Phase|Physician Decision|1
4772065|NCT01554176|16461984|P1|Treatment Phase|Physician Decision|1
4772066|NCT01554176|16461980|P5|Treatment Phase|Protocol Violation|0
4772067|NCT01554176|16461981|P4|Treatment Phase|Protocol Violation|0
4772068|NCT01554176|16461982|P3|Treatment Phase|Protocol Violation|0
4772069|NCT01554176|16461983|P2|Treatment Phase|Protocol Violation|2
4772070|NCT01554176|16461984|P1|Treatment Phase|Protocol Violation|1
4772071|NCT01554163|16462011|P2|Overall Study|Not Treated|0
4772072|NCT01554163|16462012|P1|Overall Study|Not Treated|1
4772073|NCT01554163|16462011|P2|Overall Study|Withdrawal by Subject|5
4772074|NCT01554163|16462012|P1|Overall Study|Withdrawal by Subject|1
4772075|NCT01554163|16462011|P2|Overall Study|Protocol Violation|4
4772076|NCT01554163|16462012|P1|Overall Study|Protocol Violation|0
4772077|NCT01554163|16462011|P2|Overall Study|Non-Compliance With Study Drug|1
4772078|NCT01554163|16462012|P1|Overall Study|Non-Compliance With Study Drug|1
4772079|NCT01554163|16462011|P2|Overall Study|Lost to Follow-up|0
4772080|NCT01554163|16462012|P1|Overall Study|Lost to Follow-up|1
4772081|NCT01554163|16462011|P2|Overall Study|Lack of Efficacy|0
4772082|NCT01554163|16462012|P1|Overall Study|Lack of Efficacy|1
4772083|NCT01554163|16462011|P2|Overall Study|Adverse Event|0
4772084|NCT01554163|16462012|P1|Overall Study|Adverse Event|3
4772085|NCT01553916|16462030|P1|Overall Study|Pre-treatment MRI metastatic disease|1
4772086|NCT01553916|16462030|P1|Overall Study|Withdrawal by Subject|2
4772087|NCT01553851|16462047|P1|Overall Study|constipation|1
4772088|NCT01553851|16462047|P1|Overall Study|Adverse Event|2
4772089|NCT01553747|16462062|P3|Overall Study|Physician decision: lack of efficacy|3
4772090|NCT01553747|16462063|P2|Overall Study|Physician decision: lack of efficacy|5
4772091|NCT01553747|16462064|P1|Overall Study|Physician decision: lack of efficacy|1
4772092|NCT01553747|16462062|P3|Overall Study|Sponsor decision, specify|0
4772093|NCT01553747|16462063|P2|Overall Study|Sponsor decision, specify|5
4772094|NCT01553747|16462064|P1|Overall Study|Sponsor decision, specify|7
4772095|NCT01553747|16462062|P3|Overall Study|Lost to Follow-up|6
4772096|NCT01553747|16462063|P2|Overall Study|Lost to Follow-up|5
4772097|NCT01553747|16462064|P1|Overall Study|Lost to Follow-up|11
4772098|NCT01553747|16462062|P3|Overall Study|Physician decision: other|7
4772099|NCT01553747|16462063|P2|Overall Study|Physician decision: other|8
4772100|NCT01553747|16462064|P1|Overall Study|Physician decision: other|10
4772101|NCT01553747|16462062|P3|Overall Study|Adverse event or SAE|19
4772102|NCT01553747|16462063|P2|Overall Study|Adverse event or SAE|28
4772103|NCT01553747|16462064|P1|Overall Study|Adverse event or SAE|32
4772104|NCT01553747|16462062|P3|Overall Study|Voluntarily withdrew|74
4772105|NCT01553747|16462063|P2|Overall Study|Voluntarily withdrew|66
4772106|NCT01553747|16462064|P1|Overall Study|Voluntarily withdrew|70
4772107|NCT01553747|16462062|P3|Overall Study|Protocol Violation|0
4772108|NCT01553747|16462063|P2|Overall Study|Protocol Violation|2
4772109|NCT01553747|16462064|P1|Overall Study|Protocol Violation|0
4772110|NCT01553591|16462126|P3|Overall Study|Randomized and never dispensed drug|0
4772111|NCT01553591|16462127|P2|Overall Study|Randomized and never dispensed drug|1
4772112|NCT01553591|16462128|P1|Overall Study|Randomized and never dispensed drug|0
4772113|NCT01553591|16462126|P3|Overall Study|Sponsor decision|3
4772114|NCT01553591|16462127|P2|Overall Study|Sponsor decision|0
4772115|NCT01553591|16462128|P1|Overall Study|Sponsor decision|1
4772116|NCT01553591|16462126|P3|Overall Study|Protocol Violation|4
4772117|NCT01553591|16462127|P2|Overall Study|Protocol Violation|4
4772118|NCT01553591|16462128|P1|Overall Study|Protocol Violation|3
4772119|NCT01553591|16462126|P3|Overall Study|Physician decision: lack of efficacy|7
4772120|NCT01553591|16462127|P2|Overall Study|Physician decision: lack of efficacy|3
4772121|NCT01553591|16462128|P1|Overall Study|Physician decision: lack of efficacy|2
4772122|NCT01553591|16462126|P3|Overall Study|Physician decision: other|16
4772123|NCT01553591|16462127|P2|Overall Study|Physician decision: other|14
4772124|NCT01553591|16462128|P1|Overall Study|Physician decision: other|11
4772125|NCT01553591|16462126|P3|Overall Study|Lost to Follow-up|16
4772126|NCT01553591|16462127|P2|Overall Study|Lost to Follow-up|23
4772127|NCT01553591|16462128|P1|Overall Study|Lost to Follow-up|25
4772128|NCT01553591|16462126|P3|Overall Study|Adverse Event|16
4772129|NCT01553591|16462127|P2|Overall Study|Adverse Event|45
4772130|NCT01553591|16462128|P1|Overall Study|Adverse Event|36
4772131|NCT01553591|16462126|P3|Overall Study|Voluntarily withdrew|96
4772132|NCT01553591|16462127|P2|Overall Study|Voluntarily withdrew|79
4772133|NCT01553591|16462128|P1|Overall Study|Voluntarily withdrew|94
4772134|NCT01553318|16462188|P2|Overall Study|Protocol Violation|2
4772135|NCT01553318|16462189|P1|Overall Study|Protocol Violation|3
4772136|NCT01553279|16462219|P2|Period 2: Toddler Vaccinations|Lost to Follow-up|2
4772137|NCT01553279|16462220|P1|Period 2: Toddler Vaccinations|Lost to Follow-up|3
4772138|NCT01553279|16462219|P2|Period 2: Toddler Vaccinations|Withdrawal by Subject|5
4772139|NCT01553279|16462220|P1|Period 2: Toddler Vaccinations|Withdrawal by Subject|0
4772140|NCT01553279|16462219|P2|Interim Period|Lost to Follow-up|0
4772141|NCT01553279|16462220|P1|Interim Period|Lost to Follow-up|1
4772142|NCT01553279|16462219|P2|Interim Period|Withdrawal by Subject|2
4772143|NCT01553279|16462220|P1|Interim Period|Withdrawal by Subject|2
4772144|NCT01553279|16462219|P2|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
4772145|NCT01553279|16462220|P1|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1
4772146|NCT01553279|16462219|P2|Part 1 (Infant Vaccinations)|Lost to Follow-up|0
4772147|NCT01553279|16462220|P1|Part 1 (Infant Vaccinations)|Lost to Follow-up|1
4772148|NCT01553188|16462295|P4|Overall Study|Intercurrent illness and adverse event|0
4772149|NCT01553188|16462296|P3|Overall Study|Intercurrent illness and adverse event|2
4772150|NCT01553188|16462297|P2|Overall Study|Intercurrent illness and adverse event|1
4772151|NCT01553188|16462298|P1|Overall Study|Intercurrent illness and adverse event|0
4772152|NCT01553188|16462295|P4|Overall Study|Patient choice|0
4772153|NCT01553188|16462296|P3|Overall Study|Patient choice|0
4772154|NCT01553188|16462297|P2|Overall Study|Patient choice|0
4772155|NCT01553188|16462298|P1|Overall Study|Patient choice|1
4772156|NCT01553136|16462325|P2|Overall Study|Scheduling Difficulties|4
4772157|NCT01553136|16462326|P1|Overall Study|Scheduling Difficulties|5
4772158|NCT01553136|16462325|P2|Overall Study|Physician Decision|3
4772159|NCT01553136|16462326|P1|Overall Study|Physician Decision|2
4772160|NCT01553136|16462325|P2|Overall Study|Lost to Follow-up|10
4772161|NCT01553136|16462326|P1|Overall Study|Lost to Follow-up|4
4772162|NCT01553136|16462325|P2|Overall Study|Withdrawal by Subject|3
4772163|NCT01553136|16462326|P1|Overall Study|Withdrawal by Subject|2
4772164|NCT01553136|16462325|P2|Overall Study|Adverse Event|2
4772165|NCT01553136|16462326|P1|Overall Study|Adverse Event|3
4772166|NCT01553084|16462343|P3|Overall Study|Withdrawal by Subject|35
4772167|NCT01553084|16462344|P2|Overall Study|Withdrawal by Subject|13
4772168|NCT01553084|16462345|P1|Overall Study|Withdrawal by Subject|15
4772169|NCT01552954|16462427|P2|Overall Study|diagnosed DM|0
4772170|NCT01552954|16462428|P1|Overall Study|diagnosed DM|1
4772171|NCT01552954|16462427|P2|Overall Study|Protocol Violation|2
4772172|NCT01552954|16462428|P1|Overall Study|Protocol Violation|1
4772173|NCT01552954|16462427|P2|Overall Study|Withdrawal by Subject|1
4772174|NCT01552954|16462428|P1|Overall Study|Withdrawal by Subject|1
4772175|NCT01552954|16462427|P2|Overall Study|Lost to Follow-up|1
4772176|NCT01552954|16462428|P1|Overall Study|Lost to Follow-up|1
4772177|NCT01552954|16462427|P2|Overall Study|Adverse Event|2
4772178|NCT01552954|16462428|P1|Overall Study|Adverse Event|1
4772179|NCT01552928|16462444|P4|Period 3|Adverse Event|0
4772180|NCT01552928|16462445|P3|Period 3|Adverse Event|1
4772181|NCT01552928|16462446|P2|Period 3|Adverse Event|0
4772182|NCT01552928|16462447|P1|Period 3|Adverse Event|0
4772183|NCT01552915|16462494|P3|Overall Study|Other|6
4772184|NCT01552915|16462495|P2|Overall Study|Other|0
4772185|NCT01552915|16462496|P1|Overall Study|Other|2
4772186|NCT01552915|16462494|P3|Overall Study|Lack of Efficacy|4
4772187|NCT01552915|16462495|P2|Overall Study|Lack of Efficacy|1
4772188|NCT01552915|16462496|P1|Overall Study|Lack of Efficacy|8
4772189|NCT01552915|16462494|P3|Overall Study|Protocol Violation|4
4772190|NCT01552915|16462495|P2|Overall Study|Protocol Violation|4
4772191|NCT01552915|16462496|P1|Overall Study|Protocol Violation|0
4772192|NCT01552915|16462494|P3|Overall Study|Withdrawal by Subject|5
4772193|NCT01552915|16462495|P2|Overall Study|Withdrawal by Subject|4
4772194|NCT01552915|16462496|P1|Overall Study|Withdrawal by Subject|6
4772195|NCT01552915|16462494|P3|Overall Study|Lost to Follow-up|5
4772196|NCT01552915|16462495|P2|Overall Study|Lost to Follow-up|6
4772197|NCT01552915|16462496|P1|Overall Study|Lost to Follow-up|4
4772198|NCT01552915|16462494|P3|Overall Study|Adverse Event|3
4772199|NCT01552915|16462495|P2|Overall Study|Adverse Event|14
4772200|NCT01552915|16462496|P1|Overall Study|Adverse Event|3
4772201|NCT01552902|16462519|P3|Overall Study|Other|3
4772202|NCT01552902|16462520|P2|Overall Study|Other|4
4772203|NCT01552902|16462521|P1|Overall Study|Other|3
4772204|NCT01552902|16462519|P3|Overall Study|Lost to Follow-up|6
4772205|NCT01552902|16462520|P2|Overall Study|Lost to Follow-up|3
4772206|NCT01552902|16462521|P1|Overall Study|Lost to Follow-up|1
4772207|NCT01552902|16462519|P3|Overall Study|Withdrawal by Subject|6
4772208|NCT01552902|16462520|P2|Overall Study|Withdrawal by Subject|9
4772209|NCT01552902|16462521|P1|Overall Study|Withdrawal by Subject|1
4772210|NCT01552902|16462519|P3|Overall Study|Lack of Efficacy|1
4772211|NCT01552902|16462520|P2|Overall Study|Lack of Efficacy|3
4772212|NCT01552902|16462521|P1|Overall Study|Lack of Efficacy|4
4772213|NCT01552902|16462519|P3|Overall Study|Protocol Violation|3
4772214|NCT01552902|16462520|P2|Overall Study|Protocol Violation|3
4772215|NCT01552902|16462521|P1|Overall Study|Protocol Violation|3
4772216|NCT01552902|16462519|P3|Overall Study|Adverse Event|14
4772217|NCT01552902|16462520|P2|Overall Study|Adverse Event|15
4772218|NCT01552902|16462521|P1|Overall Study|Adverse Event|1
4772219|NCT01552772|16462571|P1|Overall Study|Protocol Deviation|1
4772220|NCT01552772|16462571|P1|Overall Study|Adverse Event|1
4772221|NCT01552772|16462571|P1|Overall Study|Lost to Follow-up|2
4772222|NCT01552694|16462587|P2|Overall Study|Protocol Violation|1
4772223|NCT01552694|16462588|P1|Overall Study|Protocol Violation|0
4772224|NCT01552694|16462587|P2|Overall Study|Lost to Follow-up|1
4772225|NCT01552694|16462588|P1|Overall Study|Lost to Follow-up|0
4772226|NCT01552681|16462604|P2|Overall Study|Subject moved away|1
4772227|NCT01552681|16462605|P1|Overall Study|Subject moved away|0
4772228|NCT01552681|16462604|P2|Overall Study|Physician Decision|0
4772229|NCT01552681|16462605|P1|Overall Study|Physician Decision|1
4772230|NCT01552681|16462604|P2|Overall Study|Withdrawal by Subject|0
4772231|NCT01552681|16462605|P1|Overall Study|Withdrawal by Subject|4
4772232|NCT01552603|16462653|P1|Overall Study|Physician Decision|1
4772233|NCT01552408|16462660|P2|Overall Study|Withdrawal by Subject|1
4772234|NCT01552408|16462661|P1|Overall Study|Withdrawal by Subject|2
4772235|NCT01552408|16462660|P2|Overall Study|Relocation|1
4772236|NCT01552408|16462661|P1|Overall Study|Relocation|0
4772237|NCT01552408|16462660|P2|Overall Study|Lost to Follow-up|0
4772238|NCT01552408|16462661|P1|Overall Study|Lost to Follow-up|2
4772239|NCT01552369|16462683|P2|Overall Study|Did not consent to extended follow up|9
4772240|NCT01552369|16462684|P1|Overall Study|Did not consent to extended follow up|8
4772241|NCT01552057|16462773|P2|Overall Study|Physician Decision|0
4772242|NCT01552057|16462774|P1|Overall Study|Physician Decision|1
4772243|NCT01552057|16462773|P2|Overall Study|Entry Criteria Not Met|2
4772244|NCT01552057|16462774|P1|Overall Study|Entry Criteria Not Met|2
4772245|NCT01552057|16462773|P2|Overall Study|Withdrawal by Subject|8
4772246|NCT01552057|16462774|P1|Overall Study|Withdrawal by Subject|5
4772247|NCT01552057|16462773|P2|Overall Study|Lack of Efficacy|23
4772248|NCT01552057|16462774|P1|Overall Study|Lack of Efficacy|8
4772249|NCT01552057|16462773|P2|Overall Study|Adverse Event|15
4772250|NCT01552057|16462774|P1|Overall Study|Adverse Event|14
4772251|NCT01551758|16462840|P2|Overall Study|Withdrawal by Subject|17
4772252|NCT01551758|16462841|P1|Overall Study|Withdrawal by Subject|14
4772253|NCT01551758|16462840|P2|Overall Study|Physician Decision|3
4772254|NCT01551758|16462841|P1|Overall Study|Physician Decision|9
4772255|NCT01551758|16462840|P2|Overall Study|Lost to Follow-up|25
4772256|NCT01551758|16462841|P1|Overall Study|Lost to Follow-up|29
4772257|NCT01551758|16462840|P2|Overall Study|Met Protocol-defined stopping criteria|10
4772258|NCT01551758|16462841|P1|Overall Study|Met Protocol-defined stopping criteria|8
4772259|NCT01551758|16462840|P2|Overall Study|Protocol Violation|6
4772260|NCT01551758|16462841|P1|Overall Study|Protocol Violation|5
4772261|NCT01551758|16462840|P2|Overall Study|Lack of Efficacy|1
4772262|NCT01551758|16462841|P1|Overall Study|Lack of Efficacy|0
4772263|NCT01551758|16462840|P2|Overall Study|Adverse Event|43
4772264|NCT01551758|16462841|P1|Overall Study|Adverse Event|29
4772265|NCT01551745|16462879|P1|Overall Study|Disease Progression|2
4772266|NCT01551745|16462879|P1|Overall Study|Withdrawal by Subject|1
4772267|NCT01551693|16462888|P2|Overall Study|Withdrawal by Subject|1
4772268|NCT01551693|16462889|P1|Overall Study|Withdrawal by Subject|0
4772269|NCT01551693|16462888|P2|Overall Study|Adverse Event|1
4772270|NCT01551693|16462889|P1|Overall Study|Adverse Event|0
4772271|NCT01551693|16462888|P2|Overall Study|Disease Progression|0
4772272|NCT01551693|16462889|P1|Overall Study|Disease Progression|1
4772273|NCT01551420|16462910|P2|Home Use (Part B)|Withdrawal by staff|1
4772274|NCT01551420|16462911|P1|Home Use (Part B)|Withdrawal by staff|0
4772275|NCT01551420|16462910|P2|Home Use (Part B)|Withdrawal by Subject|0
4772276|NCT01551420|16462911|P1|Home Use (Part B)|Withdrawal by Subject|6
4772277|NCT01551420|16462910|P2|Screened for Part B Eligibility|Deemed ineligible by staff|2
4772278|NCT01551420|16462911|P1|Screened for Part B Eligibility|Deemed ineligible by staff|1
4772279|NCT01551420|16462910|P2|Screened for Part B Eligibility|Declined participation|1
4772280|NCT01551420|16462911|P1|Screened for Part B Eligibility|Declined participation|8
4772281|NCT01551420|16462910|P2|In-laboratory (Part A)|Scheduling conflict|1
4772282|NCT01551420|16462911|P1|In-laboratory (Part A)|Scheduling conflict|2
4772283|NCT01551420|16462910|P2|In-laboratory (Part A)|Withdrawal by Subject|0
4772284|NCT01551420|16462911|P1|In-laboratory (Part A)|Withdrawal by Subject|2
4772285|NCT01551420|16462910|P2|In-laboratory (Part A)|Lost to Follow-up|1
4772286|NCT01551420|16462911|P1|In-laboratory (Part A)|Lost to Follow-up|2
4772287|NCT01551355|16462941|P6|Overall Study|Lost to Follow-up|6
4772288|NCT01551355|16462942|P5|Overall Study|Lost to Follow-up|9
4772289|NCT01551355|16462943|P4|Overall Study|Lost to Follow-up|24
4772290|NCT01551355|16462944|P3|Overall Study|Lost to Follow-up|34
4772291|NCT01551355|16462945|P2|Overall Study|Lost to Follow-up|49
4772292|NCT01551355|16462946|P1|Overall Study|Lost to Follow-up|51
4772293|NCT01551303|16462960|P2|Overall Study|failed awareness check on vision test|7
4772294|NCT01551303|16462961|P1|Overall Study|failed awareness check on vision test|4
4772295|NCT01551212|16462969|P2|Overall Study|Never Received Study Treatment|4
4772296|NCT01551212|16462970|P1|Overall Study|Never Received Study Treatment|2
4772297|NCT01551212|16462969|P2|Overall Study|Death|4
4772298|NCT01551212|16462970|P1|Overall Study|Death|2
4772299|NCT01551212|16462969|P2|Overall Study|Withdrawal by Subject|7
4772300|NCT01551212|16462970|P1|Overall Study|Withdrawal by Subject|0
4772301|NCT01551212|16462969|P2|Overall Study|Protocol Violation|1
4772302|NCT01551212|16462970|P1|Overall Study|Protocol Violation|0
4772303|NCT01551212|16462969|P2|Overall Study|Lost to Follow-up|1
4772304|NCT01551212|16462970|P1|Overall Study|Lost to Follow-up|0
4772305|NCT01551212|16462969|P2|Overall Study|Administrative problems|2
4772306|NCT01551212|16462970|P1|Overall Study|Administrative problems|1
4772307|NCT01551212|16462969|P2|Overall Study|Graft loss/Retransplantation|1
4772308|NCT01551212|16462970|P1|Overall Study|Graft loss/Retransplantation|0
4772309|NCT01551173|16463005|P2|Overall Study|Other|3
4772310|NCT01551173|16463006|P1|Overall Study|Other|5
4772311|NCT01551173|16463005|P2|Overall Study|Lost to Follow-up|7
4772312|NCT01551173|16463006|P1|Overall Study|Lost to Follow-up|5
4772313|NCT01551173|16463005|P2|Overall Study|Adverse Event|6
4772314|NCT01551173|16463006|P1|Overall Study|Adverse Event|7
4772315|NCT01551173|16463005|P2|Overall Study|Withdrawal by Subject|16
4772316|NCT01551173|16463006|P1|Overall Study|Withdrawal by Subject|11
4772317|NCT01550965|16463083|P1|Overall Study|Other|13
4772318|NCT01550965|16463083|P1|Overall Study|Lack of Efficacy|59
4772319|NCT01550965|16463083|P1|Overall Study|Lost to Follow-up|2
4772320|NCT01550965|16463083|P1|Overall Study|Withdrawal by Subject|10
4772321|NCT01550965|16463083|P1|Overall Study|Adverse Event|26
4772322|NCT01550757|16463127|P4|Overall Study|Withdrawal by Subject|1
4772323|NCT01550757|16463128|P3|Overall Study|Withdrawal by Subject|3
4772324|NCT01550757|16463129|P2|Overall Study|Withdrawal by Subject|0
4772325|NCT01550757|16463130|P1|Overall Study|Withdrawal by Subject|2
4772326|NCT01550757|16463127|P4|Overall Study|Lost to Follow-up|53
4772327|NCT01550757|16463128|P3|Overall Study|Lost to Follow-up|42
4772328|NCT01550757|16463129|P2|Overall Study|Lost to Follow-up|14
4772329|NCT01550757|16463130|P1|Overall Study|Lost to Follow-up|21
4772330|NCT01550744|16463140|P3|Double-Blind|Other|10
4772331|NCT01550744|16463141|P2|Double-Blind|Other|2
4772332|NCT01550744|16463142|P1|Double-Blind|Other|0
4772333|NCT01550744|16463140|P3|Double-Blind|Pregnancy|3
4772334|NCT01550744|16463141|P2|Double-Blind|Pregnancy|0
4772335|NCT01550744|16463142|P1|Double-Blind|Pregnancy|0
4772336|NCT01550744|16463140|P3|Double-Blind|Protocol Violation|4
4772337|NCT01550744|16463141|P2|Double-Blind|Protocol Violation|0
4772338|NCT01550744|16463142|P1|Double-Blind|Protocol Violation|0
4772339|NCT01550744|16463140|P3|Double-Blind|Lack of Efficacy|8
4772340|NCT01550744|16463141|P2|Double-Blind|Lack of Efficacy|2
4772341|NCT01550744|16463142|P1|Double-Blind|Lack of Efficacy|0
4772342|NCT01550744|16463140|P3|Double-Blind|Death|0
4772343|NCT01550744|16463141|P2|Double-Blind|Death|1
4772344|NCT01550744|16463142|P1|Double-Blind|Death|0
4772345|NCT01550744|16463140|P3|Double-Blind|Adverse Event|15
4772346|NCT01550744|16463141|P2|Double-Blind|Adverse Event|4
4772347|NCT01550744|16463142|P1|Double-Blind|Adverse Event|0
4772348|NCT01550744|16463140|P3|Double-Blind|Withdrawal by Subject|15
4772349|NCT01550744|16463141|P2|Double-Blind|Withdrawal by Subject|2
4772350|NCT01550744|16463142|P1|Double-Blind|Withdrawal by Subject|0
4772351|NCT01550744|16463140|P3|Double-Blind|Lost to Follow-up|12
4772352|NCT01550744|16463141|P2|Double-Blind|Lost to Follow-up|6
4772353|NCT01550744|16463142|P1|Double-Blind|Lost to Follow-up|0
4772354|NCT01550744|16463140|P3|Open-Label|Other|0
4772355|NCT01550744|16463141|P2|Open-Label|Other|0
4772356|NCT01550744|16463142|P1|Open-Label|Other|1
4772357|NCT01550744|16463140|P3|Open-Label|Static PGA-cleared/minimal not achieved|0
4772358|NCT01550744|16463141|P2|Open-Label|Static PGA-cleared/minimal not achieved|0
4772359|NCT01550744|16463142|P1|Open-Label|Static PGA-cleared/minimal not achieved|58
4772360|NCT01550744|16463140|P3|Open-Label|Not all 3 study drug injections received|0
4772361|NCT01550744|16463141|P2|Open-Label|Not all 3 study drug injections received|0
4772362|NCT01550744|16463142|P1|Open-Label|Not all 3 study drug injections received|2
4772363|NCT01550744|16463140|P3|Open-Label|Protocol Violation|0
4772364|NCT01550744|16463141|P2|Open-Label|Protocol Violation|0
4772365|NCT01550744|16463142|P1|Open-Label|Protocol Violation|4
4772366|NCT01550744|16463140|P3|Open-Label|Lack of Efficacy|0
4772367|NCT01550744|16463141|P2|Open-Label|Lack of Efficacy|0
4772368|NCT01550744|16463142|P1|Open-Label|Lack of Efficacy|4
4772369|NCT01550744|16463140|P3|Open-Label|Adverse Event|0
4772370|NCT01550744|16463141|P2|Open-Label|Adverse Event|0
4772371|NCT01550744|16463142|P1|Open-Label|Adverse Event|11
4772372|NCT01550744|16463140|P3|Open-Label|Withdrawal by Subject|0
4772373|NCT01550744|16463141|P2|Open-Label|Withdrawal by Subject|0
4772374|NCT01550744|16463142|P1|Open-Label|Withdrawal by Subject|13
4772375|NCT01550744|16463140|P3|Open-Label|Lost to Follow-up|0
4772376|NCT01550744|16463141|P2|Open-Label|Lost to Follow-up|0
4772377|NCT01550744|16463142|P1|Open-Label|Lost to Follow-up|7
4772378|NCT01550289|16463291|P2|Overall Study|Withdrawal by Subject|3
4772379|NCT01550289|16463292|P1|Overall Study|Withdrawal by Subject|11
4772380|NCT01550289|16463291|P2|Overall Study|Lost to Follow-up|1
4772381|NCT01550289|16463292|P1|Overall Study|Lost to Follow-up|1
4772382|NCT01550289|16463291|P2|Overall Study|Protocol Violation|0
4772383|NCT01550289|16463292|P1|Overall Study|Protocol Violation|1
4772384|NCT01549964|16463368|P4|80-Week Extension Period|Pretreatment Event/Adverse Event|2
4772385|NCT01549964|16463369|P3|80-Week Extension Period|Pretreatment Event/Adverse Event|1
4772386|NCT01549964|16463370|P2|80-Week Extension Period|Pretreatment Event/Adverse Event|0
4772387|NCT01549964|16463371|P1|80-Week Extension Period|Pretreatment Event/Adverse Event|0
4772388|NCT01549964|16463368|P4|80-Week Extension Period|Lost to Follow-up|1
4772389|NCT01549964|16463369|P3|80-Week Extension Period|Lost to Follow-up|2
4772390|NCT01549964|16463370|P2|80-Week Extension Period|Lost to Follow-up|0
4772391|NCT01549964|16463371|P1|80-Week Extension Period|Lost to Follow-up|1
4772392|NCT01549964|16463368|P4|80-Week Extension Period|Voluntary Withdrawal|2
4772393|NCT01549964|16463369|P3|80-Week Extension Period|Voluntary Withdrawal|4
4772394|NCT01549964|16463370|P2|80-Week Extension Period|Voluntary Withdrawal|1
4772395|NCT01549964|16463371|P1|80-Week Extension Period|Voluntary Withdrawal|0
4772396|NCT01549964|16463368|P4|80-Week Extension Period|Study Terminated by Sponsor|132
4772397|NCT01549964|16463369|P3|80-Week Extension Period|Study Terminated by Sponsor|132
4772398|NCT01549964|16463370|P2|80-Week Extension Period|Study Terminated by Sponsor|137
4772399|NCT01549964|16463371|P1|80-Week Extension Period|Study Terminated by Sponsor|65
4772400|NCT01549964|16463368|P4|80-Week Extension Period|Pregnancy|0
4772401|NCT01549964|16463369|P3|80-Week Extension Period|Pregnancy|1
4772402|NCT01549964|16463370|P2|80-Week Extension Period|Pregnancy|0
4772403|NCT01549964|16463371|P1|80-Week Extension Period|Pregnancy|0
4772404|NCT01549964|16463368|P4|24-Week Treatment Period|Completion Status Unknown|0
4772405|NCT01549964|16463369|P3|24-Week Treatment Period|Completion Status Unknown|1
4772406|NCT01549964|16463370|P2|24-Week Treatment Period|Completion Status Unknown|0
4772407|NCT01549964|16463371|P1|24-Week Treatment Period|Completion Status Unknown|1
4772408|NCT01549964|16463368|P4|24-Week Treatment Period|Randomized but Not Treated|1
4772409|NCT01549964|16463369|P3|24-Week Treatment Period|Randomized but Not Treated|0
4772410|NCT01549964|16463370|P2|24-Week Treatment Period|Randomized but Not Treated|0
4772411|NCT01549964|16463371|P1|24-Week Treatment Period|Randomized but Not Treated|0
4772412|NCT01549964|16463368|P4|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
4772413|NCT01549964|16463369|P3|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1
4772414|NCT01549964|16463370|P2|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
4772415|NCT01549964|16463371|P1|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0
4772416|NCT01549964|16463368|P4|24-Week Treatment Period|Other|0
4772417|NCT01549964|16463369|P3|24-Week Treatment Period|Other|1
4772418|NCT01549964|16463370|P2|24-Week Treatment Period|Other|0
4772419|NCT01549964|16463371|P1|24-Week Treatment Period|Other|1
4772420|NCT01549964|16463368|P4|24-Week Treatment Period|Lack of Efficacy|1
4772421|NCT01549964|16463369|P3|24-Week Treatment Period|Lack of Efficacy|1
4772422|NCT01549964|16463370|P2|24-Week Treatment Period|Lack of Efficacy|0
4772423|NCT01549964|16463371|P1|24-Week Treatment Period|Lack of Efficacy|1
4772424|NCT01549964|16463368|P4|24-Week Treatment Period|Lost to Follow-up|2
4772425|NCT01549964|16463369|P3|24-Week Treatment Period|Lost to Follow-up|1
4772426|NCT01549964|16463370|P2|24-Week Treatment Period|Lost to Follow-up|0
4772427|NCT01549964|16463371|P1|24-Week Treatment Period|Lost to Follow-up|1
4772428|NCT01549964|16463368|P4|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
4772429|NCT01549964|16463369|P3|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
4772430|NCT01549964|16463370|P2|24-Week Treatment Period|Pretreatment Event/Adverse Event|4
4772431|NCT01549964|16463371|P1|24-Week Treatment Period|Pretreatment Event/Adverse Event|1
4772432|NCT01549964|16463368|P4|24-Week Treatment Period|Voluntary Withdrawal|8
4772433|NCT01549964|16463369|P3|24-Week Treatment Period|Voluntary Withdrawal|3
4772434|NCT01549964|16463370|P2|24-Week Treatment Period|Voluntary Withdrawal|3
4772435|NCT01549964|16463371|P1|24-Week Treatment Period|Voluntary Withdrawal|6
4772436|NCT01549964|16463368|P4|24-Week Treatment Period|Study Terminated by Sponsor|105
4772437|NCT01549964|16463369|P3|24-Week Treatment Period|Study Terminated by Sponsor|104
4772438|NCT01549964|16463370|P2|24-Week Treatment Period|Study Terminated by Sponsor|104
4772439|NCT01549964|16463371|P1|24-Week Treatment Period|Study Terminated by Sponsor|50
4772440|NCT01549951|16463389|P1|Overall Study|Other|2
4772441|NCT01549951|16463389|P1|Overall Study|Symptomatic deterioration|1
4772442|NCT01549951|16463389|P1|Overall Study|Progressive disease|29
4772443|NCT01549951|16463389|P1|Overall Study|Unsatisfactory therapeutic response|1
4772444|NCT01549951|16463389|P1|Overall Study|Withdrawal by Subject|2
4772445|NCT01549951|16463389|P1|Overall Study|Adverse Event|15
4772446|NCT01549873|16463416|P2|Overall Study|Physician Decision|1
4772447|NCT01549873|16463417|P1|Overall Study|Physician Decision|0
4772448|NCT01549860|16463429|P2|Overall Study|Physician Decision|1
4772449|NCT01549860|16463430|P1|Overall Study|Physician Decision|1
4772450|NCT01549860|16463429|P2|Overall Study|Withdrawal by Subject|0
4772451|NCT01549860|16463430|P1|Overall Study|Withdrawal by Subject|1
4772452|NCT01549652|16463443|P4|Overall Study|Withdrawal by Subject|3
4772453|NCT01549652|16463444|P3|Overall Study|Withdrawal by Subject|5
4772454|NCT01549652|16463445|P2|Overall Study|Withdrawal by Subject|0
4772455|NCT01549652|16463446|P1|Overall Study|Withdrawal by Subject|0
4772456|NCT01549652|16463443|P4|Overall Study|Titration Side Effects|3
4772457|NCT01549652|16463444|P3|Overall Study|Titration Side Effects|6
4772458|NCT01549652|16463445|P2|Overall Study|Titration Side Effects|0
4772459|NCT01549652|16463446|P1|Overall Study|Titration Side Effects|0
4772460|NCT01549652|16463443|P4|Overall Study|Titration Non-Compliance|5
4772461|NCT01549652|16463444|P3|Overall Study|Titration Non-Compliance|4
4772462|NCT01549652|16463445|P2|Overall Study|Titration Non-Compliance|3
4772463|NCT01549652|16463446|P1|Overall Study|Titration Non-Compliance|1
4772464|NCT01549652|16463443|P4|Overall Study|Problem with Infusion|0
4772465|NCT01549652|16463444|P3|Overall Study|Problem with Infusion|0
4772466|NCT01549652|16463445|P2|Overall Study|Problem with Infusion|0
4772467|NCT01549652|16463446|P1|Overall Study|Problem with Infusion|1
4772468|NCT01549652|16463443|P4|Overall Study|Did Not Return Due to Withdrawal Effect|0
4772469|NCT01549652|16463444|P3|Overall Study|Did Not Return Due to Withdrawal Effect|0
4772470|NCT01549652|16463445|P2|Overall Study|Did Not Return Due to Withdrawal Effect|1
4772471|NCT01549652|16463446|P1|Overall Study|Did Not Return Due to Withdrawal Effect|5
4772472|NCT01549652|16463443|P4|Overall Study|Withdrawal Effect|0
4772473|NCT01549652|16463444|P3|Overall Study|Withdrawal Effect|0
4772474|NCT01549652|16463445|P2|Overall Study|Withdrawal Effect|2
4772475|NCT01549652|16463446|P1|Overall Study|Withdrawal Effect|0
4772476|NCT01549652|16463443|P4|Overall Study|Study Drug Titration Failure|0
4772477|NCT01549652|16463444|P3|Overall Study|Study Drug Titration Failure|0
4772478|NCT01549652|16463445|P2|Overall Study|Study Drug Titration Failure|6
4772479|NCT01549652|16463446|P1|Overall Study|Study Drug Titration Failure|5
4772480|NCT01549652|16463443|P4|Overall Study|Did Not Receive Allocated Intervention|0
4772481|NCT01549652|16463444|P3|Overall Study|Did Not Receive Allocated Intervention|2
4772482|NCT01549652|16463445|P2|Overall Study|Did Not Receive Allocated Intervention|0
4772483|NCT01549652|16463446|P1|Overall Study|Did Not Receive Allocated Intervention|0
4772484|NCT01549613|16463464|P2|Overall Study|Lost to Follow-up|11
4772485|NCT01549613|16463465|P1|Overall Study|Lost to Follow-up|11
4772486|NCT01549392|16463503|P2|Overall Study|Withdrawal by Subject|0
4772487|NCT01549392|16463504|P1|Overall Study|Withdrawal by Subject|1
4772488|NCT01549275|16463542|P2|Overall Study|Lost to Follow-up|0
4772489|NCT01549275|16463543|P1|Overall Study|Lost to Follow-up|1
4772490|NCT01549041|16463566|P2|Overall Study|Adverse Event|4
4772491|NCT01549041|16463567|P1|Overall Study|Adverse Event|0
4772492|NCT01549041|16463566|P2|Overall Study|Lack of Efficacy|4
4772493|NCT01549041|16463567|P1|Overall Study|Lack of Efficacy|2
4772494|NCT01549002|16463577|P2|Overall Study|Moderate sedation required|2
4772495|NCT01549002|16463578|P1|Overall Study|Moderate sedation required|0
4772496|NCT01549002|16463577|P2|Overall Study|Excessive pain|2
4772497|NCT01549002|16463578|P1|Overall Study|Excessive pain|0
4772498|NCT01548638|16463664|P1|Overall Study|Withdrawal by Subject|1
4772499|NCT01548638|16463664|P1|Overall Study|Protocol Violation|3
4772500|NCT01548599|16463676|P2|Overall Study|Death|1
4772501|NCT01548599|16463677|P1|Overall Study|Death|2
4772502|NCT01548599|16463676|P2|Overall Study|Withdrawal by Subject|0
4772503|NCT01548599|16463677|P1|Overall Study|Withdrawal by Subject|4
4772504|NCT01548599|16463676|P2|Overall Study|Lost to Follow-up|1
4772505|NCT01548599|16463677|P1|Overall Study|Lost to Follow-up|0
4772506|NCT01548573|16463693|P1|Overall Study|Withdrawal by Subject|2
4772507|NCT01548573|16463693|P1|Overall Study|Death|3
4772508|NCT01548417|16463702|P2|Overall Study|Withdrawal by Subject|2
4772509|NCT01548417|16463703|P1|Overall Study|Withdrawal by Subject|0
4772510|NCT01548404|16463713|P2|Overall Study|Other than specified above|2
4772511|NCT01548404|16463714|P1|Overall Study|Other than specified above|0
4772512|NCT01548404|16463713|P2|Overall Study|Withdrawal by Subject|3
4772513|NCT01548404|16463714|P1|Overall Study|Withdrawal by Subject|0
4772514|NCT01548404|16463713|P2|Overall Study|Lost to Follow-up|0
4772515|NCT01548404|16463714|P1|Overall Study|Lost to Follow-up|2
4772516|NCT01548404|16463713|P2|Overall Study|Inadequate response to study treatment|7
4772517|NCT01548404|16463714|P1|Overall Study|Inadequate response to study treatment|23
4772518|NCT01548404|16463713|P2|Overall Study|Physician Decision|1
4772519|NCT01548404|16463714|P1|Overall Study|Physician Decision|2
4772520|NCT01548404|16463713|P2|Overall Study|Adverse Event|1
4772521|NCT01548404|16463714|P1|Overall Study|Adverse Event|3
4772522|NCT01548287|16463753|P5|Randomized Period|Adverse Event|0
4772523|NCT01548287|16463754|P4|Randomized Period|Adverse Event|0
4772524|NCT01548287|16463755|P3|Randomized Period|Adverse Event|5
4772525|NCT01548287|16463756|P2|Randomized Period|Adverse Event|2
4772526|NCT01548287|16463757|P1|Randomized Period|Adverse Event|0
4772527|NCT01548287|16463753|P5|Randomized Period|Did not meet inclusion criteria|0
4772528|NCT01548287|16463754|P4|Randomized Period|Did not meet inclusion criteria|0
4772529|NCT01548287|16463755|P3|Randomized Period|Did not meet inclusion criteria|2
4772530|NCT01548287|16463756|P2|Randomized Period|Did not meet inclusion criteria|0
4772531|NCT01548287|16463757|P1|Randomized Period|Did not meet inclusion criteria|0
4772532|NCT01548287|16463753|P5|Screening|Did not meet eligibility criteria|74
4772533|NCT01548287|16463754|P4|Screening|Did not meet eligibility criteria|0
4772534|NCT01548287|16463755|P3|Screening|Did not meet eligibility criteria|0
4772535|NCT01548287|16463756|P2|Screening|Did not meet eligibility criteria|0
4772536|NCT01548287|16463757|P1|Screening|Did not meet eligibility criteria|0
4772537|NCT01548287|16463753|P5|Screening|No reason provided|9
4772538|NCT01548287|16463754|P4|Screening|No reason provided|0
4772539|NCT01548287|16463755|P3|Screening|No reason provided|0
4772540|NCT01548287|16463756|P2|Screening|No reason provided|0
4772541|NCT01548287|16463757|P1|Screening|No reason provided|0
4772542|NCT01547728|16463814|P1|Overall Study|Screen failure|39
4772543|NCT01547728|16463814|P1|Overall Study|Drug not ready for subject|1
4772544|NCT01547728|16463814|P1|Overall Study|Change in procedure and equipment|1
4772545|NCT01547598|16463923|P2|Overall Study|Other Miscellaneous Reasons|1
4772546|NCT01547598|16463924|P1|Overall Study|Other Miscellaneous Reasons|2
4772547|NCT01547598|16463923|P2|Overall Study|Protocol Violation|1
4772548|NCT01547598|16463924|P1|Overall Study|Protocol Violation|1
4772549|NCT01547598|16463923|P2|Overall Study|Adverse Event|1
4772550|NCT01547598|16463924|P1|Overall Study|Adverse Event|1
4772551|NCT01547598|16463923|P2|Overall Study|Lost to Follow-up|1
4772552|NCT01547598|16463924|P1|Overall Study|Lost to Follow-up|1
4772553|NCT01547598|16463923|P2|Overall Study|Withdrew consent|1
4772554|NCT01547598|16463924|P1|Overall Study|Withdrew consent|1
4772555|NCT01547390|16463941|P2|Overall Study|Adverse Event|0
4772556|NCT01547390|16463942|P1|Overall Study|Adverse Event|3
4772557|NCT01547390|16463941|P2|Overall Study|Lost to Follow-up|2
4772558|NCT01547390|16463942|P1|Overall Study|Lost to Follow-up|0
4772559|NCT01547390|16463941|P2|Overall Study|termination of pregnancy|1
4772560|NCT01547390|16463942|P1|Overall Study|termination of pregnancy|0
4772561|NCT01547390|16463941|P2|Overall Study|Withdrawal by Subject|7
4772562|NCT01547390|16463942|P1|Overall Study|Withdrawal by Subject|10
4772563|NCT01547299|16463952|P2|Overall Study|Withdrawal by Subject|2
4772564|NCT01547299|16463953|P1|Overall Study|Withdrawal by Subject|2
4772565|NCT01547286|16464019|P1|Overall Study|Physician Decision|1
4772566|NCT01547286|16464019|P1|Overall Study|Did not meet all eligibility criteria|1
4772567|NCT01547130|16464039|P2|Overall Study|Lost to Follow-up|5
4772568|NCT01547130|16464040|P1|Overall Study|Lost to Follow-up|9
4772569|NCT01546922|16464063|P2|Second Period of 10 Weeks|Withdrawal by Subject|2
4772570|NCT01546922|16464064|P1|Second Period of 10 Weeks|Withdrawal by Subject|0
4772571|NCT01546922|16464063|P2|Second Period of 10 Weeks|Protocol Violation|1
4772572|NCT01546922|16464064|P1|Second Period of 10 Weeks|Protocol Violation|3
4772573|NCT01546922|16464063|P2|First Period of 10 Weeks|Investigator's judgment|0
4772574|NCT01546922|16464064|P1|First Period of 10 Weeks|Investigator's judgment|1
4772575|NCT01546922|16464063|P2|First Period of 10 Weeks|Withdrawal by Subject|1
4772576|NCT01546922|16464064|P1|First Period of 10 Weeks|Withdrawal by Subject|1
4772577|NCT01546922|16464063|P2|First Period of 10 Weeks|Protocol Violation|1
4772578|NCT01546922|16464064|P1|First Period of 10 Weeks|Protocol Violation|3
4772579|NCT01546883|16464070|P1|Overall Study|other unrelated illness|1
4772580|NCT01546883|16464070|P1|Overall Study|early closure of study|2
4772581|NCT01546883|16464070|P1|Overall Study|Lost to Follow-up|2
4772582|NCT01546883|16464070|P1|Overall Study|Adverse Event|4
4772583|NCT01546883|16464070|P1|Overall Study|Withdrawal by Subject|3
4772584|NCT01546688|16464076|P2|Overall Study|Lack of Efficacy|0
4772585|NCT01546688|16464077|P1|Overall Study|Lack of Efficacy|1
4772586|NCT01546688|16464076|P2|Overall Study|Withdrawal by Subject|1
4772587|NCT01546688|16464077|P1|Overall Study|Withdrawal by Subject|2
4772588|NCT01546688|16464076|P2|Overall Study|Adverse Event|4
4772589|NCT01546688|16464077|P1|Overall Study|Adverse Event|0
4772590|NCT01546649|16464109|P2|Overall Study|Withdrawal by Subject|2
4772591|NCT01546649|16464110|P1|Overall Study|Withdrawal by Subject|1
4772592|NCT01546649|16464109|P2|Overall Study|Discovery of secondary cancer|1
4772593|NCT01546649|16464110|P1|Overall Study|Discovery of secondary cancer|0
4772594|NCT01546649|16464109|P2|Overall Study|Recurrence|1
4772595|NCT01546649|16464110|P1|Overall Study|Recurrence|1
4772596|NCT01546649|16464109|P2|Overall Study|Lack of Efficacy|0
4772597|NCT01546649|16464110|P1|Overall Study|Lack of Efficacy|1
4772598|NCT01546649|16464109|P2|Overall Study|Protocol Violation|0
4772599|NCT01546649|16464110|P1|Overall Study|Protocol Violation|1
4772600|NCT01546649|16464109|P2|Overall Study|Adverse Event|5
4772601|NCT01546649|16464110|P1|Overall Study|Adverse Event|4
4772602|NCT01546623|16464145|P2|Overall Study|Did Not Receive Study Drug|1
4772603|NCT01546623|16464146|P1|Overall Study|Did Not Receive Study Drug|1
4772604|NCT01546623|16464145|P2|Overall Study|High Prostate specific antigen|1
4772605|NCT01546623|16464146|P1|Overall Study|High Prostate specific antigen|2
4772606|NCT01546623|16464145|P2|Overall Study|Major Protocol Deviation|1
4772607|NCT01546623|16464146|P1|Overall Study|Major Protocol Deviation|1
4772608|NCT01546623|16464145|P2|Overall Study|Adverse Event|3
4772609|NCT01546623|16464146|P1|Overall Study|Adverse Event|2
4772610|NCT01546519|16464176|P4|Overall Study|Withdrawal by Subject|0
4772611|NCT01546519|16464177|P3|Overall Study|Withdrawal by Subject|0
4772612|NCT01546519|16464178|P2|Overall Study|Withdrawal by Subject|0
4772613|NCT01546519|16464179|P1|Overall Study|Withdrawal by Subject|1
4772614|NCT01546519|16464176|P4|Overall Study|Physician Decision|3
4772615|NCT01546519|16464177|P3|Overall Study|Physician Decision|2
4772616|NCT01546519|16464178|P2|Overall Study|Physician Decision|5
4772617|NCT01546519|16464179|P1|Overall Study|Physician Decision|6
4772618|NCT01546519|16464176|P4|Overall Study|related to disease progression|1
4772619|NCT01546519|16464177|P3|Overall Study|related to disease progression|2
4772620|NCT01546519|16464178|P2|Overall Study|related to disease progression|2
4772621|NCT01546519|16464179|P1|Overall Study|related to disease progression|2
4772622|NCT01546519|16464176|P4|Overall Study|Death|1
4772623|NCT01546519|16464177|P3|Overall Study|Death|3
4772624|NCT01546519|16464178|P2|Overall Study|Death|1
4772625|NCT01546519|16464179|P1|Overall Study|Death|0
4772626|NCT01546519|16464176|P4|Overall Study|Adverse Event|1
4772627|NCT01546519|16464177|P3|Overall Study|Adverse Event|1
4772628|NCT01546519|16464178|P2|Overall Study|Adverse Event|0
4772629|NCT01546519|16464179|P1|Overall Study|Adverse Event|0
4772630|NCT01546207|16464244|P1|Overall Study|Death|1
4772631|NCT01546168|16464259|P2|Overall Study|ineligible after signing consent|0
4772632|NCT01546168|16464260|P1|Overall Study|ineligible after signing consent|2
4772633|NCT01546168|16464259|P2|Overall Study|Withdrawal by Subject|0
4772634|NCT01546168|16464260|P1|Overall Study|Withdrawal by Subject|1
4772635|NCT01546168|16464259|P2|Overall Study|Lost to Follow-up|0
4772636|NCT01546168|16464260|P1|Overall Study|Lost to Follow-up|1
4772637|NCT01546155|16464272|P1|Overall Study|could not tolerate long scan duration|3
4772638|NCT01546142|16464278|P2|Overall Study|Subject Randomized but Not Treated|0
4772639|NCT01546142|16464279|P1|Overall Study|Subject Randomized but Not Treated|1
4772640|NCT01546142|16464278|P2|Overall Study|Consent Withdrawn (Subject Discomfort)|0
4772641|NCT01546142|16464279|P1|Overall Study|Consent Withdrawn (Subject Discomfort)|1
4772642|NCT01546142|16464278|P2|Overall Study|Lost to Follow-up|15
4772643|NCT01546142|16464279|P1|Overall Study|Lost to Follow-up|20
4772644|NCT01546142|16464278|P2|Overall Study|Adverse Event|3
4772645|NCT01546142|16464279|P1|Overall Study|Adverse Event|6
4772646|NCT01546142|16464278|P2|Overall Study|Subject Noncompliance|1
4772647|NCT01546142|16464279|P1|Overall Study|Subject Noncompliance|1
4772648|NCT01546142|16464278|P2|Overall Study|Consent Withdrawn (Subject Convenience)|15
4772649|NCT01546142|16464279|P1|Overall Study|Consent Withdrawn (Subject Convenience)|15
4772650|NCT01546038|16464297|P9|Overall Study|: Randomized, not treated|3
4772651|NCT01546038|16464298|P8|Overall Study|: Randomized, not treated|4
4772652|NCT01546038|16464299|P7|Overall Study|: Randomized, not treated|2
4772653|NCT01546038|16464300|P6|Overall Study|: Randomized, not treated|0
4772654|NCT01546038|16464301|P5|Overall Study|: Randomized, not treated|0
4772655|NCT01546038|16464302|P4|Overall Study|: Randomized, not treated|0
4772656|NCT01546038|16464303|P3|Overall Study|: Randomized, not treated|0
4772657|NCT01546038|16464304|P2|Overall Study|: Randomized, not treated|0
4772658|NCT01546038|16464305|P1|Overall Study|: Randomized, not treated|0
4772659|NCT01546038|16464297|P9|Overall Study|Withdrawal by Subject|1
4772660|NCT01546038|16464298|P8|Overall Study|Withdrawal by Subject|3
4772661|NCT01546038|16464299|P7|Overall Study|Withdrawal by Subject|3
4772662|NCT01546038|16464300|P6|Overall Study|Withdrawal by Subject|1
4772663|NCT01546038|16464301|P5|Overall Study|Withdrawal by Subject|0
4772664|NCT01546038|16464302|P4|Overall Study|Withdrawal by Subject|1
4772665|NCT01546038|16464303|P3|Overall Study|Withdrawal by Subject|0
4772666|NCT01546038|16464304|P2|Overall Study|Withdrawal by Subject|0
4772667|NCT01546038|16464305|P1|Overall Study|Withdrawal by Subject|1
4772668|NCT01546038|16464297|P9|Overall Study|Lost to Follow-up|0
4772669|NCT01546038|16464298|P8|Overall Study|Lost to Follow-up|1
4772670|NCT01546038|16464299|P7|Overall Study|Lost to Follow-up|2
4772671|NCT01546038|16464300|P6|Overall Study|Lost to Follow-up|0
4772672|NCT01546038|16464301|P5|Overall Study|Lost to Follow-up|1
4772673|NCT01546038|16464302|P4|Overall Study|Lost to Follow-up|0
4772674|NCT01546038|16464303|P3|Overall Study|Lost to Follow-up|0
4772675|NCT01546038|16464304|P2|Overall Study|Lost to Follow-up|0
4772676|NCT01546038|16464305|P1|Overall Study|Lost to Follow-up|0
4772677|NCT01546038|16464297|P9|Overall Study|Death|39
4772678|NCT01546038|16464298|P8|Overall Study|Death|76
4772679|NCT01546038|16464299|P7|Overall Study|Death|46
4772680|NCT01546038|16464300|P6|Overall Study|Death|3
4772681|NCT01546038|16464301|P5|Overall Study|Death|9
4772682|NCT01546038|16464302|P4|Overall Study|Death|2
4772683|NCT01546038|16464303|P3|Overall Study|Death|4
4772684|NCT01546038|16464304|P2|Overall Study|Death|6
4772685|NCT01546038|16464305|P1|Overall Study|Death|15
4772686|NCT01545817|16464499|P2|Everolimus|Adverse Event|6
4772687|NCT01545817|16464500|P1|Everolimus|Adverse Event|0
4772688|NCT01545817|16464499|P2|Everolimus|Disease progression|25
4772689|NCT01545817|16464500|P1|Everolimus|Disease progression|0
4772690|NCT01545817|16464499|P2|Everolimus|Other reason|7
4772691|NCT01545817|16464500|P1|Everolimus|Other reason|0
4772692|NCT01545817|16464499|P2|Pazopanib|Other reason|0
4772693|NCT01545817|16464500|P1|Pazopanib|Other reason|4
4772694|NCT01545817|16464499|P2|Pazopanib|Adverse Event|0
4772695|NCT01545817|16464500|P1|Pazopanib|Adverse Event|19
4772696|NCT01545817|16464499|P2|Pazopanib|Disease progression|0
4772697|NCT01545817|16464500|P1|Pazopanib|Disease progression|51
4772698|NCT01545388|16464649|P3|Overall Study|Other|0
4772699|NCT01545388|16464650|P2|Overall Study|Other|1
4772700|NCT01545388|16464651|P1|Overall Study|Other|1
4772701|NCT01545388|16464649|P3|Overall Study|Withdrawal by Subject|2
4772702|NCT01545388|16464650|P2|Overall Study|Withdrawal by Subject|4
4772703|NCT01545388|16464651|P1|Overall Study|Withdrawal by Subject|1
4772704|NCT01545388|16464649|P3|Overall Study|Participant moved or relocated|0
4772705|NCT01545388|16464650|P2|Overall Study|Participant moved or relocated|0
4772706|NCT01545388|16464651|P1|Overall Study|Participant moved or relocated|1
4772707|NCT01545388|16464649|P3|Overall Study|Lack of Efficacy|5
4772708|NCT01545388|16464650|P2|Overall Study|Lack of Efficacy|2
4772709|NCT01545388|16464651|P1|Overall Study|Lack of Efficacy|3
4772710|NCT01545388|16464649|P3|Overall Study|Adverse Event|1
4772711|NCT01545388|16464650|P2|Overall Study|Adverse Event|4
4772712|NCT01545388|16464651|P1|Overall Study|Adverse Event|2
4772713|NCT01545375|16464670|P2|Overall Study|Withdrawal by Subject|55
4772714|NCT01545375|16464671|P1|Overall Study|Withdrawal by Subject|58
4772715|NCT01545375|16464670|P2|Overall Study|Protocol Violation|3
4772716|NCT01545375|16464671|P1|Overall Study|Protocol Violation|3
4772717|NCT01545375|16464670|P2|Overall Study|Lost to Follow-up|31
4772718|NCT01545375|16464671|P1|Overall Study|Lost to Follow-up|34
4772719|NCT01545375|16464670|P2|Overall Study|Adverse Event|1
4772720|NCT01545375|16464671|P1|Overall Study|Adverse Event|2
4772721|NCT01545076|16464803|P5|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
4772722|NCT01545076|16464804|P4|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3
4772723|NCT01545076|16464805|P3|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2
4772724|NCT01545076|16464806|P2|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8
4772725|NCT01545076|16464807|P1|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0
4772726|NCT01545076|16464803|P5|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
4772727|NCT01545076|16464804|P4|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
4772728|NCT01545076|16464805|P3|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
4772729|NCT01545076|16464806|P2|IgPro20 Subcutaneous Treatment Period|Adverse Event|1
4772730|NCT01545076|16464807|P1|IgPro20 Subcutaneous Treatment Period|Adverse Event|0
4772731|NCT01545076|16464803|P5|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
4772732|NCT01545076|16464804|P4|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32
4772733|NCT01545076|16464805|P3|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18
4772734|NCT01545076|16464806|P2|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10
4772735|NCT01545076|16464807|P1|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0
4772736|NCT01545076|16464803|P5|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4772737|NCT01545076|16464804|P4|IgPro20 Subcutaneous Treatment Period|Physician Decision|1
4772738|NCT01545076|16464805|P3|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4772739|NCT01545076|16464806|P2|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4772740|NCT01545076|16464807|P1|IgPro20 Subcutaneous Treatment Period|Physician Decision|0
4772741|NCT01545076|16464803|P5|IgPro10 Restabilization Period|Withdrawal by Subject|0
4772742|NCT01545076|16464804|P4|IgPro10 Restabilization Period|Withdrawal by Subject|0
4772743|NCT01545076|16464805|P3|IgPro10 Restabilization Period|Withdrawal by Subject|0
4772744|NCT01545076|16464806|P2|IgPro10 Restabilization Period|Withdrawal by Subject|0
4772745|NCT01545076|16464807|P1|IgPro10 Restabilization Period|Withdrawal by Subject|7
4772746|NCT01545076|16464803|P5|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4772747|NCT01545076|16464804|P4|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4772748|NCT01545076|16464805|P3|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4772749|NCT01545076|16464806|P2|IgPro10 Restabilization Period|Failure to meet randomization criteria|0
4772750|NCT01545076|16464807|P1|IgPro10 Restabilization Period|Failure to meet randomization criteria|22
4772751|NCT01545076|16464803|P5|IgPro10 Restabilization Period|Protocol Violation|0
4772752|NCT01545076|16464804|P4|IgPro10 Restabilization Period|Protocol Violation|0
4772753|NCT01545076|16464805|P3|IgPro10 Restabilization Period|Protocol Violation|0
4772754|NCT01545076|16464806|P2|IgPro10 Restabilization Period|Protocol Violation|0
4772755|NCT01545076|16464807|P1|IgPro10 Restabilization Period|Protocol Violation|1
4772756|NCT01545076|16464803|P5|IgPro10 Restabilization Period|Physician Decision|0
4772757|NCT01545076|16464804|P4|IgPro10 Restabilization Period|Physician Decision|0
4772758|NCT01545076|16464805|P3|IgPro10 Restabilization Period|Physician Decision|0
4772759|NCT01545076|16464806|P2|IgPro10 Restabilization Period|Physician Decision|0
4772760|NCT01545076|16464807|P1|IgPro10 Restabilization Period|Physician Decision|2
4772761|NCT01545076|16464803|P5|IgPro10 Restabilization Period|Adverse Event|0
4772762|NCT01545076|16464804|P4|IgPro10 Restabilization Period|Adverse Event|0
4772763|NCT01545076|16464805|P3|IgPro10 Restabilization Period|Adverse Event|0
4772764|NCT01545076|16464806|P2|IgPro10 Restabilization Period|Adverse Event|0
4772765|NCT01545076|16464807|P1|IgPro10 Restabilization Period|Adverse Event|4
4772766|NCT01544920|16464878|P2|Overall Study|Withdrawal by Subject|4
4772767|NCT01544920|16464879|P1|Overall Study|Withdrawal by Subject|4
4772768|NCT01544920|16464878|P2|Overall Study|Physician Decision|1
4772769|NCT01544920|16464879|P1|Overall Study|Physician Decision|4
4772770|NCT01544920|16464878|P2|Overall Study|Protocol Violation|2
4772771|NCT01544920|16464879|P1|Overall Study|Protocol Violation|0
4772772|NCT01544920|16464878|P2|Overall Study|Lost to Follow-up|12
4772773|NCT01544920|16464879|P1|Overall Study|Lost to Follow-up|11
4772774|NCT01544920|16464878|P2|Overall Study|Death|1
4772775|NCT01544920|16464879|P1|Overall Study|Death|0
4772776|NCT01544920|16464878|P2|Overall Study|Adverse Event|3
4772777|NCT01544920|16464879|P1|Overall Study|Adverse Event|0
4772778|NCT01544595|16464893|P6|Status at Week 156|Lack of Efficacy|5
4772779|NCT01544595|16464894|P5|Status at Week 156|Lack of Efficacy|10
4772780|NCT01544595|16464895|P4|Status at Week 156|Lack of Efficacy|4
4772781|NCT01544595|16464896|P3|Status at Week 156|Lack of Efficacy|1
4772782|NCT01544595|16464897|P2|Status at Week 156|Lack of Efficacy|0
4772783|NCT01544595|16464898|P1|Status at Week 156|Lack of Efficacy|1
4772784|NCT01544595|16464893|P6|Status at Week 156|Moved to treatment period ≤ wk 156|0
4772785|NCT01544595|16464894|P5|Status at Week 156|Moved to treatment period ≤ wk 156|0
4772786|NCT01544595|16464895|P4|Status at Week 156|Moved to treatment period ≤ wk 156|145
4772787|NCT01544595|16464896|P3|Status at Week 156|Moved to treatment period ≤ wk 156|131
4772788|NCT01544595|16464897|P2|Status at Week 156|Moved to treatment period ≤ wk 156|44
4772789|NCT01544595|16464898|P1|Status at Week 156|Moved to treatment period ≤ wk 156|86
4772790|NCT01544595|16464893|P6|Status at Week 156|Technical problems|0
4772791|NCT01544595|16464894|P5|Status at Week 156|Technical problems|0
4772792|NCT01544595|16464895|P4|Status at Week 156|Technical problems|1
4772793|NCT01544595|16464896|P3|Status at Week 156|Technical problems|0
4772794|NCT01544595|16464897|P2|Status at Week 156|Technical problems|1
4772795|NCT01544595|16464898|P1|Status at Week 156|Technical problems|3
4772796|NCT01544595|16464893|P6|Status at Week 156|Protocol Violation|0
4772797|NCT01544595|16464894|P5|Status at Week 156|Protocol Violation|0
4772798|NCT01544595|16464895|P4|Status at Week 156|Protocol Violation|2
4772799|NCT01544595|16464896|P3|Status at Week 156|Protocol Violation|2
4772800|NCT01544595|16464897|P2|Status at Week 156|Protocol Violation|1
4772801|NCT01544595|16464898|P1|Status at Week 156|Protocol Violation|3
4772802|NCT01544595|16464893|P6|Status at Week 156|Pregnancy|0
4772803|NCT01544595|16464894|P5|Status at Week 156|Pregnancy|0
4772804|NCT01544595|16464895|P4|Status at Week 156|Pregnancy|0
4772805|NCT01544595|16464896|P3|Status at Week 156|Pregnancy|0
4772806|NCT01544595|16464897|P2|Status at Week 156|Pregnancy|3
4772807|NCT01544595|16464898|P1|Status at Week 156|Pregnancy|2
4772808|NCT01544595|16464893|P6|Status at Week 156|Physician Decision|0
4772809|NCT01544595|16464894|P5|Status at Week 156|Physician Decision|0
4772810|NCT01544595|16464895|P4|Status at Week 156|Physician Decision|0
4772811|NCT01544595|16464896|P3|Status at Week 156|Physician Decision|1
4772812|NCT01544595|16464897|P2|Status at Week 156|Physician Decision|3
4772813|NCT01544595|16464898|P1|Status at Week 156|Physician Decision|0
4772814|NCT01544595|16464893|P6|Status at Week 156|Non-compliance with study treatement|1
4772815|NCT01544595|16464894|P5|Status at Week 156|Non-compliance with study treatement|0
4772816|NCT01544595|16464895|P4|Status at Week 156|Non-compliance with study treatement|1
4772817|NCT01544595|16464896|P3|Status at Week 156|Non-compliance with study treatement|0
4772818|NCT01544595|16464897|P2|Status at Week 156|Non-compliance with study treatement|1
4772819|NCT01544595|16464898|P1|Status at Week 156|Non-compliance with study treatement|0
4772820|NCT01544595|16464893|P6|Status at Week 156|Lost to Follow-up|1
4772821|NCT01544595|16464894|P5|Status at Week 156|Lost to Follow-up|4
4772822|NCT01544595|16464895|P4|Status at Week 156|Lost to Follow-up|1
4772823|NCT01544595|16464896|P3|Status at Week 156|Lost to Follow-up|0
4772824|NCT01544595|16464897|P2|Status at Week 156|Lost to Follow-up|4
4772825|NCT01544595|16464898|P1|Status at Week 156|Lost to Follow-up|4
4772826|NCT01544595|16464893|P6|Status at Week 156|Adverse Event|2
4772827|NCT01544595|16464894|P5|Status at Week 156|Adverse Event|4
4772828|NCT01544595|16464895|P4|Status at Week 156|Adverse Event|3
4772829|NCT01544595|16464896|P3|Status at Week 156|Adverse Event|1
4772830|NCT01544595|16464897|P2|Status at Week 156|Adverse Event|11
4772831|NCT01544595|16464898|P1|Status at Week 156|Adverse Event|9
4772832|NCT01544595|16464893|P6|Status at Week 156|Withdrawal by Subject|6
4772833|NCT01544595|16464894|P5|Status at Week 156|Withdrawal by Subject|20
4772834|NCT01544595|16464895|P4|Status at Week 156|Withdrawal by Subject|9
4772835|NCT01544595|16464896|P3|Status at Week 156|Withdrawal by Subject|4
4772836|NCT01544595|16464897|P2|Status at Week 156|Withdrawal by Subject|10
4772837|NCT01544595|16464898|P1|Status at Week 156|Withdrawal by Subject|9
4772838|NCT01544595|16464893|P6|Status at Week 68|Moved to treatment period ≤ wk 68|0
4772839|NCT01544595|16464894|P5|Status at Week 68|Moved to treatment period ≤ wk 68|0
4772840|NCT01544595|16464895|P4|Status at Week 68|Moved to treatment period ≤ wk 68|46
4772841|NCT01544595|16464896|P3|Status at Week 68|Moved to treatment period ≤ wk 68|60
4772842|NCT01544595|16464897|P2|Status at Week 68|Moved to treatment period ≤ wk 68|13
4772843|NCT01544595|16464898|P1|Status at Week 68|Moved to treatment period ≤ wk 68|30
4772844|NCT01544595|16464893|P6|Status at Week 68|Withdrawal by Subject|0
4772845|NCT01544595|16464894|P5|Status at Week 68|Withdrawal by Subject|0
4772846|NCT01544595|16464895|P4|Status at Week 68|Withdrawal by Subject|2
4772847|NCT01544595|16464896|P3|Status at Week 68|Withdrawal by Subject|1
4772848|NCT01544595|16464897|P2|Status at Week 68|Withdrawal by Subject|1
4772849|NCT01544595|16464898|P1|Status at Week 68|Withdrawal by Subject|0
4772850|NCT01544595|16464893|P6|Status at Week 68|Technical problems|0
4772851|NCT01544595|16464894|P5|Status at Week 68|Technical problems|0
4772852|NCT01544595|16464895|P4|Status at Week 68|Technical problems|1
4772853|NCT01544595|16464896|P3|Status at Week 68|Technical problems|0
4772854|NCT01544595|16464897|P2|Status at Week 68|Technical problems|0
4772855|NCT01544595|16464898|P1|Status at Week 68|Technical problems|1
4772856|NCT01544595|16464893|P6|Status at Week 68|Protocol Violation|0
4772857|NCT01544595|16464894|P5|Status at Week 68|Protocol Violation|0
4772858|NCT01544595|16464895|P4|Status at Week 68|Protocol Violation|1
4772859|NCT01544595|16464896|P3|Status at Week 68|Protocol Violation|1
4772860|NCT01544595|16464897|P2|Status at Week 68|Protocol Violation|0
4772861|NCT01544595|16464898|P1|Status at Week 68|Protocol Violation|2
4772862|NCT01544595|16464893|P6|Status at Week 68|Non-compliance with study treatment|0
4772863|NCT01544595|16464894|P5|Status at Week 68|Non-compliance with study treatment|0
4772864|NCT01544595|16464895|P4|Status at Week 68|Non-compliance with study treatment|1
4772865|NCT01544595|16464896|P3|Status at Week 68|Non-compliance with study treatment|0
4772866|NCT01544595|16464897|P2|Status at Week 68|Non-compliance with study treatment|0
4772867|NCT01544595|16464898|P1|Status at Week 68|Non-compliance with study treatment|1
4772868|NCT01544595|16464893|P6|Status at Week 68|Lost to Follow-up|0
4772869|NCT01544595|16464894|P5|Status at Week 68|Lost to Follow-up|0
4772870|NCT01544595|16464895|P4|Status at Week 68|Lost to Follow-up|0
4772871|NCT01544595|16464896|P3|Status at Week 68|Lost to Follow-up|0
4772872|NCT01544595|16464897|P2|Status at Week 68|Lost to Follow-up|1
4772873|NCT01544595|16464898|P1|Status at Week 68|Lost to Follow-up|1
4772874|NCT01544595|16464893|P6|Status at Week 68|Lack of Efficacy|0
4772875|NCT01544595|16464894|P5|Status at Week 68|Lack of Efficacy|0
4772876|NCT01544595|16464895|P4|Status at Week 68|Lack of Efficacy|0
4772877|NCT01544595|16464896|P3|Status at Week 68|Lack of Efficacy|0
4772878|NCT01544595|16464897|P2|Status at Week 68|Lack of Efficacy|0
4772879|NCT01544595|16464898|P1|Status at Week 68|Lack of Efficacy|1
4772880|NCT01544595|16464893|P6|Status at Week 68|Adverse Event|0
4772881|NCT01544595|16464894|P5|Status at Week 68|Adverse Event|0
4772882|NCT01544595|16464895|P4|Status at Week 68|Adverse Event|0
4772883|NCT01544595|16464896|P3|Status at Week 68|Adverse Event|1
4772884|NCT01544595|16464897|P2|Status at Week 68|Adverse Event|2
4772885|NCT01544595|16464898|P1|Status at Week 68|Adverse Event|3
4772886|NCT01544582|16464974|P4|Analysis Population|Participant in Jail|0
4772887|NCT01544582|16464975|P3|Analysis Population|Participant in Jail|1
4772888|NCT01544582|16464976|P2|Analysis Population|Participant in Jail|0
4772889|NCT01544582|16464977|P1|Analysis Population|Participant in Jail|0
4772890|NCT01544582|16464974|P4|Analysis Population|Programmed Surgery|0
4772891|NCT01544582|16464975|P3|Analysis Population|Programmed Surgery|0
4772892|NCT01544582|16464976|P2|Analysis Population|Programmed Surgery|1
4772893|NCT01544582|16464977|P1|Analysis Population|Programmed Surgery|0
4772894|NCT01544582|16464974|P4|Analysis Population|Poor Participant Compliance|0
4772895|NCT01544582|16464975|P3|Analysis Population|Poor Participant Compliance|0
4772896|NCT01544582|16464976|P2|Analysis Population|Poor Participant Compliance|1
4772897|NCT01544582|16464977|P1|Analysis Population|Poor Participant Compliance|0
4772898|NCT01544582|16464974|P4|Analysis Population|Poor Adherence|0
4772899|NCT01544582|16464975|P3|Analysis Population|Poor Adherence|1
4772900|NCT01544582|16464976|P2|Analysis Population|Poor Adherence|0
4772901|NCT01544582|16464977|P1|Analysis Population|Poor Adherence|0
4772902|NCT01544582|16464974|P4|Analysis Population|No Social Insurance|0
4772903|NCT01544582|16464975|P3|Analysis Population|No Social Insurance|1
4772904|NCT01544582|16464976|P2|Analysis Population|No Social Insurance|0
4772905|NCT01544582|16464977|P1|Analysis Population|No Social Insurance|0
4772906|NCT01544582|16464974|P4|Analysis Population|Liver Transplantation|0
4772907|NCT01544582|16464975|P3|Analysis Population|Liver Transplantation|1
4772908|NCT01544582|16464976|P2|Analysis Population|Liver Transplantation|0
4772909|NCT01544582|16464977|P1|Analysis Population|Liver Transplantation|0
4772910|NCT01544582|16464974|P4|Analysis Population|Intolerance|0
4772911|NCT01544582|16464975|P3|Analysis Population|Intolerance|0
4772912|NCT01544582|16464976|P2|Analysis Population|Intolerance|1
4772913|NCT01544582|16464977|P1|Analysis Population|Intolerance|0
4772914|NCT01544582|16464974|P4|Analysis Population|Did Not Meet Inclusion Criteria|0
4772915|NCT01544582|16464975|P3|Analysis Population|Did Not Meet Inclusion Criteria|3
4772916|NCT01544582|16464976|P2|Analysis Population|Did Not Meet Inclusion Criteria|0
4772917|NCT01544582|16464977|P1|Analysis Population|Did Not Meet Inclusion Criteria|0
4772918|NCT01544582|16464974|P4|Analysis Population|Bad Tolerance to Treatment|0
4772919|NCT01544582|16464975|P3|Analysis Population|Bad Tolerance to Treatment|2
4772920|NCT01544582|16464976|P2|Analysis Population|Bad Tolerance to Treatment|0
4772921|NCT01544582|16464977|P1|Analysis Population|Bad Tolerance to Treatment|0
4772922|NCT01544582|16464974|P4|Analysis Population|Lost to Follow-up|5
4772923|NCT01544582|16464975|P3|Analysis Population|Lost to Follow-up|6
4772924|NCT01544582|16464976|P2|Analysis Population|Lost to Follow-up|6
4772925|NCT01544582|16464977|P1|Analysis Population|Lost to Follow-up|0
4772926|NCT01544582|16464974|P4|Analysis Population|New Contraindication-Alcohol Abuse|1
4772927|NCT01544582|16464975|P3|Analysis Population|New Contraindication-Alcohol Abuse|0
4772928|NCT01544582|16464976|P2|Analysis Population|New Contraindication-Alcohol Abuse|0
4772929|NCT01544582|16464977|P1|Analysis Population|New Contraindication-Alcohol Abuse|0
4772930|NCT01544582|16464974|P4|Analysis Population|Effectiveness Reason|12
4772931|NCT01544582|16464975|P3|Analysis Population|Effectiveness Reason|29
4772932|NCT01544582|16464976|P2|Analysis Population|Effectiveness Reason|48
4772933|NCT01544582|16464977|P1|Analysis Population|Effectiveness Reason|0
4772934|NCT01544582|16464974|P4|Analysis Population|Safety Reason|8
4772935|NCT01544582|16464975|P3|Analysis Population|Safety Reason|31
4772936|NCT01544582|16464976|P2|Analysis Population|Safety Reason|33
4772937|NCT01544582|16464977|P1|Analysis Population|Safety Reason|0
4772938|NCT01544582|16464974|P4|Analysis Population|Physician Decision|9
4772939|NCT01544582|16464975|P3|Analysis Population|Physician Decision|10
4772940|NCT01544582|16464976|P2|Analysis Population|Physician Decision|13
4772941|NCT01544582|16464977|P1|Analysis Population|Physician Decision|0
4772942|NCT01544582|16464974|P4|Analysis Population|Participant Refuses to Continue Study|4
4772943|NCT01544582|16464975|P3|Analysis Population|Participant Refuses to Continue Study|17
4772944|NCT01544582|16464976|P2|Analysis Population|Participant Refuses to Continue Study|15
4772945|NCT01544582|16464977|P1|Analysis Population|Participant Refuses to Continue Study|0
4772946|NCT01544582|16464974|P4|Screening/Eligibility|Eligibility Criteria Not Met|0
4772947|NCT01544582|16464975|P3|Screening/Eligibility|Eligibility Criteria Not Met|0
4772948|NCT01544582|16464976|P2|Screening/Eligibility|Eligibility Criteria Not Met|0
4772949|NCT01544582|16464977|P1|Screening/Eligibility|Eligibility Criteria Not Met|33
4772950|NCT01544582|16464974|P4|Screening/Eligibility|Initiated Different CHC Treatment|0
4772951|NCT01544582|16464975|P3|Screening/Eligibility|Initiated Different CHC Treatment|0
4772952|NCT01544582|16464976|P2|Screening/Eligibility|Initiated Different CHC Treatment|0
4772953|NCT01544582|16464977|P1|Screening/Eligibility|Initiated Different CHC Treatment|1
4772954|NCT01544491|16465037|P2|Overall Study|administrative problems|0
4772955|NCT01544491|16465038|P1|Overall Study|administrative problems|2
4772956|NCT01544491|16465037|P2|Overall Study|Lost to Follow-up|1
4772957|NCT01544491|16465038|P1|Overall Study|Lost to Follow-up|0
4772958|NCT01544491|16465037|P2|Overall Study|Withdrawal by Subject|2
4772959|NCT01544491|16465038|P1|Overall Study|Withdrawal by Subject|3
4772960|NCT01544478|16465064|P1|Overall Study|Withdrawal by Subject|52
4772961|NCT01544478|16465064|P1|Overall Study|Pregnancy|1
4772962|NCT01544478|16465064|P1|Overall Study|Physician Decision|15
4772963|NCT01544478|16465064|P1|Overall Study|Lost to Follow-up|48
4772964|NCT01544478|16465064|P1|Overall Study|Death|1
4772965|NCT01544478|16465064|P1|Overall Study|Adverse Event|1
4772966|NCT01544348|16465107|P8|Overall Study|Physician Decision|0
4772967|NCT01544348|16465108|P7|Overall Study|Physician Decision|0
4772968|NCT01544348|16465109|P6|Overall Study|Physician Decision|1
4772969|NCT01544348|16465110|P5|Overall Study|Physician Decision|0
4772970|NCT01544348|16465111|P4|Overall Study|Physician Decision|0
4772971|NCT01544348|16465112|P3|Overall Study|Physician Decision|0
4772972|NCT01544348|16465113|P2|Overall Study|Physician Decision|0
4772973|NCT01544348|16465114|P1|Overall Study|Physician Decision|0
4772974|NCT01544348|16465107|P8|Overall Study|Withdrawal by Subject|0
4772975|NCT01544348|16465108|P7|Overall Study|Withdrawal by Subject|1
4772976|NCT01544348|16465109|P6|Overall Study|Withdrawal by Subject|2
4772977|NCT01544348|16465110|P5|Overall Study|Withdrawal by Subject|1
4772978|NCT01544348|16465111|P4|Overall Study|Withdrawal by Subject|0
4772979|NCT01544348|16465112|P3|Overall Study|Withdrawal by Subject|0
4772980|NCT01544348|16465113|P2|Overall Study|Withdrawal by Subject|0
4772981|NCT01544348|16465114|P1|Overall Study|Withdrawal by Subject|1
4772982|NCT01544348|16465107|P8|Overall Study|Lost to Follow-up|0
4772983|NCT01544348|16465108|P7|Overall Study|Lost to Follow-up|1
4772984|NCT01544348|16465109|P6|Overall Study|Lost to Follow-up|0
4772985|NCT01544348|16465110|P5|Overall Study|Lost to Follow-up|0
4772986|NCT01544348|16465111|P4|Overall Study|Lost to Follow-up|0
4772987|NCT01544348|16465112|P3|Overall Study|Lost to Follow-up|0
4772988|NCT01544348|16465113|P2|Overall Study|Lost to Follow-up|0
4772989|NCT01544348|16465114|P1|Overall Study|Lost to Follow-up|1
4772990|NCT01544309|16465156|P2|Overall Study|Administered prohibit prior medication|0
4772991|NCT01544309|16465157|P1|Overall Study|Administered prohibit prior medication|1
4772992|NCT01544309|16465156|P2|Overall Study|Not performed pre-dose examination|2
4772993|NCT01544309|16465157|P1|Overall Study|Not performed pre-dose examination|1
4772994|NCT01544309|16465156|P2|Overall Study|Physician Decision|1
4772995|NCT01544309|16465157|P1|Overall Study|Physician Decision|4
4772996|NCT01544309|16465156|P2|Overall Study|Protocol Violation|1
4772997|NCT01544309|16465157|P1|Overall Study|Protocol Violation|2
4772998|NCT01544309|16465156|P2|Overall Study|Withdrawal by Subject|7
4772999|NCT01544309|16465157|P1|Overall Study|Withdrawal by Subject|12
4773000|NCT01544179|16465195|P2|Overall Study|Eligibility criteria not fulfilled|0
4773001|NCT01544179|16465196|P1|Overall Study|Eligibility criteria not fulfilled|1
4773002|NCT01544179|16465195|P2|Overall Study|Withdrawal by Subject|7
4773003|NCT01544179|16465196|P1|Overall Study|Withdrawal by Subject|12
4773004|NCT01544179|16465195|P2|Overall Study|Adverse Event|1
4773005|NCT01544179|16465196|P1|Overall Study|Adverse Event|0
4773006|NCT01544179|16465195|P2|Overall Study|Lost to Follow-up|1
4773007|NCT01544179|16465196|P1|Overall Study|Lost to Follow-up|0
4773008|NCT01544179|16465195|P2|Overall Study|Death|37
4773009|NCT01544179|16465196|P1|Overall Study|Death|50
4773010|NCT01544153|16465289|P4|Overall Study|Non-smoker|0
4773011|NCT01544153|16465290|P3|Overall Study|Non-smoker|1
4773012|NCT01544153|16465291|P2|Overall Study|Non-smoker|0
4773013|NCT01544153|16465292|P1|Overall Study|Non-smoker|0
4773014|NCT01544153|16465289|P4|Overall Study|Under 18|0
4773015|NCT01544153|16465290|P3|Overall Study|Under 18|0
4773016|NCT01544153|16465291|P2|Overall Study|Under 18|1
4773017|NCT01544153|16465292|P1|Overall Study|Under 18|0
4773018|NCT01544127|16465309|P3|Overall Study|Went active duty|1
4773019|NCT01544127|16465310|P2|Overall Study|Went active duty|0
4773020|NCT01544127|16465311|P1|Overall Study|Went active duty|0
4773021|NCT01544127|16465309|P3|Overall Study|Researcher withdrew|0
4773022|NCT01544127|16465310|P2|Overall Study|Researcher withdrew|0
4773023|NCT01544127|16465311|P1|Overall Study|Researcher withdrew|1
4773024|NCT01544127|16465309|P3|Overall Study|Became Psychotic|0
4773025|NCT01544127|16465310|P2|Overall Study|Became Psychotic|0
4773026|NCT01544127|16465311|P1|Overall Study|Became Psychotic|1
4773027|NCT01544127|16465309|P3|Overall Study|Jail or Prison|2
4773028|NCT01544127|16465310|P2|Overall Study|Jail or Prison|1
4773029|NCT01544127|16465311|P1|Overall Study|Jail or Prison|1
4773030|NCT01544127|16465309|P3|Overall Study|Death|0
4773031|NCT01544127|16465310|P2|Overall Study|Death|0
4773032|NCT01544127|16465311|P1|Overall Study|Death|1
4773033|NCT01544127|16465309|P3|Overall Study|Discharged out of catchment area|1
4773034|NCT01544127|16465310|P2|Overall Study|Discharged out of catchment area|1
4773035|NCT01544127|16465311|P1|Overall Study|Discharged out of catchment area|1
4773036|NCT01544127|16465309|P3|Overall Study|Withdrawal by Subject|1
4773037|NCT01544127|16465310|P2|Overall Study|Withdrawal by Subject|2
4773038|NCT01544127|16465311|P1|Overall Study|Withdrawal by Subject|2
4773039|NCT01544127|16465309|P3|Overall Study|Lost to Follow-up|9
4773040|NCT01544127|16465310|P2|Overall Study|Lost to Follow-up|2
4773041|NCT01544127|16465311|P1|Overall Study|Lost to Follow-up|4
4773042|NCT01544114|16465331|P3|Overall Study|Protocol Violation|0
4773043|NCT01544114|16465332|P2|Overall Study|Protocol Violation|1
4773044|NCT01544114|16465333|P1|Overall Study|Protocol Violation|0
4773045|NCT01544114|16465331|P3|Overall Study|Adverse Event|2
4773046|NCT01544114|16465332|P2|Overall Study|Adverse Event|1
4773047|NCT01544114|16465333|P1|Overall Study|Adverse Event|1
4773048|NCT01544114|16465331|P3|Overall Study|Lost to Follow-up|0
4773049|NCT01544114|16465332|P2|Overall Study|Lost to Follow-up|2
4773050|NCT01544114|16465333|P1|Overall Study|Lost to Follow-up|0
4773051|NCT01544114|16465331|P3|Overall Study|Withdrawal by Subject|3
4773052|NCT01544114|16465332|P2|Overall Study|Withdrawal by Subject|0
4773053|NCT01544114|16465333|P1|Overall Study|Withdrawal by Subject|0
4773054|NCT01543958|16465431|P1|Overall Study|ART initiation|1
4773055|NCT01543958|16465431|P1|Overall Study|Loss to follow-up|3
4773056|NCT01543828|16465486|P2|Treatment 2|Lost to Follow-up|0
4773057|NCT01543828|16465487|P1|Treatment 2|Lost to Follow-up|1
4773058|NCT01543776|16465497|P2|Overall Study|Withdrawal by Subject|2
4773059|NCT01543776|16465498|P1|Overall Study|Withdrawal by Subject|2
4773060|NCT01543685|16465517|P5|Overall Study|Adverse Event|2
4773061|NCT01543685|16465518|P4|Overall Study|Adverse Event|0
4773062|NCT01543685|16465519|P3|Overall Study|Adverse Event|0
4773063|NCT01543685|16465520|P2|Overall Study|Adverse Event|1
4773064|NCT01543685|16465521|P1|Overall Study|Adverse Event|2
4773065|NCT01543685|16465517|P5|Overall Study|Lack of Efficacy|2
4773066|NCT01543685|16465518|P4|Overall Study|Lack of Efficacy|0
4773067|NCT01543685|16465519|P3|Overall Study|Lack of Efficacy|2
4773068|NCT01543685|16465520|P2|Overall Study|Lack of Efficacy|2
4773069|NCT01543685|16465521|P1|Overall Study|Lack of Efficacy|1
4773070|NCT01543503|16465593|P2|Overall Study|Screen failure|0
4773071|NCT01543503|16465594|P1|Overall Study|Screen failure|1
4773072|NCT01543503|16465593|P2|Overall Study|Participant went to United States|0
4773073|NCT01543503|16465594|P1|Overall Study|Participant went to United States|1
4773074|NCT01543503|16465593|P2|Overall Study|Participant consented to another study|2
4773075|NCT01543503|16465594|P1|Overall Study|Participant consented to another study|0
4773076|NCT01543503|16465593|P2|Overall Study|Moved to other rheumatologic site|1
4773077|NCT01543503|16465594|P1|Overall Study|Moved to other rheumatologic site|0
4773078|NCT01543503|16465593|P2|Overall Study|Participant did not attend a visit|0
4773079|NCT01543503|16465594|P1|Overall Study|Participant did not attend a visit|1
4773080|NCT01543503|16465593|P2|Overall Study|Site stopped participation|1
4773081|NCT01543503|16465594|P1|Overall Study|Site stopped participation|5
4773082|NCT01543503|16465593|P2|Overall Study|Participant recruited after closing date|1
4773083|NCT01543503|16465594|P1|Overall Study|Participant recruited after closing date|0
4773084|NCT01543503|16465593|P2|Overall Study|Investigator did not wish to participate|1
4773085|NCT01543503|16465594|P1|Overall Study|Investigator did not wish to participate|1
4773086|NCT01543503|16465593|P2|Overall Study|Participant decision to stop treatment|0
4773087|NCT01543503|16465594|P1|Overall Study|Participant decision to stop treatment|1
4773088|NCT01543503|16465593|P2|Overall Study|Participant moved to Scotland|0
4773089|NCT01543503|16465594|P1|Overall Study|Participant moved to Scotland|1
4773090|NCT01543503|16465593|P2|Overall Study|Participant transferred to another city|0
4773091|NCT01543503|16465594|P1|Overall Study|Participant transferred to another city|1
4773092|NCT01543503|16465593|P2|Overall Study|Participant will not return for visits|2
4773093|NCT01543503|16465594|P1|Overall Study|Participant will not return for visits|0
4773094|NCT01543503|16465593|P2|Overall Study|Participant moved to another city|0
4773095|NCT01543503|16465594|P1|Overall Study|Participant moved to another city|2
4773096|NCT01543503|16465593|P2|Overall Study|Incorrect medication received|0
4773097|NCT01543503|16465594|P1|Overall Study|Incorrect medication received|1
4773098|NCT01543503|16465593|P2|Overall Study|Refused to continue treatment|0
4773099|NCT01543503|16465594|P1|Overall Study|Refused to continue treatment|7
4773100|NCT01543503|16465593|P2|Overall Study|Participant did not complete last visit|2
4773101|NCT01543503|16465594|P1|Overall Study|Participant did not complete last visit|0
4773102|NCT01543503|16465593|P2|Overall Study|Probable overlap of RA with fibromyalgia|0
4773103|NCT01543503|16465594|P1|Overall Study|Probable overlap of RA with fibromyalgia|1
4773104|NCT01543503|16465593|P2|Overall Study|Intolerance to the biologic treatment|1
4773105|NCT01543503|16465594|P1|Overall Study|Intolerance to the biologic treatment|0
4773106|NCT01543503|16465593|P2|Overall Study|Change of jobs|1
4773107|NCT01543503|16465594|P1|Overall Study|Change of jobs|0
4773108|NCT01543503|16465593|P2|Overall Study|Participant withdrew informed consent|10
4773109|NCT01543503|16465594|P1|Overall Study|Participant withdrew informed consent|8
4773110|NCT01543503|16465593|P2|Overall Study|Lack of Efficacy|16
4773111|NCT01543503|16465594|P1|Overall Study|Lack of Efficacy|4
4773112|NCT01543503|16465593|P2|Overall Study|Adverse Event|13
4773113|NCT01543503|16465594|P1|Overall Study|Adverse Event|9
4773114|NCT01543503|16465593|P2|Overall Study|Lost to Follow-up|36
4773115|NCT01543503|16465594|P1|Overall Study|Lost to Follow-up|32
4773116|NCT01543204|16465638|P1|Overall Study|Lost to Follow-up|1
4773117|NCT01543204|16465638|P1|Overall Study|Requirement for Alternative Therapy|1
4773118|NCT01543204|16465638|P1|Overall Study|Withdrawal by Subject|4
4773119|NCT01543204|16465638|P1|Overall Study|Adverse Event|1
4773120|NCT01543204|16465638|P1|Overall Study|Non-compliance|1
4773121|NCT01543087|16465700|P6|Booster Stage (26 Months)|Lost to Follow-up|0
4773122|NCT01543087|16465701|P5|Booster Stage (26 Months)|Lost to Follow-up|0
4773123|NCT01543087|16465702|P4|Booster Stage (26 Months)|Lost to Follow-up|0
4773124|NCT01543087|16465703|P3|Booster Stage (26 Months)|Lost to Follow-up|1
4773125|NCT01543087|16465704|P2|Booster Stage (26 Months)|Lost to Follow-up|0
4773126|NCT01543087|16465705|P1|Booster Stage (26 Months)|Lost to Follow-up|0
4773127|NCT01543087|16465700|P6|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4773128|NCT01543087|16465701|P5|Booster Stage (26 Months)|Withdrawal before booster vaccination|2
4773129|NCT01543087|16465702|P4|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4773130|NCT01543087|16465703|P3|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4773131|NCT01543087|16465704|P2|Booster Stage (26 Months)|Withdrawal before booster vaccination|1
4773132|NCT01543087|16465705|P1|Booster Stage (26 Months)|Withdrawal before booster vaccination|0
4773133|NCT01543087|16465700|P6|Stage 1 (48 Months)|Protocol Violation|0
4773134|NCT01543087|16465701|P5|Stage 1 (48 Months)|Protocol Violation|0
4773135|NCT01543087|16465702|P4|Stage 1 (48 Months)|Protocol Violation|0
4773136|NCT01543087|16465703|P3|Stage 1 (48 Months)|Protocol Violation|0
4773137|NCT01543087|16465704|P2|Stage 1 (48 Months)|Protocol Violation|3
4773138|NCT01543087|16465705|P1|Stage 1 (48 Months)|Protocol Violation|0
4773139|NCT01543087|16465700|P6|Stage 1 (48 Months)|Other than specified|0
4773140|NCT01543087|16465701|P5|Stage 1 (48 Months)|Other than specified|0
4773141|NCT01543087|16465702|P4|Stage 1 (48 Months)|Other than specified|0
4773142|NCT01543087|16465703|P3|Stage 1 (48 Months)|Other than specified|9
4773143|NCT01543087|16465704|P2|Stage 1 (48 Months)|Other than specified|0
4773144|NCT01543087|16465705|P1|Stage 1 (48 Months)|Other than specified|5
4773145|NCT01543087|16465700|P6|Stage 1 (48 Months)|No longer willing to participate|0
4773146|NCT01543087|16465701|P5|Stage 1 (48 Months)|No longer willing to participate|3
4773147|NCT01543087|16465702|P4|Stage 1 (48 Months)|No longer willing to participate|6
4773148|NCT01543087|16465703|P3|Stage 1 (48 Months)|No longer willing to participate|18
4773149|NCT01543087|16465704|P2|Stage 1 (48 Months)|No longer willing to participate|3
4773150|NCT01543087|16465705|P1|Stage 1 (48 Months)|No longer willing to participate|5
4773151|NCT01543087|16465700|P6|Stage 1 (48 Months)|No longer met eligibility criteria|0
4773152|NCT01543087|16465701|P5|Stage 1 (48 Months)|No longer met eligibility criteria|0
4773153|NCT01543087|16465702|P4|Stage 1 (48 Months)|No longer met eligibility criteria|2
4773154|NCT01543087|16465703|P3|Stage 1 (48 Months)|No longer met eligibility criteria|1
4773155|NCT01543087|16465704|P2|Stage 1 (48 Months)|No longer met eligibility criteria|0
4773156|NCT01543087|16465705|P1|Stage 1 (48 Months)|No longer met eligibility criteria|1
4773157|NCT01543087|16465700|P6|Stage 1 (48 Months)|Lost to Follow-up|0
4773158|NCT01543087|16465701|P5|Stage 1 (48 Months)|Lost to Follow-up|0
4773159|NCT01543087|16465702|P4|Stage 1 (48 Months)|Lost to Follow-up|0
4773160|NCT01543087|16465703|P3|Stage 1 (48 Months)|Lost to Follow-up|12
4773161|NCT01543087|16465704|P2|Stage 1 (48 Months)|Lost to Follow-up|4
4773162|NCT01543087|16465705|P1|Stage 1 (48 Months)|Lost to Follow-up|3
4773163|NCT01542788|16465882|P2|Overall Study|Withdrawal by Subject|0
4773164|NCT01542788|16465883|P1|Overall Study|Withdrawal by Subject|1
4773165|NCT01542788|16465882|P2|Overall Study|Physician Decision|0
4773166|NCT01542788|16465883|P1|Overall Study|Physician Decision|1
4773167|NCT01542788|16465882|P2|Overall Study|Protocol Violation|0
4773168|NCT01542788|16465883|P1|Overall Study|Protocol Violation|2
4773169|NCT01542788|16465882|P2|Overall Study|Death|0
4773170|NCT01542788|16465883|P1|Overall Study|Death|3
4773171|NCT01542788|16465882|P2|Overall Study|Lost to Follow-up|0
4773172|NCT01542788|16465883|P1|Overall Study|Lost to Follow-up|5
4773173|NCT01542788|16465882|P2|Overall Study|Lack of Efficacy|71
4773174|NCT01542788|16465883|P1|Overall Study|Lack of Efficacy|41
4773175|NCT01542788|16465882|P2|Overall Study|Randomized but Not Treated|0
4773176|NCT01542788|16465883|P1|Overall Study|Randomized but Not Treated|2
4773177|NCT01542632|16465930|P6|Overall Study|Sponsor/Investigator Decision|0
4773178|NCT01542632|16465931|P5|Overall Study|Sponsor/Investigator Decision|1
4773179|NCT01542632|16465932|P4|Overall Study|Sponsor/Investigator Decision|0
4773180|NCT01542632|16465933|P3|Overall Study|Sponsor/Investigator Decision|0
4773181|NCT01542632|16465934|P2|Overall Study|Sponsor/Investigator Decision|0
4773182|NCT01542632|16465935|P1|Overall Study|Sponsor/Investigator Decision|0
4773183|NCT01542632|16465930|P6|Overall Study|Lost to Follow-up|0
4773184|NCT01542632|16465931|P5|Overall Study|Lost to Follow-up|0
4773185|NCT01542632|16465932|P4|Overall Study|Lost to Follow-up|0
4773186|NCT01542632|16465933|P3|Overall Study|Lost to Follow-up|0
4773187|NCT01542632|16465934|P2|Overall Study|Lost to Follow-up|1
4773188|NCT01542632|16465935|P1|Overall Study|Lost to Follow-up|0
4773189|NCT01542632|16465930|P6|Overall Study|Adverse Event|0
4773190|NCT01542632|16465931|P5|Overall Study|Adverse Event|0
4773191|NCT01542632|16465932|P4|Overall Study|Adverse Event|0
4773192|NCT01542632|16465933|P3|Overall Study|Adverse Event|1
4773193|NCT01542632|16465934|P2|Overall Study|Adverse Event|0
4773194|NCT01542632|16465935|P1|Overall Study|Adverse Event|0
4773195|NCT01542632|16465930|P6|Overall Study|Withdrawal of Consent|0
4773196|NCT01542632|16465931|P5|Overall Study|Withdrawal of Consent|3
4773197|NCT01542632|16465932|P4|Overall Study|Withdrawal of Consent|2
4773198|NCT01542632|16465933|P3|Overall Study|Withdrawal of Consent|0
4773199|NCT01542632|16465934|P2|Overall Study|Withdrawal of Consent|0
4773200|NCT01542632|16465935|P1|Overall Study|Withdrawal of Consent|0
4773201|NCT01542528|16465992|P2|Overall Study|Withdrawal by Subject|6
4773202|NCT01542528|16465993|P1|Overall Study|Withdrawal by Subject|9
4773203|NCT01542528|16465992|P2|Overall Study|Physician Decision|0
4773204|NCT01542528|16465993|P1|Overall Study|Physician Decision|1
4773205|NCT01542528|16465992|P2|Overall Study|Lost to Follow-up|1
4773206|NCT01542528|16465993|P1|Overall Study|Lost to Follow-up|2
4773207|NCT01542034|16466101|P2|Overall Study|Lost to Follow-up|6
4773208|NCT01542034|16466102|P1|Overall Study|Lost to Follow-up|7
4773209|NCT01542034|16466101|P2|Overall Study|Adverse Event|2
4773210|NCT01542034|16466102|P1|Overall Study|Adverse Event|2
4773211|NCT01542034|16466101|P2|Overall Study|Subject Noncompliance|0
4773212|NCT01542034|16466102|P1|Overall Study|Subject Noncompliance|1
4773213|NCT01542034|16466101|P2|Overall Study|Administrative decision|3
4773214|NCT01542034|16466102|P1|Overall Study|Administrative decision|0
4773215|NCT01542034|16466101|P2|Overall Study|Consent Withdrawn (Subject Convenience)|12
4773216|NCT01542034|16466102|P1|Overall Study|Consent Withdrawn (Subject Convenience)|20
4773217|NCT01541969|16466116|P2|Open Label Extension (12-36 Weeks)|Adverse Event|3
4773218|NCT01541969|16466117|P1|Open Label Extension (12-36 Weeks)|Adverse Event|2
4773219|NCT01541969|16466116|P2|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8
4773220|NCT01541969|16466117|P1|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6
4773221|NCT01541969|16466116|P2|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
4773222|NCT01541969|16466117|P1|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1
4773223|NCT01541969|16466116|P2|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0
4773224|NCT01541969|16466117|P1|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1
4773225|NCT01541969|16466116|P2|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
4773226|NCT01541969|16466117|P1|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1
4773227|NCT01541969|16466116|P2|Double-blind (0-12 Weeks)|Adverse Event|0
4773228|NCT01541969|16466117|P1|Double-blind (0-12 Weeks)|Adverse Event|2
4773229|NCT01541969|16466116|P2|Double-blind (0-12 Weeks)|Lost to Follow-up|0
4773230|NCT01541969|16466117|P1|Double-blind (0-12 Weeks)|Lost to Follow-up|1
4773231|NCT01541969|16466116|P2|Double-blind (0-12 Weeks)|Withdrawal by Subject|0
4773232|NCT01541969|16466117|P1|Double-blind (0-12 Weeks)|Withdrawal by Subject|2
4773233|NCT01541969|16466116|P2|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
4773234|NCT01541969|16466117|P1|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1
4773235|NCT01541969|16466116|P2|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1
4773236|NCT01541969|16466117|P1|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0
4773237|NCT01541930|16466133|P1|Overall Study|Withdrawal by Subject|1
4773238|NCT01541917|16466155|P2|Overall Study|Withdrawal by Subject|7
4773239|NCT01541917|16466156|P1|Overall Study|Withdrawal by Subject|13
4773240|NCT01541917|16466155|P2|Overall Study|Lost to Follow-up|2
4773241|NCT01541917|16466156|P1|Overall Study|Lost to Follow-up|2
4773242|NCT01541865|16466185|P1|Overall Study|Protocol Violation|1
4773243|NCT01541865|16466185|P1|Overall Study|Adverse Event|1
4773244|NCT01541865|16466185|P1|Overall Study|Withdrawal by Subject|9
4773245|NCT01541865|16466185|P1|Overall Study|Lost to Follow-up|11
4773246|NCT01541826|16466203|P3|Overall Study|Withdrawal by Subject|0
4773247|NCT01541826|16466204|P2|Overall Study|Withdrawal by Subject|0
4773248|NCT01541826|16466205|P1|Overall Study|Withdrawal by Subject|2
4773249|NCT01541826|16466203|P3|Overall Study|Lost to Follow-up|0
4773250|NCT01541826|16466204|P2|Overall Study|Lost to Follow-up|3
4773251|NCT01541826|16466205|P1|Overall Study|Lost to Follow-up|2
4773252|NCT01541748|16466272|P1|Overall Study|Did not receive study device|1
4773253|NCT01541748|16466272|P1|Overall Study|Screen failure|5
4773254|NCT01541748|16466272|P1|Overall Study|Withdrawal by Subject|7
4773255|NCT01541748|16466272|P1|Overall Study|Moved out of state|1
4773256|NCT01541748|16466272|P1|Overall Study|Lost to Follow-up|17
4773257|NCT01541644|16466308|P1|Overall Study|Withdrawal by Subject|3
4773258|NCT01541397|16466327|P2|Overall Study|Study ended prior to data collection|2
4773259|NCT01541397|16466328|P1|Overall Study|Study ended prior to data collection|4
4773260|NCT01541371|16466353|P1|Overall Study|Other|6
4773261|NCT01541371|16466353|P1|Overall Study|Study medication non-compliance|3
4773262|NCT01541371|16466353|P1|Overall Study|Protocol Violation|6
4773263|NCT01541371|16466353|P1|Overall Study|Lack of Efficacy|12
4773264|NCT01541371|16466353|P1|Overall Study|Adverse Event|15
4773265|NCT01541371|16466353|P1|Overall Study|Lost to Follow-up|21
4773266|NCT01541371|16466353|P1|Overall Study|Withdrawal by Subject|14
4773267|NCT01541254|16466382|P1|Overall Study|alternate stent used|1
4773268|NCT01541254|16466382|P1|Overall Study|stent not required|1
4773269|NCT01541254|16466382|P1|Overall Study|GI bleed prior to procedure|1
4773270|NCT01541254|16466382|P1|Overall Study|enrolled after study closed|1
4773271|NCT01541254|16466382|P1|Overall Study|excluded - metal allergy|1
4773272|NCT01541254|16466382|P1|Overall Study|Withdrawal by Subject|1
4773273|NCT01541215|16466389|P2|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0
4773274|NCT01541215|16466390|P1|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1
4773275|NCT01541215|16466389|P2|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0
4773276|NCT01541215|16466390|P1|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1
4773277|NCT01541215|16466389|P2|Treatment Period (52 Weeks)|Unclassified|3
4773278|NCT01541215|16466390|P1|Treatment Period (52 Weeks)|Unclassified|0
4773279|NCT01541215|16466389|P2|Treatment Period (52 Weeks)|Adverse Event|1
4773280|NCT01541215|16466390|P1|Treatment Period (52 Weeks)|Adverse Event|0
4773281|NCT01541215|16466389|P2|Treatment Period (52 Weeks)|Non-compliance|4
4773282|NCT01541215|16466390|P1|Treatment Period (52 Weeks)|Non-compliance|4
4773283|NCT01541215|16466389|P2|Treatment Period (52 Weeks)|Withdrawal criteria|8
4773284|NCT01541215|16466390|P1|Treatment Period (52 Weeks)|Withdrawal criteria|6
4773285|NCT01540981|16466536|P2|Overall Study|Withdrawal by Subject|0
4773286|NCT01540981|16466537|P1|Overall Study|Withdrawal by Subject|1
4773287|NCT01540851|16466547|P2|Overall Study|Withdrawal by Subject|3
4773288|NCT01540851|16466548|P1|Overall Study|Withdrawal by Subject|7
4773289|NCT01540851|16466547|P2|Overall Study|Lost to Follow-up|15
4773290|NCT01540851|16466548|P1|Overall Study|Lost to Follow-up|14
4773291|NCT01540838|16466560|P2|Overall Study|Not BM. Other treatment|1
4773292|NCT01540838|16466561|P1|Overall Study|Not BM. Other treatment|3
4773293|NCT01540838|16466560|P2|Overall Study|Died before treatment initiation|1
4773294|NCT01540838|16466561|P1|Overall Study|Died before treatment initiation|1
4773295|NCT01540838|16466560|P2|Overall Study|Additional antibiotic treatment|2
4773296|NCT01540838|16466561|P1|Overall Study|Additional antibiotic treatment|1
4773297|NCT01540838|16466560|P2|Overall Study|Treatment doses missing|12
4773298|NCT01540838|16466561|P1|Overall Study|Treatment doses missing|8
4773299|NCT01540838|16466560|P2|Overall Study|Open nasogastric tube|7
4773300|NCT01540838|16466561|P1|Overall Study|Open nasogastric tube|9
4773301|NCT01540565|16466711|P1|Overall Study|Ineligible|2
4773302|NCT01540487|16466730|P2|Overall Study|Protocol Violation|0
4773303|NCT01540487|16466731|P1|Overall Study|Protocol Violation|1
4773304|NCT01539837|16466870|P3|Overall Study|bad compliance|1
4773305|NCT01539837|16466871|P2|Overall Study|bad compliance|0
4773306|NCT01539837|16466872|P1|Overall Study|bad compliance|0
4773307|NCT01539837|16466870|P3|Overall Study|reduce neutrophil level|1
4773308|NCT01539837|16466871|P2|Overall Study|reduce neutrophil level|1
4773309|NCT01539837|16466872|P1|Overall Study|reduce neutrophil level|0
4773310|NCT01539759|16466894|P2|Overall Study|Lost to Follow-up|8
4773311|NCT01539759|16466895|P1|Overall Study|Lost to Follow-up|6
4773312|NCT01539642|16466916|P2|Overall Study|Withdrawal by Subject|2
4773313|NCT01539642|16466917|P1|Overall Study|Withdrawal by Subject|2
4773314|NCT01539642|16466916|P2|Overall Study|Adverse Event|4
4773315|NCT01539642|16466917|P1|Overall Study|Adverse Event|6
4773316|NCT01539642|16466916|P2|Overall Study|Patient ready for early discharge|7
4773317|NCT01539642|16466917|P1|Overall Study|Patient ready for early discharge|8
4773318|NCT01539642|16466916|P2|Overall Study|Lack of Efficacy|18
4773319|NCT01539642|16466917|P1|Overall Study|Lack of Efficacy|20
4773320|NCT01539538|16466934|P2|Overall Study|PCA no longer required or PCA problem|7
4773321|NCT01539538|16466935|P1|Overall Study|PCA no longer required or PCA problem|3
4773322|NCT01539538|16466934|P2|Overall Study|Withdrawal by Subject|3
4773323|NCT01539538|16466935|P1|Overall Study|Withdrawal by Subject|2
4773324|NCT01539538|16466934|P2|Overall Study|Lack of Efficacy|16
4773325|NCT01539538|16466935|P1|Overall Study|Lack of Efficacy|13
4773326|NCT01539538|16466934|P2|Overall Study|Adverse Event|18
4773327|NCT01539538|16466935|P1|Overall Study|Adverse Event|13
4773328|NCT01539525|16466944|P3|Overall Study|Protocol Violation|4
4773329|NCT01539525|16466945|P2|Overall Study|Protocol Violation|1
4773330|NCT01539525|16466946|P1|Overall Study|Protocol Violation|1
4773331|NCT01539525|16466944|P3|Overall Study|Withdrawal by Subject|2
4773332|NCT01539525|16466945|P2|Overall Study|Withdrawal by Subject|3
4773333|NCT01539525|16466946|P1|Overall Study|Withdrawal by Subject|0
4773334|NCT01539525|16466944|P3|Overall Study|Lost to Follow-up|11
4773335|NCT01539525|16466945|P2|Overall Study|Lost to Follow-up|12
4773336|NCT01539525|16466946|P1|Overall Study|Lost to Follow-up|19
4773337|NCT01539512|16466965|P2|Overall Study|Richter's Transformation|0
4773338|NCT01539512|16466966|P1|Overall Study|Richter's Transformation|1
4773339|NCT01539512|16466965|P2|Overall Study|Withdrawal by Subject|5
4773340|NCT01539512|16466966|P1|Overall Study|Withdrawal by Subject|12
4773341|NCT01539512|16466965|P2|Overall Study|Physician Decision|1
4773342|NCT01539512|16466966|P1|Overall Study|Physician Decision|1
4773343|NCT01539512|16466965|P2|Overall Study|Adverse Event|7
4773344|NCT01539512|16466966|P1|Overall Study|Adverse Event|9
4773345|NCT01539317|16466982|P2|Overall Study|Screening Error. Deleted from analysis.|0
4773346|NCT01539317|16466983|P1|Overall Study|Screening Error. Deleted from analysis.|1
4773347|NCT01539291|16467001|P4|Study GS-US-312-0117|Other|1
4773348|NCT01539291|16467002|P3|Study GS-US-312-0117|Other|1
4773349|NCT01539291|16467003|P2|Study GS-US-312-0117|Other|1
4773350|NCT01539291|16467004|P1|Study GS-US-312-0117|Other|2
4773351|NCT01539291|16467001|P4|Study GS-US-312-0117|Study Terminated by Sponsor|5
4773352|NCT01539291|16467002|P3|Study GS-US-312-0117|Study Terminated by Sponsor|0
4773353|NCT01539291|16467003|P2|Study GS-US-312-0117|Study Terminated by Sponsor|0
4773354|NCT01539291|16467004|P1|Study GS-US-312-0117|Study Terminated by Sponsor|3
4773355|NCT01539291|16467001|P4|Study GS-US-312-0117|Withdrawal by Subject|4
4773356|NCT01539291|16467002|P3|Study GS-US-312-0117|Withdrawal by Subject|6
4773357|NCT01539291|16467003|P2|Study GS-US-312-0117|Withdrawal by Subject|0
4773358|NCT01539291|16467004|P1|Study GS-US-312-0117|Withdrawal by Subject|5
4773359|NCT01539291|16467001|P4|Study GS-US-312-0117|Physician Decision|4
4773360|NCT01539291|16467002|P3|Study GS-US-312-0117|Physician Decision|6
4773361|NCT01539291|16467003|P2|Study GS-US-312-0117|Physician Decision|0
4773362|NCT01539291|16467004|P1|Study GS-US-312-0117|Physician Decision|9
4773363|NCT01539291|16467001|P4|Study GS-US-312-0117|Adverse Event|12
4773364|NCT01539291|16467002|P3|Study GS-US-312-0117|Adverse Event|9
4773365|NCT01539291|16467003|P2|Study GS-US-312-0117|Adverse Event|1
4773366|NCT01539291|16467004|P1|Study GS-US-312-0117|Adverse Event|22
4773367|NCT01539291|16467001|P4|Study GS-US-312-0116|Other|0
4773368|NCT01539291|16467002|P3|Study GS-US-312-0116|Other|0
4773369|NCT01539291|16467003|P2|Study GS-US-312-0116|Other|0
4773370|NCT01539291|16467004|P1|Study GS-US-312-0116|Other|1
4773371|NCT01539291|16467001|P4|Study GS-US-312-0116|Study Terminated by Sponsor|0
4773372|NCT01539291|16467002|P3|Study GS-US-312-0116|Study Terminated by Sponsor|0
4773373|NCT01539291|16467003|P2|Study GS-US-312-0116|Study Terminated by Sponsor|0
4773374|NCT01539291|16467004|P1|Study GS-US-312-0116|Study Terminated by Sponsor|2
4773375|NCT01539291|16467001|P4|Study GS-US-312-0116|Withdrawal by Subject|0
4773376|NCT01539291|16467002|P3|Study GS-US-312-0116|Withdrawal by Subject|0
4773377|NCT01539291|16467003|P2|Study GS-US-312-0116|Withdrawal by Subject|0
4773378|NCT01539291|16467004|P1|Study GS-US-312-0116|Withdrawal by Subject|12
4773379|NCT01539291|16467001|P4|Study GS-US-312-0116|Physician Decision|0
4773380|NCT01539291|16467002|P3|Study GS-US-312-0116|Physician Decision|0
4773381|NCT01539291|16467003|P2|Study GS-US-312-0116|Physician Decision|0
4773382|NCT01539291|16467004|P1|Study GS-US-312-0116|Physician Decision|1
4773383|NCT01539291|16467001|P4|Study GS-US-312-0116|Adverse Event|0
4773384|NCT01539291|16467002|P3|Study GS-US-312-0116|Adverse Event|0
4773385|NCT01539291|16467003|P2|Study GS-US-312-0116|Adverse Event|0
4773386|NCT01539291|16467004|P1|Study GS-US-312-0116|Adverse Event|9
4773387|NCT01539239|16467076|P2|Overall Study|Lost to Follow-up|12
4773388|NCT01539239|16467077|P1|Overall Study|Lost to Follow-up|7
4773389|NCT01539239|16467076|P2|Overall Study|Death|5
4773390|NCT01539239|16467077|P1|Overall Study|Death|5
4773391|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Death|11
4773392|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Death|6
4773393|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Death|0
4773394|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Progressive Disease|3
4773395|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Progressive Disease|6
4773396|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Progressive Disease|0
4773397|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Withdrawal by Subject|4
4773398|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Withdrawal by Subject|5
4773399|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Withdrawal by Subject|0
4773400|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Lost to Follow-up|2
4773401|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Lost to Follow-up|2
4773402|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Lost to Follow-up|0
4773403|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Adverse Event|1
4773404|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Adverse Event|1
4773405|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Adverse Event|0
4773406|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Other|1
4773407|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Other|1
4773408|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Other|0
4773409|NCT01539083|16467100|P3|After Randomization (TP and VTP)|Physician Decision|1
4773410|NCT01539083|16467101|P2|After Randomization (TP and VTP)|Physician Decision|0
4773411|NCT01539083|16467102|P1|After Randomization (TP and VTP)|Physician Decision|0
4773412|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Other|0
4773413|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Other|0
4773414|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Other|5
4773415|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Progressive Disease|0
4773416|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Progressive Disease|0
4773417|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Progressive Disease|8
4773418|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Physician Decision|0
4773419|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Physician Decision|0
4773420|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Physician Decision|14
4773421|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Protocol Violation|0
4773422|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Protocol Violation|0
4773423|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Protocol Violation|2
4773424|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Death|0
4773425|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Death|0
4773426|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Death|6
4773427|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Adverse Event|0
4773428|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Adverse Event|0
4773429|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Adverse Event|14
4773430|NCT01539083|16467100|P3|Before Randomization (VCD Induction)|Withdrawal by Subject|0
4773431|NCT01539083|16467101|P2|Before Randomization (VCD Induction)|Withdrawal by Subject|0
4773432|NCT01539083|16467102|P1|Before Randomization (VCD Induction)|Withdrawal by Subject|4
4773433|NCT01538719|16467146|P2|Overall Study|Lost to Follow-up|0
4773434|NCT01538719|16467147|P1|Overall Study|Lost to Follow-up|2
4773435|NCT01538472|16467170|P1|Overall Study|Death|1
4773436|NCT01538472|16467170|P1|Overall Study|Disease Progression|3
4773437|NCT01538199|16467181|P4|Overall Study|Lack of Efficacy|0
4773438|NCT01538199|16467182|P3|Overall Study|Lack of Efficacy|0
4773439|NCT01538199|16467183|P2|Overall Study|Lack of Efficacy|1
4773440|NCT01538199|16467184|P1|Overall Study|Lack of Efficacy|0
4773441|NCT01538199|16467181|P4|Overall Study|participant did not have time|2
4773442|NCT01538199|16467182|P3|Overall Study|participant did not have time|0
4773443|NCT01538199|16467183|P2|Overall Study|participant did not have time|0
4773444|NCT01538199|16467184|P1|Overall Study|participant did not have time|1
4773445|NCT01538199|16467181|P4|Overall Study|Lost to Follow-up|0
4773446|NCT01538199|16467182|P3|Overall Study|Lost to Follow-up|1
4773447|NCT01538199|16467183|P2|Overall Study|Lost to Follow-up|2
4773448|NCT01538199|16467184|P1|Overall Study|Lost to Follow-up|1
4773449|NCT01537887|16467218|P6|Period 3|Withdrawal by Subject|0
4773450|NCT01537887|16467219|P5|Period 3|Withdrawal by Subject|0
4773451|NCT01537887|16467220|P4|Period 3|Withdrawal by Subject|0
4773452|NCT01537887|16467221|P3|Period 3|Withdrawal by Subject|0
4773453|NCT01537887|16467222|P2|Period 3|Withdrawal by Subject|1
4773454|NCT01537887|16467223|P1|Period 3|Withdrawal by Subject|0
4773455|NCT01537887|16467218|P6|Period 3|Adverse Event|0
4773456|NCT01537887|16467219|P5|Period 3|Adverse Event|0
4773457|NCT01537887|16467220|P4|Period 3|Adverse Event|0
4773458|NCT01537887|16467221|P3|Period 3|Adverse Event|1
4773459|NCT01537887|16467222|P2|Period 3|Adverse Event|0
4773460|NCT01537887|16467223|P1|Period 3|Adverse Event|0
4773461|NCT01537887|16467218|P6|Period 2|Withdrawal by Subject|0
4773462|NCT01537887|16467219|P5|Period 2|Withdrawal by Subject|0
4773463|NCT01537887|16467220|P4|Period 2|Withdrawal by Subject|0
4773464|NCT01537887|16467221|P3|Period 2|Withdrawal by Subject|0
4773465|NCT01537887|16467222|P2|Period 2|Withdrawal by Subject|1
4773466|NCT01537887|16467223|P1|Period 2|Withdrawal by Subject|0
4773467|NCT01537887|16467218|P6|Period 1|Did not receive treatment|0
4773468|NCT01537887|16467219|P5|Period 1|Did not receive treatment|0
4773469|NCT01537887|16467220|P4|Period 1|Did not receive treatment|0
4773470|NCT01537887|16467221|P3|Period 1|Did not receive treatment|1
4773471|NCT01537887|16467222|P2|Period 1|Did not receive treatment|0
4773472|NCT01537887|16467223|P1|Period 1|Did not receive treatment|0
4773473|NCT01537887|16467218|P6|Period 1|Physician Decision|1
4773474|NCT01537887|16467219|P5|Period 1|Physician Decision|1
4773475|NCT01537887|16467220|P4|Period 1|Physician Decision|0
4773476|NCT01537887|16467221|P3|Period 1|Physician Decision|0
4773477|NCT01537887|16467222|P2|Period 1|Physician Decision|0
4773478|NCT01537887|16467223|P1|Period 1|Physician Decision|0
4773479|NCT01537783|16467252|P2|Overall Study|Lost to Follow-up|2
4773480|NCT01537783|16467253|P1|Overall Study|Lost to Follow-up|11
4773481|NCT01537549|16467304|P1|Overall Study|Withdrawal by Subject|2
4773482|NCT01537549|16467304|P1|Overall Study|Lost to Follow-up|1
4773483|NCT01537432|16467312|P2|Overall Study|Unsatisfactory therapeutic effect|0
4773484|NCT01537432|16467313|P1|Overall Study|Unsatisfactory therapeutic effect|1
4773485|NCT01537432|16467312|P2|Overall Study|Adverse Event|0
4773486|NCT01537432|16467313|P1|Overall Study|Adverse Event|1
4773487|NCT01537432|16467312|P2|Overall Study|Administrative problems|0
4773488|NCT01537432|16467313|P1|Overall Study|Administrative problems|1
4773489|NCT01537432|16467312|P2|Overall Study|Withdrawal by Subject|1
4773490|NCT01537432|16467313|P1|Overall Study|Withdrawal by Subject|0
4773491|NCT01537432|16467312|P2|Overall Study|Lost to Follow-up|1
4773492|NCT01537432|16467313|P1|Overall Study|Lost to Follow-up|3
4773493|NCT01537393|16467336|P2|Overall Study|Censored (severe event unrelated to PT)|1
4773494|NCT01537393|16467337|P1|Overall Study|Censored (severe event unrelated to PT)|1
4773495|NCT01537393|16467336|P2|Overall Study|Failure - Not regrafted|6
4773496|NCT01537393|16467337|P1|Overall Study|Failure - Not regrafted|2
4773497|NCT01537393|16467336|P2|Overall Study|Failure - Regrafted|43
4773498|NCT01537393|16467337|P1|Overall Study|Failure - Regrafted|28
4773499|NCT01537393|16467336|P2|Overall Study|Lost to Follow-up|48
4773500|NCT01537393|16467337|P1|Overall Study|Lost to Follow-up|53
4773501|NCT01537393|16467336|P2|Overall Study|Withdrawal by Subject|17
4773502|NCT01537393|16467337|P1|Overall Study|Withdrawal by Subject|18
4773503|NCT01537393|16467336|P2|Overall Study|Death|32
4773504|NCT01537393|16467337|P1|Overall Study|Death|20
4773505|NCT01537393|16467336|P2|Overall Study|Exclude prior to study|44
4773506|NCT01537393|16467337|P1|Overall Study|Exclude prior to study|32
4773507|NCT01537302|16467373|P1|Overall Study|Withdrawal by Subject|1
4773508|NCT01537302|16467373|P1|Overall Study|Lost to Follow-up|1
4773509|NCT01537211|16467382|P2|Overall Study|Lost to Follow-up|1
4773510|NCT01537211|16467383|P1|Overall Study|Lost to Follow-up|0
4773511|NCT01537198|16467417|P1|Overall Study|Other|111
4773512|NCT01537198|16467417|P1|Overall Study|No Further Visits to the Clinic|37
4773513|NCT01537198|16467417|P1|Overall Study|Adverse Event|4
4773514|NCT01537198|16467417|P1|Overall Study|RSV infection|2
4773515|NCT01537133|16467446|P4|Overall Study|Lost to Follow-up|0
4773516|NCT01537133|16467447|P3|Overall Study|Lost to Follow-up|0
4773517|NCT01537133|16467448|P2|Overall Study|Lost to Follow-up|0
4773518|NCT01537133|16467449|P1|Overall Study|Lost to Follow-up|1
4773519|NCT01537133|16467446|P4|Overall Study|Withdrawal by Subject|0
4773520|NCT01537133|16467447|P3|Overall Study|Withdrawal by Subject|0
4773521|NCT01537133|16467448|P2|Overall Study|Withdrawal by Subject|0
4773522|NCT01537133|16467449|P1|Overall Study|Withdrawal by Subject|2
4773523|NCT01537120|16467465|P1|3 Weeks Placebo|Withdrawal by Subject|1
4773524|NCT01537120|16467465|P1|8 Weeks Washout|Inclusion/exclusion criteria not met|1
4773525|NCT01537081|16467478|P3|Overall Study|Assigned but never dosed|0
4773526|NCT01537081|16467479|P2|Overall Study|Assigned but never dosed|0
4773527|NCT01537081|16467480|P1|Overall Study|Assigned but never dosed|1
4773528|NCT01537081|16467478|P3|Overall Study|Sponsor decision|0
4773529|NCT01537081|16467479|P2|Overall Study|Sponsor decision|1
4773530|NCT01537081|16467480|P1|Overall Study|Sponsor decision|0
4773531|NCT01537081|16467478|P3|Overall Study|Physician Decision|0
4773532|NCT01537081|16467479|P2|Overall Study|Physician Decision|6
4773533|NCT01537081|16467480|P1|Overall Study|Physician Decision|5
4773534|NCT01537081|16467478|P3|Overall Study|Withdrawal by Subject|3
4773535|NCT01537081|16467479|P2|Overall Study|Withdrawal by Subject|11
4773536|NCT01537081|16467480|P1|Overall Study|Withdrawal by Subject|6
4773537|NCT01537081|16467478|P3|Overall Study|Protocol Violation|2
4773538|NCT01537081|16467479|P2|Overall Study|Protocol Violation|2
4773539|NCT01537081|16467480|P1|Overall Study|Protocol Violation|3
4773540|NCT01537081|16467478|P3|Overall Study|Lost to Follow-up|9
4773541|NCT01537081|16467479|P2|Overall Study|Lost to Follow-up|15
4773542|NCT01537081|16467480|P1|Overall Study|Lost to Follow-up|17
4773543|NCT01537081|16467478|P3|Overall Study|Lack of Efficacy|0
4773544|NCT01537081|16467479|P2|Overall Study|Lack of Efficacy|1
4773545|NCT01537081|16467480|P1|Overall Study|Lack of Efficacy|2
4773546|NCT01537081|16467478|P3|Overall Study|Adverse Event|2
4773547|NCT01537081|16467479|P2|Overall Study|Adverse Event|2
4773548|NCT01537081|16467480|P1|Overall Study|Adverse Event|5
4773549|NCT01537068|16467493|P2|Overall Study|Lack of Efficacy|0
4773550|NCT01537068|16467494|P1|Overall Study|Lack of Efficacy|1
4773551|NCT01537068|16467493|P2|Overall Study|Withdrawal by Subject|1
4773552|NCT01537068|16467494|P1|Overall Study|Withdrawal by Subject|1
4773553|NCT01537068|16467493|P2|Overall Study|Adverse Event|1
4773554|NCT01537068|16467494|P1|Overall Study|Adverse Event|0
4773555|NCT01537068|16467493|P2|Overall Study|Lost to Follow-up|1
4773556|NCT01537068|16467494|P1|Overall Study|Lost to Follow-up|2
4773557|NCT01537042|16467506|P2|Overall Study|Other|1
4773558|NCT01537042|16467507|P1|Overall Study|Other|0
4773559|NCT01537042|16467506|P2|Overall Study|Protocol Violation|1
4773560|NCT01537042|16467507|P1|Overall Study|Protocol Violation|0
4773561|NCT01537042|16467506|P2|Overall Study|Lack of Efficacy|1
4773562|NCT01537042|16467507|P1|Overall Study|Lack of Efficacy|0
4773563|NCT01537042|16467506|P2|Overall Study|Adverse Event|2
4773564|NCT01537042|16467507|P1|Overall Study|Adverse Event|0
4773565|NCT01536951|16467549|P9|Second Intervention and Washout Period 2|Adverse Event|0
4773566|NCT01536951|16467550|P8|Second Intervention and Washout Period 2|Adverse Event|1
4773567|NCT01536951|16467551|P7|Second Intervention and Washout Period 2|Adverse Event|0
4773568|NCT01536951|16467552|P6|Second Intervention and Washout Period 2|Adverse Event|0
4773569|NCT01536951|16467553|P5|Second Intervention and Washout Period 2|Adverse Event|0
4773570|NCT01536951|16467554|P4|Second Intervention and Washout Period 2|Adverse Event|0
4773571|NCT01536951|16467555|P3|Second Intervention and Washout Period 2|Adverse Event|0
4773572|NCT01536951|16467556|P2|Second Intervention and Washout Period 2|Adverse Event|0
4773573|NCT01536951|16467557|P1|Second Intervention and Washout Period 2|Adverse Event|0
4773574|NCT01536951|16467549|P9|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773575|NCT01536951|16467550|P8|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773576|NCT01536951|16467551|P7|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773577|NCT01536951|16467552|P6|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773578|NCT01536951|16467553|P5|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773579|NCT01536951|16467554|P4|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773580|NCT01536951|16467555|P3|First Intervention and Washout Period 1|Withdrawal by Subject|1
4773581|NCT01536951|16467556|P2|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773582|NCT01536951|16467557|P1|First Intervention and Washout Period 1|Withdrawal by Subject|0
4773583|NCT01536860|16467614|P3|Washout Period (3 Days)|Lost to Follow-up|0
4773584|NCT01536860|16467615|P2|Washout Period (3 Days)|Lost to Follow-up|0
4773585|NCT01536860|16467616|P1|Washout Period (3 Days)|Lost to Follow-up|1
4773586|NCT01536704|16467624|P4|Washout Period 3|Adverse Event|0
4773587|NCT01536704|16467625|P3|Washout Period 3|Adverse Event|1
4773588|NCT01536704|16467626|P2|Washout Period 3|Adverse Event|0
4773589|NCT01536704|16467627|P1|Washout Period 3|Adverse Event|0
4773590|NCT01536704|16467624|P4|Period 3|Adverse Event|1
4773591|NCT01536704|16467625|P3|Period 3|Adverse Event|0
4773592|NCT01536704|16467626|P2|Period 3|Adverse Event|0
4773593|NCT01536704|16467627|P1|Period 3|Adverse Event|0
4773594|NCT01536704|16467624|P4|Washout Period 2|Withdrawal by Subject|1
4773595|NCT01536704|16467625|P3|Washout Period 2|Withdrawal by Subject|0
4773596|NCT01536704|16467626|P2|Washout Period 2|Withdrawal by Subject|0
4773597|NCT01536704|16467627|P1|Washout Period 2|Withdrawal by Subject|0
4773598|NCT01536704|16467624|P4|Washout Period 2|Adverse Event|0
4773599|NCT01536704|16467625|P3|Washout Period 2|Adverse Event|0
4773600|NCT01536704|16467626|P2|Washout Period 2|Adverse Event|0
4773601|NCT01536704|16467627|P1|Washout Period 2|Adverse Event|1
4773602|NCT01536704|16467624|P4|Washout Period 1|Withdrawal by Subject|0
4773603|NCT01536704|16467625|P3|Washout Period 1|Withdrawal by Subject|0
4773604|NCT01536704|16467626|P2|Washout Period 1|Withdrawal by Subject|2
4773605|NCT01536704|16467627|P1|Washout Period 1|Withdrawal by Subject|1
4773606|NCT01536587|16467657|P1|Overall Study|Adverse Event|2
4773607|NCT01536574|16467696|P2|Overall Study|Lack of Efficacy|0
4773608|NCT01536574|16467697|P1|Overall Study|Lack of Efficacy|1
4773609|NCT01536574|16467696|P2|Overall Study|Withdrawal by Subject|2
4773610|NCT01536574|16467697|P1|Overall Study|Withdrawal by Subject|1
4773611|NCT01536574|16467696|P2|Overall Study|Adverse Event|5
4773612|NCT01536574|16467697|P1|Overall Study|Adverse Event|4
4773613|NCT01536561|16467715|P1|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13
4773614|NCT01536561|16467715|P1|Dosimetric and Therapeutic Treatment|Death|2
4773615|NCT01536561|16467715|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1
4773616|NCT01536561|16467715|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
4773617|NCT01536561|16467715|P1|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2
4773618|NCT01536561|16467715|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|40
4773619|NCT01536535|16467755|P2|Overall Study|Participant moved|1
4773620|NCT01536535|16467756|P1|Overall Study|Participant moved|0
4773621|NCT01536535|16467755|P2|Overall Study|Physician Decision|1
4773622|NCT01536535|16467756|P1|Overall Study|Physician Decision|1
4773623|NCT01536535|16467755|P2|Overall Study|Lost to Follow-up|6
4773624|NCT01536535|16467756|P1|Overall Study|Lost to Follow-up|4
4773625|NCT01536535|16467755|P2|Overall Study|Withdrawal by Subject|5
4773626|NCT01536535|16467756|P1|Overall Study|Withdrawal by Subject|10
4773627|NCT01536418|16467805|P2|Overall Study|Withdrawal by Subject|3
4773628|NCT01536418|16467806|P1|Overall Study|Withdrawal by Subject|5
4773629|NCT01536418|16467805|P2|Overall Study|Met Liver Chemistry Stopping criteria|0
4773630|NCT01536418|16467806|P1|Overall Study|Met Liver Chemistry Stopping criteria|1
4773631|NCT01536418|16467805|P2|Overall Study|Adverse Event|4
4773632|NCT01536418|16467806|P1|Overall Study|Adverse Event|9
4773633|NCT01536418|16467805|P2|Overall Study|Lack of Efficacy|16
4773634|NCT01536418|16467806|P1|Overall Study|Lack of Efficacy|10
4773635|NCT01536418|16467805|P2|Overall Study|Study closed/terminated|37
4773636|NCT01536418|16467806|P1|Overall Study|Study closed/terminated|41
4773637|NCT01536418|16467805|P2|Overall Study|Physician Decision|3
4773638|NCT01536418|16467806|P1|Overall Study|Physician Decision|1
4773639|NCT01536418|16467805|P2|Overall Study|Protocol Violation|3
4773640|NCT01536418|16467806|P1|Overall Study|Protocol Violation|2
4773641|NCT01536405|16467826|P2|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
4773642|NCT01536405|16467827|P1|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20
4773643|NCT01536405|16467826|P2|Visit 4 to Extended Study Follow-up|Adverse Event|1
4773644|NCT01536405|16467827|P1|Visit 4 to Extended Study Follow-up|Adverse Event|0
4773645|NCT01536405|16467826|P2|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2
4773646|NCT01536405|16467827|P1|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0
4773647|NCT01536405|16467826|P2|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14
4773648|NCT01536405|16467827|P1|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16
4773649|NCT01536405|16467826|P2|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0
4773650|NCT01536405|16467827|P1|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1
4773651|NCT01536405|16467826|P2|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2
4773652|NCT01536405|16467827|P1|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3
4773653|NCT01536405|16467826|P2|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
4773654|NCT01536405|16467827|P1|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2
4773655|NCT01536405|16467826|P2|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10
4773656|NCT01536405|16467827|P1|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9
4773657|NCT01536405|16467826|P2|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
4773658|NCT01536405|16467827|P1|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3
4773659|NCT01536405|16467826|P2|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13
4773660|NCT01536405|16467827|P1|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17
4773661|NCT01536405|16467826|P2|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22
4773662|NCT01536405|16467827|P1|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20
4773663|NCT01536405|16467826|P2|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18
4773664|NCT01536405|16467827|P1|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12
4773665|NCT01536405|16467826|P2|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4
4773666|NCT01536405|16467827|P1|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8
4773667|NCT01536379|16467865|P2|Overall Study|Withdrawal by Subject|1
4773668|NCT01536379|16467866|P1|Overall Study|Withdrawal by Subject|1
4773669|NCT01536379|16467865|P2|Overall Study|Adverse Event|2
4773670|NCT01536379|16467866|P1|Overall Study|Adverse Event|1
4773671|NCT01536262|16467958|P3|Overall Study|Other than stated above|0
4773672|NCT01536262|16467959|P2|Overall Study|Other than stated above|0
4773673|NCT01536262|16467960|P1|Overall Study|Other than stated above|1
4773674|NCT01536262|16467958|P3|Overall Study|Withdrawal by Subject|0
4773675|NCT01536262|16467959|P2|Overall Study|Withdrawal by Subject|1
4773676|NCT01536262|16467960|P1|Overall Study|Withdrawal by Subject|1
4773677|NCT01536262|16467958|P3|Overall Study|Adverse Event|2
4773678|NCT01536262|16467959|P2|Overall Study|Adverse Event|1
4773679|NCT01536262|16467960|P1|Overall Study|Adverse Event|6
4773680|NCT01536171|16468002|P1|Overall Study|Withdrawal by Subject|1
4773681|NCT01536145|16468007|P11|Overall Study|Adverse Event|3
4773682|NCT01536145|16468008|P10|Overall Study|Adverse Event|0
4773683|NCT01536145|16468009|P9|Overall Study|Adverse Event|0
4773684|NCT01536145|16468010|P8|Overall Study|Adverse Event|2
4773685|NCT01536145|16468011|P7|Overall Study|Adverse Event|0
4773686|NCT01536145|16468012|P6|Overall Study|Adverse Event|0
4773687|NCT01536145|16468013|P5|Overall Study|Adverse Event|0
4773688|NCT01536145|16468014|P4|Overall Study|Adverse Event|0
4773689|NCT01536145|16468015|P3|Overall Study|Adverse Event|0
4773690|NCT01536145|16468016|P2|Overall Study|Adverse Event|0
4773691|NCT01536145|16468017|P1|Overall Study|Adverse Event|0
4773692|NCT01536145|16468007|P11|Overall Study|Death|0
4773693|NCT01536145|16468008|P10|Overall Study|Death|0
4773694|NCT01536145|16468009|P9|Overall Study|Death|0
4773695|NCT01536145|16468010|P8|Overall Study|Death|0
4773696|NCT01536145|16468011|P7|Overall Study|Death|1
4773697|NCT01536145|16468012|P6|Overall Study|Death|0
4773698|NCT01536145|16468013|P5|Overall Study|Death|0
4773699|NCT01536145|16468014|P4|Overall Study|Death|0
4773700|NCT01536145|16468015|P3|Overall Study|Death|0
4773701|NCT01536145|16468016|P2|Overall Study|Death|0
4773702|NCT01536145|16468017|P1|Overall Study|Death|0
4773703|NCT01536145|16468007|P11|Overall Study|Other|2
4773704|NCT01536145|16468008|P10|Overall Study|Other|3
4773705|NCT01536145|16468009|P9|Overall Study|Other|0
4773706|NCT01536145|16468010|P8|Overall Study|Other|0
4773707|NCT01536145|16468011|P7|Overall Study|Other|0
4773708|NCT01536145|16468012|P6|Overall Study|Other|0
4773709|NCT01536145|16468013|P5|Overall Study|Other|1
4773710|NCT01536145|16468014|P4|Overall Study|Other|0
4773711|NCT01536145|16468015|P3|Overall Study|Other|0
4773712|NCT01536145|16468016|P2|Overall Study|Other|0
4773713|NCT01536145|16468017|P1|Overall Study|Other|0
4773714|NCT01536145|16468007|P11|Overall Study|Withdrawal by Subject|2
4773715|NCT01536145|16468008|P10|Overall Study|Withdrawal by Subject|0
4773716|NCT01536145|16468009|P9|Overall Study|Withdrawal by Subject|2
4773717|NCT01536145|16468010|P8|Overall Study|Withdrawal by Subject|0
4773718|NCT01536145|16468011|P7|Overall Study|Withdrawal by Subject|0
4773719|NCT01536145|16468012|P6|Overall Study|Withdrawal by Subject|1
4773720|NCT01536145|16468013|P5|Overall Study|Withdrawal by Subject|0
4773721|NCT01536145|16468014|P4|Overall Study|Withdrawal by Subject|0
4773722|NCT01536145|16468015|P3|Overall Study|Withdrawal by Subject|1
4773723|NCT01536145|16468016|P2|Overall Study|Withdrawal by Subject|0
4773724|NCT01536145|16468017|P1|Overall Study|Withdrawal by Subject|0
4773725|NCT01536145|16468007|P11|Overall Study|Progressive disease|3
4773726|NCT01536145|16468008|P10|Overall Study|Progressive disease|3
4773727|NCT01536145|16468009|P9|Overall Study|Progressive disease|1
4773728|NCT01536145|16468010|P8|Overall Study|Progressive disease|2
4773729|NCT01536145|16468011|P7|Overall Study|Progressive disease|1
4773730|NCT01536145|16468012|P6|Overall Study|Progressive disease|2
4773731|NCT01536145|16468013|P5|Overall Study|Progressive disease|1
4773732|NCT01536145|16468014|P4|Overall Study|Progressive disease|2
4773733|NCT01536145|16468015|P3|Overall Study|Progressive disease|1
4773734|NCT01536145|16468016|P2|Overall Study|Progressive disease|4
4773735|NCT01536145|16468017|P1|Overall Study|Progressive disease|3
4773736|NCT01536119|16468124|P2|Overall Study|Lost to Follow-up|14
4773737|NCT01536119|16468125|P1|Overall Study|Lost to Follow-up|17
4773738|NCT01536093|16468151|P2|Overall Study|Withdrawal by Subject|1
4773739|NCT01536093|16468152|P1|Overall Study|Withdrawal by Subject|0
4773740|NCT01536093|16468151|P2|Overall Study|absence of maternal colostrum|0
4773741|NCT01536093|16468152|P1|Overall Study|absence of maternal colostrum|2
4773742|NCT01536093|16468151|P2|Overall Study|Death|2
4773743|NCT01536093|16468152|P1|Overall Study|Death|1
4773744|NCT01536067|16468168|P1|Overall Study|Disease Progression|1
4773745|NCT01536015|16468181|P2|Overall Study|Study closure|5
4773746|NCT01536015|16468182|P1|Overall Study|Study closure|5
4773747|NCT01536015|16468181|P2|Overall Study|Inclusion Criterion not met|0
4773748|NCT01536015|16468182|P1|Overall Study|Inclusion Criterion not met|2
4773749|NCT01536015|16468181|P2|Overall Study|Lost to Follow-up|1
4773750|NCT01536015|16468182|P1|Overall Study|Lost to Follow-up|0
4773751|NCT01536015|16468181|P2|Overall Study|Adverse Event|4
4773752|NCT01536015|16468182|P1|Overall Study|Adverse Event|1
4773753|NCT01535807|16468220|P2|Overall Study|Data collection error|1
4773754|NCT01535807|16468221|P1|Overall Study|Data collection error|1
4773755|NCT01535807|16468220|P2|Overall Study|Withdrawal by Subject|1
4773756|NCT01535807|16468221|P1|Overall Study|Withdrawal by Subject|1
4773757|NCT01535729|16468227|P1|Overall Study|No participant record available|5
4773758|NCT01535729|16468227|P1|Overall Study|Not treated|9
4773759|NCT01535729|16468227|P1|Overall Study|Screening failure|1
4773760|NCT01535729|16468227|P1|Overall Study|Protocol Violation|11
4773761|NCT01535729|16468227|P1|Overall Study|NSCLC grade IV histology not confirmed|20
4773762|NCT01535729|16468227|P1|Overall Study|No previous chemotherapy|33
4773763|NCT01535729|16468227|P1|Overall Study|Did not sign informed consent|1
4773764|NCT01535729|16468227|P1|Overall Study|Other|19
4773765|NCT01535729|16468227|P1|Overall Study|Death|52
4773766|NCT01535729|16468227|P1|Overall Study|Lost to Follow-up|8
4773767|NCT01535729|16468227|P1|Overall Study|Discontinued treatment|25
4773768|NCT01535729|16468227|P1|Overall Study|Disease progression|230
4773769|NCT01535729|16468227|P1|Overall Study|Withdrawal by Subject|2
4773770|NCT01535638|16468268|P6|Treatment 3 (Single Dose)|Protocol Violation|0
4773771|NCT01535638|16468269|P5|Treatment 3 (Single Dose)|Protocol Violation|0
4773772|NCT01535638|16468270|P4|Treatment 3 (Single Dose)|Protocol Violation|1
4773773|NCT01535638|16468271|P3|Treatment 3 (Single Dose)|Protocol Violation|0
4773774|NCT01535638|16468272|P2|Treatment 3 (Single Dose)|Protocol Violation|0
4773775|NCT01535638|16468273|P1|Treatment 3 (Single Dose)|Protocol Violation|0
4773776|NCT01535638|16468268|P6|Treatment 1 (Single Dose)|Protocol Violation|1
4773777|NCT01535638|16468269|P5|Treatment 1 (Single Dose)|Protocol Violation|0
4773778|NCT01535638|16468270|P4|Treatment 1 (Single Dose)|Protocol Violation|0
4773779|NCT01535638|16468271|P3|Treatment 1 (Single Dose)|Protocol Violation|0
4773780|NCT01535638|16468272|P2|Treatment 1 (Single Dose)|Protocol Violation|0
4773781|NCT01535638|16468273|P1|Treatment 1 (Single Dose)|Protocol Violation|0
4773782|NCT01535599|16468287|P2|Overall Study|Noncompliance|1
4773783|NCT01535599|16468288|P1|Overall Study|Noncompliance|0
4773784|NCT01535599|16468287|P2|Overall Study|Stopped medication|1
4773785|NCT01535599|16468288|P1|Overall Study|Stopped medication|0
4773786|NCT01535599|16468287|P2|Overall Study|Other|0
4773787|NCT01535599|16468288|P1|Overall Study|Other|1
4773788|NCT01535599|16468287|P2|Overall Study|Did not use product|0
4773789|NCT01535599|16468288|P1|Overall Study|Did not use product|1
4773790|NCT01535599|16468287|P2|Overall Study|Randomized in Error|4
4773791|NCT01535599|16468288|P1|Overall Study|Randomized in Error|2
4773792|NCT01535599|16468287|P2|Overall Study|BL Culture + for Yeast//Fungi|1
4773793|NCT01535599|16468288|P1|Overall Study|BL Culture + for Yeast//Fungi|0
4773794|NCT01535599|16468287|P2|Overall Study|BL Culture + for Group A Strep|1
4773795|NCT01535599|16468288|P1|Overall Study|BL Culture + for Group A Strep|0
4773796|NCT01535599|16468287|P2|Overall Study|Treatment Failure|66
4773797|NCT01535599|16468288|P1|Overall Study|Treatment Failure|33
4773798|NCT01535599|16468287|P2|Overall Study|Subj Decision Unrelated to Adverse Event|3
4773799|NCT01535599|16468288|P1|Overall Study|Subj Decision Unrelated to Adverse Event|4
4773800|NCT01535599|16468287|P2|Overall Study|Lost to Follow-up|4
4773801|NCT01535599|16468288|P1|Overall Study|Lost to Follow-up|3
4773802|NCT01535599|16468287|P2|Overall Study|Adverse Event|15
4773803|NCT01535599|16468288|P1|Overall Study|Adverse Event|6
4773804|NCT01535560|16468322|P2|Overall Study|Randomized in Error|1
4773805|NCT01535560|16468323|P1|Overall Study|Randomized in Error|0
4773806|NCT01535560|16468322|P2|Overall Study|Other|1
4773807|NCT01535560|16468323|P1|Overall Study|Other|0
4773808|NCT01535560|16468322|P2|Overall Study|Treatment Failure|83
4773809|NCT01535560|16468323|P1|Overall Study|Treatment Failure|21
4773810|NCT01535560|16468322|P2|Overall Study|Subj Decision Unrel to an Adverse Event|1
4773811|NCT01535560|16468323|P1|Overall Study|Subj Decision Unrel to an Adverse Event|3
4773812|NCT01535560|16468322|P2|Overall Study|Lost to Follow-up|3
4773813|NCT01535560|16468323|P1|Overall Study|Lost to Follow-up|1
4773814|NCT01535560|16468322|P2|Overall Study|Adverse Event|7
4773815|NCT01535560|16468323|P1|Overall Study|Adverse Event|12
4773816|NCT01535443|16468333|P1|Overall Study|Physician Decision|3
4773817|NCT01535287|16468383|P2|Overall Study|drug not prepared in time|6
4773818|NCT01535287|16468384|P1|Overall Study|drug not prepared in time|5
4773819|NCT01535261|16468400|P1|Overall Study|Adverse Event|12
4773820|NCT01535261|16468400|P1|Overall Study|Withdrawal by Subject|14
4773821|NCT01535261|16468400|P1|Overall Study|Lost to Follow-up|8
4773822|NCT01535261|16468400|P1|Overall Study|Death|5
4773823|NCT01535261|16468400|P1|Overall Study|Protocol Violation|3
4773824|NCT01535261|16468400|P1|Overall Study|Physician Decision|8
4773825|NCT01535235|16468413|P2|Overall Study|Adverse Event|0
4773826|NCT01535235|16468414|P1|Overall Study|Adverse Event|1
4773827|NCT01535222|16468428|P6|Overall Study|Inclusion/exclusion|0
4773828|NCT01535222|16468429|P5|Overall Study|Inclusion/exclusion|0
4773829|NCT01535222|16468430|P4|Overall Study|Inclusion/exclusion|0
4773830|NCT01535222|16468431|P3|Overall Study|Inclusion/exclusion|1
4773831|NCT01535222|16468432|P2|Overall Study|Inclusion/exclusion|0
4773832|NCT01535222|16468433|P1|Overall Study|Inclusion/exclusion|0
4773833|NCT01535053|16468464|P2|Overall Study|Ineligible|2
4773834|NCT01535053|16468465|P1|Overall Study|Ineligible|1
4773835|NCT01535040|16468483|P2|Overall Study|Multiple Reasons|1
4773836|NCT01535040|16468484|P1|Overall Study|Multiple Reasons|1
4773837|NCT01535040|16468483|P2|Overall Study|Toxicity|5
4773838|NCT01535040|16468484|P1|Overall Study|Toxicity|7
4773839|NCT01535040|16468483|P2|Overall Study|Never Started|4
4773840|NCT01535040|16468484|P1|Overall Study|Never Started|9
4773841|NCT01535040|16468483|P2|Overall Study|Withdrawal by Subject|10
4773842|NCT01535040|16468484|P1|Overall Study|Withdrawal by Subject|13
4773843|NCT01535040|16468483|P2|Overall Study|Physician Decision|1
4773844|NCT01535040|16468484|P1|Overall Study|Physician Decision|0
4773845|NCT01534962|16468581|P4|Overall Study|Discontinued at AF recurrence|31
4773846|NCT01534962|16468582|P3|Overall Study|Discontinued at AF recurrence|24
4773847|NCT01534962|16468583|P2|Overall Study|Discontinued at AF recurrence|26
4773848|NCT01534962|16468584|P1|Overall Study|Discontinued at AF recurrence|35
4773849|NCT01534962|16468581|P4|Overall Study|Randomized but did not start treatment|1
4773850|NCT01534962|16468582|P3|Overall Study|Randomized but did not start treatment|0
4773851|NCT01534962|16468583|P2|Overall Study|Randomized but did not start treatment|0
4773852|NCT01534962|16468584|P1|Overall Study|Randomized but did not start treatment|2
4773853|NCT01534676|16468641|P2|Overall Study|Study closed due to poor enrollment|1
4773854|NCT01534676|16468642|P1|Overall Study|Study closed due to poor enrollment|2
4773855|NCT01534637|16468648|P1|Overall Study|Liver Mets before treatment|1
4773856|NCT01534637|16468648|P1|Overall Study|Adverse Event|1
4773857|NCT01534637|16468648|P1|Overall Study|Withdrawal by Subject|1
4773858|NCT01534637|16468648|P1|Overall Study|Lack of Efficacy|3
4773859|NCT01534637|16468648|P1|Overall Study|Physician Decision|3
4773860|NCT01534533|16468658|P4|Overall Study|Withdrawal by Subject|1
4773861|NCT01534533|16468659|P3|Overall Study|Withdrawal by Subject|4
4773862|NCT01534533|16468660|P2|Overall Study|Withdrawal by Subject|3
4773863|NCT01534533|16468661|P1|Overall Study|Withdrawal by Subject|5
4773864|NCT01534533|16468658|P4|Overall Study|Lost to Follow-up|3
4773865|NCT01534533|16468659|P3|Overall Study|Lost to Follow-up|4
4773866|NCT01534533|16468660|P2|Overall Study|Lost to Follow-up|0
4773867|NCT01534533|16468661|P1|Overall Study|Lost to Follow-up|3
4773868|NCT01534520|16468689|P2|Overall Study|Adverse Event|1
4773869|NCT01534520|16468690|P1|Overall Study|Adverse Event|0
4773870|NCT01534351|16468724|P3|Overall Study|Study Terminated Early|0
4773871|NCT01534351|16468725|P2|Overall Study|Study Terminated Early|0
4773872|NCT01534351|16468726|P1|Overall Study|Study Terminated Early|1
4773873|NCT01534273|16468747|P7|Period 1|Physician Decision|0
4773874|NCT01534273|16468748|P6|Period 1|Physician Decision|0
4773875|NCT01534273|16468749|P5|Period 1|Physician Decision|0
4773876|NCT01534273|16468750|P4|Period 1|Physician Decision|1
4773877|NCT01534273|16468751|P3|Period 1|Physician Decision|0
4773878|NCT01534273|16468752|P2|Period 1|Physician Decision|0
4773879|NCT01534273|16468753|P1|Period 1|Physician Decision|0
4773880|NCT01534260|16468780|P2|Overall Study|No treatment, per protocol|1
4773881|NCT01534260|16468781|P1|Overall Study|No treatment, per protocol|0
4773882|NCT01534260|16468780|P2|Overall Study|Physician Decision|1
4773883|NCT01534260|16468781|P1|Overall Study|Physician Decision|3
4773884|NCT01534260|16468780|P2|Overall Study|Disease Progression|6
4773885|NCT01534260|16468781|P1|Overall Study|Disease Progression|8
4773886|NCT01534260|16468780|P2|Overall Study|Withdrawal by Subject|3
4773887|NCT01534260|16468781|P1|Overall Study|Withdrawal by Subject|1
4773888|NCT01534260|16468780|P2|Overall Study|Lack of Efficacy|1
4773889|NCT01534260|16468781|P1|Overall Study|Lack of Efficacy|1
4773890|NCT01534260|16468780|P2|Overall Study|Death|0
4773891|NCT01534260|16468781|P1|Overall Study|Death|2
4773892|NCT01534260|16468780|P2|Overall Study|Adverse Event|8
4773893|NCT01534260|16468781|P1|Overall Study|Adverse Event|1
4773894|NCT01534208|16468791|P2|Overall Study|Needed prohibited meds|0
4773895|NCT01534208|16468792|P1|Overall Study|Needed prohibited meds|1
4773896|NCT01534208|16468791|P2|Overall Study|PCP decision|0
4773897|NCT01534208|16468792|P1|Overall Study|PCP decision|1
4773898|NCT01534208|16468791|P2|Overall Study|Eligibility error|0
4773899|NCT01534208|16468792|P1|Overall Study|Eligibility error|3
4773900|NCT01534208|16468791|P2|Overall Study|Lab assessment|1
4773901|NCT01534208|16468792|P1|Overall Study|Lab assessment|2
4773902|NCT01534208|16468791|P2|Overall Study|Subject relocation|0
4773903|NCT01534208|16468792|P1|Overall Study|Subject relocation|2
4773904|NCT01534208|16468791|P2|Overall Study|Sponsor decision|1
4773905|NCT01534208|16468792|P1|Overall Study|Sponsor decision|4
4773906|NCT01534208|16468791|P2|Overall Study|Protocol Violation|2
4773907|NCT01534208|16468792|P1|Overall Study|Protocol Violation|2
4773908|NCT01534208|16468791|P2|Overall Study|Lack of Efficacy|3
4773909|NCT01534208|16468792|P1|Overall Study|Lack of Efficacy|0
4773910|NCT01534208|16468791|P2|Overall Study|Physician Decision|0
4773911|NCT01534208|16468792|P1|Overall Study|Physician Decision|2
4773912|NCT01534208|16468791|P2|Overall Study|Adverse Event|8
4773913|NCT01534208|16468792|P1|Overall Study|Adverse Event|15
4773914|NCT01534208|16468791|P2|Overall Study|Withdrawal by Subject|20
4773915|NCT01534208|16468792|P1|Overall Study|Withdrawal by Subject|6
4773916|NCT01534208|16468791|P2|Overall Study|Lost to Follow-up|14
4773917|NCT01534208|16468792|P1|Overall Study|Lost to Follow-up|19
4773918|NCT01534195|16468810|P2|Overall Study|Withdrawal by Subject|1
4773919|NCT01534195|16468811|P1|Overall Study|Withdrawal by Subject|1
4773920|NCT01534182|16468825|P2|Overall Study|Adverse Event|3
4773921|NCT01534182|16468826|P1|Overall Study|Adverse Event|7
4773922|NCT01534182|16468825|P2|Overall Study|Withdrawal by Subject|7
4773923|NCT01534182|16468826|P1|Overall Study|Withdrawal by Subject|4
4773924|NCT01534182|16468825|P2|Overall Study|Administrative problems|0
4773925|NCT01534182|16468826|P1|Overall Study|Administrative problems|1
4773926|NCT01534078|16468857|P1|Overall Study|Withdrawal by Subject|1
4773927|NCT01534078|16468857|P1|Overall Study|Death|1
4773928|NCT01533935|16468885|P5|Overall Study|Other reason not defined above|1
4773929|NCT01533935|16468886|P4|Overall Study|Other reason not defined above|0
4773930|NCT01533935|16468887|P3|Overall Study|Other reason not defined above|1
4773931|NCT01533935|16468888|P2|Overall Study|Other reason not defined above|0
4773932|NCT01533935|16468889|P1|Overall Study|Other reason not defined above|1
4773933|NCT01533935|16468885|P5|Overall Study|Withdrawal by Subject|4
4773934|NCT01533935|16468886|P4|Overall Study|Withdrawal by Subject|2
4773935|NCT01533935|16468887|P3|Overall Study|Withdrawal by Subject|5
4773936|NCT01533935|16468888|P2|Overall Study|Withdrawal by Subject|4
4773937|NCT01533935|16468889|P1|Overall Study|Withdrawal by Subject|0
4773938|NCT01533935|16468885|P5|Overall Study|Lost to Follow-up|0
4773939|NCT01533935|16468886|P4|Overall Study|Lost to Follow-up|0
4773940|NCT01533935|16468887|P3|Overall Study|Lost to Follow-up|1
4773941|NCT01533935|16468888|P2|Overall Study|Lost to Follow-up|0
4773942|NCT01533935|16468889|P1|Overall Study|Lost to Follow-up|0
4773943|NCT01533935|16468885|P5|Overall Study|Protocol Violation|0
4773944|NCT01533935|16468886|P4|Overall Study|Protocol Violation|0
4773945|NCT01533935|16468887|P3|Overall Study|Protocol Violation|0
4773946|NCT01533935|16468888|P2|Overall Study|Protocol Violation|2
4773947|NCT01533935|16468889|P1|Overall Study|Protocol Violation|0
4773948|NCT01533935|16468885|P5|Overall Study|Adverse Event|3
4773949|NCT01533935|16468886|P4|Overall Study|Adverse Event|5
4773950|NCT01533935|16468887|P3|Overall Study|Adverse Event|1
4773951|NCT01533935|16468888|P2|Overall Study|Adverse Event|7
4773952|NCT01533935|16468889|P1|Overall Study|Adverse Event|5
4773953|NCT01533922|16468916|P5|Overall Study|Other reason not defined above|0
4773954|NCT01533922|16468917|P4|Overall Study|Other reason not defined above|0
4773955|NCT01533922|16468918|P3|Overall Study|Other reason not defined above|1
4773956|NCT01533922|16468919|P2|Overall Study|Other reason not defined above|0
4773957|NCT01533922|16468920|P1|Overall Study|Other reason not defined above|2
4773958|NCT01533922|16468916|P5|Overall Study|Withdrawal by Subject|1
4773959|NCT01533922|16468917|P4|Overall Study|Withdrawal by Subject|2
4773960|NCT01533922|16468918|P3|Overall Study|Withdrawal by Subject|2
4773961|NCT01533922|16468919|P2|Overall Study|Withdrawal by Subject|1
4773962|NCT01533922|16468920|P1|Overall Study|Withdrawal by Subject|3
4773963|NCT01533922|16468916|P5|Overall Study|Protocol Violation|1
4773964|NCT01533922|16468917|P4|Overall Study|Protocol Violation|0
4773965|NCT01533922|16468918|P3|Overall Study|Protocol Violation|0
4773966|NCT01533922|16468919|P2|Overall Study|Protocol Violation|3
4773967|NCT01533922|16468920|P1|Overall Study|Protocol Violation|0
4773968|NCT01533922|16468916|P5|Overall Study|Lack of Efficacy|0
4773969|NCT01533922|16468917|P4|Overall Study|Lack of Efficacy|0
4773970|NCT01533922|16468918|P3|Overall Study|Lack of Efficacy|1
4773971|NCT01533922|16468919|P2|Overall Study|Lack of Efficacy|0
4773972|NCT01533922|16468920|P1|Overall Study|Lack of Efficacy|0
4773973|NCT01533922|16468916|P5|Overall Study|Adverse Event|4
4773974|NCT01533922|16468917|P4|Overall Study|Adverse Event|3
4773975|NCT01533922|16468918|P3|Overall Study|Adverse Event|6
4773976|NCT01533922|16468919|P2|Overall Study|Adverse Event|8
4773977|NCT01533922|16468920|P1|Overall Study|Adverse Event|5
4773978|NCT01533688|16468965|P3|Overall Study|Had colonoscopy at outside hospital|2
4773979|NCT01533688|16468966|P2|Overall Study|Had colonoscopy at outside hospital|3
4773980|NCT01533688|16468967|P1|Overall Study|Had colonoscopy at outside hospital|2
4773981|NCT01533688|16468965|P3|Overall Study|Medically unstable|3
4773982|NCT01533688|16468966|P2|Overall Study|Medically unstable|3
4773983|NCT01533688|16468967|P1|Overall Study|Medically unstable|1
4773984|NCT01533688|16468965|P3|Overall Study|Withdrawal by Subject|3
4773985|NCT01533688|16468966|P2|Overall Study|Withdrawal by Subject|4
4773986|NCT01533688|16468967|P1|Overall Study|Withdrawal by Subject|5
4773987|NCT01533493|16468999|P2|Overall Study|Lost to Follow-up|0
4773988|NCT01533493|16469000|P1|Overall Study|Lost to Follow-up|2
4773989|NCT01533493|16468999|P2|Overall Study|Withdrawal by Subject|2
4773990|NCT01533493|16469000|P1|Overall Study|Withdrawal by Subject|1
4773991|NCT01533493|16468999|P2|Overall Study|Adverse Event|1
4773992|NCT01533493|16469000|P1|Overall Study|Adverse Event|2
4773993|NCT01533428|16469008|P2|Overall Study|Withdrawal by Subject|6
4773994|NCT01533428|16469009|P1|Overall Study|Withdrawal by Subject|7
4773995|NCT01533428|16469008|P2|Overall Study|Lost to Follow-up|1
4773996|NCT01533428|16469009|P1|Overall Study|Lost to Follow-up|2
4773997|NCT01533428|16469008|P2|Overall Study|Adverse Event|1
4773998|NCT01533428|16469009|P1|Overall Study|Adverse Event|0
4773999|NCT01533246|16469055|P1|Overall Study|Withdrawal by Subject|1
4774000|NCT01533246|16469055|P1|Overall Study|Adverse Event|1
4774001|NCT01533181|16469079|P2|Overall Study|Patient withdrawal pre-active treatment|0
4774002|NCT01533181|16469080|P1|Overall Study|Patient withdrawal pre-active treatment|1
4774003|NCT01533181|16469079|P2|Overall Study|Disease progression pre-active treatment|1
4774004|NCT01533181|16469080|P1|Overall Study|Disease progression pre-active treatment|0
4774005|NCT01532999|16469197|P2|Overall Study|New job|2
4774006|NCT01532999|16469198|P1|Overall Study|New job|0
4774007|NCT01532999|16469197|P2|Overall Study|incarcerated|1
4774008|NCT01532999|16469198|P1|Overall Study|incarcerated|0
4774009|NCT01532999|16469197|P2|Overall Study|Adverse Event|1
4774010|NCT01532999|16469198|P1|Overall Study|Adverse Event|0
4774011|NCT01532999|16469197|P2|Overall Study|no show for week 9 assessments|4
4774012|NCT01532999|16469198|P1|Overall Study|no show for week 9 assessments|6
4774013|NCT01532999|16469197|P2|Overall Study|substantial noncompliance|0
4774014|NCT01532999|16469198|P1|Overall Study|substantial noncompliance|2
4774015|NCT01532999|16469197|P2|Overall Study|should not have been randomized|0
4774016|NCT01532999|16469198|P1|Overall Study|should not have been randomized|1
4774017|NCT01532999|16469197|P2|Overall Study|Relocated|0
4774018|NCT01532999|16469198|P1|Overall Study|Relocated|2
4774019|NCT01532999|16469197|P2|Overall Study|Withdrawal by Subject|0
4774020|NCT01532999|16469198|P1|Overall Study|Withdrawal by Subject|5
4774021|NCT01532999|16469197|P2|Overall Study|Physician Decision|2
4774022|NCT01532999|16469198|P1|Overall Study|Physician Decision|1
4774023|NCT01532999|16469197|P2|Overall Study|Lost to Follow-up|8
4774024|NCT01532999|16469198|P1|Overall Study|Lost to Follow-up|14
4774025|NCT01532986|16469222|P2|Overall Study|Physician Decision|5
4774026|NCT01532986|16469223|P1|Overall Study|Physician Decision|7
4774027|NCT01532986|16469222|P2|Overall Study|Withdrawal by Subject|10
4774028|NCT01532986|16469223|P1|Overall Study|Withdrawal by Subject|7
4774029|NCT01532986|16469222|P2|Overall Study|Death|9
4774030|NCT01532986|16469223|P1|Overall Study|Death|9
4774031|NCT01532934|16469307|P2|Overall Study|In controlled environment|2
4774032|NCT01532934|16469308|P1|Overall Study|In controlled environment|3
4774033|NCT01532934|16469307|P2|Overall Study|Lost to Follow-up|11
4774034|NCT01532934|16469308|P1|Overall Study|Lost to Follow-up|11
4774035|NCT01532921|16469318|P1|Overall Study|Device was explanted during procedure|1
4774036|NCT01532921|16469318|P1|Overall Study|Physician Decision|7
4774037|NCT01532921|16469318|P1|Overall Study|Lost to Follow-up|3
4774038|NCT01532921|16469318|P1|Overall Study|Withdrawal by Subject|2
4774039|NCT01532921|16469318|P1|Overall Study|Death|3
4774040|NCT01532869|16469340|P2|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
4774041|NCT01532869|16469341|P1|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1
4774042|NCT01532869|16469340|P2|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
4774043|NCT01532869|16469341|P1|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1
4774044|NCT01532869|16469340|P2|Open-label Period (Week 48 to Week 96)|Non-compliance|0
4774045|NCT01532869|16469341|P1|Open-label Period (Week 48 to Week 96)|Non-compliance|1
4774046|NCT01532869|16469340|P2|Open-label Period (Week 48 to Week 96)|Adverse Event|1
4774047|NCT01532869|16469341|P1|Open-label Period (Week 48 to Week 96)|Adverse Event|4
4774048|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0
4774133|NCT01531673|16469641|P13|Overall Study|Lost to Follow-up|0
4774049|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1
4774050|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3
4774051|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5
4774052|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1
4774053|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0
4774054|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0
4774055|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1
4774056|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1
4774057|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0
4774058|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5
4774059|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4
4774060|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 48)|Death|3
4774061|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 48)|Death|0
4774062|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2
4774063|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4
4774064|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
4774065|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1
4774066|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0
4774067|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1
4774068|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1
4774069|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0
4774070|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3
4774071|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2
4774072|NCT01532869|16469340|P2|Blinded-Treatment Period (Up to Week 24)|Death|1
4774073|NCT01532869|16469341|P1|Blinded-Treatment Period (Up to Week 24)|Death|0
4774074|NCT01532648|16469400|P2|Overall Study|Withdrawal by Subject|2
4774075|NCT01532648|16469401|P1|Overall Study|Withdrawal by Subject|16
4774076|NCT01532648|16469400|P2|Overall Study|Adverse Event|9
4774077|NCT01532648|16469401|P1|Overall Study|Adverse Event|12
4774078|NCT01532648|16469400|P2|Overall Study|Protocol Violation|1
4774079|NCT01532648|16469401|P1|Overall Study|Protocol Violation|1
4774080|NCT01532648|16469400|P2|Overall Study|Lack of Efficacy|1
4774081|NCT01532648|16469401|P1|Overall Study|Lack of Efficacy|4
4774082|NCT01532648|16469400|P2|Overall Study|Lost to Follow-up|4
4774083|NCT01532648|16469401|P1|Overall Study|Lost to Follow-up|3
4774084|NCT01532570|16469435|P4|Overall Study|Withdrawal by Subject|0
4774085|NCT01532570|16469436|P3|Overall Study|Withdrawal by Subject|0
4774086|NCT01532570|16469437|P2|Overall Study|Withdrawal by Subject|1
4774087|NCT01532570|16469438|P1|Overall Study|Withdrawal by Subject|0
4774088|NCT01532570|16469435|P4|Overall Study|Lack of Efficacy|0
4774089|NCT01532570|16469436|P3|Overall Study|Lack of Efficacy|0
4774090|NCT01532570|16469437|P2|Overall Study|Lack of Efficacy|0
4774091|NCT01532570|16469438|P1|Overall Study|Lack of Efficacy|1
4774092|NCT01532414|16469483|P3|Overall Study|Withdrawn by sponsor|0
4774093|NCT01532414|16469484|P2|Overall Study|Withdrawn by sponsor|0
4774094|NCT01532414|16469485|P1|Overall Study|Withdrawn by sponsor|1
4774095|NCT01532414|16469483|P3|Overall Study|Unable to complete 24 hour PK|1
4774096|NCT01532414|16469484|P2|Overall Study|Unable to complete 24 hour PK|0
4774097|NCT01532414|16469485|P1|Overall Study|Unable to complete 24 hour PK|0
4774098|NCT01532414|16469483|P3|Overall Study|Adverse Event|1
4774099|NCT01532414|16469484|P2|Overall Study|Adverse Event|1
4774100|NCT01532414|16469485|P1|Overall Study|Adverse Event|0
4774101|NCT01532414|16469483|P3|Overall Study|No V6 semen sample|0
4774102|NCT01532414|16469484|P2|Overall Study|No V6 semen sample|1
4774103|NCT01532414|16469485|P1|Overall Study|No V6 semen sample|0
4774104|NCT01532414|16469483|P3|Overall Study|Withdrawal by Subject|0
4774105|NCT01532414|16469484|P2|Overall Study|Withdrawal by Subject|0
4774106|NCT01532414|16469485|P1|Overall Study|Withdrawal by Subject|3
4774107|NCT01532414|16469483|P3|Overall Study|Lost to Follow-up|1
4774108|NCT01532414|16469484|P2|Overall Study|Lost to Follow-up|0
4774109|NCT01532414|16469485|P1|Overall Study|Lost to Follow-up|3
4774110|NCT01532388|16469495|P2|12-month Follow-up|Lost to Follow-up|67
4774111|NCT01532388|16469496|P1|12-month Follow-up|Lost to Follow-up|69
4774112|NCT01532388|16469495|P2|6-month Follow-up|Lost to Follow-up|66
4774113|NCT01532388|16469496|P1|6-month Follow-up|Lost to Follow-up|74
4774114|NCT01532388|16469495|P2|3-month Follow-up|Lost to Follow-up|68
4774115|NCT01532388|16469496|P1|3-month Follow-up|Lost to Follow-up|68
4774116|NCT01531998|16469601|P1|Overall Study|Withdrawal by Subject|3
4774117|NCT01531894|16469606|P1|Overall Study|Death|1
4774118|NCT01531894|16469606|P1|Overall Study|Physician Decision|8
4774119|NCT01531725|16469623|P1|Overall Study|Protocol Violation|5
4774120|NCT01531673|16469641|P13|Overall Study|Other|0
4774121|NCT01531673|16469642|P12|Overall Study|Other|0
4774122|NCT01531673|16469643|P11|Overall Study|Other|0
4774123|NCT01531673|16469644|P10|Overall Study|Other|1
4774124|NCT01531673|16469645|P9|Overall Study|Other|0
4774125|NCT01531673|16469646|P8|Overall Study|Other|0
4774126|NCT01531673|16469647|P7|Overall Study|Other|0
4774127|NCT01531673|16469648|P6|Overall Study|Other|0
4774128|NCT01531673|16469649|P5|Overall Study|Other|0
4774129|NCT01531673|16469650|P4|Overall Study|Other|1
4774130|NCT01531673|16469651|P3|Overall Study|Other|0
4774131|NCT01531673|16469652|P2|Overall Study|Other|0
4774132|NCT01531673|16469653|P1|Overall Study|Other|0
4774134|NCT01531673|16469642|P12|Overall Study|Lost to Follow-up|0
4774135|NCT01531673|16469643|P11|Overall Study|Lost to Follow-up|0
4774136|NCT01531673|16469644|P10|Overall Study|Lost to Follow-up|0
4774137|NCT01531673|16469645|P9|Overall Study|Lost to Follow-up|0
4774138|NCT01531673|16469646|P8|Overall Study|Lost to Follow-up|0
4774139|NCT01531673|16469647|P7|Overall Study|Lost to Follow-up|0
4774140|NCT01531673|16469648|P6|Overall Study|Lost to Follow-up|0
4774141|NCT01531673|16469649|P5|Overall Study|Lost to Follow-up|1
4774142|NCT01531673|16469650|P4|Overall Study|Lost to Follow-up|0
4774143|NCT01531673|16469651|P3|Overall Study|Lost to Follow-up|0
4774144|NCT01531673|16469652|P2|Overall Study|Lost to Follow-up|0
4774145|NCT01531673|16469653|P1|Overall Study|Lost to Follow-up|0
4774146|NCT01531673|16469641|P13|Overall Study|Adverse Event|0
4774147|NCT01531673|16469642|P12|Overall Study|Adverse Event|0
4774148|NCT01531673|16469643|P11|Overall Study|Adverse Event|0
4774149|NCT01531673|16469644|P10|Overall Study|Adverse Event|0
4774150|NCT01531673|16469645|P9|Overall Study|Adverse Event|0
4774151|NCT01531673|16469646|P8|Overall Study|Adverse Event|0
4774152|NCT01531673|16469647|P7|Overall Study|Adverse Event|0
4774153|NCT01531673|16469648|P6|Overall Study|Adverse Event|0
4774154|NCT01531673|16469649|P5|Overall Study|Adverse Event|0
4774155|NCT01531673|16469650|P4|Overall Study|Adverse Event|0
4774156|NCT01531673|16469651|P3|Overall Study|Adverse Event|0
4774157|NCT01531673|16469652|P2|Overall Study|Adverse Event|1
4774158|NCT01531673|16469653|P1|Overall Study|Adverse Event|0
4774159|NCT01531673|16469641|P13|Overall Study|Non-Compliance|0
4774160|NCT01531673|16469642|P12|Overall Study|Non-Compliance|0
4774161|NCT01531673|16469643|P11|Overall Study|Non-Compliance|0
4774162|NCT01531673|16469644|P10|Overall Study|Non-Compliance|0
4774163|NCT01531673|16469645|P9|Overall Study|Non-Compliance|0
4774164|NCT01531673|16469646|P8|Overall Study|Non-Compliance|0
4774165|NCT01531673|16469647|P7|Overall Study|Non-Compliance|0
4774166|NCT01531673|16469648|P6|Overall Study|Non-Compliance|1
4774167|NCT01531673|16469649|P5|Overall Study|Non-Compliance|0
4774168|NCT01531673|16469650|P4|Overall Study|Non-Compliance|0
4774169|NCT01531673|16469651|P3|Overall Study|Non-Compliance|0
4774170|NCT01531673|16469652|P2|Overall Study|Non-Compliance|0
4774171|NCT01531673|16469653|P1|Overall Study|Non-Compliance|0
4774172|NCT01531387|16469779|P2|Overall Study|Early termination of study|11
4774173|NCT01531387|16469780|P1|Overall Study|Early termination of study|11
4774174|NCT01531205|16469872|P1|Overall Study|Did not proceed to surgery|1
4774175|NCT01531153|16469884|P3|Overall Study|Withdrawal by Subject|15
4774176|NCT01531153|16469885|P2|Overall Study|Withdrawal by Subject|9
4774177|NCT01531153|16469886|P1|Overall Study|Withdrawal by Subject|10
4774178|NCT01530997|16469942|P1|Overall Study|Withdrawal by Subject|1
4774179|NCT01530997|16469942|P1|Overall Study|Physician Decision|1
4774180|NCT01530464|16469986|P2|Washout (24h)|Withdrawal by Subject|1
4774181|NCT01530464|16469987|P1|Washout (24h)|Withdrawal by Subject|0
4774182|NCT01530464|16469986|P2|Washout (24h)|Withdrawal by Subject|0
4774183|NCT01530464|16469987|P1|Washout (24h)|Withdrawal by Subject|1
4774184|NCT01530334|16470039|P1|Overall Study|Progressive disease|47
4774185|NCT01530334|16470039|P1|Overall Study|unknown reason|1
4774186|NCT01530334|16470039|P1|Overall Study|Adverse Event|3
4774187|NCT01530087|16470086|P1|Overall Study|Physician Decision|2
4774188|NCT01529749|16470102|P4|Overall Study|Protocol Violation|1
4774189|NCT01529749|16470103|P3|Overall Study|Protocol Violation|0
4774190|NCT01529749|16470104|P2|Overall Study|Protocol Violation|0
4774191|NCT01529749|16470105|P1|Overall Study|Protocol Violation|0
4774192|NCT01529749|16470102|P4|Overall Study|Withdrawal by Subject|0
4774193|NCT01529749|16470103|P3|Overall Study|Withdrawal by Subject|1
4774194|NCT01529749|16470104|P2|Overall Study|Withdrawal by Subject|1
4774195|NCT01529749|16470105|P1|Overall Study|Withdrawal by Subject|0
4774196|NCT01529749|16470102|P4|Overall Study|Physician Decision|1
4774197|NCT01529749|16470103|P3|Overall Study|Physician Decision|0
4774198|NCT01529749|16470104|P2|Overall Study|Physician Decision|0
4774199|NCT01529749|16470105|P1|Overall Study|Physician Decision|0
4774200|NCT01529749|16470102|P4|Overall Study|Lost to Follow-up|0
4774201|NCT01529749|16470103|P3|Overall Study|Lost to Follow-up|1
4774202|NCT01529749|16470104|P2|Overall Study|Lost to Follow-up|1
4774203|NCT01529749|16470105|P1|Overall Study|Lost to Follow-up|0
4774204|NCT01529645|16470189|P10|Overall Study|Withdrawal by Subject|0
4774205|NCT01529645|16470190|P9|Overall Study|Withdrawal by Subject|0
4774206|NCT01529645|16470191|P8|Overall Study|Withdrawal by Subject|0
4774207|NCT01529645|16470192|P7|Overall Study|Withdrawal by Subject|0
4774208|NCT01529645|16470193|P6|Overall Study|Withdrawal by Subject|1
4774209|NCT01529645|16470194|P5|Overall Study|Withdrawal by Subject|1
4774210|NCT01529645|16470195|P4|Overall Study|Withdrawal by Subject|1
4774211|NCT01529645|16470196|P3|Overall Study|Withdrawal by Subject|0
4774212|NCT01529645|16470197|P2|Overall Study|Withdrawal by Subject|0
4774213|NCT01529645|16470198|P1|Overall Study|Withdrawal by Subject|2
4774214|NCT01529645|16470189|P10|Overall Study|SAE - Premature contractions|0
4774215|NCT01529645|16470190|P9|Overall Study|SAE - Premature contractions|0
4774216|NCT01529645|16470191|P8|Overall Study|SAE - Premature contractions|0
4774217|NCT01529645|16470192|P7|Overall Study|SAE - Premature contractions|0
4774218|NCT01529645|16470193|P6|Overall Study|SAE - Premature contractions|0
4774219|NCT01529645|16470194|P5|Overall Study|SAE - Premature contractions|0
4774220|NCT01529645|16470195|P4|Overall Study|SAE - Premature contractions|0
4774221|NCT01529645|16470196|P3|Overall Study|SAE - Premature contractions|1
4774222|NCT01529645|16470197|P2|Overall Study|SAE - Premature contractions|0
4774223|NCT01529645|16470198|P1|Overall Study|SAE - Premature contractions|0
4774224|NCT01529645|16470189|P10|Overall Study|Lost to Follow-up|0
4774225|NCT01529645|16470190|P9|Overall Study|Lost to Follow-up|1
4774226|NCT01529645|16470191|P8|Overall Study|Lost to Follow-up|0
4774227|NCT01529645|16470192|P7|Overall Study|Lost to Follow-up|2
4774228|NCT01529645|16470193|P6|Overall Study|Lost to Follow-up|0
4774229|NCT01529645|16470194|P5|Overall Study|Lost to Follow-up|1
4774230|NCT01529645|16470195|P4|Overall Study|Lost to Follow-up|1
4774231|NCT01529645|16470196|P3|Overall Study|Lost to Follow-up|1
4774232|NCT01529645|16470197|P2|Overall Study|Lost to Follow-up|1
4774233|NCT01529645|16470198|P1|Overall Study|Lost to Follow-up|0
4774234|NCT01529632|16470296|P2|Overall Study|Adverse Event|1
4774235|NCT01529632|16470297|P1|Overall Study|Adverse Event|1
4774236|NCT01529632|16470296|P2|Overall Study|Protocol Violation|1
4774237|NCT01529632|16470297|P1|Overall Study|Protocol Violation|0
4774238|NCT01529632|16470296|P2|Overall Study|Administrative problem|1
4774239|NCT01529632|16470297|P1|Overall Study|Administrative problem|2
4774240|NCT01529606|16470317|P2|Overall Study|Lost to Follow-up|18
4774241|NCT01529606|16470318|P1|Overall Study|Lost to Follow-up|21
4774242|NCT01529515|16470330|P4|DOUBLE BLIND PHASE|Other|2
4774243|NCT01529515|16470331|P3|DOUBLE BLIND PHASE|Other|9
4774244|NCT01529515|16470332|P2|DOUBLE BLIND PHASE|Other|0
4774245|NCT01529515|16470333|P1|DOUBLE BLIND PHASE|Other|0
4774246|NCT01529515|16470330|P4|DOUBLE BLIND PHASE|Protocol Violation|0
4774247|NCT01529515|16470331|P3|DOUBLE BLIND PHASE|Protocol Violation|1
4774248|NCT01529515|16470332|P2|DOUBLE BLIND PHASE|Protocol Violation|0
4774249|NCT01529515|16470333|P1|DOUBLE BLIND PHASE|Protocol Violation|0
4774250|NCT01529515|16470330|P4|DOUBLE BLIND PHASE|Withdrawal by Subject|7
4774251|NCT01529515|16470331|P3|DOUBLE BLIND PHASE|Withdrawal by Subject|10
4774252|NCT01529515|16470332|P2|DOUBLE BLIND PHASE|Withdrawal by Subject|0
4774253|NCT01529515|16470333|P1|DOUBLE BLIND PHASE|Withdrawal by Subject|0
4774254|NCT01529515|16470330|P4|DOUBLE BLIND PHASE|Pregnancy|0
4774255|NCT01529515|16470331|P3|DOUBLE BLIND PHASE|Pregnancy|1
4774256|NCT01529515|16470332|P2|DOUBLE BLIND PHASE|Pregnancy|0
4774257|NCT01529515|16470333|P1|DOUBLE BLIND PHASE|Pregnancy|0
4774258|NCT01529515|16470330|P4|DOUBLE BLIND PHASE|Lost to Follow-up|3
4774259|NCT01529515|16470331|P3|DOUBLE BLIND PHASE|Lost to Follow-up|1
4774260|NCT01529515|16470332|P2|DOUBLE BLIND PHASE|Lost to Follow-up|0
4774261|NCT01529515|16470333|P1|DOUBLE BLIND PHASE|Lost to Follow-up|0
4774262|NCT01529515|16470330|P4|DOUBLE BLIND PHASE|Adverse Event|0
4774263|NCT01529515|16470331|P3|DOUBLE BLIND PHASE|Adverse Event|1
4774264|NCT01529515|16470332|P2|DOUBLE BLIND PHASE|Adverse Event|0
4774265|NCT01529515|16470333|P1|DOUBLE BLIND PHASE|Adverse Event|0
4774266|NCT01529515|16470330|P4|MAINTENANCE PHASE|Other|0
4774267|NCT01529515|16470331|P3|MAINTENANCE PHASE|Other|0
4774268|NCT01529515|16470332|P2|MAINTENANCE PHASE|Other|10
4774269|NCT01529515|16470333|P1|MAINTENANCE PHASE|Other|0
4774270|NCT01529515|16470330|P4|MAINTENANCE PHASE|Failed Randomization Criteria|0
4774271|NCT01529515|16470331|P3|MAINTENANCE PHASE|Failed Randomization Criteria|0
4774272|NCT01529515|16470332|P2|MAINTENANCE PHASE|Failed Randomization Criteria|13
4774273|NCT01529515|16470333|P1|MAINTENANCE PHASE|Failed Randomization Criteria|0
4774274|NCT01529515|16470330|P4|MAINTENANCE PHASE|Withdrawal by Subject|0
4774275|NCT01529515|16470331|P3|MAINTENANCE PHASE|Withdrawal by Subject|0
4774276|NCT01529515|16470332|P2|MAINTENANCE PHASE|Withdrawal by Subject|15
4774277|NCT01529515|16470333|P1|MAINTENANCE PHASE|Withdrawal by Subject|0
4774278|NCT01529515|16470330|P4|MAINTENANCE PHASE|Protocol Violation|0
4774279|NCT01529515|16470331|P3|MAINTENANCE PHASE|Protocol Violation|0
4774280|NCT01529515|16470332|P2|MAINTENANCE PHASE|Protocol Violation|12
4774281|NCT01529515|16470333|P1|MAINTENANCE PHASE|Protocol Violation|0
4774282|NCT01529515|16470330|P4|MAINTENANCE PHASE|Lost to Follow-up|0
4774283|NCT01529515|16470331|P3|MAINTENANCE PHASE|Lost to Follow-up|0
4774284|NCT01529515|16470332|P2|MAINTENANCE PHASE|Lost to Follow-up|5
4774285|NCT01529515|16470333|P1|MAINTENANCE PHASE|Lost to Follow-up|0
4774286|NCT01529515|16470330|P4|MAINTENANCE PHASE|Lack of Efficacy|0
4774287|NCT01529515|16470331|P3|MAINTENANCE PHASE|Lack of Efficacy|0
4774288|NCT01529515|16470332|P2|MAINTENANCE PHASE|Lack of Efficacy|9
4774289|NCT01529515|16470333|P1|MAINTENANCE PHASE|Lack of Efficacy|0
4774290|NCT01529515|16470330|P4|MAINTENANCE PHASE|Adverse Event|0
4774291|NCT01529515|16470331|P3|MAINTENANCE PHASE|Adverse Event|0
4774292|NCT01529515|16470332|P2|MAINTENANCE PHASE|Adverse Event|10
4774293|NCT01529515|16470333|P1|MAINTENANCE PHASE|Adverse Event|0
4774294|NCT01529515|16470330|P4|TRANSITION PHASE|Other|0
4774295|NCT01529515|16470331|P3|TRANSITION PHASE|Other|0
4774296|NCT01529515|16470332|P2|TRANSITION PHASE|Other|0
4774297|NCT01529515|16470333|P1|TRANSITION PHASE|Other|9
4774298|NCT01529515|16470330|P4|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
4774299|NCT01529515|16470331|P3|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
4774300|NCT01529515|16470332|P2|TRANSITION PHASE|Failed Maintenance Phase Criteria|0
4774301|NCT01529515|16470333|P1|TRANSITION PHASE|Failed Maintenance Phase Criteria|8
4774302|NCT01529515|16470330|P4|TRANSITION PHASE|Withdrawal by Subject|0
4774303|NCT01529515|16470331|P3|TRANSITION PHASE|Withdrawal by Subject|0
4774304|NCT01529515|16470332|P2|TRANSITION PHASE|Withdrawal by Subject|0
4774305|NCT01529515|16470333|P1|TRANSITION PHASE|Withdrawal by Subject|51
4774306|NCT01529515|16470330|P4|TRANSITION PHASE|Protocol Violation|0
4774307|NCT01529515|16470331|P3|TRANSITION PHASE|Protocol Violation|0
4774308|NCT01529515|16470332|P2|TRANSITION PHASE|Protocol Violation|0
4774309|NCT01529515|16470333|P1|TRANSITION PHASE|Protocol Violation|4
4774310|NCT01529515|16470330|P4|TRANSITION PHASE|Lost to Follow-up|0
4774311|NCT01529515|16470331|P3|TRANSITION PHASE|Lost to Follow-up|0
4774312|NCT01529515|16470332|P2|TRANSITION PHASE|Lost to Follow-up|0
4774313|NCT01529515|16470333|P1|TRANSITION PHASE|Lost to Follow-up|19
4774314|NCT01529515|16470330|P4|TRANSITION PHASE|Lack of Efficacy|0
4774315|NCT01529515|16470331|P3|TRANSITION PHASE|Lack of Efficacy|0
4774316|NCT01529515|16470332|P2|TRANSITION PHASE|Lack of Efficacy|0
4774317|NCT01529515|16470333|P1|TRANSITION PHASE|Lack of Efficacy|19
4774318|NCT01529515|16470330|P4|TRANSITION PHASE|Death|0
4774319|NCT01529515|16470331|P3|TRANSITION PHASE|Death|0
4774320|NCT01529515|16470332|P2|TRANSITION PHASE|Death|0
4774321|NCT01529515|16470333|P1|TRANSITION PHASE|Death|1
4774322|NCT01529515|16470330|P4|TRANSITION PHASE|Adverse Event|0
4774323|NCT01529515|16470331|P3|TRANSITION PHASE|Adverse Event|0
4774324|NCT01529515|16470332|P2|TRANSITION PHASE|Adverse Event|0
4774325|NCT01529515|16470333|P1|TRANSITION PHASE|Adverse Event|16
4774326|NCT01529385|16470380|P2|Overall Study|Lost to Follow-up|1
4774327|NCT01529385|16470381|P1|Overall Study|Lost to Follow-up|2
4774328|NCT01529346|16470410|P5|Overall Study|Other|0
4774329|NCT01529346|16470411|P4|Overall Study|Other|0
4774330|NCT01529346|16470412|P3|Overall Study|Other|1
4774331|NCT01529346|16470413|P2|Overall Study|Other|1
4774332|NCT01529346|16470414|P1|Overall Study|Other|0
4774333|NCT01529346|16470410|P5|Overall Study|Lost to Follow-up|0
4774334|NCT01529346|16470411|P4|Overall Study|Lost to Follow-up|0
4774335|NCT01529346|16470412|P3|Overall Study|Lost to Follow-up|1
4774336|NCT01529346|16470413|P2|Overall Study|Lost to Follow-up|0
4774337|NCT01529346|16470414|P1|Overall Study|Lost to Follow-up|2
4774338|NCT01529268|16470502|P2|Overall Study|Moved|0
4774339|NCT01529268|16470503|P1|Overall Study|Moved|3
4774340|NCT01529268|16470502|P2|Overall Study|Lost to Follow-up|3
4774341|NCT01529268|16470503|P1|Overall Study|Lost to Follow-up|9
4774342|NCT01529112|16470565|P2|Overall Study|Withdrawal by Subject|3
4774343|NCT01529112|16470566|P1|Overall Study|Withdrawal by Subject|7
4774344|NCT01529112|16470565|P2|Overall Study|Protocol Violation|0
4774345|NCT01529112|16470566|P1|Overall Study|Protocol Violation|1
4774346|NCT01529112|16470565|P2|Overall Study|Death|38
4774347|NCT01529112|16470566|P1|Overall Study|Death|59
4774348|NCT01529112|16470565|P2|Overall Study|Adverse Event|0
4774349|NCT01529112|16470566|P1|Overall Study|Adverse Event|2
4774350|NCT01529034|16470602|P1|Overall Study|Study drug not available|2
4774351|NCT01529034|16470602|P1|Overall Study|Investigator no longer available|2
4774352|NCT01529034|16470602|P1|Overall Study|Lack of Efficacy|4
4774353|NCT01529034|16470602|P1|Overall Study|Protocol Violation|4
4774354|NCT01529034|16470602|P1|Overall Study|Adverse Event|4
4774355|NCT01529034|16470602|P1|Overall Study|Caregiver no longer available|7
4774356|NCT01529034|16470602|P1|Overall Study|Noncompliance|8
4774357|NCT01529034|16470602|P1|Overall Study|No treated SCs within protocol window|13
4774358|NCT01529034|16470602|P1|Overall Study|Withdrawal by Subject|25
4774359|NCT01529034|16470602|P1|Overall Study|Study termination|29
4774360|NCT01529034|16470602|P1|Overall Study|Site closure|62
4774361|NCT01529034|16470602|P1|Overall Study|Discontinued prior to study treatment|14
4774362|NCT01528969|16470617|P2|Overall Study|absent from the school at baseline|0
4774363|NCT01528969|16470618|P1|Overall Study|absent from the school at baseline|2
4774364|NCT01528787|16470651|P4|Overall Study|Family Emergency|0
4774365|NCT01528787|16470652|P3|Overall Study|Family Emergency|1
4774366|NCT01528787|16470653|P2|Overall Study|Family Emergency|0
4774367|NCT01528787|16470654|P1|Overall Study|Family Emergency|0
4774368|NCT01528787|16470651|P4|Overall Study|Withdrawal by Subject|1
4774369|NCT01528787|16470652|P3|Overall Study|Withdrawal by Subject|0
4774370|NCT01528787|16470653|P2|Overall Study|Withdrawal by Subject|0
4774371|NCT01528787|16470654|P1|Overall Study|Withdrawal by Subject|0
4774372|NCT01528735|16470666|P2|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0
4774373|NCT01528735|16470667|P1|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1
4774374|NCT01528735|16470666|P2|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
4774375|NCT01528735|16470667|P1|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1
4774376|NCT01528709|16470769|P2|Overall Study|allergy|0
4774377|NCT01528709|16470770|P1|Overall Study|allergy|1
4774378|NCT01528709|16470769|P2|Overall Study|Withdrawal by Subject|15
4774379|NCT01528709|16470770|P1|Overall Study|Withdrawal by Subject|10
4774380|NCT01528709|16470769|P2|Overall Study|Death|0
4774381|NCT01528709|16470770|P1|Overall Study|Death|2
4774382|NCT01528696|16470780|P2|Overall Study|See detailed description|19
4774383|NCT01528696|16470781|P1|Overall Study|See detailed description|18
4774384|NCT01528605|16470797|P6|Overall Study|Death|0
4774385|NCT01528605|16470798|P5|Overall Study|Death|0
4774386|NCT01528605|16470799|P4|Overall Study|Death|0
4774387|NCT01528605|16470800|P3|Overall Study|Death|0
4774388|NCT01528605|16470801|P2|Overall Study|Death|0
4774389|NCT01528605|16470802|P1|Overall Study|Death|1
4774390|NCT01528605|16470797|P6|Overall Study|Lost to Follow-up|0
4774391|NCT01528605|16470798|P5|Overall Study|Lost to Follow-up|0
4774392|NCT01528605|16470799|P4|Overall Study|Lost to Follow-up|1
4774393|NCT01528605|16470800|P3|Overall Study|Lost to Follow-up|1
4774394|NCT01528605|16470801|P2|Overall Study|Lost to Follow-up|0
4774395|NCT01528605|16470802|P1|Overall Study|Lost to Follow-up|1
4774396|NCT01528345|16470832|P2|Overall Study|Subject/Guardian Decision|0
4774397|NCT01528345|16470833|P1|Overall Study|Subject/Guardian Decision|5
4774398|NCT01528345|16470832|P2|Overall Study|Study Terminated by Sponsor|8
4774399|NCT01528345|16470833|P1|Overall Study|Study Terminated by Sponsor|4
4774400|NCT01528345|16470832|P2|Overall Study|Progressive Disease|40
4774401|NCT01528345|16470833|P1|Overall Study|Progressive Disease|26
4774402|NCT01528345|16470832|P2|Overall Study|Non-compliance with study treatment|0
4774403|NCT01528345|16470833|P1|Overall Study|Non-compliance with study treatment|1
4774404|NCT01528345|16470832|P2|Overall Study|Death|1
4774405|NCT01528345|16470833|P1|Overall Study|Death|1
4774406|NCT01528345|16470832|P2|Overall Study|Adverse Event|1
4774407|NCT01528345|16470833|P1|Overall Study|Adverse Event|10
4774408|NCT01528254|16470884|P2|Overall Study|No longer requires study drug|1
4774409|NCT01528254|16470885|P1|Overall Study|No longer requires study drug|1
4774410|NCT01528254|16470884|P2|Overall Study|Abnormal test procedure result(s)|0
4774411|NCT01528254|16470885|P1|Overall Study|Abnormal test procedure result(s)|1
4774412|NCT01528254|16470884|P2|Overall Study|Abnormal laboratory value(s)|7
4774413|NCT01528254|16470885|P1|Overall Study|Abnormal laboratory value(s)|3
4774414|NCT01528254|16470884|P2|Overall Study|Withdrawal by Subject|4
4774415|NCT01528254|16470885|P1|Overall Study|Withdrawal by Subject|5
4774416|NCT01528254|16470884|P2|Overall Study|Unsatisfactory therapeutic effect|8
4774417|NCT01528254|16470885|P1|Overall Study|Unsatisfactory therapeutic effect|6
4774418|NCT01528254|16470884|P2|Overall Study|New therapy for study indication|6
4774419|NCT01528254|16470885|P1|Overall Study|New therapy for study indication|8
4774420|NCT01528254|16470884|P2|Overall Study|Protocol deviation|19
4774421|NCT01528254|16470885|P1|Overall Study|Protocol deviation|9
4774422|NCT01528254|16470884|P2|Overall Study|Death|9
4774423|NCT01528254|16470885|P1|Overall Study|Death|13
4774424|NCT01528254|16470884|P2|Overall Study|Lost to Follow-up|24
4774425|NCT01528254|16470885|P1|Overall Study|Lost to Follow-up|17
4774426|NCT01528254|16470884|P2|Overall Study|Adverse Event|44
4774427|NCT01528254|16470885|P1|Overall Study|Adverse Event|28
4774428|NCT01528254|16470884|P2|Overall Study|Administrative problems|94
4774429|NCT01528254|16470885|P1|Overall Study|Administrative problems|96
4774430|NCT01528215|16470917|P2|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0
4774431|NCT01528215|16470918|P1|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3
4774432|NCT01528215|16470917|P2|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13
4774433|NCT01528215|16470918|P1|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10
4774434|NCT01528215|16470917|P2|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
4774435|NCT01528215|16470918|P1|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2
4774436|NCT01528215|16470917|P2|Enrollment to 1 Year Follow-up|Adverse Event|1
4774437|NCT01528215|16470918|P1|Enrollment to 1 Year Follow-up|Adverse Event|4
4774438|NCT01528072|16470977|P1|Overall Study|Early Termination of Study|52
4774439|NCT01528072|16470977|P1|Overall Study|Death|2
4774440|NCT01528072|16470977|P1|Overall Study|Site Closure|4
4774441|NCT01528072|16470977|P1|Overall Study|Explanted|2
4774442|NCT01528072|16470977|P1|Overall Study|Lost to Follow-up|5
4774443|NCT01528072|16470977|P1|Overall Study|Missed Visit|2
4774444|NCT01528072|16470977|P1|Overall Study|Determined not eligible by AEAC|1
4774445|NCT01528072|16470977|P1|Overall Study|Physician Decision|1
4774446|NCT01528072|16470977|P1|Overall Study|Withdrawal by Subject|5
4774447|NCT01528033|16470983|P2|Follow Up|No data available|44
4774448|NCT01528033|16470984|P1|Follow Up|No data available|46
4774449|NCT01528033|16470983|P2|Primary Endpoint Assessment ITT|No post baseline documentation|2
4774450|NCT01528033|16470984|P1|Primary Endpoint Assessment ITT|No post baseline documentation|2
4774451|NCT01528033|16470983|P2|Primary Endpoint Assessment ITT|Physician Decision|1
4774452|NCT01528033|16470984|P1|Primary Endpoint Assessment ITT|Physician Decision|2
4774453|NCT01528033|16470983|P2|Primary Endpoint Assessment ITT|Death|2
4774454|NCT01528033|16470984|P1|Primary Endpoint Assessment ITT|Death|2
4774455|NCT01528033|16470983|P2|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
4774456|NCT01528033|16470984|P1|Primary Endpoint Assessment ITT|No or deliquent informed consent|3
4774457|NCT01528033|16470983|P2|Primary Endpoint Assessment ITT|Withdrawal by Subject|7
4774458|NCT01528033|16470984|P1|Primary Endpoint Assessment ITT|Withdrawal by Subject|8
4774459|NCT01527682|16471007|P1|Overall Study|Protocol Violation|8
4774460|NCT01527500|16471030|P2|Part B|Adverse Event|0
4774461|NCT01527500|16471031|P1|Part B|Adverse Event|1
4774462|NCT01527500|16471030|P2|Part A|Withdrawal by Subject|0
4774463|NCT01527500|16471031|P1|Part A|Withdrawal by Subject|2
4774464|NCT01527500|16471030|P2|Part A|Protocol Deviation|2
4774465|NCT01527500|16471031|P1|Part A|Protocol Deviation|9
4774466|NCT01527500|16471030|P2|Part A|Lost to Follow-up|1
4774467|NCT01527500|16471031|P1|Part A|Lost to Follow-up|0
4774468|NCT01527500|16471030|P2|Part A|Death|1
4774469|NCT01527500|16471031|P1|Part A|Death|4
4774470|NCT01527500|16471030|P2|Part A|Adverse Event|2
4774471|NCT01527500|16471031|P1|Part A|Adverse Event|4
4774472|NCT01527500|16471030|P2|Part A|Administrative|7
4774473|NCT01527500|16471031|P1|Part A|Administrative|11
4774474|NCT01527487|16471061|P2|Overall Study|Death|1
4774475|NCT01527487|16471062|P1|Overall Study|Death|0
4774476|NCT01527487|16471061|P2|Overall Study|Adverse Event|1
4774477|NCT01527487|16471062|P1|Overall Study|Adverse Event|1
4774478|NCT01527487|16471061|P2|Overall Study|Disease Progression|1
4774479|NCT01527487|16471062|P1|Overall Study|Disease Progression|4
4774480|NCT01527487|16471061|P2|Overall Study|MD Discretion/Lack of Efficacy|4
4774481|NCT01527487|16471062|P1|Overall Study|MD Discretion/Lack of Efficacy|3
4774482|NCT01527383|16471076|P2|Overall Study|Withdrawal by Subject|3
4774483|NCT01527383|16471077|P1|Overall Study|Withdrawal by Subject|2
4774484|NCT01527383|16471076|P2|Overall Study|Participant moved|1
4774485|NCT01527383|16471077|P1|Overall Study|Participant moved|0
4774486|NCT01527383|16471076|P2|Overall Study|Screen failure|0
4774487|NCT01527383|16471077|P1|Overall Study|Screen failure|1
4774488|NCT01527383|16471076|P2|Overall Study|Protocol Violation|0
4774489|NCT01527383|16471077|P1|Overall Study|Protocol Violation|1
4774490|NCT01527383|16471076|P2|Overall Study|Pregnancy|0
4774491|NCT01527383|16471077|P1|Overall Study|Pregnancy|1
4774492|NCT01527383|16471076|P2|Overall Study|Physician Decision|0
4774493|NCT01527383|16471077|P1|Overall Study|Physician Decision|2
4774494|NCT01527383|16471076|P2|Overall Study|Lost to Follow-up|0
4774495|NCT01527383|16471077|P1|Overall Study|Lost to Follow-up|3
4774496|NCT01527383|16471076|P2|Overall Study|Adverse Event|0
4774497|NCT01527383|16471077|P1|Overall Study|Adverse Event|5
4774498|NCT01527370|16471091|P1|Overall Study|Death|1
4774499|NCT01527370|16471091|P1|Overall Study|Physician Decision|1
4774500|NCT01527370|16471091|P1|Overall Study|Withdrawal by Subject|4
4774501|NCT01527357|16471099|P2|Overall Study|Did Not Receive Treatment|0
4774502|NCT01527357|16471100|P1|Overall Study|Did Not Receive Treatment|2
4774503|NCT01527357|16471099|P2|Overall Study|No Day 29 Visit|1
4774504|NCT01527357|16471100|P1|Overall Study|No Day 29 Visit|0
4774505|NCT01527357|16471099|P2|Overall Study|Non-compliance|1
4774506|NCT01527357|16471100|P1|Overall Study|Non-compliance|0
4774507|NCT01527357|16471099|P2|Overall Study|Withdrew Consent|1
4774508|NCT01527357|16471100|P1|Overall Study|Withdrew Consent|1
4774509|NCT01527357|16471099|P2|Overall Study|Lost to Follow-up|4
4774510|NCT01527357|16471100|P1|Overall Study|Lost to Follow-up|6
4774511|NCT01527357|16471099|P2|Overall Study|Death|2
4774512|NCT01527357|16471100|P1|Overall Study|Death|8
4774513|NCT01527292|16471122|P2|Overall Study|Physician Decision|3
4774514|NCT01527292|16471123|P1|Overall Study|Physician Decision|0
4774515|NCT01527149|16471150|P1|Overall Study|Death|2
4774516|NCT01527110|16471165|P1|Overall Study|Adverse Event|1
4774517|NCT01527006|16471246|P2|Extension Phase|Other|3
4774518|NCT01527006|16471247|P1|Extension Phase|Other|0
4774519|NCT01527006|16471246|P2|Extension Phase|Inadequate therapeutic effect|1
4774520|NCT01527006|16471247|P1|Extension Phase|Inadequate therapeutic effect|1
4774521|NCT01527006|16471246|P2|Extension Phase|Subject Choice|1
4774522|NCT01527006|16471247|P1|Extension Phase|Subject Choice|1
4774523|NCT01527006|16471246|P2|Extension Phase|Lost to Follow-up|1
4774524|NCT01527006|16471247|P1|Extension Phase|Lost to Follow-up|0
4774525|NCT01527006|16471246|P2|Extension Phase|Adverse Event|2
4774526|NCT01527006|16471247|P1|Extension Phase|Adverse Event|4
4774527|NCT01527006|16471246|P2|Core Study|Other|2
4774528|NCT01527006|16471247|P1|Core Study|Other|0
4774529|NCT01527006|16471246|P2|Core Study|Withdrawal by Subject|1
4774530|NCT01527006|16471247|P1|Core Study|Withdrawal by Subject|0
4774531|NCT01527006|16471246|P2|Core Study|Inadequate Therapeutic Effect|0
4774532|NCT01527006|16471247|P1|Core Study|Inadequate Therapeutic Effect|1
4774533|NCT01527006|16471246|P2|Core Study|Subject Choice|0
4774534|NCT01527006|16471247|P1|Core Study|Subject Choice|1
4774535|NCT01527006|16471246|P2|Core Study|Lost to Follow-up|1
4774536|NCT01527006|16471247|P1|Core Study|Lost to Follow-up|0
4774537|NCT01527006|16471246|P2|Core Study|Adverse Event|2
4774538|NCT01527006|16471247|P1|Core Study|Adverse Event|0
4774539|NCT01526928|16471303|P6|Overall Study|Missing|0
4774540|NCT01526928|16471304|P5|Overall Study|Missing|2
4774541|NCT01526928|16471305|P4|Overall Study|Missing|0
4774542|NCT01526928|16471306|P3|Overall Study|Missing|1
4774543|NCT01526928|16471307|P2|Overall Study|Missing|0
4774544|NCT01526928|16471308|P1|Overall Study|Missing|0
4774545|NCT01526928|16471303|P6|Overall Study|Protocol Deviation|0
4774546|NCT01526928|16471304|P5|Overall Study|Protocol Deviation|0
4774547|NCT01526928|16471305|P4|Overall Study|Protocol Deviation|2
4774548|NCT01526928|16471306|P3|Overall Study|Protocol Deviation|0
4774549|NCT01526928|16471307|P2|Overall Study|Protocol Deviation|0
4774550|NCT01526928|16471308|P1|Overall Study|Protocol Deviation|0
4774551|NCT01526928|16471303|P6|Overall Study|Lost to Follow-up|0
4774552|NCT01526928|16471304|P5|Overall Study|Lost to Follow-up|0
4774553|NCT01526928|16471305|P4|Overall Study|Lost to Follow-up|1
4774554|NCT01526928|16471306|P3|Overall Study|Lost to Follow-up|0
4774555|NCT01526928|16471307|P2|Overall Study|Lost to Follow-up|0
4774556|NCT01526928|16471308|P1|Overall Study|Lost to Follow-up|0
4774557|NCT01526928|16471303|P6|Overall Study|Other Reason|0
4774558|NCT01526928|16471304|P5|Overall Study|Other Reason|1
4774559|NCT01526928|16471305|P4|Overall Study|Other Reason|4
4774560|NCT01526928|16471306|P3|Overall Study|Other Reason|11
4774561|NCT01526928|16471307|P2|Overall Study|Other Reason|1
4774562|NCT01526928|16471308|P1|Overall Study|Other Reason|0
4774563|NCT01526928|16471303|P6|Overall Study|Physician Decision|0
4774564|NCT01526928|16471304|P5|Overall Study|Physician Decision|0
4774565|NCT01526928|16471305|P4|Overall Study|Physician Decision|5
4774566|NCT01526928|16471306|P3|Overall Study|Physician Decision|2
4774567|NCT01526928|16471307|P2|Overall Study|Physician Decision|0
4774568|NCT01526928|16471308|P1|Overall Study|Physician Decision|0
4774569|NCT01526928|16471303|P6|Overall Study|Withdrawal by Subject|0
4774570|NCT01526928|16471304|P5|Overall Study|Withdrawal by Subject|3
4774571|NCT01526928|16471305|P4|Overall Study|Withdrawal by Subject|11
4774572|NCT01526928|16471306|P3|Overall Study|Withdrawal by Subject|13
4774573|NCT01526928|16471307|P2|Overall Study|Withdrawal by Subject|0
4774574|NCT01526928|16471308|P1|Overall Study|Withdrawal by Subject|1
4774575|NCT01526928|16471303|P6|Overall Study|Death|0
4774576|NCT01526928|16471304|P5|Overall Study|Death|0
4774577|NCT01526928|16471305|P4|Overall Study|Death|0
4774578|NCT01526928|16471306|P3|Overall Study|Death|3
4774579|NCT01526928|16471307|P2|Overall Study|Death|0
4774580|NCT01526928|16471308|P1|Overall Study|Death|0
4774581|NCT01526928|16471303|P6|Overall Study|Adverse Event|2
4774582|NCT01526928|16471304|P5|Overall Study|Adverse Event|13
4774583|NCT01526928|16471305|P4|Overall Study|Adverse Event|40
4774584|NCT01526928|16471306|P3|Overall Study|Adverse Event|29
4774585|NCT01526928|16471307|P2|Overall Study|Adverse Event|1
4774586|NCT01526928|16471308|P1|Overall Study|Adverse Event|2
4774587|NCT01526928|16471303|P6|Overall Study|Progressive Disease|4
4774588|NCT01526928|16471304|P5|Overall Study|Progressive Disease|76
4774589|NCT01526928|16471305|P4|Overall Study|Progressive Disease|182
4774590|NCT01526928|16471306|P3|Overall Study|Progressive Disease|150
4774591|NCT01526928|16471307|P2|Overall Study|Progressive Disease|17
4774592|NCT01526928|16471308|P1|Overall Study|Progressive Disease|35
4774593|NCT01526889|16471446|P2|Treatment Extension Period|Administrative problems|0
4774594|NCT01526889|16471447|P1|Treatment Extension Period|Administrative problems|1
4774595|NCT01526889|16471446|P2|Treatment Period|Adverse Event|0
4774596|NCT01526889|16471447|P1|Treatment Period|Adverse Event|2
4774597|NCT01526785|16471468|P1|Overall Study|Withdrawal by Subject|2
4774598|NCT01526785|16471468|P1|Overall Study|Physician Decision|1
4774599|NCT01526785|16471468|P1|Overall Study|Death|2
4774600|NCT01526785|16471468|P1|Overall Study|Study Terminated by Sponsor|8
4774601|NCT01526733|16471478|P2|Phase 1|Withdrawal by Subject|1
4774602|NCT01526733|16471479|P1|Phase 1|Withdrawal by Subject|1
4774603|NCT01526733|16471478|P2|Phase 1|Protocol Violation|0
4774604|NCT01526733|16471479|P1|Phase 1|Protocol Violation|1
4774605|NCT01526551|16471518|P1|Overall Study|Lack of returned parental consent form|424
4774606|NCT01526148|16471596|P2|Overall Study|Incarcerated|2
4774607|NCT01526148|16471597|P1|Overall Study|Incarcerated|0
4774608|NCT01526148|16471596|P2|Overall Study|Moved out of state|0
4774609|NCT01526148|16471597|P1|Overall Study|Moved out of state|1
4774610|NCT01526148|16471596|P2|Overall Study|Unable to discontinue concomitant med|0
4774611|NCT01526148|16471597|P1|Overall Study|Unable to discontinue concomitant med|1
4774612|NCT01526148|16471596|P2|Overall Study|Unstable Medical Condition|0
4774613|NCT01526148|16471597|P1|Overall Study|Unstable Medical Condition|1
4774614|NCT01526148|16471596|P2|Overall Study|Withdrawal by Subject|0
4774615|NCT01526148|16471597|P1|Overall Study|Withdrawal by Subject|2
4774616|NCT01526148|16471596|P2|Overall Study|Lost to Follow-up|6
4774617|NCT01526148|16471597|P1|Overall Study|Lost to Follow-up|3
4774618|NCT01526148|16471596|P2|Overall Study|Adverse Event|5
4774619|NCT01526148|16471597|P1|Overall Study|Adverse Event|6
4774620|NCT01526057|16471608|P3|Overall Study|Protocol Violation|1
4774621|NCT01526057|16471609|P2|Overall Study|Protocol Violation|0
4774622|NCT01526057|16471610|P1|Overall Study|Protocol Violation|0
4774623|NCT01526057|16471608|P3|Overall Study|Other|1
4774624|NCT01526057|16471609|P2|Overall Study|Other|0
4774625|NCT01526057|16471610|P1|Overall Study|Other|1
4774626|NCT01526057|16471608|P3|Overall Study|Lost to Follow-up|1
4774627|NCT01526057|16471609|P2|Overall Study|Lost to Follow-up|0
4774628|NCT01526057|16471610|P1|Overall Study|Lost to Follow-up|1
4774629|NCT01526057|16471608|P3|Overall Study|Death|0
4774630|NCT01526057|16471609|P2|Overall Study|Death|0
4774631|NCT01526057|16471610|P1|Overall Study|Death|1
4774632|NCT01526057|16471608|P3|Overall Study|Adverse Event|1
4774633|NCT01526057|16471609|P2|Overall Study|Adverse Event|1
4774634|NCT01526057|16471610|P1|Overall Study|Adverse Event|3
4774635|NCT01526057|16471608|P3|Overall Study|Withdrawal by Subject|2
4774636|NCT01526057|16471609|P2|Overall Study|Withdrawal by Subject|2
4774637|NCT01526057|16471610|P1|Overall Study|Withdrawal by Subject|3
4774638|NCT01525875|16471709|P2|Open-label Period|Lost to Follow-up|2
4774639|NCT01525875|16471710|P1|Open-label Period|Lost to Follow-up|0
4774640|NCT01525875|16471709|P2|Placebo-controlled Period|Withdrawal by Subject|2
4774641|NCT01525875|16471710|P1|Placebo-controlled Period|Withdrawal by Subject|1
4774642|NCT01525849|16471733|P2|Overall Study|Anatomic exclusion criteria identified|3
4774643|NCT01525849|16471734|P1|Overall Study|Anatomic exclusion criteria identified|0
4774644|NCT01525849|16471733|P2|Overall Study|Unrelated medical issue (not treated)|2
4774645|NCT01525849|16471734|P1|Overall Study|Unrelated medical issue (not treated)|1
4774646|NCT01525849|16471733|P2|Overall Study|Withdrawal by Subject|9
4774647|NCT01525849|16471734|P1|Overall Study|Withdrawal by Subject|1
4774648|NCT01525849|16471733|P2|Overall Study|Lost to Follow-up|2
4774649|NCT01525849|16471734|P1|Overall Study|Lost to Follow-up|3
4774650|NCT01525641|16471790|P1|Overall Study|Other than stated above|7
4774651|NCT01525641|16471790|P1|Overall Study|Lost to follow-up (Changing hospital)|19
4774652|NCT01525641|16471790|P1|Overall Study|Lost to follow-up (Unknown reason)|10
4774653|NCT01525641|16471790|P1|Overall Study|Lost to follow-up (relocation)|1
4774654|NCT01525641|16471790|P1|Overall Study|Improvement|5
4774655|NCT01525641|16471790|P1|Overall Study|Lack of Efficacy|24
4774656|NCT01525641|16471790|P1|Overall Study|Adverse Event|73
4774657|NCT01525641|16471790|P1|Overall Study|No visit since the first visit|16
4774658|NCT01525641|16471790|P1|Overall Study|Case report form not collected|25
4774659|NCT01525628|16471804|P5|Overall Study|Other reason not defined above|0
4774660|NCT01525628|16471805|P4|Overall Study|Other reason not defined above|3
4774661|NCT01525628|16471806|P3|Overall Study|Other reason not defined above|0
4774662|NCT01525628|16471807|P2|Overall Study|Other reason not defined above|0
4774663|NCT01525628|16471808|P1|Overall Study|Other reason not defined above|0
4774664|NCT01525628|16471804|P5|Overall Study|Withdrawal by Subject|0
4774665|NCT01525628|16471805|P4|Overall Study|Withdrawal by Subject|0
4774666|NCT01525628|16471806|P3|Overall Study|Withdrawal by Subject|0
4774667|NCT01525628|16471807|P2|Overall Study|Withdrawal by Subject|1
4774668|NCT01525628|16471808|P1|Overall Study|Withdrawal by Subject|0
4774669|NCT01525628|16471804|P5|Overall Study|Lost to Follow-up|0
4774670|NCT01525628|16471805|P4|Overall Study|Lost to Follow-up|0
4774671|NCT01525628|16471806|P3|Overall Study|Lost to Follow-up|0
4774672|NCT01525628|16471807|P2|Overall Study|Lost to Follow-up|1
4774673|NCT01525628|16471808|P1|Overall Study|Lost to Follow-up|1
4774674|NCT01525628|16471804|P5|Overall Study|Protocol Violation|0
4774675|NCT01525628|16471805|P4|Overall Study|Protocol Violation|0
4774676|NCT01525628|16471806|P3|Overall Study|Protocol Violation|1
4774677|NCT01525628|16471807|P2|Overall Study|Protocol Violation|0
4774678|NCT01525628|16471808|P1|Overall Study|Protocol Violation|0
4774679|NCT01525628|16471804|P5|Overall Study|Lack of Efficacy|2
4774680|NCT01525628|16471805|P4|Overall Study|Lack of Efficacy|1
4774681|NCT01525628|16471806|P3|Overall Study|Lack of Efficacy|2
4774682|NCT01525628|16471807|P2|Overall Study|Lack of Efficacy|2
4774683|NCT01525628|16471808|P1|Overall Study|Lack of Efficacy|0
4774684|NCT01525628|16471804|P5|Overall Study|Adverse Event|1
4774685|NCT01525628|16471805|P4|Overall Study|Adverse Event|0
4774686|NCT01525628|16471806|P3|Overall Study|Adverse Event|2
4774687|NCT01525628|16471807|P2|Overall Study|Adverse Event|1
4774688|NCT01525628|16471808|P1|Overall Study|Adverse Event|1
4774689|NCT01525615|16471875|P3|Overall Study|Other reason not described above|1
4774690|NCT01525615|16471876|P2|Overall Study|Other reason not described above|0
4774691|NCT01525615|16471877|P1|Overall Study|Other reason not described above|1
4774692|NCT01525615|16471875|P3|Overall Study|Withdrawal by Subject|0
4774693|NCT01525615|16471876|P2|Overall Study|Withdrawal by Subject|0
4774694|NCT01525615|16471877|P1|Overall Study|Withdrawal by Subject|1
4774695|NCT01525615|16471875|P3|Overall Study|Lost to Follow-up|0
4774696|NCT01525615|16471876|P2|Overall Study|Lost to Follow-up|0
4774697|NCT01525615|16471877|P1|Overall Study|Lost to Follow-up|1
4774698|NCT01525615|16471875|P3|Overall Study|Adverse Event|5
4774699|NCT01525615|16471876|P2|Overall Study|Adverse Event|7
4774700|NCT01525615|16471877|P1|Overall Study|Adverse Event|11
4774701|NCT01525602|16471929|P8|Overall Study|Unqualified based on biopsy; not dosed|1
4774702|NCT01525602|16471930|P7|Overall Study|Unqualified based on biopsy; not dosed|1
4774703|NCT01525602|16471931|P6|Overall Study|Unqualified based on biopsy; not dosed|0
4774704|NCT01525602|16471932|P5|Overall Study|Unqualified based on biopsy; not dosed|0
4774705|NCT01525602|16471933|P4|Overall Study|Unqualified based on biopsy; not dosed|0
4774706|NCT01525602|16471934|P3|Overall Study|Unqualified based on biopsy; not dosed|0
4774707|NCT01525602|16471935|P2|Overall Study|Unqualified based on biopsy; not dosed|0
4774708|NCT01525602|16471936|P1|Overall Study|Unqualified based on biopsy; not dosed|0
4774709|NCT01525602|16471929|P8|Overall Study|Death|0
4774710|NCT01525602|16471930|P7|Overall Study|Death|0
4774711|NCT01525602|16471931|P6|Overall Study|Death|1
4774712|NCT01525602|16471932|P5|Overall Study|Death|1
4774713|NCT01525602|16471933|P4|Overall Study|Death|0
4774714|NCT01525602|16471934|P3|Overall Study|Death|0
4774715|NCT01525602|16471935|P2|Overall Study|Death|0
4774716|NCT01525602|16471936|P1|Overall Study|Death|0
4774717|NCT01525602|16471929|P8|Overall Study|Physician Decision|0
4774718|NCT01525602|16471930|P7|Overall Study|Physician Decision|1
4774719|NCT01525602|16471931|P6|Overall Study|Physician Decision|0
4774720|NCT01525602|16471932|P5|Overall Study|Physician Decision|3
4774721|NCT01525602|16471933|P4|Overall Study|Physician Decision|0
4774722|NCT01525602|16471934|P3|Overall Study|Physician Decision|0
4774723|NCT01525602|16471935|P2|Overall Study|Physician Decision|0
4774724|NCT01525602|16471936|P1|Overall Study|Physician Decision|0
4774725|NCT01525602|16471929|P8|Overall Study|Withdrawal by Subject|1
4774726|NCT01525602|16471930|P7|Overall Study|Withdrawal by Subject|0
4774727|NCT01525602|16471931|P6|Overall Study|Withdrawal by Subject|1
4774728|NCT01525602|16471932|P5|Overall Study|Withdrawal by Subject|3
4774729|NCT01525602|16471933|P4|Overall Study|Withdrawal by Subject|0
4774730|NCT01525602|16471934|P3|Overall Study|Withdrawal by Subject|0
4774731|NCT01525602|16471935|P2|Overall Study|Withdrawal by Subject|0
4774732|NCT01525602|16471936|P1|Overall Study|Withdrawal by Subject|0
4774733|NCT01525602|16471929|P8|Overall Study|Non-compliance|0
4774734|NCT01525602|16471930|P7|Overall Study|Non-compliance|0
4774735|NCT01525602|16471931|P6|Overall Study|Non-compliance|0
4774736|NCT01525602|16471932|P5|Overall Study|Non-compliance|1
4774737|NCT01525602|16471933|P4|Overall Study|Non-compliance|0
4774738|NCT01525602|16471934|P3|Overall Study|Non-compliance|0
4774739|NCT01525602|16471935|P2|Overall Study|Non-compliance|0
4774740|NCT01525602|16471936|P1|Overall Study|Non-compliance|0
4774741|NCT01525602|16471929|P8|Overall Study|Clinical progression|1
4774742|NCT01525602|16471930|P7|Overall Study|Clinical progression|1
4774743|NCT01525602|16471931|P6|Overall Study|Clinical progression|0
4774744|NCT01525602|16471932|P5|Overall Study|Clinical progression|0
4774745|NCT01525602|16471933|P4|Overall Study|Clinical progression|0
4774746|NCT01525602|16471934|P3|Overall Study|Clinical progression|0
4774747|NCT01525602|16471935|P2|Overall Study|Clinical progression|0
4774748|NCT01525602|16471936|P1|Overall Study|Clinical progression|2
4774749|NCT01525602|16471929|P8|Overall Study|Disease progression|3
4774750|NCT01525602|16471930|P7|Overall Study|Disease progression|3
4774751|NCT01525602|16471931|P6|Overall Study|Disease progression|2
4774752|NCT01525602|16471932|P5|Overall Study|Disease progression|22
4774753|NCT01525602|16471933|P4|Overall Study|Disease progression|5
4774754|NCT01525602|16471934|P3|Overall Study|Disease progression|2
4774755|NCT01525602|16471935|P2|Overall Study|Disease progression|3
4774756|NCT01525602|16471936|P1|Overall Study|Disease progression|6
4774757|NCT01525602|16471929|P8|Overall Study|Adverse Event|1
4774758|NCT01525602|16471930|P7|Overall Study|Adverse Event|0
4774759|NCT01525602|16471931|P6|Overall Study|Adverse Event|3
4774760|NCT01525602|16471932|P5|Overall Study|Adverse Event|3
4774761|NCT01525602|16471933|P4|Overall Study|Adverse Event|1
4774762|NCT01525602|16471934|P3|Overall Study|Adverse Event|1
4774763|NCT01525602|16471935|P2|Overall Study|Adverse Event|0
4774764|NCT01525602|16471936|P1|Overall Study|Adverse Event|1
4774765|NCT01525589|16472007|P3|Overall Study|Withdrawal by Subject|0
4774766|NCT01525589|16472008|P2|Overall Study|Withdrawal by Subject|1
4774767|NCT01525589|16472009|P1|Overall Study|Withdrawal by Subject|0
4774768|NCT01525589|16472007|P3|Overall Study|Other reasons|0
4774769|NCT01525589|16472008|P2|Overall Study|Other reasons|1
4774770|NCT01525589|16472009|P1|Overall Study|Other reasons|0
4774771|NCT01525589|16472007|P3|Overall Study|Treatment-related AE|2
4774772|NCT01525589|16472008|P2|Overall Study|Treatment-related AE|1
4774773|NCT01525589|16472009|P1|Overall Study|Treatment-related AE|1
4774774|NCT01525589|16472007|P3|Overall Study|Death|2
4774775|NCT01525589|16472008|P2|Overall Study|Death|0
4774776|NCT01525589|16472009|P1|Overall Study|Death|0
4774777|NCT01525589|16472007|P3|Overall Study|Physician Decision|2
4774778|NCT01525589|16472008|P2|Overall Study|Physician Decision|2
4774779|NCT01525589|16472009|P1|Overall Study|Physician Decision|4
4774780|NCT01525589|16472007|P3|Overall Study|Never treated|0
4774781|NCT01525589|16472008|P2|Overall Study|Never treated|0
4774782|NCT01525589|16472009|P1|Overall Study|Never treated|2
4774783|NCT01525589|16472007|P3|Overall Study|Progressive disease|29
4774784|NCT01525589|16472008|P2|Overall Study|Progressive disease|15
4774785|NCT01525589|16472009|P1|Overall Study|Progressive disease|48
4774786|NCT01525589|16472007|P3|Overall Study|Non-treatment-related AE|0
4774787|NCT01525589|16472008|P2|Overall Study|Non-treatment-related AE|0
4774788|NCT01525589|16472009|P1|Overall Study|Non-treatment-related AE|1
4774789|NCT01525550|16472065|P2|Overall Study|Withdrawal by Subject|0
4774790|NCT01525550|16472066|P1|Overall Study|Withdrawal by Subject|4
4774791|NCT01525550|16472065|P2|Overall Study|Sponsor's Decision|11
4774792|NCT01525550|16472066|P1|Overall Study|Sponsor's Decision|30
4774793|NCT01525550|16472065|P2|Overall Study|Other|4
4774794|NCT01525550|16472066|P1|Overall Study|Other|0
4774795|NCT01525550|16472065|P2|Overall Study|Death|28
4774796|NCT01525550|16472066|P1|Overall Study|Death|19
4774797|NCT01525550|16472065|P2|Overall Study|Lost to Follow-up|2
4774798|NCT01525550|16472066|P1|Overall Study|Lost to Follow-up|8
4774799|NCT01525407|16472137|P2|Overall Study|Delay in Transplant|0
4774800|NCT01525407|16472138|P1|Overall Study|Delay in Transplant|1
4774801|NCT01525407|16472137|P2|Overall Study|Transplant was delayed|1
4774802|NCT01525407|16472138|P1|Overall Study|Transplant was delayed|0
4774803|NCT01525407|16472137|P2|Overall Study|Withdrawal by Subject|1
4774804|NCT01525407|16472138|P1|Overall Study|Withdrawal by Subject|0
4774805|NCT01525407|16472137|P2|Overall Study|Change in recipient treatment plan|2
4774806|NCT01525407|16472138|P1|Overall Study|Change in recipient treatment plan|2
4774807|NCT01525238|16472172|P3|Overall Study|Withdrawal by Subject|0
4774808|NCT01525238|16472173|P2|Overall Study|Withdrawal by Subject|0
4774809|NCT01525238|16472174|P1|Overall Study|Withdrawal by Subject|1
4774810|NCT01525225|16472239|P1|Enrollment|Other|1
4774811|NCT01525225|16472239|P1|Enrollment|No longer met study criteria|1
4774812|NCT01524991|16472253|P1|Overall Study|Symptomatic Deterioration|1
4774813|NCT01524991|16472253|P1|Overall Study|Withdrawal by Subject|2
4774814|NCT01524991|16472253|P1|Overall Study|Other complicating disease|1
4774815|NCT01524991|16472253|P1|Overall Study|Disease ProgressionDu|17
4774816|NCT01524991|16472253|P1|Overall Study|Death|1
4774817|NCT01524991|16472253|P1|Overall Study|Adverse Event|12
4774818|NCT01524978|16472271|P11|Overall Study|Death|17
4774819|NCT01524978|16472272|P10|Overall Study|Death|6
4774820|NCT01524978|16472273|P9|Overall Study|Death|5
4774821|NCT01524978|16472274|P8|Overall Study|Death|9
4774822|NCT01524978|16472275|P7|Overall Study|Death|1
4774823|NCT01524978|16472276|P6|Overall Study|Death|4
4774824|NCT01524978|16472277|P5|Overall Study|Death|4
4774825|NCT01524978|16472278|P4|Overall Study|Death|24
4774826|NCT01524978|16472279|P3|Overall Study|Death|5
4774827|NCT01524978|16472280|P2|Overall Study|Death|2
4774828|NCT01524978|16472281|P1|Overall Study|Death|34
4774829|NCT01524978|16472271|P11|Overall Study|Lost to Follow-up|1
4774830|NCT01524978|16472272|P10|Overall Study|Lost to Follow-up|1
4774831|NCT01524978|16472273|P9|Overall Study|Lost to Follow-up|1
4774832|NCT01524978|16472274|P8|Overall Study|Lost to Follow-up|0
4774833|NCT01524978|16472275|P7|Overall Study|Lost to Follow-up|2
4774834|NCT01524978|16472276|P6|Overall Study|Lost to Follow-up|1
4774835|NCT01524978|16472277|P5|Overall Study|Lost to Follow-up|1
4774836|NCT01524978|16472278|P4|Overall Study|Lost to Follow-up|0
4774837|NCT01524978|16472279|P3|Overall Study|Lost to Follow-up|3
4774838|NCT01524978|16472280|P2|Overall Study|Lost to Follow-up|0
4774839|NCT01524978|16472281|P1|Overall Study|Lost to Follow-up|0
4774840|NCT01524978|16472271|P11|Overall Study|Withdrawal by Subject|5
4774841|NCT01524978|16472272|P10|Overall Study|Withdrawal by Subject|0
4774842|NCT01524978|16472273|P9|Overall Study|Withdrawal by Subject|4
4774843|NCT01524978|16472274|P8|Overall Study|Withdrawal by Subject|2
4774844|NCT01524978|16472275|P7|Overall Study|Withdrawal by Subject|6
4774845|NCT01524978|16472276|P6|Overall Study|Withdrawal by Subject|1
4774846|NCT01524978|16472277|P5|Overall Study|Withdrawal by Subject|3
4774847|NCT01524978|16472278|P4|Overall Study|Withdrawal by Subject|1
4774848|NCT01524978|16472279|P3|Overall Study|Withdrawal by Subject|1
4774849|NCT01524978|16472280|P2|Overall Study|Withdrawal by Subject|0
4774850|NCT01524978|16472281|P1|Overall Study|Withdrawal by Subject|12
4774851|NCT01524978|16472271|P11|Overall Study|Other|5
4774852|NCT01524978|16472272|P10|Overall Study|Other|2
4774853|NCT01524978|16472273|P9|Overall Study|Other|2
4774854|NCT01524978|16472274|P8|Overall Study|Other|1
4774855|NCT01524978|16472275|P7|Overall Study|Other|17
4774856|NCT01524978|16472276|P6|Overall Study|Other|3
4774857|NCT01524978|16472277|P5|Overall Study|Other|1
4774858|NCT01524978|16472278|P4|Overall Study|Other|2
4774859|NCT01524978|16472279|P3|Overall Study|Other|1
4774860|NCT01524978|16472280|P2|Overall Study|Other|2
4774861|NCT01524978|16472281|P1|Overall Study|Other|16
4774862|NCT01524913|16472409|P3|Overall Study|Lost to Follow-up|0
4774863|NCT01524913|16472410|P2|Overall Study|Lost to Follow-up|0
4774864|NCT01524913|16472411|P1|Overall Study|Lost to Follow-up|4
4774865|NCT01524900|16472433|P5|Overall Study|No reason documented|0
4774866|NCT01524900|16472434|P4|Overall Study|No reason documented|1
4774867|NCT01524900|16472435|P3|Overall Study|No reason documented|0
4774868|NCT01524900|16472436|P2|Overall Study|No reason documented|1
4774869|NCT01524900|16472437|P1|Overall Study|No reason documented|2
4774870|NCT01524900|16472433|P5|Overall Study|Other reason than stated above|0
4774871|NCT01524900|16472434|P4|Overall Study|Other reason than stated above|0
4774872|NCT01524900|16472435|P3|Overall Study|Other reason than stated above|0
4774873|NCT01524900|16472436|P2|Overall Study|Other reason than stated above|1
4774874|NCT01524900|16472437|P1|Overall Study|Other reason than stated above|1
4774875|NCT01524900|16472433|P5|Overall Study|Lost to Follow-up|0
4774876|NCT01524900|16472434|P4|Overall Study|Lost to Follow-up|0
4774877|NCT01524900|16472435|P3|Overall Study|Lost to Follow-up|1
4774878|NCT01524900|16472436|P2|Overall Study|Lost to Follow-up|12
4774879|NCT01524900|16472437|P1|Overall Study|Lost to Follow-up|3
4774880|NCT01524887|16472482|P3|Overall Study|Use of prohibited medication|0
4774881|NCT01524887|16472483|P2|Overall Study|Use of prohibited medication|0
4774882|NCT01524887|16472484|P1|Overall Study|Use of prohibited medication|1
4774883|NCT01524887|16472482|P3|Overall Study|Withdrawal by Caregiver|2
4774884|NCT01524887|16472483|P2|Overall Study|Withdrawal by Caregiver|0
4774885|NCT01524887|16472484|P1|Overall Study|Withdrawal by Caregiver|0
4774886|NCT01524887|16472482|P3|Overall Study|Study termination|79
4774887|NCT01524887|16472483|P2|Overall Study|Study termination|87
4774888|NCT01524887|16472484|P1|Overall Study|Study termination|73
4774889|NCT01524887|16472482|P3|Overall Study|Protocol Violation|1
4774890|NCT01524887|16472483|P2|Overall Study|Protocol Violation|0
4774891|NCT01524887|16472484|P1|Overall Study|Protocol Violation|0
4774892|NCT01524887|16472482|P3|Overall Study|Adverse Event|1
4774893|NCT01524887|16472483|P2|Overall Study|Adverse Event|1
4774894|NCT01524887|16472484|P1|Overall Study|Adverse Event|5
4774895|NCT01524887|16472482|P3|Overall Study|Withdrawal by Subject|3
4774896|NCT01524887|16472483|P2|Overall Study|Withdrawal by Subject|2
4774897|NCT01524887|16472484|P1|Overall Study|Withdrawal by Subject|6
4774898|NCT01524796|16472528|P1|Overall Study|Adverse Event and Lack of Efficacy|1
4774899|NCT01524796|16472528|P1|Overall Study|Switch to carbamazapine|1
4774900|NCT01524796|16472528|P1|Overall Study|Nervous about confidentiality|1
4774901|NCT01524796|16472528|P1|Overall Study|Gall stone surgery|1
4774902|NCT01524796|16472528|P1|Overall Study|Deterioration of pains|1
4774903|NCT01524796|16472528|P1|Overall Study|Move|1
4774904|NCT01524796|16472528|P1|Overall Study|Withdrawal by Subject|4
4774905|NCT01524796|16472528|P1|Overall Study|The price|1
4774906|NCT01524796|16472528|P1|Overall Study|Lost to Follow-up|1
4774907|NCT01524796|16472528|P1|Overall Study|Lack of Efficacy|3
4774908|NCT01524796|16472528|P1|Overall Study|Adverse Event|13
4774909|NCT01524783|16472543|P2|Randomized and Treated|Death|1
4774910|NCT01524783|16472544|P1|Randomized and Treated|Death|4
4774911|NCT01524783|16472543|P2|Randomized and Treated|Protocol Violation|1
4774912|NCT01524783|16472544|P1|Randomized and Treated|Protocol Violation|1
4774913|NCT01524783|16472543|P2|Randomized and Treated|Withdrawal by Subject|5
4774914|NCT01524783|16472544|P1|Randomized and Treated|Withdrawal by Subject|15
4774915|NCT01524783|16472543|P2|Randomized and Treated|Disease Progression|70
4774916|NCT01524783|16472544|P1|Randomized and Treated|Disease Progression|76
4774917|NCT01524783|16472543|P2|Randomized and Treated|Adverse Event|7
4774918|NCT01524783|16472544|P1|Randomized and Treated|Adverse Event|59
4774919|NCT01524783|16472543|P2|Randomized But Not Treated|Randomized, did not receive drug|0
4774920|NCT01524783|16472544|P1|Randomized But Not Treated|Randomized, did not receive drug|2
4774921|NCT01524770|16472552|P2|First Intervention|Protocol Violation|0
4774922|NCT01524770|16472553|P1|First Intervention|Protocol Violation|1
4774923|NCT01524770|16472552|P2|First Intervention|Adverse Event|1
4774924|NCT01524770|16472553|P1|First Intervention|Adverse Event|1
4774925|NCT01524770|16472552|P2|First Intervention|Withdrawal by Subject|0
4774926|NCT01524770|16472553|P1|First Intervention|Withdrawal by Subject|1
4774927|NCT01524692|16472563|P1|Overall Study|Withdrawal by Subject|3
4774928|NCT01524679|16472573|P2|Overall Study|e.g.wish for children, relocation|1
4774929|NCT01524679|16472574|P1|Overall Study|e.g.wish for children, relocation|6
4774930|NCT01524679|16472573|P2|Overall Study|Lack of Efficacy|0
4774931|NCT01524679|16472574|P1|Overall Study|Lack of Efficacy|2
4774932|NCT01524679|16472573|P2|Overall Study|Protocol Violation|0
4774933|NCT01524679|16472574|P1|Overall Study|Protocol Violation|1
4774934|NCT01524679|16472573|P2|Overall Study|Adverse Event|0
4774935|NCT01524679|16472574|P1|Overall Study|Adverse Event|9
4774936|NCT01524679|16472573|P2|Overall Study|Withdrawal by Subject|4
4774937|NCT01524679|16472574|P1|Overall Study|Withdrawal by Subject|4
4774938|NCT01524679|16472573|P2|Overall Study|Lost to Follow-up|4
4774939|NCT01524679|16472574|P1|Overall Study|Lost to Follow-up|1
4774940|NCT01524627|16472586|P2|Overall Study|Lost to Follow-up|1
4774941|NCT01524627|16472587|P1|Overall Study|Lost to Follow-up|1
4774942|NCT01524627|16472586|P2|Overall Study|Physician Decision|1
4774943|NCT01524627|16472587|P1|Overall Study|Physician Decision|0
4774944|NCT01524289|16472614|P2|Overall Study|Did not take study medication|0
4774945|NCT01524289|16472615|P1|Overall Study|Did not take study medication|1
4774946|NCT01524289|16472614|P2|Overall Study|Adverse Event|5
4774947|NCT01524289|16472615|P1|Overall Study|Adverse Event|12
4774948|NCT01524289|16472614|P2|Overall Study|Withdrawal by Subject|7
4774949|NCT01524289|16472615|P1|Overall Study|Withdrawal by Subject|11
4774950|NCT01524289|16472614|P2|Overall Study|Protocol Violation|1
4774951|NCT01524289|16472615|P1|Overall Study|Protocol Violation|5
4774952|NCT01524289|16472614|P2|Overall Study|Physician Decision|0
4774953|NCT01524289|16472615|P1|Overall Study|Physician Decision|1
4774954|NCT01524289|16472614|P2|Overall Study|Lost to Follow-up|1
4774955|NCT01524289|16472615|P1|Overall Study|Lost to Follow-up|0
4774956|NCT01524224|16472673|P8|Overall Study|Sponsor Decision|0
4774957|NCT01524224|16472674|P7|Overall Study|Sponsor Decision|0
4774958|NCT01524224|16472675|P6|Overall Study|Sponsor Decision|0
4774959|NCT01524224|16472676|P5|Overall Study|Sponsor Decision|1
4774960|NCT01524224|16472677|P4|Overall Study|Sponsor Decision|0
4774961|NCT01524224|16472678|P3|Overall Study|Sponsor Decision|0
4774962|NCT01524224|16472679|P2|Overall Study|Sponsor Decision|0
4774963|NCT01524224|16472680|P1|Overall Study|Sponsor Decision|0
4774964|NCT01524224|16472673|P8|Overall Study|Physician Decision|1
4774965|NCT01524224|16472674|P7|Overall Study|Physician Decision|0
4774966|NCT01524224|16472675|P6|Overall Study|Physician Decision|0
4774967|NCT01524224|16472676|P5|Overall Study|Physician Decision|1
4774968|NCT01524224|16472677|P4|Overall Study|Physician Decision|1
4774969|NCT01524224|16472678|P3|Overall Study|Physician Decision|0
4774970|NCT01524224|16472679|P2|Overall Study|Physician Decision|0
4774971|NCT01524224|16472680|P1|Overall Study|Physician Decision|0
4774972|NCT01524224|16472673|P8|Overall Study|Adverse Event|0
4774973|NCT01524224|16472674|P7|Overall Study|Adverse Event|0
4774974|NCT01524224|16472675|P6|Overall Study|Adverse Event|1
4774975|NCT01524224|16472676|P5|Overall Study|Adverse Event|0
4774976|NCT01524224|16472677|P4|Overall Study|Adverse Event|0
4774977|NCT01524224|16472678|P3|Overall Study|Adverse Event|0
4774978|NCT01524224|16472679|P2|Overall Study|Adverse Event|1
4774979|NCT01524224|16472680|P1|Overall Study|Adverse Event|0
4774980|NCT01524224|16472673|P8|Overall Study|Withdrawal by Subject|0
4774981|NCT01524224|16472674|P7|Overall Study|Withdrawal by Subject|2
4774982|NCT01524224|16472675|P6|Overall Study|Withdrawal by Subject|0
4774983|NCT01524224|16472676|P5|Overall Study|Withdrawal by Subject|0
4774984|NCT01524224|16472677|P4|Overall Study|Withdrawal by Subject|0
4774985|NCT01524224|16472678|P3|Overall Study|Withdrawal by Subject|0
4774986|NCT01524224|16472679|P2|Overall Study|Withdrawal by Subject|0
4774987|NCT01524224|16472680|P1|Overall Study|Withdrawal by Subject|2
4774988|NCT01524224|16472673|P8|Overall Study|Progressive Disease|5
4774989|NCT01524224|16472674|P7|Overall Study|Progressive Disease|1
4774990|NCT01524224|16472675|P6|Overall Study|Progressive Disease|1
4774991|NCT01524224|16472676|P5|Overall Study|Progressive Disease|2
4774992|NCT01524224|16472677|P4|Overall Study|Progressive Disease|1
4774993|NCT01524224|16472678|P3|Overall Study|Progressive Disease|2
4774994|NCT01524224|16472679|P2|Overall Study|Progressive Disease|0
4774995|NCT01524224|16472680|P1|Overall Study|Progressive Disease|1
4774996|NCT01524198|16472716|P2|Overall Study|Withdrawal by Subject|10
4774997|NCT01524198|16472717|P1|Overall Study|Withdrawal by Subject|15
4774998|NCT01524198|16472716|P2|Overall Study|Protocol Violation|6
4774999|NCT01524198|16472717|P1|Overall Study|Protocol Violation|8
4775000|NCT01524133|16472728|P3|Overall Study 52 Weeks|Lost to Follow-up|15
4775001|NCT01524133|16472729|P2|Overall Study 52 Weeks|Lost to Follow-up|15
4775002|NCT01524133|16472730|P1|Overall Study 52 Weeks|Lost to Follow-up|16
4775003|NCT01524133|16472728|P3|Overall Study 52 Weeks|Physician Decision|2
4775004|NCT01524133|16472729|P2|Overall Study 52 Weeks|Physician Decision|0
4775005|NCT01524133|16472730|P1|Overall Study 52 Weeks|Physician Decision|1
4775006|NCT01524133|16472728|P3|Overall Study 52 Weeks|Withdrawal by Subject|10
4775007|NCT01524133|16472729|P2|Overall Study 52 Weeks|Withdrawal by Subject|5
4775008|NCT01524133|16472730|P1|Overall Study 52 Weeks|Withdrawal by Subject|4
4775009|NCT01524133|16472728|P3|Treatment Phase|Lost to Follow-up|2
4775010|NCT01524133|16472729|P2|Treatment Phase|Lost to Follow-up|1
4775011|NCT01524133|16472730|P1|Treatment Phase|Lost to Follow-up|0
4775012|NCT01524133|16472728|P3|Treatment Phase|Physician Decision|3
4775013|NCT01524133|16472729|P2|Treatment Phase|Physician Decision|3
4775014|NCT01524133|16472730|P1|Treatment Phase|Physician Decision|6
4775015|NCT01524133|16472728|P3|Treatment Phase|Withdrawal by Subject|31
4775016|NCT01524133|16472729|P2|Treatment Phase|Withdrawal by Subject|28
4775017|NCT01524133|16472730|P1|Treatment Phase|Withdrawal by Subject|13
4775018|NCT01523886|16472773|P2|Overall Study|surgery cancelled|1
4775019|NCT01523886|16472774|P1|Overall Study|surgery cancelled|0
4775020|NCT01523873|16472780|P1|Overall Study|Protocol Violation|422
4775021|NCT01523756|16472875|P2|Test Period 2|Withdrawal by Subject|1
4775022|NCT01523756|16472876|P1|Test Period 2|Withdrawal by Subject|0
4775023|NCT01523756|16472875|P2|Test Period 1|Adverse Event|0
4775024|NCT01523756|16472876|P1|Test Period 1|Adverse Event|1
4775025|NCT01523756|16472875|P2|Baseline Period|Adverse Event|1
4775026|NCT01523756|16472876|P1|Baseline Period|Adverse Event|0
4775027|NCT01523743|16472884|P2|Period 2|Adverse Event|0
4775028|NCT01523743|16472885|P1|Period 2|Adverse Event|1
4775029|NCT01523743|16472884|P2|Period 2|Withdrawal by Subject|2
4775030|NCT01523743|16472885|P1|Period 2|Withdrawal by Subject|0
4775031|NCT01523743|16472884|P2|Period 1|Felt unable to empty bladder|0
4775032|NCT01523743|16472885|P1|Period 1|Felt unable to empty bladder|1
4775033|NCT01523743|16472884|P2|Period 1|Lack of Efficacy|0
4775034|NCT01523743|16472885|P1|Period 1|Lack of Efficacy|1
4775035|NCT01523743|16472884|P2|Period 1|Lost to Follow-up|0
4775036|NCT01523743|16472885|P1|Period 1|Lost to Follow-up|1
4775037|NCT01523743|16472884|P2|Period 1|Withdrawal by Subject|2
4775038|NCT01523743|16472885|P1|Period 1|Withdrawal by Subject|6
4775039|NCT01523743|16472884|P2|Period 1|Adverse Event|0
4775040|NCT01523743|16472885|P1|Period 1|Adverse Event|1
4775041|NCT01523587|16472908|P2|Overall Study|Randomised but bot treated|2
4775042|NCT01523587|16472909|P1|Overall Study|Randomised but bot treated|6
4775043|NCT01523587|16472908|P2|Overall Study|Withdrew due to Progressive disease|279
4775044|NCT01523587|16472909|P1|Overall Study|Withdrew due to Progressive disease|265
4775045|NCT01523587|16472908|P2|Overall Study|Withdrawal by Subject|20
4775046|NCT01523587|16472909|P1|Overall Study|Withdrawal by Subject|28
4775047|NCT01523587|16472908|P2|Overall Study|Lost to Follow-up|2
4775048|NCT01523587|16472909|P1|Overall Study|Lost to Follow-up|2
4775049|NCT01523587|16472908|P2|Overall Study|Protocol Violation|3
4775050|NCT01523587|16472909|P1|Overall Study|Protocol Violation|5
4775051|NCT01523587|16472908|P2|Overall Study|Adverse Event|52
4775052|NCT01523587|16472909|P1|Overall Study|Adverse Event|68
4775053|NCT01523587|16472908|P2|Overall Study|Worsening of underlying cancer disease|34
4775054|NCT01523587|16472909|P1|Overall Study|Worsening of underlying cancer disease|19
4775055|NCT01523587|16472908|P2|Overall Study|Other than listed|5
4775056|NCT01523587|16472909|P1|Overall Study|Other than listed|5
4775057|NCT01523457|16472952|P2|Overall Study|Withdrawal by Subject|2
4775058|NCT01523457|16472953|P1|Overall Study|Withdrawal by Subject|7
4775059|NCT01523392|16472971|P2|Washout Period - 10 to 14 Days|Adverse Event|0
4775060|NCT01523392|16472972|P1|Washout Period - 10 to 14 Days|Adverse Event|1
4775061|NCT01523392|16472971|P2|Treatment Period 1|Did not complete 7-9 days of treatment.|0
4775062|NCT01523392|16472972|P1|Treatment Period 1|Did not complete 7-9 days of treatment.|1
4775063|NCT01523392|16472971|P2|Treatment Period 1|Withdrawal by Subject|0
4775064|NCT01523392|16472972|P1|Treatment Period 1|Withdrawal by Subject|2
4775065|NCT01523366|16472988|P2|Treatment Period 2|Not completed at least 7 days treatment|0
4775066|NCT01523366|16472989|P1|Treatment Period 2|Not completed at least 7 days treatment|1
4775067|NCT01523366|16472988|P2|Treatment Period 1|Withdrawal by Subject|0
4775068|NCT01523366|16472989|P1|Treatment Period 1|Withdrawal by Subject|1
4775069|NCT01523301|16473005|P2|Overall Study|Other Reason|2
4775070|NCT01523301|16473006|P1|Overall Study|Other Reason|0
4775071|NCT01523301|16473005|P2|Overall Study|Withdrawal by Subject|8
4775072|NCT01523301|16473006|P1|Overall Study|Withdrawal by Subject|6
4775073|NCT01523301|16473005|P2|Overall Study|Lost to Follow-up|0
4775074|NCT01523301|16473006|P1|Overall Study|Lost to Follow-up|1
4775075|NCT01523301|16473005|P2|Overall Study|Protocol Violation|4
4775076|NCT01523301|16473006|P1|Overall Study|Protocol Violation|3
4775077|NCT01523301|16473005|P2|Overall Study|Lack of Efficacy|2
4775078|NCT01523301|16473006|P1|Overall Study|Lack of Efficacy|0
4775079|NCT01523301|16473005|P2|Overall Study|Adverse Event|16
4775080|NCT01523301|16473006|P1|Overall Study|Adverse Event|25
4775081|NCT01523275|16473026|P2|Overall Study|Withdrawal by Subject|0
4775082|NCT01523275|16473027|P1|Overall Study|Withdrawal by Subject|1
4775083|NCT01523275|16473026|P2|Overall Study|Lost to Follow-up|2
4775084|NCT01523275|16473027|P1|Overall Study|Lost to Follow-up|1
4775085|NCT01522976|16473040|P3|Overall Study|Not protocol specified|27
4775086|NCT01522976|16473041|P2|Overall Study|Not protocol specified|27
4775087|NCT01522976|16473042|P1|Overall Study|Not protocol specified|22
4775088|NCT01522976|16473040|P3|Overall Study|Refusal unrelated to adverse event|14
4775089|NCT01522976|16473041|P2|Overall Study|Refusal unrelated to adverse event|13
4775090|NCT01522976|16473042|P1|Overall Study|Refusal unrelated to adverse event|10
4775091|NCT01522976|16473040|P3|Overall Study|Adverse Event|18
4775092|NCT01522976|16473041|P2|Overall Study|Adverse Event|7
4775093|NCT01522976|16473042|P1|Overall Study|Adverse Event|17
4775094|NCT01522976|16473040|P3|Overall Study|Disease progression|25
4775095|NCT01522976|16473041|P2|Overall Study|Disease progression|30
4775096|NCT01522976|16473042|P1|Overall Study|Disease progression|28
4775097|NCT01522976|16473040|P3|Overall Study|Still on treatment|6
4775098|NCT01522976|16473041|P2|Overall Study|Still on treatment|9
4775099|NCT01522976|16473042|P1|Overall Study|Still on treatment|9
4775100|NCT01522976|16473040|P3|Overall Study|Death|2
4775101|NCT01522976|16473041|P2|Overall Study|Death|6
4775102|NCT01522976|16473042|P1|Overall Study|Death|7
4775103|NCT01522976|16473040|P3|Overall Study|Ineligible|1
4775104|NCT01522976|16473041|P2|Overall Study|Ineligible|0
4775105|NCT01522976|16473042|P1|Overall Study|Ineligible|4
4775106|NCT01522950|16473087|P3|Overall Study|Study Medication Sensitivity|0
4775107|NCT01522950|16473088|P2|Overall Study|Study Medication Sensitivity|1
4775108|NCT01522950|16473089|P1|Overall Study|Study Medication Sensitivity|0
4775109|NCT01522950|16473087|P3|Overall Study|Death|1
4775110|NCT01522950|16473088|P2|Overall Study|Death|1
4775111|NCT01522950|16473089|P1|Overall Study|Death|0
4775112|NCT01522950|16473087|P3|Overall Study|Protocol Violation|2
4775113|NCT01522950|16473088|P2|Overall Study|Protocol Violation|0
4775114|NCT01522950|16473089|P1|Overall Study|Protocol Violation|0
4775115|NCT01522950|16473087|P3|Overall Study|Adverse Event|1
4775116|NCT01522950|16473088|P2|Overall Study|Adverse Event|1
4775117|NCT01522950|16473089|P1|Overall Study|Adverse Event|3
4775118|NCT01522950|16473087|P3|Overall Study|Withdrawal by Subject|1
4775119|NCT01522950|16473088|P2|Overall Study|Withdrawal by Subject|2
4775120|NCT01522950|16473089|P1|Overall Study|Withdrawal by Subject|3
4775121|NCT01522456|16473152|P1|Overall Study|Tolerability Assessment|1
4775122|NCT01522456|16473152|P1|Overall Study|Pregnancy|1
4775123|NCT01522456|16473152|P1|Overall Study|Withdrawal by Subject|2
4775124|NCT01522456|16473152|P1|Overall Study|Lost to Follow-up|2
4775125|NCT01522456|16473152|P1|Overall Study|Adverse Event|2
4775126|NCT01522443|16473215|P2|Overall Study|Other|3
4775127|NCT01522443|16473216|P1|Overall Study|Other|1
4775128|NCT01522443|16473215|P2|Overall Study|No study treatment given|1
4775129|NCT01522443|16473216|P1|Overall Study|No study treatment given|1
4775130|NCT01522443|16473215|P2|Overall Study|Withdrawal by Subject|8
4775131|NCT01522443|16473216|P1|Overall Study|Withdrawal by Subject|5
4775132|NCT01522443|16473215|P2|Overall Study|Adverse Event|15
4775133|NCT01522443|16473216|P1|Overall Study|Adverse Event|10
4775134|NCT01522443|16473215|P2|Overall Study|No longer receiving clinical benefit|28
4775135|NCT01522443|16473216|P1|Overall Study|No longer receiving clinical benefit|36
4775136|NCT01522404|16473228|P2|Second Intervention (up to Week 58)|Withdrawal by Subject|0
4775137|NCT01522404|16473229|P1|Second Intervention (up to Week 58)|Withdrawal by Subject|1
4775138|NCT01522404|16473228|P2|First Intervention (up to Week 29)|Adverse Event|0
4775139|NCT01522404|16473229|P1|First Intervention (up to Week 29)|Adverse Event|1
4775140|NCT01522404|16473228|P2|First Intervention (up to Week 29)|Withdrawal by Subject|0
4775141|NCT01522404|16473229|P1|First Intervention (up to Week 29)|Withdrawal by Subject|1
4775142|NCT01522248|16473315|P2|Overall Study|Lost to Follow-up|0
4775143|NCT01522248|16473316|P1|Overall Study|Lost to Follow-up|1
4775144|NCT01522235|16473331|P2|Overall Study|Physician Decision|1
4775145|NCT01522235|16473332|P1|Overall Study|Physician Decision|1
4775146|NCT01521923|16473368|P4|Overall Study|AE, captured in Period 1|1
4775147|NCT01521923|16473369|P3|Overall Study|AE, captured in Period 1|0
4775148|NCT01521923|16473370|P2|Overall Study|AE, captured in Period 1|1
4775149|NCT01521923|16473371|P1|Overall Study|AE, captured in Period 1|0
4775150|NCT01521923|16473368|P4|Overall Study|Other|6
4775151|NCT01521923|16473369|P3|Overall Study|Other|3
4775152|NCT01521923|16473370|P2|Overall Study|Other|1
4775153|NCT01521923|16473371|P1|Overall Study|Other|2
4775154|NCT01521923|16473368|P4|Overall Study|Withdrawal by Subject|2
4775155|NCT01521923|16473369|P3|Overall Study|Withdrawal by Subject|1
4775156|NCT01521923|16473370|P2|Overall Study|Withdrawal by Subject|1
4775157|NCT01521923|16473371|P1|Overall Study|Withdrawal by Subject|1
4775158|NCT01521923|16473368|P4|Overall Study|Lost to Follow-up|1
4775159|NCT01521923|16473369|P3|Overall Study|Lost to Follow-up|2
4775160|NCT01521923|16473370|P2|Overall Study|Lost to Follow-up|0
4775161|NCT01521923|16473371|P1|Overall Study|Lost to Follow-up|1
4775162|NCT01521923|16473368|P4|Overall Study|Protocol Violation|0
4775163|NCT01521923|16473369|P3|Overall Study|Protocol Violation|1
4775164|NCT01521923|16473370|P2|Overall Study|Protocol Violation|0
4775165|NCT01521923|16473371|P1|Overall Study|Protocol Violation|0
4775166|NCT01521923|16473368|P4|Overall Study|Lack of Efficacy|0
4775167|NCT01521923|16473369|P3|Overall Study|Lack of Efficacy|0
4775168|NCT01521923|16473370|P2|Overall Study|Lack of Efficacy|1
4775169|NCT01521923|16473371|P1|Overall Study|Lack of Efficacy|1
4775170|NCT01521923|16473368|P4|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1
4775171|NCT01521923|16473369|P3|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
4775172|NCT01521923|16473370|P2|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
4775173|NCT01521923|16473371|P1|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0
4775174|NCT01521923|16473368|P4|Overall Study|AE, non-serious, non-fatal|2
4775175|NCT01521923|16473369|P3|Overall Study|AE, non-serious, non-fatal|6
4775176|NCT01521923|16473370|P2|Overall Study|AE, non-serious, non-fatal|3
4775177|NCT01521923|16473371|P1|Overall Study|AE, non-serious, non-fatal|1
4775178|NCT01521923|16473368|P4|Overall Study|SAE, non-fatal|0
4775179|NCT01521923|16473369|P3|Overall Study|SAE, non-fatal|2
4775180|NCT01521923|16473370|P2|Overall Study|SAE, non-fatal|2
4775181|NCT01521923|16473371|P1|Overall Study|SAE, non-fatal|0
4775182|NCT01521923|16473368|P4|Overall Study|AE, serious fatal|0
4775183|NCT01521923|16473369|P3|Overall Study|AE, serious fatal|0
4775184|NCT01521923|16473370|P2|Overall Study|AE, serious fatal|0
4775185|NCT01521923|16473371|P1|Overall Study|AE, serious fatal|1
4775186|NCT01521897|16473491|P1|Overall Study|Lost to Follow-up|5
4775187|NCT01521897|16473491|P1|Overall Study|Protocol Violation|18
4775188|NCT01521884|16473503|P1|Overall Study|Lost to Follow-up|4
4775189|NCT01521884|16473503|P1|Overall Study|Participant non-eligible|1
4775190|NCT01521884|16473503|P1|Overall Study|Protocol Violation|3
4775191|NCT01521884|16473503|P1|Overall Study|Physician Decision|2
4775192|NCT01521884|16473503|P1|Overall Study|Withdrawal by Subject|1
4775193|NCT01521884|16473503|P1|Overall Study|Pregnancy|1
4775194|NCT01521884|16473503|P1|Overall Study|Adverse Event|5
4775195|NCT01521884|16473503|P1|Overall Study|Non Responders|10
4775196|NCT01521559|16473600|P2|Overall Study|Other|2
4775197|NCT01521559|16473601|P1|Overall Study|Other|1
4775198|NCT01521559|16473600|P2|Overall Study|Protocol Violation|0
4775199|NCT01521559|16473601|P1|Overall Study|Protocol Violation|1
4775200|NCT01521559|16473600|P2|Overall Study|Lost to Follow-up|1
4775201|NCT01521559|16473601|P1|Overall Study|Lost to Follow-up|3
4775202|NCT01521559|16473600|P2|Overall Study|Withdrawal by Subject|11
4775203|NCT01521559|16473601|P1|Overall Study|Withdrawal by Subject|9
4775204|NCT01521559|16473600|P2|Overall Study|Death|0
4775205|NCT01521559|16473601|P1|Overall Study|Death|1
4775206|NCT01521559|16473600|P2|Overall Study|Adverse Event|4
4775207|NCT01521559|16473601|P1|Overall Study|Adverse Event|0
4775208|NCT01521507|16473624|P2|Stage 2: Observational Design|Physician Decision|0
4775209|NCT01521507|16473625|P1|Stage 2: Observational Design|Physician Decision|1
4775210|NCT01521507|16473624|P2|Stage 2: Observational Design|Withdrawal by Subject|1
4775211|NCT01521507|16473625|P1|Stage 2: Observational Design|Withdrawal by Subject|3
4775212|NCT01521507|16473624|P2|Stage 2: Observational Design|Device did not fit, No Treatment|1
4775213|NCT01521507|16473625|P1|Stage 2: Observational Design|Device did not fit, No Treatment|0
4775214|NCT01521507|16473624|P2|Stage 1: Randomized Design|Lost to Follow-up|2
4775215|NCT01521507|16473625|P1|Stage 1: Randomized Design|Lost to Follow-up|0
4775216|NCT01521507|16473624|P2|Stage 1: Randomized Design|Withdrawal by Subject|3
4775217|NCT01521507|16473625|P1|Stage 1: Randomized Design|Withdrawal by Subject|1
4775218|NCT01521507|16473624|P2|Stage 1: Randomized Design|Device did not fit, No Treatment|0
4775219|NCT01521507|16473625|P1|Stage 1: Randomized Design|Device did not fit, No Treatment|2
4775220|NCT01521494|16473647|P5|Overall Study|Physician Decision|2
4775221|NCT01521494|16473648|P4|Overall Study|Physician Decision|0
4775222|NCT01521494|16473649|P3|Overall Study|Physician Decision|0
4775223|NCT01521494|16473650|P2|Overall Study|Physician Decision|0
4775224|NCT01521494|16473651|P1|Overall Study|Physician Decision|0
4775225|NCT01521494|16473647|P5|Overall Study|Decrease in serum calcium|1
4775226|NCT01521494|16473648|P4|Overall Study|Decrease in serum calcium|1
4775227|NCT01521494|16473649|P3|Overall Study|Decrease in serum calcium|0
4775228|NCT01521494|16473650|P2|Overall Study|Decrease in serum calcium|0
4775229|NCT01521494|16473651|P1|Overall Study|Decrease in serum calcium|0
4775230|NCT01521494|16473647|P5|Overall Study|Decrease in serum phosphate|0
4775231|NCT01521494|16473648|P4|Overall Study|Decrease in serum phosphate|12
4775232|NCT01521494|16473649|P3|Overall Study|Decrease in serum phosphate|3
4775233|NCT01521494|16473650|P2|Overall Study|Decrease in serum phosphate|2
4775234|NCT01521494|16473651|P1|Overall Study|Decrease in serum phosphate|0
4775235|NCT01521494|16473647|P5|Overall Study|Withdrawal by Subject|0
4775236|NCT01521494|16473648|P4|Overall Study|Withdrawal by Subject|2
4775237|NCT01521494|16473649|P3|Overall Study|Withdrawal by Subject|0
4775238|NCT01521494|16473650|P2|Overall Study|Withdrawal by Subject|1
4775239|NCT01521494|16473651|P1|Overall Study|Withdrawal by Subject|1
4775240|NCT01521494|16473647|P5|Overall Study|Lack of Efficacy|2
4775241|NCT01521494|16473648|P4|Overall Study|Lack of Efficacy|0
4775242|NCT01521494|16473649|P3|Overall Study|Lack of Efficacy|0
4775243|NCT01521494|16473650|P2|Overall Study|Lack of Efficacy|0
4775244|NCT01521494|16473651|P1|Overall Study|Lack of Efficacy|0
4775245|NCT01521494|16473647|P5|Overall Study|Adverse Event|2
4775246|NCT01521494|16473648|P4|Overall Study|Adverse Event|6
4775247|NCT01521494|16473649|P3|Overall Study|Adverse Event|9
4775248|NCT01521494|16473650|P2|Overall Study|Adverse Event|2
4775249|NCT01521494|16473651|P1|Overall Study|Adverse Event|1
4775250|NCT01521364|16473673|P1|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1
4775251|NCT01521364|16473673|P1|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1
4775252|NCT01520987|16473749|P8|Overall Study|Withdrawal by Subject|0
4775253|NCT01520987|16473750|P7|Overall Study|Withdrawal by Subject|0
4775254|NCT01520987|16473751|P6|Overall Study|Withdrawal by Subject|1
4775255|NCT01520987|16473752|P5|Overall Study|Withdrawal by Subject|0
4775256|NCT01520987|16473753|P4|Overall Study|Withdrawal by Subject|0
4775257|NCT01520987|16473754|P3|Overall Study|Withdrawal by Subject|0
4775258|NCT01520987|16473755|P2|Overall Study|Withdrawal by Subject|0
4775259|NCT01520987|16473756|P1|Overall Study|Withdrawal by Subject|1
4775260|NCT01520922|16473816|P2|Survival Follow-up|Withdrawal by Subject|0
4775261|NCT01520922|16473817|P1|Survival Follow-up|Withdrawal by Subject|1
4775262|NCT01520922|16473816|P2|Follow up|Lost to Follow-up|1
4775263|NCT01520922|16473817|P1|Follow up|Lost to Follow-up|0
4775264|NCT01520922|16473816|P2|Treatment Phase|Adverse Event|5
4775265|NCT01520922|16473817|P1|Treatment Phase|Adverse Event|3
4775266|NCT01520922|16473816|P2|Treatment Phase|Progression|2
4775267|NCT01520922|16473817|P1|Treatment Phase|Progression|0
4775268|NCT01520922|16473816|P2|Treatment Phase|Physician Decision|1
4775269|NCT01520922|16473817|P1|Treatment Phase|Physician Decision|2
4775270|NCT01520909|16473879|P3|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1
4775271|NCT01520909|16473880|P2|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
4775272|NCT01520909|16473881|P1|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0
4775273|NCT01520909|16473879|P3|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2
4775274|NCT01520909|16473880|P2|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
4775275|NCT01520909|16473881|P1|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0
4775276|NCT01520909|16473879|P3|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4
4775277|NCT01520909|16473880|P2|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
4775278|NCT01520909|16473881|P1|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0
4775279|NCT01520909|16473879|P3|Part 1 (Randomized Period)|Adverse Event|0
4775280|NCT01520909|16473880|P2|Part 1 (Randomized Period)|Adverse Event|2
4775281|NCT01520909|16473881|P1|Part 1 (Randomized Period)|Adverse Event|1
4775282|NCT01520714|16473998|P2|Overall Study|Lack of Efficacy|1
4775283|NCT01520714|16473999|P1|Overall Study|Lack of Efficacy|0
4775284|NCT01520714|16473998|P2|Overall Study|Adverse Event|2
4775285|NCT01520714|16473999|P1|Overall Study|Adverse Event|0
4775286|NCT01520714|16473998|P2|Overall Study|Protocol Violation|3
4775287|NCT01520714|16473999|P1|Overall Study|Protocol Violation|0
4775288|NCT01520506|16474044|P1|Overall Study|Withdrawal by Subject|1
4775289|NCT01520506|16474044|P1|Overall Study|Lost to Follow-up|1
4775290|NCT01520506|16474044|P1|Overall Study|Missed Visit|4
4775291|NCT01520402|16474099|P1|Overall Study|Physician Decision|3
4775292|NCT01520402|16474099|P1|Overall Study|Withdrawal by Subject|2
4775293|NCT01520363|16474112|P2|Overall Study|Withdrawal by Subject|0
4775294|NCT01520363|16474113|P1|Overall Study|Withdrawal by Subject|2
4775295|NCT01520324|16474187|P1|Overall Study|Subject discontinued (moderate illness)|1
4775296|NCT01519960|16474216|P3|Overall Study|Lost to Follow-up|0
4775297|NCT01519960|16474217|P2|Overall Study|Lost to Follow-up|1
4775298|NCT01519960|16474218|P1|Overall Study|Lost to Follow-up|0
4775299|NCT01519960|16474216|P3|Overall Study|Withdrawal by Subject|0
4775300|NCT01519960|16474217|P2|Overall Study|Withdrawal by Subject|4
4775301|NCT01519960|16474218|P1|Overall Study|Withdrawal by Subject|0
4775302|NCT01519960|16474216|P3|Overall Study|Adverse Event|0
4775303|NCT01519960|16474217|P2|Overall Study|Adverse Event|1
4775304|NCT01519960|16474218|P1|Overall Study|Adverse Event|0
4775305|NCT01519960|16474216|P3|Overall Study|Ongoing/Switched to PEG-IFN|0
4775306|NCT01519960|16474217|P2|Overall Study|Ongoing/Switched to PEG-IFN|33
4775307|NCT01519960|16474218|P1|Overall Study|Ongoing/Switched to PEG-IFN|0
4775308|NCT01519960|16474216|P3|Overall Study|Ongoing in Follow-Up|10
4775309|NCT01519960|16474217|P2|Overall Study|Ongoing in Follow-Up|11
4775310|NCT01519960|16474218|P1|Overall Study|Ongoing in Follow-Up|101
4775311|NCT01519947|16474328|P4|Overall Study|Adverse Event|1
4775312|NCT01519947|16474329|P3|Overall Study|Adverse Event|1
4775313|NCT01519947|16474330|P2|Overall Study|Adverse Event|0
4775314|NCT01519947|16474331|P1|Overall Study|Adverse Event|1
4775315|NCT01519947|16474328|P4|Overall Study|Poor Response|1
4775316|NCT01519947|16474329|P3|Overall Study|Poor Response|0
4775317|NCT01519947|16474330|P2|Overall Study|Poor Response|0
4775318|NCT01519947|16474331|P1|Overall Study|Poor Response|1
4775319|NCT01519947|16474328|P4|Overall Study|Lost to Follow-up|2
4775320|NCT01519947|16474329|P3|Overall Study|Lost to Follow-up|3
4775321|NCT01519947|16474330|P2|Overall Study|Lost to Follow-up|0
4775322|NCT01519947|16474331|P1|Overall Study|Lost to Follow-up|0
4775323|NCT01519947|16474328|P4|Overall Study|Withdrawal by Subject|1
4775324|NCT01519947|16474329|P3|Overall Study|Withdrawal by Subject|0
4775325|NCT01519947|16474330|P2|Overall Study|Withdrawal by Subject|1
4775326|NCT01519947|16474331|P1|Overall Study|Withdrawal by Subject|0
4775327|NCT01519947|16474328|P4|Overall Study|Blood Transfusion|0
4775328|NCT01519947|16474329|P3|Overall Study|Blood Transfusion|1
4775329|NCT01519947|16474330|P2|Overall Study|Blood Transfusion|1
4775330|NCT01519947|16474331|P1|Overall Study|Blood Transfusion|0
4775331|NCT01519947|16474328|P4|Overall Study|Development of Anemia|1
4775332|NCT01519947|16474329|P3|Overall Study|Development of Anemia|0
4775333|NCT01519947|16474330|P2|Overall Study|Development of Anemia|1
4775334|NCT01519947|16474331|P1|Overall Study|Development of Anemia|0
4775335|NCT01519947|16474328|P4|Overall Study|Peritoneal Dialysis Needed|0
4775336|NCT01519947|16474329|P3|Overall Study|Peritoneal Dialysis Needed|0
4775337|NCT01519947|16474330|P2|Overall Study|Peritoneal Dialysis Needed|1
4775338|NCT01519947|16474331|P1|Overall Study|Peritoneal Dialysis Needed|0
4775339|NCT01519947|16474328|P4|Overall Study|Protocol Violation|1
4775340|NCT01519947|16474329|P3|Overall Study|Protocol Violation|2
4775341|NCT01519947|16474330|P2|Overall Study|Protocol Violation|0
4775342|NCT01519947|16474331|P1|Overall Study|Protocol Violation|0
4775343|NCT01519947|16474328|P4|Overall Study|Death|1
4775344|NCT01519947|16474329|P3|Overall Study|Death|0
4775345|NCT01519947|16474330|P2|Overall Study|Death|0
4775346|NCT01519947|16474331|P1|Overall Study|Death|0
4775347|NCT01519934|16474361|P1|Overall Study|Lost to Follow-up|3
4775348|NCT01519921|16474370|P2|Overall Study|High alanine aminotransferase (ALT)|1
4775349|NCT01519921|16474371|P1|Overall Study|High alanine aminotransferase (ALT)|0
4775350|NCT01519921|16474370|P2|Overall Study|Treatment refusal|1
4775351|NCT01519921|16474371|P1|Overall Study|Treatment refusal|2
4775352|NCT01519921|16474370|P2|Overall Study|Lost to Follow-up|1
4775353|NCT01519921|16474371|P1|Overall Study|Lost to Follow-up|2
4775354|NCT01519921|16474370|P2|Overall Study|Withdrawal by Subject|0
4775355|NCT01519921|16474371|P1|Overall Study|Withdrawal by Subject|3
4775356|NCT01519921|16474370|P2|Overall Study|Lack of Efficacy|3
4775357|NCT01519921|16474371|P1|Overall Study|Lack of Efficacy|4
4775358|NCT01519921|16474370|P2|Overall Study|Adverse Event|9
4775359|NCT01519921|16474371|P1|Overall Study|Adverse Event|10
4775360|NCT01519817|16474420|P4|Overall Study|Off study due to infection|1
4775361|NCT01519817|16474421|P3|Overall Study|Off study due to infection|0
4775362|NCT01519817|16474422|P2|Overall Study|Off study due to infection|0
4775363|NCT01519817|16474423|P1|Overall Study|Off study due to infection|0
4775364|NCT01519817|16474420|P4|Overall Study|Withdrawal by Subject|0
4775365|NCT01519817|16474421|P3|Overall Study|Withdrawal by Subject|0
4775366|NCT01519817|16474422|P2|Overall Study|Withdrawal by Subject|0
4775367|NCT01519817|16474423|P1|Overall Study|Withdrawal by Subject|1
4775368|NCT01519791|16474463|P2|Overall Study|Lost to Follow-up|14
4775369|NCT01519791|16474464|P1|Overall Study|Lost to Follow-up|6
4775370|NCT01519791|16474463|P2|Overall Study|Withdrawal by Subject|37
4775371|NCT01519791|16474464|P1|Overall Study|Withdrawal by Subject|15
4775372|NCT01519791|16474463|P2|Overall Study|AE, non-serious non-fatal|31
4775373|NCT01519791|16474464|P1|Overall Study|AE, non-serious non-fatal|12
4775374|NCT01519791|16474463|P2|Overall Study|SAE, fatal + SAE, non-fatal|1
4775375|NCT01519791|16474464|P1|Overall Study|SAE, fatal + SAE, non-fatal|0
4775376|NCT01519791|16474463|P2|Overall Study|AE, serious fatal|1
4775377|NCT01519791|16474464|P1|Overall Study|AE, serious fatal|0
4775378|NCT01519791|16474463|P2|Overall Study|SAE, non-fatal|22
4775379|NCT01519791|16474464|P1|Overall Study|SAE, non-fatal|6
4775380|NCT01519791|16474463|P2|Overall Study|Lack of Efficacy|20
4775381|NCT01519791|16474464|P1|Overall Study|Lack of Efficacy|16
4775382|NCT01519791|16474463|P2|Overall Study|subjects randomized in error|0
4775383|NCT01519791|16474464|P1|Overall Study|subjects randomized in error|2
4775384|NCT01519791|16474463|P2|Overall Study|Other Reason|222
4775385|NCT01519791|16474464|P1|Overall Study|Other Reason|87
4775386|NCT01519791|16474463|P2|Overall Study|Protocol Violation|19
4775387|NCT01519791|16474464|P1|Overall Study|Protocol Violation|6
4775388|NCT01519791|16474463|P2|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1
4775389|NCT01519791|16474464|P1|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2
4775390|NCT01519778|16474528|P1|Overall Study|Physician Decision|1
4775391|NCT01519778|16474528|P1|Overall Study|Lost to Follow-up|10
4775392|NCT01519778|16474528|P1|Overall Study|Withdrawal by Subject|3
4775393|NCT01519765|16474534|P2|Overall Study|Withdrawal by Subject|1
4775394|NCT01519765|16474535|P1|Overall Study|Withdrawal by Subject|0
4775395|NCT01519765|16474534|P2|Overall Study|Protocol Violation|0
4775396|NCT01519765|16474535|P1|Overall Study|Protocol Violation|1
4775397|NCT01519765|16474534|P2|Overall Study|Lack of Efficacy|0
4775398|NCT01519765|16474535|P1|Overall Study|Lack of Efficacy|2
4775399|NCT01519765|16474534|P2|Overall Study|Adverse Event|1
4775400|NCT01519765|16474535|P1|Overall Study|Adverse Event|0
4775401|NCT01519700|16474613|P4|Overall Study|Other Reason|4
4775402|NCT01519700|16474614|P3|Overall Study|Other Reason|0
4775403|NCT01519700|16474615|P2|Overall Study|Other Reason|2
4775404|NCT01519700|16474616|P1|Overall Study|Other Reason|2
4775405|NCT01519700|16474613|P4|Overall Study|Withdrawal by Subject|2
4775406|NCT01519700|16474614|P3|Overall Study|Withdrawal by Subject|3
4775407|NCT01519700|16474615|P2|Overall Study|Withdrawal by Subject|3
4775408|NCT01519700|16474616|P1|Overall Study|Withdrawal by Subject|5
4775409|NCT01519700|16474613|P4|Overall Study|Physician Decision|0
4775410|NCT01519700|16474614|P3|Overall Study|Physician Decision|3
4775411|NCT01519700|16474615|P2|Overall Study|Physician Decision|1
4775412|NCT01519700|16474616|P1|Overall Study|Physician Decision|1
4775413|NCT01519700|16474613|P4|Overall Study|Lost to Follow-up|1
4775414|NCT01519700|16474614|P3|Overall Study|Lost to Follow-up|1
4775415|NCT01519700|16474615|P2|Overall Study|Lost to Follow-up|0
4775416|NCT01519700|16474616|P1|Overall Study|Lost to Follow-up|0
4775417|NCT01519700|16474613|P4|Overall Study|Death|0
4775418|NCT01519700|16474614|P3|Overall Study|Death|0
4775419|NCT01519700|16474615|P2|Overall Study|Death|0
4775420|NCT01519700|16474616|P1|Overall Study|Death|1
4775421|NCT01519674|16474651|P3|Overall Study|Unsclassified|3
4775422|NCT01519674|16474652|P2|Overall Study|Unsclassified|4
4775423|NCT01519674|16474653|P1|Overall Study|Unsclassified|10
4775424|NCT01519674|16474651|P3|Overall Study|Withdrawal Criteria|7
4775425|NCT01519674|16474652|P2|Overall Study|Withdrawal Criteria|2
4775426|NCT01519674|16474653|P1|Overall Study|Withdrawal Criteria|7
4775427|NCT01519674|16474651|P3|Overall Study|Protocol Violation|1
4775428|NCT01519674|16474652|P2|Overall Study|Protocol Violation|3
4775429|NCT01519674|16474653|P1|Overall Study|Protocol Violation|0
4775430|NCT01519674|16474651|P3|Overall Study|Lack of Efficacy|1
4775431|NCT01519674|16474652|P2|Overall Study|Lack of Efficacy|1
4775432|NCT01519674|16474653|P1|Overall Study|Lack of Efficacy|1
4775433|NCT01519674|16474651|P3|Overall Study|Adverse Event|0
4775434|NCT01519674|16474652|P2|Overall Study|Adverse Event|3
4775435|NCT01519674|16474653|P1|Overall Study|Adverse Event|3
4775436|NCT01519661|16474691|P1|Overall Study|Adverse Event|29
4775437|NCT01519661|16474691|P1|Overall Study|Lack of Efficacy|6
4775438|NCT01519661|16474691|P1|Overall Study|Withdrawal by Subject|17
4775439|NCT01519661|16474691|P1|Overall Study|Lost to Follow-up|3
4775440|NCT01519661|16474691|P1|Overall Study|Protocol deviation|6
4775441|NCT01519635|16474717|P2|Overall Study|No possibility to put a catheter|2
4775442|NCT01519635|16474718|P1|Overall Study|No possibility to put a catheter|1
4775443|NCT01519635|16474717|P2|Overall Study|Withdrawal by Subject|1
4775444|NCT01519635|16474718|P1|Overall Study|Withdrawal by Subject|0
4775445|NCT01519518|16474735|P2|Overall Study|Consent not available|10
4775446|NCT01519518|16474736|P1|Overall Study|Consent not available|7
4775447|NCT01519427|16474761|P1|Overall Study|disease progression|2
4775448|NCT01519323|16474793|P2|Overall Study|Study terminated by sponsor|1
4775449|NCT01519323|16474794|P1|Overall Study|Study terminated by sponsor|0
4775450|NCT01519323|16474793|P2|Overall Study|Death|2
4775451|NCT01519323|16474794|P1|Overall Study|Death|3
4775452|NCT01519245|16474854|P2|Overall Study|Met exclusion criteria, not analysed|2
4775453|NCT01519245|16474855|P1|Overall Study|Met exclusion criteria, not analysed|1
4775454|NCT01519206|16474867|P1|Overall Study|Missed Visit|2
4775455|NCT01519206|16474867|P1|Overall Study|Lost to Follow-up|3
4775456|NCT01519167|16474881|P2|Overall Study|Physician Decision|1
4775457|NCT01519167|16474882|P1|Overall Study|Physician Decision|0
4775458|NCT01519167|16474881|P2|Overall Study|Medical condition changes&deep sedation|2
4775459|NCT01519167|16474882|P1|Overall Study|Medical condition changes&deep sedation|0
4775460|NCT01519167|16474881|P2|Overall Study|Lack of Efficacy|1
4775461|NCT01519167|16474882|P1|Overall Study|Lack of Efficacy|0
4775462|NCT01519167|16474881|P2|Overall Study|Adverse Event|1
4775463|NCT01519167|16474882|P1|Overall Study|Adverse Event|0
4775464|NCT01519167|16474881|P2|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3
4775465|NCT01519167|16474882|P1|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0
4775466|NCT01519089|16474908|P2|Overall Study|Not received study drug|1
4775467|NCT01519089|16474909|P1|Overall Study|Not received study drug|0
4775468|NCT01519089|16474908|P2|Overall Study|Other|6
4775469|NCT01519089|16474909|P1|Overall Study|Other|2
4775470|NCT01519089|16474908|P2|Overall Study|Withdrawal by Subject|2
4775471|NCT01519089|16474909|P1|Overall Study|Withdrawal by Subject|0
4775472|NCT01519089|16474908|P2|Overall Study|Lost to Follow-up|0
4775473|NCT01519089|16474909|P1|Overall Study|Lost to Follow-up|1
4775474|NCT01519089|16474908|P2|Overall Study|Lack of Efficacy|2
4775475|NCT01519089|16474909|P1|Overall Study|Lack of Efficacy|0
4775476|NCT01519089|16474908|P2|Overall Study|Adverse Event|4
4775477|NCT01519089|16474909|P1|Overall Study|Adverse Event|4
4775478|NCT01518972|16475051|P2|Overall Study|Declined medication starting on day 12|1
4775479|NCT01518972|16475052|P1|Overall Study|Declined medication starting on day 12|0
4775480|NCT01518972|16475051|P2|Overall Study|Exclusionary medication|1
4775481|NCT01518972|16475052|P1|Overall Study|Exclusionary medication|0
4775482|NCT01518972|16475051|P2|Overall Study|Missed safety visits|1
4775483|NCT01518972|16475052|P1|Overall Study|Missed safety visits|0
4775484|NCT01518972|16475051|P2|Overall Study|Exclusionary medical condition|0
4775485|NCT01518972|16475052|P1|Overall Study|Exclusionary medical condition|1
4775486|NCT01518972|16475051|P2|Overall Study|Transportation problems|0
4775487|NCT01518972|16475052|P1|Overall Study|Transportation problems|1
4775488|NCT01518972|16475051|P2|Overall Study|Moved from area|0
4775489|NCT01518972|16475052|P1|Overall Study|Moved from area|1
4775490|NCT01518972|16475051|P2|Overall Study|Withdrawal by Subject|0
4775491|NCT01518972|16475052|P1|Overall Study|Withdrawal by Subject|1
4775492|NCT01518972|16475051|P2|Overall Study|Lost to Follow-up|1
4775493|NCT01518972|16475052|P1|Overall Study|Lost to Follow-up|2
4775494|NCT01518946|16475066|P3|Randomized Phase (First Intervention)|Other|0
4775495|NCT01518946|16475067|P2|Randomized Phase (First Intervention)|Other|1
4775496|NCT01518946|16475068|P1|Randomized Phase (First Intervention)|Other|0
4775497|NCT01518946|16475066|P3|Open-label Phase|Other|0
4775498|NCT01518946|16475067|P2|Open-label Phase|Other|0
4775499|NCT01518946|16475068|P1|Open-label Phase|Other|4
4775500|NCT01518374|16475088|P1|Overall Study|Lost to Follow-up|2
4775501|NCT01518374|16475088|P1|Overall Study|Protocol Violation|3
4775502|NCT01518374|16475088|P1|Overall Study|Withdrawal by Subject|2
4775503|NCT01518322|16475092|P1|Overall Study|FeNO measurement was missing|13
4775504|NCT01518257|16475113|P2|Overall Study|Other Miscellaneous Reason|0
4775505|NCT01518257|16475114|P1|Overall Study|Other Miscellaneous Reason|1
4775506|NCT01518257|16475113|P2|Overall Study|Lost to Follow-up|0
4775507|NCT01518257|16475114|P1|Overall Study|Lost to Follow-up|1
4775508|NCT01518244|16475136|P1|Overall Study|Adverse Event|3
4775509|NCT01518192|16475144|P3|Overall Study|Lost to Follow-up|35
4775510|NCT01518192|16475145|P2|Overall Study|Lost to Follow-up|26
4775511|NCT01518192|16475146|P1|Overall Study|Lost to Follow-up|29
4775512|NCT01518153|16475167|P3|Donor Lymphocyte Infusion|Death|1
4775513|NCT01518153|16475168|P2|Donor Lymphocyte Infusion|Death|2
4775514|NCT01518153|16475169|P1|Donor Lymphocyte Infusion|Death|0
4775515|NCT01518153|16475167|P3|Stem Cell Transplant|Adverse Event|0
4775516|NCT01518153|16475168|P2|Stem Cell Transplant|Adverse Event|0
4775517|NCT01518153|16475169|P1|Stem Cell Transplant|Adverse Event|1
4775518|NCT01518153|16475167|P3|Stem Cell Transplant|Secondary graft failure|0
4775519|NCT01518153|16475168|P2|Stem Cell Transplant|Secondary graft failure|0
4775520|NCT01518153|16475169|P1|Stem Cell Transplant|Secondary graft failure|1
4775521|NCT01518153|16475167|P3|Stem Cell Transplant|Death|0
4775522|NCT01518153|16475168|P2|Stem Cell Transplant|Death|0
4775523|NCT01518153|16475169|P1|Stem Cell Transplant|Death|2
4775524|NCT01518153|16475167|P3|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
4775525|NCT01518153|16475168|P2|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0
4775526|NCT01518153|16475169|P1|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5
4775527|NCT01517984|16475180|P4|Overall Study|Ineligible for randomization|0
4775528|NCT01517984|16475181|P3|Overall Study|Ineligible for randomization|0
4775529|NCT01517984|16475182|P2|Overall Study|Ineligible for randomization|14
4775530|NCT01517984|16475183|P1|Overall Study|Ineligible for randomization|0
4775531|NCT01517984|16475180|P4|Overall Study|Screen Failure|0
4775532|NCT01517984|16475181|P3|Overall Study|Screen Failure|0
4775533|NCT01517984|16475182|P2|Overall Study|Screen Failure|0
4775534|NCT01517984|16475183|P1|Overall Study|Screen Failure|4
4775535|NCT01517984|16475180|P4|Overall Study|Withdrawal by Subject|1
4775536|NCT01517984|16475181|P3|Overall Study|Withdrawal by Subject|4
4775537|NCT01517984|16475182|P2|Overall Study|Withdrawal by Subject|8
4775538|NCT01517984|16475183|P1|Overall Study|Withdrawal by Subject|1
4775539|NCT01517984|16475180|P4|Overall Study|Lost to Follow-up|0
4775540|NCT01517984|16475181|P3|Overall Study|Lost to Follow-up|0
4775541|NCT01517984|16475182|P2|Overall Study|Lost to Follow-up|1
4775542|NCT01517984|16475183|P1|Overall Study|Lost to Follow-up|0
4775543|NCT01517893|16475209|P2|Overall Study|Withdrawal by Subject|0
4775544|NCT01517893|16475210|P1|Overall Study|Withdrawal by Subject|3
4775545|NCT01517867|16475232|P2|Overall Study|Still in treatment at study end|3
4775546|NCT01517867|16475233|P1|Overall Study|Still in treatment at study end|0
4775547|NCT01517867|16475232|P2|Overall Study|Withdrawal by Subject|30
4775548|NCT01517867|16475233|P1|Overall Study|Withdrawal by Subject|34
4775549|NCT01517867|16475232|P2|Overall Study|never started treatment|32
4775550|NCT01517867|16475233|P1|Overall Study|never started treatment|29
4775551|NCT01517750|16475261|P4|Overall Study|Lost to Follow-up|1
4775552|NCT01517750|16475262|P3|Overall Study|Lost to Follow-up|4
4775553|NCT01517750|16475263|P2|Overall Study|Lost to Follow-up|2
4775554|NCT01517750|16475264|P1|Overall Study|Lost to Follow-up|1
4775555|NCT01517412|16475301|P2|Overall Study|Other than specified above|5
4775556|NCT01517412|16475302|P1|Overall Study|Other than specified above|8
4775557|NCT01517412|16475301|P2|Overall Study|Poor compliance to protocol|3
4775558|NCT01517412|16475302|P1|Overall Study|Poor compliance to protocol|8
4775559|NCT01517412|16475301|P2|Overall Study|Lack of Efficacy|5
4775560|NCT01517412|16475302|P1|Overall Study|Lack of Efficacy|10
4775561|NCT01517412|16475301|P2|Overall Study|Adverse Event|11
4775562|NCT01517412|16475302|P1|Overall Study|Adverse Event|10
4775563|NCT01517373|16475331|P6|Treatment Period|Medication error without AEs|2
4775564|NCT01517373|16475332|P5|Treatment Period|Medication error without AEs|0
4775565|NCT01517373|16475333|P4|Treatment Period|Medication error without AEs|1
4775566|NCT01517373|16475334|P3|Treatment Period|Medication error without AEs|2
4775567|NCT01517373|16475335|P2|Treatment Period|Medication error without AEs|0
4775568|NCT01517373|16475336|P1|Treatment Period|Medication error without AEs|0
4775569|NCT01517373|16475331|P6|Treatment Period|Lack of Efficacy|0
4775570|NCT01517373|16475332|P5|Treatment Period|Lack of Efficacy|2
4775571|NCT01517373|16475333|P4|Treatment Period|Lack of Efficacy|3
4775572|NCT01517373|16475334|P3|Treatment Period|Lack of Efficacy|1
4775573|NCT01517373|16475335|P2|Treatment Period|Lack of Efficacy|1
4775574|NCT01517373|16475336|P1|Treatment Period|Lack of Efficacy|0
4775575|NCT01517373|16475331|P6|Treatment Period|Protocol Violation|0
4775576|NCT01517373|16475332|P5|Treatment Period|Protocol Violation|1
4775577|NCT01517373|16475333|P4|Treatment Period|Protocol Violation|0
4775578|NCT01517373|16475334|P3|Treatment Period|Protocol Violation|0
4775579|NCT01517373|16475335|P2|Treatment Period|Protocol Violation|0
4775580|NCT01517373|16475336|P1|Treatment Period|Protocol Violation|0
4775581|NCT01517373|16475331|P6|Treatment Period|Other|0
4775582|NCT01517373|16475332|P5|Treatment Period|Other|1
4775583|NCT01517373|16475333|P4|Treatment Period|Other|0
4775584|NCT01517373|16475334|P3|Treatment Period|Other|0
4775585|NCT01517373|16475335|P2|Treatment Period|Other|0
4775586|NCT01517373|16475336|P1|Treatment Period|Other|0
4775587|NCT01517373|16475331|P6|Treatment Period|Withdrawal by Subject|3
4775588|NCT01517373|16475332|P5|Treatment Period|Withdrawal by Subject|2
4775589|NCT01517373|16475333|P4|Treatment Period|Withdrawal by Subject|2
4775590|NCT01517373|16475334|P3|Treatment Period|Withdrawal by Subject|2
4775591|NCT01517373|16475335|P2|Treatment Period|Withdrawal by Subject|3
4775592|NCT01517373|16475336|P1|Treatment Period|Withdrawal by Subject|0
4775593|NCT01517373|16475331|P6|Treatment Period|Lost to Follow-up|0
4775594|NCT01517373|16475332|P5|Treatment Period|Lost to Follow-up|0
4775595|NCT01517373|16475333|P4|Treatment Period|Lost to Follow-up|1
4775596|NCT01517373|16475334|P3|Treatment Period|Lost to Follow-up|1
4775597|NCT01517373|16475335|P2|Treatment Period|Lost to Follow-up|0
4775598|NCT01517373|16475336|P1|Treatment Period|Lost to Follow-up|0
4775599|NCT01517373|16475331|P6|Treatment Period|Adverse Event|2
4775600|NCT01517373|16475332|P5|Treatment Period|Adverse Event|0
4775601|NCT01517373|16475333|P4|Treatment Period|Adverse Event|0
4775602|NCT01517373|16475334|P3|Treatment Period|Adverse Event|0
4775603|NCT01517373|16475335|P2|Treatment Period|Adverse Event|0
4775604|NCT01517373|16475336|P1|Treatment Period|Adverse Event|0
4775605|NCT01517373|16475331|P6|Run-in Period|Other|0
4775606|NCT01517373|16475332|P5|Run-in Period|Other|0
4775607|NCT01517373|16475333|P4|Run-in Period|Other|0
4775608|NCT01517373|16475334|P3|Run-in Period|Other|0
4775609|NCT01517373|16475335|P2|Run-in Period|Other|0
4775610|NCT01517373|16475336|P1|Run-in Period|Other|1
4775611|NCT01517373|16475331|P6|Run-in Period|Sponsor Decision|0
4775612|NCT01517373|16475332|P5|Run-in Period|Sponsor Decision|0
4775613|NCT01517373|16475333|P4|Run-in Period|Sponsor Decision|0
4775614|NCT01517373|16475334|P3|Run-in Period|Sponsor Decision|0
4775615|NCT01517373|16475335|P2|Run-in Period|Sponsor Decision|0
4775616|NCT01517373|16475336|P1|Run-in Period|Sponsor Decision|3
4775617|NCT01517373|16475331|P6|Run-in Period|Withdrawal by Subject|0
4775618|NCT01517373|16475332|P5|Run-in Period|Withdrawal by Subject|0
4775619|NCT01517373|16475333|P4|Run-in Period|Withdrawal by Subject|0
4775620|NCT01517373|16475334|P3|Run-in Period|Withdrawal by Subject|0
4775621|NCT01517373|16475335|P2|Run-in Period|Withdrawal by Subject|0
4775622|NCT01517373|16475336|P1|Run-in Period|Withdrawal by Subject|12
4775623|NCT01517373|16475331|P6|Run-in Period|Lost to Follow-up|0
4775624|NCT01517373|16475332|P5|Run-in Period|Lost to Follow-up|0
4775625|NCT01517373|16475333|P4|Run-in Period|Lost to Follow-up|0
4775626|NCT01517373|16475334|P3|Run-in Period|Lost to Follow-up|0
4775627|NCT01517373|16475335|P2|Run-in Period|Lost to Follow-up|0
4775628|NCT01517373|16475336|P1|Run-in Period|Lost to Follow-up|1
4775629|NCT01517373|16475331|P6|Run-in Period|Did not meet eligibility criteria|0
4775630|NCT01517373|16475332|P5|Run-in Period|Did not meet eligibility criteria|0
4775631|NCT01517373|16475333|P4|Run-in Period|Did not meet eligibility criteria|0
4775632|NCT01517373|16475334|P3|Run-in Period|Did not meet eligibility criteria|0
4775633|NCT01517373|16475335|P2|Run-in Period|Did not meet eligibility criteria|0
4775634|NCT01517373|16475336|P1|Run-in Period|Did not meet eligibility criteria|34
4775635|NCT01517373|16475331|P6|Run-in Period|Adverse Event|0
4775636|NCT01517373|16475332|P5|Run-in Period|Adverse Event|0
4775637|NCT01517373|16475333|P4|Run-in Period|Adverse Event|0
4775638|NCT01517373|16475334|P3|Run-in Period|Adverse Event|0
4775639|NCT01517373|16475335|P2|Run-in Period|Adverse Event|0
4775640|NCT01517373|16475336|P1|Run-in Period|Adverse Event|5
4775641|NCT01517373|16475331|P6|Run-in Period|Death|0
4775642|NCT01517373|16475332|P5|Run-in Period|Death|0
4775643|NCT01517373|16475333|P4|Run-in Period|Death|0
4775644|NCT01517373|16475334|P3|Run-in Period|Death|0
4775645|NCT01517373|16475335|P2|Run-in Period|Death|0
4775646|NCT01517373|16475336|P1|Run-in Period|Death|1
4775647|NCT01517295|16475406|P2|Overall Study|Physician Decision|0
4775648|NCT01517295|16475407|P1|Overall Study|Physician Decision|1
4775649|NCT01517282|16475421|P4|Overall Study|Physician Decision|0
4775650|NCT01517282|16475422|P3|Overall Study|Physician Decision|0
4775651|NCT01517282|16475423|P2|Overall Study|Physician Decision|0
4775652|NCT01517282|16475424|P1|Overall Study|Physician Decision|1
4775653|NCT01517282|16475421|P4|Overall Study|Consent withdrawn|1
4775654|NCT01517282|16475422|P3|Overall Study|Consent withdrawn|1
4775655|NCT01517282|16475423|P2|Overall Study|Consent withdrawn|1
4775656|NCT01517282|16475424|P1|Overall Study|Consent withdrawn|0
4775657|NCT01517178|16475458|P2|Period 2|E.g. study termination|2
4775658|NCT01517178|16475459|P1|Period 2|E.g. study termination|2
4775659|NCT01517178|16475458|P2|Period 2|Withdrawal by Subject|0
4775660|NCT01517178|16475459|P1|Period 2|Withdrawal by Subject|3
4775661|NCT01517178|16475458|P2|Period 2|Adverse Event|0
4775662|NCT01517178|16475459|P1|Period 2|Adverse Event|1
4775663|NCT01517178|16475458|P2|Period 1|Withdrawal by Subject|1
4775664|NCT01517178|16475459|P1|Period 1|Withdrawal by Subject|0
4775665|NCT01517178|16475458|P2|Period 1|E.g. study termination|1
4775666|NCT01517178|16475459|P1|Period 1|E.g. study termination|3
4775667|NCT01517178|16475458|P2|Period 1|Lack of Efficacy|1
4775668|NCT01517178|16475459|P1|Period 1|Lack of Efficacy|0
4775669|NCT01517178|16475458|P2|Period 1|Adverse Event|2
4775670|NCT01517178|16475459|P1|Period 1|Adverse Event|1
4775671|NCT01516970|16475487|P2|Overall Study|Other|7
4775672|NCT01516970|16475488|P1|Overall Study|Other|9
4775673|NCT01516970|16475487|P2|Overall Study|Withdrawal by Subject|1
4775674|NCT01516970|16475488|P1|Overall Study|Withdrawal by Subject|1
4775675|NCT01516970|16475487|P2|Overall Study|Adverse Event|5
4775676|NCT01516970|16475488|P1|Overall Study|Adverse Event|1
4775677|NCT01516970|16475487|P2|Overall Study|Lost to Follow-up|8
4775678|NCT01516970|16475488|P1|Overall Study|Lost to Follow-up|7
4775679|NCT01516892|16475527|P1|Overall Study|Missing|1
4775680|NCT01516892|16475527|P1|Overall Study|Other Miscellaneous Reasons|43
4775681|NCT01516892|16475527|P1|Overall Study|Protocol Violation|60
4775682|NCT01516892|16475527|P1|Overall Study|Subject Withdrew Consent|92
4775683|NCT01516892|16475527|P1|Overall Study|Lost to Follow-up|82
4775684|NCT01516892|16475527|P1|Overall Study|Pregnancy|5
4775685|NCT01516892|16475527|P1|Overall Study|Lack of Efficacy|35
4775686|NCT01516892|16475527|P1|Overall Study|Adverse Event|25
4775687|NCT01516879|16475535|P2|Overall Study|Other|10
4775688|NCT01516879|16475536|P1|Overall Study|Other|5
4775689|NCT01516879|16475535|P2|Overall Study|Lost to Follow-up|11
4775690|NCT01516879|16475536|P1|Overall Study|Lost to Follow-up|2
4775691|NCT01516879|16475535|P2|Overall Study|Death|2
4775692|NCT01516879|16475536|P1|Overall Study|Death|0
4775693|NCT01516879|16475535|P2|Overall Study|Withdrawal by Subject|11
4775694|NCT01516879|16475536|P1|Overall Study|Withdrawal by Subject|9
4775695|NCT01516749|16475570|P1|Follow-up Off Therapy|Lost to Follow-up|1
4775696|NCT01516749|16475570|P1|Active Therapy|Lost to Follow-up|1
4775697|NCT01516736|16475579|P2|Overall Study|Other (not specified)|1
4775698|NCT01516736|16475580|P1|Overall Study|Other (not specified)|0
4775699|NCT01516736|16475579|P2|Overall Study|Protocol Violation|1
4775700|NCT01516736|16475580|P1|Overall Study|Protocol Violation|0
4775701|NCT01516736|16475579|P2|Overall Study|Lack of Efficacy|0
4775702|NCT01516736|16475580|P1|Overall Study|Lack of Efficacy|1
4775703|NCT01516736|16475579|P2|Overall Study|Physician Decision|1
4775704|NCT01516736|16475580|P1|Overall Study|Physician Decision|2
4775705|NCT01516736|16475579|P2|Overall Study|Death|1
4775706|NCT01516736|16475580|P1|Overall Study|Death|3
4775707|NCT01516736|16475579|P2|Overall Study|Adverse Event|5
4775708|NCT01516736|16475580|P1|Overall Study|Adverse Event|4
4775709|NCT01516736|16475579|P2|Overall Study|Withdrawal by Subject|4
4775710|NCT01516736|16475580|P1|Overall Study|Withdrawal by Subject|10
4775711|NCT01516437|16475634|P4|Overall Study|Reason not specified|1
4775712|NCT01516437|16475635|P3|Overall Study|Reason not specified|1
4775713|NCT01516437|16475636|P2|Overall Study|Reason not specified|0
4775714|NCT01516437|16475637|P1|Overall Study|Reason not specified|0
4775715|NCT01516034|16475709|P1|Overall Study|Lack of Efficacy|7
4775716|NCT01516034|16475709|P1|Overall Study|Physician Decision|1
4775717|NCT01516008|16475716|P3|Overall Study|Reason not specified|1
4775718|NCT01516008|16475717|P2|Overall Study|Reason not specified|0
4775719|NCT01516008|16475718|P1|Overall Study|Reason not specified|0
4775720|NCT01516008|16475716|P3|Overall Study|Protocol Violation|0
4775721|NCT01516008|16475717|P2|Overall Study|Protocol Violation|0
4775722|NCT01516008|16475718|P1|Overall Study|Protocol Violation|1
4775723|NCT01516008|16475716|P3|Overall Study|Lack of Efficacy|10
4775724|NCT01516008|16475717|P2|Overall Study|Lack of Efficacy|14
4775725|NCT01516008|16475718|P1|Overall Study|Lack of Efficacy|44
4775726|NCT01516008|16475716|P3|Overall Study|Adverse Event|7
4775727|NCT01516008|16475717|P2|Overall Study|Adverse Event|2
4775728|NCT01516008|16475718|P1|Overall Study|Adverse Event|0
4775729|NCT01515865|16475823|P3|Part B (Open-label)|Other|0
4775730|NCT01515865|16475824|P2|Part B (Open-label)|Other|0
4775731|NCT01515865|16475825|P1|Part B (Open-label)|Other|1
4775732|NCT01515865|16475823|P3|Part B (Open-label)|Withdrawal by Subject|0
4775733|NCT01515865|16475824|P2|Part B (Open-label)|Withdrawal by Subject|0
4775734|NCT01515865|16475825|P1|Part B (Open-label)|Withdrawal by Subject|1
4775735|NCT01515865|16475823|P3|Part A (Open-label)|Other|0
4775736|NCT01515865|16475824|P2|Part A (Open-label)|Other|0
4775737|NCT01515865|16475825|P1|Part A (Open-label)|Other|3
4775738|NCT01515748|16475835|P2|Overall Study|Ongoing|90
4775739|NCT01515748|16475836|P1|Overall Study|Ongoing|86
4775740|NCT01515748|16475835|P2|Overall Study|Lost to Follow-up|4
4775741|NCT01515748|16475836|P1|Overall Study|Lost to Follow-up|2
4775742|NCT01515748|16475835|P2|Overall Study|Withdrawal by Subject|41
4775743|NCT01515748|16475836|P1|Overall Study|Withdrawal by Subject|32
4775744|NCT01515475|16475919|P4|Overall Study|Lost to Follow-up|12
4775745|NCT01515475|16475920|P3|Overall Study|Lost to Follow-up|12
4775746|NCT01515475|16475921|P2|Overall Study|Lost to Follow-up|15
4775747|NCT01515475|16475922|P1|Overall Study|Lost to Follow-up|20
4775748|NCT01515423|16475996|P3|DOUBLE BLIND|Blind broken by investigator|0
4775749|NCT01515423|16475997|P2|DOUBLE BLIND|Blind broken by investigator|1
4775750|NCT01515423|16475998|P1|DOUBLE BLIND|Blind broken by investigator|0
4775751|NCT01515423|16475996|P3|DOUBLE BLIND|Other|12
4775752|NCT01515423|16475997|P2|DOUBLE BLIND|Other|6
4775753|NCT01515423|16475998|P1|DOUBLE BLIND|Other|0
4775754|NCT01515423|16475996|P3|DOUBLE BLIND|Withdrawal by Subject|53
4775755|NCT01515423|16475997|P2|DOUBLE BLIND|Withdrawal by Subject|50
4775756|NCT01515423|16475998|P1|DOUBLE BLIND|Withdrawal by Subject|0
4775757|NCT01515423|16475996|P3|DOUBLE BLIND|Pregnancy|0
4775758|NCT01515423|16475997|P2|DOUBLE BLIND|Pregnancy|2
4775759|NCT01515423|16475998|P1|DOUBLE BLIND|Pregnancy|0
4775760|NCT01515423|16475996|P3|DOUBLE BLIND|Lost to Follow-up|12
4775761|NCT01515423|16475997|P2|DOUBLE BLIND|Lost to Follow-up|7
4775762|NCT01515423|16475998|P1|DOUBLE BLIND|Lost to Follow-up|0
4775763|NCT01515423|16475996|P3|DOUBLE BLIND|Death|2
4775764|NCT01515423|16475997|P2|DOUBLE BLIND|Death|1
4775765|NCT01515423|16475998|P1|DOUBLE BLIND|Death|0
4775766|NCT01515423|16475996|P3|DOUBLE BLIND|Adverse Event|13
4775767|NCT01515423|16475997|P2|DOUBLE BLIND|Adverse Event|15
4775768|NCT01515423|16475998|P1|DOUBLE BLIND|Adverse Event|0
4775769|NCT01515423|16475996|P3|Open Label Phase|Other|0
4775770|NCT01515423|16475997|P2|Open Label Phase|Other|0
4775771|NCT01515423|16475998|P1|Open Label Phase|Other|28
4775772|NCT01515423|16475996|P3|Open Label Phase|excluded from DB Phase|0
4775773|NCT01515423|16475997|P2|Open Label Phase|excluded from DB Phase|0
4775774|NCT01515423|16475998|P1|Open Label Phase|excluded from DB Phase|70
4775775|NCT01515423|16475996|P3|Open Label Phase|Withdrawal by Subject|0
4775776|NCT01515423|16475997|P2|Open Label Phase|Withdrawal by Subject|0
4775777|NCT01515423|16475998|P1|Open Label Phase|Withdrawal by Subject|118
4775778|NCT01515423|16475996|P3|Open Label Phase|Lost to Follow-up|0
4775779|NCT01515423|16475997|P2|Open Label Phase|Lost to Follow-up|0
4775780|NCT01515423|16475998|P1|Open Label Phase|Lost to Follow-up|21
4775781|NCT01515423|16475996|P3|Open Label Phase|Lack of Efficacy|0
4775782|NCT01515423|16475997|P2|Open Label Phase|Lack of Efficacy|0
4775783|NCT01515423|16475998|P1|Open Label Phase|Lack of Efficacy|117
4775784|NCT01515423|16475996|P3|Open Label Phase|Death|0
4775785|NCT01515423|16475997|P2|Open Label Phase|Death|0
4775786|NCT01515423|16475998|P1|Open Label Phase|Death|2
4775787|NCT01515423|16475996|P3|Open Label Phase|Adverse Event|0
4775788|NCT01515423|16475997|P2|Open Label Phase|Adverse Event|0
4775789|NCT01515423|16475998|P1|Open Label Phase|Adverse Event|57
4775790|NCT01515306|16476039|P2|Overall Study|Ongoing receiving treatment|14
4775791|NCT01515306|16476040|P1|Overall Study|Ongoing receiving treatment|9
4775792|NCT01515306|16476039|P2|Overall Study|Progressive Disease|0
4775793|NCT01515306|16476040|P1|Overall Study|Progressive Disease|1
4775794|NCT01515306|16476039|P2|Overall Study|Adverse Event|0
4775795|NCT01515306|16476040|P1|Overall Study|Adverse Event|2
4775796|NCT01515189|16476053|P2|First Re-Induction Phase|Other|0
4775797|NCT01515189|16476054|P1|First Re-Induction Phase|Other|1
4775798|NCT01515189|16476053|P2|First Re-Induction Phase|No longer meets study criteria|0
4775799|NCT01515189|16476054|P1|First Re-Induction Phase|No longer meets study criteria|1
4775800|NCT01515189|16476053|P2|First Re-Induction Phase|Withdrawal by Subject|1
4775801|NCT01515189|16476054|P1|First Re-Induction Phase|Withdrawal by Subject|1
4775802|NCT01515189|16476053|P2|First Re-Induction Phase|Study drug toxicity|0
4775803|NCT01515189|16476054|P1|First Re-Induction Phase|Study drug toxicity|5
4775804|NCT01515189|16476053|P2|First Re-Induction Phase|Disease progression|14
4775805|NCT01515189|16476054|P1|First Re-Induction Phase|Disease progression|6
4775806|NCT01515189|16476053|P2|Induction|Other|4
4775807|NCT01515189|16476054|P1|Induction|Other|0
4775808|NCT01515189|16476053|P2|Induction|Lost to Follow-up|0
4775809|NCT01515189|16476054|P1|Induction|Lost to Follow-up|1
4775810|NCT01515189|16476053|P2|Induction|No longer meets study criteria|2
4775811|NCT01515189|16476054|P1|Induction|No longer meets study criteria|0
4775812|NCT01515189|16476053|P2|Induction|Withdrawal by Subject|9
4775813|NCT01515189|16476054|P1|Induction|Withdrawal by Subject|3
4775814|NCT01515189|16476053|P2|Induction|Adverse Event|9
4775815|NCT01515189|16476054|P1|Induction|Adverse Event|14
4775816|NCT01515189|16476053|P2|Induction|Death|17
4775817|NCT01515189|16476054|P1|Induction|Death|24
4775818|NCT01515189|16476053|P2|Induction|Study drug toxicity|36
4775819|NCT01515189|16476054|P1|Induction|Study drug toxicity|86
4775820|NCT01515189|16476053|P2|Induction|Disease Progression|155
4775821|NCT01515189|16476054|P1|Induction|Disease Progression|109
4775822|NCT01514864|16476142|P2|Overall Study|Study drug toxicity|0
4775823|NCT01514864|16476143|P1|Overall Study|Study drug toxicity|2
4775824|NCT01514864|16476142|P2|Overall Study|Disease progression|5
4775825|NCT01514864|16476143|P1|Overall Study|Disease progression|7
4775826|NCT01514760|16476168|P1|Overall Study|Lost to Follow-up|2
4775827|NCT01514682|16476181|P2|Overall Study|Physician Decision|3
4775828|NCT01514682|16476182|P1|Overall Study|Physician Decision|4
4775829|NCT01514682|16476181|P2|Overall Study|Withdrawal by Subject|3
4775830|NCT01514682|16476182|P1|Overall Study|Withdrawal by Subject|2
4775831|NCT01514461|16476216|P3|Overall Study|Death|0
4775832|NCT01514461|16476217|P2|Overall Study|Death|0
4775833|NCT01514461|16476218|P1|Overall Study|Death|1
4775834|NCT01514461|16476216|P3|Overall Study|Patient/guardian decision|1
4775835|NCT01514461|16476217|P2|Overall Study|Patient/guardian decision|1
4775836|NCT01514461|16476218|P1|Overall Study|Patient/guardian decision|1
4775837|NCT01514461|16476216|P3|Overall Study|Physician Decision|0
4775838|NCT01514461|16476217|P2|Overall Study|Physician Decision|1
4775839|NCT01514461|16476218|P1|Overall Study|Physician Decision|1
4775840|NCT01514461|16476216|P3|Overall Study|Adverse Event|3
4775841|NCT01514461|16476217|P2|Overall Study|Adverse Event|1
4775842|NCT01514461|16476218|P1|Overall Study|Adverse Event|2
4775843|NCT01514448|16476257|P2|Overall Study|New Cancer Therapy|0
4775844|NCT01514448|16476258|P1|Overall Study|New Cancer Therapy|1
4775845|NCT01514448|16476257|P2|Overall Study|Lost to Follow-up|0
4775846|NCT01514448|16476258|P1|Overall Study|Lost to Follow-up|2
4775847|NCT01514448|16476257|P2|Overall Study|Withdrawal by Subject|0
4775848|NCT01514448|16476258|P1|Overall Study|Withdrawal by Subject|2
4775849|NCT01514448|16476257|P2|Overall Study|Death|8
4775850|NCT01514448|16476258|P1|Overall Study|Death|7
4775851|NCT01514422|16476273|P1|Overall Study|Lost to Follow-up|1
4775852|NCT01514370|16476291|P2|Overall Study|Other|7
4775853|NCT01514370|16476292|P1|Overall Study|Other|6
4775854|NCT01514370|16476291|P2|Overall Study|Adverse Event|3
4775855|NCT01514370|16476292|P1|Overall Study|Adverse Event|1
4775856|NCT01514370|16476291|P2|Overall Study|Withdrawal by Subject|1
4775857|NCT01514370|16476292|P1|Overall Study|Withdrawal by Subject|2
4775858|NCT01514370|16476291|P2|Overall Study|Lost to Follow-up|2
4775859|NCT01514370|16476292|P1|Overall Study|Lost to Follow-up|0
4775860|NCT01514370|16476291|P2|Overall Study|Protocol Violation|3
4775861|NCT01514370|16476292|P1|Overall Study|Protocol Violation|2
4775862|NCT01514357|16476338|P2|Overall Study|Withdrawal by Subject|0
4775863|NCT01514357|16476339|P1|Overall Study|Withdrawal by Subject|2
4775864|NCT01514357|16476338|P2|Overall Study|Screen failure|0
4775865|NCT01514357|16476339|P1|Overall Study|Screen failure|2
4775866|NCT01514240|16476424|P2|Overall Study|Subject Decision|7
4775867|NCT01514240|16476425|P1|Overall Study|Subject Decision|2
4775868|NCT01514240|16476424|P2|Overall Study|Adverse Event|4
4775869|NCT01514240|16476425|P1|Overall Study|Adverse Event|4
4775870|NCT01514201|16476503|P4|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22
4775871|NCT01514201|16476504|P3|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4775872|NCT01514201|16476505|P2|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4775873|NCT01514201|16476506|P1|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4775874|NCT01514201|16476503|P4|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7
4775875|NCT01514201|16476504|P3|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4775876|NCT01514201|16476505|P2|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4775877|NCT01514201|16476506|P1|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4775878|NCT01514201|16476503|P4|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4
4775879|NCT01514201|16476504|P3|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
4775880|NCT01514201|16476505|P2|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
4775881|NCT01514201|16476506|P1|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0
4775882|NCT01514201|16476503|P4|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6
4775883|NCT01514201|16476504|P3|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
4775884|NCT01514201|16476505|P2|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
4775885|NCT01514201|16476506|P1|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0
4775886|NCT01514201|16476503|P4|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2
4775887|NCT01514201|16476504|P3|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
4775888|NCT01514201|16476505|P2|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
4775889|NCT01514201|16476506|P1|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0
4775890|NCT01514201|16476503|P4|PHASE II: Veliparib + Radiation Therapy|Death|1
4775891|NCT01514201|16476504|P3|PHASE II: Veliparib + Radiation Therapy|Death|0
4775892|NCT01514201|16476505|P2|PHASE II: Veliparib + Radiation Therapy|Death|0
4775893|NCT01514201|16476506|P1|PHASE II: Veliparib + Radiation Therapy|Death|0
4775894|NCT01514201|16476503|P4|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2
4775895|NCT01514201|16476504|P3|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
4775896|NCT01514201|16476505|P2|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
4775897|NCT01514201|16476506|P1|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0
4775898|NCT01514201|16476503|P4|PHASE II: Veliparib + Radiation Therapy|Ineligible|1
4775899|NCT01514201|16476504|P3|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
4775900|NCT01514201|16476505|P2|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
4775901|NCT01514201|16476506|P1|PHASE II: Veliparib + Radiation Therapy|Ineligible|0
4775902|NCT01514201|16476503|P4|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4775903|NCT01514201|16476504|P3|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0
4775904|NCT01514201|16476505|P2|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
4775905|NCT01514201|16476506|P1|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1
4775906|NCT01514201|16476503|P4|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0
4775907|NCT01514201|16476504|P3|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5
4775908|NCT01514201|16476505|P2|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
4775909|NCT01514201|16476506|P1|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4
4775910|NCT01514201|16476503|P4|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
4775911|NCT01514201|16476504|P3|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
4775912|NCT01514201|16476505|P2|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1
4775913|NCT01514201|16476506|P1|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0
4775914|NCT01514201|16476503|P4|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
4775915|NCT01514201|16476504|P3|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
4775916|NCT01514201|16476505|P2|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0
4775917|NCT01514201|16476506|P1|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1
4775918|NCT01514136|16476604|P8|Test Period 2; Test C*|Protocol Violation|0
4775919|NCT01514136|16476605|P7|Test Period 2; Test C*|Protocol Violation|1
4775920|NCT01514136|16476606|P6|Test Period 2; Test C*|Protocol Violation|0
4775921|NCT01514136|16476607|P5|Test Period 2; Test C*|Protocol Violation|0
4775922|NCT01514136|16476608|P4|Test Period 2; Test C*|Protocol Violation|0
4775923|NCT01514136|16476609|P3|Test Period 2; Test C*|Protocol Violation|0
4775924|NCT01514136|16476610|P2|Test Period 2; Test C*|Protocol Violation|0
4775925|NCT01514136|16476611|P1|Test Period 2; Test C*|Protocol Violation|0
4775926|NCT01514136|16476604|P8|Test Period 2; Test C*|holiday|0
4775927|NCT01514136|16476605|P7|Test Period 2; Test C*|holiday|1
4775928|NCT01514136|16476606|P6|Test Period 2; Test C*|holiday|0
4775929|NCT01514136|16476607|P5|Test Period 2; Test C*|holiday|0
4775930|NCT01514136|16476608|P4|Test Period 2; Test C*|holiday|0
4775931|NCT01514136|16476609|P3|Test Period 2; Test C*|holiday|0
4775932|NCT01514136|16476610|P2|Test Period 2; Test C*|holiday|0
4775933|NCT01514136|16476611|P1|Test Period 2; Test C*|holiday|0
4775934|NCT01514136|16476604|P8|Test Period 2; Test C*|Withdrawal by Subject|0
4775935|NCT01514136|16476605|P7|Test Period 2; Test C*|Withdrawal by Subject|1
4775936|NCT01514136|16476606|P6|Test Period 2; Test C*|Withdrawal by Subject|0
4775937|NCT01514136|16476607|P5|Test Period 2; Test C*|Withdrawal by Subject|0
4775938|NCT01514136|16476608|P4|Test Period 2; Test C*|Withdrawal by Subject|0
4775939|NCT01514136|16476609|P3|Test Period 2; Test C*|Withdrawal by Subject|0
4775940|NCT01514136|16476610|P2|Test Period 2; Test C*|Withdrawal by Subject|0
4775941|NCT01514136|16476611|P1|Test Period 2; Test C*|Withdrawal by Subject|0
4775942|NCT01514136|16476604|P8|Test Period 2; Test B*|Withdrawal by Subject|0
4775943|NCT01514136|16476605|P7|Test Period 2; Test B*|Withdrawal by Subject|0
4775944|NCT01514136|16476606|P6|Test Period 2; Test B*|Withdrawal by Subject|2
4775945|NCT01514136|16476607|P5|Test Period 2; Test B*|Withdrawal by Subject|0
4775946|NCT01514136|16476608|P4|Test Period 2; Test B*|Withdrawal by Subject|0
4775947|NCT01514136|16476609|P3|Test Period 2; Test B*|Withdrawal by Subject|0
4775948|NCT01514136|16476610|P2|Test Period 2; Test B*|Withdrawal by Subject|0
4775949|NCT01514136|16476611|P1|Test Period 2; Test B*|Withdrawal by Subject|0
4775950|NCT01514136|16476604|P8|Test Period 2; Test A*|Holiday|0
4775951|NCT01514136|16476605|P7|Test Period 2; Test A*|Holiday|0
4775952|NCT01514136|16476606|P6|Test Period 2; Test A*|Holiday|0
4775953|NCT01514136|16476607|P5|Test Period 2; Test A*|Holiday|1
4775954|NCT01514136|16476608|P4|Test Period 2; Test A*|Holiday|0
4775955|NCT01514136|16476609|P3|Test Period 2; Test A*|Holiday|0
4775956|NCT01514136|16476610|P2|Test Period 2; Test A*|Holiday|0
4775957|NCT01514136|16476611|P1|Test Period 2; Test A*|Holiday|0
4775958|NCT01514136|16476604|P8|Test Period 2; Test A*|Adverse Event|0
4775959|NCT01514136|16476605|P7|Test Period 2; Test A*|Adverse Event|0
4775960|NCT01514136|16476606|P6|Test Period 2; Test A*|Adverse Event|0
4775961|NCT01514136|16476607|P5|Test Period 2; Test A*|Adverse Event|1
4775962|NCT01514136|16476608|P4|Test Period 2; Test A*|Adverse Event|0
4775963|NCT01514136|16476609|P3|Test Period 2; Test A*|Adverse Event|0
4775964|NCT01514136|16476610|P2|Test Period 2; Test A*|Adverse Event|0
4775965|NCT01514136|16476611|P1|Test Period 2; Test A*|Adverse Event|0
4775966|NCT01514136|16476604|P8|Test Period 1; Test D|Subject took a break due to holiday|0
4775967|NCT01514136|16476605|P7|Test Period 1; Test D|Subject took a break due to holiday|0
4775968|NCT01514136|16476606|P6|Test Period 1; Test D|Subject took a break due to holiday|0
4775969|NCT01514136|16476607|P5|Test Period 1; Test D|Subject took a break due to holiday|0
4775970|NCT01514136|16476608|P4|Test Period 1; Test D|Subject took a break due to holiday|2
4775971|NCT01514136|16476609|P3|Test Period 1; Test D|Subject took a break due to holiday|0
4775972|NCT01514136|16476610|P2|Test Period 1; Test D|Subject took a break due to holiday|0
4775973|NCT01514136|16476611|P1|Test Period 1; Test D|Subject took a break due to holiday|0
4775974|NCT01514136|16476604|P8|Test Period 1; Test B|Withdrawal by Subject|0
4775975|NCT01514136|16476605|P7|Test Period 1; Test B|Withdrawal by Subject|0
4775976|NCT01514136|16476606|P6|Test Period 1; Test B|Withdrawal by Subject|0
4775977|NCT01514136|16476607|P5|Test Period 1; Test B|Withdrawal by Subject|0
4775978|NCT01514136|16476608|P4|Test Period 1; Test B|Withdrawal by Subject|0
4775979|NCT01514136|16476609|P3|Test Period 1; Test B|Withdrawal by Subject|0
4775980|NCT01514136|16476610|P2|Test Period 1; Test B|Withdrawal by Subject|1
4775981|NCT01514136|16476611|P1|Test Period 1; Test B|Withdrawal by Subject|0
4775982|NCT01514136|16476604|P8|Test Period 1; Test A|Break from study holiday|0
4775983|NCT01514136|16476605|P7|Test Period 1; Test A|Break from study holiday|0
4775984|NCT01514136|16476606|P6|Test Period 1; Test A|Break from study holiday|0
4775985|NCT01514136|16476607|P5|Test Period 1; Test A|Break from study holiday|0
4775986|NCT01514136|16476608|P4|Test Period 1; Test A|Break from study holiday|0
4775987|NCT01514136|16476609|P3|Test Period 1; Test A|Break from study holiday|0
4775988|NCT01514136|16476610|P2|Test Period 1; Test A|Break from study holiday|0
4775989|NCT01514136|16476611|P1|Test Period 1; Test A|Break from study holiday|2
4775990|NCT01514136|16476604|P8|Test Period 1; Test A|Protocol Violation|0
4775991|NCT01514136|16476605|P7|Test Period 1; Test A|Protocol Violation|0
4775992|NCT01514136|16476606|P6|Test Period 1; Test A|Protocol Violation|0
4775993|NCT01514136|16476607|P5|Test Period 1; Test A|Protocol Violation|0
4775994|NCT01514136|16476608|P4|Test Period 1; Test A|Protocol Violation|0
4775995|NCT01514136|16476609|P3|Test Period 1; Test A|Protocol Violation|0
4775996|NCT01514136|16476610|P2|Test Period 1; Test A|Protocol Violation|0
4775997|NCT01514136|16476611|P1|Test Period 1; Test A|Protocol Violation|1
4775998|NCT01513967|16476645|P8|Overall Study|Physician Decision|0
4775999|NCT01513967|16476646|P7|Overall Study|Physician Decision|0
4776000|NCT01513967|16476647|P6|Overall Study|Physician Decision|1
4776001|NCT01513967|16476648|P5|Overall Study|Physician Decision|0
4776002|NCT01513967|16476649|P4|Overall Study|Physician Decision|0
4776003|NCT01513967|16476650|P3|Overall Study|Physician Decision|0
4776004|NCT01513967|16476651|P2|Overall Study|Physician Decision|0
4776005|NCT01513967|16476652|P1|Overall Study|Physician Decision|0
4776006|NCT01513967|16476645|P8|Overall Study|excluded due to positive drug screen|2
4776007|NCT01513967|16476646|P7|Overall Study|excluded due to positive drug screen|0
4776008|NCT01513967|16476647|P6|Overall Study|excluded due to positive drug screen|0
4776009|NCT01513967|16476648|P5|Overall Study|excluded due to positive drug screen|0
4776010|NCT01513967|16476649|P4|Overall Study|excluded due to positive drug screen|0
4776011|NCT01513967|16476650|P3|Overall Study|excluded due to positive drug screen|0
4776012|NCT01513967|16476651|P2|Overall Study|excluded due to positive drug screen|0
4776013|NCT01513967|16476652|P1|Overall Study|excluded due to positive drug screen|0
4776014|NCT01513967|16476645|P8|Overall Study|missed a study visit|0
4776015|NCT01513967|16476646|P7|Overall Study|missed a study visit|1
4776016|NCT01513967|16476647|P6|Overall Study|missed a study visit|0
4776017|NCT01513967|16476648|P5|Overall Study|missed a study visit|0
4776018|NCT01513967|16476649|P4|Overall Study|missed a study visit|0
4776019|NCT01513967|16476650|P3|Overall Study|missed a study visit|0
4776020|NCT01513967|16476651|P2|Overall Study|missed a study visit|0
4776021|NCT01513967|16476652|P1|Overall Study|missed a study visit|0
4776022|NCT01513967|16476645|P8|Overall Study|Pregnancy|0
4776023|NCT01513967|16476646|P7|Overall Study|Pregnancy|1
4776024|NCT01513967|16476647|P6|Overall Study|Pregnancy|0
4776025|NCT01513967|16476648|P5|Overall Study|Pregnancy|0
4776026|NCT01513967|16476649|P4|Overall Study|Pregnancy|0
4776027|NCT01513967|16476650|P3|Overall Study|Pregnancy|0
4776028|NCT01513967|16476651|P2|Overall Study|Pregnancy|0
4776029|NCT01513967|16476652|P1|Overall Study|Pregnancy|0
4776030|NCT01513759|16476710|P1|Overall Study|Death during catheter placement|1
4776031|NCT01513759|16476710|P1|Overall Study|Protocol Violation|4
4776032|NCT01513590|16476721|P2|Overall Study|Unclassified|10
4776033|NCT01513590|16476722|P1|Overall Study|Unclassified|5
4776034|NCT01513590|16476721|P2|Overall Study|Withdrawal Criteria|0
4776035|NCT01513590|16476722|P1|Overall Study|Withdrawal Criteria|3
4776036|NCT01513590|16476721|P2|Overall Study|Adverse Event|3
4776037|NCT01513590|16476722|P1|Overall Study|Adverse Event|2
4776038|NCT01513551|16476743|P3|Overall Study|Randomized but not vaccinated|1
4776039|NCT01513551|16476744|P2|Overall Study|Randomized but not vaccinated|0
4776040|NCT01513551|16476745|P1|Overall Study|Randomized but not vaccinated|0
4776041|NCT01513551|16476743|P3|Overall Study|Withdrawal by Subject|2
4776042|NCT01513551|16476744|P2|Overall Study|Withdrawal by Subject|0
4776043|NCT01513551|16476745|P1|Overall Study|Withdrawal by Subject|1
4776044|NCT01513551|16476743|P3|Overall Study|Lost to Follow-up|2
4776045|NCT01513551|16476744|P2|Overall Study|Lost to Follow-up|5
4776046|NCT01513551|16476745|P1|Overall Study|Lost to Follow-up|3
4776047|NCT01513551|16476743|P3|Overall Study|Death|0
4776048|NCT01513551|16476744|P2|Overall Study|Death|1
4776049|NCT01513551|16476745|P1|Overall Study|Death|0
4776050|NCT01513473|16476777|P2|Extension Trial (26 Weeks)|Withdrawal by Subject|5
4776051|NCT01513473|16476778|P1|Extension Trial (26 Weeks)|Withdrawal by Subject|1
4776052|NCT01513473|16476777|P2|Extension Trial (26 Weeks)|Adverse Event|1
4776053|NCT01513473|16476778|P1|Extension Trial (26 Weeks)|Adverse Event|0
4776054|NCT01513473|16476777|P2|Main Trial (26 Weeks)|Unclassified|2
4776055|NCT01513473|16476778|P1|Main Trial (26 Weeks)|Unclassified|0
4776056|NCT01513473|16476777|P2|Main Trial (26 Weeks)|Withdrawal by Subject|7
4776057|NCT01513473|16476778|P1|Main Trial (26 Weeks)|Withdrawal by Subject|4
4776058|NCT01513473|16476777|P2|Main Trial (26 Weeks)|Adverse Event|2
4776059|NCT01513473|16476778|P1|Main Trial (26 Weeks)|Adverse Event|0
4776060|NCT01513460|16476805|P3|Overall Study|Abnormal test procedure|0
4776061|NCT01513460|16476806|P2|Overall Study|Abnormal test procedure|0
4776062|NCT01513460|16476807|P1|Overall Study|Abnormal test procedure|1
4776063|NCT01513460|16476805|P3|Overall Study|Adverse Event|23
4776064|NCT01513460|16476806|P2|Overall Study|Adverse Event|18
4776065|NCT01513460|16476807|P1|Overall Study|Adverse Event|16
4776066|NCT01513460|16476805|P3|Overall Study|Withdrawal by Subject|21
4776067|NCT01513460|16476806|P2|Overall Study|Withdrawal by Subject|8
4776068|NCT01513460|16476807|P1|Overall Study|Withdrawal by Subject|7
4776069|NCT01513460|16476805|P3|Overall Study|Protocol deviations|3
4776070|NCT01513460|16476806|P2|Overall Study|Protocol deviations|4
4776071|NCT01513460|16476807|P1|Overall Study|Protocol deviations|3
4776072|NCT01513460|16476805|P3|Overall Study|Lack of Efficacy|5
4776073|NCT01513460|16476806|P2|Overall Study|Lack of Efficacy|2
4776074|NCT01513460|16476807|P1|Overall Study|Lack of Efficacy|1
4776075|NCT01513460|16476805|P3|Overall Study|Abnormal laboratory value|1
4776076|NCT01513460|16476806|P2|Overall Study|Abnormal laboratory value|0
4776077|NCT01513460|16476807|P1|Overall Study|Abnormal laboratory value|1
4776078|NCT01513460|16476805|P3|Overall Study|Lost to Follow-up|2
4776079|NCT01513460|16476806|P2|Overall Study|Lost to Follow-up|0
4776080|NCT01513460|16476807|P1|Overall Study|Lost to Follow-up|0
4776081|NCT01513460|16476805|P3|Overall Study|Death|1
4776082|NCT01513460|16476806|P2|Overall Study|Death|0
4776083|NCT01513460|16476807|P1|Overall Study|Death|0
4776084|NCT01513330|16476842|P2|Standard Care First,|Other|0
4776085|NCT01513330|16476843|P1|Standard Care First,|Other|1
4776086|NCT01513330|16476842|P2|Standard Care First,|Withdrawal by Subject|2
4776087|NCT01513330|16476843|P1|Standard Care First,|Withdrawal by Subject|1
4776088|NCT01513330|16476842|P2|Standard Care First,|Lack of Efficacy|2
4776089|NCT01513330|16476843|P1|Standard Care First,|Lack of Efficacy|2
4776090|NCT01513330|16476842|P2|SenSura Mio First,|Other|0
4776091|NCT01513330|16476843|P1|SenSura Mio First,|Other|1
4776092|NCT01513330|16476842|P2|SenSura Mio First,|Withdrawal by Subject|1
4776093|NCT01513330|16476843|P1|SenSura Mio First,|Withdrawal by Subject|1
4776094|NCT01513330|16476842|P2|SenSura Mio First,|Lack of Efficacy|1
4776095|NCT01513330|16476843|P1|SenSura Mio First,|Lack of Efficacy|0
4776096|NCT01513330|16476842|P2|SenSura Mio First,|Adverse Event|0
4776097|NCT01513330|16476843|P1|SenSura Mio First,|Adverse Event|2
4776098|NCT01513317|16476851|P2|Overall Study|Other|1
4776099|NCT01513317|16476852|P1|Overall Study|Other|0
4776100|NCT01513317|16476851|P2|Overall Study|Study terminated by sponsor|18
4776101|NCT01513317|16476852|P1|Overall Study|Study terminated by sponsor|18
4776102|NCT01513317|16476851|P2|Overall Study|Death|1
4776103|NCT01513317|16476852|P1|Overall Study|Death|1
4776104|NCT01513317|16476851|P2|Overall Study|Withdrawal by Subject|4
4776105|NCT01513317|16476852|P1|Overall Study|Withdrawal by Subject|15
4776106|NCT01513291|16476870|P5|Run-out Period|Withdrawal by Subject|0
4776107|NCT01513291|16476871|P4|Run-out Period|Withdrawal by Subject|1
4776108|NCT01513291|16476872|P3|Run-out Period|Withdrawal by Subject|0
4776109|NCT01513291|16476873|P2|Run-out Period|Withdrawal by Subject|0
4776110|NCT01513291|16476874|P1|Run-out Period|Withdrawal by Subject|0
4776111|NCT01513291|16476870|P5|Run-out Period|Lost to Follow-up|0
4776112|NCT01513291|16476871|P4|Run-out Period|Lost to Follow-up|1
4776113|NCT01513291|16476872|P3|Run-out Period|Lost to Follow-up|0
4776114|NCT01513291|16476873|P2|Run-out Period|Lost to Follow-up|0
4776115|NCT01513291|16476874|P1|Run-out Period|Lost to Follow-up|0
4776116|NCT01513291|16476870|P5|Treatment Period|Randomized not treated|0
4776117|NCT01513291|16476871|P4|Treatment Period|Randomized not treated|0
4776118|NCT01513291|16476872|P3|Treatment Period|Randomized not treated|0
4776119|NCT01513291|16476873|P2|Treatment Period|Randomized not treated|2
4776120|NCT01513291|16476874|P1|Treatment Period|Randomized not treated|0
4776121|NCT01513291|16476870|P5|Treatment Period|Withdrawal by Subject|0
4776122|NCT01513291|16476871|P4|Treatment Period|Withdrawal by Subject|0
4776123|NCT01513291|16476872|P3|Treatment Period|Withdrawal by Subject|0
4776124|NCT01513291|16476873|P2|Treatment Period|Withdrawal by Subject|5
4776125|NCT01513291|16476874|P1|Treatment Period|Withdrawal by Subject|8
4776126|NCT01513291|16476870|P5|Treatment Period|Protocol Violation|0
4776127|NCT01513291|16476871|P4|Treatment Period|Protocol Violation|0
4776128|NCT01513291|16476872|P3|Treatment Period|Protocol Violation|0
4776129|NCT01513291|16476873|P2|Treatment Period|Protocol Violation|2
4776130|NCT01513291|16476874|P1|Treatment Period|Protocol Violation|1
4776131|NCT01513291|16476870|P5|Treatment Period|Physician Decision|0
4776132|NCT01513291|16476871|P4|Treatment Period|Physician Decision|0
4776133|NCT01513291|16476872|P3|Treatment Period|Physician Decision|0
4776134|NCT01513291|16476873|P2|Treatment Period|Physician Decision|0
4776135|NCT01513291|16476874|P1|Treatment Period|Physician Decision|1
4776136|NCT01513291|16476870|P5|Treatment Period|Lost to Follow-up|0
4776137|NCT01513291|16476871|P4|Treatment Period|Lost to Follow-up|0
4776138|NCT01513291|16476872|P3|Treatment Period|Lost to Follow-up|0
4776139|NCT01513291|16476873|P2|Treatment Period|Lost to Follow-up|3
4776140|NCT01513291|16476874|P1|Treatment Period|Lost to Follow-up|2
4776141|NCT01513291|16476870|P5|Treatment Period|Lack of Efficacy|0
4776142|NCT01513291|16476871|P4|Treatment Period|Lack of Efficacy|0
4776143|NCT01513291|16476872|P3|Treatment Period|Lack of Efficacy|0
4776144|NCT01513291|16476873|P2|Treatment Period|Lack of Efficacy|0
4776145|NCT01513291|16476874|P1|Treatment Period|Lack of Efficacy|3
4776146|NCT01513291|16476870|P5|Treatment Period|Adverse Event|0
4776147|NCT01513291|16476871|P4|Treatment Period|Adverse Event|0
4776148|NCT01513291|16476872|P3|Treatment Period|Adverse Event|0
4776149|NCT01513291|16476873|P2|Treatment Period|Adverse Event|4
4776150|NCT01513291|16476874|P1|Treatment Period|Adverse Event|8
4776151|NCT01513239|16476902|P6|Period 2: 9 Month Extension Phase|Technical Problems|1
4776152|NCT01513239|16476903|P5|Period 2: 9 Month Extension Phase|Technical Problems|1
4776153|NCT01513239|16476904|P4|Period 2: 9 Month Extension Phase|Technical Problems|0
4776154|NCT01513239|16476905|P3|Period 2: 9 Month Extension Phase|Technical Problems|0
4776155|NCT01513239|16476906|P2|Period 2: 9 Month Extension Phase|Technical Problems|0
4776156|NCT01513239|16476907|P1|Period 2: 9 Month Extension Phase|Technical Problems|0
4776157|NCT01513239|16476902|P6|Period 2: 9 Month Extension Phase|Physician Decision|0
4776158|NCT01513239|16476903|P5|Period 2: 9 Month Extension Phase|Physician Decision|0
4776159|NCT01513239|16476904|P4|Period 2: 9 Month Extension Phase|Physician Decision|1
4776160|NCT01513239|16476905|P3|Period 2: 9 Month Extension Phase|Physician Decision|0
4776161|NCT01513239|16476906|P2|Period 2: 9 Month Extension Phase|Physician Decision|0
4776162|NCT01513239|16476907|P1|Period 2: 9 Month Extension Phase|Physician Decision|0
4776163|NCT01513239|16476902|P6|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4776164|NCT01513239|16476903|P5|Period 2: 9 Month Extension Phase|Lost to Follow-up|1
4776165|NCT01513239|16476904|P4|Period 2: 9 Month Extension Phase|Lost to Follow-up|2
4776166|NCT01513239|16476905|P3|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4776167|NCT01513239|16476906|P2|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4776168|NCT01513239|16476907|P1|Period 2: 9 Month Extension Phase|Lost to Follow-up|0
4776169|NCT01513239|16476902|P6|Period 2: 9 Month Extension Phase|Death|2
4776170|NCT01513239|16476903|P5|Period 2: 9 Month Extension Phase|Death|5
4776171|NCT01513239|16476904|P4|Period 2: 9 Month Extension Phase|Death|2
4776172|NCT01513239|16476905|P3|Period 2: 9 Month Extension Phase|Death|0
4776173|NCT01513239|16476906|P2|Period 2: 9 Month Extension Phase|Death|0
4776174|NCT01513239|16476907|P1|Period 2: 9 Month Extension Phase|Death|0
4776175|NCT01513239|16476902|P6|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2
4776176|NCT01513239|16476903|P5|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3
4776177|NCT01513239|16476904|P4|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5
4776178|NCT01513239|16476905|P3|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
4776179|NCT01513239|16476906|P2|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
4776180|NCT01513239|16476907|P1|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0
4776181|NCT01513239|16476902|P6|Period 1: Main Phase|Withdrawal by Subject|0
4776182|NCT01513239|16476903|P5|Period 1: Main Phase|Withdrawal by Subject|0
4776183|NCT01513239|16476904|P4|Period 1: Main Phase|Withdrawal by Subject|0
4776184|NCT01513239|16476905|P3|Period 1: Main Phase|Withdrawal by Subject|42
4776185|NCT01513239|16476906|P2|Period 1: Main Phase|Withdrawal by Subject|29
4776186|NCT01513239|16476907|P1|Period 1: Main Phase|Withdrawal by Subject|27
4776187|NCT01513239|16476902|P6|Period 1: Main Phase|Technical Problems|0
4776188|NCT01513239|16476903|P5|Period 1: Main Phase|Technical Problems|0
4776189|NCT01513239|16476904|P4|Period 1: Main Phase|Technical Problems|0
4776190|NCT01513239|16476905|P3|Period 1: Main Phase|Technical Problems|0
4776191|NCT01513239|16476906|P2|Period 1: Main Phase|Technical Problems|2
4776192|NCT01513239|16476907|P1|Period 1: Main Phase|Technical Problems|1
4776193|NCT01513239|16476902|P6|Period 1: Main Phase|Protocol Violation|0
4776194|NCT01513239|16476903|P5|Period 1: Main Phase|Protocol Violation|0
4776195|NCT01513239|16476904|P4|Period 1: Main Phase|Protocol Violation|0
4776196|NCT01513239|16476905|P3|Period 1: Main Phase|Protocol Violation|2
4776197|NCT01513239|16476906|P2|Period 1: Main Phase|Protocol Violation|2
4776198|NCT01513239|16476907|P1|Period 1: Main Phase|Protocol Violation|2
4776199|NCT01513239|16476902|P6|Period 1: Main Phase|Physician Decision|0
4776200|NCT01513239|16476903|P5|Period 1: Main Phase|Physician Decision|0
4776201|NCT01513239|16476904|P4|Period 1: Main Phase|Physician Decision|0
4776202|NCT01513239|16476905|P3|Period 1: Main Phase|Physician Decision|4
4776203|NCT01513239|16476906|P2|Period 1: Main Phase|Physician Decision|4
4776204|NCT01513239|16476907|P1|Period 1: Main Phase|Physician Decision|4
4776205|NCT01513239|16476902|P6|Period 1: Main Phase|Lost to Follow-up|0
4776206|NCT01513239|16476903|P5|Period 1: Main Phase|Lost to Follow-up|0
4776207|NCT01513239|16476904|P4|Period 1: Main Phase|Lost to Follow-up|0
4776208|NCT01513239|16476905|P3|Period 1: Main Phase|Lost to Follow-up|6
4776209|NCT01513239|16476906|P2|Period 1: Main Phase|Lost to Follow-up|10
4776210|NCT01513239|16476907|P1|Period 1: Main Phase|Lost to Follow-up|11
4776211|NCT01513239|16476902|P6|Period 1: Main Phase|Death|0
4776212|NCT01513239|16476903|P5|Period 1: Main Phase|Death|0
4776213|NCT01513239|16476904|P4|Period 1: Main Phase|Death|0
4776214|NCT01513239|16476905|P3|Period 1: Main Phase|Death|32
4776215|NCT01513239|16476906|P2|Period 1: Main Phase|Death|22
4776216|NCT01513239|16476907|P1|Period 1: Main Phase|Death|29
4776217|NCT01513239|16476902|P6|Period 1: Main Phase|Adverse Event|0
4776218|NCT01513239|16476903|P5|Period 1: Main Phase|Adverse Event|0
4776219|NCT01513239|16476904|P4|Period 1: Main Phase|Adverse Event|0
4776220|NCT01513239|16476905|P3|Period 1: Main Phase|Adverse Event|2
4776221|NCT01513239|16476906|P2|Period 1: Main Phase|Adverse Event|1
4776222|NCT01513239|16476907|P1|Period 1: Main Phase|Adverse Event|1
4776223|NCT01513148|16476960|P2|Overall Study|Protocol Violation|2
4776224|NCT01513148|16476961|P1|Overall Study|Protocol Violation|2
4776225|NCT01512979|16477028|P2|Overall Study|Reason other than stated above|9
4776226|NCT01512979|16477029|P1|Overall Study|Reason other than stated above|13
4776227|NCT01512979|16477028|P2|Overall Study|Withdrawal by Subject|2
4776228|NCT01512979|16477029|P1|Overall Study|Withdrawal by Subject|1
4776229|NCT01512979|16477028|P2|Overall Study|Lost to Follow-up|5
4776230|NCT01512979|16477029|P1|Overall Study|Lost to Follow-up|2
4776231|NCT01512979|16477028|P2|Overall Study|Protocol Violation|4
4776232|NCT01512979|16477029|P1|Overall Study|Protocol Violation|1
4776233|NCT01512979|16477028|P2|Overall Study|Adverse Event|2
4776234|NCT01512979|16477029|P1|Overall Study|Adverse Event|2
4776235|NCT01512745|16477129|P2|Overall Study|Protocol Violation|0
4776236|NCT01512745|16477130|P1|Overall Study|Protocol Violation|1
4776237|NCT01512745|16477129|P2|Overall Study|Lack of Efficacy|2
4776238|NCT01512745|16477130|P1|Overall Study|Lack of Efficacy|2
4776239|NCT01512745|16477129|P2|Overall Study|Lost to Follow-up|0
4776240|NCT01512745|16477130|P1|Overall Study|Lost to Follow-up|4
4776241|NCT01512745|16477129|P2|Overall Study|Withdrawal by Subject|2
4776242|NCT01512745|16477130|P1|Overall Study|Withdrawal by Subject|2
4776243|NCT01512745|16477129|P2|Overall Study|Death|13
4776244|NCT01512745|16477130|P1|Overall Study|Death|9
4776245|NCT01512745|16477129|P2|Overall Study|Adverse Event|3
4776246|NCT01512745|16477130|P1|Overall Study|Adverse Event|22
4776247|NCT01512693|16477146|P2|Overall Study|Withdrawal by Subject|1
4776248|NCT01512693|16477147|P1|Overall Study|Withdrawal by Subject|0
4776249|NCT01512368|16477187|P1|Overall Study|Protocol Violation|3
4776250|NCT01512264|16477200|P4|Overall Study|Lost to Follow-up|1
4776251|NCT01512264|16477201|P3|Overall Study|Lost to Follow-up|0
4776252|NCT01512264|16477202|P2|Overall Study|Lost to Follow-up|0
4776253|NCT01512264|16477203|P1|Overall Study|Lost to Follow-up|0
4776254|NCT01512160|16477342|P4|Overall Study|Withdrawal by Subject|1
4776255|NCT01512160|16477343|P3|Overall Study|Withdrawal by Subject|0
4776256|NCT01512160|16477344|P2|Overall Study|Withdrawal by Subject|0
4776257|NCT01512160|16477345|P1|Overall Study|Withdrawal by Subject|1
4776258|NCT01512160|16477342|P4|Overall Study|Lost to Follow-up|0
4776259|NCT01512160|16477343|P3|Overall Study|Lost to Follow-up|0
4776260|NCT01512160|16477344|P2|Overall Study|Lost to Follow-up|0
4776261|NCT01512160|16477345|P1|Overall Study|Lost to Follow-up|1
4776262|NCT01512108|16477437|P2|Overall Study|Unclassified|3
4776263|NCT01512108|16477438|P1|Overall Study|Unclassified|11
4776264|NCT01512108|16477437|P2|Overall Study|Withdrawal Criteria|0
4776265|NCT01512108|16477438|P1|Overall Study|Withdrawal Criteria|1
4776266|NCT01512108|16477437|P2|Overall Study|Protocol Violation|2
4776267|NCT01512108|16477438|P1|Overall Study|Protocol Violation|1
4776268|NCT01512108|16477437|P2|Overall Study|Adverse Event|4
4776269|NCT01512108|16477438|P1|Overall Study|Adverse Event|9
4776270|NCT01511939|16477464|P3|Overall Study|Withdrawal by Subject|0
4776271|NCT01511939|16477465|P2|Overall Study|Withdrawal by Subject|1
4776272|NCT01511939|16477466|P1|Overall Study|Withdrawal by Subject|2
4776273|NCT01511536|16477495|P3|Phase 2|Other|9
4776274|NCT01511536|16477496|P2|Phase 2|Other|0
4776275|NCT01511536|16477497|P1|Phase 2|Other|0
4776276|NCT01511536|16477495|P3|Phase 1|Other|0
4776277|NCT01511536|16477496|P2|Phase 1|Other|1
4776278|NCT01511536|16477497|P1|Phase 1|Other|0
4776279|NCT01511445|16477519|P2|Overall Study|Protocol Violation|0
4776280|NCT01511445|16477520|P1|Overall Study|Protocol Violation|1
4776281|NCT01511445|16477519|P2|Overall Study|Protocol Violation|3
4776282|NCT01511445|16477520|P1|Overall Study|Protocol Violation|1
4776283|NCT01511445|16477519|P2|Overall Study|Lost to Follow-up|1
4776284|NCT01511445|16477520|P1|Overall Study|Lost to Follow-up|3
4776285|NCT01511419|16477530|P2|Dose 2|Physician Decision|0
4776286|NCT01511419|16477531|P1|Dose 2|Physician Decision|1
4776287|NCT01511250|16477643|P10|Overall Study|Protocol Violation|0
4776288|NCT01511250|16477644|P9|Overall Study|Protocol Violation|0
4776289|NCT01511250|16477645|P8|Overall Study|Protocol Violation|0
4776290|NCT01511250|16477646|P7|Overall Study|Protocol Violation|0
4776291|NCT01511250|16477647|P6|Overall Study|Protocol Violation|0
4776292|NCT01511250|16477648|P5|Overall Study|Protocol Violation|0
4776293|NCT01511250|16477649|P4|Overall Study|Protocol Violation|0
4776294|NCT01511250|16477650|P3|Overall Study|Protocol Violation|1
4776295|NCT01511250|16477651|P2|Overall Study|Protocol Violation|2
4776296|NCT01511250|16477652|P1|Overall Study|Protocol Violation|0
4776297|NCT01511250|16477643|P10|Overall Study|Lost to Follow-up|5
4776298|NCT01511250|16477644|P9|Overall Study|Lost to Follow-up|13
4776299|NCT01511250|16477645|P8|Overall Study|Lost to Follow-up|3
4776300|NCT01511250|16477646|P7|Overall Study|Lost to Follow-up|2
4776301|NCT01511250|16477647|P6|Overall Study|Lost to Follow-up|0
4776302|NCT01511250|16477648|P5|Overall Study|Lost to Follow-up|0
4776303|NCT01511250|16477649|P4|Overall Study|Lost to Follow-up|3
4776304|NCT01511250|16477650|P3|Overall Study|Lost to Follow-up|3
4776305|NCT01511250|16477651|P2|Overall Study|Lost to Follow-up|3
4776306|NCT01511250|16477652|P1|Overall Study|Lost to Follow-up|7
4776307|NCT01511250|16477643|P10|Overall Study|Sponsor/Investigator Decision|0
4776308|NCT01511250|16477644|P9|Overall Study|Sponsor/Investigator Decision|0
4776309|NCT01511250|16477645|P8|Overall Study|Sponsor/Investigator Decision|0
4776310|NCT01511250|16477646|P7|Overall Study|Sponsor/Investigator Decision|0
4776311|NCT01511250|16477647|P6|Overall Study|Sponsor/Investigator Decision|0
4776312|NCT01511250|16477648|P5|Overall Study|Sponsor/Investigator Decision|0
4776313|NCT01511250|16477649|P4|Overall Study|Sponsor/Investigator Decision|0
4776314|NCT01511250|16477650|P3|Overall Study|Sponsor/Investigator Decision|0
4776315|NCT01511250|16477651|P2|Overall Study|Sponsor/Investigator Decision|0
4776316|NCT01511250|16477652|P1|Overall Study|Sponsor/Investigator Decision|1
4776317|NCT01511250|16477643|P10|Overall Study|Withdrawal of Consent|0
4776318|NCT01511250|16477644|P9|Overall Study|Withdrawal of Consent|1
4776319|NCT01511250|16477645|P8|Overall Study|Withdrawal of Consent|1
4776320|NCT01511250|16477646|P7|Overall Study|Withdrawal of Consent|0
4776321|NCT01511250|16477647|P6|Overall Study|Withdrawal of Consent|0
4776322|NCT01511250|16477648|P5|Overall Study|Withdrawal of Consent|0
4776323|NCT01511250|16477649|P4|Overall Study|Withdrawal of Consent|0
4776324|NCT01511250|16477650|P3|Overall Study|Withdrawal of Consent|0
4776325|NCT01511250|16477651|P2|Overall Study|Withdrawal of Consent|0
4776326|NCT01511250|16477652|P1|Overall Study|Withdrawal of Consent|1
4776327|NCT01511107|16477800|P2|Overall Study|Withdrawal by Subject|20
4776328|NCT01511107|16477801|P1|Overall Study|Withdrawal by Subject|9
4776329|NCT01511107|16477800|P2|Overall Study|Lost to Follow-up|19
4776330|NCT01511107|16477801|P1|Overall Study|Lost to Follow-up|10
4776331|NCT01511107|16477800|P2|Overall Study|Ineligible|2
4776332|NCT01511107|16477801|P1|Overall Study|Ineligible|3
4776333|NCT01511055|16477873|P1|Overall Study|Withdrawal by Subject|6
4776334|NCT01510912|16477897|P1|Overall Study|Other, including joint replacement|5
4776335|NCT01510912|16477897|P1|Overall Study|Lost to Follow-up|26
4776336|NCT01510912|16477897|P1|Overall Study|Protocol Violation|27
4776337|NCT01510912|16477897|P1|Overall Study|Physician Decision|1
4776338|NCT01510912|16477897|P1|Overall Study|Withdrawal by Subject|49
4776339|NCT01510912|16477897|P1|Overall Study|Non-compliance with trial drug|23
4776340|NCT01510912|16477897|P1|Overall Study|Lack of Efficacy|12
4776341|NCT01510912|16477897|P1|Overall Study|Adverse Event|99
4776342|NCT01510769|16477913|P3|Overall Study|Death|0
4776343|NCT01510769|16477914|P2|Overall Study|Death|1
4776344|NCT01510769|16477915|P1|Overall Study|Death|1
4776345|NCT01510769|16477913|P3|Overall Study|Withdrawal by Subject|3
4776346|NCT01510769|16477914|P2|Overall Study|Withdrawal by Subject|4
4776347|NCT01510769|16477915|P1|Overall Study|Withdrawal by Subject|3
4776348|NCT01510769|16477913|P3|Overall Study|Lost to Follow-up|5
4776349|NCT01510769|16477914|P2|Overall Study|Lost to Follow-up|1
4776350|NCT01510769|16477915|P1|Overall Study|Lost to Follow-up|5
4776351|NCT01510769|16477913|P3|Overall Study|Protocol Violation|9
4776352|NCT01510769|16477914|P2|Overall Study|Protocol Violation|10
4776353|NCT01510769|16477915|P1|Overall Study|Protocol Violation|11
4776354|NCT01510769|16477913|P3|Overall Study|Gout Flare|1
4776355|NCT01510769|16477914|P2|Overall Study|Gout Flare|3
4776356|NCT01510769|16477915|P1|Overall Study|Gout Flare|0
4776357|NCT01510769|16477913|P3|Overall Study|Adverse Event|4
4776358|NCT01510769|16477914|P2|Overall Study|Adverse Event|6
4776359|NCT01510769|16477915|P1|Overall Study|Adverse Event|7
4776360|NCT01510756|16477932|P1|Overall Study|Physician Decision|1
4776361|NCT01510756|16477932|P1|Overall Study|Lack of Efficacy|2
4776362|NCT01510756|16477932|P1|Overall Study|Death|1
4776363|NCT01510717|16477940|P2|Overall Study|Withdrawal by Subject|2
4776364|NCT01510717|16477941|P1|Overall Study|Withdrawal by Subject|0
4776365|NCT01510717|16477940|P2|Overall Study|Lost to Follow-up|1
4776366|NCT01510717|16477941|P1|Overall Study|Lost to Follow-up|0
4776367|NCT01510717|16477940|P2|Overall Study|Death|0
4776368|NCT01510717|16477941|P1|Overall Study|Death|1
4776369|NCT01510717|16477940|P2|Overall Study|Adverse Event|2
4776370|NCT01510717|16477941|P1|Overall Study|Adverse Event|1
4776371|NCT01510158|16478061|P3|Overall Study|Death|0
4776372|NCT01510158|16478062|P2|Overall Study|Death|0
4776373|NCT01510158|16478063|P1|Overall Study|Death|1
4776374|NCT01510158|16478061|P3|Overall Study|Withdrawal by Subject|10
4776375|NCT01510158|16478062|P2|Overall Study|Withdrawal by Subject|13
4776376|NCT01510158|16478063|P1|Overall Study|Withdrawal by Subject|10
4776377|NCT01510158|16478061|P3|Overall Study|Lost to Follow-up|9
4776378|NCT01510158|16478062|P2|Overall Study|Lost to Follow-up|16
4776379|NCT01510158|16478063|P1|Overall Study|Lost to Follow-up|13
4776380|NCT01510158|16478061|P3|Overall Study|Sponsor terminated study.|2
4776381|NCT01510158|16478062|P2|Overall Study|Sponsor terminated study.|0
4776382|NCT01510158|16478063|P1|Overall Study|Sponsor terminated study.|2
4776383|NCT01510158|16478061|P3|Overall Study|Protocol Violation|24
4776384|NCT01510158|16478062|P2|Overall Study|Protocol Violation|16
4776385|NCT01510158|16478063|P1|Overall Study|Protocol Violation|17
4776386|NCT01510158|16478061|P3|Overall Study|Gout flare|0
4776387|NCT01510158|16478062|P2|Overall Study|Gout flare|0
4776388|NCT01510158|16478063|P1|Overall Study|Gout flare|1
4776389|NCT01510158|16478061|P3|Overall Study|Adverse Event|5
4776390|NCT01510158|16478062|P2|Overall Study|Adverse Event|8
4776391|NCT01510158|16478063|P1|Overall Study|Adverse Event|7
4776392|NCT01510145|16478077|P1|Overall Study|Relative reported subject withdrew|1
4776393|NCT01510145|16478077|P1|Overall Study|Withdrawal by Subject|6
4776394|NCT01510145|16478077|P1|Overall Study|Lost to Follow-up|5
4776395|NCT01510145|16478077|P1|Overall Study|Adverse Event|6
4776396|NCT01510028|16478086|P4|Overall Study|Lack of Efficacy|0
4776397|NCT01510028|16478087|P3|Overall Study|Lack of Efficacy|0
4776398|NCT01510028|16478088|P2|Overall Study|Lack of Efficacy|0
4776399|NCT01510028|16478089|P1|Overall Study|Lack of Efficacy|1
4776400|NCT01509664|16478350|P2|Overall Study|Lost to Follow-up|21
4776401|NCT01509664|16478351|P1|Overall Study|Lost to Follow-up|15
4776402|NCT01509547|16478411|P2|Overall Study|Physician Decision|1
4776403|NCT01509547|16478412|P1|Overall Study|Physician Decision|0
4776404|NCT01509547|16478411|P2|Overall Study|Withdrawal by Subject|24
4776405|NCT01509547|16478412|P1|Overall Study|Withdrawal by Subject|11
4776406|NCT01509547|16478411|P2|Overall Study|Lost to Follow-up|14
4776407|NCT01509547|16478412|P1|Overall Study|Lost to Follow-up|24
4776408|NCT01509079|16478479|P2|Overall Study|started an excluded medication|1
4776409|NCT01509079|16478480|P1|Overall Study|started an excluded medication|0
4776410|NCT01509079|16478479|P2|Overall Study|Lack of Efficacy|2
4776411|NCT01509079|16478480|P1|Overall Study|Lack of Efficacy|0
4776412|NCT01509053|16478500|P1|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3
4776413|NCT01509053|16478500|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1
4776414|NCT01509053|16478500|P1|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1
4776415|NCT01509053|16478500|P1|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13
4776416|NCT01509053|16478500|P1|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1
4776417|NCT01509053|16478500|P1|Oral Aripirazole (Phase A)|Sponsor discontinued study|11
4776418|NCT01508936|16478562|P2|Overall Study|Data from 2 sites deemed invalid|11
4776419|NCT01508936|16478563|P1|Overall Study|Data from 2 sites deemed invalid|4
4776420|NCT01508936|16478562|P2|Overall Study|Other|5
4776421|NCT01508936|16478563|P1|Overall Study|Other|0
4776422|NCT01508936|16478562|P2|Overall Study|Lost to Follow-up|9
4776423|NCT01508936|16478563|P1|Overall Study|Lost to Follow-up|2
4776424|NCT01508936|16478562|P2|Overall Study|Protocol Violation|3
4776425|NCT01508936|16478563|P1|Overall Study|Protocol Violation|2
4776426|NCT01508936|16478562|P2|Overall Study|Withdrawal by Subject|18
4776427|NCT01508936|16478563|P1|Overall Study|Withdrawal by Subject|4
4776428|NCT01508936|16478562|P2|Overall Study|Lack of Efficacy|1
4776429|NCT01508936|16478563|P1|Overall Study|Lack of Efficacy|0
4776430|NCT01508936|16478562|P2|Overall Study|Adverse Event|32
4776431|NCT01508936|16478563|P1|Overall Study|Adverse Event|11
4776432|NCT01508910|16478602|P4|Treatment|Sponsor Decision|1
4776433|NCT01508910|16478603|P3|Treatment|Sponsor Decision|0
4776434|NCT01508910|16478604|P2|Treatment|Sponsor Decision|0
4776435|NCT01508910|16478605|P1|Treatment|Sponsor Decision|0
4776436|NCT01508910|16478602|P4|Treatment|Withdrawal by Subject|1
4776437|NCT01508910|16478603|P3|Treatment|Withdrawal by Subject|6
4776438|NCT01508910|16478604|P2|Treatment|Withdrawal by Subject|1
4776439|NCT01508910|16478605|P1|Treatment|Withdrawal by Subject|0
4776440|NCT01508910|16478602|P4|Treatment|Lost to Follow-up|1
4776441|NCT01508910|16478603|P3|Treatment|Lost to Follow-up|2
4776442|NCT01508910|16478604|P2|Treatment|Lost to Follow-up|0
4776443|NCT01508910|16478605|P1|Treatment|Lost to Follow-up|0
4776444|NCT01508910|16478602|P4|Treatment|Death|0
4776445|NCT01508910|16478603|P3|Treatment|Death|2
4776446|NCT01508910|16478604|P2|Treatment|Death|3
4776447|NCT01508910|16478605|P1|Treatment|Death|2
4776448|NCT01508702|16478638|P2|Overall Study|Withdrawal by Subject|7
4776449|NCT01508702|16478639|P1|Overall Study|Withdrawal by Subject|11
4776450|NCT01508702|16478638|P2|Overall Study|Lost to Follow-up|2
4776451|NCT01508702|16478639|P1|Overall Study|Lost to Follow-up|1
4776452|NCT01508702|16478638|P2|Overall Study|Protocol Violation|1
4776453|NCT01508702|16478639|P1|Overall Study|Protocol Violation|2
4776454|NCT01508702|16478638|P2|Overall Study|Gout flare|0
4776455|NCT01508702|16478639|P1|Overall Study|Gout flare|2
4776456|NCT01508702|16478638|P2|Overall Study|Adverse Event|3
4776457|NCT01508702|16478639|P1|Overall Study|Adverse Event|7
4776458|NCT01508676|16478647|P2|Phase II (2 Weeks)|Medication Exclusion|0
4776459|NCT01508676|16478648|P1|Phase II (2 Weeks)|Medication Exclusion|1
4776460|NCT01508676|16478647|P2|Phase II (2 Weeks)|Skin Sensitivity|1
4776461|NCT01508676|16478648|P1|Phase II (2 Weeks)|Skin Sensitivity|0
4776462|NCT01508676|16478647|P2|Phase I (2 Weeks)|Positive Drug Screen|2
4776463|NCT01508676|16478648|P1|Phase I (2 Weeks)|Positive Drug Screen|0
4776464|NCT01508676|16478647|P2|Phase I (2 Weeks)|Wrong Pain Type|0
4776465|NCT01508676|16478648|P1|Phase I (2 Weeks)|Wrong Pain Type|1
4776466|NCT01508676|16478647|P2|Phase I (2 Weeks)|Medication Exclusion|1
4776467|NCT01508676|16478648|P1|Phase I (2 Weeks)|Medication Exclusion|1
4776468|NCT01508650|16478660|P2|Overall Study|Lost to Follow-up|3
4776469|NCT01508650|16478661|P1|Overall Study|Lost to Follow-up|0
4776470|NCT01508325|16478680|P2|Overall Study|Other|2
4776471|NCT01508325|16478681|P1|Overall Study|Other|2
4776472|NCT01508325|16478680|P2|Overall Study|Lost to Follow-up|6
4776473|NCT01508325|16478681|P1|Overall Study|Lost to Follow-up|5
4776474|NCT01508325|16478680|P2|Overall Study|Adverse Event|0
4776475|NCT01508325|16478681|P1|Overall Study|Adverse Event|1
4776476|NCT01508325|16478680|P2|Overall Study|Physician Decision|1
4776477|NCT01508325|16478681|P1|Overall Study|Physician Decision|2
4776478|NCT01508325|16478680|P2|Overall Study|Protocol Violation|3
4776479|NCT01508325|16478681|P1|Overall Study|Protocol Violation|0
4776480|NCT01508325|16478680|P2|Overall Study|Withdrawal by Subject|9
4776481|NCT01508325|16478681|P1|Overall Study|Withdrawal by Subject|8
4776482|NCT01508169|16478711|P2|Overall Study|Lost to Follow-up|2
4776483|NCT01508169|16478712|P1|Overall Study|Lost to Follow-up|1
4776484|NCT01508169|16478711|P2|Overall Study|Withdrawal by Subject|0
4776485|NCT01508169|16478712|P1|Overall Study|Withdrawal by Subject|1
4776486|NCT01508169|16478711|P2|Overall Study|Adverse Event|0
4776487|NCT01508169|16478712|P1|Overall Study|Adverse Event|1
4776488|NCT01508130|16478726|P2|Overall Study|Administrative|3
4776489|NCT01508130|16478727|P1|Overall Study|Administrative|14
4776490|NCT01508130|16478726|P2|Overall Study|Insufficient therapeutic response|23
4776491|NCT01508130|16478727|P1|Overall Study|Insufficient therapeutic response|74
4776492|NCT01508130|16478726|P2|Overall Study|Subject's substantial non-compliance|9
4776493|NCT01508130|16478727|P1|Overall Study|Subject's substantial non-compliance|25
4776494|NCT01508130|16478726|P2|Overall Study|Withdrawal by Subject|3
4776495|NCT01508130|16478727|P1|Overall Study|Withdrawal by Subject|3
4776496|NCT01508130|16478726|P2|Overall Study|Lost to Follow-up|2
4776497|NCT01508130|16478727|P1|Overall Study|Lost to Follow-up|25
4776498|NCT01508130|16478726|P2|Overall Study|Protocol Violation|0
4776499|NCT01508130|16478727|P1|Overall Study|Protocol Violation|2
4776500|NCT01508130|16478726|P2|Overall Study|Death|1
4776501|NCT01508130|16478727|P1|Overall Study|Death|3
4776502|NCT01508130|16478726|P2|Overall Study|Adverse Event|28
4776503|NCT01508130|16478727|P1|Overall Study|Adverse Event|81
4776504|NCT01507896|16478795|P1|Overall Study|The surgery was denied by the sponsor.|1
4776505|NCT01507896|16478795|P1|Overall Study|Withdrawal by Subject|1
4776506|NCT01507831|16478838|P2|Overall Study|Other|6
4776507|NCT01507831|16478839|P1|Overall Study|Other|3
4776508|NCT01507831|16478838|P2|Overall Study|Potential lost to follow-up|0
4776509|NCT01507831|16478839|P1|Overall Study|Potential lost to follow-up|3
4776510|NCT01507831|16478838|P2|Overall Study|Site closure|3
4776511|NCT01507831|16478839|P1|Overall Study|Site closure|0
4776512|NCT01507831|16478838|P2|Overall Study|Selection criteria finally not met|1
4776513|NCT01507831|16478839|P1|Overall Study|Selection criteria finally not met|0
4776514|NCT01507831|16478838|P2|Overall Study|Last visit outside protocol visit window|143
4776515|NCT01507831|16478839|P1|Overall Study|Last visit outside protocol visit window|51
4776516|NCT01507831|16478838|P2|Overall Study|Related to study drug administration|14
4776517|NCT01507831|16478839|P1|Overall Study|Related to study drug administration|5
4776518|NCT01507831|16478838|P2|Overall Study|Consent withdrawn by participant|72
4776519|NCT01507831|16478839|P1|Overall Study|Consent withdrawn by participant|34
4776520|NCT01507831|16478838|P2|Overall Study|Participant moved|19
4776521|NCT01507831|16478839|P1|Overall Study|Participant moved|5
4776522|NCT01507831|16478838|P2|Overall Study|Physician Decision|4
4776523|NCT01507831|16478839|P1|Overall Study|Physician Decision|0
4776524|NCT01507831|16478838|P2|Overall Study|Poor compliance to protocol|60
4776525|NCT01507831|16478839|P1|Overall Study|Poor compliance to protocol|38
4776526|NCT01507831|16478838|P2|Overall Study|Death|2
4776527|NCT01507831|16478839|P1|Overall Study|Death|6
4776528|NCT01507831|16478838|P2|Overall Study|Adverse Event|113
4776529|NCT01507831|16478839|P1|Overall Study|Adverse Event|48
4776530|NCT01507831|16478838|P2|Overall Study|Randomized but not treated|3
4776531|NCT01507831|16478839|P1|Overall Study|Randomized but not treated|0
4776532|NCT01507662|16478959|P2|Overall Study|Proxy interview done|3
4776533|NCT01507662|16478960|P1|Overall Study|Proxy interview done|2
4776534|NCT01507662|16478959|P2|Overall Study|Lost to Follow-up|523
4776535|NCT01507662|16478960|P1|Overall Study|Lost to Follow-up|498
4776536|NCT01507662|16478959|P2|Overall Study|Withdrawal by Subject|287
4776537|NCT01507662|16478960|P1|Overall Study|Withdrawal by Subject|290
4776538|NCT01507662|16478959|P2|Overall Study|Death|18
4776539|NCT01507662|16478960|P1|Overall Study|Death|26
4776540|NCT01507298|16478995|P2|Overall Study|Protocol Violation|6
4776541|NCT01507298|16478996|P1|Overall Study|Protocol Violation|0
4776542|NCT01507246|16479006|P2|Overall Study|Required different surgical procedures|1
4776543|NCT01507246|16479007|P1|Overall Study|Required different surgical procedures|2
4776544|NCT01507090|16479105|P1|Overall Study|incomplete dataset|18
4776545|NCT01507051|16479144|P4|Overall Study|Adverse Event|0
4776546|NCT01507051|16479145|P3|Overall Study|Adverse Event|0
4776547|NCT01507051|16479146|P2|Overall Study|Adverse Event|0
4776548|NCT01507051|16479147|P1|Overall Study|Adverse Event|1
4776549|NCT01507051|16479144|P4|Overall Study|Physician Decision|1
4776550|NCT01507051|16479145|P3|Overall Study|Physician Decision|0
4776551|NCT01507051|16479146|P2|Overall Study|Physician Decision|0
4776552|NCT01507051|16479147|P1|Overall Study|Physician Decision|0
4776553|NCT01507051|16479144|P4|Overall Study|Withdrawal by Subject|6
4776554|NCT01507051|16479145|P3|Overall Study|Withdrawal by Subject|1
4776555|NCT01507051|16479146|P2|Overall Study|Withdrawal by Subject|3
4776556|NCT01507051|16479147|P1|Overall Study|Withdrawal by Subject|1
4776557|NCT01506960|16479265|P1|Overall Study|Did not meet angiographic criteria|47
4776558|NCT01506947|16479271|P1|Overall Study|Did Not Meet Eligibility Criteria|3
4776559|NCT01506947|16479271|P1|Overall Study|Death|1
4776560|NCT01506947|16479271|P1|Overall Study|Adverse Event|5
4776561|NCT01506947|16479271|P1|Overall Study|Lost to Follow-up|7
4776562|NCT01506908|16479289|P2|Overall Study|Adverse Event|0
4776563|NCT01506908|16479290|P1|Overall Study|Adverse Event|1
4776564|NCT01506882|16479308|P2|Overall Study|Other Reason|0
4776565|NCT01506882|16479309|P1|Overall Study|Other Reason|2
4776566|NCT01506882|16479308|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4776567|NCT01506882|16479309|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
4776568|NCT01506882|16479308|P2|Overall Study|AE, non-serious non-fatal|1
4776569|NCT01506882|16479309|P1|Overall Study|AE, non-serious non-fatal|3
4776570|NCT01506882|16479308|P2|Overall Study|SAE, non-fatal|0
4776571|NCT01506882|16479309|P1|Overall Study|SAE, non-fatal|2
4776572|NCT01506882|16479308|P2|Overall Study|Withdrawal by Subject|3
4776573|NCT01506882|16479309|P1|Overall Study|Withdrawal by Subject|9
4776574|NCT01506882|16479308|P2|Overall Study|Lost to Follow-up|0
4776575|NCT01506882|16479309|P1|Overall Study|Lost to Follow-up|1
4776576|NCT01506882|16479308|P2|Overall Study|Lack of Efficacy|3
4776577|NCT01506882|16479309|P1|Overall Study|Lack of Efficacy|4
4776578|NCT01506726|16479323|P2|Overall Study|Adverse Event|2
4776579|NCT01506726|16479324|P1|Overall Study|Adverse Event|1
4776580|NCT01506596|16479364|P1|Overall Study|ineligible pathology|1
4776581|NCT01506479|16479375|P3|Overall Study|Adverse Event|0
4776582|NCT01506479|16479376|P2|Overall Study|Adverse Event|1
4776583|NCT01506479|16479377|P1|Overall Study|Adverse Event|0
4776584|NCT01506479|16479375|P3|Overall Study|Missing assessment|0
4776585|NCT01506479|16479376|P2|Overall Study|Missing assessment|0
4776586|NCT01506479|16479377|P1|Overall Study|Missing assessment|1
4776587|NCT01506479|16479375|P3|Overall Study|Withdrawal by Subject|1
4776588|NCT01506479|16479376|P2|Overall Study|Withdrawal by Subject|2
4776589|NCT01506479|16479377|P1|Overall Study|Withdrawal by Subject|1
4776590|NCT01506479|16479375|P3|Overall Study|Lost to Follow-up|2
4776591|NCT01506479|16479376|P2|Overall Study|Lost to Follow-up|2
4776592|NCT01506479|16479377|P1|Overall Study|Lost to Follow-up|1
4776593|NCT01506453|16479391|P2|Overall Study|Withdrawal prior to treatment|2
4776594|NCT01506453|16479392|P1|Overall Study|Withdrawal prior to treatment|0
4776595|NCT01506323|16479408|P2|Overall Study|Started another treatment|0
4776596|NCT01506323|16479409|P1|Overall Study|Started another treatment|1
4776597|NCT01506323|16479408|P2|Overall Study|Schedule or Transportation conflict|0
4776598|NCT01506323|16479409|P1|Overall Study|Schedule or Transportation conflict|8
4776599|NCT01506323|16479408|P2|Overall Study|Moved out of area|2
4776600|NCT01506323|16479409|P1|Overall Study|Moved out of area|5
4776601|NCT01506323|16479408|P2|Overall Study|Lack of Efficacy|3
4776602|NCT01506323|16479409|P1|Overall Study|Lack of Efficacy|1
4776603|NCT01506323|16479408|P2|Overall Study|Withdrawal by Subject|4
4776604|NCT01506323|16479409|P1|Overall Study|Withdrawal by Subject|4
4776605|NCT01506323|16479408|P2|Overall Study|Lost to Follow-up|4
4776606|NCT01506323|16479409|P1|Overall Study|Lost to Follow-up|5
4776607|NCT01506271|16479438|P3|Overall Study|Lost to Follow-up|2
4776608|NCT01506271|16479439|P2|Overall Study|Lost to Follow-up|1
4776609|NCT01506271|16479440|P1|Overall Study|Lost to Follow-up|0
4776610|NCT01506271|16479438|P3|Overall Study|Withdrawal by Subject|1
4776611|NCT01506271|16479439|P2|Overall Study|Withdrawal by Subject|1
4776612|NCT01506271|16479440|P1|Overall Study|Withdrawal by Subject|0
4776613|NCT01506271|16479438|P3|Overall Study|Insufficient supply of study drug|0
4776614|NCT01506271|16479439|P2|Overall Study|Insufficient supply of study drug|0
4776615|NCT01506271|16479440|P1|Overall Study|Insufficient supply of study drug|1
4776616|NCT01506271|16479438|P3|Overall Study|Adverse Event|0
4776617|NCT01506271|16479439|P2|Overall Study|Adverse Event|2
4776618|NCT01506271|16479440|P1|Overall Study|Adverse Event|0
4776619|NCT01506271|16479438|P3|Overall Study|Death|0
4776620|NCT01506271|16479439|P2|Overall Study|Death|1
4776621|NCT01506271|16479440|P1|Overall Study|Death|0
4776622|NCT01506271|16479438|P3|Overall Study|Protocol Violation|0
4776623|NCT01506271|16479439|P2|Overall Study|Protocol Violation|1
4776624|NCT01506271|16479440|P1|Overall Study|Protocol Violation|3
4776625|NCT01506271|16479438|P3|Overall Study|Progressive disease|0
4776626|NCT01506271|16479439|P2|Overall Study|Progressive disease|1
4776627|NCT01506271|16479440|P1|Overall Study|Progressive disease|0
4776628|NCT01506193|16479502|P3|Overall Study|Lost to Follow-up|3
4776629|NCT01506193|16479503|P2|Overall Study|Lost to Follow-up|3
4776630|NCT01506193|16479504|P1|Overall Study|Lost to Follow-up|8
4776631|NCT01506193|16479502|P3|Overall Study|Withdrawal by Subject|8
4776632|NCT01506193|16479503|P2|Overall Study|Withdrawal by Subject|1
4776633|NCT01506193|16479504|P1|Overall Study|Withdrawal by Subject|5
4776634|NCT01506193|16479502|P3|Overall Study|Adverse event, non-fatal|1
4776635|NCT01506193|16479503|P2|Overall Study|Adverse event, non-fatal|0
4776636|NCT01506193|16479504|P1|Overall Study|Adverse event, non-fatal|0
4776637|NCT01506193|16479502|P3|Overall Study|Migrated/moved from study area|1
4776638|NCT01506193|16479503|P2|Overall Study|Migrated/moved from study area|0
4776639|NCT01506193|16479504|P1|Overall Study|Migrated/moved from study area|0
4776640|NCT01506193|16479502|P3|Overall Study|Protocol Violation|1
4776641|NCT01506193|16479503|P2|Overall Study|Protocol Violation|0
4776642|NCT01506193|16479504|P1|Overall Study|Protocol Violation|1
4776643|NCT01505881|16479550|P2|Overall Study|Withdrawal by Subject|0
4776644|NCT01505881|16479551|P1|Overall Study|Withdrawal by Subject|2
4776645|NCT01505881|16479550|P2|Overall Study|Lost to Follow-up|0
4776646|NCT01505881|16479551|P1|Overall Study|Lost to Follow-up|2
4776647|NCT01505881|16479550|P2|Overall Study|Adverse Event|1
4776648|NCT01505881|16479551|P1|Overall Study|Adverse Event|0
4776649|NCT01505647|16479657|P2|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2
4776650|NCT01505647|16479658|P1|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1
4776651|NCT01505647|16479657|P2|Day 43 Through Day 182 Follow-up|Death|1
4776652|NCT01505647|16479658|P1|Day 43 Through Day 182 Follow-up|Death|0
4776653|NCT01505647|16479657|P2|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0
4776654|NCT01505647|16479658|P1|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1
4776655|NCT01505647|16479657|P2|Day 1 Through Day 42 Follow-up|Physician Decision|0
4776656|NCT01505647|16479658|P1|Day 1 Through Day 42 Follow-up|Physician Decision|1
4776657|NCT01505647|16479657|P2|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0
4776658|NCT01505647|16479658|P1|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1
4776659|NCT01505634|16479675|P3|Overall Study|In a conflict zone|1
4776660|NCT01505634|16479676|P2|Overall Study|In a conflict zone|0
4776661|NCT01505634|16479677|P1|Overall Study|In a conflict zone|0
4776662|NCT01505634|16479675|P3|Overall Study|Death|0
4776663|NCT01505634|16479676|P2|Overall Study|Death|0
4776664|NCT01505634|16479677|P1|Overall Study|Death|1
4776665|NCT01505634|16479675|P3|Overall Study|Lost to Follow-up|4
4776666|NCT01505634|16479676|P2|Overall Study|Lost to Follow-up|4
4776667|NCT01505634|16479677|P1|Overall Study|Lost to Follow-up|1
4776668|NCT01505634|16479675|P3|Overall Study|Protocol Violation|0
4776669|NCT01505634|16479676|P2|Overall Study|Protocol Violation|0
4776670|NCT01505634|16479677|P1|Overall Study|Protocol Violation|2
4776671|NCT01505634|16479675|P3|Overall Study|Insufficient supply of drug at site|0
4776672|NCT01505634|16479676|P2|Overall Study|Insufficient supply of drug at site|0
4776673|NCT01505634|16479677|P1|Overall Study|Insufficient supply of drug at site|1
4776674|NCT01505634|16479675|P3|Overall Study|Adverse Event|0
4776675|NCT01505634|16479676|P2|Overall Study|Adverse Event|0
4776676|NCT01505634|16479677|P1|Overall Study|Adverse Event|1
4776677|NCT01505634|16479675|P3|Overall Study|Physician Decision|0
4776678|NCT01505634|16479676|P2|Overall Study|Physician Decision|1
4776679|NCT01505634|16479677|P1|Overall Study|Physician Decision|1
4776680|NCT01505634|16479675|P3|Overall Study|Withdrawal by Subject|1
4776681|NCT01505634|16479676|P2|Overall Study|Withdrawal by Subject|5
4776682|NCT01505634|16479677|P1|Overall Study|Withdrawal by Subject|2
4776683|NCT01505608|16479732|P2|Phase II|Protocol Violation|1
4776684|NCT01505608|16479733|P1|Phase II|Protocol Violation|0
4776685|NCT01505608|16479732|P2|Phase II|Lack of Efficacy|1
4776686|NCT01505608|16479733|P1|Phase II|Lack of Efficacy|2
4776687|NCT01505608|16479732|P2|Phase I|Withdrawal by Subject|1
4776688|NCT01505608|16479733|P1|Phase I|Withdrawal by Subject|0
4776689|NCT01505608|16479732|P2|Phase I|Adverse Event|1
4776690|NCT01505608|16479733|P1|Phase I|Adverse Event|0
4776691|NCT01505608|16479732|P2|Phase I|Lack of Efficacy|4
4776692|NCT01505608|16479733|P1|Phase I|Lack of Efficacy|0
4776693|NCT01505530|16479752|P3|Overall Study|entry criteria not met|0
4776694|NCT01505530|16479753|P2|Overall Study|entry criteria not met|1
4776695|NCT01505530|16479754|P1|Overall Study|entry criteria not met|0
4776696|NCT01505530|16479752|P3|Overall Study|Death|5
4776697|NCT01505530|16479753|P2|Overall Study|Death|6
4776698|NCT01505530|16479754|P1|Overall Study|Death|7
4776699|NCT01505530|16479752|P3|Overall Study|Sponsor Decision|7
4776700|NCT01505530|16479753|P2|Overall Study|Sponsor Decision|8
4776701|NCT01505530|16479754|P1|Overall Study|Sponsor Decision|1
4776702|NCT01505530|16479752|P3|Overall Study|Physician Decision|5
4776703|NCT01505530|16479753|P2|Overall Study|Physician Decision|2
4776704|NCT01505530|16479754|P1|Overall Study|Physician Decision|6
4776705|NCT01505530|16479752|P3|Overall Study|Withdrawal by Subject|6
4776706|NCT01505530|16479753|P2|Overall Study|Withdrawal by Subject|8
4776707|NCT01505530|16479754|P1|Overall Study|Withdrawal by Subject|7
4776708|NCT01505530|16479752|P3|Overall Study|Adverse Event|0
4776709|NCT01505530|16479753|P2|Overall Study|Adverse Event|1
4776710|NCT01505530|16479754|P1|Overall Study|Adverse Event|1
4776711|NCT01505530|16479752|P3|Overall Study|Progressive Disease|18
4776712|NCT01505530|16479753|P2|Overall Study|Progressive Disease|17
4776713|NCT01505530|16479754|P1|Overall Study|Progressive Disease|19
4776714|NCT01505491|16479798|P3|Overall Study|Lost to Follow-up|1
4776715|NCT01505491|16479799|P2|Overall Study|Lost to Follow-up|0
4776716|NCT01505491|16479800|P1|Overall Study|Lost to Follow-up|0
4776717|NCT01505491|16479798|P3|Overall Study|Withdrawal by Subject|4
4776718|NCT01505491|16479799|P2|Overall Study|Withdrawal by Subject|1
4776719|NCT01505491|16479800|P1|Overall Study|Withdrawal by Subject|1
4776720|NCT01505491|16479798|P3|Overall Study|Other reason not listed|0
4776721|NCT01505491|16479799|P2|Overall Study|Other reason not listed|0
4776722|NCT01505491|16479800|P1|Overall Study|Other reason not listed|1
4776723|NCT01505387|16479839|P2|Overall Study|Withdrawal by Subject|1
4776724|NCT01505387|16479840|P1|Overall Study|Withdrawal by Subject|1
4776725|NCT01505387|16479839|P2|Overall Study|Protocol Violation|0
4776726|NCT01505387|16479840|P1|Overall Study|Protocol Violation|1
4776727|NCT01505374|16479846|P2|Overall Study|Lost to Follow-up|0
4776728|NCT01505374|16479847|P1|Overall Study|Lost to Follow-up|1
4776729|NCT01505114|16479897|P4|Overall Study|investigator decision|0
4776730|NCT01505114|16479898|P3|Overall Study|investigator decision|1
4776731|NCT01505114|16479899|P2|Overall Study|investigator decision|0
4776732|NCT01505114|16479900|P1|Overall Study|investigator decision|1
4776733|NCT01505114|16479897|P4|Overall Study|staff safety concerns|1
4776734|NCT01505114|16479898|P3|Overall Study|staff safety concerns|0
4776735|NCT01505114|16479899|P2|Overall Study|staff safety concerns|0
4776736|NCT01505114|16479900|P1|Overall Study|staff safety concerns|0
4776737|NCT01505114|16479897|P4|Overall Study|inadvertent enrollment due to peanut all|1
4776738|NCT01505114|16479898|P3|Overall Study|inadvertent enrollment due to peanut all|0
4776739|NCT01505114|16479899|P2|Overall Study|inadvertent enrollment due to peanut all|0
4776740|NCT01505114|16479900|P1|Overall Study|inadvertent enrollment due to peanut all|0
4776741|NCT01505114|16479897|P4|Overall Study|relocated|3
4776742|NCT01505114|16479898|P3|Overall Study|relocated|2
4776743|NCT01505114|16479899|P2|Overall Study|relocated|2
4776744|NCT01505114|16479900|P1|Overall Study|relocated|4
4776745|NCT01505114|16479897|P4|Overall Study|Lost to Follow-up|7
4776746|NCT01505114|16479898|P3|Overall Study|Lost to Follow-up|8
4776747|NCT01505114|16479899|P2|Overall Study|Lost to Follow-up|5
4776748|NCT01505114|16479900|P1|Overall Study|Lost to Follow-up|11
4776749|NCT01505114|16479897|P4|Overall Study|unable to adhere to visit schedule|3
4776750|NCT01505114|16479898|P3|Overall Study|unable to adhere to visit schedule|3
4776751|NCT01505114|16479899|P2|Overall Study|unable to adhere to visit schedule|2
4776752|NCT01505114|16479900|P1|Overall Study|unable to adhere to visit schedule|3
4776753|NCT01505114|16479897|P4|Overall Study|Death|1
4776754|NCT01505114|16479898|P3|Overall Study|Death|0
4776755|NCT01505114|16479899|P2|Overall Study|Death|0
4776756|NCT01505114|16479900|P1|Overall Study|Death|1
4776757|NCT01505114|16479897|P4|Overall Study|Withdrawal by Subject|7
4776758|NCT01505114|16479898|P3|Overall Study|Withdrawal by Subject|4
4776759|NCT01505114|16479899|P2|Overall Study|Withdrawal by Subject|4
4776760|NCT01505114|16479900|P1|Overall Study|Withdrawal by Subject|5
4776761|NCT01505010|16479928|P2|Overall Study|Lost to Follow-up|1
4776762|NCT01505010|16479929|P1|Overall Study|Lost to Follow-up|0
4776763|NCT01505010|16479928|P2|Overall Study|Protocol Violation|1
4776764|NCT01505010|16479929|P1|Overall Study|Protocol Violation|0
4776765|NCT01504971|16479943|P1|Overall Study|Physician Decision|13
4776766|NCT01504867|16479972|P2|Overall Study|Consent revoked|1
4776767|NCT01504867|16479973|P1|Overall Study|Consent revoked|5
4776768|NCT01504867|16479972|P2|Overall Study|Inclusion criteria not met|2
4776769|NCT01504867|16479973|P1|Overall Study|Inclusion criteria not met|2
4776770|NCT01504841|16480011|P3|Overall Study|On study due to Long-term Follow-up|0
4776771|NCT01504841|16480012|P2|Overall Study|On study due to Long-term Follow-up|3
4776772|NCT01504841|16480013|P1|Overall Study|On study due to Long-term Follow-up|15
4776773|NCT01504841|16480011|P3|Overall Study|Withdrawal by Subject|0
4776774|NCT01504841|16480012|P2|Overall Study|Withdrawal by Subject|1
4776775|NCT01504841|16480013|P1|Overall Study|Withdrawal by Subject|1
4776776|NCT01504412|16480066|P5|Overall Study|Death|0
4776777|NCT01504412|16480067|P4|Overall Study|Death|1
4776778|NCT01504412|16480068|P3|Overall Study|Death|0
4776779|NCT01504412|16480069|P2|Overall Study|Death|0
4776780|NCT01504412|16480070|P1|Overall Study|Death|0
4776781|NCT01504412|16480066|P5|Overall Study|Lack of Efficacy|1
4776782|NCT01504412|16480067|P4|Overall Study|Lack of Efficacy|0
4776783|NCT01504412|16480068|P3|Overall Study|Lack of Efficacy|1
4776784|NCT01504412|16480069|P2|Overall Study|Lack of Efficacy|0
4776785|NCT01504412|16480070|P1|Overall Study|Lack of Efficacy|0
4776786|NCT01504412|16480066|P5|Overall Study|Lost to Follow-up|0
4776787|NCT01504412|16480067|P4|Overall Study|Lost to Follow-up|0
4776788|NCT01504412|16480068|P3|Overall Study|Lost to Follow-up|0
4776789|NCT01504412|16480069|P2|Overall Study|Lost to Follow-up|2
4776790|NCT01504412|16480070|P1|Overall Study|Lost to Follow-up|0
4776791|NCT01504412|16480066|P5|Overall Study|Other|1
4776792|NCT01504412|16480067|P4|Overall Study|Other|6
4776793|NCT01504412|16480068|P3|Overall Study|Other|1
4776794|NCT01504412|16480069|P2|Overall Study|Other|1
4776795|NCT01504412|16480070|P1|Overall Study|Other|2
4776796|NCT01504412|16480066|P5|Overall Study|Withdrawal by Subject|1
4776797|NCT01504412|16480067|P4|Overall Study|Withdrawal by Subject|5
4776798|NCT01504412|16480068|P3|Overall Study|Withdrawal by Subject|1
4776799|NCT01504412|16480069|P2|Overall Study|Withdrawal by Subject|1
4776800|NCT01504412|16480070|P1|Overall Study|Withdrawal by Subject|2
4776801|NCT01504412|16480066|P5|Overall Study|Adverse Event|10
4776802|NCT01504412|16480067|P4|Overall Study|Adverse Event|7
4776803|NCT01504412|16480068|P3|Overall Study|Adverse Event|1
4776804|NCT01504412|16480069|P2|Overall Study|Adverse Event|8
4776805|NCT01504412|16480070|P1|Overall Study|Adverse Event|1
4776806|NCT01504204|16480089|P2|Overall Study|Lost to Follow-up|1
4776807|NCT01504204|16480090|P1|Overall Study|Lost to Follow-up|1
4776808|NCT01503164|16480147|P2|Overall Study|Withdrawal by Subject|1
4776809|NCT01503164|16480148|P1|Overall Study|Withdrawal by Subject|2
4776810|NCT01503021|16480178|P2|Overall Study|Moved, received transplant, etc.|7
4776811|NCT01503021|16480179|P1|Overall Study|Moved, received transplant, etc.|5
4776812|NCT01503021|16480178|P2|Overall Study|Withdrawal by Subject|8
4776813|NCT01503021|16480179|P1|Overall Study|Withdrawal by Subject|9
4776814|NCT01503021|16480178|P2|Overall Study|Protocol Violation|3
4776815|NCT01503021|16480179|P1|Overall Study|Protocol Violation|1
4776816|NCT01503021|16480178|P2|Overall Study|Physician Decision|0
4776817|NCT01503021|16480179|P1|Overall Study|Physician Decision|3
4776818|NCT01503021|16480178|P2|Overall Study|Lost to Follow-up|0
4776819|NCT01503021|16480179|P1|Overall Study|Lost to Follow-up|2
4776820|NCT01503021|16480178|P2|Overall Study|Death|2
4776821|NCT01503021|16480179|P1|Overall Study|Death|0
4776822|NCT01503021|16480178|P2|Overall Study|Adverse Event|6
4776823|NCT01503021|16480179|P1|Overall Study|Adverse Event|7
4776824|NCT01502956|16480228|P2|Overall Study|Withdrawal by Subject|10
4776825|NCT01502956|16480229|P1|Overall Study|Withdrawal by Subject|8
4776826|NCT01502956|16480228|P2|Overall Study|Physician Decision|3
4776827|NCT01502956|16480229|P1|Overall Study|Physician Decision|2
4776828|NCT01502956|16480228|P2|Overall Study|Lost to Follow-up|11
4776829|NCT01502956|16480229|P1|Overall Study|Lost to Follow-up|14
4776830|NCT01502956|16480228|P2|Overall Study|Death|2
4776831|NCT01502956|16480229|P1|Overall Study|Death|0
4776832|NCT01502709|16480287|P2|Overall Study|Lost to Follow-up|0
4776833|NCT01502709|16480288|P1|Overall Study|Lost to Follow-up|4
4776834|NCT01502644|16480301|P4|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
4776835|NCT01502644|16480302|P3|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1
4776836|NCT01502644|16480303|P2|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
4776837|NCT01502644|16480304|P1|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0
4776838|NCT01502644|16480301|P4|Assigned to NA Groups|Drop Out due to Side Effects|7
4776839|NCT01502644|16480302|P3|Assigned to NA Groups|Drop Out due to Side Effects|2
4776840|NCT01502644|16480303|P2|Assigned to NA Groups|Drop Out due to Side Effects|6
4776841|NCT01502644|16480304|P1|Assigned to NA Groups|Drop Out due to Side Effects|0
4776842|NCT01502644|16480301|P4|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
4776843|NCT01502644|16480302|P3|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
4776844|NCT01502644|16480303|P2|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0
4776845|NCT01502644|16480304|P1|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6
4776931|NCT01502293|16480429|P1|Overall Study|Progressive Disease|20
4776846|NCT01502644|16480301|P4|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
4776847|NCT01502644|16480302|P3|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
4776848|NCT01502644|16480303|P2|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0
4776849|NCT01502644|16480304|P1|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2
4776850|NCT01502644|16480301|P4|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
4776851|NCT01502644|16480302|P3|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
4776852|NCT01502644|16480303|P2|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0
4776853|NCT01502644|16480304|P1|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1
4776854|NCT01502423|16480314|P2|Overall Study|Withdrawal by Subject|1
4776855|NCT01502423|16480315|P1|Overall Study|Withdrawal by Subject|0
4776856|NCT01502410|16480337|P4|Overall Study|Withdrawal by Subject|0
4776857|NCT01502410|16480338|P3|Overall Study|Withdrawal by Subject|0
4776858|NCT01502410|16480339|P2|Overall Study|Withdrawal by Subject|0
4776859|NCT01502410|16480340|P1|Overall Study|Withdrawal by Subject|2
4776860|NCT01502410|16480337|P4|Overall Study|Physician Decision|0
4776861|NCT01502410|16480338|P3|Overall Study|Physician Decision|0
4776862|NCT01502410|16480339|P2|Overall Study|Physician Decision|1
4776863|NCT01502410|16480340|P1|Overall Study|Physician Decision|0
4776864|NCT01502410|16480337|P4|Overall Study|Lack of Efficacy|0
4776865|NCT01502410|16480338|P3|Overall Study|Lack of Efficacy|0
4776866|NCT01502410|16480339|P2|Overall Study|Lack of Efficacy|7
4776867|NCT01502410|16480340|P1|Overall Study|Lack of Efficacy|7
4776868|NCT01502410|16480337|P4|Overall Study|Adverse Event|0
4776869|NCT01502410|16480338|P3|Overall Study|Adverse Event|0
4776870|NCT01502410|16480339|P2|Overall Study|Adverse Event|2
4776871|NCT01502410|16480340|P1|Overall Study|Adverse Event|1
4776872|NCT01502371|16480358|P5|Overall Study|Excluded Medication|1
4776873|NCT01502371|16480359|P4|Overall Study|Excluded Medication|0
4776874|NCT01502371|16480360|P3|Overall Study|Excluded Medication|1
4776875|NCT01502371|16480361|P2|Overall Study|Excluded Medication|1
4776876|NCT01502371|16480362|P1|Overall Study|Excluded Medication|0
4776877|NCT01502371|16480358|P5|Overall Study|Protocol Violation|10
4776878|NCT01502371|16480359|P4|Overall Study|Protocol Violation|5
4776879|NCT01502371|16480360|P3|Overall Study|Protocol Violation|6
4776880|NCT01502371|16480361|P2|Overall Study|Protocol Violation|5
4776881|NCT01502371|16480362|P1|Overall Study|Protocol Violation|9
4776882|NCT01502371|16480358|P5|Overall Study|Technical Problems|1
4776883|NCT01502371|16480359|P4|Overall Study|Technical Problems|4
4776884|NCT01502371|16480360|P3|Overall Study|Technical Problems|2
4776885|NCT01502371|16480361|P2|Overall Study|Technical Problems|0
4776886|NCT01502371|16480362|P1|Overall Study|Technical Problems|1
4776887|NCT01502371|16480358|P5|Overall Study|Noncompliance with Study Drug|1
4776888|NCT01502371|16480359|P4|Overall Study|Noncompliance with Study Drug|2
4776889|NCT01502371|16480360|P3|Overall Study|Noncompliance with Study Drug|1
4776890|NCT01502371|16480361|P2|Overall Study|Noncompliance with Study Drug|0
4776891|NCT01502371|16480362|P1|Overall Study|Noncompliance with Study Drug|0
4776892|NCT01502371|16480358|P5|Overall Study|Physician Decision|1
4776893|NCT01502371|16480359|P4|Overall Study|Physician Decision|0
4776894|NCT01502371|16480360|P3|Overall Study|Physician Decision|0
4776895|NCT01502371|16480361|P2|Overall Study|Physician Decision|0
4776896|NCT01502371|16480362|P1|Overall Study|Physician Decision|3
4776897|NCT01502371|16480358|P5|Overall Study|Lack of Efficacy|4
4776898|NCT01502371|16480359|P4|Overall Study|Lack of Efficacy|2
4776899|NCT01502371|16480360|P3|Overall Study|Lack of Efficacy|2
4776900|NCT01502371|16480361|P2|Overall Study|Lack of Efficacy|3
4776901|NCT01502371|16480362|P1|Overall Study|Lack of Efficacy|3
4776902|NCT01502371|16480358|P5|Overall Study|Treatment Failure|30
4776903|NCT01502371|16480359|P4|Overall Study|Treatment Failure|19
4776904|NCT01502371|16480360|P3|Overall Study|Treatment Failure|12
4776905|NCT01502371|16480361|P2|Overall Study|Treatment Failure|20
4776906|NCT01502371|16480362|P1|Overall Study|Treatment Failure|22
4776907|NCT01502371|16480358|P5|Overall Study|Adverse Event|3
4776908|NCT01502371|16480359|P4|Overall Study|Adverse Event|4
4776909|NCT01502371|16480360|P3|Overall Study|Adverse Event|0
4776910|NCT01502371|16480361|P2|Overall Study|Adverse Event|1
4776911|NCT01502371|16480362|P1|Overall Study|Adverse Event|2
4776912|NCT01502371|16480358|P5|Overall Study|Withdrawal by Subject|1
4776913|NCT01502371|16480359|P4|Overall Study|Withdrawal by Subject|1
4776914|NCT01502371|16480360|P3|Overall Study|Withdrawal by Subject|1
4776915|NCT01502371|16480361|P2|Overall Study|Withdrawal by Subject|2
4776916|NCT01502371|16480362|P1|Overall Study|Withdrawal by Subject|1
4776917|NCT01502293|16480427|P3|Overall Study|Physician Decision|1
4776918|NCT01502293|16480428|P2|Overall Study|Physician Decision|0
4776919|NCT01502293|16480429|P1|Overall Study|Physician Decision|0
4776920|NCT01502293|16480427|P3|Overall Study|Reason Not Specified|0
4776921|NCT01502293|16480428|P2|Overall Study|Reason Not Specified|0
4776922|NCT01502293|16480429|P1|Overall Study|Reason Not Specified|2
4776923|NCT01502293|16480427|P3|Overall Study|Adverse Event|0
4776924|NCT01502293|16480428|P2|Overall Study|Adverse Event|2
4776925|NCT01502293|16480429|P1|Overall Study|Adverse Event|0
4776926|NCT01502293|16480427|P3|Overall Study|Withdrawal by Subject|1
4776927|NCT01502293|16480428|P2|Overall Study|Withdrawal by Subject|3
4776928|NCT01502293|16480429|P1|Overall Study|Withdrawal by Subject|3
4776929|NCT01502293|16480427|P3|Overall Study|Progressive Disease|2
4776930|NCT01502293|16480428|P2|Overall Study|Progressive Disease|12
4776932|NCT01502228|16480458|P1|Overall Study|Death|1
4776933|NCT01502033|16480463|P1|Overall Study|1 participant went back to school|1
4776934|NCT01502033|16480463|P1|Overall Study|1 participant had worsening depression|1
4776935|NCT01502033|16480463|P1|Overall Study|1 participant had scalp discomfort|1
4776936|NCT01501955|16480471|P2|Overall Study|Adverse Event|3
4776937|NCT01501955|16480472|P1|Overall Study|Adverse Event|1
4776938|NCT01501955|16480471|P2|Overall Study|Withdrawal by Subject|0
4776939|NCT01501955|16480472|P1|Overall Study|Withdrawal by Subject|1
4776940|NCT01501110|16480536|P2|Overall Study|Death|1
4776941|NCT01501110|16480537|P1|Overall Study|Death|0
4776942|NCT01500720|16480622|P2|Overall Study|Other|8
4776943|NCT01500720|16480623|P1|Overall Study|Other|4
4776944|NCT01500720|16480622|P2|Overall Study|Randomized But Not Treated|1
4776945|NCT01500720|16480623|P1|Overall Study|Randomized But Not Treated|1
4776946|NCT01500694|16480637|P2|Overall Study|Other|3
4776947|NCT01500694|16480638|P1|Overall Study|Other|9
4776948|NCT01500694|16480637|P2|Overall Study|Lack of Efficacy|5
4776949|NCT01500694|16480638|P1|Overall Study|Lack of Efficacy|14
4776950|NCT01500694|16480637|P2|Overall Study|Lost to Follow-up|3
4776951|NCT01500694|16480638|P1|Overall Study|Lost to Follow-up|2
4776952|NCT01500694|16480637|P2|Overall Study|Withdrawal by Subject|14
4776953|NCT01500694|16480638|P1|Overall Study|Withdrawal by Subject|23
4776954|NCT01500694|16480637|P2|Overall Study|Protocol Violation|1
4776955|NCT01500694|16480638|P1|Overall Study|Protocol Violation|0
4776956|NCT01500694|16480637|P2|Overall Study|Adverse Event|3
4776957|NCT01500694|16480638|P1|Overall Study|Adverse Event|4
4776958|NCT01500629|16480664|P2|Washout Period of 14 to 30 Days|Pregnancy|0
4776959|NCT01500629|16480665|P1|Washout Period of 14 to 30 Days|Pregnancy|1
4776960|NCT01500434|16480749|P1|Overall Study|Missed 12-month follow-up|5
4776961|NCT01500434|16480749|P1|Overall Study|Withdrawal by Subject|1
4776962|NCT01500434|16480749|P1|Overall Study|Death|1
4776963|NCT01500382|16480782|P4|Washout Period|Study site went out of business|0
4776964|NCT01500382|16480783|P3|Washout Period|Study site went out of business|1
4776965|NCT01500382|16480784|P2|Washout Period|Study site went out of business|0
4776966|NCT01500382|16480785|P1|Washout Period|Study site went out of business|0
4776967|NCT01500317|16480810|P3|Overall Study|Withdrawal by Subject|0
4776968|NCT01500317|16480811|P2|Overall Study|Withdrawal by Subject|2
4776969|NCT01500317|16480812|P1|Overall Study|Withdrawal by Subject|3
4776970|NCT01500278|16480834|P2|Week 13 - Week 104|Adverse Event|54
4776971|NCT01500278|16480835|P1|Week 13 - Week 104|Adverse Event|54
4776972|NCT01500278|16480834|P2|Week 13 - Week 104|Death|4
4776973|NCT01500278|16480835|P1|Week 13 - Week 104|Death|2
4776974|NCT01500278|16480834|P2|Week 13 - Week 104|Not completed|1
4776975|NCT01500278|16480835|P1|Week 13 - Week 104|Not completed|0
4776976|NCT01500278|16480834|P2|Week 13 - Week 104|Personal reason|1
4776977|NCT01500278|16480835|P1|Week 13 - Week 104|Personal reason|0
4776978|NCT01500278|16480834|P2|Week 13 - Week 104|Medical monitor decision|2
4776979|NCT01500278|16480835|P1|Week 13 - Week 104|Medical monitor decision|0
4776980|NCT01500278|16480834|P2|Week 13 - Week 104|Sponsor decision|2
4776981|NCT01500278|16480835|P1|Week 13 - Week 104|Sponsor decision|0
4776982|NCT01500278|16480834|P2|Week 13 - Week 104|Relocation|1
4776983|NCT01500278|16480835|P1|Week 13 - Week 104|Relocation|0
4776984|NCT01500278|16480834|P2|Week 13 - Week 104|Abnormal questionable chest X-ray|2
4776985|NCT01500278|16480835|P1|Week 13 - Week 104|Abnormal questionable chest X-ray|0
4776986|NCT01500278|16480834|P2|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0
4776987|NCT01500278|16480835|P1|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1
4776988|NCT01500278|16480834|P2|Week 13 - Week 104|Principal investigator retiring|0
4776989|NCT01500278|16480835|P1|Week 13 - Week 104|Principal investigator retiring|1
4776990|NCT01500278|16480834|P2|Week 13 - Week 104|Protocol deviation|0
4776991|NCT01500278|16480835|P1|Week 13 - Week 104|Protocol deviation|1
4776992|NCT01500278|16480834|P2|Week 13 - Week 104|Exclusion criteria not met|0
4776993|NCT01500278|16480835|P1|Week 13 - Week 104|Exclusion criteria not met|1
4776994|NCT01500278|16480834|P2|Week 13 - Week 104|Withdrawn in error|0
4776995|NCT01500278|16480835|P1|Week 13 - Week 104|Withdrawn in error|1
4776996|NCT01500278|16480834|P2|Week 13 - Week 104|Sponsor request|0
4776997|NCT01500278|16480835|P1|Week 13 - Week 104|Sponsor request|4
4776998|NCT01500278|16480834|P2|Week 13 - Week 104|False positive test|2
4776999|NCT01500278|16480835|P1|Week 13 - Week 104|False positive test|1
4777000|NCT01500278|16480834|P2|Week 13 - Week 104|Recurrent infections|0
4777001|NCT01500278|16480835|P1|Week 13 - Week 104|Recurrent infections|1
4777002|NCT01500278|16480834|P2|Week 13 - Week 104|Non/bad compliance|5
4777003|NCT01500278|16480835|P1|Week 13 - Week 104|Non/bad compliance|7
4777004|NCT01500278|16480834|P2|Week 13 - Week 104|Week 24 Non-Responder|16
4777005|NCT01500278|16480835|P1|Week 13 - Week 104|Week 24 Non-Responder|20
4777006|NCT01500278|16480834|P2|Week 13 - Week 104|Withdrawal by Subject|13
4777007|NCT01500278|16480835|P1|Week 13 - Week 104|Withdrawal by Subject|22
4777008|NCT01500278|16480834|P2|Week 13 - Week 104|Lost to Follow-up|5
4777009|NCT01500278|16480835|P1|Week 13 - Week 104|Lost to Follow-up|6
4777010|NCT01500278|16480834|P2|Week 13 - Week 104|Protocol Violation|6
4777011|NCT01500278|16480835|P1|Week 13 - Week 104|Protocol Violation|6
4777012|NCT01500278|16480834|P2|Week 13 - Week 104|Lack of Efficacy|12
4777013|NCT01500278|16480835|P1|Week 13 - Week 104|Lack of Efficacy|11
4777014|NCT01500278|16480834|P2|Week 0 - Week 12|Adverse event (AE), not fatal|8
4777015|NCT01500278|16480835|P1|Week 0 - Week 12|Adverse event (AE), not fatal|7
4777016|NCT01500278|16480834|P2|Week 0 - Week 12|Other serious disease|1
4777017|NCT01500278|16480835|P1|Week 0 - Week 12|Other serious disease|0
4777018|NCT01500278|16480834|P2|Week 0 - Week 12|Personal reason|1
4777019|NCT01500278|16480835|P1|Week 0 - Week 12|Personal reason|0
4777020|NCT01500278|16480834|P2|Week 0 - Week 12|Sponsor decision|0
4777021|NCT01500278|16480835|P1|Week 0 - Week 12|Sponsor decision|1
4777022|NCT01500278|16480834|P2|Week 0 - Week 12|Prior history of serious disease|0
4777023|NCT01500278|16480835|P1|Week 0 - Week 12|Prior history of serious disease|1
4777024|NCT01500278|16480834|P2|Week 0 - Week 12|Investigator decision|0
4777025|NCT01500278|16480835|P1|Week 0 - Week 12|Investigator decision|1
4777026|NCT01500278|16480834|P2|Week 0 - Week 12|Exclusion criteria not met|0
4777027|NCT01500278|16480835|P1|Week 0 - Week 12|Exclusion criteria not met|1
4777028|NCT01500278|16480834|P2|Week 0 - Week 12|Patient decision|0
4777029|NCT01500278|16480835|P1|Week 0 - Week 12|Patient decision|1
4777030|NCT01500278|16480834|P2|Week 0 - Week 12|Protocol violation on screening X-ray|0
4777031|NCT01500278|16480835|P1|Week 0 - Week 12|Protocol violation on screening X-ray|1
4777032|NCT01500278|16480834|P2|Week 0 - Week 12|Withdrawal by Subject|2
4777033|NCT01500278|16480835|P1|Week 0 - Week 12|Withdrawal by Subject|7
4777034|NCT01500278|16480834|P2|Week 0 - Week 12|Lost to Follow-up|1
4777035|NCT01500278|16480835|P1|Week 0 - Week 12|Lost to Follow-up|1
4777036|NCT01500278|16480834|P2|Week 0 - Week 12|Protocol Violation|16
4777037|NCT01500278|16480835|P1|Week 0 - Week 12|Protocol Violation|10
4777038|NCT01500278|16480834|P2|Week 0 - Week 12|Lack of Efficacy|1
4777039|NCT01500278|16480835|P1|Week 0 - Week 12|Lack of Efficacy|0
4777040|NCT01500252|16480859|P2|Overall Study|Lost to Follow-up|4
4777041|NCT01500252|16480860|P1|Overall Study|Lost to Follow-up|5
4777042|NCT01500252|16480859|P2|Overall Study|Death|2
4777043|NCT01500252|16480860|P1|Overall Study|Death|4
4777044|NCT01500226|16480886|P2|Overall Study|Other Reasons|16
4777045|NCT01500226|16480887|P1|Overall Study|Other Reasons|19
4777046|NCT01500226|16480886|P2|Overall Study|Lost to Follow-up|5
4777047|NCT01500226|16480887|P1|Overall Study|Lost to Follow-up|9
4777048|NCT01500226|16480886|P2|Overall Study|Lack of Efficacy|30
4777049|NCT01500226|16480887|P1|Overall Study|Lack of Efficacy|14
4777050|NCT01500226|16480886|P2|Overall Study|Physician Decision|15
4777051|NCT01500226|16480887|P1|Overall Study|Physician Decision|17
4777052|NCT01500226|16480886|P2|Overall Study|Protocol Violation|39
4777053|NCT01500226|16480887|P1|Overall Study|Protocol Violation|53
4777054|NCT01500226|16480886|P2|Overall Study|Disease Progression|14
4777055|NCT01500226|16480887|P1|Overall Study|Disease Progression|16
4777056|NCT01500226|16480886|P2|Overall Study|Death|4
4777057|NCT01500226|16480887|P1|Overall Study|Death|12
4777058|NCT01500226|16480886|P2|Overall Study|Withdrawal by Subject|96
4777059|NCT01500226|16480887|P1|Overall Study|Withdrawal by Subject|93
4777060|NCT01500226|16480886|P2|Overall Study|Chemo Completed or Change in Therapy|237
4777061|NCT01500226|16480887|P1|Overall Study|Chemo Completed or Change in Therapy|235
4777062|NCT01500226|16480886|P2|Overall Study|Adverse Event|38
4777063|NCT01500226|16480887|P1|Overall Study|Adverse Event|31
4777064|NCT01500213|16480899|P2|Overall Study|Other Reasons|5
4777065|NCT01500213|16480900|P1|Overall Study|Other Reasons|7
4777066|NCT01500213|16480899|P2|Overall Study|Lost to Follow-up|6
4777067|NCT01500213|16480900|P1|Overall Study|Lost to Follow-up|3
4777068|NCT01500213|16480899|P2|Overall Study|Lack of Efficacy|7
4777069|NCT01500213|16480900|P1|Overall Study|Lack of Efficacy|9
4777070|NCT01500213|16480899|P2|Overall Study|Physician Decision|10
4777071|NCT01500213|16480900|P1|Overall Study|Physician Decision|12
4777072|NCT01500213|16480899|P2|Overall Study|Protocol Violation|19
4777073|NCT01500213|16480900|P1|Overall Study|Protocol Violation|19
4777074|NCT01500213|16480899|P2|Overall Study|Disease Progression|21
4777075|NCT01500213|16480900|P1|Overall Study|Disease Progression|13
4777076|NCT01500213|16480899|P2|Overall Study|Death|3
4777077|NCT01500213|16480900|P1|Overall Study|Death|7
4777078|NCT01500213|16480899|P2|Overall Study|Withdrawal by Subject|37
4777079|NCT01500213|16480900|P1|Overall Study|Withdrawal by Subject|28
4777080|NCT01500213|16480899|P2|Overall Study|Chemo Completed or Change in Therapy|81
4777081|NCT01500213|16480900|P1|Overall Study|Chemo Completed or Change in Therapy|84
4777082|NCT01500213|16480899|P2|Overall Study|Adverse Event|35
4777083|NCT01500213|16480900|P1|Overall Study|Adverse Event|35
4777084|NCT01500200|16480913|P6|Stage 2|Adverse Event|4
4777085|NCT01500200|16480914|P5|Stage 2|Adverse Event|5
4777086|NCT01500200|16480915|P4|Stage 2|Adverse Event|0
4777087|NCT01500200|16480916|P3|Stage 2|Adverse Event|0
4777088|NCT01500200|16480917|P2|Stage 2|Adverse Event|0
4777089|NCT01500200|16480918|P1|Stage 2|Adverse Event|0
4777090|NCT01500200|16480913|P6|Stage 1|Physician Decision|0
4777091|NCT01500200|16480914|P5|Stage 1|Physician Decision|0
4777092|NCT01500200|16480915|P4|Stage 1|Physician Decision|0
4777093|NCT01500200|16480916|P3|Stage 1|Physician Decision|0
4777094|NCT01500200|16480917|P2|Stage 1|Physician Decision|0
4777095|NCT01500200|16480918|P1|Stage 1|Physician Decision|1
4777096|NCT01500200|16480913|P6|Stage 1|Noncompliance with Study Drug|0
4777097|NCT01500200|16480914|P5|Stage 1|Noncompliance with Study Drug|0
4777098|NCT01500200|16480915|P4|Stage 1|Noncompliance with Study Drug|0
4777099|NCT01500200|16480916|P3|Stage 1|Noncompliance with Study Drug|0
4777100|NCT01500200|16480917|P2|Stage 1|Noncompliance with Study Drug|0
4777101|NCT01500200|16480918|P1|Stage 1|Noncompliance with Study Drug|1
4777102|NCT01500200|16480913|P6|Stage 1|Withdrawal by Subject|0
4777103|NCT01500200|16480914|P5|Stage 1|Withdrawal by Subject|0
4777104|NCT01500200|16480915|P4|Stage 1|Withdrawal by Subject|0
4777105|NCT01500200|16480916|P3|Stage 1|Withdrawal by Subject|0
4777106|NCT01500200|16480917|P2|Stage 1|Withdrawal by Subject|0
4777107|NCT01500200|16480918|P1|Stage 1|Withdrawal by Subject|3
4777108|NCT01500200|16480913|P6|Stage 1|Lost to Follow-up|0
4777109|NCT01500200|16480914|P5|Stage 1|Lost to Follow-up|0
4777110|NCT01500200|16480915|P4|Stage 1|Lost to Follow-up|0
4777111|NCT01500200|16480916|P3|Stage 1|Lost to Follow-up|1
4777112|NCT01500200|16480917|P2|Stage 1|Lost to Follow-up|2
4777113|NCT01500200|16480918|P1|Stage 1|Lost to Follow-up|2
4777114|NCT01500200|16480913|P6|Stage 1|Adverse Event|0
4777115|NCT01500200|16480914|P5|Stage 1|Adverse Event|0
4777116|NCT01500200|16480915|P4|Stage 1|Adverse Event|0
4777117|NCT01500200|16480916|P3|Stage 1|Adverse Event|5
4777118|NCT01500200|16480917|P2|Stage 1|Adverse Event|4
4777119|NCT01500200|16480918|P1|Stage 1|Adverse Event|1
4777120|NCT01500187|16480952|P2|Overall Study|Lost to Follow-up|0
4777121|NCT01500187|16480953|P1|Overall Study|Lost to Follow-up|6
4777122|NCT01500135|16480961|P2|Overall Study|Patient Unable to Make Follow-up Visit|1
4777123|NCT01500135|16480962|P1|Overall Study|Patient Unable to Make Follow-up Visit|0
4777124|NCT01500135|16480961|P2|Overall Study|Participant was a Safety Concern|0
4777125|NCT01500135|16480962|P1|Overall Study|Participant was a Safety Concern|1
4777126|NCT01500135|16480961|P2|Overall Study|Patient Missed Scheduled Appointments|1
4777127|NCT01500135|16480962|P1|Overall Study|Patient Missed Scheduled Appointments|0
4777128|NCT01500135|16480961|P2|Overall Study|Principal Investigator (PI) Discretion|0
4777129|NCT01500135|16480962|P1|Overall Study|Principal Investigator (PI) Discretion|1
4777130|NCT01500135|16480961|P2|Overall Study|Fatal Adverse Event (AE)|5
4777131|NCT01500135|16480962|P1|Overall Study|Fatal Adverse Event (AE)|5
4777132|NCT01500135|16480961|P2|Overall Study|Lost to Follow-up|4
4777133|NCT01500135|16480962|P1|Overall Study|Lost to Follow-up|6
4777134|NCT01500135|16480961|P2|Overall Study|Withdrawal of Consent|0
4777135|NCT01500135|16480962|P1|Overall Study|Withdrawal of Consent|4
4777136|NCT01500096|16480989|P4|Overall Study|Lost to Follow-up|2
4777137|NCT01500096|16480990|P3|Overall Study|Lost to Follow-up|0
4777138|NCT01500096|16480991|P2|Overall Study|Lost to Follow-up|0
4777139|NCT01500096|16480992|P1|Overall Study|Lost to Follow-up|1
4777140|NCT01500083|16481048|P2|Overall Study|Other Reasons|5
4777141|NCT01500083|16481049|P1|Overall Study|Other Reasons|2
4777142|NCT01500083|16481048|P2|Overall Study|Investigator Discretion|8
4777143|NCT01500083|16481049|P1|Overall Study|Investigator Discretion|3
4777144|NCT01500083|16481048|P2|Overall Study|Disease Progression|10
4777145|NCT01500083|16481049|P1|Overall Study|Disease Progression|2
4777146|NCT01500083|16481048|P2|Overall Study|Withdrawal of Consent|1
4777147|NCT01500083|16481049|P1|Overall Study|Withdrawal of Consent|0
4777148|NCT01500083|16481048|P2|Overall Study|Lost to Follow-up|0
4777149|NCT01500083|16481049|P1|Overall Study|Lost to Follow-up|1
4777150|NCT01500083|16481048|P2|Overall Study|Death|2
4777151|NCT01500083|16481049|P1|Overall Study|Death|0
4777152|NCT01500083|16481048|P2|Overall Study|Adverse Event|17
4777153|NCT01500083|16481049|P1|Overall Study|Adverse Event|4
4777154|NCT01500057|16481057|P2|Overall Study|Lost to Follow-up|4
4777155|NCT01500057|16481058|P1|Overall Study|Lost to Follow-up|6
4777156|NCT01500031|16481068|P1|Overall Study|Withdrawal by Subject|4
4777157|NCT01500031|16481068|P1|Overall Study|Death|1
4777158|NCT01499849|16481103|P2|Overall Study|Other Reasons|30
4777159|NCT01499849|16481104|P1|Overall Study|Other Reasons|27
4777160|NCT01499849|16481103|P2|Overall Study|Lost to Follow-up|3
4777161|NCT01499849|16481104|P1|Overall Study|Lost to Follow-up|6
4777162|NCT01499849|16481103|P2|Overall Study|Lack of Efficacy|4
4777163|NCT01499849|16481104|P1|Overall Study|Lack of Efficacy|3
4777164|NCT01499849|16481103|P2|Overall Study|Physician Decision|19
4777165|NCT01499849|16481104|P1|Overall Study|Physician Decision|20
4777166|NCT01499849|16481103|P2|Overall Study|Protocol Violation|11
4777167|NCT01499849|16481104|P1|Overall Study|Protocol Violation|11
4777168|NCT01499849|16481103|P2|Overall Study|Disease Progression|10
4777169|NCT01499849|16481104|P1|Overall Study|Disease Progression|11
4777170|NCT01499849|16481103|P2|Overall Study|Death|7
4777171|NCT01499849|16481104|P1|Overall Study|Death|5
4777172|NCT01499849|16481103|P2|Overall Study|Withdrawal by Subject|43
4777173|NCT01499849|16481104|P1|Overall Study|Withdrawal by Subject|43
4777174|NCT01499849|16481103|P2|Overall Study|Chemo completed or Change in Therapy|67
4777175|NCT01499849|16481104|P1|Overall Study|Chemo completed or Change in Therapy|70
4777176|NCT01499849|16481103|P2|Overall Study|Adverse Event|32
4777177|NCT01499849|16481104|P1|Overall Study|Adverse Event|28
4777178|NCT01499810|16481114|P1|Overall Study|Withdrawal by Subject|1
4777179|NCT01499810|16481114|P1|Overall Study|Protocol Violation|1
4777180|NCT01499810|16481114|P1|Overall Study|Lost to Follow-up|10
4777181|NCT01499667|16481164|P3|Overall Study|Lack of Efficacy|0
4777182|NCT01499667|16481165|P2|Overall Study|Lack of Efficacy|0
4777183|NCT01499667|16481166|P1|Overall Study|Lack of Efficacy|2
4777184|NCT01499667|16481164|P3|Overall Study|Withdrawal by Subject|1
4777185|NCT01499667|16481165|P2|Overall Study|Withdrawal by Subject|1
4777186|NCT01499667|16481166|P1|Overall Study|Withdrawal by Subject|2
4777187|NCT01499667|16481164|P3|Overall Study|Adverse Event|2
4777188|NCT01499667|16481165|P2|Overall Study|Adverse Event|2
4777189|NCT01499667|16481166|P1|Overall Study|Adverse Event|0
4777190|NCT01499667|16481164|P3|Overall Study|Protocol Violation|2
4777191|NCT01499667|16481165|P2|Overall Study|Protocol Violation|3
4777192|NCT01499667|16481166|P1|Overall Study|Protocol Violation|1
4777193|NCT01499667|16481164|P3|Overall Study|administrative problems|5
4777194|NCT01499667|16481165|P2|Overall Study|administrative problems|5
4777195|NCT01499667|16481166|P1|Overall Study|administrative problems|4
4777196|NCT01499576|16481214|P1|Overall Study|Withdrawal by Subject|9
4777197|NCT01499576|16481214|P1|Overall Study|Physician Decision|12
4777198|NCT01499511|16481222|P2|Overall Study|Death|0
4777199|NCT01499511|16481223|P1|Overall Study|Death|1
4777200|NCT01499368|16481251|P3|Overall Study|Error of Prescriptions|1
4777201|NCT01499368|16481252|P2|Overall Study|Error of Prescriptions|0
4777202|NCT01499368|16481253|P1|Overall Study|Error of Prescriptions|0
4777203|NCT01499368|16481251|P3|Overall Study|Deviation from visit window|1
4777204|NCT01499368|16481252|P2|Overall Study|Deviation from visit window|0
4777205|NCT01499368|16481253|P1|Overall Study|Deviation from visit window|0
4777206|NCT01499368|16481251|P3|Overall Study|Physician Decision|0
4777207|NCT01499368|16481252|P2|Overall Study|Physician Decision|1
4777208|NCT01499368|16481253|P1|Overall Study|Physician Decision|0
4777209|NCT01499368|16481251|P3|Overall Study|Adverse Event|2
4777210|NCT01499368|16481252|P2|Overall Study|Adverse Event|0
4777211|NCT01499368|16481253|P1|Overall Study|Adverse Event|4
4777212|NCT01499368|16481251|P3|Overall Study|Lost to Follow-up|5
4777213|NCT01499368|16481252|P2|Overall Study|Lost to Follow-up|2
4777214|NCT01499368|16481253|P1|Overall Study|Lost to Follow-up|3
4777215|NCT01499368|16481251|P3|Overall Study|Withdrawal by Subject|8
4777216|NCT01499368|16481252|P2|Overall Study|Withdrawal by Subject|10
4777217|NCT01499368|16481253|P1|Overall Study|Withdrawal by Subject|11
4777218|NCT01499368|16481251|P3|Overall Study|Prohibited Concomitant medication|0
4777219|NCT01499368|16481252|P2|Overall Study|Prohibited Concomitant medication|1
4777220|NCT01499368|16481253|P1|Overall Study|Prohibited Concomitant medication|1
4777221|NCT01499368|16481251|P3|Overall Study|Did not meet I/E criteria|4
4777222|NCT01499368|16481252|P2|Overall Study|Did not meet I/E criteria|4
4777223|NCT01499368|16481253|P1|Overall Study|Did not meet I/E criteria|8
4777224|NCT01499355|16481270|P4|Double-Blind Period|Lost to Follow-up|0
4777225|NCT01499355|16481271|P3|Double-Blind Period|Lost to Follow-up|0
4777226|NCT01499355|16481272|P2|Double-Blind Period|Lost to Follow-up|1
4777227|NCT01499355|16481273|P1|Double-Blind Period|Lost to Follow-up|0
4777228|NCT01499355|16481270|P4|Double-Blind Period|Consent Withdrawn|2
4777229|NCT01499355|16481271|P3|Double-Blind Period|Consent Withdrawn|1
4777230|NCT01499355|16481272|P2|Double-Blind Period|Consent Withdrawn|0
4777231|NCT01499355|16481273|P1|Double-Blind Period|Consent Withdrawn|0
4777232|NCT01499355|16481270|P4|Double-Blind Period|Investigator Decision|3
4777233|NCT01499355|16481271|P3|Double-Blind Period|Investigator Decision|3
4777234|NCT01499355|16481272|P2|Double-Blind Period|Investigator Decision|0
4777235|NCT01499355|16481273|P1|Double-Blind Period|Investigator Decision|0
4777236|NCT01499355|16481270|P4|Double-Blind Period|Death|0
4777237|NCT01499355|16481271|P3|Double-Blind Period|Death|0
4777238|NCT01499355|16481272|P2|Double-Blind Period|Death|1
4777239|NCT01499355|16481273|P1|Double-Blind Period|Death|0
4777240|NCT01499355|16481270|P4|Double-Blind Period|Other|2
4777241|NCT01499355|16481271|P3|Double-Blind Period|Other|2
4777242|NCT01499355|16481272|P2|Double-Blind Period|Other|1
4777243|NCT01499355|16481273|P1|Double-Blind Period|Other|0
4777244|NCT01499355|16481270|P4|Double-Blind Period|Study Termination|14
4777245|NCT01499355|16481271|P3|Double-Blind Period|Study Termination|16
4777246|NCT01499355|16481272|P2|Double-Blind Period|Study Termination|18
4777247|NCT01499355|16481273|P1|Double-Blind Period|Study Termination|0
4777248|NCT01499355|16481270|P4|Double-Blind Period|Adverse Event|2
4777249|NCT01499355|16481271|P3|Double-Blind Period|Adverse Event|3
4777250|NCT01499355|16481272|P2|Double-Blind Period|Adverse Event|2
4777251|NCT01499355|16481273|P1|Double-Blind Period|Adverse Event|0
4777252|NCT01499355|16481270|P4|Run-In Period|Adverse Event|0
4777253|NCT01499355|16481271|P3|Run-In Period|Adverse Event|0
4777254|NCT01499355|16481272|P2|Run-In Period|Adverse Event|0
4777255|NCT01499355|16481273|P1|Run-In Period|Adverse Event|8
4777256|NCT01499355|16481270|P4|Run-In Period|Consent Withdrawn|0
4777257|NCT01499355|16481271|P3|Run-In Period|Consent Withdrawn|0
4777258|NCT01499355|16481272|P2|Run-In Period|Consent Withdrawn|0
4777259|NCT01499355|16481273|P1|Run-In Period|Consent Withdrawn|1
4777260|NCT01499355|16481270|P4|Run-In Period|Investigator Decision|0
4777261|NCT01499355|16481271|P3|Run-In Period|Investigator Decision|0
4777262|NCT01499355|16481272|P2|Run-In Period|Investigator Decision|0
4777263|NCT01499355|16481273|P1|Run-In Period|Investigator Decision|2
4777264|NCT01499355|16481270|P4|Run-In Period|Death|0
4777265|NCT01499355|16481271|P3|Run-In Period|Death|0
4777266|NCT01499355|16481272|P2|Run-In Period|Death|0
4777267|NCT01499355|16481273|P1|Run-In Period|Death|2
4777268|NCT01499355|16481270|P4|Run-In Period|Other|0
4777269|NCT01499355|16481271|P3|Run-In Period|Other|0
4777270|NCT01499355|16481272|P2|Run-In Period|Other|0
4777271|NCT01499355|16481273|P1|Run-In Period|Other|3
4777272|NCT01499355|16481270|P4|Run-In Period|Study Termination|0
4777273|NCT01499355|16481271|P3|Run-In Period|Study Termination|0
4777274|NCT01499355|16481272|P2|Run-In Period|Study Termination|0
4777275|NCT01499355|16481273|P1|Run-In Period|Study Termination|15
4777276|NCT01499303|16481306|P2|Overall Study|Other|1
4777277|NCT01499303|16481307|P1|Overall Study|Other|0
4777278|NCT01499303|16481306|P2|Overall Study|Adverse Event|4
4777279|NCT01499303|16481307|P1|Overall Study|Adverse Event|1
4777280|NCT01499303|16481306|P2|Overall Study|Withdrawal by Subject|1
4777281|NCT01499303|16481307|P1|Overall Study|Withdrawal by Subject|0
4777282|NCT01499303|16481306|P2|Overall Study|Ongoing|1
4777283|NCT01499303|16481307|P1|Overall Study|Ongoing|2
4777284|NCT01499290|16481315|P2|Overall Study|Adverse Event|7
4777285|NCT01499290|16481316|P1|Overall Study|Adverse Event|14
4777286|NCT01499290|16481315|P2|Overall Study|Lack of Efficacy|8
4777287|NCT01499290|16481316|P1|Overall Study|Lack of Efficacy|7
4777288|NCT01499290|16481315|P2|Overall Study|Condition improved/subject recovered|0
4777289|NCT01499290|16481316|P1|Overall Study|Condition improved/subject recovered|1
4777290|NCT01499290|16481315|P2|Overall Study|Not specified in study report|5
4777291|NCT01499290|16481316|P1|Overall Study|Not specified in study report|11
4777292|NCT01499290|16481315|P2|Overall Study|Withdrawal by Subject|15
4777293|NCT01499290|16481316|P1|Overall Study|Withdrawal by Subject|22
4777294|NCT01499277|16481366|P2|Overall Study|Lack of therapeutic response and other|7
4777295|NCT01499277|16481367|P1|Overall Study|Lack of therapeutic response and other|8
4777296|NCT01499277|16481366|P2|Overall Study|Withdrawal by Subject|6
4777297|NCT01499277|16481367|P1|Overall Study|Withdrawal by Subject|16
4777298|NCT01499277|16481366|P2|Overall Study|Protocol Violation|3
4777299|NCT01499277|16481367|P1|Overall Study|Protocol Violation|2
4777300|NCT01499277|16481366|P2|Overall Study|Lost to Follow-up|8
4777301|NCT01499277|16481367|P1|Overall Study|Lost to Follow-up|15
4777302|NCT01499277|16481366|P2|Overall Study|Death|2
4777303|NCT01499277|16481367|P1|Overall Study|Death|3
4777304|NCT01499277|16481366|P2|Overall Study|Adverse Event|6
4777305|NCT01499277|16481367|P1|Overall Study|Adverse Event|3
4777306|NCT01499199|16481389|P1|Overall Study|Lack of Efficacy|1
4777307|NCT01499199|16481389|P1|Overall Study|Adverse Event|1
4777308|NCT01499160|16481418|P1|Overall Study|Withdrawal by Subject|1
4777309|NCT01499160|16481418|P1|Overall Study|Adverse Event|1
4777310|NCT01499134|16481441|P2|Overall Study|Withdrawal by Subject|1
4777311|NCT01499134|16481442|P1|Overall Study|Withdrawal by Subject|0
4777312|NCT01499095|16481464|P2|Overall Study|Perceived Lack of Efficacy|1
4777313|NCT01499095|16481465|P1|Overall Study|Perceived Lack of Efficacy|1
4777314|NCT01499095|16481464|P2|Overall Study|Change in Injection Schedule|0
4777315|NCT01499095|16481465|P1|Overall Study|Change in Injection Schedule|2
4777316|NCT01499095|16481464|P2|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1
4777317|NCT01499095|16481465|P1|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2
4777318|NCT01499095|16481464|P2|Overall Study|Hypoglycemia|1
4777319|NCT01499095|16481465|P1|Overall Study|Hypoglycemia|3
4777320|NCT01499095|16481464|P2|Overall Study|Insulin Dropped Below Authorized Dose|5
4777321|NCT01499095|16481465|P1|Overall Study|Insulin Dropped Below Authorized Dose|0
4777322|NCT01499095|16481464|P2|Overall Study|Lost to Follow-up|4
4777323|NCT01499095|16481465|P1|Overall Study|Lost to Follow-up|6
4777324|NCT01499095|16481464|P2|Overall Study|Diverse Reasons|25
4777325|NCT01499095|16481465|P1|Overall Study|Diverse Reasons|22
4777326|NCT01499095|16481464|P2|Overall Study|Received Rescue Therapy|40
4777327|NCT01499095|16481465|P1|Overall Study|Received Rescue Therapy|32
4777328|NCT01499095|16481464|P2|Overall Study|Protocol Violation|7
4777329|NCT01499095|16481465|P1|Overall Study|Protocol Violation|6
4777330|NCT01499095|16481464|P2|Overall Study|Lack of Efficacy|1
4777331|NCT01499095|16481465|P1|Overall Study|Lack of Efficacy|2
4777332|NCT01499095|16481464|P2|Overall Study|Adverse Event|7
4777333|NCT01499095|16481465|P1|Overall Study|Adverse Event|12
4777334|NCT01499095|16481464|P2|Overall Study|Randomized But Not Treated|1
4777335|NCT01499095|16481465|P1|Overall Study|Randomized But Not Treated|1
4777336|NCT01499082|16481495|P2|Overall Study|Lost to Follow-up|3
4777337|NCT01499082|16481496|P1|Overall Study|Lost to Follow-up|1
4777338|NCT01499082|16481495|P2|Overall Study|Hypoglycemia|3
4777339|NCT01499082|16481496|P1|Overall Study|Hypoglycemia|2
4777340|NCT01499082|16481495|P2|Overall Study|Site Closure for Noncompliance|2
4777341|NCT01499082|16481496|P1|Overall Study|Site Closure for Noncompliance|5
4777342|NCT01499082|16481495|P2|Overall Study|Diverse Reasons|14
4777343|NCT01499082|16481496|P1|Overall Study|Diverse Reasons|18
4777344|NCT01499082|16481495|P2|Overall Study|Protocol Violation|8
4777345|NCT01499082|16481496|P1|Overall Study|Protocol Violation|6
4777346|NCT01499082|16481495|P2|Overall Study|Lack of Efficacy|1
4777347|NCT01499082|16481496|P1|Overall Study|Lack of Efficacy|1
4777348|NCT01499082|16481495|P2|Overall Study|Adverse Event|16
4777349|NCT01499082|16481496|P1|Overall Study|Adverse Event|12
4777350|NCT01499082|16481495|P2|Overall Study|Randomized but not Treated|1
4777351|NCT01499082|16481496|P1|Overall Study|Randomized but not Treated|0
4777352|NCT01499043|16481524|P1|Overall Study|Adverse Event|1
4777353|NCT01499043|16481524|P1|Overall Study|Withdrawal by Subject|2
4777354|NCT01499043|16481524|P1|Overall Study|Progressive disease (clinical)|1
4777355|NCT01499043|16481524|P1|Overall Study|Progressive disease (radiographic)|2
4777356|NCT01498952|16481567|P5|Overall Study|Death|0
4777357|NCT01498952|16481568|P4|Overall Study|Death|0
4777358|NCT01498952|16481569|P3|Overall Study|Death|0
4777359|NCT01498952|16481570|P2|Overall Study|Death|2
4777360|NCT01498952|16481571|P1|Overall Study|Death|2
4777361|NCT01498887|16481613|P2|Overall Study|Adverse Event|1
4777362|NCT01498887|16481614|P1|Overall Study|Adverse Event|4
4777363|NCT01498887|16481613|P2|Overall Study|Abnormal laboratory value|2
4777364|NCT01498887|16481614|P1|Overall Study|Abnormal laboratory value|2
4777365|NCT01498887|16481613|P2|Overall Study|Abnormal result from test procedure|1
4777366|NCT01498887|16481614|P1|Overall Study|Abnormal result from test procedure|1
4777367|NCT01498887|16481613|P2|Overall Study|Lack of Efficacy|3
4777368|NCT01498887|16481614|P1|Overall Study|Lack of Efficacy|5
4777369|NCT01498887|16481613|P2|Overall Study|Protocol Violation|3
4777370|NCT01498887|16481614|P1|Overall Study|Protocol Violation|1
4777371|NCT01498887|16481613|P2|Overall Study|Withdrawal by Subject|0
4777372|NCT01498887|16481614|P1|Overall Study|Withdrawal by Subject|1
4777373|NCT01498887|16481613|P2|Overall Study|Lost to Follow-up|1
4777374|NCT01498887|16481614|P1|Overall Study|Lost to Follow-up|1
4777375|NCT01498887|16481613|P2|Overall Study|Administrative problems|0
4777376|NCT01498887|16481614|P1|Overall Study|Administrative problems|1
4777377|NCT01498822|16481635|P2|Overall Study|Lost to Follow-up|3
4777378|NCT01498822|16481636|P1|Overall Study|Lost to Follow-up|8
4777379|NCT01498822|16481635|P2|Overall Study|Withdrawal by Subject|25
4777380|NCT01498822|16481636|P1|Overall Study|Withdrawal by Subject|15
4777381|NCT01498822|16481635|P2|Overall Study|Adverse Event, serious fatal|1
4777382|NCT01498822|16481636|P1|Overall Study|Adverse Event, serious fatal|1
4777383|NCT01498822|16481635|P2|Overall Study|SAE, non-fatal|2
4777384|NCT01498822|16481636|P1|Overall Study|SAE, non-fatal|2
4777385|NCT01498822|16481635|P2|Overall Study|AE, non-serious non-fatal|17
4777386|NCT01498822|16481636|P1|Overall Study|AE, non-serious non-fatal|8
4777387|NCT01498822|16481635|P2|Overall Study|Lack of Efficacy|2
4777388|NCT01498822|16481636|P1|Overall Study|Lack of Efficacy|7
4777389|NCT01498822|16481635|P2|Overall Study|Other Reason|2
4777390|NCT01498822|16481636|P1|Overall Study|Other Reason|5
4777391|NCT01498822|16481635|P2|Overall Study|Protocol Violation|4
4777392|NCT01498822|16481636|P1|Overall Study|Protocol Violation|8
4777393|NCT01498692|16481663|P1|Overall Study|Missed 12-month visit|3
4777394|NCT01498692|16481663|P1|Overall Study|Withdrawal by Subject|1
4777395|NCT01498692|16481663|P1|Overall Study|Death|4
4777396|NCT01498679|16481694|P2|Overall Study|Withdrawal by Subject|4
4777397|NCT01498679|16481695|P1|Overall Study|Withdrawal by Subject|12
4777398|NCT01498679|16481694|P2|Overall Study|Physician Decision|2
4777399|NCT01498679|16481695|P1|Overall Study|Physician Decision|0
4777400|NCT01498679|16481694|P2|Overall Study|Protocol Violation|0
4777401|NCT01498679|16481695|P1|Overall Study|Protocol Violation|4
4777402|NCT01498679|16481694|P2|Overall Study|Lack of Efficacy|12
4777403|NCT01498679|16481695|P1|Overall Study|Lack of Efficacy|72
4777404|NCT01498679|16481694|P2|Overall Study|Adverse Event|4
4777405|NCT01498679|16481695|P1|Overall Study|Adverse Event|1
4777406|NCT01498653|16481711|P2|Overall Study|Withdrawal by Subject|3
4777407|NCT01498653|16481712|P1|Overall Study|Withdrawal by Subject|2
4777408|NCT01498653|16481711|P2|Overall Study|Physician Decision|0
4777409|NCT01498653|16481712|P1|Overall Study|Physician Decision|2
4777410|NCT01498653|16481711|P2|Overall Study|Lost to Follow-up|0
4777411|NCT01498653|16481712|P1|Overall Study|Lost to Follow-up|1
4777412|NCT01498653|16481711|P2|Overall Study|Protocol Violation|4
4777413|NCT01498653|16481712|P1|Overall Study|Protocol Violation|0
4777414|NCT01498653|16481711|P2|Overall Study|Lack of Efficacy|26
4777415|NCT01498653|16481712|P1|Overall Study|Lack of Efficacy|12
4777416|NCT01498653|16481711|P2|Overall Study|Adverse Event|2
4777417|NCT01498653|16481712|P1|Overall Study|Adverse Event|2
4777418|NCT01498640|16481726|P1|Overall Study|Other|3
4777419|NCT01498640|16481726|P1|Overall Study|Death|1
4777420|NCT01498640|16481726|P1|Overall Study|Lost to Follow-up|1
4777421|NCT01498575|16481756|P2|On the Road Driving Assessment (ODA)|Protocol Violation|18
4777422|NCT01498575|16481757|P1|On the Road Driving Assessment (ODA)|Protocol Violation|23
4777423|NCT01498575|16481756|P2|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6
4777424|NCT01498575|16481757|P1|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19
4777425|NCT01498575|16481756|P2|Overall Sample|Withdrawal by Subject|14
4777426|NCT01498575|16481757|P1|Overall Sample|Withdrawal by Subject|60
4777427|NCT01498458|16481774|P1|Overall Study|Physician Decision|3
4777428|NCT01498458|16481774|P1|Overall Study|Adverse Event|4
4777429|NCT01498445|16481789|P6|Overall Study|Screen Failure|1
4777430|NCT01498445|16481790|P5|Overall Study|Screen Failure|1
4777431|NCT01498445|16481791|P4|Overall Study|Screen Failure|0
4777432|NCT01498445|16481792|P3|Overall Study|Screen Failure|0
4777433|NCT01498445|16481793|P2|Overall Study|Screen Failure|0
4777434|NCT01498445|16481794|P1|Overall Study|Screen Failure|0
4777435|NCT01498445|16481789|P6|Overall Study|Lack of Efficacy|0
4777436|NCT01498445|16481790|P5|Overall Study|Lack of Efficacy|0
4777437|NCT01498445|16481791|P4|Overall Study|Lack of Efficacy|2
4777438|NCT01498445|16481792|P3|Overall Study|Lack of Efficacy|1
4777439|NCT01498445|16481793|P2|Overall Study|Lack of Efficacy|0
4777440|NCT01498445|16481794|P1|Overall Study|Lack of Efficacy|0
4777441|NCT01498289|16481869|P2|Overall Study|Reason under review|1
4777442|NCT01498289|16481870|P1|Overall Study|Reason under review|0
4777443|NCT01498289|16481869|P2|Overall Study|Not protocol specified|2
4777444|NCT01498289|16481870|P1|Overall Study|Not protocol specified|7
4777445|NCT01498289|16481869|P2|Overall Study|Progression/relapse|59
4777446|NCT01498289|16481870|P1|Overall Study|Progression/relapse|53
4777447|NCT01498289|16481869|P2|Overall Study|Withdrawal unrelated to AE|16
4777448|NCT01498289|16481870|P1|Overall Study|Withdrawal unrelated to AE|16
4777449|NCT01498289|16481869|P2|Overall Study|Death|8
4777450|NCT01498289|16481870|P1|Overall Study|Death|6
4777451|NCT01498289|16481869|P2|Overall Study|Adverse Event|18
4777452|NCT01498289|16481870|P1|Overall Study|Adverse Event|16
4777453|NCT01498185|16481891|P5|Overall Study|No longer met criteria, etc|2
4777454|NCT01498185|16481892|P4|Overall Study|No longer met criteria, etc|0
4777455|NCT01498185|16481893|P3|Overall Study|No longer met criteria, etc|0
4777456|NCT01498185|16481894|P2|Overall Study|No longer met criteria, etc|0
4777457|NCT01498185|16481895|P1|Overall Study|No longer met criteria, etc|0
4777458|NCT01498185|16481891|P5|Overall Study|Withdrawal by Subject|1
4777459|NCT01498185|16481892|P4|Overall Study|Withdrawal by Subject|2
4777460|NCT01498185|16481893|P3|Overall Study|Withdrawal by Subject|0
4777461|NCT01498185|16481894|P2|Overall Study|Withdrawal by Subject|1
4777462|NCT01498185|16481895|P1|Overall Study|Withdrawal by Subject|1
4777463|NCT01498185|16481891|P5|Overall Study|Adverse Event|0
4777464|NCT01498185|16481892|P4|Overall Study|Adverse Event|1
4777465|NCT01498185|16481893|P3|Overall Study|Adverse Event|0
4777466|NCT01498185|16481894|P2|Overall Study|Adverse Event|0
4777467|NCT01498185|16481895|P1|Overall Study|Adverse Event|0
4777468|NCT01498120|16481935|P1|Overall Study|Other|4
4777469|NCT01498120|16481935|P1|Overall Study|AE, non-serious non-fatal|3
4777470|NCT01498120|16481935|P1|Overall Study|Withdrawal by Subject|5
4777471|NCT01498120|16481935|P1|Overall Study|Lost to Follow-up|1
4777472|NCT01498068|16481942|P2|Overall Study|Withdrawal by Subject|1
4777473|NCT01498068|16481943|P1|Overall Study|Withdrawal by Subject|1
4777474|NCT01497938|16481961|P2|Overall Study|Device Violation|0
4777475|NCT01497938|16481962|P1|Overall Study|Device Violation|1
4777476|NCT01497938|16481961|P2|Overall Study|Withdrawal by Subject|0
4777477|NCT01497938|16481962|P1|Overall Study|Withdrawal by Subject|4
4777478|NCT01497938|16481961|P2|Overall Study|Physician Decision|1
4777479|NCT01497938|16481962|P1|Overall Study|Physician Decision|0
4777480|NCT01497938|16481961|P2|Overall Study|Adverse Event|1
4777481|NCT01497938|16481962|P1|Overall Study|Adverse Event|0
4777482|NCT01497899|16481974|P4|Open-Label Extension Phase|Lost to Follow-up|5
4777483|NCT01497899|16481975|P3|Open-Label Extension Phase|Lost to Follow-up|5
4777484|NCT01497899|16481976|P2|Open-Label Extension Phase|Lost to Follow-up|3
4777485|NCT01497899|16481977|P1|Open-Label Extension Phase|Lost to Follow-up|9
4777486|NCT01497899|16481974|P4|Open-Label Extension Phase|Protocol Violation|0
4777487|NCT01497899|16481975|P3|Open-Label Extension Phase|Protocol Violation|1
4777488|NCT01497899|16481976|P2|Open-Label Extension Phase|Protocol Violation|0
4777489|NCT01497899|16481977|P1|Open-Label Extension Phase|Protocol Violation|0
4777490|NCT01497899|16481974|P4|Open-Label Extension Phase|Pregnancy|0
4777491|NCT01497899|16481975|P3|Open-Label Extension Phase|Pregnancy|1
4777492|NCT01497899|16481976|P2|Open-Label Extension Phase|Pregnancy|1
4777493|NCT01497899|16481977|P1|Open-Label Extension Phase|Pregnancy|0
4777494|NCT01497899|16481974|P4|Open-Label Extension Phase|Withdrew Consent|0
4777495|NCT01497899|16481975|P3|Open-Label Extension Phase|Withdrew Consent|2
4777496|NCT01497899|16481976|P2|Open-Label Extension Phase|Withdrew Consent|3
4777497|NCT01497899|16481977|P1|Open-Label Extension Phase|Withdrew Consent|8
4777498|NCT01497899|16481974|P4|Open-Label Extension Phase|Death|0
4777499|NCT01497899|16481975|P3|Open-Label Extension Phase|Death|0
4777500|NCT01497899|16481976|P2|Open-Label Extension Phase|Death|0
4777501|NCT01497899|16481977|P1|Open-Label Extension Phase|Death|1
4777502|NCT01497899|16481974|P4|Open-Label Extension Phase|Adverse Event|0
4777503|NCT01497899|16481975|P3|Open-Label Extension Phase|Adverse Event|0
4777504|NCT01497899|16481976|P2|Open-Label Extension Phase|Adverse Event|0
4777505|NCT01497899|16481977|P1|Open-Label Extension Phase|Adverse Event|1
4777506|NCT01497899|16481974|P4|Double-Blind Phase|Subject Non-Compliance|0
4777507|NCT01497899|16481975|P3|Double-Blind Phase|Subject Non-Compliance|0
4777508|NCT01497899|16481976|P2|Double-Blind Phase|Subject Non-Compliance|1
4777509|NCT01497899|16481977|P1|Double-Blind Phase|Subject Non-Compliance|0
4777510|NCT01497899|16481974|P4|Double-Blind Phase|Lost to Follow-up|0
4777511|NCT01497899|16481975|P3|Double-Blind Phase|Lost to Follow-up|0
4777512|NCT01497899|16481976|P2|Double-Blind Phase|Lost to Follow-up|2
4777513|NCT01497899|16481977|P1|Double-Blind Phase|Lost to Follow-up|3
4777514|NCT01497899|16481974|P4|Double-Blind Phase|Withdrew Consent|0
4777515|NCT01497899|16481975|P3|Double-Blind Phase|Withdrew Consent|0
4777516|NCT01497899|16481976|P2|Double-Blind Phase|Withdrew Consent|1
4777517|NCT01497899|16481977|P1|Double-Blind Phase|Withdrew Consent|0
4777518|NCT01497899|16481974|P4|Double-Blind Phase|Investigator's Discretion|0
4777519|NCT01497899|16481975|P3|Double-Blind Phase|Investigator's Discretion|0
4777520|NCT01497899|16481976|P2|Double-Blind Phase|Investigator's Discretion|0
4777521|NCT01497899|16481977|P1|Double-Blind Phase|Investigator's Discretion|1
4777522|NCT01497899|16481974|P4|Double-Blind Phase|Lack of Efficacy|0
4777523|NCT01497899|16481975|P3|Double-Blind Phase|Lack of Efficacy|0
4777524|NCT01497899|16481976|P2|Double-Blind Phase|Lack of Efficacy|1
4777525|NCT01497899|16481977|P1|Double-Blind Phase|Lack of Efficacy|0
4777526|NCT01497899|16481974|P4|Double-Blind Phase|Adverse Event|0
4777527|NCT01497899|16481975|P3|Double-Blind Phase|Adverse Event|0
4777528|NCT01497899|16481976|P2|Double-Blind Phase|Adverse Event|0
4777529|NCT01497899|16481977|P1|Double-Blind Phase|Adverse Event|1
4777530|NCT01497899|16481974|P4|Double-Blind Phase|Randomized but not Treated|0
4777531|NCT01497899|16481975|P3|Double-Blind Phase|Randomized but not Treated|0
4777532|NCT01497899|16481976|P2|Double-Blind Phase|Randomized but not Treated|0
4777533|NCT01497899|16481977|P1|Double-Blind Phase|Randomized but not Treated|1
4777534|NCT01497366|16482048|P2|Overall Study|Randomized but not treated|21
4777535|NCT01497366|16482049|P1|Overall Study|Randomized but not treated|7
4777536|NCT01497366|16482048|P2|Overall Study|Death|1
4777537|NCT01497366|16482049|P1|Overall Study|Death|1
4777538|NCT01497366|16482048|P2|Overall Study|Other|0
4777539|NCT01497366|16482049|P1|Overall Study|Other|5
4777540|NCT01497366|16482048|P2|Overall Study|Initiated Non-protocol HCV Treatment|0
4777541|NCT01497366|16482049|P1|Overall Study|Initiated Non-protocol HCV Treatment|7
4777542|NCT01497366|16482048|P2|Overall Study|Withdrawal by Subject|6
4777543|NCT01497366|16482049|P1|Overall Study|Withdrawal by Subject|6
4777544|NCT01497366|16482048|P2|Overall Study|Lost to Follow-up|10
4777545|NCT01497366|16482049|P1|Overall Study|Lost to Follow-up|11
4777546|NCT01497366|16482048|P2|Overall Study|Virologic failure|50
4777547|NCT01497366|16482049|P1|Overall Study|Virologic failure|2
4777548|NCT01497275|16482067|P1|Overall Study|Adverse Event|1
4777549|NCT01497275|16482067|P1|Overall Study|Death|1
4777550|NCT01497262|16482074|P1|Overall Study|Protocol Violation|1
4777551|NCT01497262|16482074|P1|Overall Study|Adverse Event|2
4777552|NCT01497262|16482074|P1|Overall Study|Withdrawal by Subject|2
4777553|NCT01497262|16482074|P1|Overall Study|Physician Decision|1
4777554|NCT01497262|16482074|P1|Overall Study|Abnormal Test Procedure Result|1
4777555|NCT01497262|16482074|P1|Overall Study|Abnormal Lab Values|4
4777556|NCT01497197|16482081|P2|Overall Study|Other|1
4777557|NCT01497197|16482082|P1|Overall Study|Other|3
4777558|NCT01497197|16482081|P2|Overall Study|All embryos discarded|3
4777559|NCT01497197|16482082|P1|Overall Study|All embryos discarded|0
4777560|NCT01497197|16482081|P2|Overall Study|Intention to freeze all embryos|1
4777561|NCT01497197|16482082|P1|Overall Study|Intention to freeze all embryos|0
4777562|NCT01497197|16482081|P2|Overall Study|No fertilisation|5
4777563|NCT01497197|16482082|P1|Overall Study|No fertilisation|6
4777564|NCT01497197|16482081|P2|Overall Study|No oocytes retrieved|2
4777565|NCT01497197|16482082|P1|Overall Study|No oocytes retrieved|3
4777566|NCT01497197|16482081|P2|Overall Study|Risk of OHSS|0
4777567|NCT01497197|16482082|P1|Overall Study|Risk of OHSS|1
4777568|NCT01497197|16482081|P2|Overall Study|Excessive/lack of response to treatment|0
4777569|NCT01497197|16482082|P1|Overall Study|Excessive/lack of response to treatment|1
4777570|NCT01497197|16482081|P2|Overall Study|Withdrawal by Subject|1
4777571|NCT01497197|16482082|P1|Overall Study|Withdrawal by Subject|2
4777572|NCT01497197|16482081|P2|Overall Study|Protocol Violation|2
4777573|NCT01497197|16482082|P1|Overall Study|Protocol Violation|0
4777574|NCT01497197|16482081|P2|Overall Study|Lost to Follow-up|0
4777575|NCT01497197|16482082|P1|Overall Study|Lost to Follow-up|1
4777576|NCT01497067|16482117|P1|Overall Study|Other|13
4777577|NCT01497067|16482117|P1|Overall Study|Patient decision unrel to Adverse Event|10
4777578|NCT01497067|16482117|P1|Overall Study|Adverse Event|3
4777579|NCT01497067|16482117|P1|Overall Study|Lost to Follow-up|56
4777580|NCT01496846|16482128|P6|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4777581|NCT01496846|16482129|P5|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4777582|NCT01496846|16482130|P4|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4777583|NCT01496846|16482131|P3|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0
4777584|NCT01496846|16482132|P2|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
4777585|NCT01496846|16482133|P1|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1
4777586|NCT01496807|16482144|P1|Overall Study|Change in diagnosis|1
4777587|NCT01496807|16482144|P1|Overall Study|Participant preference/toxicity|8
4777588|NCT01496807|16482144|P1|Overall Study|Progressive Disease|21
4777589|NCT01496469|16482156|P2|Overall Study|Other|1
4777590|NCT01496469|16482157|P1|Overall Study|Other|1
4777591|NCT01496469|16482156|P2|Overall Study|BP exceeds protocol limits|2
4777592|NCT01496469|16482157|P1|Overall Study|BP exceeds protocol limits|1
4777593|NCT01496469|16482156|P2|Overall Study|Withdrawal by Subject|4
4777594|NCT01496469|16482157|P1|Overall Study|Withdrawal by Subject|4
4777595|NCT01496469|16482156|P2|Overall Study|Lost to Follow-up|1
4777596|NCT01496469|16482157|P1|Overall Study|Lost to Follow-up|1
4777597|NCT01496469|16482156|P2|Overall Study|Protocol Violation|0
4777598|NCT01496469|16482157|P1|Overall Study|Protocol Violation|2
4777599|NCT01496469|16482156|P2|Overall Study|Adverse Event|0
4777600|NCT01496469|16482157|P1|Overall Study|Adverse Event|1
4777601|NCT01496456|16482167|P1|Overall Study|Lost to Follow-up|7
4777602|NCT01496456|16482167|P1|Overall Study|Protocol Violation|1
4777603|NCT01496430|16482180|P3|Overall Study|Other|0
4777604|NCT01496430|16482181|P2|Overall Study|Other|0
4777605|NCT01496430|16482182|P1|Overall Study|Other|2
4777606|NCT01496430|16482180|P3|Overall Study|Principal Investigator Discretion|1
4777607|NCT01496430|16482181|P2|Overall Study|Principal Investigator Discretion|1
4777608|NCT01496430|16482182|P1|Overall Study|Principal Investigator Discretion|0
4777609|NCT01496430|16482180|P3|Overall Study|Voluntary Withdrawal|6
4777610|NCT01496430|16482181|P2|Overall Study|Voluntary Withdrawal|1
4777611|NCT01496430|16482182|P1|Overall Study|Voluntary Withdrawal|2
4777612|NCT01496430|16482180|P3|Overall Study|Lost to Follow-up|1
4777613|NCT01496430|16482181|P2|Overall Study|Lost to Follow-up|3
4777614|NCT01496430|16482182|P1|Overall Study|Lost to Follow-up|2
4777615|NCT01496430|16482180|P3|Overall Study|Major Protocol Deviation|1
4777616|NCT01496430|16482181|P2|Overall Study|Major Protocol Deviation|0
4777617|NCT01496430|16482182|P1|Overall Study|Major Protocol Deviation|0
4777618|NCT01496430|16482180|P3|Overall Study|Adverse Event|1
4777619|NCT01496430|16482181|P2|Overall Study|Adverse Event|0
4777620|NCT01496430|16482182|P1|Overall Study|Adverse Event|0
4777621|NCT01496287|16482294|P1|Overall Study|Incomplete anesthesia|5
4777622|NCT01496287|16482294|P1|Overall Study|Lost to Follow-up|1
4777623|NCT01496274|16482304|P2|Overall Study|Lost to Follow-up|3
4777624|NCT01496274|16482305|P1|Overall Study|Lost to Follow-up|0
4777625|NCT01496274|16482304|P2|Overall Study|Withdrawal by Subject|0
4777626|NCT01496274|16482305|P1|Overall Study|Withdrawal by Subject|2
4777627|NCT01496274|16482304|P2|Overall Study|Adverse Event|1
4777628|NCT01496274|16482305|P1|Overall Study|Adverse Event|1
4777629|NCT01496274|16482304|P2|Overall Study|Protocol Violation|1
4777630|NCT01496274|16482305|P1|Overall Study|Protocol Violation|0
4777631|NCT01496183|16482350|P2|Overall Study|Withdrawal by Subject|1
4777632|NCT01496183|16482351|P1|Overall Study|Withdrawal by Subject|0
4777633|NCT01496183|16482350|P2|Overall Study|Physician Decision|1
4777634|NCT01496183|16482351|P1|Overall Study|Physician Decision|3
4777635|NCT01496066|16482403|P2|Overall Study|Death|4
4777636|NCT01496066|16482404|P1|Overall Study|Death|1
4777637|NCT01496066|16482403|P2|Overall Study|Explant|0
4777638|NCT01496066|16482404|P1|Overall Study|Explant|3
4777639|NCT01496066|16482403|P2|Overall Study|Lost to Follow-up|5
4777640|NCT01496066|16482404|P1|Overall Study|Lost to Follow-up|8
4777641|NCT01495975|16482466|P2|Overall Study|Lost to Follow-up|0
4777642|NCT01495975|16482467|P1|Overall Study|Lost to Follow-up|1
4777643|NCT01495793|16482591|P1|Overall Study|Violation of inclusion criteria|1
4777644|NCT01495793|16482591|P1|Overall Study|Lost to Follow-up|1
4777645|NCT01495702|16482604|P2|Randomized Phase|Protocol Violation|1
4777646|NCT01495702|16482605|P1|Randomized Phase|Protocol Violation|3
4777647|NCT01495702|16482604|P2|Randomized Phase|Participant Noncompliance|0
4777648|NCT01495702|16482605|P1|Randomized Phase|Participant Noncompliance|1
4777649|NCT01495702|16482604|P2|Randomized Phase|Lost to Follow-up|3
4777650|NCT01495702|16482605|P1|Randomized Phase|Lost to Follow-up|4
4777651|NCT01495702|16482604|P2|Randomized Phase|Withdrew Consent|18
4777652|NCT01495702|16482605|P1|Randomized Phase|Withdrew Consent|10
4777653|NCT01495702|16482604|P2|Randomized Phase|Investigators Discretion|0
4777654|NCT01495702|16482605|P1|Randomized Phase|Investigators Discretion|2
4777655|NCT01495702|16482604|P2|Randomized Phase|Lack of Efficacy|0
4777656|NCT01495702|16482605|P1|Randomized Phase|Lack of Efficacy|2
4777657|NCT01495702|16482604|P2|Randomized Phase|Death|0
4777658|NCT01495702|16482605|P1|Randomized Phase|Death|1
4777659|NCT01495702|16482604|P2|Randomized Phase|Adverse Event|2
4777660|NCT01495702|16482605|P1|Randomized Phase|Adverse Event|2
4777661|NCT01495702|16482604|P2|Randomized Phase|Randomized But Not Treated|4
4777662|NCT01495702|16482605|P1|Randomized Phase|Randomized But Not Treated|1
4777663|NCT01495000|16482683|P2|Overall Study|Withdrawal by Subject|10
4777664|NCT01495000|16482684|P1|Overall Study|Withdrawal by Subject|10
4777665|NCT01495000|16482683|P2|Overall Study|Protocol Violation|0
4777666|NCT01495000|16482684|P1|Overall Study|Protocol Violation|1
4777667|NCT01495000|16482683|P2|Overall Study|Lost to Follow-up|2
4777668|NCT01495000|16482684|P1|Overall Study|Lost to Follow-up|2
4777669|NCT01494987|16482726|P2|Overall Study|Subject Withdrew Consent|3
4777670|NCT01494987|16482727|P1|Overall Study|Subject Withdrew Consent|2
4777671|NCT01494987|16482726|P2|Overall Study|Subject Non-Compliance|10
4777672|NCT01494987|16482727|P1|Overall Study|Subject Non-Compliance|9
4777673|NCT01494987|16482726|P2|Overall Study|Protocol Violation|3
4777674|NCT01494987|16482727|P1|Overall Study|Protocol Violation|3
4777675|NCT01494987|16482726|P2|Overall Study|Lost to Follow-up|1
4777676|NCT01494987|16482727|P1|Overall Study|Lost to Follow-up|1
4777677|NCT01494987|16482726|P2|Overall Study|Investigator's Discretion|2
4777678|NCT01494987|16482727|P1|Overall Study|Investigator's Discretion|1
4777679|NCT01494987|16482726|P2|Overall Study|Hyperglycemia|4
4777680|NCT01494987|16482727|P1|Overall Study|Hyperglycemia|6
4777681|NCT01494987|16482726|P2|Overall Study|Adverse Event|5
4777682|NCT01494987|16482727|P1|Overall Study|Adverse Event|6
4777683|NCT01494818|16482741|P2|Overall Study|Lost to Follow-up|0
4777684|NCT01494818|16482742|P1|Overall Study|Lost to Follow-up|1
4777685|NCT01494818|16482741|P2|Overall Study|Relocation|2
4777686|NCT01494818|16482742|P1|Overall Study|Relocation|1
4777687|NCT01494649|16482773|P2|Overall Study|Lost to Follow-up|1
4777688|NCT01494649|16482774|P1|Overall Study|Lost to Follow-up|0
4777689|NCT01494610|16482790|P2|Period 4|Protocol Violation|0
4777690|NCT01494610|16482791|P1|Period 4|Protocol Violation|1
4777691|NCT01494610|16482790|P2|Period 3|Withdrawal by Subject|0
4777692|NCT01494610|16482791|P1|Period 3|Withdrawal by Subject|1
4777693|NCT01494610|16482790|P2|Period 3|Adverse Event|0
4777694|NCT01494610|16482791|P1|Period 3|Adverse Event|1
4777695|NCT01494610|16482790|P2|Period 1|Withdrawal by Subject|1
4777696|NCT01494610|16482791|P1|Period 1|Withdrawal by Subject|1
4777697|NCT01494584|16482859|P1|Overall Study|Study Closed/Terminated|1
4777698|NCT01494532|16482991|P6|Overall Study|Withdrawal by Subject|0
4777699|NCT01494532|16482992|P5|Overall Study|Withdrawal by Subject|2
4777700|NCT01494532|16482993|P4|Overall Study|Withdrawal by Subject|3
4777701|NCT01494532|16482994|P3|Overall Study|Withdrawal by Subject|4
4777702|NCT01494532|16482995|P2|Overall Study|Withdrawal by Subject|1
4777703|NCT01494532|16482996|P1|Overall Study|Withdrawal by Subject|3
4777704|NCT01494532|16482991|P6|Overall Study|Physician Decision|0
4777705|NCT01494532|16482992|P5|Overall Study|Physician Decision|0
4777706|NCT01494532|16482993|P4|Overall Study|Physician Decision|2
4777707|NCT01494532|16482994|P3|Overall Study|Physician Decision|1
4777708|NCT01494532|16482995|P2|Overall Study|Physician Decision|1
4777709|NCT01494532|16482996|P1|Overall Study|Physician Decision|0
4777710|NCT01494532|16482991|P6|Overall Study|Lost to Follow-up|0
4777711|NCT01494532|16482992|P5|Overall Study|Lost to Follow-up|0
4777712|NCT01494532|16482993|P4|Overall Study|Lost to Follow-up|2
4777713|NCT01494532|16482994|P3|Overall Study|Lost to Follow-up|0
4777714|NCT01494532|16482995|P2|Overall Study|Lost to Follow-up|0
4777715|NCT01494532|16482996|P1|Overall Study|Lost to Follow-up|1
4777716|NCT01494532|16482991|P6|Overall Study|Protocol-defined stopping criteria|0
4777717|NCT01494532|16482992|P5|Overall Study|Protocol-defined stopping criteria|0
4777718|NCT01494532|16482993|P4|Overall Study|Protocol-defined stopping criteria|0
4777719|NCT01494532|16482994|P3|Overall Study|Protocol-defined stopping criteria|1
4777720|NCT01494532|16482995|P2|Overall Study|Protocol-defined stopping criteria|0
4777721|NCT01494532|16482996|P1|Overall Study|Protocol-defined stopping criteria|0
4777722|NCT01494532|16482991|P6|Overall Study|Protocol deviation|0
4777723|NCT01494532|16482992|P5|Overall Study|Protocol deviation|3
4777724|NCT01494532|16482993|P4|Overall Study|Protocol deviation|2
4777725|NCT01494532|16482994|P3|Overall Study|Protocol deviation|3
4777726|NCT01494532|16482995|P2|Overall Study|Protocol deviation|1
4777727|NCT01494532|16482996|P1|Overall Study|Protocol deviation|2
4777728|NCT01494532|16482991|P6|Overall Study|Lack of Efficacy|0
4777729|NCT01494532|16482992|P5|Overall Study|Lack of Efficacy|2
4777730|NCT01494532|16482993|P4|Overall Study|Lack of Efficacy|0
4777731|NCT01494532|16482994|P3|Overall Study|Lack of Efficacy|0
4777732|NCT01494532|16482995|P2|Overall Study|Lack of Efficacy|0
4777733|NCT01494532|16482996|P1|Overall Study|Lack of Efficacy|0
4777734|NCT01494532|16482991|P6|Overall Study|Adverse Event|0
4777735|NCT01494532|16482992|P5|Overall Study|Adverse Event|5
4777736|NCT01494532|16482993|P4|Overall Study|Adverse Event|6
4777737|NCT01494532|16482994|P3|Overall Study|Adverse Event|8
4777738|NCT01494532|16482995|P2|Overall Study|Adverse Event|1
4777739|NCT01494532|16482996|P1|Overall Study|Adverse Event|4
4777740|NCT01494506|16483151|P3|Overall Study|Other|1
4777741|NCT01494506|16483152|P2|Overall Study|Other|3
4777742|NCT01494506|16483153|P1|Overall Study|Other|0
4777743|NCT01494506|16483151|P3|Overall Study|Sponsor Decision|1
4777744|NCT01494506|16483152|P2|Overall Study|Sponsor Decision|0
4777745|NCT01494506|16483153|P1|Overall Study|Sponsor Decision|0
4777746|NCT01494506|16483151|P3|Overall Study|Clinical Deterioration|13
4777747|NCT01494506|16483152|P2|Overall Study|Clinical Deterioration|17
4777748|NCT01494506|16483153|P1|Overall Study|Clinical Deterioration|21
4777749|NCT01494506|16483151|P3|Overall Study|Withdrawal by Subject|14
4777750|NCT01494506|16483152|P2|Overall Study|Withdrawal by Subject|20
4777751|NCT01494506|16483153|P1|Overall Study|Withdrawal by Subject|17
4777752|NCT01494506|16483151|P3|Overall Study|Physician Decision|4
4777753|NCT01494506|16483152|P2|Overall Study|Physician Decision|5
4777754|NCT01494506|16483153|P1|Overall Study|Physician Decision|7
4777755|NCT01494506|16483151|P3|Overall Study|Death|2
4777756|NCT01494506|16483152|P2|Overall Study|Death|5
4777757|NCT01494506|16483153|P1|Overall Study|Death|9
4777758|NCT01494506|16483151|P3|Overall Study|Adverse Event|11
4777759|NCT01494506|16483152|P2|Overall Study|Adverse Event|10
4777760|NCT01494506|16483153|P1|Overall Study|Adverse Event|17
4777761|NCT01494506|16483151|P3|Overall Study|Lack of Efficacy|57
4777762|NCT01494506|16483152|P2|Overall Study|Lack of Efficacy|83
4777763|NCT01494506|16483153|P1|Overall Study|Lack of Efficacy|77
4777764|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2
4777765|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8
4777766|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
4777767|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26
4777768|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|5
4777769|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|3
4777770|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24
4777771|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32
4777772|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|5
4777773|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|3
4777774|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
4777775|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1
4777776|NCT01494467|16483190|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|0
4777777|NCT01494467|16483191|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|2
4777778|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
4777779|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
4777780|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Other|1
4777781|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Other|1
4777782|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
4777783|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
4777784|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|0
4777785|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|4
4777786|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8
4777787|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9
4777788|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
4777789|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|6
4777790|NCT01494467|16483190|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
4777791|NCT01494467|16483191|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|1
4777792|NCT01494350|16483207|P1|Overall Study|Worsening of lesion|1
4777793|NCT01494298|16483217|P2|Overall Study|Protocol Violation|8
4777794|NCT01494298|16483218|P1|Overall Study|Protocol Violation|2
4777795|NCT01494038|16483241|P2|Overall Study|Death|4
4777796|NCT01494038|16483242|P1|Overall Study|Death|2
4777797|NCT01494038|16483241|P2|Overall Study|Not willing to adhere to reqs|9
4777798|NCT01494038|16483242|P1|Overall Study|Not willing to adhere to reqs|2
4777799|NCT01494038|16483241|P2|Overall Study|Not able to get to clinic|15
4777800|NCT01494038|16483242|P1|Overall Study|Not able to get to clinic|21
4777801|NCT01494038|16483241|P2|Overall Study|Withdrawal by Subject|34
4777802|NCT01494038|16483242|P1|Overall Study|Withdrawal by Subject|44
4777803|NCT01494038|16483241|P2|Overall Study|Lost to Follow-up|20
4777804|NCT01494038|16483242|P1|Overall Study|Lost to Follow-up|18
4777805|NCT01494038|16483241|P2|Overall Study|Protocol Violation|1
4777806|NCT01494038|16483242|P1|Overall Study|Protocol Violation|1
4777807|NCT01493960|16483330|P2|Overall Study|Non-specified|4
4777808|NCT01493960|16483331|P1|Overall Study|Non-specified|4
4777809|NCT01493960|16483330|P2|Overall Study|Withdrawal by Subject|4
4777810|NCT01493960|16483331|P1|Overall Study|Withdrawal by Subject|10
4777811|NCT01493960|16483330|P2|Overall Study|Protocol Violation|0
4777812|NCT01493960|16483331|P1|Overall Study|Protocol Violation|3
4777813|NCT01493960|16483330|P2|Overall Study|Lack of Efficacy|9
4777814|NCT01493960|16483331|P1|Overall Study|Lack of Efficacy|15
4777815|NCT01493960|16483330|P2|Overall Study|Adverse Event|1
4777816|NCT01493960|16483331|P1|Overall Study|Adverse Event|0
4777817|NCT01493778|16483362|P1|Overall Study|Withdrawal by Subject|8
4777818|NCT01493687|16483424|P2|Part C Safety Follow up (4 Weeks)|Adverse Event|1
4777819|NCT01493687|16483425|P1|Part C Safety Follow up (4 Weeks)|Adverse Event|0
4777820|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1
4777821|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5
4777822|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10
4777823|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16
4777824|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Protocol Violation|0
4777825|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Protocol Violation|1
4777826|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16
4777827|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27
4777828|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Adverse Event|4
4777829|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Adverse Event|5
4777830|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3
4777831|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2
4777832|NCT01493687|16483424|P2|Part B Long Term Active Control 40 Weeks|Pregnancy|1
4777833|NCT01493687|16483425|P1|Part B Long Term Active Control 40 Weeks|Pregnancy|5
4777834|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
4777835|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1
4777836|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8
4777837|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7
4777838|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Protocol Violation|1
4777839|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Protocol Violation|2
4777840|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7
4777841|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18
4777842|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Adverse Event|4
4777843|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Adverse Event|7
4777844|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1
4777845|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0
4777846|NCT01493687|16483424|P2|Part A Vehicle Control (12 Weeks)|Pregnancy|0
4777847|NCT01493687|16483425|P1|Part A Vehicle Control (12 Weeks)|Pregnancy|2
4777848|NCT01493557|16483444|P3|Adding the Second Strategy|Withdrawal by Subject|0
4777849|NCT01493557|16483445|P2|Adding the Second Strategy|Withdrawal by Subject|1
4777850|NCT01493557|16483446|P1|Adding the Second Strategy|Withdrawal by Subject|0
4777851|NCT01493557|16483444|P3|Adding the Second Strategy|Other adverse event|0
4777852|NCT01493557|16483445|P2|Adding the Second Strategy|Other adverse event|2
4777853|NCT01493557|16483446|P1|Adding the Second Strategy|Other adverse event|1
4777854|NCT01493557|16483444|P3|Adding the Second Strategy|Worsening of events associate with GIS|0
4777855|NCT01493557|16483445|P2|Adding the Second Strategy|Worsening of events associate with GIS|1
4777856|NCT01493557|16483446|P1|Adding the Second Strategy|Worsening of events associate with GIS|1
4777857|NCT01493557|16483444|P3|Randomized to Management Strategies|Other than stated above|0
4777858|NCT01493557|16483445|P2|Randomized to Management Strategies|Other than stated above|3
4777859|NCT01493557|16483446|P1|Randomized to Management Strategies|Other than stated above|1
4777860|NCT01493557|16483444|P3|Randomized to Management Strategies|Withdrawal by Subject|0
4777861|NCT01493557|16483445|P2|Randomized to Management Strategies|Withdrawal by Subject|1
4777862|NCT01493557|16483446|P1|Randomized to Management Strategies|Withdrawal by Subject|0
4777863|NCT01493557|16483444|P3|Randomized to Management Strategies|Protocol Violation|0
4777864|NCT01493557|16483445|P2|Randomized to Management Strategies|Protocol Violation|0
4777865|NCT01493557|16483446|P1|Randomized to Management Strategies|Protocol Violation|3
4777866|NCT01493557|16483444|P3|Randomized to Management Strategies|Other adverse event|0
4777867|NCT01493557|16483445|P2|Randomized to Management Strategies|Other adverse event|5
4777868|NCT01493557|16483446|P1|Randomized to Management Strategies|Other adverse event|8
4777869|NCT01493557|16483444|P3|Randomized to Management Strategies|Worsening of events associate with GIS|0
4777870|NCT01493557|16483445|P2|Randomized to Management Strategies|Worsening of events associate with GIS|2
4777871|NCT01493557|16483446|P1|Randomized to Management Strategies|Worsening of events associate with GIS|3
4777872|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Other than stated above|21
4777873|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Other than stated above|0
4777874|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Other than stated above|0
4777875|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Early termination|34
4777876|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Early termination|0
4777877|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Early termination|0
4777878|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Withdrawal by Subject|10
4777879|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Withdrawal by Subject|0
4777880|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Withdrawal by Subject|0
4777881|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Lost to Follow-up|4
4777882|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Lost to Follow-up|0
4777883|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Lost to Follow-up|0
4777884|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Protocol Violation|1
4777885|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Protocol Violation|0
4777886|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Protocol Violation|0
4777887|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Other adverse event|54
4777888|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Other adverse event|0
4777889|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Other adverse event|0
4777890|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9
4777891|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
4777892|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0
4777893|NCT01493557|16483444|P3|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1
4777894|NCT01493557|16483445|P2|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
4777895|NCT01493557|16483446|P1|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0
4777896|NCT01493531|16483474|P3|Overall Study|Death|0
4777897|NCT01493531|16483475|P2|Overall Study|Death|1
4777898|NCT01493531|16483476|P1|Overall Study|Death|0
4777899|NCT01493531|16483474|P3|Overall Study|Withdrawal by Subject|11
4777900|NCT01493531|16483475|P2|Overall Study|Withdrawal by Subject|13
4777901|NCT01493531|16483476|P1|Overall Study|Withdrawal by Subject|16
4777902|NCT01493531|16483474|P3|Overall Study|Lost to Follow-up|11
4777903|NCT01493531|16483475|P2|Overall Study|Lost to Follow-up|7
4777904|NCT01493531|16483476|P1|Overall Study|Lost to Follow-up|5
4777905|NCT01493531|16483474|P3|Overall Study|Sponsor terminated study|3
4777906|NCT01493531|16483475|P2|Overall Study|Sponsor terminated study|2
4777907|NCT01493531|16483476|P1|Overall Study|Sponsor terminated study|5
4777908|NCT01493531|16483474|P3|Overall Study|Protocol Violation|12
4777909|NCT01493531|16483475|P2|Overall Study|Protocol Violation|15
4777910|NCT01493531|16483476|P1|Overall Study|Protocol Violation|8
4777911|NCT01493531|16483474|P3|Overall Study|Gout flare|2
4777912|NCT01493531|16483475|P2|Overall Study|Gout flare|0
4777913|NCT01493531|16483476|P1|Overall Study|Gout flare|3
4777914|NCT01493531|16483474|P3|Overall Study|Adverse Event|9
4777915|NCT01493531|16483475|P2|Overall Study|Adverse Event|12
4777916|NCT01493531|16483476|P1|Overall Study|Adverse Event|4
4777917|NCT01493427|16483490|P1|Overall Study|Other|2
4777918|NCT01493427|16483490|P1|Overall Study|Inability to Follow Instructions|2
4777919|NCT01493427|16483490|P1|Overall Study|Lost to Follow-up|2
4777920|NCT01493427|16483490|P1|Overall Study|Personal Reasons|4
4777921|NCT01493427|16483490|P1|Overall Study|Adverse Event|10
4777922|NCT01493414|16483495|P1|Overall Study|Lost to Follow-up|16
4777923|NCT01493414|16483495|P1|Overall Study|Administrative problems|25
4777924|NCT01493414|16483495|P1|Overall Study|Protocol deviation|27
4777925|NCT01493414|16483495|P1|Overall Study|Withdrawal by Subject|79
4777926|NCT01493414|16483495|P1|Overall Study|Physician Decision|93
4777927|NCT01493414|16483495|P1|Overall Study|Death|101
4777928|NCT01493414|16483495|P1|Overall Study|Disease progression|204
4777929|NCT01493414|16483495|P1|Overall Study|Adverse Event|405
4777930|NCT01493284|16483508|P1|Overall Study|Withdrawal by Subject|32
4777931|NCT01493284|16483508|P1|Overall Study|Death|29
4777932|NCT01493089|16483530|P2|Overall Study|Physician Decision|1
4777933|NCT01493089|16483531|P1|Overall Study|Physician Decision|0
4777934|NCT01493089|16483530|P2|Overall Study|Withdrawal by Subject|0
4777935|NCT01493089|16483531|P1|Overall Study|Withdrawal by Subject|1
4777936|NCT01493089|16483530|P2|Overall Study|Protocol Violation|2
4777937|NCT01493089|16483531|P1|Overall Study|Protocol Violation|2
4777938|NCT01492686|16483630|P2|Open-label Phase|Due to a discontinuation criterion|9
4777939|NCT01492686|16483631|P1|Open-label Phase|Due to a discontinuation criterion|4
4777940|NCT01492686|16483630|P2|Open-label Phase|Withdrawal by Subject|7
4777941|NCT01492686|16483631|P1|Open-label Phase|Withdrawal by Subject|6
4777942|NCT01492686|16483630|P2|Open-label Phase|Physician Decision|0
4777943|NCT01492686|16483631|P1|Open-label Phase|Physician Decision|1
4777944|NCT01492686|16483630|P2|Open-label Phase|Adverse Event|2
4777945|NCT01492686|16483631|P1|Open-label Phase|Adverse Event|1
4777946|NCT01492686|16483630|P2|Double-blind Phase|Due to a discontinuation criterion|3
4777947|NCT01492686|16483631|P1|Double-blind Phase|Due to a discontinuation criterion|2
4777948|NCT01492686|16483630|P2|Double-blind Phase|Withdrawal by Subject|2
4777949|NCT01492686|16483631|P1|Double-blind Phase|Withdrawal by Subject|0
4777950|NCT01492686|16483630|P2|Double-blind Phase|Physician Decision|1
4777951|NCT01492686|16483631|P1|Double-blind Phase|Physician Decision|0
4777952|NCT01492686|16483630|P2|Double-blind Phase|Adverse Event|2
4777953|NCT01492686|16483631|P1|Double-blind Phase|Adverse Event|0
4777954|NCT01492439|16483688|P2|Overall Study|Withdrew from RTE|9
4777955|NCT01492439|16483689|P1|Overall Study|Withdrew from RTE|4
4777956|NCT01492426|16483737|P2|Follow-Up|Lost to Follow-up|6
4777957|NCT01492426|16483738|P1|Follow-Up|Lost to Follow-up|12
4777958|NCT01492426|16483737|P2|Follow-Up|Participant Withdrew Consent|1
4777959|NCT01492426|16483738|P1|Follow-Up|Participant Withdrew Consent|6
4777960|NCT01492426|16483737|P2|Follow-Up|Other|2
4777961|NCT01492426|16483738|P1|Follow-Up|Other|4
4777962|NCT01492426|16483737|P2|Follow-Up|Death|0
4777963|NCT01492426|16483738|P1|Follow-Up|Death|1
4777964|NCT01492426|16483737|P2|Follow-Up|Protocol Requires no Follow-Up|1
4777965|NCT01492426|16483738|P1|Follow-Up|Protocol Requires no Follow-Up|2
4777966|NCT01492426|16483737|P2|Treatment|Participant does not meet study criteria|0
4777967|NCT01492426|16483738|P1|Treatment|Participant does not meet study criteria|1
4777968|NCT01492426|16483737|P2|Treatment|Lost to Follow-up|4
4777969|NCT01492426|16483738|P1|Treatment|Lost to Follow-up|9
4777970|NCT01492426|16483737|P2|Treatment|Subject requested discontinue study drug|3
4777971|NCT01492426|16483738|P1|Treatment|Subject requested discontinue study drug|7
4777972|NCT01492426|16483737|P2|Treatment|Poor compliance/noncompliance|0
4777973|NCT01492426|16483738|P1|Treatment|Poor compliance/noncompliance|1
4777974|NCT01492426|16483737|P2|Treatment|Participant withdrew consent|2
4777975|NCT01492426|16483738|P1|Treatment|Participant withdrew consent|1
4777976|NCT01492426|16483737|P2|Treatment|Lack of Efficacy|5
4777977|NCT01492426|16483738|P1|Treatment|Lack of Efficacy|38
4777978|NCT01492426|16483737|P2|Treatment|Adverse Event|25
4777979|NCT01492426|16483738|P1|Treatment|Adverse Event|25
4777980|NCT01492426|16483737|P2|Treatment|Other|0
4777981|NCT01492426|16483738|P1|Treatment|Other|1
4777982|NCT01492426|16483737|P2|Treatment|Death|1
4777983|NCT01492426|16483738|P1|Treatment|Death|0
4777984|NCT01492400|16483756|P2|Overall Study|Adverse Event|5
4777985|NCT01492400|16483757|P1|Overall Study|Adverse Event|10
4777986|NCT01492400|16483756|P2|Overall Study|Lack of Efficacy|1
4777987|NCT01492400|16483757|P1|Overall Study|Lack of Efficacy|1
4777988|NCT01492400|16483756|P2|Overall Study|Pregnancy|1
4777989|NCT01492400|16483757|P1|Overall Study|Pregnancy|0
4777990|NCT01492400|16483756|P2|Overall Study|Lost to Follow-up|1
4777991|NCT01492400|16483757|P1|Overall Study|Lost to Follow-up|3
4777992|NCT01492400|16483756|P2|Overall Study|Personal Reasons|5
4777993|NCT01492400|16483757|P1|Overall Study|Personal Reasons|0
4777994|NCT01492400|16483756|P2|Overall Study|Miscellaneous Reasons|3
4777995|NCT01492400|16483757|P1|Overall Study|Miscellaneous Reasons|2
4777996|NCT01492088|16483781|P3|Overall Study|Alive at Last Follow-up|11
4777997|NCT01492088|16483782|P2|Overall Study|Alive at Last Follow-up|6
4777998|NCT01492088|16483783|P1|Overall Study|Alive at Last Follow-up|0
4777999|NCT01492088|16483781|P3|Overall Study|Completed Post Treatment Followup (PTFU)|1
4778000|NCT01492088|16483782|P2|Overall Study|Completed Post Treatment Followup (PTFU)|0
4778001|NCT01492088|16483783|P1|Overall Study|Completed Post Treatment Followup (PTFU)|2
4778002|NCT01492088|16483781|P3|Overall Study|Death|2
4778003|NCT01492088|16483782|P2|Overall Study|Death|6
4778004|NCT01492088|16483783|P1|Overall Study|Death|1
4778005|NCT01492088|16483781|P3|Overall Study|Withdrawal by Patient|0
4778006|NCT01492088|16483782|P2|Overall Study|Withdrawal by Patient|2
4778007|NCT01492088|16483783|P1|Overall Study|Withdrawal by Patient|0
4778008|NCT01491919|16483864|P3|Overall Study|Insufficient PK sampling|1
4778009|NCT01491919|16483865|P2|Overall Study|Insufficient PK sampling|2
4778010|NCT01491919|16483866|P1|Overall Study|Insufficient PK sampling|1
4778011|NCT01491854|16483937|P1|Overall Study|Lost to Follow-up|33
4778012|NCT01491854|16483937|P1|Overall Study|Withdrawal by Subject|3
4778013|NCT01491854|16483937|P1|Overall Study|Death|1
4778014|NCT01491854|16483937|P1|Overall Study|mainly due to premature termination|93
4778015|NCT01491841|16483948|P1|Overall Study|Withdrawal by Subject|1
4778016|NCT01491841|16483948|P1|Overall Study|Screen Failure|10
4778017|NCT01491802|16483962|P2|Overall Study|Withdrawal by Subject|1
4778018|NCT01491802|16483963|P1|Overall Study|Withdrawal by Subject|0
4778019|NCT01491802|16483962|P2|Overall Study|Adverse Event|1
4778020|NCT01491802|16483963|P1|Overall Study|Adverse Event|1
4778021|NCT01491672|16483991|P3|Overall Study|Death|0
4778022|NCT01491672|16483992|P2|Overall Study|Death|4
4778023|NCT01491672|16483993|P1|Overall Study|Death|0
4778024|NCT01491672|16483991|P3|Overall Study|Protocol deviation|0
4778025|NCT01491672|16483992|P2|Overall Study|Protocol deviation|1
4778026|NCT01491672|16483993|P1|Overall Study|Protocol deviation|0
4778027|NCT01491672|16483991|P3|Overall Study|Disease progression|6
4778028|NCT01491672|16483992|P2|Overall Study|Disease progression|34
4778029|NCT01491672|16483993|P1|Overall Study|Disease progression|42
4778030|NCT01491672|16483991|P3|Overall Study|Adverse Event|4
4778031|NCT01491672|16483992|P2|Overall Study|Adverse Event|10
4778032|NCT01491672|16483993|P1|Overall Study|Adverse Event|8
4778033|NCT01491672|16483991|P3|Overall Study|Withdrawal by Subject|0
4778034|NCT01491672|16483992|P2|Overall Study|Withdrawal by Subject|7
4778035|NCT01491672|16483993|P1|Overall Study|Withdrawal by Subject|6
4778036|NCT01491672|16483991|P3|Overall Study|Lost to Follow-up|1
4778037|NCT01491672|16483992|P2|Overall Study|Lost to Follow-up|4
4778038|NCT01491672|16483993|P1|Overall Study|Lost to Follow-up|0
4778039|NCT01491607|16484030|P1|Overall Study|Withdrawal by Subject|3
4778040|NCT01491607|16484030|P1|Overall Study|Lost to Follow-up|7
4778041|NCT01491178|16484135|P1|Overall Study|Other than specified above|657
4778042|NCT01491178|16484135|P1|Overall Study|To take a contraindication|20
4778043|NCT01491178|16484135|P1|Overall Study|Lost to follow-up (changing hospital)|545
4778044|NCT01491178|16484135|P1|Overall Study|Lost to follow-up (unknown reason)|287
4778045|NCT01491178|16484135|P1|Overall Study|To conduct invasive treatment|59
4778046|NCT01491178|16484135|P1|Overall Study|Improvement of NVAF|210
4778047|NCT01491178|16484135|P1|Overall Study|Adverse Event|1016
4778048|NCT01491035|16484244|P8|Overall Study|Lost to Follow-up|0
4778049|NCT01491035|16484245|P7|Overall Study|Lost to Follow-up|0
4778050|NCT01491035|16484246|P6|Overall Study|Lost to Follow-up|0
4778051|NCT01491035|16484247|P5|Overall Study|Lost to Follow-up|1
4778052|NCT01491035|16484248|P4|Overall Study|Lost to Follow-up|0
4778053|NCT01491035|16484249|P3|Overall Study|Lost to Follow-up|0
4778054|NCT01491035|16484250|P2|Overall Study|Lost to Follow-up|0
4778055|NCT01491035|16484251|P1|Overall Study|Lost to Follow-up|0
4778056|NCT01490918|16484355|P3|Overall Study|other cause|8
4778057|NCT01490918|16484356|P2|Overall Study|other cause|5
4778058|NCT01490918|16484357|P1|Overall Study|other cause|4
4778059|NCT01490918|16484355|P3|Overall Study|Adverse Event|1
4778060|NCT01490918|16484356|P2|Overall Study|Adverse Event|0
4778061|NCT01490918|16484357|P1|Overall Study|Adverse Event|0
4778062|NCT01490918|16484355|P3|Overall Study|Withdrawal by Subject|3
4778063|NCT01490918|16484356|P2|Overall Study|Withdrawal by Subject|8
4778064|NCT01490918|16484357|P1|Overall Study|Withdrawal by Subject|7
4778065|NCT01490918|16484355|P3|Overall Study|Lost to Follow-up|0
4778066|NCT01490918|16484356|P2|Overall Study|Lost to Follow-up|1
4778067|NCT01490918|16484357|P1|Overall Study|Lost to Follow-up|2
4778068|NCT01490866|16484395|P1|Axitinib Maintenance Therapy|Intercurrent illness|2
4778069|NCT01490866|16484395|P1|Axitinib Maintenance Therapy|Protocol Violation|2
4778070|NCT01490866|16484395|P1|Axitinib Maintenance Therapy|Withdrawal by Subject|3
4778071|NCT01490866|16484395|P1|Axitinib Maintenance Therapy|Adverse Event|12
4778072|NCT01490866|16484395|P1|Axitinib Maintenance Therapy|Disease Progression|30
4778073|NCT01490866|16484395|P1|FOLFOX/Bevacizumab Treatment|Physician Decision|2
4778074|NCT01490866|16484395|P1|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1
4778075|NCT01490866|16484395|P1|FOLFOX/Bevacizumab Treatment|Protocol Violation|1
4778076|NCT01490866|16484395|P1|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5
4778077|NCT01490866|16484395|P1|FOLFOX/Bevacizumab Treatment|Adverse Event|6
4778078|NCT01490866|16484395|P1|FOLFOX/Bevacizumab Treatment|Disease Progression|6
4778079|NCT01490840|16484406|P2|Phase 2|Adverse Event|1
4778080|NCT01490840|16484407|P1|Phase 2|Adverse Event|1
4778081|NCT01490840|16484406|P2|Phase 2|Lost to Follow-up|1
4778082|NCT01490840|16484407|P1|Phase 2|Lost to Follow-up|1
4778083|NCT01490840|16484406|P2|Phase 2|Permanent interruption of fingolimod|1
4778084|NCT01490840|16484407|P1|Phase 2|Permanent interruption of fingolimod|0
4778085|NCT01490840|16484406|P2|Phase 2|Withdrawal by Subject|3
4778086|NCT01490840|16484407|P1|Phase 2|Withdrawal by Subject|4
4778087|NCT01490840|16484406|P2|Phase 1|Visit 6a omitted|0
4778088|NCT01490840|16484407|P1|Phase 1|Visit 6a omitted|1
4778089|NCT01490840|16484406|P2|Phase 1|Withdrawal by Subject|5
4778090|NCT01490840|16484407|P1|Phase 1|Withdrawal by Subject|6
4778091|NCT01490840|16484406|P2|Phase 1|Adverse Event|1
4778092|NCT01490840|16484407|P1|Phase 1|Adverse Event|2
4778093|NCT01490840|16484406|P2|Phase 1|Lost to Follow-up|0
4778094|NCT01490840|16484407|P1|Phase 1|Lost to Follow-up|1
4778095|NCT01490814|16484431|P2|Overall Study|Withdrawal by Subject|5
4778096|NCT01490814|16484432|P1|Overall Study|Withdrawal by Subject|0
4778097|NCT01490814|16484431|P2|Overall Study|Physician Decision|0
4778098|NCT01490814|16484432|P1|Overall Study|Physician Decision|1
4778099|NCT01490814|16484431|P2|Overall Study|Inclusion/Exclusion Criteria Violation|3
4778100|NCT01490814|16484432|P1|Overall Study|Inclusion/Exclusion Criteria Violation|3
4778101|NCT01490697|16484475|P2|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2
4778102|NCT01490697|16484476|P1|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1
4778103|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Withdrawal by Subject|1
4778104|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Withdrawal by Subject|1
4778105|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Withdrawal by Subject|1
4778106|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778107|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778108|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778109|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778110|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778111|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778112|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778113|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778114|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778115|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778116|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778117|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778118|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778119|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778120|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778121|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778122|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Withdrawal by Subject|0
4778123|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Protocol Violation|0
4778124|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Protocol Violation|1
4778125|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Protocol Violation|0
4778126|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Protocol Violation|0
4778127|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Protocol Violation|0
4778128|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Protocol Violation|0
4778205|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Death|0
4778129|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Protocol Violation|0
4778130|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Protocol Violation|0
4778131|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Protocol Violation|0
4778132|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Protocol Violation|0
4778133|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Protocol Violation|0
4778134|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Protocol Violation|0
4778135|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Protocol Violation|0
4778136|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Protocol Violation|0
4778137|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Protocol Violation|0
4778138|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Protocol Violation|0
4778139|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Protocol Violation|0
4778140|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Protocol Violation|0
4778141|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Protocol Violation|0
4778142|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Protocol Violation|0
4778143|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Physician Decision|1
4778144|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Physician Decision|1
4778145|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Physician Decision|0
4778146|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Physician Decision|0
4778147|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Physician Decision|0
4778148|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Physician Decision|0
4778149|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Physician Decision|0
4778150|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Physician Decision|0
4778151|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Physician Decision|0
4778152|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Physician Decision|0
4778153|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Physician Decision|0
4778154|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Physician Decision|0
4778155|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Physician Decision|0
4778156|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Physician Decision|0
4778157|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Physician Decision|0
4778158|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Physician Decision|0
4778159|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Physician Decision|0
4778160|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Physician Decision|0
4778161|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Physician Decision|0
4778162|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Physician Decision|0
4778163|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Lost to Follow-up|0
4778164|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Lost to Follow-up|1
4778165|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Lost to Follow-up|0
4778166|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Lost to Follow-up|0
4778167|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Lost to Follow-up|0
4778168|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Lost to Follow-up|0
4778169|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Lost to Follow-up|0
4778170|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Lost to Follow-up|0
4778171|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Lost to Follow-up|0
4778172|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Lost to Follow-up|0
4778173|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Lost to Follow-up|0
4778174|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Lost to Follow-up|0
4778175|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Lost to Follow-up|0
4778176|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Lost to Follow-up|0
4778177|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Lost to Follow-up|0
4778178|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Lost to Follow-up|0
4778179|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Lost to Follow-up|0
4778180|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Lost to Follow-up|0
4778181|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Lost to Follow-up|0
4778182|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Lost to Follow-up|0
4778183|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Lack of Efficacy|2
4778184|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Lack of Efficacy|1
4778185|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Lack of Efficacy|3
4778186|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Lack of Efficacy|0
4778187|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Lack of Efficacy|0
4778188|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Lack of Efficacy|0
4778189|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Lack of Efficacy|0
4778190|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Lack of Efficacy|0
4778191|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Lack of Efficacy|0
4778192|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Lack of Efficacy|0
4778193|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Lack of Efficacy|0
4778194|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Lack of Efficacy|0
4778195|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Lack of Efficacy|0
4778196|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Lack of Efficacy|0
4778197|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Lack of Efficacy|0
4778198|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Lack of Efficacy|0
4778199|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Lack of Efficacy|0
4778200|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Lack of Efficacy|0
4778201|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Lack of Efficacy|0
4778202|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Lack of Efficacy|0
4778203|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Death|0
4778204|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Death|1
4778206|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Death|0
4778207|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Death|0
4778208|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Death|0
4778209|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Death|0
4778210|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Death|0
4778211|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Death|0
4778212|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Death|0
4778213|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Death|0
4778214|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Death|0
4778215|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Death|0
4778216|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Death|0
4778217|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Death|0
4778218|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Death|0
4778219|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Death|0
4778220|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Death|0
4778221|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Death|0
4778222|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Death|0
4778223|NCT01490632|16484496|P20|Part D: Re-Treatment Period|Adverse Event|3
4778224|NCT01490632|16484497|P19|Part D: Re-Treatment Period|Adverse Event|1
4778225|NCT01490632|16484498|P18|Part D: Re-Treatment Period|Adverse Event|1
4778226|NCT01490632|16484499|P17|Part D: Re-Treatment Period|Adverse Event|0
4778227|NCT01490632|16484500|P16|Part D: Re-Treatment Period|Adverse Event|0
4778228|NCT01490632|16484501|P15|Part D: Re-Treatment Period|Adverse Event|0
4778229|NCT01490632|16484502|P14|Part D: Re-Treatment Period|Adverse Event|0
4778230|NCT01490632|16484503|P13|Part D: Re-Treatment Period|Adverse Event|0
4778231|NCT01490632|16484504|P12|Part D: Re-Treatment Period|Adverse Event|0
4778232|NCT01490632|16484505|P11|Part D: Re-Treatment Period|Adverse Event|0
4778233|NCT01490632|16484506|P10|Part D: Re-Treatment Period|Adverse Event|0
4778234|NCT01490632|16484507|P9|Part D: Re-Treatment Period|Adverse Event|0
4778235|NCT01490632|16484508|P8|Part D: Re-Treatment Period|Adverse Event|0
4778236|NCT01490632|16484509|P7|Part D: Re-Treatment Period|Adverse Event|0
4778237|NCT01490632|16484510|P6|Part D: Re-Treatment Period|Adverse Event|0
4778238|NCT01490632|16484511|P5|Part D: Re-Treatment Period|Adverse Event|0
4778239|NCT01490632|16484512|P4|Part D: Re-Treatment Period|Adverse Event|0
4778240|NCT01490632|16484513|P3|Part D: Re-Treatment Period|Adverse Event|0
4778241|NCT01490632|16484514|P2|Part D: Re-Treatment Period|Adverse Event|0
4778242|NCT01490632|16484515|P1|Part D: Re-Treatment Period|Adverse Event|0
4778243|NCT01490632|16484496|P20|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778244|NCT01490632|16484497|P19|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778245|NCT01490632|16484498|P18|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778246|NCT01490632|16484499|P17|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778247|NCT01490632|16484500|P16|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34
4778248|NCT01490632|16484501|P15|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14
4778249|NCT01490632|16484502|P14|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9
4778250|NCT01490632|16484503|P13|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5
4778251|NCT01490632|16484504|P12|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778252|NCT01490632|16484505|P11|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778253|NCT01490632|16484506|P10|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778254|NCT01490632|16484507|P9|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778255|NCT01490632|16484508|P8|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778256|NCT01490632|16484509|P7|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778257|NCT01490632|16484510|P6|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778258|NCT01490632|16484511|P5|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778259|NCT01490632|16484512|P4|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778260|NCT01490632|16484513|P3|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778261|NCT01490632|16484514|P2|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778262|NCT01490632|16484515|P1|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0
4778263|NCT01490632|16484496|P20|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778264|NCT01490632|16484497|P19|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778265|NCT01490632|16484498|P18|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778266|NCT01490632|16484499|P17|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778267|NCT01490632|16484500|P16|Part C: Washout or Step-Down Period|Withdrawal by Subject|1
4778268|NCT01490632|16484501|P15|Part C: Washout or Step-Down Period|Withdrawal by Subject|2
4778269|NCT01490632|16484502|P14|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778270|NCT01490632|16484503|P13|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778271|NCT01490632|16484504|P12|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778272|NCT01490632|16484505|P11|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778273|NCT01490632|16484506|P10|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778274|NCT01490632|16484507|P9|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778275|NCT01490632|16484508|P8|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778276|NCT01490632|16484509|P7|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778277|NCT01490632|16484510|P6|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778278|NCT01490632|16484511|P5|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778644|NCT01490125|16484957|P6|Period II|Lost to Follow-up|0
4778279|NCT01490632|16484512|P4|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778280|NCT01490632|16484513|P3|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778281|NCT01490632|16484514|P2|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778282|NCT01490632|16484515|P1|Part C: Washout or Step-Down Period|Withdrawal by Subject|0
4778283|NCT01490632|16484496|P20|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778284|NCT01490632|16484497|P19|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778285|NCT01490632|16484498|P18|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778286|NCT01490632|16484499|P17|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778287|NCT01490632|16484500|P16|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778288|NCT01490632|16484501|P15|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778289|NCT01490632|16484502|P14|Part C: Washout or Step-Down Period|Lost to Follow-up|1
4778290|NCT01490632|16484503|P13|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778291|NCT01490632|16484504|P12|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778292|NCT01490632|16484505|P11|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778293|NCT01490632|16484506|P10|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778294|NCT01490632|16484507|P9|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778295|NCT01490632|16484508|P8|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778296|NCT01490632|16484509|P7|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778297|NCT01490632|16484510|P6|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778298|NCT01490632|16484511|P5|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778299|NCT01490632|16484512|P4|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778300|NCT01490632|16484513|P3|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778301|NCT01490632|16484514|P2|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778302|NCT01490632|16484515|P1|Part C: Washout or Step-Down Period|Lost to Follow-up|0
4778303|NCT01490632|16484496|P20|Part C: Washout or Step-Down Period|Adverse Event|0
4778304|NCT01490632|16484497|P19|Part C: Washout or Step-Down Period|Adverse Event|0
4778305|NCT01490632|16484498|P18|Part C: Washout or Step-Down Period|Adverse Event|0
4778306|NCT01490632|16484499|P17|Part C: Washout or Step-Down Period|Adverse Event|0
4778307|NCT01490632|16484500|P16|Part C: Washout or Step-Down Period|Adverse Event|2
4778308|NCT01490632|16484501|P15|Part C: Washout or Step-Down Period|Adverse Event|2
4778309|NCT01490632|16484502|P14|Part C: Washout or Step-Down Period|Adverse Event|0
4778310|NCT01490632|16484503|P13|Part C: Washout or Step-Down Period|Adverse Event|0
4778311|NCT01490632|16484504|P12|Part C: Washout or Step-Down Period|Adverse Event|0
4778312|NCT01490632|16484505|P11|Part C: Washout or Step-Down Period|Adverse Event|0
4778313|NCT01490632|16484506|P10|Part C: Washout or Step-Down Period|Adverse Event|0
4778314|NCT01490632|16484507|P9|Part C: Washout or Step-Down Period|Adverse Event|0
4778315|NCT01490632|16484508|P8|Part C: Washout or Step-Down Period|Adverse Event|0
4778316|NCT01490632|16484509|P7|Part C: Washout or Step-Down Period|Adverse Event|0
4778317|NCT01490632|16484510|P6|Part C: Washout or Step-Down Period|Adverse Event|0
4778318|NCT01490632|16484511|P5|Part C: Washout or Step-Down Period|Adverse Event|0
4778319|NCT01490632|16484512|P4|Part C: Washout or Step-Down Period|Adverse Event|0
4778320|NCT01490632|16484513|P3|Part C: Washout or Step-Down Period|Adverse Event|0
4778321|NCT01490632|16484514|P2|Part C: Washout or Step-Down Period|Adverse Event|0
4778322|NCT01490632|16484515|P1|Part C: Washout or Step-Down Period|Adverse Event|0
4778323|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778324|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778325|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778326|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778327|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778328|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778329|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778330|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778331|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5
4778332|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16
4778333|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19
4778334|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8
4778335|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
4778336|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6
4778337|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1
4778338|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778339|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778340|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778341|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778342|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0
4778343|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778344|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778345|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778346|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778347|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778348|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778349|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778350|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778351|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Withdrawal by Subject|2
4778352|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
4778353|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778354|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
4778355|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778356|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Withdrawal by Subject|1
4778357|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778358|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778359|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778360|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778361|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778362|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Withdrawal by Subject|0
4778363|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778364|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778365|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778366|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778367|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778368|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778369|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778370|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778371|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778372|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778373|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778374|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778375|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778376|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778377|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Sponsor Decision|1
4778378|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778379|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778380|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778381|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778382|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Sponsor Decision|0
4778383|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Physician Decision|0
4778384|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Physician Decision|0
4778385|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Physician Decision|0
4778386|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Physician Decision|0
4778387|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Physician Decision|0
4778388|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Physician Decision|0
4778389|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Physician Decision|0
4778390|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Physician Decision|0
4778391|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Physician Decision|0
4778392|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Physician Decision|0
4778393|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Physician Decision|0
4778394|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Physician Decision|0
4778395|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Physician Decision|0
4778396|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Physician Decision|1
4778397|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Physician Decision|0
4778398|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Physician Decision|0
4778399|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Physician Decision|0
4778400|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Physician Decision|0
4778401|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Physician Decision|0
4778402|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Physician Decision|0
4778403|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778404|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778405|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778406|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778407|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778408|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778409|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778410|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778411|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778412|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778413|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Lost to Follow-up|1
4778414|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778415|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778416|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Lost to Follow-up|2
4778417|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778418|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778419|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778420|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778421|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778422|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Lost to Follow-up|0
4778423|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778424|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778425|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778426|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778427|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778428|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778429|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778430|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778431|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778432|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Lack of Efficacy|1
4778433|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Lack of Efficacy|3
4778434|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Lack of Efficacy|1
4778435|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778436|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Lack of Efficacy|1
4778437|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778438|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778439|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778440|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778441|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778442|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Lack of Efficacy|0
4778443|NCT01490632|16484496|P20|Part B: Extension or Step-Up Period|Adverse Event|0
4778444|NCT01490632|16484497|P19|Part B: Extension or Step-Up Period|Adverse Event|0
4778445|NCT01490632|16484498|P18|Part B: Extension or Step-Up Period|Adverse Event|0
4778446|NCT01490632|16484499|P17|Part B: Extension or Step-Up Period|Adverse Event|0
4778447|NCT01490632|16484500|P16|Part B: Extension or Step-Up Period|Adverse Event|0
4778448|NCT01490632|16484501|P15|Part B: Extension or Step-Up Period|Adverse Event|0
4778449|NCT01490632|16484502|P14|Part B: Extension or Step-Up Period|Adverse Event|0
4778450|NCT01490632|16484503|P13|Part B: Extension or Step-Up Period|Adverse Event|0
4778451|NCT01490632|16484504|P12|Part B: Extension or Step-Up Period|Adverse Event|1
4778452|NCT01490632|16484505|P11|Part B: Extension or Step-Up Period|Adverse Event|3
4778453|NCT01490632|16484506|P10|Part B: Extension or Step-Up Period|Adverse Event|2
4778454|NCT01490632|16484507|P9|Part B: Extension or Step-Up Period|Adverse Event|0
4778455|NCT01490632|16484508|P8|Part B: Extension or Step-Up Period|Adverse Event|0
4778456|NCT01490632|16484509|P7|Part B: Extension or Step-Up Period|Adverse Event|2
4778457|NCT01490632|16484510|P6|Part B: Extension or Step-Up Period|Adverse Event|2
4778458|NCT01490632|16484511|P5|Part B: Extension or Step-Up Period|Adverse Event|0
4778459|NCT01490632|16484512|P4|Part B: Extension or Step-Up Period|Adverse Event|0
4778460|NCT01490632|16484513|P3|Part B: Extension or Step-Up Period|Adverse Event|0
4778461|NCT01490632|16484514|P2|Part B: Extension or Step-Up Period|Adverse Event|0
4778462|NCT01490632|16484515|P1|Part B: Extension or Step-Up Period|Adverse Event|0
4778463|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778464|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778465|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778466|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778467|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778468|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778469|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778470|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778471|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778472|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778473|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778474|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778475|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778476|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778477|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778478|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9
4778479|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778480|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778481|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778482|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0
4778483|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778484|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778485|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778486|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778487|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778488|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778489|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778490|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778491|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778492|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778493|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778494|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778495|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778496|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778497|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778498|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Withdrawal by Subject|2
4778499|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Withdrawal by Subject|1
4778500|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Withdrawal by Subject|0
4778501|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Withdrawal by Subject|2
4778502|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Withdrawal by Subject|2
4778503|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Sponsor Decision|0
4778504|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Sponsor Decision|0
4778505|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Sponsor Decision|0
4778506|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Sponsor Decision|0
4778507|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Sponsor Decision|0
4778508|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Sponsor Decision|0
4778509|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Sponsor Decision|0
4778510|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Sponsor Decision|0
4778511|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Sponsor Decision|0
4778512|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Sponsor Decision|0
4778513|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Sponsor Decision|0
4778514|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Sponsor Decision|0
4778515|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Sponsor Decision|0
4778516|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Sponsor Decision|0
4778517|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Sponsor Decision|0
4778518|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Sponsor Decision|0
4778519|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Sponsor Decision|0
4778520|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Sponsor Decision|0
4778521|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Sponsor Decision|0
4778522|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Sponsor Decision|2
4778523|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Physician Decision|0
4778524|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Physician Decision|0
4778525|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Physician Decision|0
4778526|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Physician Decision|0
4778527|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Physician Decision|0
4778528|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Physician Decision|0
4778529|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Physician Decision|0
4778530|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Physician Decision|0
4778531|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Physician Decision|0
4778532|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Physician Decision|0
4778533|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Physician Decision|0
4778534|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Physician Decision|0
4778535|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Physician Decision|0
4778536|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Physician Decision|0
4778537|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Physician Decision|0
4778538|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Physician Decision|0
4778539|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Physician Decision|1
4778540|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Physician Decision|0
4778541|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Physician Decision|1
4778542|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Physician Decision|0
4778543|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Lost to Follow-up|0
4778544|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Lost to Follow-up|0
4778545|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Lost to Follow-up|0
4778546|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Lost to Follow-up|0
4778547|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Lost to Follow-up|0
4778548|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Lost to Follow-up|0
4778549|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Lost to Follow-up|0
4778550|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Lost to Follow-up|0
4778551|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Lost to Follow-up|0
4778552|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Lost to Follow-up|0
4778553|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Lost to Follow-up|0
4778554|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Lost to Follow-up|0
4778555|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Lost to Follow-up|0
4778556|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Lost to Follow-up|0
4778557|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Lost to Follow-up|0
4778558|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Lost to Follow-up|2
4778559|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Lost to Follow-up|1
4778560|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Lost to Follow-up|1
4778561|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Lost to Follow-up|0
4778562|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Lost to Follow-up|0
4778563|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Lack of Efficacy|0
4778564|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Lack of Efficacy|0
4778565|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Lack of Efficacy|0
4778566|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Lack of Efficacy|0
4778567|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Lack of Efficacy|0
4778568|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Lack of Efficacy|0
4778569|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Lack of Efficacy|0
4778570|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Lack of Efficacy|0
4778571|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Lack of Efficacy|0
4778572|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Lack of Efficacy|0
4778573|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Lack of Efficacy|0
4778574|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Lack of Efficacy|0
4778575|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Lack of Efficacy|0
4778576|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Lack of Efficacy|0
4778577|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Lack of Efficacy|0
4778578|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Lack of Efficacy|0
4778579|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Lack of Efficacy|2
4778580|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Lack of Efficacy|2
4778581|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Lack of Efficacy|1
4778582|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Lack of Efficacy|3
4778583|NCT01490632|16484496|P20|Part A: Initial Treatment Period|Adverse Event|0
4778584|NCT01490632|16484497|P19|Part A: Initial Treatment Period|Adverse Event|0
4778585|NCT01490632|16484498|P18|Part A: Initial Treatment Period|Adverse Event|0
4778586|NCT01490632|16484499|P17|Part A: Initial Treatment Period|Adverse Event|0
4778587|NCT01490632|16484500|P16|Part A: Initial Treatment Period|Adverse Event|0
4778588|NCT01490632|16484501|P15|Part A: Initial Treatment Period|Adverse Event|0
4778589|NCT01490632|16484502|P14|Part A: Initial Treatment Period|Adverse Event|0
4778590|NCT01490632|16484503|P13|Part A: Initial Treatment Period|Adverse Event|0
4778591|NCT01490632|16484504|P12|Part A: Initial Treatment Period|Adverse Event|0
4778592|NCT01490632|16484505|P11|Part A: Initial Treatment Period|Adverse Event|0
4778593|NCT01490632|16484506|P10|Part A: Initial Treatment Period|Adverse Event|0
4778594|NCT01490632|16484507|P9|Part A: Initial Treatment Period|Adverse Event|0
4778595|NCT01490632|16484508|P8|Part A: Initial Treatment Period|Adverse Event|0
4778596|NCT01490632|16484509|P7|Part A: Initial Treatment Period|Adverse Event|0
4778597|NCT01490632|16484510|P6|Part A: Initial Treatment Period|Adverse Event|0
4778598|NCT01490632|16484511|P5|Part A: Initial Treatment Period|Adverse Event|4
4778599|NCT01490632|16484512|P4|Part A: Initial Treatment Period|Adverse Event|4
4778600|NCT01490632|16484513|P3|Part A: Initial Treatment Period|Adverse Event|2
4778601|NCT01490632|16484514|P2|Part A: Initial Treatment Period|Adverse Event|0
4778602|NCT01490632|16484515|P1|Part A: Initial Treatment Period|Adverse Event|0
4778603|NCT01490580|16484645|P2|Overall Study|Parents withdrew consent|2
4778604|NCT01490580|16484646|P1|Overall Study|Parents withdrew consent|0
4778605|NCT01490294|16484693|P4|Overall Study|Adverse Event|0
4778606|NCT01490294|16484694|P3|Overall Study|Adverse Event|0
4778607|NCT01490294|16484695|P2|Overall Study|Adverse Event|0
4778608|NCT01490294|16484696|P1|Overall Study|Adverse Event|1
4778609|NCT01490294|16484693|P4|Overall Study|Prematurely discontinuation|1
4778610|NCT01490294|16484694|P3|Overall Study|Prematurely discontinuation|1
4778611|NCT01490294|16484695|P2|Overall Study|Prematurely discontinuation|0
4778612|NCT01490294|16484696|P1|Overall Study|Prematurely discontinuation|4
4778613|NCT01490190|16484930|P1|Overall Study|Ring expulsion|2
4778614|NCT01490190|16484930|P1|Overall Study|Inconvenience|1
4778615|NCT01490190|16484930|P1|Overall Study|Relocation|1
4778616|NCT01490190|16484930|P1|Overall Study|Lost to Follow-up|13
4778617|NCT01490190|16484930|P1|Overall Study|Protocol Violation|5
4778618|NCT01490190|16484930|P1|Overall Study|Adverse Event|17
4778619|NCT01490190|16484930|P1|Overall Study|Withdrawal by Subject|9
4778620|NCT01490125|16484957|P6|Period III|Lack of Efficacy|0
4778621|NCT01490125|16484958|P5|Period III|Lack of Efficacy|1
4778622|NCT01490125|16484959|P4|Period III|Lack of Efficacy|0
4778623|NCT01490125|16484960|P3|Period III|Lack of Efficacy|0
4778624|NCT01490125|16484961|P2|Period III|Lack of Efficacy|0
4778625|NCT01490125|16484962|P1|Period III|Lack of Efficacy|0
4778626|NCT01490125|16484957|P6|Period III|Death|0
4778627|NCT01490125|16484958|P5|Period III|Death|0
4778628|NCT01490125|16484959|P4|Period III|Death|1
4778629|NCT01490125|16484960|P3|Period III|Death|0
4778630|NCT01490125|16484961|P2|Period III|Death|0
4778631|NCT01490125|16484962|P1|Period III|Death|0
4778632|NCT01490125|16484957|P6|Period III|Adverse Event|0
4778633|NCT01490125|16484958|P5|Period III|Adverse Event|0
4778634|NCT01490125|16484959|P4|Period III|Adverse Event|1
4778635|NCT01490125|16484960|P3|Period III|Adverse Event|0
4778636|NCT01490125|16484961|P2|Period III|Adverse Event|1
4778637|NCT01490125|16484962|P1|Period III|Adverse Event|3
4778638|NCT01490125|16484957|P6|Period II|Withdrawal by Subject|0
4778639|NCT01490125|16484958|P5|Period II|Withdrawal by Subject|0
4778640|NCT01490125|16484959|P4|Period II|Withdrawal by Subject|0
4778641|NCT01490125|16484960|P3|Period II|Withdrawal by Subject|0
4778642|NCT01490125|16484961|P2|Period II|Withdrawal by Subject|0
4778643|NCT01490125|16484962|P1|Period II|Withdrawal by Subject|1
4778645|NCT01490125|16484958|P5|Period II|Lost to Follow-up|0
4778646|NCT01490125|16484959|P4|Period II|Lost to Follow-up|0
4778647|NCT01490125|16484960|P3|Period II|Lost to Follow-up|0
4778648|NCT01490125|16484961|P2|Period II|Lost to Follow-up|1
4778649|NCT01490125|16484962|P1|Period II|Lost to Follow-up|0
4778650|NCT01490125|16484957|P6|Period II|Protocol Violation|0
4778651|NCT01490125|16484958|P5|Period II|Protocol Violation|0
4778652|NCT01490125|16484959|P4|Period II|Protocol Violation|1
4778653|NCT01490125|16484960|P3|Period II|Protocol Violation|1
4778654|NCT01490125|16484961|P2|Period II|Protocol Violation|0
4778655|NCT01490125|16484962|P1|Period II|Protocol Violation|0
4778656|NCT01490125|16484957|P6|Period II|Adverse Event|2
4778657|NCT01490125|16484958|P5|Period II|Adverse Event|4
4778658|NCT01490125|16484959|P4|Period II|Adverse Event|2
4778659|NCT01490125|16484960|P3|Period II|Adverse Event|2
4778660|NCT01490125|16484961|P2|Period II|Adverse Event|3
4778661|NCT01490125|16484962|P1|Period II|Adverse Event|2
4778662|NCT01490125|16484957|P6|Period I|Withdrawal by Subject|1
4778663|NCT01490125|16484958|P5|Period I|Withdrawal by Subject|2
4778664|NCT01490125|16484959|P4|Period I|Withdrawal by Subject|1
4778665|NCT01490125|16484960|P3|Period I|Withdrawal by Subject|2
4778666|NCT01490125|16484961|P2|Period I|Withdrawal by Subject|3
4778667|NCT01490125|16484962|P1|Period I|Withdrawal by Subject|1
4778668|NCT01490125|16484957|P6|Period I|Protocol Violation|0
4778669|NCT01490125|16484958|P5|Period I|Protocol Violation|0
4778670|NCT01490125|16484959|P4|Period I|Protocol Violation|1
4778671|NCT01490125|16484960|P3|Period I|Protocol Violation|1
4778672|NCT01490125|16484961|P2|Period I|Protocol Violation|1
4778673|NCT01490125|16484962|P1|Period I|Protocol Violation|1
4778674|NCT01490125|16484957|P6|Period I|Adverse Event|4
4778675|NCT01490125|16484958|P5|Period I|Adverse Event|2
4778676|NCT01490125|16484959|P4|Period I|Adverse Event|3
4778677|NCT01490125|16484960|P3|Period I|Adverse Event|1
4778678|NCT01490125|16484961|P2|Period I|Adverse Event|1
4778679|NCT01490125|16484962|P1|Period I|Adverse Event|4
4778680|NCT01490086|16484990|P5|Overall Study|Subject left hospital|0
4778681|NCT01490086|16484991|P4|Overall Study|Subject left hospital|1
4778682|NCT01490086|16484992|P3|Overall Study|Subject left hospital|0
4778683|NCT01490086|16484993|P2|Overall Study|Subject left hospital|1
4778684|NCT01490086|16484994|P1|Overall Study|Subject left hospital|0
4778685|NCT01490086|16484990|P5|Overall Study|Subject uncontrollable and abusive|0
4778686|NCT01490086|16484991|P4|Overall Study|Subject uncontrollable and abusive|0
4778687|NCT01490086|16484992|P3|Overall Study|Subject uncontrollable and abusive|0
4778688|NCT01490086|16484993|P2|Overall Study|Subject uncontrollable and abusive|1
4778689|NCT01490086|16484994|P1|Overall Study|Subject uncontrollable and abusive|0
4778690|NCT01490086|16484990|P5|Overall Study|Worsening of symptoms|0
4778691|NCT01490086|16484991|P4|Overall Study|Worsening of symptoms|1
4778692|NCT01490086|16484992|P3|Overall Study|Worsening of symptoms|0
4778693|NCT01490086|16484993|P2|Overall Study|Worsening of symptoms|1
4778694|NCT01490086|16484994|P1|Overall Study|Worsening of symptoms|0
4778695|NCT01490086|16484990|P5|Overall Study|Lack of Efficacy|8
4778696|NCT01490086|16484991|P4|Overall Study|Lack of Efficacy|0
4778697|NCT01490086|16484992|P3|Overall Study|Lack of Efficacy|1
4778698|NCT01490086|16484993|P2|Overall Study|Lack of Efficacy|3
4778699|NCT01490086|16484994|P1|Overall Study|Lack of Efficacy|0
4778700|NCT01490086|16484990|P5|Overall Study|Adverse Event|0
4778701|NCT01490086|16484991|P4|Overall Study|Adverse Event|2
4778702|NCT01490086|16484992|P3|Overall Study|Adverse Event|1
4778703|NCT01490086|16484993|P2|Overall Study|Adverse Event|0
4778704|NCT01490086|16484994|P1|Overall Study|Adverse Event|0
4778705|NCT01490086|16484990|P5|Overall Study|Physician Decision|1
4778706|NCT01490086|16484991|P4|Overall Study|Physician Decision|3
4778707|NCT01490086|16484992|P3|Overall Study|Physician Decision|2
4778708|NCT01490086|16484993|P2|Overall Study|Physician Decision|4
4778709|NCT01490086|16484994|P1|Overall Study|Physician Decision|3
4778710|NCT01490086|16484990|P5|Overall Study|Lost to Follow-up|1
4778711|NCT01490086|16484991|P4|Overall Study|Lost to Follow-up|0
4778712|NCT01490086|16484992|P3|Overall Study|Lost to Follow-up|0
4778713|NCT01490086|16484993|P2|Overall Study|Lost to Follow-up|0
4778714|NCT01490086|16484994|P1|Overall Study|Lost to Follow-up|0
4778715|NCT01490086|16484990|P5|Overall Study|Abnormal laboratory findings|0
4778716|NCT01490086|16484991|P4|Overall Study|Abnormal laboratory findings|0
4778717|NCT01490086|16484992|P3|Overall Study|Abnormal laboratory findings|0
4778718|NCT01490086|16484993|P2|Overall Study|Abnormal laboratory findings|0
4778719|NCT01490086|16484994|P1|Overall Study|Abnormal laboratory findings|1
4778720|NCT01490086|16484990|P5|Overall Study|Non-compliance|0
4778721|NCT01490086|16484991|P4|Overall Study|Non-compliance|0
4778722|NCT01490086|16484992|P3|Overall Study|Non-compliance|0
4778723|NCT01490086|16484993|P2|Overall Study|Non-compliance|1
4778724|NCT01490086|16484994|P1|Overall Study|Non-compliance|0
4778725|NCT01490086|16484990|P5|Overall Study|Consent withdrawn|1
4778726|NCT01490086|16484991|P4|Overall Study|Consent withdrawn|0
4778727|NCT01490086|16484992|P3|Overall Study|Consent withdrawn|3
4778728|NCT01490086|16484993|P2|Overall Study|Consent withdrawn|4
4778729|NCT01490086|16484994|P1|Overall Study|Consent withdrawn|4
4778730|NCT01490060|16485039|P4|Cycle 2|Adverse Event Related to Chemotherapy|0
4778731|NCT01490060|16485040|P3|Cycle 2|Adverse Event Related to Chemotherapy|0
4778732|NCT01490060|16485041|P2|Cycle 2|Adverse Event Related to Chemotherapy|0
4778733|NCT01490060|16485042|P1|Cycle 2|Adverse Event Related to Chemotherapy|1
4778734|NCT01490060|16485039|P4|Cycle 2|Non-Compliance|0
4778735|NCT01490060|16485040|P3|Cycle 2|Non-Compliance|1
4778736|NCT01490060|16485041|P2|Cycle 2|Non-Compliance|0
4778737|NCT01490060|16485042|P1|Cycle 2|Non-Compliance|0
4778738|NCT01490060|16485039|P4|Cycle 2|Change of Treatment|0
4778739|NCT01490060|16485040|P3|Cycle 2|Change of Treatment|0
4778740|NCT01490060|16485041|P2|Cycle 2|Change of Treatment|1
4778741|NCT01490060|16485042|P1|Cycle 2|Change of Treatment|1
4778742|NCT01490060|16485039|P4|Cycle 1|Treatment at Another Facility|1
4778743|NCT01490060|16485040|P3|Cycle 1|Treatment at Another Facility|0
4778744|NCT01490060|16485041|P2|Cycle 1|Treatment at Another Facility|0
4778745|NCT01490060|16485042|P1|Cycle 1|Treatment at Another Facility|0
4778746|NCT01490060|16485039|P4|Cycle 1|Withdrawal by Subject|1
4778747|NCT01490060|16485040|P3|Cycle 1|Withdrawal by Subject|0
4778748|NCT01490060|16485041|P2|Cycle 1|Withdrawal by Subject|0
4778749|NCT01490060|16485042|P1|Cycle 1|Withdrawal by Subject|0
4778750|NCT01490060|16485039|P4|Cycle 1|Insurance Denied|0
4778751|NCT01490060|16485040|P3|Cycle 1|Insurance Denied|2
4778752|NCT01490060|16485041|P2|Cycle 1|Insurance Denied|0
4778753|NCT01490060|16485042|P1|Cycle 1|Insurance Denied|0
4778754|NCT01490060|16485039|P4|Cycle 1|Change of Treatment|1
4778755|NCT01490060|16485040|P3|Cycle 1|Change of Treatment|1
4778756|NCT01490060|16485041|P2|Cycle 1|Change of Treatment|1
4778757|NCT01490060|16485042|P1|Cycle 1|Change of Treatment|0
4778758|NCT01489956|16485071|P3|Overall Study|Withdrawal by Subject|1
4778759|NCT01489956|16485072|P2|Overall Study|Withdrawal by Subject|0
4778760|NCT01489956|16485073|P1|Overall Study|Withdrawal by Subject|0
4778761|NCT01489956|16485071|P3|Overall Study|Lost to Follow-up|0
4778762|NCT01489956|16485072|P2|Overall Study|Lost to Follow-up|0
4778763|NCT01489956|16485073|P1|Overall Study|Lost to Follow-up|1
4778764|NCT01489891|16485110|P2|Overall Study|Endoscopy failure|0
4778765|NCT01489891|16485111|P1|Overall Study|Endoscopy failure|1
4778766|NCT01489527|16485266|P2|Overall Study|Not compliant|0
4778767|NCT01489527|16485267|P1|Overall Study|Not compliant|1
4778768|NCT01489527|16485266|P2|Overall Study|Procedures|0
4778769|NCT01489527|16485267|P1|Overall Study|Procedures|1
4778770|NCT01489527|16485266|P2|Overall Study|Lost to Follow-up|1
4778771|NCT01489527|16485267|P1|Overall Study|Lost to Follow-up|5
4778772|NCT01489527|16485266|P2|Overall Study|Withdrawal by Subject|4
4778773|NCT01489527|16485267|P1|Overall Study|Withdrawal by Subject|0
4778774|NCT01489527|16485266|P2|Overall Study|Participant moved|7
4778775|NCT01489527|16485267|P1|Overall Study|Participant moved|6
4778776|NCT01489527|16485266|P2|Overall Study|Pregnancy|14
4778777|NCT01489527|16485267|P1|Overall Study|Pregnancy|9
4778778|NCT01489358|16485284|P3|Overall Study|Lost to Follow-up|2
4778779|NCT01489358|16485285|P2|Overall Study|Lost to Follow-up|0
4778780|NCT01489358|16485286|P1|Overall Study|Lost to Follow-up|0
4778781|NCT01489254|16485336|P4|Open-label Extension Part|Other reasons for not completing study|5
4778782|NCT01489254|16485337|P3|Open-label Extension Part|Other reasons for not completing study|0
4778783|NCT01489254|16485338|P2|Open-label Extension Part|Other reasons for not completing study|0
4778784|NCT01489254|16485339|P1|Open-label Extension Part|Other reasons for not completing study|0
4778785|NCT01489254|16485336|P4|Open-label Extension Part|Lost to Follow-up|9
4778786|NCT01489254|16485337|P3|Open-label Extension Part|Lost to Follow-up|0
4778787|NCT01489254|16485338|P2|Open-label Extension Part|Lost to Follow-up|0
4778788|NCT01489254|16485339|P1|Open-label Extension Part|Lost to Follow-up|0
4778789|NCT01489254|16485336|P4|Open-label Extension Part|Protocol Violation|1
4778790|NCT01489254|16485337|P3|Open-label Extension Part|Protocol Violation|0
4778791|NCT01489254|16485338|P2|Open-label Extension Part|Protocol Violation|0
4778792|NCT01489254|16485339|P1|Open-label Extension Part|Protocol Violation|0
4778793|NCT01489254|16485336|P4|Open-label Extension Part|Withdrawal by Subject|30
4778794|NCT01489254|16485337|P3|Open-label Extension Part|Withdrawal by Subject|0
4778795|NCT01489254|16485338|P2|Open-label Extension Part|Withdrawal by Subject|0
4778796|NCT01489254|16485339|P1|Open-label Extension Part|Withdrawal by Subject|0
4778797|NCT01489254|16485336|P4|Open-label Extension Part|Pregnancy|3
4778798|NCT01489254|16485337|P3|Open-label Extension Part|Pregnancy|0
4778799|NCT01489254|16485338|P2|Open-label Extension Part|Pregnancy|0
4778800|NCT01489254|16485339|P1|Open-label Extension Part|Pregnancy|0
4778801|NCT01489254|16485336|P4|Open-label Extension Part|Adverse Event|10
4778802|NCT01489254|16485337|P3|Open-label Extension Part|Adverse Event|0
4778803|NCT01489254|16485338|P2|Open-label Extension Part|Adverse Event|0
4778804|NCT01489254|16485339|P1|Open-label Extension Part|Adverse Event|0
4778805|NCT01489254|16485336|P4|Double-blind Part|Other reasons for not completing study|0
4778806|NCT01489254|16485337|P3|Double-blind Part|Other reasons for not completing study|0
4778807|NCT01489254|16485338|P2|Double-blind Part|Other reasons for not completing study|6
4778808|NCT01489254|16485339|P1|Double-blind Part|Other reasons for not completing study|4
4778809|NCT01489254|16485336|P4|Double-blind Part|Lost to Follow-up|0
4778810|NCT01489254|16485337|P3|Double-blind Part|Lost to Follow-up|0
4778811|NCT01489254|16485338|P2|Double-blind Part|Lost to Follow-up|2
4778812|NCT01489254|16485339|P1|Double-blind Part|Lost to Follow-up|1
4778813|NCT01489254|16485336|P4|Double-blind Part|Withdrawal by Subject|0
4778814|NCT01489254|16485337|P3|Double-blind Part|Withdrawal by Subject|1
4778815|NCT01489254|16485338|P2|Double-blind Part|Withdrawal by Subject|20
4778816|NCT01489254|16485339|P1|Double-blind Part|Withdrawal by Subject|12
4778817|NCT01489254|16485336|P4|Double-blind Part|Pregnancy|0
4778818|NCT01489254|16485337|P3|Double-blind Part|Pregnancy|0
4778819|NCT01489254|16485338|P2|Double-blind Part|Pregnancy|3
4778820|NCT01489254|16485339|P1|Double-blind Part|Pregnancy|1
4778821|NCT01489254|16485336|P4|Double-blind Part|Adverse Event|0
4778822|NCT01489254|16485337|P3|Double-blind Part|Adverse Event|2
4778823|NCT01489254|16485338|P2|Double-blind Part|Adverse Event|2
4778824|NCT01489254|16485339|P1|Double-blind Part|Adverse Event|7
4778825|NCT01489189|16485350|P2|Overall Study|Missed Visit|4
4778826|NCT01489189|16485351|P1|Overall Study|Missed Visit|1
4778827|NCT01489189|16485350|P2|Overall Study|Death|8
4778828|NCT01489189|16485351|P1|Overall Study|Death|10
4778829|NCT01489189|16485350|P2|Overall Study|Withdrawal by Subject|23
4778830|NCT01489189|16485351|P1|Overall Study|Withdrawal by Subject|20
4778831|NCT01489111|16485376|P1|Overall Study|Withdrawal criterion|1
4778832|NCT01489020|16485397|P6|Overall Study|Concomitant disease|0
4778833|NCT01489020|16485398|P5|Overall Study|Concomitant disease|3
4778834|NCT01489020|16485399|P4|Overall Study|Concomitant disease|0
4778835|NCT01489020|16485400|P3|Overall Study|Concomitant disease|0
4778836|NCT01489020|16485401|P2|Overall Study|Concomitant disease|0
4778837|NCT01489020|16485402|P1|Overall Study|Concomitant disease|0
4778838|NCT01489020|16485397|P6|Overall Study|Adverse Event|0
4778839|NCT01489020|16485398|P5|Overall Study|Adverse Event|3
4778840|NCT01489020|16485399|P4|Overall Study|Adverse Event|0
4778841|NCT01489020|16485400|P3|Overall Study|Adverse Event|3
4778842|NCT01489020|16485401|P2|Overall Study|Adverse Event|0
4778843|NCT01489020|16485402|P1|Overall Study|Adverse Event|0
4778844|NCT01489020|16485397|P6|Overall Study|Withdrawal by Subject|0
4778845|NCT01489020|16485398|P5|Overall Study|Withdrawal by Subject|0
4778846|NCT01489020|16485399|P4|Overall Study|Withdrawal by Subject|0
4778847|NCT01489020|16485400|P3|Overall Study|Withdrawal by Subject|0
4778848|NCT01489020|16485401|P2|Overall Study|Withdrawal by Subject|0
4778849|NCT01489020|16485402|P1|Overall Study|Withdrawal by Subject|1
4778850|NCT01488994|16485436|P2|Overall Study|Withdrawal by Subject|1
4778851|NCT01488994|16485437|P1|Overall Study|Withdrawal by Subject|0
4778852|NCT01488890|16485528|P4|Overall Study|Withdrawal by Subject|2
4778853|NCT01488890|16485529|P3|Overall Study|Withdrawal by Subject|11
4778854|NCT01488890|16485530|P2|Overall Study|Withdrawal by Subject|10
4778855|NCT01488890|16485531|P1|Overall Study|Withdrawal by Subject|14
4778856|NCT01488890|16485528|P4|Overall Study|Lost to Follow-up|3
4778857|NCT01488890|16485529|P3|Overall Study|Lost to Follow-up|20
4778858|NCT01488890|16485530|P2|Overall Study|Lost to Follow-up|10
4778859|NCT01488890|16485531|P1|Overall Study|Lost to Follow-up|13
4778860|NCT01488890|16485528|P4|Overall Study|Protocol Violation|0
4778861|NCT01488890|16485529|P3|Overall Study|Protocol Violation|4
4778862|NCT01488890|16485530|P2|Overall Study|Protocol Violation|0
4778863|NCT01488890|16485531|P1|Overall Study|Protocol Violation|3
4778864|NCT01488890|16485528|P4|Overall Study|Serious adverse event|0
4778865|NCT01488890|16485529|P3|Overall Study|Serious adverse event|0
4778866|NCT01488890|16485530|P2|Overall Study|Serious adverse event|0
4778867|NCT01488890|16485531|P1|Overall Study|Serious adverse event|2
4778868|NCT01488578|16485609|P1|Overall Study|Protocol Violation|1836
4778869|NCT01488487|16485643|P1|Overall Study|Withdrawal by Subject|2
4778870|NCT01488487|16485643|P1|Overall Study|Death|1
4778871|NCT01488487|16485643|P1|Overall Study|Adverse Event|6
4778872|NCT01488448|16485652|P2|Overall Study|Protocol Violation|3
4778873|NCT01488448|16485653|P1|Overall Study|Protocol Violation|4
4778874|NCT01488448|16485652|P2|Overall Study|Physician Decision|9
4778875|NCT01488448|16485653|P1|Overall Study|Physician Decision|4
4778876|NCT01488448|16485652|P2|Overall Study|Adverse Event|4
4778877|NCT01488448|16485653|P1|Overall Study|Adverse Event|9
4778878|NCT01488448|16485652|P2|Overall Study|Withdrawal by Subject|1
4778879|NCT01488448|16485653|P1|Overall Study|Withdrawal by Subject|3
4778880|NCT01488370|16485695|P3|Overall Study|Protocol Violation|1
4778881|NCT01488370|16485696|P2|Overall Study|Protocol Violation|1
4778882|NCT01488370|16485697|P1|Overall Study|Protocol Violation|0
4778883|NCT01488097|16485756|P1|Overall Study|Lost to Follow-up|1
4778884|NCT01488071|16485769|P2|Overall Study|Administrative or Other Reason(s)|4
4778885|NCT01488071|16485770|P1|Overall Study|Administrative or Other Reason(s)|5
4778886|NCT01488071|16485769|P2|Overall Study|Lost to Follow-up|0
4778887|NCT01488071|16485770|P1|Overall Study|Lost to Follow-up|1
4778888|NCT01488071|16485769|P2|Overall Study|Withdrawal of Consent|12
4778889|NCT01488071|16485770|P1|Overall Study|Withdrawal of Consent|14
4778890|NCT01488071|16485769|P2|Overall Study|Protocol Violation|7
4778891|NCT01488071|16485770|P1|Overall Study|Protocol Violation|5
4778892|NCT01488071|16485769|P2|Overall Study|Non-compliance with study drug|0
4778893|NCT01488071|16485770|P1|Overall Study|Non-compliance with study drug|2
4778894|NCT01488071|16485769|P2|Overall Study|Lack of Efficacy|17
4778895|NCT01488071|16485770|P1|Overall Study|Lack of Efficacy|11
4778896|NCT01488071|16485769|P2|Overall Study|Adverse Event|23
4778897|NCT01488071|16485770|P1|Overall Study|Adverse Event|15
4778898|NCT01487863|16485850|P2|Overall Study|Death|19
4778899|NCT01487863|16485851|P1|Overall Study|Death|19
4778900|NCT01487577|16485868|P1|Overall Study|Became ineligible after signing consent|1
4778901|NCT01487525|16485882|P2|Overall Study|Withdrawal by Subject|1
4778902|NCT01487525|16485883|P1|Overall Study|Withdrawal by Subject|0
4778903|NCT01487265|16485899|P1|Overall Study|Still on Treatment|1
4778904|NCT01487265|16485899|P1|Overall Study|Death|2
4778905|NCT01487265|16485899|P1|Overall Study|Disease Progression|21
4778906|NCT01487265|16485899|P1|Overall Study|Withdrawal by Subject|5
4778907|NCT01487265|16485899|P1|Overall Study|Adverse Event|8
4778908|NCT01487200|16485911|P4|Overall Study|Withdrawal by Subject|0
4778909|NCT01487200|16485912|P3|Overall Study|Withdrawal by Subject|0
4778910|NCT01487200|16485913|P2|Overall Study|Withdrawal by Subject|1
4778911|NCT01487200|16485914|P1|Overall Study|Withdrawal by Subject|0
4778912|NCT01487161|16485944|P4|Overall Study|missing data|0
4778913|NCT01487161|16485945|P3|Overall Study|missing data|0
4778914|NCT01487161|16485946|P2|Overall Study|missing data|1
4778915|NCT01487161|16485947|P1|Overall Study|missing data|0
4778916|NCT01487161|16485944|P4|Overall Study|Withdrawal by Subject|2
4778917|NCT01487161|16485945|P3|Overall Study|Withdrawal by Subject|1
4778918|NCT01487161|16485946|P2|Overall Study|Withdrawal by Subject|1
4778919|NCT01487161|16485947|P1|Overall Study|Withdrawal by Subject|1
4778920|NCT01487161|16485944|P4|Overall Study|Adverse Event|0
4778921|NCT01487161|16485945|P3|Overall Study|Adverse Event|0
4778922|NCT01487161|16485946|P2|Overall Study|Adverse Event|0
4778923|NCT01487161|16485947|P1|Overall Study|Adverse Event|1
4778924|NCT01486966|16486012|P2|Overall Study|Withdrawal by Subject|1
4778925|NCT01486966|16486013|P1|Overall Study|Withdrawal by Subject|0
4778926|NCT01486966|16486012|P2|Overall Study|Adverse Event|1
4778927|NCT01486966|16486013|P1|Overall Study|Adverse Event|0
4778928|NCT01486927|16486037|P1|Overall Study|Subject did not reach 6 mo of treatment|1
4778929|NCT01486927|16486037|P1|Overall Study|Withdrawal by Subject|8
4778930|NCT01486927|16486037|P1|Overall Study|50 Exposure days not reached|2
4778931|NCT01486927|16486037|P1|Overall Study|Physician Decision|1
4778932|NCT01486927|16486037|P1|Overall Study|Knee surgery (prior to surgery substudy)|1
4778933|NCT01486758|16486075|P2|Overall Study|Lost to Follow-up|1
4778934|NCT01486758|16486076|P1|Overall Study|Lost to Follow-up|0
4778935|NCT01486446|16486143|P2|Overall Study|Adverse Event|0
4778936|NCT01486446|16486144|P1|Overall Study|Adverse Event|1
4778937|NCT01486316|16486167|P4|Overall Study|Death|0
4778938|NCT01486316|16486168|P3|Overall Study|Death|0
4778939|NCT01486316|16486169|P2|Overall Study|Death|1
4778940|NCT01486316|16486170|P1|Overall Study|Death|0
4778941|NCT01486316|16486167|P4|Overall Study|Physician Decision|0
4778942|NCT01486316|16486168|P3|Overall Study|Physician Decision|1
4778943|NCT01486316|16486169|P2|Overall Study|Physician Decision|0
4778944|NCT01486316|16486170|P1|Overall Study|Physician Decision|0
4778945|NCT01486316|16486167|P4|Overall Study|Withdrawal by Subject|0
4778946|NCT01486316|16486168|P3|Overall Study|Withdrawal by Subject|3
4778947|NCT01486316|16486169|P2|Overall Study|Withdrawal by Subject|0
4778948|NCT01486316|16486170|P1|Overall Study|Withdrawal by Subject|1
4778949|NCT01486316|16486167|P4|Overall Study|Not meeting eligibility criteria|0
4778950|NCT01486316|16486168|P3|Overall Study|Not meeting eligibility criteria|1
4778951|NCT01486316|16486169|P2|Overall Study|Not meeting eligibility criteria|0
4778952|NCT01486316|16486170|P1|Overall Study|Not meeting eligibility criteria|0
4778953|NCT01486316|16486167|P4|Overall Study|Device explanted with/without re-implant|2
4778954|NCT01486316|16486168|P3|Overall Study|Device explanted with/without re-implant|0
4778955|NCT01486316|16486169|P2|Overall Study|Device explanted with/without re-implant|2
4778956|NCT01486316|16486170|P1|Overall Study|Device explanted with/without re-implant|3
4778957|NCT01486264|16486182|P2|Overall Study|Not treated|1
4778958|NCT01486264|16486183|P1|Overall Study|Not treated|0
4778959|NCT01486264|16486182|P2|Overall Study|Other|11
4778960|NCT01486264|16486183|P1|Overall Study|Other|5
4778961|NCT01486264|16486182|P2|Overall Study|Lost to Follow-up|2
4778962|NCT01486264|16486183|P1|Overall Study|Lost to Follow-up|3
4778963|NCT01486264|16486182|P2|Overall Study|Protocol Violation|0
4778964|NCT01486264|16486183|P1|Overall Study|Protocol Violation|3
4778965|NCT01486264|16486182|P2|Overall Study|Physician Decision|1
4778966|NCT01486264|16486183|P1|Overall Study|Physician Decision|1
4778967|NCT01486264|16486182|P2|Overall Study|Withdrawal by Subject|18
4778968|NCT01486264|16486183|P1|Overall Study|Withdrawal by Subject|7
4778969|NCT01486264|16486182|P2|Overall Study|Lack of Efficacy|10
4778970|NCT01486264|16486183|P1|Overall Study|Lack of Efficacy|6
4778971|NCT01486264|16486182|P2|Overall Study|Adverse Event|3
4778972|NCT01486264|16486183|P1|Overall Study|Adverse Event|3
4778973|NCT01486264|16486182|P2|Overall Study|Death|1
4778974|NCT01486264|16486183|P1|Overall Study|Death|1
4778975|NCT01486238|16486215|P2|Overall Study|Lost to Follow-up|3
4778976|NCT01486238|16486216|P1|Overall Study|Lost to Follow-up|0
4778977|NCT01486238|16486215|P2|Overall Study|Withdrawal by Subject|1
4778978|NCT01486238|16486216|P1|Overall Study|Withdrawal by Subject|2
4778979|NCT01486238|16486215|P2|Overall Study|Death|2
4778980|NCT01486238|16486216|P1|Overall Study|Death|0
4778981|NCT01486199|16486224|P2|Two Year Period Between Study Days|Physician Decision|0
4778982|NCT01486199|16486225|P1|Two Year Period Between Study Days|Physician Decision|1
4778983|NCT01485991|16486245|P2|Overall Study|randomized but not treated|2
4778984|NCT01485991|16486246|P1|Overall Study|randomized but not treated|6
4778985|NCT01485991|16486245|P2|Overall Study|Withdrawal by Subject|20
4778986|NCT01485991|16486246|P1|Overall Study|Withdrawal by Subject|13
4778987|NCT01485991|16486245|P2|Overall Study|Lost to Follow-up|10
4778988|NCT01485991|16486246|P1|Overall Study|Lost to Follow-up|13
4778989|NCT01485991|16486245|P2|Overall Study|Adverse Event|4
4778990|NCT01485991|16486246|P1|Overall Study|Adverse Event|0
4778991|NCT01485887|16486256|P1|Overall Study|Primary disease markedly improved|1
4778992|NCT01485887|16486256|P1|Overall Study|Deterioration of primary disease|1
4778993|NCT01485887|16486256|P1|Overall Study|Adverse Event|8
4778994|NCT01485887|16486256|P1|Overall Study|Withdrawal by Subject|2
4778995|NCT01485796|16486268|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2
4778996|NCT01485796|16486268|P1|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3
4778997|NCT01485796|16486268|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6
4778998|NCT01485796|16486268|P1|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1
4778999|NCT01485796|16486268|P1|Period 2: Epoch 2|Switch to safety follow-up|26
4779000|NCT01485796|16486268|P1|Period 2: Epoch 2|Adverse Event|3
4779001|NCT01485796|16486268|P1|Period 2: Epoch 2|Withdrawal by Subject|6
4779002|NCT01485796|16486268|P1|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1
4779003|NCT01485640|16486290|P1|Overall Study|Terminated by Sponsor|95
4779004|NCT01485640|16486290|P1|Overall Study|Withdrawal by Subject|14
4779005|NCT01485640|16486290|P1|Overall Study|Protocol Violation|1
4779006|NCT01485640|16486290|P1|Overall Study|Lack of Efficacy|2
4779007|NCT01485640|16486290|P1|Overall Study|Adverse Event|10
4779008|NCT01485627|16486297|P2|Overall Study|caregiver was not bereaved|35
4779009|NCT01485627|16486298|P1|Overall Study|caregiver was not bereaved|42
4779010|NCT01485627|16486297|P2|Overall Study|Caregiver died|0
4779011|NCT01485627|16486298|P1|Overall Study|Caregiver died|1
4779012|NCT01485627|16486297|P2|Overall Study|Caregiver lost to follow up|12
4779013|NCT01485627|16486298|P1|Overall Study|Caregiver lost to follow up|11
4779014|NCT01485627|16486297|P2|Overall Study|Caregiver withdrew|3
4779015|NCT01485627|16486298|P1|Overall Study|Caregiver withdrew|3
4779016|NCT01485627|16486297|P2|Overall Study|Patient lost to followup|1
4779017|NCT01485627|16486298|P1|Overall Study|Patient lost to followup|0
4779018|NCT01485627|16486297|P2|Overall Study|Patient died|1
4779019|NCT01485627|16486298|P1|Overall Study|Patient died|3
4779020|NCT01485627|16486297|P2|Overall Study|Patient withdrew|5
4779021|NCT01485627|16486298|P1|Overall Study|Patient withdrew|6
4779022|NCT01485536|16486316|P1|Overall Study|Adverse Event|1
4779023|NCT01485536|16486316|P1|Overall Study|Withdrawal by Subject|3
4779024|NCT01485354|16486334|P1|Overall Study|Withdrawal by Subject|5
4779025|NCT01485172|16486348|P6|Overall Study|Withdrawal by Subject|1
4779026|NCT01485172|16486349|P5|Overall Study|Withdrawal by Subject|1
4779027|NCT01485172|16486350|P4|Overall Study|Withdrawal by Subject|1
4779028|NCT01485172|16486351|P3|Overall Study|Withdrawal by Subject|0
4779029|NCT01485172|16486352|P2|Overall Study|Withdrawal by Subject|0
4779030|NCT01485172|16486353|P1|Overall Study|Withdrawal by Subject|2
4779031|NCT01485172|16486348|P6|Overall Study|Physician Decision|0
4779032|NCT01485172|16486349|P5|Overall Study|Physician Decision|1
4779033|NCT01485172|16486350|P4|Overall Study|Physician Decision|0
4779034|NCT01485172|16486351|P3|Overall Study|Physician Decision|0
4779035|NCT01485172|16486352|P2|Overall Study|Physician Decision|0
4779036|NCT01485172|16486353|P1|Overall Study|Physician Decision|0
4779037|NCT01485172|16486348|P6|Overall Study|Lost to Follow-up|1
4779038|NCT01485172|16486349|P5|Overall Study|Lost to Follow-up|0
4779039|NCT01485172|16486350|P4|Overall Study|Lost to Follow-up|0
4779040|NCT01485172|16486351|P3|Overall Study|Lost to Follow-up|1
4779041|NCT01485172|16486352|P2|Overall Study|Lost to Follow-up|0
4779042|NCT01485172|16486353|P1|Overall Study|Lost to Follow-up|0
4779043|NCT01485172|16486348|P6|Overall Study|Protocol defined stopping criteria|0
4779044|NCT01485172|16486349|P5|Overall Study|Protocol defined stopping criteria|1
4779045|NCT01485172|16486350|P4|Overall Study|Protocol defined stopping criteria|0
4779046|NCT01485172|16486351|P3|Overall Study|Protocol defined stopping criteria|0
4779047|NCT01485172|16486352|P2|Overall Study|Protocol defined stopping criteria|0
4779048|NCT01485172|16486353|P1|Overall Study|Protocol defined stopping criteria|1
4779049|NCT01485172|16486348|P6|Overall Study|Protocol Violation|0
4779050|NCT01485172|16486349|P5|Overall Study|Protocol Violation|1
4779051|NCT01485172|16486350|P4|Overall Study|Protocol Violation|5
4779052|NCT01485172|16486351|P3|Overall Study|Protocol Violation|4
4779053|NCT01485172|16486352|P2|Overall Study|Protocol Violation|0
4779054|NCT01485172|16486353|P1|Overall Study|Protocol Violation|0
4779055|NCT01485172|16486348|P6|Overall Study|Lack of Efficacy|0
4779056|NCT01485172|16486349|P5|Overall Study|Lack of Efficacy|0
4779057|NCT01485172|16486350|P4|Overall Study|Lack of Efficacy|0
4779058|NCT01485172|16486351|P3|Overall Study|Lack of Efficacy|0
4779059|NCT01485172|16486352|P2|Overall Study|Lack of Efficacy|0
4779060|NCT01485172|16486353|P1|Overall Study|Lack of Efficacy|2
4779061|NCT01485172|16486348|P6|Overall Study|Adverse Event|2
4779062|NCT01485172|16486349|P5|Overall Study|Adverse Event|1
4779063|NCT01485172|16486350|P4|Overall Study|Adverse Event|2
4779064|NCT01485172|16486351|P3|Overall Study|Adverse Event|2
4779065|NCT01485172|16486352|P2|Overall Study|Adverse Event|1
4779066|NCT01485172|16486353|P1|Overall Study|Adverse Event|2
4779067|NCT01485120|16486427|P1|Overall Study|Withdrawal by Subject|2
4779068|NCT01485094|16486435|P3|Overall Study|Withdrawal by Subject|0
4779069|NCT01485094|16486436|P2|Overall Study|Withdrawal by Subject|1
4779070|NCT01485094|16486437|P1|Overall Study|Withdrawal by Subject|1
4779071|NCT01485094|16486435|P3|Overall Study|Lost to Follow-up|0
4779072|NCT01485094|16486436|P2|Overall Study|Lost to Follow-up|0
4779073|NCT01485094|16486437|P1|Overall Study|Lost to Follow-up|1
4779074|NCT01485094|16486435|P3|Overall Study|Adverse Event|1
4779075|NCT01485094|16486436|P2|Overall Study|Adverse Event|1
4779076|NCT01485094|16486437|P1|Overall Study|Adverse Event|1
4779077|NCT01484977|16486482|P1|Overall Study|Lack of Compliance|1
4779078|NCT01484977|16486482|P1|Overall Study|Low White Blood Cell Count|1
4779079|NCT01484977|16486482|P1|Overall Study|Moving Overseas|1
4779080|NCT01484977|16486482|P1|Overall Study|Subject Protocol Non-compliant|1
4779081|NCT01484977|16486482|P1|Overall Study|Withdrawal by Subject|4
4779082|NCT01484977|16486482|P1|Overall Study|Lost to Follow-up|1
4779083|NCT01484977|16486482|P1|Overall Study|Protocol Violation|6
4779084|NCT01484977|16486482|P1|Overall Study|Lack of Efficacy|4
4779085|NCT01484977|16486482|P1|Overall Study|Adverse Event|8
4779086|NCT01484951|16486486|P1|Overall Study|Non-Compliance|1
4779087|NCT01484951|16486486|P1|Overall Study|Personal Reasons|1
4779088|NCT01484951|16486486|P1|Overall Study|Adverse Event|3
4779089|NCT01484938|16486491|P1|Overall Study|Noncompliance|1
4779090|NCT01484938|16486491|P1|Overall Study|Lost to Follow-up|1
4779091|NCT01484938|16486491|P1|Overall Study|Adverse Event|2
4779092|NCT01484912|16486498|P2|Overall Study|Physician Decision|1
4779093|NCT01484912|16486499|P1|Overall Study|Physician Decision|0
4779094|NCT01484912|16486498|P2|Overall Study|Withdrawal by Subject|0
4779095|NCT01484912|16486499|P1|Overall Study|Withdrawal by Subject|1
4779096|NCT01484873|16486509|P1|Overall Study|Withdrawal by Subject|2
4779097|NCT01484834|16486521|P4|Overall Study|Lost to Follow-up|4
4779098|NCT01484834|16486522|P3|Overall Study|Lost to Follow-up|1
4779099|NCT01484834|16486523|P2|Overall Study|Lost to Follow-up|8
4779100|NCT01484834|16486524|P1|Overall Study|Lost to Follow-up|5
4779101|NCT01484561|16486565|P2|Overall Study|Adverse Event|4
4779102|NCT01484561|16486566|P1|Overall Study|Adverse Event|1
4779103|NCT01484561|16486565|P2|Overall Study|Other|1
4779104|NCT01484561|16486566|P1|Overall Study|Other|1
4779105|NCT01484561|16486565|P2|Overall Study|Withdrawal by Subject|0
4779106|NCT01484561|16486566|P1|Overall Study|Withdrawal by Subject|3
4779107|NCT01484561|16486565|P2|Overall Study|Lost to Follow-up|0
4779108|NCT01484561|16486566|P1|Overall Study|Lost to Follow-up|1
4779109|NCT01484561|16486565|P2|Overall Study|Lack of Efficacy|1
4779110|NCT01484561|16486566|P1|Overall Study|Lack of Efficacy|3
4779111|NCT01484496|16486656|P4|Period 2|Other|6
4779112|NCT01484496|16486657|P3|Period 2|Other|9
4779113|NCT01484496|16486658|P2|Period 2|Other|0
4779114|NCT01484496|16486659|P1|Period 2|Other|0
4779115|NCT01484496|16486656|P4|Period 2|Adverse Event|13
4779116|NCT01484496|16486657|P3|Period 2|Adverse Event|5
4779117|NCT01484496|16486658|P2|Period 2|Adverse Event|0
4779118|NCT01484496|16486659|P1|Period 2|Adverse Event|0
4779119|NCT01484496|16486656|P4|Period 2|Lack of Efficacy|3
4779120|NCT01484496|16486657|P3|Period 2|Lack of Efficacy|1
4779121|NCT01484496|16486658|P2|Period 2|Lack of Efficacy|0
4779122|NCT01484496|16486659|P1|Period 2|Lack of Efficacy|0
4779123|NCT01484496|16486656|P4|Period 1|Unable to Visit Site|0
4779124|NCT01484496|16486657|P3|Period 1|Unable to Visit Site|0
4779125|NCT01484496|16486658|P2|Period 1|Unable to Visit Site|2
4779126|NCT01484496|16486659|P1|Period 1|Unable to Visit Site|0
4779127|NCT01484496|16486656|P4|Period 1|Lack of Compliance|0
4779128|NCT01484496|16486657|P3|Period 1|Lack of Compliance|0
4779129|NCT01484496|16486658|P2|Period 1|Lack of Compliance|1
4779130|NCT01484496|16486659|P1|Period 1|Lack of Compliance|2
4779131|NCT01484496|16486656|P4|Period 1|Treatment Failure|0
4779132|NCT01484496|16486657|P3|Period 1|Treatment Failure|0
4779133|NCT01484496|16486658|P2|Period 1|Treatment Failure|6
4779134|NCT01484496|16486659|P1|Period 1|Treatment Failure|3
4779135|NCT01484496|16486656|P4|Period 1|Positive Pregnancy|0
4779136|NCT01484496|16486657|P3|Period 1|Positive Pregnancy|0
4779137|NCT01484496|16486658|P2|Period 1|Positive Pregnancy|6
4779138|NCT01484496|16486659|P1|Period 1|Positive Pregnancy|1
4779139|NCT01484496|16486656|P4|Period 1|Lost to Follow-up|0
4779140|NCT01484496|16486657|P3|Period 1|Lost to Follow-up|0
4779141|NCT01484496|16486658|P2|Period 1|Lost to Follow-up|6
4779142|NCT01484496|16486659|P1|Period 1|Lost to Follow-up|2
4779143|NCT01484496|16486656|P4|Period 1|Withdrawal by Subject|0
4779144|NCT01484496|16486657|P3|Period 1|Withdrawal by Subject|0
4779145|NCT01484496|16486658|P2|Period 1|Withdrawal by Subject|12
4779146|NCT01484496|16486659|P1|Period 1|Withdrawal by Subject|15
4779147|NCT01484496|16486656|P4|Period 1|Adverse Event|0
4779148|NCT01484496|16486657|P3|Period 1|Adverse Event|0
4779149|NCT01484496|16486658|P2|Period 1|Adverse Event|40
4779150|NCT01484496|16486659|P1|Period 1|Adverse Event|25
4779151|NCT01484496|16486656|P4|Period 1|Lack of Efficacy|0
4779152|NCT01484496|16486657|P3|Period 1|Lack of Efficacy|0
4779153|NCT01484496|16486658|P2|Period 1|Lack of Efficacy|15
4779154|NCT01484496|16486659|P1|Period 1|Lack of Efficacy|10
4779155|NCT01484496|16486656|P4|Period 1|Physician Decision|0
4779156|NCT01484496|16486657|P3|Period 1|Physician Decision|0
4779157|NCT01484496|16486658|P2|Period 1|Physician Decision|1
4779158|NCT01484496|16486659|P1|Period 1|Physician Decision|5
4779159|NCT01484496|16486656|P4|Period 1|Protocol Violation|0
4779160|NCT01484496|16486657|P3|Period 1|Protocol Violation|0
4779161|NCT01484496|16486658|P2|Period 1|Protocol Violation|4
4779162|NCT01484496|16486659|P1|Period 1|Protocol Violation|3
4779163|NCT01484431|16486674|P3|Period 2|Non-Compliance with Study Drug|0
4779164|NCT01484431|16486675|P2|Period 2|Non-Compliance with Study Drug|0
4779165|NCT01484431|16486676|P1|Period 2|Non-Compliance with Study Drug|1
4779166|NCT01484431|16486674|P3|Period 2|Physician Decision|1
4779167|NCT01484431|16486675|P2|Period 2|Physician Decision|0
4779168|NCT01484431|16486676|P1|Period 2|Physician Decision|0
4779169|NCT01484431|16486674|P3|Period 2|Death|1
4779170|NCT01484431|16486675|P2|Period 2|Death|1
4779171|NCT01484431|16486676|P1|Period 2|Death|0
4779172|NCT01484431|16486674|P3|Period 1: High Dose|Physician Decision|0
4779173|NCT01484431|16486675|P2|Period 1: High Dose|Physician Decision|1
4779174|NCT01484431|16486676|P1|Period 1: High Dose|Physician Decision|0
4779175|NCT01484275|16486714|P2|Overall Study|Lost to Follow-up|1
4779176|NCT01484275|16486715|P1|Overall Study|Lost to Follow-up|1
4779177|NCT01484275|16486714|P2|Overall Study|Withdrawal by Subject|5
4779178|NCT01484275|16486715|P1|Overall Study|Withdrawal by Subject|1
4779179|NCT01484275|16486714|P2|Overall Study|Death|4
4779180|NCT01484275|16486715|P1|Overall Study|Death|3
4779181|NCT01484275|16486714|P2|Overall Study|Other|0
4779182|NCT01484275|16486715|P1|Overall Study|Other|10
4779183|NCT01484275|16486714|P2|Overall Study|Study terminated by sponsor|32
4779184|NCT01484275|16486715|P1|Overall Study|Study terminated by sponsor|28
4779185|NCT01484197|16486737|P4|Treatment Period 2|Subject withdrew consent|1
4779186|NCT01484197|16486738|P3|Treatment Period 2|Subject withdrew consent|0
4779187|NCT01484197|16486739|P2|Treatment Period 2|Subject withdrew consent|0
4779188|NCT01484197|16486740|P1|Treatment Period 2|Subject withdrew consent|0
4779189|NCT01484197|16486737|P4|Treatment Period 1|Adverse Event|0
4779190|NCT01484197|16486738|P3|Treatment Period 1|Adverse Event|0
4779191|NCT01484197|16486739|P2|Treatment Period 1|Adverse Event|0
4779192|NCT01484197|16486740|P1|Treatment Period 1|Adverse Event|1
4779193|NCT01484132|16486823|P1|Overall Study|No post-treatment urine sample collected|10
4779194|NCT01484132|16486823|P1|Overall Study|No pre-treatment urine sample collected|1
4779195|NCT01484132|16486823|P1|Overall Study|Ineligible|1
4779196|NCT01484132|16486823|P1|Overall Study|Difficulty with time commitment|2
4779197|NCT01484132|16486823|P1|Overall Study|Lost to Follow-up|8
4779198|NCT01484054|16486831|P2|Period 1|Withdrawal by Subject|1
4779199|NCT01484054|16486832|P1|Period 1|Withdrawal by Subject|0
4779200|NCT01484028|16486850|P4|Period 1|Lens Discomfort|0
4779201|NCT01484028|16486851|P3|Period 1|Lens Discomfort|0
4779202|NCT01484028|16486852|P2|Period 1|Lens Discomfort|1
4779203|NCT01484028|16486853|P1|Period 1|Lens Discomfort|0
4779204|NCT01484028|16486850|P4|Period 1|Non-Compliance to Protocol|1
4779205|NCT01484028|16486851|P3|Period 1|Non-Compliance to Protocol|0
4779206|NCT01484028|16486852|P2|Period 1|Non-Compliance to Protocol|1
4779207|NCT01484028|16486853|P1|Period 1|Non-Compliance to Protocol|0
4779208|NCT01484028|16486850|P4|Period 1|Lost to Follow-up|0
4779209|NCT01484028|16486851|P3|Period 1|Lost to Follow-up|0
4779210|NCT01484028|16486852|P2|Period 1|Lost to Follow-up|1
4779211|NCT01484028|16486853|P1|Period 1|Lost to Follow-up|0
4779212|NCT01483937|16486946|P2|Overall Study|Withdrawal by Subject|3
4779213|NCT01483937|16486947|P1|Overall Study|Withdrawal by Subject|4
4779214|NCT01483924|16486974|P5|Overall Study|Sponsor concern over ECG result|0
4779215|NCT01483924|16486975|P4|Overall Study|Sponsor concern over ECG result|1
4779216|NCT01483924|16486976|P3|Overall Study|Sponsor concern over ECG result|0
4779217|NCT01483924|16486977|P2|Overall Study|Sponsor concern over ECG result|0
4779218|NCT01483924|16486978|P1|Overall Study|Sponsor concern over ECG result|0
4779219|NCT01483924|16486974|P5|Overall Study|Non-compliance|1
4779220|NCT01483924|16486975|P4|Overall Study|Non-compliance|1
4779221|NCT01483924|16486976|P3|Overall Study|Non-compliance|0
4779222|NCT01483924|16486977|P2|Overall Study|Non-compliance|0
4779223|NCT01483924|16486978|P1|Overall Study|Non-compliance|0
4779224|NCT01483924|16486974|P5|Overall Study|Adverse Event|0
4779225|NCT01483924|16486975|P4|Overall Study|Adverse Event|1
4779226|NCT01483924|16486976|P3|Overall Study|Adverse Event|1
4779227|NCT01483924|16486977|P2|Overall Study|Adverse Event|0
4779228|NCT01483924|16486978|P1|Overall Study|Adverse Event|0
4779229|NCT01483924|16486974|P5|Overall Study|Withdrawal by Subject|1
4779230|NCT01483924|16486975|P4|Overall Study|Withdrawal by Subject|1
4779231|NCT01483924|16486976|P3|Overall Study|Withdrawal by Subject|0
4779232|NCT01483924|16486977|P2|Overall Study|Withdrawal by Subject|0
4779233|NCT01483924|16486978|P1|Overall Study|Withdrawal by Subject|2
4779234|NCT01483820|16487031|P1|Overall Study|Death|1
4779235|NCT01483820|16487031|P1|Overall Study|Adverse Event|1
4779236|NCT01483820|16487031|P1|Overall Study|Lack of Efficacy|6
4779237|NCT01483690|16487054|P2|Overall Study|exclusionary procedure|1
4779238|NCT01483690|16487055|P1|Overall Study|exclusionary procedure|0
4779239|NCT01483690|16487054|P2|Overall Study|Physician Decision|2
4779240|NCT01483690|16487055|P1|Overall Study|Physician Decision|0
4779241|NCT01483690|16487054|P2|Overall Study|clinical deterioration|0
4779242|NCT01483690|16487055|P1|Overall Study|clinical deterioration|1
4779243|NCT01483690|16487054|P2|Overall Study|Adverse Event|2
4779244|NCT01483690|16487055|P1|Overall Study|Adverse Event|1
4779245|NCT01483651|16487063|P6|Overall Study|Withdrawal by Subject|1
4779246|NCT01483651|16487064|P5|Overall Study|Withdrawal by Subject|0
4779247|NCT01483651|16487065|P4|Overall Study|Withdrawal by Subject|0
4779248|NCT01483651|16487066|P3|Overall Study|Withdrawal by Subject|1
4779249|NCT01483651|16487067|P2|Overall Study|Withdrawal by Subject|1
4779250|NCT01483651|16487068|P1|Overall Study|Withdrawal by Subject|0
4779251|NCT01483625|16487078|P2|Overall Study|Due to other reason|0
4779252|NCT01483625|16487079|P1|Overall Study|Due to other reason|1
4779253|NCT01483625|16487078|P2|Overall Study|Refused to continue medication|1
4779254|NCT01483625|16487079|P1|Overall Study|Refused to continue medication|2
4779255|NCT01483625|16487078|P2|Overall Study|Adverse Event|1
4779256|NCT01483625|16487079|P1|Overall Study|Adverse Event|1
4779257|NCT01483599|16487102|P14|After Controlled Period(Week 16-Week 40)|Other|0
4779258|NCT01483599|16487103|P13|After Controlled Period(Week 16-Week 40)|Other|1
4779259|NCT01483599|16487104|P12|After Controlled Period(Week 16-Week 40)|Other|0
4779260|NCT01483599|16487105|P11|After Controlled Period(Week 16-Week 40)|Other|0
4779261|NCT01483599|16487106|P10|After Controlled Period(Week 16-Week 40)|Other|4
4779262|NCT01483599|16487107|P9|After Controlled Period(Week 16-Week 40)|Other|0
4779263|NCT01483599|16487108|P8|After Controlled Period(Week 16-Week 40)|Other|1
4779264|NCT01483599|16487109|P7|After Controlled Period(Week 16-Week 40)|Other|0
4779265|NCT01483599|16487110|P6|After Controlled Period(Week 16-Week 40)|Other|0
4779266|NCT01483599|16487111|P5|After Controlled Period(Week 16-Week 40)|Other|0
4779267|NCT01483599|16487112|P4|After Controlled Period(Week 16-Week 40)|Other|0
4779268|NCT01483599|16487113|P3|After Controlled Period(Week 16-Week 40)|Other|0
4779269|NCT01483599|16487114|P2|After Controlled Period(Week 16-Week 40)|Other|0
4779270|NCT01483599|16487115|P1|After Controlled Period(Week 16-Week 40)|Other|0
4779271|NCT01483599|16487102|P14|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4
4779272|NCT01483599|16487103|P13|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1
4779273|NCT01483599|16487104|P12|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779274|NCT01483599|16487105|P11|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779275|NCT01483599|16487106|P10|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779276|NCT01483599|16487107|P9|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5
4779277|NCT01483599|16487108|P8|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779278|NCT01483599|16487109|P7|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779279|NCT01483599|16487110|P6|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779280|NCT01483599|16487111|P5|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779281|NCT01483599|16487112|P4|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779282|NCT01483599|16487113|P3|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779283|NCT01483599|16487114|P2|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779284|NCT01483599|16487115|P1|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0
4779285|NCT01483599|16487102|P14|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
4779286|NCT01483599|16487103|P13|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779287|NCT01483599|16487104|P12|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779288|NCT01483599|16487105|P11|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2
4779289|NCT01483599|16487106|P10|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779290|NCT01483599|16487107|P9|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1
4779291|NCT01483599|16487108|P8|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779292|NCT01483599|16487109|P7|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779293|NCT01483599|16487110|P6|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779294|NCT01483599|16487111|P5|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779295|NCT01483599|16487112|P4|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779296|NCT01483599|16487113|P3|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779297|NCT01483599|16487114|P2|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779298|NCT01483599|16487115|P1|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0
4779299|NCT01483599|16487102|P14|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
4779300|NCT01483599|16487103|P13|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779301|NCT01483599|16487104|P12|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
4779302|NCT01483599|16487105|P11|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779303|NCT01483599|16487106|P10|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779304|NCT01483599|16487107|P9|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1
4779305|NCT01483599|16487108|P8|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779306|NCT01483599|16487109|P7|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779307|NCT01483599|16487110|P6|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779308|NCT01483599|16487111|P5|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779309|NCT01483599|16487112|P4|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779310|NCT01483599|16487113|P3|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779311|NCT01483599|16487114|P2|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779312|NCT01483599|16487115|P1|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0
4779313|NCT01483599|16487102|P14|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4779314|NCT01483599|16487103|P13|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4779315|NCT01483599|16487104|P12|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779316|NCT01483599|16487105|P11|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779317|NCT01483599|16487106|P10|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779318|NCT01483599|16487107|P9|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4779319|NCT01483599|16487108|P8|After Controlled Period(Week 16-Week 40)|Adverse Event|1
4779320|NCT01483599|16487109|P7|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779321|NCT01483599|16487110|P6|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779322|NCT01483599|16487111|P5|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779323|NCT01483599|16487112|P4|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779324|NCT01483599|16487113|P3|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779325|NCT01483599|16487114|P2|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779326|NCT01483599|16487115|P1|After Controlled Period(Week 16-Week 40)|Adverse Event|0
4779327|NCT01483599|16487102|P14|After Controlled Period(Week 16-Week 40)|Death|0
4779328|NCT01483599|16487103|P13|After Controlled Period(Week 16-Week 40)|Death|0
4779329|NCT01483599|16487104|P12|After Controlled Period(Week 16-Week 40)|Death|0
4779330|NCT01483599|16487105|P11|After Controlled Period(Week 16-Week 40)|Death|0
4779331|NCT01483599|16487106|P10|After Controlled Period(Week 16-Week 40)|Death|0
4779332|NCT01483599|16487107|P9|After Controlled Period(Week 16-Week 40)|Death|1
4779333|NCT01483599|16487108|P8|After Controlled Period(Week 16-Week 40)|Death|0
4779334|NCT01483599|16487109|P7|After Controlled Period(Week 16-Week 40)|Death|0
4779335|NCT01483599|16487110|P6|After Controlled Period(Week 16-Week 40)|Death|0
4779336|NCT01483599|16487111|P5|After Controlled Period(Week 16-Week 40)|Death|0
4779337|NCT01483599|16487112|P4|After Controlled Period(Week 16-Week 40)|Death|0
4779338|NCT01483599|16487113|P3|After Controlled Period(Week 16-Week 40)|Death|0
4779339|NCT01483599|16487114|P2|After Controlled Period(Week 16-Week 40)|Death|0
4779340|NCT01483599|16487115|P1|After Controlled Period(Week 16-Week 40)|Death|0
4779341|NCT01483599|16487102|P14|Controlled Period (CP) (up to Week 16)|Other|0
4779342|NCT01483599|16487103|P13|Controlled Period (CP) (up to Week 16)|Other|0
4779343|NCT01483599|16487104|P12|Controlled Period (CP) (up to Week 16)|Other|0
4779344|NCT01483599|16487105|P11|Controlled Period (CP) (up to Week 16)|Other|0
4779345|NCT01483599|16487106|P10|Controlled Period (CP) (up to Week 16)|Other|0
4779346|NCT01483599|16487107|P9|Controlled Period (CP) (up to Week 16)|Other|0
4779347|NCT01483599|16487108|P8|Controlled Period (CP) (up to Week 16)|Other|0
4779348|NCT01483599|16487109|P7|Controlled Period (CP) (up to Week 16)|Other|0
4779349|NCT01483599|16487110|P6|Controlled Period (CP) (up to Week 16)|Other|0
4779350|NCT01483599|16487111|P5|Controlled Period (CP) (up to Week 16)|Other|1
4779351|NCT01483599|16487112|P4|Controlled Period (CP) (up to Week 16)|Other|1
4779352|NCT01483599|16487113|P3|Controlled Period (CP) (up to Week 16)|Other|0
4779353|NCT01483599|16487114|P2|Controlled Period (CP) (up to Week 16)|Other|2
4779354|NCT01483599|16487115|P1|Controlled Period (CP) (up to Week 16)|Other|0
4779355|NCT01483599|16487102|P14|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779356|NCT01483599|16487103|P13|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779357|NCT01483599|16487104|P12|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779358|NCT01483599|16487105|P11|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779359|NCT01483599|16487106|P10|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779360|NCT01483599|16487107|P9|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779361|NCT01483599|16487108|P8|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779362|NCT01483599|16487109|P7|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779363|NCT01483599|16487110|P6|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779364|NCT01483599|16487111|P5|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779365|NCT01483599|16487112|P4|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779366|NCT01483599|16487113|P3|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779367|NCT01483599|16487114|P2|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0
4779368|NCT01483599|16487115|P1|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1
4779369|NCT01483599|16487102|P14|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779370|NCT01483599|16487103|P13|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779371|NCT01483599|16487104|P12|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779372|NCT01483599|16487105|P11|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779373|NCT01483599|16487106|P10|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779374|NCT01483599|16487107|P9|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779375|NCT01483599|16487108|P8|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779376|NCT01483599|16487109|P7|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
4779377|NCT01483599|16487110|P6|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779378|NCT01483599|16487111|P5|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779379|NCT01483599|16487112|P4|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
4779380|NCT01483599|16487113|P3|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779381|NCT01483599|16487114|P2|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1
4779382|NCT01483599|16487115|P1|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0
4779383|NCT01483599|16487102|P14|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779384|NCT01483599|16487103|P13|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779385|NCT01483599|16487104|P12|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779386|NCT01483599|16487105|P11|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779387|NCT01483599|16487106|P10|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779388|NCT01483599|16487107|P9|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779389|NCT01483599|16487108|P8|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779390|NCT01483599|16487109|P7|Controlled Period (CP) (up to Week 16)|Adverse Event|3
4779391|NCT01483599|16487110|P6|Controlled Period (CP) (up to Week 16)|Adverse Event|4
4779392|NCT01483599|16487111|P5|Controlled Period (CP) (up to Week 16)|Adverse Event|1
4779393|NCT01483599|16487112|P4|Controlled Period (CP) (up to Week 16)|Adverse Event|1
4779394|NCT01483599|16487113|P3|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779395|NCT01483599|16487114|P2|Controlled Period (CP) (up to Week 16)|Adverse Event|0
4779396|NCT01483599|16487115|P1|Controlled Period (CP) (up to Week 16)|Adverse Event|2
4779397|NCT01483183|16487228|P10|Overall Study|Withdrawal by Subject|1
4779398|NCT01483183|16487229|P9|Overall Study|Withdrawal by Subject|0
4779399|NCT01483183|16487230|P8|Overall Study|Withdrawal by Subject|0
4779400|NCT01483183|16487231|P7|Overall Study|Withdrawal by Subject|0
4779401|NCT01483183|16487232|P6|Overall Study|Withdrawal by Subject|0
4779402|NCT01483183|16487233|P5|Overall Study|Withdrawal by Subject|0
4779403|NCT01483183|16487234|P4|Overall Study|Withdrawal by Subject|0
4779404|NCT01483183|16487235|P3|Overall Study|Withdrawal by Subject|0
4779405|NCT01483183|16487236|P2|Overall Study|Withdrawal by Subject|0
4779406|NCT01483183|16487237|P1|Overall Study|Withdrawal by Subject|0
4779407|NCT01483183|16487228|P10|Overall Study|Physician Decision|0
4779408|NCT01483183|16487229|P9|Overall Study|Physician Decision|0
4779409|NCT01483183|16487230|P8|Overall Study|Physician Decision|0
4779410|NCT01483183|16487231|P7|Overall Study|Physician Decision|2
4779411|NCT01483183|16487232|P6|Overall Study|Physician Decision|0
4779412|NCT01483183|16487233|P5|Overall Study|Physician Decision|0
4779413|NCT01483183|16487234|P4|Overall Study|Physician Decision|0
4779414|NCT01483183|16487235|P3|Overall Study|Physician Decision|0
4779415|NCT01483183|16487236|P2|Overall Study|Physician Decision|0
4779416|NCT01483183|16487237|P1|Overall Study|Physician Decision|0
4779417|NCT01483118|16487307|P2|Overall Study|Lost to Follow-up|16
4779418|NCT01483118|16487308|P1|Overall Study|Lost to Follow-up|12
4779419|NCT01482962|16487320|P2|Overall Study|Did not Receive Study Drug|6
4779420|NCT01482962|16487321|P1|Overall Study|Did not Receive Study Drug|1
4779421|NCT01482962|16487320|P2|Overall Study|Study Terminated by Sponsor|2
4779422|NCT01482962|16487321|P1|Overall Study|Study Terminated by Sponsor|5
4779423|NCT01482962|16487320|P2|Overall Study|Other Reason|5
4779424|NCT01482962|16487321|P1|Overall Study|Other Reason|1
4779425|NCT01482962|16487320|P2|Overall Study|Hematopoietic Stem Cell Transplant|9
4779426|NCT01482962|16487321|P1|Overall Study|Hematopoietic Stem Cell Transplant|3
4779427|NCT01482962|16487320|P2|Overall Study|Withdrawal by Participant|13
4779428|NCT01482962|16487321|P1|Overall Study|Withdrawal by Participant|8
4779429|NCT01482962|16487320|P2|Overall Study|Adverse Event|22
4779430|NCT01482962|16487321|P1|Overall Study|Adverse Event|18
4779431|NCT01482962|16487320|P2|Overall Study|Unsatisfactory Therapeutic Response|23
4779432|NCT01482962|16487321|P1|Overall Study|Unsatisfactory Therapeutic Response|37
4779433|NCT01482962|16487320|P2|Overall Study|Progressive Disease|53
4779434|NCT01482962|16487321|P1|Overall Study|Progressive Disease|65
4779435|NCT01482910|16487354|P2|Overall Study|Death|0
4779436|NCT01482910|16487355|P1|Overall Study|Death|1
4779437|NCT01482910|16487354|P2|Overall Study|Withdrawal by Subject|2
4779438|NCT01482910|16487355|P1|Overall Study|Withdrawal by Subject|7
4779439|NCT01482910|16487354|P2|Overall Study|Protocol Violation|1
4779440|NCT01482910|16487355|P1|Overall Study|Protocol Violation|1
4779441|NCT01482910|16487354|P2|Overall Study|Lost to Follow-up|1
4779442|NCT01482910|16487355|P1|Overall Study|Lost to Follow-up|0
4779443|NCT01482910|16487354|P2|Overall Study|Adverse Event|5
4779444|NCT01482910|16487355|P1|Overall Study|Adverse Event|6
4779445|NCT01482884|16487367|P2|Overall Study|Withdrawal by Subject|13
4779446|NCT01482884|16487368|P1|Overall Study|Withdrawal by Subject|8
4779447|NCT01482884|16487367|P2|Overall Study|Adverse Event|1
4779448|NCT01482884|16487368|P1|Overall Study|Adverse Event|2
4779449|NCT01482884|16487367|P2|Overall Study|Lack of Efficacy|1
4779450|NCT01482884|16487368|P1|Overall Study|Lack of Efficacy|0
4779451|NCT01482884|16487367|P2|Overall Study|Lost to Follow-up|2
4779452|NCT01482884|16487368|P1|Overall Study|Lost to Follow-up|2
4779453|NCT01482884|16487367|P2|Overall Study|Protocol Violation|0
4779454|NCT01482884|16487368|P1|Overall Study|Protocol Violation|1
4779455|NCT01482884|16487367|P2|Overall Study|Medical decision due to lack of efficacy|1
4779456|NCT01482884|16487368|P1|Overall Study|Medical decision due to lack of efficacy|0
4779457|NCT01482819|16487394|P1|Overall Study|Lost to Follow-up|2
4779458|NCT01482767|16487414|P2|Overall Study|Nurse error|0
4779459|NCT01482767|16487415|P1|Overall Study|Nurse error|1
4779460|NCT01482767|16487414|P2|Overall Study|Ineligible|5
4779461|NCT01482767|16487415|P1|Overall Study|Ineligible|0
4779462|NCT01482767|16487414|P2|Overall Study|Alternate HCV treatment|8
4779463|NCT01482767|16487415|P1|Overall Study|Alternate HCV treatment|7
4779464|NCT01482767|16487414|P2|Overall Study|Non-adherence to study requirements|7
4779465|NCT01482767|16487415|P1|Overall Study|Non-adherence to study requirements|4
4779466|NCT01482767|16487414|P2|Overall Study|Site closure|14
4779467|NCT01482767|16487415|P1|Overall Study|Site closure|22
4779468|NCT01482767|16487414|P2|Overall Study|Adverse Event|3
4779469|NCT01482767|16487415|P1|Overall Study|Adverse Event|0
4779470|NCT01482767|16487414|P2|Overall Study|Lost to Follow-up|6
4779471|NCT01482767|16487415|P1|Overall Study|Lost to Follow-up|12
4779472|NCT01482767|16487414|P2|Overall Study|Withdrawal by Subject|5
4779473|NCT01482767|16487415|P1|Overall Study|Withdrawal by Subject|7
4779474|NCT01482767|16487414|P2|Overall Study|Death|1
4779475|NCT01482767|16487415|P1|Overall Study|Death|1
4779476|NCT01482429|16487437|P2|Protocol|Protocol Violation|0
4779477|NCT01482429|16487438|P1|Protocol|Protocol Violation|275
4779478|NCT01482429|16487437|P2|Care Usual|Lost to Follow-up|1
4779479|NCT01482429|16487438|P1|Care Usual|Lost to Follow-up|0
4779480|NCT01482429|16487437|P2|Care Usual|Protocol Violation|172
4779481|NCT01482429|16487438|P1|Care Usual|Protocol Violation|0
4779482|NCT01482312|16487474|P3|Period 2, 90 Minutes of Wear|Other|0
4779483|NCT01482312|16487475|P2|Period 2, 90 Minutes of Wear|Other|0
4779484|NCT01482312|16487476|P1|Period 2, 90 Minutes of Wear|Other|1
4779485|NCT01482312|16487474|P3|Period 1, 90 Minutes of Wear|Other|0
4779486|NCT01482312|16487475|P2|Period 1, 90 Minutes of Wear|Other|0
4779487|NCT01482312|16487476|P1|Period 1, 90 Minutes of Wear|Other|1
4779488|NCT01482221|16487490|P3|Overall Study|Physician Decision|0
4779489|NCT01482221|16487491|P2|Overall Study|Physician Decision|1
4779490|NCT01482221|16487492|P1|Overall Study|Physician Decision|0
4779491|NCT01482221|16487490|P3|Overall Study|Incorrect randomization|0
4779492|NCT01482221|16487491|P2|Overall Study|Incorrect randomization|1
4779493|NCT01482221|16487492|P1|Overall Study|Incorrect randomization|0
4779494|NCT01482221|16487490|P3|Overall Study|Withdrawal by Subject|12
4779495|NCT01482221|16487491|P2|Overall Study|Withdrawal by Subject|7
4779496|NCT01482221|16487492|P1|Overall Study|Withdrawal by Subject|10
4779497|NCT01482221|16487490|P3|Overall Study|Adverse Event|3
4779498|NCT01482221|16487491|P2|Overall Study|Adverse Event|7
4779499|NCT01482221|16487492|P1|Overall Study|Adverse Event|1
4779500|NCT01482221|16487490|P3|Overall Study|Severe Non-Compliance to Protocol|1
4779501|NCT01482221|16487491|P2|Overall Study|Severe Non-Compliance to Protocol|0
4779502|NCT01482221|16487492|P1|Overall Study|Severe Non-Compliance to Protocol|1
4779503|NCT01482221|16487490|P3|Overall Study|Condition under Investigation Worsened|4
4779504|NCT01482221|16487491|P2|Overall Study|Condition under Investigation Worsened|2
4779505|NCT01482221|16487492|P1|Overall Study|Condition under Investigation Worsened|3
4779506|NCT01482221|16487490|P3|Overall Study|Study-Specific Withdrawal Criteria|1
4779507|NCT01482221|16487491|P2|Overall Study|Study-Specific Withdrawal Criteria|0
4779508|NCT01482221|16487492|P1|Overall Study|Study-Specific Withdrawal Criteria|2
4779509|NCT01482221|16487490|P3|Overall Study|Lost to Follow-up|1
4779510|NCT01482221|16487491|P2|Overall Study|Lost to Follow-up|2
4779511|NCT01482221|16487492|P1|Overall Study|Lost to Follow-up|3
4779512|NCT01482221|16487490|P3|Overall Study|Lack of Efficacy|1
4779513|NCT01482221|16487491|P2|Overall Study|Lack of Efficacy|0
4779514|NCT01482221|16487492|P1|Overall Study|Lack of Efficacy|1
4779515|NCT01482169|16487533|P1|Overall Study|Physician Decision|2
4779516|NCT01482065|16487575|P2|Overall Study|Withdrawal by Subject|1
4779517|NCT01482065|16487576|P1|Overall Study|Withdrawal by Subject|0
4779518|NCT01481896|16487597|P1|Overall Study|Lost to Follow-up|12
4779519|NCT01481779|16487613|P2|Overall Study|Sponsor Decision|1
4779520|NCT01481779|16487614|P1|Overall Study|Sponsor Decision|3
4779521|NCT01481779|16487613|P2|Overall Study|Physician Decision|4
4779522|NCT01481779|16487614|P1|Overall Study|Physician Decision|13
4779523|NCT01481779|16487613|P2|Overall Study|Withdrawal by Subject|13
4779524|NCT01481779|16487614|P1|Overall Study|Withdrawal by Subject|26
4779525|NCT01481779|16487613|P2|Overall Study|Protocol Violation|3
4779526|NCT01481779|16487614|P1|Overall Study|Protocol Violation|2
4779527|NCT01481779|16487613|P2|Overall Study|Lost to Follow-up|2
4779528|NCT01481779|16487614|P1|Overall Study|Lost to Follow-up|3
4779529|NCT01481779|16487613|P2|Overall Study|Adverse Event|5
4779530|NCT01481779|16487614|P1|Overall Study|Adverse Event|23
4779531|NCT01481324|16487699|P3|Overall Study|Missing Data|2
4779532|NCT01481324|16487700|P2|Overall Study|Missing Data|2
4779533|NCT01481324|16487701|P1|Overall Study|Missing Data|0
4779534|NCT01481116|16487720|P3|Overall Study|Hypoglycemic Event|0
4779535|NCT01481116|16487721|P2|Overall Study|Hypoglycemic Event|0
4779536|NCT01481116|16487722|P1|Overall Study|Hypoglycemic Event|4
4779537|NCT01481116|16487720|P3|Overall Study|Death|0
4779538|NCT01481116|16487721|P2|Overall Study|Death|1
4779539|NCT01481116|16487722|P1|Overall Study|Death|2
4779540|NCT01481116|16487720|P3|Overall Study|Investigator's Discretion|0
4779541|NCT01481116|16487721|P2|Overall Study|Investigator's Discretion|0
4779542|NCT01481116|16487722|P1|Overall Study|Investigator's Discretion|2
4779543|NCT01481116|16487720|P3|Overall Study|Non-Compliant With Study Drug|1
4779544|NCT01481116|16487721|P2|Overall Study|Non-Compliant With Study Drug|1
4779545|NCT01481116|16487722|P1|Overall Study|Non-Compliant With Study Drug|0
4779546|NCT01481116|16487720|P3|Overall Study|Sponsor Decision|3
4779547|NCT01481116|16487721|P2|Overall Study|Sponsor Decision|1
4779548|NCT01481116|16487722|P1|Overall Study|Sponsor Decision|0
4779549|NCT01481116|16487720|P3|Overall Study|Investigator Decision|1
4779550|NCT01481116|16487721|P2|Overall Study|Investigator Decision|2
4779551|NCT01481116|16487722|P1|Overall Study|Investigator Decision|3
4779552|NCT01481116|16487720|P3|Overall Study|Participant Moved Out of Country|1
4779553|NCT01481116|16487721|P2|Overall Study|Participant Moved Out of Country|0
4779554|NCT01481116|16487722|P1|Overall Study|Participant Moved Out of Country|1
4779555|NCT01481116|16487720|P3|Overall Study|Participant Moved Out of Area|1
4779556|NCT01481116|16487721|P2|Overall Study|Participant Moved Out of Area|0
4779557|NCT01481116|16487722|P1|Overall Study|Participant Moved Out of Area|2
4779558|NCT01481116|16487720|P3|Overall Study|Participant Started Taking Glipizide|0
4779559|NCT01481116|16487721|P2|Overall Study|Participant Started Taking Glipizide|0
4779560|NCT01481116|16487722|P1|Overall Study|Participant Started Taking Glipizide|1
4779561|NCT01481116|16487720|P3|Overall Study|Other|0
4779562|NCT01481116|16487721|P2|Overall Study|Other|1
4779563|NCT01481116|16487722|P1|Overall Study|Other|1
4779564|NCT01481116|16487720|P3|Overall Study|Contraindications|0
4779565|NCT01481116|16487721|P2|Overall Study|Contraindications|1
4779566|NCT01481116|16487722|P1|Overall Study|Contraindications|1
4779567|NCT01481116|16487720|P3|Overall Study|Lack of Efficacy|1
4779568|NCT01481116|16487721|P2|Overall Study|Lack of Efficacy|3
4779569|NCT01481116|16487722|P1|Overall Study|Lack of Efficacy|3
4779570|NCT01481116|16487720|P3|Overall Study|Pregnancy|1
4779571|NCT01481116|16487721|P2|Overall Study|Pregnancy|0
4779572|NCT01481116|16487722|P1|Overall Study|Pregnancy|0
4779573|NCT01481116|16487720|P3|Overall Study|Study Termination|713
4779574|NCT01481116|16487721|P2|Overall Study|Study Termination|729
4779575|NCT01481116|16487722|P1|Overall Study|Study Termination|730
4779576|NCT01481116|16487720|P3|Overall Study|Withdrawal by Subject|37
4779577|NCT01481116|16487721|P2|Overall Study|Withdrawal by Subject|33
4779578|NCT01481116|16487722|P1|Overall Study|Withdrawal by Subject|37
4779579|NCT01481116|16487720|P3|Overall Study|Lost to Follow-up|11
4779580|NCT01481116|16487721|P2|Overall Study|Lost to Follow-up|12
4779581|NCT01481116|16487722|P1|Overall Study|Lost to Follow-up|8
4779582|NCT01481116|16487720|P3|Overall Study|Major Protocol Deviation|1
4779583|NCT01481116|16487721|P2|Overall Study|Major Protocol Deviation|7
4779584|NCT01481116|16487722|P1|Overall Study|Major Protocol Deviation|3
4779585|NCT01481116|16487720|P3|Overall Study|Adverse Event|42
4779586|NCT01481116|16487721|P2|Overall Study|Adverse Event|26
4779587|NCT01481116|16487722|P1|Overall Study|Adverse Event|26
4779588|NCT01480674|16487753|P1|Overall Study|visit not done|10
4779589|NCT01480674|16487753|P1|Overall Study|Lost to Follow-up|2
4779590|NCT01480674|16487753|P1|Overall Study|Death|23
4779591|NCT01480596|16487767|P2|Overall Study|MG exacerbation or change in medication|2
4779592|NCT01480596|16487768|P1|Overall Study|MG exacerbation or change in medication|2
4779593|NCT01480596|16487767|P2|Overall Study|Adverse Event|0
4779594|NCT01480596|16487768|P1|Overall Study|Adverse Event|3
4779595|NCT01480284|16487816|P2|Overall Study|Physician Decision|0
4779596|NCT01480284|16487817|P1|Overall Study|Physician Decision|1
4779597|NCT01480284|16487816|P2|Overall Study|Lost to Follow-up|0
4779598|NCT01480284|16487817|P1|Overall Study|Lost to Follow-up|1
4779599|NCT01480284|16487816|P2|Overall Study|Study closed/terminated|0
4779600|NCT01480284|16487817|P1|Overall Study|Study closed/terminated|3
4779601|NCT01480284|16487816|P2|Overall Study|Adverse Event|0
4779602|NCT01480284|16487817|P1|Overall Study|Adverse Event|1
4779603|NCT01480284|16487816|P2|Overall Study|Withdrawal by Subject|0
4779604|NCT01480284|16487817|P1|Overall Study|Withdrawal by Subject|2
4779605|NCT01480258|16487847|P2|Interim Period|Withdrawal by Subject|6
4779606|NCT01480258|16487848|P1|Interim Period|Withdrawal by Subject|9
4779607|NCT01480258|16487847|P2|Interim Period|Protocol Violation|1
4779608|NCT01480258|16487848|P1|Interim Period|Protocol Violation|0
4779609|NCT01480258|16487847|P2|Interim Period|Physician Decision|0
4779610|NCT01480258|16487848|P1|Interim Period|Physician Decision|1
4779611|NCT01480258|16487847|P2|Interim Period|Lost to Follow-up|2
4779612|NCT01480258|16487848|P1|Interim Period|Lost to Follow-up|0
4779613|NCT01480258|16487847|P2|Infant Series|Withdrawal by Subject|6
4779614|NCT01480258|16487848|P1|Infant Series|Withdrawal by Subject|1
4779615|NCT01480258|16487847|P2|Infant Series|Adverse Event|1
4779616|NCT01480258|16487848|P1|Infant Series|Adverse Event|1
4779617|NCT01480258|16487847|P2|Infant Series|Not Vaccinated|0
4779618|NCT01480258|16487848|P1|Infant Series|Not Vaccinated|3
4779619|NCT01480258|16487847|P2|Infant Series|Physician Decision|1
4779620|NCT01480258|16487848|P1|Infant Series|Physician Decision|0
4779621|NCT01480258|16487847|P2|Infant Series|Protocol Violation|0
4779622|NCT01480258|16487848|P1|Infant Series|Protocol Violation|2
4779623|NCT01480180|16487914|P6|Extension Phase, Part 2|Unclassified|0
4779624|NCT01480180|16487915|P5|Extension Phase, Part 2|Unclassified|1
4779625|NCT01480180|16487916|P4|Extension Phase, Part 2|Unclassified|1
4779626|NCT01480180|16487917|P3|Extension Phase, Part 2|Unclassified|3
4779627|NCT01480180|16487918|P2|Extension Phase, Part 2|Unclassified|0
4779628|NCT01480180|16487919|P1|Extension Phase, Part 2|Unclassified|0
4779629|NCT01480180|16487914|P6|Extension Phase, Part 2|Lack of Efficacy|0
4779630|NCT01480180|16487915|P5|Extension Phase, Part 2|Lack of Efficacy|0
4779631|NCT01480180|16487916|P4|Extension Phase, Part 2|Lack of Efficacy|0
4779632|NCT01480180|16487917|P3|Extension Phase, Part 2|Lack of Efficacy|4
4779633|NCT01480180|16487918|P2|Extension Phase, Part 2|Lack of Efficacy|0
4779634|NCT01480180|16487919|P1|Extension Phase, Part 2|Lack of Efficacy|0
4779635|NCT01480180|16487914|P6|Extension Phase, Part 2|Withdrawal criteria|0
4779636|NCT01480180|16487915|P5|Extension Phase, Part 2|Withdrawal criteria|1
4779637|NCT01480180|16487916|P4|Extension Phase, Part 2|Withdrawal criteria|6
4779638|NCT01480180|16487917|P3|Extension Phase, Part 2|Withdrawal criteria|10
4779639|NCT01480180|16487918|P2|Extension Phase, Part 2|Withdrawal criteria|0
4779640|NCT01480180|16487919|P1|Extension Phase, Part 2|Withdrawal criteria|0
4779641|NCT01480180|16487914|P6|Extension Phase, Part 1|Change of treatment|0
4779642|NCT01480180|16487915|P5|Extension Phase, Part 1|Change of treatment|0
4779643|NCT01480180|16487916|P4|Extension Phase, Part 1|Change of treatment|9
4779644|NCT01480180|16487917|P3|Extension Phase, Part 1|Change of treatment|0
4779645|NCT01480180|16487918|P2|Extension Phase, Part 1|Change of treatment|0
4779646|NCT01480180|16487919|P1|Extension Phase, Part 1|Change of treatment|0
4779647|NCT01480180|16487914|P6|Extension Phase, Part 1|Adverse Event|0
4779648|NCT01480180|16487915|P5|Extension Phase, Part 1|Adverse Event|0
4779649|NCT01480180|16487916|P4|Extension Phase, Part 1|Adverse Event|1
4779650|NCT01480180|16487917|P3|Extension Phase, Part 1|Adverse Event|4
4779651|NCT01480180|16487918|P2|Extension Phase, Part 1|Adverse Event|0
4779652|NCT01480180|16487919|P1|Extension Phase, Part 1|Adverse Event|0
4779653|NCT01480180|16487914|P6|Extension Phase, Part 1|Unclassified|0
4779654|NCT01480180|16487915|P5|Extension Phase, Part 1|Unclassified|0
4779655|NCT01480180|16487916|P4|Extension Phase, Part 1|Unclassified|0
4779656|NCT01480180|16487917|P3|Extension Phase, Part 1|Unclassified|1
4779657|NCT01480180|16487918|P2|Extension Phase, Part 1|Unclassified|0
4779658|NCT01480180|16487919|P1|Extension Phase, Part 1|Unclassified|0
4779659|NCT01480180|16487914|P6|Extension Phase, Part 1|Withdrawal criteria|0
4779660|NCT01480180|16487915|P5|Extension Phase, Part 1|Withdrawal criteria|0
4779661|NCT01480180|16487916|P4|Extension Phase, Part 1|Withdrawal criteria|0
4779662|NCT01480180|16487917|P3|Extension Phase, Part 1|Withdrawal criteria|5
4779663|NCT01480180|16487918|P2|Extension Phase, Part 1|Withdrawal criteria|0
4779664|NCT01480180|16487919|P1|Extension Phase, Part 1|Withdrawal criteria|0
4779665|NCT01480180|16487914|P6|Main Phase|Unclassified|0
4779666|NCT01480180|16487915|P5|Main Phase|Unclassified|0
4779667|NCT01480180|16487916|P4|Main Phase|Unclassified|0
4779668|NCT01480180|16487917|P3|Main Phase|Unclassified|0
4779669|NCT01480180|16487918|P2|Main Phase|Unclassified|0
4779670|NCT01480180|16487919|P1|Main Phase|Unclassified|3
4779671|NCT01480180|16487914|P6|Main Phase|Non-compliance|0
4779672|NCT01480180|16487915|P5|Main Phase|Non-compliance|0
4779673|NCT01480180|16487916|P4|Main Phase|Non-compliance|0
4779674|NCT01480180|16487917|P3|Main Phase|Non-compliance|0
4779675|NCT01480180|16487918|P2|Main Phase|Non-compliance|0
4779676|NCT01480180|16487919|P1|Main Phase|Non-compliance|3
4779677|NCT01480180|16487914|P6|Main Phase|Lack of Efficacy|0
4779678|NCT01480180|16487915|P5|Main Phase|Lack of Efficacy|0
4779679|NCT01480180|16487916|P4|Main Phase|Lack of Efficacy|0
4779680|NCT01480180|16487917|P3|Main Phase|Lack of Efficacy|0
4779681|NCT01480180|16487918|P2|Main Phase|Lack of Efficacy|0
4779682|NCT01480180|16487919|P1|Main Phase|Lack of Efficacy|1
4779683|NCT01480180|16487914|P6|Main Phase|Withdrawal criteria|0
4779684|NCT01480180|16487915|P5|Main Phase|Withdrawal criteria|0
4779685|NCT01480180|16487916|P4|Main Phase|Withdrawal criteria|0
4779686|NCT01480180|16487917|P3|Main Phase|Withdrawal criteria|0
4779687|NCT01480180|16487918|P2|Main Phase|Withdrawal criteria|1
4779688|NCT01480180|16487919|P1|Main Phase|Withdrawal criteria|12
4779689|NCT01480076|16488087|P1|Overall Study|Other|52
4779690|NCT01480076|16488087|P1|Overall Study|Investigator Decision|13
4779691|NCT01480076|16488087|P1|Overall Study|Lost to Follow-up|7
4779692|NCT01480076|16488087|P1|Overall Study|Withdrawal by Subject|105
4779693|NCT01480076|16488087|P1|Overall Study|Non-compliance With Study Protocol|15
4779694|NCT01480076|16488087|P1|Overall Study|Disease Progression|5
4779695|NCT01480076|16488087|P1|Overall Study|Death|2
4779696|NCT01480076|16488087|P1|Overall Study|Adverse Event|39
4779697|NCT01480076|16488087|P1|Overall Study|Run-in Failure|52
4779698|NCT01479985|16488208|P2|Overall Study|No post-visit survey|3
4779699|NCT01479985|16488209|P1|Overall Study|No post-visit survey|5
4779700|NCT01479985|16488208|P2|Overall Study|No decisional conflict scale responses|2
4779701|NCT01479985|16488209|P1|Overall Study|No decisional conflict scale responses|0
4779702|NCT01479985|16488208|P2|Overall Study|Tablet malfunction, no data saved|1
4779703|NCT01479985|16488209|P1|Overall Study|Tablet malfunction, no data saved|1
4779704|NCT01479868|16488217|P1|Overall Study|Initiation of new HCV Therapy|1
4779705|NCT01479868|16488217|P1|Overall Study|Sponsor's Decision|1
4779706|NCT01479868|16488217|P1|Overall Study|Withdrawal by Subject|1
4779707|NCT01479868|16488217|P1|Overall Study|Protocol Violation|1
4779708|NCT01479868|16488217|P1|Overall Study|Lost to Follow-up|4
4779709|NCT01479868|16488217|P1|Overall Study|Adverse Event|1
4779710|NCT01479777|16488232|P1|Overall Study|Physician Decision|2
4779711|NCT01479764|16488244|P2|Treated|Lost to Follow-up|2
4779712|NCT01479764|16488245|P1|Treated|Lost to Follow-up|0
4779713|NCT01479764|16488244|P2|Randomized|Withdrawal by Subject|0
4779714|NCT01479764|16488245|P1|Randomized|Withdrawal by Subject|1
4779715|NCT01479764|16488244|P2|Randomized|Adverse Event|1
4779716|NCT01479764|16488245|P1|Randomized|Adverse Event|1
4779717|NCT01479621|16488268|P7|Treatment Period|Met stopping criteria|6
4779718|NCT01479621|16488269|P6|Treatment Period|Met stopping criteria|20
4779719|NCT01479621|16488270|P5|Treatment Period|Met stopping criteria|9
4779720|NCT01479621|16488271|P4|Treatment Period|Met stopping criteria|4
4779721|NCT01479621|16488272|P3|Treatment Period|Met stopping criteria|7
4779722|NCT01479621|16488273|P2|Treatment Period|Met stopping criteria|8
4779723|NCT01479621|16488274|P1|Treatment Period|Met stopping criteria|0
4779724|NCT01479621|16488268|P7|Treatment Period|Lost to Follow-up|1
4779725|NCT01479621|16488269|P6|Treatment Period|Lost to Follow-up|2
4779726|NCT01479621|16488270|P5|Treatment Period|Lost to Follow-up|2
4779727|NCT01479621|16488271|P4|Treatment Period|Lost to Follow-up|0
4779728|NCT01479621|16488272|P3|Treatment Period|Lost to Follow-up|1
4779729|NCT01479621|16488273|P2|Treatment Period|Lost to Follow-up|0
4779730|NCT01479621|16488274|P1|Treatment Period|Lost to Follow-up|0
4779731|NCT01479621|16488268|P7|Treatment Period|Sponsor request subject to be withdrawn|3
4779732|NCT01479621|16488269|P6|Treatment Period|Sponsor request subject to be withdrawn|1
4779733|NCT01479621|16488270|P5|Treatment Period|Sponsor request subject to be withdrawn|1
4779734|NCT01479621|16488271|P4|Treatment Period|Sponsor request subject to be withdrawn|1
4779735|NCT01479621|16488272|P3|Treatment Period|Sponsor request subject to be withdrawn|3
4779736|NCT01479621|16488273|P2|Treatment Period|Sponsor request subject to be withdrawn|2
4779737|NCT01479621|16488274|P1|Treatment Period|Sponsor request subject to be withdrawn|0
4779738|NCT01479621|16488268|P7|Treatment Period|Pregnancy|0
4779739|NCT01479621|16488269|P6|Treatment Period|Pregnancy|0
4779740|NCT01479621|16488270|P5|Treatment Period|Pregnancy|0
4779741|NCT01479621|16488271|P4|Treatment Period|Pregnancy|0
4779742|NCT01479621|16488272|P3|Treatment Period|Pregnancy|2
4779743|NCT01479621|16488273|P2|Treatment Period|Pregnancy|0
4779744|NCT01479621|16488274|P1|Treatment Period|Pregnancy|0
4779745|NCT01479621|16488268|P7|Treatment Period|Protocol Violation|6
4779746|NCT01479621|16488269|P6|Treatment Period|Protocol Violation|10
4779747|NCT01479621|16488270|P5|Treatment Period|Protocol Violation|2
4779748|NCT01479621|16488271|P4|Treatment Period|Protocol Violation|5
4779749|NCT01479621|16488272|P3|Treatment Period|Protocol Violation|6
4779750|NCT01479621|16488273|P2|Treatment Period|Protocol Violation|9
4779751|NCT01479621|16488274|P1|Treatment Period|Protocol Violation|0
4779752|NCT01479621|16488268|P7|Treatment Period|Non-compliance to study drug|1
4779753|NCT01479621|16488269|P6|Treatment Period|Non-compliance to study drug|0
4779754|NCT01479621|16488270|P5|Treatment Period|Non-compliance to study drug|0
4779755|NCT01479621|16488271|P4|Treatment Period|Non-compliance to study drug|0
4779756|NCT01479621|16488272|P3|Treatment Period|Non-compliance to study drug|0
4779757|NCT01479621|16488273|P2|Treatment Period|Non-compliance to study drug|1
4779758|NCT01479621|16488274|P1|Treatment Period|Non-compliance to study drug|0
4779759|NCT01479621|16488268|P7|Treatment Period|Physician Decision|0
4779760|NCT01479621|16488269|P6|Treatment Period|Physician Decision|1
4779761|NCT01479621|16488270|P5|Treatment Period|Physician Decision|1
4779762|NCT01479621|16488271|P4|Treatment Period|Physician Decision|0
4779763|NCT01479621|16488272|P3|Treatment Period|Physician Decision|0
4779764|NCT01479621|16488273|P2|Treatment Period|Physician Decision|0
4779765|NCT01479621|16488274|P1|Treatment Period|Physician Decision|0
4779766|NCT01479621|16488268|P7|Treatment Period|Withdrawal by Subject|1
4779767|NCT01479621|16488269|P6|Treatment Period|Withdrawal by Subject|5
4779768|NCT01479621|16488270|P5|Treatment Period|Withdrawal by Subject|5
4779769|NCT01479621|16488271|P4|Treatment Period|Withdrawal by Subject|2
4779770|NCT01479621|16488272|P3|Treatment Period|Withdrawal by Subject|2
4779771|NCT01479621|16488273|P2|Treatment Period|Withdrawal by Subject|4
4779772|NCT01479621|16488274|P1|Treatment Period|Withdrawal by Subject|0
4779773|NCT01479621|16488268|P7|Treatment Period|Adverse Event|2
4779774|NCT01479621|16488269|P6|Treatment Period|Adverse Event|2
4779775|NCT01479621|16488270|P5|Treatment Period|Adverse Event|1
4779776|NCT01479621|16488271|P4|Treatment Period|Adverse Event|0
4779777|NCT01479621|16488272|P3|Treatment Period|Adverse Event|0
4779778|NCT01479621|16488273|P2|Treatment Period|Adverse Event|0
4779779|NCT01479621|16488274|P1|Treatment Period|Adverse Event|0
4779780|NCT01479621|16488268|P7|Pre-Assignment Period (Run-In Placebo)|Other|0
4779781|NCT01479621|16488269|P6|Pre-Assignment Period (Run-In Placebo)|Other|0
4779782|NCT01479621|16488270|P5|Pre-Assignment Period (Run-In Placebo)|Other|0
4779783|NCT01479621|16488271|P4|Pre-Assignment Period (Run-In Placebo)|Other|0
4779784|NCT01479621|16488272|P3|Pre-Assignment Period (Run-In Placebo)|Other|0
4779785|NCT01479621|16488273|P2|Pre-Assignment Period (Run-In Placebo)|Other|0
4779786|NCT01479621|16488274|P1|Pre-Assignment Period (Run-In Placebo)|Other|15
4779787|NCT01479621|16488268|P7|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4779788|NCT01479621|16488269|P6|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4779789|NCT01479621|16488270|P5|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4779790|NCT01479621|16488271|P4|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4779791|NCT01479621|16488272|P3|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4779792|NCT01479621|16488273|P2|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0
4779793|NCT01479621|16488274|P1|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7
4779794|NCT01479621|16488268|P7|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4779795|NCT01479621|16488269|P6|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4779796|NCT01479621|16488270|P5|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4779797|NCT01479621|16488271|P4|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4779798|NCT01479621|16488272|P3|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4779799|NCT01479621|16488273|P2|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0
4779800|NCT01479621|16488274|P1|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153
4779801|NCT01479621|16488268|P7|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4779802|NCT01479621|16488269|P6|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4779803|NCT01479621|16488270|P5|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4779804|NCT01479621|16488271|P4|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4779805|NCT01479621|16488272|P3|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4779806|NCT01479621|16488273|P2|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0
4779807|NCT01479621|16488274|P1|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19
4779808|NCT01479621|16488268|P7|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4779809|NCT01479621|16488269|P6|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4779810|NCT01479621|16488270|P5|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4779811|NCT01479621|16488271|P4|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4779812|NCT01479621|16488272|P3|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4779813|NCT01479621|16488273|P2|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0
4779814|NCT01479621|16488274|P1|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93
4779815|NCT01479595|16488362|P2|Overall Study|Adverse Event|1
4779816|NCT01479595|16488363|P1|Overall Study|Adverse Event|2
4779817|NCT01479595|16488362|P2|Overall Study|Protocol deviation|1
4779818|NCT01479595|16488363|P1|Overall Study|Protocol deviation|0
4779819|NCT01479530|16488408|P2|Overall Study|Withdrawal of Consent|2
4779820|NCT01479530|16488409|P1|Overall Study|Withdrawal of Consent|3
4779821|NCT01479530|16488408|P2|Overall Study|Protocol Violation|3
4779822|NCT01479530|16488409|P1|Overall Study|Protocol Violation|2
4779823|NCT01479530|16488408|P2|Overall Study|Lack of Efficacy|1
4779824|NCT01479530|16488409|P1|Overall Study|Lack of Efficacy|0
4779825|NCT01479530|16488408|P2|Overall Study|Adverse Event|6
4779826|NCT01479530|16488409|P1|Overall Study|Adverse Event|5
4779827|NCT01479465|16488490|P4|Overall Study|Lost to Follow-up|0
4779828|NCT01479465|16488491|P3|Overall Study|Lost to Follow-up|1
4779829|NCT01479465|16488492|P2|Overall Study|Lost to Follow-up|0
4779830|NCT01479465|16488493|P1|Overall Study|Lost to Follow-up|0
4779831|NCT01479465|16488490|P4|Overall Study|Death|1
4779832|NCT01479465|16488491|P3|Overall Study|Death|0
4779833|NCT01479465|16488492|P2|Overall Study|Death|0
4779834|NCT01479465|16488493|P1|Overall Study|Death|0
4779835|NCT01479465|16488490|P4|Overall Study|Protocol Violation|0
4779836|NCT01479465|16488491|P3|Overall Study|Protocol Violation|1
4779837|NCT01479465|16488492|P2|Overall Study|Protocol Violation|1
4779838|NCT01479465|16488493|P1|Overall Study|Protocol Violation|0
4779839|NCT01479465|16488490|P4|Overall Study|Subject Withdrew Consent|1
4779840|NCT01479465|16488491|P3|Overall Study|Subject Withdrew Consent|2
4779841|NCT01479465|16488492|P2|Overall Study|Subject Withdrew Consent|5
4779842|NCT01479465|16488493|P1|Overall Study|Subject Withdrew Consent|0
4779843|NCT01479465|16488490|P4|Overall Study|Subject Request|2
4779844|NCT01479465|16488491|P3|Overall Study|Subject Request|4
4779845|NCT01479465|16488492|P2|Overall Study|Subject Request|3
4779846|NCT01479465|16488493|P1|Overall Study|Subject Request|1
4779847|NCT01479465|16488490|P4|Overall Study|Investigator Discretion|4
4779848|NCT01479465|16488491|P3|Overall Study|Investigator Discretion|2
4779849|NCT01479465|16488492|P2|Overall Study|Investigator Discretion|4
4779850|NCT01479465|16488493|P1|Overall Study|Investigator Discretion|1
4779851|NCT01479465|16488490|P4|Overall Study|Adverse Event|4
4779852|NCT01479465|16488491|P3|Overall Study|Adverse Event|6
4779853|NCT01479465|16488492|P2|Overall Study|Adverse Event|3
4779854|NCT01479465|16488493|P1|Overall Study|Adverse Event|0
4779855|NCT01479465|16488490|P4|Overall Study|Study Discontinued by Sponsor|3
4779856|NCT01479465|16488491|P3|Overall Study|Study Discontinued by Sponsor|5
4779857|NCT01479465|16488492|P2|Overall Study|Study Discontinued by Sponsor|7
4779858|NCT01479465|16488493|P1|Overall Study|Study Discontinued by Sponsor|0
4779859|NCT01479465|16488490|P4|Overall Study|Disease Progression|70
4779860|NCT01479465|16488491|P3|Overall Study|Disease Progression|65
4779861|NCT01479465|16488492|P2|Overall Study|Disease Progression|61
4779862|NCT01479465|16488493|P1|Overall Study|Disease Progression|9
4779863|NCT01479439|16488514|P3|Overall Study|Protocol Violation|2
4779864|NCT01479439|16488515|P2|Overall Study|Protocol Violation|0
4779865|NCT01479439|16488516|P1|Overall Study|Protocol Violation|0
4779866|NCT01479439|16488514|P3|Overall Study|Lost to Follow-up|0
4779867|NCT01479439|16488515|P2|Overall Study|Lost to Follow-up|1
4779868|NCT01479439|16488516|P1|Overall Study|Lost to Follow-up|0
4779869|NCT01479439|16488514|P3|Overall Study|Adverse Event|0
4779870|NCT01479439|16488515|P2|Overall Study|Adverse Event|0
4779871|NCT01479439|16488516|P1|Overall Study|Adverse Event|1
4779872|NCT01479374|16488548|P3|Overall Study|Other|5
4779873|NCT01479374|16488549|P2|Overall Study|Other|4
4779874|NCT01479374|16488550|P1|Overall Study|Other|0
4779875|NCT01479374|16488548|P3|Overall Study|Decision Unrelated to Adverse Event|0
4779876|NCT01479374|16488549|P2|Overall Study|Decision Unrelated to Adverse Event|1
4779877|NCT01479374|16488550|P1|Overall Study|Decision Unrelated to Adverse Event|0
4779878|NCT01479374|16488548|P3|Overall Study|Lost to Follow-up|0
4779879|NCT01479374|16488549|P2|Overall Study|Lost to Follow-up|2
4779880|NCT01479374|16488550|P1|Overall Study|Lost to Follow-up|1
4779881|NCT01479374|16488548|P3|Overall Study|Adverse Event|0
4779882|NCT01479374|16488549|P2|Overall Study|Adverse Event|1
4779883|NCT01479374|16488550|P1|Overall Study|Adverse Event|2
4779884|NCT01478971|16488644|P1|Peginesatide Treatment Period|Other|4
4779885|NCT01478971|16488644|P1|Peginesatide Treatment Period|Lost to Follow-up|4
4779886|NCT01478971|16488644|P1|Peginesatide Treatment Period|Death|4
4779887|NCT01478971|16488644|P1|Peginesatide Treatment Period|Withdrawal by Subject|1
4779888|NCT01478971|16488644|P1|Peginesatide Treatment Period|Adverse Event|1
4779889|NCT01478971|16488644|P1|Standard of Care Period|Other|4
4779890|NCT01478971|16488644|P1|Standard of Care Period|Lost to Follow-up|9
4779891|NCT01478971|16488644|P1|Standard of Care Period|Death|8
4779892|NCT01478971|16488644|P1|Standard of Care Period|Withdrawal by Subject|3
4779893|NCT01478971|16488644|P1|Standard of Care Period|Adverse Event|1
4779894|NCT01478958|16488661|P3|Overall Study|Unable to comply|2
4779895|NCT01478958|16488662|P2|Overall Study|Unable to comply|0
4779896|NCT01478958|16488663|P1|Overall Study|Unable to comply|0
4779897|NCT01478958|16488661|P3|Overall Study|Re-located|0
4779898|NCT01478958|16488662|P2|Overall Study|Re-located|1
4779899|NCT01478958|16488663|P1|Overall Study|Re-located|0
4779900|NCT01478958|16488661|P3|Overall Study|Weight loss|0
4779901|NCT01478958|16488662|P2|Overall Study|Weight loss|0
4779902|NCT01478958|16488663|P1|Overall Study|Weight loss|1
4779903|NCT01478958|16488661|P3|Overall Study|Withdrawal by Subject|1
4779904|NCT01478958|16488662|P2|Overall Study|Withdrawal by Subject|1
4779905|NCT01478958|16488663|P1|Overall Study|Withdrawal by Subject|1
4779906|NCT01478828|16488683|P1|Overall Study|Adverse Event|1
4779907|NCT01478620|16488694|P1|Overall Study|Lost to Follow-up|6
4779908|NCT01478594|16488700|P2|Overall Study|Study Closed by Sponsor|5
4779909|NCT01478594|16488701|P1|Overall Study|Study Closed by Sponsor|8
4779910|NCT01478594|16488700|P2|Overall Study|Withdrawal by Subject|3
4779911|NCT01478594|16488701|P1|Overall Study|Withdrawal by Subject|9
4779912|NCT01478594|16488700|P2|Overall Study|Lost to Follow-up|1
4779913|NCT01478594|16488701|P1|Overall Study|Lost to Follow-up|3
4779914|NCT01478594|16488700|P2|Overall Study|Death|18
4779915|NCT01478594|16488701|P1|Overall Study|Death|45
4779916|NCT01478594|16488700|P2|Overall Study|Randomized but Never Received Study Drug|1
4779917|NCT01478594|16488701|P1|Overall Study|Randomized but Never Received Study Drug|0
4779918|NCT01478373|16488830|P1|Survival Phase|Progressive Disease|27
4779919|NCT01478373|16488830|P1|Survival Phase|crossover to another study|2
4779920|NCT01478373|16488830|P1|Survival Phase|Protocol Violation|1
4779921|NCT01478373|16488830|P1|Survival Phase|Adverse Event|8
4779922|NCT01478373|16488830|P1|Treatment Phase|Protocol Violation|1
4779923|NCT01478360|16488843|P2|Overall Study|Administrative problems|2
4779924|NCT01478360|16488844|P1|Overall Study|Administrative problems|1
4779925|NCT01478360|16488843|P2|Overall Study|Adverse Event|1
4779926|NCT01478360|16488844|P1|Overall Study|Adverse Event|0
4779927|NCT01478360|16488843|P2|Overall Study|Lost to Follow-up|0
4779928|NCT01478360|16488844|P1|Overall Study|Lost to Follow-up|1
4779929|NCT01478347|16488850|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4
4779930|NCT01478347|16488850|P1|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4
4779931|NCT01478347|16488850|P1|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1
4779932|NCT01478321|16488855|P1|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8
4779933|NCT01478321|16488855|P1|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1
4779934|NCT01478321|16488855|P1|Adjuvant Therapy Until PD or Toxicity|Death|1
4779935|NCT01478321|16488855|P1|Started Adjuvant Therapy|Withdrawal by Subject|1
4779936|NCT01478321|16488855|P1|Concurrent Therapy (5 Weeks)|Progressive Disease|5
4779937|NCT01478321|16488855|P1|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5
4779938|NCT01478321|16488855|P1|Concurrent Therapy (5 Weeks)|Death|2
4779939|NCT01478321|16488855|P1|Concurrent Therapy (5 Weeks)|Adverse Event|4
4779940|NCT01478113|16488878|P2|Overall Study|Physician Decision|0
4779941|NCT01478113|16488879|P1|Overall Study|Physician Decision|1
4779942|NCT01478113|16488878|P2|Overall Study|Withdrawal by Subject|1
4779943|NCT01478113|16488879|P1|Overall Study|Withdrawal by Subject|0
4779944|NCT01478087|16488897|P1|Overall Study|due to sponsor closing study|1
4779945|NCT01478048|16488904|P2|Overall Study|no longer meets study criteria|0
4779946|NCT01478048|16488905|P1|Overall Study|no longer meets study criteria|1
4779947|NCT01478048|16488904|P2|Overall Study|poor/non-compliance|1
4779948|NCT01478048|16488905|P1|Overall Study|poor/non-compliance|0
4779949|NCT01478048|16488904|P2|Overall Study|non-specified|4
4779950|NCT01478048|16488905|P1|Overall Study|non-specified|6
4779951|NCT01478048|16488904|P2|Overall Study|Withdrawal by Subject|5
4779952|NCT01478048|16488905|P1|Overall Study|Withdrawal by Subject|2
4779953|NCT01478048|16488904|P2|Overall Study|subject request to discontinue treatment|5
4779954|NCT01478048|16488905|P1|Overall Study|subject request to discontinue treatment|3
4779955|NCT01478048|16488904|P2|Overall Study|Adverse Event|11
4779956|NCT01478048|16488905|P1|Overall Study|Adverse Event|2
4779957|NCT01478048|16488904|P2|Overall Study|study drug toxicity|14
4779958|NCT01478048|16488905|P1|Overall Study|study drug toxicity|11
4779959|NCT01478048|16488904|P2|Overall Study|Disease Progression|35
4779960|NCT01478048|16488905|P1|Overall Study|Disease Progression|52
4779961|NCT01477892|16488934|P2|Overall Study|Withdrawal by Subject|2
4779962|NCT01477892|16488935|P1|Overall Study|Withdrawal by Subject|0
4779963|NCT01477853|16488946|P3|Phase B|Study terminated by sponsor|11
4779964|NCT01477853|16488947|P2|Phase B|Study terminated by sponsor|10
4779965|NCT01477853|16488948|P1|Phase B|Study terminated by sponsor|12
4779966|NCT01477853|16488946|P3|Phase B|Lost to Follow-up|0
4779967|NCT01477853|16488947|P2|Phase B|Lost to Follow-up|1
4779968|NCT01477853|16488948|P1|Phase B|Lost to Follow-up|0
4779969|NCT01477853|16488946|P3|Phase A|Study terminated by sponsor|39
4779970|NCT01477853|16488947|P2|Phase A|Study terminated by sponsor|40
4779971|NCT01477853|16488948|P1|Phase A|Study terminated by sponsor|37
4779972|NCT01477853|16488946|P3|Phase A|Physician Decision|1
4779973|NCT01477853|16488947|P2|Phase A|Physician Decision|0
4779974|NCT01477853|16488948|P1|Phase A|Physician Decision|1
4779975|NCT01477853|16488946|P3|Phase A|Lost to Follow-up|2
4779976|NCT01477853|16488947|P2|Phase A|Lost to Follow-up|3
4779977|NCT01477853|16488948|P1|Phase A|Lost to Follow-up|4
4779978|NCT01477853|16488946|P3|Phase A|Adverse Event|2
4779979|NCT01477853|16488947|P2|Phase A|Adverse Event|2
4779980|NCT01477853|16488948|P1|Phase A|Adverse Event|1
4779981|NCT01477749|16489015|P1|Overall Study|Physician Decision|4
4779982|NCT01477333|16489123|P1|Overall Study|Clinical Deterioration|1
4779983|NCT01477333|16489123|P1|Overall Study|Withdrawal by Subject|1
4779984|NCT01477333|16489123|P1|Overall Study|Adverse Event|1
4779985|NCT01476722|16489174|P1|Overall Study|Adverse Event|1
4779986|NCT01476696|16489181|P3|Overall Study|Withdrawal by Subject|0
4779987|NCT01476696|16489182|P2|Overall Study|Withdrawal by Subject|0
4779988|NCT01476696|16489183|P1|Overall Study|Withdrawal by Subject|1
4779989|NCT01476696|16489181|P3|Overall Study|Sponsor decision|0
4779990|NCT01476696|16489182|P2|Overall Study|Sponsor decision|1
4779991|NCT01476696|16489183|P1|Overall Study|Sponsor decision|2
4779992|NCT01476644|16489197|P1|Overall Study|Withdrawal by Subject|13
4779993|NCT01476644|16489197|P1|Overall Study|Lost to Follow-up|19
4779994|NCT01476644|16489197|P1|Overall Study|moved to another state|2
4779995|NCT01476644|16489197|P1|Overall Study|Death|5
4779996|NCT01476475|16489204|P2|Overall Study|Other reasons|2
4779997|NCT01476475|16489205|P1|Overall Study|Other reasons|4
4779998|NCT01476475|16489204|P2|Overall Study|Poor compliance to protocol|1
4779999|NCT01476475|16489205|P1|Overall Study|Poor compliance to protocol|1
4780000|NCT01476475|16489204|P2|Overall Study|Adverse Event|0
4780001|NCT01476475|16489205|P1|Overall Study|Adverse Event|6
4780002|NCT01475851|16489656|P2|Overall Study|Protocol defined stopping criteria|0
4780003|NCT01475851|16489657|P1|Overall Study|Protocol defined stopping criteria|1
4780004|NCT01475838|16489685|P2|Extension Phase|Participant Noncompliance|0
4780005|NCT01475838|16489686|P1|Extension Phase|Participant Noncompliance|1
4780006|NCT01475838|16489685|P2|Randomized Phase|Protocol Violation|4
4780007|NCT01475838|16489686|P1|Randomized Phase|Protocol Violation|9
4780008|NCT01475838|16489685|P2|Randomized Phase|Participant Noncompliance|5
4780009|NCT01475838|16489686|P1|Randomized Phase|Participant Noncompliance|1
4780010|NCT01475838|16489685|P2|Randomized Phase|Lost to Follow-up|4
4780011|NCT01475838|16489686|P1|Randomized Phase|Lost to Follow-up|3
4780012|NCT01475838|16489685|P2|Randomized Phase|Withdrew Consent|14
4780013|NCT01475838|16489686|P1|Randomized Phase|Withdrew Consent|10
4780014|NCT01475838|16489685|P2|Randomized Phase|Investigators Discretion|2
4780015|NCT01475838|16489686|P1|Randomized Phase|Investigators Discretion|1
4780016|NCT01475838|16489685|P2|Randomized Phase|Pregnancy|1
4780017|NCT01475838|16489686|P1|Randomized Phase|Pregnancy|0
4780018|NCT01475838|16489685|P2|Randomized Phase|Adverse Event|1
4780019|NCT01475838|16489686|P1|Randomized Phase|Adverse Event|6
4780020|NCT01475838|16489685|P2|Randomized Phase|Randomized but Not Treated|5
4780021|NCT01475838|16489686|P1|Randomized Phase|Randomized but Not Treated|0
4780022|NCT01475825|16489703|P4|Overall Study|Did not enter OLC|11
4780023|NCT01475825|16489704|P3|Overall Study|Did not enter OLC|15
4780024|NCT01475825|16489705|P2|Overall Study|Did not enter OLC|11
4780025|NCT01475825|16489706|P1|Overall Study|Did not enter OLC|15
4780026|NCT01475825|16489703|P4|Overall Study|Withdrawal by Subject|7
4780027|NCT01475825|16489704|P3|Overall Study|Withdrawal by Subject|11
4780028|NCT01475825|16489705|P2|Overall Study|Withdrawal by Subject|3
4780029|NCT01475825|16489706|P1|Overall Study|Withdrawal by Subject|8
4780030|NCT01475825|16489703|P4|Overall Study|Physician Decision|0
4780031|NCT01475825|16489704|P3|Overall Study|Physician Decision|0
4780032|NCT01475825|16489705|P2|Overall Study|Physician Decision|1
4780033|NCT01475825|16489706|P1|Overall Study|Physician Decision|0
4780034|NCT01475825|16489703|P4|Overall Study|Protocol Violation|0
4780035|NCT01475825|16489704|P3|Overall Study|Protocol Violation|0
4780036|NCT01475825|16489705|P2|Overall Study|Protocol Violation|0
4780037|NCT01475825|16489706|P1|Overall Study|Protocol Violation|1
4780038|NCT01475825|16489703|P4|Overall Study|Other: Not available|0
4780039|NCT01475825|16489704|P3|Overall Study|Other: Not available|2
4780040|NCT01475825|16489705|P2|Overall Study|Other: Not available|0
4780041|NCT01475825|16489706|P1|Overall Study|Other: Not available|0
4780042|NCT01475825|16489703|P4|Overall Study|Non-compliance with Study Drug|0
4780043|NCT01475825|16489704|P3|Overall Study|Non-compliance with Study Drug|4
4780044|NCT01475825|16489705|P2|Overall Study|Non-compliance with Study Drug|2
4780045|NCT01475825|16489706|P1|Overall Study|Non-compliance with Study Drug|1
4780046|NCT01475825|16489703|P4|Overall Study|Lost to Follow-up|1
4780047|NCT01475825|16489704|P3|Overall Study|Lost to Follow-up|3
4780048|NCT01475825|16489705|P2|Overall Study|Lost to Follow-up|0
4780049|NCT01475825|16489706|P1|Overall Study|Lost to Follow-up|0
4780050|NCT01475825|16489703|P4|Overall Study|Lack of Efficacy|0
4780051|NCT01475825|16489704|P3|Overall Study|Lack of Efficacy|1
4780052|NCT01475825|16489705|P2|Overall Study|Lack of Efficacy|0
4780053|NCT01475825|16489706|P1|Overall Study|Lack of Efficacy|0
4780054|NCT01475825|16489703|P4|Overall Study|Death|0
4780055|NCT01475825|16489704|P3|Overall Study|Death|1
4780056|NCT01475825|16489705|P2|Overall Study|Death|0
4780057|NCT01475825|16489706|P1|Overall Study|Death|1
4780058|NCT01475825|16489703|P4|Overall Study|Adverse Event|11
4780059|NCT01475825|16489704|P3|Overall Study|Adverse Event|27
4780060|NCT01475825|16489705|P2|Overall Study|Adverse Event|15
4780061|NCT01475825|16489706|P1|Overall Study|Adverse Event|41
4780062|NCT01475734|16489738|P2|Overall Study|Physician Decision|1
4780063|NCT01475734|16489739|P1|Overall Study|Physician Decision|0
4780064|NCT01475734|16489738|P2|Overall Study|Protocol Violation|0
4780065|NCT01475734|16489739|P1|Overall Study|Protocol Violation|1
4780066|NCT01475734|16489738|P2|Overall Study|Withdrawal by Subject|0
4780067|NCT01475734|16489739|P1|Overall Study|Withdrawal by Subject|1
4780068|NCT01475721|16489767|P2|Overall Study|Withdrawal by Subject|8
4780069|NCT01475721|16489768|P1|Overall Study|Withdrawal by Subject|8
4780070|NCT01475721|16489767|P2|Overall Study|Death|6
4780071|NCT01475721|16489768|P1|Overall Study|Death|3
4780072|NCT01475487|16489834|P2|Overall Study|had to leave early for personal reasons|1
4780073|NCT01475487|16489835|P1|Overall Study|had to leave early for personal reasons|2
4780074|NCT01475474|16489847|P1|Baseline Period - 4 Weeks|Withdrawal by Subject|2
4780075|NCT01475474|16489847|P1|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4
4780076|NCT01475461|16489858|P7|Treatment Period|Adverse Event|0
4780077|NCT01475461|16489859|P6|Treatment Period|Adverse Event|0
4780078|NCT01475461|16489860|P5|Treatment Period|Adverse Event|0
4780079|NCT01475461|16489861|P4|Treatment Period|Adverse Event|1
4780080|NCT01475461|16489862|P3|Treatment Period|Adverse Event|0
4780081|NCT01475461|16489863|P2|Treatment Period|Adverse Event|0
4780082|NCT01475461|16489864|P1|Treatment Period|Adverse Event|0
4780083|NCT01475461|16489858|P7|Treatment Period|Medication Error|0
4780084|NCT01475461|16489859|P6|Treatment Period|Medication Error|0
4780085|NCT01475461|16489860|P5|Treatment Period|Medication Error|0
4780086|NCT01475461|16489861|P4|Treatment Period|Medication Error|1
4780087|NCT01475461|16489862|P3|Treatment Period|Medication Error|0
4780088|NCT01475461|16489863|P2|Treatment Period|Medication Error|0
4780089|NCT01475461|16489864|P1|Treatment Period|Medication Error|0
4780090|NCT01475461|16489858|P7|Treatment Period|Lack of Efficacy|0
4780091|NCT01475461|16489859|P6|Treatment Period|Lack of Efficacy|1
4780092|NCT01475461|16489860|P5|Treatment Period|Lack of Efficacy|1
4780093|NCT01475461|16489861|P4|Treatment Period|Lack of Efficacy|2
4780094|NCT01475461|16489862|P3|Treatment Period|Lack of Efficacy|0
4780095|NCT01475461|16489863|P2|Treatment Period|Lack of Efficacy|2
4780096|NCT01475461|16489864|P1|Treatment Period|Lack of Efficacy|0
4780097|NCT01475461|16489858|P7|Treatment Period|Protocol Violation|1
4780098|NCT01475461|16489859|P6|Treatment Period|Protocol Violation|0
4780099|NCT01475461|16489860|P5|Treatment Period|Protocol Violation|0
4780100|NCT01475461|16489861|P4|Treatment Period|Protocol Violation|0
4780101|NCT01475461|16489862|P3|Treatment Period|Protocol Violation|0
4780102|NCT01475461|16489863|P2|Treatment Period|Protocol Violation|1
4780103|NCT01475461|16489864|P1|Treatment Period|Protocol Violation|0
4780104|NCT01475461|16489858|P7|Treatment Period|Other|0
4780105|NCT01475461|16489859|P6|Treatment Period|Other|0
4780106|NCT01475461|16489860|P5|Treatment Period|Other|0
4780107|NCT01475461|16489861|P4|Treatment Period|Other|0
4780108|NCT01475461|16489862|P3|Treatment Period|Other|0
4780109|NCT01475461|16489863|P2|Treatment Period|Other|1
4780110|NCT01475461|16489864|P1|Treatment Period|Other|0
4780111|NCT01475461|16489858|P7|Treatment Period|Withdrawal by Subject|0
4780112|NCT01475461|16489859|P6|Treatment Period|Withdrawal by Subject|2
4780113|NCT01475461|16489860|P5|Treatment Period|Withdrawal by Subject|2
4780114|NCT01475461|16489861|P4|Treatment Period|Withdrawal by Subject|0
4780115|NCT01475461|16489862|P3|Treatment Period|Withdrawal by Subject|2
4780116|NCT01475461|16489863|P2|Treatment Period|Withdrawal by Subject|2
4780117|NCT01475461|16489864|P1|Treatment Period|Withdrawal by Subject|0
4780118|NCT01475461|16489858|P7|Treatment Period|Lost to Follow-up|1
4780119|NCT01475461|16489859|P6|Treatment Period|Lost to Follow-up|2
4780120|NCT01475461|16489860|P5|Treatment Period|Lost to Follow-up|1
4780121|NCT01475461|16489861|P4|Treatment Period|Lost to Follow-up|3
4780122|NCT01475461|16489862|P3|Treatment Period|Lost to Follow-up|2
4780123|NCT01475461|16489863|P2|Treatment Period|Lost to Follow-up|3
4780124|NCT01475461|16489864|P1|Treatment Period|Lost to Follow-up|0
4780125|NCT01475461|16489858|P7|Treatment Period|Death|0
4780126|NCT01475461|16489859|P6|Treatment Period|Death|0
4780127|NCT01475461|16489860|P5|Treatment Period|Death|0
4780128|NCT01475461|16489861|P4|Treatment Period|Death|1
4780129|NCT01475461|16489862|P3|Treatment Period|Death|0
4780130|NCT01475461|16489863|P2|Treatment Period|Death|0
4780131|NCT01475461|16489864|P1|Treatment Period|Death|0
4780132|NCT01475461|16489858|P7|Run-in Period|Protocol Violation|0
4780133|NCT01475461|16489859|P6|Run-in Period|Protocol Violation|0
4780134|NCT01475461|16489860|P5|Run-in Period|Protocol Violation|0
4780135|NCT01475461|16489861|P4|Run-in Period|Protocol Violation|0
4780136|NCT01475461|16489862|P3|Run-in Period|Protocol Violation|0
4780137|NCT01475461|16489863|P2|Run-in Period|Protocol Violation|0
4780138|NCT01475461|16489864|P1|Run-in Period|Protocol Violation|4
4780139|NCT01475461|16489858|P7|Run-in Period|Other|0
4780140|NCT01475461|16489859|P6|Run-in Period|Other|0
4780141|NCT01475461|16489860|P5|Run-in Period|Other|0
4780142|NCT01475461|16489861|P4|Run-in Period|Other|0
4780143|NCT01475461|16489862|P3|Run-in Period|Other|0
4780144|NCT01475461|16489863|P2|Run-in Period|Other|0
4780145|NCT01475461|16489864|P1|Run-in Period|Other|3
4780146|NCT01475461|16489858|P7|Run-in Period|Withdrawal by Subject|0
4780147|NCT01475461|16489859|P6|Run-in Period|Withdrawal by Subject|0
4780148|NCT01475461|16489860|P5|Run-in Period|Withdrawal by Subject|0
4780149|NCT01475461|16489861|P4|Run-in Period|Withdrawal by Subject|0
4780150|NCT01475461|16489862|P3|Run-in Period|Withdrawal by Subject|0
4780151|NCT01475461|16489863|P2|Run-in Period|Withdrawal by Subject|0
4780152|NCT01475461|16489864|P1|Run-in Period|Withdrawal by Subject|11
4780153|NCT01475461|16489858|P7|Run-in Period|Lost to Follow-up|0
4780154|NCT01475461|16489859|P6|Run-in Period|Lost to Follow-up|0
4780155|NCT01475461|16489860|P5|Run-in Period|Lost to Follow-up|0
4780156|NCT01475461|16489861|P4|Run-in Period|Lost to Follow-up|0
4780157|NCT01475461|16489862|P3|Run-in Period|Lost to Follow-up|0
4780158|NCT01475461|16489863|P2|Run-in Period|Lost to Follow-up|0
4780159|NCT01475461|16489864|P1|Run-in Period|Lost to Follow-up|7
4780160|NCT01475461|16489858|P7|Run-in Period|Not meet eligibility criteria|0
4780161|NCT01475461|16489859|P6|Run-in Period|Not meet eligibility criteria|0
4780162|NCT01475461|16489860|P5|Run-in Period|Not meet eligibility criteria|0
4780163|NCT01475461|16489861|P4|Run-in Period|Not meet eligibility criteria|0
4780164|NCT01475461|16489862|P3|Run-in Period|Not meet eligibility criteria|0
4780165|NCT01475461|16489863|P2|Run-in Period|Not meet eligibility criteria|0
4780166|NCT01475461|16489864|P1|Run-in Period|Not meet eligibility criteria|16
4780167|NCT01475331|16489944|P2|Overall Study|cyst found to be prohibitively small|1
4780168|NCT01475331|16489945|P1|Overall Study|cyst found to be prohibitively small|0
4780169|NCT01475331|16489944|P2|Overall Study|Sign of malignancy during the procedure|0
4780170|NCT01475331|16489945|P1|Overall Study|Sign of malignancy during the procedure|2
4780171|NCT01475331|16489944|P2|Overall Study|Loss of needle positioning due pt. cough|0
4780172|NCT01475331|16489945|P1|Overall Study|Loss of needle positioning due pt. cough|1
4780173|NCT01475331|16489944|P2|Overall Study|excessive main duct communication|1
4780174|NCT01475331|16489945|P1|Overall Study|excessive main duct communication|1
4780175|NCT01475331|16489944|P2|Overall Study|Osteophyte obstruction of the proximal|0
4780176|NCT01475331|16489945|P1|Overall Study|Osteophyte obstruction of the proximal|1
4780177|NCT01475253|16489997|P4|Randomized, Blinded Study|Lost to Follow-up|0
4780178|NCT01475253|16489998|P3|Randomized, Blinded Study|Lost to Follow-up|0
4780179|NCT01475253|16489999|P2|Randomized, Blinded Study|Lost to Follow-up|0
4780180|NCT01475253|16490000|P1|Randomized, Blinded Study|Lost to Follow-up|1
4780181|NCT01475253|16489997|P4|Randomized, Blinded Study|Withdrawal by Subject|0
4780182|NCT01475253|16489998|P3|Randomized, Blinded Study|Withdrawal by Subject|0
4780183|NCT01475253|16489999|P2|Randomized, Blinded Study|Withdrawal by Subject|1
4780184|NCT01475253|16490000|P1|Randomized, Blinded Study|Withdrawal by Subject|1
4780185|NCT01475214|16490029|P3|Overall Study|Withdrawal by Subject|1
4780186|NCT01475214|16490030|P2|Overall Study|Withdrawal by Subject|4
4780187|NCT01475214|16490031|P1|Overall Study|Withdrawal by Subject|2
4780188|NCT01475214|16490029|P3|Overall Study|Physician Decision|0
4780189|NCT01475214|16490030|P2|Overall Study|Physician Decision|0
4780190|NCT01475214|16490031|P1|Overall Study|Physician Decision|2
4780191|NCT01475214|16490029|P3|Overall Study|Lost to Follow-up|1
4780192|NCT01475214|16490030|P2|Overall Study|Lost to Follow-up|0
4780193|NCT01475214|16490031|P1|Overall Study|Lost to Follow-up|1
4780194|NCT01475162|16490054|P1|Overall Study|Study closed for safety|3
4780195|NCT01475162|16490054|P1|Overall Study|Death|10
4780196|NCT01475162|16490054|P1|Overall Study|Physician Decision|1
4780197|NCT01475097|16490067|P2|Overall Study|Protocol Violation|1
4780198|NCT01475097|16490068|P1|Overall Study|Protocol Violation|1
4780199|NCT01475071|16490076|P1|Overall Study|Lost to Follow-up|1
4780200|NCT01475071|16490076|P1|Overall Study|Withdrawal by Subject|6
4780201|NCT01475071|16490076|P1|Overall Study|Physician Decision|1
4780202|NCT01474993|16490086|P2|Overall Study|Adverse Event|1
4780203|NCT01474993|16490087|P1|Overall Study|Adverse Event|0
4780204|NCT01474993|16490086|P2|Overall Study|Lost to Follow-up|2
4780205|NCT01474993|16490087|P1|Overall Study|Lost to Follow-up|1
4780206|NCT01474876|16490129|P3|Overall Study|Investigator's decision and pt request|0
4780207|NCT01474876|16490130|P2|Overall Study|Investigator's decision and pt request|0
4780208|NCT01474876|16490131|P1|Overall Study|Investigator's decision and pt request|1
4780209|NCT01474876|16490129|P3|Overall Study|Patient's request|0
4780210|NCT01474876|16490130|P2|Overall Study|Patient's request|5
4780211|NCT01474876|16490131|P1|Overall Study|Patient's request|19
4780212|NCT01474876|16490129|P3|Overall Study|Investigator's decision|0
4780213|NCT01474876|16490130|P2|Overall Study|Investigator's decision|6
4780214|NCT01474876|16490131|P1|Overall Study|Investigator's decision|28
4780215|NCT01474876|16490129|P3|Overall Study|Lost to Follow-up|0
4780216|NCT01474876|16490130|P2|Overall Study|Lost to Follow-up|4
4780217|NCT01474876|16490131|P1|Overall Study|Lost to Follow-up|5
4780218|NCT01474876|16490129|P3|Overall Study|Serious Adverse Event|0
4780219|NCT01474876|16490130|P2|Overall Study|Serious Adverse Event|3
4780220|NCT01474876|16490131|P1|Overall Study|Serious Adverse Event|2
4780221|NCT01474876|16490129|P3|Overall Study|Adverse Event|0
4780222|NCT01474876|16490130|P2|Overall Study|Adverse Event|5
4780223|NCT01474876|16490131|P1|Overall Study|Adverse Event|11
4780224|NCT01474772|16490177|P2|Follow-up|AE not Related to Study Drug|1
4780225|NCT01474772|16490178|P1|Follow-up|AE not Related to Study Drug|0
4780226|NCT01474772|16490177|P2|Period 2|Reason not Specified|2
4780227|NCT01474772|16490178|P1|Period 2|Reason not Specified|0
4780228|NCT01474772|16490177|P2|Period 2|Lost to Follow-up|1
4780229|NCT01474772|16490178|P1|Period 2|Lost to Follow-up|1
4780230|NCT01474772|16490177|P2|Period 2|Withdrawal by Subject|4
4780231|NCT01474772|16490178|P1|Period 2|Withdrawal by Subject|3
4780232|NCT01474772|16490177|P2|Period 2|Lack of Efficacy|0
4780233|NCT01474772|16490178|P1|Period 2|Lack of Efficacy|1
4780234|NCT01474772|16490177|P2|Period 2|AE not Related to Study Drug|1
4780235|NCT01474772|16490178|P1|Period 2|AE not Related to Study Drug|4
4780236|NCT01474772|16490177|P2|Period 2|AE Related to Study Drug|1
4780237|NCT01474772|16490178|P1|Period 2|AE Related to Study Drug|0
4780238|NCT01474772|16490177|P2|Period 2|Death|1
4780239|NCT01474772|16490178|P1|Period 2|Death|0
4780240|NCT01474772|16490177|P2|Washout|Reason not Specified|1
4780241|NCT01474772|16490178|P1|Washout|Reason not Specified|0
4780242|NCT01474772|16490177|P2|Washout|Lost to Follow-up|1
4780243|NCT01474772|16490178|P1|Washout|Lost to Follow-up|0
4780244|NCT01474772|16490177|P2|Washout|Withdrawal by Subject|0
4780245|NCT01474772|16490178|P1|Washout|Withdrawal by Subject|1
4780246|NCT01474772|16490177|P2|Washout|AE not Related to Study Drug|0
4780247|NCT01474772|16490178|P1|Washout|AE not Related to Study Drug|2
4780248|NCT01474772|16490177|P2|Period 1|Reason not Specified|1
4780249|NCT01474772|16490178|P1|Period 1|Reason not Specified|1
4780250|NCT01474772|16490177|P2|Period 1|Lost to Follow-up|0
4780251|NCT01474772|16490178|P1|Period 1|Lost to Follow-up|1
4780252|NCT01474772|16490177|P2|Period 1|Withdrawal by Subject|1
4780253|NCT01474772|16490178|P1|Period 1|Withdrawal by Subject|3
4780254|NCT01474772|16490177|P2|Period 1|AE not Related to Study Drug|0
4780255|NCT01474772|16490178|P1|Period 1|AE not Related to Study Drug|1
4780256|NCT01474772|16490177|P2|Period 1|Adverse Event (AE) Related to Study Drug|1
4780257|NCT01474772|16490178|P1|Period 1|Adverse Event (AE) Related to Study Drug|6
4780258|NCT01474746|16490228|P2|Overall Study|Withdrawal by Subject|1
4780259|NCT01474746|16490229|P1|Overall Study|Withdrawal by Subject|2
4780260|NCT01474746|16490228|P2|Overall Study|Lost to Follow-up|1
4780261|NCT01474746|16490229|P1|Overall Study|Lost to Follow-up|1
4780262|NCT01474681|16490293|P4|Overall Study|Death|6
4780263|NCT01474681|16490294|P3|Overall Study|Death|2
4780264|NCT01474681|16490295|P2|Overall Study|Death|3
4780265|NCT01474681|16490296|P1|Overall Study|Death|0
4780266|NCT01474551|16490347|P1|Overall Study|Death|1
4780267|NCT01474538|16490353|P2|Treatment Period 2|Protocol Violation|0
4780268|NCT01474538|16490354|P1|Treatment Period 2|Protocol Violation|1
4780269|NCT01474538|16490353|P2|Treatment Period 2|Physician Decision|1
4780270|NCT01474538|16490354|P1|Treatment Period 2|Physician Decision|0
4780271|NCT01474538|16490353|P2|Treatment Period 2|Sponsor decision|0
4780272|NCT01474538|16490354|P1|Treatment Period 2|Sponsor decision|1
4780273|NCT01474538|16490353|P2|Treatment Period 2|Withdrawal by Subject|0
4780274|NCT01474538|16490354|P1|Treatment Period 2|Withdrawal by Subject|2
4780275|NCT01474538|16490353|P2|Treatment Period 2|Adverse Event|1
4780276|NCT01474538|16490354|P1|Treatment Period 2|Adverse Event|1
4780277|NCT01474538|16490353|P2|Treatment Period 2|Death|0
4780278|NCT01474538|16490354|P1|Treatment Period 2|Death|1
4780279|NCT01474538|16490353|P2|Treatment Period 1|Protocol Violation|1
4780280|NCT01474538|16490354|P1|Treatment Period 1|Protocol Violation|0
4780281|NCT01474538|16490353|P2|Treatment Period 1|Withdrawal by Subject|3
4780282|NCT01474538|16490354|P1|Treatment Period 1|Withdrawal by Subject|1
4780283|NCT01474538|16490353|P2|Treatment Period 1|Physician Decision|0
4780284|NCT01474538|16490354|P1|Treatment Period 1|Physician Decision|1
4780285|NCT01474538|16490353|P2|Treatment Period 1|Death|0
4780286|NCT01474538|16490354|P1|Treatment Period 1|Death|1
4780287|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Death|0
4780288|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Death|1
4780289|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Death|0
4780290|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Death|0
4780291|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Death|0
4780292|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Death|0
4780293|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Death|0
4780294|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Death|0
4780295|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Death|0
4780296|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Death|0
4780297|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Death|0
4780298|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Death|0
4780299|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Death|0
4780300|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Death|0
4780301|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Death|0
4780302|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Death|0
4780303|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Death|0
4780304|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Death|0
4780305|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
4780306|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780307|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780308|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Parent/Caregiver Decision|1
4780309|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780310|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780311|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780312|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780313|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780314|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780315|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780316|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780317|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780318|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780319|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780320|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780321|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780322|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Parent/Caregiver Decision|0
4780323|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Sponsor Decision|0
4780324|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Sponsor Decision|4
4780325|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Sponsor Decision|0
4780326|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Sponsor Decision|1
4780327|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Sponsor Decision|0
4780328|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Sponsor Decision|0
4780329|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Sponsor Decision|0
4780330|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Sponsor Decision|0
4780331|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Sponsor Decision|0
4780332|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Sponsor Decision|0
4780333|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Sponsor Decision|0
4780334|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Sponsor Decision|0
4780335|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Sponsor Decision|0
4780336|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Sponsor Decision|0
4780337|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Sponsor Decision|0
4780338|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Sponsor Decision|0
4780339|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Sponsor Decision|0
4780340|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Sponsor Decision|0
4780341|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Protocol Violation|0
4780342|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Protocol Violation|4
4780343|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Protocol Violation|2
4780344|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Protocol Violation|2
4780345|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Protocol Violation|0
4780346|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Protocol Violation|0
4780347|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Protocol Violation|0
4780348|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Protocol Violation|0
4780349|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Protocol Violation|0
4780350|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Protocol Violation|0
4780351|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Protocol Violation|0
4780352|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Protocol Violation|0
4780353|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Protocol Violation|0
4780354|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Protocol Violation|0
4780355|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Protocol Violation|0
4780356|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Protocol Violation|0
4780357|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Protocol Violation|0
4780358|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Protocol Violation|0
4780359|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Clinical Relapse|2
4780360|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Clinical Relapse|6
4780361|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Clinical Relapse|0
4780362|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Clinical Relapse|0
4780363|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Clinical Relapse|0
4780364|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Clinical Relapse|0
4780365|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Clinical Relapse|0
4780366|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Clinical Relapse|0
4780367|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Clinical Relapse|0
4780368|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Clinical Relapse|0
4780369|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Clinical Relapse|0
4780370|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Clinical Relapse|0
4780371|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Clinical Relapse|0
4780372|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Clinical Relapse|0
4780373|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Clinical Relapse|0
4780374|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Clinical Relapse|0
4780375|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Clinical Relapse|0
4780376|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Clinical Relapse|0
4780377|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Physician Decision|5
4780378|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Physician Decision|4
4780379|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Physician Decision|0
4780380|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Physician Decision|0
4780381|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Physician Decision|0
4780382|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Physician Decision|0
4780383|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Physician Decision|0
4780384|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Physician Decision|0
4780385|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Physician Decision|0
4780386|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Physician Decision|0
4780387|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Physician Decision|0
4780388|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Physician Decision|0
4780389|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Physician Decision|0
4780390|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Physician Decision|0
4780391|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Physician Decision|0
4780392|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Physician Decision|0
4780393|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Physician Decision|0
4780394|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Physician Decision|0
4780395|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Lost to Follow-up|7
4780396|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Lost to Follow-up|12
4780397|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Lost to Follow-up|0
4780398|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Lost to Follow-up|0
4780399|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Lost to Follow-up|0
4780400|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Lost to Follow-up|0
4780401|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Lost to Follow-up|0
4780402|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Lost to Follow-up|0
4780403|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Lost to Follow-up|0
4780404|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Lost to Follow-up|0
4780405|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Lost to Follow-up|0
4780406|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Lost to Follow-up|0
4780407|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Lost to Follow-up|0
4780408|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Lost to Follow-up|0
4780409|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Lost to Follow-up|0
4780410|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Lost to Follow-up|0
4780411|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Lost to Follow-up|0
4780412|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Lost to Follow-up|0
4780413|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Lack of Efficacy|3
4780414|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Lack of Efficacy|31
4780415|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Lack of Efficacy|2
4780416|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Lack of Efficacy|3
4780417|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Lack of Efficacy|0
4780418|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Lack of Efficacy|0
4780419|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Lack of Efficacy|0
4780420|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Lack of Efficacy|0
4780421|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Lack of Efficacy|0
4780422|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Lack of Efficacy|0
4780423|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Lack of Efficacy|0
4780424|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Lack of Efficacy|0
4780425|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Lack of Efficacy|0
4780426|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Lack of Efficacy|0
4780427|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Lack of Efficacy|0
4780428|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Lack of Efficacy|0
4780429|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Lack of Efficacy|0
4780430|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Lack of Efficacy|0
4780431|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Withdrawal by Subject|17
4780432|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Withdrawal by Subject|36
4780433|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Withdrawal by Subject|2
4780434|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Withdrawal by Subject|3
4780435|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780436|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780437|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780438|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780596|NCT01474512|16490374|P15|Long-Term Extension Period|Lack of Efficacy|0
4780439|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780440|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780441|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780442|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780443|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780444|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780445|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780446|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780447|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780448|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Withdrawal by Subject|0
4780449|NCT01474512|16490371|P18|Post-Treatment Follow-Up|Adverse Event|11
4780450|NCT01474512|16490372|P17|Post-Treatment Follow-Up|Adverse Event|58
4780451|NCT01474512|16490373|P16|Post-Treatment Follow-Up|Adverse Event|2
4780452|NCT01474512|16490374|P15|Post-Treatment Follow-Up|Adverse Event|8
4780453|NCT01474512|16490375|P14|Post-Treatment Follow-Up|Adverse Event|0
4780454|NCT01474512|16490376|P13|Post-Treatment Follow-Up|Adverse Event|0
4780455|NCT01474512|16490377|P12|Post-Treatment Follow-Up|Adverse Event|0
4780456|NCT01474512|16490378|P11|Post-Treatment Follow-Up|Adverse Event|0
4780457|NCT01474512|16490379|P10|Post-Treatment Follow-Up|Adverse Event|0
4780458|NCT01474512|16490380|P9|Post-Treatment Follow-Up|Adverse Event|0
4780459|NCT01474512|16490381|P8|Post-Treatment Follow-Up|Adverse Event|0
4780460|NCT01474512|16490382|P7|Post-Treatment Follow-Up|Adverse Event|0
4780461|NCT01474512|16490383|P6|Post-Treatment Follow-Up|Adverse Event|0
4780462|NCT01474512|16490384|P5|Post-Treatment Follow-Up|Adverse Event|0
4780463|NCT01474512|16490385|P4|Post-Treatment Follow-Up|Adverse Event|0
4780464|NCT01474512|16490386|P3|Post-Treatment Follow-Up|Adverse Event|0
4780465|NCT01474512|16490387|P2|Post-Treatment Follow-Up|Adverse Event|0
4780466|NCT01474512|16490388|P1|Post-Treatment Follow-Up|Adverse Event|0
4780467|NCT01474512|16490371|P18|Long-Term Extension Period|Switched From PBO to Ixe|0
4780468|NCT01474512|16490372|P17|Long-Term Extension Period|Switched From PBO to Ixe|0
4780469|NCT01474512|16490373|P16|Long-Term Extension Period|Switched From PBO to Ixe|0
4780470|NCT01474512|16490374|P15|Long-Term Extension Period|Switched From PBO to Ixe|0
4780471|NCT01474512|16490375|P14|Long-Term Extension Period|Switched From PBO to Ixe|0
4780472|NCT01474512|16490376|P13|Long-Term Extension Period|Switched From PBO to Ixe|0
4780473|NCT01474512|16490377|P12|Long-Term Extension Period|Switched From PBO to Ixe|21
4780474|NCT01474512|16490378|P11|Long-Term Extension Period|Switched From PBO to Ixe|0
4780475|NCT01474512|16490379|P10|Long-Term Extension Period|Switched From PBO to Ixe|0
4780476|NCT01474512|16490380|P9|Long-Term Extension Period|Switched From PBO to Ixe|0
4780477|NCT01474512|16490381|P8|Long-Term Extension Period|Switched From PBO to Ixe|0
4780478|NCT01474512|16490382|P7|Long-Term Extension Period|Switched From PBO to Ixe|0
4780479|NCT01474512|16490383|P6|Long-Term Extension Period|Switched From PBO to Ixe|0
4780480|NCT01474512|16490384|P5|Long-Term Extension Period|Switched From PBO to Ixe|0
4780481|NCT01474512|16490385|P4|Long-Term Extension Period|Switched From PBO to Ixe|0
4780482|NCT01474512|16490386|P3|Long-Term Extension Period|Switched From PBO to Ixe|0
4780483|NCT01474512|16490387|P2|Long-Term Extension Period|Switched From PBO to Ixe|0
4780484|NCT01474512|16490388|P1|Long-Term Extension Period|Switched From PBO to Ixe|0
4780485|NCT01474512|16490371|P18|Long-Term Extension Period|Parent/Caregiver Decision|0
4780486|NCT01474512|16490372|P17|Long-Term Extension Period|Parent/Caregiver Decision|0
4780487|NCT01474512|16490373|P16|Long-Term Extension Period|Parent/Caregiver Decision|0
4780488|NCT01474512|16490374|P15|Long-Term Extension Period|Parent/Caregiver Decision|0
4780489|NCT01474512|16490375|P14|Long-Term Extension Period|Parent/Caregiver Decision|1
4780490|NCT01474512|16490376|P13|Long-Term Extension Period|Parent/Caregiver Decision|1
4780491|NCT01474512|16490377|P12|Long-Term Extension Period|Parent/Caregiver Decision|0
4780492|NCT01474512|16490378|P11|Long-Term Extension Period|Parent/Caregiver Decision|0
4780493|NCT01474512|16490379|P10|Long-Term Extension Period|Parent/Caregiver Decision|0
4780494|NCT01474512|16490380|P9|Long-Term Extension Period|Parent/Caregiver Decision|0
4780495|NCT01474512|16490381|P8|Long-Term Extension Period|Parent/Caregiver Decision|0
4780496|NCT01474512|16490382|P7|Long-Term Extension Period|Parent/Caregiver Decision|0
4780497|NCT01474512|16490383|P6|Long-Term Extension Period|Parent/Caregiver Decision|0
4780498|NCT01474512|16490384|P5|Long-Term Extension Period|Parent/Caregiver Decision|0
4780499|NCT01474512|16490385|P4|Long-Term Extension Period|Parent/Caregiver Decision|0
4780500|NCT01474512|16490386|P3|Long-Term Extension Period|Parent/Caregiver Decision|0
4780501|NCT01474512|16490387|P2|Long-Term Extension Period|Parent/Caregiver Decision|0
4780502|NCT01474512|16490388|P1|Long-Term Extension Period|Parent/Caregiver Decision|0
4780503|NCT01474512|16490371|P18|Long-Term Extension Period|Protocol Violation|0
4780504|NCT01474512|16490372|P17|Long-Term Extension Period|Protocol Violation|0
4780505|NCT01474512|16490373|P16|Long-Term Extension Period|Protocol Violation|0
4780506|NCT01474512|16490374|P15|Long-Term Extension Period|Protocol Violation|0
4780507|NCT01474512|16490375|P14|Long-Term Extension Period|Protocol Violation|5
4780508|NCT01474512|16490376|P13|Long-Term Extension Period|Protocol Violation|5
4780509|NCT01474512|16490377|P12|Long-Term Extension Period|Protocol Violation|0
4780510|NCT01474512|16490378|P11|Long-Term Extension Period|Protocol Violation|0
4780511|NCT01474512|16490379|P10|Long-Term Extension Period|Protocol Violation|0
4780512|NCT01474512|16490380|P9|Long-Term Extension Period|Protocol Violation|0
4780513|NCT01474512|16490381|P8|Long-Term Extension Period|Protocol Violation|0
4780514|NCT01474512|16490382|P7|Long-Term Extension Period|Protocol Violation|0
4780515|NCT01474512|16490383|P6|Long-Term Extension Period|Protocol Violation|0
4780516|NCT01474512|16490384|P5|Long-Term Extension Period|Protocol Violation|0
4780517|NCT01474512|16490385|P4|Long-Term Extension Period|Protocol Violation|0
4780518|NCT01474512|16490386|P3|Long-Term Extension Period|Protocol Violation|0
4780519|NCT01474512|16490387|P2|Long-Term Extension Period|Protocol Violation|0
4780520|NCT01474512|16490388|P1|Long-Term Extension Period|Protocol Violation|0
4780521|NCT01474512|16490371|P18|Long-Term Extension Period|Sponsor Decision|0
4780522|NCT01474512|16490372|P17|Long-Term Extension Period|Sponsor Decision|0
4780523|NCT01474512|16490373|P16|Long-Term Extension Period|Sponsor Decision|0
4780524|NCT01474512|16490374|P15|Long-Term Extension Period|Sponsor Decision|0
4780525|NCT01474512|16490375|P14|Long-Term Extension Period|Sponsor Decision|6
4780526|NCT01474512|16490376|P13|Long-Term Extension Period|Sponsor Decision|6
4780527|NCT01474512|16490377|P12|Long-Term Extension Period|Sponsor Decision|0
4780528|NCT01474512|16490378|P11|Long-Term Extension Period|Sponsor Decision|0
4780529|NCT01474512|16490379|P10|Long-Term Extension Period|Sponsor Decision|0
4780530|NCT01474512|16490380|P9|Long-Term Extension Period|Sponsor Decision|0
4780531|NCT01474512|16490381|P8|Long-Term Extension Period|Sponsor Decision|0
4780532|NCT01474512|16490382|P7|Long-Term Extension Period|Sponsor Decision|0
4780533|NCT01474512|16490383|P6|Long-Term Extension Period|Sponsor Decision|0
4780534|NCT01474512|16490384|P5|Long-Term Extension Period|Sponsor Decision|0
4780535|NCT01474512|16490385|P4|Long-Term Extension Period|Sponsor Decision|0
4780536|NCT01474512|16490386|P3|Long-Term Extension Period|Sponsor Decision|0
4780537|NCT01474512|16490387|P2|Long-Term Extension Period|Sponsor Decision|0
4780538|NCT01474512|16490388|P1|Long-Term Extension Period|Sponsor Decision|0
4780539|NCT01474512|16490371|P18|Long-Term Extension Period|Death|0
4780540|NCT01474512|16490372|P17|Long-Term Extension Period|Death|0
4780541|NCT01474512|16490373|P16|Long-Term Extension Period|Death|0
4780542|NCT01474512|16490374|P15|Long-Term Extension Period|Death|0
4780543|NCT01474512|16490375|P14|Long-Term Extension Period|Death|9
4780544|NCT01474512|16490376|P13|Long-Term Extension Period|Death|9
4780545|NCT01474512|16490377|P12|Long-Term Extension Period|Death|0
4780546|NCT01474512|16490378|P11|Long-Term Extension Period|Death|0
4780547|NCT01474512|16490379|P10|Long-Term Extension Period|Death|0
4780548|NCT01474512|16490380|P9|Long-Term Extension Period|Death|0
4780549|NCT01474512|16490381|P8|Long-Term Extension Period|Death|0
4780550|NCT01474512|16490382|P7|Long-Term Extension Period|Death|0
4780551|NCT01474512|16490383|P6|Long-Term Extension Period|Death|0
4780552|NCT01474512|16490384|P5|Long-Term Extension Period|Death|0
4780553|NCT01474512|16490385|P4|Long-Term Extension Period|Death|0
4780554|NCT01474512|16490386|P3|Long-Term Extension Period|Death|0
4780555|NCT01474512|16490387|P2|Long-Term Extension Period|Death|0
4780556|NCT01474512|16490388|P1|Long-Term Extension Period|Death|0
4780557|NCT01474512|16490371|P18|Long-Term Extension Period|Clinical Relapse|0
4780558|NCT01474512|16490372|P17|Long-Term Extension Period|Clinical Relapse|0
4780559|NCT01474512|16490373|P16|Long-Term Extension Period|Clinical Relapse|0
4780560|NCT01474512|16490374|P15|Long-Term Extension Period|Clinical Relapse|0
4780561|NCT01474512|16490375|P14|Long-Term Extension Period|Clinical Relapse|9
4780562|NCT01474512|16490376|P13|Long-Term Extension Period|Clinical Relapse|9
4780563|NCT01474512|16490377|P12|Long-Term Extension Period|Clinical Relapse|0
4780564|NCT01474512|16490378|P11|Long-Term Extension Period|Clinical Relapse|0
4780565|NCT01474512|16490379|P10|Long-Term Extension Period|Clinical Relapse|0
4780566|NCT01474512|16490380|P9|Long-Term Extension Period|Clinical Relapse|0
4780567|NCT01474512|16490381|P8|Long-Term Extension Period|Clinical Relapse|0
4780568|NCT01474512|16490382|P7|Long-Term Extension Period|Clinical Relapse|0
4780569|NCT01474512|16490383|P6|Long-Term Extension Period|Clinical Relapse|0
4780570|NCT01474512|16490384|P5|Long-Term Extension Period|Clinical Relapse|0
4780571|NCT01474512|16490385|P4|Long-Term Extension Period|Clinical Relapse|0
4780572|NCT01474512|16490386|P3|Long-Term Extension Period|Clinical Relapse|0
4780573|NCT01474512|16490387|P2|Long-Term Extension Period|Clinical Relapse|0
4780574|NCT01474512|16490388|P1|Long-Term Extension Period|Clinical Relapse|0
4780575|NCT01474512|16490371|P18|Long-Term Extension Period|Physician Decision|0
4780576|NCT01474512|16490372|P17|Long-Term Extension Period|Physician Decision|0
4780577|NCT01474512|16490373|P16|Long-Term Extension Period|Physician Decision|0
4780578|NCT01474512|16490374|P15|Long-Term Extension Period|Physician Decision|0
4780579|NCT01474512|16490375|P14|Long-Term Extension Period|Physician Decision|21
4780580|NCT01474512|16490376|P13|Long-Term Extension Period|Physician Decision|21
4780581|NCT01474512|16490377|P12|Long-Term Extension Period|Physician Decision|0
4780582|NCT01474512|16490378|P11|Long-Term Extension Period|Physician Decision|0
4780583|NCT01474512|16490379|P10|Long-Term Extension Period|Physician Decision|0
4780584|NCT01474512|16490380|P9|Long-Term Extension Period|Physician Decision|0
4780585|NCT01474512|16490381|P8|Long-Term Extension Period|Physician Decision|0
4780586|NCT01474512|16490382|P7|Long-Term Extension Period|Physician Decision|0
4780587|NCT01474512|16490383|P6|Long-Term Extension Period|Physician Decision|0
4780588|NCT01474512|16490384|P5|Long-Term Extension Period|Physician Decision|0
4780589|NCT01474512|16490385|P4|Long-Term Extension Period|Physician Decision|0
4780590|NCT01474512|16490386|P3|Long-Term Extension Period|Physician Decision|0
4780591|NCT01474512|16490387|P2|Long-Term Extension Period|Physician Decision|0
4780592|NCT01474512|16490388|P1|Long-Term Extension Period|Physician Decision|0
4780593|NCT01474512|16490371|P18|Long-Term Extension Period|Lack of Efficacy|0
4780594|NCT01474512|16490372|P17|Long-Term Extension Period|Lack of Efficacy|0
4780595|NCT01474512|16490373|P16|Long-Term Extension Period|Lack of Efficacy|0
4780597|NCT01474512|16490375|P14|Long-Term Extension Period|Lack of Efficacy|25
4780598|NCT01474512|16490376|P13|Long-Term Extension Period|Lack of Efficacy|24
4780599|NCT01474512|16490377|P12|Long-Term Extension Period|Lack of Efficacy|1
4780600|NCT01474512|16490378|P11|Long-Term Extension Period|Lack of Efficacy|0
4780601|NCT01474512|16490379|P10|Long-Term Extension Period|Lack of Efficacy|0
4780602|NCT01474512|16490380|P9|Long-Term Extension Period|Lack of Efficacy|0
4780603|NCT01474512|16490381|P8|Long-Term Extension Period|Lack of Efficacy|0
4780604|NCT01474512|16490382|P7|Long-Term Extension Period|Lack of Efficacy|0
4780605|NCT01474512|16490383|P6|Long-Term Extension Period|Lack of Efficacy|0
4780606|NCT01474512|16490384|P5|Long-Term Extension Period|Lack of Efficacy|0
4780607|NCT01474512|16490385|P4|Long-Term Extension Period|Lack of Efficacy|0
4780608|NCT01474512|16490386|P3|Long-Term Extension Period|Lack of Efficacy|0
4780609|NCT01474512|16490387|P2|Long-Term Extension Period|Lack of Efficacy|0
4780610|NCT01474512|16490388|P1|Long-Term Extension Period|Lack of Efficacy|0
4780611|NCT01474512|16490371|P18|Long-Term Extension Period|Lost to Follow-up|0
4780612|NCT01474512|16490372|P17|Long-Term Extension Period|Lost to Follow-up|0
4780613|NCT01474512|16490373|P16|Long-Term Extension Period|Lost to Follow-up|0
4780614|NCT01474512|16490374|P15|Long-Term Extension Period|Lost to Follow-up|0
4780615|NCT01474512|16490375|P14|Long-Term Extension Period|Lost to Follow-up|25
4780616|NCT01474512|16490376|P13|Long-Term Extension Period|Lost to Follow-up|25
4780617|NCT01474512|16490377|P12|Long-Term Extension Period|Lost to Follow-up|0
4780618|NCT01474512|16490378|P11|Long-Term Extension Period|Lost to Follow-up|0
4780619|NCT01474512|16490379|P10|Long-Term Extension Period|Lost to Follow-up|0
4780620|NCT01474512|16490380|P9|Long-Term Extension Period|Lost to Follow-up|0
4780621|NCT01474512|16490381|P8|Long-Term Extension Period|Lost to Follow-up|0
4780622|NCT01474512|16490382|P7|Long-Term Extension Period|Lost to Follow-up|0
4780623|NCT01474512|16490383|P6|Long-Term Extension Period|Lost to Follow-up|0
4780624|NCT01474512|16490384|P5|Long-Term Extension Period|Lost to Follow-up|0
4780625|NCT01474512|16490385|P4|Long-Term Extension Period|Lost to Follow-up|0
4780626|NCT01474512|16490386|P3|Long-Term Extension Period|Lost to Follow-up|0
4780627|NCT01474512|16490387|P2|Long-Term Extension Period|Lost to Follow-up|0
4780628|NCT01474512|16490388|P1|Long-Term Extension Period|Lost to Follow-up|0
4780629|NCT01474512|16490371|P18|Long-Term Extension Period|Adverse Event|0
4780630|NCT01474512|16490372|P17|Long-Term Extension Period|Adverse Event|0
4780631|NCT01474512|16490373|P16|Long-Term Extension Period|Adverse Event|0
4780632|NCT01474512|16490374|P15|Long-Term Extension Period|Adverse Event|0
4780633|NCT01474512|16490375|P14|Long-Term Extension Period|Adverse Event|58
4780634|NCT01474512|16490376|P13|Long-Term Extension Period|Adverse Event|57
4780635|NCT01474512|16490377|P12|Long-Term Extension Period|Adverse Event|1
4780636|NCT01474512|16490378|P11|Long-Term Extension Period|Adverse Event|0
4780637|NCT01474512|16490379|P10|Long-Term Extension Period|Adverse Event|0
4780638|NCT01474512|16490380|P9|Long-Term Extension Period|Adverse Event|0
4780639|NCT01474512|16490381|P8|Long-Term Extension Period|Adverse Event|0
4780640|NCT01474512|16490382|P7|Long-Term Extension Period|Adverse Event|0
4780641|NCT01474512|16490383|P6|Long-Term Extension Period|Adverse Event|0
4780642|NCT01474512|16490384|P5|Long-Term Extension Period|Adverse Event|0
4780643|NCT01474512|16490385|P4|Long-Term Extension Period|Adverse Event|0
4780644|NCT01474512|16490386|P3|Long-Term Extension Period|Adverse Event|0
4780645|NCT01474512|16490387|P2|Long-Term Extension Period|Adverse Event|0
4780646|NCT01474512|16490388|P1|Long-Term Extension Period|Adverse Event|0
4780647|NCT01474512|16490371|P18|Long-Term Extension Period|Withdrawal by Subject|0
4780648|NCT01474512|16490372|P17|Long-Term Extension Period|Withdrawal by Subject|0
4780649|NCT01474512|16490373|P16|Long-Term Extension Period|Withdrawal by Subject|0
4780650|NCT01474512|16490374|P15|Long-Term Extension Period|Withdrawal by Subject|0
4780651|NCT01474512|16490375|P14|Long-Term Extension Period|Withdrawal by Subject|61
4780652|NCT01474512|16490376|P13|Long-Term Extension Period|Withdrawal by Subject|61
4780653|NCT01474512|16490377|P12|Long-Term Extension Period|Withdrawal by Subject|3
4780654|NCT01474512|16490378|P11|Long-Term Extension Period|Withdrawal by Subject|0
4780655|NCT01474512|16490379|P10|Long-Term Extension Period|Withdrawal by Subject|0
4780656|NCT01474512|16490380|P9|Long-Term Extension Period|Withdrawal by Subject|0
4780657|NCT01474512|16490381|P8|Long-Term Extension Period|Withdrawal by Subject|0
4780658|NCT01474512|16490382|P7|Long-Term Extension Period|Withdrawal by Subject|0
4780659|NCT01474512|16490383|P6|Long-Term Extension Period|Withdrawal by Subject|0
4780660|NCT01474512|16490384|P5|Long-Term Extension Period|Withdrawal by Subject|0
4780661|NCT01474512|16490385|P4|Long-Term Extension Period|Withdrawal by Subject|0
4780662|NCT01474512|16490386|P3|Long-Term Extension Period|Withdrawal by Subject|0
4780663|NCT01474512|16490387|P2|Long-Term Extension Period|Withdrawal by Subject|0
4780664|NCT01474512|16490388|P1|Long-Term Extension Period|Withdrawal by Subject|0
4780665|NCT01474512|16490371|P18|Maintenance Period|Treated but Discontinued in Induction|0
4780666|NCT01474512|16490372|P17|Maintenance Period|Treated but Discontinued in Induction|0
4780667|NCT01474512|16490373|P16|Maintenance Period|Treated but Discontinued in Induction|0
4780668|NCT01474512|16490374|P15|Maintenance Period|Treated but Discontinued in Induction|0
4780669|NCT01474512|16490375|P14|Maintenance Period|Treated but Discontinued in Induction|0
4780670|NCT01474512|16490376|P13|Maintenance Period|Treated but Discontinued in Induction|0
4780671|NCT01474512|16490377|P12|Maintenance Period|Treated but Discontinued in Induction|0
4780672|NCT01474512|16490378|P11|Maintenance Period|Treated but Discontinued in Induction|0
4780673|NCT01474512|16490379|P10|Maintenance Period|Treated but Discontinued in Induction|0
4780757|NCT01474512|16490373|P16|Maintenance Period|Death|0
4780674|NCT01474512|16490380|P9|Maintenance Period|Treated but Discontinued in Induction|0
4780675|NCT01474512|16490381|P8|Maintenance Period|Treated but Discontinued in Induction|0
4780676|NCT01474512|16490382|P7|Maintenance Period|Treated but Discontinued in Induction|0
4780677|NCT01474512|16490383|P6|Maintenance Period|Treated but Discontinued in Induction|0
4780678|NCT01474512|16490384|P5|Maintenance Period|Treated but Discontinued in Induction|1
4780679|NCT01474512|16490385|P4|Maintenance Period|Treated but Discontinued in Induction|0
4780680|NCT01474512|16490386|P3|Maintenance Period|Treated but Discontinued in Induction|0
4780681|NCT01474512|16490387|P2|Maintenance Period|Treated but Discontinued in Induction|0
4780682|NCT01474512|16490388|P1|Maintenance Period|Treated but Discontinued in Induction|0
4780683|NCT01474512|16490371|P18|Maintenance Period|Protocol Violation|0
4780684|NCT01474512|16490372|P17|Maintenance Period|Protocol Violation|0
4780685|NCT01474512|16490373|P16|Maintenance Period|Protocol Violation|0
4780686|NCT01474512|16490374|P15|Maintenance Period|Protocol Violation|0
4780687|NCT01474512|16490375|P14|Maintenance Period|Protocol Violation|0
4780688|NCT01474512|16490376|P13|Maintenance Period|Protocol Violation|0
4780689|NCT01474512|16490377|P12|Maintenance Period|Protocol Violation|0
4780690|NCT01474512|16490378|P11|Maintenance Period|Protocol Violation|0
4780691|NCT01474512|16490379|P10|Maintenance Period|Protocol Violation|1
4780692|NCT01474512|16490380|P9|Maintenance Period|Protocol Violation|0
4780693|NCT01474512|16490381|P8|Maintenance Period|Protocol Violation|1
4780694|NCT01474512|16490382|P7|Maintenance Period|Protocol Violation|0
4780695|NCT01474512|16490383|P6|Maintenance Period|Protocol Violation|0
4780696|NCT01474512|16490384|P5|Maintenance Period|Protocol Violation|0
4780697|NCT01474512|16490385|P4|Maintenance Period|Protocol Violation|1
4780698|NCT01474512|16490386|P3|Maintenance Period|Protocol Violation|0
4780699|NCT01474512|16490387|P2|Maintenance Period|Protocol Violation|0
4780700|NCT01474512|16490388|P1|Maintenance Period|Protocol Violation|0
4780701|NCT01474512|16490371|P18|Maintenance Period|Lack of Efficacy|0
4780702|NCT01474512|16490372|P17|Maintenance Period|Lack of Efficacy|0
4780703|NCT01474512|16490373|P16|Maintenance Period|Lack of Efficacy|0
4780704|NCT01474512|16490374|P15|Maintenance Period|Lack of Efficacy|0
4780705|NCT01474512|16490375|P14|Maintenance Period|Lack of Efficacy|0
4780706|NCT01474512|16490376|P13|Maintenance Period|Lack of Efficacy|0
4780707|NCT01474512|16490377|P12|Maintenance Period|Lack of Efficacy|0
4780708|NCT01474512|16490378|P11|Maintenance Period|Lack of Efficacy|0
4780709|NCT01474512|16490379|P10|Maintenance Period|Lack of Efficacy|12
4780710|NCT01474512|16490380|P9|Maintenance Period|Lack of Efficacy|11
4780711|NCT01474512|16490381|P8|Maintenance Period|Lack of Efficacy|11
4780712|NCT01474512|16490382|P7|Maintenance Period|Lack of Efficacy|0
4780713|NCT01474512|16490383|P6|Maintenance Period|Lack of Efficacy|0
4780714|NCT01474512|16490384|P5|Maintenance Period|Lack of Efficacy|0
4780715|NCT01474512|16490385|P4|Maintenance Period|Lack of Efficacy|1
4780716|NCT01474512|16490386|P3|Maintenance Period|Lack of Efficacy|0
4780717|NCT01474512|16490387|P2|Maintenance Period|Lack of Efficacy|0
4780718|NCT01474512|16490388|P1|Maintenance Period|Lack of Efficacy|0
4780719|NCT01474512|16490371|P18|Maintenance Period|Clinical Relapse|0
4780720|NCT01474512|16490372|P17|Maintenance Period|Clinical Relapse|0
4780721|NCT01474512|16490373|P16|Maintenance Period|Clinical Relapse|0
4780722|NCT01474512|16490374|P15|Maintenance Period|Clinical Relapse|0
4780723|NCT01474512|16490375|P14|Maintenance Period|Clinical Relapse|0
4780724|NCT01474512|16490376|P13|Maintenance Period|Clinical Relapse|0
4780725|NCT01474512|16490377|P12|Maintenance Period|Clinical Relapse|0
4780726|NCT01474512|16490378|P11|Maintenance Period|Clinical Relapse|0
4780727|NCT01474512|16490379|P10|Maintenance Period|Clinical Relapse|0
4780728|NCT01474512|16490380|P9|Maintenance Period|Clinical Relapse|0
4780729|NCT01474512|16490381|P8|Maintenance Period|Clinical Relapse|0
4780730|NCT01474512|16490382|P7|Maintenance Period|Clinical Relapse|0
4780731|NCT01474512|16490383|P6|Maintenance Period|Clinical Relapse|0
4780732|NCT01474512|16490384|P5|Maintenance Period|Clinical Relapse|0
4780733|NCT01474512|16490385|P4|Maintenance Period|Clinical Relapse|1
4780734|NCT01474512|16490386|P3|Maintenance Period|Clinical Relapse|0
4780735|NCT01474512|16490387|P2|Maintenance Period|Clinical Relapse|0
4780736|NCT01474512|16490388|P1|Maintenance Period|Clinical Relapse|0
4780737|NCT01474512|16490371|P18|Maintenance Period|Physician Decision|0
4780738|NCT01474512|16490372|P17|Maintenance Period|Physician Decision|0
4780739|NCT01474512|16490373|P16|Maintenance Period|Physician Decision|0
4780740|NCT01474512|16490374|P15|Maintenance Period|Physician Decision|0
4780741|NCT01474512|16490375|P14|Maintenance Period|Physician Decision|0
4780742|NCT01474512|16490376|P13|Maintenance Period|Physician Decision|0
4780743|NCT01474512|16490377|P12|Maintenance Period|Physician Decision|0
4780744|NCT01474512|16490378|P11|Maintenance Period|Physician Decision|0
4780745|NCT01474512|16490379|P10|Maintenance Period|Physician Decision|0
4780746|NCT01474512|16490380|P9|Maintenance Period|Physician Decision|0
4780747|NCT01474512|16490381|P8|Maintenance Period|Physician Decision|2
4780748|NCT01474512|16490382|P7|Maintenance Period|Physician Decision|0
4780749|NCT01474512|16490383|P6|Maintenance Period|Physician Decision|1
4780750|NCT01474512|16490384|P5|Maintenance Period|Physician Decision|0
4780751|NCT01474512|16490385|P4|Maintenance Period|Physician Decision|0
4780752|NCT01474512|16490386|P3|Maintenance Period|Physician Decision|0
4780753|NCT01474512|16490387|P2|Maintenance Period|Physician Decision|0
4780754|NCT01474512|16490388|P1|Maintenance Period|Physician Decision|0
4780755|NCT01474512|16490371|P18|Maintenance Period|Death|0
4780756|NCT01474512|16490372|P17|Maintenance Period|Death|0
4780758|NCT01474512|16490374|P15|Maintenance Period|Death|0
4780759|NCT01474512|16490375|P14|Maintenance Period|Death|0
4780760|NCT01474512|16490376|P13|Maintenance Period|Death|0
4780761|NCT01474512|16490377|P12|Maintenance Period|Death|0
4780762|NCT01474512|16490378|P11|Maintenance Period|Death|0
4780763|NCT01474512|16490379|P10|Maintenance Period|Death|0
4780764|NCT01474512|16490380|P9|Maintenance Period|Death|0
4780765|NCT01474512|16490381|P8|Maintenance Period|Death|0
4780766|NCT01474512|16490382|P7|Maintenance Period|Death|0
4780767|NCT01474512|16490383|P6|Maintenance Period|Death|2
4780768|NCT01474512|16490384|P5|Maintenance Period|Death|0
4780769|NCT01474512|16490385|P4|Maintenance Period|Death|0
4780770|NCT01474512|16490386|P3|Maintenance Period|Death|0
4780771|NCT01474512|16490387|P2|Maintenance Period|Death|0
4780772|NCT01474512|16490388|P1|Maintenance Period|Death|0
4780773|NCT01474512|16490371|P18|Maintenance Period|Lost to Follow-up|0
4780774|NCT01474512|16490372|P17|Maintenance Period|Lost to Follow-up|0
4780775|NCT01474512|16490373|P16|Maintenance Period|Lost to Follow-up|0
4780776|NCT01474512|16490374|P15|Maintenance Period|Lost to Follow-up|0
4780777|NCT01474512|16490375|P14|Maintenance Period|Lost to Follow-up|0
4780778|NCT01474512|16490376|P13|Maintenance Period|Lost to Follow-up|0
4780779|NCT01474512|16490377|P12|Maintenance Period|Lost to Follow-up|0
4780780|NCT01474512|16490378|P11|Maintenance Period|Lost to Follow-up|0
4780781|NCT01474512|16490379|P10|Maintenance Period|Lost to Follow-up|1
4780782|NCT01474512|16490380|P9|Maintenance Period|Lost to Follow-up|1
4780783|NCT01474512|16490381|P8|Maintenance Period|Lost to Follow-up|2
4780784|NCT01474512|16490382|P7|Maintenance Period|Lost to Follow-up|0
4780785|NCT01474512|16490383|P6|Maintenance Period|Lost to Follow-up|0
4780786|NCT01474512|16490384|P5|Maintenance Period|Lost to Follow-up|3
4780787|NCT01474512|16490385|P4|Maintenance Period|Lost to Follow-up|3
4780788|NCT01474512|16490386|P3|Maintenance Period|Lost to Follow-up|0
4780789|NCT01474512|16490387|P2|Maintenance Period|Lost to Follow-up|0
4780790|NCT01474512|16490388|P1|Maintenance Period|Lost to Follow-up|0
4780791|NCT01474512|16490371|P18|Maintenance Period|Withdrawal by Subject|0
4780792|NCT01474512|16490372|P17|Maintenance Period|Withdrawal by Subject|0
4780793|NCT01474512|16490373|P16|Maintenance Period|Withdrawal by Subject|0
4780794|NCT01474512|16490374|P15|Maintenance Period|Withdrawal by Subject|0
4780795|NCT01474512|16490375|P14|Maintenance Period|Withdrawal by Subject|0
4780796|NCT01474512|16490376|P13|Maintenance Period|Withdrawal by Subject|0
4780797|NCT01474512|16490377|P12|Maintenance Period|Withdrawal by Subject|0
4780798|NCT01474512|16490378|P11|Maintenance Period|Withdrawal by Subject|0
4780799|NCT01474512|16490379|P10|Maintenance Period|Withdrawal by Subject|1
4780800|NCT01474512|16490380|P9|Maintenance Period|Withdrawal by Subject|3
4780801|NCT01474512|16490381|P8|Maintenance Period|Withdrawal by Subject|6
4780802|NCT01474512|16490382|P7|Maintenance Period|Withdrawal by Subject|1
4780803|NCT01474512|16490383|P6|Maintenance Period|Withdrawal by Subject|3
4780804|NCT01474512|16490384|P5|Maintenance Period|Withdrawal by Subject|2
4780805|NCT01474512|16490385|P4|Maintenance Period|Withdrawal by Subject|6
4780806|NCT01474512|16490386|P3|Maintenance Period|Withdrawal by Subject|0
4780807|NCT01474512|16490387|P2|Maintenance Period|Withdrawal by Subject|0
4780808|NCT01474512|16490388|P1|Maintenance Period|Withdrawal by Subject|0
4780809|NCT01474512|16490371|P18|Maintenance Period|Adverse Event|0
4780810|NCT01474512|16490372|P17|Maintenance Period|Adverse Event|0
4780811|NCT01474512|16490373|P16|Maintenance Period|Adverse Event|0
4780812|NCT01474512|16490374|P15|Maintenance Period|Adverse Event|0
4780813|NCT01474512|16490375|P14|Maintenance Period|Adverse Event|0
4780814|NCT01474512|16490376|P13|Maintenance Period|Adverse Event|0
4780815|NCT01474512|16490377|P12|Maintenance Period|Adverse Event|0
4780816|NCT01474512|16490378|P11|Maintenance Period|Adverse Event|0
4780817|NCT01474512|16490379|P10|Maintenance Period|Adverse Event|3
4780818|NCT01474512|16490380|P9|Maintenance Period|Adverse Event|1
4780819|NCT01474512|16490381|P8|Maintenance Period|Adverse Event|19
4780820|NCT01474512|16490382|P7|Maintenance Period|Adverse Event|0
4780821|NCT01474512|16490383|P6|Maintenance Period|Adverse Event|7
4780822|NCT01474512|16490384|P5|Maintenance Period|Adverse Event|2
4780823|NCT01474512|16490385|P4|Maintenance Period|Adverse Event|4
4780824|NCT01474512|16490386|P3|Maintenance Period|Adverse Event|0
4780825|NCT01474512|16490387|P2|Maintenance Period|Adverse Event|0
4780826|NCT01474512|16490388|P1|Maintenance Period|Adverse Event|0
4780827|NCT01474512|16490371|P18|Maintenance Period|Relapsed (sPGA ≥3)|0
4780828|NCT01474512|16490372|P17|Maintenance Period|Relapsed (sPGA ≥3)|0
4780829|NCT01474512|16490373|P16|Maintenance Period|Relapsed (sPGA ≥3)|0
4780830|NCT01474512|16490374|P15|Maintenance Period|Relapsed (sPGA ≥3)|0
4780831|NCT01474512|16490375|P14|Maintenance Period|Relapsed (sPGA ≥3)|0
4780832|NCT01474512|16490376|P13|Maintenance Period|Relapsed (sPGA ≥3)|0
4780833|NCT01474512|16490377|P12|Maintenance Period|Relapsed (sPGA ≥3)|0
4780834|NCT01474512|16490378|P11|Maintenance Period|Relapsed (sPGA ≥3)|0
4780835|NCT01474512|16490379|P10|Maintenance Period|Relapsed (sPGA ≥3)|0
4780836|NCT01474512|16490380|P9|Maintenance Period|Relapsed (sPGA ≥3)|0
4780837|NCT01474512|16490381|P8|Maintenance Period|Relapsed (sPGA ≥3)|0
4780838|NCT01474512|16490382|P7|Maintenance Period|Relapsed (sPGA ≥3)|9
4780839|NCT01474512|16490383|P6|Maintenance Period|Relapsed (sPGA ≥3)|39
4780840|NCT01474512|16490384|P5|Maintenance Period|Relapsed (sPGA ≥3)|111
4780841|NCT01474512|16490385|P4|Maintenance Period|Relapsed (sPGA ≥3)|186
4780842|NCT01474512|16490386|P3|Maintenance Period|Relapsed (sPGA ≥3)|0
4780843|NCT01474512|16490387|P2|Maintenance Period|Relapsed (sPGA ≥3)|0
4780844|NCT01474512|16490388|P1|Maintenance Period|Relapsed (sPGA ≥3)|0
4780845|NCT01474512|16490371|P18|Induction Period|Lost to Follow-up|0
4780846|NCT01474512|16490372|P17|Induction Period|Lost to Follow-up|0
4780847|NCT01474512|16490373|P16|Induction Period|Lost to Follow-up|0
4780848|NCT01474512|16490374|P15|Induction Period|Lost to Follow-up|0
4780849|NCT01474512|16490375|P14|Induction Period|Lost to Follow-up|0
4780850|NCT01474512|16490376|P13|Induction Period|Lost to Follow-up|0
4780851|NCT01474512|16490377|P12|Induction Period|Lost to Follow-up|0
4780852|NCT01474512|16490378|P11|Induction Period|Lost to Follow-up|0
4780853|NCT01474512|16490379|P10|Induction Period|Lost to Follow-up|0
4780854|NCT01474512|16490380|P9|Induction Period|Lost to Follow-up|0
4780855|NCT01474512|16490381|P8|Induction Period|Lost to Follow-up|0
4780856|NCT01474512|16490382|P7|Induction Period|Lost to Follow-up|0
4780857|NCT01474512|16490383|P6|Induction Period|Lost to Follow-up|0
4780858|NCT01474512|16490384|P5|Induction Period|Lost to Follow-up|0
4780859|NCT01474512|16490385|P4|Induction Period|Lost to Follow-up|0
4780860|NCT01474512|16490386|P3|Induction Period|Lost to Follow-up|2
4780861|NCT01474512|16490387|P2|Induction Period|Lost to Follow-up|0
4780862|NCT01474512|16490388|P1|Induction Period|Lost to Follow-up|1
4780863|NCT01474512|16490371|P18|Induction Period|Sponsor Decision|0
4780864|NCT01474512|16490372|P17|Induction Period|Sponsor Decision|0
4780865|NCT01474512|16490373|P16|Induction Period|Sponsor Decision|0
4780866|NCT01474512|16490374|P15|Induction Period|Sponsor Decision|0
4780867|NCT01474512|16490375|P14|Induction Period|Sponsor Decision|0
4780868|NCT01474512|16490376|P13|Induction Period|Sponsor Decision|0
4780869|NCT01474512|16490377|P12|Induction Period|Sponsor Decision|0
4780870|NCT01474512|16490378|P11|Induction Period|Sponsor Decision|0
4780871|NCT01474512|16490379|P10|Induction Period|Sponsor Decision|0
4780872|NCT01474512|16490380|P9|Induction Period|Sponsor Decision|0
4780873|NCT01474512|16490381|P8|Induction Period|Sponsor Decision|0
4780874|NCT01474512|16490382|P7|Induction Period|Sponsor Decision|0
4780875|NCT01474512|16490383|P6|Induction Period|Sponsor Decision|0
4780876|NCT01474512|16490384|P5|Induction Period|Sponsor Decision|0
4780877|NCT01474512|16490385|P4|Induction Period|Sponsor Decision|0
4780878|NCT01474512|16490386|P3|Induction Period|Sponsor Decision|1
4780879|NCT01474512|16490387|P2|Induction Period|Sponsor Decision|1
4780880|NCT01474512|16490388|P1|Induction Period|Sponsor Decision|1
4780881|NCT01474512|16490371|P18|Induction Period|Protocol Violation|0
4780882|NCT01474512|16490372|P17|Induction Period|Protocol Violation|0
4780883|NCT01474512|16490373|P16|Induction Period|Protocol Violation|0
4780884|NCT01474512|16490374|P15|Induction Period|Protocol Violation|0
4780885|NCT01474512|16490375|P14|Induction Period|Protocol Violation|0
4780886|NCT01474512|16490376|P13|Induction Period|Protocol Violation|0
4780887|NCT01474512|16490377|P12|Induction Period|Protocol Violation|0
4780888|NCT01474512|16490378|P11|Induction Period|Protocol Violation|0
4780889|NCT01474512|16490379|P10|Induction Period|Protocol Violation|0
4780890|NCT01474512|16490380|P9|Induction Period|Protocol Violation|0
4780891|NCT01474512|16490381|P8|Induction Period|Protocol Violation|0
4780892|NCT01474512|16490382|P7|Induction Period|Protocol Violation|0
4780893|NCT01474512|16490383|P6|Induction Period|Protocol Violation|0
4780894|NCT01474512|16490384|P5|Induction Period|Protocol Violation|0
4780895|NCT01474512|16490385|P4|Induction Period|Protocol Violation|0
4780896|NCT01474512|16490386|P3|Induction Period|Protocol Violation|0
4780897|NCT01474512|16490387|P2|Induction Period|Protocol Violation|6
4780898|NCT01474512|16490388|P1|Induction Period|Protocol Violation|3
4780899|NCT01474512|16490371|P18|Induction Period|Withdrawal by Subject|0
4780900|NCT01474512|16490372|P17|Induction Period|Withdrawal by Subject|0
4780901|NCT01474512|16490373|P16|Induction Period|Withdrawal by Subject|0
4780902|NCT01474512|16490374|P15|Induction Period|Withdrawal by Subject|0
4780903|NCT01474512|16490375|P14|Induction Period|Withdrawal by Subject|0
4780904|NCT01474512|16490376|P13|Induction Period|Withdrawal by Subject|0
4780905|NCT01474512|16490377|P12|Induction Period|Withdrawal by Subject|0
4780906|NCT01474512|16490378|P11|Induction Period|Withdrawal by Subject|0
4780907|NCT01474512|16490379|P10|Induction Period|Withdrawal by Subject|0
4780908|NCT01474512|16490380|P9|Induction Period|Withdrawal by Subject|0
4780909|NCT01474512|16490381|P8|Induction Period|Withdrawal by Subject|0
4780910|NCT01474512|16490382|P7|Induction Period|Withdrawal by Subject|0
4780911|NCT01474512|16490383|P6|Induction Period|Withdrawal by Subject|0
4780912|NCT01474512|16490384|P5|Induction Period|Withdrawal by Subject|0
4780913|NCT01474512|16490385|P4|Induction Period|Withdrawal by Subject|0
4780914|NCT01474512|16490386|P3|Induction Period|Withdrawal by Subject|5
4780915|NCT01474512|16490387|P2|Induction Period|Withdrawal by Subject|6
4780916|NCT01474512|16490388|P1|Induction Period|Withdrawal by Subject|6
4780917|NCT01474512|16490371|P18|Induction Period|Lack of Efficacy|0
4780918|NCT01474512|16490372|P17|Induction Period|Lack of Efficacy|0
4780919|NCT01474512|16490373|P16|Induction Period|Lack of Efficacy|0
4780920|NCT01474512|16490374|P15|Induction Period|Lack of Efficacy|0
4780921|NCT01474512|16490375|P14|Induction Period|Lack of Efficacy|0
4780922|NCT01474512|16490376|P13|Induction Period|Lack of Efficacy|0
4780923|NCT01474512|16490377|P12|Induction Period|Lack of Efficacy|0
4780924|NCT01474512|16490378|P11|Induction Period|Lack of Efficacy|0
4780925|NCT01474512|16490379|P10|Induction Period|Lack of Efficacy|0
4780926|NCT01474512|16490380|P9|Induction Period|Lack of Efficacy|0
4780927|NCT01474512|16490381|P8|Induction Period|Lack of Efficacy|0
4780928|NCT01474512|16490382|P7|Induction Period|Lack of Efficacy|0
4780929|NCT01474512|16490383|P6|Induction Period|Lack of Efficacy|0
4780930|NCT01474512|16490384|P5|Induction Period|Lack of Efficacy|0
4780931|NCT01474512|16490385|P4|Induction Period|Lack of Efficacy|0
4780932|NCT01474512|16490386|P3|Induction Period|Lack of Efficacy|0
4780933|NCT01474512|16490387|P2|Induction Period|Lack of Efficacy|1
4780934|NCT01474512|16490388|P1|Induction Period|Lack of Efficacy|7
4780935|NCT01474512|16490371|P18|Induction Period|Adverse Event|0
4780936|NCT01474512|16490372|P17|Induction Period|Adverse Event|0
4780937|NCT01474512|16490373|P16|Induction Period|Adverse Event|0
4780938|NCT01474512|16490374|P15|Induction Period|Adverse Event|0
4780939|NCT01474512|16490375|P14|Induction Period|Adverse Event|0
4780940|NCT01474512|16490376|P13|Induction Period|Adverse Event|0
4780941|NCT01474512|16490377|P12|Induction Period|Adverse Event|0
4780942|NCT01474512|16490378|P11|Induction Period|Adverse Event|0
4780943|NCT01474512|16490379|P10|Induction Period|Adverse Event|0
4780944|NCT01474512|16490380|P9|Induction Period|Adverse Event|0
4780945|NCT01474512|16490381|P8|Induction Period|Adverse Event|0
4780946|NCT01474512|16490382|P7|Induction Period|Adverse Event|0
4780947|NCT01474512|16490383|P6|Induction Period|Adverse Event|0
4780948|NCT01474512|16490384|P5|Induction Period|Adverse Event|0
4780949|NCT01474512|16490385|P4|Induction Period|Adverse Event|0
4780950|NCT01474512|16490386|P3|Induction Period|Adverse Event|10
4780951|NCT01474512|16490387|P2|Induction Period|Adverse Event|10
4780952|NCT01474512|16490388|P1|Induction Period|Adverse Event|6
4780953|NCT01474434|16490464|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
4780954|NCT01474434|16490465|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
4780955|NCT01474434|16490466|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0
4780956|NCT01474434|16490467|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1
4780957|NCT01474434|16490464|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1
4780958|NCT01474434|16490465|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
4780959|NCT01474434|16490466|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
4780960|NCT01474434|16490467|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0
4780961|NCT01474434|16490464|P4|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
4780962|NCT01474434|16490465|P3|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1
4780963|NCT01474434|16490466|P2|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
4780964|NCT01474434|16490467|P1|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0
4780965|NCT01474317|16490509|P1|Overall Study|Subject ineligible for study|1
4780966|NCT01474317|16490509|P1|Overall Study|Adverse Event|1
4780967|NCT01474291|16490518|P1|Overall Study|Death|2
4780968|NCT01474291|16490518|P1|Overall Study|No Reason Reported|10
4780969|NCT01474291|16490518|P1|Overall Study|Patient No Longer Wanted to Participate|12
4780970|NCT01474291|16490518|P1|Overall Study|Lost to Follow-up|29
4780971|NCT01474291|16490518|P1|Overall Study|Adverse Event|53
4780972|NCT01474291|16490518|P1|Overall Study|Lack of Treatment Efficacy|88
4780973|NCT01474291|16490518|P1|Overall Study|Not Evaluable for Efficacy|26
4780974|NCT01474239|16490562|P2|Overall Study|Withdrawal for Economic Reason|0
4780975|NCT01474239|16490563|P1|Overall Study|Withdrawal for Economic Reason|1
4780976|NCT01474239|16490562|P2|Overall Study|Clinical Disease Progression|1
4780977|NCT01474239|16490563|P1|Overall Study|Clinical Disease Progression|7
4780978|NCT01474239|16490562|P2|Overall Study|Death|1
4780979|NCT01474239|16490563|P1|Overall Study|Death|1
4780980|NCT01474239|16490562|P2|Overall Study|Withdrawal by Subject|2
4780981|NCT01474239|16490563|P1|Overall Study|Withdrawal by Subject|1
4780982|NCT01474239|16490562|P2|Overall Study|Adverse Event|3
4780983|NCT01474239|16490563|P1|Overall Study|Adverse Event|12
4780984|NCT01474239|16490562|P2|Overall Study|Disease Progression|25
4780985|NCT01474239|16490563|P1|Overall Study|Disease Progression|37
4780986|NCT01474018|16490735|P2|Overall Study|Withdrawal by Subject|2
4780987|NCT01474018|16490736|P1|Overall Study|Withdrawal by Subject|0
4780988|NCT01474018|16490735|P2|Overall Study|Lost to Follow-up|1
4780989|NCT01474018|16490736|P1|Overall Study|Lost to Follow-up|0
4780990|NCT01473953|16490768|P5|Overall Study|Other|0
4780991|NCT01473953|16490769|P4|Overall Study|Other|0
4780992|NCT01473953|16490770|P3|Overall Study|Other|0
4780993|NCT01473953|16490771|P2|Overall Study|Other|0
4780994|NCT01473953|16490772|P1|Overall Study|Other|1
4780995|NCT01473940|16490818|P4|Maintenance Therapy|Progressive Disease|4
4780996|NCT01473940|16490819|P3|Maintenance Therapy|Progressive Disease|1
4780997|NCT01473940|16490820|P2|Maintenance Therapy|Progressive Disease|2
4780998|NCT01473940|16490821|P1|Maintenance Therapy|Progressive Disease|1
4780999|NCT01473940|16490818|P4|Induction Therapy|Progressive Disease|0
4781000|NCT01473940|16490819|P3|Induction Therapy|Progressive Disease|1
4781001|NCT01473940|16490820|P2|Induction Therapy|Progressive Disease|1
4781002|NCT01473940|16490821|P1|Induction Therapy|Progressive Disease|0
4781003|NCT01473940|16490818|P4|Induction Therapy|Death|1
4781004|NCT01473940|16490819|P3|Induction Therapy|Death|1
4781005|NCT01473940|16490820|P2|Induction Therapy|Death|0
4781006|NCT01473940|16490821|P1|Induction Therapy|Death|0
4781007|NCT01473836|16490851|P1|Overall Study|Does not meet entrance criteria|1
4781008|NCT01473836|16490851|P1|Overall Study|Lack of Efficacy|1
4781009|NCT01473836|16490851|P1|Overall Study|Adverse Event|4
4781010|NCT01473758|16490862|P4|Cycle 2|Adverse Event|0
4781011|NCT01473758|16490863|P3|Cycle 2|Adverse Event|5
4781012|NCT01473758|16490864|P2|Cycle 2|Adverse Event|0
4781013|NCT01473758|16490865|P1|Cycle 2|Adverse Event|0
4781014|NCT01473758|16490862|P4|Cycle 1|Withdrawal by Subject|0
4781015|NCT01473758|16490863|P3|Cycle 1|Withdrawal by Subject|0
4781016|NCT01473758|16490864|P2|Cycle 1|Withdrawal by Subject|1
4781017|NCT01473758|16490865|P1|Cycle 1|Withdrawal by Subject|1
4781018|NCT01473758|16490862|P4|Cycle 1|Adverse Event|0
4781019|NCT01473758|16490863|P3|Cycle 1|Adverse Event|0
4781020|NCT01473758|16490864|P2|Cycle 1|Adverse Event|2
4781021|NCT01473758|16490865|P1|Cycle 1|Adverse Event|10
4781022|NCT01473732|16491002|P2|Overall Study|Death|0
4781023|NCT01473732|16491003|P1|Overall Study|Death|1
4781024|NCT01473732|16491002|P2|Overall Study|Adverse Event|0
4781025|NCT01473732|16491003|P1|Overall Study|Adverse Event|1
4781026|NCT01473602|16491011|P2|Overall Study|Physician Decision|0
4781027|NCT01473602|16491012|P1|Overall Study|Physician Decision|1
4781028|NCT01473602|16491011|P2|Overall Study|Withdrawal by Subject|4
4781029|NCT01473602|16491012|P1|Overall Study|Withdrawal by Subject|5
4781030|NCT01473602|16491011|P2|Overall Study|Lost to Follow-up|1
4781031|NCT01473602|16491012|P1|Overall Study|Lost to Follow-up|1
4781032|NCT01473602|16491011|P2|Overall Study|Death|1
4781033|NCT01473602|16491012|P1|Overall Study|Death|0
4781034|NCT01473602|16491011|P2|Overall Study|Adverse Event|2
4781035|NCT01473602|16491012|P1|Overall Study|Adverse Event|1
4781036|NCT01473589|16491048|P2|Overall Study|Entry criteria not met|1
4781037|NCT01473589|16491049|P1|Overall Study|Entry criteria not met|0
4781038|NCT01473589|16491048|P2|Overall Study|Physician Decision|1
4781039|NCT01473589|16491049|P1|Overall Study|Physician Decision|0
4781040|NCT01473589|16491048|P2|Overall Study|Withdrawal by Subject|11
4781041|NCT01473589|16491049|P1|Overall Study|Withdrawal by Subject|5
4781042|NCT01473589|16491048|P2|Overall Study|Protocol Violation|0
4781043|NCT01473589|16491049|P1|Overall Study|Protocol Violation|1
4781044|NCT01473589|16491048|P2|Overall Study|Lost to Follow-up|2
4781045|NCT01473589|16491049|P1|Overall Study|Lost to Follow-up|2
4781046|NCT01473589|16491048|P2|Overall Study|Death|0
4781047|NCT01473589|16491049|P1|Overall Study|Death|2
4781048|NCT01473589|16491048|P2|Overall Study|Adverse Event|1
4781049|NCT01473589|16491049|P1|Overall Study|Adverse Event|1
4781050|NCT01473563|16491083|P1|Overall Study|Lost to FU post tx discontinuation|1
4781051|NCT01473524|16491105|P6|LTSE Phase|Protocol Violation|1
4781052|NCT01473524|16491106|P5|LTSE Phase|Protocol Violation|0
4781053|NCT01473524|16491107|P4|LTSE Phase|Protocol Violation|0
4781054|NCT01473524|16491108|P3|LTSE Phase|Protocol Violation|0
4781055|NCT01473524|16491109|P2|LTSE Phase|Protocol Violation|0
4781056|NCT01473524|16491110|P1|LTSE Phase|Protocol Violation|0
4781057|NCT01473524|16491105|P6|LTSE Phase|Pregnancy|0
4781058|NCT01473524|16491106|P5|LTSE Phase|Pregnancy|0
4781059|NCT01473524|16491107|P4|LTSE Phase|Pregnancy|1
4781060|NCT01473524|16491108|P3|LTSE Phase|Pregnancy|0
4781061|NCT01473524|16491109|P2|LTSE Phase|Pregnancy|0
4781062|NCT01473524|16491110|P1|LTSE Phase|Pregnancy|0
4781063|NCT01473524|16491105|P6|LTSE Phase|Liver Transplantation|1
4781064|NCT01473524|16491106|P5|LTSE Phase|Liver Transplantation|0
4781065|NCT01473524|16491107|P4|LTSE Phase|Liver Transplantation|0
4781066|NCT01473524|16491108|P3|LTSE Phase|Liver Transplantation|0
4781067|NCT01473524|16491109|P2|LTSE Phase|Liver Transplantation|0
4781068|NCT01473524|16491110|P1|LTSE Phase|Liver Transplantation|0
4781069|NCT01473524|16491105|P6|LTSE Phase|Principal Investigator Decision|3
4781070|NCT01473524|16491106|P5|LTSE Phase|Principal Investigator Decision|1
4781071|NCT01473524|16491107|P4|LTSE Phase|Principal Investigator Decision|1
4781072|NCT01473524|16491108|P3|LTSE Phase|Principal Investigator Decision|0
4781073|NCT01473524|16491109|P2|LTSE Phase|Principal Investigator Decision|0
4781074|NCT01473524|16491110|P1|LTSE Phase|Principal Investigator Decision|0
4781075|NCT01473524|16491105|P6|LTSE Phase|Lost to Follow-up|2
4781076|NCT01473524|16491106|P5|LTSE Phase|Lost to Follow-up|3
4781077|NCT01473524|16491107|P4|LTSE Phase|Lost to Follow-up|1
4781078|NCT01473524|16491108|P3|LTSE Phase|Lost to Follow-up|0
4781079|NCT01473524|16491109|P2|LTSE Phase|Lost to Follow-up|0
4781080|NCT01473524|16491110|P1|LTSE Phase|Lost to Follow-up|0
4781081|NCT01473524|16491105|P6|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6
4781082|NCT01473524|16491106|P5|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4
4781083|NCT01473524|16491107|P4|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2
4781084|NCT01473524|16491108|P3|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
4781085|NCT01473524|16491109|P2|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
4781086|NCT01473524|16491110|P1|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0
4781087|NCT01473524|16491105|P6|LTSE Phase|Adverse Event of Pruritus|2
4781088|NCT01473524|16491106|P5|LTSE Phase|Adverse Event of Pruritus|5
4781089|NCT01473524|16491107|P4|LTSE Phase|Adverse Event of Pruritus|1
4781090|NCT01473524|16491108|P3|LTSE Phase|Adverse Event of Pruritus|0
4781091|NCT01473524|16491109|P2|LTSE Phase|Adverse Event of Pruritus|0
4781092|NCT01473524|16491110|P1|LTSE Phase|Adverse Event of Pruritus|0
4781093|NCT01473524|16491105|P6|LTSE Phase|Death|0
4781094|NCT01473524|16491106|P5|LTSE Phase|Death|1
4781095|NCT01473524|16491107|P4|LTSE Phase|Death|0
4781096|NCT01473524|16491108|P3|LTSE Phase|Death|0
4781097|NCT01473524|16491109|P2|LTSE Phase|Death|0
4781098|NCT01473524|16491110|P1|LTSE Phase|Death|0
4781099|NCT01473524|16491105|P6|LTSE Phase|Withdrawal by Subject|6
4781100|NCT01473524|16491106|P5|LTSE Phase|Withdrawal by Subject|3
4781101|NCT01473524|16491107|P4|LTSE Phase|Withdrawal by Subject|3
4781102|NCT01473524|16491108|P3|LTSE Phase|Withdrawal by Subject|0
4781103|NCT01473524|16491109|P2|LTSE Phase|Withdrawal by Subject|0
4781104|NCT01473524|16491110|P1|LTSE Phase|Withdrawal by Subject|0
4781105|NCT01473524|16491105|P6|DB Phase|Withdrawal by Subject|0
4781106|NCT01473524|16491106|P5|DB Phase|Withdrawal by Subject|0
4781107|NCT01473524|16491107|P4|DB Phase|Withdrawal by Subject|0
4781108|NCT01473524|16491108|P3|DB Phase|Withdrawal by Subject|1
4781109|NCT01473524|16491109|P2|DB Phase|Withdrawal by Subject|1
4781110|NCT01473524|16491110|P1|DB Phase|Withdrawal by Subject|2
4781111|NCT01473524|16491105|P6|DB Phase|Death|0
4781112|NCT01473524|16491106|P5|DB Phase|Death|0
4781113|NCT01473524|16491107|P4|DB Phase|Death|0
4781114|NCT01473524|16491108|P3|DB Phase|Death|0
4781115|NCT01473524|16491109|P2|DB Phase|Death|0
4781116|NCT01473524|16491110|P1|DB Phase|Death|1
4781117|NCT01473524|16491105|P6|DB Phase|Adverse Event|0
4781118|NCT01473524|16491106|P5|DB Phase|Adverse Event|0
4781119|NCT01473524|16491107|P4|DB Phase|Adverse Event|0
4781120|NCT01473524|16491108|P3|DB Phase|Adverse Event|2
4781121|NCT01473524|16491109|P2|DB Phase|Adverse Event|8
4781122|NCT01473524|16491110|P1|DB Phase|Adverse Event|4
4781123|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0
4781124|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1
4781125|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Sponsor's Decision|0
4781126|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Sponsor's Decision|1
4781127|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Long term hospitalization|1
4781128|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Long term hospitalization|0
4781129|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0
4781130|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1
4781131|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Site closure|1
4781132|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Site closure|3
4781133|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Withdrawal by Subject|6
4781134|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Withdrawal by Subject|4
4781135|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Lost to Follow-up|2
4781136|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Lost to Follow-up|1
4781137|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Kidney transplant|1
4781138|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Kidney transplant|3
4781139|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Did not meet criteria|2
4781140|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Did not meet criteria|0
4781141|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Physician Decision|2
4781142|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Physician Decision|1
4781143|NCT01473420|16491159|P2|Maintenance Period (16 Weeks)|Adverse Event|2
4781144|NCT01473420|16491160|P1|Maintenance Period (16 Weeks)|Adverse Event|3
4781145|NCT01473420|16491159|P2|Titration Period (18 Weeks)|Did not meet criteria|32
4781146|NCT01473420|16491160|P1|Titration Period (18 Weeks)|Did not meet criteria|32
4781147|NCT01473420|16491159|P2|Titration Period (18 Weeks)|Adverse Event|6
4781148|NCT01473420|16491160|P1|Titration Period (18 Weeks)|Adverse Event|4
4781149|NCT01473407|16491244|P2|Overall Study|Site Closure|0
4781150|NCT01473407|16491245|P1|Overall Study|Site Closure|1
4781151|NCT01473407|16491244|P2|Overall Study|Sponsor's Decision|10
4781152|NCT01473407|16491245|P1|Overall Study|Sponsor's Decision|10
4781153|NCT01473407|16491244|P2|Overall Study|Transfer to Another Facility/Unit|3
4781154|NCT01473407|16491245|P1|Overall Study|Transfer to Another Facility/Unit|4
4781155|NCT01473407|16491244|P2|Overall Study|Temperature Excursion|3
4781156|NCT01473407|16491245|P1|Overall Study|Temperature Excursion|2
4781157|NCT01473407|16491244|P2|Overall Study|Patient Lost Green Card Status|0
4781158|NCT01473407|16491245|P1|Overall Study|Patient Lost Green Card Status|1
4781159|NCT01473407|16491244|P2|Overall Study|Patient Received Aranesp|0
4781160|NCT01473407|16491245|P1|Overall Study|Patient Received Aranesp|1
4781161|NCT01473407|16491244|P2|Overall Study|Elevated Hemoglobin|0
4781162|NCT01473407|16491245|P1|Overall Study|Elevated Hemoglobin|1
4781163|NCT01473407|16491244|P2|Overall Study|Vacation/Travel|1
4781164|NCT01473407|16491245|P1|Overall Study|Vacation/Travel|1
4781165|NCT01473407|16491244|P2|Overall Study|Kidney Transplant|6
4781166|NCT01473407|16491245|P1|Overall Study|Kidney Transplant|7
4781167|NCT01473407|16491244|P2|Overall Study|Withdrawal by Subject|7
4781168|NCT01473407|16491245|P1|Overall Study|Withdrawal by Subject|4
4781169|NCT01473407|16491244|P2|Overall Study|Randomization Error|1
4781170|NCT01473407|16491245|P1|Overall Study|Randomization Error|3
4781171|NCT01473407|16491244|P2|Overall Study|Adverse Event|8
4781172|NCT01473407|16491245|P1|Overall Study|Adverse Event|8
4781173|NCT01473407|16491244|P2|Overall Study|Lost to Follow-up|4
4781174|NCT01473407|16491245|P1|Overall Study|Lost to Follow-up|10
4781175|NCT01473407|16491244|P2|Overall Study|Physician Decision|4
4781176|NCT01473407|16491245|P1|Overall Study|Physician Decision|1
4781177|NCT01473394|16491299|P2|Overall Study|Lost to Follow-up|11
4781178|NCT01473394|16491300|P1|Overall Study|Lost to Follow-up|9
4781179|NCT01473394|16491299|P2|Overall Study|Withdrew Consent|10
4781180|NCT01473394|16491300|P1|Overall Study|Withdrew Consent|12
4781181|NCT01473394|16491299|P2|Overall Study|Protocol Violation|5
4781182|NCT01473394|16491300|P1|Overall Study|Protocol Violation|7
4781183|NCT01473394|16491299|P2|Overall Study|Insufficient Therapeutic Response|1
4781184|NCT01473394|16491300|P1|Overall Study|Insufficient Therapeutic Response|4
4781185|NCT01473394|16491299|P2|Overall Study|Adverse Event|16
4781186|NCT01473394|16491300|P1|Overall Study|Adverse Event|13
4781187|NCT01473381|16491314|P4|Overall Study|Other Reasons|3
4781188|NCT01473381|16491315|P3|Overall Study|Other Reasons|1
4781189|NCT01473381|16491316|P2|Overall Study|Other Reasons|0
4781190|NCT01473381|16491317|P1|Overall Study|Other Reasons|0
4781191|NCT01473381|16491314|P4|Overall Study|Lost to Follow-up|23
4781192|NCT01473381|16491315|P3|Overall Study|Lost to Follow-up|35
4781193|NCT01473381|16491316|P2|Overall Study|Lost to Follow-up|28
4781194|NCT01473381|16491317|P1|Overall Study|Lost to Follow-up|25
4781195|NCT01473381|16491314|P4|Overall Study|Withdrawal of Consent|26
4781196|NCT01473381|16491315|P3|Overall Study|Withdrawal of Consent|20
4781197|NCT01473381|16491316|P2|Overall Study|Withdrawal of Consent|21
4781198|NCT01473381|16491317|P1|Overall Study|Withdrawal of Consent|20
4781199|NCT01473381|16491314|P4|Overall Study|Protocol Violation|17
4781200|NCT01473381|16491315|P3|Overall Study|Protocol Violation|19
4781201|NCT01473381|16491316|P2|Overall Study|Protocol Violation|23
4781202|NCT01473381|16491317|P1|Overall Study|Protocol Violation|17
4781203|NCT01473381|16491314|P4|Overall Study|Insufficient Therapeutic Response|3
4781204|NCT01473381|16491315|P3|Overall Study|Insufficient Therapeutic Response|2
4781205|NCT01473381|16491316|P2|Overall Study|Insufficient Therapeutic Response|1
4781206|NCT01473381|16491317|P1|Overall Study|Insufficient Therapeutic Response|10
4781207|NCT01473381|16491314|P4|Overall Study|Adverse Event|17
4781208|NCT01473381|16491315|P3|Overall Study|Adverse Event|25
4781209|NCT01473381|16491316|P2|Overall Study|Adverse Event|20
4781210|NCT01473381|16491317|P1|Overall Study|Adverse Event|8
4781211|NCT01473355|16491379|P1|Overall Study|Lost to Follow-up|2
4781212|NCT01473355|16491379|P1|Overall Study|Adverse Event|2
4781213|NCT01473355|16491379|P1|Overall Study|Protocol Violation|2
4781214|NCT01472965|16491408|P2|Overall Study|Withdrawal by Subject|0
4781215|NCT01472965|16491409|P1|Overall Study|Withdrawal by Subject|1
4781216|NCT01472939|16491429|P4|Overall Study|Withdrawal by Subject|4
4781217|NCT01472939|16491430|P3|Overall Study|Withdrawal by Subject|1
4781218|NCT01472939|16491431|P2|Overall Study|Withdrawal by Subject|3
4781219|NCT01472939|16491432|P1|Overall Study|Withdrawal by Subject|9
4781220|NCT01472939|16491429|P4|Overall Study|Protocol Violation|1
4781221|NCT01472939|16491430|P3|Overall Study|Protocol Violation|0
4781222|NCT01472939|16491431|P2|Overall Study|Protocol Violation|3
4781223|NCT01472939|16491432|P1|Overall Study|Protocol Violation|3
4781224|NCT01472939|16491429|P4|Overall Study|Withdrawal By PI|0
4781225|NCT01472939|16491430|P3|Overall Study|Withdrawal By PI|0
4781226|NCT01472939|16491431|P2|Overall Study|Withdrawal By PI|0
4781227|NCT01472939|16491432|P1|Overall Study|Withdrawal By PI|1
4781228|NCT01472939|16491429|P4|Overall Study|Prohibited Medication|0
4781229|NCT01472939|16491430|P3|Overall Study|Prohibited Medication|0
4781230|NCT01472939|16491431|P2|Overall Study|Prohibited Medication|1
4781231|NCT01472939|16491432|P1|Overall Study|Prohibited Medication|0
4781232|NCT01472939|16491429|P4|Overall Study|Clinically Significant Pre-Dose ECG|0
4781233|NCT01472939|16491430|P3|Overall Study|Clinically Significant Pre-Dose ECG|1
4781234|NCT01472939|16491431|P2|Overall Study|Clinically Significant Pre-Dose ECG|0
4781235|NCT01472939|16491432|P1|Overall Study|Clinically Significant Pre-Dose ECG|0
4781236|NCT01472939|16491429|P4|Overall Study|Lost to Follow-up|0
4781237|NCT01472939|16491430|P3|Overall Study|Lost to Follow-up|2
4781238|NCT01472939|16491431|P2|Overall Study|Lost to Follow-up|0
4781239|NCT01472939|16491432|P1|Overall Study|Lost to Follow-up|3
4781240|NCT01472939|16491429|P4|Overall Study|Lack of Efficacy|1
4781241|NCT01472939|16491430|P3|Overall Study|Lack of Efficacy|0
4781242|NCT01472939|16491431|P2|Overall Study|Lack of Efficacy|0
4781243|NCT01472939|16491432|P1|Overall Study|Lack of Efficacy|1
4781244|NCT01472939|16491429|P4|Overall Study|Adverse Event|14
4781245|NCT01472939|16491430|P3|Overall Study|Adverse Event|7
4781246|NCT01472939|16491431|P2|Overall Study|Adverse Event|7
4781247|NCT01472939|16491432|P1|Overall Study|Adverse Event|3
4781248|NCT01472835|16491476|P2|Overall Study|Lost to Follow-up|0
4781249|NCT01472835|16491477|P1|Overall Study|Lost to Follow-up|2
4781250|NCT01472757|16491512|P4|Overall Study|Other reasons|2
4781251|NCT01472757|16491513|P3|Overall Study|Other reasons|2
4781252|NCT01472757|16491514|P2|Overall Study|Other reasons|0
4781253|NCT01472757|16491515|P1|Overall Study|Other reasons|1
4781254|NCT01472757|16491512|P4|Overall Study|Protocol Violation|4
4781255|NCT01472757|16491513|P3|Overall Study|Protocol Violation|4
4781256|NCT01472757|16491514|P2|Overall Study|Protocol Violation|2
4781257|NCT01472757|16491515|P1|Overall Study|Protocol Violation|3
4781258|NCT01472757|16491512|P4|Overall Study|Treatment period withdrawal criteria met|12
4781259|NCT01472757|16491513|P3|Overall Study|Treatment period withdrawal criteria met|9
4781260|NCT01472757|16491514|P2|Overall Study|Treatment period withdrawal criteria met|8
4781261|NCT01472757|16491515|P1|Overall Study|Treatment period withdrawal criteria met|21
4781262|NCT01472757|16491512|P4|Overall Study|Asthma exacerbation|1
4781263|NCT01472757|16491513|P3|Overall Study|Asthma exacerbation|2
4781264|NCT01472757|16491514|P2|Overall Study|Asthma exacerbation|1
4781265|NCT01472757|16491515|P1|Overall Study|Asthma exacerbation|4
4781266|NCT01472757|16491512|P4|Overall Study|Withdrawal by Subject|0
4781267|NCT01472757|16491513|P3|Overall Study|Withdrawal by Subject|2
4781268|NCT01472757|16491514|P2|Overall Study|Withdrawal by Subject|2
4781269|NCT01472757|16491515|P1|Overall Study|Withdrawal by Subject|1
4781270|NCT01472380|16491630|P1|1 Day Period Between Dosing|Protocol Violation|1
4781271|NCT01472380|16491630|P1|Efavirenz Alone|Withdrawal by Subject|1
4781272|NCT01472341|16491641|P1|Overall Study|Death|9
4781273|NCT01472341|16491641|P1|Overall Study|Laboratory parameters unavailable|25
4781274|NCT01472341|16491641|P1|Overall Study|Lost to Follow-up|52
4781275|NCT01472341|16491641|P1|Overall Study|Withdrawal by Subject|39
4781276|NCT01472341|16491641|P1|Overall Study|Started therapy with a DPP-IV/GLP-1|92
4781277|NCT01472341|16491641|P1|Overall Study|Started insulin therapy|55
4781278|NCT01472289|16491647|P1|Overall Study|Death|2
4781279|NCT01472185|16491659|P2|Overall Study|Subject Withdrew Consent|3
4781280|NCT01472185|16491660|P1|Overall Study|Subject Withdrew Consent|6
4781281|NCT01472185|16491659|P2|Overall Study|Subject Noncompliance|15
4781282|NCT01472185|16491660|P1|Overall Study|Subject Noncompliance|8
4781283|NCT01472185|16491659|P2|Overall Study|Protocol Violation|1
4781284|NCT01472185|16491660|P1|Overall Study|Protocol Violation|5
4781285|NCT01472185|16491659|P2|Overall Study|Lost to Follow-up|1
4781286|NCT01472185|16491660|P1|Overall Study|Lost to Follow-up|4
4781287|NCT01472185|16491659|P2|Overall Study|Investigator's Discretion|1
4781288|NCT01472185|16491660|P1|Overall Study|Investigator's Discretion|3
4781289|NCT01472185|16491659|P2|Overall Study|Hyperglycemia|2
4781290|NCT01472185|16491660|P1|Overall Study|Hyperglycemia|5
4781291|NCT01472185|16491659|P2|Overall Study|Adverse Event Other than Hyperglycemia|10
4781292|NCT01472185|16491660|P1|Overall Study|Adverse Event Other than Hyperglycemia|3
4781293|NCT01472185|16491659|P2|Overall Study|Randomized but Not Treated|1
4781294|NCT01472185|16491660|P1|Overall Study|Randomized but Not Treated|0
4781295|NCT01472081|16491680|P6|Overall Study|Subject request to discontinue treatment|0
4781296|NCT01472081|16491681|P5|Overall Study|Subject request to discontinue treatment|0
4781297|NCT01472081|16491682|P4|Overall Study|Subject request to discontinue treatment|1
4781298|NCT01472081|16491683|P3|Overall Study|Subject request to discontinue treatment|1
4781299|NCT01472081|16491684|P2|Overall Study|Subject request to discontinue treatment|3
4781300|NCT01472081|16491685|P1|Overall Study|Subject request to discontinue treatment|0
4781301|NCT01472081|16491680|P6|Overall Study|No longer meets study criteria|0
4781302|NCT01472081|16491681|P5|Overall Study|No longer meets study criteria|0
4781303|NCT01472081|16491682|P4|Overall Study|No longer meets study criteria|0
4781304|NCT01472081|16491683|P3|Overall Study|No longer meets study criteria|1
4781305|NCT01472081|16491684|P2|Overall Study|No longer meets study criteria|0
4781306|NCT01472081|16491685|P1|Overall Study|No longer meets study criteria|0
4781307|NCT01472081|16491680|P6|Overall Study|Poor/non-compliance|0
4781308|NCT01472081|16491681|P5|Overall Study|Poor/non-compliance|1
4781309|NCT01472081|16491682|P4|Overall Study|Poor/non-compliance|0
4781310|NCT01472081|16491683|P3|Overall Study|Poor/non-compliance|1
4781311|NCT01472081|16491684|P2|Overall Study|Poor/non-compliance|0
4781312|NCT01472081|16491685|P1|Overall Study|Poor/non-compliance|0
4781313|NCT01472081|16491680|P6|Overall Study|Withdrawal by Subject|1
4781314|NCT01472081|16491681|P5|Overall Study|Withdrawal by Subject|0
4781315|NCT01472081|16491682|P4|Overall Study|Withdrawal by Subject|0
4781316|NCT01472081|16491683|P3|Overall Study|Withdrawal by Subject|0
4781317|NCT01472081|16491684|P2|Overall Study|Withdrawal by Subject|0
4781318|NCT01472081|16491685|P1|Overall Study|Withdrawal by Subject|0
4781319|NCT01472081|16491680|P6|Overall Study|Adverse Event unrelated to study drug|0
4781320|NCT01472081|16491681|P5|Overall Study|Adverse Event unrelated to study drug|1
4781321|NCT01472081|16491682|P4|Overall Study|Adverse Event unrelated to study drug|0
4781322|NCT01472081|16491683|P3|Overall Study|Adverse Event unrelated to study drug|0
4781323|NCT01472081|16491684|P2|Overall Study|Adverse Event unrelated to study drug|0
4781324|NCT01472081|16491685|P1|Overall Study|Adverse Event unrelated to study drug|0
4781325|NCT01472081|16491680|P6|Overall Study|Death|0
4781326|NCT01472081|16491681|P5|Overall Study|Death|1
4781327|NCT01472081|16491682|P4|Overall Study|Death|0
4781328|NCT01472081|16491683|P3|Overall Study|Death|0
4781329|NCT01472081|16491684|P2|Overall Study|Death|0
4781330|NCT01472081|16491685|P1|Overall Study|Death|0
4781331|NCT01472081|16491680|P6|Overall Study|Study drug toxicity|2
4781332|NCT01472081|16491681|P5|Overall Study|Study drug toxicity|13
4781333|NCT01472081|16491682|P4|Overall Study|Study drug toxicity|6
4781334|NCT01472081|16491683|P3|Overall Study|Study drug toxicity|4
4781335|NCT01472081|16491684|P2|Overall Study|Study drug toxicity|9
4781336|NCT01472081|16491685|P1|Overall Study|Study drug toxicity|2
4781337|NCT01472081|16491680|P6|Overall Study|Disease Progression|3
4781338|NCT01472081|16491681|P5|Overall Study|Disease Progression|22
4781339|NCT01472081|16491682|P4|Overall Study|Disease Progression|31
4781340|NCT01472081|16491683|P3|Overall Study|Disease Progression|12
4781341|NCT01472081|16491684|P2|Overall Study|Disease Progression|10
4781342|NCT01472081|16491685|P1|Overall Study|Disease Progression|4
4781343|NCT01472081|16491680|P6|Overall Study|Continuing treatment at time of analysis|0
4781344|NCT01472081|16491681|P5|Overall Study|Continuing treatment at time of analysis|9
4781345|NCT01472081|16491682|P4|Overall Study|Continuing treatment at time of analysis|8
4781346|NCT01472081|16491683|P3|Overall Study|Continuing treatment at time of analysis|1
4781347|NCT01472081|16491684|P2|Overall Study|Continuing treatment at time of analysis|4
4781348|NCT01472081|16491685|P1|Overall Study|Continuing treatment at time of analysis|1
4781349|NCT01471782|16491734|P6|Overall Study|Death|1
4781350|NCT01471782|16491735|P5|Overall Study|Death|0
4781351|NCT01471782|16491736|P4|Overall Study|Death|0
4781352|NCT01471782|16491737|P3|Overall Study|Death|0
4781353|NCT01471782|16491738|P2|Overall Study|Death|0
4781354|NCT01471782|16491739|P1|Overall Study|Death|0
4781355|NCT01471782|16491734|P6|Overall Study|Withdrawal by Parent/Guardian|0
4781356|NCT01471782|16491735|P5|Overall Study|Withdrawal by Parent/Guardian|1
4781357|NCT01471782|16491736|P4|Overall Study|Withdrawal by Parent/Guardian|0
4781358|NCT01471782|16491737|P3|Overall Study|Withdrawal by Parent/Guardian|0
4781359|NCT01471782|16491738|P2|Overall Study|Withdrawal by Parent/Guardian|0
4781360|NCT01471782|16491739|P1|Overall Study|Withdrawal by Parent/Guardian|0
4781361|NCT01471782|16491734|P6|Overall Study|Physician Decision|8
4781362|NCT01471782|16491735|P5|Overall Study|Physician Decision|3
4781363|NCT01471782|16491736|P4|Overall Study|Physician Decision|0
4781364|NCT01471782|16491737|P3|Overall Study|Physician Decision|0
4781365|NCT01471782|16491738|P2|Overall Study|Physician Decision|0
4781366|NCT01471782|16491739|P1|Overall Study|Physician Decision|0
4781367|NCT01471782|16491734|P6|Overall Study|Disease Relapse|1
4781368|NCT01471782|16491735|P5|Overall Study|Disease Relapse|2
4781369|NCT01471782|16491736|P4|Overall Study|Disease Relapse|1
4781370|NCT01471782|16491737|P3|Overall Study|Disease Relapse|0
4781371|NCT01471782|16491738|P2|Overall Study|Disease Relapse|0
4781372|NCT01471782|16491739|P1|Overall Study|Disease Relapse|0
4781373|NCT01471782|16491734|P6|Overall Study|Change of Chemotherapy|4
4781374|NCT01471782|16491735|P5|Overall Study|Change of Chemotherapy|1
4781375|NCT01471782|16491736|P4|Overall Study|Change of Chemotherapy|0
4781376|NCT01471782|16491737|P3|Overall Study|Change of Chemotherapy|0
4781377|NCT01471782|16491738|P2|Overall Study|Change of Chemotherapy|1
4781378|NCT01471782|16491739|P1|Overall Study|Change of Chemotherapy|1
4781379|NCT01471782|16491734|P6|Overall Study|Other|5
4781380|NCT01471782|16491735|P5|Overall Study|Other|6
4781381|NCT01471782|16491736|P4|Overall Study|Other|1
4781382|NCT01471782|16491737|P3|Overall Study|Other|1
4781383|NCT01471782|16491738|P2|Overall Study|Other|0
4781384|NCT01471782|16491739|P1|Overall Study|Other|0
4781385|NCT01471782|16491734|P6|Overall Study|Adverse Event|1
4781386|NCT01471782|16491735|P5|Overall Study|Adverse Event|3
4781387|NCT01471782|16491736|P4|Overall Study|Adverse Event|2
4781388|NCT01471782|16491737|P3|Overall Study|Adverse Event|2
4781389|NCT01471782|16491738|P2|Overall Study|Adverse Event|1
4781390|NCT01471782|16491739|P1|Overall Study|Adverse Event|1
4781391|NCT01471782|16491734|P6|Overall Study|Lack of Efficacy|18
4781392|NCT01471782|16491735|P5|Overall Study|Lack of Efficacy|5
4781393|NCT01471782|16491736|P4|Overall Study|Lack of Efficacy|1
4781394|NCT01471782|16491737|P3|Overall Study|Lack of Efficacy|1
4781395|NCT01471782|16491738|P2|Overall Study|Lack of Efficacy|2
4781396|NCT01471782|16491739|P1|Overall Study|Lack of Efficacy|1
4781397|NCT01471782|16491734|P6|Overall Study|Hematopoietic Stem Cell Transplantation|3
4781398|NCT01471782|16491735|P5|Overall Study|Hematopoietic Stem Cell Transplantation|5
4781399|NCT01471782|16491736|P4|Overall Study|Hematopoietic Stem Cell Transplantation|0
4781400|NCT01471782|16491737|P3|Overall Study|Hematopoietic Stem Cell Transplantation|1
4781401|NCT01471782|16491738|P2|Overall Study|Hematopoietic Stem Cell Transplantation|2
4781402|NCT01471782|16491739|P1|Overall Study|Hematopoietic Stem Cell Transplantation|2
4781403|NCT01471691|16491793|P2|Overall Study|Lack of Efficacy|1
4781404|NCT01471691|16491794|P1|Overall Study|Lack of Efficacy|0
4781405|NCT01471379|16491803|P3|Overall Study|Study terminated|0
4781406|NCT01471379|16491804|P2|Overall Study|Study terminated|1
4781407|NCT01471379|16491805|P1|Overall Study|Study terminated|0
4781408|NCT01471379|16491803|P3|Overall Study|Adverse Event|0
4781409|NCT01471379|16491804|P2|Overall Study|Adverse Event|0
4781410|NCT01471379|16491805|P1|Overall Study|Adverse Event|1
4781411|NCT01471353|16491825|P1|Overall Study|remain on study|3
4781412|NCT01471340|16491836|P2|Overall Study|Invalid informed consent|0
4781413|NCT01471340|16491837|P1|Overall Study|Invalid informed consent|1
4781414|NCT01471340|16491836|P2|Overall Study|Investigational site closure|1
4781415|NCT01471340|16491837|P1|Overall Study|Investigational site closure|0
4781416|NCT01471340|16491836|P2|Overall Study|Lost to Follow-up|1
4781417|NCT01471340|16491837|P1|Overall Study|Lost to Follow-up|0
4781418|NCT01471340|16491836|P2|Overall Study|Death|4
4781419|NCT01471340|16491837|P1|Overall Study|Death|5
4781420|NCT01471574|16491860|P4|Follow-up Period|Follow-up no longer required|0
4781421|NCT01471574|16491861|P3|Follow-up Period|Follow-up no longer required|0
4781422|NCT01471574|16491862|P2|Follow-up Period|Follow-up no longer required|1
4781423|NCT01471574|16491863|P1|Follow-up Period|Follow-up no longer required|0
4781424|NCT01471574|16491860|P4|Follow-up Period|Death|0
4781425|NCT01471574|16491861|P3|Follow-up Period|Death|1
4781426|NCT01471574|16491862|P2|Follow-up Period|Death|0
4781427|NCT01471574|16491863|P1|Follow-up Period|Death|0
4781428|NCT01471574|16491860|P4|Follow-up Period|Lost to Follow-up|2
4781429|NCT01471574|16491861|P3|Follow-up Period|Lost to Follow-up|3
4781430|NCT01471574|16491862|P2|Follow-up Period|Lost to Follow-up|1
4781431|NCT01471574|16491863|P1|Follow-up Period|Lost to Follow-up|4
4781432|NCT01471574|16491860|P4|Follow-up Period|Withdrawal by Subject|1
4781433|NCT01471574|16491861|P3|Follow-up Period|Withdrawal by Subject|3
4781434|NCT01471574|16491862|P2|Follow-up Period|Withdrawal by Subject|0
4781435|NCT01471574|16491863|P1|Follow-up Period|Withdrawal by Subject|3
4781436|NCT01471574|16491860|P4|Treatment Period|Other|0
4781437|NCT01471574|16491861|P3|Treatment Period|Other|0
4781438|NCT01471574|16491862|P2|Treatment Period|Other|0
4781439|NCT01471574|16491863|P1|Treatment Period|Other|1
4781440|NCT01471574|16491860|P4|Treatment Period|Patient no Longer Meets Study Criteria|0
4781441|NCT01471574|16491861|P3|Treatment Period|Patient no Longer Meets Study Criteria|0
4781442|NCT01471574|16491862|P2|Treatment Period|Patient no Longer Meets Study Criteria|0
4781443|NCT01471574|16491863|P1|Treatment Period|Patient no Longer Meets Study Criteria|1
4781444|NCT01471574|16491860|P4|Treatment Period|Lost to Follow-up|0
4781445|NCT01471574|16491861|P3|Treatment Period|Lost to Follow-up|2
4781446|NCT01471574|16491862|P2|Treatment Period|Lost to Follow-up|2
4781447|NCT01471574|16491863|P1|Treatment Period|Lost to Follow-up|1
4781448|NCT01471574|16491860|P4|Treatment Period|Patient Requested Discontinue Study drug|1
4781449|NCT01471574|16491861|P3|Treatment Period|Patient Requested Discontinue Study drug|1
4781450|NCT01471574|16491862|P2|Treatment Period|Patient Requested Discontinue Study drug|0
4781451|NCT01471574|16491863|P1|Treatment Period|Patient Requested Discontinue Study drug|4
4781452|NCT01471574|16491860|P4|Treatment Period|Withdrawal by Subject|0
4781453|NCT01471574|16491861|P3|Treatment Period|Withdrawal by Subject|1
4781454|NCT01471574|16491862|P2|Treatment Period|Withdrawal by Subject|1
4781455|NCT01471574|16491863|P1|Treatment Period|Withdrawal by Subject|5
4781456|NCT01471574|16491860|P4|Treatment Period|Adverse Event|1
4781457|NCT01471574|16491861|P3|Treatment Period|Adverse Event|6
4781458|NCT01471574|16491862|P2|Treatment Period|Adverse Event|3
4781459|NCT01471574|16491863|P1|Treatment Period|Adverse Event|7
4781460|NCT01471574|16491860|P4|Treatment Period|Lack of Efficacy|1
4781461|NCT01471574|16491861|P3|Treatment Period|Lack of Efficacy|14
4781462|NCT01471574|16491862|P2|Treatment Period|Lack of Efficacy|4
4781463|NCT01471574|16491863|P1|Treatment Period|Lack of Efficacy|12
4781464|NCT01471522|16491894|P2|Overall Study|Lost to Follow-up|26
4781465|NCT01471522|16491895|P1|Overall Study|Lost to Follow-up|36
4781466|NCT01471522|16491894|P2|Overall Study|Withdrawal by Subject|22
4781467|NCT01471522|16491895|P1|Overall Study|Withdrawal by Subject|28
4781468|NCT01471197|16491932|P2|Overall Study|Study Drug Toxicity|0
4781469|NCT01471197|16491933|P1|Overall Study|Study Drug Toxicity|1
4781470|NCT01471197|16491932|P2|Overall Study|Death|0
4781471|NCT01471197|16491933|P1|Overall Study|Death|1
4781472|NCT01471197|16491932|P2|Overall Study|Disease Progression|2
4781473|NCT01471197|16491933|P1|Overall Study|Disease Progression|4
4781474|NCT01471171|16491943|P2|Treatment Period 2|Adverse Event|0
4781475|NCT01471171|16491944|P1|Treatment Period 2|Adverse Event|1
4781476|NCT01471171|16491943|P2|Treatment Period 1|Adverse Event|1
4781477|NCT01471171|16491944|P1|Treatment Period 1|Adverse Event|4
4781478|NCT01471054|16491956|P2|Overall Study|Study terminated prematurely|0
4781479|NCT01471054|16491957|P1|Overall Study|Study terminated prematurely|4
4781480|NCT01471028|16491980|P2|VTI-208E|Lost to Follow-up|2
4781481|NCT01471028|16491981|P1|VTI-208E|Lost to Follow-up|0
4781482|NCT01471028|16491980|P2|VTI-208E|Withdrawal by Subject|0
4781483|NCT01471028|16491981|P1|VTI-208E|Withdrawal by Subject|1
4781484|NCT01471028|16491980|P2|VTI-208E|Death|10
4781485|NCT01471028|16491981|P1|VTI-208E|Death|7
4781486|NCT01471028|16491980|P2|VTI-208|Lost to Follow-up|1
4781487|NCT01471028|16491981|P1|VTI-208|Lost to Follow-up|1
4781488|NCT01471028|16491980|P2|VTI-208|Withdrawal by Subject|2
4781489|NCT01471028|16491981|P1|VTI-208|Withdrawal by Subject|0
4781490|NCT01471028|16491980|P2|VTI-208|Adverse Event|41
4781491|NCT01471028|16491981|P1|VTI-208|Adverse Event|39
4781492|NCT01471015|16491996|P3|Overall Study|Death|1
4781493|NCT01471015|16491997|P2|Overall Study|Death|1
4781494|NCT01471015|16491998|P1|Overall Study|Death|0
4781495|NCT01470599|16492059|P2|Overall Study|Adverse event not related to study drug|5
4781496|NCT01470599|16492060|P1|Overall Study|Adverse event not related to study drug|1
4781497|NCT01470599|16492059|P2|Overall Study|Insufficient clinical response|27
4781498|NCT01470599|16492060|P1|Overall Study|Insufficient clinical response|6
4781499|NCT01470599|16492059|P2|Overall Study|Adverse event related to study drug|5
4781500|NCT01470599|16492060|P1|Overall Study|Adverse event related to study drug|2
4781501|NCT01470599|16492059|P2|Overall Study|Protocol Violation|1
4781502|NCT01470599|16492060|P1|Overall Study|Protocol Violation|3
4781503|NCT01470599|16492059|P2|Overall Study|Other|0
4781504|NCT01470599|16492060|P1|Overall Study|Other|1
4781505|NCT01470599|16492059|P2|Overall Study|Withdrawal by Subject|4
4781506|NCT01470599|16492060|P1|Overall Study|Withdrawal by Subject|3
4781507|NCT01470599|16492059|P2|Overall Study|Lost to Follow-up|1
4781508|NCT01470599|16492060|P1|Overall Study|Lost to Follow-up|2
4781509|NCT01470599|16492059|P2|Overall Study|Did not meet entrance criteria|0
4781510|NCT01470599|16492060|P1|Overall Study|Did not meet entrance criteria|1
4781511|NCT01470469|16492124|P2|Overall Study|Other|1
4781512|NCT01470469|16492125|P1|Overall Study|Other|2
4781513|NCT01470469|16492124|P2|Overall Study|Protocol Violation|1
4781514|NCT01470469|16492125|P1|Overall Study|Protocol Violation|1
4781515|NCT01470469|16492124|P2|Overall Study|Lost to Follow-up|2
4781516|NCT01470469|16492125|P1|Overall Study|Lost to Follow-up|2
4781517|NCT01470469|16492124|P2|Overall Study|Adverse Event|7
4781518|NCT01470469|16492125|P1|Overall Study|Adverse Event|0
4781519|NCT01470469|16492124|P2|Overall Study|Lack of Efficacy|7
4781520|NCT01470469|16492125|P1|Overall Study|Lack of Efficacy|1
4781521|NCT01470469|16492124|P2|Overall Study|Withdrawal by Subject|6
4781522|NCT01470469|16492125|P1|Overall Study|Withdrawal by Subject|4
4781523|NCT01470417|16492145|P2|Overall Study|Disease progression|2
4781524|NCT01470417|16492146|P1|Overall Study|Disease progression|0
4781525|NCT01470326|16492158|P1|Overall Study|No Visit After 1st Day of Treatment|119
4781526|NCT01470326|16492158|P1|Overall Study|No Drug Administration Information|2
4781527|NCT01470326|16492158|P1|Overall Study|Protocol Violation|32
4781528|NCT01470248|16492169|P1|Overall Study|Withdrawal by Subject|1
4781529|NCT01470144|16492225|P1|Overall Study|Patient's and investigator's decision|1
4781530|NCT01470144|16492225|P1|Overall Study|Lung transplant|6
4781531|NCT01470144|16492225|P1|Overall Study|Death|1
4781532|NCT01470144|16492225|P1|Overall Study|Adverse Event|2
4781533|NCT01470001|16492330|P2|Overall Study|Withdrawal by Subject|1
4781534|NCT01470001|16492331|P1|Overall Study|Withdrawal by Subject|2
4781535|NCT01470001|16492330|P2|Overall Study|Physician Decision|0
4781536|NCT01470001|16492331|P1|Overall Study|Physician Decision|2
4781537|NCT01470001|16492330|P2|Overall Study|Lost to Follow-up|1
4781538|NCT01470001|16492331|P1|Overall Study|Lost to Follow-up|1
4781627|NCT01469052|16492591|P4|Overall Study|Adverse Event|2
4781539|NCT01469819|16492341|P1|Overall Study|Technical malfunction of SmartPill data|3
4781540|NCT01469819|16492341|P1|Overall Study|Could not swallow SmartPill|2
4781541|NCT01469819|16492341|P1|Overall Study|Did not meet inclusionary criteria|2
4781542|NCT01469819|16492341|P1|Overall Study|Withdrawal by Subject|1
4781543|NCT01469637|16492365|P2|Second Intervention|Incarcerated|0
4781544|NCT01469637|16492366|P1|Second Intervention|Incarcerated|1
4781545|NCT01469637|16492365|P2|First Intervention|Unacceptable behavior|1
4781546|NCT01469637|16492366|P1|First Intervention|Unacceptable behavior|0
4781547|NCT01469546|16492374|P1|Received 5 mg Dose|Physician Decision|3
4781548|NCT01469546|16492374|P1|Received 5 mg Dose|Progressive Disease|3
4781549|NCT01469546|16492374|P1|Received 5 mg Dose|Protocol Violation|2
4781550|NCT01469546|16492374|P1|Received 5 mg Dose|Death|2
4781551|NCT01469546|16492374|P1|Received 5 mg Dose|Adverse Event|13
4781552|NCT01469377|16492384|P3|Overall Study|Other Miscellaneous Reasons|0
4781553|NCT01469377|16492385|P2|Overall Study|Other Miscellaneous Reasons|0
4781554|NCT01469377|16492386|P1|Overall Study|Other Miscellaneous Reasons|2
4781555|NCT01469377|16492384|P3|Overall Study|Insufficient Therapeutic Response|0
4781556|NCT01469377|16492385|P2|Overall Study|Insufficient Therapeutic Response|4
4781557|NCT01469377|16492386|P1|Overall Study|Insufficient Therapeutic Response|3
4781558|NCT01469377|16492384|P3|Overall Study|Adverse Event|36
4781559|NCT01469377|16492385|P2|Overall Study|Adverse Event|18
4781560|NCT01469377|16492386|P1|Overall Study|Adverse Event|8
4781561|NCT01469377|16492384|P3|Overall Study|Withdrawal of Consent|15
4781562|NCT01469377|16492385|P2|Overall Study|Withdrawal of Consent|14
4781563|NCT01469377|16492386|P1|Overall Study|Withdrawal of Consent|12
4781564|NCT01469377|16492384|P3|Overall Study|Lost to Follow-up|5
4781565|NCT01469377|16492385|P2|Overall Study|Lost to Follow-up|2
4781566|NCT01469377|16492386|P1|Overall Study|Lost to Follow-up|3
4781567|NCT01469377|16492384|P3|Overall Study|Protocol Deviation|10
4781568|NCT01469377|16492385|P2|Overall Study|Protocol Deviation|10
4781569|NCT01469377|16492386|P1|Overall Study|Protocol Deviation|7
4781570|NCT01469364|16492397|P1|Overall Study|Withdrawal by Subject|1
4781571|NCT01469364|16492397|P1|Overall Study|Adverse Event|1
4781572|NCT01469221|16492448|P3|Double Blind Phase|Sponsor Terminate Study|0
4781573|NCT01469221|16492449|P2|Double Blind Phase|Sponsor Terminate Study|16
4781574|NCT01469221|16492450|P1|Double Blind Phase|Sponsor Terminate Study|12
4781575|NCT01469221|16492448|P3|Double Blind Phase|Physician Decision|0
4781576|NCT01469221|16492449|P2|Double Blind Phase|Physician Decision|1
4781577|NCT01469221|16492450|P1|Double Blind Phase|Physician Decision|1
4781578|NCT01469221|16492448|P3|Double Blind Phase|Protocol Violation|0
4781579|NCT01469221|16492449|P2|Double Blind Phase|Protocol Violation|0
4781580|NCT01469221|16492450|P1|Double Blind Phase|Protocol Violation|1
4781581|NCT01469182|16492461|P2|Overall Study|Did not meet Protocol Eligibility|0
4781582|NCT01469182|16492462|P1|Overall Study|Did not meet Protocol Eligibility|3
4781583|NCT01469182|16492461|P2|Overall Study|Protocol Violation|2
4781584|NCT01469182|16492462|P1|Overall Study|Protocol Violation|4
4781585|NCT01469182|16492461|P2|Overall Study|Withdrawal by Subject|1
4781586|NCT01469182|16492462|P1|Overall Study|Withdrawal by Subject|4
4781587|NCT01469182|16492461|P2|Overall Study|Lost to Follow-up|0
4781588|NCT01469182|16492462|P1|Overall Study|Lost to Follow-up|3
4781589|NCT01469182|16492461|P2|Overall Study|Adverse Event|3
4781590|NCT01469182|16492462|P1|Overall Study|Adverse Event|21
4781591|NCT01469065|16492489|P5|Overall Study|Other|0
4781592|NCT01469065|16492490|P4|Overall Study|Other|0
4781593|NCT01469065|16492491|P3|Overall Study|Other|0
4781594|NCT01469065|16492492|P2|Overall Study|Other|1
4781595|NCT01469065|16492493|P1|Overall Study|Other|0
4781596|NCT01469065|16492489|P5|Overall Study|Lack of Efficacy|1
4781597|NCT01469065|16492490|P4|Overall Study|Lack of Efficacy|0
4781598|NCT01469065|16492491|P3|Overall Study|Lack of Efficacy|0
4781599|NCT01469065|16492492|P2|Overall Study|Lack of Efficacy|0
4781600|NCT01469065|16492493|P1|Overall Study|Lack of Efficacy|0
4781601|NCT01469052|16492589|P6|Overall Study|Other|0
4781602|NCT01469052|16492590|P5|Overall Study|Other|1
4781603|NCT01469052|16492591|P4|Overall Study|Other|0
4781604|NCT01469052|16492592|P3|Overall Study|Other|0
4781605|NCT01469052|16492593|P2|Overall Study|Other|1
4781606|NCT01469052|16492594|P1|Overall Study|Other|0
4781607|NCT01469052|16492589|P6|Overall Study|Moved to rollover protocol|1
4781608|NCT01469052|16492590|P5|Overall Study|Moved to rollover protocol|0
4781609|NCT01469052|16492591|P4|Overall Study|Moved to rollover protocol|0
4781610|NCT01469052|16492592|P3|Overall Study|Moved to rollover protocol|1
4781611|NCT01469052|16492593|P2|Overall Study|Moved to rollover protocol|0
4781612|NCT01469052|16492594|P1|Overall Study|Moved to rollover protocol|1
4781613|NCT01469052|16492589|P6|Overall Study|Lack of Efficacy|2
4781614|NCT01469052|16492590|P5|Overall Study|Lack of Efficacy|0
4781615|NCT01469052|16492591|P4|Overall Study|Lack of Efficacy|0
4781616|NCT01469052|16492592|P3|Overall Study|Lack of Efficacy|0
4781617|NCT01469052|16492593|P2|Overall Study|Lack of Efficacy|0
4781618|NCT01469052|16492594|P1|Overall Study|Lack of Efficacy|0
4781619|NCT01469052|16492589|P6|Overall Study|Progressive disease|2
4781620|NCT01469052|16492590|P5|Overall Study|Progressive disease|7
4781621|NCT01469052|16492591|P4|Overall Study|Progressive disease|3
4781622|NCT01469052|16492592|P3|Overall Study|Progressive disease|5
4781623|NCT01469052|16492593|P2|Overall Study|Progressive disease|0
4781624|NCT01469052|16492594|P1|Overall Study|Progressive disease|3
4781625|NCT01469052|16492589|P6|Overall Study|Adverse Event|1
4781626|NCT01469052|16492590|P5|Overall Study|Adverse Event|0
4781628|NCT01469052|16492592|P3|Overall Study|Adverse Event|0
4781629|NCT01469052|16492593|P2|Overall Study|Adverse Event|3
4781630|NCT01469052|16492594|P1|Overall Study|Adverse Event|2
4781631|NCT01469013|16492659|P13|Part B (Extension Period)|Withdrawal by Subject|3
4781632|NCT01469013|16492660|P12|Part B (Extension Period)|Withdrawal by Subject|0
4781633|NCT01469013|16492661|P11|Part B (Extension Period)|Withdrawal by Subject|1
4781634|NCT01469013|16492662|P10|Part B (Extension Period)|Withdrawal by Subject|0
4781635|NCT01469013|16492663|P9|Part B (Extension Period)|Withdrawal by Subject|1
4781636|NCT01469013|16492664|P8|Part B (Extension Period)|Withdrawal by Subject|0
4781637|NCT01469013|16492665|P7|Part B (Extension Period)|Withdrawal by Subject|0
4781638|NCT01469013|16492666|P6|Part B (Extension Period)|Withdrawal by Subject|0
4781639|NCT01469013|16492667|P5|Part B (Extension Period)|Withdrawal by Subject|0
4781640|NCT01469013|16492668|P4|Part B (Extension Period)|Withdrawal by Subject|0
4781641|NCT01469013|16492669|P3|Part B (Extension Period)|Withdrawal by Subject|0
4781642|NCT01469013|16492670|P2|Part B (Extension Period)|Withdrawal by Subject|0
4781643|NCT01469013|16492671|P1|Part B (Extension Period)|Withdrawal by Subject|0
4781644|NCT01469013|16492659|P13|Part B (Extension Period)|Adverse Event|3
4781645|NCT01469013|16492660|P12|Part B (Extension Period)|Adverse Event|6
4781646|NCT01469013|16492661|P11|Part B (Extension Period)|Adverse Event|1
4781647|NCT01469013|16492662|P10|Part B (Extension Period)|Adverse Event|3
4781648|NCT01469013|16492663|P9|Part B (Extension Period)|Adverse Event|3
4781649|NCT01469013|16492664|P8|Part B (Extension Period)|Adverse Event|5
4781650|NCT01469013|16492665|P7|Part B (Extension Period)|Adverse Event|5
4781651|NCT01469013|16492666|P6|Part B (Extension Period)|Adverse Event|2
4781652|NCT01469013|16492667|P5|Part B (Extension Period)|Adverse Event|0
4781653|NCT01469013|16492668|P4|Part B (Extension Period)|Adverse Event|0
4781654|NCT01469013|16492669|P3|Part B (Extension Period)|Adverse Event|0
4781655|NCT01469013|16492670|P2|Part B (Extension Period)|Adverse Event|0
4781656|NCT01469013|16492671|P1|Part B (Extension Period)|Adverse Event|0
4781657|NCT01469013|16492659|P13|Part A (Treatment Period)|Withdrawal by Subject|0
4781658|NCT01469013|16492660|P12|Part A (Treatment Period)|Withdrawal by Subject|0
4781659|NCT01469013|16492661|P11|Part A (Treatment Period)|Withdrawal by Subject|0
4781660|NCT01469013|16492662|P10|Part A (Treatment Period)|Withdrawal by Subject|0
4781661|NCT01469013|16492663|P9|Part A (Treatment Period)|Withdrawal by Subject|0
4781662|NCT01469013|16492664|P8|Part A (Treatment Period)|Withdrawal by Subject|0
4781663|NCT01469013|16492665|P7|Part A (Treatment Period)|Withdrawal by Subject|0
4781664|NCT01469013|16492666|P6|Part A (Treatment Period)|Withdrawal by Subject|0
4781665|NCT01469013|16492667|P5|Part A (Treatment Period)|Withdrawal by Subject|0
4781666|NCT01469013|16492668|P4|Part A (Treatment Period)|Withdrawal by Subject|0
4781667|NCT01469013|16492669|P3|Part A (Treatment Period)|Withdrawal by Subject|1
4781668|NCT01469013|16492670|P2|Part A (Treatment Period)|Withdrawal by Subject|0
4781669|NCT01469013|16492671|P1|Part A (Treatment Period)|Withdrawal by Subject|0
4781670|NCT01469013|16492659|P13|Part A (Treatment Period)|Adverse Event|0
4781671|NCT01469013|16492660|P12|Part A (Treatment Period)|Adverse Event|0
4781672|NCT01469013|16492661|P11|Part A (Treatment Period)|Adverse Event|0
4781673|NCT01469013|16492662|P10|Part A (Treatment Period)|Adverse Event|0
4781674|NCT01469013|16492663|P9|Part A (Treatment Period)|Adverse Event|0
4781675|NCT01469013|16492664|P8|Part A (Treatment Period)|Adverse Event|0
4781676|NCT01469013|16492665|P7|Part A (Treatment Period)|Adverse Event|0
4781677|NCT01469013|16492666|P6|Part A (Treatment Period)|Adverse Event|0
4781678|NCT01469013|16492667|P5|Part A (Treatment Period)|Adverse Event|1
4781679|NCT01469013|16492668|P4|Part A (Treatment Period)|Adverse Event|0
4781680|NCT01469013|16492669|P3|Part A (Treatment Period)|Adverse Event|0
4781681|NCT01469013|16492670|P2|Part A (Treatment Period)|Adverse Event|0
4781682|NCT01469013|16492671|P1|Part A (Treatment Period)|Adverse Event|1
4781683|NCT01469000|16492756|P2|Overall Study|Sponsor Decision|1
4781684|NCT01469000|16492757|P1|Overall Study|Sponsor Decision|4
4781685|NCT01469000|16492756|P2|Overall Study|Withdrawal by Subject|3
4781686|NCT01469000|16492757|P1|Overall Study|Withdrawal by Subject|16
4781687|NCT01468987|16492777|P2|Overall Study|Sponsor Decision|0
4781688|NCT01468987|16492778|P1|Overall Study|Sponsor Decision|1
4781689|NCT01468987|16492777|P2|Overall Study|Physician Decision|15
4781690|NCT01468987|16492778|P1|Overall Study|Physician Decision|8
4781691|NCT01468987|16492777|P2|Overall Study|Withdrawal by Subject|28
4781692|NCT01468987|16492778|P1|Overall Study|Withdrawal by Subject|28
4781693|NCT01468987|16492777|P2|Overall Study|Protocol Violation|2
4781694|NCT01468987|16492778|P1|Overall Study|Protocol Violation|8
4781695|NCT01468987|16492777|P2|Overall Study|Lost to Follow-up|5
4781696|NCT01468987|16492778|P1|Overall Study|Lost to Follow-up|10
4781697|NCT01468987|16492777|P2|Overall Study|Death|1
4781698|NCT01468987|16492778|P1|Overall Study|Death|4
4781699|NCT01468987|16492777|P2|Overall Study|Adverse Event|9
4781700|NCT01468987|16492778|P1|Overall Study|Adverse Event|12
4781701|NCT01468909|16492955|P2|Overall Study|Never Treated|2
4781702|NCT01468909|16492956|P1|Overall Study|Never Treated|2
4781703|NCT01468818|16492989|P1|Overall Study|Death during treatment|2
4781704|NCT01468597|16493003|P1|Overall Study|no platelet function data|5
4781705|NCT01468597|16493003|P1|Overall Study|off-pump CABG|1
4781706|NCT01468597|16493003|P1|Overall Study|concomitant valves|12
4781707|NCT01468597|16493003|P1|Overall Study|Found ineligible|17
4781708|NCT01468311|16493052|P1|Overall Study|Withdrawal by Subject|1
4781709|NCT01468311|16493052|P1|Overall Study|mobilization failure|1
4781710|NCT01468233|16493064|P6|Treatment Period 2|Other|0
4781711|NCT01468233|16493065|P5|Treatment Period 2|Other|1
4781712|NCT01468233|16493066|P4|Treatment Period 2|Other|0
4781713|NCT01468233|16493067|P3|Treatment Period 2|Other|3
4781714|NCT01468233|16493068|P2|Treatment Period 2|Other|0
4781715|NCT01468233|16493069|P1|Treatment Period 2|Other|0
4781716|NCT01468233|16493064|P6|Treatment Period 2|Lost to Follow-up|0
4781717|NCT01468233|16493065|P5|Treatment Period 2|Lost to Follow-up|2
4781718|NCT01468233|16493066|P4|Treatment Period 2|Lost to Follow-up|0
4781719|NCT01468233|16493067|P3|Treatment Period 2|Lost to Follow-up|3
4781720|NCT01468233|16493068|P2|Treatment Period 2|Lost to Follow-up|0
4781721|NCT01468233|16493069|P1|Treatment Period 2|Lost to Follow-up|0
4781722|NCT01468233|16493064|P6|Treatment Period 2|Loss/absence of response (per protocol)|20
4781723|NCT01468233|16493065|P5|Treatment Period 2|Loss/absence of response (per protocol)|22
4781724|NCT01468233|16493066|P4|Treatment Period 2|Loss/absence of response (per protocol)|25
4781725|NCT01468233|16493067|P3|Treatment Period 2|Loss/absence of response (per protocol)|84
4781726|NCT01468233|16493068|P2|Treatment Period 2|Loss/absence of response (per protocol)|0
4781727|NCT01468233|16493069|P1|Treatment Period 2|Loss/absence of response (per protocol)|0
4781728|NCT01468233|16493064|P6|Treatment Period 2|Withdrawal by Subject|1
4781729|NCT01468233|16493065|P5|Treatment Period 2|Withdrawal by Subject|1
4781730|NCT01468233|16493066|P4|Treatment Period 2|Withdrawal by Subject|1
4781731|NCT01468233|16493067|P3|Treatment Period 2|Withdrawal by Subject|9
4781732|NCT01468233|16493068|P2|Treatment Period 2|Withdrawal by Subject|0
4781733|NCT01468233|16493069|P1|Treatment Period 2|Withdrawal by Subject|0
4781734|NCT01468233|16493064|P6|Treatment Period 2|Lack of Efficacy|1
4781735|NCT01468233|16493065|P5|Treatment Period 2|Lack of Efficacy|0
4781736|NCT01468233|16493066|P4|Treatment Period 2|Lack of Efficacy|2
4781737|NCT01468233|16493067|P3|Treatment Period 2|Lack of Efficacy|9
4781738|NCT01468233|16493068|P2|Treatment Period 2|Lack of Efficacy|0
4781739|NCT01468233|16493069|P1|Treatment Period 2|Lack of Efficacy|0
4781740|NCT01468233|16493064|P6|Treatment Period 2|Adverse Event|1
4781741|NCT01468233|16493065|P5|Treatment Period 2|Adverse Event|2
4781742|NCT01468233|16493066|P4|Treatment Period 2|Adverse Event|0
4781743|NCT01468233|16493067|P3|Treatment Period 2|Adverse Event|3
4781744|NCT01468233|16493068|P2|Treatment Period 2|Adverse Event|0
4781745|NCT01468233|16493069|P1|Treatment Period 2|Adverse Event|0
4781746|NCT01468233|16493064|P6|Treatment Period 1|Other|0
4781747|NCT01468233|16493065|P5|Treatment Period 1|Other|0
4781748|NCT01468233|16493066|P4|Treatment Period 1|Other|0
4781749|NCT01468233|16493067|P3|Treatment Period 1|Other|0
4781750|NCT01468233|16493068|P2|Treatment Period 1|Other|1
4781751|NCT01468233|16493069|P1|Treatment Period 1|Other|1
4781752|NCT01468233|16493064|P6|Treatment Period 1|Lost to Follow-up|0
4781753|NCT01468233|16493065|P5|Treatment Period 1|Lost to Follow-up|0
4781754|NCT01468233|16493066|P4|Treatment Period 1|Lost to Follow-up|0
4781755|NCT01468233|16493067|P3|Treatment Period 1|Lost to Follow-up|0
4781756|NCT01468233|16493068|P2|Treatment Period 1|Lost to Follow-up|0
4781757|NCT01468233|16493069|P1|Treatment Period 1|Lost to Follow-up|3
4781758|NCT01468233|16493064|P6|Treatment Period 1|Withdrawal by Subject|0
4781759|NCT01468233|16493065|P5|Treatment Period 1|Withdrawal by Subject|0
4781760|NCT01468233|16493066|P4|Treatment Period 1|Withdrawal by Subject|0
4781761|NCT01468233|16493067|P3|Treatment Period 1|Withdrawal by Subject|0
4781762|NCT01468233|16493068|P2|Treatment Period 1|Withdrawal by Subject|4
4781763|NCT01468233|16493069|P1|Treatment Period 1|Withdrawal by Subject|3
4781764|NCT01468233|16493064|P6|Treatment Period 1|Adverse Event|0
4781765|NCT01468233|16493065|P5|Treatment Period 1|Adverse Event|0
4781766|NCT01468233|16493066|P4|Treatment Period 1|Adverse Event|0
4781767|NCT01468233|16493067|P3|Treatment Period 1|Adverse Event|0
4781768|NCT01468233|16493068|P2|Treatment Period 1|Adverse Event|3
4781769|NCT01468233|16493069|P1|Treatment Period 1|Adverse Event|5
4781770|NCT01468207|16493091|P6|Treatment Period 2|Other|2
4781771|NCT01468207|16493092|P5|Treatment Period 2|Other|1
4781772|NCT01468207|16493093|P4|Treatment Period 2|Other|1
4781773|NCT01468207|16493094|P3|Treatment Period 2|Other|5
4781774|NCT01468207|16493095|P2|Treatment Period 2|Other|0
4781775|NCT01468207|16493096|P1|Treatment Period 2|Other|0
4781776|NCT01468207|16493091|P6|Treatment Period 2|Lost to Follow-up|0
4781777|NCT01468207|16493092|P5|Treatment Period 2|Lost to Follow-up|0
4781778|NCT01468207|16493093|P4|Treatment Period 2|Lost to Follow-up|1
4781779|NCT01468207|16493094|P3|Treatment Period 2|Lost to Follow-up|5
4781780|NCT01468207|16493095|P2|Treatment Period 2|Lost to Follow-up|0
4781781|NCT01468207|16493096|P1|Treatment Period 2|Lost to Follow-up|0
4781782|NCT01468207|16493091|P6|Treatment Period 2|Loss/abscence of response (per protocol)|13
4781783|NCT01468207|16493092|P5|Treatment Period 2|Loss/abscence of response (per protocol)|18
4781784|NCT01468207|16493093|P4|Treatment Period 2|Loss/abscence of response (per protocol)|23
4781785|NCT01468207|16493094|P3|Treatment Period 2|Loss/abscence of response (per protocol)|30
4781786|NCT01468207|16493095|P2|Treatment Period 2|Loss/abscence of response (per protocol)|0
4781787|NCT01468207|16493096|P1|Treatment Period 2|Loss/abscence of response (per protocol)|0
4781788|NCT01468207|16493091|P6|Treatment Period 2|Withdrawal by Subject|2
4781789|NCT01468207|16493092|P5|Treatment Period 2|Withdrawal by Subject|0
4781790|NCT01468207|16493093|P4|Treatment Period 2|Withdrawal by Subject|0
4781791|NCT01468207|16493094|P3|Treatment Period 2|Withdrawal by Subject|5
4781792|NCT01468207|16493095|P2|Treatment Period 2|Withdrawal by Subject|0
4781793|NCT01468207|16493096|P1|Treatment Period 2|Withdrawal by Subject|0
4781794|NCT01468207|16493091|P6|Treatment Period 2|Lack of Efficacy|2
4781795|NCT01468207|16493092|P5|Treatment Period 2|Lack of Efficacy|0
4781796|NCT01468207|16493093|P4|Treatment Period 2|Lack of Efficacy|1
4781797|NCT01468207|16493094|P3|Treatment Period 2|Lack of Efficacy|1
4781798|NCT01468207|16493095|P2|Treatment Period 2|Lack of Efficacy|0
4781799|NCT01468207|16493096|P1|Treatment Period 2|Lack of Efficacy|0
4781800|NCT01468207|16493091|P6|Treatment Period 2|Adverse Event|1
4781801|NCT01468207|16493092|P5|Treatment Period 2|Adverse Event|2
4781802|NCT01468207|16493093|P4|Treatment Period 2|Adverse Event|1
4781803|NCT01468207|16493094|P3|Treatment Period 2|Adverse Event|6
4781804|NCT01468207|16493095|P2|Treatment Period 2|Adverse Event|0
4781805|NCT01468207|16493096|P1|Treatment Period 2|Adverse Event|0
4781806|NCT01468207|16493091|P6|Treatment Period 1|Other|0
4781807|NCT01468207|16493092|P5|Treatment Period 1|Other|0
4781808|NCT01468207|16493093|P4|Treatment Period 1|Other|0
4781809|NCT01468207|16493094|P3|Treatment Period 1|Other|0
4781810|NCT01468207|16493095|P2|Treatment Period 1|Other|2
4781811|NCT01468207|16493096|P1|Treatment Period 1|Other|0
4781812|NCT01468207|16493091|P6|Treatment Period 1|Lost to Follow-up|0
4781813|NCT01468207|16493092|P5|Treatment Period 1|Lost to Follow-up|0
4781814|NCT01468207|16493093|P4|Treatment Period 1|Lost to Follow-up|0
4781815|NCT01468207|16493094|P3|Treatment Period 1|Lost to Follow-up|0
4781816|NCT01468207|16493095|P2|Treatment Period 1|Lost to Follow-up|1
4781817|NCT01468207|16493096|P1|Treatment Period 1|Lost to Follow-up|2
4781818|NCT01468207|16493091|P6|Treatment Period 1|Withdrawal by Subject|0
4781819|NCT01468207|16493092|P5|Treatment Period 1|Withdrawal by Subject|0
4781820|NCT01468207|16493093|P4|Treatment Period 1|Withdrawal by Subject|0
4781821|NCT01468207|16493094|P3|Treatment Period 1|Withdrawal by Subject|0
4781822|NCT01468207|16493095|P2|Treatment Period 1|Withdrawal by Subject|4
4781823|NCT01468207|16493096|P1|Treatment Period 1|Withdrawal by Subject|5
4781824|NCT01468207|16493091|P6|Treatment Period 1|Protocol Violation|0
4781825|NCT01468207|16493092|P5|Treatment Period 1|Protocol Violation|0
4781826|NCT01468207|16493093|P4|Treatment Period 1|Protocol Violation|0
4781827|NCT01468207|16493094|P3|Treatment Period 1|Protocol Violation|0
4781828|NCT01468207|16493095|P2|Treatment Period 1|Protocol Violation|1
4781829|NCT01468207|16493096|P1|Treatment Period 1|Protocol Violation|1
4781830|NCT01468207|16493091|P6|Treatment Period 1|Adverse Event|0
4781831|NCT01468207|16493092|P5|Treatment Period 1|Adverse Event|0
4781832|NCT01468207|16493093|P4|Treatment Period 1|Adverse Event|0
4781833|NCT01468207|16493094|P3|Treatment Period 1|Adverse Event|0
4781834|NCT01468207|16493095|P2|Treatment Period 1|Adverse Event|0
4781835|NCT01468207|16493096|P1|Treatment Period 1|Adverse Event|1
4781836|NCT01468181|16493121|P5|Overall Study|Withdrawal by Subject|0
4781837|NCT01468181|16493122|P4|Overall Study|Withdrawal by Subject|0
4781838|NCT01468181|16493123|P3|Overall Study|Withdrawal by Subject|0
4781839|NCT01468181|16493124|P2|Overall Study|Withdrawal by Subject|1
4781840|NCT01468181|16493125|P1|Overall Study|Withdrawal by Subject|0
4781841|NCT01468181|16493121|P5|Overall Study|Lost to Follow-up|1
4781842|NCT01468181|16493122|P4|Overall Study|Lost to Follow-up|0
4781843|NCT01468181|16493123|P3|Overall Study|Lost to Follow-up|1
4781844|NCT01468181|16493124|P2|Overall Study|Lost to Follow-up|0
4781845|NCT01468181|16493125|P1|Overall Study|Lost to Follow-up|0
4781846|NCT01468181|16493121|P5|Overall Study|Physician Decision|1
4781847|NCT01468181|16493122|P4|Overall Study|Physician Decision|1
4781848|NCT01468181|16493123|P3|Overall Study|Physician Decision|0
4781849|NCT01468181|16493124|P2|Overall Study|Physician Decision|0
4781850|NCT01468181|16493125|P1|Overall Study|Physician Decision|0
4781851|NCT01468181|16493121|P5|Overall Study|Protocol Violation|1
4781852|NCT01468181|16493122|P4|Overall Study|Protocol Violation|0
4781853|NCT01468181|16493123|P3|Overall Study|Protocol Violation|1
4781854|NCT01468181|16493124|P2|Overall Study|Protocol Violation|0
4781855|NCT01468181|16493125|P1|Overall Study|Protocol Violation|2
4781856|NCT01468181|16493121|P5|Overall Study|Adverse Event|2
4781857|NCT01468181|16493122|P4|Overall Study|Adverse Event|2
4781858|NCT01468181|16493123|P3|Overall Study|Adverse Event|6
4781859|NCT01468181|16493124|P2|Overall Study|Adverse Event|1
4781860|NCT01468181|16493125|P1|Overall Study|Adverse Event|8
4781861|NCT01468077|16493174|P2|Overall Study|Physician Decision|0
4781862|NCT01468077|16493175|P1|Overall Study|Physician Decision|1
4781863|NCT01468077|16493174|P2|Overall Study|Lack of Efficacy|1
4781864|NCT01468077|16493175|P1|Overall Study|Lack of Efficacy|1
4781865|NCT01468077|16493174|P2|Overall Study|Adverse Event|2
4781866|NCT01468077|16493175|P1|Overall Study|Adverse Event|2
4781867|NCT01467960|16493237|P6|Overall Study|Enrollment of patients (PD) in 09/2013|30
4781868|NCT01467960|16493238|P5|Overall Study|Enrollment of patients (PD) in 09/2013|30
4781869|NCT01467960|16493239|P4|Overall Study|Enrollment of patients (PD) in 09/2013|30
4781870|NCT01467960|16493240|P3|Overall Study|Enrollment of patients (PD) in 09/2013|0
4781871|NCT01467960|16493241|P2|Overall Study|Enrollment of patients (PD) in 09/2013|0
4781872|NCT01467960|16493242|P1|Overall Study|Enrollment of patients (PD) in 09/2013|0
4781873|NCT01467713|16493301|P4|Overall Study|Reason not Specified|7
4781874|NCT01467713|16493302|P3|Overall Study|Reason not Specified|8
4781875|NCT01467713|16493303|P2|Overall Study|Reason not Specified|11
4781876|NCT01467713|16493304|P1|Overall Study|Reason not Specified|6
4781877|NCT01467713|16493301|P4|Overall Study|Relapse|35
4781878|NCT01467713|16493302|P3|Overall Study|Relapse|28
4781879|NCT01467713|16493303|P2|Overall Study|Relapse|25
4781880|NCT01467713|16493304|P1|Overall Study|Relapse|35
4781881|NCT01467713|16493301|P4|Overall Study|Pregnancy|3
4781882|NCT01467713|16493302|P3|Overall Study|Pregnancy|1
4781883|NCT01467713|16493303|P2|Overall Study|Pregnancy|1
4781884|NCT01467713|16493304|P1|Overall Study|Pregnancy|0
4781885|NCT01467713|16493301|P4|Overall Study|Study Termination|29
4781886|NCT01467713|16493302|P3|Overall Study|Study Termination|28
4781887|NCT01467713|16493303|P2|Overall Study|Study Termination|33
4781888|NCT01467713|16493304|P1|Overall Study|Study Termination|23
4781889|NCT01467713|16493301|P4|Overall Study|Voluntary Withdrawal|20
4781890|NCT01467713|16493302|P3|Overall Study|Voluntary Withdrawal|21
4781891|NCT01467713|16493303|P2|Overall Study|Voluntary Withdrawal|14
4781892|NCT01467713|16493304|P1|Overall Study|Voluntary Withdrawal|18
4781893|NCT01467713|16493301|P4|Overall Study|Lost to Follow-up|9
4781894|NCT01467713|16493302|P3|Overall Study|Lost to Follow-up|6
4781895|NCT01467713|16493303|P2|Overall Study|Lost to Follow-up|12
4781896|NCT01467713|16493304|P1|Overall Study|Lost to Follow-up|9
4781897|NCT01467713|16493301|P4|Overall Study|Major Protocol Deviation|1
4781898|NCT01467713|16493302|P3|Overall Study|Major Protocol Deviation|4
4781899|NCT01467713|16493303|P2|Overall Study|Major Protocol Deviation|4
4781900|NCT01467713|16493304|P1|Overall Study|Major Protocol Deviation|2
4781901|NCT01467713|16493301|P4|Overall Study|Pretreatment Event or Adverse Event|5
4781902|NCT01467713|16493302|P3|Overall Study|Pretreatment Event or Adverse Event|6
4781903|NCT01467713|16493303|P2|Overall Study|Pretreatment Event or Adverse Event|4
4781904|NCT01467713|16493304|P1|Overall Study|Pretreatment Event or Adverse Event|9
4781905|NCT01467700|16493358|P4|Overall Study|Reason not Specified|8
4781906|NCT01467700|16493359|P3|Overall Study|Reason not Specified|2
4781907|NCT01467700|16493360|P2|Overall Study|Reason not Specified|3
4781908|NCT01467700|16493361|P1|Overall Study|Reason not Specified|1
4781909|NCT01467700|16493358|P4|Overall Study|Lack of Efficacy|1
4781910|NCT01467700|16493359|P3|Overall Study|Lack of Efficacy|2
4781911|NCT01467700|16493360|P2|Overall Study|Lack of Efficacy|0
4781912|NCT01467700|16493361|P1|Overall Study|Lack of Efficacy|2
4781913|NCT01467700|16493358|P4|Overall Study|Pregnancy|0
4781914|NCT01467700|16493359|P3|Overall Study|Pregnancy|1
4781915|NCT01467700|16493360|P2|Overall Study|Pregnancy|1
4781916|NCT01467700|16493361|P1|Overall Study|Pregnancy|0
4781917|NCT01467700|16493358|P4|Overall Study|Study Termination|7
4781918|NCT01467700|16493359|P3|Overall Study|Study Termination|10
4781919|NCT01467700|16493360|P2|Overall Study|Study Termination|5
4781920|NCT01467700|16493361|P1|Overall Study|Study Termination|6
4781921|NCT01467700|16493358|P4|Overall Study|Voluntary Withdrawal|2
4781922|NCT01467700|16493359|P3|Overall Study|Voluntary Withdrawal|6
4781923|NCT01467700|16493360|P2|Overall Study|Voluntary Withdrawal|7
4781924|NCT01467700|16493361|P1|Overall Study|Voluntary Withdrawal|5
4781925|NCT01467700|16493358|P4|Overall Study|Lost to Follow-up|3
4781926|NCT01467700|16493359|P3|Overall Study|Lost to Follow-up|2
4781927|NCT01467700|16493360|P2|Overall Study|Lost to Follow-up|5
4781928|NCT01467700|16493361|P1|Overall Study|Lost to Follow-up|6
4781929|NCT01467700|16493358|P4|Overall Study|Major Protocol Deviation|3
4781930|NCT01467700|16493359|P3|Overall Study|Major Protocol Deviation|2
4781931|NCT01467700|16493360|P2|Overall Study|Major Protocol Deviation|3
4781932|NCT01467700|16493361|P1|Overall Study|Major Protocol Deviation|3
4781933|NCT01467700|16493358|P4|Overall Study|Pretreatment Event or Adverse Event|3
4781934|NCT01467700|16493359|P3|Overall Study|Pretreatment Event or Adverse Event|2
4781935|NCT01467700|16493360|P2|Overall Study|Pretreatment Event or Adverse Event|4
4781936|NCT01467700|16493361|P1|Overall Study|Pretreatment Event or Adverse Event|6
4781937|NCT01467661|16493403|P1|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1
4781938|NCT01467661|16493403|P1|Overall Study|Lack of Efficacy|3
4781939|NCT01467661|16493403|P1|Overall Study|Withdrawal by Subject|1
4781940|NCT01467661|16493403|P1|Overall Study|Adverse Event|16
4781941|NCT01467583|16493423|P3|Overall Study|Protocol Violation|2
4781942|NCT01467583|16493424|P2|Overall Study|Protocol Violation|0
4781943|NCT01467583|16493425|P1|Overall Study|Protocol Violation|0
4781944|NCT01467583|16493423|P3|Overall Study|Withdrawal by Subject|0
4781945|NCT01467583|16493424|P2|Overall Study|Withdrawal by Subject|0
4781946|NCT01467583|16493425|P1|Overall Study|Withdrawal by Subject|1
4781947|NCT01467583|16493423|P3|Overall Study|Death|0
4781948|NCT01467583|16493424|P2|Overall Study|Death|1
4781949|NCT01467583|16493425|P1|Overall Study|Death|1
4781950|NCT01467570|16493438|P2|Overall Study|Lost to Follow-up|9
4781951|NCT01467570|16493439|P1|Overall Study|Lost to Follow-up|8
4781952|NCT01467505|16493476|P2|Overall Study|Study Terminated by Sponsor|3
4781953|NCT01467505|16493477|P1|Overall Study|Study Terminated by Sponsor|28
4781954|NCT01467505|16493476|P2|Overall Study|Withdrawal by Subject|0
4781955|NCT01467505|16493477|P1|Overall Study|Withdrawal by Subject|4
4781956|NCT01467505|16493476|P2|Overall Study|Adverse Event|0
4781957|NCT01467505|16493477|P1|Overall Study|Adverse Event|1
4781958|NCT01467492|16493509|P2|Overall Study|Enrolled But Not Treated|0
4781959|NCT01467492|16493510|P1|Overall Study|Enrolled But Not Treated|1
4781960|NCT01467492|16493509|P2|Overall Study|Undefined|0
4781961|NCT01467492|16493510|P1|Overall Study|Undefined|2
4781962|NCT01467492|16493509|P2|Overall Study|Lost to Follow-up|2
4781963|NCT01467492|16493510|P1|Overall Study|Lost to Follow-up|3
4781964|NCT01467492|16493509|P2|Overall Study|Adverse Event|3
4781965|NCT01467492|16493510|P1|Overall Study|Adverse Event|4
4781966|NCT01467492|16493509|P2|Overall Study|Study Terminated by Sponsor|4
4781967|NCT01467492|16493510|P1|Overall Study|Study Terminated by Sponsor|6
4781968|NCT01467492|16493509|P2|Overall Study|Withdrawal by Subject|4
4781969|NCT01467492|16493510|P1|Overall Study|Withdrawal by Subject|6
4781970|NCT01467479|16493534|P3|Overall Study|Other|0
4781971|NCT01467479|16493535|P2|Overall Study|Other|0
4781972|NCT01467479|16493536|P1|Overall Study|Other|1
4781973|NCT01467479|16493534|P3|Overall Study|Study Terminated by Sponsor|3
4781974|NCT01467479|16493535|P2|Overall Study|Study Terminated by Sponsor|3
4781975|NCT01467479|16493536|P1|Overall Study|Study Terminated by Sponsor|1
4781976|NCT01467479|16493534|P3|Overall Study|Withdrawal of Consent|7
4781977|NCT01467479|16493535|P2|Overall Study|Withdrawal of Consent|7
4781978|NCT01467479|16493536|P1|Overall Study|Withdrawal of Consent|3
4781979|NCT01467479|16493534|P3|Overall Study|Lost to Follow-up|3
4781980|NCT01467479|16493535|P2|Overall Study|Lost to Follow-up|5
4781981|NCT01467479|16493536|P1|Overall Study|Lost to Follow-up|2
4781982|NCT01467479|16493534|P3|Overall Study|Death|1
4781983|NCT01467479|16493535|P2|Overall Study|Death|0
4781984|NCT01467479|16493536|P1|Overall Study|Death|0
4781985|NCT01467479|16493534|P3|Overall Study|Adverse Event|0
4781986|NCT01467479|16493535|P2|Overall Study|Adverse Event|2
4781987|NCT01467479|16493536|P1|Overall Study|Adverse Event|1
4781988|NCT01467479|16493534|P3|Overall Study|No Study Medication|2
4781989|NCT01467479|16493535|P2|Overall Study|No Study Medication|0
4781990|NCT01467479|16493536|P1|Overall Study|No Study Medication|1
4781991|NCT01467466|16493567|P4|Overall Study|No Endpoint Blood Draw|43
4781992|NCT01467466|16493568|P3|Overall Study|No Endpoint Blood Draw|51
4781993|NCT01467466|16493569|P2|Overall Study|No Endpoint Blood Draw|32
4781994|NCT01467466|16493570|P1|Overall Study|No Endpoint Blood Draw|38
4781995|NCT01467466|16493567|P4|Overall Study|Procedure Cancelled|29
4781996|NCT01467466|16493568|P3|Overall Study|Procedure Cancelled|25
4781997|NCT01467466|16493569|P2|Overall Study|Procedure Cancelled|45
4781998|NCT01467466|16493570|P1|Overall Study|Procedure Cancelled|46
4781999|NCT01467466|16493567|P4|Overall Study|Revoked Consent Prior To Procedure|5
4782000|NCT01467466|16493568|P3|Overall Study|Revoked Consent Prior To Procedure|15
4782001|NCT01467466|16493569|P2|Overall Study|Revoked Consent Prior To Procedure|9
4782002|NCT01467466|16493570|P1|Overall Study|Revoked Consent Prior To Procedure|10
4782003|NCT01467466|16493567|P4|Overall Study|Withdrawal by Subject|11
4782004|NCT01467466|16493568|P3|Overall Study|Withdrawal by Subject|13
4782005|NCT01467466|16493569|P2|Overall Study|Withdrawal by Subject|18
4782006|NCT01467466|16493570|P1|Overall Study|Withdrawal by Subject|15
4782007|NCT01467427|16493582|P2|Overall Study|Not continuing in extension phase|2
4782008|NCT01467427|16493583|P1|Overall Study|Not continuing in extension phase|0
4782009|NCT01467427|16493582|P2|Overall Study|Entered extension phase|11
4782010|NCT01467427|16493583|P1|Overall Study|Entered extension phase|11
4782011|NCT01467427|16493582|P2|Overall Study|Withdrawal by Subject|0
4782012|NCT01467427|16493583|P1|Overall Study|Withdrawal by Subject|1
4782013|NCT01467271|16493601|P1|Overall Study|Other reason|14
4782014|NCT01467271|16493601|P1|Overall Study|Retraction of patient's consent|21
4782015|NCT01467271|16493601|P1|Overall Study|Lost to Follow-up|83
4782016|NCT01467271|16493601|P1|Overall Study|Death|84
4782017|NCT01467076|16493608|P3|Overall Study|Lost to Follow-up|0
4782018|NCT01467076|16493609|P2|Overall Study|Lost to Follow-up|0
4782019|NCT01467076|16493610|P1|Overall Study|Lost to Follow-up|1
4782020|NCT01466881|16493682|P1|Overall Study|Other reason not protocol specified|5
4782021|NCT01466881|16493682|P1|Overall Study|Death|4
4782022|NCT01466881|16493682|P1|Overall Study|Progression/relapse|20
4782023|NCT01466881|16493682|P1|Overall Study|Adverse Event|6
4782024|NCT01466881|16493682|P1|Overall Study|Ineligible|5
4782025|NCT01466790|16493699|P8|Overall Study|Withdrawal by Subject|1
4782026|NCT01466790|16493700|P7|Overall Study|Withdrawal by Subject|1
4782027|NCT01466790|16493701|P6|Overall Study|Withdrawal by Subject|0
4782028|NCT01466790|16493702|P5|Overall Study|Withdrawal by Subject|1
4782029|NCT01466790|16493703|P4|Overall Study|Withdrawal by Subject|0
4782030|NCT01466790|16493704|P3|Overall Study|Withdrawal by Subject|0
4782031|NCT01466790|16493705|P2|Overall Study|Withdrawal by Subject|1
4782032|NCT01466790|16493706|P1|Overall Study|Withdrawal by Subject|1
4782033|NCT01466790|16493699|P8|Overall Study|Lost to Follow-up|0
4782034|NCT01466790|16493700|P7|Overall Study|Lost to Follow-up|0
4782035|NCT01466790|16493701|P6|Overall Study|Lost to Follow-up|0
4782036|NCT01466790|16493702|P5|Overall Study|Lost to Follow-up|0
4782037|NCT01466790|16493703|P4|Overall Study|Lost to Follow-up|0
4782038|NCT01466790|16493704|P3|Overall Study|Lost to Follow-up|0
4782039|NCT01466790|16493705|P2|Overall Study|Lost to Follow-up|0
4782040|NCT01466790|16493706|P1|Overall Study|Lost to Follow-up|2
4782041|NCT01466790|16493699|P8|Overall Study|Adverse Event|0
4782042|NCT01466790|16493700|P7|Overall Study|Adverse Event|0
4782043|NCT01466790|16493701|P6|Overall Study|Adverse Event|0
4782044|NCT01466790|16493702|P5|Overall Study|Adverse Event|2
4782045|NCT01466790|16493703|P4|Overall Study|Adverse Event|0
4782046|NCT01466790|16493704|P3|Overall Study|Adverse Event|0
4782047|NCT01466790|16493705|P2|Overall Study|Adverse Event|0
4782048|NCT01466790|16493706|P1|Overall Study|Adverse Event|1
4782049|NCT01466673|16493802|P2|Overall Study|Adverse Event|1
4782050|NCT01466673|16493803|P1|Overall Study|Adverse Event|2
4782051|NCT01466673|16493802|P2|Overall Study|Lost to Follow-up|5
4782052|NCT01466673|16493803|P1|Overall Study|Lost to Follow-up|3
4782053|NCT01466673|16493802|P2|Overall Study|Non-compliance with study treatment|0
4782054|NCT01466673|16493803|P1|Overall Study|Non-compliance with study treatment|2
4782055|NCT01466660|16493829|P2|Overall Study|Other reason not defined above|8
4782056|NCT01466660|16493830|P1|Overall Study|Other reason not defined above|10
4782057|NCT01466660|16493829|P2|Overall Study|Refused continuation of trial medication|3
4782058|NCT01466660|16493830|P1|Overall Study|Refused continuation of trial medication|4
4782059|NCT01466660|16493829|P2|Overall Study|Protocol Violation|1
4782060|NCT01466660|16493830|P1|Overall Study|Protocol Violation|2
4782061|NCT01466660|16493829|P2|Overall Study|Other adverse event|18
4782062|NCT01466660|16493830|P1|Overall Study|Other adverse event|19
4782063|NCT01466660|16493829|P2|Overall Study|Worsening of underlying cancer disease|2
4782064|NCT01466660|16493830|P1|Overall Study|Worsening of underlying cancer disease|5
4782065|NCT01466660|16493829|P2|Overall Study|Progressive Disease (RECIST 1.1)|127
4782066|NCT01466660|16493830|P1|Overall Study|Progressive Disease (RECIST 1.1)|120
4782067|NCT01466595|16493856|P2|Overall Study|Withdrawal by Subject|1
4782068|NCT01466595|16493857|P1|Overall Study|Withdrawal by Subject|0
4782069|NCT01466491|16493951|P4|Overall Study|Missing Data|0
4782070|NCT01466491|16493952|P3|Overall Study|Missing Data|1
4782071|NCT01466491|16493953|P2|Overall Study|Missing Data|0
4782072|NCT01466491|16493954|P1|Overall Study|Missing Data|0
4782073|NCT01466491|16493951|P4|Overall Study|Protocol Violation|0
4782074|NCT01466491|16493952|P3|Overall Study|Protocol Violation|2
4782075|NCT01466491|16493953|P2|Overall Study|Protocol Violation|3
4782076|NCT01466491|16493954|P1|Overall Study|Protocol Violation|0
4782077|NCT01466387|16493974|P6|Overall Study|Protocol Violation|0
4782078|NCT01466387|16493975|P5|Overall Study|Protocol Violation|0
4782079|NCT01466387|16493976|P4|Overall Study|Protocol Violation|1
4782080|NCT01466387|16493977|P3|Overall Study|Protocol Violation|0
4782081|NCT01466387|16493978|P2|Overall Study|Protocol Violation|0
4782082|NCT01466387|16493979|P1|Overall Study|Protocol Violation|1
4782083|NCT01466387|16493974|P6|Overall Study|Lost to Follow-up|1
4782084|NCT01466387|16493975|P5|Overall Study|Lost to Follow-up|0
4782085|NCT01466387|16493976|P4|Overall Study|Lost to Follow-up|0
4782086|NCT01466387|16493977|P3|Overall Study|Lost to Follow-up|0
4782087|NCT01466387|16493978|P2|Overall Study|Lost to Follow-up|0
4782088|NCT01466387|16493979|P1|Overall Study|Lost to Follow-up|0
4782089|NCT01466387|16493974|P6|Overall Study|Adverse Event|0
4782090|NCT01466387|16493975|P5|Overall Study|Adverse Event|0
4782091|NCT01466387|16493976|P4|Overall Study|Adverse Event|1
4782092|NCT01466387|16493977|P3|Overall Study|Adverse Event|1
4782093|NCT01466387|16493978|P2|Overall Study|Adverse Event|0
4782094|NCT01466387|16493979|P1|Overall Study|Adverse Event|0
4782095|NCT01466348|16494040|P2|Period I - First Intervention|Withdrawal by Subject|1
4782096|NCT01466348|16494041|P1|Period I - First Intervention|Withdrawal by Subject|0
4782097|NCT01466270|16494069|P2|Overall Study|Multiple|1
4782098|NCT01466270|16494070|P1|Overall Study|Multiple|1
4782099|NCT01466270|16494069|P2|Overall Study|Toxicity|1
4782100|NCT01466270|16494070|P1|Overall Study|Toxicity|4
4782101|NCT01466270|16494069|P2|Overall Study|Progression|0
4782102|NCT01466270|16494070|P1|Overall Study|Progression|1
4782103|NCT01466270|16494069|P2|Overall Study|Lost to Follow-up|3
4782104|NCT01466270|16494070|P1|Overall Study|Lost to Follow-up|1
4782105|NCT01466270|16494069|P2|Overall Study|Physician Decision|0
4782106|NCT01466270|16494070|P1|Overall Study|Physician Decision|1
4782107|NCT01466270|16494069|P2|Overall Study|Withdrawal by Subject|1
4782108|NCT01466270|16494070|P1|Overall Study|Withdrawal by Subject|4
4782109|NCT01466192|16494082|P1|Overall Study|Withdrawal by Subject|3
4782110|NCT01466192|16494082|P1|Overall Study|Physician Decision|1
4782111|NCT01466179|16494086|P1|Overall Study|Other|3
4782112|NCT01466179|16494086|P1|Overall Study|Protocol Violation|2
4782113|NCT01466179|16494086|P1|Overall Study|Withdrawal by Subject|7
4782114|NCT01466179|16494086|P1|Overall Study|Death|7
4782115|NCT01466179|16494086|P1|Overall Study|Lack of Efficacy|14
4782116|NCT01466179|16494086|P1|Overall Study|Disease relapse|23
4782117|NCT01466179|16494086|P1|Overall Study|Adverse Event|32
4782118|NCT01466179|16494086|P1|Overall Study|Progressive disease|43
4782119|NCT01466179|16494086|P1|Overall Study|Physician Decision|46
4782120|NCT01466179|16494086|P1|Overall Study|Ongoing in core study|2
4782121|NCT01466166|16494106|P1|Overall Study|Other|20
4782122|NCT01466166|16494106|P1|Overall Study|Protocol Violation/Noncompliance|2
4782123|NCT01466166|16494106|P1|Overall Study|Sponsor Decision|4
4782124|NCT01466166|16494106|P1|Overall Study|Withdrawal by Subject|13
4782125|NCT01466166|16494106|P1|Overall Study|Elevated Serum Uric Acid|78
4782126|NCT01466166|16494106|P1|Overall Study|Adverse Event (Other than IR)|11
4782127|NCT01466166|16494106|P1|Overall Study|Infusion Reaction (IR)|27
4782128|NCT01466166|16494106|P1|Overall Study|Lost to Follow-up|7
4782129|NCT01466166|16494106|P1|Overall Study|Death|1
4782130|NCT01466153|16494120|P3|Overall Study|Other-Unspecified|2
4782131|NCT01466153|16494121|P2|Overall Study|Other-Unspecified|4
4782132|NCT01466153|16494122|P1|Overall Study|Other-Unspecified|6
4782133|NCT01466153|16494120|P3|Overall Study|Randomized-Not Treated|4
4782134|NCT01466153|16494121|P2|Overall Study|Randomized-Not Treated|3
4782135|NCT01466153|16494122|P1|Overall Study|Randomized-Not Treated|2
4782136|NCT01466153|16494120|P3|Overall Study|Investigator Discretion|2
4782137|NCT01466153|16494121|P2|Overall Study|Investigator Discretion|2
4782138|NCT01466153|16494122|P1|Overall Study|Investigator Discretion|3
4782139|NCT01466153|16494120|P3|Overall Study|Withdrawal of Consent|0
4782140|NCT01466153|16494121|P2|Overall Study|Withdrawal of Consent|0
4782141|NCT01466153|16494122|P1|Overall Study|Withdrawal of Consent|2
4782142|NCT01466153|16494120|P3|Overall Study|Adverse Event|17
4782143|NCT01466153|16494121|P2|Overall Study|Adverse Event|13
4782144|NCT01466153|16494122|P1|Overall Study|Adverse Event|14
4782145|NCT01466153|16494120|P3|Overall Study|Disease Progression|0
4782146|NCT01466153|16494121|P2|Overall Study|Disease Progression|2
4782147|NCT01466153|16494122|P1|Overall Study|Disease Progression|2
4782148|NCT01466062|16494177|P1|Overall Study|Withdrawal by Subject|1
4782149|NCT01466062|16494177|P1|Overall Study|Adverse Event|1
4782150|NCT01465997|16494200|P2|Overall Study|subject left participation SP0993|1
4782151|NCT01465997|16494201|P1|Overall Study|subject left participation SP0993|0
4782152|NCT01465997|16494200|P2|Overall Study|decision by site staff|1
4782153|NCT01465997|16494201|P1|Overall Study|decision by site staff|0
4782154|NCT01465997|16494200|P2|Overall Study|withdrew before follow-up|13
4782155|NCT01465997|16494201|P1|Overall Study|withdrew before follow-up|0
4782156|NCT01465997|16494200|P2|Overall Study|local lab unblinded site|0
4782157|NCT01465997|16494201|P1|Overall Study|local lab unblinded site|1
4782158|NCT01465997|16494200|P2|Overall Study|subject withdrew consent|0
4782159|NCT01465997|16494201|P1|Overall Study|subject withdrew consent|1
4782160|NCT01465997|16494200|P2|Overall Study|sponsor's decision|1
4782161|NCT01465997|16494201|P1|Overall Study|sponsor's decision|1
4782162|NCT01465997|16494200|P2|Overall Study|Death|1
4782163|NCT01465997|16494201|P1|Overall Study|Death|0
4782164|NCT01465997|16494200|P2|Overall Study|investigator's decision|1
4782165|NCT01465997|16494201|P1|Overall Study|investigator's decision|1
4782166|NCT01465997|16494200|P2|Overall Study|Withdrawal by Subject|35
4782167|NCT01465997|16494201|P1|Overall Study|Withdrawal by Subject|32
4782168|NCT01465997|16494200|P2|Overall Study|Lost to Follow-up|9
4782169|NCT01465997|16494201|P1|Overall Study|Lost to Follow-up|6
4782170|NCT01465997|16494200|P2|Overall Study|Protocol Violation|4
4782171|NCT01465997|16494201|P1|Overall Study|Protocol Violation|1
4782172|NCT01465997|16494200|P2|Overall Study|Lack of Efficacy|1
4782173|NCT01465997|16494201|P1|Overall Study|Lack of Efficacy|13
4782174|NCT01465997|16494200|P2|Overall Study|Adverse Event|22
4782175|NCT01465997|16494201|P1|Overall Study|Adverse Event|12
4782176|NCT01465958|16494211|P2|Subcutaneous (SC) Phase|Adverse Event|1
4782177|NCT01465958|16494212|P1|Subcutaneous (SC) Phase|Adverse Event|0
4782178|NCT01465958|16494211|P2|Run-in Phase|Protocol Violation|0
4782179|NCT01465958|16494212|P1|Run-in Phase|Protocol Violation|1
4782180|NCT01465802|16494233|P5|Overall Study|Death|2
4782181|NCT01465802|16494234|P4|Overall Study|Death|10
4782182|NCT01465802|16494235|P3|Overall Study|Death|0
4782183|NCT01465802|16494236|P2|Overall Study|Death|12
4782184|NCT01465802|16494237|P1|Overall Study|Death|15
4782185|NCT01465802|16494233|P5|Overall Study|Reason not specified|2
4782186|NCT01465802|16494234|P4|Overall Study|Reason not specified|10
4782187|NCT01465802|16494235|P3|Overall Study|Reason not specified|0
4782188|NCT01465802|16494236|P2|Overall Study|Reason not specified|4
4782189|NCT01465802|16494237|P1|Overall Study|Reason not specified|9
4782190|NCT01465802|16494233|P5|Overall Study|Lost to Follow-up|0
4782191|NCT01465802|16494234|P4|Overall Study|Lost to Follow-up|0
4782192|NCT01465802|16494235|P3|Overall Study|Lost to Follow-up|0
4782193|NCT01465802|16494236|P2|Overall Study|Lost to Follow-up|1
4782194|NCT01465802|16494237|P1|Overall Study|Lost to Follow-up|1
4782195|NCT01465802|16494233|P5|Overall Study|Withdrawal by Subject|1
4782196|NCT01465802|16494234|P4|Overall Study|Withdrawal by Subject|8
4782197|NCT01465802|16494235|P3|Overall Study|Withdrawal by Subject|0
4782198|NCT01465802|16494236|P2|Overall Study|Withdrawal by Subject|7
4782199|NCT01465802|16494237|P1|Overall Study|Withdrawal by Subject|7
4782200|NCT01465802|16494233|P5|Overall Study|Study terminated by sponsor|7
4782201|NCT01465802|16494234|P4|Overall Study|Study terminated by sponsor|1
4782202|NCT01465802|16494235|P3|Overall Study|Study terminated by sponsor|0
4782203|NCT01465802|16494236|P2|Overall Study|Study terminated by sponsor|0
4782204|NCT01465802|16494237|P1|Overall Study|Study terminated by sponsor|1
4782205|NCT01465763|16494289|P3|Overall Study|Death|0
4782206|NCT01465763|16494290|P2|Overall Study|Death|0
4782207|NCT01465763|16494291|P1|Overall Study|Death|1
4782208|NCT01465763|16494289|P3|Overall Study|Protocol Violation|1
4782209|NCT01465763|16494290|P2|Overall Study|Protocol Violation|1
4782210|NCT01465763|16494291|P1|Overall Study|Protocol Violation|4
4782211|NCT01465763|16494289|P3|Overall Study|Other|0
4782212|NCT01465763|16494290|P2|Overall Study|Other|0
4782213|NCT01465763|16494291|P1|Overall Study|Other|2
4782214|NCT01465763|16494289|P3|Overall Study|Adverse Event|1
4782215|NCT01465763|16494290|P2|Overall Study|Adverse Event|0
4782216|NCT01465763|16494291|P1|Overall Study|Adverse Event|9
4782217|NCT01465763|16494289|P3|Overall Study|Insufficient Clinical Response|1
4782218|NCT01465763|16494290|P2|Overall Study|Insufficient Clinical Response|0
4782219|NCT01465763|16494291|P1|Overall Study|Insufficient Clinical Response|11
4782220|NCT01465763|16494289|P3|Overall Study|Withdrawal by Subject|1
4782221|NCT01465763|16494290|P2|Overall Study|Withdrawal by Subject|0
4782222|NCT01465763|16494291|P1|Overall Study|Withdrawal by Subject|4
4782223|NCT01465659|16494320|P4|Completed Follow for 1 Year|Still in FU|2
4782224|NCT01465659|16494321|P3|Completed Follow for 1 Year|Still in FU|1
4782225|NCT01465659|16494322|P2|Completed Follow for 1 Year|Still in FU|0
4782226|NCT01465659|16494323|P1|Completed Follow for 1 Year|Still in FU|0
4782227|NCT01465659|16494320|P4|Completed Follow for 1 Year|Death|4
4782228|NCT01465659|16494321|P3|Completed Follow for 1 Year|Death|1
4782229|NCT01465659|16494322|P2|Completed Follow for 1 Year|Death|3
4782230|NCT01465659|16494323|P1|Completed Follow for 1 Year|Death|6
4782231|NCT01465659|16494320|P4|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
4782232|NCT01465659|16494321|P3|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
4782233|NCT01465659|16494322|P2|Completed 2 Cycles/Reached 1st Response|Adverse Event|0
4782234|NCT01465659|16494323|P1|Completed 2 Cycles/Reached 1st Response|Adverse Event|1
4782235|NCT01465659|16494320|P4|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
4782236|NCT01465659|16494321|P3|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
4782237|NCT01465659|16494322|P2|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0
4782238|NCT01465659|16494323|P1|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1
4782239|NCT01465659|16494320|P4|Completed 1 Cycle of Treatment|Adverse Event|1
4782240|NCT01465659|16494321|P3|Completed 1 Cycle of Treatment|Adverse Event|0
4782241|NCT01465659|16494322|P2|Completed 1 Cycle of Treatment|Adverse Event|0
4782242|NCT01465659|16494323|P1|Completed 1 Cycle of Treatment|Adverse Event|0
4782243|NCT01465659|16494320|P4|Completed 1 Cycle of Treatment|Death|0
4782244|NCT01465659|16494321|P3|Completed 1 Cycle of Treatment|Death|0
4782245|NCT01465659|16494322|P2|Completed 1 Cycle of Treatment|Death|1
4782246|NCT01465659|16494323|P1|Completed 1 Cycle of Treatment|Death|0
4782247|NCT01465464|16494333|P2|Overall Study|Ongoing treatment at cutoff date|166
4782248|NCT01465464|16494334|P1|Overall Study|Ongoing treatment at cutoff date|140
4782249|NCT01465464|16494333|P2|Overall Study|Other|3
4782250|NCT01465464|16494334|P1|Overall Study|Other|9
4782251|NCT01465464|16494333|P2|Overall Study|Withdrawal by Subject|30
4782252|NCT01465464|16494334|P1|Overall Study|Withdrawal by Subject|46
4782253|NCT01465464|16494333|P2|Overall Study|Protocol Violation|1
4782254|NCT01465464|16494334|P1|Overall Study|Protocol Violation|1
4782255|NCT01465464|16494333|P2|Overall Study|Physician Decision|5
4782256|NCT01465464|16494334|P1|Overall Study|Physician Decision|13
4782257|NCT01465464|16494333|P2|Overall Study|Lack of Efficacy|190
4782258|NCT01465464|16494334|P1|Overall Study|Lack of Efficacy|139
4782259|NCT01465464|16494333|P2|Overall Study|Adverse Event|49
4782260|NCT01465464|16494334|P1|Overall Study|Adverse Event|96
4782261|NCT01465386|16494387|P1|Overall Study|Adverse Event|1
4782262|NCT01465386|16494387|P1|Overall Study|Lack of Efficacy|3
4782263|NCT01465347|16494391|P2|Overall Study|Admitted to hospice|1
4782264|NCT01465347|16494392|P1|Overall Study|Admitted to hospice|0
4782265|NCT01465347|16494391|P2|Overall Study|Physician Decision|1
4782266|NCT01465347|16494392|P1|Overall Study|Physician Decision|0
4782267|NCT01465347|16494391|P2|Overall Study|Withdrawal by Subject|1
4782268|NCT01465347|16494392|P1|Overall Study|Withdrawal by Subject|1
4782269|NCT01465334|16494404|P2|Overall Study|Refractory Disease|3
4782270|NCT01465334|16494405|P1|Overall Study|Refractory Disease|0
4782271|NCT01465334|16494404|P2|Overall Study|Richter's transformation|3
4782272|NCT01465334|16494405|P1|Overall Study|Richter's transformation|0
4782273|NCT01465334|16494404|P2|Overall Study|Adverse Event|0
4782274|NCT01465334|16494405|P1|Overall Study|Adverse Event|1
4782275|NCT01465334|16494404|P2|Overall Study|Disease Progression|0
4782276|NCT01465334|16494405|P1|Overall Study|Disease Progression|1
4782277|NCT01465230|16494431|P1|Overall Study|Withdrawal by Subject|2
4782278|NCT01465178|16494437|P2|Overall Study|Withdrawal by Subject|0
4782279|NCT01465178|16494438|P1|Overall Study|Withdrawal by Subject|1
4782280|NCT01465022|16494462|P3|Overall Study|Not Randomized|70
4782281|NCT01465022|16494463|P2|Overall Study|Not Randomized|0
4782282|NCT01465022|16494464|P1|Overall Study|Not Randomized|0
4782283|NCT01465022|16494462|P3|Overall Study|Breastfeeding discontinuation before 8 w|0
4782284|NCT01465022|16494463|P2|Overall Study|Breastfeeding discontinuation before 8 w|9
4782285|NCT01465022|16494464|P1|Overall Study|Breastfeeding discontinuation before 8 w|8
4782286|NCT01465022|16494462|P3|Overall Study|Lost to Follow-up|0
4782287|NCT01465022|16494463|P2|Overall Study|Lost to Follow-up|14
4782288|NCT01465022|16494464|P1|Overall Study|Lost to Follow-up|15
4782289|NCT01464931|16494498|P2|Overall Study|Withdrawal by Subject|0
4782290|NCT01464931|16494499|P1|Overall Study|Withdrawal by Subject|1
4782291|NCT01464879|16494536|P1|Overall Study|Non-compliance|1
4782292|NCT01464879|16494536|P1|Overall Study|Physician Decision|1
4782293|NCT01464827|16494597|P14|Overall Study|Not Treated|2
4782294|NCT01464827|16494598|P13|Overall Study|Not Treated|0
4782295|NCT01464827|16494599|P12|Overall Study|Not Treated|1
4782296|NCT01464827|16494600|P11|Overall Study|Not Treated|0
4782297|NCT01464827|16494601|P10|Overall Study|Not Treated|2
4782298|NCT01464827|16494602|P9|Overall Study|Not Treated|0
4782299|NCT01464827|16494603|P8|Overall Study|Not Treated|0
4782300|NCT01464827|16494604|P7|Overall Study|Not Treated|1
4782301|NCT01464827|16494605|P6|Overall Study|Not Treated|0
4782302|NCT01464827|16494606|P5|Overall Study|Not Treated|1
4782303|NCT01464827|16494607|P4|Overall Study|Not Treated|0
4782304|NCT01464827|16494608|P3|Overall Study|Not Treated|0
4782305|NCT01464827|16494609|P2|Overall Study|Not Treated|2
4782306|NCT01464827|16494610|P1|Overall Study|Not Treated|0
4782307|NCT01464827|16494597|P14|Overall Study|Other|0
4782308|NCT01464827|16494598|P13|Overall Study|Other|1
4782309|NCT01464827|16494599|P12|Overall Study|Other|0
4782310|NCT01464827|16494600|P11|Overall Study|Other|2
4782311|NCT01464827|16494601|P10|Overall Study|Other|1
4782312|NCT01464827|16494602|P9|Overall Study|Other|3
4782313|NCT01464827|16494603|P8|Overall Study|Other|0
4782314|NCT01464827|16494604|P7|Overall Study|Other|1
4782315|NCT01464827|16494605|P6|Overall Study|Other|0
4782316|NCT01464827|16494606|P5|Overall Study|Other|3
4782317|NCT01464827|16494607|P4|Overall Study|Other|2
4782318|NCT01464827|16494608|P3|Overall Study|Other|0
4782319|NCT01464827|16494609|P2|Overall Study|Other|3
4782320|NCT01464827|16494610|P1|Overall Study|Other|2
4782321|NCT01464827|16494597|P14|Overall Study|Lost to Follow-up|1
4782322|NCT01464827|16494598|P13|Overall Study|Lost to Follow-up|0
4782323|NCT01464827|16494599|P12|Overall Study|Lost to Follow-up|1
4782324|NCT01464827|16494600|P11|Overall Study|Lost to Follow-up|0
4782325|NCT01464827|16494601|P10|Overall Study|Lost to Follow-up|0
4782326|NCT01464827|16494602|P9|Overall Study|Lost to Follow-up|0
4782327|NCT01464827|16494603|P8|Overall Study|Lost to Follow-up|2
4782328|NCT01464827|16494604|P7|Overall Study|Lost to Follow-up|2
4782329|NCT01464827|16494605|P6|Overall Study|Lost to Follow-up|1
4782330|NCT01464827|16494606|P5|Overall Study|Lost to Follow-up|3
4782331|NCT01464827|16494607|P4|Overall Study|Lost to Follow-up|2
4782332|NCT01464827|16494608|P3|Overall Study|Lost to Follow-up|0
4782333|NCT01464827|16494609|P2|Overall Study|Lost to Follow-up|2
4782334|NCT01464827|16494610|P1|Overall Study|Lost to Follow-up|0
4782335|NCT01464827|16494597|P14|Overall Study|Withdrawal by Subject|0
4782336|NCT01464827|16494598|P13|Overall Study|Withdrawal by Subject|0
4782337|NCT01464827|16494599|P12|Overall Study|Withdrawal by Subject|0
4782338|NCT01464827|16494600|P11|Overall Study|Withdrawal by Subject|0
4782339|NCT01464827|16494601|P10|Overall Study|Withdrawal by Subject|0
4782340|NCT01464827|16494602|P9|Overall Study|Withdrawal by Subject|0
4782341|NCT01464827|16494603|P8|Overall Study|Withdrawal by Subject|1
4782342|NCT01464827|16494604|P7|Overall Study|Withdrawal by Subject|0
4782343|NCT01464827|16494605|P6|Overall Study|Withdrawal by Subject|0
4782344|NCT01464827|16494606|P5|Overall Study|Withdrawal by Subject|1
4782345|NCT01464827|16494607|P4|Overall Study|Withdrawal by Subject|0
4782346|NCT01464827|16494608|P3|Overall Study|Withdrawal by Subject|0
4782347|NCT01464827|16494609|P2|Overall Study|Withdrawal by Subject|0
4782348|NCT01464827|16494610|P1|Overall Study|Withdrawal by Subject|1
4782349|NCT01464827|16494597|P14|Overall Study|Adverse Event|0
4782350|NCT01464827|16494598|P13|Overall Study|Adverse Event|1
4782351|NCT01464827|16494599|P12|Overall Study|Adverse Event|0
4782352|NCT01464827|16494600|P11|Overall Study|Adverse Event|0
4782353|NCT01464827|16494601|P10|Overall Study|Adverse Event|0
4782354|NCT01464827|16494602|P9|Overall Study|Adverse Event|0
4782355|NCT01464827|16494603|P8|Overall Study|Adverse Event|0
4782356|NCT01464827|16494604|P7|Overall Study|Adverse Event|0
4782357|NCT01464827|16494605|P6|Overall Study|Adverse Event|0
4782358|NCT01464827|16494606|P5|Overall Study|Adverse Event|0
4782359|NCT01464827|16494607|P4|Overall Study|Adverse Event|0
4782360|NCT01464827|16494608|P3|Overall Study|Adverse Event|0
4782361|NCT01464827|16494609|P2|Overall Study|Adverse Event|0
4782362|NCT01464827|16494610|P1|Overall Study|Adverse Event|0
4782363|NCT01464788|16494657|P3|Overall Study|Patient had hemorrhage after tPA started|0
4782364|NCT01464788|16494658|P2|Overall Study|Patient had hemorrhage after tPA started|1
4782365|NCT01464788|16494659|P1|Overall Study|Patient had hemorrhage after tPA started|0
4782366|NCT01464788|16494657|P3|Overall Study|Lost to Follow-up|0
4782367|NCT01464788|16494658|P2|Overall Study|Lost to Follow-up|1
4782368|NCT01464788|16494659|P1|Overall Study|Lost to Follow-up|0
4782369|NCT01464619|16494745|P2|Overall Study|Lost to Follow-up|4
4782370|NCT01464619|16494746|P1|Overall Study|Lost to Follow-up|3
4782371|NCT01464424|16494766|P2|Period 1, First 6 Weeks|Adverse Event|1
4782372|NCT01464424|16494767|P1|Period 1, First 6 Weeks|Adverse Event|0
4782373|NCT01464346|16494787|P3|Overall Study|Withdrawal by Subject|1
4782374|NCT01464346|16494788|P2|Overall Study|Withdrawal by Subject|0
4782375|NCT01464346|16494789|P1|Overall Study|Withdrawal by Subject|0
4782376|NCT01464333|16494798|P1|Overall Study|No Hospital Visit|42
4782377|NCT01464333|16494798|P1|Overall Study|Other|4
4782378|NCT01464333|16494798|P1|Overall Study|Withdrawal by Subject|11
4782379|NCT01464333|16494798|P1|Overall Study|Lack of Efficacy|72
4782380|NCT01464333|16494798|P1|Overall Study|Adverse Event|34
4782381|NCT01464307|16494811|P2|Open-Label Extension Period|Predefined discontinuation criteria|0
4782382|NCT01464307|16494812|P1|Open-Label Extension Period|Predefined discontinuation criteria|6
4782383|NCT01464307|16494811|P2|Open-Label Extension Period|Non-compliance|0
4782384|NCT01464307|16494812|P1|Open-Label Extension Period|Non-compliance|9
4782385|NCT01464307|16494811|P2|Open-Label Extension Period|Lost to Follow-up|0
4782386|NCT01464307|16494812|P1|Open-Label Extension Period|Lost to Follow-up|1
4782387|NCT01464307|16494811|P2|Open-Label Extension Period|Death|0
4782388|NCT01464307|16494812|P1|Open-Label Extension Period|Death|1
4782389|NCT01464307|16494811|P2|Open-Label Extension Period|Lack of Efficacy|0
4782390|NCT01464307|16494812|P1|Open-Label Extension Period|Lack of Efficacy|5
4782391|NCT01464307|16494811|P2|Open-Label Extension Period|Withdrawal by Subject|0
4782392|NCT01464307|16494812|P1|Open-Label Extension Period|Withdrawal by Subject|14
4782393|NCT01464307|16494811|P2|Open-Label Extension Period|Adverse Event|0
4782394|NCT01464307|16494812|P1|Open-Label Extension Period|Adverse Event|15
4782395|NCT01464307|16494811|P2|Main Period|Predefined discontinuation criteria|1
4782396|NCT01464307|16494812|P1|Main Period|Predefined discontinuation criteria|2
4782397|NCT01464307|16494811|P2|Main Period|Withdrawal by Subject|2
4782398|NCT01464307|16494812|P1|Main Period|Withdrawal by Subject|5
4782399|NCT01464307|16494811|P2|Main Period|Lack of Efficacy|0
4782400|NCT01464307|16494812|P1|Main Period|Lack of Efficacy|2
4782401|NCT01464307|16494811|P2|Main Period|Adverse Event|1
4782402|NCT01464307|16494812|P1|Main Period|Adverse Event|6
4782403|NCT01464307|16494811|P2|Main Period|Death|1
4782404|NCT01464307|16494812|P1|Main Period|Death|0
4782405|NCT01464255|16494827|P2|Overall Study|unresolve corneal staining|1
4782406|NCT01464255|16494828|P1|Overall Study|unresolve corneal staining|0
4782407|NCT01464021|16494873|P1|Overall Study|various|11
4782408|NCT01464021|16494873|P1|Overall Study|Lack of Efficacy|1
4782409|NCT01464021|16494873|P1|Overall Study|Lost to Follow-up|1
4782410|NCT01464021|16494873|P1|Overall Study|Withdrawal by Subject|13
4782411|NCT01463982|16494889|P4|Overall Study|Treatment delay over 5 week|0
4782412|NCT01463982|16494890|P3|Overall Study|Treatment delay over 5 week|1
4782413|NCT01463982|16494891|P2|Overall Study|Treatment delay over 5 week|0
4782414|NCT01463982|16494892|P1|Overall Study|Treatment delay over 5 week|0
4782415|NCT01463982|16494889|P4|Overall Study|Withdrawal by Subject|0
4782416|NCT01463982|16494890|P3|Overall Study|Withdrawal by Subject|1
4782417|NCT01463982|16494891|P2|Overall Study|Withdrawal by Subject|1
4782418|NCT01463982|16494892|P1|Overall Study|Withdrawal by Subject|0
4782419|NCT01463878|16494908|P2|Overall Study|no longer met criteria for tube feed|2
4782420|NCT01463878|16494909|P1|Overall Study|no longer met criteria for tube feed|2
4782421|NCT01463696|16494923|P8|Overall Study|Not Treated|0
4782422|NCT01463696|16494924|P7|Overall Study|Not Treated|1
4782423|NCT01463696|16494925|P6|Overall Study|Not Treated|0
4782424|NCT01463696|16494926|P5|Overall Study|Not Treated|0
4782425|NCT01463696|16494927|P4|Overall Study|Not Treated|0
4782426|NCT01463696|16494928|P3|Overall Study|Not Treated|0
4782427|NCT01463696|16494929|P2|Overall Study|Not Treated|0
4782428|NCT01463696|16494930|P1|Overall Study|Not Treated|0
4782429|NCT01463696|16494923|P8|Overall Study|Withdrawal by Subject|0
4782430|NCT01463696|16494924|P7|Overall Study|Withdrawal by Subject|2
4782431|NCT01463696|16494925|P6|Overall Study|Withdrawal by Subject|1
4782432|NCT01463696|16494926|P5|Overall Study|Withdrawal by Subject|1
4782433|NCT01463696|16494927|P4|Overall Study|Withdrawal by Subject|1
4782434|NCT01463696|16494928|P3|Overall Study|Withdrawal by Subject|0
4782435|NCT01463696|16494929|P2|Overall Study|Withdrawal by Subject|0
4782436|NCT01463696|16494930|P1|Overall Study|Withdrawal by Subject|0
4782437|NCT01463696|16494923|P8|Overall Study|Progressive Disease|2
4782438|NCT01463696|16494924|P7|Overall Study|Progressive Disease|4
4782439|NCT01463696|16494925|P6|Overall Study|Progressive Disease|1
4782440|NCT01463696|16494926|P5|Overall Study|Progressive Disease|0
4782441|NCT01463696|16494927|P4|Overall Study|Progressive Disease|1
4782442|NCT01463696|16494928|P3|Overall Study|Progressive Disease|0
4782443|NCT01463696|16494929|P2|Overall Study|Progressive Disease|1
4782444|NCT01463696|16494930|P1|Overall Study|Progressive Disease|0
4782445|NCT01463696|16494923|P8|Overall Study|Lost to Follow-up|0
4782446|NCT01463696|16494924|P7|Overall Study|Lost to Follow-up|0
4782447|NCT01463696|16494925|P6|Overall Study|Lost to Follow-up|0
4782448|NCT01463696|16494926|P5|Overall Study|Lost to Follow-up|0
4782449|NCT01463696|16494927|P4|Overall Study|Lost to Follow-up|0
4782450|NCT01463696|16494928|P3|Overall Study|Lost to Follow-up|1
4782451|NCT01463696|16494929|P2|Overall Study|Lost to Follow-up|0
4782452|NCT01463696|16494930|P1|Overall Study|Lost to Follow-up|0
4782453|NCT01463696|16494923|P8|Overall Study|Adverse Event|2
4782454|NCT01463696|16494924|P7|Overall Study|Adverse Event|3
4782455|NCT01463696|16494925|P6|Overall Study|Adverse Event|1
4782456|NCT01463696|16494926|P5|Overall Study|Adverse Event|0
4782457|NCT01463696|16494927|P4|Overall Study|Adverse Event|2
4782458|NCT01463696|16494928|P3|Overall Study|Adverse Event|0
4782459|NCT01463696|16494929|P2|Overall Study|Adverse Event|1
4782460|NCT01463696|16494930|P1|Overall Study|Adverse Event|0
4782461|NCT01463683|16494983|P3|Overall Study|Withdrawal by Subject|2
4782462|NCT01463683|16494984|P2|Overall Study|Withdrawal by Subject|17
4782463|NCT01463683|16494985|P1|Overall Study|Withdrawal by Subject|5
4782464|NCT01463683|16494983|P3|Overall Study|Pregnancy|1
4782465|NCT01463683|16494984|P2|Overall Study|Pregnancy|2
4782466|NCT01463683|16494985|P1|Overall Study|Pregnancy|2
4782467|NCT01463683|16494983|P3|Overall Study|Physician Decision|1
4782468|NCT01463683|16494984|P2|Overall Study|Physician Decision|3
4782469|NCT01463683|16494985|P1|Overall Study|Physician Decision|0
4782470|NCT01463683|16494983|P3|Overall Study|Lost to Follow-up|7
4782471|NCT01463683|16494984|P2|Overall Study|Lost to Follow-up|9
4782472|NCT01463683|16494985|P1|Overall Study|Lost to Follow-up|10
4782473|NCT01463683|16494983|P3|Overall Study|Adverse Event|0
4782474|NCT01463683|16494984|P2|Overall Study|Adverse Event|0
4782475|NCT01463683|16494985|P1|Overall Study|Adverse Event|2
4782476|NCT01463631|16495002|P4|Overall Study|Progressive Disease|5
4782477|NCT01463631|16495003|P3|Overall Study|Progressive Disease|0
4782478|NCT01463631|16495004|P2|Overall Study|Progressive Disease|0
4782479|NCT01463631|16495005|P1|Overall Study|Progressive Disease|0
4782480|NCT01463631|16495002|P4|Overall Study|Death|0
4782481|NCT01463631|16495003|P3|Overall Study|Death|1
4782482|NCT01463631|16495004|P2|Overall Study|Death|0
4782483|NCT01463631|16495005|P1|Overall Study|Death|0
4782484|NCT01463631|16495002|P4|Overall Study|Withdrawal by Subject|1
4782485|NCT01463631|16495003|P3|Overall Study|Withdrawal by Subject|0
4782486|NCT01463631|16495004|P2|Overall Study|Withdrawal by Subject|0
4782487|NCT01463631|16495005|P1|Overall Study|Withdrawal by Subject|0
4782488|NCT01463527|16495027|P2|Overall Study|Crying >20% of sedation|6
4782489|NCT01463527|16495028|P1|Overall Study|Crying >20% of sedation|5
4782490|NCT01463527|16495027|P2|Overall Study|Protocol Violation|1
4782491|NCT01463527|16495028|P1|Overall Study|Protocol Violation|1
4782492|NCT01463306|16495051|P3|Overall Study|Approval expiry at site|0
4782493|NCT01463306|16495052|P2|Overall Study|Approval expiry at site|0
4782494|NCT01463306|16495053|P1|Overall Study|Approval expiry at site|1
4782495|NCT01463306|16495051|P3|Overall Study|Other|0
4782496|NCT01463306|16495052|P2|Overall Study|Other|13
4782497|NCT01463306|16495053|P1|Overall Study|Other|26
4782498|NCT01463306|16495051|P3|Overall Study|Withdrawal by Subject|1
4782499|NCT01463306|16495052|P2|Overall Study|Withdrawal by Subject|9
4782500|NCT01463306|16495053|P1|Overall Study|Withdrawal by Subject|19
4782501|NCT01463306|16495051|P3|Overall Study|Protocol Violation|0
4782502|NCT01463306|16495052|P2|Overall Study|Protocol Violation|0
4782503|NCT01463306|16495053|P1|Overall Study|Protocol Violation|4
4782504|NCT01463306|16495051|P3|Overall Study|Lost to Follow-up|0
4782505|NCT01463306|16495052|P2|Overall Study|Lost to Follow-up|2
4782506|NCT01463306|16495053|P1|Overall Study|Lost to Follow-up|5
4782507|NCT01463306|16495051|P3|Overall Study|Lack of Efficacy|1
4782508|NCT01463306|16495052|P2|Overall Study|Lack of Efficacy|16
4782509|NCT01463306|16495053|P1|Overall Study|Lack of Efficacy|22
4782510|NCT01463306|16495051|P3|Overall Study|Death|0
4782511|NCT01463306|16495052|P2|Overall Study|Death|3
4782512|NCT01463306|16495053|P1|Overall Study|Death|3
4782513|NCT01463306|16495051|P3|Overall Study|Adverse Event|3
4782514|NCT01463306|16495052|P2|Overall Study|Adverse Event|9
4782515|NCT01463306|16495053|P1|Overall Study|Adverse Event|6
4782516|NCT01463293|16495124|P3|Overall Study|Other|2
4782517|NCT01463293|16495125|P2|Overall Study|Other|0
4782518|NCT01463293|16495126|P1|Overall Study|Other|0
4782519|NCT01463293|16495124|P3|Overall Study|Withdrawal by Subject|5
4782520|NCT01463293|16495125|P2|Overall Study|Withdrawal by Subject|10
4782521|NCT01463293|16495126|P1|Overall Study|Withdrawal by Subject|4
4782522|NCT01463293|16495124|P3|Overall Study|Adverse Event|0
4782523|NCT01463293|16495125|P2|Overall Study|Adverse Event|2
4782524|NCT01463293|16495126|P1|Overall Study|Adverse Event|1
4782525|NCT01463293|16495124|P3|Overall Study|Lost to Follow-up|5
4782526|NCT01463293|16495125|P2|Overall Study|Lost to Follow-up|4
4782527|NCT01463293|16495126|P1|Overall Study|Lost to Follow-up|1
4782528|NCT01463111|16495149|P1|Overall Study|Physician Decision|2
4782529|NCT01463111|16495149|P1|Overall Study|Lost to Follow-up|5
4782530|NCT01463111|16495149|P1|Overall Study|Withdrawal by Subject|2
4782531|NCT01463098|16495171|P14|Part B (11 Days)|Participant Choice|0
4782532|NCT01463098|16495172|P13|Part B (11 Days)|Participant Choice|0
4782533|NCT01463098|16495173|P12|Part B (11 Days)|Participant Choice|1
4782534|NCT01463098|16495174|P11|Part B (11 Days)|Participant Choice|0
4782535|NCT01463098|16495175|P10|Part B (11 Days)|Participant Choice|0
4782536|NCT01463098|16495176|P9|Part B (11 Days)|Participant Choice|0
4782537|NCT01463098|16495177|P8|Part B (11 Days)|Participant Choice|0
4782538|NCT01463098|16495178|P7|Part B (11 Days)|Participant Choice|0
4782539|NCT01463098|16495179|P6|Part B (11 Days)|Participant Choice|0
4782540|NCT01463098|16495180|P5|Part B (11 Days)|Participant Choice|0
4782541|NCT01463098|16495181|P4|Part B (11 Days)|Participant Choice|0
4782542|NCT01463098|16495182|P3|Part B (11 Days)|Participant Choice|0
4782543|NCT01463098|16495183|P2|Part B (11 Days)|Participant Choice|0
4782544|NCT01463098|16495184|P1|Part B (11 Days)|Participant Choice|0
4782545|NCT01463098|16495171|P14|Part A (11 Days)|Lost to Follow-up|0
4782546|NCT01463098|16495172|P13|Part A (11 Days)|Lost to Follow-up|0
4782547|NCT01463098|16495173|P12|Part A (11 Days)|Lost to Follow-up|0
4782548|NCT01463098|16495174|P11|Part A (11 Days)|Lost to Follow-up|0
4782549|NCT01463098|16495175|P10|Part A (11 Days)|Lost to Follow-up|0
4782550|NCT01463098|16495176|P9|Part A (11 Days)|Lost to Follow-up|0
4782551|NCT01463098|16495177|P8|Part A (11 Days)|Lost to Follow-up|0
4782552|NCT01463098|16495178|P7|Part A (11 Days)|Lost to Follow-up|0
4782553|NCT01463098|16495179|P6|Part A (11 Days)|Lost to Follow-up|0
4782554|NCT01463098|16495180|P5|Part A (11 Days)|Lost to Follow-up|1
4782555|NCT01463098|16495181|P4|Part A (11 Days)|Lost to Follow-up|0
4782556|NCT01463098|16495182|P3|Part A (11 Days)|Lost to Follow-up|0
4782557|NCT01463098|16495183|P2|Part A (11 Days)|Lost to Follow-up|0
4782558|NCT01463098|16495184|P1|Part A (11 Days)|Lost to Follow-up|0
4782559|NCT01463098|16495171|P14|Part A (11 Days)|Participant Choice|0
4782560|NCT01463098|16495172|P13|Part A (11 Days)|Participant Choice|0
4782561|NCT01463098|16495173|P12|Part A (11 Days)|Participant Choice|0
4782562|NCT01463098|16495174|P11|Part A (11 Days)|Participant Choice|0
4782563|NCT01463098|16495175|P10|Part A (11 Days)|Participant Choice|0
4782564|NCT01463098|16495176|P9|Part A (11 Days)|Participant Choice|1
4782565|NCT01463098|16495177|P8|Part A (11 Days)|Participant Choice|0
4782566|NCT01463098|16495178|P7|Part A (11 Days)|Participant Choice|0
4782567|NCT01463098|16495179|P6|Part A (11 Days)|Participant Choice|0
4782568|NCT01463098|16495180|P5|Part A (11 Days)|Participant Choice|0
4782569|NCT01463098|16495181|P4|Part A (11 Days)|Participant Choice|0
4782570|NCT01463098|16495182|P3|Part A (11 Days)|Participant Choice|0
4782571|NCT01463098|16495183|P2|Part A (11 Days)|Participant Choice|0
4782572|NCT01463098|16495184|P1|Part A (11 Days)|Participant Choice|2
4782573|NCT01463033|16495507|P2|Overall Study|Death|2
4782574|NCT01463033|16495508|P1|Overall Study|Death|3
4782575|NCT01463033|16495507|P2|Overall Study|Lost to Follow-up|4
4782576|NCT01463033|16495508|P1|Overall Study|Lost to Follow-up|4
4782577|NCT01463007|16495515|P1|Overall Study|Physician Decision|1
4782578|NCT01462942|16495526|P5|Overall Study|Protocol Violation|6
4782579|NCT01462942|16495527|P4|Overall Study|Protocol Violation|9
4782580|NCT01462942|16495528|P3|Overall Study|Protocol Violation|9
4782581|NCT01462942|16495529|P2|Overall Study|Protocol Violation|6
4782582|NCT01462942|16495530|P1|Overall Study|Protocol Violation|4
4782583|NCT01462942|16495526|P5|Overall Study|Lost to Follow-up|1
4782584|NCT01462942|16495527|P4|Overall Study|Lost to Follow-up|1
4782585|NCT01462942|16495528|P3|Overall Study|Lost to Follow-up|1
4782586|NCT01462942|16495529|P2|Overall Study|Lost to Follow-up|1
4782587|NCT01462942|16495530|P1|Overall Study|Lost to Follow-up|0
4782588|NCT01462942|16495526|P5|Overall Study|Lack of Efficacy|3
4782589|NCT01462942|16495527|P4|Overall Study|Lack of Efficacy|5
4782590|NCT01462942|16495528|P3|Overall Study|Lack of Efficacy|4
4782591|NCT01462942|16495529|P2|Overall Study|Lack of Efficacy|0
4782592|NCT01462942|16495530|P1|Overall Study|Lack of Efficacy|6
4782593|NCT01462942|16495526|P5|Overall Study|Withdrawal by Subject|19
4782594|NCT01462942|16495527|P4|Overall Study|Withdrawal by Subject|16
4782595|NCT01462942|16495528|P3|Overall Study|Withdrawal by Subject|14
4782596|NCT01462942|16495529|P2|Overall Study|Withdrawal by Subject|10
4782597|NCT01462942|16495530|P1|Overall Study|Withdrawal by Subject|14
4782598|NCT01462942|16495526|P5|Overall Study|Other, including COPD exacerbation|5
4782599|NCT01462942|16495527|P4|Overall Study|Other, including COPD exacerbation|8
4782600|NCT01462942|16495528|P3|Overall Study|Other, including COPD exacerbation|2
4782601|NCT01462942|16495529|P2|Overall Study|Other, including COPD exacerbation|5
4782602|NCT01462942|16495530|P1|Overall Study|Other, including COPD exacerbation|3
4782603|NCT01462942|16495526|P5|Overall Study|Adverse Event|11
4782604|NCT01462942|16495527|P4|Overall Study|Adverse Event|11
4782605|NCT01462942|16495528|P3|Overall Study|Adverse Event|10
4782606|NCT01462942|16495529|P2|Overall Study|Adverse Event|12
4782607|NCT01462942|16495530|P1|Overall Study|Adverse Event|7
4782608|NCT01462929|16495560|P3|Overall Study|Lack of Efficacy|1
4782609|NCT01462929|16495561|P2|Overall Study|Lack of Efficacy|0
4782610|NCT01462929|16495562|P1|Overall Study|Lack of Efficacy|0
4782611|NCT01462929|16495560|P3|Overall Study|Withdrawal by Subject|0
4782612|NCT01462929|16495561|P2|Overall Study|Withdrawal by Subject|1
4782613|NCT01462929|16495562|P1|Overall Study|Withdrawal by Subject|2
4782614|NCT01462929|16495560|P3|Overall Study|Adverse Event|4
4782615|NCT01462929|16495561|P2|Overall Study|Adverse Event|3
4782616|NCT01462929|16495562|P1|Overall Study|Adverse Event|3
4782617|NCT01462695|16495603|P2|Overall Study|Inevaluable (did not receive study drug)|0
4782618|NCT01462695|16495604|P1|Overall Study|Inevaluable (did not receive study drug)|1
4782619|NCT01462695|16495603|P2|Overall Study|Withdrawal by Subject|0
4782620|NCT01462695|16495604|P1|Overall Study|Withdrawal by Subject|2
4782621|NCT01462695|16495603|P2|Overall Study|Physician Decision|0
4782622|NCT01462695|16495604|P1|Overall Study|Physician Decision|5
4782623|NCT01462695|16495603|P2|Overall Study|Lack of Efficacy|12
4782624|NCT01462695|16495604|P1|Overall Study|Lack of Efficacy|6
4782625|NCT01462695|16495603|P2|Overall Study|Death|0
4782626|NCT01462695|16495604|P1|Overall Study|Death|2
4782627|NCT01462695|16495603|P2|Overall Study|Adverse Event|1
4782628|NCT01462695|16495604|P1|Overall Study|Adverse Event|1
4782629|NCT01462435|16495632|P4|Overall Study|Lost to Follow-up|1
4782630|NCT01462435|16495633|P3|Overall Study|Lost to Follow-up|0
4782631|NCT01462435|16495634|P2|Overall Study|Lost to Follow-up|0
4782632|NCT01462435|16495635|P1|Overall Study|Lost to Follow-up|0
4782633|NCT01462435|16495632|P4|Overall Study|Withdrawal by Subject|1
4782634|NCT01462435|16495633|P3|Overall Study|Withdrawal by Subject|0
4782635|NCT01462435|16495634|P2|Overall Study|Withdrawal by Subject|0
4782636|NCT01462435|16495635|P1|Overall Study|Withdrawal by Subject|0
4782637|NCT01462435|16495632|P4|Overall Study|Physician Decision|0
4782638|NCT01462435|16495633|P3|Overall Study|Physician Decision|1
4782639|NCT01462435|16495634|P2|Overall Study|Physician Decision|0
4782640|NCT01462435|16495635|P1|Overall Study|Physician Decision|0
4782641|NCT01462435|16495632|P4|Overall Study|Lack of Efficacy|3
4782642|NCT01462435|16495633|P3|Overall Study|Lack of Efficacy|0
4782643|NCT01462435|16495634|P2|Overall Study|Lack of Efficacy|0
4782644|NCT01462435|16495635|P1|Overall Study|Lack of Efficacy|1
4782645|NCT01462370|16495673|P2|Overall Study|Withdrawal by Subject|3
4782646|NCT01462370|16495674|P1|Overall Study|Withdrawal by Subject|0
4782647|NCT01462370|16495673|P2|Overall Study|Physician Decision|1
4782648|NCT01462370|16495674|P1|Overall Study|Physician Decision|0
4782649|NCT01462370|16495673|P2|Overall Study|Lack of Qualifying Event|1
4782650|NCT01462370|16495674|P1|Overall Study|Lack of Qualifying Event|1
4782651|NCT01462357|16495709|P3|Overall Study|Lost to Follow-up|7
4782652|NCT01462357|16495710|P2|Overall Study|Lost to Follow-up|5
4782653|NCT01462357|16495711|P1|Overall Study|Lost to Follow-up|3
4782654|NCT01462357|16495709|P3|Overall Study|Migrated/moved from study area|1
4782655|NCT01462357|16495710|P2|Overall Study|Migrated/moved from study area|3
4782656|NCT01462357|16495711|P1|Overall Study|Migrated/moved from study area|2
4782657|NCT01462357|16495709|P3|Overall Study|Withdrawal by Subject|3
4782658|NCT01462357|16495710|P2|Overall Study|Withdrawal by Subject|11
4782659|NCT01462357|16495711|P1|Overall Study|Withdrawal by Subject|3
4782660|NCT01462357|16495709|P3|Overall Study|Death|1
4782661|NCT01462357|16495710|P2|Overall Study|Death|0
4782662|NCT01462357|16495711|P1|Overall Study|Death|0
4782663|NCT01462344|16495784|P2|Overall Study|Lost to Follow-up|7
4782664|NCT01462344|16495785|P1|Overall Study|Lost to Follow-up|7
4782665|NCT01462344|16495784|P2|Overall Study|Protocol Violation|53
4782666|NCT01462344|16495785|P1|Overall Study|Protocol Violation|68
4782667|NCT01462344|16495784|P2|Overall Study|Lack of Efficacy|6
4782668|NCT01462344|16495785|P1|Overall Study|Lack of Efficacy|5
4782669|NCT01462344|16495784|P2|Overall Study|Asthma Exacerbation|35
4782670|NCT01462344|16495785|P1|Overall Study|Asthma Exacerbation|34
4782671|NCT01462344|16495784|P2|Overall Study|Adverse Event|23
4782672|NCT01462344|16495785|P1|Overall Study|Adverse Event|24
4782673|NCT01462344|16495784|P2|Overall Study|Withdrawal by Subject|226
4782674|NCT01462344|16495785|P1|Overall Study|Withdrawal by Subject|245
4782675|NCT01462318|16495807|P3|Extension Phase|Adverse Event|22
4782676|NCT01462318|16495808|P2|Extension Phase|Adverse Event|0
4782677|NCT01462318|16495809|P1|Extension Phase|Adverse Event|0
4782678|NCT01462318|16495807|P3|Extension Phase|Investigator Decision|5
4782679|NCT01462318|16495808|P2|Extension Phase|Investigator Decision|0
4782680|NCT01462318|16495809|P1|Extension Phase|Investigator Decision|0
4782681|NCT01462318|16495807|P3|Extension Phase|Withdrawal by Subject|15
4782682|NCT01462318|16495808|P2|Extension Phase|Withdrawal by Subject|0
4782683|NCT01462318|16495809|P1|Extension Phase|Withdrawal by Subject|0
4782684|NCT01462318|16495807|P3|Extension Phase|Disease Progression|1
4782685|NCT01462318|16495808|P2|Extension Phase|Disease Progression|0
4782686|NCT01462318|16495809|P1|Extension Phase|Disease Progression|0
4782687|NCT01462318|16495807|P3|Extension Phase|Other|1
4782688|NCT01462318|16495808|P2|Extension Phase|Other|0
4782689|NCT01462318|16495809|P1|Extension Phase|Other|0
4782690|NCT01462318|16495807|P3|Extension Phase|Lost to Follow-up|1
4782691|NCT01462318|16495808|P2|Extension Phase|Lost to Follow-up|0
4782692|NCT01462318|16495809|P1|Extension Phase|Lost to Follow-up|0
4782693|NCT01462318|16495807|P3|Main Study / TP-DI Study|Adverse Event|0
4782694|NCT01462318|16495808|P2|Main Study / TP-DI Study|Adverse Event|0
4782695|NCT01462318|16495809|P1|Main Study / TP-DI Study|Adverse Event|4
4782696|NCT01462318|16495807|P3|Main Study / TP-DI Study|Withdrawal by Subject|0
4782697|NCT01462318|16495808|P2|Main Study / TP-DI Study|Withdrawal by Subject|0
4782698|NCT01462318|16495809|P1|Main Study / TP-DI Study|Withdrawal by Subject|2
4782699|NCT01462318|16495807|P3|Main Study / TP-DI Study|Other|0
4782700|NCT01462318|16495808|P2|Main Study / TP-DI Study|Other|0
4782701|NCT01462318|16495809|P1|Main Study / TP-DI Study|Other|2
4782702|NCT01462266|16495910|P2|Overall Study|Screen failure|1
4782703|NCT01462266|16495911|P1|Overall Study|Screen failure|1
4782704|NCT01462266|16495910|P2|Overall Study|Withdrawal by Subject|2
4782705|NCT01462266|16495911|P1|Overall Study|Withdrawal by Subject|7
4782706|NCT01462266|16495910|P2|Overall Study|Protocol Violation|3
4782707|NCT01462266|16495911|P1|Overall Study|Protocol Violation|1
4782708|NCT01462266|16495910|P2|Overall Study|Physician Decision|5
4782709|NCT01462266|16495911|P1|Overall Study|Physician Decision|2
4782710|NCT01462266|16495910|P2|Overall Study|Creatinine and eGFR, excluded medication|4
4782711|NCT01462266|16495911|P1|Overall Study|Creatinine and eGFR, excluded medication|8
4782712|NCT01462266|16495910|P2|Overall Study|Non-compliance with study drug|0
4782713|NCT01462266|16495911|P1|Overall Study|Non-compliance with study drug|3
4782714|NCT01462266|16495910|P2|Overall Study|Lost to Follow-up|3
4782715|NCT01462266|16495911|P1|Overall Study|Lost to Follow-up|4
4782716|NCT01462266|16495910|P2|Overall Study|Lack of Efficacy|2
4782717|NCT01462266|16495911|P1|Overall Study|Lack of Efficacy|0
4782718|NCT01462266|16495910|P2|Overall Study|Death|1
4782719|NCT01462266|16495911|P1|Overall Study|Death|2
4782720|NCT01462266|16495910|P2|Overall Study|Adverse Event|6
4782721|NCT01462266|16495911|P1|Overall Study|Adverse Event|7
4782722|NCT01462227|16495936|P4|Second Assignment|Protocol Violation|0
4782723|NCT01462227|16495937|P3|Second Assignment|Protocol Violation|1
4782724|NCT01462227|16495938|P2|Second Assignment|Protocol Violation|1
4782725|NCT01462227|16495939|P1|Second Assignment|Protocol Violation|0
4782726|NCT01462227|16495936|P4|Second Assignment|Lost to Follow-up|0
4782727|NCT01462227|16495937|P3|Second Assignment|Lost to Follow-up|0
4782728|NCT01462227|16495938|P2|Second Assignment|Lost to Follow-up|0
4782729|NCT01462227|16495939|P1|Second Assignment|Lost to Follow-up|1
4782730|NCT01462162|16495957|P1|Overall Study|Other|2
4782731|NCT01462162|16495957|P1|Overall Study|Abnormal laboratory parameters|1
4782732|NCT01462162|16495957|P1|Overall Study|Lack of Efficacy|4
4782733|NCT01462162|16495957|P1|Overall Study|Adverse Event|5
4782734|NCT01462110|16495984|P2|Overall Study|Adverse Event|0
4782735|NCT01462110|16495985|P1|Overall Study|Adverse Event|1
4782736|NCT01462084|16496005|P2|Overall Study|Protocol Violation|1
4782737|NCT01462084|16496006|P1|Overall Study|Protocol Violation|1
4782738|NCT01462084|16496005|P2|Overall Study|Withdrawal by Subject|0
4782739|NCT01462084|16496006|P1|Overall Study|Withdrawal by Subject|1
4782740|NCT01462045|16496017|P3|Overall Study|Family matter|0
4782741|NCT01462045|16496018|P2|Overall Study|Family matter|1
4782742|NCT01462045|16496019|P1|Overall Study|Family matter|0
4782743|NCT01461993|16496033|P3|Overall Study|Other|6
4782744|NCT01461993|16496034|P2|Overall Study|Other|15
4782745|NCT01461993|16496035|P1|Overall Study|Other|13
4782746|NCT01461993|16496033|P3|Overall Study|Did not meet entrance criteria|0
4782747|NCT01461993|16496034|P2|Overall Study|Did not meet entrance criteria|3
4782748|NCT01461993|16496035|P1|Overall Study|Did not meet entrance criteria|2
4782749|NCT01461993|16496033|P3|Overall Study|No longer met eligibility criteria|10
4782750|NCT01461993|16496034|P2|Overall Study|No longer met eligibility criteria|18
4782751|NCT01461993|16496035|P1|Overall Study|No longer met eligibility criteria|13
4782752|NCT01461993|16496033|P3|Overall Study|Adverse Event|3
4782753|NCT01461993|16496034|P2|Overall Study|Adverse Event|11
4782754|NCT01461993|16496035|P1|Overall Study|Adverse Event|9
4782755|NCT01461993|16496033|P3|Overall Study|Protocol Violation|7
4782756|NCT01461993|16496034|P2|Overall Study|Protocol Violation|9
4782757|NCT01461993|16496035|P1|Overall Study|Protocol Violation|10
4782758|NCT01461993|16496033|P3|Overall Study|Lost to Follow-up|22
4782759|NCT01461993|16496034|P2|Overall Study|Lost to Follow-up|48
4782760|NCT01461993|16496035|P1|Overall Study|Lost to Follow-up|44
4782761|NCT01461993|16496033|P3|Overall Study|Withdrawal by Subject|16
4782762|NCT01461993|16496034|P2|Overall Study|Withdrawal by Subject|53
4782763|NCT01461993|16496035|P1|Overall Study|Withdrawal by Subject|60
4782764|NCT01461980|16496060|P3|Overall Study|Randomized but not vaccinated|7
4782765|NCT01461980|16496061|P2|Overall Study|Randomized but not vaccinated|8
4782766|NCT01461980|16496062|P1|Overall Study|Randomized but not vaccinated|4
4782767|NCT01461980|16496060|P3|Overall Study|No longer willing to participate|54
4782768|NCT01461980|16496061|P2|Overall Study|No longer willing to participate|38
4782769|NCT01461980|16496062|P1|Overall Study|No longer willing to participate|52
4782770|NCT01461980|16496060|P3|Overall Study|Lost to Follow-up|51
4782771|NCT01461980|16496061|P2|Overall Study|Lost to Follow-up|53
4782772|NCT01461980|16496062|P1|Overall Study|Lost to Follow-up|52
4782773|NCT01461980|16496060|P3|Overall Study|No longer meets eligibility criteria|19
4782774|NCT01461980|16496061|P2|Overall Study|No longer meets eligibility criteria|9
4782775|NCT01461980|16496062|P1|Overall Study|No longer meets eligibility criteria|18
4782776|NCT01461980|16496060|P3|Overall Study|Protocol Violation|16
4782777|NCT01461980|16496061|P2|Overall Study|Protocol Violation|19
4782778|NCT01461980|16496062|P1|Overall Study|Protocol Violation|12
4782779|NCT01461980|16496060|P3|Overall Study|Adverse Event|6
4782780|NCT01461980|16496061|P2|Overall Study|Adverse Event|5
4782781|NCT01461980|16496062|P1|Overall Study|Adverse Event|12
4782782|NCT01461980|16496060|P3|Overall Study|Medication error|6
4782783|NCT01461980|16496061|P2|Overall Study|Medication error|5
4782784|NCT01461980|16496062|P1|Overall Study|Medication error|7
4782785|NCT01461980|16496060|P3|Overall Study|Other|6
4782786|NCT01461980|16496061|P2|Overall Study|Other|8
4782787|NCT01461980|16496062|P1|Overall Study|Other|9
4782788|NCT01461928|16496092|P3|Maintenance II (15 Months)|Refused to be transferred to other site|1
4782789|NCT01461928|16496093|P2|Maintenance II (15 Months)|Refused to be transferred to other site|0
4782790|NCT01461928|16496094|P1|Maintenance II (15 Months)|Refused to be transferred to other site|0
4782791|NCT01461928|16496092|P3|Maintenance II (15 Months)|Withdrew informed consent|1
4782792|NCT01461928|16496093|P2|Maintenance II (15 Months)|Withdrew informed consent|0
4782793|NCT01461928|16496094|P1|Maintenance II (15 Months)|Withdrew informed consent|0
4782794|NCT01461928|16496092|P3|Maintenance II (15 Months)|Squamous lung carcinoma|1
4782795|NCT01461928|16496093|P2|Maintenance II (15 Months)|Squamous lung carcinoma|0
4782796|NCT01461928|16496094|P1|Maintenance II (15 Months)|Squamous lung carcinoma|0
4782797|NCT01461928|16496092|P3|Maintenance II (15 Months)|Changed physician in another hospital|1
4782798|NCT01461928|16496093|P2|Maintenance II (15 Months)|Changed physician in another hospital|0
4782799|NCT01461928|16496094|P1|Maintenance II (15 Months)|Changed physician in another hospital|0
4782800|NCT01461928|16496092|P3|Maintenance II (15 Months)|Withdrawal by Subject|8
4782801|NCT01461928|16496093|P2|Maintenance II (15 Months)|Withdrawal by Subject|9
4782802|NCT01461928|16496094|P1|Maintenance II (15 Months)|Withdrawal by Subject|0
4782803|NCT01461928|16496092|P3|Maintenance II (15 Months)|Disease progression|3
4782804|NCT01461928|16496093|P2|Maintenance II (15 Months)|Disease progression|0
4782805|NCT01461928|16496094|P1|Maintenance II (15 Months)|Disease progression|0
4782806|NCT01461928|16496092|P3|Maintenance II (15 Months)|Moved to another town|0
4782807|NCT01461928|16496093|P2|Maintenance II (15 Months)|Moved to another town|1
4782808|NCT01461928|16496094|P1|Maintenance II (15 Months)|Moved to another town|0
4782809|NCT01461928|16496092|P3|Maintenance II (15 Months)|Lost to Follow-up|0
4782810|NCT01461928|16496093|P2|Maintenance II (15 Months)|Lost to Follow-up|1
4782811|NCT01461928|16496094|P1|Maintenance II (15 Months)|Lost to Follow-up|0
4782812|NCT01461928|16496092|P3|Maintenance II (15 Months)|Physician Decision|4
4782813|NCT01461928|16496093|P2|Maintenance II (15 Months)|Physician Decision|0
4782814|NCT01461928|16496094|P1|Maintenance II (15 Months)|Physician Decision|0
4782815|NCT01461928|16496092|P3|Maintenance II (15 Months)|Death|8
4782816|NCT01461928|16496093|P2|Maintenance II (15 Months)|Death|10
4782817|NCT01461928|16496094|P1|Maintenance II (15 Months)|Death|0
4782818|NCT01461928|16496092|P3|Maintenance II (15 Months)|Adverse Event|0
4782819|NCT01461928|16496093|P2|Maintenance II (15 Months)|Adverse Event|2
4782820|NCT01461928|16496094|P1|Maintenance II (15 Months)|Adverse Event|0
4782821|NCT01461928|16496092|P3|Maintenance I (24 Months)|Did not meet criteria|0
4782822|NCT01461928|16496093|P2|Maintenance I (24 Months)|Did not meet criteria|0
4782823|NCT01461928|16496094|P1|Maintenance I (24 Months)|Did not meet criteria|5
4782824|NCT01461928|16496092|P3|Maintenance I (24 Months)|Not compliant|0
4782825|NCT01461928|16496093|P2|Maintenance I (24 Months)|Not compliant|0
4782826|NCT01461928|16496094|P1|Maintenance I (24 Months)|Not compliant|1
4782827|NCT01461928|16496092|P3|Maintenance I (24 Months)|Delay in rituximab administration|0
4782828|NCT01461928|16496093|P2|Maintenance I (24 Months)|Delay in rituximab administration|0
4782829|NCT01461928|16496094|P1|Maintenance I (24 Months)|Delay in rituximab administration|1
4782830|NCT01461928|16496092|P3|Maintenance I (24 Months)|Did not perform scheduled assessment|0
4782831|NCT01461928|16496093|P2|Maintenance I (24 Months)|Did not perform scheduled assessment|0
4782832|NCT01461928|16496094|P1|Maintenance I (24 Months)|Did not perform scheduled assessment|2
4782833|NCT01461928|16496092|P3|Maintenance I (24 Months)|Did not meet randomization criteria|0
4782834|NCT01461928|16496093|P2|Maintenance I (24 Months)|Did not meet randomization criteria|0
4782835|NCT01461928|16496094|P1|Maintenance I (24 Months)|Did not meet randomization criteria|2
4782836|NCT01461928|16496092|P3|Maintenance I (24 Months)|Physician Decision|0
4782837|NCT01461928|16496093|P2|Maintenance I (24 Months)|Physician Decision|0
4782838|NCT01461928|16496094|P1|Maintenance I (24 Months)|Physician Decision|9
4782839|NCT01461928|16496092|P3|Maintenance I (24 Months)|Adverse Event|0
4782840|NCT01461928|16496093|P2|Maintenance I (24 Months)|Adverse Event|0
4782841|NCT01461928|16496094|P1|Maintenance I (24 Months)|Adverse Event|70
4782842|NCT01461928|16496092|P3|Maintenance I (24 Months)|Diseases progression|0
4782843|NCT01461928|16496093|P2|Maintenance I (24 Months)|Diseases progression|0
4782844|NCT01461928|16496094|P1|Maintenance I (24 Months)|Diseases progression|91
4782845|NCT01461928|16496092|P3|Maintenance I (24 Months)|Lost to Follow-up|0
4782846|NCT01461928|16496093|P2|Maintenance I (24 Months)|Lost to Follow-up|0
4782847|NCT01461928|16496094|P1|Maintenance I (24 Months)|Lost to Follow-up|2
4782848|NCT01461928|16496092|P3|Maintenance I (24 Months)|Withdrawal by Subject|0
4782849|NCT01461928|16496093|P2|Maintenance I (24 Months)|Withdrawal by Subject|0
4782850|NCT01461928|16496094|P1|Maintenance I (24 Months)|Withdrawal by Subject|32
4782851|NCT01461928|16496092|P3|Maintenance I (24 Months)|Death|0
4782852|NCT01461928|16496093|P2|Maintenance I (24 Months)|Death|0
4782853|NCT01461928|16496094|P1|Maintenance I (24 Months)|Death|3
4782854|NCT01461928|16496092|P3|Induction (up to 8 Months)|Medical advisor request|0
4782855|NCT01461928|16496093|P2|Induction (up to 8 Months)|Medical advisor request|0
4782856|NCT01461928|16496094|P1|Induction (up to 8 Months)|Medical advisor request|1
4782857|NCT01461928|16496092|P3|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
4782858|NCT01461928|16496093|P2|Induction (up to 8 Months)|Exceeded time limit for next cycle|0
4782859|NCT01461928|16496094|P1|Induction (up to 8 Months)|Exceeded time limit for next cycle|1
4782860|NCT01461928|16496092|P3|Induction (up to 8 Months)|Promotor request|0
4782861|NCT01461928|16496093|P2|Induction (up to 8 Months)|Promotor request|0
4782862|NCT01461928|16496094|P1|Induction (up to 8 Months)|Promotor request|1
4782863|NCT01461928|16496092|P3|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
4782864|NCT01461928|16496093|P2|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0
4782865|NCT01461928|16496094|P1|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1
4782866|NCT01461928|16496092|P3|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
4782867|NCT01461928|16496093|P2|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0
4782868|NCT01461928|16496094|P1|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1
4782869|NCT01461928|16496092|P3|Induction (up to 8 Months)|Protocol deviation|0
4782870|NCT01461928|16496093|P2|Induction (up to 8 Months)|Protocol deviation|0
4782871|NCT01461928|16496094|P1|Induction (up to 8 Months)|Protocol deviation|2
4782872|NCT01461928|16496092|P3|Induction (up to 8 Months)|Sponsor decision|0
4782873|NCT01461928|16496093|P2|Induction (up to 8 Months)|Sponsor decision|0
4782874|NCT01461928|16496094|P1|Induction (up to 8 Months)|Sponsor decision|1
4782875|NCT01461928|16496092|P3|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
4782876|NCT01461928|16496093|P2|Induction (up to 8 Months)|Treated before eligibility was confirmed|0
4782877|NCT01461928|16496094|P1|Induction (up to 8 Months)|Treated before eligibility was confirmed|1
4782878|NCT01461928|16496092|P3|Induction (up to 8 Months)|Termination of study in Switzerland|0
4782879|NCT01461928|16496093|P2|Induction (up to 8 Months)|Termination of study in Switzerland|0
4782880|NCT01461928|16496094|P1|Induction (up to 8 Months)|Termination of study in Switzerland|1
4782881|NCT01461928|16496092|P3|Induction (up to 8 Months)|Not responding to treatment|0
4782882|NCT01461928|16496093|P2|Induction (up to 8 Months)|Not responding to treatment|0
4782883|NCT01461928|16496094|P1|Induction (up to 8 Months)|Not responding to treatment|11
4782884|NCT01461928|16496092|P3|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
4782885|NCT01461928|16496093|P2|Induction (up to 8 Months)|Completed Induction, no Maint I received|0
4782886|NCT01461928|16496094|P1|Induction (up to 8 Months)|Completed Induction, no Maint I received|11
4782887|NCT01461928|16496092|P3|Induction (up to 8 Months)|Eligibility criteria deviation|0
4782888|NCT01461928|16496093|P2|Induction (up to 8 Months)|Eligibility criteria deviation|0
4782889|NCT01461928|16496094|P1|Induction (up to 8 Months)|Eligibility criteria deviation|10
4782890|NCT01461928|16496092|P3|Induction (up to 8 Months)|Disease progression|0
4782891|NCT01461928|16496093|P2|Induction (up to 8 Months)|Disease progression|0
4782892|NCT01461928|16496094|P1|Induction (up to 8 Months)|Disease progression|45
4782893|NCT01461928|16496092|P3|Induction (up to 8 Months)|Withdrawal by Subject|0
4782894|NCT01461928|16496093|P2|Induction (up to 8 Months)|Withdrawal by Subject|0
4782895|NCT01461928|16496094|P1|Induction (up to 8 Months)|Withdrawal by Subject|18
4782896|NCT01461928|16496092|P3|Induction (up to 8 Months)|Physician Decision|0
4782897|NCT01461928|16496093|P2|Induction (up to 8 Months)|Physician Decision|0
4782898|NCT01461928|16496094|P1|Induction (up to 8 Months)|Physician Decision|9
4782899|NCT01461928|16496092|P3|Induction (up to 8 Months)|Lost to Follow-up|0
4782900|NCT01461928|16496093|P2|Induction (up to 8 Months)|Lost to Follow-up|0
4782901|NCT01461928|16496094|P1|Induction (up to 8 Months)|Lost to Follow-up|5
4782902|NCT01461928|16496092|P3|Induction (up to 8 Months)|Death|0
4782903|NCT01461928|16496093|P2|Induction (up to 8 Months)|Death|0
4782904|NCT01461928|16496094|P1|Induction (up to 8 Months)|Death|3
4782905|NCT01461928|16496092|P3|Induction (up to 8 Months)|Adverse Event|0
4782906|NCT01461928|16496093|P2|Induction (up to 8 Months)|Adverse Event|0
4782907|NCT01461928|16496094|P1|Induction (up to 8 Months)|Adverse Event|76
4782908|NCT01461811|16496145|P2|Overall Study|Noncompliance|1
4782909|NCT01461811|16496146|P1|Overall Study|Noncompliance|1
4782910|NCT01461811|16496145|P2|Overall Study|Subject decision unrelated to an AE|1
4782911|NCT01461811|16496146|P1|Overall Study|Subject decision unrelated to an AE|1
4782912|NCT01461811|16496145|P2|Overall Study|Adverse Event|1
4782913|NCT01461811|16496146|P1|Overall Study|Adverse Event|2
4782914|NCT01461707|16496185|P2|Overall Study|Withdrawal by Subject|0
4782915|NCT01461707|16496186|P1|Overall Study|Withdrawal by Subject|1
4782916|NCT01461551|16496223|P3|Overall Study|Physician Decision|2
4782917|NCT01461551|16496224|P2|Overall Study|Physician Decision|1
4782918|NCT01461551|16496225|P1|Overall Study|Physician Decision|2
4782919|NCT01461538|16496236|P3|Overall Study|Withdrawal by Subject|0
4782920|NCT01461538|16496237|P2|Overall Study|Withdrawal by Subject|1
4782921|NCT01461538|16496238|P1|Overall Study|Withdrawal by Subject|1
4782922|NCT01461538|16496236|P3|Overall Study|Study Stopped by Sponsor|0
4782923|NCT01461538|16496237|P2|Overall Study|Study Stopped by Sponsor|1
4782924|NCT01461538|16496238|P1|Overall Study|Study Stopped by Sponsor|2
4782925|NCT01461538|16496236|P3|Overall Study|Death|2
4782926|NCT01461538|16496237|P2|Overall Study|Death|6
4782927|NCT01461538|16496238|P1|Overall Study|Death|15
4782928|NCT01461369|16496307|P3|Overall Study|Withdrawal by Subject|2
4782929|NCT01461369|16496308|P2|Overall Study|Withdrawal by Subject|3
4782930|NCT01461369|16496309|P1|Overall Study|Withdrawal by Subject|1
4782931|NCT01461369|16496307|P3|Overall Study|Protocol Violation|2
4782932|NCT01461369|16496308|P2|Overall Study|Protocol Violation|2
4782933|NCT01461369|16496309|P1|Overall Study|Protocol Violation|1
4782934|NCT01461369|16496307|P3|Overall Study|Adverse Event|4
4782935|NCT01461369|16496308|P2|Overall Study|Adverse Event|12
4782936|NCT01461369|16496309|P1|Overall Study|Adverse Event|9
4782937|NCT01461369|16496307|P3|Overall Study|Lost to Follow-up|3
4782938|NCT01461369|16496308|P2|Overall Study|Lost to Follow-up|0
4782939|NCT01461369|16496309|P1|Overall Study|Lost to Follow-up|0
4782940|NCT01461369|16496307|P3|Overall Study|Lack of Efficacy|6
4782941|NCT01461369|16496308|P2|Overall Study|Lack of Efficacy|0
4782942|NCT01461369|16496309|P1|Overall Study|Lack of Efficacy|2
4782943|NCT01461096|16496334|P2|Overall Study|Lost to Follow-up|4
4782944|NCT01461096|16496335|P1|Overall Study|Lost to Follow-up|8
4782945|NCT01461096|16496334|P2|Overall Study|Subj not willing to adhere to reqs|4
4782946|NCT01461096|16496335|P1|Overall Study|Subj not willing to adhere to reqs|3
4782947|NCT01461096|16496334|P2|Overall Study|Withdrawal by Subject|3
4782948|NCT01461096|16496335|P1|Overall Study|Withdrawal by Subject|5
4782949|NCT01461096|16496334|P2|Overall Study|Site is closing|30
4782950|NCT01461096|16496335|P1|Overall Study|Site is closing|27
4782951|NCT01461096|16496334|P2|Overall Study|Subj not able to get to clinic|13
4782952|NCT01461096|16496335|P1|Overall Study|Subj not able to get to clinic|15
4782953|NCT01461096|16496334|P2|Overall Study|Severe debilitation, unable to continue|1
4782954|NCT01461096|16496335|P1|Overall Study|Severe debilitation, unable to continue|1
4782955|NCT01461096|16496334|P2|Overall Study|Death|6
4782956|NCT01461096|16496335|P1|Overall Study|Death|3
4782957|NCT01461057|16496351|P2|Overall Study|Study Terminated by Sponsor|0
4782958|NCT01461057|16496352|P1|Overall Study|Study Terminated by Sponsor|2
4782959|NCT01461057|16496351|P2|Overall Study|Progression of Disease|0
4782960|NCT01461057|16496352|P1|Overall Study|Progression of Disease|1
4782961|NCT01461057|16496351|P2|Overall Study|Adverse Event|1
4782962|NCT01461057|16496352|P1|Overall Study|Adverse Event|0
4782963|NCT01461057|16496351|P2|Overall Study|Physician Decision|2
4782964|NCT01461057|16496352|P1|Overall Study|Physician Decision|0
4782965|NCT01461057|16496351|P2|Overall Study|Withdrawal by Subject|3
4782966|NCT01461057|16496352|P1|Overall Study|Withdrawal by Subject|2
4782967|NCT01461057|16496351|P2|Overall Study|Death|9
4782968|NCT01461057|16496352|P1|Overall Study|Death|10
4782969|NCT01461044|16496362|P2|Overall Study|Lost to Follow-up|5
4782970|NCT01461044|16496363|P1|Overall Study|Lost to Follow-up|12
4782971|NCT01461044|16496362|P2|Overall Study|Death|35
4782972|NCT01461044|16496363|P1|Overall Study|Death|58
4782973|NCT01461005|16496436|P1|Overall Study|FDA reclassified Dynamic Stabilization D|1
4782974|NCT01460901|16496459|P1|Overall Study|Withdrawal by Subject|2
4782975|NCT01460719|16496491|P1|Overall Study|Withdrawal by Subject|1
4782976|NCT01460719|16496491|P1|Overall Study|Adverse Event|1
4782977|NCT01460628|16496501|P1|Overall Study|Withdrawal by Subject|2
4782978|NCT01460628|16496501|P1|Overall Study|Adverse Event|3
4782979|NCT01460446|16496513|P2|Overall Study|Other Reasons Incl. Lost for Follow-Up|3
4782980|NCT01460446|16496514|P1|Overall Study|Other Reasons Incl. Lost for Follow-Up|0
4782981|NCT01460446|16496513|P2|Overall Study|Pregnancy|0
4782982|NCT01460446|16496514|P1|Overall Study|Pregnancy|1
4782983|NCT01460446|16496513|P2|Overall Study|Surgery/Illness|1
4782984|NCT01460446|16496514|P1|Overall Study|Surgery/Illness|1
4782985|NCT01460446|16496513|P2|Overall Study|Non-compliance & Consent Withdrawn|3
4782986|NCT01460446|16496514|P1|Overall Study|Non-compliance & Consent Withdrawn|1
4782987|NCT01460446|16496513|P2|Overall Study|Consent Withdrawn|4
4782988|NCT01460446|16496514|P1|Overall Study|Consent Withdrawn|0
4782989|NCT01460446|16496513|P2|Overall Study|Non-compliance|9
4782990|NCT01460446|16496514|P1|Overall Study|Non-compliance|2
4782991|NCT01460407|16496541|P2|Period 2: Day 6 to Day 14|Adverse Event|1
4782992|NCT01460407|16496542|P1|Period 2: Day 6 to Day 14|Adverse Event|0
4782993|NCT01460381|16496555|P2|Period 2 (Days 8-15)|Lost to Follow-up|0
4782994|NCT01460381|16496556|P1|Period 2 (Days 8-15)|Lost to Follow-up|1
4782995|NCT01460368|16496572|P7|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4782996|NCT01460368|16496573|P6|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
4782997|NCT01460368|16496574|P5|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4782998|NCT01460368|16496575|P4|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
4782999|NCT01460368|16496576|P3|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1
4783000|NCT01460368|16496577|P2|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4783001|NCT01460368|16496578|P1|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0
4783002|NCT01460368|16496572|P7|Part B: Washout (up to 15 Days)|Protocol Violation|0
4783003|NCT01460368|16496573|P6|Part B: Washout (up to 15 Days)|Protocol Violation|0
4783004|NCT01460368|16496574|P5|Part B: Washout (up to 15 Days)|Protocol Violation|0
4783005|NCT01460368|16496575|P4|Part B: Washout (up to 15 Days)|Protocol Violation|0
4783006|NCT01460368|16496576|P3|Part B: Washout (up to 15 Days)|Protocol Violation|1
4783007|NCT01460368|16496577|P2|Part B: Washout (up to 15 Days)|Protocol Violation|0
4783008|NCT01460368|16496578|P1|Part B: Washout (up to 15 Days)|Protocol Violation|0
4783009|NCT01460368|16496572|P7|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4783010|NCT01460368|16496573|P6|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4783011|NCT01460368|16496574|P5|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4783012|NCT01460368|16496575|P4|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4783013|NCT01460368|16496576|P3|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4783014|NCT01460368|16496577|P2|Part B: Second Intervention (Period 2)|Lost to Follow-up|1
4783015|NCT01460368|16496578|P1|Part B: Second Intervention (Period 2)|Lost to Follow-up|0
4783016|NCT01460368|16496572|P7|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
4783017|NCT01460368|16496573|P6|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4783018|NCT01460368|16496574|P5|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4783019|NCT01460368|16496575|P4|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4783020|NCT01460368|16496576|P3|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4783021|NCT01460368|16496577|P2|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1
4783022|NCT01460368|16496578|P1|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0
4783023|NCT01460368|16496572|P7|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4783024|NCT01460368|16496573|P6|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4783025|NCT01460368|16496574|P5|Part B: First Intervention (Period 1)|Lost to Follow-up|1
4783026|NCT01460368|16496575|P4|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4783027|NCT01460368|16496576|P3|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4783028|NCT01460368|16496577|P2|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4783029|NCT01460368|16496578|P1|Part B: First Intervention (Period 1)|Lost to Follow-up|0
4783030|NCT01460342|16496590|P2|Overall Study|Lack of Efficacy|0
4783031|NCT01460342|16496591|P1|Overall Study|Lack of Efficacy|1
4783032|NCT01460342|16496590|P2|Overall Study|Physician Decision|3
4783033|NCT01460342|16496591|P1|Overall Study|Physician Decision|1
4783034|NCT01460342|16496590|P2|Overall Study|Withdrawal by Subject|4
4783035|NCT01460342|16496591|P1|Overall Study|Withdrawal by Subject|3
4783036|NCT01460342|16496590|P2|Overall Study|Protocol Violation|1
4783037|NCT01460342|16496591|P1|Overall Study|Protocol Violation|0
4783038|NCT01460342|16496590|P2|Overall Study|Lost to Follow-up|2
4783039|NCT01460342|16496591|P1|Overall Study|Lost to Follow-up|1
4783040|NCT01460342|16496590|P2|Overall Study|Adverse Event|4
4783041|NCT01460342|16496591|P1|Overall Study|Adverse Event|5
4783042|NCT01460290|16496622|P1|Overall Study|Elevated liver function|1
4783043|NCT01460290|16496622|P1|Overall Study|Adverse Event|3
4783044|NCT01459913|16496651|P4|Overall Study|Did Not Meet Inclusion Criteria|1
4783045|NCT01459913|16496652|P3|Overall Study|Did Not Meet Inclusion Criteria|0
4783046|NCT01459913|16496653|P2|Overall Study|Did Not Meet Inclusion Criteria|0
4783047|NCT01459913|16496654|P1|Overall Study|Did Not Meet Inclusion Criteria|0
4783048|NCT01459913|16496651|P4|Overall Study|Other|1
4783049|NCT01459913|16496652|P3|Overall Study|Other|3
4783050|NCT01459913|16496653|P2|Overall Study|Other|0
4783051|NCT01459913|16496654|P1|Overall Study|Other|0
4783052|NCT01459913|16496651|P4|Overall Study|Study Terminated by Sponsor|11
4783053|NCT01459913|16496652|P3|Overall Study|Study Terminated by Sponsor|9
4783054|NCT01459913|16496653|P2|Overall Study|Study Terminated by Sponsor|15
4783055|NCT01459913|16496654|P1|Overall Study|Study Terminated by Sponsor|30
4783056|NCT01459913|16496651|P4|Overall Study|Physician Decision|0
4783057|NCT01459913|16496652|P3|Overall Study|Physician Decision|0
4783058|NCT01459913|16496653|P2|Overall Study|Physician Decision|1
4783059|NCT01459913|16496654|P1|Overall Study|Physician Decision|0
4783060|NCT01459913|16496651|P4|Overall Study|Non- Compliance|3
4783061|NCT01459913|16496652|P3|Overall Study|Non- Compliance|0
4783062|NCT01459913|16496653|P2|Overall Study|Non- Compliance|0
4783063|NCT01459913|16496654|P1|Overall Study|Non- Compliance|0
4783064|NCT01459913|16496651|P4|Overall Study|Death|1
4783065|NCT01459913|16496652|P3|Overall Study|Death|0
4783066|NCT01459913|16496653|P2|Overall Study|Death|0
4783067|NCT01459913|16496654|P1|Overall Study|Death|0
4783068|NCT01459913|16496651|P4|Overall Study|Lost to Follow-up|8
4783069|NCT01459913|16496652|P3|Overall Study|Lost to Follow-up|1
4783070|NCT01459913|16496653|P2|Overall Study|Lost to Follow-up|4
4783071|NCT01459913|16496654|P1|Overall Study|Lost to Follow-up|7
4783072|NCT01459913|16496651|P4|Overall Study|Withdrawal by Subject|5
4783073|NCT01459913|16496652|P3|Overall Study|Withdrawal by Subject|0
4783074|NCT01459913|16496653|P2|Overall Study|Withdrawal by Subject|0
4783075|NCT01459913|16496654|P1|Overall Study|Withdrawal by Subject|4
4783076|NCT01459913|16496651|P4|Overall Study|Adverse Event|3
4783077|NCT01459913|16496652|P3|Overall Study|Adverse Event|0
4783078|NCT01459913|16496653|P2|Overall Study|Adverse Event|0
4783079|NCT01459913|16496654|P1|Overall Study|Adverse Event|0
4783080|NCT01459796|16496685|P2|Overall Study|Decision by the sponsor|108
4783081|NCT01459796|16496686|P1|Overall Study|Decision by the sponsor|75
4783082|NCT01459796|16496685|P2|Overall Study|Reason unspecified|2
4783083|NCT01459796|16496686|P1|Overall Study|Reason unspecified|1
4783084|NCT01459796|16496685|P2|Overall Study|Lost to Follow-up|4
4783085|NCT01459796|16496686|P1|Overall Study|Lost to Follow-up|5
4783086|NCT01459796|16496685|P2|Overall Study|Withdrawal by Subject|3
4783087|NCT01459796|16496686|P1|Overall Study|Withdrawal by Subject|6
4783088|NCT01459796|16496685|P2|Overall Study|Adverse Event|5
4783089|NCT01459796|16496686|P1|Overall Study|Adverse Event|5
4783090|NCT01459796|16496685|P2|Overall Study|Non compliance with protocol|4
4783091|NCT01459796|16496686|P1|Overall Study|Non compliance with protocol|2
4783092|NCT01459783|16496704|P2|6 Months to 12 Months|Study ended before 12-month follow-up|17
4783093|NCT01459783|16496705|P1|6 Months to 12 Months|Study ended before 12-month follow-up|11
4783094|NCT01459783|16496704|P2|6 Months to 12 Months|Lost to Follow-up|7
4783095|NCT01459783|16496705|P1|6 Months to 12 Months|Lost to Follow-up|2
4783096|NCT01459783|16496704|P2|6 Months to 12 Months|Withdrawal by Subject|5
4783097|NCT01459783|16496705|P1|6 Months to 12 Months|Withdrawal by Subject|6
4783098|NCT01459783|16496704|P2|6 Months to 12 Months|Death|1
4783099|NCT01459783|16496705|P1|6 Months to 12 Months|Death|0
4783100|NCT01459783|16496704|P2|Baseline to 6 Months|Lost to Follow-up|14
4783101|NCT01459783|16496705|P1|Baseline to 6 Months|Lost to Follow-up|19
4783102|NCT01459783|16496704|P2|Baseline to 6 Months|Withdrawal by Subject|6
4783103|NCT01459783|16496705|P1|Baseline to 6 Months|Withdrawal by Subject|12
4783104|NCT01459783|16496704|P2|Baseline to 6 Months|Death|0
4783105|NCT01459783|16496705|P1|Baseline to 6 Months|Death|1
4783106|NCT01459718|16496713|P1|Overall Study|Adverse Event|1
4783107|NCT01459718|16496713|P1|Overall Study|Lost to Follow-up|1
4783108|NCT01459718|16496713|P1|Overall Study|Physician Decision|1
4783109|NCT01459614|16496895|P2|Overall Study|Adverse Event|0
4783110|NCT01459614|16496896|P1|Overall Study|Adverse Event|1
4783111|NCT01459068|16496943|P2|Overall Study|Death|1
4783112|NCT01459068|16496944|P1|Overall Study|Death|0
4783113|NCT01459068|16496943|P2|Overall Study|Lost to Follow-up|15
4783114|NCT01459068|16496944|P1|Overall Study|Lost to Follow-up|31
4783115|NCT01459068|16496943|P2|Overall Study|Withdrawal by Subject|18
4783116|NCT01459068|16496944|P1|Overall Study|Withdrawal by Subject|8
4783117|NCT01459016|16496960|P1|Overall Study|Amendment Discontinuation Criteria|4
4783118|NCT01459016|16496960|P1|Overall Study|Withdrawal by Subject|11
4783119|NCT01458951|16496988|P3|Overall Study|Insufficient Clinical Response|11
4783120|NCT01458951|16496989|P2|Overall Study|Insufficient Clinical Response|0
4783121|NCT01458951|16496990|P1|Overall Study|Insufficient Clinical Response|17
4783122|NCT01458951|16496988|P3|Overall Study|Adverse Event|2
4783123|NCT01458951|16496989|P2|Overall Study|Adverse Event|0
4783124|NCT01458951|16496990|P1|Overall Study|Adverse Event|7
4783125|NCT01458951|16496988|P3|Overall Study|Withdrawal by Subject|2
4783126|NCT01458951|16496989|P2|Overall Study|Withdrawal by Subject|0
4783127|NCT01458951|16496990|P1|Overall Study|Withdrawal by Subject|2
4783128|NCT01458951|16496988|P3|Overall Study|Protocol Violation|0
4783129|NCT01458951|16496989|P2|Overall Study|Protocol Violation|1
4783130|NCT01458951|16496990|P1|Overall Study|Protocol Violation|5
4783131|NCT01458951|16496988|P3|Overall Study|Other|0
4783132|NCT01458951|16496989|P2|Overall Study|Other|0
4783133|NCT01458951|16496990|P1|Overall Study|Other|1
4783134|NCT01458639|16497015|P1|Overall Study|Inability to obtain subject blood sample|1
4783135|NCT01458639|16497015|P1|Overall Study|Equipment issue|1
4783136|NCT01458639|16497015|P1|Overall Study|Physician Decision|4
4783137|NCT01458587|16497027|P2|Overall Study|Withdrawal by Subject|0
4783138|NCT01458587|16497028|P1|Overall Study|Withdrawal by Subject|1
4783139|NCT01458574|16497191|P3|Overall Study|Randomized but not treated|0
4783140|NCT01458574|16497192|P2|Overall Study|Randomized but not treated|1
4783141|NCT01458574|16497193|P1|Overall Study|Randomized but not treated|0
4783142|NCT01458574|16497191|P3|Overall Study|Other|0
4783143|NCT01458574|16497192|P2|Overall Study|Other|1
4783144|NCT01458574|16497193|P1|Overall Study|Other|2
4783145|NCT01458574|16497191|P3|Overall Study|Withdrawal by Subject|5
4783146|NCT01458574|16497192|P2|Overall Study|Withdrawal by Subject|3
4783147|NCT01458574|16497193|P1|Overall Study|Withdrawal by Subject|6
4783148|NCT01458574|16497191|P3|Overall Study|Protocol Violation|0
4783149|NCT01458574|16497192|P2|Overall Study|Protocol Violation|1
4783150|NCT01458574|16497193|P1|Overall Study|Protocol Violation|0
4783151|NCT01458574|16497191|P3|Overall Study|Pregnancy|0
4783152|NCT01458574|16497192|P2|Overall Study|Pregnancy|1
4783153|NCT01458574|16497193|P1|Overall Study|Pregnancy|1
4783154|NCT01458574|16497191|P3|Overall Study|Lost to Follow-up|1
4783155|NCT01458574|16497192|P2|Overall Study|Lost to Follow-up|2
4783156|NCT01458574|16497193|P1|Overall Study|Lost to Follow-up|3
4783157|NCT01458574|16497191|P3|Overall Study|Lack of Efficacy|132
4783158|NCT01458574|16497192|P2|Overall Study|Lack of Efficacy|53
4783159|NCT01458574|16497193|P1|Overall Study|Lack of Efficacy|70
4783160|NCT01458574|16497191|P3|Overall Study|Adverse Event|7
4783161|NCT01458574|16497192|P2|Overall Study|Adverse Event|9
4783162|NCT01458574|16497193|P1|Overall Study|Adverse Event|5
4783163|NCT01458535|16497323|P6|Overall Study|Adverse Event|0
4783164|NCT01458535|16497324|P5|Overall Study|Adverse Event|0
4783165|NCT01458535|16497325|P4|Overall Study|Adverse Event|1
4783166|NCT01458535|16497326|P3|Overall Study|Adverse Event|0
4783167|NCT01458535|16497327|P2|Overall Study|Adverse Event|0
4783168|NCT01458535|16497328|P1|Overall Study|Adverse Event|0
4783169|NCT01458535|16497323|P6|Overall Study|Lost to Follow-up|2
4783170|NCT01458535|16497324|P5|Overall Study|Lost to Follow-up|2
4783171|NCT01458535|16497325|P4|Overall Study|Lost to Follow-up|3
4783172|NCT01458535|16497326|P3|Overall Study|Lost to Follow-up|0
4783173|NCT01458535|16497327|P2|Overall Study|Lost to Follow-up|2
4783174|NCT01458535|16497328|P1|Overall Study|Lost to Follow-up|0
4783175|NCT01458535|16497323|P6|Overall Study|Withdrawal by Subject|1
4783176|NCT01458535|16497324|P5|Overall Study|Withdrawal by Subject|1
4783177|NCT01458535|16497325|P4|Overall Study|Withdrawal by Subject|0
4783178|NCT01458535|16497326|P3|Overall Study|Withdrawal by Subject|2
4783179|NCT01458535|16497327|P2|Overall Study|Withdrawal by Subject|0
4783180|NCT01458535|16497328|P1|Overall Study|Withdrawal by Subject|0
4783181|NCT01458535|16497323|P6|Overall Study|Other|1
4783182|NCT01458535|16497324|P5|Overall Study|Other|1
4783183|NCT01458535|16497325|P4|Overall Study|Other|0
4783184|NCT01458535|16497326|P3|Overall Study|Other|0
4783185|NCT01458535|16497327|P2|Overall Study|Other|0
4783186|NCT01458535|16497328|P1|Overall Study|Other|0
4783187|NCT01458522|16497380|P2|Overall Study|Physician Decision|9
4783188|NCT01458522|16497381|P1|Overall Study|Physician Decision|1
4783189|NCT01458522|16497380|P2|Overall Study|Withdrawal by Subject|2
4783190|NCT01458522|16497381|P1|Overall Study|Withdrawal by Subject|2
4783191|NCT01458392|16497410|P3|Overall Study|Patient unwilling to comply with protoco|2
4783192|NCT01458392|16497411|P2|Overall Study|Patient unwilling to comply with protoco|0
4783193|NCT01458392|16497412|P1|Overall Study|Patient unwilling to comply with protoco|0
4783194|NCT01458392|16497410|P3|Overall Study|At the discretion of the sponsor|7
4783195|NCT01458392|16497411|P2|Overall Study|At the discretion of the sponsor|2
4783196|NCT01458392|16497412|P1|Overall Study|At the discretion of the sponsor|0
4783197|NCT01458392|16497410|P3|Overall Study|Death|22
4783198|NCT01458392|16497411|P2|Overall Study|Death|11
4783199|NCT01458392|16497412|P1|Overall Study|Death|2
4783200|NCT01458366|16497437|P5|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1
4783201|NCT01458366|16497438|P4|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4783202|NCT01458366|16497439|P3|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4783203|NCT01458366|16497440|P2|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4783204|NCT01458366|16497441|P1|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0
4783205|NCT01458366|16497437|P5|Period 1: 70mg/m^2|Physician Decision|0
4783206|NCT01458366|16497438|P4|Period 1: 70mg/m^2|Physician Decision|0
4783207|NCT01458366|16497439|P3|Period 1: 70mg/m^2|Physician Decision|0
4783208|NCT01458366|16497440|P2|Period 1: 70mg/m^2|Physician Decision|0
4783209|NCT01458366|16497441|P1|Period 1: 70mg/m^2|Physician Decision|2
4783210|NCT01458275|16497468|P3|Overall Study|Withdrawal by Subject|1
4783211|NCT01458275|16497469|P2|Overall Study|Withdrawal by Subject|2
4783212|NCT01458275|16497470|P1|Overall Study|Withdrawal by Subject|3
4783213|NCT01458275|16497468|P3|Overall Study|Protocol Violation|2
4783214|NCT01458275|16497469|P2|Overall Study|Protocol Violation|5
4783215|NCT01458275|16497470|P1|Overall Study|Protocol Violation|5
4783216|NCT01458275|16497468|P3|Overall Study|Lost to Follow-up|5
4783217|NCT01458275|16497469|P2|Overall Study|Lost to Follow-up|2
4783218|NCT01458275|16497470|P1|Overall Study|Lost to Follow-up|3
4783219|NCT01458275|16497468|P3|Overall Study|Adverse Event|1
4783220|NCT01458275|16497469|P2|Overall Study|Adverse Event|4
4783221|NCT01458275|16497470|P1|Overall Study|Adverse Event|3
4783222|NCT01458249|16497512|P1|Overall Study|Ongoing|1
4783223|NCT01458249|16497512|P1|Overall Study|Other|2
4783224|NCT01458249|16497512|P1|Overall Study|Adverse Event|4
4783225|NCT01458249|16497512|P1|Overall Study|Not treated|1
4783226|NCT01458210|16497531|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1
4783227|NCT01458210|16497531|P1|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2
4783228|NCT01458210|16497531|P1|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2
4783229|NCT01458210|16497531|P1|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2
4783230|NCT01458171|16497548|P1|Overall Study|Adverse Event|1
4783231|NCT01458132|16497571|P2|Overall Study|Other|3
4783232|NCT01458132|16497572|P1|Overall Study|Other|15
4783233|NCT01458119|16497580|P1|Overall Study|Non-compliance With Study Drug|3
4783234|NCT01458119|16497580|P1|Overall Study|Consent Withdrawn by Participant|8
4783235|NCT01458119|16497580|P1|Overall Study|Adverse Event|1
4783236|NCT01458119|16497580|P1|Overall Study|Death|2
4783237|NCT01458119|16497580|P1|Overall Study|Pregnancy|1
4783238|NCT01458119|16497580|P1|Overall Study|Withdrawal Due to Nonamenable Mutation|1
4783239|NCT01458119|16497580|P1|Overall Study|Physician Decision|4
4783240|NCT01458106|16497587|P2|Overall Study|Withdrawn Per Protocol|1
4783241|NCT01458106|16497588|P1|Overall Study|Withdrawn Per Protocol|0
4783242|NCT01458106|16497587|P2|Overall Study|Pre-rFVIIIFc Adverse Event|0
4783243|NCT01458106|16497588|P1|Overall Study|Pre-rFVIIIFc Adverse Event|1
4783244|NCT01458106|16497587|P2|Overall Study|Withdrawal by Subject|0
4783245|NCT01458106|16497588|P1|Overall Study|Withdrawal by Subject|2
4783246|NCT01457950|16497665|P4|Open-Label Phase|Withdrawal by Subject|0
4783247|NCT01457950|16497666|P3|Open-Label Phase|Withdrawal by Subject|2
4783248|NCT01457950|16497667|P2|Open-Label Phase|Withdrawal by Subject|0
4783249|NCT01457950|16497668|P1|Open-Label Phase|Withdrawal by Subject|0
4783250|NCT01457950|16497665|P4|Open-Label Phase|Protocol Violation|1
4783251|NCT01457950|16497666|P3|Open-Label Phase|Protocol Violation|0
4783252|NCT01457950|16497667|P2|Open-Label Phase|Protocol Violation|0
4783253|NCT01457950|16497668|P1|Open-Label Phase|Protocol Violation|0
4783254|NCT01457950|16497665|P4|Open-Label Phase|Adverse Event|1
4783255|NCT01457950|16497666|P3|Open-Label Phase|Adverse Event|0
4783256|NCT01457950|16497667|P2|Open-Label Phase|Adverse Event|0
4783257|NCT01457950|16497668|P1|Open-Label Phase|Adverse Event|0
4783258|NCT01457950|16497665|P4|Double-Blind Phase|Withdrawal by Subject|0
4783259|NCT01457950|16497666|P3|Double-Blind Phase|Withdrawal by Subject|0
4783260|NCT01457950|16497667|P2|Double-Blind Phase|Withdrawal by Subject|2
4783261|NCT01457950|16497668|P1|Double-Blind Phase|Withdrawal by Subject|6
4783262|NCT01457950|16497665|P4|Double-Blind Phase|Protocol Violation|0
4783263|NCT01457950|16497666|P3|Double-Blind Phase|Protocol Violation|0
4783264|NCT01457950|16497667|P2|Double-Blind Phase|Protocol Violation|1
4783265|NCT01457950|16497668|P1|Double-Blind Phase|Protocol Violation|2
4783266|NCT01457950|16497665|P4|Double-Blind Phase|Continuation Criteria Not Met|0
4783267|NCT01457950|16497666|P3|Double-Blind Phase|Continuation Criteria Not Met|0
4783268|NCT01457950|16497667|P2|Double-Blind Phase|Continuation Criteria Not Met|0
4783269|NCT01457950|16497668|P1|Double-Blind Phase|Continuation Criteria Not Met|1
4783270|NCT01457924|16497747|P5|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
4783271|NCT01457924|16497748|P4|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2
4783272|NCT01457924|16497749|P3|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
4783273|NCT01457924|16497750|P2|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0
4783274|NCT01457924|16497751|P1|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1
4783275|NCT01457924|16497747|P5|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5
4783276|NCT01457924|16497748|P4|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
4783277|NCT01457924|16497749|P3|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2
4783278|NCT01457924|16497750|P2|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4
4783279|NCT01457924|16497751|P1|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3
4783280|NCT01457924|16497747|P5|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
4783281|NCT01457924|16497748|P4|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
4783282|NCT01457924|16497749|P3|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
4783283|NCT01457924|16497750|P2|Individualized FUP (Weeks 48+)|Lost to Follow-up|0
4783284|NCT01457924|16497751|P1|Individualized FUP (Weeks 48+)|Lost to Follow-up|1
4783285|NCT01457924|16497747|P5|FUP (Weeks 24-48)|Withdrawal by Subject|2
4783286|NCT01457924|16497748|P4|FUP (Weeks 24-48)|Withdrawal by Subject|0
4783287|NCT01457924|16497749|P3|FUP (Weeks 24-48)|Withdrawal by Subject|0
4783288|NCT01457924|16497750|P2|FUP (Weeks 24-48)|Withdrawal by Subject|1
4783289|NCT01457924|16497751|P1|FUP (Weeks 24-48)|Withdrawal by Subject|2
4783290|NCT01457924|16497747|P5|FUP (Weeks 24-48)|Lost to Follow-up|0
4783291|NCT01457924|16497748|P4|FUP (Weeks 24-48)|Lost to Follow-up|1
4783292|NCT01457924|16497749|P3|FUP (Weeks 24-48)|Lost to Follow-up|0
4783293|NCT01457924|16497750|P2|FUP (Weeks 24-48)|Lost to Follow-up|0
4783294|NCT01457924|16497751|P1|FUP (Weeks 24-48)|Lost to Follow-up|0
4783295|NCT01457924|16497747|P5|FUP (Weeks 24-48)|Physician Decision|0
4783296|NCT01457924|16497748|P4|FUP (Weeks 24-48)|Physician Decision|0
4783297|NCT01457924|16497749|P3|FUP (Weeks 24-48)|Physician Decision|1
4783298|NCT01457924|16497750|P2|FUP (Weeks 24-48)|Physician Decision|0
4783299|NCT01457924|16497751|P1|FUP (Weeks 24-48)|Physician Decision|1
4783300|NCT01457924|16497747|P5|FUP (Weeks 24-48)|Adverse Event|0
4783301|NCT01457924|16497748|P4|FUP (Weeks 24-48)|Adverse Event|0
4783302|NCT01457924|16497749|P3|FUP (Weeks 24-48)|Adverse Event|1
4783303|NCT01457924|16497750|P2|FUP (Weeks 24-48)|Adverse Event|0
4783304|NCT01457924|16497751|P1|FUP (Weeks 24-48)|Adverse Event|0
4783305|NCT01457924|16497747|P5|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2
4783306|NCT01457924|16497748|P4|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
4783307|NCT01457924|16497749|P3|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0
4783308|NCT01457924|16497750|P2|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
4783309|NCT01457924|16497751|P1|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1
4783310|NCT01457924|16497747|P5|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
4783311|NCT01457924|16497748|P4|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1
4783312|NCT01457924|16497749|P3|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
4783313|NCT01457924|16497750|P2|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
4783314|NCT01457924|16497751|P1|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0
4783315|NCT01457924|16497747|P5|Treatment Phase (Weeks 0-24)|Protocol Violation|0
4783316|NCT01457924|16497748|P4|Treatment Phase (Weeks 0-24)|Protocol Violation|0
4783317|NCT01457924|16497749|P3|Treatment Phase (Weeks 0-24)|Protocol Violation|1
4783318|NCT01457924|16497750|P2|Treatment Phase (Weeks 0-24)|Protocol Violation|0
4783319|NCT01457924|16497751|P1|Treatment Phase (Weeks 0-24)|Protocol Violation|1
4783320|NCT01457924|16497747|P5|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4783321|NCT01457924|16497748|P4|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4783322|NCT01457924|16497749|P3|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4783323|NCT01457924|16497750|P2|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0
4783324|NCT01457924|16497751|P1|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1
4783325|NCT01457924|16497747|P5|Treatment Phase (Weeks 0-24)|Physician Decision|1
4783326|NCT01457924|16497748|P4|Treatment Phase (Weeks 0-24)|Physician Decision|0
4783327|NCT01457924|16497749|P3|Treatment Phase (Weeks 0-24)|Physician Decision|0
4783328|NCT01457924|16497750|P2|Treatment Phase (Weeks 0-24)|Physician Decision|0
4783329|NCT01457924|16497751|P1|Treatment Phase (Weeks 0-24)|Physician Decision|0
4783330|NCT01457924|16497747|P5|Treatment Phase (Weeks 0-24)|Adverse Event|2
4783331|NCT01457924|16497748|P4|Treatment Phase (Weeks 0-24)|Adverse Event|0
4783332|NCT01457924|16497749|P3|Treatment Phase (Weeks 0-24)|Adverse Event|1
4783333|NCT01457924|16497750|P2|Treatment Phase (Weeks 0-24)|Adverse Event|4
4783334|NCT01457924|16497751|P1|Treatment Phase (Weeks 0-24)|Adverse Event|0
4783335|NCT01457846|16497821|P2|Overall Study|Lost to Follow-up|0
4783336|NCT01457846|16497822|P1|Overall Study|Lost to Follow-up|1
4783337|NCT01457846|16497821|P2|Overall Study|Withdrawal by Subject|1
4783338|NCT01457846|16497822|P1|Overall Study|Withdrawal by Subject|1
4783339|NCT01457846|16497821|P2|Overall Study|Unclassified reason for not completed|10
4783340|NCT01457846|16497822|P1|Overall Study|Unclassified reason for not completed|11
4783341|NCT01457846|16497821|P2|Overall Study|Death|16
4783342|NCT01457846|16497822|P1|Overall Study|Death|27
4783343|NCT01457846|16497821|P2|Overall Study|Did not receive treatment|1
4783344|NCT01457846|16497822|P1|Overall Study|Did not receive treatment|0
4783345|NCT01457846|16497821|P2|Overall Study|Death before treatment|2
4783346|NCT01457846|16497822|P1|Overall Study|Death before treatment|1
4783347|NCT01457703|16497838|P2|Overall Study|Withdrawal by Subject|4
4783348|NCT01457703|16497839|P1|Overall Study|Withdrawal by Subject|1
4783349|NCT01457703|16497838|P2|Overall Study|Screen Failure|7
4783350|NCT01457703|16497839|P1|Overall Study|Screen Failure|5
4783351|NCT01457352|16497950|P2|Period 3|Sponsor's withdrawal|1
4783352|NCT01457352|16497951|P1|Period 3|Sponsor's withdrawal|0
4783353|NCT01457352|16497950|P2|Period 3|incorrect treatment|1
4783354|NCT01457352|16497951|P1|Period 3|incorrect treatment|0
4783355|NCT01457352|16497950|P2|Period 3|Withdrawal by Subject|2
4783356|NCT01457352|16497951|P1|Period 3|Withdrawal by Subject|0
4783357|NCT01457352|16497950|P2|Period 3|Adverse Event|1
4783358|NCT01457352|16497951|P1|Period 3|Adverse Event|1
4783359|NCT01457352|16497950|P2|Period 2|Did not meet eligibility criteria|0
4783360|NCT01457352|16497951|P1|Period 2|Did not meet eligibility criteria|3
4783361|NCT01457352|16497950|P2|Period 2|Physician Decision|0
4783362|NCT01457352|16497951|P1|Period 2|Physician Decision|1
4783363|NCT01457352|16497950|P2|Period 2|dose change|0
4783364|NCT01457352|16497951|P1|Period 2|dose change|1
4783365|NCT01457352|16497950|P2|Period 2|Lost to Follow-up|0
4783366|NCT01457352|16497951|P1|Period 2|Lost to Follow-up|1
4783367|NCT01457352|16497950|P2|Period 2|Sponsor's withdrawal|0
4783368|NCT01457352|16497951|P1|Period 2|Sponsor's withdrawal|7
4783369|NCT01457352|16497950|P2|Period 2|Protocol Violation|0
4783370|NCT01457352|16497951|P1|Period 2|Protocol Violation|4
4783371|NCT01457352|16497950|P2|Period 2|Lack of Efficacy|0
4783372|NCT01457352|16497951|P1|Period 2|Lack of Efficacy|8
4783373|NCT01457352|16497950|P2|Period 2|no analysis|0
4783374|NCT01457352|16497951|P1|Period 2|no analysis|10
4783375|NCT01457352|16497950|P2|Period 2|Adverse Event|0
4783376|NCT01457352|16497951|P1|Period 2|Adverse Event|22
4783377|NCT01457352|16497950|P2|Period 2|Withdrawal by Subject|0
4783378|NCT01457352|16497951|P1|Period 2|Withdrawal by Subject|23
4783379|NCT01457352|16497950|P2|Period 1|Did not meet eligibility criteria|0
4783380|NCT01457352|16497951|P1|Period 1|Did not meet eligibility criteria|3
4783381|NCT01457352|16497950|P2|Period 1|Protocol Violation|0
4783382|NCT01457352|16497951|P1|Period 1|Protocol Violation|4
4783383|NCT01457352|16497950|P2|Period 1|withdrew per sponsor|0
4783384|NCT01457352|16497951|P1|Period 1|withdrew per sponsor|1
4783385|NCT01457352|16497950|P2|Period 1|Withdrawn|0
4783386|NCT01457352|16497951|P1|Period 1|Withdrawn|1
4783387|NCT01457352|16497950|P2|Period 1|MS related disease progression|0
4783388|NCT01457352|16497951|P1|Period 1|MS related disease progression|1
4783389|NCT01457352|16497950|P2|Period 1|Physician Decision|0
4783390|NCT01457352|16497951|P1|Period 1|Physician Decision|2
4783391|NCT01457352|16497950|P2|Period 1|Withdrawal by Subject|0
4783392|NCT01457352|16497951|P1|Period 1|Withdrawal by Subject|2
4783393|NCT01457352|16497950|P2|Period 1|Adverse Event|0
4783394|NCT01457352|16497951|P1|Period 1|Adverse Event|2
4783395|NCT01457339|16497963|P2|Period 6 (250 mg)|Personal appointment|1
4783396|NCT01457339|16497964|P1|Period 6 (250 mg)|Personal appointment|0
4783397|NCT01457339|16497963|P2|Period 6 (250 mg)|Family Emergency|0
4783398|NCT01457339|16497964|P1|Period 6 (250 mg)|Family Emergency|1
4783399|NCT01457339|16497963|P2|Period 5 (200 mg)|Met stopping criteria for PANSS score|1
4783400|NCT01457339|16497964|P1|Period 5 (200 mg)|Met stopping criteria for PANSS score|0
4783401|NCT01457339|16497963|P2|Period 3 (100 mg)|Adverse Event|1
4783402|NCT01457339|16497964|P1|Period 3 (100 mg)|Adverse Event|0
4783403|NCT01457053|16498136|P2|Overall Study|Unable to undergo selected treatment|1
4783404|NCT01457053|16498137|P1|Overall Study|Unable to undergo selected treatment|1
4783405|NCT01457014|16498143|P4|First Night|Withdrawal by Subject|0
4783406|NCT01457014|16498144|P3|First Night|Withdrawal by Subject|0
4783407|NCT01457014|16498145|P2|First Night|Withdrawal by Subject|0
4783408|NCT01457014|16498146|P1|First Night|Withdrawal by Subject|3
4783409|NCT01457014|16498143|P4|First Night|Didn't meet inclusion/exclusion criteria|0
4783410|NCT01457014|16498144|P3|First Night|Didn't meet inclusion/exclusion criteria|0
4783411|NCT01457014|16498145|P2|First Night|Didn't meet inclusion/exclusion criteria|0
4783412|NCT01457014|16498146|P1|First Night|Didn't meet inclusion/exclusion criteria|37
4783413|NCT01456962|16498163|P2|Overall Study|Lost to Follow-up|1
4783414|NCT01456962|16498164|P1|Overall Study|Lost to Follow-up|2
4783415|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4
4783416|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6
4783417|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2
4783418|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Subject Relocation|10
4783419|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Physician Decision|1
4783420|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11
4783421|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23
4783422|NCT01456949|16498170|P1|Study Cryoablation Procedure & Follow-up|Death|5
4783423|NCT01456949|16498170|P1|Enrollment|Withdrawal by Subject|7
4783424|NCT01456949|16498170|P1|Enrollment|Physician Decision|10
4783425|NCT01456949|16498170|P1|Enrollment|I/E criteria not met prior to procedure|13
4783426|NCT01456949|16498170|P1|Enrollment|Death|1
4783427|NCT01456949|16498170|P1|Enrollment|PI death- incomplete data|6
4783428|NCT01456936|16498181|P4|Overall Study|Randomized but not treated|21
4783429|NCT01456936|16498182|P3|Overall Study|Randomized but not treated|16
4783430|NCT01456936|16498183|P2|Overall Study|Randomized but not treated|28
4783431|NCT01456936|16498184|P1|Overall Study|Randomized but not treated|21
4783432|NCT01456936|16498181|P4|Overall Study|Death|3
4783433|NCT01456936|16498182|P3|Overall Study|Death|1
4783434|NCT01456936|16498183|P2|Overall Study|Death|3
4783435|NCT01456936|16498184|P1|Overall Study|Death|0
4783436|NCT01456936|16498181|P4|Overall Study|Adverse event (study drug unrelated)|9
4783437|NCT01456936|16498182|P3|Overall Study|Adverse event (study drug unrelated)|9
4783438|NCT01456936|16498183|P2|Overall Study|Adverse event (study drug unrelated)|7
4783439|NCT01456936|16498184|P1|Overall Study|Adverse event (study drug unrelated)|9
4783440|NCT01456936|16498181|P4|Overall Study|Adverse event (study drug)|17
4783441|NCT01456936|16498182|P3|Overall Study|Adverse event (study drug)|26
4783442|NCT01456936|16498183|P2|Overall Study|Adverse event (study drug)|21
4783443|NCT01456936|16498184|P1|Overall Study|Adverse event (study drug)|25
4783444|NCT01456936|16498181|P4|Overall Study|Medication error|1
4783445|NCT01456936|16498182|P3|Overall Study|Medication error|0
4783446|NCT01456936|16498183|P2|Overall Study|Medication error|1
4783447|NCT01456936|16498184|P1|Overall Study|Medication error|0
4783448|NCT01456936|16498181|P4|Overall Study|Lost to Follow-up|127
4783449|NCT01456936|16498182|P3|Overall Study|Lost to Follow-up|144
4783450|NCT01456936|16498183|P2|Overall Study|Lost to Follow-up|126
4783451|NCT01456936|16498184|P1|Overall Study|Lost to Follow-up|135
4783452|NCT01456936|16498181|P4|Overall Study|No longer willing to participate|248
4783453|NCT01456936|16498182|P3|Overall Study|No longer willing to participate|224
4783454|NCT01456936|16498183|P2|Overall Study|No longer willing to participate|218
4783455|NCT01456936|16498184|P1|Overall Study|No longer willing to participate|195
4783456|NCT01456936|16498181|P4|Overall Study|Insufficient clinical response|13
4783457|NCT01456936|16498182|P3|Overall Study|Insufficient clinical response|14
4783458|NCT01456936|16498183|P2|Overall Study|Insufficient clinical response|4
4783459|NCT01456936|16498184|P1|Overall Study|Insufficient clinical response|4
4783460|NCT01456936|16498181|P4|Overall Study|Pregnancy|1
4783461|NCT01456936|16498182|P3|Overall Study|Pregnancy|0
4783462|NCT01456936|16498183|P2|Overall Study|Pregnancy|0
4783463|NCT01456936|16498184|P1|Overall Study|Pregnancy|1
4783464|NCT01456936|16498181|P4|Overall Study|Protocol Violation|5
4783465|NCT01456936|16498182|P3|Overall Study|Protocol Violation|5
4783466|NCT01456936|16498183|P2|Overall Study|Protocol Violation|2
4783467|NCT01456936|16498184|P1|Overall Study|Protocol Violation|4
4783468|NCT01456936|16498181|P4|Overall Study|No longer meets eligibility criteria|5
4783469|NCT01456936|16498182|P3|Overall Study|No longer meets eligibility criteria|6
4783470|NCT01456936|16498183|P2|Overall Study|No longer meets eligibility criteria|8
4783471|NCT01456936|16498184|P1|Overall Study|No longer meets eligibility criteria|4
4783472|NCT01456936|16498181|P4|Overall Study|Other reason|33
4783473|NCT01456936|16498182|P3|Overall Study|Other reason|36
4783474|NCT01456936|16498183|P2|Overall Study|Other reason|30
4783475|NCT01456936|16498184|P1|Overall Study|Other reason|41
4783476|NCT01456897|16498292|P2|Overall Study|Lack of Efficacy|11
4783477|NCT01456897|16498293|P1|Overall Study|Lack of Efficacy|4
4783478|NCT01456897|16498292|P2|Overall Study|Withdrawal by Subject|17
4783479|NCT01456897|16498293|P1|Overall Study|Withdrawal by Subject|44
4783480|NCT01456897|16498292|P2|Overall Study|Physician Decision|3
4783481|NCT01456897|16498293|P1|Overall Study|Physician Decision|5
4783482|NCT01456897|16498292|P2|Overall Study|Protocol Violation|4
4783483|NCT01456897|16498293|P1|Overall Study|Protocol Violation|3
4783484|NCT01456897|16498292|P2|Overall Study|Adverse Event|22
4783485|NCT01456897|16498293|P1|Overall Study|Adverse Event|19
4783486|NCT01456780|16498312|P3|Overall Study|Lost to Follow-up|0
4783487|NCT01456780|16498313|P2|Overall Study|Lost to Follow-up|3
4783488|NCT01456780|16498314|P1|Overall Study|Lost to Follow-up|3
4783489|NCT01456221|16498363|P2|Overall Study|Incomplete data|2
4783490|NCT01456221|16498364|P1|Overall Study|Incomplete data|4
4783491|NCT01456221|16498363|P2|Overall Study|Received medication|2
4783492|NCT01456221|16498364|P1|Overall Study|Received medication|3
4783493|NCT01456221|16498363|P2|Overall Study|Lost to Follow-up|4
4783494|NCT01456221|16498364|P1|Overall Study|Lost to Follow-up|1
4783495|NCT01456221|16498363|P2|Overall Study|Withdrawal by Subject|49
4783496|NCT01456221|16498364|P1|Overall Study|Withdrawal by Subject|56
4783497|NCT01456195|16498379|P3|Overall Study|Other Reasons|3
4783498|NCT01456195|16498380|P2|Overall Study|Other Reasons|1
4783499|NCT01456195|16498381|P1|Overall Study|Other Reasons|2
4783500|NCT01456195|16498379|P3|Overall Study|Lack of Efficacy|0
4783501|NCT01456195|16498380|P2|Overall Study|Lack of Efficacy|1
4783502|NCT01456195|16498381|P1|Overall Study|Lack of Efficacy|0
4783503|NCT01456195|16498379|P3|Overall Study|Voluntary Withdrawal|7
4783504|NCT01456195|16498380|P2|Overall Study|Voluntary Withdrawal|3
4783505|NCT01456195|16498381|P1|Overall Study|Voluntary Withdrawal|5
4783506|NCT01456195|16498379|P3|Overall Study|Lost to Follow-up|3
4783507|NCT01456195|16498380|P2|Overall Study|Lost to Follow-up|1
4783508|NCT01456195|16498381|P1|Overall Study|Lost to Follow-up|3
4783509|NCT01456195|16498379|P3|Overall Study|Pretreatment Event/Adverse Event|1
4783510|NCT01456195|16498380|P2|Overall Study|Pretreatment Event/Adverse Event|4
4783511|NCT01456195|16498381|P1|Overall Study|Pretreatment Event/Adverse Event|1
4783512|NCT01456169|16498401|P3|Overall Study|Other|0
4783513|NCT01456169|16498402|P2|Overall Study|Other|1
4783514|NCT01456169|16498403|P1|Overall Study|Other|1
4783515|NCT01456169|16498401|P3|Overall Study|Lack of Efficacy|0
4783516|NCT01456169|16498402|P2|Overall Study|Lack of Efficacy|0
4783517|NCT01456169|16498403|P1|Overall Study|Lack of Efficacy|2
4783518|NCT01456169|16498401|P3|Overall Study|Voluntary Withdrawal|2
4783519|NCT01456169|16498402|P2|Overall Study|Voluntary Withdrawal|0
4783520|NCT01456169|16498403|P1|Overall Study|Voluntary Withdrawal|3
4783521|NCT01456169|16498401|P3|Overall Study|Major Protocol Deviation|3
4783522|NCT01456169|16498402|P2|Overall Study|Major Protocol Deviation|2
4783523|NCT01456169|16498403|P1|Overall Study|Major Protocol Deviation|3
4783524|NCT01456169|16498401|P3|Overall Study|Adverse Event|7
4783525|NCT01456169|16498402|P2|Overall Study|Adverse Event|2
4783526|NCT01456169|16498403|P1|Overall Study|Adverse Event|1
4783527|NCT01456130|16498463|P1|Overall Study|Other|1
4783528|NCT01456130|16498463|P1|Overall Study|Lack of Efficacy|4
4783529|NCT01456130|16498463|P1|Overall Study|Voluntary Withdrawal|1
4783530|NCT01456130|16498463|P1|Overall Study|Adverse Event|4
4783531|NCT01456052|16498473|P3|Overall Study|Treatment Failure|1
4783532|NCT01456052|16498474|P2|Overall Study|Treatment Failure|1
4783533|NCT01456052|16498475|P1|Overall Study|Treatment Failure|0
4783534|NCT01456052|16498473|P3|Overall Study|Physician Decision|1
4783535|NCT01456052|16498474|P2|Overall Study|Physician Decision|0
4783536|NCT01456052|16498475|P1|Overall Study|Physician Decision|1
4783537|NCT01456052|16498473|P3|Overall Study|Protocol Violation|0
4783538|NCT01456052|16498474|P2|Overall Study|Protocol Violation|1
4783539|NCT01456052|16498475|P1|Overall Study|Protocol Violation|0
4783540|NCT01456052|16498473|P3|Overall Study|Consent withdrawn|1
4783541|NCT01456052|16498474|P2|Overall Study|Consent withdrawn|2
4783542|NCT01456052|16498475|P1|Overall Study|Consent withdrawn|0
4783543|NCT01456052|16498473|P3|Overall Study|Adverse Event|2
4783544|NCT01456052|16498474|P2|Overall Study|Adverse Event|1
4783545|NCT01456052|16498475|P1|Overall Study|Adverse Event|1
4783546|NCT01456039|16498495|P3|Phase 2 (Second Step)|Other|1
4783547|NCT01456039|16498496|P2|Phase 2 (Second Step)|Other|0
4783548|NCT01456039|16498497|P1|Phase 2 (Second Step)|Other|0
4783549|NCT01456039|16498495|P3|Phase 2 (Second Step)|Protocol Violation|1
4783550|NCT01456039|16498496|P2|Phase 2 (Second Step)|Protocol Violation|0
4783551|NCT01456039|16498497|P1|Phase 2 (Second Step)|Protocol Violation|0
4783552|NCT01456039|16498495|P3|Phase 2 (Second Step)|Withdrawal by Subject|4
4783553|NCT01456039|16498496|P2|Phase 2 (Second Step)|Withdrawal by Subject|0
4783554|NCT01456039|16498497|P1|Phase 2 (Second Step)|Withdrawal by Subject|0
4783555|NCT01456039|16498495|P3|Phase 2 (Second Step)|Adverse Event|10
4783556|NCT01456039|16498496|P2|Phase 2 (Second Step)|Adverse Event|0
4783557|NCT01456039|16498497|P1|Phase 2 (Second Step)|Adverse Event|0
4783558|NCT01456039|16498495|P3|Phase 2 (Second Step)|Disease Progression|17
4783559|NCT01456039|16498496|P2|Phase 2 (Second Step)|Disease Progression|0
4783560|NCT01456039|16498497|P1|Phase 2 (Second Step)|Disease Progression|0
4783561|NCT01456039|16498495|P3|Phase 1 (First Step)|Other|0
4783562|NCT01456039|16498496|P2|Phase 1 (First Step)|Other|1
4783563|NCT01456039|16498497|P1|Phase 1 (First Step)|Other|0
4783564|NCT01456039|16498495|P3|Phase 1 (First Step)|Adverse Event|0
4783565|NCT01456039|16498496|P2|Phase 1 (First Step)|Adverse Event|3
4783566|NCT01456039|16498497|P1|Phase 1 (First Step)|Adverse Event|0
4783567|NCT01456039|16498495|P3|Phase 1 (First Step)|Withdrawal by Subject|0
4783568|NCT01456039|16498496|P2|Phase 1 (First Step)|Withdrawal by Subject|2
4783569|NCT01456039|16498497|P1|Phase 1 (First Step)|Withdrawal by Subject|1
4783570|NCT01456039|16498495|P3|Phase 1 (First Step)|Disease Progression|0
4783571|NCT01456039|16498496|P2|Phase 1 (First Step)|Disease Progression|1
4783572|NCT01456039|16498497|P1|Phase 1 (First Step)|Disease Progression|1
4783573|NCT01455428|16498640|P2|Overall Study|Other|4
4783574|NCT01455428|16498641|P1|Overall Study|Other|2
4783575|NCT01455428|16498640|P2|Overall Study|Did not receive treatment|1
4783576|NCT01455428|16498641|P1|Overall Study|Did not receive treatment|1
4783577|NCT01455428|16498640|P2|Overall Study|Insufficient clinical response|2
4783578|NCT01455428|16498641|P1|Overall Study|Insufficient clinical response|0
4783579|NCT01455428|16498640|P2|Overall Study|Did not meet entrance criteria|2
4783580|NCT01455428|16498641|P1|Overall Study|Did not meet entrance criteria|0
4783581|NCT01455428|16498640|P2|Overall Study|Withdrawal by Subject|5
4783582|NCT01455428|16498641|P1|Overall Study|Withdrawal by Subject|2
4783583|NCT01455428|16498640|P2|Overall Study|Lost to Follow-up|1
4783584|NCT01455428|16498641|P1|Overall Study|Lost to Follow-up|1
4783585|NCT01455428|16498640|P2|Overall Study|Adverse Event|2
4783586|NCT01455428|16498641|P1|Overall Study|Adverse Event|6
4783587|NCT01455428|16498640|P2|Overall Study|Protocol Violation|1
4783588|NCT01455428|16498641|P1|Overall Study|Protocol Violation|2
4783589|NCT01455415|16498697|P2|Follow-up|Unspecified Reason|0
4783590|NCT01455415|16498698|P1|Follow-up|Unspecified Reason|1
4783591|NCT01455415|16498697|P2|Follow-up|Withdrawal by Subject|0
4783592|NCT01455415|16498698|P1|Follow-up|Withdrawal by Subject|2
4783593|NCT01455415|16498697|P2|Follow-up|Lack of Efficacy|1
4783594|NCT01455415|16498698|P1|Follow-up|Lack of Efficacy|0
4783595|NCT01455415|16498697|P2|Follow-up|AE Related to Study Drug|1
4783596|NCT01455415|16498698|P1|Follow-up|AE Related to Study Drug|0
4783597|NCT01455415|16498697|P2|Period 2|Protocol Violation|0
4783598|NCT01455415|16498698|P1|Period 2|Protocol Violation|2
4783599|NCT01455415|16498697|P2|Period 2|Unspecified Reason|3
4783600|NCT01455415|16498698|P1|Period 2|Unspecified Reason|2
4783601|NCT01455415|16498697|P2|Period 2|Withdrawal by Subject|3
4783602|NCT01455415|16498698|P1|Period 2|Withdrawal by Subject|2
4783603|NCT01455415|16498697|P2|Period 2|Lack of Efficacy|0
4783604|NCT01455415|16498698|P1|Period 2|Lack of Efficacy|2
4783605|NCT01455415|16498697|P2|Period 2|AE Not Related to Study Drug|1
4783606|NCT01455415|16498698|P1|Period 2|AE Not Related to Study Drug|2
4783607|NCT01455415|16498697|P2|Period 2|Lost to Follow-up|1
4783608|NCT01455415|16498698|P1|Period 2|Lost to Follow-up|2
4783609|NCT01455415|16498697|P2|Period 2|AE Related to Study Drug|2
4783610|NCT01455415|16498698|P1|Period 2|AE Related to Study Drug|1
4783611|NCT01455415|16498697|P2|Washout|Protocol Violation|1
4783612|NCT01455415|16498698|P1|Washout|Protocol Violation|0
4783613|NCT01455415|16498697|P2|Washout|Unspecified Reason|2
4783614|NCT01455415|16498698|P1|Washout|Unspecified Reason|1
4783615|NCT01455415|16498697|P2|Washout|AE Not Related to Study Drug|3
4783616|NCT01455415|16498698|P1|Washout|AE Not Related to Study Drug|2
4783617|NCT01455415|16498697|P2|Washout|Drug Error not Associated to AE|1
4783618|NCT01455415|16498698|P1|Washout|Drug Error not Associated to AE|2
4783619|NCT01455415|16498697|P2|Washout|Lost to Follow-up|0
4783620|NCT01455415|16498698|P1|Washout|Lost to Follow-up|1
4783621|NCT01455415|16498697|P2|Washout|AE Related to Study Drug|0
4783622|NCT01455415|16498698|P1|Washout|AE Related to Study Drug|2
4783623|NCT01455415|16498697|P2|Period 1|Protocol Violation|2
4783624|NCT01455415|16498698|P1|Period 1|Protocol Violation|0
4783625|NCT01455415|16498697|P2|Period 1|Unspecified Reason|1
4783626|NCT01455415|16498698|P1|Period 1|Unspecified Reason|1
4783627|NCT01455415|16498697|P2|Period 1|Withdrawal by Subject|5
4783628|NCT01455415|16498698|P1|Period 1|Withdrawal by Subject|4
4783629|NCT01455415|16498697|P2|Period 1|AE Not Related to Study Drug|6
4783630|NCT01455415|16498698|P1|Period 1|AE Not Related to Study Drug|2
4783631|NCT01455415|16498697|P2|Period 1|Drug Error not Associated to AE|1
4783632|NCT01455415|16498698|P1|Period 1|Drug Error not Associated to AE|0
4783633|NCT01455415|16498697|P2|Period 1|Lost To Follow-up Related to Study Drug|3
4783634|NCT01455415|16498698|P1|Period 1|Lost To Follow-up Related to Study Drug|3
4783635|NCT01455415|16498697|P2|Period 1|Adverse Event (AE) Related to Study Drug|6
4783636|NCT01455415|16498698|P1|Period 1|Adverse Event (AE) Related to Study Drug|9
4783637|NCT01455220|16498748|P1|Overall Study|screen fail|30
4783638|NCT01455194|16498758|P4|Overall Study|Miscellaneous|4
4783639|NCT01455194|16498759|P3|Overall Study|Miscellaneous|1
4783640|NCT01455194|16498760|P2|Overall Study|Miscellaneous|5
4783641|NCT01455194|16498761|P1|Overall Study|Miscellaneous|4
4783642|NCT01455194|16498758|P4|Overall Study|Discontinuation criterion fulfilled|2
4783643|NCT01455194|16498759|P3|Overall Study|Discontinuation criterion fulfilled|0
4783644|NCT01455194|16498760|P2|Overall Study|Discontinuation criterion fulfilled|2
4783645|NCT01455194|16498761|P1|Overall Study|Discontinuation criterion fulfilled|3
4783646|NCT01455194|16498758|P4|Overall Study|Pregnancy|0
4783647|NCT01455194|16498759|P3|Overall Study|Pregnancy|1
4783648|NCT01455194|16498760|P2|Overall Study|Pregnancy|1
4783649|NCT01455194|16498761|P1|Overall Study|Pregnancy|0
4783650|NCT01455194|16498758|P4|Overall Study|Lost to Follow-up|1
4783651|NCT01455194|16498759|P3|Overall Study|Lost to Follow-up|1
4783652|NCT01455194|16498760|P2|Overall Study|Lost to Follow-up|0
4783653|NCT01455194|16498761|P1|Overall Study|Lost to Follow-up|2
4783654|NCT01455194|16498758|P4|Overall Study|Withdrawal by Subject|9
4783655|NCT01455194|16498759|P3|Overall Study|Withdrawal by Subject|12
4783656|NCT01455194|16498760|P2|Overall Study|Withdrawal by Subject|16
4783657|NCT01455194|16498761|P1|Overall Study|Withdrawal by Subject|21
4783658|NCT01455194|16498758|P4|Overall Study|Adverse Event|3
4783659|NCT01455194|16498759|P3|Overall Study|Adverse Event|1
4783660|NCT01455194|16498760|P2|Overall Study|Adverse Event|1
4783661|NCT01455194|16498761|P1|Overall Study|Adverse Event|1
4783662|NCT01455194|16498758|P4|Overall Study|Deterioration in asthma|9
4783663|NCT01455194|16498759|P3|Overall Study|Deterioration in asthma|14
4783664|NCT01455194|16498760|P2|Overall Study|Deterioration in asthma|6
4783665|NCT01455194|16498761|P1|Overall Study|Deterioration in asthma|12
4783666|NCT01455194|16498758|P4|Overall Study|Randomisation Failure|0
4783667|NCT01455194|16498759|P3|Overall Study|Randomisation Failure|0
4783668|NCT01455194|16498760|P2|Overall Study|Randomisation Failure|0
4783669|NCT01455194|16498761|P1|Overall Study|Randomisation Failure|90
4783670|NCT01455194|16498758|P4|Overall Study|Screen Failure|0
4783671|NCT01455194|16498759|P3|Overall Study|Screen Failure|0
4783672|NCT01455194|16498760|P2|Overall Study|Screen Failure|0
4783673|NCT01455194|16498761|P1|Overall Study|Screen Failure|20
4783674|NCT01455012|16498824|P2|Overall Study|Unknown reason|0
4783675|NCT01455012|16498825|P1|Overall Study|Unknown reason|2
4783676|NCT01455012|16498824|P2|Overall Study|Withdrawal by Subject|1
4783677|NCT01455012|16498825|P1|Overall Study|Withdrawal by Subject|3
4783678|NCT01455012|16498824|P2|Overall Study|Lack of Efficacy|1
4783679|NCT01455012|16498825|P1|Overall Study|Lack of Efficacy|6
4783680|NCT01455012|16498824|P2|Overall Study|Adverse Event|2
4783681|NCT01455012|16498825|P1|Overall Study|Adverse Event|0
4783682|NCT01454934|16498892|P2|Overall Study|Not treated|2
4783683|NCT01454934|16498893|P1|Overall Study|Not treated|1
4783684|NCT01454934|16498892|P2|Overall Study|Lost to Follow-up|1
4783685|NCT01454934|16498893|P1|Overall Study|Lost to Follow-up|0
4783686|NCT01454934|16498892|P2|Overall Study|Disease progression|181
4783687|NCT01454934|16498893|P1|Overall Study|Disease progression|194
4783688|NCT01454934|16498892|P2|Overall Study|Withdrawal by Subject|15
4783689|NCT01454934|16498893|P1|Overall Study|Withdrawal by Subject|11
4783690|NCT01454934|16498892|P2|Overall Study|Withdrawn consent|5
4783691|NCT01454934|16498893|P1|Overall Study|Withdrawn consent|2
4783692|NCT01454934|16498892|P2|Overall Study|Adverse Event|24
4783693|NCT01454934|16498893|P1|Overall Study|Adverse Event|28
4783694|NCT01454934|16498892|P2|Overall Study|Other|17
4783695|NCT01454934|16498893|P1|Overall Study|Other|6
4783696|NCT01454934|16498892|P2|Overall Study|Clinical progression|25
4783697|NCT01454934|16498893|P1|Overall Study|Clinical progression|28
4783698|NCT01454830|16498905|P2|Overall Study|Withdrawal - no polysomnography|2
4783699|NCT01454830|16498906|P1|Overall Study|Withdrawal - no polysomnography|3
4783700|NCT01454830|16498905|P2|Overall Study|Post-allocation Exclude-other treatment|7
4783701|NCT01454830|16498906|P1|Overall Study|Post-allocation Exclude-other treatment|6
4783702|NCT01454830|16498905|P2|Overall Study|Post-allocation Exclude-refused PAP|2
4783703|NCT01454830|16498906|P1|Overall Study|Post-allocation Exclude-refused PAP|0
4783704|NCT01454830|16498905|P2|Overall Study|Post-allocation Exclude- AHI<10|12
4783705|NCT01454830|16498906|P1|Overall Study|Post-allocation Exclude- AHI<10|18
4783706|NCT01454830|16498905|P2|Overall Study|Withdrawal by Subject|4
4783707|NCT01454830|16498906|P1|Overall Study|Withdrawal by Subject|4
4783708|NCT01454778|16498937|P1|Overall Study|Death|1
4783709|NCT01454778|16498937|P1|Overall Study|Lost to Follow-up|2
4783710|NCT01454739|16498948|P2|Overall Study|Adverse Event|1
4783711|NCT01454739|16498949|P1|Overall Study|Adverse Event|0
4783712|NCT01454739|16498948|P2|Overall Study|Lost to Follow-up|1
4783713|NCT01454739|16498949|P1|Overall Study|Lost to Follow-up|0
4783714|NCT01454739|16498948|P2|Overall Study|Physician Decision|5
4783715|NCT01454739|16498949|P1|Overall Study|Physician Decision|0
4783716|NCT01454739|16498948|P2|Overall Study|Other|5
4783717|NCT01454739|16498949|P1|Overall Study|Other|3
4783718|NCT01454739|16498948|P2|Overall Study|Withdrawal by Subject|6
4783719|NCT01454739|16498949|P1|Overall Study|Withdrawal by Subject|2
4783720|NCT01454739|16498948|P2|Overall Study|Protocol Violation|3
4783721|NCT01454739|16498949|P1|Overall Study|Protocol Violation|2
4783722|NCT01454726|16498978|P2|Overall Study|Withdrawal by Subject|1
4783723|NCT01454726|16498979|P1|Overall Study|Withdrawal by Subject|0
4783724|NCT01454596|16498997|P12|Overall Study|Death|0
4783725|NCT01454596|16498998|P11|Overall Study|Death|1
4783726|NCT01454596|16498999|P10|Overall Study|Death|1
4783727|NCT01454596|16499000|P9|Overall Study|Death|0
4783728|NCT01454596|16499001|P8|Overall Study|Death|0
4783729|NCT01454596|16499002|P7|Overall Study|Death|0
4783730|NCT01454596|16499003|P6|Overall Study|Death|0
4783731|NCT01454596|16499004|P5|Overall Study|Death|0
4783732|NCT01454596|16499005|P4|Overall Study|Death|0
4783733|NCT01454596|16499006|P3|Overall Study|Death|0
4783734|NCT01454596|16499007|P2|Overall Study|Death|0
4783735|NCT01454596|16499008|P1|Overall Study|Death|0
4783736|NCT01454583|16499085|P3|3rd Year|Lost to Follow-up|297
4783737|NCT01454583|16499086|P2|3rd Year|Lost to Follow-up|512
4783738|NCT01454583|16499087|P1|3rd Year|Lost to Follow-up|1959
4783739|NCT01454583|16499085|P3|2nd Year|Lost to Follow-up|737
4783740|NCT01454583|16499086|P2|2nd Year|Lost to Follow-up|1049
4783741|NCT01454583|16499087|P1|2nd Year|Lost to Follow-up|3965
4783742|NCT01454583|16499085|P3|1st Year|Lost to Follow-up|180
4783743|NCT01454583|16499086|P2|1st Year|Lost to Follow-up|318
4783744|NCT01454583|16499087|P1|1st Year|Lost to Follow-up|1057
4783745|NCT01454570|16499155|P1|Overall Study|Screen Failure|7
4783746|NCT01454570|16499155|P1|Overall Study|Withdrawal by Subject|2
4783747|NCT01454531|16499159|P1|Overall Study|Other|1
4783748|NCT01454531|16499159|P1|Overall Study|Delay in IMP administration|1
4783749|NCT01454531|16499159|P1|Overall Study|Physician Decision|1
4783750|NCT01454531|16499159|P1|Overall Study|Lost to Follow-up|1
4783751|NCT01454531|16499159|P1|Overall Study|Withdrawal by Subject|5
4783752|NCT01454531|16499159|P1|Overall Study|Adverse Event|14
4783753|NCT01454401|16499195|P1|Overall Study|non-adherence|1
4783754|NCT01454401|16499195|P1|Overall Study|osteomyelitis|2
4783755|NCT01454401|16499195|P1|Overall Study|hospitalised|1
4783756|NCT01454401|16499195|P1|Overall Study|Death|1
4783757|NCT01454284|16499219|P2|Overall Study|Sponsor Decision|2
4783758|NCT01454284|16499220|P1|Overall Study|Sponsor Decision|0
4783759|NCT01454284|16499219|P2|Overall Study|Physician Decision|11
4783760|NCT01454284|16499220|P1|Overall Study|Physician Decision|16
4783761|NCT01454284|16499219|P2|Overall Study|Withdrawal by Subject|36
4783762|NCT01454284|16499220|P1|Overall Study|Withdrawal by Subject|58
4783763|NCT01454284|16499219|P2|Overall Study|Protocol Violation|6
4783764|NCT01454284|16499220|P1|Overall Study|Protocol Violation|9
4783765|NCT01454284|16499219|P2|Overall Study|Lost to Follow-up|8
4783766|NCT01454284|16499220|P1|Overall Study|Lost to Follow-up|13
4783767|NCT01454284|16499219|P2|Overall Study|Death|3
4783768|NCT01454284|16499220|P1|Overall Study|Death|0
4783769|NCT01454284|16499219|P2|Overall Study|Adverse Event|7
4783770|NCT01454284|16499220|P1|Overall Study|Adverse Event|20
4783771|NCT01454102|16499290|P16|Overall Study|Continuing in the treatment period|1
4783772|NCT01454102|16499291|P15|Overall Study|Continuing in the treatment period|3
4783773|NCT01454102|16499292|P14|Overall Study|Continuing in the treatment period|4
4783774|NCT01454102|16499293|P13|Overall Study|Continuing in the treatment period|7
4783775|NCT01454102|16499294|P12|Overall Study|Continuing in the treatment period|4
4783776|NCT01454102|16499295|P11|Overall Study|Continuing in the treatment period|0
4783777|NCT01454102|16499296|P10|Overall Study|Continuing in the treatment period|0
4783778|NCT01454102|16499297|P9|Overall Study|Continuing in the treatment period|1
4783779|NCT01454102|16499298|P8|Overall Study|Continuing in the treatment period|0
4783780|NCT01454102|16499299|P7|Overall Study|Continuing in the treatment period|2
4783781|NCT01454102|16499300|P6|Overall Study|Continuing in the treatment period|3
4783782|NCT01454102|16499301|P5|Overall Study|Continuing in the treatment period|3
4783783|NCT01454102|16499302|P4|Overall Study|Continuing in the treatment period|0
4783784|NCT01454102|16499303|P3|Overall Study|Continuing in the treatment period|0
4783785|NCT01454102|16499304|P2|Overall Study|Continuing in the treatment period|0
4783786|NCT01454102|16499305|P1|Overall Study|Continuing in the treatment period|0
4783787|NCT01454076|16499425|P5|Overall Study|Adverse Event|2
4783788|NCT01454076|16499426|P4|Overall Study|Adverse Event|0
4783789|NCT01454076|16499427|P3|Overall Study|Adverse Event|7
4783790|NCT01454076|16499428|P2|Overall Study|Adverse Event|2
4783791|NCT01454076|16499429|P1|Overall Study|Adverse Event|8
4783792|NCT01454076|16499425|P5|Overall Study|Withdrawal by Subject|2
4783793|NCT01454076|16499426|P4|Overall Study|Withdrawal by Subject|1
4783794|NCT01454076|16499427|P3|Overall Study|Withdrawal by Subject|2
4783795|NCT01454076|16499428|P2|Overall Study|Withdrawal by Subject|4
4783796|NCT01454076|16499429|P1|Overall Study|Withdrawal by Subject|3
4783797|NCT01454076|16499425|P5|Overall Study|Other|2
4783798|NCT01454076|16499426|P4|Overall Study|Other|1
4783799|NCT01454076|16499427|P3|Overall Study|Other|0
4783800|NCT01454076|16499428|P2|Overall Study|Other|0
4783801|NCT01454076|16499429|P1|Overall Study|Other|2
4783802|NCT01454063|16499482|P2|Randomized|Protocol Violation|1
4783803|NCT01454063|16499483|P1|Randomized|Protocol Violation|0
4783804|NCT01454063|16499482|P2|Randomized|Adverse Event|1
4783805|NCT01454063|16499483|P1|Randomized|Adverse Event|1
4783806|NCT01453998|16499504|P3|After Protocol Amendment 2.|Withdrawal by Subject|0
4783807|NCT01453998|16499505|P2|After Protocol Amendment 2.|Withdrawal by Subject|0
4783808|NCT01453998|16499506|P1|After Protocol Amendment 2.|Withdrawal by Subject|1
4783809|NCT01453946|16499670|P1|Overall Study|Adverse Event|3
4783810|NCT01453946|16499670|P1|Overall Study|Lack of Efficacy|3
4783811|NCT01453946|16499670|P1|Overall Study|Protocol Violation|2
4783812|NCT01453946|16499670|P1|Overall Study|Did not receive drug for the taper phase|1
4783813|NCT01453855|16499687|P2|Overall Study|Other|1
4783814|NCT01453855|16499688|P1|Overall Study|Other|0
4783815|NCT01453855|16499687|P2|Overall Study|Inadequate Control of IOP|5
4783816|NCT01453855|16499688|P1|Overall Study|Inadequate Control of IOP|1
4783817|NCT01453855|16499687|P2|Overall Study|Noncompliance|0
4783818|NCT01453855|16499688|P1|Overall Study|Noncompliance|1
4783819|NCT01453855|16499687|P2|Overall Study|Patient Decision Unrel to Adverse Event|3
4783820|NCT01453855|16499688|P1|Overall Study|Patient Decision Unrel to Adverse Event|3
4783821|NCT01453855|16499687|P2|Overall Study|Lost to Follow-up|1
4783822|NCT01453855|16499688|P1|Overall Study|Lost to Follow-up|2
4783823|NCT01453855|16499687|P2|Overall Study|Adverse Event|4
4783824|NCT01453855|16499688|P1|Overall Study|Adverse Event|3
4783825|NCT01453725|16499696|P2|Overall Study|Physician Decision|1
4783826|NCT01453725|16499697|P1|Overall Study|Physician Decision|1
4783827|NCT01453725|16499696|P2|Overall Study|Pregnancy|0
4783828|NCT01453725|16499697|P1|Overall Study|Pregnancy|1
4783829|NCT01453725|16499696|P2|Overall Study|Pregnancy Wish|2
4783830|NCT01453725|16499697|P1|Overall Study|Pregnancy Wish|0
4783831|NCT01453725|16499696|P2|Overall Study|Withdrawal by Subject|3
4783832|NCT01453725|16499697|P1|Overall Study|Withdrawal by Subject|2
4783833|NCT01453725|16499696|P2|Overall Study|Protocol Violation|0
4783834|NCT01453725|16499697|P1|Overall Study|Protocol Violation|1
4783835|NCT01453725|16499696|P2|Overall Study|Non-compliance With Protocol|2
4783836|NCT01453725|16499697|P1|Overall Study|Non-compliance With Protocol|1
4783837|NCT01453725|16499696|P2|Overall Study|Lost to Follow-up|0
4783838|NCT01453725|16499697|P1|Overall Study|Lost to Follow-up|4
4783839|NCT01453725|16499696|P2|Overall Study|Adverse Event|3
4783840|NCT01453725|16499697|P1|Overall Study|Adverse Event|3
4783841|NCT01453595|16499720|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
4783842|NCT01453595|16499721|P2|Overall Study|Dose Limiting Toxicity (DLT)|1
4783843|NCT01453595|16499722|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
4783844|NCT01453439|16499752|P2|Follow-up|Lost to Follow-up|10
4783845|NCT01453439|16499753|P1|Follow-up|Lost to Follow-up|5
4783846|NCT01453439|16499752|P2|Follow-up|Withdrawal by Subject|1
4783847|NCT01453439|16499753|P1|Follow-up|Withdrawal by Subject|0
4783848|NCT01453439|16499752|P2|Treatment Phase|Therapist conflict of interest|0
4783849|NCT01453439|16499753|P1|Treatment Phase|Therapist conflict of interest|1
4783850|NCT01453439|16499752|P2|Treatment Phase|Need for higher level of care|1
4783851|NCT01453439|16499753|P1|Treatment Phase|Need for higher level of care|1
4783852|NCT01453439|16499752|P2|Treatment Phase|Suicidal Ideation|0
4783853|NCT01453439|16499753|P1|Treatment Phase|Suicidal Ideation|2
4783854|NCT01453439|16499752|P2|Treatment Phase|Withdrawal by Subject|10
4783855|NCT01453439|16499753|P1|Treatment Phase|Withdrawal by Subject|13
4783856|NCT01453374|16499864|P1|Overall Study|Incarcerated|2
4783857|NCT01453374|16499864|P1|Overall Study|Withdrawal by Subject|5
4783858|NCT01453374|16499864|P1|Overall Study|Lost to Follow-up|3
4783859|NCT01453374|16499864|P1|Overall Study|Lack of Efficacy|1
4783860|NCT01453374|16499864|P1|Overall Study|Adverse Event|7
4783861|NCT01453361|16499880|P1|Overall Study|Screen-Failures|10
4783862|NCT01453361|16499880|P1|Overall Study|Disease Progression|6
4783863|NCT01453348|16499888|P3|Overall Study|Protocol Violation|0
4783864|NCT01453348|16499889|P2|Overall Study|Protocol Violation|0
4783865|NCT01453348|16499890|P1|Overall Study|Protocol Violation|1
4783866|NCT01453348|16499888|P3|Overall Study|Withdrawal by Subject|0
4783867|NCT01453348|16499889|P2|Overall Study|Withdrawal by Subject|1
4783868|NCT01453348|16499890|P1|Overall Study|Withdrawal by Subject|0
4783869|NCT01453348|16499888|P3|Overall Study|Death|1
4783870|NCT01453348|16499889|P2|Overall Study|Death|0
4783871|NCT01453348|16499890|P1|Overall Study|Death|0
4783872|NCT01453296|16499906|P2|Treatment Period 2|Withdrawal by Subject|0
4783873|NCT01453296|16499907|P1|Treatment Period 2|Withdrawal by Subject|1
4783874|NCT01453296|16499906|P2|Treatment Period 2|Adverse Event|0
4783875|NCT01453296|16499907|P1|Treatment Period 2|Adverse Event|1
4783876|NCT01453296|16499906|P2|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0
4783877|NCT01453296|16499907|P1|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1
4783878|NCT01453296|16499906|P2|Treatment Period 1|Adverse Event|1
4783879|NCT01453296|16499907|P1|Treatment Period 1|Adverse Event|0
4783880|NCT01453205|16499974|P3|Overall Study|Other|35
4783881|NCT01453205|16499975|P2|Overall Study|Other|27
4783882|NCT01453205|16499976|P1|Overall Study|Other|45
4783883|NCT01453205|16499974|P3|Overall Study|Death|18
4783884|NCT01453205|16499975|P2|Overall Study|Death|22
4783885|NCT01453205|16499976|P1|Overall Study|Death|24
4783886|NCT01453205|16499974|P3|Overall Study|Withdrawal by Subject|0
4783887|NCT01453205|16499975|P2|Overall Study|Withdrawal by Subject|3
4783888|NCT01453205|16499976|P1|Overall Study|Withdrawal by Subject|8
4783889|NCT01453205|16499974|P3|Overall Study|Lost to Follow-up|1
4783890|NCT01453205|16499975|P2|Overall Study|Lost to Follow-up|0
4783891|NCT01453205|16499976|P1|Overall Study|Lost to Follow-up|3
4783892|NCT01453153|16500052|P3|Overall Study|Adverse Event|1
4783893|NCT01453153|16500053|P2|Overall Study|Adverse Event|1
4783894|NCT01453153|16500054|P1|Overall Study|Adverse Event|1
4783895|NCT01453153|16500052|P3|Overall Study|Withdrawal by Subject|2
4783896|NCT01453153|16500053|P2|Overall Study|Withdrawal by Subject|1
4783897|NCT01453153|16500054|P1|Overall Study|Withdrawal by Subject|0
4783898|NCT01453153|16500052|P3|Overall Study|Progressive Disease|16
4783899|NCT01453153|16500053|P2|Overall Study|Progressive Disease|2
4783900|NCT01453153|16500054|P1|Overall Study|Progressive Disease|3
4783901|NCT01453153|16500052|P3|Overall Study|Physician Decision|1
4783902|NCT01453153|16500053|P2|Overall Study|Physician Decision|0
4783903|NCT01453153|16500054|P1|Overall Study|Physician Decision|0
4783904|NCT01453049|16500136|P2|Overall Study|Randomized in Error|0
4783905|NCT01453049|16500137|P1|Overall Study|Randomized in Error|1
4783906|NCT01453049|16500136|P2|Overall Study|Withdrawal by Subject|0
4783907|NCT01453049|16500137|P1|Overall Study|Withdrawal by Subject|1
4783908|NCT01453049|16500136|P2|Overall Study|Withdrawn When Sponsor Terminated Study|36
4783909|NCT01453049|16500137|P1|Overall Study|Withdrawn When Sponsor Terminated Study|35
4783910|NCT01453049|16500136|P2|Overall Study|Lost to Follow-up|1
4783911|NCT01453049|16500137|P1|Overall Study|Lost to Follow-up|2
4783912|NCT01453049|16500136|P2|Overall Study|Protocol Violation|5
4783913|NCT01453049|16500137|P1|Overall Study|Protocol Violation|2
4783914|NCT01453036|16500210|P3|Overall Study|Lost to Follow-up|31
4783915|NCT01453036|16500211|P2|Overall Study|Lost to Follow-up|115
4783916|NCT01453036|16500212|P1|Overall Study|Lost to Follow-up|26
4783917|NCT01453023|16500220|P2|Treatment Period 2|Protocol Violation|1
4783918|NCT01453023|16500221|P1|Treatment Period 2|Protocol Violation|0
4783919|NCT01453023|16500220|P2|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1
4783920|NCT01453023|16500221|P1|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0
4783921|NCT01453023|16500220|P2|Treatment Period (TP) 1|Protocol Violation|0
4783922|NCT01453023|16500221|P1|Treatment Period (TP) 1|Protocol Violation|1
4783923|NCT01452789|16500295|P2|Overall Study|Withdrawal by Subject|2
4783924|NCT01452789|16500296|P1|Overall Study|Withdrawal by Subject|3
4783925|NCT01452529|16500310|P3|Double-blind (DB) Period|Administrative|7
4783926|NCT01452529|16500311|P2|Double-blind (DB) Period|Administrative|11
4783927|NCT01452529|16500312|P1|Double-blind (DB) Period|Administrative|0
4783928|NCT01452529|16500310|P3|Double-blind (DB) Period|Confirmed or suspected diversion|3
4783929|NCT01452529|16500311|P2|Double-blind (DB) Period|Confirmed or suspected diversion|2
4783930|NCT01452529|16500312|P1|Double-blind (DB) Period|Confirmed or suspected diversion|0
4783931|NCT01452529|16500310|P3|Double-blind (DB) Period|Lack of Efficacy|44
4783932|NCT01452529|16500311|P2|Double-blind (DB) Period|Lack of Efficacy|16
4783933|NCT01452529|16500312|P1|Double-blind (DB) Period|Lack of Efficacy|0
4783934|NCT01452529|16500310|P3|Double-blind (DB) Period|Lost to Follow-up|3
4783935|NCT01452529|16500311|P2|Double-blind (DB) Period|Lost to Follow-up|5
4783936|NCT01452529|16500312|P1|Double-blind (DB) Period|Lost to Follow-up|0
4783937|NCT01452529|16500310|P3|Double-blind (DB) Period|Withdrawal by Subject|14
4783938|NCT01452529|16500311|P2|Double-blind (DB) Period|Withdrawal by Subject|15
4783939|NCT01452529|16500312|P1|Double-blind (DB) Period|Withdrawal by Subject|0
4783940|NCT01452529|16500310|P3|Double-blind (DB) Period|Adverse Event|11
4783941|NCT01452529|16500311|P2|Double-blind (DB) Period|Adverse Event|18
4783942|NCT01452529|16500312|P1|Double-blind (DB) Period|Adverse Event|0
4783943|NCT01452529|16500310|P3|Run-in Period|Did not qualify for Double-Blind Phase|0
4783944|NCT01452529|16500311|P2|Run-in Period|Did not qualify for Double-Blind Phase|0
4783945|NCT01452529|16500312|P1|Run-in Period|Did not qualify for Double-Blind Phase|59
4783946|NCT01452529|16500310|P3|Run-in Period|Administrative|0
4783947|NCT01452529|16500311|P2|Run-in Period|Administrative|0
4783948|NCT01452529|16500312|P1|Run-in Period|Administrative|21
4783949|NCT01452529|16500310|P3|Run-in Period|Confirmed or suspected diversion|0
4783950|NCT01452529|16500311|P2|Run-in Period|Confirmed or suspected diversion|0
4783951|NCT01452529|16500312|P1|Run-in Period|Confirmed or suspected diversion|23
4783952|NCT01452529|16500310|P3|Run-in Period|Lack of Efficacy|0
4783953|NCT01452529|16500311|P2|Run-in Period|Lack of Efficacy|0
4783954|NCT01452529|16500312|P1|Run-in Period|Lack of Efficacy|46
4783955|NCT01452529|16500310|P3|Run-in Period|Lost to Follow-up|0
4783956|NCT01452529|16500311|P2|Run-in Period|Lost to Follow-up|0
4783957|NCT01452529|16500312|P1|Run-in Period|Lost to Follow-up|19
4783958|NCT01452529|16500310|P3|Run-in Period|Withdrawal by Subject|0
4783959|NCT01452529|16500311|P2|Run-in Period|Withdrawal by Subject|0
4783960|NCT01452529|16500312|P1|Run-in Period|Withdrawal by Subject|49
4783961|NCT01452529|16500310|P3|Run-in Period|Adverse Event|0
4783962|NCT01452529|16500311|P2|Run-in Period|Adverse Event|0
4783963|NCT01452529|16500312|P1|Run-in Period|Adverse Event|96
4783964|NCT01452412|16500334|P2|Overall Study|Other|0
4783965|NCT01452412|16500335|P1|Overall Study|Other|2
4783966|NCT01452412|16500334|P2|Overall Study|Initiated dialysis|0
4783967|NCT01452412|16500335|P1|Overall Study|Initiated dialysis|1
4783968|NCT01452412|16500334|P2|Overall Study|Death|0
4783969|NCT01452412|16500335|P1|Overall Study|Death|1
4783970|NCT01452412|16500334|P2|Overall Study|Lost to Follow-up|3
4783971|NCT01452412|16500335|P1|Overall Study|Lost to Follow-up|5
4783972|NCT01452412|16500334|P2|Overall Study|Adverse Event|3
4783973|NCT01452412|16500335|P1|Overall Study|Adverse Event|4
4783974|NCT01452412|16500334|P2|Overall Study|Withdrawal by Subject|11
4783975|NCT01452412|16500335|P1|Overall Study|Withdrawal by Subject|15
4783976|NCT01452347|16500351|P2|Overall Study|Other reason not defined above|0
4783977|NCT01452347|16500352|P1|Overall Study|Other reason not defined above|2
4783978|NCT01452347|16500351|P2|Overall Study|Not treated|3
4783979|NCT01452347|16500352|P1|Overall Study|Not treated|6
4783980|NCT01452347|16500351|P2|Overall Study|Withdrawal by Subject|3
4783981|NCT01452347|16500352|P1|Overall Study|Withdrawal by Subject|3
4783982|NCT01452347|16500351|P2|Overall Study|Lost to Follow-up|0
4783983|NCT01452347|16500352|P1|Overall Study|Lost to Follow-up|2
4783984|NCT01452347|16500351|P2|Overall Study|Non compliance protocol|0
4783985|NCT01452347|16500352|P1|Overall Study|Non compliance protocol|2
4783986|NCT01452347|16500351|P2|Overall Study|Adverse Event|1
4783987|NCT01452347|16500352|P1|Overall Study|Adverse Event|2
4783988|NCT01452152|16500412|P3|Overall Study|Study termination by sponsor|4
4783989|NCT01452152|16500413|P2|Overall Study|Study termination by sponsor|0
4783990|NCT01452152|16500414|P1|Overall Study|Study termination by sponsor|5
4783991|NCT01451931|16500486|P3|Overall Study|Withdrawal by Subject|22
4783992|NCT01451931|16500487|P2|Overall Study|Withdrawal by Subject|22
4783993|NCT01451931|16500488|P1|Overall Study|Withdrawal by Subject|16
4783994|NCT01451931|16500486|P3|Overall Study|Lost to Follow-up|21
4783995|NCT01451931|16500487|P2|Overall Study|Lost to Follow-up|36
4783996|NCT01451931|16500488|P1|Overall Study|Lost to Follow-up|17
4783997|NCT01451827|16500512|P4|Overall Study|Withdrawal by Subject|1
4783998|NCT01451827|16500513|P3|Overall Study|Withdrawal by Subject|1
4783999|NCT01451827|16500514|P2|Overall Study|Withdrawal by Subject|0
4784000|NCT01451827|16500515|P1|Overall Study|Withdrawal by Subject|0
4784001|NCT01451827|16500512|P4|Overall Study|Participant met withdrawal criteria|0
4784002|NCT01451827|16500513|P3|Overall Study|Participant met withdrawal criteria|0
4784003|NCT01451827|16500514|P2|Overall Study|Participant met withdrawal criteria|2
4784004|NCT01451827|16500515|P1|Overall Study|Participant met withdrawal criteria|0
4784005|NCT01451827|16500512|P4|Overall Study|Lost to Follow-up|2
4784006|NCT01451827|16500513|P3|Overall Study|Lost to Follow-up|0
4784007|NCT01451827|16500514|P2|Overall Study|Lost to Follow-up|3
4784008|NCT01451827|16500515|P1|Overall Study|Lost to Follow-up|0
4784009|NCT01451827|16500512|P4|Overall Study|Protocol deviation|0
4784010|NCT01451827|16500513|P3|Overall Study|Protocol deviation|0
4784011|NCT01451827|16500514|P2|Overall Study|Protocol deviation|0
4784012|NCT01451827|16500515|P1|Overall Study|Protocol deviation|1
4784013|NCT01451827|16500512|P4|Overall Study|Adverse Event|1
4784014|NCT01451827|16500513|P3|Overall Study|Adverse Event|1
4784015|NCT01451827|16500514|P2|Overall Study|Adverse Event|0
4784016|NCT01451827|16500515|P1|Overall Study|Adverse Event|2
4784017|NCT01451814|16500535|P2|Overall Study|Lost to Follow-up|4
4784018|NCT01451814|16500536|P1|Overall Study|Lost to Follow-up|5
4784019|NCT01451814|16500535|P2|Overall Study|Withdrawal by Subject|1
4784020|NCT01451814|16500536|P1|Overall Study|Withdrawal by Subject|1
4784021|NCT01451762|16500568|P3|Overall Study|Lost to Follow-up|6
4784022|NCT01451762|16500569|P2|Overall Study|Lost to Follow-up|6
4784023|NCT01451762|16500570|P1|Overall Study|Lost to Follow-up|3
4784024|NCT01451749|16500580|P2|Overall Study|Withdrawal by Subject|1
4784025|NCT01451749|16500581|P1|Overall Study|Withdrawal by Subject|0
4784026|NCT01451749|16500580|P2|Overall Study|Adverse Event|0
4784027|NCT01451749|16500581|P1|Overall Study|Adverse Event|2
4784028|NCT01451749|16500580|P2|Overall Study|Meet the exclusion criteria,and|1
4784029|NCT01451749|16500581|P1|Overall Study|Meet the exclusion criteria,and|1
4784030|NCT01451749|16500580|P2|Overall Study|Lost to Follow-up|5
4784031|NCT01451749|16500581|P1|Overall Study|Lost to Follow-up|15
4784032|NCT01451749|16500580|P2|Overall Study|Protocol Violation|7
4784033|NCT01451749|16500581|P1|Overall Study|Protocol Violation|14
4784034|NCT01451723|16500593|P2|Overall Study|study halted|5
4784035|NCT01451723|16500594|P1|Overall Study|study halted|6
4784036|NCT01451645|16500604|P2|Overall Study|Lost to Follow-up|3
4784037|NCT01451645|16500605|P1|Overall Study|Lost to Follow-up|4
4784038|NCT01451645|16500604|P2|Overall Study|Withdrawal by Subject|2
4784039|NCT01451645|16500605|P1|Overall Study|Withdrawal by Subject|4
4784040|NCT01451645|16500604|P2|Overall Study|Adverse Event|3
4784041|NCT01451645|16500605|P1|Overall Study|Adverse Event|0
4784042|NCT01451645|16500604|P2|Overall Study|Protocol Violation|0
4784043|NCT01451645|16500605|P1|Overall Study|Protocol Violation|1
4784044|NCT01451606|16500676|P2|Overall Study|Withdrawal by Subject|3
4784045|NCT01451606|16500677|P1|Overall Study|Withdrawal by Subject|4
4784046|NCT01451554|16500687|P2|Overall Study|Withdrawal by Subject|9
4784047|NCT01451554|16500688|P1|Overall Study|Withdrawal by Subject|14
4784048|NCT01451541|16500699|P3|Overall Study|randomization error, noncompliance|8
4784049|NCT01451541|16500700|P2|Overall Study|randomization error, noncompliance|10
4784050|NCT01451541|16500701|P1|Overall Study|randomization error, noncompliance|11
4784051|NCT01451541|16500699|P3|Overall Study|Withdrawal by Subject|6
4784052|NCT01451541|16500700|P2|Overall Study|Withdrawal by Subject|8
4784053|NCT01451541|16500701|P1|Overall Study|Withdrawal by Subject|15
4784054|NCT01451541|16500699|P3|Overall Study|Lost to Follow-up|7
4784055|NCT01451541|16500700|P2|Overall Study|Lost to Follow-up|4
4784056|NCT01451541|16500701|P1|Overall Study|Lost to Follow-up|4
4784057|NCT01451541|16500699|P3|Overall Study|Lack of Efficacy|0
4784058|NCT01451541|16500700|P2|Overall Study|Lack of Efficacy|0
4784059|NCT01451541|16500701|P1|Overall Study|Lack of Efficacy|2
4784060|NCT01451541|16500699|P3|Overall Study|Adverse Event|6
4784061|NCT01451541|16500700|P2|Overall Study|Adverse Event|3
4784062|NCT01451541|16500701|P1|Overall Study|Adverse Event|4
4784063|NCT01451437|16500759|P9|Overall Study|Withdrawal by Subject|0
4784064|NCT01451437|16500760|P8|Overall Study|Withdrawal by Subject|0
4784065|NCT01451437|16500761|P7|Overall Study|Withdrawal by Subject|1
4784066|NCT01451437|16500762|P6|Overall Study|Withdrawal by Subject|0
4784067|NCT01451437|16500763|P5|Overall Study|Withdrawal by Subject|1
4784068|NCT01451437|16500764|P4|Overall Study|Withdrawal by Subject|0
4784069|NCT01451437|16500765|P3|Overall Study|Withdrawal by Subject|0
4784070|NCT01451437|16500766|P2|Overall Study|Withdrawal by Subject|0
4784071|NCT01451437|16500767|P1|Overall Study|Withdrawal by Subject|0
4784072|NCT01451437|16500759|P9|Overall Study|Protocol Violation|0
4784073|NCT01451437|16500760|P8|Overall Study|Protocol Violation|0
4784074|NCT01451437|16500761|P7|Overall Study|Protocol Violation|1
4784075|NCT01451437|16500762|P6|Overall Study|Protocol Violation|0
4784076|NCT01451437|16500763|P5|Overall Study|Protocol Violation|0
4784077|NCT01451437|16500764|P4|Overall Study|Protocol Violation|0
4784078|NCT01451437|16500765|P3|Overall Study|Protocol Violation|0
4784079|NCT01451437|16500766|P2|Overall Study|Protocol Violation|0
4784080|NCT01451437|16500767|P1|Overall Study|Protocol Violation|0
4784081|NCT01451437|16500759|P9|Overall Study|Disease Progression|3
4784082|NCT01451437|16500760|P8|Overall Study|Disease Progression|1
4784083|NCT01451437|16500761|P7|Overall Study|Disease Progression|3
4784084|NCT01451437|16500762|P6|Overall Study|Disease Progression|2
4784085|NCT01451437|16500763|P5|Overall Study|Disease Progression|3
4784086|NCT01451437|16500764|P4|Overall Study|Disease Progression|1
4784087|NCT01451437|16500765|P3|Overall Study|Disease Progression|1
4784088|NCT01451437|16500766|P2|Overall Study|Disease Progression|0
4784089|NCT01451437|16500767|P1|Overall Study|Disease Progression|0
4784090|NCT01451437|16500759|P9|Overall Study|Physician Decision|0
4784091|NCT01451437|16500760|P8|Overall Study|Physician Decision|0
4784092|NCT01451437|16500761|P7|Overall Study|Physician Decision|0
4784093|NCT01451437|16500762|P6|Overall Study|Physician Decision|0
4784094|NCT01451437|16500763|P5|Overall Study|Physician Decision|0
4784095|NCT01451437|16500764|P4|Overall Study|Physician Decision|0
4784096|NCT01451437|16500765|P3|Overall Study|Physician Decision|2
4784097|NCT01451437|16500766|P2|Overall Study|Physician Decision|1
4784098|NCT01451437|16500767|P1|Overall Study|Physician Decision|1
4784099|NCT01451437|16500759|P9|Overall Study|Adverse Event|1
4784100|NCT01451437|16500760|P8|Overall Study|Adverse Event|2
4784101|NCT01451437|16500761|P7|Overall Study|Adverse Event|1
4784102|NCT01451437|16500762|P6|Overall Study|Adverse Event|1
4784103|NCT01451437|16500763|P5|Overall Study|Adverse Event|0
4784104|NCT01451437|16500764|P4|Overall Study|Adverse Event|0
4784105|NCT01451437|16500765|P3|Overall Study|Adverse Event|0
4784106|NCT01451437|16500766|P2|Overall Study|Adverse Event|0
4784107|NCT01451437|16500767|P1|Overall Study|Adverse Event|0
4784108|NCT01451424|16500899|P4|Overall Study|Adverse Event|1
4784109|NCT01451424|16500900|P3|Overall Study|Adverse Event|0
4784110|NCT01451424|16500901|P2|Overall Study|Adverse Event|0
4784111|NCT01451424|16500902|P1|Overall Study|Adverse Event|0
4784112|NCT01451424|16500899|P4|Overall Study|Physician Decision|1
4784113|NCT01451424|16500900|P3|Overall Study|Physician Decision|1
4784114|NCT01451424|16500901|P2|Overall Study|Physician Decision|0
4784115|NCT01451424|16500902|P1|Overall Study|Physician Decision|0
4784116|NCT01451424|16500899|P4|Overall Study|Lost to Follow-up|1
4784117|NCT01451424|16500900|P3|Overall Study|Lost to Follow-up|0
4784118|NCT01451424|16500901|P2|Overall Study|Lost to Follow-up|1
4784119|NCT01451424|16500902|P1|Overall Study|Lost to Follow-up|0
4784120|NCT01451424|16500899|P4|Overall Study|Withdrawal by Subject|2
4784121|NCT01451424|16500900|P3|Overall Study|Withdrawal by Subject|0
4784122|NCT01451424|16500901|P2|Overall Study|Withdrawal by Subject|1
4784123|NCT01451424|16500902|P1|Overall Study|Withdrawal by Subject|1
4784124|NCT01451398|16500960|P2|Overall Study|Lack of Efficacy|1
4784125|NCT01451398|16500961|P1|Overall Study|Lack of Efficacy|0
4784126|NCT01451398|16500960|P2|Overall Study|Adverse Event + Elevated Fasting Glucose|1
4784127|NCT01451398|16500961|P1|Overall Study|Adverse Event + Elevated Fasting Glucose|0
4784128|NCT01451398|16500960|P2|Overall Study|Moved out of country|1
4784129|NCT01451398|16500961|P1|Overall Study|Moved out of country|0
4784130|NCT01451398|16500960|P2|Overall Study|Non-compliance with protocol|1
4784131|NCT01451398|16500961|P1|Overall Study|Non-compliance with protocol|1
4784132|NCT01451398|16500960|P2|Overall Study|Non-compliance with study drug|3
4784133|NCT01451398|16500961|P1|Overall Study|Non-compliance with study drug|1
4784134|NCT01451398|16500960|P2|Overall Study|Lost to Follow-up|4
4784135|NCT01451398|16500961|P1|Overall Study|Lost to Follow-up|6
4784136|NCT01451398|16500960|P2|Overall Study|Withdrawal by Subject|14
4784137|NCT01451398|16500961|P1|Overall Study|Withdrawal by Subject|10
4784138|NCT01451398|16500960|P2|Overall Study|Physician Decision|1
4784139|NCT01451398|16500961|P1|Overall Study|Physician Decision|1
4784140|NCT01451398|16500960|P2|Overall Study|Protocol Violation|2
4784141|NCT01451398|16500961|P1|Overall Study|Protocol Violation|1
4784142|NCT01451398|16500960|P2|Overall Study|Adverse Event|9
4784143|NCT01451398|16500961|P1|Overall Study|Adverse Event|7
4784144|NCT01451203|16501012|P2|Post-treatment Period|Investigator decision|1
4784145|NCT01451203|16501013|P1|Post-treatment Period|Investigator decision|0
4784146|NCT01451203|16501012|P2|Post-treatment Period|Adverse Event|1
4784147|NCT01451203|16501013|P1|Post-treatment Period|Adverse Event|0
4784148|NCT01451203|16501012|P2|Post-treatment Period|Lack of Efficacy|28
4784149|NCT01451203|16501013|P1|Post-treatment Period|Lack of Efficacy|12
4784150|NCT01451203|16501012|P2|Post-treatment Period|Consent withdrawn|4
4784151|NCT01451203|16501013|P1|Post-treatment Period|Consent withdrawn|2
4784152|NCT01451203|16501012|P2|Double-blind Treatment Period|Investigator decision|0
4784153|NCT01451203|16501013|P1|Double-blind Treatment Period|Investigator decision|2
4784154|NCT01451203|16501012|P2|Double-blind Treatment Period|Violation of eligibility criteria|0
4784155|NCT01451203|16501013|P1|Double-blind Treatment Period|Violation of eligibility criteria|1
4784156|NCT01451203|16501012|P2|Double-blind Treatment Period|Missing study medication ≥6 times|0
4784157|NCT01451203|16501013|P1|Double-blind Treatment Period|Missing study medication ≥6 times|1
4784158|NCT01451203|16501012|P2|Double-blind Treatment Period|Adverse Event|9
4784159|NCT01451203|16501013|P1|Double-blind Treatment Period|Adverse Event|6
4784160|NCT01451203|16501012|P2|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1
4784161|NCT01451203|16501013|P1|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0
4784162|NCT01451203|16501012|P2|Double-blind Treatment Period|Lack of Efficacy|36
4784163|NCT01451203|16501013|P1|Double-blind Treatment Period|Lack of Efficacy|71
4784164|NCT01451203|16501012|P2|Double-blind Treatment Period|Consent Withdrawn|2
4784165|NCT01451203|16501013|P1|Double-blind Treatment Period|Consent Withdrawn|3
4784166|NCT01451203|16501012|P2|Double-blind Treatment Period|Did not receive treatment|2
4784167|NCT01451203|16501013|P1|Double-blind Treatment Period|Did not receive treatment|1
4784168|NCT01451164|16501031|P4|Overall Study|Lack of Efficacy|7
4784169|NCT01451164|16501032|P3|Overall Study|Lack of Efficacy|9
4784170|NCT01451164|16501033|P2|Overall Study|Lack of Efficacy|9
4784171|NCT01451164|16501034|P1|Overall Study|Lack of Efficacy|7
4784172|NCT01451164|16501031|P4|Overall Study|Protocol Violation|0
4784173|NCT01451164|16501032|P3|Overall Study|Protocol Violation|0
4784174|NCT01451164|16501033|P2|Overall Study|Protocol Violation|1
4784175|NCT01451164|16501034|P1|Overall Study|Protocol Violation|0
4784176|NCT01451164|16501031|P4|Overall Study|Withdrawal by Subject|17
4784177|NCT01451164|16501032|P3|Overall Study|Withdrawal by Subject|16
4784178|NCT01451164|16501033|P2|Overall Study|Withdrawal by Subject|11
4784179|NCT01451164|16501034|P1|Overall Study|Withdrawal by Subject|14
4784180|NCT01451164|16501031|P4|Overall Study|Physician Decision|0
4784181|NCT01451164|16501032|P3|Overall Study|Physician Decision|1
4784182|NCT01451164|16501033|P2|Overall Study|Physician Decision|0
4784183|NCT01451164|16501034|P1|Overall Study|Physician Decision|2
4784184|NCT01451164|16501031|P4|Overall Study|Withdrawal Criteria|1
4784185|NCT01451164|16501032|P3|Overall Study|Withdrawal Criteria|1
4784186|NCT01451164|16501033|P2|Overall Study|Withdrawal Criteria|1
4784187|NCT01451164|16501034|P1|Overall Study|Withdrawal Criteria|1
4784188|NCT01451164|16501031|P4|Overall Study|Adverse Event|21
4784189|NCT01451164|16501032|P3|Overall Study|Adverse Event|18
4784190|NCT01451164|16501033|P2|Overall Study|Adverse Event|12
4784191|NCT01451164|16501034|P1|Overall Study|Adverse Event|19
4784192|NCT01450943|16501063|P3|Overall Study|Screen failure, loss to follow-up|6
4784193|NCT01450943|16501064|P2|Overall Study|Screen failure, loss to follow-up|7
4784194|NCT01450943|16501065|P1|Overall Study|Screen failure, loss to follow-up|2
4784195|NCT01450813|16501098|P4|Overall Study|Physician Decision|3
4784196|NCT01450813|16501099|P3|Overall Study|Physician Decision|0
4784197|NCT01450813|16501100|P2|Overall Study|Physician Decision|1
4784198|NCT01450813|16501101|P1|Overall Study|Physician Decision|1
4784199|NCT01450800|16501115|P2|Overall Study|Protocol Violation|3
4784200|NCT01450800|16501116|P1|Overall Study|Protocol Violation|1
4784201|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3
4784202|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2
4784203|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Poor/non-compliance|0
4784204|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Poor/non-compliance|1
4784205|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Not reported|2
4784206|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Not reported|2
4784207|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|No longer meets study criteria|2
4784208|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|No longer meets study criteria|1
4784209|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Maximum clinical benefit|2
4784210|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Maximum clinical benefit|1
4784211|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Lost to Follow-up|1
4784212|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Lost to Follow-up|2
4784213|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Other/Unspecified|4
4784214|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Other/Unspecified|5
4784215|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Death|6
4784216|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Death|5
4784217|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Withdrawal by Subject|5
4784218|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Withdrawal by Subject|12
4784219|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8
4784220|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15
4784221|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19
4784222|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27
4784223|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Study drug toxicity|9
4784224|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Study drug toxicity|87
4784225|NCT01450761|16501151|P2|Treatment With Blinded Study Therapy|Disease progression|415
4784226|NCT01450761|16501152|P1|Treatment With Blinded Study Therapy|Disease progression|318
4784227|NCT01450761|16501151|P2|Lead-in Chemotherapy|Lost to Follow-up|0
4784228|NCT01450761|16501152|P1|Lead-in Chemotherapy|Lost to Follow-up|2
4784229|NCT01450761|16501151|P2|Lead-in Chemotherapy|Other|2
4784230|NCT01450761|16501152|P1|Lead-in Chemotherapy|Other|2
4784231|NCT01450761|16501151|P2|Lead-in Chemotherapy|Death|3
4784232|NCT01450761|16501152|P1|Lead-in Chemotherapy|Death|3
4784233|NCT01450761|16501151|P2|Lead-in Chemotherapy|No longer meets study criteria|7
4784234|NCT01450761|16501152|P1|Lead-in Chemotherapy|No longer meets study criteria|3
4784235|NCT01450761|16501151|P2|Lead-in Chemotherapy|Study drug toxicity|10
4784236|NCT01450761|16501152|P1|Lead-in Chemotherapy|Study drug toxicity|6
4784237|NCT01450761|16501151|P2|Lead-in Chemotherapy|Withdrawal by Subject|12
4784238|NCT01450761|16501152|P1|Lead-in Chemotherapy|Withdrawal by Subject|14
4784239|NCT01450761|16501151|P2|Lead-in Chemotherapy|Adverse event unrelated to study drug|19
4784240|NCT01450761|16501152|P1|Lead-in Chemotherapy|Adverse event unrelated to study drug|21
4784241|NCT01450761|16501151|P2|Lead-in Chemotherapy|Disease progression|32
4784242|NCT01450761|16501152|P1|Lead-in Chemotherapy|Disease progression|33
4784243|NCT01450761|16501151|P2|Randomization|Other|1
4784244|NCT01450761|16501152|P1|Randomization|Other|0
4784245|NCT01450761|16501151|P2|Randomization|Adverse Event unrelated to study drug|0
4784246|NCT01450761|16501152|P1|Randomization|Adverse Event unrelated to study drug|1
4784247|NCT01450761|16501151|P2|Randomization|Disease progression|2
4784248|NCT01450761|16501152|P1|Randomization|Disease progression|0
4784249|NCT01450761|16501151|P2|Randomization|Withdrawal by Subject|0
4784250|NCT01450761|16501152|P1|Randomization|Withdrawal by Subject|2
4784251|NCT01450761|16501151|P2|Randomization|Subject no longer meets study criteria|2
4784252|NCT01450761|16501152|P1|Randomization|Subject no longer meets study criteria|1
4784253|NCT01450696|16501164|P2|Overall Study|Study Terminated by Sponsor|58
4784254|NCT01450696|16501165|P1|Overall Study|Study Terminated by Sponsor|53
4784255|NCT01450696|16501164|P2|Overall Study|Withdrawal by Subject|2
4784256|NCT01450696|16501165|P1|Overall Study|Withdrawal by Subject|13
4784257|NCT01450696|16501164|P2|Overall Study|Non-Compliance|0
4784258|NCT01450696|16501165|P1|Overall Study|Non-Compliance|1
4784259|NCT01450696|16501164|P2|Overall Study|Lost to Follow-up|3
4784260|NCT01450696|16501165|P1|Overall Study|Lost to Follow-up|3
4784261|NCT01450696|16501164|P2|Overall Study|Death|84
4784262|NCT01450696|16501165|P1|Overall Study|Death|77
4784263|NCT01450696|16501164|P2|Overall Study|Never Treated|1
4784264|NCT01450696|16501165|P1|Overall Study|Never Treated|1
4784265|NCT01450683|16501187|P1|Overall Study|Adverse Event|2
4784266|NCT01450631|16501193|P2|Overall Study|Withdrawal by Subject|0
4784267|NCT01450631|16501194|P1|Overall Study|Withdrawal by Subject|1
4784268|NCT01450631|16501193|P2|Overall Study|Lost to Follow-up|4
4784269|NCT01450631|16501194|P1|Overall Study|Lost to Follow-up|2
4784270|NCT01450137|16501324|P2|Week 12 to Study End|Withdrawal by Subject|1
4784271|NCT01450137|16501325|P1|Week 12 to Study End|Withdrawal by Subject|0
4784272|NCT01450137|16501324|P2|Week 12 to Study End|Death|1
4784273|NCT01450137|16501325|P1|Week 12 to Study End|Death|0
4784274|NCT01450137|16501324|P2|Up to Week 12|Withdrawal by Subject|2
4784275|NCT01450137|16501325|P1|Up to Week 12|Withdrawal by Subject|0
4784276|NCT01450137|16501324|P2|Up to Week 12|Adverse Event|1
4784277|NCT01450137|16501325|P1|Up to Week 12|Adverse Event|2
4784278|NCT01450098|16501339|P2|Period 3|Withdrawal by Subject|2
4784279|NCT01450098|16501340|P1|Period 3|Withdrawal by Subject|0
4784280|NCT01450098|16501339|P2|Period 3|Protocol Violation|1
4784281|NCT01450098|16501340|P1|Period 3|Protocol Violation|0
4784282|NCT01450007|16501359|P3|Overall Study|Adverse Event|0
4784283|NCT01450007|16501360|P2|Overall Study|Adverse Event|1
4784284|NCT01450007|16501361|P1|Overall Study|Adverse Event|0
4784285|NCT01450007|16501359|P3|Overall Study|Protocol Violation|1
4784286|NCT01450007|16501360|P2|Overall Study|Protocol Violation|1
4784287|NCT01450007|16501361|P1|Overall Study|Protocol Violation|0
4784288|NCT01450007|16501359|P3|Overall Study|Late exclusion before treatment|2
4784289|NCT01450007|16501360|P2|Overall Study|Late exclusion before treatment|3
4784290|NCT01450007|16501361|P1|Overall Study|Late exclusion before treatment|2
4784291|NCT01449955|16501380|P2|Overall Study|Withdrawal by Subject|2
4784292|NCT01449955|16501381|P1|Overall Study|Withdrawal by Subject|1
4784293|NCT01449929|16501409|P3|Extension Phase Approximately 3 Years|Lost to Follow-up|4
4784294|NCT01449929|16501410|P2|Extension Phase Approximately 3 Years|Lost to Follow-up|0
4784295|NCT01449929|16501411|P1|Extension Phase Approximately 3 Years|Lost to Follow-up|0
4784296|NCT01449929|16501409|P3|Extension Phase Approximately 3 Years|Lack of Efficacy|2
4784297|NCT01449929|16501410|P2|Extension Phase Approximately 3 Years|Lack of Efficacy|0
4784298|NCT01449929|16501411|P1|Extension Phase Approximately 3 Years|Lack of Efficacy|0
4784299|NCT01449929|16501409|P3|Extension Phase Approximately 3 Years|Adverse Event|2
4784300|NCT01449929|16501410|P2|Extension Phase Approximately 3 Years|Adverse Event|0
4784301|NCT01449929|16501411|P1|Extension Phase Approximately 3 Years|Adverse Event|0
4784302|NCT01449929|16501409|P3|Randomization Phase 96 Week|Other: study closed/terminated|0
4784303|NCT01449929|16501410|P2|Randomization Phase 96 Week|Other: study closed/terminated|1
4784304|NCT01449929|16501411|P1|Randomization Phase 96 Week|Other: study closed/terminated|0
4784305|NCT01449929|16501409|P3|Randomization Phase 96 Week|Physician Decision|0
4784306|NCT01449929|16501410|P2|Randomization Phase 96 Week|Physician Decision|3
4784307|NCT01449929|16501411|P1|Randomization Phase 96 Week|Physician Decision|2
4784308|NCT01449929|16501409|P3|Randomization Phase 96 Week|Withdrawal by Subject|0
4784309|NCT01449929|16501410|P2|Randomization Phase 96 Week|Withdrawal by Subject|8
4784310|NCT01449929|16501411|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
4784311|NCT01449929|16501409|P3|Randomization Phase 96 Week|Lost to Follow-up|0
4784312|NCT01449929|16501410|P2|Randomization Phase 96 Week|Lost to Follow-up|18
4784313|NCT01449929|16501411|P1|Randomization Phase 96 Week|Lost to Follow-up|15
4784314|NCT01449929|16501409|P3|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
4784315|NCT01449929|16501410|P2|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0
4784316|NCT01449929|16501411|P1|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1
4784317|NCT01449929|16501409|P3|Randomization Phase 96 Week|Protocol Violation|0
4784318|NCT01449929|16501410|P2|Randomization Phase 96 Week|Protocol Violation|6
4784319|NCT01449929|16501411|P1|Randomization Phase 96 Week|Protocol Violation|5
4784320|NCT01449929|16501409|P3|Randomization Phase 96 Week|Lack of Efficacy|0
4784321|NCT01449929|16501410|P2|Randomization Phase 96 Week|Lack of Efficacy|4
4784322|NCT01449929|16501411|P1|Randomization Phase 96 Week|Lack of Efficacy|3
4784323|NCT01449929|16501409|P3|Randomization Phase 96 Week|Adverse Event|0
4784324|NCT01449929|16501410|P2|Randomization Phase 96 Week|Adverse Event|13
4784325|NCT01449929|16501411|P1|Randomization Phase 96 Week|Adverse Event|5
4784326|NCT01449812|16501456|P3|Overall Study|Lost to Follow-up|0
4784327|NCT01449812|16501457|P2|Overall Study|Lost to Follow-up|0
4784328|NCT01449812|16501458|P1|Overall Study|Lost to Follow-up|1
4784329|NCT01449812|16501456|P3|Overall Study|Withdrawal by Subject|1
4784330|NCT01449812|16501457|P2|Overall Study|Withdrawal by Subject|0
4784331|NCT01449812|16501458|P1|Overall Study|Withdrawal by Subject|0
4784332|NCT01449812|16501456|P3|Overall Study|Migrated/moved from study area|0
4784333|NCT01449812|16501457|P2|Overall Study|Migrated/moved from study area|0
4784334|NCT01449812|16501458|P1|Overall Study|Migrated/moved from study area|1
4784335|NCT01449721|16501573|P2|Overall Study|Physician Decision|1
4784336|NCT01449721|16501574|P1|Overall Study|Physician Decision|0
4784337|NCT01449721|16501573|P2|Overall Study|Physician Decision|1
4784338|NCT01449721|16501574|P1|Overall Study|Physician Decision|0
4784339|NCT01449708|16501586|P2|Overall Study|respiratory failure|0
4784340|NCT01449708|16501587|P1|Overall Study|respiratory failure|1
4784341|NCT01449708|16501586|P2|Overall Study|surgical complication|2
4784342|NCT01449708|16501587|P1|Overall Study|surgical complication|1
4784343|NCT01449708|16501586|P2|Overall Study|Protocol Violation|1
4784344|NCT01449708|16501587|P1|Overall Study|Protocol Violation|0
4784345|NCT01449682|16501598|P2|Overall Study|Adverse Event|0
4784346|NCT01449682|16501599|P1|Overall Study|Adverse Event|1
4784347|NCT01449682|16501598|P2|Overall Study|Death|1
4784348|NCT01449682|16501599|P1|Overall Study|Death|0
4784349|NCT01449630|16501620|P9|Period 2|Sponsor Decision|0
4784350|NCT01449630|16501621|P8|Period 2|Sponsor Decision|0
4784351|NCT01449630|16501622|P7|Period 2|Sponsor Decision|1
4784352|NCT01449630|16501623|P6|Period 2|Sponsor Decision|0
4784353|NCT01449630|16501624|P5|Period 2|Sponsor Decision|0
4784354|NCT01449630|16501625|P4|Period 2|Sponsor Decision|0
4784355|NCT01449630|16501626|P3|Period 2|Sponsor Decision|0
4784356|NCT01449630|16501627|P2|Period 2|Sponsor Decision|0
4784357|NCT01449630|16501628|P1|Period 2|Sponsor Decision|0
4784358|NCT01449630|16501620|P9|Period 1|Sponsor Decision|0
4784359|NCT01449630|16501621|P8|Period 1|Sponsor Decision|0
4784360|NCT01449630|16501622|P7|Period 1|Sponsor Decision|0
4784361|NCT01449630|16501623|P6|Period 1|Sponsor Decision|1
4784362|NCT01449630|16501624|P5|Period 1|Sponsor Decision|0
4784363|NCT01449630|16501625|P4|Period 1|Sponsor Decision|0
4784364|NCT01449630|16501626|P3|Period 1|Sponsor Decision|0
4784365|NCT01449630|16501627|P2|Period 1|Sponsor Decision|0
4784366|NCT01449630|16501628|P1|Period 1|Sponsor Decision|0
4784367|NCT01449630|16501620|P9|Period 1|Physician Decision|0
4784368|NCT01449630|16501621|P8|Period 1|Physician Decision|0
4784369|NCT01449630|16501622|P7|Period 1|Physician Decision|0
4784370|NCT01449630|16501623|P6|Period 1|Physician Decision|0
4784371|NCT01449630|16501624|P5|Period 1|Physician Decision|0
4784372|NCT01449630|16501625|P4|Period 1|Physician Decision|1
4784373|NCT01449630|16501626|P3|Period 1|Physician Decision|0
4784374|NCT01449630|16501627|P2|Period 1|Physician Decision|0
4784375|NCT01449630|16501628|P1|Period 1|Physician Decision|1
4784376|NCT01449539|16501698|P1|Overall Study|Toxicity not study related|1
4784377|NCT01449539|16501698|P1|Overall Study|Withdrawal by Subject|3
4784378|NCT01449526|16501704|P2|Overall Study|Cannot maintain visits|1
4784379|NCT01449526|16501705|P1|Overall Study|Cannot maintain visits|0
4784380|NCT01449526|16501704|P2|Overall Study|Lack of Motivation|1
4784381|NCT01449526|16501705|P1|Overall Study|Lack of Motivation|0
4784382|NCT01449526|16501704|P2|Overall Study|Symptoms/complaints|1
4784383|NCT01449526|16501705|P1|Overall Study|Symptoms/complaints|0
4784384|NCT01449526|16501704|P2|Overall Study|Withdrawal by Subject|1
4784385|NCT01449526|16501705|P1|Overall Study|Withdrawal by Subject|1
4784386|NCT01449526|16501704|P2|Overall Study|Lost to Follow-up|2
4784387|NCT01449526|16501705|P1|Overall Study|Lost to Follow-up|1
4784388|NCT01449461|16501774|P6|Overall Study|Reason not specified|1
4784389|NCT01449461|16501775|P5|Overall Study|Reason not specified|0
4784390|NCT01449461|16501776|P4|Overall Study|Reason not specified|3
4784391|NCT01449461|16501777|P3|Overall Study|Reason not specified|0
4784392|NCT01449461|16501778|P2|Overall Study|Reason not specified|1
4784393|NCT01449461|16501779|P1|Overall Study|Reason not specified|0
4784394|NCT01449461|16501774|P6|Overall Study|Clinical progressive disease|3
4784395|NCT01449461|16501775|P5|Overall Study|Clinical progressive disease|3
4784396|NCT01449461|16501776|P4|Overall Study|Clinical progressive disease|0
4784397|NCT01449461|16501777|P3|Overall Study|Clinical progressive disease|0
4784398|NCT01449461|16501778|P2|Overall Study|Clinical progressive disease|1
4784399|NCT01449461|16501779|P1|Overall Study|Clinical progressive disease|2
4784400|NCT01449461|16501774|P6|Overall Study|Documented progressive disease|5
4784401|NCT01449461|16501775|P5|Overall Study|Documented progressive disease|21
4784402|NCT01449461|16501776|P4|Overall Study|Documented progressive disease|11
4784403|NCT01449461|16501777|P3|Overall Study|Documented progressive disease|14
4784404|NCT01449461|16501778|P2|Overall Study|Documented progressive disease|6
4784405|NCT01449461|16501779|P1|Overall Study|Documented progressive disease|4
4784406|NCT01449461|16501774|P6|Overall Study|Death|1
4784407|NCT01449461|16501775|P5|Overall Study|Death|4
4784408|NCT01449461|16501776|P4|Overall Study|Death|0
4784409|NCT01449461|16501777|P3|Overall Study|Death|0
4784410|NCT01449461|16501778|P2|Overall Study|Death|1
4784411|NCT01449461|16501779|P1|Overall Study|Death|0
4784412|NCT01449461|16501774|P6|Overall Study|Adverse Event|3
4784413|NCT01449461|16501775|P5|Overall Study|Adverse Event|3
4784414|NCT01449461|16501776|P4|Overall Study|Adverse Event|3
4784415|NCT01449461|16501777|P3|Overall Study|Adverse Event|2
4784416|NCT01449461|16501778|P2|Overall Study|Adverse Event|3
4784417|NCT01449461|16501779|P1|Overall Study|Adverse Event|0
4784418|NCT01449461|16501774|P6|Overall Study|Ongoing|2
4784419|NCT01449461|16501775|P5|Overall Study|Ongoing|17
4784420|NCT01449461|16501776|P4|Overall Study|Ongoing|15
4784421|NCT01449461|16501777|P3|Overall Study|Ongoing|2
4784422|NCT01449461|16501778|P2|Overall Study|Ongoing|6
4784423|NCT01449461|16501779|P1|Overall Study|Ongoing|0
4784424|NCT01449370|16501916|P25|Overall Study|Death|1
4784425|NCT01449370|16501917|P24|Overall Study|Death|0
4784426|NCT01449370|16501918|P23|Overall Study|Death|0
4784427|NCT01449370|16501919|P22|Overall Study|Death|0
4784428|NCT01449370|16501920|P21|Overall Study|Death|0
4784429|NCT01449370|16501921|P20|Overall Study|Death|0
4784430|NCT01449370|16501922|P19|Overall Study|Death|0
4784431|NCT01449370|16501923|P18|Overall Study|Death|0
4784432|NCT01449370|16501924|P17|Overall Study|Death|0
4784433|NCT01449370|16501925|P16|Overall Study|Death|0
4784434|NCT01449370|16501926|P15|Overall Study|Death|0
4784435|NCT01449370|16501927|P14|Overall Study|Death|0
4784436|NCT01449370|16501928|P13|Overall Study|Death|0
4784437|NCT01449370|16501929|P12|Overall Study|Death|0
4784438|NCT01449370|16501930|P11|Overall Study|Death|0
4784439|NCT01449370|16501931|P10|Overall Study|Death|0
4784440|NCT01449370|16501932|P9|Overall Study|Death|0
4784441|NCT01449370|16501933|P8|Overall Study|Death|0
4784442|NCT01449370|16501934|P7|Overall Study|Death|0
4784443|NCT01449370|16501935|P6|Overall Study|Death|0
4784444|NCT01449370|16501936|P5|Overall Study|Death|0
4784445|NCT01449370|16501937|P4|Overall Study|Death|0
4784446|NCT01449370|16501938|P3|Overall Study|Death|0
4784447|NCT01449370|16501939|P2|Overall Study|Death|0
4784448|NCT01449370|16501940|P1|Overall Study|Death|0
4784449|NCT01449370|16501916|P25|Overall Study|Medication Prohibited by Protocol|0
4784450|NCT01449370|16501917|P24|Overall Study|Medication Prohibited by Protocol|1
4784451|NCT01449370|16501918|P23|Overall Study|Medication Prohibited by Protocol|0
4784452|NCT01449370|16501919|P22|Overall Study|Medication Prohibited by Protocol|0
4784453|NCT01449370|16501920|P21|Overall Study|Medication Prohibited by Protocol|0
4784454|NCT01449370|16501921|P20|Overall Study|Medication Prohibited by Protocol|0
4784455|NCT01449370|16501922|P19|Overall Study|Medication Prohibited by Protocol|0
4784456|NCT01449370|16501923|P18|Overall Study|Medication Prohibited by Protocol|0
4784457|NCT01449370|16501924|P17|Overall Study|Medication Prohibited by Protocol|0
4784458|NCT01449370|16501925|P16|Overall Study|Medication Prohibited by Protocol|0
4784459|NCT01449370|16501926|P15|Overall Study|Medication Prohibited by Protocol|0
4784460|NCT01449370|16501927|P14|Overall Study|Medication Prohibited by Protocol|0
4784461|NCT01449370|16501928|P13|Overall Study|Medication Prohibited by Protocol|0
4784462|NCT01449370|16501929|P12|Overall Study|Medication Prohibited by Protocol|0
4784463|NCT01449370|16501930|P11|Overall Study|Medication Prohibited by Protocol|0
4784464|NCT01449370|16501931|P10|Overall Study|Medication Prohibited by Protocol|0
4784465|NCT01449370|16501932|P9|Overall Study|Medication Prohibited by Protocol|0
4784466|NCT01449370|16501933|P8|Overall Study|Medication Prohibited by Protocol|0
4784467|NCT01449370|16501934|P7|Overall Study|Medication Prohibited by Protocol|0
4784468|NCT01449370|16501935|P6|Overall Study|Medication Prohibited by Protocol|0
4784469|NCT01449370|16501936|P5|Overall Study|Medication Prohibited by Protocol|0
4784470|NCT01449370|16501937|P4|Overall Study|Medication Prohibited by Protocol|0
4784471|NCT01449370|16501938|P3|Overall Study|Medication Prohibited by Protocol|0
4784472|NCT01449370|16501939|P2|Overall Study|Medication Prohibited by Protocol|0
4784473|NCT01449370|16501940|P1|Overall Study|Medication Prohibited by Protocol|0
4784474|NCT01449370|16501916|P25|Overall Study|Other|0
4784475|NCT01449370|16501917|P24|Overall Study|Other|1
4784476|NCT01449370|16501918|P23|Overall Study|Other|1
4784477|NCT01449370|16501919|P22|Overall Study|Other|0
4784478|NCT01449370|16501920|P21|Overall Study|Other|0
4784479|NCT01449370|16501921|P20|Overall Study|Other|0
4784480|NCT01449370|16501922|P19|Overall Study|Other|0
4784481|NCT01449370|16501923|P18|Overall Study|Other|0
4784482|NCT01449370|16501924|P17|Overall Study|Other|0
4784483|NCT01449370|16501925|P16|Overall Study|Other|0
4784484|NCT01449370|16501926|P15|Overall Study|Other|0
4784485|NCT01449370|16501927|P14|Overall Study|Other|0
4784486|NCT01449370|16501928|P13|Overall Study|Other|0
4784487|NCT01449370|16501929|P12|Overall Study|Other|0
4784488|NCT01449370|16501930|P11|Overall Study|Other|0
4784489|NCT01449370|16501931|P10|Overall Study|Other|1
4784490|NCT01449370|16501932|P9|Overall Study|Other|1
4784491|NCT01449370|16501933|P8|Overall Study|Other|0
4784492|NCT01449370|16501934|P7|Overall Study|Other|0
4784493|NCT01449370|16501935|P6|Overall Study|Other|0
4784494|NCT01449370|16501936|P5|Overall Study|Other|0
4784495|NCT01449370|16501937|P4|Overall Study|Other|0
4784496|NCT01449370|16501938|P3|Overall Study|Other|0
4784497|NCT01449370|16501939|P2|Overall Study|Other|0
4784498|NCT01449370|16501940|P1|Overall Study|Other|0
4784499|NCT01449370|16501916|P25|Overall Study|Lost to Follow-up|0
4784500|NCT01449370|16501917|P24|Overall Study|Lost to Follow-up|0
4784501|NCT01449370|16501918|P23|Overall Study|Lost to Follow-up|0
4784502|NCT01449370|16501919|P22|Overall Study|Lost to Follow-up|0
4784503|NCT01449370|16501920|P21|Overall Study|Lost to Follow-up|1
4784504|NCT01449370|16501921|P20|Overall Study|Lost to Follow-up|0
4784505|NCT01449370|16501922|P19|Overall Study|Lost to Follow-up|0
4784506|NCT01449370|16501923|P18|Overall Study|Lost to Follow-up|0
4784507|NCT01449370|16501924|P17|Overall Study|Lost to Follow-up|0
4784508|NCT01449370|16501925|P16|Overall Study|Lost to Follow-up|0
4784509|NCT01449370|16501926|P15|Overall Study|Lost to Follow-up|0
4784510|NCT01449370|16501927|P14|Overall Study|Lost to Follow-up|0
4784511|NCT01449370|16501928|P13|Overall Study|Lost to Follow-up|0
4784512|NCT01449370|16501929|P12|Overall Study|Lost to Follow-up|0
4784513|NCT01449370|16501930|P11|Overall Study|Lost to Follow-up|0
4784514|NCT01449370|16501931|P10|Overall Study|Lost to Follow-up|0
4784515|NCT01449370|16501932|P9|Overall Study|Lost to Follow-up|0
4784516|NCT01449370|16501933|P8|Overall Study|Lost to Follow-up|0
4784517|NCT01449370|16501934|P7|Overall Study|Lost to Follow-up|0
4784518|NCT01449370|16501935|P6|Overall Study|Lost to Follow-up|0
4784519|NCT01449370|16501936|P5|Overall Study|Lost to Follow-up|0
4784520|NCT01449370|16501937|P4|Overall Study|Lost to Follow-up|0
4784521|NCT01449370|16501938|P3|Overall Study|Lost to Follow-up|0
4784522|NCT01449370|16501939|P2|Overall Study|Lost to Follow-up|0
4784523|NCT01449370|16501940|P1|Overall Study|Lost to Follow-up|0
4784524|NCT01449370|16501916|P25|Overall Study|Participant Decision|1
4784525|NCT01449370|16501917|P24|Overall Study|Participant Decision|0
4784526|NCT01449370|16501918|P23|Overall Study|Participant Decision|0
4784527|NCT01449370|16501919|P22|Overall Study|Participant Decision|1
4784528|NCT01449370|16501920|P21|Overall Study|Participant Decision|0
4784529|NCT01449370|16501921|P20|Overall Study|Participant Decision|0
4784530|NCT01449370|16501922|P19|Overall Study|Participant Decision|1
4784531|NCT01449370|16501923|P18|Overall Study|Participant Decision|0
4784532|NCT01449370|16501924|P17|Overall Study|Participant Decision|3
4784533|NCT01449370|16501925|P16|Overall Study|Participant Decision|1
4784534|NCT01449370|16501926|P15|Overall Study|Participant Decision|0
4784535|NCT01449370|16501927|P14|Overall Study|Participant Decision|1
4784536|NCT01449370|16501928|P13|Overall Study|Participant Decision|1
4784537|NCT01449370|16501929|P12|Overall Study|Participant Decision|0
4784538|NCT01449370|16501930|P11|Overall Study|Participant Decision|0
4784539|NCT01449370|16501931|P10|Overall Study|Participant Decision|0
4784540|NCT01449370|16501932|P9|Overall Study|Participant Decision|1
4784541|NCT01449370|16501933|P8|Overall Study|Participant Decision|1
4784542|NCT01449370|16501934|P7|Overall Study|Participant Decision|0
4784543|NCT01449370|16501935|P6|Overall Study|Participant Decision|0
4784544|NCT01449370|16501936|P5|Overall Study|Participant Decision|0
4784545|NCT01449370|16501937|P4|Overall Study|Participant Decision|0
4784546|NCT01449370|16501938|P3|Overall Study|Participant Decision|0
4784547|NCT01449370|16501939|P2|Overall Study|Participant Decision|0
4784548|NCT01449370|16501940|P1|Overall Study|Participant Decision|0
4784549|NCT01449370|16501916|P25|Overall Study|Adverse Event|3
4784550|NCT01449370|16501917|P24|Overall Study|Adverse Event|1
4784551|NCT01449370|16501918|P23|Overall Study|Adverse Event|0
4784552|NCT01449370|16501919|P22|Overall Study|Adverse Event|1
4784553|NCT01449370|16501920|P21|Overall Study|Adverse Event|0
4784554|NCT01449370|16501921|P20|Overall Study|Adverse Event|1
4784555|NCT01449370|16501922|P19|Overall Study|Adverse Event|1
4784556|NCT01449370|16501923|P18|Overall Study|Adverse Event|0
4784557|NCT01449370|16501924|P17|Overall Study|Adverse Event|0
4784558|NCT01449370|16501925|P16|Overall Study|Adverse Event|1
4784559|NCT01449370|16501926|P15|Overall Study|Adverse Event|0
4784560|NCT01449370|16501927|P14|Overall Study|Adverse Event|2
4784561|NCT01449370|16501928|P13|Overall Study|Adverse Event|0
4784562|NCT01449370|16501929|P12|Overall Study|Adverse Event|0
4784563|NCT01449370|16501930|P11|Overall Study|Adverse Event|0
4784564|NCT01449370|16501931|P10|Overall Study|Adverse Event|1
4784565|NCT01449370|16501932|P9|Overall Study|Adverse Event|1
4784566|NCT01449370|16501933|P8|Overall Study|Adverse Event|0
4784567|NCT01449370|16501934|P7|Overall Study|Adverse Event|0
4784568|NCT01449370|16501935|P6|Overall Study|Adverse Event|0
4784569|NCT01449370|16501936|P5|Overall Study|Adverse Event|0
4784570|NCT01449370|16501937|P4|Overall Study|Adverse Event|1
4784571|NCT01449370|16501938|P3|Overall Study|Adverse Event|0
4784572|NCT01449370|16501939|P2|Overall Study|Adverse Event|2
4784573|NCT01449370|16501940|P1|Overall Study|Adverse Event|1
4784574|NCT01449370|16501916|P25|Overall Study|Disease Progression|3
4784575|NCT01449370|16501917|P24|Overall Study|Disease Progression|7
4784576|NCT01449370|16501918|P23|Overall Study|Disease Progression|3
4784577|NCT01449370|16501919|P22|Overall Study|Disease Progression|2
4784578|NCT01449370|16501920|P21|Overall Study|Disease Progression|5
4784579|NCT01449370|16501921|P20|Overall Study|Disease Progression|2
4784580|NCT01449370|16501922|P19|Overall Study|Disease Progression|1
4784581|NCT01449370|16501923|P18|Overall Study|Disease Progression|3
4784582|NCT01449370|16501924|P17|Overall Study|Disease Progression|4
4784583|NCT01449370|16501925|P16|Overall Study|Disease Progression|1
4784584|NCT01449370|16501926|P15|Overall Study|Disease Progression|3
4784585|NCT01449370|16501927|P14|Overall Study|Disease Progression|8
4784586|NCT01449370|16501928|P13|Overall Study|Disease Progression|2
4784587|NCT01449370|16501929|P12|Overall Study|Disease Progression|3
4784588|NCT01449370|16501930|P11|Overall Study|Disease Progression|3
4784589|NCT01449370|16501931|P10|Overall Study|Disease Progression|1
4784590|NCT01449370|16501932|P9|Overall Study|Disease Progression|9
4784591|NCT01449370|16501933|P8|Overall Study|Disease Progression|2
4784592|NCT01449370|16501934|P7|Overall Study|Disease Progression|3
4784593|NCT01449370|16501935|P6|Overall Study|Disease Progression|3
4784594|NCT01449370|16501936|P5|Overall Study|Disease Progression|3
4784595|NCT01449370|16501937|P4|Overall Study|Disease Progression|3
4784596|NCT01449370|16501938|P3|Overall Study|Disease Progression|8
4784597|NCT01449370|16501939|P2|Overall Study|Disease Progression|4
4784598|NCT01449370|16501940|P1|Overall Study|Disease Progression|5
4784599|NCT01449279|16502318|P1|Overall Study|Toxicity|2
4784600|NCT01449279|16502318|P1|Overall Study|Lack of Efficacy|5
4784601|NCT01449006|16502343|P2|Overall Study|Protocol Violation|0
4784602|NCT01449006|16502344|P1|Overall Study|Protocol Violation|1
4784603|NCT01449006|16502343|P2|Overall Study|Withdrawal by Subject|0
4784604|NCT01449006|16502344|P1|Overall Study|Withdrawal by Subject|1
4784605|NCT01449006|16502343|P2|Overall Study|Lost to Follow-up|0
4784606|NCT01449006|16502344|P1|Overall Study|Lost to Follow-up|1
4784607|NCT01448850|16502358|P2|Overall Study|Other|12
4784608|NCT01448850|16502359|P1|Overall Study|Other|15
4784609|NCT01448850|16502358|P2|Overall Study|Lost to Follow-up|1
4784610|NCT01448850|16502359|P1|Overall Study|Lost to Follow-up|3
4784611|NCT01448850|16502358|P2|Overall Study|Withdrawal by Subject|21
4784612|NCT01448850|16502359|P1|Overall Study|Withdrawal by Subject|13
4784613|NCT01448850|16502358|P2|Overall Study|Death|6
4784614|NCT01448850|16502359|P1|Overall Study|Death|3
4784615|NCT01448824|16502390|P8|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1
4784616|NCT01448824|16502391|P7|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784617|NCT01448824|16502392|P6|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784618|NCT01448824|16502393|P5|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784619|NCT01448824|16502394|P4|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784620|NCT01448824|16502395|P3|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784621|NCT01448824|16502396|P2|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784622|NCT01448824|16502397|P1|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0
4784623|NCT01448824|16502390|P8|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1
4784624|NCT01448824|16502391|P7|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784625|NCT01448824|16502392|P6|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784626|NCT01448824|16502393|P5|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784627|NCT01448824|16502394|P4|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784628|NCT01448824|16502395|P3|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784629|NCT01448824|16502396|P2|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784630|NCT01448824|16502397|P1|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0
4784631|NCT01448824|16502390|P8|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1
4784632|NCT01448824|16502391|P7|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784633|NCT01448824|16502392|P6|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784634|NCT01448824|16502393|P5|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784635|NCT01448824|16502394|P4|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784636|NCT01448824|16502395|P3|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784637|NCT01448824|16502396|P2|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784638|NCT01448824|16502397|P1|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0
4784639|NCT01448824|16502390|P8|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1
4784640|NCT01448824|16502391|P7|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784641|NCT01448824|16502392|P6|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784642|NCT01448824|16502393|P5|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784643|NCT01448824|16502394|P4|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784644|NCT01448824|16502395|P3|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784645|NCT01448824|16502396|P2|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784646|NCT01448824|16502397|P1|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0
4784647|NCT01448824|16502390|P8|Part 1: Washout Period|Lost to Follow-up|0
4784648|NCT01448824|16502391|P7|Part 1: Washout Period|Lost to Follow-up|0
4784649|NCT01448824|16502392|P6|Part 1: Washout Period|Lost to Follow-up|0
4784650|NCT01448824|16502393|P5|Part 1: Washout Period|Lost to Follow-up|0
4784651|NCT01448824|16502394|P4|Part 1: Washout Period|Lost to Follow-up|0
4784652|NCT01448824|16502395|P3|Part 1: Washout Period|Lost to Follow-up|0
4784653|NCT01448824|16502396|P2|Part 1: Washout Period|Lost to Follow-up|0
4784654|NCT01448824|16502397|P1|Part 1: Washout Period|Lost to Follow-up|1
4784655|NCT01448824|16502390|P8|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784656|NCT01448824|16502391|P7|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784657|NCT01448824|16502392|P6|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1
4784658|NCT01448824|16502393|P5|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784659|NCT01448824|16502394|P4|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784660|NCT01448824|16502395|P3|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784661|NCT01448824|16502396|P2|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784662|NCT01448824|16502397|P1|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0
4784663|NCT01448824|16502390|P8|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4784664|NCT01448824|16502391|P7|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4784665|NCT01448824|16502392|P6|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
4784666|NCT01448824|16502393|P5|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2
4784667|NCT01448824|16502394|P4|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1
4784668|NCT01448824|16502395|P3|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4784669|NCT01448824|16502396|P2|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4784670|NCT01448824|16502397|P1|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0
4784671|NCT01448824|16502390|P8|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784672|NCT01448824|16502391|P7|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1
4784673|NCT01448824|16502392|P6|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784674|NCT01448824|16502393|P5|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784675|NCT01448824|16502394|P4|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784676|NCT01448824|16502395|P3|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784677|NCT01448824|16502396|P2|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784678|NCT01448824|16502397|P1|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0
4784679|NCT01448707|16502448|P2|Overall Study|Other|4
4784680|NCT01448707|16502449|P1|Overall Study|Other|7
4784681|NCT01448707|16502448|P2|Overall Study|Withdrawal by Subject|7
4784682|NCT01448707|16502449|P1|Overall Study|Withdrawal by Subject|6
4784683|NCT01448707|16502448|P2|Overall Study|Lost to Follow-up|6
4784684|NCT01448707|16502449|P1|Overall Study|Lost to Follow-up|2
4784685|NCT01448707|16502448|P2|Overall Study|Adverse Event|1
4784686|NCT01448707|16502449|P1|Overall Study|Adverse Event|3
4784687|NCT01448616|16502470|P4|Study Drug (Treatment Phase)|Withdrawal by Subject|2
4784688|NCT01448616|16502471|P3|Study Drug (Treatment Phase)|Withdrawal by Subject|2
4784689|NCT01448616|16502472|P2|Study Drug (Treatment Phase)|Withdrawal by Subject|1
4784690|NCT01448616|16502473|P1|Study Drug (Treatment Phase)|Withdrawal by Subject|0
4784691|NCT01448616|16502470|P4|Study Drug (Treatment Phase)|Never initiated study drug|2
4784692|NCT01448616|16502471|P3|Study Drug (Treatment Phase)|Never initiated study drug|1
4784693|NCT01448616|16502472|P2|Study Drug (Treatment Phase)|Never initiated study drug|0
4784694|NCT01448616|16502473|P1|Study Drug (Treatment Phase)|Never initiated study drug|0
4784695|NCT01448616|16502470|P4|Study Drug (Treatment Phase)|Adverse Event|0
4784696|NCT01448616|16502471|P3|Study Drug (Treatment Phase)|Adverse Event|1
4784697|NCT01448616|16502472|P2|Study Drug (Treatment Phase)|Adverse Event|1
4784698|NCT01448616|16502473|P1|Study Drug (Treatment Phase)|Adverse Event|0
4784699|NCT01448616|16502470|P4|Lead-In (Observational Phase)|Collected <90% of required swabs|0
4784700|NCT01448616|16502471|P3|Lead-In (Observational Phase)|Collected <90% of required swabs|0
4784701|NCT01448616|16502472|P2|Lead-In (Observational Phase)|Collected <90% of required swabs|0
4784702|NCT01448616|16502473|P1|Lead-In (Observational Phase)|Collected <90% of required swabs|6
4784703|NCT01448616|16502470|P4|Lead-In (Observational Phase)|Collected no genital swabs|0
4784704|NCT01448616|16502471|P3|Lead-In (Observational Phase)|Collected no genital swabs|0
4784705|NCT01448616|16502472|P2|Lead-In (Observational Phase)|Collected no genital swabs|0
4784706|NCT01448616|16502473|P1|Lead-In (Observational Phase)|Collected no genital swabs|3
4784707|NCT01448213|16502525|P2|Overall Study|Protocol Violation|2
4784708|NCT01448213|16502526|P1|Overall Study|Protocol Violation|1
4784709|NCT01448213|16502525|P2|Overall Study|Adverse Event|10
4784710|NCT01448213|16502526|P1|Overall Study|Adverse Event|4
4784711|NCT01448213|16502525|P2|Overall Study|Lost to Follow-up|10
4784712|NCT01448213|16502526|P1|Overall Study|Lost to Follow-up|12
4784713|NCT01448057|16502536|P2|Overall Study|Withdrawal by Subject|0
4784714|NCT01448057|16502537|P1|Overall Study|Withdrawal by Subject|2
4784715|NCT01448057|16502536|P2|Overall Study|Adverse Event|2
4784716|NCT01448057|16502537|P1|Overall Study|Adverse Event|0
4784717|NCT01448057|16502536|P2|Overall Study|Lost to Follow-up|0
4784718|NCT01448057|16502537|P1|Overall Study|Lost to Follow-up|3
4784719|NCT01448057|16502536|P2|Overall Study|Protocol Violation|2
4784720|NCT01448057|16502537|P1|Overall Study|Protocol Violation|3
4784721|NCT01448044|16502547|P2|Follow Up Period|Other|11
4784722|NCT01448044|16502548|P1|Follow Up Period|Other|5
4784723|NCT01448044|16502547|P2|Follow Up Period|Lost to Follow-up|2
4784724|NCT01448044|16502548|P1|Follow Up Period|Lost to Follow-up|6
4784725|NCT01448044|16502547|P2|Follow Up Period|Withdrawal by Subject|1
4784726|NCT01448044|16502548|P1|Follow Up Period|Withdrawal by Subject|1
4784727|NCT01448044|16502547|P2|Treatment Period|Other reason|0
4784728|NCT01448044|16502548|P1|Treatment Period|Other reason|2
4784729|NCT01448044|16502547|P2|Treatment Period|Lost to Follow-up|1
4784730|NCT01448044|16502548|P1|Treatment Period|Lost to Follow-up|2
4784731|NCT01448044|16502547|P2|Treatment Period|Participant does not meet study criteria|0
4784732|NCT01448044|16502548|P1|Treatment Period|Participant does not meet study criteria|1
4784733|NCT01448044|16502547|P2|Treatment Period|Completed 24 weeks treatment period only|0
4784734|NCT01448044|16502548|P1|Treatment Period|Completed 24 weeks treatment period only|8
4784735|NCT01448044|16502547|P2|Treatment Period|Subject requested discontinue study drug|0
4784736|NCT01448044|16502548|P1|Treatment Period|Subject requested discontinue study drug|1
4784737|NCT01448044|16502547|P2|Treatment Period|Lack of Efficacy|12
4784738|NCT01448044|16502548|P1|Treatment Period|Lack of Efficacy|5
4784739|NCT01448044|16502547|P2|Treatment Period|Adverse Event|3
4784740|NCT01448044|16502548|P1|Treatment Period|Adverse Event|4
4784741|NCT01447927|16502564|P2|Overall Study|Withdrawal by Subject|0
4784742|NCT01447927|16502565|P1|Overall Study|Withdrawal by Subject|1
4784743|NCT01447927|16502564|P2|Overall Study|Adverse Event|3
4784744|NCT01447927|16502565|P1|Overall Study|Adverse Event|4
4784745|NCT01447719|16502610|P1|Overall Study|Family withdrew autopsy consent|7
4784746|NCT01447719|16502610|P1|Overall Study|Withdrawal by Subject|2
4784747|NCT01447719|16502610|P1|Overall Study|Subject still living at end of study|79
4784748|NCT01447719|16502610|P1|Overall Study|Invalid image or not imaged|3
4784749|NCT01447719|16502610|P1|Overall Study|Image acquisition failure|2
4784750|NCT01447576|16502636|P1|Overall Study|Physician Decision|6
4784751|NCT01447576|16502636|P1|Overall Study|Lack of Efficacy|68
4784752|NCT01447576|16502636|P1|Overall Study|Protocol deviation|83
4784753|NCT01447576|16502636|P1|Overall Study|Withdrawal by Subject|100
4784754|NCT01447576|16502636|P1|Overall Study|Participant met withdrawal criteria|40
4784755|NCT01447576|16502636|P1|Overall Study|Adverse Event|127
4784756|NCT01447576|16502636|P1|Overall Study|Lost to Follow-up|52
4784757|NCT01447446|16502669|P6|Overall Study|Reason not Specified|0
4784758|NCT01447446|16502670|P5|Overall Study|Reason not Specified|1
4784759|NCT01447446|16502671|P4|Overall Study|Reason not Specified|1
4784760|NCT01447446|16502672|P3|Overall Study|Reason not Specified|1
4784761|NCT01447446|16502673|P2|Overall Study|Reason not Specified|1
4784762|NCT01447446|16502674|P1|Overall Study|Reason not Specified|1
4784763|NCT01447446|16502669|P6|Overall Study|New Treatment Started|0
4784764|NCT01447446|16502670|P5|Overall Study|New Treatment Started|2
4784765|NCT01447446|16502671|P4|Overall Study|New Treatment Started|0
4784766|NCT01447446|16502672|P3|Overall Study|New Treatment Started|1
4784767|NCT01447446|16502673|P2|Overall Study|New Treatment Started|2
4784768|NCT01447446|16502674|P1|Overall Study|New Treatment Started|8
4784769|NCT01447446|16502669|P6|Overall Study|SVR12 Assessment|5
4784770|NCT01447446|16502670|P5|Overall Study|SVR12 Assessment|5
4784771|NCT01447446|16502671|P4|Overall Study|SVR12 Assessment|1
4784772|NCT01447446|16502672|P3|Overall Study|SVR12 Assessment|2
4784773|NCT01447446|16502673|P2|Overall Study|SVR12 Assessment|1
4784774|NCT01447446|16502674|P1|Overall Study|SVR12 Assessment|13
4784775|NCT01447446|16502669|P6|Overall Study|Administrative/Other|4
4784776|NCT01447446|16502670|P5|Overall Study|Administrative/Other|33
4784777|NCT01447446|16502671|P4|Overall Study|Administrative/Other|2
4784778|NCT01447446|16502672|P3|Overall Study|Administrative/Other|10
4784779|NCT01447446|16502673|P2|Overall Study|Administrative/Other|9
4784780|NCT01447446|16502674|P1|Overall Study|Administrative/Other|34
4784781|NCT01447446|16502669|P6|Overall Study|Insuff. VR/TRT too Short to Expect VR|14
4784782|NCT01447446|16502670|P5|Overall Study|Insuff. VR/TRT too Short to Expect VR|92
4784783|NCT01447446|16502671|P4|Overall Study|Insuff. VR/TRT too Short to Expect VR|21
4784784|NCT01447446|16502672|P3|Overall Study|Insuff. VR/TRT too Short to Expect VR|52
4784785|NCT01447446|16502673|P2|Overall Study|Insuff. VR/TRT too Short to Expect VR|71
4784786|NCT01447446|16502674|P1|Overall Study|Insuff. VR/TRT too Short to Expect VR|300
4784787|NCT01447446|16502669|P6|Overall Study|Failure to Return/Consent Withdrawn|9
4784788|NCT01447446|16502670|P5|Overall Study|Failure to Return/Consent Withdrawn|69
4784789|NCT01447446|16502671|P4|Overall Study|Failure to Return/Consent Withdrawn|7
4784790|NCT01447446|16502672|P3|Overall Study|Failure to Return/Consent Withdrawn|31
4784791|NCT01447446|16502673|P2|Overall Study|Failure to Return/Consent Withdrawn|78
4784792|NCT01447446|16502674|P1|Overall Study|Failure to Return/Consent Withdrawn|357
4784793|NCT01447446|16502669|P6|Overall Study|Adverse Event|0
4784794|NCT01447446|16502670|P5|Overall Study|Adverse Event|2
4784795|NCT01447446|16502671|P4|Overall Study|Adverse Event|0
4784796|NCT01447446|16502672|P3|Overall Study|Adverse Event|1
4784797|NCT01447446|16502673|P2|Overall Study|Adverse Event|0
4784798|NCT01447446|16502674|P1|Overall Study|Adverse Event|3
4784799|NCT01447446|16502669|P6|Overall Study|Death|0
4784800|NCT01447446|16502670|P5|Overall Study|Death|7
4784801|NCT01447446|16502671|P4|Overall Study|Death|1
4784802|NCT01447446|16502672|P3|Overall Study|Death|2
4784803|NCT01447446|16502673|P2|Overall Study|Death|3
4784804|NCT01447446|16502674|P1|Overall Study|Death|6
4784805|NCT01447433|16502764|P2|Overall Study|Protocol Violation|1
4784806|NCT01447433|16502765|P1|Overall Study|Protocol Violation|1
4784807|NCT01447433|16502764|P2|Overall Study|Withdrawal by Subject|3
4784808|NCT01447433|16502765|P1|Overall Study|Withdrawal by Subject|3
4784809|NCT01447433|16502764|P2|Overall Study|Lost to Follow-up|2
4784810|NCT01447433|16502765|P1|Overall Study|Lost to Follow-up|0
4784811|NCT01447420|16502792|P3|Overall Study|Lack of Efficacy|8
4784812|NCT01447420|16502793|P2|Overall Study|Lack of Efficacy|19
4784813|NCT01447420|16502794|P1|Overall Study|Lack of Efficacy|1
4784814|NCT01447420|16502792|P3|Overall Study|Withdrawal by Subject|0
4784815|NCT01447420|16502793|P2|Overall Study|Withdrawal by Subject|1
4784816|NCT01447420|16502794|P1|Overall Study|Withdrawal by Subject|4
4784817|NCT01447420|16502792|P3|Overall Study|Protocol Violation|0
4784818|NCT01447420|16502793|P2|Overall Study|Protocol Violation|3
4784819|NCT01447420|16502794|P1|Overall Study|Protocol Violation|3
4784820|NCT01447420|16502792|P3|Overall Study|Adverse Event|2
4784821|NCT01447420|16502793|P2|Overall Study|Adverse Event|4
4784822|NCT01447420|16502794|P1|Overall Study|Adverse Event|2
4784823|NCT01447407|16502814|P4|Overall Study|Physician Decision|1
4784824|NCT01447407|16502815|P3|Overall Study|Physician Decision|1
4784825|NCT01447407|16502816|P2|Overall Study|Physician Decision|0
4784826|NCT01447407|16502817|P1|Overall Study|Physician Decision|0
4784827|NCT01447407|16502814|P4|Overall Study|Withdrawal by Subject|1
4784828|NCT01447407|16502815|P3|Overall Study|Withdrawal by Subject|0
4784829|NCT01447407|16502816|P2|Overall Study|Withdrawal by Subject|0
4784830|NCT01447407|16502817|P1|Overall Study|Withdrawal by Subject|2
4784831|NCT01446874|16502951|P3|Overall Study|Withdrawal by Subject|4
4784832|NCT01446874|16502952|P2|Overall Study|Withdrawal by Subject|0
4784833|NCT01446874|16502953|P1|Overall Study|Withdrawal by Subject|0
4784834|NCT01446874|16502951|P3|Overall Study|Antibiotics for pre-op infection|2
4784835|NCT01446874|16502952|P2|Overall Study|Antibiotics for pre-op infection|0
4784836|NCT01446874|16502953|P1|Overall Study|Antibiotics for pre-op infection|0
4784837|NCT01446874|16502951|P3|Overall Study|Non-compliance|0
4784838|NCT01446874|16502952|P2|Overall Study|Non-compliance|4
4784839|NCT01446874|16502953|P1|Overall Study|Non-compliance|0
4784840|NCT01446874|16502951|P3|Overall Study|No surgery/No qualifying surgery|12
4784841|NCT01446874|16502952|P2|Overall Study|No surgery/No qualifying surgery|0
4784842|NCT01446874|16502953|P1|Overall Study|No surgery/No qualifying surgery|1
4784843|NCT01446874|16502951|P3|Overall Study|Not eligible|0
4784844|NCT01446874|16502952|P2|Overall Study|Not eligible|0
4784845|NCT01446874|16502953|P1|Overall Study|Not eligible|1
4784846|NCT01446809|16502981|P3|Overall Study|Failure to complete study procedures|1
4784847|NCT01446809|16502982|P2|Overall Study|Failure to complete study procedures|0
4784848|NCT01446809|16502983|P1|Overall Study|Failure to complete study procedures|0
4784849|NCT01446809|16502981|P3|Overall Study|Adverse Event|1
4784850|NCT01446809|16502982|P2|Overall Study|Adverse Event|0
4784851|NCT01446809|16502983|P1|Overall Study|Adverse Event|0
4784852|NCT01446796|16503006|P2|Overall Study|Withdrawal by Subject|0
4784853|NCT01446796|16503007|P1|Overall Study|Withdrawal by Subject|1
4784854|NCT01446419|16503053|P2|Overall Study|Terminated per protocol|0
4784855|NCT01446419|16503054|P1|Overall Study|Terminated per protocol|3
4784856|NCT01446419|16503053|P2|Overall Study|Withdrawal by Subject|1
4784857|NCT01446419|16503054|P1|Overall Study|Withdrawal by Subject|1
4784858|NCT01446419|16503053|P2|Overall Study|Death|0
4784859|NCT01446419|16503054|P1|Overall Study|Death|1
4784860|NCT01446289|16503068|P4|Overall Study|Withdrawal by Subject|0
4784861|NCT01446289|16503069|P3|Overall Study|Withdrawal by Subject|1
4784862|NCT01446289|16503070|P2|Overall Study|Withdrawal by Subject|0
4784863|NCT01446289|16503071|P1|Overall Study|Withdrawal by Subject|1
4784864|NCT01446237|16503114|P1|Overall Study|Withdrawal by Subject|7
4784865|NCT01446237|16503114|P1|Overall Study|Lost to Follow-up|2
4784866|NCT01446237|16503114|P1|Overall Study|Adverse Event|1
4784867|NCT01446159|16503126|P4|Overall Study|Other|13
4784868|NCT01446159|16503127|P3|Overall Study|Other|13
4784869|NCT01446159|16503128|P2|Overall Study|Other|0
4784870|NCT01446159|16503129|P1|Overall Study|Other|0
4784871|NCT01446159|16503126|P4|Overall Study|Death|36
4784872|NCT01446159|16503127|P3|Overall Study|Death|43
4784873|NCT01446159|16503128|P2|Overall Study|Death|3
4784874|NCT01446159|16503129|P1|Overall Study|Death|2
4784875|NCT01446159|16503126|P4|Overall Study|Lost to Follow-up|2
4784876|NCT01446159|16503127|P3|Overall Study|Lost to Follow-up|1
4784877|NCT01446159|16503128|P2|Overall Study|Lost to Follow-up|0
4784878|NCT01446159|16503129|P1|Overall Study|Lost to Follow-up|0
4784879|NCT01446159|16503126|P4|Overall Study|Withdrawal by Subject|11
4784880|NCT01446159|16503127|P3|Overall Study|Withdrawal by Subject|14
4784881|NCT01446159|16503128|P2|Overall Study|Withdrawal by Subject|0
4784882|NCT01446159|16503129|P1|Overall Study|Withdrawal by Subject|1
4784883|NCT01446042|16503204|P3|Overall Study|Other reasons|1
4784884|NCT01446042|16503205|P2|Overall Study|Other reasons|1
4784885|NCT01446042|16503206|P1|Overall Study|Other reasons|2
4784886|NCT01446042|16503204|P3|Overall Study|Lost to Follow-up|0
4784887|NCT01446042|16503205|P2|Overall Study|Lost to Follow-up|0
4784888|NCT01446042|16503206|P1|Overall Study|Lost to Follow-up|5
4784889|NCT01446042|16503204|P3|Overall Study|Adverse Event|4
4784890|NCT01446042|16503205|P2|Overall Study|Adverse Event|0
4784891|NCT01446042|16503206|P1|Overall Study|Adverse Event|1
4784892|NCT01446042|16503204|P3|Overall Study|Withdrawal by Subject|4
4784893|NCT01446042|16503205|P2|Overall Study|Withdrawal by Subject|2
4784894|NCT01446042|16503206|P1|Overall Study|Withdrawal by Subject|12
4784895|NCT01446003|16503217|P2|Period 2|Adverse Event|0
4784896|NCT01446003|16503218|P1|Period 2|Adverse Event|1
4784897|NCT01446003|16503217|P2|Period 1|Protocol Violation|0
4784898|NCT01446003|16503218|P1|Period 1|Protocol Violation|2
4784899|NCT01445951|16503239|P3|Overall Study|Cough|0
4784900|NCT01445951|16503240|P2|Overall Study|Cough|1
4784901|NCT01445951|16503241|P1|Overall Study|Cough|0
4784902|NCT01445951|16503239|P3|Overall Study|Sponsor decision - subject travel|0
4784903|NCT01445951|16503240|P2|Overall Study|Sponsor decision - subject travel|1
4784904|NCT01445951|16503241|P1|Overall Study|Sponsor decision - subject travel|0
4784905|NCT01445951|16503239|P3|Overall Study|Non-compliance with protocol|0
4784906|NCT01445951|16503240|P2|Overall Study|Non-compliance with protocol|1
4784907|NCT01445951|16503241|P1|Overall Study|Non-compliance with protocol|0
4784908|NCT01445951|16503239|P3|Overall Study|Non-compliance with study drug|0
4784909|NCT01445951|16503240|P2|Overall Study|Non-compliance with study drug|2
4784910|NCT01445951|16503241|P1|Overall Study|Non-compliance with study drug|1
4784911|NCT01445951|16503239|P3|Overall Study|Death|1
4784912|NCT01445951|16503240|P2|Overall Study|Death|0
4784913|NCT01445951|16503241|P1|Overall Study|Death|0
4784914|NCT01445951|16503239|P3|Overall Study|Pregnancy|4
4784915|NCT01445951|16503240|P2|Overall Study|Pregnancy|1
4784916|NCT01445951|16503241|P1|Overall Study|Pregnancy|0
4784917|NCT01445951|16503239|P3|Overall Study|Lost to Follow-up|4
4784918|NCT01445951|16503240|P2|Overall Study|Lost to Follow-up|2
4784919|NCT01445951|16503241|P1|Overall Study|Lost to Follow-up|1
4784920|NCT01445951|16503239|P3|Overall Study|Physician Decision|0
4784921|NCT01445951|16503240|P2|Overall Study|Physician Decision|1
4784922|NCT01445951|16503241|P1|Overall Study|Physician Decision|3
4784923|NCT01445951|16503239|P3|Overall Study|Withdrawal by Subject|8
4784924|NCT01445951|16503240|P2|Overall Study|Withdrawal by Subject|16
4784925|NCT01445951|16503241|P1|Overall Study|Withdrawal by Subject|21
4784926|NCT01445951|16503239|P3|Overall Study|Protocol Violation|2
4784927|NCT01445951|16503240|P2|Overall Study|Protocol Violation|2
4784928|NCT01445951|16503241|P1|Overall Study|Protocol Violation|2
4784929|NCT01445951|16503239|P3|Overall Study|Adverse Event|0
4784930|NCT01445951|16503240|P2|Overall Study|Adverse Event|9
4784931|NCT01445951|16503241|P1|Overall Study|Adverse Event|16
4784932|NCT01445886|16503279|P1|Overall Study|Protocol Violation|3
4784933|NCT01445886|16503279|P1|Overall Study|Lost to Follow-up|2
4784934|NCT01445847|16503319|P2|Overall Study|Missed Data|0
4784935|NCT01445847|16503320|P1|Overall Study|Missed Data|1
4784936|NCT01445847|16503319|P2|Overall Study|Protocol Violation|14
4784937|NCT01445847|16503320|P1|Overall Study|Protocol Violation|13
4784938|NCT01445769|16503337|P1|Overall Study|Lost to Follow-up|5
4784939|NCT01445769|16503337|P1|Overall Study|Disease Progression|1
4784940|NCT01445769|16503337|P1|Overall Study|Consent Withdrawn|2
4784941|NCT01445678|16503357|P2|Overall Study|Withdrawal by Subject|5
4784942|NCT01445678|16503358|P1|Overall Study|Withdrawal by Subject|9
4784943|NCT01445678|16503357|P2|Overall Study|Protocol Violation|1
4784944|NCT01445678|16503358|P1|Overall Study|Protocol Violation|1
4784945|NCT01445678|16503357|P2|Overall Study|Lost to Follow-up|5
4784946|NCT01445678|16503358|P1|Overall Study|Lost to Follow-up|8
4784947|NCT01445678|16503357|P2|Overall Study|Lack of Efficacy|2
4784948|NCT01445678|16503358|P1|Overall Study|Lack of Efficacy|0
4784949|NCT01445678|16503357|P2|Overall Study|Adverse Event|8
4784950|NCT01445678|16503358|P1|Overall Study|Adverse Event|12
4784951|NCT01445652|16503376|P2|Overall Study|Adverse Event|0
4784952|NCT01445652|16503377|P1|Overall Study|Adverse Event|1
4784953|NCT01445652|16503376|P2|Overall Study|Failed teach session|0
4784954|NCT01445652|16503377|P1|Overall Study|Failed teach session|2
4784955|NCT01445652|16503376|P2|Overall Study|Failed to attend scheduled visit|3
4784956|NCT01445652|16503377|P1|Overall Study|Failed to attend scheduled visit|2
4784957|NCT01445652|16503376|P2|Overall Study|Not comfortable in lenses|0
4784958|NCT01445652|16503377|P1|Overall Study|Not comfortable in lenses|5
4784959|NCT01445613|16503395|P1|1-year Follow-up|Received a non-study stent|2
4784960|NCT01445613|16503395|P1|1-year Follow-up|Physician Decision|2
4784961|NCT01445613|16503395|P1|1-year Follow-up|Death|30
4784962|NCT01445613|16503395|P1|1-year Follow-up|Lost to Follow-up|2
4784963|NCT01445613|16503395|P1|1-year Follow-up|Missed visit|29
4784964|NCT01445613|16503395|P1|1-year Follow-up|Withdrawal by Subject|12
4784965|NCT01445613|16503395|P1|30-day Follow-up|Death|3
4784966|NCT01445613|16503395|P1|30-day Follow-up|Missed visit|23
4784967|NCT01445613|16503395|P1|30-day Follow-up|Physician Decision|3
4784968|NCT01445613|16503395|P1|30-day Follow-up|Withdrawal by Subject|6
4784969|NCT01445548|16503413|P1|Overall Study|Adverse Event|1
4784970|NCT01445535|16503439|P4|Overall Study|PI discretion|1
4784971|NCT01445535|16503440|P3|Overall Study|PI discretion|0
4784972|NCT01445535|16503441|P2|Overall Study|PI discretion|0
4784973|NCT01445535|16503442|P1|Overall Study|PI discretion|0
4784974|NCT01445535|16503439|P4|Overall Study|Disease progression|0
4784975|NCT01445535|16503440|P3|Overall Study|Disease progression|1
4784976|NCT01445535|16503441|P2|Overall Study|Disease progression|0
4784977|NCT01445535|16503442|P1|Overall Study|Disease progression|1
4784978|NCT01445535|16503439|P4|Overall Study|Enrolled/taken off study, no drug avail.|1
4784979|NCT01445535|16503440|P3|Overall Study|Enrolled/taken off study, no drug avail.|0
4784980|NCT01445535|16503441|P2|Overall Study|Enrolled/taken off study, no drug avail.|0
4784981|NCT01445535|16503442|P1|Overall Study|Enrolled/taken off study, no drug avail.|0
4784982|NCT01445301|16503466|P3|Overall Study|Withdrawal by Subject|4
4784983|NCT01445301|16503467|P2|Overall Study|Withdrawal by Subject|6
4784984|NCT01445301|16503468|P1|Overall Study|Withdrawal by Subject|5
4784985|NCT01445301|16503466|P3|Overall Study|Physician Decision|0
4784986|NCT01445301|16503467|P2|Overall Study|Physician Decision|2
4784987|NCT01445301|16503468|P1|Overall Study|Physician Decision|0
4784988|NCT01445301|16503466|P3|Overall Study|Protocol-Defined Stopping Criteria|1
4784989|NCT01445301|16503467|P2|Overall Study|Protocol-Defined Stopping Criteria|1
4784990|NCT01445301|16503468|P1|Overall Study|Protocol-Defined Stopping Criteria|0
4784991|NCT01445301|16503466|P3|Overall Study|Protocol Violation|0
4784992|NCT01445301|16503467|P2|Overall Study|Protocol Violation|0
4784993|NCT01445301|16503468|P1|Overall Study|Protocol Violation|1
4784994|NCT01445301|16503466|P3|Overall Study|Lack of Efficacy|0
4784995|NCT01445301|16503467|P2|Overall Study|Lack of Efficacy|1
4784996|NCT01445301|16503468|P1|Overall Study|Lack of Efficacy|0
4784997|NCT01445301|16503466|P3|Overall Study|Adverse Event|4
4784998|NCT01445301|16503467|P2|Overall Study|Adverse Event|25
4784999|NCT01445301|16503468|P1|Overall Study|Adverse Event|15
4785000|NCT01445171|16503503|P1|Overall Study|Consented but did not receive device|8
4785001|NCT01445171|16503503|P1|Overall Study|Subjects declined to return for followup|9
4785002|NCT01445171|16503503|P1|Overall Study|Death|51
4785003|NCT01445171|16503503|P1|Overall Study|Withdrawal by Subject|16
4785004|NCT01445171|16503503|P1|Overall Study|Lost to Follow-up|11
4785005|NCT01444898|16503559|P1|Overall Study|Withdrawal by Subject|1
4785006|NCT01444781|16503574|P3|Overall Study|Withdrawal by Subject|2
4785007|NCT01444781|16503575|P2|Overall Study|Withdrawal by Subject|1
4785008|NCT01444781|16503576|P1|Overall Study|Withdrawal by Subject|3
4785009|NCT01444781|16503574|P3|Overall Study|Lost to Follow-up|1
4785010|NCT01444781|16503575|P2|Overall Study|Lost to Follow-up|3
4785011|NCT01444781|16503576|P1|Overall Study|Lost to Follow-up|0
4785012|NCT01444742|16503614|P1|Overall Study|Death|1
4785013|NCT01444651|16503621|P2|Overall Study|Missing data|1
4785014|NCT01444651|16503622|P1|Overall Study|Missing data|1
4785015|NCT01444651|16503621|P2|Overall Study|Non-fasting|1
4785016|NCT01444651|16503622|P1|Overall Study|Non-fasting|2
4785017|NCT01444651|16503621|P2|Overall Study|Lost to Follow-up|5
4785018|NCT01444651|16503622|P1|Overall Study|Lost to Follow-up|5
4785019|NCT01444651|16503621|P2|Overall Study|Adverse Event|2
4785020|NCT01444651|16503622|P1|Overall Study|Adverse Event|3
4785021|NCT01444456|16503638|P1|Overall Study|Not treated|104
4785022|NCT01444456|16503638|P1|Overall Study|Other|18
4785023|NCT01444456|16503638|P1|Overall Study|Ineligibility determined|23
4785024|NCT01444456|16503638|P1|Overall Study|Death|73
4785025|NCT01444456|16503638|P1|Overall Study|Lost to Follow-up|37
4785026|NCT01444456|16503638|P1|Overall Study|Physician Decision|9
4785027|NCT01444456|16503638|P1|Overall Study|Withdrawal by Subject|21
4785028|NCT01444430|16503649|P2|Overall Study|CRF termination module not completed.|1
4785029|NCT01444430|16503650|P1|Overall Study|CRF termination module not completed.|0
4785030|NCT01444430|16503649|P2|Overall Study|Lost to Follow-up|0
4785031|NCT01444430|16503650|P1|Overall Study|Lost to Follow-up|2
4785032|NCT01444430|16503649|P2|Overall Study|Death|8
4785033|NCT01444430|16503650|P1|Overall Study|Death|6
4785034|NCT01444430|16503649|P2|Overall Study|Withdrawal by Subject|72
4785035|NCT01444430|16503650|P1|Overall Study|Withdrawal by Subject|53
4785036|NCT01444417|16503672|P2|Overall Study|Withdrawal by Subject|0
4785037|NCT01444417|16503673|P1|Overall Study|Withdrawal by Subject|2
4785038|NCT01444417|16503672|P2|Overall Study|Ineligibility Determined|1
4785039|NCT01444417|16503673|P1|Overall Study|Ineligibility Determined|0
4785040|NCT01444391|16503689|P1|Overall Study|Death|1
4785041|NCT01444378|16503697|P1|Overall Study|Missed Visits|10
4785042|NCT01444378|16503697|P1|Overall Study|Administrative Closure Of The Study|2
4785043|NCT01444378|16503697|P1|Overall Study|Death|3
4785044|NCT01444378|16503697|P1|Overall Study|Withdrawal by Subject|1
4785045|NCT01444378|16503697|P1|Overall Study|Lost to Follow-up|1
4785046|NCT01444300|16503809|P2|Overall Study|Adverse Event|0
4785047|NCT01444300|16503810|P1|Overall Study|Adverse Event|4
4785048|NCT01444092|16503842|P1|Overall Study|Other Eligibility criteria|7
4785049|NCT01444092|16503842|P1|Overall Study|Withdrawal by Subject|1
4785050|NCT01444092|16503842|P1|Overall Study|Protocol Violation|1
4785051|NCT01444092|16503842|P1|Overall Study|Adverse Event|8
4785052|NCT01444027|16503851|P3|Overall Study|Lost to Follow-up|14
4785053|NCT01444027|16503852|P2|Overall Study|Lost to Follow-up|20
4785054|NCT01444027|16503853|P1|Overall Study|Lost to Follow-up|26
4785055|NCT01444027|16503851|P3|Overall Study|Withdrawal by Subject|24
4785056|NCT01444027|16503852|P2|Overall Study|Withdrawal by Subject|10
4785057|NCT01444027|16503853|P1|Overall Study|Withdrawal by Subject|4
4785058|NCT01443923|16503875|P2|Overall Study|Adverse Event|0
4785059|NCT01443923|16503876|P1|Overall Study|Adverse Event|1
4785060|NCT01443858|16503893|P3|Overall Study|Lost to Follow-up|2
4785061|NCT01443858|16503894|P2|Overall Study|Lost to Follow-up|5
4785062|NCT01443858|16503895|P1|Overall Study|Lost to Follow-up|5
4785063|NCT01443858|16503893|P3|Overall Study|Lack of Efficacy|0
4785064|NCT01443858|16503894|P2|Overall Study|Lack of Efficacy|0
4785065|NCT01443858|16503895|P1|Overall Study|Lack of Efficacy|1
4785066|NCT01443858|16503893|P3|Overall Study|Withdrawal by Subject|5
4785067|NCT01443858|16503894|P2|Overall Study|Withdrawal by Subject|8
4785068|NCT01443858|16503895|P1|Overall Study|Withdrawal by Subject|9
4785069|NCT01443845|16503917|P2|Overall Study|Lost to Follow-up|13
4785070|NCT01443845|16503918|P1|Overall Study|Lost to Follow-up|9
4785071|NCT01443845|16503917|P2|Overall Study|Military Conflict - Site Terminated|21
4785072|NCT01443845|16503918|P1|Overall Study|Military Conflict - Site Terminated|20
4785073|NCT01443845|16503917|P2|Overall Study|Withdrawal by Subject|67
4785074|NCT01443845|16503918|P1|Overall Study|Withdrawal by Subject|63
4785075|NCT01443845|16503917|P2|Overall Study|Adverse Event|138
4785076|NCT01443845|16503918|P1|Overall Study|Adverse Event|64
4785077|NCT01443845|16503917|P2|Overall Study|Lack of Efficacy|5
4785078|NCT01443845|16503918|P1|Overall Study|Lack of Efficacy|10
4785079|NCT01443845|16503917|P2|Overall Study|Deterioration in pulmonary function|4
4785080|NCT01443845|16503918|P1|Overall Study|Deterioration in pulmonary function|1
4785081|NCT01443845|16503917|P2|Overall Study|Other reasons, such as COPD exacerbation|44
4785082|NCT01443845|16503918|P1|Overall Study|Other reasons, such as COPD exacerbation|44
4785083|NCT01443845|16503917|P2|Overall Study|Protocol Violation|45
4785084|NCT01443845|16503918|P1|Overall Study|Protocol Violation|43
4785085|NCT01443403|16503973|P4|Overall Study|Other - Miscellaneous|1
4785086|NCT01443403|16503974|P3|Overall Study|Other - Miscellaneous|0
4785087|NCT01443403|16503975|P2|Overall Study|Other - Miscellaneous|0
4785088|NCT01443403|16503976|P1|Overall Study|Other - Miscellaneous|1
4785089|NCT01443403|16503973|P4|Overall Study|Use of Prohibited Treatment|0
4785090|NCT01443403|16503974|P3|Overall Study|Use of Prohibited Treatment|0
4785091|NCT01443403|16503975|P2|Overall Study|Use of Prohibited Treatment|3
4785092|NCT01443403|16503976|P1|Overall Study|Use of Prohibited Treatment|2
4785093|NCT01443403|16503973|P4|Overall Study|Protocol Violation|1
4785094|NCT01443403|16503974|P3|Overall Study|Protocol Violation|1
4785095|NCT01443403|16503975|P2|Overall Study|Protocol Violation|1
4785096|NCT01443403|16503976|P1|Overall Study|Protocol Violation|2
4785097|NCT01443403|16503973|P4|Overall Study|Lost to Follow-up|1
4785098|NCT01443403|16503974|P3|Overall Study|Lost to Follow-up|0
4785099|NCT01443403|16503975|P2|Overall Study|Lost to Follow-up|0
4785100|NCT01443403|16503976|P1|Overall Study|Lost to Follow-up|0
4785101|NCT01443403|16503973|P4|Overall Study|Withdrawal by Subject|1
4785102|NCT01443403|16503974|P3|Overall Study|Withdrawal by Subject|2
4785103|NCT01443403|16503975|P2|Overall Study|Withdrawal by Subject|1
4785104|NCT01443403|16503976|P1|Overall Study|Withdrawal by Subject|0
4785105|NCT01443403|16503973|P4|Overall Study|Adverse Event|5
4785106|NCT01443403|16503974|P3|Overall Study|Adverse Event|4
4785107|NCT01443403|16503975|P2|Overall Study|Adverse Event|1
4785108|NCT01443403|16503976|P1|Overall Study|Adverse Event|1
4785109|NCT01443364|16504123|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4785110|NCT01443364|16504123|P1|Overall Study|AE, non-serious non-fatal|8
4785111|NCT01443364|16504123|P1|Overall Study|SAE, non-fatal|6
4785112|NCT01443364|16504123|P1|Overall Study|Other Reason|4
4785113|NCT01443364|16504123|P1|Overall Study|Withdrawal by Subject|5
4785114|NCT01443364|16504123|P1|Overall Study|Lost to Follow-up|3
4785115|NCT01443364|16504123|P1|Overall Study|Lack of Efficacy|14
4785116|NCT01443130|16504252|P6|Overall Study|Death of Subject's Infant|0
4785117|NCT01443130|16504253|P5|Overall Study|Death of Subject's Infant|0
4785118|NCT01443130|16504254|P4|Overall Study|Death of Subject's Infant|0
4785119|NCT01443130|16504255|P3|Overall Study|Death of Subject's Infant|11
4785120|NCT01443130|16504256|P2|Overall Study|Death of Subject's Infant|10
4785121|NCT01443130|16504257|P1|Overall Study|Death of Subject's Infant|5
4785122|NCT01443130|16504252|P6|Overall Study|Withdrawal by Subject|2
4785123|NCT01443130|16504253|P5|Overall Study|Withdrawal by Subject|7
4785124|NCT01443130|16504254|P4|Overall Study|Withdrawal by Subject|7
4785125|NCT01443130|16504255|P3|Overall Study|Withdrawal by Subject|12
4785126|NCT01443130|16504256|P2|Overall Study|Withdrawal by Subject|14
4785127|NCT01443130|16504257|P1|Overall Study|Withdrawal by Subject|15
4785128|NCT01443130|16504252|P6|Overall Study|Protocol Violation|3
4785129|NCT01443130|16504253|P5|Overall Study|Protocol Violation|2
4785130|NCT01443130|16504254|P4|Overall Study|Protocol Violation|2
4785131|NCT01443130|16504255|P3|Overall Study|Protocol Violation|3
4785132|NCT01443130|16504256|P2|Overall Study|Protocol Violation|1
4785133|NCT01443130|16504257|P1|Overall Study|Protocol Violation|2
4785134|NCT01443130|16504252|P6|Overall Study|Adverse Event|0
4785135|NCT01443130|16504253|P5|Overall Study|Adverse Event|0
4785136|NCT01443130|16504254|P4|Overall Study|Adverse Event|0
4785137|NCT01443130|16504255|P3|Overall Study|Adverse Event|1
4785138|NCT01443130|16504256|P2|Overall Study|Adverse Event|1
4785139|NCT01443130|16504257|P1|Overall Study|Adverse Event|2
4785140|NCT01443130|16504252|P6|Overall Study|Death|8
4785141|NCT01443130|16504253|P5|Overall Study|Death|10
4785142|NCT01443130|16504254|P4|Overall Study|Death|7
4785143|NCT01443130|16504255|P3|Overall Study|Death|0
4785144|NCT01443130|16504256|P2|Overall Study|Death|1
4785145|NCT01443130|16504257|P1|Overall Study|Death|0
4785146|NCT01443130|16504252|P6|Overall Study|Lost to Follow-up|21
4785147|NCT01443130|16504253|P5|Overall Study|Lost to Follow-up|25
4785148|NCT01443130|16504254|P4|Overall Study|Lost to Follow-up|23
4785149|NCT01443130|16504255|P3|Overall Study|Lost to Follow-up|50
4785150|NCT01443130|16504256|P2|Overall Study|Lost to Follow-up|42
4785151|NCT01443130|16504257|P1|Overall Study|Lost to Follow-up|44
4785152|NCT01443078|16504307|P1|Overall Study|Patient had brain mets|1
4785153|NCT01443078|16504307|P1|Overall Study|Withdrawal by Subject|1
4785154|NCT01443078|16504307|P1|Overall Study|Responded to neoadjuvant platinum txt|27
4785155|NCT01443026|16504314|P2|Overall Study|Lost to Follow-up|1
4785156|NCT01443026|16504315|P1|Overall Study|Lost to Follow-up|2
4785157|NCT01443026|16504314|P2|Overall Study|Withdrawal by Subject|3
4785158|NCT01443026|16504315|P1|Overall Study|Withdrawal by Subject|0
4785159|NCT01443026|16504314|P2|Overall Study|Death|1
4785160|NCT01443026|16504315|P1|Overall Study|Death|0
4785161|NCT01443026|16504314|P2|Overall Study|Physician Decision|0
4785162|NCT01443026|16504315|P1|Overall Study|Physician Decision|1
4785163|NCT01442779|16504330|P1|Overall Study|Non-compliance|1
4785164|NCT01442779|16504330|P1|Overall Study|Death|3
4785165|NCT01442779|16504330|P1|Overall Study|Withdrawal by Subject|3
4785166|NCT01442714|16504336|P1|Overall Study|Withdrawal by Subject|1
4785167|NCT01442714|16504336|P1|Overall Study|Death|11
4785168|NCT01442688|16504344|P2|Second Intervention|Adverse Event|0
4785169|NCT01442688|16504345|P1|Second Intervention|Adverse Event|1
4785170|NCT01442688|16504344|P2|First Intervention|subject incarcerated|0
4785171|NCT01442688|16504345|P1|First Intervention|subject incarcerated|1
4785172|NCT01442688|16504344|P2|First Intervention|Withdrawal by Subject|0
4785173|NCT01442688|16504345|P1|First Intervention|Withdrawal by Subject|1
4785174|NCT01442675|16504353|P1|Overall Study|Withdrawal by Subject|4
4785175|NCT01442675|16504353|P1|Overall Study|Lost to Follow-up|2
4785176|NCT01442675|16504353|P1|Overall Study|Protocol Violation|6
4785177|NCT01442493|16504365|P2|Overall Study|withdrawn from study|2
4785178|NCT01442493|16504366|P1|Overall Study|withdrawn from study|3
4785179|NCT01442376|16504387|P3|Overall Study|Not eligible for subsequent cycles|0
4785180|NCT01442376|16504388|P2|Overall Study|Not eligible for subsequent cycles|2
4785181|NCT01442376|16504389|P1|Overall Study|Not eligible for subsequent cycles|1
4785182|NCT01442376|16504387|P3|Overall Study|Patients not treated|1
4785183|NCT01442376|16504388|P2|Overall Study|Patients not treated|3
4785184|NCT01442376|16504389|P1|Overall Study|Patients not treated|2
4785185|NCT01442376|16504387|P3|Overall Study|Withdrawal of consent|1
4785186|NCT01442376|16504388|P2|Overall Study|Withdrawal of consent|0
4785187|NCT01442376|16504389|P1|Overall Study|Withdrawal of consent|0
4785188|NCT01442376|16504387|P3|Overall Study|Death|1
4785189|NCT01442376|16504388|P2|Overall Study|Death|1
4785190|NCT01442376|16504389|P1|Overall Study|Death|0
4785191|NCT01442376|16504387|P3|Overall Study|Adverse Event|2
4785192|NCT01442376|16504388|P2|Overall Study|Adverse Event|3
4785193|NCT01442376|16504389|P1|Overall Study|Adverse Event|0
4785194|NCT01442181|16504402|P2|Overall Study|atrial fibrillation not noted|1
4785195|NCT01442181|16504403|P1|Overall Study|atrial fibrillation not noted|0
4785196|NCT01442181|16504402|P2|Overall Study|patient in an additional study|0
4785197|NCT01442181|16504403|P1|Overall Study|patient in an additional study|1
4785198|NCT01442181|16504402|P2|Overall Study|Lost to Follow-up|1
4785199|NCT01442181|16504403|P1|Overall Study|Lost to Follow-up|1
4785200|NCT01442181|16504402|P2|Overall Study|low ejection factor|1
4785201|NCT01442181|16504403|P1|Overall Study|low ejection factor|0
4785202|NCT01442181|16504402|P2|Overall Study|no insurance for surgery|0
4785203|NCT01442181|16504403|P1|Overall Study|no insurance for surgery|1
4785204|NCT01442181|16504402|P2|Overall Study|patient refused surgery|0
4785205|NCT01442181|16504403|P1|Overall Study|patient refused surgery|1
4785206|NCT01442155|16504427|P1|Overall Study|Lost to Follow-up|2
4785207|NCT01442155|16504427|P1|Overall Study|Adverse Event|2
4785208|NCT01442155|16504427|P1|Overall Study|Recurrence|26
4785209|NCT01442155|16504427|P1|Overall Study|Complete remission|35
4785210|NCT01442103|16504443|P1|Overall Study|Lost to Follow-up|2
4785211|NCT01442064|16504453|P6|Overall Study|Condition mandated other intervention|2
4785212|NCT01442064|16504454|P5|Overall Study|Condition mandated other intervention|0
4785213|NCT01442064|16504455|P4|Overall Study|Condition mandated other intervention|0
4785214|NCT01442064|16504456|P3|Overall Study|Condition mandated other intervention|2
4785215|NCT01442064|16504457|P2|Overall Study|Condition mandated other intervention|1
4785216|NCT01442064|16504458|P1|Overall Study|Condition mandated other intervention|1
4785217|NCT01442064|16504453|P6|Overall Study|Subject non-compliance|2
4785218|NCT01442064|16504454|P5|Overall Study|Subject non-compliance|0
4785219|NCT01442064|16504455|P4|Overall Study|Subject non-compliance|0
4785220|NCT01442064|16504456|P3|Overall Study|Subject non-compliance|0
4785221|NCT01442064|16504457|P2|Overall Study|Subject non-compliance|0
4785222|NCT01442064|16504458|P1|Overall Study|Subject non-compliance|0
4785223|NCT01442064|16504453|P6|Overall Study|Sponsor decision|87
4785224|NCT01442064|16504454|P5|Overall Study|Sponsor decision|95
4785225|NCT01442064|16504455|P4|Overall Study|Sponsor decision|88
4785226|NCT01442064|16504456|P3|Overall Study|Sponsor decision|92
4785227|NCT01442064|16504457|P2|Overall Study|Sponsor decision|88
4785228|NCT01442064|16504458|P1|Overall Study|Sponsor decision|82
4785229|NCT01442064|16504453|P6|Overall Study|Withdrawal by Subject|1
4785230|NCT01442064|16504454|P5|Overall Study|Withdrawal by Subject|2
4785231|NCT01442064|16504455|P4|Overall Study|Withdrawal by Subject|2
4785232|NCT01442064|16504456|P3|Overall Study|Withdrawal by Subject|2
4785233|NCT01442064|16504457|P2|Overall Study|Withdrawal by Subject|3
4785234|NCT01442064|16504458|P1|Overall Study|Withdrawal by Subject|6
4785235|NCT01442064|16504453|P6|Overall Study|Physician Decision|1
4785236|NCT01442064|16504454|P5|Overall Study|Physician Decision|3
4785237|NCT01442064|16504455|P4|Overall Study|Physician Decision|3
4785238|NCT01442064|16504456|P3|Overall Study|Physician Decision|2
4785239|NCT01442064|16504457|P2|Overall Study|Physician Decision|1
4785240|NCT01442064|16504458|P1|Overall Study|Physician Decision|1
4785241|NCT01442064|16504453|P6|Overall Study|Lost to Follow-up|3
4785242|NCT01442064|16504454|P5|Overall Study|Lost to Follow-up|3
4785243|NCT01442064|16504455|P4|Overall Study|Lost to Follow-up|1
4785244|NCT01442064|16504456|P3|Overall Study|Lost to Follow-up|1
4785245|NCT01442064|16504457|P2|Overall Study|Lost to Follow-up|5
4785246|NCT01442064|16504458|P1|Overall Study|Lost to Follow-up|5
4785247|NCT01442064|16504453|P6|Overall Study|Death|3
4785248|NCT01442064|16504454|P5|Overall Study|Death|1
4785249|NCT01442064|16504455|P4|Overall Study|Death|3
4785250|NCT01442064|16504456|P3|Overall Study|Death|3
4785251|NCT01442064|16504457|P2|Overall Study|Death|1
4785252|NCT01442064|16504458|P1|Overall Study|Death|0
4785253|NCT01442064|16504453|P6|Overall Study|Adverse Event|0
4785254|NCT01442064|16504454|P5|Overall Study|Adverse Event|2
4785255|NCT01442064|16504455|P4|Overall Study|Adverse Event|1
4785256|NCT01442064|16504456|P3|Overall Study|Adverse Event|2
4785257|NCT01442064|16504457|P2|Overall Study|Adverse Event|2
4785258|NCT01442064|16504458|P1|Overall Study|Adverse Event|2
4785259|NCT01442038|16504495|P2|Overall Study|Study Terminated By Sponsor|3
4785260|NCT01442038|16504496|P1|Overall Study|Study Terminated By Sponsor|2
4785261|NCT01442038|16504495|P2|Overall Study|Investigator's Discretion|16
4785262|NCT01442038|16504496|P1|Overall Study|Investigator's Discretion|13
4785263|NCT01442038|16504495|P2|Overall Study|Protocol Deviation|20
4785264|NCT01442038|16504496|P1|Overall Study|Protocol Deviation|9
4785265|NCT01442038|16504495|P2|Overall Study|Adverse Event|15
4785266|NCT01442038|16504496|P1|Overall Study|Adverse Event|26
4785267|NCT01442038|16504495|P2|Overall Study|Lost to Follow-up|51
4785268|NCT01442038|16504496|P1|Overall Study|Lost to Follow-up|37
4785269|NCT01442038|16504495|P2|Overall Study|Participant Withdrew Consent|102
4785270|NCT01442038|16504496|P1|Overall Study|Participant Withdrew Consent|137
4785271|NCT01442038|16504495|P2|Overall Study|Investigator-Initiated Early Closure|43
4785272|NCT01442038|16504496|P1|Overall Study|Investigator-Initiated Early Closure|44
4785273|NCT01442038|16504495|P2|Overall Study|Death|29
4785274|NCT01442038|16504496|P1|Overall Study|Death|35
4785275|NCT01441973|16504510|P2|Overall Study|Participant withdrew consent|1
4785276|NCT01441973|16504511|P1|Overall Study|Participant withdrew consent|0
4785277|NCT01441973|16504510|P2|Overall Study|Administrative reason by sponsor|5
4785278|NCT01441973|16504511|P1|Overall Study|Administrative reason by sponsor|3
4785279|NCT01441973|16504510|P2|Overall Study|Poor compliance/noncompliance|1
4785280|NCT01441973|16504511|P1|Overall Study|Poor compliance/noncompliance|0
4785281|NCT01441973|16504510|P2|Overall Study|Participant request to discontinue|1
4785282|NCT01441973|16504511|P1|Overall Study|Participant request to discontinue|1
4785283|NCT01441973|16504510|P2|Overall Study|Adverse event unrelated to study drug|2
4785284|NCT01441973|16504511|P1|Overall Study|Adverse event unrelated to study drug|3
4785285|NCT01441973|16504510|P2|Overall Study|Disease progression|6
4785286|NCT01441973|16504511|P1|Overall Study|Disease progression|8
4785287|NCT01441960|16504533|P2|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0
4785288|NCT01441960|16504534|P1|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1
4785289|NCT01441960|16504533|P2|First Neuromuscular Blocking Agent:|Protocol Violation|1
4785290|NCT01441960|16504534|P1|First Neuromuscular Blocking Agent:|Protocol Violation|1
4785291|NCT01441960|16504533|P2|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5
4785292|NCT01441960|16504534|P1|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6
4785293|NCT01441765|16504559|P2|Overall Study|Death|0
4785294|NCT01441765|16504560|P1|Overall Study|Death|1
4785295|NCT01441635|16504584|P10|Overall Study|Other|0
4785296|NCT01441635|16504585|P9|Overall Study|Other|0
4785297|NCT01441635|16504586|P8|Overall Study|Other|1
4785298|NCT01441635|16504587|P7|Overall Study|Other|0
4785299|NCT01441635|16504588|P6|Overall Study|Other|0
4785300|NCT01441635|16504589|P5|Overall Study|Other|0
4785301|NCT01441635|16504590|P4|Overall Study|Other|0
4785302|NCT01441635|16504591|P3|Overall Study|Other|0
4785303|NCT01441635|16504592|P2|Overall Study|Other|0
4785304|NCT01441635|16504593|P1|Overall Study|Other|0
4785305|NCT01441635|16504584|P10|Overall Study|Received Exclusionary Medication|0
4785306|NCT01441635|16504585|P9|Overall Study|Received Exclusionary Medication|0
4785307|NCT01441635|16504586|P8|Overall Study|Received Exclusionary Medication|0
4785308|NCT01441635|16504587|P7|Overall Study|Received Exclusionary Medication|0
4785309|NCT01441635|16504588|P6|Overall Study|Received Exclusionary Medication|0
4785310|NCT01441635|16504589|P5|Overall Study|Received Exclusionary Medication|0
4785311|NCT01441635|16504590|P4|Overall Study|Received Exclusionary Medication|0
4785312|NCT01441635|16504591|P3|Overall Study|Received Exclusionary Medication|0
4785313|NCT01441635|16504592|P2|Overall Study|Received Exclusionary Medication|0
4785314|NCT01441635|16504593|P1|Overall Study|Received Exclusionary Medication|1
4785315|NCT01441635|16504584|P10|Overall Study|Surgery or Invasive Intervention|0
4785316|NCT01441635|16504585|P9|Overall Study|Surgery or Invasive Intervention|0
4785317|NCT01441635|16504586|P8|Overall Study|Surgery or Invasive Intervention|0
4785318|NCT01441635|16504587|P7|Overall Study|Surgery or Invasive Intervention|0
4785319|NCT01441635|16504588|P6|Overall Study|Surgery or Invasive Intervention|0
4785320|NCT01441635|16504589|P5|Overall Study|Surgery or Invasive Intervention|0
4785321|NCT01441635|16504590|P4|Overall Study|Surgery or Invasive Intervention|0
4785322|NCT01441635|16504591|P3|Overall Study|Surgery or Invasive Intervention|1
4785323|NCT01441635|16504592|P2|Overall Study|Surgery or Invasive Intervention|0
4785324|NCT01441635|16504593|P1|Overall Study|Surgery or Invasive Intervention|0
4785325|NCT01441635|16504584|P10|Overall Study|Noncompliance|0
4785326|NCT01441635|16504585|P9|Overall Study|Noncompliance|0
4785327|NCT01441635|16504586|P8|Overall Study|Noncompliance|0
4785328|NCT01441635|16504587|P7|Overall Study|Noncompliance|1
4785329|NCT01441635|16504588|P6|Overall Study|Noncompliance|0
4785330|NCT01441635|16504589|P5|Overall Study|Noncompliance|0
4785331|NCT01441635|16504590|P4|Overall Study|Noncompliance|0
4785332|NCT01441635|16504591|P3|Overall Study|Noncompliance|0
4785333|NCT01441635|16504592|P2|Overall Study|Noncompliance|1
4785334|NCT01441635|16504593|P1|Overall Study|Noncompliance|0
4785335|NCT01441635|16504584|P10|Overall Study|Lost to Follow-up|1
4785336|NCT01441635|16504585|P9|Overall Study|Lost to Follow-up|0
4785337|NCT01441635|16504586|P8|Overall Study|Lost to Follow-up|1
4785338|NCT01441635|16504587|P7|Overall Study|Lost to Follow-up|1
4785339|NCT01441635|16504588|P6|Overall Study|Lost to Follow-up|3
4785340|NCT01441635|16504589|P5|Overall Study|Lost to Follow-up|1
4785341|NCT01441635|16504590|P4|Overall Study|Lost to Follow-up|1
4785342|NCT01441635|16504591|P3|Overall Study|Lost to Follow-up|1
4785343|NCT01441635|16504592|P2|Overall Study|Lost to Follow-up|1
4785344|NCT01441635|16504593|P1|Overall Study|Lost to Follow-up|0
4785345|NCT01441635|16504584|P10|Overall Study|Withdrawal by Subject|1
4785346|NCT01441635|16504585|P9|Overall Study|Withdrawal by Subject|1
4785347|NCT01441635|16504586|P8|Overall Study|Withdrawal by Subject|0
4785348|NCT01441635|16504587|P7|Overall Study|Withdrawal by Subject|2
4785349|NCT01441635|16504588|P6|Overall Study|Withdrawal by Subject|0
4785350|NCT01441635|16504589|P5|Overall Study|Withdrawal by Subject|0
4785351|NCT01441635|16504590|P4|Overall Study|Withdrawal by Subject|1
4785352|NCT01441635|16504591|P3|Overall Study|Withdrawal by Subject|0
4785353|NCT01441635|16504592|P2|Overall Study|Withdrawal by Subject|1
4785354|NCT01441635|16504593|P1|Overall Study|Withdrawal by Subject|1
4785355|NCT01441635|16504584|P10|Overall Study|Adverse Event|0
4785356|NCT01441635|16504585|P9|Overall Study|Adverse Event|1
4785357|NCT01441635|16504586|P8|Overall Study|Adverse Event|2
4785358|NCT01441635|16504587|P7|Overall Study|Adverse Event|2
4785359|NCT01441635|16504588|P6|Overall Study|Adverse Event|2
4785360|NCT01441635|16504589|P5|Overall Study|Adverse Event|1
4785361|NCT01441635|16504590|P4|Overall Study|Adverse Event|5
4785362|NCT01441635|16504591|P3|Overall Study|Adverse Event|1
4785363|NCT01441635|16504592|P2|Overall Study|Adverse Event|3
4785364|NCT01441635|16504593|P1|Overall Study|Adverse Event|4
4785365|NCT01441596|16504808|P3|Overall Study|Not treated|1
4785366|NCT01441596|16504809|P2|Overall Study|Not treated|1
4785367|NCT01441596|16504810|P1|Overall Study|Not treated|0
4785368|NCT01441596|16504808|P3|Overall Study|Withdrawal by Subject|2
4785369|NCT01441596|16504809|P2|Overall Study|Withdrawal by Subject|0
4785370|NCT01441596|16504810|P1|Overall Study|Withdrawal by Subject|4
4785371|NCT01441596|16504808|P3|Overall Study|Other reason not defined below|1
4785372|NCT01441596|16504809|P2|Overall Study|Other reason not defined below|2
4785373|NCT01441596|16504810|P1|Overall Study|Other reason not defined below|0
4785374|NCT01441440|16504884|P3|Overall Study|Difficllty in keeping the schedule|0
4785375|NCT01441440|16504885|P2|Overall Study|Difficllty in keeping the schedule|1
4785376|NCT01441440|16504886|P1|Overall Study|Difficllty in keeping the schedule|1
4785377|NCT01441440|16504884|P3|Overall Study|Work-related matter|0
4785378|NCT01441440|16504885|P2|Overall Study|Work-related matter|1
4785379|NCT01441440|16504886|P1|Overall Study|Work-related matter|0
4785380|NCT01441440|16504884|P3|Overall Study|Moving|1
4785381|NCT01441440|16504885|P2|Overall Study|Moving|1
4785382|NCT01441440|16504886|P1|Overall Study|Moving|0
4785383|NCT01441440|16504884|P3|Overall Study|Lack of Efficacy|1
4785384|NCT01441440|16504885|P2|Overall Study|Lack of Efficacy|0
4785385|NCT01441440|16504886|P1|Overall Study|Lack of Efficacy|1
4785386|NCT01441440|16504884|P3|Overall Study|Pregnancy|0
4785387|NCT01441440|16504885|P2|Overall Study|Pregnancy|0
4785388|NCT01441440|16504886|P1|Overall Study|Pregnancy|1
4785389|NCT01441440|16504884|P3|Overall Study|Withdrawal by Subject|9
4785390|NCT01441440|16504885|P2|Overall Study|Withdrawal by Subject|9
4785391|NCT01441440|16504886|P1|Overall Study|Withdrawal by Subject|11
4785392|NCT01441440|16504884|P3|Overall Study|Lost to Follow-up|1
4785393|NCT01441440|16504885|P2|Overall Study|Lost to Follow-up|2
4785394|NCT01441440|16504886|P1|Overall Study|Lost to Follow-up|0
4785395|NCT01441440|16504884|P3|Overall Study|Adverse Event|9
4785396|NCT01441440|16504885|P2|Overall Study|Adverse Event|9
4785397|NCT01441440|16504886|P1|Overall Study|Adverse Event|2
4785398|NCT01441440|16504884|P3|Overall Study|Death|1
4785399|NCT01441440|16504885|P2|Overall Study|Death|0
4785400|NCT01441440|16504886|P1|Overall Study|Death|1
4785401|NCT01441414|16504909|P1|Overall Study|Subject refused further follow-up|1
4785402|NCT01441414|16504909|P1|Overall Study|Study terminated by sponsor|2
4785403|NCT01441414|16504909|P1|Overall Study|Other reasons|3
4785404|NCT01441414|16504909|P1|Overall Study|Participant died|9
4785405|NCT01441180|16504988|P3|Overall Study|Discontinued|2
4785406|NCT01441180|16504989|P2|Overall Study|Discontinued|0
4785407|NCT01441180|16504990|P1|Overall Study|Discontinued|0
4785408|NCT01441180|16504988|P3|Overall Study|Lost to Follow-up|1
4785409|NCT01441180|16504989|P2|Overall Study|Lost to Follow-up|1
4785410|NCT01441180|16504990|P1|Overall Study|Lost to Follow-up|1
4785411|NCT01441102|16505001|P1|Overall Study|Withdrawal by Subject|2
4785412|NCT01441102|16505001|P1|Overall Study|Adverse Event|1
4785413|NCT01441063|16505039|P1|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1
4785414|NCT01441063|16505039|P1|Tocilizumab Alone|Required AZT/VGC addition|3
4785415|NCT01440972|16505074|P2|Overall Study|Withdrawal by Subject|2
4785416|NCT01440972|16505075|P1|Overall Study|Withdrawal by Subject|3
4785417|NCT01440946|16505099|P2|Overall Study|Physician Decision|0
4785418|NCT01440946|16505100|P1|Overall Study|Physician Decision|1
4785419|NCT01440946|16505099|P2|Overall Study|Lost to Follow-up|1
4785420|NCT01440946|16505100|P1|Overall Study|Lost to Follow-up|1
4785421|NCT01440881|16505139|P2|Overall Study|Death|1
4785422|NCT01440881|16505140|P1|Overall Study|Death|0
4785423|NCT01440816|16505154|P2|Overall Study|To Be Seen By Local Oncologist|2
4785424|NCT01440816|16505155|P1|Overall Study|To Be Seen By Local Oncologist|1
4785425|NCT01440816|16505154|P2|Overall Study|Disease Progression|9
4785426|NCT01440816|16505155|P1|Overall Study|Disease Progression|0
4785427|NCT01440803|16505171|P2|Overall Study|Withdrawal by Subject|1
4785428|NCT01440803|16505172|P1|Overall Study|Withdrawal by Subject|0
4785429|NCT01440803|16505171|P2|Overall Study|Lost to Follow-up|2
4785430|NCT01440803|16505172|P1|Overall Study|Lost to Follow-up|0
4785431|NCT01440803|16505171|P2|Overall Study|Met study stopping rule|1
4785432|NCT01440803|16505172|P1|Overall Study|Met study stopping rule|2
4785433|NCT01440647|16505208|P2|Overall Study|Death|3
4785434|NCT01440647|16505209|P1|Overall Study|Death|2
4785435|NCT01440595|16505228|P3|Overall Study|Study terminated by sponsor.|1
4785436|NCT01440595|16505229|P2|Overall Study|Study terminated by sponsor.|2
4785437|NCT01440595|16505230|P1|Overall Study|Study terminated by sponsor.|1
4785438|NCT01440595|16505228|P3|Overall Study|Lost to Follow-up|0
4785439|NCT01440595|16505229|P2|Overall Study|Lost to Follow-up|1
4785440|NCT01440595|16505230|P1|Overall Study|Lost to Follow-up|0
4785441|NCT01440569|16505250|P2|Open-Label Rollover Phase|Subject Non-Compliance|1
4785442|NCT01440569|16505251|P1|Open-Label Rollover Phase|Subject Non-Compliance|1
4785443|NCT01440569|16505250|P2|Open-Label Rollover Phase|Lost to Follow-up|3
4785444|NCT01440569|16505251|P1|Open-Label Rollover Phase|Lost to Follow-up|26
4785445|NCT01440569|16505250|P2|Open-Label Rollover Phase|Withdrew Consent|1
4785446|NCT01440569|16505251|P1|Open-Label Rollover Phase|Withdrew Consent|11
4785447|NCT01440569|16505250|P2|Open-Label Rollover Phase|Investigator's Discretion|1
4785448|NCT01440569|16505251|P1|Open-Label Rollover Phase|Investigator's Discretion|3
4785449|NCT01440569|16505250|P2|Open-Label Rollover Phase|Lack of Efficacy|0
4785450|NCT01440569|16505251|P1|Open-Label Rollover Phase|Lack of Efficacy|2
4785451|NCT01440569|16505250|P2|Open-Label Rollover Phase|Pregnancy|0
4785452|NCT01440569|16505251|P1|Open-Label Rollover Phase|Pregnancy|1
4785453|NCT01440569|16505250|P2|Open-Label Rollover Phase|Adverse Event|0
4785454|NCT01440569|16505251|P1|Open-Label Rollover Phase|Adverse Event|3
4785455|NCT01440569|16505250|P2|Main Study|Protocol Violation|0
4785456|NCT01440569|16505251|P1|Main Study|Protocol Violation|1
4785457|NCT01440569|16505250|P2|Main Study|Subject Non-Compliance|0
4785458|NCT01440569|16505251|P1|Main Study|Subject Non-Compliance|3
4785459|NCT01440569|16505250|P2|Main Study|Lost to Follow-up|2
4785460|NCT01440569|16505251|P1|Main Study|Lost to Follow-up|13
4785461|NCT01440569|16505250|P2|Main Study|Withdrew Consent|1
4785462|NCT01440569|16505251|P1|Main Study|Withdrew Consent|7
4785463|NCT01440569|16505250|P2|Main Study|Investigator's Discretion|1
4785464|NCT01440569|16505251|P1|Main Study|Investigator's Discretion|1
4785465|NCT01440569|16505250|P2|Main Study|Pregnancy|0
4785466|NCT01440569|16505251|P1|Main Study|Pregnancy|1
4785467|NCT01440569|16505250|P2|Main Study|Adverse Event|0
4785468|NCT01440569|16505251|P1|Main Study|Adverse Event|9
4785469|NCT01440569|16505250|P2|Main Study|Enrolled but not treated|0
4785470|NCT01440569|16505251|P1|Main Study|Enrolled but not treated|1
4785471|NCT01440517|16505286|P1|Overall Study|Subject withdrawn prior to dosing|1
4785472|NCT01440374|16505362|P4|Part 3: Extension|Physician Decision|14
4785473|NCT01440374|16505363|P3|Part 3: Extension|Physician Decision|0
4785474|NCT01440374|16505364|P2|Part 3: Extension|Physician Decision|0
4785475|NCT01440374|16505365|P1|Part 3: Extension|Physician Decision|0
4785476|NCT01440374|16505362|P4|Part 3: Extension|Adverse Event|13
4785477|NCT01440374|16505363|P3|Part 3: Extension|Adverse Event|0
4785478|NCT01440374|16505364|P2|Part 3: Extension|Adverse Event|0
4785479|NCT01440374|16505365|P1|Part 3: Extension|Adverse Event|0
4785480|NCT01440374|16505362|P4|Part 3: Extension|Withdrawal by Subject|5
4785481|NCT01440374|16505363|P3|Part 3: Extension|Withdrawal by Subject|0
4785482|NCT01440374|16505364|P2|Part 3: Extension|Withdrawal by Subject|0
4785483|NCT01440374|16505365|P1|Part 3: Extension|Withdrawal by Subject|0
4785484|NCT01440374|16505362|P4|Part 2; Double-blind Phase|Not treated|0
4785485|NCT01440374|16505363|P3|Part 2; Double-blind Phase|Not treated|1
4785486|NCT01440374|16505364|P2|Part 2; Double-blind Phase|Not treated|0
4785487|NCT01440374|16505365|P1|Part 2; Double-blind Phase|Not treated|0
4785488|NCT01440374|16505362|P4|Part 2; Double-blind Phase|Adverse Event|0
4785489|NCT01440374|16505363|P3|Part 2; Double-blind Phase|Adverse Event|31
4785490|NCT01440374|16505364|P2|Part 2; Double-blind Phase|Adverse Event|7
4785491|NCT01440374|16505365|P1|Part 2; Double-blind Phase|Adverse Event|0
4785492|NCT01440374|16505362|P4|Part 2; Double-blind Phase|Lack of Efficacy|0
4785493|NCT01440374|16505363|P3|Part 2; Double-blind Phase|Lack of Efficacy|0
4785494|NCT01440374|16505364|P2|Part 2; Double-blind Phase|Lack of Efficacy|1
4785495|NCT01440374|16505365|P1|Part 2; Double-blind Phase|Lack of Efficacy|0
4785496|NCT01440374|16505362|P4|Part 2; Double-blind Phase|Protocol Violation|0
4785497|NCT01440374|16505363|P3|Part 2; Double-blind Phase|Protocol Violation|1
4785498|NCT01440374|16505364|P2|Part 2; Double-blind Phase|Protocol Violation|0
4785499|NCT01440374|16505365|P1|Part 2; Double-blind Phase|Protocol Violation|0
4785500|NCT01440374|16505362|P4|Part 2; Double-blind Phase|Withdrawal by Subject|0
4785501|NCT01440374|16505363|P3|Part 2; Double-blind Phase|Withdrawal by Subject|5
4785502|NCT01440374|16505364|P2|Part 2; Double-blind Phase|Withdrawal by Subject|4
4785503|NCT01440374|16505365|P1|Part 2; Double-blind Phase|Withdrawal by Subject|0
4785504|NCT01440374|16505362|P4|Part 2; Double-blind Phase|Physician Decision|0
4785505|NCT01440374|16505363|P3|Part 2; Double-blind Phase|Physician Decision|17
4785506|NCT01440374|16505364|P2|Part 2; Double-blind Phase|Physician Decision|8
4785507|NCT01440374|16505365|P1|Part 2; Double-blind Phase|Physician Decision|0
4785508|NCT01440374|16505362|P4|Part 1: Open-label Phase|Physician Decision|0
4785509|NCT01440374|16505363|P3|Part 1: Open-label Phase|Physician Decision|0
4785510|NCT01440374|16505364|P2|Part 1: Open-label Phase|Physician Decision|0
4785511|NCT01440374|16505365|P1|Part 1: Open-label Phase|Physician Decision|1
4785512|NCT01440374|16505362|P4|Part 1: Open-label Phase|Adverse Event|0
4785513|NCT01440374|16505363|P3|Part 1: Open-label Phase|Adverse Event|0
4785514|NCT01440374|16505364|P2|Part 1: Open-label Phase|Adverse Event|0
4785515|NCT01440374|16505365|P1|Part 1: Open-label Phase|Adverse Event|5
4785516|NCT01440322|16505400|P2|Overall Study|Other Non-Product Related|0
4785517|NCT01440322|16505401|P1|Overall Study|Other Non-Product Related|1
4785518|NCT01440322|16505400|P2|Overall Study|Unrelated Medical Problem|1
4785519|NCT01440322|16505401|P1|Overall Study|Unrelated Medical Problem|0
4785520|NCT01440322|16505400|P2|Overall Study|Other Product Related|0
4785521|NCT01440322|16505401|P1|Overall Study|Other Product Related|1
4785522|NCT01440322|16505400|P2|Overall Study|Unacceptable Subjective Vision|0
4785523|NCT01440322|16505401|P1|Overall Study|Unacceptable Subjective Vision|1
4785524|NCT01440322|16505400|P2|Overall Study|Symptoms and Problems|0
4785525|NCT01440322|16505401|P1|Overall Study|Symptoms and Problems|1
4785526|NCT01440322|16505400|P2|Overall Study|Biomicroscopy|0
4785527|NCT01440322|16505401|P1|Overall Study|Biomicroscopy|1
4785528|NCT01440322|16505400|P2|Overall Study|Discomfort|0
4785529|NCT01440322|16505401|P1|Overall Study|Discomfort|2
4785530|NCT01440283|16505423|P1|Overall Study|Physician Decision|3
4785531|NCT01440283|16505423|P1|Overall Study|Withdrawal by Subject|4
4785532|NCT01440283|16505423|P1|Overall Study|Death|3
4785533|NCT01440101|16505438|P3|Overall Study|Other|0
4785534|NCT01440101|16505439|P2|Overall Study|Other|1
4785535|NCT01440101|16505440|P1|Overall Study|Other|0
4785536|NCT01440101|16505438|P3|Overall Study|Withdrawal by Subject|1
4785537|NCT01440101|16505439|P2|Overall Study|Withdrawal by Subject|3
4785538|NCT01440101|16505440|P1|Overall Study|Withdrawal by Subject|0
4785539|NCT01440101|16505438|P3|Overall Study|Adverse Event|0
4785540|NCT01440101|16505439|P2|Overall Study|Adverse Event|0
4785541|NCT01440101|16505440|P1|Overall Study|Adverse Event|2
4785542|NCT01440049|16505473|P1|Overall Study|Adverse Event|5
4785543|NCT01439971|16505505|P5|Overall Study|Required number in cohort dosed|1
4785544|NCT01439971|16505506|P4|Overall Study|Required number in cohort dosed|0
4785545|NCT01439971|16505507|P3|Overall Study|Required number in cohort dosed|2
4785546|NCT01439971|16505508|P2|Overall Study|Required number in cohort dosed|1
4785547|NCT01439971|16505509|P1|Overall Study|Required number in cohort dosed|0
4785548|NCT01439945|16505689|P4|Double-Blind Treatment Phase|Ineligible|1
4785549|NCT01439945|16505690|P3|Double-Blind Treatment Phase|Ineligible|0
4785550|NCT01439945|16505691|P2|Double-Blind Treatment Phase|Ineligible|2
4785551|NCT01439945|16505692|P1|Double-Blind Treatment Phase|Ineligible|1
4785552|NCT01439945|16505689|P4|Double-Blind Treatment Phase|Withdrawal by Subject|1
4785553|NCT01439945|16505690|P3|Double-Blind Treatment Phase|Withdrawal by Subject|3
4785554|NCT01439945|16505691|P2|Double-Blind Treatment Phase|Withdrawal by Subject|3
4785555|NCT01439945|16505692|P1|Double-Blind Treatment Phase|Withdrawal by Subject|3
4785556|NCT01439880|16505717|P2|All-IP Period (Years 2 to 5)|Reason Missing|0
4785557|NCT01439880|16505718|P1|All-IP Period (Years 2 to 5)|Reason Missing|1
4785558|NCT01439880|16505717|P2|All-IP Period (Years 2 to 5)|Other|31
4785559|NCT01439880|16505718|P1|All-IP Period (Years 2 to 5)|Other|14
4785560|NCT01439880|16505717|P2|All-IP Period (Years 2 to 5)|Sponsor Decision|0
4785561|NCT01439880|16505718|P1|All-IP Period (Years 2 to 5)|Sponsor Decision|1
4785562|NCT01439880|16505717|P2|All-IP Period (Years 2 to 5)|Death|13
4785563|NCT01439880|16505718|P1|All-IP Period (Years 2 to 5)|Death|3
4785564|NCT01439880|16505717|P2|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66
4785565|NCT01439880|16505718|P1|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30
4785566|NCT01439880|16505717|P2|All-IP Period (Years 2 to 5)|Lost to Follow-up|30
4785567|NCT01439880|16505718|P1|All-IP Period (Years 2 to 5)|Lost to Follow-up|21
4785568|NCT01439880|16505717|P2|SOC-controlled Period (Year 1)|Reason Missing|2
4785569|NCT01439880|16505718|P1|SOC-controlled Period (Year 1)|Reason Missing|0
4785570|NCT01439880|16505717|P2|SOC-controlled Period (Year 1)|Other|13
4785571|NCT01439880|16505718|P1|SOC-controlled Period (Year 1)|Other|8
4785572|NCT01439880|16505717|P2|SOC-controlled Period (Year 1)|Lost to Follow-up|5
4785573|NCT01439880|16505718|P1|SOC-controlled Period (Year 1)|Lost to Follow-up|10
4785574|NCT01439880|16505717|P2|SOC-controlled Period (Year 1)|Sponsor Decision|1
4785575|NCT01439880|16505718|P1|SOC-controlled Period (Year 1)|Sponsor Decision|0
4785576|NCT01439880|16505717|P2|SOC-controlled Period (Year 1)|Death|1
4785577|NCT01439880|16505718|P1|SOC-controlled Period (Year 1)|Death|2
4785578|NCT01439880|16505717|P2|SOC-controlled Period (Year 1)|Withdrawal by Subject|38
4785579|NCT01439880|16505718|P1|SOC-controlled Period (Year 1)|Withdrawal by Subject|24
4785580|NCT01439867|16505761|P2|Overall Study|Protocol-specified Criteria|0
4785581|NCT01439867|16505762|P1|Overall Study|Protocol-specified Criteria|1
4785582|NCT01439867|16505761|P2|Overall Study|Administrative Decision|5
4785583|NCT01439867|16505762|P1|Overall Study|Administrative Decision|4
4785584|NCT01439867|16505761|P2|Overall Study|Withdrawal by Subject|2
4785585|NCT01439867|16505762|P1|Overall Study|Withdrawal by Subject|1
4785586|NCT01439867|16505761|P2|Overall Study|Non-compliance|1
4785587|NCT01439867|16505762|P1|Overall Study|Non-compliance|0
4785588|NCT01439724|16505814|P2|Overall Study|missing consultation|8
4785589|NCT01439724|16505815|P1|Overall Study|missing consultation|9
4785590|NCT01439711|16505821|P1|Overall Study|No MRI|9
4785591|NCT01439711|16505821|P1|Overall Study|Noncompliance|3
4785592|NCT01439711|16505821|P1|Overall Study|Progression During Active Tx|3
4785593|NCT01439711|16505821|P1|Overall Study|Withdrawal by Subject|3
4785594|NCT01439711|16505821|P1|Overall Study|Adverse Event|5
4785595|NCT01439711|16505821|P1|Overall Study|Progression Prior to Beginning Tx|1
4785596|NCT01439711|16505821|P1|Overall Study|Cancel|3
4785597|NCT01439711|16505821|P1|Overall Study|Ineligible|13
4785598|NCT01439568|16505859|P2|Overall Study|Withdrawal by Subject|2
4785599|NCT01439568|16505860|P1|Overall Study|Withdrawal by Subject|2
4785600|NCT01439568|16505859|P2|Overall Study|Lost to Follow-up|0
4785601|NCT01439568|16505860|P1|Overall Study|Lost to Follow-up|1
4785602|NCT01439555|16505872|P1|Overall Study|Protocol Violation|1
4785603|NCT01439373|16505884|P2|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0
4785604|NCT01439373|16505885|P1|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2
4785605|NCT01439373|16505884|P2|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1
4785606|NCT01439373|16505885|P1|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0
4785607|NCT01439360|16505928|P2|Overall Study|Withdrawal by Subject|129
4785608|NCT01439360|16505929|P1|Overall Study|Withdrawal by Subject|140
4785609|NCT01439360|16505928|P2|Overall Study|Protocol Violation|0
4785610|NCT01439360|16505929|P1|Overall Study|Protocol Violation|1
4785611|NCT01439360|16505928|P2|Overall Study|Others|5
4785612|NCT01439360|16505929|P1|Overall Study|Others|10
4785613|NCT01439360|16505928|P2|Overall Study|Lost to Follow-up|58
4785614|NCT01439360|16505929|P1|Overall Study|Lost to Follow-up|43
4785615|NCT01439360|16505928|P2|Overall Study|Adverse Event|16
4785616|NCT01439360|16505929|P1|Overall Study|Adverse Event|4
4785617|NCT01439282|16505979|P2|Overall Study|Other|1
4785618|NCT01439282|16505980|P1|Overall Study|Other|1
4785619|NCT01439282|16505979|P2|Overall Study|Withdrawal by Subject|0
4785620|NCT01439282|16505980|P1|Overall Study|Withdrawal by Subject|2
4785621|NCT01439282|16505979|P2|Overall Study|Adverse Event|0
4785622|NCT01439282|16505980|P1|Overall Study|Adverse Event|5
4785623|NCT01439204|16505992|P2|Overall Study|poor/non-compliance|0
4785624|NCT01439204|16505993|P1|Overall Study|poor/non-compliance|3
4785625|NCT01439204|16505992|P2|Overall Study|No longer meets study criteria|0
4785626|NCT01439204|16505993|P1|Overall Study|No longer meets study criteria|1
4785627|NCT01439204|16505992|P2|Overall Study|Lost to Follow-up|2
4785628|NCT01439204|16505993|P1|Overall Study|Lost to Follow-up|0
4785629|NCT01439204|16505992|P2|Overall Study|Withdrawal by Subject|1
4785630|NCT01439204|16505993|P1|Overall Study|Withdrawal by Subject|0
4785631|NCT01439165|16506027|P2|Overall Study|Withdrawal by Subject|1
4785632|NCT01439165|16506028|P1|Overall Study|Withdrawal by Subject|7
4785633|NCT01439165|16506027|P2|Overall Study|Lost to Follow-up|1
4785634|NCT01439165|16506028|P1|Overall Study|Lost to Follow-up|11
4785635|NCT01439165|16506027|P2|Overall Study|Protocol Violation|0
4785636|NCT01439165|16506028|P1|Overall Study|Protocol Violation|3
4785637|NCT01439126|16506042|P2|Overall Study|Other-Miscellaneous|12
4785638|NCT01439126|16506043|P1|Overall Study|Other-Miscellaneous|12
4785639|NCT01439126|16506042|P2|Overall Study|Other-Use of prohibited treatment|2
4785640|NCT01439126|16506043|P1|Overall Study|Other-Use of prohibited treatment|0
4785641|NCT01439126|16506042|P2|Overall Study|Lost to Follow-up|3
4785642|NCT01439126|16506043|P1|Overall Study|Lost to Follow-up|6
4785643|NCT01439126|16506042|P2|Overall Study|Protocol Violation|4
4785644|NCT01439126|16506043|P1|Overall Study|Protocol Violation|6
4785645|NCT01439126|16506042|P2|Overall Study|Withdrawal by Subject|21
4785646|NCT01439126|16506043|P1|Overall Study|Withdrawal by Subject|5
4785647|NCT01439126|16506042|P2|Overall Study|Adverse Event|0
4785648|NCT01439126|16506043|P1|Overall Study|Adverse Event|2
4785649|NCT01439074|16506069|P2|Overall Study|Other|4
4785650|NCT01439074|16506070|P1|Overall Study|Other|4
4785651|NCT01439074|16506069|P2|Overall Study|Withdrawal by Subject|5
4785652|NCT01439074|16506070|P1|Overall Study|Withdrawal by Subject|1
4785653|NCT01439074|16506069|P2|Overall Study|Subject shedding|0
4785654|NCT01439074|16506070|P1|Overall Study|Subject shedding|1
4785655|NCT01439074|16506069|P2|Overall Study|Lost to Follow-up|4
4785656|NCT01439074|16506070|P1|Overall Study|Lost to Follow-up|3
4785657|NCT01439009|16506088|P2|Overall Study|Deviation of exclusion criteria|0
4785658|NCT01439009|16506089|P1|Overall Study|Deviation of exclusion criteria|1
4785659|NCT01439009|16506088|P2|Overall Study|Protocol Violation|0
4785660|NCT01439009|16506089|P1|Overall Study|Protocol Violation|2
4785661|NCT01439009|16506088|P2|Overall Study|Physician Decision|3
4785662|NCT01439009|16506089|P1|Overall Study|Physician Decision|5
4785663|NCT01438996|16506122|P3|Overall Study|Not meeting Inclusion Criteria|0
4785664|NCT01438996|16506123|P2|Overall Study|Not meeting Inclusion Criteria|1
4785665|NCT01438996|16506124|P1|Overall Study|Not meeting Inclusion Criteria|4
4785666|NCT01438840|16506158|P3|Extension Phase|Other|1
4785667|NCT01438840|16506159|P2|Extension Phase|Other|0
4785668|NCT01438840|16506160|P1|Extension Phase|Other|0
4785669|NCT01438840|16506158|P3|Extension Phase|Lack of Efficacy|2
4785670|NCT01438840|16506159|P2|Extension Phase|Lack of Efficacy|0
4785671|NCT01438840|16506160|P1|Extension Phase|Lack of Efficacy|0
4785672|NCT01438840|16506158|P3|Extension Phase|Withdrawal by Subject|3
4785673|NCT01438840|16506159|P2|Extension Phase|Withdrawal by Subject|0
4785674|NCT01438840|16506160|P1|Extension Phase|Withdrawal by Subject|0
4785675|NCT01438840|16506158|P3|Extension Phase|Lost to Follow-up|1
4785676|NCT01438840|16506159|P2|Extension Phase|Lost to Follow-up|0
4785677|NCT01438840|16506160|P1|Extension Phase|Lost to Follow-up|0
4785678|NCT01438840|16506158|P3|Extension Phase|Adverse Event|3
4785679|NCT01438840|16506159|P2|Extension Phase|Adverse Event|0
4785680|NCT01438840|16506160|P1|Extension Phase|Adverse Event|0
4785681|NCT01438840|16506158|P3|Core Study|Withdrawal of consent|0
4785682|NCT01438840|16506159|P2|Core Study|Withdrawal of consent|0
4785683|NCT01438840|16506160|P1|Core Study|Withdrawal of consent|1
4785684|NCT01438840|16506158|P3|Core Study|Lack of Efficacy|0
4785685|NCT01438840|16506159|P2|Core Study|Lack of Efficacy|7
4785686|NCT01438840|16506160|P1|Core Study|Lack of Efficacy|15
4785687|NCT01438840|16506158|P3|Core Study|Adverse Event|0
4785688|NCT01438840|16506159|P2|Core Study|Adverse Event|3
4785689|NCT01438840|16506160|P1|Core Study|Adverse Event|0
4785690|NCT01438814|16506173|P2|Overall Study|Other|4
4785691|NCT01438814|16506174|P1|Overall Study|Other|2
4785692|NCT01438814|16506173|P2|Overall Study|Withdrawal by Subject|2
4785693|NCT01438814|16506174|P1|Overall Study|Withdrawal by Subject|4
4785694|NCT01438814|16506173|P2|Overall Study|Lost to Follow-up|3
4785695|NCT01438814|16506174|P1|Overall Study|Lost to Follow-up|4
4785696|NCT01438814|16506173|P2|Overall Study|Protocol Violation|2
4785697|NCT01438814|16506174|P1|Overall Study|Protocol Violation|1
4785698|NCT01438814|16506173|P2|Overall Study|Adverse Event|3
4785699|NCT01438814|16506174|P1|Overall Study|Adverse Event|3
4785700|NCT01438541|16506210|P1|Overall Study|discharge from the hospital|5
4785701|NCT01438541|16506210|P1|Overall Study|Withdrawal by Subject|1
4785702|NCT01438541|16506210|P1|Overall Study|Physician Decision|1
4785703|NCT01438489|16506219|P3|Overall Study|Inadequate venous access|0
4785704|NCT01438489|16506220|P2|Overall Study|Inadequate venous access|2
4785705|NCT01438489|16506221|P1|Overall Study|Inadequate venous access|0
4785706|NCT01438489|16506219|P3|Overall Study|Did not complete all 3 follow-up visits|2
4785707|NCT01438489|16506220|P2|Overall Study|Did not complete all 3 follow-up visits|5
4785708|NCT01438489|16506221|P1|Overall Study|Did not complete all 3 follow-up visits|2
4785709|NCT01438489|16506219|P3|Overall Study|Received prohibited medication|0
4785710|NCT01438489|16506220|P2|Overall Study|Received prohibited medication|0
4785711|NCT01438489|16506221|P1|Overall Study|Received prohibited medication|1
4785712|NCT01438489|16506219|P3|Overall Study|AE/SAEs|1
4785713|NCT01438489|16506220|P2|Overall Study|AE/SAEs|1
4785714|NCT01438489|16506221|P1|Overall Study|AE/SAEs|2
4785715|NCT01438489|16506219|P3|Overall Study|Investigator decision|0
4785716|NCT01438489|16506220|P2|Overall Study|Investigator decision|1
4785717|NCT01438489|16506221|P1|Overall Study|Investigator decision|0
4785718|NCT01438489|16506219|P3|Overall Study|Subject choice/Subject moved|1
4785719|NCT01438489|16506220|P2|Overall Study|Subject choice/Subject moved|1
4785720|NCT01438489|16506221|P1|Overall Study|Subject choice/Subject moved|2
4785721|NCT01438489|16506219|P3|Overall Study|Sponsor decision|4
4785722|NCT01438489|16506220|P2|Overall Study|Sponsor decision|1
4785723|NCT01438489|16506221|P1|Overall Study|Sponsor decision|4
4785724|NCT01438489|16506219|P3|Overall Study|Death|1
4785725|NCT01438489|16506220|P2|Overall Study|Death|0
4785726|NCT01438489|16506221|P1|Overall Study|Death|0
4785727|NCT01438489|16506219|P3|Overall Study|Withdrawal by Subject|8
4785728|NCT01438489|16506220|P2|Overall Study|Withdrawal by Subject|3
4785729|NCT01438489|16506221|P1|Overall Study|Withdrawal by Subject|11
4785730|NCT01438489|16506219|P3|Overall Study|Lost to Follow-up|2
4785731|NCT01438489|16506220|P2|Overall Study|Lost to Follow-up|2
4785732|NCT01438489|16506221|P1|Overall Study|Lost to Follow-up|4
4785733|NCT01438476|16506266|P2|Overall Study|Communication barrier|1
4785734|NCT01438476|16506267|P1|Overall Study|Communication barrier|0
4785735|NCT01438476|16506266|P2|Overall Study|No Surgery- Disease|10
4785736|NCT01438476|16506267|P1|Overall Study|No Surgery- Disease|8
4785737|NCT01438476|16506266|P2|Overall Study|Withdrawal by Subject|0
4785738|NCT01438476|16506267|P1|Overall Study|Withdrawal by Subject|1
4785739|NCT01438476|16506266|P2|Overall Study|Protocol Violation|0
4785740|NCT01438476|16506267|P1|Overall Study|Protocol Violation|1
4785741|NCT01438424|16506273|P1|Overall Study|Participant noncompliance|20
4785742|NCT01438424|16506273|P1|Overall Study|No longer met inclusion criteria|1
4785743|NCT01438424|16506273|P1|Overall Study|Pregnancy|7
4785744|NCT01438424|16506273|P1|Overall Study|Need for drug prohibited by protocol|14
4785745|NCT01438424|16506273|P1|Overall Study|Abnormal laboratory test result|14
4785746|NCT01438424|16506273|P1|Overall Study|Lost to Follow-up|17
4785747|NCT01438424|16506273|P1|Overall Study|Adverse Event|17
4785748|NCT01438424|16506273|P1|Overall Study|Death|22
4785749|NCT01438424|16506273|P1|Overall Study|Progression of chronic hepatitis B|22
4785750|NCT01438424|16506273|P1|Overall Study|Withdrawal by Subject|104
4785751|NCT01438424|16506273|P1|Overall Study|Not identified|55
4785752|NCT01438424|16506273|P1|Overall Study|Minimal virologic response|95
4785753|NCT01438424|16506273|P1|Overall Study|Continuing treatment|29
4785754|NCT01438411|16506309|P1|Overall Study|Withdrawal by Subject|3
4785755|NCT01438411|16506309|P1|Overall Study|Lack of Efficacy|1
4785756|NCT01438411|16506309|P1|Overall Study|Lost to Follow-up|1
4785757|NCT01438411|16506309|P1|Overall Study|Adverse Event|8
4785758|NCT01438307|16506324|P2|Overall Study|Death|1
4785759|NCT01438307|16506325|P1|Overall Study|Death|1
4785760|NCT01438294|16506339|P2|Overall Study|Lost to Follow-up|7
4785761|NCT01438294|16506340|P1|Overall Study|Lost to Follow-up|3
4785762|NCT01438177|16506383|P1|Overall Study|Initiation of new therapy|1
4785763|NCT01438177|16506383|P1|Overall Study|Withdrawal by Subject|1
4785764|NCT01438151|16506390|P1|Overall Study|study terminated|8
4785765|NCT01438060|16506396|P2|On Study Beyond Week 140|Other Reason|3
4785766|NCT01438060|16506397|P1|On Study Beyond Week 140|Other Reason|0
4785767|NCT01438060|16506396|P2|On Study Beyond Week 140|Death|1
4785768|NCT01438060|16506397|P1|On Study Beyond Week 140|Death|0
4785769|NCT01438060|16506396|P2|On Study Beyond Week 140|Withdrawal by Subject|1
4785770|NCT01438060|16506397|P1|On Study Beyond Week 140|Withdrawal by Subject|0
4785771|NCT01438060|16506396|P2|On Study Beyond Week 140|Lack of Efficacy|1
4785772|NCT01438060|16506397|P1|On Study Beyond Week 140|Lack of Efficacy|0
4785773|NCT01438060|16506396|P2|On Study Beyond Week 140|Adverse Event|2
4785774|NCT01438060|16506397|P1|On Study Beyond Week 140|Adverse Event|0
4785775|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Other Reason|15
4785776|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Other Reason|7
4785777|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Death|12
4785778|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Death|22
4785779|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0
4785780|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2
4785781|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Participant Unreliability|0
4785782|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Participant Unreliability|1
4785783|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5
4785784|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3
4785785|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
4785786|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8
4785787|NCT01438060|16506396|P2|Extension Phase: Week 10 to Week 130|Adverse Event|16
4785788|NCT01438060|16506397|P1|Extension Phase: Week 10 to Week 130|Adverse Event|15
4785789|NCT01438060|16506396|P2|Acute Phase: Double-blind, 10 Weeks|Other Reason|0
4785790|NCT01438060|16506397|P1|Acute Phase: Double-blind, 10 Weeks|Other Reason|1
4785791|NCT01438060|16506396|P2|Acute Phase: Double-blind, 10 Weeks|Death|2
4785792|NCT01438060|16506397|P1|Acute Phase: Double-blind, 10 Weeks|Death|0
4785793|NCT01438060|16506396|P2|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0
4785794|NCT01438060|16506397|P1|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1
4785795|NCT01438060|16506396|P2|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4
4785796|NCT01438060|16506397|P1|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3
4785797|NCT01438060|16506396|P2|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3
4785798|NCT01438060|16506397|P1|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6
4785799|NCT01438060|16506396|P2|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9
4785800|NCT01438060|16506397|P1|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7
4785801|NCT01437995|16506489|P3|Overall Study|Lost to Follow-up|20
4785802|NCT01437995|16506490|P2|Overall Study|Lost to Follow-up|18
4785803|NCT01437995|16506491|P1|Overall Study|Lost to Follow-up|11
4785804|NCT01437943|16506513|P2|Overall Study|Adverse Event|0
4785805|NCT01437943|16506514|P1|Overall Study|Adverse Event|2
4785806|NCT01437943|16506513|P2|Overall Study|Subject expressed pregnancy plans|0
4785807|NCT01437943|16506514|P1|Overall Study|Subject expressed pregnancy plans|1
4785808|NCT01437943|16506513|P2|Overall Study|Aliskiren trials terminated by Novartis|2
4785809|NCT01437943|16506514|P1|Overall Study|Aliskiren trials terminated by Novartis|4
4785810|NCT01437878|16506522|P2|Overall Study|Withdrawal by Subject|0
4785811|NCT01437878|16506523|P1|Overall Study|Withdrawal by Subject|1
4785812|NCT01437540|16506590|P2|Overall Study|Withdrawal by Subject|15
4785813|NCT01437540|16506591|P1|Overall Study|Withdrawal by Subject|31
4785814|NCT01437540|16506590|P2|Overall Study|Adverse Event|13
4785815|NCT01437540|16506591|P1|Overall Study|Adverse Event|26
4785816|NCT01437540|16506590|P2|Overall Study|Protocol Violation|12
4785817|NCT01437540|16506591|P1|Overall Study|Protocol Violation|24
4785818|NCT01437540|16506590|P2|Overall Study|Lack of Efficacy|11
4785819|NCT01437540|16506591|P1|Overall Study|Lack of Efficacy|23
4785820|NCT01437540|16506590|P2|Overall Study|Lost to Follow-up|5
4785821|NCT01437540|16506591|P1|Overall Study|Lost to Follow-up|3
4785822|NCT01437540|16506590|P2|Overall Study|COPD exacerbation|3
4785823|NCT01437540|16506591|P1|Overall Study|COPD exacerbation|13
4785824|NCT01437540|16506590|P2|Overall Study|Not listed below|6
4785825|NCT01437540|16506591|P1|Overall Study|Not listed below|7
4785826|NCT01437423|16506628|P1|Overall Study|Off label usage|3
4785827|NCT01437423|16506628|P1|Overall Study|Lost to Follow-up|12
4785828|NCT01437397|16506640|P5|Overall Study|Site termination/COPD exacerbation/other|14
4785829|NCT01437397|16506641|P4|Overall Study|Site termination/COPD exacerbation/other|9
4785830|NCT01437397|16506642|P3|Overall Study|Site termination/COPD exacerbation/other|9
4785831|NCT01437397|16506643|P2|Overall Study|Site termination/COPD exacerbation/other|8
4785832|NCT01437397|16506644|P1|Overall Study|Site termination/COPD exacerbation/other|10
4785833|NCT01437397|16506640|P5|Overall Study|Adverse Event|21
4785834|NCT01437397|16506641|P4|Overall Study|Adverse Event|14
4785835|NCT01437397|16506642|P3|Overall Study|Adverse Event|16
4785836|NCT01437397|16506643|P2|Overall Study|Adverse Event|22
4785837|NCT01437397|16506644|P1|Overall Study|Adverse Event|21
4785838|NCT01437397|16506640|P5|Overall Study|Lack of Efficacy|20
4785839|NCT01437397|16506641|P4|Overall Study|Lack of Efficacy|10
4785840|NCT01437397|16506642|P3|Overall Study|Lack of Efficacy|8
4785841|NCT01437397|16506643|P2|Overall Study|Lack of Efficacy|4
4785842|NCT01437397|16506644|P1|Overall Study|Lack of Efficacy|5
4785843|NCT01437397|16506640|P5|Overall Study|Protocol Violation|19
4785844|NCT01437397|16506641|P4|Overall Study|Protocol Violation|21
4785845|NCT01437397|16506642|P3|Overall Study|Protocol Violation|13
4785846|NCT01437397|16506643|P2|Overall Study|Protocol Violation|12
4785847|NCT01437397|16506644|P1|Overall Study|Protocol Violation|10
4785848|NCT01437397|16506640|P5|Overall Study|Withdrawal by Subject|22
4785849|NCT01437397|16506641|P4|Overall Study|Withdrawal by Subject|11
4785850|NCT01437397|16506642|P3|Overall Study|Withdrawal by Subject|24
4785851|NCT01437397|16506643|P2|Overall Study|Withdrawal by Subject|12
4785852|NCT01437397|16506644|P1|Overall Study|Withdrawal by Subject|11
4785853|NCT01437397|16506640|P5|Overall Study|Lost to Follow-up|5
4785854|NCT01437397|16506641|P4|Overall Study|Lost to Follow-up|4
4785855|NCT01437397|16506642|P3|Overall Study|Lost to Follow-up|2
4785856|NCT01437397|16506643|P2|Overall Study|Lost to Follow-up|4
4785857|NCT01437397|16506644|P1|Overall Study|Lost to Follow-up|9
4785858|NCT01437319|16506671|P3|Phase II|Protocol Violation|0
4785859|NCT01437319|16506672|P2|Phase II|Protocol Violation|1
4785860|NCT01437319|16506673|P1|Phase II|Protocol Violation|0
4785861|NCT01437319|16506671|P3|Phase II|Study related symptoms/complaints|19
4785862|NCT01437319|16506672|P2|Phase II|Study related symptoms/complaints|28
4785863|NCT01437319|16506673|P1|Phase II|Study related symptoms/complaints|0
4785864|NCT01437319|16506671|P3|Phase II|Lost to Follow-up|2
4785865|NCT01437319|16506672|P2|Phase II|Lost to Follow-up|7
4785866|NCT01437319|16506673|P1|Phase II|Lost to Follow-up|0
4785867|NCT01437319|16506671|P3|Phase II|Withdrawal by Subject|16
4785868|NCT01437319|16506672|P2|Phase II|Withdrawal by Subject|8
4785869|NCT01437319|16506673|P1|Phase II|Withdrawal by Subject|0
4785870|NCT01437319|16506671|P3|Phase I|Withdrawal by Subject|0
4785871|NCT01437319|16506672|P2|Phase I|Withdrawal by Subject|0
4785872|NCT01437319|16506673|P1|Phase I|Withdrawal by Subject|25
4785873|NCT01437319|16506671|P3|Phase I|Study related symptoms/complaints|0
4785874|NCT01437319|16506672|P2|Phase I|Study related symptoms/complaints|0
4785875|NCT01437319|16506673|P1|Phase I|Study related symptoms/complaints|27
4785876|NCT01437319|16506671|P3|Phase I|Protocol Violation|0
4785877|NCT01437319|16506672|P2|Phase I|Protocol Violation|0
4785878|NCT01437319|16506673|P1|Phase I|Protocol Violation|1
4785879|NCT01437319|16506671|P3|Phase I|Lost to Follow-up|0
4785880|NCT01437319|16506672|P2|Phase I|Lost to Follow-up|0
4785881|NCT01437319|16506673|P1|Phase I|Lost to Follow-up|2
4785882|NCT01437267|16506688|P6|Overall Study|Protocol Violation|0
4785883|NCT01437267|16506689|P5|Overall Study|Protocol Violation|0
4785884|NCT01437267|16506690|P4|Overall Study|Protocol Violation|0
4785885|NCT01437267|16506691|P3|Overall Study|Protocol Violation|0
4785886|NCT01437267|16506692|P2|Overall Study|Protocol Violation|1
4785887|NCT01437267|16506693|P1|Overall Study|Protocol Violation|0
4785888|NCT01437267|16506688|P6|Overall Study|Withdrawal by Subject|0
4785889|NCT01437267|16506689|P5|Overall Study|Withdrawal by Subject|0
4785890|NCT01437267|16506690|P4|Overall Study|Withdrawal by Subject|1
4785891|NCT01437267|16506691|P3|Overall Study|Withdrawal by Subject|0
4785892|NCT01437267|16506692|P2|Overall Study|Withdrawal by Subject|0
4785893|NCT01437267|16506693|P1|Overall Study|Withdrawal by Subject|0
4785894|NCT01437111|16506736|P1|Overall Study|Protocol Violation|1
4785895|NCT01437111|16506736|P1|Overall Study|Lost to Follow-up|5
4785896|NCT01437111|16506736|P1|Overall Study|Physician Decision|1
4785897|NCT01437111|16506736|P1|Overall Study|Not reported|5
4785898|NCT01437111|16506736|P1|Overall Study|Withdrawal by Subject|4
4785899|NCT01437111|16506736|P1|Overall Study|Adverse Event|2
4785900|NCT01436643|16506814|P4|Core Phase (16 Weeks)|Protocol Violation|0
4785901|NCT01436643|16506815|P3|Core Phase (16 Weeks)|Protocol Violation|1
4785902|NCT01436643|16506816|P2|Core Phase (16 Weeks)|Protocol Violation|1
4785903|NCT01436643|16506817|P1|Core Phase (16 Weeks)|Protocol Violation|1
4785904|NCT01436643|16506814|P4|Core Phase (16 Weeks)|Abnormal Test result|0
4785905|NCT01436643|16506815|P3|Core Phase (16 Weeks)|Abnormal Test result|1
4785906|NCT01436643|16506816|P2|Core Phase (16 Weeks)|Abnormal Test result|0
4785907|NCT01436643|16506817|P1|Core Phase (16 Weeks)|Abnormal Test result|0
4785908|NCT01436643|16506814|P4|Core Phase (16 Weeks)|Adverse Event|0
4785909|NCT01436643|16506815|P3|Core Phase (16 Weeks)|Adverse Event|1
4785910|NCT01436643|16506816|P2|Core Phase (16 Weeks)|Adverse Event|3
4785911|NCT01436643|16506817|P1|Core Phase (16 Weeks)|Adverse Event|0
4785912|NCT01436643|16506814|P4|2-week Pre-treatment|Protocol Violation|4
4785913|NCT01436643|16506815|P3|2-week Pre-treatment|Protocol Violation|0
4785914|NCT01436643|16506816|P2|2-week Pre-treatment|Protocol Violation|0
4785915|NCT01436643|16506817|P1|2-week Pre-treatment|Protocol Violation|0
4785916|NCT01436643|16506814|P4|2-week Pre-treatment|Adverse Event|5
4785917|NCT01436643|16506815|P3|2-week Pre-treatment|Adverse Event|0
4785918|NCT01436643|16506816|P2|2-week Pre-treatment|Adverse Event|0
4785919|NCT01436643|16506817|P1|2-week Pre-treatment|Adverse Event|0
4785920|NCT01436643|16506814|P4|2-week Pre-treatment|Abnormal test result|1
4785921|NCT01436643|16506815|P3|2-week Pre-treatment|Abnormal test result|0
4785922|NCT01436643|16506816|P2|2-week Pre-treatment|Abnormal test result|0
4785923|NCT01436643|16506817|P1|2-week Pre-treatment|Abnormal test result|0
4785924|NCT01436500|16506852|P5|Overall Study|Other|0
4785925|NCT01436500|16506853|P4|Overall Study|Other|1
4785926|NCT01436500|16506854|P3|Overall Study|Other|0
4785927|NCT01436500|16506855|P2|Overall Study|Other|1
4785928|NCT01436500|16506856|P1|Overall Study|Other|0
4785929|NCT01436500|16506852|P5|Overall Study|discontinued study drug|0
4785930|NCT01436500|16506853|P4|Overall Study|discontinued study drug|0
4785931|NCT01436500|16506854|P3|Overall Study|discontinued study drug|0
4785932|NCT01436500|16506855|P2|Overall Study|discontinued study drug|0
4785933|NCT01436500|16506856|P1|Overall Study|discontinued study drug|1
4785934|NCT01436500|16506852|P5|Overall Study|initiation of dialysis|1
4785935|NCT01436500|16506853|P4|Overall Study|initiation of dialysis|0
4785936|NCT01436500|16506854|P3|Overall Study|initiation of dialysis|0
4785937|NCT01436500|16506855|P2|Overall Study|initiation of dialysis|0
4785938|NCT01436500|16506856|P1|Overall Study|initiation of dialysis|0
4785939|NCT01436500|16506852|P5|Overall Study|liver transplant|0
4785940|NCT01436500|16506853|P4|Overall Study|liver transplant|0
4785941|NCT01436500|16506854|P3|Overall Study|liver transplant|0
4785942|NCT01436500|16506855|P2|Overall Study|liver transplant|0
4785943|NCT01436500|16506856|P1|Overall Study|liver transplant|1
4785944|NCT01436500|16506852|P5|Overall Study|Physician Decision|0
4785945|NCT01436500|16506853|P4|Overall Study|Physician Decision|0
4785946|NCT01436500|16506854|P3|Overall Study|Physician Decision|1
4785947|NCT01436500|16506855|P2|Overall Study|Physician Decision|0
4785948|NCT01436500|16506856|P1|Overall Study|Physician Decision|0
4785949|NCT01436500|16506852|P5|Overall Study|Withdrawal by Subject|2
4785950|NCT01436500|16506853|P4|Overall Study|Withdrawal by Subject|0
4785951|NCT01436500|16506854|P3|Overall Study|Withdrawal by Subject|2
4785952|NCT01436500|16506855|P2|Overall Study|Withdrawal by Subject|0
4785953|NCT01436500|16506856|P1|Overall Study|Withdrawal by Subject|0
4785954|NCT01436500|16506852|P5|Overall Study|Adverse Event|1
4785955|NCT01436500|16506853|P4|Overall Study|Adverse Event|0
4785956|NCT01436500|16506854|P3|Overall Study|Adverse Event|2
4785957|NCT01436500|16506855|P2|Overall Study|Adverse Event|2
4785958|NCT01436500|16506856|P1|Overall Study|Adverse Event|0
4785959|NCT01436500|16506852|P5|Overall Study|Death|0
4785960|NCT01436500|16506853|P4|Overall Study|Death|0
4785961|NCT01436500|16506854|P3|Overall Study|Death|0
4785962|NCT01436500|16506855|P2|Overall Study|Death|0
4785963|NCT01436500|16506856|P1|Overall Study|Death|1
4785964|NCT01436396|16506900|P2|Overall Study|Lost to Follow-up|3
4785965|NCT01436396|16506901|P1|Overall Study|Lost to Follow-up|3
4785966|NCT01436396|16506900|P2|Overall Study|Serious adverse event|3
4785967|NCT01436396|16506901|P1|Overall Study|Serious adverse event|2
4785968|NCT01436396|16506900|P2|Overall Study|Withdrawal by Subject|29
4785969|NCT01436396|16506901|P1|Overall Study|Withdrawal by Subject|19
4785970|NCT01436396|16506900|P2|Overall Study|Adverse Event|2
4785971|NCT01436396|16506901|P1|Overall Study|Adverse Event|1
4785972|NCT01436396|16506900|P2|Overall Study|Protocol Violation|5
4785973|NCT01436396|16506901|P1|Overall Study|Protocol Violation|7
4785974|NCT01436370|16506941|P8|Overall Study|Lost to Follow-up|0
4785975|NCT01436370|16506942|P7|Overall Study|Lost to Follow-up|0
4785976|NCT01436370|16506943|P6|Overall Study|Lost to Follow-up|0
4785977|NCT01436370|16506944|P5|Overall Study|Lost to Follow-up|1
4785978|NCT01436370|16506945|P4|Overall Study|Lost to Follow-up|0
4785979|NCT01436370|16506946|P3|Overall Study|Lost to Follow-up|0
4785980|NCT01436370|16506947|P2|Overall Study|Lost to Follow-up|0
4785981|NCT01436370|16506948|P1|Overall Study|Lost to Follow-up|0
4785982|NCT01436357|16507028|P2|Overall Study|Subject in rehab|1
4785983|NCT01436357|16507029|P1|Overall Study|Subject in rehab|0
4785984|NCT01436357|16507028|P2|Overall Study|Moved out of area|2
4785985|NCT01436357|16507029|P1|Overall Study|Moved out of area|1
4785986|NCT01436357|16507028|P2|Overall Study|Physician Decision|4
4785987|NCT01436357|16507029|P1|Overall Study|Physician Decision|3
4785988|NCT01436357|16507028|P2|Overall Study|Withdrawal by Subject|38
4785989|NCT01436357|16507029|P1|Overall Study|Withdrawal by Subject|26
4785990|NCT01436357|16507028|P2|Overall Study|Protocol Violation|0
4785991|NCT01436357|16507029|P1|Overall Study|Protocol Violation|1
4785992|NCT01436357|16507028|P2|Overall Study|Lost to Follow-up|61
4785993|NCT01436357|16507029|P1|Overall Study|Lost to Follow-up|67
4785994|NCT01436357|16507028|P2|Overall Study|Incarceration|20
4785995|NCT01436357|16507029|P1|Overall Study|Incarceration|18
4785996|NCT01436357|16507028|P2|Overall Study|Enrolled but not vaccinated|1
4785997|NCT01436357|16507029|P1|Overall Study|Enrolled but not vaccinated|1
4785998|NCT01436357|16507028|P2|Overall Study|Death|1
4785999|NCT01436357|16507029|P1|Overall Study|Death|5
4786000|NCT01436305|16507050|P3|Overall Study|Withdrawal by Subject|0
4786001|NCT01436305|16507051|P2|Overall Study|Withdrawal by Subject|3
4786002|NCT01436305|16507052|P1|Overall Study|Withdrawal by Subject|1
4786003|NCT01436305|16507050|P3|Overall Study|Lost to Follow-up|0
4786004|NCT01436305|16507051|P2|Overall Study|Lost to Follow-up|1
4786005|NCT01436305|16507052|P1|Overall Study|Lost to Follow-up|0
4786006|NCT01436305|16507050|P3|Overall Study|Death|0
4786007|NCT01436305|16507051|P2|Overall Study|Death|0
4786008|NCT01436305|16507052|P1|Overall Study|Death|1
4786009|NCT01436253|16507179|P1|Overall Study|Not meeting all eligibility criteria|117
4786010|NCT01436253|16507179|P1|Overall Study|Lost to Follow-up|182
4786011|NCT01436201|16507184|P1|Overall Study|Protocol Violation|1
4786012|NCT01436201|16507184|P1|Overall Study|Withdrawal by Subject|1
4786013|NCT01436201|16507184|P1|Overall Study|Adverse Event|2
4786014|NCT01436175|16507194|P1|Overall Study|Other|826
4786015|NCT01436175|16507194|P1|Overall Study|Met blood pressure or pulse withdrawal|63
4786016|NCT01436175|16507194|P1|Overall Study|Lack of Efficacy|24
4786017|NCT01436175|16507194|P1|Overall Study|Lost to Follow-up|89
4786018|NCT01436175|16507194|P1|Overall Study|Withdrawal by Subject|108
4786019|NCT01436175|16507194|P1|Overall Study|Protocol Violation|49
4786020|NCT01436175|16507194|P1|Overall Study|Adverse Event|111
4786021|NCT01436162|16507221|P3|Randomized Phase|Other|4
4786022|NCT01436162|16507222|P2|Randomized Phase|Other|5
4786023|NCT01436162|16507223|P1|Randomized Phase|Other|2
4786024|NCT01436162|16507221|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0
4786025|NCT01436162|16507222|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
4786026|NCT01436162|16507223|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4
4786027|NCT01436162|16507221|P3|Randomized Phase|Lack of Efficacy|1
4786028|NCT01436162|16507222|P2|Randomized Phase|Lack of Efficacy|1
4786029|NCT01436162|16507223|P1|Randomized Phase|Lack of Efficacy|0
4786030|NCT01436162|16507221|P3|Randomized Phase|Lost to Follow-up|4
4786031|NCT01436162|16507222|P2|Randomized Phase|Lost to Follow-up|5
4786032|NCT01436162|16507223|P1|Randomized Phase|Lost to Follow-up|17
4786033|NCT01436162|16507221|P3|Randomized Phase|Withdrawal by Subject|8
4786034|NCT01436162|16507222|P2|Randomized Phase|Withdrawal by Subject|9
4786035|NCT01436162|16507223|P1|Randomized Phase|Withdrawal by Subject|16
4786036|NCT01436162|16507221|P3|Randomized Phase|Protocol Violation|2
4786037|NCT01436162|16507222|P2|Randomized Phase|Protocol Violation|4
4786038|NCT01436162|16507223|P1|Randomized Phase|Protocol Violation|4
4786039|NCT01436162|16507221|P3|Randomized Phase|Adverse Event|6
4786040|NCT01436162|16507222|P2|Randomized Phase|Adverse Event|5
4786041|NCT01436162|16507223|P1|Randomized Phase|Adverse Event|1
4786042|NCT01436162|16507221|P3|Single-blind Lead-in Phase|Other|0
4786043|NCT01436162|16507222|P2|Single-blind Lead-in Phase|Other|0
4786044|NCT01436162|16507223|P1|Single-blind Lead-in Phase|Other|107
4786045|NCT01436162|16507221|P3|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786046|NCT01436162|16507222|P2|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786047|NCT01436162|16507223|P1|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13
4786048|NCT01436162|16507221|P3|Single-blind Lead-in Phase|Lost to Follow-up|0
4786049|NCT01436162|16507222|P2|Single-blind Lead-in Phase|Lost to Follow-up|0
4786050|NCT01436162|16507223|P1|Single-blind Lead-in Phase|Lost to Follow-up|43
4786051|NCT01436162|16507221|P3|Single-blind Lead-in Phase|Withdrawal by Subject|0
4786052|NCT01436162|16507222|P2|Single-blind Lead-in Phase|Withdrawal by Subject|0
4786053|NCT01436162|16507223|P1|Single-blind Lead-in Phase|Withdrawal by Subject|69
4786054|NCT01436162|16507221|P3|Single-blind Lead-in Phase|Protocol Violation|0
4786055|NCT01436162|16507222|P2|Single-blind Lead-in Phase|Protocol Violation|0
4786056|NCT01436162|16507223|P1|Single-blind Lead-in Phase|Protocol Violation|24
4786057|NCT01436162|16507221|P3|Single-blind Lead-in Phase|Adverse Event|0
4786058|NCT01436162|16507222|P2|Single-blind Lead-in Phase|Adverse Event|0
4786059|NCT01436162|16507223|P1|Single-blind Lead-in Phase|Adverse Event|26
4786060|NCT01436149|16507257|P3|Randomized Phase|Other|11
4786061|NCT01436149|16507258|P2|Randomized Phase|Other|5
4786062|NCT01436149|16507259|P1|Randomized Phase|Other|12
4786063|NCT01436149|16507257|P3|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
4786064|NCT01436149|16507258|P2|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3
4786065|NCT01436149|16507259|P1|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2
4786066|NCT01436149|16507257|P3|Randomized Phase|Lack of Efficacy|1
4786067|NCT01436149|16507258|P2|Randomized Phase|Lack of Efficacy|0
4786068|NCT01436149|16507259|P1|Randomized Phase|Lack of Efficacy|0
4786069|NCT01436149|16507257|P3|Randomized Phase|Lost to Follow-up|6
4786070|NCT01436149|16507258|P2|Randomized Phase|Lost to Follow-up|5
4786071|NCT01436149|16507259|P1|Randomized Phase|Lost to Follow-up|34
4786072|NCT01436149|16507257|P3|Randomized Phase|Withdrawal by Subject|10
4786073|NCT01436149|16507258|P2|Randomized Phase|Withdrawal by Subject|10
4786074|NCT01436149|16507259|P1|Randomized Phase|Withdrawal by Subject|16
4786075|NCT01436149|16507257|P3|Randomized Phase|Protocol Violation|0
4786076|NCT01436149|16507258|P2|Randomized Phase|Protocol Violation|5
4786077|NCT01436149|16507259|P1|Randomized Phase|Protocol Violation|4
4786078|NCT01436149|16507257|P3|Randomized Phase|Adverse Event|11
4786079|NCT01436149|16507258|P2|Randomized Phase|Adverse Event|10
4786080|NCT01436149|16507259|P1|Randomized Phase|Adverse Event|9
4786081|NCT01436149|16507257|P3|Antidepressant Lead-in Phase|Other|0
4786082|NCT01436149|16507258|P2|Antidepressant Lead-in Phase|Other|0
4786083|NCT01436149|16507259|P1|Antidepressant Lead-in Phase|Other|119
4786084|NCT01436149|16507257|P3|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
4786085|NCT01436149|16507258|P2|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0
4786086|NCT01436149|16507259|P1|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22
4786087|NCT01436149|16507257|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786088|NCT01436149|16507258|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786089|NCT01436149|16507259|P1|Antidepressant Lead-in Phase|Lost to Follow-up|96
4786090|NCT01436149|16507257|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786091|NCT01436149|16507258|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786092|NCT01436149|16507259|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|61
4786093|NCT01436149|16507257|P3|Antidepressant Lead-in Phase|Protocol Violation|0
4786094|NCT01436149|16507258|P2|Antidepressant Lead-in Phase|Protocol Violation|0
4786095|NCT01436149|16507259|P1|Antidepressant Lead-in Phase|Protocol Violation|29
4786096|NCT01436149|16507257|P3|Antidepressant Lead-in Phase|Adverse Event|0
4786097|NCT01436149|16507258|P2|Antidepressant Lead-in Phase|Adverse Event|0
4786098|NCT01436149|16507259|P1|Antidepressant Lead-in Phase|Adverse Event|39
4786099|NCT01436110|16507290|P3|Overall Study|Did Not Receive Trial Medication|3
4786100|NCT01436110|16507291|P2|Overall Study|Did Not Receive Trial Medication|0
4786101|NCT01436110|16507292|P1|Overall Study|Did Not Receive Trial Medication|1
4786102|NCT01436110|16507290|P3|Overall Study|Protocol Violation|1
4786103|NCT01436110|16507291|P2|Overall Study|Protocol Violation|1
4786104|NCT01436110|16507292|P1|Overall Study|Protocol Violation|3
4786105|NCT01436110|16507290|P3|Overall Study|Lost to Follow-up|3
4786106|NCT01436110|16507291|P2|Overall Study|Lost to Follow-up|1
4786107|NCT01436110|16507292|P1|Overall Study|Lost to Follow-up|1
4786108|NCT01436110|16507290|P3|Overall Study|Physician Decision|1
4786109|NCT01436110|16507291|P2|Overall Study|Physician Decision|1
4786110|NCT01436110|16507292|P1|Overall Study|Physician Decision|3
4786111|NCT01436110|16507290|P3|Overall Study|Adverse Event|2
4786112|NCT01436110|16507291|P2|Overall Study|Adverse Event|1
4786113|NCT01436110|16507292|P1|Overall Study|Adverse Event|2
4786114|NCT01436110|16507290|P3|Overall Study|Withdrawal by Subject|4
4786115|NCT01436110|16507291|P2|Overall Study|Withdrawal by Subject|8
4786116|NCT01436110|16507292|P1|Overall Study|Withdrawal by Subject|6
4786117|NCT01436110|16507290|P3|Overall Study|Lack of Efficacy|9
4786118|NCT01436110|16507291|P2|Overall Study|Lack of Efficacy|14
4786119|NCT01436110|16507292|P1|Overall Study|Lack of Efficacy|23
4786120|NCT01436084|16507315|P1|Overall Study|Early Closure of Study|1
4786121|NCT01436084|16507315|P1|Overall Study|Withdrawal by Subject|1
4786122|NCT01436084|16507315|P1|Overall Study|Disease Progression|2
4786123|NCT01436071|16507321|P2|Overall Study|Did Not Receive Trial Medication|3
4786124|NCT01436071|16507322|P1|Overall Study|Did Not Receive Trial Medication|3
4786125|NCT01436071|16507321|P2|Overall Study|Withdrawal by Subject|2
4786126|NCT01436071|16507322|P1|Overall Study|Withdrawal by Subject|2
4786127|NCT01436071|16507321|P2|Overall Study|Physician Decision|0
4786128|NCT01436071|16507322|P1|Overall Study|Physician Decision|1
4786129|NCT01436071|16507321|P2|Overall Study|Lost to Follow-up|1
4786130|NCT01436071|16507322|P1|Overall Study|Lost to Follow-up|3
4786131|NCT01436071|16507321|P2|Overall Study|Protocol Violation|1
4786132|NCT01436071|16507322|P1|Overall Study|Protocol Violation|0
4786133|NCT01436071|16507321|P2|Overall Study|Lack of Efficacy|7
4786134|NCT01436071|16507322|P1|Overall Study|Lack of Efficacy|16
4786135|NCT01436071|16507321|P2|Overall Study|Adverse Event|0
4786136|NCT01436071|16507322|P1|Overall Study|Adverse Event|1
4786137|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Administrative|2
4786138|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Administrative|5
4786139|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Administrative|0
4786140|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Relapse criteria met|58
4786141|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Relapse criteria met|43
4786142|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Relapse criteria met|0
4786143|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Terminated at study completion|39
4786144|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Terminated at study completion|47
4786145|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Terminated at study completion|0
4786146|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12
4786147|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5
4786148|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0
4786149|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Protocol Violation|4
4786150|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Protocol Violation|11
4786151|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Protocol Violation|0
4786152|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Lost to Follow-up|5
4786153|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Lost to Follow-up|2
4786154|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Lost to Follow-up|0
4786155|NCT01435928|16507364|P3|Double Blind Phase - 28 Weeks|Adverse Event|1
4786156|NCT01435928|16507365|P2|Double Blind Phase - 28 Weeks|Adverse Event|3
4786157|NCT01435928|16507366|P1|Double Blind Phase - 28 Weeks|Adverse Event|0
4786158|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Administrative|0
4786159|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Administrative|0
4786160|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Administrative|14
4786161|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
4786162|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Terminated at study completion|0
4786163|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Terminated at study completion|6
4786164|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
4786165|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0
4786166|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44
4786167|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
4786168|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0
4786169|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96
4786170|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Protocol Violation|0
4786171|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Protocol Violation|0
4786172|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Protocol Violation|39
4786173|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
4786174|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0
4786175|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60
4786176|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
4786177|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0
4786178|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46
4786179|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Death|0
4786180|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Death|0
4786181|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Death|1
4786182|NCT01435928|16507364|P3|Open Label Phase - up to 24 Weeks|Adverse Event|0
4786183|NCT01435928|16507365|P2|Open Label Phase - up to 24 Weeks|Adverse Event|0
4786184|NCT01435928|16507366|P1|Open Label Phase - up to 24 Weeks|Adverse Event|83
4786185|NCT01435798|16507412|P1|Overall Study|Withdrawal by Subject|1
4786186|NCT01435772|16507429|P3|Overall Study|Other - study termination|10
4786187|NCT01435772|16507430|P2|Overall Study|Other - study termination|2
4786188|NCT01435772|16507431|P1|Overall Study|Other - study termination|2
4786189|NCT01435772|16507429|P3|Overall Study|Withdrawal by Subject|3
4786190|NCT01435772|16507430|P2|Overall Study|Withdrawal by Subject|1
4786191|NCT01435772|16507431|P1|Overall Study|Withdrawal by Subject|0
4786192|NCT01435772|16507429|P3|Overall Study|Adverse Event|2
4786193|NCT01435772|16507430|P2|Overall Study|Adverse Event|0
4786194|NCT01435772|16507431|P1|Overall Study|Adverse Event|1
4786195|NCT01435759|16507481|P6|Double-blind Phase|Other|0
4786196|NCT01435759|16507482|P5|Double-blind Phase|Other|0
4786197|NCT01435759|16507483|P4|Double-blind Phase|Other|2
4786198|NCT01435759|16507484|P3|Double-blind Phase|Other|0
4786199|NCT01435759|16507485|P2|Double-blind Phase|Other|2
4786200|NCT01435759|16507486|P1|Double-blind Phase|Other|8
4786201|NCT01435759|16507481|P6|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4786202|NCT01435759|16507482|P5|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3
4786203|NCT01435759|16507483|P4|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4786204|NCT01435759|16507484|P3|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4786205|NCT01435759|16507485|P2|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0
4786206|NCT01435759|16507486|P1|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1
4786207|NCT01435759|16507481|P6|Double-blind Phase|Lost to Follow-up|3
4786208|NCT01435759|16507482|P5|Double-blind Phase|Lost to Follow-up|3
4786209|NCT01435759|16507483|P4|Double-blind Phase|Lost to Follow-up|0
4786210|NCT01435759|16507484|P3|Double-blind Phase|Lost to Follow-up|2
4786211|NCT01435759|16507485|P2|Double-blind Phase|Lost to Follow-up|1
4786212|NCT01435759|16507486|P1|Double-blind Phase|Lost to Follow-up|31
4786213|NCT01435759|16507481|P6|Double-blind Phase|Withdrawal by Subject|2
4786214|NCT01435759|16507482|P5|Double-blind Phase|Withdrawal by Subject|2
4786215|NCT01435759|16507483|P4|Double-blind Phase|Withdrawal by Subject|4
4786216|NCT01435759|16507484|P3|Double-blind Phase|Withdrawal by Subject|3
4786217|NCT01435759|16507485|P2|Double-blind Phase|Withdrawal by Subject|4
4786218|NCT01435759|16507486|P1|Double-blind Phase|Withdrawal by Subject|17
4786219|NCT01435759|16507481|P6|Double-blind Phase|Protocol Violation|1
4786220|NCT01435759|16507482|P5|Double-blind Phase|Protocol Violation|0
4786221|NCT01435759|16507483|P4|Double-blind Phase|Protocol Violation|2
4786222|NCT01435759|16507484|P3|Double-blind Phase|Protocol Violation|1
4786223|NCT01435759|16507485|P2|Double-blind Phase|Protocol Violation|0
4786224|NCT01435759|16507486|P1|Double-blind Phase|Protocol Violation|2
4786225|NCT01435759|16507481|P6|Double-blind Phase|Adverse Event|3
4786226|NCT01435759|16507482|P5|Double-blind Phase|Adverse Event|1
4786227|NCT01435759|16507483|P4|Double-blind Phase|Adverse Event|1
4786228|NCT01435759|16507484|P3|Double-blind Phase|Adverse Event|1
4786229|NCT01435759|16507485|P2|Double-blind Phase|Adverse Event|0
4786230|NCT01435759|16507486|P1|Double-blind Phase|Adverse Event|7
4786231|NCT01435759|16507481|P6|Antidepressant Lead-in Phase|Other|0
4786232|NCT01435759|16507482|P5|Antidepressant Lead-in Phase|Other|0
4786233|NCT01435759|16507483|P4|Antidepressant Lead-in Phase|Other|0
4786234|NCT01435759|16507484|P3|Antidepressant Lead-in Phase|Other|0
4786235|NCT01435759|16507485|P2|Antidepressant Lead-in Phase|Other|0
4786236|NCT01435759|16507486|P1|Antidepressant Lead-in Phase|Other|119
4786237|NCT01435759|16507481|P6|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786238|NCT01435759|16507482|P5|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786239|NCT01435759|16507483|P4|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786240|NCT01435759|16507484|P3|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786241|NCT01435759|16507485|P2|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0
4786242|NCT01435759|16507486|P1|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10
4786243|NCT01435759|16507481|P6|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786244|NCT01435759|16507482|P5|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786245|NCT01435759|16507483|P4|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786246|NCT01435759|16507484|P3|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786247|NCT01435759|16507485|P2|Antidepressant Lead-in Phase|Lost to Follow-up|0
4786248|NCT01435759|16507486|P1|Antidepressant Lead-in Phase|Lost to Follow-up|83
4786249|NCT01435759|16507481|P6|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786250|NCT01435759|16507482|P5|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786251|NCT01435759|16507483|P4|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786252|NCT01435759|16507484|P3|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786253|NCT01435759|16507485|P2|Antidepressant Lead-in Phase|Withdrawal by Subject|0
4786254|NCT01435759|16507486|P1|Antidepressant Lead-in Phase|Withdrawal by Subject|74
4786255|NCT01435759|16507481|P6|Antidepressant Lead-in Phase|Protocol Violation|0
4786256|NCT01435759|16507482|P5|Antidepressant Lead-in Phase|Protocol Violation|0
4786257|NCT01435759|16507483|P4|Antidepressant Lead-in Phase|Protocol Violation|0
4786258|NCT01435759|16507484|P3|Antidepressant Lead-in Phase|Protocol Violation|0
4786259|NCT01435759|16507485|P2|Antidepressant Lead-in Phase|Protocol Violation|0
4786260|NCT01435759|16507486|P1|Antidepressant Lead-in Phase|Protocol Violation|16
4786261|NCT01435759|16507481|P6|Antidepressant Lead-in Phase|Adverse Event|0
4786262|NCT01435759|16507482|P5|Antidepressant Lead-in Phase|Adverse Event|0
4786263|NCT01435759|16507483|P4|Antidepressant Lead-in Phase|Adverse Event|0
4786264|NCT01435759|16507484|P3|Antidepressant Lead-in Phase|Adverse Event|0
4786265|NCT01435759|16507485|P2|Antidepressant Lead-in Phase|Adverse Event|0
4786266|NCT01435759|16507486|P1|Antidepressant Lead-in Phase|Adverse Event|40
4786267|NCT01435655|16507513|P1|Overall Study|Other|1
4786268|NCT01435655|16507513|P1|Overall Study|Death|2
4786269|NCT01435616|16507527|P2|Overall Study|Sponsor Decision|0
4786270|NCT01435616|16507528|P1|Overall Study|Sponsor Decision|1
4786271|NCT01435616|16507527|P2|Overall Study|Physician Decision|7
4786272|NCT01435616|16507528|P1|Overall Study|Physician Decision|20
4786273|NCT01435616|16507527|P2|Overall Study|Withdrawal by Subject|24
4786274|NCT01435616|16507528|P1|Overall Study|Withdrawal by Subject|66
4786275|NCT01435616|16507527|P2|Overall Study|Protocol Violation|13
4786276|NCT01435616|16507528|P1|Overall Study|Protocol Violation|16
4786277|NCT01435616|16507527|P2|Overall Study|Lost to Follow-up|13
4786278|NCT01435616|16507528|P1|Overall Study|Lost to Follow-up|22
4786279|NCT01435616|16507527|P2|Overall Study|Death|2
4786280|NCT01435616|16507528|P1|Overall Study|Death|7
4786281|NCT01435616|16507527|P2|Overall Study|Adverse Event|21
4786282|NCT01435616|16507528|P1|Overall Study|Adverse Event|39
4786283|NCT01435577|16507583|P2|Overall Study|Alternative treatment started|1
4786284|NCT01435577|16507584|P1|Overall Study|Alternative treatment started|0
4786285|NCT01435577|16507583|P2|Overall Study|Lack of Efficacy|51
4786286|NCT01435577|16507584|P1|Overall Study|Lack of Efficacy|7
4786287|NCT01435577|16507583|P2|Overall Study|Adverse Event|0
4786288|NCT01435577|16507584|P1|Overall Study|Adverse Event|10
4786289|NCT01435460|16507645|P2|Overall Study|Did not meet eligibility criteria|0
4786290|NCT01435460|16507646|P1|Overall Study|Did not meet eligibility criteria|2
4786291|NCT01435460|16507645|P2|Overall Study|Protocol Violation|1
4786292|NCT01435460|16507646|P1|Overall Study|Protocol Violation|0
4786293|NCT01435460|16507645|P2|Overall Study|Withdrawal by Subject|3
4786294|NCT01435460|16507646|P1|Overall Study|Withdrawal by Subject|1
4786295|NCT01435460|16507645|P2|Overall Study|Lost to Follow-up|1
4786296|NCT01435460|16507646|P1|Overall Study|Lost to Follow-up|6
4786297|NCT01435460|16507645|P2|Overall Study|Adverse Event|1
4786298|NCT01435460|16507646|P1|Overall Study|Adverse Event|2
4786299|NCT01435382|16507662|P4|Overall Study|Withdrawal by Subject|1
4786300|NCT01435382|16507663|P3|Overall Study|Withdrawal by Subject|0
4786301|NCT01435382|16507664|P2|Overall Study|Withdrawal by Subject|2
4786302|NCT01435382|16507665|P1|Overall Study|Withdrawal by Subject|0
4786303|NCT01435382|16507662|P4|Overall Study|Lost to Follow-up|0
4786304|NCT01435382|16507663|P3|Overall Study|Lost to Follow-up|1
4786305|NCT01435382|16507664|P2|Overall Study|Lost to Follow-up|0
4786306|NCT01435382|16507665|P1|Overall Study|Lost to Follow-up|1
4786307|NCT01435356|16507754|P2|Overall Study|Patient moved to another city|1
4786308|NCT01435356|16507755|P1|Overall Study|Patient moved to another city|1
4786309|NCT01435356|16507754|P2|Overall Study|Patient decision|0
4786310|NCT01435356|16507755|P1|Overall Study|Patient decision|3
4786311|NCT01435356|16507754|P2|Overall Study|Physician Decision|0
4786312|NCT01435356|16507755|P1|Overall Study|Physician Decision|1
4786313|NCT01435356|16507754|P2|Overall Study|IC withdrawal due to study cancellation|0
4786314|NCT01435356|16507755|P1|Overall Study|IC withdrawal due to study cancellation|1
4786315|NCT01435356|16507754|P2|Overall Study|Facial palsy|0
4786316|NCT01435356|16507755|P1|Overall Study|Facial palsy|1
4786317|NCT01435356|16507754|P2|Overall Study|Withdrawal by Subject|1
4786318|NCT01435356|16507755|P1|Overall Study|Withdrawal by Subject|1
4786319|NCT01435356|16507754|P2|Overall Study|Study Discontinuation, amendment 4|11
4786320|NCT01435356|16507755|P1|Overall Study|Study Discontinuation, amendment 4|5
4786321|NCT01435356|16507754|P2|Overall Study|Protocol Violation|1
4786322|NCT01435356|16507755|P1|Overall Study|Protocol Violation|0
4786323|NCT01435356|16507754|P2|Overall Study|Disease progression/recurrence|10
4786324|NCT01435356|16507755|P1|Overall Study|Disease progression/recurrence|17
4786325|NCT01435356|16507754|P2|Overall Study|Adverse Event|0
4786326|NCT01435356|16507755|P1|Overall Study|Adverse Event|2
4786327|NCT01435265|16507788|P2|Overall Study|Lost to Follow-up|1
4786328|NCT01435265|16507789|P1|Overall Study|Lost to Follow-up|0
4786329|NCT01435122|16507803|P1|Overall Study|Early withdrawal due to toxicity|8
4786330|NCT01435031|16507812|P1|ITT at 4 Years|Lost to Follow-up|1
4786331|NCT01435031|16507812|P1|ITT at 4 Years|Withdrawal by Subject|2
4786332|NCT01435031|16507812|P1|ITT at 4 Years|Death|4
4786333|NCT01435031|16507812|P1|ITT at 3 Years|Lost to Follow-up|4
4786334|NCT01435031|16507812|P1|ITT at 3 Years|Withdrawal by Subject|2
4786335|NCT01435031|16507812|P1|ITT at 3 Years|Death|5
4786336|NCT01435031|16507812|P1|ITT at 2 Years|Lost to Follow-up|4
4786337|NCT01435031|16507812|P1|ITT at 2 Years|Withdrawal by Subject|2
4786338|NCT01435031|16507812|P1|ITT at 2 Years|Death|7
4786339|NCT01435031|16507812|P1|ITT at 1 Year|Lost to Follow-up|6
4786340|NCT01435031|16507812|P1|ITT at 1 Year|Withdrawal by Subject|2
4786341|NCT01435031|16507812|P1|ITT at 1 Year|Death|1
4786342|NCT01435031|16507812|P1|ITT at 6 Months|Lost to Follow-up|3
4786343|NCT01435031|16507812|P1|ITT at 6 Months|Death|2
4786344|NCT01435031|16507812|P1|ITT at 1 Month|Lost to Follow-up|4
4786345|NCT01435031|16507812|P1|ITT at 1 Month|Death|1
4786346|NCT01435031|16507812|P1|ITT at 1 Month|Withdrawal by Subject|1
4786347|NCT01435018|16507913|P3|Overall Study|Never started chemotherapy|1
4786348|NCT01435018|16507914|P2|Overall Study|Never started chemotherapy|0
4786349|NCT01435018|16507915|P1|Overall Study|Never started chemotherapy|3
4786350|NCT01435018|16507913|P3|Overall Study|Enrollment Violation|0
4786351|NCT01435018|16507914|P2|Overall Study|Enrollment Violation|1
4786352|NCT01435018|16507915|P1|Overall Study|Enrollment Violation|0
4786353|NCT01435018|16507913|P3|Overall Study|Unable to contact participant/parent|1
4786354|NCT01435018|16507914|P2|Overall Study|Unable to contact participant/parent|1
4786355|NCT01435018|16507915|P1|Overall Study|Unable to contact participant/parent|1
4786356|NCT01435018|16507913|P3|Overall Study|Severe debilitation, unable to continue|1
4786357|NCT01435018|16507914|P2|Overall Study|Severe debilitation, unable to continue|0
4786358|NCT01435018|16507915|P1|Overall Study|Severe debilitation, unable to continue|0
4786359|NCT01435018|16507913|P3|Overall Study|Not able to get to clinic|2
4786360|NCT01435018|16507914|P2|Overall Study|Not able to get to clinic|0
4786361|NCT01435018|16507915|P1|Overall Study|Not able to get to clinic|2
4786362|NCT01435018|16507913|P3|Overall Study|Not willing to adhere to requirements|3
4786363|NCT01435018|16507914|P2|Overall Study|Not willing to adhere to requirements|2
4786364|NCT01435018|16507915|P1|Overall Study|Not willing to adhere to requirements|0
4786365|NCT01435018|16507913|P3|Overall Study|Withdrew consent|1
4786366|NCT01435018|16507914|P2|Overall Study|Withdrew consent|3
4786367|NCT01435018|16507915|P1|Overall Study|Withdrew consent|0
4786368|NCT01435018|16507913|P3|Overall Study|Site is closing|7
4786369|NCT01435018|16507914|P2|Overall Study|Site is closing|9
4786370|NCT01435018|16507915|P1|Overall Study|Site is closing|4
4786371|NCT01435018|16507913|P3|Overall Study|Death|25
4786372|NCT01435018|16507914|P2|Overall Study|Death|18
4786373|NCT01435018|16507915|P1|Overall Study|Death|37
4786374|NCT01434823|16508008|P2|Overall Study|Incomplete data in medical record|7
4786375|NCT01434823|16508009|P1|Overall Study|Incomplete data in medical record|4
4786376|NCT01434810|16508027|P2|Overall Study|Missing data/received <5hr phototherapy|7
4786377|NCT01434810|16508028|P1|Overall Study|Missing data/received <5hr phototherapy|12
4786378|NCT01434810|16508027|P2|Overall Study|Did not receive treatment|3
4786379|NCT01434810|16508028|P1|Overall Study|Did not receive treatment|11
4786380|NCT01434693|16508063|P4|Overall Study|Lost to Follow-up|0
4786381|NCT01434693|16508064|P3|Overall Study|Lost to Follow-up|0
4786382|NCT01434693|16508065|P2|Overall Study|Lost to Follow-up|0
4786383|NCT01434693|16508066|P1|Overall Study|Lost to Follow-up|1
4786384|NCT01434693|16508063|P4|Overall Study|Withdrawal by Subject|1
4786385|NCT01434693|16508064|P3|Overall Study|Withdrawal by Subject|1
4786386|NCT01434693|16508065|P2|Overall Study|Withdrawal by Subject|0
4786387|NCT01434693|16508066|P1|Overall Study|Withdrawal by Subject|1
4786388|NCT01434693|16508063|P4|Overall Study|Adverse Event|0
4786389|NCT01434693|16508064|P3|Overall Study|Adverse Event|0
4786390|NCT01434693|16508065|P2|Overall Study|Adverse Event|0
4786391|NCT01434693|16508066|P1|Overall Study|Adverse Event|1
4786392|NCT01434680|16508080|P4|Overall Study|Protocol Violation|0
4786393|NCT01434680|16508081|P3|Overall Study|Protocol Violation|0
4786394|NCT01434680|16508082|P2|Overall Study|Protocol Violation|1
4786395|NCT01434680|16508083|P1|Overall Study|Protocol Violation|1
4786396|NCT01434680|16508080|P4|Overall Study|Lost to Follow-up|0
4786397|NCT01434680|16508081|P3|Overall Study|Lost to Follow-up|0
4786398|NCT01434680|16508082|P2|Overall Study|Lost to Follow-up|1
4786399|NCT01434680|16508083|P1|Overall Study|Lost to Follow-up|1
4786400|NCT01434680|16508080|P4|Overall Study|Withdrawal by Subject|0
4786401|NCT01434680|16508081|P3|Overall Study|Withdrawal by Subject|2
4786402|NCT01434680|16508082|P2|Overall Study|Withdrawal by Subject|0
4786403|NCT01434680|16508083|P1|Overall Study|Withdrawal by Subject|1
4786404|NCT01434667|16508100|P2|Overall Study|Lost to Follow-up|10
4786405|NCT01434667|16508101|P1|Overall Study|Lost to Follow-up|5
4786406|NCT01434654|16508127|P2|Overall Study|Lost to Follow-up|0
4786407|NCT01434654|16508128|P1|Overall Study|Lost to Follow-up|1
4786408|NCT01434654|16508127|P2|Overall Study|Withdrawal by Subject|0
4786409|NCT01434654|16508128|P1|Overall Study|Withdrawal by Subject|1
4786410|NCT01434290|16508175|P2|Overall Study|No protocol treatment|4
4786411|NCT01434290|16508176|P1|Overall Study|No protocol treatment|2
4786412|NCT01434290|16508175|P2|Overall Study|Protocol Violation|3
4786413|NCT01434290|16508176|P1|Overall Study|Protocol Violation|6
4786414|NCT01433978|16508249|P3|Extension Phase|Study Terminated by Sponsor|4
4786415|NCT01433978|16508250|P2|Extension Phase|Study Terminated by Sponsor|0
4786416|NCT01433978|16508251|P1|Extension Phase|Study Terminated by Sponsor|0
4786417|NCT01433978|16508249|P3|Extension Phase|Lack of Efficacy|1
4786418|NCT01433978|16508250|P2|Extension Phase|Lack of Efficacy|0
4786419|NCT01433978|16508251|P1|Extension Phase|Lack of Efficacy|0
4786420|NCT01433978|16508249|P3|Extension Phase|Adverse Event, Non-Fatal|1
4786421|NCT01433978|16508250|P2|Extension Phase|Adverse Event, Non-Fatal|0
4786422|NCT01433978|16508251|P1|Extension Phase|Adverse Event, Non-Fatal|0
4786423|NCT01433978|16508249|P3|Core Study|Study Terminated by Sponsor|0
4786424|NCT01433978|16508250|P2|Core Study|Study Terminated by Sponsor|9
4786425|NCT01433978|16508251|P1|Core Study|Study Terminated by Sponsor|6
4786426|NCT01433978|16508249|P3|Core Study|Lack of Efficacy|0
4786427|NCT01433978|16508250|P2|Core Study|Lack of Efficacy|1
4786428|NCT01433978|16508251|P1|Core Study|Lack of Efficacy|5
4786429|NCT01433978|16508249|P3|Core Study|Adverse Event, Non-Fatal|0
4786430|NCT01433978|16508250|P2|Core Study|Adverse Event, Non-Fatal|1
4786431|NCT01433978|16508251|P1|Core Study|Adverse Event, Non-Fatal|0
4786432|NCT01433549|16508308|P2|Phase 2: Second Study Product|Adverse Event|1
4786433|NCT01433549|16508309|P1|Phase 2: Second Study Product|Adverse Event|0
4786434|NCT01433471|16508319|P2|Overall Study|Withdrawal by Subject|1
4786435|NCT01433471|16508320|P1|Overall Study|Withdrawal by Subject|0
4786436|NCT01433354|16508336|P1|Overall Study|Subject Withdrew Consent|3
4786437|NCT01433354|16508336|P1|Overall Study|Lack of Efficacy|17
4786438|NCT01433354|16508336|P1|Overall Study|Protocol Violation|2
4786439|NCT01433354|16508336|P1|Overall Study|Administrative problems|90
4786440|NCT01433354|16508336|P1|Overall Study|Lost to Follow-up|1
4786441|NCT01433354|16508336|P1|Overall Study|Adverse Event|6
4786442|NCT01433263|16508352|P2|Overall Study|Withdrawal by Subject|7
4786443|NCT01433263|16508353|P1|Overall Study|Withdrawal by Subject|10
4786444|NCT01433263|16508352|P2|Overall Study|Protocol Deviation|0
4786445|NCT01433263|16508353|P1|Overall Study|Protocol Deviation|1
4786446|NCT01433263|16508352|P2|Overall Study|Lost to Follow-up|1
4786447|NCT01433263|16508353|P1|Overall Study|Lost to Follow-up|0
4786448|NCT01433263|16508352|P2|Overall Study|Death|3
4786449|NCT01433263|16508353|P1|Overall Study|Death|5
4786450|NCT01433263|16508352|P2|Overall Study|Adverse Event|1
4786451|NCT01433263|16508353|P1|Overall Study|Adverse Event|3
4786452|NCT01433250|16508382|P2|Overall Study|Withdrawal by Subject|2
4786453|NCT01433250|16508383|P1|Overall Study|Withdrawal by Subject|3
4786454|NCT01433250|16508382|P2|Overall Study|Protocol Violation|1
4786455|NCT01433250|16508383|P1|Overall Study|Protocol Violation|0
4786456|NCT01433172|16508402|P3|Overall Study|Death|0
4786457|NCT01433172|16508403|P2|Overall Study|Death|2
4786458|NCT01433172|16508404|P1|Overall Study|Death|0
4786459|NCT01433172|16508402|P3|Overall Study|Disease Progression|1
4786460|NCT01433172|16508403|P2|Overall Study|Disease Progression|0
4786461|NCT01433172|16508404|P1|Overall Study|Disease Progression|0
4786462|NCT01433172|16508402|P3|Overall Study|Withdrawal by Subject|0
4786463|NCT01433172|16508403|P2|Overall Study|Withdrawal by Subject|1
4786464|NCT01433172|16508404|P1|Overall Study|Withdrawal by Subject|0
4786465|NCT01433159|16508416|P2|Overall Study|Protocol Violation|1
4786466|NCT01433159|16508417|P1|Overall Study|Protocol Violation|0
4786467|NCT01433159|16508416|P2|Overall Study|Physician Decision|0
4786468|NCT01433159|16508417|P1|Overall Study|Physician Decision|1
4786469|NCT01433159|16508416|P2|Overall Study|Adverse Event|0
4786470|NCT01433159|16508417|P1|Overall Study|Adverse Event|1
4786471|NCT01433055|16508449|P2|Overall Study|Severely elevated triglycerides at entry|0
4786472|NCT01433055|16508450|P1|Overall Study|Severely elevated triglycerides at entry|1
4786473|NCT01433055|16508449|P2|Overall Study|Diagnosed with cancer unrelated to study|0
4786474|NCT01433055|16508450|P1|Overall Study|Diagnosed with cancer unrelated to study|1
4786475|NCT01432951|16508472|P1|Treatment Phase (Day 1 to 30)|Never Treated|1
4786476|NCT01432938|16508481|P2|Second Intervention|Adverse Event|0
4786477|NCT01432938|16508482|P1|Second Intervention|Adverse Event|1
4786478|NCT01432938|16508481|P2|First Intervention|Physician Decision|0
4786479|NCT01432938|16508482|P1|First Intervention|Physician Decision|1
4786480|NCT01432938|16508481|P2|First Intervention|Protocol Violation|0
4786481|NCT01432938|16508482|P1|First Intervention|Protocol Violation|1
4786482|NCT01432756|16508512|P4|Overall Study|Lost to Follow-up|1
4786483|NCT01432756|16508513|P3|Overall Study|Lost to Follow-up|2
4786484|NCT01432756|16508514|P2|Overall Study|Lost to Follow-up|0
4786485|NCT01432756|16508515|P1|Overall Study|Lost to Follow-up|1
4786486|NCT01432626|16508523|P1|Overall Study|Imaging agent not available|1
4786487|NCT01432626|16508523|P1|Overall Study|Only 1 image competed|2
4786488|NCT01432626|16508523|P1|Overall Study|Withdrawal by Subject|2
4786489|NCT01432626|16508523|P1|Overall Study|LV function recovered|2
4786490|NCT01432600|16508530|P3|Overall Study|Rapid PD, allocated intv. not rec'd|1
4786491|NCT01432600|16508531|P2|Overall Study|Rapid PD, allocated intv. not rec'd|1
4786492|NCT01432600|16508532|P1|Overall Study|Rapid PD, allocated intv. not rec'd|0
4786493|NCT01432457|16508588|P3|Overall Study|Did not take study drug|3
4786494|NCT01432457|16508589|P2|Overall Study|Did not take study drug|6
4786495|NCT01432457|16508590|P1|Overall Study|Did not take study drug|6
4786496|NCT01432457|16508588|P3|Overall Study|Reasons not defined|4
4786497|NCT01432457|16508589|P2|Overall Study|Reasons not defined|3
4786498|NCT01432457|16508590|P1|Overall Study|Reasons not defined|2
4786499|NCT01432457|16508588|P3|Overall Study|Withdrawal by Subject|9
4786500|NCT01432457|16508589|P2|Overall Study|Withdrawal by Subject|11
4786501|NCT01432457|16508590|P1|Overall Study|Withdrawal by Subject|6
4786502|NCT01432457|16508588|P3|Overall Study|Protocol Violation|6
4786503|NCT01432457|16508589|P2|Overall Study|Protocol Violation|2
4786504|NCT01432457|16508590|P1|Overall Study|Protocol Violation|3
4786505|NCT01432457|16508588|P3|Overall Study|Lost to Follow-up|20
4786506|NCT01432457|16508589|P2|Overall Study|Lost to Follow-up|15
4786507|NCT01432457|16508590|P1|Overall Study|Lost to Follow-up|11
4786508|NCT01432457|16508588|P3|Overall Study|Lack of Efficacy|1
4786509|NCT01432457|16508589|P2|Overall Study|Lack of Efficacy|1
4786510|NCT01432457|16508590|P1|Overall Study|Lack of Efficacy|2
4786511|NCT01432457|16508588|P3|Overall Study|Adverse Event|16
4786512|NCT01432457|16508589|P2|Overall Study|Adverse Event|10
4786513|NCT01432457|16508590|P1|Overall Study|Adverse Event|7
4786514|NCT01432444|16508619|P3|Extension Phase|Withdrawal by Subject|13
4786515|NCT01432444|16508620|P2|Extension Phase|Withdrawal by Subject|0
4786516|NCT01432444|16508621|P1|Extension Phase|Withdrawal by Subject|0
4786517|NCT01432444|16508619|P3|Extension Phase|Physician Decision|1
4786518|NCT01432444|16508620|P2|Extension Phase|Physician Decision|0
4786519|NCT01432444|16508621|P1|Extension Phase|Physician Decision|0
4786520|NCT01432444|16508619|P3|Extension Phase|Met Withdrawal Criteria|144
4786521|NCT01432444|16508620|P2|Extension Phase|Met Withdrawal Criteria|0
4786522|NCT01432444|16508621|P1|Extension Phase|Met Withdrawal Criteria|0
4786523|NCT01432444|16508619|P3|Extension Phase|Sponsor Discontinued Trial|7
4786524|NCT01432444|16508620|P2|Extension Phase|Sponsor Discontinued Trial|0
4786525|NCT01432444|16508621|P1|Extension Phase|Sponsor Discontinued Trial|0
4786526|NCT01432444|16508619|P3|Extension Phase|Adverse Event|10
4786527|NCT01432444|16508620|P2|Extension Phase|Adverse Event|0
4786528|NCT01432444|16508621|P1|Extension Phase|Adverse Event|0
4786529|NCT01432444|16508619|P3|Extension Phase|Lost to Follow-up|17
4786530|NCT01432444|16508620|P2|Extension Phase|Lost to Follow-up|0
4786531|NCT01432444|16508621|P1|Extension Phase|Lost to Follow-up|0
4786532|NCT01432444|16508619|P3|Treatment Phase|Lack of Efficacy|0
4786533|NCT01432444|16508620|P2|Treatment Phase|Lack of Efficacy|10
4786534|NCT01432444|16508621|P1|Treatment Phase|Lack of Efficacy|0
4786535|NCT01432444|16508619|P3|Treatment Phase|Protocol Deviation|0
4786536|NCT01432444|16508620|P2|Treatment Phase|Protocol Deviation|3
4786537|NCT01432444|16508621|P1|Treatment Phase|Protocol Deviation|0
4786538|NCT01432444|16508619|P3|Treatment Phase|Withdrawal by Subject|0
4786539|NCT01432444|16508620|P2|Treatment Phase|Withdrawal by Subject|41
4786540|NCT01432444|16508621|P1|Treatment Phase|Withdrawal by Subject|0
4786541|NCT01432444|16508619|P3|Treatment Phase|Physician Decision|0
4786542|NCT01432444|16508620|P2|Treatment Phase|Physician Decision|5
4786543|NCT01432444|16508621|P1|Treatment Phase|Physician Decision|0
4786544|NCT01432444|16508619|P3|Treatment Phase|Met Withdrawal Criteria|0
4786545|NCT01432444|16508620|P2|Treatment Phase|Met Withdrawal Criteria|11
4786546|NCT01432444|16508621|P1|Treatment Phase|Met Withdrawal Criteria|0
4786547|NCT01432444|16508619|P3|Treatment Phase|Adverse Event|0
4786548|NCT01432444|16508620|P2|Treatment Phase|Adverse Event|37
4786549|NCT01432444|16508621|P1|Treatment Phase|Adverse Event|0
4786550|NCT01432444|16508619|P3|Treatment Phase|Lost to Follow-up|0
4786551|NCT01432444|16508620|P2|Treatment Phase|Lost to Follow-up|33
4786552|NCT01432444|16508621|P1|Treatment Phase|Lost to Follow-up|0
4786553|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Lack of Efficacy|0
4786554|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Lack of Efficacy|0
4786555|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Lack of Efficacy|5
4786556|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Protocol Deviation|0
4786557|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Protocol Deviation|0
4786558|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Protocol Deviation|1
4786559|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
4786560|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Withdrawal by Subject|0
4786561|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Withdrawal by Subject|15
4786562|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Physician Decision|0
4786563|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Physician Decision|0
4786564|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Physician Decision|8
4786565|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
4786566|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0
4786567|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5
4786568|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Adverse Event|0
4786569|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Adverse Event|0
4786570|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Adverse Event|16
4786571|NCT01432444|16508619|P3|Tolerability/Cross-titration Phase|Lost to Follow-up|0
4786572|NCT01432444|16508620|P2|Tolerability/Cross-titration Phase|Lost to Follow-up|0
4786573|NCT01432444|16508621|P1|Tolerability/Cross-titration Phase|Lost to Follow-up|10
4786574|NCT01432366|16508647|P1|Overall Study|Other|14
4786575|NCT01432366|16508647|P1|Overall Study|Investigator Forget to Complete Visits|1
4786576|NCT01432366|16508647|P1|Overall Study|Site Closed|20
4786577|NCT01432366|16508647|P1|Overall Study|Lack of Efficacy|1
4786578|NCT01432366|16508647|P1|Overall Study|Lost to Follow-up|13
4786579|NCT01432366|16508647|P1|Overall Study|Pregnancy|1
4786580|NCT01432366|16508647|P1|Overall Study|Withdrawal Due to Non-Compliance|3
4786581|NCT01432366|16508647|P1|Overall Study|Adverse Event|8
4786582|NCT01432366|16508647|P1|Overall Study|Non-Responder|7
4786583|NCT01432327|16508669|P4|Posttest 1 Year|Allergic reaction|1
4786584|NCT01432327|16508670|P3|Posttest 1 Year|Allergic reaction|1
4786585|NCT01432327|16508671|P2|Posttest 1 Year|Allergic reaction|0
4786586|NCT01432327|16508672|P1|Posttest 1 Year|Allergic reaction|0
4786587|NCT01432327|16508669|P4|Posttest 1 Year|Lost to Follow-up|2
4786588|NCT01432327|16508670|P3|Posttest 1 Year|Lost to Follow-up|4
4786589|NCT01432327|16508671|P2|Posttest 1 Year|Lost to Follow-up|0
4786590|NCT01432327|16508672|P1|Posttest 1 Year|Lost to Follow-up|0
4786591|NCT01432327|16508669|P4|Posttest 1 Year|Measurement have to take place in future|20
4786592|NCT01432327|16508670|P3|Posttest 1 Year|Measurement have to take place in future|15
4786593|NCT01432327|16508671|P2|Posttest 1 Year|Measurement have to take place in future|28
4786594|NCT01432327|16508672|P1|Posttest 1 Year|Measurement have to take place in future|24
4786595|NCT01432327|16508669|P4|Posttest 6 Months|Withdrawal by Subject|0
4786596|NCT01432327|16508670|P3|Posttest 6 Months|Withdrawal by Subject|1
4786597|NCT01432327|16508671|P2|Posttest 6 Months|Withdrawal by Subject|0
4786598|NCT01432327|16508672|P1|Posttest 6 Months|Withdrawal by Subject|0
4786599|NCT01432327|16508669|P4|Posttest 6 Months|Allergic reaction|0
4786600|NCT01432327|16508670|P3|Posttest 6 Months|Allergic reaction|1
4786601|NCT01432327|16508671|P2|Posttest 6 Months|Allergic reaction|0
4786602|NCT01432327|16508672|P1|Posttest 6 Months|Allergic reaction|0
4786603|NCT01432327|16508669|P4|Posttest 6 Months|Lost to Follow-up|2
4786604|NCT01432327|16508670|P3|Posttest 6 Months|Lost to Follow-up|3
4786605|NCT01432327|16508671|P2|Posttest 6 Months|Lost to Follow-up|0
4786606|NCT01432327|16508672|P1|Posttest 6 Months|Lost to Follow-up|0
4786607|NCT01432327|16508669|P4|Posttest 3 Months|Allergic reaction|0
4786608|NCT01432327|16508670|P3|Posttest 3 Months|Allergic reaction|0
4786609|NCT01432327|16508671|P2|Posttest 3 Months|Allergic reaction|2
4786610|NCT01432327|16508672|P1|Posttest 3 Months|Allergic reaction|0
4786611|NCT01432327|16508669|P4|Posttest 3 Months|Lost to Follow-up|1
4786612|NCT01432327|16508670|P3|Posttest 3 Months|Lost to Follow-up|2
4786613|NCT01432327|16508671|P2|Posttest 3 Months|Lost to Follow-up|0
4786614|NCT01432327|16508672|P1|Posttest 3 Months|Lost to Follow-up|1
4786615|NCT01432327|16508669|P4|Posttest 3 Months|depression|0
4786616|NCT01432327|16508670|P3|Posttest 3 Months|depression|0
4786617|NCT01432327|16508671|P2|Posttest 3 Months|depression|0
4786618|NCT01432327|16508672|P1|Posttest 3 Months|depression|3
4786619|NCT01432275|16508682|P2|ADC With Calculator (10 Days)|Protocol Violation|1
4786620|NCT01432275|16508683|P1|ADC With Calculator (10 Days)|Protocol Violation|0
4786621|NCT01432275|16508682|P2|ADC With Calculator (10 Days)|Withdrawal by Subject|0
4786622|NCT01432275|16508683|P1|ADC With Calculator (10 Days)|Withdrawal by Subject|2
4786623|NCT01432275|16508682|P2|ADC With Calculator (10 Days)|Physician Decision|1
4786624|NCT01432275|16508683|P1|ADC With Calculator (10 Days)|Physician Decision|1
4786625|NCT01432275|16508682|P2|Second BG Meter System (7 Days)|Withdrawal by Subject|1
4786626|NCT01432275|16508683|P1|Second BG Meter System (7 Days)|Withdrawal by Subject|0
4786627|NCT01432275|16508682|P2|Second BG Meter System (7 Days)|Physician Decision|1
4786628|NCT01432275|16508683|P1|Second BG Meter System (7 Days)|Physician Decision|0
4786629|NCT01432275|16508682|P2|Second BG Meter System (7 Days)|Lost to Follow-up|0
4786630|NCT01432275|16508683|P1|Second BG Meter System (7 Days)|Lost to Follow-up|1
4786631|NCT01432275|16508682|P2|Second BG Meter System (7 Days)|Adverse Event|1
4786632|NCT01432275|16508683|P1|Second BG Meter System (7 Days)|Adverse Event|1
4786633|NCT01432275|16508682|P2|First BG Meter System (7 Days)|Withdrawal by Subject|1
4786634|NCT01432275|16508683|P1|First BG Meter System (7 Days)|Withdrawal by Subject|0
4786635|NCT01432275|16508682|P2|First BG Meter System (7 Days)|Adverse Event|2
4786636|NCT01432275|16508683|P1|First BG Meter System (7 Days)|Adverse Event|0
4786637|NCT01432262|16508692|P2|Overall Study|Withdrawal by Subject|1
4786638|NCT01432262|16508693|P1|Overall Study|Withdrawal by Subject|2
4786639|NCT01432171|16508759|P2|Overall Study|Patient moved to palliative care|0
4786640|NCT01432171|16508760|P1|Overall Study|Patient moved to palliative care|1
4786641|NCT01432171|16508759|P2|Overall Study|Insurance denial trial coverage|0
4786642|NCT01432171|16508760|P1|Overall Study|Insurance denial trial coverage|1
4786643|NCT01432171|16508759|P2|Overall Study|Noncompliance|3
4786644|NCT01432171|16508760|P1|Overall Study|Noncompliance|2
4786645|NCT01432171|16508759|P2|Overall Study|Withdrawal by Subject|1
4786646|NCT01432171|16508760|P1|Overall Study|Withdrawal by Subject|3
4786647|NCT01432171|16508759|P2|Overall Study|Lost to Follow-up|5
4786648|NCT01432171|16508760|P1|Overall Study|Lost to Follow-up|6
4786649|NCT01432171|16508759|P2|Overall Study|Death|2
4786650|NCT01432171|16508760|P1|Overall Study|Death|1
4786651|NCT01431976|16508801|P1|Overall Study|Withdrawal by Subject|1
4786652|NCT01431976|16508801|P1|Overall Study|Physician Decision|1
4786653|NCT01431976|16508801|P1|Overall Study|Met Protocol-defined Stopping Criteria|4
4786654|NCT01431976|16508801|P1|Overall Study|Lack of Efficacy|2
4786655|NCT01431976|16508801|P1|Overall Study|Adverse Event|6
4786656|NCT01431963|16508812|P1|Overall Study|Withdrawal by Subject|3
4786657|NCT01431963|16508812|P1|Overall Study|Physician Decision|4
4786658|NCT01431963|16508812|P1|Overall Study|Protocol-defined Stopping Criteria|2
4786659|NCT01431963|16508812|P1|Overall Study|Protocol Violation|1
4786660|NCT01431963|16508812|P1|Overall Study|Lack of Efficacy|7
4786661|NCT01431963|16508812|P1|Overall Study|Adverse Event|18
4786662|NCT01431950|16508820|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
4786663|NCT01431950|16508821|P1|Overall Study|Met Protocol-defined Stopping Criteria|0
4786664|NCT01431950|16508820|P2|Overall Study|Lost to Follow-up|1
4786665|NCT01431950|16508821|P1|Overall Study|Lost to Follow-up|0
4786666|NCT01431950|16508820|P2|Overall Study|Lack of Efficacy|1
4786667|NCT01431950|16508821|P1|Overall Study|Lack of Efficacy|2
4786668|NCT01431950|16508820|P2|Overall Study|Physician Decision|1
4786669|NCT01431950|16508821|P1|Overall Study|Physician Decision|2
4786670|NCT01431950|16508820|P2|Overall Study|Adverse Event|2
4786671|NCT01431950|16508821|P1|Overall Study|Adverse Event|2
4786672|NCT01431950|16508820|P2|Overall Study|Protocol Violation|3
4786673|NCT01431950|16508821|P1|Overall Study|Protocol Violation|2
4786674|NCT01431950|16508820|P2|Overall Study|Withdrawal by Subject|3
4786675|NCT01431950|16508821|P1|Overall Study|Withdrawal by Subject|4
4786676|NCT01431950|16508820|P2|Overall Study|Study Site Closed/Terminated|3
4786677|NCT01431950|16508821|P1|Overall Study|Study Site Closed/Terminated|7
4786678|NCT01431716|16508886|P1|Overall Study|Withdrawal of consent|1
4786679|NCT01431534|16508910|P3|Treatment Phase|Progressive Disease|10
4786680|NCT01431534|16508911|P2|Treatment Phase|Progressive Disease|3
4786681|NCT01431534|16508912|P1|Treatment Phase|Progressive Disease|4
4786682|NCT01431534|16508910|P3|Treatment Phase|Adverse Event|1
4786683|NCT01431534|16508911|P2|Treatment Phase|Adverse Event|0
4786684|NCT01431534|16508912|P1|Treatment Phase|Adverse Event|0
4786685|NCT01431521|16508927|P4|Overall Study|Withdrawal by Subject|0
4786686|NCT01431521|16508928|P3|Overall Study|Withdrawal by Subject|1
4786687|NCT01431521|16508929|P2|Overall Study|Withdrawal by Subject|0
4786688|NCT01431521|16508930|P1|Overall Study|Withdrawal by Subject|0
4786689|NCT01431508|16508951|P1|Overall Study|Unable to Follow Protocol Procedures|1
4786690|NCT01431508|16508951|P1|Overall Study|Lack of Efficacy|1
4786691|NCT01431287|16509036|P5|Overall Study|not stated above|1
4786692|NCT01431287|16509037|P4|Overall Study|not stated above|2
4786693|NCT01431287|16509038|P3|Overall Study|not stated above|2
4786694|NCT01431287|16509039|P2|Overall Study|not stated above|2
4786695|NCT01431287|16509040|P1|Overall Study|not stated above|4
4786696|NCT01431287|16509036|P5|Overall Study|Consent withdrawn not due to AE|29
4786697|NCT01431287|16509037|P4|Overall Study|Consent withdrawn not due to AE|19
4786698|NCT01431287|16509038|P3|Overall Study|Consent withdrawn not due to AE|34
4786699|NCT01431287|16509039|P2|Overall Study|Consent withdrawn not due to AE|30
4786700|NCT01431287|16509040|P1|Overall Study|Consent withdrawn not due to AE|29
4786701|NCT01431287|16509036|P5|Overall Study|Lost to Follow-up|1
4786702|NCT01431287|16509037|P4|Overall Study|Lost to Follow-up|3
4786703|NCT01431287|16509038|P3|Overall Study|Lost to Follow-up|2
4786704|NCT01431287|16509039|P2|Overall Study|Lost to Follow-up|3
4786705|NCT01431287|16509040|P1|Overall Study|Lost to Follow-up|0
4786706|NCT01431287|16509036|P5|Overall Study|Non compliant with protocol|5
4786707|NCT01431287|16509037|P4|Overall Study|Non compliant with protocol|6
4786708|NCT01431287|16509038|P3|Overall Study|Non compliant with protocol|5
4786709|NCT01431287|16509039|P2|Overall Study|Non compliant with protocol|6
4786710|NCT01431287|16509040|P1|Overall Study|Non compliant with protocol|6
4786711|NCT01431287|16509036|P5|Overall Study|Adverse Event|41
4786712|NCT01431287|16509037|P4|Overall Study|Adverse Event|33
4786713|NCT01431287|16509038|P3|Overall Study|Adverse Event|53
4786714|NCT01431287|16509039|P2|Overall Study|Adverse Event|57
4786715|NCT01431287|16509040|P1|Overall Study|Adverse Event|59
4786716|NCT01431287|16509036|P5|Overall Study|not treated|0
4786717|NCT01431287|16509037|P4|Overall Study|not treated|0
4786718|NCT01431287|16509038|P3|Overall Study|not treated|1
4786719|NCT01431287|16509039|P2|Overall Study|not treated|0
4786720|NCT01431287|16509040|P1|Overall Study|not treated|0
4786721|NCT01431274|16509202|P5|Overall Study|Other reason not stated above|4
4786722|NCT01431274|16509203|P4|Overall Study|Other reason not stated above|2
4786723|NCT01431274|16509204|P3|Overall Study|Other reason not stated above|7
4786724|NCT01431274|16509205|P2|Overall Study|Other reason not stated above|5
4786725|NCT01431274|16509206|P1|Overall Study|Other reason not stated above|6
4786726|NCT01431274|16509202|P5|Overall Study|Lost to Follow-up|0
4786727|NCT01431274|16509203|P4|Overall Study|Lost to Follow-up|4
4786728|NCT01431274|16509204|P3|Overall Study|Lost to Follow-up|1
4786729|NCT01431274|16509205|P2|Overall Study|Lost to Follow-up|7
4786730|NCT01431274|16509206|P1|Overall Study|Lost to Follow-up|6
4786731|NCT01431274|16509202|P5|Overall Study|Non compliant with protocol|4
4786732|NCT01431274|16509203|P4|Overall Study|Non compliant with protocol|4
4786733|NCT01431274|16509204|P3|Overall Study|Non compliant with protocol|4
4786734|NCT01431274|16509205|P2|Overall Study|Non compliant with protocol|8
4786735|NCT01431274|16509206|P1|Overall Study|Non compliant with protocol|5
4786736|NCT01431274|16509202|P5|Overall Study|Consent withdrawn not due to AE|11
4786737|NCT01431274|16509203|P4|Overall Study|Consent withdrawn not due to AE|20
4786738|NCT01431274|16509204|P3|Overall Study|Consent withdrawn not due to AE|17
4786739|NCT01431274|16509205|P2|Overall Study|Consent withdrawn not due to AE|20
4786740|NCT01431274|16509206|P1|Overall Study|Consent withdrawn not due to AE|29
4786741|NCT01431274|16509202|P5|Overall Study|Adverse Event|37
4786742|NCT01431274|16509203|P4|Overall Study|Adverse Event|30
4786743|NCT01431274|16509204|P3|Overall Study|Adverse Event|43
4786744|NCT01431274|16509205|P2|Overall Study|Adverse Event|37
4786745|NCT01431274|16509206|P1|Overall Study|Adverse Event|51
4786746|NCT01431144|16509384|P2|Overall Study|Implant mobility and removal|0
4786747|NCT01431144|16509385|P1|Overall Study|Implant mobility and removal|2
4786748|NCT01431079|16509408|P2|Overall Study|Lost to Follow-up|39
4786749|NCT01431079|16509409|P1|Overall Study|Lost to Follow-up|35
4786750|NCT01430754|16509488|P2|Run-In Phase|Lost to Follow-up|0
4786751|NCT01430754|16509489|P1|Run-In Phase|Lost to Follow-up|1
4786752|NCT01430754|16509488|P2|Run-In Phase|Withdrawal by Subject|0
4786753|NCT01430754|16509489|P1|Run-In Phase|Withdrawal by Subject|2
4786754|NCT01430754|16509488|P2|Run-In Phase|Other|0
4786755|NCT01430754|16509489|P1|Run-In Phase|Other|2
4786756|NCT01430754|16509488|P2|Run-In Phase|Adverse Event|0
4786757|NCT01430754|16509489|P1|Run-In Phase|Adverse Event|2
4786758|NCT01430754|16509488|P2|Run-In Phase|Protocol Violation|0
4786759|NCT01430754|16509489|P1|Run-In Phase|Protocol Violation|6
4786760|NCT01430754|16509488|P2|Run-In Phase|Circadian Period Ineligible|0
4786761|NCT01430754|16509489|P1|Run-In Phase|Circadian Period Ineligible|24
4786762|NCT01430624|16509547|P3|Overall Study|technical or eligibility|2
4786763|NCT01430624|16509548|P2|Overall Study|technical or eligibility|5
4786764|NCT01430624|16509549|P1|Overall Study|technical or eligibility|5
4786765|NCT01430624|16509547|P3|Overall Study|Lost to Follow-up|27
4786766|NCT01430624|16509548|P2|Overall Study|Lost to Follow-up|29
4786767|NCT01430624|16509549|P1|Overall Study|Lost to Follow-up|23
4786768|NCT01430611|16509580|P2|Overall Study|Withdrawal by Subject|14
4786769|NCT01430611|16509581|P1|Overall Study|Withdrawal by Subject|15
4786770|NCT01430611|16509580|P2|Overall Study|Lost to Follow-up|0
4786771|NCT01430611|16509581|P1|Overall Study|Lost to Follow-up|1
4786772|NCT01430611|16509580|P2|Overall Study|Protocol Violation|0
4786773|NCT01430611|16509581|P1|Overall Study|Protocol Violation|1
4786774|NCT01430611|16509580|P2|Overall Study|Adverse Event|1
4786775|NCT01430611|16509581|P1|Overall Study|Adverse Event|0
4786776|NCT01430585|16509599|P1|Overall Study|Other|7
4786777|NCT01430585|16509599|P1|Overall Study|Study Terminated by Sponsor|3
4786778|NCT01430585|16509599|P1|Overall Study|Objective Progression or Relapse|3
4786779|NCT01430585|16509599|P1|Overall Study|Death|1
4786780|NCT01430468|16509634|P2|Overall Study|Withdrawal by Subject|5
4786781|NCT01430468|16509635|P1|Overall Study|Withdrawal by Subject|5
4786782|NCT01430468|16509634|P2|Overall Study|Physician Decision|1
4786783|NCT01430468|16509635|P1|Overall Study|Physician Decision|2
4786784|NCT01430455|16509643|P1|Overall Study|Switched to follow-up phase|1
4786785|NCT01430455|16509643|P1|Overall Study|Withdrawal by Subject|1
4786786|NCT01430442|16509655|P8|Overall Study|Patient No Longer Meets Study Criteria|6
4786787|NCT01430442|16509656|P7|Overall Study|Patient No Longer Meets Study Criteria|9
4786788|NCT01430442|16509657|P6|Overall Study|Patient No Longer Meets Study Criteria|5
4786789|NCT01430442|16509658|P5|Overall Study|Patient No Longer Meets Study Criteria|5
4786790|NCT01430442|16509659|P4|Overall Study|Patient No Longer Meets Study Criteria|2
4786791|NCT01430442|16509660|P3|Overall Study|Patient No Longer Meets Study Criteria|3
4786792|NCT01430442|16509661|P2|Overall Study|Patient No Longer Meets Study Criteria|6
4786793|NCT01430442|16509662|P1|Overall Study|Patient No Longer Meets Study Criteria|7
4786794|NCT01430442|16509655|P8|Overall Study|Pregnancy|0
4786795|NCT01430442|16509656|P7|Overall Study|Pregnancy|0
4786796|NCT01430442|16509657|P6|Overall Study|Pregnancy|1
4786797|NCT01430442|16509658|P5|Overall Study|Pregnancy|0
4786798|NCT01430442|16509659|P4|Overall Study|Pregnancy|0
4786799|NCT01430442|16509660|P3|Overall Study|Pregnancy|0
4786800|NCT01430442|16509661|P2|Overall Study|Pregnancy|0
4786801|NCT01430442|16509662|P1|Overall Study|Pregnancy|1
4786802|NCT01430442|16509655|P8|Overall Study|Lost to Follow-up|1
4786803|NCT01430442|16509656|P7|Overall Study|Lost to Follow-up|5
4786804|NCT01430442|16509657|P6|Overall Study|Lost to Follow-up|1
4786805|NCT01430442|16509658|P5|Overall Study|Lost to Follow-up|2
4786806|NCT01430442|16509659|P4|Overall Study|Lost to Follow-up|2
4786807|NCT01430442|16509660|P3|Overall Study|Lost to Follow-up|1
4786808|NCT01430442|16509661|P2|Overall Study|Lost to Follow-up|0
4786809|NCT01430442|16509662|P1|Overall Study|Lost to Follow-up|2
4786810|NCT01430442|16509655|P8|Overall Study|Subject Withdrew Consent|2
4786811|NCT01430442|16509656|P7|Overall Study|Subject Withdrew Consent|5
4786812|NCT01430442|16509657|P6|Overall Study|Subject Withdrew Consent|1
4786813|NCT01430442|16509658|P5|Overall Study|Subject Withdrew Consent|2
4786814|NCT01430442|16509659|P4|Overall Study|Subject Withdrew Consent|0
4786815|NCT01430442|16509660|P3|Overall Study|Subject Withdrew Consent|1
4786816|NCT01430442|16509661|P2|Overall Study|Subject Withdrew Consent|0
4786817|NCT01430442|16509662|P1|Overall Study|Subject Withdrew Consent|3
4786818|NCT01430403|16509715|P3|Overall Study|Withdrawal by Subject|3
4786819|NCT01430403|16509716|P2|Overall Study|Withdrawal by Subject|1
4786820|NCT01430403|16509717|P1|Overall Study|Withdrawal by Subject|9
4786821|NCT01430403|16509715|P3|Overall Study|Protocol Violation|2
4786822|NCT01430403|16509716|P2|Overall Study|Protocol Violation|3
4786823|NCT01430403|16509717|P1|Overall Study|Protocol Violation|2
4786824|NCT01430403|16509715|P3|Overall Study|Physician Decision|0
4786825|NCT01430403|16509716|P2|Overall Study|Physician Decision|0
4786826|NCT01430403|16509717|P1|Overall Study|Physician Decision|1
4786827|NCT01430403|16509715|P3|Overall Study|Lost to Follow-up|3
4786828|NCT01430403|16509716|P2|Overall Study|Lost to Follow-up|5
4786829|NCT01430403|16509717|P1|Overall Study|Lost to Follow-up|5
4786830|NCT01430130|16509824|P1|Overall Study|Infection on Control Side of Incision|1
4786831|NCT01430130|16509824|P1|Overall Study|Lost to Follow-up|1
4786832|NCT01430104|16509830|P1|28-Day Teriparatide Treatment Period|Adverse Event|1
4786833|NCT01429792|16509897|P1|Overall Study|Lost to Follow-up|88
4786834|NCT01429792|16509897|P1|Overall Study|Withdrawal by Subject|70
4786835|NCT01429792|16509897|P1|Overall Study|Positive HCV-RNA at Week 24|50
4786836|NCT01429792|16509897|P1|Overall Study|Decrease of less than 2-log in HCV RNA|32
4786837|NCT01429792|16509897|P1|Overall Study|Negative HCV-RNA at Week 12|4
4786838|NCT01429792|16509897|P1|Overall Study|Negative HCV-RNA at Week 4|1
4786839|NCT01429792|16509897|P1|Overall Study|Unknown Disposition|94
4786840|NCT01429792|16509897|P1|Overall Study|Other Reasons|67
4786841|NCT01429623|16509911|P2|Overall Study|No post baseline data|4
4786842|NCT01429623|16509912|P1|Overall Study|No post baseline data|4
4786843|NCT01429623|16509911|P2|Overall Study|Conversion to Alzheimer's disease|21
4786844|NCT01429623|16509912|P1|Overall Study|Conversion to Alzheimer's disease|14
4786845|NCT01429623|16509911|P2|Overall Study|Assorted|2
4786846|NCT01429623|16509912|P1|Overall Study|Assorted|1
4786847|NCT01429623|16509911|P2|Overall Study|Protocol Violation|2
4786848|NCT01429623|16509912|P1|Overall Study|Protocol Violation|3
4786849|NCT01429623|16509911|P2|Overall Study|Physician Decision|3
4786850|NCT01429623|16509912|P1|Overall Study|Physician Decision|2
4786851|NCT01429623|16509911|P2|Overall Study|Withdrawal by Subject|13
4786852|NCT01429623|16509912|P1|Overall Study|Withdrawal by Subject|19
4786853|NCT01429623|16509911|P2|Overall Study|Adverse Event|14
4786854|NCT01429623|16509912|P1|Overall Study|Adverse Event|7
4786855|NCT01429623|16509911|P2|Overall Study|Death|0
4786856|NCT01429623|16509912|P1|Overall Study|Death|1
4786857|NCT01429584|16509926|P2|Overall Study|Protocol Violation|1
4786858|NCT01429584|16509927|P1|Overall Study|Protocol Violation|0
4786859|NCT01429584|16509926|P2|Overall Study|Withdrawal by Subject|0
4786860|NCT01429584|16509927|P1|Overall Study|Withdrawal by Subject|1
4786861|NCT01429441|16509969|P2|Overall Study|Withdrawal by Subject|18
4786862|NCT01429441|16509970|P1|Overall Study|Withdrawal by Subject|27
4786863|NCT01429441|16509969|P2|Overall Study|Physician Decision|0
4786864|NCT01429441|16509970|P1|Overall Study|Physician Decision|1
4786865|NCT01429441|16509969|P2|Overall Study|Lost to Follow-up|2
4786866|NCT01429441|16509970|P1|Overall Study|Lost to Follow-up|5
4786867|NCT01429441|16509969|P2|Overall Study|Death|2
4786868|NCT01429441|16509970|P1|Overall Study|Death|0
4786869|NCT01429441|16509969|P2|Overall Study|Adverse Event|1
4786870|NCT01429441|16509970|P1|Overall Study|Adverse Event|5
4786871|NCT01429298|16509995|P2|Overall Study|Protocol Violation|6
4786872|NCT01429298|16509996|P1|Overall Study|Protocol Violation|4
4786873|NCT01429285|16510012|P2|Overall Study|Erroneously Enrolled Twice|2
4786874|NCT01429285|16510013|P1|Overall Study|Erroneously Enrolled Twice|8
4786875|NCT01429285|16510012|P2|Overall Study|Missing Data|3
4786876|NCT01429285|16510013|P1|Overall Study|Missing Data|5
4786877|NCT01429285|16510012|P2|Overall Study|Protocol Violation|4
4786878|NCT01429285|16510013|P1|Overall Study|Protocol Violation|9
4786879|NCT01429077|16510059|P2|Overall Study|Lost to Follow-up|3
4786880|NCT01429077|16510060|P1|Overall Study|Lost to Follow-up|0
4786881|NCT01429051|16510083|P1|Tolerability Phase|Other|2
4786882|NCT01429051|16510083|P1|Tolerability Phase|Physician Decision|1
4786883|NCT01429051|16510083|P1|Tolerability Phase|Withdrawal by Subject|5
4786884|NCT01429051|16510083|P1|Tolerability Phase|Adverse Event|2
4786885|NCT01429051|16510083|P1|Tolerability Phase|Death|5
4786886|NCT01429051|16510083|P1|Efficacy Phase|Death|1
4786887|NCT01429051|16510083|P1|Efficacy Phase|Adverse Event|1
4786888|NCT01429051|16510083|P1|Titration Phase|Less than 3 BTP episodes per week|2
4786889|NCT01429051|16510083|P1|Titration Phase|Unsuccessful titration at any dose|1
4786890|NCT01429051|16510083|P1|Titration Phase|Physician Decision|1
4786891|NCT01429051|16510083|P1|Titration Phase|Withdrawal by Subject|7
4786892|NCT01429051|16510083|P1|Titration Phase|Death|1
4786893|NCT01428882|16510106|P2|Overall Study|Protocol Violation|3
4786894|NCT01428882|16510107|P1|Overall Study|Protocol Violation|4
4786895|NCT01428882|16510106|P2|Overall Study|Lack of Efficacy|7
4786896|NCT01428882|16510107|P1|Overall Study|Lack of Efficacy|2
4786897|NCT01428713|16510130|P2|Overall Study|Adverse Event|2
4786898|NCT01428713|16510131|P1|Overall Study|Adverse Event|0
4786899|NCT01428713|16510130|P2|Overall Study|Withdrawal by Subject|1
4786900|NCT01428713|16510131|P1|Overall Study|Withdrawal by Subject|1
4786901|NCT01428713|16510130|P2|Overall Study|Non-compliance|2
4786902|NCT01428713|16510131|P1|Overall Study|Non-compliance|2
4786903|NCT01428661|16510140|P3|Open Label Extension|**Various|185
4786904|NCT01428661|16510141|P2|Open Label Extension|**Various|0
4786905|NCT01428661|16510142|P1|Open Label Extension|**Various|0
4786906|NCT01428661|16510140|P3|Open Label Extension|Lack of Efficacy|24
4786907|NCT01428661|16510141|P2|Open Label Extension|Lack of Efficacy|0
4786908|NCT01428661|16510142|P1|Open Label Extension|Lack of Efficacy|0
4786909|NCT01428661|16510140|P3|Open Label Extension|Withdrawal by Subject|49
4786910|NCT01428661|16510141|P2|Open Label Extension|Withdrawal by Subject|0
4786911|NCT01428661|16510142|P1|Open Label Extension|Withdrawal by Subject|0
4786912|NCT01428661|16510140|P3|Open Label Extension|Lost to Follow-up|38
4786913|NCT01428661|16510141|P2|Open Label Extension|Lost to Follow-up|0
4786914|NCT01428661|16510142|P1|Open Label Extension|Lost to Follow-up|0
4786915|NCT01428661|16510140|P3|Open Label Extension|Adverse Event|15
4786916|NCT01428661|16510141|P2|Open Label Extension|Adverse Event|0
4786917|NCT01428661|16510142|P1|Open Label Extension|Adverse Event|0
4786918|NCT01428661|16510140|P3|Open Label Extension|Protocol Violation|9
4786919|NCT01428661|16510141|P2|Open Label Extension|Protocol Violation|0
4786920|NCT01428661|16510142|P1|Open Label Extension|Protocol Violation|0
4786921|NCT01428661|16510140|P3|Double-Masked Phase|*Various|0
4786922|NCT01428661|16510141|P2|Double-Masked Phase|*Various|6
4786923|NCT01428661|16510142|P1|Double-Masked Phase|*Various|1
4786924|NCT01428661|16510140|P3|Double-Masked Phase|Lack of Efficacy|0
4786925|NCT01428661|16510141|P2|Double-Masked Phase|Lack of Efficacy|1
4786926|NCT01428661|16510142|P1|Double-Masked Phase|Lack of Efficacy|2
4786927|NCT01428661|16510140|P3|Double-Masked Phase|Withdrawal by Subject|0
4786928|NCT01428661|16510141|P2|Double-Masked Phase|Withdrawal by Subject|20
4786929|NCT01428661|16510142|P1|Double-Masked Phase|Withdrawal by Subject|18
4786930|NCT01428661|16510140|P3|Double-Masked Phase|Lost to Follow-up|0
4786931|NCT01428661|16510141|P2|Double-Masked Phase|Lost to Follow-up|14
4786932|NCT01428661|16510142|P1|Double-Masked Phase|Lost to Follow-up|14
4786933|NCT01428661|16510140|P3|Double-Masked Phase|Adverse Event|0
4786934|NCT01428661|16510141|P2|Double-Masked Phase|Adverse Event|4
4786935|NCT01428661|16510142|P1|Double-Masked Phase|Adverse Event|13
4786936|NCT01428661|16510140|P3|Double-Masked Phase|Protocol Violation|0
4786937|NCT01428661|16510141|P2|Double-Masked Phase|Protocol Violation|4
4786938|NCT01428661|16510142|P1|Double-Masked Phase|Protocol Violation|9
4786939|NCT01428583|16510150|P1|Overall Study|Other|6
4786940|NCT01428583|16510150|P1|Overall Study|Sponsor's request|3
4786941|NCT01428583|16510150|P1|Overall Study|Confirmed positive urine drug test|8
4786942|NCT01428583|16510150|P1|Overall Study|Non-compliant|25
4786943|NCT01428583|16510150|P1|Overall Study|Physician Decision|12
4786944|NCT01428583|16510150|P1|Overall Study|Protocol Violation|1
4786945|NCT01428583|16510150|P1|Overall Study|Pregnancy|1
4786946|NCT01428583|16510150|P1|Overall Study|Death|1
4786947|NCT01428583|16510150|P1|Overall Study|Lost to Follow-up|17
4786948|NCT01428583|16510150|P1|Overall Study|Lack of Efficacy|37
4786949|NCT01428583|16510150|P1|Overall Study|Withdrawal by Subject|51
4786950|NCT01428583|16510150|P1|Overall Study|Adverse Event|75
4786951|NCT01428453|16510174|P2|Overall Study|Withdrawal by Subject|1
4786952|NCT01428453|16510175|P1|Overall Study|Withdrawal by Subject|3
4786953|NCT01428453|16510174|P2|Overall Study|Lost to Follow-up|1
4786954|NCT01428453|16510175|P1|Overall Study|Lost to Follow-up|0
4786955|NCT01428453|16510174|P2|Overall Study|Protocol Violation|0
4786956|NCT01428453|16510175|P1|Overall Study|Protocol Violation|1
4786957|NCT01428453|16510174|P2|Overall Study|Adverse Event|7
4786958|NCT01428453|16510175|P1|Overall Study|Adverse Event|2
4786959|NCT01428258|16510214|P2|Intervention 1|Withdrawal by Subject|0
4786960|NCT01428258|16510215|P1|Intervention 1|Withdrawal by Subject|2
4786961|NCT01428219|16510233|P1|Overall Study|25 patients enrolled, 3 were not treated|3
4786962|NCT01428193|16510244|P1|Overall Study|Elevated screening liver enzymes|1
4786963|NCT01428193|16510244|P1|Overall Study|Physician Decision|1
4786964|NCT01428128|16510248|P1|Overall Study|Adverse Event|1
4786965|NCT01428128|16510248|P1|Overall Study|Received Neulasta in one cycle|2
4786966|NCT01428128|16510248|P1|Overall Study|Screen failure by p53|10
4786967|NCT01428128|16510248|P1|Overall Study|Withdrawal by Subject|4
4786968|NCT01428115|16510253|P1|Overall Study|Withdrawal by Subject|4
4786969|NCT01428115|16510253|P1|Overall Study|Protocol Violation|3
4786970|NCT01428115|16510253|P1|Overall Study|Pregnancy|1
4786971|NCT01428115|16510253|P1|Overall Study|Lost to Follow-up|10
4786972|NCT01428115|16510253|P1|Overall Study|Lack of Efficacy|3
4786973|NCT01428076|16510268|P2|Overall Study|Adverse Event|1
4786974|NCT01428076|16510269|P1|Overall Study|Adverse Event|0
4786975|NCT01428063|16510280|P3|Overall Study|No longer meets study criteria|0
4786976|NCT01428063|16510281|P2|Overall Study|No longer meets study criteria|1
4786977|NCT01428063|16510282|P1|Overall Study|No longer meets study criteria|0
4786978|NCT01428063|16510280|P3|Overall Study|Lost to Follow-up|0
4786979|NCT01428063|16510281|P2|Overall Study|Lost to Follow-up|2
4786980|NCT01428063|16510282|P1|Overall Study|Lost to Follow-up|0
4786981|NCT01428063|16510280|P3|Overall Study|Adverse Event|0
4786982|NCT01428063|16510281|P2|Overall Study|Adverse Event|3
4786983|NCT01428063|16510282|P1|Overall Study|Adverse Event|2
4786984|NCT01428063|16510280|P3|Overall Study|Lack of Efficacy|1
4786985|NCT01428063|16510281|P2|Overall Study|Lack of Efficacy|4
4786986|NCT01428063|16510282|P1|Overall Study|Lack of Efficacy|8
4786987|NCT01427972|16510383|P12|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786988|NCT01427972|16510384|P11|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786989|NCT01427972|16510385|P10|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786990|NCT01427972|16510386|P9|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786991|NCT01427972|16510387|P8|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786992|NCT01427972|16510388|P7|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786993|NCT01427972|16510389|P6|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786994|NCT01427972|16510390|P5|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786995|NCT01427972|16510391|P4|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786996|NCT01427972|16510392|P3|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786997|NCT01427972|16510393|P2|Treatment Period 2 (21 Days)|Withdrawal by Subject|1
4786998|NCT01427972|16510394|P1|Treatment Period 2 (21 Days)|Withdrawal by Subject|0
4786999|NCT01427972|16510383|P12|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787000|NCT01427972|16510384|P11|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787001|NCT01427972|16510385|P10|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787002|NCT01427972|16510386|P9|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787003|NCT01427972|16510387|P8|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787004|NCT01427972|16510388|P7|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787005|NCT01427972|16510389|P6|Washout (at Least 28 Days)|Withdrawal by Subject|2
4787006|NCT01427972|16510390|P5|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787007|NCT01427972|16510391|P4|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787008|NCT01427972|16510392|P3|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787009|NCT01427972|16510393|P2|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787010|NCT01427972|16510394|P1|Washout (at Least 28 Days)|Withdrawal by Subject|0
4787011|NCT01427972|16510383|P12|Treatment Period 1 (21 Days)|Protocol Violation|0
4787012|NCT01427972|16510384|P11|Treatment Period 1 (21 Days)|Protocol Violation|0
4787013|NCT01427972|16510385|P10|Treatment Period 1 (21 Days)|Protocol Violation|0
4787014|NCT01427972|16510386|P9|Treatment Period 1 (21 Days)|Protocol Violation|0
4787015|NCT01427972|16510387|P8|Treatment Period 1 (21 Days)|Protocol Violation|1
4787016|NCT01427972|16510388|P7|Treatment Period 1 (21 Days)|Protocol Violation|0
4787017|NCT01427972|16510389|P6|Treatment Period 1 (21 Days)|Protocol Violation|0
4787018|NCT01427972|16510390|P5|Treatment Period 1 (21 Days)|Protocol Violation|0
4787019|NCT01427972|16510391|P4|Treatment Period 1 (21 Days)|Protocol Violation|0
4787020|NCT01427972|16510392|P3|Treatment Period 1 (21 Days)|Protocol Violation|0
4787021|NCT01427972|16510393|P2|Treatment Period 1 (21 Days)|Protocol Violation|0
4787022|NCT01427972|16510394|P1|Treatment Period 1 (21 Days)|Protocol Violation|0
4787023|NCT01427933|16510420|P2|Overall Study|Investigator's Decision|0
4787024|NCT01427933|16510421|P1|Overall Study|Investigator's Decision|1
4787025|NCT01427933|16510420|P2|Overall Study|Other|0
4787026|NCT01427933|16510421|P1|Overall Study|Other|1
4787027|NCT01427933|16510420|P2|Overall Study|Lost to Follow-up|5
4787028|NCT01427933|16510421|P1|Overall Study|Lost to Follow-up|1
4787029|NCT01427933|16510420|P2|Overall Study|Withdrawal by Subject|8
4787030|NCT01427933|16510421|P1|Overall Study|Withdrawal by Subject|5
4787031|NCT01427920|16510441|P2|Overall Study|Unclassified|8
4787032|NCT01427920|16510442|P1|Overall Study|Unclassified|2
4787033|NCT01427920|16510441|P2|Overall Study|Withdrawal Criteria|4
4787034|NCT01427920|16510442|P1|Overall Study|Withdrawal Criteria|4
4787035|NCT01427920|16510441|P2|Overall Study|Protocol Violation|3
4787036|NCT01427920|16510442|P1|Overall Study|Protocol Violation|1
4787037|NCT01427920|16510441|P2|Overall Study|Lack of Efficacy|0
4787038|NCT01427920|16510442|P1|Overall Study|Lack of Efficacy|1
4787039|NCT01427920|16510441|P2|Overall Study|Adverse Event|2
4787040|NCT01427920|16510442|P1|Overall Study|Adverse Event|1
4787041|NCT01427907|16510462|P2|Overall Study|Withdrawal by Subject|4
4787042|NCT01427907|16510463|P1|Overall Study|Withdrawal by Subject|3
4787043|NCT01427803|16510484|P2|Overall Study|did not take product|0
4787044|NCT01427803|16510485|P1|Overall Study|did not take product|1
4787045|NCT01427803|16510484|P2|Overall Study|Physician Decision|0
4787046|NCT01427803|16510485|P1|Overall Study|Physician Decision|3
4787047|NCT01427803|16510484|P2|Overall Study|Protocol Violation|0
4787048|NCT01427803|16510485|P1|Overall Study|Protocol Violation|1
4787049|NCT01427803|16510484|P2|Overall Study|Unable to complete full treatment period|0
4787050|NCT01427803|16510485|P1|Overall Study|Unable to complete full treatment period|6
4787051|NCT01427803|16510484|P2|Overall Study|Withdrawal by Subject|0
4787052|NCT01427803|16510485|P1|Overall Study|Withdrawal by Subject|20
4787053|NCT01427803|16510484|P2|Overall Study|Lost to Follow-up|26
4787054|NCT01427803|16510485|P1|Overall Study|Lost to Follow-up|32
4787055|NCT01427751|16510499|P2|Overall Study|Other miscellaneous reasons|4
4787056|NCT01427751|16510500|P1|Overall Study|Other miscellaneous reasons|6
4787057|NCT01427751|16510499|P2|Overall Study|Death|0
4787058|NCT01427751|16510500|P1|Overall Study|Death|2
4787059|NCT01427751|16510499|P2|Overall Study|Protocol Violation|4
4787060|NCT01427751|16510500|P1|Overall Study|Protocol Violation|6
4787061|NCT01427751|16510499|P2|Overall Study|Withdrawal of consent|2
4787062|NCT01427751|16510500|P1|Overall Study|Withdrawal of consent|2
4787063|NCT01427751|16510499|P2|Overall Study|Lost to Follow-up|1
4787064|NCT01427751|16510500|P1|Overall Study|Lost to Follow-up|3
4787065|NCT01427751|16510499|P2|Overall Study|No further treatment benefit expected|1
4787066|NCT01427751|16510500|P1|Overall Study|No further treatment benefit expected|5
4787067|NCT01427751|16510499|P2|Overall Study|Adverse Event|2
4787068|NCT01427751|16510500|P1|Overall Study|Adverse Event|18
4787069|NCT01427738|16510520|P2|Overall Study|Lost to Follow-up|5
4787070|NCT01427738|16510521|P1|Overall Study|Lost to Follow-up|1
4787071|NCT01427738|16510520|P2|Overall Study|Subject not willing to adhere to reqs|2
4787072|NCT01427738|16510521|P1|Overall Study|Subject not willing to adhere to reqs|1
4787073|NCT01427738|16510520|P2|Overall Study|Withdrawal by Subject|2
4787074|NCT01427738|16510521|P1|Overall Study|Withdrawal by Subject|0
4787075|NCT01427738|16510520|P2|Overall Study|Subject unable to get to clinic|2
4787076|NCT01427738|16510521|P1|Overall Study|Subject unable to get to clinic|5
4787077|NCT01427738|16510520|P2|Overall Study|Severe debilitation, unable to continue|1
4787078|NCT01427738|16510521|P1|Overall Study|Severe debilitation, unable to continue|0
4787079|NCT01427738|16510520|P2|Overall Study|Death|9
4787080|NCT01427738|16510521|P1|Overall Study|Death|12
4787081|NCT01427608|16510541|P2|Overall Study|Events not attributed to study meds|1
4787082|NCT01427608|16510542|P1|Overall Study|Events not attributed to study meds|0
4787083|NCT01427608|16510541|P2|Overall Study|Relapsed-all cause|34
4787084|NCT01427608|16510542|P1|Overall Study|Relapsed-all cause|13
4787085|NCT01427608|16510541|P2|Overall Study|Withdrawal by Subject|3
4787086|NCT01427608|16510542|P1|Overall Study|Withdrawal by Subject|7
4787087|NCT01427608|16510541|P2|Overall Study|Death|0
4787088|NCT01427608|16510542|P1|Overall Study|Death|1
4787089|NCT01427309|16510599|P4|Overall Study|Withdrawal by Subject|55
4787090|NCT01427309|16510600|P3|Overall Study|Withdrawal by Subject|61
4787091|NCT01427309|16510601|P2|Overall Study|Withdrawal by Subject|148
4787092|NCT01427309|16510602|P1|Overall Study|Withdrawal by Subject|148
4787093|NCT01427309|16510599|P4|Overall Study|Serious adverse event|61
4787094|NCT01427309|16510600|P3|Overall Study|Serious adverse event|50
4787095|NCT01427309|16510601|P2|Overall Study|Serious adverse event|45
4787096|NCT01427309|16510602|P1|Overall Study|Serious adverse event|52
4787097|NCT01427309|16510599|P4|Overall Study|Adverse Event|1
4787098|NCT01427309|16510600|P3|Overall Study|Adverse Event|3
4787099|NCT01427309|16510601|P2|Overall Study|Adverse Event|0
4787100|NCT01427309|16510602|P1|Overall Study|Adverse Event|0
4787101|NCT01427309|16510599|P4|Overall Study|Protocol Violation|124
4787102|NCT01427309|16510600|P3|Overall Study|Protocol Violation|125
4787103|NCT01427309|16510601|P2|Overall Study|Protocol Violation|69
4787104|NCT01427309|16510602|P1|Overall Study|Protocol Violation|42
4787105|NCT01427309|16510599|P4|Overall Study|Lost to Follow-up|135
4787106|NCT01427309|16510600|P3|Overall Study|Lost to Follow-up|122
4787107|NCT01427309|16510601|P2|Overall Study|Lost to Follow-up|145
4787108|NCT01427309|16510602|P1|Overall Study|Lost to Follow-up|130
4787109|NCT01426958|16510649|P1|Overall Study|Adverse Event|2
4787110|NCT01426854|16510678|P2|Overall Study|Other|2
4787111|NCT01426854|16510679|P1|Overall Study|Other|3
4787112|NCT01426854|16510678|P2|Overall Study|Protocol Deviation|1
4787113|NCT01426854|16510679|P1|Overall Study|Protocol Deviation|0
4787114|NCT01426854|16510678|P2|Overall Study|Treatment Failure|16
4787115|NCT01426854|16510679|P1|Overall Study|Treatment Failure|0
4787116|NCT01426854|16510678|P2|Overall Study|Noncompliance|1
4787117|NCT01426854|16510679|P1|Overall Study|Noncompliance|0
4787118|NCT01426854|16510678|P2|Overall Study|Lost to Follow-up|0
4787119|NCT01426854|16510679|P1|Overall Study|Lost to Follow-up|3
4787120|NCT01426854|16510678|P2|Overall Study|Subject Decision Unrelated to AE|6
4787121|NCT01426854|16510679|P1|Overall Study|Subject Decision Unrelated to AE|5
4787122|NCT01426854|16510678|P2|Overall Study|Adverse Event|5
4787123|NCT01426854|16510679|P1|Overall Study|Adverse Event|1
4787124|NCT01426789|16510689|P6|Part 2|Adverse Event|0
4787125|NCT01426789|16510690|P5|Part 2|Adverse Event|1
4787126|NCT01426789|16510691|P4|Part 2|Adverse Event|0
4787127|NCT01426789|16510692|P3|Part 2|Adverse Event|2
4787128|NCT01426789|16510693|P2|Part 2|Adverse Event|0
4787129|NCT01426789|16510694|P1|Part 2|Adverse Event|0
4787130|NCT01426789|16510689|P6|Part 2|Lack of Efficacy|0
4787131|NCT01426789|16510690|P5|Part 2|Lack of Efficacy|2
4787132|NCT01426789|16510691|P4|Part 2|Lack of Efficacy|0
4787133|NCT01426789|16510692|P3|Part 2|Lack of Efficacy|5
4787134|NCT01426789|16510693|P2|Part 2|Lack of Efficacy|0
4787135|NCT01426789|16510694|P1|Part 2|Lack of Efficacy|0
4787136|NCT01426789|16510689|P6|Part 2|Withdrawal by Subject|0
4787137|NCT01426789|16510690|P5|Part 2|Withdrawal by Subject|2
4787138|NCT01426789|16510691|P4|Part 2|Withdrawal by Subject|1
4787139|NCT01426789|16510692|P3|Part 2|Withdrawal by Subject|0
4787140|NCT01426789|16510693|P2|Part 2|Withdrawal by Subject|0
4787141|NCT01426789|16510694|P1|Part 2|Withdrawal by Subject|0
4787142|NCT01426789|16510689|P6|Part 2|Lost to Follow-up|0
4787143|NCT01426789|16510690|P5|Part 2|Lost to Follow-up|1
4787144|NCT01426789|16510691|P4|Part 2|Lost to Follow-up|0
4787145|NCT01426789|16510692|P3|Part 2|Lost to Follow-up|4
4787146|NCT01426789|16510693|P2|Part 2|Lost to Follow-up|0
4787147|NCT01426789|16510694|P1|Part 2|Lost to Follow-up|0
4787148|NCT01426789|16510689|P6|Part 2|Administrative problems|0
4787149|NCT01426789|16510690|P5|Part 2|Administrative problems|1
4787150|NCT01426789|16510691|P4|Part 2|Administrative problems|0
4787151|NCT01426789|16510692|P3|Part 2|Administrative problems|2
4787152|NCT01426789|16510693|P2|Part 2|Administrative problems|0
4787153|NCT01426789|16510694|P1|Part 2|Administrative problems|0
4787154|NCT01426789|16510689|P6|Part 2|Death|0
4787155|NCT01426789|16510690|P5|Part 2|Death|1
4787156|NCT01426789|16510691|P4|Part 2|Death|0
4787157|NCT01426789|16510692|P3|Part 2|Death|1
4787158|NCT01426789|16510693|P2|Part 2|Death|0
4787159|NCT01426789|16510694|P1|Part 2|Death|0
4787160|NCT01426789|16510689|P6|Part 2|Protocol deviation|0
4787161|NCT01426789|16510690|P5|Part 2|Protocol deviation|0
4787162|NCT01426789|16510691|P4|Part 2|Protocol deviation|0
4787163|NCT01426789|16510692|P3|Part 2|Protocol deviation|1
4787164|NCT01426789|16510693|P2|Part 2|Protocol deviation|0
4787165|NCT01426789|16510694|P1|Part 2|Protocol deviation|0
4787166|NCT01426789|16510689|P6|Part 1|Adverse Event|0
4787167|NCT01426789|16510690|P5|Part 1|Adverse Event|0
4787168|NCT01426789|16510691|P4|Part 1|Adverse Event|0
4787169|NCT01426789|16510692|P3|Part 1|Adverse Event|0
4787170|NCT01426789|16510693|P2|Part 1|Adverse Event|0
4787171|NCT01426789|16510694|P1|Part 1|Adverse Event|3
4787172|NCT01426789|16510689|P6|Part 1|Lack of Efficacy|0
4787173|NCT01426789|16510690|P5|Part 1|Lack of Efficacy|0
4787174|NCT01426789|16510691|P4|Part 1|Lack of Efficacy|0
4787175|NCT01426789|16510692|P3|Part 1|Lack of Efficacy|0
4787176|NCT01426789|16510693|P2|Part 1|Lack of Efficacy|1
4787177|NCT01426789|16510694|P1|Part 1|Lack of Efficacy|2
4787178|NCT01426789|16510689|P6|Part 1|Lost to Follow-up|0
4787179|NCT01426789|16510690|P5|Part 1|Lost to Follow-up|0
4787180|NCT01426789|16510691|P4|Part 1|Lost to Follow-up|0
4787181|NCT01426789|16510692|P3|Part 1|Lost to Follow-up|0
4787182|NCT01426789|16510693|P2|Part 1|Lost to Follow-up|2
4787183|NCT01426789|16510694|P1|Part 1|Lost to Follow-up|1
4787184|NCT01426789|16510689|P6|Part 1|Protocol deviation|0
4787185|NCT01426789|16510690|P5|Part 1|Protocol deviation|0
4787186|NCT01426789|16510691|P4|Part 1|Protocol deviation|0
4787187|NCT01426789|16510692|P3|Part 1|Protocol deviation|0
4787188|NCT01426789|16510693|P2|Part 1|Protocol deviation|1
4787189|NCT01426789|16510694|P1|Part 1|Protocol deviation|0
4787190|NCT01426438|16510756|P2|Overall Study|Missed Scan|2
4787191|NCT01426438|16510757|P1|Overall Study|Missed Scan|2
4787192|NCT01426438|16510756|P2|Overall Study|Poor scan quality|2
4787193|NCT01426438|16510757|P1|Overall Study|Poor scan quality|3
4787194|NCT01426438|16510756|P2|Overall Study|Off study Treatment|3
4787195|NCT01426438|16510757|P1|Overall Study|Off study Treatment|9
4787196|NCT01426438|16510756|P2|Overall Study|Lost to Follow-up|3
4787197|NCT01426438|16510757|P1|Overall Study|Lost to Follow-up|1
4787198|NCT01426425|16510789|P1|Overall Study|Met inclusion/exclusion, not treated|2
4787199|NCT01426425|16510789|P1|Overall Study|Inclusion/exclusion criteria not met|151
4787200|NCT01426425|16510789|P1|Overall Study|Exited prior to EP study|22
4787201|NCT01426412|16510804|P9|Overall Study|Withdrawal by Subject|1
4787202|NCT01426412|16510805|P8|Overall Study|Withdrawal by Subject|3
4787203|NCT01426412|16510806|P7|Overall Study|Withdrawal by Subject|0
4787204|NCT01426412|16510807|P6|Overall Study|Withdrawal by Subject|0
4787205|NCT01426412|16510808|P5|Overall Study|Withdrawal by Subject|1
4787206|NCT01426412|16510809|P4|Overall Study|Withdrawal by Subject|0
4787207|NCT01426412|16510810|P3|Overall Study|Withdrawal by Subject|0
4787208|NCT01426412|16510811|P2|Overall Study|Withdrawal by Subject|0
4787209|NCT01426412|16510812|P1|Overall Study|Withdrawal by Subject|1
4787210|NCT01426386|16510875|P6|Overall Study|Personal reasons|0
4787211|NCT01426386|16510876|P5|Overall Study|Personal reasons|1
4787212|NCT01426386|16510877|P4|Overall Study|Personal reasons|0
4787213|NCT01426386|16510878|P3|Overall Study|Personal reasons|0
4787214|NCT01426386|16510879|P2|Overall Study|Personal reasons|0
4787215|NCT01426386|16510880|P1|Overall Study|Personal reasons|0
4787216|NCT01426386|16510875|P6|Overall Study|Poor response|0
4787217|NCT01426386|16510876|P5|Overall Study|Poor response|1
4787218|NCT01426386|16510877|P4|Overall Study|Poor response|0
4787219|NCT01426386|16510878|P3|Overall Study|Poor response|2
4787220|NCT01426386|16510879|P2|Overall Study|Poor response|1
4787221|NCT01426386|16510880|P1|Overall Study|Poor response|2
4787222|NCT01426386|16510875|P6|Overall Study|Did not attend scheduled visit|1
4787223|NCT01426386|16510876|P5|Overall Study|Did not attend scheduled visit|2
4787224|NCT01426386|16510877|P4|Overall Study|Did not attend scheduled visit|0
4787225|NCT01426386|16510878|P3|Overall Study|Did not attend scheduled visit|0
4787226|NCT01426386|16510879|P2|Overall Study|Did not attend scheduled visit|4
4787227|NCT01426386|16510880|P1|Overall Study|Did not attend scheduled visit|1
4787228|NCT01426386|16510875|P6|Overall Study|Adverse Event|0
4787229|NCT01426386|16510876|P5|Overall Study|Adverse Event|0
4787230|NCT01426386|16510877|P4|Overall Study|Adverse Event|0
4787231|NCT01426386|16510878|P3|Overall Study|Adverse Event|0
4787232|NCT01426386|16510879|P2|Overall Study|Adverse Event|1
4787233|NCT01426386|16510880|P1|Overall Study|Adverse Event|0
4787234|NCT01426373|16510936|P1|Overall Study|Miscellaneous Reasons|4
4787235|NCT01426373|16510936|P1|Overall Study|Participant Convenience|10
4787236|NCT01426373|16510936|P1|Overall Study|Lost to Follow-up|14
4787237|NCT01426373|16510936|P1|Overall Study|Adverse Event|6
4787238|NCT01426347|16510969|P2|Overall Study|Withdrawal by Subject|0
4787239|NCT01426347|16510970|P1|Overall Study|Withdrawal by Subject|5
4787240|NCT01426347|16510969|P2|Overall Study|Protocol Violation|0
4787241|NCT01426347|16510970|P1|Overall Study|Protocol Violation|2
4787242|NCT01426347|16510969|P2|Overall Study|Lost to Follow-up|3
4787243|NCT01426347|16510970|P1|Overall Study|Lost to Follow-up|0
4787244|NCT01426269|16510978|P3|Period 2: 40 Weeks|Relapsed|18
4787245|NCT01426269|16510979|P2|Period 2: 40 Weeks|Relapsed|9
4787246|NCT01426269|16510980|P1|Period 2: 40 Weeks|Relapsed|0
4787247|NCT01426269|16510978|P3|Period 2: 40 Weeks|Site closed|5
4787248|NCT01426269|16510979|P2|Period 2: 40 Weeks|Site closed|6
4787249|NCT01426269|16510980|P1|Period 2: 40 Weeks|Site closed|0
4787250|NCT01426269|16510978|P3|Period 2: 40 Weeks|Lost to Follow-up|6
4787251|NCT01426269|16510979|P2|Period 2: 40 Weeks|Lost to Follow-up|8
4787252|NCT01426269|16510980|P1|Period 2: 40 Weeks|Lost to Follow-up|0
4787253|NCT01426269|16510978|P3|Period 2: 40 Weeks|Protocol Violation|5
4787254|NCT01426269|16510979|P2|Period 2: 40 Weeks|Protocol Violation|5
4787255|NCT01426269|16510980|P1|Period 2: 40 Weeks|Protocol Violation|0
4787256|NCT01426269|16510978|P3|Period 2: 40 Weeks|Withdrawal by Subject|11
4787257|NCT01426269|16510979|P2|Period 2: 40 Weeks|Withdrawal by Subject|9
4787258|NCT01426269|16510980|P1|Period 2: 40 Weeks|Withdrawal by Subject|0
4787259|NCT01426269|16510978|P3|Period 2: 40 Weeks|Adverse Event|2
4787260|NCT01426269|16510979|P2|Period 2: 40 Weeks|Adverse Event|1
4787261|NCT01426269|16510980|P1|Period 2: 40 Weeks|Adverse Event|0
4787262|NCT01426269|16510978|P3|Eligibility for Period 2, Randomization|Qualified, opted out|0
4787263|NCT01426269|16510979|P2|Eligibility for Period 2, Randomization|Qualified, opted out|0
4787264|NCT01426269|16510980|P1|Eligibility for Period 2, Randomization|Qualified, opted out|8
4787265|NCT01426269|16510978|P3|Eligibility for Period 2, Randomization|Did not qualify|0
4787266|NCT01426269|16510979|P2|Eligibility for Period 2, Randomization|Did not qualify|0
4787267|NCT01426269|16510980|P1|Eligibility for Period 2, Randomization|Did not qualify|42
4787268|NCT01426269|16510978|P3|Period 1: 12 Weeks|Pregnancy|0
4787269|NCT01426269|16510979|P2|Period 1: 12 Weeks|Pregnancy|0
4787270|NCT01426269|16510980|P1|Period 1: 12 Weeks|Pregnancy|1
4787271|NCT01426269|16510978|P3|Period 1: 12 Weeks|Lost to Follow-up|0
4787272|NCT01426269|16510979|P2|Period 1: 12 Weeks|Lost to Follow-up|0
4787273|NCT01426269|16510980|P1|Period 1: 12 Weeks|Lost to Follow-up|22
4787274|NCT01426269|16510978|P3|Period 1: 12 Weeks|Protocol Violation|0
4787275|NCT01426269|16510979|P2|Period 1: 12 Weeks|Protocol Violation|0
4787276|NCT01426269|16510980|P1|Period 1: 12 Weeks|Protocol Violation|5
4787277|NCT01426269|16510978|P3|Period 1: 12 Weeks|Withdrawal by Subject|0
4787278|NCT01426269|16510979|P2|Period 1: 12 Weeks|Withdrawal by Subject|0
4787279|NCT01426269|16510980|P1|Period 1: 12 Weeks|Withdrawal by Subject|22
4787280|NCT01426269|16510978|P3|Period 1: 12 Weeks|Adverse Event|0
4787281|NCT01426269|16510979|P2|Period 1: 12 Weeks|Adverse Event|0
4787282|NCT01426269|16510980|P1|Period 1: 12 Weeks|Adverse Event|5
4787283|NCT01426217|16511015|P2|Overall Study|lost sample|14
4787284|NCT01426217|16511016|P1|Overall Study|lost sample|8
4787285|NCT01426113|16511029|P2|Overall Study|Adverse Event|1
4787286|NCT01426113|16511030|P1|Overall Study|Adverse Event|0
4787287|NCT01426113|16511029|P2|Overall Study|Study Discontinued|1
4787288|NCT01426113|16511030|P1|Overall Study|Study Discontinued|1
4787289|NCT01426009|16511036|P1|Washout 4|Lost to Follow-up|1
4787290|NCT01426009|16511036|P1|Period 4-Fourth Intervention (7 Days)|personal reasons|1
4787291|NCT01426009|16511036|P1|Washout 3|personal reasons|1
4787292|NCT01426009|16511036|P1|Washout 2|electrive surgery|1
4787293|NCT01426009|16511036|P1|Period 2-Second Intervention (7 Days)|personal reasons|1
4787294|NCT01426009|16511036|P1|Period 2-Second Intervention (7 Days)|Adverse Event|4
4787295|NCT01426009|16511036|P1|Washout 1|Personal Reasons|1
4787296|NCT01426009|16511036|P1|Washout 1|Withdrawal by Subject|1
4787297|NCT01426009|16511036|P1|Period 1-First Intervention (7 Days)|Personal Reasons|1
4787298|NCT01426009|16511036|P1|Period 1-First Intervention (7 Days)|Adverse Event|1
4787299|NCT01425814|16511132|P6|Period 5|Stability criteria not fulfilled|1
4787300|NCT01425814|16511133|P5|Period 5|Stability criteria not fulfilled|0
4787301|NCT01425814|16511134|P4|Period 5|Stability criteria not fulfilled|0
4787302|NCT01425814|16511135|P3|Period 5|Stability criteria not fulfilled|1
4787303|NCT01425814|16511136|P2|Period 5|Stability criteria not fulfilled|0
4787304|NCT01425814|16511137|P1|Period 5|Stability criteria not fulfilled|0
4787305|NCT01425814|16511132|P6|Period 4|Adverse Event|0
4787306|NCT01425814|16511133|P5|Period 4|Adverse Event|0
4787307|NCT01425814|16511134|P4|Period 4|Adverse Event|0
4787308|NCT01425814|16511135|P3|Period 4|Adverse Event|1
4787309|NCT01425814|16511136|P2|Period 4|Adverse Event|0
4787310|NCT01425814|16511137|P1|Period 4|Adverse Event|1
4787311|NCT01425814|16511132|P6|Period 3|Adverse Event|1
4787312|NCT01425814|16511133|P5|Period 3|Adverse Event|0
4787313|NCT01425814|16511134|P4|Period 3|Adverse Event|0
4787314|NCT01425814|16511135|P3|Period 3|Adverse Event|0
4787315|NCT01425814|16511136|P2|Period 3|Adverse Event|0
4787316|NCT01425814|16511137|P1|Period 3|Adverse Event|0
4787317|NCT01425814|16511132|P6|Period 2|Stability criteria not fulfilled|0
4787318|NCT01425814|16511133|P5|Period 2|Stability criteria not fulfilled|0
4787319|NCT01425814|16511134|P4|Period 2|Stability criteria not fulfilled|0
4787320|NCT01425814|16511135|P3|Period 2|Stability criteria not fulfilled|0
4787321|NCT01425814|16511136|P2|Period 2|Stability criteria not fulfilled|1
4787322|NCT01425814|16511137|P1|Period 2|Stability criteria not fulfilled|0
4787323|NCT01425814|16511132|P6|Period 1|Stability criteria not fulfilled|0
4787324|NCT01425814|16511133|P5|Period 1|Stability criteria not fulfilled|0
4787325|NCT01425814|16511134|P4|Period 1|Stability criteria not fulfilled|0
4787326|NCT01425814|16511135|P3|Period 1|Stability criteria not fulfilled|0
4787327|NCT01425814|16511136|P2|Period 1|Stability criteria not fulfilled|1
4787328|NCT01425814|16511137|P1|Period 1|Stability criteria not fulfilled|0
4787329|NCT01425801|16511229|P6|Period 4|Not able to maintain visit schedule|0
4787330|NCT01425801|16511230|P5|Period 4|Not able to maintain visit schedule|0
4787331|NCT01425801|16511231|P4|Period 4|Not able to maintain visit schedule|0
4787332|NCT01425801|16511232|P3|Period 4|Not able to maintain visit schedule|1
4787333|NCT01425801|16511233|P2|Period 4|Not able to maintain visit schedule|0
4787334|NCT01425801|16511234|P1|Period 4|Not able to maintain visit schedule|0
4787335|NCT01425801|16511229|P6|Period 3|Stability criteria not fullfilled|0
4787336|NCT01425801|16511230|P5|Period 3|Stability criteria not fullfilled|0
4787337|NCT01425801|16511231|P4|Period 3|Stability criteria not fullfilled|0
4787338|NCT01425801|16511232|P3|Period 3|Stability criteria not fullfilled|1
4787339|NCT01425801|16511233|P2|Period 3|Stability criteria not fullfilled|0
4787340|NCT01425801|16511234|P1|Period 3|Stability criteria not fullfilled|0
4787341|NCT01425801|16511229|P6|Period 2|Withdrawal by Subject|0
4787342|NCT01425801|16511230|P5|Period 2|Withdrawal by Subject|1
4787343|NCT01425801|16511231|P4|Period 2|Withdrawal by Subject|0
4787344|NCT01425801|16511232|P3|Period 2|Withdrawal by Subject|0
4787345|NCT01425801|16511233|P2|Period 2|Withdrawal by Subject|0
4787346|NCT01425801|16511234|P1|Period 2|Withdrawal by Subject|0
4787347|NCT01425801|16511229|P6|Period 1|Withdrawal by Subject|0
4787348|NCT01425801|16511230|P5|Period 1|Withdrawal by Subject|1
4787349|NCT01425801|16511231|P4|Period 1|Withdrawal by Subject|0
4787350|NCT01425801|16511232|P3|Period 1|Withdrawal by Subject|0
4787351|NCT01425801|16511233|P2|Period 1|Withdrawal by Subject|0
4787352|NCT01425801|16511234|P1|Period 1|Withdrawal by Subject|0
4787353|NCT01425749|16511340|P2|Overall Study|progression of melanoma|1
4787354|NCT01425749|16511341|P1|Overall Study|progression of melanoma|0
4787355|NCT01425723|16511358|P2|Overall Study|Other|10
4787356|NCT01425723|16511359|P1|Overall Study|Other|1
4787357|NCT01425723|16511358|P2|Overall Study|Physician Decision|0
4787358|NCT01425723|16511359|P1|Overall Study|Physician Decision|2
4787359|NCT01425723|16511358|P2|Overall Study|Lost to Follow-up|3
4787360|NCT01425723|16511359|P1|Overall Study|Lost to Follow-up|0
4787361|NCT01425723|16511358|P2|Overall Study|Withdrawal by Subject|4
4787362|NCT01425723|16511359|P1|Overall Study|Withdrawal by Subject|1
4787363|NCT01425723|16511358|P2|Overall Study|Lack of Efficacy|1
4787364|NCT01425723|16511359|P1|Overall Study|Lack of Efficacy|0
4787365|NCT01425632|16511389|P3|Overall Study|Withdrawal by Subject|1
4787366|NCT01425632|16511390|P2|Overall Study|Withdrawal by Subject|0
4787367|NCT01425632|16511391|P1|Overall Study|Withdrawal by Subject|0
4787368|NCT01425632|16511389|P3|Overall Study|Protocol Violation|2
4787369|NCT01425632|16511390|P2|Overall Study|Protocol Violation|0
4787370|NCT01425632|16511391|P1|Overall Study|Protocol Violation|0
4787371|NCT01425632|16511389|P3|Overall Study|Physician Decision|0
4787372|NCT01425632|16511390|P2|Overall Study|Physician Decision|0
4787373|NCT01425632|16511391|P1|Overall Study|Physician Decision|1
4787374|NCT01425632|16511389|P3|Overall Study|Adverse Event|1
4787375|NCT01425632|16511390|P2|Overall Study|Adverse Event|1
4787376|NCT01425632|16511391|P1|Overall Study|Adverse Event|0
4787377|NCT01425528|16511401|P2|Overall Study|Withdrawal by Subject|1
4787378|NCT01425528|16511402|P1|Overall Study|Withdrawal by Subject|1
4787379|NCT01425463|16511410|P2|Overall Study|Unknown Reason|7
4787380|NCT01425463|16511411|P1|Overall Study|Unknown Reason|4
4787381|NCT01425463|16511410|P2|Overall Study|Withdrawal by Subject|5
4787382|NCT01425463|16511411|P1|Overall Study|Withdrawal by Subject|7
4787383|NCT01425463|16511410|P2|Overall Study|Lost to Follow-up|2
4787384|NCT01425463|16511411|P1|Overall Study|Lost to Follow-up|5
4787385|NCT01425463|16511410|P2|Overall Study|Protocol Violation|2
4787386|NCT01425463|16511411|P1|Overall Study|Protocol Violation|2
4787387|NCT01425463|16511410|P2|Overall Study|Lack of Efficacy|1
4787388|NCT01425463|16511411|P1|Overall Study|Lack of Efficacy|1
4787389|NCT01425463|16511410|P2|Overall Study|Adverse Event|7
4787390|NCT01425463|16511411|P1|Overall Study|Adverse Event|5
4787391|NCT01425359|16511427|P2|Overall Study|Did Not Meet Qualifying Criteria|5
4787392|NCT01425359|16511428|P1|Overall Study|Did Not Meet Qualifying Criteria|3
4787393|NCT01425359|16511427|P2|Overall Study|Investigator's Discretion|0
4787394|NCT01425359|16511428|P1|Overall Study|Investigator's Discretion|2
4787395|NCT01425359|16511427|P2|Overall Study|Subject Withdrew Consent|2
4787396|NCT01425359|16511428|P1|Overall Study|Subject Withdrew Consent|1
4787397|NCT01425359|16511427|P2|Overall Study|Protocol Violation|2
4787398|NCT01425359|16511428|P1|Overall Study|Protocol Violation|1
4787399|NCT01425359|16511427|P2|Overall Study|Unsatisfactory Response|0
4787400|NCT01425359|16511428|P1|Overall Study|Unsatisfactory Response|1
4787401|NCT01425359|16511427|P2|Overall Study|Death|1
4787402|NCT01425359|16511428|P1|Overall Study|Death|0
4787403|NCT01425359|16511427|P2|Overall Study|Revascularization|1
4787404|NCT01425359|16511428|P1|Overall Study|Revascularization|0
4787405|NCT01425359|16511427|P2|Overall Study|Adverse Event|8
4787406|NCT01425359|16511428|P1|Overall Study|Adverse Event|9
4787407|NCT01425359|16511427|P2|Overall Study|Randomized but Not Treated|3
4787408|NCT01425359|16511428|P1|Overall Study|Randomized but Not Treated|2
4787409|NCT01425281|16511459|P2|At 5-year Clinical Follow-up|Refused/terminated|3
4787410|NCT01425281|16511460|P1|At 5-year Clinical Follow-up|Refused/terminated|9
4787411|NCT01425281|16511459|P2|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7
4787412|NCT01425281|16511460|P1|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19
4787413|NCT01425281|16511459|P2|At 5-year Clinical Follow-up|Lost to Follow-up|1
4787414|NCT01425281|16511460|P1|At 5-year Clinical Follow-up|Lost to Follow-up|2
4787415|NCT01425281|16511459|P2|At 5-year Clinical Follow-up|Death|0
4787416|NCT01425281|16511460|P1|At 5-year Clinical Follow-up|Death|2
4787417|NCT01425281|16511459|P2|At 4-year Clinical Follow-up|Lost to Follow-up|1
4787418|NCT01425281|16511460|P1|At 4-year Clinical Follow-up|Lost to Follow-up|4
4787419|NCT01425281|16511459|P2|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5
4787420|NCT01425281|16511460|P1|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6
4787421|NCT01425281|16511459|P2|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
4787422|NCT01425281|16511460|P1|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10
4787423|NCT01425281|16511459|P2|At 4-year Clinical Follow-up|Withdrawal by Subject|2
4787424|NCT01425281|16511460|P1|At 4-year Clinical Follow-up|Withdrawal by Subject|3
4787425|NCT01425281|16511459|P2|At 4-year Clinical Follow-up|Death|3
4787426|NCT01425281|16511460|P1|At 4-year Clinical Follow-up|Death|7
4787427|NCT01425281|16511459|P2|At 3-year Clinical Follow-up|Death|3
4787428|NCT01425281|16511460|P1|At 3-year Clinical Follow-up|Death|2
4787429|NCT01425281|16511459|P2|At 3-year Clinical Follow-up|Withdrawal by Subject|3
4787430|NCT01425281|16511460|P1|At 3-year Clinical Follow-up|Withdrawal by Subject|3
4787431|NCT01425281|16511459|P2|At 2-year Clinical Follow-up|Patient did not want to participate in t|0
4787432|NCT01425281|16511460|P1|At 2-year Clinical Follow-up|Patient did not want to participate in t|1
4787433|NCT01425281|16511459|P2|At 2-year Clinical Follow-up|Lost to Follow-up|0
4787434|NCT01425281|16511460|P1|At 2-year Clinical Follow-up|Lost to Follow-up|1
4787435|NCT01425281|16511459|P2|At 2-year Clinical Follow-up|Death|0
4787436|NCT01425281|16511460|P1|At 2-year Clinical Follow-up|Death|2
4787437|NCT01425281|16511459|P2|At 2-year Clinical Follow-up|Withdrawal by Subject|1
4787438|NCT01425281|16511460|P1|At 2-year Clinical Follow-up|Withdrawal by Subject|2
4787439|NCT01425281|16511459|P2|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0
4787440|NCT01425281|16511460|P1|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1
4787441|NCT01425281|16511459|P2|At 1-year Clinical Follow-up|Withdrawal by Subject|1
4787442|NCT01425281|16511460|P1|At 1-year Clinical Follow-up|Withdrawal by Subject|1
4787443|NCT01425281|16511459|P2|At 180-day Clinical Follow-up|Death|1
4787444|NCT01425281|16511460|P1|At 180-day Clinical Follow-up|Death|0
4787445|NCT01425281|16511459|P2|At 180-day Clinical Follow-up|Withdrawal by Subject|0
4787446|NCT01425281|16511460|P1|At 180-day Clinical Follow-up|Withdrawal by Subject|3
4787447|NCT01425281|16511459|P2|At 30-day Clinical Follow-up|Withdrawal by Subject|0
4787448|NCT01425281|16511460|P1|At 30-day Clinical Follow-up|Withdrawal by Subject|1
4787449|NCT01425268|16511678|P2|Overall Study|Physician Decision|0
4787450|NCT01425268|16511679|P1|Overall Study|Physician Decision|1
4787451|NCT01425268|16511678|P2|Overall Study|Sponsor Decision|0
4787452|NCT01425268|16511679|P1|Overall Study|Sponsor Decision|5
4787453|NCT01425268|16511678|P2|Overall Study|Withdrawal by Subject|0
4787454|NCT01425268|16511679|P1|Overall Study|Withdrawal by Subject|2
4787455|NCT01425203|16511700|P3|Crossover Phase|Other virologic failure criteria|3
4787456|NCT01425203|16511701|P2|Crossover Phase|Other virologic failure criteria|0
4787457|NCT01425203|16511702|P1|Crossover Phase|Other virologic failure criteria|0
4787458|NCT01425203|16511700|P3|Crossover Phase|Failure at futility timepoint|3
4787459|NCT01425203|16511701|P2|Crossover Phase|Failure at futility timepoint|0
4787460|NCT01425203|16511702|P1|Crossover Phase|Failure at futility timepoint|0
4787461|NCT01425203|16511700|P3|Treatment Phase|Did not receive treatment|0
4787462|NCT01425203|16511701|P2|Treatment Phase|Did not receive treatment|1
4787463|NCT01425203|16511702|P1|Treatment Phase|Did not receive treatment|0
4787464|NCT01425203|16511700|P3|Treatment Phase|Unidentified reasons|0
4787465|NCT01425203|16511701|P2|Treatment Phase|Unidentified reasons|5
4787466|NCT01425203|16511702|P1|Treatment Phase|Unidentified reasons|11
4787467|NCT01425203|16511700|P3|Treatment Phase|Other virologic failure criteria|0
4787468|NCT01425203|16511701|P2|Treatment Phase|Other virologic failure criteria|3
4787469|NCT01425203|16511702|P1|Treatment Phase|Other virologic failure criteria|5
4787470|NCT01425203|16511700|P3|Treatment Phase|Failure at futility timepoint|0
4787471|NCT01425203|16511701|P2|Treatment Phase|Failure at futility timepoint|27
4787472|NCT01425203|16511702|P1|Treatment Phase|Failure at futility timepoint|8
4787473|NCT01425203|16511700|P3|Treatment Phase|DC during PR Lead-in Phase|0
4787474|NCT01425203|16511701|P2|Treatment Phase|DC during PR Lead-in Phase|1
4787475|NCT01425203|16511702|P1|Treatment Phase|DC during PR Lead-in Phase|3
4787476|NCT01425190|16511719|P3|Overall Study|Full dose not consumed.|0
4787477|NCT01425190|16511720|P2|Overall Study|Full dose not consumed.|0
4787478|NCT01425190|16511721|P1|Overall Study|Full dose not consumed.|1
4787558|NCT01425008|16511760|P16|Dose Expansion Phase|Other|0
4787479|NCT01425008|16511757|P19|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1
4787480|NCT01425008|16511758|P18|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787481|NCT01425008|16511759|P17|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787482|NCT01425008|16511760|P16|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787483|NCT01425008|16511761|P15|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787484|NCT01425008|16511762|P14|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787485|NCT01425008|16511763|P13|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787486|NCT01425008|16511764|P12|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787487|NCT01425008|16511765|P11|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787488|NCT01425008|16511766|P10|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787489|NCT01425008|16511767|P9|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787490|NCT01425008|16511768|P8|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787491|NCT01425008|16511769|P7|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787492|NCT01425008|16511770|P6|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787493|NCT01425008|16511771|P5|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787494|NCT01425008|16511772|P4|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787495|NCT01425008|16511773|P3|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787496|NCT01425008|16511774|P2|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787497|NCT01425008|16511775|P1|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0
4787498|NCT01425008|16511757|P19|Dose Expansion Phase|Lost to Follow-up|0
4787499|NCT01425008|16511758|P18|Dose Expansion Phase|Lost to Follow-up|0
4787500|NCT01425008|16511759|P17|Dose Expansion Phase|Lost to Follow-up|1
4787501|NCT01425008|16511760|P16|Dose Expansion Phase|Lost to Follow-up|0
4787502|NCT01425008|16511761|P15|Dose Expansion Phase|Lost to Follow-up|0
4787503|NCT01425008|16511762|P14|Dose Expansion Phase|Lost to Follow-up|0
4787504|NCT01425008|16511763|P13|Dose Expansion Phase|Lost to Follow-up|0
4787505|NCT01425008|16511764|P12|Dose Expansion Phase|Lost to Follow-up|0
4787506|NCT01425008|16511765|P11|Dose Expansion Phase|Lost to Follow-up|0
4787507|NCT01425008|16511766|P10|Dose Expansion Phase|Lost to Follow-up|0
4787508|NCT01425008|16511767|P9|Dose Expansion Phase|Lost to Follow-up|0
4787509|NCT01425008|16511768|P8|Dose Expansion Phase|Lost to Follow-up|0
4787510|NCT01425008|16511769|P7|Dose Expansion Phase|Lost to Follow-up|0
4787511|NCT01425008|16511770|P6|Dose Expansion Phase|Lost to Follow-up|0
4787512|NCT01425008|16511771|P5|Dose Expansion Phase|Lost to Follow-up|0
4787513|NCT01425008|16511772|P4|Dose Expansion Phase|Lost to Follow-up|0
4787514|NCT01425008|16511773|P3|Dose Expansion Phase|Lost to Follow-up|0
4787515|NCT01425008|16511774|P2|Dose Expansion Phase|Lost to Follow-up|0
4787516|NCT01425008|16511775|P1|Dose Expansion Phase|Lost to Follow-up|0
4787517|NCT01425008|16511757|P19|Dose Expansion Phase|Adverse Event|3
4787518|NCT01425008|16511758|P18|Dose Expansion Phase|Adverse Event|0
4787519|NCT01425008|16511759|P17|Dose Expansion Phase|Adverse Event|5
4787520|NCT01425008|16511760|P16|Dose Expansion Phase|Adverse Event|1
4787521|NCT01425008|16511761|P15|Dose Expansion Phase|Adverse Event|1
4787522|NCT01425008|16511762|P14|Dose Expansion Phase|Adverse Event|0
4787523|NCT01425008|16511763|P13|Dose Expansion Phase|Adverse Event|3
4787524|NCT01425008|16511764|P12|Dose Expansion Phase|Adverse Event|3
4787525|NCT01425008|16511765|P11|Dose Expansion Phase|Adverse Event|2
4787526|NCT01425008|16511766|P10|Dose Expansion Phase|Adverse Event|0
4787527|NCT01425008|16511767|P9|Dose Expansion Phase|Adverse Event|0
4787528|NCT01425008|16511768|P8|Dose Expansion Phase|Adverse Event|0
4787529|NCT01425008|16511769|P7|Dose Expansion Phase|Adverse Event|0
4787530|NCT01425008|16511770|P6|Dose Expansion Phase|Adverse Event|0
4787531|NCT01425008|16511771|P5|Dose Expansion Phase|Adverse Event|0
4787532|NCT01425008|16511772|P4|Dose Expansion Phase|Adverse Event|0
4787533|NCT01425008|16511773|P3|Dose Expansion Phase|Adverse Event|0
4787534|NCT01425008|16511774|P2|Dose Expansion Phase|Adverse Event|0
4787535|NCT01425008|16511775|P1|Dose Expansion Phase|Adverse Event|0
4787536|NCT01425008|16511757|P19|Dose Expansion Phase|Symptomatic Deterioration|1
4787537|NCT01425008|16511758|P18|Dose Expansion Phase|Symptomatic Deterioration|0
4787538|NCT01425008|16511759|P17|Dose Expansion Phase|Symptomatic Deterioration|2
4787539|NCT01425008|16511760|P16|Dose Expansion Phase|Symptomatic Deterioration|1
4787540|NCT01425008|16511761|P15|Dose Expansion Phase|Symptomatic Deterioration|0
4787541|NCT01425008|16511762|P14|Dose Expansion Phase|Symptomatic Deterioration|0
4787542|NCT01425008|16511763|P13|Dose Expansion Phase|Symptomatic Deterioration|0
4787543|NCT01425008|16511764|P12|Dose Expansion Phase|Symptomatic Deterioration|1
4787544|NCT01425008|16511765|P11|Dose Expansion Phase|Symptomatic Deterioration|2
4787545|NCT01425008|16511766|P10|Dose Expansion Phase|Symptomatic Deterioration|0
4787546|NCT01425008|16511767|P9|Dose Expansion Phase|Symptomatic Deterioration|0
4787547|NCT01425008|16511768|P8|Dose Expansion Phase|Symptomatic Deterioration|0
4787548|NCT01425008|16511769|P7|Dose Expansion Phase|Symptomatic Deterioration|0
4787549|NCT01425008|16511770|P6|Dose Expansion Phase|Symptomatic Deterioration|0
4787550|NCT01425008|16511771|P5|Dose Expansion Phase|Symptomatic Deterioration|0
4787551|NCT01425008|16511772|P4|Dose Expansion Phase|Symptomatic Deterioration|0
4787552|NCT01425008|16511773|P3|Dose Expansion Phase|Symptomatic Deterioration|0
4787553|NCT01425008|16511774|P2|Dose Expansion Phase|Symptomatic Deterioration|0
4787554|NCT01425008|16511775|P1|Dose Expansion Phase|Symptomatic Deterioration|0
4787555|NCT01425008|16511757|P19|Dose Expansion Phase|Other|4
4787556|NCT01425008|16511758|P18|Dose Expansion Phase|Other|0
4787557|NCT01425008|16511759|P17|Dose Expansion Phase|Other|2
4787559|NCT01425008|16511761|P15|Dose Expansion Phase|Other|0
4787560|NCT01425008|16511762|P14|Dose Expansion Phase|Other|0
4787561|NCT01425008|16511763|P13|Dose Expansion Phase|Other|1
4787562|NCT01425008|16511764|P12|Dose Expansion Phase|Other|0
4787563|NCT01425008|16511765|P11|Dose Expansion Phase|Other|0
4787564|NCT01425008|16511766|P10|Dose Expansion Phase|Other|0
4787565|NCT01425008|16511767|P9|Dose Expansion Phase|Other|0
4787566|NCT01425008|16511768|P8|Dose Expansion Phase|Other|0
4787567|NCT01425008|16511769|P7|Dose Expansion Phase|Other|0
4787568|NCT01425008|16511770|P6|Dose Expansion Phase|Other|0
4787569|NCT01425008|16511771|P5|Dose Expansion Phase|Other|0
4787570|NCT01425008|16511772|P4|Dose Expansion Phase|Other|0
4787571|NCT01425008|16511773|P3|Dose Expansion Phase|Other|0
4787572|NCT01425008|16511774|P2|Dose Expansion Phase|Other|0
4787573|NCT01425008|16511775|P1|Dose Expansion Phase|Other|0
4787574|NCT01425008|16511757|P19|Dose Expansion Phase|Withdrawal by Subject|0
4787575|NCT01425008|16511758|P18|Dose Expansion Phase|Withdrawal by Subject|0
4787576|NCT01425008|16511759|P17|Dose Expansion Phase|Withdrawal by Subject|1
4787577|NCT01425008|16511760|P16|Dose Expansion Phase|Withdrawal by Subject|1
4787578|NCT01425008|16511761|P15|Dose Expansion Phase|Withdrawal by Subject|0
4787579|NCT01425008|16511762|P14|Dose Expansion Phase|Withdrawal by Subject|0
4787580|NCT01425008|16511763|P13|Dose Expansion Phase|Withdrawal by Subject|0
4787581|NCT01425008|16511764|P12|Dose Expansion Phase|Withdrawal by Subject|0
4787582|NCT01425008|16511765|P11|Dose Expansion Phase|Withdrawal by Subject|1
4787583|NCT01425008|16511766|P10|Dose Expansion Phase|Withdrawal by Subject|0
4787584|NCT01425008|16511767|P9|Dose Expansion Phase|Withdrawal by Subject|0
4787585|NCT01425008|16511768|P8|Dose Expansion Phase|Withdrawal by Subject|0
4787586|NCT01425008|16511769|P7|Dose Expansion Phase|Withdrawal by Subject|0
4787587|NCT01425008|16511770|P6|Dose Expansion Phase|Withdrawal by Subject|0
4787588|NCT01425008|16511771|P5|Dose Expansion Phase|Withdrawal by Subject|0
4787589|NCT01425008|16511772|P4|Dose Expansion Phase|Withdrawal by Subject|0
4787590|NCT01425008|16511773|P3|Dose Expansion Phase|Withdrawal by Subject|0
4787591|NCT01425008|16511774|P2|Dose Expansion Phase|Withdrawal by Subject|0
4787592|NCT01425008|16511775|P1|Dose Expansion Phase|Withdrawal by Subject|0
4787593|NCT01425008|16511757|P19|Dose Expansion Phase|Progressive Disease|10
4787594|NCT01425008|16511758|P18|Dose Expansion Phase|Progressive Disease|2
4787595|NCT01425008|16511759|P17|Dose Expansion Phase|Progressive Disease|9
4787596|NCT01425008|16511760|P16|Dose Expansion Phase|Progressive Disease|8
4787597|NCT01425008|16511761|P15|Dose Expansion Phase|Progressive Disease|5
4787598|NCT01425008|16511762|P14|Dose Expansion Phase|Progressive Disease|1
4787599|NCT01425008|16511763|P13|Dose Expansion Phase|Progressive Disease|12
4787600|NCT01425008|16511764|P12|Dose Expansion Phase|Progressive Disease|4
4787601|NCT01425008|16511765|P11|Dose Expansion Phase|Progressive Disease|10
4787602|NCT01425008|16511766|P10|Dose Expansion Phase|Progressive Disease|0
4787603|NCT01425008|16511767|P9|Dose Expansion Phase|Progressive Disease|0
4787604|NCT01425008|16511768|P8|Dose Expansion Phase|Progressive Disease|0
4787605|NCT01425008|16511769|P7|Dose Expansion Phase|Progressive Disease|0
4787606|NCT01425008|16511770|P6|Dose Expansion Phase|Progressive Disease|0
4787607|NCT01425008|16511771|P5|Dose Expansion Phase|Progressive Disease|0
4787608|NCT01425008|16511772|P4|Dose Expansion Phase|Progressive Disease|0
4787609|NCT01425008|16511773|P3|Dose Expansion Phase|Progressive Disease|0
4787610|NCT01425008|16511774|P2|Dose Expansion Phase|Progressive Disease|0
4787611|NCT01425008|16511775|P1|Dose Expansion Phase|Progressive Disease|0
4787612|NCT01425008|16511757|P19|Dose Escalation Phase|Other|0
4787613|NCT01425008|16511758|P18|Dose Escalation Phase|Other|0
4787614|NCT01425008|16511759|P17|Dose Escalation Phase|Other|0
4787615|NCT01425008|16511760|P16|Dose Escalation Phase|Other|0
4787616|NCT01425008|16511761|P15|Dose Escalation Phase|Other|0
4787617|NCT01425008|16511762|P14|Dose Escalation Phase|Other|0
4787618|NCT01425008|16511763|P13|Dose Escalation Phase|Other|0
4787619|NCT01425008|16511764|P12|Dose Escalation Phase|Other|0
4787620|NCT01425008|16511765|P11|Dose Escalation Phase|Other|0
4787621|NCT01425008|16511766|P10|Dose Escalation Phase|Other|0
4787622|NCT01425008|16511767|P9|Dose Escalation Phase|Other|1
4787623|NCT01425008|16511768|P8|Dose Escalation Phase|Other|0
4787624|NCT01425008|16511769|P7|Dose Escalation Phase|Other|0
4787625|NCT01425008|16511770|P6|Dose Escalation Phase|Other|0
4787626|NCT01425008|16511771|P5|Dose Escalation Phase|Other|0
4787627|NCT01425008|16511772|P4|Dose Escalation Phase|Other|0
4787628|NCT01425008|16511773|P3|Dose Escalation Phase|Other|0
4787629|NCT01425008|16511774|P2|Dose Escalation Phase|Other|0
4787630|NCT01425008|16511775|P1|Dose Escalation Phase|Other|0
4787631|NCT01425008|16511757|P19|Dose Escalation Phase|Symptomatic Deterioration|0
4787632|NCT01425008|16511758|P18|Dose Escalation Phase|Symptomatic Deterioration|0
4787633|NCT01425008|16511759|P17|Dose Escalation Phase|Symptomatic Deterioration|0
4787634|NCT01425008|16511760|P16|Dose Escalation Phase|Symptomatic Deterioration|0
4787635|NCT01425008|16511761|P15|Dose Escalation Phase|Symptomatic Deterioration|0
4787636|NCT01425008|16511762|P14|Dose Escalation Phase|Symptomatic Deterioration|0
4787637|NCT01425008|16511763|P13|Dose Escalation Phase|Symptomatic Deterioration|0
4787638|NCT01425008|16511764|P12|Dose Escalation Phase|Symptomatic Deterioration|0
4787639|NCT01425008|16511765|P11|Dose Escalation Phase|Symptomatic Deterioration|0
4787640|NCT01425008|16511766|P10|Dose Escalation Phase|Symptomatic Deterioration|2
4787641|NCT01425008|16511767|P9|Dose Escalation Phase|Symptomatic Deterioration|2
4787642|NCT01425008|16511768|P8|Dose Escalation Phase|Symptomatic Deterioration|0
4787643|NCT01425008|16511769|P7|Dose Escalation Phase|Symptomatic Deterioration|0
4787644|NCT01425008|16511770|P6|Dose Escalation Phase|Symptomatic Deterioration|0
4787645|NCT01425008|16511771|P5|Dose Escalation Phase|Symptomatic Deterioration|0
4787646|NCT01425008|16511772|P4|Dose Escalation Phase|Symptomatic Deterioration|0
4787647|NCT01425008|16511773|P3|Dose Escalation Phase|Symptomatic Deterioration|1
4787648|NCT01425008|16511774|P2|Dose Escalation Phase|Symptomatic Deterioration|0
4787649|NCT01425008|16511775|P1|Dose Escalation Phase|Symptomatic Deterioration|0
4787650|NCT01425008|16511757|P19|Dose Escalation Phase|Withdrawal by Subject|0
4787651|NCT01425008|16511758|P18|Dose Escalation Phase|Withdrawal by Subject|0
4787652|NCT01425008|16511759|P17|Dose Escalation Phase|Withdrawal by Subject|0
4787653|NCT01425008|16511760|P16|Dose Escalation Phase|Withdrawal by Subject|0
4787654|NCT01425008|16511761|P15|Dose Escalation Phase|Withdrawal by Subject|0
4787655|NCT01425008|16511762|P14|Dose Escalation Phase|Withdrawal by Subject|0
4787656|NCT01425008|16511763|P13|Dose Escalation Phase|Withdrawal by Subject|0
4787657|NCT01425008|16511764|P12|Dose Escalation Phase|Withdrawal by Subject|0
4787658|NCT01425008|16511765|P11|Dose Escalation Phase|Withdrawal by Subject|0
4787659|NCT01425008|16511766|P10|Dose Escalation Phase|Withdrawal by Subject|0
4787660|NCT01425008|16511767|P9|Dose Escalation Phase|Withdrawal by Subject|1
4787661|NCT01425008|16511768|P8|Dose Escalation Phase|Withdrawal by Subject|0
4787662|NCT01425008|16511769|P7|Dose Escalation Phase|Withdrawal by Subject|1
4787663|NCT01425008|16511770|P6|Dose Escalation Phase|Withdrawal by Subject|1
4787664|NCT01425008|16511771|P5|Dose Escalation Phase|Withdrawal by Subject|1
4787665|NCT01425008|16511772|P4|Dose Escalation Phase|Withdrawal by Subject|0
4787666|NCT01425008|16511773|P3|Dose Escalation Phase|Withdrawal by Subject|0
4787667|NCT01425008|16511774|P2|Dose Escalation Phase|Withdrawal by Subject|0
4787668|NCT01425008|16511775|P1|Dose Escalation Phase|Withdrawal by Subject|0
4787669|NCT01425008|16511757|P19|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787670|NCT01425008|16511758|P18|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787671|NCT01425008|16511759|P17|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787672|NCT01425008|16511760|P16|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787673|NCT01425008|16511761|P15|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787674|NCT01425008|16511762|P14|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787675|NCT01425008|16511763|P13|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787676|NCT01425008|16511764|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787677|NCT01425008|16511765|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787678|NCT01425008|16511766|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787679|NCT01425008|16511767|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4787680|NCT01425008|16511768|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4787681|NCT01425008|16511769|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2
4787682|NCT01425008|16511770|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787683|NCT01425008|16511771|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4787684|NCT01425008|16511772|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787685|NCT01425008|16511773|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787686|NCT01425008|16511774|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787687|NCT01425008|16511775|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4787688|NCT01425008|16511757|P19|Dose Escalation Phase|Adverse Event|0
4787689|NCT01425008|16511758|P18|Dose Escalation Phase|Adverse Event|0
4787690|NCT01425008|16511759|P17|Dose Escalation Phase|Adverse Event|0
4787691|NCT01425008|16511760|P16|Dose Escalation Phase|Adverse Event|0
4787692|NCT01425008|16511761|P15|Dose Escalation Phase|Adverse Event|0
4787693|NCT01425008|16511762|P14|Dose Escalation Phase|Adverse Event|0
4787694|NCT01425008|16511763|P13|Dose Escalation Phase|Adverse Event|0
4787695|NCT01425008|16511764|P12|Dose Escalation Phase|Adverse Event|0
4787696|NCT01425008|16511765|P11|Dose Escalation Phase|Adverse Event|0
4787697|NCT01425008|16511766|P10|Dose Escalation Phase|Adverse Event|0
4787698|NCT01425008|16511767|P9|Dose Escalation Phase|Adverse Event|2
4787699|NCT01425008|16511768|P8|Dose Escalation Phase|Adverse Event|0
4787700|NCT01425008|16511769|P7|Dose Escalation Phase|Adverse Event|0
4787701|NCT01425008|16511770|P6|Dose Escalation Phase|Adverse Event|2
4787702|NCT01425008|16511771|P5|Dose Escalation Phase|Adverse Event|0
4787703|NCT01425008|16511772|P4|Dose Escalation Phase|Adverse Event|0
4787704|NCT01425008|16511773|P3|Dose Escalation Phase|Adverse Event|0
4787705|NCT01425008|16511774|P2|Dose Escalation Phase|Adverse Event|0
4787706|NCT01425008|16511775|P1|Dose Escalation Phase|Adverse Event|2
4787707|NCT01425008|16511757|P19|Dose Escalation Phase|Progressive Disease|0
4787708|NCT01425008|16511758|P18|Dose Escalation Phase|Progressive Disease|0
4787709|NCT01425008|16511759|P17|Dose Escalation Phase|Progressive Disease|0
4787710|NCT01425008|16511760|P16|Dose Escalation Phase|Progressive Disease|0
4787711|NCT01425008|16511761|P15|Dose Escalation Phase|Progressive Disease|0
4787712|NCT01425008|16511762|P14|Dose Escalation Phase|Progressive Disease|0
4787713|NCT01425008|16511763|P13|Dose Escalation Phase|Progressive Disease|0
4787714|NCT01425008|16511764|P12|Dose Escalation Phase|Progressive Disease|0
4787715|NCT01425008|16511765|P11|Dose Escalation Phase|Progressive Disease|0
4787716|NCT01425008|16511766|P10|Dose Escalation Phase|Progressive Disease|2
4787717|NCT01425008|16511767|P9|Dose Escalation Phase|Progressive Disease|6
4787718|NCT01425008|16511768|P8|Dose Escalation Phase|Progressive Disease|2
4787719|NCT01425008|16511769|P7|Dose Escalation Phase|Progressive Disease|0
4787720|NCT01425008|16511770|P6|Dose Escalation Phase|Progressive Disease|4
4787721|NCT01425008|16511771|P5|Dose Escalation Phase|Progressive Disease|5
4787722|NCT01425008|16511772|P4|Dose Escalation Phase|Progressive Disease|3
4787723|NCT01425008|16511773|P3|Dose Escalation Phase|Progressive Disease|2
4787724|NCT01425008|16511774|P2|Dose Escalation Phase|Progressive Disease|3
4787725|NCT01425008|16511775|P1|Dose Escalation Phase|Progressive Disease|2
4787726|NCT01424930|16512078|P2|Overall Study|Reason not specified|6
4787727|NCT01424930|16512079|P1|Overall Study|Reason not specified|0
4787728|NCT01424930|16512078|P2|Overall Study|Screen Failure|1
4787729|NCT01424930|16512079|P1|Overall Study|Screen Failure|0
4787730|NCT01424930|16512078|P2|Overall Study|Progressive Disease|6
4787731|NCT01424930|16512079|P1|Overall Study|Progressive Disease|3
4787732|NCT01424930|16512078|P2|Overall Study|Death|0
4787733|NCT01424930|16512079|P1|Overall Study|Death|1
4787734|NCT01424930|16512078|P2|Overall Study|Adverse Event|1
4787735|NCT01424930|16512079|P1|Overall Study|Adverse Event|0
4787736|NCT01424813|16512093|P2|Overall Study|Other|2
4787737|NCT01424813|16512094|P1|Overall Study|Other|1
4787738|NCT01424813|16512093|P2|Overall Study|Protocol Violation|0
4787739|NCT01424813|16512094|P1|Overall Study|Protocol Violation|1
4787740|NCT01424813|16512093|P2|Overall Study|Withdrawal by Subject|0
4787741|NCT01424813|16512094|P1|Overall Study|Withdrawal by Subject|3
4787742|NCT01424670|16512114|P2|Continuation Period|Withdrawal by Subject|4
4787743|NCT01424670|16512115|P1|Continuation Period|Withdrawal by Subject|13
4787744|NCT01424670|16512114|P2|Continuation Period|Physician Decision|4
4787745|NCT01424670|16512115|P1|Continuation Period|Physician Decision|5
4787746|NCT01424670|16512114|P2|Continuation Period|Met Protocol Withdrawal Criteria|1
4787747|NCT01424670|16512115|P1|Continuation Period|Met Protocol Withdrawal Criteria|1
4787748|NCT01424670|16512114|P2|Continuation Period|Lost to Follow-up|0
4787749|NCT01424670|16512115|P1|Continuation Period|Lost to Follow-up|2
4787750|NCT01424670|16512114|P2|Continuation Period|Adverse Event|5
4787751|NCT01424670|16512115|P1|Continuation Period|Adverse Event|13
4787752|NCT01424670|16512114|P2|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7
4787753|NCT01424670|16512115|P1|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13
4787754|NCT01424670|16512114|P2|6-Month Intensive Period (182 Days)|Physician Decision|3
4787755|NCT01424670|16512115|P1|6-Month Intensive Period (182 Days)|Physician Decision|2
4787756|NCT01424670|16512114|P2|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1
4787757|NCT01424670|16512115|P1|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2
4787758|NCT01424670|16512114|P2|6-Month Intensive Period (182 Days)|Lost to Follow-up|1
4787759|NCT01424670|16512115|P1|6-Month Intensive Period (182 Days)|Lost to Follow-up|0
4787760|NCT01424670|16512114|P2|6-Month Intensive Period (182 Days)|Adverse Event|2
4787761|NCT01424670|16512115|P1|6-Month Intensive Period (182 Days)|Adverse Event|2
4787762|NCT01424644|16512137|P2|Overall Study|Unable to Classify|0
4787763|NCT01424644|16512138|P1|Overall Study|Unable to Classify|1
4787764|NCT01424644|16512137|P2|Overall Study|Administrative Reason|0
4787765|NCT01424644|16512138|P1|Overall Study|Administrative Reason|1
4787766|NCT01424644|16512137|P2|Overall Study|Protocol Violation|3
4787767|NCT01424644|16512138|P1|Overall Study|Protocol Violation|4
4787768|NCT01424644|16512137|P2|Overall Study|Lost to Follow-up|12
4787769|NCT01424644|16512138|P1|Overall Study|Lost to Follow-up|16
4787770|NCT01424644|16512137|P2|Overall Study|Withdrawal by Subject|12
4787771|NCT01424644|16512138|P1|Overall Study|Withdrawal by Subject|9
4787772|NCT01424644|16512137|P2|Overall Study|Adverse Event|0
4787773|NCT01424644|16512138|P1|Overall Study|Adverse Event|2
4787774|NCT01424566|16512152|P3|Double-blind Treatment|Lack of Efficacy|1
4787775|NCT01424566|16512153|P2|Double-blind Treatment|Lack of Efficacy|1
4787776|NCT01424566|16512154|P1|Double-blind Treatment|Lack of Efficacy|0
4787777|NCT01424566|16512152|P3|Double-blind Treatment|Withdrawal by Investigator|1
4787778|NCT01424566|16512153|P2|Double-blind Treatment|Withdrawal by Investigator|1
4787779|NCT01424566|16512154|P1|Double-blind Treatment|Withdrawal by Investigator|0
4787780|NCT01424566|16512152|P3|Double-blind Treatment|Withdrawal by Subject|0
4787781|NCT01424566|16512153|P2|Double-blind Treatment|Withdrawal by Subject|2
4787782|NCT01424566|16512154|P1|Double-blind Treatment|Withdrawal by Subject|0
4787783|NCT01424566|16512152|P3|Double-blind Treatment|Adverse Event|13
4787784|NCT01424566|16512153|P2|Double-blind Treatment|Adverse Event|21
4787785|NCT01424566|16512154|P1|Double-blind Treatment|Adverse Event|0
4787786|NCT01424566|16512152|P3|Single-blind Treatment|Did Not Administer Any Study Drug|0
4787787|NCT01424566|16512153|P2|Single-blind Treatment|Did Not Administer Any Study Drug|0
4787788|NCT01424566|16512154|P1|Single-blind Treatment|Did Not Administer Any Study Drug|2
4787789|NCT01424566|16512152|P3|Single-blind Treatment|Met Exclusion Criteria|0
4787790|NCT01424566|16512153|P2|Single-blind Treatment|Met Exclusion Criteria|0
4787791|NCT01424566|16512154|P1|Single-blind Treatment|Met Exclusion Criteria|1
4787792|NCT01424566|16512152|P3|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
4787793|NCT01424566|16512153|P2|Single-blind Treatment|Did Not Meet Inclusion Criteria|0
4787794|NCT01424566|16512154|P1|Single-blind Treatment|Did Not Meet Inclusion Criteria|108
4787795|NCT01424566|16512152|P3|Single-blind Treatment|Withdrawal by Investigator|0
4787796|NCT01424566|16512153|P2|Single-blind Treatment|Withdrawal by Investigator|0
4787797|NCT01424566|16512154|P1|Single-blind Treatment|Withdrawal by Investigator|2
4787798|NCT01424566|16512152|P3|Single-blind Treatment|Withdrawal by Subject|0
4787799|NCT01424566|16512153|P2|Single-blind Treatment|Withdrawal by Subject|0
4787800|NCT01424566|16512154|P1|Single-blind Treatment|Withdrawal by Subject|16
4787801|NCT01424566|16512152|P3|Single-blind Treatment|Adverse Event|0
4787802|NCT01424566|16512153|P2|Single-blind Treatment|Adverse Event|0
4787803|NCT01424566|16512154|P1|Single-blind Treatment|Adverse Event|71
4787804|NCT01424514|16512181|P2|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0
4787893|NCT01423604|16512718|P2|Randomized|Adverse Event|10
4787805|NCT01424514|16512182|P1|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1
4787806|NCT01424514|16512181|P2|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
4787807|NCT01424514|16512182|P1|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1
4787808|NCT01424501|16512227|P6|Overall Study|Lost to Follow-up|0
4787809|NCT01424501|16512228|P5|Overall Study|Lost to Follow-up|0
4787810|NCT01424501|16512229|P4|Overall Study|Lost to Follow-up|0
4787811|NCT01424501|16512230|P3|Overall Study|Lost to Follow-up|1
4787812|NCT01424501|16512231|P2|Overall Study|Lost to Follow-up|1
4787813|NCT01424501|16512232|P1|Overall Study|Lost to Follow-up|0
4787814|NCT01424501|16512227|P6|Overall Study|Withdrawal by Subject|0
4787815|NCT01424501|16512228|P5|Overall Study|Withdrawal by Subject|0
4787816|NCT01424501|16512229|P4|Overall Study|Withdrawal by Subject|0
4787817|NCT01424501|16512230|P3|Overall Study|Withdrawal by Subject|1
4787818|NCT01424501|16512231|P2|Overall Study|Withdrawal by Subject|0
4787819|NCT01424501|16512232|P1|Overall Study|Withdrawal by Subject|1
4787820|NCT01424397|16512408|P12|Period-2 (8 Days)|Withdrawal by Subject|0
4787821|NCT01424397|16512409|P11|Period-2 (8 Days)|Withdrawal by Subject|0
4787822|NCT01424397|16512410|P10|Period-2 (8 Days)|Withdrawal by Subject|0
4787823|NCT01424397|16512411|P9|Period-2 (8 Days)|Withdrawal by Subject|0
4787824|NCT01424397|16512412|P8|Period-2 (8 Days)|Withdrawal by Subject|0
4787825|NCT01424397|16512413|P7|Period-2 (8 Days)|Withdrawal by Subject|0
4787826|NCT01424397|16512414|P6|Period-2 (8 Days)|Withdrawal by Subject|0
4787827|NCT01424397|16512415|P5|Period-2 (8 Days)|Withdrawal by Subject|0
4787828|NCT01424397|16512416|P4|Period-2 (8 Days)|Withdrawal by Subject|0
4787829|NCT01424397|16512417|P3|Period-2 (8 Days)|Withdrawal by Subject|1
4787830|NCT01424397|16512418|P2|Period-2 (8 Days)|Withdrawal by Subject|0
4787831|NCT01424397|16512419|P1|Period-2 (8 Days)|Withdrawal by Subject|0
4787832|NCT01424306|16512465|P6|Overall Study|Protocol Violation|0
4787833|NCT01424306|16512466|P5|Overall Study|Protocol Violation|1
4787834|NCT01424306|16512467|P4|Overall Study|Protocol Violation|0
4787835|NCT01424306|16512468|P3|Overall Study|Protocol Violation|0
4787836|NCT01424306|16512469|P2|Overall Study|Protocol Violation|0
4787837|NCT01424306|16512470|P1|Overall Study|Protocol Violation|0
4787838|NCT01424228|16512519|P2|Overall Study|Unplanned journey|1
4787839|NCT01424228|16512520|P1|Overall Study|Unplanned journey|0
4787840|NCT01424228|16512519|P2|Overall Study|Worsening of symptoms|0
4787841|NCT01424228|16512520|P1|Overall Study|Worsening of symptoms|1
4787842|NCT01424228|16512519|P2|Overall Study|Non-compliance|0
4787843|NCT01424228|16512520|P1|Overall Study|Non-compliance|2
4787844|NCT01424228|16512519|P2|Overall Study|inclusion/exclusion criteria not met|2
4787845|NCT01424228|16512520|P1|Overall Study|inclusion/exclusion criteria not met|2
4787846|NCT01424228|16512519|P2|Overall Study|Lack of Efficacy|7
4787847|NCT01424228|16512520|P1|Overall Study|Lack of Efficacy|5
4787848|NCT01424228|16512519|P2|Overall Study|Sponsor's decision|12
4787849|NCT01424228|16512520|P1|Overall Study|Sponsor's decision|9
4787850|NCT01424228|16512519|P2|Overall Study|Adverse Event|14
4787851|NCT01424228|16512520|P1|Overall Study|Adverse Event|10
4787852|NCT01424228|16512519|P2|Overall Study|Withdrawal by Subject|11
4787853|NCT01424228|16512520|P1|Overall Study|Withdrawal by Subject|27
4787854|NCT01424189|16512571|P2|Overall Study|Death|1
4787855|NCT01424189|16512572|P1|Overall Study|Death|3
4787856|NCT01424189|16512571|P2|Overall Study|Subject moved|0
4787857|NCT01424189|16512572|P1|Overall Study|Subject moved|1
4787858|NCT01424189|16512571|P2|Overall Study|Withdrawal by Subject|4
4787859|NCT01424189|16512572|P1|Overall Study|Withdrawal by Subject|4
4787860|NCT01424189|16512571|P2|Overall Study|Lost to Follow-up|1
4787861|NCT01424189|16512572|P1|Overall Study|Lost to Follow-up|4
4787862|NCT01424189|16512571|P2|Overall Study|Adverse Event|0
4787863|NCT01424189|16512572|P1|Overall Study|Adverse Event|1
4787864|NCT01423916|16512613|P3|Overall Study|Protocol Deviation|0
4787865|NCT01423916|16512614|P2|Overall Study|Protocol Deviation|0
4787866|NCT01423916|16512615|P1|Overall Study|Protocol Deviation|1
4787867|NCT01423916|16512613|P3|Overall Study|Withdrawal by Subject|3
4787868|NCT01423916|16512614|P2|Overall Study|Withdrawal by Subject|10
4787869|NCT01423916|16512615|P1|Overall Study|Withdrawal by Subject|3
4787870|NCT01423916|16512613|P3|Overall Study|Physician Decision|1
4787871|NCT01423916|16512614|P2|Overall Study|Physician Decision|0
4787872|NCT01423916|16512615|P1|Overall Study|Physician Decision|1
4787873|NCT01423916|16512613|P3|Overall Study|Met Withdrawal Criteria|1
4787874|NCT01423916|16512614|P2|Overall Study|Met Withdrawal Criteria|1
4787875|NCT01423916|16512615|P1|Overall Study|Met Withdrawal Criteria|1
4787876|NCT01423916|16512613|P3|Overall Study|Adverse Event|2
4787877|NCT01423916|16512614|P2|Overall Study|Adverse Event|9
4787878|NCT01423916|16512615|P1|Overall Study|Adverse Event|5
4787879|NCT01423812|16512671|P2|Overall Study|Withdrawal by Subject|2
4787880|NCT01423812|16512672|P1|Overall Study|Withdrawal by Subject|1
4787881|NCT01423812|16512671|P2|Overall Study|Lost to Follow-up|2
4787882|NCT01423812|16512672|P1|Overall Study|Lost to Follow-up|2
4787883|NCT01423617|16512700|P2|Overall Study|Lost to Follow-up|1
4787884|NCT01423617|16512701|P1|Overall Study|Lost to Follow-up|0
4787885|NCT01423604|16512718|P2|Randomized|Patient decision|9
4787886|NCT01423604|16512719|P1|Randomized|Patient decision|5
4787887|NCT01423604|16512718|P2|Randomized|Other - unspecified|31
4787888|NCT01423604|16512719|P1|Randomized|Other - unspecified|37
4787889|NCT01423604|16512718|P2|Randomized|Physician Decision|13
4787890|NCT01423604|16512719|P1|Randomized|Physician Decision|16
4787891|NCT01423604|16512718|P2|Randomized|Death|0
4787892|NCT01423604|16512719|P1|Randomized|Death|1
4787894|NCT01423604|16512719|P1|Randomized|Adverse Event|4
4787895|NCT01423604|16512718|P2|Safety Run-In|Patient decision|0
4787896|NCT01423604|16512719|P1|Safety Run-In|Patient decision|1
4787897|NCT01423604|16512718|P2|Safety Run-In|Disease progression|0
4787898|NCT01423604|16512719|P1|Safety Run-In|Disease progression|3
4787899|NCT01423604|16512718|P2|Safety Run-In|Physician Decision|0
4787900|NCT01423604|16512719|P1|Safety Run-In|Physician Decision|1
4787901|NCT01423604|16512718|P2|Safety Run-In|Death|0
4787902|NCT01423604|16512719|P1|Safety Run-In|Death|1
4787903|NCT01423604|16512718|P2|Safety Run-In|Adverse Event|0
4787904|NCT01423604|16512719|P1|Safety Run-In|Adverse Event|3
4787905|NCT01423253|16512734|P1|Overall Study|Withdrawal by Subject|2
4787906|NCT01423253|16512734|P1|Overall Study|Protocol Violation|2
4787907|NCT01423253|16512734|P1|Overall Study|Lost to Follow-up|1
4787908|NCT01423253|16512734|P1|Overall Study|Lack of Efficacy|2
4787909|NCT01423253|16512734|P1|Overall Study|Adverse Event|2
4787910|NCT01423084|16512756|P2|Overall Study|Withdrawal by Subject|3
4787911|NCT01423084|16512757|P1|Overall Study|Withdrawal by Subject|2
4787912|NCT01423084|16512756|P2|Overall Study|Adverse Event|1
4787913|NCT01423084|16512757|P1|Overall Study|Adverse Event|0
4787914|NCT01422915|16512787|P1|Overall Study|Adverse Event|1
4787915|NCT01422889|16512792|P1|Overall Study|No Data Entered for Study Stent|9
4787916|NCT01422876|16512807|P10|Week 52|Death|0
4787917|NCT01422876|16512808|P9|Week 52|Death|1
4787918|NCT01422876|16512809|P8|Week 52|Death|3
4787919|NCT01422876|16512810|P7|Week 52|Death|1
4787920|NCT01422876|16512811|P6|Week 52|Death|0
4787921|NCT01422876|16512812|P5|Week 52|Death|0
4787922|NCT01422876|16512813|P4|Week 52|Death|1
4787923|NCT01422876|16512814|P3|Week 52|Death|0
4787924|NCT01422876|16512815|P2|Week 52|Death|1
4787925|NCT01422876|16512816|P1|Week 52|Death|0
4787926|NCT01422876|16512807|P10|Week 52|Consent withdrawn|9
4787927|NCT01422876|16512808|P9|Week 52|Consent withdrawn|13
4787928|NCT01422876|16512809|P8|Week 52|Consent withdrawn|12
4787929|NCT01422876|16512810|P7|Week 52|Consent withdrawn|10
4787930|NCT01422876|16512811|P6|Week 52|Consent withdrawn|12
4787931|NCT01422876|16512812|P5|Week 52|Consent withdrawn|7
4787932|NCT01422876|16512813|P4|Week 52|Consent withdrawn|12
4787933|NCT01422876|16512814|P3|Week 52|Consent withdrawn|6
4787934|NCT01422876|16512815|P2|Week 52|Consent withdrawn|4
4787935|NCT01422876|16512816|P1|Week 52|Consent withdrawn|9
4787936|NCT01422876|16512807|P10|Week 52|Lost to Follow-up|8
4787937|NCT01422876|16512808|P9|Week 52|Lost to Follow-up|7
4787938|NCT01422876|16512809|P8|Week 52|Lost to Follow-up|8
4787939|NCT01422876|16512810|P7|Week 52|Lost to Follow-up|5
4787940|NCT01422876|16512811|P6|Week 52|Lost to Follow-up|5
4787941|NCT01422876|16512812|P5|Week 52|Lost to Follow-up|8
4787942|NCT01422876|16512813|P4|Week 52|Lost to Follow-up|5
4787943|NCT01422876|16512814|P3|Week 52|Lost to Follow-up|7
4787944|NCT01422876|16512815|P2|Week 52|Lost to Follow-up|5
4787945|NCT01422876|16512816|P1|Week 52|Lost to Follow-up|3
4787946|NCT01422876|16512807|P10|Week 24|Death|0
4787947|NCT01422876|16512808|P9|Week 24|Death|0
4787948|NCT01422876|16512809|P8|Week 24|Death|0
4787949|NCT01422876|16512810|P7|Week 24|Death|0
4787950|NCT01422876|16512811|P6|Week 24|Death|0
4787951|NCT01422876|16512812|P5|Week 24|Death|0
4787952|NCT01422876|16512813|P4|Week 24|Death|0
4787953|NCT01422876|16512814|P3|Week 24|Death|0
4787954|NCT01422876|16512815|P2|Week 24|Death|1
4787955|NCT01422876|16512816|P1|Week 24|Death|0
4787956|NCT01422876|16512807|P10|Week 24|Consent withdrawn|6
4787957|NCT01422876|16512808|P9|Week 24|Consent withdrawn|3
4787958|NCT01422876|16512809|P8|Week 24|Consent withdrawn|4
4787959|NCT01422876|16512810|P7|Week 24|Consent withdrawn|5
4787960|NCT01422876|16512811|P6|Week 24|Consent withdrawn|6
4787961|NCT01422876|16512812|P5|Week 24|Consent withdrawn|5
4787962|NCT01422876|16512813|P4|Week 24|Consent withdrawn|4
4787963|NCT01422876|16512814|P3|Week 24|Consent withdrawn|3
4787964|NCT01422876|16512815|P2|Week 24|Consent withdrawn|1
4787965|NCT01422876|16512816|P1|Week 24|Consent withdrawn|5
4787966|NCT01422876|16512807|P10|Week 24|Lost to Follow-up|4
4787967|NCT01422876|16512808|P9|Week 24|Lost to Follow-up|3
4787968|NCT01422876|16512809|P8|Week 24|Lost to Follow-up|3
4787969|NCT01422876|16512810|P7|Week 24|Lost to Follow-up|1
4787970|NCT01422876|16512811|P6|Week 24|Lost to Follow-up|0
4787971|NCT01422876|16512812|P5|Week 24|Lost to Follow-up|2
4787972|NCT01422876|16512813|P4|Week 24|Lost to Follow-up|4
4787973|NCT01422876|16512814|P3|Week 24|Lost to Follow-up|2
4787974|NCT01422876|16512815|P2|Week 24|Lost to Follow-up|1
4787975|NCT01422876|16512816|P1|Week 24|Lost to Follow-up|1
4787976|NCT01422850|16512863|P1|Overall Study|Physician Decision|3
4787977|NCT01422824|16512869|P1|Overall Study|Lost to Follow-up|37
4787978|NCT01422824|16512869|P1|Overall Study|Case record form not evaluated|1
4787979|NCT01422720|16512874|P1|Overall Study|Ineligibility|1
4787980|NCT01422720|16512874|P1|Overall Study|Withdrawal by Subject|4
4787981|NCT01422720|16512874|P1|Overall Study|Lack of Efficacy|1
4787982|NCT01422720|16512874|P1|Overall Study|Adverse Event|16
4787983|NCT01422538|16512885|P3|Overall Study|Missed visit|1
4787984|NCT01422538|16512886|P2|Overall Study|Missed visit|1
4787985|NCT01422538|16512887|P1|Overall Study|Missed visit|0
4787986|NCT01422538|16512885|P3|Overall Study|Lost to Follow-up|1
4787987|NCT01422538|16512886|P2|Overall Study|Lost to Follow-up|1
4787988|NCT01422538|16512887|P1|Overall Study|Lost to Follow-up|0
4787989|NCT01422408|16512931|P1|Overall Study|Withdrawal by Subject|3
4787990|NCT01422408|16512931|P1|Overall Study|Adverse Event|1
4787991|NCT01422382|16512960|P1|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1
4787992|NCT01422304|16512976|P2|Overall Study|Not Treated|11
4787993|NCT01422304|16512977|P1|Overall Study|Not Treated|3
4787994|NCT01422304|16512976|P2|Overall Study|Did Not Meet Protocol Eligibility|2
4787995|NCT01422304|16512977|P1|Overall Study|Did Not Meet Protocol Eligibility|0
4787996|NCT01422304|16512976|P2|Overall Study|Withdrawal by Subject|2
4787997|NCT01422304|16512977|P1|Overall Study|Withdrawal by Subject|4
4787998|NCT01422304|16512976|P2|Overall Study|Protocol Violation|0
4787999|NCT01422304|16512977|P1|Overall Study|Protocol Violation|1
4788000|NCT01422304|16512976|P2|Overall Study|Never Entered Follow-up|1
4788001|NCT01422304|16512977|P1|Overall Study|Never Entered Follow-up|2
4788002|NCT01422304|16512976|P2|Overall Study|Lost to Follow-up|20
4788003|NCT01422304|16512977|P1|Overall Study|Lost to Follow-up|14
4788004|NCT01422304|16512976|P2|Overall Study|Adverse Event|1
4788005|NCT01422304|16512977|P1|Overall Study|Adverse Event|0
4788006|NCT01422239|16513009|P2|Overall Study|Lost to Follow-up|3
4788007|NCT01422239|16513010|P1|Overall Study|Lost to Follow-up|4
4788008|NCT01422213|16513032|P3|Overall Study|Administrative or Other Reason(s)|2
4788009|NCT01422213|16513033|P2|Overall Study|Administrative or Other Reason(s)|4
4788010|NCT01422213|16513034|P1|Overall Study|Administrative or Other Reason(s)|5
4788011|NCT01422213|16513032|P3|Overall Study|Lost to Follow-up|5
4788012|NCT01422213|16513033|P2|Overall Study|Lost to Follow-up|3
4788013|NCT01422213|16513034|P1|Overall Study|Lost to Follow-up|3
4788014|NCT01422213|16513032|P3|Overall Study|Withdrawal of Consent|5
4788015|NCT01422213|16513033|P2|Overall Study|Withdrawal of Consent|3
4788016|NCT01422213|16513034|P1|Overall Study|Withdrawal of Consent|7
4788017|NCT01422213|16513032|P3|Overall Study|Protocol Violation|4
4788018|NCT01422213|16513033|P2|Overall Study|Protocol Violation|2
4788019|NCT01422213|16513034|P1|Overall Study|Protocol Violation|0
4788020|NCT01422213|16513032|P3|Overall Study|Non-compliance with study drug|0
4788021|NCT01422213|16513033|P2|Overall Study|Non-compliance with study drug|1
4788022|NCT01422213|16513034|P1|Overall Study|Non-compliance with study drug|0
4788023|NCT01422213|16513032|P3|Overall Study|Lack of Efficacy|2
4788024|NCT01422213|16513033|P2|Overall Study|Lack of Efficacy|2
4788025|NCT01422213|16513034|P1|Overall Study|Lack of Efficacy|10
4788026|NCT01422213|16513032|P3|Overall Study|Adverse Event|11
4788027|NCT01422213|16513033|P2|Overall Study|Adverse Event|7
4788028|NCT01422213|16513034|P1|Overall Study|Adverse Event|8
4788029|NCT01422187|16513106|P3|Overall Study|Lost to Follow-up|0
4788030|NCT01422187|16513107|P2|Overall Study|Lost to Follow-up|1
4788031|NCT01422187|16513108|P1|Overall Study|Lost to Follow-up|0
4788032|NCT01422187|16513106|P3|Overall Study|Personal reason|0
4788033|NCT01422187|16513107|P2|Overall Study|Personal reason|0
4788034|NCT01422187|16513108|P1|Overall Study|Personal reason|1
4788035|NCT01421719|16513172|P1|Overall Study|Withdrawal by Subject|4
4788036|NCT01421667|16513181|P4|Overall Study|Lost to Follow-up|0
4788037|NCT01421667|16513182|P3|Overall Study|Lost to Follow-up|0
4788038|NCT01421667|16513183|P2|Overall Study|Lost to Follow-up|1
4788039|NCT01421667|16513184|P1|Overall Study|Lost to Follow-up|0
4788040|NCT01421667|16513181|P4|Overall Study|Withdrawal by Subject|1
4788041|NCT01421667|16513182|P3|Overall Study|Withdrawal by Subject|2
4788042|NCT01421667|16513183|P2|Overall Study|Withdrawal by Subject|1
4788043|NCT01421667|16513184|P1|Overall Study|Withdrawal by Subject|0
4788044|NCT01421641|16513245|P2|Overall Study|Protocol Violation|2
4788045|NCT01421641|16513246|P1|Overall Study|Protocol Violation|2
4788046|NCT01421511|16513268|P2|Overall Study|Death|1
4788047|NCT01421511|16513269|P1|Overall Study|Death|1
4788048|NCT01421511|16513268|P2|Overall Study|Withdrawal by Subject|5
4788049|NCT01421511|16513269|P1|Overall Study|Withdrawal by Subject|6
4788050|NCT01421511|16513268|P2|Overall Study|Physician Decision|1
4788051|NCT01421511|16513269|P1|Overall Study|Physician Decision|0
4788052|NCT01421511|16513268|P2|Overall Study|Randomized but didn't receive study drug|7
4788053|NCT01421511|16513269|P1|Overall Study|Randomized but didn't receive study drug|1
4788054|NCT01421511|16513268|P2|Overall Study|Lost to Follow-up|14
4788055|NCT01421511|16513269|P1|Overall Study|Lost to Follow-up|11
4788056|NCT01421459|16513319|P2|Overall Study|Withdrawal by Subject|16
4788057|NCT01421459|16513320|P1|Overall Study|Withdrawal by Subject|12
4788058|NCT01421459|16513319|P2|Overall Study|Protocol Violation|5
4788059|NCT01421459|16513320|P1|Overall Study|Protocol Violation|8
4788060|NCT01421459|16513319|P2|Overall Study|Physician Decision|9
4788061|NCT01421459|16513320|P1|Overall Study|Physician Decision|9
4788062|NCT01421459|16513319|P2|Overall Study|Lost to Follow-up|9
4788063|NCT01421459|16513320|P1|Overall Study|Lost to Follow-up|8
4788064|NCT01421459|16513319|P2|Overall Study|Lack of Efficacy|2
4788065|NCT01421459|16513320|P1|Overall Study|Lack of Efficacy|1
4788066|NCT01421459|16513319|P2|Overall Study|Death|1
4788067|NCT01421459|16513320|P1|Overall Study|Death|1
4788068|NCT01421459|16513319|P2|Overall Study|Adverse Event|10
4788069|NCT01421459|16513320|P1|Overall Study|Adverse Event|6
4788070|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7
4788071|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0
4788072|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6
4788073|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
4788074|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
4788075|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2
4788076|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Participant moved away|3
4788077|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Participant moved away|1
4788078|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Participant moved away|4
4788079|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|End of Study Time|14
4788080|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|End of Study Time|20
4788081|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|End of Study Time|15
4788082|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Non-adherence|4
4788083|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Non-adherence|8
4788084|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Non-adherence|3
4788085|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9
4788086|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11
4788087|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4
4788088|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4
4788089|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6
4788090|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7
4788091|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Adverse Event|11
4788092|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Adverse Event|6
4788093|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Adverse Event|0
4788094|NCT01421342|16513361|P3|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
4788095|NCT01421342|16513362|P2|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5
4788096|NCT01421342|16513363|P1|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11
4788097|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|End of Study Time|2
4788098|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|End of Study Time|0
4788099|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|End of Study Time|0
4788100|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4
4788101|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
4788102|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3
4788103|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
4788104|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5
4788105|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1
4788106|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2
4788107|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0
4788108|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1
4788109|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Non-adherence|5
4788110|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Non-adherence|4
4788111|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Non-adherence|5
4788112|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
4788113|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3
4788114|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4
4788115|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11
4788116|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4
4788117|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13
4788118|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Adverse Event|6
4788119|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Adverse Event|3
4788120|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Adverse Event|4
4788121|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12
4788122|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10
4788123|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7
4788124|NCT01421342|16513361|P3|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88
4788125|NCT01421342|16513362|P2|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93
4788126|NCT01421342|16513363|P1|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111
4788127|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4
4788128|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9
4788129|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8
4788130|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Participant moved away|1
4788131|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Participant moved away|6
4788132|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Participant moved away|1
4788133|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Dure to other illness|4
4788134|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Dure to other illness|2
4788135|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Dure to other illness|3
4788136|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Non-adherence|13
4788137|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Non-adherence|7
4788138|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Non-adherence|15
4788139|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21
4788140|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18
4788141|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6
4788142|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Death|3
4788143|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Death|0
4788144|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Death|0
4788145|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13
4788146|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20
4788147|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23
4788148|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Adverse Event|27
4788149|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Adverse Event|38
4788150|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Adverse Event|53
4788151|NCT01421342|16513361|P3|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13
4788152|NCT01421342|16513362|P2|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28
4788153|NCT01421342|16513363|P1|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49
4788154|NCT01421303|16513380|P1|Overall Study|Withdrawal by Subject|1
4788155|NCT01421303|16513380|P1|Overall Study|Other|7
4788156|NCT01421303|16513380|P1|Overall Study|Non compliance with study procedure|1
4788157|NCT01421303|16513380|P1|Overall Study|Lost to Follow-up|13
4788158|NCT01421277|16513407|P2|Overall Study|Incomplete baseline data|31
4788159|NCT01421277|16513408|P1|Overall Study|Incomplete baseline data|0
4788160|NCT01421277|16513407|P2|Overall Study|Lack of qualifying event|61
4788161|NCT01421277|16513408|P1|Overall Study|Lack of qualifying event|0
4788162|NCT01421225|16513420|P2|Overall Study|Withdrawal by Subject|1
4788163|NCT01421225|16513421|P1|Overall Study|Withdrawal by Subject|0
4788164|NCT01421147|16513435|P2|Extension Period|Withdrawal by Subject|3
4788165|NCT01421147|16513436|P1|Extension Period|Withdrawal by Subject|5
4788166|NCT01421147|16513435|P2|Extension Period|Physician Decision|0
4788167|NCT01421147|16513436|P1|Extension Period|Physician Decision|1
4788168|NCT01421147|16513435|P2|Extension Period|Lost to Follow-up|5
4788169|NCT01421147|16513436|P1|Extension Period|Lost to Follow-up|2
4788170|NCT01421147|16513435|P2|Extension Period|Death|1
4788171|NCT01421147|16513436|P1|Extension Period|Death|0
4788172|NCT01421147|16513435|P2|Extension Period|Adverse Event|2
4788173|NCT01421147|16513436|P1|Extension Period|Adverse Event|0
4788174|NCT01421147|16513435|P2|Treatment Period|Withdrawal by Subject|5
4788175|NCT01421147|16513436|P1|Treatment Period|Withdrawal by Subject|10
4788176|NCT01421147|16513435|P2|Treatment Period|Physician Decision|2
4788177|NCT01421147|16513436|P1|Treatment Period|Physician Decision|2
4788178|NCT01421147|16513435|P2|Treatment Period|Lost to Follow-up|1
4788179|NCT01421147|16513436|P1|Treatment Period|Lost to Follow-up|2
4788180|NCT01421147|16513435|P2|Treatment Period|Adverse Event|3
4788181|NCT01421147|16513436|P1|Treatment Period|Adverse Event|2
4788182|NCT01421134|16513468|P2|Overall Study|Lost to Follow-up|1
4788183|NCT01421134|16513469|P1|Overall Study|Lost to Follow-up|1
4788184|NCT01421134|16513468|P2|Overall Study|Administrative|1
4788185|NCT01421134|16513469|P1|Overall Study|Administrative|0
4788186|NCT01421134|16513468|P2|Overall Study|Withdrawal by Subject|1
4788187|NCT01421134|16513469|P1|Overall Study|Withdrawal by Subject|1
4788188|NCT01421134|16513468|P2|Overall Study|Protocol Violation|3
4788189|NCT01421134|16513469|P1|Overall Study|Protocol Violation|0
4788190|NCT01421134|16513468|P2|Overall Study|Lack of Efficacy|4
4788191|NCT01421134|16513469|P1|Overall Study|Lack of Efficacy|2
4788192|NCT01421134|16513468|P2|Overall Study|Adverse Event|5
4788193|NCT01421134|16513469|P1|Overall Study|Adverse Event|3
4788194|NCT01420965|16513490|P3|Overall Study|Adverse Event|0
4788195|NCT01420965|16513491|P2|Overall Study|Adverse Event|1
4788196|NCT01420965|16513492|P1|Overall Study|Adverse Event|0
4788197|NCT01420965|16513490|P3|Overall Study|Withdrawal by Subject|0
4788198|NCT01420965|16513491|P2|Overall Study|Withdrawal by Subject|0
4788199|NCT01420965|16513492|P1|Overall Study|Withdrawal by Subject|1
4788200|NCT01420926|16513505|P2|Overall Study|Continues on active treatment|3
4788201|NCT01420926|16513506|P1|Overall Study|Continues on active treatment|1
4788202|NCT01420926|16513505|P2|Overall Study|Physician Decision|5
4788203|NCT01420926|16513506|P1|Overall Study|Physician Decision|7
4788204|NCT01420926|16513505|P2|Overall Study|Non-protocol treatment|20
4788205|NCT01420926|16513506|P1|Overall Study|Non-protocol treatment|17
4788206|NCT01420926|16513505|P2|Overall Study|Withdrawal by Subject|16
4788207|NCT01420926|16513506|P1|Overall Study|Withdrawal by Subject|11
4788208|NCT01420926|16513505|P2|Overall Study|Death|17
4788209|NCT01420926|16513506|P1|Overall Study|Death|18
4788210|NCT01420926|16513505|P2|Overall Study|Adverse Event|4
4788211|NCT01420926|16513506|P1|Overall Study|Adverse Event|6
4788212|NCT01420627|16513553|P1|EZN-2279 Treatment Period|Adverse Event|1
4788213|NCT01420549|16513569|P2|Overall Study|Non-adherence to medication|1
4788214|NCT01420549|16513570|P1|Overall Study|Non-adherence to medication|4
4788215|NCT01420549|16513569|P2|Overall Study|Protocol Violation|1
4788216|NCT01420549|16513570|P1|Overall Study|Protocol Violation|0
4788217|NCT01420549|16513569|P2|Overall Study|Lost to Follow-up|2
4788218|NCT01420549|16513570|P1|Overall Study|Lost to Follow-up|2
4788219|NCT01420549|16513569|P2|Overall Study|Adverse Event|1
4788220|NCT01420549|16513570|P1|Overall Study|Adverse Event|1
4788221|NCT01420081|16513604|P9|Overall Study|Other Reasons|0
4788222|NCT01420081|16513605|P8|Overall Study|Other Reasons|0
4788223|NCT01420081|16513606|P7|Overall Study|Other Reasons|0
4788224|NCT01420081|16513607|P6|Overall Study|Other Reasons|0
4788225|NCT01420081|16513608|P5|Overall Study|Other Reasons|0
4788226|NCT01420081|16513609|P4|Overall Study|Other Reasons|0
4788227|NCT01420081|16513610|P3|Overall Study|Other Reasons|1
4788228|NCT01420081|16513611|P2|Overall Study|Other Reasons|0
4788229|NCT01420081|16513612|P1|Overall Study|Other Reasons|0
4788230|NCT01420081|16513604|P9|Overall Study|Subject Refused Futher Follow-up|0
4788231|NCT01420081|16513605|P8|Overall Study|Subject Refused Futher Follow-up|0
4788232|NCT01420081|16513606|P7|Overall Study|Subject Refused Futher Follow-up|0
4788233|NCT01420081|16513607|P6|Overall Study|Subject Refused Futher Follow-up|0
4788234|NCT01420081|16513608|P5|Overall Study|Subject Refused Futher Follow-up|1
4788235|NCT01420081|16513609|P4|Overall Study|Subject Refused Futher Follow-up|0
4788236|NCT01420081|16513610|P3|Overall Study|Subject Refused Futher Follow-up|1
4788237|NCT01420081|16513611|P2|Overall Study|Subject Refused Futher Follow-up|0
4788238|NCT01420081|16513612|P1|Overall Study|Subject Refused Futher Follow-up|0
4788239|NCT01420081|16513604|P9|Overall Study|Study Terminated by Sponsor|2
4788240|NCT01420081|16513605|P8|Overall Study|Study Terminated by Sponsor|2
4788241|NCT01420081|16513606|P7|Overall Study|Study Terminated by Sponsor|3
4788242|NCT01420081|16513607|P6|Overall Study|Study Terminated by Sponsor|7
4788243|NCT01420081|16513608|P5|Overall Study|Study Terminated by Sponsor|11
4788244|NCT01420081|16513609|P4|Overall Study|Study Terminated by Sponsor|3
4788245|NCT01420081|16513610|P3|Overall Study|Study Terminated by Sponsor|1
4788246|NCT01420081|16513611|P2|Overall Study|Study Terminated by Sponsor|1
4788247|NCT01420081|16513612|P1|Overall Study|Study Terminated by Sponsor|2
4788248|NCT01420081|16513604|P9|Overall Study|Lost to Follow-up|0
4788249|NCT01420081|16513605|P8|Overall Study|Lost to Follow-up|0
4788250|NCT01420081|16513606|P7|Overall Study|Lost to Follow-up|0
4788251|NCT01420081|16513607|P6|Overall Study|Lost to Follow-up|1
4788252|NCT01420081|16513608|P5|Overall Study|Lost to Follow-up|1
4788253|NCT01420081|16513609|P4|Overall Study|Lost to Follow-up|0
4788254|NCT01420081|16513610|P3|Overall Study|Lost to Follow-up|0
4788255|NCT01420081|16513611|P2|Overall Study|Lost to Follow-up|0
4788256|NCT01420081|16513612|P1|Overall Study|Lost to Follow-up|0
4788257|NCT01420081|16513604|P9|Overall Study|Death|1
4788258|NCT01420081|16513605|P8|Overall Study|Death|1
4788259|NCT01420081|16513606|P7|Overall Study|Death|0
4788260|NCT01420081|16513607|P6|Overall Study|Death|12
4788261|NCT01420081|16513608|P5|Overall Study|Death|7
4788262|NCT01420081|16513609|P4|Overall Study|Death|0
4788263|NCT01420081|16513610|P3|Overall Study|Death|8
4788264|NCT01420081|16513611|P2|Overall Study|Death|0
4788265|NCT01420081|16513612|P1|Overall Study|Death|1
4788266|NCT01420068|16513693|P2|Overall Study|Withdrawal by Subject|2
4788267|NCT01420068|16513694|P1|Overall Study|Withdrawal by Subject|1
4788268|NCT01420068|16513693|P2|Overall Study|Administrative problems|3
4788269|NCT01420068|16513694|P1|Overall Study|Administrative problems|1
4788270|NCT01419769|16513765|P1|Overall Study|Not evaluable due to pigtail stents|1
4788271|NCT01419769|16513765|P1|Overall Study|Did not receive the AXIOS stent|3
4788272|NCT01419717|16513778|P1|Overall Study|Noncompliance|1
4788273|NCT01419717|16513778|P1|Overall Study|Administrative Decision|1
4788274|NCT01419717|16513778|P1|Overall Study|Lost to Follow-up|2
4788275|NCT01419717|16513778|P1|Overall Study|Other|4
4788276|NCT01419717|16513778|P1|Overall Study|Disease Progression|9
4788277|NCT01419717|16513778|P1|Overall Study|Withdrawal by Subject|10
4788278|NCT01419717|16513778|P1|Overall Study|Death|17
4788279|NCT01419717|16513778|P1|Overall Study|Adverse Event|19
4788280|NCT01419717|16513778|P1|Overall Study|Protocol-specified Criteria|62
4788281|NCT01419626|16513792|P3|Overall Study|Lost to Follow-up|1
4788282|NCT01419626|16513793|P2|Overall Study|Lost to Follow-up|1
4788283|NCT01419626|16513794|P1|Overall Study|Lost to Follow-up|0
4788284|NCT01419626|16513792|P3|Overall Study|Withdrawal by Subject|0
4788285|NCT01419626|16513793|P2|Overall Study|Withdrawal by Subject|0
4788286|NCT01419626|16513794|P1|Overall Study|Withdrawal by Subject|1
4788287|NCT01419626|16513792|P3|Overall Study|Protocol Violation|2
4788288|NCT01419626|16513793|P2|Overall Study|Protocol Violation|2
4788289|NCT01419626|16513794|P1|Overall Study|Protocol Violation|3
4788290|NCT01419314|16513825|P2|Follow-up at Week 6 of the Trial|Lost to Follow-up|2
4788291|NCT01419314|16513826|P1|Follow-up at Week 6 of the Trial|Lost to Follow-up|1
4788292|NCT01419314|16513825|P2|Follow-up at Week 3 of the Trial|Lost to Follow-up|0
4788293|NCT01419314|16513826|P1|Follow-up at Week 3 of the Trial|Lost to Follow-up|3
4788294|NCT01419314|16513825|P2|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1
4788295|NCT01419314|16513826|P1|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3
4788296|NCT01419236|16513867|P2|Overall Study|Entry Criteria Not Met|0
4788297|NCT01419236|16513868|P1|Overall Study|Entry Criteria Not Met|1
4788298|NCT01419236|16513867|P2|Overall Study|Withdrawal by Subject|4
4788299|NCT01419236|16513868|P1|Overall Study|Withdrawal by Subject|1
4788300|NCT01419236|16513867|P2|Overall Study|Physician Decision|0
4788301|NCT01419236|16513868|P1|Overall Study|Physician Decision|1
4788302|NCT01419236|16513867|P2|Overall Study|Lost to Follow-up|0
4788303|NCT01419236|16513868|P1|Overall Study|Lost to Follow-up|1
4788304|NCT01419236|16513867|P2|Overall Study|Lack of Efficacy|1
4788305|NCT01419236|16513868|P1|Overall Study|Lack of Efficacy|0
4788306|NCT01419236|16513867|P2|Overall Study|Adverse Event|0
4788307|NCT01419236|16513868|P1|Overall Study|Adverse Event|1
4788308|NCT01419197|16513892|P2|Overall Study|Lost to Follow-up|4
4788309|NCT01419197|16513893|P1|Overall Study|Lost to Follow-up|14
4788310|NCT01419197|16513892|P2|Overall Study|Reason Not Specified|1
4788311|NCT01419197|16513893|P1|Overall Study|Reason Not Specified|0
4788312|NCT01419197|16513892|P2|Overall Study|Study Completed by Sponsor|34
4788313|NCT01419197|16513893|P1|Overall Study|Study Completed by Sponsor|103
4788314|NCT01419197|16513892|P2|Overall Study|Withdrawal by Subject|32
4788315|NCT01419197|16513893|P1|Overall Study|Withdrawal by Subject|33
4788316|NCT01419197|16513892|P2|Overall Study|Non-compliance|1
4788317|NCT01419197|16513893|P1|Overall Study|Non-compliance|3
4788318|NCT01419197|16513892|P2|Overall Study|Physician Decision|4
4788319|NCT01419197|16513893|P1|Overall Study|Physician Decision|4
4788320|NCT01419197|16513892|P2|Overall Study|Death|122
4788321|NCT01419197|16513893|P1|Overall Study|Death|247
4788322|NCT01419184|16513918|P2|Overall Study|Participant randomized, not treated|0
4788323|NCT01419184|16513919|P1|Overall Study|Participant randomized, not treated|1
4788324|NCT01419184|16513918|P2|Overall Study|No IRLOS-No adverse event treatment date|1
4788325|NCT01419184|16513919|P1|Overall Study|No IRLOS-No adverse event treatment date|0
4788326|NCT01419184|16513918|P2|Overall Study|No IRLOS-non trial antibiotic used|2
4788327|NCT01419184|16513919|P1|Overall Study|No IRLOS-non trial antibiotic used|1
4788328|NCT01419184|16513918|P2|Overall Study|No IRLOS-randomized, not treated|4
4788329|NCT01419184|16513919|P1|Overall Study|No IRLOS-randomized, not treated|2
4788330|NCT01419184|16513918|P2|Overall Study|No IRLOS-No in-patient end date reported|6
4788331|NCT01419184|16513919|P1|Overall Study|No IRLOS-No in-patient end date reported|3
4788332|NCT01419184|16513918|P2|Overall Study|Site data not available|2
4788333|NCT01419184|16513919|P1|Overall Study|Site data not available|3
4788334|NCT01419080|16513952|P1|Overall Study|Too Ill|3
4788335|NCT01419080|16513952|P1|Overall Study|Lost to Follow-up|23
4788336|NCT01419080|16513952|P1|Overall Study|Death|30
4788337|NCT01419080|16513952|P1|Overall Study|Withdrawal by Subject|75
4788338|NCT01419015|16513963|P1|Overall Study|Death|2
4788339|NCT01418937|16513967|P1|Overall Study|Withdrawal by Subject|1
4788340|NCT01418937|16513967|P1|Overall Study|Pregnancy|1
4788341|NCT01418937|16513967|P1|Overall Study|Protocol Violation|1
4788342|NCT01418937|16513967|P1|Overall Study|Lost to Follow-up|5
4788343|NCT01418378|16513998|P2|Overall Study|developed chronic myopathy|1
4788344|NCT01418378|16513999|P1|Overall Study|developed chronic myopathy|0
4788345|NCT01418378|16513998|P2|Overall Study|ligament imbalance|1
4788346|NCT01418378|16513999|P1|Overall Study|ligament imbalance|0
4788347|NCT01418378|16513998|P2|Overall Study|Physician Decision|1
4788348|NCT01418378|16513999|P1|Overall Study|Physician Decision|0
4788349|NCT01418378|16513998|P2|Overall Study|Death|2
4788350|NCT01418378|16513999|P1|Overall Study|Death|1
4788351|NCT01418365|16514073|P2|Second Intervention|Withdrawal by Subject|1
4788352|NCT01418365|16514074|P1|Second Intervention|Withdrawal by Subject|0
4788353|NCT01418365|16514073|P2|First Intervention|Non-compliance|0
4788354|NCT01418365|16514074|P1|First Intervention|Non-compliance|1
4788355|NCT01418365|16514073|P2|First Intervention|Withdrawal by Subject|1
4788356|NCT01418365|16514074|P1|First Intervention|Withdrawal by Subject|0
4788357|NCT01418209|16514085|P3|Overall Study|Did not provide hot flash diary data|3
4788358|NCT01418209|16514086|P2|Overall Study|Did not provide hot flash diary data|3
4788359|NCT01418209|16514087|P1|Overall Study|Did not provide hot flash diary data|1
4788360|NCT01418209|16514085|P3|Overall Study|Withdrawal by Subject|1
4788361|NCT01418209|16514086|P2|Overall Study|Withdrawal by Subject|0
4788362|NCT01418209|16514087|P1|Overall Study|Withdrawal by Subject|1
4788363|NCT01417481|16514151|P2|First Intervention (8 Weeks)|Withdrawal by Subject|2
4788364|NCT01417481|16514152|P1|First Intervention (8 Weeks)|Withdrawal by Subject|0
4788365|NCT01417377|16514217|P1|Overall Study|Enrolled, but not treated|1
4788366|NCT01417377|16514217|P1|Overall Study|Lost to Follow-up|12
4788367|NCT01417195|16514226|P2|Overall Study|No transfer due to elevated progesterone|0
4788368|NCT01417195|16514227|P1|Overall Study|No transfer due to elevated progesterone|1
4788369|NCT01417195|16514226|P2|Overall Study|No transfer due to risk of OHSS|0
4788370|NCT01417195|16514227|P1|Overall Study|No transfer due to risk of OHSS|1
4788371|NCT01417195|16514226|P2|Overall Study|No embryos for transfer|1
4788372|NCT01417195|16514227|P1|Overall Study|No embryos for transfer|0
4788373|NCT01417195|16514226|P2|Overall Study|Stimulation failure|0
4788374|NCT01417195|16514227|P1|Overall Study|Stimulation failure|1
4788375|NCT01417156|16514243|P1|Overall Study|Protocol Violation|2
4788376|NCT01417156|16514243|P1|Overall Study|Adverse Event|12
4788377|NCT01417104|16514253|P2|Overall Study|Adverse Event|0
4788378|NCT01417104|16514254|P1|Overall Study|Adverse Event|1
4788379|NCT01417104|16514253|P2|Overall Study|Failure to make contact|1
4788380|NCT01417104|16514254|P1|Overall Study|Failure to make contact|0
4788381|NCT01417104|16514253|P2|Overall Study|Withdrawal by Subject|1
4788382|NCT01417104|16514254|P1|Overall Study|Withdrawal by Subject|5
4788383|NCT01417078|16514264|P1|Overall Study|Withdrawal by Subject|1
4788384|NCT01417000|16514289|P2|Overall Study|Study Terminated by Sponsor|1
4788385|NCT01417000|16514290|P1|Overall Study|Study Terminated by Sponsor|1
4788386|NCT01417000|16514289|P2|Overall Study|Lost to Follow-up|0
4788387|NCT01417000|16514290|P1|Overall Study|Lost to Follow-up|1
4788388|NCT01417000|16514289|P2|Overall Study|Death|28
4788389|NCT01417000|16514290|P1|Overall Study|Death|59
4788390|NCT01416805|16514307|P2|Overall Study|Lost to Follow-up|4
4788391|NCT01416805|16514308|P1|Overall Study|Lost to Follow-up|4
4788392|NCT01416610|16514347|P1|Overall Study|Sufficient treatment duration (PCR neg.)|7
4788393|NCT01416610|16514347|P1|Overall Study|Lost to Follow-up|7
4788394|NCT01416610|16514347|P1|Overall Study|Withdrawal by Subject|13
4788395|NCT01416610|16514347|P1|Overall Study|No reason given|5
4788396|NCT01416610|16514347|P1|Overall Study|Lack of Efficacy|4
4788397|NCT01416610|16514347|P1|Overall Study|Adverse Event -Patient decision|3
4788398|NCT01416610|16514347|P1|Overall Study|Adverse Event|4
4788399|NCT01416571|16514401|P1|Overall Study|Lost to Follow-up|2
4788400|NCT01416389|16514430|P2|Overall Study|Started New Therapy|0
4788401|NCT01416389|16514431|P1|Overall Study|Started New Therapy|2
4788402|NCT01416389|16514430|P2|Overall Study|Lost to Follow-up|0
4788403|NCT01416389|16514431|P1|Overall Study|Lost to Follow-up|1
4788404|NCT01416272|16514448|P1|Overall Study|Study related complaints|1
4788405|NCT01416272|16514448|P1|Overall Study|Lost to Follow-up|1
4788406|NCT01416272|16514448|P1|Overall Study|Unacceptable distance visual acuity|2
4788407|NCT01416181|16514505|P2|Part 2|Lost to Follow-up|2
4788408|NCT01416181|16514506|P1|Part 2|Lost to Follow-up|2
4788409|NCT01416181|16514505|P2|Part 2|Lack of Efficacy|1
4788410|NCT01416181|16514506|P1|Part 2|Lack of Efficacy|4
4788411|NCT01416181|16514505|P2|Part 2|Withdrawal by Subject|5
4788412|NCT01416181|16514506|P1|Part 2|Withdrawal by Subject|14
4788413|NCT01416181|16514505|P2|Part 2|Investigator Decision|7
4788414|NCT01416181|16514506|P1|Part 2|Investigator Decision|6
4788415|NCT01416181|16514505|P2|Part 2|Other|267
4788416|NCT01416181|16514506|P1|Part 2|Other|234
4788417|NCT01416181|16514505|P2|Part 2|Adverse Event|4
4788418|NCT01416181|16514506|P1|Part 2|Adverse Event|11
4788419|NCT01416181|16514505|P2|Part 1|Ongoing in Follow-Up|8
4788420|NCT01416181|16514506|P1|Part 1|Ongoing in Follow-Up|14
4788421|NCT01416181|16514505|P2|Part 1|Adverse Event|18
4788422|NCT01416181|16514506|P1|Part 1|Adverse Event|15
4788423|NCT01416181|16514505|P2|Part 1|Lost to Follow-up|1
4788424|NCT01416181|16514506|P1|Part 1|Lost to Follow-up|1
4788425|NCT01416181|16514505|P2|Part 1|Lack of Efficacy|8
4788426|NCT01416181|16514506|P1|Part 1|Lack of Efficacy|16
4788427|NCT01416181|16514505|P2|Part 1|Withdrawal by Subject|48
4788428|NCT01416181|16514506|P1|Part 1|Withdrawal by Subject|74
4788429|NCT01416181|16514505|P2|Part 1|Investigator Decision|6
4788430|NCT01416181|16514506|P1|Part 1|Investigator Decision|7
4788431|NCT01416181|16514505|P2|Part 1|Death|1
4788432|NCT01416181|16514506|P1|Part 1|Death|0
4788433|NCT01416181|16514505|P2|Part 1|Other|24
4788434|NCT01416181|16514506|P1|Part 1|Other|10
4788435|NCT01416155|16514568|P1|Overall Study|Other|7
4788436|NCT01416155|16514568|P1|Overall Study|Investigator decision|8
4788437|NCT01416155|16514568|P1|Overall Study|Withdrawal by Subject|33
4788438|NCT01416155|16514568|P1|Overall Study|Positive for anti-BG00002 antibodies|2
4788439|NCT01416155|16514568|P1|Overall Study|Adverse Event|8
4788440|NCT01416142|16514575|P3|PureVision2 HD|Inability to maintain lens wear|1
4788441|NCT01416142|16514576|P2|PureVision2 HD|Inability to maintain lens wear|0
4788442|NCT01416142|16514577|P1|PureVision2 HD|Inability to maintain lens wear|0
4788443|NCT01415986|16514604|P1|Overall Study|Lost to Follow-up|1
4788444|NCT01415921|16514630|P2|Overall Study|Other|0
4788445|NCT01415921|16514631|P1|Overall Study|Other|2
4788446|NCT01415921|16514630|P2|Overall Study|Withdrawal by Subject|1
4788447|NCT01415921|16514631|P1|Overall Study|Withdrawal by Subject|0
4788448|NCT01415921|16514630|P2|Overall Study|Physician Decision|1
4788449|NCT01415921|16514631|P1|Overall Study|Physician Decision|1
4788450|NCT01415921|16514630|P2|Overall Study|Adverse Event|1
4788451|NCT01415921|16514631|P1|Overall Study|Adverse Event|0
4788452|NCT01415908|16514641|P2|Overall Study|Withdrawal by Subject|0
4788453|NCT01415908|16514642|P1|Overall Study|Withdrawal by Subject|1
4788454|NCT01415531|16514679|P2|Overall Study|Other Reasons|2
4788455|NCT01415531|16514680|P1|Overall Study|Other Reasons|3
4788456|NCT01415531|16514679|P2|Overall Study|Lack of Compliance|4
4788457|NCT01415531|16514680|P1|Overall Study|Lack of Compliance|1
4788458|NCT01415531|16514679|P2|Overall Study|Lost to Follow-up|14
4788459|NCT01415531|16514680|P1|Overall Study|Lost to Follow-up|6
4788460|NCT01415531|16514679|P2|Overall Study|Withdrawal by Subject|4
4788461|NCT01415531|16514680|P1|Overall Study|Withdrawal by Subject|5
4788462|NCT01415531|16514679|P2|Overall Study|Protocol Violation|1
4788463|NCT01415531|16514680|P1|Overall Study|Protocol Violation|0
4788464|NCT01415531|16514679|P2|Overall Study|Lack of Efficacy|2
4788465|NCT01415531|16514680|P1|Overall Study|Lack of Efficacy|3
4788466|NCT01415531|16514679|P2|Overall Study|Adverse Event|10
4788467|NCT01415531|16514680|P1|Overall Study|Adverse Event|7
4788468|NCT01415518|16514690|P2|Overall Study|Condition under Investigation Worsened|1
4788469|NCT01415518|16514691|P1|Overall Study|Condition under Investigation Worsened|1
4788470|NCT01415518|16514690|P2|Overall Study|Death|1
4788471|NCT01415518|16514691|P1|Overall Study|Death|1
4788472|NCT01415518|16514690|P2|Overall Study|Adverse Event|4
4788473|NCT01415518|16514691|P1|Overall Study|Adverse Event|3
4788474|NCT01415518|16514690|P2|Overall Study|Lost to Follow-up|5
4788475|NCT01415518|16514691|P1|Overall Study|Lost to Follow-up|3
4788476|NCT01415518|16514690|P2|Overall Study|Protocol Violation|8
4788477|NCT01415518|16514691|P1|Overall Study|Protocol Violation|6
4788478|NCT01415518|16514690|P2|Overall Study|Withdrawal by Subject|12
4788479|NCT01415518|16514691|P1|Overall Study|Withdrawal by Subject|2
4788480|NCT01415440|16514750|P3|Overall Study|Withdrawal by Subject|0
4788481|NCT01415440|16514751|P2|Overall Study|Withdrawal by Subject|0
4788482|NCT01415440|16514752|P1|Overall Study|Withdrawal by Subject|1
4788483|NCT01415440|16514750|P3|Overall Study|Physician Decision|0
4788484|NCT01415440|16514751|P2|Overall Study|Physician Decision|0
4788485|NCT01415440|16514752|P1|Overall Study|Physician Decision|3
4788486|NCT01415440|16514750|P3|Overall Study|Lost to Follow-up|2
4788487|NCT01415440|16514751|P2|Overall Study|Lost to Follow-up|1
4788488|NCT01415440|16514752|P1|Overall Study|Lost to Follow-up|0
4788489|NCT01415401|16514803|P1|Overall Study|Terminated by Sponsor|1
4788490|NCT01415401|16514803|P1|Overall Study|DId not meet inclusion/exclusion criteri|1
4788491|NCT01415401|16514803|P1|Overall Study|Adverse Event|5
4788492|NCT01415349|16514808|P2|Treatment Period 1|Withdrawal by Subject|1
4788493|NCT01415349|16514809|P1|Treatment Period 1|Withdrawal by Subject|0
4788494|NCT01415349|16514808|P2|Treatment Period 1|Adverse Event|1
4788495|NCT01415349|16514809|P1|Treatment Period 1|Adverse Event|0
4788496|NCT01414855|16514821|P1|Overall Study|Withdrawal by Subject|7
4788497|NCT01414855|16514821|P1|Overall Study|Lost to Follow-up|5
4788498|NCT01414855|16514821|P1|Overall Study|Death|17
4788499|NCT01414257|16514870|P1|Overall Study|Protocol Violation|10
4788500|NCT01414257|16514870|P1|Overall Study|No Visit After First Day of Treatment|12
4788501|NCT01414205|16514898|P2|Overall Study|Randomized but not Treated|1
4788502|NCT01414205|16514899|P1|Overall Study|Randomized but not Treated|1
4788503|NCT01414205|16514898|P2|Overall Study|Physician Decision|1
4788504|NCT01414205|16514899|P1|Overall Study|Physician Decision|0
4788505|NCT01414205|16514898|P2|Overall Study|Lost to Follow-up|4
4788506|NCT01414205|16514899|P1|Overall Study|Lost to Follow-up|1
4788507|NCT01414205|16514898|P2|Overall Study|Death|1
4788508|NCT01414205|16514899|P1|Overall Study|Death|5
4788509|NCT01414166|16514968|P2|Overall Study|Withdrawal by Subject|5
4788510|NCT01414166|16514969|P1|Overall Study|Withdrawal by Subject|3
4788511|NCT01414166|16514968|P2|Overall Study|Study terminated by Sponsor|75
4788512|NCT01414166|16514969|P1|Overall Study|Study terminated by Sponsor|68
4788513|NCT01414166|16514968|P2|Overall Study|Protocol Violation|0
4788514|NCT01414166|16514969|P1|Overall Study|Protocol Violation|2
4788515|NCT01414166|16514968|P2|Overall Study|Physician Decision|0
4788516|NCT01414166|16514969|P1|Overall Study|Physician Decision|2
4788517|NCT01414166|16514968|P2|Overall Study|Non-compliance with study drug|0
4788518|NCT01414166|16514969|P1|Overall Study|Non-compliance with study drug|2
4788519|NCT01414166|16514968|P2|Overall Study|Lost to Follow-up|1
4788520|NCT01414166|16514969|P1|Overall Study|Lost to Follow-up|4
4788521|NCT01414166|16514968|P2|Overall Study|Adverse Event|2
4788522|NCT01414166|16514969|P1|Overall Study|Adverse Event|10
4788523|NCT01414114|16515032|P1|Overall Study|Other|2
4788524|NCT01414114|16515032|P1|Overall Study|Withdrawal by Subject|1
4788525|NCT01414114|16515032|P1|Overall Study|Adverse Event|2
4788526|NCT01413958|16515088|P2|Overall Study|Lost to Follow-up|1
4788527|NCT01413958|16515089|P1|Overall Study|Lost to Follow-up|0
4788528|NCT01413542|16515140|P4|Overall Study|Adverse Event|1
4788529|NCT01413542|16515141|P3|Overall Study|Adverse Event|0
4788530|NCT01413542|16515142|P2|Overall Study|Adverse Event|0
4788531|NCT01413542|16515143|P1|Overall Study|Adverse Event|0
4788532|NCT01413542|16515140|P4|Overall Study|Physician Decision|0
4788533|NCT01413542|16515141|P3|Overall Study|Physician Decision|3
4788534|NCT01413542|16515142|P2|Overall Study|Physician Decision|0
4788535|NCT01413542|16515143|P1|Overall Study|Physician Decision|1
4788536|NCT01413503|16515165|P1|Overall Study|Lost to Follow-up|1
4788537|NCT01413360|16515169|P1|Overall Study|Adverse Event|1
4788538|NCT01413360|16515169|P1|Overall Study|Lost to Follow-up|2
4788539|NCT01413204|16515177|P3|Overall Study|Fasting plasma glucose level increased|10
4788540|NCT01413204|16515178|P2|Overall Study|Fasting plasma glucose level increased|0
4788541|NCT01413204|16515179|P1|Overall Study|Fasting plasma glucose level increased|1
4788542|NCT01413204|16515177|P3|Overall Study|Clearly not eligible for the study|1
4788543|NCT01413204|16515178|P2|Overall Study|Clearly not eligible for the study|0
4788544|NCT01413204|16515179|P1|Overall Study|Clearly not eligible for the study|0
4788545|NCT01413204|16515177|P3|Overall Study|Withdrawal by Subject|4
4788546|NCT01413204|16515178|P2|Overall Study|Withdrawal by Subject|4
4788547|NCT01413204|16515179|P1|Overall Study|Withdrawal by Subject|1
4788548|NCT01413204|16515177|P3|Overall Study|Physician Decision|2
4788549|NCT01413204|16515178|P2|Overall Study|Physician Decision|0
4788550|NCT01413204|16515179|P1|Overall Study|Physician Decision|3
4788551|NCT01413204|16515177|P3|Overall Study|Adverse Event|2
4788552|NCT01413204|16515178|P2|Overall Study|Adverse Event|2
4788553|NCT01413204|16515179|P1|Overall Study|Adverse Event|1
4788554|NCT01413191|16515187|P1|Overall Study|Death|1
4788555|NCT01413191|16515187|P1|Overall Study|Disease Progression|5
4788556|NCT01413191|16515187|P1|Overall Study|Lost to Follow-up|5
4788557|NCT01413178|16515199|P2|Overall Study|Ineligible|2
4788558|NCT01413178|16515200|P1|Overall Study|Ineligible|0
4788559|NCT01413178|16515199|P2|Overall Study|Toxicity|0
4788560|NCT01413178|16515200|P1|Overall Study|Toxicity|1
4788561|NCT01412983|16515243|P2|1st Period|Inability to maintain wear|1
4788562|NCT01412983|16515244|P1|1st Period|Inability to maintain wear|0
4788563|NCT01412983|16515243|P2|1st Period|Unacceptable lens movement|1
4788564|NCT01412983|16515244|P1|1st Period|Unacceptable lens movement|0
4788565|NCT01412983|16515243|P2|1st Period|Positive slit lamp finding|1
4788566|NCT01412983|16515244|P1|1st Period|Positive slit lamp finding|0
4788567|NCT01412983|16515243|P2|1st Period|Ineligible|1
4788568|NCT01412983|16515244|P1|1st Period|Ineligible|0
4788569|NCT01412957|16515254|P2|Overall Study|Death|133
4788570|NCT01412957|16515255|P1|Overall Study|Death|136
4788571|NCT01412957|16515254|P2|Overall Study|Lost to Follow-up|2
4788572|NCT01412957|16515255|P1|Overall Study|Lost to Follow-up|7
4788573|NCT01412957|16515254|P2|Overall Study|Withdrawal by Subject|22
4788574|NCT01412957|16515255|P1|Overall Study|Withdrawal by Subject|6
4788575|NCT01412944|16515277|P6|Entire: IV + Maintenance|Adverse Event|0
4788576|NCT01412944|16515278|P5|Entire: IV + Maintenance|Adverse Event|0
4788577|NCT01412944|16515279|P4|Entire: IV + Maintenance|Adverse Event|0
4788578|NCT01412944|16515280|P3|Entire: IV + Maintenance|Adverse Event|0
4788579|NCT01412944|16515281|P2|Entire: IV + Maintenance|Adverse Event|1
4788580|NCT01412944|16515282|P1|Entire: IV + Maintenance|Adverse Event|0
4788581|NCT01412944|16515277|P6|Entire: IV + Maintenance|Lack of Efficacy|0
4788582|NCT01412944|16515278|P5|Entire: IV + Maintenance|Lack of Efficacy|0
4788583|NCT01412944|16515279|P4|Entire: IV + Maintenance|Lack of Efficacy|0
4788584|NCT01412944|16515280|P3|Entire: IV + Maintenance|Lack of Efficacy|0
4788585|NCT01412944|16515281|P2|Entire: IV + Maintenance|Lack of Efficacy|1
4788586|NCT01412944|16515282|P1|Entire: IV + Maintenance|Lack of Efficacy|0
4788587|NCT01412944|16515277|P6|Entire: IV + Maintenance|Lost to Follow-up|0
4788588|NCT01412944|16515278|P5|Entire: IV + Maintenance|Lost to Follow-up|0
4788589|NCT01412944|16515279|P4|Entire: IV + Maintenance|Lost to Follow-up|0
4788590|NCT01412944|16515280|P3|Entire: IV + Maintenance|Lost to Follow-up|0
4788591|NCT01412944|16515281|P2|Entire: IV + Maintenance|Lost to Follow-up|1
4788592|NCT01412944|16515282|P1|Entire: IV + Maintenance|Lost to Follow-up|0
4788593|NCT01412944|16515277|P6|Entire: IV + Maintenance|Protocol deviation|0
4788594|NCT01412944|16515278|P5|Entire: IV + Maintenance|Protocol deviation|0
4788595|NCT01412944|16515279|P4|Entire: IV + Maintenance|Protocol deviation|0
4788596|NCT01412944|16515280|P3|Entire: IV + Maintenance|Protocol deviation|0
4788597|NCT01412944|16515281|P2|Entire: IV + Maintenance|Protocol deviation|1
4788598|NCT01412944|16515282|P1|Entire: IV + Maintenance|Protocol deviation|0
4788599|NCT01412944|16515277|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
4788600|NCT01412944|16515278|P5|Entire: IV + Maintenance|Withdrawal by Subject|0
4788601|NCT01412944|16515279|P4|Entire: IV + Maintenance|Withdrawal by Subject|0
4788602|NCT01412944|16515280|P3|Entire: IV + Maintenance|Withdrawal by Subject|0
4788603|NCT01412944|16515281|P2|Entire: IV + Maintenance|Withdrawal by Subject|1
4788604|NCT01412944|16515282|P1|Entire: IV + Maintenance|Withdrawal by Subject|2
4788605|NCT01412944|16515277|P6|Entire: IV + Maintenance|Lack of Efficacy|0
4788606|NCT01412944|16515278|P5|Entire: IV + Maintenance|Lack of Efficacy|1
4788607|NCT01412944|16515279|P4|Entire: IV + Maintenance|Lack of Efficacy|0
4788608|NCT01412944|16515280|P3|Entire: IV + Maintenance|Lack of Efficacy|0
4788609|NCT01412944|16515281|P2|Entire: IV + Maintenance|Lack of Efficacy|0
4788610|NCT01412944|16515282|P1|Entire: IV + Maintenance|Lack of Efficacy|0
4788611|NCT01412944|16515277|P6|Entire: IV + Maintenance|Lost to Follow-up|1
4788612|NCT01412944|16515278|P5|Entire: IV + Maintenance|Lost to Follow-up|0
4788613|NCT01412944|16515279|P4|Entire: IV + Maintenance|Lost to Follow-up|0
4788614|NCT01412944|16515280|P3|Entire: IV + Maintenance|Lost to Follow-up|0
4788615|NCT01412944|16515281|P2|Entire: IV + Maintenance|Lost to Follow-up|0
4788616|NCT01412944|16515282|P1|Entire: IV + Maintenance|Lost to Follow-up|0
4788617|NCT01412944|16515277|P6|Entire: IV + Maintenance|Protocol deviation|1
4788618|NCT01412944|16515278|P5|Entire: IV + Maintenance|Protocol deviation|0
4788619|NCT01412944|16515279|P4|Entire: IV + Maintenance|Protocol deviation|0
4788620|NCT01412944|16515280|P3|Entire: IV + Maintenance|Protocol deviation|0
4788621|NCT01412944|16515281|P2|Entire: IV + Maintenance|Protocol deviation|0
4788622|NCT01412944|16515282|P1|Entire: IV + Maintenance|Protocol deviation|0
4788623|NCT01412944|16515277|P6|Entire: IV + Maintenance|Adverse Event|0
4788624|NCT01412944|16515278|P5|Entire: IV + Maintenance|Adverse Event|1
4788625|NCT01412944|16515279|P4|Entire: IV + Maintenance|Adverse Event|0
4788626|NCT01412944|16515280|P3|Entire: IV + Maintenance|Adverse Event|0
4788627|NCT01412944|16515281|P2|Entire: IV + Maintenance|Adverse Event|0
4788628|NCT01412944|16515282|P1|Entire: IV + Maintenance|Adverse Event|0
4788629|NCT01412944|16515277|P6|Entire: IV + Maintenance|Withdrawal by Subject|0
4788630|NCT01412944|16515278|P5|Entire: IV + Maintenance|Withdrawal by Subject|1
4788631|NCT01412944|16515279|P4|Entire: IV + Maintenance|Withdrawal by Subject|1
4788632|NCT01412944|16515280|P3|Entire: IV + Maintenance|Withdrawal by Subject|1
4788633|NCT01412944|16515281|P2|Entire: IV + Maintenance|Withdrawal by Subject|0
4788634|NCT01412944|16515282|P1|Entire: IV + Maintenance|Withdrawal by Subject|0
4788635|NCT01412944|16515277|P6|IV: Per CAIN457A2307|Lost to Follow-up|0
4788636|NCT01412944|16515278|P5|IV: Per CAIN457A2307|Lost to Follow-up|0
4788637|NCT01412944|16515279|P4|IV: Per CAIN457A2307|Lost to Follow-up|0
4788638|NCT01412944|16515280|P3|IV: Per CAIN457A2307|Lost to Follow-up|0
4788639|NCT01412944|16515281|P2|IV: Per CAIN457A2307|Lost to Follow-up|1
4788640|NCT01412944|16515282|P1|IV: Per CAIN457A2307|Lost to Follow-up|0
4788641|NCT01412944|16515277|P6|IV: Per CAIN457A2307|Protocol deviation|0
4788642|NCT01412944|16515278|P5|IV: Per CAIN457A2307|Protocol deviation|0
4788643|NCT01412944|16515279|P4|IV: Per CAIN457A2307|Protocol deviation|0
4788644|NCT01412944|16515280|P3|IV: Per CAIN457A2307|Protocol deviation|0
4788645|NCT01412944|16515281|P2|IV: Per CAIN457A2307|Protocol deviation|1
4788646|NCT01412944|16515282|P1|IV: Per CAIN457A2307|Protocol deviation|0
4788647|NCT01412944|16515277|P6|IV: Per CAIN457A2307|Withdrawal by Subject|0
4788648|NCT01412944|16515278|P5|IV: Per CAIN457A2307|Withdrawal by Subject|0
4788649|NCT01412944|16515279|P4|IV: Per CAIN457A2307|Withdrawal by Subject|0
4788650|NCT01412944|16515280|P3|IV: Per CAIN457A2307|Withdrawal by Subject|0
4788651|NCT01412944|16515281|P2|IV: Per CAIN457A2307|Withdrawal by Subject|0
4788652|NCT01412944|16515282|P1|IV: Per CAIN457A2307|Withdrawal by Subject|1
4788653|NCT01412944|16515277|P6|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1
4788654|NCT01412944|16515278|P5|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4788655|NCT01412944|16515279|P4|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4788656|NCT01412944|16515280|P3|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4788657|NCT01412944|16515281|P2|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4788658|NCT01412944|16515282|P1|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0
4788659|NCT01412944|16515277|P6|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1
4788660|NCT01412944|16515278|P5|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4788661|NCT01412944|16515279|P4|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4788662|NCT01412944|16515280|P3|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4788894|NCT01411215|16515890|P1|Overall Study|Other|12
4788663|NCT01412944|16515281|P2|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4788664|NCT01412944|16515282|P1|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0
4788665|NCT01412944|16515277|P6|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4788666|NCT01412944|16515278|P5|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4788667|NCT01412944|16515279|P4|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4788668|NCT01412944|16515280|P3|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1
4788669|NCT01412944|16515281|P2|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4788670|NCT01412944|16515282|P1|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0
4788671|NCT01412879|16515328|P3|Initial Registration (Induction Therapy)|Treatment not Given|0
4788672|NCT01412879|16515329|P2|Initial Registration (Induction Therapy)|Treatment not Given|0
4788673|NCT01412879|16515330|P1|Initial Registration (Induction Therapy)|Treatment not Given|1
4788674|NCT01412879|16515328|P3|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0
4788675|NCT01412879|16515329|P2|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1
4788676|NCT01412879|16515330|P1|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6
4788677|NCT01412879|16515328|P3|Initial Registration (Induction Therapy)|Progression/Relapse|0
4788678|NCT01412879|16515329|P2|Initial Registration (Induction Therapy)|Progression/Relapse|1
4788679|NCT01412879|16515330|P1|Initial Registration (Induction Therapy)|Progression/Relapse|0
4788680|NCT01412879|16515328|P3|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0
4788681|NCT01412879|16515329|P2|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3
4788682|NCT01412879|16515330|P1|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1
4788683|NCT01412879|16515328|P3|Initial Registration (Induction Therapy)|Adverse Event|0
4788684|NCT01412879|16515329|P2|Initial Registration (Induction Therapy)|Adverse Event|3
4788685|NCT01412879|16515330|P1|Initial Registration (Induction Therapy)|Adverse Event|5
4788686|NCT01412801|16515359|P6|Overall Study|Relocated to another area|0
4788687|NCT01412801|16515360|P5|Overall Study|Relocated to another area|0
4788688|NCT01412801|16515361|P4|Overall Study|Relocated to another area|0
4788689|NCT01412801|16515362|P3|Overall Study|Relocated to another area|2
4788690|NCT01412801|16515363|P2|Overall Study|Relocated to another area|0
4788691|NCT01412801|16515364|P1|Overall Study|Relocated to another area|0
4788692|NCT01412801|16515359|P6|Overall Study|Withdrawal by Subject|0
4788693|NCT01412801|16515360|P5|Overall Study|Withdrawal by Subject|0
4788694|NCT01412801|16515361|P4|Overall Study|Withdrawal by Subject|0
4788695|NCT01412801|16515362|P3|Overall Study|Withdrawal by Subject|1
4788696|NCT01412801|16515363|P2|Overall Study|Withdrawal by Subject|2
4788697|NCT01412801|16515364|P1|Overall Study|Withdrawal by Subject|3
4788698|NCT01412801|16515359|P6|Overall Study|Lost to Follow-up|1
4788699|NCT01412801|16515360|P5|Overall Study|Lost to Follow-up|1
4788700|NCT01412801|16515361|P4|Overall Study|Lost to Follow-up|0
4788701|NCT01412801|16515362|P3|Overall Study|Lost to Follow-up|4
4788702|NCT01412801|16515363|P2|Overall Study|Lost to Follow-up|2
4788703|NCT01412801|16515364|P1|Overall Study|Lost to Follow-up|1
4788704|NCT01412801|16515359|P6|Overall Study|Death|2
4788705|NCT01412801|16515360|P5|Overall Study|Death|2
4788706|NCT01412801|16515361|P4|Overall Study|Death|4
4788707|NCT01412801|16515362|P3|Overall Study|Death|0
4788708|NCT01412801|16515363|P2|Overall Study|Death|1
4788709|NCT01412801|16515364|P1|Overall Study|Death|0
4788710|NCT01412424|16515459|P1|Extension Treatment Period|Patient Request|2
4788711|NCT01412424|16515459|P1|Extension Treatment Period|Treatment Failure|2
4788712|NCT01412424|16515459|P1|Extension Treatment Period|Adverse Event|2
4788713|NCT01412424|16515459|P1|Core Treatment Period|Sponsor Request|1
4788714|NCT01412424|16515459|P1|Core Treatment Period|Lost to Follow-up|2
4788715|NCT01412424|16515459|P1|Core Treatment Period|Patient Request|5
4788716|NCT01412424|16515459|P1|Core Treatment Period|Adverse Event|21
4788717|NCT01412424|16515459|P1|Core Treatment Period|Treatment Failure|24
4788718|NCT01412333|16515477|P2|Overall Study|Lost to Follow-up|6
4788719|NCT01412333|16515478|P1|Overall Study|Lost to Follow-up|10
4788720|NCT01412333|16515477|P2|Overall Study|Adverse Event|16
4788721|NCT01412333|16515478|P1|Overall Study|Adverse Event|25
4788722|NCT01412333|16515477|P2|Overall Study|Consent withdrawn by participant|12
4788723|NCT01412333|16515478|P1|Overall Study|Consent withdrawn by participant|25
4788724|NCT01412333|16515477|P2|Overall Study|Pregnancy|0
4788725|NCT01412333|16515478|P1|Overall Study|Pregnancy|3
4788726|NCT01412333|16515477|P2|Overall Study|Lack of Efficacy|6
4788727|NCT01412333|16515478|P1|Overall Study|Lack of Efficacy|15
4788728|NCT01412333|16515477|P2|Overall Study|Non-compliance|3
4788729|NCT01412333|16515478|P1|Overall Study|Non-compliance|1
4788730|NCT01412333|16515477|P2|Overall Study|Protocol Violation|1
4788731|NCT01412333|16515478|P1|Overall Study|Protocol Violation|1
4788732|NCT01412333|16515477|P2|Overall Study|Non-compliance with study drug|1
4788733|NCT01412333|16515478|P1|Overall Study|Non-compliance with study drug|1
4788734|NCT01412333|16515477|P2|Overall Study|Reason not specified|10
4788735|NCT01412333|16515478|P1|Overall Study|Reason not specified|16
4788736|NCT01412333|16515477|P2|Overall Study|Physician Decision|1
4788737|NCT01412333|16515478|P1|Overall Study|Physician Decision|0
4788738|NCT01412333|16515477|P2|Overall Study|Death|1
4788739|NCT01412333|16515478|P1|Overall Study|Death|1
4788740|NCT01412229|16515538|P1|Overall Study|Physician Decision|1
4788741|NCT01412151|16515561|P1|Week 306 - 310 - Washout Period|Withdrawal by Subject|2
4788742|NCT01412151|16515561|P1|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3
4788743|NCT01412151|16515561|P1|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1
4788744|NCT01412151|16515561|P1|Week 0 - 306 - Treatment Period|Death|1
4788745|NCT01412060|16515572|P3|Double-blind Treatment Phase (DBP)|Relapse|25
4788746|NCT01412060|16515573|P2|Double-blind Treatment Phase (DBP)|Relapse|47
4788747|NCT01412060|16515574|P1|Double-blind Treatment Phase (DBP)|Relapse|0
4788748|NCT01412060|16515572|P3|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27
4788749|NCT01412060|16515573|P2|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11
4788750|NCT01412060|16515574|P1|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0
4788751|NCT01412060|16515572|P3|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5
4788752|NCT01412060|16515573|P2|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6
4788753|NCT01412060|16515574|P1|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0
4788754|NCT01412060|16515572|P3|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15
4788755|NCT01412060|16515573|P2|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10
4788756|NCT01412060|16515574|P1|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0
4788757|NCT01412060|16515572|P3|Double-blind Treatment Phase (DBP)|Protocol Violation|5
4788758|NCT01412060|16515573|P2|Double-blind Treatment Phase (DBP)|Protocol Violation|4
4788759|NCT01412060|16515574|P1|Double-blind Treatment Phase (DBP)|Protocol Violation|0
4788760|NCT01412060|16515572|P3|Double-blind Treatment Phase (DBP)|Adverse Event|6
4788761|NCT01412060|16515573|P2|Double-blind Treatment Phase (DBP)|Adverse Event|5
4788762|NCT01412060|16515574|P1|Double-blind Treatment Phase (DBP)|Adverse Event|0
4788763|NCT01412060|16515572|P3|Period Between SP and DBP|Other Miscellaneous Reasons|0
4788764|NCT01412060|16515573|P2|Period Between SP and DBP|Other Miscellaneous Reasons|0
4788765|NCT01412060|16515574|P1|Period Between SP and DBP|Other Miscellaneous Reasons|55
4788766|NCT01412060|16515572|P3|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
4788767|NCT01412060|16515573|P2|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0
4788768|NCT01412060|16515574|P1|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4
4788769|NCT01412060|16515572|P3|Period Between SP and DBP|Lost to Follow-up|0
4788770|NCT01412060|16515573|P2|Period Between SP and DBP|Lost to Follow-up|0
4788771|NCT01412060|16515574|P1|Period Between SP and DBP|Lost to Follow-up|1
4788772|NCT01412060|16515572|P3|Period Between SP and DBP|Withdrawal of Consent|0
4788773|NCT01412060|16515573|P2|Period Between SP and DBP|Withdrawal of Consent|0
4788774|NCT01412060|16515574|P1|Period Between SP and DBP|Withdrawal of Consent|2
4788775|NCT01412060|16515572|P3|Period Between SP and DBP|Protocol Violation|0
4788776|NCT01412060|16515573|P2|Period Between SP and DBP|Protocol Violation|0
4788777|NCT01412060|16515574|P1|Period Between SP and DBP|Protocol Violation|2
4788778|NCT01412060|16515572|P3|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
4788779|NCT01412060|16515573|P2|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0
4788780|NCT01412060|16515574|P1|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19
4788781|NCT01412060|16515572|P3|Open-label Stabilization Period (SP)|Lost to Follow-up|0
4788782|NCT01412060|16515573|P2|Open-label Stabilization Period (SP)|Lost to Follow-up|0
4788783|NCT01412060|16515574|P1|Open-label Stabilization Period (SP)|Lost to Follow-up|9
4788784|NCT01412060|16515572|P3|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
4788785|NCT01412060|16515573|P2|Open-label Stabilization Period (SP)|Withdrawal of Consent|0
4788786|NCT01412060|16515574|P1|Open-label Stabilization Period (SP)|Withdrawal of Consent|40
4788787|NCT01412060|16515572|P3|Open-label Stabilization Period (SP)|Protocol Violation|0
4788788|NCT01412060|16515573|P2|Open-label Stabilization Period (SP)|Protocol Violation|0
4788789|NCT01412060|16515574|P1|Open-label Stabilization Period (SP)|Protocol Violation|14
4788790|NCT01412060|16515572|P3|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
4788791|NCT01412060|16515573|P2|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0
4788792|NCT01412060|16515574|P1|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9
4788793|NCT01412060|16515572|P3|Open-label Stabilization Period (SP)|Adverse Event|0
4788794|NCT01412060|16515573|P2|Open-label Stabilization Period (SP)|Adverse Event|0
4788795|NCT01412060|16515574|P1|Open-label Stabilization Period (SP)|Adverse Event|9
4788796|NCT01412060|16515572|P3|Period Between RIP and SP|Other Miscellaneous Reasons|0
4788797|NCT01412060|16515573|P2|Period Between RIP and SP|Other Miscellaneous Reasons|0
4788798|NCT01412060|16515574|P1|Period Between RIP and SP|Other Miscellaneous Reasons|23
4788799|NCT01412060|16515572|P3|Period Between RIP and SP|Lost to Follow-up|0
4788800|NCT01412060|16515573|P2|Period Between RIP and SP|Lost to Follow-up|0
4788801|NCT01412060|16515574|P1|Period Between RIP and SP|Lost to Follow-up|5
4788802|NCT01412060|16515572|P3|Period Between RIP and SP|Withdrawal of Consent|0
4788803|NCT01412060|16515573|P2|Period Between RIP and SP|Withdrawal of Consent|0
4788804|NCT01412060|16515574|P1|Period Between RIP and SP|Withdrawal of Consent|1
4788805|NCT01412060|16515572|P3|Period Between RIP and SP|Protocol Violation|0
4788806|NCT01412060|16515573|P2|Period Between RIP and SP|Protocol Violation|0
4788807|NCT01412060|16515574|P1|Period Between RIP and SP|Protocol Violation|2
4788808|NCT01412060|16515572|P3|Period Between RIP and SP|Insufficient Therapeutic Response|0
4788809|NCT01412060|16515573|P2|Period Between RIP and SP|Insufficient Therapeutic Response|0
4788810|NCT01412060|16515574|P1|Period Between RIP and SP|Insufficient Therapeutic Response|19
4788811|NCT01412060|16515572|P3|Period Between RIP and SP|Adverse Event|0
4788812|NCT01412060|16515573|P2|Period Between RIP and SP|Adverse Event|0
4788813|NCT01412060|16515574|P1|Period Between RIP and SP|Adverse Event|4
4788814|NCT01412060|16515572|P3|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
4788815|NCT01412060|16515573|P2|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0
4788816|NCT01412060|16515574|P1|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19
4788817|NCT01412060|16515572|P3|Open-label Run-in Period (RIP)|Lost to Follow-up|0
4788818|NCT01412060|16515573|P2|Open-label Run-in Period (RIP)|Lost to Follow-up|0
4788819|NCT01412060|16515574|P1|Open-label Run-in Period (RIP)|Lost to Follow-up|32
4788820|NCT01412060|16515572|P3|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
4788821|NCT01412060|16515573|P2|Open-label Run-in Period (RIP)|Withdrawal of Consent|0
4788822|NCT01412060|16515574|P1|Open-label Run-in Period (RIP)|Withdrawal of Consent|117
4788823|NCT01412060|16515572|P3|Open-label Run-in Period (RIP)|Protocol Violation|0
4788824|NCT01412060|16515573|P2|Open-label Run-in Period (RIP)|Protocol Violation|0
4788825|NCT01412060|16515574|P1|Open-label Run-in Period (RIP)|Protocol Violation|27
4788826|NCT01412060|16515572|P3|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
4788827|NCT01412060|16515573|P2|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0
4788828|NCT01412060|16515574|P1|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66
4788829|NCT01412060|16515572|P3|Open-label Run-in Period (RIP)|Adverse Event|0
4788830|NCT01412060|16515573|P2|Open-label Run-in Period (RIP)|Adverse Event|0
4788831|NCT01412060|16515574|P1|Open-label Run-in Period (RIP)|Adverse Event|86
4788832|NCT01412021|16515584|P1|Overall Study|Transferred to Other Hospital|9
4788833|NCT01412021|16515584|P1|Overall Study|Treatment Prior to Approval|3
4788834|NCT01412021|16515584|P1|Overall Study|Case Report Forms Not Retrieved|7
4788835|NCT01411995|16515621|P2|Overall Study|Failed IUD insertion|1
4788836|NCT01411995|16515622|P1|Overall Study|Failed IUD insertion|0
4788837|NCT01411917|16515630|P2|Overall Study|Patient did not undergo scheduled surger|1
4788838|NCT01411917|16515631|P1|Overall Study|Patient did not undergo scheduled surger|0
4788839|NCT01411891|16515653|P2|Overall Study|Catheter dislodgement or loss to follow-|2
4788840|NCT01411891|16515654|P1|Overall Study|Catheter dislodgement or loss to follow-|3
4788841|NCT01411852|16515664|P2|Hospital Intervention Phase|Vascular access failed|0
4788842|NCT01411852|16515665|P1|Hospital Intervention Phase|Vascular access failed|1
4788843|NCT01411852|16515664|P2|Hospital Intervention Phase|Withdrawal by Subject|0
4788844|NCT01411852|16515665|P1|Hospital Intervention Phase|Withdrawal by Subject|1
4788845|NCT01411852|16515664|P2|Hospital Intervention Phase|Spinal cord injury|0
4788846|NCT01411852|16515665|P1|Hospital Intervention Phase|Spinal cord injury|2
4788847|NCT01411852|16515664|P2|Hospital Intervention Phase|Other ineligible|2
4788848|NCT01411852|16515665|P1|Hospital Intervention Phase|Other ineligible|2
4788849|NCT01411852|16515664|P2|Hospital Intervention Phase|Physician/hospital staff noncompliance|4
4788850|NCT01411852|16515665|P1|Hospital Intervention Phase|Physician/hospital staff noncompliance|0
4788851|NCT01411852|16515664|P2|Hospital Intervention Phase|Diagnosis of dehydration|1
4788852|NCT01411852|16515665|P1|Hospital Intervention Phase|Diagnosis of dehydration|0
4788853|NCT01411852|16515664|P2|Hospital Intervention Phase|Diagnosis of sepsis|2
4788854|NCT01411852|16515665|P1|Hospital Intervention Phase|Diagnosis of sepsis|0
4788855|NCT01411852|16515664|P2|Hospital Intervention Phase|Misunderstanding of protocol|1
4788856|NCT01411852|16515665|P1|Hospital Intervention Phase|Misunderstanding of protocol|4
4788857|NCT01411852|16515664|P2|Hospital Intervention Phase|CPR administered|1
4788858|NCT01411852|16515665|P1|Hospital Intervention Phase|CPR administered|3
4788859|NCT01411852|16515664|P2|Hospital Intervention Phase|Miscommunication error|2
4788860|NCT01411852|16515665|P1|Hospital Intervention Phase|Miscommunication error|1
4788861|NCT01411852|16515664|P2|Hospital Intervention Phase|No qualifying SBP|1
4788862|NCT01411852|16515665|P1|Hospital Intervention Phase|No qualifying SBP|5
4788863|NCT01411852|16515664|P2|Hospital Intervention Phase|Severe head injury|4
4788864|NCT01411852|16515665|P1|Hospital Intervention Phase|Severe head injury|5
4788865|NCT01411852|16515664|P2|Prehospital Intervention Phase|Severe head injury with GCS≤8|0
4788866|NCT01411852|16515665|P1|Prehospital Intervention Phase|Severe head injury with GCS≤8|5
4788867|NCT01411852|16515664|P2|Prehospital Intervention Phase|Found to be under age|1
4788868|NCT01411852|16515665|P1|Prehospital Intervention Phase|Found to be under age|0
4788869|NCT01411852|16515664|P2|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
4788870|NCT01411852|16515665|P1|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2
4788871|NCT01411852|16515664|P2|Prehospital Intervention Phase|No qualifying SBP|4
4788872|NCT01411852|16515665|P1|Prehospital Intervention Phase|No qualifying SBP|5
4788873|NCT01411839|16515710|P2|Overall Study|Lost to Follow-up|3
4788874|NCT01411839|16515711|P1|Overall Study|Lost to Follow-up|4
4788875|NCT01411774|16515723|P2|Overall Study|Withdrawal by Subject|3
4788876|NCT01411774|16515724|P1|Overall Study|Withdrawal by Subject|0
4788877|NCT01411241|16515839|P2|Overall Study|Lost to Follow-up|4
4788878|NCT01411241|16515840|P1|Overall Study|Lost to Follow-up|2
4788879|NCT01411241|16515839|P2|Overall Study|Serious Adverse Event|3
4788880|NCT01411241|16515840|P1|Overall Study|Serious Adverse Event|0
4788881|NCT01411241|16515839|P2|Overall Study|Withdrawal by Subject|10
4788882|NCT01411241|16515840|P1|Overall Study|Withdrawal by Subject|9
4788883|NCT01411241|16515839|P2|Overall Study|Protocol Violation|5
4788884|NCT01411241|16515840|P1|Overall Study|Protocol Violation|0
4788885|NCT01411228|16515865|P3|Overall Study|Withdrawal by Subject|0
4788886|NCT01411228|16515866|P2|Overall Study|Withdrawal by Subject|0
4788887|NCT01411228|16515867|P1|Overall Study|Withdrawal by Subject|1
4788888|NCT01411228|16515865|P3|Overall Study|Lost to Follow-up|1
4788889|NCT01411228|16515866|P2|Overall Study|Lost to Follow-up|0
4788890|NCT01411228|16515867|P1|Overall Study|Lost to Follow-up|0
4788891|NCT01411215|16515889|P2|Overall Study|Screen failure|1
4788892|NCT01411215|16515890|P1|Overall Study|Screen failure|0
4788893|NCT01411215|16515889|P2|Overall Study|Other|17
4788895|NCT01411215|16515889|P2|Overall Study|Withdrawal by Subject|21
4788896|NCT01411215|16515890|P1|Overall Study|Withdrawal by Subject|34
4788897|NCT01411215|16515889|P2|Overall Study|Protocol Violation|5
4788898|NCT01411215|16515890|P1|Overall Study|Protocol Violation|3
4788899|NCT01411215|16515889|P2|Overall Study|Study terminated by sponsor|15
4788900|NCT01411215|16515890|P1|Overall Study|Study terminated by sponsor|2
4788901|NCT01411215|16515889|P2|Overall Study|Did not meet entrance criteria|1
4788902|NCT01411215|16515890|P1|Overall Study|Did not meet entrance criteria|0
4788903|NCT01411215|16515889|P2|Overall Study|Lost to Follow-up|18
4788904|NCT01411215|16515890|P1|Overall Study|Lost to Follow-up|12
4788905|NCT01411215|16515889|P2|Overall Study|Lack of Efficacy|4
4788906|NCT01411215|16515890|P1|Overall Study|Lack of Efficacy|2
4788907|NCT01411215|16515889|P2|Overall Study|Adverse Event|2
4788908|NCT01411215|16515890|P1|Overall Study|Adverse Event|1
4788909|NCT01411085|16515942|P1|Overall Study|Adverse Event|1
4788910|NCT01411085|16515942|P1|Overall Study|Protocol Violation|1
4788911|NCT01411085|16515942|P1|Overall Study|Physician Decision|1
4788912|NCT01410799|16515962|P1|Overall Study|PI decision|13
4788913|NCT01410604|16515978|P2|Overall Study|Physician Decision|1
4788914|NCT01410604|16515979|P1|Overall Study|Physician Decision|0
4788915|NCT01410604|16515978|P2|Overall Study|Lost to Follow-up|0
4788916|NCT01410604|16515979|P1|Overall Study|Lost to Follow-up|1
4788917|NCT01410604|16515978|P2|Overall Study|Adverse Event|1
4788918|NCT01410604|16515979|P1|Overall Study|Adverse Event|2
4788919|NCT01410474|16516020|P2|Overall Study|Withdrawal by Subject|1
4788920|NCT01410474|16516021|P1|Overall Study|Withdrawal by Subject|0
4788921|NCT01410448|16516044|P2|Overall Study|Death|3
4788922|NCT01410448|16516045|P1|Overall Study|Death|2
4788923|NCT01410448|16516044|P2|Overall Study|Protocol Violation|4
4788924|NCT01410448|16516045|P1|Overall Study|Protocol Violation|0
4788925|NCT01410448|16516044|P2|Overall Study|Withdrawal by Subject|2
4788926|NCT01410448|16516045|P1|Overall Study|Withdrawal by Subject|3
4788927|NCT01410448|16516044|P2|Overall Study|Lost to Follow-up|0
4788928|NCT01410448|16516045|P1|Overall Study|Lost to Follow-up|1
4788929|NCT01410448|16516044|P2|Overall Study|Administrative issues|1
4788930|NCT01410448|16516045|P1|Overall Study|Administrative issues|2
4788931|NCT01410448|16516044|P2|Overall Study|Graft loss|1
4788932|NCT01410448|16516045|P1|Overall Study|Graft loss|4
4788933|NCT01410448|16516044|P2|Overall Study|No conversion to everolimus|24
4788934|NCT01410448|16516045|P1|Overall Study|No conversion to everolimus|0
4788935|NCT01410357|16516110|P2|Overall Study|Lost to Follow-up|21
4788936|NCT01410357|16516111|P1|Overall Study|Lost to Follow-up|23
4788937|NCT01410357|16516110|P2|Overall Study|Withdrawal by Subject|2
4788938|NCT01410357|16516111|P1|Overall Study|Withdrawal by Subject|1
4788939|NCT01410357|16516110|P2|Overall Study|Death|1
4788940|NCT01410357|16516111|P1|Overall Study|Death|2
4788941|NCT01410240|16516182|P3|Overall Study|Missed week 6 assessments|1
4788942|NCT01410240|16516183|P2|Overall Study|Missed week 6 assessments|1
4788943|NCT01410240|16516184|P1|Overall Study|Missed week 6 assessments|1
4788944|NCT01410240|16516182|P3|Overall Study|Physician Decision|1
4788945|NCT01410240|16516183|P2|Overall Study|Physician Decision|0
4788946|NCT01410240|16516184|P1|Overall Study|Physician Decision|0
4788947|NCT01410227|16516255|P4|Overall Study|Met Excl. Criteria After Starting Study|0
4788948|NCT01410227|16516256|P3|Overall Study|Met Excl. Criteria After Starting Study|1
4788949|NCT01410227|16516257|P2|Overall Study|Met Excl. Criteria After Starting Study|0
4788950|NCT01410227|16516258|P1|Overall Study|Met Excl. Criteria After Starting Study|0
4788951|NCT01410227|16516255|P4|Overall Study|Pregnancy|1
4788952|NCT01410227|16516256|P3|Overall Study|Pregnancy|0
4788953|NCT01410227|16516257|P2|Overall Study|Pregnancy|0
4788954|NCT01410227|16516258|P1|Overall Study|Pregnancy|0
4788955|NCT01410227|16516255|P4|Overall Study|Withdrawal by Subject|0
4788956|NCT01410227|16516256|P3|Overall Study|Withdrawal by Subject|1
4788957|NCT01410227|16516257|P2|Overall Study|Withdrawal by Subject|0
4788958|NCT01410227|16516258|P1|Overall Study|Withdrawal by Subject|3
4788959|NCT01410227|16516255|P4|Overall Study|Adverse Event|0
4788960|NCT01410227|16516256|P3|Overall Study|Adverse Event|0
4788961|NCT01410227|16516257|P2|Overall Study|Adverse Event|0
4788962|NCT01410227|16516258|P1|Overall Study|Adverse Event|1
4788963|NCT01410110|16516330|P2|Overall Study|Withdrawal by Subject|2
4788964|NCT01410110|16516331|P1|Overall Study|Withdrawal by Subject|4
4788965|NCT01409993|16516406|P4|Overall Study|Lost to Follow-up|0
4788966|NCT01409993|16516407|P3|Overall Study|Lost to Follow-up|0
4788967|NCT01409993|16516408|P2|Overall Study|Lost to Follow-up|1
4788968|NCT01409993|16516409|P1|Overall Study|Lost to Follow-up|0
4788969|NCT01409993|16516406|P4|Overall Study|Withdrawal by Subject|4
4788970|NCT01409993|16516407|P3|Overall Study|Withdrawal by Subject|0
4788971|NCT01409993|16516408|P2|Overall Study|Withdrawal by Subject|0
4788972|NCT01409993|16516409|P1|Overall Study|Withdrawal by Subject|0
4788973|NCT01409993|16516406|P4|Overall Study|Adverse Event|1
4788974|NCT01409993|16516407|P3|Overall Study|Adverse Event|3
4788975|NCT01409993|16516408|P2|Overall Study|Adverse Event|4
4788976|NCT01409993|16516409|P1|Overall Study|Adverse Event|4
4788977|NCT01409928|16516427|P1|Overall Study|Physician Decision|12
4788978|NCT01409837|16516433|P2|Overall Study|Physician Decision|1
4788979|NCT01409837|16516434|P1|Overall Study|Physician Decision|0
4788980|NCT01409837|16516433|P2|Overall Study|Lost to Follow-up|0
4788981|NCT01409837|16516434|P1|Overall Study|Lost to Follow-up|1
4788982|NCT01409837|16516433|P2|Overall Study|Withdrawal by Subject|1
4788983|NCT01409837|16516434|P1|Overall Study|Withdrawal by Subject|2
4788984|NCT01409811|16516456|P1|Overall Study|Insurance denial|1
4788985|NCT01409707|16516463|P3|Overall Study|Withdrawal by Subject|16
4788986|NCT01409707|16516464|P2|Overall Study|Withdrawal by Subject|17
4788987|NCT01409707|16516465|P1|Overall Study|Withdrawal by Subject|5
4788988|NCT01409564|16516477|P2|Overall Study|brain abnormalities found in T1 MR|2
4788989|NCT01409564|16516478|P1|Overall Study|brain abnormalities found in T1 MR|1
4788990|NCT01409564|16516477|P2|Overall Study|low medication compliance|3
4788991|NCT01409564|16516478|P1|Overall Study|low medication compliance|4
4788992|NCT01409434|16516496|P1|Overall Study|Protocol Violation|4
4788993|NCT01409382|16516506|P2|Overall Study|Had a 2nd trimester loss after accident|0
4788994|NCT01409382|16516507|P1|Overall Study|Had a 2nd trimester loss after accident|1
4788995|NCT01409382|16516506|P2|Overall Study|Did not manage to get pregnant|70
4788996|NCT01409382|16516507|P1|Overall Study|Did not manage to get pregnant|64
4788997|NCT01409382|16516506|P2|Overall Study|Still pregnant when study ended|2
4788998|NCT01409382|16516507|P1|Overall Study|Still pregnant when study ended|13
4788999|NCT01409382|16516506|P2|Overall Study|Multiple pregnancy|4
4789000|NCT01409382|16516507|P1|Overall Study|Multiple pregnancy|2
4789001|NCT01409382|16516506|P2|Overall Study|Protocol Violation|3
4789002|NCT01409382|16516507|P1|Overall Study|Protocol Violation|0
4789003|NCT01409382|16516506|P2|Overall Study|Lost to Follow-up|1
4789004|NCT01409382|16516507|P1|Overall Study|Lost to Follow-up|1
4789005|NCT01409031|16516561|P2|Overall Study|transferred to other hosp|0
4789006|NCT01409031|16516562|P1|Overall Study|transferred to other hosp|1
4789007|NCT01408914|16516593|P3|Overall Study|Change in local TB/HIV norms|1
4789008|NCT01408914|16516594|P2|Overall Study|Change in local TB/HIV norms|1
4789009|NCT01408914|16516595|P1|Overall Study|Change in local TB/HIV norms|0
4789010|NCT01408914|16516593|P3|Overall Study|Late exclusion|3
4789011|NCT01408914|16516594|P2|Overall Study|Late exclusion|3
4789012|NCT01408914|16516595|P1|Overall Study|Late exclusion|0
4789013|NCT01408914|16516593|P3|Overall Study|Moved out of study jurisdiction|0
4789014|NCT01408914|16516594|P2|Overall Study|Moved out of study jurisdiction|1
4789015|NCT01408914|16516595|P1|Overall Study|Moved out of study jurisdiction|1
4789016|NCT01408914|16516593|P3|Overall Study|Withdrawal by Subject|1
4789017|NCT01408914|16516594|P2|Overall Study|Withdrawal by Subject|0
4789018|NCT01408914|16516595|P1|Overall Study|Withdrawal by Subject|1
4789019|NCT01408914|16516593|P3|Overall Study|Physician Decision|0
4789020|NCT01408914|16516594|P2|Overall Study|Physician Decision|1
4789021|NCT01408914|16516595|P1|Overall Study|Physician Decision|1
4789022|NCT01408914|16516593|P3|Overall Study|Lost to Follow-up|2
4789023|NCT01408914|16516594|P2|Overall Study|Lost to Follow-up|1
4789024|NCT01408914|16516595|P1|Overall Study|Lost to Follow-up|4
4789025|NCT01408914|16516593|P3|Overall Study|Could not complete tx in protocol period|6
4789026|NCT01408914|16516594|P2|Overall Study|Could not complete tx in protocol period|5
4789027|NCT01408914|16516595|P1|Overall Study|Could not complete tx in protocol period|5
4789028|NCT01408901|16516613|P4|26-Week Follow-Up|Death|0
4789029|NCT01408901|16516614|P3|26-Week Follow-Up|Death|0
4789030|NCT01408901|16516615|P2|26-Week Follow-Up|Death|1
4789031|NCT01408901|16516616|P1|26-Week Follow-Up|Death|0
4789032|NCT01408901|16516613|P4|26-Week Follow-Up|Lost to Follow-up|1
4789033|NCT01408901|16516614|P3|26-Week Follow-Up|Lost to Follow-up|0
4789034|NCT01408901|16516615|P2|26-Week Follow-Up|Lost to Follow-up|1
4789035|NCT01408901|16516616|P1|26-Week Follow-Up|Lost to Follow-up|1
4789036|NCT01408901|16516613|P4|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1
4789037|NCT01408901|16516614|P3|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
4789038|NCT01408901|16516615|P2|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2
4789039|NCT01408901|16516616|P1|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0
4789040|NCT01408901|16516613|P4|12-Week Follow-Up (Primary Endpoint)|Death|0
4789041|NCT01408901|16516614|P3|12-Week Follow-Up (Primary Endpoint)|Death|0
4789042|NCT01408901|16516615|P2|12-Week Follow-Up (Primary Endpoint)|Death|0
4789043|NCT01408901|16516616|P1|12-Week Follow-Up (Primary Endpoint)|Death|1
4789044|NCT01408901|16516613|P4|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2
4789045|NCT01408901|16516614|P3|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
4789046|NCT01408901|16516615|P2|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
4789047|NCT01408901|16516616|P1|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0
4789048|NCT01408901|16516613|P4|6-Week Follow-Up|Cancelled visit|2
4789049|NCT01408901|16516614|P3|6-Week Follow-Up|Cancelled visit|0
4789050|NCT01408901|16516615|P2|6-Week Follow-Up|Cancelled visit|1
4789051|NCT01408901|16516616|P1|6-Week Follow-Up|Cancelled visit|0
4789052|NCT01408901|16516613|P4|6-Week Follow-Up|Death|0
4789053|NCT01408901|16516614|P3|6-Week Follow-Up|Death|0
4789054|NCT01408901|16516615|P2|6-Week Follow-Up|Death|0
4789055|NCT01408901|16516616|P1|6-Week Follow-Up|Death|1
4789056|NCT01408901|16516613|P4|6-Week Follow-Up|Lost to Follow-up|2
4789057|NCT01408901|16516614|P3|6-Week Follow-Up|Lost to Follow-up|3
4789058|NCT01408901|16516615|P2|6-Week Follow-Up|Lost to Follow-up|1
4789059|NCT01408901|16516616|P1|6-Week Follow-Up|Lost to Follow-up|2
4789060|NCT01408888|16516642|P2|Second Intervention|Adverse Event|0
4789061|NCT01408888|16516643|P1|Second Intervention|Adverse Event|1
4789062|NCT01408888|16516642|P2|Second Intervention|Withdrawal by Subject|0
4789063|NCT01408888|16516643|P1|Second Intervention|Withdrawal by Subject|1
4789064|NCT01408888|16516642|P2|First Intervention|Withdrawal by Subject|2
4789065|NCT01408888|16516643|P1|First Intervention|Withdrawal by Subject|0
4789066|NCT01408888|16516642|P2|First Intervention|Adverse Event|1
4789067|NCT01408888|16516643|P1|First Intervention|Adverse Event|0
4789068|NCT01408732|16516671|P2|Overall Study|Withdrawal by Subject|2
4789069|NCT01408732|16516672|P1|Overall Study|Withdrawal by Subject|2
4789070|NCT01408706|16516729|P2|Overall Study|Physician Decision|0
4789071|NCT01408706|16516730|P1|Overall Study|Physician Decision|1
4789072|NCT01408641|16516742|P2|Overall Study|Physician Decision|0
4789073|NCT01408641|16516743|P1|Overall Study|Physician Decision|1
4789074|NCT01408628|16516751|P1|Completed 6 Month Follow-Up|Withdrawal by Subject|5
4789075|NCT01408628|16516751|P1|Completed 6 Month Follow-Up|Protocol Violation|6
4789076|NCT01408628|16516751|P1|Completed 6 Month Follow-Up|Lost to Follow-up|3
4789077|NCT01408628|16516751|P1|Consented|Withdrawal by Subject|12
4789078|NCT01408576|16516760|P3|Overall Study|Other|18
4789079|NCT01408576|16516761|P2|Overall Study|Other|16
4789080|NCT01408576|16516762|P1|Overall Study|Other|10
4789081|NCT01408576|16516760|P3|Overall Study|AE, unknown type|0
4789082|NCT01408576|16516761|P2|Overall Study|AE, unknown type|1
4789083|NCT01408576|16516762|P1|Overall Study|AE, unknown type|0
4789084|NCT01408576|16516760|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4789085|NCT01408576|16516761|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4789086|NCT01408576|16516762|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4789087|NCT01408576|16516760|P3|Overall Study|AE, non-serious non-fatal|11
4789088|NCT01408576|16516761|P2|Overall Study|AE, non-serious non-fatal|19
4789089|NCT01408576|16516762|P1|Overall Study|AE, non-serious non-fatal|12
4789090|NCT01408576|16516760|P3|Overall Study|SAE, non-fatal|14
4789091|NCT01408576|16516761|P2|Overall Study|SAE, non-fatal|23
4789092|NCT01408576|16516762|P1|Overall Study|SAE, non-fatal|11
4789093|NCT01408576|16516760|P3|Overall Study|AE, serious fatal|1
4789094|NCT01408576|16516761|P2|Overall Study|AE, serious fatal|4
4789095|NCT01408576|16516762|P1|Overall Study|AE, serious fatal|4
4789096|NCT01408576|16516760|P3|Overall Study|Sponsor terminated study|330
4789097|NCT01408576|16516761|P2|Overall Study|Sponsor terminated study|333
4789098|NCT01408576|16516762|P1|Overall Study|Sponsor terminated study|89
4789099|NCT01408576|16516760|P3|Overall Study|Withdrawal by Subject|66
4789100|NCT01408576|16516761|P2|Overall Study|Withdrawal by Subject|60
4789101|NCT01408576|16516762|P1|Overall Study|Withdrawal by Subject|34
4789102|NCT01408576|16516760|P3|Overall Study|Lost to Follow-up|17
4789103|NCT01408576|16516761|P2|Overall Study|Lost to Follow-up|9
4789104|NCT01408576|16516762|P1|Overall Study|Lost to Follow-up|10
4789105|NCT01408576|16516760|P3|Overall Study|Protocol Violation|2
4789106|NCT01408576|16516761|P2|Overall Study|Protocol Violation|2
4789107|NCT01408576|16516762|P1|Overall Study|Protocol Violation|1
4789108|NCT01408576|16516760|P3|Overall Study|Lack of Efficacy|48
4789109|NCT01408576|16516761|P2|Overall Study|Lack of Efficacy|30
4789110|NCT01408576|16516762|P1|Overall Study|Lack of Efficacy|17
4789111|NCT01408563|16516809|P1|Overall Study|Ineligible after consent/ registration|2
4789112|NCT01408537|16516825|P1|Overall Study|Lost to Follow-up|3
4789113|NCT01408537|16516825|P1|Overall Study|Protocol Violation|3
4789114|NCT01408537|16516825|P1|Overall Study|Withdrawal by Subject|2
4789115|NCT01408485|16516841|P1|Overall Study|Withdrawal by Subject|21
4789116|NCT01408303|16516859|P3|Overall Study|Noncompliance|1
4789117|NCT01408303|16516860|P2|Overall Study|Noncompliance|0
4789118|NCT01408303|16516861|P1|Overall Study|Noncompliance|1
4789119|NCT01408303|16516859|P3|Overall Study|Protocol Violation|0
4789120|NCT01408303|16516860|P2|Overall Study|Protocol Violation|1
4789121|NCT01408303|16516861|P1|Overall Study|Protocol Violation|0
4789122|NCT01408303|16516859|P3|Overall Study|Withdrawal by Subject|1
4789123|NCT01408303|16516860|P2|Overall Study|Withdrawal by Subject|3
4789124|NCT01408303|16516861|P1|Overall Study|Withdrawal by Subject|2
4789125|NCT01408303|16516859|P3|Overall Study|Lost to Follow-up|2
4789126|NCT01408303|16516860|P2|Overall Study|Lost to Follow-up|1
4789127|NCT01408303|16516861|P1|Overall Study|Lost to Follow-up|0
4789128|NCT01408303|16516859|P3|Overall Study|Adverse Event|2
4789129|NCT01408303|16516860|P2|Overall Study|Adverse Event|7
4789130|NCT01408303|16516861|P1|Overall Study|Adverse Event|3
4789131|NCT01408277|16516871|P2|Overall Study|Protocol Violation|0
4789132|NCT01408277|16516872|P1|Overall Study|Protocol Violation|2
4789133|NCT01408277|16516871|P2|Overall Study|Withdrawal by Subject|0
4789134|NCT01408277|16516872|P1|Overall Study|Withdrawal by Subject|2
4789135|NCT01408277|16516871|P2|Overall Study|Lost to Follow-up|0
4789136|NCT01408277|16516872|P1|Overall Study|Lost to Follow-up|1
4789137|NCT01408277|16516871|P2|Overall Study|Adverse Event|4
4789138|NCT01408277|16516872|P1|Overall Study|Adverse Event|3
4789139|NCT01408147|16516880|P2|Overall Study|Withdrawal by Subject|1
4789140|NCT01408147|16516881|P1|Overall Study|Withdrawal by Subject|0
4789141|NCT01408043|16516889|P1|Overall Study|unable to collect cells|1
4789142|NCT01408030|16516908|P4|Observation Phase (Off Drug)|Other|1
4789143|NCT01408030|16516909|P3|Observation Phase (Off Drug)|Other|1
4789144|NCT01408030|16516910|P2|Observation Phase (Off Drug)|Other|1
4789145|NCT01408030|16516911|P1|Observation Phase (Off Drug)|Other|1
4789146|NCT01408030|16516908|P4|Observation Phase (Off Drug)|Physician Decision|0
4789147|NCT01408030|16516909|P3|Observation Phase (Off Drug)|Physician Decision|2
4789148|NCT01408030|16516910|P2|Observation Phase (Off Drug)|Physician Decision|1
4789149|NCT01408030|16516911|P1|Observation Phase (Off Drug)|Physician Decision|0
4789150|NCT01408030|16516908|P4|Observation Phase (Off Drug)|Withdrawal by Subject|3
4789151|NCT01408030|16516909|P3|Observation Phase (Off Drug)|Withdrawal by Subject|1
4789152|NCT01408030|16516910|P2|Observation Phase (Off Drug)|Withdrawal by Subject|2
4789153|NCT01408030|16516911|P1|Observation Phase (Off Drug)|Withdrawal by Subject|3
4789154|NCT01408030|16516908|P4|Observation Phase (Off Drug)|Lost to Follow-up|0
4789155|NCT01408030|16516909|P3|Observation Phase (Off Drug)|Lost to Follow-up|2
4789156|NCT01408030|16516910|P2|Observation Phase (Off Drug)|Lost to Follow-up|2
4789157|NCT01408030|16516911|P1|Observation Phase (Off Drug)|Lost to Follow-up|0
4789158|NCT01408030|16516908|P4|Treatment Phase (on Drug)|Protocol Violation|0
4789159|NCT01408030|16516909|P3|Treatment Phase (on Drug)|Protocol Violation|0
4789160|NCT01408030|16516910|P2|Treatment Phase (on Drug)|Protocol Violation|1
4789161|NCT01408030|16516911|P1|Treatment Phase (on Drug)|Protocol Violation|0
4789162|NCT01408030|16516908|P4|Treatment Phase (on Drug)|Lack of Efficacy|3
4789163|NCT01408030|16516909|P3|Treatment Phase (on Drug)|Lack of Efficacy|0
4789164|NCT01408030|16516910|P2|Treatment Phase (on Drug)|Lack of Efficacy|6
4789165|NCT01408030|16516911|P1|Treatment Phase (on Drug)|Lack of Efficacy|2
4789166|NCT01408030|16516908|P4|Treatment Phase (on Drug)|Lost to Follow-up|0
4789167|NCT01408030|16516909|P3|Treatment Phase (on Drug)|Lost to Follow-up|1
4789168|NCT01408030|16516910|P2|Treatment Phase (on Drug)|Lost to Follow-up|0
4789169|NCT01408030|16516911|P1|Treatment Phase (on Drug)|Lost to Follow-up|1
4789170|NCT01407926|16516970|P1|Overall Study|Lost to Follow-up|55
4789171|NCT01407367|16517018|P2|Overall Study|Lost to Follow-up|2
4789172|NCT01407367|16517019|P1|Overall Study|Lost to Follow-up|0
4789173|NCT01407367|16517018|P2|Overall Study|Withdrawal by Subject|15
4789174|NCT01407367|16517019|P1|Overall Study|Withdrawal by Subject|4
4789175|NCT01407367|16517018|P2|Overall Study|Renal Replacement Therapy (RRT)|29
4789176|NCT01407367|16517019|P1|Overall Study|Renal Replacement Therapy (RRT)|12
4789177|NCT01407367|16517018|P2|Overall Study|Death|32
4789178|NCT01407367|16517019|P1|Overall Study|Death|24
4789179|NCT01407354|16517033|P2|First Intervention|Physician Decision|0
4789180|NCT01407354|16517034|P1|First Intervention|Physician Decision|1
4789181|NCT01407354|16517033|P2|First Intervention|Adverse Event|0
4789182|NCT01407354|16517034|P1|First Intervention|Adverse Event|1
4789183|NCT01407354|16517033|P2|First Intervention|Withdrawal by Subject|2
4789184|NCT01407354|16517034|P1|First Intervention|Withdrawal by Subject|0
4789185|NCT01407276|16517050|P8|Overall Study|Withdrawal by Subject|1
4789186|NCT01407276|16517051|P7|Overall Study|Withdrawal by Subject|0
4789187|NCT01407276|16517052|P6|Overall Study|Withdrawal by Subject|0
4789188|NCT01407276|16517053|P5|Overall Study|Withdrawal by Subject|0
4789189|NCT01407276|16517054|P4|Overall Study|Withdrawal by Subject|0
4789190|NCT01407276|16517055|P3|Overall Study|Withdrawal by Subject|0
4789191|NCT01407276|16517056|P2|Overall Study|Withdrawal by Subject|0
4789192|NCT01407276|16517057|P1|Overall Study|Withdrawal by Subject|0
4789193|NCT01406938|16517209|P6|Follow up|Lost to Follow-up|1
4789194|NCT01406938|16517210|P5|Follow up|Lost to Follow-up|2
4789195|NCT01406938|16517211|P4|Follow up|Lost to Follow-up|1
4789196|NCT01406938|16517212|P3|Follow up|Lost to Follow-up|0
4789197|NCT01406938|16517213|P2|Follow up|Lost to Follow-up|1
4789198|NCT01406938|16517214|P1|Follow up|Lost to Follow-up|1
4789199|NCT01406938|16517209|P6|Follow up|Physician Decision|1
4789200|NCT01406938|16517210|P5|Follow up|Physician Decision|3
4789201|NCT01406938|16517211|P4|Follow up|Physician Decision|0
4789202|NCT01406938|16517212|P3|Follow up|Physician Decision|2
4789203|NCT01406938|16517213|P2|Follow up|Physician Decision|0
4789204|NCT01406938|16517214|P1|Follow up|Physician Decision|0
4789205|NCT01406938|16517209|P6|Follow up|Protocol Violation|0
4789206|NCT01406938|16517210|P5|Follow up|Protocol Violation|0
4789207|NCT01406938|16517211|P4|Follow up|Protocol Violation|0
4789208|NCT01406938|16517212|P3|Follow up|Protocol Violation|1
4789209|NCT01406938|16517213|P2|Follow up|Protocol Violation|0
4789210|NCT01406938|16517214|P1|Follow up|Protocol Violation|0
4789211|NCT01406938|16517209|P6|Follow up|Patient/guardian decision|1
4789212|NCT01406938|16517210|P5|Follow up|Patient/guardian decision|4
4789213|NCT01406938|16517211|P4|Follow up|Patient/guardian decision|2
4789214|NCT01406938|16517212|P3|Follow up|Patient/guardian decision|4
4789215|NCT01406938|16517213|P2|Follow up|Patient/guardian decision|2
4789216|NCT01406938|16517214|P1|Follow up|Patient/guardian decision|4
4789217|NCT01406938|16517209|P6|Follow up|Lack of Efficacy|0
4789218|NCT01406938|16517210|P5|Follow up|Lack of Efficacy|0
4789219|NCT01406938|16517211|P4|Follow up|Lack of Efficacy|0
4789220|NCT01406938|16517212|P3|Follow up|Lack of Efficacy|1
4789221|NCT01406938|16517213|P2|Follow up|Lack of Efficacy|2
4789222|NCT01406938|16517214|P1|Follow up|Lack of Efficacy|3
4789223|NCT01406938|16517209|P6|Maintenance Period|Lack of Efficacy|5
4789224|NCT01406938|16517210|P5|Maintenance Period|Lack of Efficacy|3
4789225|NCT01406938|16517211|P4|Maintenance Period|Lack of Efficacy|1
4789226|NCT01406938|16517212|P3|Maintenance Period|Lack of Efficacy|2
4789227|NCT01406938|16517213|P2|Maintenance Period|Lack of Efficacy|0
4789228|NCT01406938|16517214|P1|Maintenance Period|Lack of Efficacy|0
4789229|NCT01406938|16517209|P6|Maintenance Period|Lost to Follow-up|0
4789230|NCT01406938|16517210|P5|Maintenance Period|Lost to Follow-up|4
4789231|NCT01406938|16517211|P4|Maintenance Period|Lost to Follow-up|0
4789232|NCT01406938|16517212|P3|Maintenance Period|Lost to Follow-up|0
4789233|NCT01406938|16517213|P2|Maintenance Period|Lost to Follow-up|0
4789234|NCT01406938|16517214|P1|Maintenance Period|Lost to Follow-up|0
4789235|NCT01406938|16517209|P6|Maintenance Period|Pregnancy|0
4789236|NCT01406938|16517210|P5|Maintenance Period|Pregnancy|1
4789237|NCT01406938|16517211|P4|Maintenance Period|Pregnancy|0
4789238|NCT01406938|16517212|P3|Maintenance Period|Pregnancy|0
4789239|NCT01406938|16517213|P2|Maintenance Period|Pregnancy|0
4789240|NCT01406938|16517214|P1|Maintenance Period|Pregnancy|0
4789241|NCT01406938|16517209|P6|Maintenance Period|Protocol Violation|2
4789242|NCT01406938|16517210|P5|Maintenance Period|Protocol Violation|2
4789243|NCT01406938|16517211|P4|Maintenance Period|Protocol Violation|2
4789244|NCT01406938|16517212|P3|Maintenance Period|Protocol Violation|2
4789245|NCT01406938|16517213|P2|Maintenance Period|Protocol Violation|0
4789246|NCT01406938|16517214|P1|Maintenance Period|Protocol Violation|0
4789247|NCT01406938|16517209|P6|Maintenance Period|Subject/guardian decision|7
4789248|NCT01406938|16517210|P5|Maintenance Period|Subject/guardian decision|10
4789249|NCT01406938|16517211|P4|Maintenance Period|Subject/guardian decision|7
4789250|NCT01406938|16517212|P3|Maintenance Period|Subject/guardian decision|11
4789251|NCT01406938|16517213|P2|Maintenance Period|Subject/guardian decision|0
4789252|NCT01406938|16517214|P1|Maintenance Period|Subject/guardian decision|0
4789253|NCT01406938|16517209|P6|Maintenance Period|Death|0
4789254|NCT01406938|16517210|P5|Maintenance Period|Death|1
4789255|NCT01406938|16517211|P4|Maintenance Period|Death|0
4789256|NCT01406938|16517212|P3|Maintenance Period|Death|0
4789257|NCT01406938|16517213|P2|Maintenance Period|Death|0
4789258|NCT01406938|16517214|P1|Maintenance Period|Death|0
4789259|NCT01406938|16517209|P6|Maintenance Period|Adverse Event|2
4789260|NCT01406938|16517210|P5|Maintenance Period|Adverse Event|4
4789261|NCT01406938|16517211|P4|Maintenance Period|Adverse Event|8
4789262|NCT01406938|16517212|P3|Maintenance Period|Adverse Event|2
4789263|NCT01406938|16517213|P2|Maintenance Period|Adverse Event|0
4789264|NCT01406938|16517214|P1|Maintenance Period|Adverse Event|0
4789265|NCT01406938|16517209|P6|Induction Period|Lost to Follow-up|0
4789266|NCT01406938|16517210|P5|Induction Period|Lost to Follow-up|0
4789267|NCT01406938|16517211|P4|Induction Period|Lost to Follow-up|0
4789268|NCT01406938|16517212|P3|Induction Period|Lost to Follow-up|0
4789269|NCT01406938|16517213|P2|Induction Period|Lost to Follow-up|3
4789270|NCT01406938|16517214|P1|Induction Period|Lost to Follow-up|2
4789271|NCT01406938|16517209|P6|Induction Period|Lack of Efficacy|0
4789272|NCT01406938|16517210|P5|Induction Period|Lack of Efficacy|0
4789273|NCT01406938|16517211|P4|Induction Period|Lack of Efficacy|0
4789274|NCT01406938|16517212|P3|Induction Period|Lack of Efficacy|0
4789275|NCT01406938|16517213|P2|Induction Period|Lack of Efficacy|0
4789276|NCT01406938|16517214|P1|Induction Period|Lack of Efficacy|1
4789277|NCT01406938|16517209|P6|Induction Period|Adverse Event|0
4789278|NCT01406938|16517210|P5|Induction Period|Adverse Event|0
4789279|NCT01406938|16517211|P4|Induction Period|Adverse Event|0
4789280|NCT01406938|16517212|P3|Induction Period|Adverse Event|0
4789281|NCT01406938|16517213|P2|Induction Period|Adverse Event|9
4789282|NCT01406938|16517214|P1|Induction Period|Adverse Event|8
4789283|NCT01406938|16517209|P6|Induction Period|Protocol deviation|0
4789284|NCT01406938|16517210|P5|Induction Period|Protocol deviation|0
4789285|NCT01406938|16517211|P4|Induction Period|Protocol deviation|0
4789286|NCT01406938|16517212|P3|Induction Period|Protocol deviation|0
4789287|NCT01406938|16517213|P2|Induction Period|Protocol deviation|0
4789288|NCT01406938|16517214|P1|Induction Period|Protocol deviation|1
4789289|NCT01406938|16517209|P6|Induction Period|Subject/guardian decision|0
4789290|NCT01406938|16517210|P5|Induction Period|Subject/guardian decision|0
4789291|NCT01406938|16517211|P4|Induction Period|Subject/guardian decision|0
4789292|NCT01406938|16517212|P3|Induction Period|Subject/guardian decision|0
4789293|NCT01406938|16517213|P2|Induction Period|Subject/guardian decision|8
4789294|NCT01406938|16517214|P1|Induction Period|Subject/guardian decision|6
4789295|NCT01406873|16517332|P2|Overall Study|Withdrawal by Subject|1
4789296|NCT01406873|16517333|P1|Overall Study|Withdrawal by Subject|1
4789297|NCT01406795|16517364|P1|Overall Study|Withdrawal by Subject|1
4789298|NCT01406717|16517380|P2|Overall Study|Non-completion of visit activity|1
4789299|NCT01406717|16517381|P1|Overall Study|Non-completion of visit activity|0
4789300|NCT01406717|16517380|P2|Overall Study|Lack of Efficacy|1
4789301|NCT01406717|16517381|P1|Overall Study|Lack of Efficacy|0
4789302|NCT01406717|16517380|P2|Overall Study|Adverse Event|2
4789303|NCT01406717|16517381|P1|Overall Study|Adverse Event|1
4789304|NCT01406717|16517380|P2|Overall Study|Withdrawal by Subject|15
4789305|NCT01406717|16517381|P1|Overall Study|Withdrawal by Subject|19
4789306|NCT01406717|16517380|P2|Overall Study|Lost to Follow-up|8
4789307|NCT01406717|16517381|P1|Overall Study|Lost to Follow-up|14
4789308|NCT01406717|16517380|P2|Overall Study|Protocol Violation|1
4789309|NCT01406717|16517381|P1|Overall Study|Protocol Violation|5
4789310|NCT01406717|16517380|P2|Overall Study|Subject non-compliance|3
4789311|NCT01406717|16517381|P1|Overall Study|Subject non-compliance|4
4789312|NCT01406652|16517411|P2|Overall Study|Infection not sure|10
4789313|NCT01406652|16517412|P1|Overall Study|Infection not sure|10
4789314|NCT01406652|16517411|P2|Overall Study|Insufficient follow-up|4
4789315|NCT01406652|16517412|P1|Overall Study|Insufficient follow-up|5
4789316|NCT01406652|16517411|P2|Overall Study|Withdrawal by Subject|2
4789317|NCT01406652|16517412|P1|Overall Study|Withdrawal by Subject|2
4789318|NCT01406652|16517411|P2|Overall Study|Lost-to-follow-up|4
4789319|NCT01406652|16517412|P1|Overall Study|Lost-to-follow-up|3
4789320|NCT01406574|16517420|P4|Overall Study|Definite progression of primary disease|0
4789321|NCT01406574|16517421|P3|Overall Study|Definite progression of primary disease|0
4789322|NCT01406574|16517422|P2|Overall Study|Definite progression of primary disease|0
4789323|NCT01406574|16517423|P1|Overall Study|Definite progression of primary disease|1
4789324|NCT01406574|16517420|P4|Overall Study|Withdrawal by Subject|0
4789325|NCT01406574|16517421|P3|Overall Study|Withdrawal by Subject|0
4789326|NCT01406574|16517422|P2|Overall Study|Withdrawal by Subject|1
4789327|NCT01406574|16517423|P1|Overall Study|Withdrawal by Subject|0
4789328|NCT01406574|16517420|P4|Overall Study|Physician Decision|1
4789329|NCT01406574|16517421|P3|Overall Study|Physician Decision|0
4789330|NCT01406574|16517422|P2|Overall Study|Physician Decision|0
4789331|NCT01406574|16517423|P1|Overall Study|Physician Decision|0
4789332|NCT01406574|16517420|P4|Overall Study|Adverse Event|3
4789333|NCT01406574|16517421|P3|Overall Study|Adverse Event|1
4789334|NCT01406574|16517422|P2|Overall Study|Adverse Event|0
4789335|NCT01406574|16517423|P1|Overall Study|Adverse Event|0
4789336|NCT01406015|16517474|P2|Overall Study|Withdrawal by Subject|3
4789337|NCT01406015|16517475|P1|Overall Study|Withdrawal by Subject|3
4789338|NCT01405950|16517491|P4|Overall Study|Withdrawal by Subject|0
4789339|NCT01405950|16517492|P3|Overall Study|Withdrawal by Subject|0
4789340|NCT01405950|16517493|P2|Overall Study|Withdrawal by Subject|0
4789341|NCT01405950|16517494|P1|Overall Study|Withdrawal by Subject|1
4789342|NCT01405924|16517529|P1|Overall Study|Missing/Incomplete Data|2
4789343|NCT01405924|16517529|P1|Overall Study|Protocol Violation|8
4789344|NCT01405911|16517542|P3|Overall Study|Withdrawal by Subject|1
4789345|NCT01405911|16517543|P2|Overall Study|Withdrawal by Subject|1
4789346|NCT01405911|16517544|P1|Overall Study|Withdrawal by Subject|3
4789347|NCT01405911|16517542|P3|Overall Study|Protocol Violation|0
4789348|NCT01405911|16517543|P2|Overall Study|Protocol Violation|0
4789349|NCT01405911|16517544|P1|Overall Study|Protocol Violation|1
4789350|NCT01405911|16517542|P3|Overall Study|Lost to Follow-up|0
4789351|NCT01405911|16517543|P2|Overall Study|Lost to Follow-up|1
4789352|NCT01405911|16517544|P1|Overall Study|Lost to Follow-up|0
4789353|NCT01405911|16517542|P3|Overall Study|Pre-treatment lab AE|0
4789354|NCT01405911|16517543|P2|Overall Study|Pre-treatment lab AE|1
4789355|NCT01405911|16517544|P1|Overall Study|Pre-treatment lab AE|0
4789356|NCT01405898|16517563|P2|Overall Study|Withdrawal by Subject|2
4789357|NCT01405898|16517564|P1|Overall Study|Withdrawal by Subject|2
4789358|NCT01405820|16517588|P6|Open-Label Treatment Period|Adverse Event|0
4789359|NCT01405820|16517589|P5|Open-Label Treatment Period|Adverse Event|0
4789360|NCT01405820|16517590|P4|Open-Label Treatment Period|Adverse Event|1
4789361|NCT01405820|16517591|P3|Open-Label Treatment Period|Adverse Event|0
4789362|NCT01405820|16517592|P2|Open-Label Treatment Period|Adverse Event|0
4789363|NCT01405820|16517593|P1|Open-Label Treatment Period|Adverse Event|0
4789364|NCT01405820|16517588|P6|Open-Label Treatment Period|Physician Decision|0
4789365|NCT01405820|16517589|P5|Open-Label Treatment Period|Physician Decision|1
4789366|NCT01405820|16517590|P4|Open-Label Treatment Period|Physician Decision|2
4789367|NCT01405820|16517591|P3|Open-Label Treatment Period|Physician Decision|1
4789368|NCT01405820|16517592|P2|Open-Label Treatment Period|Physician Decision|0
4789369|NCT01405820|16517593|P1|Open-Label Treatment Period|Physician Decision|0
4789370|NCT01405820|16517588|P6|Open-Label Treatment Period|Other|1
4789371|NCT01405820|16517589|P5|Open-Label Treatment Period|Other|1
4789372|NCT01405820|16517590|P4|Open-Label Treatment Period|Other|1
4789373|NCT01405820|16517591|P3|Open-Label Treatment Period|Other|1
4789374|NCT01405820|16517592|P2|Open-Label Treatment Period|Other|1
4789375|NCT01405820|16517593|P1|Open-Label Treatment Period|Other|1
4789376|NCT01405820|16517588|P6|Open-Label Treatment Period|Withdrawal by Subject|1
4789377|NCT01405820|16517589|P5|Open-Label Treatment Period|Withdrawal by Subject|0
4789378|NCT01405820|16517590|P4|Open-Label Treatment Period|Withdrawal by Subject|1
4789379|NCT01405820|16517591|P3|Open-Label Treatment Period|Withdrawal by Subject|1
4789380|NCT01405820|16517592|P2|Open-Label Treatment Period|Withdrawal by Subject|1
4789381|NCT01405820|16517593|P1|Open-Label Treatment Period|Withdrawal by Subject|3
4789382|NCT01405820|16517588|P6|Randomized Treatment Period|Withdrew Prior to Dosing|0
4789383|NCT01405820|16517589|P5|Randomized Treatment Period|Withdrew Prior to Dosing|0
4789384|NCT01405820|16517590|P4|Randomized Treatment Period|Withdrew Prior to Dosing|1
4789385|NCT01405820|16517591|P3|Randomized Treatment Period|Withdrew Prior to Dosing|0
4789386|NCT01405820|16517592|P2|Randomized Treatment Period|Withdrew Prior to Dosing|0
4789387|NCT01405820|16517593|P1|Randomized Treatment Period|Withdrew Prior to Dosing|0
4789388|NCT01405820|16517588|P6|Randomized Treatment Period|Death|0
4789389|NCT01405820|16517589|P5|Randomized Treatment Period|Death|0
4789390|NCT01405820|16517590|P4|Randomized Treatment Period|Death|1
4789391|NCT01405820|16517591|P3|Randomized Treatment Period|Death|0
4789392|NCT01405820|16517592|P2|Randomized Treatment Period|Death|0
4789393|NCT01405820|16517593|P1|Randomized Treatment Period|Death|0
4789394|NCT01405820|16517588|P6|Randomized Treatment Period|Treatment Arm Closed|28
4789395|NCT01405820|16517589|P5|Randomized Treatment Period|Treatment Arm Closed|33
4789396|NCT01405820|16517590|P4|Randomized Treatment Period|Treatment Arm Closed|36
4789397|NCT01405820|16517591|P3|Randomized Treatment Period|Treatment Arm Closed|20
4789398|NCT01405820|16517592|P2|Randomized Treatment Period|Treatment Arm Closed|0
4789399|NCT01405820|16517593|P1|Randomized Treatment Period|Treatment Arm Closed|0
4789400|NCT01405820|16517588|P6|Randomized Treatment Period|Incorrect Study Treatment|0
4789401|NCT01405820|16517589|P5|Randomized Treatment Period|Incorrect Study Treatment|2
4789402|NCT01405820|16517590|P4|Randomized Treatment Period|Incorrect Study Treatment|0
4789403|NCT01405820|16517591|P3|Randomized Treatment Period|Incorrect Study Treatment|3
4789404|NCT01405820|16517592|P2|Randomized Treatment Period|Incorrect Study Treatment|0
4789405|NCT01405820|16517593|P1|Randomized Treatment Period|Incorrect Study Treatment|0
4789406|NCT01405820|16517588|P6|Randomized Treatment Period|Rescue|8
4789407|NCT01405820|16517589|P5|Randomized Treatment Period|Rescue|8
4789408|NCT01405820|16517590|P4|Randomized Treatment Period|Rescue|10
4789409|NCT01405820|16517591|P3|Randomized Treatment Period|Rescue|13
4789410|NCT01405820|16517592|P2|Randomized Treatment Period|Rescue|1
4789411|NCT01405820|16517593|P1|Randomized Treatment Period|Rescue|0
4789412|NCT01405820|16517588|P6|Randomized Treatment Period|Physician Decision|0
4789413|NCT01405820|16517589|P5|Randomized Treatment Period|Physician Decision|0
4789414|NCT01405820|16517590|P4|Randomized Treatment Period|Physician Decision|0
4789415|NCT01405820|16517591|P3|Randomized Treatment Period|Physician Decision|1
4789416|NCT01405820|16517592|P2|Randomized Treatment Period|Physician Decision|2
4789417|NCT01405820|16517593|P1|Randomized Treatment Period|Physician Decision|0
4789418|NCT01405820|16517588|P6|Randomized Treatment Period|Other|0
4789419|NCT01405820|16517589|P5|Randomized Treatment Period|Other|0
4789420|NCT01405820|16517590|P4|Randomized Treatment Period|Other|1
4789421|NCT01405820|16517591|P3|Randomized Treatment Period|Other|1
4789422|NCT01405820|16517592|P2|Randomized Treatment Period|Other|2
4789423|NCT01405820|16517593|P1|Randomized Treatment Period|Other|2
4789424|NCT01405820|16517588|P6|Randomized Treatment Period|Withdrawal by Subject|0
4789425|NCT01405820|16517589|P5|Randomized Treatment Period|Withdrawal by Subject|0
4789426|NCT01405820|16517590|P4|Randomized Treatment Period|Withdrawal by Subject|2
4789427|NCT01405820|16517591|P3|Randomized Treatment Period|Withdrawal by Subject|2
4789428|NCT01405820|16517592|P2|Randomized Treatment Period|Withdrawal by Subject|2
4789429|NCT01405820|16517593|P1|Randomized Treatment Period|Withdrawal by Subject|6
4789430|NCT01405820|16517588|P6|Randomized Treatment Period|Adverse Event|1
4789431|NCT01405820|16517589|P5|Randomized Treatment Period|Adverse Event|2
4789432|NCT01405820|16517590|P4|Randomized Treatment Period|Adverse Event|0
4789433|NCT01405820|16517591|P3|Randomized Treatment Period|Adverse Event|3
4789434|NCT01405820|16517592|P2|Randomized Treatment Period|Adverse Event|3
4789435|NCT01405820|16517593|P1|Randomized Treatment Period|Adverse Event|3
4789436|NCT01405768|16517689|P2|Overall Study|Didn't complete questionnaire correctly|0
4789437|NCT01405768|16517690|P1|Overall Study|Didn't complete questionnaire correctly|4
4789438|NCT01405742|16517702|P2|Overall Study|Lost to Follow-up|0
4789439|NCT01405742|16517703|P1|Overall Study|Lost to Follow-up|1
4789440|NCT01405560|16517713|P1|Overall Study|Physician Decision|1
4789441|NCT01405508|16517728|P4|Overall Study|AE, non-serious non-fatal|0
4789442|NCT01405508|16517729|P3|Overall Study|AE, non-serious non-fatal|0
4789443|NCT01405508|16517730|P2|Overall Study|AE, non-serious non-fatal|1
4789444|NCT01405508|16517731|P1|Overall Study|AE, non-serious non-fatal|1
4789445|NCT01405456|16517763|P2|Overall Study|Physician Decision|0
4789446|NCT01405456|16517764|P1|Overall Study|Physician Decision|1
4789447|NCT01405456|16517763|P2|Overall Study|Lost to Follow-up|1
4789448|NCT01405456|16517764|P1|Overall Study|Lost to Follow-up|2
4789449|NCT01405196|16517804|P4|Overall Study|Lost to Follow-up|1
4789450|NCT01405196|16517805|P3|Overall Study|Lost to Follow-up|3
4789451|NCT01405196|16517806|P2|Overall Study|Lost to Follow-up|2
4789452|NCT01405196|16517807|P1|Overall Study|Lost to Follow-up|2
4789453|NCT01405196|16517804|P4|Overall Study|Death|0
4789454|NCT01405196|16517805|P3|Overall Study|Death|3
4789455|NCT01405196|16517806|P2|Overall Study|Death|0
4789456|NCT01405196|16517807|P1|Overall Study|Death|1
4789457|NCT01405196|16517804|P4|Overall Study|Adverse Event|2
4789458|NCT01405196|16517805|P3|Overall Study|Adverse Event|0
4789459|NCT01405196|16517806|P2|Overall Study|Adverse Event|2
4789460|NCT01405196|16517807|P1|Overall Study|Adverse Event|2
4789461|NCT01405196|16517804|P4|Overall Study|Withdrawal by Subject|6
4789462|NCT01405196|16517805|P3|Overall Study|Withdrawal by Subject|3
4789463|NCT01405196|16517806|P2|Overall Study|Withdrawal by Subject|6
4789464|NCT01405196|16517807|P1|Overall Study|Withdrawal by Subject|4
4789465|NCT01405196|16517804|P4|Overall Study|Other|0
4789466|NCT01405196|16517805|P3|Overall Study|Other|5
4789467|NCT01405196|16517806|P2|Overall Study|Other|2
4789468|NCT01405196|16517807|P1|Overall Study|Other|2
4789469|NCT01405196|16517804|P4|Overall Study|Study Terminated by Sponsor|0
4789470|NCT01405196|16517805|P3|Overall Study|Study Terminated by Sponsor|9
4789471|NCT01405196|16517806|P2|Overall Study|Study Terminated by Sponsor|0
4789472|NCT01405196|16517807|P1|Overall Study|Study Terminated by Sponsor|0
4789473|NCT01405053|16517894|P2|Overall Study|Other|1
4789474|NCT01405053|16517895|P1|Overall Study|Other|0
4789475|NCT01405053|16517894|P2|Overall Study|Withdrawal by Subject|4
4789476|NCT01405053|16517895|P1|Overall Study|Withdrawal by Subject|3
4789477|NCT01405053|16517894|P2|Overall Study|Inadequate therapeutic effect|1
4789478|NCT01405053|16517895|P1|Overall Study|Inadequate therapeutic effect|2
4789479|NCT01405053|16517894|P2|Overall Study|Participant choice|1
4789480|NCT01405053|16517895|P1|Overall Study|Participant choice|2
4789481|NCT01405053|16517894|P2|Overall Study|Lost to Follow-up|1
4789482|NCT01405053|16517895|P1|Overall Study|Lost to Follow-up|0
4789483|NCT01405053|16517894|P2|Overall Study|Adverse Event|0
4789484|NCT01405053|16517895|P1|Overall Study|Adverse Event|3
4789485|NCT01405027|16517921|P2|Overall Study|Other or Unknown|25
4789486|NCT01405027|16517922|P1|Overall Study|Other or Unknown|12
4789487|NCT01405027|16517921|P2|Overall Study|Death|0
4789488|NCT01405027|16517922|P1|Overall Study|Death|1
4789489|NCT01405027|16517921|P2|Overall Study|Investigator judgement|2
4789490|NCT01405027|16517922|P1|Overall Study|Investigator judgement|0
4789491|NCT01405027|16517921|P2|Overall Study|Lost to Follow-up|24
4789492|NCT01405027|16517922|P1|Overall Study|Lost to Follow-up|16
4789493|NCT01405027|16517921|P2|Overall Study|Withdrawn consent|0
4789494|NCT01405027|16517922|P1|Overall Study|Withdrawn consent|3
4789495|NCT01404988|16517939|P3|Overall Study|Lost to Follow-up|1
4789496|NCT01404988|16517940|P2|Overall Study|Lost to Follow-up|2
4789497|NCT01404988|16517941|P1|Overall Study|Lost to Follow-up|1
4789498|NCT01404988|16517939|P3|Overall Study|Withdrawal by Subject|0
4789499|NCT01404988|16517940|P2|Overall Study|Withdrawal by Subject|2
4789500|NCT01404988|16517941|P1|Overall Study|Withdrawal by Subject|2
4789501|NCT01404988|16517939|P3|Overall Study|Adverse Event|0
4789502|NCT01404988|16517940|P2|Overall Study|Adverse Event|0
4789503|NCT01404988|16517941|P1|Overall Study|Adverse Event|1
4789504|NCT01404988|16517939|P3|Overall Study|Death|2
4789505|NCT01404988|16517940|P2|Overall Study|Death|0
4789506|NCT01404988|16517941|P1|Overall Study|Death|2
4789507|NCT01404325|16518062|P2|Overall Study|non-specified reason|2
4789508|NCT01404325|16518063|P1|Overall Study|non-specified reason|0
4789509|NCT01404325|16518062|P2|Overall Study|Graft loss/Retransplantation|0
4789510|NCT01404325|16518063|P1|Overall Study|Graft loss/Retransplantation|1
4789511|NCT01404325|16518062|P2|Overall Study|Death|0
4789512|NCT01404325|16518063|P1|Overall Study|Death|2
4789513|NCT01404325|16518062|P2|Overall Study|Lost to Follow-up|0
4789514|NCT01404325|16518063|P1|Overall Study|Lost to Follow-up|1
4789515|NCT01404312|16518121|P2|Overall Study|Severe debilitation, unable to continue|2
4789516|NCT01404312|16518122|P1|Overall Study|Severe debilitation, unable to continue|1
4789517|NCT01404312|16518121|P2|Overall Study|Participant not willing to adhere to req|29
4789518|NCT01404312|16518122|P1|Overall Study|Participant not willing to adhere to req|31
4789519|NCT01404312|16518121|P2|Overall Study|Site closed|21
4789520|NCT01404312|16518122|P1|Overall Study|Site closed|22
4789521|NCT01404312|16518121|P2|Overall Study|Lost to Follow-up|111
4789522|NCT01404312|16518122|P1|Overall Study|Lost to Follow-up|115
4789523|NCT01404312|16518121|P2|Overall Study|Participant Unable to get to clinic|103
4789524|NCT01404312|16518122|P1|Overall Study|Participant Unable to get to clinic|93
4789525|NCT01404312|16518121|P2|Overall Study|Withdrawal by Subject|18
4789526|NCT01404312|16518122|P1|Overall Study|Withdrawal by Subject|15
4789527|NCT01404312|16518121|P2|Overall Study|Death|27
4789528|NCT01404312|16518122|P1|Overall Study|Death|21
4789529|NCT01404234|16518151|P1|Overall Study|Withdrawal by Subject|2
4789530|NCT01404208|16518167|P2|Overall Study|Discontinued|0
4789531|NCT01404208|16518168|P1|Overall Study|Discontinued|3
4789532|NCT01403987|16518233|P3|Overall Study|Residents forgot their secret PIN|18
4789533|NCT01403987|16518234|P2|Overall Study|Residents forgot their secret PIN|17
4789534|NCT01403987|16518235|P1|Overall Study|Residents forgot their secret PIN|18
4789535|NCT01403948|16518259|P10|Overall Study|other than above|0
4789536|NCT01403948|16518260|P9|Overall Study|other than above|0
4789537|NCT01403948|16518261|P8|Overall Study|other than above|0
4789538|NCT01403948|16518262|P7|Overall Study|other than above|2
4789539|NCT01403948|16518263|P6|Overall Study|other than above|1
4789540|NCT01403948|16518264|P5|Overall Study|other than above|1
4789541|NCT01403948|16518265|P4|Overall Study|other than above|0
4789542|NCT01403948|16518266|P3|Overall Study|other than above|1
4789543|NCT01403948|16518267|P2|Overall Study|other than above|2
4789544|NCT01403948|16518268|P1|Overall Study|other than above|1
4789545|NCT01403948|16518259|P10|Overall Study|Refused cont. medication|1
4789546|NCT01403948|16518260|P9|Overall Study|Refused cont. medication|0
4789547|NCT01403948|16518261|P8|Overall Study|Refused cont. medication|0
4789548|NCT01403948|16518262|P7|Overall Study|Refused cont. medication|0
4789549|NCT01403948|16518263|P6|Overall Study|Refused cont. medication|0
4789550|NCT01403948|16518264|P5|Overall Study|Refused cont. medication|1
4789551|NCT01403948|16518265|P4|Overall Study|Refused cont. medication|0
4789552|NCT01403948|16518266|P3|Overall Study|Refused cont. medication|0
4789553|NCT01403948|16518267|P2|Overall Study|Refused cont. medication|0
4789554|NCT01403948|16518268|P1|Overall Study|Refused cont. medication|0
4789555|NCT01403948|16518259|P10|Overall Study|Lost to Follow-up|1
4789556|NCT01403948|16518260|P9|Overall Study|Lost to Follow-up|0
4789557|NCT01403948|16518261|P8|Overall Study|Lost to Follow-up|0
4789558|NCT01403948|16518262|P7|Overall Study|Lost to Follow-up|0
4789559|NCT01403948|16518263|P6|Overall Study|Lost to Follow-up|0
4789560|NCT01403948|16518264|P5|Overall Study|Lost to Follow-up|0
4789561|NCT01403948|16518265|P4|Overall Study|Lost to Follow-up|0
4789562|NCT01403948|16518266|P3|Overall Study|Lost to Follow-up|0
4789563|NCT01403948|16518267|P2|Overall Study|Lost to Follow-up|0
4789564|NCT01403948|16518268|P1|Overall Study|Lost to Follow-up|0
4789565|NCT01403948|16518259|P10|Overall Study|Other Adverse Event (Other than DLT)|0
4789566|NCT01403948|16518260|P9|Overall Study|Other Adverse Event (Other than DLT)|1
4789567|NCT01403948|16518261|P8|Overall Study|Other Adverse Event (Other than DLT)|0
4789568|NCT01403948|16518262|P7|Overall Study|Other Adverse Event (Other than DLT)|2
4789569|NCT01403948|16518263|P6|Overall Study|Other Adverse Event (Other than DLT)|0
4789570|NCT01403948|16518264|P5|Overall Study|Other Adverse Event (Other than DLT)|2
4789571|NCT01403948|16518265|P4|Overall Study|Other Adverse Event (Other than DLT)|0
4789572|NCT01403948|16518266|P3|Overall Study|Other Adverse Event (Other than DLT)|0
4789573|NCT01403948|16518267|P2|Overall Study|Other Adverse Event (Other than DLT)|0
4789574|NCT01403948|16518268|P1|Overall Study|Other Adverse Event (Other than DLT)|0
4789575|NCT01403948|16518259|P10|Overall Study|Progressive disease|5
4789576|NCT01403948|16518260|P9|Overall Study|Progressive disease|5
4789577|NCT01403948|16518261|P8|Overall Study|Progressive disease|4
4789578|NCT01403948|16518262|P7|Overall Study|Progressive disease|2
4789579|NCT01403948|16518263|P6|Overall Study|Progressive disease|6
4789580|NCT01403948|16518264|P5|Overall Study|Progressive disease|2
4789581|NCT01403948|16518265|P4|Overall Study|Progressive disease|4
4789582|NCT01403948|16518266|P3|Overall Study|Progressive disease|2
4789583|NCT01403948|16518267|P2|Overall Study|Progressive disease|2
4789584|NCT01403948|16518268|P1|Overall Study|Progressive disease|0
4789585|NCT01403805|16518341|P2|Overall Study|Death|1
4789586|NCT01403805|16518342|P1|Overall Study|Death|0
4789587|NCT01403805|16518341|P2|Overall Study|Lost to Follow-up|2
4789588|NCT01403805|16518342|P1|Overall Study|Lost to Follow-up|0
4789589|NCT01403805|16518341|P2|Overall Study|Withdrawal by Subject|4
4789590|NCT01403805|16518342|P1|Overall Study|Withdrawal by Subject|0
4789591|NCT01403610|16518358|P4|Overall Study|Didn't recover from surgery sufficiently|0
4789592|NCT01403610|16518359|P3|Overall Study|Didn't recover from surgery sufficiently|0
4789593|NCT01403610|16518360|P2|Overall Study|Didn't recover from surgery sufficiently|3
4789594|NCT01403610|16518361|P1|Overall Study|Didn't recover from surgery sufficiently|0
4789595|NCT01403610|16518358|P4|Overall Study|Withdrawal by Subject|0
4789596|NCT01403610|16518359|P3|Overall Study|Withdrawal by Subject|0
4789597|NCT01403610|16518360|P2|Overall Study|Withdrawal by Subject|0
4789598|NCT01403610|16518361|P1|Overall Study|Withdrawal by Subject|2
4789599|NCT01403194|16518407|P1|Overall Study|Lost to Follow-up|8
4789600|NCT01403194|16518407|P1|Overall Study|Screen Failure|2
4789601|NCT01403116|16518415|P2|Overall Study|unable to keep appointments|2
4789602|NCT01403116|16518416|P1|Overall Study|unable to keep appointments|0
4789603|NCT01403116|16518415|P2|Overall Study|Hct >54%|0
4789604|NCT01403116|16518416|P1|Overall Study|Hct >54%|2
4789605|NCT01403116|16518415|P2|Overall Study|undisclosed Hx of Prostate Ca|0
4789606|NCT01403116|16518416|P1|Overall Study|undisclosed Hx of Prostate Ca|1
4789607|NCT01403116|16518415|P2|Overall Study|Protocol Violation|1
4789608|NCT01403116|16518416|P1|Overall Study|Protocol Violation|0
4789609|NCT01403116|16518415|P2|Overall Study|Non-compliance of study drug|0
4789610|NCT01403116|16518416|P1|Overall Study|Non-compliance of study drug|3
4789611|NCT01403116|16518415|P2|Overall Study|Withdrawal by Subject|15
4789612|NCT01403116|16518416|P1|Overall Study|Withdrawal by Subject|12
4789613|NCT01403116|16518415|P2|Overall Study|Lost to Follow-up|5
4789614|NCT01403116|16518416|P1|Overall Study|Lost to Follow-up|7
4789615|NCT01403116|16518415|P2|Overall Study|Adverse Event|4
4789616|NCT01403116|16518416|P1|Overall Study|Adverse Event|7
4789617|NCT01403051|16518429|P2|Overall Study|Lost to Follow-up|5
4789618|NCT01403051|16518430|P1|Overall Study|Lost to Follow-up|5
4789619|NCT01403051|16518429|P2|Overall Study|Withdrawal by Subject|1
4789620|NCT01403051|16518430|P1|Overall Study|Withdrawal by Subject|2
4789621|NCT01403051|16518429|P2|Overall Study|Death|0
4789622|NCT01403051|16518430|P1|Overall Study|Death|1
4789623|NCT01403051|16518429|P2|Overall Study|Protocol Violation|0
4789624|NCT01403051|16518430|P1|Overall Study|Protocol Violation|2
4789625|NCT01402986|16518466|P4|Overall Study|Other|6
4789626|NCT01402986|16518467|P3|Overall Study|Other|1
4789627|NCT01402986|16518468|P2|Overall Study|Other|5
4789628|NCT01402986|16518469|P1|Overall Study|Other|2
4789629|NCT01402986|16518466|P4|Overall Study|Lost to Follow-up|1
4789630|NCT01402986|16518467|P3|Overall Study|Lost to Follow-up|0
4789631|NCT01402986|16518468|P2|Overall Study|Lost to Follow-up|0
4789632|NCT01402986|16518469|P1|Overall Study|Lost to Follow-up|0
4789633|NCT01402986|16518466|P4|Overall Study|Death|2
4789634|NCT01402986|16518467|P3|Overall Study|Death|0
4789635|NCT01402986|16518468|P2|Overall Study|Death|0
4789636|NCT01402986|16518469|P1|Overall Study|Death|0
4789637|NCT01402986|16518466|P4|Overall Study|Withdrawal by Subject|13
4789638|NCT01402986|16518467|P3|Overall Study|Withdrawal by Subject|7
4789639|NCT01402986|16518468|P2|Overall Study|Withdrawal by Subject|10
4789640|NCT01402986|16518469|P1|Overall Study|Withdrawal by Subject|7
4789641|NCT01402947|16518604|P2|First Intervention|Adverse Event|1
4789642|NCT01402947|16518605|P1|First Intervention|Adverse Event|0
4789643|NCT01402869|16518616|P3|Overall Study|Required Tooth Extraction|1
4789644|NCT01402869|16518617|P2|Overall Study|Required Tooth Extraction|0
4789645|NCT01402869|16518618|P1|Overall Study|Required Tooth Extraction|0
4789646|NCT01402817|16518632|P1|Overall Study|Study Suspended by FDA|8
4789647|NCT01402817|16518632|P1|Overall Study|Withdrawal by Subject|3
4789648|NCT01402700|16518637|P1|Overall Study|Missed Visit|1
4789649|NCT01402700|16518637|P1|Overall Study|Withdrawal by Subject|3
4789650|NCT01402700|16518637|P1|Overall Study|Death|3
4789651|NCT01402570|16518641|P1|Overall Study|Adverse Event|1
4789652|NCT01402544|16518648|P1|Overall Study|Withdrawal by Subject|6
4789653|NCT01402284|16518722|P1|Overall Study|Disease progression on study|10
4789654|NCT01402284|16518722|P1|Overall Study|Physician Decision|1
4789655|NCT01402284|16518722|P1|Overall Study|Follows up at Memorial Sloan Kettering|1
4789656|NCT01402284|16518722|P1|Overall Study|Withdrawal consent|2
4789657|NCT01402102|16518804|P2|Overall Study|Withdrawal by Subject|2
4789658|NCT01402102|16518805|P1|Overall Study|Withdrawal by Subject|0
4789659|NCT01402102|16518804|P2|Overall Study|Insufficiency of compliance|1
4789660|NCT01402102|16518805|P1|Overall Study|Insufficiency of compliance|1
4789661|NCT01402102|16518804|P2|Overall Study|Protocol Violation|0
4789662|NCT01402102|16518805|P1|Overall Study|Protocol Violation|1
4789663|NCT01402063|16518825|P2|Overall Study|Withdrawal by Subject|3
4789664|NCT01402063|16518826|P1|Overall Study|Withdrawal by Subject|3
4789665|NCT01402011|16518844|P3|Nine Month Follow-up|Withdrawal by Subject|0
4789666|NCT01402011|16518845|P2|Nine Month Follow-up|Withdrawal by Subject|1
4789667|NCT01402011|16518846|P1|Nine Month Follow-up|Withdrawal by Subject|0
4789668|NCT01402011|16518844|P3|Active Treatment Period|Withdrawal by Subject|0
4789669|NCT01402011|16518845|P2|Active Treatment Period|Withdrawal by Subject|3
4789670|NCT01402011|16518846|P1|Active Treatment Period|Withdrawal by Subject|1
4789671|NCT01402011|16518844|P3|Delayed Treatment Period|Withdrawal by Subject|0
4789672|NCT01402011|16518845|P2|Delayed Treatment Period|Withdrawal by Subject|0
4789673|NCT01402011|16518846|P1|Delayed Treatment Period|Withdrawal by Subject|1
4789674|NCT01401959|16518875|P3|Treated|Protocol Violation|0
4789675|NCT01401959|16518876|P2|Treated|Protocol Violation|1
4789676|NCT01401959|16518877|P1|Treated|Protocol Violation|0
4789677|NCT01401959|16518875|P3|Treated|Withdrawal by Subject|2
4789678|NCT01401959|16518876|P2|Treated|Withdrawal by Subject|2
4789679|NCT01401959|16518877|P1|Treated|Withdrawal by Subject|1
4789680|NCT01401959|16518875|P3|Treated|Adverse Event|2
4789681|NCT01401959|16518876|P2|Treated|Adverse Event|3
4789682|NCT01401959|16518877|P1|Treated|Adverse Event|4
4789683|NCT01401959|16518875|P3|Treated|Disease Progression|1
4789684|NCT01401959|16518876|P2|Treated|Disease Progression|2
4789685|NCT01401959|16518877|P1|Treated|Disease Progression|2
4789686|NCT01401959|16518875|P3|Enrolled|Withdrawal by Subject|0
4789687|NCT01401959|16518876|P2|Enrolled|Withdrawal by Subject|0
4789688|NCT01401959|16518877|P1|Enrolled|Withdrawal by Subject|1
4789689|NCT01401842|16518916|P2|Overall Study|other/unknown|17
4789690|NCT01401842|16518917|P1|Overall Study|other/unknown|28
4789691|NCT01401842|16518916|P2|Overall Study|on profile|5
4789692|NCT01401842|16518917|P1|Overall Study|on profile|9
4789693|NCT01401842|16518916|P2|Overall Study|invalid follow-up strength data|4
4789694|NCT01401842|16518917|P1|Overall Study|invalid follow-up strength data|1
4789695|NCT01401842|16518916|P2|Overall Study|discharged from US Army|4
4789696|NCT01401842|16518917|P1|Overall Study|discharged from US Army|3
4789697|NCT01401842|16518916|P2|Overall Study|changed companies|34
4789698|NCT01401842|16518917|P1|Overall Study|changed companies|20
4789699|NCT01401842|16518916|P2|Overall Study|academic reason|1
4789700|NCT01401842|16518917|P1|Overall Study|academic reason|4
4789701|NCT01401842|16518916|P2|Overall Study|Withdrawal by Subject|2
4789702|NCT01401842|16518917|P1|Overall Study|Withdrawal by Subject|3
4789703|NCT01401647|16518934|P3|Overall Study|Lost to Follow-up|1
4789704|NCT01401647|16518935|P2|Overall Study|Lost to Follow-up|3
4789705|NCT01401647|16518936|P1|Overall Study|Lost to Follow-up|3
4789706|NCT01401647|16518934|P3|Overall Study|Withdrawal by Subject|2
4789707|NCT01401647|16518935|P2|Overall Study|Withdrawal by Subject|5
4789708|NCT01401647|16518936|P1|Overall Study|Withdrawal by Subject|1
4789709|NCT01401530|16519006|P3|Overall Study|Physician Decision|0
4789710|NCT01401530|16519007|P2|Overall Study|Physician Decision|1
4789711|NCT01401530|16519008|P1|Overall Study|Physician Decision|0
4789712|NCT01401530|16519006|P3|Overall Study|Participant Choice|1
4789713|NCT01401530|16519007|P2|Overall Study|Participant Choice|2
4789714|NCT01401530|16519008|P1|Overall Study|Participant Choice|1
4789715|NCT01401530|16519006|P3|Overall Study|Adverse Event|1
4789716|NCT01401530|16519007|P2|Overall Study|Adverse Event|1
4789717|NCT01401530|16519008|P1|Overall Study|Adverse Event|1
4789718|NCT01401530|16519006|P3|Overall Study|Disease Progression|1
4789719|NCT01401530|16519007|P2|Overall Study|Disease Progression|2
4789720|NCT01401530|16519008|P1|Overall Study|Disease Progression|1
4789721|NCT01401478|16519067|P1|Overall Study|Serious adverse event|1
4789722|NCT01401478|16519067|P1|Overall Study|Low intact parathyroid hormone|1
4789723|NCT01401478|16519067|P1|Overall Study|Hyperphosphatemia and adverse event|1
4789724|NCT01401478|16519067|P1|Overall Study|Blood samples not available|1
4789725|NCT01401478|16519067|P1|Overall Study|Withdrawal by Subject|3
4789726|NCT01401478|16519067|P1|Overall Study|Kidney transplantation|3
4789727|NCT01401478|16519067|P1|Overall Study|Lost to Follow-up|5
4789728|NCT01401478|16519067|P1|Overall Study|Hyperphosphatemia|5
4789729|NCT01401478|16519067|P1|Overall Study|Adverse Event|5
4789730|NCT01401478|16519067|P1|Overall Study|Study drug not available|6
4789731|NCT01401465|16519080|P2|Treatment Period 2|Withdrawal by Subject|1
4789732|NCT01401465|16519081|P1|Treatment Period 2|Withdrawal by Subject|0
4789733|NCT01401465|16519080|P2|Treatment Period 2|Lost to Follow-up|1
4789734|NCT01401465|16519081|P1|Treatment Period 2|Lost to Follow-up|0
4789735|NCT01401465|16519080|P2|Treatment Period 1|Scheduling Difficulties|1
4789736|NCT01401465|16519081|P1|Treatment Period 1|Scheduling Difficulties|1
4789737|NCT01401465|16519080|P2|Treatment Period 1|Inability to Meet Continuation Criteria|9
4789738|NCT01401465|16519081|P1|Treatment Period 1|Inability to Meet Continuation Criteria|3
4789739|NCT01401465|16519080|P2|Treatment Period 1|Non-Compliance to Study Drug|0
4789740|NCT01401465|16519081|P1|Treatment Period 1|Non-Compliance to Study Drug|1
4789741|NCT01401465|16519080|P2|Treatment Period 1|Withdrawal by Subject|4
4789742|NCT01401465|16519081|P1|Treatment Period 1|Withdrawal by Subject|1
4789743|NCT01401465|16519080|P2|Treatment Period 1|Protocol Violation|0
4789744|NCT01401465|16519081|P1|Treatment Period 1|Protocol Violation|5
4789745|NCT01401465|16519080|P2|Treatment Period 1|Pregnancy|1
4789746|NCT01401465|16519081|P1|Treatment Period 1|Pregnancy|0
4789747|NCT01401465|16519080|P2|Treatment Period 1|Adverse Event|1
4789748|NCT01401465|16519081|P1|Treatment Period 1|Adverse Event|4
4789749|NCT01401452|16519144|P1|Overall Study|Participant withdrew consent|1
4789750|NCT01401452|16519144|P1|Overall Study|Subject chose to discontinue treatment|1
4789751|NCT01401452|16519144|P1|Overall Study|Subject withdrew because of Tx success|1
4789752|NCT01401452|16519144|P1|Overall Study|Unsatisfactory output|1
4789753|NCT01401452|16519144|P1|Overall Study|Treatment failure|1
4789754|NCT01401452|16519144|P1|Overall Study|Discontinuation for personal reasons|1
4789755|NCT01401452|16519144|P1|Overall Study|Participant stopped Tx|2
4789756|NCT01401452|16519144|P1|Overall Study|Psoriatic arthritis|1
4789757|NCT01401452|16519144|P1|Overall Study|Subject's wife wants to get pregnant|1
4789758|NCT01401452|16519144|P1|Overall Study|Subject moved to another city|1
4789759|NCT01401452|16519144|P1|Overall Study|Subject didn't return for routine visits|1
4789760|NCT01401452|16519144|P1|Overall Study|Subject did not come to follow up visits|2
4789761|NCT01401452|16519144|P1|Overall Study|No more visits within the 36 wk followup|4
4789762|NCT01401452|16519144|P1|Overall Study|Tx stopped by psychiatrist|1
4789763|NCT01401452|16519144|P1|Overall Study|Tx stopped due to financial reasons|1
4789764|NCT01401452|16519144|P1|Overall Study|Participant developed breast cancer|1
4789765|NCT01401452|16519144|P1|Overall Study|Lack of Efficacy|30
4789766|NCT01401452|16519144|P1|Overall Study|Lost to Follow-up|12
4789767|NCT01401452|16519144|P1|Overall Study|Adverse reaction|9
4789768|NCT01401361|16519156|P1|Overall Study|Subject/family decision post procedure|2
4789769|NCT01401361|16519156|P1|Overall Study|Lost to Follow-up|3
4789770|NCT01401361|16519156|P1|Overall Study|Physician Decision|1
4789771|NCT01401361|16519156|P1|Overall Study|Lack of Efficacy|6
4789772|NCT01401361|16519156|P1|Overall Study|Withdrawal by Subject|16
4789773|NCT01401322|16519162|P1|Overall Study|Physician Decision|1
4789774|NCT01401322|16519162|P1|Overall Study|Withdrawal by Subject|1
4789775|NCT01401283|16519168|P2|Overall Study|suspicion of malignant hyperthermia|1
4789776|NCT01401283|16519169|P1|Overall Study|suspicion of malignant hyperthermia|0
4789777|NCT01401283|16519168|P2|Overall Study|no central venous access|1
4789778|NCT01401283|16519169|P1|Overall Study|no central venous access|0
4789779|NCT01401283|16519168|P2|Overall Study|preoperative arrhythmia|0
4789780|NCT01401283|16519169|P1|Overall Study|preoperative arrhythmia|5
4789781|NCT01401283|16519168|P2|Overall Study|surgery cancelled|8
4789782|NCT01401283|16519169|P1|Overall Study|surgery cancelled|5
4789783|NCT01401153|16519235|P2|Second Test Day|illness|5
4789784|NCT01401153|16519236|P1|Second Test Day|illness|0
4789785|NCT01401153|16519235|P2|First Test Day|Learning disabilities; illness|10
4789786|NCT01401153|16519236|P1|First Test Day|Learning disabilities; illness|1
4789787|NCT01401062|16519283|P2|Overall Study|Withdrawal by Subject|1
4789788|NCT01401062|16519284|P1|Overall Study|Withdrawal by Subject|1
4789789|NCT01401062|16519283|P2|Overall Study|Physician Decision|0
4789790|NCT01401062|16519284|P1|Overall Study|Physician Decision|1
4789791|NCT01401062|16519283|P2|Overall Study|Death|7
4789792|NCT01401062|16519284|P1|Overall Study|Death|9
4789793|NCT01401010|16519311|P2|Overall Study|Could not interpret assay results|0
4789794|NCT01401010|16519312|P1|Overall Study|Could not interpret assay results|1
4789795|NCT01400971|16519335|P1|Overall Study|Other|422
4789796|NCT01400971|16519335|P1|Overall Study|Withdrawal by Subject|158
4789797|NCT01400971|16519335|P1|Overall Study|Physician Decision|57
4789798|NCT01400971|16519335|P1|Overall Study|Lost to follow up + Subject Decision|2
4789799|NCT01400971|16519335|P1|Overall Study|Lost to Follow-up|196
4789800|NCT01400971|16519335|P1|Overall Study|Death|82
4789801|NCT01400958|16519344|P2|Overall Study|Adverse Event|0
4789802|NCT01400958|16519345|P1|Overall Study|Adverse Event|1
4789803|NCT01400958|16519344|P2|Overall Study|Withdrawal by Subject|1
4789804|NCT01400958|16519345|P1|Overall Study|Withdrawal by Subject|0
4789805|NCT01400958|16519344|P2|Overall Study|Physician Decision|1
4789806|NCT01400958|16519345|P1|Overall Study|Physician Decision|0
4789807|NCT01400932|16519355|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
4789808|NCT01400932|16519356|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
4789809|NCT01400932|16519355|P2|Overall Study|Protocol Deviation|1
4789810|NCT01400932|16519356|P1|Overall Study|Protocol Deviation|0
4789811|NCT01400932|16519355|P2|Overall Study|Lost to Follow-up|0
4789812|NCT01400932|16519356|P1|Overall Study|Lost to Follow-up|1
4789813|NCT01400932|16519355|P2|Overall Study|Withdrawal by Subject|6
4789814|NCT01400932|16519356|P1|Overall Study|Withdrawal by Subject|2
4789815|NCT01400932|16519355|P2|Overall Study|Lack of Efficacy|3
4789816|NCT01400932|16519356|P1|Overall Study|Lack of Efficacy|0
4789817|NCT01400932|16519355|P2|Overall Study|Adverse Event|5
4789818|NCT01400932|16519356|P1|Overall Study|Adverse Event|10
4789819|NCT01400919|16519378|P1|Overall Study|Missed visit|2
4789820|NCT01400919|16519378|P1|Overall Study|Lost to Follow-up|2
4789821|NCT01400919|16519378|P1|Overall Study|Withdrawal by Subject|4
4789822|NCT01400893|16519421|P2|Overall Study|Lost to Follow-up|6
4789823|NCT01400893|16519422|P1|Overall Study|Lost to Follow-up|0
4789824|NCT01400893|16519421|P2|Overall Study|Death|21
4789825|NCT01400893|16519422|P1|Overall Study|Death|27
4789826|NCT01400841|16519434|P1|Extended Study Phase (2 Years)|Adverse Event|2
4789827|NCT01400841|16519434|P1|Initial Study Phase (6 Months)|Death|1
4789828|NCT01400698|16519472|P6|Overall Study|Other|0
4789829|NCT01400698|16519473|P5|Overall Study|Other|1
4789830|NCT01400698|16519474|P4|Overall Study|Other|2
4789831|NCT01400698|16519475|P3|Overall Study|Other|0
4789832|NCT01400698|16519476|P2|Overall Study|Other|2
4789833|NCT01400698|16519477|P1|Overall Study|Other|4
4789834|NCT01400698|16519472|P6|Overall Study|Adverse Event|0
4789835|NCT01400698|16519473|P5|Overall Study|Adverse Event|0
4789836|NCT01400698|16519474|P4|Overall Study|Adverse Event|0
4789837|NCT01400698|16519475|P3|Overall Study|Adverse Event|0
4789838|NCT01400698|16519476|P2|Overall Study|Adverse Event|0
4789839|NCT01400698|16519477|P1|Overall Study|Adverse Event|1
4789840|NCT01400698|16519472|P6|Overall Study|Non-compliance|0
4789841|NCT01400698|16519473|P5|Overall Study|Non-compliance|0
4789842|NCT01400698|16519474|P4|Overall Study|Non-compliance|1
4789843|NCT01400698|16519475|P3|Overall Study|Non-compliance|0
4789844|NCT01400698|16519476|P2|Overall Study|Non-compliance|1
4789845|NCT01400698|16519477|P1|Overall Study|Non-compliance|0
4789846|NCT01400698|16519472|P6|Overall Study|Protocol Violation|0
4789847|NCT01400698|16519473|P5|Overall Study|Protocol Violation|1
4789848|NCT01400698|16519474|P4|Overall Study|Protocol Violation|0
4789849|NCT01400698|16519475|P3|Overall Study|Protocol Violation|0
4789850|NCT01400698|16519476|P2|Overall Study|Protocol Violation|1
4789851|NCT01400698|16519477|P1|Overall Study|Protocol Violation|0
4789852|NCT01400698|16519472|P6|Overall Study|Withdrawal by Subject|3
4789853|NCT01400698|16519473|P5|Overall Study|Withdrawal by Subject|1
4789854|NCT01400698|16519474|P4|Overall Study|Withdrawal by Subject|4
4789855|NCT01400698|16519475|P3|Overall Study|Withdrawal by Subject|0
4789856|NCT01400698|16519476|P2|Overall Study|Withdrawal by Subject|2
4789857|NCT01400698|16519477|P1|Overall Study|Withdrawal by Subject|8
4789858|NCT01400698|16519472|P6|Overall Study|Lost to Follow-up|3
4789859|NCT01400698|16519473|P5|Overall Study|Lost to Follow-up|4
4789860|NCT01400698|16519474|P4|Overall Study|Lost to Follow-up|1
4789861|NCT01400698|16519475|P3|Overall Study|Lost to Follow-up|2
4789862|NCT01400698|16519476|P2|Overall Study|Lost to Follow-up|5
4789863|NCT01400698|16519477|P1|Overall Study|Lost to Follow-up|2
4789864|NCT01400516|16519501|P2|Primary Trial|Withdrawal by Subject|2
4789865|NCT01400516|16519502|P1|Primary Trial|Withdrawal by Subject|0
4789866|NCT01400503|16519512|P1|Overall Study|Other|1
4789867|NCT01400503|16519512|P1|Overall Study|Study Terminated by Sponsor|58
4789868|NCT01400503|16519512|P1|Overall Study|Withdrawal by Subject|1
4789869|NCT01400451|16519535|P3|Combination Treatment (or Intended)|Dose-limiting toxicity|0
4789870|NCT01400451|16519536|P2|Combination Treatment (or Intended)|Dose-limiting toxicity|1
4789871|NCT01400451|16519537|P1|Combination Treatment (or Intended)|Dose-limiting toxicity|0
4789872|NCT01400451|16519535|P3|Combination Treatment (or Intended)|Disease Progression|1
4789873|NCT01400451|16519536|P2|Combination Treatment (or Intended)|Disease Progression|1
4789874|NCT01400451|16519537|P1|Combination Treatment (or Intended)|Disease Progression|3
4789875|NCT01400451|16519535|P3|Combination Treatment (or Intended)|Adverse Event|0
4789876|NCT01400451|16519536|P2|Combination Treatment (or Intended)|Adverse Event|0
4789877|NCT01400451|16519537|P1|Combination Treatment (or Intended)|Adverse Event|1
4789878|NCT01400451|16519535|P3|Combination Treatment (or Intended)|Drug Toxicity|0
4789879|NCT01400451|16519536|P2|Combination Treatment (or Intended)|Drug Toxicity|1
4789880|NCT01400451|16519537|P1|Combination Treatment (or Intended)|Drug Toxicity|0
4789881|NCT01400451|16519535|P3|Combination Treatment (or Intended)|Withdrawal by Subject|1
4789882|NCT01400451|16519536|P2|Combination Treatment (or Intended)|Withdrawal by Subject|1
4789883|NCT01400451|16519537|P1|Combination Treatment (or Intended)|Withdrawal by Subject|2
4789884|NCT01400425|16519551|P1|Overall Study|Withdrawal by Subject|10
4789885|NCT01400412|16519564|P2|Overall Study|Never started study treatment|3
4789886|NCT01400412|16519565|P1|Overall Study|Never started study treatment|0
4789887|NCT01400412|16519564|P2|Overall Study|Unable to complete|3
4789888|NCT01400412|16519565|P1|Overall Study|Unable to complete|3
4789889|NCT01400412|16519564|P2|Overall Study|Withdrawal by Subject|4
4789890|NCT01400412|16519565|P1|Overall Study|Withdrawal by Subject|3
4789891|NCT01400412|16519564|P2|Overall Study|Lost to Follow-up|7
4789892|NCT01400412|16519565|P1|Overall Study|Lost to Follow-up|4
4789893|NCT01400243|16519611|P2|Overall Study|Protocol Violation|11
4789894|NCT01400243|16519612|P1|Overall Study|Protocol Violation|8
4789895|NCT01400139|16519634|P1|HYD Extension Period|Administrative|10
4789896|NCT01400139|16519634|P1|HYD Extension Period|Withdrawal by Subject|5
4789897|NCT01400139|16519634|P1|HYD Extension Period|Adverse Event|8
4789898|NCT01400139|16519634|P1|HYD Core Study|Did not qualify for Maintenance Period|14
4789899|NCT01400139|16519634|P1|HYD Core Study|Administrative|56
4789900|NCT01400139|16519634|P1|HYD Core Study|Confirmed or suspected diversion|20
4789901|NCT01400139|16519634|P1|HYD Core Study|Lost to Follow-up|39
4789902|NCT01400139|16519634|P1|HYD Core Study|Withdrawal by Subject|114
4789903|NCT01400139|16519634|P1|HYD Core Study|Lack of Efficacy|59
4789904|NCT01400139|16519634|P1|HYD Core Study|Adverse Event|210
4789905|NCT01400113|16519657|P2|Overall Study|Withdrawal by Subject|1
4789906|NCT01400113|16519658|P1|Overall Study|Withdrawal by Subject|1
4789907|NCT01399905|16519666|P2|Overall Study|Withdrawal by Subject|1
4789908|NCT01399905|16519667|P1|Overall Study|Withdrawal by Subject|1
4789909|NCT01399788|16519715|P2|First Intervention Period|Adverse Event|0
4789910|NCT01399788|16519716|P1|First Intervention Period|Adverse Event|1
4789911|NCT01399736|16519738|P2|Overall Study|Lost to Follow-up|2
4789912|NCT01399736|16519739|P1|Overall Study|Lost to Follow-up|0
4789913|NCT01399736|16519738|P2|Overall Study|Withdrawal by Subject|2
4789914|NCT01399736|16519739|P1|Overall Study|Withdrawal by Subject|4
4789915|NCT01399723|16519815|P2|Overall Study|Lost to Follow-up|1
4789916|NCT01399723|16519816|P1|Overall Study|Lost to Follow-up|0
4789917|NCT01399697|16519829|P3|Overall Study|Sponsor Decision|0
4789918|NCT01399697|16519830|P2|Overall Study|Sponsor Decision|0
4789919|NCT01399697|16519831|P1|Overall Study|Sponsor Decision|1
4789920|NCT01399697|16519829|P3|Overall Study|Clinical RA remission|0
4789921|NCT01399697|16519830|P2|Overall Study|Clinical RA remission|0
4789922|NCT01399697|16519831|P1|Overall Study|Clinical RA remission|1
4789923|NCT01399697|16519829|P3|Overall Study|Positive result for hepatitis B|0
4789924|NCT01399697|16519830|P2|Overall Study|Positive result for hepatitis B|0
4789925|NCT01399697|16519831|P1|Overall Study|Positive result for hepatitis B|1
4789926|NCT01399697|16519829|P3|Overall Study|Inclusion Error|0
4789927|NCT01399697|16519830|P2|Overall Study|Inclusion Error|0
4789928|NCT01399697|16519831|P1|Overall Study|Inclusion Error|2
4789929|NCT01399697|16519829|P3|Overall Study|Non-Compliant|0
4789930|NCT01399697|16519830|P2|Overall Study|Non-Compliant|0
4789931|NCT01399697|16519831|P1|Overall Study|Non-Compliant|1
4789932|NCT01399697|16519829|P3|Overall Study|Protocol Violation|0
4789933|NCT01399697|16519830|P2|Overall Study|Protocol Violation|0
4789934|NCT01399697|16519831|P1|Overall Study|Protocol Violation|2
4789935|NCT01399697|16519829|P3|Overall Study|Lack of Efficacy|1
4789936|NCT01399697|16519830|P2|Overall Study|Lack of Efficacy|0
4789937|NCT01399697|16519831|P1|Overall Study|Lack of Efficacy|9
4789938|NCT01399697|16519829|P3|Overall Study|Investigator Decisión|2
4789939|NCT01399697|16519830|P2|Overall Study|Investigator Decisión|0
4789940|NCT01399697|16519831|P1|Overall Study|Investigator Decisión|1
4789941|NCT01399697|16519829|P3|Overall Study|Withdrawal by Subject|0
4789942|NCT01399697|16519830|P2|Overall Study|Withdrawal by Subject|0
4789943|NCT01399697|16519831|P1|Overall Study|Withdrawal by Subject|8
4789944|NCT01399697|16519829|P3|Overall Study|Lost to Follow-up|0
4789945|NCT01399697|16519830|P2|Overall Study|Lost to Follow-up|0
4789946|NCT01399697|16519831|P1|Overall Study|Lost to Follow-up|2
4789947|NCT01399697|16519829|P3|Overall Study|Adverse Event|1
4789948|NCT01399697|16519830|P2|Overall Study|Adverse Event|3
4789949|NCT01399697|16519831|P1|Overall Study|Adverse Event|13
4789950|NCT01399619|16519858|P4|Overall Study|Not treated|2
4789951|NCT01399619|16519859|P3|Overall Study|Not treated|0
4789952|NCT01399619|16519860|P2|Overall Study|Not treated|0
4789953|NCT01399619|16519861|P1|Overall Study|Not treated|0
4789954|NCT01399619|16519858|P4|Overall Study|Protocol Violation|1
4789955|NCT01399619|16519859|P3|Overall Study|Protocol Violation|0
4789956|NCT01399619|16519860|P2|Overall Study|Protocol Violation|0
4789957|NCT01399619|16519861|P1|Overall Study|Protocol Violation|0
4789958|NCT01399619|16519858|P4|Overall Study|Withdrawal by Subject|4
4789959|NCT01399619|16519859|P3|Overall Study|Withdrawal by Subject|3
4789960|NCT01399619|16519860|P2|Overall Study|Withdrawal by Subject|0
4789961|NCT01399619|16519861|P1|Overall Study|Withdrawal by Subject|6
4789962|NCT01399619|16519858|P4|Overall Study|Lack of Efficacy|0
4789963|NCT01399619|16519859|P3|Overall Study|Lack of Efficacy|5
4789964|NCT01399619|16519860|P2|Overall Study|Lack of Efficacy|0
4789965|NCT01399619|16519861|P1|Overall Study|Lack of Efficacy|9
4789966|NCT01399619|16519858|P4|Overall Study|Adverse Event|10
4789967|NCT01399619|16519859|P3|Overall Study|Adverse Event|4
4789968|NCT01399619|16519860|P2|Overall Study|Adverse Event|0
4789969|NCT01399619|16519861|P1|Overall Study|Adverse Event|10
4789970|NCT01399593|16519924|P2|Overall Study|Transplantectomy|1
4789971|NCT01399593|16519925|P1|Overall Study|Transplantectomy|0
4789972|NCT01399593|16519924|P2|Overall Study|Death|1
4789973|NCT01399593|16519925|P1|Overall Study|Death|1
4789974|NCT01399593|16519924|P2|Overall Study|Adverse Event|0
4789975|NCT01399593|16519925|P1|Overall Study|Adverse Event|1
4789976|NCT01399593|16519924|P2|Overall Study|Physician Decision|0
4789977|NCT01399593|16519925|P1|Overall Study|Physician Decision|1
4789978|NCT01399190|16519958|P1|Overall Study|Physician Decision|2
4789979|NCT01399190|16519958|P1|Overall Study|Participant's Request|5
4789980|NCT01399190|16519958|P1|Overall Study|Adverse Event|8
4789981|NCT01399190|16519958|P1|Overall Study|Not Eligible for Final Analysis|5
4789982|NCT01399125|16519966|P2|Overall Study|Protocol Deviation|2
4789983|NCT01399125|16519967|P1|Overall Study|Protocol Deviation|5
4789984|NCT01399125|16519966|P2|Overall Study|Death|1
4789985|NCT01399125|16519967|P1|Overall Study|Death|0
4789986|NCT01399125|16519966|P2|Overall Study|Administrative Problems|11
4789987|NCT01399125|16519967|P1|Overall Study|Administrative Problems|7
4789988|NCT01399125|16519966|P2|Overall Study|Lost to Follow-up|3
4789989|NCT01399125|16519967|P1|Overall Study|Lost to Follow-up|2
4789990|NCT01399125|16519966|P2|Overall Study|Withdrawal by Subject|8
4789991|NCT01399125|16519967|P1|Overall Study|Withdrawal by Subject|5
4789992|NCT01399125|16519966|P2|Overall Study|Unsatisfactory Therapeutic Effect|4
4789993|NCT01399125|16519967|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
4789994|NCT01399125|16519966|P2|Overall Study|Abnormal Lab values|1
4789995|NCT01399125|16519967|P1|Overall Study|Abnormal Lab values|0
4789996|NCT01399125|16519966|P2|Overall Study|Adverse Event|30
4789997|NCT01399125|16519967|P1|Overall Study|Adverse Event|32
4789998|NCT01399099|16519981|P1|Overall Study|Miscellaneous|4
4789999|NCT01399099|16519981|P1|Overall Study|Infection|1
4790000|NCT01399099|16519981|P1|Overall Study|Skin Irritation|13
4790001|NCT01399099|16519981|P1|Overall Study|Protocol Violation|1
4790002|NCT01399099|16519981|P1|Overall Study|Physician Decision|1
4790003|NCT01399099|16519981|P1|Overall Study|Lost to Follow-up|11
4790004|NCT01399047|16519988|P2|Overall Study|Withdrawal by Subject|1
4790005|NCT01399047|16519989|P1|Overall Study|Withdrawal by Subject|0
4790006|NCT01398956|16520025|P1|Overall Study|Subject moved a long distance|1
4790007|NCT01398956|16520025|P1|Overall Study|Withdrawal Criteria No.3|1
4790008|NCT01398956|16520025|P1|Overall Study|AE, non-serious non-fatal|4
4790009|NCT01398956|16520025|P1|Overall Study|Withdrawal by Subject|4
4790010|NCT01398787|16520057|P1|Overall Study|Adverse Event|1
4790011|NCT01398514|16520075|P2|Overall Study|Failure to show a conditioned response|3
4790012|NCT01398514|16520076|P1|Overall Study|Failure to show a conditioned response|4
4790013|NCT01398514|16520075|P2|Overall Study|Physiologic non-responsiveness|3
4790014|NCT01398514|16520076|P1|Overall Study|Physiologic non-responsiveness|1
4790015|NCT01398514|16520075|P2|Overall Study|Non-compliance with study procedures|0
4790016|NCT01398514|16520076|P1|Overall Study|Non-compliance with study procedures|2
4790017|NCT01398514|16520075|P2|Overall Study|Adverse Event|0
4790018|NCT01398514|16520076|P1|Overall Study|Adverse Event|1
4790019|NCT01398410|16520111|P2|Overall Study|Other|29
4790020|NCT01398410|16520112|P1|Overall Study|Other|36
4790021|NCT01398410|16520111|P2|Overall Study|Inadequate Therapeutic Effect|0
4790022|NCT01398410|16520112|P1|Overall Study|Inadequate Therapeutic Effect|2
4790023|NCT01398410|16520111|P2|Overall Study|Participants Choice|11
4790024|NCT01398410|16520112|P1|Overall Study|Participants Choice|8
4790025|NCT01398410|16520111|P2|Overall Study|Adverse Event|16
4790026|NCT01398410|16520112|P1|Overall Study|Adverse Event|12
4790027|NCT01398358|16520123|P3|Overall Study|no longer eligible|1
4790028|NCT01398358|16520124|P2|Overall Study|no longer eligible|0
4790029|NCT01398358|16520125|P1|Overall Study|no longer eligible|1
4790030|NCT01398358|16520123|P3|Overall Study|Withdrawal by Subject|2
4790031|NCT01398358|16520124|P2|Overall Study|Withdrawal by Subject|2
4790032|NCT01398358|16520125|P1|Overall Study|Withdrawal by Subject|3
4790033|NCT01398358|16520123|P3|Overall Study|Lost to Follow-up|18
4790034|NCT01398358|16520124|P2|Overall Study|Lost to Follow-up|21
4790035|NCT01398358|16520125|P1|Overall Study|Lost to Follow-up|11
4790036|NCT01398176|16520147|P2|Overall Study|Physician Decision|3
4790037|NCT01398176|16520148|P1|Overall Study|Physician Decision|2
4790038|NCT01398176|16520147|P2|Overall Study|Lost to Follow-up|3
4790039|NCT01398176|16520148|P1|Overall Study|Lost to Follow-up|1
4790040|NCT01397890|16520181|P2|Overall Study|Others|1
4790041|NCT01397890|16520182|P1|Overall Study|Others|2
4790042|NCT01397890|16520181|P2|Overall Study|Severe Non-Compliance to Protocol|1
4790043|NCT01397890|16520182|P1|Overall Study|Severe Non-Compliance to Protocol|2
4790044|NCT01397890|16520181|P2|Overall Study|Adverse Event|2
4790045|NCT01397890|16520182|P1|Overall Study|Adverse Event|1
4790046|NCT01397890|16520181|P2|Overall Study|Condition under Investigation Worsened|3
4790047|NCT01397890|16520182|P1|Overall Study|Condition under Investigation Worsened|1
4790048|NCT01397890|16520181|P2|Overall Study|Lost to Follow-up|4
4790049|NCT01397890|16520182|P1|Overall Study|Lost to Follow-up|1
4790050|NCT01397890|16520181|P2|Overall Study|Death|3
4790051|NCT01397890|16520182|P1|Overall Study|Death|2
4790052|NCT01397890|16520181|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
4790053|NCT01397890|16520182|P1|Overall Study|Eligibility Criteria Not Fulfilled|7
4790054|NCT01397890|16520181|P2|Overall Study|Withdrawal by Subject|11
4790055|NCT01397890|16520182|P1|Overall Study|Withdrawal by Subject|7
4790056|NCT01397825|16520253|P5|Overall Study|Withdrawal by Subject|0
4790057|NCT01397825|16520254|P4|Overall Study|Withdrawal by Subject|1
4790058|NCT01397825|16520255|P3|Overall Study|Withdrawal by Subject|5
4790059|NCT01397825|16520256|P2|Overall Study|Withdrawal by Subject|0
4790060|NCT01397825|16520257|P1|Overall Study|Withdrawal by Subject|1
4790061|NCT01397825|16520253|P5|Overall Study|Adverse Event|0
4790062|NCT01397825|16520254|P4|Overall Study|Adverse Event|1
4790063|NCT01397825|16520255|P3|Overall Study|Adverse Event|5
4790064|NCT01397825|16520256|P2|Overall Study|Adverse Event|1
4790065|NCT01397825|16520257|P1|Overall Study|Adverse Event|0
4790066|NCT01397825|16520253|P5|Overall Study|Symptomatic Deterioration|0
4790067|NCT01397825|16520254|P4|Overall Study|Symptomatic Deterioration|0
4790068|NCT01397825|16520255|P3|Overall Study|Symptomatic Deterioration|4
4790069|NCT01397825|16520256|P2|Overall Study|Symptomatic Deterioration|0
4790070|NCT01397825|16520257|P1|Overall Study|Symptomatic Deterioration|2
4790071|NCT01397825|16520253|P5|Overall Study|Progressive Disease|0
4790072|NCT01397825|16520254|P4|Overall Study|Progressive Disease|1
4790073|NCT01397825|16520255|P3|Overall Study|Progressive Disease|11
4790074|NCT01397825|16520256|P2|Overall Study|Progressive Disease|3
4790075|NCT01397825|16520257|P1|Overall Study|Progressive Disease|10
4790076|NCT01397786|16520327|P3|Phase B|Lack of Efficacy|14
4790077|NCT01397786|16520328|P2|Phase B|Lack of Efficacy|7
4790078|NCT01397786|16520329|P1|Phase B|Lack of Efficacy|22
4790079|NCT01397786|16520327|P3|Phase B|Protocol Deviation|4
4790080|NCT01397786|16520328|P2|Phase B|Protocol Deviation|2
4790081|NCT01397786|16520329|P1|Phase B|Protocol Deviation|1
4790082|NCT01397786|16520327|P3|Phase B|Withdrawal by Subject|30
4790083|NCT01397786|16520328|P2|Phase B|Withdrawal by Subject|45
4790084|NCT01397786|16520329|P1|Phase B|Withdrawal by Subject|102
4790085|NCT01397786|16520327|P3|Phase B|Physician Decision|3
4790086|NCT01397786|16520328|P2|Phase B|Physician Decision|1
4790087|NCT01397786|16520329|P1|Phase B|Physician Decision|9
4790088|NCT01397786|16520327|P3|Phase B|Subject Met Withdrawal Criteria|38
4790089|NCT01397786|16520328|P2|Phase B|Subject Met Withdrawal Criteria|5
4790090|NCT01397786|16520329|P1|Phase B|Subject Met Withdrawal Criteria|38
4790091|NCT01397786|16520327|P3|Phase B|Adverse Event|27
4790092|NCT01397786|16520328|P2|Phase B|Adverse Event|23
4790093|NCT01397786|16520329|P1|Phase B|Adverse Event|109
4790094|NCT01397786|16520327|P3|Phase B|Lost to Follow-up|22
4790095|NCT01397786|16520328|P2|Phase B|Lost to Follow-up|12
4790096|NCT01397786|16520329|P1|Phase B|Lost to Follow-up|22
4790097|NCT01397786|16520327|P3|Phase A|Lack of Efficacy|1
4790098|NCT01397786|16520328|P2|Phase A|Lack of Efficacy|0
4790099|NCT01397786|16520329|P1|Phase A|Lack of Efficacy|0
4790100|NCT01397786|16520327|P3|Phase A|Withdrawal by Subject|5
4790101|NCT01397786|16520328|P2|Phase A|Withdrawal by Subject|0
4790102|NCT01397786|16520329|P1|Phase A|Withdrawal by Subject|0
4790103|NCT01397786|16520327|P3|Phase A|Physician Decision|1
4790104|NCT01397786|16520328|P2|Phase A|Physician Decision|0
4790105|NCT01397786|16520329|P1|Phase A|Physician Decision|0
4790106|NCT01397786|16520327|P3|Phase A|Subject Met Withdrawal Criteria|7
4790107|NCT01397786|16520328|P2|Phase A|Subject Met Withdrawal Criteria|0
4790108|NCT01397786|16520329|P1|Phase A|Subject Met Withdrawal Criteria|0
4790109|NCT01397786|16520327|P3|Phase A|Adverse Event|8
4790110|NCT01397786|16520328|P2|Phase A|Adverse Event|0
4790111|NCT01397786|16520329|P1|Phase A|Adverse Event|0
4790112|NCT01397786|16520327|P3|Phase A|Lost to Follow-up|6
4790113|NCT01397786|16520328|P2|Phase A|Lost to Follow-up|0
4790114|NCT01397786|16520329|P1|Phase A|Lost to Follow-up|0
4790115|NCT01397747|16520395|P1|Overall Study|FIT excluded|34
4790116|NCT01397747|16520395|P1|Overall Study|Colonoscopy excluded|304
4790117|NCT01397747|16520395|P1|Overall Study|Multitarget DNA test excluded|689
4790118|NCT01397552|16520445|P2|Overall Study|Withdrawal by Subject|1
4790119|NCT01397552|16520446|P1|Overall Study|Withdrawal by Subject|2
4790120|NCT01397552|16520445|P2|Overall Study|Adverse Event|0
4790121|NCT01397552|16520446|P1|Overall Study|Adverse Event|1
4790122|NCT01397461|16520455|P3|Overall Study|Not treated|1
4790123|NCT01397461|16520456|P2|Overall Study|Not treated|0
4790124|NCT01397461|16520457|P1|Overall Study|Not treated|0
4790125|NCT01397461|16520455|P3|Overall Study|Lack of Efficacy|0
4790126|NCT01397461|16520456|P2|Overall Study|Lack of Efficacy|3
4790127|NCT01397461|16520457|P1|Overall Study|Lack of Efficacy|0
4790128|NCT01397461|16520455|P3|Overall Study|Lost to Follow-up|1
4790129|NCT01397461|16520456|P2|Overall Study|Lost to Follow-up|2
4790130|NCT01397461|16520457|P1|Overall Study|Lost to Follow-up|0
4790131|NCT01397461|16520455|P3|Overall Study|Withdrawal by Subject|0
4790132|NCT01397461|16520456|P2|Overall Study|Withdrawal by Subject|1
4790133|NCT01397461|16520457|P1|Overall Study|Withdrawal by Subject|2
4790134|NCT01397448|16520468|P3|Overall Study|Other|4
4790135|NCT01397448|16520469|P2|Overall Study|Other|7
4790136|NCT01397448|16520470|P1|Overall Study|Other|8
4790137|NCT01397448|16520468|P3|Overall Study|Lack of Efficacy|5
4790138|NCT01397448|16520469|P2|Overall Study|Lack of Efficacy|0
4790139|NCT01397448|16520470|P1|Overall Study|Lack of Efficacy|2
4790140|NCT01397448|16520468|P3|Overall Study|Withdrawal by Subject|3
4790141|NCT01397448|16520469|P2|Overall Study|Withdrawal by Subject|4
4790142|NCT01397448|16520470|P1|Overall Study|Withdrawal by Subject|4
4790143|NCT01397448|16520468|P3|Overall Study|Adverse Event|6
4790144|NCT01397448|16520469|P2|Overall Study|Adverse Event|4
4790145|NCT01397448|16520470|P1|Overall Study|Adverse Event|4
4790146|NCT01397422|16520485|P4|Overall Study|Increased bradykinesia related to PD|0
4790147|NCT01397422|16520486|P3|Overall Study|Increased bradykinesia related to PD|0
4790148|NCT01397422|16520487|P2|Overall Study|Increased bradykinesia related to PD|0
4790149|NCT01397422|16520488|P1|Overall Study|Increased bradykinesia related to PD|1
4790150|NCT01397422|16520485|P4|Overall Study|Withdrawal by Subject|0
4790151|NCT01397422|16520486|P3|Overall Study|Withdrawal by Subject|0
4790152|NCT01397422|16520487|P2|Overall Study|Withdrawal by Subject|0
4790153|NCT01397422|16520488|P1|Overall Study|Withdrawal by Subject|1
4790154|NCT01397422|16520485|P4|Overall Study|Adverse Event|8
4790155|NCT01397422|16520486|P3|Overall Study|Adverse Event|3
4790156|NCT01397422|16520487|P2|Overall Study|Adverse Event|3
4790157|NCT01397422|16520488|P1|Overall Study|Adverse Event|0
4790158|NCT01397409|16520528|P10|Stage 3|Other Miscellaneous Reasons|0
4790159|NCT01397409|16520529|P9|Stage 3|Other Miscellaneous Reasons|0
4790160|NCT01397409|16520530|P8|Stage 3|Other Miscellaneous Reasons|1
4790161|NCT01397409|16520531|P7|Stage 3|Other Miscellaneous Reasons|0
4790162|NCT01397409|16520532|P6|Stage 3|Other Miscellaneous Reasons|0
4790163|NCT01397409|16520533|P5|Stage 3|Other Miscellaneous Reasons|0
4790164|NCT01397409|16520534|P4|Stage 3|Other Miscellaneous Reasons|0
4790165|NCT01397409|16520535|P3|Stage 3|Other Miscellaneous Reasons|0
4790166|NCT01397409|16520536|P2|Stage 3|Other Miscellaneous Reasons|0
4790167|NCT01397409|16520537|P1|Stage 3|Other Miscellaneous Reasons|0
4790168|NCT01397409|16520528|P10|Stage 3|Adverse Event|0
4790169|NCT01397409|16520529|P9|Stage 3|Adverse Event|0
4790170|NCT01397409|16520530|P8|Stage 3|Adverse Event|1
4790171|NCT01397409|16520531|P7|Stage 3|Adverse Event|0
4790172|NCT01397409|16520532|P6|Stage 3|Adverse Event|0
4790173|NCT01397409|16520533|P5|Stage 3|Adverse Event|0
4790174|NCT01397409|16520534|P4|Stage 3|Adverse Event|0
4790175|NCT01397409|16520535|P3|Stage 3|Adverse Event|0
4790176|NCT01397409|16520536|P2|Stage 3|Adverse Event|0
4790177|NCT01397409|16520537|P1|Stage 3|Adverse Event|0
4790178|NCT01397409|16520528|P10|Stage 2|Other Miscellaneous Reasons|0
4790179|NCT01397409|16520529|P9|Stage 2|Other Miscellaneous Reasons|0
4790180|NCT01397409|16520530|P8|Stage 2|Other Miscellaneous Reasons|0
4790181|NCT01397409|16520531|P7|Stage 2|Other Miscellaneous Reasons|0
4790182|NCT01397409|16520532|P6|Stage 2|Other Miscellaneous Reasons|1
4790183|NCT01397409|16520533|P5|Stage 2|Other Miscellaneous Reasons|1
4790184|NCT01397409|16520534|P4|Stage 2|Other Miscellaneous Reasons|0
4790185|NCT01397409|16520535|P3|Stage 2|Other Miscellaneous Reasons|0
4790186|NCT01397409|16520536|P2|Stage 2|Other Miscellaneous Reasons|0
4790187|NCT01397409|16520537|P1|Stage 2|Other Miscellaneous Reasons|0
4790188|NCT01397409|16520528|P10|Stage 2|Personal Reasons|0
4790189|NCT01397409|16520529|P9|Stage 2|Personal Reasons|0
4790190|NCT01397409|16520530|P8|Stage 2|Personal Reasons|0
4790191|NCT01397409|16520531|P7|Stage 2|Personal Reasons|0
4790192|NCT01397409|16520532|P6|Stage 2|Personal Reasons|0
4790193|NCT01397409|16520533|P5|Stage 2|Personal Reasons|1
4790194|NCT01397409|16520534|P4|Stage 2|Personal Reasons|0
4790195|NCT01397409|16520535|P3|Stage 2|Personal Reasons|0
4790196|NCT01397409|16520536|P2|Stage 2|Personal Reasons|0
4790197|NCT01397409|16520537|P1|Stage 2|Personal Reasons|0
4790198|NCT01397409|16520528|P10|Stage 2|Adverse Event|0
4790199|NCT01397409|16520529|P9|Stage 2|Adverse Event|0
4790200|NCT01397409|16520530|P8|Stage 2|Adverse Event|0
4790201|NCT01397409|16520531|P7|Stage 2|Adverse Event|0
4790202|NCT01397409|16520532|P6|Stage 2|Adverse Event|3
4790203|NCT01397409|16520533|P5|Stage 2|Adverse Event|6
4790204|NCT01397409|16520534|P4|Stage 2|Adverse Event|0
4790205|NCT01397409|16520535|P3|Stage 2|Adverse Event|0
4790206|NCT01397409|16520536|P2|Stage 2|Adverse Event|0
4790207|NCT01397409|16520537|P1|Stage 2|Adverse Event|0
4790208|NCT01397253|16520577|P2|Overall Study|Reviewed by only 1 pharmacist|149
4790209|NCT01397253|16520578|P1|Overall Study|Reviewed by only 1 pharmacist|126
4790210|NCT01397084|16520584|P1|Overall Study|Used other proton pump inhibitor|1
4790211|NCT01397084|16520584|P1|Overall Study|Lost to Follow-up|1
4790212|NCT01397084|16520584|P1|Overall Study|Withdrawal by Subject|1
4790213|NCT01397084|16520584|P1|Overall Study|Adverse Event|2
4790214|NCT01397084|16520584|P1|Overall Study|Protocol Violation|2
4790215|NCT01397084|16520584|P1|Overall Study|Severe Non-Compliance to Protocol|1
4790216|NCT01396525|16520603|P1|Overall Study|Lost to Follow-up|4
4790217|NCT01396525|16520603|P1|Overall Study|Death|14
4790218|NCT01396525|16520603|P1|Overall Study|Withdrawal by Subject|8
4790219|NCT01396512|16520703|P2|Overall Study|Withdrawal by Subject|1
4790220|NCT01396512|16520704|P1|Overall Study|Withdrawal by Subject|0
4790221|NCT01396447|16520736|P4|Overall Study|Other Miscellaneous Reasons|0
4790222|NCT01396447|16520737|P3|Overall Study|Other Miscellaneous Reasons|1
4790223|NCT01396447|16520738|P2|Overall Study|Other Miscellaneous Reasons|2
4790224|NCT01396447|16520739|P1|Overall Study|Other Miscellaneous Reasons|0
4790225|NCT01396447|16520736|P4|Overall Study|Lost to Follow-up|9
4790226|NCT01396447|16520737|P3|Overall Study|Lost to Follow-up|7
4790227|NCT01396447|16520738|P2|Overall Study|Lost to Follow-up|8
4790228|NCT01396447|16520739|P1|Overall Study|Lost to Follow-up|4
4790229|NCT01396447|16520736|P4|Overall Study|Withdrawal of Consent|15
4790230|NCT01396447|16520737|P3|Overall Study|Withdrawal of Consent|4
4790231|NCT01396447|16520738|P2|Overall Study|Withdrawal of Consent|9
4790232|NCT01396447|16520739|P1|Overall Study|Withdrawal of Consent|11
4790233|NCT01396447|16520736|P4|Overall Study|Protocol Violation|7
4790234|NCT01396447|16520737|P3|Overall Study|Protocol Violation|3
4790235|NCT01396447|16520738|P2|Overall Study|Protocol Violation|2
4790236|NCT01396447|16520739|P1|Overall Study|Protocol Violation|5
4790237|NCT01396447|16520736|P4|Overall Study|Insufficient Therapeutic Response|4
4790238|NCT01396447|16520737|P3|Overall Study|Insufficient Therapeutic Response|2
4790239|NCT01396447|16520738|P2|Overall Study|Insufficient Therapeutic Response|5
4790240|NCT01396447|16520739|P1|Overall Study|Insufficient Therapeutic Response|5
4790241|NCT01396447|16520736|P4|Overall Study|Adverse Event|17
4790242|NCT01396447|16520737|P3|Overall Study|Adverse Event|12
4790243|NCT01396447|16520738|P2|Overall Study|Adverse Event|12
4790244|NCT01396447|16520739|P1|Overall Study|Adverse Event|15
4790245|NCT01396447|16520736|P4|Overall Study|Did Not Receive Treatment|0
4790246|NCT01396447|16520737|P3|Overall Study|Did Not Receive Treatment|1
4790247|NCT01396447|16520738|P2|Overall Study|Did Not Receive Treatment|2
4790248|NCT01396447|16520739|P1|Overall Study|Did Not Receive Treatment|3
4790249|NCT01396434|16520756|P3|Overall Study|Other|0
4790250|NCT01396434|16520757|P2|Overall Study|Other|0
4790251|NCT01396434|16520758|P1|Overall Study|Other|10
4790252|NCT01396434|16520756|P3|Overall Study|Lost to Follow-up|0
4790253|NCT01396434|16520757|P2|Overall Study|Lost to Follow-up|0
4790254|NCT01396434|16520758|P1|Overall Study|Lost to Follow-up|1
4790255|NCT01396421|16520770|P4|Overall Study|Lack of Efficacy|18
4790256|NCT01396421|16520771|P3|Overall Study|Lack of Efficacy|7
4790257|NCT01396421|16520772|P2|Overall Study|Lack of Efficacy|17
4790258|NCT01396421|16520773|P1|Overall Study|Lack of Efficacy|7
4790259|NCT01396421|16520770|P4|Overall Study|Protocol Deviation|0
4790260|NCT01396421|16520771|P3|Overall Study|Protocol Deviation|1
4790261|NCT01396421|16520772|P2|Overall Study|Protocol Deviation|1
4790262|NCT01396421|16520773|P1|Overall Study|Protocol Deviation|2
4790263|NCT01396421|16520770|P4|Overall Study|Withdrawal by Subject|21
4790264|NCT01396421|16520771|P3|Overall Study|Withdrawal by Subject|13
4790265|NCT01396421|16520772|P2|Overall Study|Withdrawal by Subject|24
4790266|NCT01396421|16520773|P1|Overall Study|Withdrawal by Subject|31
4790267|NCT01396421|16520770|P4|Overall Study|Physician Decision|3
4790268|NCT01396421|16520771|P3|Overall Study|Physician Decision|0
4790269|NCT01396421|16520772|P2|Overall Study|Physician Decision|1
4790270|NCT01396421|16520773|P1|Overall Study|Physician Decision|1
4790271|NCT01396421|16520770|P4|Overall Study|Participant Met Withdrawal Criteria|0
4790272|NCT01396421|16520771|P3|Overall Study|Participant Met Withdrawal Criteria|1
4790273|NCT01396421|16520772|P2|Overall Study|Participant Met Withdrawal Criteria|0
4790274|NCT01396421|16520773|P1|Overall Study|Participant Met Withdrawal Criteria|1
4790275|NCT01396421|16520770|P4|Overall Study|Adverse Event|32
4790276|NCT01396421|16520771|P3|Overall Study|Adverse Event|12
4790277|NCT01396421|16520772|P2|Overall Study|Adverse Event|15
4790278|NCT01396421|16520773|P1|Overall Study|Adverse Event|17
4790279|NCT01396421|16520770|P4|Overall Study|Lost to Follow-up|1
4790280|NCT01396421|16520771|P3|Overall Study|Lost to Follow-up|0
4790281|NCT01396421|16520772|P2|Overall Study|Lost to Follow-up|0
4790282|NCT01396421|16520773|P1|Overall Study|Lost to Follow-up|0
4790283|NCT01396395|16520845|P2|Overall Study|Other|1
4790284|NCT01396395|16520846|P1|Overall Study|Other|0
4790285|NCT01396395|16520845|P2|Overall Study|Lost to Follow-up|11
4790286|NCT01396395|16520846|P1|Overall Study|Lost to Follow-up|17
4790287|NCT01396395|16520845|P2|Overall Study|Adverse Event|2
4790288|NCT01396395|16520846|P1|Overall Study|Adverse Event|10
4790289|NCT01396395|16520845|P2|Overall Study|Protocol Violation|1
4790290|NCT01396395|16520846|P1|Overall Study|Protocol Violation|3
4790291|NCT01396395|16520845|P2|Overall Study|Withdrawal by Subject|12
4790292|NCT01396395|16520846|P1|Overall Study|Withdrawal by Subject|10
4790293|NCT01396317|16520888|P2|Overall Study|Adverse Event|0
4790294|NCT01396317|16520889|P1|Overall Study|Adverse Event|1
4790295|NCT01396265|16520903|P1|Rifa+Afatinib|Withdrawal by Subject|1
4790296|NCT01396187|16520992|P5|Overall Study|Other|1
4790297|NCT01396187|16520993|P4|Overall Study|Other|0
4790298|NCT01396187|16520994|P3|Overall Study|Other|0
4790299|NCT01396187|16520995|P2|Overall Study|Other|1
4790300|NCT01396187|16520996|P1|Overall Study|Other|1
4790301|NCT01396187|16520992|P5|Overall Study|Withdrawal by Subject|0
4790302|NCT01396187|16520993|P4|Overall Study|Withdrawal by Subject|0
4790303|NCT01396187|16520994|P3|Overall Study|Withdrawal by Subject|1
4790304|NCT01396187|16520995|P2|Overall Study|Withdrawal by Subject|1
4790305|NCT01396187|16520996|P1|Overall Study|Withdrawal by Subject|0
4790306|NCT01396187|16520992|P5|Overall Study|Adverse Event|0
4790307|NCT01396187|16520993|P4|Overall Study|Adverse Event|0
4790308|NCT01396187|16520994|P3|Overall Study|Adverse Event|0
4790309|NCT01396187|16520995|P2|Overall Study|Adverse Event|1
4790310|NCT01396187|16520996|P1|Overall Study|Adverse Event|0
4790311|NCT01396161|16521096|P7|Overall Study|Other|1
4790312|NCT01396161|16521097|P6|Overall Study|Other|0
4790313|NCT01396161|16521098|P5|Overall Study|Other|0
4790314|NCT01396161|16521099|P4|Overall Study|Other|0
4790315|NCT01396161|16521100|P3|Overall Study|Other|0
4790316|NCT01396161|16521101|P2|Overall Study|Other|0
4790317|NCT01396161|16521102|P1|Overall Study|Other|0
4790318|NCT01396161|16521096|P7|Overall Study|Withdrawal by Subject|0
4790319|NCT01396161|16521097|P6|Overall Study|Withdrawal by Subject|0
4790320|NCT01396161|16521098|P5|Overall Study|Withdrawal by Subject|1
4790321|NCT01396161|16521099|P4|Overall Study|Withdrawal by Subject|0
4790322|NCT01396161|16521100|P3|Overall Study|Withdrawal by Subject|0
4790323|NCT01396161|16521101|P2|Overall Study|Withdrawal by Subject|0
4790324|NCT01396161|16521102|P1|Overall Study|Withdrawal by Subject|0
4790325|NCT01396148|16521155|P1|Overall Study|Patient Decision|1
4790326|NCT01396083|16521185|P2|Overall Study|Lost to Follow-up|0
4790327|NCT01396083|16521186|P1|Overall Study|Lost to Follow-up|1
4790328|NCT01396083|16521185|P2|Overall Study|Administrative problems|0
4790329|NCT01396083|16521186|P1|Overall Study|Administrative problems|1
4790330|NCT01396083|16521185|P2|Overall Study|Abnormal laboratory value(s)|0
4790331|NCT01396083|16521186|P1|Overall Study|Abnormal laboratory value(s)|1
4790332|NCT01396083|16521185|P2|Overall Study|Protocol deviation(s)|1
4790333|NCT01396083|16521186|P1|Overall Study|Protocol deviation(s)|0
4790334|NCT01396083|16521185|P2|Overall Study|Consent withdrawn|5
4790335|NCT01396083|16521186|P1|Overall Study|Consent withdrawn|4
4790336|NCT01396083|16521185|P2|Overall Study|Unsatisfactory therapeutic effect|13
4790337|NCT01396083|16521186|P1|Overall Study|Unsatisfactory therapeutic effect|2
4790338|NCT01396083|16521185|P2|Overall Study|Adverse Event|28
4790339|NCT01396083|16521186|P1|Overall Study|Adverse Event|2
4790340|NCT01396070|16521210|P1|Overall Study|Lack of Efficacy|4
4790341|NCT01396070|16521210|P1|Overall Study|Physician Decision|3
4790342|NCT01396070|16521210|P1|Overall Study|Adverse Event|8
4790343|NCT01396070|16521210|P1|Overall Study|Death|2
4790344|NCT01396070|16521210|P1|Overall Study|Withdrawal by Subject|2
4790345|NCT01396057|16521219|P2|Overall Study|Consent withdrawn|2
4790346|NCT01396057|16521220|P1|Overall Study|Consent withdrawn|3
4790347|NCT01396057|16521219|P2|Overall Study|Protocol deviation|4
4790348|NCT01396057|16521220|P1|Overall Study|Protocol deviation|4
4790349|NCT01396057|16521219|P2|Overall Study|Unsatisfactory therapeutic effect|6
4790350|NCT01396057|16521220|P1|Overall Study|Unsatisfactory therapeutic effect|2
4790351|NCT01396057|16521219|P2|Overall Study|Adverse Event|6
4790352|NCT01396057|16521220|P1|Overall Study|Adverse Event|2
4790353|NCT01396005|16521269|P2|Overall Study|Non-compliance with protocol|1
4790354|NCT01396005|16521270|P1|Overall Study|Non-compliance with protocol|0
4790355|NCT01396005|16521269|P2|Overall Study|Withdrawal by Subject|1
4790356|NCT01396005|16521270|P1|Overall Study|Withdrawal by Subject|0
4790357|NCT01395914|16521301|P2|Overall Study|Lost to Follow-up|2
4790358|NCT01395914|16521302|P1|Overall Study|Lost to Follow-up|6
4790359|NCT01395914|16521301|P2|Overall Study|Study drug-related AE|0
4790360|NCT01395914|16521302|P1|Overall Study|Study drug-related AE|1
4790361|NCT01395914|16521301|P2|Overall Study|Withdrawal by patient|14
4790362|NCT01395914|16521302|P1|Overall Study|Withdrawal by patient|27
4790363|NCT01395914|16521301|P2|Overall Study|Other|3
4790364|NCT01395914|16521302|P1|Overall Study|Other|9
4790365|NCT01395914|16521301|P2|Overall Study|Death|17
4790366|NCT01395914|16521302|P1|Overall Study|Death|23
4790367|NCT01395914|16521301|P2|Overall Study|Unrelated to study drug AE|1
4790368|NCT01395914|16521302|P1|Overall Study|Unrelated to study drug AE|6
4790369|NCT01395901|16521316|P2|Overall Study|Withdrawal of consent|0
4790370|NCT01395901|16521317|P1|Overall Study|Withdrawal of consent|1
4790371|NCT01395901|16521316|P2|Overall Study|Adverse Event|1
4790372|NCT01395901|16521317|P1|Overall Study|Adverse Event|0
4790373|NCT01395901|16521316|P2|Overall Study|Randomized but not received study drug|4
4790374|NCT01395901|16521317|P1|Overall Study|Randomized but not received study drug|5
4790375|NCT01395901|16521316|P2|Overall Study|Lost to Follow-up|0
4790376|NCT01395901|16521317|P1|Overall Study|Lost to Follow-up|4
4790377|NCT01395888|16521333|P3|Treatment Period (TP)|Withdrawal by Subject|3
4790378|NCT01395888|16521334|P2|Treatment Period (TP)|Withdrawal by Subject|2
4790379|NCT01395888|16521335|P1|Treatment Period (TP)|Withdrawal by Subject|0
4790380|NCT01395888|16521333|P3|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
4790381|NCT01395888|16521334|P2|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1
4790382|NCT01395888|16521335|P1|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0
4790383|NCT01395888|16521333|P3|Treatment Period (TP)|Protocol Violation|5
4790384|NCT01395888|16521334|P2|Treatment Period (TP)|Protocol Violation|1
4790385|NCT01395888|16521335|P1|Treatment Period (TP)|Protocol Violation|0
4790386|NCT01395888|16521333|P3|Treatment Period (TP)|Lack of Efficacy|3
4790387|NCT01395888|16521334|P2|Treatment Period (TP)|Lack of Efficacy|4
4790388|NCT01395888|16521335|P1|Treatment Period (TP)|Lack of Efficacy|0
4790389|NCT01395888|16521333|P3|Treatment Period (TP)|Adverse Event|6
4790390|NCT01395888|16521334|P2|Treatment Period (TP)|Adverse Event|7
4790391|NCT01395888|16521335|P1|Treatment Period (TP)|Adverse Event|0
4790392|NCT01395888|16521333|P3|2-week Run-in Period|Withdrawal by Subject|0
4790393|NCT01395888|16521334|P2|2-week Run-in Period|Withdrawal by Subject|0
4790394|NCT01395888|16521335|P1|2-week Run-in Period|Withdrawal by Subject|4
4790395|NCT01395888|16521333|P3|2-week Run-in Period|Protocol Violation|0
4790396|NCT01395888|16521334|P2|2-week Run-in Period|Protocol Violation|0
4790397|NCT01395888|16521335|P1|2-week Run-in Period|Protocol Violation|2
4790398|NCT01395888|16521333|P3|2-week Run-in Period|Lost to Follow-up|0
4790399|NCT01395888|16521334|P2|2-week Run-in Period|Lost to Follow-up|0
4790400|NCT01395888|16521335|P1|2-week Run-in Period|Lost to Follow-up|1
4790401|NCT01395888|16521333|P3|2-week Run-in Period|Continuation Criteria Not Met|0
4790402|NCT01395888|16521334|P2|2-week Run-in Period|Continuation Criteria Not Met|0
4790403|NCT01395888|16521335|P1|2-week Run-in Period|Continuation Criteria Not Met|13
4790404|NCT01395888|16521333|P3|2-week Run-in Period|Adverse Event|0
4790405|NCT01395888|16521334|P2|2-week Run-in Period|Adverse Event|0
4790406|NCT01395888|16521335|P1|2-week Run-in Period|Adverse Event|2
4790407|NCT01395823|16521343|P2|Overall Study|Withdrawal by Subject|4
4790408|NCT01395823|16521344|P1|Overall Study|Withdrawal by Subject|5
4790409|NCT01395823|16521343|P2|Overall Study|GI symptoms|0
4790410|NCT01395823|16521344|P1|Overall Study|GI symptoms|1
4790411|NCT01395823|16521343|P2|Overall Study|Transplant|0
4790412|NCT01395823|16521344|P1|Overall Study|Transplant|1
4790413|NCT01395823|16521343|P2|Overall Study|Lost to Follow-up|0
4790414|NCT01395823|16521344|P1|Overall Study|Lost to Follow-up|1
4790415|NCT01395823|16521343|P2|Overall Study|Physician Decision|1
4790416|NCT01395823|16521344|P1|Overall Study|Physician Decision|3
4790417|NCT01395823|16521343|P2|Overall Study|Death|4
4790418|NCT01395823|16521344|P1|Overall Study|Death|4
4790419|NCT01395810|16521354|P4|Overall Study|Unclassified|0
4790420|NCT01395810|16521355|P3|Overall Study|Unclassified|0
4790421|NCT01395810|16521356|P2|Overall Study|Unclassified|0
4790422|NCT01395810|16521357|P1|Overall Study|Unclassified|2
4790423|NCT01395810|16521354|P4|Overall Study|Withdrawal criteria|0
4790424|NCT01395810|16521355|P3|Overall Study|Withdrawal criteria|0
4790425|NCT01395810|16521356|P2|Overall Study|Withdrawal criteria|2
4790426|NCT01395810|16521357|P1|Overall Study|Withdrawal criteria|0
4790427|NCT01395810|16521354|P4|Overall Study|Lack of Efficacy|0
4790428|NCT01395810|16521355|P3|Overall Study|Lack of Efficacy|0
4790429|NCT01395810|16521356|P2|Overall Study|Lack of Efficacy|1
4790430|NCT01395810|16521357|P1|Overall Study|Lack of Efficacy|0
4790431|NCT01395810|16521354|P4|Overall Study|Adverse Event|0
4790432|NCT01395810|16521355|P3|Overall Study|Adverse Event|0
4790433|NCT01395810|16521356|P2|Overall Study|Adverse Event|1
4790434|NCT01395810|16521357|P1|Overall Study|Adverse Event|0
4790435|NCT01395784|16521416|P1|Overall Study|Physician Decision|5
4790436|NCT01395784|16521416|P1|Overall Study|Withdrawal by Subject|3
4790437|NCT01395784|16521416|P1|Overall Study|Lost to Follow-up|7
4790438|NCT01395758|16521423|P3|Open-label Treatment Period|Withdrawal by Subject|0
4790439|NCT01395758|16521424|P2|Open-label Treatment Period|Withdrawal by Subject|0
4790440|NCT01395758|16521425|P1|Open-label Treatment Period|Withdrawal by Subject|4
4790441|NCT01395524|16521445|P3|Overall Study|Subject had spinal surgery|1
4790442|NCT01395524|16521446|P2|Overall Study|Subject had spinal surgery|0
4790443|NCT01395524|16521447|P1|Overall Study|Subject had spinal surgery|0
4790444|NCT01395524|16521445|P3|Overall Study|Did not receive treatment|3
4790445|NCT01395524|16521446|P2|Overall Study|Did not receive treatment|1
4790446|NCT01395524|16521447|P1|Overall Study|Did not receive treatment|1
4790447|NCT01395524|16521445|P3|Overall Study|Withdrawal by Subject|8
4790448|NCT01395524|16521446|P2|Overall Study|Withdrawal by Subject|8
4790449|NCT01395524|16521447|P1|Overall Study|Withdrawal by Subject|4
4790450|NCT01395524|16521445|P3|Overall Study|Eligibility Criteria Not Fulfilled|0
4790451|NCT01395524|16521446|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
4790452|NCT01395524|16521447|P1|Overall Study|Eligibility Criteria Not Fulfilled|2
4790453|NCT01395524|16521445|P3|Overall Study|Death|0
4790454|NCT01395524|16521446|P2|Overall Study|Death|0
4790455|NCT01395524|16521447|P1|Overall Study|Death|1
4790456|NCT01395524|16521445|P3|Overall Study|Adverse Event|3
4790457|NCT01395524|16521446|P2|Overall Study|Adverse Event|4
4790458|NCT01395524|16521447|P1|Overall Study|Adverse Event|4
4790459|NCT01395524|16521445|P3|Overall Study|Severe noncompliance with protocol|0
4790460|NCT01395524|16521446|P2|Overall Study|Severe noncompliance with protocol|0
4790461|NCT01395524|16521447|P1|Overall Study|Severe noncompliance with protocol|1
4790462|NCT01395524|16521445|P3|Overall Study|Study-Specific Withdrawal Criteria|0
4790463|NCT01395524|16521446|P2|Overall Study|Study-Specific Withdrawal Criteria|2
4790464|NCT01395524|16521447|P1|Overall Study|Study-Specific Withdrawal Criteria|1
4790465|NCT01395524|16521445|P3|Overall Study|Lost to Follow-up|1
4790466|NCT01395524|16521446|P2|Overall Study|Lost to Follow-up|1
4790467|NCT01395524|16521447|P1|Overall Study|Lost to Follow-up|3
4790468|NCT01395524|16521445|P3|Overall Study|Non-compliance with study schedule|1
4790469|NCT01395524|16521446|P2|Overall Study|Non-compliance with study schedule|0
4790470|NCT01395524|16521447|P1|Overall Study|Non-compliance with study schedule|1
4790471|NCT01395394|16521470|P3|Baseline Study Visit|Protocol Violation|0
4790472|NCT01395394|16521471|P2|Baseline Study Visit|Protocol Violation|0
4790473|NCT01395394|16521472|P1|Baseline Study Visit|Protocol Violation|1
4790474|NCT01395368|16521483|P1|Overall Study|Withdrawal by Subject|2
4790475|NCT01395368|16521483|P1|Overall Study|Physician Decision|14
4790476|NCT01395316|16521539|P1|Overall Study|poor MRI quality|1
4790477|NCT01395316|16521539|P1|Overall Study|Lost to Follow-up|2
4790478|NCT01395030|16521559|P1|Overall Study|Did not complete FCH PET/CT|7
4790479|NCT01395017|16521569|P2|Overall Study|Sponsor discontinued study|4
4790480|NCT01395017|16521570|P1|Overall Study|Sponsor discontinued study|1
4790481|NCT01395017|16521569|P2|Overall Study|Disease progression|58
4790482|NCT01395017|16521570|P1|Overall Study|Disease progression|42
4790483|NCT01395017|16521569|P2|Overall Study|Death|3
4790484|NCT01395017|16521570|P1|Overall Study|Death|4
4790485|NCT01395017|16521569|P2|Overall Study|Protocol deviation|2
4790486|NCT01395017|16521570|P1|Overall Study|Protocol deviation|1
4790487|NCT01395017|16521569|P2|Overall Study|Withdrawal by Subject|8
4790488|NCT01395017|16521570|P1|Overall Study|Withdrawal by Subject|14
4790489|NCT01395017|16521569|P2|Overall Study|Physician Decision|15
4790490|NCT01395017|16521570|P1|Overall Study|Physician Decision|11
4790491|NCT01395017|16521569|P2|Overall Study|Adverse Event|12
4790492|NCT01395017|16521570|P1|Overall Study|Adverse Event|26
4790493|NCT01395017|16521569|P2|Overall Study|Lost to Follow-up|0
4790494|NCT01395017|16521570|P1|Overall Study|Lost to Follow-up|1
4790495|NCT01394991|16521580|P2|Overall Study|Prematurely Termination of Trial|10
4790496|NCT01394991|16521581|P1|Overall Study|Prematurely Termination of Trial|9
4790497|NCT01394991|16521580|P2|Overall Study|Disease Progression|7
4790498|NCT01394991|16521581|P1|Overall Study|Disease Progression|7
4790499|NCT01394991|16521580|P2|Overall Study|Chemotherapy Termination|15
4790500|NCT01394991|16521581|P1|Overall Study|Chemotherapy Termination|10
4790501|NCT01394991|16521580|P2|Overall Study|Withdrawal by Subject|17
4790502|NCT01394991|16521581|P1|Overall Study|Withdrawal by Subject|20
4790503|NCT01394991|16521580|P2|Overall Study|Protocol Violation|1
4790504|NCT01394991|16521581|P1|Overall Study|Protocol Violation|1
4790505|NCT01394991|16521580|P2|Overall Study|Physician Decision|3
4790506|NCT01394991|16521581|P1|Overall Study|Physician Decision|1
4790507|NCT01394991|16521580|P2|Overall Study|Lost to Follow-up|8
4790508|NCT01394991|16521581|P1|Overall Study|Lost to Follow-up|6
4790509|NCT01394991|16521580|P2|Overall Study|Lack of Efficacy|7
4790510|NCT01394991|16521581|P1|Overall Study|Lack of Efficacy|5
4790511|NCT01394991|16521580|P2|Overall Study|Adverse Event|4
4790512|NCT01394991|16521581|P1|Overall Study|Adverse Event|0
4790513|NCT01394978|16521603|P2|Overall Study|Death|7
4790514|NCT01394978|16521604|P1|Overall Study|Death|6
4790515|NCT01394978|16521603|P2|Overall Study|Lost to Follow-up|20
4790516|NCT01394978|16521604|P1|Overall Study|Lost to Follow-up|13
4790517|NCT01394978|16521603|P2|Overall Study|Withdrawal by Subject|4
4790518|NCT01394978|16521604|P1|Overall Study|Withdrawal by Subject|2
4790519|NCT01394952|16521612|P2|Overall Study|Sponsor Decision|7
4790520|NCT01394952|16521613|P1|Overall Study|Sponsor Decision|5
4790521|NCT01394952|16521612|P2|Overall Study|Physician Decision|0
4790522|NCT01394952|16521613|P1|Overall Study|Physician Decision|2
4790523|NCT01394952|16521612|P2|Overall Study|Withdrawal by Subject|5
4790524|NCT01394952|16521613|P1|Overall Study|Withdrawal by Subject|10
4790525|NCT01394952|16521612|P2|Overall Study|Lost to Follow-up|5
4790526|NCT01394952|16521613|P1|Overall Study|Lost to Follow-up|0
4790527|NCT01394718|16521640|P2|Overall Study|Met protocol-specific stopping criteria|1
4790528|NCT01394718|16521641|P1|Overall Study|Met protocol-specific stopping criteria|2
4790529|NCT01394627|16521673|P2|Washout (1-3 Months)|concurrent enrollment in another study|0
4790530|NCT01394627|16521674|P1|Washout (1-3 Months)|concurrent enrollment in another study|1
4790531|NCT01394627|16521673|P2|First Intervention (1 Day)|poor intravenous access|1
4790532|NCT01394627|16521674|P1|First Intervention (1 Day)|poor intravenous access|0
4790533|NCT01394523|16521694|P3|Overall Study|Unable to place block|0
4790534|NCT01394523|16521695|P2|Overall Study|Unable to place block|0
4790535|NCT01394523|16521696|P1|Overall Study|Unable to place block|1
4790536|NCT01394276|16521710|P1|Overall Study|Symptoms of concurrent diseases|1
4790537|NCT01394276|16521710|P1|Overall Study|unavailability of drug at the Hospital|2
4790538|NCT01394276|16521710|P1|Overall Study|Pregnancy|1
4790539|NCT01394276|16521710|P1|Overall Study|Participant moved to another site|1
4790540|NCT01394276|16521710|P1|Overall Study|Lost to Follow-up|5
4790541|NCT01394276|16521710|P1|Overall Study|Insufficient compliance|9
4790542|NCT01394276|16521710|P1|Overall Study|Insufficient therapeutic effect|17
4790543|NCT01394276|16521710|P1|Overall Study|Remission of disease|2
4790544|NCT01394276|16521710|P1|Overall Study|Not related AEs|9
4790545|NCT01394276|16521710|P1|Overall Study|Related Adverse event (AEs)|15
4790546|NCT01394250|16521734|P2|Successful IV Placement & Follow-Up|Withdrawal by Subject|11
4790547|NCT01394250|16521735|P1|Successful IV Placement & Follow-Up|Withdrawal by Subject|6
4790723|NCT01393743|16522081|P2|Core Study|Participant's Choice|3
4790548|NCT01394250|16521734|P2|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13
4790549|NCT01394250|16521735|P1|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14
4790550|NCT01394185|16521749|P6|Overall Study|Protocol Violation|1
4790551|NCT01394185|16521750|P5|Overall Study|Protocol Violation|0
4790552|NCT01394185|16521751|P4|Overall Study|Protocol Violation|1
4790553|NCT01394185|16521752|P3|Overall Study|Protocol Violation|0
4790554|NCT01394185|16521753|P2|Overall Study|Protocol Violation|0
4790555|NCT01394185|16521754|P1|Overall Study|Protocol Violation|1
4790556|NCT01394185|16521749|P6|Overall Study|Change in protocol|0
4790557|NCT01394185|16521750|P5|Overall Study|Change in protocol|3
4790558|NCT01394185|16521751|P4|Overall Study|Change in protocol|0
4790559|NCT01394185|16521752|P3|Overall Study|Change in protocol|0
4790560|NCT01394185|16521753|P2|Overall Study|Change in protocol|0
4790561|NCT01394185|16521754|P1|Overall Study|Change in protocol|3
4790562|NCT01394185|16521749|P6|Overall Study|Withdrawal by Subject|0
4790563|NCT01394185|16521750|P5|Overall Study|Withdrawal by Subject|1
4790564|NCT01394185|16521751|P4|Overall Study|Withdrawal by Subject|0
4790565|NCT01394185|16521752|P3|Overall Study|Withdrawal by Subject|0
4790566|NCT01394185|16521753|P2|Overall Study|Withdrawal by Subject|0
4790567|NCT01394185|16521754|P1|Overall Study|Withdrawal by Subject|2
4790568|NCT01393990|16521858|P18|Overall Study|Withdrawal by Subject|0
4790569|NCT01393990|16521859|P17|Overall Study|Withdrawal by Subject|0
4790570|NCT01393990|16521860|P16|Overall Study|Withdrawal by Subject|1
4790571|NCT01393990|16521861|P15|Overall Study|Withdrawal by Subject|1
4790572|NCT01393990|16521862|P14|Overall Study|Withdrawal by Subject|0
4790573|NCT01393990|16521863|P13|Overall Study|Withdrawal by Subject|0
4790574|NCT01393990|16521864|P12|Overall Study|Withdrawal by Subject|0
4790575|NCT01393990|16521865|P11|Overall Study|Withdrawal by Subject|0
4790576|NCT01393990|16521866|P10|Overall Study|Withdrawal by Subject|0
4790577|NCT01393990|16521867|P9|Overall Study|Withdrawal by Subject|0
4790578|NCT01393990|16521868|P8|Overall Study|Withdrawal by Subject|0
4790579|NCT01393990|16521869|P7|Overall Study|Withdrawal by Subject|0
4790580|NCT01393990|16521870|P6|Overall Study|Withdrawal by Subject|0
4790581|NCT01393990|16521871|P5|Overall Study|Withdrawal by Subject|0
4790582|NCT01393990|16521872|P4|Overall Study|Withdrawal by Subject|0
4790583|NCT01393990|16521873|P3|Overall Study|Withdrawal by Subject|0
4790584|NCT01393990|16521874|P2|Overall Study|Withdrawal by Subject|0
4790585|NCT01393990|16521875|P1|Overall Study|Withdrawal by Subject|0
4790586|NCT01393990|16521858|P18|Overall Study|Death|0
4790587|NCT01393990|16521859|P17|Overall Study|Death|0
4790588|NCT01393990|16521860|P16|Overall Study|Death|0
4790589|NCT01393990|16521861|P15|Overall Study|Death|1
4790590|NCT01393990|16521862|P14|Overall Study|Death|1
4790591|NCT01393990|16521863|P13|Overall Study|Death|0
4790592|NCT01393990|16521864|P12|Overall Study|Death|0
4790593|NCT01393990|16521865|P11|Overall Study|Death|0
4790594|NCT01393990|16521866|P10|Overall Study|Death|0
4790595|NCT01393990|16521867|P9|Overall Study|Death|0
4790596|NCT01393990|16521868|P8|Overall Study|Death|0
4790597|NCT01393990|16521869|P7|Overall Study|Death|0
4790598|NCT01393990|16521870|P6|Overall Study|Death|0
4790599|NCT01393990|16521871|P5|Overall Study|Death|1
4790600|NCT01393990|16521872|P4|Overall Study|Death|0
4790601|NCT01393990|16521873|P3|Overall Study|Death|0
4790602|NCT01393990|16521874|P2|Overall Study|Death|0
4790603|NCT01393990|16521875|P1|Overall Study|Death|0
4790604|NCT01393990|16521858|P18|Overall Study|Progressive Disease|0
4790605|NCT01393990|16521859|P17|Overall Study|Progressive Disease|0
4790606|NCT01393990|16521860|P16|Overall Study|Progressive Disease|1
4790607|NCT01393990|16521861|P15|Overall Study|Progressive Disease|6
4790608|NCT01393990|16521862|P14|Overall Study|Progressive Disease|1
4790609|NCT01393990|16521863|P13|Overall Study|Progressive Disease|0
4790610|NCT01393990|16521864|P12|Overall Study|Progressive Disease|0
4790611|NCT01393990|16521865|P11|Overall Study|Progressive Disease|0
4790612|NCT01393990|16521866|P10|Overall Study|Progressive Disease|1
4790613|NCT01393990|16521867|P9|Overall Study|Progressive Disease|3
4790614|NCT01393990|16521868|P8|Overall Study|Progressive Disease|1
4790615|NCT01393990|16521869|P7|Overall Study|Progressive Disease|1
4790616|NCT01393990|16521870|P6|Overall Study|Progressive Disease|1
4790617|NCT01393990|16521871|P5|Overall Study|Progressive Disease|1
4790618|NCT01393990|16521872|P4|Overall Study|Progressive Disease|1
4790619|NCT01393990|16521873|P3|Overall Study|Progressive Disease|0
4790620|NCT01393990|16521874|P2|Overall Study|Progressive Disease|0
4790621|NCT01393990|16521875|P1|Overall Study|Progressive Disease|1
4790622|NCT01393990|16521858|P18|Overall Study|Adverse Event|0
4790623|NCT01393990|16521859|P17|Overall Study|Adverse Event|0
4790624|NCT01393990|16521860|P16|Overall Study|Adverse Event|1
4790625|NCT01393990|16521861|P15|Overall Study|Adverse Event|1
4790626|NCT01393990|16521862|P14|Overall Study|Adverse Event|0
4790627|NCT01393990|16521863|P13|Overall Study|Adverse Event|0
4790628|NCT01393990|16521864|P12|Overall Study|Adverse Event|0
4790629|NCT01393990|16521865|P11|Overall Study|Adverse Event|0
4790630|NCT01393990|16521866|P10|Overall Study|Adverse Event|0
4790631|NCT01393990|16521867|P9|Overall Study|Adverse Event|0
4790632|NCT01393990|16521868|P8|Overall Study|Adverse Event|0
4790633|NCT01393990|16521869|P7|Overall Study|Adverse Event|0
4790634|NCT01393990|16521870|P6|Overall Study|Adverse Event|0
4790635|NCT01393990|16521871|P5|Overall Study|Adverse Event|0
4790636|NCT01393990|16521872|P4|Overall Study|Adverse Event|0
4790637|NCT01393990|16521873|P3|Overall Study|Adverse Event|0
4790638|NCT01393990|16521874|P2|Overall Study|Adverse Event|0
4790639|NCT01393990|16521875|P1|Overall Study|Adverse Event|0
4790640|NCT01393964|16521966|P3|Overall Study|Subject to receive non-protocol therapy|1
4790641|NCT01393964|16521967|P2|Overall Study|Subject to receive non-protocol therapy|0
4790642|NCT01393964|16521968|P1|Overall Study|Subject to receive non-protocol therapy|0
4790643|NCT01393964|16521966|P3|Overall Study|Subject converted to roll-over study|0
4790644|NCT01393964|16521967|P2|Overall Study|Subject converted to roll-over study|1
4790645|NCT01393964|16521968|P1|Overall Study|Subject converted to roll-over study|0
4790646|NCT01393964|16521966|P3|Overall Study|Investigator removed subject from study|0
4790647|NCT01393964|16521967|P2|Overall Study|Investigator removed subject from study|1
4790648|NCT01393964|16521968|P1|Overall Study|Investigator removed subject from study|0
4790649|NCT01393964|16521966|P3|Overall Study|Subject plateaued in terms of effect|0
4790650|NCT01393964|16521967|P2|Overall Study|Subject plateaued in terms of effect|0
4790651|NCT01393964|16521968|P1|Overall Study|Subject plateaued in terms of effect|1
4790652|NCT01393964|16521966|P3|Overall Study|Subject switched to commercial supply|2
4790653|NCT01393964|16521967|P2|Overall Study|Subject switched to commercial supply|0
4790654|NCT01393964|16521968|P1|Overall Study|Subject switched to commercial supply|1
4790655|NCT01393964|16521966|P3|Overall Study|Subject decided to move to transplant|0
4790656|NCT01393964|16521967|P2|Overall Study|Subject decided to move to transplant|0
4790657|NCT01393964|16521968|P1|Overall Study|Subject decided to move to transplant|1
4790658|NCT01393964|16521966|P3|Overall Study|Subject request stop study treatment|0
4790659|NCT01393964|16521967|P2|Overall Study|Subject request stop study treatment|1
4790660|NCT01393964|16521968|P1|Overall Study|Subject request stop study treatment|0
4790661|NCT01393964|16521966|P3|Overall Study|Adverse event unrelated to study drug|0
4790662|NCT01393964|16521967|P2|Overall Study|Adverse event unrelated to study drug|3
4790663|NCT01393964|16521968|P1|Overall Study|Adverse event unrelated to study drug|0
4790664|NCT01393964|16521966|P3|Overall Study|Withdrawal by Subject|1
4790665|NCT01393964|16521967|P2|Overall Study|Withdrawal by Subject|0
4790666|NCT01393964|16521968|P1|Overall Study|Withdrawal by Subject|0
4790667|NCT01393964|16521966|P3|Overall Study|Study drug toxicity|0
4790668|NCT01393964|16521967|P2|Overall Study|Study drug toxicity|0
4790669|NCT01393964|16521968|P1|Overall Study|Study drug toxicity|1
4790670|NCT01393964|16521966|P3|Overall Study|Disease Progression|5
4790671|NCT01393964|16521967|P2|Overall Study|Disease Progression|3
4790672|NCT01393964|16521968|P1|Overall Study|Disease Progression|4
4790673|NCT01393899|16522009|P3|Overall Study|Adverse Event|3
4790674|NCT01393899|16522010|P2|Overall Study|Adverse Event|5
4790675|NCT01393899|16522011|P1|Overall Study|Adverse Event|1
4790676|NCT01393899|16522009|P3|Overall Study|Lack of Efficacy|16
4790677|NCT01393899|16522010|P2|Overall Study|Lack of Efficacy|21
4790678|NCT01393899|16522011|P1|Overall Study|Lack of Efficacy|26
4790679|NCT01393899|16522009|P3|Overall Study|Does not meet entrance criteria|1
4790680|NCT01393899|16522010|P2|Overall Study|Does not meet entrance criteria|0
4790681|NCT01393899|16522011|P1|Overall Study|Does not meet entrance criteria|1
4790682|NCT01393899|16522009|P3|Overall Study|Lost to Follow-up|1
4790683|NCT01393899|16522010|P2|Overall Study|Lost to Follow-up|0
4790684|NCT01393899|16522011|P1|Overall Study|Lost to Follow-up|0
4790685|NCT01393899|16522009|P3|Overall Study|Withdrawal by Subject|1
4790686|NCT01393899|16522010|P2|Overall Study|Withdrawal by Subject|2
4790687|NCT01393899|16522011|P1|Overall Study|Withdrawal by Subject|2
4790688|NCT01393899|16522009|P3|Overall Study|Other|0
4790689|NCT01393899|16522010|P2|Overall Study|Other|0
4790690|NCT01393899|16522011|P1|Overall Study|Other|1
4790691|NCT01393899|16522009|P3|Overall Study|Study terminated by sponsor|1
4790692|NCT01393899|16522010|P2|Overall Study|Study terminated by sponsor|0
4790693|NCT01393899|16522011|P1|Overall Study|Study terminated by sponsor|1
4790694|NCT01393821|16522065|P2|Overall Study|not evaluable for primary endpoint|2
4790695|NCT01393821|16522066|P1|Overall Study|not evaluable for primary endpoint|4
4790696|NCT01393821|16522065|P2|Overall Study|Cancel|1
4790697|NCT01393821|16522066|P1|Overall Study|Cancel|1
4790698|NCT01393743|16522080|P3|Extension Phase|Other|14
4790699|NCT01393743|16522081|P2|Extension Phase|Other|0
4790700|NCT01393743|16522082|P1|Extension Phase|Other|0
4790701|NCT01393743|16522080|P3|Extension Phase|Pregnancy|1
4790702|NCT01393743|16522081|P2|Extension Phase|Pregnancy|0
4790703|NCT01393743|16522082|P1|Extension Phase|Pregnancy|0
4790704|NCT01393743|16522080|P3|Extension Phase|Withdrawal by Subject|8
4790705|NCT01393743|16522081|P2|Extension Phase|Withdrawal by Subject|0
4790706|NCT01393743|16522082|P1|Extension Phase|Withdrawal by Subject|0
4790707|NCT01393743|16522080|P3|Extension Phase|Inadequate therapeutic effect|7
4790708|NCT01393743|16522081|P2|Extension Phase|Inadequate therapeutic effect|0
4790709|NCT01393743|16522082|P1|Extension Phase|Inadequate therapeutic effect|0
4790710|NCT01393743|16522080|P3|Extension Phase|Participant choice|16
4790711|NCT01393743|16522081|P2|Extension Phase|Participant choice|0
4790712|NCT01393743|16522082|P1|Extension Phase|Participant choice|0
4790713|NCT01393743|16522080|P3|Extension Phase|Lost to Follow-up|2
4790714|NCT01393743|16522081|P2|Extension Phase|Lost to Follow-up|0
4790715|NCT01393743|16522082|P1|Extension Phase|Lost to Follow-up|0
4790716|NCT01393743|16522080|P3|Extension Phase|Adverse Event|12
4790717|NCT01393743|16522081|P2|Extension Phase|Adverse Event|0
4790718|NCT01393743|16522082|P1|Extension Phase|Adverse Event|0
4790719|NCT01393743|16522080|P3|Core Study|Inadequate therapeutic effect|0
4790720|NCT01393743|16522081|P2|Core Study|Inadequate therapeutic effect|0
4790721|NCT01393743|16522082|P1|Core Study|Inadequate therapeutic effect|2
4790722|NCT01393743|16522080|P3|Core Study|Participant's Choice|0
4790724|NCT01393743|16522082|P1|Core Study|Participant's Choice|2
4790725|NCT01393743|16522080|P3|Core Study|Lost to Follow-up|0
4790726|NCT01393743|16522081|P2|Core Study|Lost to Follow-up|1
4790727|NCT01393743|16522082|P1|Core Study|Lost to Follow-up|1
4790728|NCT01393743|16522080|P3|Core Study|Adverse Event|0
4790729|NCT01393743|16522081|P2|Core Study|Adverse Event|9
4790730|NCT01393743|16522082|P1|Core Study|Adverse Event|5
4790731|NCT01393730|16522105|P1|Overall Study|Adverse Event|1
4790732|NCT01393730|16522105|P1|Overall Study|Other|2
4790733|NCT01393730|16522105|P1|Overall Study|Withdrawal by Subject|3
4790734|NCT01393626|16522151|P4|Overall Study|Protocol Violation|0
4790735|NCT01393626|16522152|P3|Overall Study|Protocol Violation|2
4790736|NCT01393626|16522153|P2|Overall Study|Protocol Violation|0
4790737|NCT01393626|16522154|P1|Overall Study|Protocol Violation|1
4790738|NCT01393626|16522151|P4|Overall Study|Other|0
4790739|NCT01393626|16522152|P3|Overall Study|Other|0
4790740|NCT01393626|16522153|P2|Overall Study|Other|0
4790741|NCT01393626|16522154|P1|Overall Study|Other|1
4790742|NCT01393626|16522151|P4|Overall Study|Withdrawal by Subject|0
4790743|NCT01393626|16522152|P3|Overall Study|Withdrawal by Subject|0
4790744|NCT01393626|16522153|P2|Overall Study|Withdrawal by Subject|4
4790745|NCT01393626|16522154|P1|Overall Study|Withdrawal by Subject|6
4790746|NCT01393626|16522151|P4|Overall Study|Lost to Follow-up|0
4790747|NCT01393626|16522152|P3|Overall Study|Lost to Follow-up|1
4790748|NCT01393626|16522153|P2|Overall Study|Lost to Follow-up|1
4790749|NCT01393626|16522154|P1|Overall Study|Lost to Follow-up|1
4790750|NCT01393626|16522151|P4|Overall Study|Lack of Efficacy|1
4790751|NCT01393626|16522152|P3|Overall Study|Lack of Efficacy|4
4790752|NCT01393626|16522153|P2|Overall Study|Lack of Efficacy|6
4790753|NCT01393626|16522154|P1|Overall Study|Lack of Efficacy|6
4790754|NCT01393626|16522151|P4|Overall Study|Did not meet entrance criteria|0
4790755|NCT01393626|16522152|P3|Overall Study|Did not meet entrance criteria|0
4790756|NCT01393626|16522153|P2|Overall Study|Did not meet entrance criteria|0
4790757|NCT01393626|16522154|P1|Overall Study|Did not meet entrance criteria|1
4790758|NCT01393626|16522151|P4|Overall Study|Adverse Event|0
4790759|NCT01393626|16522152|P3|Overall Study|Adverse Event|5
4790760|NCT01393626|16522153|P2|Overall Study|Adverse Event|1
4790761|NCT01393626|16522154|P1|Overall Study|Adverse Event|2
4790762|NCT01393613|16522234|P4|Overall Study|Lack of Efficacy|21
4790763|NCT01393613|16522235|P3|Overall Study|Lack of Efficacy|16
4790764|NCT01393613|16522236|P2|Overall Study|Lack of Efficacy|20
4790765|NCT01393613|16522237|P1|Overall Study|Lack of Efficacy|9
4790766|NCT01393613|16522234|P4|Overall Study|Protocol Deviation|0
4790767|NCT01393613|16522235|P3|Overall Study|Protocol Deviation|0
4790768|NCT01393613|16522236|P2|Overall Study|Protocol Deviation|1
4790769|NCT01393613|16522237|P1|Overall Study|Protocol Deviation|2
4790770|NCT01393613|16522234|P4|Overall Study|Withdrawal by Subject|21
4790771|NCT01393613|16522235|P3|Overall Study|Withdrawal by Subject|23
4790772|NCT01393613|16522236|P2|Overall Study|Withdrawal by Subject|25
4790773|NCT01393613|16522237|P1|Overall Study|Withdrawal by Subject|15
4790774|NCT01393613|16522234|P4|Overall Study|Physician Decision|1
4790775|NCT01393613|16522235|P3|Overall Study|Physician Decision|0
4790776|NCT01393613|16522236|P2|Overall Study|Physician Decision|0
4790777|NCT01393613|16522237|P1|Overall Study|Physician Decision|2
4790778|NCT01393613|16522234|P4|Overall Study|Participant Met Withdrawal Criteria|1
4790779|NCT01393613|16522235|P3|Overall Study|Participant Met Withdrawal Criteria|2
4790780|NCT01393613|16522236|P2|Overall Study|Participant Met Withdrawal Criteria|0
4790781|NCT01393613|16522237|P1|Overall Study|Participant Met Withdrawal Criteria|0
4790782|NCT01393613|16522234|P4|Overall Study|Adverse Event|22
4790783|NCT01393613|16522235|P3|Overall Study|Adverse Event|13
4790784|NCT01393613|16522236|P2|Overall Study|Adverse Event|11
4790785|NCT01393613|16522237|P1|Overall Study|Adverse Event|11
4790786|NCT01393600|16522299|P4|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
4790787|NCT01393600|16522300|P3|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1
4790788|NCT01393600|16522301|P2|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
4790789|NCT01393600|16522302|P1|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0
4790790|NCT01393600|16522299|P4|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
4790791|NCT01393600|16522300|P3|Treatment Period 2 (Day 15 to 28)|Physician Decision|1
4790792|NCT01393600|16522301|P2|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
4790793|NCT01393600|16522302|P1|Treatment Period 2 (Day 15 to 28)|Physician Decision|0
4790794|NCT01393600|16522299|P4|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
4790795|NCT01393600|16522300|P3|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1
4790796|NCT01393600|16522301|P2|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
4790797|NCT01393600|16522302|P1|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0
4790798|NCT01393600|16522299|P4|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1
4790799|NCT01393600|16522300|P3|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
4790800|NCT01393600|16522301|P2|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
4790801|NCT01393600|16522302|P1|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0
4790802|NCT01393600|16522299|P4|Treatment Period 1 (Day 1 to 14)|Adverse Event|1
4790803|NCT01393600|16522300|P3|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
4790804|NCT01393600|16522301|P2|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
4790805|NCT01393600|16522302|P1|Treatment Period 1 (Day 1 to 14)|Adverse Event|0
4790806|NCT01393600|16522299|P4|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
4790807|NCT01393600|16522300|P3|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1
4790892|NCT01392495|16522572|P1|Overall Study|Withdrawal by Subject|2
4790808|NCT01393600|16522301|P2|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
4790809|NCT01393600|16522302|P1|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0
4790810|NCT01393600|16522299|P4|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
4790811|NCT01393600|16522300|P3|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
4790812|NCT01393600|16522301|P2|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1
4790813|NCT01393600|16522302|P1|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0
4790814|NCT01393444|16522338|P1|Overall Study|Determined ineligible during screening.|2
4790815|NCT01393444|16522338|P1|Overall Study|Withdrawal by Subject|1
4790816|NCT01393405|16522343|P3|Maintenance Period Week|Lost to Follow-up|0
4790817|NCT01393405|16522344|P2|Maintenance Period Week|Lost to Follow-up|1
4790818|NCT01393405|16522345|P1|Maintenance Period Week|Lost to Follow-up|0
4790819|NCT01393405|16522343|P3|Maintenance Period Week|Withdrawal by Subject|0
4790820|NCT01393405|16522344|P2|Maintenance Period Week|Withdrawal by Subject|1
4790821|NCT01393405|16522345|P1|Maintenance Period Week|Withdrawal by Subject|0
4790822|NCT01393405|16522343|P3|Maintenance Period Week|Adverse Event|2
4790823|NCT01393405|16522344|P2|Maintenance Period Week|Adverse Event|5
4790824|NCT01393405|16522345|P1|Maintenance Period Week|Adverse Event|0
4790825|NCT01393405|16522343|P3|Maintenance Period Week|Lack of Efficacy|22
4790826|NCT01393405|16522344|P2|Maintenance Period Week|Lack of Efficacy|22
4790827|NCT01393405|16522345|P1|Maintenance Period Week|Lack of Efficacy|0
4790828|NCT01393405|16522343|P3|Induction Period (week1-16)|Withdrawal by Subject|0
4790829|NCT01393405|16522344|P2|Induction Period (week1-16)|Withdrawal by Subject|0
4790830|NCT01393405|16522345|P1|Induction Period (week1-16)|Withdrawal by Subject|9
4790831|NCT01393405|16522343|P3|Induction Period (week1-16)|Adverse Event|0
4790832|NCT01393405|16522344|P2|Induction Period (week1-16)|Adverse Event|0
4790833|NCT01393405|16522345|P1|Induction Period (week1-16)|Adverse Event|16
4790834|NCT01393405|16522343|P3|Induction Period (week1-16)|Lack of Efficacy|0
4790835|NCT01393405|16522344|P2|Induction Period (week1-16)|Lack of Efficacy|0
4790836|NCT01393405|16522345|P1|Induction Period (week1-16)|Lack of Efficacy|70
4790837|NCT01393301|16522383|P2|Overall Study|Completed <7 sessions (intervention)|0
4790838|NCT01393301|16522384|P1|Overall Study|Completed <7 sessions (intervention)|2
4790839|NCT01393301|16522383|P2|Overall Study|Withdrawal by Subject|0
4790840|NCT01393301|16522384|P1|Overall Study|Withdrawal by Subject|2
4790841|NCT01393301|16522383|P2|Overall Study|Lost to Follow-up|3
4790842|NCT01393301|16522384|P1|Overall Study|Lost to Follow-up|5
4790843|NCT01393158|16522397|P2|Overall Study|Adverse Event|0
4790844|NCT01393158|16522398|P1|Overall Study|Adverse Event|1
4790845|NCT01393106|16522425|P1|Overall Study|Lack of Efficacy|1
4790846|NCT01393106|16522425|P1|Overall Study|Withdrawal by Subject|1
4790847|NCT01393106|16522425|P1|Overall Study|Adverse Event|3
4790848|NCT01392963|16522452|P2|Week 24 Follow-up|Lost to Follow-up|0
4790849|NCT01392963|16522453|P1|Week 24 Follow-up|Lost to Follow-up|2
4790850|NCT01392963|16522452|P2|Week 0 (First Intervention)|Withdrawal by Subject|1
4790851|NCT01392963|16522453|P1|Week 0 (First Intervention)|Withdrawal by Subject|0
4790852|NCT01392963|16522452|P2|Week 0 (First Intervention)|Lost to Follow-up|1
4790853|NCT01392963|16522453|P1|Week 0 (First Intervention)|Lost to Follow-up|0
4790854|NCT01392742|16522461|P1|Overall Study|Missing information|13
4790855|NCT01392742|16522461|P1|Overall Study|Other|3
4790856|NCT01392742|16522461|P1|Overall Study|Protocol Violation|14
4790857|NCT01392742|16522461|P1|Overall Study|Adverse event/intercurrent illness|17
4790858|NCT01392742|16522461|P1|Overall Study|ITR and Protocol deviation|1
4790859|NCT01392742|16522461|P1|Overall Study|Insufficient therapeutic response (ITR)|30
4790860|NCT01392742|16522461|P1|Overall Study|Lost to Follow-up|34
4790861|NCT01392742|16522461|P1|Overall Study|No treatment/no cooperation/withdrew|12
4790862|NCT01392742|16522461|P1|Overall Study|Failure to return|35
4790863|NCT01392742|16522461|P1|Overall Study|Premature study termination|42
4790864|NCT01392677|16522507|P2|Overall Study|Other reason|2
4790865|NCT01392677|16522508|P1|Overall Study|Other reason|3
4790866|NCT01392677|16522507|P2|Overall Study|Incorrect enrollment|3
4790867|NCT01392677|16522508|P1|Overall Study|Incorrect enrollment|2
4790868|NCT01392677|16522507|P2|Overall Study|Withdrawal by Subject|2
4790869|NCT01392677|16522508|P1|Overall Study|Withdrawal by Subject|0
4790870|NCT01392677|16522507|P2|Overall Study|Adverse Event|1
4790871|NCT01392677|16522508|P1|Overall Study|Adverse Event|3
4790872|NCT01392573|16522543|P2|Overall Study|Unclassified|6
4790873|NCT01392573|16522544|P1|Overall Study|Unclassified|9
4790874|NCT01392573|16522543|P2|Overall Study|Site closure|7
4790875|NCT01392573|16522544|P1|Overall Study|Site closure|8
4790876|NCT01392573|16522543|P2|Overall Study|Withdrawal Criteria|15
4790877|NCT01392573|16522544|P1|Overall Study|Withdrawal Criteria|13
4790878|NCT01392573|16522543|P2|Overall Study|Protocol Violation|2
4790879|NCT01392573|16522544|P1|Overall Study|Protocol Violation|0
4790880|NCT01392573|16522543|P2|Overall Study|Lack of Efficacy|2
4790881|NCT01392573|16522544|P1|Overall Study|Lack of Efficacy|1
4790882|NCT01392573|16522543|P2|Overall Study|Adverse Event|3
4790883|NCT01392573|16522544|P1|Overall Study|Adverse Event|1
4790884|NCT01392560|16522552|P1|Overall Study|discontinued during placebo run-in|2
4790885|NCT01392560|16522552|P1|Overall Study|not entered|8
4790886|NCT01392560|16522552|P1|Overall Study|Adverse Event|2
4790887|NCT01392547|16522558|P1|Overall Study|Unclassified|1
4790888|NCT01392547|16522558|P1|Overall Study|Withdrawal criteria|3
4790889|NCT01392547|16522558|P1|Overall Study|Non-compliance|2
4790890|NCT01392547|16522558|P1|Overall Study|Adverse Event|2
4790891|NCT01392495|16522572|P1|Overall Study|Adverse Event|3
4790893|NCT01392495|16522572|P1|Overall Study|Administrative problems|8
4790894|NCT01392495|16522572|P1|Overall Study|Death|3
4790895|NCT01392443|16522584|P1|Overall Study|Protocol Violation|1
4790896|NCT01392443|16522584|P1|Overall Study|Lost to Follow-up|1
4790897|NCT01392443|16522584|P1|Overall Study|Withdrawal by Subject|5
4790898|NCT01392443|16522584|P1|Overall Study|Death|7
4790899|NCT01392443|16522584|P1|Overall Study|Adverse Event|24
4790900|NCT01392443|16522584|P1|Overall Study|Disease progression|30
4790901|NCT01392378|16522597|P5|Toddler Dose|Withdrawal by Parent|1
4790902|NCT01392378|16522598|P4|Toddler Dose|Withdrawal by Parent|1
4790903|NCT01392378|16522599|P3|Toddler Dose|Withdrawal by Parent|0
4790904|NCT01392378|16522600|P2|Toddler Dose|Withdrawal by Parent|1
4790905|NCT01392378|16522601|P1|Toddler Dose|Withdrawal by Parent|0
4790906|NCT01392378|16522597|P5|Toddler Dose|Lost to Follow-up|0
4790907|NCT01392378|16522598|P4|Toddler Dose|Lost to Follow-up|1
4790908|NCT01392378|16522599|P3|Toddler Dose|Lost to Follow-up|0
4790909|NCT01392378|16522600|P2|Toddler Dose|Lost to Follow-up|0
4790910|NCT01392378|16522601|P1|Toddler Dose|Lost to Follow-up|0
4790911|NCT01392378|16522597|P5|After Infant Series|Withdrawal by Parent|1
4790912|NCT01392378|16522598|P4|After Infant Series|Withdrawal by Parent|0
4790913|NCT01392378|16522599|P3|After Infant Series|Withdrawal by Parent|1
4790914|NCT01392378|16522600|P2|After Infant Series|Withdrawal by Parent|1
4790915|NCT01392378|16522601|P1|After Infant Series|Withdrawal by Parent|0
4790916|NCT01392378|16522597|P5|After Infant Series|Lost to Follow-up|0
4790917|NCT01392378|16522598|P4|After Infant Series|Lost to Follow-up|0
4790918|NCT01392378|16522599|P3|After Infant Series|Lost to Follow-up|1
4790919|NCT01392378|16522600|P2|After Infant Series|Lost to Follow-up|0
4790920|NCT01392378|16522601|P1|After Infant Series|Lost to Follow-up|0
4790921|NCT01392378|16522597|P5|Infant Series|Withdrawal by Parent|0
4790922|NCT01392378|16522598|P4|Infant Series|Withdrawal by Parent|0
4790923|NCT01392378|16522599|P3|Infant Series|Withdrawal by Parent|0
4790924|NCT01392378|16522600|P2|Infant Series|Withdrawal by Parent|1
4790925|NCT01392378|16522601|P1|Infant Series|Withdrawal by Parent|4
4790926|NCT01392378|16522597|P5|Infant Series|Protocol Violation|0
4790927|NCT01392378|16522598|P4|Infant Series|Protocol Violation|0
4790928|NCT01392378|16522599|P3|Infant Series|Protocol Violation|0
4790929|NCT01392378|16522600|P2|Infant Series|Protocol Violation|1
4790930|NCT01392378|16522601|P1|Infant Series|Protocol Violation|0
4790931|NCT01392378|16522597|P5|Infant Series|Lost to Follow-up|0
4790932|NCT01392378|16522598|P4|Infant Series|Lost to Follow-up|1
4790933|NCT01392378|16522599|P3|Infant Series|Lost to Follow-up|0
4790934|NCT01392378|16522600|P2|Infant Series|Lost to Follow-up|0
4790935|NCT01392378|16522601|P1|Infant Series|Lost to Follow-up|0
4790936|NCT01392378|16522597|P5|Infant Series|Adverse Event|0
4790937|NCT01392378|16522598|P4|Infant Series|Adverse Event|1
4790938|NCT01392378|16522599|P3|Infant Series|Adverse Event|0
4790939|NCT01392378|16522600|P2|Infant Series|Adverse Event|0
4790940|NCT01392378|16522601|P1|Infant Series|Adverse Event|0
4790941|NCT01392326|16522741|P3|Overall Study|Adverse Event|11
4790942|NCT01392326|16522742|P2|Overall Study|Adverse Event|6
4790943|NCT01392326|16522743|P1|Overall Study|Adverse Event|9
4790944|NCT01392326|16522741|P3|Overall Study|Lack of Efficacy|15
4790945|NCT01392326|16522742|P2|Overall Study|Lack of Efficacy|10
4790946|NCT01392326|16522743|P1|Overall Study|Lack of Efficacy|14
4790947|NCT01392326|16522741|P3|Overall Study|Lost to Follow-up|4
4790948|NCT01392326|16522742|P2|Overall Study|Lost to Follow-up|3
4790949|NCT01392326|16522743|P1|Overall Study|Lost to Follow-up|1
4790950|NCT01392326|16522741|P3|Overall Study|Physician Decision|2
4790951|NCT01392326|16522742|P2|Overall Study|Physician Decision|5
4790952|NCT01392326|16522743|P1|Overall Study|Physician Decision|7
4790953|NCT01392326|16522741|P3|Overall Study|Pregnancy|1
4790954|NCT01392326|16522742|P2|Overall Study|Pregnancy|0
4790955|NCT01392326|16522743|P1|Overall Study|Pregnancy|0
4790956|NCT01392326|16522741|P3|Overall Study|Protocol Violation|0
4790957|NCT01392326|16522742|P2|Overall Study|Protocol Violation|0
4790958|NCT01392326|16522743|P1|Overall Study|Protocol Violation|2
4790959|NCT01392326|16522741|P3|Overall Study|Withdrawal by Subject|15
4790960|NCT01392326|16522742|P2|Overall Study|Withdrawal by Subject|11
4790961|NCT01392326|16522743|P1|Overall Study|Withdrawal by Subject|12
4790962|NCT01392326|16522741|P3|Overall Study|Death|0
4790963|NCT01392326|16522742|P2|Overall Study|Death|0
4790964|NCT01392326|16522743|P1|Overall Study|Death|2
4790965|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Lost to Follow-up|6
4790966|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Lost to Follow-up|0
4790967|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Lost to Follow-up|0
4790968|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Withdrawal by Subject|17
4790969|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
4790970|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Withdrawal by Subject|0
4790971|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Adverse Event|7
4790972|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Adverse Event|0
4790973|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Adverse Event|0
4790974|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Death|4
4790975|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Death|0
4790976|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Death|0
4790977|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Non-compliance|1
4790978|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Non-compliance|0
4790979|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Non-compliance|0
4790980|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Lack of Efficacy|3
4790981|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Lack of Efficacy|0
4790982|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Lack of Efficacy|0
4790983|NCT01392300|16522780|P3|Open Label Extension (OLEX) Period|Protocol Violation|13
4790984|NCT01392300|16522781|P2|Open Label Extension (OLEX) Period|Protocol Violation|0
4790985|NCT01392300|16522782|P1|Open Label Extension (OLEX) Period|Protocol Violation|0
4790986|NCT01392300|16522780|P3|Main Period (MP)|Non-compliance|0
4790987|NCT01392300|16522781|P2|Main Period (MP)|Non-compliance|0
4790988|NCT01392300|16522782|P1|Main Period (MP)|Non-compliance|1
4790989|NCT01392300|16522780|P3|Main Period (MP)|Lost to Follow-up|0
4790990|NCT01392300|16522781|P2|Main Period (MP)|Lost to Follow-up|3
4790991|NCT01392300|16522782|P1|Main Period (MP)|Lost to Follow-up|3
4790992|NCT01392300|16522780|P3|Main Period (MP)|Withdrawal by Subject|0
4790993|NCT01392300|16522781|P2|Main Period (MP)|Withdrawal by Subject|1
4790994|NCT01392300|16522782|P1|Main Period (MP)|Withdrawal by Subject|5
4790995|NCT01392300|16522780|P3|Main Period (MP)|Predefined discontinuation criteria|0
4790996|NCT01392300|16522781|P2|Main Period (MP)|Predefined discontinuation criteria|3
4790997|NCT01392300|16522782|P1|Main Period (MP)|Predefined discontinuation criteria|2
4790998|NCT01392170|16522887|P1|Overall Study|Ineligible|1
4790999|NCT01392170|16522887|P1|Overall Study|Withdrawal by Subject|1
4791000|NCT01391832|16522937|P2|Overall Study|Lost to Follow-up|1
4791001|NCT01391832|16522938|P1|Overall Study|Lost to Follow-up|0
4791002|NCT01391832|16522937|P2|Overall Study|Withdrawal by Subject|22
4791003|NCT01391832|16522938|P1|Overall Study|Withdrawal by Subject|21
4791004|NCT01391819|16522946|P1|Overall Study|Other|9
4791005|NCT01391819|16522946|P1|Overall Study|Death|3
4791006|NCT01391819|16522946|P1|Overall Study|Lost to Follow-up|252
4791007|NCT01391819|16522946|P1|Overall Study|Migrated/moved from study area|82
4791008|NCT01391819|16522946|P1|Overall Study|Withdrawal by Subject|56
4791009|NCT01391793|16522990|P2|Overall Study|No DMSA|57
4791010|NCT01391793|16522991|P1|Overall Study|No DMSA|73
4791011|NCT01391793|16522990|P2|Overall Study|Urine Culture Negative or Indeterminate|87
4791012|NCT01391793|16522991|P1|Overall Study|Urine Culture Negative or Indeterminate|71
4791013|NCT01391793|16522990|P2|Overall Study|Ineligible|0
4791014|NCT01391793|16522991|P1|Overall Study|Ineligible|3
4791015|NCT01391663|16523005|P4|Overall Study|Withdrawal by Subject|0
4791016|NCT01391663|16523006|P3|Overall Study|Withdrawal by Subject|1
4791017|NCT01391663|16523007|P2|Overall Study|Withdrawal by Subject|0
4791018|NCT01391663|16523008|P1|Overall Study|Withdrawal by Subject|0
4791019|NCT01391546|16523052|P2|Overall Study|History of Herpes Zoster (HZ)|0
4791020|NCT01391546|16523053|P1|Overall Study|History of Herpes Zoster (HZ)|1
4791021|NCT01391507|16523075|P4|Overall Study|Protocol Violation|2
4791022|NCT01391507|16523076|P3|Overall Study|Protocol Violation|1
4791023|NCT01391507|16523077|P2|Overall Study|Protocol Violation|1
4791024|NCT01391507|16523078|P1|Overall Study|Protocol Violation|2
4791025|NCT01391507|16523075|P4|Overall Study|Lack of Efficacy|1
4791026|NCT01391507|16523076|P3|Overall Study|Lack of Efficacy|0
4791027|NCT01391507|16523077|P2|Overall Study|Lack of Efficacy|0
4791028|NCT01391507|16523078|P1|Overall Study|Lack of Efficacy|0
4791029|NCT01391507|16523075|P4|Overall Study|Withdrawal by Subject|1
4791030|NCT01391507|16523076|P3|Overall Study|Withdrawal by Subject|1
4791031|NCT01391507|16523077|P2|Overall Study|Withdrawal by Subject|2
4791032|NCT01391507|16523078|P1|Overall Study|Withdrawal by Subject|1
4791033|NCT01391507|16523075|P4|Overall Study|Adverse Event|2
4791034|NCT01391507|16523076|P3|Overall Study|Adverse Event|2
4791035|NCT01391507|16523077|P2|Overall Study|Adverse Event|1
4791036|NCT01391507|16523078|P1|Overall Study|Adverse Event|1
4791037|NCT01391507|16523075|P4|Overall Study|Death|1
4791038|NCT01391507|16523076|P3|Overall Study|Death|0
4791039|NCT01391507|16523077|P2|Overall Study|Death|0
4791040|NCT01391507|16523078|P1|Overall Study|Death|0
4791041|NCT01391130|16523229|P2|Overall Study|Did not Receive Drug|1
4791042|NCT01391130|16523230|P1|Overall Study|Did not Receive Drug|1
4791043|NCT01391130|16523229|P2|Overall Study|Physician Decision|3
4791044|NCT01391130|16523230|P1|Overall Study|Physician Decision|2
4791045|NCT01391130|16523229|P2|Overall Study|Withdrawal by Subject|2
4791046|NCT01391130|16523230|P1|Overall Study|Withdrawal by Subject|3
4791047|NCT01391000|16523287|P2|Overall Study|Lost to Follow-up|0
4791048|NCT01391000|16523288|P1|Overall Study|Lost to Follow-up|2
4791049|NCT01390948|16523301|P3|Overall Study|Death during follow-up|1
4791050|NCT01390948|16523302|P2|Overall Study|Death during follow-up|11
4791051|NCT01390948|16523303|P1|Overall Study|Death during follow-up|10
4791052|NCT01390948|16523301|P3|Overall Study|Progressive Disease|0
4791053|NCT01390948|16523302|P2|Overall Study|Progressive Disease|5
4791054|NCT01390948|16523303|P1|Overall Study|Progressive Disease|2
4791055|NCT01390948|16523301|P3|Overall Study|Withdrew consent|0
4791056|NCT01390948|16523302|P2|Overall Study|Withdrew consent|2
4791057|NCT01390948|16523303|P1|Overall Study|Withdrew consent|2
4791058|NCT01390948|16523301|P3|Overall Study|End of Study|0
4791059|NCT01390948|16523302|P2|Overall Study|End of Study|0
4791060|NCT01390948|16523303|P1|Overall Study|End of Study|1
4791061|NCT01390857|16523371|P1|Overall Study|No Visit after the First Visit|7
4791062|NCT01390857|16523371|P1|Overall Study|Lost to Follow-up|1
4791063|NCT01390857|16523371|P1|Overall Study|Protocol Violation|2
4791064|NCT01390844|16523382|P4|Follow-Up Phase|Non-Medical Reasons|0
4791065|NCT01390844|16523383|P3|Follow-Up Phase|Non-Medical Reasons|1
4791066|NCT01390844|16523384|P2|Follow-Up Phase|Non-Medical Reasons|1
4791067|NCT01390844|16523385|P1|Follow-Up Phase|Non-Medical Reasons|1
4791068|NCT01390844|16523382|P4|Treatment Phase|Non-GCP Compliant|3
4791069|NCT01390844|16523383|P3|Treatment Phase|Non-GCP Compliant|10
4791070|NCT01390844|16523384|P2|Treatment Phase|Non-GCP Compliant|0
4791071|NCT01390844|16523385|P1|Treatment Phase|Non-GCP Compliant|0
4791072|NCT01390844|16523382|P4|Treatment Phase|Non-Medical Reasons|1
4791073|NCT01390844|16523383|P3|Treatment Phase|Non-Medical Reasons|8
4791074|NCT01390844|16523384|P2|Treatment Phase|Non-Medical Reasons|1
4791075|NCT01390844|16523385|P1|Treatment Phase|Non-Medical Reasons|5
4791076|NCT01390844|16523382|P4|Treatment Phase|Treatment Failure|13
4791077|NCT01390844|16523383|P3|Treatment Phase|Treatment Failure|10
4791078|NCT01390844|16523384|P2|Treatment Phase|Treatment Failure|25
4791079|NCT01390844|16523385|P1|Treatment Phase|Treatment Failure|23
4791080|NCT01390844|16523382|P4|Treatment Phase|Adverse Event|2
4791081|NCT01390844|16523383|P3|Treatment Phase|Adverse Event|3
4791082|NCT01390844|16523384|P2|Treatment Phase|Adverse Event|2
4791083|NCT01390844|16523385|P1|Treatment Phase|Adverse Event|12
4791084|NCT01390779|16523712|P1|Overall Study|Physician Decision|1
4791085|NCT01390649|16523717|P1|Overall Study|Physician Decision|1
4791086|NCT01390441|16523727|P5|Extension Period|Protocol Violation|0
4791087|NCT01390441|16523728|P4|Extension Period|Protocol Violation|1
4791088|NCT01390441|16523729|P3|Extension Period|Protocol Violation|0
4791089|NCT01390441|16523730|P2|Extension Period|Protocol Violation|1
4791090|NCT01390441|16523731|P1|Extension Period|Protocol Violation|3
4791091|NCT01390441|16523727|P5|Treatment Period|Lost to Follow-up|0
4791092|NCT01390441|16523728|P4|Treatment Period|Lost to Follow-up|0
4791093|NCT01390441|16523729|P3|Treatment Period|Lost to Follow-up|0
4791094|NCT01390441|16523730|P2|Treatment Period|Lost to Follow-up|0
4791095|NCT01390441|16523731|P1|Treatment Period|Lost to Follow-up|1
4791096|NCT01390441|16523727|P5|Treatment Period|Withdrawal by Subject|1
4791097|NCT01390441|16523728|P4|Treatment Period|Withdrawal by Subject|0
4791098|NCT01390441|16523729|P3|Treatment Period|Withdrawal by Subject|1
4791099|NCT01390441|16523730|P2|Treatment Period|Withdrawal by Subject|0
4791100|NCT01390441|16523731|P1|Treatment Period|Withdrawal by Subject|0
4791101|NCT01390441|16523727|P5|Treatment Period|Adverse Event|2
4791102|NCT01390441|16523728|P4|Treatment Period|Adverse Event|1
4791103|NCT01390441|16523729|P3|Treatment Period|Adverse Event|1
4791104|NCT01390441|16523730|P2|Treatment Period|Adverse Event|0
4791105|NCT01390441|16523731|P1|Treatment Period|Adverse Event|0
4791106|NCT01390441|16523727|P5|Treatment Period|Unknown due to early stopping of study|7
4791107|NCT01390441|16523728|P4|Treatment Period|Unknown due to early stopping of study|11
4791108|NCT01390441|16523729|P3|Treatment Period|Unknown due to early stopping of study|8
4791109|NCT01390441|16523730|P2|Treatment Period|Unknown due to early stopping of study|0
4791110|NCT01390441|16523731|P1|Treatment Period|Unknown due to early stopping of study|0
4791111|NCT01390441|16523727|P5|Treatment Period|Lack of Efficacy|1
4791112|NCT01390441|16523728|P4|Treatment Period|Lack of Efficacy|0
4791113|NCT01390441|16523729|P3|Treatment Period|Lack of Efficacy|0
4791114|NCT01390441|16523730|P2|Treatment Period|Lack of Efficacy|0
4791115|NCT01390441|16523731|P1|Treatment Period|Lack of Efficacy|0
4791116|NCT01390441|16523727|P5|Treatment Period|Physician Decision|0
4791117|NCT01390441|16523728|P4|Treatment Period|Physician Decision|1
4791118|NCT01390441|16523729|P3|Treatment Period|Physician Decision|0
4791119|NCT01390441|16523730|P2|Treatment Period|Physician Decision|0
4791120|NCT01390441|16523731|P1|Treatment Period|Physician Decision|0
4791121|NCT01390441|16523727|P5|Treatment Period|Protocol Violation|0
4791122|NCT01390441|16523728|P4|Treatment Period|Protocol Violation|0
4791123|NCT01390441|16523729|P3|Treatment Period|Protocol Violation|0
4791124|NCT01390441|16523730|P2|Treatment Period|Protocol Violation|1
4791125|NCT01390441|16523731|P1|Treatment Period|Protocol Violation|0
4791126|NCT01390428|16523796|P6|Overall Study|Withdrawal by Subject|0
4791127|NCT01390428|16523797|P5|Overall Study|Withdrawal by Subject|0
4791128|NCT01390428|16523798|P4|Overall Study|Withdrawal by Subject|0
4791129|NCT01390428|16523799|P3|Overall Study|Withdrawal by Subject|1
4791130|NCT01390428|16523800|P2|Overall Study|Withdrawal by Subject|0
4791131|NCT01390428|16523801|P1|Overall Study|Withdrawal by Subject|0
4791132|NCT01390428|16523796|P6|Overall Study|Elective Surgery|0
4791133|NCT01390428|16523797|P5|Overall Study|Elective Surgery|1
4791134|NCT01390428|16523798|P4|Overall Study|Elective Surgery|0
4791135|NCT01390428|16523799|P3|Overall Study|Elective Surgery|0
4791136|NCT01390428|16523800|P2|Overall Study|Elective Surgery|0
4791137|NCT01390428|16523801|P1|Overall Study|Elective Surgery|0
4791138|NCT01390402|16523864|P1|Overall Study|Disease Progression|4
4791139|NCT01390402|16523864|P1|Overall Study|Death|1
4791140|NCT01390389|16523870|P2|Overall Study|Screen Fail|1
4791141|NCT01390389|16523871|P1|Overall Study|Screen Fail|2
4791142|NCT01390389|16523870|P2|Overall Study|Withdrawal by Subject|0
4791143|NCT01390389|16523871|P1|Overall Study|Withdrawal by Subject|2
4791144|NCT01390298|16523881|P1|Overall Study|Surgery cancelled|1
4791145|NCT01390298|16523881|P1|Overall Study|Lost to Follow-up|7
4791146|NCT01390298|16523881|P1|Overall Study|Withdrawal by Subject|14
4791147|NCT01390298|16523881|P1|Overall Study|long term ICU admission|1
4791148|NCT01390298|16523881|P1|Overall Study|Death|1
4791149|NCT01390272|16523887|P2|Overall Study|Patient moved, no longer eligible|8
4791150|NCT01390272|16523888|P1|Overall Study|Patient moved, no longer eligible|5
4791151|NCT01390272|16523887|P2|Overall Study|Withdrawal by Subject|5
4791152|NCT01390272|16523888|P1|Overall Study|Withdrawal by Subject|9
4791153|NCT01390272|16523887|P2|Overall Study|Death|2
4791154|NCT01390272|16523888|P1|Overall Study|Death|3
4791155|NCT01390220|16523956|P3|Comparative Phase|Withdrawal by Subject|0
4791156|NCT01390220|16523957|P2|Comparative Phase|Withdrawal by Subject|1
4791157|NCT01390220|16523958|P1|Comparative Phase|Withdrawal by Subject|0
4791158|NCT01390220|16523956|P3|Test Dose Phase|Logistical|0
4791159|NCT01390220|16523957|P2|Test Dose Phase|Logistical|0
4791160|NCT01390220|16523958|P1|Test Dose Phase|Logistical|6
4791161|NCT01390220|16523956|P3|Test Dose Phase|Noncompliance|0
4791162|NCT01390220|16523957|P2|Test Dose Phase|Noncompliance|0
4791163|NCT01390220|16523958|P1|Test Dose Phase|Noncompliance|2
4791164|NCT01390220|16523956|P3|Test Dose Phase|Caregiver no longer available|0
4791165|NCT01390220|16523957|P2|Test Dose Phase|Caregiver no longer available|0
4791166|NCT01390220|16523958|P1|Test Dose Phase|Caregiver no longer available|5
4791167|NCT01390220|16523956|P3|Test Dose Phase|Study/Site closure|0
4791168|NCT01390220|16523957|P2|Test Dose Phase|Study/Site closure|0
4791169|NCT01390220|16523958|P1|Test Dose Phase|Study/Site closure|6
4791170|NCT01390220|16523956|P3|Test Dose Phase|No treated seizure cluster episode|0
4791171|NCT01390220|16523957|P2|Test Dose Phase|No treated seizure cluster episode|0
4791172|NCT01390220|16523958|P1|Test Dose Phase|No treated seizure cluster episode|37
4791173|NCT01390220|16523956|P3|Test Dose Phase|Protocol Violation|0
4791174|NCT01390220|16523957|P2|Test Dose Phase|Protocol Violation|0
4791175|NCT01390220|16523958|P1|Test Dose Phase|Protocol Violation|8
4791176|NCT01390220|16523956|P3|Test Dose Phase|Lost to Follow-up|0
4791177|NCT01390220|16523957|P2|Test Dose Phase|Lost to Follow-up|0
4791178|NCT01390220|16523958|P1|Test Dose Phase|Lost to Follow-up|2
4791179|NCT01390220|16523956|P3|Test Dose Phase|Withdrawal by Subject|0
4791180|NCT01390220|16523957|P2|Test Dose Phase|Withdrawal by Subject|0
4791181|NCT01390220|16523958|P1|Test Dose Phase|Withdrawal by Subject|8
4791182|NCT01390220|16523956|P3|Test Dose Phase|Adverse Event|0
4791183|NCT01390220|16523957|P2|Test Dose Phase|Adverse Event|0
4791184|NCT01390220|16523958|P1|Test Dose Phase|Adverse Event|17
4791185|NCT01390181|16523973|P1|Overall Study|Study Terminated due to Low Accrual|3
4791186|NCT01390181|16523973|P1|Overall Study|Lost to Follow-up|1
4791187|NCT01390038|16523986|P1|Overall Study|Simpliciti System Removal|2
4791188|NCT01390038|16523986|P1|Overall Study|Withdrawal by Subject|4
4791189|NCT01390038|16523986|P1|Overall Study|Lost to Follow-up|1
4791190|NCT01390038|16523986|P1|Overall Study|Death|1
4791191|NCT01389973|16523996|P1|Overall Study|Other|10
4791192|NCT01389973|16523996|P1|Overall Study|Trial Stopped by Sponsor|9
4791193|NCT01389973|16523996|P1|Overall Study|Lost to Follow-up|1
4791194|NCT01389882|16524006|P2|Overall Study|Withdrawal by Subject|1
4791195|NCT01389882|16524007|P1|Overall Study|Withdrawal by Subject|0
4791196|NCT01389882|16524006|P2|Overall Study|Respiratory rate > 80/min during study|3
4791197|NCT01389882|16524007|P1|Overall Study|Respiratory rate > 80/min during study|1
4791198|NCT01389817|16524095|P2|Overall Study|Withdrawal by Subject|0
4791199|NCT01389817|16524096|P1|Overall Study|Withdrawal by Subject|2
4791200|NCT01389817|16524095|P2|Overall Study|Lost to Follow-up|0
4791201|NCT01389817|16524096|P1|Overall Study|Lost to Follow-up|1
4791202|NCT01389817|16524095|P2|Overall Study|Physician Decision|0
4791203|NCT01389817|16524096|P1|Overall Study|Physician Decision|1
4791204|NCT01389752|16524113|P2|Study Period 2|Sponsor decision|0
4791205|NCT01389752|16524114|P1|Study Period 2|Sponsor decision|1
4791206|NCT01389752|16524113|P2|Study Period 1|Sponsor decision|2
4791207|NCT01389752|16524114|P1|Study Period 1|Sponsor decision|0
4791208|NCT01389596|16524127|P3|Overall Study|Other Unspecified|0
4791209|NCT01389596|16524128|P2|Overall Study|Other Unspecified|1
4791210|NCT01389596|16524129|P1|Overall Study|Other Unspecified|2
4791211|NCT01389596|16524127|P3|Overall Study|Death|0
4791212|NCT01389596|16524128|P2|Overall Study|Death|1
4791213|NCT01389596|16524129|P1|Overall Study|Death|0
4791214|NCT01389596|16524127|P3|Overall Study|Adverse Event|0
4791215|NCT01389596|16524128|P2|Overall Study|Adverse Event|4
4791216|NCT01389596|16524129|P1|Overall Study|Adverse Event|1
4791217|NCT01389596|16524127|P3|Overall Study|Insufficient Clinical Response|5
4791218|NCT01389596|16524128|P2|Overall Study|Insufficient Clinical Response|4
4791219|NCT01389596|16524129|P1|Overall Study|Insufficient Clinical Response|3
4791220|NCT01389596|16524127|P3|Overall Study|Withdrawal by Subject|2
4791221|NCT01389596|16524128|P2|Overall Study|Withdrawal by Subject|2
4791222|NCT01389596|16524129|P1|Overall Study|Withdrawal by Subject|1
4791223|NCT01389596|16524127|P3|Overall Study|Protocol Violation|3
4791224|NCT01389596|16524128|P2|Overall Study|Protocol Violation|4
4791225|NCT01389596|16524129|P1|Overall Study|Protocol Violation|3
4791226|NCT01389323|16524188|P1|Follow-up Period (up to 48 Weeks)|Other|3
4791227|NCT01389323|16524188|P1|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2
4791228|NCT01389323|16524188|P1|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22
4791229|NCT01389323|16524188|P1|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10
4791230|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2
4791231|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5
4791232|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10
4791233|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7
4791234|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6
4791235|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Adverse Event|24
4791236|NCT01389323|16524188|P1|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41
4791237|NCT01389258|16524245|P1|Overall Study|Lost to Follow-up|5
4791238|NCT01389245|16524255|P1|Overall Study|Withdrawal by Subject|2
4791239|NCT01389245|16524255|P1|Overall Study|Lost to Follow-up|3
4791240|NCT01389245|16524255|P1|Overall Study|Protocol Violation|10
4791241|NCT01389128|16524265|P2|Overall Study|Intolerance to procedure|2
4791242|NCT01389128|16524266|P1|Overall Study|Intolerance to procedure|0
4791243|NCT01389128|16524265|P2|Overall Study|Rapid labor evolution|2
4791244|NCT01389128|16524266|P1|Overall Study|Rapid labor evolution|3
4791245|NCT01389128|16524265|P2|Overall Study|Cervix dilation stop|2
4791246|NCT01389128|16524266|P1|Overall Study|Cervix dilation stop|1
4791247|NCT01389128|16524265|P2|Overall Study|Fetal distress|0
4791248|NCT01389128|16524266|P1|Overall Study|Fetal distress|1
4791249|NCT01389102|16524290|P6|Overall Study|Investigator Judgement|0
4791250|NCT01389102|16524291|P5|Overall Study|Investigator Judgement|0
4791251|NCT01389102|16524292|P4|Overall Study|Investigator Judgement|0
4791252|NCT01389102|16524293|P3|Overall Study|Investigator Judgement|0
4791253|NCT01389102|16524294|P2|Overall Study|Investigator Judgement|1
4791254|NCT01389102|16524295|P1|Overall Study|Investigator Judgement|0
4791255|NCT01389102|16524290|P6|Overall Study|Unavailable due to husband's illness|0
4791256|NCT01389102|16524291|P5|Overall Study|Unavailable due to husband's illness|0
4791257|NCT01389102|16524292|P4|Overall Study|Unavailable due to husband's illness|0
4791258|NCT01389102|16524293|P3|Overall Study|Unavailable due to husband's illness|0
4791259|NCT01389102|16524294|P2|Overall Study|Unavailable due to husband's illness|1
4791260|NCT01389102|16524295|P1|Overall Study|Unavailable due to husband's illness|0
4791261|NCT01389102|16524290|P6|Overall Study|Subject Moved|0
4791262|NCT01389102|16524291|P5|Overall Study|Subject Moved|0
4791263|NCT01389102|16524292|P4|Overall Study|Subject Moved|0
4791264|NCT01389102|16524293|P3|Overall Study|Subject Moved|1
4791265|NCT01389102|16524294|P2|Overall Study|Subject Moved|0
4791266|NCT01389102|16524295|P1|Overall Study|Subject Moved|2
4791267|NCT01389102|16524290|P6|Overall Study|Subject Traveling Out of Country|0
4791268|NCT01389102|16524291|P5|Overall Study|Subject Traveling Out of Country|0
4791269|NCT01389102|16524292|P4|Overall Study|Subject Traveling Out of Country|1
4791270|NCT01389102|16524293|P3|Overall Study|Subject Traveling Out of Country|0
4791271|NCT01389102|16524294|P2|Overall Study|Subject Traveling Out of Country|0
4791272|NCT01389102|16524295|P1|Overall Study|Subject Traveling Out of Country|0
4791273|NCT01389102|16524290|P6|Overall Study|Withdrawal by Subject|3
4791274|NCT01389102|16524291|P5|Overall Study|Withdrawal by Subject|3
4791275|NCT01389102|16524292|P4|Overall Study|Withdrawal by Subject|2
4791276|NCT01389102|16524293|P3|Overall Study|Withdrawal by Subject|9
4791277|NCT01389102|16524294|P2|Overall Study|Withdrawal by Subject|4
4791278|NCT01389102|16524295|P1|Overall Study|Withdrawal by Subject|7
4791279|NCT01389102|16524290|P6|Overall Study|Protocol Violation|1
4791280|NCT01389102|16524291|P5|Overall Study|Protocol Violation|1
4791281|NCT01389102|16524292|P4|Overall Study|Protocol Violation|0
4791282|NCT01389102|16524293|P3|Overall Study|Protocol Violation|3
4791283|NCT01389102|16524294|P2|Overall Study|Protocol Violation|0
4791284|NCT01389102|16524295|P1|Overall Study|Protocol Violation|0
4791285|NCT01389102|16524290|P6|Overall Study|Lost to Follow-up|1
4791286|NCT01389102|16524291|P5|Overall Study|Lost to Follow-up|4
4791287|NCT01389102|16524292|P4|Overall Study|Lost to Follow-up|2
4791288|NCT01389102|16524293|P3|Overall Study|Lost to Follow-up|1
4791289|NCT01389102|16524294|P2|Overall Study|Lost to Follow-up|1
4791290|NCT01389102|16524295|P1|Overall Study|Lost to Follow-up|4
4791291|NCT01389102|16524290|P6|Overall Study|Hurricane Katrina|1
4791292|NCT01389102|16524291|P5|Overall Study|Hurricane Katrina|3
4791293|NCT01389102|16524292|P4|Overall Study|Hurricane Katrina|0
4791294|NCT01389102|16524293|P3|Overall Study|Hurricane Katrina|3
4791295|NCT01389102|16524294|P2|Overall Study|Hurricane Katrina|2
4791296|NCT01389102|16524295|P1|Overall Study|Hurricane Katrina|4
4791297|NCT01389102|16524290|P6|Overall Study|Adverse Event|2
4791298|NCT01389102|16524291|P5|Overall Study|Adverse Event|2
4791299|NCT01389102|16524292|P4|Overall Study|Adverse Event|2
4791300|NCT01389102|16524293|P3|Overall Study|Adverse Event|2
4791301|NCT01389102|16524294|P2|Overall Study|Adverse Event|3
4791302|NCT01389102|16524295|P1|Overall Study|Adverse Event|1
4791303|NCT01388985|16524325|P2|Overall Study|Error of nurse|1
4791304|NCT01388985|16524326|P1|Overall Study|Error of nurse|5
4791305|NCT01388985|16524325|P2|Overall Study|Other (no reason)|1
4791306|NCT01388985|16524326|P1|Overall Study|Other (no reason)|0
4791307|NCT01388985|16524325|P2|Overall Study|Subject unavailable|1
4791308|NCT01388985|16524326|P1|Overall Study|Subject unavailable|1
4791309|NCT01388985|16524325|P2|Overall Study|Withdrawal by Subject|4
4791310|NCT01388985|16524326|P1|Overall Study|Withdrawal by Subject|13
4791311|NCT01388985|16524325|P2|Overall Study|Lost to Follow-up|30
4791312|NCT01388985|16524326|P1|Overall Study|Lost to Follow-up|30
4791313|NCT01388985|16524325|P2|Overall Study|Death|1
4791314|NCT01388985|16524326|P1|Overall Study|Death|0
4791315|NCT01388907|16524390|P2|Overall Study|Adverse Event|0
4791316|NCT01388907|16524391|P1|Overall Study|Adverse Event|2
4791317|NCT01388816|16524407|P4|Overall Study|Protocol Violation|0
4791318|NCT01388816|16524408|P3|Overall Study|Protocol Violation|2
4791319|NCT01388816|16524409|P2|Overall Study|Protocol Violation|0
4791320|NCT01388816|16524410|P1|Overall Study|Protocol Violation|0
4791321|NCT01388816|16524407|P4|Overall Study|Withdrawal by Subject|0
4791322|NCT01388816|16524408|P3|Overall Study|Withdrawal by Subject|1
4791323|NCT01388816|16524409|P2|Overall Study|Withdrawal by Subject|1
4791324|NCT01388816|16524410|P1|Overall Study|Withdrawal by Subject|2
4791325|NCT01388816|16524407|P4|Overall Study|Lost to Follow-up|0
4791326|NCT01388816|16524408|P3|Overall Study|Lost to Follow-up|0
4791327|NCT01388816|16524409|P2|Overall Study|Lost to Follow-up|1
4791328|NCT01388816|16524410|P1|Overall Study|Lost to Follow-up|0
4791329|NCT01388816|16524407|P4|Overall Study|Adverse Event|0
4791330|NCT01388816|16524408|P3|Overall Study|Adverse Event|0
4791331|NCT01388816|16524409|P2|Overall Study|Adverse Event|2
4791332|NCT01388816|16524410|P1|Overall Study|Adverse Event|0
4791333|NCT01388790|16524439|P1|Overall Study|Ongoing at data cut-off date|8
4791334|NCT01388647|16524450|P2|Overall Study|Adverse Event|2
4791335|NCT01388647|16524451|P1|Overall Study|Adverse Event|1
4791336|NCT01388543|16524464|P2|Day 14|Adverse Event|4
4791337|NCT01388543|16524465|P1|Day 14|Adverse Event|1
4791338|NCT01388530|16524471|P1|Overall Study|Lost to Follow-up|5
4791339|NCT01388491|16524480|P2|Overall Study|Pregnancy|0
4791340|NCT01388491|16524481|P1|Overall Study|Pregnancy|1
4791341|NCT01388491|16524480|P2|Overall Study|Noncompliance|0
4791342|NCT01388491|16524481|P1|Overall Study|Noncompliance|2
4791343|NCT01388491|16524480|P2|Overall Study|Protocol Violation|0
4791344|NCT01388491|16524481|P1|Overall Study|Protocol Violation|2
4791345|NCT01388491|16524480|P2|Overall Study|Lost to Follow-up|3
4791346|NCT01388491|16524481|P1|Overall Study|Lost to Follow-up|4
4791347|NCT01388491|16524480|P2|Overall Study|Withdrawal by Subject|10
4791348|NCT01388491|16524481|P1|Overall Study|Withdrawal by Subject|6
4791349|NCT01388491|16524480|P2|Overall Study|Sponsor Request|7
4791350|NCT01388491|16524481|P1|Overall Study|Sponsor Request|9
4791351|NCT01388491|16524480|P2|Overall Study|Adverse Event|9
4791352|NCT01388491|16524481|P1|Overall Study|Adverse Event|10
4791353|NCT01388361|16524516|P3|Overall Study|Unclassified|1
4791354|NCT01388361|16524517|P2|Overall Study|Unclassified|0
4791355|NCT01388361|16524518|P1|Overall Study|Unclassified|0
4791356|NCT01388361|16524516|P3|Overall Study|Withdrawal criteria|10
4791357|NCT01388361|16524517|P2|Overall Study|Withdrawal criteria|7
4791358|NCT01388361|16524518|P1|Overall Study|Withdrawal criteria|12
4791359|NCT01388361|16524516|P3|Overall Study|Protocol Violation|2
4791360|NCT01388361|16524517|P2|Overall Study|Protocol Violation|0
4791361|NCT01388361|16524518|P1|Overall Study|Protocol Violation|0
4791362|NCT01388361|16524516|P3|Overall Study|Adverse Event|1
4791363|NCT01388361|16524517|P2|Overall Study|Adverse Event|5
4791364|NCT01388361|16524518|P1|Overall Study|Adverse Event|0
4791365|NCT01388335|16524535|P1|Safety Extension|Progressive Disease|7
4791366|NCT01388335|16524535|P1|Period 2|Sponsor Decision|1
4791367|NCT01388335|16524535|P1|Period 2|Progressive Disease|2
4791368|NCT01388335|16524535|P1|Period 1|Progressive Disease|1
4791369|NCT01388166|16524562|P1|Overall Study|Others than specified above|13
4791370|NCT01388166|16524562|P1|Overall Study|Lost to Follow-up|30
4791371|NCT01388166|16524562|P1|Overall Study|Adverse Event|16
4791372|NCT01387789|16524865|P1|Overall Study|Lost to Follow-up|1
4791373|NCT01387789|16524865|P1|Overall Study|Lack of Efficacy|2
4791374|NCT01387789|16524865|P1|Overall Study|Adverse Event|5
4791375|NCT01387737|16524879|P2|Overall Study|Clearly not eligible for the study|3
4791376|NCT01387737|16524880|P1|Overall Study|Clearly not eligible for the study|1
4791377|NCT01387737|16524879|P2|Overall Study|Withdrawal by Subject|31
4791378|NCT01387737|16524880|P1|Overall Study|Withdrawal by Subject|27
4791379|NCT01387737|16524879|P2|Overall Study|Physician Decision|10
4791380|NCT01387737|16524880|P1|Overall Study|Physician Decision|3
4791381|NCT01387737|16524879|P2|Overall Study|Lack of Efficacy|0
4791382|NCT01387737|16524880|P1|Overall Study|Lack of Efficacy|1
4791383|NCT01387737|16524879|P2|Overall Study|Adverse Event|30
4791384|NCT01387737|16524880|P1|Overall Study|Adverse Event|20
4791385|NCT01387607|16524914|P2|Overall Study|Randomized, not treated|6
4791386|NCT01387607|16524915|P1|Overall Study|Randomized, not treated|3
4791387|NCT01387607|16524914|P2|Overall Study|Other|1
4791388|NCT01387607|16524915|P1|Overall Study|Other|1
4791389|NCT01387607|16524914|P2|Overall Study|Withdrawal by Subject|14
4791390|NCT01387607|16524915|P1|Overall Study|Withdrawal by Subject|13
4791391|NCT01387607|16524914|P2|Overall Study|Protocol Violation|5
4791392|NCT01387607|16524915|P1|Overall Study|Protocol Violation|1
4791393|NCT01387607|16524914|P2|Overall Study|No longer meets eligibility criteria|1
4791394|NCT01387607|16524915|P1|Overall Study|No longer meets eligibility criteria|0
4791395|NCT01387607|16524914|P2|Overall Study|Lost to Follow-up|1
4791396|NCT01387607|16524915|P1|Overall Study|Lost to Follow-up|2
4791397|NCT01387607|16524914|P2|Overall Study|Lack of Efficacy|6
4791398|NCT01387607|16524915|P1|Overall Study|Lack of Efficacy|8
4791399|NCT01387607|16524914|P2|Overall Study|Adverse Event|11
4791400|NCT01387607|16524915|P1|Overall Study|Adverse Event|23
4791401|NCT01387594|16524969|P2|Overall Study|Lost to Follow-up|1
4791402|NCT01387594|16524970|P1|Overall Study|Lost to Follow-up|0
4791403|NCT01387594|16524969|P2|Overall Study|Withdrawal by Subject|2
4791404|NCT01387594|16524970|P1|Overall Study|Withdrawal by Subject|0
4791405|NCT01387542|16524998|P1|Overall Study|Lost to Follow-up|1
4791406|NCT01387542|16524998|P1|Overall Study|Non-compliant|1
4791407|NCT01387542|16524998|P1|Overall Study|Insufficient response|1
4791408|NCT01387542|16524998|P1|Overall Study|Changed diagnosis|1
4791409|NCT01387542|16524998|P1|Overall Study|Withdrawal by Subject|1
4791410|NCT01387542|16524998|P1|Overall Study|Adverse Event|3
4791411|NCT01387516|16525009|P4|Overall Study|Death|1
4791412|NCT01387516|16525010|P3|Overall Study|Death|0
4791413|NCT01387516|16525011|P2|Overall Study|Death|0
4791414|NCT01387516|16525012|P1|Overall Study|Death|0
4791415|NCT01387516|16525009|P4|Overall Study|Withdrawal by Subject|0
4791416|NCT01387516|16525010|P3|Overall Study|Withdrawal by Subject|2
4791417|NCT01387516|16525011|P2|Overall Study|Withdrawal by Subject|1
4791418|NCT01387516|16525012|P1|Overall Study|Withdrawal by Subject|1
4791419|NCT01387516|16525009|P4|Overall Study|Lost to Follow-up|3
4791420|NCT01387516|16525010|P3|Overall Study|Lost to Follow-up|2
4791421|NCT01387516|16525011|P2|Overall Study|Lost to Follow-up|4
4791422|NCT01387516|16525012|P1|Overall Study|Lost to Follow-up|4
4791423|NCT01387347|16525045|P2|Overall Study|Lost to Follow-up|1
4791424|NCT01387347|16525046|P1|Overall Study|Lost to Follow-up|2
4791425|NCT01387282|16525058|P2|Overall Study|Lost to Follow-up|1
4791426|NCT01387282|16525059|P1|Overall Study|Lost to Follow-up|4
4791427|NCT01387282|16525058|P2|Overall Study|Study drug-related AE|2
4791428|NCT01387282|16525059|P1|Overall Study|Study drug-related AE|2
4791429|NCT01387282|16525058|P2|Overall Study|Withdrawal by patient|23
4791430|NCT01387282|16525059|P1|Overall Study|Withdrawal by patient|33
4791431|NCT01387282|16525058|P2|Overall Study|Unrelated AE|4
4791432|NCT01387282|16525059|P1|Overall Study|Unrelated AE|6
4791433|NCT01387282|16525058|P2|Overall Study|Other|1
4791434|NCT01387282|16525059|P1|Overall Study|Other|5
4791435|NCT01387282|16525058|P2|Overall Study|Death|16
4791436|NCT01387282|16525059|P1|Overall Study|Death|47
4791437|NCT01387269|16525075|P2|Overall Study|Lost to Follow-up|0
4791438|NCT01387269|16525076|P1|Overall Study|Lost to Follow-up|1
4791439|NCT01387269|16525075|P2|Overall Study|Study drug-related AE|0
4791440|NCT01387269|16525076|P1|Overall Study|Study drug-related AE|1
4791441|NCT01387269|16525075|P2|Overall Study|Withdrawal by patient|10
4791442|NCT01387269|16525076|P1|Overall Study|Withdrawal by patient|32
4791443|NCT01387269|16525075|P2|Overall Study|Unrelated AE|3
4791444|NCT01387269|16525076|P1|Overall Study|Unrelated AE|12
4791445|NCT01387269|16525075|P2|Overall Study|Other|7
4791446|NCT01387269|16525076|P1|Overall Study|Other|8
4791447|NCT01387269|16525075|P2|Overall Study|Death|20
4791448|NCT01387269|16525076|P1|Overall Study|Death|38
4791449|NCT01387230|16525093|P3|Overall Study|Withdrawal by Subject|0
4791450|NCT01387230|16525094|P2|Overall Study|Withdrawal by Subject|1
4791451|NCT01387230|16525095|P1|Overall Study|Withdrawal by Subject|4
4791452|NCT01387230|16525093|P3|Overall Study|Lost to Follow-up|1
4791453|NCT01387230|16525094|P2|Overall Study|Lost to Follow-up|0
4791454|NCT01387230|16525095|P1|Overall Study|Lost to Follow-up|0
4791455|NCT01387230|16525093|P3|Overall Study|Protocol-defined Stopping Criteria|5
4791456|NCT01387230|16525094|P2|Overall Study|Protocol-defined Stopping Criteria|0
4791457|NCT01387230|16525095|P1|Overall Study|Protocol-defined Stopping Criteria|6
4791458|NCT01387230|16525093|P3|Overall Study|Lack of Efficacy|4
4791459|NCT01387230|16525094|P2|Overall Study|Lack of Efficacy|5
4791460|NCT01387230|16525095|P1|Overall Study|Lack of Efficacy|8
4791461|NCT01387230|16525093|P3|Overall Study|Adverse Event|3
4791462|NCT01387230|16525094|P2|Overall Study|Adverse Event|1
4791463|NCT01387230|16525095|P1|Overall Study|Adverse Event|0
4791464|NCT01387074|16525141|P1|Overall Study|Lack of Efficacy|1
4791465|NCT01387074|16525141|P1|Overall Study|Lost to Follow-up|7
4791466|NCT01387022|16525154|P2|Overall Study|Lost to Follow-up|3
4791467|NCT01387022|16525155|P1|Overall Study|Lost to Follow-up|0
4791468|NCT01387022|16525154|P2|Overall Study|Death|1
4791469|NCT01387022|16525155|P1|Overall Study|Death|1
4791470|NCT01386970|16525184|P2|Overall Study|Adverse Event|1
4791471|NCT01386970|16525185|P1|Overall Study|Adverse Event|4
4791472|NCT01386970|16525184|P2|Overall Study|Withdrawal by Subject|1
4791473|NCT01386970|16525185|P1|Overall Study|Withdrawal by Subject|0
4791474|NCT01386944|16525193|P1|Overall Study|Unspecified reason|8
4791475|NCT01386944|16525193|P1|Overall Study|Lost to Follow-up|8
4791476|NCT01386944|16525193|P1|Overall Study|Lack of Efficacy|14
4791477|NCT01386944|16525193|P1|Overall Study|Adverse Event|26
4791478|NCT01386788|16525203|P1|Overall Study|Lost to Follow-up|2
4791479|NCT01386684|16525208|P1|Overall Study|Missing|3
4791480|NCT01386684|16525208|P1|Overall Study|Protocol Violation|4
4791481|NCT01386684|16525208|P1|Overall Study|Noncompliance|8
4791482|NCT01386684|16525208|P1|Overall Study|Adverse Event|20
4791483|NCT01386684|16525208|P1|Overall Study|Disease Progression|28
4791484|NCT01386684|16525208|P1|Overall Study|Alternative Therapy Required|37
4791485|NCT01386684|16525208|P1|Overall Study|Withdrawal of Consent|44
4791486|NCT01386684|16525208|P1|Overall Study|Death|47
4791487|NCT01386684|16525208|P1|Overall Study|Other|51
4791488|NCT01386684|16525208|P1|Overall Study|Lost to Follow-up|51
4791489|NCT01386658|16525249|P2|Initial Icatibant Exposure|Lack of adherence and poor compliance|3
4791490|NCT01386658|16525250|P1|Initial Icatibant Exposure|Lack of adherence and poor compliance|0
4791491|NCT01386658|16525249|P2|Initial Icatibant Exposure|Withdrawal by Subject|9
4791492|NCT01386658|16525250|P1|Initial Icatibant Exposure|Withdrawal by Subject|0
4791493|NCT01386645|16525316|P3|Overall Study|Withdrawal by Subject|1
4791494|NCT01386645|16525317|P2|Overall Study|Withdrawal by Subject|1
4791495|NCT01386645|16525318|P1|Overall Study|Withdrawal by Subject|0
4791496|NCT01386645|16525316|P3|Overall Study|Physician Decision|1
4791497|NCT01386645|16525317|P2|Overall Study|Physician Decision|0
4791498|NCT01386645|16525318|P1|Overall Study|Physician Decision|0
4791499|NCT01386606|16525347|P4|Overall Study|T levels too high|0
4791500|NCT01386606|16525348|P3|Overall Study|T levels too high|1
4791501|NCT01386606|16525349|P2|Overall Study|T levels too high|1
4791502|NCT01386606|16525350|P1|Overall Study|T levels too high|0
4791503|NCT01386606|16525347|P4|Overall Study|Unable to draw PK|0
4791504|NCT01386606|16525348|P3|Overall Study|Unable to draw PK|0
4791505|NCT01386606|16525349|P2|Overall Study|Unable to draw PK|0
4791506|NCT01386606|16525350|P1|Overall Study|Unable to draw PK|1
4791507|NCT01386606|16525347|P4|Overall Study|Subject incarcerated|0
4791508|NCT01386606|16525348|P3|Overall Study|Subject incarcerated|0
4791509|NCT01386606|16525349|P2|Overall Study|Subject incarcerated|1
4791510|NCT01386606|16525350|P1|Overall Study|Subject incarcerated|0
4791511|NCT01386606|16525347|P4|Overall Study|Lost to Follow-up|0
4791512|NCT01386606|16525348|P3|Overall Study|Lost to Follow-up|0
4791513|NCT01386606|16525349|P2|Overall Study|Lost to Follow-up|0
4791514|NCT01386606|16525350|P1|Overall Study|Lost to Follow-up|2
4791515|NCT01386606|16525347|P4|Overall Study|Protocol Violation|1
4791516|NCT01386606|16525348|P3|Overall Study|Protocol Violation|1
4791517|NCT01386606|16525349|P2|Overall Study|Protocol Violation|0
4791518|NCT01386606|16525350|P1|Overall Study|Protocol Violation|1
4791519|NCT01386606|16525347|P4|Overall Study|Withdrawal by Subject|0
4791520|NCT01386606|16525348|P3|Overall Study|Withdrawal by Subject|1
4791521|NCT01386606|16525349|P2|Overall Study|Withdrawal by Subject|1
4791522|NCT01386606|16525350|P1|Overall Study|Withdrawal by Subject|0
4791523|NCT01386606|16525347|P4|Overall Study|Adverse Event|0
4791524|NCT01386606|16525348|P3|Overall Study|Adverse Event|0
4791525|NCT01386606|16525349|P2|Overall Study|Adverse Event|1
4791526|NCT01386606|16525350|P1|Overall Study|Adverse Event|0
4791527|NCT01386554|16525381|P3|Overall Study|Reason not collected|0
4791528|NCT01386554|16525382|P2|Overall Study|Reason not collected|1
4791529|NCT01386554|16525383|P1|Overall Study|Reason not collected|0
4791530|NCT01386554|16525381|P3|Overall Study|Investigator discretion|1
4791531|NCT01386554|16525382|P2|Overall Study|Investigator discretion|0
4791532|NCT01386554|16525383|P1|Overall Study|Investigator discretion|0
4791533|NCT01386554|16525381|P3|Overall Study|Administration of live vaccines|0
4791534|NCT01386554|16525382|P2|Overall Study|Administration of live vaccines|1
4791535|NCT01386554|16525383|P1|Overall Study|Administration of live vaccines|0
4791536|NCT01386554|16525381|P3|Overall Study|Progressive disease|2
4791537|NCT01386554|16525382|P2|Overall Study|Progressive disease|2
4791538|NCT01386554|16525383|P1|Overall Study|Progressive disease|1
4791539|NCT01386554|16525381|P3|Overall Study|Adverse Event|2
4791540|NCT01386554|16525382|P2|Overall Study|Adverse Event|5
4791541|NCT01386554|16525383|P1|Overall Study|Adverse Event|2
4791542|NCT01386554|16525381|P3|Overall Study|Lost to Follow-up|1
4791543|NCT01386554|16525382|P2|Overall Study|Lost to Follow-up|0
4791544|NCT01386554|16525383|P1|Overall Study|Lost to Follow-up|0
4791545|NCT01386125|16525406|P2|Overall Study|Participant Leaving Country|0
4791546|NCT01386125|16525407|P1|Overall Study|Participant Leaving Country|1
4791547|NCT01386125|16525406|P2|Overall Study|Lack of Efficacy|1
4791548|NCT01386125|16525407|P1|Overall Study|Lack of Efficacy|0
4791549|NCT01386125|16525406|P2|Overall Study|Adverse Event|5
4791550|NCT01386125|16525407|P1|Overall Study|Adverse Event|2
4791551|NCT01386125|16525406|P2|Overall Study|Withdrawal by Subject|12
4791552|NCT01386125|16525407|P1|Overall Study|Withdrawal by Subject|13
4791553|NCT01386125|16525406|P2|Overall Study|Disease Progress|2
4791554|NCT01386125|16525407|P1|Overall Study|Disease Progress|1
4791555|NCT01386125|16525406|P2|Overall Study|Protocol Violation|7
4791556|NCT01386125|16525407|P1|Overall Study|Protocol Violation|5
4791557|NCT01386125|16525406|P2|Overall Study|Physician Decision|1
4791558|NCT01386125|16525407|P1|Overall Study|Physician Decision|0
4791559|NCT01386125|16525406|P2|Overall Study|Lost to Follow-up|9
4791560|NCT01386125|16525407|P1|Overall Study|Lost to Follow-up|3
4791561|NCT01386008|16525415|P1|Overall Study|Adverse Event|3
4791562|NCT01386008|16525415|P1|Overall Study|exited w/o incident /study discontinued|17
4791563|NCT01385995|16525424|P2|Period 1, 2 Months|Physician Decision|0
4791564|NCT01385995|16525425|P1|Period 1, 2 Months|Physician Decision|1
4791565|NCT01385748|16525442|P3|Overall Study|Adverse Event|1
4791566|NCT01385748|16525443|P2|Overall Study|Adverse Event|2
4791567|NCT01385748|16525444|P1|Overall Study|Adverse Event|4
4791568|NCT01385748|16525442|P3|Overall Study|Other|1
4791569|NCT01385748|16525443|P2|Overall Study|Other|7
4791570|NCT01385748|16525444|P1|Overall Study|Other|1
4791571|NCT01385748|16525442|P3|Overall Study|Noncompliance|6
4791572|NCT01385748|16525443|P2|Overall Study|Noncompliance|1
4791573|NCT01385748|16525444|P1|Overall Study|Noncompliance|3
4791574|NCT01385748|16525442|P3|Overall Study|Withdrawal by Subject|5
4791575|NCT01385748|16525443|P2|Overall Study|Withdrawal by Subject|4
4791576|NCT01385748|16525444|P1|Overall Study|Withdrawal by Subject|7
4791577|NCT01385566|16525529|P6|Overall Study|Withdrawal by Subject|0
4791578|NCT01385566|16525530|P5|Overall Study|Withdrawal by Subject|0
4791579|NCT01385566|16525531|P4|Overall Study|Withdrawal by Subject|1
4791580|NCT01385566|16525532|P3|Overall Study|Withdrawal by Subject|0
4791581|NCT01385566|16525533|P2|Overall Study|Withdrawal by Subject|0
4791582|NCT01385566|16525534|P1|Overall Study|Withdrawal by Subject|0
4791583|NCT01385566|16525529|P6|Overall Study|Lost to Follow-up|0
4791584|NCT01385566|16525530|P5|Overall Study|Lost to Follow-up|0
4791585|NCT01385566|16525531|P4|Overall Study|Lost to Follow-up|0
4791586|NCT01385566|16525532|P3|Overall Study|Lost to Follow-up|0
4791587|NCT01385566|16525533|P2|Overall Study|Lost to Follow-up|0
4791588|NCT01385566|16525534|P1|Overall Study|Lost to Follow-up|1
4791589|NCT01385371|16525588|P2|Overall Study|Administrative|2
4791590|NCT01385371|16525589|P1|Overall Study|Administrative|2
4791591|NCT01385371|16525588|P2|Overall Study|Protocol Violation|21
4791592|NCT01385371|16525589|P1|Overall Study|Protocol Violation|25
4791593|NCT01385371|16525588|P2|Overall Study|Withdrawal by Subject|39
4791594|NCT01385371|16525589|P1|Overall Study|Withdrawal by Subject|52
4791595|NCT01385371|16525588|P2|Overall Study|Lost to Follow-up|16
4791596|NCT01385371|16525589|P1|Overall Study|Lost to Follow-up|16
4791597|NCT01385371|16525588|P2|Overall Study|Adverse Event|19
4791598|NCT01385371|16525589|P1|Overall Study|Adverse Event|54
4791599|NCT01385202|16525637|P1|Overall Study|Withdrawn|1
4791600|NCT01385202|16525637|P1|Overall Study|Not Eligible|11
4791601|NCT01385202|16525637|P1|Overall Study|Lost to Follow-up|6
4791602|NCT01385176|16525674|P2|6-18 Month All VNS Active|Heart Transplant|0
4791603|NCT01385176|16525675|P1|6-18 Month All VNS Active|Heart Transplant|1
4791604|NCT01385176|16525674|P2|6-18 Month All VNS Active|Withdrawal by Subject|0
4791605|NCT01385176|16525675|P1|6-18 Month All VNS Active|Withdrawal by Subject|2
4791606|NCT01385176|16525674|P2|6-18 Month All VNS Active|Physician Decision|1
4791607|NCT01385176|16525675|P1|6-18 Month All VNS Active|Physician Decision|0
4791608|NCT01385176|16525674|P2|6-18 Month All VNS Active|Death|2
4791609|NCT01385176|16525675|P1|6-18 Month All VNS Active|Death|1
4791610|NCT01385176|16525674|P2|Randomization Phase|Death|2
4791611|NCT01385176|16525675|P1|Randomization Phase|Death|1
4791612|NCT01385098|16525706|P1|Overall Study|Lost to Follow-up|4
4791613|NCT01385098|16525706|P1|Overall Study|Adverse Event|10
4791614|NCT01384877|16525728|P2|Treatment 2|Lost to Follow-up|2
4791615|NCT01384877|16525729|P1|Treatment 2|Lost to Follow-up|2
4791616|NCT01384760|16525755|P2|Overall Study|Protocol Violation|0
4791617|NCT01384760|16525756|P1|Overall Study|Protocol Violation|16
4791618|NCT01384760|16525755|P2|Overall Study|Lost to Follow-up|6
4791619|NCT01384760|16525756|P1|Overall Study|Lost to Follow-up|0
4791620|NCT01384734|16525769|P5|Overall Study|Physician Decision|0
4791621|NCT01384734|16525770|P4|Overall Study|Physician Decision|0
4791622|NCT01384734|16525771|P3|Overall Study|Physician Decision|0
4791623|NCT01384734|16525772|P2|Overall Study|Physician Decision|0
4791624|NCT01384734|16525773|P1|Overall Study|Physician Decision|1
4791625|NCT01384734|16525769|P5|Overall Study|Early termination|1
4791626|NCT01384734|16525770|P4|Overall Study|Early termination|0
4791627|NCT01384734|16525771|P3|Overall Study|Early termination|0
4791628|NCT01384734|16525772|P2|Overall Study|Early termination|0
4791629|NCT01384734|16525773|P1|Overall Study|Early termination|0
4791630|NCT01384734|16525769|P5|Overall Study|Adhesion problem|0
4791631|NCT01384734|16525770|P4|Overall Study|Adhesion problem|1
4791632|NCT01384734|16525771|P3|Overall Study|Adhesion problem|0
4791633|NCT01384734|16525772|P2|Overall Study|Adhesion problem|0
4791634|NCT01384734|16525773|P1|Overall Study|Adhesion problem|0
4791635|NCT01384734|16525769|P5|Overall Study|Missed End of treatment visit|0
4791636|NCT01384734|16525770|P4|Overall Study|Missed End of treatment visit|1
4791637|NCT01384734|16525771|P3|Overall Study|Missed End of treatment visit|0
4791638|NCT01384734|16525772|P2|Overall Study|Missed End of treatment visit|0
4791639|NCT01384734|16525773|P1|Overall Study|Missed End of treatment visit|0
4791640|NCT01384734|16525769|P5|Overall Study|As per Exclusion criteria|0
4791641|NCT01384734|16525770|P4|Overall Study|As per Exclusion criteria|0
4791642|NCT01384734|16525771|P3|Overall Study|As per Exclusion criteria|0
4791643|NCT01384734|16525772|P2|Overall Study|As per Exclusion criteria|1
4791644|NCT01384734|16525773|P1|Overall Study|As per Exclusion criteria|0
4791645|NCT01384734|16525769|P5|Overall Study|Prison|0
4791646|NCT01384734|16525770|P4|Overall Study|Prison|0
4791647|NCT01384734|16525771|P3|Overall Study|Prison|1
4791648|NCT01384734|16525772|P2|Overall Study|Prison|0
4791649|NCT01384734|16525773|P1|Overall Study|Prison|0
4791650|NCT01384734|16525769|P5|Overall Study|Unable to come back for visit|0
4791651|NCT01384734|16525770|P4|Overall Study|Unable to come back for visit|1
4791652|NCT01384734|16525771|P3|Overall Study|Unable to come back for visit|1
4791653|NCT01384734|16525772|P2|Overall Study|Unable to come back for visit|0
4791654|NCT01384734|16525773|P1|Overall Study|Unable to come back for visit|1
4791655|NCT01384734|16525769|P5|Overall Study|Investigator relocating|1
4791656|NCT01384734|16525770|P4|Overall Study|Investigator relocating|3
4791657|NCT01384734|16525771|P3|Overall Study|Investigator relocating|0
4791658|NCT01384734|16525772|P2|Overall Study|Investigator relocating|2
4791659|NCT01384734|16525773|P1|Overall Study|Investigator relocating|0
4791660|NCT01384734|16525769|P5|Overall Study|Withdrawal by Subject|9
4791661|NCT01384734|16525770|P4|Overall Study|Withdrawal by Subject|7
4791662|NCT01384734|16525771|P3|Overall Study|Withdrawal by Subject|6
4791663|NCT01384734|16525772|P2|Overall Study|Withdrawal by Subject|5
4791664|NCT01384734|16525773|P1|Overall Study|Withdrawal by Subject|5
4791665|NCT01384734|16525769|P5|Overall Study|Sponsor terminated|1
4791666|NCT01384734|16525770|P4|Overall Study|Sponsor terminated|0
4791667|NCT01384734|16525771|P3|Overall Study|Sponsor terminated|0
4791668|NCT01384734|16525772|P2|Overall Study|Sponsor terminated|0
4791669|NCT01384734|16525773|P1|Overall Study|Sponsor terminated|0
4791670|NCT01384734|16525769|P5|Overall Study|Pregnancy|1
4791671|NCT01384734|16525770|P4|Overall Study|Pregnancy|0
4791672|NCT01384734|16525771|P3|Overall Study|Pregnancy|0
4791673|NCT01384734|16525772|P2|Overall Study|Pregnancy|1
4791674|NCT01384734|16525773|P1|Overall Study|Pregnancy|0
4791675|NCT01384734|16525769|P5|Overall Study|Non-compliance with study drug|2
4791676|NCT01384734|16525770|P4|Overall Study|Non-compliance with study drug|0
4791677|NCT01384734|16525771|P3|Overall Study|Non-compliance with study drug|6
4791678|NCT01384734|16525772|P2|Overall Study|Non-compliance with study drug|2
4791679|NCT01384734|16525773|P1|Overall Study|Non-compliance with study drug|1
4791680|NCT01384734|16525769|P5|Overall Study|Lost to Follow-up|5
4791681|NCT01384734|16525770|P4|Overall Study|Lost to Follow-up|8
4791682|NCT01384734|16525771|P3|Overall Study|Lost to Follow-up|3
4791683|NCT01384734|16525772|P2|Overall Study|Lost to Follow-up|3
4791684|NCT01384734|16525773|P1|Overall Study|Lost to Follow-up|5
4791685|NCT01384734|16525769|P5|Overall Study|Lack of Efficacy|2
4791686|NCT01384734|16525770|P4|Overall Study|Lack of Efficacy|4
4791687|NCT01384734|16525771|P3|Overall Study|Lack of Efficacy|4
4791688|NCT01384734|16525772|P2|Overall Study|Lack of Efficacy|7
4791689|NCT01384734|16525773|P1|Overall Study|Lack of Efficacy|3
4791690|NCT01384734|16525769|P5|Overall Study|Continuation criteria not met|0
4791691|NCT01384734|16525770|P4|Overall Study|Continuation criteria not met|1
4791692|NCT01384734|16525771|P3|Overall Study|Continuation criteria not met|1
4791693|NCT01384734|16525772|P2|Overall Study|Continuation criteria not met|0
4791694|NCT01384734|16525773|P1|Overall Study|Continuation criteria not met|0
4791695|NCT01384734|16525769|P5|Overall Study|Death|0
4791696|NCT01384734|16525770|P4|Overall Study|Death|0
4791697|NCT01384734|16525771|P3|Overall Study|Death|1
4791698|NCT01384734|16525772|P2|Overall Study|Death|0
4791699|NCT01384734|16525773|P1|Overall Study|Death|1
4791700|NCT01384734|16525769|P5|Overall Study|Adverse Event|7
4791701|NCT01384734|16525770|P4|Overall Study|Adverse Event|2
4791702|NCT01384734|16525771|P3|Overall Study|Adverse Event|0
4791703|NCT01384734|16525772|P2|Overall Study|Adverse Event|3
4791704|NCT01384734|16525773|P1|Overall Study|Adverse Event|0
4791705|NCT01384292|16526002|P3|Part B|Severe non-compliance to protocol|0
4791706|NCT01384292|16526003|P2|Part B|Severe non-compliance to protocol|0
4791707|NCT01384292|16526004|P1|Part B|Severe non-compliance to protocol|1
4791708|NCT01384019|16526016|P2|Overall Study|MRI refusal|6
4791709|NCT01384019|16526017|P1|Overall Study|MRI refusal|6
4791710|NCT01384019|16526016|P2|Overall Study|Death|0
4791711|NCT01384019|16526017|P1|Overall Study|Death|1
4791712|NCT01384019|16526016|P2|Overall Study|Withdrawal by Subject|0
4791713|NCT01384019|16526017|P1|Overall Study|Withdrawal by Subject|3
4791714|NCT01383993|16526026|P3|Overall Study|Marketed voriconazole in post-therapy|0
4791715|NCT01383993|16526027|P2|Overall Study|Marketed voriconazole in post-therapy|0
4791716|NCT01383993|16526028|P1|Overall Study|Marketed voriconazole in post-therapy|2
4791717|NCT01383993|16526026|P3|Overall Study|Withdrawal by Subject|1
4791718|NCT01383993|16526027|P2|Overall Study|Withdrawal by Subject|0
4791719|NCT01383993|16526028|P1|Overall Study|Withdrawal by Subject|0
4791720|NCT01383993|16526026|P3|Overall Study|Adverse Event|0
4791721|NCT01383993|16526027|P2|Overall Study|Adverse Event|1
4791722|NCT01383993|16526028|P1|Overall Study|Adverse Event|1
4791723|NCT01383954|16526075|P1|Overall Study|Reason Not Specified|9
4791724|NCT01383954|16526075|P1|Overall Study|Adverse Event|1
4791725|NCT01383954|16526075|P1|Overall Study|Electronic Diary Too Cumbersome to Use|2
4791726|NCT01383954|16526075|P1|Overall Study|Lack of Efficacy|2
4791727|NCT01383928|16526083|P3|Overall Study|Unsatisfactory Therapeutic Response|1
4791728|NCT01383928|16526084|P2|Overall Study|Unsatisfactory Therapeutic Response|0
4791729|NCT01383928|16526085|P1|Overall Study|Unsatisfactory Therapeutic Response|0
4791730|NCT01383928|16526083|P3|Overall Study|Withdrawal by Subject|4
4791731|NCT01383928|16526084|P2|Overall Study|Withdrawal by Subject|0
4791732|NCT01383928|16526085|P1|Overall Study|Withdrawal by Subject|0
4791733|NCT01383928|16526083|P3|Overall Study|Progressive Disease|5
4791734|NCT01383928|16526084|P2|Overall Study|Progressive Disease|1
4791735|NCT01383928|16526085|P1|Overall Study|Progressive Disease|1
4791736|NCT01383928|16526083|P3|Overall Study|Other|4
4791737|NCT01383928|16526084|P2|Overall Study|Other|3
4791738|NCT01383928|16526085|P1|Overall Study|Other|1
4791739|NCT01383928|16526083|P3|Overall Study|Adverse Event|8
4791740|NCT01383928|16526084|P2|Overall Study|Adverse Event|2
4791741|NCT01383928|16526085|P1|Overall Study|Adverse Event|1
4791742|NCT01383928|16526083|P3|Overall Study|Initiation of ASCT|18
4791743|NCT01383928|16526084|P2|Overall Study|Initiation of ASCT|1
4791744|NCT01383928|16526085|P1|Overall Study|Initiation of ASCT|2
4791745|NCT01383707|16526166|P1|Overall Study|Progressive disease|23
4791746|NCT01383707|16526166|P1|Overall Study|Adverse Event|14
4791747|NCT01383707|16526166|P1|Overall Study|Sponsor's decision|2
4791748|NCT01383707|16526166|P1|Overall Study|Other|8
4791749|NCT01383707|16526166|P1|Overall Study|Death|19
4791750|NCT01383707|16526166|P1|Overall Study|Consent withdrawal|6
4791751|NCT01383499|16526206|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
4791752|NCT01383499|16526207|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
4791753|NCT01383499|16526208|P2|Period 1 (4 Weeks)|Withdrawal by Subject|0
4791754|NCT01383499|16526209|P1|Period 1 (4 Weeks)|Withdrawal by Subject|1
4791755|NCT01383486|16526259|P1|Overall Study|Did not take any product|6
4791756|NCT01383486|16526259|P1|Overall Study|Incomplete information for analysis|2
4791757|NCT01383486|16526259|P1|Overall Study|Lost to Follow-up|10
4791758|NCT01383356|16526336|P2|Period 1|Personal|2
4791759|NCT01383356|16526337|P1|Period 1|Personal|0
4791760|NCT01383356|16526336|P2|Period 1|Out of Range Mid-study-Test|1
4791761|NCT01383356|16526337|P1|Period 1|Out of Range Mid-study-Test|0
4791762|NCT01383356|16526336|P2|Period 1|Non-compliance|0
4791763|NCT01383356|16526337|P1|Period 1|Non-compliance|3
4791764|NCT01383356|16526336|P2|Period 1|Adverse Event|3
4791765|NCT01383356|16526337|P1|Period 1|Adverse Event|5
4791766|NCT01383317|16526349|P2|Overall Study|Adverse Event|1
4791767|NCT01383317|16526350|P1|Overall Study|Adverse Event|0
4791768|NCT01383317|16526349|P2|Overall Study|Death|0
4791769|NCT01383317|16526350|P1|Overall Study|Death|1
4791770|NCT01383317|16526349|P2|Overall Study|Lost to Follow-up|1
4791771|NCT01383317|16526350|P1|Overall Study|Lost to Follow-up|2
4791772|NCT01383174|16526392|P2|6 Month Assessment|Refused to complete|0
4791773|NCT01383174|16526393|P1|6 Month Assessment|Refused to complete|4
4791774|NCT01383174|16526392|P2|6 Month Assessment|Lost to Follow-up|1
4791775|NCT01383174|16526393|P1|6 Month Assessment|Lost to Follow-up|1
4791776|NCT01383174|16526392|P2|3 Month Assessment|Refused to complete|0
4791777|NCT01383174|16526393|P1|3 Month Assessment|Refused to complete|4
4791778|NCT01383174|16526392|P2|3 Month Assessment|Lost to Follow-up|0
4791779|NCT01383174|16526393|P1|3 Month Assessment|Lost to Follow-up|2
4791780|NCT01383174|16526392|P2|3 Month Assessment|Death|1
4791781|NCT01383174|16526393|P1|3 Month Assessment|Death|0
4791782|NCT01383161|16526419|P2|Overall Study|Lack of Efficacy|1
4791783|NCT01383161|16526420|P1|Overall Study|Lack of Efficacy|0
4791784|NCT01383161|16526419|P2|Overall Study|Withdrawal by Subject|2
4791785|NCT01383161|16526420|P1|Overall Study|Withdrawal by Subject|0
4791786|NCT01383161|16526419|P2|Overall Study|Adverse Event|1
4791787|NCT01383161|16526420|P1|Overall Study|Adverse Event|5
4791788|NCT01383096|16526439|P3|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
4791789|NCT01383096|16526440|P2|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0
4791790|NCT01383096|16526441|P1|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1
4791791|NCT01383096|16526439|P3|Fifth Intervention (8 Days)|Withdrawal by Subject|0
4791792|NCT01383096|16526440|P2|Fifth Intervention (8 Days)|Withdrawal by Subject|0
4791793|NCT01383096|16526441|P1|Fifth Intervention (8 Days)|Withdrawal by Subject|1
4791794|NCT01383096|16526439|P3|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
4791795|NCT01383096|16526440|P2|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0
4791796|NCT01383096|16526441|P1|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1
4791797|NCT01383096|16526439|P3|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
4791798|NCT01383096|16526440|P2|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
4791799|NCT01383096|16526441|P1|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
4791800|NCT01383096|16526439|P3|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
4791801|NCT01383096|16526440|P2|Third Intervention (8 Days)|QTcF was greater than 450 msec|0
4791802|NCT01383096|16526441|P1|Third Intervention (8 Days)|QTcF was greater than 450 msec|1
4791803|NCT01383096|16526439|P3|Third Intervention (8 Days)|Withdrawal by Subject|0
4791804|NCT01383096|16526440|P2|Third Intervention (8 Days)|Withdrawal by Subject|0
4791805|NCT01383096|16526441|P1|Third Intervention (8 Days)|Withdrawal by Subject|1
4791806|NCT01383096|16526439|P3|Third Intervention (8 Days)|Adverse Event|0
4791807|NCT01383096|16526440|P2|Third Intervention (8 Days)|Adverse Event|0
4791808|NCT01383096|16526441|P1|Third Intervention (8 Days)|Adverse Event|1
4791809|NCT01383096|16526439|P3|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
4791810|NCT01383096|16526440|P2|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3
4791811|NCT01383096|16526441|P1|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
4791812|NCT01383096|16526439|P3|Third Intervention (8 Days)|Elevated AST|0
4791813|NCT01383096|16526440|P2|Third Intervention (8 Days)|Elevated AST|1
4791814|NCT01383096|16526441|P1|Third Intervention (8 Days)|Elevated AST|0
4791815|NCT01383096|16526439|P3|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
4791816|NCT01383096|16526440|P2|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1
4791817|NCT01383096|16526441|P1|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0
4791818|NCT01383096|16526439|P3|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1
4791819|NCT01383096|16526440|P2|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
4791820|NCT01383096|16526441|P1|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0
4791821|NCT01383018|16526487|P1|Overall Study|Subject Incarcerated|1
4791822|NCT01383018|16526487|P1|Overall Study|Patient moved away from site|1
4791823|NCT01383018|16526487|P1|Overall Study|Site closed early-not compliance related|7
4791824|NCT01383018|16526487|P1|Overall Study|Missed Visit|247
4791825|NCT01383018|16526487|P1|Overall Study|Subject not implanted|76
4791826|NCT01383018|16526487|P1|Overall Study|Withdrawal by Subject|9
4791827|NCT01383018|16526487|P1|Overall Study|Physician Decision|5
4791828|NCT01383018|16526487|P1|Overall Study|Lost to Follow-up|5
4791829|NCT01383018|16526487|P1|Overall Study|Death|10
4791830|NCT01383018|16526487|P1|Overall Study|Adverse Event|14
4791831|NCT01382940|16526549|P1|Overall Study|Protocol Violation|20
4791832|NCT01382940|16526549|P1|Overall Study|Withdrawal by Subject|23
4791833|NCT01382940|16526549|P1|Overall Study|Physician Decision|7
4791834|NCT01382940|16526549|P1|Overall Study|Lost to Follow-up|4
4791835|NCT01382940|16526549|P1|Overall Study|Adverse Event|19
4791836|NCT01382602|16526611|P2|Overall Study|Withdrawal by Subject|1
4791837|NCT01382602|16526612|P1|Overall Study|Withdrawal by Subject|0
4791838|NCT01382602|16526611|P2|Overall Study|Protocol Violation|3
4791839|NCT01382602|16526612|P1|Overall Study|Protocol Violation|0
4791840|NCT01382446|16526620|P2|Overall Study|Removal from Mechanical Ventilation|3
4791841|NCT01382446|16526621|P1|Overall Study|Removal from Mechanical Ventilation|3
4791842|NCT01382446|16526620|P2|Overall Study|Withdrawal by Subject|1
4791843|NCT01382446|16526621|P1|Overall Study|Withdrawal by Subject|0
4791844|NCT01382251|16526648|P2|Overall Study|Contacted after study closed|1
4791845|NCT01382251|16526649|P1|Overall Study|Contacted after study closed|1
4791846|NCT01382251|16526648|P2|Overall Study|Lost to Follow-up|4
4791847|NCT01382251|16526649|P1|Overall Study|Lost to Follow-up|4
4791848|NCT01382251|16526648|P2|Overall Study|Surgeries cancelled or delayed|16
4791849|NCT01382251|16526649|P1|Overall Study|Surgeries cancelled or delayed|16
4791850|NCT01382225|16526662|P2|Overall Study|Other|2
4791851|NCT01382225|16526663|P1|Overall Study|Other|4
4791852|NCT01382225|16526662|P2|Overall Study|Subject Withdrew Consent|2
4791853|NCT01382225|16526663|P1|Overall Study|Subject Withdrew Consent|5
4791854|NCT01382225|16526662|P2|Overall Study|Protocol Violation|1
4791855|NCT01382225|16526663|P1|Overall Study|Protocol Violation|2
4791856|NCT01382225|16526662|P2|Overall Study|Adverse Event|2
4791857|NCT01382225|16526663|P1|Overall Study|Adverse Event|3
4791858|NCT01382212|16526685|P1|Overall Study|Withdrew consent|1
4791859|NCT01382212|16526685|P1|Overall Study|Kidney transplant|1
4791860|NCT01381926|16526748|P2|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1
4791861|NCT01381926|16526749|P1|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0
4791862|NCT01381926|16526748|P2|Low/High Dose of 1st Treatment (2months)|Adverse Event|0
4791863|NCT01381926|16526749|P1|Low/High Dose of 1st Treatment (2months)|Adverse Event|2
4791864|NCT01381900|16526762|P3|Overall Study|Early withdraw|1
4791865|NCT01381900|16526763|P2|Overall Study|Early withdraw|1
4791866|NCT01381900|16526764|P1|Overall Study|Early withdraw|3
4791867|NCT01381900|16526762|P3|Overall Study|Withdrawal by Subject|1
4791868|NCT01381900|16526763|P2|Overall Study|Withdrawal by Subject|0
4791869|NCT01381900|16526764|P1|Overall Study|Withdrawal by Subject|0
4791870|NCT01381900|16526762|P3|Overall Study|Protocol Violation|1
4791871|NCT01381900|16526763|P2|Overall Study|Protocol Violation|1
4791872|NCT01381900|16526764|P1|Overall Study|Protocol Violation|0
4791873|NCT01381900|16526762|P3|Overall Study|Physician Decision|1
4791874|NCT01381900|16526763|P2|Overall Study|Physician Decision|1
4791875|NCT01381900|16526764|P1|Overall Study|Physician Decision|0
4791876|NCT01381900|16526762|P3|Overall Study|Noncompliance with study drug|1
4791877|NCT01381900|16526763|P2|Overall Study|Noncompliance with study drug|0
4791878|NCT01381900|16526764|P1|Overall Study|Noncompliance with study drug|0
4791879|NCT01381900|16526762|P3|Overall Study|Adverse Event|7
4791880|NCT01381900|16526763|P2|Overall Study|Adverse Event|6
4791881|NCT01381900|16526764|P1|Overall Study|Adverse Event|4
4791882|NCT01381900|16526762|P3|Overall Study|Subject meets glycemic withdrawal crit.|0
4791883|NCT01381900|16526763|P2|Overall Study|Subject meets glycemic withdrawal crit.|0
4791884|NCT01381900|16526764|P1|Overall Study|Subject meets glycemic withdrawal crit.|2
4791885|NCT01381874|16526787|P3|Overall Study|Other|67
4791886|NCT01381874|16526788|P2|Overall Study|Other|52
4791887|NCT01381874|16526789|P1|Overall Study|Other|67
4791888|NCT01381874|16526787|P3|Overall Study|Withdrawal by Subject|9
4791889|NCT01381874|16526788|P2|Overall Study|Withdrawal by Subject|10
4791890|NCT01381874|16526789|P1|Overall Study|Withdrawal by Subject|9
4791891|NCT01381874|16526787|P3|Overall Study|Lost to Follow-up|0
4791892|NCT01381874|16526788|P2|Overall Study|Lost to Follow-up|1
4791893|NCT01381874|16526789|P1|Overall Study|Lost to Follow-up|1
4791894|NCT01381679|16526826|P1|Overall Study|Lost to Follow-up|885
4791895|NCT01381679|16526826|P1|Overall Study|Adverse Event|3
4791896|NCT01381575|16526841|P3|Overall Study|Lost to Follow-up|9
4791897|NCT01381575|16526842|P2|Overall Study|Lost to Follow-up|17
4791898|NCT01381575|16526843|P1|Overall Study|Lost to Follow-up|8
4791899|NCT01381575|16526841|P3|Overall Study|Migrated/moved from study area|2
4791900|NCT01381575|16526842|P2|Overall Study|Migrated/moved from study area|12
4791901|NCT01381575|16526843|P1|Overall Study|Migrated/moved from study area|2
4791902|NCT01381575|16526841|P3|Overall Study|Withdrawal by Subject|7
4791903|NCT01381575|16526842|P2|Overall Study|Withdrawal by Subject|9
4791904|NCT01381575|16526843|P1|Overall Study|Withdrawal by Subject|15
4791905|NCT01381575|16526841|P3|Overall Study|Protocol Violation|1
4791906|NCT01381575|16526842|P2|Overall Study|Protocol Violation|1
4791907|NCT01381575|16526843|P1|Overall Study|Protocol Violation|0
4791908|NCT01381575|16526841|P3|Overall Study|Non-Serious Adverse Event|1
4791909|NCT01381575|16526842|P2|Overall Study|Non-Serious Adverse Event|0
4791910|NCT01381575|16526843|P1|Overall Study|Non-Serious Adverse Event|0
4791911|NCT01381575|16526841|P3|Overall Study|Serious Adverse Event|0
4791912|NCT01381575|16526842|P2|Overall Study|Serious Adverse Event|0
4791913|NCT01381575|16526843|P1|Overall Study|Serious Adverse Event|1
4791914|NCT01381562|16526900|P3|Overall Study|Adverse Event|0
4791915|NCT01381562|16526901|P2|Overall Study|Adverse Event|1
4791916|NCT01381562|16526902|P1|Overall Study|Adverse Event|0
4791917|NCT01381549|16526970|P3|Overall Study|Ineligible: No organisms isolated|1
4791918|NCT01381549|16526971|P2|Overall Study|Ineligible: No organisms isolated|0
4791919|NCT01381549|16526972|P1|Overall Study|Ineligible: No organisms isolated|0
4791920|NCT01381068|16527098|P2|Overall Study|Death|0
4791921|NCT01381068|16527099|P1|Overall Study|Death|1
4791922|NCT01381016|16527119|P2|Overall Study|Physician Decision|2
4791923|NCT01381016|16527120|P1|Overall Study|Physician Decision|0
4791924|NCT01381016|16527119|P2|Overall Study|Withdrawal by Subject|1
4791925|NCT01381016|16527120|P1|Overall Study|Withdrawal by Subject|0
4791926|NCT01381016|16527119|P2|Overall Study|Screen Failure|2
4791927|NCT01381016|16527120|P1|Overall Study|Screen Failure|2
4791928|NCT01381016|16527119|P2|Overall Study|Lost to Follow-up|1
4791929|NCT01381016|16527120|P1|Overall Study|Lost to Follow-up|1
4791930|NCT01380834|16527130|P2|Overall Study|Physician Decision|0
4791931|NCT01380834|16527131|P1|Overall Study|Physician Decision|1
4791932|NCT01380782|16527143|P4|Overall Study|Withdrawal by Subject|1
4791933|NCT01380782|16527144|P3|Overall Study|Withdrawal by Subject|1
4791934|NCT01380782|16527145|P2|Overall Study|Withdrawal by Subject|0
4791935|NCT01380782|16527146|P1|Overall Study|Withdrawal by Subject|0
4791936|NCT01380782|16527143|P4|Overall Study|Physician Decision|0
4791937|NCT01380782|16527144|P3|Overall Study|Physician Decision|0
4791938|NCT01380782|16527145|P2|Overall Study|Physician Decision|0
4791939|NCT01380782|16527146|P1|Overall Study|Physician Decision|1
4791940|NCT01380782|16527143|P4|Overall Study|Lack of Efficacy|3
4791941|NCT01380782|16527144|P3|Overall Study|Lack of Efficacy|10
4791942|NCT01380782|16527145|P2|Overall Study|Lack of Efficacy|9
4791943|NCT01380782|16527146|P1|Overall Study|Lack of Efficacy|10
4791944|NCT01380782|16527143|P4|Overall Study|Death|0
4791945|NCT01380782|16527144|P3|Overall Study|Death|0
4791946|NCT01380782|16527145|P2|Overall Study|Death|0
4791947|NCT01380782|16527146|P1|Overall Study|Death|1
4791948|NCT01380782|16527143|P4|Overall Study|Adverse Event|0
4791949|NCT01380782|16527144|P3|Overall Study|Adverse Event|0
4791950|NCT01380782|16527145|P2|Overall Study|Adverse Event|1
4791951|NCT01380782|16527146|P1|Overall Study|Adverse Event|0
4791952|NCT01380769|16527169|P2|Overall Study|Protocol Violation|1
4791953|NCT01380769|16527170|P1|Overall Study|Protocol Violation|0
4791954|NCT01380769|16527169|P2|Overall Study|Adverse Event|1
4791955|NCT01380769|16527170|P1|Overall Study|Adverse Event|1
4791956|NCT01380769|16527169|P2|Overall Study|Physician Decision|1
4791957|NCT01380769|16527170|P1|Overall Study|Physician Decision|1
4791958|NCT01380769|16527169|P2|Overall Study|Withdrawal by Subject|11
4791959|NCT01380769|16527170|P1|Overall Study|Withdrawal by Subject|7
4791960|NCT01380730|16527231|P8|Overall Study|Death|0
4791961|NCT01380730|16527232|P7|Overall Study|Death|0
4791962|NCT01380730|16527233|P6|Overall Study|Death|0
4791963|NCT01380730|16527234|P5|Overall Study|Death|1
4791964|NCT01380730|16527235|P4|Overall Study|Death|0
4791965|NCT01380730|16527236|P3|Overall Study|Death|0
4791966|NCT01380730|16527237|P2|Overall Study|Death|0
4791967|NCT01380730|16527238|P1|Overall Study|Death|0
4791968|NCT01380691|16527296|P4|Washout (7 Days)|Withdrawal by Subject|0
4791969|NCT01380691|16527297|P3|Washout (7 Days)|Withdrawal by Subject|1
4791970|NCT01380691|16527298|P2|Washout (7 Days)|Withdrawal by Subject|0
4791971|NCT01380691|16527299|P1|Washout (7 Days)|Withdrawal by Subject|0
4791972|NCT01380691|16527296|P4|Washout (7 Days)|Protocol Violation|1
4791973|NCT01380691|16527297|P3|Washout (7 Days)|Protocol Violation|0
4791974|NCT01380691|16527298|P2|Washout (7 Days)|Protocol Violation|0
4791975|NCT01380691|16527299|P1|Washout (7 Days)|Protocol Violation|0
4791976|NCT01380535|16527360|P2|Overall Study|Lack of Efficacy|3
4791977|NCT01380535|16527361|P1|Overall Study|Lack of Efficacy|0
4791978|NCT01380535|16527360|P2|Overall Study|Protocol Violation|2
4791979|NCT01380535|16527361|P1|Overall Study|Protocol Violation|0
4791980|NCT01380535|16527360|P2|Overall Study|Withdrawal by Subject|2
4791981|NCT01380535|16527361|P1|Overall Study|Withdrawal by Subject|1
4791982|NCT01380535|16527360|P2|Overall Study|Study site closed|5
4791983|NCT01380535|16527361|P1|Overall Study|Study site closed|0
4791984|NCT01380535|16527360|P2|Overall Study|Death|0
4791985|NCT01380535|16527361|P1|Overall Study|Death|3
4791986|NCT01380535|16527360|P2|Overall Study|Adverse Event|3
4791987|NCT01380535|16527361|P1|Overall Study|Adverse Event|3
4791988|NCT01380379|16527367|P1|Overall Study|Pregnancy|1
4791989|NCT01380327|16527380|P3|Overall Study|Questionable onset of epilepsy|1
4791990|NCT01380327|16527381|P2|Overall Study|Questionable onset of epilepsy|0
4791991|NCT01380327|16527382|P1|Overall Study|Questionable onset of epilepsy|0
4791992|NCT01380327|16527380|P3|Overall Study|Housing situation precluded ability to k|1
4791993|NCT01380327|16527381|P2|Overall Study|Housing situation precluded ability to k|0
4791994|NCT01380327|16527382|P1|Overall Study|Housing situation precluded ability to k|0
4791995|NCT01380327|16527380|P3|Overall Study|Withdrawal by Subject|1
4791996|NCT01380327|16527381|P2|Overall Study|Withdrawal by Subject|0
4791997|NCT01380327|16527382|P1|Overall Study|Withdrawal by Subject|0
4791998|NCT01380327|16527380|P3|Overall Study|Protocol Violation|3
4791999|NCT01380327|16527381|P2|Overall Study|Protocol Violation|2
4792000|NCT01380327|16527382|P1|Overall Study|Protocol Violation|3
4792001|NCT01380327|16527380|P3|Overall Study|Lost to Follow-up|1
4792002|NCT01380327|16527381|P2|Overall Study|Lost to Follow-up|1
4792003|NCT01380327|16527382|P1|Overall Study|Lost to Follow-up|0
4792004|NCT01380184|16527413|P1|Part 2|Lost to Follow-up|1
4792005|NCT01380184|16527413|P1|Part 2|Disease Progression|8
4792006|NCT01380184|16527413|P1|Part 2|Adverse Event|5
4792007|NCT01380184|16527413|P1|Part 1 (19 Days)|Adverse Event|1
4792008|NCT01380145|16527424|P1|Overall Study|Progressive disease|4
4792009|NCT01380093|16527432|P9|Treatment Phase: Third Intervention|Other|1
4792010|NCT01380093|16527433|P8|Treatment Phase: Third Intervention|Other|0
4792011|NCT01380093|16527434|P7|Treatment Phase: Third Intervention|Other|0
4792012|NCT01380093|16527435|P6|Treatment Phase: Third Intervention|Other|0
4792013|NCT01380093|16527436|P5|Treatment Phase: Third Intervention|Other|0
4792014|NCT01380093|16527437|P4|Treatment Phase: Third Intervention|Other|0
4792015|NCT01380093|16527438|P3|Treatment Phase: Third Intervention|Other|0
4792016|NCT01380093|16527439|P2|Treatment Phase: Third Intervention|Other|0
4792017|NCT01380093|16527440|P1|Treatment Phase: Third Intervention|Other|0
4792018|NCT01380093|16527432|P9|Treatment Phase: Third Intervention|Non-compliance|1
4792019|NCT01380093|16527433|P8|Treatment Phase: Third Intervention|Non-compliance|0
4792020|NCT01380093|16527434|P7|Treatment Phase: Third Intervention|Non-compliance|0
4792021|NCT01380093|16527435|P6|Treatment Phase: Third Intervention|Non-compliance|0
4792022|NCT01380093|16527436|P5|Treatment Phase: Third Intervention|Non-compliance|0
4792023|NCT01380093|16527437|P4|Treatment Phase: Third Intervention|Non-compliance|0
4792024|NCT01380093|16527438|P3|Treatment Phase: Third Intervention|Non-compliance|0
4792025|NCT01380093|16527439|P2|Treatment Phase: Third Intervention|Non-compliance|0
4792026|NCT01380093|16527440|P1|Treatment Phase: Third Intervention|Non-compliance|0
4792027|NCT01380093|16527432|P9|Treatment Phase: Second Intervention|Other|0
4792028|NCT01380093|16527433|P8|Treatment Phase: Second Intervention|Other|0
4792029|NCT01380093|16527434|P7|Treatment Phase: Second Intervention|Other|0
4792030|NCT01380093|16527435|P6|Treatment Phase: Second Intervention|Other|0
4792031|NCT01380093|16527436|P5|Treatment Phase: Second Intervention|Other|0
4792032|NCT01380093|16527437|P4|Treatment Phase: Second Intervention|Other|1
4792033|NCT01380093|16527438|P3|Treatment Phase: Second Intervention|Other|0
4792034|NCT01380093|16527439|P2|Treatment Phase: Second Intervention|Other|0
4792035|NCT01380093|16527440|P1|Treatment Phase: Second Intervention|Other|0
4792036|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792037|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792038|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792039|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792040|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792041|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792042|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 2|Sponsor decision|1
4792043|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792044|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 2|Sponsor decision|0
4792045|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 2|Backup participant|0
4792046|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 2|Backup participant|0
4792047|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 2|Backup participant|0
4792048|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 2|Backup participant|0
4792049|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 2|Backup participant|0
4792050|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 2|Backup participant|0
4792051|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 2|Backup participant|1
4792052|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 2|Backup participant|0
4792053|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 2|Backup participant|0
4792054|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792055|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792056|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792057|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792058|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792059|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792060|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
4792061|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 2|Positive urine drug screen|1
4792062|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 2|Positive urine drug screen|0
4792063|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792064|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792065|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792066|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792067|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792068|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792069|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 2|Discrimination failure|9
4792070|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 2|Discrimination failure|4
4792071|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 2|Discrimination failure|0
4792072|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792073|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792074|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792075|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792076|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792077|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792078|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792079|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1
4792080|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0
4792081|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 2|Physician Decision|0
4792082|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 2|Physician Decision|0
4792083|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 2|Physician Decision|0
4792084|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 2|Physician Decision|0
4792085|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 2|Physician Decision|0
4792086|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 2|Physician Decision|0
4792087|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 2|Physician Decision|1
4792088|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 2|Physician Decision|3
4792089|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 2|Physician Decision|0
4792090|NCT01380093|16527432|P9|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792091|NCT01380093|16527433|P8|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792092|NCT01380093|16527434|P7|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792093|NCT01380093|16527435|P6|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792094|NCT01380093|16527436|P5|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792095|NCT01380093|16527437|P4|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792096|NCT01380093|16527438|P3|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792097|NCT01380093|16527439|P2|Drug Discrimination Phase: Day 1|Discrimination failure|1
4792098|NCT01380093|16527440|P1|Drug Discrimination Phase: Day 1|Discrimination failure|0
4792099|NCT01380093|16527432|P9|Naloxone Challenge Phase|Screen failures|0
4792100|NCT01380093|16527433|P8|Naloxone Challenge Phase|Screen failures|0
4792101|NCT01380093|16527434|P7|Naloxone Challenge Phase|Screen failures|0
4792102|NCT01380093|16527435|P6|Naloxone Challenge Phase|Screen failures|0
4792103|NCT01380093|16527436|P5|Naloxone Challenge Phase|Screen failures|0
4792104|NCT01380093|16527437|P4|Naloxone Challenge Phase|Screen failures|0
4792105|NCT01380093|16527438|P3|Naloxone Challenge Phase|Screen failures|0
4792106|NCT01380093|16527439|P2|Naloxone Challenge Phase|Screen failures|0
4792107|NCT01380093|16527440|P1|Naloxone Challenge Phase|Screen failures|21
4792108|NCT01380080|16527732|P2|Overall Study|Lost to Follow-up|0
4792109|NCT01380080|16527733|P1|Overall Study|Lost to Follow-up|2
4792110|NCT01380080|16527732|P2|Overall Study|Not willing to adhere to requirements|1
4792111|NCT01380080|16527733|P1|Overall Study|Not willing to adhere to requirements|3
4792112|NCT01380080|16527732|P2|Overall Study|Not able to get to clinic|0
4792113|NCT01380080|16527733|P1|Overall Study|Not able to get to clinic|4
4792114|NCT01380080|16527732|P2|Overall Study|Withdrawal by Subject|0
4792115|NCT01380080|16527733|P1|Overall Study|Withdrawal by Subject|4
4792116|NCT01380080|16527732|P2|Overall Study|Death|22
4792117|NCT01380080|16527733|P1|Overall Study|Death|20
4792118|NCT01379937|16527758|P4|Overall Study|Lost to Follow-up|0
4792119|NCT01379937|16527759|P3|Overall Study|Lost to Follow-up|2
4792120|NCT01379937|16527760|P2|Overall Study|Lost to Follow-up|2
4792121|NCT01379937|16527761|P1|Overall Study|Lost to Follow-up|1
4792122|NCT01379937|16527758|P4|Overall Study|Consent withdrawal|0
4792123|NCT01379937|16527759|P3|Overall Study|Consent withdrawal|0
4792124|NCT01379937|16527760|P2|Overall Study|Consent withdrawal|1
4792125|NCT01379937|16527761|P1|Overall Study|Consent withdrawal|0
4792126|NCT01379937|16527758|P4|Overall Study|Protocol Violation|1
4792127|NCT01379937|16527759|P3|Overall Study|Protocol Violation|0
4792128|NCT01379937|16527760|P2|Overall Study|Protocol Violation|0
4792129|NCT01379937|16527761|P1|Overall Study|Protocol Violation|0
4792130|NCT01379781|16527881|P2|Overall Study|Lost to Follow-up|8
4792131|NCT01379781|16527882|P1|Overall Study|Lost to Follow-up|11
4792132|NCT01379768|16527891|P3|Overall Study|Lost to Follow-up|0
4792133|NCT01379768|16527892|P2|Overall Study|Lost to Follow-up|0
4792134|NCT01379768|16527893|P1|Overall Study|Lost to Follow-up|2
4792135|NCT01379768|16527891|P3|Overall Study|Adverse Event|0
4792136|NCT01379768|16527892|P2|Overall Study|Adverse Event|1
4792137|NCT01379768|16527893|P1|Overall Study|Adverse Event|1
4792138|NCT01379703|16527916|P3|9 Months Through 18 Months|Reason Unknown|0
4792139|NCT01379703|16527917|P2|9 Months Through 18 Months|Reason Unknown|23
4792140|NCT01379703|16527918|P1|9 Months Through 18 Months|Reason Unknown|0
4792141|NCT01379703|16527916|P3|9 Months Through 18 Months|Fatigue|0
4792142|NCT01379703|16527917|P2|9 Months Through 18 Months|Fatigue|1
4792143|NCT01379703|16527918|P1|9 Months Through 18 Months|Fatigue|0
4792144|NCT01379703|16527916|P3|9 Months Through 18 Months|Tuberculosis/TB treatment|0
4792145|NCT01379703|16527917|P2|9 Months Through 18 Months|Tuberculosis/TB treatment|2
4792146|NCT01379703|16527918|P1|9 Months Through 18 Months|Tuberculosis/TB treatment|0
4792147|NCT01379703|16527916|P3|9 Months Through 18 Months|Patient Noncompliance|0
4792148|NCT01379703|16527917|P2|9 Months Through 18 Months|Patient Noncompliance|4
4792149|NCT01379703|16527918|P1|9 Months Through 18 Months|Patient Noncompliance|0
4792150|NCT01379703|16527916|P3|9 Months Through 18 Months|Treatment failure|0
4792151|NCT01379703|16527917|P2|9 Months Through 18 Months|Treatment failure|5
4792152|NCT01379703|16527918|P1|9 Months Through 18 Months|Treatment failure|0
4792153|NCT01379703|16527916|P3|9 Months Through 18 Months|Adverse Event|0
4792154|NCT01379703|16527917|P2|9 Months Through 18 Months|Adverse Event|6
4792155|NCT01379703|16527918|P1|9 Months Through 18 Months|Adverse Event|0
4792156|NCT01379703|16527916|P3|9 Months Through 18 Months|Withdrawal by Subject|0
4792157|NCT01379703|16527917|P2|9 Months Through 18 Months|Withdrawal by Subject|11
4792158|NCT01379703|16527918|P1|9 Months Through 18 Months|Withdrawal by Subject|0
4792159|NCT01379703|16527916|P3|9 Months Through 18 Months|Lost to Follow-up|0
4792160|NCT01379703|16527917|P2|9 Months Through 18 Months|Lost to Follow-up|178
4792161|NCT01379703|16527918|P1|9 Months Through 18 Months|Lost to Follow-up|0
4792162|NCT01379703|16527916|P3|Study Start Through 9 Months|Reason unknown|24
4792163|NCT01379703|16527917|P2|Study Start Through 9 Months|Reason unknown|31
4792164|NCT01379703|16527918|P1|Study Start Through 9 Months|Reason unknown|2
4792165|NCT01379703|16527916|P3|Study Start Through 9 Months|Increased triglycerides|0
4792166|NCT01379703|16527917|P2|Study Start Through 9 Months|Increased triglycerides|1
4792167|NCT01379703|16527918|P1|Study Start Through 9 Months|Increased triglycerides|0
4792168|NCT01379703|16527916|P3|Study Start Through 9 Months|Poor general condition|0
4792169|NCT01379703|16527917|P2|Study Start Through 9 Months|Poor general condition|1
4792170|NCT01379703|16527918|P1|Study Start Through 9 Months|Poor general condition|0
4792171|NCT01379703|16527916|P3|Study Start Through 9 Months|Medication not available|1
4792172|NCT01379703|16527917|P2|Study Start Through 9 Months|Medication not available|2
4792173|NCT01379703|16527918|P1|Study Start Through 9 Months|Medication not available|0
4792174|NCT01379703|16527916|P3|Study Start Through 9 Months|Tuberculosis/TB treatment|0
4792175|NCT01379703|16527917|P2|Study Start Through 9 Months|Tuberculosis/TB treatment|4
4792176|NCT01379703|16527918|P1|Study Start Through 9 Months|Tuberculosis/TB treatment|0
4792177|NCT01379703|16527916|P3|Study Start Through 9 Months|Patient Noncompliance|1
4792178|NCT01379703|16527917|P2|Study Start Through 9 Months|Patient Noncompliance|0
4792179|NCT01379703|16527918|P1|Study Start Through 9 Months|Patient Noncompliance|0
4792180|NCT01379703|16527916|P3|Study Start Through 9 Months|Treatment Failure|2
4792181|NCT01379703|16527917|P2|Study Start Through 9 Months|Treatment Failure|2
4792182|NCT01379703|16527918|P1|Study Start Through 9 Months|Treatment Failure|0
4792183|NCT01379703|16527916|P3|Study Start Through 9 Months|Withdrawal by Subject|1
4792184|NCT01379703|16527917|P2|Study Start Through 9 Months|Withdrawal by Subject|6
4792185|NCT01379703|16527918|P1|Study Start Through 9 Months|Withdrawal by Subject|0
4792186|NCT01379703|16527916|P3|Study Start Through 9 Months|Adverse Event|10
4792187|NCT01379703|16527917|P2|Study Start Through 9 Months|Adverse Event|14
4792188|NCT01379703|16527918|P1|Study Start Through 9 Months|Adverse Event|0
4792189|NCT01379703|16527916|P3|Study Start Through 9 Months|Lost to Follow-up|104
4792190|NCT01379703|16527917|P2|Study Start Through 9 Months|Lost to Follow-up|61
4792191|NCT01379703|16527918|P1|Study Start Through 9 Months|Lost to Follow-up|2
4792192|NCT01379573|16528016|P1|Overall Study|Screen Failure|10
4792193|NCT01379573|16528016|P1|Overall Study|Lost to Follow-up|1
4792194|NCT01379534|16528030|P2|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0
4792195|NCT01379534|16528031|P1|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1
4792196|NCT01379534|16528030|P2|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1
4792197|NCT01379534|16528031|P1|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0
4792198|NCT01379534|16528030|P2|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0
4792199|NCT01379534|16528031|P1|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3
4792200|NCT01379534|16528030|P2|Tumor Assessment Follow-up (f/u) Phase|Death|1
4792201|NCT01379534|16528031|P1|Tumor Assessment Follow-up (f/u) Phase|Death|0
4792202|NCT01379534|16528030|P2|Treatment Phase|Adverse Event|7
4792203|NCT01379534|16528031|P1|Treatment Phase|Adverse Event|7
4792204|NCT01379534|16528030|P2|Treatment Phase|Progressive disease|22
4792205|NCT01379534|16528031|P1|Treatment Phase|Progressive disease|13
4792206|NCT01379534|16528030|P2|Treatment Phase|Withdrawal by Subject|2
4792207|NCT01379534|16528031|P1|Treatment Phase|Withdrawal by Subject|2
4792208|NCT01379521|16528051|P2|Post-Treatment Evaluations|Death|0
4792209|NCT01379521|16528052|P1|Post-Treatment Evaluations|Death|1
4792210|NCT01379521|16528051|P2|Post-Treatment Evaluations|Withdrawal by Subject|1
4792211|NCT01379521|16528052|P1|Post-Treatment Evaluations|Withdrawal by Subject|2
4792212|NCT01379521|16528051|P2|Post-Treatment Evaluations|Disease Progression|20
4792213|NCT01379521|16528052|P1|Post-Treatment Evaluations|Disease Progression|22
4792214|NCT01379521|16528051|P2|Overall Study -Treatment Period|Death|1
4792215|NCT01379521|16528052|P1|Overall Study -Treatment Period|Death|2
4792216|NCT01379521|16528051|P2|Overall Study -Treatment Period|Administrative Problems|0
4792217|NCT01379521|16528052|P1|Overall Study -Treatment Period|Administrative Problems|1
4792218|NCT01379521|16528051|P2|Overall Study -Treatment Period|Withdrawal by Subject|0
4792219|NCT01379521|16528052|P1|Overall Study -Treatment Period|Withdrawal by Subject|3
4792220|NCT01379521|16528051|P2|Overall Study -Treatment Period|Protocol Deviation|2
4792221|NCT01379521|16528052|P1|Overall Study -Treatment Period|Protocol Deviation|0
4792222|NCT01379521|16528051|P2|Overall Study -Treatment Period|New Cancer Therapy|0
4792223|NCT01379521|16528052|P1|Overall Study -Treatment Period|New Cancer Therapy|1
4792224|NCT01379521|16528051|P2|Overall Study -Treatment Period|Disease Progression|22
4792225|NCT01379521|16528052|P1|Overall Study -Treatment Period|Disease Progression|23
4792226|NCT01379521|16528051|P2|Overall Study -Treatment Period|Abnormal test procedure results|1
4792227|NCT01379521|16528052|P1|Overall Study -Treatment Period|Abnormal test procedure results|0
4792228|NCT01379521|16528051|P2|Overall Study -Treatment Period|Adverse Event|0
4792229|NCT01379521|16528052|P1|Overall Study -Treatment Period|Adverse Event|3
4792230|NCT01379508|16528074|P4|Extension Period Weeks 109-156|Protocol Violation|0
4792231|NCT01379508|16528075|P3|Extension Period Weeks 109-156|Protocol Violation|0
4792232|NCT01379508|16528076|P2|Extension Period Weeks 109-156|Protocol Violation|1
4792233|NCT01379508|16528077|P1|Extension Period Weeks 109-156|Protocol Violation|2
4792234|NCT01379508|16528074|P4|Extension Period Weeks 109-156|Administrative problems|0
4792235|NCT01379508|16528075|P3|Extension Period Weeks 109-156|Administrative problems|1
4792236|NCT01379508|16528076|P2|Extension Period Weeks 109-156|Administrative problems|0
4792237|NCT01379508|16528077|P1|Extension Period Weeks 109-156|Administrative problems|3
4792238|NCT01379508|16528074|P4|Extension Period Weeks 109-156|Lost to Follow-up|0
4792239|NCT01379508|16528075|P3|Extension Period Weeks 109-156|Lost to Follow-up|5
4792240|NCT01379508|16528076|P2|Extension Period Weeks 109-156|Lost to Follow-up|1
4792241|NCT01379508|16528077|P1|Extension Period Weeks 109-156|Lost to Follow-up|6
4792242|NCT01379508|16528074|P4|Extension Period Weeks 109-156|Withdrawal by Subject|0
4792243|NCT01379508|16528075|P3|Extension Period Weeks 109-156|Withdrawal by Subject|8
4792244|NCT01379508|16528076|P2|Extension Period Weeks 109-156|Withdrawal by Subject|1
4792245|NCT01379508|16528077|P1|Extension Period Weeks 109-156|Withdrawal by Subject|8
4792246|NCT01379508|16528074|P4|Treatment to Week 104|Protocol Violation|0
4792247|NCT01379508|16528075|P3|Treatment to Week 104|Protocol Violation|1
4792248|NCT01379508|16528076|P2|Treatment to Week 104|Protocol Violation|1
4792249|NCT01379508|16528077|P1|Treatment to Week 104|Protocol Violation|1
4792250|NCT01379508|16528074|P4|Treatment to Week 104|Administrative problems|0
4792251|NCT01379508|16528075|P3|Treatment to Week 104|Administrative problems|0
4792252|NCT01379508|16528076|P2|Treatment to Week 104|Administrative problems|1
4792253|NCT01379508|16528077|P1|Treatment to Week 104|Administrative problems|3
4792254|NCT01379508|16528074|P4|Treatment to Week 104|Lost to Follow-up|0
4792255|NCT01379508|16528075|P3|Treatment to Week 104|Lost to Follow-up|3
4792256|NCT01379508|16528076|P2|Treatment to Week 104|Lost to Follow-up|0
4792257|NCT01379508|16528077|P1|Treatment to Week 104|Lost to Follow-up|5
4792258|NCT01379508|16528074|P4|Treatment to Week 104|Withdrawal by Subject|0
4792259|NCT01379508|16528075|P3|Treatment to Week 104|Withdrawal by Subject|4
4792260|NCT01379508|16528076|P2|Treatment to Week 104|Withdrawal by Subject|1
4792261|NCT01379508|16528077|P1|Treatment to Week 104|Withdrawal by Subject|6
4792262|NCT01379508|16528074|P4|Treatment to Week 104|Abnormal test procedure result(s)|0
4792263|NCT01379508|16528075|P3|Treatment to Week 104|Abnormal test procedure result(s)|0
4792264|NCT01379508|16528076|P2|Treatment to Week 104|Abnormal test procedure result(s)|0
4792265|NCT01379508|16528077|P1|Treatment to Week 104|Abnormal test procedure result(s)|1
4792266|NCT01379508|16528074|P4|Treatment to Week 104|Abnormal lab value|0
4792267|NCT01379508|16528075|P3|Treatment to Week 104|Abnormal lab value|0
4792268|NCT01379508|16528076|P2|Treatment to Week 104|Abnormal lab value|0
4792269|NCT01379508|16528077|P1|Treatment to Week 104|Abnormal lab value|1
4792270|NCT01379508|16528074|P4|Treatment to Week 104|Adverse Event|0
4792271|NCT01379508|16528075|P3|Treatment to Week 104|Adverse Event|5
4792272|NCT01379508|16528076|P2|Treatment to Week 104|Adverse Event|0
4792273|NCT01379508|16528077|P1|Treatment to Week 104|Adverse Event|2
4792274|NCT01378975|16528159|P2|Overall Study|Withdrew Consent|3
4792275|NCT01378975|16528160|P1|Overall Study|Withdrew Consent|4
4792276|NCT01378975|16528159|P2|Overall Study|Lost to Follow-up|1
4792277|NCT01378975|16528160|P1|Overall Study|Lost to Follow-up|4
4792278|NCT01378975|16528159|P2|Overall Study|Investigator Request|0
4792279|NCT01378975|16528160|P1|Overall Study|Investigator Request|1
4792280|NCT01378975|16528159|P2|Overall Study|Death|46
4792281|NCT01378975|16528160|P1|Overall Study|Death|77
4792282|NCT01378962|16528186|P1|Overall Study|Other|2
4792283|NCT01378962|16528186|P1|Overall Study|Lost to Follow-up|1
4792284|NCT01378962|16528186|P1|Overall Study|Death|14
4792285|NCT01378429|16528212|P2|Overall Study|Noncompliance with study drug|0
4792286|NCT01378429|16528213|P1|Overall Study|Noncompliance with study drug|1
4792287|NCT01378325|16528326|P2|Overall Study|Protocol Violation|1
4792288|NCT01378325|16528327|P1|Overall Study|Protocol Violation|0
4792289|NCT01378195|16528396|P2|Overall Study|Lost to Follow-up|18
4792290|NCT01378195|16528397|P1|Overall Study|Lost to Follow-up|29
4792291|NCT01378117|16528410|P3|Overall Study|discharged before med given|1
4792292|NCT01378117|16528411|P2|Overall Study|discharged before med given|0
4792293|NCT01378117|16528412|P1|Overall Study|discharged before med given|2
4792294|NCT01378117|16528410|P3|Overall Study|withdrawal|2
4792295|NCT01378117|16528411|P2|Overall Study|withdrawal|1
4792296|NCT01378117|16528412|P1|Overall Study|withdrawal|2
4792297|NCT01378104|16528446|P2|Overall Study|Withdrawal by Subject|13
4792298|NCT01378104|16528447|P1|Overall Study|Withdrawal by Subject|12
4792299|NCT01378104|16528446|P2|Overall Study|Lack of Efficacy|5
4792300|NCT01378104|16528447|P1|Overall Study|Lack of Efficacy|7
4792301|NCT01378104|16528446|P2|Overall Study|Adverse Event|8
4792302|NCT01378104|16528447|P1|Overall Study|Adverse Event|8
4792303|NCT01377987|16528492|P2|Washout (7 Days)|Withdrawal by Subject|1
4792304|NCT01377987|16528493|P1|Washout (7 Days)|Withdrawal by Subject|1
4792305|NCT01377922|16528511|P2|Overall Study|rescue tx after part 2, entered part 4|0
4792306|NCT01377922|16528512|P1|Overall Study|rescue tx after part 2, entered part 4|1
4792307|NCT01377480|16528597|P4|Overall Study|Other|6
4792308|NCT01377480|16528598|P3|Overall Study|Other|7
4792309|NCT01377480|16528599|P2|Overall Study|Other|0
4792310|NCT01377480|16528600|P1|Overall Study|Other|0
4792311|NCT01377480|16528597|P4|Overall Study|Serious adverse event|1
4792312|NCT01377480|16528598|P3|Overall Study|Serious adverse event|1
4792313|NCT01377480|16528599|P2|Overall Study|Serious adverse event|0
4792314|NCT01377480|16528600|P1|Overall Study|Serious adverse event|0
4792315|NCT01377480|16528597|P4|Overall Study|Withdrawal by Subject|0
4792316|NCT01377480|16528598|P3|Overall Study|Withdrawal by Subject|1
4792317|NCT01377480|16528599|P2|Overall Study|Withdrawal by Subject|0
4792318|NCT01377480|16528600|P1|Overall Study|Withdrawal by Subject|0
4792319|NCT01377480|16528597|P4|Overall Study|Evidence of drug-induced hepatotoxicity|0
4792320|NCT01377480|16528598|P3|Overall Study|Evidence of drug-induced hepatotoxicity|1
4792321|NCT01377480|16528599|P2|Overall Study|Evidence of drug-induced hepatotoxicity|1
4792322|NCT01377480|16528600|P1|Overall Study|Evidence of drug-induced hepatotoxicity|0
4792323|NCT01377480|16528597|P4|Overall Study|Protocol Violation|4
4792324|NCT01377480|16528598|P3|Overall Study|Protocol Violation|0
4792325|NCT01377480|16528599|P2|Overall Study|Protocol Violation|0
4792326|NCT01377480|16528600|P1|Overall Study|Protocol Violation|0
4792327|NCT01377389|16528676|P1|Overall Study|Screen failure|2
4792328|NCT01377389|16528676|P1|Overall Study|Withdrawal by Subject|1
4792329|NCT01377233|16528690|P5|Double-blind|Administrative or other|1
4792330|NCT01377233|16528691|P4|Double-blind|Administrative or other|1
4792331|NCT01377233|16528692|P3|Double-blind|Administrative or other|0
4792332|NCT01377233|16528693|P2|Double-blind|Administrative or other|0
4792333|NCT01377233|16528694|P1|Double-blind|Administrative or other|0
4792334|NCT01377233|16528690|P5|Double-blind|Withdrawal by Subject|0
4792335|NCT01377233|16528691|P4|Double-blind|Withdrawal by Subject|1
4792336|NCT01377233|16528692|P3|Double-blind|Withdrawal by Subject|0
4792337|NCT01377233|16528693|P2|Double-blind|Withdrawal by Subject|0
4792338|NCT01377233|16528694|P1|Double-blind|Withdrawal by Subject|0
4792339|NCT01377233|16528690|P5|Double-blind|Protocol Violation|1
4792340|NCT01377233|16528691|P4|Double-blind|Protocol Violation|0
4792341|NCT01377233|16528692|P3|Double-blind|Protocol Violation|0
4792342|NCT01377233|16528693|P2|Double-blind|Protocol Violation|0
4792343|NCT01377233|16528694|P1|Double-blind|Protocol Violation|0
4792344|NCT01377233|16528690|P5|Double-blind|Adverse Event|0
4792345|NCT01377233|16528691|P4|Double-blind|Adverse Event|2
4792346|NCT01377233|16528692|P3|Double-blind|Adverse Event|2
4792347|NCT01377233|16528693|P2|Double-blind|Adverse Event|1
4792348|NCT01377233|16528694|P1|Double-blind|Adverse Event|0
4792349|NCT01377233|16528690|P5|Open-label|Withdrawal by Subject|0
4792350|NCT01377233|16528691|P4|Open-label|Withdrawal by Subject|0
4792351|NCT01377233|16528692|P3|Open-label|Withdrawal by Subject|0
4792352|NCT01377233|16528693|P2|Open-label|Withdrawal by Subject|0
4792353|NCT01377233|16528694|P1|Open-label|Withdrawal by Subject|3
4792354|NCT01377233|16528690|P5|Open-label|Adverse Event|0
4792355|NCT01377233|16528691|P4|Open-label|Adverse Event|0
4792356|NCT01377233|16528692|P3|Open-label|Adverse Event|0
4792357|NCT01377233|16528693|P2|Open-label|Adverse Event|0
4792358|NCT01377233|16528694|P1|Open-label|Adverse Event|1
4792359|NCT01377194|16528721|P3|Overall Study|Lost to Follow-up|11
4792360|NCT01377194|16528722|P2|Overall Study|Lost to Follow-up|8
4792361|NCT01377194|16528723|P1|Overall Study|Lost to Follow-up|14
4792362|NCT01377194|16528721|P3|Overall Study|Withdrawal by Subject|7
4792363|NCT01377194|16528722|P2|Overall Study|Withdrawal by Subject|10
4792364|NCT01377194|16528723|P1|Overall Study|Withdrawal by Subject|8
4792365|NCT01377194|16528721|P3|Overall Study|Protocol Violation|6
4792366|NCT01377194|16528722|P2|Overall Study|Protocol Violation|10
4792367|NCT01377194|16528723|P1|Overall Study|Protocol Violation|4
4792368|NCT01377194|16528721|P3|Overall Study|Lack of Efficacy|3
4792369|NCT01377194|16528722|P2|Overall Study|Lack of Efficacy|3
4792370|NCT01377194|16528723|P1|Overall Study|Lack of Efficacy|3
4792371|NCT01377194|16528721|P3|Overall Study|Adverse Event|19
4792372|NCT01377194|16528722|P2|Overall Study|Adverse Event|12
4792373|NCT01377194|16528723|P1|Overall Study|Adverse Event|3
4792374|NCT01377012|16528737|P3|Extension Study, Weeks 104-260|Adverse Event|1
4792375|NCT01377012|16528738|P2|Extension Study, Weeks 104-260|Adverse Event|2
4792376|NCT01377012|16528739|P1|Extension Study, Weeks 104-260|Adverse Event|0
4792377|NCT01377012|16528737|P3|Extension Study, Weeks 104-260|Lost to Follow-up|1
4792378|NCT01377012|16528738|P2|Extension Study, Weeks 104-260|Lost to Follow-up|0
4792379|NCT01377012|16528739|P1|Extension Study, Weeks 104-260|Lost to Follow-up|0
4792380|NCT01377012|16528737|P3|Extension Study, Weeks 104-260|Physician Decision|0
4792381|NCT01377012|16528738|P2|Extension Study, Weeks 104-260|Physician Decision|0
4792382|NCT01377012|16528739|P1|Extension Study, Weeks 104-260|Physician Decision|1
4792383|NCT01377012|16528737|P3|Extension Study, Weeks 104-260|Withdrawal by Subject|3
4792384|NCT01377012|16528738|P2|Extension Study, Weeks 104-260|Withdrawal by Subject|0
4792385|NCT01377012|16528739|P1|Extension Study, Weeks 104-260|Withdrawal by Subject|1
4792386|NCT01377012|16528737|P3|Extension Study, Weeks 104-260|Study terminated by sponsor|63
4792387|NCT01377012|16528738|P2|Extension Study, Weeks 104-260|Study terminated by sponsor|69
4792388|NCT01377012|16528739|P1|Extension Study, Weeks 104-260|Study terminated by sponsor|52
4792389|NCT01377012|16528737|P3|Extension Study, Weeks 104-260|Lack of Efficacy|0
4792390|NCT01377012|16528738|P2|Extension Study, Weeks 104-260|Lack of Efficacy|0
4792391|NCT01377012|16528739|P1|Extension Study, Weeks 104-260|Lack of Efficacy|3
4792392|NCT01377012|16528737|P3|Core Study|Adverse Event|13
4792393|NCT01377012|16528738|P2|Core Study|Adverse Event|14
4792394|NCT01377012|16528739|P1|Core Study|Adverse Event|10
4792395|NCT01377012|16528737|P3|Core Study|Death|1
4792396|NCT01377012|16528738|P2|Core Study|Death|1
4792397|NCT01377012|16528739|P1|Core Study|Death|1
4792398|NCT01377012|16528737|P3|Core Study|Lack of Efficacy|37
4792399|NCT01377012|16528738|P2|Core Study|Lack of Efficacy|28
4792400|NCT01377012|16528739|P1|Core Study|Lack of Efficacy|41
4792401|NCT01377012|16528737|P3|Core Study|Lost to Follow-up|4
4792402|NCT01377012|16528738|P2|Core Study|Lost to Follow-up|5
4792403|NCT01377012|16528739|P1|Core Study|Lost to Follow-up|7
4792404|NCT01377012|16528737|P3|Core Study|No Longer require treatment|1
4792405|NCT01377012|16528738|P2|Core Study|No Longer require treatment|0
4792406|NCT01377012|16528739|P1|Core Study|No Longer require treatment|0
4792407|NCT01377012|16528737|P3|Core Study|Non-Compliant with study treatment|1
4792408|NCT01377012|16528738|P2|Core Study|Non-Compliant with study treatment|0
4792409|NCT01377012|16528739|P1|Core Study|Non-Compliant with study treatment|0
4792410|NCT01377012|16528737|P3|Core Study|Physician Decision|10
4792411|NCT01377012|16528738|P2|Core Study|Physician Decision|4
4792412|NCT01377012|16528739|P1|Core Study|Physician Decision|5
4792413|NCT01377012|16528737|P3|Core Study|Pregnancy|1
4792414|NCT01377012|16528738|P2|Core Study|Pregnancy|0
4792415|NCT01377012|16528739|P1|Core Study|Pregnancy|0
4792416|NCT01377012|16528737|P3|Core Study|Protocol Violation|2
4792417|NCT01377012|16528738|P2|Core Study|Protocol Violation|3
4792418|NCT01377012|16528739|P1|Core Study|Protocol Violation|7
4792419|NCT01377012|16528737|P3|Core Study|Withdrawal by Subject|18
4792420|NCT01377012|16528738|P2|Core Study|Withdrawal by Subject|23
4792421|NCT01377012|16528739|P1|Core Study|Withdrawal by Subject|15
4792422|NCT01377012|16528737|P3|Core Study|Technical problems|0
4792423|NCT01377012|16528738|P2|Core Study|Technical problems|0
4792424|NCT01377012|16528739|P1|Core Study|Technical problems|1
4792425|NCT01377012|16528737|P3|Core Study|Study terminated by Sponsor|46
4792426|NCT01377012|16528738|P2|Core Study|Study terminated by Sponsor|54
4792427|NCT01377012|16528739|P1|Core Study|Study terminated by Sponsor|47
4792428|NCT01376908|16528776|P2|Overall Study|Withdrawal by Subject|2
4792429|NCT01376908|16528777|P1|Overall Study|Withdrawal by Subject|1
4792430|NCT01376908|16528776|P2|Overall Study|Protocol Violation|1
4792431|NCT01376908|16528777|P1|Overall Study|Protocol Violation|1
4792432|NCT01376804|16528810|P1|Treatment Period|Patient did not receive study drug|1
4792433|NCT01376804|16528810|P1|Treatment Period|Adverse Event|6
4792434|NCT01376804|16528810|P1|Treatment Period|Withdrawal by Subject|1
4792435|NCT01376700|16528821|P1|Overall Study|Low or high titer inhibitor|8
4792436|NCT01376700|16528821|P1|Overall Study|Sponsor terminated study early|8
4792437|NCT01376388|16528883|P1|Overall Study|Withdrawal by Subject|3
4792438|NCT01376388|16528883|P1|Overall Study|Lack of Efficacy|2
4792439|NCT01376388|16528883|P1|Overall Study|Adverse Event|13
4792440|NCT01376349|16528921|P3|Raondomized Treatment|Alternative Treatment|1
4792441|NCT01376349|16528922|P2|Raondomized Treatment|Alternative Treatment|0
4792442|NCT01376349|16528923|P1|Raondomized Treatment|Alternative Treatment|0
4792443|NCT01376349|16528921|P3|Raondomized Treatment|Unkown|1
4792444|NCT01376349|16528922|P2|Raondomized Treatment|Unkown|2
4792445|NCT01376349|16528923|P1|Raondomized Treatment|Unkown|1
4792446|NCT01376349|16528921|P3|Raondomized Treatment|Adverse Event|14
4792447|NCT01376349|16528922|P2|Raondomized Treatment|Adverse Event|17
4792448|NCT01376349|16528923|P1|Raondomized Treatment|Adverse Event|13
4792449|NCT01376349|16528921|P3|Raondomized Treatment|Withdrawal by Subject|13
4792450|NCT01376349|16528922|P2|Raondomized Treatment|Withdrawal by Subject|16
4792451|NCT01376349|16528923|P1|Raondomized Treatment|Withdrawal by Subject|10
4792452|NCT01376323|16528937|P5|Overall Study|Withdrawal by Subject|0
4792453|NCT01376323|16528938|P4|Overall Study|Withdrawal by Subject|0
4792454|NCT01376323|16528939|P3|Overall Study|Withdrawal by Subject|1
4792455|NCT01376323|16528940|P2|Overall Study|Withdrawal by Subject|1
4792456|NCT01376323|16528941|P1|Overall Study|Withdrawal by Subject|0
4792457|NCT01376323|16528937|P5|Overall Study|Physician Decision|1
4792458|NCT01376323|16528938|P4|Overall Study|Physician Decision|1
4792459|NCT01376323|16528939|P3|Overall Study|Physician Decision|2
4792460|NCT01376323|16528940|P2|Overall Study|Physician Decision|0
4792461|NCT01376323|16528941|P1|Overall Study|Physician Decision|1
4792462|NCT01376323|16528937|P5|Overall Study|Lost to Follow-up|0
4792463|NCT01376323|16528938|P4|Overall Study|Lost to Follow-up|2
4792464|NCT01376323|16528939|P3|Overall Study|Lost to Follow-up|0
4792465|NCT01376323|16528940|P2|Overall Study|Lost to Follow-up|0
4792466|NCT01376323|16528941|P1|Overall Study|Lost to Follow-up|0
4792467|NCT01376323|16528937|P5|Overall Study|Adverse Event|0
4792468|NCT01376323|16528938|P4|Overall Study|Adverse Event|2
4792469|NCT01376323|16528939|P3|Overall Study|Adverse Event|0
4792470|NCT01376323|16528940|P2|Overall Study|Adverse Event|0
4792471|NCT01376323|16528941|P1|Overall Study|Adverse Event|1
4792472|NCT01376310|16529025|P2|Overall Study|Lost to Follow-up|0
4792473|NCT01376310|16529026|P1|Overall Study|Lost to Follow-up|1
4792474|NCT01376310|16529025|P2|Overall Study|Physician Decision|7
4792475|NCT01376310|16529026|P1|Overall Study|Physician Decision|26
4792476|NCT01376310|16529025|P2|Overall Study|Withdrawal by Subject|2
4792477|NCT01376310|16529026|P1|Overall Study|Withdrawal by Subject|8
4792478|NCT01376310|16529025|P2|Overall Study|Study closed/terminated|2
4792479|NCT01376310|16529026|P1|Overall Study|Study closed/terminated|1
4792480|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
4792481|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
4792482|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4792483|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|6
4792484|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4792485|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Physician Decision|0
4792486|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Physician Decision|1
4792487|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Physician Decision|1
4792488|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Physician Decision|0
4792489|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Physician Decision|0
4792490|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4792491|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4792492|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4792493|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4792494|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4792495|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4792496|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1
4792497|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3
4792498|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2
4792499|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4792500|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
4792501|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
4792502|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Protocol Violation|0
4792503|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Protocol Violation|2
4792504|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
4792505|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Lack of Efficacy|3
4792506|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Lack of Efficacy|4
4792507|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Lack of Efficacy|5
4792508|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Lack of Efficacy|4
4792509|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Lack of Efficacy|0
4792510|NCT01376245|16529045|P5|24-week, Double-blind Treatment Period|Adverse Event|18
4792511|NCT01376245|16529046|P4|24-week, Double-blind Treatment Period|Adverse Event|8
4792593|NCT01375764|16529281|P3|Overall Study|Withdrawal by Subject|0
4792512|NCT01376245|16529047|P3|24-week, Double-blind Treatment Period|Adverse Event|7
4792513|NCT01376245|16529048|P2|24-week, Double-blind Treatment Period|Adverse Event|16
4792514|NCT01376245|16529049|P1|24-week, Double-blind Treatment Period|Adverse Event|0
4792515|NCT01376245|16529045|P5|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4792516|NCT01376245|16529046|P4|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4792517|NCT01376245|16529047|P3|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4792518|NCT01376245|16529048|P2|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0
4792519|NCT01376245|16529049|P1|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28
4792520|NCT01376245|16529045|P5|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4792521|NCT01376245|16529046|P4|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4792522|NCT01376245|16529047|P3|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4792523|NCT01376245|16529048|P2|2-wk Single-blind Placebo Run-in Period|Physician Decision|0
4792524|NCT01376245|16529049|P1|2-wk Single-blind Placebo Run-in Period|Physician Decision|2
4792525|NCT01376245|16529045|P5|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4792526|NCT01376245|16529046|P4|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4792527|NCT01376245|16529047|P3|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4792528|NCT01376245|16529048|P2|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0
4792529|NCT01376245|16529049|P1|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1
4792530|NCT01376245|16529045|P5|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4792531|NCT01376245|16529046|P4|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4792532|NCT01376245|16529047|P3|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4792533|NCT01376245|16529048|P2|2-wk Single-blind Placebo Run-in Period|Adverse Event|0
4792534|NCT01376245|16529049|P1|2-wk Single-blind Placebo Run-in Period|Adverse Event|4
4792535|NCT01376245|16529045|P5|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4792536|NCT01376245|16529046|P4|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4792537|NCT01376245|16529047|P3|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4792538|NCT01376245|16529048|P2|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0
4792539|NCT01376245|16529049|P1|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66
4792540|NCT01376167|16529066|P3|Overall Study|Withdrawal by Subject|4
4792541|NCT01376167|16529067|P2|Overall Study|Withdrawal by Subject|5
4792542|NCT01376167|16529068|P1|Overall Study|Withdrawal by Subject|1
4792543|NCT01376167|16529066|P3|Overall Study|Physician Decision|0
4792544|NCT01376167|16529067|P2|Overall Study|Physician Decision|1
4792545|NCT01376167|16529068|P1|Overall Study|Physician Decision|1
4792546|NCT01376167|16529066|P3|Overall Study|Lost to Follow-up|2
4792547|NCT01376167|16529067|P2|Overall Study|Lost to Follow-up|4
4792548|NCT01376167|16529068|P1|Overall Study|Lost to Follow-up|2
4792549|NCT01376089|16529139|P2|Overall Study|Patient received no contrast media|4
4792550|NCT01376089|16529140|P1|Overall Study|Patient received no contrast media|3
4792551|NCT01376037|16529163|P2|Overall Study|Lost to Follow-up|2
4792552|NCT01376037|16529164|P1|Overall Study|Lost to Follow-up|0
4792553|NCT01375959|16529172|P2|Second Intervention (6 Weeks)|Adverse Event|2
4792554|NCT01375959|16529173|P1|Second Intervention (6 Weeks)|Adverse Event|0
4792555|NCT01375959|16529172|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|1
4792556|NCT01375959|16529173|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|0
4792557|NCT01375959|16529172|P2|First Intervention (6 Weeks)|Adverse Event|3
4792558|NCT01375959|16529173|P1|First Intervention (6 Weeks)|Adverse Event|2
4792559|NCT01375777|16529201|P9|Overall Study|Other|1
4792560|NCT01375777|16529202|P8|Overall Study|Other|0
4792561|NCT01375777|16529203|P7|Overall Study|Other|0
4792562|NCT01375777|16529204|P6|Overall Study|Other|0
4792563|NCT01375777|16529205|P5|Overall Study|Other|0
4792564|NCT01375777|16529206|P4|Overall Study|Other|0
4792565|NCT01375777|16529207|P3|Overall Study|Other|0
4792566|NCT01375777|16529208|P2|Overall Study|Other|1
4792567|NCT01375777|16529209|P1|Overall Study|Other|1
4792568|NCT01375777|16529201|P9|Overall Study|Lost to Follow-up|0
4792569|NCT01375777|16529202|P8|Overall Study|Lost to Follow-up|0
4792570|NCT01375777|16529203|P7|Overall Study|Lost to Follow-up|1
4792571|NCT01375777|16529204|P6|Overall Study|Lost to Follow-up|0
4792572|NCT01375777|16529205|P5|Overall Study|Lost to Follow-up|0
4792573|NCT01375777|16529206|P4|Overall Study|Lost to Follow-up|0
4792574|NCT01375777|16529207|P3|Overall Study|Lost to Follow-up|0
4792575|NCT01375777|16529208|P2|Overall Study|Lost to Follow-up|0
4792576|NCT01375777|16529209|P1|Overall Study|Lost to Follow-up|1
4792577|NCT01375777|16529201|P9|Overall Study|Withdrawal by Subject|1
4792578|NCT01375777|16529202|P8|Overall Study|Withdrawal by Subject|2
4792579|NCT01375777|16529203|P7|Overall Study|Withdrawal by Subject|1
4792580|NCT01375777|16529204|P6|Overall Study|Withdrawal by Subject|1
4792581|NCT01375777|16529205|P5|Overall Study|Withdrawal by Subject|1
4792582|NCT01375777|16529206|P4|Overall Study|Withdrawal by Subject|0
4792583|NCT01375777|16529207|P3|Overall Study|Withdrawal by Subject|1
4792584|NCT01375777|16529208|P2|Overall Study|Withdrawal by Subject|2
4792585|NCT01375777|16529209|P1|Overall Study|Withdrawal by Subject|0
4792586|NCT01375764|16529279|P5|Overall Study|Other|0
4792587|NCT01375764|16529280|P4|Overall Study|Other|1
4792588|NCT01375764|16529281|P3|Overall Study|Other|0
4792589|NCT01375764|16529282|P2|Overall Study|Other|0
4792590|NCT01375764|16529283|P1|Overall Study|Other|0
4792591|NCT01375764|16529279|P5|Overall Study|Withdrawal by Subject|1
4792592|NCT01375764|16529280|P4|Overall Study|Withdrawal by Subject|0
4792594|NCT01375764|16529282|P2|Overall Study|Withdrawal by Subject|0
4792595|NCT01375764|16529283|P1|Overall Study|Withdrawal by Subject|2
4792596|NCT01375764|16529279|P5|Overall Study|Lost to Follow-up|0
4792597|NCT01375764|16529280|P4|Overall Study|Lost to Follow-up|0
4792598|NCT01375764|16529281|P3|Overall Study|Lost to Follow-up|0
4792599|NCT01375764|16529282|P2|Overall Study|Lost to Follow-up|1
4792600|NCT01375764|16529283|P1|Overall Study|Lost to Follow-up|0
4792601|NCT01375751|16529329|P3|Overall Study|Other|0
4792602|NCT01375751|16529330|P2|Overall Study|Other|1
4792603|NCT01375751|16529331|P1|Overall Study|Other|0
4792604|NCT01375673|16529356|P2|Overall Study|Withdrawal by Subject|1
4792605|NCT01375673|16529357|P1|Overall Study|Withdrawal by Subject|0
4792606|NCT01375608|16529388|P1|Overall Study|Withdrawal by Subject|2
4792607|NCT01375374|16529416|P1|Overall Study|Adverse Event|1
4792608|NCT01375205|16529425|P2|Overall Study|Withdrawal by Subject|1
4792609|NCT01375205|16529426|P1|Overall Study|Withdrawal by Subject|6
4792610|NCT01375205|16529425|P2|Overall Study|Lost to Follow-up|12
4792611|NCT01375205|16529426|P1|Overall Study|Lost to Follow-up|15
4792612|NCT01375075|16529499|P6|Overall Study|Withdrawal by Subject|1
4792613|NCT01375075|16529500|P5|Overall Study|Withdrawal by Subject|0
4792614|NCT01375075|16529501|P4|Overall Study|Withdrawal by Subject|0
4792615|NCT01375075|16529502|P3|Overall Study|Withdrawal by Subject|0
4792616|NCT01375075|16529503|P2|Overall Study|Withdrawal by Subject|1
4792617|NCT01375075|16529504|P1|Overall Study|Withdrawal by Subject|0
4792618|NCT01375075|16529499|P6|Overall Study|Entry Criterion Not Met|1
4792619|NCT01375075|16529500|P5|Overall Study|Entry Criterion Not Met|0
4792620|NCT01375075|16529501|P4|Overall Study|Entry Criterion Not Met|0
4792621|NCT01375075|16529502|P3|Overall Study|Entry Criterion Not Met|0
4792622|NCT01375075|16529503|P2|Overall Study|Entry Criterion Not Met|0
4792623|NCT01375075|16529504|P1|Overall Study|Entry Criterion Not Met|1
4792624|NCT01375075|16529499|P6|Overall Study|Adverse Event|1
4792625|NCT01375075|16529500|P5|Overall Study|Adverse Event|0
4792626|NCT01375075|16529501|P4|Overall Study|Adverse Event|1
4792627|NCT01375075|16529502|P3|Overall Study|Adverse Event|3
4792628|NCT01375075|16529503|P2|Overall Study|Adverse Event|0
4792629|NCT01375075|16529504|P1|Overall Study|Adverse Event|0
4792630|NCT01375049|16529588|P1|Overall Study|Protocol-Specified Withdrawal Criteria|45
4792631|NCT01375049|16529588|P1|Overall Study|Withdrawal by Subject|2
4792632|NCT01375049|16529588|P1|Overall Study|Lost to Follow-up|1
4792633|NCT01375049|16529588|P1|Overall Study|Adverse Event|2
4792634|NCT01375010|16529605|P2|Overall Study|Withdrawal by Subject|2
4792635|NCT01375010|16529606|P1|Overall Study|Withdrawal by Subject|4
4792636|NCT01375010|16529605|P2|Overall Study|Lost to Follow-up|2
4792637|NCT01375010|16529606|P1|Overall Study|Lost to Follow-up|8
4792638|NCT01374971|16529620|P1|Overall Study|Withdrawal by Subject|1
4792639|NCT01374919|16529625|P1|Overall Study|Withdrawal by Subject|2
4792640|NCT01374906|16529632|P2|Overall Study|Unsatisfactory therapeutic effect|19
4792641|NCT01374906|16529633|P1|Overall Study|Unsatisfactory therapeutic effect|11
4792642|NCT01374906|16529632|P2|Overall Study|Withdrawal by Subject|9
4792643|NCT01374906|16529633|P1|Overall Study|Withdrawal by Subject|15
4792644|NCT01374906|16529632|P2|Overall Study|Protocol Violation|2
4792645|NCT01374906|16529633|P1|Overall Study|Protocol Violation|2
4792646|NCT01374906|16529632|P2|Overall Study|Death|2
4792647|NCT01374906|16529633|P1|Overall Study|Death|0
4792648|NCT01374906|16529632|P2|Overall Study|Adverse Event|11
4792649|NCT01374906|16529633|P1|Overall Study|Adverse Event|10
4792650|NCT01374906|16529632|P2|Overall Study|Administrative problems|2
4792651|NCT01374906|16529633|P1|Overall Study|Administrative problems|2
4792652|NCT01374906|16529632|P2|Overall Study|Abnormal laboratory value(s)|3
4792653|NCT01374906|16529633|P1|Overall Study|Abnormal laboratory value(s)|0
4792654|NCT01374568|16529714|P2|Overall Study|Lab unable to analyze BTM|2
4792655|NCT01374568|16529715|P1|Overall Study|Lab unable to analyze BTM|0
4792656|NCT01374516|16529725|P2|Surveillance Expansion Period|Serious adverse event|5
4792657|NCT01374516|16529726|P1|Surveillance Expansion Period|Serious adverse event|20
4792658|NCT01374516|16529725|P2|Surveillance Expansion Period|Lost to Follow-up|45
4792659|NCT01374516|16529726|P1|Surveillance Expansion Period|Lost to Follow-up|73
4792660|NCT01374516|16529725|P2|Surveillance Expansion Period|Withdrawal by Subject|986
4792661|NCT01374516|16529726|P1|Surveillance Expansion Period|Withdrawal by Subject|1870
4792662|NCT01374516|16529725|P2|Surveillance Expansion Period|Protocol Violation|217
4792663|NCT01374516|16529726|P1|Surveillance Expansion Period|Protocol Violation|386
4792664|NCT01374516|16529725|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|9
4792665|NCT01374516|16529726|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|7
4792666|NCT01374516|16529725|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46
4792667|NCT01374516|16529726|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106
4792668|NCT01374516|16529725|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240
4792669|NCT01374516|16529726|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480
4792670|NCT01374516|16529725|P2|Vaccination Phase (Up to 25 Months)|Adverse Event|0
4792671|NCT01374516|16529726|P1|Vaccination Phase (Up to 25 Months)|Adverse Event|3
4792672|NCT01374516|16529725|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|14
4792673|NCT01374516|16529726|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|43
4792674|NCT01374451|16529764|P2|Overall Study|Administrative problems|0
4792675|NCT01374451|16529765|P1|Overall Study|Administrative problems|1
4792676|NCT01374425|16529811|P2|Overall Study|Other|43
4792677|NCT01374425|16529812|P1|Overall Study|Other|41
4792678|NCT01374425|16529811|P2|Overall Study|Lost to Follow-up|1
4792679|NCT01374425|16529812|P1|Overall Study|Lost to Follow-up|2
4792680|NCT01374425|16529811|P2|Overall Study|Sponsor Decision|1
4792681|NCT01374425|16529812|P1|Overall Study|Sponsor Decision|0
4792682|NCT01374425|16529811|P2|Overall Study|Protocol Violation|3
4792683|NCT01374425|16529812|P1|Overall Study|Protocol Violation|2
4792684|NCT01374425|16529811|P2|Overall Study|Refused Treatment|24
4792685|NCT01374425|16529812|P1|Overall Study|Refused Treatment|10
4792686|NCT01374425|16529811|P2|Overall Study|Withdrawal by Subject|7
4792687|NCT01374425|16529812|P1|Overall Study|Withdrawal by Subject|6
4792688|NCT01374425|16529811|P2|Overall Study|Death (Adverse Event)|4
4792689|NCT01374425|16529812|P1|Overall Study|Death (Adverse Event)|2
4792690|NCT01374425|16529811|P2|Overall Study|Death (Progression of Disease)|0
4792691|NCT01374425|16529812|P1|Overall Study|Death (Progression of Disease)|1
4792692|NCT01374425|16529811|P2|Overall Study|Adverse Event|18
4792693|NCT01374425|16529812|P1|Overall Study|Adverse Event|29
4792694|NCT01374425|16529811|P2|Overall Study|Clinical Disease Progression|6
4792695|NCT01374425|16529812|P1|Overall Study|Clinical Disease Progression|9
4792696|NCT01374425|16529811|P2|Overall Study|Radiographic Disease Progression|81
4792697|NCT01374425|16529812|P1|Overall Study|Radiographic Disease Progression|86
4792698|NCT01374269|16529892|P2|Overall Study|closed research|2
4792699|NCT01374269|16529893|P1|Overall Study|closed research|1
4792700|NCT01374269|16529892|P2|Overall Study|Lost to Follow-up|3
4792701|NCT01374269|16529893|P1|Overall Study|Lost to Follow-up|1
4792702|NCT01374269|16529892|P2|Overall Study|Withdrawal by Subject|0
4792703|NCT01374269|16529893|P1|Overall Study|Withdrawal by Subject|4
4792704|NCT01374217|16530021|P1|Overall Study|Lack of Efficacy|13
4792705|NCT01374178|16530029|P2|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0
4792706|NCT01374178|16530030|P1|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2
4792707|NCT01374178|16530029|P2|Washout Period of at Least 7 Days|Withdrawal by Subject|0
4792708|NCT01374178|16530030|P1|Washout Period of at Least 7 Days|Withdrawal by Subject|1
4792709|NCT01374087|16530048|P2|Overall Study|Study discontinued|13
4792710|NCT01374087|16530049|P1|Overall Study|Study discontinued|13
4792711|NCT01374087|16530048|P2|Overall Study|Disease progression|2
4792712|NCT01374087|16530049|P1|Overall Study|Disease progression|2
4792713|NCT01374087|16530048|P2|Overall Study|Adverse Event|0
4792714|NCT01374087|16530049|P1|Overall Study|Adverse Event|1
4792715|NCT01373931|16530069|P2|Period 1|Withdrawal by Subject|2
4792716|NCT01373931|16530070|P1|Period 1|Withdrawal by Subject|0
4792717|NCT01373931|16530069|P2|Period 1|Adverse Event|0
4792718|NCT01373931|16530070|P1|Period 1|Adverse Event|2
4792719|NCT01373931|16530069|P2|Lead-in Period|Adverse Event|0
4792720|NCT01373931|16530070|P1|Lead-in Period|Adverse Event|2
4792721|NCT01373918|16530083|P2|Overall Study|Physician Decision|1
4792722|NCT01373918|16530084|P1|Overall Study|Physician Decision|0
4792723|NCT01373346|16530143|P1|Overall Study|Death|1
4792724|NCT01373294|16530166|P2|Overall Study|Adverse Event|0
4792725|NCT01373294|16530167|P1|Overall Study|Adverse Event|1
4792726|NCT01373281|16530176|P2|Surveillance Expansion Period|Serious adverse event|4
4792727|NCT01373281|16530177|P1|Surveillance Expansion Period|Serious adverse event|3
4792728|NCT01373281|16530176|P2|Surveillance Expansion Period|Lost to Follow-up|8
4792729|NCT01373281|16530177|P1|Surveillance Expansion Period|Lost to Follow-up|10
4792730|NCT01373281|16530176|P2|Surveillance Expansion Period|Protocol Violation|1
4792731|NCT01373281|16530177|P1|Surveillance Expansion Period|Protocol Violation|9
4792732|NCT01373281|16530176|P2|Surveillance Expansion Period|Withdrawal by Subject|105
4792733|NCT01373281|16530177|P1|Surveillance Expansion Period|Withdrawal by Subject|180
4792734|NCT01373281|16530176|P2|Vaccination Phase (Up to 25 Months)|Serious adverse event|1
4792735|NCT01373281|16530177|P1|Vaccination Phase (Up to 25 Months)|Serious adverse event|4
4792736|NCT01373281|16530176|P2|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1
4792737|NCT01373281|16530177|P1|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5
4792738|NCT01373281|16530176|P2|Vaccination Phase (Up to 25 Months)|Protocol Violation|2
4792739|NCT01373281|16530177|P1|Vaccination Phase (Up to 25 Months)|Protocol Violation|5
4792740|NCT01373281|16530176|P2|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23
4792741|NCT01373281|16530177|P1|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40
4792742|NCT01373229|16530225|P1|Overall Study|Physician Decision|3
4792743|NCT01373229|16530225|P1|Overall Study|Death|3
4792744|NCT01373164|16530239|P5|Overall Study|Withdrawal by Subject|2
4792745|NCT01373164|16530240|P4|Overall Study|Withdrawal by Subject|10
4792746|NCT01373164|16530241|P3|Overall Study|Withdrawal by Subject|0
4792747|NCT01373164|16530242|P2|Overall Study|Withdrawal by Subject|1
4792748|NCT01373164|16530243|P1|Overall Study|Withdrawal by Subject|0
4792749|NCT01373164|16530239|P5|Overall Study|Lost to Follow-up|0
4792750|NCT01373164|16530240|P4|Overall Study|Lost to Follow-up|2
4792751|NCT01373164|16530241|P3|Overall Study|Lost to Follow-up|1
4792752|NCT01373164|16530242|P2|Overall Study|Lost to Follow-up|0
4792753|NCT01373164|16530243|P1|Overall Study|Lost to Follow-up|0
4792754|NCT01372995|16530277|P3|Overall Study|Physician Decision|1
4792755|NCT01372995|16530278|P2|Overall Study|Physician Decision|0
4792756|NCT01372995|16530279|P1|Overall Study|Physician Decision|0
4792757|NCT01372995|16530277|P3|Overall Study|Spouse withdrew participant from study|0
4792758|NCT01372995|16530278|P2|Overall Study|Spouse withdrew participant from study|1
4792759|NCT01372995|16530279|P1|Overall Study|Spouse withdrew participant from study|0
4792760|NCT01372878|16530326|P1|Overall Study|incomplete study procedure|104
4792761|NCT01372878|16530326|P1|Overall Study|Protocol Violation|17
4792762|NCT01372878|16530326|P1|Overall Study|Withdrawal by Subject|63
4792763|NCT01372774|16530346|P2|Overall Study|Withdrawal prior to treatment|5
4792764|NCT01372774|16530347|P1|Overall Study|Withdrawal prior to treatment|4
4792765|NCT01372748|16530363|P2|Overall Study|Withdrawal by Subject|5
4792766|NCT01372748|16530364|P1|Overall Study|Withdrawal by Subject|7
4792767|NCT01372748|16530363|P2|Overall Study|Lost to Follow-up|34
4792768|NCT01372748|16530364|P1|Overall Study|Lost to Follow-up|16
4792769|NCT01372618|16530372|P1|Overall Study|PI Died. Study Terminated|9
4792770|NCT01372605|16530380|P2|Overall Study|Changed medical home|0
4792771|NCT01372605|16530381|P1|Overall Study|Changed medical home|2
4792772|NCT01372605|16530380|P2|Overall Study|Moved|0
4792773|NCT01372605|16530381|P1|Overall Study|Moved|3
4792774|NCT01372605|16530380|P2|Overall Study|Withdrawal by Subject|7
4792775|NCT01372605|16530381|P1|Overall Study|Withdrawal by Subject|4
4792776|NCT01372605|16530380|P2|Overall Study|Lost to Follow-up|1
4792777|NCT01372605|16530381|P1|Overall Study|Lost to Follow-up|2
4792778|NCT01372605|16530380|P2|Overall Study|Death|2
4792779|NCT01372605|16530381|P1|Overall Study|Death|1
4792780|NCT01372501|16530407|P1|Overall Study|Device migration|1
4792781|NCT01372501|16530407|P1|Overall Study|Adverse Event|4
4792782|NCT01372410|16530430|P8|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792783|NCT01372410|16530431|P7|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792784|NCT01372410|16530432|P6|Treatment Period 3 (7 Days)|Protocol Deviation|1
4792785|NCT01372410|16530433|P5|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792786|NCT01372410|16530434|P4|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792787|NCT01372410|16530435|P3|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792788|NCT01372410|16530436|P2|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792789|NCT01372410|16530437|P1|Treatment Period 3 (7 Days)|Protocol Deviation|0
4792790|NCT01372410|16530430|P8|Treatment Period 3 (7 Days)|Adverse Event|0
4792791|NCT01372410|16530431|P7|Treatment Period 3 (7 Days)|Adverse Event|0
4792792|NCT01372410|16530432|P6|Treatment Period 3 (7 Days)|Adverse Event|0
4792793|NCT01372410|16530433|P5|Treatment Period 3 (7 Days)|Adverse Event|0
4792794|NCT01372410|16530434|P4|Treatment Period 3 (7 Days)|Adverse Event|0
4792795|NCT01372410|16530435|P3|Treatment Period 3 (7 Days)|Adverse Event|1
4792796|NCT01372410|16530436|P2|Treatment Period 3 (7 Days)|Adverse Event|0
4792797|NCT01372410|16530437|P1|Treatment Period 3 (7 Days)|Adverse Event|0
4792798|NCT01372410|16530430|P8|Washout Period 2 (10-14 Days)|Lack of Efficacy|1
4792799|NCT01372410|16530431|P7|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792800|NCT01372410|16530432|P6|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792801|NCT01372410|16530433|P5|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792802|NCT01372410|16530434|P4|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792803|NCT01372410|16530435|P3|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792804|NCT01372410|16530436|P2|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792805|NCT01372410|16530437|P1|Washout Period 2 (10-14 Days)|Lack of Efficacy|0
4792806|NCT01372410|16530430|P8|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
4792807|NCT01372410|16530431|P7|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
4792808|NCT01372410|16530432|P6|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4792809|NCT01372410|16530433|P5|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1
4792810|NCT01372410|16530434|P4|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4792811|NCT01372410|16530435|P3|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4792812|NCT01372410|16530436|P2|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4792813|NCT01372410|16530437|P1|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0
4792814|NCT01372410|16530430|P8|Washout Period 2 (10-14 Days)|Adverse Event|0
4792815|NCT01372410|16530431|P7|Washout Period 2 (10-14 Days)|Adverse Event|0
4792816|NCT01372410|16530432|P6|Washout Period 2 (10-14 Days)|Adverse Event|0
4792817|NCT01372410|16530433|P5|Washout Period 2 (10-14 Days)|Adverse Event|1
4792818|NCT01372410|16530434|P4|Washout Period 2 (10-14 Days)|Adverse Event|0
4792819|NCT01372410|16530435|P3|Washout Period 2 (10-14 Days)|Adverse Event|0
4792820|NCT01372410|16530436|P2|Washout Period 2 (10-14 Days)|Adverse Event|0
4792821|NCT01372410|16530437|P1|Washout Period 2 (10-14 Days)|Adverse Event|0
4792822|NCT01372410|16530430|P8|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
4792823|NCT01372410|16530431|P7|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4792824|NCT01372410|16530432|P6|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4792825|NCT01372410|16530433|P5|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4792826|NCT01372410|16530434|P4|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4792827|NCT01372410|16530435|P3|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4792828|NCT01372410|16530436|P2|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0
4792829|NCT01372410|16530437|P1|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1
4792830|NCT01372410|16530430|P8|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792831|NCT01372410|16530431|P7|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1
4792832|NCT01372410|16530432|P6|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792833|NCT01372410|16530433|P5|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792834|NCT01372410|16530434|P4|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792835|NCT01372410|16530435|P3|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792836|NCT01372410|16530436|P2|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792837|NCT01372410|16530437|P1|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0
4792838|NCT01372410|16530430|P8|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792839|NCT01372410|16530431|P7|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792840|NCT01372410|16530432|P6|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792841|NCT01372410|16530433|P5|Treatment Period 1 (7 Days)|Lost to Follow-up|1
4792842|NCT01372410|16530434|P4|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792843|NCT01372410|16530435|P3|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792844|NCT01372410|16530436|P2|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792845|NCT01372410|16530437|P1|Treatment Period 1 (7 Days)|Lost to Follow-up|0
4792846|NCT01372410|16530430|P8|Treatment Period 1 (7 Days)|Adverse Event|0
4792847|NCT01372410|16530431|P7|Treatment Period 1 (7 Days)|Adverse Event|1
4792848|NCT01372410|16530432|P6|Treatment Period 1 (7 Days)|Adverse Event|0
4792849|NCT01372410|16530433|P5|Treatment Period 1 (7 Days)|Adverse Event|0
4792850|NCT01372410|16530434|P4|Treatment Period 1 (7 Days)|Adverse Event|0
4792851|NCT01372410|16530435|P3|Treatment Period 1 (7 Days)|Adverse Event|0
4792852|NCT01372410|16530436|P2|Treatment Period 1 (7 Days)|Adverse Event|1
4792853|NCT01372410|16530437|P1|Treatment Period 1 (7 Days)|Adverse Event|0
4792854|NCT01372410|16530430|P8|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4792855|NCT01372410|16530431|P7|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4792856|NCT01372410|16530432|P6|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4792857|NCT01372410|16530433|P5|Treatment Period 1 (7 Days)|Lack of Efficacy|1
4792858|NCT01372410|16530434|P4|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4792859|NCT01372410|16530435|P3|Treatment Period 1 (7 Days)|Lack of Efficacy|0
4792860|NCT01372410|16530436|P2|Treatment Period 1 (7 Days)|Lack of Efficacy|1
4792861|NCT01372410|16530437|P1|Treatment Period 1 (7 Days)|Lack of Efficacy|1
4792862|NCT01372384|16530474|P1|Overall Study|Progression of disease|3
4792863|NCT01372150|16530515|P3|Overall Study|Randomized but not treated|0
4792864|NCT01372150|16530516|P2|Overall Study|Randomized but not treated|1
4792865|NCT01372150|16530517|P1|Overall Study|Randomized but not treated|0
4792866|NCT01372150|16530515|P3|Overall Study|Adverse Event|2
4792867|NCT01372150|16530516|P2|Overall Study|Adverse Event|1
4792868|NCT01372150|16530517|P1|Overall Study|Adverse Event|2
4792869|NCT01372150|16530515|P3|Overall Study|Other|2
4792870|NCT01372150|16530516|P2|Overall Study|Other|0
4792871|NCT01372150|16530517|P1|Overall Study|Other|1
4792872|NCT01372150|16530515|P3|Overall Study|Withdrawal by Subject|2
4792873|NCT01372150|16530516|P2|Overall Study|Withdrawal by Subject|7
4792874|NCT01372150|16530517|P1|Overall Study|Withdrawal by Subject|2
4792875|NCT01372150|16530515|P3|Overall Study|Protocol Violation|3
4792876|NCT01372150|16530516|P2|Overall Study|Protocol Violation|0
4792877|NCT01372150|16530517|P1|Overall Study|Protocol Violation|1
4792878|NCT01372150|16530515|P3|Overall Study|Lost to Follow-up|6
4792879|NCT01372150|16530516|P2|Overall Study|Lost to Follow-up|5
4792880|NCT01372150|16530517|P1|Overall Study|Lost to Follow-up|4
4792881|NCT01372150|16530515|P3|Overall Study|Lack of Efficacy|1
4792882|NCT01372150|16530516|P2|Overall Study|Lack of Efficacy|0
4792883|NCT01372150|16530517|P1|Overall Study|Lack of Efficacy|3
4792884|NCT01372085|16530544|P10|Washout Period 3|Withdrawal by Subject|0
4792885|NCT01372085|16530545|P9|Washout Period 3|Withdrawal by Subject|0
4792886|NCT01372085|16530546|P8|Washout Period 3|Withdrawal by Subject|0
4792887|NCT01372085|16530547|P7|Washout Period 3|Withdrawal by Subject|0
4792888|NCT01372085|16530548|P6|Washout Period 3|Withdrawal by Subject|2
4792889|NCT01372085|16530549|P5|Washout Period 3|Withdrawal by Subject|0
4792890|NCT01372085|16530550|P4|Washout Period 3|Withdrawal by Subject|0
4792891|NCT01372085|16530551|P3|Washout Period 3|Withdrawal by Subject|0
4792892|NCT01372085|16530552|P2|Washout Period 3|Withdrawal by Subject|0
4792893|NCT01372085|16530553|P1|Washout Period 3|Withdrawal by Subject|0
4792894|NCT01372085|16530544|P10|Washout Period 2|Physician Decision|0
4792895|NCT01372085|16530545|P9|Washout Period 2|Physician Decision|0
4792896|NCT01372085|16530546|P8|Washout Period 2|Physician Decision|0
4792897|NCT01372085|16530547|P7|Washout Period 2|Physician Decision|0
4792898|NCT01372085|16530548|P6|Washout Period 2|Physician Decision|0
4792899|NCT01372085|16530549|P5|Washout Period 2|Physician Decision|1
4792900|NCT01372085|16530550|P4|Washout Period 2|Physician Decision|0
4792901|NCT01372085|16530551|P3|Washout Period 2|Physician Decision|0
4792902|NCT01372085|16530552|P2|Washout Period 2|Physician Decision|0
4792903|NCT01372085|16530553|P1|Washout Period 2|Physician Decision|0
4792904|NCT01371994|16530585|P2|Overall Study|Miscellaneous Reasons|4
4792905|NCT01371994|16530586|P1|Overall Study|Miscellaneous Reasons|6
4792906|NCT01371994|16530585|P2|Overall Study|Physician Decision|1
4792907|NCT01371994|16530586|P1|Overall Study|Physician Decision|1
4792908|NCT01371994|16530585|P2|Overall Study|Randomized but Never Received Study Drug|6
4792909|NCT01371994|16530586|P1|Overall Study|Randomized but Never Received Study Drug|6
4792910|NCT01371994|16530585|P2|Overall Study|Protocol Violation|17
4792911|NCT01371994|16530586|P1|Overall Study|Protocol Violation|24
4792912|NCT01371994|16530585|P2|Overall Study|Lost to Follow-up|1
4792913|NCT01371994|16530586|P1|Overall Study|Lost to Follow-up|1
4792914|NCT01371994|16530585|P2|Overall Study|Withdrawal by Subject|7
4792915|NCT01371994|16530586|P1|Overall Study|Withdrawal by Subject|13
4792916|NCT01371994|16530585|P2|Overall Study|Lack of Efficacy|0
4792917|NCT01371994|16530586|P1|Overall Study|Lack of Efficacy|3
4792918|NCT01371994|16530585|P2|Overall Study|Adverse Event|6
4792919|NCT01371994|16530586|P1|Overall Study|Adverse Event|3
4792920|NCT01371981|16530634|P6|Overall Study|Did not start treatment|2
4792921|NCT01371981|16530635|P5|Overall Study|Did not start treatment|0
4792922|NCT01371981|16530636|P4|Overall Study|Did not start treatment|0
4792923|NCT01371981|16530637|P3|Overall Study|Did not start treatment|0
4792924|NCT01371981|16530638|P2|Overall Study|Did not start treatment|3
4792925|NCT01371981|16530639|P1|Overall Study|Did not start treatment|2
4792926|NCT01371981|16530634|P6|Overall Study|Ineligible|4
4792927|NCT01371981|16530635|P5|Overall Study|Ineligible|0
4792928|NCT01371981|16530636|P4|Overall Study|Ineligible|0
4792929|NCT01371981|16530637|P3|Overall Study|Ineligible|0
4792930|NCT01371981|16530638|P2|Overall Study|Ineligible|13
4792931|NCT01371981|16530639|P1|Overall Study|Ineligible|19
4792932|NCT01371981|16530634|P6|Overall Study|Withdrawal by Subject|3
4792933|NCT01371981|16530635|P5|Overall Study|Withdrawal by Subject|10
4792934|NCT01371981|16530636|P4|Overall Study|Withdrawal by Subject|2
4792935|NCT01371981|16530637|P3|Overall Study|Withdrawal by Subject|1
4792936|NCT01371981|16530638|P2|Overall Study|Withdrawal by Subject|19
4792937|NCT01371981|16530639|P1|Overall Study|Withdrawal by Subject|12
4792938|NCT01371981|16530634|P6|Overall Study|Physician Decision|3
4792939|NCT01371981|16530635|P5|Overall Study|Physician Decision|14
4792940|NCT01371981|16530636|P4|Overall Study|Physician Decision|7
4792941|NCT01371981|16530637|P3|Overall Study|Physician Decision|1
4792942|NCT01371981|16530638|P2|Overall Study|Physician Decision|63
4792943|NCT01371981|16530639|P1|Overall Study|Physician Decision|48
4792944|NCT01371981|16530634|P6|Overall Study|Lack of Efficacy|0
4792945|NCT01371981|16530635|P5|Overall Study|Lack of Efficacy|5
4792946|NCT01371981|16530636|P4|Overall Study|Lack of Efficacy|8
4792947|NCT01371981|16530637|P3|Overall Study|Lack of Efficacy|4
4792948|NCT01371981|16530638|P2|Overall Study|Lack of Efficacy|61
4792949|NCT01371981|16530639|P1|Overall Study|Lack of Efficacy|69
4792950|NCT01371981|16530634|P6|Overall Study|Death|2
4792951|NCT01371981|16530635|P5|Overall Study|Death|2
4792952|NCT01371981|16530636|P4|Overall Study|Death|0
4792953|NCT01371981|16530637|P3|Overall Study|Death|0
4792954|NCT01371981|16530638|P2|Overall Study|Death|16
4792955|NCT01371981|16530639|P1|Overall Study|Death|22
4792956|NCT01371981|16530634|P6|Overall Study|Adverse Event|0
4792957|NCT01371981|16530635|P5|Overall Study|Adverse Event|1
4792958|NCT01371981|16530636|P4|Overall Study|Adverse Event|4
4792959|NCT01371981|16530637|P3|Overall Study|Adverse Event|0
4792960|NCT01371981|16530638|P2|Overall Study|Adverse Event|17
4792961|NCT01371981|16530639|P1|Overall Study|Adverse Event|12
4792962|NCT01371877|16530698|P2|Overall Study|3 for unknown reasons and 1 pregnant|4
4792963|NCT01371877|16530699|P1|Overall Study|3 for unknown reasons and 1 pregnant|0
4792964|NCT01371851|16530711|P2|Overall Study|Blood Pressure outside study parameters|0
4792965|NCT01371851|16530712|P1|Overall Study|Blood Pressure outside study parameters|2
4792966|NCT01371851|16530711|P2|Overall Study|non study related adverse event|0
4792967|NCT01371851|16530712|P1|Overall Study|non study related adverse event|1
4792968|NCT01371851|16530711|P2|Overall Study|was arrested and put in jail|1
4792969|NCT01371851|16530712|P1|Overall Study|was arrested and put in jail|0
4792970|NCT01371851|16530711|P2|Overall Study|Lost to Follow-up|8
4792971|NCT01371851|16530712|P1|Overall Study|Lost to Follow-up|5
4792972|NCT01371838|16530720|P2|Overall Study|Surgery|0
4792973|NCT01371838|16530721|P1|Overall Study|Surgery|1
4792974|NCT01371838|16530720|P2|Overall Study|Lack of therapeutic response|1
4792975|NCT01371838|16530721|P1|Overall Study|Lack of therapeutic response|0
4792976|NCT01371838|16530720|P2|Overall Study|Last follow-up visit not conducted|0
4792977|NCT01371838|16530721|P1|Overall Study|Last follow-up visit not conducted|2
4792978|NCT01371838|16530720|P2|Overall Study|Investigator Decision|8
4792979|NCT01371838|16530721|P1|Overall Study|Investigator Decision|3
4792980|NCT01371838|16530720|P2|Overall Study|Protocol Violation|0
4792981|NCT01371838|16530721|P1|Overall Study|Protocol Violation|3
4792982|NCT01371838|16530720|P2|Overall Study|Death|4
4792983|NCT01371838|16530721|P1|Overall Study|Death|3
4792984|NCT01371838|16530720|P2|Overall Study|Lost to Follow-up|20
4792985|NCT01371838|16530721|P1|Overall Study|Lost to Follow-up|10
4792986|NCT01371838|16530720|P2|Overall Study|Withdrawal by Subject|33
4792987|NCT01371838|16530721|P1|Overall Study|Withdrawal by Subject|27
4792988|NCT01371825|16530757|P1|Overall Study|Death|4
4792989|NCT01371747|16530791|P6|Overall Study|Other Reasons|1
4792990|NCT01371747|16530792|P5|Overall Study|Other Reasons|0
4792991|NCT01371747|16530793|P4|Overall Study|Other Reasons|0
4792992|NCT01371747|16530794|P3|Overall Study|Other Reasons|2
4792993|NCT01371747|16530795|P2|Overall Study|Other Reasons|1
4792994|NCT01371747|16530796|P1|Overall Study|Other Reasons|2
4792995|NCT01371747|16530791|P6|Overall Study|Withdrawal by Subject|4
4792996|NCT01371747|16530792|P5|Overall Study|Withdrawal by Subject|2
4792997|NCT01371747|16530793|P4|Overall Study|Withdrawal by Subject|2
4792998|NCT01371747|16530794|P3|Overall Study|Withdrawal by Subject|5
4792999|NCT01371747|16530795|P2|Overall Study|Withdrawal by Subject|12
4793000|NCT01371747|16530796|P1|Overall Study|Withdrawal by Subject|6
4793001|NCT01371747|16530791|P6|Overall Study|Physician Decision|0
4793002|NCT01371747|16530792|P5|Overall Study|Physician Decision|1
4793003|NCT01371747|16530793|P4|Overall Study|Physician Decision|0
4793004|NCT01371747|16530794|P3|Overall Study|Physician Decision|0
4793005|NCT01371747|16530795|P2|Overall Study|Physician Decision|0
4793006|NCT01371747|16530796|P1|Overall Study|Physician Decision|0
4793007|NCT01371747|16530791|P6|Overall Study|Non-Compliance|1
4793008|NCT01371747|16530792|P5|Overall Study|Non-Compliance|0
4793009|NCT01371747|16530793|P4|Overall Study|Non-Compliance|0
4793010|NCT01371747|16530794|P3|Overall Study|Non-Compliance|3
4793011|NCT01371747|16530795|P2|Overall Study|Non-Compliance|4
4793012|NCT01371747|16530796|P1|Overall Study|Non-Compliance|3
4793013|NCT01371747|16530791|P6|Overall Study|Protocol Violation|0
4793014|NCT01371747|16530792|P5|Overall Study|Protocol Violation|0
4793015|NCT01371747|16530793|P4|Overall Study|Protocol Violation|0
4793016|NCT01371747|16530794|P3|Overall Study|Protocol Violation|1
4793017|NCT01371747|16530795|P2|Overall Study|Protocol Violation|0
4793018|NCT01371747|16530796|P1|Overall Study|Protocol Violation|0
4793019|NCT01371747|16530791|P6|Overall Study|Low Serum Potassium Results|3
4793020|NCT01371747|16530792|P5|Overall Study|Low Serum Potassium Results|0
4793021|NCT01371747|16530793|P4|Overall Study|Low Serum Potassium Results|1
4793022|NCT01371747|16530794|P3|Overall Study|Low Serum Potassium Results|1
4793023|NCT01371747|16530795|P2|Overall Study|Low Serum Potassium Results|1
4793024|NCT01371747|16530796|P1|Overall Study|Low Serum Potassium Results|1
4793025|NCT01371747|16530791|P6|Overall Study|High Serum Potassium Results|2
4793026|NCT01371747|16530792|P5|Overall Study|High Serum Potassium Results|0
4793027|NCT01371747|16530793|P4|Overall Study|High Serum Potassium Results|2
4793028|NCT01371747|16530794|P3|Overall Study|High Serum Potassium Results|1
4793029|NCT01371747|16530795|P2|Overall Study|High Serum Potassium Results|1
4793030|NCT01371747|16530796|P1|Overall Study|High Serum Potassium Results|1
4793031|NCT01371747|16530791|P6|Overall Study|Abnormal Renal Function|1
4793032|NCT01371747|16530792|P5|Overall Study|Abnormal Renal Function|0
4793033|NCT01371747|16530793|P4|Overall Study|Abnormal Renal Function|1
4793034|NCT01371747|16530794|P3|Overall Study|Abnormal Renal Function|0
4793035|NCT01371747|16530795|P2|Overall Study|Abnormal Renal Function|2
4793036|NCT01371747|16530796|P1|Overall Study|Abnormal Renal Function|0
4793037|NCT01371747|16530791|P6|Overall Study|Death|0
4793038|NCT01371747|16530792|P5|Overall Study|Death|2
4793039|NCT01371747|16530793|P4|Overall Study|Death|1
4793040|NCT01371747|16530794|P3|Overall Study|Death|4
4793041|NCT01371747|16530795|P2|Overall Study|Death|0
4793042|NCT01371747|16530796|P1|Overall Study|Death|1
4793043|NCT01371747|16530791|P6|Overall Study|Adverse Event|2
4793044|NCT01371747|16530792|P5|Overall Study|Adverse Event|2
4793045|NCT01371747|16530793|P4|Overall Study|Adverse Event|2
4793046|NCT01371747|16530794|P3|Overall Study|Adverse Event|7
4793047|NCT01371747|16530795|P2|Overall Study|Adverse Event|2
4793048|NCT01371747|16530796|P1|Overall Study|Adverse Event|4
4793049|NCT01371734|16530861|P3|Overall Study|Lack of Efficacy|0
4793050|NCT01371734|16530862|P2|Overall Study|Lack of Efficacy|2
4793051|NCT01371734|16530863|P1|Overall Study|Lack of Efficacy|2
4793052|NCT01371734|16530861|P3|Overall Study|Adverse Event|3
4793053|NCT01371734|16530862|P2|Overall Study|Adverse Event|8
4793054|NCT01371734|16530863|P1|Overall Study|Adverse Event|8
4793055|NCT01371734|16530861|P3|Overall Study|Protocol Violation|2
4793056|NCT01371734|16530862|P2|Overall Study|Protocol Violation|1
4793057|NCT01371734|16530863|P1|Overall Study|Protocol Violation|3
4793058|NCT01371734|16530861|P3|Overall Study|Lost to Follow-up|1
4793059|NCT01371734|16530862|P2|Overall Study|Lost to Follow-up|3
4793060|NCT01371734|16530863|P1|Overall Study|Lost to Follow-up|5
4793061|NCT01371734|16530861|P3|Overall Study|Withdrawal by Subject|9
4793062|NCT01371734|16530862|P2|Overall Study|Withdrawal by Subject|4
4793063|NCT01371734|16530863|P1|Overall Study|Withdrawal by Subject|3
4793064|NCT01371734|16530861|P3|Overall Study|Other|2
4793065|NCT01371734|16530862|P2|Overall Study|Other|1
4793066|NCT01371734|16530863|P1|Overall Study|Other|2
4793067|NCT01371721|16530883|P3|Overall Study|Randomized but not treated|0
4793068|NCT01371721|16530884|P2|Overall Study|Randomized but not treated|0
4793069|NCT01371721|16530885|P1|Overall Study|Randomized but not treated|1
4793070|NCT01371721|16530883|P3|Overall Study|Lack of Efficacy|3
4793071|NCT01371721|16530884|P2|Overall Study|Lack of Efficacy|4
4793072|NCT01371721|16530885|P1|Overall Study|Lack of Efficacy|2
4793073|NCT01371721|16530883|P3|Overall Study|Other|0
4793074|NCT01371721|16530884|P2|Overall Study|Other|3
4793075|NCT01371721|16530885|P1|Overall Study|Other|2
4793076|NCT01371721|16530883|P3|Overall Study|Withdrawal by Subject|11
4793077|NCT01371721|16530884|P2|Overall Study|Withdrawal by Subject|7
4793078|NCT01371721|16530885|P1|Overall Study|Withdrawal by Subject|5
4793079|NCT01371721|16530883|P3|Overall Study|Lost to Follow-up|6
4793080|NCT01371721|16530884|P2|Overall Study|Lost to Follow-up|2
4793081|NCT01371721|16530885|P1|Overall Study|Lost to Follow-up|8
4793082|NCT01371721|16530883|P3|Overall Study|Protocol Violation|5
4793083|NCT01371721|16530884|P2|Overall Study|Protocol Violation|4
4793084|NCT01371721|16530885|P1|Overall Study|Protocol Violation|6
4793085|NCT01371721|16530883|P3|Overall Study|Adverse Event|5
4793086|NCT01371721|16530884|P2|Overall Study|Adverse Event|4
4793087|NCT01371721|16530885|P1|Overall Study|Adverse Event|5
4793088|NCT01371708|16530918|P3|Overall Study|Started but did not receive treatment|1
4793089|NCT01371708|16530919|P2|Overall Study|Started but did not receive treatment|0
4793090|NCT01371708|16530920|P1|Overall Study|Started but did not receive treatment|1
4793091|NCT01371708|16530918|P3|Overall Study|Adverse Event|12
4793092|NCT01371708|16530919|P2|Overall Study|Adverse Event|8
4793093|NCT01371708|16530920|P1|Overall Study|Adverse Event|5
4793094|NCT01371708|16530918|P3|Overall Study|Other|4
4793095|NCT01371708|16530919|P2|Overall Study|Other|2
4793096|NCT01371708|16530920|P1|Overall Study|Other|3
4793097|NCT01371708|16530918|P3|Overall Study|Medication error/not related to AE|0
4793098|NCT01371708|16530919|P2|Overall Study|Medication error/not related to AE|1
4793099|NCT01371708|16530920|P1|Overall Study|Medication error/not related to AE|0
4793100|NCT01371708|16530918|P3|Overall Study|No longer willing to participate|13
4793101|NCT01371708|16530919|P2|Overall Study|No longer willing to participate|7
4793102|NCT01371708|16530920|P1|Overall Study|No longer willing to participate|7
4793103|NCT01371708|16530918|P3|Overall Study|Protocol Violation|2
4793104|NCT01371708|16530919|P2|Overall Study|Protocol Violation|1
4793105|NCT01371708|16530920|P1|Overall Study|Protocol Violation|2
4793106|NCT01371708|16530918|P3|Overall Study|Lost to Follow-up|7
4793107|NCT01371708|16530919|P2|Overall Study|Lost to Follow-up|9
4793108|NCT01371708|16530920|P1|Overall Study|Lost to Follow-up|5
4793109|NCT01371708|16530918|P3|Overall Study|Insufficient clinical response|0
4793110|NCT01371708|16530919|P2|Overall Study|Insufficient clinical response|2
4793111|NCT01371708|16530920|P1|Overall Study|Insufficient clinical response|3
4793112|NCT01371656|16530952|P2|Overall Study|Ineligible|3
4793113|NCT01371656|16530953|P1|Overall Study|Ineligible|4
4793114|NCT01371656|16530952|P2|Overall Study|Withdrawal by Subject|0
4793115|NCT01371656|16530953|P1|Overall Study|Withdrawal by Subject|7
4793116|NCT01371656|16530952|P2|Overall Study|Physician Decision|7
4793117|NCT01371656|16530953|P1|Overall Study|Physician Decision|46
4793118|NCT01371656|16530952|P2|Overall Study|Death|4
4793119|NCT01371656|16530953|P1|Overall Study|Death|7
4793120|NCT01371643|16530973|P2|Overall Study|Withdrawal by Subject|0
4793121|NCT01371643|16530974|P1|Overall Study|Withdrawal by Subject|3
4793122|NCT01371565|16530984|P1|Overall Study|Resection of neuroendocrine tumor|1
4793123|NCT01371565|16530984|P1|Overall Study|Death|1
4793124|NCT01371565|16530984|P1|Overall Study|Withdrawal by Subject|1
4793125|NCT01371552|16530988|P6|Part 1, First 3 Days|Inconvenience|0
4793126|NCT01371552|16530989|P5|Part 1, First 3 Days|Inconvenience|0
4793127|NCT01371552|16530990|P4|Part 1, First 3 Days|Inconvenience|0
4793128|NCT01371552|16530991|P3|Part 1, First 3 Days|Inconvenience|1
4793129|NCT01371552|16530992|P2|Part 1, First 3 Days|Inconvenience|0
4793130|NCT01371552|16530993|P1|Part 1, First 3 Days|Inconvenience|0
4793131|NCT01371539|16531020|P2|Period Two: One Week|Time/job conflict|1
4793132|NCT01371539|16531021|P1|Period Two: One Week|Time/job conflict|0
4793133|NCT01371539|16531020|P2|Period Two: One Week|Unacceptable Objective Visual Acuity|1
4793134|NCT01371539|16531021|P1|Period Two: One Week|Unacceptable Objective Visual Acuity|0
4793135|NCT01371539|16531020|P2|Period Two: One Week|Lost to Follow-up|1
4793136|NCT01371539|16531021|P1|Period Two: One Week|Lost to Follow-up|0
4793137|NCT01371539|16531020|P2|Period One: One Week|Lost to Follow-up|1
4793138|NCT01371539|16531021|P1|Period One: One Week|Lost to Follow-up|0
4793139|NCT01371305|16531035|P6|Overall Study|Subject request|1
4793140|NCT01371305|16531036|P5|Overall Study|Subject request|0
4793141|NCT01371305|16531037|P4|Overall Study|Subject request|0
4793142|NCT01371305|16531038|P3|Overall Study|Subject request|0
4793143|NCT01371305|16531039|P2|Overall Study|Subject request|0
4793144|NCT01371305|16531040|P1|Overall Study|Subject request|0
4793145|NCT01371305|16531035|P6|Overall Study|Study terminated by sponsor|1
4793146|NCT01371305|16531036|P5|Overall Study|Study terminated by sponsor|3
4793147|NCT01371305|16531037|P4|Overall Study|Study terminated by sponsor|0
4793148|NCT01371305|16531038|P3|Overall Study|Study terminated by sponsor|0
4793149|NCT01371305|16531039|P2|Overall Study|Study terminated by sponsor|0
4793150|NCT01371305|16531040|P1|Overall Study|Study terminated by sponsor|0
4793151|NCT01371305|16531035|P6|Overall Study|Adverse Event|0
4793152|NCT01371305|16531036|P5|Overall Study|Adverse Event|1
4793153|NCT01371305|16531037|P4|Overall Study|Adverse Event|2
4793154|NCT01371305|16531038|P3|Overall Study|Adverse Event|0
4793155|NCT01371305|16531039|P2|Overall Study|Adverse Event|0
4793156|NCT01371305|16531040|P1|Overall Study|Adverse Event|0
4793157|NCT01371006|16531124|P2|Overall Study|Adverse Event|0
4793158|NCT01371006|16531125|P1|Overall Study|Adverse Event|1
4793159|NCT01370863|16531166|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
4793160|NCT01370863|16531167|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
4793161|NCT01370863|16531166|P2|Overall Study|Did not want second pH/MII monitoring|1
4793162|NCT01370863|16531167|P1|Overall Study|Did not want second pH/MII monitoring|1
4793163|NCT01370863|16531166|P2|Overall Study|Adverse Event|1
4793164|NCT01370863|16531167|P1|Overall Study|Adverse Event|1
4793165|NCT01370733|16531192|P2|Overall Study|Protocol Violation|3
4793166|NCT01370733|16531193|P1|Overall Study|Protocol Violation|1
4793167|NCT01370733|16531192|P2|Overall Study|Physician Decision|2
4793168|NCT01370733|16531193|P1|Overall Study|Physician Decision|0
4793169|NCT01370733|16531192|P2|Overall Study|Lack of Efficacy|5
4793170|NCT01370733|16531193|P1|Overall Study|Lack of Efficacy|3
4793171|NCT01370733|16531192|P2|Overall Study|Adverse Event|4
4793172|NCT01370733|16531193|P1|Overall Study|Adverse Event|2
4793173|NCT01370733|16531192|P2|Overall Study|Lost to Follow-up|0
4793174|NCT01370733|16531193|P1|Overall Study|Lost to Follow-up|3
4793175|NCT01370733|16531192|P2|Overall Study|Withdrawal by Subject|8
4793176|NCT01370733|16531193|P1|Overall Study|Withdrawal by Subject|8
4793177|NCT01370694|16531215|P1|Overall Study|Progressive disease|2
4793178|NCT01370694|16531215|P1|Overall Study|Switched to rituximab|4
4793179|NCT01370655|16531237|P12|Period 2|Withdrawal by Subject|0
4793180|NCT01370655|16531238|P11|Period 2|Withdrawal by Subject|0
4793181|NCT01370655|16531239|P10|Period 2|Withdrawal by Subject|0
4793182|NCT01370655|16531240|P9|Period 2|Withdrawal by Subject|1
4793183|NCT01370655|16531241|P8|Period 2|Withdrawal by Subject|0
4793184|NCT01370655|16531242|P7|Period 2|Withdrawal by Subject|0
4793185|NCT01370655|16531243|P6|Period 2|Withdrawal by Subject|0
4793186|NCT01370655|16531244|P5|Period 2|Withdrawal by Subject|0
4793187|NCT01370655|16531245|P4|Period 2|Withdrawal by Subject|0
4793188|NCT01370655|16531246|P3|Period 2|Withdrawal by Subject|0
4793189|NCT01370655|16531247|P2|Period 2|Withdrawal by Subject|0
4793190|NCT01370655|16531248|P1|Period 2|Withdrawal by Subject|0
4793191|NCT01370655|16531237|P12|Period 2|met protocol specified stopping criteria|0
4793192|NCT01370655|16531238|P11|Period 2|met protocol specified stopping criteria|1
4793193|NCT01370655|16531239|P10|Period 2|met protocol specified stopping criteria|0
4793194|NCT01370655|16531240|P9|Period 2|met protocol specified stopping criteria|1
4793195|NCT01370655|16531241|P8|Period 2|met protocol specified stopping criteria|0
4793196|NCT01370655|16531242|P7|Period 2|met protocol specified stopping criteria|1
4793197|NCT01370655|16531243|P6|Period 2|met protocol specified stopping criteria|0
4793198|NCT01370655|16531244|P5|Period 2|met protocol specified stopping criteria|0
4793199|NCT01370655|16531245|P4|Period 2|met protocol specified stopping criteria|0
4793200|NCT01370655|16531246|P3|Period 2|met protocol specified stopping criteria|1
4793201|NCT01370655|16531247|P2|Period 2|met protocol specified stopping criteria|0
4793202|NCT01370655|16531248|P1|Period 2|met protocol specified stopping criteria|0
4793203|NCT01370655|16531237|P12|Period 2|Adverse Event|0
4793204|NCT01370655|16531238|P11|Period 2|Adverse Event|0
4793205|NCT01370655|16531239|P10|Period 2|Adverse Event|0
4793206|NCT01370655|16531240|P9|Period 2|Adverse Event|0
4793207|NCT01370655|16531241|P8|Period 2|Adverse Event|1
4793208|NCT01370655|16531242|P7|Period 2|Adverse Event|0
4793209|NCT01370655|16531243|P6|Period 2|Adverse Event|0
4793210|NCT01370655|16531244|P5|Period 2|Adverse Event|1
4793211|NCT01370655|16531245|P4|Period 2|Adverse Event|0
4793212|NCT01370655|16531246|P3|Period 2|Adverse Event|1
4793213|NCT01370655|16531247|P2|Period 2|Adverse Event|0
4793214|NCT01370655|16531248|P1|Period 2|Adverse Event|0
4793215|NCT01370655|16531237|P12|Period 1|Adverse Event|0
4793216|NCT01370655|16531238|P11|Period 1|Adverse Event|0
4793217|NCT01370655|16531239|P10|Period 1|Adverse Event|0
4793218|NCT01370655|16531240|P9|Period 1|Adverse Event|0
4793219|NCT01370655|16531241|P8|Period 1|Adverse Event|0
4793220|NCT01370655|16531242|P7|Period 1|Adverse Event|1
4793221|NCT01370655|16531243|P6|Period 1|Adverse Event|0
4793222|NCT01370655|16531244|P5|Period 1|Adverse Event|0
4793223|NCT01370655|16531245|P4|Period 1|Adverse Event|0
4793224|NCT01370655|16531246|P3|Period 1|Adverse Event|0
4793225|NCT01370655|16531247|P2|Period 1|Adverse Event|0
4793226|NCT01370655|16531248|P1|Period 1|Adverse Event|2
4793227|NCT01370642|16531285|P3|Overall Study|Withdrawal by Subject|3
4793228|NCT01370642|16531286|P2|Overall Study|Withdrawal by Subject|4
4793229|NCT01370642|16531287|P1|Overall Study|Withdrawal by Subject|2
4793230|NCT01370642|16531285|P3|Overall Study|Physician Decision|2
4793231|NCT01370642|16531286|P2|Overall Study|Physician Decision|1
4793232|NCT01370642|16531287|P1|Overall Study|Physician Decision|4
4793233|NCT01370642|16531285|P3|Overall Study|Lost to Follow-up|1
4793234|NCT01370642|16531286|P2|Overall Study|Lost to Follow-up|0
4793235|NCT01370642|16531287|P1|Overall Study|Lost to Follow-up|0
4793236|NCT01370642|16531285|P3|Overall Study|Detectable HCV RNA|22
4793237|NCT01370642|16531286|P2|Overall Study|Detectable HCV RNA|0
4793238|NCT01370642|16531287|P1|Overall Study|Detectable HCV RNA|0
4793239|NCT01370642|16531285|P3|Overall Study|Adverse Event|1
4793240|NCT01370642|16531286|P2|Overall Study|Adverse Event|1
4793241|NCT01370642|16531287|P1|Overall Study|Adverse Event|2
4793242|NCT01370616|16531326|P2|Overall Study|Withdrawal by Subject|34
4793243|NCT01370616|16531327|P1|Overall Study|Withdrawal by Subject|34
4793244|NCT01370616|16531326|P2|Overall Study|Technical Problems|5
4793245|NCT01370616|16531327|P1|Overall Study|Technical Problems|3
4793246|NCT01370616|16531326|P2|Overall Study|Recovery|0
4793247|NCT01370616|16531327|P1|Overall Study|Recovery|1
4793248|NCT01370616|16531326|P2|Overall Study|Progressive Disease|1
4793249|NCT01370616|16531327|P1|Overall Study|Progressive Disease|0
4793250|NCT01370616|16531326|P2|Overall Study|Physician Decision|6
4793251|NCT01370616|16531327|P1|Overall Study|Physician Decision|6
4793252|NCT01370616|16531326|P2|Overall Study|Lost to Follow-up|3
4793253|NCT01370616|16531327|P1|Overall Study|Lost to Follow-up|0
4793254|NCT01370616|16531326|P2|Overall Study|Lack of Efficacy|2
4793255|NCT01370616|16531327|P1|Overall Study|Lack of Efficacy|6
4793256|NCT01370616|16531326|P2|Overall Study|Death|0
4793257|NCT01370616|16531327|P1|Overall Study|Death|1
4793258|NCT01370616|16531326|P2|Overall Study|Adverse Event|16
4793259|NCT01370616|16531327|P1|Overall Study|Adverse Event|11
4793260|NCT01370603|16531351|P2|Period 2|Withdrawal by Subject|0
4793261|NCT01370603|16531352|P1|Period 2|Withdrawal by Subject|1
4793262|NCT01370603|16531351|P2|Period 2|Lost to Follow-up|0
4793263|NCT01370603|16531352|P1|Period 2|Lost to Follow-up|1
4793264|NCT01370603|16531351|P2|Period 2|Adverse Event|4
4793265|NCT01370603|16531352|P1|Period 2|Adverse Event|1
4793266|NCT01370603|16531351|P2|Crossover Washout|Non-compliance with Study Drug|2
4793267|NCT01370603|16531352|P1|Crossover Washout|Non-compliance with Study Drug|0
4793268|NCT01370603|16531351|P2|Crossover Washout|Withdrawal by Subject|1
4793269|NCT01370603|16531352|P1|Crossover Washout|Withdrawal by Subject|4
4793270|NCT01370603|16531351|P2|Crossover Washout|Protocol Violation|0
4793271|NCT01370603|16531352|P1|Crossover Washout|Protocol Violation|1
4793272|NCT01370603|16531351|P2|Crossover Washout|Lost to Follow-up|0
4793273|NCT01370603|16531352|P1|Crossover Washout|Lost to Follow-up|2
4793274|NCT01370603|16531351|P2|Crossover Washout|Adverse Event|1
4793275|NCT01370603|16531352|P1|Crossover Washout|Adverse Event|2
4793276|NCT01370603|16531351|P2|Period 1|Withdrawal by Subject|5
4793277|NCT01370603|16531352|P1|Period 1|Withdrawal by Subject|5
4793278|NCT01370603|16531351|P2|Period 1|Protocol Violation|2
4793279|NCT01370603|16531352|P1|Period 1|Protocol Violation|2
4793280|NCT01370603|16531351|P2|Period 1|Lost to Follow-up|0
4793281|NCT01370603|16531352|P1|Period 1|Lost to Follow-up|2
4793282|NCT01370603|16531351|P2|Period 1|Adverse Event|3
4793283|NCT01370603|16531352|P1|Period 1|Adverse Event|5
4793284|NCT01370590|16531370|P2|Period 2|Withdrawal by Subject|1
4793285|NCT01370590|16531371|P1|Period 2|Withdrawal by Subject|1
4793286|NCT01370590|16531370|P2|Period 2|Adverse Event|1
4793287|NCT01370590|16531371|P1|Period 2|Adverse Event|0
4793288|NCT01370590|16531370|P2|Crossover Washout Period|Withdrawal by Subject|2
4793289|NCT01370590|16531371|P1|Crossover Washout Period|Withdrawal by Subject|2
4793290|NCT01370590|16531370|P2|Crossover Washout Period|Non-compliance with Study Drug|0
4793291|NCT01370590|16531371|P1|Crossover Washout Period|Non-compliance with Study Drug|1
4793292|NCT01370590|16531370|P2|Crossover Washout Period|Lost to Follow-up|0
4793293|NCT01370590|16531371|P1|Crossover Washout Period|Lost to Follow-up|2
4793294|NCT01370590|16531370|P2|Crossover Washout Period|Adverse Event|4
4793295|NCT01370590|16531371|P1|Crossover Washout Period|Adverse Event|1
4793296|NCT01370590|16531370|P2|Period 1|Could not access randomization system|1
4793297|NCT01370590|16531371|P1|Period 1|Could not access randomization system|0
4793298|NCT01370590|16531370|P2|Period 1|Withdrawal by Subject|2
4793299|NCT01370590|16531371|P1|Period 1|Withdrawal by Subject|4
4793300|NCT01370590|16531370|P2|Period 1|Protocol Violation|2
4793301|NCT01370590|16531371|P1|Period 1|Protocol Violation|2
4793302|NCT01370590|16531370|P2|Period 1|Lost to Follow-up|2
4793303|NCT01370590|16531371|P1|Period 1|Lost to Follow-up|2
4793304|NCT01370590|16531370|P2|Period 1|Adverse Event|4
4793305|NCT01370590|16531371|P1|Period 1|Adverse Event|8
4793306|NCT01370538|16531399|P2|Overall Study|Lost to follow up|10
4793307|NCT01370538|16531400|P1|Overall Study|Lost to follow up|6
4793308|NCT01370538|16531399|P2|Overall Study|Development of study specific withdrawal|1
4793309|NCT01370538|16531400|P1|Overall Study|Development of study specific withdrawal|1
4793310|NCT01370538|16531399|P2|Overall Study|Protocol Violation|5
4793311|NCT01370538|16531400|P1|Overall Study|Protocol Violation|8
4793312|NCT01370538|16531399|P2|Overall Study|Adverse Event|0
4793313|NCT01370538|16531400|P1|Overall Study|Adverse Event|1
4793314|NCT01370538|16531399|P2|Overall Study|Eligibility criteria not fulfilled|1
4793315|NCT01370538|16531400|P1|Overall Study|Eligibility criteria not fulfilled|0
4793316|NCT01370538|16531399|P2|Overall Study|Voluntary Discontinuation by Subject|2
4793317|NCT01370538|16531400|P1|Overall Study|Voluntary Discontinuation by Subject|3
4793318|NCT01370525|16531416|P2|Overall Study|Lost to follow up|6
4793319|NCT01370525|16531417|P1|Overall Study|Lost to follow up|2
4793320|NCT01370525|16531416|P2|Overall Study|Protocol Violation|1
4793321|NCT01370525|16531417|P1|Overall Study|Protocol Violation|2
4793322|NCT01370525|16531416|P2|Overall Study|Adverse Event|1
4793323|NCT01370525|16531417|P1|Overall Study|Adverse Event|0
4793324|NCT01370525|16531416|P2|Overall Study|Eligibility criteria not fulfilled|0
4793325|NCT01370525|16531417|P1|Overall Study|Eligibility criteria not fulfilled|2
4793326|NCT01370525|16531416|P2|Overall Study|Voluntary Discontinuation by Subject|3
4793327|NCT01370525|16531417|P1|Overall Study|Voluntary Discontinuation by Subject|2
4793328|NCT01370499|16531433|P2|Overall Study|Sponsor Decision|15
4793329|NCT01370499|16531434|P1|Overall Study|Sponsor Decision|41
4793330|NCT01370499|16531433|P2|Overall Study|Withdrawal by Subject|7
4793331|NCT01370499|16531434|P1|Overall Study|Withdrawal by Subject|18
4793332|NCT01370499|16531433|P2|Overall Study|Protocol Violation|4
4793333|NCT01370499|16531434|P1|Overall Study|Protocol Violation|5
4793334|NCT01370499|16531433|P2|Overall Study|Physician Decision|3
4793335|NCT01370499|16531434|P1|Overall Study|Physician Decision|3
4793336|NCT01370499|16531433|P2|Overall Study|Lost to Follow-up|1
4793337|NCT01370499|16531434|P1|Overall Study|Lost to Follow-up|2
4793338|NCT01370499|16531433|P2|Overall Study|Lack of Efficacy|2
4793339|NCT01370499|16531434|P1|Overall Study|Lack of Efficacy|4
4793340|NCT01370499|16531433|P2|Overall Study|Adverse Event|12
4793341|NCT01370499|16531434|P1|Overall Study|Adverse Event|38
4793342|NCT01370408|16531476|P1|Overall Study|treatment failure|9
4793343|NCT01370356|16531536|P2|Overall Study|AE Not Related to Study Drug|4
4793344|NCT01370356|16531537|P1|Overall Study|AE Not Related to Study Drug|1
4793345|NCT01370356|16531536|P2|Overall Study|Adverse event (AE) Related to Study Drug|9
4793346|NCT01370356|16531537|P1|Overall Study|Adverse event (AE) Related to Study Drug|12
4793347|NCT01370356|16531536|P2|Overall Study|Protocol Violation|3
4793348|NCT01370356|16531537|P1|Overall Study|Protocol Violation|3
4793349|NCT01370356|16531536|P2|Overall Study|Reason not specified|43
4793350|NCT01370356|16531537|P1|Overall Study|Reason not specified|39
4793351|NCT01370356|16531536|P2|Overall Study|Withdrawal by Subject|59
4793352|NCT01370356|16531537|P1|Overall Study|Withdrawal by Subject|54
4793353|NCT01370356|16531536|P2|Overall Study|Lost to Follow-up|81
4793354|NCT01370356|16531537|P1|Overall Study|Lost to Follow-up|76
4793355|NCT01370356|16531536|P2|Overall Study|Lack of Efficacy|28
4793356|NCT01370356|16531537|P1|Overall Study|Lack of Efficacy|6
4793357|NCT01370356|16531536|P2|Overall Study|Death|0
4793358|NCT01370356|16531537|P1|Overall Study|Death|1
4793359|NCT01370317|16531553|P2|Overall Study|Protocol deviation|1
4793360|NCT01370317|16531554|P1|Overall Study|Protocol deviation|0
4793361|NCT01370317|16531553|P2|Overall Study|Participant withdrew consent|0
4793362|NCT01370317|16531554|P1|Overall Study|Participant withdrew consent|1
4793363|NCT01370265|16531565|P2|First Intervention|Adverse Event|1
4793364|NCT01370265|16531566|P1|First Intervention|Adverse Event|1
4793365|NCT01370213|16531586|P3|Overall Study|Not evaluable|0
4793366|NCT01370213|16531587|P2|Overall Study|Not evaluable|2
4793367|NCT01370213|16531588|P1|Overall Study|Not evaluable|0
4793368|NCT01370213|16531586|P3|Overall Study|Early Death|0
4793369|NCT01370213|16531587|P2|Overall Study|Early Death|0
4793370|NCT01370213|16531588|P1|Overall Study|Early Death|1
4793371|NCT01370083|16531608|P2|Overall Study|Adverse Event|1
4793372|NCT01370083|16531609|P1|Overall Study|Adverse Event|0
4793373|NCT01370083|16531608|P2|Overall Study|Lost to Follow-up|0
4793374|NCT01370083|16531609|P1|Overall Study|Lost to Follow-up|2
4793375|NCT01370005|16531622|P3|Overall Study|Other reason not defined above|2
4793376|NCT01370005|16531623|P2|Overall Study|Other reason not defined above|0
4793377|NCT01370005|16531624|P1|Overall Study|Other reason not defined above|3
4793378|NCT01370005|16531622|P3|Overall Study|Patient refusal to continue,not due toAE|0
4793379|NCT01370005|16531623|P2|Overall Study|Patient refusal to continue,not due toAE|4
4793380|NCT01370005|16531624|P1|Overall Study|Patient refusal to continue,not due toAE|5
4793381|NCT01370005|16531622|P3|Overall Study|Lost to Follow-up|1
4793382|NCT01370005|16531623|P2|Overall Study|Lost to Follow-up|1
4793383|NCT01370005|16531624|P1|Overall Study|Lost to Follow-up|1
4793384|NCT01370005|16531622|P3|Overall Study|Non compliant with protocol|2
4793385|NCT01370005|16531623|P2|Overall Study|Non compliant with protocol|1
4793386|NCT01370005|16531624|P1|Overall Study|Non compliant with protocol|0
4793387|NCT01370005|16531622|P3|Overall Study|Lack of Efficacy|0
4793388|NCT01370005|16531623|P2|Overall Study|Lack of Efficacy|0
4793389|NCT01370005|16531624|P1|Overall Study|Lack of Efficacy|1
4793390|NCT01370005|16531622|P3|Overall Study|Adverse Event|6
4793391|NCT01370005|16531623|P2|Overall Study|Adverse Event|5
4793392|NCT01370005|16531624|P1|Overall Study|Adverse Event|5
4793393|NCT01370005|16531622|P3|Overall Study|Not treated|0
4793394|NCT01370005|16531623|P2|Overall Study|Not treated|0
4793395|NCT01370005|16531624|P1|Overall Study|Not treated|1
4793396|NCT01369849|16531706|P3|Overall Study|Ineligible after receiving treatment|0
4793397|NCT01369849|16531707|P2|Overall Study|Ineligible after receiving treatment|1
4793398|NCT01369849|16531708|P1|Overall Study|Ineligible after receiving treatment|0
4793399|NCT01369849|16531706|P3|Overall Study|Ineligible prior to treatment|1
4793400|NCT01369849|16531707|P2|Overall Study|Ineligible prior to treatment|0
4793401|NCT01369849|16531708|P1|Overall Study|Ineligible prior to treatment|0
4793402|NCT01369784|16531730|P1|Overall Study|Protocol Violation|12
4793403|NCT01369680|16531818|P4|Overall Study|Lost to Follow-up|2
4793404|NCT01369680|16531819|P3|Overall Study|Lost to Follow-up|1
4793405|NCT01369680|16531820|P2|Overall Study|Lost to Follow-up|0
4793406|NCT01369680|16531821|P1|Overall Study|Lost to Follow-up|0
4793407|NCT01369641|16531842|P1|Overall Study|Withdrawal by Subject|1
4793408|NCT01369615|16531848|P2|Overall Study|Lost to Follow-up|1
4793409|NCT01369615|16531849|P1|Overall Study|Lost to Follow-up|0
4793410|NCT01369615|16531848|P2|Overall Study|Withdrawal by Subject|1
4793411|NCT01369615|16531849|P1|Overall Study|Withdrawal by Subject|0
4793412|NCT01369511|16531859|P4|Overall Study|Withdrawal by Subject|6
4793413|NCT01369511|16531860|P3|Overall Study|Withdrawal by Subject|4
4793414|NCT01369511|16531861|P2|Overall Study|Withdrawal by Subject|6
4793415|NCT01369511|16531862|P1|Overall Study|Withdrawal by Subject|5
4793416|NCT01369511|16531859|P4|Overall Study|Sponsor decision|0
4793417|NCT01369511|16531860|P3|Overall Study|Sponsor decision|1
4793418|NCT01369511|16531861|P2|Overall Study|Sponsor decision|0
4793419|NCT01369511|16531862|P1|Overall Study|Sponsor decision|2
4793420|NCT01369511|16531859|P4|Overall Study|Physician Decision|0
4793421|NCT01369511|16531860|P3|Overall Study|Physician Decision|0
4793422|NCT01369511|16531861|P2|Overall Study|Physician Decision|4
4793423|NCT01369511|16531862|P1|Overall Study|Physician Decision|3
4793424|NCT01369511|16531859|P4|Overall Study|Protocol Violation|2
4793425|NCT01369511|16531860|P3|Overall Study|Protocol Violation|0
4793426|NCT01369511|16531861|P2|Overall Study|Protocol Violation|1
4793427|NCT01369511|16531862|P1|Overall Study|Protocol Violation|0
4793428|NCT01369511|16531859|P4|Overall Study|Lost to Follow-up|2
4793429|NCT01369511|16531860|P3|Overall Study|Lost to Follow-up|1
4793430|NCT01369511|16531861|P2|Overall Study|Lost to Follow-up|1
4793431|NCT01369511|16531862|P1|Overall Study|Lost to Follow-up|0
4793432|NCT01369511|16531859|P4|Overall Study|Entry criteria not met|1
4793433|NCT01369511|16531860|P3|Overall Study|Entry criteria not met|0
4793434|NCT01369511|16531861|P2|Overall Study|Entry criteria not met|0
4793435|NCT01369511|16531862|P1|Overall Study|Entry criteria not met|2
4793436|NCT01369511|16531859|P4|Overall Study|Adverse Event|0
4793437|NCT01369511|16531860|P3|Overall Study|Adverse Event|5
4793438|NCT01369511|16531861|P2|Overall Study|Adverse Event|1
4793439|NCT01369511|16531862|P1|Overall Study|Adverse Event|1
4793440|NCT01369498|16531880|P4|Overall Study|Disease Progression|1
4793441|NCT01369498|16531881|P3|Overall Study|Disease Progression|0
4793442|NCT01369498|16531882|P2|Overall Study|Disease Progression|0
4793443|NCT01369498|16531883|P1|Overall Study|Disease Progression|0
4793444|NCT01369498|16531880|P4|Overall Study|Unknown Reason|6
4793445|NCT01369498|16531881|P3|Overall Study|Unknown Reason|11
4793446|NCT01369498|16531882|P2|Overall Study|Unknown Reason|0
4793447|NCT01369498|16531883|P1|Overall Study|Unknown Reason|1
4793448|NCT01369498|16531880|P4|Overall Study|Investigator's Discretion|3
4793449|NCT01369498|16531881|P3|Overall Study|Investigator's Discretion|1
4793450|NCT01369498|16531882|P2|Overall Study|Investigator's Discretion|0
4793451|NCT01369498|16531883|P1|Overall Study|Investigator's Discretion|1
4793452|NCT01369498|16531880|P4|Overall Study|Death|0
4793453|NCT01369498|16531881|P3|Overall Study|Death|1
4793454|NCT01369498|16531882|P2|Overall Study|Death|0
4793455|NCT01369498|16531883|P1|Overall Study|Death|0
4793456|NCT01369498|16531880|P4|Overall Study|Withdrawal of Consent|1
4793457|NCT01369498|16531881|P3|Overall Study|Withdrawal of Consent|1
4793458|NCT01369498|16531882|P2|Overall Study|Withdrawal of Consent|1
4793459|NCT01369498|16531883|P1|Overall Study|Withdrawal of Consent|0
4793460|NCT01369498|16531880|P4|Overall Study|Adverse Event|1
4793461|NCT01369498|16531881|P3|Overall Study|Adverse Event|0
4793462|NCT01369498|16531882|P2|Overall Study|Adverse Event|2
4793463|NCT01369498|16531883|P1|Overall Study|Adverse Event|1
4793464|NCT01369498|16531880|P4|Overall Study|Lack of Efficacy|3
4793465|NCT01369498|16531881|P3|Overall Study|Lack of Efficacy|1
4793466|NCT01369498|16531882|P2|Overall Study|Lack of Efficacy|9
4793467|NCT01369498|16531883|P1|Overall Study|Lack of Efficacy|9
4793468|NCT01369485|16531915|P2|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3
4793469|NCT01369485|16531916|P1|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0
4793470|NCT01369485|16531915|P2|Open Label Phase (Week 12 to Month 12)|Death|1
4793471|NCT01369485|16531916|P1|Open Label Phase (Week 12 to Month 12)|Death|0
4793472|NCT01369485|16531915|P2|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20
4793473|NCT01369485|16531916|P1|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17
4793474|NCT01369485|16531915|P2|Open Label Phase (Week 12 to Month 12)|Physician Decision|4
4793475|NCT01369485|16531916|P1|Open Label Phase (Week 12 to Month 12)|Physician Decision|3
4793476|NCT01369485|16531915|P2|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3
4793477|NCT01369485|16531916|P1|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2
4793478|NCT01369485|16531915|P2|Open Label Phase (Week 12 to Month 12)|Adverse Event|9
4793479|NCT01369485|16531916|P1|Open Label Phase (Week 12 to Month 12)|Adverse Event|11
4793480|NCT01369485|16531915|P2|Randomized Phase (Day 0 to Week 12)|expired patches|0
4793481|NCT01369485|16531916|P1|Randomized Phase (Day 0 to Week 12)|expired patches|2
4793482|NCT01369485|16531915|P2|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4
4793483|NCT01369485|16531916|P1|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2
4793484|NCT01369485|16531915|P2|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8
4793485|NCT01369485|16531916|P1|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12
4793486|NCT01369485|16531915|P2|Randomized Phase (Day 0 to Week 12)|Adverse Event|5
4793487|NCT01369485|16531916|P1|Randomized Phase (Day 0 to Week 12)|Adverse Event|7
4793488|NCT01369433|16531958|P2|Overall Study|Progressive Disease|12
4793489|NCT01369433|16531959|P1|Overall Study|Progressive Disease|92
4793490|NCT01369433|16531958|P2|Overall Study|Investigator discretion|1
4793491|NCT01369433|16531959|P1|Overall Study|Investigator discretion|6
4793492|NCT01369433|16531958|P2|Overall Study|Death|0
4793493|NCT01369433|16531959|P1|Overall Study|Death|5
4793494|NCT01369433|16531958|P2|Overall Study|Lost to Follow-up|0
4793495|NCT01369433|16531959|P1|Overall Study|Lost to Follow-up|1
4793496|NCT01369433|16531958|P2|Overall Study|Study terminated by Sponsor|0
4793497|NCT01369433|16531959|P1|Overall Study|Study terminated by Sponsor|67
4793498|NCT01369433|16531958|P2|Overall Study|Withdrawal by Subject|2
4793499|NCT01369433|16531959|P1|Overall Study|Withdrawal by Subject|5
4793500|NCT01369433|16531958|P2|Overall Study|Non-compliance|0
4793501|NCT01369433|16531959|P1|Overall Study|Non-compliance|1
4793502|NCT01369433|16531958|P2|Overall Study|Required significant surgical procedure|0
4793503|NCT01369433|16531959|P1|Overall Study|Required significant surgical procedure|1
4793504|NCT01369433|16531958|P2|Overall Study|Adverse Event|1
4793505|NCT01369433|16531959|P1|Overall Study|Adverse Event|31
4793506|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Other|17
4793507|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Other|9
4793508|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Other|110
4793509|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Other|0
4793510|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Other|0
4793511|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Other|0
4793512|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Other|0
4793513|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Other|0
4793514|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Other|0
4793515|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Withdrawal by Subject|47
4793516|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Withdrawal by Subject|30
4793517|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Withdrawal by Subject|12
4793518|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4793519|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4793520|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4793521|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4793522|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4793523|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Withdrawal by Subject|0
4793524|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Lost to Follow-up|9
4793525|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Lost to Follow-up|5
4793526|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Lost to Follow-up|1
4793527|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4793528|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4793529|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4793530|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4793531|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4793532|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Lost to Follow-up|0
4793533|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Physician Decision|11
4793534|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Physician Decision|5
4793535|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Physician Decision|1
4793536|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Physician Decision|0
4793537|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Physician Decision|0
4793538|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Physician Decision|0
4793539|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Physician Decision|0
4793540|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Physician Decision|0
4793541|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Physician Decision|0
4793542|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Protocol Violation|2
4793543|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Protocol Violation|1
4793544|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Protocol Violation|0
4793545|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Protocol Violation|0
4793546|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Protocol Violation|0
4793547|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Protocol Violation|0
4793548|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Protocol Violation|0
4793549|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Protocol Violation|0
4793550|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Protocol Violation|0
4793551|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Lack of Efficacy|29
4793552|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Lack of Efficacy|26
4793553|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Lack of Efficacy|12
4793554|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4793555|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4793556|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4793557|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4793558|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4793559|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Lack of Efficacy|0
4793560|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Death|3
4793561|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Death|1
4793562|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Death|0
4793563|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Death|0
4793564|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Death|0
4793565|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Death|0
4793566|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Death|0
4793567|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Death|0
4793568|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Death|0
4793569|NCT01369355|16531971|P9|Long-term Extension (Week 44-272)|Adverse Event|53
4793570|NCT01369355|16531972|P8|Long-term Extension (Week 44-272)|Adverse Event|29
4793571|NCT01369355|16531973|P7|Long-term Extension (Week 44-272)|Adverse Event|15
4793572|NCT01369355|16531974|P6|Long-term Extension (Week 44-272)|Adverse Event|0
4793573|NCT01369355|16531975|P5|Long-term Extension (Week 44-272)|Adverse Event|0
4793574|NCT01369355|16531976|P4|Long-term Extension (Week 44-272)|Adverse Event|0
4793575|NCT01369355|16531977|P3|Long-term Extension (Week 44-272)|Adverse Event|0
4793576|NCT01369355|16531978|P2|Long-term Extension (Week 44-272)|Adverse Event|0
4793577|NCT01369355|16531979|P1|Long-term Extension (Week 44-272)|Adverse Event|0
4793578|NCT01369355|16531971|P9|Week 0 - Week 44 (Maintenance)|Other|0
4793579|NCT01369355|16531972|P8|Week 0 - Week 44 (Maintenance)|Other|0
4793580|NCT01369355|16531973|P7|Week 0 - Week 44 (Maintenance)|Other|0
4793581|NCT01369355|16531974|P6|Week 0 - Week 44 (Maintenance)|Other|0
4793582|NCT01369355|16531975|P5|Week 0 - Week 44 (Maintenance)|Other|1
4793583|NCT01369355|16531976|P4|Week 0 - Week 44 (Maintenance)|Other|0
4793584|NCT01369355|16531977|P3|Week 0 - Week 44 (Maintenance)|Other|1
4793585|NCT01369355|16531978|P2|Week 0 - Week 44 (Maintenance)|Other|0
4793586|NCT01369355|16531979|P1|Week 0 - Week 44 (Maintenance)|Other|0
4793587|NCT01369355|16531971|P9|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
4793588|NCT01369355|16531972|P8|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
4793589|NCT01369355|16531973|P7|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0
4793590|NCT01369355|16531974|P6|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22
4793591|NCT01369355|16531975|P5|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8
4793592|NCT01369355|16531976|P4|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
4793593|NCT01369355|16531977|P3|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7
4793594|NCT01369355|16531978|P2|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2
4793595|NCT01369355|16531979|P1|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6
4793596|NCT01369355|16531971|P9|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4793597|NCT01369355|16531972|P8|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4793598|NCT01369355|16531973|P7|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4793599|NCT01369355|16531974|P6|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6
4793600|NCT01369355|16531975|P5|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5
4793601|NCT01369355|16531976|P4|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2
4793602|NCT01369355|16531977|P3|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
4793603|NCT01369355|16531978|P2|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0
4793604|NCT01369355|16531979|P1|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1
4793605|NCT01369355|16531971|P9|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4793606|NCT01369355|16531972|P8|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4793607|NCT01369355|16531973|P7|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4793608|NCT01369355|16531974|P6|Week 0 - Week 44 (Maintenance)|Protocol Violation|2
4793609|NCT01369355|16531975|P5|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4793610|NCT01369355|16531976|P4|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4793611|NCT01369355|16531977|P3|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
4793612|NCT01369355|16531978|P2|Week 0 - Week 44 (Maintenance)|Protocol Violation|1
4793613|NCT01369355|16531979|P1|Week 0 - Week 44 (Maintenance)|Protocol Violation|0
4793614|NCT01369355|16531971|P9|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
4793615|NCT01369355|16531972|P8|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
4793616|NCT01369355|16531973|P7|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0
4793617|NCT01369355|16531974|P6|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217
4793618|NCT01369355|16531975|P5|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126
4793619|NCT01369355|16531976|P4|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
4793620|NCT01369355|16531977|P3|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
4793621|NCT01369355|16531978|P2|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14
4793622|NCT01369355|16531979|P1|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15
4793623|NCT01369355|16531971|P9|Week 0 - Week 44 (Maintenance)|Adverse Event|0
4793624|NCT01369355|16531972|P8|Week 0 - Week 44 (Maintenance)|Adverse Event|0
4793625|NCT01369355|16531973|P7|Week 0 - Week 44 (Maintenance)|Adverse Event|0
4793626|NCT01369355|16531974|P6|Week 0 - Week 44 (Maintenance)|Adverse Event|25
4793627|NCT01369355|16531975|P5|Week 0 - Week 44 (Maintenance)|Adverse Event|14
4793628|NCT01369355|16531976|P4|Week 0 - Week 44 (Maintenance)|Adverse Event|7
4793629|NCT01369355|16531977|P3|Week 0 - Week 44 (Maintenance)|Adverse Event|6
4793630|NCT01369355|16531978|P2|Week 0 - Week 44 (Maintenance)|Adverse Event|12
4793631|NCT01369355|16531979|P1|Week 0 - Week 44 (Maintenance)|Adverse Event|9
4793632|NCT01369342|16532011|P3|Overall Study|Not Treated|0
4793633|NCT01369342|16532012|P2|Overall Study|Not Treated|0
4793634|NCT01369342|16532013|P1|Overall Study|Not Treated|1
4793635|NCT01369342|16532011|P3|Overall Study|Lost to Follow-up|1
4793636|NCT01369342|16532012|P2|Overall Study|Lost to Follow-up|2
4793637|NCT01369342|16532013|P1|Overall Study|Lost to Follow-up|5
4793638|NCT01369342|16532011|P3|Overall Study|Withdrawal by Subject|2
4793639|NCT01369342|16532012|P2|Overall Study|Withdrawal by Subject|7
4793640|NCT01369342|16532013|P1|Overall Study|Withdrawal by Subject|7
4793641|NCT01369329|16532036|P3|Overall Study|Other|2
4793642|NCT01369329|16532037|P2|Overall Study|Other|3
4793643|NCT01369329|16532038|P1|Overall Study|Other|2
4793644|NCT01369329|16532036|P3|Overall Study|Lost to Follow-up|2
4793645|NCT01369329|16532037|P2|Overall Study|Lost to Follow-up|2
4793646|NCT01369329|16532038|P1|Overall Study|Lost to Follow-up|2
4793647|NCT01369329|16532036|P3|Overall Study|Withdrawal by Subject|10
4793648|NCT01369329|16532037|P2|Overall Study|Withdrawal by Subject|6
4793649|NCT01369329|16532038|P1|Overall Study|Withdrawal by Subject|8
4793650|NCT01369225|16532064|P6|Overall Study|Adverse Event|0
4793651|NCT01369225|16532065|P5|Overall Study|Adverse Event|1
4793652|NCT01369225|16532066|P4|Overall Study|Adverse Event|1
4793653|NCT01369225|16532067|P3|Overall Study|Adverse Event|0
4793654|NCT01369225|16532068|P2|Overall Study|Adverse Event|0
4793655|NCT01369225|16532069|P1|Overall Study|Adverse Event|0
4793656|NCT01369225|16532064|P6|Overall Study|Other|0
4793657|NCT01369225|16532065|P5|Overall Study|Other|1
4793658|NCT01369225|16532066|P4|Overall Study|Other|0
4793659|NCT01369225|16532067|P3|Overall Study|Other|0
4793660|NCT01369225|16532068|P2|Overall Study|Other|0
4793661|NCT01369225|16532069|P1|Overall Study|Other|1
4793662|NCT01369225|16532064|P6|Overall Study|Does Not Meet Entrance Criteria|0
4793663|NCT01369225|16532065|P5|Overall Study|Does Not Meet Entrance Criteria|0
4793664|NCT01369225|16532066|P4|Overall Study|Does Not Meet Entrance Criteria|0
4793665|NCT01369225|16532067|P3|Overall Study|Does Not Meet Entrance Criteria|1
4793666|NCT01369225|16532068|P2|Overall Study|Does Not Meet Entrance Criteria|0
4793667|NCT01369225|16532069|P1|Overall Study|Does Not Meet Entrance Criteria|0
4793668|NCT01369225|16532064|P6|Overall Study|Withdrawal by Subject|0
4793669|NCT01369225|16532065|P5|Overall Study|Withdrawal by Subject|0
4793670|NCT01369225|16532066|P4|Overall Study|Withdrawal by Subject|1
4793671|NCT01369225|16532067|P3|Overall Study|Withdrawal by Subject|2
4793672|NCT01369225|16532068|P2|Overall Study|Withdrawal by Subject|0
4793673|NCT01369225|16532069|P1|Overall Study|Withdrawal by Subject|1
4793674|NCT01369199|16532161|P1|Overall Study|Lost to Follow-up|2
4793675|NCT01369199|16532161|P1|Overall Study|Withdrawal by Subject|1
4793676|NCT01369069|16532192|P2|Overall Study|Withdrawal by Subject|7
4793677|NCT01369069|16532193|P1|Overall Study|Withdrawal by Subject|9
4793678|NCT01369069|16532192|P2|Overall Study|Lost to Follow-up|9
4793679|NCT01369069|16532193|P1|Overall Study|Lost to Follow-up|8
4793680|NCT01368965|16532215|P1|Overall Study|Lost to Follow-up|12
4793681|NCT01368900|16532224|P1|Overall Study|Lost to Follow-up|7
4793682|NCT01368835|16532299|P1|Overall Study|Lost to Follow-up|11
4793683|NCT01368835|16532299|P1|Overall Study|Inclusion criteria/photography quality|22
4793684|NCT01368614|16532338|P4|Study Period|Lost to Follow-up|0
4793685|NCT01368614|16532339|P3|Study Period|Lost to Follow-up|1
4793686|NCT01368614|16532340|P2|Study Period|Lost to Follow-up|0
4793687|NCT01368614|16532341|P1|Study Period|Lost to Follow-up|0
4793688|NCT01368614|16532338|P4|Study Period|Withdrawal by Subject|3
4793689|NCT01368614|16532339|P3|Study Period|Withdrawal by Subject|1
4793690|NCT01368614|16532340|P2|Study Period|Withdrawal by Subject|1
4793691|NCT01368614|16532341|P1|Study Period|Withdrawal by Subject|0
4793692|NCT01368614|16532338|P4|Screening Period|Screen Failure|0
4793693|NCT01368614|16532339|P3|Screening Period|Screen Failure|0
4793694|NCT01368614|16532340|P2|Screening Period|Screen Failure|0
4793695|NCT01368614|16532341|P1|Screening Period|Screen Failure|58
4793696|NCT01368562|16532394|P1|Overall Study|Other than specified|2
4793697|NCT01368562|16532394|P1|Overall Study|Other|3
4793698|NCT01368562|16532394|P1|Overall Study|Unresponsive to treatment|5
4793699|NCT01368562|16532394|P1|Overall Study|Death|6
4793700|NCT01368562|16532394|P1|Overall Study|Lost to Follow-up|1
4793701|NCT01368562|16532394|P1|Overall Study|Disease progression|1
4793702|NCT01368562|16532394|P1|Overall Study|Adverse Event|1
4793703|NCT01368536|16532401|P3|Overall Study|Protocol deviation|1
4793704|NCT01368536|16532402|P2|Overall Study|Protocol deviation|3
4793705|NCT01368536|16532403|P1|Overall Study|Protocol deviation|0
4793706|NCT01368536|16532401|P3|Overall Study|Administrative problems|35
4793707|NCT01368536|16532402|P2|Overall Study|Administrative problems|39
4793708|NCT01368536|16532403|P1|Overall Study|Administrative problems|34
4793709|NCT01368536|16532401|P3|Overall Study|Lost to Follow-up|5
4793710|NCT01368536|16532402|P2|Overall Study|Lost to Follow-up|3
4793711|NCT01368536|16532403|P1|Overall Study|Lost to Follow-up|3
4793712|NCT01368536|16532401|P3|Overall Study|Withdrawal by Subject|4
4793713|NCT01368536|16532402|P2|Overall Study|Withdrawal by Subject|5
4793714|NCT01368536|16532403|P1|Overall Study|Withdrawal by Subject|2
4793715|NCT01368536|16532401|P3|Overall Study|No longer required study medication|1
4793716|NCT01368536|16532402|P2|Overall Study|No longer required study medication|0
4793717|NCT01368536|16532403|P1|Overall Study|No longer required study medication|0
4793718|NCT01368536|16532401|P3|Overall Study|Unsatisfactory therapeutic effect|2
4793719|NCT01368536|16532402|P2|Overall Study|Unsatisfactory therapeutic effect|2
4793720|NCT01368536|16532403|P1|Overall Study|Unsatisfactory therapeutic effect|7
4793721|NCT01368536|16532401|P3|Overall Study|Abnormal test procedure result(s)|1
4793722|NCT01368536|16532402|P2|Overall Study|Abnormal test procedure result(s)|0
4793723|NCT01368536|16532403|P1|Overall Study|Abnormal test procedure result(s)|0
4793724|NCT01368536|16532401|P3|Overall Study|Abnormal laboratory value(s)|2
4793725|NCT01368536|16532402|P2|Overall Study|Abnormal laboratory value(s)|1
4793726|NCT01368536|16532403|P1|Overall Study|Abnormal laboratory value(s)|0
4793727|NCT01368536|16532401|P3|Overall Study|Adverse Event|8
4793728|NCT01368536|16532402|P2|Overall Study|Adverse Event|6
4793729|NCT01368536|16532403|P1|Overall Study|Adverse Event|5
4793730|NCT01368497|16532424|P1|Overall Study|Lost to Follow-up|2
4793731|NCT01368432|16532452|P2|Overall Study|Lost to Follow-up|1
4793732|NCT01368432|16532453|P1|Overall Study|Lost to Follow-up|0
4793733|NCT01368406|16532487|P2|Overall Study|started working|3
4793734|NCT01368406|16532488|P1|Overall Study|started working|2
4793735|NCT01368406|16532487|P2|Overall Study|relapse of the disease|2
4793736|NCT01368406|16532488|P1|Overall Study|relapse of the disease|3
4793737|NCT01368406|16532487|P2|Overall Study|Withdrawal by Subject|4
4793738|NCT01368406|16532488|P1|Overall Study|Withdrawal by Subject|8
4793739|NCT01368406|16532487|P2|Overall Study|Lost to Follow-up|4
4793740|NCT01368406|16532488|P1|Overall Study|Lost to Follow-up|8
4793741|NCT01368276|16532496|P2|Overall Study|Death|10
4793742|NCT01368276|16532497|P1|Overall Study|Death|1
4793743|NCT01368211|16532534|P2|Second Platelets Transfusion|No need for additional transfusion|2
4793744|NCT01368211|16532535|P1|Second Platelets Transfusion|No need for additional transfusion|1
4793745|NCT01368081|16532563|P13|Overall Study|Other reason not defined above|3
4793746|NCT01368081|16532564|P12|Overall Study|Other reason not defined above|0
4793747|NCT01368081|16532565|P11|Overall Study|Other reason not defined above|0
4793748|NCT01368081|16532566|P10|Overall Study|Other reason not defined above|1
4793749|NCT01368081|16532567|P9|Overall Study|Other reason not defined above|0
4793750|NCT01368081|16532568|P8|Overall Study|Other reason not defined above|0
4793751|NCT01368081|16532569|P7|Overall Study|Other reason not defined above|2
4793752|NCT01368081|16532570|P6|Overall Study|Other reason not defined above|1
4793753|NCT01368081|16532571|P5|Overall Study|Other reason not defined above|0
4793754|NCT01368081|16532572|P4|Overall Study|Other reason not defined above|1
4793755|NCT01368081|16532573|P3|Overall Study|Other reason not defined above|0
4793756|NCT01368081|16532574|P2|Overall Study|Other reason not defined above|0
4793757|NCT01368081|16532575|P1|Overall Study|Other reason not defined above|2
4793758|NCT01368081|16532563|P13|Overall Study|Withdrawal by Subject|0
4793759|NCT01368081|16532564|P12|Overall Study|Withdrawal by Subject|2
4793760|NCT01368081|16532565|P11|Overall Study|Withdrawal by Subject|3
4793761|NCT01368081|16532566|P10|Overall Study|Withdrawal by Subject|4
4793762|NCT01368081|16532567|P9|Overall Study|Withdrawal by Subject|5
4793763|NCT01368081|16532568|P8|Overall Study|Withdrawal by Subject|2
4793764|NCT01368081|16532569|P7|Overall Study|Withdrawal by Subject|4
4793765|NCT01368081|16532570|P6|Overall Study|Withdrawal by Subject|3
4793766|NCT01368081|16532571|P5|Overall Study|Withdrawal by Subject|0
4793767|NCT01368081|16532572|P4|Overall Study|Withdrawal by Subject|1
4793768|NCT01368081|16532573|P3|Overall Study|Withdrawal by Subject|1
4793769|NCT01368081|16532574|P2|Overall Study|Withdrawal by Subject|4
4793770|NCT01368081|16532575|P1|Overall Study|Withdrawal by Subject|4
4793771|NCT01368081|16532563|P13|Overall Study|Lost to Follow-up|1
4793772|NCT01368081|16532564|P12|Overall Study|Lost to Follow-up|0
4793773|NCT01368081|16532565|P11|Overall Study|Lost to Follow-up|0
4793774|NCT01368081|16532566|P10|Overall Study|Lost to Follow-up|0
4793775|NCT01368081|16532567|P9|Overall Study|Lost to Follow-up|0
4793776|NCT01368081|16532568|P8|Overall Study|Lost to Follow-up|0
4793777|NCT01368081|16532569|P7|Overall Study|Lost to Follow-up|0
4793778|NCT01368081|16532570|P6|Overall Study|Lost to Follow-up|0
4793779|NCT01368081|16532571|P5|Overall Study|Lost to Follow-up|0
4793780|NCT01368081|16532572|P4|Overall Study|Lost to Follow-up|0
4793781|NCT01368081|16532573|P3|Overall Study|Lost to Follow-up|0
4793782|NCT01368081|16532574|P2|Overall Study|Lost to Follow-up|0
4793783|NCT01368081|16532575|P1|Overall Study|Lost to Follow-up|0
4793784|NCT01368081|16532563|P13|Overall Study|Protocol Violation|0
4793785|NCT01368081|16532564|P12|Overall Study|Protocol Violation|0
4793786|NCT01368081|16532565|P11|Overall Study|Protocol Violation|0
4793787|NCT01368081|16532566|P10|Overall Study|Protocol Violation|0
4793788|NCT01368081|16532567|P9|Overall Study|Protocol Violation|0
4793789|NCT01368081|16532568|P8|Overall Study|Protocol Violation|1
4793790|NCT01368081|16532569|P7|Overall Study|Protocol Violation|0
4793791|NCT01368081|16532570|P6|Overall Study|Protocol Violation|1
4793792|NCT01368081|16532571|P5|Overall Study|Protocol Violation|0
4793793|NCT01368081|16532572|P4|Overall Study|Protocol Violation|0
4793794|NCT01368081|16532573|P3|Overall Study|Protocol Violation|0
4793795|NCT01368081|16532574|P2|Overall Study|Protocol Violation|0
4793796|NCT01368081|16532575|P1|Overall Study|Protocol Violation|0
4793797|NCT01368081|16532563|P13|Overall Study|Lack of Efficacy|0
4793798|NCT01368081|16532564|P12|Overall Study|Lack of Efficacy|0
4793799|NCT01368081|16532565|P11|Overall Study|Lack of Efficacy|0
4793800|NCT01368081|16532566|P10|Overall Study|Lack of Efficacy|0
4793801|NCT01368081|16532567|P9|Overall Study|Lack of Efficacy|0
4793802|NCT01368081|16532568|P8|Overall Study|Lack of Efficacy|2
4793803|NCT01368081|16532569|P7|Overall Study|Lack of Efficacy|0
4793804|NCT01368081|16532570|P6|Overall Study|Lack of Efficacy|0
4793805|NCT01368081|16532571|P5|Overall Study|Lack of Efficacy|0
4793806|NCT01368081|16532572|P4|Overall Study|Lack of Efficacy|1
4793807|NCT01368081|16532573|P3|Overall Study|Lack of Efficacy|0
4793808|NCT01368081|16532574|P2|Overall Study|Lack of Efficacy|1
4793809|NCT01368081|16532575|P1|Overall Study|Lack of Efficacy|0
4793810|NCT01368081|16532563|P13|Overall Study|Adverse Event|3
4793811|NCT01368081|16532564|P12|Overall Study|Adverse Event|1
4793812|NCT01368081|16532565|P11|Overall Study|Adverse Event|6
4793813|NCT01368081|16532566|P10|Overall Study|Adverse Event|5
4793814|NCT01368081|16532567|P9|Overall Study|Adverse Event|3
4793815|NCT01368081|16532568|P8|Overall Study|Adverse Event|2
4793816|NCT01368081|16532569|P7|Overall Study|Adverse Event|6
4793817|NCT01368081|16532570|P6|Overall Study|Adverse Event|5
4793818|NCT01368081|16532571|P5|Overall Study|Adverse Event|2
4793819|NCT01368081|16532572|P4|Overall Study|Adverse Event|2
4793820|NCT01368081|16532573|P3|Overall Study|Adverse Event|3
4793821|NCT01368081|16532574|P2|Overall Study|Adverse Event|4
4793822|NCT01368081|16532575|P1|Overall Study|Adverse Event|4
4793823|NCT01368042|16532629|P1|Overall Study|Transplanted|1
4793824|NCT01368042|16532629|P1|Overall Study|Lost to Follow-up|4
4793825|NCT01368042|16532629|P1|Overall Study|Protocol Violation|11
4793826|NCT01368042|16532629|P1|Overall Study|Death|14
4793827|NCT01367886|16532649|P1|Overall Study|Death|1
4793828|NCT01367886|16532649|P1|Overall Study|Lack of Efficacy|2
4793829|NCT01367886|16532649|P1|Overall Study|Lost to Follow-up|4
4793830|NCT01367847|16532699|P2|Overall Study|Withdrawal by Subject|2
4793831|NCT01367847|16532700|P1|Overall Study|Withdrawal by Subject|2
4793832|NCT01367834|16532716|P2|Overall Study|Study was ended.|1
4793833|NCT01367834|16532717|P1|Overall Study|Study was ended.|0
4793834|NCT01367834|16532716|P2|Overall Study|Withdrawal by Subject|2
4793835|NCT01367834|16532717|P1|Overall Study|Withdrawal by Subject|2
4793836|NCT01367704|16532741|P2|Overall Study|Lost to Follow-up|161
4793837|NCT01367704|16532742|P1|Overall Study|Lost to Follow-up|47
4793838|NCT01367665|16532754|P2|Overall Study|Not Done|14
4793839|NCT01367665|16532755|P1|Overall Study|Not Done|118
4793840|NCT01367665|16532754|P2|Overall Study|Lost to Follow-up|22
4793841|NCT01367665|16532755|P1|Overall Study|Lost to Follow-up|222
4793842|NCT01367665|16532754|P2|Overall Study|Death|19
4793843|NCT01367665|16532755|P1|Overall Study|Death|102
4793844|NCT01367457|16532786|P3|Overall Study|Suspected DP/suspected active infection|0
4793845|NCT01367457|16532787|P2|Overall Study|Suspected DP/suspected active infection|0
4793846|NCT01367457|16532788|P1|Overall Study|Suspected DP/suspected active infection|1
4793847|NCT01367457|16532786|P3|Overall Study|Palliative. Overall decline|0
4793848|NCT01367457|16532787|P2|Overall Study|Palliative. Overall decline|0
4793849|NCT01367457|16532788|P1|Overall Study|Palliative. Overall decline|1
4793850|NCT01367457|16532786|P3|Overall Study|Patient's Wish|0
4793851|NCT01367457|16532787|P2|Overall Study|Patient's Wish|0
4793852|NCT01367457|16532788|P1|Overall Study|Patient's Wish|1
4793853|NCT01367457|16532786|P3|Overall Study|CD, Suspected disease progression (DP)|0
4793854|NCT01367457|16532787|P2|Overall Study|CD, Suspected disease progression (DP)|0
4793855|NCT01367457|16532788|P1|Overall Study|CD, Suspected disease progression (DP)|1
4793856|NCT01367457|16532786|P3|Overall Study|Death from septic shock|0
4793857|NCT01367457|16532787|P2|Overall Study|Death from septic shock|0
4793858|NCT01367457|16532788|P1|Overall Study|Death from septic shock|1
4793859|NCT01367457|16532786|P3|Overall Study|Lost to Follow-up|0
4793860|NCT01367457|16532787|P2|Overall Study|Lost to Follow-up|0
4793861|NCT01367457|16532788|P1|Overall Study|Lost to Follow-up|1
4793862|NCT01367457|16532786|P3|Overall Study|Rejection of treatment|0
4793863|NCT01367457|16532787|P2|Overall Study|Rejection of treatment|0
4793864|NCT01367457|16532788|P1|Overall Study|Rejection of treatment|1
4793865|NCT01367457|16532786|P3|Overall Study|Overall decline|0
4793866|NCT01367457|16532787|P2|Overall Study|Overall decline|0
4793867|NCT01367457|16532788|P1|Overall Study|Overall decline|1
4793868|NCT01367457|16532786|P3|Overall Study|Intestinal obstruction with necrosis|0
4793869|NCT01367457|16532787|P2|Overall Study|Intestinal obstruction with necrosis|0
4793870|NCT01367457|16532788|P1|Overall Study|Intestinal obstruction with necrosis|1
4793871|NCT01367457|16532786|P3|Overall Study|No clinical benefit|0
4793872|NCT01367457|16532787|P2|Overall Study|No clinical benefit|0
4793873|NCT01367457|16532788|P1|Overall Study|No clinical benefit|1
4793874|NCT01367457|16532786|P3|Overall Study|Stabilisation + frequent infections|0
4793875|NCT01367457|16532787|P2|Overall Study|Stabilisation + frequent infections|0
4793876|NCT01367457|16532788|P1|Overall Study|Stabilisation + frequent infections|1
4793877|NCT01367457|16532786|P3|Overall Study|Overall status worsens to grade 4|0
4793878|NCT01367457|16532787|P2|Overall Study|Overall status worsens to grade 4|0
4793879|NCT01367457|16532788|P1|Overall Study|Overall status worsens to grade 4|1
4793880|NCT01367457|16532786|P3|Overall Study|Uncontrolled pain|0
4793881|NCT01367457|16532787|P2|Overall Study|Uncontrolled pain|0
4793882|NCT01367457|16532788|P1|Overall Study|Uncontrolled pain|1
4793883|NCT01367457|16532786|P3|Overall Study|CD, associated leukaemia|0
4793884|NCT01367457|16532787|P2|Overall Study|CD, associated leukaemia|0
4793885|NCT01367457|16532788|P1|Overall Study|CD, associated leukaemia|1
4793886|NCT01367457|16532786|P3|Overall Study|Withdrawal by Subject|0
4793887|NCT01367457|16532787|P2|Overall Study|Withdrawal by Subject|0
4793888|NCT01367457|16532788|P1|Overall Study|Withdrawal by Subject|1
4793889|NCT01367457|16532786|P3|Overall Study|Choledocolithiasis and pancreatitis|0
4793890|NCT01367457|16532787|P2|Overall Study|Choledocolithiasis and pancreatitis|0
4793891|NCT01367457|16532788|P1|Overall Study|Choledocolithiasis and pancreatitis|1
4793892|NCT01367457|16532786|P3|Overall Study|low grade toxicities + stable disease|0
4793893|NCT01367457|16532787|P2|Overall Study|low grade toxicities + stable disease|0
4793894|NCT01367457|16532788|P1|Overall Study|low grade toxicities + stable disease|1
4793895|NCT01367457|16532786|P3|Overall Study|3 yr Temsirolimus treatment (no disease)|0
4793896|NCT01367457|16532787|P2|Overall Study|3 yr Temsirolimus treatment (no disease)|0
4793897|NCT01367457|16532788|P1|Overall Study|3 yr Temsirolimus treatment (no disease)|1
4793898|NCT01367457|16532786|P3|Overall Study|Bleeding from cavernous haemangioma|0
4793899|NCT01367457|16532787|P2|Overall Study|Bleeding from cavernous haemangioma|0
4793900|NCT01367457|16532788|P1|Overall Study|Bleeding from cavernous haemangioma|1
4793901|NCT01367457|16532786|P3|Overall Study|Investigator's opinion, stable disease|0
4793902|NCT01367457|16532787|P2|Overall Study|Investigator's opinion, stable disease|0
4793903|NCT01367457|16532788|P1|Overall Study|Investigator's opinion, stable disease|1
4793904|NCT01367457|16532786|P3|Overall Study|Patient asks for rest + slow progression|0
4793905|NCT01367457|16532787|P2|Overall Study|Patient asks for rest + slow progression|0
4793906|NCT01367457|16532788|P1|Overall Study|Patient asks for rest + slow progression|1
4793907|NCT01367457|16532786|P3|Overall Study|Progression|0
4793908|NCT01367457|16532787|P2|Overall Study|Progression|0
4793909|NCT01367457|16532788|P1|Overall Study|Progression|137
4793910|NCT01367457|16532786|P3|Overall Study|Toxicity|0
4793911|NCT01367457|16532787|P2|Overall Study|Toxicity|0
4793912|NCT01367457|16532788|P1|Overall Study|Toxicity|16
4793913|NCT01367457|16532786|P3|Overall Study|Progression and death|0
4793914|NCT01367457|16532787|P2|Overall Study|Progression and death|0
4793915|NCT01367457|16532788|P1|Overall Study|Progression and death|8
4793916|NCT01367457|16532786|P3|Overall Study|Clinical decline (CD)|0
4793917|NCT01367457|16532787|P2|Overall Study|Clinical decline (CD)|0
4793918|NCT01367457|16532788|P1|Overall Study|Clinical decline (CD)|2
4793919|NCT01367457|16532786|P3|Overall Study|Investigator's decision|0
4793920|NCT01367457|16532787|P2|Overall Study|Investigator's decision|0
4793921|NCT01367457|16532788|P1|Overall Study|Investigator's decision|2
4793922|NCT01367457|16532786|P3|Overall Study|Death|0
4793923|NCT01367457|16532787|P2|Overall Study|Death|0
4793924|NCT01367457|16532788|P1|Overall Study|Death|2
4793925|NCT01367275|16532844|P1|Overall Study|Disease Progression|2
4793926|NCT01367275|16532844|P1|Overall Study|Ineligible|1
4793927|NCT01367249|16532861|P2|Overall Study|Other|10
4793928|NCT01367249|16532862|P1|Overall Study|Other|3
4793929|NCT01367249|16532861|P2|Overall Study|Withdrawal by Subject|6
4793930|NCT01367249|16532862|P1|Overall Study|Withdrawal by Subject|6
4793931|NCT01367236|16532872|P2|Overall Study|Withdrawal by Subject|1
4793932|NCT01367236|16532873|P1|Overall Study|Withdrawal by Subject|3
4793933|NCT01367158|16532892|P11|Overall Study|Protocol Violation|0
4793934|NCT01367158|16532893|P10|Overall Study|Protocol Violation|0
4793935|NCT01367158|16532894|P9|Overall Study|Protocol Violation|0
4793936|NCT01367158|16532895|P8|Overall Study|Protocol Violation|0
4793937|NCT01367158|16532896|P7|Overall Study|Protocol Violation|0
4793938|NCT01367158|16532897|P6|Overall Study|Protocol Violation|0
4793939|NCT01367158|16532898|P5|Overall Study|Protocol Violation|0
4793940|NCT01367158|16532899|P4|Overall Study|Protocol Violation|0
4793941|NCT01367158|16532900|P3|Overall Study|Protocol Violation|0
4793942|NCT01367158|16532901|P2|Overall Study|Protocol Violation|1
4793943|NCT01367158|16532902|P1|Overall Study|Protocol Violation|0
4793944|NCT01367158|16532892|P11|Overall Study|Lost to Follow-up|1
4793945|NCT01367158|16532893|P10|Overall Study|Lost to Follow-up|0
4793946|NCT01367158|16532894|P9|Overall Study|Lost to Follow-up|0
4793947|NCT01367158|16532895|P8|Overall Study|Lost to Follow-up|1
4793948|NCT01367158|16532896|P7|Overall Study|Lost to Follow-up|0
4793949|NCT01367158|16532897|P6|Overall Study|Lost to Follow-up|2
4793950|NCT01367158|16532898|P5|Overall Study|Lost to Follow-up|0
4793951|NCT01367158|16532899|P4|Overall Study|Lost to Follow-up|1
4793952|NCT01367158|16532900|P3|Overall Study|Lost to Follow-up|0
4793953|NCT01367158|16532901|P2|Overall Study|Lost to Follow-up|0
4793954|NCT01367158|16532902|P1|Overall Study|Lost to Follow-up|0
4793955|NCT01367158|16532892|P11|Overall Study|Withdrew consent|0
4793956|NCT01367158|16532893|P10|Overall Study|Withdrew consent|0
4793957|NCT01367158|16532894|P9|Overall Study|Withdrew consent|0
4793958|NCT01367158|16532895|P8|Overall Study|Withdrew consent|1
4793959|NCT01367158|16532896|P7|Overall Study|Withdrew consent|0
4793960|NCT01367158|16532897|P6|Overall Study|Withdrew consent|0
4793961|NCT01367158|16532898|P5|Overall Study|Withdrew consent|2
4793962|NCT01367158|16532899|P4|Overall Study|Withdrew consent|0
4793963|NCT01367158|16532900|P3|Overall Study|Withdrew consent|1
4793964|NCT01367158|16532901|P2|Overall Study|Withdrew consent|2
4793965|NCT01367158|16532902|P1|Overall Study|Withdrew consent|0
4793966|NCT01367119|16533046|P2|Overall Study|Withdrawal by Subject|1
4793967|NCT01367119|16533047|P1|Overall Study|Withdrawal by Subject|1
4793968|NCT01367119|16533046|P2|Overall Study|Adverse Event|0
4793969|NCT01367119|16533047|P1|Overall Study|Adverse Event|1
4793970|NCT01366846|16533102|P4|Overall Study|Scheduling Conflicts|0
4793971|NCT01366846|16533103|P3|Overall Study|Scheduling Conflicts|1
4793972|NCT01366846|16533104|P2|Overall Study|Scheduling Conflicts|0
4793973|NCT01366846|16533105|P1|Overall Study|Scheduling Conflicts|0
4793974|NCT01366846|16533102|P4|Overall Study|Communication Difficulties|1
4793975|NCT01366846|16533103|P3|Overall Study|Communication Difficulties|0
4793976|NCT01366846|16533104|P2|Overall Study|Communication Difficulties|4
4793977|NCT01366846|16533105|P1|Overall Study|Communication Difficulties|1
4793978|NCT01366846|16533102|P4|Overall Study|Withdrawal by Subject|0
4793979|NCT01366846|16533103|P3|Overall Study|Withdrawal by Subject|0
4793980|NCT01366846|16533104|P2|Overall Study|Withdrawal by Subject|0
4793981|NCT01366846|16533105|P1|Overall Study|Withdrawal by Subject|2
4793982|NCT01366638|16533128|P3|Overall Study|Other|0
4793983|NCT01366638|16533129|P2|Overall Study|Other|0
4793984|NCT01366638|16533130|P1|Overall Study|Other|1
4793985|NCT01366638|16533128|P3|Overall Study|Withdrawal by Subject|6
4793986|NCT01366638|16533129|P2|Overall Study|Withdrawal by Subject|0
4793987|NCT01366638|16533130|P1|Overall Study|Withdrawal by Subject|0
4793988|NCT01366534|16533167|P3|Overall Study|Declined challenged|0
4793989|NCT01366534|16533168|P2|Overall Study|Declined challenged|1
4793990|NCT01366534|16533169|P1|Overall Study|Declined challenged|0
4793991|NCT01366534|16533167|P3|Overall Study|Migrated|0
4793992|NCT01366534|16533168|P2|Overall Study|Migrated|1
4793993|NCT01366534|16533169|P1|Overall Study|Migrated|1
4793994|NCT01366534|16533167|P3|Overall Study|Lost to Follow-up|0
4793995|NCT01366534|16533168|P2|Overall Study|Lost to Follow-up|0
4793996|NCT01366534|16533169|P1|Overall Study|Lost to Follow-up|1
4793997|NCT01366521|16533219|P4|Overall Study|Withdrawal by Subject|0
4793998|NCT01366521|16533220|P3|Overall Study|Withdrawal by Subject|0
4793999|NCT01366521|16533221|P2|Overall Study|Withdrawal by Subject|1
4794000|NCT01366521|16533222|P1|Overall Study|Withdrawal by Subject|0
4794001|NCT01366521|16533219|P4|Overall Study|Physician Decision|0
4794002|NCT01366521|16533220|P3|Overall Study|Physician Decision|1
4794003|NCT01366521|16533221|P2|Overall Study|Physician Decision|0
4794004|NCT01366521|16533222|P1|Overall Study|Physician Decision|0
4794005|NCT01366521|16533219|P4|Overall Study|Protocol Violation|0
4794006|NCT01366521|16533220|P3|Overall Study|Protocol Violation|1
4794007|NCT01366521|16533221|P2|Overall Study|Protocol Violation|0
4794008|NCT01366521|16533222|P1|Overall Study|Protocol Violation|0
4794009|NCT01366521|16533219|P4|Overall Study|Adverse Event|0
4794010|NCT01366521|16533220|P3|Overall Study|Adverse Event|0
4794011|NCT01366521|16533221|P2|Overall Study|Adverse Event|0
4794012|NCT01366521|16533222|P1|Overall Study|Adverse Event|1
4794013|NCT01366443|16533318|P1|Overall Study|Under 18 yo|1
4794014|NCT01366443|16533318|P1|Overall Study|Lost to Follow-up|2
4794015|NCT01366209|16533332|P2|Overall Study|Withdrew consent|3
4794016|NCT01366209|16533333|P1|Overall Study|Withdrew consent|4
4794017|NCT01366209|16533332|P2|Overall Study|Sponsors decision|1
4794018|NCT01366209|16533333|P1|Overall Study|Sponsors decision|0
4794019|NCT01366209|16533332|P2|Overall Study|Physician Decision|0
4794020|NCT01366209|16533333|P1|Overall Study|Physician Decision|1
4794021|NCT01366209|16533332|P2|Overall Study|Lost to Follow-up|1
4794022|NCT01366209|16533333|P1|Overall Study|Lost to Follow-up|2
4794023|NCT01366209|16533332|P2|Overall Study|Lung transplantation|1
4794024|NCT01366209|16533333|P1|Overall Study|Lung transplantation|6
4794025|NCT01366209|16533332|P2|Overall Study|Death|19
4794026|NCT01366209|16533333|P1|Overall Study|Death|12
4794027|NCT01366209|16533332|P2|Overall Study|Withdrawal by Subject|4
4794028|NCT01366209|16533333|P1|Overall Study|Withdrawal by Subject|4
4794029|NCT01366209|16533332|P2|Overall Study|Adverse Event|7
4794030|NCT01366209|16533333|P1|Overall Study|Adverse Event|6
4794031|NCT01366092|16533356|P1|Overall Study|Withdrawal by Subject|1
4794032|NCT01366092|16533356|P1|Overall Study|Physician Decision|1
4794033|NCT01366092|16533356|P1|Overall Study|Progressive cGVHD|2
4794034|NCT01365910|16533365|P1|Overall Study|pt did not get tx, nausea/vomiting|1
4794035|NCT01365910|16533365|P1|Overall Study|other complicating disease|1
4794036|NCT01365910|16533365|P1|Overall Study|Adverse Event|3
4794037|NCT01365910|16533365|P1|Overall Study|disease progression|18
4794038|NCT01365910|16533365|P1|Overall Study|Withdrawal by Subject|7
4794039|NCT01365546|16533501|P1|Overall Study|Study termination|1
4794040|NCT01365546|16533501|P1|Overall Study|Screen failure|9
4794041|NCT01365546|16533501|P1|Overall Study|Withdrawal by Subject|1
4794042|NCT01365507|16533511|P2|Overall Study|Unclassified|4
4794043|NCT01365507|16533512|P1|Overall Study|Unclassified|1
4794044|NCT01365507|16533511|P2|Overall Study|Withdrawal Criteria|5
4794045|NCT01365507|16533512|P1|Overall Study|Withdrawal Criteria|8
4794046|NCT01365494|16533528|P2|Overall Study|Lost to Follow-up|2
4794047|NCT01365494|16533529|P1|Overall Study|Lost to Follow-up|1
4794048|NCT01365494|16533528|P2|Overall Study|Withdrawal by Subject|1
4794049|NCT01365494|16533529|P1|Overall Study|Withdrawal by Subject|0
4794050|NCT01365494|16533528|P2|Overall Study|Adverse Event|0
4794051|NCT01365494|16533529|P1|Overall Study|Adverse Event|1
4794052|NCT01365481|16533545|P4|Overall Study|Unsatisfactory therapeutic effect|0
4794053|NCT01365481|16533546|P3|Overall Study|Unsatisfactory therapeutic effect|1
4794054|NCT01365481|16533547|P2|Overall Study|Unsatisfactory therapeutic effect|0
4794055|NCT01365481|16533548|P1|Overall Study|Unsatisfactory therapeutic effect|0
4794056|NCT01365481|16533545|P4|Overall Study|Protocol deviation|1
4794057|NCT01365481|16533546|P3|Overall Study|Protocol deviation|0
4794058|NCT01365481|16533547|P2|Overall Study|Protocol deviation|1
4794059|NCT01365481|16533548|P1|Overall Study|Protocol deviation|0
4794060|NCT01365481|16533545|P4|Overall Study|Administrative problems|0
4794061|NCT01365481|16533546|P3|Overall Study|Administrative problems|0
4794062|NCT01365481|16533547|P2|Overall Study|Administrative problems|1
4794063|NCT01365481|16533548|P1|Overall Study|Administrative problems|0
4794064|NCT01365481|16533545|P4|Overall Study|Abnormal laboratory value(s)|0
4794065|NCT01365481|16533546|P3|Overall Study|Abnormal laboratory value(s)|0
4794066|NCT01365481|16533547|P2|Overall Study|Abnormal laboratory value(s)|1
4794067|NCT01365481|16533548|P1|Overall Study|Abnormal laboratory value(s)|0
4794068|NCT01365481|16533545|P4|Overall Study|Lost to Follow-up|3
4794069|NCT01365481|16533546|P3|Overall Study|Lost to Follow-up|2
4794070|NCT01365481|16533547|P2|Overall Study|Lost to Follow-up|1
4794071|NCT01365481|16533548|P1|Overall Study|Lost to Follow-up|1
4794072|NCT01365481|16533545|P4|Overall Study|Withdrawal by Subject|1
4794073|NCT01365481|16533546|P3|Overall Study|Withdrawal by Subject|1
4794074|NCT01365481|16533547|P2|Overall Study|Withdrawal by Subject|2
4794075|NCT01365481|16533548|P1|Overall Study|Withdrawal by Subject|0
4794076|NCT01365481|16533545|P4|Overall Study|Adverse Event|2
4794077|NCT01365481|16533546|P3|Overall Study|Adverse Event|0
4794078|NCT01365481|16533547|P2|Overall Study|Adverse Event|9
4794079|NCT01365481|16533548|P1|Overall Study|Adverse Event|6
4794080|NCT01365468|16533568|P2|Overall Study|Lost to Follow-up|0
4794081|NCT01365468|16533569|P1|Overall Study|Lost to Follow-up|2
4794082|NCT01365468|16533568|P2|Overall Study|Disease progression|0
4794083|NCT01365468|16533569|P1|Overall Study|Disease progression|1
4794084|NCT01365468|16533568|P2|Overall Study|Physician Decision|0
4794085|NCT01365468|16533569|P1|Overall Study|Physician Decision|1
4794086|NCT01365455|16533584|P5|Maintenance Period|Subject/guardian decision|1
4794087|NCT01365455|16533585|P4|Maintenance Period|Subject/guardian decision|4
4794088|NCT01365455|16533586|P3|Maintenance Period|Subject/guardian decision|2
4794089|NCT01365455|16533587|P2|Maintenance Period|Subject/guardian decision|6
4794090|NCT01365455|16533588|P1|Maintenance Period|Subject/guardian decision|4
4794091|NCT01365455|16533584|P5|Maintenance Period|Protocol deviation|0
4794092|NCT01365455|16533585|P4|Maintenance Period|Protocol deviation|0
4794093|NCT01365455|16533586|P3|Maintenance Period|Protocol deviation|0
4794094|NCT01365455|16533587|P2|Maintenance Period|Protocol deviation|1
4794095|NCT01365455|16533588|P1|Maintenance Period|Protocol deviation|1
4794096|NCT01365455|16533584|P5|Maintenance Period|Pregnancy|2
4794097|NCT01365455|16533585|P4|Maintenance Period|Pregnancy|0
4794098|NCT01365455|16533586|P3|Maintenance Period|Pregnancy|0
4794099|NCT01365455|16533587|P2|Maintenance Period|Pregnancy|4
4794100|NCT01365455|16533588|P1|Maintenance Period|Pregnancy|0
4794101|NCT01365455|16533584|P5|Maintenance Period|Physician Decision|1
4794102|NCT01365455|16533585|P4|Maintenance Period|Physician Decision|0
4794103|NCT01365455|16533586|P3|Maintenance Period|Physician Decision|0
4794104|NCT01365455|16533587|P2|Maintenance Period|Physician Decision|1
4794105|NCT01365455|16533588|P1|Maintenance Period|Physician Decision|0
4794106|NCT01365455|16533584|P5|Maintenance Period|Non-compliance with study treatment|0
4794107|NCT01365455|16533585|P4|Maintenance Period|Non-compliance with study treatment|1
4794108|NCT01365455|16533586|P3|Maintenance Period|Non-compliance with study treatment|0
4794109|NCT01365455|16533587|P2|Maintenance Period|Non-compliance with study treatment|0
4794110|NCT01365455|16533588|P1|Maintenance Period|Non-compliance with study treatment|0
4794111|NCT01365455|16533584|P5|Maintenance Period|Lost to Follow-up|3
4794112|NCT01365455|16533585|P4|Maintenance Period|Lost to Follow-up|0
4794113|NCT01365455|16533586|P3|Maintenance Period|Lost to Follow-up|0
4794114|NCT01365455|16533587|P2|Maintenance Period|Lost to Follow-up|4
4794115|NCT01365455|16533588|P1|Maintenance Period|Lost to Follow-up|2
4794116|NCT01365455|16533584|P5|Maintenance Period|Lack of Efficacy|2
4794117|NCT01365455|16533585|P4|Maintenance Period|Lack of Efficacy|2
4794118|NCT01365455|16533586|P3|Maintenance Period|Lack of Efficacy|0
4794119|NCT01365455|16533587|P2|Maintenance Period|Lack of Efficacy|2
4794120|NCT01365455|16533588|P1|Maintenance Period|Lack of Efficacy|10
4794121|NCT01365455|16533584|P5|Maintenance Period|Adverse Event|4
4794122|NCT01365455|16533585|P4|Maintenance Period|Adverse Event|2
4794123|NCT01365455|16533586|P3|Maintenance Period|Adverse Event|1
4794124|NCT01365455|16533587|P2|Maintenance Period|Adverse Event|5
4794125|NCT01365455|16533588|P1|Maintenance Period|Adverse Event|12
4794126|NCT01365455|16533584|P5|Induction Period|Lost to Follow-up|0
4794127|NCT01365455|16533585|P4|Induction Period|Lost to Follow-up|0
4794128|NCT01365455|16533586|P3|Induction Period|Lost to Follow-up|3
4794129|NCT01365455|16533587|P2|Induction Period|Lost to Follow-up|0
4794130|NCT01365455|16533588|P1|Induction Period|Lost to Follow-up|0
4794131|NCT01365455|16533584|P5|Induction Period|Subject/guardian decision|0
4794132|NCT01365455|16533585|P4|Induction Period|Subject/guardian decision|0
4794133|NCT01365455|16533586|P3|Induction Period|Subject/guardian decision|8
4794134|NCT01365455|16533587|P2|Induction Period|Subject/guardian decision|1
4794135|NCT01365455|16533588|P1|Induction Period|Subject/guardian decision|9
4794136|NCT01365455|16533584|P5|Induction Period|Protocol deviation|0
4794137|NCT01365455|16533585|P4|Induction Period|Protocol deviation|0
4794138|NCT01365455|16533586|P3|Induction Period|Protocol deviation|1
4794139|NCT01365455|16533587|P2|Induction Period|Protocol deviation|1
4794140|NCT01365455|16533588|P1|Induction Period|Protocol deviation|0
4794141|NCT01365455|16533584|P5|Induction Period|Pregnancy|0
4794142|NCT01365455|16533585|P4|Induction Period|Pregnancy|0
4794143|NCT01365455|16533586|P3|Induction Period|Pregnancy|0
4794144|NCT01365455|16533587|P2|Induction Period|Pregnancy|1
4794145|NCT01365455|16533588|P1|Induction Period|Pregnancy|0
4794146|NCT01365455|16533584|P5|Induction Period|Lack of Efficacy|0
4794147|NCT01365455|16533585|P4|Induction Period|Lack of Efficacy|0
4794148|NCT01365455|16533586|P3|Induction Period|Lack of Efficacy|0
4794149|NCT01365455|16533587|P2|Induction Period|Lack of Efficacy|1
4794150|NCT01365455|16533588|P1|Induction Period|Lack of Efficacy|1
4794151|NCT01365455|16533584|P5|Induction Period|Adverse Event|0
4794152|NCT01365455|16533585|P4|Induction Period|Adverse Event|0
4794153|NCT01365455|16533586|P3|Induction Period|Adverse Event|4
4794154|NCT01365455|16533587|P2|Induction Period|Adverse Event|3
4794155|NCT01365455|16533588|P1|Induction Period|Adverse Event|5
4794156|NCT01365273|16533678|P2|Overall Study|Physician Decision|0
4794157|NCT01365273|16533679|P1|Overall Study|Physician Decision|1
4794158|NCT01365273|16533678|P2|Overall Study|Protocol Violation|1
4794159|NCT01365273|16533679|P1|Overall Study|Protocol Violation|0
4794160|NCT01365273|16533678|P2|Overall Study|Lost to Follow-up|0
4794161|NCT01365273|16533679|P1|Overall Study|Lost to Follow-up|1
4794162|NCT01365130|16533689|P1|Overall Study|Progression/worsening of Dx prior to txt|2
4794163|NCT01365091|16533698|P4|Period 2|Adverse Event|0
4794164|NCT01365091|16533699|P3|Period 2|Adverse Event|1
4794165|NCT01365091|16533700|P2|Period 2|Adverse Event|0
4794166|NCT01365091|16533701|P1|Period 2|Adverse Event|0
4794167|NCT01365091|16533698|P4|Period 2|Withdrawal by Subject|0
4794168|NCT01365091|16533699|P3|Period 2|Withdrawal by Subject|0
4794169|NCT01365091|16533700|P2|Period 2|Withdrawal by Subject|0
4794170|NCT01365091|16533701|P1|Period 2|Withdrawal by Subject|1
4794171|NCT01365091|16533698|P4|Period 1|Personal reasons|0
4794172|NCT01365091|16533699|P3|Period 1|Personal reasons|1
4794173|NCT01365091|16533700|P2|Period 1|Personal reasons|0
4794174|NCT01365091|16533701|P1|Period 1|Personal reasons|0
4794175|NCT01365091|16533698|P4|Period 1|Withdrawal by Subject|0
4794176|NCT01365091|16533699|P3|Period 1|Withdrawal by Subject|0
4794177|NCT01365091|16533700|P2|Period 1|Withdrawal by Subject|1
4794178|NCT01365091|16533701|P1|Period 1|Withdrawal by Subject|0
4794179|NCT01365091|16533698|P4|Period 1|No longer met study criteria|0
4794180|NCT01365091|16533699|P3|Period 1|No longer met study criteria|0
4794181|NCT01365091|16533700|P2|Period 1|No longer met study criteria|1
4794182|NCT01365091|16533701|P1|Period 1|No longer met study criteria|0
4794183|NCT01365091|16533698|P4|Period 1|Positive test result for drugs of abuse|0
4794184|NCT01365091|16533699|P3|Period 1|Positive test result for drugs of abuse|0
4794185|NCT01365091|16533700|P2|Period 1|Positive test result for drugs of abuse|0
4794186|NCT01365091|16533701|P1|Period 1|Positive test result for drugs of abuse|1
4794187|NCT01365091|16533698|P4|Period 1|Adverse Event|3
4794188|NCT01365091|16533699|P3|Period 1|Adverse Event|2
4794189|NCT01365091|16533700|P2|Period 1|Adverse Event|0
4794190|NCT01365091|16533701|P1|Period 1|Adverse Event|1
4794191|NCT01365052|16533729|P2|Overall Study|Adverse Event|4
4794192|NCT01365052|16533730|P1|Overall Study|Adverse Event|4
4794193|NCT01365039|16533746|P2|Overall Study|Study related symptoms and complaints|0
4794194|NCT01365039|16533747|P1|Overall Study|Study related symptoms and complaints|1
4794195|NCT01364922|16533758|P3|Double-Blind (DB) Period|Other, Unspecified|0
4794196|NCT01364922|16533759|P2|Double-Blind (DB) Period|Other, Unspecified|1
4794197|NCT01364922|16533760|P1|Double-Blind (DB) Period|Other, Unspecified|0
4794198|NCT01364922|16533758|P3|Double-Blind (DB) Period|Adverse Event|1
4794199|NCT01364922|16533759|P2|Double-Blind (DB) Period|Adverse Event|0
4794200|NCT01364922|16533760|P1|Double-Blind (DB) Period|Adverse Event|0
4794201|NCT01364922|16533758|P3|Double-Blind (DB) Period|Subject Noncompliant|0
4794202|NCT01364922|16533759|P2|Double-Blind (DB) Period|Subject Noncompliant|1
4794203|NCT01364922|16533760|P1|Double-Blind (DB) Period|Subject Noncompliant|0
4794204|NCT01364922|16533758|P3|Double-Blind (DB) Period|Lack of Efficacy|4
4794205|NCT01364922|16533759|P2|Double-Blind (DB) Period|Lack of Efficacy|3
4794206|NCT01364922|16533760|P1|Double-Blind (DB) Period|Lack of Efficacy|0
4794207|NCT01364922|16533758|P3|Open-label (OL) Period|Other, Unspecified|0
4794208|NCT01364922|16533759|P2|Open-label (OL) Period|Other, Unspecified|0
4794209|NCT01364922|16533760|P1|Open-label (OL) Period|Other, Unspecified|1
4794210|NCT01364922|16533758|P3|Open-label (OL) Period|Lost to Follow-up|0
4794211|NCT01364922|16533759|P2|Open-label (OL) Period|Lost to Follow-up|0
4794212|NCT01364922|16533760|P1|Open-label (OL) Period|Lost to Follow-up|1
4794213|NCT01364922|16533758|P3|Open-label (OL) Period|Lack of Efficacy|0
4794214|NCT01364922|16533759|P2|Open-label (OL) Period|Lack of Efficacy|0
4794215|NCT01364922|16533760|P1|Open-label (OL) Period|Lack of Efficacy|3
4794216|NCT01364922|16533758|P3|Open-label (OL) Period|Withdrawal by Subject|0
4794217|NCT01364922|16533759|P2|Open-label (OL) Period|Withdrawal by Subject|0
4794218|NCT01364922|16533760|P1|Open-label (OL) Period|Withdrawal by Subject|4
4794219|NCT01364922|16533758|P3|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
4794220|NCT01364922|16533759|P2|Open-label (OL) Period|Did Not Meet Randomization Criteria|0
4794221|NCT01364922|16533760|P1|Open-label (OL) Period|Did Not Meet Randomization Criteria|6
4794222|NCT01364922|16533758|P3|Open-label (OL) Period|Adverse Event|0
4794223|NCT01364922|16533759|P2|Open-label (OL) Period|Adverse Event|0
4794224|NCT01364922|16533760|P1|Open-label (OL) Period|Adverse Event|7
4794225|NCT01364870|16533782|P3|Overall Study|Protocol Violation|0
4794226|NCT01364870|16533783|P2|Overall Study|Protocol Violation|0
4794227|NCT01364870|16533784|P1|Overall Study|Protocol Violation|1
4794228|NCT01364870|16533782|P3|Overall Study|Adverse Event|4
4794229|NCT01364870|16533783|P2|Overall Study|Adverse Event|6
4794230|NCT01364870|16533784|P1|Overall Study|Adverse Event|8
4794231|NCT01364870|16533782|P3|Overall Study|Withdrawal by Subject|10
4794232|NCT01364870|16533783|P2|Overall Study|Withdrawal by Subject|24
4794233|NCT01364870|16533784|P1|Overall Study|Withdrawal by Subject|13
4794234|NCT01364727|16533803|P1|Overall Study|Not Eligible|2
4794235|NCT01364649|16533811|P2|Overall Study|Other|1
4794236|NCT01364649|16533812|P1|Overall Study|Other|4
4794237|NCT01364649|16533811|P2|Overall Study|Lost to Follow-up|13
4794238|NCT01364649|16533812|P1|Overall Study|Lost to Follow-up|12
4794239|NCT01364649|16533811|P2|Overall Study|Withdrawal of Consent|7
4794240|NCT01364649|16533812|P1|Overall Study|Withdrawal of Consent|9
4794241|NCT01364649|16533811|P2|Overall Study|Protocol Deviations|8
4794242|NCT01364649|16533812|P1|Overall Study|Protocol Deviations|4
4794243|NCT01364649|16533811|P2|Overall Study|Non-compliance with Investigational Drug|0
4794244|NCT01364649|16533812|P1|Overall Study|Non-compliance with Investigational Drug|1
4794245|NCT01364649|16533811|P2|Overall Study|Lack of Efficacy|0
4794246|NCT01364649|16533812|P1|Overall Study|Lack of Efficacy|6
4794247|NCT01364649|16533811|P2|Overall Study|Pretreatment Event or Adverse Event|14
4794248|NCT01364649|16533812|P1|Overall Study|Pretreatment Event or Adverse Event|20
4794249|NCT01364467|16533900|P2|Overall Study|Lost to Follow-up|2
4794250|NCT01364467|16533901|P1|Overall Study|Lost to Follow-up|1
4794251|NCT01364428|16533913|P2|Overall Study|Other|3
4794252|NCT01364428|16533914|P1|Overall Study|Other|3
4794253|NCT01364428|16533913|P2|Overall Study|Withdrawal Criteria|10
4794254|NCT01364428|16533914|P1|Overall Study|Withdrawal Criteria|14
4794255|NCT01364428|16533913|P2|Overall Study|Protocol Violation|0
4794256|NCT01364428|16533914|P1|Overall Study|Protocol Violation|2
4794257|NCT01364428|16533913|P2|Overall Study|Adverse Event|2
4794258|NCT01364428|16533914|P1|Overall Study|Adverse Event|1
4794259|NCT01364389|16533931|P3|Overall Study|Adverse Event|0
4794260|NCT01364389|16533932|P2|Overall Study|Adverse Event|0
4794261|NCT01364389|16533933|P1|Overall Study|Adverse Event|1
4794262|NCT01364389|16533931|P3|Overall Study|Administrative problems|0
4794263|NCT01364389|16533932|P2|Overall Study|Administrative problems|0
4794264|NCT01364389|16533933|P1|Overall Study|Administrative problems|1
4794265|NCT01364389|16533931|P3|Overall Study|Protocol deviation|1
4794266|NCT01364389|16533932|P2|Overall Study|Protocol deviation|0
4794267|NCT01364389|16533933|P1|Overall Study|Protocol deviation|0
4794268|NCT01364389|16533931|P3|Overall Study|Withdrawal by Subject|0
4794269|NCT01364389|16533932|P2|Overall Study|Withdrawal by Subject|1
4794270|NCT01364389|16533933|P1|Overall Study|Withdrawal by Subject|0
4794271|NCT01364298|16533952|P2|Overall Study|Other|3
4794272|NCT01364298|16533953|P1|Overall Study|Other|1
4794273|NCT01364298|16533952|P2|Overall Study|Withdrawal by Subject|3
4794274|NCT01364298|16533953|P1|Overall Study|Withdrawal by Subject|3
4794275|NCT01364298|16533952|P2|Overall Study|Lost to Follow-up|10
4794276|NCT01364298|16533953|P1|Overall Study|Lost to Follow-up|5
4794277|NCT01364298|16533952|P2|Overall Study|Lack of Efficacy|0
4794278|NCT01364298|16533953|P1|Overall Study|Lack of Efficacy|1
4794279|NCT01364298|16533952|P2|Overall Study|Lack of adherence to treatment|3
4794280|NCT01364298|16533953|P1|Overall Study|Lack of adherence to treatment|1
4794281|NCT01364298|16533952|P2|Overall Study|Adverse Event|4
4794282|NCT01364298|16533953|P1|Overall Study|Adverse Event|3
4794283|NCT01364233|16533986|P1|Overall Study|Lost to Follow-up|1
4794284|NCT01363986|16534031|P1|Overall Study|Disease progression|1
4794285|NCT01363908|16534041|P2|Chronic Dosing (CD) Phase|Early study termination|3
4794286|NCT01363908|16534042|P1|Chronic Dosing (CD) Phase|Early study termination|9
4794287|NCT01363908|16534041|P2|Chronic Dosing (CD) Phase|Physician Decision|1
4794288|NCT01363908|16534042|P1|Chronic Dosing (CD) Phase|Physician Decision|0
4794289|NCT01363908|16534041|P2|Chronic Dosing (CD) Phase|Patient decision|1
4794290|NCT01363908|16534042|P1|Chronic Dosing (CD) Phase|Patient decision|0
4794291|NCT01363908|16534041|P2|Chronic Dosing (CD) Phase|Adverse Event|1
4794292|NCT01363908|16534042|P1|Chronic Dosing (CD) Phase|Adverse Event|1
4794293|NCT01363765|16534079|P2|Overall Study|smear during intervention|0
4794294|NCT01363765|16534080|P1|Overall Study|smear during intervention|2170
4794295|NCT01363765|16534079|P2|Overall Study|age not recorded (used for cross-linkage|354
4794296|NCT01363765|16534080|P1|Overall Study|age not recorded (used for cross-linkage|117
4794297|NCT01363765|16534079|P2|Overall Study|non-resident|76
4794298|NCT01363765|16534080|P1|Overall Study|non-resident|156
4794299|NCT01363765|16534079|P2|Overall Study|duplicate records|3177
4794300|NCT01363765|16534080|P1|Overall Study|duplicate records|736
4794301|NCT01363765|16534079|P2|Overall Study|non-diagnostic|1124
4794302|NCT01363765|16534080|P1|Overall Study|non-diagnostic|2621
4794303|NCT01363713|16534092|P1|Overall Study|Withdrawal by Subject|2
4794304|NCT01363713|16534092|P1|Overall Study|Protocol Violation|3
4794305|NCT01363713|16534092|P1|Overall Study|Adverse Event|1
4794306|NCT01363700|16534101|P5|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4794307|NCT01363700|16534102|P4|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4794308|NCT01363700|16534103|P3|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4794309|NCT01363700|16534104|P2|Epinastine vs Placebo Period1|Withdrawal by Subject|1
4794310|NCT01363700|16534105|P1|Epinastine vs Placebo Period1|Withdrawal by Subject|0
4794311|NCT01363661|16534124|P2|Overall Study|Lost to Follow-up|1
4794312|NCT01363661|16534125|P1|Overall Study|Lost to Follow-up|3
4794313|NCT01363661|16534124|P2|Overall Study|Protocol Violation|0
4794314|NCT01363661|16534125|P1|Overall Study|Protocol Violation|1
4794315|NCT01363661|16534124|P2|Overall Study|Withdrawal by Subject|1
4794316|NCT01363661|16534125|P1|Overall Study|Withdrawal by Subject|1
4794317|NCT01363661|16534124|P2|Overall Study|Adverse Event|2
4794318|NCT01363661|16534125|P1|Overall Study|Adverse Event|9
4794319|NCT01363440|16534166|P3|Overall Study|Other|2
4794320|NCT01363440|16534167|P2|Overall Study|Other|5
4794321|NCT01363440|16534168|P1|Overall Study|Other|4
4794322|NCT01363440|16534166|P3|Overall Study|Lost to Follow-up|5
4794323|NCT01363440|16534167|P2|Overall Study|Lost to Follow-up|4
4794324|NCT01363440|16534168|P1|Overall Study|Lost to Follow-up|2
4794325|NCT01363440|16534166|P3|Overall Study|Withdrawal by Subject|11
4794326|NCT01363440|16534167|P2|Overall Study|Withdrawal by Subject|11
4794327|NCT01363440|16534168|P1|Overall Study|Withdrawal by Subject|9
4794328|NCT01363440|16534166|P3|Overall Study|Death|5
4794329|NCT01363440|16534167|P2|Overall Study|Death|7
4794330|NCT01363440|16534168|P1|Overall Study|Death|3
4794331|NCT01363440|16534166|P3|Overall Study|Adverse Event|4
4794332|NCT01363440|16534167|P2|Overall Study|Adverse Event|4
4794333|NCT01363440|16534168|P1|Overall Study|Adverse Event|5
4794334|NCT01363349|16534227|P2|Overall Study|missing|2
4794335|NCT01363349|16534228|P1|Overall Study|missing|1
4794336|NCT01363349|16534227|P2|Overall Study|Not reported|37
4794337|NCT01363349|16534228|P1|Overall Study|Not reported|36
4794338|NCT01363349|16534227|P2|Overall Study|Lost to Follow-up|6
4794339|NCT01363349|16534228|P1|Overall Study|Lost to Follow-up|5
4794340|NCT01363349|16534227|P2|Overall Study|Withdrawal by Subject|6
4794341|NCT01363349|16534228|P1|Overall Study|Withdrawal by Subject|14
4794342|NCT01363349|16534227|P2|Overall Study|Non compliance/Protocol deviations|2
4794343|NCT01363349|16534228|P1|Overall Study|Non compliance/Protocol deviations|2
4794344|NCT01363349|16534227|P2|Overall Study|Lack of Efficacy|10
4794345|NCT01363349|16534228|P1|Overall Study|Lack of Efficacy|3
4794346|NCT01363349|16534227|P2|Overall Study|Adverse Event|7
4794347|NCT01363349|16534228|P1|Overall Study|Adverse Event|6
4794348|NCT01363297|16534239|P5|Overall Study|Death|30
4794349|NCT01363297|16534240|P4|Overall Study|Death|10
4794350|NCT01363297|16534241|P3|Overall Study|Death|6
4794351|NCT01363297|16534242|P2|Overall Study|Death|6
4794352|NCT01363297|16534243|P1|Overall Study|Death|3
4794353|NCT01363297|16534239|P5|Overall Study|Other|1
4794354|NCT01363297|16534240|P4|Overall Study|Other|0
4794355|NCT01363297|16534241|P3|Overall Study|Other|0
4794356|NCT01363297|16534242|P2|Overall Study|Other|0
4794357|NCT01363297|16534243|P1|Overall Study|Other|0
4794358|NCT01363076|16534346|P2|Overall Study|Withdrawal by Subject|1
4794359|NCT01363076|16534347|P1|Overall Study|Withdrawal by Subject|0
4794360|NCT01363011|16534379|P2|Extension Phase|Rolled Over to Another Gilead Study|1
4794361|NCT01363011|16534380|P1|Extension Phase|Rolled Over to Another Gilead Study|2
4794362|NCT01363011|16534379|P2|Extension Phase|Lost to Follow-up|2
4794363|NCT01363011|16534380|P1|Extension Phase|Lost to Follow-up|0
4794364|NCT01363011|16534379|P2|Extension Phase|Withdrew Consent|1
4794365|NCT01363011|16534380|P1|Extension Phase|Withdrew Consent|0
4794366|NCT01363011|16534379|P2|Extension Phase|Investigator's Discretion|2
4794367|NCT01363011|16534380|P1|Extension Phase|Investigator's Discretion|2
4794368|NCT01363011|16534379|P2|Extension Phase|Lack of Efficacy|1
4794369|NCT01363011|16534380|P1|Extension Phase|Lack of Efficacy|0
4794370|NCT01363011|16534379|P2|Extension Phase|Adverse Event|1
4794371|NCT01363011|16534380|P1|Extension Phase|Adverse Event|1
4794372|NCT01363011|16534379|P2|Main Study|Protocol Violation|1
4794373|NCT01363011|16534380|P1|Main Study|Protocol Violation|0
4794374|NCT01363011|16534379|P2|Main Study|Withdrew Consent|4
4794375|NCT01363011|16534380|P1|Main Study|Withdrew Consent|1
4794376|NCT01363011|16534379|P2|Main Study|Investigator's Discretion|1
4794377|NCT01363011|16534380|P1|Main Study|Investigator's Discretion|1
4794378|NCT01363011|16534379|P2|Main Study|Adverse Event|3
4794379|NCT01363011|16534380|P1|Main Study|Adverse Event|2
4794380|NCT01362790|16534507|P7|Dose De-escalation of Regimen A|Progressive disease|0
4794381|NCT01362790|16534508|P6|Dose De-escalation of Regimen A|Progressive disease|0
4794382|NCT01362790|16534509|P5|Dose De-escalation of Regimen A|Progressive disease|2
4794383|NCT01362790|16534510|P4|Dose De-escalation of Regimen A|Progressive disease|0
4794384|NCT01362790|16534511|P3|Dose De-escalation of Regimen A|Progressive disease|0
4794385|NCT01362790|16534512|P2|Dose De-escalation of Regimen A|Progressive disease|0
4794386|NCT01362790|16534513|P1|Dose De-escalation of Regimen A|Progressive disease|0
4794387|NCT01362790|16534507|P7|Dose De-escalation of Regimen A|Deveoped antibodies|0
4794388|NCT01362790|16534508|P6|Dose De-escalation of Regimen A|Deveoped antibodies|0
4794389|NCT01362790|16534509|P5|Dose De-escalation of Regimen A|Deveoped antibodies|3
4794390|NCT01362790|16534510|P4|Dose De-escalation of Regimen A|Deveoped antibodies|0
4794391|NCT01362790|16534511|P3|Dose De-escalation of Regimen A|Deveoped antibodies|0
4794392|NCT01362790|16534512|P2|Dose De-escalation of Regimen A|Deveoped antibodies|0
4794393|NCT01362790|16534513|P1|Dose De-escalation of Regimen A|Deveoped antibodies|0
4794394|NCT01362790|16534507|P7|Dose De-escalation of Regimen A|Adverse Event|0
4794395|NCT01362790|16534508|P6|Dose De-escalation of Regimen A|Adverse Event|0
4794396|NCT01362790|16534509|P5|Dose De-escalation of Regimen A|Adverse Event|1
4794397|NCT01362790|16534510|P4|Dose De-escalation of Regimen A|Adverse Event|0
4794398|NCT01362790|16534511|P3|Dose De-escalation of Regimen A|Adverse Event|0
4794399|NCT01362790|16534512|P2|Dose De-escalation of Regimen A|Adverse Event|0
4794400|NCT01362790|16534513|P1|Dose De-escalation of Regimen A|Adverse Event|0
4794401|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Death on study|0
4794402|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Death on study|0
4794403|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Death on study|0
4794404|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Death on study|1
4794405|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Death on study|0
4794406|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Death on study|0
4794407|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Death on study|0
4794408|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4794409|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4794410|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4794411|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4794412|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4794413|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2
4794414|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0
4794415|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4794416|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4794417|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4794418|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4794419|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4794420|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Treatment delay >3 weeks|0
4794421|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Treatment delay >3 weeks|1
4794422|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Progressive disease|0
4794423|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Progressive disease|2
4794424|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Progressive disease|0
4794425|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Progressive disease|3
4794426|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Progressive disease|2
4794427|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Progressive disease|2
4794428|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Progressive disease|1
4794429|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Refused further treatment|0
4794430|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Refused further treatment|0
4794431|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Refused further treatment|0
4794432|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Refused further treatment|0
4794433|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Refused further treatment|0
4794434|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Refused further treatment|1
4794435|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Refused further treatment|0
4794436|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Developed antibodies|0
4794437|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Developed antibodies|0
4794438|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Developed antibodies|0
4794439|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Developed antibodies|8
4794440|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Developed antibodies|3
4794441|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Developed antibodies|2
4794442|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Developed antibodies|7
4794443|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Physician Decision|0
4794444|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Physician Decision|0
4794445|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Physician Decision|0
4794446|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Physician Decision|1
4794447|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Physician Decision|0
4794448|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Physician Decision|0
4794449|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Physician Decision|0
4794450|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Adverse Event|0
4794451|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Adverse Event|2
4794452|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Adverse Event|0
4794453|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Adverse Event|1
4794454|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Adverse Event|0
4794455|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Adverse Event|1
4794456|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Adverse Event|0
4794457|NCT01362790|16534507|P7|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4794458|NCT01362790|16534508|P6|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4794459|NCT01362790|16534509|P5|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4794460|NCT01362790|16534510|P4|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4794461|NCT01362790|16534511|P3|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4794462|NCT01362790|16534512|P2|Pilot Phase & Phase 2|Changed treatment, too early to assess|0
4794463|NCT01362790|16534513|P1|Pilot Phase & Phase 2|Changed treatment, too early to assess|1
4794464|NCT01362608|16534581|P2|Overall Study|Adverse Event|2
4794465|NCT01362608|16534582|P1|Overall Study|Adverse Event|0
4794466|NCT01362608|16534581|P2|Overall Study|Lack of Efficacy|2
4794467|NCT01362608|16534582|P1|Overall Study|Lack of Efficacy|0
4794468|NCT01362608|16534581|P2|Overall Study|Withdrawal by Subject|2
4794469|NCT01362608|16534582|P1|Overall Study|Withdrawal by Subject|1
4794470|NCT01362608|16534581|P2|Overall Study|Lost to Follow-up|1
4794471|NCT01362608|16534582|P1|Overall Study|Lost to Follow-up|3
4794472|NCT01362608|16534581|P2|Overall Study|Protocol Violation|1
4794473|NCT01362608|16534582|P1|Overall Study|Protocol Violation|0
4794474|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0
4794475|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18
4794476|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Protocol Violation|0
4794477|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Protocol Violation|4
4794478|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Physician Decision|0
4794479|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Physician Decision|19
4794480|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Lost to Follow-up|0
4794481|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Lost to Follow-up|1
4794482|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Lack of Efficacy|0
4794483|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Lack of Efficacy|1
4794484|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0
4794485|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4
4794486|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0
4794487|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25
4794488|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0
4794489|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51
4794490|NCT01362530|16534620|P2|Optional Extension (Cycles 2-6)|Adverse Event|0
4794491|NCT01362530|16534621|P1|Optional Extension (Cycles 2-6)|Adverse Event|2
4794492|NCT01362530|16534620|P2|Base Study (Cycle 1)|Withdrawal by Subject|2
4794493|NCT01362530|16534621|P1|Base Study (Cycle 1)|Withdrawal by Subject|1
4794494|NCT01362530|16534620|P2|Base Study (Cycle 1)|Protocol Violation|0
4794495|NCT01362530|16534621|P1|Base Study (Cycle 1)|Protocol Violation|2
4794496|NCT01362530|16534620|P2|Base Study (Cycle 1)|Physician Decision|1
4794497|NCT01362530|16534621|P1|Base Study (Cycle 1)|Physician Decision|0
4794498|NCT01362530|16534620|P2|Base Study (Cycle 1)|Adverse Event|0
4794499|NCT01362530|16534621|P1|Base Study (Cycle 1)|Adverse Event|2
4794500|NCT01362517|16534634|P1|Overall Study|Lost to Follow-up|1
4794501|NCT01362517|16534634|P1|Overall Study|Protocol Violation|1
4794502|NCT01362491|16534645|P3|Overall Study|Ineligible|0
4794503|NCT01362491|16534646|P2|Overall Study|Ineligible|0
4794504|NCT01362491|16534647|P1|Overall Study|Ineligible|1
4794505|NCT01362439|16534695|P1|Overall Study|Participant who withdrew consent|8
4794506|NCT01362439|16534695|P1|Overall Study|Study medication non-compliant|1
4794507|NCT01362439|16534695|P1|Overall Study|Lost to Follow-up|2
4794508|NCT01362439|16534695|P1|Overall Study|Lack of Efficacy|3
4794509|NCT01362439|16534695|P1|Overall Study|Adverse Event|1
4794510|NCT01362348|16534710|P1|Overall Study|Study closed/terminated|5
4794511|NCT01362348|16534710|P1|Overall Study|Protocol-defined stopping criteria|9
4794512|NCT01362322|16534729|P2|Overall Study|Lost to Follow-up|6
4794513|NCT01362322|16534730|P1|Overall Study|Lost to Follow-up|2
4794514|NCT01362322|16534729|P2|Overall Study|Withdrawal by Subject|1
4794515|NCT01362322|16534730|P1|Overall Study|Withdrawal by Subject|3
4794516|NCT01362296|16534762|P4|Crossover Phase|Study Closed/Terminated|0
4794517|NCT01362296|16534763|P3|Crossover Phase|Study Closed/Terminated|1
4794518|NCT01362296|16534764|P2|Crossover Phase|Study Closed/Terminated|0
4794519|NCT01362296|16534765|P1|Crossover Phase|Study Closed/Terminated|0
4794520|NCT01362296|16534762|P4|Crossover Phase|Adverse Event|0
4794521|NCT01362296|16534763|P3|Crossover Phase|Adverse Event|4
4794522|NCT01362296|16534764|P2|Crossover Phase|Adverse Event|0
4794523|NCT01362296|16534765|P1|Crossover Phase|Adverse Event|0
4794524|NCT01362296|16534762|P4|Crossover Phase|Withdrawal by Subject|1
4794525|NCT01362296|16534763|P3|Crossover Phase|Withdrawal by Subject|2
4794526|NCT01362296|16534764|P2|Crossover Phase|Withdrawal by Subject|0
4794527|NCT01362296|16534765|P1|Crossover Phase|Withdrawal by Subject|0
4794528|NCT01362296|16534762|P4|Crossover Phase|PD including Death due to PD|1
4794529|NCT01362296|16534763|P3|Crossover Phase|PD including Death due to PD|16
4794530|NCT01362296|16534764|P2|Crossover Phase|PD including Death due to PD|0
4794531|NCT01362296|16534765|P1|Crossover Phase|PD including Death due to PD|0
4794532|NCT01362296|16534762|P4|Randomized Phase (RP)|Study Closed/Terminated|0
4794533|NCT01362296|16534763|P3|Randomized Phase (RP)|Study Closed/Terminated|0
4794534|NCT01362296|16534764|P2|Randomized Phase (RP)|Study Closed/Terminated|1
4794535|NCT01362296|16534765|P1|Randomized Phase (RP)|Study Closed/Terminated|8
4794536|NCT01362296|16534762|P4|Randomized Phase (RP)|Adverse Event|0
4794537|NCT01362296|16534763|P3|Randomized Phase (RP)|Adverse Event|0
4794538|NCT01362296|16534764|P2|Randomized Phase (RP)|Adverse Event|4
4794539|NCT01362296|16534765|P1|Randomized Phase (RP)|Adverse Event|20
4794540|NCT01362296|16534762|P4|Randomized Phase (RP)|Withdrawal by Subject|0
4794541|NCT01362296|16534763|P3|Randomized Phase (RP)|Withdrawal by Subject|0
4794542|NCT01362296|16534764|P2|Randomized Phase (RP)|Withdrawal by Subject|1
4794543|NCT01362296|16534765|P1|Randomized Phase (RP)|Withdrawal by Subject|2
4794544|NCT01362296|16534762|P4|Randomized Phase (RP)|Physician Decision|0
4794545|NCT01362296|16534763|P3|Randomized Phase (RP)|Physician Decision|0
4794546|NCT01362296|16534764|P2|Randomized Phase (RP)|Physician Decision|9
4794547|NCT01362296|16534765|P1|Randomized Phase (RP)|Physician Decision|1
4794548|NCT01362296|16534762|P4|Randomized Phase (RP)|PD including Death due to PD|0
4794549|NCT01362296|16534763|P3|Randomized Phase (RP)|PD including Death due to PD|0
4794550|NCT01362296|16534764|P2|Randomized Phase (RP)|PD including Death due to PD|28
4794551|NCT01362296|16534765|P1|Randomized Phase (RP)|PD including Death due to PD|56
4794552|NCT01362270|16534813|P2|Overall Study|Met excl. criteria before 1st session|1
4794553|NCT01362270|16534814|P1|Overall Study|Met excl. criteria before 1st session|1
4794554|NCT01362270|16534813|P2|Overall Study|Met exclusion criteria after 1st session|1
4794555|NCT01362270|16534814|P1|Overall Study|Met exclusion criteria after 1st session|0
4794556|NCT01362270|16534813|P2|Overall Study|Withdrawal by Subject|0
4794557|NCT01362270|16534814|P1|Overall Study|Withdrawal by Subject|1
4794558|NCT01362244|16534826|P2|Overall Study|Protocol Defined Stopping Criteria|1
4794559|NCT01362244|16534827|P1|Overall Study|Protocol Defined Stopping Criteria|0
4794560|NCT01362244|16534826|P2|Overall Study|Did not Meet Continuation Criteria|11
4794561|NCT01362244|16534827|P1|Overall Study|Did not Meet Continuation Criteria|17
4794562|NCT01362244|16534826|P2|Overall Study|Withdrawal by Subject|1
4794563|NCT01362244|16534827|P1|Overall Study|Withdrawal by Subject|2
4794564|NCT01362244|16534826|P2|Overall Study|Protocol Violation|1
4794565|NCT01362244|16534827|P1|Overall Study|Protocol Violation|5
4794566|NCT01362244|16534826|P2|Overall Study|Lost to Follow-up|2
4794567|NCT01362244|16534827|P1|Overall Study|Lost to Follow-up|0
4794568|NCT01362244|16534826|P2|Overall Study|Lack of Efficacy|11
4794569|NCT01362244|16534827|P1|Overall Study|Lack of Efficacy|5
4794570|NCT01362244|16534826|P2|Overall Study|Adverse Event|5
4794571|NCT01362244|16534827|P1|Overall Study|Adverse Event|3
4794572|NCT01362140|16534939|P2|Overall Study|Discontinued Without Receiving Treatment|1
4794573|NCT01362140|16534940|P1|Overall Study|Discontinued Without Receiving Treatment|0
4794574|NCT01362140|16534939|P2|Overall Study|Protocol-specified Criteria|2
4794575|NCT01362140|16534940|P1|Overall Study|Protocol-specified Criteria|1
4794576|NCT01362140|16534939|P2|Overall Study|Other|1
4794577|NCT01362140|16534940|P1|Overall Study|Other|1
4794578|NCT01362140|16534939|P2|Overall Study|Death|1
4794579|NCT01362140|16534940|P1|Overall Study|Death|2
4794580|NCT01362140|16534939|P2|Overall Study|Administrative Decision|1
4794581|NCT01362140|16534940|P1|Overall Study|Administrative Decision|0
4794582|NCT01362140|16534939|P2|Overall Study|Withdrawal by Subject|3
4794583|NCT01362140|16534940|P1|Overall Study|Withdrawal by Subject|3
4794584|NCT01362140|16534939|P2|Overall Study|Adverse Event|2
4794585|NCT01362140|16534940|P1|Overall Study|Adverse Event|2
4794586|NCT01362140|16534939|P2|Overall Study|Noncompliance|0
4794587|NCT01362140|16534940|P1|Overall Study|Noncompliance|1
4794588|NCT01362062|16534977|P2|Overall Study|Had significant improvement|0
4794589|NCT01362062|16534978|P1|Overall Study|Had significant improvement|9
4794590|NCT01362062|16534977|P2|Overall Study|Detected with Spondylo-arthritis|0
4794591|NCT01362062|16534978|P1|Overall Study|Detected with Spondylo-arthritis|1
4794592|NCT01362062|16534977|P2|Overall Study|Non-compliant participant|0
4794593|NCT01362062|16534978|P1|Overall Study|Non-compliant participant|2
4794594|NCT01362062|16534977|P2|Overall Study|Withdrawal by Subject|0
4794595|NCT01362062|16534978|P1|Overall Study|Withdrawal by Subject|2
4794596|NCT01362062|16534977|P2|Overall Study|Lost to Follow-up|0
4794597|NCT01362062|16534978|P1|Overall Study|Lost to Follow-up|11
4794598|NCT01362062|16534977|P2|Overall Study|Adverse Event|0
4794599|NCT01362062|16534978|P1|Overall Study|Adverse Event|1
4794600|NCT01362049|16534999|P4|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
4794601|NCT01362049|16535000|P3|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2
4794602|NCT01362049|16535001|P2|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3
4794603|NCT01362049|16535002|P1|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5
4794604|NCT01362049|16534999|P4|Follow-Up at 7 Weeks|Lost to Follow-up|1
4794605|NCT01362049|16535000|P3|Follow-Up at 7 Weeks|Lost to Follow-up|2
4794606|NCT01362049|16535001|P2|Follow-Up at 7 Weeks|Lost to Follow-up|3
4794607|NCT01362049|16535002|P1|Follow-Up at 7 Weeks|Lost to Follow-up|3
4794608|NCT01361919|16535043|P3|Overall Study|technical issues|10
4794609|NCT01361919|16535044|P2|Overall Study|technical issues|12
4794610|NCT01361919|16535045|P1|Overall Study|technical issues|10
4794611|NCT01361607|16535086|P2|Overall Study|Met Withdrawal Criteria|1
4794612|NCT01361607|16535087|P1|Overall Study|Met Withdrawal Criteria|1
4794613|NCT01361607|16535086|P2|Overall Study|Lost to Follow-up|0
4794614|NCT01361607|16535087|P1|Overall Study|Lost to Follow-up|1
4794615|NCT01361607|16535086|P2|Overall Study|Withdrawal by Investigator|3
4794616|NCT01361607|16535087|P1|Overall Study|Withdrawal by Investigator|5
4794617|NCT01361607|16535086|P2|Overall Study|Withdrawal by Subject|8
4794618|NCT01361607|16535087|P1|Overall Study|Withdrawal by Subject|19
4794619|NCT01361607|16535086|P2|Overall Study|Adverse Event|29
4794620|NCT01361607|16535087|P1|Overall Study|Adverse Event|38
4794621|NCT01361594|16535115|P2|Overall Study|Withdrawal by Subject|2
4794622|NCT01361594|16535116|P1|Overall Study|Withdrawal by Subject|1
4794623|NCT01361568|16535130|P6|Overall Study|Withdrawal by Subject|1
4794624|NCT01361568|16535131|P5|Overall Study|Withdrawal by Subject|0
4794625|NCT01361568|16535132|P4|Overall Study|Withdrawal by Subject|0
4794626|NCT01361568|16535133|P3|Overall Study|Withdrawal by Subject|0
4794627|NCT01361568|16535134|P2|Overall Study|Withdrawal by Subject|1
4794628|NCT01361568|16535135|P1|Overall Study|Withdrawal by Subject|2
4794629|NCT01361568|16535130|P6|Overall Study|Physician Decision|1
4794630|NCT01361568|16535131|P5|Overall Study|Physician Decision|0
4794631|NCT01361568|16535132|P4|Overall Study|Physician Decision|0
4794632|NCT01361568|16535133|P3|Overall Study|Physician Decision|0
4794633|NCT01361568|16535134|P2|Overall Study|Physician Decision|0
4794634|NCT01361568|16535135|P1|Overall Study|Physician Decision|0
4794635|NCT01361568|16535130|P6|Overall Study|Adverse Event|0
4794636|NCT01361568|16535131|P5|Overall Study|Adverse Event|1
4794637|NCT01361568|16535132|P4|Overall Study|Adverse Event|0
4794638|NCT01361568|16535133|P3|Overall Study|Adverse Event|0
4794639|NCT01361568|16535134|P2|Overall Study|Adverse Event|0
4794640|NCT01361568|16535135|P1|Overall Study|Adverse Event|0
4794641|NCT01361464|16535165|P1|Overall Study|Withdrawal by Subject|2
4794642|NCT01361464|16535165|P1|Overall Study|Death|1
4794643|NCT01361308|16535174|P2|Overall Study|Other|1
4794644|NCT01361308|16535175|P1|Overall Study|Other|0
4794645|NCT01361308|16535174|P2|Overall Study|Failed C-SSRS|2
4794646|NCT01361308|16535175|P1|Overall Study|Failed C-SSRS|5
4794647|NCT01361308|16535174|P2|Overall Study|Eligibility Criteria Not Met|3
4794648|NCT01361308|16535175|P1|Overall Study|Eligibility Criteria Not Met|2
4794649|NCT01361308|16535174|P2|Overall Study|Adverse Event|4
4794650|NCT01361308|16535175|P1|Overall Study|Adverse Event|8
4794651|NCT01361308|16535174|P2|Overall Study|Lost to Follow-up|4
4794652|NCT01361308|16535175|P1|Overall Study|Lost to Follow-up|5
4794653|NCT01361308|16535174|P2|Overall Study|Protocol Violation|0
4794654|NCT01361308|16535175|P1|Overall Study|Protocol Violation|1
4794655|NCT01361308|16535174|P2|Overall Study|Lack of Efficacy|0
4794656|NCT01361308|16535175|P1|Overall Study|Lack of Efficacy|2
4794657|NCT01361308|16535174|P2|Overall Study|Physician Decision|3
4794658|NCT01361308|16535175|P1|Overall Study|Physician Decision|3
4794659|NCT01361308|16535174|P2|Overall Study|Withdrawal by Subject|13
4794660|NCT01361308|16535175|P1|Overall Study|Withdrawal by Subject|9
4794661|NCT01361178|16535223|P2|Overall Study|Death|0
4794662|NCT01361178|16535224|P1|Overall Study|Death|13
4794663|NCT01361126|16535232|P2|Overall Study|Sponsor decision|2
4794664|NCT01361126|16535233|P1|Overall Study|Sponsor decision|0
4794665|NCT01361009|16535272|P1|Overall Study|Protocol Violation|116
4794666|NCT01360996|16535282|P3|Overall Study|Noncompliant|0
4794667|NCT01360996|16535283|P2|Overall Study|Noncompliant|0
4794668|NCT01360996|16535284|P1|Overall Study|Noncompliant|2
4794669|NCT01360996|16535282|P3|Overall Study|Withdrawal by Subject|2
4794670|NCT01360996|16535283|P2|Overall Study|Withdrawal by Subject|3
4794671|NCT01360996|16535284|P1|Overall Study|Withdrawal by Subject|4
4794672|NCT01360866|16535307|P4|Overall Study|Lack of Efficacy|4
4794673|NCT01360866|16535308|P3|Overall Study|Lack of Efficacy|30
4794674|NCT01360866|16535309|P2|Overall Study|Lack of Efficacy|40
4794675|NCT01360866|16535310|P1|Overall Study|Lack of Efficacy|30
4794676|NCT01360866|16535307|P4|Overall Study|Protocol Deviation|2
4794677|NCT01360866|16535308|P3|Overall Study|Protocol Deviation|61
4794678|NCT01360866|16535309|P2|Overall Study|Protocol Deviation|33
4794679|NCT01360866|16535310|P1|Overall Study|Protocol Deviation|25
4794680|NCT01360866|16535307|P4|Overall Study|Withdrawal by participant|8
4794681|NCT01360866|16535308|P3|Overall Study|Withdrawal by participant|168
4794682|NCT01360866|16535309|P2|Overall Study|Withdrawal by participant|89
4794683|NCT01360866|16535310|P1|Overall Study|Withdrawal by participant|79
4794684|NCT01360866|16535307|P4|Overall Study|Withdrawn by Investigator|2
4794685|NCT01360866|16535308|P3|Overall Study|Withdrawn by Investigator|31
4794686|NCT01360866|16535309|P2|Overall Study|Withdrawn by Investigator|8
4794687|NCT01360866|16535310|P1|Overall Study|Withdrawn by Investigator|9
4794688|NCT01360866|16535307|P4|Overall Study|Paticipant met withdrawal criteria|0
4794689|NCT01360866|16535308|P3|Overall Study|Paticipant met withdrawal criteria|54
4794690|NCT01360866|16535309|P2|Overall Study|Paticipant met withdrawal criteria|28
4794691|NCT01360866|16535310|P1|Overall Study|Paticipant met withdrawal criteria|11
4794692|NCT01360866|16535307|P4|Overall Study|Adverse Event|6
4794693|NCT01360866|16535308|P3|Overall Study|Adverse Event|134
4794694|NCT01360866|16535309|P2|Overall Study|Adverse Event|61
4794695|NCT01360866|16535310|P1|Overall Study|Adverse Event|56
4794696|NCT01360866|16535307|P4|Overall Study|Lost to Follow-up|0
4794697|NCT01360866|16535308|P3|Overall Study|Lost to Follow-up|41
4794698|NCT01360866|16535309|P2|Overall Study|Lost to Follow-up|28
4794699|NCT01360866|16535310|P1|Overall Study|Lost to Follow-up|11
4794700|NCT01360840|16535339|P3|Overall Study|Ongoing at data cut-off|9
4794701|NCT01360840|16535340|P2|Overall Study|Ongoing at data cut-off|10
4794702|NCT01360840|16535341|P1|Overall Study|Ongoing at data cut-off|10
4794703|NCT01360762|16535391|P1|Whole Study Period|Discontinuation of study drug for safety|1
4794704|NCT01360762|16535391|P1|Whole Study Period|Patient relapsed|18
4794705|NCT01360762|16535391|P1|Whole Study Period|Death|7
4794706|NCT01360762|16535391|P1|Whole Study Period|Lost to Follow-up|10
4794707|NCT01360762|16535391|P1|Main Study Period (12-month Treatment)|Discontinuation|1
4794708|NCT01360762|16535391|P1|Main Study Period (12-month Treatment)|Patient relapsed|15
4794709|NCT01360762|16535391|P1|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1
4794710|NCT01360762|16535391|P1|Main Study Period (12-month Treatment)|Death|5
4794711|NCT01360762|16535391|P1|Main Study Period (12-month Treatment)|Lost to Follow-up|7
4794712|NCT01360645|16535401|P4|Phase A+|Protocol Deviation|4
4794713|NCT01360645|16535402|P3|Phase A+|Protocol Deviation|0
4794714|NCT01360645|16535403|P2|Phase A+|Protocol Deviation|0
4794715|NCT01360645|16535404|P1|Phase A+|Protocol Deviation|0
4794716|NCT01360645|16535401|P4|Phase A+|Withdrawal by Subject|5
4794717|NCT01360645|16535402|P3|Phase A+|Withdrawal by Subject|0
4794718|NCT01360645|16535403|P2|Phase A+|Withdrawal by Subject|0
4794719|NCT01360645|16535404|P1|Phase A+|Withdrawal by Subject|0
4794720|NCT01360645|16535401|P4|Phase A+|Physician Decision|2
4794721|NCT01360645|16535402|P3|Phase A+|Physician Decision|0
4794722|NCT01360645|16535403|P2|Phase A+|Physician Decision|0
4794723|NCT01360645|16535404|P1|Phase A+|Physician Decision|0
4794724|NCT01360645|16535401|P4|Phase A+|Met Withdrawal Criteria|4
4794725|NCT01360645|16535402|P3|Phase A+|Met Withdrawal Criteria|0
4794726|NCT01360645|16535403|P2|Phase A+|Met Withdrawal Criteria|0
4794727|NCT01360645|16535404|P1|Phase A+|Met Withdrawal Criteria|0
4794728|NCT01360645|16535401|P4|Phase A+|Adverse Event|2
4794729|NCT01360645|16535402|P3|Phase A+|Adverse Event|0
4794730|NCT01360645|16535403|P2|Phase A+|Adverse Event|0
4794731|NCT01360645|16535404|P1|Phase A+|Adverse Event|0
4794732|NCT01360645|16535401|P4|Phase A+|Lost to Follow-up|7
4794733|NCT01360645|16535402|P3|Phase A+|Lost to Follow-up|0
4794734|NCT01360645|16535403|P2|Phase A+|Lost to Follow-up|0
4794735|NCT01360645|16535404|P1|Phase A+|Lost to Follow-up|0
4794736|NCT01360645|16535401|P4|Phase B (6 Weeks)|Protocol Deviation|0
4794737|NCT01360645|16535402|P3|Phase B (6 Weeks)|Protocol Deviation|3
4794738|NCT01360645|16535403|P2|Phase B (6 Weeks)|Protocol Deviation|1
4794739|NCT01360645|16535404|P1|Phase B (6 Weeks)|Protocol Deviation|0
4794740|NCT01360645|16535401|P4|Phase B (6 Weeks)|Withdrawal by Subject|0
4794741|NCT01360645|16535402|P3|Phase B (6 Weeks)|Withdrawal by Subject|8
4794742|NCT01360645|16535403|P2|Phase B (6 Weeks)|Withdrawal by Subject|3
4794743|NCT01360645|16535404|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
4794744|NCT01360645|16535401|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4794745|NCT01360645|16535402|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
4794746|NCT01360645|16535403|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|3
4794747|NCT01360645|16535404|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4794748|NCT01360645|16535401|P4|Phase B (6 Weeks)|Adverse Event|0
4794749|NCT01360645|16535402|P3|Phase B (6 Weeks)|Adverse Event|0
4794750|NCT01360645|16535403|P2|Phase B (6 Weeks)|Adverse Event|6
4794751|NCT01360645|16535404|P1|Phase B (6 Weeks)|Adverse Event|0
4794752|NCT01360645|16535401|P4|Phase B (6 Weeks)|Lost to Follow-up|0
4794753|NCT01360645|16535402|P3|Phase B (6 Weeks)|Lost to Follow-up|0
4794754|NCT01360645|16535403|P2|Phase B (6 Weeks)|Lost to Follow-up|1
4794755|NCT01360645|16535404|P1|Phase B (6 Weeks)|Lost to Follow-up|0
4794756|NCT01360645|16535401|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
4794757|NCT01360645|16535402|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
4794758|NCT01360645|16535403|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0
4794759|NCT01360645|16535404|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5
4794760|NCT01360645|16535401|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
4794761|NCT01360645|16535402|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
4794762|NCT01360645|16535403|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0
4794763|NCT01360645|16535404|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24
4794764|NCT01360645|16535401|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
4794765|NCT01360645|16535402|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
4794766|NCT01360645|16535403|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0
4794767|NCT01360645|16535404|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34
4794768|NCT01360645|16535401|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
4794769|NCT01360645|16535402|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
4794770|NCT01360645|16535403|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0
4794771|NCT01360645|16535404|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16
4794772|NCT01360645|16535401|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
4794773|NCT01360645|16535402|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
4794774|NCT01360645|16535403|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0
4794775|NCT01360645|16535404|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19
4794776|NCT01360645|16535401|P4|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
4794777|NCT01360645|16535402|P3|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
4794778|NCT01360645|16535403|P2|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0
4794779|NCT01360645|16535404|P1|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16
4794780|NCT01360632|16535459|P5|Phase A+|Protocol Deviation|3
4794781|NCT01360632|16535460|P4|Phase A+|Protocol Deviation|0
4794782|NCT01360632|16535461|P3|Phase A+|Protocol Deviation|0
4794783|NCT01360632|16535462|P2|Phase A+|Protocol Deviation|0
4794784|NCT01360632|16535463|P1|Phase A+|Protocol Deviation|0
4794785|NCT01360632|16535459|P5|Phase A+|Withdrawal by Subject|8
4794786|NCT01360632|16535460|P4|Phase A+|Withdrawal by Subject|0
4794787|NCT01360632|16535461|P3|Phase A+|Withdrawal by Subject|0
4794788|NCT01360632|16535462|P2|Phase A+|Withdrawal by Subject|0
4794789|NCT01360632|16535463|P1|Phase A+|Withdrawal by Subject|0
4794790|NCT01360632|16535459|P5|Phase A+|Physician Decision|3
4794791|NCT01360632|16535460|P4|Phase A+|Physician Decision|0
4794792|NCT01360632|16535461|P3|Phase A+|Physician Decision|0
4794793|NCT01360632|16535462|P2|Phase A+|Physician Decision|0
4794794|NCT01360632|16535463|P1|Phase A+|Physician Decision|0
4794795|NCT01360632|16535459|P5|Phase A+|Met Withdrawal Criteria|7
4794796|NCT01360632|16535460|P4|Phase A+|Met Withdrawal Criteria|0
4794797|NCT01360632|16535461|P3|Phase A+|Met Withdrawal Criteria|0
4794798|NCT01360632|16535462|P2|Phase A+|Met Withdrawal Criteria|0
4794799|NCT01360632|16535463|P1|Phase A+|Met Withdrawal Criteria|0
4794800|NCT01360632|16535459|P5|Phase A+|Adverse Event|2
4794801|NCT01360632|16535460|P4|Phase A+|Adverse Event|0
4794802|NCT01360632|16535461|P3|Phase A+|Adverse Event|0
4794803|NCT01360632|16535462|P2|Phase A+|Adverse Event|0
4794804|NCT01360632|16535463|P1|Phase A+|Adverse Event|0
4794805|NCT01360632|16535459|P5|Phase A+|Lost to Follow-up|2
4794806|NCT01360632|16535460|P4|Phase A+|Lost to Follow-up|0
4794807|NCT01360632|16535461|P3|Phase A+|Lost to Follow-up|0
4794808|NCT01360632|16535462|P2|Phase A+|Lost to Follow-up|0
4794809|NCT01360632|16535463|P1|Phase A+|Lost to Follow-up|0
4794810|NCT01360632|16535459|P5|Phase B (6 Weeks)|Lack of Efficacy|0
4794811|NCT01360632|16535460|P4|Phase B (6 Weeks)|Lack of Efficacy|0
4794812|NCT01360632|16535461|P3|Phase B (6 Weeks)|Lack of Efficacy|0
4794813|NCT01360632|16535462|P2|Phase B (6 Weeks)|Lack of Efficacy|1
4794814|NCT01360632|16535463|P1|Phase B (6 Weeks)|Lack of Efficacy|0
4794815|NCT01360632|16535459|P5|Phase B (6 Weeks)|Protocol Deviation|0
4794816|NCT01360632|16535460|P4|Phase B (6 Weeks)|Protocol Deviation|1
4794817|NCT01360632|16535461|P3|Phase B (6 Weeks)|Protocol Deviation|4
4794818|NCT01360632|16535462|P2|Phase B (6 Weeks)|Protocol Deviation|1
4794819|NCT01360632|16535463|P1|Phase B (6 Weeks)|Protocol Deviation|0
4794820|NCT01360632|16535459|P5|Phase B (6 Weeks)|Withdrawal by Subject|0
4794821|NCT01360632|16535460|P4|Phase B (6 Weeks)|Withdrawal by Subject|7
4794822|NCT01360632|16535461|P3|Phase B (6 Weeks)|Withdrawal by Subject|4
4794823|NCT01360632|16535462|P2|Phase B (6 Weeks)|Withdrawal by Subject|4
4794824|NCT01360632|16535463|P1|Phase B (6 Weeks)|Withdrawal by Subject|0
4794825|NCT01360632|16535459|P5|Phase B (6 Weeks)|Physician Decision|0
4794826|NCT01360632|16535460|P4|Phase B (6 Weeks)|Physician Decision|1
4794827|NCT01360632|16535461|P3|Phase B (6 Weeks)|Physician Decision|0
4794828|NCT01360632|16535462|P2|Phase B (6 Weeks)|Physician Decision|0
4794829|NCT01360632|16535463|P1|Phase B (6 Weeks)|Physician Decision|0
4794830|NCT01360632|16535459|P5|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4794831|NCT01360632|16535460|P4|Phase B (6 Weeks)|Met Withdrawal Criteria|1
4794832|NCT01360632|16535461|P3|Phase B (6 Weeks)|Met Withdrawal Criteria|2
4794833|NCT01360632|16535462|P2|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4794834|NCT01360632|16535463|P1|Phase B (6 Weeks)|Met Withdrawal Criteria|0
4794835|NCT01360632|16535459|P5|Phase B (6 Weeks)|Adverse Event|0
4794836|NCT01360632|16535460|P4|Phase B (6 Weeks)|Adverse Event|3
4794837|NCT01360632|16535461|P3|Phase B (6 Weeks)|Adverse Event|9
4794838|NCT01360632|16535462|P2|Phase B (6 Weeks)|Adverse Event|3
4794839|NCT01360632|16535463|P1|Phase B (6 Weeks)|Adverse Event|0
4794840|NCT01360632|16535459|P5|Phase B (6 Weeks)|Lost to Follow-up|0
4794841|NCT01360632|16535460|P4|Phase B (6 Weeks)|Lost to Follow-up|0
4794842|NCT01360632|16535461|P3|Phase B (6 Weeks)|Lost to Follow-up|1
4794843|NCT01360632|16535462|P2|Phase B (6 Weeks)|Lost to Follow-up|1
4794844|NCT01360632|16535463|P1|Phase B (6 Weeks)|Lost to Follow-up|0
4794845|NCT01360632|16535459|P5|Phase A (8 Weeks)|Protocol Deviation|0
4794846|NCT01360632|16535460|P4|Phase A (8 Weeks)|Protocol Deviation|0
4794847|NCT01360632|16535461|P3|Phase A (8 Weeks)|Protocol Deviation|0
4794848|NCT01360632|16535462|P2|Phase A (8 Weeks)|Protocol Deviation|0
4794849|NCT01360632|16535463|P1|Phase A (8 Weeks)|Protocol Deviation|39
4794850|NCT01360632|16535459|P5|Phase A (8 Weeks)|Withdrawal by Subject|0
4794851|NCT01360632|16535460|P4|Phase A (8 Weeks)|Withdrawal by Subject|0
4794852|NCT01360632|16535461|P3|Phase A (8 Weeks)|Withdrawal by Subject|0
4794853|NCT01360632|16535462|P2|Phase A (8 Weeks)|Withdrawal by Subject|0
4794854|NCT01360632|16535463|P1|Phase A (8 Weeks)|Withdrawal by Subject|74
4794855|NCT01360632|16535459|P5|Phase A (8 Weeks)|Physician Decision|0
4794856|NCT01360632|16535460|P4|Phase A (8 Weeks)|Physician Decision|0
4794857|NCT01360632|16535461|P3|Phase A (8 Weeks)|Physician Decision|0
4794858|NCT01360632|16535462|P2|Phase A (8 Weeks)|Physician Decision|0
4794859|NCT01360632|16535463|P1|Phase A (8 Weeks)|Physician Decision|10
4794860|NCT01360632|16535459|P5|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4794861|NCT01360632|16535460|P4|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4794862|NCT01360632|16535461|P3|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4794863|NCT01360632|16535462|P2|Phase A (8 Weeks)|Met Withdrawal Criteria|0
4794864|NCT01360632|16535463|P1|Phase A (8 Weeks)|Met Withdrawal Criteria|45
4794865|NCT01360632|16535459|P5|Phase A (8 Weeks)|Adverse Event|0
4794866|NCT01360632|16535460|P4|Phase A (8 Weeks)|Adverse Event|0
4794867|NCT01360632|16535461|P3|Phase A (8 Weeks)|Adverse Event|0
4794868|NCT01360632|16535462|P2|Phase A (8 Weeks)|Adverse Event|0
4794869|NCT01360632|16535463|P1|Phase A (8 Weeks)|Adverse Event|60
4794870|NCT01360632|16535459|P5|Phase A (8 Weeks)|Lost to Follow-up|0
4794871|NCT01360632|16535460|P4|Phase A (8 Weeks)|Lost to Follow-up|0
4794872|NCT01360632|16535461|P3|Phase A (8 Weeks)|Lost to Follow-up|0
4794873|NCT01360632|16535462|P2|Phase A (8 Weeks)|Lost to Follow-up|0
4794874|NCT01360632|16535463|P1|Phase A (8 Weeks)|Lost to Follow-up|27
4794875|NCT01360554|16535542|P2|Overall Study|Randomized but not treated.|3
4794876|NCT01360554|16535543|P1|Overall Study|Randomized but not treated.|3
4794877|NCT01360554|16535542|P2|Overall Study|Other, not specified|0
4794878|NCT01360554|16535543|P1|Overall Study|Other, not specified|1
4794879|NCT01360554|16535542|P2|Overall Study|Study terminated by sponsor|37
4794880|NCT01360554|16535543|P1|Overall Study|Study terminated by sponsor|49
4794881|NCT01360554|16535542|P2|Overall Study|Withdrawal by Subject|24
4794882|NCT01360554|16535543|P1|Overall Study|Withdrawal by Subject|23
4794883|NCT01360554|16535542|P2|Overall Study|Lost to Follow-up|4
4794884|NCT01360554|16535543|P1|Overall Study|Lost to Follow-up|4
4794885|NCT01360554|16535542|P2|Overall Study|Death|371
4794886|NCT01360554|16535543|P1|Overall Study|Death|359
4794887|NCT01360398|16535592|P1|Overall Study|Migrated/moved from study area|1
4794888|NCT01360398|16535592|P1|Overall Study|Other|7
4794889|NCT01360398|16535592|P1|Overall Study|Withdrawal by Subject|14
4794890|NCT01360021|16535626|P3|Overall Study|Adverse Event|3
4794891|NCT01360021|16535627|P2|Overall Study|Adverse Event|3
4794892|NCT01360021|16535628|P1|Overall Study|Adverse Event|2
4794893|NCT01360021|16535626|P3|Overall Study|Withdrawal by Subject|2
4794894|NCT01360021|16535627|P2|Overall Study|Withdrawal by Subject|0
4794895|NCT01360021|16535628|P1|Overall Study|Withdrawal by Subject|4
4794896|NCT01360021|16535626|P3|Overall Study|Protocol Violation|1
4794897|NCT01360021|16535627|P2|Overall Study|Protocol Violation|0
4794898|NCT01360021|16535628|P1|Overall Study|Protocol Violation|0
4794899|NCT01360021|16535626|P3|Overall Study|Eligibility criteria + other|1
4794900|NCT01360021|16535627|P2|Overall Study|Eligibility criteria + other|1
4794901|NCT01360021|16535628|P1|Overall Study|Eligibility criteria + other|2
4794902|NCT01359943|16535654|P3|Follow-up (Weeks 52 - 60)|Adverse Event|1
4794903|NCT01359943|16535655|P2|Follow-up (Weeks 52 - 60)|Adverse Event|5
4794904|NCT01359943|16535656|P1|Follow-up (Weeks 52 - 60)|Adverse Event|3
4794905|NCT01359943|16535654|P3|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
4794906|NCT01359943|16535655|P2|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1
4794907|NCT01359943|16535656|P1|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0
4794908|NCT01359943|16535654|P3|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
4794909|NCT01359943|16535655|P2|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
4794910|NCT01359943|16535656|P1|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3
4794911|NCT01359943|16535654|P3|Follow-up (Weeks 52 - 60)|Protocol deviation|0
4794912|NCT01359943|16535655|P2|Follow-up (Weeks 52 - 60)|Protocol deviation|1
4794913|NCT01359943|16535656|P1|Follow-up (Weeks 52 - 60)|Protocol deviation|0
4794914|NCT01359943|16535654|P3|Follow-up (Weeks 52 - 60)|Administrative problems|0
4794915|NCT01359943|16535655|P2|Follow-up (Weeks 52 - 60)|Administrative problems|0
4794916|NCT01359943|16535656|P1|Follow-up (Weeks 52 - 60)|Administrative problems|1
4794917|NCT01359943|16535654|P3|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4
4794918|NCT01359943|16535655|P2|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5
4794919|NCT01359943|16535656|P1|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1
4794920|NCT01359943|16535654|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1
4794921|NCT01359943|16535655|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5
4794922|NCT01359943|16535656|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3
4794923|NCT01359943|16535654|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
4794924|NCT01359943|16535655|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1
4794925|NCT01359943|16535656|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0
4794926|NCT01359943|16535654|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
4794927|NCT01359943|16535655|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
4794928|NCT01359943|16535656|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3
4794929|NCT01359943|16535654|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
4794930|NCT01359943|16535655|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1
4794931|NCT01359943|16535656|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0
4794932|NCT01359943|16535654|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4
4794933|NCT01359943|16535655|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3
4794934|NCT01359943|16535656|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1
4794935|NCT01359943|16535654|P3|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
4794936|NCT01359943|16535655|P2|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0
4794937|NCT01359943|16535656|P1|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1
4794938|NCT01359943|16535654|P3|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
4794939|NCT01359943|16535655|P2|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2
4794940|NCT01359943|16535656|P1|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0
4794941|NCT01359943|16535654|P3|Double-blind (Weeks 0 - 16)|Adverse Event|0
4794942|NCT01359943|16535655|P2|Double-blind (Weeks 0 - 16)|Adverse Event|2
4794943|NCT01359943|16535656|P1|Double-blind (Weeks 0 - 16)|Adverse Event|1
4794944|NCT01359943|16535654|P3|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
4794945|NCT01359943|16535655|P2|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0
4794946|NCT01359943|16535656|P1|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1
4794947|NCT01359904|16535704|P2|Overall Study|Withdrawal by Subject|0
4794948|NCT01359904|16535705|P1|Overall Study|Withdrawal by Subject|1
4794949|NCT01359644|16535759|P10|Follow-up Period|Lost to Follow-up|0
4794950|NCT01359644|16535760|P9|Follow-up Period|Lost to Follow-up|0
4794951|NCT01359644|16535761|P8|Follow-up Period|Lost to Follow-up|2
4794952|NCT01359644|16535762|P7|Follow-up Period|Lost to Follow-up|1
4794953|NCT01359644|16535763|P6|Follow-up Period|Lost to Follow-up|0
4794954|NCT01359644|16535764|P5|Follow-up Period|Lost to Follow-up|0
4794955|NCT01359644|16535765|P4|Follow-up Period|Lost to Follow-up|0
4794956|NCT01359644|16535766|P3|Follow-up Period|Lost to Follow-up|0
4794957|NCT01359644|16535767|P2|Follow-up Period|Lost to Follow-up|0
4794958|NCT01359644|16535768|P1|Follow-up Period|Lost to Follow-up|0
4794959|NCT01359644|16535759|P10|Follow-up Period|Withdrawal by Subject|0
4794960|NCT01359644|16535760|P9|Follow-up Period|Withdrawal by Subject|0
4794961|NCT01359644|16535761|P8|Follow-up Period|Withdrawal by Subject|0
4794962|NCT01359644|16535762|P7|Follow-up Period|Withdrawal by Subject|0
4794963|NCT01359644|16535763|P6|Follow-up Period|Withdrawal by Subject|1
4794964|NCT01359644|16535764|P5|Follow-up Period|Withdrawal by Subject|0
4794965|NCT01359644|16535765|P4|Follow-up Period|Withdrawal by Subject|0
4794966|NCT01359644|16535766|P3|Follow-up Period|Withdrawal by Subject|0
4794967|NCT01359644|16535767|P2|Follow-up Period|Withdrawal by Subject|0
4794968|NCT01359644|16535768|P1|Follow-up Period|Withdrawal by Subject|0
4794969|NCT01359644|16535759|P10|Treatment Period|Lost to Follow-up|0
4794970|NCT01359644|16535760|P9|Treatment Period|Lost to Follow-up|0
4794971|NCT01359644|16535761|P8|Treatment Period|Lost to Follow-up|0
4794972|NCT01359644|16535762|P7|Treatment Period|Lost to Follow-up|0
4794973|NCT01359644|16535763|P6|Treatment Period|Lost to Follow-up|1
4794974|NCT01359644|16535764|P5|Treatment Period|Lost to Follow-up|0
4794975|NCT01359644|16535765|P4|Treatment Period|Lost to Follow-up|0
4794976|NCT01359644|16535766|P3|Treatment Period|Lost to Follow-up|0
4794977|NCT01359644|16535767|P2|Treatment Period|Lost to Follow-up|0
4794978|NCT01359644|16535768|P1|Treatment Period|Lost to Follow-up|0
4794979|NCT01359644|16535759|P10|Treatment Period|Adverse Event|0
4794980|NCT01359644|16535760|P9|Treatment Period|Adverse Event|0
4794981|NCT01359644|16535761|P8|Treatment Period|Adverse Event|0
4794982|NCT01359644|16535762|P7|Treatment Period|Adverse Event|0
4794983|NCT01359644|16535763|P6|Treatment Period|Adverse Event|1
4794984|NCT01359644|16535764|P5|Treatment Period|Adverse Event|0
4794985|NCT01359644|16535765|P4|Treatment Period|Adverse Event|0
4794986|NCT01359644|16535766|P3|Treatment Period|Adverse Event|1
4794987|NCT01359644|16535767|P2|Treatment Period|Adverse Event|0
4794988|NCT01359644|16535768|P1|Treatment Period|Adverse Event|0
4794989|NCT01359644|16535759|P10|Treatment Period|Lack of Efficacy|0
4794990|NCT01359644|16535760|P9|Treatment Period|Lack of Efficacy|0
4794991|NCT01359644|16535761|P8|Treatment Period|Lack of Efficacy|0
4794992|NCT01359644|16535762|P7|Treatment Period|Lack of Efficacy|0
4794993|NCT01359644|16535763|P6|Treatment Period|Lack of Efficacy|0
4794994|NCT01359644|16535764|P5|Treatment Period|Lack of Efficacy|0
4794995|NCT01359644|16535765|P4|Treatment Period|Lack of Efficacy|0
4794996|NCT01359644|16535766|P3|Treatment Period|Lack of Efficacy|0
4794997|NCT01359644|16535767|P2|Treatment Period|Lack of Efficacy|1
4794998|NCT01359644|16535768|P1|Treatment Period|Lack of Efficacy|0
4794999|NCT01359449|16535812|P2|Overall Study|Withdrawal by Subject|2
4795000|NCT01359449|16535813|P1|Overall Study|Withdrawal by Subject|3
4795001|NCT01359449|16535812|P2|Overall Study|Protocol Violation|2
4795002|NCT01359449|16535813|P1|Overall Study|Protocol Violation|0
4795003|NCT01359449|16535812|P2|Overall Study|Lost to Follow-up|0
4795004|NCT01359449|16535813|P1|Overall Study|Lost to Follow-up|1
4795005|NCT01359254|16535859|P2|Overall Study|Death|0
4795006|NCT01359254|16535860|P1|Overall Study|Death|1
4795007|NCT01359150|16535870|P2|Overall Study|Other|0
4795008|NCT01359150|16535871|P1|Overall Study|Other|1
4795009|NCT01359150|16535870|P2|Overall Study|Adverse Event|3
4795010|NCT01359150|16535871|P1|Overall Study|Adverse Event|4
4795011|NCT01359150|16535870|P2|Overall Study|Withdrawal by Subject|1
4795012|NCT01359150|16535871|P1|Overall Study|Withdrawal by Subject|1
4795013|NCT01359150|16535870|P2|Overall Study|Lack of Efficacy|1
4795014|NCT01359150|16535871|P1|Overall Study|Lack of Efficacy|1
4795015|NCT01359046|16535902|P2|Overall Study|Physician Decision|11
4795016|NCT01359046|16535903|P1|Overall Study|Physician Decision|1
4795017|NCT01359046|16535902|P2|Overall Study|Did not receive allocated intervention|6
4795018|NCT01359046|16535903|P1|Overall Study|Did not receive allocated intervention|6
4795019|NCT01358981|16535926|P7|Period 1|Withdrawal by Subject|0
4795020|NCT01358981|16535927|P6|Period 1|Withdrawal by Subject|0
4795021|NCT01358981|16535928|P5|Period 1|Withdrawal by Subject|0
4795022|NCT01358981|16535929|P4|Period 1|Withdrawal by Subject|1
4795023|NCT01358981|16535930|P3|Period 1|Withdrawal by Subject|0
4795024|NCT01358981|16535931|P2|Period 1|Withdrawal by Subject|0
4795025|NCT01358981|16535932|P1|Period 1|Withdrawal by Subject|0
4795026|NCT01358968|16535993|P4|Continued Access Phase|Death|1
4795027|NCT01358968|16535994|P3|Continued Access Phase|Death|1
4795028|NCT01358968|16535995|P2|Continued Access Phase|Death|0
4795029|NCT01358968|16535996|P1|Continued Access Phase|Death|0
4795030|NCT01358968|16535993|P4|Continued Access Phase|Withdrawal by Subject|0
4795031|NCT01358968|16535994|P3|Continued Access Phase|Withdrawal by Subject|3
4795032|NCT01358968|16535995|P2|Continued Access Phase|Withdrawal by Subject|0
4795033|NCT01358968|16535996|P1|Continued Access Phase|Withdrawal by Subject|0
4795034|NCT01358968|16535993|P4|Continued Access Phase|Protocol Violation|2
4795035|NCT01358968|16535994|P3|Continued Access Phase|Protocol Violation|0
4795036|NCT01358968|16535995|P2|Continued Access Phase|Protocol Violation|0
4795037|NCT01358968|16535996|P1|Continued Access Phase|Protocol Violation|0
4795038|NCT01358968|16535993|P4|Continued Access Phase|Progression of Disease|4
4795039|NCT01358968|16535994|P3|Continued Access Phase|Progression of Disease|8
4795040|NCT01358968|16535995|P2|Continued Access Phase|Progression of Disease|0
4795041|NCT01358968|16535996|P1|Continued Access Phase|Progression of Disease|0
4795042|NCT01358968|16535993|P4|Period 2|Adverse Event|0
4795043|NCT01358968|16535994|P3|Period 2|Adverse Event|0
4795044|NCT01358968|16535995|P2|Period 2|Adverse Event|1
4795045|NCT01358968|16535996|P1|Period 2|Adverse Event|0
4795046|NCT01358877|16536012|P2|Overall Study|Other|129
4795047|NCT01358877|16536013|P1|Overall Study|Other|142
4795048|NCT01358877|16536012|P2|Overall Study|Ongoing follow-up for overall survival|5
4795049|NCT01358877|16536013|P1|Overall Study|Ongoing follow-up for overall survival|7
4795050|NCT01358877|16536012|P2|Overall Study|Ongoing follow-up for IDFS event|2073
4795051|NCT01358877|16536013|P1|Overall Study|Ongoing follow-up for IDFS event|2084
4795052|NCT01358877|16536012|P2|Overall Study|Ongoing follow-up for post-recurrence|108
4795053|NCT01358877|16536013|P1|Overall Study|Ongoing follow-up for post-recurrence|87
4795054|NCT01358877|16536012|P2|Overall Study|Death|89
4795055|NCT01358877|16536013|P1|Overall Study|Death|80
4795056|NCT01358864|16536083|P8|Overall Study|Not treated|0
4795057|NCT01358864|16536084|P7|Overall Study|Not treated|1
4795058|NCT01358864|16536085|P6|Overall Study|Not treated|0
4795059|NCT01358864|16536086|P5|Overall Study|Not treated|0
4795060|NCT01358864|16536087|P4|Overall Study|Not treated|0
4795061|NCT01358864|16536088|P3|Overall Study|Not treated|0
4795062|NCT01358864|16536089|P2|Overall Study|Not treated|0
4795063|NCT01358864|16536090|P1|Overall Study|Not treated|0
4795064|NCT01358864|16536083|P8|Overall Study|Other reason not defined above|0
4795065|NCT01358864|16536084|P7|Overall Study|Other reason not defined above|2
4795066|NCT01358864|16536085|P6|Overall Study|Other reason not defined above|0
4795067|NCT01358864|16536086|P5|Overall Study|Other reason not defined above|0
4795068|NCT01358864|16536087|P4|Overall Study|Other reason not defined above|0
4795069|NCT01358864|16536088|P3|Overall Study|Other reason not defined above|0
4795070|NCT01358864|16536089|P2|Overall Study|Other reason not defined above|0
4795071|NCT01358864|16536090|P1|Overall Study|Other reason not defined above|2
4795072|NCT01358864|16536083|P8|Overall Study|Withdrawal by Subject|3
4795073|NCT01358864|16536084|P7|Overall Study|Withdrawal by Subject|1
4795074|NCT01358864|16536085|P6|Overall Study|Withdrawal by Subject|1
4795075|NCT01358864|16536086|P5|Overall Study|Withdrawal by Subject|0
4795076|NCT01358864|16536087|P4|Overall Study|Withdrawal by Subject|0
4795077|NCT01358864|16536088|P3|Overall Study|Withdrawal by Subject|2
4795078|NCT01358864|16536089|P2|Overall Study|Withdrawal by Subject|4
4795079|NCT01358864|16536090|P1|Overall Study|Withdrawal by Subject|3
4795080|NCT01358864|16536083|P8|Overall Study|Lost to Follow-up|1
4795081|NCT01358864|16536084|P7|Overall Study|Lost to Follow-up|0
4795082|NCT01358864|16536085|P6|Overall Study|Lost to Follow-up|0
4795083|NCT01358864|16536086|P5|Overall Study|Lost to Follow-up|0
4795084|NCT01358864|16536087|P4|Overall Study|Lost to Follow-up|0
4795085|NCT01358864|16536088|P3|Overall Study|Lost to Follow-up|1
4795086|NCT01358864|16536089|P2|Overall Study|Lost to Follow-up|0
4795087|NCT01358864|16536090|P1|Overall Study|Lost to Follow-up|0
4795088|NCT01358864|16536083|P8|Overall Study|Lack of Efficacy|44
4795089|NCT01358864|16536084|P7|Overall Study|Lack of Efficacy|49
4795090|NCT01358864|16536085|P6|Overall Study|Lack of Efficacy|4
4795091|NCT01358864|16536086|P5|Overall Study|Lack of Efficacy|7
4795092|NCT01358864|16536087|P4|Overall Study|Lack of Efficacy|19
4795093|NCT01358864|16536088|P3|Overall Study|Lack of Efficacy|4
4795094|NCT01358864|16536089|P2|Overall Study|Lack of Efficacy|3
4795095|NCT01358864|16536090|P1|Overall Study|Lack of Efficacy|26
4795096|NCT01358864|16536083|P8|Overall Study|Adverse Event|7
4795097|NCT01358864|16536084|P7|Overall Study|Adverse Event|12
4795098|NCT01358864|16536085|P6|Overall Study|Adverse Event|8
4795099|NCT01358864|16536086|P5|Overall Study|Adverse Event|4
4795100|NCT01358864|16536087|P4|Overall Study|Adverse Event|0
4795101|NCT01358864|16536088|P3|Overall Study|Adverse Event|9
4795102|NCT01358864|16536089|P2|Overall Study|Adverse Event|6
4795103|NCT01358864|16536090|P1|Overall Study|Adverse Event|0
4795104|NCT01358825|16536181|P2|Overall Study|Blood sample not drawn|1
4795105|NCT01358825|16536182|P1|Overall Study|Blood sample not drawn|0
4795106|NCT01358760|16536206|P3|Overall Study|Entry criteria not met/Non-compliance|16
4795107|NCT01358760|16536207|P2|Overall Study|Entry criteria not met/Non-compliance|12
4795108|NCT01358760|16536208|P1|Overall Study|Entry criteria not met/Non-compliance|12
4795109|NCT01358760|16536206|P3|Overall Study|Physician Decision|1
4795110|NCT01358760|16536207|P2|Overall Study|Physician Decision|0
4795111|NCT01358760|16536208|P1|Overall Study|Physician Decision|1
4795112|NCT01358760|16536206|P3|Overall Study|Withdrawal by Subject|2
4795113|NCT01358760|16536207|P2|Overall Study|Withdrawal by Subject|3
4795114|NCT01358760|16536208|P1|Overall Study|Withdrawal by Subject|5
4795115|NCT01358760|16536206|P3|Overall Study|Lost to Follow-up|3
4795116|NCT01358760|16536207|P2|Overall Study|Lost to Follow-up|1
4795117|NCT01358760|16536208|P1|Overall Study|Lost to Follow-up|1
4795118|NCT01358760|16536206|P3|Overall Study|Adverse Event|3
4795119|NCT01358760|16536207|P2|Overall Study|Adverse Event|4
4795120|NCT01358760|16536208|P1|Overall Study|Adverse Event|3
4795121|NCT01358734|16536243|P3|Overall Study|Protocol Violation|2
4795122|NCT01358734|16536244|P2|Overall Study|Protocol Violation|0
4795123|NCT01358734|16536245|P1|Overall Study|Protocol Violation|0
4795124|NCT01358734|16536243|P3|Overall Study|Other|4
4795125|NCT01358734|16536244|P2|Overall Study|Other|5
4795126|NCT01358734|16536245|P1|Overall Study|Other|2
4795127|NCT01358734|16536243|P3|Overall Study|Non-compliance with study drug|1
4795128|NCT01358734|16536244|P2|Overall Study|Non-compliance with study drug|0
4795129|NCT01358734|16536245|P1|Overall Study|Non-compliance with study drug|0
4795130|NCT01358734|16536243|P3|Overall Study|Progressive Disease|16
4795131|NCT01358734|16536244|P2|Overall Study|Progressive Disease|13
4795132|NCT01358734|16536245|P1|Overall Study|Progressive Disease|5
4795133|NCT01358734|16536243|P3|Overall Study|Death|2
4795134|NCT01358734|16536244|P2|Overall Study|Death|7
4795135|NCT01358734|16536245|P1|Overall Study|Death|3
4795136|NCT01358734|16536243|P3|Overall Study|Withdrawal by Subject|3
4795137|NCT01358734|16536244|P2|Overall Study|Withdrawal by Subject|6
4795138|NCT01358734|16536245|P1|Overall Study|Withdrawal by Subject|1
4795139|NCT01358734|16536243|P3|Overall Study|Lack of Efficacy|3
4795140|NCT01358734|16536244|P2|Overall Study|Lack of Efficacy|1
4795141|NCT01358734|16536245|P1|Overall Study|Lack of Efficacy|0
4795142|NCT01358734|16536243|P3|Overall Study|Adverse Event|3
4795143|NCT01358734|16536244|P2|Overall Study|Adverse Event|7
4795144|NCT01358734|16536245|P1|Overall Study|Adverse Event|4
4795145|NCT01358708|16536291|P2|Double-Blind Treatment Phase|Protocol Violation|0
4795146|NCT01358708|16536292|P1|Double-Blind Treatment Phase|Protocol Violation|1
4795147|NCT01358708|16536291|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
4795148|NCT01358708|16536292|P1|Double-Blind Treatment Phase|Lost to Follow-up|2
4795149|NCT01358578|16536315|P6|Follow-up Period|Physician Decision|0
4795150|NCT01358578|16536316|P5|Follow-up Period|Physician Decision|0
4795151|NCT01358578|16536317|P4|Follow-up Period|Physician Decision|2
4795152|NCT01358578|16536318|P3|Follow-up Period|Physician Decision|0
4795153|NCT01358578|16536319|P2|Follow-up Period|Physician Decision|1
4795154|NCT01358578|16536320|P1|Follow-up Period|Physician Decision|1
4795155|NCT01358578|16536315|P6|Follow-up Period|Withdrawal by Subject|0
4795156|NCT01358578|16536316|P5|Follow-up Period|Withdrawal by Subject|0
4795157|NCT01358578|16536317|P4|Follow-up Period|Withdrawal by Subject|12
4795158|NCT01358578|16536318|P3|Follow-up Period|Withdrawal by Subject|1
4795159|NCT01358578|16536319|P2|Follow-up Period|Withdrawal by Subject|3
4795160|NCT01358578|16536320|P1|Follow-up Period|Withdrawal by Subject|3
4795161|NCT01358578|16536315|P6|Follow-up Period|Pregnancy|0
4795162|NCT01358578|16536316|P5|Follow-up Period|Pregnancy|0
4795163|NCT01358578|16536317|P4|Follow-up Period|Pregnancy|0
4795164|NCT01358578|16536318|P3|Follow-up Period|Pregnancy|0
4795165|NCT01358578|16536319|P2|Follow-up Period|Pregnancy|0
4795166|NCT01358578|16536320|P1|Follow-up Period|Pregnancy|1
4795167|NCT01358578|16536315|P6|Follow-up Period|non- compliance with study treatment|0
4795168|NCT01358578|16536316|P5|Follow-up Period|non- compliance with study treatment|0
4795169|NCT01358578|16536317|P4|Follow-up Period|non- compliance with study treatment|0
4795170|NCT01358578|16536318|P3|Follow-up Period|non- compliance with study treatment|0
4795171|NCT01358578|16536319|P2|Follow-up Period|non- compliance with study treatment|0
4795172|NCT01358578|16536320|P1|Follow-up Period|non- compliance with study treatment|1
4795173|NCT01358578|16536315|P6|Follow-up Period|Lost to Follow-up|0
4795174|NCT01358578|16536316|P5|Follow-up Period|Lost to Follow-up|0
4795175|NCT01358578|16536317|P4|Follow-up Period|Lost to Follow-up|4
4795176|NCT01358578|16536318|P3|Follow-up Period|Lost to Follow-up|0
4795177|NCT01358578|16536319|P2|Follow-up Period|Lost to Follow-up|1
4795178|NCT01358578|16536320|P1|Follow-up Period|Lost to Follow-up|0
4795179|NCT01358578|16536315|P6|Follow-up Period|Lack of Efficacy|0
4795180|NCT01358578|16536316|P5|Follow-up Period|Lack of Efficacy|0
4795181|NCT01358578|16536317|P4|Follow-up Period|Lack of Efficacy|1
4795182|NCT01358578|16536318|P3|Follow-up Period|Lack of Efficacy|4
4795183|NCT01358578|16536319|P2|Follow-up Period|Lack of Efficacy|0
4795184|NCT01358578|16536320|P1|Follow-up Period|Lack of Efficacy|3
4795185|NCT01358578|16536315|P6|Follow-up Period|Adverse Event|0
4795186|NCT01358578|16536316|P5|Follow-up Period|Adverse Event|0
4795187|NCT01358578|16536317|P4|Follow-up Period|Adverse Event|0
4795188|NCT01358578|16536318|P3|Follow-up Period|Adverse Event|0
4795189|NCT01358578|16536319|P2|Follow-up Period|Adverse Event|1
4795190|NCT01358578|16536320|P1|Follow-up Period|Adverse Event|1
4795191|NCT01358578|16536315|P6|Maintenance Period|Withdrawal by Subject|3
4795192|NCT01358578|16536316|P5|Maintenance Period|Withdrawal by Subject|6
4795193|NCT01358578|16536317|P4|Maintenance Period|Withdrawal by Subject|15
4795194|NCT01358578|16536318|P3|Maintenance Period|Withdrawal by Subject|2
4795195|NCT01358578|16536319|P2|Maintenance Period|Withdrawal by Subject|7
4795196|NCT01358578|16536320|P1|Maintenance Period|Withdrawal by Subject|12
4795197|NCT01358578|16536315|P6|Maintenance Period|Protocol deviation|2
4795198|NCT01358578|16536316|P5|Maintenance Period|Protocol deviation|2
4795199|NCT01358578|16536317|P4|Maintenance Period|Protocol deviation|2
4795200|NCT01358578|16536318|P3|Maintenance Period|Protocol deviation|0
4795201|NCT01358578|16536319|P2|Maintenance Period|Protocol deviation|4
4795202|NCT01358578|16536320|P1|Maintenance Period|Protocol deviation|7
4795203|NCT01358578|16536315|P6|Maintenance Period|Pregnancy|0
4795204|NCT01358578|16536316|P5|Maintenance Period|Pregnancy|0
4795205|NCT01358578|16536317|P4|Maintenance Period|Pregnancy|0
4795206|NCT01358578|16536318|P3|Maintenance Period|Pregnancy|0
4795207|NCT01358578|16536319|P2|Maintenance Period|Pregnancy|0
4795208|NCT01358578|16536320|P1|Maintenance Period|Pregnancy|1
4795209|NCT01358578|16536315|P6|Maintenance Period|Physician Decision|0
4795210|NCT01358578|16536316|P5|Maintenance Period|Physician Decision|0
4795211|NCT01358578|16536317|P4|Maintenance Period|Physician Decision|1
4795212|NCT01358578|16536318|P3|Maintenance Period|Physician Decision|0
4795213|NCT01358578|16536319|P2|Maintenance Period|Physician Decision|1
4795214|NCT01358578|16536320|P1|Maintenance Period|Physician Decision|0
4795215|NCT01358578|16536315|P6|Maintenance Period|Non-compliance with study treatment|2
4795216|NCT01358578|16536316|P5|Maintenance Period|Non-compliance with study treatment|1
4795217|NCT01358578|16536317|P4|Maintenance Period|Non-compliance with study treatment|2
4795218|NCT01358578|16536318|P3|Maintenance Period|Non-compliance with study treatment|0
4795219|NCT01358578|16536319|P2|Maintenance Period|Non-compliance with study treatment|1
4795220|NCT01358578|16536320|P1|Maintenance Period|Non-compliance with study treatment|3
4795221|NCT01358578|16536315|P6|Maintenance Period|Lost to Follow-up|1
4795222|NCT01358578|16536316|P5|Maintenance Period|Lost to Follow-up|1
4795223|NCT01358578|16536317|P4|Maintenance Period|Lost to Follow-up|5
4795224|NCT01358578|16536318|P3|Maintenance Period|Lost to Follow-up|0
4795225|NCT01358578|16536319|P2|Maintenance Period|Lost to Follow-up|0
4795226|NCT01358578|16536320|P1|Maintenance Period|Lost to Follow-up|4
4795227|NCT01358578|16536315|P6|Maintenance Period|Lack of Efficacy|0
4795228|NCT01358578|16536316|P5|Maintenance Period|Lack of Efficacy|3
4795229|NCT01358578|16536317|P4|Maintenance Period|Lack of Efficacy|11
4795230|NCT01358578|16536318|P3|Maintenance Period|Lack of Efficacy|0
4795231|NCT01358578|16536319|P2|Maintenance Period|Lack of Efficacy|2
4795232|NCT01358578|16536320|P1|Maintenance Period|Lack of Efficacy|10
4795233|NCT01358578|16536315|P6|Maintenance Period|Adverse Event|3
4795234|NCT01358578|16536316|P5|Maintenance Period|Adverse Event|4
4795235|NCT01358578|16536317|P4|Maintenance Period|Adverse Event|6
4795236|NCT01358578|16536318|P3|Maintenance Period|Adverse Event|0
4795237|NCT01358578|16536319|P2|Maintenance Period|Adverse Event|7
4795238|NCT01358578|16536320|P1|Maintenance Period|Adverse Event|2
4795239|NCT01358578|16536315|P6|Induction Period|Withdrawal by Subject|0
4795240|NCT01358578|16536316|P5|Induction Period|Withdrawal by Subject|0
4795241|NCT01358578|16536317|P4|Induction Period|Withdrawal by Subject|6
4795242|NCT01358578|16536318|P3|Induction Period|Withdrawal by Subject|10
4795243|NCT01358578|16536319|P2|Induction Period|Withdrawal by Subject|5
4795244|NCT01358578|16536320|P1|Induction Period|Withdrawal by Subject|5
4795245|NCT01358578|16536315|P6|Induction Period|technical problems|0
4795246|NCT01358578|16536316|P5|Induction Period|technical problems|0
4795247|NCT01358578|16536317|P4|Induction Period|technical problems|1
4795248|NCT01358578|16536318|P3|Induction Period|technical problems|1
4795249|NCT01358578|16536319|P2|Induction Period|technical problems|0
4795250|NCT01358578|16536320|P1|Induction Period|technical problems|0
4795251|NCT01358578|16536315|P6|Induction Period|Protocol Deviation|0
4795252|NCT01358578|16536316|P5|Induction Period|Protocol Deviation|0
4795253|NCT01358578|16536317|P4|Induction Period|Protocol Deviation|3
4795254|NCT01358578|16536318|P3|Induction Period|Protocol Deviation|0
4795255|NCT01358578|16536319|P2|Induction Period|Protocol Deviation|5
4795256|NCT01358578|16536320|P1|Induction Period|Protocol Deviation|3
4795257|NCT01358578|16536315|P6|Induction Period|Physician Decision|0
4795258|NCT01358578|16536316|P5|Induction Period|Physician Decision|0
4795259|NCT01358578|16536317|P4|Induction Period|Physician Decision|0
4795260|NCT01358578|16536318|P3|Induction Period|Physician Decision|2
4795261|NCT01358578|16536319|P2|Induction Period|Physician Decision|1
4795262|NCT01358578|16536320|P1|Induction Period|Physician Decision|2
4795263|NCT01358578|16536315|P6|Induction Period|Lost to Follow-up|0
4795264|NCT01358578|16536316|P5|Induction Period|Lost to Follow-up|0
4795265|NCT01358578|16536317|P4|Induction Period|Lost to Follow-up|4
4795266|NCT01358578|16536318|P3|Induction Period|Lost to Follow-up|1
4795267|NCT01358578|16536319|P2|Induction Period|Lost to Follow-up|0
4795268|NCT01358578|16536320|P1|Induction Period|Lost to Follow-up|0
4795269|NCT01358578|16536315|P6|Induction Period|Lack of Efficacy|0
4795270|NCT01358578|16536316|P5|Induction Period|Lack of Efficacy|0
4795271|NCT01358578|16536317|P4|Induction Period|Lack of Efficacy|1
4795272|NCT01358578|16536318|P3|Induction Period|Lack of Efficacy|9
4795273|NCT01358578|16536319|P2|Induction Period|Lack of Efficacy|0
4795274|NCT01358578|16536320|P1|Induction Period|Lack of Efficacy|0
4795275|NCT01358578|16536315|P6|Induction Period|Adverse Event|0
4795276|NCT01358578|16536316|P5|Induction Period|Adverse Event|0
4795277|NCT01358578|16536317|P4|Induction Period|Adverse Event|6
4795278|NCT01358578|16536318|P3|Induction Period|Adverse Event|2
4795279|NCT01358578|16536319|P2|Induction Period|Adverse Event|4
4795280|NCT01358578|16536320|P1|Induction Period|Adverse Event|2
4795281|NCT01358526|16536372|P3|Double-blind Phase|Administrative|10
4795282|NCT01358526|16536373|P2|Double-blind Phase|Administrative|6
4795283|NCT01358526|16536374|P1|Double-blind Phase|Administrative|0
4795284|NCT01358526|16536372|P3|Double-blind Phase|Confirmed or suspected diversion|6
4795285|NCT01358526|16536373|P2|Double-blind Phase|Confirmed or suspected diversion|5
4795286|NCT01358526|16536374|P1|Double-blind Phase|Confirmed or suspected diversion|0
4795287|NCT01358526|16536372|P3|Double-blind Phase|Lack of Efficacy|73
4795288|NCT01358526|16536373|P2|Double-blind Phase|Lack of Efficacy|31
4795289|NCT01358526|16536374|P1|Double-blind Phase|Lack of Efficacy|0
4795290|NCT01358526|16536372|P3|Double-blind Phase|Lost to Follow-up|1
4795291|NCT01358526|16536373|P2|Double-blind Phase|Lost to Follow-up|4
4795292|NCT01358526|16536374|P1|Double-blind Phase|Lost to Follow-up|0
4795293|NCT01358526|16536372|P3|Double-blind Phase|Withdrawal by Subject|8
4795294|NCT01358526|16536373|P2|Double-blind Phase|Withdrawal by Subject|10
4795295|NCT01358526|16536374|P1|Double-blind Phase|Withdrawal by Subject|0
4795296|NCT01358526|16536372|P3|Double-blind Phase|Adverse Event|23
4795297|NCT01358526|16536373|P2|Double-blind Phase|Adverse Event|24
4795298|NCT01358526|16536374|P1|Double-blind Phase|Adverse Event|0
4795299|NCT01358526|16536372|P3|Open-label Titration Period|Did not qualify|0
4795300|NCT01358526|16536373|P2|Open-label Titration Period|Did not qualify|0
4795301|NCT01358526|16536374|P1|Open-label Titration Period|Did not qualify|178
4795302|NCT01358526|16536372|P3|Open-label Titration Period|Administrative|0
4795303|NCT01358526|16536373|P2|Open-label Titration Period|Administrative|0
4795304|NCT01358526|16536374|P1|Open-label Titration Period|Administrative|8
4795305|NCT01358526|16536372|P3|Open-label Titration Period|Confirmed or suspected diversion|0
4795306|NCT01358526|16536373|P2|Open-label Titration Period|Confirmed or suspected diversion|0
4795307|NCT01358526|16536374|P1|Open-label Titration Period|Confirmed or suspected diversion|16
4795308|NCT01358526|16536372|P3|Open-label Titration Period|Lack of Efficacy|0
4795309|NCT01358526|16536373|P2|Open-label Titration Period|Lack of Efficacy|0
4795310|NCT01358526|16536374|P1|Open-label Titration Period|Lack of Efficacy|107
4795311|NCT01358526|16536372|P3|Open-label Titration Period|Lost to Follow-up|0
4795312|NCT01358526|16536373|P2|Open-label Titration Period|Lost to Follow-up|0
4795313|NCT01358526|16536374|P1|Open-label Titration Period|Lost to Follow-up|25
4795314|NCT01358526|16536372|P3|Open-label Titration Period|Withdrawal by Subject|0
4795315|NCT01358526|16536373|P2|Open-label Titration Period|Withdrawal by Subject|0
4795316|NCT01358526|16536374|P1|Open-label Titration Period|Withdrawal by Subject|65
4795317|NCT01358526|16536372|P3|Open-label Titration Period|Adverse Event|0
4795318|NCT01358526|16536373|P2|Open-label Titration Period|Adverse Event|0
4795319|NCT01358526|16536374|P1|Open-label Titration Period|Adverse Event|95
4795320|NCT01358357|16536391|P3|Double-Blind Phase|Administrative|0
4795321|NCT01358357|16536392|P2|Double-Blind Phase|Administrative|1
4795322|NCT01358357|16536393|P1|Double-Blind Phase|Administrative|0
4795323|NCT01358357|16536391|P3|Double-Blind Phase|Recurrence of mood event|0
4795324|NCT01358357|16536392|P2|Double-Blind Phase|Recurrence of mood event|64
4795325|NCT01358357|16536393|P1|Double-Blind Phase|Recurrence of mood event|48
4795326|NCT01358357|16536391|P3|Double-Blind Phase|Terminated at study completion|0
4795327|NCT01358357|16536392|P2|Double-Blind Phase|Terminated at study completion|0
4795328|NCT01358357|16536393|P1|Double-Blind Phase|Terminated at study completion|2
4795329|NCT01358357|16536391|P3|Double-Blind Phase|Protocol Violation|0
4795330|NCT01358357|16536392|P2|Double-Blind Phase|Protocol Violation|12
4795331|NCT01358357|16536393|P1|Double-Blind Phase|Protocol Violation|16
4795332|NCT01358357|16536391|P3|Double-Blind Phase|Protocol Violation|0
4795333|NCT01358357|16536392|P2|Double-Blind Phase|Protocol Violation|11
4795334|NCT01358357|16536393|P1|Double-Blind Phase|Protocol Violation|1
4795335|NCT01358357|16536391|P3|Double-Blind Phase|Lost to Follow-up|0
4795336|NCT01358357|16536392|P2|Double-Blind Phase|Lost to Follow-up|7
4795337|NCT01358357|16536393|P1|Double-Blind Phase|Lost to Follow-up|5
4795338|NCT01358357|16536391|P3|Double-Blind Phase|Adverse Event|0
4795339|NCT01358357|16536392|P2|Double-Blind Phase|Adverse Event|5
4795340|NCT01358357|16536393|P1|Double-Blind Phase|Adverse Event|8
4795341|NCT01358357|16536391|P3|Open Label Phase|Mood episode|42
4795342|NCT01358357|16536392|P2|Open Label Phase|Mood episode|0
4795343|NCT01358357|16536393|P1|Open Label Phase|Mood episode|0
4795344|NCT01358357|16536391|P3|Open Label Phase|Terminated at study completion|5
4795345|NCT01358357|16536392|P2|Open Label Phase|Terminated at study completion|0
4795346|NCT01358357|16536393|P1|Open Label Phase|Terminated at study completion|0
4795347|NCT01358357|16536391|P3|Open Label Phase|Did not meet criteria for DB phase|16
4795348|NCT01358357|16536392|P2|Open Label Phase|Did not meet criteria for DB phase|0
4795349|NCT01358357|16536393|P1|Open Label Phase|Did not meet criteria for DB phase|0
4795350|NCT01358357|16536391|P3|Open Label Phase|Withdrawal by Subject|112
4795351|NCT01358357|16536392|P2|Open Label Phase|Withdrawal by Subject|0
4795352|NCT01358357|16536393|P1|Open Label Phase|Withdrawal by Subject|0
4795353|NCT01358357|16536391|P3|Open Label Phase|Protocol Violation|45
4795354|NCT01358357|16536392|P2|Open Label Phase|Protocol Violation|0
4795355|NCT01358357|16536393|P1|Open Label Phase|Protocol Violation|0
4795356|NCT01358357|16536391|P3|Open Label Phase|Lost to Follow-up|76
4795357|NCT01358357|16536392|P2|Open Label Phase|Lost to Follow-up|0
4795358|NCT01358357|16536393|P1|Open Label Phase|Lost to Follow-up|0
4795359|NCT01358357|16536391|P3|Open Label Phase|Lack of Efficacy|107
4795360|NCT01358357|16536392|P2|Open Label Phase|Lack of Efficacy|0
4795361|NCT01358357|16536393|P1|Open Label Phase|Lack of Efficacy|0
4795362|NCT01358357|16536391|P3|Open Label Phase|Adverse Event|59
4795363|NCT01358357|16536392|P2|Open Label Phase|Adverse Event|0
4795364|NCT01358357|16536393|P1|Open Label Phase|Adverse Event|0
4795365|NCT01358331|16536432|P6|Overall Study|Progress of disease under investigation|0
4795366|NCT01358331|16536433|P5|Overall Study|Progress of disease under investigation|3
4795367|NCT01358331|16536434|P4|Overall Study|Progress of disease under investigation|1
4795368|NCT01358331|16536435|P3|Overall Study|Progress of disease under investigation|3
4795369|NCT01358331|16536436|P2|Overall Study|Progress of disease under investigation|2
4795370|NCT01358331|16536437|P1|Overall Study|Progress of disease under investigation|1
4795371|NCT01358331|16536432|P6|Overall Study|Participants did not wish to continue|0
4795372|NCT01358331|16536433|P5|Overall Study|Participants did not wish to continue|1
4795373|NCT01358331|16536434|P4|Overall Study|Participants did not wish to continue|0
4795374|NCT01358331|16536435|P3|Overall Study|Participants did not wish to continue|0
4795375|NCT01358331|16536436|P2|Overall Study|Participants did not wish to continue|0
4795376|NCT01358331|16536437|P1|Overall Study|Participants did not wish to continue|0
4795377|NCT01358331|16536432|P6|Overall Study|Symptomatic Deterioration|0
4795378|NCT01358331|16536433|P5|Overall Study|Symptomatic Deterioration|1
4795379|NCT01358331|16536434|P4|Overall Study|Symptomatic Deterioration|0
4795380|NCT01358331|16536435|P3|Overall Study|Symptomatic Deterioration|0
4795381|NCT01358331|16536436|P2|Overall Study|Symptomatic Deterioration|0
4795382|NCT01358331|16536437|P1|Overall Study|Symptomatic Deterioration|0
4795383|NCT01358331|16536432|P6|Overall Study|Adverse Events|5
4795384|NCT01358331|16536433|P5|Overall Study|Adverse Events|1
4795385|NCT01358331|16536434|P4|Overall Study|Adverse Events|0
4795386|NCT01358331|16536435|P3|Overall Study|Adverse Events|1
4795387|NCT01358331|16536436|P2|Overall Study|Adverse Events|1
4795388|NCT01358331|16536437|P1|Overall Study|Adverse Events|1
4795389|NCT01358331|16536432|P6|Overall Study|Withdrawal by Subject|1
4795390|NCT01358331|16536433|P5|Overall Study|Withdrawal by Subject|1
4795391|NCT01358331|16536434|P4|Overall Study|Withdrawal by Subject|1
4795392|NCT01358331|16536435|P3|Overall Study|Withdrawal by Subject|0
4795393|NCT01358331|16536436|P2|Overall Study|Withdrawal by Subject|0
4795394|NCT01358331|16536437|P1|Overall Study|Withdrawal by Subject|0
4795395|NCT01358331|16536432|P6|Overall Study|Lost to Follow-up|0
4795396|NCT01358331|16536433|P5|Overall Study|Lost to Follow-up|0
4795397|NCT01358331|16536434|P4|Overall Study|Lost to Follow-up|1
4795398|NCT01358331|16536435|P3|Overall Study|Lost to Follow-up|0
4795399|NCT01358331|16536436|P2|Overall Study|Lost to Follow-up|0
4795400|NCT01358331|16536437|P1|Overall Study|Lost to Follow-up|0
4795401|NCT01358175|16536489|P3|Overall Study|Adverse Event|11
4795402|NCT01358175|16536490|P2|Overall Study|Adverse Event|11
4795403|NCT01358175|16536491|P1|Overall Study|Adverse Event|6
4795404|NCT01358175|16536489|P3|Overall Study|Lack of Efficacy|6
4795405|NCT01358175|16536490|P2|Overall Study|Lack of Efficacy|8
4795406|NCT01358175|16536491|P1|Overall Study|Lack of Efficacy|3
4795407|NCT01358175|16536489|P3|Overall Study|Lost to Follow-up|3
4795408|NCT01358175|16536490|P2|Overall Study|Lost to Follow-up|1
4795409|NCT01358175|16536491|P1|Overall Study|Lost to Follow-up|1
4795410|NCT01358175|16536489|P3|Overall Study|Non Compliance with Study Treatment|1
4795411|NCT01358175|16536490|P2|Overall Study|Non Compliance with Study Treatment|1
4795412|NCT01358175|16536491|P1|Overall Study|Non Compliance with Study Treatment|0
4795413|NCT01358175|16536489|P3|Overall Study|Physician Decision|0
4795414|NCT01358175|16536490|P2|Overall Study|Physician Decision|0
4795415|NCT01358175|16536491|P1|Overall Study|Physician Decision|1
4795416|NCT01358175|16536489|P3|Overall Study|Pregnancy|0
4795417|NCT01358175|16536490|P2|Overall Study|Pregnancy|1
4795418|NCT01358175|16536491|P1|Overall Study|Pregnancy|0
4795419|NCT01358175|16536489|P3|Overall Study|Technical issues|0
4795420|NCT01358175|16536490|P2|Overall Study|Technical issues|1
4795421|NCT01358175|16536491|P1|Overall Study|Technical issues|0
4795422|NCT01358175|16536489|P3|Overall Study|Withdrawal by Subject|10
4795423|NCT01358175|16536490|P2|Overall Study|Withdrawal by Subject|5
4795424|NCT01358175|16536491|P1|Overall Study|Withdrawal by Subject|9
4795425|NCT01358175|16536489|P3|Overall Study|Death|1
4795426|NCT01358175|16536490|P2|Overall Study|Death|0
4795427|NCT01358175|16536491|P1|Overall Study|Death|1
4795428|NCT01357980|16536528|P4|Overall Study|Consent withdrawn|0
4795429|NCT01357980|16536529|P3|Overall Study|Consent withdrawn|1
4795430|NCT01357980|16536530|P2|Overall Study|Consent withdrawn|0
4795431|NCT01357980|16536531|P1|Overall Study|Consent withdrawn|0
4795432|NCT01357980|16536528|P4|Overall Study|Lack of Efficacy|0
4795433|NCT01357980|16536529|P3|Overall Study|Lack of Efficacy|0
4795434|NCT01357980|16536530|P2|Overall Study|Lack of Efficacy|1
4795435|NCT01357980|16536531|P1|Overall Study|Lack of Efficacy|0
4795436|NCT01357915|16536575|P2|Overall Study|Lost to Follow-up|0
4795437|NCT01357915|16536576|P1|Overall Study|Lost to Follow-up|3
4795438|NCT01357889|16536594|P2|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0
4795439|NCT01357889|16536595|P1|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1
4795440|NCT01357889|16536594|P2|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0
4795441|NCT01357889|16536595|P1|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1
4795442|NCT01357889|16536594|P2|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4
4795443|NCT01357889|16536595|P1|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0
4795444|NCT01357889|16536594|P2|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0
4795445|NCT01357889|16536595|P1|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1
4795446|NCT01357889|16536594|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
4795447|NCT01357889|16536595|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7
4795448|NCT01357889|16536594|P2|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1
4795449|NCT01357889|16536595|P1|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2
4795450|NCT01357889|16536594|P2|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2
4795451|NCT01357889|16536595|P1|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5
4795452|NCT01357889|16536594|P2|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2
4795453|NCT01357889|16536595|P1|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0
4795454|NCT01357889|16536594|P2|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2
4795455|NCT01357889|16536595|P1|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0
4795456|NCT01357889|16536594|P2|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
4795457|NCT01357889|16536595|P1|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2
4795458|NCT01357889|16536594|P2|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0
4795459|NCT01357889|16536595|P1|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1
4795460|NCT01357889|16536594|P2|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
4795461|NCT01357889|16536595|P1|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1
4795462|NCT01357889|16536594|P2|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1
4795463|NCT01357889|16536595|P1|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2
4795464|NCT01357850|16536639|P4|Overall Study|Lost to Follow-up|0
4795465|NCT01357850|16536640|P3|Overall Study|Lost to Follow-up|0
4795466|NCT01357850|16536641|P2|Overall Study|Lost to Follow-up|0
4795467|NCT01357850|16536642|P1|Overall Study|Lost to Follow-up|1
4795468|NCT01357655|16536733|P2|Overall Study|Subject Withdrew Consent|0
4795469|NCT01357655|16536734|P1|Overall Study|Subject Withdrew Consent|1
4795470|NCT01357655|16536733|P2|Overall Study|Study Drug Toxicity|0
4795471|NCT01357655|16536734|P1|Overall Study|Study Drug Toxicity|11
4795472|NCT01357655|16536733|P2|Overall Study|Reason Unspecified|0
4795473|NCT01357655|16536734|P1|Overall Study|Reason Unspecified|1
4795474|NCT01357655|16536733|P2|Overall Study|Maximum Clinical Benefit|0
4795475|NCT01357655|16536734|P1|Overall Study|Maximum Clinical Benefit|2
4795476|NCT01357655|16536733|P2|Overall Study|Lost to Follow-up|0
4795477|NCT01357655|16536734|P1|Overall Study|Lost to Follow-up|2
4795478|NCT01357655|16536733|P2|Overall Study|Disease Progression|0
4795479|NCT01357655|16536734|P1|Overall Study|Disease Progression|1
4795480|NCT01357655|16536733|P2|Overall Study|Adverse Event Unrelated to Study Drug|0
4795481|NCT01357655|16536734|P1|Overall Study|Adverse Event Unrelated to Study Drug|3
4795482|NCT01357655|16536733|P2|Overall Study|Administrative Reason by Sponsor|0
4795563|NCT01356966|16536958|P2|Overall Study|Withdrawal by Subject|2
4795483|NCT01357655|16536734|P1|Overall Study|Administrative Reason by Sponsor|45
4795484|NCT01357616|16536751|P2|Overall Study|Withdrawal by Subject|0
4795485|NCT01357616|16536752|P1|Overall Study|Withdrawal by Subject|1
4795486|NCT01357616|16536751|P2|Overall Study|Decision Unrelated to Adverse Event|1
4795487|NCT01357616|16536752|P1|Overall Study|Decision Unrelated to Adverse Event|3
4795488|NCT01357616|16536751|P2|Overall Study|Inadequate Control of IOP|2
4795489|NCT01357616|16536752|P1|Overall Study|Inadequate Control of IOP|1
4795490|NCT01357616|16536751|P2|Overall Study|Protocol Violation|2
4795491|NCT01357616|16536752|P1|Overall Study|Protocol Violation|0
4795492|NCT01357616|16536751|P2|Overall Study|Lost to Follow-up|3
4795493|NCT01357616|16536752|P1|Overall Study|Lost to Follow-up|4
4795494|NCT01357616|16536751|P2|Overall Study|Adverse Event|1
4795495|NCT01357616|16536752|P1|Overall Study|Adverse Event|1
4795496|NCT01357577|16536766|P2|Overall Study|look at data in database?|2
4795497|NCT01357577|16536767|P1|Overall Study|look at data in database?|1
4795498|NCT01357577|16536766|P2|Overall Study|Withdrawal by Subject|8
4795499|NCT01357577|16536767|P1|Overall Study|Withdrawal by Subject|16
4795500|NCT01357577|16536766|P2|Overall Study|Lost to Follow-up|16
4795501|NCT01357577|16536767|P1|Overall Study|Lost to Follow-up|20
4795502|NCT01357551|16536794|P2|Overall Study|Lost to Follow-up|6
4795503|NCT01357551|16536795|P1|Overall Study|Lost to Follow-up|16
4795504|NCT01357551|16536794|P2|Overall Study|Death|1
4795505|NCT01357551|16536795|P1|Overall Study|Death|0
4795506|NCT01357551|16536794|P2|Overall Study|Withdrawal by Subject|4
4795507|NCT01357551|16536795|P1|Overall Study|Withdrawal by Subject|6
4795508|NCT01357239|16536843|P4|Stratum II: Partially-Methylated|Subject withdrew consent|1
4795509|NCT01357239|16536844|P3|Stratum II: Partially-Methylated|Subject withdrew consent|1
4795510|NCT01357239|16536845|P2|Stratum II: Partially-Methylated|Subject withdrew consent|0
4795511|NCT01357239|16536846|P1|Stratum II: Partially-Methylated|Subject withdrew consent|0
4795512|NCT01357239|16536843|P4|Stratum II: Partially-Methylated|Adverse Event|1
4795513|NCT01357239|16536844|P3|Stratum II: Partially-Methylated|Adverse Event|0
4795514|NCT01357239|16536845|P2|Stratum II: Partially-Methylated|Adverse Event|0
4795515|NCT01357239|16536846|P1|Stratum II: Partially-Methylated|Adverse Event|0
4795516|NCT01357239|16536843|P4|Stratum I: Fully-Methylated|Adverse Event|0
4795517|NCT01357239|16536844|P3|Stratum I: Fully-Methylated|Adverse Event|1
4795518|NCT01357239|16536845|P2|Stratum I: Fully-Methylated|Adverse Event|0
4795519|NCT01357239|16536846|P1|Stratum I: Fully-Methylated|Adverse Event|0
4795520|NCT01357239|16536843|P4|Stratum: All Patients|Subject withdrew consent|1
4795521|NCT01357239|16536844|P3|Stratum: All Patients|Subject withdrew consent|1
4795522|NCT01357239|16536845|P2|Stratum: All Patients|Subject withdrew consent|0
4795523|NCT01357239|16536846|P1|Stratum: All Patients|Subject withdrew consent|0
4795524|NCT01357239|16536843|P4|Stratum: All Patients|Adverse Event|1
4795525|NCT01357239|16536844|P3|Stratum: All Patients|Adverse Event|1
4795526|NCT01357239|16536845|P2|Stratum: All Patients|Adverse Event|0
4795527|NCT01357239|16536846|P1|Stratum: All Patients|Adverse Event|0
4795528|NCT01357161|16536904|P3|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4
4795529|NCT01357161|16536905|P2|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5
4795530|NCT01357161|16536906|P1|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0
4795531|NCT01357161|16536904|P3|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26
4795532|NCT01357161|16536905|P2|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29
4795533|NCT01357161|16536906|P1|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0
4795534|NCT01357161|16536904|P3|Part 2 (Double-Blind Comparison)|Progressive Disease|3
4795535|NCT01357161|16536905|P2|Part 2 (Double-Blind Comparison)|Progressive Disease|1
4795536|NCT01357161|16536906|P1|Part 2 (Double-Blind Comparison)|Progressive Disease|0
4795537|NCT01357161|16536904|P3|Part 2 (Double-Blind Comparison)|Physician Decision|4
4795538|NCT01357161|16536905|P2|Part 2 (Double-Blind Comparison)|Physician Decision|1
4795539|NCT01357161|16536906|P1|Part 2 (Double-Blind Comparison)|Physician Decision|0
4795540|NCT01357161|16536904|P3|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6
4795541|NCT01357161|16536905|P2|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1
4795542|NCT01357161|16536906|P1|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0
4795543|NCT01357161|16536904|P3|Part 2 (Double-Blind Comparison)|Death|19
4795544|NCT01357161|16536905|P2|Part 2 (Double-Blind Comparison)|Death|22
4795545|NCT01357161|16536906|P1|Part 2 (Double-Blind Comparison)|Death|0
4795546|NCT01357161|16536904|P3|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
4795547|NCT01357161|16536905|P2|Part 1 (Open Label Run-in)|Withdrawal by Subject|0
4795548|NCT01357161|16536906|P1|Part 1 (Open Label Run-in)|Withdrawal by Subject|1
4795549|NCT01357161|16536904|P3|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
4795550|NCT01357161|16536905|P2|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0
4795551|NCT01357161|16536906|P1|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5
4795552|NCT01357161|16536904|P3|Part 1 (Open Label Run-in)|Physician Decision|0
4795553|NCT01357161|16536905|P2|Part 1 (Open Label Run-in)|Physician Decision|0
4795554|NCT01357161|16536906|P1|Part 1 (Open Label Run-in)|Physician Decision|1
4795555|NCT01357161|16536904|P3|Part 1 (Open Label Run-in)|Lost to Follow-up|0
4795556|NCT01357161|16536905|P2|Part 1 (Open Label Run-in)|Lost to Follow-up|0
4795557|NCT01357161|16536906|P1|Part 1 (Open Label Run-in)|Lost to Follow-up|3
4795558|NCT01357161|16536904|P3|Part 1 (Open Label Run-in)|Death|0
4795559|NCT01357161|16536905|P2|Part 1 (Open Label Run-in)|Death|0
4795560|NCT01357161|16536906|P1|Part 1 (Open Label Run-in)|Death|5
4795561|NCT01356966|16536958|P2|Overall Study|Physician Decision|0
4795562|NCT01356966|16536959|P1|Overall Study|Physician Decision|1
4795564|NCT01356966|16536959|P1|Overall Study|Withdrawal by Subject|1
4795565|NCT01356940|16536971|P2|Second Intervention (28 Days)|Withdrawal by Subject|0
4795566|NCT01356940|16536972|P1|Second Intervention (28 Days)|Withdrawal by Subject|1
4795567|NCT01356940|16536971|P2|First Intervention (28 Days)|Adverse Event|0
4795568|NCT01356940|16536972|P1|First Intervention (28 Days)|Adverse Event|1
4795569|NCT01356602|16537001|P3|Overall Study|Adverse Event|1
4795570|NCT01356602|16537002|P2|Overall Study|Adverse Event|1
4795571|NCT01356602|16537003|P1|Overall Study|Adverse Event|0
4795572|NCT01356602|16537001|P3|Overall Study|Lack of Efficacy|4
4795573|NCT01356602|16537002|P2|Overall Study|Lack of Efficacy|1
4795574|NCT01356602|16537003|P1|Overall Study|Lack of Efficacy|0
4795575|NCT01356602|16537001|P3|Overall Study|Withdrawal by Subject|7
4795576|NCT01356602|16537002|P2|Overall Study|Withdrawal by Subject|3
4795577|NCT01356602|16537003|P1|Overall Study|Withdrawal by Subject|4
4795578|NCT01356602|16537001|P3|Overall Study|Lost to Follow-up|6
4795579|NCT01356602|16537002|P2|Overall Study|Lost to Follow-up|5
4795580|NCT01356602|16537003|P1|Overall Study|Lost to Follow-up|4
4795581|NCT01356602|16537001|P3|Overall Study|Administrative Problems|5
4795582|NCT01356602|16537002|P2|Overall Study|Administrative Problems|4
4795583|NCT01356602|16537003|P1|Overall Study|Administrative Problems|1
4795584|NCT01356602|16537001|P3|Overall Study|Protocol Deviation|1
4795585|NCT01356602|16537002|P2|Overall Study|Protocol Deviation|1
4795586|NCT01356602|16537003|P1|Overall Study|Protocol Deviation|0
4795587|NCT01356589|16537062|P1|Overall Study|Dose data not recorded|2
4795588|NCT01356589|16537062|P1|Overall Study|Enrolled, but not treated|3
4795589|NCT01356407|16537119|P2|Overall Study|Not complete Endoscopy|2
4795590|NCT01356407|16537120|P1|Overall Study|Not complete Endoscopy|2
4795591|NCT01356407|16537119|P2|Overall Study|Could not afford IMP administration|1
4795592|NCT01356407|16537120|P1|Overall Study|Could not afford IMP administration|0
4795593|NCT01356407|16537119|P2|Overall Study|Patient Withdrew Consent|1
4795594|NCT01356407|16537120|P1|Overall Study|Patient Withdrew Consent|2
4795595|NCT01356407|16537119|P2|Overall Study|Lost to Follow-up|0
4795596|NCT01356407|16537120|P1|Overall Study|Lost to Follow-up|2
4795597|NCT01355679|16537192|P1|Overall Study|benign tumor types found at biopsy|2
4795598|NCT01355627|16537201|P2|Overall Study|Other|1
4795599|NCT01355627|16537202|P1|Overall Study|Other|1
4795600|NCT01355627|16537201|P2|Overall Study|Fatal Adverse Event|23
4795601|NCT01355627|16537202|P1|Overall Study|Fatal Adverse Event|19
4795602|NCT01355627|16537201|P2|Overall Study|Lost to Follow-up|7
4795603|NCT01355627|16537202|P1|Overall Study|Lost to Follow-up|8
4795604|NCT01355627|16537201|P2|Overall Study|Request By the Patient to Discontinue|7
4795605|NCT01355627|16537202|P1|Overall Study|Request By the Patient to Discontinue|5
4795606|NCT01355523|16537241|P2|Overall Study|Adverse Event|2
4795607|NCT01355523|16537242|P1|Overall Study|Adverse Event|0
4795608|NCT01355523|16537241|P2|Overall Study|Protocol Violation|2
4795609|NCT01355523|16537242|P1|Overall Study|Protocol Violation|0
4795610|NCT01355523|16537241|P2|Overall Study|Lost to Follow-up|2
4795611|NCT01355523|16537242|P1|Overall Study|Lost to Follow-up|0
4795612|NCT01355523|16537241|P2|Overall Study|Withdrawal by Subject|4
4795613|NCT01355523|16537242|P1|Overall Study|Withdrawal by Subject|1
4795614|NCT01355302|16537318|P3|Phase 1b|Study terminated by sponsor|0
4795615|NCT01355302|16537319|P2|Phase 1b|Study terminated by sponsor|0
4795616|NCT01355302|16537320|P1|Phase 1b|Study terminated by sponsor|2
4795617|NCT01355302|16537318|P3|Phase 1b|Death|0
4795618|NCT01355302|16537319|P2|Phase 1b|Death|0
4795619|NCT01355302|16537320|P1|Phase 1b|Death|4
4795620|NCT01355289|16537335|P5|Open Label Extension|Other|3
4795621|NCT01355289|16537336|P4|Open Label Extension|Other|0
4795622|NCT01355289|16537337|P3|Open Label Extension|Other|0
4795623|NCT01355289|16537338|P2|Open Label Extension|Other|0
4795624|NCT01355289|16537339|P1|Open Label Extension|Other|0
4795625|NCT01355289|16537335|P5|Open Label Extension|Inadequate Therapeutic Effect|29
4795626|NCT01355289|16537336|P4|Open Label Extension|Inadequate Therapeutic Effect|0
4795627|NCT01355289|16537337|P3|Open Label Extension|Inadequate Therapeutic Effect|0
4795628|NCT01355289|16537338|P2|Open Label Extension|Inadequate Therapeutic Effect|0
4795629|NCT01355289|16537339|P1|Open Label Extension|Inadequate Therapeutic Effect|0
4795630|NCT01355289|16537335|P5|Open Label Extension|Lost to Follow-up|1
4795631|NCT01355289|16537336|P4|Open Label Extension|Lost to Follow-up|0
4795632|NCT01355289|16537337|P3|Open Label Extension|Lost to Follow-up|0
4795633|NCT01355289|16537338|P2|Open Label Extension|Lost to Follow-up|0
4795634|NCT01355289|16537339|P1|Open Label Extension|Lost to Follow-up|0
4795635|NCT01355289|16537335|P5|Open Label Extension|Adverse Event, Non-Fatal|1
4795636|NCT01355289|16537336|P4|Open Label Extension|Adverse Event, Non-Fatal|0
4795637|NCT01355289|16537337|P3|Open Label Extension|Adverse Event, Non-Fatal|0
4795638|NCT01355289|16537338|P2|Open Label Extension|Adverse Event, Non-Fatal|0
4795639|NCT01355289|16537339|P1|Open Label Extension|Adverse Event, Non-Fatal|0
4795640|NCT01355289|16537335|P5|Core Study|Other|0
4795641|NCT01355289|16537336|P4|Core Study|Other|1
4795642|NCT01355289|16537337|P3|Core Study|Other|0
4795643|NCT01355289|16537338|P2|Core Study|Other|0
4795644|NCT01355289|16537339|P1|Core Study|Other|0
4795645|NCT01355289|16537335|P5|Core Study|Inadequate Therapeutic Effect|0
4795646|NCT01355289|16537336|P4|Core Study|Inadequate Therapeutic Effect|1
4795647|NCT01355289|16537337|P3|Core Study|Inadequate Therapeutic Effect|0
4795648|NCT01355289|16537338|P2|Core Study|Inadequate Therapeutic Effect|0
4795649|NCT01355289|16537339|P1|Core Study|Inadequate Therapeutic Effect|0
4795650|NCT01355289|16537335|P5|Core Study|Adverse Event, Non-Fatal|0
4795651|NCT01355289|16537336|P4|Core Study|Adverse Event, Non-Fatal|0
4795652|NCT01355289|16537337|P3|Core Study|Adverse Event, Non-Fatal|0
4795653|NCT01355289|16537338|P2|Core Study|Adverse Event, Non-Fatal|0
4795654|NCT01355289|16537339|P1|Core Study|Adverse Event, Non-Fatal|1
4795655|NCT01355159|16537391|P2|Overall Study|Early intrauterine fetal death|6
4795656|NCT01355159|16537392|P1|Overall Study|Early intrauterine fetal death|6
4795657|NCT01355159|16537391|P2|Overall Study|Spontaneous abortion (<20 weeks)|15
4795658|NCT01355159|16537392|P1|Overall Study|Spontaneous abortion (<20 weeks)|22
4795659|NCT01355159|16537391|P2|Overall Study|No primary outcome data|11
4795660|NCT01355159|16537392|P1|Overall Study|No primary outcome data|17
4795661|NCT01355159|16537391|P2|Overall Study|Withdrew consent|47
4795662|NCT01355159|16537392|P1|Overall Study|Withdrew consent|39
4795663|NCT01355081|16537449|P3|Overall Study|Non Compliance with Study Medication|0
4795664|NCT01355081|16537450|P2|Overall Study|Non Compliance with Study Medication|1
4795665|NCT01355081|16537451|P1|Overall Study|Non Compliance with Study Medication|0
4795666|NCT01355081|16537449|P3|Overall Study|Lack of Efficacy|1
4795667|NCT01355081|16537450|P2|Overall Study|Lack of Efficacy|1
4795668|NCT01355081|16537451|P1|Overall Study|Lack of Efficacy|2
4795669|NCT01355081|16537449|P3|Overall Study|Withdrawal of Consent|3
4795670|NCT01355081|16537450|P2|Overall Study|Withdrawal of Consent|3
4795671|NCT01355081|16537451|P1|Overall Study|Withdrawal of Consent|2
4795672|NCT01355081|16537449|P3|Overall Study|Lost to Follow-up|1
4795673|NCT01355081|16537450|P2|Overall Study|Lost to Follow-up|0
4795674|NCT01355081|16537451|P1|Overall Study|Lost to Follow-up|0
4795675|NCT01355081|16537449|P3|Overall Study|Major Protocol Deviation|0
4795676|NCT01355081|16537450|P2|Overall Study|Major Protocol Deviation|1
4795677|NCT01355081|16537451|P1|Overall Study|Major Protocol Deviation|0
4795678|NCT01355081|16537449|P3|Overall Study|Pretreatment Event or Adverse Event|6
4795679|NCT01355081|16537450|P2|Overall Study|Pretreatment Event or Adverse Event|4
4795680|NCT01355081|16537451|P1|Overall Study|Pretreatment Event or Adverse Event|3
4795681|NCT01355068|16537474|P2|First Intervention Period|Withdrawal by Subject|1
4795682|NCT01355068|16537475|P1|First Intervention Period|Withdrawal by Subject|0
4795683|NCT01355068|16537474|P2|First Intervention Period|Adverse Event|1
4795684|NCT01355068|16537475|P1|First Intervention Period|Adverse Event|0
4795685|NCT01354964|16537500|P2|Overall Study|Physician Decision|0
4795686|NCT01354964|16537501|P1|Overall Study|Physician Decision|1
4795687|NCT01354964|16537500|P2|Overall Study|IV access issues|1
4795688|NCT01354964|16537501|P1|Overall Study|IV access issues|1
4795689|NCT01354964|16537500|P2|Overall Study|Lost to Follow-up|0
4795690|NCT01354964|16537501|P1|Overall Study|Lost to Follow-up|2
4795691|NCT01354938|16537524|P1|Overall Study|Lost to Follow-up|1
4795692|NCT01354899|16537530|P1|Overall Study|Protocol Violation|1
4795693|NCT01354899|16537530|P1|Overall Study|discharge from the hospital|2
4795694|NCT01354496|16537582|P6|Washout (at Least 14 Days)|Scheduling Conflict|0
4795695|NCT01354496|16537583|P5|Washout (at Least 14 Days)|Scheduling Conflict|0
4795696|NCT01354496|16537584|P4|Washout (at Least 14 Days)|Scheduling Conflict|1
4795697|NCT01354496|16537585|P3|Washout (at Least 14 Days)|Scheduling Conflict|0
4795698|NCT01354496|16537586|P2|Washout (at Least 14 Days)|Scheduling Conflict|1
4795699|NCT01354496|16537587|P1|Washout (at Least 14 Days)|Scheduling Conflict|0
4795700|NCT01354496|16537582|P6|Period 2|Adverse Event|0
4795701|NCT01354496|16537583|P5|Period 2|Adverse Event|0
4795702|NCT01354496|16537584|P4|Period 2|Adverse Event|1
4795703|NCT01354496|16537585|P3|Period 2|Adverse Event|0
4795704|NCT01354496|16537586|P2|Period 2|Adverse Event|0
4795705|NCT01354496|16537587|P1|Period 2|Adverse Event|0
4795706|NCT01354496|16537582|P6|Period 1|Physician Decision|0
4795707|NCT01354496|16537583|P5|Period 1|Physician Decision|0
4795708|NCT01354496|16537584|P4|Period 1|Physician Decision|0
4795709|NCT01354496|16537585|P3|Period 1|Physician Decision|1
4795710|NCT01354496|16537586|P2|Period 1|Physician Decision|0
4795711|NCT01354496|16537587|P1|Period 1|Physician Decision|0
4795712|NCT01354496|16537582|P6|Period 1|Adverse Event|0
4795713|NCT01354496|16537583|P5|Period 1|Adverse Event|0
4795714|NCT01354496|16537584|P4|Period 1|Adverse Event|0
4795715|NCT01354496|16537585|P3|Period 1|Adverse Event|1
4795716|NCT01354496|16537586|P2|Period 1|Adverse Event|0
4795717|NCT01354496|16537587|P1|Period 1|Adverse Event|0
4795718|NCT01354431|16537630|P3|Participants Treated|Withdrawal by Subject|1
4795719|NCT01354431|16537631|P2|Participants Treated|Withdrawal by Subject|2
4795720|NCT01354431|16537632|P1|Participants Treated|Withdrawal by Subject|1
4795721|NCT01354431|16537630|P3|Participants Treated|Adverse Event|4
4795722|NCT01354431|16537631|P2|Participants Treated|Adverse Event|2
4795723|NCT01354431|16537632|P1|Participants Treated|Adverse Event|1
4795724|NCT01354431|16537630|P3|Participants Treated|Death|0
4795725|NCT01354431|16537631|P2|Participants Treated|Death|1
4795726|NCT01354431|16537632|P1|Participants Treated|Death|0
4795727|NCT01354431|16537630|P3|Participants Treated|Study Drug Toxicity|4
4795728|NCT01354431|16537631|P2|Participants Treated|Study Drug Toxicity|7
4795729|NCT01354431|16537632|P1|Participants Treated|Study Drug Toxicity|2
4795730|NCT01354431|16537630|P3|Participants Treated|Disease Progression|41
4795731|NCT01354431|16537631|P2|Participants Treated|Disease Progression|40
4795732|NCT01354431|16537632|P1|Participants Treated|Disease Progression|49
4795733|NCT01354431|16537630|P3|Participants Treated|Continuing Treatment|4
4795734|NCT01354431|16537631|P2|Participants Treated|Continuing Treatment|2
4795735|NCT01354431|16537632|P1|Participants Treated|Continuing Treatment|6
4795736|NCT01354431|16537630|P3|Randomized to Enter Treatment Period|No longer met criteria|0
4795737|NCT01354431|16537631|P2|Randomized to Enter Treatment Period|No longer met criteria|0
4795738|NCT01354431|16537632|P1|Randomized to Enter Treatment Period|No longer met criteria|1
4795739|NCT01354314|16537656|P4|Overall Study|Less than 90% Adherence|4
4795740|NCT01354314|16537657|P3|Overall Study|Less than 90% Adherence|6
4795741|NCT01354314|16537658|P2|Overall Study|Less than 90% Adherence|2
4795742|NCT01354314|16537659|P1|Overall Study|Less than 90% Adherence|4
4795743|NCT01354314|16537656|P4|Overall Study|Protocol Violation|0
4795744|NCT01354314|16537657|P3|Overall Study|Protocol Violation|0
4795745|NCT01354314|16537658|P2|Overall Study|Protocol Violation|1
4795746|NCT01354314|16537659|P1|Overall Study|Protocol Violation|1
4795747|NCT01354314|16537656|P4|Overall Study|Adverse Event|1
4795748|NCT01354314|16537657|P3|Overall Study|Adverse Event|0
4795749|NCT01354314|16537658|P2|Overall Study|Adverse Event|0
4795750|NCT01354314|16537659|P1|Overall Study|Adverse Event|0
4795751|NCT01354314|16537656|P4|Overall Study|Withdrawal by Subject|0
4795752|NCT01354314|16537657|P3|Overall Study|Withdrawal by Subject|1
4795753|NCT01354314|16537658|P2|Overall Study|Withdrawal by Subject|0
4795754|NCT01354314|16537659|P1|Overall Study|Withdrawal by Subject|0
4795755|NCT01354314|16537656|P4|Overall Study|Lost to Follow-up|1
4795756|NCT01354314|16537657|P3|Overall Study|Lost to Follow-up|1
4795757|NCT01354314|16537658|P2|Overall Study|Lost to Follow-up|0
4795758|NCT01354314|16537659|P1|Overall Study|Lost to Follow-up|1
4795759|NCT01354223|16537795|P2|Overall Study|Withdrawal by Subject|1
4795760|NCT01354223|16537796|P1|Overall Study|Withdrawal by Subject|3
4795761|NCT01354132|16537855|P2|1 Month Post Study Medication|Withdrawal by Subject|3
4795762|NCT01354132|16537856|P1|1 Month Post Study Medication|Withdrawal by Subject|1
4795763|NCT01354132|16537855|P2|Double Blind (Visits 1-7)|Withdrawal by Subject|11
4795764|NCT01354132|16537856|P1|Double Blind (Visits 1-7)|Withdrawal by Subject|8
4795765|NCT01354132|16537855|P2|Double Blind (Visits 1-7)|Adverse Event|0
4795766|NCT01354132|16537856|P1|Double Blind (Visits 1-7)|Adverse Event|1
4795767|NCT01354132|16537855|P2|Randomization|Withdrawal by Subject|1
4795768|NCT01354132|16537856|P1|Randomization|Withdrawal by Subject|0
4795769|NCT01354132|16537855|P2|Randomization|Physician Decision|0
4795770|NCT01354132|16537856|P1|Randomization|Physician Decision|1
4795771|NCT01354106|16537894|P1|Overall Study|Withdrawal by Subject|2
4795772|NCT01354028|16537900|P2|Overall Study|No quiet alert state|1
4795773|NCT01354028|16537901|P1|Overall Study|No quiet alert state|0
4795774|NCT01354028|16537900|P2|Overall Study|Discharged before study start|2
4795775|NCT01354028|16537901|P1|Overall Study|Discharged before study start|2
4795776|NCT01354028|16537900|P2|Overall Study|Physician Decision|2
4795777|NCT01354028|16537901|P1|Overall Study|Physician Decision|0
4795778|NCT01353963|16537937|P1|Overall Study|Adverse Event|2
4795779|NCT01353911|16537955|P8|Overall Study|Status Not Recorded|0
4795780|NCT01353911|16537956|P7|Overall Study|Status Not Recorded|0
4795781|NCT01353911|16537957|P6|Overall Study|Status Not Recorded|0
4795782|NCT01353911|16537958|P5|Overall Study|Status Not Recorded|0
4795783|NCT01353911|16537959|P4|Overall Study|Status Not Recorded|0
4795784|NCT01353911|16537960|P3|Overall Study|Status Not Recorded|1
4795785|NCT01353911|16537961|P2|Overall Study|Status Not Recorded|0
4795786|NCT01353911|16537962|P1|Overall Study|Status Not Recorded|4
4795787|NCT01353911|16537955|P8|Overall Study|Withdrawal by Subject|9
4795788|NCT01353911|16537956|P7|Overall Study|Withdrawal by Subject|3
4795789|NCT01353911|16537957|P6|Overall Study|Withdrawal by Subject|3
4795790|NCT01353911|16537958|P5|Overall Study|Withdrawal by Subject|2
4795791|NCT01353911|16537959|P4|Overall Study|Withdrawal by Subject|2
4795792|NCT01353911|16537960|P3|Overall Study|Withdrawal by Subject|4
4795793|NCT01353911|16537961|P2|Overall Study|Withdrawal by Subject|3
4795794|NCT01353911|16537962|P1|Overall Study|Withdrawal by Subject|2
4795795|NCT01353911|16537955|P8|Overall Study|Lost to Follow-up|6
4795796|NCT01353911|16537956|P7|Overall Study|Lost to Follow-up|3
4795797|NCT01353911|16537957|P6|Overall Study|Lost to Follow-up|4
4795798|NCT01353911|16537958|P5|Overall Study|Lost to Follow-up|4
4795799|NCT01353911|16537959|P4|Overall Study|Lost to Follow-up|0
4795800|NCT01353911|16537960|P3|Overall Study|Lost to Follow-up|4
4795801|NCT01353911|16537961|P2|Overall Study|Lost to Follow-up|6
4795802|NCT01353911|16537962|P1|Overall Study|Lost to Follow-up|2
4795803|NCT01353898|16538042|P6|Overall Study|Study site terminated|1
4795804|NCT01353898|16538043|P5|Overall Study|Study site terminated|0
4795805|NCT01353898|16538044|P4|Overall Study|Study site terminated|0
4795806|NCT01353898|16538045|P3|Overall Study|Study site terminated|0
4795807|NCT01353898|16538046|P2|Overall Study|Study site terminated|0
4795808|NCT01353898|16538047|P1|Overall Study|Study site terminated|0
4795809|NCT01353859|16538073|P1|Overall Study|Lack of Efficacy|1
4795810|NCT01353859|16538073|P1|Overall Study|Adverse Event|3
4795811|NCT01353703|16538088|P2|Overall Study|Migrated/moved from study area|0
4795812|NCT01353703|16538089|P1|Overall Study|Migrated/moved from study area|1
4795813|NCT01353664|16538135|P1|Overall Study|Disease Progression|16
4795814|NCT01353664|16538135|P1|Overall Study|Other|3
4795815|NCT01353586|16538141|P2|Overall Study|Neurological exam not done|1
4795816|NCT01353586|16538142|P1|Overall Study|Neurological exam not done|0
4795817|NCT01353586|16538141|P2|Overall Study|Never had insertion of study catheter|1
4795818|NCT01353586|16538142|P1|Overall Study|Never had insertion of study catheter|4
4795819|NCT01353586|16538141|P2|Overall Study|Procedure terminated prior to ablation|0
4795820|NCT01353586|16538142|P1|Overall Study|Procedure terminated prior to ablation|3
4795821|NCT01353508|16538160|P4|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
4795822|NCT01353508|16538161|P3|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
4795823|NCT01353508|16538162|P2|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0
4795824|NCT01353508|16538163|P1|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1
4795825|NCT01353508|16538160|P4|Period 1 - First Intervention (7 Days)|Adverse Event|1
4795826|NCT01353508|16538161|P3|Period 1 - First Intervention (7 Days)|Adverse Event|0
4795827|NCT01353508|16538162|P2|Period 1 - First Intervention (7 Days)|Adverse Event|0
4795828|NCT01353508|16538163|P1|Period 1 - First Intervention (7 Days)|Adverse Event|0
4795829|NCT01353274|16538241|P1|Overall Study|No case report form (CRF) collected|28
4795830|NCT01353222|16538251|P2|Overall Study|Site closed research department|0
4795831|NCT01353222|16538252|P1|Overall Study|Site closed research department|1
4795832|NCT01353222|16538251|P2|Overall Study|Study Terminated|37
4795833|NCT01353222|16538252|P1|Overall Study|Study Terminated|31
4795834|NCT01353222|16538251|P2|Overall Study|Withdrawal by Subject|5
4795835|NCT01353222|16538252|P1|Overall Study|Withdrawal by Subject|8
4795836|NCT01353222|16538251|P2|Overall Study|Death|30
4795837|NCT01353222|16538252|P1|Overall Study|Death|30
4795838|NCT01352845|16538295|P2|Overall Study|Death|0
4795839|NCT01352845|16538296|P1|Overall Study|Death|3
4795840|NCT01352845|16538295|P2|Overall Study|Protocol Violation|6
4795841|NCT01352845|16538296|P1|Overall Study|Protocol Violation|12
4795842|NCT01352845|16538295|P2|Overall Study|Other|7
4795843|NCT01352845|16538296|P1|Overall Study|Other|17
4795844|NCT01352845|16538295|P2|Overall Study|Adverse Event|6
4795845|NCT01352845|16538296|P1|Overall Study|Adverse Event|22
4795846|NCT01352845|16538295|P2|Overall Study|Pregnancy|7
4795847|NCT01352845|16538296|P1|Overall Study|Pregnancy|27
4795848|NCT01352845|16538295|P2|Overall Study|No Longer Meets Eligibility Criteria|11
4795849|NCT01352845|16538296|P1|Overall Study|No Longer Meets Eligibility Criteria|24
4795850|NCT01352845|16538295|P2|Overall Study|Withdrawal by Subject|16
4795851|NCT01352845|16538296|P1|Overall Study|Withdrawal by Subject|48
4795852|NCT01352845|16538295|P2|Overall Study|No Longer Willing to Participate|58
4795853|NCT01352845|16538296|P1|Overall Study|No Longer Willing to Participate|205
4795854|NCT01352845|16538295|P2|Overall Study|Lost to Follow-up|92
4795855|NCT01352845|16538296|P1|Overall Study|Lost to Follow-up|313
4795856|NCT01352793|16538385|P2|Overall Study|No longer meets eligibility criteria|15
4795857|NCT01352793|16538386|P1|Overall Study|No longer meets eligibility criteria|25
4795858|NCT01352793|16538385|P2|Overall Study|Randomized but not vaccinated|0
4795859|NCT01352793|16538386|P1|Overall Study|Randomized but not vaccinated|8
4795860|NCT01352793|16538385|P2|Overall Study|Death|0
4795861|NCT01352793|16538386|P1|Overall Study|Death|1
4795862|NCT01352793|16538385|P2|Overall Study|Medication error|2
4795863|NCT01352793|16538386|P1|Overall Study|Medication error|2
4795864|NCT01352793|16538385|P2|Overall Study|Other|7
4795865|NCT01352793|16538386|P1|Overall Study|Other|25
4795866|NCT01352793|16538385|P2|Overall Study|Pregnancy|8
4795867|NCT01352793|16538386|P1|Overall Study|Pregnancy|26
4795868|NCT01352793|16538385|P2|Overall Study|Physician Decision|0
4795869|NCT01352793|16538386|P1|Overall Study|Physician Decision|1
4795870|NCT01352793|16538385|P2|Overall Study|Adverse Event|10
4795871|NCT01352793|16538386|P1|Overall Study|Adverse Event|44
4795872|NCT01352793|16538385|P2|Overall Study|Protocol Violation|23
4795873|NCT01352793|16538386|P1|Overall Study|Protocol Violation|44
4795874|NCT01352793|16538385|P2|Overall Study|Withdrawal by Subject|55
4795875|NCT01352793|16538386|P1|Overall Study|Withdrawal by Subject|120
4795876|NCT01352793|16538385|P2|Overall Study|Lost to Follow-up|125
4795877|NCT01352793|16538386|P1|Overall Study|Lost to Follow-up|289
4795878|NCT01352741|16538410|P2|Open-Label Tapentadol Continuation Arm|Protocol Violation|0
4795879|NCT01352741|16538411|P1|Open-Label Tapentadol Continuation Arm|Protocol Violation|1
4795880|NCT01352741|16538410|P2|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0
4795881|NCT01352741|16538411|P1|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2
4795882|NCT01352741|16538410|P2|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0
4795883|NCT01352741|16538411|P1|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1
4795884|NCT01352741|16538410|P2|Open-Label Tapentadol Continuation Arm|Adverse Event|0
4795885|NCT01352741|16538411|P1|Open-Label Tapentadol Continuation Arm|Adverse Event|4
4795886|NCT01352741|16538410|P2|Double-blind Comparative Period|Other|2
4795887|NCT01352741|16538411|P1|Double-blind Comparative Period|Other|1
4795888|NCT01352741|16538410|P2|Double-blind Comparative Period|Withdrawal of consent|3
4795889|NCT01352741|16538411|P1|Double-blind Comparative Period|Withdrawal of consent|8
4795890|NCT01352741|16538410|P2|Double-blind Comparative Period|Death|1
4795891|NCT01352741|16538411|P1|Double-blind Comparative Period|Death|0
4795892|NCT01352741|16538410|P2|Double-blind Comparative Period|Lost to Follow-up|0
4795893|NCT01352741|16538411|P1|Double-blind Comparative Period|Lost to Follow-up|1
4795894|NCT01352741|16538410|P2|Double-blind Comparative Period|Adverse Event|17
4795895|NCT01352741|16538411|P1|Double-blind Comparative Period|Adverse Event|16
4795896|NCT01352741|16538410|P2|Double-blind Comparative Period|Lack of Efficacy|3
4795897|NCT01352741|16538411|P1|Double-blind Comparative Period|Lack of Efficacy|0
4795898|NCT01352741|16538410|P2|Double-blind Comparative Period|Protocol Violation|0
4795899|NCT01352741|16538411|P1|Double-blind Comparative Period|Protocol Violation|2
4795900|NCT01352741|16538410|P2|Open-label Tapentadol Titration Period|Other|0
4795901|NCT01352741|16538411|P1|Open-label Tapentadol Titration Period|Other|4
4795902|NCT01352741|16538410|P2|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0
4795903|NCT01352741|16538411|P1|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5
4795904|NCT01352741|16538410|P2|Open-label Tapentadol Titration Period|Withdrawal of consent|0
4795905|NCT01352741|16538411|P1|Open-label Tapentadol Titration Period|Withdrawal of consent|7
4795906|NCT01352741|16538410|P2|Open-label Tapentadol Titration Period|Adverse Event|0
4795907|NCT01352741|16538411|P1|Open-label Tapentadol Titration Period|Adverse Event|34
4795908|NCT01352741|16538410|P2|Open-label Tapentadol Titration Period|Lack of Efficacy|0
4795909|NCT01352741|16538411|P1|Open-label Tapentadol Titration Period|Lack of Efficacy|19
4795910|NCT01352741|16538410|P2|Open-label Tapentadol Titration Period|Protocol Violation|0
4795911|NCT01352741|16538411|P1|Open-label Tapentadol Titration Period|Protocol Violation|4
4795912|NCT01352715|16538505|P2|Overall Study|major ineligibility|1
4795913|NCT01352715|16538506|P1|Overall Study|major ineligibility|2
4795914|NCT01352715|16538505|P2|Overall Study|no final visit in closeout period|12
4795915|NCT01352715|16538506|P1|Overall Study|no final visit in closeout period|15
4795916|NCT01352715|16538505|P2|Overall Study|site closure|15
4795917|NCT01352715|16538506|P1|Overall Study|site closure|16
4795918|NCT01352715|16538505|P2|Overall Study|Withdrawal by Subject|8
4795919|NCT01352715|16538506|P1|Overall Study|Withdrawal by Subject|4
4795920|NCT01352715|16538505|P2|Overall Study|Lost to Follow-up|7
4795921|NCT01352715|16538506|P1|Overall Study|Lost to Follow-up|5
4795922|NCT01352715|16538505|P2|Overall Study|Death|3
4795923|NCT01352715|16538506|P1|Overall Study|Death|3
4795924|NCT01352585|16538550|P1|Overall Study|Other|7
4795925|NCT01352585|16538550|P1|Overall Study|Lost to Follow-up|1
4795926|NCT01352585|16538550|P1|Overall Study|Adverse Event|3
4795927|NCT01352507|16538567|P2|Treatment Period 2|Lack of Efficacy|0
4795928|NCT01352507|16538568|P1|Treatment Period 2|Lack of Efficacy|1
4795929|NCT01352507|16538567|P2|Treatment Period 2|Withdrawal by Subject|3
4795930|NCT01352507|16538568|P1|Treatment Period 2|Withdrawal by Subject|4
4795931|NCT01352507|16538567|P2|Treatment Period 2|Entry Criteria Not Met|0
4795932|NCT01352507|16538568|P1|Treatment Period 2|Entry Criteria Not Met|1
4795933|NCT01352507|16538567|P2|Washout Period|Withdrawal by Subject|1
4795934|NCT01352507|16538568|P1|Washout Period|Withdrawal by Subject|0
4795935|NCT01352507|16538567|P2|Treatment Period 1|Physician Decision|0
4795936|NCT01352507|16538568|P1|Treatment Period 1|Physician Decision|1
4795937|NCT01352507|16538567|P2|Treatment Period 1|Withdrawal by Subject|5
4795938|NCT01352507|16538568|P1|Treatment Period 1|Withdrawal by Subject|7
4795939|NCT01352507|16538567|P2|Treatment Period 1|Lost to Follow-up|4
4795940|NCT01352507|16538568|P1|Treatment Period 1|Lost to Follow-up|3
4795941|NCT01352507|16538567|P2|Treatment Period 1|Adverse Event|0
4795942|NCT01352507|16538568|P1|Treatment Period 1|Adverse Event|3
4795943|NCT01352416|16538621|P4|Overall Study|Physician Decision|1
4795944|NCT01352416|16538622|P3|Overall Study|Physician Decision|2
4795945|NCT01352416|16538623|P2|Overall Study|Physician Decision|2
4795946|NCT01352416|16538624|P1|Overall Study|Physician Decision|1
4795947|NCT01352117|16538665|P2|Overall Study|Ineligible (no KS diagnosis)|0
4795948|NCT01352117|16538666|P1|Overall Study|Ineligible (no KS diagnosis)|1
4795949|NCT01352117|16538665|P2|Overall Study|Did not initiate study treatment|0
4795950|NCT01352117|16538666|P1|Overall Study|Did not initiate study treatment|1
4795951|NCT01352117|16538665|P2|Overall Study|Non-adherent to study requirements|1
4795952|NCT01352117|16538666|P1|Overall Study|Non-adherent to study requirements|1
4795953|NCT01352117|16538665|P2|Overall Study|Lost to Follow-up|7
4795954|NCT01352117|16538666|P1|Overall Study|Lost to Follow-up|2
4795955|NCT01352117|16538665|P2|Overall Study|Withdrawal by Subject|0
4795956|NCT01352117|16538666|P1|Overall Study|Withdrawal by Subject|1
4795957|NCT01352117|16538665|P2|Overall Study|Death|16
4795958|NCT01352117|16538666|P1|Overall Study|Death|15
4795959|NCT01351623|16538729|P1|Overall Study|Death|2
4795960|NCT01351623|16538729|P1|Overall Study|Withdrawal by Subject|1
4795961|NCT01351623|16538729|P1|Overall Study|Adverse Event|4
4795962|NCT01351623|16538729|P1|Overall Study|Protocol Violation|2
4795963|NCT01351415|16538755|P2|Overall Study|Never Started|5
4795964|NCT01351415|16538756|P1|Overall Study|Never Started|5
4795965|NCT01351415|16538755|P2|Overall Study|Reason unknown|2
4795966|NCT01351415|16538756|P1|Overall Study|Reason unknown|0
4795967|NCT01351415|16538755|P2|Overall Study|Physician Decision|3
4795968|NCT01351415|16538756|P1|Overall Study|Physician Decision|2
4795969|NCT01351415|16538755|P2|Overall Study|Death|187
4795970|NCT01351415|16538756|P1|Overall Study|Death|190
4795971|NCT01351415|16538755|P2|Overall Study|Lost to Follow-up|7
4795972|NCT01351415|16538756|P1|Overall Study|Lost to Follow-up|5
4795973|NCT01351415|16538755|P2|Overall Study|Trial termination by the Sponsor|19
4795974|NCT01351415|16538756|P1|Overall Study|Trial termination by the Sponsor|28
4795975|NCT01351415|16538755|P2|Overall Study|Withdrawal by Subject|17
4795976|NCT01351415|16538756|P1|Overall Study|Withdrawal by Subject|15
4795977|NCT01351350|16538792|P5|Overall Study|Enrolled but not Treated|0
4795978|NCT01351350|16538793|P4|Overall Study|Enrolled but not Treated|0
4795979|NCT01351350|16538794|P3|Overall Study|Enrolled but not Treated|1
4795980|NCT01351350|16538795|P2|Overall Study|Enrolled but not Treated|0
4795981|NCT01351350|16538796|P1|Overall Study|Enrolled but not Treated|0
4795982|NCT01351350|16538792|P5|Overall Study|Participant Decision|2
4795983|NCT01351350|16538793|P4|Overall Study|Participant Decision|3
4795984|NCT01351350|16538794|P3|Overall Study|Participant Decision|3
4795985|NCT01351350|16538795|P2|Overall Study|Participant Decision|6
4795986|NCT01351350|16538796|P1|Overall Study|Participant Decision|2
4795987|NCT01351350|16538792|P5|Overall Study|Adverse Event|0
4795988|NCT01351350|16538793|P4|Overall Study|Adverse Event|2
4795989|NCT01351350|16538794|P3|Overall Study|Adverse Event|1
4795990|NCT01351350|16538795|P2|Overall Study|Adverse Event|10
4795991|NCT01351350|16538796|P1|Overall Study|Adverse Event|1
4795992|NCT01351350|16538792|P5|Overall Study|Disease Progression|5
4795993|NCT01351350|16538793|P4|Overall Study|Disease Progression|8
4795994|NCT01351350|16538794|P3|Overall Study|Disease Progression|6
4795995|NCT01351350|16538795|P2|Overall Study|Disease Progression|13
4795996|NCT01351350|16538796|P1|Overall Study|Disease Progression|5
4795997|NCT01351025|16538967|P2|Week 24 - 44|unable to get to clinic|1
4795998|NCT01351025|16538968|P1|Week 24 - 44|unable to get to clinic|1
4795999|NCT01351025|16538967|P2|Week 24 - 44|Site closed|1
4796000|NCT01351025|16538968|P1|Week 24 - 44|Site closed|0
4796001|NCT01351025|16538967|P2|Week 24 - 44|Lost to Follow-up|2
4796002|NCT01351025|16538968|P1|Week 24 - 44|Lost to Follow-up|0
4796003|NCT01351025|16538967|P2|Week 0 - 20|Withdrawal by Subject|0
4796004|NCT01351025|16538968|P1|Week 0 - 20|Withdrawal by Subject|1
4796005|NCT01351025|16538967|P2|Week 0 - 20|Lost to Follow-up|1
4796006|NCT01351025|16538968|P1|Week 0 - 20|Lost to Follow-up|2
4796007|NCT01350999|16539001|P3|Overall Study|Difficulty Making it to Study Visit|5
4796008|NCT01350999|16539002|P2|Overall Study|Difficulty Making it to Study Visit|1
4796009|NCT01350999|16539003|P1|Overall Study|Difficulty Making it to Study Visit|1
4796010|NCT01350999|16539001|P3|Overall Study|Voluntary withdrawal|6
4796011|NCT01350999|16539002|P2|Overall Study|Voluntary withdrawal|4
4796012|NCT01350999|16539003|P1|Overall Study|Voluntary withdrawal|3
4796013|NCT01350999|16539001|P3|Overall Study|Adverse Event|10
4796014|NCT01350999|16539002|P2|Overall Study|Adverse Event|9
4796015|NCT01350999|16539003|P1|Overall Study|Adverse Event|4
4796016|NCT01350973|16539041|P3|Overall Study|Voluntary Withdrawal|1
4796017|NCT01350973|16539042|P2|Overall Study|Voluntary Withdrawal|1
4796018|NCT01350973|16539043|P1|Overall Study|Voluntary Withdrawal|2
4796019|NCT01350973|16539041|P3|Overall Study|Adverse Event|7
4796020|NCT01350973|16539042|P2|Overall Study|Adverse Event|7
4796021|NCT01350973|16539043|P1|Overall Study|Adverse Event|4
4796022|NCT01350934|16539084|P2|Extension Study|Withdrawal by Subject|1
4796023|NCT01350934|16539085|P1|Extension Study|Withdrawal by Subject|0
4796024|NCT01350934|16539084|P2|Extension Study|Lack of Efficacy|1
4796025|NCT01350934|16539085|P1|Extension Study|Lack of Efficacy|0
4796026|NCT01350934|16539084|P2|Extension Study|Protocol Violation|1
4796027|NCT01350934|16539085|P1|Extension Study|Protocol Violation|1
4796028|NCT01350934|16539084|P2|Extension Study|Lost to Follow-up|0
4796029|NCT01350934|16539085|P1|Extension Study|Lost to Follow-up|2
4796030|NCT01350934|16539084|P2|Extension Study|Adverse Event|1
4796031|NCT01350934|16539085|P1|Extension Study|Adverse Event|2
4796032|NCT01350934|16539084|P2|Base Study|Non-Compliance With Study Drug|0
4796033|NCT01350934|16539085|P1|Base Study|Non-Compliance With Study Drug|2
4796034|NCT01350934|16539084|P2|Base Study|Withdrawal by Subject|2
4796035|NCT01350934|16539085|P1|Base Study|Withdrawal by Subject|1
4796036|NCT01350934|16539084|P2|Base Study|Protocol Violation|1
4796037|NCT01350934|16539085|P1|Base Study|Protocol Violation|1
4796038|NCT01350934|16539084|P2|Base Study|Lost to Follow-up|0
4796039|NCT01350934|16539085|P1|Base Study|Lost to Follow-up|1
4796040|NCT01350934|16539084|P2|Base Study|Adverse Event|0
4796041|NCT01350934|16539085|P1|Base Study|Adverse Event|6
4796042|NCT01350804|16539107|P4|Extension Study, Weeks 52 - 260|Adverse Event|3
4796043|NCT01350804|16539108|P3|Extension Study, Weeks 52 - 260|Adverse Event|2
4796044|NCT01350804|16539109|P2|Extension Study, Weeks 52 - 260|Adverse Event|1
4796045|NCT01350804|16539110|P1|Extension Study, Weeks 52 - 260|Adverse Event|3
4796046|NCT01350804|16539107|P4|Extension Study, Weeks 52 - 260|Lack of Efficacy|1
4796047|NCT01350804|16539108|P3|Extension Study, Weeks 52 - 260|Lack of Efficacy|0
4796048|NCT01350804|16539109|P2|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
4796049|NCT01350804|16539110|P1|Extension Study, Weeks 52 - 260|Lack of Efficacy|4
4796050|NCT01350804|16539107|P4|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
4796051|NCT01350804|16539108|P3|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
4796052|NCT01350804|16539109|P2|Extension Study, Weeks 52 - 260|Lost to Follow-up|1
4796053|NCT01350804|16539110|P1|Extension Study, Weeks 52 - 260|Lost to Follow-up|0
4796054|NCT01350804|16539107|P4|Extension Study, Weeks 52 - 260|Physician Decision|0
4796055|NCT01350804|16539108|P3|Extension Study, Weeks 52 - 260|Physician Decision|2
4796056|NCT01350804|16539109|P2|Extension Study, Weeks 52 - 260|Physician Decision|0
4796057|NCT01350804|16539110|P1|Extension Study, Weeks 52 - 260|Physician Decision|1
4796058|NCT01350804|16539107|P4|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16
4796059|NCT01350804|16539108|P3|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64
4796060|NCT01350804|16539109|P2|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
4796061|NCT01350804|16539110|P1|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67
4796062|NCT01350804|16539107|P4|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3
4796063|NCT01350804|16539108|P3|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4
4796064|NCT01350804|16539109|P2|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6
4796065|NCT01350804|16539110|P1|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5
4796066|NCT01350804|16539107|P4|Core Study|Adverse Event|8
4796067|NCT01350804|16539108|P3|Core Study|Adverse Event|8
4796068|NCT01350804|16539109|P2|Core Study|Adverse Event|10
4796069|NCT01350804|16539110|P1|Core Study|Adverse Event|8
4796070|NCT01350804|16539107|P4|Core Study|Death|0
4796071|NCT01350804|16539108|P3|Core Study|Death|1
4796072|NCT01350804|16539109|P2|Core Study|Death|1
4796073|NCT01350804|16539110|P1|Core Study|Death|1
4796074|NCT01350804|16539107|P4|Core Study|Lack of Efficacy|5
4796075|NCT01350804|16539108|P3|Core Study|Lack of Efficacy|18
4796076|NCT01350804|16539109|P2|Core Study|Lack of Efficacy|19
4796077|NCT01350804|16539110|P1|Core Study|Lack of Efficacy|16
4796078|NCT01350804|16539107|P4|Core Study|Lost to Follow-up|1
4796079|NCT01350804|16539108|P3|Core Study|Lost to Follow-up|2
4796080|NCT01350804|16539109|P2|Core Study|Lost to Follow-up|0
4796081|NCT01350804|16539110|P1|Core Study|Lost to Follow-up|3
4796082|NCT01350804|16539107|P4|Core Study|Physician Decision|3
4796083|NCT01350804|16539108|P3|Core Study|Physician Decision|1
4796084|NCT01350804|16539109|P2|Core Study|Physician Decision|0
4796085|NCT01350804|16539110|P1|Core Study|Physician Decision|1
4796086|NCT01350804|16539107|P4|Core Study|Protocol deviation|0
4796087|NCT01350804|16539108|P3|Core Study|Protocol deviation|1
4796088|NCT01350804|16539109|P2|Core Study|Protocol deviation|0
4796089|NCT01350804|16539110|P1|Core Study|Protocol deviation|1
4796090|NCT01350804|16539107|P4|Core Study|Study terminated by Sponsor|2
4796091|NCT01350804|16539108|P3|Core Study|Study terminated by Sponsor|0
4796092|NCT01350804|16539109|P2|Core Study|Study terminated by Sponsor|0
4796093|NCT01350804|16539110|P1|Core Study|Study terminated by Sponsor|0
4796094|NCT01350804|16539107|P4|Core Study|Withdrawal by Subject|7
4796095|NCT01350804|16539108|P3|Core Study|Withdrawal by Subject|16
4796096|NCT01350804|16539109|P2|Core Study|Withdrawal by Subject|17
4796097|NCT01350804|16539110|P1|Core Study|Withdrawal by Subject|11
4796098|NCT01350544|16539207|P2|Overall Study|Lost to Follow-up|15
4796099|NCT01350544|16539208|P1|Overall Study|Lost to Follow-up|18
4796100|NCT01350544|16539207|P2|Overall Study|Incarceration|0
4796101|NCT01350544|16539208|P1|Overall Study|Incarceration|1
4796102|NCT01350544|16539207|P2|Overall Study|Withdrawal by Subject|1
4796103|NCT01350544|16539208|P1|Overall Study|Withdrawal by Subject|0
4796104|NCT01350544|16539207|P2|Overall Study|Medical Issues|1
4796105|NCT01350544|16539208|P1|Overall Study|Medical Issues|1
4796106|NCT01350544|16539207|P2|Overall Study|Moved out of LA County|2
4796107|NCT01350544|16539208|P1|Overall Study|Moved out of LA County|2
4796108|NCT01350544|16539207|P2|Overall Study|Death|2
4796109|NCT01350544|16539208|P1|Overall Study|Death|1
4796110|NCT01350544|16539207|P2|Overall Study|Administrative Withdrawal|1
4796111|NCT01350544|16539208|P1|Overall Study|Administrative Withdrawal|0
4796112|NCT01350505|16539214|P1|Overall Study|Lost to Follow-up|4
4796113|NCT01350492|16539220|P2|Post Intervention Follow-Up|Withdrawal by Subject|1
4796114|NCT01350492|16539221|P1|Post Intervention Follow-Up|Withdrawal by Subject|0
4796115|NCT01350492|16539220|P2|Post Intervention Follow-Up|Lost to Follow-up|1
4796116|NCT01350492|16539221|P1|Post Intervention Follow-Up|Lost to Follow-up|6
4796117|NCT01350492|16539220|P2|Intervention|Withdrawal by Subject|1
4796118|NCT01350492|16539221|P1|Intervention|Withdrawal by Subject|3
4796119|NCT01350492|16539220|P2|Intervention|Lost to Follow-up|5
4796120|NCT01350492|16539221|P1|Intervention|Lost to Follow-up|2
4796121|NCT01350414|16539263|P1|Overall Study|Physician Decision|2
4796122|NCT01350414|16539263|P1|Overall Study|Withdrawal by Subject|4
4796123|NCT01350414|16539263|P1|Overall Study|Lost to Follow-up|13
4796124|NCT01350271|16539312|P3|Overall Study|Lost to Follow-up|26
4796125|NCT01350271|16539313|P2|Overall Study|Lost to Follow-up|17
4796126|NCT01350271|16539314|P1|Overall Study|Lost to Follow-up|21
4796127|NCT01350141|16539356|P3|Overall Study|Randomized but not treated|0
4796128|NCT01350141|16539357|P2|Overall Study|Randomized but not treated|0
4796129|NCT01350141|16539358|P1|Overall Study|Randomized but not treated|1
4796130|NCT01350141|16539356|P3|Overall Study|Withdrawal by Subject|0
4796131|NCT01350141|16539357|P2|Overall Study|Withdrawal by Subject|0
4796132|NCT01350141|16539358|P1|Overall Study|Withdrawal by Subject|1
4796133|NCT01350141|16539356|P3|Overall Study|Lost to Follow-up|1
4796134|NCT01350141|16539357|P2|Overall Study|Lost to Follow-up|0
4796135|NCT01350141|16539358|P1|Overall Study|Lost to Follow-up|1
4796136|NCT01350128|16539392|P1|Overall Study|Lost to Follow-up|2
4796137|NCT01350128|16539392|P1|Overall Study|Physician Decision|1
4796138|NCT01350128|16539392|P1|Overall Study|Protocol discontinuation criteria|8
4796139|NCT01350128|16539392|P1|Overall Study|Withdrawal by Subject|3
4796140|NCT01350115|16539456|P2|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0
4796141|NCT01350115|16539457|P1|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1
4796142|NCT01350115|16539456|P2|Long Term Follow-Up (All Patients)|Adverse Event|1
4796143|NCT01350115|16539457|P1|Long Term Follow-Up (All Patients)|Adverse Event|0
4796144|NCT01350115|16539456|P2|Long Term Follow-Up (All Patients)|Lost to Follow-up|1
4796145|NCT01350115|16539457|P1|Long Term Follow-Up (All Patients)|Lost to Follow-up|0
4796146|NCT01350102|16539473|P4|Overall Study|Adverse Event|0
4796147|NCT01350102|16539474|P3|Overall Study|Adverse Event|1
4796148|NCT01350102|16539475|P2|Overall Study|Adverse Event|0
4796149|NCT01350102|16539476|P1|Overall Study|Adverse Event|0
4796150|NCT01349959|16539513|P1|Overall Study|Adverse Event|7
4796151|NCT01349907|16539554|P2|Overall Study|Administrative|1
4796152|NCT01349907|16539555|P1|Overall Study|Administrative|1
4796153|NCT01349907|16539554|P2|Overall Study|Protocol Violation|13
4796154|NCT01349907|16539555|P1|Overall Study|Protocol Violation|33
4796155|NCT01349907|16539554|P2|Overall Study|Withdrawal by Subject|8
4796156|NCT01349907|16539555|P1|Overall Study|Withdrawal by Subject|30
4796157|NCT01349907|16539554|P2|Overall Study|Lost to Follow-up|6
4796158|NCT01349907|16539555|P1|Overall Study|Lost to Follow-up|25
4796159|NCT01349907|16539554|P2|Overall Study|Treatment failure|4
4796160|NCT01349907|16539555|P1|Overall Study|Treatment failure|13
4796161|NCT01349907|16539554|P2|Overall Study|Adverse Event|11
4796162|NCT01349907|16539555|P1|Overall Study|Adverse Event|37
4796163|NCT01349829|16539593|P2|Overall Study|Migrated/moved|7
4796164|NCT01349829|16539594|P1|Overall Study|Migrated/moved|2
4796165|NCT01349829|16539593|P2|Overall Study|Consent withdrawal|8
4796166|NCT01349829|16539594|P1|Overall Study|Consent withdrawal|3
4796167|NCT01349829|16539593|P2|Overall Study|Lost to Follow-up|8
4796168|NCT01349829|16539594|P1|Overall Study|Lost to Follow-up|4
4796169|NCT01349816|16539612|P1|Overall Study|Protocol-specified criteria|8
4796170|NCT01349816|16539612|P1|Overall Study|Protocol Violation|1
4796171|NCT01349816|16539612|P1|Overall Study|Lost to Follow-up|2
4796172|NCT01349816|16539612|P1|Overall Study|Adverse Event|14
4796173|NCT01349816|16539612|P1|Overall Study|Physician Decision|1
4796174|NCT01349816|16539612|P1|Overall Study|Withdrawal by Subject|4
4796175|NCT01349803|16539678|P4|Overall Study|Protocol-specified criteria|0
4796176|NCT01349803|16539679|P3|Overall Study|Protocol-specified criteria|3
4796177|NCT01349803|16539680|P2|Overall Study|Protocol-specified criteria|1
4796178|NCT01349803|16539681|P1|Overall Study|Protocol-specified criteria|0
4796179|NCT01349803|16539678|P4|Overall Study|Withdrawal by Subject|0
4796180|NCT01349803|16539679|P3|Overall Study|Withdrawal by Subject|0
4796181|NCT01349803|16539680|P2|Overall Study|Withdrawal by Subject|0
4796182|NCT01349803|16539681|P1|Overall Study|Withdrawal by Subject|1
4796183|NCT01349803|16539678|P4|Overall Study|Adverse Event|2
4796184|NCT01349803|16539679|P3|Overall Study|Adverse Event|0
4796185|NCT01349803|16539680|P2|Overall Study|Adverse Event|0
4796186|NCT01349803|16539681|P1|Overall Study|Adverse Event|0
4796187|NCT01349790|16539751|P1|Overall Study|Lost to Follow-up|1
4796188|NCT01349790|16539751|P1|Overall Study|Adverse Event|1
4796189|NCT01349790|16539751|P1|Overall Study|Withdrawal by Patient|2
4796190|NCT01349790|16539751|P1|Overall Study|Death|2
4796191|NCT01349790|16539751|P1|Overall Study|Investigator Judgement|3
4796192|NCT01349673|16539770|P1|Overall Study|Lack of Efficacy|8
4796193|NCT01349673|16539770|P1|Overall Study|Study Terminated By Sponsor|50
4796194|NCT01349673|16539770|P1|Overall Study|Adverse Event|17
4796195|NCT01349673|16539770|P1|Overall Study|Lost to Follow-up|6
4796196|NCT01349673|16539770|P1|Overall Study|Withdrawal by Subject|21
4796197|NCT01349673|16539770|P1|Overall Study|Site Closure|10
4796198|NCT01349673|16539770|P1|Overall Study|No Longer Qualified For Study|1
4796199|NCT01349673|16539770|P1|Overall Study|Progression Of Disease Past 40 cm|1
4796200|NCT01349660|16539780|P3|Overall Study|Declining Performance Status|1
4796201|NCT01349660|16539781|P2|Overall Study|Declining Performance Status|0
4796202|NCT01349660|16539782|P1|Overall Study|Declining Performance Status|0
4796203|NCT01349660|16539780|P3|Overall Study|Study Compliance|1
4796204|NCT01349660|16539781|P2|Overall Study|Study Compliance|0
4796205|NCT01349660|16539782|P1|Overall Study|Study Compliance|0
4796206|NCT01349660|16539780|P3|Overall Study|Non-Permitted Interventions|2
4796207|NCT01349660|16539781|P2|Overall Study|Non-Permitted Interventions|0
4796208|NCT01349660|16539782|P1|Overall Study|Non-Permitted Interventions|0
4796209|NCT01349660|16539780|P3|Overall Study|Death|0
4796210|NCT01349660|16539781|P2|Overall Study|Death|1
4796211|NCT01349660|16539782|P1|Overall Study|Death|1
4796212|NCT01349660|16539780|P3|Overall Study|Withdrawal by Subject|9
4796213|NCT01349660|16539781|P2|Overall Study|Withdrawal by Subject|0
4796214|NCT01349660|16539782|P1|Overall Study|Withdrawal by Subject|2
4796215|NCT01349660|16539780|P3|Overall Study|Adverse Event|12
4796216|NCT01349660|16539781|P2|Overall Study|Adverse Event|1
4796217|NCT01349660|16539782|P1|Overall Study|Adverse Event|1
4796218|NCT01349660|16539780|P3|Overall Study|Disease Progression|50
4796219|NCT01349660|16539781|P2|Overall Study|Disease Progression|4
4796220|NCT01349660|16539782|P1|Overall Study|Disease Progression|2
4796221|NCT01349660|16539780|P3|Overall Study|Still Receiving Study Treatment|1
4796222|NCT01349660|16539781|P2|Overall Study|Still Receiving Study Treatment|0
4796223|NCT01349660|16539782|P1|Overall Study|Still Receiving Study Treatment|0
4796224|NCT01349595|16539800|P2|Overall Study|Lack of funding|2
4796225|NCT01349595|16539801|P1|Overall Study|Lack of funding|2
4796226|NCT01349569|16539807|P1|Overall Study|Lack of Efficacy|4
4796227|NCT01349465|16539828|P2|Overall Study|Subject Ineligible To Continue The Trial|19
4796228|NCT01349465|16539829|P1|Overall Study|Subject Ineligible To Continue The Trial|0
4796229|NCT01349465|16539828|P2|Overall Study|Withdrawal by Subject|2
4796230|NCT01349465|16539829|P1|Overall Study|Withdrawal by Subject|4
4796231|NCT01349465|16539828|P2|Overall Study|Lost to Follow-up|1
4796232|NCT01349465|16539829|P1|Overall Study|Lost to Follow-up|10
4796233|NCT01349465|16539828|P2|Overall Study|Death|0
4796234|NCT01349465|16539829|P1|Overall Study|Death|3
4796235|NCT01349465|16539828|P2|Overall Study|Adverse Event|0
4796236|NCT01349465|16539829|P1|Overall Study|Adverse Event|1
4796237|NCT01349192|16539850|P2|Overall Study|Failure to adhere to Protocol|0
4796238|NCT01349192|16539851|P1|Overall Study|Failure to adhere to Protocol|2
4796239|NCT01349192|16539850|P2|Overall Study|Lost to Follow-up|3
4796240|NCT01349192|16539851|P1|Overall Study|Lost to Follow-up|1
4796241|NCT01349192|16539850|P2|Overall Study|Withdrawal by Subject|2
4796242|NCT01349192|16539851|P1|Overall Study|Withdrawal by Subject|0
4796243|NCT01349192|16539850|P2|Overall Study|Protocol Violation|1
4796244|NCT01349192|16539851|P1|Overall Study|Protocol Violation|0
4796245|NCT01349049|16539883|P9|Overall Study|Withdrawal by Subject|6
4796246|NCT01349049|16539884|P8|Overall Study|Withdrawal by Subject|0
4796247|NCT01349049|16539885|P7|Overall Study|Withdrawal by Subject|0
4796248|NCT01349049|16539886|P6|Overall Study|Withdrawal by Subject|0
4796249|NCT01349049|16539887|P5|Overall Study|Withdrawal by Subject|0
4796250|NCT01349049|16539888|P4|Overall Study|Withdrawal by Subject|0
4796251|NCT01349049|16539889|P3|Overall Study|Withdrawal by Subject|0
4796252|NCT01349049|16539890|P2|Overall Study|Withdrawal by Subject|0
4796253|NCT01349049|16539891|P1|Overall Study|Withdrawal by Subject|0
4796254|NCT01349049|16539883|P9|Overall Study|Non-compliance|0
4796255|NCT01349049|16539884|P8|Overall Study|Non-compliance|0
4796256|NCT01349049|16539885|P7|Overall Study|Non-compliance|0
4796257|NCT01349049|16539886|P6|Overall Study|Non-compliance|0
4796258|NCT01349049|16539887|P5|Overall Study|Non-compliance|0
4796259|NCT01349049|16539888|P4|Overall Study|Non-compliance|1
4796260|NCT01349049|16539889|P3|Overall Study|Non-compliance|0
4796261|NCT01349049|16539890|P2|Overall Study|Non-compliance|0
4796262|NCT01349049|16539891|P1|Overall Study|Non-compliance|0
4796263|NCT01349049|16539883|P9|Overall Study|Death|5
4796264|NCT01349049|16539884|P8|Overall Study|Death|1
4796265|NCT01349049|16539885|P7|Overall Study|Death|0
4796266|NCT01349049|16539886|P6|Overall Study|Death|0
4796267|NCT01349049|16539887|P5|Overall Study|Death|0
4796268|NCT01349049|16539888|P4|Overall Study|Death|0
4796269|NCT01349049|16539889|P3|Overall Study|Death|0
4796270|NCT01349049|16539890|P2|Overall Study|Death|0
4796271|NCT01349049|16539891|P1|Overall Study|Death|0
4796272|NCT01349049|16539883|P9|Overall Study|Other|4
4796273|NCT01349049|16539884|P8|Overall Study|Other|0
4796274|NCT01349049|16539885|P7|Overall Study|Other|0
4796275|NCT01349049|16539886|P6|Overall Study|Other|1
4796276|NCT01349049|16539887|P5|Overall Study|Other|0
4796277|NCT01349049|16539888|P4|Overall Study|Other|0
4796278|NCT01349049|16539889|P3|Overall Study|Other|0
4796279|NCT01349049|16539890|P2|Overall Study|Other|0
4796280|NCT01349049|16539891|P1|Overall Study|Other|0
4796281|NCT01349049|16539883|P9|Overall Study|Hematopoietic stem cell transplant|0
4796282|NCT01349049|16539884|P8|Overall Study|Hematopoietic stem cell transplant|1
4796283|NCT01349049|16539885|P7|Overall Study|Hematopoietic stem cell transplant|1
4796284|NCT01349049|16539886|P6|Overall Study|Hematopoietic stem cell transplant|0
4796285|NCT01349049|16539887|P5|Overall Study|Hematopoietic stem cell transplant|1
4796286|NCT01349049|16539888|P4|Overall Study|Hematopoietic stem cell transplant|0
4796287|NCT01349049|16539889|P3|Overall Study|Hematopoietic stem cell transplant|0
4796288|NCT01349049|16539890|P2|Overall Study|Hematopoietic stem cell transplant|0
4796289|NCT01349049|16539891|P1|Overall Study|Hematopoietic stem cell transplant|0
4796290|NCT01349049|16539883|P9|Overall Study|Protocol Violation|1
4796291|NCT01349049|16539884|P8|Overall Study|Protocol Violation|0
4796292|NCT01349049|16539885|P7|Overall Study|Protocol Violation|0
4796293|NCT01349049|16539886|P6|Overall Study|Protocol Violation|0
4796294|NCT01349049|16539887|P5|Overall Study|Protocol Violation|0
4796295|NCT01349049|16539888|P4|Overall Study|Protocol Violation|0
4796296|NCT01349049|16539889|P3|Overall Study|Protocol Violation|0
4796297|NCT01349049|16539890|P2|Overall Study|Protocol Violation|0
4796298|NCT01349049|16539891|P1|Overall Study|Protocol Violation|0
4796299|NCT01349049|16539883|P9|Overall Study|Physician Decision|2
4796300|NCT01349049|16539884|P8|Overall Study|Physician Decision|0
4796301|NCT01349049|16539885|P7|Overall Study|Physician Decision|0
4796302|NCT01349049|16539886|P6|Overall Study|Physician Decision|0
4796303|NCT01349049|16539887|P5|Overall Study|Physician Decision|0
4796304|NCT01349049|16539888|P4|Overall Study|Physician Decision|0
4796305|NCT01349049|16539889|P3|Overall Study|Physician Decision|0
4796306|NCT01349049|16539890|P2|Overall Study|Physician Decision|1
4796307|NCT01349049|16539891|P1|Overall Study|Physician Decision|0
4796308|NCT01349049|16539883|P9|Overall Study|Adverse Event|4
4796309|NCT01349049|16539884|P8|Overall Study|Adverse Event|0
4796310|NCT01349049|16539885|P7|Overall Study|Adverse Event|1
4796311|NCT01349049|16539886|P6|Overall Study|Adverse Event|3
4796312|NCT01349049|16539887|P5|Overall Study|Adverse Event|0
4796313|NCT01349049|16539888|P4|Overall Study|Adverse Event|0
4796314|NCT01349049|16539889|P3|Overall Study|Adverse Event|0
4796315|NCT01349049|16539890|P2|Overall Study|Adverse Event|1
4796316|NCT01349049|16539891|P1|Overall Study|Adverse Event|0
4796317|NCT01349049|16539883|P9|Overall Study|Disease progression|33
4796318|NCT01349049|16539884|P8|Overall Study|Disease progression|2
4796319|NCT01349049|16539885|P7|Overall Study|Disease progression|3
4796320|NCT01349049|16539886|P6|Overall Study|Disease progression|2
4796321|NCT01349049|16539887|P5|Overall Study|Disease progression|2
4796322|NCT01349049|16539888|P4|Overall Study|Disease progression|2
4796323|NCT01349049|16539889|P3|Overall Study|Disease progression|3
4796324|NCT01349049|16539890|P2|Overall Study|Disease progression|5
4796325|NCT01349049|16539891|P1|Overall Study|Disease progression|3
4796326|NCT01349036|16539945|P2|Overall Study|Withdrawal by Subject|2
4796327|NCT01349036|16539946|P1|Overall Study|Withdrawal by Subject|0
4796328|NCT01349036|16539945|P2|Overall Study|Other|0
4796329|NCT01349036|16539946|P1|Overall Study|Other|1
4796330|NCT01349036|16539945|P2|Overall Study|Disease progression|22
4796331|NCT01349036|16539946|P1|Overall Study|Disease progression|13
4796332|NCT01348854|16539964|P2|Overall Study|Withdrawal by Subject|0
4796333|NCT01348854|16539965|P1|Overall Study|Withdrawal by Subject|1
4796334|NCT01348854|16539964|P2|Overall Study|Lost to Follow-up|1
4796335|NCT01348854|16539965|P1|Overall Study|Lost to Follow-up|2
4796336|NCT01348789|16539973|P1|Overall Study|Withdrawal by Subject|2
4796337|NCT01348789|16539973|P1|Overall Study|Protocol Violation|2
4796338|NCT01348776|16539984|P1|Overall Study|Lost to Follow-up|3
4796339|NCT01348763|16539997|P1|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1
4796340|NCT01348763|16539997|P1|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1
4796341|NCT01348698|16540002|P1|Overall Study|PI decision to close study|68
4796342|NCT01348698|16540002|P1|Overall Study|Death|3
4796343|NCT01348698|16540002|P1|Overall Study|Does not meet lesion size criteria|1
4796344|NCT01348542|16540027|P2|Overall Study|Withdrawal by Subject|0
4796345|NCT01348542|16540028|P1|Overall Study|Withdrawal by Subject|3
4796346|NCT01348490|16540044|P1|Overall Study|Other Unspecified|8
4796347|NCT01348490|16540044|P1|Overall Study|Termination of clinical trial by sponsor|1
4796348|NCT01348490|16540044|P1|Overall Study|Lost to Follow-up|1
4796349|NCT01348490|16540044|P1|Overall Study|Disease progression|3
4796350|NCT01348490|16540044|P1|Overall Study|Consent withdrawn|7
4796351|NCT01348490|16540044|P1|Overall Study|Adverse Event|3
4796352|NCT01348490|16540044|P1|Overall Study|Death|1
4796353|NCT01348425|16540102|P2|Overall Study|Imaging was not taken.|1
4796354|NCT01348425|16540103|P1|Overall Study|Imaging was not taken.|1
4796355|NCT01348347|16540111|P3|Overall Study|Progressive disease|5
4796356|NCT01348347|16540112|P2|Overall Study|Progressive disease|5
4796357|NCT01348347|16540113|P1|Overall Study|Progressive disease|2
4796358|NCT01348347|16540111|P3|Overall Study|Withdrawal by Subject|1
4796359|NCT01348347|16540112|P2|Overall Study|Withdrawal by Subject|1
4796360|NCT01348347|16540113|P1|Overall Study|Withdrawal by Subject|1
4796361|NCT01348165|16540144|P7|Overall Study|Adverse Event|1
4796362|NCT01348165|16540145|P6|Overall Study|Adverse Event|0
4796363|NCT01348165|16540146|P5|Overall Study|Adverse Event|0
4796364|NCT01348165|16540147|P4|Overall Study|Adverse Event|0
4796365|NCT01348165|16540148|P3|Overall Study|Adverse Event|0
4796366|NCT01348165|16540149|P2|Overall Study|Adverse Event|0
4796367|NCT01348165|16540150|P1|Overall Study|Adverse Event|0
4796368|NCT01348139|16540279|P6|Period 1|Adverse Event|0
4796369|NCT01348139|16540280|P5|Period 1|Adverse Event|0
4796370|NCT01348139|16540281|P4|Period 1|Adverse Event|0
4796371|NCT01348139|16540282|P3|Period 1|Adverse Event|0
4796372|NCT01348139|16540283|P2|Period 1|Adverse Event|0
4796373|NCT01348139|16540284|P1|Period 1|Adverse Event|1
4796374|NCT01348100|16540365|P7|Overall Study|Administrative Problems|1
4796375|NCT01348100|16540366|P6|Overall Study|Administrative Problems|1
4796376|NCT01348100|16540367|P5|Overall Study|Administrative Problems|0
4796377|NCT01348100|16540368|P4|Overall Study|Administrative Problems|0
4796378|NCT01348100|16540369|P3|Overall Study|Administrative Problems|0
4796379|NCT01348100|16540370|P2|Overall Study|Administrative Problems|0
4796380|NCT01348100|16540371|P1|Overall Study|Administrative Problems|0
4796381|NCT01348100|16540365|P7|Overall Study|Lost to Follow-up|1
4796382|NCT01348100|16540366|P6|Overall Study|Lost to Follow-up|0
4796383|NCT01348100|16540367|P5|Overall Study|Lost to Follow-up|0
4796384|NCT01348100|16540368|P4|Overall Study|Lost to Follow-up|0
4796385|NCT01348100|16540369|P3|Overall Study|Lost to Follow-up|0
4796386|NCT01348100|16540370|P2|Overall Study|Lost to Follow-up|0
4796387|NCT01348100|16540371|P1|Overall Study|Lost to Follow-up|0
4796388|NCT01348100|16540365|P7|Overall Study|Unsatisfactory Therapeutic Effect|0
4796389|NCT01348100|16540366|P6|Overall Study|Unsatisfactory Therapeutic Effect|1
4796390|NCT01348100|16540367|P5|Overall Study|Unsatisfactory Therapeutic Effect|0
4796391|NCT01348100|16540368|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
4796392|NCT01348100|16540369|P3|Overall Study|Unsatisfactory Therapeutic Effect|0
4796393|NCT01348100|16540370|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
4796394|NCT01348100|16540371|P1|Overall Study|Unsatisfactory Therapeutic Effect|0
4796395|NCT01348100|16540365|P7|Overall Study|Protocol Deviation|0
4796396|NCT01348100|16540366|P6|Overall Study|Protocol Deviation|0
4796397|NCT01348100|16540367|P5|Overall Study|Protocol Deviation|0
4796398|NCT01348100|16540368|P4|Overall Study|Protocol Deviation|1
4796399|NCT01348100|16540369|P3|Overall Study|Protocol Deviation|0
4796400|NCT01348100|16540370|P2|Overall Study|Protocol Deviation|0
4796401|NCT01348100|16540371|P1|Overall Study|Protocol Deviation|0
4796402|NCT01348100|16540365|P7|Overall Study|Subject Withdrew Consent|1
4796403|NCT01348100|16540366|P6|Overall Study|Subject Withdrew Consent|0
4796404|NCT01348100|16540367|P5|Overall Study|Subject Withdrew Consent|1
4796405|NCT01348100|16540368|P4|Overall Study|Subject Withdrew Consent|0
4796406|NCT01348100|16540369|P3|Overall Study|Subject Withdrew Consent|2
4796407|NCT01348100|16540370|P2|Overall Study|Subject Withdrew Consent|0
4796408|NCT01348100|16540371|P1|Overall Study|Subject Withdrew Consent|0
4796409|NCT01348087|16540416|P1|Overall Study|Adverse Event|25
4796410|NCT01348087|16540416|P1|Overall Study|Subject withdrew consent|7
4796411|NCT01348087|16540416|P1|Overall Study|Lost to Follow-up|1
4796412|NCT01348087|16540416|P1|Overall Study|protocol deviation|1
4796413|NCT01348087|16540416|P1|Overall Study|Administrative problems|79
4796414|NCT01348087|16540416|P1|Overall Study|Unsatisfactory therapeutic effect|35
4796415|NCT01347931|16540430|P1|Standard Oxygen Therapy|Withdrawal by Subject|1
4796416|NCT01347879|16540442|P2|Overall Study|Other|3
4796417|NCT01347879|16540443|P1|Overall Study|Other|2
4796418|NCT01347879|16540442|P2|Overall Study|Withdrawal by Subject|2
4796419|NCT01347879|16540443|P1|Overall Study|Withdrawal by Subject|3
4796420|NCT01347879|16540442|P2|Overall Study|Lost to Follow-up|0
4796421|NCT01347879|16540443|P1|Overall Study|Lost to Follow-up|2
4796422|NCT01347879|16540442|P2|Overall Study|Adverse Event|12
4796423|NCT01347879|16540443|P1|Overall Study|Adverse Event|0
4796424|NCT01347866|16540492|P17|Overall Study|Subject refused further follow-up|2
4796425|NCT01347866|16540493|P16|Overall Study|Subject refused further follow-up|0
4796426|NCT01347866|16540494|P15|Overall Study|Subject refused further follow-up|1
4796427|NCT01347866|16540495|P14|Overall Study|Subject refused further follow-up|3
4796428|NCT01347866|16540496|P13|Overall Study|Subject refused further follow-up|1
4796429|NCT01347866|16540497|P12|Overall Study|Subject refused further follow-up|0
4796430|NCT01347866|16540498|P11|Overall Study|Subject refused further follow-up|0
4796431|NCT01347866|16540499|P10|Overall Study|Subject refused further follow-up|1
4796432|NCT01347866|16540500|P9|Overall Study|Subject refused further follow-up|4
4796433|NCT01347866|16540501|P8|Overall Study|Subject refused further follow-up|0
4796434|NCT01347866|16540502|P7|Overall Study|Subject refused further follow-up|0
4796435|NCT01347866|16540503|P6|Overall Study|Subject refused further follow-up|1
4796436|NCT01347866|16540504|P5|Overall Study|Subject refused further follow-up|0
4796437|NCT01347866|16540505|P4|Overall Study|Subject refused further follow-up|2
4796438|NCT01347866|16540506|P3|Overall Study|Subject refused further follow-up|0
4796439|NCT01347866|16540507|P2|Overall Study|Subject refused further follow-up|0
4796440|NCT01347866|16540508|P1|Overall Study|Subject refused further follow-up|2
4796441|NCT01347866|16540492|P17|Overall Study|Other|0
4796442|NCT01347866|16540493|P16|Overall Study|Other|3
4796443|NCT01347866|16540494|P15|Overall Study|Other|2
4796444|NCT01347866|16540495|P14|Overall Study|Other|4
4796445|NCT01347866|16540496|P13|Overall Study|Other|4
4796446|NCT01347866|16540497|P12|Overall Study|Other|3
4796447|NCT01347866|16540498|P11|Overall Study|Other|0
4796448|NCT01347866|16540499|P10|Overall Study|Other|5
4796449|NCT01347866|16540500|P9|Overall Study|Other|22
4796450|NCT01347866|16540501|P8|Overall Study|Other|3
4796451|NCT01347866|16540502|P7|Overall Study|Other|5
4796452|NCT01347866|16540503|P6|Overall Study|Other|0
4796453|NCT01347866|16540504|P5|Overall Study|Other|5
4796454|NCT01347866|16540505|P4|Overall Study|Other|4
4796455|NCT01347866|16540506|P3|Overall Study|Other|1
4796456|NCT01347866|16540507|P2|Overall Study|Other|1
4796457|NCT01347866|16540508|P1|Overall Study|Other|3
4796458|NCT01347866|16540492|P17|Overall Study|Lost to Follow-up|0
4796459|NCT01347866|16540493|P16|Overall Study|Lost to Follow-up|0
4796460|NCT01347866|16540494|P15|Overall Study|Lost to Follow-up|0
4796461|NCT01347866|16540495|P14|Overall Study|Lost to Follow-up|0
4796462|NCT01347866|16540496|P13|Overall Study|Lost to Follow-up|0
4796463|NCT01347866|16540497|P12|Overall Study|Lost to Follow-up|0
4796464|NCT01347866|16540498|P11|Overall Study|Lost to Follow-up|0
4796465|NCT01347866|16540499|P10|Overall Study|Lost to Follow-up|0
4796466|NCT01347866|16540500|P9|Overall Study|Lost to Follow-up|1
4796467|NCT01347866|16540501|P8|Overall Study|Lost to Follow-up|1
4796468|NCT01347866|16540502|P7|Overall Study|Lost to Follow-up|0
4796469|NCT01347866|16540503|P6|Overall Study|Lost to Follow-up|0
4796470|NCT01347866|16540504|P5|Overall Study|Lost to Follow-up|0
4796471|NCT01347866|16540505|P4|Overall Study|Lost to Follow-up|0
4796472|NCT01347866|16540506|P3|Overall Study|Lost to Follow-up|0
4796473|NCT01347866|16540507|P2|Overall Study|Lost to Follow-up|0
4796474|NCT01347866|16540508|P1|Overall Study|Lost to Follow-up|0
4796475|NCT01347866|16540492|P17|Overall Study|Death|0
4796476|NCT01347866|16540493|P16|Overall Study|Death|1
4796477|NCT01347866|16540494|P15|Overall Study|Death|0
4796478|NCT01347866|16540495|P14|Overall Study|Death|0
4796479|NCT01347866|16540496|P13|Overall Study|Death|2
4796480|NCT01347866|16540497|P12|Overall Study|Death|1
4796481|NCT01347866|16540498|P11|Overall Study|Death|3
4796482|NCT01347866|16540499|P10|Overall Study|Death|1
4796483|NCT01347866|16540500|P9|Overall Study|Death|4
4796484|NCT01347866|16540501|P8|Overall Study|Death|0
4796485|NCT01347866|16540502|P7|Overall Study|Death|1
4796486|NCT01347866|16540503|P6|Overall Study|Death|2
4796487|NCT01347866|16540504|P5|Overall Study|Death|2
4796488|NCT01347866|16540505|P4|Overall Study|Death|1
4796489|NCT01347866|16540506|P3|Overall Study|Death|0
4796490|NCT01347866|16540507|P2|Overall Study|Death|0
4796491|NCT01347866|16540508|P1|Overall Study|Death|0
4796492|NCT01347840|16540882|P1|Overall Study|Withdrawal by Subject|1
4796493|NCT01347762|16540909|P4|Overall Study|Withdrawal by Subject|3
4796494|NCT01347762|16540910|P3|Overall Study|Withdrawal by Subject|3
4796495|NCT01347762|16540911|P2|Overall Study|Withdrawal by Subject|1
4796496|NCT01347762|16540912|P1|Overall Study|Withdrawal by Subject|4
4796497|NCT01347762|16540909|P4|Overall Study|Lost to Follow-up|5
4796498|NCT01347762|16540910|P3|Overall Study|Lost to Follow-up|6
4796499|NCT01347762|16540911|P2|Overall Study|Lost to Follow-up|1
4796500|NCT01347762|16540912|P1|Overall Study|Lost to Follow-up|0
4796501|NCT01347710|16540938|P1|Overall Study|Other|3
4796502|NCT01347710|16540938|P1|Overall Study|Physician Decision|2
4796503|NCT01347710|16540938|P1|Overall Study|Lost to Follow-up|1
4796504|NCT01347710|16540938|P1|Overall Study|issue with vitals prior to dosing|1
4796505|NCT01347710|16540938|P1|Overall Study|Angio or SPECT not completed|18
4796506|NCT01347710|16540938|P1|Overall Study|Adverse Event|4
4796507|NCT01347710|16540938|P1|Overall Study|Withdrawal by Subject|2
4796508|NCT01347580|16540960|P2|Overall Study|Had other reason|6
4796509|NCT01347580|16540961|P1|Overall Study|Had other reason|9
4796510|NCT01347580|16540960|P2|Overall Study|Lost to Follow-up|1
4796511|NCT01347580|16540961|P1|Overall Study|Lost to Follow-up|3
4796512|NCT01347580|16540960|P2|Overall Study|Protocol Violation|7
4796513|NCT01347580|16540961|P1|Overall Study|Protocol Violation|10
4796514|NCT01347580|16540960|P2|Overall Study|Death|19
4796515|NCT01347580|16540961|P1|Overall Study|Death|30
4796516|NCT01347580|16540960|P2|Overall Study|Withdrawal by Subject|23
4796517|NCT01347580|16540961|P1|Overall Study|Withdrawal by Subject|13
4796518|NCT01347554|16540991|P2|Overall Study|Lack of Efficacy|11
4796519|NCT01347554|16540992|P1|Overall Study|Lack of Efficacy|7
4796520|NCT01347307|16541017|P2|Overall Study|Physician Decision|1
4796521|NCT01347307|16541018|P1|Overall Study|Physician Decision|0
4796522|NCT01347307|16541017|P2|Overall Study|Death|4
4796523|NCT01347307|16541018|P1|Overall Study|Death|0
4796524|NCT01347112|16541053|P2|Overall Study|Lost to Follow-up|5
4796525|NCT01347112|16541054|P1|Overall Study|Lost to Follow-up|3
4796526|NCT01347112|16541053|P2|Overall Study|Withdrawal by Subject|7
4796527|NCT01347112|16541054|P1|Overall Study|Withdrawal by Subject|1
4796528|NCT01347086|16541074|P10|Overall Study|failed screening visit|1
4796529|NCT01347086|16541075|P9|Overall Study|failed screening visit|0
4796530|NCT01347086|16541076|P8|Overall Study|failed screening visit|1
4796531|NCT01347086|16541077|P7|Overall Study|failed screening visit|1
4796532|NCT01347086|16541078|P6|Overall Study|failed screening visit|0
4796533|NCT01347086|16541079|P5|Overall Study|failed screening visit|0
4796534|NCT01347086|16541080|P4|Overall Study|failed screening visit|0
4796535|NCT01347086|16541081|P3|Overall Study|failed screening visit|1
4796536|NCT01347086|16541082|P2|Overall Study|failed screening visit|0
4796537|NCT01347086|16541083|P1|Overall Study|failed screening visit|0
4796538|NCT01347073|16541182|P1|Overall Study|Liver Transplant|1
4796539|NCT01347073|16541182|P1|Overall Study|Adverse Event|1
4796540|NCT01346774|16541261|P2|Overall Study|Adverse Event|2
4796541|NCT01346774|16541262|P1|Overall Study|Adverse Event|1
4796542|NCT01346774|16541261|P2|Overall Study|Protocol Violation|3
4796543|NCT01346774|16541262|P1|Overall Study|Protocol Violation|2
4796544|NCT01346774|16541261|P2|Overall Study|Withdrawal by Subject|4
4796545|NCT01346774|16541262|P1|Overall Study|Withdrawal by Subject|1
4796546|NCT01346774|16541261|P2|Overall Study|Lost to Follow-up|4
4796547|NCT01346774|16541262|P1|Overall Study|Lost to Follow-up|3
4796548|NCT01346774|16541261|P2|Overall Study|Did not take a single dose|4
4796549|NCT01346774|16541262|P1|Overall Study|Did not take a single dose|6
4796550|NCT01346696|16541268|P1|Overall Study|Death|1
4796551|NCT01346592|16541290|P3|Overall Study|Unable to Classify|6
4796552|NCT01346592|16541291|P2|Overall Study|Unable to Classify|3
4796553|NCT01346592|16541292|P1|Overall Study|Unable to Classify|7
4796554|NCT01346592|16541290|P3|Overall Study|Administrative reason|0
4796555|NCT01346592|16541291|P2|Overall Study|Administrative reason|0
4796556|NCT01346592|16541292|P1|Overall Study|Administrative reason|1
4796557|NCT01346592|16541290|P3|Overall Study|Inappropriate enrollment|1
4796558|NCT01346592|16541291|P2|Overall Study|Inappropriate enrollment|1
4796559|NCT01346592|16541292|P1|Overall Study|Inappropriate enrollment|3
4796560|NCT01346592|16541290|P3|Overall Study|Withdrawal by Subject|38
4796561|NCT01346592|16541291|P2|Overall Study|Withdrawal by Subject|51
4796562|NCT01346592|16541292|P1|Overall Study|Withdrawal by Subject|77
4796563|NCT01346592|16541290|P3|Overall Study|Adverse Event|0
4796564|NCT01346592|16541291|P2|Overall Study|Adverse Event|1
4796565|NCT01346592|16541292|P1|Overall Study|Adverse Event|0
4796566|NCT01346592|16541290|P3|Overall Study|Death|4
4796567|NCT01346592|16541291|P2|Overall Study|Death|3
4796568|NCT01346592|16541292|P1|Overall Study|Death|1
4796569|NCT01346592|16541290|P3|Overall Study|Protocol Violation|0
4796570|NCT01346592|16541291|P2|Overall Study|Protocol Violation|1
4796571|NCT01346592|16541292|P1|Overall Study|Protocol Violation|2
4796572|NCT01346592|16541290|P3|Overall Study|Lost to Follow-up|29
4796573|NCT01346592|16541291|P2|Overall Study|Lost to Follow-up|29
4796574|NCT01346592|16541292|P1|Overall Study|Lost to Follow-up|62
4796575|NCT01346540|16541384|P2|Overall Study|Adverse Event|4
4796576|NCT01346540|16541385|P1|Overall Study|Adverse Event|0
4796577|NCT01346540|16541384|P2|Overall Study|Progressive disease-RECIST 1.1 criteria|8
4796578|NCT01346540|16541385|P1|Overall Study|Progressive disease-RECIST 1.1 criteria|3
4796579|NCT01346514|16541396|P2|Overall Study|Death|4
4796580|NCT01346514|16541397|P1|Overall Study|Death|3
4796581|NCT01346514|16541396|P2|Overall Study|Withdrawal by Subject|3
4796582|NCT01346514|16541397|P1|Overall Study|Withdrawal by Subject|7
4796583|NCT01346514|16541396|P2|Overall Study|Lost to Follow-up|30
4796584|NCT01346514|16541397|P1|Overall Study|Lost to Follow-up|19
4796585|NCT01346501|16541417|P2|Overall Study|Other|12
4796586|NCT01346501|16541418|P1|Overall Study|Other|8
4796587|NCT01346501|16541417|P2|Overall Study|Initiated Other Biological Agents|1
4796588|NCT01346501|16541418|P1|Overall Study|Initiated Other Biological Agents|3
4796589|NCT01346475|16541451|P2|First Intervention|Lost to Follow-up|3
4796590|NCT01346475|16541452|P1|First Intervention|Lost to Follow-up|4
4796591|NCT01346410|16541464|P1|Overall Study|Death|1
4796592|NCT01346371|16541482|P2|Overall Study|Lost to Follow-up|0
4796593|NCT01346371|16541483|P1|Overall Study|Lost to Follow-up|2
4796594|NCT01346293|16541491|P2|Overall Study|Other|0
4796595|NCT01346293|16541492|P1|Overall Study|Other|1
4796596|NCT01346293|16541491|P2|Overall Study|Withdrawal by Subject|4
4796597|NCT01346293|16541492|P1|Overall Study|Withdrawal by Subject|15
4796598|NCT01346293|16541491|P2|Overall Study|Lost to Follow-up|8
4796599|NCT01346293|16541492|P1|Overall Study|Lost to Follow-up|21
4796600|NCT01346293|16541491|P2|Overall Study|Protocol Violation|9
4796601|NCT01346293|16541492|P1|Overall Study|Protocol Violation|30
4796602|NCT01346189|16541522|P4|Overall Study|Travel|3
4796603|NCT01346189|16541523|P3|Overall Study|Travel|0
4796604|NCT01346189|16541524|P2|Overall Study|Travel|0
4796605|NCT01346189|16541525|P1|Overall Study|Travel|0
4796606|NCT01346189|16541522|P4|Overall Study|Non-health system primary care physician|0
4796607|NCT01346189|16541523|P3|Overall Study|Non-health system primary care physician|0
4796608|NCT01346189|16541524|P2|Overall Study|Non-health system primary care physician|5
4796609|NCT01346189|16541525|P1|Overall Study|Non-health system primary care physician|0
4796610|NCT01346189|16541522|P4|Overall Study|Death|0
4796611|NCT01346189|16541523|P3|Overall Study|Death|0
4796612|NCT01346189|16541524|P2|Overall Study|Death|3
4796613|NCT01346189|16541525|P1|Overall Study|Death|0
4796614|NCT01346189|16541522|P4|Overall Study|Other|3
4796615|NCT01346189|16541523|P3|Overall Study|Other|7
4796616|NCT01346189|16541524|P2|Overall Study|Other|4
4796617|NCT01346189|16541525|P1|Overall Study|Other|2
4796618|NCT01346189|16541522|P4|Overall Study|Moved|0
4796619|NCT01346189|16541523|P3|Overall Study|Moved|4
4796620|NCT01346189|16541524|P2|Overall Study|Moved|0
4796621|NCT01346189|16541525|P1|Overall Study|Moved|3
4796622|NCT01346189|16541522|P4|Overall Study|Physician Decision|0
4796623|NCT01346189|16541523|P3|Overall Study|Physician Decision|0
4796624|NCT01346189|16541524|P2|Overall Study|Physician Decision|0
4796625|NCT01346189|16541525|P1|Overall Study|Physician Decision|4
4796626|NCT01346189|16541522|P4|Overall Study|Withdrawal by Subject|5
4796627|NCT01346189|16541523|P3|Overall Study|Withdrawal by Subject|3
4796628|NCT01346189|16541524|P2|Overall Study|Withdrawal by Subject|5
4796629|NCT01346189|16541525|P1|Overall Study|Withdrawal by Subject|7
4796630|NCT01346176|16541542|P3|Completed Satisfaction Survey|Lost to Follow-up|4
4796631|NCT01346176|16541543|P2|Completed Satisfaction Survey|Lost to Follow-up|4
4796632|NCT01346176|16541544|P1|Completed Satisfaction Survey|Lost to Follow-up|3
4796633|NCT01346176|16541542|P3|Completed Satisfaction Survey|Death|2
4796634|NCT01346176|16541543|P2|Completed Satisfaction Survey|Death|0
4796635|NCT01346176|16541544|P1|Completed Satisfaction Survey|Death|3
4796636|NCT01346176|16541542|P3|Completed Advance Directive|Other reason did not complete AD|7
4796637|NCT01346176|16541543|P2|Completed Advance Directive|Other reason did not complete AD|12
4796638|NCT01346176|16541544|P1|Completed Advance Directive|Other reason did not complete AD|7
4796639|NCT01346176|16541542|P3|Completed Advance Directive|Became Ineligible|1
4796640|NCT01346176|16541543|P2|Completed Advance Directive|Became Ineligible|0
4796641|NCT01346176|16541544|P1|Completed Advance Directive|Became Ineligible|3
4796642|NCT01346176|16541542|P3|Completed Advance Directive|Death|2
4796643|NCT01346176|16541543|P2|Completed Advance Directive|Death|2
4796644|NCT01346176|16541544|P1|Completed Advance Directive|Death|3
4796645|NCT01346176|16541542|P3|Recruited|Protocol Violation|0
4796646|NCT01346176|16541543|P2|Recruited|Protocol Violation|0
4796647|NCT01346176|16541544|P1|Recruited|Protocol Violation|1
4796648|NCT01346059|16541573|P2|Overall Study|Withdrawal by Subject|0
4796649|NCT01346059|16541574|P1|Overall Study|Withdrawal by Subject|1
4796650|NCT01345929|16541586|P2|Overall Study|Patient withdrawal|1
4796651|NCT01345929|16541587|P1|Overall Study|Patient withdrawal|0
4796652|NCT01345929|16541586|P2|Overall Study|40,000 CFU/ML|0
4796653|NCT01345929|16541587|P1|Overall Study|40,000 CFU/ML|1
4796654|NCT01345929|16541586|P2|Overall Study|Didn't meet eligibility criteria|0
4796655|NCT01345929|16541587|P1|Overall Study|Didn't meet eligibility criteria|2
4796656|NCT01345929|16541586|P2|Overall Study|Adverse Event|1
4796657|NCT01345929|16541587|P1|Overall Study|Adverse Event|0
4796658|NCT01345929|16541586|P2|Overall Study|Lost to Follow-up|9
4796659|NCT01345929|16541587|P1|Overall Study|Lost to Follow-up|9
4796660|NCT01345929|16541586|P2|Overall Study|Withdrawal by Subject|8
4796661|NCT01345929|16541587|P1|Overall Study|Withdrawal by Subject|9
4796662|NCT01345786|16541599|P4|Overall Study|Lost to Follow-up|2
4796663|NCT01345786|16541600|P3|Overall Study|Lost to Follow-up|0
4796664|NCT01345786|16541601|P2|Overall Study|Lost to Follow-up|0
4796665|NCT01345786|16541602|P1|Overall Study|Lost to Follow-up|0
4796666|NCT01345786|16541599|P4|Overall Study|Administrative|0
4796667|NCT01345786|16541600|P3|Overall Study|Administrative|0
4796668|NCT01345786|16541601|P2|Overall Study|Administrative|5
4796669|NCT01345786|16541602|P1|Overall Study|Administrative|3
4796670|NCT01345786|16541599|P4|Overall Study|Noncompliance with protocol|0
4796671|NCT01345786|16541600|P3|Overall Study|Noncompliance with protocol|1
4796672|NCT01345786|16541601|P2|Overall Study|Noncompliance with protocol|0
4796673|NCT01345786|16541602|P1|Overall Study|Noncompliance with protocol|1
4796674|NCT01345786|16541599|P4|Overall Study|Subject withdrew consent|0
4796675|NCT01345786|16541600|P3|Overall Study|Subject withdrew consent|1
4796676|NCT01345786|16541601|P2|Overall Study|Subject withdrew consent|2
4796677|NCT01345786|16541602|P1|Overall Study|Subject withdrew consent|2
4796678|NCT01345786|16541599|P4|Overall Study|Adverse Event|1
4796679|NCT01345786|16541600|P3|Overall Study|Adverse Event|3
4796680|NCT01345786|16541601|P2|Overall Study|Adverse Event|1
4796681|NCT01345786|16541602|P1|Overall Study|Adverse Event|0
4796682|NCT01345682|16541682|P2|Overall Study|Reason other than those specified above|3
4796683|NCT01345682|16541683|P1|Overall Study|Reason other than those specified above|4
4796684|NCT01345682|16541682|P2|Overall Study|Not treated|1
4796685|NCT01345682|16541683|P1|Overall Study|Not treated|2
4796686|NCT01345682|16541682|P2|Overall Study|Refused to continue trial medication|9
4796687|NCT01345682|16541683|P1|Overall Study|Refused to continue trial medication|16
4796688|NCT01345682|16541682|P2|Overall Study|Lost to Follow-up|1
4796689|NCT01345682|16541683|P1|Overall Study|Lost to Follow-up|0
4796690|NCT01345682|16541682|P2|Overall Study|Non-compliance with protocol|1
4796691|NCT01345682|16541683|P1|Overall Study|Non-compliance with protocol|0
4796692|NCT01345682|16541682|P2|Overall Study|Adverse Event|41
4796693|NCT01345682|16541683|P1|Overall Study|Adverse Event|51
4796694|NCT01345682|16541682|P2|Overall Study|Worsening of underlying cancer disease|12
4796695|NCT01345682|16541683|P1|Overall Study|Worsening of underlying cancer disease|23
4796696|NCT01345682|16541682|P2|Overall Study|Progressive disease per RECIST|93
4796697|NCT01345682|16541683|P1|Overall Study|Progressive disease per RECIST|226
4796698|NCT01345669|16541717|P2|Overall Study|Other Reasons|60
4796699|NCT01345669|16541718|P1|Overall Study|Other Reasons|111
4796700|NCT01345669|16541717|P2|Overall Study|Withdrawal by Subject|13
4796701|NCT01345669|16541718|P1|Overall Study|Withdrawal by Subject|52
4796702|NCT01345669|16541717|P2|Overall Study|Lost to Follow-up|1
4796703|NCT01345669|16541718|P1|Overall Study|Lost to Follow-up|1
4796704|NCT01345669|16541717|P2|Overall Study|Protocol Violation|1
4796705|NCT01345669|16541718|P1|Overall Study|Protocol Violation|3
4796706|NCT01345669|16541717|P2|Overall Study|Adverse Event|9
4796707|NCT01345669|16541718|P1|Overall Study|Adverse Event|63
4796708|NCT01345669|16541717|P2|Overall Study|Second primary tumour|3
4796709|NCT01345669|16541718|P1|Overall Study|Second primary tumour|4
4796710|NCT01345669|16541717|P2|Overall Study|Primary tumour recurrence|32
4796711|NCT01345669|16541718|P1|Overall Study|Primary tumour recurrence|53
4796712|NCT01345630|16541736|P2|Overall Study|Insufficient clinical response|11
4796713|NCT01345630|16541737|P1|Overall Study|Insufficient clinical response|48
4796714|NCT01345630|16541736|P2|Overall Study|No longer willing to participate|12
4796715|NCT01345630|16541737|P1|Overall Study|No longer willing to participate|9
4796716|NCT01345630|16541736|P2|Overall Study|Withdrawn due to pregnancy|2
4796717|NCT01345630|16541737|P1|Overall Study|Withdrawn due to pregnancy|1
4796718|NCT01345630|16541736|P2|Overall Study|Other reasons|8
4796719|NCT01345630|16541737|P1|Overall Study|Other reasons|6
4796720|NCT01345630|16541736|P2|Overall Study|Study terminated by sponsor|285
4796721|NCT01345630|16541737|P1|Overall Study|Study terminated by sponsor|254
4796722|NCT01345630|16541736|P2|Overall Study|Medication error without associated AE|1
4796723|NCT01345630|16541737|P1|Overall Study|Medication error without associated AE|0
4796724|NCT01345630|16541736|P2|Overall Study|Protocol Violation|1
4796725|NCT01345630|16541737|P1|Overall Study|Protocol Violation|4
4796726|NCT01345630|16541736|P2|Overall Study|Lost to Follow-up|16
4796727|NCT01345630|16541737|P1|Overall Study|Lost to Follow-up|17
4796728|NCT01345630|16541736|P2|Overall Study|Adverse Event|23
4796729|NCT01345630|16541737|P1|Overall Study|Adverse Event|22
4796730|NCT01345591|16541793|P1|Overall Study|Lost to Follow-up|1
4796731|NCT01345318|16541809|P1|Overall Study|Other|3
4796732|NCT01345318|16541809|P1|Overall Study|Withdrawal by Subject|41
4796733|NCT01345318|16541809|P1|Overall Study|Protocol Violation|1
4796734|NCT01345318|16541809|P1|Overall Study|Lost to Follow-up|2
4796735|NCT01345318|16541809|P1|Overall Study|Lack of Efficacy|17
4796736|NCT01345318|16541809|P1|Overall Study|Adverse Event|16
4796737|NCT01345292|16541817|P3|Overall Study|Withdrawal by Subject|1
4796738|NCT01345292|16541818|P2|Overall Study|Withdrawal by Subject|0
4796739|NCT01345292|16541819|P1|Overall Study|Withdrawal by Subject|2
4796740|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
4796741|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1
4796742|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82
4796743|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37
4796744|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24
4796745|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11
4796746|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6
4796747|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4
4796748|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5
4796749|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2
4796750|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7
4796751|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3
4796752|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Death|1
4796753|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Death|0
4796754|NCT01345253|16541850|P2|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18
4796755|NCT01345253|16541851|P1|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7
4796756|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19
4796757|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9
4796758|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12
4796759|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4
4796760|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8
4796761|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3
4796762|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1
4796763|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6
4796764|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5
4796765|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1
4796766|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7
4796767|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11
4796768|NCT01345253|16541850|P2|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27
4796769|NCT01345253|16541851|P1|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22
4796770|NCT01345240|16541872|P5|Overall Study|Lost to Follow-up|9
4796771|NCT01345240|16541873|P4|Overall Study|Lost to Follow-up|7
4796772|NCT01345240|16541874|P3|Overall Study|Lost to Follow-up|14
4796773|NCT01345240|16541875|P2|Overall Study|Lost to Follow-up|9
4796774|NCT01345240|16541876|P1|Overall Study|Lost to Follow-up|8
4796775|NCT01345240|16541872|P5|Overall Study|Adverse Event|1
4796776|NCT01345240|16541873|P4|Overall Study|Adverse Event|2
4796777|NCT01345240|16541874|P3|Overall Study|Adverse Event|4
4796778|NCT01345240|16541875|P2|Overall Study|Adverse Event|5
4796779|NCT01345240|16541876|P1|Overall Study|Adverse Event|3
4796780|NCT01345188|16541996|P1|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1
4796781|NCT01345188|16541996|P1|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2
4796782|NCT01345162|16542008|P2|Overall Study|Protocol Violation|4
4796783|NCT01345162|16542009|P1|Overall Study|Protocol Violation|2
4796784|NCT01345123|16542018|P3|Overall Study|participants no longer with health plan|88
4796785|NCT01345123|16542019|P2|Overall Study|participants no longer with health plan|85
4796786|NCT01345123|16542020|P1|Overall Study|participants no longer with health plan|79
4796787|NCT01345058|16542042|P2|Overall Study|Participant No-Show at Multiple Visits|0
4796788|NCT01345058|16542043|P1|Overall Study|Participant No-Show at Multiple Visits|1
4796789|NCT01345058|16542042|P2|Overall Study|Participant Stopped Taking Study Drug|0
4796790|NCT01345058|16542043|P1|Overall Study|Participant Stopped Taking Study Drug|1
4796791|NCT01345058|16542042|P2|Overall Study|Side Effects of Hair Loss and Itchiness|0
4796792|NCT01345058|16542043|P1|Overall Study|Side Effects of Hair Loss and Itchiness|1
4796793|NCT01345058|16542042|P2|Overall Study|Participant Reported Increase in Events|0
4796794|NCT01345058|16542043|P1|Overall Study|Participant Reported Increase in Events|1
4796795|NCT01345058|16542042|P2|Overall Study|Withdrawal by Subject|0
4796796|NCT01345058|16542043|P1|Overall Study|Withdrawal by Subject|1
4796797|NCT01345019|16542059|P2|Open Label Treatment Phase|Protocol Violation|1
4796798|NCT01345019|16542060|P1|Open Label Treatment Phase|Protocol Violation|0
4796799|NCT01345019|16542059|P2|Open Label Treatment Phase|Other, Not Specified|7
4796800|NCT01345019|16542060|P1|Open Label Treatment Phase|Other, Not Specified|9
4796801|NCT01345019|16542059|P2|Open Label Treatment Phase|Pregnancy|0
4796802|NCT01345019|16542060|P1|Open Label Treatment Phase|Pregnancy|1
4796803|NCT01345019|16542059|P2|Open Label Treatment Phase|Lost to Follow-up|2
4796804|NCT01345019|16542060|P1|Open Label Treatment Phase|Lost to Follow-up|1
4796805|NCT01345019|16542059|P2|Open Label Treatment Phase|Noncompliance|4
4796806|NCT01345019|16542060|P1|Open Label Treatment Phase|Noncompliance|5
4796807|NCT01345019|16542059|P2|Open Label Treatment Phase|Disease Progression|18
4796808|NCT01345019|16542060|P1|Open Label Treatment Phase|Disease Progression|17
4796809|NCT01345019|16542059|P2|Open Label Treatment Phase|Administrative Decision|15
4796810|NCT01345019|16542060|P1|Open Label Treatment Phase|Administrative Decision|30
4796811|NCT01345019|16542059|P2|Open Label Treatment Phase|Adverse Event|51
4796812|NCT01345019|16542060|P1|Open Label Treatment Phase|Adverse Event|30
4796813|NCT01345019|16542059|P2|Open Label Treatment Phase|Withdrawal by Subject|47
4796814|NCT01345019|16542060|P1|Open Label Treatment Phase|Withdrawal by Subject|49
4796815|NCT01345019|16542059|P2|Open Label Treatment Phase|Death|48
4796816|NCT01345019|16542060|P1|Open Label Treatment Phase|Death|49
4796817|NCT01345019|16542059|P2|Blinded Treatment Phase|Lost to Follow-up|3
4796818|NCT01345019|16542060|P1|Blinded Treatment Phase|Lost to Follow-up|6
4796819|NCT01345019|16542059|P2|Blinded Treatment Phase|Other, Not Specified|3
4796820|NCT01345019|16542060|P1|Blinded Treatment Phase|Other, Not Specified|2
4796821|NCT01345019|16542059|P2|Blinded Treatment Phase|Protocol Deviation|0
4796822|NCT01345019|16542060|P1|Blinded Treatment Phase|Protocol Deviation|5
4796823|NCT01345019|16542059|P2|Blinded Treatment Phase|Ineligibility Determined|6
4796824|NCT01345019|16542060|P1|Blinded Treatment Phase|Ineligibility Determined|1
4796825|NCT01345019|16542059|P2|Blinded Treatment Phase|Noncompliance|3
4796826|NCT01345019|16542060|P1|Blinded Treatment Phase|Noncompliance|5
4796827|NCT01345019|16542059|P2|Blinded Treatment Phase|Administrative Decision|8
4796828|NCT01345019|16542060|P1|Blinded Treatment Phase|Administrative Decision|10
4796829|NCT01345019|16542059|P2|Blinded Treatment Phase|Adverse Event|13
4796830|NCT01345019|16542060|P1|Blinded Treatment Phase|Adverse Event|6
4796831|NCT01345019|16542059|P2|Blinded Treatment Phase|Disease Progression|10
4796832|NCT01345019|16542060|P1|Blinded Treatment Phase|Disease Progression|12
4796833|NCT01345019|16542059|P2|Blinded Treatment Phase|Completed Survival Follow-up|9
4796834|NCT01345019|16542060|P1|Blinded Treatment Phase|Completed Survival Follow-up|21
4796835|NCT01345019|16542059|P2|Blinded Treatment Phase|Withdrawal by Subject|112
4796836|NCT01345019|16542060|P1|Blinded Treatment Phase|Withdrawal by Subject|103
4796837|NCT01345019|16542059|P2|Blinded Treatment Phase|Death|137
4796838|NCT01345019|16542060|P1|Blinded Treatment Phase|Death|147
4796839|NCT01344876|16542082|P5|Overall Study|Definite progression of primary disease|0
4796840|NCT01344876|16542083|P4|Overall Study|Definite progression of primary disease|3
4796841|NCT01344876|16542084|P3|Overall Study|Definite progression of primary disease|0
4796842|NCT01344876|16542085|P2|Overall Study|Definite progression of primary disease|0
4796843|NCT01344876|16542086|P1|Overall Study|Definite progression of primary disease|1
4796844|NCT01344876|16542082|P5|Overall Study|Withdrawal by Subject|0
4796845|NCT01344876|16542083|P4|Overall Study|Withdrawal by Subject|0
4796846|NCT01344876|16542084|P3|Overall Study|Withdrawal by Subject|1
4796847|NCT01344876|16542085|P2|Overall Study|Withdrawal by Subject|0
4796848|NCT01344876|16542086|P1|Overall Study|Withdrawal by Subject|0
4796849|NCT01344876|16542082|P5|Overall Study|Adverse Event|1
4796850|NCT01344876|16542083|P4|Overall Study|Adverse Event|0
4796851|NCT01344876|16542084|P3|Overall Study|Adverse Event|0
4796852|NCT01344876|16542085|P2|Overall Study|Adverse Event|0
4796853|NCT01344876|16542086|P1|Overall Study|Adverse Event|0
4796854|NCT01344824|16542100|P1|Overall Study|Progression|15
4796855|NCT01344824|16542100|P1|Overall Study|Other complicating disease|1
4796856|NCT01344824|16542100|P1|Overall Study|Withdrawal by Subject|6
4796857|NCT01344824|16542100|P1|Overall Study|Adverse Event|15
4796858|NCT01344759|16542108|P2|Overall Study|Patients failed to reach sedation level|2
4796859|NCT01344759|16542109|P1|Overall Study|Patients failed to reach sedation level|0
4796860|NCT01344629|16542141|P2|Crossover Period 2|Withdrawal by Subject|1
4796861|NCT01344629|16542142|P1|Crossover Period 2|Withdrawal by Subject|0
4796862|NCT01344538|16542171|P2|Overall Study|Lost to Follow-up|0
4796863|NCT01344538|16542172|P1|Overall Study|Lost to Follow-up|1
4796864|NCT01344538|16542171|P2|Overall Study|Adverse Event|1
4796865|NCT01344538|16542172|P1|Overall Study|Adverse Event|1
4796866|NCT01344460|16542178|P1|Overall Study|Lost to Follow-up|2
4796867|NCT01344460|16542178|P1|Overall Study|Withdrawal by Subject|1
4796868|NCT01344447|16542223|P1|Overall Study|Error of power injector|1
4796869|NCT01344447|16542223|P1|Overall Study|Bolus tracking failed|1
4796870|NCT01344447|16542223|P1|Overall Study|MRA unsuccessful|1
4796871|NCT01344447|16542223|P1|Overall Study|Physician Decision|1
4796872|NCT01344447|16542223|P1|Overall Study|The contrast was not seen|1
4796873|NCT01344447|16542223|P1|Overall Study|Withdrawal by Subject|1
4796874|NCT01344447|16542223|P1|Overall Study|Protocol Violation|1
4796875|NCT01344447|16542223|P1|Overall Study|Adverse Event|1
4796876|NCT01344369|16542267|P2|Second Intervention|Emesis within 2 x Tmax|1
4796877|NCT01344369|16542268|P1|Second Intervention|Emesis within 2 x Tmax|0
4796878|NCT01344369|16542267|P2|Washout of 28 Days|Physician Decision|1
4796879|NCT01344369|16542268|P1|Washout of 28 Days|Physician Decision|0
4796880|NCT01344369|16542267|P2|Washout of 28 Days|Withdrawal by Subject|0
4796881|NCT01344369|16542268|P1|Washout of 28 Days|Withdrawal by Subject|1
4796882|NCT01344356|16542286|P2|Overall Study|Lost to Follow-up|6
4796883|NCT01344356|16542287|P1|Overall Study|Lost to Follow-up|0
4796884|NCT01344356|16542286|P2|Overall Study|Physician Decision|3
4796885|NCT01344356|16542287|P1|Overall Study|Physician Decision|0
4796886|NCT01344226|16542299|P1|Overall Study|Lack of Efficacy|3
4796887|NCT01344226|16542299|P1|Overall Study|Withdrawal by Subject|3
4796888|NCT01344226|16542299|P1|Overall Study|Protocol Violation|2
4796889|NCT01344161|16542308|P2|Overall Study|Protocol Violation|1
4796890|NCT01344161|16542309|P1|Overall Study|Protocol Violation|1
4796891|NCT01344161|16542308|P2|Overall Study|Pregnancy|1
4796892|NCT01344161|16542309|P1|Overall Study|Pregnancy|0
4796893|NCT01344161|16542308|P2|Overall Study|Lost to Follow-up|1
4796894|NCT01344161|16542309|P1|Overall Study|Lost to Follow-up|4
4796895|NCT01344057|16542321|P1|Overall Study|Premature Withdrawal|1
4796896|NCT01343901|16542328|P1|Overall Study|Participant decision|1
4796897|NCT01343901|16542328|P1|Overall Study|Management by another medical team|11
4796898|NCT01343901|16542328|P1|Overall Study|Lost to Follow-up|12
4796899|NCT01343901|16542328|P1|Overall Study|Physician Decision|4
4796900|NCT01343901|16542328|P1|Overall Study|Death|85
4796901|NCT01343888|16542352|P3|Overall Study|other than stated above|1
4796902|NCT01343888|16542353|P2|Overall Study|other than stated above|0
4796903|NCT01343888|16542354|P1|Overall Study|other than stated above|0
4796904|NCT01343888|16542352|P3|Overall Study|Withdrawal by Subject|2
4796905|NCT01343888|16542353|P2|Overall Study|Withdrawal by Subject|4
4796906|NCT01343888|16542354|P1|Overall Study|Withdrawal by Subject|4
4796907|NCT01343888|16542352|P3|Overall Study|Protocol Violation|0
4796908|NCT01343888|16542353|P2|Overall Study|Protocol Violation|2
4796909|NCT01343888|16542354|P1|Overall Study|Protocol Violation|0
4796910|NCT01343888|16542352|P3|Overall Study|Lost to Follow-up|1
4796911|NCT01343888|16542353|P2|Overall Study|Lost to Follow-up|2
4796912|NCT01343888|16542354|P1|Overall Study|Lost to Follow-up|0
4796913|NCT01343888|16542352|P3|Overall Study|Lack of Efficacy|13
4796914|NCT01343888|16542353|P2|Overall Study|Lack of Efficacy|9
4796915|NCT01343888|16542354|P1|Overall Study|Lack of Efficacy|9
4796916|NCT01343888|16542352|P3|Overall Study|Adverse Event|5
4796917|NCT01343888|16542353|P2|Overall Study|Adverse Event|22
4796918|NCT01343888|16542354|P1|Overall Study|Adverse Event|12
4796919|NCT01343823|16542396|P4|Overall Study|Withdrawal by Subject|0
4796920|NCT01343823|16542397|P3|Overall Study|Withdrawal by Subject|0
4796921|NCT01343823|16542398|P2|Overall Study|Withdrawal by Subject|0
4796922|NCT01343823|16542399|P1|Overall Study|Withdrawal by Subject|1
4796923|NCT01343823|16542396|P4|Overall Study|Study Terminated|1
4796924|NCT01343823|16542397|P3|Overall Study|Study Terminated|0
4796925|NCT01343823|16542398|P2|Overall Study|Study Terminated|0
4796926|NCT01343823|16542399|P1|Overall Study|Study Terminated|1
4796927|NCT01343693|16542413|P1|Overall Study|Lost to Follow-up|9
4796928|NCT01343407|16542436|P6|Second Washout (Part 2)|Withdrawal by Subject|0
4796929|NCT01343407|16542437|P5|Second Washout (Part 2)|Withdrawal by Subject|0
4796930|NCT01343407|16542438|P4|Second Washout (Part 2)|Withdrawal by Subject|0
4796931|NCT01343407|16542439|P3|Second Washout (Part 2)|Withdrawal by Subject|1
4796932|NCT01343407|16542440|P2|Second Washout (Part 2)|Withdrawal by Subject|0
4796933|NCT01343407|16542441|P1|Second Washout (Part 2)|Withdrawal by Subject|0
4796934|NCT01343407|16542436|P6|Second Treatment Period (Part 2)|Adverse Event|0
4796935|NCT01343407|16542437|P5|Second Treatment Period (Part 2)|Adverse Event|0
4796936|NCT01343407|16542438|P4|Second Treatment Period (Part 2)|Adverse Event|0
4796937|NCT01343407|16542439|P3|Second Treatment Period (Part 2)|Adverse Event|1
4796938|NCT01343407|16542440|P2|Second Treatment Period (Part 2)|Adverse Event|0
4796939|NCT01343407|16542441|P1|Second Treatment Period (Part 2)|Adverse Event|0
4796940|NCT01343368|16542469|P2|Overall Study|Lost to Follow-up|0
4796941|NCT01343368|16542470|P1|Overall Study|Lost to Follow-up|1
4796942|NCT01343368|16542469|P2|Overall Study|Death|0
4796943|NCT01343368|16542470|P1|Overall Study|Death|1
4796944|NCT01343277|16542506|P2|Overall Study|Subsequent anticancer therapy|0
4796945|NCT01343277|16542507|P1|Overall Study|Subsequent anticancer therapy|1
4796946|NCT01343277|16542506|P2|Overall Study|Treatment ongoing|2
4796947|NCT01343277|16542507|P1|Overall Study|Treatment ongoing|8
4796948|NCT01343277|16542506|P2|Overall Study|Randomized not treated|21
4796949|NCT01343277|16542507|P1|Overall Study|Randomized not treated|6
4796950|NCT01343277|16542506|P2|Overall Study|Disease progression|138
4796951|NCT01343277|16542507|P1|Overall Study|Disease progression|270
4796952|NCT01343277|16542506|P2|Overall Study|Adverse Event|13
4796953|NCT01343277|16542507|P1|Overall Study|Adverse Event|67
4796954|NCT01343277|16542506|P2|Overall Study|Death|1
4796955|NCT01343277|16542507|P1|Overall Study|Death|10
4796956|NCT01343277|16542506|P2|Overall Study|Physician Decision|2
4796957|NCT01343277|16542507|P1|Overall Study|Physician Decision|1
4796958|NCT01343277|16542506|P2|Overall Study|Withdrawal by Subject|13
4796959|NCT01343277|16542507|P1|Overall Study|Withdrawal by Subject|18
4796960|NCT01343277|16542506|P2|Overall Study|Other|3
4796961|NCT01343277|16542507|P1|Overall Study|Other|3
4796962|NCT01343082|16542568|P3|Treatment Period , Switched to DE-111|Withdrawal by Subject|5
4796963|NCT01343082|16542569|P2|Treatment Period , Switched to DE-111|Withdrawal by Subject|2
4796964|NCT01343082|16542570|P1|Treatment Period , Switched to DE-111|Withdrawal by Subject|4
4796965|NCT01343082|16542568|P3|Treatment Period , Switched to DE-111|Physician Decision|2
4796966|NCT01343082|16542569|P2|Treatment Period , Switched to DE-111|Physician Decision|2
4796967|NCT01343082|16542570|P1|Treatment Period , Switched to DE-111|Physician Decision|0
4796968|NCT01343082|16542568|P3|Treatment Period , Switched to DE-111|Lack of Efficacy|2
4796969|NCT01343082|16542569|P2|Treatment Period , Switched to DE-111|Lack of Efficacy|1
4796970|NCT01343082|16542570|P1|Treatment Period , Switched to DE-111|Lack of Efficacy|0
4796971|NCT01343082|16542568|P3|Treatment Period , Switched to DE-111|Adverse Event|3
4796972|NCT01343082|16542569|P2|Treatment Period , Switched to DE-111|Adverse Event|4
4796973|NCT01343082|16542570|P1|Treatment Period , Switched to DE-111|Adverse Event|1
4796974|NCT01343082|16542568|P3|The run-in Period|Not meeting criteria|5
4796975|NCT01343082|16542569|P2|The run-in Period|Not meeting criteria|4
4796976|NCT01343082|16542570|P1|The run-in Period|Not meeting criteria|3
4796977|NCT01343056|16542578|P4|Overall Study|Lost to Follow-up|9
4796978|NCT01343056|16542579|P3|Overall Study|Lost to Follow-up|3
4796979|NCT01343056|16542580|P2|Overall Study|Lost to Follow-up|5
4796980|NCT01343056|16542581|P1|Overall Study|Lost to Follow-up|7
4796981|NCT01343043|16542623|P4|Overall Study|Death|1
4796982|NCT01343043|16542624|P3|Overall Study|Death|0
4796983|NCT01343043|16542625|P2|Overall Study|Death|1
4796984|NCT01343043|16542626|P1|Overall Study|Death|1
4796985|NCT01343043|16542623|P4|Overall Study|Withdrawal by Subject|0
4796986|NCT01343043|16542624|P3|Overall Study|Withdrawal by Subject|0
4796987|NCT01343043|16542625|P2|Overall Study|Withdrawal by Subject|0
4796988|NCT01343043|16542626|P1|Overall Study|Withdrawal by Subject|1
4796989|NCT01343043|16542623|P4|Overall Study|Disease progression before treatment|0
4796990|NCT01343043|16542624|P3|Overall Study|Disease progression before treatment|0
4796991|NCT01343043|16542625|P2|Overall Study|Disease progression before treatment|0
4796992|NCT01343043|16542626|P1|Overall Study|Disease progression before treatment|1
4796993|NCT01342965|16542714|P2|Overall Study|Withdrawal by Subject|9
4796994|NCT01342965|16542715|P1|Overall Study|Withdrawal by Subject|2
4796995|NCT01342965|16542714|P2|Overall Study|Other Reasons- Unspecified|38
4796996|NCT01342965|16542715|P1|Overall Study|Other Reasons- Unspecified|44
4796997|NCT01342965|16542714|P2|Overall Study|Lost to Follow-up|3
4796998|NCT01342965|16542715|P1|Overall Study|Lost to Follow-up|5
4796999|NCT01342965|16542714|P2|Overall Study|Death|57
4797000|NCT01342965|16542715|P1|Overall Study|Death|58
4797001|NCT01342926|16542733|P4|Overall Study|Withdrawal by Subject|5
4797002|NCT01342926|16542734|P3|Overall Study|Withdrawal by Subject|3
4797003|NCT01342926|16542735|P2|Overall Study|Withdrawal by Subject|4
4797004|NCT01342926|16542736|P1|Overall Study|Withdrawal by Subject|2
4797005|NCT01342926|16542733|P4|Overall Study|Investigator Discretion|0
4797006|NCT01342926|16542734|P3|Overall Study|Investigator Discretion|0
4797007|NCT01342926|16542735|P2|Overall Study|Investigator Discretion|2
4797008|NCT01342926|16542736|P1|Overall Study|Investigator Discretion|2
4797009|NCT01342926|16542733|P4|Overall Study|Lost to Follow-up|0
4797010|NCT01342926|16542734|P3|Overall Study|Lost to Follow-up|1
4797011|NCT01342926|16542735|P2|Overall Study|Lost to Follow-up|1
4797012|NCT01342926|16542736|P1|Overall Study|Lost to Follow-up|0
4797013|NCT01342926|16542733|P4|Overall Study|Adverse Event|7
4797014|NCT01342926|16542734|P3|Overall Study|Adverse Event|10
4797015|NCT01342926|16542735|P2|Overall Study|Adverse Event|8
4797016|NCT01342926|16542736|P1|Overall Study|Adverse Event|5
4797017|NCT01342913|16542816|P3|Double-Blind Treatment Period|Withdrawal by Subject|2
4797018|NCT01342913|16542817|P2|Double-Blind Treatment Period|Withdrawal by Subject|2
4797019|NCT01342913|16542818|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
4797020|NCT01342913|16542816|P3|Double-Blind Treatment Period|Physician Decision|0
4797021|NCT01342913|16542817|P2|Double-Blind Treatment Period|Physician Decision|2
4797022|NCT01342913|16542818|P1|Double-Blind Treatment Period|Physician Decision|0
4797023|NCT01342913|16542816|P3|Double-Blind Treatment Period|Lost to Follow-up|3
4797024|NCT01342913|16542817|P2|Double-Blind Treatment Period|Lost to Follow-up|1
4797025|NCT01342913|16542818|P1|Double-Blind Treatment Period|Lost to Follow-up|0
4797026|NCT01342913|16542816|P3|Double-Blind Treatment Period|Protocol Violation|9
4797027|NCT01342913|16542817|P2|Double-Blind Treatment Period|Protocol Violation|6
4797028|NCT01342913|16542818|P1|Double-Blind Treatment Period|Protocol Violation|0
4797029|NCT01342913|16542816|P3|Double-Blind Treatment Period|Lack of Efficacy|3
4797030|NCT01342913|16542817|P2|Double-Blind Treatment Period|Lack of Efficacy|2
4797031|NCT01342913|16542818|P1|Double-Blind Treatment Period|Lack of Efficacy|0
4797032|NCT01342913|16542816|P3|Double-Blind Treatment Period|Adverse Event|6
4797033|NCT01342913|16542817|P2|Double-Blind Treatment Period|Adverse Event|3
4797034|NCT01342913|16542818|P1|Double-Blind Treatment Period|Adverse Event|0
4797035|NCT01342913|16542816|P3|2-week Run-in Period|Continuation Criteria Not Met|0
4797036|NCT01342913|16542817|P2|2-week Run-in Period|Continuation Criteria Not Met|0
4797037|NCT01342913|16542818|P1|2-week Run-in Period|Continuation Criteria Not Met|88
4797038|NCT01342913|16542816|P3|2-week Run-in Period|Protocol Violation|0
4797039|NCT01342913|16542817|P2|2-week Run-in Period|Protocol Violation|0
4797040|NCT01342913|16542818|P1|2-week Run-in Period|Protocol Violation|5
4797041|NCT01342913|16542816|P3|2-week Run-in Period|Adverse Event|0
4797042|NCT01342913|16542817|P2|2-week Run-in Period|Adverse Event|0
4797043|NCT01342913|16542818|P1|2-week Run-in Period|Adverse Event|2
4797044|NCT01342913|16542816|P3|2-week Run-in Period|Withdrawal by Subject|0
4797045|NCT01342913|16542817|P2|2-week Run-in Period|Withdrawal by Subject|0
4797046|NCT01342913|16542818|P1|2-week Run-in Period|Withdrawal by Subject|7
4797047|NCT01342913|16542816|P3|2-week Run-in Period|Physician Decision|0
4797048|NCT01342913|16542817|P2|2-week Run-in Period|Physician Decision|0
4797049|NCT01342913|16542818|P1|2-week Run-in Period|Physician Decision|6
4797050|NCT01342913|16542816|P3|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4797051|NCT01342913|16542817|P2|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0
4797052|NCT01342913|16542818|P1|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66
4797053|NCT01342887|16542828|P1|Overall Study|Death|2
4797054|NCT01342640|16542869|P1|Overall Study|Other|1
4797055|NCT01342640|16542869|P1|Overall Study|Lost to Follow-up|21
4797056|NCT01342640|16542869|P1|Overall Study|Protocol Violation|16
4797057|NCT01342640|16542869|P1|Overall Study|Adverse Event|3
4797058|NCT01342510|16542964|P4|Overall Study|Protocol Violation|11
4797059|NCT01342510|16542965|P3|Overall Study|Protocol Violation|13
4797060|NCT01342510|16542966|P2|Overall Study|Protocol Violation|6
4797061|NCT01342510|16542967|P1|Overall Study|Protocol Violation|12
4797062|NCT01342484|16542984|P3|Overall Study|Withdrawal by Subject|0
4797063|NCT01342484|16542985|P2|Overall Study|Withdrawal by Subject|0
4797064|NCT01342484|16542986|P1|Overall Study|Withdrawal by Subject|1
4797065|NCT01342484|16542984|P3|Overall Study|Protocol Violation|1
4797066|NCT01342484|16542985|P2|Overall Study|Protocol Violation|0
4797067|NCT01342484|16542986|P1|Overall Study|Protocol Violation|0
4797068|NCT01342484|16542984|P3|Overall Study|Other Reasons|0
4797069|NCT01342484|16542985|P2|Overall Study|Other Reasons|0
4797070|NCT01342484|16542986|P1|Overall Study|Other Reasons|1
4797071|NCT01342445|16543042|P2|Overall Study|Experienced side effects|2
4797072|NCT01342445|16543043|P1|Overall Study|Experienced side effects|0
4797073|NCT01342341|16543059|P2|Overall Study|Lost to Follow-up|4
4797074|NCT01342341|16543060|P1|Overall Study|Lost to Follow-up|4
4797075|NCT01342211|16543071|P5|Overall Study|Randomized, but not Treated|1
4797076|NCT01342211|16543072|P4|Overall Study|Randomized, but not Treated|0
4797077|NCT01342211|16543073|P3|Overall Study|Randomized, but not Treated|0
4797078|NCT01342211|16543074|P2|Overall Study|Randomized, but not Treated|2
4797079|NCT01342211|16543075|P1|Overall Study|Randomized, but not Treated|0
4797080|NCT01342211|16543071|P5|Overall Study|Withdrawal by Subject|0
4797081|NCT01342211|16543072|P4|Overall Study|Withdrawal by Subject|1
4797082|NCT01342211|16543073|P3|Overall Study|Withdrawal by Subject|0
4797083|NCT01342211|16543074|P2|Overall Study|Withdrawal by Subject|0
4797084|NCT01342211|16543075|P1|Overall Study|Withdrawal by Subject|0
4797085|NCT01342211|16543071|P5|Overall Study|Adverse Event|1
4797086|NCT01342211|16543072|P4|Overall Study|Adverse Event|0
4797087|NCT01342211|16543073|P3|Overall Study|Adverse Event|0
4797088|NCT01342211|16543074|P2|Overall Study|Adverse Event|0
4797089|NCT01342211|16543075|P1|Overall Study|Adverse Event|0
4797090|NCT01342211|16543071|P5|Overall Study|Lost to Follow-up|0
4797091|NCT01342211|16543072|P4|Overall Study|Lost to Follow-up|1
4797092|NCT01342211|16543073|P3|Overall Study|Lost to Follow-up|0
4797093|NCT01342211|16543074|P2|Overall Study|Lost to Follow-up|0
4797094|NCT01342211|16543075|P1|Overall Study|Lost to Follow-up|0
4797095|NCT01342094|16543163|P2|Overall Study|Withdrawal by Subject|2
4797096|NCT01342094|16543164|P1|Overall Study|Withdrawal by Subject|0
4797097|NCT01342094|16543163|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
4797098|NCT01342094|16543164|P1|Overall Study|Not meeting inclusion/exclusion criteria|0
4797099|NCT01342094|16543163|P2|Overall Study|Adverse Event|0
4797100|NCT01342094|16543164|P1|Overall Study|Adverse Event|5
4797101|NCT01342081|16543173|P3|Overall Study|Withdrawal by Subject|0
4797102|NCT01342081|16543174|P2|Overall Study|Withdrawal by Subject|1
4797103|NCT01342081|16543175|P1|Overall Study|Withdrawal by Subject|1
4797104|NCT01342081|16543173|P3|Overall Study|Physician Decision|0
4797105|NCT01342081|16543174|P2|Overall Study|Physician Decision|1
4797106|NCT01342081|16543175|P1|Overall Study|Physician Decision|0
4797107|NCT01342081|16543173|P3|Overall Study|Adverse Event|0
4797108|NCT01342081|16543174|P2|Overall Study|Adverse Event|0
4797109|NCT01342081|16543175|P1|Overall Study|Adverse Event|1
4797110|NCT01342081|16543173|P3|Overall Study|Did not receive allocated intervention|1
4797111|NCT01342081|16543174|P2|Overall Study|Did not receive allocated intervention|0
4797112|NCT01342081|16543175|P1|Overall Study|Did not receive allocated intervention|0
4797113|NCT01341990|16543194|P2|Overall Study|Withdrawal by Subject|0
4797114|NCT01341990|16543195|P1|Overall Study|Withdrawal by Subject|2
4797115|NCT01341990|16543194|P2|Overall Study|Torn Study Lens|0
4797116|NCT01341990|16543195|P1|Overall Study|Torn Study Lens|1
4797117|NCT01341990|16543194|P2|Overall Study|Adverse Event|1
4797118|NCT01341990|16543195|P1|Overall Study|Adverse Event|0
4797119|NCT01341782|16543219|P2|Overall Study|Other|0
4797120|NCT01341782|16543220|P1|Overall Study|Other|5
4797121|NCT01341782|16543219|P2|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
4797122|NCT01341782|16543220|P1|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3
4797123|NCT01341782|16543219|P2|Overall Study|2 consecutive calcium values >11.5 mg/dL|1
4797124|NCT01341782|16543220|P1|Overall Study|2 consecutive calcium values >11.5 mg/dL|0
4797125|NCT01341782|16543219|P2|Overall Study|Missed 3 consecutive doses|4
4797126|NCT01341782|16543220|P1|Overall Study|Missed 3 consecutive doses|0
4797127|NCT01341782|16543219|P2|Overall Study|Withdrawal by Subject|5
4797128|NCT01341782|16543220|P1|Overall Study|Withdrawal by Subject|6
4797129|NCT01341782|16543219|P2|Overall Study|Adverse Event|1
4797130|NCT01341782|16543220|P1|Overall Study|Adverse Event|1
4797131|NCT01341639|16543249|P2|Post-Treatment|Adverse Event|2
4797132|NCT01341639|16543250|P1|Post-Treatment|Adverse Event|0
4797133|NCT01341639|16543249|P2|Post-Treatment|Withdrawal by Subject|1
4797134|NCT01341639|16543250|P1|Post-Treatment|Withdrawal by Subject|0
4797135|NCT01341639|16543249|P2|Interim Period|Protocol Violation|1
4797136|NCT01341639|16543250|P1|Interim Period|Protocol Violation|0
4797137|NCT01341639|16543249|P2|Interim Period|Physician Decision|1
4797138|NCT01341639|16543250|P1|Interim Period|Physician Decision|0
4797139|NCT01341639|16543249|P2|Interim Period|Lost to Follow-up|0
4797140|NCT01341639|16543250|P1|Interim Period|Lost to Follow-up|2
4797141|NCT01341639|16543249|P2|Interim Period|Withdrawal by Subject|7
4797142|NCT01341639|16543250|P1|Interim Period|Withdrawal by Subject|6
4797143|NCT01341639|16543249|P2|Infant Series|Site 0048 Participants|16
4797144|NCT01341639|16543250|P1|Infant Series|Site 0048 Participants|17
4797145|NCT01341639|16543249|P2|Infant Series|Lost to Follow-up|2
4797146|NCT01341639|16543250|P1|Infant Series|Lost to Follow-up|0
4797147|NCT01341639|16543249|P2|Infant Series|Withdrawal by Subject|8
4797148|NCT01341639|16543250|P1|Infant Series|Withdrawal by Subject|11
4797149|NCT01341639|16543249|P2|Infant Series|Adverse Event|5
4797150|NCT01341639|16543250|P1|Infant Series|Adverse Event|0
4797151|NCT01341639|16543249|P2|Infant Series|Not Vaccinated|1
4797152|NCT01341639|16543250|P1|Infant Series|Not Vaccinated|0
4797153|NCT01341639|16543249|P2|Infant Series|Protocol Violation|0
4797154|NCT01341639|16543250|P1|Infant Series|Protocol Violation|1
4797155|NCT01341587|16543295|P2|Overall Study|stopped using the meters|10
4797156|NCT01341587|16543296|P1|Overall Study|stopped using the meters|2
4797157|NCT01341587|16543295|P2|Overall Study|Lost to Follow-up|0
4797158|NCT01341587|16543296|P1|Overall Study|Lost to Follow-up|2
4797159|NCT01341470|16543308|P6|Overall Study|Sponsor decision|1
4797160|NCT01341470|16543309|P5|Overall Study|Sponsor decision|0
4797161|NCT01341470|16543310|P4|Overall Study|Sponsor decision|1
4797162|NCT01341470|16543311|P3|Overall Study|Sponsor decision|1
4797163|NCT01341470|16543312|P2|Overall Study|Sponsor decision|0
4797164|NCT01341470|16543313|P1|Overall Study|Sponsor decision|0
4797165|NCT01341457|16543347|P2|Overall Study|Adverse Event|0
4797166|NCT01341457|16543348|P1|Overall Study|Adverse Event|2
4797167|NCT01340976|16543393|P6|Overall Study|Adverse Event|0
4797168|NCT01340976|16543394|P5|Overall Study|Adverse Event|0
4797169|NCT01340976|16543395|P4|Overall Study|Adverse Event|0
4797170|NCT01340976|16543396|P3|Overall Study|Adverse Event|0
4797171|NCT01340976|16543397|P2|Overall Study|Adverse Event|1
4797172|NCT01340976|16543398|P1|Overall Study|Adverse Event|0
4797173|NCT01340976|16543393|P6|Overall Study|Other anemia treatment|1
4797174|NCT01340976|16543394|P5|Overall Study|Other anemia treatment|0
4797175|NCT01340976|16543395|P4|Overall Study|Other anemia treatment|1
4797176|NCT01340976|16543396|P3|Overall Study|Other anemia treatment|2
4797177|NCT01340976|16543397|P2|Overall Study|Other anemia treatment|0
4797178|NCT01340976|16543398|P1|Overall Study|Other anemia treatment|1
4797179|NCT01340976|16543393|P6|Overall Study|Withdrawal by Subject|0
4797180|NCT01340976|16543394|P5|Overall Study|Withdrawal by Subject|1
4797181|NCT01340976|16543395|P4|Overall Study|Withdrawal by Subject|1
4797182|NCT01340976|16543396|P3|Overall Study|Withdrawal by Subject|0
4797183|NCT01340976|16543397|P2|Overall Study|Withdrawal by Subject|0
4797184|NCT01340976|16543398|P1|Overall Study|Withdrawal by Subject|0
4797185|NCT01340976|16543393|P6|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4797186|NCT01340976|16543394|P5|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4797187|NCT01340976|16543395|P4|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4797188|NCT01340976|16543396|P3|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4797189|NCT01340976|16543397|P2|Overall Study|Dose Limiting Toxicity Stopping Rule|0
4797190|NCT01340976|16543398|P1|Overall Study|Dose Limiting Toxicity Stopping Rule|1
4797191|NCT01340976|16543393|P6|Overall Study|Death|0
4797192|NCT01340976|16543394|P5|Overall Study|Death|0
4797193|NCT01340976|16543395|P4|Overall Study|Death|0
4797194|NCT01340976|16543396|P3|Overall Study|Death|0
4797195|NCT01340976|16543397|P2|Overall Study|Death|1
4797196|NCT01340976|16543398|P1|Overall Study|Death|0
4797197|NCT01340976|16543393|P6|Overall Study|Physician Decision|0
4797198|NCT01340976|16543394|P5|Overall Study|Physician Decision|1
4797199|NCT01340976|16543395|P4|Overall Study|Physician Decision|1
4797200|NCT01340976|16543396|P3|Overall Study|Physician Decision|1
4797201|NCT01340976|16543397|P2|Overall Study|Physician Decision|0
4797202|NCT01340976|16543398|P1|Overall Study|Physician Decision|2
4797203|NCT01340937|16543436|P4|Period 3: Toddler Vaccinations|Technical problem|0
4797204|NCT01340937|16543437|P3|Period 3: Toddler Vaccinations|Technical problem|1
4797205|NCT01340937|16543438|P2|Period 3: Toddler Vaccinations|Technical problem|1
4797206|NCT01340937|16543439|P1|Period 3: Toddler Vaccinations|Technical problem|1
4797207|NCT01340937|16543436|P4|Period 3: Toddler Vaccinations|Protocol Violation|1
4797208|NCT01340937|16543437|P3|Period 3: Toddler Vaccinations|Protocol Violation|0
4797209|NCT01340937|16543438|P2|Period 3: Toddler Vaccinations|Protocol Violation|0
4797210|NCT01340937|16543439|P1|Period 3: Toddler Vaccinations|Protocol Violation|0
4797211|NCT01340937|16543436|P4|Period 3: Toddler Vaccinations|Lost to Follow-up|8
4797212|NCT01340937|16543437|P3|Period 3: Toddler Vaccinations|Lost to Follow-up|7
4797213|NCT01340937|16543438|P2|Period 3: Toddler Vaccinations|Lost to Follow-up|14
4797214|NCT01340937|16543439|P1|Period 3: Toddler Vaccinations|Lost to Follow-up|6
4797215|NCT01340937|16543436|P4|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
4797216|NCT01340937|16543437|P3|Period 3: Toddler Vaccinations|Withdrawal by Subject|1
4797217|NCT01340937|16543438|P2|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
4797218|NCT01340937|16543439|P1|Period 3: Toddler Vaccinations|Withdrawal by Subject|2
4797219|NCT01340937|16543436|P4|Period 2: Interim Period|Technical problems|3
4797220|NCT01340937|16543437|P3|Period 2: Interim Period|Technical problems|6
4797221|NCT01340937|16543438|P2|Period 2: Interim Period|Technical problems|4
4797222|NCT01340937|16543439|P1|Period 2: Interim Period|Technical problems|4
4797223|NCT01340937|16543436|P4|Period 2: Interim Period|Protocol Violation|3
4797224|NCT01340937|16543437|P3|Period 2: Interim Period|Protocol Violation|6
4797225|NCT01340937|16543438|P2|Period 2: Interim Period|Protocol Violation|3
4797226|NCT01340937|16543439|P1|Period 2: Interim Period|Protocol Violation|5
4797227|NCT01340937|16543436|P4|Period 2: Interim Period|Physician Decision|0
4797228|NCT01340937|16543437|P3|Period 2: Interim Period|Physician Decision|1
4797229|NCT01340937|16543438|P2|Period 2: Interim Period|Physician Decision|1
4797230|NCT01340937|16543439|P1|Period 2: Interim Period|Physician Decision|0
4797231|NCT01340937|16543436|P4|Period 2: Interim Period|Lost to Follow-up|23
4797232|NCT01340937|16543437|P3|Period 2: Interim Period|Lost to Follow-up|53
4797233|NCT01340937|16543438|P2|Period 2: Interim Period|Lost to Follow-up|48
4797234|NCT01340937|16543439|P1|Period 2: Interim Period|Lost to Follow-up|29
4797235|NCT01340937|16543436|P4|Period 2: Interim Period|Adverse Event|0
4797236|NCT01340937|16543437|P3|Period 2: Interim Period|Adverse Event|1
4797237|NCT01340937|16543438|P2|Period 2: Interim Period|Adverse Event|0
4797238|NCT01340937|16543439|P1|Period 2: Interim Period|Adverse Event|1
4797239|NCT01340937|16543436|P4|Period 2: Interim Period|Withdrawal by Subject|12
4797240|NCT01340937|16543437|P3|Period 2: Interim Period|Withdrawal by Subject|17
4797241|NCT01340937|16543438|P2|Period 2: Interim Period|Withdrawal by Subject|23
4797242|NCT01340937|16543439|P1|Period 2: Interim Period|Withdrawal by Subject|28
4797243|NCT01340937|16543436|P4|Period 1: Infant Series|Randomized but not vaccinated|1
4797244|NCT01340937|16543437|P3|Period 1: Infant Series|Randomized but not vaccinated|2
4797245|NCT01340937|16543438|P2|Period 1: Infant Series|Randomized but not vaccinated|5
4797246|NCT01340937|16543439|P1|Period 1: Infant Series|Randomized but not vaccinated|0
4797247|NCT01340937|16543436|P4|Period 1: Infant Series|Withdrawal by Subject|15
4797248|NCT01340937|16543437|P3|Period 1: Infant Series|Withdrawal by Subject|30
4797249|NCT01340937|16543438|P2|Period 1: Infant Series|Withdrawal by Subject|32
4797250|NCT01340937|16543439|P1|Period 1: Infant Series|Withdrawal by Subject|33
4797251|NCT01340937|16543436|P4|Period 1: Infant Series|Protocol Violation|3
4797252|NCT01340937|16543437|P3|Period 1: Infant Series|Protocol Violation|4
4797253|NCT01340937|16543438|P2|Period 1: Infant Series|Protocol Violation|4
4797254|NCT01340937|16543439|P1|Period 1: Infant Series|Protocol Violation|1
4797255|NCT01340937|16543436|P4|Period 1: Infant Series|Physician Decision|0
4797256|NCT01340937|16543437|P3|Period 1: Infant Series|Physician Decision|1
4797257|NCT01340937|16543438|P2|Period 1: Infant Series|Physician Decision|3
4797258|NCT01340937|16543439|P1|Period 1: Infant Series|Physician Decision|2
4797259|NCT01340937|16543436|P4|Period 1: Infant Series|Lost to Follow-up|13
4797260|NCT01340937|16543437|P3|Period 1: Infant Series|Lost to Follow-up|12
4797261|NCT01340937|16543438|P2|Period 1: Infant Series|Lost to Follow-up|14
4797262|NCT01340937|16543439|P1|Period 1: Infant Series|Lost to Follow-up|20
4797263|NCT01340937|16543436|P4|Period 1: Infant Series|Death|0
4797264|NCT01340937|16543437|P3|Period 1: Infant Series|Death|2
4797265|NCT01340937|16543438|P2|Period 1: Infant Series|Death|0
4797266|NCT01340937|16543439|P1|Period 1: Infant Series|Death|2
4797267|NCT01340937|16543436|P4|Period 1: Infant Series|Adverse Event|0
4797268|NCT01340937|16543437|P3|Period 1: Infant Series|Adverse Event|4
4797269|NCT01340937|16543438|P2|Period 1: Infant Series|Adverse Event|1
4797270|NCT01340937|16543439|P1|Period 1: Infant Series|Adverse Event|0
4797271|NCT01340937|16543436|P4|Period 1: Infant Series|Other protocol criterion not met|0
4797272|NCT01340937|16543437|P3|Period 1: Infant Series|Other protocol criterion not met|1
4797273|NCT01340937|16543438|P2|Period 1: Infant Series|Other protocol criterion not met|1
4797274|NCT01340937|16543439|P1|Period 1: Infant Series|Other protocol criterion not met|0
4797275|NCT01340898|16543599|P3|Booster Phase|Lost to Follow-up|3
4797276|NCT01340898|16543600|P2|Booster Phase|Lost to Follow-up|2
4797277|NCT01340898|16543601|P1|Booster Phase|Lost to Follow-up|4
4797278|NCT01340898|16543599|P3|Booster Phase|Migrated/moved from study area|0
4797279|NCT01340898|16543600|P2|Booster Phase|Migrated/moved from study area|0
4797280|NCT01340898|16543601|P1|Booster Phase|Migrated/moved from study area|3
4797281|NCT01340898|16543599|P3|Booster Phase|Withdrawal by Subject|4
4797282|NCT01340898|16543600|P2|Booster Phase|Withdrawal by Subject|0
4797283|NCT01340898|16543601|P1|Booster Phase|Withdrawal by Subject|3
4797284|NCT01340898|16543599|P3|Primary Phase|Lost to Follow-up|0
4797285|NCT01340898|16543600|P2|Primary Phase|Lost to Follow-up|1
4797286|NCT01340898|16543601|P1|Primary Phase|Lost to Follow-up|4
4797287|NCT01340898|16543599|P3|Primary Phase|Migrated/moved from study area|0
4797288|NCT01340898|16543600|P2|Primary Phase|Migrated/moved from study area|1
4797289|NCT01340898|16543601|P1|Primary Phase|Migrated/moved from study area|4
4797290|NCT01340898|16543599|P3|Primary Phase|Withdrawal by Subject|5
4797291|NCT01340898|16543600|P2|Primary Phase|Withdrawal by Subject|7
4797292|NCT01340898|16543601|P1|Primary Phase|Withdrawal by Subject|8
4797293|NCT01340898|16543599|P3|Primary Phase|Serious Adverse Events|1
4797294|NCT01340898|16543600|P2|Primary Phase|Serious Adverse Events|0
4797295|NCT01340898|16543601|P1|Primary Phase|Serious Adverse Events|0
4797296|NCT01340794|16543731|P2|Overall Study|Withdrawal by Subject|1
4797297|NCT01340794|16543732|P1|Overall Study|Withdrawal by Subject|0
4797298|NCT01340768|16543748|P2|Overall Study|Other|0
4797299|NCT01340768|16543749|P1|Overall Study|Other|2
4797300|NCT01340768|16543748|P2|Overall Study|Withdrawal by Subject|1
4797301|NCT01340768|16543749|P1|Overall Study|Withdrawal by Subject|5
4797302|NCT01340768|16543748|P2|Overall Study|Lost to Follow-up|4
4797303|NCT01340768|16543749|P1|Overall Study|Lost to Follow-up|10
4797304|NCT01340664|16543760|P3|Overall Study|Other|2
4797305|NCT01340664|16543761|P2|Overall Study|Other|2
4797306|NCT01340664|16543762|P1|Overall Study|Other|1
4797307|NCT01340664|16543760|P3|Overall Study|Creatinine or eGFR withdrawal criteria|2
4797308|NCT01340664|16543761|P2|Overall Study|Creatinine or eGFR withdrawal criteria|1
4797309|NCT01340664|16543762|P1|Overall Study|Creatinine or eGFR withdrawal criteria|0
4797310|NCT01340664|16543760|P3|Overall Study|Glycemic withdrawal criteria|0
4797311|NCT01340664|16543761|P2|Overall Study|Glycemic withdrawal criteria|0
4797312|NCT01340664|16543762|P1|Overall Study|Glycemic withdrawal criteria|2
4797313|NCT01340664|16543760|P3|Overall Study|Withdrawal by Subject|0
4797314|NCT01340664|16543761|P2|Overall Study|Withdrawal by Subject|4
4797315|NCT01340664|16543762|P1|Overall Study|Withdrawal by Subject|2
4797316|NCT01340664|16543760|P3|Overall Study|Lost to Follow-up|2
4797317|NCT01340664|16543761|P2|Overall Study|Lost to Follow-up|0
4797318|NCT01340664|16543762|P1|Overall Study|Lost to Follow-up|2
4797319|NCT01340664|16543760|P3|Overall Study|Adverse Event|7
4797320|NCT01340664|16543761|P2|Overall Study|Adverse Event|1
4797321|NCT01340664|16543762|P1|Overall Study|Adverse Event|0
4797322|NCT01340651|16543779|P1|Overall Study|Commercial Supply per Sponsor|12
4797323|NCT01340651|16543779|P1|Overall Study|Consent Withdrawn|2
4797324|NCT01340651|16543779|P1|Overall Study|Adverse Event|3
4797325|NCT01340625|16543795|P2|Washout Period of 28 Days|Withdrawal by Subject|0
4797326|NCT01340625|16543796|P1|Washout Period of 28 Days|Withdrawal by Subject|1
4797327|NCT01340625|16543795|P2|First Intervention|Adverse Event|0
4797328|NCT01340625|16543796|P1|First Intervention|Adverse Event|1
4797329|NCT01340495|16543901|P1|Overall Study|Withdrawal by Subject|1
4797330|NCT01340482|16543911|P3|Overall Study|Adverse Event|0
4797331|NCT01340482|16543912|P2|Overall Study|Adverse Event|0
4797332|NCT01340482|16543913|P1|Overall Study|Adverse Event|2
4797333|NCT01340300|16543928|P4|Overall Study|Unrelated sickness|1
4797334|NCT01340300|16543929|P3|Overall Study|Unrelated sickness|0
4797335|NCT01340300|16543930|P2|Overall Study|Unrelated sickness|2
4797336|NCT01340300|16543931|P1|Overall Study|Unrelated sickness|0
4797337|NCT01340300|16543928|P4|Overall Study|Physician Decision|0
4797338|NCT01340300|16543929|P3|Overall Study|Physician Decision|0
4797339|NCT01340300|16543930|P2|Overall Study|Physician Decision|1
4797340|NCT01340300|16543931|P1|Overall Study|Physician Decision|0
4797341|NCT01340300|16543928|P4|Overall Study|Adverse Event|0
4797342|NCT01340300|16543929|P3|Overall Study|Adverse Event|4
4797343|NCT01340300|16543930|P2|Overall Study|Adverse Event|0
4797344|NCT01340300|16543931|P1|Overall Study|Adverse Event|1
4797345|NCT01340300|16543928|P4|Overall Study|Withdrawal by Subject|3
4797346|NCT01340300|16543929|P3|Overall Study|Withdrawal by Subject|6
4797347|NCT01340300|16543930|P2|Overall Study|Withdrawal by Subject|6
4797348|NCT01340300|16543931|P1|Overall Study|Withdrawal by Subject|5
4797349|NCT01340300|16543928|P4|Overall Study|Lost to Follow-up|10
4797350|NCT01340300|16543929|P3|Overall Study|Lost to Follow-up|5
4797351|NCT01340300|16543930|P2|Overall Study|Lost to Follow-up|0
4797352|NCT01340300|16543931|P1|Overall Study|Lost to Follow-up|3
4797353|NCT01340209|16543964|P3|Overall Study|Other reason not defined above|4
4797354|NCT01340209|16543965|P2|Overall Study|Other reason not defined above|5
4797355|NCT01340209|16543966|P1|Overall Study|Other reason not defined above|3
4797356|NCT01340209|16543964|P3|Overall Study|Withdrawal by Subject|1
4797357|NCT01340209|16543965|P2|Overall Study|Withdrawal by Subject|0
4797358|NCT01340209|16543966|P1|Overall Study|Withdrawal by Subject|0
4797359|NCT01340209|16543964|P3|Overall Study|Protocol Violation|1
4797360|NCT01340209|16543965|P2|Overall Study|Protocol Violation|2
4797361|NCT01340209|16543966|P1|Overall Study|Protocol Violation|1
4797362|NCT01340209|16543964|P3|Overall Study|Adverse Event|2
4797363|NCT01340209|16543965|P2|Overall Study|Adverse Event|1
4797364|NCT01340209|16543966|P1|Overall Study|Adverse Event|1
4797365|NCT01340196|16544001|P1|Treat. Period 3 (Faldaprevir)|Adverse Event|2
4797366|NCT01340066|16544041|P3|5 Week Double Blind Randomization Period|Withdrawal by Subject|1
4797367|NCT01340066|16544042|P2|5 Week Double Blind Randomization Period|Withdrawal by Subject|2
4797368|NCT01340066|16544043|P1|5 Week Double Blind Randomization Period|Withdrawal by Subject|0
4797369|NCT01340066|16544041|P3|5 Week Double Blind Randomization Period|Physician Decision|0
4797370|NCT01340066|16544042|P2|5 Week Double Blind Randomization Period|Physician Decision|1
4797371|NCT01340066|16544043|P1|5 Week Double Blind Randomization Period|Physician Decision|0
4797372|NCT01340066|16544041|P3|5 Week Double Blind Randomization Period|Adverse Event|2
4797373|NCT01340066|16544042|P2|5 Week Double Blind Randomization Period|Adverse Event|2
4797374|NCT01340066|16544043|P1|5 Week Double Blind Randomization Period|Adverse Event|0
4797375|NCT01340066|16544041|P3|Placebo Run in Period|Screen Failures|0
4797376|NCT01340066|16544042|P2|Placebo Run in Period|Screen Failures|0
4797377|NCT01340066|16544043|P1|Placebo Run in Period|Screen Failures|27
4797378|NCT01340027|16544083|P12|Overall Study|Miscellaneous|0
4797379|NCT01340027|16544084|P11|Overall Study|Miscellaneous|1
4797380|NCT01340027|16544085|P10|Overall Study|Miscellaneous|0
4797381|NCT01340027|16544086|P9|Overall Study|Miscellaneous|0
4797382|NCT01340027|16544087|P8|Overall Study|Miscellaneous|0
4797383|NCT01340027|16544088|P7|Overall Study|Miscellaneous|0
4797384|NCT01340027|16544089|P6|Overall Study|Miscellaneous|0
4797385|NCT01340027|16544090|P5|Overall Study|Miscellaneous|0
4797386|NCT01340027|16544091|P4|Overall Study|Miscellaneous|1
4797387|NCT01340027|16544092|P3|Overall Study|Miscellaneous|0
4797388|NCT01340027|16544093|P2|Overall Study|Miscellaneous|0
4797389|NCT01340027|16544094|P1|Overall Study|Miscellaneous|0
4797390|NCT01340027|16544083|P12|Overall Study|Withdrawal by Subject|1
4797391|NCT01340027|16544084|P11|Overall Study|Withdrawal by Subject|0
4797392|NCT01340027|16544085|P10|Overall Study|Withdrawal by Subject|2
4797393|NCT01340027|16544086|P9|Overall Study|Withdrawal by Subject|1
4797394|NCT01340027|16544087|P8|Overall Study|Withdrawal by Subject|4
4797395|NCT01340027|16544088|P7|Overall Study|Withdrawal by Subject|3
4797396|NCT01340027|16544089|P6|Overall Study|Withdrawal by Subject|2
4797397|NCT01340027|16544090|P5|Overall Study|Withdrawal by Subject|3
4797398|NCT01340027|16544091|P4|Overall Study|Withdrawal by Subject|3
4797399|NCT01340027|16544092|P3|Overall Study|Withdrawal by Subject|1
4797400|NCT01340027|16544093|P2|Overall Study|Withdrawal by Subject|3
4797401|NCT01340027|16544094|P1|Overall Study|Withdrawal by Subject|4
4797402|NCT01340027|16544083|P12|Overall Study|Protocol Violation|0
4797403|NCT01340027|16544084|P11|Overall Study|Protocol Violation|0
4797404|NCT01340027|16544085|P10|Overall Study|Protocol Violation|2
4797405|NCT01340027|16544086|P9|Overall Study|Protocol Violation|2
4797406|NCT01340027|16544087|P8|Overall Study|Protocol Violation|1
4797407|NCT01340027|16544088|P7|Overall Study|Protocol Violation|0
4797408|NCT01340027|16544089|P6|Overall Study|Protocol Violation|0
4797409|NCT01340027|16544090|P5|Overall Study|Protocol Violation|6
4797410|NCT01340027|16544091|P4|Overall Study|Protocol Violation|0
4797411|NCT01340027|16544092|P3|Overall Study|Protocol Violation|0
4797412|NCT01340027|16544093|P2|Overall Study|Protocol Violation|2
4797413|NCT01340027|16544094|P1|Overall Study|Protocol Violation|1
4797414|NCT01340027|16544083|P12|Overall Study|Lost to Follow-up|0
4797415|NCT01340027|16544084|P11|Overall Study|Lost to Follow-up|0
4797416|NCT01340027|16544085|P10|Overall Study|Lost to Follow-up|1
4797417|NCT01340027|16544086|P9|Overall Study|Lost to Follow-up|0
4797418|NCT01340027|16544087|P8|Overall Study|Lost to Follow-up|0
4797419|NCT01340027|16544088|P7|Overall Study|Lost to Follow-up|1
4797420|NCT01340027|16544089|P6|Overall Study|Lost to Follow-up|0
4797421|NCT01340027|16544090|P5|Overall Study|Lost to Follow-up|0
4797422|NCT01340027|16544091|P4|Overall Study|Lost to Follow-up|0
4797423|NCT01340027|16544092|P3|Overall Study|Lost to Follow-up|0
4797424|NCT01340027|16544093|P2|Overall Study|Lost to Follow-up|1
4797425|NCT01340027|16544094|P1|Overall Study|Lost to Follow-up|0
4797426|NCT01340027|16544083|P12|Overall Study|Lack of Efficacy|0
4797427|NCT01340027|16544084|P11|Overall Study|Lack of Efficacy|0
4797428|NCT01340027|16544085|P10|Overall Study|Lack of Efficacy|0
4797429|NCT01340027|16544086|P9|Overall Study|Lack of Efficacy|1
4797430|NCT01340027|16544087|P8|Overall Study|Lack of Efficacy|1
4797431|NCT01340027|16544088|P7|Overall Study|Lack of Efficacy|1
4797432|NCT01340027|16544089|P6|Overall Study|Lack of Efficacy|0
4797433|NCT01340027|16544090|P5|Overall Study|Lack of Efficacy|0
4797434|NCT01340027|16544091|P4|Overall Study|Lack of Efficacy|0
4797435|NCT01340027|16544092|P3|Overall Study|Lack of Efficacy|0
4797436|NCT01340027|16544093|P2|Overall Study|Lack of Efficacy|0
4797437|NCT01340027|16544094|P1|Overall Study|Lack of Efficacy|0
4797438|NCT01340027|16544083|P12|Overall Study|Adverse Event|3
4797439|NCT01340027|16544084|P11|Overall Study|Adverse Event|1
4797440|NCT01340027|16544085|P10|Overall Study|Adverse Event|1
4797441|NCT01340027|16544086|P9|Overall Study|Adverse Event|4
4797442|NCT01340027|16544087|P8|Overall Study|Adverse Event|1
4797443|NCT01340027|16544088|P7|Overall Study|Adverse Event|2
4797444|NCT01340027|16544089|P6|Overall Study|Adverse Event|2
4797445|NCT01340027|16544090|P5|Overall Study|Adverse Event|1
4797446|NCT01340027|16544091|P4|Overall Study|Adverse Event|0
4797447|NCT01340027|16544092|P3|Overall Study|Adverse Event|2
4797448|NCT01340027|16544093|P2|Overall Study|Adverse Event|1
4797449|NCT01340027|16544094|P1|Overall Study|Adverse Event|0
4797450|NCT01340027|16544083|P12|Overall Study|Randomized but Never Received Study Drug|0
4797451|NCT01340027|16544084|P11|Overall Study|Randomized but Never Received Study Drug|0
4797452|NCT01340027|16544085|P10|Overall Study|Randomized but Never Received Study Drug|0
4797453|NCT01340027|16544086|P9|Overall Study|Randomized but Never Received Study Drug|0
4797454|NCT01340027|16544087|P8|Overall Study|Randomized but Never Received Study Drug|0
4797455|NCT01340027|16544088|P7|Overall Study|Randomized but Never Received Study Drug|0
4797456|NCT01340027|16544089|P6|Overall Study|Randomized but Never Received Study Drug|0
4797457|NCT01340027|16544090|P5|Overall Study|Randomized but Never Received Study Drug|0
4797458|NCT01340027|16544091|P4|Overall Study|Randomized but Never Received Study Drug|0
4797459|NCT01340027|16544092|P3|Overall Study|Randomized but Never Received Study Drug|1
4797460|NCT01340027|16544093|P2|Overall Study|Randomized but Never Received Study Drug|0
4797461|NCT01340027|16544094|P1|Overall Study|Randomized but Never Received Study Drug|0
4797462|NCT01340014|16544470|P2|Period 2, Second 7 Days|Adverse Event|1
4797463|NCT01340014|16544471|P1|Period 2, Second 7 Days|Adverse Event|0
4797464|NCT01340014|16544470|P2|Period 1, First 7 Days|Personal Reasons|0
4797465|NCT01340014|16544471|P1|Period 1, First 7 Days|Personal Reasons|1
4797466|NCT01340014|16544470|P2|Period 1, First 7 Days|Adverse Event|0
4797467|NCT01340014|16544471|P1|Period 1, First 7 Days|Adverse Event|1
4797468|NCT01339923|16544492|P7|Overall Study|Withdrawal by Subject|2
4797469|NCT01339923|16544493|P6|Overall Study|Withdrawal by Subject|3
4797470|NCT01339923|16544494|P5|Overall Study|Withdrawal by Subject|4
4797471|NCT01339923|16544495|P4|Overall Study|Withdrawal by Subject|1
4797472|NCT01339923|16544496|P3|Overall Study|Withdrawal by Subject|6
4797473|NCT01339923|16544497|P2|Overall Study|Withdrawal by Subject|11
4797474|NCT01339923|16544498|P1|Overall Study|Withdrawal by Subject|7
4797475|NCT01339923|16544492|P7|Overall Study|Unable to Classify|5
4797476|NCT01339923|16544493|P6|Overall Study|Unable to Classify|1
4797477|NCT01339923|16544494|P5|Overall Study|Unable to Classify|0
4797478|NCT01339923|16544495|P4|Overall Study|Unable to Classify|0
4797479|NCT01339923|16544496|P3|Overall Study|Unable to Classify|1
4797480|NCT01339923|16544497|P2|Overall Study|Unable to Classify|0
4797481|NCT01339923|16544498|P1|Overall Study|Unable to Classify|1
4797482|NCT01339923|16544492|P7|Overall Study|Protocol Violation|1
4797483|NCT01339923|16544493|P6|Overall Study|Protocol Violation|3
4797484|NCT01339923|16544494|P5|Overall Study|Protocol Violation|0
4797485|NCT01339923|16544495|P4|Overall Study|Protocol Violation|0
4797486|NCT01339923|16544496|P3|Overall Study|Protocol Violation|0
4797487|NCT01339923|16544497|P2|Overall Study|Protocol Violation|0
4797488|NCT01339923|16544498|P1|Overall Study|Protocol Violation|0
4797489|NCT01339923|16544492|P7|Overall Study|Lost to Follow-up|5
4797490|NCT01339923|16544493|P6|Overall Study|Lost to Follow-up|1
4797491|NCT01339923|16544494|P5|Overall Study|Lost to Follow-up|1
4797492|NCT01339923|16544495|P4|Overall Study|Lost to Follow-up|3
4797493|NCT01339923|16544496|P3|Overall Study|Lost to Follow-up|0
4797494|NCT01339923|16544497|P2|Overall Study|Lost to Follow-up|4
4797495|NCT01339923|16544498|P1|Overall Study|Lost to Follow-up|4
4797496|NCT01339923|16544492|P7|Overall Study|Inappropriate Enrollment|0
4797497|NCT01339923|16544493|P6|Overall Study|Inappropriate Enrollment|1
4797498|NCT01339923|16544494|P5|Overall Study|Inappropriate Enrollment|0
4797499|NCT01339923|16544495|P4|Overall Study|Inappropriate Enrollment|0
4797500|NCT01339923|16544496|P3|Overall Study|Inappropriate Enrollment|0
4797501|NCT01339923|16544497|P2|Overall Study|Inappropriate Enrollment|0
4797502|NCT01339923|16544498|P1|Overall Study|Inappropriate Enrollment|1
4797503|NCT01339923|16544492|P7|Overall Study|Adverse Event|1
4797504|NCT01339923|16544493|P6|Overall Study|Adverse Event|0
4797505|NCT01339923|16544494|P5|Overall Study|Adverse Event|0
4797506|NCT01339923|16544495|P4|Overall Study|Adverse Event|0
4797507|NCT01339923|16544496|P3|Overall Study|Adverse Event|1
4797508|NCT01339923|16544497|P2|Overall Study|Adverse Event|1
4797509|NCT01339923|16544498|P1|Overall Study|Adverse Event|1
4797510|NCT01339910|16544569|P2|Overall Study|Disease relapse|4
4797511|NCT01339910|16544570|P1|Overall Study|Disease relapse|1
4797512|NCT01339910|16544569|P2|Overall Study|Physician Decision|0
4797513|NCT01339910|16544570|P1|Overall Study|Physician Decision|1
4797514|NCT01339910|16544569|P2|Overall Study|Withdrawal by Subject|0
4797515|NCT01339910|16544570|P1|Overall Study|Withdrawal by Subject|1
4797516|NCT01339897|16544608|P4|Overall Study|Adverse Event|1
4797517|NCT01339897|16544609|P3|Overall Study|Adverse Event|0
4797518|NCT01339897|16544610|P2|Overall Study|Adverse Event|0
4797519|NCT01339897|16544611|P1|Overall Study|Adverse Event|1
4797520|NCT01339832|16544664|P1|Overall Study|Death|11
4797521|NCT01339832|16544664|P1|Overall Study|Lost to Follow-up|3
4797522|NCT01339559|16544675|P1|Overall Study|PI decision|1
4797523|NCT01339559|16544675|P1|Overall Study|Patient didn't wish to continue|1
4797524|NCT01339559|16544675|P1|Overall Study|Investigator decision|2
4797525|NCT01339559|16544675|P1|Overall Study|Left the country|1
4797526|NCT01339559|16544675|P1|Overall Study|Pregnancy planned|2
4797527|NCT01339559|16544675|P1|Overall Study|Epilepsy surgery|1
4797528|NCT01339559|16544675|P1|Overall Study|Incarcerated|2
4797529|NCT01339559|16544675|P1|Overall Study|Study closure at site|1
4797530|NCT01339559|16544675|P1|Overall Study|Protocol Violation|15
4797531|NCT01339559|16544675|P1|Overall Study|Subject choice|89
4797532|NCT01339559|16544675|P1|Overall Study|Lost to Follow-up|22
4797533|NCT01339559|16544675|P1|Overall Study|Lack of Efficacy|164
4797534|NCT01339559|16544675|P1|Overall Study|Death|5
4797535|NCT01339559|16544675|P1|Overall Study|Adverse Event|92
4797536|NCT01339429|16544684|P1|Overall Study|Physician Decision|3
4797537|NCT01339429|16544684|P1|Overall Study|Withdrawal by Subject|1
4797538|NCT01339390|16544724|P2|Overall Study|Lost to Follow-up|127
4797539|NCT01339390|16544725|P1|Overall Study|Lost to Follow-up|125
4797540|NCT01339390|16544724|P2|Overall Study|Death|29
4797541|NCT01339390|16544725|P1|Overall Study|Death|32
4797542|NCT01339273|16544742|P2|Overall Study|Lost to Follow-up|8
4797543|NCT01339273|16544743|P1|Overall Study|Lost to Follow-up|8
4797544|NCT01339052|16544818|P2|Overall Study|Physician Decision|0
4797545|NCT01339052|16544819|P1|Overall Study|Physician Decision|1
4797546|NCT01339052|16544818|P2|Overall Study|Withdrawal by Subject|3
4797547|NCT01339052|16544819|P1|Overall Study|Withdrawal by Subject|0
4797548|NCT01339052|16544818|P2|Overall Study|Adverse Event|1
4797549|NCT01339052|16544819|P1|Overall Study|Adverse Event|1
4797550|NCT01339052|16544818|P2|Overall Study|Disease progression|46
4797551|NCT01339052|16544819|P1|Overall Study|Disease progression|13
4797552|NCT01339000|16544845|P2|Overall Study|study closed due to lack of drug supply|0
4797553|NCT01339000|16544846|P1|Overall Study|study closed due to lack of drug supply|1
4797554|NCT01338987|16544865|P5|Overall Study|Disease progression on study|0
4797555|NCT01338987|16544866|P4|Overall Study|Disease progression on study|0
4797556|NCT01338987|16544867|P3|Overall Study|Disease progression on study|1
4797557|NCT01338987|16544868|P2|Overall Study|Disease progression on study|1
4797558|NCT01338987|16544869|P1|Overall Study|Disease progression on study|2
4797559|NCT01338987|16544865|P5|Overall Study|enrolled on new protocol|0
4797560|NCT01338987|16544866|P4|Overall Study|enrolled on new protocol|0
4797561|NCT01338987|16544867|P3|Overall Study|enrolled on new protocol|1
4797562|NCT01338987|16544868|P2|Overall Study|enrolled on new protocol|0
4797563|NCT01338987|16544869|P1|Overall Study|enrolled on new protocol|0
4797564|NCT01338870|16544890|P6|Overall Study|Adverse Event|1
4797565|NCT01338870|16544891|P5|Overall Study|Adverse Event|4
4797566|NCT01338870|16544892|P4|Overall Study|Adverse Event|5
4797567|NCT01338870|16544893|P3|Overall Study|Adverse Event|1
4797568|NCT01338870|16544894|P2|Overall Study|Adverse Event|4
4797569|NCT01338870|16544895|P1|Overall Study|Adverse Event|4
4797570|NCT01338870|16544890|P6|Overall Study|Protocol Violation|1
4797571|NCT01338870|16544891|P5|Overall Study|Protocol Violation|1
4797572|NCT01338870|16544892|P4|Overall Study|Protocol Violation|2
4797573|NCT01338870|16544893|P3|Overall Study|Protocol Violation|2
4797574|NCT01338870|16544894|P2|Overall Study|Protocol Violation|2
4797575|NCT01338870|16544895|P1|Overall Study|Protocol Violation|0
4797576|NCT01338870|16544890|P6|Overall Study|Other|2
4797577|NCT01338870|16544891|P5|Overall Study|Other|0
4797578|NCT01338870|16544892|P4|Overall Study|Other|2
4797579|NCT01338870|16544893|P3|Overall Study|Other|3
4797580|NCT01338870|16544894|P2|Overall Study|Other|3
4797581|NCT01338870|16544895|P1|Overall Study|Other|3
4797582|NCT01338870|16544890|P6|Overall Study|Withdrawal by Subject|2
4797583|NCT01338870|16544891|P5|Overall Study|Withdrawal by Subject|0
4797584|NCT01338870|16544892|P4|Overall Study|Withdrawal by Subject|0
4797585|NCT01338870|16544893|P3|Overall Study|Withdrawal by Subject|4
4797586|NCT01338870|16544894|P2|Overall Study|Withdrawal by Subject|3
4797587|NCT01338870|16544895|P1|Overall Study|Withdrawal by Subject|2
4797588|NCT01338870|16544890|P6|Overall Study|Lost to Follow-up|0
4797589|NCT01338870|16544891|P5|Overall Study|Lost to Follow-up|1
4797590|NCT01338870|16544892|P4|Overall Study|Lost to Follow-up|0
4797591|NCT01338870|16544893|P3|Overall Study|Lost to Follow-up|1
4797592|NCT01338870|16544894|P2|Overall Study|Lost to Follow-up|0
4797593|NCT01338870|16544895|P1|Overall Study|Lost to Follow-up|0
4797594|NCT01338818|16544950|P1|Overall Study|Protocol Deviation|4
4797595|NCT01338818|16544950|P1|Overall Study|Administrative problems|3
4797596|NCT01338818|16544950|P1|Overall Study|Lost to Follow-up|4
4797597|NCT01338818|16544950|P1|Overall Study|Withdrawal by Subject|11
4797598|NCT01338818|16544950|P1|Overall Study|no longer require study drug|1
4797599|NCT01338818|16544950|P1|Overall Study|Lack of Efficacy|5
4797600|NCT01338818|16544950|P1|Overall Study|Adverse Event|8
4797601|NCT01338792|16544956|P1|Overall Study|Withdrawal by Subject|1
4797602|NCT01338792|16544956|P1|Overall Study|Death|1
4797603|NCT01338792|16544956|P1|Overall Study|Adverse Event|2
4797604|NCT01338636|16544971|P1|Overall Study|Withdrawn due to lack of improvement|8
4797605|NCT01338610|16544985|P3|Overall Study|Adverse Event|0
4797606|NCT01338610|16544986|P2|Overall Study|Adverse Event|0
4797607|NCT01338610|16544987|P1|Overall Study|Adverse Event|3
4797608|NCT01338610|16544985|P3|Overall Study|Protocol Violation|1
4797609|NCT01338610|16544986|P2|Overall Study|Protocol Violation|0
4797610|NCT01338610|16544987|P1|Overall Study|Protocol Violation|1
4797611|NCT01338610|16544985|P3|Overall Study|Patient Decision Unrelated to Advs Event|0
4797612|NCT01338610|16544986|P2|Overall Study|Patient Decision Unrelated to Advs Event|1
4797613|NCT01338610|16544987|P1|Overall Study|Patient Decision Unrelated to Advs Event|1
4797614|NCT01338493|16545013|P1|12 Months Follow up|Lost to Follow-up|9
4797615|NCT01338493|16545013|P1|6 Months Follow up|Missed visit|8
4797616|NCT01338493|16545013|P1|6 Months Follow up|Lost to Follow-up|11
4797617|NCT01338493|16545013|P1|Discharge|Missed visit|1
4797618|NCT01338493|16545013|P1|Discharge|Death|1
4797619|NCT01338493|16545013|P1|Enrolled|Patient not implanted|4
4797620|NCT01338493|16545013|P1|Enrolled|Withdrawal by Subject|1
4797621|NCT01338415|16545020|P2|Overall Study|Other (administrative reason)|0
4797622|NCT01338415|16545021|P1|Overall Study|Other (administrative reason)|1
4797623|NCT01338415|16545020|P2|Overall Study|Other (PAH not the main etiology of PH)|2
4797624|NCT01338415|16545021|P1|Overall Study|Other (PAH not the main etiology of PH)|0
4797625|NCT01338415|16545020|P2|Overall Study|Withdrawal by Subject|1
4797626|NCT01338415|16545021|P1|Overall Study|Withdrawal by Subject|1
4797627|NCT01338415|16545020|P2|Overall Study|Adverse Event|6
4797628|NCT01338415|16545021|P1|Overall Study|Adverse Event|8
4797629|NCT01338298|16545043|P2|Overall Study|Non-adherence|0
4797630|NCT01338298|16545044|P1|Overall Study|Non-adherence|1
4797631|NCT01338298|16545043|P2|Overall Study|Depressive symptoms and nausea|0
4797632|NCT01338298|16545044|P1|Overall Study|Depressive symptoms and nausea|1
4797633|NCT01338298|16545043|P2|Overall Study|Positive symptom worsening|0
4797634|NCT01338298|16545044|P1|Overall Study|Positive symptom worsening|1
4797635|NCT01338298|16545043|P2|Overall Study|Administrative error|1
4797636|NCT01338298|16545044|P1|Overall Study|Administrative error|0
4797637|NCT01338298|16545043|P2|Overall Study|Abdominal Pain and scheduled surgery|1
4797638|NCT01338298|16545044|P1|Overall Study|Abdominal Pain and scheduled surgery|0
4797639|NCT01338298|16545043|P2|Overall Study|Withdrawal by Subject|1
4797640|NCT01338298|16545044|P1|Overall Study|Withdrawal by Subject|1
4797641|NCT01338025|16545054|P2|Overall Study|Found ineligible after starting|0
4797642|NCT01338025|16545055|P1|Overall Study|Found ineligible after starting|1
4797643|NCT01338025|16545054|P2|Overall Study|Withdrawal by Subject|2
4797644|NCT01338025|16545055|P1|Overall Study|Withdrawal by Subject|0
4797645|NCT01338025|16545054|P2|Overall Study|Unexpected closure of study|9
4797646|NCT01338025|16545055|P1|Overall Study|Unexpected closure of study|10
4797647|NCT01338012|16545067|P1|Overall Study|Study terminated|4
4797648|NCT01338012|16545067|P1|Overall Study|Death|4
4797649|NCT01337986|16545073|P2|Overall Study|Protocol Violation|3
4797650|NCT01337986|16545074|P1|Overall Study|Protocol Violation|0
4797651|NCT01337986|16545073|P2|Overall Study|Lost to Follow-up|0
4797652|NCT01337986|16545074|P1|Overall Study|Lost to Follow-up|1
4797653|NCT01337986|16545073|P2|Overall Study|Adverse Event|2
4797654|NCT01337986|16545074|P1|Overall Study|Adverse Event|2
4797655|NCT01337973|16545111|P3|Overall Study|missing data on primary outcome|3
4797656|NCT01337973|16545112|P2|Overall Study|missing data on primary outcome|1
4797657|NCT01337973|16545113|P1|Overall Study|missing data on primary outcome|3
4797658|NCT01337973|16545111|P3|Overall Study|Withdrawal by Subject|4
4797659|NCT01337973|16545112|P2|Overall Study|Withdrawal by Subject|8
4797660|NCT01337973|16545113|P1|Overall Study|Withdrawal by Subject|10
4797661|NCT01337973|16545111|P3|Overall Study|Death|1
4797662|NCT01337973|16545112|P2|Overall Study|Death|2
4797663|NCT01337973|16545113|P1|Overall Study|Death|1
4797664|NCT01337973|16545111|P3|Overall Study|Lost to Follow-up|3
4797665|NCT01337973|16545112|P2|Overall Study|Lost to Follow-up|4
4797666|NCT01337973|16545113|P1|Overall Study|Lost to Follow-up|2
4797667|NCT01337960|16545127|P3|Overall Study|Withdrawal by Subject|0
4797668|NCT01337960|16545128|P2|Overall Study|Withdrawal by Subject|0
4797669|NCT01337960|16545129|P1|Overall Study|Withdrawal by Subject|1
4797670|NCT01337960|16545127|P3|Overall Study|Lost to Follow-up|0
4797671|NCT01337960|16545128|P2|Overall Study|Lost to Follow-up|0
4797672|NCT01337960|16545129|P1|Overall Study|Lost to Follow-up|1
4797673|NCT01337674|16545194|P4|Treatment Period 2|Withdrawal by Subject|0
4797674|NCT01337674|16545195|P3|Treatment Period 2|Withdrawal by Subject|1
4797675|NCT01337674|16545196|P2|Treatment Period 2|Withdrawal by Subject|0
4797676|NCT01337674|16545197|P1|Treatment Period 2|Withdrawal by Subject|0
4797677|NCT01337674|16545194|P4|Treatment Period 1|Discontinued due to blood draws|1
4797678|NCT01337674|16545195|P3|Treatment Period 1|Discontinued due to blood draws|0
4797679|NCT01337674|16545196|P2|Treatment Period 1|Discontinued due to blood draws|0
4797680|NCT01337674|16545197|P1|Treatment Period 1|Discontinued due to blood draws|0
4797681|NCT01337674|16545194|P4|Treatment Period 1|Adverse Event|0
4797682|NCT01337674|16545195|P3|Treatment Period 1|Adverse Event|0
4797683|NCT01337674|16545196|P2|Treatment Period 1|Adverse Event|1
4797684|NCT01337674|16545197|P1|Treatment Period 1|Adverse Event|0
4797685|NCT01337635|16545215|P2|Overall Study|Lost to Follow-up|1
4797686|NCT01337635|16545216|P1|Overall Study|Lost to Follow-up|0
4797687|NCT01337596|16545258|P9|Overall Study|Withdrawal by Subject|0
4797688|NCT01337596|16545259|P8|Overall Study|Withdrawal by Subject|0
4797689|NCT01337596|16545260|P7|Overall Study|Withdrawal by Subject|0
4797690|NCT01337596|16545261|P6|Overall Study|Withdrawal by Subject|0
4797691|NCT01337596|16545262|P5|Overall Study|Withdrawal by Subject|2
4797692|NCT01337596|16545263|P4|Overall Study|Withdrawal by Subject|0
4797693|NCT01337596|16545264|P3|Overall Study|Withdrawal by Subject|0
4797694|NCT01337596|16545265|P2|Overall Study|Withdrawal by Subject|0
4797695|NCT01337596|16545266|P1|Overall Study|Withdrawal by Subject|0
4797696|NCT01337297|16545317|P2|Overall Study|Lost to Follow-up|3
4797697|NCT01337297|16545318|P1|Overall Study|Lost to Follow-up|1
4797698|NCT01337297|16545317|P2|Overall Study|They entered to single anodal tDCS|3
4797699|NCT01337297|16545318|P1|Overall Study|They entered to single anodal tDCS|4
4797700|NCT01337167|16545326|P2|Toddler Vaccinations|Withdrawal by Subject|0
4797701|NCT01337167|16545327|P1|Toddler Vaccinations|Withdrawal by Subject|3
4797702|NCT01337167|16545326|P2|Toddler Vaccinations|Protocol Violation|1
4797703|NCT01337167|16545327|P1|Toddler Vaccinations|Protocol Violation|0
4797704|NCT01337167|16545326|P2|Toddler Vaccinations|Lost to Follow-up|12
4797705|NCT01337167|16545327|P1|Toddler Vaccinations|Lost to Follow-up|11
4797706|NCT01337167|16545326|P2|Interim Period|Other protocol criterion not met|1
4797707|NCT01337167|16545327|P1|Interim Period|Other protocol criterion not met|0
4797708|NCT01337167|16545326|P2|Interim Period|Withdrawal by Subject|10
4797709|NCT01337167|16545327|P1|Interim Period|Withdrawal by Subject|18
4797710|NCT01337167|16545326|P2|Interim Period|Protocol Violation|3
4797711|NCT01337167|16545327|P1|Interim Period|Protocol Violation|5
4797712|NCT01337167|16545326|P2|Interim Period|Physician Decision|3
4797713|NCT01337167|16545327|P1|Interim Period|Physician Decision|6
4797714|NCT01337167|16545326|P2|Interim Period|Non-compliance with study drug|0
4797715|NCT01337167|16545327|P1|Interim Period|Non-compliance with study drug|1
4797716|NCT01337167|16545326|P2|Interim Period|Lost to Follow-up|23
4797717|NCT01337167|16545327|P1|Interim Period|Lost to Follow-up|51
4797718|NCT01337167|16545326|P2|Infant Series|Randomized but not vaccinated|3
4797719|NCT01337167|16545327|P1|Infant Series|Randomized but not vaccinated|5
4797720|NCT01337167|16545326|P2|Infant Series|Withdrawal by Subject|4
4797721|NCT01337167|16545327|P1|Infant Series|Withdrawal by Subject|15
4797722|NCT01337167|16545326|P2|Infant Series|Protocol Violation|9
4797723|NCT01337167|16545327|P1|Infant Series|Protocol Violation|22
4797724|NCT01337167|16545326|P2|Infant Series|Physician Decision|1
4797725|NCT01337167|16545327|P1|Infant Series|Physician Decision|3
4797726|NCT01337167|16545326|P2|Infant Series|Non-compliance with study drug|1
4797727|NCT01337167|16545327|P1|Infant Series|Non-compliance with study drug|2
4797728|NCT01337167|16545326|P2|Infant Series|Lost to Follow-up|7
4797729|NCT01337167|16545327|P1|Infant Series|Lost to Follow-up|13
4797730|NCT01337167|16545326|P2|Infant Series|Death|1
4797731|NCT01337167|16545327|P1|Infant Series|Death|1
4797732|NCT01337167|16545326|P2|Infant Series|Adverse Event|1
4797733|NCT01337167|16545327|P1|Infant Series|Adverse Event|1
4797734|NCT01337115|16545395|P2|Overall Study|Protocol Violation|0
4797735|NCT01337115|16545396|P1|Overall Study|Protocol Violation|2
4797736|NCT01337089|16545408|P1|Overall Study|Lost to Follow-up|2
4797737|NCT01337089|16545408|P1|Overall Study|Met Withdrawal Criteria|3
4797738|NCT01337089|16545408|P1|Overall Study|Withdrawal by Investigator|33
4797739|NCT01337089|16545408|P1|Overall Study|Withdrawal by Subject|129
4797740|NCT01337089|16545408|P1|Overall Study|Adverse Event|237
4797741|NCT01337050|16545423|P3|Overall Study|Participants refused further follow-up|7
4797742|NCT01337050|16545424|P2|Overall Study|Participants refused further follow-up|7
4797743|NCT01337050|16545425|P1|Overall Study|Participants refused further follow-up|0
4797744|NCT01337050|16545423|P3|Overall Study|Other|8
4797745|NCT01337050|16545424|P2|Overall Study|Other|6
4797746|NCT01337050|16545425|P1|Overall Study|Other|4
4797747|NCT01337050|16545423|P3|Overall Study|Death|4
4797748|NCT01337050|16545424|P2|Overall Study|Death|0
4797749|NCT01337050|16545425|P1|Overall Study|Death|0
4797750|NCT01336972|16545486|P3|Overall Study|Adverse Event|0
4797751|NCT01336972|16545487|P2|Overall Study|Adverse Event|1
4797752|NCT01336972|16545488|P1|Overall Study|Adverse Event|1
4797753|NCT01336894|16545550|P2|Follow-up|Study terminated prematurely|7
4797754|NCT01336894|16545551|P1|Follow-up|Study terminated prematurely|2
4797755|NCT01336764|16545583|P2|Overall Study|Withdrawal by Subject|5
4797756|NCT01336764|16545584|P1|Overall Study|Withdrawal by Subject|5
4797757|NCT01336738|16545595|P5|Overall Study|Other|4
4797758|NCT01336738|16545596|P4|Overall Study|Other|3
4797759|NCT01336738|16545597|P3|Overall Study|Other|2
4797760|NCT01336738|16545598|P2|Overall Study|Other|3
4797761|NCT01336738|16545599|P1|Overall Study|Other|3
4797762|NCT01336738|16545595|P5|Overall Study|Withdrawal by Subject|1
4797763|NCT01336738|16545596|P4|Overall Study|Withdrawal by Subject|1
4797764|NCT01336738|16545597|P3|Overall Study|Withdrawal by Subject|2
4797765|NCT01336738|16545598|P2|Overall Study|Withdrawal by Subject|0
4797766|NCT01336738|16545599|P1|Overall Study|Withdrawal by Subject|2
4797767|NCT01336738|16545595|P5|Overall Study|Protocol Violation|0
4797768|NCT01336738|16545596|P4|Overall Study|Protocol Violation|0
4797769|NCT01336738|16545597|P3|Overall Study|Protocol Violation|0
4797770|NCT01336738|16545598|P2|Overall Study|Protocol Violation|1
4797771|NCT01336738|16545599|P1|Overall Study|Protocol Violation|0
4797772|NCT01336738|16545595|P5|Overall Study|Did not meet entrance criteria|0
4797773|NCT01336738|16545596|P4|Overall Study|Did not meet entrance criteria|0
4797774|NCT01336738|16545597|P3|Overall Study|Did not meet entrance criteria|0
4797775|NCT01336738|16545598|P2|Overall Study|Did not meet entrance criteria|1
4797776|NCT01336738|16545599|P1|Overall Study|Did not meet entrance criteria|0
4797777|NCT01336738|16545595|P5|Overall Study|Lost to Follow-up|2
4797778|NCT01336738|16545596|P4|Overall Study|Lost to Follow-up|2
4797779|NCT01336738|16545597|P3|Overall Study|Lost to Follow-up|2
4797780|NCT01336738|16545598|P2|Overall Study|Lost to Follow-up|1
4797781|NCT01336738|16545599|P1|Overall Study|Lost to Follow-up|2
4797782|NCT01336738|16545595|P5|Overall Study|Adverse Event|3
4797783|NCT01336738|16545596|P4|Overall Study|Adverse Event|1
4797784|NCT01336738|16545597|P3|Overall Study|Adverse Event|2
4797785|NCT01336738|16545598|P2|Overall Study|Adverse Event|3
4797786|NCT01336738|16545599|P1|Overall Study|Adverse Event|0
4797787|NCT01336712|16545641|P1|Overall Study|Lack of Efficacy|1
4797788|NCT01336712|16545641|P1|Overall Study|Death|2
4797789|NCT01336647|16545654|P3|Overall Study|Lost to Follow-up|3
4797790|NCT01336647|16545655|P2|Overall Study|Lost to Follow-up|1
4797791|NCT01336647|16545656|P1|Overall Study|Lost to Follow-up|4
4797792|NCT01336634|16545670|P3|Overall Study|Ongoing|24
4797793|NCT01336634|16545671|P2|Overall Study|Ongoing|22
4797794|NCT01336634|16545672|P1|Overall Study|Ongoing|15
4797795|NCT01336634|16545670|P3|Overall Study|Physician Decision|0
4797796|NCT01336634|16545671|P2|Overall Study|Physician Decision|1
4797797|NCT01336634|16545672|P1|Overall Study|Physician Decision|1
4797798|NCT01336634|16545670|P3|Overall Study|Withdrawal by Subject|1
4797799|NCT01336634|16545671|P2|Overall Study|Withdrawal by Subject|0
4797800|NCT01336634|16545672|P1|Overall Study|Withdrawal by Subject|6
4797801|NCT01336634|16545670|P3|Overall Study|Lost to Follow-up|1
4797802|NCT01336634|16545671|P2|Overall Study|Lost to Follow-up|1
4797803|NCT01336634|16545672|P1|Overall Study|Lost to Follow-up|2
4797804|NCT01336634|16545670|P3|Overall Study|Death|10
4797805|NCT01336634|16545671|P2|Overall Study|Death|33
4797806|NCT01336634|16545672|P1|Overall Study|Death|60
4797807|NCT01336621|16545713|P1|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3
4797808|NCT01336621|16545713|P1|SFUCP (up to 2.6 Years)|Physician Decision|1
4797809|NCT01336621|16545713|P1|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3
4797810|NCT01336621|16545713|P1|SFUCP (up to 2.6 Years)|Adverse Event|1
4797811|NCT01336621|16545713|P1|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1
4797812|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9
4797813|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2
4797814|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22
4797815|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2
4797816|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11
4797817|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27
4797818|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12
4797819|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2
4797820|NCT01336621|16545713|P1|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11
4797821|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|1
4797822|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|4
4797823|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
4797824|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4797825|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Physician Decision|1
4797826|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Physician Decision|1
4797827|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Physician Decision|3
4797828|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Physician Decision|0
4797829|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4797830|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4797831|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
4797832|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4797833|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6
4797834|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3
4797835|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
4797836|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
4797837|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Protocol Violation|3
4797838|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Protocol Violation|3
4797839|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Protocol Violation|4
4797840|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
4797841|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6
4797842|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
4797843|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
4797844|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
4797845|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4797846|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4797847|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
4797848|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4797849|NCT01336608|16545763|P4|24-week, Double-blind Treatment Period|Adverse Event|7
4797850|NCT01336608|16545764|P3|24-week, Double-blind Treatment Period|Adverse Event|6
4797851|NCT01336608|16545765|P2|24-week, Double-blind Treatment Period|Adverse Event|8
4797852|NCT01336608|16545766|P1|24-week, Double-blind Treatment Period|Adverse Event|0
4797853|NCT01336608|16545763|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4797854|NCT01336608|16545764|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4797855|NCT01336608|16545765|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4797856|NCT01336608|16545766|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|2
4797857|NCT01336608|16545763|P4|2-week, Single-blind Run-In Period|Physician Decision|0
4797858|NCT01336608|16545764|P3|2-week, Single-blind Run-In Period|Physician Decision|0
4797859|NCT01336608|16545765|P2|2-week, Single-blind Run-In Period|Physician Decision|0
4797860|NCT01336608|16545766|P1|2-week, Single-blind Run-In Period|Physician Decision|1
4797861|NCT01336608|16545763|P4|2-week, Single-blind Run-In Period|Adverse Event|0
4797862|NCT01336608|16545764|P3|2-week, Single-blind Run-In Period|Adverse Event|0
4797863|NCT01336608|16545765|P2|2-week, Single-blind Run-In Period|Adverse Event|0
4797864|NCT01336608|16545766|P1|2-week, Single-blind Run-In Period|Adverse Event|1
4797865|NCT01336608|16545763|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4797866|NCT01336608|16545764|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4797867|NCT01336608|16545765|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4797868|NCT01336608|16545766|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|9
4797869|NCT01336608|16545763|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4797870|NCT01336608|16545764|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4797871|NCT01336608|16545765|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4797872|NCT01336608|16545766|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102
4797873|NCT01336569|16545780|P1|Overall Study|Lost to Follow-up|4
4797874|NCT01336205|16545828|P2|Overall Study|Did not receive treatment|0
4797875|NCT01336205|16545829|P1|Overall Study|Did not receive treatment|4
4797876|NCT01336205|16545828|P2|Overall Study|Withdrawal by Subject|38
4797877|NCT01336205|16545829|P1|Overall Study|Withdrawal by Subject|72
4797878|NCT01336205|16545828|P2|Overall Study|Eligibility Criteria Not Fulfilled|6
4797879|NCT01336205|16545829|P1|Overall Study|Eligibility Criteria Not Fulfilled|9
4797880|NCT01336205|16545828|P2|Overall Study|Death|1
4797881|NCT01336205|16545829|P1|Overall Study|Death|1
4797882|NCT01336205|16545828|P2|Overall Study|Adverse Event|6
4797883|NCT01336205|16545829|P1|Overall Study|Adverse Event|56
4797884|NCT01336205|16545828|P2|Overall Study|Severe noncompliance with protocol|2
4797885|NCT01336205|16545829|P1|Overall Study|Severe noncompliance with protocol|9
4797886|NCT01336205|16545828|P2|Overall Study|Lack of Efficacy|0
4797887|NCT01336205|16545829|P1|Overall Study|Lack of Efficacy|4
4797888|NCT01336205|16545828|P2|Overall Study|Study-Specific Withdrawal Criteria|7
4797889|NCT01336205|16545829|P1|Overall Study|Study-Specific Withdrawal Criteria|16
4797890|NCT01336205|16545828|P2|Overall Study|Lost to Follow-up|20
4797891|NCT01336205|16545829|P1|Overall Study|Lost to Follow-up|40
4797892|NCT01336205|16545828|P2|Overall Study|Other|9
4797893|NCT01336205|16545829|P1|Overall Study|Other|22
4797894|NCT01336023|16545857|P3|Week 27 to 52|Unclassified|9
4797895|NCT01336023|16545858|P2|Week 27 to 52|Unclassified|18
4797896|NCT01336023|16545859|P1|Week 27 to 52|Unclassified|13
4797897|NCT01336023|16545857|P3|Week 27 to 52|Withdrawal Criteria|16
4797898|NCT01336023|16545858|P2|Week 27 to 52|Withdrawal Criteria|19
4797899|NCT01336023|16545859|P1|Week 27 to 52|Withdrawal Criteria|14
4797900|NCT01336023|16545857|P3|Week 27 to 52|Protocol Violation|1
4797901|NCT01336023|16545858|P2|Week 27 to 52|Protocol Violation|2
4797902|NCT01336023|16545859|P1|Week 27 to 52|Protocol Violation|0
4797903|NCT01336023|16545857|P3|Week 27 to 52|Adverse Event|2
4797904|NCT01336023|16545858|P2|Week 27 to 52|Adverse Event|5
4797905|NCT01336023|16545859|P1|Week 27 to 52|Adverse Event|1
4797906|NCT01336023|16545857|P3|Week 0 to Week 26|Unclassified|9
4797907|NCT01336023|16545858|P2|Week 0 to Week 26|Unclassified|16
4797908|NCT01336023|16545859|P1|Week 0 to Week 26|Unclassified|5
4797909|NCT01336023|16545857|P3|Week 0 to Week 26|Withdrawal Criteria|40
4797910|NCT01336023|16545858|P2|Week 0 to Week 26|Withdrawal Criteria|69
4797911|NCT01336023|16545859|P1|Week 0 to Week 26|Withdrawal Criteria|34
4797912|NCT01336023|16545857|P3|Week 0 to Week 26|Protocol Violation|0
4797913|NCT01336023|16545858|P2|Week 0 to Week 26|Protocol Violation|2
4797914|NCT01336023|16545859|P1|Week 0 to Week 26|Protocol Violation|1
4797915|NCT01336023|16545857|P3|Week 0 to Week 26|Lack of Efficacy|0
4797916|NCT01336023|16545858|P2|Week 0 to Week 26|Lack of Efficacy|1
4797917|NCT01336023|16545859|P1|Week 0 to Week 26|Lack of Efficacy|0
4797918|NCT01336023|16545857|P3|Week 0 to Week 26|Adverse Event|24
4797919|NCT01336023|16545858|P2|Week 0 to Week 26|Adverse Event|10
4797920|NCT01336023|16545859|P1|Week 0 to Week 26|Adverse Event|8
4797921|NCT01335997|16545880|P2|Period III|Lost to Follow-up|0
4797922|NCT01335997|16545881|P1|Period III|Lost to Follow-up|1
4797923|NCT01335997|16545880|P2|Period III|Protocol Violation|1
4797924|NCT01335997|16545881|P1|Period III|Protocol Violation|0
4797925|NCT01335997|16545880|P2|Period III|Study Terminated by Sponsor|76
4797926|NCT01335997|16545881|P1|Period III|Study Terminated by Sponsor|77
4797927|NCT01335997|16545880|P2|Period III|Adverse Event|2
4797928|NCT01335997|16545881|P1|Period III|Adverse Event|0
4797929|NCT01335997|16545880|P2|Period I and II|Physician Decision|1
4797930|NCT01335997|16545881|P1|Period I and II|Physician Decision|2
4797931|NCT01335997|16545880|P2|Period I and II|Protocol Violation|10
4797932|NCT01335997|16545881|P1|Period I and II|Protocol Violation|9
4797933|NCT01335997|16545880|P2|Period I and II|Study Terminated by Sponsor|415
4797934|NCT01335997|16545881|P1|Period I and II|Study Terminated by Sponsor|406
4797935|NCT01335997|16545880|P2|Period I and II|Withdrawal by Subject|4
4797936|NCT01335997|16545881|P1|Period I and II|Withdrawal by Subject|9
4797937|NCT01335997|16545880|P2|Period I and II|Lost to Follow-up|5
4797938|NCT01335997|16545881|P1|Period I and II|Lost to Follow-up|3
4797939|NCT01335997|16545880|P2|Period I and II|Noncompliance with Study Drug|1
4797940|NCT01335997|16545881|P1|Period I and II|Noncompliance with Study Drug|1
4797941|NCT01335997|16545880|P2|Period I and II|Adverse Event|43
4797942|NCT01335997|16545881|P1|Period I and II|Adverse Event|63
4797943|NCT01335971|16545894|P3|Overall Study|Did not complete bronchoscopy|1
4797944|NCT01335971|16545895|P2|Overall Study|Did not complete bronchoscopy|1
4797945|NCT01335971|16545896|P1|Overall Study|Did not complete bronchoscopy|1
4797946|NCT01335971|16545894|P3|Overall Study|Withdrawal by Subject|0
4797947|NCT01335971|16545895|P2|Overall Study|Withdrawal by Subject|0
4797948|NCT01335971|16545896|P1|Overall Study|Withdrawal by Subject|1
4797949|NCT01335698|16546139|P5|Treatment Stage 2|Switched to another formulation|0
4797950|NCT01335698|16546140|P4|Treatment Stage 2|Switched to another formulation|0
4797951|NCT01335698|16546141|P3|Treatment Stage 2|Switched to another formulation|0
4797952|NCT01335698|16546142|P2|Treatment Stage 2|Switched to another formulation|1
4797953|NCT01335698|16546143|P1|Treatment Stage 2|Switched to another formulation|1
4797954|NCT01335698|16546139|P5|Treatment Stage 2|Subject no longer meets study criteria|0
4797955|NCT01335698|16546140|P4|Treatment Stage 2|Subject no longer meets study criteria|1
4797956|NCT01335698|16546141|P3|Treatment Stage 2|Subject no longer meets study criteria|0
4797957|NCT01335698|16546142|P2|Treatment Stage 2|Subject no longer meets study criteria|0
4797958|NCT01335698|16546143|P1|Treatment Stage 2|Subject no longer meets study criteria|0
4797959|NCT01335698|16546139|P5|Treatment Stage 2|Capsules received at state hospital|0
4797960|NCT01335698|16546140|P4|Treatment Stage 2|Capsules received at state hospital|0
4797961|NCT01335698|16546141|P3|Treatment Stage 2|Capsules received at state hospital|0
4797962|NCT01335698|16546142|P2|Treatment Stage 2|Capsules received at state hospital|0
4797963|NCT01335698|16546143|P1|Treatment Stage 2|Capsules received at state hospital|1
4797964|NCT01335698|16546139|P5|Treatment Stage 2|Lost to Follow-up|0
4797965|NCT01335698|16546140|P4|Treatment Stage 2|Lost to Follow-up|0
4797966|NCT01335698|16546141|P3|Treatment Stage 2|Lost to Follow-up|0
4797967|NCT01335698|16546142|P2|Treatment Stage 2|Lost to Follow-up|0
4797968|NCT01335698|16546143|P1|Treatment Stage 2|Lost to Follow-up|1
4797969|NCT01335698|16546139|P5|Treatment Stage 2|Poor compliance/noncompliance|1
4797970|NCT01335698|16546140|P4|Treatment Stage 2|Poor compliance/noncompliance|3
4797971|NCT01335698|16546141|P3|Treatment Stage 2|Poor compliance/noncompliance|1
4797972|NCT01335698|16546142|P2|Treatment Stage 2|Poor compliance/noncompliance|0
4797973|NCT01335698|16546143|P1|Treatment Stage 2|Poor compliance/noncompliance|1
4797974|NCT01335698|16546139|P5|Treatment Stage 2|Withdrawal by Subject|0
4797975|NCT01335698|16546140|P4|Treatment Stage 2|Withdrawal by Subject|0
4797976|NCT01335698|16546141|P3|Treatment Stage 2|Withdrawal by Subject|1
4797977|NCT01335698|16546142|P2|Treatment Stage 2|Withdrawal by Subject|1
4797978|NCT01335698|16546143|P1|Treatment Stage 2|Withdrawal by Subject|3
4797979|NCT01335698|16546139|P5|Treatment Stage 2|Adverse Event|0
4797980|NCT01335698|16546140|P4|Treatment Stage 2|Adverse Event|3
4797981|NCT01335698|16546141|P3|Treatment Stage 2|Adverse Event|0
4797982|NCT01335698|16546142|P2|Treatment Stage 2|Adverse Event|0
4797983|NCT01335698|16546143|P1|Treatment Stage 2|Adverse Event|2
4797984|NCT01335698|16546139|P5|Treatment Stage 2|Lack of Efficacy|0
4797985|NCT01335698|16546140|P4|Treatment Stage 2|Lack of Efficacy|1
4797986|NCT01335698|16546141|P3|Treatment Stage 2|Lack of Efficacy|3
4797987|NCT01335698|16546142|P2|Treatment Stage 2|Lack of Efficacy|1
4797988|NCT01335698|16546143|P1|Treatment Stage 2|Lack of Efficacy|2
4797989|NCT01335698|16546139|P5|Treatment Stage 1|Other|0
4797990|NCT01335698|16546140|P4|Treatment Stage 1|Other|1
4797991|NCT01335698|16546141|P3|Treatment Stage 1|Other|0
4797992|NCT01335698|16546142|P2|Treatment Stage 1|Other|0
4797993|NCT01335698|16546143|P1|Treatment Stage 1|Other|1
4797994|NCT01335698|16546139|P5|Treatment Stage 1|No longer meets study criteria|0
4797995|NCT01335698|16546140|P4|Treatment Stage 1|No longer meets study criteria|1
4797996|NCT01335698|16546141|P3|Treatment Stage 1|No longer meets study criteria|0
4797997|NCT01335698|16546142|P2|Treatment Stage 1|No longer meets study criteria|1
4797998|NCT01335698|16546143|P1|Treatment Stage 1|No longer meets study criteria|1
4797999|NCT01335698|16546139|P5|Treatment Stage 1|Poor compliance/noncompliance|0
4798000|NCT01335698|16546140|P4|Treatment Stage 1|Poor compliance/noncompliance|2
4798001|NCT01335698|16546141|P3|Treatment Stage 1|Poor compliance/noncompliance|0
4798002|NCT01335698|16546142|P2|Treatment Stage 1|Poor compliance/noncompliance|1
4798003|NCT01335698|16546143|P1|Treatment Stage 1|Poor compliance/noncompliance|0
4798004|NCT01335698|16546139|P5|Treatment Stage 1|Lost to Follow-up|0
4798005|NCT01335698|16546140|P4|Treatment Stage 1|Lost to Follow-up|0
4798006|NCT01335698|16546141|P3|Treatment Stage 1|Lost to Follow-up|0
4798007|NCT01335698|16546142|P2|Treatment Stage 1|Lost to Follow-up|1
4798008|NCT01335698|16546143|P1|Treatment Stage 1|Lost to Follow-up|1
4798009|NCT01335698|16546139|P5|Treatment Stage 1|Withdrawal by Subject|0
4798010|NCT01335698|16546140|P4|Treatment Stage 1|Withdrawal by Subject|1
4798011|NCT01335698|16546141|P3|Treatment Stage 1|Withdrawal by Subject|0
4798012|NCT01335698|16546142|P2|Treatment Stage 1|Withdrawal by Subject|2
4798013|NCT01335698|16546143|P1|Treatment Stage 1|Withdrawal by Subject|1
4798014|NCT01335698|16546139|P5|Treatment Stage 1|Adverse Event|1
4798015|NCT01335698|16546140|P4|Treatment Stage 1|Adverse Event|1
4798016|NCT01335698|16546141|P3|Treatment Stage 1|Adverse Event|2
4798017|NCT01335698|16546142|P2|Treatment Stage 1|Adverse Event|2
4798018|NCT01335698|16546143|P1|Treatment Stage 1|Adverse Event|1
4798019|NCT01335698|16546139|P5|Treatment Stage 1|Lack of Efficacy|1
4798020|NCT01335698|16546140|P4|Treatment Stage 1|Lack of Efficacy|3
4798021|NCT01335698|16546141|P3|Treatment Stage 1|Lack of Efficacy|3
4798022|NCT01335698|16546142|P2|Treatment Stage 1|Lack of Efficacy|1
4798023|NCT01335698|16546143|P1|Treatment Stage 1|Lack of Efficacy|3
4798024|NCT01335685|16546208|P8|Overall Study|Reason not Specified|0
4798025|NCT01335685|16546209|P7|Overall Study|Reason not Specified|0
4798026|NCT01335685|16546210|P6|Overall Study|Reason not Specified|1
4798027|NCT01335685|16546211|P5|Overall Study|Reason not Specified|0
4798028|NCT01335685|16546212|P4|Overall Study|Reason not Specified|0
4798029|NCT01335685|16546213|P3|Overall Study|Reason not Specified|1
4798030|NCT01335685|16546214|P2|Overall Study|Reason not Specified|0
4798031|NCT01335685|16546215|P1|Overall Study|Reason not Specified|0
4798032|NCT01335685|16546208|P8|Overall Study|Withdrawal by Subject|0
4798033|NCT01335685|16546209|P7|Overall Study|Withdrawal by Subject|0
4798034|NCT01335685|16546210|P6|Overall Study|Withdrawal by Subject|0
4798035|NCT01335685|16546211|P5|Overall Study|Withdrawal by Subject|0
4798036|NCT01335685|16546212|P4|Overall Study|Withdrawal by Subject|1
4798037|NCT01335685|16546213|P3|Overall Study|Withdrawal by Subject|0
4798038|NCT01335685|16546214|P2|Overall Study|Withdrawal by Subject|0
4798039|NCT01335685|16546215|P1|Overall Study|Withdrawal by Subject|1
4798040|NCT01335685|16546208|P8|Overall Study|Study Terminated by Sponsor|3
4798041|NCT01335685|16546209|P7|Overall Study|Study Terminated by Sponsor|2
4798042|NCT01335685|16546210|P6|Overall Study|Study Terminated by Sponsor|4
4798043|NCT01335685|16546211|P5|Overall Study|Study Terminated by Sponsor|0
4798044|NCT01335685|16546212|P4|Overall Study|Study Terminated by Sponsor|10
4798045|NCT01335685|16546213|P3|Overall Study|Study Terminated by Sponsor|1
4798046|NCT01335685|16546214|P2|Overall Study|Study Terminated by Sponsor|1
4798047|NCT01335685|16546215|P1|Overall Study|Study Terminated by Sponsor|2
4798048|NCT01335477|16546335|P2|Overall Study|Reason other than those stated above|2
4798049|NCT01335477|16546336|P1|Overall Study|Reason other than those stated above|2
4798050|NCT01335477|16546335|P2|Overall Study|Not treated|2
4798051|NCT01335477|16546336|P1|Overall Study|Not treated|1
4798052|NCT01335477|16546335|P2|Overall Study|Consent withdrawn, not due to AE|9
4798053|NCT01335477|16546336|P1|Overall Study|Consent withdrawn, not due to AE|7
4798054|NCT01335477|16546335|P2|Overall Study|Lost to Follow-up|2
4798055|NCT01335477|16546336|P1|Overall Study|Lost to Follow-up|1
4798056|NCT01335477|16546335|P2|Overall Study|Non compliant with protocol|2
4798057|NCT01335477|16546336|P1|Overall Study|Non compliant with protocol|0
4798058|NCT01335477|16546335|P2|Overall Study|Adverse Event|42
4798059|NCT01335477|16546336|P1|Overall Study|Adverse Event|30
4798060|NCT01335464|16546400|P2|Overall Study|Reason other than those stated above|1
4798061|NCT01335464|16546401|P1|Overall Study|Reason other than those stated above|1
4798062|NCT01335464|16546400|P2|Overall Study|Not treated|0
4798063|NCT01335464|16546401|P1|Overall Study|Not treated|2
4798064|NCT01335464|16546400|P2|Overall Study|Consent withdrawn, not due to AE|23
4798065|NCT01335464|16546401|P1|Overall Study|Consent withdrawn, not due to AE|12
4798066|NCT01335464|16546400|P2|Overall Study|Non compliant with protocol|0
4798067|NCT01335464|16546401|P1|Overall Study|Non compliant with protocol|2
4798068|NCT01335464|16546400|P2|Overall Study|Adverse Event|25
4798069|NCT01335464|16546401|P1|Overall Study|Adverse Event|15
4798070|NCT01335399|16546465|P2|Treatment Period|Not reported|0
4798071|NCT01335399|16546466|P1|Treatment Period|Not reported|1
4798072|NCT01335399|16546465|P2|Treatment Period|No longer meet study criteria|1
4798073|NCT01335399|16546466|P1|Treatment Period|No longer meet study criteria|0
4798074|NCT01335399|16546465|P2|Treatment Period|Maximum clinical benefit|1
4798075|NCT01335399|16546466|P1|Treatment Period|Maximum clinical benefit|1
4798076|NCT01335399|16546465|P2|Treatment Period|Lost to Follow-up|2
4798077|NCT01335399|16546466|P1|Treatment Period|Lost to Follow-up|0
4798078|NCT01335399|16546465|P2|Treatment Period|Poor/Non-compliance|4
4798079|NCT01335399|16546466|P1|Treatment Period|Poor/Non-compliance|3
4798080|NCT01335399|16546465|P2|Treatment Period|Death|8
4798081|NCT01335399|16546466|P1|Treatment Period|Death|7
4798082|NCT01335399|16546465|P2|Treatment Period|Consent withdrawal|6
4798083|NCT01335399|16546466|P1|Treatment Period|Consent withdrawal|10
4798084|NCT01335399|16546465|P2|Treatment Period|Other reasons|26
4798085|NCT01335399|16546466|P1|Treatment Period|Other reasons|14
4798086|NCT01335399|16546465|P2|Treatment Period|Participant request to discontinue|21
4798087|NCT01335399|16546466|P1|Treatment Period|Participant request to discontinue|27
4798088|NCT01335399|16546465|P2|Treatment Period|Study drug toxicity|64
4798089|NCT01335399|16546466|P1|Treatment Period|Study drug toxicity|51
4798090|NCT01335399|16546465|P2|Treatment Period|Adverse event unrelated to study drug|65
4798091|NCT01335399|16546466|P1|Treatment Period|Adverse event unrelated to study drug|105
4798092|NCT01335399|16546465|P2|Treatment Period|Disease progression|141
4798093|NCT01335399|16546466|P1|Treatment Period|Disease progression|114
4798094|NCT01335399|16546465|P2|Pre-treatment Period|Consent withdrawal|0
4798095|NCT01335399|16546466|P1|Pre-treatment Period|Consent withdrawal|3
4798096|NCT01335399|16546465|P2|Pre-treatment Period|Adverse event unrelated to study drug|1
4798097|NCT01335399|16546466|P1|Pre-treatment Period|Adverse event unrelated to study drug|0
4798098|NCT01335399|16546465|P2|Pre-treatment Period|Participant request to discontinue|1
4798099|NCT01335399|16546466|P1|Pre-treatment Period|Participant request to discontinue|0
4798100|NCT01335399|16546465|P2|Pre-treatment Period|No longer meeting study criteria|1
4798101|NCT01335399|16546466|P1|Pre-treatment Period|No longer meeting study criteria|0
4798102|NCT01334918|16546587|P2|Overall Study|Withdrawal by Subject|1
4798103|NCT01334918|16546588|P1|Overall Study|Withdrawal by Subject|0
4798104|NCT01334918|16546587|P2|Overall Study|Adverse Event|0
4798105|NCT01334918|16546588|P1|Overall Study|Adverse Event|2
4798106|NCT01334918|16546587|P2|Overall Study|Did not receive study drug|0
4798107|NCT01334918|16546588|P1|Overall Study|Did not receive study drug|6
4798108|NCT01334866|16546614|P1|Overall Study|medically necessary post-procedure|1
4798109|NCT01334866|16546614|P1|Overall Study|medically necessary prior to procedure|2
4798110|NCT01334866|16546614|P1|Overall Study|Physician Decision|3
4798111|NCT01334866|16546614|P1|Overall Study|Lost to Follow-up|3
4798112|NCT01334866|16546614|P1|Overall Study|Withdrawal by Subject|10
4798113|NCT01334710|16546651|P1|Overall Study|Trial was terminated|3
4798114|NCT01334606|16546656|P1|Overall Study|Study Terminated due to slow enrolment|18
4798115|NCT01334554|16546664|P2|Overall Study|Adverse Event|2
4798116|NCT01334554|16546665|P1|Overall Study|Adverse Event|4
4798117|NCT01334515|16546675|P2|Overall Study|Withdrawal by Subject|1
4798118|NCT01334515|16546676|P1|Overall Study|Withdrawal by Subject|1
4798119|NCT01334515|16546675|P2|Overall Study|Physician Decision|1
4798120|NCT01334515|16546676|P1|Overall Study|Physician Decision|1
4798121|NCT01334515|16546675|P2|Overall Study|Lack of Efficacy|21
4798122|NCT01334515|16546676|P1|Overall Study|Lack of Efficacy|8
4798123|NCT01334515|16546675|P2|Overall Study|Death|0
4798124|NCT01334515|16546676|P1|Overall Study|Death|1
4798125|NCT01334515|16546675|P2|Overall Study|Adverse Event|6
4798126|NCT01334515|16546676|P1|Overall Study|Adverse Event|1
4798127|NCT01334125|16546714|P2|Overall Study|Lost to Follow-up|3
4798128|NCT01334125|16546715|P1|Overall Study|Lost to Follow-up|3
4798129|NCT01333956|16546731|P4|Overall Study|Withdrawal by Subject|0
4798130|NCT01333956|16546732|P3|Overall Study|Withdrawal by Subject|1
4798131|NCT01333956|16546733|P2|Overall Study|Withdrawal by Subject|2
4798132|NCT01333956|16546734|P1|Overall Study|Withdrawal by Subject|0
4798133|NCT01333956|16546731|P4|Overall Study|Unable to complete study procedure|1
4798134|NCT01333956|16546732|P3|Overall Study|Unable to complete study procedure|0
4798135|NCT01333956|16546733|P2|Overall Study|Unable to complete study procedure|0
4798136|NCT01333956|16546734|P1|Overall Study|Unable to complete study procedure|1
4798137|NCT01333956|16546731|P4|Overall Study|Lost to Follow-up|1
4798138|NCT01333956|16546732|P3|Overall Study|Lost to Follow-up|0
4798139|NCT01333956|16546733|P2|Overall Study|Lost to Follow-up|2
4798140|NCT01333956|16546734|P1|Overall Study|Lost to Follow-up|1
4798141|NCT01333943|16546770|P2|Overall Study|Known neuropathy|0
4798142|NCT01333943|16546771|P1|Overall Study|Known neuropathy|1
4798143|NCT01333865|16546787|P1|Overall Study|Adverse Event|2
4798144|NCT01333722|16546807|P2|Overall Study|Withdrawal by Subject|1
4798145|NCT01333722|16546808|P1|Overall Study|Withdrawal by Subject|0
4798146|NCT01333722|16546807|P2|Overall Study|Lack of Efficacy|2
4798147|NCT01333722|16546808|P1|Overall Study|Lack of Efficacy|0
4798148|NCT01333501|16546833|P2|Overall Study|Withdrawn consent|12
4798149|NCT01333501|16546834|P1|Overall Study|Withdrawn consent|3
4798150|NCT01333501|16546833|P2|Overall Study|Unsatisfactory therapeutic effect|7
4798151|NCT01333501|16546834|P1|Overall Study|Unsatisfactory therapeutic effect|1
4798152|NCT01333501|16546833|P2|Overall Study|Abnormal laboratory value|1
4798153|NCT01333501|16546834|P1|Overall Study|Abnormal laboratory value|2
4798154|NCT01333501|16546833|P2|Overall Study|Adverse Event|1
4798155|NCT01333501|16546834|P1|Overall Study|Adverse Event|3
4798156|NCT01333475|16546901|P2|Overall Study|Toxicity|3
4798157|NCT01333475|16546902|P1|Overall Study|Toxicity|1
4798158|NCT01333475|16546901|P2|Overall Study|pt withdrew-need emergent radiation trmt|0
4798159|NCT01333475|16546902|P1|Overall Study|pt withdrew-need emergent radiation trmt|1
4798160|NCT01333397|16546928|P5|Overall Study|Lost to Follow-up|0
4798161|NCT01333397|16546929|P4|Overall Study|Lost to Follow-up|1
4798162|NCT01333397|16546930|P3|Overall Study|Lost to Follow-up|0
4798163|NCT01333397|16546931|P2|Overall Study|Lost to Follow-up|0
4798164|NCT01333397|16546932|P1|Overall Study|Lost to Follow-up|1
4798165|NCT01333189|16547006|P2|Overall Study|Moved from region|1
4798166|NCT01333189|16547007|P1|Overall Study|Moved from region|0
4798167|NCT01333189|16547006|P2|Overall Study|Transportation difficulties|1
4798168|NCT01333189|16547007|P1|Overall Study|Transportation difficulties|0
4798169|NCT01333189|16547006|P2|Overall Study|Adverse Event|0
4798170|NCT01333189|16547007|P1|Overall Study|Adverse Event|1
4798171|NCT01333189|16547006|P2|Overall Study|Time constraints|0
4798172|NCT01333189|16547007|P1|Overall Study|Time constraints|1
4798173|NCT01333111|16547038|P3|Overall Study|Ineffective therapy|1
4798174|NCT01333111|16547039|P2|Overall Study|Ineffective therapy|0
4798175|NCT01333111|16547040|P1|Overall Study|Ineffective therapy|0
4798176|NCT01333111|16547038|P3|Overall Study|Non-compliance|0
4798177|NCT01333111|16547039|P2|Overall Study|Non-compliance|0
4798178|NCT01333111|16547040|P1|Overall Study|Non-compliance|1
4798179|NCT01333111|16547038|P3|Overall Study|withdrawal criteria|0
4798180|NCT01333111|16547039|P2|Overall Study|withdrawal criteria|1
4798181|NCT01333111|16547040|P1|Overall Study|withdrawal criteria|0
4798182|NCT01333111|16547038|P3|Overall Study|unclassified|0
4798183|NCT01333111|16547039|P2|Overall Study|unclassified|0
4798184|NCT01333111|16547040|P1|Overall Study|unclassified|1
4798185|NCT01333111|16547038|P3|Overall Study|personal reasons|1
4798186|NCT01333111|16547039|P2|Overall Study|personal reasons|0
4798187|NCT01333111|16547040|P1|Overall Study|personal reasons|0
4798188|NCT01333111|16547038|P3|Overall Study|patient undergoing major surgery|0
4798189|NCT01333111|16547039|P2|Overall Study|patient undergoing major surgery|2
4798190|NCT01333111|16547040|P1|Overall Study|patient undergoing major surgery|0
4798191|NCT01333072|16547075|P2|Overall Study|Physician Decision|0
4798192|NCT01333072|16547076|P1|Overall Study|Physician Decision|1
4798193|NCT01333072|16547075|P2|Overall Study|Adverse Event|4
4798194|NCT01333072|16547076|P1|Overall Study|Adverse Event|2
4798195|NCT01333072|16547075|P2|Overall Study|Lost to Follow-up|0
4798196|NCT01333072|16547076|P1|Overall Study|Lost to Follow-up|3
4798197|NCT01333059|16547084|P2|Overall Study|Protocol Violation|0
4798198|NCT01333059|16547085|P1|Overall Study|Protocol Violation|3
4798199|NCT01333059|16547084|P2|Overall Study|Physician Decision|3
4798200|NCT01333059|16547085|P1|Overall Study|Physician Decision|3
4798201|NCT01332994|16547095|P1|Overall Study|Other|8
4798202|NCT01332994|16547095|P1|Overall Study|Administrative Problem|2
4798203|NCT01332994|16547095|P1|Overall Study|Withdrawal by Subject|15
4798204|NCT01332994|16547095|P1|Overall Study|Protocol Violation|6
4798205|NCT01332994|16547095|P1|Overall Study|Lost to Follow-up|4
4798206|NCT01332994|16547095|P1|Overall Study|Lack of Efficacy|1
4798207|NCT01332994|16547095|P1|Overall Study|Death|1
4798208|NCT01332994|16547095|P1|Overall Study|Adverse Event|34
4798209|NCT01332968|16547164|P8|Follow-Up Period|Lost to Follow-up|2
4798210|NCT01332968|16547165|P7|Follow-Up Period|Lost to Follow-up|1
4798211|NCT01332968|16547166|P6|Follow-Up Period|Lost to Follow-up|0
4798212|NCT01332968|16547167|P5|Follow-Up Period|Lost to Follow-up|0
4798213|NCT01332968|16547168|P4|Follow-Up Period|Lost to Follow-up|0
4798214|NCT01332968|16547169|P3|Follow-Up Period|Lost to Follow-up|0
4798215|NCT01332968|16547170|P2|Follow-Up Period|Lost to Follow-up|0
4798216|NCT01332968|16547171|P1|Follow-Up Period|Lost to Follow-up|0
4798217|NCT01332968|16547164|P8|Follow-Up Period|Withdrawal by Subject|2
4798218|NCT01332968|16547165|P7|Follow-Up Period|Withdrawal by Subject|1
4798219|NCT01332968|16547166|P6|Follow-Up Period|Withdrawal by Subject|0
4798220|NCT01332968|16547167|P5|Follow-Up Period|Withdrawal by Subject|0
4798221|NCT01332968|16547168|P4|Follow-Up Period|Withdrawal by Subject|0
4798222|NCT01332968|16547169|P3|Follow-Up Period|Withdrawal by Subject|0
4798223|NCT01332968|16547170|P2|Follow-Up Period|Withdrawal by Subject|0
4798224|NCT01332968|16547171|P1|Follow-Up Period|Withdrawal by Subject|0
4798225|NCT01332968|16547164|P8|Follow-Up Period|Follow-up ongoing|505
4798226|NCT01332968|16547165|P7|Follow-Up Period|Follow-up ongoing|502
4798227|NCT01332968|16547166|P6|Follow-Up Period|Follow-up ongoing|0
4798228|NCT01332968|16547167|P5|Follow-Up Period|Follow-up ongoing|0
4798229|NCT01332968|16547168|P4|Follow-Up Period|Follow-up ongoing|0
4798230|NCT01332968|16547169|P3|Follow-Up Period|Follow-up ongoing|0
4798231|NCT01332968|16547170|P2|Follow-Up Period|Follow-up ongoing|0
4798232|NCT01332968|16547171|P1|Follow-Up Period|Follow-up ongoing|0
4798233|NCT01332968|16547164|P8|Follow-Up Period|Death|22
4798234|NCT01332968|16547165|P7|Follow-Up Period|Death|38
4798235|NCT01332968|16547166|P6|Follow-Up Period|Death|0
4798236|NCT01332968|16547167|P5|Follow-Up Period|Death|0
4798237|NCT01332968|16547168|P4|Follow-Up Period|Death|0
4798238|NCT01332968|16547169|P3|Follow-Up Period|Death|0
4798239|NCT01332968|16547170|P2|Follow-Up Period|Death|0
4798240|NCT01332968|16547171|P1|Follow-Up Period|Death|0
4798241|NCT01332968|16547164|P8|Maintenance/Observation Period|Treatment ongoing|0
4798242|NCT01332968|16547165|P7|Maintenance/Observation Period|Treatment ongoing|0
4798243|NCT01332968|16547166|P6|Maintenance/Observation Period|Treatment ongoing|8
4798244|NCT01332968|16547167|P5|Maintenance/Observation Period|Treatment ongoing|10
4798245|NCT01332968|16547168|P4|Maintenance/Observation Period|Treatment ongoing|62
4798246|NCT01332968|16547169|P3|Maintenance/Observation Period|Treatment ongoing|54
4798247|NCT01332968|16547170|P2|Maintenance/Observation Period|Treatment ongoing|0
4798248|NCT01332968|16547171|P1|Maintenance/Observation Period|Treatment ongoing|0
4798249|NCT01332968|16547164|P8|Maintenance/Observation Period|Adverse Event|0
4798250|NCT01332968|16547165|P7|Maintenance/Observation Period|Adverse Event|0
4798251|NCT01332968|16547166|P6|Maintenance/Observation Period|Adverse Event|0
4798252|NCT01332968|16547167|P5|Maintenance/Observation Period|Adverse Event|0
4798253|NCT01332968|16547168|P4|Maintenance/Observation Period|Adverse Event|65
4798254|NCT01332968|16547169|P3|Maintenance/Observation Period|Adverse Event|50
4798255|NCT01332968|16547170|P2|Maintenance/Observation Period|Adverse Event|0
4798256|NCT01332968|16547171|P1|Maintenance/Observation Period|Adverse Event|0
4798257|NCT01332968|16547164|P8|Maintenance/Observation Period|Death|0
4798258|NCT01332968|16547165|P7|Maintenance/Observation Period|Death|0
4798259|NCT01332968|16547166|P6|Maintenance/Observation Period|Death|0
4798260|NCT01332968|16547167|P5|Maintenance/Observation Period|Death|0
4798261|NCT01332968|16547168|P4|Maintenance/Observation Period|Death|6
4798262|NCT01332968|16547169|P3|Maintenance/Observation Period|Death|5
4798263|NCT01332968|16547170|P2|Maintenance/Observation Period|Death|0
4798264|NCT01332968|16547171|P1|Maintenance/Observation Period|Death|0
4798265|NCT01332968|16547164|P8|Maintenance/Observation Period|Lost to Follow-up|0
4798266|NCT01332968|16547165|P7|Maintenance/Observation Period|Lost to Follow-up|0
4798267|NCT01332968|16547166|P6|Maintenance/Observation Period|Lost to Follow-up|0
4798268|NCT01332968|16547167|P5|Maintenance/Observation Period|Lost to Follow-up|0
4798269|NCT01332968|16547168|P4|Maintenance/Observation Period|Lost to Follow-up|2
4798270|NCT01332968|16547169|P3|Maintenance/Observation Period|Lost to Follow-up|1
4798271|NCT01332968|16547170|P2|Maintenance/Observation Period|Lost to Follow-up|0
4798272|NCT01332968|16547171|P1|Maintenance/Observation Period|Lost to Follow-up|0
4798273|NCT01332968|16547164|P8|Maintenance/Observation Period|Non-compliance|0
4798274|NCT01332968|16547165|P7|Maintenance/Observation Period|Non-compliance|0
4798275|NCT01332968|16547166|P6|Maintenance/Observation Period|Non-compliance|1
4798276|NCT01332968|16547167|P5|Maintenance/Observation Period|Non-compliance|0
4798277|NCT01332968|16547168|P4|Maintenance/Observation Period|Non-compliance|3
4798278|NCT01332968|16547169|P3|Maintenance/Observation Period|Non-compliance|2
4798279|NCT01332968|16547170|P2|Maintenance/Observation Period|Non-compliance|0
4798280|NCT01332968|16547171|P1|Maintenance/Observation Period|Non-compliance|0
4798281|NCT01332968|16547164|P8|Maintenance/Observation Period|Other|0
4798282|NCT01332968|16547165|P7|Maintenance/Observation Period|Other|0
4798283|NCT01332968|16547166|P6|Maintenance/Observation Period|Other|0
4798284|NCT01332968|16547167|P5|Maintenance/Observation Period|Other|0
4798285|NCT01332968|16547168|P4|Maintenance/Observation Period|Other|5
4798286|NCT01332968|16547169|P3|Maintenance/Observation Period|Other|4
4798287|NCT01332968|16547170|P2|Maintenance/Observation Period|Other|0
4798288|NCT01332968|16547171|P1|Maintenance/Observation Period|Other|0
4798289|NCT01332968|16547164|P8|Maintenance/Observation Period|Physician Decision|0
4798290|NCT01332968|16547165|P7|Maintenance/Observation Period|Physician Decision|0
4798291|NCT01332968|16547166|P6|Maintenance/Observation Period|Physician Decision|0
4798292|NCT01332968|16547167|P5|Maintenance/Observation Period|Physician Decision|0
4798293|NCT01332968|16547168|P4|Maintenance/Observation Period|Physician Decision|19
4798294|NCT01332968|16547169|P3|Maintenance/Observation Period|Physician Decision|14
4798295|NCT01332968|16547170|P2|Maintenance/Observation Period|Physician Decision|0
4798296|NCT01332968|16547171|P1|Maintenance/Observation Period|Physician Decision|0
4798297|NCT01332968|16547164|P8|Maintenance/Observation Period|Progressive disease|0
4798298|NCT01332968|16547165|P7|Maintenance/Observation Period|Progressive disease|0
4798299|NCT01332968|16547166|P6|Maintenance/Observation Period|Progressive disease|0
4798300|NCT01332968|16547167|P5|Maintenance/Observation Period|Progressive disease|0
4798301|NCT01332968|16547168|P4|Maintenance/Observation Period|Progressive disease|39
4798302|NCT01332968|16547169|P3|Maintenance/Observation Period|Progressive disease|72
4798303|NCT01332968|16547170|P2|Maintenance/Observation Period|Progressive disease|0
4798304|NCT01332968|16547171|P1|Maintenance/Observation Period|Progressive disease|0
4798305|NCT01332968|16547164|P8|Maintenance/Observation Period|Protocol Violation|0
4798306|NCT01332968|16547165|P7|Maintenance/Observation Period|Protocol Violation|0
4798307|NCT01332968|16547166|P6|Maintenance/Observation Period|Protocol Violation|0
4798308|NCT01332968|16547167|P5|Maintenance/Observation Period|Protocol Violation|0
4798309|NCT01332968|16547168|P4|Maintenance/Observation Period|Protocol Violation|1
4798310|NCT01332968|16547169|P3|Maintenance/Observation Period|Protocol Violation|1
4798311|NCT01332968|16547170|P2|Maintenance/Observation Period|Protocol Violation|0
4798312|NCT01332968|16547171|P1|Maintenance/Observation Period|Protocol Violation|0
4798313|NCT01332968|16547164|P8|Maintenance/Observation Period|Withdrawal by Subject|0
4798314|NCT01332968|16547165|P7|Maintenance/Observation Period|Withdrawal by Subject|0
4798315|NCT01332968|16547166|P6|Maintenance/Observation Period|Withdrawal by Subject|0
4798316|NCT01332968|16547167|P5|Maintenance/Observation Period|Withdrawal by Subject|0
4798317|NCT01332968|16547168|P4|Maintenance/Observation Period|Withdrawal by Subject|5
4798318|NCT01332968|16547169|P3|Maintenance/Observation Period|Withdrawal by Subject|10
4798319|NCT01332968|16547170|P2|Maintenance/Observation Period|Withdrawal by Subject|0
4798320|NCT01332968|16547171|P1|Maintenance/Observation Period|Withdrawal by Subject|0
4798321|NCT01332968|16547164|P8|Induction Period|Randomized, but not treated|0
4798322|NCT01332968|16547165|P7|Induction Period|Randomized, but not treated|0
4798323|NCT01332968|16547166|P6|Induction Period|Randomized, but not treated|0
4798324|NCT01332968|16547167|P5|Induction Period|Randomized, but not treated|0
4798325|NCT01332968|16547168|P4|Induction Period|Randomized, but not treated|0
4798326|NCT01332968|16547169|P3|Induction Period|Randomized, but not treated|0
4798327|NCT01332968|16547170|P2|Induction Period|Randomized, but not treated|7
4798328|NCT01332968|16547171|P1|Induction Period|Randomized, but not treated|4
4798329|NCT01332968|16547164|P8|Induction Period|Adverse Event|0
4798330|NCT01332968|16547165|P7|Induction Period|Adverse Event|0
4798331|NCT01332968|16547166|P6|Induction Period|Adverse Event|0
4798332|NCT01332968|16547167|P5|Induction Period|Adverse Event|0
4798333|NCT01332968|16547168|P4|Induction Period|Adverse Event|0
4798334|NCT01332968|16547169|P3|Induction Period|Adverse Event|0
4798335|NCT01332968|16547170|P2|Induction Period|Adverse Event|26
4798336|NCT01332968|16547171|P1|Induction Period|Adverse Event|23
4798337|NCT01332968|16547164|P8|Induction Period|Death|0
4798338|NCT01332968|16547165|P7|Induction Period|Death|0
4798339|NCT01332968|16547166|P6|Induction Period|Death|0
4798340|NCT01332968|16547167|P5|Induction Period|Death|0
4798341|NCT01332968|16547168|P4|Induction Period|Death|0
4798342|NCT01332968|16547169|P3|Induction Period|Death|0
4798343|NCT01332968|16547170|P2|Induction Period|Death|4
4798344|NCT01332968|16547171|P1|Induction Period|Death|1
4798345|NCT01332968|16547164|P8|Induction Period|Non-compliance|0
4798346|NCT01332968|16547165|P7|Induction Period|Non-compliance|0
4798347|NCT01332968|16547166|P6|Induction Period|Non-compliance|0
4798348|NCT01332968|16547167|P5|Induction Period|Non-compliance|0
4798349|NCT01332968|16547168|P4|Induction Period|Non-compliance|0
4798350|NCT01332968|16547169|P3|Induction Period|Non-compliance|0
4798351|NCT01332968|16547170|P2|Induction Period|Non-compliance|0
4798352|NCT01332968|16547171|P1|Induction Period|Non-compliance|1
4798353|NCT01332968|16547164|P8|Induction Period|Other|0
4798354|NCT01332968|16547165|P7|Induction Period|Other|0
4798355|NCT01332968|16547166|P6|Induction Period|Other|0
4798356|NCT01332968|16547167|P5|Induction Period|Other|0
4798357|NCT01332968|16547168|P4|Induction Period|Other|0
4798358|NCT01332968|16547169|P3|Induction Period|Other|0
4798359|NCT01332968|16547170|P2|Induction Period|Other|2
4798360|NCT01332968|16547171|P1|Induction Period|Other|2
4798361|NCT01332968|16547164|P8|Induction Period|Physician Decision|0
4798362|NCT01332968|16547165|P7|Induction Period|Physician Decision|0
4798363|NCT01332968|16547166|P6|Induction Period|Physician Decision|0
4798364|NCT01332968|16547167|P5|Induction Period|Physician Decision|0
4798365|NCT01332968|16547168|P4|Induction Period|Physician Decision|0
4798366|NCT01332968|16547169|P3|Induction Period|Physician Decision|0
4798367|NCT01332968|16547170|P2|Induction Period|Physician Decision|1
4798368|NCT01332968|16547171|P1|Induction Period|Physician Decision|6
4798369|NCT01332968|16547164|P8|Induction Period|Progressive disease|0
4798370|NCT01332968|16547165|P7|Induction Period|Progressive disease|0
4798371|NCT01332968|16547166|P6|Induction Period|Progressive disease|0
4798372|NCT01332968|16547167|P5|Induction Period|Progressive disease|0
4798373|NCT01332968|16547168|P4|Induction Period|Progressive disease|0
4798374|NCT01332968|16547169|P3|Induction Period|Progressive disease|0
4798375|NCT01332968|16547170|P2|Induction Period|Progressive disease|7
4798376|NCT01332968|16547171|P1|Induction Period|Progressive disease|15
4798377|NCT01332968|16547164|P8|Induction Period|Protocol Violation|0
4798378|NCT01332968|16547165|P7|Induction Period|Protocol Violation|0
4798379|NCT01332968|16547166|P6|Induction Period|Protocol Violation|0
4798380|NCT01332968|16547167|P5|Induction Period|Protocol Violation|0
4798381|NCT01332968|16547168|P4|Induction Period|Protocol Violation|0
4798382|NCT01332968|16547169|P3|Induction Period|Protocol Violation|0
4798383|NCT01332968|16547170|P2|Induction Period|Protocol Violation|4
4798384|NCT01332968|16547171|P1|Induction Period|Protocol Violation|3
4798385|NCT01332968|16547164|P8|Induction Period|Withdrawal by Subject|0
4798386|NCT01332968|16547165|P7|Induction Period|Withdrawal by Subject|0
4798387|NCT01332968|16547166|P6|Induction Period|Withdrawal by Subject|0
4798388|NCT01332968|16547167|P5|Induction Period|Withdrawal by Subject|0
4798389|NCT01332968|16547168|P4|Induction Period|Withdrawal by Subject|0
4798390|NCT01332968|16547169|P3|Induction Period|Withdrawal by Subject|0
4798391|NCT01332968|16547170|P2|Induction Period|Withdrawal by Subject|5
4798392|NCT01332968|16547171|P1|Induction Period|Withdrawal by Subject|3
4798393|NCT01332851|16547237|P2|Overall Study|Lost to Follow-up|11
4798394|NCT01332851|16547238|P1|Overall Study|Lost to Follow-up|7
4798395|NCT01332851|16547237|P2|Overall Study|Withdrawal by Subject|2
4798396|NCT01332851|16547238|P1|Overall Study|Withdrawal by Subject|4
4798397|NCT01332799|16547272|P2|Overall Study|Insufficient funding|10
4798398|NCT01332799|16547273|P1|Overall Study|Insufficient funding|10
4798399|NCT01332630|16547289|P1|Overall Study|Withdrawal by Subject|3
4798400|NCT01332331|16547405|P2|Overall Study|Physician Decision|0
4798401|NCT01332331|16547406|P1|Overall Study|Physician Decision|1
4798402|NCT01332331|16547405|P2|Overall Study|Adverse Event|1
4798403|NCT01332331|16547406|P1|Overall Study|Adverse Event|1
4798404|NCT01332331|16547405|P2|Overall Study|Lost to Follow-up|1
4798405|NCT01332331|16547406|P1|Overall Study|Lost to Follow-up|0
4798406|NCT01332318|16547458|P4|Overall Study|Protocol Violation|1
4798407|NCT01332318|16547459|P3|Overall Study|Protocol Violation|1
4798408|NCT01332318|16547460|P2|Overall Study|Protocol Violation|0
4798409|NCT01332318|16547461|P1|Overall Study|Protocol Violation|1
4798410|NCT01332318|16547458|P4|Overall Study|Withdrawal by Subject|1
4798411|NCT01332318|16547459|P3|Overall Study|Withdrawal by Subject|0
4798412|NCT01332318|16547460|P2|Overall Study|Withdrawal by Subject|1
4798413|NCT01332318|16547461|P1|Overall Study|Withdrawal by Subject|1
4798414|NCT01332318|16547458|P4|Overall Study|Adverse Event|0
4798415|NCT01332318|16547459|P3|Overall Study|Adverse Event|0
4798416|NCT01332318|16547460|P2|Overall Study|Adverse Event|3
4798417|NCT01332318|16547461|P1|Overall Study|Adverse Event|0
4798418|NCT01332305|16547572|P5|Overall Study|Physician Decision|0
4798419|NCT01332305|16547573|P4|Overall Study|Physician Decision|1
4798420|NCT01332305|16547574|P3|Overall Study|Physician Decision|0
4798421|NCT01332305|16547575|P2|Overall Study|Physician Decision|0
4798422|NCT01332305|16547576|P1|Overall Study|Physician Decision|0
4798423|NCT01332305|16547572|P5|Overall Study|Treatment Failure|0
4798424|NCT01332305|16547573|P4|Overall Study|Treatment Failure|0
4798425|NCT01332305|16547574|P3|Overall Study|Treatment Failure|0
4798426|NCT01332305|16547575|P2|Overall Study|Treatment Failure|1
4798427|NCT01332305|16547576|P1|Overall Study|Treatment Failure|1
4798428|NCT01332305|16547572|P5|Overall Study|Withdrawal by Sponsor|1
4798429|NCT01332305|16547573|P4|Overall Study|Withdrawal by Sponsor|1
4798430|NCT01332305|16547574|P3|Overall Study|Withdrawal by Sponsor|0
4798431|NCT01332305|16547575|P2|Overall Study|Withdrawal by Sponsor|0
4798432|NCT01332305|16547576|P1|Overall Study|Withdrawal by Sponsor|1
4798433|NCT01332305|16547572|P5|Overall Study|Protocol Violation|3
4798434|NCT01332305|16547573|P4|Overall Study|Protocol Violation|0
4798435|NCT01332305|16547574|P3|Overall Study|Protocol Violation|1
4798436|NCT01332305|16547575|P2|Overall Study|Protocol Violation|2
4798437|NCT01332305|16547576|P1|Overall Study|Protocol Violation|1
4798438|NCT01332305|16547572|P5|Overall Study|Lost to Follow-up|3
4798439|NCT01332305|16547573|P4|Overall Study|Lost to Follow-up|2
4798440|NCT01332305|16547574|P3|Overall Study|Lost to Follow-up|3
4798441|NCT01332305|16547575|P2|Overall Study|Lost to Follow-up|2
4798442|NCT01332305|16547576|P1|Overall Study|Lost to Follow-up|0
4798443|NCT01332305|16547572|P5|Overall Study|Withdrawal by Subject|0
4798444|NCT01332305|16547573|P4|Overall Study|Withdrawal by Subject|1
4798445|NCT01332305|16547574|P3|Overall Study|Withdrawal by Subject|4
4798446|NCT01332305|16547575|P2|Overall Study|Withdrawal by Subject|5
4798447|NCT01332305|16547576|P1|Overall Study|Withdrawal by Subject|6
4798448|NCT01332305|16547572|P5|Overall Study|Adverse Event|5
4798449|NCT01332305|16547573|P4|Overall Study|Adverse Event|3
4798450|NCT01332305|16547574|P3|Overall Study|Adverse Event|6
4798451|NCT01332305|16547575|P2|Overall Study|Adverse Event|4
4798452|NCT01332305|16547576|P1|Overall Study|Adverse Event|1
4798453|NCT01332292|16547598|P2|Treatment Period 2 (14 Days)|Physician Decision|1
4798454|NCT01332292|16547599|P1|Treatment Period 2 (14 Days)|Physician Decision|1
4798455|NCT01332292|16547598|P2|Treatment Period 1 (14 Days)|Protocol Violation|1
4798456|NCT01332292|16547599|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
4798457|NCT01332292|16547598|P2|Treatment Period 1 (14 Days)|Adverse Event|0
4798458|NCT01332292|16547599|P1|Treatment Period 1 (14 Days)|Adverse Event|1
4798459|NCT01332227|16547690|P2|Overall Study|Patient began prohibited medication|1
4798460|NCT01332227|16547691|P1|Overall Study|Patient began prohibited medication|0
4798461|NCT01332227|16547690|P2|Overall Study|Patient moved from area|0
4798462|NCT01332227|16547691|P1|Overall Study|Patient moved from area|1
4798463|NCT01332227|16547690|P2|Overall Study|Poor compliance/noncompliance|1
4798464|NCT01332227|16547691|P1|Overall Study|Poor compliance/noncompliance|1
4798465|NCT01332227|16547690|P2|Overall Study|Lack of Efficacy|1
4798466|NCT01332227|16547691|P1|Overall Study|Lack of Efficacy|3
4798467|NCT01332227|16547690|P2|Overall Study|Lost to Follow-up|0
4798468|NCT01332227|16547691|P1|Overall Study|Lost to Follow-up|2
4798469|NCT01332227|16547690|P2|Overall Study|Withdrawal by Subject|1
4798470|NCT01332227|16547691|P1|Overall Study|Withdrawal by Subject|5
4798471|NCT01332227|16547690|P2|Overall Study|Adverse Event|1
4798472|NCT01332227|16547691|P1|Overall Study|Adverse Event|4
4798473|NCT01332149|16547872|P2|Overall Study|Randomized but not treated|2
4798474|NCT01332149|16547873|P1|Overall Study|Randomized but not treated|1
4798475|NCT01332149|16547872|P2|Overall Study|Did not meet entrance criteria|4
4798476|NCT01332149|16547873|P1|Overall Study|Did not meet entrance criteria|3
4798477|NCT01332149|16547872|P2|Overall Study|Insufficient clinical response|7
4798478|NCT01332149|16547873|P1|Overall Study|Insufficient clinical response|4
4798479|NCT01332149|16547872|P2|Overall Study|Lost to Follow-up|1
4798480|NCT01332149|16547873|P1|Overall Study|Lost to Follow-up|1
4798481|NCT01332149|16547872|P2|Overall Study|Withdrawal by Subject|5
4798482|NCT01332149|16547873|P1|Overall Study|Withdrawal by Subject|4
4798483|NCT01332149|16547872|P2|Overall Study|Protocol Violation|3
4798484|NCT01332149|16547873|P1|Overall Study|Protocol Violation|1
4798485|NCT01332149|16547872|P2|Overall Study|Other unspecified|7
4798486|NCT01332149|16547873|P1|Overall Study|Other unspecified|5
4798487|NCT01332149|16547872|P2|Overall Study|Adverse Event|9
4798488|NCT01332149|16547873|P1|Overall Study|Adverse Event|11
4798489|NCT01332019|16547951|P2|Overall Study|Adverse Event|22
4798490|NCT01332019|16547952|P1|Overall Study|Adverse Event|13
4798491|NCT01332019|16547951|P2|Overall Study|Lost to Follow-up|7
4798492|NCT01332019|16547952|P1|Overall Study|Lost to Follow-up|4
4798493|NCT01332019|16547951|P2|Overall Study|Withdrawal by Subject|71
4798494|NCT01332019|16547952|P1|Overall Study|Withdrawal by Subject|73
4798495|NCT01332019|16547951|P2|Overall Study|Physician Decision|3
4798496|NCT01332019|16547952|P1|Overall Study|Physician Decision|4
4798497|NCT01332019|16547951|P2|Overall Study|Death|1
4798498|NCT01332019|16547952|P1|Overall Study|Death|2
4798499|NCT01332019|16547951|P2|Overall Study|Other|18
4798500|NCT01332019|16547952|P1|Overall Study|Other|16
4798501|NCT01332019|16547951|P2|Overall Study|Was Not Dosed|0
4798502|NCT01332019|16547952|P1|Overall Study|Was Not Dosed|1
4798503|NCT01331837|16548036|P2|Overall Study|Withdrawal by Subject|16
4798504|NCT01331837|16548037|P1|Overall Study|Withdrawal by Subject|13
4798505|NCT01331837|16548036|P2|Overall Study|Info not recorded|16
4798506|NCT01331837|16548037|P1|Overall Study|Info not recorded|10
4798507|NCT01331837|16548036|P2|Overall Study|Lost to Follow-up|1
4798508|NCT01331837|16548037|P1|Overall Study|Lost to Follow-up|3
4798509|NCT01331837|16548036|P2|Overall Study|Death|34
4798510|NCT01331837|16548037|P1|Overall Study|Death|30
4798511|NCT01331824|16548077|P1|Overall Study|Withdrawal by Subject|1
4798512|NCT01331824|16548077|P1|Overall Study|Disease Progression|9
4798513|NCT01331824|16548077|P1|Overall Study|Death|1
4798514|NCT01331824|16548077|P1|Overall Study|Adverse Event|2
4798515|NCT01331681|16548112|P3|Overall Study|Not Received Study Treatment|2
4798516|NCT01331681|16548113|P2|Overall Study|Not Received Study Treatment|0
4798517|NCT01331681|16548114|P1|Overall Study|Not Received Study Treatment|0
4798518|NCT01331681|16548112|P3|Overall Study|Switching to other therapy|1
4798519|NCT01331681|16548113|P2|Overall Study|Switching to other therapy|0
4798520|NCT01331681|16548114|P1|Overall Study|Switching to other therapy|0
4798521|NCT01331681|16548112|P3|Overall Study|Sponsor decision|0
4798522|NCT01331681|16548113|P2|Overall Study|Sponsor decision|1
4798523|NCT01331681|16548114|P1|Overall Study|Sponsor decision|1
4798524|NCT01331681|16548112|P3|Overall Study|Therapeutic procedure required|0
4798525|NCT01331681|16548113|P2|Overall Study|Therapeutic procedure required|0
4798526|NCT01331681|16548114|P1|Overall Study|Therapeutic procedure required|1
4798527|NCT01331681|16548112|P3|Overall Study|Physician Decision|4
4798528|NCT01331681|16548113|P2|Overall Study|Physician Decision|0
4798529|NCT01331681|16548114|P1|Overall Study|Physician Decision|2
4798530|NCT01331681|16548112|P3|Overall Study|Lost to Follow-up|1
4798531|NCT01331681|16548113|P2|Overall Study|Lost to Follow-up|4
4798532|NCT01331681|16548114|P1|Overall Study|Lost to Follow-up|2
4798533|NCT01331681|16548112|P3|Overall Study|Protocol Violation|0
4798534|NCT01331681|16548113|P2|Overall Study|Protocol Violation|1
4798535|NCT01331681|16548114|P1|Overall Study|Protocol Violation|1
4798536|NCT01331681|16548112|P3|Overall Study|Withdrawal by Subject|15
4798537|NCT01331681|16548113|P2|Overall Study|Withdrawal by Subject|8
4798538|NCT01331681|16548114|P1|Overall Study|Withdrawal by Subject|12
4798539|NCT01331681|16548112|P3|Overall Study|Lack of Efficacy|0
4798540|NCT01331681|16548113|P2|Overall Study|Lack of Efficacy|1
4798541|NCT01331681|16548114|P1|Overall Study|Lack of Efficacy|0
4798542|NCT01331681|16548112|P3|Overall Study|Death|2
4798543|NCT01331681|16548113|P2|Overall Study|Death|6
4798544|NCT01331681|16548114|P1|Overall Study|Death|6
4798545|NCT01331681|16548112|P3|Overall Study|Adverse Event|10
4798546|NCT01331681|16548113|P2|Overall Study|Adverse Event|13
4798547|NCT01331681|16548114|P1|Overall Study|Adverse Event|10
4798548|NCT01331291|16548163|P2|Overall Study|Death|1
4798549|NCT01331291|16548164|P1|Overall Study|Death|0
4798550|NCT01331291|16548163|P2|Overall Study|Lack of Efficacy|8
4798551|NCT01331291|16548164|P1|Overall Study|Lack of Efficacy|2
4798552|NCT01331161|16548198|P2|Overall Study|Pregnancy|1
4798553|NCT01331161|16548199|P1|Overall Study|Pregnancy|0
4798554|NCT01331161|16548198|P2|Overall Study|Lost to Follow-up|1
4798555|NCT01331161|16548199|P1|Overall Study|Lost to Follow-up|0
4798556|NCT01331161|16548198|P2|Overall Study|Physician Decision|0
4798557|NCT01331161|16548199|P1|Overall Study|Physician Decision|1
4798558|NCT01331109|16548207|P1|Overall Study|Study Terminated by Sponsor|38
4798559|NCT01331109|16548207|P1|Overall Study|Lost to Follow-up|1
4798560|NCT01331109|16548207|P1|Overall Study|Withdrawal by Subject|7
4798561|NCT01331109|16548207|P1|Overall Study|Protocol Violation|3
4798562|NCT01331109|16548207|P1|Overall Study|Lack of Efficacy|2
4798563|NCT01331109|16548207|P1|Overall Study|Adverse Event|6
4798564|NCT01331005|16548234|P2|Overall Study|Withdrawal by Subject|3
4798565|NCT01331005|16548235|P1|Overall Study|Withdrawal by Subject|2
4798566|NCT01331005|16548234|P2|Overall Study|Lost to Follow-up|1
4798567|NCT01331005|16548235|P1|Overall Study|Lost to Follow-up|2
4798568|NCT01330914|16548306|P1|Overall Study|No longer eligible (sleeve gastrectomy)|3
4798569|NCT01330914|16548306|P1|Overall Study|Withdrawal by Subject|4
4798570|NCT01330628|16548314|P2|Overall Study|Didn't receive study treatment|0
4798571|NCT01330628|16548315|P1|Overall Study|Didn't receive study treatment|1
4798572|NCT01330628|16548314|P2|Overall Study|Withdrawn|6
4798573|NCT01330628|16548315|P1|Overall Study|Withdrawn|18
4798574|NCT01330628|16548314|P2|Overall Study|Adverse Event|25
4798575|NCT01330628|16548315|P1|Overall Study|Adverse Event|44
4798576|NCT01330628|16548314|P2|Overall Study|Lost to Follow-up|6
4798577|NCT01330628|16548315|P1|Overall Study|Lost to Follow-up|5
4798578|NCT01330628|16548314|P2|Overall Study|Death|3
4798579|NCT01330628|16548315|P1|Overall Study|Death|2
4798580|NCT01330459|16548325|P2|Overall Study|Physician Decision|2
4798581|NCT01330459|16548326|P1|Overall Study|Physician Decision|0
4798582|NCT01330433|16548342|P2|Overall Study|Lost to Follow-up|0
4798583|NCT01330433|16548343|P1|Overall Study|Lost to Follow-up|1
4798584|NCT01330433|16548342|P2|Overall Study|Death|3
4798585|NCT01330433|16548343|P1|Overall Study|Death|1
4798586|NCT01330381|16548382|P3|Open-label Treatment Period (16 Weeks)|Non-compliance|1
4798587|NCT01330381|16548383|P2|Open-label Treatment Period (16 Weeks)|Non-compliance|0
4798588|NCT01330381|16548384|P1|Open-label Treatment Period (16 Weeks)|Non-compliance|0
4798589|NCT01330381|16548382|P3|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
4798590|NCT01330381|16548383|P2|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0
4798591|NCT01330381|16548384|P1|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1
4798592|NCT01330381|16548382|P3|Open-label Treatment Period (16 Weeks)|Adverse Event|0
4798593|NCT01330381|16548383|P2|Open-label Treatment Period (16 Weeks)|Adverse Event|0
4798594|NCT01330381|16548384|P1|Open-label Treatment Period (16 Weeks)|Adverse Event|2
4798595|NCT01330381|16548382|P3|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16
4798596|NCT01330381|16548383|P2|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0
4798597|NCT01330381|16548384|P1|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7
4798598|NCT01330381|16548382|P3|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0
4798599|NCT01330381|16548383|P2|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
4798600|NCT01330381|16548384|P1|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1
4798601|NCT01330381|16548382|P3|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
4798602|NCT01330381|16548383|P2|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0
4798603|NCT01330381|16548384|P1|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1
4798604|NCT01330381|16548382|P3|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
4798605|NCT01330381|16548383|P2|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0
4798606|NCT01330381|16548384|P1|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1
4798607|NCT01330381|16548382|P3|Double-blind Treatment Period (8 Weeks)|Adverse Event|0
4798608|NCT01330381|16548383|P2|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
4798609|NCT01330381|16548384|P1|Double-blind Treatment Period (8 Weeks)|Adverse Event|1
4798610|NCT01330381|16548382|P3|Double-blind Treatment Period (8 Weeks)|Non-compliance|0
4798611|NCT01330381|16548383|P2|Double-blind Treatment Period (8 Weeks)|Non-compliance|1
4798612|NCT01330381|16548384|P1|Double-blind Treatment Period (8 Weeks)|Non-compliance|2
4798613|NCT01330381|16548382|P3|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0
4798614|NCT01330381|16548383|P2|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4
4798615|NCT01330381|16548384|P1|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5
4798616|NCT01330316|16548445|P2|Overall Study|other than above|1
4798617|NCT01330316|16548446|P1|Overall Study|other than above|0
4798618|NCT01330316|16548445|P2|Overall Study|Withdrawal by Subject|1
4798619|NCT01330316|16548446|P1|Overall Study|Withdrawal by Subject|0
4798620|NCT01330316|16548445|P2|Overall Study|Lost to Follow-up|1
4798621|NCT01330316|16548446|P1|Overall Study|Lost to Follow-up|0
4798622|NCT01330316|16548445|P2|Overall Study|Lack of Efficacy|10
4798623|NCT01330316|16548446|P1|Overall Study|Lack of Efficacy|0
4798624|NCT01330316|16548445|P2|Overall Study|Adverse Event|2
4798625|NCT01330316|16548446|P1|Overall Study|Adverse Event|2
4798626|NCT01330303|16548482|P2|Period 1|Withdrawal by Subject|1
4798627|NCT01330303|16548483|P1|Period 1|Withdrawal by Subject|0
4798628|NCT01330303|16548482|P2|Period 1|Protocol Violation|1
4798629|NCT01330303|16548483|P1|Period 1|Protocol Violation|0
4798630|NCT01330303|16548482|P2|Period 1|Adverse Event|0
4798631|NCT01330303|16548483|P1|Period 1|Adverse Event|1
4798632|NCT01330108|16548530|P1|Overall Study|Withdrawal by Subject|4
4798633|NCT01330030|16548548|P2|Overall Study|Lost to Follow-up|17
4798634|NCT01330030|16548549|P1|Overall Study|Lost to Follow-up|16
4798635|NCT01330017|16548560|P5|Overall Study|Unknown Reason|2
4798636|NCT01330017|16548561|P4|Overall Study|Unknown Reason|7
4798637|NCT01330017|16548562|P3|Overall Study|Unknown Reason|5
4798638|NCT01330017|16548563|P2|Overall Study|Unknown Reason|3
4798639|NCT01330017|16548564|P1|Overall Study|Unknown Reason|5
4798640|NCT01330017|16548560|P5|Overall Study|Protocol Violation|0
4798641|NCT01330017|16548561|P4|Overall Study|Protocol Violation|1
4798642|NCT01330017|16548562|P3|Overall Study|Protocol Violation|0
4798643|NCT01330017|16548563|P2|Overall Study|Protocol Violation|0
4798644|NCT01330017|16548564|P1|Overall Study|Protocol Violation|0
4798645|NCT01330017|16548560|P5|Overall Study|Lost to Follow-up|0
4798646|NCT01330017|16548561|P4|Overall Study|Lost to Follow-up|0
4798647|NCT01330017|16548562|P3|Overall Study|Lost to Follow-up|1
4798648|NCT01330017|16548563|P2|Overall Study|Lost to Follow-up|0
4798649|NCT01330017|16548564|P1|Overall Study|Lost to Follow-up|0
4798650|NCT01330017|16548560|P5|Overall Study|Withdrawal by Subject|1
4798651|NCT01330017|16548561|P4|Overall Study|Withdrawal by Subject|0
4798652|NCT01330017|16548562|P3|Overall Study|Withdrawal by Subject|1
4798653|NCT01330017|16548563|P2|Overall Study|Withdrawal by Subject|0
4798654|NCT01330017|16548564|P1|Overall Study|Withdrawal by Subject|0
4798655|NCT01330017|16548560|P5|Overall Study|Adverse Event|0
4798656|NCT01330017|16548561|P4|Overall Study|Adverse Event|4
4798657|NCT01330017|16548562|P3|Overall Study|Adverse Event|1
4798658|NCT01330017|16548563|P2|Overall Study|Adverse Event|1
4798659|NCT01330017|16548564|P1|Overall Study|Adverse Event|0
4798660|NCT01329978|16548613|P5|Rerandomization Treatment Period|Withdrawal by Subject|1
4798661|NCT01329978|16548614|P4|Rerandomization Treatment Period|Withdrawal by Subject|0
4798662|NCT01329978|16548615|P3|Rerandomization Treatment Period|Withdrawal by Subject|0
4798663|NCT01329978|16548616|P2|Rerandomization Treatment Period|Withdrawal by Subject|0
4798664|NCT01329978|16548617|P1|Rerandomization Treatment Period|Withdrawal by Subject|0
4798665|NCT01329978|16548613|P5|Rerandomization Treatment Period|Lost to Follow-up|3
4798666|NCT01329978|16548614|P4|Rerandomization Treatment Period|Lost to Follow-up|5
4798667|NCT01329978|16548615|P3|Rerandomization Treatment Period|Lost to Follow-up|0
4798668|NCT01329978|16548616|P2|Rerandomization Treatment Period|Lost to Follow-up|0
4798669|NCT01329978|16548617|P1|Rerandomization Treatment Period|Lost to Follow-up|0
4798670|NCT01329978|16548613|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4798671|NCT01329978|16548614|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4798672|NCT01329978|16548615|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4798673|NCT01329978|16548616|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1
4798674|NCT01329978|16548617|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0
4798675|NCT01329978|16548613|P5|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4798676|NCT01329978|16548614|P4|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4798677|NCT01329978|16548615|P3|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4798678|NCT01329978|16548616|P2|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1
4798679|NCT01329978|16548617|P1|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0
4798680|NCT01329978|16548613|P5|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
4798681|NCT01329978|16548614|P4|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0
4798682|NCT01329978|16548615|P3|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3
4798683|NCT01329978|16548616|P2|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
4798684|NCT01329978|16548617|P1|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1
4798685|NCT01329978|16548613|P5|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
4798686|NCT01329978|16548614|P4|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0
4798687|NCT01329978|16548615|P3|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
4798688|NCT01329978|16548616|P2|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8
4798689|NCT01329978|16548617|P1|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2
4798690|NCT01329978|16548613|P5|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
4798691|NCT01329978|16548614|P4|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
4798692|NCT01329978|16548615|P3|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0
4798693|NCT01329978|16548616|P2|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2
4798694|NCT01329978|16548617|P1|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1
4798695|NCT01329939|16548691|P4|Overall Study|Adverse Event|3
4798696|NCT01329939|16548692|P3|Overall Study|Adverse Event|0
4798697|NCT01329939|16548693|P2|Overall Study|Adverse Event|0
4798698|NCT01329939|16548694|P1|Overall Study|Adverse Event|0
4798699|NCT01329939|16548691|P4|Overall Study|Withdrawal by Subject|0
4798700|NCT01329939|16548692|P3|Overall Study|Withdrawal by Subject|0
4798701|NCT01329939|16548693|P2|Overall Study|Withdrawal by Subject|1
4798702|NCT01329939|16548694|P1|Overall Study|Withdrawal by Subject|0
4798703|NCT01329939|16548691|P4|Overall Study|Lost to Follow-up|2
4798704|NCT01329939|16548692|P3|Overall Study|Lost to Follow-up|1
4798705|NCT01329939|16548693|P2|Overall Study|Lost to Follow-up|0
4798706|NCT01329939|16548694|P1|Overall Study|Lost to Follow-up|3
4798707|NCT01329900|16548732|P1|Overall Study|Elevated creatinine/renal function|1
4798708|NCT01329562|16548762|P2|Overall Study|Physician Decision|1
4798709|NCT01329562|16548763|P1|Overall Study|Physician Decision|0
4798710|NCT01329562|16548762|P2|Overall Study|Subject withdrew due to personal issues.|2
4798711|NCT01329562|16548763|P1|Overall Study|Subject withdrew due to personal issues.|3
4798712|NCT01329562|16548762|P2|Overall Study|Lost to Follow-up|1
4798713|NCT01329562|16548763|P1|Overall Study|Lost to Follow-up|1
4798714|NCT01329562|16548762|P2|Overall Study|Protocol Violation|3
4798715|NCT01329562|16548763|P1|Overall Study|Protocol Violation|5
4798716|NCT01329549|16548812|P1|Overall Study|Adverse Event|1
4798717|NCT01329549|16548812|P1|Overall Study|Withdrawal by Subject|1
4798718|NCT01329419|16548823|P1|Overall Study|Protocol Violation|235
4798719|NCT01329328|16548842|P3|Overall Study|Withdrawal by Subject|3
4798720|NCT01329328|16548843|P2|Overall Study|Withdrawal by Subject|4
4798721|NCT01329328|16548844|P1|Overall Study|Withdrawal by Subject|2
4798722|NCT01329263|16548857|P2|Overall Study|Withdrawal by Subject|2
4798723|NCT01329263|16548858|P1|Overall Study|Withdrawal by Subject|1
4798724|NCT01329263|16548857|P2|Overall Study|Lost to Follow-up|21
4798725|NCT01329263|16548858|P1|Overall Study|Lost to Follow-up|4
4798726|NCT01329029|16548895|P2|Overall Study|Met Pre-defined Discontinuation Criteria|1
4798727|NCT01329029|16548896|P1|Overall Study|Met Pre-defined Discontinuation Criteria|5
4798728|NCT01329029|16548895|P2|Overall Study|Lost to Follow-up|5
4798729|NCT01329029|16548896|P1|Overall Study|Lost to Follow-up|8
4798730|NCT01329029|16548895|P2|Overall Study|Physician Decision|13
4798731|NCT01329029|16548896|P1|Overall Study|Physician Decision|16
4798732|NCT01329029|16548895|P2|Overall Study|COPD Exacerbation|18
4798733|NCT01329029|16548896|P1|Overall Study|COPD Exacerbation|11
4798734|NCT01329029|16548895|P2|Overall Study|Other|20
4798735|NCT01329029|16548896|P1|Overall Study|Other|14
4798736|NCT01329029|16548895|P2|Overall Study|Death|19
4798737|NCT01329029|16548896|P1|Overall Study|Death|16
4798738|NCT01329029|16548895|P2|Overall Study|Adverse Event|29
4798739|NCT01329029|16548896|P1|Overall Study|Adverse Event|82
4798740|NCT01329029|16548895|P2|Overall Study|Withdrawal by Subject|87
4798741|NCT01329029|16548896|P1|Overall Study|Withdrawal by Subject|117
4798742|NCT01328951|16548986|P2|Overall Study|Other|6
4798743|NCT01328951|16548987|P1|Overall Study|Other|11
4798744|NCT01328951|16548986|P2|Overall Study|Study Closed by the Sponsor|31
4798745|NCT01328951|16548987|P1|Overall Study|Study Closed by the Sponsor|36
4798746|NCT01328951|16548986|P2|Overall Study|Withdrawal by Subject|6
4798747|NCT01328951|16548987|P1|Overall Study|Withdrawal by Subject|6
4798748|NCT01328951|16548986|P2|Overall Study|Lost to Follow-up|7
4798749|NCT01328951|16548987|P1|Overall Study|Lost to Follow-up|6
4798750|NCT01328951|16548986|P2|Overall Study|Death|258
4798751|NCT01328951|16548987|P1|Overall Study|Death|243
4798752|NCT01328951|16548986|P2|Overall Study|Adverse Event|0
4798753|NCT01328951|16548987|P1|Overall Study|Adverse Event|2
4798754|NCT01328951|16548986|P2|Overall Study|Disease Progression|14
4798755|NCT01328951|16548987|P1|Overall Study|Disease Progression|17
4798756|NCT01328756|16549056|P1|Overall Study|Other|29
4798757|NCT01328756|16549056|P1|Overall Study|Lost to Follow-up|5
4798758|NCT01328756|16549056|P1|Overall Study|Withdrawal by Subject|41
4798759|NCT01328756|16549056|P1|Overall Study|Lack of Efficacy|5
4798760|NCT01328756|16549056|P1|Overall Study|Adverse Event|39
4798761|NCT01328756|16549056|P1|Overall Study|Protocol Violation|4
4798762|NCT01328717|16549092|P1|Overall Study|Adverse Event|1
4798763|NCT01328574|16549101|P1|Overall Study|Refused further treatment|1
4798764|NCT01328548|16549115|P2|Overall Study|Protocol Violation|0
4798765|NCT01328548|16549116|P1|Overall Study|Protocol Violation|1
4798766|NCT01328548|16549115|P2|Overall Study|Death|0
4798767|NCT01328548|16549116|P1|Overall Study|Death|3
4798768|NCT01328535|16549134|P1|Overall Study|Ineligible|1
4798769|NCT01328496|16549145|P2|Overall Study|Significant Change in Health Status|0
4798770|NCT01328496|16549146|P1|Overall Study|Significant Change in Health Status|1
4798771|NCT01328444|16549164|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4798772|NCT01328444|16549165|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4798773|NCT01328444|16549166|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4798774|NCT01328444|16549167|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4798775|NCT01328444|16549168|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4798776|NCT01328444|16549169|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4798777|NCT01328444|16549164|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
4798778|NCT01328444|16549165|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4798779|NCT01328444|16549166|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4798780|NCT01328444|16549167|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4798781|NCT01328444|16549168|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4798782|NCT01328444|16549169|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4798783|NCT01328444|16549164|P6|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4798784|NCT01328444|16549165|P5|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
4798785|NCT01328444|16549166|P4|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1
4798786|NCT01328444|16549167|P3|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4798787|NCT01328444|16549168|P2|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4798788|NCT01328444|16549169|P1|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0
4798789|NCT01328444|16549164|P6|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4798790|NCT01328444|16549165|P5|Treatment Period 2 (12 Weeks)|Protocol Violation|1
4798791|NCT01328444|16549166|P4|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4798792|NCT01328444|16549167|P3|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4798793|NCT01328444|16549168|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|0
4798794|NCT01328444|16549169|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|1
4798795|NCT01328444|16549164|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4
4798796|NCT01328444|16549165|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
4798797|NCT01328444|16549166|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
4798798|NCT01328444|16549167|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4798799|NCT01328444|16549168|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4798800|NCT01328444|16549169|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5
4798801|NCT01328444|16549164|P6|Treatment Period 2 (12 Weeks)|Adverse Event|0
4798802|NCT01328444|16549165|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
4798803|NCT01328444|16549166|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
4798804|NCT01328444|16549167|P3|Treatment Period 2 (12 Weeks)|Adverse Event|1
4798805|NCT01328444|16549168|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
4798806|NCT01328444|16549169|P1|Treatment Period 2 (12 Weeks)|Adverse Event|5
4798807|NCT01328444|16549164|P6|Washout Period (14 Days)|Withdrawal by Subject|1
4798808|NCT01328444|16549165|P5|Washout Period (14 Days)|Withdrawal by Subject|0
4798809|NCT01328444|16549166|P4|Washout Period (14 Days)|Withdrawal by Subject|0
4798810|NCT01328444|16549167|P3|Washout Period (14 Days)|Withdrawal by Subject|0
4798811|NCT01328444|16549168|P2|Washout Period (14 Days)|Withdrawal by Subject|0
4798812|NCT01328444|16549169|P1|Washout Period (14 Days)|Withdrawal by Subject|0
4798813|NCT01328444|16549164|P6|Washout Period (14 Days)|Lack of Efficacy|1
4798814|NCT01328444|16549165|P5|Washout Period (14 Days)|Lack of Efficacy|0
4798815|NCT01328444|16549166|P4|Washout Period (14 Days)|Lack of Efficacy|0
4798816|NCT01328444|16549167|P3|Washout Period (14 Days)|Lack of Efficacy|0
4798817|NCT01328444|16549168|P2|Washout Period (14 Days)|Lack of Efficacy|0
4798818|NCT01328444|16549169|P1|Washout Period (14 Days)|Lack of Efficacy|0
4798819|NCT01328444|16549164|P6|Washout Period (14 Days)|Adverse Event|2
4798820|NCT01328444|16549165|P5|Washout Period (14 Days)|Adverse Event|1
4798821|NCT01328444|16549166|P4|Washout Period (14 Days)|Adverse Event|1
4798822|NCT01328444|16549167|P3|Washout Period (14 Days)|Adverse Event|0
4798823|NCT01328444|16549168|P2|Washout Period (14 Days)|Adverse Event|1
4798824|NCT01328444|16549169|P1|Washout Period (14 Days)|Adverse Event|1
4798825|NCT01328444|16549164|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4798826|NCT01328444|16549165|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4798827|NCT01328444|16549166|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
4798828|NCT01328444|16549167|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4798829|NCT01328444|16549168|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2
4798830|NCT01328444|16549169|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4798831|NCT01328444|16549164|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4798832|NCT01328444|16549165|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4798833|NCT01328444|16549166|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4798834|NCT01328444|16549167|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4798835|NCT01328444|16549168|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4798836|NCT01328444|16549169|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2
4798837|NCT01328444|16549164|P6|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4798838|NCT01328444|16549165|P5|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2
4798839|NCT01328444|16549166|P4|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4798840|NCT01328444|16549167|P3|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4798841|NCT01328444|16549168|P2|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1
4798842|NCT01328444|16549169|P1|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0
4798843|NCT01328444|16549164|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4798844|NCT01328444|16549165|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4798845|NCT01328444|16549166|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4798846|NCT01328444|16549167|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4798847|NCT01328444|16549168|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4798848|NCT01328444|16549169|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4798849|NCT01328444|16549164|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
4798850|NCT01328444|16549165|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
4798851|NCT01328444|16549166|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4798852|NCT01328444|16549167|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4798853|NCT01328444|16549168|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4798854|NCT01328444|16549169|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
4798855|NCT01328444|16549164|P6|Treatment Period 1 (12 Weeks)|Adverse Event|2
4798856|NCT01328444|16549165|P5|Treatment Period 1 (12 Weeks)|Adverse Event|5
4798857|NCT01328444|16549166|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
4798858|NCT01328444|16549167|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
4798859|NCT01328444|16549168|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
4798860|NCT01328444|16549169|P1|Treatment Period 1 (12 Weeks)|Adverse Event|3
4798861|NCT01328431|16549215|P2|12 Month (12M)|Lost to Follow-up|91
4798862|NCT01328431|16549216|P1|12 Month (12M)|Lost to Follow-up|82
4798863|NCT01328431|16549215|P2|12 Month (12M)|Death|6
4798864|NCT01328431|16549216|P1|12 Month (12M)|Death|2
4798865|NCT01328431|16549215|P2|3 Month (3M)|Lost to Follow-up|70
4798866|NCT01328431|16549216|P1|3 Month (3M)|Lost to Follow-up|75
4798867|NCT01328431|16549215|P2|3 Month (3M)|Death|2
4798868|NCT01328431|16549216|P1|3 Month (3M)|Death|2
4798869|NCT01328431|16549215|P2|1 Month (1M)|Lost to Follow-up|58
4798870|NCT01328431|16549216|P1|1 Month (1M)|Lost to Follow-up|55
4798871|NCT01328431|16549215|P2|Baseline|Protocol Violation|2
4798872|NCT01328431|16549216|P1|Baseline|Protocol Violation|0
4798873|NCT01328366|16549272|P1|Overall Study|Lost to Follow-up|7
4798874|NCT01328366|16549272|P1|Overall Study|Withdrawal by Subject|2
4798875|NCT01328366|16549272|P1|Overall Study|Death|1
4798876|NCT01328249|16549292|P2|Overall Study|Protocol Violation|1
4798877|NCT01328249|16549293|P1|Overall Study|Protocol Violation|0
4798878|NCT01328249|16549292|P2|Overall Study|Subject choice|1
4798879|NCT01328249|16549293|P1|Overall Study|Subject choice|1
4798880|NCT01328249|16549292|P2|Overall Study|Moved before end of treatment visit|0
4798881|NCT01328249|16549293|P1|Overall Study|Moved before end of treatment visit|1
4798882|NCT01328249|16549292|P2|Overall Study|Withdrawal by Subject|1
4798883|NCT01328249|16549293|P1|Overall Study|Withdrawal by Subject|1
4798884|NCT01328249|16549292|P2|Overall Study|Disease progression|0
4798885|NCT01328249|16549293|P1|Overall Study|Disease progression|1
4798886|NCT01328249|16549292|P2|Overall Study|Adverse Event|0
4798887|NCT01328249|16549293|P1|Overall Study|Adverse Event|3
4798888|NCT01328080|16549379|P1|Overall Study|Lost to Follow-up|5
4798889|NCT01328054|16549383|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2
4798890|NCT01328054|16549384|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0
4798891|NCT01328054|16549383|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1
4798892|NCT01328054|16549384|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0
4798893|NCT01328054|16549383|P2|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2
4798894|NCT01328054|16549384|P1|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0
4798895|NCT01328041|16549409|P1|Overall Study|Withdrawal by Subject|7
4798896|NCT01328041|16549409|P1|Overall Study|Physician Decision|2
4798897|NCT01328041|16549409|P1|Overall Study|Lost to Follow-up|7
4798898|NCT01328041|16549409|P1|Overall Study|Protocol Violation|7
4798899|NCT01328041|16549409|P1|Overall Study|Lack of Efficacy|27
4798900|NCT01328041|16549409|P1|Overall Study|Adverse Event|7
4798901|NCT01328002|16549431|P2|Double-Blind Period|Lack of Efficacy|0
4798902|NCT01328002|16549432|P1|Double-Blind Period|Lack of Efficacy|1
4798903|NCT01328002|16549431|P2|Double-Blind Period|Adverse Event|0
4798904|NCT01328002|16549432|P1|Double-Blind Period|Adverse Event|1
4798905|NCT01328002|16549431|P2|Open-Label Period|Other Reason|0
4798906|NCT01328002|16549432|P1|Open-Label Period|Other Reason|2
4798907|NCT01328002|16549431|P2|Open-Label Period|Lost to Follow-up|0
4798908|NCT01328002|16549432|P1|Open-Label Period|Lost to Follow-up|6
4798909|NCT01328002|16549431|P2|Open-Label Period|Withdrawal by Subject|0
4798910|NCT01328002|16549432|P1|Open-Label Period|Withdrawal by Subject|9
4798911|NCT01328002|16549431|P2|Open-Label Period|Protocol Violation|0
4798912|NCT01328002|16549432|P1|Open-Label Period|Protocol Violation|2
4798913|NCT01328002|16549431|P2|Open-Label Period|Lack of Efficacy|0
4798914|NCT01328002|16549432|P1|Open-Label Period|Lack of Efficacy|3
4798915|NCT01328002|16549431|P2|Open-Label Period|Adverse Event|0
4798916|NCT01328002|16549432|P1|Open-Label Period|Adverse Event|8
4798917|NCT01328002|16549431|P2|Open-Label Period|Inclusion/exclusion criteria not met|0
4798918|NCT01328002|16549432|P1|Open-Label Period|Inclusion/exclusion criteria not met|66
4798919|NCT01327885|16549468|P2|Overall Study|Administrative decision|1
4798920|NCT01327885|16549469|P1|Overall Study|Administrative decision|0
4798921|NCT01327885|16549468|P2|Overall Study|Not treated|1
4798922|NCT01327885|16549469|P1|Overall Study|Not treated|1
4798923|NCT01327885|16549468|P2|Overall Study|Withdrawal of consent from study|4
4798924|NCT01327885|16549469|P1|Overall Study|Withdrawal of consent from study|3
4798925|NCT01327885|16549468|P2|Overall Study|Other|6
4798926|NCT01327885|16549469|P1|Overall Study|Other|8
4798927|NCT01327885|16549468|P2|Overall Study|Subject choice|10
4798928|NCT01327885|16549469|P1|Overall Study|Subject choice|5
4798929|NCT01327885|16549468|P2|Overall Study|Adverse Event|10
4798930|NCT01327885|16549469|P1|Overall Study|Adverse Event|14
4798931|NCT01327885|16549468|P2|Overall Study|Clinical progression|27
4798932|NCT01327885|16549469|P1|Overall Study|Clinical progression|24
4798933|NCT01327885|16549468|P2|Overall Study|Disease progression-according to RECIST|165
4798934|NCT01327885|16549469|P1|Overall Study|Disease progression-according to RECIST|173
4798935|NCT01327846|16549485|P4|Extension Phase|Technical Problems|2
4798936|NCT01327846|16549486|P3|Extension Phase|Technical Problems|2
4798937|NCT01327846|16549487|P2|Extension Phase|Technical Problems|4
4798938|NCT01327846|16549488|P1|Extension Phase|Technical Problems|2
4798939|NCT01327846|16549485|P4|Extension Phase|Lost to Follow-up|7
4798940|NCT01327846|16549486|P3|Extension Phase|Lost to Follow-up|4
4798941|NCT01327846|16549487|P2|Extension Phase|Lost to Follow-up|3
4798942|NCT01327846|16549488|P1|Extension Phase|Lost to Follow-up|4
4798943|NCT01327846|16549485|P4|Extension Phase|Withdrawal by Subject|37
4798944|NCT01327846|16549486|P3|Extension Phase|Withdrawal by Subject|19
4798945|NCT01327846|16549487|P2|Extension Phase|Withdrawal by Subject|13
4798946|NCT01327846|16549488|P1|Extension Phase|Withdrawal by Subject|20
4798947|NCT01327846|16549485|P4|Extension Phase|Study terminated by sponsor|1660
4798948|NCT01327846|16549486|P3|Extension Phase|Study terminated by sponsor|1067
4798949|NCT01327846|16549487|P2|Extension Phase|Study terminated by sponsor|1124
4798950|NCT01327846|16549488|P1|Extension Phase|Study terminated by sponsor|1073
4798951|NCT01327846|16549485|P4|Core Phase|Lost to Follow-up|5
4798952|NCT01327846|16549486|P3|Core Phase|Lost to Follow-up|4
4798953|NCT01327846|16549487|P2|Core Phase|Lost to Follow-up|3
4798954|NCT01327846|16549488|P1|Core Phase|Lost to Follow-up|3
4798955|NCT01327846|16549485|P4|Core Phase|Subject decision (vital stat: alive)|20
4798956|NCT01327846|16549486|P3|Core Phase|Subject decision (vital stat: alive)|13
4798957|NCT01327846|16549487|P2|Core Phase|Subject decision (vital stat: alive)|24
4798958|NCT01327846|16549488|P1|Core Phase|Subject decision (vital stat: alive)|23
4798959|NCT01327846|16549485|P4|Core Phase|Subject decision (vital stat: dead)|4
4798960|NCT01327846|16549486|P3|Core Phase|Subject decision (vital stat: dead)|4
4798961|NCT01327846|16549487|P2|Core Phase|Subject decision (vital stat: dead)|3
4798962|NCT01327846|16549488|P1|Core Phase|Subject decision (vital stat: dead)|1
4798963|NCT01327846|16549485|P4|Core Phase|Subject decision (vital stat: unkn)|3
4798964|NCT01327846|16549486|P3|Core Phase|Subject decision (vital stat: unkn)|3
4798965|NCT01327846|16549487|P2|Core Phase|Subject decision (vital stat: unkn)|0
4798966|NCT01327846|16549488|P1|Core Phase|Subject decision (vital stat: unkn)|0
4798967|NCT01327846|16549485|P4|Core Phase|Subject decision (vital status: missing)|1
4798968|NCT01327846|16549486|P3|Core Phase|Subject decision (vital status: missing)|2
4798969|NCT01327846|16549487|P2|Core Phase|Subject decision (vital status: missing)|2
4798970|NCT01327846|16549488|P1|Core Phase|Subject decision (vital status: missing)|1
4798971|NCT01327703|16549563|P2|Second Treatment Period|Protocol Violation|1
4798972|NCT01327703|16549564|P1|Second Treatment Period|Protocol Violation|0
4798973|NCT01327703|16549563|P2|Second Treatment Period|Adverse Event|1
4798974|NCT01327703|16549564|P1|Second Treatment Period|Adverse Event|1
4798975|NCT01327651|16549620|P9|Post Study Follow-up|Lost to Follow-up|2
4798976|NCT01327651|16549621|P8|Post Study Follow-up|Lost to Follow-up|1
4798977|NCT01327651|16549622|P7|Post Study Follow-up|Lost to Follow-up|4
4798978|NCT01327651|16549623|P6|Post Study Follow-up|Lost to Follow-up|0
4798979|NCT01327651|16549624|P5|Post Study Follow-up|Lost to Follow-up|0
4798980|NCT01327651|16549625|P4|Post Study Follow-up|Lost to Follow-up|0
4798981|NCT01327651|16549626|P3|Post Study Follow-up|Lost to Follow-up|1
4798982|NCT01327651|16549627|P2|Post Study Follow-up|Lost to Follow-up|1
4798983|NCT01327651|16549628|P1|Post Study Follow-up|Lost to Follow-up|0
4798984|NCT01327651|16549620|P9|Self-administered Dosing Period|Withdrawal by Subject|1
4798985|NCT01327651|16549621|P8|Self-administered Dosing Period|Withdrawal by Subject|1
4798986|NCT01327651|16549622|P7|Self-administered Dosing Period|Withdrawal by Subject|2
4798987|NCT01327651|16549623|P6|Self-administered Dosing Period|Withdrawal by Subject|0
4798988|NCT01327651|16549624|P5|Self-administered Dosing Period|Withdrawal by Subject|0
4798989|NCT01327651|16549625|P4|Self-administered Dosing Period|Withdrawal by Subject|1
4798990|NCT01327651|16549626|P3|Self-administered Dosing Period|Withdrawal by Subject|0
4798991|NCT01327651|16549627|P2|Self-administered Dosing Period|Withdrawal by Subject|1
4798992|NCT01327651|16549628|P1|Self-administered Dosing Period|Withdrawal by Subject|0
4798993|NCT01327651|16549620|P9|Self-administered Dosing Period|Ineligible (retrospective result)|0
4798994|NCT01327651|16549621|P8|Self-administered Dosing Period|Ineligible (retrospective result)|0
4798995|NCT01327651|16549622|P7|Self-administered Dosing Period|Ineligible (retrospective result)|0
4798996|NCT01327651|16549623|P6|Self-administered Dosing Period|Ineligible (retrospective result)|0
4798997|NCT01327651|16549624|P5|Self-administered Dosing Period|Ineligible (retrospective result)|0
4798998|NCT01327651|16549625|P4|Self-administered Dosing Period|Ineligible (retrospective result)|0
4798999|NCT01327651|16549626|P3|Self-administered Dosing Period|Ineligible (retrospective result)|0
4799000|NCT01327651|16549627|P2|Self-administered Dosing Period|Ineligible (retrospective result)|0
4799001|NCT01327651|16549628|P1|Self-administered Dosing Period|Ineligible (retrospective result)|1
4799002|NCT01327651|16549620|P9|Self-administered Dosing Period|Lost to Follow-up|10
4799003|NCT01327651|16549621|P8|Self-administered Dosing Period|Lost to Follow-up|9
4799004|NCT01327651|16549622|P7|Self-administered Dosing Period|Lost to Follow-up|8
4799005|NCT01327651|16549623|P6|Self-administered Dosing Period|Lost to Follow-up|0
4799006|NCT01327651|16549624|P5|Self-administered Dosing Period|Lost to Follow-up|3
4799007|NCT01327651|16549625|P4|Self-administered Dosing Period|Lost to Follow-up|2
4799008|NCT01327651|16549626|P3|Self-administered Dosing Period|Lost to Follow-up|4
4799009|NCT01327651|16549627|P2|Self-administered Dosing Period|Lost to Follow-up|2
4799010|NCT01327651|16549628|P1|Self-administered Dosing Period|Lost to Follow-up|3
4799011|NCT01327599|16549747|P1|Overall Study|Withdrawal of Consent|1
4799012|NCT01327599|16549747|P1|Overall Study|Could Not Attend Visit|1
4799013|NCT01327599|16549747|P1|Overall Study|Adverse Event|1
4799014|NCT01327573|16549757|P2|Overall Study|Physician Decision|1
4799015|NCT01327573|16549758|P1|Overall Study|Physician Decision|3
4799016|NCT01327547|16549769|P2|Overall Study|By investigator in subject's interest|1
4799017|NCT01327547|16549770|P1|Overall Study|By investigator in subject's interest|0
4799018|NCT01327547|16549769|P2|Overall Study|Non-compliance with study procedures|0
4799019|NCT01327547|16549770|P1|Overall Study|Non-compliance with study procedures|1
4799020|NCT01327547|16549769|P2|Overall Study|Required prohibited medication|0
4799021|NCT01327547|16549770|P1|Overall Study|Required prohibited medication|2
4799022|NCT01327547|16549769|P2|Overall Study|Non-compliance due to alcohol intake|1
4799023|NCT01327547|16549770|P1|Overall Study|Non-compliance due to alcohol intake|0
4799024|NCT01327547|16549769|P2|Overall Study|Protocol Violation|0
4799025|NCT01327547|16549770|P1|Overall Study|Protocol Violation|1
4799026|NCT01327547|16549769|P2|Overall Study|Does Not Meet Entrance Criteria|2
4799027|NCT01327547|16549770|P1|Overall Study|Does Not Meet Entrance Criteria|2
4799028|NCT01327547|16549769|P2|Overall Study|Withdrawal by Subject|7
4799029|NCT01327547|16549770|P1|Overall Study|Withdrawal by Subject|3
4799030|NCT01327547|16549769|P2|Overall Study|Non-Compliance With Study Treatment|2
4799031|NCT01327547|16549770|P1|Overall Study|Non-Compliance With Study Treatment|0
4799032|NCT01327547|16549769|P2|Overall Study|Lost to Follow-up|6
4799033|NCT01327547|16549770|P1|Overall Study|Lost to Follow-up|6
4799034|NCT01327547|16549769|P2|Overall Study|Death|2
4799035|NCT01327547|16549770|P1|Overall Study|Death|1
4799036|NCT01327547|16549769|P2|Overall Study|Adverse Event|1
4799037|NCT01327547|16549770|P1|Overall Study|Adverse Event|4
4799038|NCT01327495|16549838|P6|Overall Study|Physician Decision|0
4799039|NCT01327495|16549839|P5|Overall Study|Physician Decision|2
4799040|NCT01327495|16549840|P4|Overall Study|Physician Decision|0
4799041|NCT01327495|16549841|P3|Overall Study|Physician Decision|0
4799042|NCT01327495|16549842|P2|Overall Study|Physician Decision|0
4799043|NCT01327495|16549843|P1|Overall Study|Physician Decision|0
4799044|NCT01327495|16549838|P6|Overall Study|Withdrawal by Subject|0
4799045|NCT01327495|16549839|P5|Overall Study|Withdrawal by Subject|1
4799046|NCT01327495|16549840|P4|Overall Study|Withdrawal by Subject|0
4799047|NCT01327495|16549841|P3|Overall Study|Withdrawal by Subject|1
4799048|NCT01327495|16549842|P2|Overall Study|Withdrawal by Subject|1
4799049|NCT01327495|16549843|P1|Overall Study|Withdrawal by Subject|0
4799050|NCT01327495|16549838|P6|Overall Study|Adverse Event|2
4799051|NCT01327495|16549839|P5|Overall Study|Adverse Event|0
4799052|NCT01327495|16549840|P4|Overall Study|Adverse Event|0
4799053|NCT01327495|16549841|P3|Overall Study|Adverse Event|1
4799054|NCT01327495|16549842|P2|Overall Study|Adverse Event|1
4799055|NCT01327495|16549843|P1|Overall Study|Adverse Event|2
4799056|NCT01327482|16549935|P1|Overall Study|Adverse Event|1
4799057|NCT01327339|16549940|P1|Overall Study|Protocol Violation|8
4799058|NCT01327300|16550075|P2|Washout (3 Weeks)|Withdrawal by Subject|0
4799059|NCT01327300|16550076|P1|Washout (3 Weeks)|Withdrawal by Subject|1
4799060|NCT01327053|16550116|P2|Overall Study|Untreated|1
4799061|NCT01327053|16550117|P1|Overall Study|Untreated|0
4799062|NCT01327053|16550116|P2|Overall Study|Protocol Violation|1
4799063|NCT01327053|16550117|P1|Overall Study|Protocol Violation|0
4799064|NCT01327053|16550116|P2|Overall Study|Progressive disease|26
4799065|NCT01327053|16550117|P1|Overall Study|Progressive disease|31
4799066|NCT01327053|16550116|P2|Overall Study|Study terminated by Sponsor|3
4799067|NCT01327053|16550117|P1|Overall Study|Study terminated by Sponsor|1
4799068|NCT01327053|16550116|P2|Overall Study|Non-compliance with study treatment|5
4799069|NCT01327053|16550117|P1|Overall Study|Non-compliance with study treatment|0
4799070|NCT01327053|16550116|P2|Overall Study|Lost to Follow-up|4
4799071|NCT01327053|16550117|P1|Overall Study|Lost to Follow-up|2
4799072|NCT01327053|16550116|P2|Overall Study|Death|5
4799073|NCT01327053|16550117|P1|Overall Study|Death|1
4799074|NCT01327053|16550116|P2|Overall Study|Physician Decision|14
4799075|NCT01327053|16550117|P1|Overall Study|Physician Decision|10
4799076|NCT01327053|16550116|P2|Overall Study|Patient/guardian decision|35
4799077|NCT01327053|16550117|P1|Overall Study|Patient/guardian decision|11
4799078|NCT01327053|16550116|P2|Overall Study|Adverse Event|57
4799079|NCT01327053|16550117|P1|Overall Study|Adverse Event|23
4799080|NCT01326962|16550191|P1|Overall Study|Other|2
4799081|NCT01326962|16550191|P1|Overall Study|Lost to Follow-up|3
4799082|NCT01326962|16550191|P1|Overall Study|Withdrawal by Subject|1
4799083|NCT01326962|16550191|P1|Overall Study|Adverse Event|1
4799084|NCT01326910|16550214|P2|Overall Study|Protocol Violation|1
4799085|NCT01326910|16550215|P1|Overall Study|Protocol Violation|1
4799086|NCT01326910|16550214|P2|Overall Study|Withdrawal by Subject|2
4799087|NCT01326910|16550215|P1|Overall Study|Withdrawal by Subject|3
4799088|NCT01326845|16550229|P2|Overall Study|Misisng|3
4799089|NCT01326845|16550230|P1|Overall Study|Misisng|1
4799090|NCT01326845|16550229|P2|Overall Study|Adverse Event|0
4799091|NCT01326845|16550230|P1|Overall Study|Adverse Event|1
4799092|NCT01326845|16550229|P2|Overall Study|Administrative Problems|2
4799093|NCT01326845|16550230|P1|Overall Study|Administrative Problems|5
4799094|NCT01326728|16550291|P2|Overall Study|Early closure of study|9
4799095|NCT01326728|16550292|P1|Overall Study|Early closure of study|34
4799096|NCT01326728|16550291|P2|Overall Study|Death|0
4799097|NCT01326728|16550292|P1|Overall Study|Death|13
4799098|NCT01326702|16550316|P7|Overall Study|Not Treated|0
4799099|NCT01326702|16550317|P6|Overall Study|Not Treated|1
4799100|NCT01326702|16550318|P5|Overall Study|Not Treated|0
4799101|NCT01326702|16550319|P4|Overall Study|Not Treated|1
4799102|NCT01326702|16550320|P3|Overall Study|Not Treated|0
4799103|NCT01326702|16550321|P2|Overall Study|Not Treated|0
4799104|NCT01326702|16550322|P1|Overall Study|Not Treated|0
4799105|NCT01326702|16550316|P7|Overall Study|Withdrawal by Subject|3
4799106|NCT01326702|16550317|P6|Overall Study|Withdrawal by Subject|1
4799107|NCT01326702|16550318|P5|Overall Study|Withdrawal by Subject|1
4799108|NCT01326702|16550319|P4|Overall Study|Withdrawal by Subject|0
4799109|NCT01326702|16550320|P3|Overall Study|Withdrawal by Subject|1
4799110|NCT01326702|16550321|P2|Overall Study|Withdrawal by Subject|0
4799111|NCT01326702|16550322|P1|Overall Study|Withdrawal by Subject|0
4799112|NCT01326702|16550316|P7|Overall Study|Adverse Event|1
4799113|NCT01326702|16550317|P6|Overall Study|Adverse Event|3
4799114|NCT01326702|16550318|P5|Overall Study|Adverse Event|0
4799115|NCT01326702|16550319|P4|Overall Study|Adverse Event|1
4799116|NCT01326702|16550320|P3|Overall Study|Adverse Event|1
4799117|NCT01326702|16550321|P2|Overall Study|Adverse Event|0
4799118|NCT01326702|16550322|P1|Overall Study|Adverse Event|0
4799119|NCT01326702|16550316|P7|Overall Study|Death|0
4799120|NCT01326702|16550317|P6|Overall Study|Death|0
4799121|NCT01326702|16550318|P5|Overall Study|Death|0
4799122|NCT01326702|16550319|P4|Overall Study|Death|0
4799123|NCT01326702|16550320|P3|Overall Study|Death|0
4799124|NCT01326702|16550321|P2|Overall Study|Death|1
4799125|NCT01326702|16550322|P1|Overall Study|Death|0
4799126|NCT01326702|16550316|P7|Overall Study|progressive disease|3
4799127|NCT01326702|16550317|P6|Overall Study|progressive disease|2
4799128|NCT01326702|16550318|P5|Overall Study|progressive disease|3
4799129|NCT01326702|16550319|P4|Overall Study|progressive disease|1
4799130|NCT01326702|16550320|P3|Overall Study|progressive disease|3
4799131|NCT01326702|16550321|P2|Overall Study|progressive disease|1
4799132|NCT01326702|16550322|P1|Overall Study|progressive disease|1
4799133|NCT01326702|16550316|P7|Overall Study|Other|0
4799134|NCT01326702|16550317|P6|Overall Study|Other|1
4799135|NCT01326702|16550318|P5|Overall Study|Other|0
4799136|NCT01326702|16550319|P4|Overall Study|Other|0
4799137|NCT01326702|16550320|P3|Overall Study|Other|0
4799138|NCT01326702|16550321|P2|Overall Study|Other|0
4799139|NCT01326702|16550322|P1|Overall Study|Other|1
4799140|NCT01326546|16550378|P2|Overall Study|Withdrawal by Subject|1
4799141|NCT01326546|16550379|P1|Overall Study|Withdrawal by Subject|5
4799142|NCT01326546|16550378|P2|Overall Study|Adverse Event|0
4799143|NCT01326546|16550379|P1|Overall Study|Adverse Event|1
4799144|NCT01326546|16550378|P2|Overall Study|Pregnancy|1
4799145|NCT01326546|16550379|P1|Overall Study|Pregnancy|0
4799146|NCT01326546|16550378|P2|Overall Study|Protocol Violation|4
4799147|NCT01326546|16550379|P1|Overall Study|Protocol Violation|3
4799148|NCT01326546|16550378|P2|Overall Study|Lost to Follow-up|7
4799149|NCT01326546|16550379|P1|Overall Study|Lost to Follow-up|8
4799150|NCT01326533|16550387|P2|Overall Study|Adverse Event|0
4799151|NCT01326533|16550388|P1|Overall Study|Adverse Event|1
4799152|NCT01326533|16550387|P2|Overall Study|Withdrawal by Subject|0
4799153|NCT01326533|16550388|P1|Overall Study|Withdrawal by Subject|1
4799154|NCT01326533|16550387|P2|Overall Study|Lost to Follow-up|0
4799155|NCT01326533|16550388|P1|Overall Study|Lost to Follow-up|2
4799156|NCT01326481|16550396|P1|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1
4799157|NCT01326026|16550405|P2|Overall Study|Other|3
4799158|NCT01326026|16550406|P1|Overall Study|Other|3
4799159|NCT01326026|16550405|P2|Overall Study|Withdrawal Criteria|7
4799160|NCT01326026|16550406|P1|Overall Study|Withdrawal Criteria|5
4799161|NCT01326026|16550405|P2|Overall Study|Adverse Event|3
4799162|NCT01326026|16550406|P1|Overall Study|Adverse Event|4
4799163|NCT01325701|16550471|P2|Overall Study|Rollerover Extension Study|0
4799164|NCT01325701|16550472|P1|Overall Study|Rollerover Extension Study|4
4799165|NCT01325701|16550471|P2|Overall Study|Withdrawal by Subject|1
4799166|NCT01325701|16550472|P1|Overall Study|Withdrawal by Subject|2
4799167|NCT01325701|16550471|P2|Overall Study|Physician Decision|2
4799168|NCT01325701|16550472|P1|Overall Study|Physician Decision|2
4799169|NCT01325701|16550471|P2|Overall Study|Protocol Violation|0
4799170|NCT01325701|16550472|P1|Overall Study|Protocol Violation|1
4799171|NCT01325701|16550471|P2|Overall Study|Adverse Event|0
4799172|NCT01325701|16550472|P1|Overall Study|Adverse Event|12
4799173|NCT01325623|16550482|P1|Overall Study|Withdrawal by Subject|3
4799174|NCT01325584|16550524|P1|Overall Study|Death|1
4799175|NCT01325532|16550534|P2|Overall Study|Withdrawal by Subject|0
4799176|NCT01325532|16550535|P1|Overall Study|Withdrawal by Subject|2
4799177|NCT01325493|16550547|P2|Overall Study|Allergy|0
4799178|NCT01325493|16550548|P1|Overall Study|Allergy|1
4799179|NCT01325493|16550547|P2|Overall Study|loss of neuromonitoring signals|2
4799180|NCT01325493|16550548|P1|Overall Study|loss of neuromonitoring signals|0
4799181|NCT01325493|16550547|P2|Overall Study|Protocol Violation|1
4799182|NCT01325493|16550548|P1|Overall Study|Protocol Violation|0
4799183|NCT01325428|16550560|P1|Part B|Other reason not defined above|1
4799184|NCT01325428|16550560|P1|Part B|Refused continue taking trial medication|2
4799185|NCT01325428|16550560|P1|Part A|Other reason not defined above|2
4799186|NCT01325428|16550560|P1|Part A|Refused continue taking trial medication|2
4799187|NCT01325428|16550560|P1|Part A|Other adverse event|1
4799188|NCT01325428|16550560|P1|Part A|Clinical signs, symptoms of progression|2
4799189|NCT01325428|16550560|P1|Part A|Progressive disease according to RECIST|9
4799190|NCT01325350|16550580|P5|Overall Study|Did Not Receive Treatment|1
4799191|NCT01325350|16550581|P4|Overall Study|Did Not Receive Treatment|0
4799192|NCT01325350|16550582|P3|Overall Study|Did Not Receive Treatment|1
4799193|NCT01325350|16550583|P2|Overall Study|Did Not Receive Treatment|1
4799194|NCT01325350|16550584|P1|Overall Study|Did Not Receive Treatment|0
4799195|NCT01325350|16550580|P5|Overall Study|Withdrawal by Subject|0
4799196|NCT01325350|16550581|P4|Overall Study|Withdrawal by Subject|1
4799197|NCT01325350|16550582|P3|Overall Study|Withdrawal by Subject|1
4799198|NCT01325350|16550583|P2|Overall Study|Withdrawal by Subject|0
4799199|NCT01325350|16550584|P1|Overall Study|Withdrawal by Subject|0
4799200|NCT01325350|16550580|P5|Overall Study|Protocol Violation|0
4799201|NCT01325350|16550581|P4|Overall Study|Protocol Violation|1
4799202|NCT01325350|16550582|P3|Overall Study|Protocol Violation|0
4799203|NCT01325350|16550583|P2|Overall Study|Protocol Violation|0
4799204|NCT01325350|16550584|P1|Overall Study|Protocol Violation|0
4799205|NCT01325350|16550580|P5|Overall Study|Personal Reasons|3
4799206|NCT01325350|16550581|P4|Overall Study|Personal Reasons|5
4799207|NCT01325350|16550582|P3|Overall Study|Personal Reasons|6
4799208|NCT01325350|16550583|P2|Overall Study|Personal Reasons|1
4799209|NCT01325350|16550584|P1|Overall Study|Personal Reasons|2
4799210|NCT01325350|16550580|P5|Overall Study|Lost to Follow-up|5
4799211|NCT01325350|16550581|P4|Overall Study|Lost to Follow-up|1
4799212|NCT01325350|16550582|P3|Overall Study|Lost to Follow-up|5
4799213|NCT01325350|16550583|P2|Overall Study|Lost to Follow-up|0
4799214|NCT01325350|16550584|P1|Overall Study|Lost to Follow-up|1
4799215|NCT01325350|16550580|P5|Overall Study|Pregnancy|1
4799216|NCT01325350|16550581|P4|Overall Study|Pregnancy|0
4799217|NCT01325350|16550582|P3|Overall Study|Pregnancy|1
4799218|NCT01325350|16550583|P2|Overall Study|Pregnancy|0
4799219|NCT01325350|16550584|P1|Overall Study|Pregnancy|0
4799220|NCT01325350|16550580|P5|Overall Study|Adverse Event|2
4799221|NCT01325350|16550581|P4|Overall Study|Adverse Event|1
4799222|NCT01325350|16550582|P3|Overall Study|Adverse Event|3
4799223|NCT01325350|16550583|P2|Overall Study|Adverse Event|3
4799224|NCT01325350|16550584|P1|Overall Study|Adverse Event|3
4799225|NCT01325337|16550626|P5|Overall Study|Withdrawal by Subject|1
4799226|NCT01325337|16550627|P4|Overall Study|Withdrawal by Subject|0
4799227|NCT01325337|16550628|P3|Overall Study|Withdrawal by Subject|1
4799228|NCT01325337|16550629|P2|Overall Study|Withdrawal by Subject|0
4799229|NCT01325337|16550630|P1|Overall Study|Withdrawal by Subject|1
4799230|NCT01325337|16550626|P5|Overall Study|Personal Reasons|3
4799231|NCT01325337|16550627|P4|Overall Study|Personal Reasons|8
4799232|NCT01325337|16550628|P3|Overall Study|Personal Reasons|4
4799233|NCT01325337|16550629|P2|Overall Study|Personal Reasons|5
4799234|NCT01325337|16550630|P1|Overall Study|Personal Reasons|2
4799235|NCT01325337|16550626|P5|Overall Study|Lost to Follow-up|2
4799236|NCT01325337|16550627|P4|Overall Study|Lost to Follow-up|1
4799237|NCT01325337|16550628|P3|Overall Study|Lost to Follow-up|2
4799238|NCT01325337|16550629|P2|Overall Study|Lost to Follow-up|2
4799239|NCT01325337|16550630|P1|Overall Study|Lost to Follow-up|2
4799240|NCT01325337|16550626|P5|Overall Study|Adverse Event|2
4799241|NCT01325337|16550627|P4|Overall Study|Adverse Event|1
4799242|NCT01325337|16550628|P3|Overall Study|Adverse Event|2
4799243|NCT01325337|16550629|P2|Overall Study|Adverse Event|2
4799244|NCT01325337|16550630|P1|Overall Study|Adverse Event|0
4799245|NCT01325207|16550710|P6|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4799246|NCT01325207|16550711|P5|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1
4799247|NCT01325207|16550712|P4|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4799248|NCT01325207|16550713|P3|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4799249|NCT01325207|16550714|P2|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4799250|NCT01325207|16550715|P1|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0
4799251|NCT01325207|16550710|P6|Follow-up Every 3 Months Until Death|Lost to Follow-up|1
4799252|NCT01325207|16550711|P5|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4799253|NCT01325207|16550712|P4|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4799254|NCT01325207|16550713|P3|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4799255|NCT01325207|16550714|P2|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4799256|NCT01325207|16550715|P1|Follow-up Every 3 Months Until Death|Lost to Follow-up|0
4799257|NCT01325207|16550710|P6|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1
4799258|NCT01325207|16550711|P5|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4799259|NCT01325207|16550712|P4|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4799260|NCT01325207|16550713|P3|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4799261|NCT01325207|16550714|P2|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4799262|NCT01325207|16550715|P1|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0
4799263|NCT01325207|16550710|P6|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4799264|NCT01325207|16550711|P5|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4799265|NCT01325207|16550712|P4|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4799266|NCT01325207|16550713|P3|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4799267|NCT01325207|16550714|P2|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1
4799268|NCT01325207|16550715|P1|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0
4799269|NCT01325207|16550710|P6|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4
4799270|NCT01325207|16550711|P5|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0
4799271|NCT01325207|16550712|P4|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4799272|NCT01325207|16550713|P3|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4799273|NCT01325207|16550714|P2|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4799274|NCT01325207|16550715|P1|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1
4799275|NCT01325207|16550710|P6|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5
4799276|NCT01325207|16550711|P5|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2
4799277|NCT01325207|16550712|P4|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
4799278|NCT01325207|16550713|P3|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0
4799279|NCT01325207|16550714|P2|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
4799280|NCT01325207|16550715|P1|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1
4799281|NCT01325207|16550710|P6|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4799282|NCT01325207|16550711|P5|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2
4799283|NCT01325207|16550712|P4|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4799284|NCT01325207|16550713|P3|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4799285|NCT01325207|16550714|P2|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4799286|NCT01325207|16550715|P1|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0
4799287|NCT01324999|16550747|P1|Overall Study|Withdrawal by Subject|2
4799288|NCT01324999|16550747|P1|Overall Study|Adverse Event|3
4799289|NCT01324947|16550758|P1|Overall Study|1 discontinued before starting drug|1
4799290|NCT01324947|16550758|P1|Overall Study|Withdrawal by Subject|3
4799291|NCT01324947|16550758|P1|Overall Study|Progressive Disease|50
4799292|NCT01324947|16550758|P1|Overall Study|Other|3
4799293|NCT01324947|16550758|P1|Overall Study|Death|10
4799294|NCT01324947|16550758|P1|Overall Study|Adverse Event|7
4799295|NCT01324830|16550799|P19|Overall Study|Withdrawal by Subject|1
4799296|NCT01324830|16550800|P18|Overall Study|Withdrawal by Subject|0
4799297|NCT01324830|16550801|P17|Overall Study|Withdrawal by Subject|0
4799298|NCT01324830|16550802|P16|Overall Study|Withdrawal by Subject|0
4799299|NCT01324830|16550803|P15|Overall Study|Withdrawal by Subject|0
4799300|NCT01324830|16550804|P14|Overall Study|Withdrawal by Subject|0
4799301|NCT01324830|16550805|P13|Overall Study|Withdrawal by Subject|0
4799302|NCT01324830|16550806|P12|Overall Study|Withdrawal by Subject|0
4799303|NCT01324830|16550807|P11|Overall Study|Withdrawal by Subject|1
4799304|NCT01324830|16550808|P10|Overall Study|Withdrawal by Subject|0
4799305|NCT01324830|16550809|P9|Overall Study|Withdrawal by Subject|0
4799306|NCT01324830|16550810|P8|Overall Study|Withdrawal by Subject|0
4799307|NCT01324830|16550811|P7|Overall Study|Withdrawal by Subject|0
4799308|NCT01324830|16550812|P6|Overall Study|Withdrawal by Subject|1
4799309|NCT01324830|16550813|P5|Overall Study|Withdrawal by Subject|0
4799310|NCT01324830|16550814|P4|Overall Study|Withdrawal by Subject|0
4799311|NCT01324830|16550815|P3|Overall Study|Withdrawal by Subject|0
4799312|NCT01324830|16550816|P2|Overall Study|Withdrawal by Subject|0
4799313|NCT01324830|16550817|P1|Overall Study|Withdrawal by Subject|0
4799314|NCT01324830|16550799|P19|Overall Study|Adverse Event, non-fatal|0
4799315|NCT01324830|16550800|P18|Overall Study|Adverse Event, non-fatal|1
4799316|NCT01324830|16550801|P17|Overall Study|Adverse Event, non-fatal|0
4799317|NCT01324830|16550802|P16|Overall Study|Adverse Event, non-fatal|0
4799318|NCT01324830|16550803|P15|Overall Study|Adverse Event, non-fatal|0
4799319|NCT01324830|16550804|P14|Overall Study|Adverse Event, non-fatal|0
4799320|NCT01324830|16550805|P13|Overall Study|Adverse Event, non-fatal|0
4799321|NCT01324830|16550806|P12|Overall Study|Adverse Event, non-fatal|0
4799322|NCT01324830|16550807|P11|Overall Study|Adverse Event, non-fatal|1
4799323|NCT01324830|16550808|P10|Overall Study|Adverse Event, non-fatal|0
4799324|NCT01324830|16550809|P9|Overall Study|Adverse Event, non-fatal|2
4799325|NCT01324830|16550810|P8|Overall Study|Adverse Event, non-fatal|0
4799326|NCT01324830|16550811|P7|Overall Study|Adverse Event, non-fatal|0
4799327|NCT01324830|16550812|P6|Overall Study|Adverse Event, non-fatal|0
4799328|NCT01324830|16550813|P5|Overall Study|Adverse Event, non-fatal|0
4799329|NCT01324830|16550814|P4|Overall Study|Adverse Event, non-fatal|0
4799330|NCT01324830|16550815|P3|Overall Study|Adverse Event, non-fatal|0
4799331|NCT01324830|16550816|P2|Overall Study|Adverse Event, non-fatal|0
4799332|NCT01324830|16550817|P1|Overall Study|Adverse Event, non-fatal|0
4799333|NCT01324830|16550799|P19|Overall Study|Adverse Event, serious fatal|0
4799334|NCT01324830|16550800|P18|Overall Study|Adverse Event, serious fatal|0
4799335|NCT01324830|16550801|P17|Overall Study|Adverse Event, serious fatal|0
4799336|NCT01324830|16550802|P16|Overall Study|Adverse Event, serious fatal|0
4799337|NCT01324830|16550803|P15|Overall Study|Adverse Event, serious fatal|0
4799338|NCT01324830|16550804|P14|Overall Study|Adverse Event, serious fatal|0
4799339|NCT01324830|16550805|P13|Overall Study|Adverse Event, serious fatal|0
4799340|NCT01324830|16550806|P12|Overall Study|Adverse Event, serious fatal|0
4799341|NCT01324830|16550807|P11|Overall Study|Adverse Event, serious fatal|0
4799342|NCT01324830|16550808|P10|Overall Study|Adverse Event, serious fatal|0
4799343|NCT01324830|16550809|P9|Overall Study|Adverse Event, serious fatal|0
4799344|NCT01324830|16550810|P8|Overall Study|Adverse Event, serious fatal|0
4799345|NCT01324830|16550811|P7|Overall Study|Adverse Event, serious fatal|0
4799346|NCT01324830|16550812|P6|Overall Study|Adverse Event, serious fatal|0
4799347|NCT01324830|16550813|P5|Overall Study|Adverse Event, serious fatal|0
4799348|NCT01324830|16550814|P4|Overall Study|Adverse Event, serious fatal|0
4799349|NCT01324830|16550815|P3|Overall Study|Adverse Event, serious fatal|0
4799350|NCT01324830|16550816|P2|Overall Study|Adverse Event, serious fatal|1
4799351|NCT01324830|16550817|P1|Overall Study|Adverse Event, serious fatal|0
4799352|NCT01324830|16550799|P19|Overall Study|Reason not mentioned above|0
4799353|NCT01324830|16550800|P18|Overall Study|Reason not mentioned above|1
4799354|NCT01324830|16550801|P17|Overall Study|Reason not mentioned above|0
4799355|NCT01324830|16550802|P16|Overall Study|Reason not mentioned above|0
4799356|NCT01324830|16550803|P15|Overall Study|Reason not mentioned above|0
4799357|NCT01324830|16550804|P14|Overall Study|Reason not mentioned above|0
4799358|NCT01324830|16550805|P13|Overall Study|Reason not mentioned above|0
4799359|NCT01324830|16550806|P12|Overall Study|Reason not mentioned above|0
4799360|NCT01324830|16550807|P11|Overall Study|Reason not mentioned above|0
4799361|NCT01324830|16550808|P10|Overall Study|Reason not mentioned above|0
4799362|NCT01324830|16550809|P9|Overall Study|Reason not mentioned above|0
4799363|NCT01324830|16550810|P8|Overall Study|Reason not mentioned above|0
4799364|NCT01324830|16550811|P7|Overall Study|Reason not mentioned above|0
4799365|NCT01324830|16550812|P6|Overall Study|Reason not mentioned above|0
4799366|NCT01324830|16550813|P5|Overall Study|Reason not mentioned above|0
4799367|NCT01324830|16550814|P4|Overall Study|Reason not mentioned above|0
4799368|NCT01324830|16550815|P3|Overall Study|Reason not mentioned above|0
4799369|NCT01324830|16550816|P2|Overall Study|Reason not mentioned above|0
4799370|NCT01324830|16550817|P1|Overall Study|Reason not mentioned above|0
4799371|NCT01324830|16550799|P19|Overall Study|Dose limiting toxicity|1
4799372|NCT01324830|16550800|P18|Overall Study|Dose limiting toxicity|1
4799373|NCT01324830|16550801|P17|Overall Study|Dose limiting toxicity|1
4799374|NCT01324830|16550802|P16|Overall Study|Dose limiting toxicity|0
4799375|NCT01324830|16550803|P15|Overall Study|Dose limiting toxicity|0
4799376|NCT01324830|16550804|P14|Overall Study|Dose limiting toxicity|0
4799377|NCT01324830|16550805|P13|Overall Study|Dose limiting toxicity|0
4799378|NCT01324830|16550806|P12|Overall Study|Dose limiting toxicity|0
4799379|NCT01324830|16550807|P11|Overall Study|Dose limiting toxicity|0
4799380|NCT01324830|16550808|P10|Overall Study|Dose limiting toxicity|0
4799381|NCT01324830|16550809|P9|Overall Study|Dose limiting toxicity|0
4799382|NCT01324830|16550810|P8|Overall Study|Dose limiting toxicity|0
4799383|NCT01324830|16550811|P7|Overall Study|Dose limiting toxicity|0
4799384|NCT01324830|16550812|P6|Overall Study|Dose limiting toxicity|0
4799385|NCT01324830|16550813|P5|Overall Study|Dose limiting toxicity|1
4799386|NCT01324830|16550814|P4|Overall Study|Dose limiting toxicity|0
4799387|NCT01324830|16550815|P3|Overall Study|Dose limiting toxicity|0
4799388|NCT01324830|16550816|P2|Overall Study|Dose limiting toxicity|0
4799389|NCT01324830|16550817|P1|Overall Study|Dose limiting toxicity|0
4799390|NCT01324830|16550799|P19|Overall Study|Progressive Disease|4
4799391|NCT01324830|16550800|P18|Overall Study|Progressive Disease|3
4799392|NCT01324830|16550801|P17|Overall Study|Progressive Disease|2
4799393|NCT01324830|16550802|P16|Overall Study|Progressive Disease|3
4799394|NCT01324830|16550803|P15|Overall Study|Progressive Disease|1
4799395|NCT01324830|16550804|P14|Overall Study|Progressive Disease|1
4799396|NCT01324830|16550805|P13|Overall Study|Progressive Disease|1
4799397|NCT01324830|16550806|P12|Overall Study|Progressive Disease|1
4799398|NCT01324830|16550807|P11|Overall Study|Progressive Disease|2
4799399|NCT01324830|16550808|P10|Overall Study|Progressive Disease|6
4799400|NCT01324830|16550809|P9|Overall Study|Progressive Disease|3
4799401|NCT01324830|16550810|P8|Overall Study|Progressive Disease|3
4799402|NCT01324830|16550811|P7|Overall Study|Progressive Disease|3
4799403|NCT01324830|16550812|P6|Overall Study|Progressive Disease|6
4799404|NCT01324830|16550813|P5|Overall Study|Progressive Disease|6
4799405|NCT01324830|16550814|P4|Overall Study|Progressive Disease|3
4799406|NCT01324830|16550815|P3|Overall Study|Progressive Disease|3
4799407|NCT01324830|16550816|P2|Overall Study|Progressive Disease|2
4799408|NCT01324830|16550817|P1|Overall Study|Progressive Disease|3
4799409|NCT01324622|16550963|P2|Overall Study|Lack of Efficacy|0
4799410|NCT01324622|16550964|P1|Overall Study|Lack of Efficacy|1
4799411|NCT01324622|16550963|P2|Overall Study|Death|0
4799412|NCT01324622|16550964|P1|Overall Study|Death|1
4799413|NCT01324622|16550963|P2|Overall Study|Lost to Follow-up|7
4799414|NCT01324622|16550964|P1|Overall Study|Lost to Follow-up|7
4799415|NCT01324570|16550994|P2|Overall Study|Administrative|2
4799416|NCT01324570|16550995|P1|Overall Study|Administrative|0
4799417|NCT01324570|16550994|P2|Overall Study|Confirmed or suspected diversion|1
4799418|NCT01324570|16550995|P1|Overall Study|Confirmed or suspected diversion|0
4799419|NCT01324570|16550994|P2|Overall Study|Lack of Efficacy|1
4799420|NCT01324570|16550995|P1|Overall Study|Lack of Efficacy|0
4799421|NCT01324570|16550994|P2|Overall Study|Withdrawal by Subject|3
4799422|NCT01324570|16550995|P1|Overall Study|Withdrawal by Subject|0
4799423|NCT01324570|16550994|P2|Overall Study|Adverse Event|7
4799424|NCT01324570|16550995|P1|Overall Study|Adverse Event|4
4799425|NCT01324440|16551032|P2|Overall Study|Subject moved|1
4799426|NCT01324440|16551033|P1|Overall Study|Subject moved|0
4799427|NCT01324401|16551047|P2|Overall Study|Adverse Event|3
4799428|NCT01324401|16551048|P1|Overall Study|Adverse Event|1
4799429|NCT01324401|16551047|P2|Overall Study|Withdrawn before any treatment|3
4799430|NCT01324401|16551048|P1|Overall Study|Withdrawn before any treatment|0
4799431|NCT01324388|16551059|P4|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
4799432|NCT01324388|16551060|P3|Part 2 of Study: Second Intervention|Withdrawal by Subject|1
4799433|NCT01324388|16551061|P2|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
4799434|NCT01324388|16551062|P1|Part 2 of Study: Second Intervention|Withdrawal by Subject|0
4799435|NCT01324388|16551059|P4|Part 2 of Study: First Intervention|Protocol Violation|1
4799436|NCT01324388|16551060|P3|Part 2 of Study: First Intervention|Protocol Violation|0
4799437|NCT01324388|16551061|P2|Part 2 of Study: First Intervention|Protocol Violation|0
4799438|NCT01324388|16551062|P1|Part 2 of Study: First Intervention|Protocol Violation|0
4799439|NCT01324388|16551059|P4|Part 1 of Study|Physician Decision|0
4799440|NCT01324388|16551060|P3|Part 1 of Study|Physician Decision|0
4799441|NCT01324388|16551061|P2|Part 1 of Study|Physician Decision|0
4799442|NCT01324388|16551062|P1|Part 1 of Study|Physician Decision|1
4799443|NCT01324388|16551059|P4|Part 1 of Study|Protocol Violation|0
4799444|NCT01324388|16551060|P3|Part 1 of Study|Protocol Violation|0
4799445|NCT01324388|16551061|P2|Part 1 of Study|Protocol Violation|2
4799446|NCT01324388|16551062|P1|Part 1 of Study|Protocol Violation|1
4799447|NCT01324388|16551059|P4|Part 1 of Study|Adverse Event|0
4799448|NCT01324388|16551060|P3|Part 1 of Study|Adverse Event|0
4799449|NCT01324388|16551061|P2|Part 1 of Study|Adverse Event|0
4799450|NCT01324388|16551062|P1|Part 1 of Study|Adverse Event|2
4799451|NCT01324349|16551083|P2|Overall Study|Withdrawal by Subject|1
4799452|NCT01324349|16551084|P1|Overall Study|Withdrawal by Subject|0
4799453|NCT01324349|16551083|P2|Overall Study|Death|1
4799454|NCT01324349|16551084|P1|Overall Study|Death|1
4799455|NCT01324323|16551094|P1|Overall Study|Withdrawal by Subject|1
4799456|NCT01324310|16551114|P1|Overall Study|Disease Progression|1
4799457|NCT01324310|16551114|P1|Overall Study|Adverse Event|1
4799458|NCT01324271|16551134|P2|Overall Study|Physician Decision|0
4799459|NCT01324271|16551135|P1|Overall Study|Physician Decision|1
4799460|NCT01324271|16551134|P2|Overall Study|Lost to Follow-up|0
4799461|NCT01324271|16551135|P1|Overall Study|Lost to Follow-up|3
4799462|NCT01324102|16551158|P2|Overall Study|illness|6
4799463|NCT01324102|16551159|P1|Overall Study|illness|1
4799464|NCT01324024|16551166|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4799465|NCT01324024|16551167|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|2
4799466|NCT01323972|16551205|P4|Overall Study|Lost to Follow-up|1
4799467|NCT01323972|16551206|P3|Overall Study|Lost to Follow-up|1
4799468|NCT01323972|16551207|P2|Overall Study|Lost to Follow-up|1
4799469|NCT01323972|16551208|P1|Overall Study|Lost to Follow-up|0
4799470|NCT01323972|16551205|P4|Overall Study|Migrated/moved from study area|0
4799471|NCT01323972|16551206|P3|Overall Study|Migrated/moved from study area|0
4799472|NCT01323972|16551207|P2|Overall Study|Migrated/moved from study area|2
4799473|NCT01323972|16551208|P1|Overall Study|Migrated/moved from study area|1
4799474|NCT01323972|16551205|P4|Overall Study|Withdrawal by Subject|0
4799475|NCT01323972|16551206|P3|Overall Study|Withdrawal by Subject|1
4799476|NCT01323972|16551207|P2|Overall Study|Withdrawal by Subject|0
4799477|NCT01323972|16551208|P1|Overall Study|Withdrawal by Subject|1
4799478|NCT01323946|16551304|P3|Overall Study|Withdrawal by Subject|0
4799479|NCT01323946|16551305|P2|Overall Study|Withdrawal by Subject|2
4799480|NCT01323946|16551306|P1|Overall Study|Withdrawal by Subject|2
4799481|NCT01323946|16551304|P3|Overall Study|Parents refused the last blood draw|0
4799482|NCT01323946|16551305|P2|Overall Study|Parents refused the last blood draw|0
4799483|NCT01323946|16551306|P1|Overall Study|Parents refused the last blood draw|1
4799484|NCT01323946|16551304|P3|Overall Study|Lost to Follow-up|0
4799485|NCT01323946|16551305|P2|Overall Study|Lost to Follow-up|1
4799486|NCT01323946|16551306|P1|Overall Study|Lost to Follow-up|0
4799487|NCT01323920|16551427|P1|Overall Study|Withdrawal by Subject|1
4799488|NCT01323920|16551427|P1|Overall Study|Death|5
4799489|NCT01323790|16551468|P3|Overall Study|Severe non-compliance with protocol|2
4799490|NCT01323790|16551469|P2|Overall Study|Severe non-compliance with protocol|2
4799491|NCT01323790|16551470|P1|Overall Study|Severe non-compliance with protocol|2
4799492|NCT01323790|16551468|P3|Overall Study|Did Not Receive Treatment|1
4799493|NCT01323790|16551469|P2|Overall Study|Did Not Receive Treatment|0
4799494|NCT01323790|16551470|P1|Overall Study|Did Not Receive Treatment|2
4799495|NCT01323790|16551468|P3|Overall Study|Withdrawal by Subject|13
4799496|NCT01323790|16551469|P2|Overall Study|Withdrawal by Subject|20
4799497|NCT01323790|16551470|P1|Overall Study|Withdrawal by Subject|23
4799498|NCT01323790|16551468|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
4799499|NCT01323790|16551469|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
4799500|NCT01323790|16551470|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
4799501|NCT01323790|16551468|P3|Overall Study|Adverse Event|12
4799502|NCT01323790|16551469|P2|Overall Study|Adverse Event|24
4799503|NCT01323790|16551470|P1|Overall Study|Adverse Event|11
4799504|NCT01323790|16551468|P3|Overall Study|Lack of Efficacy|3
4799505|NCT01323790|16551469|P2|Overall Study|Lack of Efficacy|0
4799506|NCT01323790|16551470|P1|Overall Study|Lack of Efficacy|3
4799507|NCT01323790|16551468|P3|Overall Study|Study-Specific Withdrawal Criteria|3
4799508|NCT01323790|16551469|P2|Overall Study|Study-Specific Withdrawal Criteria|3
4799509|NCT01323790|16551470|P1|Overall Study|Study-Specific Withdrawal Criteria|0
4799510|NCT01323790|16551468|P3|Overall Study|Lost to Follow-up|9
4799511|NCT01323790|16551469|P2|Overall Study|Lost to Follow-up|9
4799512|NCT01323790|16551470|P1|Overall Study|Lost to Follow-up|11
4799513|NCT01323790|16551468|P3|Overall Study|Other|1
4799514|NCT01323790|16551469|P2|Overall Study|Other|2
4799515|NCT01323790|16551470|P1|Overall Study|Other|3
4799516|NCT01323673|16551521|P2|Overall Study|Withdrawal by Subject|3
4799517|NCT01323673|16551522|P1|Overall Study|Withdrawal by Subject|2
4799518|NCT01323673|16551521|P2|Overall Study|Protocol Violation|0
4799519|NCT01323673|16551522|P1|Overall Study|Protocol Violation|1
4799520|NCT01323673|16551521|P2|Overall Study|Lost to Follow-up|1
4799521|NCT01323673|16551522|P1|Overall Study|Lost to Follow-up|0
4799522|NCT01323673|16551521|P2|Overall Study|Adverse Event|1
4799523|NCT01323673|16551522|P1|Overall Study|Adverse Event|0
4799524|NCT01323660|16551542|P6|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4799525|NCT01323660|16551543|P5|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2
4799526|NCT01323660|16551544|P4|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0
4799527|NCT01323660|16551545|P3|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4799528|NCT01323660|16551546|P2|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4799529|NCT01323660|16551547|P1|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1
4799530|NCT01323660|16551542|P6|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4799531|NCT01323660|16551543|P5|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4799532|NCT01323660|16551544|P4|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4799533|NCT01323660|16551545|P3|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4799534|NCT01323660|16551546|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0
4799535|NCT01323660|16551547|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1
4799536|NCT01323660|16551542|P6|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1
4799537|NCT01323660|16551543|P5|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4799538|NCT01323660|16551544|P4|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4799539|NCT01323660|16551545|P3|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4799540|NCT01323660|16551546|P2|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4799541|NCT01323660|16551547|P1|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0
4799542|NCT01323660|16551542|P6|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3
4799543|NCT01323660|16551543|P5|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1
4799544|NCT01323660|16551544|P4|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
4799545|NCT01323660|16551545|P3|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2
4799546|NCT01323660|16551546|P2|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0
4799547|NCT01323660|16551547|P1|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9
4799548|NCT01323660|16551542|P6|Treatment Period 2 (12 Weeks)|Adverse Event|2
4799549|NCT01323660|16551543|P5|Treatment Period 2 (12 Weeks)|Adverse Event|1
4799550|NCT01323660|16551544|P4|Treatment Period 2 (12 Weeks)|Adverse Event|1
4799551|NCT01323660|16551545|P3|Treatment Period 2 (12 Weeks)|Adverse Event|0
4799552|NCT01323660|16551546|P2|Treatment Period 2 (12 Weeks)|Adverse Event|0
4799553|NCT01323660|16551547|P1|Treatment Period 2 (12 Weeks)|Adverse Event|1
4799554|NCT01323660|16551542|P6|Washout Period (14 Days)|Lack of Efficacy|2
4799555|NCT01323660|16551543|P5|Washout Period (14 Days)|Lack of Efficacy|2
4799556|NCT01323660|16551544|P4|Washout Period (14 Days)|Lack of Efficacy|3
4799557|NCT01323660|16551545|P3|Washout Period (14 Days)|Lack of Efficacy|1
4799558|NCT01323660|16551546|P2|Washout Period (14 Days)|Lack of Efficacy|0
4799559|NCT01323660|16551547|P1|Washout Period (14 Days)|Lack of Efficacy|0
4799560|NCT01323660|16551542|P6|Washout Period (14 Days)|Adverse Event|0
4799561|NCT01323660|16551543|P5|Washout Period (14 Days)|Adverse Event|1
4799562|NCT01323660|16551544|P4|Washout Period (14 Days)|Adverse Event|0
4799563|NCT01323660|16551545|P3|Washout Period (14 Days)|Adverse Event|0
4799564|NCT01323660|16551546|P2|Washout Period (14 Days)|Adverse Event|0
4799565|NCT01323660|16551547|P1|Washout Period (14 Days)|Adverse Event|0
4799566|NCT01323660|16551542|P6|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4799567|NCT01323660|16551543|P5|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3
4799568|NCT01323660|16551544|P4|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4799569|NCT01323660|16551545|P3|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1
4799570|NCT01323660|16551546|P2|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0
4799571|NCT01323660|16551547|P1|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5
4799572|NCT01323660|16551542|P6|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4799573|NCT01323660|16551543|P5|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4799574|NCT01323660|16551544|P4|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4799575|NCT01323660|16551545|P3|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4799576|NCT01323660|16551546|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4799577|NCT01323660|16551547|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4799578|NCT01323660|16551542|P6|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4799579|NCT01323660|16551543|P5|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1
4799580|NCT01323660|16551544|P4|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4799581|NCT01323660|16551545|P3|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4799582|NCT01323660|16551546|P2|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4799583|NCT01323660|16551547|P1|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0
4799584|NCT01323660|16551542|P6|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4799585|NCT01323660|16551543|P5|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4799586|NCT01323660|16551544|P4|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4799587|NCT01323660|16551545|P3|Treatment Period 1 (12 Weeks)|Protocol Violation|1
4799588|NCT01323660|16551546|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|0
4799589|NCT01323660|16551547|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4799590|NCT01323660|16551542|P6|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3
4799591|NCT01323660|16551543|P5|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1
4799592|NCT01323660|16551544|P4|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
4799593|NCT01323660|16551545|P3|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2
4799594|NCT01323660|16551546|P2|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0
4799595|NCT01323660|16551547|P1|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6
4799596|NCT01323660|16551542|P6|Treatment Period 1 (12 Weeks)|Adverse Event|4
4799597|NCT01323660|16551543|P5|Treatment Period 1 (12 Weeks)|Adverse Event|3
4799598|NCT01323660|16551544|P4|Treatment Period 1 (12 Weeks)|Adverse Event|3
4799599|NCT01323660|16551545|P3|Treatment Period 1 (12 Weeks)|Adverse Event|1
4799600|NCT01323660|16551546|P2|Treatment Period 1 (12 Weeks)|Adverse Event|1
4799601|NCT01323660|16551547|P1|Treatment Period 1 (12 Weeks)|Adverse Event|6
4799602|NCT01323647|16551593|P2|Overall Study|Lost to Follow-up|0
4799603|NCT01323647|16551594|P1|Overall Study|Lost to Follow-up|2
4799604|NCT01323647|16551593|P2|Overall Study|Withdrawal by Subject|0
4799605|NCT01323647|16551594|P1|Overall Study|Withdrawal by Subject|5
4799606|NCT01323647|16551593|P2|Overall Study|Migrated/moved from study area|0
4799607|NCT01323647|16551594|P1|Overall Study|Migrated/moved from study area|2
4799608|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
4799609|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1
4799610|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0
4799611|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4
4799612|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7
4799613|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0
4799614|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Physician Decision|3
4799615|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Physician Decision|2
4799616|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Physician Decision|0
4799617|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4799618|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Lost to Follow-up|1
4799619|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Lost to Follow-up|0
4799620|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Protocol Violation|7
4799621|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Protocol Violation|6
4799622|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Protocol Violation|0
4799623|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Lack of Efficacy|2
4799624|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4799625|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Lack of Efficacy|0
4799626|NCT01323634|16551611|P3|Double-Blind (DB) Treatment Period|Adverse Event|4
4799627|NCT01323634|16551612|P2|Double-Blind (DB) Treatment Period|Adverse Event|8
4799628|NCT01323634|16551613|P1|Double-Blind (DB) Treatment Period|Adverse Event|0
4799629|NCT01323634|16551611|P3|2-week Run-in Period|Adverse Event|0
4799630|NCT01323634|16551612|P2|2-week Run-in Period|Adverse Event|0
4799631|NCT01323634|16551613|P1|2-week Run-in Period|Adverse Event|1
4799632|NCT01323634|16551611|P3|2-week Run-in Period|Protocol Violation|0
4799633|NCT01323634|16551612|P2|2-week Run-in Period|Protocol Violation|0
4799634|NCT01323634|16551613|P1|2-week Run-in Period|Protocol Violation|1
4799635|NCT01323634|16551611|P3|2-week Run-in Period|Physician Decision|0
4799636|NCT01323634|16551612|P2|2-week Run-in Period|Physician Decision|0
4799637|NCT01323634|16551613|P1|2-week Run-in Period|Physician Decision|5
4799638|NCT01323634|16551611|P3|2-week Run-in Period|Withdrawal by Subject|0
4799639|NCT01323634|16551612|P2|2-week Run-in Period|Withdrawal by Subject|0
4799640|NCT01323634|16551613|P1|2-week Run-in Period|Withdrawal by Subject|7
4799641|NCT01323634|16551611|P3|2-week Run-in Period|Continuation Criteria not Met|0
4799642|NCT01323634|16551612|P2|2-week Run-in Period|Continuation Criteria not Met|0
4799643|NCT01323634|16551613|P1|2-week Run-in Period|Continuation Criteria not Met|73
4799644|NCT01323634|16551611|P3|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
4799645|NCT01323634|16551612|P2|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0
4799646|NCT01323634|16551613|P1|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125
4799647|NCT01323621|16551623|P3|12-week, Double-blind Treatment Period|Withdrawal by Subject|4
4799648|NCT01323621|16551624|P2|12-week, Double-blind Treatment Period|Withdrawal by Subject|5
4799649|NCT01323621|16551625|P1|12-week, Double-blind Treatment Period|Withdrawal by Subject|0
4799650|NCT01323621|16551623|P3|12-week, Double-blind Treatment Period|Physician Decision|1
4799651|NCT01323621|16551624|P2|12-week, Double-blind Treatment Period|Physician Decision|2
4799652|NCT01323621|16551625|P1|12-week, Double-blind Treatment Period|Physician Decision|0
4799653|NCT01323621|16551623|P3|12-week, Double-blind Treatment Period|Lost to Follow-up|0
4799654|NCT01323621|16551624|P2|12-week, Double-blind Treatment Period|Lost to Follow-up|1
4799655|NCT01323621|16551625|P1|12-week, Double-blind Treatment Period|Lost to Follow-up|0
4799656|NCT01323621|16551623|P3|12-week, Double-blind Treatment Period|Protocol Violation|4
4799657|NCT01323621|16551624|P2|12-week, Double-blind Treatment Period|Protocol Violation|4
4799658|NCT01323621|16551625|P1|12-week, Double-blind Treatment Period|Protocol Violation|0
4799659|NCT01323621|16551623|P3|12-week, Double-blind Treatment Period|Lack of Efficacy|6
4799660|NCT01323621|16551624|P2|12-week, Double-blind Treatment Period|Lack of Efficacy|2
4799661|NCT01323621|16551625|P1|12-week, Double-blind Treatment Period|Lack of Efficacy|0
4799662|NCT01323621|16551623|P3|12-week, Double-blind Treatment Period|Adverse Event|5
4799663|NCT01323621|16551624|P2|12-week, Double-blind Treatment Period|Adverse Event|1
4799664|NCT01323621|16551625|P1|12-week, Double-blind Treatment Period|Adverse Event|0
4799665|NCT01323621|16551623|P3|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
4799666|NCT01323621|16551624|P2|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0
4799667|NCT01323621|16551625|P1|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86
4799668|NCT01323621|16551623|P3|2-week, Single-blind Run In Period|Lost to Follow-up|0
4799669|NCT01323621|16551624|P2|2-week, Single-blind Run In Period|Lost to Follow-up|0
4799670|NCT01323621|16551625|P1|2-week, Single-blind Run In Period|Lost to Follow-up|1
4799671|NCT01323621|16551623|P3|2-week, Single-blind Run In Period|Protocol Violation|0
4799672|NCT01323621|16551624|P2|2-week, Single-blind Run In Period|Protocol Violation|0
4799673|NCT01323621|16551625|P1|2-week, Single-blind Run In Period|Protocol Violation|1
4799674|NCT01323621|16551623|P3|2-week, Single-blind Run In Period|Withdrawal by Subject|0
4799675|NCT01323621|16551624|P2|2-week, Single-blind Run In Period|Withdrawal by Subject|0
4799676|NCT01323621|16551625|P1|2-week, Single-blind Run In Period|Withdrawal by Subject|12
4799677|NCT01323621|16551623|P3|2-week, Single-blind Run In Period|Physician Decision|0
4799678|NCT01323621|16551624|P2|2-week, Single-blind Run In Period|Physician Decision|0
4799679|NCT01323621|16551625|P1|2-week, Single-blind Run In Period|Physician Decision|7
4799680|NCT01323621|16551623|P3|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
4799681|NCT01323621|16551624|P2|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0
4799682|NCT01323621|16551625|P1|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121
4799683|NCT01323582|16551646|P2|Weeks 8-11 (Period 2)|Withdrawal by Subject|1
4799684|NCT01323582|16551647|P1|Weeks 8-11 (Period 2)|Withdrawal by Subject|0
4799685|NCT01323582|16551646|P2|Weeks 5-7 (Washout)|Withdrawal by Subject|1
4799686|NCT01323582|16551647|P1|Weeks 5-7 (Washout)|Withdrawal by Subject|0
4799687|NCT01323582|16551646|P2|Weeks 1-4 (First Period)|Withdrawal by Subject|2
4799688|NCT01323582|16551647|P1|Weeks 1-4 (First Period)|Withdrawal by Subject|2
4799689|NCT01323478|16551670|P1|Overall Study|Administrative or Other Reasons|8
4799690|NCT01323478|16551670|P1|Overall Study|Withdrawal of Consent|1
4799691|NCT01323478|16551670|P1|Overall Study|Protocol Violation|1
4799692|NCT01323478|16551670|P1|Overall Study|Non-compliance With Study Product|3
4799693|NCT01323478|16551670|P1|Overall Study|Lack of Efficacy|4
4799694|NCT01323478|16551670|P1|Overall Study|Adverse Event|7
4799695|NCT01323387|16551683|P1|Overall Study|Randomized but Never Treated|16
4799696|NCT01323387|16551683|P1|Overall Study|Protocol Violation|12
4799697|NCT01323387|16551683|P1|Overall Study|Revision|14
4799698|NCT01323387|16551683|P1|Overall Study|Radiographic Data Unavailable|1
4799699|NCT01323387|16551683|P1|Overall Study|Withdrawal by Subject|41
4799700|NCT01323270|16551696|P2|Overall Study|Randomized, but not vaccinated|0
4799701|NCT01323270|16551697|P1|Overall Study|Randomized, but not vaccinated|1
4799702|NCT01323270|16551696|P2|Overall Study|Death|0
4799703|NCT01323270|16551697|P1|Overall Study|Death|1
4799704|NCT01323270|16551696|P2|Overall Study|Not eligible|1
4799705|NCT01323270|16551697|P1|Overall Study|Not eligible|1
4799706|NCT01323270|16551696|P2|Overall Study|Physician Decision|2
4799707|NCT01323270|16551697|P1|Overall Study|Physician Decision|0
4799708|NCT01323270|16551696|P2|Overall Study|Other|3
4799709|NCT01323270|16551697|P1|Overall Study|Other|0
4799710|NCT01323270|16551696|P2|Overall Study|Adverse Event|0
4799711|NCT01323270|16551697|P1|Overall Study|Adverse Event|8
4799712|NCT01323270|16551696|P2|Overall Study|Lost to Follow-up|6
4799713|NCT01323270|16551697|P1|Overall Study|Lost to Follow-up|4
4799714|NCT01323270|16551696|P2|Overall Study|Protocol Violation|7
4799715|NCT01323270|16551697|P1|Overall Study|Protocol Violation|9
4799716|NCT01323270|16551696|P2|Overall Study|Withdrawal by Subject|10
4799717|NCT01323270|16551697|P1|Overall Study|Withdrawal by Subject|19
4799718|NCT01323192|16551719|P2|Overall Study|Nonmedical reasons|1
4799719|NCT01323192|16551720|P1|Overall Study|Nonmedical reasons|0
4799720|NCT01323192|16551719|P2|Overall Study|Noncompliance with study medication|3
4799721|NCT01323192|16551720|P1|Overall Study|Noncompliance with study medication|0
4799722|NCT01323192|16551719|P2|Overall Study|Withdrawal by Subject|1
4799723|NCT01323192|16551720|P1|Overall Study|Withdrawal by Subject|3
4799724|NCT01323192|16551719|P2|Overall Study|Adverse Event|1
4799725|NCT01323192|16551720|P1|Overall Study|Adverse Event|6
4799726|NCT01322490|16551969|P3|Long Term Follow-up Period|Unknown/Missing|1
4799727|NCT01322490|16551970|P2|Long Term Follow-up Period|Unknown/Missing|1
4799728|NCT01322490|16551971|P1|Long Term Follow-up Period|Unknown/Missing|0
4799729|NCT01322490|16551969|P3|Long Term Follow-up Period|Other per report|2
4799730|NCT01322490|16551970|P2|Long Term Follow-up Period|Other per report|2
4799731|NCT01322490|16551971|P1|Long Term Follow-up Period|Other per report|3
4799732|NCT01322490|16551969|P3|Long Term Follow-up Period|Study Terminated by Sponsor|165
4799733|NCT01322490|16551970|P2|Long Term Follow-up Period|Study Terminated by Sponsor|158
4799734|NCT01322490|16551971|P1|Long Term Follow-up Period|Study Terminated by Sponsor|160
4799735|NCT01322490|16551969|P3|Long Term Follow-up Period|Withdrawal by Subject|6
4799736|NCT01322490|16551970|P2|Long Term Follow-up Period|Withdrawal by Subject|6
4799737|NCT01322490|16551971|P1|Long Term Follow-up Period|Withdrawal by Subject|9
4799738|NCT01322490|16551969|P3|Long Term Follow-up Period|Lost to Follow-up|3
4799739|NCT01322490|16551970|P2|Long Term Follow-up Period|Lost to Follow-up|2
4799740|NCT01322490|16551971|P1|Long Term Follow-up Period|Lost to Follow-up|2
4799741|NCT01322490|16551969|P3|Long Term Follow-up Period|Death|236
4799742|NCT01322490|16551970|P2|Long Term Follow-up Period|Death|239
4799743|NCT01322490|16551971|P1|Long Term Follow-up Period|Death|235
4799744|NCT01322490|16551969|P3|Treatment Period|Randomized but Not Treated|5
4799745|NCT01322490|16551970|P2|Treatment Period|Randomized but Not Treated|3
4799746|NCT01322490|16551971|P1|Treatment Period|Randomized but Not Treated|3
4799747|NCT01322490|16551969|P3|Treatment Period|Other per report|1
4799748|NCT01322490|16551970|P2|Treatment Period|Other per report|2
4799749|NCT01322490|16551971|P1|Treatment Period|Other per report|2
4799750|NCT01322490|16551969|P3|Treatment Period|Non-compliance with study drug|1
4799751|NCT01322490|16551970|P2|Treatment Period|Non-compliance with study drug|0
4799752|NCT01322490|16551971|P1|Treatment Period|Non-compliance with study drug|0
4799753|NCT01322490|16551969|P3|Treatment Period|Withdrawal by Subject|11
4799754|NCT01322490|16551970|P2|Treatment Period|Withdrawal by Subject|16
4799755|NCT01322490|16551971|P1|Treatment Period|Withdrawal by Subject|14
4799756|NCT01322490|16551969|P3|Treatment Period|Protocol Violation|4
4799757|NCT01322490|16551970|P2|Treatment Period|Protocol Violation|5
4799758|NCT01322490|16551971|P1|Treatment Period|Protocol Violation|7
4799759|NCT01322490|16551969|P3|Treatment Period|Physician Decision|1
4799760|NCT01322490|16551970|P2|Treatment Period|Physician Decision|2
4799761|NCT01322490|16551971|P1|Treatment Period|Physician Decision|0
4799762|NCT01322490|16551969|P3|Treatment Period|Lack of Efficacy|112
4799763|NCT01322490|16551970|P2|Treatment Period|Lack of Efficacy|100
4799764|NCT01322490|16551971|P1|Treatment Period|Lack of Efficacy|89
4799765|NCT01322490|16551969|P3|Treatment Period|Death|3
4799766|NCT01322490|16551970|P2|Treatment Period|Death|7
4799767|NCT01322490|16551971|P1|Treatment Period|Death|5
4799768|NCT01322490|16551969|P3|Treatment Period|Adverse Event|15
4799769|NCT01322490|16551970|P2|Treatment Period|Adverse Event|18
4799770|NCT01322490|16551971|P1|Treatment Period|Adverse Event|12
4799771|NCT01322386|16551984|P2|Overall Study|Physician Decision|1
4799772|NCT01322386|16551985|P1|Overall Study|Physician Decision|0
4799773|NCT01322386|16551984|P2|Overall Study|Protocol Violation|1
4799774|NCT01322386|16551985|P1|Overall Study|Protocol Violation|0
4799775|NCT01322347|16552000|P2|Overall Study|moved/changed dialysis|4
4799776|NCT01322347|16552001|P1|Overall Study|moved/changed dialysis|2
4799777|NCT01322347|16552000|P2|Overall Study|study drug withheld > 12 wks|1
4799778|NCT01322347|16552001|P1|Overall Study|study drug withheld > 12 wks|0
4799779|NCT01322347|16552000|P2|Overall Study|kidney transplant|1
4799780|NCT01322347|16552001|P1|Overall Study|kidney transplant|3
4799781|NCT01322347|16552000|P2|Overall Study|ineligible|3
4799782|NCT01322347|16552001|P1|Overall Study|ineligible|6
4799783|NCT01322347|16552000|P2|Overall Study|sponsor decision|3
4799784|NCT01322347|16552001|P1|Overall Study|sponsor decision|1
4799785|NCT01322347|16552000|P2|Overall Study|blood transfusion|5
4799786|NCT01322347|16552001|P1|Overall Study|blood transfusion|5
4799787|NCT01322347|16552000|P2|Overall Study|non-protocol change to ESA or IV iron|6
4799788|NCT01322347|16552001|P1|Overall Study|non-protocol change to ESA or IV iron|14
4799789|NCT01322347|16552000|P2|Overall Study|Withdrawal by Subject|4
4799790|NCT01322347|16552001|P1|Overall Study|Withdrawal by Subject|1
4799791|NCT01322347|16552000|P2|Overall Study|Protocol Violation|2
4799792|NCT01322347|16552001|P1|Overall Study|Protocol Violation|5
4799793|NCT01322347|16552000|P2|Overall Study|Physician Decision|1
4799794|NCT01322347|16552001|P1|Overall Study|Physician Decision|2
4799795|NCT01322347|16552000|P2|Overall Study|Death|3
4799796|NCT01322347|16552001|P1|Overall Study|Death|5
4799797|NCT01322347|16552000|P2|Overall Study|Adverse Event|2
4799798|NCT01322347|16552001|P1|Overall Study|Adverse Event|7
4799799|NCT01322009|16552064|P2|Overall Study|ng tube discontinued|1
4799800|NCT01322009|16552065|P1|Overall Study|ng tube discontinued|0
4799801|NCT01322009|16552064|P2|Overall Study|Adverse Event|1
4799802|NCT01322009|16552065|P1|Overall Study|Adverse Event|0
4799803|NCT01322009|16552064|P2|Overall Study|Death|1
4799804|NCT01322009|16552065|P1|Overall Study|Death|0
4799805|NCT01321879|16552073|P1|Overall Study|Withdrawal by Subject|1
4799806|NCT01321879|16552073|P1|Overall Study|Death|3
4799807|NCT01321879|16552073|P1|Overall Study|Adverse Event|5
4799808|NCT01321879|16552073|P1|Overall Study|Lack of Efficacy|5
4799809|NCT01321749|16552079|P2|Overall Study|Withdrawal by Subject|4
4799810|NCT01321749|16552080|P1|Overall Study|Withdrawal by Subject|5
4799811|NCT01321749|16552079|P2|Overall Study|Protocol Violation|7
4799812|NCT01321749|16552080|P1|Overall Study|Protocol Violation|4
4799813|NCT01321749|16552079|P2|Overall Study|Lost to Follow-up|11
4799814|NCT01321749|16552080|P1|Overall Study|Lost to Follow-up|4
4799815|NCT01321723|16552089|P3|Overall Study|Withdrawal by Subject|2
4799816|NCT01321723|16552090|P2|Overall Study|Withdrawal by Subject|0
4799817|NCT01321723|16552091|P1|Overall Study|Withdrawal by Subject|2
4799818|NCT01321723|16552089|P3|Overall Study|Adverse Event|2
4799819|NCT01321723|16552090|P2|Overall Study|Adverse Event|5
4799820|NCT01321723|16552091|P1|Overall Study|Adverse Event|3
4799821|NCT01321710|16552113|P3|Overall Study|Lost to Follow-up|0
4799822|NCT01321710|16552114|P2|Overall Study|Lost to Follow-up|5
4799823|NCT01321710|16552115|P1|Overall Study|Lost to Follow-up|4
4799824|NCT01321697|16552130|P1|Overall Study|Study Terminated|7
4799825|NCT01321606|16552136|P4|Overall Study|Lost to Follow-up|1
4799826|NCT01321606|16552137|P3|Overall Study|Lost to Follow-up|0
4799827|NCT01321606|16552138|P2|Overall Study|Lost to Follow-up|0
4799828|NCT01321606|16552139|P1|Overall Study|Lost to Follow-up|0
4799829|NCT01321073|16552175|P1|Overall Study|Death|3
4799830|NCT01321073|16552175|P1|Overall Study|Did not attempt implant|4
4799831|NCT01321008|16552179|P1|Overall Study|Early Study Termination|1
4799832|NCT01320943|16552185|P2|Overall Study|Randomized but not Treated|1
4799833|NCT01320943|16552186|P1|Overall Study|Randomized but not Treated|0
4799834|NCT01320943|16552185|P2|Overall Study|Physician Decision|1
4799835|NCT01320943|16552186|P1|Overall Study|Physician Decision|0
4799836|NCT01320943|16552185|P2|Overall Study|Lost to Follow-up|0
4799837|NCT01320943|16552186|P1|Overall Study|Lost to Follow-up|1
4799838|NCT01320735|16552220|P1|Overall Study|Investigator Unable to be Contacted|17
4799839|NCT01320735|16552220|P1|Overall Study|No Decrease of Prostate Specific Antigen|7
4799840|NCT01320735|16552220|P1|Overall Study|Other|1
4799841|NCT01320735|16552220|P1|Overall Study|Protocol Violation|1
4799842|NCT01320735|16552220|P1|Overall Study|Progression/Hormone-Refractory Pca|55
4799843|NCT01320735|16552220|P1|Overall Study|Administrative Reason|6
4799844|NCT01320735|16552220|P1|Overall Study|Lost to Follow-up|13
4799845|NCT01320735|16552220|P1|Overall Study|Withdrawal by Subject|3
4799846|NCT01320735|16552220|P1|Overall Study|Adverse Event|3
4799847|NCT01320722|16552242|P5|Overall Study|Withdrew due to Health Condition|1
4799848|NCT01320722|16552243|P4|Overall Study|Withdrew due to Health Condition|0
4799849|NCT01320722|16552244|P3|Overall Study|Withdrew due to Health Condition|0
4799850|NCT01320722|16552245|P2|Overall Study|Withdrew due to Health Condition|0
4799851|NCT01320722|16552246|P1|Overall Study|Withdrew due to Health Condition|0
4799852|NCT01320722|16552242|P5|Overall Study|Started an Exclusionary Medication|1
4799853|NCT01320722|16552243|P4|Overall Study|Started an Exclusionary Medication|0
4799854|NCT01320722|16552244|P3|Overall Study|Started an Exclusionary Medication|0
4799855|NCT01320722|16552245|P2|Overall Study|Started an Exclusionary Medication|0
4799856|NCT01320722|16552246|P1|Overall Study|Started an Exclusionary Medication|0
4799857|NCT01320722|16552242|P5|Overall Study|Pregnancy|0
4799858|NCT01320722|16552243|P4|Overall Study|Pregnancy|1
4799859|NCT01320722|16552244|P3|Overall Study|Pregnancy|0
4799860|NCT01320722|16552245|P2|Overall Study|Pregnancy|0
4799861|NCT01320722|16552246|P1|Overall Study|Pregnancy|0
4799862|NCT01320722|16552242|P5|Overall Study|Not Compliant with Study Procedures|0
4799863|NCT01320722|16552243|P4|Overall Study|Not Compliant with Study Procedures|4
4799864|NCT01320722|16552244|P3|Overall Study|Not Compliant with Study Procedures|0
4799865|NCT01320722|16552245|P2|Overall Study|Not Compliant with Study Procedures|0
4799866|NCT01320722|16552246|P1|Overall Study|Not Compliant with Study Procedures|0
4799867|NCT01320722|16552242|P5|Overall Study|Adverse Event|0
4799868|NCT01320722|16552243|P4|Overall Study|Adverse Event|6
4799869|NCT01320722|16552244|P3|Overall Study|Adverse Event|3
4799870|NCT01320722|16552245|P2|Overall Study|Adverse Event|0
4799871|NCT01320722|16552246|P1|Overall Study|Adverse Event|0
4799872|NCT01320722|16552242|P5|Overall Study|Non-compliant with Medication|0
4799873|NCT01320722|16552243|P4|Overall Study|Non-compliant with Medication|0
4799874|NCT01320722|16552244|P3|Overall Study|Non-compliant with Medication|1
4799875|NCT01320722|16552245|P2|Overall Study|Non-compliant with Medication|0
4799876|NCT01320722|16552246|P1|Overall Study|Non-compliant with Medication|0
4799877|NCT01320722|16552242|P5|Overall Study|Participant Developed a Rash|1
4799878|NCT01320722|16552243|P4|Overall Study|Participant Developed a Rash|1
4799879|NCT01320722|16552244|P3|Overall Study|Participant Developed a Rash|2
4799880|NCT01320722|16552245|P2|Overall Study|Participant Developed a Rash|0
4799881|NCT01320722|16552246|P1|Overall Study|Participant Developed a Rash|0
4799882|NCT01320722|16552242|P5|Overall Study|Not Available for the 8 Week Visit|0
4799883|NCT01320722|16552243|P4|Overall Study|Not Available for the 8 Week Visit|0
4799884|NCT01320722|16552244|P3|Overall Study|Not Available for the 8 Week Visit|0
4799885|NCT01320722|16552245|P2|Overall Study|Not Available for the 8 Week Visit|3
4799886|NCT01320722|16552246|P1|Overall Study|Not Available for the 8 Week Visit|0
4799887|NCT01320722|16552242|P5|Overall Study|Lost to Follow-up|3
4799888|NCT01320722|16552243|P4|Overall Study|Lost to Follow-up|1
4799889|NCT01320722|16552244|P3|Overall Study|Lost to Follow-up|0
4799890|NCT01320722|16552245|P2|Overall Study|Lost to Follow-up|1
4799891|NCT01320722|16552246|P1|Overall Study|Lost to Follow-up|0
4799892|NCT01320722|16552242|P5|Overall Study|Did not Receive Intervention|2
4799893|NCT01320722|16552243|P4|Overall Study|Did not Receive Intervention|1
4799894|NCT01320722|16552244|P3|Overall Study|Did not Receive Intervention|1
4799895|NCT01320722|16552245|P2|Overall Study|Did not Receive Intervention|2
4799896|NCT01320722|16552246|P1|Overall Study|Did not Receive Intervention|3
4799897|NCT01320683|16552283|P1|Overall Study|Positive antibody response|1
4799898|NCT01320293|16552309|P1|Overall Study|Adverse Event|1
4799899|NCT01320293|16552309|P1|Overall Study|Lack of Efficacy|1
4799900|NCT01320202|16552317|P2|Overall Study|regained renal function|0
4799901|NCT01320202|16552318|P1|Overall Study|regained renal function|1
4799902|NCT01320202|16552317|P2|Overall Study|ineligible|0
4799903|NCT01320202|16552318|P1|Overall Study|ineligible|3
4799904|NCT01320202|16552317|P2|Overall Study|sponsor request|0
4799905|NCT01320202|16552318|P1|Overall Study|sponsor request|2
4799906|NCT01320202|16552317|P2|Overall Study|moved/changed dialysis|2
4799907|NCT01320202|16552318|P1|Overall Study|moved/changed dialysis|5
4799908|NCT01320202|16552317|P2|Overall Study|blood transfusion|7
4799909|NCT01320202|16552318|P1|Overall Study|blood transfusion|1
4799910|NCT01320202|16552317|P2|Overall Study|kidney transplant|2
4799911|NCT01320202|16552318|P1|Overall Study|kidney transplant|1
4799912|NCT01320202|16552317|P2|Overall Study|non-protocol change to ESA or IV iron|20
4799913|NCT01320202|16552318|P1|Overall Study|non-protocol change to ESA or IV iron|17
4799914|NCT01320202|16552317|P2|Overall Study|Withdrawal by Subject|3
4799915|NCT01320202|16552318|P1|Overall Study|Withdrawal by Subject|10
4799916|NCT01320202|16552317|P2|Overall Study|Protocol Violation|1
4799917|NCT01320202|16552318|P1|Overall Study|Protocol Violation|2
4799918|NCT01320202|16552317|P2|Overall Study|Physician Decision|1
4799919|NCT01320202|16552318|P1|Overall Study|Physician Decision|3
4799920|NCT01320202|16552317|P2|Overall Study|Lost to Follow-up|0
4799921|NCT01320202|16552318|P1|Overall Study|Lost to Follow-up|1
4799922|NCT01320202|16552317|P2|Overall Study|Death|3
4799923|NCT01320202|16552318|P1|Overall Study|Death|5
4799924|NCT01320202|16552317|P2|Overall Study|Adverse Event|5
4799925|NCT01320202|16552318|P1|Overall Study|Adverse Event|5
4799926|NCT01320150|16552355|P1|Overall Study|Lost to Follow-up|44
4799927|NCT01320150|16552355|P1|Overall Study|Death|2
4799928|NCT01320150|16552355|P1|Overall Study|Withdrawal by Subject|5
4799929|NCT01320150|16552355|P1|Overall Study|Protocol Violation|15
4799930|NCT01320033|16552389|P3|Overall Study|Other|1
4799931|NCT01320033|16552390|P2|Overall Study|Other|3
4799932|NCT01320033|16552391|P1|Overall Study|Other|2
4799933|NCT01320033|16552389|P3|Overall Study|Lost to Follow-up|17
4799934|NCT01320033|16552390|P2|Overall Study|Lost to Follow-up|26
4799935|NCT01320033|16552391|P1|Overall Study|Lost to Follow-up|22
4799936|NCT01320033|16552389|P3|Overall Study|Protocol Violation|3
4799937|NCT01320033|16552390|P2|Overall Study|Protocol Violation|5
4799938|NCT01320033|16552391|P1|Overall Study|Protocol Violation|3
4799939|NCT01320033|16552389|P3|Overall Study|Withdrawal by Subject|23
4799940|NCT01320033|16552390|P2|Overall Study|Withdrawal by Subject|23
4799941|NCT01320033|16552391|P1|Overall Study|Withdrawal by Subject|22
4799942|NCT01320033|16552389|P3|Overall Study|Adverse Event|8
4799943|NCT01320033|16552390|P2|Overall Study|Adverse Event|7
4799944|NCT01320033|16552391|P1|Overall Study|Adverse Event|9
4799945|NCT01320033|16552389|P3|Overall Study|Lack of Efficacy|1
4799946|NCT01320033|16552390|P2|Overall Study|Lack of Efficacy|0
4799947|NCT01320033|16552391|P1|Overall Study|Lack of Efficacy|0
4799948|NCT01319994|16552419|P2|Overall Study|Protocol Violation|6
4799949|NCT01319994|16552420|P1|Overall Study|Protocol Violation|7
4799950|NCT01319929|16552430|P2|Second Treatment Period (4 Weeks)|Sponsor Decision|1
4799951|NCT01319929|16552431|P1|Second Treatment Period (4 Weeks)|Sponsor Decision|0
4799952|NCT01319929|16552430|P2|Second Treatment Period (4 Weeks)|Adverse Event|0
4799953|NCT01319929|16552431|P1|Second Treatment Period (4 Weeks)|Adverse Event|1
4799954|NCT01319929|16552430|P2|First Treatment Period (4 Weeks)|Protocol Violation|1
4799955|NCT01319929|16552431|P1|First Treatment Period (4 Weeks)|Protocol Violation|0
4799956|NCT01319929|16552430|P2|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
4799957|NCT01319929|16552431|P1|First Treatment Period (4 Weeks)|Withdrawal by Subject|1
4799958|NCT01319929|16552430|P2|First Treatment Period (4 Weeks)|Adverse Event|0
4799959|NCT01319929|16552431|P1|First Treatment Period (4 Weeks)|Adverse Event|2
4799960|NCT01319877|16552463|P2|Overall Study|Reason Not Specified|5
4799961|NCT01319877|16552464|P1|Overall Study|Reason Not Specified|4
4799962|NCT01319877|16552463|P2|Overall Study|Withdrawal by Subject|1
4799963|NCT01319877|16552464|P1|Overall Study|Withdrawal by Subject|0
4799964|NCT01319877|16552463|P2|Overall Study|Disease Progression|2
4799965|NCT01319877|16552464|P1|Overall Study|Disease Progression|2
4799966|NCT01319877|16552463|P2|Overall Study|Physician Decision|0
4799967|NCT01319877|16552464|P1|Overall Study|Physician Decision|2
4799968|NCT01319877|16552463|P2|Overall Study|Lost to Follow-up|37
4799969|NCT01319877|16552464|P1|Overall Study|Lost to Follow-up|100
4799970|NCT01319721|16552632|P2|Overall Study|Lost to Follow-up|6
4799971|NCT01319721|16552633|P1|Overall Study|Lost to Follow-up|1
4799972|NCT01319422|16552686|P2|Overall Study|Withdrawal by Subject|0
4799973|NCT01319422|16552687|P1|Overall Study|Withdrawal by Subject|1
4799974|NCT01319383|16552705|P2|Overall Study|No in vivo response to interval doses|1
4799975|NCT01319383|16552706|P1|Overall Study|No in vivo response to interval doses|0
4799976|NCT01319383|16552705|P2|Overall Study|Lack of Efficacy|9
4799977|NCT01319383|16552706|P1|Overall Study|Lack of Efficacy|5
4799978|NCT01319383|16552705|P2|Overall Study|Physician Decision|0
4799979|NCT01319383|16552706|P1|Overall Study|Physician Decision|3
4799980|NCT01319383|16552705|P2|Overall Study|No ex vivo or in vivo response|0
4799981|NCT01319383|16552706|P1|Overall Study|No ex vivo or in vivo response|4
4799982|NCT01318993|16552745|P1|Overall Study|Withdrawal by Subject|24
4799983|NCT01318993|16552745|P1|Overall Study|Physician Decision|13
4799984|NCT01318993|16552745|P1|Overall Study|Lost to Follow-up|4
4799985|NCT01318993|16552745|P1|Overall Study|Study closed or terminated|174
4799986|NCT01318993|16552745|P1|Overall Study|Protocol based stopping criteria|6
4799987|NCT01318993|16552745|P1|Overall Study|Protocol Violation|3
4799988|NCT01318993|16552745|P1|Overall Study|Lack of Efficacy|121
4799989|NCT01318993|16552745|P1|Overall Study|Adverse Event|53
4799990|NCT01318915|16552766|P1|Overall Study|Lost to Follow-up|1
4799991|NCT01318902|16552795|P4|Overall Study|Terminated by Sponsor|0
4799992|NCT01318902|16552796|P3|Overall Study|Terminated by Sponsor|1
4799993|NCT01318902|16552797|P2|Overall Study|Terminated by Sponsor|0
4799994|NCT01318902|16552798|P1|Overall Study|Terminated by Sponsor|0
4799995|NCT01318902|16552795|P4|Overall Study|Adverse Event|0
4799996|NCT01318902|16552796|P3|Overall Study|Adverse Event|0
4799997|NCT01318902|16552797|P2|Overall Study|Adverse Event|1
4799998|NCT01318902|16552798|P1|Overall Study|Adverse Event|0
4799999|NCT01318902|16552795|P4|Overall Study|Unsatisfactory Therapeutic Response|1
4800000|NCT01318902|16552796|P3|Overall Study|Unsatisfactory Therapeutic Response|0
4800001|NCT01318902|16552797|P2|Overall Study|Unsatisfactory Therapeutic Response|0
4800002|NCT01318902|16552798|P1|Overall Study|Unsatisfactory Therapeutic Response|1
4800003|NCT01318902|16552795|P4|Overall Study|Withdrawal by Patient|3
4800004|NCT01318902|16552796|P3|Overall Study|Withdrawal by Patient|0
4800005|NCT01318902|16552797|P2|Overall Study|Withdrawal by Patient|1
4800006|NCT01318902|16552798|P1|Overall Study|Withdrawal by Patient|0
4800007|NCT01318902|16552795|P4|Overall Study|Symptomatic Deterioration|2
4800008|NCT01318902|16552796|P3|Overall Study|Symptomatic Deterioration|1
4800009|NCT01318902|16552797|P2|Overall Study|Symptomatic Deterioration|1
4800010|NCT01318902|16552798|P1|Overall Study|Symptomatic Deterioration|0
4800011|NCT01318876|16552875|P1|Day 29 Survey|survey not completed-don't know why|1825
4800012|NCT01318876|16552875|P1|Day 8 Survey|survey not completed-don't know why|1724
4800013|NCT01318876|16552875|P1|Day 8 Survey|email address invalid|96
4800014|NCT01318811|16552882|P2|Overall Study|CRRT stopped for head MRI|1
4800015|NCT01318811|16552883|P1|Overall Study|CRRT stopped for head MRI|0
4800016|NCT01318811|16552882|P2|Overall Study|Death|1
4800017|NCT01318811|16552883|P1|Overall Study|Death|0
4800018|NCT01318811|16552882|P2|Overall Study|CRRT stopped for head CT|1
4800019|NCT01318811|16552883|P1|Overall Study|CRRT stopped for head CT|0
4800020|NCT01318811|16552882|P2|Overall Study|Physician Decision|1
4800021|NCT01318811|16552883|P1|Overall Study|Physician Decision|1
4800022|NCT01318512|16552993|P1|Maintenance Period (6 Months)|Protocol Violation|9
4800023|NCT01318512|16552993|P1|Maintenance Period (6 Months)|Death|2
4800024|NCT01318499|16553012|P3|Overall Study|Other|22
4800025|NCT01318499|16553013|P2|Overall Study|Other|10
4800026|NCT01318499|16553014|P1|Overall Study|Other|7
4800027|NCT01318499|16553012|P3|Overall Study|Patient Did Not Use Study Medication|14
4800028|NCT01318499|16553013|P2|Overall Study|Patient Did Not Use Study Medication|28
4800029|NCT01318499|16553014|P1|Overall Study|Patient Did Not Use Study Medication|18
4800030|NCT01318499|16553012|P3|Overall Study|Protocol Violation|2
4800031|NCT01318499|16553013|P2|Overall Study|Protocol Violation|4
4800032|NCT01318499|16553014|P1|Overall Study|Protocol Violation|2
4800033|NCT01318499|16553012|P3|Overall Study|Treatment Failure|101
4800034|NCT01318499|16553013|P2|Overall Study|Treatment Failure|19
4800035|NCT01318499|16553014|P1|Overall Study|Treatment Failure|19
4800036|NCT01318499|16553012|P3|Overall Study|Noncompliance|0
4800037|NCT01318499|16553013|P2|Overall Study|Noncompliance|3
4800038|NCT01318499|16553014|P1|Overall Study|Noncompliance|2
4800039|NCT01318499|16553012|P3|Overall Study|Pt Decision Unrelated to Adverse Event|2
4800040|NCT01318499|16553013|P2|Overall Study|Pt Decision Unrelated to Adverse Event|1
4800041|NCT01318499|16553014|P1|Overall Study|Pt Decision Unrelated to Adverse Event|1
4800042|NCT01318499|16553012|P3|Overall Study|Adverse Event|6
4800043|NCT01318499|16553013|P2|Overall Study|Adverse Event|11
4800044|NCT01318499|16553014|P1|Overall Study|Adverse Event|16
4800045|NCT01318382|16553037|P1|Overall Study|Protocol Violation|1
4800046|NCT01318382|16553037|P1|Overall Study|Device Malfunction|10
4800047|NCT01318382|16553037|P1|Overall Study|Physician Decision|2
4800048|NCT01318135|16553095|P8|Entered - Long-Term Extension Study|Use of Excluded Medications|1
4800049|NCT01318135|16553096|P7|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800050|NCT01318135|16553097|P6|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800051|NCT01318135|16553098|P5|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800052|NCT01318135|16553099|P4|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800053|NCT01318135|16553100|P3|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800054|NCT01318135|16553101|P2|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800055|NCT01318135|16553102|P1|Entered - Long-Term Extension Study|Use of Excluded Medications|0
4800056|NCT01318135|16553095|P8|Entered - Long-Term Extension Study|Lack of Efficacy|1
4800057|NCT01318135|16553096|P7|Entered - Long-Term Extension Study|Lack of Efficacy|1
4800058|NCT01318135|16553097|P6|Entered - Long-Term Extension Study|Lack of Efficacy|2
4800059|NCT01318135|16553098|P5|Entered - Long-Term Extension Study|Lack of Efficacy|2
4800060|NCT01318135|16553099|P4|Entered - Long-Term Extension Study|Lack of Efficacy|3
4800061|NCT01318135|16553100|P3|Entered - Long-Term Extension Study|Lack of Efficacy|2
4800062|NCT01318135|16553101|P2|Entered - Long-Term Extension Study|Lack of Efficacy|7
4800063|NCT01318135|16553102|P1|Entered - Long-Term Extension Study|Lack of Efficacy|5
4800064|NCT01318135|16553095|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4800065|NCT01318135|16553096|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4800066|NCT01318135|16553097|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4800067|NCT01318135|16553098|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4800068|NCT01318135|16553099|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4800069|NCT01318135|16553100|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4800070|NCT01318135|16553101|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4800071|NCT01318135|16553102|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4800072|NCT01318135|16553095|P8|Entered - Long-Term Extension Study|Protocol Violation|0
4800073|NCT01318135|16553096|P7|Entered - Long-Term Extension Study|Protocol Violation|0
4800074|NCT01318135|16553097|P6|Entered - Long-Term Extension Study|Protocol Violation|0
4800075|NCT01318135|16553098|P5|Entered - Long-Term Extension Study|Protocol Violation|1
4800076|NCT01318135|16553099|P4|Entered - Long-Term Extension Study|Protocol Violation|0
4800077|NCT01318135|16553100|P3|Entered - Long-Term Extension Study|Protocol Violation|0
4800078|NCT01318135|16553101|P2|Entered - Long-Term Extension Study|Protocol Violation|1
4800079|NCT01318135|16553102|P1|Entered - Long-Term Extension Study|Protocol Violation|1
4800080|NCT01318135|16553095|P8|Entered - Long-Term Extension Study|Adverse Event|0
4800081|NCT01318135|16553096|P7|Entered - Long-Term Extension Study|Adverse Event|0
4800082|NCT01318135|16553097|P6|Entered - Long-Term Extension Study|Adverse Event|2
4800083|NCT01318135|16553098|P5|Entered - Long-Term Extension Study|Adverse Event|4
4800084|NCT01318135|16553099|P4|Entered - Long-Term Extension Study|Adverse Event|3
4800085|NCT01318135|16553100|P3|Entered - Long-Term Extension Study|Adverse Event|4
4800086|NCT01318135|16553101|P2|Entered - Long-Term Extension Study|Adverse Event|3
4800087|NCT01318135|16553102|P1|Entered - Long-Term Extension Study|Adverse Event|9
4800088|NCT01318135|16553095|P8|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800089|NCT01318135|16553096|P7|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800090|NCT01318135|16553097|P6|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800091|NCT01318135|16553098|P5|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800092|NCT01318135|16553099|P4|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800093|NCT01318135|16553100|P3|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800094|NCT01318135|16553101|P2|Enrolled - Long-Term Extension Study|Treatment Complications|0
4800095|NCT01318135|16553102|P1|Enrolled - Long-Term Extension Study|Treatment Complications|1
4800096|NCT01318135|16553095|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
4800097|NCT01318135|16553096|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
4800098|NCT01318135|16553097|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
4800099|NCT01318135|16553098|P5|Enrolled - Long-Term Extension Study|Adverse Event|0
4800100|NCT01318135|16553099|P4|Enrolled - Long-Term Extension Study|Adverse Event|0
4800101|NCT01318135|16553100|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
4800102|NCT01318135|16553101|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
4800103|NCT01318135|16553102|P1|Enrolled - Long-Term Extension Study|Adverse Event|1
4800104|NCT01318122|16553234|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
4800105|NCT01318122|16553235|P3|Entered - Long-Term Extension Study|Lack of Efficacy|3
4800106|NCT01318122|16553236|P2|Entered - Long-Term Extension Study|Lack of Efficacy|2
4800107|NCT01318122|16553237|P1|Entered - Long-Term Extension Study|Lack of Efficacy|0
4800108|NCT01318122|16553234|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4800109|NCT01318122|16553235|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4800110|NCT01318122|16553236|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|3
4800111|NCT01318122|16553237|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4800112|NCT01318122|16553234|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
4800113|NCT01318122|16553235|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
4800114|NCT01318122|16553236|P2|Entered - Long-Term Extension Study|Lost to Follow-up|0
4800115|NCT01318122|16553237|P1|Entered - Long-Term Extension Study|Lost to Follow-up|1
4800116|NCT01318122|16553234|P4|Entered - Long-Term Extension Study|Adverse Event|4
4800117|NCT01318122|16553235|P3|Entered - Long-Term Extension Study|Adverse Event|2
4800118|NCT01318122|16553236|P2|Entered - Long-Term Extension Study|Adverse Event|6
4800119|NCT01318122|16553237|P1|Entered - Long-Term Extension Study|Adverse Event|6
4800120|NCT01318122|16553234|P4|Enrolled - Long-Term Extension Study|Other|0
4800121|NCT01318122|16553235|P3|Enrolled - Long-Term Extension Study|Other|0
4800122|NCT01318122|16553236|P2|Enrolled - Long-Term Extension Study|Other|0
4800123|NCT01318122|16553237|P1|Enrolled - Long-Term Extension Study|Other|1
4800124|NCT01318122|16553234|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
4800125|NCT01318122|16553235|P3|Enrolled - Long-Term Extension Study|Adverse Event|2
4800126|NCT01318122|16553236|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
4800127|NCT01318122|16553237|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
4800128|NCT01318109|16553306|P3|Overall Study|Schedule Conflict|0
4800129|NCT01318109|16553307|P2|Overall Study|Schedule Conflict|1
4800130|NCT01318109|16553308|P1|Overall Study|Schedule Conflict|0
4800131|NCT01318109|16553306|P3|Overall Study|Withdrawal by Subject|0
4800132|NCT01318109|16553307|P2|Overall Study|Withdrawal by Subject|0
4800133|NCT01318109|16553308|P1|Overall Study|Withdrawal by Subject|1
4800134|NCT01318109|16553306|P3|Overall Study|Adverse Event|0
4800135|NCT01318109|16553307|P2|Overall Study|Adverse Event|2
4800136|NCT01318109|16553308|P1|Overall Study|Adverse Event|0
4800137|NCT01318083|16553343|P3|Overall Study|Lack of Study Medication Compliance|0
4800138|NCT01318083|16553344|P2|Overall Study|Lack of Study Medication Compliance|1
4800139|NCT01318083|16553345|P1|Overall Study|Lack of Study Medication Compliance|0
4800140|NCT01318083|16553343|P3|Overall Study|Treatment Complications|0
4800141|NCT01318083|16553344|P2|Overall Study|Treatment Complications|0
4800142|NCT01318083|16553345|P1|Overall Study|Treatment Complications|1
4800143|NCT01318083|16553343|P3|Overall Study|Lack of Efficacy|1
4800144|NCT01318083|16553344|P2|Overall Study|Lack of Efficacy|0
4800145|NCT01318083|16553345|P1|Overall Study|Lack of Efficacy|0
4800146|NCT01318083|16553343|P3|Overall Study|Withdrawal by Subject|2
4800147|NCT01318083|16553344|P2|Overall Study|Withdrawal by Subject|0
4800148|NCT01318083|16553345|P1|Overall Study|Withdrawal by Subject|1
4800149|NCT01318083|16553343|P3|Overall Study|Adverse Event|2
4800150|NCT01318083|16553344|P2|Overall Study|Adverse Event|1
4800151|NCT01318083|16553345|P1|Overall Study|Adverse Event|4
4800152|NCT01318070|16553380|P3|Overall Study|Principal Investigator Discretion|0
4800153|NCT01318070|16553381|P2|Overall Study|Principal Investigator Discretion|0
4800154|NCT01318070|16553382|P1|Overall Study|Principal Investigator Discretion|1
4800155|NCT01318070|16553380|P3|Overall Study|Lack of Efficacy|1
4800156|NCT01318070|16553381|P2|Overall Study|Lack of Efficacy|0
4800157|NCT01318070|16553382|P1|Overall Study|Lack of Efficacy|0
4800158|NCT01318070|16553380|P3|Overall Study|Withdrawal by Subject|1
4800159|NCT01318070|16553381|P2|Overall Study|Withdrawal by Subject|1
4800160|NCT01318070|16553382|P1|Overall Study|Withdrawal by Subject|0
4800161|NCT01318070|16553380|P3|Overall Study|Adverse Event|5
4800162|NCT01318070|16553381|P2|Overall Study|Adverse Event|1
4800163|NCT01318070|16553382|P1|Overall Study|Adverse Event|1
4800164|NCT01317940|16553429|P6|Overall Study|Change in therapy plan|0
4800165|NCT01317940|16553430|P5|Overall Study|Change in therapy plan|0
4800166|NCT01317940|16553431|P4|Overall Study|Change in therapy plan|0
4800167|NCT01317940|16553432|P3|Overall Study|Change in therapy plan|3
4800168|NCT01317940|16553433|P2|Overall Study|Change in therapy plan|0
4800169|NCT01317940|16553434|P1|Overall Study|Change in therapy plan|0
4800170|NCT01317940|16553429|P6|Overall Study|Lost to Follow-up|0
4800171|NCT01317940|16553430|P5|Overall Study|Lost to Follow-up|1
4800172|NCT01317940|16553431|P4|Overall Study|Lost to Follow-up|1
4800173|NCT01317940|16553432|P3|Overall Study|Lost to Follow-up|1
4800174|NCT01317940|16553433|P2|Overall Study|Lost to Follow-up|0
4800175|NCT01317940|16553434|P1|Overall Study|Lost to Follow-up|0
4800176|NCT01317940|16553429|P6|Overall Study|Death|0
4800177|NCT01317940|16553430|P5|Overall Study|Death|0
4800178|NCT01317940|16553431|P4|Overall Study|Death|0
4800179|NCT01317940|16553432|P3|Overall Study|Death|1
4800180|NCT01317940|16553433|P2|Overall Study|Death|0
4800181|NCT01317940|16553434|P1|Overall Study|Death|1
4800182|NCT01317797|16553465|P3|Overall Study|Withdrawal of Patient|1
4800183|NCT01317797|16553466|P2|Overall Study|Withdrawal of Patient|0
4800184|NCT01317797|16553467|P1|Overall Study|Withdrawal of Patient|0
4800185|NCT01317797|16553465|P3|Overall Study|Other|0
4800186|NCT01317797|16553466|P2|Overall Study|Other|1
4800187|NCT01317797|16553467|P1|Overall Study|Other|0
4800188|NCT01317641|16553544|P9|Overall Study|Withdrawal by Subject|0
4800189|NCT01317641|16553545|P8|Overall Study|Withdrawal by Subject|0
4800190|NCT01317641|16553546|P7|Overall Study|Withdrawal by Subject|1
4800191|NCT01317641|16553547|P6|Overall Study|Withdrawal by Subject|0
4800192|NCT01317641|16553548|P5|Overall Study|Withdrawal by Subject|0
4800193|NCT01317641|16553549|P4|Overall Study|Withdrawal by Subject|0
4800194|NCT01317641|16553550|P3|Overall Study|Withdrawal by Subject|0
4800195|NCT01317641|16553551|P2|Overall Study|Withdrawal by Subject|0
4800196|NCT01317641|16553552|P1|Overall Study|Withdrawal by Subject|0
4800197|NCT01317641|16553544|P9|Overall Study|Disease progression|4
4800198|NCT01317641|16553545|P8|Overall Study|Disease progression|3
4800199|NCT01317641|16553546|P7|Overall Study|Disease progression|0
4800200|NCT01317641|16553547|P6|Overall Study|Disease progression|0
4800201|NCT01317641|16553548|P5|Overall Study|Disease progression|0
4800202|NCT01317641|16553549|P4|Overall Study|Disease progression|0
4800203|NCT01317641|16553550|P3|Overall Study|Disease progression|0
4800204|NCT01317641|16553551|P2|Overall Study|Disease progression|0
4800205|NCT01317641|16553552|P1|Overall Study|Disease progression|0
4800206|NCT01317641|16553544|P9|Overall Study|Protocol Violation|0
4800207|NCT01317641|16553545|P8|Overall Study|Protocol Violation|0
4800208|NCT01317641|16553546|P7|Overall Study|Protocol Violation|0
4800209|NCT01317641|16553547|P6|Overall Study|Protocol Violation|0
4800210|NCT01317641|16553548|P5|Overall Study|Protocol Violation|0
4800211|NCT01317641|16553549|P4|Overall Study|Protocol Violation|0
4800212|NCT01317641|16553550|P3|Overall Study|Protocol Violation|0
4800213|NCT01317641|16553551|P2|Overall Study|Protocol Violation|0
4800214|NCT01317641|16553552|P1|Overall Study|Protocol Violation|1
4800215|NCT01317641|16553544|P9|Overall Study|Adverse Event|0
4800216|NCT01317641|16553545|P8|Overall Study|Adverse Event|1
4800217|NCT01317641|16553546|P7|Overall Study|Adverse Event|2
4800218|NCT01317641|16553547|P6|Overall Study|Adverse Event|0
4800219|NCT01317641|16553548|P5|Overall Study|Adverse Event|0
4800220|NCT01317641|16553549|P4|Overall Study|Adverse Event|1
4800221|NCT01317641|16553550|P3|Overall Study|Adverse Event|0
4800222|NCT01317641|16553551|P2|Overall Study|Adverse Event|1
4800223|NCT01317641|16553552|P1|Overall Study|Adverse Event|0
4800224|NCT01317641|16553544|P9|Overall Study|Not treated|1
4800225|NCT01317641|16553545|P8|Overall Study|Not treated|1
4800226|NCT01317641|16553546|P7|Overall Study|Not treated|0
4800227|NCT01317641|16553547|P6|Overall Study|Not treated|0
4800228|NCT01317641|16553548|P5|Overall Study|Not treated|0
4800229|NCT01317641|16553549|P4|Overall Study|Not treated|0
4800230|NCT01317641|16553550|P3|Overall Study|Not treated|0
4800231|NCT01317641|16553551|P2|Overall Study|Not treated|0
4800232|NCT01317641|16553552|P1|Overall Study|Not treated|0
4800233|NCT01317615|16553654|P1|Overall Study|Adverse Event|7
4800234|NCT01317615|16553654|P1|Overall Study|Abnormal laboratory value(s)|1
4800235|NCT01317615|16553654|P1|Overall Study|Withdrawal by Subject|5
4800236|NCT01317615|16553654|P1|Overall Study|Death|6
4800237|NCT01317615|16553654|P1|Overall Study|New cancer therapy|5
4800238|NCT01317615|16553654|P1|Overall Study|Disease progression|25
4800239|NCT01317550|16553667|P4|Overall Study|Lack of compliance study med|0
4800240|NCT01317550|16553668|P3|Overall Study|Lack of compliance study med|0
4800241|NCT01317550|16553669|P2|Overall Study|Lack of compliance study med|0
4800242|NCT01317550|16553670|P1|Overall Study|Lack of compliance study med|1
4800243|NCT01317550|16553667|P4|Overall Study|Withdrawal by Subject|0
4800244|NCT01317550|16553668|P3|Overall Study|Withdrawal by Subject|0
4800245|NCT01317550|16553669|P2|Overall Study|Withdrawal by Subject|0
4800246|NCT01317550|16553670|P1|Overall Study|Withdrawal by Subject|1
4800247|NCT01317472|16553682|P2|Overall Study|Unrelated hospitalization|0
4800248|NCT01317472|16553683|P1|Overall Study|Unrelated hospitalization|1
4800249|NCT01317472|16553682|P2|Overall Study|Withdrawal by Subject|0
4800250|NCT01317472|16553683|P1|Overall Study|Withdrawal by Subject|1
4800251|NCT01317199|16553693|P4|Randomized Phase 2|Patient transferred to other facility|0
4800252|NCT01317199|16553694|P3|Randomized Phase 2|Patient transferred to other facility|1
4800253|NCT01317199|16553695|P2|Randomized Phase 2|Patient transferred to other facility|0
4800254|NCT01317199|16553696|P1|Randomized Phase 2|Patient transferred to other facility|0
4800255|NCT01317199|16553693|P4|Randomized Phase 2|Patient stopped taking study drug|1
4800256|NCT01317199|16553694|P3|Randomized Phase 2|Patient stopped taking study drug|0
4800257|NCT01317199|16553695|P2|Randomized Phase 2|Patient stopped taking study drug|0
4800258|NCT01317199|16553696|P1|Randomized Phase 2|Patient stopped taking study drug|0
4800259|NCT01317199|16553693|P4|Randomized Phase 2|Disenrolled before treatment|2
4800260|NCT01317199|16553694|P3|Randomized Phase 2|Disenrolled before treatment|1
4800261|NCT01317199|16553695|P2|Randomized Phase 2|Disenrolled before treatment|1
4800262|NCT01317199|16553696|P1|Randomized Phase 2|Disenrolled before treatment|0
4800263|NCT01317199|16553693|P4|Randomized Phase 2|Rising PSA, not as defined by protocol|2
4800264|NCT01317199|16553694|P3|Randomized Phase 2|Rising PSA, not as defined by protocol|5
4800265|NCT01317199|16553695|P2|Randomized Phase 2|Rising PSA, not as defined by protocol|2
4800266|NCT01317199|16553696|P1|Randomized Phase 2|Rising PSA, not as defined by protocol|0
4800267|NCT01317199|16553693|P4|Randomized Phase 2|Comorbidities|2
4800268|NCT01317199|16553694|P3|Randomized Phase 2|Comorbidities|2
4800269|NCT01317199|16553695|P2|Randomized Phase 2|Comorbidities|2
4800270|NCT01317199|16553696|P1|Randomized Phase 2|Comorbidities|0
4800271|NCT01317199|16553693|P4|Randomized Phase 2|Adverse Event|1
4800272|NCT01317199|16553694|P3|Randomized Phase 2|Adverse Event|0
4800273|NCT01317199|16553695|P2|Randomized Phase 2|Adverse Event|0
4800274|NCT01317199|16553696|P1|Randomized Phase 2|Adverse Event|0
4800275|NCT01317199|16553693|P4|Randomized Phase 2|Withdrawal by Subject|4
4800276|NCT01317199|16553694|P3|Randomized Phase 2|Withdrawal by Subject|5
4800277|NCT01317199|16553695|P2|Randomized Phase 2|Withdrawal by Subject|3
4800278|NCT01317199|16553696|P1|Randomized Phase 2|Withdrawal by Subject|0
4800279|NCT01317199|16553693|P4|Randomized Phase 2|Disease progression|5
4800280|NCT01317199|16553694|P3|Randomized Phase 2|Disease progression|7
4800281|NCT01317199|16553695|P2|Randomized Phase 2|Disease progression|3
4800282|NCT01317199|16553696|P1|Randomized Phase 2|Disease progression|0
4800283|NCT01317199|16553693|P4|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
4800284|NCT01317199|16553694|P3|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
4800285|NCT01317199|16553695|P2|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0
4800286|NCT01317199|16553696|P1|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1
4800287|NCT01317199|16553693|P4|Dose-escalation Phase 1|Disease progression|0
4800288|NCT01317199|16553694|P3|Dose-escalation Phase 1|Disease progression|0
4800289|NCT01317199|16553695|P2|Dose-escalation Phase 1|Disease progression|0
4800290|NCT01317199|16553696|P1|Dose-escalation Phase 1|Disease progression|1
4800291|NCT01317199|16553693|P4|Dose-escalation Phase 1|Physician Decision|0
4800292|NCT01317199|16553694|P3|Dose-escalation Phase 1|Physician Decision|0
4800293|NCT01317199|16553695|P2|Dose-escalation Phase 1|Physician Decision|0
4800294|NCT01317199|16553696|P1|Dose-escalation Phase 1|Physician Decision|5
4800295|NCT01317160|16553725|P2|Overall Study|Withdrawal by Subject|2
4800296|NCT01317160|16553726|P1|Overall Study|Withdrawal by Subject|0
4800297|NCT01317160|16553725|P2|Overall Study|Lost to Follow-up|3
4800298|NCT01317160|16553726|P1|Overall Study|Lost to Follow-up|3
4800299|NCT01317160|16553725|P2|Overall Study|Incorrect inclusion|1
4800300|NCT01317160|16553726|P1|Overall Study|Incorrect inclusion|1
4800301|NCT01317004|16553760|P2|Overall Study|Adverse Event|3
4800302|NCT01317004|16553761|P1|Overall Study|Adverse Event|3
4800303|NCT01317004|16553760|P2|Overall Study|Protocol Violation|2
4800304|NCT01317004|16553761|P1|Overall Study|Protocol Violation|0
4800305|NCT01317004|16553760|P2|Overall Study|Withdrawal by Subject|4
4800306|NCT01317004|16553761|P1|Overall Study|Withdrawal by Subject|1
4800307|NCT01316939|16553782|P3|Overall Study|Protocol Violation|0
4800308|NCT01316939|16553783|P2|Overall Study|Protocol Violation|1
4800309|NCT01316939|16553784|P1|Overall Study|Protocol Violation|0
4800310|NCT01316939|16553782|P3|Overall Study|Met Liver chemistry stopping criteria|1
4800311|NCT01316939|16553783|P2|Overall Study|Met Liver chemistry stopping criteria|0
4800312|NCT01316939|16553784|P1|Overall Study|Met Liver chemistry stopping criteria|1
4800313|NCT01316939|16553782|P3|Overall Study|Lost to Follow-up|2
4800314|NCT01316939|16553783|P2|Overall Study|Lost to Follow-up|0
4800315|NCT01316939|16553784|P1|Overall Study|Lost to Follow-up|0
4800316|NCT01316939|16553782|P3|Overall Study|Physician Decision|1
4800317|NCT01316939|16553783|P2|Overall Study|Physician Decision|2
4800318|NCT01316939|16553784|P1|Overall Study|Physician Decision|2
4800319|NCT01316939|16553782|P3|Overall Study|Withdrawal by Subject|6
4800320|NCT01316939|16553783|P2|Overall Study|Withdrawal by Subject|3
4800321|NCT01316939|16553784|P1|Overall Study|Withdrawal by Subject|1
4800322|NCT01316939|16553782|P3|Overall Study|Adverse Event|11
4800323|NCT01316939|16553783|P2|Overall Study|Adverse Event|12
4800324|NCT01316939|16553784|P1|Overall Study|Adverse Event|9
4800325|NCT01316939|16553782|P3|Overall Study|Lack of Efficacy|25
4800326|NCT01316939|16553783|P2|Overall Study|Lack of Efficacy|25
4800327|NCT01316939|16553784|P1|Overall Study|Lack of Efficacy|24
4800328|NCT01316939|16553782|P3|Overall Study|Study closed/terminated|23
4800329|NCT01316939|16553783|P2|Overall Study|Study closed/terminated|25
4800330|NCT01316939|16553784|P1|Overall Study|Study closed/terminated|26
4800331|NCT01316913|16553879|P4|Overall Study|Withdrawal by Subject|6
4800332|NCT01316913|16553880|P3|Overall Study|Withdrawal by Subject|10
4800333|NCT01316913|16553881|P2|Overall Study|Withdrawal by Subject|9
4800334|NCT01316913|16553882|P1|Overall Study|Withdrawal by Subject|10
4800335|NCT01316913|16553879|P4|Overall Study|Lost to Follow-up|2
4800336|NCT01316913|16553880|P3|Overall Study|Lost to Follow-up|0
4800337|NCT01316913|16553881|P2|Overall Study|Lost to Follow-up|1
4800338|NCT01316913|16553882|P1|Overall Study|Lost to Follow-up|0
4800339|NCT01316913|16553879|P4|Overall Study|Protocol-defined Stopping Criteria|6
4800340|NCT01316913|16553880|P3|Overall Study|Protocol-defined Stopping Criteria|11
4800341|NCT01316913|16553881|P2|Overall Study|Protocol-defined Stopping Criteria|8
4800342|NCT01316913|16553882|P1|Overall Study|Protocol-defined Stopping Criteria|7
4800343|NCT01316913|16553879|P4|Overall Study|Protocol Violation|1
4800344|NCT01316913|16553880|P3|Overall Study|Protocol Violation|4
4800345|NCT01316913|16553881|P2|Overall Study|Protocol Violation|4
4800346|NCT01316913|16553882|P1|Overall Study|Protocol Violation|1
4800347|NCT01316913|16553879|P4|Overall Study|Lack of Efficacy|13
4800348|NCT01316913|16553880|P3|Overall Study|Lack of Efficacy|9
4800349|NCT01316913|16553881|P2|Overall Study|Lack of Efficacy|12
4800350|NCT01316913|16553882|P1|Overall Study|Lack of Efficacy|22
4800351|NCT01316913|16553879|P4|Overall Study|Adverse Event|11
4800352|NCT01316913|16553880|P3|Overall Study|Adverse Event|15
4800353|NCT01316913|16553881|P2|Overall Study|Adverse Event|20
4800354|NCT01316913|16553882|P1|Overall Study|Adverse Event|17
4800355|NCT01316900|16553904|P4|Overall Study|Withdrawal by Subject|9
4800356|NCT01316900|16553905|P3|Overall Study|Withdrawal by Subject|6
4800357|NCT01316900|16553906|P2|Overall Study|Withdrawal by Subject|8
4800358|NCT01316900|16553907|P1|Overall Study|Withdrawal by Subject|7
4800359|NCT01316900|16553904|P4|Overall Study|Lost to Follow-up|1
4800360|NCT01316900|16553905|P3|Overall Study|Lost to Follow-up|1
4800361|NCT01316900|16553906|P2|Overall Study|Lost to Follow-up|0
4800362|NCT01316900|16553907|P1|Overall Study|Lost to Follow-up|1
4800363|NCT01316900|16553904|P4|Overall Study|Protocol-defined Stopping Criteria|5
4800364|NCT01316900|16553905|P3|Overall Study|Protocol-defined Stopping Criteria|10
4800365|NCT01316900|16553906|P2|Overall Study|Protocol-defined Stopping Criteria|3
4800366|NCT01316900|16553907|P1|Overall Study|Protocol-defined Stopping Criteria|2
4800367|NCT01316900|16553904|P4|Overall Study|Protocol Violation|0
4800368|NCT01316900|16553905|P3|Overall Study|Protocol Violation|4
4800369|NCT01316900|16553906|P2|Overall Study|Protocol Violation|1
4800370|NCT01316900|16553907|P1|Overall Study|Protocol Violation|7
4800371|NCT01316900|16553904|P4|Overall Study|Lack of Efficacy|7
4800372|NCT01316900|16553905|P3|Overall Study|Lack of Efficacy|5
4800373|NCT01316900|16553906|P2|Overall Study|Lack of Efficacy|9
4800374|NCT01316900|16553907|P1|Overall Study|Lack of Efficacy|17
4800375|NCT01316900|16553904|P4|Overall Study|Adverse Event|9
4800376|NCT01316900|16553905|P3|Overall Study|Adverse Event|15
4800377|NCT01316900|16553906|P2|Overall Study|Adverse Event|10
4800378|NCT01316900|16553907|P1|Overall Study|Adverse Event|10
4800379|NCT01316887|16553928|P3|Overall Study|Withdrawal by Subject|15
4800380|NCT01316887|16553929|P2|Overall Study|Withdrawal by Subject|16
4800381|NCT01316887|16553930|P1|Overall Study|Withdrawal by Subject|8
4800382|NCT01316887|16553928|P3|Overall Study|Lost to Follow-up|5
4800383|NCT01316887|16553929|P2|Overall Study|Lost to Follow-up|7
4800384|NCT01316887|16553930|P1|Overall Study|Lost to Follow-up|1
4800385|NCT01316887|16553928|P3|Overall Study|Study Closed/Terminated|3
4800386|NCT01316887|16553929|P2|Overall Study|Study Closed/Terminated|4
4800387|NCT01316887|16553930|P1|Overall Study|Study Closed/Terminated|2
4800388|NCT01316887|16553928|P3|Overall Study|Protocol-defined Stopping Criteria|36
4800389|NCT01316887|16553929|P2|Overall Study|Protocol-defined Stopping Criteria|37
4800390|NCT01316887|16553930|P1|Overall Study|Protocol-defined Stopping Criteria|8
4800391|NCT01316887|16553928|P3|Overall Study|Protocol Violation|6
4800392|NCT01316887|16553929|P2|Overall Study|Protocol Violation|6
4800393|NCT01316887|16553930|P1|Overall Study|Protocol Violation|2
4800394|NCT01316887|16553928|P3|Overall Study|Lack of Efficacy|1
4800395|NCT01316887|16553929|P2|Overall Study|Lack of Efficacy|3
4800396|NCT01316887|16553930|P1|Overall Study|Lack of Efficacy|9
4800397|NCT01316887|16553928|P3|Overall Study|Adverse Event|17
4800398|NCT01316887|16553929|P2|Overall Study|Adverse Event|21
4800399|NCT01316887|16553930|P1|Overall Study|Adverse Event|13
4800400|NCT01316692|16554055|P1|Overall Study|Disease Progression|7
4800401|NCT01316692|16554055|P1|Overall Study|Adverse Event|5
4800402|NCT01316614|16554064|P1|Overall Study|Medically unstable|1
4800403|NCT01316614|16554064|P1|Overall Study|Inadequate number of passes|2
4800404|NCT01316614|16554064|P1|Overall Study|Cystic lesion|5
4800405|NCT01316614|16554064|P1|Overall Study|Cytology slides not available for review|4
4800406|NCT01316614|16554064|P1|Overall Study|No solid lesion and FNA not indicated|25
4800407|NCT01316575|16554081|P2|Overall Study|Required alternate treatment|1
4800408|NCT01316575|16554082|P1|Overall Study|Required alternate treatment|0
4800409|NCT01316575|16554081|P2|Overall Study|Withdrawal by Subject|0
4800410|NCT01316575|16554082|P1|Overall Study|Withdrawal by Subject|2
4800411|NCT01316419|16554105|P1|Overall Study|Lost to Follow-up|19
4800412|NCT01316419|16554105|P1|Overall Study|Violated inclusion/exclusion criterion|143
4800413|NCT01316419|16554105|P1|Overall Study|Not treated|103
4800414|NCT01316380|16554131|P3|Overall Study|Not treated|0
4800415|NCT01316380|16554132|P2|Overall Study|Not treated|0
4800416|NCT01316380|16554133|P1|Overall Study|Not treated|1
4800417|NCT01316380|16554131|P3|Overall Study|Other|1
4800418|NCT01316380|16554132|P2|Overall Study|Other|1
4800419|NCT01316380|16554133|P1|Overall Study|Other|0
4800420|NCT01316380|16554131|P3|Overall Study|Withdrawal by Subject|0
4800421|NCT01316380|16554132|P2|Overall Study|Withdrawal by Subject|2
4800422|NCT01316380|16554133|P1|Overall Study|Withdrawal by Subject|1
4800423|NCT01316380|16554131|P3|Overall Study|Protocol Violation|1
4800424|NCT01316380|16554132|P2|Overall Study|Protocol Violation|0
4800425|NCT01316380|16554133|P1|Overall Study|Protocol Violation|0
4800426|NCT01316380|16554131|P3|Overall Study|Adverse Event|1
4800427|NCT01316380|16554132|P2|Overall Study|Adverse Event|2
4800428|NCT01316380|16554133|P1|Overall Study|Adverse Event|0
4800429|NCT01316276|16554270|P1|Overall Study|Other|22
4800430|NCT01316276|16554270|P1|Overall Study|Lost to Follow-up|1
4800431|NCT01316276|16554270|P1|Overall Study|Withdrawal of consent|24
4800432|NCT01316276|16554270|P1|Overall Study|Adverse Event|19
4800433|NCT01316276|16554270|P1|Overall Study|Death|1
4800434|NCT01316224|16554318|P1|Overall Study|Other|1
4800435|NCT01316224|16554318|P1|Overall Study|Adverse Event With Treatment Failure|1
4800436|NCT01316224|16554318|P1|Overall Study|Withdrawal by Subject|1
4800437|NCT01316224|16554318|P1|Overall Study|Lack of Efficacy|1
4800438|NCT01316224|16554318|P1|Overall Study|Adverse Event|3
4800439|NCT01316224|16554318|P1|Overall Study|Protocol Violation|3
4800440|NCT01316055|16554371|P3|Overall Study|Lost to Follow-up|0
4800441|NCT01316055|16554372|P2|Overall Study|Lost to Follow-up|0
4800442|NCT01316055|16554373|P1|Overall Study|Lost to Follow-up|1
4800443|NCT01315847|16554404|P2|Part III, Period 1|[11C]MK-4232 synthesis failure|1
4800444|NCT01315847|16554405|P1|Part III, Period 1|[11C]MK-4232 synthesis failure|0
4800445|NCT01315847|16554404|P2|Part I, Period 1|Reached maximum number of arterial lines|0
4800446|NCT01315847|16554405|P1|Part I, Period 1|Reached maximum number of arterial lines|3
4800447|NCT01315678|16554419|P2|Overall Study|similar reason to those listed above|2
4800448|NCT01315678|16554420|P1|Overall Study|similar reason to those listed above|3
4800449|NCT01315678|16554419|P2|Overall Study|Lost to Follow-up|0
4800450|NCT01315678|16554420|P1|Overall Study|Lost to Follow-up|1
4800451|NCT01315678|16554419|P2|Overall Study|Adverse Event|1
4800452|NCT01315678|16554420|P1|Overall Study|Adverse Event|3
4800453|NCT01315678|16554419|P2|Overall Study|Withdrawal by Subject|3
4800454|NCT01315678|16554420|P1|Overall Study|Withdrawal by Subject|7
4800455|NCT01315353|16554471|P3|Overall Study|Inadvertent randomization/assignment|2
4800456|NCT01315353|16554472|P2|Overall Study|Inadvertent randomization/assignment|0
4800457|NCT01315353|16554473|P1|Overall Study|Inadvertent randomization/assignment|0
4800458|NCT01315353|16554471|P3|Overall Study|Taken off study by site in error|0
4800459|NCT01315353|16554472|P2|Overall Study|Taken off study by site in error|1
4800460|NCT01315353|16554473|P1|Overall Study|Taken off study by site in error|0
4800461|NCT01315353|16554471|P3|Overall Study|Site closing|0
4800462|NCT01315353|16554472|P2|Overall Study|Site closing|4
4800463|NCT01315353|16554473|P1|Overall Study|Site closing|7
4800464|NCT01315353|16554471|P3|Overall Study|Unwilling to adhere to requirements|4
4800465|NCT01315353|16554472|P2|Overall Study|Unwilling to adhere to requirements|5
4800466|NCT01315353|16554473|P1|Overall Study|Unwilling to adhere to requirements|5
4800467|NCT01315353|16554471|P3|Overall Study|Lost to Follow-up|6
4800468|NCT01315353|16554472|P2|Overall Study|Lost to Follow-up|6
4800469|NCT01315353|16554473|P1|Overall Study|Lost to Follow-up|13
4800470|NCT01315353|16554471|P3|Overall Study|Withdrawal by Subject|1
4800471|NCT01315353|16554472|P2|Overall Study|Withdrawal by Subject|6
4800472|NCT01315353|16554473|P1|Overall Study|Withdrawal by Subject|2
4800473|NCT01315353|16554471|P3|Overall Study|Death|0
4800474|NCT01315353|16554472|P2|Overall Study|Death|1
4800475|NCT01315353|16554473|P1|Overall Study|Death|2
4800476|NCT01315249|16554500|P2|Overall Study|Death|1
4800477|NCT01315249|16554501|P1|Overall Study|Death|0
4800478|NCT01315249|16554500|P2|Overall Study|Lost to Follow-up|2
4800479|NCT01315249|16554501|P1|Overall Study|Lost to Follow-up|0
4800480|NCT01315249|16554500|P2|Overall Study|Lack of Efficacy|1
4800481|NCT01315249|16554501|P1|Overall Study|Lack of Efficacy|0
4800482|NCT01315249|16554500|P2|Overall Study|inability to use device|0
4800483|NCT01315249|16554501|P1|Overall Study|inability to use device|1
4800484|NCT01315249|16554500|P2|Overall Study|Administrative problems|0
4800485|NCT01315249|16554501|P1|Overall Study|Administrative problems|1
4800486|NCT01315249|16554500|P2|Overall Study|Abnormal test results|2
4800487|NCT01315249|16554501|P1|Overall Study|Abnormal test results|1
4800488|NCT01315249|16554500|P2|Overall Study|Protocol Violation|5
4800489|NCT01315249|16554501|P1|Overall Study|Protocol Violation|8
4800490|NCT01315249|16554500|P2|Overall Study|Withdrawal by Subject|10
4800491|NCT01315249|16554501|P1|Overall Study|Withdrawal by Subject|11
4800492|NCT01315249|16554500|P2|Overall Study|Adverse Event|26
4800493|NCT01315249|16554501|P1|Overall Study|Adverse Event|22
4800494|NCT01315236|16554529|P2|12-Month Follow-up Period|Did not return to the site for Month 12|0
4800495|NCT01315236|16554530|P1|12-Month Follow-up Period|Did not return to the site for Month 12|1
4800496|NCT01315236|16554529|P2|12-Month Follow-up Period|Death|1
4800497|NCT01315236|16554530|P1|12-Month Follow-up Period|Death|0
4800498|NCT01315236|16554529|P2|Open-label Phase|Other|1
4800499|NCT01315236|16554530|P1|Open-label Phase|Other|0
4800500|NCT01315236|16554529|P2|Open-label Phase|Adverse Event|1
4800501|NCT01315236|16554530|P1|Open-label Phase|Adverse Event|0
4800502|NCT01315236|16554529|P2|Open-label Phase|Death|0
4800503|NCT01315236|16554530|P1|Open-label Phase|Death|1
4800504|NCT01315236|16554529|P2|Double-blind Phase|Lost to Follow-up|0
4800505|NCT01315236|16554530|P1|Double-blind Phase|Lost to Follow-up|1
4800506|NCT01315236|16554529|P2|Double-blind Phase|Withdrawal of Consent|0
4800507|NCT01315236|16554530|P1|Double-blind Phase|Withdrawal of Consent|1
4800508|NCT01315236|16554529|P2|Double-blind Phase|Adverse Event|0
4800509|NCT01315236|16554530|P1|Double-blind Phase|Adverse Event|1
4800510|NCT01315236|16554529|P2|Double-blind Phase|Death|0
4800511|NCT01315236|16554530|P1|Double-blind Phase|Death|1
4800512|NCT01315132|16554586|P1|Overall Study|not treated due to disease progression|1
4800513|NCT01315028|16554593|P2|Overall Study|Death|1
4800514|NCT01315028|16554594|P1|Overall Study|Death|0
4800515|NCT01315028|16554593|P2|Overall Study|Lost to Follow-up|0
4800516|NCT01315028|16554594|P1|Overall Study|Lost to Follow-up|1
4800517|NCT01314911|16554621|P2|Overall Study|Never Started Treatment|0
4800518|NCT01314911|16554622|P1|Overall Study|Never Started Treatment|1
4800519|NCT01314911|16554621|P2|Overall Study|Received Non-randomized Study Drug|1
4800520|NCT01314911|16554622|P1|Overall Study|Received Non-randomized Study Drug|0
4800521|NCT01314911|16554621|P2|Overall Study|Withdrawal by Subject|3
4800522|NCT01314911|16554622|P1|Overall Study|Withdrawal by Subject|1
4800523|NCT01314911|16554621|P2|Overall Study|Lost to Follow-up|2
4800524|NCT01314911|16554622|P1|Overall Study|Lost to Follow-up|3
4800525|NCT01314872|16554673|P15|Period 2|Lost to Follow-up|6
4800526|NCT01314872|16554674|P14|Period 2|Lost to Follow-up|2
4800527|NCT01314872|16554675|P13|Period 2|Lost to Follow-up|7
4800528|NCT01314872|16554676|P12|Period 2|Lost to Follow-up|6
4800529|NCT01314872|16554677|P11|Period 2|Lost to Follow-up|0
4800530|NCT01314872|16554678|P10|Period 2|Lost to Follow-up|0
4800531|NCT01314872|16554679|P9|Period 2|Lost to Follow-up|0
4800532|NCT01314872|16554680|P8|Period 2|Lost to Follow-up|0
4800533|NCT01314872|16554681|P7|Period 2|Lost to Follow-up|0
4800534|NCT01314872|16554682|P6|Period 2|Lost to Follow-up|0
4800535|NCT01314872|16554683|P5|Period 2|Lost to Follow-up|0
4800536|NCT01314872|16554684|P4|Period 2|Lost to Follow-up|0
4800537|NCT01314872|16554685|P3|Period 2|Lost to Follow-up|0
4800538|NCT01314872|16554686|P2|Period 2|Lost to Follow-up|0
4800539|NCT01314872|16554687|P1|Period 2|Lost to Follow-up|0
4800540|NCT01314872|16554673|P15|Period 2|Withdrawal by Subject|4
4800541|NCT01314872|16554674|P14|Period 2|Withdrawal by Subject|12
4800542|NCT01314872|16554675|P13|Period 2|Withdrawal by Subject|17
4800543|NCT01314872|16554676|P12|Period 2|Withdrawal by Subject|14
4800544|NCT01314872|16554677|P11|Period 2|Withdrawal by Subject|0
4800545|NCT01314872|16554678|P10|Period 2|Withdrawal by Subject|0
4800546|NCT01314872|16554679|P9|Period 2|Withdrawal by Subject|0
4800547|NCT01314872|16554680|P8|Period 2|Withdrawal by Subject|0
4800548|NCT01314872|16554681|P7|Period 2|Withdrawal by Subject|0
4800549|NCT01314872|16554682|P6|Period 2|Withdrawal by Subject|0
4800550|NCT01314872|16554683|P5|Period 2|Withdrawal by Subject|0
4800551|NCT01314872|16554684|P4|Period 2|Withdrawal by Subject|0
4800552|NCT01314872|16554685|P3|Period 2|Withdrawal by Subject|0
4800553|NCT01314872|16554686|P2|Period 2|Withdrawal by Subject|0
4800554|NCT01314872|16554687|P1|Period 2|Withdrawal by Subject|0
4800555|NCT01314872|16554673|P15|Period 2|Adverse event, non-fatal|9
4800556|NCT01314872|16554674|P14|Period 2|Adverse event, non-fatal|24
4800557|NCT01314872|16554675|P13|Period 2|Adverse event, non-fatal|16
4800558|NCT01314872|16554676|P12|Period 2|Adverse event, non-fatal|13
4800559|NCT01314872|16554677|P11|Period 2|Adverse event, non-fatal|0
4800560|NCT01314872|16554678|P10|Period 2|Adverse event, non-fatal|0
4800561|NCT01314872|16554679|P9|Period 2|Adverse event, non-fatal|0
4800562|NCT01314872|16554680|P8|Period 2|Adverse event, non-fatal|0
4800563|NCT01314872|16554681|P7|Period 2|Adverse event, non-fatal|0
4800564|NCT01314872|16554682|P6|Period 2|Adverse event, non-fatal|0
4800565|NCT01314872|16554683|P5|Period 2|Adverse event, non-fatal|0
4800566|NCT01314872|16554684|P4|Period 2|Adverse event, non-fatal|0
4800567|NCT01314872|16554685|P3|Period 2|Adverse event, non-fatal|0
4800568|NCT01314872|16554686|P2|Period 2|Adverse event, non-fatal|0
4800569|NCT01314872|16554687|P1|Period 2|Adverse event, non-fatal|0
4800570|NCT01314872|16554673|P15|Period 2|Study terminated by Sponsor|0
4800571|NCT01314872|16554674|P14|Period 2|Study terminated by Sponsor|3
4800572|NCT01314872|16554675|P13|Period 2|Study terminated by Sponsor|2
4800573|NCT01314872|16554676|P12|Period 2|Study terminated by Sponsor|2
4800574|NCT01314872|16554677|P11|Period 2|Study terminated by Sponsor|0
4800575|NCT01314872|16554678|P10|Period 2|Study terminated by Sponsor|0
4800576|NCT01314872|16554679|P9|Period 2|Study terminated by Sponsor|0
4800577|NCT01314872|16554680|P8|Period 2|Study terminated by Sponsor|0
4800578|NCT01314872|16554681|P7|Period 2|Study terminated by Sponsor|0
4800579|NCT01314872|16554682|P6|Period 2|Study terminated by Sponsor|0
4800580|NCT01314872|16554683|P5|Period 2|Study terminated by Sponsor|0
4800581|NCT01314872|16554684|P4|Period 2|Study terminated by Sponsor|0
4800582|NCT01314872|16554685|P3|Period 2|Study terminated by Sponsor|0
4800583|NCT01314872|16554686|P2|Period 2|Study terminated by Sponsor|0
4800584|NCT01314872|16554687|P1|Period 2|Study terminated by Sponsor|0
4800585|NCT01314872|16554673|P15|Period 2|Pregnancy|1
4800586|NCT01314872|16554674|P14|Period 2|Pregnancy|0
4800587|NCT01314872|16554675|P13|Period 2|Pregnancy|0
4800588|NCT01314872|16554676|P12|Period 2|Pregnancy|0
4800589|NCT01314872|16554677|P11|Period 2|Pregnancy|0
4800590|NCT01314872|16554678|P10|Period 2|Pregnancy|0
4800591|NCT01314872|16554679|P9|Period 2|Pregnancy|0
4800592|NCT01314872|16554680|P8|Period 2|Pregnancy|0
4800593|NCT01314872|16554681|P7|Period 2|Pregnancy|0
4800594|NCT01314872|16554682|P6|Period 2|Pregnancy|0
4800595|NCT01314872|16554683|P5|Period 2|Pregnancy|0
4800596|NCT01314872|16554684|P4|Period 2|Pregnancy|0
4800597|NCT01314872|16554685|P3|Period 2|Pregnancy|0
4800598|NCT01314872|16554686|P2|Period 2|Pregnancy|0
4800599|NCT01314872|16554687|P1|Period 2|Pregnancy|0
4800600|NCT01314872|16554673|P15|Period 2|Lack of Efficacy|2
4800601|NCT01314872|16554674|P14|Period 2|Lack of Efficacy|9
4800602|NCT01314872|16554675|P13|Period 2|Lack of Efficacy|12
4800603|NCT01314872|16554676|P12|Period 2|Lack of Efficacy|7
4800604|NCT01314872|16554677|P11|Period 2|Lack of Efficacy|0
4800605|NCT01314872|16554678|P10|Period 2|Lack of Efficacy|0
4800606|NCT01314872|16554679|P9|Period 2|Lack of Efficacy|0
4800607|NCT01314872|16554680|P8|Period 2|Lack of Efficacy|0
4800608|NCT01314872|16554681|P7|Period 2|Lack of Efficacy|0
4800609|NCT01314872|16554682|P6|Period 2|Lack of Efficacy|0
4800610|NCT01314872|16554683|P5|Period 2|Lack of Efficacy|0
4800611|NCT01314872|16554684|P4|Period 2|Lack of Efficacy|0
4800612|NCT01314872|16554685|P3|Period 2|Lack of Efficacy|0
4800613|NCT01314872|16554686|P2|Period 2|Lack of Efficacy|0
4800614|NCT01314872|16554687|P1|Period 2|Lack of Efficacy|0
4800615|NCT01314872|16554673|P15|Period 2|Non-compliance with study drug|2
4800616|NCT01314872|16554674|P14|Period 2|Non-compliance with study drug|1
4800617|NCT01314872|16554675|P13|Period 2|Non-compliance with study drug|3
4800618|NCT01314872|16554676|P12|Period 2|Non-compliance with study drug|3
4800619|NCT01314872|16554677|P11|Period 2|Non-compliance with study drug|0
4800620|NCT01314872|16554678|P10|Period 2|Non-compliance with study drug|0
4800621|NCT01314872|16554679|P9|Period 2|Non-compliance with study drug|0
4800622|NCT01314872|16554680|P8|Period 2|Non-compliance with study drug|0
4800623|NCT01314872|16554681|P7|Period 2|Non-compliance with study drug|0
4800624|NCT01314872|16554682|P6|Period 2|Non-compliance with study drug|0
4800625|NCT01314872|16554683|P5|Period 2|Non-compliance with study drug|0
4800626|NCT01314872|16554684|P4|Period 2|Non-compliance with study drug|0
4800627|NCT01314872|16554685|P3|Period 2|Non-compliance with study drug|0
4800628|NCT01314872|16554686|P2|Period 2|Non-compliance with study drug|0
4800629|NCT01314872|16554687|P1|Period 2|Non-compliance with study drug|0
4800630|NCT01314872|16554673|P15|Period 2|Protocol Violation|0
4800631|NCT01314872|16554674|P14|Period 2|Protocol Violation|2
4800632|NCT01314872|16554675|P13|Period 2|Protocol Violation|3
4800633|NCT01314872|16554676|P12|Period 2|Protocol Violation|3
4800634|NCT01314872|16554677|P11|Period 2|Protocol Violation|0
4800635|NCT01314872|16554678|P10|Period 2|Protocol Violation|0
4800636|NCT01314872|16554679|P9|Period 2|Protocol Violation|0
4800637|NCT01314872|16554680|P8|Period 2|Protocol Violation|0
4800638|NCT01314872|16554681|P7|Period 2|Protocol Violation|0
4800639|NCT01314872|16554682|P6|Period 2|Protocol Violation|0
4800640|NCT01314872|16554683|P5|Period 2|Protocol Violation|0
4800641|NCT01314872|16554684|P4|Period 2|Protocol Violation|0
4800642|NCT01314872|16554685|P3|Period 2|Protocol Violation|0
4800643|NCT01314872|16554686|P2|Period 2|Protocol Violation|0
4800644|NCT01314872|16554687|P1|Period 2|Protocol Violation|0
4800645|NCT01314872|16554673|P15|Treatment Period 1|Lost to Follow-up|0
4800646|NCT01314872|16554674|P14|Treatment Period 1|Lost to Follow-up|0
4800647|NCT01314872|16554675|P13|Treatment Period 1|Lost to Follow-up|0
4800648|NCT01314872|16554676|P12|Treatment Period 1|Lost to Follow-up|0
4800649|NCT01314872|16554677|P11|Treatment Period 1|Lost to Follow-up|0
4800650|NCT01314872|16554678|P10|Treatment Period 1|Lost to Follow-up|0
4800651|NCT01314872|16554679|P9|Treatment Period 1|Lost to Follow-up|1
4800652|NCT01314872|16554680|P8|Treatment Period 1|Lost to Follow-up|1
4800653|NCT01314872|16554681|P7|Treatment Period 1|Lost to Follow-up|1
4800654|NCT01314872|16554682|P6|Treatment Period 1|Lost to Follow-up|1
4800655|NCT01314872|16554683|P5|Treatment Period 1|Lost to Follow-up|1
4800656|NCT01314872|16554684|P4|Treatment Period 1|Lost to Follow-up|2
4800657|NCT01314872|16554685|P3|Treatment Period 1|Lost to Follow-up|2
4800658|NCT01314872|16554686|P2|Treatment Period 1|Lost to Follow-up|1
4800659|NCT01314872|16554687|P1|Treatment Period 1|Lost to Follow-up|0
4800660|NCT01314872|16554673|P15|Treatment Period 1|Withdrawal by Subject|0
4800661|NCT01314872|16554674|P14|Treatment Period 1|Withdrawal by Subject|0
4800662|NCT01314872|16554675|P13|Treatment Period 1|Withdrawal by Subject|0
4800663|NCT01314872|16554676|P12|Treatment Period 1|Withdrawal by Subject|0
4800664|NCT01314872|16554677|P11|Treatment Period 1|Withdrawal by Subject|1
4800665|NCT01314872|16554678|P10|Treatment Period 1|Withdrawal by Subject|2
4800666|NCT01314872|16554679|P9|Treatment Period 1|Withdrawal by Subject|2
4800667|NCT01314872|16554680|P8|Treatment Period 1|Withdrawal by Subject|2
4800668|NCT01314872|16554681|P7|Treatment Period 1|Withdrawal by Subject|3
4800669|NCT01314872|16554682|P6|Treatment Period 1|Withdrawal by Subject|1
4800670|NCT01314872|16554683|P5|Treatment Period 1|Withdrawal by Subject|3
4800671|NCT01314872|16554684|P4|Treatment Period 1|Withdrawal by Subject|2
4800672|NCT01314872|16554685|P3|Treatment Period 1|Withdrawal by Subject|0
4800673|NCT01314872|16554686|P2|Treatment Period 1|Withdrawal by Subject|1
4800674|NCT01314872|16554687|P1|Treatment Period 1|Withdrawal by Subject|3
4800675|NCT01314872|16554673|P15|Treatment Period 1|Adverse event, non-fatal|0
4800676|NCT01314872|16554674|P14|Treatment Period 1|Adverse event, non-fatal|0
4800677|NCT01314872|16554675|P13|Treatment Period 1|Adverse event, non-fatal|0
4800678|NCT01314872|16554676|P12|Treatment Period 1|Adverse event, non-fatal|0
4800679|NCT01314872|16554677|P11|Treatment Period 1|Adverse event, non-fatal|1
4800680|NCT01314872|16554678|P10|Treatment Period 1|Adverse event, non-fatal|0
4800681|NCT01314872|16554679|P9|Treatment Period 1|Adverse event, non-fatal|3
4800682|NCT01314872|16554680|P8|Treatment Period 1|Adverse event, non-fatal|2
4800683|NCT01314872|16554681|P7|Treatment Period 1|Adverse event, non-fatal|4
4800684|NCT01314872|16554682|P6|Treatment Period 1|Adverse event, non-fatal|4
4800685|NCT01314872|16554683|P5|Treatment Period 1|Adverse event, non-fatal|2
4800686|NCT01314872|16554684|P4|Treatment Period 1|Adverse event, non-fatal|2
4800687|NCT01314872|16554685|P3|Treatment Period 1|Adverse event, non-fatal|3
4800688|NCT01314872|16554686|P2|Treatment Period 1|Adverse event, non-fatal|2
4800689|NCT01314872|16554687|P1|Treatment Period 1|Adverse event, non-fatal|4
4800690|NCT01314872|16554673|P15|Treatment Period 1|Lack of Efficacy|0
4800691|NCT01314872|16554674|P14|Treatment Period 1|Lack of Efficacy|0
4800692|NCT01314872|16554675|P13|Treatment Period 1|Lack of Efficacy|0
4800693|NCT01314872|16554676|P12|Treatment Period 1|Lack of Efficacy|0
4800694|NCT01314872|16554677|P11|Treatment Period 1|Lack of Efficacy|0
4800695|NCT01314872|16554678|P10|Treatment Period 1|Lack of Efficacy|0
4800696|NCT01314872|16554679|P9|Treatment Period 1|Lack of Efficacy|0
4800697|NCT01314872|16554680|P8|Treatment Period 1|Lack of Efficacy|2
4800698|NCT01314872|16554681|P7|Treatment Period 1|Lack of Efficacy|0
4800699|NCT01314872|16554682|P6|Treatment Period 1|Lack of Efficacy|1
4800700|NCT01314872|16554683|P5|Treatment Period 1|Lack of Efficacy|0
4800701|NCT01314872|16554684|P4|Treatment Period 1|Lack of Efficacy|0
4800702|NCT01314872|16554685|P3|Treatment Period 1|Lack of Efficacy|0
4800703|NCT01314872|16554686|P2|Treatment Period 1|Lack of Efficacy|0
4800704|NCT01314872|16554687|P1|Treatment Period 1|Lack of Efficacy|1
4800705|NCT01314872|16554673|P15|Treatment Period 1|Physician Decision|0
4800706|NCT01314872|16554674|P14|Treatment Period 1|Physician Decision|0
4800707|NCT01314872|16554675|P13|Treatment Period 1|Physician Decision|0
4800708|NCT01314872|16554676|P12|Treatment Period 1|Physician Decision|0
4800709|NCT01314872|16554677|P11|Treatment Period 1|Physician Decision|0
4800710|NCT01314872|16554678|P10|Treatment Period 1|Physician Decision|1
4800711|NCT01314872|16554679|P9|Treatment Period 1|Physician Decision|0
4800712|NCT01314872|16554680|P8|Treatment Period 1|Physician Decision|0
4800713|NCT01314872|16554681|P7|Treatment Period 1|Physician Decision|0
4800714|NCT01314872|16554682|P6|Treatment Period 1|Physician Decision|0
4800715|NCT01314872|16554683|P5|Treatment Period 1|Physician Decision|0
4800716|NCT01314872|16554684|P4|Treatment Period 1|Physician Decision|1
4800717|NCT01314872|16554685|P3|Treatment Period 1|Physician Decision|0
4800718|NCT01314872|16554686|P2|Treatment Period 1|Physician Decision|1
4800719|NCT01314872|16554687|P1|Treatment Period 1|Physician Decision|0
4800720|NCT01314872|16554673|P15|Treatment Period 1|Protocol Violation|0
4800721|NCT01314872|16554674|P14|Treatment Period 1|Protocol Violation|0
4800722|NCT01314872|16554675|P13|Treatment Period 1|Protocol Violation|0
4800723|NCT01314872|16554676|P12|Treatment Period 1|Protocol Violation|0
4800724|NCT01314872|16554677|P11|Treatment Period 1|Protocol Violation|1
4800725|NCT01314872|16554678|P10|Treatment Period 1|Protocol Violation|1
4800726|NCT01314872|16554679|P9|Treatment Period 1|Protocol Violation|0
4800727|NCT01314872|16554680|P8|Treatment Period 1|Protocol Violation|0
4800728|NCT01314872|16554681|P7|Treatment Period 1|Protocol Violation|0
4800729|NCT01314872|16554682|P6|Treatment Period 1|Protocol Violation|0
4800730|NCT01314872|16554683|P5|Treatment Period 1|Protocol Violation|1
4800731|NCT01314872|16554684|P4|Treatment Period 1|Protocol Violation|0
4800732|NCT01314872|16554685|P3|Treatment Period 1|Protocol Violation|1
4800733|NCT01314872|16554686|P2|Treatment Period 1|Protocol Violation|1
4800734|NCT01314872|16554687|P1|Treatment Period 1|Protocol Violation|2
4800735|NCT01314716|16554791|P2|Open-Label Phase|Physician Decision|4
4800736|NCT01314716|16554792|P1|Open-Label Phase|Physician Decision|5
4800737|NCT01314716|16554791|P2|Open-Label Phase|Withdrawal by Subject|2
4800738|NCT01314716|16554792|P1|Open-Label Phase|Withdrawal by Subject|1
4800739|NCT01314716|16554791|P2|Open-Label Phase|Adverse Event|6
4800740|NCT01314716|16554792|P1|Open-Label Phase|Adverse Event|4
4800741|NCT01314716|16554791|P2|Double-Blind Phase|Physician Decision|1
4800742|NCT01314716|16554792|P1|Double-Blind Phase|Physician Decision|0
4800743|NCT01314716|16554791|P2|Double-Blind Phase|Sponsor request|2
4800744|NCT01314716|16554792|P1|Double-Blind Phase|Sponsor request|1
4800745|NCT01314716|16554791|P2|Double-Blind Phase|Lost to Follow-up|1
4800746|NCT01314716|16554792|P1|Double-Blind Phase|Lost to Follow-up|0
4800747|NCT01314716|16554791|P2|Double-Blind Phase|Withdrawal by Subject|6
4800748|NCT01314716|16554792|P1|Double-Blind Phase|Withdrawal by Subject|5
4800749|NCT01314716|16554791|P2|Double-Blind Phase|Adverse Event|4
4800750|NCT01314716|16554792|P1|Double-Blind Phase|Adverse Event|10
4800751|NCT01314716|16554791|P2|Double-Blind Phase|Randomized but not treated|1
4800752|NCT01314716|16554792|P1|Double-Blind Phase|Randomized but not treated|1
4800753|NCT01314703|16554804|P1|Overall Study|screen failure and closed enrollment|8
4800754|NCT01314443|16554813|P4|Overall Study|Protocol Violation|1
4800755|NCT01314443|16554814|P3|Overall Study|Protocol Violation|1
4800756|NCT01314443|16554815|P2|Overall Study|Protocol Violation|2
4800757|NCT01314443|16554816|P1|Overall Study|Protocol Violation|2
4800758|NCT01314443|16554813|P4|Overall Study|Withdrawal by Subject|1
4800759|NCT01314443|16554814|P3|Overall Study|Withdrawal by Subject|1
4800760|NCT01314443|16554815|P2|Overall Study|Withdrawal by Subject|1
4800761|NCT01314443|16554816|P1|Overall Study|Withdrawal by Subject|2
4800762|NCT01314261|16554886|P4|Overall Study|Virologic Failure|1
4800763|NCT01314261|16554887|P3|Overall Study|Virologic Failure|0
4800764|NCT01314261|16554888|P2|Overall Study|Virologic Failure|1
4800765|NCT01314261|16554889|P1|Overall Study|Virologic Failure|0
4800766|NCT01314261|16554886|P4|Overall Study|Lost to Follow-up|2
4800767|NCT01314261|16554887|P3|Overall Study|Lost to Follow-up|2
4800768|NCT01314261|16554888|P2|Overall Study|Lost to Follow-up|0
4800769|NCT01314261|16554889|P1|Overall Study|Lost to Follow-up|1
4800770|NCT01314261|16554886|P4|Overall Study|Withdrawal by Subject|0
4800771|NCT01314261|16554887|P3|Overall Study|Withdrawal by Subject|1
4800772|NCT01314261|16554888|P2|Overall Study|Withdrawal by Subject|3
4800773|NCT01314261|16554889|P1|Overall Study|Withdrawal by Subject|0
4800774|NCT01314261|16554886|P4|Overall Study|Adverse Event|0
4800775|NCT01314261|16554887|P3|Overall Study|Adverse Event|0
4800776|NCT01314261|16554888|P2|Overall Study|Adverse Event|0
4800777|NCT01314261|16554889|P1|Overall Study|Adverse Event|1
4800778|NCT01314118|16554940|P1|Overall Study|Ongoing|62
4800779|NCT01314118|16554940|P1|Overall Study|Other|2
4800780|NCT01314118|16554940|P1|Overall Study|Withdrawal by Subject|11
4800781|NCT01314118|16554940|P1|Overall Study|Protocol Violation|5
4800782|NCT01314118|16554940|P1|Overall Study|Death|4
4800783|NCT01314118|16554940|P1|Overall Study|Physician Decision|11
4800784|NCT01314118|16554940|P1|Overall Study|Progressive disease|27
4800785|NCT01314118|16554940|P1|Overall Study|Adverse Event|9
4800786|NCT01314105|16554949|P2|Overall Study|Other Adverse Event|1
4800787|NCT01314105|16554950|P1|Overall Study|Other Adverse Event|1
4800788|NCT01314105|16554949|P2|Overall Study|Refused to continue taking medication|1
4800789|NCT01314105|16554950|P1|Overall Study|Refused to continue taking medication|0
4800790|NCT01314105|16554949|P2|Overall Study|Progressive Disease|10
4800791|NCT01314105|16554950|P1|Overall Study|Progressive Disease|6
4800792|NCT01313923|16555068|P1|Overall Study|Physician Decision|3
4800793|NCT01313884|16555084|P1|Overall Study|Per insurance pvdr, pt can't be on cl tr|1
4800794|NCT01313858|16555092|P3|Overall Study|Lost to Follow-up|47
4800795|NCT01313858|16555093|P2|Overall Study|Lost to Follow-up|51
4800796|NCT01313858|16555094|P1|Overall Study|Lost to Follow-up|35
4800797|NCT01313858|16555092|P3|Overall Study|Premature Treatment Termination|191
4800798|NCT01313858|16555093|P2|Overall Study|Premature Treatment Termination|219
4800799|NCT01313858|16555094|P1|Overall Study|Premature Treatment Termination|251
4800800|NCT01313780|16555117|P2|Overall Study|missing data|3
4800801|NCT01313780|16555118|P1|Overall Study|missing data|3
4800802|NCT01313780|16555117|P2|Overall Study|Protocol Violation|4
4800803|NCT01313780|16555118|P1|Overall Study|Protocol Violation|10
4800804|NCT01313780|16555117|P2|Overall Study|Withdrawal by Subject|8
4800805|NCT01313780|16555118|P1|Overall Study|Withdrawal by Subject|2
4800806|NCT01313780|16555117|P2|Overall Study|Adverse Event|11
4800807|NCT01313780|16555118|P1|Overall Study|Adverse Event|6
4800808|NCT01313780|16555117|P2|Overall Study|Lack of Efficacy|2
4800809|NCT01313780|16555118|P1|Overall Study|Lack of Efficacy|4
4800810|NCT01313767|16555128|P2|Overall Study|Protocol Violation|1
4800811|NCT01313767|16555129|P1|Overall Study|Protocol Violation|3
4800812|NCT01313767|16555128|P2|Overall Study|Withdrawal by Subject|1
4800813|NCT01313767|16555129|P1|Overall Study|Withdrawal by Subject|2
4800814|NCT01313767|16555128|P2|Overall Study|Lost to Follow-up|0
4800815|NCT01313767|16555129|P1|Overall Study|Lost to Follow-up|1
4800816|NCT01313767|16555128|P2|Overall Study|Adverse Event|0
4800817|NCT01313767|16555129|P1|Overall Study|Adverse Event|1
4800818|NCT01313728|16555171|P1|Informed Consent to Baseline|Withdrawal by Subject|1
4800819|NCT01313689|16555191|P5|24-Week Randomization 2|Physician Decision|4
4800820|NCT01313689|16555192|P4|24-Week Randomization 2|Physician Decision|0
4800821|NCT01313689|16555193|P3|24-Week Randomization 2|Physician Decision|0
4800822|NCT01313689|16555194|P2|24-Week Randomization 2|Physician Decision|0
4800823|NCT01313689|16555195|P1|24-Week Randomization 2|Physician Decision|0
4800824|NCT01313689|16555191|P5|24-Week Randomization 2|Withdrawal by Subject|3
4800825|NCT01313689|16555192|P4|24-Week Randomization 2|Withdrawal by Subject|1
4800826|NCT01313689|16555193|P3|24-Week Randomization 2|Withdrawal by Subject|1
4800827|NCT01313689|16555194|P2|24-Week Randomization 2|Withdrawal by Subject|0
4800828|NCT01313689|16555195|P1|24-Week Randomization 2|Withdrawal by Subject|0
4800829|NCT01313689|16555191|P5|24-Week Randomization 2|Adverse Event|8
4800830|NCT01313689|16555192|P4|24-Week Randomization 2|Adverse Event|0
4800831|NCT01313689|16555193|P3|24-Week Randomization 2|Adverse Event|2
4800832|NCT01313689|16555194|P2|24-Week Randomization 2|Adverse Event|0
4800833|NCT01313689|16555195|P1|24-Week Randomization 2|Adverse Event|0
4800834|NCT01313689|16555191|P5|24-Week Randomization 1|Withdrawal by Subject|0
4800835|NCT01313689|16555192|P4|24-Week Randomization 1|Withdrawal by Subject|0
4800836|NCT01313689|16555193|P3|24-Week Randomization 1|Withdrawal by Subject|0
4800837|NCT01313689|16555194|P2|24-Week Randomization 1|Withdrawal by Subject|0
4800838|NCT01313689|16555195|P1|24-Week Randomization 1|Withdrawal by Subject|5
4800839|NCT01313689|16555191|P5|24-Week Randomization 1|Physician Decision|0
4800840|NCT01313689|16555192|P4|24-Week Randomization 1|Physician Decision|0
4800841|NCT01313689|16555193|P3|24-Week Randomization 1|Physician Decision|0
4800842|NCT01313689|16555194|P2|24-Week Randomization 1|Physician Decision|5
4800843|NCT01313689|16555195|P1|24-Week Randomization 1|Physician Decision|4
4800844|NCT01313689|16555191|P5|24-Week Randomization 1|Adverse Event|0
4800845|NCT01313689|16555192|P4|24-Week Randomization 1|Adverse Event|0
4800846|NCT01313689|16555193|P3|24-Week Randomization 1|Adverse Event|0
4800847|NCT01313689|16555194|P2|24-Week Randomization 1|Adverse Event|5
4800848|NCT01313689|16555195|P1|24-Week Randomization 1|Adverse Event|10
4800849|NCT01313676|16555274|P4|Overall Study|Missing|0
4800850|NCT01313676|16555275|P3|Overall Study|Missing|1
4800851|NCT01313676|16555276|P2|Overall Study|Missing|1
4800852|NCT01313676|16555277|P1|Overall Study|Missing|1
4800853|NCT01313676|16555274|P4|Overall Study|Investigator Site Closed|10
4800854|NCT01313676|16555275|P3|Overall Study|Investigator Site Closed|15
4800855|NCT01313676|16555276|P2|Overall Study|Investigator Site Closed|11
4800856|NCT01313676|16555277|P1|Overall Study|Investigator Site Closed|12
4800857|NCT01313676|16555274|P4|Overall Study|Sponsor Terminated Study Treatment|1
4800858|NCT01313676|16555275|P3|Overall Study|Sponsor Terminated Study Treatment|0
4800859|NCT01313676|16555276|P2|Overall Study|Sponsor Terminated Study Treatment|1
4800860|NCT01313676|16555277|P1|Overall Study|Sponsor Terminated Study Treatment|1
4800861|NCT01313676|16555274|P4|Overall Study|Decision by Participant or Proxy|492
4800862|NCT01313676|16555275|P3|Overall Study|Decision by Participant or Proxy|515
4800863|NCT01313676|16555276|P2|Overall Study|Decision by Participant or Proxy|527
4800864|NCT01313676|16555277|P1|Overall Study|Decision by Participant or Proxy|643
4800865|NCT01313676|16555274|P4|Overall Study|Physician Decision|48
4800866|NCT01313676|16555275|P3|Overall Study|Physician Decision|62
4800867|NCT01313676|16555276|P2|Overall Study|Physician Decision|64
4800868|NCT01313676|16555277|P1|Overall Study|Physician Decision|53
4800869|NCT01313676|16555274|P4|Overall Study|Lost to Follow-up|0
4800870|NCT01313676|16555275|P3|Overall Study|Lost to Follow-up|1
4800871|NCT01313676|16555276|P2|Overall Study|Lost to Follow-up|0
4800872|NCT01313676|16555277|P1|Overall Study|Lost to Follow-up|0
4800873|NCT01313676|16555274|P4|Overall Study|Study Closed/terminated|9
4800874|NCT01313676|16555275|P3|Overall Study|Study Closed/terminated|9
4800875|NCT01313676|16555276|P2|Overall Study|Study Closed/terminated|6
4800876|NCT01313676|16555277|P1|Overall Study|Study Closed/terminated|7
4800877|NCT01313676|16555274|P4|Overall Study|Met Protocol-Defined Stopping Critera|11
4800878|NCT01313676|16555275|P3|Overall Study|Met Protocol-Defined Stopping Critera|2
4800879|NCT01313676|16555276|P2|Overall Study|Met Protocol-Defined Stopping Critera|4
4800880|NCT01313676|16555277|P1|Overall Study|Met Protocol-Defined Stopping Critera|3
4800881|NCT01313676|16555274|P4|Overall Study|Protocol Violation|44
4800882|NCT01313676|16555275|P3|Overall Study|Protocol Violation|46
4800883|NCT01313676|16555276|P2|Overall Study|Protocol Violation|44
4800884|NCT01313676|16555277|P1|Overall Study|Protocol Violation|37
4800885|NCT01313676|16555274|P4|Overall Study|Lack of Efficacy|46
4800886|NCT01313676|16555275|P3|Overall Study|Lack of Efficacy|65
4800887|NCT01313676|16555276|P2|Overall Study|Lack of Efficacy|90
4800888|NCT01313676|16555277|P1|Overall Study|Lack of Efficacy|98
4800889|NCT01313676|16555274|P4|Overall Study|Adverse Event|333
4800890|NCT01313676|16555275|P3|Overall Study|Adverse Event|372
4800891|NCT01313676|16555276|P2|Overall Study|Adverse Event|365
4800892|NCT01313676|16555277|P1|Overall Study|Adverse Event|395
4800893|NCT01313663|16555297|P2|Overall Study|Withdrawal by Subject|1
4800894|NCT01313663|16555298|P1|Overall Study|Withdrawal by Subject|2
4800895|NCT01313663|16555297|P2|Overall Study|Physician Decision|2
4800896|NCT01313663|16555298|P1|Overall Study|Physician Decision|0
4800897|NCT01313663|16555297|P2|Overall Study|Lost to Follow-up|1
4800898|NCT01313663|16555298|P1|Overall Study|Lost to Follow-up|0
4800899|NCT01313663|16555297|P2|Overall Study|Study Closed/Terminated|4
4800900|NCT01313663|16555298|P1|Overall Study|Study Closed/Terminated|2
4800901|NCT01313650|16555336|P4|Overall Study|Met Protocol-defined Stopping Criteria|15
4800902|NCT01313650|16555337|P3|Overall Study|Met Protocol-defined Stopping Criteria|24
4800903|NCT01313650|16555338|P2|Overall Study|Met Protocol-defined Stopping Criteria|13
4800904|NCT01313650|16555339|P1|Overall Study|Met Protocol-defined Stopping Criteria|9
4800905|NCT01313650|16555336|P4|Overall Study|Protocol Violation|6
4800906|NCT01313650|16555337|P3|Overall Study|Protocol Violation|5
4800907|NCT01313650|16555338|P2|Overall Study|Protocol Violation|7
4800908|NCT01313650|16555339|P1|Overall Study|Protocol Violation|4
4800909|NCT01313650|16555336|P4|Overall Study|Withdrawal by Subject|15
4800910|NCT01313650|16555337|P3|Overall Study|Withdrawal by Subject|15
4800911|NCT01313650|16555338|P2|Overall Study|Withdrawal by Subject|20
4800912|NCT01313650|16555339|P1|Overall Study|Withdrawal by Subject|16
4800913|NCT01313650|16555336|P4|Overall Study|Lost to Follow-up|2
4800914|NCT01313650|16555337|P3|Overall Study|Lost to Follow-up|3
4800915|NCT01313650|16555338|P2|Overall Study|Lost to Follow-up|0
4800916|NCT01313650|16555339|P1|Overall Study|Lost to Follow-up|1
4800917|NCT01313650|16555336|P4|Overall Study|Lack of Efficacy|20
4800918|NCT01313650|16555337|P3|Overall Study|Lack of Efficacy|32
4800919|NCT01313650|16555338|P2|Overall Study|Lack of Efficacy|20
4800920|NCT01313650|16555339|P1|Overall Study|Lack of Efficacy|37
4800921|NCT01313650|16555336|P4|Overall Study|Adverse Event|23
4800922|NCT01313650|16555337|P3|Overall Study|Adverse Event|24
4800923|NCT01313650|16555338|P2|Overall Study|Adverse Event|34
4800924|NCT01313650|16555339|P1|Overall Study|Adverse Event|9
4800925|NCT01313637|16555365|P4|Overall Study|Withdrawal by Subject|15
4800926|NCT01313637|16555366|P3|Overall Study|Withdrawal by Subject|18
4800927|NCT01313637|16555367|P2|Overall Study|Withdrawal by Subject|13
4800928|NCT01313637|16555368|P1|Overall Study|Withdrawal by Subject|11
4800929|NCT01313637|16555365|P4|Overall Study|Lost to Follow-up|3
4800930|NCT01313637|16555366|P3|Overall Study|Lost to Follow-up|1
4800931|NCT01313637|16555367|P2|Overall Study|Lost to Follow-up|2
4800932|NCT01313637|16555368|P1|Overall Study|Lost to Follow-up|0
4800933|NCT01313637|16555365|P4|Overall Study|Met Protocol- Defined Stopping Criteria|13
4800934|NCT01313637|16555366|P3|Overall Study|Met Protocol- Defined Stopping Criteria|14
4800935|NCT01313637|16555367|P2|Overall Study|Met Protocol- Defined Stopping Criteria|15
4800936|NCT01313637|16555368|P1|Overall Study|Met Protocol- Defined Stopping Criteria|16
4800937|NCT01313637|16555365|P4|Overall Study|Protocol Violation|5
4800938|NCT01313637|16555366|P3|Overall Study|Protocol Violation|11
4800939|NCT01313637|16555367|P2|Overall Study|Protocol Violation|3
4800940|NCT01313637|16555368|P1|Overall Study|Protocol Violation|4
4800941|NCT01313637|16555365|P4|Overall Study|Lack of Efficacy|24
4800942|NCT01313637|16555366|P3|Overall Study|Lack of Efficacy|37
4800943|NCT01313637|16555367|P2|Overall Study|Lack of Efficacy|38
4800944|NCT01313637|16555368|P1|Overall Study|Lack of Efficacy|44
4800945|NCT01313637|16555365|P4|Overall Study|Adverse Event|18
4800946|NCT01313637|16555366|P3|Overall Study|Adverse Event|25
4800947|NCT01313637|16555367|P2|Overall Study|Adverse Event|24
4800948|NCT01313637|16555368|P1|Overall Study|Adverse Event|17
4800949|NCT01313624|16555392|P2|Open-Label Phase|Lost to Follow-up|1
4800950|NCT01313624|16555393|P1|Open-Label Phase|Lost to Follow-up|1
4800951|NCT01313624|16555392|P2|Open-Label Phase|Withdrawal by Subject|2
4800952|NCT01313624|16555393|P1|Open-Label Phase|Withdrawal by Subject|2
4800953|NCT01313624|16555392|P2|Open-Label Phase|Adverse Event|10
4800954|NCT01313624|16555393|P1|Open-Label Phase|Adverse Event|1
4800955|NCT01313624|16555392|P2|Double-Blind Phase|Lack of Efficacy|0
4800956|NCT01313624|16555393|P1|Double-Blind Phase|Lack of Efficacy|1
4800957|NCT01313624|16555392|P2|Double-Blind Phase|Physician Decision|0
4800958|NCT01313624|16555393|P1|Double-Blind Phase|Physician Decision|1
4800959|NCT01313624|16555392|P2|Double-Blind Phase|Lost to Follow-up|2
4800960|NCT01313624|16555393|P1|Double-Blind Phase|Lost to Follow-up|0
4800961|NCT01313624|16555392|P2|Double-Blind Phase|Withdrawal by Subject|4
4800962|NCT01313624|16555393|P1|Double-Blind Phase|Withdrawal by Subject|9
4800963|NCT01313624|16555392|P2|Double-Blind Phase|Adverse Event|4
4800964|NCT01313624|16555393|P1|Double-Blind Phase|Adverse Event|27
4800965|NCT01313559|16555407|P2|Overall Study|Rising PSA|0
4800966|NCT01313559|16555408|P1|Overall Study|Rising PSA|2
4800967|NCT01313559|16555407|P2|Overall Study|Disease progression|0
4800968|NCT01313559|16555408|P1|Overall Study|Disease progression|1
4800969|NCT01313559|16555407|P2|Overall Study|Withdrawal by Subject|2
4800970|NCT01313559|16555408|P1|Overall Study|Withdrawal by Subject|1
4800971|NCT01313312|16555509|P1|Overall Study|Did Not Receive Treatment with Dysport®|4
4800972|NCT01313312|16555509|P1|Overall Study|Subject Withdrawn Early in Error|4
4800973|NCT01313312|16555509|P1|Overall Study|Observational Phase|1
4800974|NCT01313312|16555509|P1|Overall Study|Investigator Decision|1
4800975|NCT01313312|16555509|P1|Overall Study|Lack of Efficacy|3
4800976|NCT01313312|16555509|P1|Overall Study|Withdrawal by Subject|18
4800977|NCT01313312|16555509|P1|Overall Study|Adverse Event|5
4800978|NCT01313299|16555556|P3|Overall Study|Lack of subject compliance|1
4800979|NCT01313299|16555557|P2|Overall Study|Lack of subject compliance|0
4800980|NCT01313299|16555558|P1|Overall Study|Lack of subject compliance|0
4800981|NCT01313299|16555556|P3|Overall Study|Family reason and moved out of state|0
4800982|NCT01313299|16555557|P2|Overall Study|Family reason and moved out of state|2
4800983|NCT01313299|16555558|P1|Overall Study|Family reason and moved out of state|0
4800984|NCT01313299|16555556|P3|Overall Study|Withdrawal by Subject|2
4800985|NCT01313299|16555557|P2|Overall Study|Withdrawal by Subject|0
4800986|NCT01313299|16555558|P1|Overall Study|Withdrawal by Subject|1
4800987|NCT01313299|16555556|P3|Overall Study|Protocol Violation|0
4800988|NCT01313299|16555557|P2|Overall Study|Protocol Violation|0
4800989|NCT01313299|16555558|P1|Overall Study|Protocol Violation|2
4800990|NCT01313299|16555556|P3|Overall Study|Lost to Follow-up|0
4800991|NCT01313299|16555557|P2|Overall Study|Lost to Follow-up|0
4800992|NCT01313299|16555558|P1|Overall Study|Lost to Follow-up|1
4800993|NCT01313299|16555556|P3|Overall Study|Adverse Event|1
4800994|NCT01313299|16555557|P2|Overall Study|Adverse Event|1
4800995|NCT01313299|16555558|P1|Overall Study|Adverse Event|3
4800996|NCT01313286|16555572|P2|Period 1|Withdrawal by Subject|0
4800997|NCT01313286|16555573|P1|Period 1|Withdrawal by Subject|2
4800998|NCT01313273|16555583|P2|Overall Study|Screening Chromogranin A-in normal range|1
4800999|NCT01313273|16555584|P1|Overall Study|Screening Chromogranin A-in normal range|0
4801000|NCT01313273|16555583|P2|Overall Study|Withdrawal by Subject|0
4801001|NCT01313273|16555584|P1|Overall Study|Withdrawal by Subject|1
4801002|NCT01313273|16555583|P2|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0
4801003|NCT01313273|16555584|P1|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1
4801004|NCT01313221|16555599|P3|Overall Study|Pregnancy|2
4801005|NCT01313221|16555600|P2|Overall Study|Pregnancy|0
4801006|NCT01313221|16555601|P1|Overall Study|Pregnancy|0
4801007|NCT01313221|16555599|P3|Overall Study|Physician Decision|2
4801008|NCT01313221|16555600|P2|Overall Study|Physician Decision|0
4801009|NCT01313221|16555601|P1|Overall Study|Physician Decision|0
4801010|NCT01313221|16555599|P3|Overall Study|Disease progression|2
4801011|NCT01313221|16555600|P2|Overall Study|Disease progression|0
4801012|NCT01313221|16555601|P1|Overall Study|Disease progression|0
4801013|NCT01313221|16555599|P3|Overall Study|Adverse Event|7
4801014|NCT01313221|16555600|P2|Overall Study|Adverse Event|0
4801015|NCT01313221|16555601|P1|Overall Study|Adverse Event|0
4801016|NCT01313221|16555599|P3|Overall Study|Other|0
4801017|NCT01313221|16555600|P2|Overall Study|Other|0
4801018|NCT01313221|16555601|P1|Overall Study|Other|1
4801019|NCT01313221|16555599|P3|Overall Study|Lost to Follow-up|1
4801020|NCT01313221|16555600|P2|Overall Study|Lost to Follow-up|3
4801021|NCT01313221|16555601|P1|Overall Study|Lost to Follow-up|6
4801022|NCT01313221|16555599|P3|Overall Study|Requirement for alternative therapy|1
4801023|NCT01313221|16555600|P2|Overall Study|Requirement for alternative therapy|1
4801024|NCT01313221|16555601|P1|Overall Study|Requirement for alternative therapy|0
4801025|NCT01313221|16555599|P3|Overall Study|Withdrawal by Subject|5
4801026|NCT01313221|16555600|P2|Overall Study|Withdrawal by Subject|3
4801027|NCT01313221|16555601|P1|Overall Study|Withdrawal by Subject|2
4801028|NCT01313221|16555599|P3|Overall Study|Non-compliance|2
4801029|NCT01313221|16555600|P2|Overall Study|Non-compliance|0
4801030|NCT01313221|16555601|P1|Overall Study|Non-compliance|3
4801031|NCT01313221|16555599|P3|Overall Study|Protocol Violation|1
4801032|NCT01313221|16555600|P2|Overall Study|Protocol Violation|1
4801033|NCT01313221|16555601|P1|Overall Study|Protocol Violation|0
4801034|NCT01313208|16555653|P2|Open-label Phase (Weeks 13 - 24)|Other|0
4801035|NCT01313208|16555654|P1|Open-label Phase (Weeks 13 - 24)|Other|2
4801036|NCT01313208|16555653|P2|Open-label Phase (Weeks 13 - 24)|Adverse Event|0
4801037|NCT01313208|16555654|P1|Open-label Phase (Weeks 13 - 24)|Adverse Event|1
4801038|NCT01313208|16555653|P2|Open-label Phase (Weeks 13 - 24)|Noncompliance|2
4801039|NCT01313208|16555654|P1|Open-label Phase (Weeks 13 - 24)|Noncompliance|0
4801040|NCT01313208|16555653|P2|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1
4801041|NCT01313208|16555654|P1|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3
4801042|NCT01313208|16555653|P2|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0
4801043|NCT01313208|16555654|P1|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1
4801044|NCT01313208|16555653|P2|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0
4801045|NCT01313208|16555654|P1|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1
4801046|NCT01313208|16555653|P2|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1
4801047|NCT01313208|16555654|P1|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0
4801048|NCT01313208|16555653|P2|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2
4801049|NCT01313208|16555654|P1|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1
4801050|NCT01313208|16555653|P2|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2
4801051|NCT01313208|16555654|P1|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3
4801052|NCT01313182|16555744|P2|Overall Study|Protocol Violation|92
4801053|NCT01313182|16555745|P1|Overall Study|Protocol Violation|66
4801054|NCT01313117|16555757|P1|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
4801055|NCT01313117|16555757|P1|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1
4801056|NCT01313078|16555764|P1|Overall Study|Withdrawal by Subject|1
4801057|NCT01313078|16555764|P1|Overall Study|Discontinued study drug|1
4801058|NCT01313078|16555764|P1|Overall Study|Death|1
4801059|NCT01313039|16555769|P1|Overall Study|Adverse Event|1
4801060|NCT01313039|16555769|P1|Overall Study|Physician Decision|1
4801061|NCT01312961|16555775|P2|Overall Study|Other than specified above|3
4801062|NCT01312961|16555776|P1|Overall Study|Other than specified above|2
4801063|NCT01312961|16555775|P2|Overall Study|Poor compliance to protocol|0
4801064|NCT01312961|16555776|P1|Overall Study|Poor compliance to protocol|1
4801065|NCT01312961|16555775|P2|Overall Study|Lack of Efficacy|1
4801066|NCT01312961|16555776|P1|Overall Study|Lack of Efficacy|11
4801067|NCT01312961|16555775|P2|Overall Study|Adverse Event|3
4801068|NCT01312961|16555776|P1|Overall Study|Adverse Event|3
4801069|NCT01312909|16555812|P3|Overall Study|Entrance criteria not met|2
4801070|NCT01312909|16555813|P2|Overall Study|Entrance criteria not met|0
4801071|NCT01312909|16555814|P1|Overall Study|Entrance criteria not met|0
4801072|NCT01312909|16555812|P3|Overall Study|Insufficient clinical response|1
4801073|NCT01312909|16555813|P2|Overall Study|Insufficient clinical response|0
4801074|NCT01312909|16555814|P1|Overall Study|Insufficient clinical response|0
4801075|NCT01312909|16555812|P3|Overall Study|Lost to Follow-up|20
4801076|NCT01312909|16555813|P2|Overall Study|Lost to Follow-up|17
4801077|NCT01312909|16555814|P1|Overall Study|Lost to Follow-up|21
4801078|NCT01312909|16555812|P3|Overall Study|Withdrawal by Subject|7
4801079|NCT01312909|16555813|P2|Overall Study|Withdrawal by Subject|10
4801080|NCT01312909|16555814|P1|Overall Study|Withdrawal by Subject|8
4801081|NCT01312909|16555812|P3|Overall Study|Other|11
4801082|NCT01312909|16555813|P2|Overall Study|Other|6
4801083|NCT01312909|16555814|P1|Overall Study|Other|9
4801084|NCT01312909|16555812|P3|Overall Study|Protocol Violation|2
4801085|NCT01312909|16555813|P2|Overall Study|Protocol Violation|0
4801086|NCT01312909|16555814|P1|Overall Study|Protocol Violation|2
4801087|NCT01312909|16555812|P3|Overall Study|Adverse Event|3
4801088|NCT01312909|16555813|P2|Overall Study|Adverse Event|0
4801089|NCT01312909|16555814|P1|Overall Study|Adverse Event|1
4801090|NCT01312909|16555812|P3|Overall Study|Randomized but not treated|1
4801091|NCT01312909|16555813|P2|Overall Study|Randomized but not treated|3
4801092|NCT01312909|16555814|P1|Overall Study|Randomized but not treated|1
4801093|NCT01312779|16555901|P1|Overall Study|Not Implanted with Device|27
4801094|NCT01312779|16555901|P1|Overall Study|Death|3
4801095|NCT01312779|16555901|P1|Overall Study|Withdrawal by Subject|2
4801096|NCT01312467|16555984|P1|Overall Study|Ineligible|4
4801097|NCT01312467|16555984|P1|Overall Study|Another medical condition|1
4801098|NCT01312467|16555984|P1|Overall Study|Deported to country of origin|1
4801099|NCT01312467|16555984|P1|Overall Study|Withdrawal by Subject|2
4801100|NCT01312467|16555984|P1|Overall Study|Lost to Follow-up|1
4801101|NCT01312467|16555984|P1|Overall Study|Adverse Event|4
4801102|NCT01312428|16555993|P2|Overall Study|Study Termination|4
4801103|NCT01312428|16555994|P1|Overall Study|Study Termination|3
4801104|NCT01312129|16556064|P2|Second Intervention (24 Hours)|Lost to Follow-up|1
4801105|NCT01312129|16556065|P1|Second Intervention (24 Hours)|Lost to Follow-up|0
4801106|NCT01311661|16556150|P1|Overall Study|Withdrawal by Subject|2
4801107|NCT01311661|16556150|P1|Overall Study|Protocol Violation|3
4801108|NCT01311661|16556150|P1|Overall Study|Adverse Event|2
4801109|NCT01311557|16556294|P2|Overall Study|Withdrawal by Subject|2
4801110|NCT01311557|16556295|P1|Overall Study|Withdrawal by Subject|1
4801111|NCT01311557|16556294|P2|Overall Study|Lost to Follow-up|1
4801112|NCT01311557|16556295|P1|Overall Study|Lost to Follow-up|0
4801113|NCT01311557|16556294|P2|Overall Study|Protocol Violation|2
4801114|NCT01311557|16556295|P1|Overall Study|Protocol Violation|4
4801115|NCT01311557|16556294|P2|Overall Study|Serious adverse event|1
4801116|NCT01311557|16556295|P1|Overall Study|Serious adverse event|0
4801117|NCT01311505|16556311|P2|First Intervention Period|Protocol Violation|1
4801118|NCT01311505|16556312|P1|First Intervention Period|Protocol Violation|0
4801119|NCT01311024|16556368|P2|Overall Study|Protocol Violation|22
4801120|NCT01311024|16556369|P1|Overall Study|Protocol Violation|35
4801121|NCT01310868|16556375|P1|Overall Study|Do not have histologically confirmed GBM|13
4801122|NCT01310803|16556392|P2|Overall Study|Subject terminated by Sponsor|0
4801123|NCT01310803|16556393|P1|Overall Study|Subject terminated by Sponsor|1
4801124|NCT01310777|16556404|P3|Overall Study|Other|2
4801125|NCT01310777|16556405|P2|Overall Study|Other|1
4801126|NCT01310777|16556406|P1|Overall Study|Other|4
4801127|NCT01310777|16556404|P3|Overall Study|Inadequate Control of IOP|10
4801128|NCT01310777|16556405|P2|Overall Study|Inadequate Control of IOP|7
4801129|NCT01310777|16556406|P1|Overall Study|Inadequate Control of IOP|5
4801130|NCT01310777|16556404|P3|Overall Study|Patient's Decision Unrelated to AE|2
4801131|NCT01310777|16556405|P2|Overall Study|Patient's Decision Unrelated to AE|1
4801132|NCT01310777|16556406|P1|Overall Study|Patient's Decision Unrelated to AE|1
4801133|NCT01310777|16556404|P3|Overall Study|Lost to Follow-up|1
4801134|NCT01310777|16556405|P2|Overall Study|Lost to Follow-up|4
4801135|NCT01310777|16556406|P1|Overall Study|Lost to Follow-up|0
4801136|NCT01310777|16556404|P3|Overall Study|Adverse Event|15
4801137|NCT01310777|16556405|P2|Overall Study|Adverse Event|1
4801138|NCT01310777|16556406|P1|Overall Study|Adverse Event|23
4801139|NCT01310699|16556416|P2|Overall Study|Patients did not complete tandem.|6
4801140|NCT01310699|16556417|P1|Overall Study|Patients did not complete tandem.|4
4801141|NCT01310413|16556444|P7|From Day U0 to Day U385|Lost to Follow-up|2
4801142|NCT01310413|16556445|P6|From Day U0 to Day U385|Lost to Follow-up|0
4801143|NCT01310413|16556446|P5|From Day U0 to Day U385|Lost to Follow-up|0
4801144|NCT01310413|16556447|P4|From Day U0 to Day U385|Lost to Follow-up|0
4801145|NCT01310413|16556448|P3|From Day U0 to Day U385|Lost to Follow-up|0
4801146|NCT01310413|16556449|P2|From Day U0 to Day U385|Lost to Follow-up|0
4801147|NCT01310413|16556450|P1|From Day U0 to Day U385|Lost to Follow-up|0
4801148|NCT01310413|16556444|P7|From Day U0 to Day U385|Withdrawal by Subject|1
4801149|NCT01310413|16556445|P6|From Day U0 to Day U385|Withdrawal by Subject|0
4801150|NCT01310413|16556446|P5|From Day U0 to Day U385|Withdrawal by Subject|0
4801151|NCT01310413|16556447|P4|From Day U0 to Day U385|Withdrawal by Subject|0
4801152|NCT01310413|16556448|P3|From Day U0 to Day U385|Withdrawal by Subject|0
4801153|NCT01310413|16556449|P2|From Day U0 to Day U385|Withdrawal by Subject|0
4801154|NCT01310413|16556450|P1|From Day U0 to Day U385|Withdrawal by Subject|0
4801155|NCT01310413|16556444|P7|Day 0 to Day 385|Other|0
4801156|NCT01310413|16556445|P6|Day 0 to Day 385|Other|0
4801157|NCT01310413|16556446|P5|Day 0 to Day 385|Other|0
4801158|NCT01310413|16556447|P4|Day 0 to Day 385|Other|0
4801159|NCT01310413|16556448|P3|Day 0 to Day 385|Other|3
4801160|NCT01310413|16556449|P2|Day 0 to Day 385|Other|0
4801161|NCT01310413|16556450|P1|Day 0 to Day 385|Other|1
4801162|NCT01310413|16556444|P7|Day 0 to Day 385|Migrated/moved from study area|0
4801163|NCT01310413|16556445|P6|Day 0 to Day 385|Migrated/moved from study area|0
4801164|NCT01310413|16556446|P5|Day 0 to Day 385|Migrated/moved from study area|1
4801165|NCT01310413|16556447|P4|Day 0 to Day 385|Migrated/moved from study area|1
4801166|NCT01310413|16556448|P3|Day 0 to Day 385|Migrated/moved from study area|1
4801167|NCT01310413|16556449|P2|Day 0 to Day 385|Migrated/moved from study area|3
4801168|NCT01310413|16556450|P1|Day 0 to Day 385|Migrated/moved from study area|3
4801169|NCT01310413|16556444|P7|Day 0 to Day 385|Lost to Follow-up|0
4801170|NCT01310413|16556445|P6|Day 0 to Day 385|Lost to Follow-up|2
4801171|NCT01310413|16556446|P5|Day 0 to Day 385|Lost to Follow-up|1
4801172|NCT01310413|16556447|P4|Day 0 to Day 385|Lost to Follow-up|5
4801173|NCT01310413|16556448|P3|Day 0 to Day 385|Lost to Follow-up|3
4801174|NCT01310413|16556449|P2|Day 0 to Day 385|Lost to Follow-up|3
4801175|NCT01310413|16556450|P1|Day 0 to Day 385|Lost to Follow-up|18
4801176|NCT01310413|16556444|P7|Day 0 to Day 385|Withdrawal by Subject|0
4801177|NCT01310413|16556445|P6|Day 0 to Day 385|Withdrawal by Subject|1
4801178|NCT01310413|16556446|P5|Day 0 to Day 385|Withdrawal by Subject|1
4801179|NCT01310413|16556447|P4|Day 0 to Day 385|Withdrawal by Subject|2
4801180|NCT01310413|16556448|P3|Day 0 to Day 385|Withdrawal by Subject|0
4801181|NCT01310413|16556449|P2|Day 0 to Day 385|Withdrawal by Subject|2
4801182|NCT01310413|16556450|P1|Day 0 to Day 385|Withdrawal by Subject|5
4801183|NCT01310075|16556632|P2|Overall Study|Withdrawal by Subject|1
4801184|NCT01310075|16556633|P1|Overall Study|Withdrawal by Subject|1
4801185|NCT01310075|16556632|P2|Overall Study|Protocol Violation|2
4801186|NCT01310075|16556633|P1|Overall Study|Protocol Violation|2
4801187|NCT01310075|16556632|P2|Overall Study|Physician Decision|7
4801188|NCT01310075|16556633|P1|Overall Study|Physician Decision|10
4801189|NCT01310075|16556632|P2|Overall Study|Lost to Follow-up|0
4801190|NCT01310075|16556633|P1|Overall Study|Lost to Follow-up|1
4801191|NCT01310036|16556639|P1|Overall Study|Adverse event or intercurrent illness|12
4801192|NCT01310036|16556639|P1|Overall Study|Death|1
4801193|NCT01310036|16556639|P1|Overall Study|Progression of Disease|164
4801194|NCT01310036|16556639|P1|Overall Study|Refused Treatment/Did not Cooperate|4
4801195|NCT01310036|16556639|P1|Overall Study|Withdrew Consent|11
4801196|NCT01310036|16556639|P1|Overall Study|Administrative/other|10
4801197|NCT01309997|16556652|P2|Overall Study|Withdrawal by Subject|1
4801198|NCT01309997|16556653|P1|Overall Study|Withdrawal by Subject|1
4801199|NCT01309997|16556652|P2|Overall Study|Lack of Efficacy|2
4801200|NCT01309997|16556653|P1|Overall Study|Lack of Efficacy|2
4801201|NCT01309997|16556652|P2|Overall Study|Death|3
4801202|NCT01309997|16556653|P1|Overall Study|Death|1
4801203|NCT01309997|16556652|P2|Overall Study|Adverse Event|0
4801204|NCT01309997|16556653|P1|Overall Study|Adverse Event|1
4801205|NCT01309919|16556677|P2|Overall Study|Did not receive a postpartum IUD|48
4801206|NCT01309919|16556678|P1|Overall Study|Did not receive a postpartum IUD|17
4801207|NCT01309893|16556701|P2|Week 2 - Crossover Intervention|Missed crossover visit|1
4801208|NCT01309893|16556702|P1|Week 2 - Crossover Intervention|Missed crossover visit|0
4801209|NCT01309893|16556701|P2|Week 2 - Crossover Intervention|Lost to Follow-up|0
4801210|NCT01309893|16556702|P1|Week 2 - Crossover Intervention|Lost to Follow-up|1
4801211|NCT01309841|16556739|P3|Overall Study|Severe non-compliance with protocol|2
4801212|NCT01309841|16556740|P2|Overall Study|Severe non-compliance with protocol|5
4801213|NCT01309841|16556741|P1|Overall Study|Severe non-compliance with protocol|0
4801214|NCT01309841|16556739|P3|Overall Study|Did Not Receive Treatment|1
4801215|NCT01309841|16556740|P2|Overall Study|Did Not Receive Treatment|0
4801216|NCT01309841|16556741|P1|Overall Study|Did Not Receive Treatment|2
4801217|NCT01309841|16556739|P3|Overall Study|Withdrawal by Subject|13
4801218|NCT01309841|16556740|P2|Overall Study|Withdrawal by Subject|6
4801219|NCT01309841|16556741|P1|Overall Study|Withdrawal by Subject|17
4801220|NCT01309841|16556739|P3|Overall Study|Eligibility Criteria Not Fulfilled|1
4801221|NCT01309841|16556740|P2|Overall Study|Eligibility Criteria Not Fulfilled|0
4801222|NCT01309841|16556741|P1|Overall Study|Eligibility Criteria Not Fulfilled|0
4801223|NCT01309841|16556739|P3|Overall Study|Death|0
4801224|NCT01309841|16556740|P2|Overall Study|Death|0
4801225|NCT01309841|16556741|P1|Overall Study|Death|1
4801226|NCT01309841|16556739|P3|Overall Study|Adverse Event|11
4801227|NCT01309841|16556740|P2|Overall Study|Adverse Event|22
4801228|NCT01309841|16556741|P1|Overall Study|Adverse Event|9
4801229|NCT01309841|16556739|P3|Overall Study|Lack of Efficacy|2
4801230|NCT01309841|16556740|P2|Overall Study|Lack of Efficacy|0
4801231|NCT01309841|16556741|P1|Overall Study|Lack of Efficacy|0
4801232|NCT01309841|16556739|P3|Overall Study|Study-Specific Withdrawal Criteria|2
4801233|NCT01309841|16556740|P2|Overall Study|Study-Specific Withdrawal Criteria|1
4801234|NCT01309841|16556741|P1|Overall Study|Study-Specific Withdrawal Criteria|3
4801235|NCT01309841|16556739|P3|Overall Study|Lost to Follow-up|4
4801236|NCT01309841|16556740|P2|Overall Study|Lost to Follow-up|6
4801237|NCT01309841|16556741|P1|Overall Study|Lost to Follow-up|7
4801238|NCT01309841|16556739|P3|Overall Study|Other|1
4801239|NCT01309841|16556740|P2|Overall Study|Other|1
4801240|NCT01309841|16556741|P1|Overall Study|Other|0
4801241|NCT01309828|16556781|P2|Overall Study|Other|0
4801242|NCT01309828|16556782|P1|Overall Study|Other|1
4801243|NCT01309828|16556781|P2|Overall Study|Major Protocol Deviation|1
4801244|NCT01309828|16556782|P1|Overall Study|Major Protocol Deviation|0
4801245|NCT01309828|16556781|P2|Overall Study|Voluntary Withdrawal|4
4801246|NCT01309828|16556782|P1|Overall Study|Voluntary Withdrawal|5
4801247|NCT01309828|16556781|P2|Overall Study|Adverse Event|11
4801248|NCT01309828|16556782|P1|Overall Study|Adverse Event|10
4801249|NCT01309737|16556816|P5|Week 16 to 52|Other|0
4801250|NCT01309737|16556817|P4|Week 16 to 52|Other|2
4801251|NCT01309737|16556818|P3|Week 16 to 52|Other|0
4801252|NCT01309737|16556819|P2|Week 16 to 52|Other|12
4801253|NCT01309737|16556820|P1|Week 16 to 52|Other|10
4801254|NCT01309737|16556816|P5|Week 16 to 52|Withdrawal by Subject|2
4801255|NCT01309737|16556817|P4|Week 16 to 52|Withdrawal by Subject|0
4801256|NCT01309737|16556818|P3|Week 16 to 52|Withdrawal by Subject|0
4801257|NCT01309737|16556819|P2|Week 16 to 52|Withdrawal by Subject|6
4801258|NCT01309737|16556820|P1|Week 16 to 52|Withdrawal by Subject|5
4801259|NCT01309737|16556816|P5|Week 16 to 52|Lost to Follow-up|4
4801260|NCT01309737|16556817|P4|Week 16 to 52|Lost to Follow-up|1
4801261|NCT01309737|16556818|P3|Week 16 to 52|Lost to Follow-up|0
4801262|NCT01309737|16556819|P2|Week 16 to 52|Lost to Follow-up|2
4801263|NCT01309737|16556820|P1|Week 16 to 52|Lost to Follow-up|4
4801264|NCT01309737|16556816|P5|Week 16 to 52|Lack of Efficacy|21
4801265|NCT01309737|16556817|P4|Week 16 to 52|Lack of Efficacy|25
4801266|NCT01309737|16556818|P3|Week 16 to 52|Lack of Efficacy|0
4801267|NCT01309737|16556819|P2|Week 16 to 52|Lack of Efficacy|76
4801268|NCT01309737|16556820|P1|Week 16 to 52|Lack of Efficacy|107
4801269|NCT01309737|16556816|P5|Week 16 to 52|Adverse Event|5
4801270|NCT01309737|16556817|P4|Week 16 to 52|Adverse Event|6
4801271|NCT01309737|16556818|P3|Week 16 to 52|Adverse Event|0
4801272|NCT01309737|16556819|P2|Week 16 to 52|Adverse Event|7
4801273|NCT01309737|16556820|P1|Week 16 to 52|Adverse Event|7
4801274|NCT01309737|16556816|P5|Week 16 to 52|Death|1
4801275|NCT01309737|16556817|P4|Week 16 to 52|Death|0
4801276|NCT01309737|16556818|P3|Week 16 to 52|Death|0
4801277|NCT01309737|16556819|P2|Week 16 to 52|Death|0
4801278|NCT01309737|16556820|P1|Week 16 to 52|Death|0
4801279|NCT01309737|16556816|P5|Week 0 to 16|Randomized, but not treated|0
4801280|NCT01309737|16556817|P4|Week 0 to 16|Randomized, but not treated|0
4801281|NCT01309737|16556818|P3|Week 0 to 16|Randomized, but not treated|0
4801282|NCT01309737|16556819|P2|Week 0 to 16|Randomized, but not treated|0
4801283|NCT01309737|16556820|P1|Week 0 to 16|Randomized, but not treated|1
4801284|NCT01309737|16556816|P5|Week 0 to 16|Other|0
4801285|NCT01309737|16556817|P4|Week 0 to 16|Other|0
4801286|NCT01309737|16556818|P3|Week 0 to 16|Other|4
4801287|NCT01309737|16556819|P2|Week 0 to 16|Other|14
4801288|NCT01309737|16556820|P1|Week 0 to 16|Other|10
4801289|NCT01309737|16556816|P5|Week 0 to 16|Withdrawal by Subject|0
4801290|NCT01309737|16556817|P4|Week 0 to 16|Withdrawal by Subject|0
4801291|NCT01309737|16556818|P3|Week 0 to 16|Withdrawal by Subject|7
4801292|NCT01309737|16556819|P2|Week 0 to 16|Withdrawal by Subject|6
4801293|NCT01309737|16556820|P1|Week 0 to 16|Withdrawal by Subject|7
4801294|NCT01309737|16556816|P5|Week 0 to 16|Lost to Follow-up|0
4801295|NCT01309737|16556817|P4|Week 0 to 16|Lost to Follow-up|0
4801296|NCT01309737|16556818|P3|Week 0 to 16|Lost to Follow-up|3
4801297|NCT01309737|16556819|P2|Week 0 to 16|Lost to Follow-up|8
4801298|NCT01309737|16556820|P1|Week 0 to 16|Lost to Follow-up|7
4801299|NCT01309737|16556816|P5|Week 0 to 16|Lack of Efficacy|0
4801300|NCT01309737|16556817|P4|Week 0 to 16|Lack of Efficacy|0
4801301|NCT01309737|16556818|P3|Week 0 to 16|Lack of Efficacy|24
4801302|NCT01309737|16556819|P2|Week 0 to 16|Lack of Efficacy|2
4801303|NCT01309737|16556820|P1|Week 0 to 16|Lack of Efficacy|15
4801304|NCT01309737|16556816|P5|Week 0 to 16|Adverse Event|0
4801305|NCT01309737|16556817|P4|Week 0 to 16|Adverse Event|0
4801306|NCT01309737|16556818|P3|Week 0 to 16|Adverse Event|5
4801307|NCT01309737|16556819|P2|Week 0 to 16|Adverse Event|10
4801308|NCT01309737|16556820|P1|Week 0 to 16|Adverse Event|11
4801309|NCT01309737|16556816|P5|Week 0 to 16|Death|0
4801310|NCT01309737|16556817|P4|Week 0 to 16|Death|0
4801311|NCT01309737|16556818|P3|Week 0 to 16|Death|1
4801312|NCT01309737|16556819|P2|Week 0 to 16|Death|0
4801313|NCT01309737|16556820|P1|Week 0 to 16|Death|1
4801314|NCT01309672|16557015|P1|Overall Study|Withdrawal by Subject|3
4801315|NCT01309672|16557015|P1|Overall Study|Adverse Event|5
4801316|NCT01309672|16557015|P1|Overall Study|Other|9
4801317|NCT01309672|16557015|P1|Overall Study|Lack of Efficacy|20
4801318|NCT01309659|16557025|P2|Overall Study|Protocol Violation|1
4801319|NCT01309659|16557026|P1|Overall Study|Protocol Violation|0
4801320|NCT01309386|16557131|P2|Overall Study|Adverse Event|8
4801321|NCT01309386|16557132|P1|Overall Study|Adverse Event|5
4801322|NCT01309386|16557131|P2|Overall Study|Lack of Efficacy|1
4801323|NCT01309386|16557132|P1|Overall Study|Lack of Efficacy|3
4801324|NCT01309386|16557131|P2|Overall Study|Physician Decision|1
4801325|NCT01309386|16557132|P1|Overall Study|Physician Decision|1
4801326|NCT01309386|16557131|P2|Overall Study|Progressive disease|11
4801327|NCT01309386|16557132|P1|Overall Study|Progressive disease|9
4801328|NCT01309386|16557131|P2|Overall Study|Withdrawal by Subject|0
4801329|NCT01309386|16557132|P1|Overall Study|Withdrawal by Subject|2
4801330|NCT01309386|16557131|P2|Overall Study|Other|0
4801331|NCT01309386|16557132|P1|Overall Study|Other|2
4801332|NCT01309308|16557180|P2|Overall Study|Lost to Follow-up|4
4801333|NCT01309308|16557181|P1|Overall Study|Lost to Follow-up|6
4801334|NCT01309282|16557189|P1|Overall Study|Lost to Follow-up|1
4801335|NCT01309269|16557206|P1|Overall Study|Enrolled but not Treated|107
4801336|NCT01309269|16557206|P1|Overall Study|Study Completion Data Not Recorded|95
4801337|NCT01309269|16557206|P1|Overall Study|Other|1
4801338|NCT01309269|16557206|P1|Overall Study|Other|256
4801339|NCT01309269|16557206|P1|Overall Study|Administrative Problems|141
4801340|NCT01309269|16557206|P1|Overall Study|Kidney Transplant|25
4801341|NCT01309269|16557206|P1|Overall Study|Other Erythropoiesis-stimulating Agents|119
4801342|NCT01309269|16557206|P1|Overall Study|Lack of Acceptance|15
4801343|NCT01309269|16557206|P1|Overall Study|Withdrawal by Subject|25
4801344|NCT01309269|16557206|P1|Overall Study|Adverse Event|56
4801345|NCT01309243|16557214|P2|Extension Phase|Lost to Follow-up|0
4801346|NCT01309243|16557215|P1|Extension Phase|Lost to Follow-up|6
4801347|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Protocol Violation|1
4801348|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Protocol Violation|1
4801349|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Subject Non-Compliance|7
4801350|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Subject Non-Compliance|9
4801351|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Lost to Follow-up|22
4801352|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Lost to Follow-up|23
4801353|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Withdrew Consent|18
4801354|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Withdrew Consent|12
4801355|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Investigators Discretion|6
4801356|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Investigators Discretion|3
4801357|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Lack of Efficacy|4
4801358|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Lack of Efficacy|16
4801359|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Pregnancy|0
4801360|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Pregnancy|2
4801361|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Death|1
4801362|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Death|0
4801363|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Adverse Event|43
4801364|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Adverse Event|12
4801365|NCT01309243|16557214|P2|Randomized Phase Through Week 96|Randomized but not treated|7
4801366|NCT01309243|16557215|P1|Randomized Phase Through Week 96|Randomized but not treated|6
4801367|NCT01309204|16557241|P2|Overall Study|Other|1
4801368|NCT01309204|16557242|P1|Overall Study|Other|4
4801369|NCT01309204|16557241|P2|Overall Study|Inadequate control of IOP|4
4801370|NCT01309204|16557242|P1|Overall Study|Inadequate control of IOP|4
4801371|NCT01309204|16557241|P2|Overall Study|Subject's decision unrelated to an AE|10
4801372|NCT01309204|16557242|P1|Overall Study|Subject's decision unrelated to an AE|9
4801373|NCT01309204|16557241|P2|Overall Study|Lost to Follow-up|2
4801374|NCT01309204|16557242|P1|Overall Study|Lost to Follow-up|2
4801375|NCT01309204|16557241|P2|Overall Study|Adverse Event|58
4801376|NCT01309204|16557242|P1|Overall Study|Adverse Event|48
4801377|NCT01309165|16557250|P2|Overall Study|Admitted to hospital for second stroke|0
4801378|NCT01309165|16557251|P1|Overall Study|Admitted to hospital for second stroke|1
4801379|NCT01309165|16557250|P2|Overall Study|No transportation|1
4801380|NCT01309165|16557251|P1|Overall Study|No transportation|0
4801381|NCT01309165|16557250|P2|Overall Study|Left country|1
4801382|NCT01309165|16557251|P1|Overall Study|Left country|0
4801383|NCT01309165|16557250|P2|Overall Study|Return to work|2
4801384|NCT01309165|16557251|P1|Overall Study|Return to work|1
4801385|NCT01309165|16557250|P2|Overall Study|Lost to Follow-up|3
4801386|NCT01309165|16557251|P1|Overall Study|Lost to Follow-up|4
4801387|NCT01309100|16557263|P1|Overall Study|Positive Slit lamp finding|1
4801388|NCT01309100|16557263|P1|Overall Study|Protocol Violation|1
4801389|NCT01308853|16557281|P1|Overall Study|Insertion of permanent implants|1
4801390|NCT01308853|16557281|P1|Overall Study|Lost to Follow-up|2
4801391|NCT01308853|16557281|P1|Overall Study|Adverse Event|1
4801392|NCT01308788|16557316|P2|2-year Treatment|medication change by treating physician|11
4801393|NCT01308788|16557317|P1|2-year Treatment|medication change by treating physician|4
4801394|NCT01308762|16557352|P3|Overall Study|Protocol Violation|0
4801395|NCT01308762|16557353|P2|Overall Study|Protocol Violation|1
4801396|NCT01308762|16557354|P1|Overall Study|Protocol Violation|0
4801397|NCT01308749|16557367|P2|Period 2: Open Label Treatment|Lost to Follow-up|1
4801398|NCT01308749|16557368|P1|Period 2: Open Label Treatment|Lost to Follow-up|0
4801399|NCT01308749|16557367|P2|Period 2: Open Label Treatment|Adverse Event|1
4801400|NCT01308749|16557368|P1|Period 2: Open Label Treatment|Adverse Event|0
4801401|NCT01308749|16557367|P2|Period 1: Double Blind Treatment|Adverse Event|0
4801402|NCT01308749|16557368|P1|Period 1: Double Blind Treatment|Adverse Event|1
4801403|NCT01308736|16557398|P2|Overall Study|Did not attend a single session|5
4801404|NCT01308736|16557399|P1|Overall Study|Did not attend a single session|6
4801405|NCT01308580|16557422|P2|Overall Study|Lost to Follow-up|7
4801406|NCT01308580|16557423|P1|Overall Study|Lost to Follow-up|12
4801407|NCT01308567|16557466|P3|Overall Study|Lost to Follow-up|4
4801408|NCT01308567|16557467|P2|Overall Study|Lost to Follow-up|4
4801409|NCT01308567|16557468|P1|Overall Study|Lost to Follow-up|2
4801410|NCT01308476|16557508|P2|Overall Study|Other|0
4801411|NCT01308476|16557509|P1|Overall Study|Other|1
4801412|NCT01308476|16557508|P2|Overall Study|Lost to Follow-up|2
4801413|NCT01308476|16557509|P1|Overall Study|Lost to Follow-up|2
4801414|NCT01308463|16557529|P1|Overall Study|Revision|2
4801415|NCT01308463|16557529|P1|Overall Study|Death|4
4801416|NCT01308463|16557529|P1|Overall Study|Study Discontinued|23
4801417|NCT01308424|16557542|P3|Randomization|Physician Decision|1
4801418|NCT01308424|16557543|P2|Randomization|Physician Decision|1
4801419|NCT01308424|16557544|P1|Randomization|Physician Decision|0
4801420|NCT01308424|16557542|P3|Randomization|Lost to Follow-up|0
4801421|NCT01308424|16557543|P2|Randomization|Lost to Follow-up|1
4801422|NCT01308424|16557544|P1|Randomization|Lost to Follow-up|0
4801423|NCT01308424|16557542|P3|Randomization|Adverse Event|1
4801424|NCT01308424|16557543|P2|Randomization|Adverse Event|1
4801425|NCT01308424|16557544|P1|Randomization|Adverse Event|0
4801426|NCT01308424|16557542|P3|Baseline Eligibility|Screen Failures|0
4801427|NCT01308424|16557543|P2|Baseline Eligibility|Screen Failures|0
4801428|NCT01308424|16557544|P1|Baseline Eligibility|Screen Failures|71
4801429|NCT01308008|16557596|P2|4 Weeks|Illness, disinterest, time|2
4801430|NCT01308008|16557597|P1|4 Weeks|Illness, disinterest, time|9
4801431|NCT01307891|16557620|P2|Overall Study|Progressive Disease|1
4801432|NCT01307891|16557621|P1|Overall Study|Progressive Disease|3
4801433|NCT01307787|16557633|P2|Overall Study|Withdrawal by Subject|0
4801434|NCT01307787|16557634|P1|Overall Study|Withdrawal by Subject|2
4801435|NCT01307579|16557703|P2|Overall Study|Ineligible|4
4801436|NCT01307579|16557704|P1|Overall Study|Ineligible|3
4801437|NCT01307579|16557703|P2|Overall Study|Refractory or relapsed AML|23
4801438|NCT01307579|16557704|P1|Overall Study|Refractory or relapsed AML|38
4801439|NCT01307579|16557703|P2|Overall Study|Begin conditioning for HSCT|44
4801440|NCT01307579|16557704|P1|Overall Study|Begin conditioning for HSCT|42
4801441|NCT01307579|16557703|P2|Overall Study|Institutional diagnosis of IFD|36
4801442|NCT01307579|16557704|P1|Overall Study|Institutional diagnosis of IFD|21
4801443|NCT01307579|16557703|P2|Overall Study|Withdrawal by Subject|3
4801444|NCT01307579|16557704|P1|Overall Study|Withdrawal by Subject|7
4801445|NCT01307579|16557703|P2|Overall Study|Physician Decision|29
4801446|NCT01307579|16557704|P1|Overall Study|Physician Decision|26
4801447|NCT01307579|16557703|P2|Overall Study|Death|6
4801448|NCT01307579|16557704|P1|Overall Study|Death|3
4801449|NCT01307501|16557716|P1|Overall Study|Starting Hospice|1
4801450|NCT01307501|16557716|P1|Overall Study|Lost to Follow-up|1
4801451|NCT01307501|16557716|P1|Overall Study|Death|20
4801452|NCT01307501|16557716|P1|Overall Study|Treatment Failure|1
4801453|NCT01307449|16557746|P4|Overall Study|Adverse Event|0
4801454|NCT01307449|16557747|P3|Overall Study|Adverse Event|0
4801455|NCT01307449|16557748|P2|Overall Study|Adverse Event|0
4801456|NCT01307449|16557749|P1|Overall Study|Adverse Event|1
4801457|NCT01307423|16557782|P9|Long-term Safety Phase (Year 5)|Miscellaneous|1
4801458|NCT01307423|16557783|P8|Long-term Safety Phase (Year 5)|Miscellaneous|1
4801459|NCT01307423|16557784|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
4801460|NCT01307423|16557785|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
4801461|NCT01307423|16557786|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
4801462|NCT01307423|16557787|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
4801463|NCT01307423|16557788|P3|Long-term Safety Phase (Year 5)|Miscellaneous|2
4801464|NCT01307423|16557789|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
4801465|NCT01307423|16557790|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
4801466|NCT01307423|16557782|P9|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801467|NCT01307423|16557783|P8|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801468|NCT01307423|16557784|P7|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801469|NCT01307423|16557785|P6|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801470|NCT01307423|16557786|P5|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801471|NCT01307423|16557787|P4|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801472|NCT01307423|16557788|P3|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801473|NCT01307423|16557789|P2|Long-term Safety Phase (Year 5)|Lost to Follow-up|1
4801474|NCT01307423|16557790|P1|Long-term Safety Phase (Year 5)|Lost to Follow-up|0
4801475|NCT01307423|16557782|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
4801476|NCT01307423|16557783|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4801477|NCT01307423|16557784|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4801478|NCT01307423|16557785|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4801479|NCT01307423|16557786|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4801480|NCT01307423|16557787|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4801481|NCT01307423|16557788|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
4801482|NCT01307423|16557789|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6
4801483|NCT01307423|16557790|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4801484|NCT01307423|16557782|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801485|NCT01307423|16557783|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801486|NCT01307423|16557784|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801487|NCT01307423|16557785|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801488|NCT01307423|16557786|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801489|NCT01307423|16557787|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801490|NCT01307423|16557788|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|1
4801491|NCT01307423|16557789|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|2
4801492|NCT01307423|16557790|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4801493|NCT01307423|16557782|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
4801494|NCT01307423|16557783|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
4801495|NCT01307423|16557784|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
4801496|NCT01307423|16557785|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
4801497|NCT01307423|16557786|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
4801498|NCT01307423|16557787|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
4801499|NCT01307423|16557788|P3|Long-term Safety Phase (Year 5)|Adverse Event|1
4801500|NCT01307423|16557789|P2|Long-term Safety Phase (Year 5)|Adverse Event|1
4801501|NCT01307423|16557790|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
4801502|NCT01307423|16557782|P9|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801503|NCT01307423|16557783|P8|Long-term Safety Phase (Year 4)|Miscellaneous|1
4801504|NCT01307423|16557784|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801505|NCT01307423|16557785|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801506|NCT01307423|16557786|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801507|NCT01307423|16557787|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801508|NCT01307423|16557788|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801509|NCT01307423|16557789|P2|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801510|NCT01307423|16557790|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
4801511|NCT01307423|16557782|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801512|NCT01307423|16557783|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801513|NCT01307423|16557784|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801514|NCT01307423|16557785|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801515|NCT01307423|16557786|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801516|NCT01307423|16557787|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801517|NCT01307423|16557788|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
4801518|NCT01307423|16557789|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801519|NCT01307423|16557790|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4801520|NCT01307423|16557782|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
4801521|NCT01307423|16557783|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1
4801522|NCT01307423|16557784|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4801523|NCT01307423|16557785|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4801524|NCT01307423|16557786|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4801525|NCT01307423|16557787|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4801526|NCT01307423|16557788|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4
4801527|NCT01307423|16557789|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5
4801528|NCT01307423|16557790|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4801529|NCT01307423|16557782|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
4801530|NCT01307423|16557783|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801531|NCT01307423|16557784|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801532|NCT01307423|16557785|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801533|NCT01307423|16557786|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801534|NCT01307423|16557787|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801535|NCT01307423|16557788|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801536|NCT01307423|16557789|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
4801537|NCT01307423|16557790|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4801538|NCT01307423|16557782|P9|Long-term Safety Phase (Year 4)|Adverse Event|0
4801539|NCT01307423|16557783|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
4801540|NCT01307423|16557784|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
4801541|NCT01307423|16557785|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
4801542|NCT01307423|16557786|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
4801543|NCT01307423|16557787|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
4801544|NCT01307423|16557788|P3|Long-term Safety Phase (Year 4)|Adverse Event|0
4801545|NCT01307423|16557789|P2|Long-term Safety Phase (Year 4)|Adverse Event|2
4801546|NCT01307423|16557790|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
4801547|NCT01307423|16557782|P9|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801548|NCT01307423|16557783|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
4801549|NCT01307423|16557784|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801550|NCT01307423|16557785|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801551|NCT01307423|16557786|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801552|NCT01307423|16557787|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801553|NCT01307423|16557788|P3|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801554|NCT01307423|16557789|P2|Long-term Safety Phase (Year 3)|Miscellaneous|1
4801555|NCT01307423|16557790|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
4801556|NCT01307423|16557782|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
4801557|NCT01307423|16557783|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
4801558|NCT01307423|16557784|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4801559|NCT01307423|16557785|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4801560|NCT01307423|16557786|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4801561|NCT01307423|16557787|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4801562|NCT01307423|16557788|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|3
4801563|NCT01307423|16557789|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|2
4801564|NCT01307423|16557790|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4801565|NCT01307423|16557782|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
4801566|NCT01307423|16557783|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
4801567|NCT01307423|16557784|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4801568|NCT01307423|16557785|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4801569|NCT01307423|16557786|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4801570|NCT01307423|16557787|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4801571|NCT01307423|16557788|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8
4801572|NCT01307423|16557789|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2
4801573|NCT01307423|16557790|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4801574|NCT01307423|16557782|P9|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801575|NCT01307423|16557783|P8|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801576|NCT01307423|16557784|P7|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801577|NCT01307423|16557785|P6|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801578|NCT01307423|16557786|P5|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801579|NCT01307423|16557787|P4|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801580|NCT01307423|16557788|P3|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
4801581|NCT01307423|16557789|P2|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1
4801582|NCT01307423|16557790|P1|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0
4801583|NCT01307423|16557782|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4801584|NCT01307423|16557783|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|1
4801585|NCT01307423|16557784|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4801586|NCT01307423|16557785|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4801587|NCT01307423|16557786|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4801588|NCT01307423|16557787|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4801589|NCT01307423|16557788|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
4801590|NCT01307423|16557789|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4801591|NCT01307423|16557790|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4801592|NCT01307423|16557782|P9|Long-term Safety Phase (Year 3)|Adverse Event|4
4801593|NCT01307423|16557783|P8|Long-term Safety Phase (Year 3)|Adverse Event|3
4801594|NCT01307423|16557784|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
4801595|NCT01307423|16557785|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
4801596|NCT01307423|16557786|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
4801597|NCT01307423|16557787|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
4801598|NCT01307423|16557788|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
4801599|NCT01307423|16557789|P2|Long-term Safety Phase (Year 3)|Adverse Event|1
4801600|NCT01307423|16557790|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
4801601|NCT01307423|16557782|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
4801602|NCT01307423|16557783|P8|Long-term Safety Phase (Year 2)|Miscellaneous|1
4801603|NCT01307423|16557784|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
4801604|NCT01307423|16557785|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
4801605|NCT01307423|16557786|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
4801606|NCT01307423|16557787|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
4801607|NCT01307423|16557788|P3|Long-term Safety Phase (Year 2)|Miscellaneous|0
4801608|NCT01307423|16557789|P2|Long-term Safety Phase (Year 2)|Miscellaneous|1
4801609|NCT01307423|16557790|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
4801610|NCT01307423|16557782|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2
4801611|NCT01307423|16557783|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
4801612|NCT01307423|16557784|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4801613|NCT01307423|16557785|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4801614|NCT01307423|16557786|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4801615|NCT01307423|16557787|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4801616|NCT01307423|16557788|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12
4801617|NCT01307423|16557789|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13
4801618|NCT01307423|16557790|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4801619|NCT01307423|16557782|P9|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801620|NCT01307423|16557783|P8|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801621|NCT01307423|16557784|P7|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801622|NCT01307423|16557785|P6|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801623|NCT01307423|16557786|P5|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801624|NCT01307423|16557787|P4|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801625|NCT01307423|16557788|P3|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1
4801626|NCT01307423|16557789|P2|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801627|NCT01307423|16557790|P1|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0
4801628|NCT01307423|16557782|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|3
4801629|NCT01307423|16557783|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
4801630|NCT01307423|16557784|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4801631|NCT01307423|16557785|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4801632|NCT01307423|16557786|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4801633|NCT01307423|16557787|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4801634|NCT01307423|16557788|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|5
4801635|NCT01307423|16557789|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
4801636|NCT01307423|16557790|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4801637|NCT01307423|16557782|P9|Long-term Safety Phase (Year 2)|Adverse Event|1
4801638|NCT01307423|16557783|P8|Long-term Safety Phase (Year 2)|Adverse Event|1
4801639|NCT01307423|16557784|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
4801640|NCT01307423|16557785|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
4801641|NCT01307423|16557786|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
4801642|NCT01307423|16557787|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
4801643|NCT01307423|16557788|P3|Long-term Safety Phase (Year 2)|Adverse Event|7
4801644|NCT01307423|16557789|P2|Long-term Safety Phase (Year 2)|Adverse Event|2
4801645|NCT01307423|16557790|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
4801646|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801647|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801648|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801649|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Protocol Violation|1
4801650|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801651|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801652|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801653|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801654|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Protocol Violation|0
4801655|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Other|0
4801656|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Other|0
4801657|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Other|0
4801658|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Other|0
4801659|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Other|0
4801660|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Other|1
4801661|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Other|0
4801662|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Other|0
4801663|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Other|0
4801664|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801665|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801666|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801667|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801668|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801669|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2
4801670|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801671|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801672|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0
4801673|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4801674|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4801675|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
4801676|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1
4801677|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4801678|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4801679|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2
4801680|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11
4801681|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0
4801682|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801683|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801684|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801685|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1
4801686|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801687|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801688|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801689|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801690|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0
4801691|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4801692|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4801693|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4801694|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4801695|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1
4801696|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3
4801697|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
4801698|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5
4801699|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0
4801700|NCT01307423|16557782|P9|Active Treatment Phase (Week 25-52)|Adverse Event|0
4801701|NCT01307423|16557783|P8|Active Treatment Phase (Week 25-52)|Adverse Event|0
4801702|NCT01307423|16557784|P7|Active Treatment Phase (Week 25-52)|Adverse Event|0
4801703|NCT01307423|16557785|P6|Active Treatment Phase (Week 25-52)|Adverse Event|0
4801704|NCT01307423|16557786|P5|Active Treatment Phase (Week 25-52)|Adverse Event|2
4801705|NCT01307423|16557787|P4|Active Treatment Phase (Week 25-52)|Adverse Event|2
4801706|NCT01307423|16557788|P3|Active Treatment Phase (Week 25-52)|Adverse Event|2
4801707|NCT01307423|16557789|P2|Active Treatment Phase (Week 25-52)|Adverse Event|3
4801708|NCT01307423|16557790|P1|Active Treatment Phase (Week 25-52)|Adverse Event|0
4801709|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801710|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801711|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801712|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801713|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801714|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801715|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
4801716|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1
4801717|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0
4801718|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801719|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801720|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801721|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801722|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801723|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801724|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
4801725|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
4801726|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
4801727|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801728|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801729|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801730|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801731|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801732|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801733|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801734|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4801735|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4801736|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4801737|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4801738|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4801739|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4801740|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4801741|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4801742|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
4801743|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4801744|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5
4801745|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801746|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801747|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801748|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801749|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801750|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801751|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
4801752|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801753|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4801754|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4801755|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4801756|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4801757|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4801758|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4801759|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4801760|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10
4801761|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
4801762|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8
4801763|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4801764|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4801765|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4801766|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4801767|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4801768|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4801769|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
4801770|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
4801771|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1
4801772|NCT01307423|16557782|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4801773|NCT01307423|16557783|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4801774|NCT01307423|16557784|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4801775|NCT01307423|16557785|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4801776|NCT01307423|16557786|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4801777|NCT01307423|16557787|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4801778|NCT01307423|16557788|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6
4801779|NCT01307423|16557789|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
4801780|NCT01307423|16557790|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
4801781|NCT01307319|16557996|P3|Overall Study|Other|3
4801782|NCT01307319|16557997|P2|Overall Study|Other|4
4801783|NCT01307319|16557998|P1|Overall Study|Other|0
4801784|NCT01307319|16557996|P3|Overall Study|Withdrawal by Subject|2
4801785|NCT01307319|16557997|P2|Overall Study|Withdrawal by Subject|1
4801786|NCT01307319|16557998|P1|Overall Study|Withdrawal by Subject|0
4801787|NCT01307319|16557996|P3|Overall Study|Protocol Violation|0
4801788|NCT01307319|16557997|P2|Overall Study|Protocol Violation|1
4801789|NCT01307319|16557998|P1|Overall Study|Protocol Violation|1
4801790|NCT01307319|16557996|P3|Overall Study|Lost to Follow-up|1
4801791|NCT01307319|16557997|P2|Overall Study|Lost to Follow-up|0
4801792|NCT01307319|16557998|P1|Overall Study|Lost to Follow-up|1
4801793|NCT01307319|16557996|P3|Overall Study|Adverse Event|1
4801794|NCT01307319|16557997|P2|Overall Study|Adverse Event|2
4801795|NCT01307319|16557998|P1|Overall Study|Adverse Event|2
4801796|NCT01307267|16558032|P23|Overall Study|Other|2
4801797|NCT01307267|16558033|P22|Overall Study|Other|3
4801798|NCT01307267|16558034|P21|Overall Study|Other|2
4801799|NCT01307267|16558035|P20|Overall Study|Other|19
4801800|NCT01307267|16558036|P19|Overall Study|Other|0
4801801|NCT01307267|16558037|P18|Overall Study|Other|0
4801802|NCT01307267|16558038|P17|Overall Study|Other|0
4801803|NCT01307267|16558039|P16|Overall Study|Other|1
4801804|NCT01307267|16558040|P15|Overall Study|Other|2
4801805|NCT01307267|16558041|P14|Overall Study|Other|0
4801806|NCT01307267|16558042|P13|Overall Study|Other|1
4801807|NCT01307267|16558043|P12|Overall Study|Other|1
4801808|NCT01307267|16558044|P11|Overall Study|Other|1
4801809|NCT01307267|16558045|P10|Overall Study|Other|0
4801810|NCT01307267|16558046|P9|Overall Study|Other|3
4801811|NCT01307267|16558047|P8|Overall Study|Other|1
4801812|NCT01307267|16558048|P7|Overall Study|Other|0
4801813|NCT01307267|16558049|P6|Overall Study|Other|7
4801814|NCT01307267|16558050|P5|Overall Study|Other|0
4801815|NCT01307267|16558051|P4|Overall Study|Other|0
4801816|NCT01307267|16558052|P3|Overall Study|Other|0
4801817|NCT01307267|16558053|P2|Overall Study|Other|0
4801818|NCT01307267|16558054|P1|Overall Study|Other|0
4801819|NCT01307267|16558032|P23|Overall Study|Withdrawal by Subject|0
4801820|NCT01307267|16558033|P22|Overall Study|Withdrawal by Subject|0
4801821|NCT01307267|16558034|P21|Overall Study|Withdrawal by Subject|0
4801822|NCT01307267|16558035|P20|Overall Study|Withdrawal by Subject|3
4801823|NCT01307267|16558036|P19|Overall Study|Withdrawal by Subject|0
4801824|NCT01307267|16558037|P18|Overall Study|Withdrawal by Subject|0
4801825|NCT01307267|16558038|P17|Overall Study|Withdrawal by Subject|0
4801826|NCT01307267|16558039|P16|Overall Study|Withdrawal by Subject|0
4801827|NCT01307267|16558040|P15|Overall Study|Withdrawal by Subject|0
4801828|NCT01307267|16558041|P14|Overall Study|Withdrawal by Subject|0
4801829|NCT01307267|16558042|P13|Overall Study|Withdrawal by Subject|0
4801830|NCT01307267|16558043|P12|Overall Study|Withdrawal by Subject|1
4801831|NCT01307267|16558044|P11|Overall Study|Withdrawal by Subject|1
4801832|NCT01307267|16558045|P10|Overall Study|Withdrawal by Subject|1
4801833|NCT01307267|16558046|P9|Overall Study|Withdrawal by Subject|5
4801834|NCT01307267|16558047|P8|Overall Study|Withdrawal by Subject|1
4801835|NCT01307267|16558048|P7|Overall Study|Withdrawal by Subject|0
4801836|NCT01307267|16558049|P6|Overall Study|Withdrawal by Subject|1
4801837|NCT01307267|16558050|P5|Overall Study|Withdrawal by Subject|0
4801838|NCT01307267|16558051|P4|Overall Study|Withdrawal by Subject|0
4801839|NCT01307267|16558052|P3|Overall Study|Withdrawal by Subject|0
4801840|NCT01307267|16558053|P2|Overall Study|Withdrawal by Subject|0
4801841|NCT01307267|16558054|P1|Overall Study|Withdrawal by Subject|0
4801842|NCT01307267|16558032|P23|Overall Study|Lost to Follow-up|0
4801843|NCT01307267|16558033|P22|Overall Study|Lost to Follow-up|0
4801844|NCT01307267|16558034|P21|Overall Study|Lost to Follow-up|0
4801845|NCT01307267|16558035|P20|Overall Study|Lost to Follow-up|2
4801846|NCT01307267|16558036|P19|Overall Study|Lost to Follow-up|0
4801847|NCT01307267|16558037|P18|Overall Study|Lost to Follow-up|0
4801848|NCT01307267|16558038|P17|Overall Study|Lost to Follow-up|0
4801849|NCT01307267|16558039|P16|Overall Study|Lost to Follow-up|0
4801850|NCT01307267|16558040|P15|Overall Study|Lost to Follow-up|0
4801851|NCT01307267|16558041|P14|Overall Study|Lost to Follow-up|0
4801852|NCT01307267|16558042|P13|Overall Study|Lost to Follow-up|0
4801853|NCT01307267|16558043|P12|Overall Study|Lost to Follow-up|0
4801854|NCT01307267|16558044|P11|Overall Study|Lost to Follow-up|1
4801855|NCT01307267|16558045|P10|Overall Study|Lost to Follow-up|2
4801856|NCT01307267|16558046|P9|Overall Study|Lost to Follow-up|1
4801857|NCT01307267|16558047|P8|Overall Study|Lost to Follow-up|0
4801858|NCT01307267|16558048|P7|Overall Study|Lost to Follow-up|0
4801859|NCT01307267|16558049|P6|Overall Study|Lost to Follow-up|7
4801860|NCT01307267|16558050|P5|Overall Study|Lost to Follow-up|0
4801861|NCT01307267|16558051|P4|Overall Study|Lost to Follow-up|0
4801862|NCT01307267|16558052|P3|Overall Study|Lost to Follow-up|0
4801863|NCT01307267|16558053|P2|Overall Study|Lost to Follow-up|0
4801864|NCT01307267|16558054|P1|Overall Study|Lost to Follow-up|0
4801865|NCT01307267|16558032|P23|Overall Study|Death|2
4801866|NCT01307267|16558033|P22|Overall Study|Death|2
4801867|NCT01307267|16558034|P21|Overall Study|Death|1
4801868|NCT01307267|16558035|P20|Overall Study|Death|8
4801869|NCT01307267|16558036|P19|Overall Study|Death|2
4801870|NCT01307267|16558037|P18|Overall Study|Death|1
4801871|NCT01307267|16558038|P17|Overall Study|Death|1
4801872|NCT01307267|16558039|P16|Overall Study|Death|0
4801873|NCT01307267|16558040|P15|Overall Study|Death|0
4801874|NCT01307267|16558041|P14|Overall Study|Death|0
4801875|NCT01307267|16558042|P13|Overall Study|Death|0
4801876|NCT01307267|16558043|P12|Overall Study|Death|9
4801877|NCT01307267|16558044|P11|Overall Study|Death|3
4801878|NCT01307267|16558045|P10|Overall Study|Death|2
4801879|NCT01307267|16558046|P9|Overall Study|Death|21
4801880|NCT01307267|16558047|P8|Overall Study|Death|2
4801881|NCT01307267|16558048|P7|Overall Study|Death|2
4801882|NCT01307267|16558049|P6|Overall Study|Death|26
4801883|NCT01307267|16558050|P5|Overall Study|Death|1
4801884|NCT01307267|16558051|P4|Overall Study|Death|3
4801885|NCT01307267|16558052|P3|Overall Study|Death|5
4801886|NCT01307267|16558053|P2|Overall Study|Death|3
4801887|NCT01307267|16558054|P1|Overall Study|Death|4
4801888|NCT01307111|16558645|P2|1-2 Week IUD Check up|IUD expulsion/removal|2
4801889|NCT01307111|16558646|P1|1-2 Week IUD Check up|IUD expulsion/removal|2
4801890|NCT01307111|16558645|P2|IUD Insertion|Lost to Follow-up|0
4801891|NCT01307111|16558646|P1|IUD Insertion|Lost to Follow-up|2
4801892|NCT01307046|16558669|P2|Overall Study|Blood Pressure Withdrawal Criteria Met|3
4801893|NCT01307046|16558670|P1|Overall Study|Blood Pressure Withdrawal Criteria Met|2
4801894|NCT01307046|16558669|P2|Overall Study|Serum Potassium Withdrawal Criteria Met|2
4801895|NCT01307046|16558670|P1|Overall Study|Serum Potassium Withdrawal Criteria Met|4
4801896|NCT01307046|16558669|P2|Overall Study|Withdrawal by Subject|1
4801897|NCT01307046|16558670|P1|Overall Study|Withdrawal by Subject|1
4801898|NCT01307046|16558669|P2|Overall Study|Physician Decision|0
4801899|NCT01307046|16558670|P1|Overall Study|Physician Decision|2
4801900|NCT01307046|16558669|P2|Overall Study|Lack of Efficacy|2
4801901|NCT01307046|16558670|P1|Overall Study|Lack of Efficacy|0
4801902|NCT01307046|16558669|P2|Overall Study|Adverse Event|3
4801903|NCT01307046|16558670|P1|Overall Study|Adverse Event|3
4801904|NCT01307033|16558682|P4|44-week Open-label Extension|Death|1
4801905|NCT01307033|16558683|P3|44-week Open-label Extension|Death|0
4801906|NCT01307033|16558684|P2|44-week Open-label Extension|Death|0
4801907|NCT01307033|16558685|P1|44-week Open-label Extension|Death|0
4801908|NCT01307033|16558682|P4|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7
4801909|NCT01307033|16558683|P3|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6
4801910|NCT01307033|16558684|P2|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
4801911|NCT01307033|16558685|P1|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0
4801912|NCT01307033|16558682|P4|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2
4801913|NCT01307033|16558683|P3|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
4801914|NCT01307033|16558684|P2|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
4801915|NCT01307033|16558685|P1|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0
4801916|NCT01307033|16558682|P4|44-week Open-label Extension|Physician Decision|0
4801917|NCT01307033|16558683|P3|44-week Open-label Extension|Physician Decision|1
4801918|NCT01307033|16558684|P2|44-week Open-label Extension|Physician Decision|0
4801919|NCT01307033|16558685|P1|44-week Open-label Extension|Physician Decision|0
4801920|NCT01307033|16558682|P4|44-week Open-label Extension|Withdrawal by Subject|1
4801921|NCT01307033|16558683|P3|44-week Open-label Extension|Withdrawal by Subject|2
4801922|NCT01307033|16558684|P2|44-week Open-label Extension|Withdrawal by Subject|0
4801923|NCT01307033|16558685|P1|44-week Open-label Extension|Withdrawal by Subject|0
4801924|NCT01307033|16558682|P4|44-week Open-label Extension|Adverse Event|1
4801925|NCT01307033|16558683|P3|44-week Open-label Extension|Adverse Event|2
4801926|NCT01307033|16558684|P2|44-week Open-label Extension|Adverse Event|0
4801927|NCT01307033|16558685|P1|44-week Open-label Extension|Adverse Event|0
4801928|NCT01307033|16558682|P4|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
4801929|NCT01307033|16558683|P3|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0
4801930|NCT01307033|16558684|P2|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3
4801931|NCT01307033|16558685|P1|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6
4801932|NCT01307033|16558682|P4|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
4801933|NCT01307033|16558683|P3|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
4801934|NCT01307033|16558684|P2|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3
4801935|NCT01307033|16558685|P1|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0
4801936|NCT01307033|16558682|P4|8-week Double-blind Period|Lack of Efficacy|0
4801937|NCT01307033|16558683|P3|8-week Double-blind Period|Lack of Efficacy|0
4801938|NCT01307033|16558684|P2|8-week Double-blind Period|Lack of Efficacy|0
4801939|NCT01307033|16558685|P1|8-week Double-blind Period|Lack of Efficacy|1
4801940|NCT01307033|16558682|P4|8-week Double-blind Period|Withdrawal by Subject|0
4801941|NCT01307033|16558683|P3|8-week Double-blind Period|Withdrawal by Subject|0
4801942|NCT01307033|16558684|P2|8-week Double-blind Period|Withdrawal by Subject|1
4801943|NCT01307033|16558685|P1|8-week Double-blind Period|Withdrawal by Subject|4
4801944|NCT01307033|16558682|P4|8-week Double-blind Period|Adverse Event|0
4801945|NCT01307033|16558683|P3|8-week Double-blind Period|Adverse Event|0
4801946|NCT01307033|16558684|P2|8-week Double-blind Period|Adverse Event|0
4801947|NCT01307033|16558685|P1|8-week Double-blind Period|Adverse Event|2
4801948|NCT01307020|16558707|P10|Overall Study|Electronic data capture failure|0
4801949|NCT01307020|16558708|P9|Overall Study|Electronic data capture failure|0
4801950|NCT01307020|16558709|P8|Overall Study|Electronic data capture failure|0
4801951|NCT01307020|16558710|P7|Overall Study|Electronic data capture failure|0
4801952|NCT01307020|16558711|P6|Overall Study|Electronic data capture failure|0
4801953|NCT01307020|16558712|P5|Overall Study|Electronic data capture failure|0
4801954|NCT01307020|16558713|P4|Overall Study|Electronic data capture failure|0
4801955|NCT01307020|16558714|P3|Overall Study|Electronic data capture failure|0
4801956|NCT01307020|16558715|P2|Overall Study|Electronic data capture failure|1
4801957|NCT01307020|16558716|P1|Overall Study|Electronic data capture failure|0
4801958|NCT01307020|16558707|P10|Overall Study|Lost to Follow-up|0
4801959|NCT01307020|16558708|P9|Overall Study|Lost to Follow-up|0
4801960|NCT01307020|16558709|P8|Overall Study|Lost to Follow-up|0
4801961|NCT01307020|16558710|P7|Overall Study|Lost to Follow-up|1
4801962|NCT01307020|16558711|P6|Overall Study|Lost to Follow-up|0
4801963|NCT01307020|16558712|P5|Overall Study|Lost to Follow-up|0
4801964|NCT01307020|16558713|P4|Overall Study|Lost to Follow-up|1
4801965|NCT01307020|16558714|P3|Overall Study|Lost to Follow-up|1
4801966|NCT01307020|16558715|P2|Overall Study|Lost to Follow-up|0
4801967|NCT01307020|16558716|P1|Overall Study|Lost to Follow-up|0
4801968|NCT01306968|16558771|P4|Overall Study|Withdrew over privacy concerns|1
4801969|NCT01306968|16558772|P3|Overall Study|Withdrew over privacy concerns|0
4801970|NCT01306968|16558773|P2|Overall Study|Withdrew over privacy concerns|0
4801971|NCT01306968|16558774|P1|Overall Study|Withdrew over privacy concerns|0
4801972|NCT01306968|16558771|P4|Overall Study|Withdrew - time commitment|2
4801973|NCT01306968|16558772|P3|Overall Study|Withdrew - time commitment|0
4801974|NCT01306968|16558773|P2|Overall Study|Withdrew - time commitment|0
4801975|NCT01306968|16558774|P1|Overall Study|Withdrew - time commitment|0
4801976|NCT01306968|16558771|P4|Overall Study|Relocated and left active duty|1
4801977|NCT01306968|16558772|P3|Overall Study|Relocated and left active duty|1
4801978|NCT01306968|16558773|P2|Overall Study|Relocated and left active duty|1
4801979|NCT01306968|16558774|P1|Overall Study|Relocated and left active duty|0
4801980|NCT01306968|16558771|P4|Overall Study|Physician Decision|0
4801981|NCT01306968|16558772|P3|Overall Study|Physician Decision|0
4801982|NCT01306968|16558773|P2|Overall Study|Physician Decision|1
4801983|NCT01306968|16558774|P1|Overall Study|Physician Decision|0
4801984|NCT01306968|16558771|P4|Overall Study|Lost to Follow-up|0
4801985|NCT01306968|16558772|P3|Overall Study|Lost to Follow-up|0
4801986|NCT01306968|16558773|P2|Overall Study|Lost to Follow-up|1
4801987|NCT01306968|16558774|P1|Overall Study|Lost to Follow-up|1
4801988|NCT01306942|16558799|P4|Phase II|Protocol Violation|1
4801989|NCT01306942|16558800|P3|Phase II|Protocol Violation|0
4801990|NCT01306942|16558801|P2|Phase II|Protocol Violation|0
4801991|NCT01306942|16558802|P1|Phase II|Protocol Violation|0
4801992|NCT01306942|16558799|P4|Phase II|Not finished treatment|1
4801993|NCT01306942|16558800|P3|Phase II|Not finished treatment|0
4801994|NCT01306942|16558801|P2|Phase II|Not finished treatment|0
4801995|NCT01306942|16558802|P1|Phase II|Not finished treatment|0
4801996|NCT01306942|16558799|P4|Phase II|Death|1
4801997|NCT01306942|16558800|P3|Phase II|Death|0
4801998|NCT01306942|16558801|P2|Phase II|Death|0
4801999|NCT01306942|16558802|P1|Phase II|Death|0
4802000|NCT01306942|16558799|P4|Phase II|Withdrawal by Subject|2
4802001|NCT01306942|16558800|P3|Phase II|Withdrawal by Subject|0
4802002|NCT01306942|16558801|P2|Phase II|Withdrawal by Subject|0
4802003|NCT01306942|16558802|P1|Phase II|Withdrawal by Subject|0
4802004|NCT01306942|16558799|P4|Phase II|Physician Decision|5
4802005|NCT01306942|16558800|P3|Phase II|Physician Decision|0
4802006|NCT01306942|16558801|P2|Phase II|Physician Decision|0
4802007|NCT01306942|16558802|P1|Phase II|Physician Decision|2
4802008|NCT01306942|16558799|P4|Phase II|Adverse Event|6
4802009|NCT01306942|16558800|P3|Phase II|Adverse Event|0
4802010|NCT01306942|16558801|P2|Phase II|Adverse Event|0
4802011|NCT01306942|16558802|P1|Phase II|Adverse Event|0
4802012|NCT01306942|16558799|P4|Phase I|Physician Decision|0
4802013|NCT01306942|16558800|P3|Phase I|Physician Decision|0
4802014|NCT01306942|16558801|P2|Phase I|Physician Decision|1
4802015|NCT01306942|16558802|P1|Phase I|Physician Decision|3
4802016|NCT01306942|16558799|P4|Phase I|Adverse Event|0
4802017|NCT01306942|16558800|P3|Phase I|Adverse Event|0
4802018|NCT01306942|16558801|P2|Phase I|Adverse Event|2
4802019|NCT01306942|16558802|P1|Phase I|Adverse Event|2
4802020|NCT01306890|16558834|P1|Overall Study|No discontinuation documentation|41
4802021|NCT01306890|16558834|P1|Overall Study|Study Termination|3
4802022|NCT01306890|16558834|P1|Overall Study|Unspecified reasons|104
4802023|NCT01306890|16558834|P1|Overall Study|Withdrawal by Subject|88
4802024|NCT01306890|16558834|P1|Overall Study|Lost to Follow-up|58
4802025|NCT01306890|16558834|P1|Overall Study|Death|1223
4802026|NCT01306890|16558834|P1|Overall Study|Adverse Event|2
4802027|NCT01306877|16558841|P2|Overall Study|Physician Decision|1
4802028|NCT01306877|16558842|P1|Overall Study|Physician Decision|0
4802029|NCT01306877|16558841|P2|Overall Study|Lost to Follow-up|3
4802030|NCT01306877|16558842|P1|Overall Study|Lost to Follow-up|3
4802031|NCT01306656|16558862|P2|Overall Study|Lost to Follow-up|0
4802032|NCT01306656|16558863|P1|Overall Study|Lost to Follow-up|1
4802033|NCT01306643|16558875|P1|Overall Study|Other: Change in Eligibility Status|1
4802034|NCT01306643|16558875|P1|Overall Study|Disease Progression|7
4802035|NCT01306643|16558875|P1|Overall Study|Adverse Event|5
4802036|NCT01306617|16558887|P3|Overall Study|Non-compliance|0
4802037|NCT01306617|16558888|P2|Overall Study|Non-compliance|1
4802038|NCT01306617|16558889|P1|Overall Study|Non-compliance|0
4802039|NCT01306617|16558887|P3|Overall Study|Virologic Failure|5
4802040|NCT01306617|16558888|P2|Overall Study|Virologic Failure|0
4802041|NCT01306617|16558889|P1|Overall Study|Virologic Failure|0
4802042|NCT01306617|16558887|P3|Overall Study|Adverse Event|0
4802043|NCT01306617|16558888|P2|Overall Study|Adverse Event|0
4802044|NCT01306617|16558889|P1|Overall Study|Adverse Event|1
4802045|NCT01306331|16558932|P2|Overall Study|Other|32
4802046|NCT01306331|16558933|P1|Overall Study|Other|34
4802047|NCT01306331|16558932|P2|Overall Study|Meth. no longer prim. meth. birth cntrl|20
4802048|NCT01306331|16558933|P1|Overall Study|Meth. no longer prim. meth. birth cntrl|10
4802049|NCT01306331|16558932|P2|Overall Study|Not sexually active|28
4802050|NCT01306331|16558933|P1|Overall Study|Not sexually active|29
4802051|NCT01306331|16558932|P2|Overall Study|Withdrawal by Subject|152
4802052|NCT01306331|16558933|P1|Overall Study|Withdrawal by Subject|163
4802053|NCT01306331|16558932|P2|Overall Study|Protocol Violation|124
4802054|NCT01306331|16558933|P1|Overall Study|Protocol Violation|154
4802055|NCT01306331|16558932|P2|Overall Study|Pregnancy|151
4802056|NCT01306331|16558933|P1|Overall Study|Pregnancy|136
4802057|NCT01306331|16558932|P2|Overall Study|Physician Decision|22
4802058|NCT01306331|16558933|P1|Overall Study|Physician Decision|26
4802059|NCT01306331|16558932|P2|Overall Study|Lost to Follow-up|323
4802060|NCT01306331|16558933|P1|Overall Study|Lost to Follow-up|321
4802061|NCT01306331|16558932|P2|Overall Study|Adverse Event|25
4802062|NCT01306331|16558933|P1|Overall Study|Adverse Event|28
4802063|NCT01306305|16558943|P2|Overall Study|Withdrew consent|0
4802064|NCT01306305|16558944|P1|Overall Study|Withdrew consent|1
4802065|NCT01306305|16558943|P2|Overall Study|Lost to Follow-up|0
4802066|NCT01306305|16558944|P1|Overall Study|Lost to Follow-up|1
4802067|NCT01306253|16558981|P2|Overall Study|Lost to Follow-up|1
4802068|NCT01306253|16558982|P1|Overall Study|Lost to Follow-up|1
4802069|NCT01306214|16558999|P3|Overall Study|Not treated|1
4802070|NCT01306214|16559000|P2|Overall Study|Not treated|1
4802071|NCT01306214|16559001|P1|Overall Study|Not treated|1
4802072|NCT01306214|16558999|P3|Overall Study|Withdrawal by Subject|16
4802073|NCT01306214|16559000|P2|Overall Study|Withdrawal by Subject|22
4802074|NCT01306214|16559001|P1|Overall Study|Withdrawal by Subject|24
4802075|NCT01306214|16558999|P3|Overall Study|Lost to Follow-up|4
4802076|NCT01306214|16559000|P2|Overall Study|Lost to Follow-up|5
4802077|NCT01306214|16559001|P1|Overall Study|Lost to Follow-up|3
4802078|NCT01306214|16558999|P3|Overall Study|Death|1
4802079|NCT01306214|16559000|P2|Overall Study|Death|0
4802080|NCT01306214|16559001|P1|Overall Study|Death|0
4802081|NCT01306201|16559018|P1|Overall Study|Files unreadable|3
4802082|NCT01306201|16559018|P1|Overall Study|Files could not be processed|3
4802083|NCT01306201|16559018|P1|Overall Study|Arrhythmia|4
4802084|NCT01306162|16559040|P4|Washout 1|Non-compliance to protocol|0
4802085|NCT01306162|16559041|P3|Washout 1|Non-compliance to protocol|0
4802086|NCT01306162|16559042|P2|Washout 1|Non-compliance to protocol|1
4802087|NCT01306162|16559043|P1|Washout 1|Non-compliance to protocol|0
4802088|NCT01306162|16559040|P4|Period 1|Adverse Event|1
4802089|NCT01306162|16559041|P3|Period 1|Adverse Event|0
4802090|NCT01306162|16559042|P2|Period 1|Adverse Event|0
4802091|NCT01306162|16559043|P1|Period 1|Adverse Event|0
4802092|NCT01306058|16559071|P1|Overall Study|Enrolled but did not get treatment|1
4802093|NCT01306058|16559071|P1|Overall Study|Death|1
4802094|NCT01306032|16559098|P6|Disease Progression/Crossover|other/symptomatic progression|0
4802095|NCT01306032|16559099|P5|Disease Progression/Crossover|other/symptomatic progression|0
4802096|NCT01306032|16559100|P4|Disease Progression/Crossover|other/symptomatic progression|2
4802097|NCT01306032|16559101|P3|Disease Progression/Crossover|other/symptomatic progression|0
4802098|NCT01306032|16559102|P2|Disease Progression/Crossover|other/symptomatic progression|2
4802099|NCT01306032|16559103|P1|Disease Progression/Crossover|other/symptomatic progression|0
4802100|NCT01306032|16559098|P6|Disease Progression/Crossover|Withdrawal by Subject|0
4802101|NCT01306032|16559099|P5|Disease Progression/Crossover|Withdrawal by Subject|0
4802102|NCT01306032|16559100|P4|Disease Progression/Crossover|Withdrawal by Subject|1
4802103|NCT01306032|16559101|P3|Disease Progression/Crossover|Withdrawal by Subject|0
4802104|NCT01306032|16559102|P2|Disease Progression/Crossover|Withdrawal by Subject|0
4802105|NCT01306032|16559103|P1|Disease Progression/Crossover|Withdrawal by Subject|0
4802106|NCT01306032|16559098|P6|First Intervention|Progressive disease|0
4802107|NCT01306032|16559099|P5|First Intervention|Progressive disease|2
4802108|NCT01306032|16559100|P4|First Intervention|Progressive disease|0
4802109|NCT01306032|16559101|P3|First Intervention|Progressive disease|0
4802110|NCT01306032|16559102|P2|First Intervention|Progressive disease|0
4802111|NCT01306032|16559103|P1|First Intervention|Progressive disease|0
4802112|NCT01306032|16559098|P6|First Intervention|Ineligible|1
4802113|NCT01306032|16559099|P5|First Intervention|Ineligible|0
4802114|NCT01306032|16559100|P4|First Intervention|Ineligible|0
4802115|NCT01306032|16559101|P3|First Intervention|Ineligible|0
4802116|NCT01306032|16559102|P2|First Intervention|Ineligible|0
4802117|NCT01306032|16559103|P1|First Intervention|Ineligible|0
4802118|NCT01306032|16559098|P6|First Intervention|Death|0
4802119|NCT01306032|16559099|P5|First Intervention|Death|0
4802120|NCT01306032|16559100|P4|First Intervention|Death|0
4802121|NCT01306032|16559101|P3|First Intervention|Death|1
4802122|NCT01306032|16559102|P2|First Intervention|Death|0
4802123|NCT01306032|16559103|P1|First Intervention|Death|0
4802124|NCT01306032|16559098|P6|First Intervention|Withdrawal by Subject|0
4802125|NCT01306032|16559099|P5|First Intervention|Withdrawal by Subject|0
4802126|NCT01306032|16559100|P4|First Intervention|Withdrawal by Subject|1
4802127|NCT01306032|16559101|P3|First Intervention|Withdrawal by Subject|0
4802128|NCT01306032|16559102|P2|First Intervention|Withdrawal by Subject|2
4802129|NCT01306032|16559103|P1|First Intervention|Withdrawal by Subject|0
4802130|NCT01306032|16559098|P6|First Intervention|Adverse Event|1
4802131|NCT01306032|16559099|P5|First Intervention|Adverse Event|0
4802132|NCT01306032|16559100|P4|First Intervention|Adverse Event|0
4802133|NCT01306032|16559101|P3|First Intervention|Adverse Event|1
4802134|NCT01306032|16559102|P2|First Intervention|Adverse Event|0
4802135|NCT01306032|16559103|P1|First Intervention|Adverse Event|1
4802136|NCT01305941|16559155|P1|Overall Study|Death|1
4802137|NCT01305941|16559155|P1|Overall Study|Withdrawal by Subject|1
4802138|NCT01305941|16559155|P1|Overall Study|Clinical decline|2
4802139|NCT01305941|16559155|P1|Overall Study|Adverse Event|6
4802140|NCT01305577|16559195|P3|Overall Study|Protocol Deviation|1
4802141|NCT01305577|16559196|P2|Overall Study|Protocol Deviation|1
4802142|NCT01305577|16559197|P1|Overall Study|Protocol Deviation|0
4802143|NCT01305577|16559195|P3|Overall Study|Lost to Follow-up|2
4802144|NCT01305577|16559196|P2|Overall Study|Lost to Follow-up|3
4802145|NCT01305577|16559197|P1|Overall Study|Lost to Follow-up|4
4802146|NCT01305577|16559195|P3|Overall Study|Withdrawal by Subject|6
4802147|NCT01305577|16559196|P2|Overall Study|Withdrawal by Subject|5
4802148|NCT01305577|16559197|P1|Overall Study|Withdrawal by Subject|7
4802149|NCT01305577|16559195|P3|Overall Study|Adverse Event|1
4802150|NCT01305577|16559196|P2|Overall Study|Adverse Event|2
4802151|NCT01305577|16559197|P1|Overall Study|Adverse Event|2
4802152|NCT01305564|16559226|P1|Overall Study|Physician Decision|3
4802153|NCT01305564|16559226|P1|Overall Study|Withdrawal by Subject|1
4802154|NCT01305564|16559226|P1|Overall Study|Lost to Follow-up|12
4802155|NCT01305564|16559226|P1|Overall Study|Death|21
4802156|NCT01305408|16559253|P2|Overall Study|Other|0
4802157|NCT01305408|16559254|P1|Overall Study|Other|1
4802158|NCT01305408|16559253|P2|Overall Study|Noncompliance with study procedures|1
4802159|NCT01305408|16559254|P1|Overall Study|Noncompliance with study procedures|0
4802160|NCT01305408|16559253|P2|Overall Study|Noncompliance with study medication|1
4802161|NCT01305408|16559254|P1|Overall Study|Noncompliance with study medication|0
4802162|NCT01305408|16559253|P2|Overall Study|Lost to Follow-up|3
4802163|NCT01305408|16559254|P1|Overall Study|Lost to Follow-up|5
4802164|NCT01305408|16559253|P2|Overall Study|Protocol Violation|6
4802165|NCT01305408|16559254|P1|Overall Study|Protocol Violation|4
4802166|NCT01305408|16559253|P2|Overall Study|Withdrawal by Subject|9
4802167|NCT01305408|16559254|P1|Overall Study|Withdrawal by Subject|9
4802168|NCT01305408|16559253|P2|Overall Study|Lack of Efficacy|4
4802169|NCT01305408|16559254|P1|Overall Study|Lack of Efficacy|3
4802170|NCT01305408|16559253|P2|Overall Study|Adverse Event|7
4802171|NCT01305408|16559254|P1|Overall Study|Adverse Event|10
4802172|NCT01305239|16559347|P1|Overall Study|Exemestane taken prior to inclusion only|1
4802173|NCT01305239|16559347|P1|Overall Study|Adverse Event|22
4802174|NCT01305200|16559377|P3|Overall Study|Death|0
4802175|NCT01305200|16559378|P2|Overall Study|Death|2
4802176|NCT01305200|16559379|P1|Overall Study|Death|0
4802177|NCT01305200|16559377|P3|Overall Study|Ineligible|1
4802178|NCT01305200|16559378|P2|Overall Study|Ineligible|2
4802179|NCT01305200|16559379|P1|Overall Study|Ineligible|1
4802180|NCT01305200|16559377|P3|Overall Study|Withdrawal by Subject|1
4802181|NCT01305200|16559378|P2|Overall Study|Withdrawal by Subject|21
4802182|NCT01305200|16559379|P1|Overall Study|Withdrawal by Subject|24
4802183|NCT01305200|16559377|P3|Overall Study|Physician Decision|1
4802184|NCT01305200|16559378|P2|Overall Study|Physician Decision|6
4802185|NCT01305200|16559379|P1|Overall Study|Physician Decision|4
4802186|NCT01305044|16559409|P2|Overall Study|Withdrawal by Subject|6
4802187|NCT01305044|16559410|P1|Overall Study|Withdrawal by Subject|3
4802188|NCT01304940|16559442|P2|Overall Study|not meet symptom severity requirement|0
4802189|NCT01304940|16559443|P1|Overall Study|not meet symptom severity requirement|3
4802190|NCT01304706|16559449|P1|Overall Study|Discontinued due to failed drug admin.|1
4802191|NCT01304706|16559449|P1|Overall Study|Lost to Follow-up|7
4802192|NCT01304706|16559449|P1|Overall Study|Withdrawal by Subject|3
4802193|NCT01304706|16559449|P1|Overall Study|Death|3
4802194|NCT01304706|16559449|P1|Overall Study|Lack of Efficacy|1
4802195|NCT01304706|16559449|P1|Overall Study|Adverse Event|2
4802196|NCT01304693|16559458|P5|Overall Study|Decision Unrelated to an Adverse Event|0
4802197|NCT01304693|16559459|P4|Overall Study|Decision Unrelated to an Adverse Event|1
4802198|NCT01304693|16559460|P3|Overall Study|Decision Unrelated to an Adverse Event|1
4802199|NCT01304693|16559461|P2|Overall Study|Decision Unrelated to an Adverse Event|0
4802200|NCT01304693|16559462|P1|Overall Study|Decision Unrelated to an Adverse Event|0
4802201|NCT01304693|16559458|P5|Overall Study|Adverse Event|1
4802202|NCT01304693|16559459|P4|Overall Study|Adverse Event|0
4802203|NCT01304693|16559460|P3|Overall Study|Adverse Event|0
4802204|NCT01304693|16559461|P2|Overall Study|Adverse Event|0
4802205|NCT01304693|16559462|P1|Overall Study|Adverse Event|0
4802206|NCT01304498|16559509|P2|Overall Study|Lost to Follow-up|1
4802207|NCT01304498|16559510|P1|Overall Study|Lost to Follow-up|2
4802208|NCT01304498|16559509|P2|Overall Study|Protocol Violation|0
4802209|NCT01304498|16559510|P1|Overall Study|Protocol Violation|1
4802210|NCT01304498|16559509|P2|Overall Study|Withdrawal by Subject|3
4802211|NCT01304498|16559510|P1|Overall Study|Withdrawal by Subject|2
4802212|NCT01304498|16559509|P2|Overall Study|Adverse Event|1
4802213|NCT01304498|16559510|P1|Overall Study|Adverse Event|1
4802214|NCT01304329|16559534|P6|Third Intervention (3 Days)|Adverse Event|0
4802215|NCT01304329|16559535|P5|Third Intervention (3 Days)|Adverse Event|0
4802216|NCT01304329|16559536|P4|Third Intervention (3 Days)|Adverse Event|0
4802217|NCT01304329|16559537|P3|Third Intervention (3 Days)|Adverse Event|0
4802218|NCT01304329|16559538|P2|Third Intervention (3 Days)|Adverse Event|1
4802219|NCT01304329|16559539|P1|Third Intervention (3 Days)|Adverse Event|0
4802220|NCT01304147|16559673|P2|Second Intervention (7days)|Withdrawal by Subject|1
4802221|NCT01304147|16559674|P1|Second Intervention (7days)|Withdrawal by Subject|1
4802222|NCT01303965|16559705|P2|Overall Study|Disease Progression|6
4802223|NCT01303965|16559706|P1|Overall Study|Disease Progression|1
4802224|NCT01303965|16559705|P2|Overall Study|Withdrawal by Subject|0
4802225|NCT01303965|16559706|P1|Overall Study|Withdrawal by Subject|1
4802226|NCT01303965|16559705|P2|Overall Study|Death|3
4802227|NCT01303965|16559706|P1|Overall Study|Death|0
4802228|NCT01303965|16559705|P2|Overall Study|Adverse Event|1
4802229|NCT01303965|16559706|P1|Overall Study|Adverse Event|1
4802230|NCT01303861|16559734|P4|Overall Study|Pregnancy|0
4802231|NCT01303861|16559735|P3|Overall Study|Pregnancy|0
4802232|NCT01303861|16559736|P2|Overall Study|Pregnancy|0
4802233|NCT01303861|16559737|P1|Overall Study|Pregnancy|1
4802234|NCT01303861|16559734|P4|Overall Study|Adverse Event|5
4802235|NCT01303861|16559735|P3|Overall Study|Adverse Event|0
4802236|NCT01303861|16559736|P2|Overall Study|Adverse Event|1
4802237|NCT01303861|16559737|P1|Overall Study|Adverse Event|4
4802238|NCT01303861|16559734|P4|Overall Study|Withdrawal by Subject|23
4802239|NCT01303861|16559735|P3|Overall Study|Withdrawal by Subject|8
4802240|NCT01303861|16559736|P2|Overall Study|Withdrawal by Subject|8
4802241|NCT01303861|16559737|P1|Overall Study|Withdrawal by Subject|16
4802242|NCT01303861|16559734|P4|Overall Study|Lack of Efficacy|0
4802243|NCT01303861|16559735|P3|Overall Study|Lack of Efficacy|1
4802244|NCT01303861|16559736|P2|Overall Study|Lack of Efficacy|2
4802245|NCT01303861|16559737|P1|Overall Study|Lack of Efficacy|3
4802246|NCT01303861|16559734|P4|Overall Study|Lost to Follow-up|31
4802247|NCT01303861|16559735|P3|Overall Study|Lost to Follow-up|27
4802248|NCT01303861|16559736|P2|Overall Study|Lost to Follow-up|14
4802249|NCT01303861|16559737|P1|Overall Study|Lost to Follow-up|34
4802250|NCT01303627|16559796|P2|Overall Study|the failure while performing URS|1
4802251|NCT01303627|16559797|P1|Overall Study|the failure while performing URS|0
4802252|NCT01303510|16559805|P2|Overall Study|Lost to Follow-up|0
4802253|NCT01303510|16559806|P1|Overall Study|Lost to Follow-up|1
4802254|NCT01303445|16559820|P2|Follow-up Period (14 Days)|Withdrawal by Subject|1
4802255|NCT01303445|16559821|P1|Follow-up Period (14 Days)|Withdrawal by Subject|0
4802256|NCT01303445|16559820|P2|Fourth Intervention (7 Days)|Withdrawal by Subject|0
4802257|NCT01303445|16559821|P1|Fourth Intervention (7 Days)|Withdrawal by Subject|1
4802258|NCT01303445|16559820|P2|Washout (14 Days)|Lost to Follow-up|2
4802259|NCT01303445|16559821|P1|Washout (14 Days)|Lost to Follow-up|0
4802260|NCT01303445|16559820|P2|Washout (14 Days)|Protocol Violation|0
4802261|NCT01303445|16559821|P1|Washout (14 Days)|Protocol Violation|1
4802262|NCT01303445|16559820|P2|Second Intervention (7 Days)|Withdrawal by Subject|0
4802263|NCT01303445|16559821|P1|Second Intervention (7 Days)|Withdrawal by Subject|1
4802264|NCT01303445|16559820|P2|Second Intervention (7 Days)|Adverse Event|2
4802265|NCT01303445|16559821|P1|Second Intervention (7 Days)|Adverse Event|0
4802266|NCT01303445|16559820|P2|First Intervention (7 Days)|Withdrawal by Subject|0
4802267|NCT01303445|16559821|P1|First Intervention (7 Days)|Withdrawal by Subject|1
4802268|NCT01303419|16559851|P1|Overall Study|Did not meet all I/E after screening|31
4802269|NCT01303419|16559851|P1|Overall Study|Did not complete both imaging methods|5
4802270|NCT01303419|16559851|P1|Overall Study|Discontinuation of study|60
4802271|NCT01303380|16559870|P1|Overall Study|Lack of compliance to study procedures|1
4802272|NCT01303159|16559929|P1|Overall Study|Study Termination|7
4802273|NCT01303159|16559929|P1|Overall Study|Death|16
4802274|NCT01302964|16559947|P2|Overall Study|Adverse Event|0
4802275|NCT01302964|16559948|P1|Overall Study|Adverse Event|1
4802276|NCT01302938|16559958|P2|Overall Study|Adverse Event|0
4802277|NCT01302938|16559959|P1|Overall Study|Adverse Event|1
4802278|NCT01302938|16559958|P2|Overall Study|Withdrawal by Subject|0
4802279|NCT01302938|16559959|P1|Overall Study|Withdrawal by Subject|1
4802280|NCT01302899|16560004|P2|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1
4802281|NCT01302899|16560005|P1|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0
4802282|NCT01302899|16560004|P2|Period 2 (Weeks 7 to 12)|Protocol Deviation|0
4802283|NCT01302899|16560005|P1|Period 2 (Weeks 7 to 12)|Protocol Deviation|1
4802284|NCT01302834|16560069|P2|Overall Study|HIV positive|3
4802285|NCT01302834|16560070|P1|Overall Study|HIV positive|1
4802286|NCT01302834|16560069|P2|Overall Study|Protocol Violation|23
4802287|NCT01302834|16560070|P1|Overall Study|Protocol Violation|17
4802288|NCT01302691|16560130|P2|Overall Study|Protocol Violation|0
4802289|NCT01302691|16560131|P1|Overall Study|Protocol Violation|1
4802290|NCT01302691|16560130|P2|Overall Study|Physician Decision|1
4802291|NCT01302691|16560131|P1|Overall Study|Physician Decision|0
4802292|NCT01302691|16560130|P2|Overall Study|Blood Pressure/Potassium Criteria Met|4
4802293|NCT01302691|16560131|P1|Overall Study|Blood Pressure/Potassium Criteria Met|6
4802294|NCT01302691|16560130|P2|Overall Study|Lost to Follow-up|0
4802295|NCT01302691|16560131|P1|Overall Study|Lost to Follow-up|1
4802296|NCT01302691|16560130|P2|Overall Study|Death|1
4802297|NCT01302691|16560131|P1|Overall Study|Death|0
4802298|NCT01302691|16560130|P2|Overall Study|Adverse Event|0
4802299|NCT01302691|16560131|P1|Overall Study|Adverse Event|2
4802300|NCT01302548|16560151|P2|Overall Study|Lost to Follow-up|1
4802301|NCT01302548|16560152|P1|Overall Study|Lost to Follow-up|2
4802302|NCT01302418|16560202|P1|Overall Study|Non-evaluable|9
4802303|NCT01302418|16560202|P1|Overall Study|Protocol Violation|9
4802304|NCT01302392|16560208|P2|Overall Study|Withdrawal by Subject|1
4802305|NCT01302392|16560209|P1|Overall Study|Withdrawal by Subject|6
4802306|NCT01302392|16560208|P2|Overall Study|Lost to Follow-up|0
4802307|NCT01302392|16560209|P1|Overall Study|Lost to Follow-up|1
4802308|NCT01302366|16560260|P1|Overall Study|patient choice or noncompliance|5
4802309|NCT01302119|16560268|P2|Overall Study|Non-specific|1
4802310|NCT01302119|16560269|P1|Overall Study|Non-specific|4
4802311|NCT01302119|16560268|P2|Overall Study|Non-compliance|2
4802312|NCT01302119|16560269|P1|Overall Study|Non-compliance|4
4802313|NCT01302119|16560268|P2|Overall Study|Adverse Event|1
4802314|NCT01302119|16560269|P1|Overall Study|Adverse Event|2
4802315|NCT01302119|16560268|P2|Overall Study|Lost to Follow-up|4
4802316|NCT01302119|16560269|P1|Overall Study|Lost to Follow-up|10
4802317|NCT01302119|16560268|P2|Overall Study|Withdrawal by Subject|20
4802318|NCT01302119|16560269|P1|Overall Study|Withdrawal by Subject|30
4802319|NCT01302067|16560284|P3|Overall Study|Adverse Event|45
4802320|NCT01302067|16560285|P2|Overall Study|Adverse Event|14
4802321|NCT01302067|16560286|P1|Overall Study|Adverse Event|27
4802322|NCT01302067|16560284|P3|Overall Study|Protocol Violation|8
4802323|NCT01302067|16560285|P2|Overall Study|Protocol Violation|0
4802324|NCT01302067|16560286|P1|Overall Study|Protocol Violation|11
4802325|NCT01302067|16560284|P3|Overall Study|Other|3
4802326|NCT01302067|16560285|P2|Overall Study|Other|1
4802327|NCT01302067|16560286|P1|Overall Study|Other|1
4802328|NCT01302067|16560284|P3|Overall Study|Withdrawal by Subject|10
4802329|NCT01302067|16560285|P2|Overall Study|Withdrawal by Subject|6
4802330|NCT01302067|16560286|P1|Overall Study|Withdrawal by Subject|13
4802331|NCT01302067|16560284|P3|Overall Study|Lost to Follow-up|15
4802332|NCT01302067|16560285|P2|Overall Study|Lost to Follow-up|4
4802333|NCT01302067|16560286|P1|Overall Study|Lost to Follow-up|9
4802334|NCT01302067|16560284|P3|Overall Study|Lack of Efficacy|2
4802335|NCT01302067|16560285|P2|Overall Study|Lack of Efficacy|4
4802336|NCT01302067|16560286|P1|Overall Study|Lack of Efficacy|8
4802337|NCT01302067|16560284|P3|Overall Study|Physician Decision|14
4802338|NCT01302067|16560285|P2|Overall Study|Physician Decision|5
4802339|NCT01302067|16560286|P1|Overall Study|Physician Decision|9
4802340|NCT01302067|16560284|P3|Overall Study|Death|1
4802341|NCT01302067|16560285|P2|Overall Study|Death|0
4802342|NCT01302067|16560286|P1|Overall Study|Death|0
4802343|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Other|9
4802344|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Other|4
4802345|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Other|0
4802346|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2
4802347|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
4802348|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0
4802349|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Adverse Event|10
4802350|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Adverse Event|10
4802351|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Adverse Event|0
4802352|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Protocol Violation|6
4802353|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Protocol Violation|3
4802354|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Protocol Violation|0
4802355|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Withdrawal by Subject|14
4802356|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Withdrawal by Subject|6
4802357|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
4802358|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
4802359|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Lost to Follow-up|2
4802360|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
4802361|NCT01302054|16560357|P3|Double-Blind Treatment Phase|Lack of Efficacy|4
4802362|NCT01302054|16560358|P2|Double-Blind Treatment Phase|Lack of Efficacy|2
4802363|NCT01302054|16560359|P1|Double-Blind Treatment Phase|Lack of Efficacy|0
4802364|NCT01302054|16560357|P3|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
4802365|NCT01302054|16560358|P2|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0
4802366|NCT01302054|16560359|P1|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2
4802367|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Other|0
4802368|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Other|0
4802369|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Other|7
4802370|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
4802371|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0
4802372|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314
4802373|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Adverse Event|0
4802374|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Adverse Event|0
4802375|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Adverse Event|13
4802376|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
4802377|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Protocol Violation|0
4802378|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Protocol Violation|8
4802379|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
4802380|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0
4802381|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16
4802382|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
4802383|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0
4802384|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17
4802385|NCT01302054|16560357|P3|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
4802386|NCT01302054|16560358|P2|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0
4802387|NCT01302054|16560359|P1|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4
4802388|NCT01302041|16560386|P1|Overall Study|Other-Miscellaneous Reason|2
4802389|NCT01302041|16560386|P1|Overall Study|Other-Transitioned to 9785-CL-0123|29
4802390|NCT01302041|16560386|P1|Overall Study|Withdrawal by Subject|4
4802391|NCT01302041|16560386|P1|Overall Study|Death|5
4802392|NCT01301950|16560428|P2|Overall Study|Surgery was cancelled by patient|1
4802393|NCT01301950|16560429|P1|Overall Study|Surgery was cancelled by patient|0
4802394|NCT01301833|16560447|P4|Overall Study|Personal matter|0
4802395|NCT01301833|16560448|P3|Overall Study|Personal matter|0
4802396|NCT01301833|16560449|P2|Overall Study|Personal matter|0
4802397|NCT01301833|16560450|P1|Overall Study|Personal matter|1
4802398|NCT01301833|16560447|P4|Overall Study|Withdrawal by Subject|2
4802399|NCT01301833|16560448|P3|Overall Study|Withdrawal by Subject|1
4802400|NCT01301833|16560449|P2|Overall Study|Withdrawal by Subject|1
4802401|NCT01301833|16560450|P1|Overall Study|Withdrawal by Subject|3
4802402|NCT01301833|16560447|P4|Overall Study|Physician Decision|0
4802403|NCT01301833|16560448|P3|Overall Study|Physician Decision|1
4802404|NCT01301833|16560449|P2|Overall Study|Physician Decision|1
4802405|NCT01301833|16560450|P1|Overall Study|Physician Decision|3
4802406|NCT01301833|16560447|P4|Overall Study|Lack of Efficacy|0
4802407|NCT01301833|16560448|P3|Overall Study|Lack of Efficacy|0
4802408|NCT01301833|16560449|P2|Overall Study|Lack of Efficacy|1
4802409|NCT01301833|16560450|P1|Overall Study|Lack of Efficacy|1
4802410|NCT01301833|16560447|P4|Overall Study|Adverse Event|5
4802411|NCT01301833|16560448|P3|Overall Study|Adverse Event|5
4802412|NCT01301833|16560449|P2|Overall Study|Adverse Event|5
4802413|NCT01301833|16560450|P1|Overall Study|Adverse Event|7
4802414|NCT01301729|16560488|P1|Overall Study|Violated Selection Criteria|1
4802415|NCT01301729|16560488|P1|Overall Study|Participant did not Return for Treatment|1
4802416|NCT01301729|16560488|P1|Overall Study|Withdrawal by Subject|2
4802417|NCT01301625|16560499|P1|Overall Study|Lost to Follow-up|1
4802418|NCT01301625|16560499|P1|Overall Study|Expected|8
4802419|NCT01301625|16560499|P1|Overall Study|Not Due|21
4802420|NCT01301625|16560499|P1|Overall Study|Death|5
4802421|NCT01301508|16560571|P2|Overall Study|Lost to Follow-up|1
4802422|NCT01301508|16560572|P1|Overall Study|Lost to Follow-up|0
4802423|NCT01301508|16560571|P2|Overall Study|Withdrawal by Subject|2
4802424|NCT01301508|16560572|P1|Overall Study|Withdrawal by Subject|1
4802425|NCT01301456|16560602|P12|Stage 2|Adverse Event|0
4802426|NCT01301456|16560603|P11|Stage 2|Adverse Event|1
4802427|NCT01301456|16560604|P10|Stage 2|Adverse Event|0
4802428|NCT01301456|16560605|P9|Stage 2|Adverse Event|0
4802429|NCT01301456|16560606|P8|Stage 2|Adverse Event|0
4802430|NCT01301456|16560607|P7|Stage 2|Adverse Event|0
4802431|NCT01301456|16560608|P6|Stage 2|Adverse Event|0
4802432|NCT01301456|16560609|P5|Stage 2|Adverse Event|0
4802433|NCT01301456|16560610|P4|Stage 2|Adverse Event|0
4802434|NCT01301456|16560611|P3|Stage 2|Adverse Event|0
4802435|NCT01301456|16560612|P2|Stage 2|Adverse Event|0
4802436|NCT01301456|16560613|P1|Stage 2|Adverse Event|0
4802437|NCT01301456|16560602|P12|Stage 1|Randomized but not treated|0
4802438|NCT01301456|16560603|P11|Stage 1|Randomized but not treated|0
4802439|NCT01301456|16560604|P10|Stage 1|Randomized but not treated|0
4802440|NCT01301456|16560605|P9|Stage 1|Randomized but not treated|0
4802441|NCT01301456|16560606|P8|Stage 1|Randomized but not treated|0
4802442|NCT01301456|16560607|P7|Stage 1|Randomized but not treated|1
4802443|NCT01301456|16560608|P6|Stage 1|Randomized but not treated|0
4802444|NCT01301456|16560609|P5|Stage 1|Randomized but not treated|0
4802445|NCT01301456|16560610|P4|Stage 1|Randomized but not treated|0
4802446|NCT01301456|16560611|P3|Stage 1|Randomized but not treated|0
4802447|NCT01301456|16560612|P2|Stage 1|Randomized but not treated|0
4802448|NCT01301456|16560613|P1|Stage 1|Randomized but not treated|0
4802449|NCT01301456|16560602|P12|Stage 1|Withdrawal by Subject|0
4802450|NCT01301456|16560603|P11|Stage 1|Withdrawal by Subject|0
4802451|NCT01301456|16560604|P10|Stage 1|Withdrawal by Subject|0
4802452|NCT01301456|16560605|P9|Stage 1|Withdrawal by Subject|0
4802453|NCT01301456|16560606|P8|Stage 1|Withdrawal by Subject|0
4802454|NCT01301456|16560607|P7|Stage 1|Withdrawal by Subject|0
4802455|NCT01301456|16560608|P6|Stage 1|Withdrawal by Subject|0
4802456|NCT01301456|16560609|P5|Stage 1|Withdrawal by Subject|1
4802457|NCT01301456|16560610|P4|Stage 1|Withdrawal by Subject|0
4802458|NCT01301456|16560611|P3|Stage 1|Withdrawal by Subject|1
4802459|NCT01301456|16560612|P2|Stage 1|Withdrawal by Subject|0
4802460|NCT01301456|16560613|P1|Stage 1|Withdrawal by Subject|0
4802461|NCT01301391|16560839|P1|Overall Study|Sponsor's decision|8
4802462|NCT01301391|16560839|P1|Overall Study|Physician Decision|2
4802463|NCT01301391|16560839|P1|Overall Study|Lost to Follow-up|3
4802464|NCT01301391|16560839|P1|Overall Study|Death|13
4802465|NCT01301274|16560851|P2|Overall Study|Physician Decision|1
4802466|NCT01301274|16560852|P1|Overall Study|Physician Decision|2
4802467|NCT01301092|16560867|P3|Overall Study|Lost to Follow-up|1
4802468|NCT01301092|16560868|P2|Overall Study|Lost to Follow-up|0
4802469|NCT01301092|16560869|P1|Overall Study|Lost to Follow-up|0
4802470|NCT01301079|16560886|P2|Overall Study|Lost to Follow-up|2
4802471|NCT01301079|16560887|P1|Overall Study|Lost to Follow-up|2
4802472|NCT01301066|16560965|P2|Overall Study|Other|0
4802473|NCT01301066|16560966|P1|Overall Study|Other|2
4802474|NCT01301066|16560965|P2|Overall Study|Physician Decision|1
4802475|NCT01301066|16560966|P1|Overall Study|Physician Decision|0
4802476|NCT01301066|16560965|P2|Overall Study|Sponsor Decision|1
4802477|NCT01301066|16560966|P1|Overall Study|Sponsor Decision|2
4802478|NCT01301066|16560965|P2|Overall Study|Adverse Event|6
4802479|NCT01301066|16560966|P1|Overall Study|Adverse Event|6
4802480|NCT01301066|16560965|P2|Overall Study|Withdrawal by Subject|9
4802481|NCT01301066|16560966|P1|Overall Study|Withdrawal by Subject|4
4802482|NCT01301066|16560965|P2|Overall Study|Protocol Violation|7
4802483|NCT01301066|16560966|P1|Overall Study|Protocol Violation|8
4802484|NCT01301066|16560965|P2|Overall Study|Lost to Follow-up|11
4802485|NCT01301066|16560966|P1|Overall Study|Lost to Follow-up|5
4802486|NCT01301027|16560974|P2|Overall Study|Volume Overload|0
4802487|NCT01301027|16560975|P1|Overall Study|Volume Overload|3
4802488|NCT01301027|16560974|P2|Overall Study|Transplant|2
4802489|NCT01301027|16560975|P1|Overall Study|Transplant|0
4802490|NCT01301027|16560974|P2|Overall Study|Fracture|3
4802491|NCT01301027|16560975|P1|Overall Study|Fracture|1
4802492|NCT01301027|16560974|P2|Overall Study|Adverse Event|2
4802493|NCT01301027|16560975|P1|Overall Study|Adverse Event|0
4802494|NCT01301027|16560974|P2|Overall Study|Withdrawal by Subject|3
4802495|NCT01301027|16560975|P1|Overall Study|Withdrawal by Subject|2
4802496|NCT01301027|16560974|P2|Overall Study|Physician Decision|0
4802497|NCT01301027|16560975|P1|Overall Study|Physician Decision|2
4802498|NCT01301001|16560987|P2|Second Intervention|Withdrawal by Subject|0
4802499|NCT01301001|16560988|P1|Second Intervention|Withdrawal by Subject|2
4802500|NCT01301001|16560987|P2|Second Intervention|Adverse Event|0
4802501|NCT01301001|16560988|P1|Second Intervention|Adverse Event|2
4802502|NCT01301001|16560987|P2|First Intervention|Protocol Violation|1
4802503|NCT01301001|16560988|P1|First Intervention|Protocol Violation|0
4802504|NCT01301001|16560987|P2|First Intervention|Adverse Event|0
4802505|NCT01301001|16560988|P1|First Intervention|Adverse Event|5
4802506|NCT01301001|16560987|P2|First Intervention|Withdrawal by Subject|4
4802507|NCT01301001|16560988|P1|First Intervention|Withdrawal by Subject|1
4802508|NCT01301001|16560987|P2|First Intervention|Lost to Follow-up|4
4802509|NCT01301001|16560988|P1|First Intervention|Lost to Follow-up|4
4802510|NCT01300923|16561011|P2|Overall Study|Physician Decision|2
4802511|NCT01300923|16561012|P1|Overall Study|Physician Decision|0
4802512|NCT01300819|16561025|P2|Overall Study|Follow up call was not done|0
4802513|NCT01300819|16561026|P1|Overall Study|Follow up call was not done|1
4802514|NCT01300819|16561025|P2|Overall Study|Safety follow up not done by mistake|1
4802515|NCT01300819|16561026|P1|Overall Study|Safety follow up not done by mistake|0
4802516|NCT01300819|16561025|P2|Overall Study|Administrative reason|1
4802517|NCT01300819|16561026|P1|Overall Study|Administrative reason|0
4802518|NCT01300819|16561025|P2|Overall Study|Refusal to down titrate study drug|1
4802519|NCT01300819|16561026|P1|Overall Study|Refusal to down titrate study drug|0
4802520|NCT01300819|16561025|P2|Overall Study|Patient was 1 month late for Visit 10|1
4802521|NCT01300819|16561026|P1|Overall Study|Patient was 1 month late for Visit 10|0
4802522|NCT01300819|16561025|P2|Overall Study|Withdrawal by Subject|12
4802523|NCT01300819|16561026|P1|Overall Study|Withdrawal by Subject|10
4802524|NCT01300819|16561025|P2|Overall Study|Lack of Efficacy|1
4802525|NCT01300819|16561026|P1|Overall Study|Lack of Efficacy|2
4802526|NCT01300819|16561025|P2|Overall Study|Adverse Event|27
4802527|NCT01300819|16561026|P1|Overall Study|Adverse Event|9
4802528|NCT01300767|16561054|P1|Overall Study|Unacceptable fit|1
4802529|NCT01300767|16561054|P1|Overall Study|Biomicroscopy|1
4802530|NCT01300767|16561054|P1|Overall Study|Discomfort|2
4802531|NCT01300741|16561082|P1|Overall Study|Discomfort|1
4802532|NCT01300741|16561082|P1|Overall Study|Lost to Follow-up|1
4802533|NCT01300741|16561082|P1|Overall Study|Lens deposits|1
4802534|NCT01300728|16561112|P2|Overall Study|Physician Decision|0
4802535|NCT01300728|16561113|P1|Overall Study|Physician Decision|1
4802536|NCT01300728|16561112|P2|Overall Study|Withdrawal by Subject|1
4802537|NCT01300728|16561113|P1|Overall Study|Withdrawal by Subject|1
4802538|NCT01300650|16561127|P1|Overall Study|Adverse Event|1
4802539|NCT01300572|16561143|P1|Overall Study|HAMA + post dosimetry|1
4802540|NCT01300546|16561167|P2|Overall Study|Adverse Event|1
4802541|NCT01300546|16561168|P1|Overall Study|Adverse Event|0
4802542|NCT01300546|16561167|P2|Overall Study|Lack of Efficacy|3
4802543|NCT01300546|16561168|P1|Overall Study|Lack of Efficacy|0
4802544|NCT01300546|16561167|P2|Overall Study|Lost to Follow-up|2
4802545|NCT01300546|16561168|P1|Overall Study|Lost to Follow-up|0
4802546|NCT01300546|16561167|P2|Overall Study|Withdrawal by Subject|0
4802547|NCT01300546|16561168|P1|Overall Study|Withdrawal by Subject|1
4802548|NCT01300455|16561198|P2|Washout|Withdrawal by Subject|0
4802549|NCT01300455|16561199|P1|Washout|Withdrawal by Subject|1
4802550|NCT01300351|16561219|P2|Overall Study|Withdrawal by Subject|10
4802551|NCT01300351|16561220|P1|Overall Study|Withdrawal by Subject|7
4802552|NCT01300351|16561219|P2|Overall Study|Adverse Event|4
4802553|NCT01300351|16561220|P1|Overall Study|Adverse Event|0
4802554|NCT01300351|16561219|P2|Overall Study|Lost to Follow-up|1
4802555|NCT01300351|16561220|P1|Overall Study|Lost to Follow-up|0
4802556|NCT01300351|16561219|P2|Overall Study|Ongoing treatment at data cut-off|23
4802557|NCT01300351|16561220|P1|Overall Study|Ongoing treatment at data cut-off|27
4802558|NCT01300351|16561219|P2|Overall Study|Did not receive treatment|0
4802559|NCT01300351|16561220|P1|Overall Study|Did not receive treatment|2
4802560|NCT01300338|16561236|P2|Overall Study|Lost to Follow-up|0
4802561|NCT01300338|16561237|P1|Overall Study|Lost to Follow-up|5
4802562|NCT01300286|16561245|P1|Overall Study|did not get dosed|1
4802563|NCT01300260|16561255|P2|Period 2 of Study: Second Intervention|Adverse Event|1
4802564|NCT01300260|16561256|P1|Period 2 of Study: Second Intervention|Adverse Event|0
4802565|NCT01300260|16561255|P2|Period 1 of Study: First Intervention|Withdrawal by Subject|0
4802566|NCT01300260|16561256|P1|Period 1 of Study: First Intervention|Withdrawal by Subject|1
4802567|NCT01300260|16561255|P2|Period 1 of Study: First Intervention|Adverse Event|1
4802568|NCT01300260|16561256|P1|Period 1 of Study: First Intervention|Adverse Event|0
4802569|NCT01300247|16561288|P2|Overall Study|Non-Compliance|1
4802570|NCT01300247|16561289|P1|Overall Study|Non-Compliance|0
4802571|NCT01300247|16561288|P2|Overall Study|Withdrawal by Subject|0
4802572|NCT01300247|16561289|P1|Overall Study|Withdrawal by Subject|1
4802573|NCT01300247|16561288|P2|Overall Study|Lost to Follow-up|0
4802574|NCT01300247|16561289|P1|Overall Study|Lost to Follow-up|2
4802575|NCT01300247|16561288|P2|Overall Study|Death|1
4802576|NCT01300247|16561289|P1|Overall Study|Death|1
4802577|NCT01300234|16561321|P2|Overall Study|Participant refused return to hospital|0
4802578|NCT01300234|16561322|P1|Overall Study|Participant refused return to hospital|1
4802579|NCT01300234|16561321|P2|Overall Study|Participant stopped medication|1
4802580|NCT01300234|16561322|P1|Overall Study|Participant stopped medication|1
4802581|NCT01300234|16561321|P2|Overall Study|Participant reached stopping critera|0
4802582|NCT01300234|16561322|P1|Overall Study|Participant reached stopping critera|2
4802583|NCT01300234|16561321|P2|Overall Study|Pregnancy|1
4802584|NCT01300234|16561322|P1|Overall Study|Pregnancy|2
4802585|NCT01300234|16561321|P2|Overall Study|Lost to Follow-up|12
4802586|NCT01300234|16561322|P1|Overall Study|Lost to Follow-up|14
4802587|NCT01300234|16561321|P2|Overall Study|Withdrawal by Subject|9
4802588|NCT01300234|16561322|P1|Overall Study|Withdrawal by Subject|5
4802589|NCT01300234|16561321|P2|Overall Study|Protocol Violation|3
4802590|NCT01300234|16561322|P1|Overall Study|Protocol Violation|2
4802591|NCT01300234|16561321|P2|Overall Study|Adverse Event|1
4802592|NCT01300234|16561322|P1|Overall Study|Adverse Event|1
4802593|NCT01300052|16561369|P2|Overall Study|Protocol Violation|1
4802594|NCT01300052|16561370|P1|Overall Study|Protocol Violation|1
4802595|NCT01300052|16561369|P2|Overall Study|Withdrawal by Subject|2
4802596|NCT01300052|16561370|P1|Overall Study|Withdrawal by Subject|2
4802597|NCT01300052|16561369|P2|Overall Study|Adverse Event|0
4802598|NCT01300052|16561370|P1|Overall Study|Adverse Event|3
4802599|NCT01299961|16561388|P1|Overall Study|Lost to Follow-up|1
4802600|NCT01299961|16561388|P1|Overall Study|Lack of Efficacy|2
4802601|NCT01299961|16561388|P1|Overall Study|Adverse Event|3
4802602|NCT01299909|16561397|P3|Overall Study|Lost to Follow-up|17
4802603|NCT01299909|16561398|P2|Overall Study|Lost to Follow-up|18
4802604|NCT01299909|16561399|P1|Overall Study|Lost to Follow-up|22
4802605|NCT01299896|16561414|P2|Overall Study|Lost to Follow-up|11
4802606|NCT01299896|16561415|P1|Overall Study|Lost to Follow-up|0
4802607|NCT01299896|16561414|P2|Overall Study|Withdrawal by Subject|7
4802608|NCT01299896|16561415|P1|Overall Study|Withdrawal by Subject|1
4802609|NCT01299805|16561423|P2|Overall Study|Adverse Event|0
4802610|NCT01299805|16561424|P1|Overall Study|Adverse Event|2
4802611|NCT01299766|16561454|P2|Overall Study|Withdrawal by Subject|19
4802612|NCT01299766|16561455|P1|Overall Study|Withdrawal by Subject|29
4802613|NCT01299766|16561454|P2|Overall Study|Death|4
4802614|NCT01299766|16561455|P1|Overall Study|Death|5
4802615|NCT01299727|16561466|P3|Overall Study|Completed the Treatment Period|3
4802616|NCT01299727|16561467|P2|Overall Study|Completed the Treatment Period|4
4802617|NCT01299727|16561468|P1|Overall Study|Completed the Treatment Period|3
4802618|NCT01299727|16561466|P3|Overall Study|Adverse Event|1
4802619|NCT01299727|16561467|P2|Overall Study|Adverse Event|0
4802620|NCT01299727|16561468|P1|Overall Study|Adverse Event|0
4802621|NCT01299727|16561466|P3|Overall Study|Withdrawal by Subject|0
4802622|NCT01299727|16561467|P2|Overall Study|Withdrawal by Subject|0
4802623|NCT01299727|16561468|P1|Overall Study|Withdrawal by Subject|1
4802624|NCT01299584|16561562|P1|Overall Study|Protocol Violation|9
4802625|NCT01299571|16561569|P1|Overall Study|Protocol Violation|107
4802626|NCT01299480|16561580|P5|Overall Study|Started, but not vaccinated|0
4802627|NCT01299480|16561581|P4|Overall Study|Started, but not vaccinated|1
4802628|NCT01299480|16561582|P3|Overall Study|Started, but not vaccinated|1
4802629|NCT01299480|16561583|P2|Overall Study|Started, but not vaccinated|0
4802630|NCT01299480|16561584|P1|Overall Study|Started, but not vaccinated|0
4802631|NCT01299480|16561580|P5|Overall Study|Other|3
4802632|NCT01299480|16561581|P4|Overall Study|Other|0
4802633|NCT01299480|16561582|P3|Overall Study|Other|3
4802634|NCT01299480|16561583|P2|Overall Study|Other|2
4802635|NCT01299480|16561584|P1|Overall Study|Other|3
4802636|NCT01299480|16561580|P5|Overall Study|Lost to Follow-up|2
4802637|NCT01299480|16561581|P4|Overall Study|Lost to Follow-up|1
4802638|NCT01299480|16561582|P3|Overall Study|Lost to Follow-up|2
4802639|NCT01299480|16561583|P2|Overall Study|Lost to Follow-up|1
4802640|NCT01299480|16561584|P1|Overall Study|Lost to Follow-up|3
4802641|NCT01299480|16561580|P5|Overall Study|Physician Decision|0
4802642|NCT01299480|16561581|P4|Overall Study|Physician Decision|2
4802643|NCT01299480|16561582|P3|Overall Study|Physician Decision|0
4802644|NCT01299480|16561583|P2|Overall Study|Physician Decision|1
4802645|NCT01299480|16561584|P1|Overall Study|Physician Decision|1
4802646|NCT01299480|16561580|P5|Overall Study|Withdrawal due to pregnancy|0
4802647|NCT01299480|16561581|P4|Overall Study|Withdrawal due to pregnancy|0
4802648|NCT01299480|16561582|P3|Overall Study|Withdrawal due to pregnancy|1
4802649|NCT01299480|16561583|P2|Overall Study|Withdrawal due to pregnancy|1
4802650|NCT01299480|16561584|P1|Overall Study|Withdrawal due to pregnancy|0
4802651|NCT01299480|16561580|P5|Overall Study|Adverse Event|0
4802652|NCT01299480|16561581|P4|Overall Study|Adverse Event|4
4802653|NCT01299480|16561582|P3|Overall Study|Adverse Event|5
4802654|NCT01299480|16561583|P2|Overall Study|Adverse Event|4
4802655|NCT01299480|16561584|P1|Overall Study|Adverse Event|6
4802656|NCT01299480|16561580|P5|Overall Study|Withdrawal by Subject|4
4802657|NCT01299480|16561581|P4|Overall Study|Withdrawal by Subject|3
4802658|NCT01299480|16561582|P3|Overall Study|Withdrawal by Subject|7
4802659|NCT01299480|16561583|P2|Overall Study|Withdrawal by Subject|4
4802660|NCT01299480|16561584|P1|Overall Study|Withdrawal by Subject|3
4802661|NCT01299480|16561580|P5|Overall Study|Protocol Violation|1
4802662|NCT01299480|16561581|P4|Overall Study|Protocol Violation|1
4802663|NCT01299480|16561582|P3|Overall Study|Protocol Violation|8
4802664|NCT01299480|16561583|P2|Overall Study|Protocol Violation|5
4802665|NCT01299480|16561584|P1|Overall Study|Protocol Violation|7
4802666|NCT01299480|16561580|P5|Overall Study|No longer willing to participate|10
4802667|NCT01299480|16561581|P4|Overall Study|No longer willing to participate|13
4802668|NCT01299480|16561582|P3|Overall Study|No longer willing to participate|14
4802669|NCT01299480|16561583|P2|Overall Study|No longer willing to participate|17
4802670|NCT01299480|16561584|P1|Overall Study|No longer willing to participate|19
4802671|NCT01299389|16561786|P4|Post-observational|Other|6
4802672|NCT01299389|16561787|P3|Post-observational|Other|12
4802673|NCT01299389|16561788|P2|Post-observational|Other|0
4802674|NCT01299389|16561789|P1|Post-observational|Other|0
4802675|NCT01299389|16561786|P4|Double-blind|"fail to meet study population criteria"|0
4802676|NCT01299389|16561787|P3|Double-blind|"fail to meet study population criteria"|0
4802677|NCT01299389|16561788|P2|Double-blind|"fail to meet study population criteria"|1
4802678|NCT01299389|16561789|P1|Double-blind|"fail to meet study population criteria"|0
4802679|NCT01299389|16561786|P4|Double-blind|Other|0
4802680|NCT01299389|16561787|P3|Double-blind|Other|0
4802681|NCT01299389|16561788|P2|Double-blind|Other|1
4802682|NCT01299389|16561789|P1|Double-blind|Other|1
4802683|NCT01299389|16561786|P4|Double-blind|Withdrawal by Subject|0
4802684|NCT01299389|16561787|P3|Double-blind|Withdrawal by Subject|0
4802685|NCT01299389|16561788|P2|Double-blind|Withdrawal by Subject|13
4802686|NCT01299389|16561789|P1|Double-blind|Withdrawal by Subject|16
4802687|NCT01299389|16561786|P4|Double-blind|Lost to Follow-up|0
4802688|NCT01299389|16561787|P3|Double-blind|Lost to Follow-up|0
4802689|NCT01299389|16561788|P2|Double-blind|Lost to Follow-up|1
4802690|NCT01299389|16561789|P1|Double-blind|Lost to Follow-up|2
4802691|NCT01299389|16561786|P4|Double-blind|Lack of Efficacy|0
4802692|NCT01299389|16561787|P3|Double-blind|Lack of Efficacy|0
4802693|NCT01299389|16561788|P2|Double-blind|Lack of Efficacy|21
4802694|NCT01299389|16561789|P1|Double-blind|Lack of Efficacy|45
4802695|NCT01299389|16561786|P4|Double-blind|Adverse Event|0
4802696|NCT01299389|16561787|P3|Double-blind|Adverse Event|0
4802697|NCT01299389|16561788|P2|Double-blind|Adverse Event|27
4802698|NCT01299389|16561789|P1|Double-blind|Adverse Event|45
4802699|NCT01299376|16561811|P2|Extension (Weeks 9 to 52)|Physician Decision|0
4802700|NCT01299376|16561812|P1|Extension (Weeks 9 to 52)|Physician Decision|1
4802701|NCT01299376|16561811|P2|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9
4802702|NCT01299376|16561812|P1|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4
4802703|NCT01299376|16561811|P2|Extension (Weeks 9 to 52)|Lost to Follow-up|2
4802704|NCT01299376|16561812|P1|Extension (Weeks 9 to 52)|Lost to Follow-up|1
4802705|NCT01299376|16561811|P2|Extension (Weeks 9 to 52)|Adverse Event|3
4802706|NCT01299376|16561812|P1|Extension (Weeks 9 to 52)|Adverse Event|2
4802707|NCT01299376|16561811|P2|Extension (Weeks 9 to 52)|Withdrawal by Subject|1
4802708|NCT01299376|16561812|P1|Extension (Weeks 9 to 52)|Withdrawal by Subject|2
4802709|NCT01299376|16561811|P2|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
4802710|NCT01299376|16561812|P1|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1
4802711|NCT01299376|16561811|P2|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0
4802712|NCT01299376|16561812|P1|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1
4802713|NCT01299376|16561811|P2|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7
4802714|NCT01299376|16561812|P1|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4
4802715|NCT01299376|16561811|P2|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1
4802716|NCT01299376|16561812|P1|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0
4802717|NCT01299376|16561811|P2|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1
4802718|NCT01299376|16561812|P1|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0
4802719|NCT01299376|16561811|P2|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2
4802720|NCT01299376|16561812|P1|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1
4802721|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Sponsor Decision|1
4802722|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Sponsor Decision|1
4802723|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Sponsor Decision|0
4802724|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Sponsor Decision|0
4802725|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Physician Decision|1
4802726|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Physician Decision|2
4802727|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Physician Decision|0
4802728|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Physician Decision|0
4802729|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10
4802730|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4
4802731|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
4802732|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0
4802733|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Lost to Follow-up|5
4802734|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Lost to Follow-up|5
4802735|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Lost to Follow-up|0
4802736|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Lost to Follow-up|0
4802737|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Protocol Violation|7
4802738|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Protocol Violation|8
4802739|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Protocol Violation|0
4802740|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Protocol Violation|0
4802741|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Adverse Event|9
4802742|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Adverse Event|8
4802743|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Adverse Event|0
4802744|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Adverse Event|0
4802745|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Lack of Efficacy|10
4802746|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Lack of Efficacy|20
4802747|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Lack of Efficacy|0
4802748|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Lack of Efficacy|0
4802749|NCT01299272|16561855|P4|Double-blind (DB) Randomized Period|Withdrawal by Subject|15
4802750|NCT01299272|16561856|P3|Double-blind (DB) Randomized Period|Withdrawal by Subject|22
4802751|NCT01299272|16561857|P2|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
4802752|NCT01299272|16561858|P1|Double-blind (DB) Randomized Period|Withdrawal by Subject|0
4802753|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Physician Decision|0
4802754|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Physician Decision|0
4802755|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Physician Decision|3
4802756|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Physician Decision|0
4802757|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
4802758|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
4802759|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6
4802760|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0
4802761|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Lost to Follow-up|0
4802762|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Lost to Follow-up|0
4802763|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Lost to Follow-up|9
4802764|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Lost to Follow-up|0
4802765|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Lack of Efficacy|0
4802766|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Lack of Efficacy|0
4802767|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Lack of Efficacy|11
4802768|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Lack of Efficacy|0
4802769|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Sponsor Decision|0
4802770|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Sponsor Decision|0
4802771|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Sponsor Decision|12
4802772|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Sponsor Decision|0
4802773|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
4802774|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
4802775|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Withdrawal by Subject|42
4802776|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Withdrawal by Subject|0
4802777|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Adverse Event|0
4802778|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Adverse Event|0
4802779|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Adverse Event|42
4802780|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Adverse Event|0
4802781|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Protocol Violation|0
4802782|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Protocol Violation|0
4802783|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Protocol Violation|44
4802784|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Protocol Violation|0
4802785|NCT01299272|16561855|P4|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
4802786|NCT01299272|16561856|P3|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
4802787|NCT01299272|16561857|P2|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80
4802788|NCT01299272|16561858|P1|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0
4802789|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Physician Decision|0
4802790|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Physician Decision|0
4802791|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Physician Decision|0
4802792|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Physician Decision|5
4802793|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Lack of Efficacy|0
4802794|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Lack of Efficacy|0
4802795|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Lack of Efficacy|0
4802796|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Lack of Efficacy|10
4802797|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Sponsor Decision|0
4802798|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Sponsor Decision|0
4802799|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Sponsor Decision|0
4802800|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Sponsor Decision|13
4802801|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Lost to Follow-up|0
4802802|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Lost to Follow-up|0
4802803|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Lost to Follow-up|0
4802804|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Lost to Follow-up|14
4802805|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Protocol Violation|0
4802806|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Protocol Violation|0
4802807|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Protocol Violation|0
4802808|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Protocol Violation|36
4802809|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Withdrawal by Subject|0
4802810|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Withdrawal by Subject|0
4802811|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Withdrawal by Subject|0
4802812|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Withdrawal by Subject|56
4802813|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Adverse Event|0
4802814|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Adverse Event|0
4802815|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Adverse Event|0
4802816|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Adverse Event|140
4802817|NCT01299272|16561855|P4|Acute Open-label (OL) Period|Remission Criteria Not Met|0
4802818|NCT01299272|16561856|P3|Acute Open-label (OL) Period|Remission Criteria Not Met|0
4802819|NCT01299272|16561857|P2|Acute Open-label (OL) Period|Remission Criteria Not Met|0
4802820|NCT01299272|16561858|P1|Acute Open-label (OL) Period|Remission Criteria Not Met|140
4802821|NCT01299116|16561913|P3|Overall Study|Lost to Follow-up|11
4802822|NCT01299116|16561914|P2|Overall Study|Lost to Follow-up|9
4802823|NCT01299116|16561915|P1|Overall Study|Lost to Follow-up|65
4802824|NCT01299038|16561960|P2|Overall Study|Withdrawal by Subject|0
4802825|NCT01299038|16561961|P1|Overall Study|Withdrawal by Subject|1
4802826|NCT01299025|16561969|P2|Overall Study|Lost to Follow-up|0
4802827|NCT01299025|16561970|P1|Overall Study|Lost to Follow-up|1
4802828|NCT01299025|16561969|P2|Overall Study|Withdrawal by Subject|1
4802829|NCT01299025|16561970|P1|Overall Study|Withdrawal by Subject|2
4802830|NCT01298778|16561995|P2|Overall Study|not meet inclusion/exclusion criteria|1
4802831|NCT01298778|16561996|P1|Overall Study|not meet inclusion/exclusion criteria|0
4802832|NCT01298778|16561995|P2|Overall Study|Protocol Violation|1
4802833|NCT01298778|16561996|P1|Overall Study|Protocol Violation|0
4802834|NCT01298778|16561995|P2|Overall Study|Withdrawal by Subject|1
4802835|NCT01298778|16561996|P1|Overall Study|Withdrawal by Subject|0
4802836|NCT01298778|16561995|P2|Overall Study|Incorrect use of VAS|0
4802837|NCT01298778|16561996|P1|Overall Study|Incorrect use of VAS|1
4802838|NCT01298778|16561995|P2|Overall Study|Lost to Follow-up|3
4802839|NCT01298778|16561996|P1|Overall Study|Lost to Follow-up|2
4802840|NCT01298765|16562016|P1|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46
4802841|NCT01298765|16562016|P1|Long-Term Treatment Period|Physician Decision|1
4802842|NCT01298765|16562016|P1|Long-Term Treatment Period|Withdrawal by Subject|19
4802843|NCT01298765|16562016|P1|Long-Term Treatment Period|Lost to Follow-up|8
4802844|NCT01298765|16562016|P1|Long-Term Treatment Period|Lack of Efficacy|6
4802845|NCT01298765|16562016|P1|Long-Term Treatment Period|Adverse Event|19
4802846|NCT01298765|16562016|P1|Titration Period|Other: Not Lack of Analgesic Effect|8
4802847|NCT01298765|16562016|P1|Titration Period|Withdrawal by Subject|10
4802848|NCT01298765|16562016|P1|Titration Period|Physician Decision|1
4802849|NCT01298765|16562016|P1|Titration Period|Lost to Follow-up|9
4802850|NCT01298765|16562016|P1|Titration Period|Lack of Efficacy|21
4802851|NCT01298765|16562016|P1|Titration Period|Death|1
4802852|NCT01298765|16562016|P1|Titration Period|Adverse Event|26
4802853|NCT01298700|16562037|P2|Overall Study|Did not Receive Study Drug|5
4802854|NCT01298700|16562038|P1|Overall Study|Did not Receive Study Drug|3
4802855|NCT01298700|16562037|P2|Overall Study|Other Miscellaneous Reasons|15
4802856|NCT01298700|16562038|P1|Overall Study|Other Miscellaneous Reasons|16
4802857|NCT01298700|16562037|P2|Overall Study|Protocol Violation|4
4802858|NCT01298700|16562038|P1|Overall Study|Protocol Violation|6
4802859|NCT01298700|16562037|P2|Overall Study|Withdrawal by Subject|9
4802860|NCT01298700|16562038|P1|Overall Study|Withdrawal by Subject|12
4802861|NCT01298700|16562037|P2|Overall Study|Lost to Follow-up|2
4802862|NCT01298700|16562038|P1|Overall Study|Lost to Follow-up|5
4802863|NCT01298700|16562037|P2|Overall Study|Lack of Efficacy|14
4802864|NCT01298700|16562038|P1|Overall Study|Lack of Efficacy|9
4802865|NCT01298700|16562037|P2|Overall Study|Adverse Event|51
4802866|NCT01298700|16562038|P1|Overall Study|Adverse Event|50
4802867|NCT01298661|16562049|P3|Overall Study|Withdrawal by Subject|2
4802868|NCT01298661|16562050|P2|Overall Study|Withdrawal by Subject|0
4802869|NCT01298661|16562051|P1|Overall Study|Withdrawal by Subject|2
4802870|NCT01298648|16562129|P1|Overall Study|Lost to Follow-up|21
4802871|NCT01298648|16562129|P1|Overall Study|Withdrawal by Subject|2
4802872|NCT01298596|16562140|P2|Overall Study|Referred for further management|15
4802873|NCT01298596|16562141|P1|Overall Study|Referred for further management|16
4802874|NCT01298596|16562140|P2|Overall Study|Lost to Follow-up|14
4802875|NCT01298596|16562141|P1|Overall Study|Lost to Follow-up|6
4802876|NCT01298596|16562140|P2|Overall Study|Death|3
4802877|NCT01298596|16562141|P1|Overall Study|Death|5
4802878|NCT01298596|16562140|P2|Overall Study|Withdrawal by Subject|1
4802879|NCT01298596|16562141|P1|Overall Study|Withdrawal by Subject|1
4802880|NCT01298570|16562151|P2|Overall Study|Ineligibility|1
4802881|NCT01298570|16562152|P1|Overall Study|Ineligibility|0
4802882|NCT01298570|16562151|P2|Overall Study|Death|1
4802883|NCT01298570|16562152|P1|Overall Study|Death|0
4802884|NCT01298570|16562151|P2|Overall Study|Symptomatic progression/deterioration|2
4802885|NCT01298570|16562152|P1|Overall Study|Symptomatic progression/deterioration|3
4802886|NCT01298570|16562151|P2|Overall Study|Surgery|1
4802887|NCT01298570|16562152|P1|Overall Study|Surgery|2
4802888|NCT01298570|16562151|P2|Overall Study|Other complicating disease|1
4802889|NCT01298570|16562152|P1|Overall Study|Other complicating disease|2
4802890|NCT01298570|16562151|P2|Overall Study|Physician Decision|2
4802891|NCT01298570|16562152|P1|Overall Study|Physician Decision|4
4802892|NCT01298570|16562151|P2|Overall Study|Treatment delay > 4 weeks|5
4802893|NCT01298570|16562152|P1|Overall Study|Treatment delay > 4 weeks|4
4802894|NCT01298570|16562151|P2|Overall Study|Withdrawal by Subject|6
4802895|NCT01298570|16562152|P1|Overall Study|Withdrawal by Subject|21
4802896|NCT01298570|16562151|P2|Overall Study|Adverse Event|2
4802897|NCT01298570|16562152|P1|Overall Study|Adverse Event|20
4802898|NCT01298570|16562151|P2|Overall Study|Disease progression, relapse during acti|40
4802899|NCT01298570|16562152|P1|Overall Study|Disease progression, relapse during acti|64
4802900|NCT01298531|16562179|P2|Overall Study|Other|1
4802901|NCT01298531|16562180|P1|Overall Study|Other|2
4802902|NCT01298531|16562179|P2|Overall Study|Does not meet entrance criteria|1
4802903|NCT01298531|16562180|P1|Overall Study|Does not meet entrance criteria|0
4802904|NCT01298531|16562179|P2|Overall Study|Adverse Event|3
4802905|NCT01298531|16562180|P1|Overall Study|Adverse Event|4
4802906|NCT01298531|16562179|P2|Overall Study|Protocol Violation|1
4802907|NCT01298531|16562180|P1|Overall Study|Protocol Violation|1
4802908|NCT01298531|16562179|P2|Overall Study|Lost to Follow-up|0
4802909|NCT01298531|16562180|P1|Overall Study|Lost to Follow-up|2
4802910|NCT01298531|16562179|P2|Overall Study|Lack of Efficacy|1
4802911|NCT01298531|16562180|P1|Overall Study|Lack of Efficacy|0
4802912|NCT01298518|16562309|P3|Overall Study|Withdrawal by Subject|1
4802913|NCT01298518|16562310|P2|Overall Study|Withdrawal by Subject|0
4802914|NCT01298518|16562311|P1|Overall Study|Withdrawal by Subject|0
4802915|NCT01298492|16562363|P1|Overall Study|Adverse Event(Not Related to Study Drug)|18
4802916|NCT01298492|16562363|P1|Overall Study|Adverse Event(Related to Study Drug)|8
4802917|NCT01298492|16562363|P1|Overall Study|Protocol Violation|2
4802918|NCT01298492|16562363|P1|Overall Study|Withdrawn Due to Pregnancy|1
4802919|NCT01298492|16562363|P1|Overall Study|Other (Unspecified)|7
4802920|NCT01298492|16562363|P1|Overall Study|Withdrawal by Subject|47
4802921|NCT01298492|16562363|P1|Overall Study|Lost to Follow-up|12
4802922|NCT01298492|16562363|P1|Overall Study|Insufficient Clinical Response|22
4802923|NCT01298492|16562363|P1|Overall Study|Death|2
4802924|NCT01298362|16562371|P2|Overall Study|Did not provide 12month BMD measurements|43
4802925|NCT01298362|16562372|P1|Overall Study|Did not provide 12month BMD measurements|38
4802926|NCT01298323|16562392|P2|Overall Study|Eligibility criteria not fulfilled|1
4802927|NCT01298323|16562393|P1|Overall Study|Eligibility criteria not fulfilled|0
4802928|NCT01298323|16562392|P2|Overall Study|Ongoing|55
4802929|NCT01298323|16562393|P1|Overall Study|Ongoing|55
4802930|NCT01298323|16562392|P2|Overall Study|Other|9
4802931|NCT01298323|16562393|P1|Overall Study|Other|10
4802932|NCT01298323|16562392|P2|Overall Study|Protocol Violation|0
4802933|NCT01298323|16562393|P1|Overall Study|Protocol Violation|1
4802934|NCT01298323|16562392|P2|Overall Study|Withdrawal by Subject|3
4802935|NCT01298323|16562393|P1|Overall Study|Withdrawal by Subject|6
4802936|NCT01298323|16562392|P2|Overall Study|Lost to Follow-up|0
4802937|NCT01298323|16562393|P1|Overall Study|Lost to Follow-up|1
4802938|NCT01298323|16562392|P2|Overall Study|Death|16
4802939|NCT01298323|16562393|P1|Overall Study|Death|11
4802940|NCT01298323|16562392|P2|Overall Study|Adverse Event|4
4802941|NCT01298323|16562393|P1|Overall Study|Adverse Event|2
4802942|NCT01298193|16562416|P1|Efficacy Phase (Second Cycle)|Death|1
4802943|NCT01298193|16562416|P1|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9
4802944|NCT01298193|16562416|P1|Observational Phase (First Cycle)|Received TC at a different dose|16
4802945|NCT01298193|16562416|P1|Observational Phase (First Cycle)|Withdrawal by Subject|2
4802946|NCT01298141|16562438|P1|Overall Study|Not treated|4
4802947|NCT01298141|16562438|P1|Overall Study|Death|6
4802948|NCT01298141|16562438|P1|Overall Study|Lost to Follow-up|1
4802949|NCT01298141|16562438|P1|Overall Study|Other|5
4802950|NCT01298141|16562438|P1|Overall Study|Termination of Study by the Investigator|5
4802951|NCT01298141|16562438|P1|Overall Study|Withdrawal by Subject|6
4802952|NCT01298141|16562438|P1|Overall Study|Refusal of Required Study Procedures|1
4802953|NCT01298141|16562438|P1|Overall Study|Adverse Event|3
4802954|NCT01297920|16562513|P3|Overall Study|Patient Did Not Meet Entrance Criteria|0
4802955|NCT01297920|16562514|P2|Overall Study|Patient Did Not Meet Entrance Criteria|0
4802956|NCT01297920|16562515|P1|Overall Study|Patient Did Not Meet Entrance Criteria|1
4802957|NCT01297920|16562513|P3|Overall Study|Inadequate Control of IOP|17
4802958|NCT01297920|16562514|P2|Overall Study|Inadequate Control of IOP|9
4802959|NCT01297920|16562515|P1|Overall Study|Inadequate Control of IOP|7
4802960|NCT01297920|16562513|P3|Overall Study|Protocol Violation|0
4802961|NCT01297920|16562514|P2|Overall Study|Protocol Violation|3
4802962|NCT01297920|16562515|P1|Overall Study|Protocol Violation|1
4802963|NCT01297920|16562513|P3|Overall Study|Noncompliance|0
4802964|NCT01297920|16562514|P2|Overall Study|Noncompliance|0
4802965|NCT01297920|16562515|P1|Overall Study|Noncompliance|1
4802966|NCT01297920|16562513|P3|Overall Study|Patient Decision Unrelated to AE|2
4802967|NCT01297920|16562514|P2|Overall Study|Patient Decision Unrelated to AE|5
4802968|NCT01297920|16562515|P1|Overall Study|Patient Decision Unrelated to AE|6
4802969|NCT01297920|16562513|P3|Overall Study|Adverse Event|38
4802970|NCT01297920|16562514|P2|Overall Study|Adverse Event|10
4802971|NCT01297920|16562515|P1|Overall Study|Adverse Event|42
4802972|NCT01297517|16562559|P3|Overall Study|Inadequate Control of IOP|2
4802973|NCT01297517|16562560|P2|Overall Study|Inadequate Control of IOP|1
4802974|NCT01297517|16562561|P1|Overall Study|Inadequate Control of IOP|1
4802975|NCT01297517|16562559|P3|Overall Study|Protocol Violation|1
4802976|NCT01297517|16562560|P2|Overall Study|Protocol Violation|1
4802977|NCT01297517|16562561|P1|Overall Study|Protocol Violation|1
4802978|NCT01297517|16562559|P3|Overall Study|Noncompliance|0
4802979|NCT01297517|16562560|P2|Overall Study|Noncompliance|0
4802980|NCT01297517|16562561|P1|Overall Study|Noncompliance|1
4802981|NCT01297517|16562559|P3|Overall Study|Patient Decision Unrelated to AE|7
4802982|NCT01297517|16562560|P2|Overall Study|Patient Decision Unrelated to AE|3
4802983|NCT01297517|16562561|P1|Overall Study|Patient Decision Unrelated to AE|2
4802984|NCT01297517|16562559|P3|Overall Study|Lost to Follow-up|1
4802985|NCT01297517|16562560|P2|Overall Study|Lost to Follow-up|0
4802986|NCT01297517|16562561|P1|Overall Study|Lost to Follow-up|1
4802987|NCT01297517|16562559|P3|Overall Study|Adverse Event|16
4802988|NCT01297517|16562560|P2|Overall Study|Adverse Event|7
4802989|NCT01297517|16562561|P1|Overall Study|Adverse Event|21
4802990|NCT01297504|16562569|P1|Overall Study|Protocol Violation|3
4802991|NCT01297504|16562569|P1|Overall Study|Site Closure|3
4802992|NCT01297504|16562569|P1|Overall Study|Withdrawal by Subject|9
4802993|NCT01297504|16562569|P1|Overall Study|Lost to Follow-up|43
4802994|NCT01297504|16562569|P1|Overall Study|Death|3
4802995|NCT01297504|16562569|P1|Overall Study|No Study Visits|4
4802996|NCT01297504|16562569|P1|Overall Study|Received Palivizumab in Previous Season|1
4802997|NCT01297504|16562569|P1|Overall Study|Invalid Consent|1
4802998|NCT01297491|16562583|P2|Overall Study|Death|1
4802999|NCT01297491|16562584|P1|Overall Study|Death|2
4803000|NCT01297491|16562583|P2|Overall Study|Patient/Guardian decision|4
4803001|NCT01297491|16562584|P1|Overall Study|Patient/Guardian decision|3
4803002|NCT01297491|16562583|P2|Overall Study|Progressive disease|20
4803003|NCT01297491|16562584|P1|Overall Study|Progressive disease|11
4803004|NCT01297491|16562583|P2|Overall Study|Physician Decision|2
4803005|NCT01297491|16562584|P1|Overall Study|Physician Decision|3
4803006|NCT01297491|16562583|P2|Overall Study|Adverse Event|6
4803007|NCT01297491|16562584|P1|Overall Study|Adverse Event|11
4803008|NCT01297465|16562602|P2|Overall Study|Intention to Freeze all Embryos|1
4803009|NCT01297465|16562603|P1|Overall Study|Intention to Freeze all Embryos|0
4803010|NCT01297465|16562602|P2|Overall Study|All Embryos Discarded|1
4803011|NCT01297465|16562603|P1|Overall Study|All Embryos Discarded|0
4803012|NCT01297465|16562602|P2|Overall Study|No Fertilization|4
4803013|NCT01297465|16562603|P1|Overall Study|No Fertilization|6
4803014|NCT01297465|16562602|P2|Overall Study|Poor oocyte quality|1
4803015|NCT01297465|16562603|P1|Overall Study|Poor oocyte quality|0
4803016|NCT01297465|16562602|P2|Overall Study|No Oocytes Retrieved|1
4803017|NCT01297465|16562603|P1|Overall Study|No Oocytes Retrieved|1
4803018|NCT01297465|16562602|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
4803019|NCT01297465|16562603|P1|Overall Study|Ovarian hyperstimulation syndrome risk|0
4803020|NCT01297465|16562602|P2|Overall Study|Lack of Ovarian Response|1
4803021|NCT01297465|16562603|P1|Overall Study|Lack of Ovarian Response|1
4803022|NCT01297322|16562656|P2|Overall Study|Protocol Violation|3
4803023|NCT01297322|16562657|P1|Overall Study|Protocol Violation|0
4803024|NCT01297322|16562656|P2|Overall Study|Withdrawal by Subject|1
4803025|NCT01297322|16562657|P1|Overall Study|Withdrawal by Subject|0
4803026|NCT01297322|16562656|P2|Overall Study|Lost to Follow-up|0
4803027|NCT01297322|16562657|P1|Overall Study|Lost to Follow-up|1
4803028|NCT01297309|16562676|P1|Overall Study|Participant not entering extensionperiod|1
4803029|NCT01297309|16562676|P1|Overall Study|Death|1
4803030|NCT01297309|16562676|P1|Overall Study|Investigator Decision|2
4803031|NCT01297309|16562676|P1|Overall Study|Adverse Event|1
4803032|NCT01297309|16562676|P1|Overall Study|Withdrawal by Subject|5
4803033|NCT01297309|16562676|P1|Overall Study|Screen failure|2
4803034|NCT01297309|16562676|P1|Overall Study|Eligibility failure|2
4803035|NCT01297270|16562701|P3|Overall Study|Not treated|0
4803036|NCT01297270|16562702|P2|Overall Study|Not treated|1
4803037|NCT01297270|16562703|P1|Overall Study|Not treated|0
4803038|NCT01297270|16562701|P3|Overall Study|Other reason not defined above|1
4803039|NCT01297270|16562702|P2|Overall Study|Other reason not defined above|3
4803040|NCT01297270|16562703|P1|Overall Study|Other reason not defined above|3
4803041|NCT01297270|16562701|P3|Overall Study|Withdrawal by Subject|7
4803042|NCT01297270|16562702|P2|Overall Study|Withdrawal by Subject|15
4803043|NCT01297270|16562703|P1|Overall Study|Withdrawal by Subject|7
4803044|NCT01297270|16562701|P3|Overall Study|Protocol Violation|0
4803045|NCT01297270|16562702|P2|Overall Study|Protocol Violation|2
4803046|NCT01297270|16562703|P1|Overall Study|Protocol Violation|0
4803047|NCT01297270|16562701|P3|Overall Study|Lost to Follow-up|1
4803048|NCT01297270|16562702|P2|Overall Study|Lost to Follow-up|2
4803049|NCT01297270|16562703|P1|Overall Study|Lost to Follow-up|1
4803050|NCT01297270|16562701|P3|Overall Study|Lack of Efficacy|15
4803051|NCT01297270|16562702|P2|Overall Study|Lack of Efficacy|17
4803052|NCT01297270|16562703|P1|Overall Study|Lack of Efficacy|15
4803053|NCT01297270|16562701|P3|Overall Study|Adverse Event|5
4803054|NCT01297270|16562702|P2|Overall Study|Adverse Event|32
4803055|NCT01297270|16562703|P1|Overall Study|Adverse Event|19
4803056|NCT01297244|16562748|P2|Overall Study|Withdrawal by Subject|0
4803057|NCT01297244|16562749|P1|Overall Study|Withdrawal by Subject|2
4803058|NCT01297244|16562748|P2|Overall Study|Clinical progression|1
4803059|NCT01297244|16562749|P1|Overall Study|Clinical progression|1
4803060|NCT01297244|16562748|P2|Overall Study|Death|1
4803061|NCT01297244|16562749|P1|Overall Study|Death|1
4803062|NCT01297244|16562748|P2|Overall Study|Adverse Event|1
4803063|NCT01297244|16562749|P1|Overall Study|Adverse Event|9
4803064|NCT01297244|16562748|P2|Overall Study|Progressive disease|3
4803065|NCT01297244|16562749|P1|Overall Study|Progressive disease|22
4803066|NCT01297062|16562769|P7|Overall Study|Subject Decision|2
4803067|NCT01297062|16562770|P6|Overall Study|Subject Decision|1
4803068|NCT01297062|16562771|P5|Overall Study|Subject Decision|1
4803069|NCT01297062|16562772|P4|Overall Study|Subject Decision|1
4803070|NCT01297062|16562773|P3|Overall Study|Subject Decision|0
4803071|NCT01297062|16562774|P2|Overall Study|Subject Decision|1
4803072|NCT01297062|16562775|P1|Overall Study|Subject Decision|1
4803073|NCT01297062|16562769|P7|Overall Study|Protocol Violation|0
4803074|NCT01297062|16562770|P6|Overall Study|Protocol Violation|0
4803075|NCT01297062|16562771|P5|Overall Study|Protocol Violation|1
4803076|NCT01297062|16562772|P4|Overall Study|Protocol Violation|0
4803077|NCT01297062|16562773|P3|Overall Study|Protocol Violation|0
4803078|NCT01297062|16562774|P2|Overall Study|Protocol Violation|0
4803079|NCT01297062|16562775|P1|Overall Study|Protocol Violation|0
4803080|NCT01297062|16562769|P7|Overall Study|Physician Decision|6
4803081|NCT01297062|16562770|P6|Overall Study|Physician Decision|0
4803082|NCT01297062|16562771|P5|Overall Study|Physician Decision|0
4803083|NCT01297062|16562772|P4|Overall Study|Physician Decision|0
4803084|NCT01297062|16562773|P3|Overall Study|Physician Decision|1
4803085|NCT01297062|16562774|P2|Overall Study|Physician Decision|0
4803086|NCT01297062|16562775|P1|Overall Study|Physician Decision|1
4803087|NCT01297062|16562769|P7|Overall Study|Adverse Event|0
4803088|NCT01297062|16562770|P6|Overall Study|Adverse Event|0
4803089|NCT01297062|16562771|P5|Overall Study|Adverse Event|0
4803090|NCT01297062|16562772|P4|Overall Study|Adverse Event|0
4803091|NCT01297062|16562773|P3|Overall Study|Adverse Event|1
4803092|NCT01297062|16562774|P2|Overall Study|Adverse Event|0
4803093|NCT01297062|16562775|P1|Overall Study|Adverse Event|2
4803094|NCT01296932|16562806|P9|Overall Study|Dosage already reduced, AE still present|1
4803095|NCT01296932|16562807|P8|Overall Study|Dosage already reduced, AE still present|0
4803096|NCT01296932|16562808|P7|Overall Study|Dosage already reduced, AE still present|0
4803097|NCT01296932|16562809|P6|Overall Study|Dosage already reduced, AE still present|0
4803098|NCT01296932|16562810|P5|Overall Study|Dosage already reduced, AE still present|0
4803099|NCT01296932|16562811|P4|Overall Study|Dosage already reduced, AE still present|0
4803100|NCT01296932|16562812|P3|Overall Study|Dosage already reduced, AE still present|0
4803101|NCT01296932|16562813|P2|Overall Study|Dosage already reduced, AE still present|0
4803102|NCT01296932|16562814|P1|Overall Study|Dosage already reduced, AE still present|0
4803103|NCT01296932|16562806|P9|Overall Study|No adequate treatment response|0
4803104|NCT01296932|16562807|P8|Overall Study|No adequate treatment response|1
4803105|NCT01296932|16562808|P7|Overall Study|No adequate treatment response|0
4803106|NCT01296932|16562809|P6|Overall Study|No adequate treatment response|0
4803107|NCT01296932|16562810|P5|Overall Study|No adequate treatment response|0
4803108|NCT01296932|16562811|P4|Overall Study|No adequate treatment response|0
4803109|NCT01296932|16562812|P3|Overall Study|No adequate treatment response|0
4803110|NCT01296932|16562813|P2|Overall Study|No adequate treatment response|0
4803111|NCT01296932|16562814|P1|Overall Study|No adequate treatment response|0
4803112|NCT01296932|16562806|P9|Overall Study|Low benefit and too many side effects|0
4803113|NCT01296932|16562807|P8|Overall Study|Low benefit and too many side effects|1
4803114|NCT01296932|16562808|P7|Overall Study|Low benefit and too many side effects|0
4803115|NCT01296932|16562809|P6|Overall Study|Low benefit and too many side effects|0
4803116|NCT01296932|16562810|P5|Overall Study|Low benefit and too many side effects|0
4803117|NCT01296932|16562811|P4|Overall Study|Low benefit and too many side effects|0
4803118|NCT01296932|16562812|P3|Overall Study|Low benefit and too many side effects|0
4803119|NCT01296932|16562813|P2|Overall Study|Low benefit and too many side effects|0
4803120|NCT01296932|16562814|P1|Overall Study|Low benefit and too many side effects|0
4803121|NCT01296932|16562806|P9|Overall Study|per protocol|0
4803122|NCT01296932|16562807|P8|Overall Study|per protocol|0
4803123|NCT01296932|16562808|P7|Overall Study|per protocol|0
4803124|NCT01296932|16562809|P6|Overall Study|per protocol|0
4803125|NCT01296932|16562810|P5|Overall Study|per protocol|0
4803126|NCT01296932|16562811|P4|Overall Study|per protocol|1
4803127|NCT01296932|16562812|P3|Overall Study|per protocol|1
4803128|NCT01296932|16562813|P2|Overall Study|per protocol|0
4803129|NCT01296932|16562814|P1|Overall Study|per protocol|0
4803130|NCT01296932|16562806|P9|Overall Study|IV problems, administration not possible|0
4803131|NCT01296932|16562807|P8|Overall Study|IV problems, administration not possible|0
4803132|NCT01296932|16562808|P7|Overall Study|IV problems, administration not possible|0
4803133|NCT01296932|16562809|P6|Overall Study|IV problems, administration not possible|0
4803134|NCT01296932|16562810|P5|Overall Study|IV problems, administration not possible|0
4803135|NCT01296932|16562811|P4|Overall Study|IV problems, administration not possible|0
4803136|NCT01296932|16562812|P3|Overall Study|IV problems, administration not possible|1
4803137|NCT01296932|16562813|P2|Overall Study|IV problems, administration not possible|0
4803138|NCT01296932|16562814|P1|Overall Study|IV problems, administration not possible|0
4803139|NCT01296932|16562806|P9|Overall Study|Physician Decision|0
4803140|NCT01296932|16562807|P8|Overall Study|Physician Decision|0
4803141|NCT01296932|16562808|P7|Overall Study|Physician Decision|0
4803142|NCT01296932|16562809|P6|Overall Study|Physician Decision|0
4803143|NCT01296932|16562810|P5|Overall Study|Physician Decision|0
4803144|NCT01296932|16562811|P4|Overall Study|Physician Decision|0
4803145|NCT01296932|16562812|P3|Overall Study|Physician Decision|1
4803146|NCT01296932|16562813|P2|Overall Study|Physician Decision|0
4803147|NCT01296932|16562814|P1|Overall Study|Physician Decision|0
4803148|NCT01296932|16562806|P9|Overall Study|No clinical benefit anymore|0
4803149|NCT01296932|16562807|P8|Overall Study|No clinical benefit anymore|0
4803150|NCT01296932|16562808|P7|Overall Study|No clinical benefit anymore|0
4803151|NCT01296932|16562809|P6|Overall Study|No clinical benefit anymore|0
4803152|NCT01296932|16562810|P5|Overall Study|No clinical benefit anymore|0
4803153|NCT01296932|16562811|P4|Overall Study|No clinical benefit anymore|0
4803154|NCT01296932|16562812|P3|Overall Study|No clinical benefit anymore|0
4803155|NCT01296932|16562813|P2|Overall Study|No clinical benefit anymore|1
4803156|NCT01296932|16562814|P1|Overall Study|No clinical benefit anymore|0
4803157|NCT01296932|16562806|P9|Overall Study|Investigator decision|1
4803158|NCT01296932|16562807|P8|Overall Study|Investigator decision|0
4803159|NCT01296932|16562808|P7|Overall Study|Investigator decision|1
4803160|NCT01296932|16562809|P6|Overall Study|Investigator decision|0
4803161|NCT01296932|16562810|P5|Overall Study|Investigator decision|0
4803162|NCT01296932|16562811|P4|Overall Study|Investigator decision|1
4803163|NCT01296932|16562812|P3|Overall Study|Investigator decision|0
4803164|NCT01296932|16562813|P2|Overall Study|Investigator decision|1
4803165|NCT01296932|16562814|P1|Overall Study|Investigator decision|0
4803166|NCT01296932|16562806|P9|Overall Study|Adverse Event|1
4803167|NCT01296932|16562807|P8|Overall Study|Adverse Event|0
4803168|NCT01296932|16562808|P7|Overall Study|Adverse Event|0
4803169|NCT01296932|16562809|P6|Overall Study|Adverse Event|0
4803170|NCT01296932|16562810|P5|Overall Study|Adverse Event|1
4803171|NCT01296932|16562811|P4|Overall Study|Adverse Event|2
4803172|NCT01296932|16562812|P3|Overall Study|Adverse Event|1
4803173|NCT01296932|16562813|P2|Overall Study|Adverse Event|1
4803174|NCT01296932|16562814|P1|Overall Study|Adverse Event|1
4803175|NCT01296932|16562806|P9|Overall Study|Withdrawal by Subject|0
4803176|NCT01296932|16562807|P8|Overall Study|Withdrawal by Subject|0
4803177|NCT01296932|16562808|P7|Overall Study|Withdrawal by Subject|3
4803178|NCT01296932|16562809|P6|Overall Study|Withdrawal by Subject|0
4803179|NCT01296932|16562810|P5|Overall Study|Withdrawal by Subject|0
4803180|NCT01296932|16562811|P4|Overall Study|Withdrawal by Subject|1
4803181|NCT01296932|16562812|P3|Overall Study|Withdrawal by Subject|1
4803182|NCT01296932|16562813|P2|Overall Study|Withdrawal by Subject|0
4803183|NCT01296932|16562814|P1|Overall Study|Withdrawal by Subject|0
4803184|NCT01296932|16562806|P9|Overall Study|Progressive disease|0
4803185|NCT01296932|16562807|P8|Overall Study|Progressive disease|0
4803186|NCT01296932|16562808|P7|Overall Study|Progressive disease|1
4803187|NCT01296932|16562809|P6|Overall Study|Progressive disease|3
4803188|NCT01296932|16562810|P5|Overall Study|Progressive disease|2
4803189|NCT01296932|16562811|P4|Overall Study|Progressive disease|1
4803190|NCT01296932|16562812|P3|Overall Study|Progressive disease|1
4803191|NCT01296932|16562813|P2|Overall Study|Progressive disease|0
4803192|NCT01296932|16562814|P1|Overall Study|Progressive disease|2
4803193|NCT01296932|16562806|P9|Overall Study|Dose limiting toxicity|1
4803194|NCT01296932|16562807|P8|Overall Study|Dose limiting toxicity|0
4803195|NCT01296932|16562808|P7|Overall Study|Dose limiting toxicity|1
4803196|NCT01296932|16562809|P6|Overall Study|Dose limiting toxicity|0
4803197|NCT01296932|16562810|P5|Overall Study|Dose limiting toxicity|0
4803198|NCT01296932|16562811|P4|Overall Study|Dose limiting toxicity|0
4803199|NCT01296932|16562812|P3|Overall Study|Dose limiting toxicity|0
4803200|NCT01296932|16562813|P2|Overall Study|Dose limiting toxicity|0
4803201|NCT01296932|16562814|P1|Overall Study|Dose limiting toxicity|0
4803202|NCT01296698|16562938|P2|Overall Study|Study Terminated by Sponsor|12
4803203|NCT01296698|16562939|P1|Overall Study|Study Terminated by Sponsor|209
4803204|NCT01296698|16562938|P2|Overall Study|Difficulty Contacting Subject|0
4803205|NCT01296698|16562939|P1|Overall Study|Difficulty Contacting Subject|2
4803206|NCT01296698|16562938|P2|Overall Study|Withdrawal by Subject|0
4803207|NCT01296698|16562939|P1|Overall Study|Withdrawal by Subject|12
4803208|NCT01296698|16562938|P2|Overall Study|Lost to Follow-up|1
4803209|NCT01296698|16562939|P1|Overall Study|Lost to Follow-up|19
4803210|NCT01296698|16562938|P2|Overall Study|Death|0
4803211|NCT01296698|16562939|P1|Overall Study|Death|1
4803212|NCT01296698|16562938|P2|Overall Study|Adverse Event|0
4803213|NCT01296698|16562939|P1|Overall Study|Adverse Event|1
4803214|NCT01296672|16562993|P2|Overall Study|Lost to Follow-up|18
4803215|NCT01296672|16562994|P1|Overall Study|Lost to Follow-up|73
4803216|NCT01296568|16563015|P1|Continued Access Phase|Disease Progression|1
4803217|NCT01296568|16563015|P1|Continued Access Phase|Withdrawal by Subject|1
4803218|NCT01296568|16563015|P1|Continued Access Phase|Lost to Follow-up|1
4803219|NCT01296412|16563031|P2|Overall Study|Withdrawal by Subject|13
4803220|NCT01296412|16563032|P1|Overall Study|Withdrawal by Subject|10
4803221|NCT01296412|16563031|P2|Overall Study|Pregnancy|1
4803222|NCT01296412|16563032|P1|Overall Study|Pregnancy|0
4803223|NCT01296412|16563031|P2|Overall Study|Physician Decision|3
4803224|NCT01296412|16563032|P1|Overall Study|Physician Decision|1
4803225|NCT01296412|16563031|P2|Overall Study|Other reason not specified|15
4803226|NCT01296412|16563032|P1|Overall Study|Other reason not specified|20
4803227|NCT01296412|16563031|P2|Overall Study|Non-compliance with study drug|2
4803228|NCT01296412|16563032|P1|Overall Study|Non-compliance with study drug|1
4803229|NCT01296412|16563031|P2|Overall Study|Lost to Follow-up|7
4803230|NCT01296412|16563032|P1|Overall Study|Lost to Follow-up|10
4803231|NCT01296412|16563031|P2|Overall Study|Lack of Efficacy|0
4803232|NCT01296412|16563032|P1|Overall Study|Lack of Efficacy|1
4803233|NCT01296412|16563031|P2|Overall Study|Adverse Event|29
4803234|NCT01296412|16563032|P1|Overall Study|Adverse Event|8
4803235|NCT01296347|16563055|P2|12 Month Follow up|Withdrawal by Subject|1
4803236|NCT01296347|16563056|P1|12 Month Follow up|Withdrawal by Subject|0
4803237|NCT01296347|16563055|P2|12 Month Follow up|Death|1
4803238|NCT01296347|16563056|P1|12 Month Follow up|Death|1
4803239|NCT01296347|16563055|P2|12 Month Follow up|Lost to Follow-up|1
4803240|NCT01296347|16563056|P1|12 Month Follow up|Lost to Follow-up|3
4803241|NCT01296347|16563055|P2|6 Month Follow up|Lost to Follow-up|1
4803242|NCT01296347|16563056|P1|6 Month Follow up|Lost to Follow-up|0
4803243|NCT01296347|16563055|P2|6 Month Follow up|Death|1
4803244|NCT01296347|16563056|P1|6 Month Follow up|Death|2
4803245|NCT01296347|16563055|P2|3 Month Follow up|Lost to Follow-up|1
4803246|NCT01296347|16563056|P1|3 Month Follow up|Lost to Follow-up|0
4803247|NCT01296347|16563055|P2|3 Month Follow up|Death|0
4803248|NCT01296347|16563056|P1|3 Month Follow up|Death|1
4803249|NCT01296347|16563055|P2|6 Week Follow up|Death|1
4803250|NCT01296347|16563056|P1|6 Week Follow up|Death|0
4803251|NCT01296347|16563055|P2|Allocation|not received infusion|0
4803252|NCT01296347|16563056|P1|Allocation|not received infusion|1
4803253|NCT01296347|16563055|P2|Allocation|Lack of Efficacy|2
4803254|NCT01296347|16563056|P1|Allocation|Lack of Efficacy|1
4803255|NCT01296347|16563055|P2|Allocation|Withdrawal by Subject|2
4803256|NCT01296347|16563056|P1|Allocation|Withdrawal by Subject|1
4803257|NCT01296152|16563081|P1|Overall Study|Unwilling to adhere to study requirement|1
4803258|NCT01296035|16563108|P1|Overall Study|Withdrawal by Subject|1
4803259|NCT01295905|16563115|P2|Overall Study|Met exclusion criteria|0
4803260|NCT01295905|16563116|P1|Overall Study|Met exclusion criteria|1
4803261|NCT01295905|16563115|P2|Overall Study|Did not meet inclusion criteria|0
4803262|NCT01295905|16563116|P1|Overall Study|Did not meet inclusion criteria|1
4803263|NCT01295827|16563160|P15|Overall Study|Other|0
4803264|NCT01295827|16563161|P14|Overall Study|Other|0
4803265|NCT01295827|16563162|P13|Overall Study|Other|0
4803266|NCT01295827|16563163|P12|Overall Study|Other|0
4803267|NCT01295827|16563164|P11|Overall Study|Other|2
4803268|NCT01295827|16563165|P10|Overall Study|Other|0
4803269|NCT01295827|16563166|P9|Overall Study|Other|1
4803270|NCT01295827|16563167|P8|Overall Study|Other|1
4803271|NCT01295827|16563168|P7|Overall Study|Other|1
4803272|NCT01295827|16563169|P6|Overall Study|Other|0
4803273|NCT01295827|16563170|P5|Overall Study|Other|0
4803274|NCT01295827|16563171|P4|Overall Study|Other|0
4803275|NCT01295827|16563172|P3|Overall Study|Other|0
4803276|NCT01295827|16563173|P2|Overall Study|Other|0
4803277|NCT01295827|16563174|P1|Overall Study|Other|0
4803278|NCT01295827|16563160|P15|Overall Study|Withdrawal by Subject|0
4803279|NCT01295827|16563161|P14|Overall Study|Withdrawal by Subject|0
4803280|NCT01295827|16563162|P13|Overall Study|Withdrawal by Subject|0
4803281|NCT01295827|16563163|P12|Overall Study|Withdrawal by Subject|13
4803282|NCT01295827|16563164|P11|Overall Study|Withdrawal by Subject|18
4803283|NCT01295827|16563165|P10|Overall Study|Withdrawal by Subject|2
4803284|NCT01295827|16563166|P9|Overall Study|Withdrawal by Subject|11
4803285|NCT01295827|16563167|P8|Overall Study|Withdrawal by Subject|35
4803286|NCT01295827|16563168|P7|Overall Study|Withdrawal by Subject|13
4803287|NCT01295827|16563169|P6|Overall Study|Withdrawal by Subject|1
4803288|NCT01295827|16563170|P5|Overall Study|Withdrawal by Subject|0
4803289|NCT01295827|16563171|P4|Overall Study|Withdrawal by Subject|0
4803290|NCT01295827|16563172|P3|Overall Study|Withdrawal by Subject|2
4803291|NCT01295827|16563173|P2|Overall Study|Withdrawal by Subject|0
4803292|NCT01295827|16563174|P1|Overall Study|Withdrawal by Subject|1
4803293|NCT01295827|16563160|P15|Overall Study|Screen Failure|0
4803294|NCT01295827|16563161|P14|Overall Study|Screen Failure|0
4803295|NCT01295827|16563162|P13|Overall Study|Screen Failure|0
4803296|NCT01295827|16563163|P12|Overall Study|Screen Failure|0
4803297|NCT01295827|16563164|P11|Overall Study|Screen Failure|1
4803298|NCT01295827|16563165|P10|Overall Study|Screen Failure|0
4803299|NCT01295827|16563166|P9|Overall Study|Screen Failure|2
4803300|NCT01295827|16563167|P8|Overall Study|Screen Failure|2
4803301|NCT01295827|16563168|P7|Overall Study|Screen Failure|2
4803302|NCT01295827|16563169|P6|Overall Study|Screen Failure|0
4803303|NCT01295827|16563170|P5|Overall Study|Screen Failure|0
4803304|NCT01295827|16563171|P4|Overall Study|Screen Failure|0
4803305|NCT01295827|16563172|P3|Overall Study|Screen Failure|0
4803306|NCT01295827|16563173|P2|Overall Study|Screen Failure|0
4803307|NCT01295827|16563174|P1|Overall Study|Screen Failure|0
4803308|NCT01295827|16563160|P15|Overall Study|Progressive Disease|0
4803309|NCT01295827|16563161|P14|Overall Study|Progressive Disease|0
4803310|NCT01295827|16563162|P13|Overall Study|Progressive Disease|0
4803311|NCT01295827|16563163|P12|Overall Study|Progressive Disease|136
4803312|NCT01295827|16563164|P11|Overall Study|Progressive Disease|175
4803313|NCT01295827|16563165|P10|Overall Study|Progressive Disease|40
4803314|NCT01295827|16563166|P9|Overall Study|Progressive Disease|85
4803315|NCT01295827|16563167|P8|Overall Study|Progressive Disease|144
4803316|NCT01295827|16563168|P7|Overall Study|Progressive Disease|87
4803317|NCT01295827|16563169|P6|Overall Study|Progressive Disease|1
4803318|NCT01295827|16563170|P5|Overall Study|Progressive Disease|0
4803319|NCT01295827|16563171|P4|Overall Study|Progressive Disease|2
4803320|NCT01295827|16563172|P3|Overall Study|Progressive Disease|5
4803321|NCT01295827|16563173|P2|Overall Study|Progressive Disease|1
4803322|NCT01295827|16563174|P1|Overall Study|Progressive Disease|2
4803323|NCT01295827|16563160|P15|Overall Study|Not Reported|0
4803324|NCT01295827|16563161|P14|Overall Study|Not Reported|0
4803325|NCT01295827|16563162|P13|Overall Study|Not Reported|0
4803326|NCT01295827|16563163|P12|Overall Study|Not Reported|13
4803327|NCT01295827|16563164|P11|Overall Study|Not Reported|23
4803328|NCT01295827|16563165|P10|Overall Study|Not Reported|2
4803329|NCT01295827|16563166|P9|Overall Study|Not Reported|41
4803330|NCT01295827|16563167|P8|Overall Study|Not Reported|58
4803331|NCT01295827|16563168|P7|Overall Study|Not Reported|24
4803332|NCT01295827|16563169|P6|Overall Study|Not Reported|0
4803333|NCT01295827|16563170|P5|Overall Study|Not Reported|0
4803334|NCT01295827|16563171|P4|Overall Study|Not Reported|1
4803335|NCT01295827|16563172|P3|Overall Study|Not Reported|0
4803336|NCT01295827|16563173|P2|Overall Study|Not Reported|0
4803337|NCT01295827|16563174|P1|Overall Study|Not Reported|0
4803338|NCT01295827|16563160|P15|Overall Study|Lost to Follow-up|0
4803339|NCT01295827|16563161|P14|Overall Study|Lost to Follow-up|0
4803340|NCT01295827|16563162|P13|Overall Study|Lost to Follow-up|0
4803341|NCT01295827|16563163|P12|Overall Study|Lost to Follow-up|3
4803342|NCT01295827|16563164|P11|Overall Study|Lost to Follow-up|7
4803343|NCT01295827|16563165|P10|Overall Study|Lost to Follow-up|4
4803344|NCT01295827|16563166|P9|Overall Study|Lost to Follow-up|7
4803345|NCT01295827|16563167|P8|Overall Study|Lost to Follow-up|8
4803346|NCT01295827|16563168|P7|Overall Study|Lost to Follow-up|4
4803347|NCT01295827|16563169|P6|Overall Study|Lost to Follow-up|0
4803348|NCT01295827|16563170|P5|Overall Study|Lost to Follow-up|1
4803349|NCT01295827|16563171|P4|Overall Study|Lost to Follow-up|0
4803350|NCT01295827|16563172|P3|Overall Study|Lost to Follow-up|3
4803351|NCT01295827|16563173|P2|Overall Study|Lost to Follow-up|0
4803352|NCT01295827|16563174|P1|Overall Study|Lost to Follow-up|0
4803353|NCT01295827|16563160|P15|Overall Study|Adverse Event|0
4803354|NCT01295827|16563161|P14|Overall Study|Adverse Event|0
4803355|NCT01295827|16563162|P13|Overall Study|Adverse Event|0
4803356|NCT01295827|16563163|P12|Overall Study|Adverse Event|21
4803357|NCT01295827|16563164|P11|Overall Study|Adverse Event|50
4803358|NCT01295827|16563165|P10|Overall Study|Adverse Event|7
4803359|NCT01295827|16563166|P9|Overall Study|Adverse Event|22
4803360|NCT01295827|16563167|P8|Overall Study|Adverse Event|49
4803361|NCT01295827|16563168|P7|Overall Study|Adverse Event|15
4803362|NCT01295827|16563169|P6|Overall Study|Adverse Event|4
4803363|NCT01295827|16563170|P5|Overall Study|Adverse Event|1
4803364|NCT01295827|16563171|P4|Overall Study|Adverse Event|1
4803365|NCT01295827|16563172|P3|Overall Study|Adverse Event|2
4803366|NCT01295827|16563173|P2|Overall Study|Adverse Event|2
4803367|NCT01295827|16563174|P1|Overall Study|Adverse Event|1
4803368|NCT01295814|16563547|P2|Overall Study|Withdrawal by Subject|0
4803369|NCT01295814|16563548|P1|Overall Study|Withdrawal by Subject|2
4803370|NCT01295814|16563547|P2|Overall Study|Lack of Efficacy|2
4803371|NCT01295814|16563548|P1|Overall Study|Lack of Efficacy|0
4803372|NCT01295671|16563628|P3|Overall Study|Withdrawal by Subject|0
4803373|NCT01295671|16563629|P2|Overall Study|Withdrawal by Subject|1
4803374|NCT01295671|16563630|P1|Overall Study|Withdrawal by Subject|3
4803375|NCT01295671|16563628|P3|Overall Study|Lost to Follow-up|3
4803376|NCT01295671|16563629|P2|Overall Study|Lost to Follow-up|6
4803377|NCT01295671|16563630|P1|Overall Study|Lost to Follow-up|4
4803378|NCT01295320|16563676|P1|Overall Study|Unable to travel|1
4803379|NCT01295320|16563676|P1|Overall Study|Subject was bedridden|1
4803380|NCT01295320|16563676|P1|Overall Study|Withdrawal by Subject|2
4803381|NCT01295320|16563676|P1|Overall Study|Lost to Follow-up|4
4803382|NCT01295320|16563676|P1|Overall Study|Adverse Event|2
4803383|NCT01295281|16563693|P2|First Intervention (7 Days)|Death|1
4803384|NCT01295281|16563694|P1|First Intervention (7 Days)|Death|0
4803385|NCT01295034|16563732|P2|Overall Study|Lost to Follow-up|5
4803386|NCT01295034|16563733|P1|Overall Study|Lost to Follow-up|5
4803387|NCT01294917|16563741|P1|Overall Study|Inconvenience|1
4803388|NCT01294917|16563741|P1|Overall Study|Relocation|5
4803389|NCT01294800|16563751|P4|Overall Study|Did Not Meet Protocol Eligibility|0
4803390|NCT01294800|16563752|P3|Overall Study|Did Not Meet Protocol Eligibility|1
4803391|NCT01294800|16563753|P2|Overall Study|Did Not Meet Protocol Eligibility|1
4803392|NCT01294800|16563754|P1|Overall Study|Did Not Meet Protocol Eligibility|2
4803393|NCT01294800|16563751|P4|Overall Study|Non-compliance With Protocol|0
4803394|NCT01294800|16563752|P3|Overall Study|Non-compliance With Protocol|1
4803395|NCT01294800|16563753|P2|Overall Study|Non-compliance With Protocol|1
4803396|NCT01294800|16563754|P1|Overall Study|Non-compliance With Protocol|0
4803397|NCT01294800|16563751|P4|Overall Study|Lost to Follow-up|0
4803398|NCT01294800|16563752|P3|Overall Study|Lost to Follow-up|1
4803399|NCT01294800|16563753|P2|Overall Study|Lost to Follow-up|0
4803400|NCT01294800|16563754|P1|Overall Study|Lost to Follow-up|0
4803401|NCT01294800|16563751|P4|Overall Study|Subject Withdrew Consent|11
4803402|NCT01294800|16563752|P3|Overall Study|Subject Withdrew Consent|2
4803403|NCT01294800|16563753|P2|Overall Study|Subject Withdrew Consent|2
4803404|NCT01294800|16563754|P1|Overall Study|Subject Withdrew Consent|2
4803405|NCT01294800|16563751|P4|Overall Study|Adverse Event|5
4803406|NCT01294800|16563752|P3|Overall Study|Adverse Event|12
4803407|NCT01294800|16563753|P2|Overall Study|Adverse Event|6
4803408|NCT01294800|16563754|P1|Overall Study|Adverse Event|7
4803409|NCT01294787|16563780|P6|Period 3|Adverse Event|0
4803410|NCT01294787|16563781|P5|Period 3|Adverse Event|1
4803411|NCT01294787|16563782|P4|Period 3|Adverse Event|0
4803412|NCT01294787|16563783|P3|Period 3|Adverse Event|0
4803413|NCT01294787|16563784|P2|Period 3|Adverse Event|0
4803414|NCT01294787|16563785|P1|Period 3|Adverse Event|0
4803415|NCT01294787|16563780|P6|Period 2|No longer needs study drug|0
4803416|NCT01294787|16563781|P5|Period 2|No longer needs study drug|0
4803417|NCT01294787|16563782|P4|Period 2|No longer needs study drug|1
4803418|NCT01294787|16563783|P3|Period 2|No longer needs study drug|0
4803419|NCT01294787|16563784|P2|Period 2|No longer needs study drug|0
4803420|NCT01294787|16563785|P1|Period 2|No longer needs study drug|0
4803421|NCT01294787|16563780|P6|Period 2|Adverse Event|0
4803422|NCT01294787|16563781|P5|Period 2|Adverse Event|0
4803423|NCT01294787|16563782|P4|Period 2|Adverse Event|1
4803424|NCT01294787|16563783|P3|Period 2|Adverse Event|0
4803425|NCT01294787|16563784|P2|Period 2|Adverse Event|3
4803426|NCT01294787|16563785|P1|Period 2|Adverse Event|0
4803427|NCT01294787|16563780|P6|Period 1|Administrative problem|1
4803428|NCT01294787|16563781|P5|Period 1|Administrative problem|0
4803429|NCT01294787|16563782|P4|Period 1|Administrative problem|0
4803430|NCT01294787|16563783|P3|Period 1|Administrative problem|1
4803431|NCT01294787|16563784|P2|Period 1|Administrative problem|0
4803432|NCT01294787|16563785|P1|Period 1|Administrative problem|0
4803433|NCT01294787|16563780|P6|Period 1|Withdrawal by Subject|1
4803434|NCT01294787|16563781|P5|Period 1|Withdrawal by Subject|1
4803435|NCT01294787|16563782|P4|Period 1|Withdrawal by Subject|1
4803436|NCT01294787|16563783|P3|Period 1|Withdrawal by Subject|0
4803437|NCT01294787|16563784|P2|Period 1|Withdrawal by Subject|0
4803438|NCT01294787|16563785|P1|Period 1|Withdrawal by Subject|0
4803439|NCT01294787|16563780|P6|Period 1|Adverse Event|0
4803440|NCT01294787|16563781|P5|Period 1|Adverse Event|1
4803441|NCT01294787|16563782|P4|Period 1|Adverse Event|0
4803442|NCT01294787|16563783|P3|Period 1|Adverse Event|0
4803443|NCT01294787|16563784|P2|Period 1|Adverse Event|0
4803444|NCT01294787|16563785|P1|Period 1|Adverse Event|0
4803445|NCT01294696|16563876|P1|Overall Study|Site closure|52
4803446|NCT01294696|16563876|P1|Overall Study|Missing BPI Response|7
4803447|NCT01294696|16563876|P1|Overall Study|Protocol Violation|8
4803448|NCT01294696|16563876|P1|Overall Study|Screening failures|7
4803449|NCT01294683|16563890|P2|Post Crossover (Period III)|Withdrawal by Subject|2
4803450|NCT01294683|16563891|P1|Post Crossover (Period III)|Withdrawal by Subject|3
4803451|NCT01294683|16563890|P2|Post Crossover (Period III)|Study Terminated by Sponsor|21
4803452|NCT01294683|16563891|P1|Post Crossover (Period III)|Study Terminated by Sponsor|23
4803453|NCT01294683|16563890|P2|Post Crossover (Period III)|Lost to Follow-up|3
4803454|NCT01294683|16563891|P1|Post Crossover (Period III)|Lost to Follow-up|1
4803455|NCT01294683|16563890|P2|Post Crossover (Period III)|Adverse Event|6
4803456|NCT01294683|16563891|P1|Post Crossover (Period III)|Adverse Event|6
4803457|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Withdrawal by Subject|9
4803458|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Withdrawal by Subject|11
4803459|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Technical Problems|1
4803460|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Technical Problems|0
4803461|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Study Terminated by Sponsor|192
4803462|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Study Terminated by Sponsor|187
4803463|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Protocol Violation|5
4803464|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Protocol Violation|5
4803465|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Physician Decision|0
4803466|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Physician Decision|1
4803467|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
4803468|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Non-compliance with Study Drug|1
4803469|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Lost to Follow-up|6
4803470|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Lost to Follow-up|3
4803471|NCT01294683|16563890|P2|Precrossover (Periods I/II)|Adverse Event|52
4803472|NCT01294683|16563891|P1|Precrossover (Periods I/II)|Adverse Event|49
4803473|NCT01294644|16563944|P3|Overall Study|Miscellaneous Reason|4
4803474|NCT01294644|16563945|P2|Overall Study|Miscellaneous Reason|1
4803475|NCT01294644|16563946|P1|Overall Study|Miscellaneous Reason|2
4803476|NCT01294644|16563944|P3|Overall Study|Lost to Follow-up|5
4803477|NCT01294644|16563945|P2|Overall Study|Lost to Follow-up|2
4803478|NCT01294644|16563946|P1|Overall Study|Lost to Follow-up|3
4803479|NCT01294644|16563944|P3|Overall Study|Withdrawal by Subject|4
4803480|NCT01294644|16563945|P2|Overall Study|Withdrawal by Subject|7
4803481|NCT01294644|16563946|P1|Overall Study|Withdrawal by Subject|3
4803482|NCT01294644|16563944|P3|Overall Study|Adverse Event|1
4803483|NCT01294644|16563945|P2|Overall Study|Adverse Event|0
4803484|NCT01294644|16563946|P1|Overall Study|Adverse Event|2
4803485|NCT01294592|16563977|P2|Overall Study|Withdrawal by Subject|28
4803486|NCT01294592|16563978|P1|Overall Study|Withdrawal by Subject|28
4803487|NCT01294592|16563977|P2|Overall Study|Physician Decision|11
4803488|NCT01294592|16563978|P1|Overall Study|Physician Decision|6
4803489|NCT01294592|16563977|P2|Overall Study|Lost to Follow-up|9
4803490|NCT01294592|16563978|P1|Overall Study|Lost to Follow-up|7
4803491|NCT01294592|16563977|P2|Overall Study|Protocol Violation|7
4803492|NCT01294592|16563978|P1|Overall Study|Protocol Violation|1
4803493|NCT01294592|16563977|P2|Overall Study|Lack of Efficacy|5
4803494|NCT01294592|16563978|P1|Overall Study|Lack of Efficacy|7
4803495|NCT01294592|16563977|P2|Overall Study|Adverse Event|13
4803496|NCT01294592|16563978|P1|Overall Study|Adverse Event|28
4803497|NCT01294579|16564006|P1|Overall Study|Withdrawal by Subject|5
4803498|NCT01294579|16564006|P1|Overall Study|Physician Decision|3
4803499|NCT01294579|16564006|P1|Overall Study|Lost to Follow-up|1
4803500|NCT01294579|16564006|P1|Overall Study|Study closed/terminated|3
4803501|NCT01294579|16564006|P1|Overall Study|Adverse Event|11
4803502|NCT01294579|16564006|P1|Overall Study|Disease progression|12
4803503|NCT01294553|16564016|P1|Overall Study|Protocol Violation|268
4803504|NCT01294553|16564016|P1|Overall Study|Duplicated Participants|1
4803505|NCT01294514|16564022|P1|Overall Study|Excluded due to Arrhythmia|1
4803506|NCT01294462|16564032|P2|Overall Study|Withdrawal by Subject|63
4803507|NCT01294462|16564033|P1|Overall Study|Withdrawal by Subject|65
4803508|NCT01294462|16564032|P2|Overall Study|Lost to Follow-up|0
4803509|NCT01294462|16564033|P1|Overall Study|Lost to Follow-up|1
4803510|NCT01294449|16564047|P2|Overall Study|Withdrawal by Subject|3
4803511|NCT01294449|16564048|P1|Overall Study|Withdrawal by Subject|1
4803512|NCT01294449|16564047|P2|Overall Study|Death|12
4803513|NCT01294449|16564048|P1|Overall Study|Death|11
4803514|NCT01294436|16564056|P2|Overall Study|poor/non-compliance|5
4803515|NCT01294436|16564057|P1|Overall Study|poor/non-compliance|2
4803516|NCT01294436|16564056|P2|Overall Study|subject no longer meets study criteria|20
4803517|NCT01294436|16564057|P1|Overall Study|subject no longer meets study criteria|5
4803518|NCT01294436|16564056|P2|Overall Study|Withdrawal by Subject|28
4803519|NCT01294436|16564057|P1|Overall Study|Withdrawal by Subject|11
4803520|NCT01294436|16564056|P2|Overall Study|Adverse Event|17
4803521|NCT01294436|16564057|P1|Overall Study|Adverse Event|10
4803522|NCT01294423|16564092|P3|Overall Study|poor/non-compliance|1
4803523|NCT01294423|16564093|P2|Overall Study|poor/non-compliance|0
4803524|NCT01294423|16564094|P1|Overall Study|poor/non-compliance|1
4803525|NCT01294423|16564092|P3|Overall Study|subject no longer meets study criteria|2
4803526|NCT01294423|16564093|P2|Overall Study|subject no longer meets study criteria|5
4803527|NCT01294423|16564094|P1|Overall Study|subject no longer meets study criteria|2
4803528|NCT01294423|16564092|P3|Overall Study|Withdrawal by Subject|2
4803529|NCT01294423|16564093|P2|Overall Study|Withdrawal by Subject|2
4803530|NCT01294423|16564094|P1|Overall Study|Withdrawal by Subject|1
4803531|NCT01294423|16564092|P3|Overall Study|Adverse Event|3
4803532|NCT01294423|16564093|P2|Overall Study|Adverse Event|2
4803533|NCT01294423|16564094|P1|Overall Study|Adverse Event|1
4803534|NCT01294397|16564108|P1|Overall Study|Administrative Decision|1
4803535|NCT01294397|16564108|P1|Overall Study|Withdrawal by Subject|1
4803536|NCT01294371|16564152|P1|Overall Study|Other|14
4803537|NCT01294371|16564152|P1|Overall Study|Administrative Reason|1
4803538|NCT01294371|16564152|P1|Overall Study|Lost to Follow-up|6
4803539|NCT01294371|16564152|P1|Overall Study|Withdrawal by Subject|12
4803540|NCT01294371|16564152|P1|Overall Study|Adverse Event|1
4803541|NCT01294358|16564160|P5|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1
4803542|NCT01294358|16564161|P4|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4803543|NCT01294358|16564162|P3|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4803544|NCT01294358|16564163|P2|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4803545|NCT01294358|16564164|P1|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0
4803546|NCT01294358|16564160|P5|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4803547|NCT01294358|16564161|P4|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1
4803548|NCT01294358|16564162|P3|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4803549|NCT01294358|16564163|P2|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4803550|NCT01294358|16564164|P1|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0
4803551|NCT01294358|16564160|P5|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4803552|NCT01294358|16564161|P4|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4803553|NCT01294358|16564162|P3|Cohort 3: 12/1/11-10/6/12|Disease progression|2
4803554|NCT01294358|16564163|P2|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4803555|NCT01294358|16564164|P1|Cohort 3: 12/1/11-10/6/12|Disease progression|0
4803556|NCT01294358|16564160|P5|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4803557|NCT01294358|16564161|P4|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4803558|NCT01294358|16564162|P3|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4803559|NCT01294358|16564163|P2|Cohort 2: 6/9/11-9/17/12|Disease progression|2
4803560|NCT01294358|16564164|P1|Cohort 2: 6/9/11-9/17/12|Disease progression|0
4803561|NCT01294150|16564292|P2|Overall Study|Physician Decision|2
4803562|NCT01294150|16564293|P1|Overall Study|Physician Decision|2
4803563|NCT01294046|16564322|P1|Overall Study|Stimulation response inadqequate|1
4803564|NCT01294046|16564322|P1|Overall Study|Eligibility criteria expanded|1
4803565|NCT01294046|16564322|P1|Overall Study|Infection and surgical explant|1
4803566|NCT01293968|16564337|P2|Overall Study|non-cooperation|3
4803567|NCT01293968|16564338|P1|Overall Study|non-cooperation|3
4803568|NCT01293695|16564358|P2|Overall Study|Lost to Follow-up|6
4803569|NCT01293695|16564359|P1|Overall Study|Lost to Follow-up|8
4803570|NCT01293695|16564358|P2|Overall Study|Withdrawal by Subject|1
4803571|NCT01293695|16564359|P1|Overall Study|Withdrawal by Subject|7
4803572|NCT01293539|16564378|P1|Overall Study|Physician Decision|1
4803573|NCT01293240|16564382|P1|Overall Study|Noncompliance|2
4803574|NCT01293123|16564399|P2|Overall Study|Lost to Follow-up|1
4803575|NCT01293123|16564400|P1|Overall Study|Lost to Follow-up|0
4803576|NCT01293084|16564414|P1|Overall Study|Withdrawal by Subject|2
4803577|NCT01293084|16564414|P1|Overall Study|Physician Decision|3
4803578|NCT01293032|16564426|P4|Treatment|Disease Progression, relapse|0
4803579|NCT01293032|16564427|P3|Treatment|Disease Progression, relapse|0
4803580|NCT01293032|16564428|P2|Treatment|Disease Progression, relapse|1
4803581|NCT01293032|16564429|P1|Treatment|Disease Progression, relapse|0
4803582|NCT01293032|16564426|P4|Treatment|Withdrawal by Subject|0
4803583|NCT01293032|16564427|P3|Treatment|Withdrawal by Subject|0
4803584|NCT01293032|16564428|P2|Treatment|Withdrawal by Subject|4
4803585|NCT01293032|16564429|P1|Treatment|Withdrawal by Subject|2
4803586|NCT01293032|16564426|P4|Treatment|Adverse Event|1
4803587|NCT01293032|16564427|P3|Treatment|Adverse Event|1
4803588|NCT01293032|16564428|P2|Treatment|Adverse Event|0
4803589|NCT01293032|16564429|P1|Treatment|Adverse Event|0
4803590|NCT01293032|16564426|P4|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
4803591|NCT01293032|16564427|P3|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5
4803592|NCT01293032|16564428|P2|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
4803593|NCT01293032|16564429|P1|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0
4803594|NCT01293006|16564440|P4|Period 2|Lost to Follow-up|0
4803595|NCT01293006|16564441|P3|Period 2|Lost to Follow-up|0
4803596|NCT01293006|16564442|P2|Period 2|Lost to Follow-up|0
4803597|NCT01293006|16564443|P1|Period 2|Lost to Follow-up|1
4803598|NCT01292928|16564464|P1|Overall Study|Physician Decision|2
4803599|NCT01292928|16564464|P1|Overall Study|Lost to Follow-up|6
4803600|NCT01292928|16564464|P1|Overall Study|Withdrawal by Subject|8
4803601|NCT01292928|16564464|P1|Overall Study|Death|8
4803602|NCT01292876|16564481|P1|Overall Study|Physician Decision|4
4803603|NCT01292837|16564487|P1|Overall Study|Further treatment determined|1
4803604|NCT01292837|16564487|P1|Overall Study|Adverse Event|1
4803605|NCT01292603|16564524|P6|Overall Survival Status|Death|10
4803606|NCT01292603|16564525|P5|Overall Survival Status|Death|16
4803607|NCT01292603|16564526|P4|Overall Survival Status|Death|1
4803608|NCT01292603|16564527|P3|Overall Survival Status|Death|3
4803609|NCT01292603|16564528|P2|Overall Survival Status|Death|1
4803610|NCT01292603|16564529|P1|Overall Survival Status|Death|3
4803611|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Adverse Event|2
4803612|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Adverse Event|2
4803613|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Adverse Event|0
4803614|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Adverse Event|0
4803615|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Adverse Event|0
4803616|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Adverse Event|0
4803617|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Lost to Follow-up|1
4803618|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Lost to Follow-up|1
4803619|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Lost to Follow-up|0
4803620|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Lost to Follow-up|0
4803621|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Lost to Follow-up|0
4803622|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Lost to Follow-up|0
4803623|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Physician Decision|0
4803624|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Physician Decision|2
4803625|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Physician Decision|0
4803626|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Physician Decision|0
4803627|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Physician Decision|0
4803628|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Physician Decision|0
4803629|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Protocol Violation|0
4803630|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Protocol Violation|2
4803631|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Protocol Violation|0
4803632|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Protocol Violation|0
4803633|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Protocol Violation|0
4803634|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Protocol Violation|0
4803635|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Withdrawal by Subject|1
4803636|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4803637|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4803638|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4803639|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4803640|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Withdrawal by Subject|0
4803641|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Noncompliance|0
4803642|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Noncompliance|1
4803643|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Noncompliance|0
4803644|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Noncompliance|0
4803645|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Noncompliance|0
4803646|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Noncompliance|0
4803647|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Disease Progression|5
4803648|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Disease Progression|5
4803649|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Disease Progression|0
4803650|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Disease Progression|0
4803651|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Disease Progression|0
4803652|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Disease Progression|0
4803653|NCT01292603|16564524|P6|Part 2: Regular Follow-Up|Death|3
4803654|NCT01292603|16564525|P5|Part 2: Regular Follow-Up|Death|6
4803655|NCT01292603|16564526|P4|Part 2: Regular Follow-Up|Death|0
4803656|NCT01292603|16564527|P3|Part 2: Regular Follow-Up|Death|0
4803657|NCT01292603|16564528|P2|Part 2: Regular Follow-Up|Death|0
4803658|NCT01292603|16564529|P1|Part 2: Regular Follow-Up|Death|0
4803659|NCT01292603|16564524|P6|Part 2: Dose Confirmation Period|Withdrawal by Subject|2
4803660|NCT01292603|16564525|P5|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4803661|NCT01292603|16564526|P4|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4803662|NCT01292603|16564527|P3|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4803663|NCT01292603|16564528|P2|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4803664|NCT01292603|16564529|P1|Part 2: Dose Confirmation Period|Withdrawal by Subject|0
4803665|NCT01292603|16564524|P6|Part 2: Dose Confirmation Period|Protocol Violation|3
4803666|NCT01292603|16564525|P5|Part 2: Dose Confirmation Period|Protocol Violation|5
4803667|NCT01292603|16564526|P4|Part 2: Dose Confirmation Period|Protocol Violation|0
4803668|NCT01292603|16564527|P3|Part 2: Dose Confirmation Period|Protocol Violation|0
4803669|NCT01292603|16564528|P2|Part 2: Dose Confirmation Period|Protocol Violation|0
4803670|NCT01292603|16564529|P1|Part 2: Dose Confirmation Period|Protocol Violation|0
4803671|NCT01292603|16564524|P6|Part 2: Dose Confirmation Period|Adverse Event|9
4803672|NCT01292603|16564525|P5|Part 2: Dose Confirmation Period|Adverse Event|7
4803673|NCT01292603|16564526|P4|Part 2: Dose Confirmation Period|Adverse Event|0
4803674|NCT01292603|16564527|P3|Part 2: Dose Confirmation Period|Adverse Event|0
4803675|NCT01292603|16564528|P2|Part 2: Dose Confirmation Period|Adverse Event|0
4803676|NCT01292603|16564529|P1|Part 2: Dose Confirmation Period|Adverse Event|0
4803677|NCT01292603|16564524|P6|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
4803678|NCT01292603|16564525|P5|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1
4803679|NCT01292603|16564526|P4|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4803680|NCT01292603|16564527|P3|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4803681|NCT01292603|16564528|P2|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4803682|NCT01292603|16564529|P1|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0
4803683|NCT01292603|16564524|P6|Part 2: Dose Confirmation Period|Physician Decision|0
4803684|NCT01292603|16564525|P5|Part 2: Dose Confirmation Period|Physician Decision|2
4803685|NCT01292603|16564526|P4|Part 2: Dose Confirmation Period|Physician Decision|0
4803686|NCT01292603|16564527|P3|Part 2: Dose Confirmation Period|Physician Decision|0
4803687|NCT01292603|16564528|P2|Part 2: Dose Confirmation Period|Physician Decision|0
4803688|NCT01292603|16564529|P1|Part 2: Dose Confirmation Period|Physician Decision|0
4803689|NCT01292603|16564524|P6|Part 2: Dose Confirmation Period|Death|0
4803690|NCT01292603|16564525|P5|Part 2: Dose Confirmation Period|Death|1
4803691|NCT01292603|16564526|P4|Part 2: Dose Confirmation Period|Death|0
4803692|NCT01292603|16564527|P3|Part 2: Dose Confirmation Period|Death|0
4803693|NCT01292603|16564528|P2|Part 2: Dose Confirmation Period|Death|0
4803694|NCT01292603|16564529|P1|Part 2: Dose Confirmation Period|Death|0
4803695|NCT01292603|16564524|P6|Part 1: Regular Follow-Up Period|Disease Progression|0
4803696|NCT01292603|16564525|P5|Part 1: Regular Follow-Up Period|Disease Progression|0
4803697|NCT01292603|16564526|P4|Part 1: Regular Follow-Up Period|Disease Progression|0
4803698|NCT01292603|16564527|P3|Part 1: Regular Follow-Up Period|Disease Progression|3
4803699|NCT01292603|16564528|P2|Part 1: Regular Follow-Up Period|Disease Progression|6
4803700|NCT01292603|16564529|P1|Part 1: Regular Follow-Up Period|Disease Progression|3
4803701|NCT01292603|16564524|P6|Part 1: Regular Follow-Up Period|Death|0
4803702|NCT01292603|16564525|P5|Part 1: Regular Follow-Up Period|Death|0
4803703|NCT01292603|16564526|P4|Part 1: Regular Follow-Up Period|Death|1
4803704|NCT01292603|16564527|P3|Part 1: Regular Follow-Up Period|Death|3
4803705|NCT01292603|16564528|P2|Part 1: Regular Follow-Up Period|Death|1
4803706|NCT01292603|16564529|P1|Part 1: Regular Follow-Up Period|Death|3
4803707|NCT01292603|16564524|P6|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4803708|NCT01292603|16564525|P5|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4803709|NCT01292603|16564526|P4|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1
4803710|NCT01292603|16564527|P3|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4803711|NCT01292603|16564528|P2|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4803712|NCT01292603|16564529|P1|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0
4803713|NCT01292603|16564524|P6|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4803714|NCT01292603|16564525|P5|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4803715|NCT01292603|16564526|P4|Part 1: Pilot Dose Selection Period|Protocol Violation|2
4803716|NCT01292603|16564527|P3|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4803717|NCT01292603|16564528|P2|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4803718|NCT01292603|16564529|P1|Part 1: Pilot Dose Selection Period|Protocol Violation|0
4803719|NCT01292603|16564524|P6|Part 1: Pilot Dose Selection Period|Death|0
4803720|NCT01292603|16564525|P5|Part 1: Pilot Dose Selection Period|Death|0
4803721|NCT01292603|16564526|P4|Part 1: Pilot Dose Selection Period|Death|1
4803722|NCT01292603|16564527|P3|Part 1: Pilot Dose Selection Period|Death|0
4803723|NCT01292603|16564528|P2|Part 1: Pilot Dose Selection Period|Death|0
4803724|NCT01292603|16564529|P1|Part 1: Pilot Dose Selection Period|Death|0
4803725|NCT01292603|16564524|P6|Part 1: Pilot Dose Selection Period|Adverse Event|0
4803726|NCT01292603|16564525|P5|Part 1: Pilot Dose Selection Period|Adverse Event|0
4803727|NCT01292603|16564526|P4|Part 1: Pilot Dose Selection Period|Adverse Event|4
4803728|NCT01292603|16564527|P3|Part 1: Pilot Dose Selection Period|Adverse Event|0
4803729|NCT01292603|16564528|P2|Part 1: Pilot Dose Selection Period|Adverse Event|0
4803730|NCT01292603|16564529|P1|Part 1: Pilot Dose Selection Period|Adverse Event|0
4803731|NCT01292486|16564582|P1|Overall Study|Physician Decision|1
4803732|NCT01292486|16564582|P1|Overall Study|Adverse Event|1
4803733|NCT01292486|16564582|P1|Overall Study|Did not meet screening criteria|2
4803734|NCT01292486|16564582|P1|Overall Study|Protocol Violation|2
4803735|NCT01292473|16564596|P4|Overall Study|Disease Progression|6
4803736|NCT01292473|16564597|P3|Overall Study|Disease Progression|3
4803737|NCT01292473|16564598|P2|Overall Study|Disease Progression|1
4803738|NCT01292473|16564599|P1|Overall Study|Disease Progression|0
4803739|NCT01292473|16564596|P4|Overall Study|Physician Decision|0
4803740|NCT01292473|16564597|P3|Overall Study|Physician Decision|0
4803741|NCT01292473|16564598|P2|Overall Study|Physician Decision|1
4803742|NCT01292473|16564599|P1|Overall Study|Physician Decision|0
4803743|NCT01292473|16564596|P4|Overall Study|Withdrawal by Subject|3
4803744|NCT01292473|16564597|P3|Overall Study|Withdrawal by Subject|3
4803745|NCT01292473|16564598|P2|Overall Study|Withdrawal by Subject|4
4803746|NCT01292473|16564599|P1|Overall Study|Withdrawal by Subject|3
4803747|NCT01292473|16564596|P4|Overall Study|Lost to Follow-up|2
4803748|NCT01292473|16564597|P3|Overall Study|Lost to Follow-up|2
4803749|NCT01292473|16564598|P2|Overall Study|Lost to Follow-up|1
4803750|NCT01292473|16564599|P1|Overall Study|Lost to Follow-up|1
4803751|NCT01292473|16564596|P4|Overall Study|Adverse Event|1
4803752|NCT01292473|16564597|P3|Overall Study|Adverse Event|1
4803753|NCT01292473|16564598|P2|Overall Study|Adverse Event|0
4803754|NCT01292473|16564599|P1|Overall Study|Adverse Event|1
4803755|NCT01292239|16564667|P2|Overall Study|Withdrawal by Subject|6
4803756|NCT01292239|16564668|P1|Overall Study|Withdrawal by Subject|3
4803757|NCT01292239|16564667|P2|Overall Study|Other|1
4803758|NCT01292239|16564668|P1|Overall Study|Other|1
4803759|NCT01292226|16564689|P1|Overall Study|Other|2
4803760|NCT01292226|16564689|P1|Overall Study|Withdrawal by Subject|1
4803761|NCT01292226|16564689|P1|Overall Study|Protocol Violation|3
4803762|NCT01292226|16564689|P1|Overall Study|Graft loss|1
4803763|NCT01292226|16564689|P1|Overall Study|Death|1
4803764|NCT01292226|16564689|P1|Overall Study|Adverse Event|5
4803765|NCT01292187|16564722|P2|Overall Study|All other reasons|3
4803766|NCT01292187|16564723|P1|Overall Study|All other reasons|1
4803767|NCT01292187|16564722|P2|Overall Study|Withdrawal by Subject|5
4803768|NCT01292187|16564723|P1|Overall Study|Withdrawal by Subject|6
4803769|NCT01292187|16564722|P2|Overall Study|Adverse Event|5
4803770|NCT01292187|16564723|P1|Overall Study|Adverse Event|10
4803771|NCT01292057|16564758|P2|Overall Study|Lost to Follow-up|1
4803772|NCT01292057|16564759|P1|Overall Study|Lost to Follow-up|1
4803773|NCT01292057|16564758|P2|Overall Study|Protocol Violation|1
4803774|NCT01292057|16564759|P1|Overall Study|Protocol Violation|1
4803775|NCT01291277|16564831|P2|Overall Study|Lost to Follow-up|1
4803776|NCT01291277|16564832|P1|Overall Study|Lost to Follow-up|3
4803777|NCT01291277|16564831|P2|Overall Study|Death|2
4803778|NCT01291277|16564832|P1|Overall Study|Death|2
4803779|NCT01291225|16564844|P2|Overall Study|Lost to Follow-up|39
4803780|NCT01291225|16564845|P1|Overall Study|Lost to Follow-up|85
4803781|NCT01291173|16564859|P4|Overall Study|Excluded therapy|0
4803782|NCT01291173|16564860|P3|Overall Study|Excluded therapy|1
4803783|NCT01291173|16564861|P2|Overall Study|Excluded therapy|0
4803784|NCT01291173|16564862|P1|Overall Study|Excluded therapy|0
4803785|NCT01291173|16564859|P4|Overall Study|Subject was unblinded|0
4803786|NCT01291173|16564860|P3|Overall Study|Subject was unblinded|1
4803787|NCT01291173|16564861|P2|Overall Study|Subject was unblinded|0
4803788|NCT01291173|16564862|P1|Overall Study|Subject was unblinded|0
4803789|NCT01291173|16564859|P4|Overall Study|Lack of compliance|1
4803790|NCT01291173|16564860|P3|Overall Study|Lack of compliance|0
4803791|NCT01291173|16564861|P2|Overall Study|Lack of compliance|0
4803792|NCT01291173|16564862|P1|Overall Study|Lack of compliance|0
4803793|NCT01291173|16564859|P4|Overall Study|Unable to meet visit schedule|0
4803794|NCT01291173|16564860|P3|Overall Study|Unable to meet visit schedule|1
4803795|NCT01291173|16564861|P2|Overall Study|Unable to meet visit schedule|0
4803796|NCT01291173|16564862|P1|Overall Study|Unable to meet visit schedule|0
4803797|NCT01291173|16564859|P4|Overall Study|Lost to Follow-up|2
4803798|NCT01291173|16564860|P3|Overall Study|Lost to Follow-up|3
4803799|NCT01291173|16564861|P2|Overall Study|Lost to Follow-up|6
4803800|NCT01291173|16564862|P1|Overall Study|Lost to Follow-up|4
4803801|NCT01291173|16564859|P4|Overall Study|Withdrawal by Subject|2
4803802|NCT01291173|16564860|P3|Overall Study|Withdrawal by Subject|4
4803803|NCT01291173|16564861|P2|Overall Study|Withdrawal by Subject|4
4803804|NCT01291173|16564862|P1|Overall Study|Withdrawal by Subject|6
4803805|NCT01291173|16564859|P4|Overall Study|Protocol Violation|5
4803806|NCT01291173|16564860|P3|Overall Study|Protocol Violation|2
4803807|NCT01291173|16564861|P2|Overall Study|Protocol Violation|2
4803808|NCT01291173|16564862|P1|Overall Study|Protocol Violation|7
4803809|NCT01291173|16564859|P4|Overall Study|Adverse Event|3
4803810|NCT01291173|16564860|P3|Overall Study|Adverse Event|1
4803811|NCT01291173|16564861|P2|Overall Study|Adverse Event|3
4803812|NCT01291173|16564862|P1|Overall Study|Adverse Event|0
4803813|NCT01291017|16564971|P1|Overall Study|Withdrawal by Subject|3
4803814|NCT01291017|16564971|P1|Overall Study|Lost to Follow-up|2
4803815|NCT01290887|16565004|P2|Overall Study|Other|6
4803816|NCT01290887|16565005|P1|Overall Study|Other|3
4803817|NCT01290887|16565004|P2|Overall Study|Sponsor closure of study|476
4803818|NCT01290887|16565005|P1|Overall Study|Sponsor closure of study|420
4803819|NCT01290887|16565004|P2|Overall Study|Non-compliance to study medications|0
4803820|NCT01290887|16565005|P1|Overall Study|Non-compliance to study medications|1
4803821|NCT01290887|16565004|P2|Overall Study|Non-compliance to study procedures|1
4803822|NCT01290887|16565005|P1|Overall Study|Non-compliance to study procedures|0
4803823|NCT01290887|16565004|P2|Overall Study|Lost to Follow-up|4
4803824|NCT01290887|16565005|P1|Overall Study|Lost to Follow-up|4
4803825|NCT01290887|16565004|P2|Overall Study|Protocol Violation|1
4803826|NCT01290887|16565005|P1|Overall Study|Protocol Violation|2
4803827|NCT01290887|16565004|P2|Overall Study|Withdrawal by Subject|32
4803828|NCT01290887|16565005|P1|Overall Study|Withdrawal by Subject|26
4803829|NCT01290887|16565004|P2|Overall Study|Lack of Efficacy|5
4803830|NCT01290887|16565005|P1|Overall Study|Lack of Efficacy|4
4803831|NCT01290887|16565004|P2|Overall Study|Adverse Event|11
4803832|NCT01290887|16565005|P1|Overall Study|Adverse Event|6
4803833|NCT01290822|16565066|P1|Overall Study|Physician Decision|10
4803834|NCT01290822|16565066|P1|Overall Study|Withdrawal by Subject|1
4803835|NCT01290796|16565075|P1|Overall Study|Withdrawal by Sponsor|1
4803836|NCT01290796|16565075|P1|Overall Study|Secondary Surgical Intervention|2
4803837|NCT01290796|16565075|P1|Overall Study|Physician Decision|2
4803838|NCT01290796|16565075|P1|Overall Study|Withdrawal by Subject|4
4803839|NCT01290796|16565075|P1|Overall Study|Lost to Follow-up|21
4803840|NCT01290757|16565091|P2|Overall Study|Other|1
4803841|NCT01290757|16565092|P1|Overall Study|Other|0
4803842|NCT01290757|16565091|P2|Overall Study|Protocol Violation|1
4803843|NCT01290757|16565092|P1|Overall Study|Protocol Violation|1
4803844|NCT01290757|16565091|P2|Overall Study|Adverse Event|0
4803845|NCT01290757|16565092|P1|Overall Study|Adverse Event|1
4803846|NCT01290731|16565108|P1|Overall Study|Withdrawal by Subject|1
4803847|NCT01290718|16565120|P1|Overall Study|Early termination of the study|4
4803848|NCT01290679|16565129|P2|Overall Study|Subject Entered Another Trial|5
4803849|NCT01290679|16565130|P1|Overall Study|Subject Entered Another Trial|0
4803850|NCT01290679|16565129|P2|Overall Study|Withdrawal by Subject|5
4803851|NCT01290679|16565130|P1|Overall Study|Withdrawal by Subject|6
4803852|NCT01290679|16565129|P2|Overall Study|Protocol Violation|1
4803853|NCT01290679|16565130|P1|Overall Study|Protocol Violation|0
4803854|NCT01290679|16565129|P2|Overall Study|Lost to Follow-up|10
4803855|NCT01290679|16565130|P1|Overall Study|Lost to Follow-up|8
4803856|NCT01290679|16565129|P2|Overall Study|Adverse Event|0
4803857|NCT01290679|16565130|P1|Overall Study|Adverse Event|2
4803858|NCT01290666|16565199|P1|Overall Study|Early Termination of Study|4
4803859|NCT01290666|16565199|P1|Overall Study|Withdrawal by Subject|23
4803860|NCT01290666|16565199|P1|Overall Study|Lost to Follow-up|11
4803861|NCT01290601|16565252|P4|Overall Study|Protocol Violation|0
4803862|NCT01290601|16565253|P3|Overall Study|Protocol Violation|0
4803863|NCT01290601|16565254|P2|Overall Study|Protocol Violation|0
4803864|NCT01290601|16565255|P1|Overall Study|Protocol Violation|1
4803865|NCT01290601|16565252|P4|Overall Study|Other|0
4803866|NCT01290601|16565253|P3|Overall Study|Other|0
4803867|NCT01290601|16565254|P2|Overall Study|Other|0
4803868|NCT01290601|16565255|P1|Overall Study|Other|1
4803869|NCT01290601|16565252|P4|Overall Study|Lost to Follow-up|0
4803870|NCT01290601|16565253|P3|Overall Study|Lost to Follow-up|0
4803871|NCT01290601|16565254|P2|Overall Study|Lost to Follow-up|2
4803872|NCT01290601|16565255|P1|Overall Study|Lost to Follow-up|7
4803873|NCT01290601|16565252|P4|Overall Study|Lack of Efficacy|0
4803874|NCT01290601|16565253|P3|Overall Study|Lack of Efficacy|0
4803875|NCT01290601|16565254|P2|Overall Study|Lack of Efficacy|1
4803876|NCT01290601|16565255|P1|Overall Study|Lack of Efficacy|2
4803877|NCT01290601|16565252|P4|Overall Study|Adverse Event|0
4803878|NCT01290601|16565253|P3|Overall Study|Adverse Event|0
4803879|NCT01290601|16565254|P2|Overall Study|Adverse Event|2
4803880|NCT01290601|16565255|P1|Overall Study|Adverse Event|0
4803881|NCT01290523|16565276|P1|Overall Study|Death|3
4803882|NCT01290341|16565315|P2|Overall Study|Negative baseline culture and others|11
4803883|NCT01290341|16565316|P1|Overall Study|Negative baseline culture and others|44
4803884|NCT01290341|16565315|P2|Overall Study|Withdrawal by Subject|5
4803885|NCT01290341|16565316|P1|Overall Study|Withdrawal by Subject|19
4803886|NCT01290341|16565315|P2|Overall Study|Lost to Follow-up|10
4803887|NCT01290341|16565316|P1|Overall Study|Lost to Follow-up|21
4803888|NCT01290341|16565315|P2|Overall Study|Adverse Event|0
4803889|NCT01290341|16565316|P1|Overall Study|Adverse Event|1
4803890|NCT01290341|16565315|P2|Overall Study|Protocol Violation|3
4803891|NCT01290341|16565316|P1|Overall Study|Protocol Violation|7
4803892|NCT01290315|16565328|P4|Overall Study|Withdrawal by Subject|0
4803893|NCT01290315|16565329|P3|Overall Study|Withdrawal by Subject|0
4803894|NCT01290315|16565330|P2|Overall Study|Withdrawal by Subject|1
4803895|NCT01290315|16565331|P1|Overall Study|Withdrawal by Subject|1
4803896|NCT01290315|16565328|P4|Overall Study|Lost to Follow-up|0
4803897|NCT01290315|16565329|P3|Overall Study|Lost to Follow-up|0
4803898|NCT01290315|16565330|P2|Overall Study|Lost to Follow-up|1
4803899|NCT01290315|16565331|P1|Overall Study|Lost to Follow-up|0
4803900|NCT01290315|16565328|P4|Overall Study|Selection criteria/compliance|2
4803901|NCT01290315|16565329|P3|Overall Study|Selection criteria/compliance|0
4803902|NCT01290315|16565330|P2|Overall Study|Selection criteria/compliance|1
4803903|NCT01290315|16565331|P1|Overall Study|Selection criteria/compliance|2
4803904|NCT01290315|16565328|P4|Overall Study|Adverse Event|3
4803905|NCT01290315|16565329|P3|Overall Study|Adverse Event|0
4803906|NCT01290315|16565330|P2|Overall Study|Adverse Event|0
4803907|NCT01290315|16565331|P1|Overall Study|Adverse Event|0
4803908|NCT01290263|16565353|P5|Overall Study|Participant Non-Compliance|1
4803909|NCT01290263|16565354|P4|Overall Study|Participant Non-Compliance|1
4803910|NCT01290263|16565355|P3|Overall Study|Participant Non-Compliance|0
4803911|NCT01290263|16565356|P2|Overall Study|Participant Non-Compliance|0
4803912|NCT01290263|16565357|P1|Overall Study|Participant Non-Compliance|0
4803913|NCT01290263|16565353|P5|Overall Study|Withdrawal by Subject|2
4803914|NCT01290263|16565354|P4|Overall Study|Withdrawal by Subject|1
4803915|NCT01290263|16565355|P3|Overall Study|Withdrawal by Subject|0
4803916|NCT01290263|16565356|P2|Overall Study|Withdrawal by Subject|1
4803917|NCT01290263|16565357|P1|Overall Study|Withdrawal by Subject|3
4803918|NCT01290263|16565353|P5|Overall Study|Lack of Efficacy|33
4803919|NCT01290263|16565354|P4|Overall Study|Lack of Efficacy|24
4803920|NCT01290263|16565355|P3|Overall Study|Lack of Efficacy|7
4803921|NCT01290263|16565356|P2|Overall Study|Lack of Efficacy|2
4803922|NCT01290263|16565357|P1|Overall Study|Lack of Efficacy|8
4803923|NCT01290263|16565353|P5|Overall Study|Adverse Event|1
4803924|NCT01290263|16565354|P4|Overall Study|Adverse Event|1
4803925|NCT01290263|16565355|P3|Overall Study|Adverse Event|0
4803926|NCT01290263|16565356|P2|Overall Study|Adverse Event|0
4803927|NCT01290263|16565357|P1|Overall Study|Adverse Event|0
4803928|NCT01290224|16565384|P1|Overall Study|Refused Further Treatment|4
4803929|NCT01290224|16565384|P1|Overall Study|Adverse Event|1
4803930|NCT01290094|16565395|P1|Overall Study|Lost to Follow-up|5
4803931|NCT01290094|16565395|P1|Overall Study|Withdrawal by Subject|1
4803932|NCT01290068|16565408|P2|Overall Study|Other|1
4803933|NCT01290068|16565409|P1|Overall Study|Other|3
4803934|NCT01290068|16565408|P2|Overall Study|Withdrawal by subject prior to implant|2
4803935|NCT01290068|16565409|P1|Overall Study|Withdrawal by subject prior to implant|0
4803936|NCT01290068|16565408|P2|Overall Study|Lost to Follow-up|0
4803937|NCT01290068|16565409|P1|Overall Study|Lost to Follow-up|3
4803938|NCT01290068|16565408|P2|Overall Study|Adverse Event|3
4803939|NCT01290068|16565409|P1|Overall Study|Adverse Event|1
4803940|NCT01290029|16565421|P1|Overall Study|Other|2
4803941|NCT01289990|16565447|P13|Overall Study|Not treated|0
4803942|NCT01289990|16565448|P12|Overall Study|Not treated|2
4803943|NCT01289990|16565449|P11|Overall Study|Not treated|1
4803944|NCT01289990|16565450|P10|Overall Study|Not treated|0
4803945|NCT01289990|16565451|P9|Overall Study|Not treated|1
4803946|NCT01289990|16565452|P8|Overall Study|Not treated|0
4803947|NCT01289990|16565453|P7|Overall Study|Not treated|1
4803948|NCT01289990|16565454|P6|Overall Study|Not treated|0
4803949|NCT01289990|16565455|P5|Overall Study|Not treated|0
4803950|NCT01289990|16565456|P4|Overall Study|Not treated|0
4803951|NCT01289990|16565457|P3|Overall Study|Not treated|0
4803952|NCT01289990|16565458|P2|Overall Study|Not treated|0
4803953|NCT01289990|16565459|P1|Overall Study|Not treated|0
4803954|NCT01289990|16565447|P13|Overall Study|did not continue in extension|56
4803955|NCT01289990|16565448|P12|Overall Study|did not continue in extension|34
4803956|NCT01289990|16565449|P11|Overall Study|did not continue in extension|45
4803957|NCT01289990|16565450|P10|Overall Study|did not continue in extension|48
4803958|NCT01289990|16565451|P9|Overall Study|did not continue in extension|44
4803959|NCT01289990|16565452|P8|Overall Study|did not continue in extension|36
4803960|NCT01289990|16565453|P7|Overall Study|did not continue in extension|54
4803961|NCT01289990|16565454|P6|Overall Study|did not continue in extension|50
4803962|NCT01289990|16565455|P5|Overall Study|did not continue in extension|48
4803963|NCT01289990|16565456|P4|Overall Study|did not continue in extension|51
4803964|NCT01289990|16565457|P3|Overall Study|did not continue in extension|51
4803965|NCT01289990|16565458|P2|Overall Study|did not continue in extension|45
4803966|NCT01289990|16565459|P1|Overall Study|did not continue in extension|41
4803967|NCT01289990|16565447|P13|Overall Study|discontinued in preceding trial|24
4803968|NCT01289990|16565448|P12|Overall Study|discontinued in preceding trial|17
4803969|NCT01289990|16565449|P11|Overall Study|discontinued in preceding trial|17
4803970|NCT01289990|16565450|P10|Overall Study|discontinued in preceding trial|21
4803971|NCT01289990|16565451|P9|Overall Study|discontinued in preceding trial|17
4803972|NCT01289990|16565452|P8|Overall Study|discontinued in preceding trial|8
4803973|NCT01289990|16565453|P7|Overall Study|discontinued in preceding trial|18
4803974|NCT01289990|16565454|P6|Overall Study|discontinued in preceding trial|12
4803975|NCT01289990|16565455|P5|Overall Study|discontinued in preceding trial|11
4803976|NCT01289990|16565456|P4|Overall Study|discontinued in preceding trial|17
4803977|NCT01289990|16565457|P3|Overall Study|discontinued in preceding trial|41
4803978|NCT01289990|16565458|P2|Overall Study|discontinued in preceding trial|20
4803979|NCT01289990|16565459|P1|Overall Study|discontinued in preceding trial|18
4803980|NCT01289990|16565447|P13|Overall Study|Withdrawal by Subject|16
4803981|NCT01289990|16565448|P12|Overall Study|Withdrawal by Subject|13
4803982|NCT01289990|16565449|P11|Overall Study|Withdrawal by Subject|11
4803983|NCT01289990|16565450|P10|Overall Study|Withdrawal by Subject|13
4803984|NCT01289990|16565451|P9|Overall Study|Withdrawal by Subject|12
4803985|NCT01289990|16565452|P8|Overall Study|Withdrawal by Subject|9
4803986|NCT01289990|16565453|P7|Overall Study|Withdrawal by Subject|13
4803987|NCT01289990|16565454|P6|Overall Study|Withdrawal by Subject|7
4803988|NCT01289990|16565455|P5|Overall Study|Withdrawal by Subject|8
4803989|NCT01289990|16565456|P4|Overall Study|Withdrawal by Subject|13
4803990|NCT01289990|16565457|P3|Overall Study|Withdrawal by Subject|12
4803991|NCT01289990|16565458|P2|Overall Study|Withdrawal by Subject|14
4803992|NCT01289990|16565459|P1|Overall Study|Withdrawal by Subject|15
4803993|NCT01289990|16565447|P13|Overall Study|Lost to Follow-up|2
4803994|NCT01289990|16565448|P12|Overall Study|Lost to Follow-up|1
4803995|NCT01289990|16565449|P11|Overall Study|Lost to Follow-up|2
4803996|NCT01289990|16565450|P10|Overall Study|Lost to Follow-up|4
4803997|NCT01289990|16565451|P9|Overall Study|Lost to Follow-up|1
4803998|NCT01289990|16565452|P8|Overall Study|Lost to Follow-up|2
4803999|NCT01289990|16565453|P7|Overall Study|Lost to Follow-up|2
4804000|NCT01289990|16565454|P6|Overall Study|Lost to Follow-up|4
4804001|NCT01289990|16565455|P5|Overall Study|Lost to Follow-up|3
4804002|NCT01289990|16565456|P4|Overall Study|Lost to Follow-up|5
4804003|NCT01289990|16565457|P3|Overall Study|Lost to Follow-up|5
4804004|NCT01289990|16565458|P2|Overall Study|Lost to Follow-up|2
4804005|NCT01289990|16565459|P1|Overall Study|Lost to Follow-up|3
4804006|NCT01289990|16565447|P13|Overall Study|Death|0
4804007|NCT01289990|16565448|P12|Overall Study|Death|1
4804008|NCT01289990|16565449|P11|Overall Study|Death|0
4804009|NCT01289990|16565450|P10|Overall Study|Death|0
4804010|NCT01289990|16565451|P9|Overall Study|Death|0
4804011|NCT01289990|16565452|P8|Overall Study|Death|0
4804012|NCT01289990|16565453|P7|Overall Study|Death|0
4804013|NCT01289990|16565454|P6|Overall Study|Death|1
4804014|NCT01289990|16565455|P5|Overall Study|Death|2
4804015|NCT01289990|16565456|P4|Overall Study|Death|1
4804016|NCT01289990|16565457|P3|Overall Study|Death|0
4804017|NCT01289990|16565458|P2|Overall Study|Death|0
4804018|NCT01289990|16565459|P1|Overall Study|Death|0
4804019|NCT01289847|16565676|P1|Overall Study|Patient could not comply with visits|1
4804020|NCT01289821|16565685|P1|Survival Follow-up Period|Clinical endpoint reached|16
4804021|NCT01289821|16565685|P1|Survival Follow-up Period|Lost to Follow-up|1
4804022|NCT01289821|16565685|P1|Survival Follow-up Period|Protocol Violation|1
4804023|NCT01289821|16565685|P1|Safety Follow-up Period|Unspecified reason|1
4804024|NCT01289821|16565685|P1|Safety Follow-up Period|Protocol Violation|3
4804025|NCT01289821|16565685|P1|Safety Follow-up Period|Withdrawal by Subject|1
4804026|NCT01289821|16565685|P1|Treatment Period|Therapeutic procedure required|1
4804027|NCT01289821|16565685|P1|Treatment Period|Clinical Progression|2
4804028|NCT01289821|16565685|P1|Treatment Period|Radiological Progression|43
4804029|NCT01289821|16565685|P1|Treatment Period|Adverse Event|4
4804030|NCT01289821|16565685|P1|Treatment Period|Physician Decision|3
4804031|NCT01289821|16565685|P1|Treatment Period|Withdrawal by Subject|1
4804032|NCT01289782|16565696|P2|Overall Study|Reason not specified|2
4804033|NCT01289782|16565697|P1|Overall Study|Reason not specified|1
4804034|NCT01289782|16565696|P2|Overall Study|Sponsor's Decision|0
4804035|NCT01289782|16565697|P1|Overall Study|Sponsor's Decision|1
4804036|NCT01289782|16565696|P2|Overall Study|Withdrawal by Subject|2
4804037|NCT01289782|16565697|P1|Overall Study|Withdrawal by Subject|8
4804038|NCT01289782|16565696|P2|Overall Study|Protocol Violation|1
4804039|NCT01289782|16565697|P1|Overall Study|Protocol Violation|1
4804040|NCT01289782|16565696|P2|Overall Study|Lost to Follow-up|7
4804041|NCT01289782|16565697|P1|Overall Study|Lost to Follow-up|14
4804042|NCT01289678|16565766|P1|Overall Study|Physician Decision|6
4804043|NCT01289639|16565773|P3|Overall Study|Lost to Follow-up|0
4804044|NCT01289639|16565774|P2|Overall Study|Lost to Follow-up|0
4804045|NCT01289639|16565775|P1|Overall Study|Lost to Follow-up|1
4804046|NCT01289574|16565801|P3|Overall Study|Subject wanted alternate treatment|0
4804047|NCT01289574|16565802|P2|Overall Study|Subject wanted alternate treatment|1
4804048|NCT01289574|16565803|P1|Overall Study|Subject wanted alternate treatment|0
4804049|NCT01289574|16565801|P3|Overall Study|Adverse Event|0
4804050|NCT01289574|16565802|P2|Overall Study|Adverse Event|1
4804051|NCT01289574|16565803|P1|Overall Study|Adverse Event|0
4804052|NCT01289574|16565801|P3|Overall Study|Withdrawal by Subject|1
4804053|NCT01289574|16565802|P2|Overall Study|Withdrawal by Subject|1
4804054|NCT01289574|16565803|P1|Overall Study|Withdrawal by Subject|1
4804055|NCT01289574|16565801|P3|Overall Study|Lost to Follow-up|1
4804056|NCT01289574|16565802|P2|Overall Study|Lost to Follow-up|0
4804057|NCT01289574|16565803|P1|Overall Study|Lost to Follow-up|2
4804058|NCT01289574|16565801|P3|Overall Study|Lack of Efficacy|1
4804059|NCT01289574|16565802|P2|Overall Study|Lack of Efficacy|0
4804060|NCT01289574|16565803|P1|Overall Study|Lack of Efficacy|4
4804061|NCT01289418|16565947|P1|Day 29 Survey|participants did not complete the survey|2185
4804062|NCT01289418|16565947|P1|Day 29 Survey|email address invalid|283
4804063|NCT01289418|16565947|P1|Day 8 Survey|participants did not complete the survey|1935
4804064|NCT01289418|16565947|P1|Day 8 Survey|email address invalid|283
4804065|NCT01289210|16565995|P1|Overall Study|Adverse Event|1
4804066|NCT01289119|16566005|P6|Overall Study|Other|0
4804067|NCT01289119|16566006|P5|Overall Study|Other|0
4804068|NCT01289119|16566007|P4|Overall Study|Other|0
4804069|NCT01289119|16566008|P3|Overall Study|Other|1
4804070|NCT01289119|16566009|P2|Overall Study|Other|0
4804071|NCT01289119|16566010|P1|Overall Study|Other|1
4804072|NCT01289119|16566005|P6|Overall Study|Lack of Efficacy|1
4804073|NCT01289119|16566006|P5|Overall Study|Lack of Efficacy|1
4804074|NCT01289119|16566007|P4|Overall Study|Lack of Efficacy|1
4804075|NCT01289119|16566008|P3|Overall Study|Lack of Efficacy|1
4804076|NCT01289119|16566009|P2|Overall Study|Lack of Efficacy|1
4804077|NCT01289119|16566010|P1|Overall Study|Lack of Efficacy|0
4804078|NCT01289119|16566005|P6|Overall Study|Pregnancy|0
4804079|NCT01289119|16566006|P5|Overall Study|Pregnancy|0
4804080|NCT01289119|16566007|P4|Overall Study|Pregnancy|0
4804081|NCT01289119|16566008|P3|Overall Study|Pregnancy|0
4804082|NCT01289119|16566009|P2|Overall Study|Pregnancy|1
4804083|NCT01289119|16566010|P1|Overall Study|Pregnancy|0
4804084|NCT01289119|16566005|P6|Overall Study|Withdrawal by Subject|1
4804085|NCT01289119|16566006|P5|Overall Study|Withdrawal by Subject|1
4804086|NCT01289119|16566007|P4|Overall Study|Withdrawal by Subject|3
4804087|NCT01289119|16566008|P3|Overall Study|Withdrawal by Subject|4
4804088|NCT01289119|16566009|P2|Overall Study|Withdrawal by Subject|2
4804089|NCT01289119|16566010|P1|Overall Study|Withdrawal by Subject|4
4804090|NCT01289119|16566005|P6|Overall Study|Lost to Follow-up|1
4804091|NCT01289119|16566006|P5|Overall Study|Lost to Follow-up|0
4804092|NCT01289119|16566007|P4|Overall Study|Lost to Follow-up|0
4804093|NCT01289119|16566008|P3|Overall Study|Lost to Follow-up|0
4804094|NCT01289119|16566009|P2|Overall Study|Lost to Follow-up|3
4804095|NCT01289119|16566010|P1|Overall Study|Lost to Follow-up|0
4804096|NCT01289119|16566005|P6|Overall Study|Major Protocol Deviation|1
4804097|NCT01289119|16566006|P5|Overall Study|Major Protocol Deviation|2
4804098|NCT01289119|16566007|P4|Overall Study|Major Protocol Deviation|0
4804099|NCT01289119|16566008|P3|Overall Study|Major Protocol Deviation|3
4804100|NCT01289119|16566009|P2|Overall Study|Major Protocol Deviation|1
4804101|NCT01289119|16566010|P1|Overall Study|Major Protocol Deviation|2
4804102|NCT01289119|16566005|P6|Overall Study|Adverse Event|0
4804103|NCT01289119|16566006|P5|Overall Study|Adverse Event|1
4804104|NCT01289119|16566007|P4|Overall Study|Adverse Event|2
4804105|NCT01289119|16566008|P3|Overall Study|Adverse Event|0
4804106|NCT01289119|16566009|P2|Overall Study|Adverse Event|1
4804107|NCT01289119|16566010|P1|Overall Study|Adverse Event|2
4804108|NCT01289041|16566131|P1|Overall Study|Death|1
4804109|NCT01289041|16566131|P1|Overall Study|Withdrawal by Subject|3
4804110|NCT01289041|16566131|P1|Overall Study|Progressive Disease|41
4804111|NCT01289041|16566131|P1|Overall Study|Physician Decision|1
4804112|NCT01289041|16566131|P1|Overall Study|Adverse Event|24
4804113|NCT01289028|16566143|P1|Overall Study|Missing reason for discon|1
4804114|NCT01289028|16566143|P1|Overall Study|Abnormal Lab Value|1
4804115|NCT01289028|16566143|P1|Overall Study|New Cancer Therapy|2
4804116|NCT01289028|16566143|P1|Overall Study|Lost to Follow-up|2
4804117|NCT01289028|16566143|P1|Overall Study|No longer required|2
4804118|NCT01289028|16566143|P1|Overall Study|Lack of Efficacy|2
4804119|NCT01289028|16566143|P1|Overall Study|Death|4
4804120|NCT01289028|16566143|P1|Overall Study|Withdrawal by Subject|6
4804121|NCT01289028|16566143|P1|Overall Study|Adverse Event|14
4804122|NCT01289028|16566143|P1|Overall Study|Progressive Disease|49
4804123|NCT01289015|16566157|P2|Overall Study|Negative baseline culture and others|20
4804124|NCT01289015|16566158|P1|Overall Study|Negative baseline culture and others|33
4804125|NCT01289015|16566157|P2|Overall Study|Disease progression|0
4804126|NCT01289015|16566158|P1|Overall Study|Disease progression|1
4804127|NCT01289015|16566157|P2|Overall Study|Withdrawal by Subject|8
4804128|NCT01289015|16566158|P1|Overall Study|Withdrawal by Subject|17
4804129|NCT01289015|16566157|P2|Overall Study|Lost to Follow-up|17
4804130|NCT01289015|16566158|P1|Overall Study|Lost to Follow-up|33
4804131|NCT01289015|16566157|P2|Overall Study|Adverse Event|0
4804132|NCT01289015|16566158|P1|Overall Study|Adverse Event|3
4804133|NCT01289015|16566157|P2|Overall Study|Protocol Violation|9
4804134|NCT01289015|16566158|P1|Overall Study|Protocol Violation|12
4804135|NCT01288989|16566171|P5|Overall Study|Withdrawal by Subject|3
4804136|NCT01288989|16566172|P4|Overall Study|Withdrawal by Subject|0
4804137|NCT01288989|16566173|P3|Overall Study|Withdrawal by Subject|0
4804138|NCT01288989|16566174|P2|Overall Study|Withdrawal by Subject|0
4804139|NCT01288989|16566175|P1|Overall Study|Withdrawal by Subject|0
4804140|NCT01288989|16566171|P5|Overall Study|Physician Decision|1
4804141|NCT01288989|16566172|P4|Overall Study|Physician Decision|0
4804142|NCT01288989|16566173|P3|Overall Study|Physician Decision|0
4804143|NCT01288989|16566174|P2|Overall Study|Physician Decision|0
4804144|NCT01288989|16566175|P1|Overall Study|Physician Decision|0
4804145|NCT01288989|16566171|P5|Overall Study|Adverse Event|2
4804146|NCT01288989|16566172|P4|Overall Study|Adverse Event|0
4804147|NCT01288989|16566173|P3|Overall Study|Adverse Event|0
4804148|NCT01288989|16566174|P2|Overall Study|Adverse Event|0
4804149|NCT01288989|16566175|P1|Overall Study|Adverse Event|0
4804150|NCT01288989|16566171|P5|Overall Study|Dose limiting toxicity|0
4804151|NCT01288989|16566172|P4|Overall Study|Dose limiting toxicity|0
4804152|NCT01288989|16566173|P3|Overall Study|Dose limiting toxicity|0
4804153|NCT01288989|16566174|P2|Overall Study|Dose limiting toxicity|0
4804154|NCT01288989|16566175|P1|Overall Study|Dose limiting toxicity|1
4804155|NCT01288989|16566171|P5|Overall Study|Death|0
4804156|NCT01288989|16566172|P4|Overall Study|Death|1
4804157|NCT01288989|16566173|P3|Overall Study|Death|0
4804158|NCT01288989|16566174|P2|Overall Study|Death|0
4804159|NCT01288989|16566175|P1|Overall Study|Death|0
4804160|NCT01288976|16566236|P3|Overall Study|Data unavailable|7
4804161|NCT01288976|16566237|P2|Overall Study|Data unavailable|9
4804162|NCT01288976|16566238|P1|Overall Study|Data unavailable|22
4804163|NCT01288976|16566236|P3|Overall Study|Death|4
4804164|NCT01288976|16566237|P2|Overall Study|Death|6
4804165|NCT01288976|16566238|P1|Overall Study|Death|98
4804166|NCT01288976|16566236|P3|Overall Study|Withdrawal by Subject|9
4804167|NCT01288976|16566237|P2|Overall Study|Withdrawal by Subject|12
4804168|NCT01288976|16566238|P1|Overall Study|Withdrawal by Subject|58
4804169|NCT01288937|16566267|P2|Overall Study|Adverse Event|0
4804170|NCT01288937|16566268|P1|Overall Study|Adverse Event|1
4804171|NCT01288911|16566276|P2|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5
4804172|NCT01288911|16566277|P1|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17
4804173|NCT01288911|16566276|P2|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0
4804174|NCT01288911|16566277|P1|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5
4804175|NCT01288911|16566276|P2|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0
4804176|NCT01288911|16566277|P1|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1
4804177|NCT01288911|16566276|P2|Open-label Period (All Enzalutamide)|Progressive disease|3
4804178|NCT01288911|16566277|P1|Open-label Period (All Enzalutamide)|Progressive disease|18
4804179|NCT01288911|16566276|P2|Open-label Period (All Enzalutamide)|Lost to Follow-up|0
4804180|NCT01288911|16566277|P1|Open-label Period (All Enzalutamide)|Lost to Follow-up|1
4804181|NCT01288911|16566276|P2|Open-label Period (All Enzalutamide)|Death|1
4804182|NCT01288911|16566277|P1|Open-label Period (All Enzalutamide)|Death|0
4804183|NCT01288911|16566276|P2|Double-blind Period|Randomized but never received study drug|2
4804184|NCT01288911|16566277|P1|Double-blind Period|Randomized but never received study drug|1
4804185|NCT01288911|16566276|P2|Double-blind Period|Miscellaneous Reason|42
4804186|NCT01288911|16566277|P1|Double-blind Period|Miscellaneous Reason|29
4804187|NCT01288911|16566276|P2|Double-blind Period|Withdrawal by Subject|26
4804188|NCT01288911|16566277|P1|Double-blind Period|Withdrawal by Subject|25
4804189|NCT01288911|16566276|P2|Double-blind Period|Protocol Violation|0
4804190|NCT01288911|16566277|P1|Double-blind Period|Protocol Violation|1
4804191|NCT01288911|16566276|P2|Double-blind Period|Progressive Disease|103
4804192|NCT01288911|16566277|P1|Double-blind Period|Progressive Disease|75
4804193|NCT01288911|16566276|P2|Double-blind Period|Lost to Follow-up|2
4804194|NCT01288911|16566277|P1|Double-blind Period|Lost to Follow-up|0
4804195|NCT01288911|16566276|P2|Double-blind Period|Death|7
4804196|NCT01288911|16566277|P1|Double-blind Period|Death|11
4804197|NCT01288729|16566387|P2|Overall Study|Withdrawal by Subject|0
4804198|NCT01288729|16566388|P1|Overall Study|Withdrawal by Subject|1
4804199|NCT01288612|16566397|P3|Overall Study|Unable to intubate|0
4804200|NCT01288612|16566398|P2|Overall Study|Unable to intubate|3
4804201|NCT01288612|16566399|P1|Overall Study|Unable to intubate|0
4804202|NCT01288612|16566397|P3|Overall Study|Declined|62
4804203|NCT01288612|16566398|P2|Overall Study|Declined|63
4804204|NCT01288612|16566399|P1|Overall Study|Declined|78
4804205|NCT01288612|16566397|P3|Overall Study|Unable to contact|20
4804206|NCT01288612|16566398|P2|Overall Study|Unable to contact|16
4804207|NCT01288612|16566399|P1|Overall Study|Unable to contact|11
4804208|NCT01288469|16566448|P3|Overall Study|Exclusion criteria finally met|0
4804209|NCT01288469|16566449|P2|Overall Study|Exclusion criteria finally met|0
4804210|NCT01288469|16566450|P1|Overall Study|Exclusion criteria finally met|1
4804211|NCT01288469|16566448|P3|Overall Study|Consent withdrawn by subject|1
4804212|NCT01288469|16566449|P2|Overall Study|Consent withdrawn by subject|1
4804213|NCT01288469|16566450|P1|Overall Study|Consent withdrawn by subject|1
4804214|NCT01288469|16566448|P3|Overall Study|Participant Moved|0
4804215|NCT01288469|16566449|P2|Overall Study|Participant Moved|0
4804216|NCT01288469|16566450|P1|Overall Study|Participant Moved|1
4804217|NCT01288469|16566448|P3|Overall Study|Poor compliance to protocol|0
4804218|NCT01288469|16566449|P2|Overall Study|Poor compliance to protocol|1
4804219|NCT01288469|16566450|P1|Overall Study|Poor compliance to protocol|0
4804220|NCT01288469|16566448|P3|Overall Study|Adverse Event|1
4804221|NCT01288469|16566449|P2|Overall Study|Adverse Event|1
4804222|NCT01288469|16566450|P1|Overall Study|Adverse Event|4
4804223|NCT01288443|16566482|P6|Overall Study|Other than above|0
4804224|NCT01288443|16566483|P5|Overall Study|Other than above|1
4804225|NCT01288443|16566484|P4|Overall Study|Other than above|2
4804226|NCT01288443|16566485|P3|Overall Study|Other than above|0
4804227|NCT01288443|16566486|P2|Overall Study|Other than above|0
4804228|NCT01288443|16566487|P1|Overall Study|Other than above|0
4804229|NCT01288443|16566482|P6|Overall Study|Study drug auto-injector administration|1
4804230|NCT01288443|16566483|P5|Overall Study|Study drug auto-injector administration|1
4804231|NCT01288443|16566484|P4|Overall Study|Study drug auto-injector administration|0
4804232|NCT01288443|16566485|P3|Overall Study|Study drug auto-injector administration|0
4804233|NCT01288443|16566486|P2|Overall Study|Study drug auto-injector administration|0
4804234|NCT01288443|16566487|P1|Overall Study|Study drug auto-injector administration|0
4804235|NCT01288443|16566482|P6|Overall Study|Lost to Follow-up|0
4804236|NCT01288443|16566483|P5|Overall Study|Lost to Follow-up|0
4804237|NCT01288443|16566484|P4|Overall Study|Lost to Follow-up|0
4804238|NCT01288443|16566485|P3|Overall Study|Lost to Follow-up|0
4804239|NCT01288443|16566486|P2|Overall Study|Lost to Follow-up|1
4804240|NCT01288443|16566487|P1|Overall Study|Lost to Follow-up|0
4804241|NCT01288443|16566482|P6|Overall Study|Consent withdrawn by Participant|1
4804242|NCT01288443|16566483|P5|Overall Study|Consent withdrawn by Participant|0
4804243|NCT01288443|16566484|P4|Overall Study|Consent withdrawn by Participant|0
4804244|NCT01288443|16566485|P3|Overall Study|Consent withdrawn by Participant|0
4804245|NCT01288443|16566486|P2|Overall Study|Consent withdrawn by Participant|0
4804246|NCT01288443|16566487|P1|Overall Study|Consent withdrawn by Participant|0
4804247|NCT01288443|16566482|P6|Overall Study|Participant Moved|1
4804248|NCT01288443|16566483|P5|Overall Study|Participant Moved|2
4804249|NCT01288443|16566484|P4|Overall Study|Participant Moved|1
4804250|NCT01288443|16566485|P3|Overall Study|Participant Moved|0
4804251|NCT01288443|16566486|P2|Overall Study|Participant Moved|0
4804252|NCT01288443|16566487|P1|Overall Study|Participant Moved|0
4804253|NCT01288443|16566482|P6|Overall Study|Poor compliance to protocol|1
4804254|NCT01288443|16566483|P5|Overall Study|Poor compliance to protocol|0
4804255|NCT01288443|16566484|P4|Overall Study|Poor compliance to protocol|0
4804256|NCT01288443|16566485|P3|Overall Study|Poor compliance to protocol|0
4804257|NCT01288443|16566486|P2|Overall Study|Poor compliance to protocol|0
4804258|NCT01288443|16566487|P1|Overall Study|Poor compliance to protocol|0
4804259|NCT01288443|16566482|P6|Overall Study|Adverse Event|1
4804260|NCT01288443|16566483|P5|Overall Study|Adverse Event|3
4804261|NCT01288443|16566484|P4|Overall Study|Adverse Event|1
4804262|NCT01288443|16566485|P3|Overall Study|Adverse Event|1
4804263|NCT01288443|16566486|P2|Overall Study|Adverse Event|0
4804264|NCT01288443|16566487|P1|Overall Study|Adverse Event|0
4804265|NCT01288430|16566547|P10|Part 2|Other|1
4804266|NCT01288430|16566548|P9|Part 2|Other|0
4804267|NCT01288430|16566549|P8|Part 2|Other|0
4804268|NCT01288430|16566550|P7|Part 2|Other|0
4804269|NCT01288430|16566551|P6|Part 2|Other|0
4804270|NCT01288430|16566552|P5|Part 2|Other|0
4804271|NCT01288430|16566553|P4|Part 2|Other|0
4804272|NCT01288430|16566554|P3|Part 2|Other|0
4804273|NCT01288430|16566555|P2|Part 2|Other|0
4804274|NCT01288430|16566556|P1|Part 2|Other|0
4804275|NCT01288430|16566547|P10|Part 2|Adverse Event|0
4804276|NCT01288430|16566548|P9|Part 2|Adverse Event|1
4804277|NCT01288430|16566549|P8|Part 2|Adverse Event|1
4804278|NCT01288430|16566550|P7|Part 2|Adverse Event|0
4804279|NCT01288430|16566551|P6|Part 2|Adverse Event|0
4804280|NCT01288430|16566552|P5|Part 2|Adverse Event|0
4804281|NCT01288430|16566553|P4|Part 2|Adverse Event|0
4804282|NCT01288430|16566554|P3|Part 2|Adverse Event|0
4804283|NCT01288430|16566555|P2|Part 2|Adverse Event|0
4804284|NCT01288430|16566556|P1|Part 2|Adverse Event|0
4804285|NCT01288430|16566547|P10|Part 2|Withdrawal by Subject|0
4804286|NCT01288430|16566548|P9|Part 2|Withdrawal by Subject|4
4804287|NCT01288430|16566549|P8|Part 2|Withdrawal by Subject|1
4804288|NCT01288430|16566550|P7|Part 2|Withdrawal by Subject|0
4804289|NCT01288430|16566551|P6|Part 2|Withdrawal by Subject|0
4804290|NCT01288430|16566552|P5|Part 2|Withdrawal by Subject|0
4804291|NCT01288430|16566553|P4|Part 2|Withdrawal by Subject|0
4804292|NCT01288430|16566554|P3|Part 2|Withdrawal by Subject|0
4804293|NCT01288430|16566555|P2|Part 2|Withdrawal by Subject|0
4804294|NCT01288430|16566556|P1|Part 2|Withdrawal by Subject|0
4804295|NCT01288430|16566547|P10|Part 2|Clinical disease progression|0
4804296|NCT01288430|16566548|P9|Part 2|Clinical disease progression|0
4804297|NCT01288430|16566549|P8|Part 2|Clinical disease progression|2
4804298|NCT01288430|16566550|P7|Part 2|Clinical disease progression|0
4804299|NCT01288430|16566551|P6|Part 2|Clinical disease progression|0
4804300|NCT01288430|16566552|P5|Part 2|Clinical disease progression|0
4804301|NCT01288430|16566553|P4|Part 2|Clinical disease progression|0
4804302|NCT01288430|16566554|P3|Part 2|Clinical disease progression|0
4804303|NCT01288430|16566555|P2|Part 2|Clinical disease progression|0
4804304|NCT01288430|16566556|P1|Part 2|Clinical disease progression|0
4804305|NCT01288430|16566547|P10|Part 2|Progressive disease|2
4804306|NCT01288430|16566548|P9|Part 2|Progressive disease|7
4804307|NCT01288430|16566549|P8|Part 2|Progressive disease|8
4804308|NCT01288430|16566550|P7|Part 2|Progressive disease|0
4804309|NCT01288430|16566551|P6|Part 2|Progressive disease|0
4804310|NCT01288430|16566552|P5|Part 2|Progressive disease|0
4804311|NCT01288430|16566553|P4|Part 2|Progressive disease|0
4804312|NCT01288430|16566554|P3|Part 2|Progressive disease|0
4804313|NCT01288430|16566555|P2|Part 2|Progressive disease|0
4804314|NCT01288430|16566556|P1|Part 2|Progressive disease|0
4804315|NCT01288430|16566547|P10|Part 1|Other|0
4804316|NCT01288430|16566548|P9|Part 1|Other|0
4804317|NCT01288430|16566549|P8|Part 1|Other|0
4804318|NCT01288430|16566550|P7|Part 1|Other|1
4804319|NCT01288430|16566551|P6|Part 1|Other|0
4804320|NCT01288430|16566552|P5|Part 1|Other|0
4804321|NCT01288430|16566553|P4|Part 1|Other|0
4804322|NCT01288430|16566554|P3|Part 1|Other|0
4804323|NCT01288430|16566555|P2|Part 1|Other|2
4804324|NCT01288430|16566556|P1|Part 1|Other|0
4804325|NCT01288430|16566547|P10|Part 1|Adverse Event|0
4804326|NCT01288430|16566548|P9|Part 1|Adverse Event|0
4804327|NCT01288430|16566549|P8|Part 1|Adverse Event|0
4804328|NCT01288430|16566550|P7|Part 1|Adverse Event|2
4804329|NCT01288430|16566551|P6|Part 1|Adverse Event|0
4804330|NCT01288430|16566552|P5|Part 1|Adverse Event|0
4804331|NCT01288430|16566553|P4|Part 1|Adverse Event|1
4804332|NCT01288430|16566554|P3|Part 1|Adverse Event|3
4804333|NCT01288430|16566555|P2|Part 1|Adverse Event|0
4804334|NCT01288430|16566556|P1|Part 1|Adverse Event|0
4804335|NCT01288430|16566547|P10|Part 1|Death due to disease progression|0
4804336|NCT01288430|16566548|P9|Part 1|Death due to disease progression|0
4804337|NCT01288430|16566549|P8|Part 1|Death due to disease progression|0
4804338|NCT01288430|16566550|P7|Part 1|Death due to disease progression|0
4804339|NCT01288430|16566551|P6|Part 1|Death due to disease progression|0
4804340|NCT01288430|16566552|P5|Part 1|Death due to disease progression|1
4804341|NCT01288430|16566553|P4|Part 1|Death due to disease progression|0
4804342|NCT01288430|16566554|P3|Part 1|Death due to disease progression|0
4804343|NCT01288430|16566555|P2|Part 1|Death due to disease progression|0
4804344|NCT01288430|16566556|P1|Part 1|Death due to disease progression|0
4804345|NCT01288430|16566547|P10|Part 1|Clinical disease progression|0
4804346|NCT01288430|16566548|P9|Part 1|Clinical disease progression|0
4804347|NCT01288430|16566549|P8|Part 1|Clinical disease progression|0
4804348|NCT01288430|16566550|P7|Part 1|Clinical disease progression|2
4804349|NCT01288430|16566551|P6|Part 1|Clinical disease progression|2
4804350|NCT01288430|16566552|P5|Part 1|Clinical disease progression|0
4804351|NCT01288430|16566553|P4|Part 1|Clinical disease progression|0
4804352|NCT01288430|16566554|P3|Part 1|Clinical disease progression|1
4804353|NCT01288430|16566555|P2|Part 1|Clinical disease progression|0
4804354|NCT01288430|16566556|P1|Part 1|Clinical disease progression|0
4804355|NCT01288430|16566547|P10|Part 1|Progressive disease|0
4804356|NCT01288430|16566548|P9|Part 1|Progressive disease|0
4804357|NCT01288430|16566549|P8|Part 1|Progressive disease|0
4804358|NCT01288430|16566550|P7|Part 1|Progressive disease|2
4804359|NCT01288430|16566551|P6|Part 1|Progressive disease|4
4804360|NCT01288430|16566552|P5|Part 1|Progressive disease|2
4804361|NCT01288430|16566553|P4|Part 1|Progressive disease|6
4804362|NCT01288430|16566554|P3|Part 1|Progressive disease|1
4804363|NCT01288430|16566555|P2|Part 1|Progressive disease|1
4804364|NCT01288430|16566556|P1|Part 1|Progressive disease|2
4804365|NCT01288287|16566680|P1|Overall Study|Unknown Status|7
4804366|NCT01288287|16566680|P1|Overall Study|Unknown Reason|1
4804367|NCT01288287|16566680|P1|Overall Study|Other Reason|13
4804368|NCT01288287|16566680|P1|Overall Study|Lack of Efficacy|13
4804369|NCT01288287|16566680|P1|Overall Study|Withdrawal by Subject|4
4804370|NCT01288287|16566680|P1|Overall Study|Lost to Follow-up|8
4804371|NCT01288209|16566695|P2|Overall Study|Other|0
4804372|NCT01288209|16566696|P1|Overall Study|Other|1
4804373|NCT01288209|16566695|P2|Overall Study|Withdrawal by Subject|3
4804374|NCT01288209|16566696|P1|Overall Study|Withdrawal by Subject|1
4804375|NCT01288079|16566726|P4|Overall Study|Other or Study Termination|8
4804376|NCT01288079|16566727|P3|Overall Study|Other or Study Termination|14
4804377|NCT01288079|16566728|P2|Overall Study|Other or Study Termination|15
4804378|NCT01288079|16566729|P1|Overall Study|Other or Study Termination|11
4804379|NCT01288079|16566726|P4|Overall Study|Lost to Follow-up|0
4804380|NCT01288079|16566727|P3|Overall Study|Lost to Follow-up|1
4804381|NCT01288079|16566728|P2|Overall Study|Lost to Follow-up|1
4804382|NCT01288079|16566729|P1|Overall Study|Lost to Follow-up|1
4804383|NCT01288079|16566726|P4|Overall Study|Study-Specific Withdrawal Criteria|0
4804384|NCT01288079|16566727|P3|Overall Study|Study-Specific Withdrawal Criteria|0
4804385|NCT01288079|16566728|P2|Overall Study|Study-Specific Withdrawal Criteria|1
4804386|NCT01288079|16566729|P1|Overall Study|Study-Specific Withdrawal Criteria|1
4804387|NCT01288079|16566726|P4|Overall Study|Lack of Efficacy|2
4804388|NCT01288079|16566727|P3|Overall Study|Lack of Efficacy|0
4804389|NCT01288079|16566728|P2|Overall Study|Lack of Efficacy|2
4804390|NCT01288079|16566729|P1|Overall Study|Lack of Efficacy|2
4804391|NCT01288079|16566726|P4|Overall Study|Condition under Investigation Worsened|1
4804392|NCT01288079|16566727|P3|Overall Study|Condition under Investigation Worsened|0
4804393|NCT01288079|16566728|P2|Overall Study|Condition under Investigation Worsened|0
4804394|NCT01288079|16566729|P1|Overall Study|Condition under Investigation Worsened|0
4804395|NCT01288079|16566726|P4|Overall Study|Severe Non-Compliance to Protocol|3
4804396|NCT01288079|16566727|P3|Overall Study|Severe Non-Compliance to Protocol|1
4804397|NCT01288079|16566728|P2|Overall Study|Severe Non-Compliance to Protocol|3
4804398|NCT01288079|16566729|P1|Overall Study|Severe Non-Compliance to Protocol|1
4804399|NCT01288079|16566726|P4|Overall Study|Adverse Event|3
4804400|NCT01288079|16566727|P3|Overall Study|Adverse Event|2
4804401|NCT01288079|16566728|P2|Overall Study|Adverse Event|1
4804402|NCT01288079|16566729|P1|Overall Study|Adverse Event|2
4804403|NCT01288079|16566726|P4|Overall Study|Withdrawal by Subject|0
4804404|NCT01288079|16566727|P3|Overall Study|Withdrawal by Subject|1
4804405|NCT01288079|16566728|P2|Overall Study|Withdrawal by Subject|4
4804406|NCT01288079|16566729|P1|Overall Study|Withdrawal by Subject|2
4804407|NCT01288053|16566739|P1|Overall Study|Death|1
4804408|NCT01287897|16566757|P4|Overall Study|Other|0
4804409|NCT01287897|16566758|P3|Overall Study|Other|1
4804410|NCT01287897|16566759|P2|Overall Study|Other|0
4804411|NCT01287897|16566760|P1|Overall Study|Other|1
4804412|NCT01287897|16566757|P4|Overall Study|Not meeting entrance criteria|0
4804413|NCT01287897|16566758|P3|Overall Study|Not meeting entrance criteria|0
4804414|NCT01287897|16566759|P2|Overall Study|Not meeting entrance criteria|1
4804415|NCT01287897|16566760|P1|Overall Study|Not meeting entrance criteria|1
4804416|NCT01287897|16566757|P4|Overall Study|Not consented properly|0
4804417|NCT01287897|16566758|P3|Overall Study|Not consented properly|0
4804418|NCT01287897|16566759|P2|Overall Study|Not consented properly|1
4804419|NCT01287897|16566760|P1|Overall Study|Not consented properly|0
4804420|NCT01287897|16566757|P4|Overall Study|Withdrawal by Subject|2
4804421|NCT01287897|16566758|P3|Overall Study|Withdrawal by Subject|3
4804422|NCT01287897|16566759|P2|Overall Study|Withdrawal by Subject|5
4804423|NCT01287897|16566760|P1|Overall Study|Withdrawal by Subject|1
4804424|NCT01287897|16566757|P4|Overall Study|Lost to Follow-up|0
4804425|NCT01287897|16566758|P3|Overall Study|Lost to Follow-up|2
4804426|NCT01287897|16566759|P2|Overall Study|Lost to Follow-up|0
4804427|NCT01287897|16566760|P1|Overall Study|Lost to Follow-up|0
4804428|NCT01287897|16566757|P4|Overall Study|Protocol Violation|1
4804429|NCT01287897|16566758|P3|Overall Study|Protocol Violation|0
4804430|NCT01287897|16566759|P2|Overall Study|Protocol Violation|1
4804431|NCT01287897|16566760|P1|Overall Study|Protocol Violation|1
4804432|NCT01287897|16566757|P4|Overall Study|Lack of Efficacy|0
4804433|NCT01287897|16566758|P3|Overall Study|Lack of Efficacy|0
4804434|NCT01287897|16566759|P2|Overall Study|Lack of Efficacy|0
4804435|NCT01287897|16566760|P1|Overall Study|Lack of Efficacy|2
4804436|NCT01287897|16566757|P4|Overall Study|Adverse Event|4
4804437|NCT01287897|16566758|P3|Overall Study|Adverse Event|6
4804438|NCT01287897|16566759|P2|Overall Study|Adverse Event|3
4804439|NCT01287897|16566760|P1|Overall Study|Adverse Event|5
4804440|NCT01287832|16566811|P2|Overall Study|Death|1
4804441|NCT01287832|16566812|P1|Overall Study|Death|0
4804442|NCT01287832|16566811|P2|Overall Study|Adverse Event|0
4804443|NCT01287832|16566812|P1|Overall Study|Adverse Event|1
4804444|NCT01287754|16566820|P2|Overall Study|Protocol Violation|3
4804445|NCT01287754|16566821|P1|Overall Study|Protocol Violation|0
4804446|NCT01287754|16566820|P2|Overall Study|Lost to Follow-up|6
4804447|NCT01287754|16566821|P1|Overall Study|Lost to Follow-up|1
4804448|NCT01287754|16566820|P2|Overall Study|Death|12
4804449|NCT01287754|16566821|P1|Overall Study|Death|2
4804450|NCT01287741|16566833|P2|Overall Study|Reason not specified|9
4804451|NCT01287741|16566834|P1|Overall Study|Reason not specified|23
4804452|NCT01287741|16566833|P2|Overall Study|Progressive disease|166
4804453|NCT01287741|16566834|P1|Overall Study|Progressive disease|190
4804454|NCT01287741|16566833|P2|Overall Study|Study terminated by Sponsor|315
4804455|NCT01287741|16566834|P1|Overall Study|Study terminated by Sponsor|307
4804456|NCT01287741|16566833|P2|Overall Study|Adverse Event|6
4804457|NCT01287741|16566834|P1|Overall Study|Adverse Event|4
4804458|NCT01287741|16566833|P2|Overall Study|Death|44
4804459|NCT01287741|16566834|P1|Overall Study|Death|32
4804460|NCT01287741|16566833|P2|Overall Study|Lost to Follow-up|8
4804461|NCT01287741|16566834|P1|Overall Study|Lost to Follow-up|10
4804462|NCT01287741|16566833|P2|Overall Study|Non-compliance|6
4804463|NCT01287741|16566834|P1|Overall Study|Non-compliance|8
4804464|NCT01287741|16566833|P2|Overall Study|Physician Decision|23
4804465|NCT01287741|16566834|P1|Overall Study|Physician Decision|15
4804466|NCT01287741|16566833|P2|Overall Study|Protocol Violation|0
4804467|NCT01287741|16566834|P1|Overall Study|Protocol Violation|2
4804468|NCT01287741|16566833|P2|Overall Study|Withdrawal by Subject|38
4804469|NCT01287741|16566834|P1|Overall Study|Withdrawal by Subject|35
4804470|NCT01287611|16566870|P2|Overall Study|Exclusion due to expanded Kerr incision|3
4804471|NCT01287611|16566871|P1|Overall Study|Exclusion due to expanded Kerr incision|4
4804472|NCT01287611|16566870|P2|Overall Study|Lost to Follow-up|16
4804473|NCT01287611|16566871|P1|Overall Study|Lost to Follow-up|29
4804474|NCT01287520|16566888|P9|Overall Study|Withdrawal by Subject|1
4804475|NCT01287520|16566889|P8|Overall Study|Withdrawal by Subject|0
4804476|NCT01287520|16566890|P7|Overall Study|Withdrawal by Subject|0
4804477|NCT01287520|16566891|P6|Overall Study|Withdrawal by Subject|1
4804478|NCT01287520|16566892|P5|Overall Study|Withdrawal by Subject|0
4804479|NCT01287520|16566893|P4|Overall Study|Withdrawal by Subject|0
4804480|NCT01287520|16566894|P3|Overall Study|Withdrawal by Subject|0
4804481|NCT01287520|16566895|P2|Overall Study|Withdrawal by Subject|0
4804482|NCT01287520|16566896|P1|Overall Study|Withdrawal by Subject|0
4804483|NCT01287520|16566888|P9|Overall Study|Progressive disease|4
4804484|NCT01287520|16566889|P8|Overall Study|Progressive disease|2
4804485|NCT01287520|16566890|P7|Overall Study|Progressive disease|2
4804486|NCT01287520|16566891|P6|Overall Study|Progressive disease|0
4804487|NCT01287520|16566892|P5|Overall Study|Progressive disease|1
4804488|NCT01287520|16566893|P4|Overall Study|Progressive disease|6
4804489|NCT01287520|16566894|P3|Overall Study|Progressive disease|1
4804490|NCT01287520|16566895|P2|Overall Study|Progressive disease|4
4804491|NCT01287520|16566896|P1|Overall Study|Progressive disease|0
4804492|NCT01287520|16566888|P9|Overall Study|Physician Decision|0
4804493|NCT01287520|16566889|P8|Overall Study|Physician Decision|1
4804494|NCT01287520|16566890|P7|Overall Study|Physician Decision|0
4804495|NCT01287520|16566891|P6|Overall Study|Physician Decision|1
4804496|NCT01287520|16566892|P5|Overall Study|Physician Decision|1
4804497|NCT01287520|16566893|P4|Overall Study|Physician Decision|0
4804498|NCT01287520|16566894|P3|Overall Study|Physician Decision|2
4804499|NCT01287520|16566895|P2|Overall Study|Physician Decision|1
4804500|NCT01287520|16566896|P1|Overall Study|Physician Decision|1
4804501|NCT01287520|16566888|P9|Overall Study|Adverse Event|0
4804502|NCT01287520|16566889|P8|Overall Study|Adverse Event|2
4804503|NCT01287520|16566890|P7|Overall Study|Adverse Event|0
4804504|NCT01287520|16566891|P6|Overall Study|Adverse Event|2
4804505|NCT01287520|16566892|P5|Overall Study|Adverse Event|1
4804506|NCT01287520|16566893|P4|Overall Study|Adverse Event|1
4804507|NCT01287520|16566894|P3|Overall Study|Adverse Event|2
4804508|NCT01287520|16566895|P2|Overall Study|Adverse Event|2
4804509|NCT01287520|16566896|P1|Overall Study|Adverse Event|2
4804510|NCT01287416|16566960|P2|6 Month Follow-up|Lost to Follow-up|2
4804511|NCT01287416|16566961|P1|6 Month Follow-up|Lost to Follow-up|3
4804512|NCT01287416|16566960|P2|Pre-post Training|Lost to Follow-up|1
4804513|NCT01287416|16566961|P1|Pre-post Training|Lost to Follow-up|5
4804514|NCT01287416|16566960|P2|Pre-post Training|Withdrawal by Subject|24
4804515|NCT01287416|16566961|P1|Pre-post Training|Withdrawal by Subject|17
4804516|NCT01287403|16566997|P1|1st Intervention (1 Day)|Adverse Event|1
4804517|NCT01287364|16567029|P2|Overall Study|Other Reason|2
4804518|NCT01287364|16567030|P1|Overall Study|Other Reason|4
4804519|NCT01287364|16567029|P2|Overall Study|Protocol Violation|5
4804520|NCT01287364|16567030|P1|Overall Study|Protocol Violation|5
4804521|NCT01287364|16567029|P2|Overall Study|Adverse Event|3
4804522|NCT01287364|16567030|P1|Overall Study|Adverse Event|0
4804523|NCT01287221|16567052|P2|Overall Study|Withdrawal by Subject|1
4804524|NCT01287221|16567053|P1|Overall Study|Withdrawal by Subject|0
4804525|NCT01287221|16567052|P2|Overall Study|Adverse Event|3
4804526|NCT01287221|16567053|P1|Overall Study|Adverse Event|3
4804527|NCT01287221|16567052|P2|Overall Study|Lack of Perceived Benefit|1
4804528|NCT01287221|16567053|P1|Overall Study|Lack of Perceived Benefit|1
4804529|NCT01287195|16567088|P1|Overall Study|Withdrawal by Subject|2
4804530|NCT01287117|16567103|P4|Overall Study|Disease Progression|5
4804531|NCT01287117|16567104|P3|Overall Study|Disease Progression|6
4804532|NCT01287117|16567105|P2|Overall Study|Disease Progression|5
4804533|NCT01287117|16567106|P1|Overall Study|Disease Progression|10
4804534|NCT01287117|16567103|P4|Overall Study|Patient/Legal Guardian's Decision|5
4804535|NCT01287117|16567104|P3|Overall Study|Patient/Legal Guardian's Decision|8
4804536|NCT01287117|16567105|P2|Overall Study|Patient/Legal Guardian's Decision|6
4804537|NCT01287117|16567106|P1|Overall Study|Patient/Legal Guardian's Decision|2
4804538|NCT01287117|16567103|P4|Overall Study|Physician Decision|1
4804539|NCT01287117|16567104|P3|Overall Study|Physician Decision|1
4804540|NCT01287117|16567105|P2|Overall Study|Physician Decision|1
4804541|NCT01287117|16567106|P1|Overall Study|Physician Decision|0
4804542|NCT01287117|16567103|P4|Overall Study|Lost to Follow-up|0
4804543|NCT01287117|16567104|P3|Overall Study|Lost to Follow-up|0
4804544|NCT01287117|16567105|P2|Overall Study|Lost to Follow-up|1
4804545|NCT01287117|16567106|P1|Overall Study|Lost to Follow-up|1
4804546|NCT01287117|16567103|P4|Overall Study|Adverse Event|1
4804547|NCT01287117|16567104|P3|Overall Study|Adverse Event|1
4804548|NCT01287117|16567105|P2|Overall Study|Adverse Event|1
4804549|NCT01287117|16567106|P1|Overall Study|Adverse Event|2
4804550|NCT01287104|16567156|P4|Overall Study|NK cells did not meet release criteria|0
4804551|NCT01287104|16567157|P3|Overall Study|NK cells did not meet release criteria|0
4804552|NCT01287104|16567158|P2|Overall Study|NK cells did not meet release criteria|1
4804553|NCT01287104|16567159|P1|Overall Study|NK cells did not meet release criteria|0
4804554|NCT01287104|16567156|P4|Overall Study|Low donor chimerism|0
4804555|NCT01287104|16567157|P3|Overall Study|Low donor chimerism|0
4804556|NCT01287104|16567158|P2|Overall Study|Low donor chimerism|1
4804557|NCT01287104|16567159|P1|Overall Study|Low donor chimerism|0
4804558|NCT01287104|16567156|P4|Overall Study|Developed GVHD or complications of BMT|0
4804559|NCT01287104|16567157|P3|Overall Study|Developed GVHD or complications of BMT|4
4804560|NCT01287104|16567158|P2|Overall Study|Developed GVHD or complications of BMT|1
4804561|NCT01287104|16567159|P1|Overall Study|Developed GVHD or complications of BMT|0
4804562|NCT01287104|16567156|P4|Overall Study|Donor anaphylaxis|1
4804563|NCT01287104|16567157|P3|Overall Study|Donor anaphylaxis|0
4804564|NCT01287104|16567158|P2|Overall Study|Donor anaphylaxis|1
4804565|NCT01287104|16567159|P1|Overall Study|Donor anaphylaxis|0
4804566|NCT01287104|16567156|P4|Overall Study|Patient developed progressive disease|2
4804567|NCT01287104|16567157|P3|Overall Study|Patient developed progressive disease|3
4804568|NCT01287104|16567158|P2|Overall Study|Patient developed progressive disease|1
4804569|NCT01287104|16567159|P1|Overall Study|Patient developed progressive disease|1
4804570|NCT01287065|16567215|P6|Treatment Period 1|Withdrawal by Subject|1
4804571|NCT01287065|16567216|P5|Treatment Period 1|Withdrawal by Subject|0
4804572|NCT01287065|16567217|P4|Treatment Period 1|Withdrawal by Subject|0
4804573|NCT01287065|16567218|P3|Treatment Period 1|Withdrawal by Subject|0
4804574|NCT01287065|16567219|P2|Treatment Period 1|Withdrawal by Subject|0
4804575|NCT01287065|16567220|P1|Treatment Period 1|Withdrawal by Subject|0
4804576|NCT01287065|16567215|P6|Treatment Period 1|Adverse Event|0
4804577|NCT01287065|16567216|P5|Treatment Period 1|Adverse Event|1
4804578|NCT01287065|16567217|P4|Treatment Period 1|Adverse Event|0
4804579|NCT01287065|16567218|P3|Treatment Period 1|Adverse Event|0
4804580|NCT01287065|16567219|P2|Treatment Period 1|Adverse Event|0
4804581|NCT01287065|16567220|P1|Treatment Period 1|Adverse Event|0
4804582|NCT01287039|16567239|P2|Overall Study|Lost to Follow-up|2
4804583|NCT01287039|16567240|P1|Overall Study|Lost to Follow-up|3
4804584|NCT01287039|16567239|P2|Overall Study|Withdrawal by Subject|11
4804585|NCT01287039|16567240|P1|Overall Study|Withdrawal by Subject|14
4804586|NCT01287039|16567239|P2|Overall Study|Adverse Event|4
4804587|NCT01287039|16567240|P1|Overall Study|Adverse Event|7
4804588|NCT01287039|16567239|P2|Overall Study|Change of residence|0
4804589|NCT01287039|16567240|P1|Overall Study|Change of residence|1
4804590|NCT01287039|16567239|P2|Overall Study|Death|0
4804591|NCT01287039|16567240|P1|Overall Study|Death|1
4804592|NCT01287039|16567239|P2|Overall Study|Problem with travel|1
4804593|NCT01287039|16567240|P1|Overall Study|Problem with travel|0
4804594|NCT01287039|16567239|P2|Overall Study|Noncompliance with study medication|1
4804595|NCT01287039|16567240|P1|Overall Study|Noncompliance with study medication|0
4804596|NCT01287039|16567239|P2|Overall Study|Excluded medication taken|0
4804597|NCT01287039|16567240|P1|Overall Study|Excluded medication taken|1
4804598|NCT01287039|16567239|P2|Overall Study|Protocol Violation|3
4804599|NCT01287039|16567240|P1|Overall Study|Protocol Violation|2
4804600|NCT01287039|16567239|P2|Overall Study|Elective surgery|1
4804601|NCT01287039|16567240|P1|Overall Study|Elective surgery|0
4804602|NCT01287039|16567239|P2|Overall Study|Change of location/residence|3
4804603|NCT01287039|16567240|P1|Overall Study|Change of location/residence|0
4804604|NCT01287039|16567239|P2|Overall Study|Noncompliance with study procedures|1
4804605|NCT01287039|16567240|P1|Overall Study|Noncompliance with study procedures|0
4804606|NCT01287013|16567273|P3|Overall Study|Non-evaluable|21
4804607|NCT01287013|16567274|P2|Overall Study|Non-evaluable|5
4804608|NCT01287013|16567275|P1|Overall Study|Non-evaluable|3
4804609|NCT01286987|16567305|P15|Part 2: Dose Expansion|Withdrawal by Subject|0
4804610|NCT01286987|16567306|P14|Part 2: Dose Expansion|Withdrawal by Subject|0
4804611|NCT01286987|16567307|P13|Part 2: Dose Expansion|Withdrawal by Subject|0
4804612|NCT01286987|16567308|P12|Part 2: Dose Expansion|Withdrawal by Subject|0
4804613|NCT01286987|16567309|P11|Part 2: Dose Expansion|Withdrawal by Subject|1
4804614|NCT01286987|16567310|P10|Part 2: Dose Expansion|Withdrawal by Subject|0
4804615|NCT01286987|16567311|P9|Part 2: Dose Expansion|Withdrawal by Subject|0
4804616|NCT01286987|16567312|P8|Part 2: Dose Expansion|Withdrawal by Subject|0
4804617|NCT01286987|16567313|P7|Part 2: Dose Expansion|Withdrawal by Subject|0
4804618|NCT01286987|16567314|P6|Part 2: Dose Expansion|Withdrawal by Subject|0
4804619|NCT01286987|16567315|P5|Part 2: Dose Expansion|Withdrawal by Subject|0
4804620|NCT01286987|16567316|P4|Part 2: Dose Expansion|Withdrawal by Subject|0
4804621|NCT01286987|16567317|P3|Part 2: Dose Expansion|Withdrawal by Subject|0
4804622|NCT01286987|16567318|P2|Part 2: Dose Expansion|Withdrawal by Subject|0
4804623|NCT01286987|16567319|P1|Part 2: Dose Expansion|Withdrawal by Subject|0
4804624|NCT01286987|16567305|P15|Part 2: Dose Expansion|Clinical Progression|0
4804625|NCT01286987|16567306|P14|Part 2: Dose Expansion|Clinical Progression|2
4804626|NCT01286987|16567307|P13|Part 2: Dose Expansion|Clinical Progression|0
4804627|NCT01286987|16567308|P12|Part 2: Dose Expansion|Clinical Progression|2
4804628|NCT01286987|16567309|P11|Part 2: Dose Expansion|Clinical Progression|2
4804629|NCT01286987|16567310|P10|Part 2: Dose Expansion|Clinical Progression|0
4804630|NCT01286987|16567311|P9|Part 2: Dose Expansion|Clinical Progression|0
4804631|NCT01286987|16567312|P8|Part 2: Dose Expansion|Clinical Progression|0
4804632|NCT01286987|16567313|P7|Part 2: Dose Expansion|Clinical Progression|0
4804633|NCT01286987|16567314|P6|Part 2: Dose Expansion|Clinical Progression|0
4804634|NCT01286987|16567315|P5|Part 2: Dose Expansion|Clinical Progression|0
4804635|NCT01286987|16567316|P4|Part 2: Dose Expansion|Clinical Progression|0
4804636|NCT01286987|16567317|P3|Part 2: Dose Expansion|Clinical Progression|0
4804637|NCT01286987|16567318|P2|Part 2: Dose Expansion|Clinical Progression|0
4804638|NCT01286987|16567319|P1|Part 2: Dose Expansion|Clinical Progression|0
4804639|NCT01286987|16567305|P15|Part 2: Dose Expansion|Progressive Disease|2
4804640|NCT01286987|16567306|P14|Part 2: Dose Expansion|Progressive Disease|19
4804641|NCT01286987|16567307|P13|Part 2: Dose Expansion|Progressive Disease|11
4804642|NCT01286987|16567308|P12|Part 2: Dose Expansion|Progressive Disease|7
4804643|NCT01286987|16567309|P11|Part 2: Dose Expansion|Progressive Disease|6
4804644|NCT01286987|16567310|P10|Part 2: Dose Expansion|Progressive Disease|11
4804645|NCT01286987|16567311|P9|Part 2: Dose Expansion|Progressive Disease|0
4804646|NCT01286987|16567312|P8|Part 2: Dose Expansion|Progressive Disease|0
4804647|NCT01286987|16567313|P7|Part 2: Dose Expansion|Progressive Disease|0
4804648|NCT01286987|16567314|P6|Part 2: Dose Expansion|Progressive Disease|0
4804649|NCT01286987|16567315|P5|Part 2: Dose Expansion|Progressive Disease|0
4804650|NCT01286987|16567316|P4|Part 2: Dose Expansion|Progressive Disease|0
4804651|NCT01286987|16567317|P3|Part 2: Dose Expansion|Progressive Disease|0
4804652|NCT01286987|16567318|P2|Part 2: Dose Expansion|Progressive Disease|0
4804653|NCT01286987|16567319|P1|Part 2: Dose Expansion|Progressive Disease|0
4804654|NCT01286987|16567305|P15|Part 2: Dose Expansion|Other|0
4804655|NCT01286987|16567306|P14|Part 2: Dose Expansion|Other|1
4804656|NCT01286987|16567307|P13|Part 2: Dose Expansion|Other|0
4804657|NCT01286987|16567308|P12|Part 2: Dose Expansion|Other|0
4804658|NCT01286987|16567309|P11|Part 2: Dose Expansion|Other|0
4804659|NCT01286987|16567310|P10|Part 2: Dose Expansion|Other|0
4804660|NCT01286987|16567311|P9|Part 2: Dose Expansion|Other|0
4804661|NCT01286987|16567312|P8|Part 2: Dose Expansion|Other|0
4804662|NCT01286987|16567313|P7|Part 2: Dose Expansion|Other|0
4804663|NCT01286987|16567314|P6|Part 2: Dose Expansion|Other|0
4804664|NCT01286987|16567315|P5|Part 2: Dose Expansion|Other|0
4804665|NCT01286987|16567316|P4|Part 2: Dose Expansion|Other|0
4804666|NCT01286987|16567317|P3|Part 2: Dose Expansion|Other|0
4804667|NCT01286987|16567318|P2|Part 2: Dose Expansion|Other|0
4804668|NCT01286987|16567319|P1|Part 2: Dose Expansion|Other|0
4804669|NCT01286987|16567305|P15|Part 2: Dose Expansion|Physician Decision|0
4804670|NCT01286987|16567306|P14|Part 2: Dose Expansion|Physician Decision|1
4804671|NCT01286987|16567307|P13|Part 2: Dose Expansion|Physician Decision|0
4804672|NCT01286987|16567308|P12|Part 2: Dose Expansion|Physician Decision|1
4804673|NCT01286987|16567309|P11|Part 2: Dose Expansion|Physician Decision|1
4804674|NCT01286987|16567310|P10|Part 2: Dose Expansion|Physician Decision|0
4804675|NCT01286987|16567311|P9|Part 2: Dose Expansion|Physician Decision|0
4804676|NCT01286987|16567312|P8|Part 2: Dose Expansion|Physician Decision|0
4804677|NCT01286987|16567313|P7|Part 2: Dose Expansion|Physician Decision|0
4804678|NCT01286987|16567314|P6|Part 2: Dose Expansion|Physician Decision|0
4804679|NCT01286987|16567315|P5|Part 2: Dose Expansion|Physician Decision|0
4804680|NCT01286987|16567316|P4|Part 2: Dose Expansion|Physician Decision|0
4804681|NCT01286987|16567317|P3|Part 2: Dose Expansion|Physician Decision|0
4804682|NCT01286987|16567318|P2|Part 2: Dose Expansion|Physician Decision|0
4804683|NCT01286987|16567319|P1|Part 2: Dose Expansion|Physician Decision|0
4804684|NCT01286987|16567305|P15|Part 2: Dose Expansion|Death|0
4804685|NCT01286987|16567306|P14|Part 2: Dose Expansion|Death|1
4804686|NCT01286987|16567307|P13|Part 2: Dose Expansion|Death|1
4804687|NCT01286987|16567308|P12|Part 2: Dose Expansion|Death|0
4804688|NCT01286987|16567309|P11|Part 2: Dose Expansion|Death|0
4804689|NCT01286987|16567310|P10|Part 2: Dose Expansion|Death|0
4804690|NCT01286987|16567311|P9|Part 2: Dose Expansion|Death|0
4804691|NCT01286987|16567312|P8|Part 2: Dose Expansion|Death|0
4804692|NCT01286987|16567313|P7|Part 2: Dose Expansion|Death|0
4804693|NCT01286987|16567314|P6|Part 2: Dose Expansion|Death|0
4804694|NCT01286987|16567315|P5|Part 2: Dose Expansion|Death|0
4804695|NCT01286987|16567316|P4|Part 2: Dose Expansion|Death|0
4804696|NCT01286987|16567317|P3|Part 2: Dose Expansion|Death|0
4804697|NCT01286987|16567318|P2|Part 2: Dose Expansion|Death|0
4804698|NCT01286987|16567319|P1|Part 2: Dose Expansion|Death|0
4804699|NCT01286987|16567305|P15|Part 1: Dose Escalation|Physician Decision|0
4804700|NCT01286987|16567306|P14|Part 1: Dose Escalation|Physician Decision|0
4804701|NCT01286987|16567307|P13|Part 1: Dose Escalation|Physician Decision|0
4804702|NCT01286987|16567308|P12|Part 1: Dose Escalation|Physician Decision|0
4804703|NCT01286987|16567309|P11|Part 1: Dose Escalation|Physician Decision|0
4804704|NCT01286987|16567310|P10|Part 1: Dose Escalation|Physician Decision|0
4804705|NCT01286987|16567311|P9|Part 1: Dose Escalation|Physician Decision|0
4804706|NCT01286987|16567312|P8|Part 1: Dose Escalation|Physician Decision|0
4804707|NCT01286987|16567313|P7|Part 1: Dose Escalation|Physician Decision|0
4804708|NCT01286987|16567314|P6|Part 1: Dose Escalation|Physician Decision|0
4804709|NCT01286987|16567315|P5|Part 1: Dose Escalation|Physician Decision|1
4804710|NCT01286987|16567316|P4|Part 1: Dose Escalation|Physician Decision|0
4804711|NCT01286987|16567317|P3|Part 1: Dose Escalation|Physician Decision|0
4804712|NCT01286987|16567318|P2|Part 1: Dose Escalation|Physician Decision|0
4804713|NCT01286987|16567319|P1|Part 1: Dose Escalation|Physician Decision|0
4804714|NCT01286987|16567305|P15|Part 1: Dose Escalation|Progressive Disease|0
4804715|NCT01286987|16567306|P14|Part 1: Dose Escalation|Progressive Disease|0
4804716|NCT01286987|16567307|P13|Part 1: Dose Escalation|Progressive Disease|0
4804717|NCT01286987|16567308|P12|Part 1: Dose Escalation|Progressive Disease|0
4804718|NCT01286987|16567309|P11|Part 1: Dose Escalation|Progressive Disease|0
4804719|NCT01286987|16567310|P10|Part 1: Dose Escalation|Progressive Disease|0
4804720|NCT01286987|16567311|P9|Part 1: Dose Escalation|Progressive Disease|5
4804721|NCT01286987|16567312|P8|Part 1: Dose Escalation|Progressive Disease|3
4804722|NCT01286987|16567313|P7|Part 1: Dose Escalation|Progressive Disease|5
4804723|NCT01286987|16567314|P6|Part 1: Dose Escalation|Progressive Disease|5
4804724|NCT01286987|16567315|P5|Part 1: Dose Escalation|Progressive Disease|1
4804725|NCT01286987|16567316|P4|Part 1: Dose Escalation|Progressive Disease|2
4804726|NCT01286987|16567317|P3|Part 1: Dose Escalation|Progressive Disease|3
4804727|NCT01286987|16567318|P2|Part 1: Dose Escalation|Progressive Disease|2
4804728|NCT01286987|16567319|P1|Part 1: Dose Escalation|Progressive Disease|2
4804729|NCT01286987|16567305|P15|Part 1: Dose Escalation|Clinical Progression|0
4804730|NCT01286987|16567306|P14|Part 1: Dose Escalation|Clinical Progression|0
4804731|NCT01286987|16567307|P13|Part 1: Dose Escalation|Clinical Progression|0
4804732|NCT01286987|16567308|P12|Part 1: Dose Escalation|Clinical Progression|0
4804733|NCT01286987|16567309|P11|Part 1: Dose Escalation|Clinical Progression|0
4804734|NCT01286987|16567310|P10|Part 1: Dose Escalation|Clinical Progression|0
4804735|NCT01286987|16567311|P9|Part 1: Dose Escalation|Clinical Progression|1
4804736|NCT01286987|16567312|P8|Part 1: Dose Escalation|Clinical Progression|2
4804737|NCT01286987|16567313|P7|Part 1: Dose Escalation|Clinical Progression|0
4804738|NCT01286987|16567314|P6|Part 1: Dose Escalation|Clinical Progression|1
4804739|NCT01286987|16567315|P5|Part 1: Dose Escalation|Clinical Progression|1
4804740|NCT01286987|16567316|P4|Part 1: Dose Escalation|Clinical Progression|1
4804741|NCT01286987|16567317|P3|Part 1: Dose Escalation|Clinical Progression|0
4804742|NCT01286987|16567318|P2|Part 1: Dose Escalation|Clinical Progression|1
4804743|NCT01286987|16567319|P1|Part 1: Dose Escalation|Clinical Progression|1
4804744|NCT01286779|16567500|P1|Overall Study|Discontinued by sponsor|1
4804745|NCT01286779|16567500|P1|Overall Study|Participant moved to another country|1
4804746|NCT01286779|16567500|P1|Overall Study|Participant had scheduled surgery|1
4804747|NCT01286779|16567500|P1|Overall Study|Physician Decision|2
4804748|NCT01286779|16567500|P1|Overall Study|Protocol Violation|5
4804749|NCT01286779|16567500|P1|Overall Study|Withdrawal by Subject|9
4804750|NCT01286753|16567552|P2|Overall Study|Participant to Receive Radiotherapy|0
4804751|NCT01286753|16567553|P1|Overall Study|Participant to Receive Radiotherapy|1
4804752|NCT01286753|16567552|P2|Overall Study|Discontinued to Join Extension Study|4
4804753|NCT01286753|16567553|P1|Overall Study|Discontinued to Join Extension Study|6
4804754|NCT01286753|16567552|P2|Overall Study|Withdrawal of Consent|2
4804755|NCT01286753|16567553|P1|Overall Study|Withdrawal of Consent|0
4804756|NCT01286753|16567552|P2|Overall Study|Refused Treatment|0
4804757|NCT01286753|16567553|P1|Overall Study|Refused Treatment|1
4804758|NCT01286753|16567552|P2|Overall Study|Progression|13
4804759|NCT01286753|16567553|P1|Overall Study|Progression|11
4804760|NCT01286753|16567552|P2|Overall Study|Adverse Event|6
4804761|NCT01286753|16567553|P1|Overall Study|Adverse Event|7
4804762|NCT01286740|16567571|P1|Overall Study|Protocol Violation|1
4804763|NCT01286740|16567571|P1|Overall Study|Enrolled but not treated|1
4804764|NCT01286558|16567589|P2|Overall Study|Withdrawal by Subject|1
4804765|NCT01286558|16567590|P1|Overall Study|Withdrawal by Subject|0
4804766|NCT01286558|16567589|P2|Overall Study|Adverse Event|1
4804767|NCT01286558|16567590|P1|Overall Study|Adverse Event|1
4804768|NCT01286480|16567626|P2|Overall Study|Withdrawal by Subject|3
4804769|NCT01286480|16567627|P1|Overall Study|Withdrawal by Subject|5
4804770|NCT01286311|16567734|P2|Overall Study|Physician did not want outreach sent|0
4804771|NCT01286311|16567735|P1|Overall Study|Physician did not want outreach sent|14
4804772|NCT01286272|16567751|P2|Overall Study|Ineligible after beginning treatment|3
4804773|NCT01286272|16567752|P1|Overall Study|Ineligible after beginning treatment|1
4804774|NCT01286207|16567772|P3|Overall Study|Other|13
4804775|NCT01286207|16567773|P2|Overall Study|Other|47
4804776|NCT01286207|16567774|P1|Overall Study|Other|37
4804777|NCT01286207|16567772|P3|Overall Study|Lack of Response|8
4804778|NCT01286207|16567773|P2|Overall Study|Lack of Response|38
4804779|NCT01286207|16567774|P1|Overall Study|Lack of Response|92
4804780|NCT01286207|16567772|P3|Overall Study|Withdrawal by Subject|41
4804781|NCT01286207|16567773|P2|Overall Study|Withdrawal by Subject|79
4804782|NCT01286207|16567774|P1|Overall Study|Withdrawal by Subject|93
4804783|NCT01286207|16567772|P3|Overall Study|Lost to Follow-up|20
4804784|NCT01286207|16567773|P2|Overall Study|Lost to Follow-up|43
4804785|NCT01286207|16567774|P1|Overall Study|Lost to Follow-up|49
4804786|NCT01286207|16567772|P3|Overall Study|Adverse Event|8
4804787|NCT01286207|16567773|P2|Overall Study|Adverse Event|41
4804788|NCT01286207|16567774|P1|Overall Study|Adverse Event|27
4804789|NCT01286168|16567794|P1|Overall Study|Surgical Drains Fell Out at Home|2
4804790|NCT01286168|16567794|P1|Overall Study|Withdrawal by Subject|1
4804791|NCT01286129|16567808|P2|Overall Study|Could not comply with study requirements|4
4804792|NCT01286129|16567809|P1|Overall Study|Could not comply with study requirements|4
4804793|NCT01286129|16567808|P2|Overall Study|Withdrawal by Subject|1
4804794|NCT01286129|16567809|P1|Overall Study|Withdrawal by Subject|4
4804795|NCT01286077|16567819|P2|Overall Study|refill medication not received in time|0
4804796|NCT01286077|16567820|P1|Overall Study|refill medication not received in time|1
4804797|NCT01286077|16567819|P2|Overall Study|Progression of disease|1
4804798|NCT01286077|16567820|P1|Overall Study|Progression of disease|0
4804799|NCT01286077|16567819|P2|Overall Study|Patient's decision to stop treatment|0
4804800|NCT01286077|16567820|P1|Overall Study|Patient's decision to stop treatment|3
4804801|NCT01286077|16567819|P2|Overall Study|The subject starts with alternative MMY|3
4804802|NCT01286077|16567820|P1|Overall Study|The subject starts with alternative MMY|0
4804803|NCT01286077|16567819|P2|Overall Study|Non-compliance|0
4804804|NCT01286077|16567820|P1|Overall Study|Non-compliance|1
4804805|NCT01286077|16567819|P2|Overall Study|Intercurrent illness|0
4804806|NCT01286077|16567820|P1|Overall Study|Intercurrent illness|1
4804807|NCT01286077|16567819|P2|Overall Study|Withdrawal by Subject|2
4804808|NCT01286077|16567820|P1|Overall Study|Withdrawal by Subject|0
4804809|NCT01286077|16567819|P2|Overall Study|Protocol Violation|1
4804810|NCT01286077|16567820|P1|Overall Study|Protocol Violation|1
4804811|NCT01286077|16567819|P2|Overall Study|Death|0
4804812|NCT01286077|16567820|P1|Overall Study|Death|1
4804813|NCT01286077|16567819|P2|Overall Study|Adverse Event|0
4804814|NCT01286077|16567820|P1|Overall Study|Adverse Event|2
4804815|NCT01286012|16567856|P2|Overall Study|peritoneal dialysis, randomized in error|3
4804816|NCT01286012|16567857|P1|Overall Study|peritoneal dialysis, randomized in error|1
4804817|NCT01286012|16567856|P2|Overall Study|Physician Decision|0
4804818|NCT01286012|16567857|P1|Overall Study|Physician Decision|2
4804819|NCT01286012|16567856|P2|Overall Study|Withdrawal by Subject|4
4804820|NCT01286012|16567857|P1|Overall Study|Withdrawal by Subject|4
4804821|NCT01286012|16567856|P2|Overall Study|Protocol Violation|1
4804822|NCT01286012|16567857|P1|Overall Study|Protocol Violation|1
4804823|NCT01286012|16567856|P2|Overall Study|Death|3
4804824|NCT01286012|16567857|P1|Overall Study|Death|2
4804825|NCT01286012|16567856|P2|Overall Study|Adverse Event|3
4804826|NCT01286012|16567857|P1|Overall Study|Adverse Event|3
4804827|NCT01285960|16567871|P1|Overall Study|2 subjects received less 10 sonications|2
4804828|NCT01285960|16567871|P1|Overall Study|Lost to Follow-up|2
4804829|NCT01285960|16567871|P1|Overall Study|Withdrawal by Subject|2
4804830|NCT01285908|16567884|P3|Baseline Measurement|unable to tolerate procedure|0
4804831|NCT01285908|16567885|P2|Baseline Measurement|unable to tolerate procedure|0
4804832|NCT01285908|16567886|P1|Baseline Measurement|unable to tolerate procedure|1
4804833|NCT01285908|16567884|P3|Baseline Measurement|History of stroke, exclusion criteria|0
4804834|NCT01285908|16567885|P2|Baseline Measurement|History of stroke, exclusion criteria|0
4804835|NCT01285908|16567886|P1|Baseline Measurement|History of stroke, exclusion criteria|1
4804836|NCT01285908|16567884|P3|Baseline Measurement|unable to insert catheter|0
4804837|NCT01285908|16567885|P2|Baseline Measurement|unable to insert catheter|0
4804838|NCT01285908|16567886|P1|Baseline Measurement|unable to insert catheter|1
4804839|NCT01285609|16567980|P2|Treated With Blinded Therapy|Worsening of general condition|1
4804840|NCT01285609|16567981|P1|Treated With Blinded Therapy|Worsening of general condition|0
4804841|NCT01285609|16567980|P2|Treated With Blinded Therapy|PI decision to discontinue|1
4804842|NCT01285609|16567981|P1|Treated With Blinded Therapy|PI decision to discontinue|0
4804843|NCT01285609|16567980|P2|Treated With Blinded Therapy|Investigator's assessment|0
4804844|NCT01285609|16567981|P1|Treated With Blinded Therapy|Investigator's assessment|1
4804845|NCT01285609|16567980|P2|Treated With Blinded Therapy|Participant hospitalized|0
4804846|NCT01285609|16567981|P1|Treated With Blinded Therapy|Participant hospitalized|1
4804847|NCT01285609|16567980|P2|Treated With Blinded Therapy|Participant started radiotherapy|0
4804848|NCT01285609|16567981|P1|Treated With Blinded Therapy|Participant started radiotherapy|1
4804849|NCT01285609|16567980|P2|Treated With Blinded Therapy|Participant refused participation|0
4804850|NCT01285609|16567981|P1|Treated With Blinded Therapy|Participant refused participation|1
4804851|NCT01285609|16567980|P2|Treated With Blinded Therapy|Physician and Patient decision|3
4804852|NCT01285609|16567981|P1|Treated With Blinded Therapy|Physician and Patient decision|1
4804853|NCT01285609|16567980|P2|Treated With Blinded Therapy|Administrative Reason by Sponsor|3
4804854|NCT01285609|16567981|P1|Treated With Blinded Therapy|Administrative Reason by Sponsor|1
4804855|NCT01285609|16567980|P2|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0
4804856|NCT01285609|16567981|P1|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1
4804857|NCT01285609|16567980|P2|Treated With Blinded Therapy|Poor/Non-Compliance|2
4804858|NCT01285609|16567981|P1|Treated With Blinded Therapy|Poor/Non-Compliance|1
4804859|NCT01285609|16567980|P2|Treated With Blinded Therapy|Not Reported|2
4804860|NCT01285609|16567981|P1|Treated With Blinded Therapy|Not Reported|0
4804861|NCT01285609|16567980|P2|Treated With Blinded Therapy|Maximum Clinical Benefit|4
4804862|NCT01285609|16567981|P1|Treated With Blinded Therapy|Maximum Clinical Benefit|2
4804863|NCT01285609|16567980|P2|Treated With Blinded Therapy|Death|3
4804864|NCT01285609|16567981|P1|Treated With Blinded Therapy|Death|11
4804865|NCT01285609|16567980|P2|Treated With Blinded Therapy|Withdrawal by Subject|7
4804866|NCT01285609|16567981|P1|Treated With Blinded Therapy|Withdrawal by Subject|20
4804867|NCT01285609|16567980|P2|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14
4804868|NCT01285609|16567981|P1|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36
4804869|NCT01285609|16567980|P2|Treated With Blinded Therapy|Study Drug Toxicity|14
4804870|NCT01285609|16567981|P1|Treated With Blinded Therapy|Study Drug Toxicity|87
4804871|NCT01285609|16567980|P2|Treated With Blinded Therapy|Progressive Disease|305
4804872|NCT01285609|16567981|P1|Treated With Blinded Therapy|Progressive Disease|223
4804873|NCT01285609|16567980|P2|Randomized|Randomized but not Treated|4
4804874|NCT01285609|16567981|P1|Randomized|Randomized but not Treated|4
4804875|NCT01285609|16567980|P2|Randomized|Undisclosed Reasons|0
4804876|NCT01285609|16567981|P1|Randomized|Undisclosed Reasons|1
4804877|NCT01285609|16567980|P2|Randomized|Subject No Longer Met Study Criteria|1
4804878|NCT01285609|16567981|P1|Randomized|Subject No Longer Met Study Criteria|1
4804879|NCT01285609|16567980|P2|Randomized|Withdrawal by Subject|11
4804880|NCT01285609|16567981|P1|Randomized|Withdrawal by Subject|8
4804881|NCT01285609|16567980|P2|Randomized|Death|7
4804882|NCT01285609|16567981|P1|Randomized|Death|5
4804883|NCT01285609|16567980|P2|Randomized|Study Drug Toxicity|14
4804884|NCT01285609|16567981|P1|Randomized|Study Drug Toxicity|13
4804885|NCT01285609|16567980|P2|Randomized|Adverse Event Unrelated to Study Drug|18
4804886|NCT01285609|16567981|P1|Randomized|Adverse Event Unrelated to Study Drug|18
4804887|NCT01285609|16567980|P2|Randomized|Progressive Disease|61
4804888|NCT01285609|16567981|P1|Randomized|Progressive Disease|41
4804889|NCT01285518|16567999|P8|Overall Study|Lost to Follow-up|0
4804890|NCT01285518|16568000|P7|Overall Study|Lost to Follow-up|0
4804891|NCT01285518|16568001|P6|Overall Study|Lost to Follow-up|1
4804892|NCT01285518|16568002|P5|Overall Study|Lost to Follow-up|0
4804893|NCT01285518|16568003|P4|Overall Study|Lost to Follow-up|0
4804894|NCT01285518|16568004|P3|Overall Study|Lost to Follow-up|0
4804895|NCT01285518|16568005|P2|Overall Study|Lost to Follow-up|0
4804896|NCT01285518|16568006|P1|Overall Study|Lost to Follow-up|0
4804897|NCT01285492|16568266|P2|Overall Study|Death|0
4804898|NCT01285492|16568267|P1|Overall Study|Death|1
4804899|NCT01285492|16568266|P2|Overall Study|Withdrawal by Subject|1
4804900|NCT01285492|16568267|P1|Overall Study|Withdrawal by Subject|2
4804901|NCT01285492|16568266|P2|Overall Study|Protocol Violation|0
4804902|NCT01285492|16568267|P1|Overall Study|Protocol Violation|3
4804903|NCT01285492|16568266|P2|Overall Study|Adverse Event|0
4804904|NCT01285492|16568267|P1|Overall Study|Adverse Event|11
4804905|NCT01285401|16568299|P2|Overall Study|Prematurely withdrawn from the study|29
4804906|NCT01285401|16568300|P1|Overall Study|Prematurely withdrawn from the study|17
4804907|NCT01285349|16568341|P3|Overall Study|Lost to Follow-up|27
4804908|NCT01285349|16568342|P2|Overall Study|Lost to Follow-up|20
4804909|NCT01285349|16568343|P1|Overall Study|Lost to Follow-up|27
4804910|NCT01285323|16568356|P2|Overall Study|Other|3
4804911|NCT01285323|16568357|P1|Overall Study|Other|1
4804912|NCT01285323|16568356|P2|Overall Study|Lost to Follow-up|1
4804913|NCT01285323|16568357|P1|Overall Study|Lost to Follow-up|1
4804914|NCT01285323|16568356|P2|Overall Study|Non-compliance with study procedures|3
4804915|NCT01285323|16568357|P1|Overall Study|Non-compliance with study procedures|2
4804916|NCT01285323|16568356|P2|Overall Study|Protocol Violation|2
4804917|NCT01285323|16568357|P1|Overall Study|Protocol Violation|1
4804918|NCT01285323|16568356|P2|Overall Study|Withdrawal by Subject|11
4804919|NCT01285323|16568357|P1|Overall Study|Withdrawal by Subject|15
4804920|NCT01285323|16568356|P2|Overall Study|Lack of Efficacy|2
4804921|NCT01285323|16568357|P1|Overall Study|Lack of Efficacy|4
4804922|NCT01285323|16568356|P2|Overall Study|Adverse Event|8
4804923|NCT01285323|16568357|P1|Overall Study|Adverse Event|9
4804924|NCT01285310|16568392|P5|Active Treatment Phase: Weeks 25-52|Non-compliance|0
4804925|NCT01285310|16568393|P4|Active Treatment Phase: Weeks 25-52|Non-compliance|1
4804926|NCT01285310|16568394|P3|Active Treatment Phase: Weeks 25-52|Non-compliance|1
4804927|NCT01285310|16568395|P2|Active Treatment Phase: Weeks 25-52|Non-compliance|1
4804928|NCT01285310|16568396|P1|Active Treatment Phase: Weeks 25-52|Non-compliance|0
4804929|NCT01285310|16568392|P5|Active Treatment Phase: Weeks 25-52|Other|0
4804930|NCT01285310|16568393|P4|Active Treatment Phase: Weeks 25-52|Other|0
4804931|NCT01285310|16568394|P3|Active Treatment Phase: Weeks 25-52|Other|0
4804932|NCT01285310|16568395|P2|Active Treatment Phase: Weeks 25-52|Other|1
4804933|NCT01285310|16568396|P1|Active Treatment Phase: Weeks 25-52|Other|0
4804934|NCT01285310|16568392|P5|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15
4804935|NCT01285310|16568393|P4|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6
4804936|NCT01285310|16568394|P3|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19
4804937|NCT01285310|16568395|P2|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21
4804938|NCT01285310|16568396|P1|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0
4804939|NCT01285310|16568392|P5|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
4804940|NCT01285310|16568393|P4|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2
4804941|NCT01285310|16568394|P3|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
4804942|NCT01285310|16568395|P2|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3
4804943|NCT01285310|16568396|P1|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0
4804944|NCT01285310|16568392|P5|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
4804945|NCT01285310|16568393|P4|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1
4804946|NCT01285310|16568394|P3|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3
4804947|NCT01285310|16568395|P2|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4
4804948|NCT01285310|16568396|P1|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0
4804949|NCT01285310|16568392|P5|Active Treatment Phase: Weeks 25-52|Adverse Event|2
4804950|NCT01285310|16568393|P4|Active Treatment Phase: Weeks 25-52|Adverse Event|0
4804951|NCT01285310|16568394|P3|Active Treatment Phase: Weeks 25-52|Adverse Event|3
4804952|NCT01285310|16568395|P2|Active Treatment Phase: Weeks 25-52|Adverse Event|2
4804953|NCT01285310|16568396|P1|Active Treatment Phase: Weeks 25-52|Adverse Event|0
4804954|NCT01285310|16568392|P5|Placebo Controlled Phase: Weeks 0-24|Other|0
4804955|NCT01285310|16568393|P4|Placebo Controlled Phase: Weeks 0-24|Other|0
4804956|NCT01285310|16568394|P3|Placebo Controlled Phase: Weeks 0-24|Other|1
4804957|NCT01285310|16568395|P2|Placebo Controlled Phase: Weeks 0-24|Other|0
4804958|NCT01285310|16568396|P1|Placebo Controlled Phase: Weeks 0-24|Other|1
4804959|NCT01285310|16568392|P5|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
4804960|NCT01285310|16568393|P4|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
4804961|NCT01285310|16568394|P3|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
4804962|NCT01285310|16568395|P2|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1
4804963|NCT01285310|16568396|P1|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0
4804964|NCT01285310|16568392|P5|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
4804965|NCT01285310|16568393|P4|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0
4804966|NCT01285310|16568394|P3|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2
4804967|NCT01285310|16568395|P2|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
4804968|NCT01285310|16568396|P1|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3
4804969|NCT01285310|16568392|P5|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
4804970|NCT01285310|16568393|P4|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
4804971|NCT01285310|16568394|P3|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2
4804972|NCT01285310|16568395|P2|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0
4804973|NCT01285310|16568396|P1|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1
4804974|NCT01285310|16568392|P5|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
4804975|NCT01285310|16568393|P4|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0
4804976|NCT01285310|16568394|P3|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3
4804977|NCT01285310|16568395|P2|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7
4804978|NCT01285310|16568396|P1|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1
4804979|NCT01285310|16568392|P5|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
4804980|NCT01285310|16568393|P4|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0
4804981|NCT01285310|16568394|P3|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6
4804982|NCT01285310|16568395|P2|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4
4804983|NCT01285310|16568396|P1|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3
4804984|NCT01284959|16568661|P3|Overall Study|Adverse Event|1
4804985|NCT01284959|16568662|P2|Overall Study|Adverse Event|0
4804986|NCT01284959|16568663|P1|Overall Study|Adverse Event|0
4804987|NCT01284959|16568661|P3|Overall Study|Withdrawal by Subject|0
4804988|NCT01284959|16568662|P2|Overall Study|Withdrawal by Subject|0
4804989|NCT01284959|16568663|P1|Overall Study|Withdrawal by Subject|1
4804990|NCT01284634|16568693|P4|Overall Study|Adverse Event|1
4804991|NCT01284634|16568694|P3|Overall Study|Adverse Event|2
4804992|NCT01284634|16568695|P2|Overall Study|Adverse Event|0
4804993|NCT01284634|16568696|P1|Overall Study|Adverse Event|1
4804994|NCT01284621|16568726|P6|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4804995|NCT01284621|16568727|P5|Washout Period 1 (7 Days)|Required unexpected medical treatment|1
4804996|NCT01284621|16568728|P4|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4804997|NCT01284621|16568729|P3|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4804998|NCT01284621|16568730|P2|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4804999|NCT01284621|16568731|P1|Washout Period 1 (7 Days)|Required unexpected medical treatment|0
4805000|NCT01284491|16568799|P1|Overall Study|Study termination|13
4805001|NCT01284361|16568809|P1|Overall Study|Lost to Follow-up|2
4805002|NCT01284361|16568809|P1|Overall Study|Adverse Event|1
4805003|NCT01284361|16568809|P1|Overall Study|Protocol Violation|5
4805004|NCT01284361|16568809|P1|Overall Study|Withdrawal by Subject|1
4805005|NCT01284140|16568905|P2|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1
4805006|NCT01284140|16568906|P1|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0
4805007|NCT01284140|16568905|P2|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
4805008|NCT01284140|16568906|P1|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5
4805009|NCT01284127|16568920|P1|Overall Study|Physician Decision|1
4805010|NCT01284127|16568920|P1|Overall Study|Withdrawal by Subject|4
4805011|NCT01284127|16568920|P1|Overall Study|Adverse Event|2
4805012|NCT01284114|16568929|P1|Overall Study|dizziness|1
4805013|NCT01284114|16568929|P1|Overall Study|Symptomatic hypotension|1
4805014|NCT01284114|16568929|P1|Overall Study|From the results of ALLTITUDE study|1
4805015|NCT01284114|16568929|P1|Overall Study|viral infection|1
4805016|NCT01284062|16568941|P4|Overall Study|Site Closed|0
4805017|NCT01284062|16568942|P3|Overall Study|Site Closed|1
4805018|NCT01284062|16568943|P2|Overall Study|Site Closed|0
4805019|NCT01284062|16568944|P1|Overall Study|Site Closed|0
4805020|NCT01284062|16568941|P4|Overall Study|Other|1
4805021|NCT01284062|16568942|P3|Overall Study|Other|0
4805022|NCT01284062|16568943|P2|Overall Study|Other|0
4805023|NCT01284062|16568944|P1|Overall Study|Other|0
4805024|NCT01284062|16568941|P4|Overall Study|Withdrawal by Subject|5
4805025|NCT01284062|16568942|P3|Overall Study|Withdrawal by Subject|2
4805026|NCT01284062|16568943|P2|Overall Study|Withdrawal by Subject|1
4805027|NCT01284062|16568944|P1|Overall Study|Withdrawal by Subject|3
4805028|NCT01284062|16568941|P4|Overall Study|Protocol Violation|2
4805029|NCT01284062|16568942|P3|Overall Study|Protocol Violation|0
4805030|NCT01284062|16568943|P2|Overall Study|Protocol Violation|0
4805031|NCT01284062|16568944|P1|Overall Study|Protocol Violation|1
4805032|NCT01284062|16568941|P4|Overall Study|Medication error without adverse event|0
4805033|NCT01284062|16568942|P3|Overall Study|Medication error without adverse event|1
4805034|NCT01284062|16568943|P2|Overall Study|Medication error without adverse event|0
4805035|NCT01284062|16568944|P1|Overall Study|Medication error without adverse event|0
4805036|NCT01284062|16568941|P4|Overall Study|Lack of Efficacy|1
4805037|NCT01284062|16568942|P3|Overall Study|Lack of Efficacy|2
4805038|NCT01284062|16568943|P2|Overall Study|Lack of Efficacy|2
4805039|NCT01284062|16568944|P1|Overall Study|Lack of Efficacy|3
4805040|NCT01284062|16568941|P4|Overall Study|Adverse Event|5
4805041|NCT01284062|16568942|P3|Overall Study|Adverse Event|0
4805042|NCT01284062|16568943|P2|Overall Study|Adverse Event|5
4805043|NCT01284062|16568944|P1|Overall Study|Adverse Event|4
4805044|NCT01283971|16569018|P2|Overall Study|Administrative reasons|1
4805045|NCT01283971|16569019|P1|Overall Study|Administrative reasons|1
4805046|NCT01283971|16569018|P2|Overall Study|Failure to return|1
4805047|NCT01283971|16569019|P1|Overall Study|Failure to return|0
4805048|NCT01283971|16569018|P2|Overall Study|Refused treatment|1
4805049|NCT01283971|16569019|P1|Overall Study|Refused treatment|3
4805050|NCT01283971|16569018|P2|Overall Study|Protocol Violation|1
4805051|NCT01283971|16569019|P1|Overall Study|Protocol Violation|5
4805052|NCT01283971|16569018|P2|Overall Study|Insufficient therapeutic responses|3
4805053|NCT01283971|16569019|P1|Overall Study|Insufficient therapeutic responses|3
4805054|NCT01283971|16569018|P2|Overall Study|Adverse Event|5
4805055|NCT01283971|16569019|P1|Overall Study|Adverse Event|3
4805056|NCT01283581|16569066|P3|Overall Study|"Early termination"|1
4805057|NCT01283581|16569067|P2|Overall Study|"Early termination"|0
4805058|NCT01283581|16569068|P1|Overall Study|"Early termination"|0
4805059|NCT01283581|16569066|P3|Overall Study|Investigator unblinded|1
4805060|NCT01283581|16569067|P2|Overall Study|Investigator unblinded|0
4805061|NCT01283581|16569068|P1|Overall Study|Investigator unblinded|0
4805062|NCT01283581|16569066|P3|Overall Study|Noncompliance|0
4805063|NCT01283581|16569067|P2|Overall Study|Noncompliance|0
4805064|NCT01283581|16569068|P1|Overall Study|Noncompliance|1
4805065|NCT01283581|16569066|P3|Overall Study|Protocol Violation|2
4805066|NCT01283581|16569067|P2|Overall Study|Protocol Violation|1
4805067|NCT01283581|16569068|P1|Overall Study|Protocol Violation|0
4805068|NCT01283581|16569066|P3|Overall Study|Physician Decision|2
4805069|NCT01283581|16569067|P2|Overall Study|Physician Decision|1
4805070|NCT01283581|16569068|P1|Overall Study|Physician Decision|0
4805071|NCT01283581|16569066|P3|Overall Study|Adverse Event|4
4805072|NCT01283581|16569067|P2|Overall Study|Adverse Event|1
4805073|NCT01283581|16569068|P1|Overall Study|Adverse Event|1
4805074|NCT01283581|16569066|P3|Overall Study|Withdrawal by Subject|2
4805075|NCT01283581|16569067|P2|Overall Study|Withdrawal by Subject|5
4805076|NCT01283581|16569068|P1|Overall Study|Withdrawal by Subject|2
4805077|NCT01283581|16569066|P3|Overall Study|Lost to Follow-up|8
4805078|NCT01283581|16569067|P2|Overall Study|Lost to Follow-up|6
4805079|NCT01283581|16569068|P1|Overall Study|Lost to Follow-up|8
4805080|NCT01283542|16569138|P1|Extension Phase|Administrative problems|1
4805081|NCT01283542|16569138|P1|Extension Phase|Adverse Event|1
4805082|NCT01283542|16569138|P1|Extension Phase|Physician Decision|1
4805083|NCT01283542|16569138|P1|Main Phase|abnormal laboratory values|5
4805084|NCT01283542|16569138|P1|Main Phase|Uncontrolled diabetes mellitus|1
4805085|NCT01283542|16569138|P1|Main Phase|Acute or progressive vision loss|1
4805086|NCT01283516|16569203|P9|Overall Study|Lost to Follow-up|1
4805087|NCT01283516|16569204|P8|Overall Study|Lost to Follow-up|0
4805088|NCT01283516|16569205|P7|Overall Study|Lost to Follow-up|0
4805089|NCT01283516|16569206|P6|Overall Study|Lost to Follow-up|0
4805090|NCT01283516|16569207|P5|Overall Study|Lost to Follow-up|0
4805091|NCT01283516|16569208|P4|Overall Study|Lost to Follow-up|0
4805092|NCT01283516|16569209|P3|Overall Study|Lost to Follow-up|0
4805093|NCT01283516|16569210|P2|Overall Study|Lost to Follow-up|0
4805094|NCT01283516|16569211|P1|Overall Study|Lost to Follow-up|0
4805095|NCT01283516|16569203|P9|Overall Study|Administrative problems|39
4805096|NCT01283516|16569204|P8|Overall Study|Administrative problems|1
4805097|NCT01283516|16569205|P7|Overall Study|Administrative problems|1
4805098|NCT01283516|16569206|P6|Overall Study|Administrative problems|1
4805099|NCT01283516|16569207|P5|Overall Study|Administrative problems|0
4805100|NCT01283516|16569208|P4|Overall Study|Administrative problems|0
4805101|NCT01283516|16569209|P3|Overall Study|Administrative problems|0
4805102|NCT01283516|16569210|P2|Overall Study|Administrative problems|0
4805103|NCT01283516|16569211|P1|Overall Study|Administrative problems|0
4805104|NCT01283516|16569203|P9|Overall Study|Withdrawal by Subject|36
4805105|NCT01283516|16569204|P8|Overall Study|Withdrawal by Subject|0
4805106|NCT01283516|16569205|P7|Overall Study|Withdrawal by Subject|1
4805107|NCT01283516|16569206|P6|Overall Study|Withdrawal by Subject|0
4805108|NCT01283516|16569207|P5|Overall Study|Withdrawal by Subject|1
4805109|NCT01283516|16569208|P4|Overall Study|Withdrawal by Subject|0
4805110|NCT01283516|16569209|P3|Overall Study|Withdrawal by Subject|0
4805111|NCT01283516|16569210|P2|Overall Study|Withdrawal by Subject|0
4805112|NCT01283516|16569211|P1|Overall Study|Withdrawal by Subject|0
4805113|NCT01283516|16569203|P9|Overall Study|Disease Progression|139
4805114|NCT01283516|16569204|P8|Overall Study|Disease Progression|3
4805115|NCT01283516|16569205|P7|Overall Study|Disease Progression|6
4805116|NCT01283516|16569206|P6|Overall Study|Disease Progression|8
4805117|NCT01283516|16569207|P5|Overall Study|Disease Progression|13
4805118|NCT01283516|16569208|P4|Overall Study|Disease Progression|3
4805119|NCT01283516|16569209|P3|Overall Study|Disease Progression|3
4805120|NCT01283516|16569210|P2|Overall Study|Disease Progression|2
4805121|NCT01283516|16569211|P1|Overall Study|Disease Progression|2
4805122|NCT01283516|16569203|P9|Overall Study|Death|12
4805123|NCT01283516|16569204|P8|Overall Study|Death|1
4805124|NCT01283516|16569205|P7|Overall Study|Death|0
4805125|NCT01283516|16569206|P6|Overall Study|Death|1
4805126|NCT01283516|16569207|P5|Overall Study|Death|0
4805127|NCT01283516|16569208|P4|Overall Study|Death|0
4805128|NCT01283516|16569209|P3|Overall Study|Death|0
4805129|NCT01283516|16569210|P2|Overall Study|Death|0
4805130|NCT01283516|16569211|P1|Overall Study|Death|0
4805131|NCT01283516|16569203|P9|Overall Study|Adverse Event|28
4805132|NCT01283516|16569204|P8|Overall Study|Adverse Event|0
4805133|NCT01283516|16569205|P7|Overall Study|Adverse Event|2
4805134|NCT01283516|16569206|P6|Overall Study|Adverse Event|0
4805135|NCT01283516|16569207|P5|Overall Study|Adverse Event|0
4805136|NCT01283516|16569208|P4|Overall Study|Adverse Event|0
4805137|NCT01283516|16569209|P3|Overall Study|Adverse Event|0
4805138|NCT01283516|16569210|P2|Overall Study|Adverse Event|0
4805139|NCT01283516|16569211|P1|Overall Study|Adverse Event|0
4805140|NCT01283464|16569333|P2|Overall Study|Physician Decision|0
4805141|NCT01283464|16569334|P1|Overall Study|Physician Decision|1
4805142|NCT01283464|16569333|P2|Overall Study|Withdrawal by Subject|0
4805143|NCT01283464|16569334|P1|Overall Study|Withdrawal by Subject|1
4805144|NCT01283464|16569333|P2|Overall Study|Lost to Follow-up|1
4805145|NCT01283464|16569334|P1|Overall Study|Lost to Follow-up|0
4805146|NCT01283386|16569342|P2|Overall Study|Protocol Violation|1
4805147|NCT01283386|16569343|P1|Overall Study|Protocol Violation|0
4805148|NCT01283386|16569342|P2|Overall Study|Reason not specified|0
4805149|NCT01283386|16569343|P1|Overall Study|Reason not specified|1
4805150|NCT01283386|16569342|P2|Overall Study|Progression of underlying disease|7
4805151|NCT01283386|16569343|P1|Overall Study|Progression of underlying disease|2
4805152|NCT01283386|16569342|P2|Overall Study|Relapse of underlying disease|3
4805153|NCT01283386|16569343|P1|Overall Study|Relapse of underlying disease|1
4805154|NCT01283386|16569342|P2|Overall Study|Withdrawal by Subject|1
4805155|NCT01283386|16569343|P1|Overall Study|Withdrawal by Subject|2
4805156|NCT01283386|16569342|P2|Overall Study|Death|0
4805157|NCT01283386|16569343|P1|Overall Study|Death|2
4805158|NCT01283334|16569367|P1|Overall Study|Physician Decision|1
4805159|NCT01283334|16569367|P1|Overall Study|Adverse Event|4
4805160|NCT01283334|16569367|P1|Overall Study|Inability to Swallow Everolimus Pills|1
4805161|NCT01283334|16569367|P1|Overall Study|Withdrawal by Subject|1
4805162|NCT01283282|16569390|P2|First Intervention (6 Weeks)|Lost to Follow-up|0
4805163|NCT01283282|16569391|P1|First Intervention (6 Weeks)|Lost to Follow-up|1
4805164|NCT01283282|16569390|P2|First Intervention (6 Weeks)|Withdrawal by Subject|3
4805165|NCT01283282|16569391|P1|First Intervention (6 Weeks)|Withdrawal by Subject|2
4805166|NCT01283282|16569390|P2|First Intervention (6 Weeks)|Physician Decision|1
4805167|NCT01283282|16569391|P1|First Intervention (6 Weeks)|Physician Decision|0
4805168|NCT01283152|16569411|P2|Overall Study|Refused HESA|0
4805169|NCT01283152|16569412|P1|Overall Study|Refused HESA|1
4805170|NCT01283152|16569411|P2|Overall Study|Discharged prior to 24 hr assessment|0
4805171|NCT01283152|16569412|P1|Overall Study|Discharged prior to 24 hr assessment|1
4805172|NCT01283139|16569426|P4|Overall Study|Participant randomized in error|0
4805173|NCT01283139|16569427|P3|Overall Study|Participant randomized in error|1
4805174|NCT01283139|16569428|P2|Overall Study|Participant randomized in error|0
4805175|NCT01283139|16569429|P1|Overall Study|Participant randomized in error|0
4805176|NCT01283139|16569426|P4|Overall Study|Missed follow-up visit|2
4805177|NCT01283139|16569427|P3|Overall Study|Missed follow-up visit|2
4805178|NCT01283139|16569428|P2|Overall Study|Missed follow-up visit|1
4805179|NCT01283139|16569429|P1|Overall Study|Missed follow-up visit|0
4805180|NCT01283139|16569426|P4|Overall Study|Pregnancy|0
4805181|NCT01283139|16569427|P3|Overall Study|Pregnancy|1
4805182|NCT01283139|16569428|P2|Overall Study|Pregnancy|1
4805183|NCT01283139|16569429|P1|Overall Study|Pregnancy|0
4805184|NCT01283139|16569426|P4|Overall Study|Participant's refusal to continue|1
4805185|NCT01283139|16569427|P3|Overall Study|Participant's refusal to continue|1
4805186|NCT01283139|16569428|P2|Overall Study|Participant's refusal to continue|3
4805187|NCT01283139|16569429|P1|Overall Study|Participant's refusal to continue|0
4805188|NCT01283139|16569426|P4|Overall Study|Early termination due to AE/SAE|0
4805189|NCT01283139|16569427|P3|Overall Study|Early termination due to AE/SAE|0
4805190|NCT01283139|16569428|P2|Overall Study|Early termination due to AE/SAE|1
4805191|NCT01283139|16569429|P1|Overall Study|Early termination due to AE/SAE|1
4805192|NCT01283139|16569426|P4|Overall Study|Lack of Efficacy|1
4805193|NCT01283139|16569427|P3|Overall Study|Lack of Efficacy|2
4805194|NCT01283139|16569428|P2|Overall Study|Lack of Efficacy|2
4805195|NCT01283139|16569429|P1|Overall Study|Lack of Efficacy|1
4805196|NCT01283139|16569426|P4|Overall Study|Death|2
4805197|NCT01283139|16569427|P3|Overall Study|Death|2
4805198|NCT01283139|16569428|P2|Overall Study|Death|0
4805199|NCT01283139|16569429|P1|Overall Study|Death|2
4805200|NCT01283139|16569426|P4|Overall Study|Withdrawal by Subject|8
4805201|NCT01283139|16569427|P3|Overall Study|Withdrawal by Subject|6
4805202|NCT01283139|16569428|P2|Overall Study|Withdrawal by Subject|8
4805203|NCT01283139|16569429|P1|Overall Study|Withdrawal by Subject|8
4805204|NCT01283139|16569426|P4|Overall Study|Lost to Follow-up|1
4805205|NCT01283139|16569427|P3|Overall Study|Lost to Follow-up|3
4805206|NCT01283139|16569428|P2|Overall Study|Lost to Follow-up|2
4805207|NCT01283139|16569429|P1|Overall Study|Lost to Follow-up|5
4805208|NCT01283035|16569471|P1|Overall Study|Subject later found ineligible|1
4805209|NCT01283009|16569488|P2|Overall Study|Patient Withdrawn by LAR/DPOA|4
4805210|NCT01283009|16569489|P1|Overall Study|Patient Withdrawn by LAR/DPOA|0
4805211|NCT01283009|16569488|P2|Overall Study|Lost to Follow-up|0
4805212|NCT01283009|16569489|P1|Overall Study|Lost to Follow-up|1
4805213|NCT01283009|16569488|P2|Overall Study|Physician Decision|1
4805214|NCT01283009|16569489|P1|Overall Study|Physician Decision|1
4805215|NCT01283009|16569488|P2|Overall Study|Withdrawal by Subject|8
4805216|NCT01283009|16569489|P1|Overall Study|Withdrawal by Subject|10
4805217|NCT01283009|16569488|P2|Overall Study|Study ended early|26
4805218|NCT01283009|16569489|P1|Overall Study|Study ended early|23
4805219|NCT01283009|16569488|P2|Overall Study|Death|78
4805220|NCT01283009|16569489|P1|Overall Study|Death|83
4805221|NCT01282866|16569495|P1|Overall Study|Adverse Event|1
4805222|NCT01282814|16569503|P2|Washout of 7 Days|Withdrawal by Subject|0
4805223|NCT01282814|16569504|P1|Washout of 7 Days|Withdrawal by Subject|2
4805224|NCT01282814|16569503|P2|First Intervention|Emesis During Dosing Interval|3
4805225|NCT01282814|16569504|P1|First Intervention|Emesis During Dosing Interval|0
4805226|NCT01282801|16569516|P2|Second Intervention|Emesis During Critical Breakfast|1
4805227|NCT01282801|16569517|P1|Second Intervention|Emesis During Critical Breakfast|0
4805228|NCT01282476|16569541|P1|Overall Study|Death|11
4805229|NCT01282463|16569550|P3|Overall Study|Physician Decision|0
4805230|NCT01282463|16569551|P2|Overall Study|Physician Decision|0
4805231|NCT01282463|16569552|P1|Overall Study|Physician Decision|1
4805232|NCT01282463|16569550|P3|Overall Study|Protocol Violation|1
4805233|NCT01282463|16569551|P2|Overall Study|Protocol Violation|0
4805234|NCT01282463|16569552|P1|Overall Study|Protocol Violation|0
4805235|NCT01282463|16569550|P3|Overall Study|"Never Treated PD"|0
4805236|NCT01282463|16569551|P2|Overall Study|"Never Treated PD"|1
4805237|NCT01282463|16569552|P1|Overall Study|"Never Treated PD"|0
4805238|NCT01282463|16569550|P3|Overall Study|"Never Treated Death"|0
4805239|NCT01282463|16569551|P2|Overall Study|"Never Treated Death"|1
4805240|NCT01282463|16569552|P1|Overall Study|"Never Treated Death"|0
4805241|NCT01282463|16569550|P3|Overall Study|Withdrawal by Subject|3
4805242|NCT01282463|16569551|P2|Overall Study|Withdrawal by Subject|2
4805243|NCT01282463|16569552|P1|Overall Study|Withdrawal by Subject|6
4805244|NCT01282463|16569550|P3|Overall Study|Lost to Follow-up|0
4805245|NCT01282463|16569551|P2|Overall Study|Lost to Follow-up|0
4805246|NCT01282463|16569552|P1|Overall Study|Lost to Follow-up|1
4805247|NCT01282424|16569590|P1|Long-term Follow-up Period (5 Years)|Other (Unknown)|21
4805248|NCT01282424|16569590|P1|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1
4805249|NCT01282424|16569590|P1|Long-term Follow-up Period (5 Years)|Death|40
4805250|NCT01282424|16569590|P1|Long-term Follow-up Period (5 Years)|Withdrew Consent|2
4805251|NCT01282424|16569590|P1|Treatment Period (TP) (81 Months)|Other (Unknown)|3
4805252|NCT01282424|16569590|P1|Treatment Period (TP) (81 Months)|Investigator Request|7
4805253|NCT01282424|16569590|P1|Treatment Period (TP) (81 Months)|Withdrew Consent|6
4805254|NCT01282424|16569590|P1|Treatment Period (TP) (81 Months)|Adverse Event|30
4805255|NCT01282372|16569607|P1|Overall Study|Adverse Event|12
4805256|NCT01282372|16569607|P1|Overall Study|Refer Pre-Assignment Detail for Reason 2|1
4805257|NCT01282372|16569607|P1|Overall Study|Presence of AE, Regression of Symptoms|1
4805258|NCT01282372|16569607|P1|Overall Study|Presence of AE, Lack of Efficacy|1
4805259|NCT01282372|16569607|P1|Overall Study|Death|1
4805260|NCT01282372|16569607|P1|Overall Study|Refer Pre-Assignment Detail for Reason 1|4
4805261|NCT01282372|16569607|P1|Overall Study|Withdrawal by Subject|11
4805262|NCT01282372|16569607|P1|Overall Study|Lost to Follow-up|23
4805263|NCT01282372|16569607|P1|Overall Study|Lack of Efficacy / Exacerbation|25
4805264|NCT01282294|16569635|P1|Overall Study|Physician Decision|1
4805265|NCT01282294|16569635|P1|Overall Study|Patient non-compliance|2
4805266|NCT01282294|16569635|P1|Overall Study|Adverse Event|1
4805267|NCT01282294|16569635|P1|Overall Study|Screening failure|1
4805268|NCT01282294|16569635|P1|Overall Study|Lost to Follow-up|14
4805269|NCT01282229|16569664|P1|Overall Study|Protocol Violation|2
4805270|NCT01282216|16569696|P4|Overall Study|Death|0
4805271|NCT01282216|16569697|P3|Overall Study|Death|2
4805272|NCT01282216|16569698|P2|Overall Study|Death|0
4805273|NCT01282216|16569699|P1|Overall Study|Death|0
4805274|NCT01282216|16569696|P4|Overall Study|Relapse|6
4805275|NCT01282216|16569697|P3|Overall Study|Relapse|17
4805276|NCT01282216|16569698|P2|Overall Study|Relapse|0
4805277|NCT01282216|16569699|P1|Overall Study|Relapse|0
4805278|NCT01282216|16569696|P4|Overall Study|Physician Decision|0
4805279|NCT01282216|16569697|P3|Overall Study|Physician Decision|11
4805280|NCT01282216|16569698|P2|Overall Study|Physician Decision|0
4805281|NCT01282216|16569699|P1|Overall Study|Physician Decision|0
4805282|NCT01282216|16569696|P4|Overall Study|Graft failure|2
4805283|NCT01282216|16569697|P3|Overall Study|Graft failure|3
4805284|NCT01282216|16569698|P2|Overall Study|Graft failure|0
4805285|NCT01282216|16569699|P1|Overall Study|Graft failure|0
4805286|NCT01282203|16569709|P1|Overall Study|Adverse Event|1
4805287|NCT01282164|16569731|P2|Overall Study|Lack of hypoglycemia during ITT|0
4805288|NCT01282164|16569732|P1|Overall Study|Lack of hypoglycemia during ITT|1
4805289|NCT01281969|16569785|P3|Overall Study|not randomized, child consent not given|2
4805290|NCT01281969|16569786|P2|Overall Study|not randomized, child consent not given|0
4805291|NCT01281969|16569787|P1|Overall Study|not randomized, child consent not given|0
4805292|NCT01281969|16569785|P3|Overall Study|AE during LP prior to IVIG admin|3
4805293|NCT01281969|16569786|P2|Overall Study|AE during LP prior to IVIG admin|0
4805294|NCT01281969|16569787|P1|Overall Study|AE during LP prior to IVIG admin|1
4805295|NCT01281969|16569785|P3|Overall Study|not randomized didn't meet criteria|7
4805296|NCT01281969|16569786|P2|Overall Study|not randomized didn't meet criteria|0
4805297|NCT01281969|16569787|P1|Overall Study|not randomized didn't meet criteria|0
4805298|NCT01281956|16569799|P2|2nd Intervention (3 Months)|Withdrawal by Subject|0
4805299|NCT01281956|16569800|P1|2nd Intervention (3 Months)|Withdrawal by Subject|1
4805300|NCT01281917|16569831|P1|Overall Study|Withdrawal by Subject|1
4805301|NCT01281865|16569843|P2|Overall Study|Lack of Efficacy|0
4805302|NCT01281865|16569844|P1|Overall Study|Lack of Efficacy|1
4805303|NCT01281865|16569843|P2|Overall Study|Withdrawal by Subject|0
4805304|NCT01281865|16569844|P1|Overall Study|Withdrawal by Subject|1
4805305|NCT01281865|16569843|P2|Overall Study|Adverse Event|1
4805306|NCT01281865|16569844|P1|Overall Study|Adverse Event|1
4805307|NCT01281839|16569852|P2|Overall Study|Reason not specified|1
4805308|NCT01281839|16569853|P1|Overall Study|Reason not specified|0
4805309|NCT01281839|16569852|P2|Overall Study|Withdrawal by Subject|10
4805310|NCT01281839|16569853|P1|Overall Study|Withdrawal by Subject|4
4805311|NCT01281839|16569852|P2|Overall Study|Lost to Follow-up|3
4805312|NCT01281839|16569853|P1|Overall Study|Lost to Follow-up|6
4805313|NCT01281644|16569914|P1|Overall Study|Withdrawal by Subject|2
4805314|NCT01281644|16569914|P1|Overall Study|Lost to Follow-up|3
4805315|NCT01281306|16569955|P7|Overall Study|Randomized in error|0
4805316|NCT01281306|16569956|P6|Overall Study|Randomized in error|0
4805317|NCT01281306|16569957|P5|Overall Study|Randomized in error|0
4805318|NCT01281306|16569958|P4|Overall Study|Randomized in error|1
4805319|NCT01281306|16569959|P3|Overall Study|Randomized in error|0
4805320|NCT01281306|16569960|P2|Overall Study|Randomized in error|0
4805321|NCT01281306|16569961|P1|Overall Study|Randomized in error|1
4805322|NCT01281306|16569955|P7|Overall Study|Adverse Event|3
4805323|NCT01281306|16569956|P6|Overall Study|Adverse Event|3
4805324|NCT01281306|16569957|P5|Overall Study|Adverse Event|5
4805325|NCT01281306|16569958|P4|Overall Study|Adverse Event|3
4805326|NCT01281306|16569959|P3|Overall Study|Adverse Event|2
4805327|NCT01281306|16569960|P2|Overall Study|Adverse Event|2
4805328|NCT01281306|16569961|P1|Overall Study|Adverse Event|3
4805329|NCT01281306|16569955|P7|Overall Study|Death|0
4805330|NCT01281306|16569956|P6|Overall Study|Death|0
4805331|NCT01281306|16569957|P5|Overall Study|Death|0
4805332|NCT01281306|16569958|P4|Overall Study|Death|0
4805333|NCT01281306|16569959|P3|Overall Study|Death|0
4805334|NCT01281306|16569960|P2|Overall Study|Death|0
4805335|NCT01281306|16569961|P1|Overall Study|Death|1
4805336|NCT01281306|16569955|P7|Overall Study|Lost to Follow-up|1
4805337|NCT01281306|16569956|P6|Overall Study|Lost to Follow-up|0
4805338|NCT01281306|16569957|P5|Overall Study|Lost to Follow-up|0
4805339|NCT01281306|16569958|P4|Overall Study|Lost to Follow-up|2
4805340|NCT01281306|16569959|P3|Overall Study|Lost to Follow-up|0
4805341|NCT01281306|16569960|P2|Overall Study|Lost to Follow-up|0
4805342|NCT01281306|16569961|P1|Overall Study|Lost to Follow-up|1
4805343|NCT01281306|16569955|P7|Overall Study|Condition no longer requires study drug|1
4805344|NCT01281306|16569956|P6|Overall Study|Condition no longer requires study drug|1
4805345|NCT01281306|16569957|P5|Overall Study|Condition no longer requires study drug|0
4805346|NCT01281306|16569958|P4|Overall Study|Condition no longer requires study drug|0
4805347|NCT01281306|16569959|P3|Overall Study|Condition no longer requires study drug|0
4805348|NCT01281306|16569960|P2|Overall Study|Condition no longer requires study drug|0
4805349|NCT01281306|16569961|P1|Overall Study|Condition no longer requires study drug|1
4805350|NCT01281306|16569955|P7|Overall Study|Protocol deviation|0
4805351|NCT01281306|16569956|P6|Overall Study|Protocol deviation|0
4805352|NCT01281306|16569957|P5|Overall Study|Protocol deviation|1
4805353|NCT01281306|16569958|P4|Overall Study|Protocol deviation|1
4805354|NCT01281306|16569959|P3|Overall Study|Protocol deviation|1
4805355|NCT01281306|16569960|P2|Overall Study|Protocol deviation|1
4805356|NCT01281306|16569961|P1|Overall Study|Protocol deviation|0
4805357|NCT01281306|16569955|P7|Overall Study|Withdrawal by Subject|1
4805358|NCT01281306|16569956|P6|Overall Study|Withdrawal by Subject|3
4805359|NCT01281306|16569957|P5|Overall Study|Withdrawal by Subject|1
4805360|NCT01281306|16569958|P4|Overall Study|Withdrawal by Subject|4
4805361|NCT01281306|16569959|P3|Overall Study|Withdrawal by Subject|2
4805362|NCT01281306|16569960|P2|Overall Study|Withdrawal by Subject|0
4805363|NCT01281306|16569961|P1|Overall Study|Withdrawal by Subject|1
4805364|NCT01281306|16569955|P7|Overall Study|Lack of Efficacy|1
4805365|NCT01281306|16569956|P6|Overall Study|Lack of Efficacy|0
4805366|NCT01281306|16569957|P5|Overall Study|Lack of Efficacy|2
4805367|NCT01281306|16569958|P4|Overall Study|Lack of Efficacy|0
4805368|NCT01281306|16569959|P3|Overall Study|Lack of Efficacy|3
4805369|NCT01281306|16569960|P2|Overall Study|Lack of Efficacy|1
4805370|NCT01281306|16569961|P1|Overall Study|Lack of Efficacy|0
4805371|NCT01281202|16570077|P2|Overall Study|Incarceration|3
4805372|NCT01281202|16570078|P1|Overall Study|Incarceration|0
4805373|NCT01281202|16570077|P2|Overall Study|Lost to Follow-up|13
4805374|NCT01281202|16570078|P1|Overall Study|Lost to Follow-up|11
4805375|NCT01281202|16570077|P2|Overall Study|Administrative|8
4805376|NCT01281202|16570078|P1|Overall Study|Administrative|2
4805377|NCT01281202|16570077|P2|Overall Study|Protocol Violation|10
4805378|NCT01281202|16570078|P1|Overall Study|Protocol Violation|11
4805379|NCT01281202|16570077|P2|Overall Study|Withdrawal by Subject|2
4805380|NCT01281202|16570078|P1|Overall Study|Withdrawal by Subject|2
4805381|NCT01281202|16570077|P2|Overall Study|Adverse Event|0
4805382|NCT01281202|16570078|P1|Overall Study|Adverse Event|2
4805383|NCT01281124|16570086|P1|Overall Study|Death|1
4805384|NCT01280981|16570101|P1|Overall Study|Study site closure|1
4805385|NCT01280981|16570101|P1|Overall Study|Elective surgery|2
4805386|NCT01280981|16570101|P1|Overall Study|Withdrawal of consent|3
4805387|NCT01280981|16570101|P1|Overall Study|Non-compliance with protocol|3
4805388|NCT01280981|16570101|P1|Overall Study|Failed to return|45
4805389|NCT01280981|16570101|P1|Overall Study|Irregular or discontinued menses|3
4805390|NCT01280981|16570101|P1|Overall Study|Adverse Event|6
4805391|NCT01280981|16570101|P1|Overall Study|Lost to Follow-up|3
4805392|NCT01280981|16570101|P1|Overall Study|Lack of Efficacy|13
4805393|NCT01280981|16570101|P1|Overall Study|Protocol Violation|2
4805394|NCT01280981|16570101|P1|Overall Study|Withdrawal by Subject|11
4805395|NCT01280968|16570112|P2|Overall Study|Unable to Smoke in Supine Position|0
4805396|NCT01280968|16570113|P1|Overall Study|Unable to Smoke in Supine Position|1
4805397|NCT01280968|16570112|P2|Overall Study|Pre-existing Neurological Condition|0
4805398|NCT01280968|16570113|P1|Overall Study|Pre-existing Neurological Condition|1
4805399|NCT01280968|16570112|P2|Overall Study|Scheduling Conflicts|1
4805400|NCT01280968|16570113|P1|Overall Study|Scheduling Conflicts|1
4805401|NCT01280968|16570112|P2|Overall Study|Adverse Event|0
4805402|NCT01280968|16570113|P1|Overall Study|Adverse Event|1
4805403|NCT01280968|16570112|P2|Overall Study|Anxiety|0
4805404|NCT01280968|16570113|P1|Overall Study|Anxiety|2
4805405|NCT01280968|16570112|P2|Overall Study|Commuting Problems|0
4805406|NCT01280968|16570113|P1|Overall Study|Commuting Problems|2
4805407|NCT01280968|16570112|P2|Overall Study|Unable to Follow Experimental Protocol|0
4805408|NCT01280968|16570113|P1|Overall Study|Unable to Follow Experimental Protocol|2
4805409|NCT01280968|16570112|P2|Overall Study|Lost to Follow-up|2
4805410|NCT01280968|16570113|P1|Overall Study|Lost to Follow-up|8
4805411|NCT01280955|16570129|P1|Overall Study|Withdrawal by Subject|1
4805412|NCT01280955|16570129|P1|Overall Study|Death|2
4805413|NCT01280903|16570173|P2|Overall Study|Lost to Follow-up|16
4805414|NCT01280903|16570174|P1|Overall Study|Lost to Follow-up|23
4805415|NCT01280812|16570241|P3|Overall Study|Lost to Follow-up|1
4805416|NCT01280812|16570242|P2|Overall Study|Lost to Follow-up|1
4805417|NCT01280812|16570243|P1|Overall Study|Lost to Follow-up|1
4805418|NCT01280812|16570241|P3|Overall Study|Withdrawal by Subject|0
4805419|NCT01280812|16570242|P2|Overall Study|Withdrawal by Subject|1
4805420|NCT01280812|16570243|P1|Overall Study|Withdrawal by Subject|2
4805421|NCT01280721|16570266|P1|Overall Study|No tolerability for the lowest dose|2
4805422|NCT01280721|16570266|P1|Overall Study|eGFR under the withdrawal criteria|7
4805423|NCT01280721|16570266|P1|Overall Study|Withdrawal by Subject|6
4805424|NCT01280721|16570266|P1|Overall Study|Physician Decision|3
4805425|NCT01280721|16570266|P1|Overall Study|Adverse Event|4
4805426|NCT01280656|16570330|P3|Overall Study|Other|7
4805427|NCT01280656|16570331|P2|Overall Study|Other|7
4805428|NCT01280656|16570332|P1|Overall Study|Other|1
4805429|NCT01280656|16570330|P3|Overall Study|Treatment shortening (RGT)|5
4805430|NCT01280656|16570331|P2|Overall Study|Treatment shortening (RGT)|4
4805431|NCT01280656|16570332|P1|Overall Study|Treatment shortening (RGT)|0
4805432|NCT01280656|16570330|P3|Overall Study|Lack of Efficacy|38
4805433|NCT01280656|16570331|P2|Overall Study|Lack of Efficacy|22
4805434|NCT01280656|16570332|P1|Overall Study|Lack of Efficacy|1
4805435|NCT01280656|16570330|P3|Overall Study|Adverse Event|13
4805436|NCT01280656|16570331|P2|Overall Study|Adverse Event|14
4805437|NCT01280656|16570332|P1|Overall Study|Adverse Event|1
4805438|NCT01280591|16570399|P4|Overall Study|Does not meet exclusion #27 criteria|1
4805439|NCT01280591|16570400|P3|Overall Study|Does not meet exclusion #27 criteria|0
4805440|NCT01280591|16570401|P2|Overall Study|Does not meet exclusion #27 criteria|0
4805441|NCT01280591|16570402|P1|Overall Study|Does not meet exclusion #27 criteria|0
4805442|NCT01280591|16570399|P4|Overall Study|Withdrawal by Subject|2
4805443|NCT01280591|16570400|P3|Overall Study|Withdrawal by Subject|0
4805444|NCT01280591|16570401|P2|Overall Study|Withdrawal by Subject|0
4805445|NCT01280591|16570402|P1|Overall Study|Withdrawal by Subject|0
4805446|NCT01280357|16570540|P1|Overall Study|IInsufficient data/No data supplied|12
4805447|NCT01280357|16570540|P1|Overall Study|Excluded no internal monitoring|14
4805448|NCT01280266|16570549|P2|First Intervention (Week 1-4)|Withdrawal by Subject|2
4805449|NCT01280266|16570550|P1|First Intervention (Week 1-4)|Withdrawal by Subject|0
4805450|NCT01280266|16570549|P2|First Intervention (Week 1-4)|Adverse Event|0
4805451|NCT01280266|16570550|P1|First Intervention (Week 1-4)|Adverse Event|1
4805452|NCT01279954|16570641|P2|Overall Study|Lack of Efficacy|4
4805453|NCT01279954|16570642|P1|Overall Study|Lack of Efficacy|3
4805454|NCT01279850|16570653|P1|Overall Study|No Visit After Treatment|34
4805455|NCT01279850|16570653|P1|Overall Study|No Drug Administration Information|7
4805456|NCT01279850|16570653|P1|Overall Study|Protocol Violation|50
4805457|NCT01279681|16570669|P2|Overall Study|Other Reason|2
4805458|NCT01279681|16570670|P1|Overall Study|Other Reason|0
4805459|NCT01279681|16570669|P2|Overall Study|Physician Decision|0
4805460|NCT01279681|16570670|P1|Overall Study|Physician Decision|1
4805461|NCT01279681|16570669|P2|Overall Study|Withdrawal Prior to Beginning Treatment|1
4805462|NCT01279681|16570670|P1|Overall Study|Withdrawal Prior to Beginning Treatment|0
4805463|NCT01279681|16570669|P2|Overall Study|Death|1
4805464|NCT01279681|16570670|P1|Overall Study|Death|0
4805465|NCT01279681|16570669|P2|Overall Study|Adverse Event|3
4805466|NCT01279681|16570670|P1|Overall Study|Adverse Event|2
4805467|NCT01279681|16570669|P2|Overall Study|Withdrawal by Subject|4
4805468|NCT01279681|16570670|P1|Overall Study|Withdrawal by Subject|3
4805469|NCT01279681|16570669|P2|Overall Study|Disease Progression|6
4805470|NCT01279681|16570670|P1|Overall Study|Disease Progression|9
4805471|NCT01279616|16570682|P1|Overall Study|no signs of sickle cell disease|2
4805472|NCT01279616|16570682|P1|Overall Study|donor could not be located|5
4805473|NCT01279486|16570695|P1|Overall Study|Lost to Follow-up|1
4805474|NCT01279447|16570701|P2|Overall Study|Lost to Follow-up|1
4805475|NCT01279447|16570702|P1|Overall Study|Lost to Follow-up|3
4805476|NCT01279343|16570710|P2|Overall Study|Did not receive treatment|6
4805477|NCT01279343|16570711|P1|Overall Study|Did not receive treatment|2
4805478|NCT01279200|16570756|P2|Overall Study|Adverse Event|0
4805479|NCT01279200|16570757|P1|Overall Study|Adverse Event|1
4805480|NCT01279200|16570756|P2|Overall Study|Lost to Follow-up|1
4805481|NCT01279200|16570757|P1|Overall Study|Lost to Follow-up|0
4805482|NCT01279200|16570756|P2|Overall Study|ultrasound screening failure|1
4805483|NCT01279200|16570757|P1|Overall Study|ultrasound screening failure|0
4805484|NCT01279200|16570756|P2|Overall Study|Inconvenience of ultrasound visit|1
4805485|NCT01279200|16570757|P1|Overall Study|Inconvenience of ultrasound visit|0
4805486|NCT01279200|16570756|P2|Overall Study|Patient withdrawal due to high cost|1
4805487|NCT01279200|16570757|P1|Overall Study|Patient withdrawal due to high cost|0
4805488|NCT01279200|16570756|P2|Overall Study|Withdrawal by Subject|3
4805489|NCT01279200|16570757|P1|Overall Study|Withdrawal by Subject|1
4805490|NCT01279070|16570795|P2|Overall Study|Acute exacerbation|1
4805491|NCT01279070|16570796|P1|Overall Study|Acute exacerbation|3
4805492|NCT01279070|16570795|P2|Overall Study|Withdrawal by Subject|3
4805493|NCT01279070|16570796|P1|Overall Study|Withdrawal by Subject|2
4805494|NCT01279044|16570815|P3|PHASE 2 - Randmonized Controlled Trial|Death|1
4805495|NCT01279044|16570816|P2|PHASE 2 - Randmonized Controlled Trial|Death|0
4805496|NCT01279044|16570817|P1|PHASE 2 - Randmonized Controlled Trial|Death|0
4805497|NCT01279044|16570815|P3|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
4805498|NCT01279044|16570816|P2|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8
4805499|NCT01279044|16570817|P1|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0
4805500|NCT01279044|16570815|P3|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2
4805501|NCT01279044|16570816|P2|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3
4805502|NCT01279044|16570817|P1|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0
4805503|NCT01278862|16570893|P2|Overall Study|Lost to Follow-up|1
4805504|NCT01278862|16570894|P1|Overall Study|Lost to Follow-up|1
4805505|NCT01278797|16570902|P2|Period 1|Protocol Violation|0
4805506|NCT01278797|16570903|P1|Period 1|Protocol Violation|1
4805507|NCT01278797|16570902|P2|Period 1|Adverse Event|1
4805508|NCT01278797|16570903|P1|Period 1|Adverse Event|0
4805509|NCT01278745|16570915|P4|Overall Study|Moves,enrollment in mx studies, et al.|1
4805510|NCT01278745|16570916|P3|Overall Study|Moves,enrollment in mx studies, et al.|5
4805511|NCT01278745|16570917|P2|Overall Study|Moves,enrollment in mx studies, et al.|0
4805512|NCT01278745|16570918|P1|Overall Study|Moves,enrollment in mx studies, et al.|0
4805513|NCT01278745|16570915|P4|Overall Study|Ineligible|61
4805514|NCT01278745|16570916|P3|Overall Study|Ineligible|42
4805515|NCT01278745|16570917|P2|Overall Study|Ineligible|0
4805516|NCT01278745|16570918|P1|Overall Study|Ineligible|0
4805517|NCT01278745|16570915|P4|Overall Study|Sponsor Decision|6
4805518|NCT01278745|16570916|P3|Overall Study|Sponsor Decision|62
4805519|NCT01278745|16570917|P2|Overall Study|Sponsor Decision|0
4805520|NCT01278745|16570918|P1|Overall Study|Sponsor Decision|1
4805521|NCT01278745|16570915|P4|Overall Study|Withdrawal by Subject|1
4805522|NCT01278745|16570916|P3|Overall Study|Withdrawal by Subject|5
4805523|NCT01278745|16570917|P2|Overall Study|Withdrawal by Subject|1
4805524|NCT01278745|16570918|P1|Overall Study|Withdrawal by Subject|1
4805525|NCT01278745|16570915|P4|Overall Study|Physician Decision|9
4805526|NCT01278745|16570916|P3|Overall Study|Physician Decision|0
4805527|NCT01278745|16570917|P2|Overall Study|Physician Decision|0
4805528|NCT01278745|16570918|P1|Overall Study|Physician Decision|1
4805529|NCT01278745|16570915|P4|Overall Study|Death|0
4805530|NCT01278745|16570916|P3|Overall Study|Death|7
4805531|NCT01278745|16570917|P2|Overall Study|Death|5
4805532|NCT01278745|16570918|P1|Overall Study|Death|2
4805533|NCT01278615|16570950|P1|Overall Study|Withdrawal by Subject|2
4805534|NCT01278407|16570976|P5|Extension Phase|Other|3
4805535|NCT01278407|16570977|P4|Extension Phase|Other|1
4805536|NCT01278407|16570978|P3|Extension Phase|Other|0
4805537|NCT01278407|16570979|P2|Extension Phase|Other|0
4805538|NCT01278407|16570980|P1|Extension Phase|Other|0
4805539|NCT01278407|16570976|P5|Extension Phase|Participant's Choice|11
4805540|NCT01278407|16570977|P4|Extension Phase|Participant's Choice|4
4805541|NCT01278407|16570978|P3|Extension Phase|Participant's Choice|0
4805542|NCT01278407|16570979|P2|Extension Phase|Participant's Choice|0
4805543|NCT01278407|16570980|P1|Extension Phase|Participant's Choice|0
4805544|NCT01278407|16570976|P5|Extension Phase|Adverse Event|16
4805545|NCT01278407|16570977|P4|Extension Phase|Adverse Event|7
4805546|NCT01278407|16570978|P3|Extension Phase|Adverse Event|0
4805547|NCT01278407|16570979|P2|Extension Phase|Adverse Event|0
4805548|NCT01278407|16570980|P1|Extension Phase|Adverse Event|0
4805549|NCT01278407|16570976|P5|Confirmatory Phase|Other|0
4805550|NCT01278407|16570977|P4|Confirmatory Phase|Other|0
4805551|NCT01278407|16570978|P3|Confirmatory Phase|Other|2
4805552|NCT01278407|16570979|P2|Confirmatory Phase|Other|1
4805553|NCT01278407|16570980|P1|Confirmatory Phase|Other|1
4805554|NCT01278407|16570976|P5|Confirmatory Phase|Participant's Choice|0
4805555|NCT01278407|16570977|P4|Confirmatory Phase|Participant's Choice|0
4805556|NCT01278407|16570978|P3|Confirmatory Phase|Participant's Choice|3
4805557|NCT01278407|16570979|P2|Confirmatory Phase|Participant's Choice|5
4805558|NCT01278407|16570980|P1|Confirmatory Phase|Participant's Choice|3
4805559|NCT01278407|16570976|P5|Confirmatory Phase|Adverse Event|0
4805560|NCT01278407|16570977|P4|Confirmatory Phase|Adverse Event|0
4805561|NCT01278407|16570978|P3|Confirmatory Phase|Adverse Event|1
4805562|NCT01278407|16570979|P2|Confirmatory Phase|Adverse Event|10
4805563|NCT01278407|16570980|P1|Confirmatory Phase|Adverse Event|5
4805564|NCT01278394|16570993|P1|Overall Study|Lost to Follow-up|1
4805565|NCT01278342|16571006|P3|Overall Study|Other|0
4805566|NCT01278342|16571007|P2|Overall Study|Other|0
4805567|NCT01278342|16571008|P1|Overall Study|Other|1
4805568|NCT01278342|16571006|P3|Overall Study|Administrative problems|0
4805569|NCT01278342|16571007|P2|Overall Study|Administrative problems|0
4805570|NCT01278342|16571008|P1|Overall Study|Administrative problems|2
4805571|NCT01278342|16571006|P3|Overall Study|Lost to Follow-up|0
4805572|NCT01278342|16571007|P2|Overall Study|Lost to Follow-up|0
4805573|NCT01278342|16571008|P1|Overall Study|Lost to Follow-up|1
4805574|NCT01278342|16571006|P3|Overall Study|Physician Decision|0
4805575|NCT01278342|16571007|P2|Overall Study|Physician Decision|1
4805576|NCT01278342|16571008|P1|Overall Study|Physician Decision|0
4805577|NCT01278173|16571028|P1|Overall Study|Withdrawal by Subject|1
4805578|NCT01278173|16571028|P1|Overall Study|Protocol Violation|1
4805579|NCT01278173|16571028|P1|Overall Study|Administrative or other reason|4
4805580|NCT01278173|16571028|P1|Overall Study|Adverse Event|8
4805581|NCT01278173|16571028|P1|Overall Study|Lack of Efficacy|13
4805582|NCT01278160|16571035|P2|Overall Study|Unclassified|2
4805583|NCT01278160|16571036|P1|Overall Study|Unclassified|1
4805584|NCT01278160|16571035|P2|Overall Study|Withdrawal by Subject|2
4805585|NCT01278160|16571036|P1|Overall Study|Withdrawal by Subject|3
4805586|NCT01278160|16571035|P2|Overall Study|Lost to Follow-up|1
4805587|NCT01278160|16571036|P1|Overall Study|Lost to Follow-up|0
4805588|NCT01278160|16571035|P2|Overall Study|Adverse Event|1
4805589|NCT01278160|16571036|P1|Overall Study|Adverse Event|1
4805590|NCT01278030|16571052|P2|Overall Study|Withdrawal by Subject|4
4805591|NCT01278030|16571053|P1|Overall Study|Withdrawal by Subject|8
4805592|NCT01277887|16571061|P2|Post-Quit Treatment Phase|No longer interested in treatment|5
4805593|NCT01277887|16571062|P1|Post-Quit Treatment Phase|No longer interested in treatment|3
4805594|NCT01277887|16571061|P2|Pre-Quit Treatment Phase|Withdrawal by Subject|0
4805595|NCT01277887|16571062|P1|Pre-Quit Treatment Phase|Withdrawal by Subject|2
4805596|NCT01277887|16571061|P2|Pre-Quit Treatment Phase|No longer interested in treatment|0
4805597|NCT01277887|16571062|P1|Pre-Quit Treatment Phase|No longer interested in treatment|1
4805598|NCT01277861|16571074|P2|Overall Study|Physician Decision|2
4805599|NCT01277861|16571075|P1|Overall Study|Physician Decision|2
4805600|NCT01277822|16571087|P2|Overall Study|Participant moved|0
4805601|NCT01277822|16571088|P1|Overall Study|Participant moved|1
4805602|NCT01277822|16571087|P2|Overall Study|Contraindicated medication used|1
4805603|NCT01277822|16571088|P1|Overall Study|Contraindicated medication used|2
4805604|NCT01277822|16571087|P2|Overall Study|Lost to Follow-up|1
4805605|NCT01277822|16571088|P1|Overall Study|Lost to Follow-up|2
4805606|NCT01277822|16571087|P2|Overall Study|Protocol Violation|0
4805607|NCT01277822|16571088|P1|Overall Study|Protocol Violation|1
4805608|NCT01277822|16571087|P2|Overall Study|Physician Decision|1
4805609|NCT01277822|16571088|P1|Overall Study|Physician Decision|1
4805610|NCT01277822|16571087|P2|Overall Study|Withdrawal by Subject|7
4805611|NCT01277822|16571088|P1|Overall Study|Withdrawal by Subject|6
4805612|NCT01277822|16571087|P2|Overall Study|Adverse Event|1
4805613|NCT01277822|16571088|P1|Overall Study|Adverse Event|2
4805614|NCT01277757|16571124|P1|Overall Study|Withdrawal by Subject|1
4805615|NCT01277757|16571124|P1|Overall Study|Disease Progression|1
4805616|NCT01277744|16571131|P1|Overall Study|Physician Decision|2
4805617|NCT01277718|16571136|P2|Period 2 - Second Intervention|Physician Decision|2
4805618|NCT01277718|16571137|P1|Period 2 - Second Intervention|Physician Decision|0
4805619|NCT01277718|16571136|P2|Period 2 - Second Intervention|Protocol Violation|1
4805620|NCT01277718|16571137|P1|Period 2 - Second Intervention|Protocol Violation|0
4805621|NCT01277666|16571151|P3|Overall Study|Death|1
4805622|NCT01277666|16571152|P2|Overall Study|Death|0
4805623|NCT01277666|16571153|P1|Overall Study|Death|0
4805624|NCT01277666|16571151|P3|Overall Study|Withdrawal by Subject|6
4805625|NCT01277666|16571152|P2|Overall Study|Withdrawal by Subject|8
4805626|NCT01277666|16571153|P1|Overall Study|Withdrawal by Subject|7
4805627|NCT01277666|16571151|P3|Overall Study|Lost to Follow-up|2
4805628|NCT01277666|16571152|P2|Overall Study|Lost to Follow-up|1
4805629|NCT01277666|16571153|P1|Overall Study|Lost to Follow-up|1
4805630|NCT01277666|16571151|P3|Overall Study|Protocol Defined Stopping criteria|6
4805631|NCT01277666|16571152|P2|Overall Study|Protocol Defined Stopping criteria|2
4805632|NCT01277666|16571153|P1|Overall Study|Protocol Defined Stopping criteria|1
4805633|NCT01277666|16571151|P3|Overall Study|Protocol Violation|2
4805634|NCT01277666|16571152|P2|Overall Study|Protocol Violation|3
4805635|NCT01277666|16571153|P1|Overall Study|Protocol Violation|2
4805636|NCT01277666|16571151|P3|Overall Study|Lack of Efficacy|12
4805637|NCT01277666|16571152|P2|Overall Study|Lack of Efficacy|20
4805638|NCT01277666|16571153|P1|Overall Study|Lack of Efficacy|8
4805639|NCT01277666|16571151|P3|Overall Study|Adverse Event|20
4805640|NCT01277666|16571152|P2|Overall Study|Adverse Event|25
4805641|NCT01277666|16571153|P1|Overall Study|Adverse Event|26
4805642|NCT01277601|16571186|P4|Overall Study|Subject Terminated from Study by Sponsor|2
4805643|NCT01277601|16571187|P3|Overall Study|Subject Terminated from Study by Sponsor|0
4805644|NCT01277601|16571188|P2|Overall Study|Subject Terminated from Study by Sponsor|1
4805645|NCT01277601|16571189|P1|Overall Study|Subject Terminated from Study by Sponsor|0
4805646|NCT01277601|16571186|P4|Overall Study|Protocol Violation|0
4805647|NCT01277601|16571187|P3|Overall Study|Protocol Violation|5
4805648|NCT01277601|16571188|P2|Overall Study|Protocol Violation|2
4805649|NCT01277601|16571189|P1|Overall Study|Protocol Violation|0
4805650|NCT01277601|16571186|P4|Overall Study|Subject Never Dosed with Study Drug|1
4805651|NCT01277601|16571187|P3|Overall Study|Subject Never Dosed with Study Drug|3
4805652|NCT01277601|16571188|P2|Overall Study|Subject Never Dosed with Study Drug|2
4805653|NCT01277601|16571189|P1|Overall Study|Subject Never Dosed with Study Drug|1
4805654|NCT01277601|16571186|P4|Overall Study|Noncompliance with Study Drug|0
4805655|NCT01277601|16571187|P3|Overall Study|Noncompliance with Study Drug|2
4805656|NCT01277601|16571188|P2|Overall Study|Noncompliance with Study Drug|3
4805657|NCT01277601|16571189|P1|Overall Study|Noncompliance with Study Drug|1
4805658|NCT01277601|16571186|P4|Overall Study|Pregnancy|1
4805659|NCT01277601|16571187|P3|Overall Study|Pregnancy|4
4805660|NCT01277601|16571188|P2|Overall Study|Pregnancy|2
4805661|NCT01277601|16571189|P1|Overall Study|Pregnancy|2
4805662|NCT01277601|16571186|P4|Overall Study|Physician Decision|6
4805663|NCT01277601|16571187|P3|Overall Study|Physician Decision|1
4805664|NCT01277601|16571188|P2|Overall Study|Physician Decision|5
4805665|NCT01277601|16571189|P1|Overall Study|Physician Decision|3
4805666|NCT01277601|16571186|P4|Overall Study|Lost to Follow-up|2
4805667|NCT01277601|16571187|P3|Overall Study|Lost to Follow-up|4
4805668|NCT01277601|16571188|P2|Overall Study|Lost to Follow-up|9
4805669|NCT01277601|16571189|P1|Overall Study|Lost to Follow-up|7
4805670|NCT01277601|16571186|P4|Overall Study|Withdrawal by Subject|17
4805671|NCT01277601|16571187|P3|Overall Study|Withdrawal by Subject|8
4805672|NCT01277601|16571188|P2|Overall Study|Withdrawal by Subject|21
4805673|NCT01277601|16571189|P1|Overall Study|Withdrawal by Subject|18
4805674|NCT01277601|16571186|P4|Overall Study|Adverse Event|7
4805675|NCT01277601|16571187|P3|Overall Study|Adverse Event|0
4805676|NCT01277601|16571188|P2|Overall Study|Adverse Event|3
4805677|NCT01277601|16571189|P1|Overall Study|Adverse Event|5
4805678|NCT01277549|16571280|P2|Overall Study|Physician Decision|1
4805679|NCT01277549|16571281|P1|Overall Study|Physician Decision|2
4805680|NCT01277549|16571280|P2|Overall Study|Protocol Violation|1
4805681|NCT01277549|16571281|P1|Overall Study|Protocol Violation|10
4805682|NCT01277549|16571280|P2|Overall Study|Withdrawal by Subject|3
4805683|NCT01277549|16571281|P1|Overall Study|Withdrawal by Subject|1
4805684|NCT01277549|16571280|P2|Overall Study|Failed to meet eligibility criteria|9
4805685|NCT01277549|16571281|P1|Overall Study|Failed to meet eligibility criteria|13
4805686|NCT01277523|16571298|P3|Overall Study|Other Reason not Defined|0
4805687|NCT01277523|16571299|P2|Overall Study|Other Reason not Defined|1
4805688|NCT01277523|16571300|P1|Overall Study|Other Reason not Defined|0
4805689|NCT01277523|16571298|P3|Overall Study|Protocol Violation|0
4805690|NCT01277523|16571299|P2|Overall Study|Protocol Violation|0
4805691|NCT01277523|16571300|P1|Overall Study|Protocol Violation|2
4805692|NCT01277523|16571298|P3|Overall Study|Adverse Event|0
4805693|NCT01277523|16571299|P2|Overall Study|Adverse Event|0
4805694|NCT01277523|16571300|P1|Overall Study|Adverse Event|1
4805695|NCT01277510|16571352|P2|Open-label Phase|Never received investigational product|0
4805696|NCT01277510|16571353|P1|Open-label Phase|Never received investigational product|2
4805697|NCT01277510|16571352|P2|Open-label Phase|Protocol-specified criteria|0
4805698|NCT01277510|16571353|P1|Open-label Phase|Protocol-specified criteria|1
4805699|NCT01277510|16571352|P2|Open-label Phase|Administrative decision|3
4805700|NCT01277510|16571353|P1|Open-label Phase|Administrative decision|4
4805701|NCT01277510|16571352|P2|Double-blind Phase|Other|1
4805702|NCT01277510|16571353|P1|Double-blind Phase|Other|1
4805703|NCT01277510|16571352|P2|Double-blind Phase|Protocol-specified criteria|6
4805704|NCT01277510|16571353|P1|Double-blind Phase|Protocol-specified criteria|2
4805705|NCT01277510|16571352|P2|Double-blind Phase|Death|1
4805706|NCT01277510|16571353|P1|Double-blind Phase|Death|0
4805707|NCT01277510|16571352|P2|Double-blind Phase|Administrative decision|9
4805708|NCT01277510|16571353|P1|Double-blind Phase|Administrative decision|7
4805709|NCT01277510|16571352|P2|Double-blind Phase|Withdrawal by Subject|0
4805710|NCT01277510|16571353|P1|Double-blind Phase|Withdrawal by Subject|2
4805711|NCT01277510|16571352|P2|Double-blind Phase|Adverse Event|0
4805712|NCT01277510|16571353|P1|Double-blind Phase|Adverse Event|1
4805713|NCT01277510|16571352|P2|Double-blind Phase|Non-compliance|1
4805714|NCT01277510|16571353|P1|Double-blind Phase|Non-compliance|0
4805715|NCT01277302|16571404|P3|8-Month Alternate Dose Regimen Period|Relocation|1
4805716|NCT01277302|16571405|P2|8-Month Alternate Dose Regimen Period|Relocation|0
4805717|NCT01277302|16571406|P1|8-Month Alternate Dose Regimen Period|Relocation|1
4805718|NCT01277302|16571404|P3|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1
4805719|NCT01277302|16571405|P2|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2
4805720|NCT01277302|16571406|P1|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0
4805721|NCT01277302|16571404|P3|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1
4805722|NCT01277302|16571405|P2|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0
4805723|NCT01277302|16571406|P1|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3
4805724|NCT01277302|16571404|P3|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3
4805725|NCT01277302|16571405|P2|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
4805726|NCT01277302|16571406|P1|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1
4805727|NCT01277302|16571404|P3|8-Month Alternate Dose Regimen Period|Death|0
4805728|NCT01277302|16571405|P2|8-Month Alternate Dose Regimen Period|Death|1
4805729|NCT01277302|16571406|P1|8-Month Alternate Dose Regimen Period|Death|0
4805730|NCT01277302|16571404|P3|7-Month Fixed Treatment Period|Subject Non-compliance|1
4805819|NCT01276639|16571609|P3|Week 0 to 16|Withdrawal by Subject|4
4805731|NCT01277302|16571405|P2|7-Month Fixed Treatment Period|Subject Non-compliance|0
4805732|NCT01277302|16571406|P1|7-Month Fixed Treatment Period|Subject Non-compliance|0
4805733|NCT01277302|16571404|P3|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1
4805734|NCT01277302|16571405|P2|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
4805735|NCT01277302|16571406|P1|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0
4805736|NCT01277302|16571404|P3|7-Month Fixed Treatment Period|Lost to Follow-up|2
4805737|NCT01277302|16571405|P2|7-Month Fixed Treatment Period|Lost to Follow-up|0
4805738|NCT01277302|16571406|P1|7-Month Fixed Treatment Period|Lost to Follow-up|0
4805739|NCT01277302|16571404|P3|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8
4805740|NCT01277302|16571405|P2|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
4805741|NCT01277302|16571406|P1|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0
4805742|NCT01277211|16571438|P2|Overall Study|Discontinued prior to treatment|13
4805743|NCT01277211|16571439|P1|Overall Study|Discontinued prior to treatment|24
4805744|NCT01277211|16571438|P2|Overall Study|Pregnancy wish|2
4805745|NCT01277211|16571439|P1|Overall Study|Pregnancy wish|0
4805746|NCT01277211|16571438|P2|Overall Study|Administrative|0
4805747|NCT01277211|16571439|P1|Overall Study|Administrative|3
4805748|NCT01277211|16571438|P2|Overall Study|Did not meet protocol eligibility|0
4805749|NCT01277211|16571439|P1|Overall Study|Did not meet protocol eligibility|1
4805750|NCT01277211|16571438|P2|Overall Study|Non-compliance with protocol|4
4805751|NCT01277211|16571439|P1|Overall Study|Non-compliance with protocol|13
4805752|NCT01277211|16571438|P2|Overall Study|Withdrew Consent|9
4805753|NCT01277211|16571439|P1|Overall Study|Withdrew Consent|9
4805754|NCT01277211|16571438|P2|Overall Study|Did not wish to continue|0
4805755|NCT01277211|16571439|P1|Overall Study|Did not wish to continue|17
4805756|NCT01277211|16571438|P2|Overall Study|Lost to Follow-up|9
4805757|NCT01277211|16571439|P1|Overall Study|Lost to Follow-up|14
4805758|NCT01277211|16571438|P2|Overall Study|Pregnancy|4
4805759|NCT01277211|16571439|P1|Overall Study|Pregnancy|9
4805760|NCT01277211|16571438|P2|Overall Study|Adverse Event|22
4805761|NCT01277211|16571439|P1|Overall Study|Adverse Event|60
4805762|NCT01277042|16571491|P2|Overall Study|Withdrawal by Subject|0
4805763|NCT01277042|16571492|P1|Overall Study|Withdrawal by Subject|2
4805764|NCT01277042|16571491|P2|Overall Study|Lost to Follow-up|2
4805765|NCT01277042|16571492|P1|Overall Study|Lost to Follow-up|2
4805766|NCT01277042|16571491|P2|Overall Study|Adverse Event|3
4805767|NCT01277042|16571492|P1|Overall Study|Adverse Event|4
4805768|NCT01276847|16571528|P3|Overall Study|Withdrawal by Subject|0
4805769|NCT01276847|16571529|P2|Overall Study|Withdrawal by Subject|0
4805770|NCT01276847|16571530|P1|Overall Study|Withdrawal by Subject|1
4805771|NCT01276821|16571540|P2|Overall Study|Protocol Violation|1
4805772|NCT01276821|16571541|P1|Overall Study|Protocol Violation|0
4805773|NCT01276756|16571561|P2|Overall Study|Adverse Event|2
4805774|NCT01276756|16571562|P1|Overall Study|Adverse Event|3
4805775|NCT01276756|16571561|P2|Overall Study|Lost to Follow-up|0
4805776|NCT01276756|16571562|P1|Overall Study|Lost to Follow-up|2
4805777|NCT01276639|16571607|P5|Week 16 to 52|Other|3
4805778|NCT01276639|16571608|P4|Week 16 to 52|Other|1
4805779|NCT01276639|16571609|P3|Week 16 to 52|Other|0
4805780|NCT01276639|16571610|P2|Week 16 to 52|Other|12
4805781|NCT01276639|16571611|P1|Week 16 to 52|Other|10
4805782|NCT01276639|16571607|P5|Week 16 to 52|Withdrawal by Subject|1
4805783|NCT01276639|16571608|P4|Week 16 to 52|Withdrawal by Subject|0
4805784|NCT01276639|16571609|P3|Week 16 to 52|Withdrawal by Subject|0
4805785|NCT01276639|16571610|P2|Week 16 to 52|Withdrawal by Subject|4
4805786|NCT01276639|16571611|P1|Week 16 to 52|Withdrawal by Subject|4
4805787|NCT01276639|16571607|P5|Week 16 to 52|Lost to Follow-up|1
4805788|NCT01276639|16571608|P4|Week 16 to 52|Lost to Follow-up|0
4805789|NCT01276639|16571609|P3|Week 16 to 52|Lost to Follow-up|0
4805790|NCT01276639|16571610|P2|Week 16 to 52|Lost to Follow-up|1
4805791|NCT01276639|16571611|P1|Week 16 to 52|Lost to Follow-up|3
4805792|NCT01276639|16571607|P5|Week 16 to 52|Lack of Efficacy|13
4805793|NCT01276639|16571608|P4|Week 16 to 52|Lack of Efficacy|14
4805794|NCT01276639|16571609|P3|Week 16 to 52|Lack of Efficacy|0
4805795|NCT01276639|16571610|P2|Week 16 to 52|Lack of Efficacy|71
4805796|NCT01276639|16571611|P1|Week 16 to 52|Lack of Efficacy|99
4805797|NCT01276639|16571607|P5|Week 16 to 52|Adverse Event|3
4805798|NCT01276639|16571608|P4|Week 16 to 52|Adverse Event|1
4805799|NCT01276639|16571609|P3|Week 16 to 52|Adverse Event|0
4805800|NCT01276639|16571610|P2|Week 16 to 52|Adverse Event|13
4805801|NCT01276639|16571611|P1|Week 16 to 52|Adverse Event|10
4805802|NCT01276639|16571607|P5|Week 16 to 52|Death|0
4805803|NCT01276639|16571608|P4|Week 16 to 52|Death|0
4805804|NCT01276639|16571609|P3|Week 16 to 52|Death|0
4805805|NCT01276639|16571610|P2|Week 16 to 52|Death|0
4805806|NCT01276639|16571611|P1|Week 16 to 52|Death|1
4805807|NCT01276639|16571607|P5|Week 0 to 16|Randomized, But Not Treated|0
4805808|NCT01276639|16571608|P4|Week 0 to 16|Randomized, But Not Treated|0
4805809|NCT01276639|16571609|P3|Week 0 to 16|Randomized, But Not Treated|0
4805810|NCT01276639|16571610|P2|Week 0 to 16|Randomized, But Not Treated|1
4805811|NCT01276639|16571611|P1|Week 0 to 16|Randomized, But Not Treated|0
4805812|NCT01276639|16571607|P5|Week 0 to 16|Other|0
4805813|NCT01276639|16571608|P4|Week 0 to 16|Other|0
4805814|NCT01276639|16571609|P3|Week 0 to 16|Other|2
4805815|NCT01276639|16571610|P2|Week 0 to 16|Other|7
4805816|NCT01276639|16571611|P1|Week 0 to 16|Other|7
4805817|NCT01276639|16571607|P5|Week 0 to 16|Withdrawal by Subject|0
4805818|NCT01276639|16571608|P4|Week 0 to 16|Withdrawal by Subject|0
4805820|NCT01276639|16571610|P2|Week 0 to 16|Withdrawal by Subject|5
4805821|NCT01276639|16571611|P1|Week 0 to 16|Withdrawal by Subject|8
4805822|NCT01276639|16571607|P5|Week 0 to 16|Lost to Follow-up|0
4805823|NCT01276639|16571608|P4|Week 0 to 16|Lost to Follow-up|0
4805824|NCT01276639|16571609|P3|Week 0 to 16|Lost to Follow-up|3
4805825|NCT01276639|16571610|P2|Week 0 to 16|Lost to Follow-up|5
4805826|NCT01276639|16571611|P1|Week 0 to 16|Lost to Follow-up|3
4805827|NCT01276639|16571607|P5|Week 0 to 16|Lack of Efficacy|0
4805828|NCT01276639|16571608|P4|Week 0 to 16|Lack of Efficacy|0
4805829|NCT01276639|16571609|P3|Week 0 to 16|Lack of Efficacy|25
4805830|NCT01276639|16571610|P2|Week 0 to 16|Lack of Efficacy|15
4805831|NCT01276639|16571611|P1|Week 0 to 16|Lack of Efficacy|20
4805832|NCT01276639|16571607|P5|Week 0 to 16|Adverse Event|0
4805833|NCT01276639|16571608|P4|Week 0 to 16|Adverse Event|0
4805834|NCT01276639|16571609|P3|Week 0 to 16|Adverse Event|11
4805835|NCT01276639|16571610|P2|Week 0 to 16|Adverse Event|8
4805836|NCT01276639|16571611|P1|Week 0 to 16|Adverse Event|11
4805837|NCT01276639|16571607|P5|Week 0 to 16|Death|0
4805838|NCT01276639|16571608|P4|Week 0 to 16|Death|0
4805839|NCT01276639|16571609|P3|Week 0 to 16|Death|0
4805840|NCT01276639|16571610|P2|Week 0 to 16|Death|0
4805841|NCT01276639|16571611|P1|Week 0 to 16|Death|1
4805842|NCT01276509|16571816|P4|Overall Study|Other|0
4805843|NCT01276509|16571817|P3|Overall Study|Other|0
4805844|NCT01276509|16571818|P2|Overall Study|Other|1
4805845|NCT01276509|16571819|P1|Overall Study|Other|0
4805846|NCT01276509|16571816|P4|Overall Study|Withdrawal by Subject|0
4805847|NCT01276509|16571817|P3|Overall Study|Withdrawal by Subject|0
4805848|NCT01276509|16571818|P2|Overall Study|Withdrawal by Subject|2
4805849|NCT01276509|16571819|P1|Overall Study|Withdrawal by Subject|1
4805850|NCT01276509|16571816|P4|Overall Study|Pregnancy|0
4805851|NCT01276509|16571817|P3|Overall Study|Pregnancy|0
4805852|NCT01276509|16571818|P2|Overall Study|Pregnancy|0
4805853|NCT01276509|16571819|P1|Overall Study|Pregnancy|1
4805854|NCT01276509|16571816|P4|Overall Study|Lack of Efficacy|2
4805855|NCT01276509|16571817|P3|Overall Study|Lack of Efficacy|1
4805856|NCT01276509|16571818|P2|Overall Study|Lack of Efficacy|1
4805857|NCT01276509|16571819|P1|Overall Study|Lack of Efficacy|2
4805858|NCT01276509|16571816|P4|Overall Study|Adverse Event|3
4805859|NCT01276509|16571817|P3|Overall Study|Adverse Event|4
4805860|NCT01276509|16571818|P2|Overall Study|Adverse Event|8
4805861|NCT01276509|16571819|P1|Overall Study|Adverse Event|9
4805862|NCT01276457|16571872|P2|Extension Study|Lack of Efficacy|1
4805863|NCT01276457|16571873|P1|Extension Study|Lack of Efficacy|3
4805864|NCT01276457|16571872|P2|Extension Study|Death|1
4805865|NCT01276457|16571873|P1|Extension Study|Death|0
4805866|NCT01276457|16571872|P2|Extension Study|Lost to Follow-up|0
4805867|NCT01276457|16571873|P1|Extension Study|Lost to Follow-up|3
4805868|NCT01276457|16571872|P2|Core Study|Lack of Efficacy|12
4805869|NCT01276457|16571873|P1|Core Study|Lack of Efficacy|3
4805870|NCT01276457|16571872|P2|Core Study|Death|2
4805871|NCT01276457|16571873|P1|Core Study|Death|2
4805872|NCT01276457|16571872|P2|Core Study|Administrative problems|1
4805873|NCT01276457|16571873|P1|Core Study|Administrative problems|1
4805874|NCT01276457|16571872|P2|Core Study|Lost to Follow-up|2
4805875|NCT01276457|16571873|P1|Core Study|Lost to Follow-up|1
4805876|NCT01276457|16571872|P2|Core Study|Adverse Event|3
4805877|NCT01276457|16571873|P1|Core Study|Adverse Event|6
4805878|NCT01276353|16571887|P2|Extension|Prohibited concomitant medications|1
4805879|NCT01276353|16571888|P1|Extension|Prohibited concomitant medications|0
4805880|NCT01276353|16571887|P2|Extension|Physician Decision|0
4805881|NCT01276353|16571888|P1|Extension|Physician Decision|1
4805882|NCT01276353|16571887|P2|Extension|Withdrawal of study drug 4 days in a row|1
4805883|NCT01276353|16571888|P1|Extension|Withdrawal of study drug 4 days in a row|3
4805884|NCT01276353|16571887|P2|Extension|Withdrawal by Subject|2
4805885|NCT01276353|16571888|P1|Extension|Withdrawal by Subject|1
4805886|NCT01276353|16571887|P2|Extension|Adverse Event|5
4805887|NCT01276353|16571888|P1|Extension|Adverse Event|2
4805888|NCT01276353|16571887|P2|Double-blind|Withdrawal by Subject|0
4805889|NCT01276353|16571888|P1|Double-blind|Withdrawal by Subject|1
4805890|NCT01276353|16571887|P2|Double-blind|Adverse Event|0
4805891|NCT01276353|16571888|P1|Double-blind|Adverse Event|2
4805892|NCT01276327|16571900|P2|Overall Study|Withdrawal by Subject|0
4805893|NCT01276327|16571901|P1|Overall Study|Withdrawal by Subject|1
4805894|NCT01276327|16571900|P2|Overall Study|Adverse Event|3
4805895|NCT01276327|16571901|P1|Overall Study|Adverse Event|1
4805896|NCT01276288|16571968|P4|Overall Study|not treated|0
4805897|NCT01276288|16571969|P3|Overall Study|not treated|0
4805898|NCT01276288|16571970|P2|Overall Study|not treated|0
4805899|NCT01276288|16571971|P1|Overall Study|not treated|1
4805900|NCT01276288|16571968|P4|Overall Study|Adverse Event|0
4805901|NCT01276288|16571969|P3|Overall Study|Adverse Event|0
4805902|NCT01276288|16571970|P2|Overall Study|Adverse Event|1
4805903|NCT01276288|16571971|P1|Overall Study|Adverse Event|1
4805904|NCT01276223|16572098|P3|Overall Study|Protocol Violation|0
4805905|NCT01276223|16572099|P2|Overall Study|Protocol Violation|0
4805906|NCT01276223|16572100|P1|Overall Study|Protocol Violation|1
4805907|NCT01276223|16572098|P3|Overall Study|Pt Decision Unrelated to Adverse Event|0
4805908|NCT01276223|16572099|P2|Overall Study|Pt Decision Unrelated to Adverse Event|0
4805909|NCT01276223|16572100|P1|Overall Study|Pt Decision Unrelated to Adverse Event|3
4805910|NCT01276223|16572098|P3|Overall Study|Other|1
4805911|NCT01276223|16572099|P2|Overall Study|Other|0
4805912|NCT01276223|16572100|P1|Overall Study|Other|0
4805913|NCT01276223|16572098|P3|Overall Study|Lost to Follow-up|1
4805914|NCT01276223|16572099|P2|Overall Study|Lost to Follow-up|0
4805915|NCT01276223|16572100|P1|Overall Study|Lost to Follow-up|0
4805916|NCT01276223|16572098|P3|Overall Study|Adverse Event|1
4805917|NCT01276223|16572099|P2|Overall Study|Adverse Event|4
4805918|NCT01276223|16572100|P1|Overall Study|Adverse Event|7
4805919|NCT01276106|16572141|P4|Overall Study|Insufficient therapeutic effects|0
4805920|NCT01276106|16572142|P3|Overall Study|Insufficient therapeutic effects|2
4805921|NCT01276106|16572143|P2|Overall Study|Insufficient therapeutic effects|0
4805922|NCT01276106|16572144|P1|Overall Study|Insufficient therapeutic effects|0
4805923|NCT01276106|16572141|P4|Overall Study|Protocol Violation|2
4805924|NCT01276106|16572142|P3|Overall Study|Protocol Violation|0
4805925|NCT01276106|16572143|P2|Overall Study|Protocol Violation|1
4805926|NCT01276106|16572144|P1|Overall Study|Protocol Violation|1
4805927|NCT01276106|16572141|P4|Overall Study|Physician Decision|1
4805928|NCT01276106|16572142|P3|Overall Study|Physician Decision|1
4805929|NCT01276106|16572143|P2|Overall Study|Physician Decision|0
4805930|NCT01276106|16572144|P1|Overall Study|Physician Decision|0
4805931|NCT01276106|16572141|P4|Overall Study|Lost to Follow-up|0
4805932|NCT01276106|16572142|P3|Overall Study|Lost to Follow-up|1
4805933|NCT01276106|16572143|P2|Overall Study|Lost to Follow-up|1
4805934|NCT01276106|16572144|P1|Overall Study|Lost to Follow-up|2
4805935|NCT01276106|16572141|P4|Overall Study|Lack of Efficacy|1
4805936|NCT01276106|16572142|P3|Overall Study|Lack of Efficacy|0
4805937|NCT01276106|16572143|P2|Overall Study|Lack of Efficacy|1
4805938|NCT01276106|16572144|P1|Overall Study|Lack of Efficacy|0
4805939|NCT01276106|16572141|P4|Overall Study|Withdrawal by Subject|6
4805940|NCT01276106|16572142|P3|Overall Study|Withdrawal by Subject|1
4805941|NCT01276106|16572143|P2|Overall Study|Withdrawal by Subject|3
4805942|NCT01276106|16572144|P1|Overall Study|Withdrawal by Subject|6
4805943|NCT01276106|16572141|P4|Overall Study|Adverse Event|3
4805944|NCT01276106|16572142|P3|Overall Study|Adverse Event|11
4805945|NCT01276106|16572143|P2|Overall Study|Adverse Event|3
4805946|NCT01276106|16572144|P1|Overall Study|Adverse Event|3
4805947|NCT01276054|16572156|P2|Overall Study|No one to oversee trial after P.I. left|2
4805948|NCT01276054|16572157|P1|Overall Study|No one to oversee trial after P.I. left|2
4805949|NCT01276041|16572163|P1|Overall Study|Protocol Violation|1
4805950|NCT01276041|16572163|P1|Overall Study|Adverse Event|2
4805951|NCT01275833|16572172|P2|Overall Study|Study terminated|1
4805952|NCT01275833|16572173|P1|Overall Study|Study terminated|1
4805953|NCT01275755|16572181|P2|Run-out Placebo Period|Lost to Follow-up|0
4805954|NCT01275755|16572182|P1|Run-out Placebo Period|Lost to Follow-up|1
4805955|NCT01275755|16572181|P2|Double-blind Treatment Period|Withdrawal by Subject|0
4805956|NCT01275755|16572182|P1|Double-blind Treatment Period|Withdrawal by Subject|1
4805957|NCT01275755|16572181|P2|Double-blind Treatment Period|Lost to Follow-up|1
4805958|NCT01275755|16572182|P1|Double-blind Treatment Period|Lost to Follow-up|1
4805959|NCT01275755|16572181|P2|Double-blind Treatment Period|Adverse Event|2
4805960|NCT01275755|16572182|P1|Double-blind Treatment Period|Adverse Event|0
4805961|NCT01275677|16572190|P2|Overall Study|No clinical follow up.|4
4805962|NCT01275677|16572191|P1|Overall Study|No clinical follow up.|1
4805963|NCT01275677|16572190|P2|Overall Study|No follow-up|37
4805964|NCT01275677|16572191|P1|Overall Study|No follow-up|26
4805965|NCT01275677|16572190|P2|Overall Study|Not at risk for recurrence.|1
4805966|NCT01275677|16572191|P1|Overall Study|Not at risk for recurrence.|1
4805967|NCT01275625|16572217|P1|Overall Study|Other|1
4805968|NCT01275625|16572217|P1|Overall Study|Adverse Event|4
4805969|NCT01275625|16572217|P1|Overall Study|Protocol Violation|1
4805970|NCT01275625|16572217|P1|Overall Study|Withdrawal by Subject|3
4805971|NCT01275625|16572217|P1|Overall Study|Lost to Follow-up|1
4805972|NCT01275625|16572217|P1|Overall Study|Lack of Efficacy|2
4805973|NCT01275625|16572217|P1|Overall Study|Death|1
4805974|NCT01275430|16572235|P1|Overall Study|Inability to achieve maximum p-wave|1
4805975|NCT01275430|16572235|P1|Overall Study|Device Malfunction|1
4805976|NCT01275430|16572235|P1|Overall Study|No Contrast Injection|6
4805977|NCT01275430|16572235|P1|Overall Study|Adverse Event|1
4805978|NCT01275339|16572300|P4|Overall Study|Withdrawal by Subject|0
4805979|NCT01275339|16572301|P3|Overall Study|Withdrawal by Subject|1
4805980|NCT01275339|16572302|P2|Overall Study|Withdrawal by Subject|0
4805981|NCT01275339|16572303|P1|Overall Study|Withdrawal by Subject|0
4805982|NCT01275339|16572300|P4|Overall Study|Referred for surgery for AS symptoms|0
4805983|NCT01275339|16572301|P3|Overall Study|Referred for surgery for AS symptoms|0
4805984|NCT01275339|16572302|P2|Overall Study|Referred for surgery for AS symptoms|0
4805985|NCT01275339|16572303|P1|Overall Study|Referred for surgery for AS symptoms|1
4805986|NCT01275196|16572331|P2|Overall Study|Suboptimal response/treatment failure|6
4805987|NCT01275196|16572332|P1|Overall Study|Suboptimal response/treatment failure|5
4805988|NCT01275196|16572331|P2|Overall Study|Protocol Violation|0
4805989|NCT01275196|16572332|P1|Overall Study|Protocol Violation|1
4805990|NCT01275196|16572331|P2|Overall Study|Disease Progression|5
4805991|NCT01275196|16572332|P1|Overall Study|Disease Progression|6
4805992|NCT01275196|16572331|P2|Overall Study|Lost to Follow-up|0
4805993|NCT01275196|16572332|P1|Overall Study|Lost to Follow-up|1
4805994|NCT01275196|16572331|P2|Overall Study|Withdrawal by Subject|5
4805995|NCT01275196|16572332|P1|Overall Study|Withdrawal by Subject|4
4805996|NCT01275196|16572331|P2|Overall Study|Adverse Event|5
4805997|NCT01275196|16572332|P1|Overall Study|Adverse Event|3
4805998|NCT01275170|16572379|P8|Part 1: Period 1|Equipment malfunction before study drug|0
4805999|NCT01275170|16572380|P7|Part 1: Period 1|Equipment malfunction before study drug|0
4806000|NCT01275170|16572381|P6|Part 1: Period 1|Equipment malfunction before study drug|0
4806001|NCT01275170|16572382|P5|Part 1: Period 1|Equipment malfunction before study drug|0
4806002|NCT01275170|16572383|P4|Part 1: Period 1|Equipment malfunction before study drug|0
4806003|NCT01275170|16572384|P3|Part 1: Period 1|Equipment malfunction before study drug|0
4806004|NCT01275170|16572385|P2|Part 1: Period 1|Equipment malfunction before study drug|0
4806005|NCT01275170|16572386|P1|Part 1: Period 1|Equipment malfunction before study drug|1
4806006|NCT01275144|16572604|P2|Second Intervention (6 Days)|Withdrawal by Subject|0
4806007|NCT01275144|16572605|P1|Second Intervention (6 Days)|Withdrawal by Subject|1
4806008|NCT01275131|16572663|P4|Period 2 (Crossover)|Withdrawal by Subject|2
4806009|NCT01275131|16572664|P3|Period 2 (Crossover)|Withdrawal by Subject|1
4806010|NCT01275131|16572665|P2|Period 2 (Crossover)|Withdrawal by Subject|0
4806011|NCT01275131|16572666|P1|Period 2 (Crossover)|Withdrawal by Subject|1
4806012|NCT01275131|16572663|P4|Period 2 (Crossover)|Adverse Event|0
4806013|NCT01275131|16572664|P3|Period 2 (Crossover)|Adverse Event|0
4806014|NCT01275131|16572665|P2|Period 2 (Crossover)|Adverse Event|1
4806015|NCT01275131|16572666|P1|Period 2 (Crossover)|Adverse Event|0
4806016|NCT01275131|16572663|P4|Period 1|Physician Decision|0
4806017|NCT01275131|16572664|P3|Period 1|Physician Decision|0
4806018|NCT01275131|16572665|P2|Period 1|Physician Decision|0
4806019|NCT01275131|16572666|P1|Period 1|Physician Decision|1
4806020|NCT01275131|16572663|P4|Period 1|Withdrawal by Subject|2
4806021|NCT01275131|16572664|P3|Period 1|Withdrawal by Subject|3
4806022|NCT01275131|16572665|P2|Period 1|Withdrawal by Subject|0
4806023|NCT01275131|16572666|P1|Period 1|Withdrawal by Subject|1
4806024|NCT01275066|16572709|P3|Overall Study|Not Diagnosed w/ Disease|0
4806025|NCT01275066|16572710|P2|Overall Study|Not Diagnosed w/ Disease|0
4806026|NCT01275066|16572711|P1|Overall Study|Not Diagnosed w/ Disease|1
4806027|NCT01275066|16572709|P3|Overall Study|Withdrawal by Subject|1
4806028|NCT01275066|16572710|P2|Overall Study|Withdrawal by Subject|0
4806029|NCT01275066|16572711|P1|Overall Study|Withdrawal by Subject|0
4806030|NCT01274715|16572744|P1|Overall Study|After consent, met exclusion criteria.|1
4806031|NCT01274715|16572744|P1|Overall Study|After consent, met exclusion criteria.|1
4806032|NCT01274715|16572744|P1|Overall Study|After consent, met exclusion criteria.|1
4806033|NCT01274715|16572744|P1|Overall Study|Lost to Follow-up|1
4806034|NCT01274637|16572751|P2|Overall Study|Lost to Follow-up|1
4806035|NCT01274637|16572752|P1|Overall Study|Lost to Follow-up|0
4806036|NCT01274637|16572751|P2|Overall Study|Withdrawal by Subject|1
4806037|NCT01274637|16572752|P1|Overall Study|Withdrawal by Subject|0
4806038|NCT01274559|16572791|P2|Overall Study|Withdrawal by Subject|13
4806039|NCT01274559|16572792|P1|Overall Study|Withdrawal by Subject|25
4806040|NCT01274559|16572791|P2|Overall Study|Study Terminated by Sponsor|87
4806041|NCT01274559|16572792|P1|Overall Study|Study Terminated by Sponsor|79
4806042|NCT01274559|16572791|P2|Overall Study|Protocol Violation|23
4806043|NCT01274559|16572792|P1|Overall Study|Protocol Violation|28
4806044|NCT01274559|16572791|P2|Overall Study|Physician Decision|1
4806045|NCT01274559|16572792|P1|Overall Study|Physician Decision|2
4806046|NCT01274559|16572791|P2|Overall Study|Non-compliance with Study Drug|4
4806047|NCT01274559|16572792|P1|Overall Study|Non-compliance with Study Drug|2
4806048|NCT01274559|16572791|P2|Overall Study|Lost to Follow-up|3
4806049|NCT01274559|16572792|P1|Overall Study|Lost to Follow-up|3
4806050|NCT01274559|16572791|P2|Overall Study|Death|1
4806051|NCT01274559|16572792|P1|Overall Study|Death|1
4806052|NCT01274559|16572791|P2|Overall Study|Adverse Event|13
4806053|NCT01274559|16572792|P1|Overall Study|Adverse Event|57
4806054|NCT01274533|16572842|P1|Overall Study|Disease progression|2
4806055|NCT01274533|16572842|P1|Overall Study|Non-compliance|1
4806056|NCT01274533|16572842|P1|Overall Study|Withdrawal by Subject|1
4806057|NCT01274429|16572878|P1|Overall Study|Study closed do to lack of funding|5
4806058|NCT01274351|16572883|P1|Overall Study|hospitalization|1
4806059|NCT01274351|16572883|P1|Overall Study|progression of disease|3
4806060|NCT01274351|16572883|P1|Overall Study|Adverse Event|8
4806061|NCT01274351|16572883|P1|Overall Study|Withdrawal by Subject|3
4806062|NCT01274351|16572883|P1|Overall Study|Death|2
4806063|NCT01274351|16572883|P1|Overall Study|Pregnancy|1
4806064|NCT01274351|16572883|P1|Overall Study|patient not compliant with the protocol|1
4806065|NCT01274351|16572883|P1|Overall Study|Lost to Follow-up|1
4806066|NCT01274182|16572895|P3|Overall Study|Death|1
4806067|NCT01274182|16572896|P2|Overall Study|Death|0
4806068|NCT01274182|16572897|P1|Overall Study|Death|1
4806069|NCT01274182|16572895|P3|Overall Study|Protocol Violation|0
4806070|NCT01274182|16572896|P2|Overall Study|Protocol Violation|2
4806071|NCT01274182|16572897|P1|Overall Study|Protocol Violation|3
4806072|NCT01274182|16572895|P3|Overall Study|Lost to Follow-up|1
4806073|NCT01274182|16572896|P2|Overall Study|Lost to Follow-up|3
4806074|NCT01274182|16572897|P1|Overall Study|Lost to Follow-up|2
4806075|NCT01274182|16572895|P3|Overall Study|Withdrawal by Subject|3
4806076|NCT01274182|16572896|P2|Overall Study|Withdrawal by Subject|5
4806077|NCT01274182|16572897|P1|Overall Study|Withdrawal by Subject|5
4806078|NCT01274182|16572895|P3|Overall Study|Adverse Event|3
4806079|NCT01274182|16572896|P2|Overall Study|Adverse Event|5
4806080|NCT01274182|16572897|P1|Overall Study|Adverse Event|4
4806081|NCT01274182|16572895|P3|Overall Study|Unsatisfactory therapeutic effect|4
4806082|NCT01274182|16572896|P2|Overall Study|Unsatisfactory therapeutic effect|3
4806083|NCT01274182|16572897|P1|Overall Study|Unsatisfactory therapeutic effect|6
4806084|NCT01273883|16572938|P2|Second Intervention|Lack of Efficacy|0
4806085|NCT01273883|16572939|P1|Second Intervention|Lack of Efficacy|1
4806086|NCT01273883|16572938|P2|Second Intervention|Lost to Follow-up|1
4806087|NCT01273883|16572939|P1|Second Intervention|Lost to Follow-up|1
4806088|NCT01273883|16572938|P2|First Intervention|Adverse Event|1
4806089|NCT01273883|16572939|P1|First Intervention|Adverse Event|2
4806090|NCT01273818|16572965|P3|Overall Study|Physician Decision|9
4806091|NCT01273818|16572966|P2|Overall Study|Physician Decision|2
4806092|NCT01273818|16572967|P1|Overall Study|Physician Decision|13
4806093|NCT01273805|16572977|P2|Overall Study|Radiologic PD or Symptom Deterioration|10
4806094|NCT01273805|16572978|P1|Overall Study|Radiologic PD or Symptom Deterioration|10
4806095|NCT01273623|16573009|P1|Overall Study|did not meet IVUS criteria|29
4806096|NCT01273597|16573016|P1|Overall Study|Reason Not Reported|1
4806097|NCT01273597|16573016|P1|Overall Study|Underwent Kidney Transplantation|2
4806098|NCT01273597|16573016|P1|Overall Study|Adverse Event|5
4806099|NCT01273519|16573031|P3|Overall Study|Other|1
4806100|NCT01273519|16573032|P2|Overall Study|Other|1
4806101|NCT01273519|16573033|P1|Overall Study|Other|6
4806102|NCT01273519|16573031|P3|Overall Study|Lack of Efficacy|4
4806103|NCT01273519|16573032|P2|Overall Study|Lack of Efficacy|3
4806104|NCT01273519|16573033|P1|Overall Study|Lack of Efficacy|8
4806105|NCT01273519|16573031|P3|Overall Study|Lost to Follow-up|3
4806106|NCT01273519|16573032|P2|Overall Study|Lost to Follow-up|1
4806107|NCT01273519|16573033|P1|Overall Study|Lost to Follow-up|2
4806108|NCT01273519|16573031|P3|Overall Study|Adverse Event|0
4806109|NCT01273519|16573032|P2|Overall Study|Adverse Event|0
4806110|NCT01273519|16573033|P1|Overall Study|Adverse Event|3
4806111|NCT01273181|16573076|P4|Phase 2, Dose 2|Death during treatment|1
4806112|NCT01273181|16573077|P3|Phase 2, Dose 2|Death during treatment|0
4806113|NCT01273181|16573078|P2|Phase 2, Dose 2|Death during treatment|0
4806114|NCT01273181|16573079|P1|Phase 2, Dose 2|Death during treatment|0
4806115|NCT01273181|16573076|P4|Phase 2, Dose 1|Study termination|0
4806116|NCT01273181|16573077|P3|Phase 2, Dose 1|Study termination|1
4806117|NCT01273181|16573078|P2|Phase 2, Dose 1|Study termination|0
4806118|NCT01273181|16573079|P1|Phase 2, Dose 1|Study termination|0
4806119|NCT01273181|16573076|P4|Phase I, Dose 2|Death during treatment|0
4806120|NCT01273181|16573077|P3|Phase I, Dose 2|Death during treatment|0
4806121|NCT01273181|16573078|P2|Phase I, Dose 2|Death during treatment|1
4806122|NCT01273181|16573079|P1|Phase I, Dose 2|Death during treatment|0
4806123|NCT01273181|16573076|P4|Phase I, Dose 1|Study termination|0
4806124|NCT01273181|16573077|P3|Phase I, Dose 1|Study termination|0
4806125|NCT01273181|16573078|P2|Phase I, Dose 1|Study termination|0
4806126|NCT01273181|16573079|P1|Phase I, Dose 1|Study termination|1
4806127|NCT01273155|16573097|P7|Overall Study|Withdrew during C1/refused further trmt|0
4806128|NCT01273155|16573098|P6|Overall Study|Withdrew during C1/refused further trmt|1
4806129|NCT01273155|16573099|P5|Overall Study|Withdrew during C1/refused further trmt|1
4806130|NCT01273155|16573100|P4|Overall Study|Withdrew during C1/refused further trmt|0
4806131|NCT01273155|16573101|P3|Overall Study|Withdrew during C1/refused further trmt|1
4806132|NCT01273155|16573102|P2|Overall Study|Withdrew during C1/refused further trmt|0
4806133|NCT01273155|16573103|P1|Overall Study|Withdrew during C1/refused further trmt|0
4806134|NCT01273155|16573097|P7|Overall Study|Died during Cycle 1|2
4806135|NCT01273155|16573098|P6|Overall Study|Died during Cycle 1|2
4806136|NCT01273155|16573099|P5|Overall Study|Died during Cycle 1|0
4806137|NCT01273155|16573100|P4|Overall Study|Died during Cycle 1|1
4806138|NCT01273155|16573101|P3|Overall Study|Died during Cycle 1|1
4806139|NCT01273155|16573102|P2|Overall Study|Died during Cycle 1|0
4806140|NCT01273155|16573103|P1|Overall Study|Died during Cycle 1|0
4806141|NCT01273155|16573097|P7|Overall Study|Off study prior to C1/due to toxicity|1
4806142|NCT01273155|16573098|P6|Overall Study|Off study prior to C1/due to toxicity|0
4806143|NCT01273155|16573099|P5|Overall Study|Off study prior to C1/due to toxicity|0
4806144|NCT01273155|16573100|P4|Overall Study|Off study prior to C1/due to toxicity|0
4806145|NCT01273155|16573101|P3|Overall Study|Off study prior to C1/due to toxicity|2
4806146|NCT01273155|16573102|P2|Overall Study|Off study prior to C1/due to toxicity|0
4806147|NCT01273155|16573103|P1|Overall Study|Off study prior to C1/due to toxicity|0
4806148|NCT01273155|16573097|P7|Overall Study|Change in liver function/no longer eval.|0
4806149|NCT01273155|16573098|P6|Overall Study|Change in liver function/no longer eval.|0
4806150|NCT01273155|16573099|P5|Overall Study|Change in liver function/no longer eval.|1
4806151|NCT01273155|16573100|P4|Overall Study|Change in liver function/no longer eval.|0
4806152|NCT01273155|16573101|P3|Overall Study|Change in liver function/no longer eval.|0
4806153|NCT01273155|16573102|P2|Overall Study|Change in liver function/no longer eval.|1
4806154|NCT01273155|16573103|P1|Overall Study|Change in liver function/no longer eval.|0
4806155|NCT01273155|16573097|P7|Overall Study|Off study trmt prior to end of C1/PD|3
4806156|NCT01273155|16573098|P6|Overall Study|Off study trmt prior to end of C1/PD|2
4806157|NCT01273155|16573099|P5|Overall Study|Off study trmt prior to end of C1/PD|0
4806158|NCT01273155|16573100|P4|Overall Study|Off study trmt prior to end of C1/PD|0
4806159|NCT01273155|16573101|P3|Overall Study|Off study trmt prior to end of C1/PD|8
4806160|NCT01273155|16573102|P2|Overall Study|Off study trmt prior to end of C1/PD|3
4806161|NCT01273155|16573103|P1|Overall Study|Off study trmt prior to end of C1/PD|2
4806162|NCT01273064|16573180|P5|Overall Study|Physician Decision|1
4806163|NCT01273064|16573181|P4|Overall Study|Physician Decision|0
4806164|NCT01273064|16573182|P3|Overall Study|Physician Decision|0
4806165|NCT01273064|16573183|P2|Overall Study|Physician Decision|0
4806166|NCT01273064|16573184|P1|Overall Study|Physician Decision|0
4806167|NCT01273064|16573180|P5|Overall Study|Lost to Follow-up|0
4806168|NCT01273064|16573181|P4|Overall Study|Lost to Follow-up|0
4806169|NCT01273064|16573182|P3|Overall Study|Lost to Follow-up|0
4806170|NCT01273064|16573183|P2|Overall Study|Lost to Follow-up|0
4806171|NCT01273064|16573184|P1|Overall Study|Lost to Follow-up|1
4806172|NCT01273064|16573180|P5|Overall Study|Study Termination|8
4806173|NCT01273064|16573181|P4|Overall Study|Study Termination|16
4806174|NCT01273064|16573182|P3|Overall Study|Study Termination|26
4806175|NCT01273064|16573183|P2|Overall Study|Study Termination|27
4806176|NCT01273064|16573184|P1|Overall Study|Study Termination|13
4806177|NCT01273064|16573180|P5|Overall Study|Withdrawal by Subject|0
4806178|NCT01273064|16573181|P4|Overall Study|Withdrawal by Subject|2
4806179|NCT01273064|16573182|P3|Overall Study|Withdrawal by Subject|2
4806180|NCT01273064|16573183|P2|Overall Study|Withdrawal by Subject|2
4806181|NCT01273064|16573184|P1|Overall Study|Withdrawal by Subject|4
4806182|NCT01273064|16573180|P5|Overall Study|Adverse Event|1
4806183|NCT01273064|16573181|P4|Overall Study|Adverse Event|2
4806184|NCT01273064|16573182|P3|Overall Study|Adverse Event|3
4806185|NCT01273064|16573183|P2|Overall Study|Adverse Event|1
4806186|NCT01273064|16573184|P1|Overall Study|Adverse Event|5
4806187|NCT01273038|16573203|P2|Second Intervention (14 Days)|Withdrawal by Subject|1
4806188|NCT01273038|16573204|P1|Second Intervention (14 Days)|Withdrawal by Subject|0
4806189|NCT01273038|16573203|P2|Second Intervention (14 Days)|Adverse Event|1
4806190|NCT01273038|16573204|P1|Second Intervention (14 Days)|Adverse Event|0
4806191|NCT01272947|16573227|P2|Overall Study|Abnormal Laboratory Value|2
4806192|NCT01272947|16573228|P1|Overall Study|Abnormal Laboratory Value|2
4806193|NCT01272934|16573238|P2|Overall Study|Abnormal Laboratory Value|1
4806194|NCT01272934|16573239|P1|Overall Study|Abnormal Laboratory Value|0
4806195|NCT01272934|16573238|P2|Overall Study|Adverse Event|1
4806196|NCT01272934|16573239|P1|Overall Study|Adverse Event|0
4806197|NCT01272921|16573249|P2|Overall Study|Protocol Violation|1
4806198|NCT01272921|16573250|P1|Overall Study|Protocol Violation|2
4806199|NCT01272908|16573258|P1|Re-Treatment Period|Withdrawal by Subject|1
4806200|NCT01272908|16573258|P1|Re-Treatment Period|Lack of Efficacy|3
4806201|NCT01272908|16573258|P1|Re-Treatment Period|Adverse Event|2
4806202|NCT01272908|16573258|P1|Initial Treatment Period|Withdrawal by Subject|1
4806203|NCT01272908|16573258|P1|Initial Treatment Period|Protocol Violation|1
4806204|NCT01272908|16573258|P1|Initial Treatment Period|Lack of Efficacy|5
4806205|NCT01272908|16573258|P1|Initial Treatment Period|Adverse Event|1
4806206|NCT01272869|16573298|P2|Period 2 (14 Days)|Adverse Event|0
4806207|NCT01272869|16573299|P1|Period 2 (14 Days)|Adverse Event|1
4806208|NCT01272804|16573326|P6|Overall Study|Adverse Event|1
4806209|NCT01272804|16573327|P5|Overall Study|Adverse Event|2
4806210|NCT01272804|16573328|P4|Overall Study|Adverse Event|0
4806211|NCT01272804|16573329|P3|Overall Study|Adverse Event|0
4806212|NCT01272804|16573330|P2|Overall Study|Adverse Event|0
4806213|NCT01272804|16573331|P1|Overall Study|Adverse Event|1
4806214|NCT01272661|16573489|P3|Overall Study|lost to followup/case closed/ no birth|72
4806215|NCT01272661|16573490|P2|Overall Study|lost to followup/case closed/ no birth|209
4806216|NCT01272661|16573491|P1|Overall Study|lost to followup/case closed/ no birth|126
4806217|NCT01272635|16573516|P4|Overall Study|Lost to Follow-up|23
4806218|NCT01272635|16573517|P3|Overall Study|Lost to Follow-up|31
4806219|NCT01272635|16573518|P2|Overall Study|Lost to Follow-up|20
4806220|NCT01272635|16573519|P1|Overall Study|Lost to Follow-up|31
4806221|NCT01272232|16573603|P3|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0
4806222|NCT01272232|16573604|P2|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
4806223|NCT01272232|16573605|P1|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2
4806224|NCT01272232|16573603|P3|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4
4806225|NCT01272232|16573604|P2|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7
4806226|NCT01272232|16573605|P1|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9
4806227|NCT01272232|16573603|P3|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
4806228|NCT01272232|16573604|P2|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0
4806229|NCT01272232|16573605|P1|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1
4806230|NCT01272232|16573603|P3|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
4806231|NCT01272232|16573604|P2|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0
4806232|NCT01272232|16573605|P1|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1
4806233|NCT01272232|16573603|P3|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0
4806234|NCT01272232|16573604|P2|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
4806235|NCT01272232|16573605|P1|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1
4806236|NCT01272232|16573603|P3|Weeks 0-56|Unclassified|12
4806237|NCT01272232|16573604|P2|Weeks 0-56|Unclassified|7
4806238|NCT01272232|16573605|P1|Weeks 0-56|Unclassified|16
4806239|NCT01272232|16573603|P3|Weeks 0-56|Withdrawal criteria|37
4806240|NCT01272232|16573604|P2|Weeks 0-56|Withdrawal criteria|14
4806241|NCT01272232|16573605|P1|Weeks 0-56|Withdrawal criteria|32
4806242|NCT01272232|16573603|P3|Weeks 0-56|Protocol Violation|13
4806243|NCT01272232|16573604|P2|Weeks 0-56|Protocol Violation|8
4806244|NCT01272232|16573605|P1|Weeks 0-56|Protocol Violation|12
4806245|NCT01272232|16573603|P3|Weeks 0-56|Lack of Efficacy|3
4806246|NCT01272232|16573604|P2|Weeks 0-56|Lack of Efficacy|0
4806247|NCT01272232|16573605|P1|Weeks 0-56|Lack of Efficacy|0
4806248|NCT01272232|16573603|P3|Weeks 0-56|Adverse Event|7
4806249|NCT01272232|16573604|P2|Weeks 0-56|Adverse Event|18
4806250|NCT01272232|16573605|P1|Weeks 0-56|Adverse Event|39
4806575|NCT01270828|16574354|P2|Double Blind Phase|Death|1
4806251|NCT01272219|16573650|P6|Main + Extension Period: Week 0-172|Unclassified|51
4806252|NCT01272219|16573651|P5|Main + Extension Period: Week 0-172|Unclassified|61
4806253|NCT01272219|16573652|P4|Main + Extension Period: Week 0-172|Unclassified|0
4806254|NCT01272219|16573653|P3|Main + Extension Period: Week 0-172|Unclassified|0
4806255|NCT01272219|16573654|P2|Main + Extension Period: Week 0-172|Unclassified|0
4806256|NCT01272219|16573655|P1|Main + Extension Period: Week 0-172|Unclassified|0
4806257|NCT01272219|16573650|P6|Main + Extension Period: Week 0-172|Missing reason|0
4806258|NCT01272219|16573651|P5|Main + Extension Period: Week 0-172|Missing reason|1
4806259|NCT01272219|16573652|P4|Main + Extension Period: Week 0-172|Missing reason|0
4806260|NCT01272219|16573653|P3|Main + Extension Period: Week 0-172|Missing reason|0
4806261|NCT01272219|16573654|P2|Main + Extension Period: Week 0-172|Missing reason|0
4806262|NCT01272219|16573655|P1|Main + Extension Period: Week 0-172|Missing reason|0
4806263|NCT01272219|16573650|P6|Main + Extension Period: Week 0-172|Withdrawal criteria|256
4806264|NCT01272219|16573651|P5|Main + Extension Period: Week 0-172|Withdrawal criteria|364
4806265|NCT01272219|16573652|P4|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4806266|NCT01272219|16573653|P3|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4806267|NCT01272219|16573654|P2|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4806268|NCT01272219|16573655|P1|Main + Extension Period: Week 0-172|Withdrawal criteria|0
4806269|NCT01272219|16573650|P6|Main + Extension Period: Week 0-172|Protocol Violation|36
4806270|NCT01272219|16573651|P5|Main + Extension Period: Week 0-172|Protocol Violation|76
4806271|NCT01272219|16573652|P4|Main + Extension Period: Week 0-172|Protocol Violation|0
4806272|NCT01272219|16573653|P3|Main + Extension Period: Week 0-172|Protocol Violation|0
4806273|NCT01272219|16573654|P2|Main + Extension Period: Week 0-172|Protocol Violation|0
4806274|NCT01272219|16573655|P1|Main + Extension Period: Week 0-172|Protocol Violation|0
4806275|NCT01272219|16573650|P6|Main + Extension Period: Week 0-172|Lack of Efficacy|36
4806276|NCT01272219|16573651|P5|Main + Extension Period: Week 0-172|Lack of Efficacy|29
4806277|NCT01272219|16573652|P4|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4806278|NCT01272219|16573653|P3|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4806279|NCT01272219|16573654|P2|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4806280|NCT01272219|16573655|P1|Main + Extension Period: Week 0-172|Lack of Efficacy|0
4806281|NCT01272219|16573650|P6|Main + Extension Period: Week 0-172|Adverse Event|43
4806282|NCT01272219|16573651|P5|Main + Extension Period: Week 0-172|Adverse Event|191
4806283|NCT01272219|16573652|P4|Main + Extension Period: Week 0-172|Adverse Event|0
4806284|NCT01272219|16573653|P3|Main + Extension Period: Week 0-172|Adverse Event|0
4806285|NCT01272219|16573654|P2|Main + Extension Period: Week 0-172|Adverse Event|0
4806286|NCT01272219|16573655|P1|Main + Extension Period: Week 0-172|Adverse Event|0
4806287|NCT01272219|16573650|P6|Re-randomised Period: Week 56 to Week 68|Unclassified|0
4806288|NCT01272219|16573651|P5|Re-randomised Period: Week 56 to Week 68|Unclassified|0
4806289|NCT01272219|16573652|P4|Re-randomised Period: Week 56 to Week 68|Unclassified|2
4806290|NCT01272219|16573653|P3|Re-randomised Period: Week 56 to Week 68|Unclassified|2
4806291|NCT01272219|16573654|P2|Re-randomised Period: Week 56 to Week 68|Unclassified|1
4806292|NCT01272219|16573655|P1|Re-randomised Period: Week 56 to Week 68|Unclassified|0
4806293|NCT01272219|16573650|P6|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
4806294|NCT01272219|16573651|P5|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
4806295|NCT01272219|16573652|P4|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7
4806296|NCT01272219|16573653|P3|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4
4806297|NCT01272219|16573654|P2|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6
4806298|NCT01272219|16573655|P1|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0
4806299|NCT01272219|16573650|P6|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4806300|NCT01272219|16573651|P5|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4806301|NCT01272219|16573652|P4|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3
4806302|NCT01272219|16573653|P3|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4806303|NCT01272219|16573654|P2|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1
4806304|NCT01272219|16573655|P1|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0
4806305|NCT01272219|16573650|P6|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4806306|NCT01272219|16573651|P5|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4806307|NCT01272219|16573652|P4|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1
4806308|NCT01272219|16573653|P3|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4806309|NCT01272219|16573654|P2|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4806310|NCT01272219|16573655|P1|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0
4806311|NCT01272219|16573650|P6|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
4806312|NCT01272219|16573651|P5|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
4806313|NCT01272219|16573652|P4|Re-randomised Period: Week 56 to Week 68|Adverse Event|2
4806314|NCT01272219|16573653|P3|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
4806315|NCT01272219|16573654|P2|Re-randomised Period: Week 56 to Week 68|Adverse Event|1
4806316|NCT01272219|16573655|P1|Re-randomised Period: Week 56 to Week 68|Adverse Event|0
4806317|NCT01272219|16573650|P6|Main Period: Week 0 to Week 56|Unclassified|34
4806318|NCT01272219|16573651|P5|Main Period: Week 0 to Week 56|Unclassified|42
4806319|NCT01272219|16573652|P4|Main Period: Week 0 to Week 56|Unclassified|29
4806320|NCT01272219|16573653|P3|Main Period: Week 0 to Week 56|Unclassified|0
4806321|NCT01272219|16573654|P2|Main Period: Week 0 to Week 56|Unclassified|0
4806322|NCT01272219|16573655|P1|Main Period: Week 0 to Week 56|Unclassified|36
4806576|NCT01270828|16574355|P1|Double Blind Phase|Death|0
4806323|NCT01272219|16573650|P6|Main Period: Week 0 to Week 56|Withdrawal criteria|147
4806324|NCT01272219|16573651|P5|Main Period: Week 0 to Week 56|Withdrawal criteria|172
4806325|NCT01272219|16573652|P4|Main Period: Week 0 to Week 56|Withdrawal criteria|114
4806326|NCT01272219|16573653|P3|Main Period: Week 0 to Week 56|Withdrawal criteria|0
4806327|NCT01272219|16573654|P2|Main Period: Week 0 to Week 56|Withdrawal criteria|0
4806328|NCT01272219|16573655|P1|Main Period: Week 0 to Week 56|Withdrawal criteria|122
4806329|NCT01272219|16573650|P6|Main Period: Week 0 to Week 56|Protocol Violation|20
4806330|NCT01272219|16573651|P5|Main Period: Week 0 to Week 56|Protocol Violation|40
4806331|NCT01272219|16573652|P4|Main Period: Week 0 to Week 56|Protocol Violation|18
4806332|NCT01272219|16573653|P3|Main Period: Week 0 to Week 56|Protocol Violation|0
4806333|NCT01272219|16573654|P2|Main Period: Week 0 to Week 56|Protocol Violation|0
4806334|NCT01272219|16573655|P1|Main Period: Week 0 to Week 56|Protocol Violation|25
4806335|NCT01272219|16573650|P6|Main Period: Week 0 to Week 56|Lack of Efficacy|22
4806336|NCT01272219|16573651|P5|Main Period: Week 0 to Week 56|Lack of Efficacy|12
4806337|NCT01272219|16573652|P4|Main Period: Week 0 to Week 56|Lack of Efficacy|14
4806338|NCT01272219|16573653|P3|Main Period: Week 0 to Week 56|Lack of Efficacy|0
4806339|NCT01272219|16573654|P2|Main Period: Week 0 to Week 56|Lack of Efficacy|0
4806340|NCT01272219|16573655|P1|Main Period: Week 0 to Week 56|Lack of Efficacy|11
4806341|NCT01272219|16573650|P6|Main Period: Week 0 to Week 56|Adverse Event|29
4806342|NCT01272219|16573651|P5|Main Period: Week 0 to Week 56|Adverse Event|152
4806343|NCT01272219|16573652|P4|Main Period: Week 0 to Week 56|Adverse Event|16
4806344|NCT01272219|16573653|P3|Main Period: Week 0 to Week 56|Adverse Event|0
4806345|NCT01272219|16573654|P2|Main Period: Week 0 to Week 56|Adverse Event|0
4806346|NCT01272219|16573655|P1|Main Period: Week 0 to Week 56|Adverse Event|86
4806347|NCT01272193|16573689|P2|Overall Study|Unclassified|7
4806348|NCT01272193|16573690|P1|Overall Study|Unclassified|8
4806349|NCT01272193|16573689|P2|Overall Study|Withdrawal Criteria|1
4806350|NCT01272193|16573690|P1|Overall Study|Withdrawal Criteria|1
4806351|NCT01272193|16573689|P2|Overall Study|Lack of Efficacy|3
4806352|NCT01272193|16573690|P1|Overall Study|Lack of Efficacy|0
4806353|NCT01272193|16573689|P2|Overall Study|Adverse Event|1
4806354|NCT01272193|16573690|P1|Overall Study|Adverse Event|1
4806355|NCT01272180|16573710|P4|Overall Study|Protocol Violation|1
4806356|NCT01272180|16573711|P3|Overall Study|Protocol Violation|0
4806357|NCT01272180|16573712|P2|Overall Study|Protocol Violation|1
4806358|NCT01272180|16573713|P1|Overall Study|Protocol Violation|0
4806359|NCT01272180|16573710|P4|Overall Study|Inappropriate enrollment|1
4806360|NCT01272180|16573711|P3|Overall Study|Inappropriate enrollment|1
4806361|NCT01272180|16573712|P2|Overall Study|Inappropriate enrollment|0
4806362|NCT01272180|16573713|P1|Overall Study|Inappropriate enrollment|0
4806363|NCT01272180|16573710|P4|Overall Study|Lost to Follow-up|10
4806364|NCT01272180|16573711|P3|Overall Study|Lost to Follow-up|8
4806365|NCT01272180|16573712|P2|Overall Study|Lost to Follow-up|14
4806366|NCT01272180|16573713|P1|Overall Study|Lost to Follow-up|15
4806367|NCT01272180|16573710|P4|Overall Study|Withdrawal by Subject|2
4806368|NCT01272180|16573711|P3|Overall Study|Withdrawal by Subject|3
4806369|NCT01272180|16573712|P2|Overall Study|Withdrawal by Subject|6
4806370|NCT01272180|16573713|P1|Overall Study|Withdrawal by Subject|2
4806371|NCT01272180|16573710|P4|Overall Study|Adverse Event|0
4806372|NCT01272180|16573711|P3|Overall Study|Adverse Event|1
4806373|NCT01272180|16573712|P2|Overall Study|Adverse Event|0
4806374|NCT01272180|16573713|P1|Overall Study|Adverse Event|0
4806375|NCT01272011|16573765|P3|Overall Study|Withdrawal By Subject or Failed Screen|0
4806376|NCT01272011|16573766|P2|Overall Study|Withdrawal By Subject or Failed Screen|2
4806377|NCT01272011|16573767|P1|Overall Study|Withdrawal By Subject or Failed Screen|0
4806378|NCT01271933|16573803|P3|Double-Blind Phase|Participant request-personal reason|0
4806379|NCT01271933|16573804|P2|Double-Blind Phase|Participant request-personal reason|1
4806380|NCT01271933|16573805|P1|Double-Blind Phase|Participant request-personal reason|0
4806381|NCT01271933|16573803|P3|Double-Blind Phase|Adverse Event|0
4806382|NCT01271933|16573804|P2|Double-Blind Phase|Adverse Event|3
4806383|NCT01271933|16573805|P1|Double-Blind Phase|Adverse Event|0
4806384|NCT01271933|16573803|P3|Double-Blind Phase|Withdrawal by Subject|1
4806385|NCT01271933|16573804|P2|Double-Blind Phase|Withdrawal by Subject|6
4806386|NCT01271933|16573805|P1|Double-Blind Phase|Withdrawal by Subject|0
4806387|NCT01271933|16573803|P3|Double-Blind Phase|Lost to Follow-up|1
4806388|NCT01271933|16573804|P2|Double-Blind Phase|Lost to Follow-up|1
4806389|NCT01271933|16573805|P1|Double-Blind Phase|Lost to Follow-up|0
4806390|NCT01271933|16573803|P3|Double-Blind Phase|Lack of Efficacy|9
4806391|NCT01271933|16573804|P2|Double-Blind Phase|Lack of Efficacy|6
4806392|NCT01271933|16573805|P1|Double-Blind Phase|Lack of Efficacy|0
4806393|NCT01271933|16573803|P3|Double-Blind Phase|Randomized but not treated|1
4806394|NCT01271933|16573804|P2|Double-Blind Phase|Randomized but not treated|0
4806395|NCT01271933|16573805|P1|Double-Blind Phase|Randomized but not treated|0
4806396|NCT01271933|16573803|P3|Single-Blind Phase|(Participant request-personal reason)|0
4806397|NCT01271933|16573804|P2|Single-Blind Phase|(Participant request-personal reason)|0
4806398|NCT01271933|16573805|P1|Single-Blind Phase|(Participant request-personal reason)|1
4806399|NCT01271933|16573803|P3|Single-Blind Phase|(Protocol non-compliance)|0
4806400|NCT01271933|16573804|P2|Single-Blind Phase|(Protocol non-compliance)|0
4806401|NCT01271933|16573805|P1|Single-Blind Phase|(Protocol non-compliance)|2
4806402|NCT01271933|16573803|P3|Single-Blind Phase|(Failed to meet dosing requirement)|0
4806403|NCT01271933|16573804|P2|Single-Blind Phase|(Failed to meet dosing requirement)|0
4806404|NCT01271933|16573805|P1|Single-Blind Phase|(Failed to meet dosing requirement)|1
4806405|NCT01271933|16573803|P3|Single-Blind Phase|Adverse Event|0
4806406|NCT01271933|16573804|P2|Single-Blind Phase|Adverse Event|0
4806407|NCT01271933|16573805|P1|Single-Blind Phase|Adverse Event|52
4806408|NCT01271933|16573803|P3|Single-Blind Phase|Protocol Violation|0
4806409|NCT01271933|16573804|P2|Single-Blind Phase|Protocol Violation|0
4806410|NCT01271933|16573805|P1|Single-Blind Phase|Protocol Violation|3
4806411|NCT01271933|16573803|P3|Single-Blind Phase|Withdrawal by Subject|0
4806412|NCT01271933|16573804|P2|Single-Blind Phase|Withdrawal by Subject|0
4806413|NCT01271933|16573805|P1|Single-Blind Phase|Withdrawal by Subject|15
4806414|NCT01271933|16573803|P3|Single-Blind Phase|Lost to Follow-up|0
4806415|NCT01271933|16573804|P2|Single-Blind Phase|Lost to Follow-up|0
4806416|NCT01271933|16573805|P1|Single-Blind Phase|Lost to Follow-up|10
4806417|NCT01271933|16573803|P3|Single-Blind Phase|Lack of Efficacy|0
4806418|NCT01271933|16573804|P2|Single-Blind Phase|Lack of Efficacy|0
4806419|NCT01271933|16573805|P1|Single-Blind Phase|Lack of Efficacy|37
4806420|NCT01271803|16573948|P3|Overall Study|Lost to Follow-up|0
4806421|NCT01271803|16573949|P2|Overall Study|Lost to Follow-up|0
4806422|NCT01271803|16573950|P1|Overall Study|Lost to Follow-up|1
4806423|NCT01271803|16573948|P3|Overall Study|Withdrawal by Subject|0
4806424|NCT01271803|16573949|P2|Overall Study|Withdrawal by Subject|5
4806425|NCT01271803|16573950|P1|Overall Study|Withdrawal by Subject|1
4806426|NCT01271803|16573948|P3|Overall Study|Death|0
4806427|NCT01271803|16573949|P2|Overall Study|Death|34
4806428|NCT01271803|16573950|P1|Overall Study|Death|53
4806429|NCT01271803|16573948|P3|Overall Study|Progressive disease|2
4806430|NCT01271803|16573949|P2|Overall Study|Progressive disease|0
4806431|NCT01271803|16573950|P1|Overall Study|Progressive disease|0
4806432|NCT01271725|16574112|P2|Part B|Withdrawal by Subject|6
4806433|NCT01271725|16574113|P1|Part B|Withdrawal by Subject|0
4806434|NCT01271725|16574112|P2|Part B|Protocol Violation|1
4806435|NCT01271725|16574113|P1|Part B|Protocol Violation|0
4806436|NCT01271725|16574112|P2|Part B|Other Adverse Event|1
4806437|NCT01271725|16574113|P1|Part B|Other Adverse Event|0
4806438|NCT01271725|16574112|P2|Part B|Clinical signs/symptoms of progression|2
4806439|NCT01271725|16574113|P1|Part B|Clinical signs/symptoms of progression|0
4806440|NCT01271725|16574112|P2|Part B|Other than specified|2
4806441|NCT01271725|16574113|P1|Part B|Other than specified|0
4806442|NCT01271725|16574112|P2|Part A|Protocol Violation|0
4806443|NCT01271725|16574113|P1|Part A|Protocol Violation|1
4806444|NCT01271725|16574112|P2|Part A|Other than specified|0
4806445|NCT01271725|16574113|P1|Part A|Other than specified|3
4806446|NCT01271725|16574112|P2|Part A|Withdrawal by Subject|0
4806447|NCT01271725|16574113|P1|Part A|Withdrawal by Subject|12
4806448|NCT01271725|16574112|P2|Part A|Lost to Follow-up|0
4806449|NCT01271725|16574113|P1|Part A|Lost to Follow-up|1
4806450|NCT01271725|16574112|P2|Part A|Other Adverse Event|0
4806451|NCT01271725|16574113|P1|Part A|Other Adverse Event|8
4806452|NCT01271725|16574112|P2|Part A|Clinical signs/symptoms of progression|0
4806453|NCT01271725|16574113|P1|Part A|Clinical signs/symptoms of progression|2
4806454|NCT01271725|16574112|P2|Part A|Progressive disease according to RECIST|0
4806455|NCT01271725|16574113|P1|Part A|Progressive disease according to RECIST|8
4806456|NCT01271712|16574142|P2|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6
4806457|NCT01271712|16574143|P1|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15
4806458|NCT01271712|16574142|P2|Safety Follow-up|Progressive disease|0
4806459|NCT01271712|16574143|P1|Safety Follow-up|Progressive disease|1
4806460|NCT01271712|16574142|P2|Safety Follow-up|No follow-up|1
4806461|NCT01271712|16574143|P1|Safety Follow-up|No follow-up|1
4806462|NCT01271712|16574142|P2|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4
4806463|NCT01271712|16574143|P1|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3
4806464|NCT01271712|16574142|P2|Safety Follow-up|Protocol Violation|1
4806465|NCT01271712|16574143|P1|Safety Follow-up|Protocol Violation|1
4806466|NCT01271712|16574142|P2|Safety Follow-up|Withdrawal by Subject|2
4806467|NCT01271712|16574143|P1|Safety Follow-up|Withdrawal by Subject|4
4806468|NCT01271712|16574142|P2|Safety Follow-up|Death|7
4806469|NCT01271712|16574143|P1|Safety Follow-up|Death|11
4806470|NCT01271712|16574142|P2|Open Label Treatment|Switching to other therapy|1
4806471|NCT01271712|16574143|P1|Open Label Treatment|Switching to other therapy|2
4806472|NCT01271712|16574142|P2|Open Label Treatment|Protocol Violation|1
4806473|NCT01271712|16574143|P1|Open Label Treatment|Protocol Violation|0
4806474|NCT01271712|16574142|P2|Open Label Treatment|Non-compliance with study drug|0
4806475|NCT01271712|16574143|P1|Open Label Treatment|Non-compliance with study drug|1
4806476|NCT01271712|16574142|P2|Open Label Treatment|transferred to rollover study|0
4806477|NCT01271712|16574143|P1|Open Label Treatment|transferred to rollover study|1
4806478|NCT01271712|16574142|P2|Open Label Treatment|Progressive disease|32
4806479|NCT01271712|16574143|P1|Open Label Treatment|Progressive disease|59
4806480|NCT01271712|16574142|P2|Open Label Treatment|Adverse Event|8
4806481|NCT01271712|16574143|P1|Open Label Treatment|Adverse Event|14
4806482|NCT01271712|16574142|P2|Open Label Treatment|Physician Decision|0
4806483|NCT01271712|16574143|P1|Open Label Treatment|Physician Decision|2
4806484|NCT01271712|16574142|P2|Open Label Treatment|Withdrawal by Subject|11
4806485|NCT01271712|16574143|P1|Open Label Treatment|Withdrawal by Subject|6
4806486|NCT01271712|16574142|P2|Open Label Treatment|Death|5
4806487|NCT01271712|16574143|P1|Open Label Treatment|Death|6
4806488|NCT01271712|16574142|P2|Double Blind Treatment|receive no study drug|0
4806489|NCT01271712|16574143|P1|Double Blind Treatment|receive no study drug|1
4806490|NCT01271712|16574142|P2|Double Blind Treatment|Non compliance with study drug|0
4806491|NCT01271712|16574143|P1|Double Blind Treatment|Non compliance with study drug|2
4806492|NCT01271712|16574142|P2|Double Blind Treatment|Withdrawal by Subject|1
4806493|NCT01271712|16574143|P1|Double Blind Treatment|Withdrawal by Subject|4
4806494|NCT01271712|16574142|P2|Double Blind Treatment|Progressive disease|3
4806495|NCT01271712|16574143|P1|Double Blind Treatment|Progressive disease|23
4806496|NCT01271712|16574142|P2|Double Blind Treatment|Adverse Event|4
4806497|NCT01271712|16574143|P1|Double Blind Treatment|Adverse Event|9
4806498|NCT01271712|16574142|P2|Double Blind Treatment|Lack of Efficacy|0
4806499|NCT01271712|16574143|P1|Double Blind Treatment|Lack of Efficacy|1
4806500|NCT01271712|16574142|P2|Double Blind Treatment|Death|0
4806501|NCT01271712|16574143|P1|Double Blind Treatment|Death|2
4806502|NCT01271010|16574239|P1|Overall Study|Disease progression|27
4806503|NCT01271010|16574239|P1|Overall Study|Withdrawal by Subject|18
4806504|NCT01271010|16574239|P1|Overall Study|Progression and relapse of disease|1
4806505|NCT01271010|16574239|P1|Overall Study|Death|2
4806506|NCT01271010|16574239|P1|Overall Study|Protocol Violation|1
4806507|NCT01271010|16574239|P1|Overall Study|Start of new CLL therapy|1
4806508|NCT01271010|16574239|P1|Overall Study|Reason not specified|11
4806509|NCT01270971|16574254|P2|Overall Study|Non-specific|3
4806510|NCT01270971|16574255|P1|Overall Study|Non-specific|7
4806511|NCT01270971|16574254|P2|Overall Study|Non compliance|2
4806512|NCT01270971|16574255|P1|Overall Study|Non compliance|2
4806513|NCT01270971|16574254|P2|Overall Study|Adverse Event|2
4806514|NCT01270971|16574255|P1|Overall Study|Adverse Event|1
4806515|NCT01270971|16574254|P2|Overall Study|Lost to Follow-up|5
4806516|NCT01270971|16574255|P1|Overall Study|Lost to Follow-up|18
4806517|NCT01270971|16574254|P2|Overall Study|Withdrawal by Subject|11
4806518|NCT01270971|16574255|P1|Overall Study|Withdrawal by Subject|24
4806519|NCT01270958|16574267|P1|Overall Study|Did not meet inclusion criteria for age|2
4806520|NCT01270958|16574267|P1|Overall Study|Lost to Follow-up|2
4806521|NCT01270880|16574296|P1|Overall Study|Never rec'd treatment, but registered.|1
4806522|NCT01270841|16574326|P4|Overall Study|Enrolled in error|0
4806523|NCT01270841|16574327|P3|Overall Study|Enrolled in error|0
4806524|NCT01270841|16574328|P2|Overall Study|Enrolled in error|1
4806525|NCT01270841|16574329|P1|Overall Study|Enrolled in error|0
4806526|NCT01270841|16574326|P4|Overall Study|Protocol Violation|0
4806527|NCT01270841|16574327|P3|Overall Study|Protocol Violation|0
4806528|NCT01270841|16574328|P2|Overall Study|Protocol Violation|5
4806529|NCT01270841|16574329|P1|Overall Study|Protocol Violation|1
4806530|NCT01270841|16574326|P4|Overall Study|Did not qualify|5
4806531|NCT01270841|16574327|P3|Overall Study|Did not qualify|4
4806532|NCT01270841|16574328|P2|Overall Study|Did not qualify|3
4806533|NCT01270841|16574329|P1|Overall Study|Did not qualify|6
4806534|NCT01270841|16574326|P4|Overall Study|Physician Decision|0
4806535|NCT01270841|16574327|P3|Overall Study|Physician Decision|0
4806536|NCT01270841|16574328|P2|Overall Study|Physician Decision|1
4806537|NCT01270841|16574329|P1|Overall Study|Physician Decision|0
4806538|NCT01270841|16574326|P4|Overall Study|Lost to Follow-up|2
4806539|NCT01270841|16574327|P3|Overall Study|Lost to Follow-up|4
4806540|NCT01270841|16574328|P2|Overall Study|Lost to Follow-up|1
4806541|NCT01270841|16574329|P1|Overall Study|Lost to Follow-up|3
4806542|NCT01270841|16574326|P4|Overall Study|Withdrawal by Subject|3
4806543|NCT01270841|16574327|P3|Overall Study|Withdrawal by Subject|3
4806544|NCT01270841|16574328|P2|Overall Study|Withdrawal by Subject|2
4806545|NCT01270841|16574329|P1|Overall Study|Withdrawal by Subject|3
4806546|NCT01270841|16574326|P4|Overall Study|Adverse Event|3
4806547|NCT01270841|16574327|P3|Overall Study|Adverse Event|0
4806548|NCT01270841|16574328|P2|Overall Study|Adverse Event|1
4806549|NCT01270841|16574329|P1|Overall Study|Adverse Event|0
4806550|NCT01270828|16574353|P3|Double Blind Phase|Adverse event related to study drug|0
4806551|NCT01270828|16574354|P2|Double Blind Phase|Adverse event related to study drug|7
4806552|NCT01270828|16574355|P1|Double Blind Phase|Adverse event related to study drug|5
4806553|NCT01270828|16574353|P3|Double Blind Phase|Adverse event not related to study drug|0
4806554|NCT01270828|16574354|P2|Double Blind Phase|Adverse event not related to study drug|1
4806555|NCT01270828|16574355|P1|Double Blind Phase|Adverse event not related to study drug|1
4806556|NCT01270828|16574353|P3|Double Blind Phase|Lack of Efficacy|0
4806557|NCT01270828|16574354|P2|Double Blind Phase|Lack of Efficacy|11
4806558|NCT01270828|16574355|P1|Double Blind Phase|Lack of Efficacy|2
4806559|NCT01270828|16574353|P3|Double Blind Phase|Lost to Follow-up|0
4806560|NCT01270828|16574354|P2|Double Blind Phase|Lost to Follow-up|2
4806561|NCT01270828|16574355|P1|Double Blind Phase|Lost to Follow-up|1
4806562|NCT01270828|16574353|P3|Double Blind Phase|Withdrawal by Subject|0
4806563|NCT01270828|16574354|P2|Double Blind Phase|Withdrawal by Subject|15
4806564|NCT01270828|16574355|P1|Double Blind Phase|Withdrawal by Subject|6
4806565|NCT01270828|16574353|P3|Double Blind Phase|Reason Unspecified|0
4806566|NCT01270828|16574354|P2|Double Blind Phase|Reason Unspecified|4
4806567|NCT01270828|16574355|P1|Double Blind Phase|Reason Unspecified|7
4806568|NCT01270828|16574353|P3|Double Blind Phase|Protocol and GCP non-compliance|0
4806569|NCT01270828|16574354|P2|Double Blind Phase|Protocol and GCP non-compliance|3
4806570|NCT01270828|16574355|P1|Double Blind Phase|Protocol and GCP non-compliance|4
4806571|NCT01270828|16574353|P3|Double Blind Phase|Protocol Violation|0
4806572|NCT01270828|16574354|P2|Double Blind Phase|Protocol Violation|1
4806573|NCT01270828|16574355|P1|Double Blind Phase|Protocol Violation|0
4806574|NCT01270828|16574353|P3|Double Blind Phase|Death|0
4806577|NCT01270828|16574353|P3|Pregabalin CR SB|Protocol Violation|8
4806578|NCT01270828|16574354|P2|Pregabalin CR SB|Protocol Violation|0
4806579|NCT01270828|16574355|P1|Pregabalin CR SB|Protocol Violation|0
4806580|NCT01270828|16574353|P3|Pregabalin CR SB|Unrelated AE|8
4806581|NCT01270828|16574354|P2|Pregabalin CR SB|Unrelated AE|0
4806582|NCT01270828|16574355|P1|Pregabalin CR SB|Unrelated AE|0
4806583|NCT01270828|16574353|P3|Pregabalin CR SB|Lost to Follow-up|10
4806584|NCT01270828|16574354|P2|Pregabalin CR SB|Lost to Follow-up|0
4806585|NCT01270828|16574355|P1|Pregabalin CR SB|Lost to Follow-up|0
4806586|NCT01270828|16574353|P3|Pregabalin CR SB|Withdrawal by Subject|29
4806587|NCT01270828|16574354|P2|Pregabalin CR SB|Withdrawal by Subject|0
4806588|NCT01270828|16574355|P1|Pregabalin CR SB|Withdrawal by Subject|0
4806589|NCT01270828|16574353|P3|Pregabalin CR SB|Lack of Efficacy|32
4806590|NCT01270828|16574354|P2|Pregabalin CR SB|Lack of Efficacy|0
4806591|NCT01270828|16574355|P1|Pregabalin CR SB|Lack of Efficacy|0
4806592|NCT01270828|16574353|P3|Pregabalin CR SB|Related adverse event|46
4806593|NCT01270828|16574354|P2|Pregabalin CR SB|Related adverse event|0
4806594|NCT01270828|16574355|P1|Pregabalin CR SB|Related adverse event|0
4806595|NCT01270828|16574353|P3|Pregabalin CR SB|Enrolled but not treated|5
4806596|NCT01270828|16574354|P2|Pregabalin CR SB|Enrolled but not treated|0
4806597|NCT01270828|16574355|P1|Pregabalin CR SB|Enrolled but not treated|0
4806598|NCT01270828|16574353|P3|Pregabalin CR SB|Reason Unspecified|8
4806599|NCT01270828|16574354|P2|Pregabalin CR SB|Reason Unspecified|0
4806600|NCT01270828|16574355|P1|Pregabalin CR SB|Reason Unspecified|0
4806601|NCT01270802|16574397|P2|Overall Study|Lost to Follow-up|1
4806602|NCT01270802|16574398|P1|Overall Study|Lost to Follow-up|0
4806603|NCT01270802|16574397|P2|Overall Study|Adverse Event|0
4806604|NCT01270802|16574398|P1|Overall Study|Adverse Event|1
4806605|NCT01270802|16574397|P2|Overall Study|Withdrawal by Subject|0
4806606|NCT01270802|16574398|P1|Overall Study|Withdrawal by Subject|1
4806607|NCT01270620|16574545|P2|Overall Study|Withdrawal by Subject|3
4806608|NCT01270620|16574546|P1|Overall Study|Withdrawal by Subject|1
4806609|NCT01270503|16574641|P1|Overall Study|Lost to Follow-up|1
4806610|NCT01270464|16574649|P3|Overall Study|Other|3
4806611|NCT01270464|16574650|P2|Overall Study|Other|1
4806612|NCT01270464|16574651|P1|Overall Study|Other|1
4806613|NCT01270464|16574649|P3|Overall Study|Lost to Follow-up|1
4806614|NCT01270464|16574650|P2|Overall Study|Lost to Follow-up|3
4806615|NCT01270464|16574651|P1|Overall Study|Lost to Follow-up|2
4806616|NCT01270464|16574649|P3|Overall Study|Withdrawal by Subject|4
4806617|NCT01270464|16574650|P2|Overall Study|Withdrawal by Subject|1
4806618|NCT01270464|16574651|P1|Overall Study|Withdrawal by Subject|2
4806619|NCT01270464|16574649|P3|Overall Study|Adverse Event|7
4806620|NCT01270464|16574650|P2|Overall Study|Adverse Event|1
4806621|NCT01270464|16574651|P1|Overall Study|Adverse Event|9
4806622|NCT01270464|16574649|P3|Overall Study|Lack of Efficacy|1
4806623|NCT01270464|16574650|P2|Overall Study|Lack of Efficacy|3
4806624|NCT01270464|16574651|P1|Overall Study|Lack of Efficacy|2
4806625|NCT01270464|16574649|P3|Overall Study|Protocol Violation|2
4806626|NCT01270464|16574650|P2|Overall Study|Protocol Violation|3
4806627|NCT01270464|16574651|P1|Overall Study|Protocol Violation|4
4806628|NCT01270321|16574701|P3|Overall Study|Adverse Event|5
4806629|NCT01270321|16574702|P2|Overall Study|Adverse Event|9
4806630|NCT01270321|16574703|P1|Overall Study|Adverse Event|7
4806631|NCT01270321|16574701|P3|Overall Study|Death|4
4806632|NCT01270321|16574702|P2|Overall Study|Death|1
4806633|NCT01270321|16574703|P1|Overall Study|Death|3
4806634|NCT01270256|16574716|P2|Overall Study|Withdrawal by Subject|0
4806635|NCT01270256|16574717|P1|Overall Study|Withdrawal by Subject|1
4806636|NCT01270139|16574726|P3|Overall Study|Lost to Follow-up|2
4806637|NCT01270139|16574727|P2|Overall Study|Lost to Follow-up|9
4806638|NCT01270139|16574728|P1|Overall Study|Lost to Follow-up|10
4806639|NCT01270139|16574726|P3|Overall Study|Adverse Event|18
4806640|NCT01270139|16574727|P2|Overall Study|Adverse Event|17
4806641|NCT01270139|16574728|P1|Overall Study|Adverse Event|8
4806642|NCT01269918|16574797|P2|Overall Study|Did not receive study drug|3
4806643|NCT01269918|16574798|P1|Overall Study|Did not receive study drug|0
4806644|NCT01269385|16574873|P4|Overall Study|Adverse Event|0
4806645|NCT01269385|16574874|P3|Overall Study|Adverse Event|0
4806646|NCT01269385|16574875|P2|Overall Study|Adverse Event|1
4806647|NCT01269385|16574876|P1|Overall Study|Adverse Event|1
4806648|NCT01269346|16574901|P1|Extension Phase|Started a prohibited con med|1
4806649|NCT01269346|16574901|P1|Extension Phase|Clinical progression|1
4806650|NCT01269346|16574901|P1|Extension Phase|Physician decision or participant choice|9
4806651|NCT01269346|16574901|P1|Extension Phase|Disease progression|22
4806652|NCT01269346|16574901|P1|Extension Phase|Withdrawal by Subject|4
4806653|NCT01269346|16574901|P1|Extension Phase|Adverse Event|6
4806654|NCT01269346|16574901|P1|Treatment Phase|Other|2
4806655|NCT01269346|16574901|P1|Treatment Phase|Withdrawal by Subject|1
4806656|NCT01269346|16574901|P1|Treatment Phase|Adverse Event|3
4806657|NCT01269346|16574901|P1|Treatment Phase|Disease progression|3
4806658|NCT01269125|16574912|P3|Overall Study|Lost to Follow-up|0
4806659|NCT01269125|16574913|P2|Overall Study|Lost to Follow-up|0
4806660|NCT01269125|16574914|P1|Overall Study|Lost to Follow-up|4
4806661|NCT01269125|16574912|P3|Overall Study|Adverse Event|0
4806662|NCT01269125|16574913|P2|Overall Study|Adverse Event|5
4806663|NCT01269125|16574914|P1|Overall Study|Adverse Event|3
4806664|NCT01268891|16574973|P2|Overall Study|Administrative or other reason(s)|0
4806665|NCT01268891|16574974|P1|Overall Study|Administrative or other reason(s)|1
4806666|NCT01268891|16574973|P2|Overall Study|Withdrawal of Consent|1
4806667|NCT01268891|16574974|P1|Overall Study|Withdrawal of Consent|3
4806668|NCT01268891|16574973|P2|Overall Study|Lack of Efficacy|0
4806669|NCT01268891|16574974|P1|Overall Study|Lack of Efficacy|1
4806670|NCT01268891|16574973|P2|Overall Study|Adverse Event|7
4806671|NCT01268891|16574974|P1|Overall Study|Adverse Event|3
4806672|NCT01268566|16575000|P1|Overall Study|Death|30
4806673|NCT01268566|16575000|P1|Overall Study|Withdrawal by Subject|12
4806674|NCT01268566|16575000|P1|Overall Study|Lost to Follow-up|1
4806675|NCT01268514|16575027|P1|Overall Study|Withdrawal by Surgeon|5
4806676|NCT01268514|16575027|P1|Overall Study|Withdrawal by Subject|3
4806677|NCT01268514|16575027|P1|Overall Study|Lost to Follow-up|5
4806678|NCT01268514|16575027|P1|Overall Study|Death|8
4806679|NCT01268514|16575027|P1|Overall Study|Adverse Event|20
4806680|NCT01268501|16575036|P1|Overall Study|Handling Difficulties|2
4806681|NCT01268501|16575036|P1|Overall Study|Unacceptable Subjective Vision|3
4806682|NCT01268501|16575036|P1|Overall Study|Withdrawal by Subject|3
4806683|NCT01268501|16575036|P1|Overall Study|Lost to Follow-up|1
4806684|NCT01268488|16575040|P1|Overall Study|Physician Decision|2
4806685|NCT01268488|16575040|P1|Overall Study|Adverse Event|3
4806686|NCT01268306|16575047|P1|Overall Study|Lost to Follow-up|1
4806687|NCT01268293|16575051|P1|Overall Study|Subject choice|1
4806688|NCT01268293|16575051|P1|Overall Study|Adverse Event|1
4806689|NCT01268293|16575051|P1|Overall Study|Disease progression|7
4806690|NCT01268267|16575056|P1|Overall Study|Protocol Violation|1
4806691|NCT01268150|16575077|P1|Extension Phase|Other|6
4806692|NCT01268150|16575077|P1|Extension Phase|Disease progression|18
4806693|NCT01268150|16575077|P1|Extension Phase|Adverse Event|3
4806694|NCT01268150|16575077|P1|Treatment Phase|Other|4
4806695|NCT01268150|16575077|P1|Treatment Phase|Withdrawal by Subject|3
4806696|NCT01268150|16575077|P1|Treatment Phase|Adverse Event|3
4806697|NCT01268150|16575077|P1|Treatment Phase|Progression of disease|18
4806698|NCT01268098|16575096|P2|Overall Study|Adverse Event|0
4806699|NCT01268098|16575097|P1|Overall Study|Adverse Event|1
4806700|NCT01268046|16575109|P4|Overall Study|Lost to Follow-up|0
4806701|NCT01268046|16575110|P3|Overall Study|Lost to Follow-up|1
4806702|NCT01268046|16575111|P2|Overall Study|Lost to Follow-up|0
4806703|NCT01268046|16575112|P1|Overall Study|Lost to Follow-up|0
4806704|NCT01268046|16575109|P4|Overall Study|Withdrawal by Subject|1
4806705|NCT01268046|16575110|P3|Overall Study|Withdrawal by Subject|0
4806706|NCT01268046|16575111|P2|Overall Study|Withdrawal by Subject|0
4806707|NCT01268046|16575112|P1|Overall Study|Withdrawal by Subject|1
4806708|NCT01267994|16575122|P1|Overall Study|Adverse Event|2
4806709|NCT01267955|16575127|P1|Stage 2 (6 Months)|Protocol Violation|1
4806710|NCT01267955|16575127|P1|Stage 2 (6 Months)|Death|5
4806711|NCT01267955|16575127|P1|Stage 1 (6 Months)|Death|3
4806712|NCT01267825|16575164|P2|Overall Study|study terminated. no data collected.|0
4806713|NCT01267825|16575165|P1|Overall Study|study terminated. no data collected.|1
4806714|NCT01267266|16575247|P2|Lead-in Phase|Withdrawal by Subject|0
4806715|NCT01267266|16575248|P1|Lead-in Phase|Withdrawal by Subject|1
4806716|NCT01267266|16575247|P2|Lead-in Phase|Adverse Event|0
4806717|NCT01267266|16575248|P1|Lead-in Phase|Adverse Event|2
4806718|NCT01267266|16575247|P2|Lead-in Phase|Lack of Efficacy|0
4806719|NCT01267266|16575248|P1|Lead-in Phase|Lack of Efficacy|20
4806720|NCT01267266|16575247|P2|Enrollment Phase|Withdrawal by Subject|0
4806721|NCT01267266|16575248|P1|Enrollment Phase|Withdrawal by Subject|2
4806722|NCT01267253|16575261|P1|Overall Study|Inevaluable-never received study treatme|2
4806723|NCT01267253|16575261|P1|Overall Study|Ineligible - required test not done|1
4806724|NCT01267201|16575300|P6|Second Intervention Period|Withdrawal by Subject|0
4806725|NCT01267201|16575301|P5|Second Intervention Period|Withdrawal by Subject|0
4806726|NCT01267201|16575302|P4|Second Intervention Period|Withdrawal by Subject|0
4806727|NCT01267201|16575303|P3|Second Intervention Period|Withdrawal by Subject|0
4806728|NCT01267201|16575304|P2|Second Intervention Period|Withdrawal by Subject|1
4806729|NCT01267201|16575305|P1|Second Intervention Period|Withdrawal by Subject|0
4806730|NCT01267201|16575300|P6|First Intervention Period|Withdrawal by Subject|0
4806731|NCT01267201|16575301|P5|First Intervention Period|Withdrawal by Subject|0
4806732|NCT01267201|16575302|P4|First Intervention Period|Withdrawal by Subject|0
4806733|NCT01267201|16575303|P3|First Intervention Period|Withdrawal by Subject|0
4806734|NCT01267201|16575304|P2|First Intervention Period|Withdrawal by Subject|0
4806735|NCT01267201|16575305|P1|First Intervention Period|Withdrawal by Subject|1
4806736|NCT01267175|16575322|P1|Overall Study|Lost to Follow-up|1
4806737|NCT01267175|16575322|P1|Overall Study|Withdrawal by Subject|1
4806738|NCT01266993|16575394|P2|Booster Phase (Month 69)|Withdrawal by Subject|1
4806739|NCT01266993|16575395|P1|Booster Phase (Month 69)|Withdrawal by Subject|0
4806740|NCT01266993|16575394|P2|Booster Phase (Month 69)|Lost to Follow-up|1
4806741|NCT01266993|16575395|P1|Booster Phase (Month 69)|Lost to Follow-up|5
4806742|NCT01266967|16575465|P2|Overall Study|Withdrawal by Subject|3
4806743|NCT01266967|16575466|P1|Overall Study|Withdrawal by Subject|3
4806744|NCT01266967|16575465|P2|Overall Study|Physician Decision|1
4806745|NCT01266967|16575466|P1|Overall Study|Physician Decision|0
4806746|NCT01266967|16575465|P2|Overall Study|Lost to Follow-up|1
4806747|NCT01266967|16575466|P1|Overall Study|Lost to Follow-up|2
4806748|NCT01266967|16575465|P2|Overall Study|Study Closed/Terminated|17
4806749|NCT01266967|16575466|P1|Overall Study|Study Closed/Terminated|15
4806750|NCT01266967|16575465|P2|Overall Study|Death|61
4806751|NCT01266967|16575466|P1|Overall Study|Death|69
4806752|NCT01266876|16575518|P5|Overall Study|Adverse Event|0
4806753|NCT01266876|16575519|P4|Overall Study|Adverse Event|1
4806754|NCT01266876|16575520|P3|Overall Study|Adverse Event|0
4806755|NCT01266876|16575521|P2|Overall Study|Adverse Event|0
4806756|NCT01266876|16575522|P1|Overall Study|Adverse Event|0
4806757|NCT01266850|16575629|P5|Overall Study|Site Closure|0
4806758|NCT01266850|16575630|P4|Overall Study|Site Closure|1
4806759|NCT01266850|16575631|P3|Overall Study|Site Closure|1
4806760|NCT01266850|16575632|P2|Overall Study|Site Closure|1
4806761|NCT01266850|16575633|P1|Overall Study|Site Closure|0
4806762|NCT01266850|16575629|P5|Overall Study|Adverse Event|1
4806763|NCT01266850|16575630|P4|Overall Study|Adverse Event|0
4806764|NCT01266850|16575631|P3|Overall Study|Adverse Event|0
4806765|NCT01266850|16575632|P2|Overall Study|Adverse Event|0
4806766|NCT01266850|16575633|P1|Overall Study|Adverse Event|0
4806767|NCT01266850|16575629|P5|Overall Study|Protocol Violation|2
4806768|NCT01266850|16575630|P4|Overall Study|Protocol Violation|1
4806769|NCT01266850|16575631|P3|Overall Study|Protocol Violation|0
4806770|NCT01266850|16575632|P2|Overall Study|Protocol Violation|1
4806771|NCT01266850|16575633|P1|Overall Study|Protocol Violation|0
4806772|NCT01266850|16575629|P5|Overall Study|Physician Decision|3
4806773|NCT01266850|16575630|P4|Overall Study|Physician Decision|4
4806774|NCT01266850|16575631|P3|Overall Study|Physician Decision|4
4806775|NCT01266850|16575632|P2|Overall Study|Physician Decision|6
4806776|NCT01266850|16575633|P1|Overall Study|Physician Decision|3
4806777|NCT01266850|16575629|P5|Overall Study|Withdrawal by Subject|12
4806778|NCT01266850|16575630|P4|Overall Study|Withdrawal by Subject|9
4806779|NCT01266850|16575631|P3|Overall Study|Withdrawal by Subject|6
4806780|NCT01266850|16575632|P2|Overall Study|Withdrawal by Subject|9
4806781|NCT01266850|16575633|P1|Overall Study|Withdrawal by Subject|8
4806782|NCT01266850|16575629|P5|Overall Study|Lost to Follow-up|12
4806783|NCT01266850|16575630|P4|Overall Study|Lost to Follow-up|13
4806784|NCT01266850|16575631|P3|Overall Study|Lost to Follow-up|13
4806785|NCT01266850|16575632|P2|Overall Study|Lost to Follow-up|19
4806786|NCT01266850|16575633|P1|Overall Study|Lost to Follow-up|19
4806787|NCT01266824|16575687|P2|Overall Study|Study terminated prior to completion|3
4806788|NCT01266824|16575688|P1|Overall Study|Study terminated prior to completion|2
4806789|NCT01266603|16575700|P1|Overall Study|Failed screening; MAGE-A3 negative|26
4806790|NCT01266603|16575700|P1|Overall Study|Withdrawal by Subject|1
4806791|NCT01266603|16575700|P1|Overall Study|Lack of Efficacy|14
4806792|NCT01266603|16575700|P1|Overall Study|Adverse Event|1
4806793|NCT01266590|16575706|P1|Overall Study|Physician Decision|1
4806794|NCT01266590|16575706|P1|Overall Study|Withdrawal by Subject|1
4806795|NCT01266590|16575706|P1|Overall Study|Lost to Follow-up|1
4806796|NCT01266590|16575706|P1|Overall Study|Adverse Event|3
4806797|NCT01266460|16575717|P1|Overall Study|Not otherwise specified|8
4806798|NCT01266460|16575717|P1|Overall Study|Disease Progression|18
4806799|NCT01266460|16575717|P1|Overall Study|Withdrawal by Subject|5
4806800|NCT01266460|16575717|P1|Overall Study|Adverse Event|3
4806801|NCT01266317|16575735|P1|Overall Study|Withdrawal by Subject|2
4806802|NCT01266291|16575740|P1|Overall Study|Adverse Event|1
4806803|NCT01266265|16575747|P2|Overall Study|Clinical worsening|1
4806804|NCT01266265|16575748|P1|Overall Study|Clinical worsening|1
4806805|NCT01266265|16575747|P2|Overall Study|Site closed early|3
4806806|NCT01266265|16575748|P1|Overall Study|Site closed early|4
4806807|NCT01266265|16575747|P2|Overall Study|Lung transplant|5
4806808|NCT01266265|16575748|P1|Overall Study|Lung transplant|6
4806809|NCT01266265|16575747|P2|Overall Study|Non-compliance|5
4806810|NCT01266265|16575748|P1|Overall Study|Non-compliance|8
4806811|NCT01266265|16575747|P2|Overall Study|Enrolled in another clinical study|26
4806812|NCT01266265|16575748|P1|Overall Study|Enrolled in another clinical study|15
4806813|NCT01266265|16575747|P2|Overall Study|Stopped/changed PAH medication(s)|9
4806814|NCT01266265|16575748|P1|Overall Study|Stopped/changed PAH medication(s)|16
4806815|NCT01266265|16575747|P2|Overall Study|Transferred care to another provider|28
4806816|NCT01266265|16575748|P1|Overall Study|Transferred care to another provider|22
4806817|NCT01266265|16575747|P2|Overall Study|Respiratory-related adverse event|1
4806818|NCT01266265|16575748|P1|Overall Study|Respiratory-related adverse event|2
4806819|NCT01266265|16575747|P2|Overall Study|Withdrawal by Subject|11
4806820|NCT01266265|16575748|P1|Overall Study|Withdrawal by Subject|13
4806821|NCT01266265|16575747|P2|Overall Study|Lost to Follow-up|28
4806822|NCT01266265|16575748|P1|Overall Study|Lost to Follow-up|23
4806823|NCT01266265|16575747|P2|Overall Study|Death|73
4806824|NCT01266265|16575748|P1|Overall Study|Death|95
4806825|NCT01266161|16575756|P2|Overall Study|Vomited within 4 hours of dosing|0
4806826|NCT01266161|16575757|P1|Overall Study|Vomited within 4 hours of dosing|3
4806827|NCT01266161|16575756|P2|Overall Study|Lack of Efficacy|1
4806828|NCT01266161|16575757|P1|Overall Study|Lack of Efficacy|0
4806829|NCT01266161|16575756|P2|Overall Study|Ineligible|0
4806830|NCT01266161|16575757|P1|Overall Study|Ineligible|1
4806831|NCT01266148|16575789|P2|Overall Study|missing mGFR value + AE|0
4806832|NCT01266148|16575790|P1|Overall Study|missing mGFR value + AE|1
4806833|NCT01266148|16575789|P2|Overall Study|Death|3
4806834|NCT01266148|16575790|P1|Overall Study|Death|2
4806835|NCT01266148|16575789|P2|Overall Study|2 2R rejections|0
4806836|NCT01266148|16575790|P1|Overall Study|2 2R rejections|1
4806837|NCT01266148|16575789|P2|Overall Study|Ongoing rejection|0
4806838|NCT01266148|16575790|P1|Overall Study|Ongoing rejection|1
4806839|NCT01266148|16575789|P2|Overall Study|Adverse Event|0
4806840|NCT01266148|16575790|P1|Overall Study|Adverse Event|2
4806841|NCT01266122|16575818|P2|Overall Study|Lost to Follow-up|6
4806842|NCT01266122|16575819|P1|Overall Study|Lost to Follow-up|6
4806843|NCT01266070|16575827|P1|Overall Study|Protocol Violation|1
4806844|NCT01266070|16575827|P1|Overall Study|Adverse Event|3
4806845|NCT01266031|16575835|P3|Overall Study|Not treated|2
4806846|NCT01266031|16575836|P2|Overall Study|Not treated|3
4806847|NCT01266031|16575837|P1|Overall Study|Not treated|0
4806848|NCT01266018|16575864|P2|Overall Study|Progressive disease|1
4806849|NCT01266018|16575865|P1|Overall Study|Progressive disease|0
4806850|NCT01266018|16575864|P2|Overall Study|Physician Decision|0
4806851|NCT01266018|16575865|P1|Overall Study|Physician Decision|1
4806852|NCT01265992|16575876|P1|Overall Study|Did not receive treatment|1
4806853|NCT01265992|16575876|P1|Overall Study|Stopped treatment|3
4806854|NCT01265992|16575876|P1|Overall Study|Administrative reasons|2
4806855|NCT01265992|16575876|P1|Overall Study|Adverse Event|1
4806856|NCT01265992|16575876|P1|Overall Study|Withdrawal by Subject|1
4806857|NCT01265992|16575876|P1|Overall Study|Lost to Follow-up|1
4806858|NCT01265953|16575904|P2|Overall Study|Non compliance|3
4806859|NCT01265953|16575905|P1|Overall Study|Non compliance|5
4806860|NCT01265875|16575917|P1|Overall Study|Uncooperative/unreliable|1
4806861|NCT01265823|16575925|P1|Overall Study|Participant Request|1
4806862|NCT01265823|16575925|P1|Overall Study|Protocol Violation|1
4806863|NCT01265823|16575925|P1|Overall Study|Failure to Return|4
4806864|NCT01265823|16575925|P1|Overall Study|Unsatisfactory Response Efficacy|1
4806865|NCT01265797|16575954|P2|Open Label Month|Lost to Follow-up|1
4806866|NCT01265797|16575955|P1|Open Label Month|Lost to Follow-up|0
4806867|NCT01265797|16575954|P2|Blinded Month|Diary data incomplete|1
4806868|NCT01265797|16575955|P1|Blinded Month|Diary data incomplete|0
4806869|NCT01265797|16575954|P2|Blinded Month|Adverse Event|0
4806870|NCT01265797|16575955|P1|Blinded Month|Adverse Event|2
4806871|NCT01265797|16575954|P2|Blinded Month|Protocol Violation|1
4806872|NCT01265797|16575955|P1|Blinded Month|Protocol Violation|2
4806873|NCT01265797|16575954|P2|Blinded Month|Lost to Follow-up|0
4806874|NCT01265797|16575955|P1|Blinded Month|Lost to Follow-up|1
4806875|NCT01265797|16575954|P2|Blinded Month|Lack of Efficacy|0
4806876|NCT01265797|16575955|P1|Blinded Month|Lack of Efficacy|5
4806877|NCT01265797|16575954|P2|Run-in Month|1st seizure during run-in month|1
4806878|NCT01265797|16575955|P1|Run-in Month|1st seizure during run-in month|0
4806879|NCT01265797|16575954|P2|Run-in Month|Withdrawal by Subject|4
4806880|NCT01265797|16575955|P1|Run-in Month|Withdrawal by Subject|0
4806881|NCT01265784|16575986|P3|Overall Study|Incorrectly Randomized|1
4806882|NCT01265784|16575987|P2|Overall Study|Incorrectly Randomized|0
4806883|NCT01265784|16575988|P1|Overall Study|Incorrectly Randomized|0
4806884|NCT01265784|16575986|P3|Overall Study|Protocol Violation|0
4806885|NCT01265784|16575987|P2|Overall Study|Protocol Violation|0
4806886|NCT01265784|16575988|P1|Overall Study|Protocol Violation|2
4806887|NCT01265784|16575986|P3|Overall Study|Death|0
4806888|NCT01265784|16575987|P2|Overall Study|Death|0
4806889|NCT01265784|16575988|P1|Overall Study|Death|3
4806890|NCT01265784|16575986|P3|Overall Study|Adverse Event|0
4806891|NCT01265784|16575987|P2|Overall Study|Adverse Event|0
4806892|NCT01265784|16575988|P1|Overall Study|Adverse Event|1
4806893|NCT01265784|16575986|P3|Overall Study|Physician Decision|1
4806894|NCT01265784|16575987|P2|Overall Study|Physician Decision|0
4806895|NCT01265784|16575988|P1|Overall Study|Physician Decision|1
4806896|NCT01265784|16575986|P3|Overall Study|Withdrawal by Subject|0
4806897|NCT01265784|16575987|P2|Overall Study|Withdrawal by Subject|5
4806898|NCT01265784|16575988|P1|Overall Study|Withdrawal by Subject|0
4806899|NCT01265784|16575986|P3|Overall Study|Lost to Follow-up|2
4806900|NCT01265784|16575987|P2|Overall Study|Lost to Follow-up|3
4806901|NCT01265784|16575988|P1|Overall Study|Lost to Follow-up|5
4806902|NCT01265719|16576056|P2|Overall Study|Adverse Event|0
4806903|NCT01265719|16576057|P1|Overall Study|Adverse Event|2
4806904|NCT01265719|16576056|P2|Overall Study|Lost to Follow-up|7
4806905|NCT01265719|16576057|P1|Overall Study|Lost to Follow-up|2
4806906|NCT01265719|16576056|P2|Overall Study|Withdrawal by Subject|3
4806907|NCT01265719|16576057|P1|Overall Study|Withdrawal by Subject|8
4806908|NCT01265719|16576056|P2|Overall Study|Other reasons|0
4806909|NCT01265719|16576057|P1|Overall Study|Other reasons|2
4806910|NCT01265719|16576056|P2|Overall Study|Does not meet entrance criteria|3
4806911|NCT01265719|16576057|P1|Overall Study|Does not meet entrance criteria|0
4806912|NCT01265615|16576108|P4|Overall Study|Protocol Violation|3
4806913|NCT01265615|16576109|P3|Overall Study|Protocol Violation|4
4806914|NCT01265615|16576110|P2|Overall Study|Protocol Violation|2
4806915|NCT01265615|16576111|P1|Overall Study|Protocol Violation|2
4806916|NCT01265563|16576162|P5|Overall Study|Withdrawal by Subject|2
4806917|NCT01265563|16576163|P4|Overall Study|Withdrawal by Subject|0
4806918|NCT01265563|16576164|P3|Overall Study|Withdrawal by Subject|1
4806919|NCT01265563|16576165|P2|Overall Study|Withdrawal by Subject|1
4806920|NCT01265563|16576166|P1|Overall Study|Withdrawal by Subject|0
4806921|NCT01265550|16576192|P4|Pre Randomization|Functional heartburn|99
4806922|NCT01265550|16576193|P3|Pre Randomization|Functional heartburn|0
4806923|NCT01265550|16576194|P2|Pre Randomization|Functional heartburn|0
4806924|NCT01265550|16576195|P1|Pre Randomization|Functional heartburn|0
4806925|NCT01265550|16576192|P4|Pre Randomization|Non-GERD organic disorders|23
4806926|NCT01265550|16576193|P3|Pre Randomization|Non-GERD organic disorders|0
4806927|NCT01265550|16576194|P2|Pre Randomization|Non-GERD organic disorders|0
4806928|NCT01265550|16576195|P1|Pre Randomization|Non-GERD organic disorders|0
4806929|NCT01265550|16576192|P4|Pre Randomization|GERD, PPI-Responsive|42
4806930|NCT01265550|16576193|P3|Pre Randomization|GERD, PPI-Responsive|0
4806931|NCT01265550|16576194|P2|Pre Randomization|GERD, PPI-Responsive|0
4806932|NCT01265550|16576195|P1|Pre Randomization|GERD, PPI-Responsive|0
4806933|NCT01265550|16576192|P4|Pre Randomization|Technical Exclusions|54
4806934|NCT01265550|16576193|P3|Pre Randomization|Technical Exclusions|0
4806935|NCT01265550|16576194|P2|Pre Randomization|Technical Exclusions|0
4806936|NCT01265550|16576195|P1|Pre Randomization|Technical Exclusions|0
4806937|NCT01265550|16576192|P4|Pre Randomization|Withdrawal by Subject|70
4806938|NCT01265550|16576193|P3|Pre Randomization|Withdrawal by Subject|0
4806939|NCT01265550|16576194|P2|Pre Randomization|Withdrawal by Subject|0
4806940|NCT01265550|16576195|P1|Pre Randomization|Withdrawal by Subject|0
4806941|NCT01265537|16576287|P2|Overall Study|Physician Decision|1
4806942|NCT01265537|16576288|P1|Overall Study|Physician Decision|0
4806943|NCT01265537|16576287|P2|Overall Study|Adverse Event|1
4806944|NCT01265537|16576288|P1|Overall Study|Adverse Event|2
4806945|NCT01265511|16576339|P2|Overall Study|Met stopping rules|2
4806946|NCT01265511|16576340|P1|Overall Study|Met stopping rules|0
4806947|NCT01265511|16576339|P2|Overall Study|Lack of Efficacy|1
4806948|NCT01265511|16576340|P1|Overall Study|Lack of Efficacy|2
4806949|NCT01265498|16576354|P2|Overall Study|Protocol modified to eliminate wk72 bx|33
4806950|NCT01265498|16576355|P1|Overall Study|Protocol modified to eliminate wk72 bx|31
4806951|NCT01265420|16576491|P1|Overall Study|Lost to Follow-up|1
4806952|NCT01265394|16576495|P1|Overall Study|Subjects withdrawn|37
4806953|NCT01265056|16576502|P2|Follow up|Lost to Follow-up|3
4806954|NCT01265056|16576503|P1|Follow up|Lost to Follow-up|7
4806955|NCT01265056|16576502|P2|Initial Study Period|Withdrawal by Subject|1
4806956|NCT01265056|16576503|P1|Initial Study Period|Withdrawal by Subject|1
4806957|NCT01265056|16576502|P2|Initial Study Period|Withdrawal by Subject|1
4806958|NCT01265056|16576503|P1|Initial Study Period|Withdrawal by Subject|1
4806959|NCT01264939|16576534|P2|Overall Study|Disease Progression|11
4806960|NCT01264939|16576535|P1|Overall Study|Disease Progression|8
4806961|NCT01264939|16576534|P2|Overall Study|Patient/Guardian Decision|10
4806962|NCT01264939|16576535|P1|Overall Study|Patient/Guardian Decision|8
4806963|NCT01264939|16576534|P2|Overall Study|Physician Decision|1
4806964|NCT01264939|16576535|P1|Overall Study|Physician Decision|1
4806965|NCT01264939|16576534|P2|Overall Study|Lost to Follow-up|3
4806966|NCT01264939|16576535|P1|Overall Study|Lost to Follow-up|0
4806967|NCT01264939|16576534|P2|Overall Study|Adverse Event|3
4806968|NCT01264939|16576535|P1|Overall Study|Adverse Event|1
4806969|NCT01264887|16576561|P1|Overall Study|Other|2
4806970|NCT01264887|16576561|P1|Overall Study|Sponsor Decision Administrative Reasons|2
4806971|NCT01264887|16576561|P1|Overall Study|Withdrawal by Subject|6
4806972|NCT01264887|16576561|P1|Overall Study|Physician Decision|4
4806973|NCT01264887|16576561|P1|Overall Study|Lack of Efficacy|5
4806974|NCT01264887|16576561|P1|Overall Study|Death|7
4806975|NCT01264887|16576561|P1|Overall Study|Adverse Event|5
4806976|NCT01264835|16576572|P1|Overall Study|Lost to Follow-up|1
4806977|NCT01264770|16576582|P6|Overall Study|Adverse Event|1
4806978|NCT01264770|16576583|P5|Overall Study|Adverse Event|2
4806979|NCT01264770|16576584|P4|Overall Study|Adverse Event|0
4806980|NCT01264770|16576585|P3|Overall Study|Adverse Event|8
4806981|NCT01264770|16576586|P2|Overall Study|Adverse Event|7
4806982|NCT01264770|16576587|P1|Overall Study|Adverse Event|7
4806983|NCT01264770|16576582|P6|Overall Study|Lost to Follow-up|0
4806984|NCT01264770|16576583|P5|Overall Study|Lost to Follow-up|0
4806985|NCT01264770|16576584|P4|Overall Study|Lost to Follow-up|1
4806986|NCT01264770|16576585|P3|Overall Study|Lost to Follow-up|1
4806987|NCT01264770|16576586|P2|Overall Study|Lost to Follow-up|0
4806988|NCT01264770|16576587|P1|Overall Study|Lost to Follow-up|0
4806989|NCT01264770|16576582|P6|Overall Study|Dev. of study specific discont. criteria|1
4806990|NCT01264770|16576583|P5|Overall Study|Dev. of study specific discont. criteria|1
4806991|NCT01264770|16576584|P4|Overall Study|Dev. of study specific discont. criteria|0
4806992|NCT01264770|16576585|P3|Overall Study|Dev. of study specific discont. criteria|0
4806993|NCT01264770|16576586|P2|Overall Study|Dev. of study specific discont. criteria|0
4806994|NCT01264770|16576587|P1|Overall Study|Dev. of study specific discont. criteria|2
4806995|NCT01264770|16576582|P6|Overall Study|Lack of therapeutic response|0
4806996|NCT01264770|16576583|P5|Overall Study|Lack of therapeutic response|1
4806997|NCT01264770|16576584|P4|Overall Study|Lack of therapeutic response|1
4806998|NCT01264770|16576585|P3|Overall Study|Lack of therapeutic response|2
4806999|NCT01264770|16576586|P2|Overall Study|Lack of therapeutic response|0
4807000|NCT01264770|16576587|P1|Overall Study|Lack of therapeutic response|1
4807001|NCT01264770|16576582|P6|Overall Study|Severe non-compliance to protocol|0
4807002|NCT01264770|16576583|P5|Overall Study|Severe non-compliance to protocol|0
4807003|NCT01264770|16576584|P4|Overall Study|Severe non-compliance to protocol|1
4807004|NCT01264770|16576585|P3|Overall Study|Severe non-compliance to protocol|1
4807005|NCT01264770|16576586|P2|Overall Study|Severe non-compliance to protocol|0
4807006|NCT01264770|16576587|P1|Overall Study|Severe non-compliance to protocol|0
4807007|NCT01264770|16576582|P6|Overall Study|e.g., change in circumstances|4
4807008|NCT01264770|16576583|P5|Overall Study|e.g., change in circumstances|4
4807009|NCT01264770|16576584|P4|Overall Study|e.g., change in circumstances|3
4807010|NCT01264770|16576585|P3|Overall Study|e.g., change in circumstances|3
4807011|NCT01264770|16576586|P2|Overall Study|e.g., change in circumstances|3
4807012|NCT01264770|16576587|P1|Overall Study|e.g., change in circumstances|8
4807013|NCT01264770|16576582|P6|Overall Study|Not reported|0
4807014|NCT01264770|16576583|P5|Overall Study|Not reported|0
4807015|NCT01264770|16576584|P4|Overall Study|Not reported|0
4807016|NCT01264770|16576585|P3|Overall Study|Not reported|1
4807017|NCT01264770|16576586|P2|Overall Study|Not reported|0
4807018|NCT01264770|16576587|P1|Overall Study|Not reported|0
4807019|NCT01264718|16576673|P2|Overall Study|Loss of Medicaid/CHIP eligibility|26
4807020|NCT01264718|16576674|P1|Overall Study|Loss of Medicaid/CHIP eligibility|37
4807021|NCT01264718|16576673|P2|Overall Study|Withdrawal by Subject|15
4807022|NCT01264718|16576674|P1|Overall Study|Withdrawal by Subject|9
4807023|NCT01264718|16576673|P2|Overall Study|Lost to Follow-up|2
4807024|NCT01264718|16576674|P1|Overall Study|Lost to Follow-up|3
4807025|NCT01264679|16576686|P1|Overall Study|Withdrawal by Subject|1
4807026|NCT01264679|16576686|P1|Overall Study|Sponsor's Suspension of Dosing|2
4807027|NCT01264679|16576686|P1|Overall Study|Physician Decision|1
4807028|NCT01264679|16576686|P1|Overall Study|Participation in Another Clinical Trial|1
4807029|NCT01264419|16576720|P1|Overall Study|Lost to Follow-up|3
4807030|NCT01264380|16576725|P3|Period C|Adverse Event|1
4807031|NCT01264380|16576726|P2|Period C|Adverse Event|0
4807032|NCT01264380|16576727|P1|Period C|Adverse Event|0
4807033|NCT01264380|16576725|P3|Period C|Withdrawal by Subject|1
4807034|NCT01264380|16576726|P2|Period C|Withdrawal by Subject|0
4807035|NCT01264380|16576727|P1|Period C|Withdrawal by Subject|0
4807036|NCT01264380|16576725|P3|Period C|Follow-up for survival status|6
4807037|NCT01264380|16576726|P2|Period C|Follow-up for survival status|0
4807038|NCT01264380|16576727|P1|Period C|Follow-up for survival status|0
4807039|NCT01264380|16576725|P3|Period C|Death|2
4807040|NCT01264380|16576726|P2|Period C|Death|0
4807041|NCT01264380|16576727|P1|Period C|Death|0
4807042|NCT01264380|16576725|P3|Period C|Disease Progression|4
4807043|NCT01264380|16576726|P2|Period C|Disease Progression|0
4807044|NCT01264380|16576727|P1|Period C|Disease Progression|0
4807045|NCT01264081|16576748|P1|Started Treatment|Not complete cycle 1 due to death|1
4807046|NCT01264081|16576748|P1|Started Treatment|Withdrawal by Subject|1
4807047|NCT01264081|16576748|P1|Participants Screened|Screening failures|30
4807048|NCT01264016|16576753|P1|Overall Study|Felt faint at sight of blood|1
4807049|NCT01264016|16576753|P1|Overall Study|Withdrawal by Subject|1
4807050|NCT01263925|16576768|P2|Overall Study|Withdrawal/ Not specified|1
4807051|NCT01263925|16576769|P1|Overall Study|Withdrawal/ Not specified|0
4807052|NCT01263925|16576768|P2|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2
4807053|NCT01263925|16576769|P1|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1
4807054|NCT01263925|16576768|P2|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
4807055|NCT01263925|16576769|P1|Overall Study|Unsatisfactory Compliance/ Withdrawal|1
4807056|NCT01263925|16576768|P2|Overall Study|AE/ Withdrawal|4
4807057|NCT01263925|16576769|P1|Overall Study|AE/ Withdrawal|1
4807058|NCT01263925|16576768|P2|Overall Study|AE/ Unsatisfactory Compliance|2
4807059|NCT01263925|16576769|P1|Overall Study|AE/ Unsatisfactory Compliance|2
4807060|NCT01263925|16576768|P2|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
4807061|NCT01263925|16576769|P1|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1
4807062|NCT01263925|16576768|P2|Overall Study|Lost to Follow-up|1
4807063|NCT01263925|16576769|P1|Overall Study|Lost to Follow-up|3
4807064|NCT01263925|16576768|P2|Overall Study|Other|4
4807065|NCT01263925|16576769|P1|Overall Study|Other|4
4807066|NCT01263925|16576768|P2|Overall Study|Withdrawal by Subject|8
4807067|NCT01263925|16576769|P1|Overall Study|Withdrawal by Subject|6
4807068|NCT01263925|16576768|P2|Overall Study|Unsatisfactory Compliance of Subject|5
4807069|NCT01263925|16576769|P1|Overall Study|Unsatisfactory Compliance of Subject|8
4807070|NCT01263925|16576768|P2|Overall Study|Adverse Event|22
4807071|NCT01263925|16576769|P1|Overall Study|Adverse Event|23
4807072|NCT01263925|16576768|P2|Overall Study|Lack of Efficacy|1
4807073|NCT01263925|16576769|P1|Overall Study|Lack of Efficacy|0
4807074|NCT01263925|16576768|P2|Overall Study|Protocol Violation|0
4807075|NCT01263925|16576769|P1|Overall Study|Protocol Violation|1
4807076|NCT01263873|16576803|P2|Overall Study|One provider unable to complete numbers|1
4807077|NCT01263873|16576804|P1|Overall Study|One provider unable to complete numbers|1
4807078|NCT01263782|16576818|P4|Overall Study|Inevaluable|0
4807079|NCT01263782|16576819|P3|Overall Study|Inevaluable|1
4807080|NCT01263782|16576820|P2|Overall Study|Inevaluable|0
4807081|NCT01263782|16576821|P1|Overall Study|Inevaluable|0
4807082|NCT01263782|16576818|P4|Overall Study|Too early|0
4807083|NCT01263782|16576819|P3|Overall Study|Too early|1
4807084|NCT01263782|16576820|P2|Overall Study|Too early|0
4807085|NCT01263782|16576821|P1|Overall Study|Too early|0
4807086|NCT01263782|16576818|P4|Overall Study|Progressive disease|1
4807087|NCT01263782|16576819|P3|Overall Study|Progressive disease|0
4807088|NCT01263782|16576820|P2|Overall Study|Progressive disease|0
4807089|NCT01263782|16576821|P1|Overall Study|Progressive disease|0
4807090|NCT01263782|16576818|P4|Overall Study|Death|0
4807091|NCT01263782|16576819|P3|Overall Study|Death|1
4807092|NCT01263782|16576820|P2|Overall Study|Death|0
4807093|NCT01263782|16576821|P1|Overall Study|Death|0
4807094|NCT01263704|16576866|P1|Overall Study|Principal Investigator (PI) decision|1
4807095|NCT01263704|16576866|P1|Overall Study|Colon metastases|1
4807096|NCT01263704|16576866|P1|Overall Study|Lost to Follow-up|1
4807097|NCT01263704|16576866|P1|Overall Study|Eligibility criteria not fulfilled|1
4807098|NCT01263704|16576866|P1|Overall Study|Patient withdrew consent|2
4807099|NCT01263704|16576866|P1|Overall Study|Death|2
4807100|NCT01263704|16576866|P1|Overall Study|Adverse Event|3
4807101|NCT01263704|16576866|P1|Overall Study|Progressive disease|18
4807102|NCT01263691|16576881|P6|Overall Study|Adverse Event|0
4807103|NCT01263691|16576882|P5|Overall Study|Adverse Event|0
4807104|NCT01263691|16576883|P4|Overall Study|Adverse Event|0
4807105|NCT01263691|16576884|P3|Overall Study|Adverse Event|0
4807106|NCT01263691|16576885|P2|Overall Study|Adverse Event|0
4807107|NCT01263691|16576886|P1|Overall Study|Adverse Event|1
4807108|NCT01263691|16576881|P6|Overall Study|Withdrawal by Subject|0
4807109|NCT01263691|16576882|P5|Overall Study|Withdrawal by Subject|0
4807110|NCT01263691|16576883|P4|Overall Study|Withdrawal by Subject|0
4807111|NCT01263691|16576884|P3|Overall Study|Withdrawal by Subject|0
4807112|NCT01263691|16576885|P2|Overall Study|Withdrawal by Subject|0
4807113|NCT01263691|16576886|P1|Overall Study|Withdrawal by Subject|1
4807114|NCT01263691|16576881|P6|Overall Study|Lost to Follow-up|0
4807115|NCT01263691|16576882|P5|Overall Study|Lost to Follow-up|0
4807116|NCT01263691|16576883|P4|Overall Study|Lost to Follow-up|1
4807117|NCT01263691|16576884|P3|Overall Study|Lost to Follow-up|1
4807118|NCT01263691|16576885|P2|Overall Study|Lost to Follow-up|0
4807119|NCT01263691|16576886|P1|Overall Study|Lost to Follow-up|1
4807120|NCT01263665|16576996|P1|Overall Study|Surgical Bypass|2
4807121|NCT01263665|16576996|P1|Overall Study|Amputation above the ankle|1
4807122|NCT01263665|16576996|P1|Overall Study|Death|2
4807123|NCT01263665|16576996|P1|Overall Study|Lost to Follow-up|3
4807124|NCT01263665|16576996|P1|Overall Study|Withdrew Consent|1
4807125|NCT01263639|16577003|P2|Overall Study|Exclusion =Admission greater than 7 days|9
4807126|NCT01263639|16577004|P1|Overall Study|Exclusion =Admission greater than 7 days|7
4807127|NCT01263639|16577003|P2|Overall Study|Lost to Follow-up|70
4807128|NCT01263639|16577004|P1|Overall Study|Lost to Follow-up|66
4807129|NCT01263561|16577012|P2|Overall Study|Death|2
4807130|NCT01263561|16577013|P1|Overall Study|Death|1
4807131|NCT01263509|16577025|P4|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1
4807132|NCT01263509|16577026|P3|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
4807133|NCT01263509|16577027|P2|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
4807134|NCT01263509|16577028|P1|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0
4807135|NCT01263509|16577025|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
4807136|NCT01263509|16577026|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
4807137|NCT01263509|16577027|P2|Entered - Long-Term Extension Study|Participant Unavailability|1
4807138|NCT01263509|16577028|P1|Entered - Long-Term Extension Study|Participant Unavailability|1
4807139|NCT01263509|16577025|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4807140|NCT01263509|16577026|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4807141|NCT01263509|16577027|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4807142|NCT01263509|16577028|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4807143|NCT01263509|16577025|P4|Entered - Long-Term Extension Study|Lack of Efficacy|0
4807144|NCT01263509|16577026|P3|Entered - Long-Term Extension Study|Lack of Efficacy|1
4807145|NCT01263509|16577027|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
4807146|NCT01263509|16577028|P1|Entered - Long-Term Extension Study|Lack of Efficacy|1
4807147|NCT01263509|16577025|P4|Entered - Long-Term Extension Study|Adverse Event|1
4807148|NCT01263509|16577026|P3|Entered - Long-Term Extension Study|Adverse Event|4
4807149|NCT01263509|16577027|P2|Entered - Long-Term Extension Study|Adverse Event|5
4807150|NCT01263509|16577028|P1|Entered - Long-Term Extension Study|Adverse Event|5
4807151|NCT01263496|16577157|P9|Entered - Long-Term Extension Study|Participant Unavailability|0
4807152|NCT01263496|16577158|P8|Entered - Long-Term Extension Study|Participant Unavailability|1
4807153|NCT01263496|16577159|P7|Entered - Long-Term Extension Study|Participant Unavailability|0
4807154|NCT01263496|16577160|P6|Entered - Long-Term Extension Study|Participant Unavailability|0
4807155|NCT01263496|16577161|P5|Entered - Long-Term Extension Study|Participant Unavailability|0
4807156|NCT01263496|16577162|P4|Entered - Long-Term Extension Study|Participant Unavailability|0
4807157|NCT01263496|16577163|P3|Entered - Long-Term Extension Study|Participant Unavailability|0
4807158|NCT01263496|16577164|P2|Entered - Long-Term Extension Study|Participant Unavailability|0
4807159|NCT01263496|16577165|P1|Entered - Long-Term Extension Study|Participant Unavailability|0
4807160|NCT01263496|16577157|P9|Entered - Long-Term Extension Study|Lack of Efficacy|1
4807161|NCT01263496|16577158|P8|Entered - Long-Term Extension Study|Lack of Efficacy|0
4807162|NCT01263496|16577159|P7|Entered - Long-Term Extension Study|Lack of Efficacy|0
4807163|NCT01263496|16577160|P6|Entered - Long-Term Extension Study|Lack of Efficacy|0
4807164|NCT01263496|16577161|P5|Entered - Long-Term Extension Study|Lack of Efficacy|5
4807165|NCT01263496|16577162|P4|Entered - Long-Term Extension Study|Lack of Efficacy|1
4807166|NCT01263496|16577163|P3|Entered - Long-Term Extension Study|Lack of Efficacy|4
4807167|NCT01263496|16577164|P2|Entered - Long-Term Extension Study|Lack of Efficacy|4
4807168|NCT01263496|16577165|P1|Entered - Long-Term Extension Study|Lack of Efficacy|8
4807169|NCT01263496|16577157|P9|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4807170|NCT01263496|16577158|P8|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4807171|NCT01263496|16577159|P7|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4807172|NCT01263496|16577160|P6|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4807173|NCT01263496|16577161|P5|Entered - Long-Term Extension Study|Withdrawal by Subject|4
4807174|NCT01263496|16577162|P4|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4807175|NCT01263496|16577163|P3|Entered - Long-Term Extension Study|Withdrawal by Subject|0
4807176|NCT01263496|16577164|P2|Entered - Long-Term Extension Study|Withdrawal by Subject|2
4807177|NCT01263496|16577165|P1|Entered - Long-Term Extension Study|Withdrawal by Subject|1
4807178|NCT01263496|16577157|P9|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807179|NCT01263496|16577158|P8|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807180|NCT01263496|16577159|P7|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807181|NCT01263496|16577160|P6|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807182|NCT01263496|16577161|P5|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807183|NCT01263496|16577162|P4|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807184|NCT01263496|16577163|P3|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807185|NCT01263496|16577164|P2|Entered - Long-Term Extension Study|Lost to Follow-up|2
4807186|NCT01263496|16577165|P1|Entered - Long-Term Extension Study|Lost to Follow-up|0
4807187|NCT01263496|16577157|P9|Entered - Long-Term Extension Study|Adverse Event|1
4807188|NCT01263496|16577158|P8|Entered - Long-Term Extension Study|Adverse Event|0
4807189|NCT01263496|16577159|P7|Entered - Long-Term Extension Study|Adverse Event|0
4807190|NCT01263496|16577160|P6|Entered - Long-Term Extension Study|Adverse Event|0
4807191|NCT01263496|16577161|P5|Entered - Long-Term Extension Study|Adverse Event|1
4807192|NCT01263496|16577162|P4|Entered - Long-Term Extension Study|Adverse Event|3
4807193|NCT01263496|16577163|P3|Entered - Long-Term Extension Study|Adverse Event|6
4807194|NCT01263496|16577164|P2|Entered - Long-Term Extension Study|Adverse Event|5
4807195|NCT01263496|16577165|P1|Entered - Long-Term Extension Study|Adverse Event|0
4807196|NCT01263496|16577157|P9|Enrolled - Long-Term Extension Study|Adverse Event|0
4807197|NCT01263496|16577158|P8|Enrolled - Long-Term Extension Study|Adverse Event|0
4807198|NCT01263496|16577159|P7|Enrolled - Long-Term Extension Study|Adverse Event|0
4807199|NCT01263496|16577160|P6|Enrolled - Long-Term Extension Study|Adverse Event|0
4807200|NCT01263496|16577161|P5|Enrolled - Long-Term Extension Study|Adverse Event|2
4807201|NCT01263496|16577162|P4|Enrolled - Long-Term Extension Study|Adverse Event|1
4807202|NCT01263496|16577163|P3|Enrolled - Long-Term Extension Study|Adverse Event|0
4807203|NCT01263496|16577164|P2|Enrolled - Long-Term Extension Study|Adverse Event|0
4807204|NCT01263496|16577165|P1|Enrolled - Long-Term Extension Study|Adverse Event|0
4807205|NCT01263496|16577157|P9|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807206|NCT01263496|16577158|P8|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807207|NCT01263496|16577159|P7|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807208|NCT01263496|16577160|P6|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807209|NCT01263496|16577161|P5|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807210|NCT01263496|16577162|P4|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807211|NCT01263496|16577163|P3|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807212|NCT01263496|16577164|P2|Enrolled - Long-Term Extension Study|Protocol Violation|0
4807213|NCT01263496|16577165|P1|Enrolled - Long-Term Extension Study|Protocol Violation|1
4807214|NCT01263483|16577460|P3|Overall Study|Participant Unavailability|1
4807215|NCT01263483|16577461|P2|Overall Study|Participant Unavailability|1
4807216|NCT01263483|16577462|P1|Overall Study|Participant Unavailability|0
4807217|NCT01263483|16577460|P3|Overall Study|Protocol Violation|1
4807218|NCT01263483|16577461|P2|Overall Study|Protocol Violation|1
4807219|NCT01263483|16577462|P1|Overall Study|Protocol Violation|0
4807220|NCT01263483|16577460|P3|Overall Study|Lack of Efficacy|0
4807221|NCT01263483|16577461|P2|Overall Study|Lack of Efficacy|0
4807222|NCT01263483|16577462|P1|Overall Study|Lack of Efficacy|2
4807223|NCT01263483|16577460|P3|Overall Study|Withdrawal by Subject|0
4807224|NCT01263483|16577461|P2|Overall Study|Withdrawal by Subject|0
4807225|NCT01263483|16577462|P1|Overall Study|Withdrawal by Subject|1
4807226|NCT01263483|16577460|P3|Overall Study|Adverse Event|3
4807227|NCT01263483|16577461|P2|Overall Study|Adverse Event|0
4807228|NCT01263483|16577462|P1|Overall Study|Adverse Event|4
4807229|NCT01263470|16577524|P6|Overall Study|Study Drug Non-compliance|0
4807230|NCT01263470|16577525|P5|Overall Study|Study Drug Non-compliance|1
4807231|NCT01263470|16577526|P4|Overall Study|Study Drug Non-compliance|0
4807232|NCT01263470|16577527|P3|Overall Study|Study Drug Non-compliance|0
4807233|NCT01263470|16577528|P2|Overall Study|Study Drug Non-compliance|0
4807234|NCT01263470|16577529|P1|Overall Study|Study Drug Non-compliance|0
4807235|NCT01263470|16577524|P6|Overall Study|Participant Unavailability|0
4807236|NCT01263470|16577525|P5|Overall Study|Participant Unavailability|0
4807237|NCT01263470|16577526|P4|Overall Study|Participant Unavailability|0
4807238|NCT01263470|16577527|P3|Overall Study|Participant Unavailability|0
4807239|NCT01263470|16577528|P2|Overall Study|Participant Unavailability|1
4807240|NCT01263470|16577529|P1|Overall Study|Participant Unavailability|0
4807241|NCT01263470|16577524|P6|Overall Study|Lack of Efficacy|0
4807242|NCT01263470|16577525|P5|Overall Study|Lack of Efficacy|0
4807243|NCT01263470|16577526|P4|Overall Study|Lack of Efficacy|0
4807244|NCT01263470|16577527|P3|Overall Study|Lack of Efficacy|2
4807245|NCT01263470|16577528|P2|Overall Study|Lack of Efficacy|0
4807246|NCT01263470|16577529|P1|Overall Study|Lack of Efficacy|0
4807247|NCT01263470|16577524|P6|Overall Study|Withdrawal by Subject|2
4807248|NCT01263470|16577525|P5|Overall Study|Withdrawal by Subject|0
4807249|NCT01263470|16577526|P4|Overall Study|Withdrawal by Subject|2
4807250|NCT01263470|16577527|P3|Overall Study|Withdrawal by Subject|1
4807251|NCT01263470|16577528|P2|Overall Study|Withdrawal by Subject|1
4807252|NCT01263470|16577529|P1|Overall Study|Withdrawal by Subject|0
4807253|NCT01263470|16577524|P6|Overall Study|Protocol Violation|1
4807254|NCT01263470|16577525|P5|Overall Study|Protocol Violation|0
4807255|NCT01263470|16577526|P4|Overall Study|Protocol Violation|0
4807256|NCT01263470|16577527|P3|Overall Study|Protocol Violation|0
4807257|NCT01263470|16577528|P2|Overall Study|Protocol Violation|1
4807258|NCT01263470|16577529|P1|Overall Study|Protocol Violation|0
4807259|NCT01263470|16577524|P6|Overall Study|Adverse Event|2
4807260|NCT01263470|16577525|P5|Overall Study|Adverse Event|2
4807261|NCT01263470|16577526|P4|Overall Study|Adverse Event|1
4807262|NCT01263470|16577527|P3|Overall Study|Adverse Event|1
4807263|NCT01263470|16577528|P2|Overall Study|Adverse Event|2
4807264|NCT01263470|16577529|P1|Overall Study|Adverse Event|2
4807265|NCT01263444|16577639|P1|Overall Study|Protocol Violation|1
4807266|NCT01263444|16577639|P1|Overall Study|Withdrawal by Subject|1
4807267|NCT01263444|16577639|P1|Overall Study|Adverse Event|8
4807268|NCT01263223|16577776|P2|7-day Follow-up|Lost to Follow-up|0
4807269|NCT01263223|16577777|P1|7-day Follow-up|Lost to Follow-up|1
4807270|NCT01263223|16577776|P2|7-day Follow-up|Withdrawal by Subject|1
4807271|NCT01263223|16577777|P1|7-day Follow-up|Withdrawal by Subject|0
4807272|NCT01263223|16577776|P2|Period 2|Withdrawal by Subject|1
4807273|NCT01263223|16577777|P1|Period 2|Withdrawal by Subject|0
4807274|NCT01263197|16577800|P6|Third Intervention (Period 3)|Adverse Event|0
4807275|NCT01263197|16577801|P5|Third Intervention (Period 3)|Adverse Event|0
4807276|NCT01263197|16577802|P4|Third Intervention (Period 3)|Adverse Event|0
4807277|NCT01263197|16577803|P3|Third Intervention (Period 3)|Adverse Event|0
4807278|NCT01263197|16577804|P2|Third Intervention (Period 3)|Adverse Event|1
4807279|NCT01263197|16577805|P1|Third Intervention (Period 3)|Adverse Event|0
4807280|NCT01263197|16577800|P6|Washout Period 2|Protocol Violation|0
4807281|NCT01263197|16577801|P5|Washout Period 2|Protocol Violation|0
4807282|NCT01263197|16577802|P4|Washout Period 2|Protocol Violation|1
4807283|NCT01263197|16577803|P3|Washout Period 2|Protocol Violation|0
4807284|NCT01263197|16577804|P2|Washout Period 2|Protocol Violation|0
4807285|NCT01263197|16577805|P1|Washout Period 2|Protocol Violation|0
4807286|NCT01263197|16577800|P6|Washout Period 2|Physician Decision|1
4807287|NCT01263197|16577801|P5|Washout Period 2|Physician Decision|0
4807288|NCT01263197|16577802|P4|Washout Period 2|Physician Decision|0
4807289|NCT01263197|16577803|P3|Washout Period 2|Physician Decision|0
4807290|NCT01263197|16577804|P2|Washout Period 2|Physician Decision|0
4807291|NCT01263197|16577805|P1|Washout Period 2|Physician Decision|0
4807292|NCT01263197|16577800|P6|Washout Period 1|Protocol Violation|0
4807293|NCT01263197|16577801|P5|Washout Period 1|Protocol Violation|1
4807294|NCT01263197|16577802|P4|Washout Period 1|Protocol Violation|0
4807295|NCT01263197|16577803|P3|Washout Period 1|Protocol Violation|0
4807296|NCT01263197|16577804|P2|Washout Period 1|Protocol Violation|0
4807297|NCT01263197|16577805|P1|Washout Period 1|Protocol Violation|0
4807298|NCT01263197|16577800|P6|First Intervention (Period 1)|Adverse Event|1
4807299|NCT01263197|16577801|P5|First Intervention (Period 1)|Adverse Event|0
4807300|NCT01263197|16577802|P4|First Intervention (Period 1)|Adverse Event|0
4807301|NCT01263197|16577803|P3|First Intervention (Period 1)|Adverse Event|0
4807302|NCT01263197|16577804|P2|First Intervention (Period 1)|Adverse Event|0
4807303|NCT01263197|16577805|P1|First Intervention (Period 1)|Adverse Event|0
4807304|NCT01263119|16577848|P1|Period 2|Adverse Event|2
4807305|NCT01263119|16577848|P1|Period 1|Protocol Violation|2
4807306|NCT01263106|16577869|P2|Washout (at Least 7 Days)|Lost to Follow-up|1
4807307|NCT01263106|16577870|P1|Washout (at Least 7 Days)|Lost to Follow-up|1
4807308|NCT01263093|16577885|P2|Period 2|Adverse Event|0
4807309|NCT01263093|16577886|P1|Period 2|Adverse Event|1
4807310|NCT01263093|16577885|P2|Washout|Physician Decision|0
4807311|NCT01263093|16577886|P1|Washout|Physician Decision|1
4807312|NCT01263054|16577903|P2|Overall Study|Other|1
4807313|NCT01263054|16577904|P1|Overall Study|Other|0
4807314|NCT01263054|16577903|P2|Overall Study|Qualification Violation|0
4807315|NCT01263054|16577904|P1|Overall Study|Qualification Violation|1
4807316|NCT01263054|16577903|P2|Overall Study|Withdrawal by Subject|3
4807317|NCT01263054|16577904|P1|Overall Study|Withdrawal by Subject|1
4807318|NCT01263054|16577903|P2|Overall Study|Lost to Follow-up|2
4807319|NCT01263054|16577904|P1|Overall Study|Lost to Follow-up|2
4807320|NCT01263054|16577903|P2|Overall Study|Death|0
4807321|NCT01263054|16577904|P1|Overall Study|Death|1
4807322|NCT01263028|16577922|P1|Overall Study|Study terminated due to low enrollment.|4
4807323|NCT01263028|16577922|P1|Overall Study|Adverse Event|1
4807324|NCT01263028|16577922|P1|Overall Study|Withdrawal by Subject|1
4807325|NCT01263015|16577932|P2|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7
4807326|NCT01263015|16577933|P1|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3
4807327|NCT01263015|16577932|P2|Open-label Phase: 48 Weeks Duration|Physician Decision|2
4807328|NCT01263015|16577933|P1|Open-label Phase: 48 Weeks Duration|Physician Decision|0
4807329|NCT01263015|16577932|P2|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
4807330|NCT01263015|16577933|P1|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8
4807331|NCT01263015|16577932|P2|Open-label Phase: 48 Weeks Duration|Protocol Violation|2
4807332|NCT01263015|16577933|P1|Open-label Phase: 48 Weeks Duration|Protocol Violation|3
4807333|NCT01263015|16577932|P2|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2
4807334|NCT01263015|16577933|P1|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7
4807335|NCT01263015|16577932|P2|Open-label Phase: 48 Weeks Duration|Adverse Event|10
4807336|NCT01263015|16577933|P1|Open-label Phase: 48 Weeks Duration|Adverse Event|3
4807337|NCT01263015|16577932|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|2
4807338|NCT01263015|16577933|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|1
4807339|NCT01263015|16577932|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15
4807340|NCT01263015|16577933|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9
4807341|NCT01263015|16577932|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18
4807342|NCT01263015|16577933|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17
4807343|NCT01263015|16577932|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12
4807344|NCT01263015|16577933|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14
4807345|NCT01263015|16577932|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14
4807346|NCT01263015|16577933|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18
4807347|NCT01263015|16577932|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|48
4807348|NCT01263015|16577933|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|13
4807349|NCT01262989|16577959|P2|Period 2|Intercurrent disease|1
4807350|NCT01262989|16577960|P1|Period 2|Intercurrent disease|0
4807351|NCT01262989|16577959|P2|Period 1|Positive answer for exclusion criteria|1
4807352|NCT01262989|16577960|P1|Period 1|Positive answer for exclusion criteria|0
4807353|NCT01262989|16577959|P2|Period 1|Intercurrent disease|1
4807354|NCT01262989|16577960|P1|Period 1|Intercurrent disease|0
4807355|NCT01262989|16577959|P2|Period 1|Lost to Follow-up|1
4807356|NCT01262989|16577960|P1|Period 1|Lost to Follow-up|1
4807357|NCT01262976|16577976|P6|Up to Year 3|Other|0
4807358|NCT01262976|16577977|P5|Up to Year 3|Other|0
4807359|NCT01262976|16577978|P4|Up to Year 3|Other|0
4807360|NCT01262976|16577979|P3|Up to Year 3|Other|0
4807361|NCT01262976|16577980|P2|Up to Year 3|Other|0
4807362|NCT01262976|16577981|P1|Up to Year 3|Other|3
4807363|NCT01262976|16577976|P6|Up to Year 3|Subjects with unknown completion status|0
4807364|NCT01262976|16577977|P5|Up to Year 3|Subjects with unknown completion status|0
4807365|NCT01262976|16577978|P4|Up to Year 3|Subjects with unknown completion status|0
4807366|NCT01262976|16577979|P3|Up to Year 3|Subjects with unknown completion status|1
4807367|NCT01262976|16577980|P2|Up to Year 3|Subjects with unknown completion status|0
4807368|NCT01262976|16577981|P1|Up to Year 3|Subjects with unknown completion status|0
4807369|NCT01262976|16577976|P6|Up to Year 3|Lost to Follow-up|3
4807370|NCT01262976|16577977|P5|Up to Year 3|Lost to Follow-up|1
4807371|NCT01262976|16577978|P4|Up to Year 3|Lost to Follow-up|3
4807372|NCT01262976|16577979|P3|Up to Year 3|Lost to Follow-up|4
4807373|NCT01262976|16577980|P2|Up to Year 3|Lost to Follow-up|2
4807374|NCT01262976|16577981|P1|Up to Year 3|Lost to Follow-up|2
4807375|NCT01262976|16577976|P6|Up to Year 3|Migrated/moved from study area|1
4807376|NCT01262976|16577977|P5|Up to Year 3|Migrated/moved from study area|1
4807377|NCT01262976|16577978|P4|Up to Year 3|Migrated/moved from study area|2
4807378|NCT01262976|16577979|P3|Up to Year 3|Migrated/moved from study area|0
4807379|NCT01262976|16577980|P2|Up to Year 3|Migrated/moved from study area|0
4807380|NCT01262976|16577981|P1|Up to Year 3|Migrated/moved from study area|0
4807381|NCT01262976|16577976|P6|Up to Year 3|Withdrawal by Subject|0
4807382|NCT01262976|16577977|P5|Up to Year 3|Withdrawal by Subject|0
4807383|NCT01262976|16577978|P4|Up to Year 3|Withdrawal by Subject|0
4807384|NCT01262976|16577979|P3|Up to Year 3|Withdrawal by Subject|0
4807385|NCT01262976|16577980|P2|Up to Year 3|Withdrawal by Subject|0
4807386|NCT01262976|16577981|P1|Up to Year 3|Withdrawal by Subject|1
4807387|NCT01262976|16577976|P6|Up to Year 3|Serious Adverse Event|0
4807388|NCT01262976|16577977|P5|Up to Year 3|Serious Adverse Event|0
4807389|NCT01262976|16577978|P4|Up to Year 3|Serious Adverse Event|0
4807390|NCT01262976|16577979|P3|Up to Year 3|Serious Adverse Event|2
4807391|NCT01262976|16577980|P2|Up to Year 3|Serious Adverse Event|0
4807392|NCT01262976|16577981|P1|Up to Year 3|Serious Adverse Event|0
4807393|NCT01262976|16577976|P6|Up to Year 2|Other|0
4807394|NCT01262976|16577977|P5|Up to Year 2|Other|0
4807395|NCT01262976|16577978|P4|Up to Year 2|Other|0
4807396|NCT01262976|16577979|P3|Up to Year 2|Other|0
4807397|NCT01262976|16577980|P2|Up to Year 2|Other|0
4807398|NCT01262976|16577981|P1|Up to Year 2|Other|3
4807399|NCT01262976|16577976|P6|Up to Year 2|Subjects with unknown completion status|0
4807400|NCT01262976|16577977|P5|Up to Year 2|Subjects with unknown completion status|0
4807401|NCT01262976|16577978|P4|Up to Year 2|Subjects with unknown completion status|0
4807402|NCT01262976|16577979|P3|Up to Year 2|Subjects with unknown completion status|1
4807403|NCT01262976|16577980|P2|Up to Year 2|Subjects with unknown completion status|0
4807404|NCT01262976|16577981|P1|Up to Year 2|Subjects with unknown completion status|0
4807405|NCT01262976|16577976|P6|Up to Year 2|Lost to Follow-up|3
4807406|NCT01262976|16577977|P5|Up to Year 2|Lost to Follow-up|3
4807407|NCT01262976|16577978|P4|Up to Year 2|Lost to Follow-up|2
4807408|NCT01262976|16577979|P3|Up to Year 2|Lost to Follow-up|2
4807409|NCT01262976|16577980|P2|Up to Year 2|Lost to Follow-up|1
4807410|NCT01262976|16577981|P1|Up to Year 2|Lost to Follow-up|1
4807411|NCT01262976|16577976|P6|Up to Year 2|Migrated/moved from study area|2
4807412|NCT01262976|16577977|P5|Up to Year 2|Migrated/moved from study area|1
4807413|NCT01262976|16577978|P4|Up to Year 2|Migrated/moved from study area|2
4807414|NCT01262976|16577979|P3|Up to Year 2|Migrated/moved from study area|0
4807415|NCT01262976|16577980|P2|Up to Year 2|Migrated/moved from study area|0
4807416|NCT01262976|16577981|P1|Up to Year 2|Migrated/moved from study area|0
4807417|NCT01262976|16577976|P6|Up to Year 2|Withdrawal by Subject|0
4807418|NCT01262976|16577977|P5|Up to Year 2|Withdrawal by Subject|0
4807419|NCT01262976|16577978|P4|Up to Year 2|Withdrawal by Subject|0
4807420|NCT01262976|16577979|P3|Up to Year 2|Withdrawal by Subject|0
4807421|NCT01262976|16577980|P2|Up to Year 2|Withdrawal by Subject|0
4807422|NCT01262976|16577981|P1|Up to Year 2|Withdrawal by Subject|1
4807423|NCT01262976|16577976|P6|Up to Year 2|Serious Adverse Event|0
4807424|NCT01262976|16577977|P5|Up to Year 2|Serious Adverse Event|0
4807425|NCT01262976|16577978|P4|Up to Year 2|Serious Adverse Event|0
4807426|NCT01262976|16577979|P3|Up to Year 2|Serious Adverse Event|2
4807427|NCT01262976|16577980|P2|Up to Year 2|Serious Adverse Event|0
4807428|NCT01262976|16577981|P1|Up to Year 2|Serious Adverse Event|0
4807429|NCT01262976|16577976|P6|Up to Year 1|Subjects with unknown completion status|1
4807430|NCT01262976|16577977|P5|Up to Year 1|Subjects with unknown completion status|0
4807431|NCT01262976|16577978|P4|Up to Year 1|Subjects with unknown completion status|0
4807432|NCT01262976|16577979|P3|Up to Year 1|Subjects with unknown completion status|1
4807433|NCT01262976|16577980|P2|Up to Year 1|Subjects with unknown completion status|0
4807434|NCT01262976|16577981|P1|Up to Year 1|Subjects with unknown completion status|0
4807435|NCT01262976|16577976|P6|Up to Year 1|Other|1
4807436|NCT01262976|16577977|P5|Up to Year 1|Other|2
4807437|NCT01262976|16577978|P4|Up to Year 1|Other|0
4807438|NCT01262976|16577979|P3|Up to Year 1|Other|0
4807439|NCT01262976|16577980|P2|Up to Year 1|Other|1
4807440|NCT01262976|16577981|P1|Up to Year 1|Other|3
4807441|NCT01262976|16577976|P6|Up to Year 1|Lost to Follow-up|5
4807442|NCT01262976|16577977|P5|Up to Year 1|Lost to Follow-up|6
4807443|NCT01262976|16577978|P4|Up to Year 1|Lost to Follow-up|1
4807444|NCT01262976|16577979|P3|Up to Year 1|Lost to Follow-up|0
4807445|NCT01262976|16577980|P2|Up to Year 1|Lost to Follow-up|0
4807446|NCT01262976|16577981|P1|Up to Year 1|Lost to Follow-up|4
4807447|NCT01262976|16577976|P6|Up to Year 1|Migrated/moved from study area|2
4807448|NCT01262976|16577977|P5|Up to Year 1|Migrated/moved from study area|3
4807449|NCT01262976|16577978|P4|Up to Year 1|Migrated/moved from study area|3
4807450|NCT01262976|16577979|P3|Up to Year 1|Migrated/moved from study area|0
4807451|NCT01262976|16577980|P2|Up to Year 1|Migrated/moved from study area|0
4807452|NCT01262976|16577981|P1|Up to Year 1|Migrated/moved from study area|1
4807453|NCT01262976|16577976|P6|Up to Year 1|Withdrawal by Subject|0
4807454|NCT01262976|16577977|P5|Up to Year 1|Withdrawal by Subject|0
4807455|NCT01262976|16577978|P4|Up to Year 1|Withdrawal by Subject|0
4807456|NCT01262976|16577979|P3|Up to Year 1|Withdrawal by Subject|0
4807457|NCT01262976|16577980|P2|Up to Year 1|Withdrawal by Subject|0
4807458|NCT01262976|16577981|P1|Up to Year 1|Withdrawal by Subject|1
4807459|NCT01262976|16577976|P6|Up to Year 1|Serious Adverse Event|0
4807460|NCT01262976|16577977|P5|Up to Year 1|Serious Adverse Event|0
4807461|NCT01262976|16577978|P4|Up to Year 1|Serious Adverse Event|0
4807462|NCT01262976|16577979|P3|Up to Year 1|Serious Adverse Event|2
4807463|NCT01262976|16577980|P2|Up to Year 1|Serious Adverse Event|0
4807464|NCT01262976|16577981|P1|Up to Year 1|Serious Adverse Event|0
4807465|NCT01262976|16577976|P6|Up to Month 7|Other|0
4807466|NCT01262976|16577977|P5|Up to Month 7|Other|0
4807467|NCT01262976|16577978|P4|Up to Month 7|Other|0
4807468|NCT01262976|16577979|P3|Up to Month 7|Other|2
4807469|NCT01262976|16577980|P2|Up to Month 7|Other|0
4807470|NCT01262976|16577981|P1|Up to Month 7|Other|3
4807471|NCT01262976|16577976|P6|Up to Month 7|Lost to Follow-up|3
4807472|NCT01262976|16577977|P5|Up to Month 7|Lost to Follow-up|1
4807473|NCT01262976|16577978|P4|Up to Month 7|Lost to Follow-up|3
4807474|NCT01262976|16577979|P3|Up to Month 7|Lost to Follow-up|1
4807475|NCT01262976|16577980|P2|Up to Month 7|Lost to Follow-up|0
4807476|NCT01262976|16577981|P1|Up to Month 7|Lost to Follow-up|1
4807477|NCT01262976|16577976|P6|Up to Month 7|Migrated/moved from study area|1
4807478|NCT01262976|16577977|P5|Up to Month 7|Migrated/moved from study area|1
4807479|NCT01262976|16577978|P4|Up to Month 7|Migrated/moved from study area|3
4807480|NCT01262976|16577979|P3|Up to Month 7|Migrated/moved from study area|1
4807481|NCT01262976|16577980|P2|Up to Month 7|Migrated/moved from study area|0
4807482|NCT01262976|16577981|P1|Up to Month 7|Migrated/moved from study area|0
4807483|NCT01262976|16577976|P6|Up to Month 7|Withdrawal by Subject|0
4807484|NCT01262976|16577977|P5|Up to Month 7|Withdrawal by Subject|0
4807485|NCT01262976|16577978|P4|Up to Month 7|Withdrawal by Subject|0
4807486|NCT01262976|16577979|P3|Up to Month 7|Withdrawal by Subject|0
4807487|NCT01262976|16577980|P2|Up to Month 7|Withdrawal by Subject|0
4807488|NCT01262976|16577981|P1|Up to Month 7|Withdrawal by Subject|1
4807489|NCT01262976|16577976|P6|Up to Month 7|Serious Adverse Event|0
4807490|NCT01262976|16577977|P5|Up to Month 7|Serious Adverse Event|0
4807491|NCT01262976|16577978|P4|Up to Month 7|Serious Adverse Event|0
4807492|NCT01262976|16577979|P3|Up to Month 7|Serious Adverse Event|2
4807493|NCT01262976|16577980|P2|Up to Month 7|Serious Adverse Event|0
4807494|NCT01262976|16577981|P1|Up to Month 7|Serious Adverse Event|0
4807495|NCT01262976|16577976|P6|Up to Month 2|Other|2
4807496|NCT01262976|16577977|P5|Up to Month 2|Other|0
4807497|NCT01262976|16577978|P4|Up to Month 2|Other|1
4807498|NCT01262976|16577979|P3|Up to Month 2|Other|0
4807499|NCT01262976|16577980|P2|Up to Month 2|Other|0
4807500|NCT01262976|16577981|P1|Up to Month 2|Other|1
4807501|NCT01262976|16577976|P6|Up to Month 2|Lost to Follow-up|1
4807502|NCT01262976|16577977|P5|Up to Month 2|Lost to Follow-up|1
4807503|NCT01262976|16577978|P4|Up to Month 2|Lost to Follow-up|1
4807504|NCT01262976|16577979|P3|Up to Month 2|Lost to Follow-up|0
4807505|NCT01262976|16577980|P2|Up to Month 2|Lost to Follow-up|0
4807506|NCT01262976|16577981|P1|Up to Month 2|Lost to Follow-up|1
4807507|NCT01262976|16577976|P6|Up to Month 2|Migrated/moved from study area|1
4807508|NCT01262976|16577977|P5|Up to Month 2|Migrated/moved from study area|1
4807509|NCT01262976|16577978|P4|Up to Month 2|Migrated/moved from study area|0
4807510|NCT01262976|16577979|P3|Up to Month 2|Migrated/moved from study area|0
4807511|NCT01262976|16577980|P2|Up to Month 2|Migrated/moved from study area|1
4807512|NCT01262976|16577981|P1|Up to Month 2|Migrated/moved from study area|0
4807513|NCT01262976|16577976|P6|Up to Month 2|Withdrawal by Subject|0
4807514|NCT01262976|16577977|P5|Up to Month 2|Withdrawal by Subject|0
4807515|NCT01262976|16577978|P4|Up to Month 2|Withdrawal by Subject|0
4807516|NCT01262976|16577979|P3|Up to Month 2|Withdrawal by Subject|0
4807517|NCT01262976|16577980|P2|Up to Month 2|Withdrawal by Subject|0
4807518|NCT01262976|16577981|P1|Up to Month 2|Withdrawal by Subject|1
4807519|NCT01262976|16577976|P6|Up to Month 2|Serious Adverse Event|0
4807520|NCT01262976|16577977|P5|Up to Month 2|Serious Adverse Event|0
4807521|NCT01262976|16577978|P4|Up to Month 2|Serious Adverse Event|0
4807522|NCT01262976|16577979|P3|Up to Month 2|Serious Adverse Event|1
4807523|NCT01262976|16577980|P2|Up to Month 2|Serious Adverse Event|0
4807524|NCT01262976|16577981|P1|Up to Month 2|Serious Adverse Event|0
4807525|NCT01262898|16578137|P4|Overall Study|Withdrawal by Subject|0
4807526|NCT01262898|16578138|P3|Overall Study|Withdrawal by Subject|0
4807527|NCT01262898|16578139|P2|Overall Study|Withdrawal by Subject|1
4807528|NCT01262898|16578140|P1|Overall Study|Withdrawal by Subject|1
4807529|NCT01262898|16578137|P4|Overall Study|Lost to Follow-up|0
4807530|NCT01262898|16578138|P3|Overall Study|Lost to Follow-up|0
4807531|NCT01262898|16578139|P2|Overall Study|Lost to Follow-up|0
4807532|NCT01262898|16578140|P1|Overall Study|Lost to Follow-up|1
4807533|NCT01262898|16578137|P4|Overall Study|Protocol Violation|0
4807534|NCT01262898|16578138|P3|Overall Study|Protocol Violation|0
4807535|NCT01262898|16578139|P2|Overall Study|Protocol Violation|1
4807536|NCT01262898|16578140|P1|Overall Study|Protocol Violation|1
4807537|NCT01262872|16578268|P8|Step 2|Migrated/moved from study area|3
4807538|NCT01262872|16578269|P7|Step 2|Migrated/moved from study area|2
4807539|NCT01262872|16578270|P6|Step 2|Migrated/moved from study area|6
4807540|NCT01262872|16578271|P5|Step 2|Migrated/moved from study area|2
4807541|NCT01262872|16578272|P4|Step 2|Migrated/moved from study area|3
4807542|NCT01262872|16578273|P3|Step 2|Migrated/moved from study area|4
4807543|NCT01262872|16578274|P2|Step 2|Migrated/moved from study area|0
4807544|NCT01262872|16578275|P1|Step 2|Migrated/moved from study area|0
4807545|NCT01262872|16578268|P8|Step 2|Withdrawal by Subject|1
4807546|NCT01262872|16578269|P7|Step 2|Withdrawal by Subject|2
4807547|NCT01262872|16578270|P6|Step 2|Withdrawal by Subject|1
4807548|NCT01262872|16578271|P5|Step 2|Withdrawal by Subject|3
4807549|NCT01262872|16578272|P4|Step 2|Withdrawal by Subject|6
4807550|NCT01262872|16578273|P3|Step 2|Withdrawal by Subject|4
4807551|NCT01262872|16578274|P2|Step 2|Withdrawal by Subject|0
4807552|NCT01262872|16578275|P1|Step 2|Withdrawal by Subject|0
4807553|NCT01262872|16578268|P8|Step 2|Protocol Violation|1
4807554|NCT01262872|16578269|P7|Step 2|Protocol Violation|3
4807555|NCT01262872|16578270|P6|Step 2|Protocol Violation|0
4807556|NCT01262872|16578271|P5|Step 2|Protocol Violation|0
4807557|NCT01262872|16578272|P4|Step 2|Protocol Violation|0
4807558|NCT01262872|16578273|P3|Step 2|Protocol Violation|1
4807559|NCT01262872|16578274|P2|Step 2|Protocol Violation|0
4807560|NCT01262872|16578275|P1|Step 2|Protocol Violation|0
4807561|NCT01262872|16578268|P8|Step 2|Death|1
4807562|NCT01262872|16578269|P7|Step 2|Death|2
4807563|NCT01262872|16578270|P6|Step 2|Death|2
4807564|NCT01262872|16578271|P5|Step 2|Death|0
4807565|NCT01262872|16578272|P4|Step 2|Death|1
4807566|NCT01262872|16578273|P3|Step 2|Death|0
4807567|NCT01262872|16578274|P2|Step 2|Death|0
4807568|NCT01262872|16578275|P1|Step 2|Death|0
4807569|NCT01262820|16578549|P1|Overall Study|Drug held for 21+ days|1
4807570|NCT01262820|16578549|P1|Overall Study|Lack of Efficacy|9
4807571|NCT01262820|16578549|P1|Overall Study|Adverse Event|5
4807572|NCT01262677|16578563|P3|Overall Study|Adverse Event (AE) related to study drug|3
4807573|NCT01262677|16578564|P2|Overall Study|Adverse Event (AE) related to study drug|8
4807574|NCT01262677|16578565|P1|Overall Study|Adverse Event (AE) related to study drug|3
4807575|NCT01262677|16578563|P3|Overall Study|Protocol Violation|1
4807576|NCT01262677|16578564|P2|Overall Study|Protocol Violation|1
4807577|NCT01262677|16578565|P1|Overall Study|Protocol Violation|0
4807578|NCT01262677|16578563|P3|Overall Study|Reason not provided|3
4807579|NCT01262677|16578564|P2|Overall Study|Reason not provided|1
4807580|NCT01262677|16578565|P1|Overall Study|Reason not provided|2
4807581|NCT01262677|16578563|P3|Overall Study|No longer willing to participate|2
4807582|NCT01262677|16578564|P2|Overall Study|No longer willing to participate|3
4807583|NCT01262677|16578565|P1|Overall Study|No longer willing to participate|3
4807584|NCT01262677|16578563|P3|Overall Study|Lost to Follow-up|2
4807585|NCT01262677|16578564|P2|Overall Study|Lost to Follow-up|0
4807586|NCT01262677|16578565|P1|Overall Study|Lost to Follow-up|1
4807587|NCT01262677|16578563|P3|Overall Study|Insufficient clinical response|1
4807588|NCT01262677|16578564|P2|Overall Study|Insufficient clinical response|0
4807589|NCT01262677|16578565|P1|Overall Study|Insufficient clinical response|0
4807590|NCT01262677|16578563|P3|Overall Study|Does not meet entrance criteria|0
4807591|NCT01262677|16578564|P2|Overall Study|Does not meet entrance criteria|2
4807592|NCT01262677|16578565|P1|Overall Study|Does not meet entrance criteria|0
4807593|NCT01262651|16578656|P2|Overall Study|Met Withdrawal Criteria|0
4807594|NCT01262651|16578657|P1|Overall Study|Met Withdrawal Criteria|1
4807595|NCT01262651|16578656|P2|Overall Study|Withdrawal by Investigator|2
4807596|NCT01262651|16578657|P1|Overall Study|Withdrawal by Investigator|2
4807597|NCT01262651|16578656|P2|Overall Study|Withdrawal by Subject|11
4807598|NCT01262651|16578657|P1|Overall Study|Withdrawal by Subject|15
4807599|NCT01262651|16578656|P2|Overall Study|Adverse Event|35
4807600|NCT01262651|16578657|P1|Overall Study|Adverse Event|40
4807601|NCT01262573|16578698|P2|Overall Study|Withdrawal by Subject|1
4807602|NCT01262573|16578699|P1|Overall Study|Withdrawal by Subject|0
4807603|NCT01262560|16578710|P3|Overall Study|Protocol Violation|2
4807604|NCT01262560|16578711|P2|Overall Study|Protocol Violation|1
4807605|NCT01262560|16578712|P1|Overall Study|Protocol Violation|0
4807606|NCT01262456|16578761|P3|1-Month Open-Label Extension Period|Other Reason|0
4807607|NCT01262456|16578762|P2|1-Month Open-Label Extension Period|Other Reason|1
4807608|NCT01262456|16578763|P1|1-Month Open-Label Extension Period|Other Reason|0
4807609|NCT01262456|16578761|P3|1-Month Open-Label Extension Period|Protocol Violation|2
4807610|NCT01262456|16578762|P2|1-Month Open-Label Extension Period|Protocol Violation|0
4807611|NCT01262456|16578763|P1|1-Month Open-Label Extension Period|Protocol Violation|1
4807612|NCT01262456|16578761|P3|1-Month Open-Label Extension Period|Adverse Event|2
4807613|NCT01262456|16578762|P2|1-Month Open-Label Extension Period|Adverse Event|0
4807614|NCT01262456|16578763|P1|1-Month Open-Label Extension Period|Adverse Event|2
4807615|NCT01262456|16578761|P3|1-Month Open-Label Extension Period|Lost to Follow-up|0
4807616|NCT01262456|16578762|P2|1-Month Open-Label Extension Period|Lost to Follow-up|1
4807617|NCT01262456|16578763|P1|1-Month Open-Label Extension Period|Lost to Follow-up|0
4807618|NCT01262456|16578761|P3|1-Month Open-Label Extension Period|Withdrawal by Subject|1
4807619|NCT01262456|16578762|P2|1-Month Open-Label Extension Period|Withdrawal by Subject|1
4807620|NCT01262456|16578763|P1|1-Month Open-Label Extension Period|Withdrawal by Subject|1
4807621|NCT01262456|16578761|P3|3-Month Double-Blind Period|Protocol Violation|6
4807622|NCT01262456|16578762|P2|3-Month Double-Blind Period|Protocol Violation|6
4807623|NCT01262456|16578763|P1|3-Month Double-Blind Period|Protocol Violation|3
4807624|NCT01262456|16578761|P3|3-Month Double-Blind Period|Adverse Event|8
4807625|NCT01262456|16578762|P2|3-Month Double-Blind Period|Adverse Event|4
4807626|NCT01262456|16578763|P1|3-Month Double-Blind Period|Adverse Event|6
4807627|NCT01262456|16578761|P3|3-Month Double-Blind Period|Lost to Follow-up|3
4807628|NCT01262456|16578762|P2|3-Month Double-Blind Period|Lost to Follow-up|5
4807629|NCT01262456|16578763|P1|3-Month Double-Blind Period|Lost to Follow-up|4
4807630|NCT01262456|16578761|P3|3-Month Double-Blind Period|Withdrawal by Subject|9
4807631|NCT01262456|16578762|P2|3-Month Double-Blind Period|Withdrawal by Subject|8
4807632|NCT01262456|16578763|P1|3-Month Double-Blind Period|Withdrawal by Subject|6
4807633|NCT01262365|16578807|P3|Overall Study|Patient unavailable|1
4807634|NCT01262365|16578808|P2|Overall Study|Patient unavailable|0
4807635|NCT01262365|16578809|P1|Overall Study|Patient unavailable|0
4807636|NCT01262365|16578807|P3|Overall Study|Cannot tolerate the protocol|0
4807637|NCT01262365|16578808|P2|Overall Study|Cannot tolerate the protocol|1
4807638|NCT01262365|16578809|P1|Overall Study|Cannot tolerate the protocol|0
4807639|NCT01262365|16578807|P3|Overall Study|Toxicity related to study drug|0
4807640|NCT01262365|16578808|P2|Overall Study|Toxicity related to study drug|1
4807641|NCT01262365|16578809|P1|Overall Study|Toxicity related to study drug|0
4807642|NCT01262365|16578807|P3|Overall Study|Patient pregnant|1
4807643|NCT01262365|16578808|P2|Overall Study|Patient pregnant|0
4807644|NCT01262365|16578809|P1|Overall Study|Patient pregnant|1
4807645|NCT01262365|16578807|P3|Overall Study|Suspected pregnancy|0
4807646|NCT01262365|16578808|P2|Overall Study|Suspected pregnancy|0
4807647|NCT01262365|16578809|P1|Overall Study|Suspected pregnancy|1
4807648|NCT01262365|16578807|P3|Overall Study|Non-compliance|2
4807649|NCT01262365|16578808|P2|Overall Study|Non-compliance|0
4807650|NCT01262365|16578809|P1|Overall Study|Non-compliance|1
4807651|NCT01262365|16578807|P3|Overall Study|Randomization error|2
4807652|NCT01262365|16578808|P2|Overall Study|Randomization error|0
4807653|NCT01262365|16578809|P1|Overall Study|Randomization error|1
4807654|NCT01262365|16578807|P3|Overall Study|sponsor decision|0
4807655|NCT01262365|16578808|P2|Overall Study|sponsor decision|1
4807656|NCT01262365|16578809|P1|Overall Study|sponsor decision|1
4807657|NCT01262365|16578807|P3|Overall Study|Adverse Event|11
4807658|NCT01262365|16578808|P2|Overall Study|Adverse Event|16
4807659|NCT01262365|16578809|P1|Overall Study|Adverse Event|26
4807660|NCT01262365|16578807|P3|Overall Study|Death|1
4807661|NCT01262365|16578808|P2|Overall Study|Death|2
4807662|NCT01262365|16578809|P1|Overall Study|Death|1
4807663|NCT01262365|16578807|P3|Overall Study|Withdrawal by Subject|22
4807664|NCT01262365|16578808|P2|Overall Study|Withdrawal by Subject|22
4807665|NCT01262365|16578809|P1|Overall Study|Withdrawal by Subject|17
4807666|NCT01262365|16578807|P3|Overall Study|Lost to Follow-up|6
4807667|NCT01262365|16578808|P2|Overall Study|Lost to Follow-up|7
4807668|NCT01262365|16578809|P1|Overall Study|Lost to Follow-up|3
4807669|NCT01262365|16578807|P3|Overall Study|Protocol Violation|1
4807670|NCT01262365|16578808|P2|Overall Study|Protocol Violation|1
4807671|NCT01262365|16578809|P1|Overall Study|Protocol Violation|3
4807672|NCT01262365|16578807|P3|Overall Study|Lack of Efficacy|47
4807673|NCT01262365|16578808|P2|Overall Study|Lack of Efficacy|30
4807674|NCT01262365|16578809|P1|Overall Study|Lack of Efficacy|35
4807675|NCT01262352|16578834|P2|Washout|Extended Washout|1
4807676|NCT01262352|16578835|P1|Washout|Extended Washout|0
4807677|NCT01262352|16578834|P2|Washout|Adverse Event|1
4807678|NCT01262352|16578835|P1|Washout|Adverse Event|1
4807679|NCT01262352|16578834|P2|Period 1|Illness after randomization|0
4807680|NCT01262352|16578835|P1|Period 1|Illness after randomization|1
4807681|NCT01262287|16578853|P2|Overall Study|Lost to Follow-up|1
4807682|NCT01262287|16578854|P1|Overall Study|Lost to Follow-up|2
4807683|NCT01262092|16578915|P2|Gabapentin Taper|noncompliance - missed medications|0
4807684|NCT01262092|16578916|P1|Gabapentin Taper|noncompliance - missed medications|1
4807685|NCT01262092|16578915|P2|Buprenorphine Taper|noncompliance - missed medication|1
4807686|NCT01262092|16578916|P1|Buprenorphine Taper|noncompliance - missed medication|1
4807687|NCT01262092|16578915|P2|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0
4807688|NCT01262092|16578916|P1|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1
4807689|NCT01262092|16578915|P2|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1
4807690|NCT01262092|16578916|P1|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2
4807691|NCT01262027|16578922|P1|Overall Study|Protocol Violation|1
4807692|NCT01262027|16578922|P1|Overall Study|Withdrawal by Subject|3
4807693|NCT01262027|16578922|P1|Overall Study|Adverse Event|1
4807694|NCT01261975|16578927|P1|Overall Study|Surgical complication|1
4807695|NCT01261793|16578958|P3|Overall Study|Patient unable to start IV line|1
4807696|NCT01261793|16578959|P2|Overall Study|Patient unable to start IV line|0
4807697|NCT01261793|16578960|P1|Overall Study|Patient unable to start IV line|0
4807698|NCT01261793|16578958|P3|Overall Study|Randomization error|0
4807699|NCT01261793|16578959|P2|Overall Study|Randomization error|1
4807700|NCT01261793|16578960|P1|Overall Study|Randomization error|0
4807701|NCT01261793|16578958|P3|Overall Study|Patient withdrew after cardiology visit|0
4807702|NCT01261793|16578959|P2|Overall Study|Patient withdrew after cardiology visit|1
4807703|NCT01261793|16578960|P1|Overall Study|Patient withdrew after cardiology visit|0
4807704|NCT01261793|16578958|P3|Overall Study|Lack of efficacy & patient not available|0
4807705|NCT01261793|16578959|P2|Overall Study|Lack of efficacy & patient not available|1
4807706|NCT01261793|16578960|P1|Overall Study|Lack of efficacy & patient not available|0
4807707|NCT01261793|16578958|P3|Overall Study|Outside the study area|1
4807708|NCT01261793|16578959|P2|Overall Study|Outside the study area|2
4807709|NCT01261793|16578960|P1|Overall Study|Outside the study area|0
4807710|NCT01261793|16578958|P3|Overall Study|Patient pregnant|0
4807711|NCT01261793|16578959|P2|Overall Study|Patient pregnant|0
4807712|NCT01261793|16578960|P1|Overall Study|Patient pregnant|1
4807713|NCT01261793|16578958|P3|Overall Study|Patient non-compliance|1
4807714|NCT01261793|16578959|P2|Overall Study|Patient non-compliance|0
4807715|NCT01261793|16578960|P1|Overall Study|Patient non-compliance|1
4807716|NCT01261793|16578958|P3|Overall Study|Suspected pregnancy|0
4807717|NCT01261793|16578959|P2|Overall Study|Suspected pregnancy|1
4807718|NCT01261793|16578960|P1|Overall Study|Suspected pregnancy|1
4807719|NCT01261793|16578958|P3|Overall Study|Patient non-availability|1
4807720|NCT01261793|16578959|P2|Overall Study|Patient non-availability|1
4807721|NCT01261793|16578960|P1|Overall Study|Patient non-availability|1
4807722|NCT01261793|16578958|P3|Overall Study|Adverse Event|19
4807723|NCT01261793|16578959|P2|Overall Study|Adverse Event|24
4807724|NCT01261793|16578960|P1|Overall Study|Adverse Event|9
4807725|NCT01261793|16578958|P3|Overall Study|Death|0
4807726|NCT01261793|16578959|P2|Overall Study|Death|1
4807727|NCT01261793|16578960|P1|Overall Study|Death|3
4807728|NCT01261793|16578958|P3|Overall Study|Withdrawal by Subject|14
4807729|NCT01261793|16578959|P2|Overall Study|Withdrawal by Subject|14
4807730|NCT01261793|16578960|P1|Overall Study|Withdrawal by Subject|12
4807731|NCT01261793|16578958|P3|Overall Study|Lost to Follow-up|7
4807732|NCT01261793|16578959|P2|Overall Study|Lost to Follow-up|3
4807733|NCT01261793|16578960|P1|Overall Study|Lost to Follow-up|10
4807734|NCT01261793|16578958|P3|Overall Study|Protocol Violation|6
4807735|NCT01261793|16578959|P2|Overall Study|Protocol Violation|5
4807736|NCT01261793|16578960|P1|Overall Study|Protocol Violation|3
4807737|NCT01261793|16578958|P3|Overall Study|Lack of Efficacy|32
4807738|NCT01261793|16578959|P2|Overall Study|Lack of Efficacy|37
4807739|NCT01261793|16578960|P1|Overall Study|Lack of Efficacy|44
4807740|NCT01261780|16578985|P2|Overall Study|Event not related to subject|2
4807741|NCT01261780|16578986|P1|Overall Study|Event not related to subject|1
4807742|NCT01261780|16578985|P2|Overall Study|Withdrawal by Subject|0
4807743|NCT01261780|16578986|P1|Overall Study|Withdrawal by Subject|1
4807744|NCT01261624|16578996|P2|Week 13 to Week 24|Insufficient Response|1
4807745|NCT01261624|16578997|P1|Week 13 to Week 24|Insufficient Response|0
4807746|NCT01261624|16578996|P2|Week 0 to Week 12|Insufficient Response|2
4807747|NCT01261624|16578997|P1|Week 0 to Week 12|Insufficient Response|0
4807748|NCT01261624|16578996|P2|Week 0 to Week 12|Disease Progression|1
4807749|NCT01261624|16578997|P1|Week 0 to Week 12|Disease Progression|1
4807750|NCT01261611|16579017|P3|Treatment Cycle 5|Lost to Follow-up|0
4807751|NCT01261611|16579018|P2|Treatment Cycle 5|Lost to Follow-up|0
4807752|NCT01261611|16579019|P1|Treatment Cycle 5|Lost to Follow-up|1
4807753|NCT01261611|16579017|P3|Treatment Cycle 5|Adverse Event|0
4807754|NCT01261611|16579018|P2|Treatment Cycle 5|Adverse Event|0
4807755|NCT01261611|16579019|P1|Treatment Cycle 5|Adverse Event|1
4807756|NCT01261611|16579017|P3|Treatment Cycle 5|Withdrawal by Subject|0
4807757|NCT01261611|16579018|P2|Treatment Cycle 5|Withdrawal by Subject|0
4807758|NCT01261611|16579019|P1|Treatment Cycle 5|Withdrawal by Subject|1
4807759|NCT01261611|16579017|P3|Treatment Cycle 4|Not otherwise specified|0
4807760|NCT01261611|16579018|P2|Treatment Cycle 4|Not otherwise specified|0
4807761|NCT01261611|16579019|P1|Treatment Cycle 4|Not otherwise specified|3
4807762|NCT01261611|16579017|P3|Treatment Cycle 4|Lost to Follow-up|0
4807763|NCT01261611|16579018|P2|Treatment Cycle 4|Lost to Follow-up|0
4807764|NCT01261611|16579019|P1|Treatment Cycle 4|Lost to Follow-up|2
4807765|NCT01261611|16579017|P3|Treatment Cycle 4|Adverse Event|0
4807766|NCT01261611|16579018|P2|Treatment Cycle 4|Adverse Event|0
4807767|NCT01261611|16579019|P1|Treatment Cycle 4|Adverse Event|1
4807768|NCT01261611|16579017|P3|Treatment Cycle 4|Withdrawal by Subject|0
4807769|NCT01261611|16579018|P2|Treatment Cycle 4|Withdrawal by Subject|0
4807770|NCT01261611|16579019|P1|Treatment Cycle 4|Withdrawal by Subject|3
4807771|NCT01261611|16579017|P3|Treatment Cycle 4|Completed study|0
4807772|NCT01261611|16579018|P2|Treatment Cycle 4|Completed study|0
4807773|NCT01261611|16579019|P1|Treatment Cycle 4|Completed study|87
4807774|NCT01261611|16579017|P3|Treatment Cycle 3|Lost to Follow-up|0
4807775|NCT01261611|16579018|P2|Treatment Cycle 3|Lost to Follow-up|0
4807776|NCT01261611|16579019|P1|Treatment Cycle 3|Lost to Follow-up|1
4807777|NCT01261611|16579017|P3|Treatment Cycle 3|Adverse Event|0
4807778|NCT01261611|16579018|P2|Treatment Cycle 3|Adverse Event|0
4807779|NCT01261611|16579019|P1|Treatment Cycle 3|Adverse Event|1
4807780|NCT01261611|16579017|P3|Treatment Cycle 3|Withdrawal by Subject|0
4807781|NCT01261611|16579018|P2|Treatment Cycle 3|Withdrawal by Subject|0
4807782|NCT01261611|16579019|P1|Treatment Cycle 3|Withdrawal by Subject|4
4807783|NCT01261611|16579017|P3|Treatment Cycle 3|Completed study|0
4807784|NCT01261611|16579018|P2|Treatment Cycle 3|Completed study|0
4807785|NCT01261611|16579019|P1|Treatment Cycle 3|Completed study|24
4807786|NCT01261611|16579017|P3|Treatment Cycle 2|Not otherwise specified|0
4807787|NCT01261611|16579018|P2|Treatment Cycle 2|Not otherwise specified|0
4807788|NCT01261611|16579019|P1|Treatment Cycle 2|Not otherwise specified|2
4807789|NCT01261611|16579017|P3|Treatment Cycle 2|Protocol Violation|0
4807790|NCT01261611|16579018|P2|Treatment Cycle 2|Protocol Violation|0
4807791|NCT01261611|16579019|P1|Treatment Cycle 2|Protocol Violation|2
4807792|NCT01261611|16579017|P3|Treatment Cycle 2|Adverse Event|0
4807793|NCT01261611|16579018|P2|Treatment Cycle 2|Adverse Event|0
4807794|NCT01261611|16579019|P1|Treatment Cycle 2|Adverse Event|1
4807795|NCT01261611|16579017|P3|Treatment Cycle 2|Withdrawal by Subject|0
4807796|NCT01261611|16579018|P2|Treatment Cycle 2|Withdrawal by Subject|0
4807797|NCT01261611|16579019|P1|Treatment Cycle 2|Withdrawal by Subject|4
4807798|NCT01261611|16579017|P3|Treatment Cycle 2|Completed study|0
4807799|NCT01261611|16579018|P2|Treatment Cycle 2|Completed study|0
4807800|NCT01261611|16579019|P1|Treatment Cycle 2|Completed study|4
4807801|NCT01261611|16579017|P3|Treatment Cycle 1|Protocol Violation|2
4807802|NCT01261611|16579018|P2|Treatment Cycle 1|Protocol Violation|0
4807803|NCT01261611|16579019|P1|Treatment Cycle 1|Protocol Violation|0
4807804|NCT01261611|16579017|P3|Treatment Cycle 1|Adverse Event|0
4807805|NCT01261611|16579018|P2|Treatment Cycle 1|Adverse Event|1
4807806|NCT01261611|16579019|P1|Treatment Cycle 1|Adverse Event|0
4807807|NCT01261611|16579017|P3|Treatment Cycle 1|Lost to Follow-up|0
4807808|NCT01261611|16579018|P2|Treatment Cycle 1|Lost to Follow-up|0
4807809|NCT01261611|16579019|P1|Treatment Cycle 1|Lost to Follow-up|1
4807810|NCT01261611|16579017|P3|Treatment Cycle 1|Withdrawal by Subject|0
4807811|NCT01261611|16579018|P2|Treatment Cycle 1|Withdrawal by Subject|2
4807812|NCT01261611|16579019|P1|Treatment Cycle 1|Withdrawal by Subject|3
4807813|NCT01261390|16579083|P4|Overall Study|Lost to Follow-up|6
4807814|NCT01261390|16579084|P3|Overall Study|Lost to Follow-up|5
4807815|NCT01261390|16579085|P2|Overall Study|Lost to Follow-up|6
4807816|NCT01261390|16579086|P1|Overall Study|Lost to Follow-up|1
4807817|NCT01261390|16579083|P4|Overall Study|Loss of Interest in the Study|0
4807818|NCT01261390|16579084|P3|Overall Study|Loss of Interest in the Study|0
4807819|NCT01261390|16579085|P2|Overall Study|Loss of Interest in the Study|1
4807820|NCT01261390|16579086|P1|Overall Study|Loss of Interest in the Study|3
4807821|NCT01261390|16579083|P4|Overall Study|Relocation|0
4807822|NCT01261390|16579084|P3|Overall Study|Relocation|0
4807823|NCT01261390|16579085|P2|Overall Study|Relocation|1
4807824|NCT01261390|16579086|P1|Overall Study|Relocation|0
4807825|NCT01261390|16579083|P4|Overall Study|Dissatisfaction with Treatment|2
4807826|NCT01261390|16579084|P3|Overall Study|Dissatisfaction with Treatment|1
4807827|NCT01261390|16579085|P2|Overall Study|Dissatisfaction with Treatment|1
4807828|NCT01261390|16579086|P1|Overall Study|Dissatisfaction with Treatment|2
4807829|NCT01261390|16579083|P4|Overall Study|Significant Concurrent Illness|0
4807830|NCT01261390|16579084|P3|Overall Study|Significant Concurrent Illness|1
4807831|NCT01261390|16579085|P2|Overall Study|Significant Concurrent Illness|0
4807832|NCT01261390|16579086|P1|Overall Study|Significant Concurrent Illness|1
4807833|NCT01261338|16579250|P2|Overall Study|Withdrawal by Subject|2
4807834|NCT01261338|16579251|P1|Overall Study|Withdrawal by Subject|3
4807835|NCT01261325|16579262|P3|Overall Study|AE, serious fatal|2
4807836|NCT01261325|16579263|P2|Overall Study|AE, serious fatal|0
4807837|NCT01261325|16579264|P1|Overall Study|AE, serious fatal|0
4807838|NCT01261325|16579262|P3|Overall Study|Lost to Follow-up|3
4807839|NCT01261325|16579263|P2|Overall Study|Lost to Follow-up|1
4807840|NCT01261325|16579264|P1|Overall Study|Lost to Follow-up|0
4807841|NCT01261325|16579262|P3|Overall Study|Protocol Violation|1
4807842|NCT01261325|16579263|P2|Overall Study|Protocol Violation|3
4807843|NCT01261325|16579264|P1|Overall Study|Protocol Violation|0
4807844|NCT01261325|16579262|P3|Overall Study|Randomized in Error|1
4807845|NCT01261325|16579263|P2|Overall Study|Randomized in Error|0
4807846|NCT01261325|16579264|P1|Overall Study|Randomized in Error|0
4807847|NCT01261325|16579262|P3|Overall Study|Screen Failure|0
4807848|NCT01261325|16579263|P2|Overall Study|Screen Failure|0
4807849|NCT01261325|16579264|P1|Overall Study|Screen Failure|1
4807850|NCT01261325|16579262|P3|Overall Study|Erroneously Randomized|0
4807851|NCT01261325|16579263|P2|Overall Study|Erroneously Randomized|0
4807852|NCT01261325|16579264|P1|Overall Study|Erroneously Randomized|1
4807853|NCT01261325|16579262|P3|Overall Study|Patient Randomized by Mistake|0
4807854|NCT01261325|16579263|P2|Overall Study|Patient Randomized by Mistake|1
4807855|NCT01261325|16579264|P1|Overall Study|Patient Randomized by Mistake|0
4807856|NCT01261325|16579262|P3|Overall Study|Non Compliance|0
4807857|NCT01261325|16579263|P2|Overall Study|Non Compliance|0
4807858|NCT01261325|16579264|P1|Overall Study|Non Compliance|2
4807859|NCT01261325|16579262|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4807860|NCT01261325|16579263|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4807861|NCT01261325|16579264|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4807862|NCT01261325|16579262|P3|Overall Study|AE, non-serious non-fatal|13
4807863|NCT01261325|16579263|P2|Overall Study|AE, non-serious non-fatal|15
4807864|NCT01261325|16579264|P1|Overall Study|AE, non-serious non-fatal|9
4807865|NCT01261325|16579262|P3|Overall Study|SAE, non-fatal|1
4807866|NCT01261325|16579263|P2|Overall Study|SAE, non-fatal|5
4807867|NCT01261325|16579264|P1|Overall Study|SAE, non-fatal|1
4807868|NCT01261325|16579262|P3|Overall Study|Withdrawal by Subject|4
4807869|NCT01261325|16579263|P2|Overall Study|Withdrawal by Subject|2
4807870|NCT01261325|16579264|P1|Overall Study|Withdrawal by Subject|2
4807871|NCT01261325|16579262|P3|Overall Study|Lack of Efficacy|0
4807872|NCT01261325|16579263|P2|Overall Study|Lack of Efficacy|1
4807873|NCT01261325|16579264|P1|Overall Study|Lack of Efficacy|1
4807874|NCT01261247|16579296|P1|Overall Study|Ineligible|2
4807875|NCT01261000|16579309|P1|Overall Study|Screen failure|1
4807876|NCT01260948|16579315|P2|Second Intervention|Emesis|1
4807877|NCT01260948|16579316|P1|Second Intervention|Emesis|0
4807878|NCT01260948|16579315|P2|Washout of 28 Days|Withdrawal by Subject|3
4807879|NCT01260948|16579316|P1|Washout of 28 Days|Withdrawal by Subject|1
4807880|NCT01260922|16579326|P2|Second Intervention|Emesis|2
4807881|NCT01260922|16579327|P1|Second Intervention|Emesis|0
4807882|NCT01260922|16579326|P2|Washout of 28 Days|Withdrawal by Subject|2
4807883|NCT01260922|16579327|P1|Washout of 28 Days|Withdrawal by Subject|4
4807884|NCT01260922|16579326|P2|First Intervention|Withdrawal by Subject|1
4807885|NCT01260922|16579327|P1|First Intervention|Withdrawal by Subject|0
4807886|NCT01260896|16579337|P2|First Intervention|Withdrawn Due to Emesis|0
4807887|NCT01260896|16579338|P1|First Intervention|Withdrawn Due to Emesis|2
4807888|NCT01260701|16579396|P1|Overall Study|Did not begin protocol therapy|1
4807889|NCT01260701|16579396|P1|Overall Study|Ineligible|4
4807890|NCT01260701|16579396|P1|Overall Study|Under review|1
4807891|NCT01260701|16579396|P1|Overall Study|Not protocol specified|3
4807892|NCT01260701|16579396|P1|Overall Study|Death|2
4807893|NCT01260701|16579396|P1|Overall Study|Progression|53
4807894|NCT01260701|16579396|P1|Overall Study|Withdrawal by Subject|2
4807895|NCT01260701|16579396|P1|Overall Study|Adverse Event|9
4807896|NCT01260584|16579477|P4|Period 2|Withdrawal by Subject|0
4807897|NCT01260584|16579478|P3|Period 2|Withdrawal by Subject|0
4807898|NCT01260584|16579479|P2|Period 2|Withdrawal by Subject|1
4807899|NCT01260584|16579480|P1|Period 2|Withdrawal by Subject|0
4807900|NCT01260584|16579477|P4|Period 2|Adverse Event|0
4807901|NCT01260584|16579478|P3|Period 2|Adverse Event|2
4807902|NCT01260584|16579479|P2|Period 2|Adverse Event|0
4807903|NCT01260584|16579480|P1|Period 2|Adverse Event|1
4807904|NCT01260584|16579477|P4|Period 2|Protocol Violation|1
4807905|NCT01260584|16579478|P3|Period 2|Protocol Violation|3
4807906|NCT01260584|16579479|P2|Period 2|Protocol Violation|2
4807907|NCT01260584|16579480|P1|Period 2|Protocol Violation|0
4807908|NCT01260584|16579477|P4|Period 1|Adverse Event|0
4807909|NCT01260584|16579478|P3|Period 1|Adverse Event|1
4807910|NCT01260584|16579479|P2|Period 1|Adverse Event|0
4807911|NCT01260584|16579480|P1|Period 1|Adverse Event|0
4807912|NCT01260584|16579477|P4|Period 1|Protocol Violation|1
4807913|NCT01260584|16579478|P3|Period 1|Protocol Violation|1
4807914|NCT01260584|16579479|P2|Period 1|Protocol Violation|0
4807915|NCT01260584|16579480|P1|Period 1|Protocol Violation|0
4807916|NCT01260467|16579523|P1|Overall Study|Withdrawal by Subject|2
4807917|NCT01260350|16579555|P22|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807918|NCT01260350|16579556|P21|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807919|NCT01260350|16579557|P20|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807920|NCT01260350|16579558|P19|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807921|NCT01260350|16579559|P18|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807922|NCT01260350|16579560|P17|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807923|NCT01260350|16579561|P16|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807924|NCT01260350|16579562|P15|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807925|NCT01260350|16579563|P14|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807926|NCT01260350|16579564|P13|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807927|NCT01260350|16579565|P12|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807928|NCT01260350|16579566|P11|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807929|NCT01260350|16579567|P10|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807930|NCT01260350|16579568|P9|Overall Study|Did Not Complete Follow-up 12 Visit|1
4807931|NCT01260350|16579569|P8|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807932|NCT01260350|16579570|P7|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807933|NCT01260350|16579571|P6|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807934|NCT01260350|16579572|P5|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807935|NCT01260350|16579573|P4|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807936|NCT01260350|16579574|P3|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807937|NCT01260350|16579575|P2|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807938|NCT01260350|16579576|P1|Overall Study|Did Not Complete Follow-up 12 Visit|0
4807939|NCT01260350|16579555|P22|Overall Study|Lack of Efficacy|0
4807940|NCT01260350|16579556|P21|Overall Study|Lack of Efficacy|3
4807941|NCT01260350|16579557|P20|Overall Study|Lack of Efficacy|0
4807942|NCT01260350|16579558|P19|Overall Study|Lack of Efficacy|0
4807943|NCT01260350|16579559|P18|Overall Study|Lack of Efficacy|1
4807944|NCT01260350|16579560|P17|Overall Study|Lack of Efficacy|0
4807945|NCT01260350|16579561|P16|Overall Study|Lack of Efficacy|0
4807946|NCT01260350|16579562|P15|Overall Study|Lack of Efficacy|0
4807947|NCT01260350|16579563|P14|Overall Study|Lack of Efficacy|0
4807948|NCT01260350|16579564|P13|Overall Study|Lack of Efficacy|0
4807949|NCT01260350|16579565|P12|Overall Study|Lack of Efficacy|0
4807950|NCT01260350|16579566|P11|Overall Study|Lack of Efficacy|0
4807951|NCT01260350|16579567|P10|Overall Study|Lack of Efficacy|0
4807952|NCT01260350|16579568|P9|Overall Study|Lack of Efficacy|0
4807953|NCT01260350|16579569|P8|Overall Study|Lack of Efficacy|0
4807954|NCT01260350|16579570|P7|Overall Study|Lack of Efficacy|0
4807955|NCT01260350|16579571|P6|Overall Study|Lack of Efficacy|0
4807956|NCT01260350|16579572|P5|Overall Study|Lack of Efficacy|0
4807957|NCT01260350|16579573|P4|Overall Study|Lack of Efficacy|0
4807958|NCT01260350|16579574|P3|Overall Study|Lack of Efficacy|0
4807959|NCT01260350|16579575|P2|Overall Study|Lack of Efficacy|0
4807960|NCT01260350|16579576|P1|Overall Study|Lack of Efficacy|0
4807961|NCT01260311|16579783|P1|Overall Study|Fesoterodine Started Before Enrollment|1
4807962|NCT01260311|16579783|P1|Overall Study|Medication Stopped|1
4807963|NCT01260311|16579783|P1|Overall Study|Gone to Province|2
4807964|NCT01260311|16579783|P1|Overall Study|Financial Constraints|77
4807965|NCT01260311|16579783|P1|Overall Study|Withdrawal by Subject|6
4807966|NCT01260311|16579783|P1|Overall Study|Lost to Follow-up|25
4807967|NCT01260311|16579783|P1|Overall Study|Lack of Efficacy|4
4807968|NCT01260311|16579783|P1|Overall Study|Adverse Event|11
4807969|NCT01260194|16579814|P1|Overall Study|Withdrawal of Consent|1
4807970|NCT01260181|16579826|P1|Overall Study|Decision of Investigator|1
4807971|NCT01260142|16579841|P6|Treatment Period 1|Withdrawal by Subject|1
4807972|NCT01260142|16579842|P5|Treatment Period 1|Withdrawal by Subject|0
4807973|NCT01260142|16579843|P4|Treatment Period 1|Withdrawal by Subject|0
4807974|NCT01260142|16579844|P3|Treatment Period 1|Withdrawal by Subject|0
4807975|NCT01260142|16579845|P2|Treatment Period 1|Withdrawal by Subject|0
4807976|NCT01260142|16579846|P1|Treatment Period 1|Withdrawal by Subject|0
4807977|NCT01260142|16579841|P6|Treatment Period 1|Unexplained elevated sys. BP|0
4807978|NCT01260142|16579842|P5|Treatment Period 1|Unexplained elevated sys. BP|1
4807979|NCT01260142|16579843|P4|Treatment Period 1|Unexplained elevated sys. BP|0
4807980|NCT01260142|16579844|P3|Treatment Period 1|Unexplained elevated sys. BP|0
4807981|NCT01260142|16579845|P2|Treatment Period 1|Unexplained elevated sys. BP|0
4807982|NCT01260142|16579846|P1|Treatment Period 1|Unexplained elevated sys. BP|0
4807983|NCT01260142|16579841|P6|Treatment Period 1|Study on hold|2
4807984|NCT01260142|16579842|P5|Treatment Period 1|Study on hold|1
4807985|NCT01260142|16579843|P4|Treatment Period 1|Study on hold|0
4807986|NCT01260142|16579844|P3|Treatment Period 1|Study on hold|0
4807987|NCT01260142|16579845|P2|Treatment Period 1|Study on hold|1
4807988|NCT01260142|16579846|P1|Treatment Period 1|Study on hold|1
4807989|NCT01259869|16579896|P1|Overall Study|Duplicated registration|1
4807990|NCT01259856|16579902|P2|Overall Study|Unknown/missing|2
4807991|NCT01259856|16579903|P1|Overall Study|Unknown/missing|2
4807992|NCT01259856|16579902|P2|Overall Study|Transfer to another study|1
4807993|NCT01259856|16579903|P1|Overall Study|Transfer to another study|0
4807994|NCT01259856|16579902|P2|Overall Study|Patient developed other disease|1
4807995|NCT01259856|16579903|P1|Overall Study|Patient developed other disease|0
4807996|NCT01259856|16579902|P2|Overall Study|Study closure by sponsor|41
4807997|NCT01259856|16579903|P1|Overall Study|Study closure by sponsor|40
4807998|NCT01259856|16579902|P2|Overall Study|Treatment never started|6
4807999|NCT01259856|16579903|P1|Overall Study|Treatment never started|0
4808000|NCT01259856|16579902|P2|Overall Study|Withdrawal by Subject|10
4808001|NCT01259856|16579903|P1|Overall Study|Withdrawal by Subject|9
4808002|NCT01259856|16579902|P2|Overall Study|Physician Decision|1
4808003|NCT01259856|16579903|P1|Overall Study|Physician Decision|2
4808004|NCT01259856|16579902|P2|Overall Study|Lost to Follow-up|1
4808005|NCT01259856|16579903|P1|Overall Study|Lost to Follow-up|1
4808006|NCT01259856|16579902|P2|Overall Study|Lack of Efficacy|1
4808007|NCT01259856|16579903|P1|Overall Study|Lack of Efficacy|3
4808008|NCT01259856|16579902|P2|Overall Study|Death|1
4808009|NCT01259856|16579903|P1|Overall Study|Death|0
4808010|NCT01259856|16579902|P2|Overall Study|Adverse Event|9
4808011|NCT01259856|16579903|P1|Overall Study|Adverse Event|12
4808012|NCT01259726|16579927|P4|Overall Study|Lost to Follow-up|3
4808013|NCT01259726|16579928|P3|Overall Study|Lost to Follow-up|1
4808014|NCT01259726|16579929|P2|Overall Study|Lost to Follow-up|1
4808015|NCT01259726|16579930|P1|Overall Study|Lost to Follow-up|1
4808016|NCT01259726|16579927|P4|Overall Study|Withdrawal by Subject|1
4808017|NCT01259726|16579928|P3|Overall Study|Withdrawal by Subject|2
4808018|NCT01259726|16579929|P2|Overall Study|Withdrawal by Subject|3
4808019|NCT01259726|16579930|P1|Overall Study|Withdrawal by Subject|1
4808020|NCT01259726|16579927|P4|Overall Study|Physician Decision|1
4808021|NCT01259726|16579928|P3|Overall Study|Physician Decision|1
4808022|NCT01259726|16579929|P2|Overall Study|Physician Decision|0
4808023|NCT01259726|16579930|P1|Overall Study|Physician Decision|2
4808024|NCT01259726|16579927|P4|Overall Study|Death|0
4808025|NCT01259726|16579928|P3|Overall Study|Death|0
4808026|NCT01259726|16579929|P2|Overall Study|Death|0
4808027|NCT01259726|16579930|P1|Overall Study|Death|1
4808028|NCT01259713|16579962|P2|Overall Study|Subject Withdrew Consent|7
4808029|NCT01259713|16579963|P1|Overall Study|Subject Withdrew Consent|12
4808030|NCT01259713|16579962|P2|Overall Study|Protocol Violation|4
4808031|NCT01259713|16579963|P1|Overall Study|Protocol Violation|5
4808032|NCT01259713|16579962|P2|Overall Study|Lack of Efficacy|0
4808033|NCT01259713|16579963|P1|Overall Study|Lack of Efficacy|2
4808034|NCT01259713|16579962|P2|Overall Study|Investigators Discretion|6
4808035|NCT01259713|16579963|P1|Overall Study|Investigators Discretion|14
4808036|NCT01259713|16579962|P2|Overall Study|Death Not Related to IFI|1
4808037|NCT01259713|16579963|P1|Overall Study|Death Not Related to IFI|8
4808038|NCT01259713|16579962|P2|Overall Study|Adverse Event|23
4808039|NCT01259713|16579963|P1|Overall Study|Adverse Event|54
4808040|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7
4808041|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3
4808042|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6
4808043|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5
4808044|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
4808045|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1
4808046|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
4808047|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0
4808048|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
4808049|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6
4808050|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4
4808051|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3
4808052|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3
4808053|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4
4808054|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6
4808055|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12
4808056|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
4808057|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
4808058|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0
4808059|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1
4808060|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62
4808061|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29
4808062|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42
4808063|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28
4808064|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
4808065|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1
4808066|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
4808067|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0
4808068|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1
4808069|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
4808070|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
4808071|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0
4808072|NCT01259492|16580010|P4|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
4808073|NCT01259492|16580011|P3|Period 3 (Week 15 to End of Week 40)|Adverse Event|6
4808074|NCT01259492|16580012|P2|Period 3 (Week 15 to End of Week 40)|Adverse Event|11
4808075|NCT01259492|16580013|P1|Period 3 (Week 15 to End of Week 40)|Adverse Event|5
4808076|NCT01259492|16580010|P4|Period 2 (Week 10 to Week 14)|Protocol Violation|0
4808077|NCT01259492|16580011|P3|Period 2 (Week 10 to Week 14)|Protocol Violation|1
4808078|NCT01259492|16580012|P2|Period 2 (Week 10 to Week 14)|Protocol Violation|2
4808079|NCT01259492|16580013|P1|Period 2 (Week 10 to Week 14)|Protocol Violation|0
4808080|NCT01259492|16580010|P4|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
4808081|NCT01259492|16580011|P3|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1
4808082|NCT01259492|16580012|P2|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
4808083|NCT01259492|16580013|P1|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3
4808084|NCT01259492|16580010|P4|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4
4808085|NCT01259492|16580011|P3|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8
4808086|NCT01259492|16580012|P2|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2
4808087|NCT01259492|16580013|P1|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6
4808088|NCT01259492|16580010|P4|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
4808089|NCT01259492|16580011|P3|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
4808090|NCT01259492|16580012|P2|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7
4808091|NCT01259492|16580013|P1|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13
4808092|NCT01259492|16580010|P4|Period 2 (Week 10 to Week 14)|Adverse Event|8
4808093|NCT01259492|16580011|P3|Period 2 (Week 10 to Week 14)|Adverse Event|7
4808094|NCT01259492|16580012|P2|Period 2 (Week 10 to Week 14)|Adverse Event|4
4808095|NCT01259492|16580013|P1|Period 2 (Week 10 to Week 14)|Adverse Event|3
4808096|NCT01259492|16580010|P4|Period 1 (9 Weeks)|Protocol Violation|1
4808097|NCT01259492|16580011|P3|Period 1 (9 Weeks)|Protocol Violation|3
4808098|NCT01259492|16580012|P2|Period 1 (9 Weeks)|Protocol Violation|6
4808099|NCT01259492|16580013|P1|Period 1 (9 Weeks)|Protocol Violation|5
4808100|NCT01259492|16580010|P4|Period 1 (9 Weeks)|Administrative Problems|2
4808101|NCT01259492|16580011|P3|Period 1 (9 Weeks)|Administrative Problems|1
4808102|NCT01259492|16580012|P2|Period 1 (9 Weeks)|Administrative Problems|1
4808103|NCT01259492|16580013|P1|Period 1 (9 Weeks)|Administrative Problems|0
4808104|NCT01259492|16580010|P4|Period 1 (9 Weeks)|Lost to Follow-up|4
4808105|NCT01259492|16580011|P3|Period 1 (9 Weeks)|Lost to Follow-up|3
4808106|NCT01259492|16580012|P2|Period 1 (9 Weeks)|Lost to Follow-up|6
4808107|NCT01259492|16580013|P1|Period 1 (9 Weeks)|Lost to Follow-up|4
4808108|NCT01259492|16580010|P4|Period 1 (9 Weeks)|Withdrawal by Subject|7
4808109|NCT01259492|16580011|P3|Period 1 (9 Weeks)|Withdrawal by Subject|6
4808110|NCT01259492|16580012|P2|Period 1 (9 Weeks)|Withdrawal by Subject|8
4808111|NCT01259492|16580013|P1|Period 1 (9 Weeks)|Withdrawal by Subject|5
4808112|NCT01259492|16580010|P4|Period 1 (9 Weeks)|Lack of Efficacy|11
4808113|NCT01259492|16580011|P3|Period 1 (9 Weeks)|Lack of Efficacy|4
4808114|NCT01259492|16580012|P2|Period 1 (9 Weeks)|Lack of Efficacy|2
4808115|NCT01259492|16580013|P1|Period 1 (9 Weeks)|Lack of Efficacy|2
4808116|NCT01259492|16580010|P4|Period 1 (9 Weeks)|Adverse Event|3
4808117|NCT01259492|16580011|P3|Period 1 (9 Weeks)|Adverse Event|26
4808118|NCT01259492|16580012|P2|Period 1 (9 Weeks)|Adverse Event|18
4808119|NCT01259492|16580013|P1|Period 1 (9 Weeks)|Adverse Event|13
4808120|NCT01259466|16580062|P2|Overall Study|Withdrawal by Subject|9
4808121|NCT01259466|16580063|P1|Overall Study|Withdrawal by Subject|1
4808122|NCT01259401|16580101|P2|4-month Follow-up|Lost to Follow-up|1
4808123|NCT01259401|16580102|P1|4-month Follow-up|Lost to Follow-up|0
4808124|NCT01259401|16580101|P2|4-month Follow-up|Death|1
4808125|NCT01259401|16580102|P1|4-month Follow-up|Death|0
4808126|NCT01259388|16580112|P2|Overall Study|Physician Decision|0
4808127|NCT01259388|16580113|P1|Overall Study|Physician Decision|1
4808128|NCT01259388|16580112|P2|Overall Study|Withdrawal by Subject|1
4808129|NCT01259388|16580113|P1|Overall Study|Withdrawal by Subject|1
4808130|NCT01259388|16580112|P2|Overall Study|Adverse Event|0
4808131|NCT01259388|16580113|P1|Overall Study|Adverse Event|3
4808132|NCT01259375|16580123|P1|Overall Study|Adverse Event|1
4808133|NCT01259297|16580140|P8|Double Blind Randomized Period|Other reasons|1
4808134|NCT01259297|16580141|P7|Double Blind Randomized Period|Other reasons|3
4808135|NCT01259297|16580142|P6|Double Blind Randomized Period|Other reasons|2
4808136|NCT01259297|16580143|P5|Double Blind Randomized Period|Other reasons|1
4808137|NCT01259297|16580144|P4|Double Blind Randomized Period|Other reasons|0
4808138|NCT01259297|16580145|P3|Double Blind Randomized Period|Other reasons|0
4808139|NCT01259297|16580146|P2|Double Blind Randomized Period|Other reasons|1
4808140|NCT01259297|16580147|P1|Double Blind Randomized Period|Other reasons|0
4808141|NCT01259297|16580140|P8|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4808142|NCT01259297|16580141|P7|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4808143|NCT01259297|16580142|P6|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4808144|NCT01259297|16580143|P5|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
4808145|NCT01259297|16580144|P4|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2
4808146|NCT01259297|16580145|P3|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0
4808147|NCT01259297|16580146|P2|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4808148|NCT01259297|16580147|P1|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1
4808149|NCT01259297|16580140|P8|Double Blind Randomized Period|Death|1
4808150|NCT01259297|16580141|P7|Double Blind Randomized Period|Death|2
4808151|NCT01259297|16580142|P6|Double Blind Randomized Period|Death|5
4808152|NCT01259297|16580143|P5|Double Blind Randomized Period|Death|1
4808153|NCT01259297|16580144|P4|Double Blind Randomized Period|Death|2
4808154|NCT01259297|16580145|P3|Double Blind Randomized Period|Death|1
4808155|NCT01259297|16580146|P2|Double Blind Randomized Period|Death|1
4808156|NCT01259297|16580147|P1|Double Blind Randomized Period|Death|1
4808157|NCT01259284|16580178|P3|Overall Study|Study Termination|0
4808158|NCT01259284|16580179|P2|Overall Study|Study Termination|0
4808159|NCT01259284|16580180|P1|Overall Study|Study Termination|2
4808160|NCT01259245|16580190|P2|Overall Study|Death|2
4808161|NCT01259245|16580191|P1|Overall Study|Death|1
4808162|NCT01259245|16580190|P2|Overall Study|Withdrawal by Subject|24
4808163|NCT01259245|16580191|P1|Overall Study|Withdrawal by Subject|27
4808164|NCT01259115|16580215|P2|Period 2|Adverse Event|0
4808165|NCT01259115|16580216|P1|Period 2|Adverse Event|1
4808166|NCT01259115|16580215|P2|Period 1|Lost to Follow-up|1
4808167|NCT01259115|16580216|P1|Period 1|Lost to Follow-up|0
4808168|NCT01259115|16580215|P2|Period 1|Protocol Violation|0
4808169|NCT01259115|16580216|P1|Period 1|Protocol Violation|2
4808170|NCT01259115|16580215|P2|Period 1|Adverse Event|0
4808171|NCT01259115|16580216|P1|Period 1|Adverse Event|1
4808172|NCT01259102|16580252|P5|Overall Study|Other|1
4808173|NCT01259102|16580253|P4|Overall Study|Other|1
4808174|NCT01259102|16580254|P3|Overall Study|Other|1
4808175|NCT01259102|16580255|P2|Overall Study|Other|0
4808176|NCT01259102|16580256|P1|Overall Study|Other|0
4808177|NCT01259102|16580252|P5|Overall Study|Adverse Event|0
4808178|NCT01259102|16580253|P4|Overall Study|Adverse Event|1
4808179|NCT01259102|16580254|P3|Overall Study|Adverse Event|1
4808180|NCT01259102|16580255|P2|Overall Study|Adverse Event|0
4808181|NCT01259102|16580256|P1|Overall Study|Adverse Event|1
4808182|NCT01259089|16580313|P6|Survival Follow up for Two Years|stopped being followed as study closed|4
4808183|NCT01259089|16580314|P5|Survival Follow up for Two Years|stopped being followed as study closed|0
4808184|NCT01259089|16580315|P4|Survival Follow up for Two Years|stopped being followed as study closed|0
4808185|NCT01259089|16580316|P3|Survival Follow up for Two Years|stopped being followed as study closed|0
4808186|NCT01259089|16580317|P2|Survival Follow up for Two Years|stopped being followed as study closed|0
4808187|NCT01259089|16580318|P1|Survival Follow up for Two Years|stopped being followed as study closed|0
4808188|NCT01259089|16580313|P6|Survival Follow up for Two Years|Lost to Follow-up|2
4808189|NCT01259089|16580314|P5|Survival Follow up for Two Years|Lost to Follow-up|0
4808190|NCT01259089|16580315|P4|Survival Follow up for Two Years|Lost to Follow-up|0
4808191|NCT01259089|16580316|P3|Survival Follow up for Two Years|Lost to Follow-up|0
4808192|NCT01259089|16580317|P2|Survival Follow up for Two Years|Lost to Follow-up|0
4808193|NCT01259089|16580318|P1|Survival Follow up for Two Years|Lost to Follow-up|0
4808194|NCT01259089|16580313|P6|Survival Follow up for Two Years|Death|13
4808195|NCT01259089|16580314|P5|Survival Follow up for Two Years|Death|6
4808196|NCT01259089|16580315|P4|Survival Follow up for Two Years|Death|3
4808197|NCT01259089|16580316|P3|Survival Follow up for Two Years|Death|2
4808198|NCT01259089|16580317|P2|Survival Follow up for Two Years|Death|2
4808199|NCT01259089|16580318|P1|Survival Follow up for Two Years|Death|3
4808200|NCT01259089|16580313|P6|Continued Treatment After 8 Weeks|Progressive disease|0
4808201|NCT01259089|16580314|P5|Continued Treatment After 8 Weeks|Progressive disease|0
4808202|NCT01259089|16580315|P4|Continued Treatment After 8 Weeks|Progressive disease|1
4808203|NCT01259089|16580316|P3|Continued Treatment After 8 Weeks|Progressive disease|1
4808204|NCT01259089|16580317|P2|Continued Treatment After 8 Weeks|Progressive disease|1
4808205|NCT01259089|16580318|P1|Continued Treatment After 8 Weeks|Progressive disease|1
4808206|NCT01259089|16580313|P6|Continued Treatment After 8 Weeks|Adverse Event|1
4808207|NCT01259089|16580314|P5|Continued Treatment After 8 Weeks|Adverse Event|2
4808208|NCT01259089|16580315|P4|Continued Treatment After 8 Weeks|Adverse Event|0
4808209|NCT01259089|16580316|P3|Continued Treatment After 8 Weeks|Adverse Event|0
4808210|NCT01259089|16580317|P2|Continued Treatment After 8 Weeks|Adverse Event|0
4808211|NCT01259089|16580318|P1|Continued Treatment After 8 Weeks|Adverse Event|0
4808212|NCT01259089|16580313|P6|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4808213|NCT01259089|16580314|P5|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4808214|NCT01259089|16580315|P4|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4808215|NCT01259089|16580316|P3|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4808216|NCT01259089|16580317|P2|Continued Treatment After 8 Weeks|Withdrawal by Subject|0
4808217|NCT01259089|16580318|P1|Continued Treatment After 8 Weeks|Withdrawal by Subject|1
4808218|NCT01259089|16580313|P6|Confirmed Response at 8 Weeks|Progressive disease|7
4808219|NCT01259089|16580314|P5|Confirmed Response at 8 Weeks|Progressive disease|3
4808220|NCT01259089|16580315|P4|Confirmed Response at 8 Weeks|Progressive disease|1
4808221|NCT01259089|16580316|P3|Confirmed Response at 8 Weeks|Progressive disease|1
4808222|NCT01259089|16580317|P2|Confirmed Response at 8 Weeks|Progressive disease|0
4808223|NCT01259089|16580318|P1|Confirmed Response at 8 Weeks|Progressive disease|0
4808224|NCT01259089|16580313|P6|Confirmed Response at 8 Weeks|Adverse Event|2
4808225|NCT01259089|16580314|P5|Confirmed Response at 8 Weeks|Adverse Event|1
4808226|NCT01259089|16580315|P4|Confirmed Response at 8 Weeks|Adverse Event|0
4808227|NCT01259089|16580316|P3|Confirmed Response at 8 Weeks|Adverse Event|0
4808228|NCT01259089|16580317|P2|Confirmed Response at 8 Weeks|Adverse Event|0
4808229|NCT01259089|16580318|P1|Confirmed Response at 8 Weeks|Adverse Event|0
4808230|NCT01259089|16580313|P6|Confirmed Response at 8 Weeks|Withdrawal by Subject|1
4808231|NCT01259089|16580314|P5|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4808232|NCT01259089|16580315|P4|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4808233|NCT01259089|16580316|P3|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4808234|NCT01259089|16580317|P2|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4808235|NCT01259089|16580318|P1|Confirmed Response at 8 Weeks|Withdrawal by Subject|0
4808236|NCT01259089|16580313|P6|Reached First Response at 4 Weeks|Adverse Event|1
4808237|NCT01259089|16580314|P5|Reached First Response at 4 Weeks|Adverse Event|0
4808238|NCT01259089|16580315|P4|Reached First Response at 4 Weeks|Adverse Event|0
4808239|NCT01259089|16580316|P3|Reached First Response at 4 Weeks|Adverse Event|0
4808240|NCT01259089|16580317|P2|Reached First Response at 4 Weeks|Adverse Event|0
4808241|NCT01259089|16580318|P1|Reached First Response at 4 Weeks|Adverse Event|0
4808242|NCT01259089|16580313|P6|Reached First Response at 4 Weeks|Patient not treated on study|1
4808243|NCT01259089|16580314|P5|Reached First Response at 4 Weeks|Patient not treated on study|0
4808244|NCT01259089|16580315|P4|Reached First Response at 4 Weeks|Patient not treated on study|0
4808245|NCT01259089|16580316|P3|Reached First Response at 4 Weeks|Patient not treated on study|0
4808246|NCT01259089|16580317|P2|Reached First Response at 4 Weeks|Patient not treated on study|0
4808247|NCT01259089|16580318|P1|Reached First Response at 4 Weeks|Patient not treated on study|0
4808248|NCT01259024|16580346|P1|Overall Study|Physician Decision|1
4808249|NCT01258998|16580366|P1|Overall Study|Ineligible|1
4808250|NCT01258803|16580420|P6|Treatment Period 3 (1 Dose)|Protocol Violation|0
4808251|NCT01258803|16580421|P5|Treatment Period 3 (1 Dose)|Protocol Violation|0
4808252|NCT01258803|16580422|P4|Treatment Period 3 (1 Dose)|Protocol Violation|0
4808253|NCT01258803|16580423|P3|Treatment Period 3 (1 Dose)|Protocol Violation|1
4808254|NCT01258803|16580424|P2|Treatment Period 3 (1 Dose)|Protocol Violation|0
4808255|NCT01258803|16580425|P1|Treatment Period 3 (1 Dose)|Protocol Violation|0
4808256|NCT01258803|16580420|P6|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4808257|NCT01258803|16580421|P5|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4808258|NCT01258803|16580422|P4|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4808259|NCT01258803|16580423|P3|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4808260|NCT01258803|16580424|P2|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1
4808261|NCT01258803|16580425|P1|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0
4808262|NCT01258803|16580420|P6|Treatment Period 2 (1 Dose)|Protocol Violation|1
4808263|NCT01258803|16580421|P5|Treatment Period 2 (1 Dose)|Protocol Violation|0
4808264|NCT01258803|16580422|P4|Treatment Period 2 (1 Dose)|Protocol Violation|0
4808265|NCT01258803|16580423|P3|Treatment Period 2 (1 Dose)|Protocol Violation|0
4808266|NCT01258803|16580424|P2|Treatment Period 2 (1 Dose)|Protocol Violation|1
4808267|NCT01258803|16580425|P1|Treatment Period 2 (1 Dose)|Protocol Violation|1
4808268|NCT01258738|16580462|P2|Open-label Period|Withdrawn due to pregnancy|1
4808269|NCT01258738|16580463|P1|Open-label Period|Withdrawn due to pregnancy|1
4808270|NCT01258738|16580462|P2|Open-label Period|Other Reasons|1
4808271|NCT01258738|16580463|P1|Open-label Period|Other Reasons|0
4808272|NCT01258738|16580462|P2|Open-label Period|Adverse Event|5
4808273|NCT01258738|16580463|P1|Open-label Period|Adverse Event|4
4808274|NCT01258738|16580462|P2|Open-label Period|Protocol Violation|2
4808275|NCT01258738|16580463|P1|Open-label Period|Protocol Violation|2
4808276|NCT01258738|16580462|P2|Open-label Period|Withdrawal by Subject|6
4808277|NCT01258738|16580463|P1|Open-label Period|Withdrawal by Subject|5
4808278|NCT01258738|16580462|P2|Open-label Period|Lost to Follow-up|2
4808279|NCT01258738|16580463|P1|Open-label Period|Lost to Follow-up|0
4808280|NCT01258738|16580462|P2|Open-label Period|Insufficient clinical response|3
4808281|NCT01258738|16580463|P1|Open-label Period|Insufficient clinical response|5
4808282|NCT01258738|16580462|P2|Open-label Period|Did not meet inclusion criteria|1
4808283|NCT01258738|16580463|P1|Open-label Period|Did not meet inclusion criteria|0
4808284|NCT01258738|16580462|P2|Double-blind Period|Adverse Event|1
4808285|NCT01258738|16580463|P1|Double-blind Period|Adverse Event|3
4808286|NCT01258738|16580462|P2|Double-blind Period|Protocol Violation|1
4808287|NCT01258738|16580463|P1|Double-blind Period|Protocol Violation|1
4808288|NCT01258738|16580462|P2|Double-blind Period|Withdrawal by Subject|2
4808289|NCT01258738|16580463|P1|Double-blind Period|Withdrawal by Subject|2
4808290|NCT01258738|16580462|P2|Double-blind Period|Did not meet inclusion criteria|3
4808291|NCT01258738|16580463|P1|Double-blind Period|Did not meet inclusion criteria|3
4808292|NCT01258660|16580601|P2|Overall Study|Invalid for primary analysis data set|6
4808293|NCT01258660|16580602|P1|Overall Study|Invalid for primary analysis data set|4
4808294|NCT01258660|16580601|P2|Overall Study|Protocol Violation|1
4808295|NCT01258660|16580602|P1|Overall Study|Protocol Violation|0
4808296|NCT01258660|16580601|P2|Overall Study|due to relocation|0
4808297|NCT01258660|16580602|P1|Overall Study|due to relocation|2
4808298|NCT01258660|16580601|P2|Overall Study|Withdrawal by Subject|0
4808299|NCT01258660|16580602|P1|Overall Study|Withdrawal by Subject|3
4808300|NCT01258660|16580601|P2|Overall Study|Adverse Event|4
4808301|NCT01258660|16580602|P1|Overall Study|Adverse Event|2
4808302|NCT01258608|16580621|P2|Overall Study|Withdrawal by Subject|5
4808303|NCT01258608|16580622|P1|Overall Study|Withdrawal by Subject|6
4808304|NCT01258608|16580621|P2|Overall Study|Adverse Event|10
4808305|NCT01258608|16580622|P1|Overall Study|Adverse Event|6
4808306|NCT01258608|16580621|P2|Overall Study|Lack of Efficacy|1
4808307|NCT01258608|16580622|P1|Overall Study|Lack of Efficacy|0
4808308|NCT01258608|16580621|P2|Overall Study|Lack of compliance|0
4808309|NCT01258608|16580622|P1|Overall Study|Lack of compliance|1
4808310|NCT01258608|16580621|P2|Overall Study|Lost to Follow-up|1
4808311|NCT01258608|16580622|P1|Overall Study|Lost to Follow-up|0
4808312|NCT01258608|16580621|P2|Overall Study|Physician Decision|1
4808313|NCT01258608|16580622|P1|Overall Study|Physician Decision|6
4808314|NCT01258608|16580621|P2|Overall Study|Sponsor decision|1
4808315|NCT01258608|16580622|P1|Overall Study|Sponsor decision|0
4808316|NCT01258608|16580621|P2|Overall Study|Clinical progression|0
4808317|NCT01258608|16580622|P1|Overall Study|Clinical progression|1
4808318|NCT01258608|16580621|P2|Overall Study|Metastatic Hepatocellular Carcinoma|0
4808319|NCT01258608|16580622|P1|Overall Study|Metastatic Hepatocellular Carcinoma|1
4808320|NCT01258595|16580670|P2|Overall Study|Withdrawal by Subject|1
4808321|NCT01258595|16580671|P1|Overall Study|Withdrawal by Subject|0
4808322|NCT01258595|16580670|P2|Overall Study|Lost to Follow-up|0
4808323|NCT01258595|16580671|P1|Overall Study|Lost to Follow-up|1
4808324|NCT01258348|16580768|P5|Overall Study|Withdrawal by Subject|0
4808325|NCT01258348|16580769|P4|Overall Study|Withdrawal by Subject|0
4808326|NCT01258348|16580770|P3|Overall Study|Withdrawal by Subject|0
4808327|NCT01258348|16580771|P2|Overall Study|Withdrawal by Subject|1
4808328|NCT01258348|16580772|P1|Overall Study|Withdrawal by Subject|0
4808329|NCT01258348|16580768|P5|Overall Study|Physician Decision|0
4808330|NCT01258348|16580769|P4|Overall Study|Physician Decision|2
4808331|NCT01258348|16580770|P3|Overall Study|Physician Decision|0
4808332|NCT01258348|16580771|P2|Overall Study|Physician Decision|0
4808333|NCT01258348|16580772|P1|Overall Study|Physician Decision|0
4808334|NCT01258348|16580768|P5|Overall Study|Progressive Disease|2
4808335|NCT01258348|16580769|P4|Overall Study|Progressive Disease|2
4808336|NCT01258348|16580770|P3|Overall Study|Progressive Disease|0
4808337|NCT01258348|16580771|P2|Overall Study|Progressive Disease|3
4808338|NCT01258348|16580772|P1|Overall Study|Progressive Disease|0
4808339|NCT01258348|16580768|P5|Overall Study|Adverse Event|4
4808340|NCT01258348|16580769|P4|Overall Study|Adverse Event|2
4808341|NCT01258348|16580770|P3|Overall Study|Adverse Event|3
4808342|NCT01258348|16580771|P2|Overall Study|Adverse Event|1
4808343|NCT01258348|16580772|P1|Overall Study|Adverse Event|1
4808344|NCT01258101|16580829|P4|Overall Study|Other reason|8
4808345|NCT01258101|16580830|P3|Overall Study|Other reason|1
4808346|NCT01258101|16580831|P2|Overall Study|Other reason|8
4808347|NCT01258101|16580832|P1|Overall Study|Other reason|7
4808348|NCT01258101|16580829|P4|Overall Study|PCR positive at week 24|1
4808349|NCT01258101|16580830|P3|Overall Study|PCR positive at week 24|0
4808350|NCT01258101|16580831|P2|Overall Study|PCR positive at week 24|0
4808351|NCT01258101|16580832|P1|Overall Study|PCR positive at week 24|0
4808352|NCT01258101|16580829|P4|Overall Study|Lost to Follow-up|6
4808353|NCT01258101|16580830|P3|Overall Study|Lost to Follow-up|0
4808354|NCT01258101|16580831|P2|Overall Study|Lost to Follow-up|5
4808355|NCT01258101|16580832|P1|Overall Study|Lost to Follow-up|5
4808356|NCT01258101|16580829|P4|Overall Study|Patient´s compliance|2
4808357|NCT01258101|16580830|P3|Overall Study|Patient´s compliance|1
4808358|NCT01258101|16580831|P2|Overall Study|Patient´s compliance|3
4808359|NCT01258101|16580832|P1|Overall Study|Patient´s compliance|4
4808360|NCT01258101|16580829|P4|Overall Study|Patient is not able to attend visits|6
4808361|NCT01258101|16580830|P3|Overall Study|Patient is not able to attend visits|7
4808362|NCT01258101|16580831|P2|Overall Study|Patient is not able to attend visits|9
4808363|NCT01258101|16580832|P1|Overall Study|Patient is not able to attend visits|8
4808364|NCT01258101|16580829|P4|Overall Study|Informed consent has been withdrawn|1
4808365|NCT01258101|16580830|P3|Overall Study|Informed consent has been withdrawn|1
4808366|NCT01258101|16580831|P2|Overall Study|Informed consent has been withdrawn|2
4808367|NCT01258101|16580832|P1|Overall Study|Informed consent has been withdrawn|2
4808368|NCT01258101|16580829|P4|Overall Study|Extra exclusion criterion amended|1
4808369|NCT01258101|16580830|P3|Overall Study|Extra exclusion criterion amended|1
4808370|NCT01258101|16580831|P2|Overall Study|Extra exclusion criterion amended|1
4808371|NCT01258101|16580832|P1|Overall Study|Extra exclusion criterion amended|2
4808372|NCT01258101|16580829|P4|Overall Study|Adverse Event|0
4808373|NCT01258101|16580830|P3|Overall Study|Adverse Event|0
4808374|NCT01258101|16580831|P2|Overall Study|Adverse Event|6
4808375|NCT01258101|16580832|P1|Overall Study|Adverse Event|5
4808376|NCT01257737|16580962|P2|Overall Study|Withdrew from study|1
4808377|NCT01257737|16580963|P1|Overall Study|Withdrew from study|0
4808378|NCT01257737|16580962|P2|Overall Study|Relocation out of the country|1
4808379|NCT01257737|16580963|P1|Overall Study|Relocation out of the country|0
4808380|NCT01257737|16580962|P2|Overall Study|Liver transplant|0
4808381|NCT01257737|16580963|P1|Overall Study|Liver transplant|1
4808382|NCT01257737|16580962|P2|Overall Study|Lost to Follow-up|2
4808383|NCT01257737|16580963|P1|Overall Study|Lost to Follow-up|1
4808384|NCT01257698|16580983|P2|Overall Study|Protocol Violation|0
4808385|NCT01257698|16580984|P1|Overall Study|Protocol Violation|4
4808386|NCT01257581|16580993|P3|Overall Study|Death|4
4808387|NCT01257581|16580994|P2|Overall Study|Death|2
4808388|NCT01257581|16580995|P1|Overall Study|Death|2
4808389|NCT01257581|16580993|P3|Overall Study|Early Termination|2
4808390|NCT01257581|16580994|P2|Overall Study|Early Termination|1
4808391|NCT01257581|16580995|P1|Overall Study|Early Termination|3
4808392|NCT01257568|16581033|P1|Overall Study|Component Revision|24
4808393|NCT01257568|16581033|P1|Overall Study|Terminated|1
4808394|NCT01257568|16581033|P1|Overall Study|Withdrawal by Subject|6
4808395|NCT01257568|16581033|P1|Overall Study|Lost to Follow-up|2
4808396|NCT01257542|16581047|P2|Overall Study|Withdrawal by Subject|2
4808397|NCT01257542|16581048|P1|Overall Study|Withdrawal by Subject|0
4808398|NCT01257542|16581047|P2|Overall Study|Protocol Violation|5
4808399|NCT01257542|16581048|P1|Overall Study|Protocol Violation|3
4808400|NCT01257503|16581068|P2|Overall Study|strep culture positive at enrollment|0
4808401|NCT01257503|16581069|P1|Overall Study|strep culture positive at enrollment|1
4808402|NCT01257503|16581068|P2|Overall Study|Over 5 years old at enrollment|1
4808403|NCT01257503|16581069|P1|Overall Study|Over 5 years old at enrollment|0
4808404|NCT01257503|16581068|P2|Overall Study|Lost to Follow-up|10
4808405|NCT01257503|16581069|P1|Overall Study|Lost to Follow-up|7
4808406|NCT01257425|16581098|P2|Overall Study|Death|0
4808407|NCT01257425|16581099|P1|Overall Study|Death|1
4808408|NCT01257425|16581098|P2|Overall Study|Withdrawal by Subject|1
4808409|NCT01257425|16581099|P1|Overall Study|Withdrawal by Subject|0
4808410|NCT01257425|16581098|P2|Overall Study|Protocol Violation|1
4808411|NCT01257425|16581099|P1|Overall Study|Protocol Violation|1
4808412|NCT01257425|16581098|P2|Overall Study|Adverse Event|1
4808413|NCT01257425|16581099|P1|Overall Study|Adverse Event|1
4808414|NCT01257425|16581098|P2|Overall Study|Lack of Efficacy|3
4808415|NCT01257425|16581099|P1|Overall Study|Lack of Efficacy|3
4808416|NCT01257230|16581141|P3|Overall Study|Other reason not defined above|3
4808417|NCT01257230|16581142|P2|Overall Study|Other reason not defined above|5
4808418|NCT01257230|16581143|P1|Overall Study|Other reason not defined above|1
4808419|NCT01257230|16581141|P3|Overall Study|Withdrawal by Subject|1
4808420|NCT01257230|16581142|P2|Overall Study|Withdrawal by Subject|4
4808421|NCT01257230|16581143|P1|Overall Study|Withdrawal by Subject|0
4808422|NCT01257230|16581141|P3|Overall Study|Protocol Violation|1
4808423|NCT01257230|16581142|P2|Overall Study|Protocol Violation|0
4808424|NCT01257230|16581143|P1|Overall Study|Protocol Violation|3
4808425|NCT01257230|16581141|P3|Overall Study|Lack of Efficacy|0
4808426|NCT01257230|16581142|P2|Overall Study|Lack of Efficacy|1
4808427|NCT01257230|16581143|P1|Overall Study|Lack of Efficacy|0
4808428|NCT01257230|16581141|P3|Overall Study|Adverse Event|0
4808429|NCT01257230|16581142|P2|Overall Study|Adverse Event|0
4808430|NCT01257230|16581143|P1|Overall Study|Adverse Event|2
4808431|NCT01257230|16581141|P3|Overall Study|Not Treated|1
4808432|NCT01257230|16581142|P2|Overall Study|Not Treated|0
4808433|NCT01257230|16581143|P1|Overall Study|Not Treated|0
4808434|NCT01257204|16581220|P3|Follow-up Period (up to Week 48)|Other|5
4808435|NCT01257204|16581221|P2|Follow-up Period (up to Week 48)|Other|0
4808436|NCT01257204|16581222|P1|Follow-up Period (up to Week 48)|Other|0
4808437|NCT01257204|16581220|P3|Follow-up Period (up to Week 48)|Lost to Follow-up|4
4808438|NCT01257204|16581221|P2|Follow-up Period (up to Week 48)|Lost to Follow-up|4
4808439|NCT01257204|16581222|P1|Follow-up Period (up to Week 48)|Lost to Follow-up|1
4808440|NCT01257204|16581220|P3|Follow-up Period (up to Week 48)|Withdrawal by Subject|1
4808441|NCT01257204|16581221|P2|Follow-up Period (up to Week 48)|Withdrawal by Subject|2
4808442|NCT01257204|16581222|P1|Follow-up Period (up to Week 48)|Withdrawal by Subject|0
4808443|NCT01257204|16581220|P3|Treatment Period (up to Week 24)|Participant's request to discontinue|2
4808444|NCT01257204|16581221|P2|Treatment Period (up to Week 24)|Participant's request to discontinue|2
4808445|NCT01257204|16581222|P1|Treatment Period (up to Week 24)|Participant's request to discontinue|1
4808446|NCT01257204|16581220|P3|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1
4808447|NCT01257204|16581221|P2|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
4808448|NCT01257204|16581222|P1|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0
4808449|NCT01257204|16581220|P3|Treatment Period (up to Week 24)|Lost to Follow-up|0
4808450|NCT01257204|16581221|P2|Treatment Period (up to Week 24)|Lost to Follow-up|2
4808451|NCT01257204|16581222|P1|Treatment Period (up to Week 24)|Lost to Follow-up|0
4808452|NCT01257204|16581220|P3|Treatment Period (up to Week 24)|Withdrawal by Subject|1
4808453|NCT01257204|16581221|P2|Treatment Period (up to Week 24)|Withdrawal by Subject|0
4808454|NCT01257204|16581222|P1|Treatment Period (up to Week 24)|Withdrawal by Subject|1
4808455|NCT01257204|16581220|P3|Treatment Period (up to Week 24)|Adverse Event|2
4808456|NCT01257204|16581221|P2|Treatment Period (up to Week 24)|Adverse Event|1
4808457|NCT01257204|16581222|P1|Treatment Period (up to Week 24)|Adverse Event|3
4808458|NCT01257204|16581220|P3|Treatment Period (up to Week 24)|Lack of Efficacy|3
4808459|NCT01257204|16581221|P2|Treatment Period (up to Week 24)|Lack of Efficacy|1
4808460|NCT01257204|16581222|P1|Treatment Period (up to Week 24)|Lack of Efficacy|0
4808461|NCT01256879|16581330|P1|Overall Study|Withdrawal by Subject|1
4808462|NCT01256788|16581356|P3|Overall Study|Lost to Follow-up|3
4808463|NCT01256788|16581357|P2|Overall Study|Lost to Follow-up|8
4808464|NCT01256788|16581358|P1|Overall Study|Lost to Follow-up|5
4808465|NCT01256684|16581369|P3|Overall Study|Entry criteria not met/non-compliance|6
4808466|NCT01256684|16581370|P2|Overall Study|Entry criteria not met/non-compliance|7
4808467|NCT01256684|16581371|P1|Overall Study|Entry criteria not met/non-compliance|4
4808468|NCT01256684|16581369|P3|Overall Study|Lack of Efficacy|1
4808469|NCT01256684|16581370|P2|Overall Study|Lack of Efficacy|1
4808470|NCT01256684|16581371|P1|Overall Study|Lack of Efficacy|0
4808471|NCT01256684|16581369|P3|Overall Study|Physician Decision|0
4808472|NCT01256684|16581370|P2|Overall Study|Physician Decision|1
4808473|NCT01256684|16581371|P1|Overall Study|Physician Decision|0
4808474|NCT01256684|16581369|P3|Overall Study|Withdrawal by Subject|2
4808475|NCT01256684|16581370|P2|Overall Study|Withdrawal by Subject|0
4808476|NCT01256684|16581371|P1|Overall Study|Withdrawal by Subject|4
4808477|NCT01256684|16581369|P3|Overall Study|Adverse Event|2
4808478|NCT01256684|16581370|P2|Overall Study|Adverse Event|4
4808479|NCT01256684|16581371|P1|Overall Study|Adverse Event|1
4808480|NCT01256671|16581403|P1|Overall Study|Non-compliance/Sponsor Decision/Other|12
4808481|NCT01256671|16581403|P1|Overall Study|Lack of Efficacy|4
4808482|NCT01256671|16581403|P1|Overall Study|Physician Decision|3
4808483|NCT01256671|16581403|P1|Overall Study|Withdrawal by Subject|31
4808484|NCT01256671|16581403|P1|Overall Study|Lost to Follow-up|16
4808485|NCT01256671|16581403|P1|Overall Study|Adverse Event|29
4808486|NCT01256658|16581416|P2|Period 1|Death|44
4808487|NCT01256658|16581417|P1|Period 1|Death|48
4808488|NCT01256658|16581416|P2|Period 1|Withdrawal by Subject|43
4808489|NCT01256658|16581417|P1|Period 1|Withdrawal by Subject|35
4808490|NCT01256658|16581416|P2|Period 1|Lost to Follow-up|661
4808491|NCT01256658|16581417|P1|Period 1|Lost to Follow-up|837
4808492|NCT01256593|16581467|P1|Overall Study|No Visit After Treatment|186
4808493|NCT01256593|16581467|P1|Overall Study|No Drug Administration Information|2
4808494|NCT01256593|16581467|P1|Overall Study|Protocol Violation|26
4808495|NCT01256567|16581481|P1|Overall Study|Withdrawal by Subject|1
4808496|NCT01256502|16581491|P1|Overall Study|Protocol deviation|1
4808497|NCT01256502|16581491|P1|Overall Study|Personal reasons|5
4808498|NCT01256502|16581491|P1|Overall Study|Had scaffold removed|4
4808499|NCT01256476|16581503|P2|Overall Study|LDL-C elevation exceeding 250 mg/dL|1
4808500|NCT01256476|16581504|P1|Overall Study|LDL-C elevation exceeding 250 mg/dL|0
4808501|NCT01256476|16581503|P2|Overall Study|Subject non-compliance|1
4808502|NCT01256476|16581504|P1|Overall Study|Subject non-compliance|0
4808503|NCT01256476|16581503|P2|Overall Study|Physician Decision|1
4808504|NCT01256476|16581504|P1|Overall Study|Physician Decision|0
4808505|NCT01256476|16581503|P2|Overall Study|Persistent ALT or AST elevation|0
4808506|NCT01256476|16581504|P1|Overall Study|Persistent ALT or AST elevation|1
4808507|NCT01256476|16581503|P2|Overall Study|Lost to Follow-up|2
4808508|NCT01256476|16581504|P1|Overall Study|Lost to Follow-up|1
4808509|NCT01256476|16581503|P2|Overall Study|Withdrawal by Subject|1
4808510|NCT01256476|16581504|P1|Overall Study|Withdrawal by Subject|2
4808511|NCT01256476|16581503|P2|Overall Study|Adverse Event|1
4808512|NCT01256476|16581504|P1|Overall Study|Adverse Event|2
4808513|NCT01256450|16581512|P3|Double-blind Treatment|Other|12
4808514|NCT01256450|16581513|P2|Double-blind Treatment|Other|9
4808515|NCT01256450|16581514|P1|Double-blind Treatment|Other|0
4808516|NCT01256450|16581512|P3|Double-blind Treatment|Opioid withdrawal symptoms|1
4808517|NCT01256450|16581513|P2|Double-blind Treatment|Opioid withdrawal symptoms|0
4808518|NCT01256450|16581514|P1|Double-blind Treatment|Opioid withdrawal symptoms|0
4808519|NCT01256450|16581512|P3|Double-blind Treatment|Non-compliance|4
4808520|NCT01256450|16581513|P2|Double-blind Treatment|Non-compliance|5
4808521|NCT01256450|16581514|P1|Double-blind Treatment|Non-compliance|0
4808522|NCT01256450|16581512|P3|Double-blind Treatment|Lack of analgesic effect|6
4808523|NCT01256450|16581513|P2|Double-blind Treatment|Lack of analgesic effect|5
4808524|NCT01256450|16581514|P1|Double-blind Treatment|Lack of analgesic effect|0
4808525|NCT01256450|16581512|P3|Double-blind Treatment|Withdrawal by Subject|1
4808526|NCT01256450|16581513|P2|Double-blind Treatment|Withdrawal by Subject|0
4808527|NCT01256450|16581514|P1|Double-blind Treatment|Withdrawal by Subject|0
4808528|NCT01256450|16581512|P3|Double-blind Treatment|Lost to Follow-up|7
4808529|NCT01256450|16581513|P2|Double-blind Treatment|Lost to Follow-up|1
4808530|NCT01256450|16581514|P1|Double-blind Treatment|Lost to Follow-up|0
4808531|NCT01256450|16581512|P3|Double-blind Treatment|Adverse Event|6
4808532|NCT01256450|16581513|P2|Double-blind Treatment|Adverse Event|8
4808533|NCT01256450|16581514|P1|Double-blind Treatment|Adverse Event|0
4808534|NCT01256450|16581512|P3|Open-label Titration|Other|0
4808535|NCT01256450|16581513|P2|Open-label Titration|Other|0
4808536|NCT01256450|16581514|P1|Open-label Titration|Other|13
4808537|NCT01256450|16581512|P3|Open-label Titration|Screen failure|0
4808538|NCT01256450|16581513|P2|Open-label Titration|Screen failure|0
4808539|NCT01256450|16581514|P1|Open-label Titration|Screen failure|1
4808540|NCT01256450|16581512|P3|Open-label Titration|Non-compliance|0
4808541|NCT01256450|16581513|P2|Open-label Titration|Non-compliance|0
4808542|NCT01256450|16581514|P1|Open-label Titration|Non-compliance|9
4808543|NCT01256450|16581512|P3|Open-label Titration|Lack of analgesic effect|0
4808544|NCT01256450|16581513|P2|Open-label Titration|Lack of analgesic effect|0
4808545|NCT01256450|16581514|P1|Open-label Titration|Lack of analgesic effect|30
4808546|NCT01256450|16581512|P3|Open-label Titration|Lost to Follow-up|0
4808547|NCT01256450|16581513|P2|Open-label Titration|Lost to Follow-up|0
4808548|NCT01256450|16581514|P1|Open-label Titration|Lost to Follow-up|7
4808549|NCT01256450|16581512|P3|Open-label Titration|Adverse Event|0
4808550|NCT01256450|16581513|P2|Open-label Titration|Adverse Event|0
4808551|NCT01256450|16581514|P1|Open-label Titration|Adverse Event|39
4808552|NCT01256411|16581572|P6|Extension by Mono or Combination Therapy|Lack of Efficacy|1
4808553|NCT01256411|16581573|P5|Extension by Mono or Combination Therapy|Lack of Efficacy|1
4808554|NCT01256411|16581574|P4|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4808555|NCT01256411|16581575|P3|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4808556|NCT01256411|16581576|P2|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4808557|NCT01256411|16581577|P1|Extension by Mono or Combination Therapy|Lack of Efficacy|0
4808558|NCT01256411|16581572|P6|Extension by Mono or Combination Therapy|Withdrawal by Subject|1
4808559|NCT01256411|16581573|P5|Extension by Mono or Combination Therapy|Withdrawal by Subject|7
4808560|NCT01256411|16581574|P4|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4808561|NCT01256411|16581575|P3|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4808562|NCT01256411|16581576|P2|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4808563|NCT01256411|16581577|P1|Extension by Mono or Combination Therapy|Withdrawal by Subject|0
4808564|NCT01256411|16581572|P6|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4808565|NCT01256411|16581573|P5|Extension by Mono or Combination Therapy|Lost to Follow-up|3
4808566|NCT01256411|16581574|P4|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4808567|NCT01256411|16581575|P3|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4808568|NCT01256411|16581576|P2|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4808569|NCT01256411|16581577|P1|Extension by Mono or Combination Therapy|Lost to Follow-up|0
4808570|NCT01256411|16581572|P6|Extension by Mono or Combination Therapy|Protocol deviation|1
4808571|NCT01256411|16581573|P5|Extension by Mono or Combination Therapy|Protocol deviation|0
4808572|NCT01256411|16581574|P4|Extension by Mono or Combination Therapy|Protocol deviation|0
4808573|NCT01256411|16581575|P3|Extension by Mono or Combination Therapy|Protocol deviation|0
4808574|NCT01256411|16581576|P2|Extension by Mono or Combination Therapy|Protocol deviation|0
4808575|NCT01256411|16581577|P1|Extension by Mono or Combination Therapy|Protocol deviation|0
4808576|NCT01256411|16581572|P6|Extension by Mono or Combination Therapy|Adverse Event|1
4808577|NCT01256411|16581573|P5|Extension by Mono or Combination Therapy|Adverse Event|6
4808578|NCT01256411|16581574|P4|Extension by Mono or Combination Therapy|Adverse Event|0
4808579|NCT01256411|16581575|P3|Extension by Mono or Combination Therapy|Adverse Event|0
4808580|NCT01256411|16581576|P2|Extension by Mono or Combination Therapy|Adverse Event|0
4808581|NCT01256411|16581577|P1|Extension by Mono or Combination Therapy|Adverse Event|0
4808582|NCT01256411|16581572|P6|Extension by Maximum Treatment|Adverse Event|0
4808583|NCT01256411|16581573|P5|Extension by Maximum Treatment|Adverse Event|0
4808584|NCT01256411|16581574|P4|Extension by Maximum Treatment|Adverse Event|0
4808585|NCT01256411|16581575|P3|Extension by Maximum Treatment|Adverse Event|1
4808586|NCT01256411|16581576|P2|Extension by Maximum Treatment|Adverse Event|2
4808587|NCT01256411|16581577|P1|Extension by Maximum Treatment|Adverse Event|4
4808588|NCT01256411|16581572|P6|Extension by Maximum Treatment|Lack of Efficacy|0
4808589|NCT01256411|16581573|P5|Extension by Maximum Treatment|Lack of Efficacy|0
4808590|NCT01256411|16581574|P4|Extension by Maximum Treatment|Lack of Efficacy|0
4808591|NCT01256411|16581575|P3|Extension by Maximum Treatment|Lack of Efficacy|1
4808592|NCT01256411|16581576|P2|Extension by Maximum Treatment|Lack of Efficacy|0
4808593|NCT01256411|16581577|P1|Extension by Maximum Treatment|Lack of Efficacy|1
4808594|NCT01256411|16581572|P6|Extension by Maximum Treatment|Withdrawal by Subject|0
4808595|NCT01256411|16581573|P5|Extension by Maximum Treatment|Withdrawal by Subject|0
4808596|NCT01256411|16581574|P4|Extension by Maximum Treatment|Withdrawal by Subject|0
4808597|NCT01256411|16581575|P3|Extension by Maximum Treatment|Withdrawal by Subject|1
4808598|NCT01256411|16581576|P2|Extension by Maximum Treatment|Withdrawal by Subject|6
4808599|NCT01256411|16581577|P1|Extension by Maximum Treatment|Withdrawal by Subject|1
4808600|NCT01256411|16581572|P6|Extension by Maximum Treatment|Lost to Follow-up|0
4808601|NCT01256411|16581573|P5|Extension by Maximum Treatment|Lost to Follow-up|0
4808602|NCT01256411|16581574|P4|Extension by Maximum Treatment|Lost to Follow-up|0
4808603|NCT01256411|16581575|P3|Extension by Maximum Treatment|Lost to Follow-up|0
4808604|NCT01256411|16581576|P2|Extension by Maximum Treatment|Lost to Follow-up|2
4808605|NCT01256411|16581577|P1|Extension by Maximum Treatment|Lost to Follow-up|1
4808606|NCT01256411|16581572|P6|Extension by Maximum Treatment|Protocol deviation|0
4808607|NCT01256411|16581573|P5|Extension by Maximum Treatment|Protocol deviation|0
4808608|NCT01256411|16581574|P4|Extension by Maximum Treatment|Protocol deviation|0
4808609|NCT01256411|16581575|P3|Extension by Maximum Treatment|Protocol deviation|1
4808610|NCT01256411|16581576|P2|Extension by Maximum Treatment|Protocol deviation|0
4808611|NCT01256411|16581577|P1|Extension by Maximum Treatment|Protocol deviation|0
4808612|NCT01256398|16581601|P1|Overall Study|Withdrawal by Subject|1
4808613|NCT01256385|16581607|P2|Overall Study|Withdrawal by Subject|2
4808614|NCT01256385|16581608|P1|Overall Study|Withdrawal by Subject|2
4808615|NCT01256385|16581607|P2|Overall Study|Physician Decision|1
4808616|NCT01256385|16581608|P1|Overall Study|Physician Decision|1
4808617|NCT01256294|16581628|P2|Overall Study|Protocol deviation|1
4808618|NCT01256294|16581629|P1|Overall Study|Protocol deviation|2
4808619|NCT01256294|16581628|P2|Overall Study|Withdrawal by Subject|1
4808620|NCT01256294|16581629|P1|Overall Study|Withdrawal by Subject|1
4808621|NCT01256294|16581628|P2|Overall Study|Adverse Event|0
4808622|NCT01256294|16581629|P1|Overall Study|Adverse Event|1
4808623|NCT01256190|16581651|P2|Overall Study|Lost to Follow-up|0
4808624|NCT01256190|16581652|P1|Overall Study|Lost to Follow-up|2
4808625|NCT01256177|16581668|P2|Overall Study|TG=593mg/dL, not fit to participate.|0
4808626|NCT01256177|16581669|P1|Overall Study|TG=593mg/dL, not fit to participate.|1
4808627|NCT01256177|16581668|P2|Overall Study|Lack of Efficacy|2
4808628|NCT01256177|16581669|P1|Overall Study|Lack of Efficacy|11
4808629|NCT01256177|16581668|P2|Overall Study|Condition under Investigation Worsened|0
4808630|NCT01256177|16581669|P1|Overall Study|Condition under Investigation Worsened|1
4808631|NCT01256177|16581668|P2|Overall Study|Severe Non-Compliance to Protocol|2
4808632|NCT01256177|16581669|P1|Overall Study|Severe Non-Compliance to Protocol|4
4808633|NCT01256177|16581668|P2|Overall Study|Adverse Event|9
4808634|NCT01256177|16581669|P1|Overall Study|Adverse Event|8
4808635|NCT01256177|16581668|P2|Overall Study|Lost to Follow-up|2
4808636|NCT01256177|16581669|P1|Overall Study|Lost to Follow-up|2
4808637|NCT01256177|16581668|P2|Overall Study|Withdrawal by Subject|22
4808638|NCT01256177|16581669|P1|Overall Study|Withdrawal by Subject|23
4808639|NCT01256060|16581725|P4|Overall Study|Lost to Follow-up|0
4808640|NCT01256060|16581726|P3|Overall Study|Lost to Follow-up|0
4808641|NCT01256060|16581727|P2|Overall Study|Lost to Follow-up|1
4808642|NCT01256060|16581728|P1|Overall Study|Lost to Follow-up|0
4808643|NCT01256008|16581747|P3|Overall Study|Withdrawal by Subject|10
4808644|NCT01256008|16581748|P2|Overall Study|Withdrawal by Subject|3
4808645|NCT01256008|16581749|P1|Overall Study|Withdrawal by Subject|2
4808646|NCT01256008|16581747|P3|Overall Study|Lost to Follow-up|11
4808647|NCT01256008|16581748|P2|Overall Study|Lost to Follow-up|4
4808648|NCT01256008|16581749|P1|Overall Study|Lost to Follow-up|6
4808649|NCT01255904|16581771|P2|Overall Study|Physician Decision|4
4808650|NCT01255904|16581772|P1|Overall Study|Physician Decision|1
4808651|NCT01255787|16581811|P4|Overall Study|Noncompliance with Study Drug|0
4808652|NCT01255787|16581812|P3|Overall Study|Noncompliance with Study Drug|0
4808653|NCT01255787|16581813|P2|Overall Study|Noncompliance with Study Drug|1
4808654|NCT01255787|16581814|P1|Overall Study|Noncompliance with Study Drug|3
4808655|NCT01255787|16581811|P4|Overall Study|Lack of Efficacy|2
4808656|NCT01255787|16581812|P3|Overall Study|Lack of Efficacy|2
4808657|NCT01255787|16581813|P2|Overall Study|Lack of Efficacy|2
4808658|NCT01255787|16581814|P1|Overall Study|Lack of Efficacy|2
4808659|NCT01255787|16581811|P4|Overall Study|Pregnancy|1
4808660|NCT01255787|16581812|P3|Overall Study|Pregnancy|0
4808661|NCT01255787|16581813|P2|Overall Study|Pregnancy|0
4808662|NCT01255787|16581814|P1|Overall Study|Pregnancy|0
4808663|NCT01255787|16581811|P4|Overall Study|Withdrawal of Consent|4
4808664|NCT01255787|16581812|P3|Overall Study|Withdrawal of Consent|3
4808665|NCT01255787|16581813|P2|Overall Study|Withdrawal of Consent|9
4808666|NCT01255787|16581814|P1|Overall Study|Withdrawal of Consent|3
4808667|NCT01255787|16581811|P4|Overall Study|Lost to Follow-up|2
4808668|NCT01255787|16581812|P3|Overall Study|Lost to Follow-up|4
4808669|NCT01255787|16581813|P2|Overall Study|Lost to Follow-up|2
4808670|NCT01255787|16581814|P1|Overall Study|Lost to Follow-up|1
4808671|NCT01255787|16581811|P4|Overall Study|Major Protocol Deviation|4
4808672|NCT01255787|16581812|P3|Overall Study|Major Protocol Deviation|0
4808673|NCT01255787|16581813|P2|Overall Study|Major Protocol Deviation|1
4808674|NCT01255787|16581814|P1|Overall Study|Major Protocol Deviation|1
4808675|NCT01255787|16581811|P4|Overall Study|Pretreatment Event or Adverse Event (AE)|9
4808676|NCT01255787|16581812|P3|Overall Study|Pretreatment Event or Adverse Event (AE)|9
4808765|NCT01254721|16582219|P1|Overall Study|Death|0
4808677|NCT01255787|16581813|P2|Overall Study|Pretreatment Event or Adverse Event (AE)|2
4808678|NCT01255787|16581814|P1|Overall Study|Pretreatment Event or Adverse Event (AE)|6
4808679|NCT01255761|16581842|P2|Overall Study|Other Reasons|18
4808680|NCT01255761|16581843|P1|Overall Study|Other Reasons|37
4808681|NCT01255761|16581842|P2|Overall Study|Withdrawal by Subject|27
4808682|NCT01255761|16581843|P1|Overall Study|Withdrawal by Subject|11
4808683|NCT01255761|16581842|P2|Overall Study|Lost to Follow-up|8
4808684|NCT01255761|16581843|P1|Overall Study|Lost to Follow-up|10
4808685|NCT01255761|16581842|P2|Overall Study|Protocol Violation|5
4808686|NCT01255761|16581843|P1|Overall Study|Protocol Violation|9
4808687|NCT01255761|16581842|P2|Overall Study|Lack of Efficacy|74
4808688|NCT01255761|16581843|P1|Overall Study|Lack of Efficacy|86
4808689|NCT01255761|16581842|P2|Overall Study|Adverse Event|43
4808690|NCT01255761|16581843|P1|Overall Study|Adverse Event|29
4808691|NCT01255722|16581928|P3|Overall Study|beta-blocker contraindicated|0
4808692|NCT01255722|16581929|P2|Overall Study|beta-blocker contraindicated|0
4808693|NCT01255722|16581930|P1|Overall Study|beta-blocker contraindicated|2
4808694|NCT01255722|16581928|P3|Overall Study|asymptomatic patient|0
4808695|NCT01255722|16581929|P2|Overall Study|asymptomatic patient|0
4808696|NCT01255722|16581930|P1|Overall Study|asymptomatic patient|1
4808697|NCT01255722|16581928|P3|Overall Study|Adverse Event|1
4808698|NCT01255722|16581929|P2|Overall Study|Adverse Event|1
4808699|NCT01255722|16581930|P1|Overall Study|Adverse Event|0
4808700|NCT01255631|16581955|P2|Overall Study|poor enrollment, no data analyzed|6
4808701|NCT01255631|16581956|P1|Overall Study|poor enrollment, no data analyzed|9
4808702|NCT01255592|16581974|P2|Overall Study|Other|1
4808703|NCT01255592|16581975|P1|Overall Study|Other|0
4808704|NCT01255592|16581974|P2|Overall Study|Withdrawal by Subject|0
4808705|NCT01255592|16581975|P1|Overall Study|Withdrawal by Subject|1
4808706|NCT01255592|16581974|P2|Overall Study|Adverse Event|0
4808707|NCT01255592|16581975|P1|Overall Study|Adverse Event|5
4808708|NCT01255436|16582038|P2|Overall Study|Death, stroke, or MI|3
4808709|NCT01255436|16582039|P1|Overall Study|Death, stroke, or MI|4
4808710|NCT01255436|16582038|P2|Overall Study|Lost to Follow-up|191
4808711|NCT01255436|16582039|P1|Overall Study|Lost to Follow-up|178
4808712|NCT01255423|16582053|P2|Overall Study|Use of prohibited medications|1
4808713|NCT01255423|16582054|P1|Overall Study|Use of prohibited medications|0
4808714|NCT01255423|16582053|P2|Overall Study|Abnormal Laboratory value|2
4808715|NCT01255423|16582054|P1|Overall Study|Abnormal Laboratory value|3
4808716|NCT01255306|16582070|P2|Overall Study|Physician Decision|1
4808717|NCT01255306|16582071|P1|Overall Study|Physician Decision|1
4808718|NCT01255163|16582082|P2|Overall Study|AstraZeneca stopped support of the study|3
4808719|NCT01255163|16582083|P1|Overall Study|AstraZeneca stopped support of the study|1
4808720|NCT01255163|16582082|P2|Overall Study|Adverse Event|2
4808721|NCT01255163|16582083|P1|Overall Study|Adverse Event|0
4808722|NCT01255163|16582082|P2|Overall Study|Lost to Follow-up|0
4808723|NCT01255163|16582083|P1|Overall Study|Lost to Follow-up|2
4808724|NCT01255163|16582082|P2|Overall Study|Withdrawal by Subject|0
4808725|NCT01255163|16582083|P1|Overall Study|Withdrawal by Subject|1
4808726|NCT01254890|16582112|P2|Overall Study|Disease Progression|5
4808727|NCT01254890|16582113|P1|Overall Study|Disease Progression|0
4808728|NCT01254890|16582112|P2|Overall Study|Withdrawal by Subject|2
4808729|NCT01254890|16582113|P1|Overall Study|Withdrawal by Subject|1
4808730|NCT01254890|16582112|P2|Overall Study|Ineligible|3
4808731|NCT01254890|16582113|P1|Overall Study|Ineligible|0
4808732|NCT01254747|16582175|P4|Overall Study|Discomfort|0
4808733|NCT01254747|16582176|P3|Overall Study|Discomfort|0
4808734|NCT01254747|16582177|P2|Overall Study|Discomfort|4
4808735|NCT01254747|16582178|P1|Overall Study|Discomfort|0
4808736|NCT01254747|16582175|P4|Overall Study|Biomicroscopy|0
4808737|NCT01254747|16582176|P3|Overall Study|Biomicroscopy|1
4808738|NCT01254747|16582177|P2|Overall Study|Biomicroscopy|0
4808739|NCT01254747|16582178|P1|Overall Study|Biomicroscopy|0
4808740|NCT01254747|16582175|P4|Overall Study|Lost to Follow-up|0
4808741|NCT01254747|16582176|P3|Overall Study|Lost to Follow-up|1
4808742|NCT01254747|16582177|P2|Overall Study|Lost to Follow-up|0
4808743|NCT01254747|16582178|P1|Overall Study|Lost to Follow-up|0
4808744|NCT01254747|16582175|P4|Overall Study|Symptoms and problems|0
4808745|NCT01254747|16582176|P3|Overall Study|Symptoms and problems|1
4808746|NCT01254747|16582177|P2|Overall Study|Symptoms and problems|2
4808747|NCT01254747|16582178|P1|Overall Study|Symptoms and problems|0
4808748|NCT01254747|16582175|P4|Overall Study|Difficult removal handling|0
4808749|NCT01254747|16582176|P3|Overall Study|Difficult removal handling|1
4808750|NCT01254747|16582177|P2|Overall Study|Difficult removal handling|0
4808751|NCT01254747|16582178|P1|Overall Study|Difficult removal handling|0
4808752|NCT01254747|16582175|P4|Overall Study|Unacceptable subjective vision|2
4808753|NCT01254747|16582176|P3|Overall Study|Unacceptable subjective vision|0
4808754|NCT01254747|16582177|P2|Overall Study|Unacceptable subjective vision|0
4808755|NCT01254747|16582178|P1|Overall Study|Unacceptable subjective vision|0
4808756|NCT01254721|16582218|P2|Overall Study|Wrongly randomization|1
4808757|NCT01254721|16582219|P1|Overall Study|Wrongly randomization|0
4808758|NCT01254721|16582218|P2|Overall Study|Withdrawal by Subject|11
4808759|NCT01254721|16582219|P1|Overall Study|Withdrawal by Subject|8
4808760|NCT01254721|16582218|P2|Overall Study|Adverse Event|3
4808761|NCT01254721|16582219|P1|Overall Study|Adverse Event|2
4808762|NCT01254721|16582218|P2|Overall Study|technical problum|0
4808763|NCT01254721|16582219|P1|Overall Study|technical problum|1
4808764|NCT01254721|16582218|P2|Overall Study|Death|1
4808766|NCT01254721|16582218|P2|Overall Study|Lack of Efficacy|2
4808767|NCT01254721|16582219|P1|Overall Study|Lack of Efficacy|4
4808768|NCT01254721|16582218|P2|Overall Study|Lost to Follow-up|4
4808769|NCT01254721|16582219|P1|Overall Study|Lost to Follow-up|0
4808770|NCT01254669|16582229|P2|Overall Study|called to clinic during intervention|1
4808771|NCT01254669|16582230|P1|Overall Study|called to clinic during intervention|1
4808772|NCT01254669|16582229|P2|Overall Study|time constraint|2
4808773|NCT01254669|16582230|P1|Overall Study|time constraint|2
4808774|NCT01254669|16582229|P2|Overall Study|Withdrawal by Subject|1
4808775|NCT01254669|16582230|P1|Overall Study|Withdrawal by Subject|0
4808776|NCT01254656|16582241|P3|Overall Study|Death|0
4808777|NCT01254656|16582242|P2|Overall Study|Death|1
4808778|NCT01254656|16582243|P1|Overall Study|Death|0
4808779|NCT01254656|16582241|P3|Overall Study|Adverse Event|0
4808780|NCT01254656|16582242|P2|Overall Study|Adverse Event|1
4808781|NCT01254656|16582243|P1|Overall Study|Adverse Event|1
4808782|NCT01254656|16582241|P3|Overall Study|Pregnancy|2
4808783|NCT01254656|16582242|P2|Overall Study|Pregnancy|0
4808784|NCT01254656|16582243|P1|Overall Study|Pregnancy|0
4808785|NCT01254656|16582241|P3|Overall Study|Withdrawal by Subject|1
4808786|NCT01254656|16582242|P2|Overall Study|Withdrawal by Subject|2
4808787|NCT01254656|16582243|P1|Overall Study|Withdrawal by Subject|2
4808788|NCT01254656|16582241|P3|Overall Study|Lost to Follow-up|2
4808789|NCT01254656|16582242|P2|Overall Study|Lost to Follow-up|0
4808790|NCT01254656|16582243|P1|Overall Study|Lost to Follow-up|1
4808791|NCT01254656|16582241|P3|Overall Study|Lack of Efficacy|0
4808792|NCT01254656|16582242|P2|Overall Study|Lack of Efficacy|0
4808793|NCT01254656|16582243|P1|Overall Study|Lack of Efficacy|3
4808794|NCT01254656|16582241|P3|Overall Study|Discontinued due to termination of study|13
4808795|NCT01254656|16582242|P2|Overall Study|Discontinued due to termination of study|39
4808796|NCT01254656|16582243|P1|Overall Study|Discontinued due to termination of study|40
4808797|NCT01254643|16582269|P1|Overall Study|Withdrawal by Subject|1
4808798|NCT01254630|16582281|P4|Overall Study|Status not recorded|0
4808799|NCT01254630|16582282|P3|Overall Study|Status not recorded|1
4808800|NCT01254630|16582283|P2|Overall Study|Status not recorded|0
4808801|NCT01254630|16582284|P1|Overall Study|Status not recorded|0
4808802|NCT01254630|16582281|P4|Overall Study|Study terminated by sponsor|1010
4808803|NCT01254630|16582282|P3|Overall Study|Study terminated by sponsor|0
4808804|NCT01254630|16582283|P2|Overall Study|Study terminated by sponsor|994
4808805|NCT01254630|16582284|P1|Overall Study|Study terminated by sponsor|0
4808806|NCT01254630|16582281|P4|Overall Study|Withdrawal by Subject|89
4808807|NCT01254630|16582282|P3|Overall Study|Withdrawal by Subject|188
4808808|NCT01254630|16582283|P2|Overall Study|Withdrawal by Subject|94
4808809|NCT01254630|16582284|P1|Overall Study|Withdrawal by Subject|201
4808810|NCT01254630|16582281|P4|Overall Study|Physician Decision|7
4808811|NCT01254630|16582282|P3|Overall Study|Physician Decision|16
4808812|NCT01254630|16582283|P2|Overall Study|Physician Decision|8
4808813|NCT01254630|16582284|P1|Overall Study|Physician Decision|24
4808814|NCT01254630|16582281|P4|Overall Study|Lost to Follow-up|32
4808815|NCT01254630|16582282|P3|Overall Study|Lost to Follow-up|89
4808816|NCT01254630|16582283|P2|Overall Study|Lost to Follow-up|26
4808817|NCT01254630|16582284|P1|Overall Study|Lost to Follow-up|80
4808818|NCT01254630|16582281|P4|Overall Study|Death|139
4808819|NCT01254630|16582282|P3|Overall Study|Death|478
4808820|NCT01254630|16582283|P2|Overall Study|Death|151
4808821|NCT01254630|16582284|P1|Overall Study|Death|461
4808822|NCT01254630|16582281|P4|Overall Study|Adverse Event|8
4808823|NCT01254630|16582282|P3|Overall Study|Adverse Event|40
4808824|NCT01254630|16582283|P2|Overall Study|Adverse Event|15
4808825|NCT01254630|16582284|P1|Overall Study|Adverse Event|36
4808826|NCT01254604|16582304|P2|Overall Study|Adverse Event|2
4808827|NCT01254604|16582305|P1|Overall Study|Adverse Event|3
4808828|NCT01254604|16582304|P2|Overall Study|Withdrawal by Subject|4
4808829|NCT01254604|16582305|P1|Overall Study|Withdrawal by Subject|2
4808830|NCT01254604|16582304|P2|Overall Study|Protocol Violation|2
4808831|NCT01254604|16582305|P1|Overall Study|Protocol Violation|2
4808832|NCT01254604|16582304|P2|Overall Study|Lost to Follow-up|1
4808833|NCT01254604|16582305|P1|Overall Study|Lost to Follow-up|1
4808834|NCT01254565|16582323|P6|Overall Study|Other|0
4808835|NCT01254565|16582324|P5|Overall Study|Other|0
4808836|NCT01254565|16582325|P4|Overall Study|Other|1
4808837|NCT01254565|16582326|P3|Overall Study|Other|0
4808838|NCT01254565|16582327|P2|Overall Study|Other|0
4808839|NCT01254565|16582328|P1|Overall Study|Other|0
4808840|NCT01254565|16582323|P6|Overall Study|Did not Receive Treatment|4
4808841|NCT01254565|16582324|P5|Overall Study|Did not Receive Treatment|3
4808842|NCT01254565|16582325|P4|Overall Study|Did not Receive Treatment|0
4808843|NCT01254565|16582326|P3|Overall Study|Did not Receive Treatment|0
4808844|NCT01254565|16582327|P2|Overall Study|Did not Receive Treatment|1
4808845|NCT01254565|16582328|P1|Overall Study|Did not Receive Treatment|1
4808846|NCT01254565|16582323|P6|Overall Study|Non-compliance to Study Procedures|0
4808847|NCT01254565|16582324|P5|Overall Study|Non-compliance to Study Procedures|1
4808848|NCT01254565|16582325|P4|Overall Study|Non-compliance to Study Procedures|0
4808849|NCT01254565|16582326|P3|Overall Study|Non-compliance to Study Procedures|0
4808850|NCT01254565|16582327|P2|Overall Study|Non-compliance to Study Procedures|0
4808851|NCT01254565|16582328|P1|Overall Study|Non-compliance to Study Procedures|0
4808852|NCT01254422|16582388|P2|Overall Study|Lost to Follow-up|0
4808853|NCT01254422|16582389|P1|Overall Study|Lost to Follow-up|1
4808854|NCT01254422|16582388|P2|Overall Study|Serious adverse event|1
4808855|NCT01254422|16582389|P1|Overall Study|Serious adverse event|0
4808856|NCT01254422|16582388|P2|Overall Study|Adverse Event|0
4808857|NCT01254422|16582389|P1|Overall Study|Adverse Event|1
4808858|NCT01254422|16582388|P2|Overall Study|Protocol Violation|0
4808859|NCT01254422|16582389|P1|Overall Study|Protocol Violation|1
4808860|NCT01254409|16582417|P4|Overall Study|Adverse Event|0
4808861|NCT01254409|16582418|P3|Overall Study|Adverse Event|0
4808862|NCT01254409|16582419|P2|Overall Study|Adverse Event|1
4808863|NCT01254409|16582420|P1|Overall Study|Adverse Event|0
4808864|NCT01254344|16582489|P2|Overall Study|Withdrawal by Subject|6
4808865|NCT01254344|16582490|P1|Overall Study|Withdrawal by Subject|3
4808866|NCT01254344|16582489|P2|Overall Study|Protocol Violation|4
4808867|NCT01254344|16582490|P1|Overall Study|Protocol Violation|1
4808868|NCT01254344|16582489|P2|Overall Study|Physician Decision|4
4808869|NCT01254344|16582490|P1|Overall Study|Physician Decision|7
4808870|NCT01254344|16582489|P2|Overall Study|Adverse Event|5
4808871|NCT01254344|16582490|P1|Overall Study|Adverse Event|2
4808872|NCT01254331|16582498|P1|Extension Phase|Lost to Follow-up|3
4808873|NCT01254331|16582498|P1|Extension Phase|Lack of Efficacy|1
4808874|NCT01254331|16582498|P1|Initial Phase|Pregnancy|1
4808875|NCT01254331|16582498|P1|Initial Phase|Withdrawal by Subject|1
4808876|NCT01254331|16582498|P1|Initial Phase|Adverse Event|3
4808877|NCT01254318|16582516|P1|Overall Study|Death|47
4808878|NCT01254318|16582516|P1|Overall Study|Lost to Follow-up|5
4808879|NCT01254305|16582525|P3|Overall Study|Other Reasons|2
4808880|NCT01254305|16582526|P2|Overall Study|Other Reasons|0
4808881|NCT01254305|16582527|P1|Overall Study|Other Reasons|0
4808882|NCT01254305|16582525|P3|Overall Study|Lost to Follow-up|5
4808883|NCT01254305|16582526|P2|Overall Study|Lost to Follow-up|6
4808884|NCT01254305|16582527|P1|Overall Study|Lost to Follow-up|10
4808885|NCT01254305|16582525|P3|Overall Study|Withdrawal by Subject|4
4808886|NCT01254305|16582526|P2|Overall Study|Withdrawal by Subject|2
4808887|NCT01254305|16582527|P1|Overall Study|Withdrawal by Subject|4
4808888|NCT01254305|16582525|P3|Overall Study|Protocol Violation|3
4808889|NCT01254305|16582526|P2|Overall Study|Protocol Violation|7
4808890|NCT01254305|16582527|P1|Overall Study|Protocol Violation|1
4808891|NCT01254305|16582525|P3|Overall Study|Lack of Efficacy|1
4808892|NCT01254305|16582526|P2|Overall Study|Lack of Efficacy|0
4808893|NCT01254305|16582527|P1|Overall Study|Lack of Efficacy|1
4808894|NCT01254305|16582525|P3|Overall Study|Adverse Event|2
4808895|NCT01254305|16582526|P2|Overall Study|Adverse Event|3
4808896|NCT01254305|16582527|P1|Overall Study|Adverse Event|6
4808897|NCT01254292|16582543|P2|LCS12 Extension Phase|Lost to Follow-up|0
4808898|NCT01254292|16582544|P1|LCS12 Extension Phase|Lost to Follow-up|1
4808899|NCT01254292|16582543|P2|LCS12 Extension Phase|Pregnancy|0
4808900|NCT01254292|16582544|P1|LCS12 Extension Phase|Pregnancy|2
4808901|NCT01254292|16582543|P2|LCS12 Extension Phase|Other unknown|0
4808902|NCT01254292|16582544|P1|LCS12 Extension Phase|Other unknown|4
4808903|NCT01254292|16582543|P2|LCS12 Extension Phase|Withdrawal by Subject|0
4808904|NCT01254292|16582544|P1|LCS12 Extension Phase|Withdrawal by Subject|7
4808905|NCT01254292|16582543|P2|LCS12 Extension Phase|Adverse Event|0
4808906|NCT01254292|16582544|P1|LCS12 Extension Phase|Adverse Event|9
4808907|NCT01254292|16582543|P2|LCS12 Extension Phase|Wish for pregnancy|0
4808908|NCT01254292|16582544|P1|LCS12 Extension Phase|Wish for pregnancy|14
4808909|NCT01254292|16582543|P2|Comparative Phase|Wish for pregnancy|6
4808910|NCT01254292|16582544|P1|Comparative Phase|Wish for pregnancy|4
4808911|NCT01254292|16582543|P2|Comparative Phase|Protocol Violation|2
4808912|NCT01254292|16582544|P1|Comparative Phase|Protocol Violation|1
4808913|NCT01254292|16582543|P2|Comparative Phase|Withdrawal by Subject|21
4808914|NCT01254292|16582544|P1|Comparative Phase|Withdrawal by Subject|20
4808915|NCT01254292|16582543|P2|Comparative Phase|Pregnancy|6
4808916|NCT01254292|16582544|P1|Comparative Phase|Pregnancy|2
4808917|NCT01254292|16582543|P2|Comparative Phase|Lost to Follow-up|21
4808918|NCT01254292|16582544|P1|Comparative Phase|Lost to Follow-up|3
4808919|NCT01254292|16582543|P2|Comparative Phase|Adverse Event|25
4808920|NCT01254292|16582544|P1|Comparative Phase|Adverse Event|25
4808921|NCT01254188|16582621|P1|Overall Study|per investigator discretion|20
4808922|NCT01254188|16582621|P1|Overall Study|Adverse Event|43
4808923|NCT01254188|16582621|P1|Overall Study|Withdrawal by Subject|7
4808924|NCT01254188|16582621|P1|Overall Study|Lost to Follow-up|5
4808925|NCT01254188|16582621|P1|Overall Study|Death|4
4808926|NCT01254188|16582621|P1|Overall Study|Pregnancy|2
4808927|NCT01254188|16582621|P1|Overall Study|Protocol Violation|6
4808928|NCT01254188|16582621|P1|Overall Study|Disease Progression|6
4808929|NCT01254045|16582632|P6|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4808930|NCT01254045|16582633|P5|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4808931|NCT01254045|16582634|P4|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4808932|NCT01254045|16582635|P3|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4808933|NCT01254045|16582636|P2|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0
4808934|NCT01254045|16582637|P1|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1
4808935|NCT01254019|16582650|P2|Overall Study|Withdrawal by Subject|2
4808936|NCT01254019|16582651|P1|Overall Study|Withdrawal by Subject|0
4808937|NCT01254019|16582650|P2|Overall Study|Protocol Violation|0
4808938|NCT01254019|16582651|P1|Overall Study|Protocol Violation|1
4808939|NCT01254019|16582650|P2|Overall Study|Adverse Event|2
4808940|NCT01254019|16582651|P1|Overall Study|Adverse Event|0
4808941|NCT01253811|16582745|P1|Overall Study|Withdrawal criteria|1
4808942|NCT01253577|16582776|P1|Overall Study|Lost to Follow-up|3
4808943|NCT01253564|16582784|P1|Overall Study|Serious Adverse Event|1
4808944|NCT01253564|16582784|P1|Overall Study|Withdrawal by Subject|1
4808945|NCT01253564|16582784|P1|Overall Study|Disease Progression|22
4808946|NCT01253447|16582833|P1|Overall Study|Adverse Event|2
4808947|NCT01253421|16582843|P5|Drug+Scanning Visit|Physician Decision|1
4808948|NCT01253421|16582844|P4|Drug+Scanning Visit|Physician Decision|0
4808949|NCT01253421|16582845|P3|Drug+Scanning Visit|Physician Decision|0
4808950|NCT01253421|16582846|P2|Drug+Scanning Visit|Physician Decision|0
4808951|NCT01253421|16582847|P1|Drug+Scanning Visit|Physician Decision|0
4808952|NCT01253421|16582843|P5|Assessment and Scheduling|Physician Decision|0
4808953|NCT01253421|16582844|P4|Assessment and Scheduling|Physician Decision|0
4808954|NCT01253421|16582845|P3|Assessment and Scheduling|Physician Decision|0
4808955|NCT01253421|16582846|P2|Assessment and Scheduling|Physician Decision|0
4808956|NCT01253421|16582847|P1|Assessment and Scheduling|Physician Decision|1
4808957|NCT01253421|16582843|P5|Assessment and Scheduling|Withdrawal by Subject|0
4808958|NCT01253421|16582844|P4|Assessment and Scheduling|Withdrawal by Subject|0
4808959|NCT01253421|16582845|P3|Assessment and Scheduling|Withdrawal by Subject|0
4808960|NCT01253421|16582846|P2|Assessment and Scheduling|Withdrawal by Subject|0
4808961|NCT01253421|16582847|P1|Assessment and Scheduling|Withdrawal by Subject|7
4808962|NCT01253421|16582843|P5|Assessment and Scheduling|Lost to Follow-up|0
4808963|NCT01253421|16582844|P4|Assessment and Scheduling|Lost to Follow-up|0
4808964|NCT01253421|16582845|P3|Assessment and Scheduling|Lost to Follow-up|0
4808965|NCT01253421|16582846|P2|Assessment and Scheduling|Lost to Follow-up|0
4808966|NCT01253421|16582847|P1|Assessment and Scheduling|Lost to Follow-up|17
4808967|NCT01253421|16582843|P5|Assessment and Scheduling|Found to be Ineligible|0
4808968|NCT01253421|16582844|P4|Assessment and Scheduling|Found to be Ineligible|0
4808969|NCT01253421|16582845|P3|Assessment and Scheduling|Found to be Ineligible|0
4808970|NCT01253421|16582846|P2|Assessment and Scheduling|Found to be Ineligible|0
4808971|NCT01253421|16582847|P1|Assessment and Scheduling|Found to be Ineligible|74
4808972|NCT01253408|16582896|P3|Overall Study|Adverse Event|0
4808973|NCT01253408|16582897|P2|Overall Study|Adverse Event|1
4808974|NCT01253408|16582898|P1|Overall Study|Adverse Event|0
4808975|NCT01253369|16582921|P1|Overall Study|Not Evaluable|3
4808976|NCT01253369|16582921|P1|Overall Study|Progressive disease|23
4808977|NCT01253369|16582921|P1|Overall Study|Death|1
4808978|NCT01253369|16582921|P1|Overall Study|Withdrawal by Subject|2
4808979|NCT01253369|16582921|P1|Overall Study|Adverse Event|4
4808980|NCT01253317|16582951|P1|Overall Study|Adverse Event|2
4808981|NCT01253304|16582963|P4|Overall Study|Adverse Event|1
4808982|NCT01253304|16582964|P3|Overall Study|Adverse Event|0
4808983|NCT01253304|16582965|P2|Overall Study|Adverse Event|0
4808984|NCT01253304|16582966|P1|Overall Study|Adverse Event|0
4808985|NCT01253291|16583005|P5|Overall Study|Physician Decision|2
4808986|NCT01253291|16583006|P4|Overall Study|Physician Decision|0
4808987|NCT01253291|16583007|P3|Overall Study|Physician Decision|0
4808988|NCT01253291|16583008|P2|Overall Study|Physician Decision|0
4808989|NCT01253291|16583009|P1|Overall Study|Physician Decision|2
4808990|NCT01253291|16583005|P5|Overall Study|Lack of Efficacy|0
4808991|NCT01253291|16583006|P4|Overall Study|Lack of Efficacy|0
4808992|NCT01253291|16583007|P3|Overall Study|Lack of Efficacy|0
4808993|NCT01253291|16583008|P2|Overall Study|Lack of Efficacy|0
4808994|NCT01253291|16583009|P1|Overall Study|Lack of Efficacy|1
4808995|NCT01253291|16583005|P5|Overall Study|Adverse Event|0
4808996|NCT01253291|16583006|P4|Overall Study|Adverse Event|0
4808997|NCT01253291|16583007|P3|Overall Study|Adverse Event|0
4808998|NCT01253291|16583008|P2|Overall Study|Adverse Event|1
4808999|NCT01253291|16583009|P1|Overall Study|Adverse Event|0
4809000|NCT01253291|16583005|P5|Overall Study|Withdrawal by Subject|0
4809001|NCT01253291|16583006|P4|Overall Study|Withdrawal by Subject|0
4809002|NCT01253291|16583007|P3|Overall Study|Withdrawal by Subject|0
4809003|NCT01253291|16583008|P2|Overall Study|Withdrawal by Subject|1
4809004|NCT01253291|16583009|P1|Overall Study|Withdrawal by Subject|1
4809005|NCT01253265|16583033|P5|Overall Study|Withdrawal by Subject|1
4809006|NCT01253265|16583034|P4|Overall Study|Withdrawal by Subject|0
4809007|NCT01253265|16583035|P3|Overall Study|Withdrawal by Subject|0
4809008|NCT01253265|16583036|P2|Overall Study|Withdrawal by Subject|0
4809009|NCT01253265|16583037|P1|Overall Study|Withdrawal by Subject|0
4809010|NCT01253265|16583033|P5|Overall Study|Met Predefined Discontinuation Criteria|0
4809011|NCT01253265|16583034|P4|Overall Study|Met Predefined Discontinuation Criteria|0
4809012|NCT01253265|16583035|P3|Overall Study|Met Predefined Discontinuation Criteria|0
4809013|NCT01253265|16583036|P2|Overall Study|Met Predefined Discontinuation Criteria|0
4809014|NCT01253265|16583037|P1|Overall Study|Met Predefined Discontinuation Criteria|1
4809015|NCT01253226|16583086|P5|Overall Study|Withdrawal by Subject|0
4809016|NCT01253226|16583087|P4|Overall Study|Withdrawal by Subject|1
4809017|NCT01253226|16583088|P3|Overall Study|Withdrawal by Subject|0
4809018|NCT01253226|16583089|P2|Overall Study|Withdrawal by Subject|0
4809019|NCT01253226|16583090|P1|Overall Study|Withdrawal by Subject|0
4809020|NCT01253226|16583086|P5|Overall Study|Physician Decision|2
4809021|NCT01253226|16583087|P4|Overall Study|Physician Decision|0
4809022|NCT01253226|16583088|P3|Overall Study|Physician Decision|0
4809023|NCT01253226|16583089|P2|Overall Study|Physician Decision|0
4809024|NCT01253226|16583090|P1|Overall Study|Physician Decision|0
4809025|NCT01253226|16583086|P5|Overall Study|Death|0
4809026|NCT01253226|16583087|P4|Overall Study|Death|0
4809027|NCT01253226|16583088|P3|Overall Study|Death|0
4809028|NCT01253226|16583089|P2|Overall Study|Death|1
4809029|NCT01253226|16583090|P1|Overall Study|Death|0
4809030|NCT01253226|16583086|P5|Overall Study|Adverse Event|0
4809031|NCT01253226|16583087|P4|Overall Study|Adverse Event|0
4809032|NCT01253226|16583088|P3|Overall Study|Adverse Event|1
4809033|NCT01253226|16583089|P2|Overall Study|Adverse Event|0
4809034|NCT01253226|16583090|P1|Overall Study|Adverse Event|0
4809035|NCT01253200|16583150|P5|Overall Study|Attempts|0
4809036|NCT01253200|16583151|P4|Overall Study|Attempts|2
4809037|NCT01253200|16583152|P3|Overall Study|Attempts|1
4809038|NCT01253200|16583153|P2|Overall Study|Attempts|4
4809039|NCT01253200|16583154|P1|Overall Study|Attempts|6
4809040|NCT01253200|16583150|P5|Overall Study|intents|0
4809041|NCT01253200|16583151|P4|Overall Study|intents|3
4809042|NCT01253200|16583152|P3|Overall Study|intents|1
4809043|NCT01253200|16583153|P2|Overall Study|intents|10
4809044|NCT01253200|16583154|P1|Overall Study|intents|10
4809045|NCT01253200|16583150|P5|Overall Study|Protocol Violation|5
4809046|NCT01253200|16583151|P4|Overall Study|Protocol Violation|0
4809047|NCT01253200|16583152|P3|Overall Study|Protocol Violation|0
4809048|NCT01253200|16583153|P2|Overall Study|Protocol Violation|4
4809049|NCT01253200|16583154|P1|Overall Study|Protocol Violation|1
4809050|NCT01253200|16583150|P5|Overall Study|Withdrawal by Subject|0
4809051|NCT01253200|16583151|P4|Overall Study|Withdrawal by Subject|0
4809052|NCT01253200|16583152|P3|Overall Study|Withdrawal by Subject|0
4809053|NCT01253200|16583153|P2|Overall Study|Withdrawal by Subject|0
4809054|NCT01253200|16583154|P1|Overall Study|Withdrawal by Subject|2
4809055|NCT01253200|16583150|P5|Overall Study|Lost to Follow-up|0
4809056|NCT01253200|16583151|P4|Overall Study|Lost to Follow-up|0
4809057|NCT01253200|16583152|P3|Overall Study|Lost to Follow-up|0
4809058|NCT01253200|16583153|P2|Overall Study|Lost to Follow-up|1
4809059|NCT01253200|16583154|P1|Overall Study|Lost to Follow-up|1
4809060|NCT01253200|16583150|P5|Overall Study|Death|0
4809061|NCT01253200|16583151|P4|Overall Study|Death|0
4809062|NCT01253200|16583152|P3|Overall Study|Death|0
4809063|NCT01253200|16583153|P2|Overall Study|Death|0
4809064|NCT01253200|16583154|P1|Overall Study|Death|1
4809065|NCT01253187|16583169|P6|Period 3|non-compliance|0
4809066|NCT01253187|16583170|P5|Period 3|non-compliance|1
4809067|NCT01253187|16583171|P4|Period 3|non-compliance|0
4809068|NCT01253187|16583172|P3|Period 3|non-compliance|0
4809069|NCT01253187|16583173|P2|Period 3|non-compliance|0
4809070|NCT01253187|16583174|P1|Period 3|non-compliance|0
4809071|NCT01253187|16583169|P6|Period 3|difficulty with blood sampling|0
4809072|NCT01253187|16583170|P5|Period 3|difficulty with blood sampling|0
4809073|NCT01253187|16583171|P4|Period 3|difficulty with blood sampling|0
4809074|NCT01253187|16583172|P3|Period 3|difficulty with blood sampling|0
4809075|NCT01253187|16583173|P2|Period 3|difficulty with blood sampling|1
4809076|NCT01253187|16583174|P1|Period 3|difficulty with blood sampling|0
4809077|NCT01253187|16583169|P6|Period 3|Pregnancy|0
4809078|NCT01253187|16583170|P5|Period 3|Pregnancy|0
4809079|NCT01253187|16583171|P4|Period 3|Pregnancy|0
4809080|NCT01253187|16583172|P3|Period 3|Pregnancy|0
4809081|NCT01253187|16583173|P2|Period 3|Pregnancy|0
4809082|NCT01253187|16583174|P1|Period 3|Pregnancy|1
4809083|NCT01253187|16583169|P6|Period 2|Withdrawal by Subject|0
4809084|NCT01253187|16583170|P5|Period 2|Withdrawal by Subject|1
4809085|NCT01253187|16583171|P4|Period 2|Withdrawal by Subject|0
4809086|NCT01253187|16583172|P3|Period 2|Withdrawal by Subject|0
4809087|NCT01253187|16583173|P2|Period 2|Withdrawal by Subject|0
4809088|NCT01253187|16583174|P1|Period 2|Withdrawal by Subject|0
4809089|NCT01253174|16583203|P6|Period 3|Pregnancy|0
4809090|NCT01253174|16583204|P5|Period 3|Pregnancy|0
4809091|NCT01253174|16583205|P4|Period 3|Pregnancy|0
4809092|NCT01253174|16583206|P3|Period 3|Pregnancy|1
4809093|NCT01253174|16583207|P2|Period 3|Pregnancy|0
4809094|NCT01253174|16583208|P1|Period 3|Pregnancy|0
4809095|NCT01253174|16583203|P6|Period 3|Withdrawal by Subject|0
4809096|NCT01253174|16583204|P5|Period 3|Withdrawal by Subject|1
4809097|NCT01253174|16583205|P4|Period 3|Withdrawal by Subject|0
4809098|NCT01253174|16583206|P3|Period 3|Withdrawal by Subject|0
4809099|NCT01253174|16583207|P2|Period 3|Withdrawal by Subject|1
4809100|NCT01253174|16583208|P1|Period 3|Withdrawal by Subject|0
4809101|NCT01253174|16583203|P6|Period 2|Adverse Event|0
4809102|NCT01253174|16583204|P5|Period 2|Adverse Event|0
4809103|NCT01253174|16583205|P4|Period 2|Adverse Event|0
4809104|NCT01253174|16583206|P3|Period 2|Adverse Event|1
4809105|NCT01253174|16583207|P2|Period 2|Adverse Event|0
4809106|NCT01253174|16583208|P1|Period 2|Adverse Event|0
4809107|NCT01253174|16583203|P6|Period 1|Randomized but not treated|0
4809108|NCT01253174|16583204|P5|Period 1|Randomized but not treated|1
4809109|NCT01253174|16583205|P4|Period 1|Randomized but not treated|0
4809110|NCT01253174|16583206|P3|Period 1|Randomized but not treated|1
4809111|NCT01253174|16583207|P2|Period 1|Randomized but not treated|1
4809112|NCT01253174|16583208|P1|Period 1|Randomized but not treated|0
4809113|NCT01253135|16583243|P1|Amended Protocol|Non-compliance|1
4809114|NCT01253135|16583243|P1|Original Protocol|Protocol Amendment|15
4809115|NCT01253044|16583262|P2|Overall Study|Lost to Follow-up|29
4809116|NCT01253044|16583263|P1|Overall Study|Lost to Follow-up|38
4809117|NCT01253018|16583273|P2|Overall Study|Withdrawal by Subject|1
4809118|NCT01253018|16583274|P1|Overall Study|Withdrawal by Subject|1
4809119|NCT01253018|16583273|P2|Overall Study|Robot Repair Issues|0
4809120|NCT01253018|16583274|P1|Overall Study|Robot Repair Issues|2
4809121|NCT01253018|16583273|P2|Overall Study|Lost to Follow-up|1
4809122|NCT01253018|16583274|P1|Overall Study|Lost to Follow-up|1
4809123|NCT01252966|16583288|P2|Overall Study|Withdrawal by Subject|3
4809124|NCT01252966|16583289|P1|Overall Study|Withdrawal by Subject|7
4809125|NCT01252966|16583288|P2|Overall Study|Lost to Follow-up|10
4809126|NCT01252966|16583289|P1|Overall Study|Lost to Follow-up|16
4809127|NCT01252953|16583305|P2|Overall Study|Lost to Follow-up|21
4809128|NCT01252953|16583306|P1|Overall Study|Lost to Follow-up|22
4809129|NCT01252953|16583305|P2|Overall Study|Withdrawal by Subject|17
4809130|NCT01252953|16583306|P1|Overall Study|Withdrawal by Subject|16
4809131|NCT01252940|16583320|P2|Extension Phase|Withdrawal by Subject|1
4809132|NCT01252940|16583321|P1|Extension Phase|Withdrawal by Subject|1
4809133|NCT01252940|16583320|P2|Extension Phase|Subject Non-compliance|0
4809134|NCT01252940|16583321|P1|Extension Phase|Subject Non-compliance|1
4809135|NCT01252940|16583320|P2|Extension Phase|Physician Decision|1
4809136|NCT01252940|16583321|P1|Extension Phase|Physician Decision|0
4809137|NCT01252940|16583320|P2|Extension Phase|Lost to Follow-up|0
4809138|NCT01252940|16583321|P1|Extension Phase|Lost to Follow-up|5
4809139|NCT01252940|16583320|P2|Extension Phase|Lack of Efficacy|0
4809140|NCT01252940|16583321|P1|Extension Phase|Lack of Efficacy|1
4809141|NCT01252940|16583320|P2|Extension Phase|Adverse Event|1
4809142|NCT01252940|16583321|P1|Extension Phase|Adverse Event|2
4809143|NCT01252940|16583320|P2|Main Study Phase|Subject Non-compliance|1
4809144|NCT01252940|16583321|P1|Main Study Phase|Subject Non-compliance|1
4809145|NCT01252940|16583320|P2|Main Study Phase|Withdrawal by Subject|5
4809146|NCT01252940|16583321|P1|Main Study Phase|Withdrawal by Subject|6
4809147|NCT01252940|16583320|P2|Main Study Phase|Protocol Violation|2
4809148|NCT01252940|16583321|P1|Main Study Phase|Protocol Violation|4
4809149|NCT01252940|16583320|P2|Main Study Phase|Physician Decision|0
4809150|NCT01252940|16583321|P1|Main Study Phase|Physician Decision|1
4809151|NCT01252940|16583320|P2|Main Study Phase|Lost to Follow-up|1
4809152|NCT01252940|16583321|P1|Main Study Phase|Lost to Follow-up|6
4809153|NCT01252940|16583320|P2|Main Study Phase|Lack of Efficacy|0
4809154|NCT01252940|16583321|P1|Main Study Phase|Lack of Efficacy|1
4809155|NCT01252940|16583320|P2|Main Study Phase|Adverse Event|1
4809156|NCT01252940|16583321|P1|Main Study Phase|Adverse Event|3
4809157|NCT01252940|16583320|P2|Main Study Phase|Randomized but not treated|2
4809158|NCT01252940|16583321|P1|Main Study Phase|Randomized but not treated|4
4809159|NCT01252810|16583352|P2|Overall Study|Various reasons|0
4809160|NCT01252810|16583353|P1|Overall Study|Various reasons|8
4809161|NCT01252810|16583352|P2|Overall Study|Physician Decision|1
4809162|NCT01252810|16583353|P1|Overall Study|Physician Decision|2
4809163|NCT01252810|16583352|P2|Overall Study|Lost to Follow-up|1
4809164|NCT01252810|16583353|P1|Overall Study|Lost to Follow-up|0
4809165|NCT01252810|16583352|P2|Overall Study|Withdrawal by Subject|1
4809166|NCT01252810|16583353|P1|Overall Study|Withdrawal by Subject|4
4809167|NCT01252667|16583388|P6|Overall Study|Transplant aborted post-conditioning|1
4809168|NCT01252667|16583389|P5|Overall Study|Transplant aborted post-conditioning|0
4809169|NCT01252667|16583390|P4|Overall Study|Transplant aborted post-conditioning|0
4809170|NCT01252667|16583391|P3|Overall Study|Transplant aborted post-conditioning|0
4809171|NCT01252667|16583392|P2|Overall Study|Transplant aborted post-conditioning|0
4809172|NCT01252667|16583393|P1|Overall Study|Transplant aborted post-conditioning|0
4809173|NCT01252563|16583455|P1|Overall Study|No drug administration|6
4809174|NCT01252563|16583455|P1|Overall Study|No visit after first day of treatment|194
4809175|NCT01252563|16583455|P1|Overall Study|Lost to Follow-up|161
4809176|NCT01252563|16583455|P1|Overall Study|Centralized Registration Deviation|30
4809177|NCT01252563|16583455|P1|Overall Study|Contract Deviation|41
4809178|NCT01252355|16583495|P3|Overall Study|Other Than Above|7
4809179|NCT01252355|16583496|P2|Overall Study|Other Than Above|7
4809180|NCT01252355|16583497|P1|Overall Study|Other Than Above|8
4809181|NCT01252355|16583495|P3|Overall Study|Randomized but not Treated|0
4809182|NCT01252355|16583496|P2|Overall Study|Randomized but not Treated|0
4809183|NCT01252355|16583497|P1|Overall Study|Randomized but not Treated|2
4809184|NCT01252355|16583495|P3|Overall Study|Sponsor Early Termination of Study|146
4809185|NCT01252355|16583496|P2|Overall Study|Sponsor Early Termination of Study|149
4809186|NCT01252355|16583497|P1|Overall Study|Sponsor Early Termination of Study|149
4809187|NCT01252355|16583495|P3|Overall Study|Progressive Disease|0
4809188|NCT01252355|16583496|P2|Overall Study|Progressive Disease|0
4809189|NCT01252355|16583497|P1|Overall Study|Progressive Disease|2
4809190|NCT01252355|16583495|P3|Overall Study|Poor Compliance to Protocol|1
4809191|NCT01252355|16583496|P2|Overall Study|Poor Compliance to Protocol|1
4809192|NCT01252355|16583497|P1|Overall Study|Poor Compliance to Protocol|1
4809193|NCT01252355|16583495|P3|Overall Study|Lost to Follow-up|1
4809194|NCT01252355|16583496|P2|Overall Study|Lost to Follow-up|0
4809195|NCT01252355|16583497|P1|Overall Study|Lost to Follow-up|0
4809196|NCT01252355|16583495|P3|Overall Study|Lack of Efficacy|2
4809197|NCT01252355|16583496|P2|Overall Study|Lack of Efficacy|4
4809198|NCT01252355|16583497|P1|Overall Study|Lack of Efficacy|6
4809199|NCT01252355|16583495|P3|Overall Study|Adverse Event|22
4809200|NCT01252355|16583496|P2|Overall Study|Adverse Event|17
4809201|NCT01252355|16583497|P1|Overall Study|Adverse Event|9
4809202|NCT01252290|16583535|P1|Overall Study|Withdrawal by Subject|1
4809203|NCT01252251|16583551|P1|Overall Study|Withdrawal by Subject|1
4809204|NCT01252238|16583563|P3|Overall Study|Sponsor terminated study|4
4809205|NCT01252238|16583564|P2|Overall Study|Sponsor terminated study|4
4809206|NCT01252238|16583565|P1|Overall Study|Sponsor terminated study|4
4809207|NCT01252186|16583582|P3|Overall Study|Other - Miscellaneous Reasons|7
4809208|NCT01252186|16583583|P2|Overall Study|Other - Miscellaneous Reasons|5
4809209|NCT01252186|16583584|P1|Overall Study|Other - Miscellaneous Reasons|5
4809210|NCT01252186|16583582|P3|Overall Study|Lost to Follow-up|11
4809211|NCT01252186|16583583|P2|Overall Study|Lost to Follow-up|10
4809212|NCT01252186|16583584|P1|Overall Study|Lost to Follow-up|10
4809213|NCT01252186|16583582|P3|Overall Study|Sponsor Request|0
4809214|NCT01252186|16583583|P2|Overall Study|Sponsor Request|1
4809215|NCT01252186|16583584|P1|Overall Study|Sponsor Request|2
4809216|NCT01252186|16583582|P3|Overall Study|Pregnancy|0
4809217|NCT01252186|16583583|P2|Overall Study|Pregnancy|2
4809218|NCT01252186|16583584|P1|Overall Study|Pregnancy|2
4809219|NCT01252186|16583582|P3|Overall Study|Protocol Violation|1
4809220|NCT01252186|16583583|P2|Overall Study|Protocol Violation|0
4809221|NCT01252186|16583584|P1|Overall Study|Protocol Violation|0
4809222|NCT01252186|16583582|P3|Overall Study|Non-compliance|4
4809223|NCT01252186|16583583|P2|Overall Study|Non-compliance|3
4809224|NCT01252186|16583584|P1|Overall Study|Non-compliance|0
4809225|NCT01252186|16583582|P3|Overall Study|Physician Decision|1
4809226|NCT01252186|16583583|P2|Overall Study|Physician Decision|0
4809227|NCT01252186|16583584|P1|Overall Study|Physician Decision|0
4809228|NCT01252186|16583582|P3|Overall Study|Withdrawal by Subject|2
4809229|NCT01252186|16583583|P2|Overall Study|Withdrawal by Subject|5
4809230|NCT01252186|16583584|P1|Overall Study|Withdrawal by Subject|2
4809231|NCT01252186|16583582|P3|Overall Study|Adverse Event|8
4809232|NCT01252186|16583583|P2|Overall Study|Adverse Event|6
4809233|NCT01252186|16583584|P1|Overall Study|Adverse Event|9
4809234|NCT01252134|16583657|P6|Period 1, 8 Hours|Personal Reasons|0
4809235|NCT01252134|16583658|P5|Period 1, 8 Hours|Personal Reasons|0
4809236|NCT01252134|16583659|P4|Period 1, 8 Hours|Personal Reasons|0
4809237|NCT01252134|16583660|P3|Period 1, 8 Hours|Personal Reasons|1
4809238|NCT01252134|16583661|P2|Period 1, 8 Hours|Personal Reasons|1
4809239|NCT01252134|16583662|P1|Period 1, 8 Hours|Personal Reasons|0
4809240|NCT01252095|16583681|P2|Overall Study|Disease progression|0
4809241|NCT01252095|16583682|P1|Overall Study|Disease progression|1
4809242|NCT01251965|16583703|P3|Overall Study|Death|11
4809243|NCT01251965|16583704|P2|Overall Study|Death|0
4809244|NCT01251965|16583705|P1|Overall Study|Death|0
4809245|NCT01251965|16583703|P3|Overall Study|Participant/physician decision|0
4809246|NCT01251965|16583704|P2|Overall Study|Participant/physician decision|2
4809247|NCT01251965|16583705|P1|Overall Study|Participant/physician decision|1
4809248|NCT01251952|16583717|P1|Overall Study|Adverse Event|1
4809249|NCT01251861|16583723|P2|Overall Study|Potential interaction of drugs|1
4809250|NCT01251861|16583724|P1|Overall Study|Potential interaction of drugs|0
4809251|NCT01251861|16583723|P2|Overall Study|Never started therapy|1
4809252|NCT01251861|16583724|P1|Overall Study|Never started therapy|4
4809253|NCT01251861|16583723|P2|Overall Study|Other|0
4809254|NCT01251861|16583724|P1|Overall Study|Other|1
4809255|NCT01251861|16583723|P2|Overall Study|Continued treatment beyond 18 cycles|0
4809256|NCT01251861|16583724|P1|Overall Study|Continued treatment beyond 18 cycles|1
4809257|NCT01251861|16583723|P2|Overall Study|Physician Decision|0
4809258|NCT01251861|16583724|P1|Overall Study|Physician Decision|1
4809259|NCT01251861|16583723|P2|Overall Study|Other complicating disease|1
4809260|NCT01251861|16583724|P1|Overall Study|Other complicating disease|0
4809261|NCT01251861|16583723|P2|Overall Study|Alternative therapy|0
4809262|NCT01251861|16583724|P1|Overall Study|Alternative therapy|1
4809263|NCT01251861|16583723|P2|Overall Study|Withdrawal by Subject|2
4809264|NCT01251861|16583724|P1|Overall Study|Withdrawal by Subject|2
4809265|NCT01251861|16583723|P2|Overall Study|Adverse Event|17
4809266|NCT01251861|16583724|P1|Overall Study|Adverse Event|2
4809267|NCT01251861|16583723|P2|Overall Study|Disease progression|6
4809268|NCT01251861|16583724|P1|Overall Study|Disease progression|6
4809269|NCT01251770|16583752|P2|Overall Study|Protocol Violation|7
4809270|NCT01251770|16583753|P1|Overall Study|Protocol Violation|13
4809271|NCT01251744|16583797|P2|Overall Study|Lost to Follow-up|0
4809272|NCT01251744|16583798|P1|Overall Study|Lost to Follow-up|1
4809273|NCT01251653|16583856|P9|Overall Study|Other reason not mentioned above|0
4809274|NCT01251653|16583857|P8|Overall Study|Other reason not mentioned above|2
4809275|NCT01251653|16583858|P7|Overall Study|Other reason not mentioned above|0
4809276|NCT01251653|16583859|P6|Overall Study|Other reason not mentioned above|0
4809277|NCT01251653|16583860|P5|Overall Study|Other reason not mentioned above|0
4809278|NCT01251653|16583861|P4|Overall Study|Other reason not mentioned above|0
4809279|NCT01251653|16583862|P3|Overall Study|Other reason not mentioned above|0
4809280|NCT01251653|16583863|P2|Overall Study|Other reason not mentioned above|0
4809281|NCT01251653|16583864|P1|Overall Study|Other reason not mentioned above|0
4809282|NCT01251653|16583856|P9|Overall Study|Withdrawal by Subject|0
4809283|NCT01251653|16583857|P8|Overall Study|Withdrawal by Subject|1
4809284|NCT01251653|16583858|P7|Overall Study|Withdrawal by Subject|0
4809285|NCT01251653|16583859|P6|Overall Study|Withdrawal by Subject|1
4809286|NCT01251653|16583860|P5|Overall Study|Withdrawal by Subject|1
4809287|NCT01251653|16583861|P4|Overall Study|Withdrawal by Subject|0
4809288|NCT01251653|16583862|P3|Overall Study|Withdrawal by Subject|1
4809289|NCT01251653|16583863|P2|Overall Study|Withdrawal by Subject|0
4809290|NCT01251653|16583864|P1|Overall Study|Withdrawal by Subject|1
4809291|NCT01251653|16583856|P9|Overall Study|Adverse Event|1
4809292|NCT01251653|16583857|P8|Overall Study|Adverse Event|2
4809293|NCT01251653|16583858|P7|Overall Study|Adverse Event|2
4809294|NCT01251653|16583859|P6|Overall Study|Adverse Event|0
4809295|NCT01251653|16583860|P5|Overall Study|Adverse Event|1
4809296|NCT01251653|16583861|P4|Overall Study|Adverse Event|1
4809297|NCT01251653|16583862|P3|Overall Study|Adverse Event|2
4809298|NCT01251653|16583863|P2|Overall Study|Adverse Event|0
4809299|NCT01251653|16583864|P1|Overall Study|Adverse Event|1
4809300|NCT01251653|16583856|P9|Overall Study|Dose-limiting toxicity|0
4809301|NCT01251653|16583857|P8|Overall Study|Dose-limiting toxicity|0
4809302|NCT01251653|16583858|P7|Overall Study|Dose-limiting toxicity|2
4809303|NCT01251653|16583859|P6|Overall Study|Dose-limiting toxicity|0
4809304|NCT01251653|16583860|P5|Overall Study|Dose-limiting toxicity|0
4809305|NCT01251653|16583861|P4|Overall Study|Dose-limiting toxicity|1
4809306|NCT01251653|16583862|P3|Overall Study|Dose-limiting toxicity|1
4809307|NCT01251653|16583863|P2|Overall Study|Dose-limiting toxicity|1
4809308|NCT01251653|16583864|P1|Overall Study|Dose-limiting toxicity|0
4809309|NCT01251653|16583856|P9|Overall Study|Progressive Disease|5
4809310|NCT01251653|16583857|P8|Overall Study|Progressive Disease|7
4809311|NCT01251653|16583858|P7|Overall Study|Progressive Disease|14
4809312|NCT01251653|16583859|P6|Overall Study|Progressive Disease|17
4809313|NCT01251653|16583860|P5|Overall Study|Progressive Disease|0
4809314|NCT01251653|16583861|P4|Overall Study|Progressive Disease|4
4809315|NCT01251653|16583862|P3|Overall Study|Progressive Disease|16
4809316|NCT01251653|16583863|P2|Overall Study|Progressive Disease|7
4809317|NCT01251653|16583864|P1|Overall Study|Progressive Disease|1
4809318|NCT01251614|16583992|P3|Overall Study|Lost to Follow-up|0
4809319|NCT01251614|16583993|P2|Overall Study|Lost to Follow-up|1
4809320|NCT01251614|16583994|P1|Overall Study|Lost to Follow-up|0
4809321|NCT01251614|16583992|P3|Overall Study|Withdrawal by Subject|1
4809322|NCT01251614|16583993|P2|Overall Study|Withdrawal by Subject|2
4809323|NCT01251614|16583994|P1|Overall Study|Withdrawal by Subject|0
4809324|NCT01251614|16583992|P3|Overall Study|Loss of Disease Control|0
4809325|NCT01251614|16583993|P2|Overall Study|Loss of Disease Control|1
4809326|NCT01251614|16583994|P1|Overall Study|Loss of Disease Control|0
4809327|NCT01251614|16583992|P3|Overall Study|Pregnancy|2
4809328|NCT01251614|16583993|P2|Overall Study|Pregnancy|0
4809329|NCT01251614|16583994|P1|Overall Study|Pregnancy|0
4809330|NCT01251614|16583992|P3|Overall Study|Clearing of Psoriatic Lesions|0
4809331|NCT01251614|16583993|P2|Overall Study|Clearing of Psoriatic Lesions|0
4809332|NCT01251614|16583994|P1|Overall Study|Clearing of Psoriatic Lesions|1
4809333|NCT01251614|16583992|P3|Overall Study|Lack of Efficacy|4
4809334|NCT01251614|16583993|P2|Overall Study|Lack of Efficacy|9
4809335|NCT01251614|16583994|P1|Overall Study|Lack of Efficacy|1
4809336|NCT01251614|16583992|P3|Overall Study|Adverse Event|1
4809337|NCT01251614|16583993|P2|Overall Study|Adverse Event|0
4809338|NCT01251614|16583994|P1|Overall Study|Adverse Event|1
4809339|NCT01251380|16584192|P1|Overall Study|Lost to Follow-up|2
4809340|NCT01251380|16584192|P1|Overall Study|Adverse Event|1
4809341|NCT01251380|16584192|P1|Overall Study|Lack of Efficacy|1
4809342|NCT01251380|16584192|P1|Overall Study|Withdrawal by Subject|6
4809343|NCT01251380|16584192|P1|Overall Study|Other (Not otherwise specified)|12
4809344|NCT01251367|16584216|P1|Overall Study|End of Study Visit Performed in Error|1
4809345|NCT01251367|16584216|P1|Overall Study|Subject had Personal or Medical Issues|4
4809346|NCT01251367|16584216|P1|Overall Study|No Study Drug Available|1
4809347|NCT01251367|16584216|P1|Overall Study|Subject Required Alternative Treatment|7
4809348|NCT01251367|16584216|P1|Overall Study|Lost to Follow-up|5
4809349|NCT01251367|16584216|P1|Overall Study|Withdrawal by Subject|36
4809350|NCT01251367|16584216|P1|Overall Study|Adverse Event|19
4809351|NCT01251367|16584216|P1|Overall Study|Lack of Efficacy|2
4809352|NCT01251367|16584216|P1|Overall Study|Protocol Violation|1
4809353|NCT01251354|16584251|P1|Overall Study|Disease Progression|4
4809354|NCT01251354|16584251|P1|Overall Study|Investigator's Decision|1
4809355|NCT01251354|16584251|P1|Overall Study|Adverse Event|1
4809356|NCT01251276|16584294|P2|Overall Study|Lost to Follow-up|1
4809357|NCT01251276|16584295|P1|Overall Study|Lost to Follow-up|0
4809358|NCT01251276|16584294|P2|Overall Study|Protocol Violation|0
4809359|NCT01251276|16584295|P1|Overall Study|Protocol Violation|1
4809360|NCT01251146|16584313|P2|Overall Study|Lost to Follow-up|10
4809361|NCT01251146|16584314|P1|Overall Study|Lost to Follow-up|3
4809362|NCT01251120|16584336|P2|Overall Study|Lack of Efficacy|1
4809363|NCT01251120|16584337|P1|Overall Study|Lack of Efficacy|0
4809364|NCT01250925|16584417|P3|Overall Study|Adverse Event|1
4809365|NCT01250925|16584418|P2|Overall Study|Adverse Event|0
4809366|NCT01250925|16584419|P1|Overall Study|Adverse Event|0
4809367|NCT01250925|16584417|P3|Overall Study|Physician Decision|1
4809368|NCT01250925|16584418|P2|Overall Study|Physician Decision|2
4809369|NCT01250925|16584419|P1|Overall Study|Physician Decision|0
4809370|NCT01250925|16584417|P3|Overall Study|Protocol Violation|0
4809371|NCT01250925|16584418|P2|Overall Study|Protocol Violation|0
4809372|NCT01250925|16584419|P1|Overall Study|Protocol Violation|2
4809373|NCT01250925|16584417|P3|Overall Study|Withdrawal by Subject|0
4809374|NCT01250925|16584418|P2|Overall Study|Withdrawal by Subject|0
4809375|NCT01250925|16584419|P1|Overall Study|Withdrawal by Subject|2
4809376|NCT01250925|16584417|P3|Overall Study|Lost to Follow-up|0
4809377|NCT01250925|16584418|P2|Overall Study|Lost to Follow-up|1
4809378|NCT01250925|16584419|P1|Overall Study|Lost to Follow-up|1
4809379|NCT01250873|16584464|P1|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1
4809380|NCT01250873|16584464|P1|Period 1: LY2216684 (Days 1-3)|Adverse Event|2
4809381|NCT01250769|16584496|P4|Overall Study|Adverse Event|0
4809382|NCT01250769|16584497|P3|Overall Study|Adverse Event|1
4809383|NCT01250769|16584498|P2|Overall Study|Adverse Event|0
4809384|NCT01250769|16584499|P1|Overall Study|Adverse Event|0
4809385|NCT01250769|16584496|P4|Overall Study|Withdrawal by Subject|0
4809386|NCT01250769|16584497|P3|Overall Study|Withdrawal by Subject|1
4809387|NCT01250769|16584498|P2|Overall Study|Withdrawal by Subject|1
4809388|NCT01250769|16584499|P1|Overall Study|Withdrawal by Subject|0
4809389|NCT01250756|16584531|P2|After Toddler Dose|Adverse Event|1
4809390|NCT01250756|16584532|P1|After Toddler Dose|Adverse Event|0
4809391|NCT01250756|16584531|P2|Toddler Dose|Adverse Event|1
4809392|NCT01250756|16584532|P1|Toddler Dose|Adverse Event|0
4809393|NCT01250756|16584531|P2|After Infant Series|Other|1
4809394|NCT01250756|16584532|P1|After Infant Series|Other|2
4809395|NCT01250756|16584531|P2|After Infant Series|Withdrawal by Subject|1
4809396|NCT01250756|16584532|P1|After Infant Series|Withdrawal by Subject|4
4809397|NCT01250756|16584531|P2|After Infant Series|Adverse Event|2
4809398|NCT01250756|16584532|P1|After Infant Series|Adverse Event|5
4809399|NCT01250756|16584531|P2|Infant Series|Other|0
4809400|NCT01250756|16584532|P1|Infant Series|Other|22
4809401|NCT01250756|16584531|P2|Infant Series|Randomized, Not Vaccinated|2
4809402|NCT01250756|16584532|P1|Infant Series|Randomized, Not Vaccinated|2
4809403|NCT01250756|16584531|P2|Infant Series|Withdrawal by Subject|5
4809404|NCT01250756|16584532|P1|Infant Series|Withdrawal by Subject|4
4809405|NCT01250509|16584649|P2|Overall Study|Lost to Follow-up|2
4809406|NCT01250509|16584650|P1|Overall Study|Lost to Follow-up|5
4809407|NCT01250418|16584664|P2|Overall Study|monitor data failure|1
4809408|NCT01250418|16584665|P1|Overall Study|monitor data failure|1
4809409|NCT01250379|16584673|P2|Overall Study|Participant noncompliance|0
4809410|NCT01250379|16584674|P1|Overall Study|Participant noncompliance|2
4809411|NCT01250379|16584673|P2|Overall Study|Other|4
4809412|NCT01250379|16584674|P1|Overall Study|Other|0
4809413|NCT01250379|16584673|P2|Overall Study|Adverse Event|4
4809414|NCT01250379|16584674|P1|Overall Study|Adverse Event|5
4809415|NCT01250379|16584673|P2|Overall Study|Lost to Follow-up|6
4809416|NCT01250379|16584674|P1|Overall Study|Lost to Follow-up|9
4809417|NCT01250379|16584673|P2|Overall Study|Protocol Violation|8
4809418|NCT01250379|16584674|P1|Overall Study|Protocol Violation|2
4809419|NCT01250379|16584673|P2|Overall Study|Physician Decision|3
4809420|NCT01250379|16584674|P1|Overall Study|Physician Decision|11
4809421|NCT01250379|16584673|P2|Overall Study|Withdrawal by Subject|20
4809422|NCT01250379|16584674|P1|Overall Study|Withdrawal by Subject|32
4809423|NCT01250379|16584673|P2|Overall Study|Death|148
4809424|NCT01250379|16584674|P1|Overall Study|Death|141
4809425|NCT01250171|16584779|P3|Overall Study|Administrative reasons|0
4809426|NCT01250171|16584780|P2|Overall Study|Administrative reasons|0
4809427|NCT01250171|16584781|P1|Overall Study|Administrative reasons|1
4809428|NCT01250145|16584812|P2|Overall Study|Withdrawal by Subject|4
4809429|NCT01250145|16584813|P1|Overall Study|Withdrawal by Subject|0
4809430|NCT01250145|16584812|P2|Overall Study|Adverse Event|1
4809431|NCT01250145|16584813|P1|Overall Study|Adverse Event|2
4809432|NCT01250119|16584833|P2|Treatment Phase|Unknown reason|4
4809433|NCT01250119|16584834|P1|Treatment Phase|Unknown reason|0
4809434|NCT01250119|16584833|P2|Treatment Phase|Adverse Event|2
4809435|NCT01250119|16584834|P1|Treatment Phase|Adverse Event|0
4809436|NCT01250119|16584833|P2|Treatment Phase|Withdrawal by Subject|1
4809437|NCT01250119|16584834|P1|Treatment Phase|Withdrawal by Subject|0
4809438|NCT01250119|16584833|P2|Treatment Phase|Death|2
4809439|NCT01250119|16584834|P1|Treatment Phase|Death|0
4809440|NCT01250119|16584833|P2|Treatment Phase|Progressive Disease|32
4809441|NCT01250119|16584834|P1|Treatment Phase|Progressive Disease|0
4809442|NCT01250119|16584833|P2|Diagnostic Phase|Participants Not Tested|0
4809443|NCT01250119|16584834|P1|Diagnostic Phase|Participants Not Tested|44
4809444|NCT01250119|16584833|P2|Diagnostic Phase|Failed to Produce a Test Results|0
4809445|NCT01250119|16584834|P1|Diagnostic Phase|Failed to Produce a Test Results|69
4809446|NCT01250054|16584849|P2|Period 2, One Week of Wear|Unacceptable subjective vision|0
4809447|NCT01250054|16584850|P1|Period 2, One Week of Wear|Unacceptable subjective vision|1
4809448|NCT01250002|16584858|P2|Overall Study|Change to open surgical procedure|3
4809449|NCT01250002|16584859|P1|Overall Study|Change to open surgical procedure|4
4809450|NCT01249833|16584924|P2|Overall Study|Lost to Follow-up|1
4809451|NCT01249833|16584925|P1|Overall Study|Lost to Follow-up|0
4809452|NCT01249664|16584939|P2|Overall Study|Adverse Event|0
4809453|NCT01249664|16584940|P1|Overall Study|Adverse Event|1
4809454|NCT01249664|16584939|P2|Overall Study|Withdrawal by Subject|0
4809455|NCT01249664|16584940|P1|Overall Study|Withdrawal by Subject|5
4809456|NCT01249651|16584990|P1|Overall Study|Sponsor Decision|1
4809457|NCT01249651|16584990|P1|Overall Study|Protocol Violation|1
4809458|NCT01249651|16584990|P1|Overall Study|Adverse Event|1
4809459|NCT01249651|16584990|P1|Overall Study|Withdrawal by Subject|4
4809460|NCT01249417|16585019|P3|Treatment Phase - ITT Population|Lost to Follow-up|1
4809461|NCT01249417|16585020|P2|Treatment Phase - ITT Population|Lost to Follow-up|1
4809462|NCT01249417|16585021|P1|Treatment Phase - ITT Population|Lost to Follow-up|0
4809463|NCT01249417|16585019|P3|Treatment Phase - ITT Population|Withdrawal by Subject|1
4809464|NCT01249417|16585020|P2|Treatment Phase - ITT Population|Withdrawal by Subject|3
4809465|NCT01249417|16585021|P1|Treatment Phase - ITT Population|Withdrawal by Subject|1
4809466|NCT01249417|16585019|P3|Treatment Phase - ITT Population|Adverse Event|1
4809467|NCT01249417|16585020|P2|Treatment Phase - ITT Population|Adverse Event|0
4809468|NCT01249417|16585021|P1|Treatment Phase - ITT Population|Adverse Event|0
4809469|NCT01249417|16585019|P3|Treatment Phase - ITT Population|Other|1
4809470|NCT01249417|16585020|P2|Treatment Phase - ITT Population|Other|0
4809471|NCT01249417|16585021|P1|Treatment Phase - ITT Population|Other|0
4809472|NCT01249417|16585019|P3|Randomised Population|No MAS score at baseline and/or Week 4|2
4809473|NCT01249417|16585020|P2|Randomised Population|No MAS score at baseline and/or Week 4|1
4809474|NCT01249417|16585021|P1|Randomised Population|No MAS score at baseline and/or Week 4|1
4809475|NCT01249417|16585019|P3|Randomised Population|Study treatment not received|2
4809476|NCT01249417|16585020|P2|Randomised Population|Study treatment not received|0
4809477|NCT01249417|16585021|P1|Randomised Population|Study treatment not received|0
4809478|NCT01249404|16585038|P3|Overall Study|Non compliance to visit schedule|0
4809479|NCT01249404|16585039|P2|Overall Study|Non compliance to visit schedule|1
4809480|NCT01249404|16585040|P1|Overall Study|Non compliance to visit schedule|0
4809481|NCT01249404|16585038|P3|Overall Study|Botulinum toxin (BTX) in upper limb|1
4809482|NCT01249404|16585039|P2|Overall Study|Botulinum toxin (BTX) in upper limb|2
4809483|NCT01249404|16585040|P1|Overall Study|Botulinum toxin (BTX) in upper limb|1
4809484|NCT01249404|16585038|P3|Overall Study|Withdrawal by Subject|0
4809485|NCT01249404|16585039|P2|Overall Study|Withdrawal by Subject|2
4809486|NCT01249404|16585040|P1|Overall Study|Withdrawal by Subject|2
4809487|NCT01249404|16585038|P3|Overall Study|Adverse Event|2
4809488|NCT01249404|16585039|P2|Overall Study|Adverse Event|2
4809489|NCT01249404|16585040|P1|Overall Study|Adverse Event|2
4809490|NCT01249404|16585038|P3|Overall Study|No MAS Score at baseline and/or Week 4|2
4809491|NCT01249404|16585039|P2|Overall Study|No MAS Score at baseline and/or Week 4|0
4809492|NCT01249404|16585040|P1|Overall Study|No MAS Score at baseline and/or Week 4|2
4809493|NCT01249404|16585038|P3|Overall Study|Study treatment not received|2
4809494|NCT01249404|16585039|P2|Overall Study|Study treatment not received|1
4809495|NCT01249404|16585040|P1|Overall Study|Study treatment not received|0
4809496|NCT01249365|16585117|P1|Overall Study|Lost to Follow-up|1
4809497|NCT01249274|16585125|P2|Overall Study|Received inpatient substance treatment|2
4809498|NCT01249274|16585126|P1|Overall Study|Received inpatient substance treatment|1
4809499|NCT01249274|16585125|P2|Overall Study|Lost to Follow-up|4
4809500|NCT01249274|16585126|P1|Overall Study|Lost to Follow-up|3
4809501|NCT01249261|16585152|P2|Overall Study|Withdrawal by Subject|0
4809502|NCT01249261|16585153|P1|Overall Study|Withdrawal by Subject|1
4809503|NCT01249157|16585181|P1|Overall Study|Withdrawal by Subject|1
4809504|NCT01249131|16585185|P6|Washout Period of 10 Days|Adverse Event|0
4809505|NCT01249131|16585186|P5|Washout Period of 10 Days|Adverse Event|1
4809506|NCT01249131|16585187|P4|Washout Period of 10 Days|Adverse Event|0
4809507|NCT01249131|16585188|P3|Washout Period of 10 Days|Adverse Event|0
4809508|NCT01249131|16585189|P2|Washout Period of 10 Days|Adverse Event|0
4809509|NCT01249131|16585190|P1|Washout Period of 10 Days|Adverse Event|0
4809510|NCT01249118|16585210|P3|First Washout Period|Physician Decision|0
4809511|NCT01249118|16585211|P2|First Washout Period|Physician Decision|1
4809512|NCT01249118|16585212|P1|First Washout Period|Physician Decision|0
4809513|NCT01249092|16585246|P1|Overall Study|Unable to tolerate expected SE -nausea|1
4809514|NCT01249092|16585246|P1|Overall Study|Expected side effect of nausea/dyspepsia|1
4809515|NCT01248962|16585323|P2|Overall Study|Progression of Disease prior to 5 Cycles|13
4809516|NCT01248962|16585324|P1|Overall Study|Progression of Disease prior to 5 Cycles|12
4809517|NCT01248962|16585323|P2|Overall Study|Complete Response after 3 Cycles|1
4809518|NCT01248962|16585324|P1|Overall Study|Complete Response after 3 Cycles|0
4809519|NCT01248962|16585323|P2|Overall Study|Complete Response after 4 Cycles|0
4809520|NCT01248962|16585324|P1|Overall Study|Complete Response after 4 Cycles|1
4809521|NCT01248962|16585323|P2|Overall Study|Adverse Event|1
4809522|NCT01248962|16585324|P1|Overall Study|Adverse Event|2
4809523|NCT01248962|16585323|P2|Overall Study|Withdrawal by Subject|1
4809524|NCT01248962|16585324|P1|Overall Study|Withdrawal by Subject|1
4809525|NCT01248949|16585340|P5|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4809526|NCT01248949|16585341|P4|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4809527|NCT01248949|16585342|P3|Overall Study|Lesion In ThoracicSpine Requires Therapy|1
4809528|NCT01248949|16585343|P2|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4809529|NCT01248949|16585344|P1|Overall Study|Lesion In ThoracicSpine Requires Therapy|0
4809530|NCT01248949|16585340|P5|Overall Study|Pi Discretion Due To Hospitalisation|0
4809531|NCT01248949|16585341|P4|Overall Study|Pi Discretion Due To Hospitalisation|0
4809532|NCT01248949|16585342|P3|Overall Study|Pi Discretion Due To Hospitalisation|0
4809533|NCT01248949|16585343|P2|Overall Study|Pi Discretion Due To Hospitalisation|1
4809534|NCT01248949|16585344|P1|Overall Study|Pi Discretion Due To Hospitalisation|0
4809535|NCT01248949|16585340|P5|Overall Study|Pi Decision Due To Declining Status|0
4809536|NCT01248949|16585341|P4|Overall Study|Pi Decision Due To Declining Status|0
4809537|NCT01248949|16585342|P3|Overall Study|Pi Decision Due To Declining Status|1
4809538|NCT01248949|16585343|P2|Overall Study|Pi Decision Due To Declining Status|0
4809539|NCT01248949|16585344|P1|Overall Study|Pi Decision Due To Declining Status|0
4809540|NCT01248949|16585340|P5|Overall Study|Per Sponsor Request o Discontinue Drug|0
4809541|NCT01248949|16585341|P4|Overall Study|Per Sponsor Request o Discontinue Drug|0
4809542|NCT01248949|16585342|P3|Overall Study|Per Sponsor Request o Discontinue Drug|0
4809543|NCT01248949|16585343|P2|Overall Study|Per Sponsor Request o Discontinue Drug|0
4809544|NCT01248949|16585344|P1|Overall Study|Per Sponsor Request o Discontinue Drug|1
4809545|NCT01248949|16585340|P5|Overall Study|Participant Went To Hospice|0
4809546|NCT01248949|16585341|P4|Overall Study|Participant Went To Hospice|0
4809547|NCT01248949|16585342|P3|Overall Study|Participant Went To Hospice|1
4809548|NCT01248949|16585343|P2|Overall Study|Participant Went To Hospice|0
4809549|NCT01248949|16585344|P1|Overall Study|Participant Went To Hospice|0
4809550|NCT01248949|16585340|P5|Overall Study|Entered Hospice And Refused Follow Up|1
4809551|NCT01248949|16585341|P4|Overall Study|Entered Hospice And Refused Follow Up|0
4809552|NCT01248949|16585342|P3|Overall Study|Entered Hospice And Refused Follow Up|0
4809553|NCT01248949|16585343|P2|Overall Study|Entered Hospice And Refused Follow Up|0
4809554|NCT01248949|16585344|P1|Overall Study|Entered Hospice And Refused Follow Up|0
4809555|NCT01248949|16585340|P5|Overall Study|Palliative Radiation To Brain Metastases|0
4809556|NCT01248949|16585341|P4|Overall Study|Palliative Radiation To Brain Metastases|0
4809557|NCT01248949|16585342|P3|Overall Study|Palliative Radiation To Brain Metastases|0
4809558|NCT01248949|16585343|P2|Overall Study|Palliative Radiation To Brain Metastases|0
4809559|NCT01248949|16585344|P1|Overall Study|Palliative Radiation To Brain Metastases|1
4809560|NCT01248949|16585340|P5|Overall Study|Alternative Therapy.|0
4809561|NCT01248949|16585341|P4|Overall Study|Alternative Therapy.|0
4809562|NCT01248949|16585342|P3|Overall Study|Alternative Therapy.|0
4809563|NCT01248949|16585343|P2|Overall Study|Alternative Therapy.|0
4809564|NCT01248949|16585344|P1|Overall Study|Alternative Therapy.|1
4809565|NCT01248949|16585340|P5|Overall Study|Alternative Therapy|0
4809566|NCT01248949|16585341|P4|Overall Study|Alternative Therapy|0
4809567|NCT01248949|16585342|P3|Overall Study|Alternative Therapy|0
4809568|NCT01248949|16585343|P2|Overall Study|Alternative Therapy|0
4809569|NCT01248949|16585344|P1|Overall Study|Alternative Therapy|1
4809570|NCT01248949|16585340|P5|Overall Study|Death|2
4809571|NCT01248949|16585341|P4|Overall Study|Death|6
4809572|NCT01248949|16585342|P3|Overall Study|Death|21
4809573|NCT01248949|16585343|P2|Overall Study|Death|7
4809574|NCT01248949|16585344|P1|Overall Study|Death|22
4809575|NCT01248949|16585340|P5|Overall Study|Withdrawal by Subject|1
4809576|NCT01248949|16585341|P4|Overall Study|Withdrawal by Subject|3
4809577|NCT01248949|16585342|P3|Overall Study|Withdrawal by Subject|11
4809578|NCT01248949|16585343|P2|Overall Study|Withdrawal by Subject|3
4809579|NCT01248949|16585344|P1|Overall Study|Withdrawal by Subject|5
4809580|NCT01248949|16585340|P5|Overall Study|Lost to Follow-up|0
4809581|NCT01248949|16585341|P4|Overall Study|Lost to Follow-up|1
4809582|NCT01248949|16585342|P3|Overall Study|Lost to Follow-up|2
4809583|NCT01248949|16585343|P2|Overall Study|Lost to Follow-up|2
4809584|NCT01248949|16585344|P1|Overall Study|Lost to Follow-up|2
4809585|NCT01248936|16585456|P1|Overall Study|Other reason|3
4809586|NCT01248936|16585456|P1|Overall Study|Refused Treatment|1
4809587|NCT01248936|16585456|P1|Overall Study|Lost to Follow-up|7
4809588|NCT01248936|16585456|P1|Overall Study|Adverse Event|8
4809589|NCT01248936|16585456|P1|Overall Study|Withdrawal of Consent|20
4809590|NCT01248936|16585456|P1|Overall Study|Death|26
4809591|NCT01248936|16585456|P1|Overall Study|Progression of Disease|50
4809592|NCT01248936|16585456|P1|Overall Study|Sponsor Decision|259
4809593|NCT01248884|16585469|P3|Overall Study|Adverse Event|0
4809594|NCT01248884|16585470|P2|Overall Study|Adverse Event|0
4809595|NCT01248884|16585471|P1|Overall Study|Adverse Event|1
4809596|NCT01248884|16585469|P3|Overall Study|Withdrawal by Subject|1
4809597|NCT01248884|16585470|P2|Overall Study|Withdrawal by Subject|3
4809598|NCT01248884|16585471|P1|Overall Study|Withdrawal by Subject|1
4809599|NCT01248793|16585529|P2|Overall Study|Withdrawal by Subject|3
4809600|NCT01248793|16585530|P1|Overall Study|Withdrawal by Subject|3
4809601|NCT01248793|16585529|P2|Overall Study|Protocol Violation|1
4809602|NCT01248793|16585530|P1|Overall Study|Protocol Violation|0
4809603|NCT01248793|16585529|P2|Overall Study|Adverse Event|1
4809604|NCT01248793|16585530|P1|Overall Study|Adverse Event|1
4809605|NCT01248793|16585529|P2|Overall Study|Lost to Follow-up|1
4809606|NCT01248793|16585530|P1|Overall Study|Lost to Follow-up|0
4809607|NCT01248780|16585544|P2|Overall Study|Not treated|1
4809608|NCT01248780|16585545|P1|Overall Study|Not treated|0
4809609|NCT01248780|16585544|P2|Overall Study|Withdrawal by Subject|4
4809610|NCT01248780|16585545|P1|Overall Study|Withdrawal by Subject|4
4809611|NCT01248780|16585544|P2|Overall Study|Protocol Violation|1
4809612|NCT01248780|16585545|P1|Overall Study|Protocol Violation|1
4809613|NCT01248780|16585544|P2|Overall Study|Adverse Event|7
4809614|NCT01248780|16585545|P1|Overall Study|Adverse Event|2
4809615|NCT01248780|16585544|P2|Overall Study|Death|1
4809616|NCT01248780|16585545|P1|Overall Study|Death|0
4809617|NCT01248780|16585544|P2|Overall Study|Lost to Follow-up|1
4809618|NCT01248780|16585545|P1|Overall Study|Lost to Follow-up|0
4809619|NCT01248780|16585544|P2|Overall Study|Lack of Efficacy|0
4809620|NCT01248780|16585545|P1|Overall Study|Lack of Efficacy|2
4809621|NCT01248728|16585559|P2|Overall Study|Lack of Efficacy|0
4809622|NCT01248728|16585560|P1|Overall Study|Lack of Efficacy|1
4809623|NCT01248728|16585559|P2|Overall Study|Withdrawal by Subject|1
4809624|NCT01248728|16585560|P1|Overall Study|Withdrawal by Subject|2
4809625|NCT01248728|16585559|P2|Overall Study|Adverse Event|1
4809626|NCT01248728|16585560|P1|Overall Study|Adverse Event|1
4809627|NCT01248715|16585576|P2|Overall Study|Not influenza positive|510
4809628|NCT01248715|16585577|P1|Overall Study|Not influenza positive|501
4809629|NCT01248468|16585615|P3|Overall Study|Withdrawal by Subject|0
4809630|NCT01248468|16585616|P2|Overall Study|Withdrawal by Subject|2
4809631|NCT01248468|16585617|P1|Overall Study|Withdrawal by Subject|4
4809632|NCT01248468|16585615|P3|Overall Study|Pregnancy|0
4809633|NCT01248468|16585616|P2|Overall Study|Pregnancy|0
4809634|NCT01248468|16585617|P1|Overall Study|Pregnancy|1
4809635|NCT01248468|16585615|P3|Overall Study|Lost to Follow-up|4
4809636|NCT01248468|16585616|P2|Overall Study|Lost to Follow-up|12
4809637|NCT01248468|16585617|P1|Overall Study|Lost to Follow-up|9
4809638|NCT01248468|16585615|P3|Overall Study|Administrative problem|0
4809639|NCT01248468|16585616|P2|Overall Study|Administrative problem|0
4809640|NCT01248468|16585617|P1|Overall Study|Administrative problem|1
4809641|NCT01248455|16585634|P1|Overall Study|switched to alternate treatment|1
4809642|NCT01248364|16585679|P4|Overall Study|Adverse Event|0
4809643|NCT01248364|16585680|P3|Overall Study|Adverse Event|0
4809644|NCT01248364|16585681|P2|Overall Study|Adverse Event|1
4809645|NCT01248364|16585682|P1|Overall Study|Adverse Event|0
4809646|NCT01248130|16585745|P2|Overall Study|Ineligible|0
4809647|NCT01248130|16585746|P1|Overall Study|Ineligible|1
4809648|NCT01248130|16585745|P2|Overall Study|Protocol Violation|0
4809649|NCT01248130|16585746|P1|Overall Study|Protocol Violation|1
4809650|NCT01248065|16585765|P2|Overall Study|Other|5
4809651|NCT01248065|16585766|P1|Overall Study|Other|3
4809652|NCT01248065|16585765|P2|Overall Study|Third treatment failure event|1
4809653|NCT01248065|16585766|P1|Overall Study|Third treatment failure event|3
4809654|NCT01248065|16585765|P2|Overall Study|Adverse Event|0
4809655|NCT01248065|16585766|P1|Overall Study|Adverse Event|3
4809656|NCT01248065|16585765|P2|Overall Study|Withdrawal by Subject|11
4809657|NCT01248065|16585766|P1|Overall Study|Withdrawal by Subject|14
4809658|NCT01248065|16585765|P2|Overall Study|Lost to Follow-up|5
4809659|NCT01248065|16585766|P1|Overall Study|Lost to Follow-up|3
4809660|NCT01248013|16585776|P1|Overall Study|Withdrawal by Subject|14
4809661|NCT01247922|16585791|P1|Overall Study|Disease progression|4
4809662|NCT01247350|16585889|P5|Overall Study|Entry criteria not met|1
4809663|NCT01247350|16585890|P4|Overall Study|Entry criteria not met|0
4809664|NCT01247350|16585891|P3|Overall Study|Entry criteria not met|0
4809665|NCT01247350|16585892|P2|Overall Study|Entry criteria not met|0
4809666|NCT01247350|16585893|P1|Overall Study|Entry criteria not met|0
4809667|NCT01247350|16585889|P5|Overall Study|Withdrawal by Subject|0
4809668|NCT01247350|16585890|P4|Overall Study|Withdrawal by Subject|1
4809669|NCT01247350|16585891|P3|Overall Study|Withdrawal by Subject|0
4809670|NCT01247350|16585892|P2|Overall Study|Withdrawal by Subject|0
4809671|NCT01247350|16585893|P1|Overall Study|Withdrawal by Subject|0
4809672|NCT01247350|16585889|P5|Overall Study|Adverse Event|0
4809673|NCT01247350|16585890|P4|Overall Study|Adverse Event|0
4809674|NCT01247350|16585891|P3|Overall Study|Adverse Event|1
4809675|NCT01247350|16585892|P2|Overall Study|Adverse Event|0
4809676|NCT01247350|16585893|P1|Overall Study|Adverse Event|0
4809677|NCT01247324|16585951|P2|Overall Study|Lost to Follow-up|1
4809678|NCT01247324|16585952|P1|Overall Study|Lost to Follow-up|1
4809679|NCT01247324|16585951|P2|Overall Study|Adverse Event|13
4809680|NCT01247324|16585952|P1|Overall Study|Adverse Event|25
4809681|NCT01247324|16585951|P2|Overall Study|Consent withdrawn by participant|8
4809682|NCT01247324|16585952|P1|Overall Study|Consent withdrawn by participant|13
4809683|NCT01247324|16585951|P2|Overall Study|Reason not specified|8
4809684|NCT01247324|16585952|P1|Overall Study|Reason not specified|11
4809685|NCT01247324|16585951|P2|Overall Study|Protocol Violation|2
4809686|NCT01247324|16585952|P1|Overall Study|Protocol Violation|1
4809687|NCT01247324|16585951|P2|Overall Study|Pregnancy|3
4809688|NCT01247324|16585952|P1|Overall Study|Pregnancy|2
4809689|NCT01247324|16585951|P2|Overall Study|Non-compliance|0
4809690|NCT01247324|16585952|P1|Overall Study|Non-compliance|2
4809691|NCT01247324|16585951|P2|Overall Study|Lack of Efficacy|8
4809692|NCT01247324|16585952|P1|Overall Study|Lack of Efficacy|12
4809693|NCT01247324|16585951|P2|Overall Study|Non-compliance with study drug|0
4809694|NCT01247324|16585952|P1|Overall Study|Non-compliance with study drug|3
4809695|NCT01247324|16585951|P2|Overall Study|Physician Decision|1
4809696|NCT01247324|16585952|P1|Overall Study|Physician Decision|0
4809697|NCT01247324|16585951|P2|Overall Study|Death|0
4809698|NCT01247324|16585952|P1|Overall Study|Death|1
4809699|NCT01247090|16586045|P3|Overall Study|Withdrawal by Subject|0
4809700|NCT01247090|16586046|P2|Overall Study|Withdrawal by Subject|1
4809701|NCT01247090|16586047|P1|Overall Study|Withdrawal by Subject|0
4809702|NCT01247090|16586045|P3|Overall Study|Physician Decision|0
4809703|NCT01247090|16586046|P2|Overall Study|Physician Decision|0
4809704|NCT01247090|16586047|P1|Overall Study|Physician Decision|1
4809705|NCT01246999|16586076|P4|Overall Study|Withdrawal by Subject|2
4809706|NCT01246999|16586077|P3|Overall Study|Withdrawal by Subject|0
4809707|NCT01246999|16586078|P2|Overall Study|Withdrawal by Subject|0
4809708|NCT01246999|16586079|P1|Overall Study|Withdrawal by Subject|0
4809709|NCT01246999|16586076|P4|Overall Study|Lost to Follow-up|0
4809710|NCT01246999|16586077|P3|Overall Study|Lost to Follow-up|0
4809711|NCT01246999|16586078|P2|Overall Study|Lost to Follow-up|1
4809712|NCT01246999|16586079|P1|Overall Study|Lost to Follow-up|0
4809713|NCT01246986|16586119|P7|Overall Study|Withdrawal by Subject|0
4809714|NCT01246986|16586120|P6|Overall Study|Withdrawal by Subject|0
4809715|NCT01246986|16586121|P5|Overall Study|Withdrawal by Subject|4
4809716|NCT01246986|16586122|P4|Overall Study|Withdrawal by Subject|0
4809717|NCT01246986|16586123|P3|Overall Study|Withdrawal by Subject|3
4809718|NCT01246986|16586124|P2|Overall Study|Withdrawal by Subject|4
4809719|NCT01246986|16586125|P1|Overall Study|Withdrawal by Subject|3
4809720|NCT01246986|16586119|P7|Overall Study|On Treatment|0
4809721|NCT01246986|16586120|P6|Overall Study|On Treatment|0
4809722|NCT01246986|16586121|P5|Overall Study|On Treatment|1
4809723|NCT01246986|16586122|P4|Overall Study|On Treatment|0
4809724|NCT01246986|16586123|P3|Overall Study|On Treatment|0
4809725|NCT01246986|16586124|P2|Overall Study|On Treatment|0
4809726|NCT01246986|16586125|P1|Overall Study|On Treatment|0
4809727|NCT01246986|16586119|P7|Overall Study|Lost to Follow-up|0
4809728|NCT01246986|16586120|P6|Overall Study|Lost to Follow-up|1
4809729|NCT01246986|16586121|P5|Overall Study|Lost to Follow-up|0
4809730|NCT01246986|16586122|P4|Overall Study|Lost to Follow-up|0
4809731|NCT01246986|16586123|P3|Overall Study|Lost to Follow-up|3
4809732|NCT01246986|16586124|P2|Overall Study|Lost to Follow-up|1
4809733|NCT01246986|16586125|P1|Overall Study|Lost to Follow-up|0
4809734|NCT01246973|16586185|P2|Overall Study|Withdrawal by Subject|13
4809735|NCT01246973|16586186|P1|Overall Study|Withdrawal by Subject|7
4809736|NCT01246973|16586185|P2|Overall Study|Adverse Event|9
4809737|NCT01246973|16586186|P1|Overall Study|Adverse Event|16
4809738|NCT01246973|16586185|P2|Overall Study|Other|25
4809739|NCT01246973|16586186|P1|Overall Study|Other|38
4809740|NCT01246960|16586196|P2|Overall Study|Withdrawal (by participant or physician)|3
4809741|NCT01246960|16586197|P1|Overall Study|Withdrawal (by participant or physician)|3
4809742|NCT01246960|16586196|P2|Overall Study|Lost to Follow-up|1
4809743|NCT01246960|16586197|P1|Overall Study|Lost to Follow-up|3
4809744|NCT01246206|16586309|P1|Overall Study|Patient did not receive study regiments.|1
4809745|NCT01246011|16586387|P3|Overall Study|Withdrawal by Subject|1
4809746|NCT01246011|16586388|P2|Overall Study|Withdrawal by Subject|0
4809747|NCT01246011|16586389|P1|Overall Study|Withdrawal by Subject|0
4809748|NCT01246011|16586387|P3|Overall Study|If needed warfarin clinically, withdrawn|3
4809749|NCT01246011|16586388|P2|Overall Study|If needed warfarin clinically, withdrawn|0
4809750|NCT01246011|16586389|P1|Overall Study|If needed warfarin clinically, withdrawn|0
4809751|NCT01245764|16586417|P4|Study Phase A|Lost to Follow-up|0
4809752|NCT01245764|16586418|P3|Study Phase A|Lost to Follow-up|5
4809753|NCT01245764|16586419|P2|Study Phase A|Lost to Follow-up|0
4809754|NCT01245764|16586420|P1|Study Phase A|Lost to Follow-up|0
4809755|NCT01245764|16586417|P4|Study Phase A|Protocol Violation|2
4809756|NCT01245764|16586418|P3|Study Phase A|Protocol Violation|2
4809757|NCT01245764|16586419|P2|Study Phase A|Protocol Violation|3
4809758|NCT01245764|16586420|P1|Study Phase A|Protocol Violation|6
4809759|NCT01245764|16586417|P4|Study Phase A|Other|1
4809760|NCT01245764|16586418|P3|Study Phase A|Other|3
4809761|NCT01245764|16586419|P2|Study Phase A|Other|2
4809762|NCT01245764|16586420|P1|Study Phase A|Other|3
4809763|NCT01245751|16586458|P4|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
4809764|NCT01245751|16586459|P3|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
4809765|NCT01245751|16586460|P2|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4
4809766|NCT01245751|16586461|P1|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0
4809767|NCT01245751|16586458|P4|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2
4809768|NCT01245751|16586459|P3|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
4809769|NCT01245751|16586460|P2|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
4809770|NCT01245751|16586461|P1|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0
4809771|NCT01245751|16586458|P4|Part 1: Day 1 to Week 52 (1 Year)|Death|0
4809772|NCT01245751|16586459|P3|Part 1: Day 1 to Week 52 (1 Year)|Death|0
4809773|NCT01245751|16586460|P2|Part 1: Day 1 to Week 52 (1 Year)|Death|1
4809774|NCT01245751|16586461|P1|Part 1: Day 1 to Week 52 (1 Year)|Death|2
4809775|NCT01245673|16586510|P1|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1
4809776|NCT01245387|16586578|P1|Overall Study|Missing discontinuation status|369
4809777|NCT01245387|16586578|P1|Overall Study|Other|131
4809778|NCT01245387|16586578|P1|Overall Study|Death|3
4809779|NCT01245387|16586578|P1|Overall Study|Adverse Event|9
4809780|NCT01245387|16586578|P1|Overall Study|Lack of Efficacy|195
4809781|NCT01245387|16586578|P1|Overall Study|Lost to Follow-up|106
4809782|NCT01245374|16586627|P1|Overall Study|Withdrawal by Subject|3
4809783|NCT01245374|16586627|P1|Overall Study|Protocol Violation|1
4809784|NCT01245283|16586650|P3|Overall Study|Lost to Follow-up|11
4809785|NCT01245283|16586651|P2|Overall Study|Lost to Follow-up|11
4809786|NCT01245283|16586652|P1|Overall Study|Lost to Follow-up|14
4809787|NCT01245140|16586697|P2|Overall Study|Refused Treatment/Did Not Coopera|1
4809788|NCT01245140|16586698|P1|Overall Study|Refused Treatment/Did Not Coopera|0
4809789|NCT01245140|16586697|P2|Overall Study|Withdrawal by Subject|1
4809790|NCT01245140|16586698|P1|Overall Study|Withdrawal by Subject|0
4809791|NCT01245140|16586697|P2|Overall Study|Protocol Violation|1
4809792|NCT01245140|16586698|P1|Overall Study|Protocol Violation|0
4809793|NCT01245140|16586697|P2|Overall Study|Lack of Efficacy|4
4809794|NCT01245140|16586698|P1|Overall Study|Lack of Efficacy|2
4809795|NCT01245140|16586697|P2|Overall Study|Adverse Event|3
4809796|NCT01245140|16586698|P1|Overall Study|Adverse Event|1
4809797|NCT01245101|16586754|P2|Period 3 (Treatment)|Withdrawal by Subject|0
4809798|NCT01245101|16586755|P1|Period 3 (Treatment)|Withdrawal by Subject|1
4809799|NCT01245101|16586754|P2|Period 2 (Washout)|Withdrawal by Subject|0
4809800|NCT01245101|16586755|P1|Period 2 (Washout)|Withdrawal by Subject|1
4809801|NCT01245101|16586754|P2|Period 1 (Treatment)|Withdrawal by Subject|0
4809802|NCT01245101|16586755|P1|Period 1 (Treatment)|Withdrawal by Subject|2
4809803|NCT01245062|16586765|P3|Cross-over Phase|Study closed/ terminated|11
4809804|NCT01245062|16586766|P2|Cross-over Phase|Study closed/ terminated|0
4809805|NCT01245062|16586767|P1|Cross-over Phase|Study closed/ terminated|0
4809806|NCT01245062|16586765|P3|Cross-over Phase|Withdrew Consent|4
4809807|NCT01245062|16586766|P2|Cross-over Phase|Withdrew Consent|0
4809808|NCT01245062|16586767|P1|Cross-over Phase|Withdrew Consent|0
4809809|NCT01245062|16586765|P3|Cross-over Phase|Physician Decision|1
4809810|NCT01245062|16586766|P2|Cross-over Phase|Physician Decision|0
4809811|NCT01245062|16586767|P1|Cross-over Phase|Physician Decision|0
4809812|NCT01245062|16586765|P3|Cross-over Phase|Lost to Follow-up|1
4809813|NCT01245062|16586766|P2|Cross-over Phase|Lost to Follow-up|0
4809814|NCT01245062|16586767|P1|Cross-over Phase|Lost to Follow-up|0
4809815|NCT01245062|16586765|P3|Randomization and Crossover Phase|Study closed/ terminated|0
4809816|NCT01245062|16586766|P2|Randomization and Crossover Phase|Study closed/ terminated|14
4809817|NCT01245062|16586767|P1|Randomization and Crossover Phase|Study closed/ terminated|23
4809818|NCT01245062|16586765|P3|Randomization and Crossover Phase|Withdrew Consent|0
4809819|NCT01245062|16586766|P2|Randomization and Crossover Phase|Withdrew Consent|11
4809820|NCT01245062|16586767|P1|Randomization and Crossover Phase|Withdrew Consent|12
4809821|NCT01245062|16586765|P3|Randomization and Crossover Phase|Physician Decision|0
4809822|NCT01245062|16586766|P2|Randomization and Crossover Phase|Physician Decision|4
4809823|NCT01245062|16586767|P1|Randomization and Crossover Phase|Physician Decision|2
4809824|NCT01245062|16586765|P3|Randomization and Crossover Phase|Lost to Follow-up|0
4809825|NCT01245062|16586766|P2|Randomization and Crossover Phase|Lost to Follow-up|2
4809826|NCT01245062|16586767|P1|Randomization and Crossover Phase|Lost to Follow-up|4
4809827|NCT01245049|16586805|P2|Overall Study|Lost to Follow-up|2
4809828|NCT01245049|16586806|P1|Overall Study|Lost to Follow-up|1
4809829|NCT01245049|16586805|P2|Overall Study|Withdrawal by Subject|1
4809830|NCT01245049|16586806|P1|Overall Study|Withdrawal by Subject|0
4809831|NCT01245049|16586805|P2|Overall Study|Migrated/moved from study area|1
4809832|NCT01245049|16586806|P1|Overall Study|Migrated/moved from study area|0
4809833|NCT01244984|16586859|P3|Overall Study|Withdrawal by Subject|2
4809834|NCT01244984|16586860|P2|Overall Study|Withdrawal by Subject|2
4809835|NCT01244984|16586861|P1|Overall Study|Withdrawal by Subject|1
4809836|NCT01244984|16586859|P3|Overall Study|Protocol Defined Stopping Criteria|0
4809837|NCT01244984|16586860|P2|Overall Study|Protocol Defined Stopping Criteria|1
4809838|NCT01244984|16586861|P1|Overall Study|Protocol Defined Stopping Criteria|1
4809839|NCT01244984|16586859|P3|Overall Study|Protocol Violation|0
4809840|NCT01244984|16586860|P2|Overall Study|Protocol Violation|0
4809841|NCT01244984|16586861|P1|Overall Study|Protocol Violation|1
4809842|NCT01244984|16586859|P3|Overall Study|Adverse Event|2
4809843|NCT01244984|16586860|P2|Overall Study|Adverse Event|11
4809844|NCT01244984|16586861|P1|Overall Study|Adverse Event|2
4809845|NCT01244906|16586935|P1|Overall Study|Progression of disease post treatment|6
4809846|NCT01244906|16586935|P1|Overall Study|Death|2
4809847|NCT01244893|16586944|P2|1-Week Follow Up|Lost to Follow-up|0
4809848|NCT01244893|16586945|P1|1-Week Follow Up|Lost to Follow-up|1
4809849|NCT01244893|16586944|P2|Baseline|Protocol Violation|1
4809850|NCT01244893|16586945|P1|Baseline|Protocol Violation|0
4809851|NCT01244828|16586957|P1|Overall Study|Other reason (not specified)|1
4809852|NCT01244828|16586957|P1|Overall Study|Lost to Follow-up|2
4809853|NCT01244828|16586957|P1|Overall Study|Lack of Efficacy|7
4809854|NCT01244828|16586957|P1|Overall Study|Withdrawal by Subject|31
4809855|NCT01244828|16586957|P1|Overall Study|Adverse Event|37
4809856|NCT01244815|16586973|P4|Overall Study|Did Not Meet Protocol Eligibility|0
4809857|NCT01244815|16586974|P3|Overall Study|Did Not Meet Protocol Eligibility|0
4809858|NCT01244815|16586975|P2|Overall Study|Did Not Meet Protocol Eligibility|1
4809859|NCT01244815|16586976|P1|Overall Study|Did Not Meet Protocol Eligibility|0
4809860|NCT01244815|16586973|P4|Overall Study|Protocol Violation|1
4809861|NCT01244815|16586974|P3|Overall Study|Protocol Violation|3
4809862|NCT01244815|16586975|P2|Overall Study|Protocol Violation|4
4809863|NCT01244815|16586976|P1|Overall Study|Protocol Violation|7
4809864|NCT01244815|16586973|P4|Overall Study|Withdrawal by Subject|3
4809865|NCT01244815|16586974|P3|Overall Study|Withdrawal by Subject|0
4809866|NCT01244815|16586975|P2|Overall Study|Withdrawal by Subject|2
4809867|NCT01244815|16586976|P1|Overall Study|Withdrawal by Subject|0
4809868|NCT01244815|16586973|P4|Overall Study|Lost to Follow-up|2
4809869|NCT01244815|16586974|P3|Overall Study|Lost to Follow-up|3
4809870|NCT01244815|16586975|P2|Overall Study|Lost to Follow-up|2
4809871|NCT01244815|16586976|P1|Overall Study|Lost to Follow-up|3
4809872|NCT01244815|16586973|P4|Overall Study|Treatment Failure|1
4809873|NCT01244815|16586974|P3|Overall Study|Treatment Failure|0
4809874|NCT01244815|16586975|P2|Overall Study|Treatment Failure|0
4809875|NCT01244815|16586976|P1|Overall Study|Treatment Failure|0
4809876|NCT01244815|16586973|P4|Overall Study|Adverse Event|5
4809877|NCT01244815|16586974|P3|Overall Study|Adverse Event|5
4809878|NCT01244815|16586975|P2|Overall Study|Adverse Event|7
4809879|NCT01244815|16586976|P1|Overall Study|Adverse Event|4
4809880|NCT01244815|16586973|P4|Overall Study|Not Treated|0
4809881|NCT01244815|16586974|P3|Overall Study|Not Treated|0
4809882|NCT01244815|16586975|P2|Overall Study|Not Treated|1
4809883|NCT01244815|16586976|P1|Overall Study|Not Treated|0
4809884|NCT01244620|16587063|P4|Overall Study|Study terminated|4
4809885|NCT01244620|16587064|P3|Overall Study|Study terminated|4
4809886|NCT01244620|16587065|P2|Overall Study|Study terminated|4
4809887|NCT01244620|16587066|P1|Overall Study|Study terminated|4
4809888|NCT01244516|16587125|P3|Period 2 (1-week to 2-week Visit)|Poor Comfort|1
4809889|NCT01244516|16587126|P2|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
4809890|NCT01244516|16587127|P1|Period 2 (1-week to 2-week Visit)|Poor Comfort|0
4809891|NCT01244516|16587125|P3|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
4809892|NCT01244516|16587126|P2|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1
4809893|NCT01244516|16587127|P1|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0
4809894|NCT01244516|16587125|P3|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
4809895|NCT01244516|16587126|P2|Period 2 (1-week to 2-week Visit)|Protocol Violation|0
4809896|NCT01244516|16587127|P1|Period 2 (1-week to 2-week Visit)|Protocol Violation|1
4809897|NCT01244516|16587125|P3|Period 2 (1-week to 2-week Visit)|Adverse Event|0
4809898|NCT01244516|16587126|P2|Period 2 (1-week to 2-week Visit)|Adverse Event|0
4809899|NCT01244516|16587127|P1|Period 2 (1-week to 2-week Visit)|Adverse Event|2
4809900|NCT01244516|16587125|P3|Period 1 (Baseline to 1-week Visit)|Poor comfort|1
4809901|NCT01244516|16587126|P2|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
4809902|NCT01244516|16587127|P1|Period 1 (Baseline to 1-week Visit)|Poor comfort|0
4809903|NCT01244516|16587125|P3|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
4809904|NCT01244516|16587126|P2|Period 1 (Baseline to 1-week Visit)|Poor Vision|1
4809905|NCT01244516|16587127|P1|Period 1 (Baseline to 1-week Visit)|Poor Vision|0
4809906|NCT01244516|16587125|P3|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2
4809907|NCT01244516|16587126|P2|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5
4809908|NCT01244516|16587127|P1|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4
4809909|NCT01244490|16587148|P3|Overall Study|Other|1
4809910|NCT01244490|16587149|P2|Overall Study|Other|0
4809911|NCT01244490|16587150|P1|Overall Study|Other|0
4809912|NCT01244490|16587148|P3|Overall Study|Lost to Follow-up|3
4809913|NCT01244490|16587149|P2|Overall Study|Lost to Follow-up|6
4809914|NCT01244490|16587150|P1|Overall Study|Lost to Follow-up|0
4809915|NCT01244490|16587148|P3|Overall Study|Adverse Event|5
4809916|NCT01244490|16587149|P2|Overall Study|Adverse Event|9
4809917|NCT01244490|16587150|P1|Overall Study|Adverse Event|1
4809918|NCT01244490|16587148|P3|Overall Study|Withdrawal by Subject|9
4809919|NCT01244490|16587149|P2|Overall Study|Withdrawal by Subject|4
4809920|NCT01244490|16587150|P1|Overall Study|Withdrawal by Subject|4
4809921|NCT01244490|16587148|P3|Overall Study|Lack of Efficacy|5
4809922|NCT01244490|16587149|P2|Overall Study|Lack of Efficacy|5
4809923|NCT01244490|16587150|P1|Overall Study|Lack of Efficacy|14
4809924|NCT01244425|16587227|P2|Overall Study|Adverse Event|1
4809925|NCT01244425|16587228|P1|Overall Study|Adverse Event|1
4809926|NCT01244425|16587227|P2|Overall Study|Withdrawal by Subject|2
4809927|NCT01244425|16587228|P1|Overall Study|Withdrawal by Subject|2
4809928|NCT01244126|16587260|P3|Overall Study|Protocol Violation|9
4809929|NCT01244126|16587261|P2|Overall Study|Protocol Violation|3
4809930|NCT01244126|16587262|P1|Overall Study|Protocol Violation|3
4809931|NCT01244061|16587275|P2|Overall Study|Randomized but not treated|2
4809932|NCT01244061|16587276|P1|Overall Study|Randomized but not treated|2
4809933|NCT01244061|16587275|P2|Overall Study|Adverse Event|2
4809934|NCT01244061|16587276|P1|Overall Study|Adverse Event|5
4809935|NCT01244061|16587275|P2|Overall Study|Protocol Violation|1
4809936|NCT01244061|16587276|P1|Overall Study|Protocol Violation|1
4809937|NCT01244061|16587275|P2|Overall Study|Other|19
4809938|NCT01244061|16587276|P1|Overall Study|Other|8
4809939|NCT01244061|16587275|P2|Overall Study|Withdrawal by Subject|46
4809940|NCT01244061|16587276|P1|Overall Study|Withdrawal by Subject|29
4809941|NCT01244061|16587275|P2|Overall Study|Lost to Follow-up|30
4809942|NCT01244061|16587276|P1|Overall Study|Lost to Follow-up|34
4809943|NCT01244061|16587275|P2|Overall Study|Lack of Efficacy|3
4809944|NCT01244061|16587276|P1|Overall Study|Lack of Efficacy|1
4809945|NCT01244061|16587275|P2|Overall Study|Did not meet entrance criteria|0
4809946|NCT01244061|16587276|P1|Overall Study|Did not meet entrance criteria|1
4809947|NCT01244061|16587275|P2|Overall Study|Death|0
4809948|NCT01244061|16587276|P1|Overall Study|Death|1
4809949|NCT01244035|16587288|P6|Part 1: Period 3|Protocol Deviation|0
4809950|NCT01244035|16587289|P5|Part 1: Period 3|Protocol Deviation|0
4809951|NCT01244035|16587290|P4|Part 1: Period 3|Protocol Deviation|0
4809952|NCT01244035|16587291|P3|Part 1: Period 3|Protocol Deviation|0
4809953|NCT01244035|16587292|P2|Part 1: Period 3|Protocol Deviation|1
4809954|NCT01244035|16587293|P1|Part 1: Period 3|Protocol Deviation|0
4809955|NCT01244035|16587288|P6|Part 1: Period 3|Withdrawal by Subject|0
4809956|NCT01244035|16587289|P5|Part 1: Period 3|Withdrawal by Subject|1
4809957|NCT01244035|16587290|P4|Part 1: Period 3|Withdrawal by Subject|0
4809958|NCT01244035|16587291|P3|Part 1: Period 3|Withdrawal by Subject|0
4809959|NCT01244035|16587292|P2|Part 1: Period 3|Withdrawal by Subject|0
4809960|NCT01244035|16587293|P1|Part 1: Period 3|Withdrawal by Subject|0
4809961|NCT01244035|16587288|P6|Part 1: Period 3|Adverse Event|1
4809962|NCT01244035|16587289|P5|Part 1: Period 3|Adverse Event|0
4809963|NCT01244035|16587290|P4|Part 1: Period 3|Adverse Event|0
4809964|NCT01244035|16587291|P3|Part 1: Period 3|Adverse Event|0
4809965|NCT01244035|16587292|P2|Part 1: Period 3|Adverse Event|0
4809966|NCT01244035|16587293|P1|Part 1: Period 3|Adverse Event|0
4809967|NCT01244035|16587288|P6|Part 1: Period 2|Fulfilled Stopping Criteria|0
4809968|NCT01244035|16587289|P5|Part 1: Period 2|Fulfilled Stopping Criteria|0
4809969|NCT01244035|16587290|P4|Part 1: Period 2|Fulfilled Stopping Criteria|0
4809970|NCT01244035|16587291|P3|Part 1: Period 2|Fulfilled Stopping Criteria|1
4809971|NCT01244035|16587292|P2|Part 1: Period 2|Fulfilled Stopping Criteria|0
4809972|NCT01244035|16587293|P1|Part 1: Period 2|Fulfilled Stopping Criteria|0
4809973|NCT01244035|16587288|P6|Part 1: Period 1|Fulfilled Stopping Criteria|1
4809974|NCT01244035|16587289|P5|Part 1: Period 1|Fulfilled Stopping Criteria|1
4809975|NCT01244035|16587290|P4|Part 1: Period 1|Fulfilled Stopping Criteria|0
4809976|NCT01244035|16587291|P3|Part 1: Period 1|Fulfilled Stopping Criteria|2
4809977|NCT01244035|16587292|P2|Part 1: Period 1|Fulfilled Stopping Criteria|0
4809978|NCT01244035|16587293|P1|Part 1: Period 1|Fulfilled Stopping Criteria|1
4809979|NCT01244035|16587288|P6|Part 1: Period 1|Withdrawal by Subject|0
4809980|NCT01244035|16587289|P5|Part 1: Period 1|Withdrawal by Subject|0
4809981|NCT01244035|16587290|P4|Part 1: Period 1|Withdrawal by Subject|0
4809982|NCT01244035|16587291|P3|Part 1: Period 1|Withdrawal by Subject|0
4809983|NCT01244035|16587292|P2|Part 1: Period 1|Withdrawal by Subject|2
4809984|NCT01244035|16587293|P1|Part 1: Period 1|Withdrawal by Subject|0
4809985|NCT01244035|16587288|P6|Part 1: Period 1|Adverse Event|1
4809986|NCT01244035|16587289|P5|Part 1: Period 1|Adverse Event|0
4809987|NCT01244035|16587290|P4|Part 1: Period 1|Adverse Event|0
4809988|NCT01244035|16587291|P3|Part 1: Period 1|Adverse Event|0
4809989|NCT01244035|16587292|P2|Part 1: Period 1|Adverse Event|0
4809990|NCT01244035|16587293|P1|Part 1: Period 1|Adverse Event|0
4809991|NCT01243944|16587334|P2|Overall Study|Non-compliance with study treatment|0
4809992|NCT01243944|16587335|P1|Overall Study|Non-compliance with study treatment|1
4809993|NCT01243944|16587334|P2|Overall Study|Death|3
4809994|NCT01243944|16587335|P1|Overall Study|Death|2
4809995|NCT01243944|16587334|P2|Overall Study|Participant decision|15
4809996|NCT01243944|16587335|P1|Overall Study|Participant decision|10
4809997|NCT01243944|16587334|P2|Overall Study|Protocol deviation|1
4809998|NCT01243944|16587335|P1|Overall Study|Protocol deviation|1
4809999|NCT01243944|16587334|P2|Overall Study|Disease progression|11
4810000|NCT01243944|16587335|P1|Overall Study|Disease progression|12
4810001|NCT01243944|16587334|P2|Overall Study|Physician Decision|7
4810002|NCT01243944|16587335|P1|Overall Study|Physician Decision|2
4810003|NCT01243944|16587334|P2|Overall Study|Lost to Follow-up|1
4810004|NCT01243944|16587335|P1|Overall Study|Lost to Follow-up|2
4810005|NCT01243944|16587334|P2|Overall Study|Adverse Event|13
4810006|NCT01243944|16587335|P1|Overall Study|Adverse Event|15
4810007|NCT01243892|16587363|P2|Overall Study|Did not meet eligibility criteria|0
4810008|NCT01243892|16587364|P1|Overall Study|Did not meet eligibility criteria|2
4810009|NCT01243775|16587374|P1|Overall Study|Withdrawal by Subject|2
4810010|NCT01243762|16587388|P7|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4810011|NCT01243762|16587389|P6|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4810012|NCT01243762|16587390|P5|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
4810013|NCT01243762|16587391|P4|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1
4810014|NCT01243762|16587392|P3|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4810015|NCT01243762|16587393|P2|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4810016|NCT01243762|16587394|P1|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0
4810017|NCT01243762|16587388|P7|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4810018|NCT01243762|16587389|P6|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4810019|NCT01243762|16587390|P5|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
4810020|NCT01243762|16587391|P4|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4810021|NCT01243762|16587392|P3|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4810022|NCT01243762|16587393|P2|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1
4810023|NCT01243762|16587394|P1|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0
4810024|NCT01243762|16587388|P7|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
4810025|NCT01243762|16587389|P6|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
4810026|NCT01243762|16587390|P5|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2
4810027|NCT01243762|16587391|P4|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
4810028|NCT01243762|16587392|P3|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0
4810029|NCT01243762|16587393|P2|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3
4810030|NCT01243762|16587394|P1|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1
4810031|NCT01243762|16587388|P7|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3
4810032|NCT01243762|16587389|P6|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4810033|NCT01243762|16587390|P5|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4810034|NCT01243762|16587391|P4|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4810035|NCT01243762|16587392|P3|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4810036|NCT01243762|16587393|P2|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1
4810037|NCT01243762|16587394|P1|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0
4810038|NCT01243762|16587388|P7|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4810039|NCT01243762|16587389|P6|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4810040|NCT01243762|16587390|P5|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4810041|NCT01243762|16587391|P4|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4810042|NCT01243762|16587392|P3|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4810043|NCT01243762|16587393|P2|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3
4810044|NCT01243762|16587394|P1|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0
4810045|NCT01243762|16587388|P7|Part 1 (Dose Escalation/MTD)|Progressive Disease|0
4810046|NCT01243762|16587389|P6|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
4810047|NCT01243762|16587390|P5|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
4810048|NCT01243762|16587391|P4|Part 1 (Dose Escalation/MTD)|Progressive Disease|5
4810049|NCT01243762|16587392|P3|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
4810050|NCT01243762|16587393|P2|Part 1 (Dose Escalation/MTD)|Progressive Disease|2
4810051|NCT01243762|16587394|P1|Part 1 (Dose Escalation/MTD)|Progressive Disease|3
4810052|NCT01243762|16587388|P7|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4810053|NCT01243762|16587389|P6|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4810054|NCT01243762|16587390|P5|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4810055|NCT01243762|16587391|P4|Part 1 (Dose Escalation/MTD)|Physician Decision|1
4810056|NCT01243762|16587392|P3|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4810057|NCT01243762|16587393|P2|Part 1 (Dose Escalation/MTD)|Physician Decision|1
4810138|NCT01243151|16587696|P2|Overall Study|Randomized but not treated|0
4810058|NCT01243762|16587394|P1|Part 1 (Dose Escalation/MTD)|Physician Decision|0
4810059|NCT01243762|16587388|P7|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4810060|NCT01243762|16587389|P6|Part 1 (Dose Escalation/MTD)|Adverse Event|1
4810061|NCT01243762|16587390|P5|Part 1 (Dose Escalation/MTD)|Adverse Event|1
4810062|NCT01243762|16587391|P4|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4810063|NCT01243762|16587392|P3|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4810064|NCT01243762|16587393|P2|Part 1 (Dose Escalation/MTD)|Adverse Event|2
4810065|NCT01243762|16587394|P1|Part 1 (Dose Escalation/MTD)|Adverse Event|0
4810066|NCT01243671|16587413|P1|Overall Study|Other|1
4810067|NCT01243671|16587413|P1|Overall Study|Anti-adalimumab antibody positive|1
4810068|NCT01243671|16587413|P1|Overall Study|Adverse Event|3
4810069|NCT01243424|16587492|P2|Discontinuation From Treatment|Other than listed above|211
4810070|NCT01243424|16587493|P1|Discontinuation From Treatment|Other than listed above|230
4810071|NCT01243424|16587492|P2|Discontinuation From Treatment|Withdrawal by Subject|328
4810072|NCT01243424|16587493|P1|Discontinuation From Treatment|Withdrawal by Subject|309
4810073|NCT01243424|16587492|P2|Discontinuation From Treatment|Lost to Follow-up|28
4810074|NCT01243424|16587493|P1|Discontinuation From Treatment|Lost to Follow-up|24
4810075|NCT01243424|16587492|P2|Discontinuation From Treatment|Protocol Violation|47
4810076|NCT01243424|16587493|P1|Discontinuation From Treatment|Protocol Violation|46
4810077|NCT01243424|16587492|P2|Discontinuation From Treatment|Lack of Efficacy|41
4810078|NCT01243424|16587493|P1|Discontinuation From Treatment|Lack of Efficacy|61
4810079|NCT01243424|16587492|P2|Discontinuation From Treatment|Adverse Event|523
4810080|NCT01243424|16587493|P1|Discontinuation From Treatment|Adverse Event|457
4810081|NCT01243424|16587492|P2|Discontinuation From Treatment|Not treated|4
4810082|NCT01243424|16587493|P1|Discontinuation From Treatment|Not treated|5
4810083|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|Not treated|4
4810084|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|Not treated|5
4810085|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
4810086|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8
4810087|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35
4810088|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38
4810089|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1
4810090|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0
4810091|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22
4810092|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15
4810093|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12
4810094|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14
4810095|NCT01243424|16587492|P2|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37
4810096|NCT01243424|16587493|P1|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49
4810097|NCT01243411|16587535|P1|Overall Study|Other|8
4810098|NCT01243411|16587535|P1|Overall Study|Adverse Event|5
4810099|NCT01243411|16587535|P1|Overall Study|Lost to Follow-up|10
4810100|NCT01243411|16587535|P1|Overall Study|Withdrawal by Subject|18
4810101|NCT01243268|16587646|P1|Overall Study|Duplicate subject|2
4810102|NCT01243268|16587646|P1|Overall Study|Deviation with contract date|7
4810103|NCT01243268|16587646|P1|Overall Study|Protocol Violation|51
4810104|NCT01243268|16587646|P1|Overall Study|Lost to Follow-up|4
4810105|NCT01243242|16587656|P2|Overall Study|non compliance|0
4810106|NCT01243242|16587657|P1|Overall Study|non compliance|1
4810107|NCT01243242|16587656|P2|Overall Study|sponsor decision|1
4810108|NCT01243242|16587657|P1|Overall Study|sponsor decision|0
4810109|NCT01243242|16587656|P2|Overall Study|Physician Decision|1
4810110|NCT01243242|16587657|P1|Overall Study|Physician Decision|0
4810111|NCT01243242|16587656|P2|Overall Study|Withdrawal by Subject|1
4810112|NCT01243242|16587657|P1|Overall Study|Withdrawal by Subject|1
4810113|NCT01243242|16587656|P2|Overall Study|Adverse Event|1
4810114|NCT01243242|16587657|P1|Overall Study|Adverse Event|1
4810115|NCT01243177|16587671|P2|Overall Study|Other Reason|12
4810116|NCT01243177|16587672|P1|Overall Study|Other Reason|11
4810117|NCT01243177|16587671|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
4810118|NCT01243177|16587672|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4810119|NCT01243177|16587671|P2|Overall Study|SAE, fatal + SAE, non-fatal|0
4810120|NCT01243177|16587672|P1|Overall Study|SAE, fatal + SAE, non-fatal|1
4810121|NCT01243177|16587671|P2|Overall Study|AE, non-serious non-fatal|58
4810122|NCT01243177|16587672|P1|Overall Study|AE, non-serious non-fatal|40
4810123|NCT01243177|16587671|P2|Overall Study|SAE, non-fatal|9
4810124|NCT01243177|16587672|P1|Overall Study|SAE, non-fatal|7
4810125|NCT01243177|16587671|P2|Overall Study|AE, serious fatal|1
4810126|NCT01243177|16587672|P1|Overall Study|AE, serious fatal|0
4810127|NCT01243177|16587671|P2|Overall Study|Withdrawal by Subject|38
4810128|NCT01243177|16587672|P1|Overall Study|Withdrawal by Subject|46
4810129|NCT01243177|16587671|P2|Overall Study|Lost to Follow-up|18
4810130|NCT01243177|16587672|P1|Overall Study|Lost to Follow-up|15
4810131|NCT01243177|16587671|P2|Overall Study|Protocol Violation|10
4810132|NCT01243177|16587672|P1|Overall Study|Protocol Violation|11
4810133|NCT01243177|16587671|P2|Overall Study|Lack of Efficacy|31
4810134|NCT01243177|16587672|P1|Overall Study|Lack of Efficacy|47
4810135|NCT01243151|16587693|P5|Overall Study|Randomized but not treated|0
4810136|NCT01243151|16587694|P4|Overall Study|Randomized but not treated|1
4810137|NCT01243151|16587695|P3|Overall Study|Randomized but not treated|0
4810139|NCT01243151|16587697|P1|Overall Study|Randomized but not treated|0
4810140|NCT01243151|16587693|P5|Overall Study|Other|0
4810141|NCT01243151|16587694|P4|Overall Study|Other|1
4810142|NCT01243151|16587695|P3|Overall Study|Other|0
4810143|NCT01243151|16587696|P2|Overall Study|Other|0
4810144|NCT01243151|16587697|P1|Overall Study|Other|0
4810145|NCT01243151|16587693|P5|Overall Study|Protocol Violation|0
4810146|NCT01243151|16587694|P4|Overall Study|Protocol Violation|0
4810147|NCT01243151|16587695|P3|Overall Study|Protocol Violation|1
4810148|NCT01243151|16587696|P2|Overall Study|Protocol Violation|0
4810149|NCT01243151|16587697|P1|Overall Study|Protocol Violation|0
4810150|NCT01243151|16587693|P5|Overall Study|Adverse Event|0
4810151|NCT01243151|16587694|P4|Overall Study|Adverse Event|0
4810152|NCT01243151|16587695|P3|Overall Study|Adverse Event|0
4810153|NCT01243151|16587696|P2|Overall Study|Adverse Event|1
4810154|NCT01243151|16587697|P1|Overall Study|Adverse Event|0
4810155|NCT01242813|16587941|P1|Overall Study|Lost to Follow-up|2
4810156|NCT01242748|16587963|P2|Overall Study|Miscellaneous reasons|3
4810157|NCT01242748|16587964|P1|Overall Study|Miscellaneous reasons|8
4810158|NCT01242748|16587963|P2|Overall Study|Withdrawal by Subject|2
4810159|NCT01242748|16587964|P1|Overall Study|Withdrawal by Subject|10
4810160|NCT01242748|16587963|P2|Overall Study|Protocol Violation|0
4810161|NCT01242748|16587964|P1|Overall Study|Protocol Violation|1
4810162|NCT01242748|16587963|P2|Overall Study|Physician Decision|2
4810163|NCT01242748|16587964|P1|Overall Study|Physician Decision|3
4810164|NCT01242748|16587963|P2|Overall Study|Lost to Follow-up|2
4810165|NCT01242748|16587964|P1|Overall Study|Lost to Follow-up|6
4810166|NCT01242748|16587963|P2|Overall Study|Adverse Event|5
4810167|NCT01242748|16587964|P1|Overall Study|Adverse Event|10
4810168|NCT01242514|16588004|P3|Overall Study|Adverse Event|19
4810169|NCT01242514|16588005|P2|Overall Study|Adverse Event|18
4810170|NCT01242514|16588006|P1|Overall Study|Adverse Event|129
4810171|NCT01242514|16588004|P3|Overall Study|Lost to Follow-up|4
4810172|NCT01242514|16588005|P2|Overall Study|Lost to Follow-up|5
4810173|NCT01242514|16588006|P1|Overall Study|Lost to Follow-up|14
4810174|NCT01242514|16588004|P3|Overall Study|Dev. of study specific discont. criteria|5
4810175|NCT01242514|16588005|P2|Overall Study|Dev. of study specific discont. criteria|3
4810176|NCT01242514|16588006|P1|Overall Study|Dev. of study specific discont. criteria|21
4810177|NCT01242514|16588004|P3|Overall Study|Lack of therapeutic response|10
4810178|NCT01242514|16588005|P2|Overall Study|Lack of therapeutic response|16
4810179|NCT01242514|16588006|P1|Overall Study|Lack of therapeutic response|99
4810180|NCT01242514|16588004|P3|Overall Study|Severe non-compliance to protocol|1
4810181|NCT01242514|16588005|P2|Overall Study|Severe non-compliance to protocol|2
4810182|NCT01242514|16588006|P1|Overall Study|Severe non-compliance to protocol|5
4810183|NCT01242514|16588004|P3|Overall Study|Subject decision|2
4810184|NCT01242514|16588005|P2|Overall Study|Subject decision|8
4810185|NCT01242514|16588006|P1|Overall Study|Subject decision|33
4810186|NCT01242514|16588004|P3|Overall Study|e.g., project closure|171
4810187|NCT01242514|16588005|P2|Overall Study|e.g., project closure|305
4810188|NCT01242514|16588006|P1|Overall Study|e.g., project closure|1042
4810189|NCT01242371|16588025|P2|Overall Study|Protocol Violation|3
4810190|NCT01242371|16588026|P1|Overall Study|Protocol Violation|0
4810191|NCT01242371|16588025|P2|Overall Study|Withdrawal by Subject|2
4810192|NCT01242371|16588026|P1|Overall Study|Withdrawal by Subject|2
4810193|NCT01242176|16588032|P2|Washout Period of 7 Days|Non-compliant with protocol|0
4810194|NCT01242176|16588033|P1|Washout Period of 7 Days|Non-compliant with protocol|1
4810195|NCT01242176|16588032|P2|Washout Period of 7 Days|Adverse Event|2
4810196|NCT01242176|16588033|P1|Washout Period of 7 Days|Adverse Event|0
4810197|NCT01242111|16588043|P1|Overall Study|Did not consent to MOR-100 follow-up|1
4810198|NCT01242111|16588043|P1|Overall Study|Withdrawal by Subject|1
4810199|NCT01242111|16588043|P1|Overall Study|Adverse Event|1
4810200|NCT01242085|16588055|P3|Overall Study|medically unable to have surgery|0
4810201|NCT01242085|16588056|P2|Overall Study|medically unable to have surgery|5
4810202|NCT01242085|16588057|P1|Overall Study|medically unable to have surgery|4
4810203|NCT01242085|16588055|P3|Overall Study|Withdrawal by Subject|0
4810204|NCT01242085|16588056|P2|Overall Study|Withdrawal by Subject|2
4810205|NCT01242085|16588057|P1|Overall Study|Withdrawal by Subject|4
4810206|NCT01242020|16588067|P2|Overall Study|Failed screening|0
4810207|NCT01242020|16588068|P1|Overall Study|Failed screening|1
4810208|NCT01242020|16588067|P2|Overall Study|Withdrawal by Subject|0
4810209|NCT01242020|16588068|P1|Overall Study|Withdrawal by Subject|2
4810210|NCT01241760|16588098|P2|Overall Study|Other|1
4810211|NCT01241760|16588099|P1|Overall Study|Other|1
4810212|NCT01241760|16588098|P2|Overall Study|Switch To Commercially Available Medicat|4
4810213|NCT01241760|16588099|P1|Overall Study|Switch To Commercially Available Medicat|1
4810214|NCT01241760|16588098|P2|Overall Study|Withdrawal by Subject|13
4810215|NCT01241760|16588099|P1|Overall Study|Withdrawal by Subject|13
4810216|NCT01241760|16588098|P2|Overall Study|Lost to Follow-up|22
4810217|NCT01241760|16588099|P1|Overall Study|Lost to Follow-up|18
4810218|NCT01241760|16588098|P2|Overall Study|Adverse Event|0
4810219|NCT01241760|16588099|P1|Overall Study|Adverse Event|1
4810220|NCT01241604|16588118|P3|Screening Period|Screen Failure|0
4810221|NCT01241604|16588119|P2|Screening Period|Screen Failure|0
4810222|NCT01241604|16588120|P1|Screening Period|Screen Failure|3
4810223|NCT01241591|16588165|P4|Overall Study|Adverse Event|4
4810224|NCT01241591|16588166|P3|Overall Study|Adverse Event|12
4810225|NCT01241591|16588167|P2|Overall Study|Adverse Event|11
4810226|NCT01241591|16588168|P1|Overall Study|Adverse Event|3
4810227|NCT01241591|16588165|P4|Overall Study|Other|1
4810228|NCT01241591|16588166|P3|Overall Study|Other|0
4810229|NCT01241591|16588167|P2|Overall Study|Other|1
4810230|NCT01241591|16588168|P1|Overall Study|Other|0
4810231|NCT01241591|16588165|P4|Overall Study|Withdrawal by Subject|2
4810232|NCT01241591|16588166|P3|Overall Study|Withdrawal by Subject|2
4810233|NCT01241591|16588167|P2|Overall Study|Withdrawal by Subject|4
4810234|NCT01241591|16588168|P1|Overall Study|Withdrawal by Subject|6
4810235|NCT01241591|16588165|P4|Overall Study|Screen Failure|0
4810236|NCT01241591|16588166|P3|Overall Study|Screen Failure|1
4810237|NCT01241591|16588167|P2|Overall Study|Screen Failure|2
4810238|NCT01241591|16588168|P1|Overall Study|Screen Failure|3
4810239|NCT01241591|16588165|P4|Overall Study|Lost to Follow-up|2
4810240|NCT01241591|16588166|P3|Overall Study|Lost to Follow-up|2
4810241|NCT01241591|16588167|P2|Overall Study|Lost to Follow-up|2
4810242|NCT01241591|16588168|P1|Overall Study|Lost to Follow-up|1
4810243|NCT01241591|16588165|P4|Overall Study|Protocol Violation|0
4810244|NCT01241591|16588166|P3|Overall Study|Protocol Violation|3
4810245|NCT01241591|16588167|P2|Overall Study|Protocol Violation|2
4810246|NCT01241591|16588168|P1|Overall Study|Protocol Violation|5
4810247|NCT01241591|16588165|P4|Overall Study|Lack of Efficacy|3
4810248|NCT01241591|16588166|P3|Overall Study|Lack of Efficacy|2
4810249|NCT01241591|16588167|P2|Overall Study|Lack of Efficacy|2
4810250|NCT01241591|16588168|P1|Overall Study|Lack of Efficacy|5
4810251|NCT01241552|16588371|P4|Overall Study|Lost to Follow-up|16
4810252|NCT01241552|16588372|P3|Overall Study|Lost to Follow-up|15
4810253|NCT01241552|16588373|P2|Overall Study|Lost to Follow-up|11
4810254|NCT01241552|16588374|P1|Overall Study|Lost to Follow-up|2
4810255|NCT01241552|16588371|P4|Overall Study|Physician Decision|3
4810256|NCT01241552|16588372|P3|Overall Study|Physician Decision|2
4810257|NCT01241552|16588373|P2|Overall Study|Physician Decision|4
4810258|NCT01241552|16588374|P1|Overall Study|Physician Decision|2
4810259|NCT01241552|16588371|P4|Overall Study|Withdrawal by Subject|15
4810260|NCT01241552|16588372|P3|Overall Study|Withdrawal by Subject|14
4810261|NCT01241552|16588373|P2|Overall Study|Withdrawal by Subject|15
4810262|NCT01241552|16588374|P1|Overall Study|Withdrawal by Subject|7
4810263|NCT01241552|16588371|P4|Overall Study|Protocol Violation|1
4810264|NCT01241552|16588372|P3|Overall Study|Protocol Violation|6
4810265|NCT01241552|16588373|P2|Overall Study|Protocol Violation|2
4810266|NCT01241552|16588374|P1|Overall Study|Protocol Violation|0
4810267|NCT01241552|16588371|P4|Overall Study|Progressive Disease|2
4810268|NCT01241552|16588372|P3|Overall Study|Progressive Disease|1
4810269|NCT01241552|16588373|P2|Overall Study|Progressive Disease|0
4810270|NCT01241552|16588374|P1|Overall Study|Progressive Disease|0
4810271|NCT01241552|16588371|P4|Overall Study|Technical Problems|2
4810272|NCT01241552|16588372|P3|Overall Study|Technical Problems|2
4810273|NCT01241552|16588373|P2|Overall Study|Technical Problems|0
4810274|NCT01241552|16588374|P1|Overall Study|Technical Problems|2
4810275|NCT01241552|16588371|P4|Overall Study|Adverse Event|0
4810276|NCT01241552|16588372|P3|Overall Study|Adverse Event|0
4810277|NCT01241552|16588373|P2|Overall Study|Adverse Event|1
4810278|NCT01241552|16588374|P1|Overall Study|Adverse Event|1
4810279|NCT01241552|16588371|P4|Overall Study|Death|25
4810280|NCT01241552|16588372|P3|Overall Study|Death|20
4810281|NCT01241552|16588373|P2|Overall Study|Death|30
4810282|NCT01241552|16588374|P1|Overall Study|Death|26
4810283|NCT01241552|16588371|P4|Overall Study|Lack of Efficacy|0
4810284|NCT01241552|16588372|P3|Overall Study|Lack of Efficacy|0
4810285|NCT01241552|16588373|P2|Overall Study|Lack of Efficacy|0
4810286|NCT01241552|16588374|P1|Overall Study|Lack of Efficacy|1
4810287|NCT01241461|16588469|P2|Overall Study|Progressive Disease|6
4810288|NCT01241461|16588470|P1|Overall Study|Progressive Disease|3
4810289|NCT01241448|16588490|P4|Overall Study|Excluded due to data integrity issues|2
4810290|NCT01241448|16588491|P3|Overall Study|Excluded due to data integrity issues|2
4810291|NCT01241448|16588492|P2|Overall Study|Excluded due to data integrity issues|2
4810292|NCT01241448|16588493|P1|Overall Study|Excluded due to data integrity issues|3
4810293|NCT01241448|16588490|P4|Overall Study|Withdrawal by Subject|6
4810294|NCT01241448|16588491|P3|Overall Study|Withdrawal by Subject|3
4810295|NCT01241448|16588492|P2|Overall Study|Withdrawal by Subject|5
4810296|NCT01241448|16588493|P1|Overall Study|Withdrawal by Subject|4
4810297|NCT01241448|16588490|P4|Overall Study|Sponsor Decision|6
4810298|NCT01241448|16588491|P3|Overall Study|Sponsor Decision|12
4810299|NCT01241448|16588492|P2|Overall Study|Sponsor Decision|14
4810300|NCT01241448|16588493|P1|Overall Study|Sponsor Decision|17
4810301|NCT01241448|16588490|P4|Overall Study|Protocol Violation|6
4810302|NCT01241448|16588491|P3|Overall Study|Protocol Violation|3
4810303|NCT01241448|16588492|P2|Overall Study|Protocol Violation|5
4810304|NCT01241448|16588493|P1|Overall Study|Protocol Violation|10
4810305|NCT01241448|16588490|P4|Overall Study|Physician Decision|0
4810306|NCT01241448|16588491|P3|Overall Study|Physician Decision|0
4810307|NCT01241448|16588492|P2|Overall Study|Physician Decision|2
4810308|NCT01241448|16588493|P1|Overall Study|Physician Decision|0
4810309|NCT01241448|16588490|P4|Overall Study|Lost to Follow-up|1
4810310|NCT01241448|16588491|P3|Overall Study|Lost to Follow-up|1
4810311|NCT01241448|16588492|P2|Overall Study|Lost to Follow-up|1
4810312|NCT01241448|16588493|P1|Overall Study|Lost to Follow-up|2
4810313|NCT01241448|16588490|P4|Overall Study|Adverse Event|2
4810314|NCT01241448|16588491|P3|Overall Study|Adverse Event|2
4810315|NCT01241448|16588492|P2|Overall Study|Adverse Event|0
4810316|NCT01241448|16588493|P1|Overall Study|Adverse Event|1
4810317|NCT01241318|16588584|P2|Overall Study|Woman: Stillborn infant|146
4810318|NCT01241318|16588585|P1|Overall Study|Woman: Stillborn infant|129
4810319|NCT01241318|16588584|P2|Overall Study|Withdrew/Lost to Follow after delivery|38
4810320|NCT01241318|16588585|P1|Overall Study|Withdrew/Lost to Follow after delivery|60
4810321|NCT01241318|16588584|P2|Overall Study|Death|4
4810322|NCT01241318|16588585|P1|Overall Study|Death|2
4810323|NCT01241318|16588584|P2|Overall Study|Lost to Follow-up|455
4810324|NCT01241318|16588585|P1|Overall Study|Lost to Follow-up|740
4810325|NCT01241318|16588584|P2|Overall Study|Withdrawal by Subject|46
4810326|NCT01241318|16588585|P1|Overall Study|Withdrawal by Subject|175
4810327|NCT01241318|16588584|P2|Overall Study|Woman: miscarriage/abortion|38
4810328|NCT01241318|16588585|P1|Overall Study|Woman: miscarriage/abortion|46
4810329|NCT01241318|16588584|P2|Overall Study|Woman: false pregnancies|15
4810330|NCT01241318|16588585|P1|Overall Study|Woman: false pregnancies|27
4810331|NCT01241292|16588602|P2|Overall Study|Participant Discontinued Treatment|2
4810332|NCT01241292|16588603|P1|Overall Study|Participant Discontinued Treatment|0
4810333|NCT01241292|16588602|P2|Overall Study|Study Drug Toxicity|1
4810334|NCT01241292|16588603|P1|Overall Study|Study Drug Toxicity|0
4810335|NCT01241292|16588602|P2|Overall Study|Disease Progression|0
4810336|NCT01241292|16588603|P1|Overall Study|Disease Progression|2
4810337|NCT01241292|16588602|P2|Overall Study|Administrative Reason by Sponsor|0
4810338|NCT01241292|16588603|P1|Overall Study|Administrative Reason by Sponsor|1
4810339|NCT01241279|16588627|P2|Overall Study|Lost to Follow-up|1
4810340|NCT01241279|16588628|P1|Overall Study|Lost to Follow-up|0
4810341|NCT01241240|16588638|P2|Overall Study|Personal Reasons|1
4810342|NCT01241240|16588639|P1|Overall Study|Personal Reasons|1
4810343|NCT01241240|16588638|P2|Overall Study|Lost to Follow-up|4
4810344|NCT01241240|16588639|P1|Overall Study|Lost to Follow-up|2
4810345|NCT01241240|16588638|P2|Overall Study|Adverse Event|4
4810346|NCT01241240|16588639|P1|Overall Study|Adverse Event|5
4810347|NCT01240915|16588657|P9|Overall Study|Insufficient Clinical Response|3
4810348|NCT01240915|16588658|P8|Overall Study|Insufficient Clinical Response|0
4810349|NCT01240915|16588659|P7|Overall Study|Insufficient Clinical Response|6
4810350|NCT01240915|16588660|P6|Overall Study|Insufficient Clinical Response|3
4810351|NCT01240915|16588661|P5|Overall Study|Insufficient Clinical Response|1
4810352|NCT01240915|16588662|P4|Overall Study|Insufficient Clinical Response|0
4810353|NCT01240915|16588663|P3|Overall Study|Insufficient Clinical Response|0
4810354|NCT01240915|16588664|P2|Overall Study|Insufficient Clinical Response|0
4810355|NCT01240915|16588665|P1|Overall Study|Insufficient Clinical Response|0
4810356|NCT01240915|16588657|P9|Overall Study|Other|0
4810357|NCT01240915|16588658|P8|Overall Study|Other|0
4810358|NCT01240915|16588659|P7|Overall Study|Other|0
4810359|NCT01240915|16588660|P6|Overall Study|Other|0
4810360|NCT01240915|16588661|P5|Overall Study|Other|2
4810361|NCT01240915|16588662|P4|Overall Study|Other|0
4810362|NCT01240915|16588663|P3|Overall Study|Other|0
4810363|NCT01240915|16588664|P2|Overall Study|Other|0
4810364|NCT01240915|16588665|P1|Overall Study|Other|0
4810365|NCT01240915|16588657|P9|Overall Study|Withdrawal by Subject|3
4810366|NCT01240915|16588658|P8|Overall Study|Withdrawal by Subject|3
4810367|NCT01240915|16588659|P7|Overall Study|Withdrawal by Subject|2
4810368|NCT01240915|16588660|P6|Overall Study|Withdrawal by Subject|4
4810369|NCT01240915|16588661|P5|Overall Study|Withdrawal by Subject|0
4810370|NCT01240915|16588662|P4|Overall Study|Withdrawal by Subject|2
4810371|NCT01240915|16588663|P3|Overall Study|Withdrawal by Subject|0
4810372|NCT01240915|16588664|P2|Overall Study|Withdrawal by Subject|1
4810373|NCT01240915|16588665|P1|Overall Study|Withdrawal by Subject|2
4810374|NCT01240915|16588657|P9|Overall Study|Lost to Follow-up|1
4810375|NCT01240915|16588658|P8|Overall Study|Lost to Follow-up|1
4810376|NCT01240915|16588659|P7|Overall Study|Lost to Follow-up|0
4810377|NCT01240915|16588660|P6|Overall Study|Lost to Follow-up|1
4810378|NCT01240915|16588661|P5|Overall Study|Lost to Follow-up|1
4810379|NCT01240915|16588662|P4|Overall Study|Lost to Follow-up|0
4810380|NCT01240915|16588663|P3|Overall Study|Lost to Follow-up|0
4810381|NCT01240915|16588664|P2|Overall Study|Lost to Follow-up|0
4810382|NCT01240915|16588665|P1|Overall Study|Lost to Follow-up|0
4810383|NCT01240915|16588657|P9|Overall Study|Adverse Event|1
4810384|NCT01240915|16588658|P8|Overall Study|Adverse Event|0
4810385|NCT01240915|16588659|P7|Overall Study|Adverse Event|0
4810386|NCT01240915|16588660|P6|Overall Study|Adverse Event|2
4810387|NCT01240915|16588661|P5|Overall Study|Adverse Event|0
4810388|NCT01240915|16588662|P4|Overall Study|Adverse Event|1
4810389|NCT01240915|16588663|P3|Overall Study|Adverse Event|0
4810390|NCT01240915|16588664|P2|Overall Study|Adverse Event|0
4810391|NCT01240915|16588665|P1|Overall Study|Adverse Event|0
4810392|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
4810393|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Physician Decision|1
4810394|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Physician Decision|0
4810395|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Other|5
4810396|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Other|1
4810397|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Other|0
4810398|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
4810399|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2
4810400|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0
4810401|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11
4810482|NCT01240356|16589164|P2|Overall Study|MRI contraindication|0
4810402|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9
4810403|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0
4810404|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14
4810405|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9
4810406|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0
4810407|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5
4810408|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3
4810409|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0
4810410|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5
4810411|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17
4810412|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0
4810413|NCT01240863|16588939|P3|Double-blind Treatment Period (12 Weeks)|Adverse Event|10
4810414|NCT01240863|16588940|P2|Double-blind Treatment Period (12 Weeks)|Adverse Event|4
4810415|NCT01240863|16588941|P1|Double-blind Treatment Period (12 Weeks)|Adverse Event|0
4810416|NCT01240863|16588939|P3|Open-label Titration Period|Other|0
4810417|NCT01240863|16588940|P2|Open-label Titration Period|Other|0
4810418|NCT01240863|16588941|P1|Open-label Titration Period|Other|7
4810419|NCT01240863|16588939|P3|Open-label Titration Period|Dropped out prior to dosing|0
4810420|NCT01240863|16588940|P2|Open-label Titration Period|Dropped out prior to dosing|0
4810421|NCT01240863|16588941|P1|Open-label Titration Period|Dropped out prior to dosing|2
4810422|NCT01240863|16588939|P3|Open-label Titration Period|Noncompliance to study procedures|0
4810423|NCT01240863|16588940|P2|Open-label Titration Period|Noncompliance to study procedures|0
4810424|NCT01240863|16588941|P1|Open-label Titration Period|Noncompliance to study procedures|3
4810425|NCT01240863|16588939|P3|Open-label Titration Period|Noncompliance to study drug admin|0
4810426|NCT01240863|16588940|P2|Open-label Titration Period|Noncompliance to study drug admin|0
4810427|NCT01240863|16588941|P1|Open-label Titration Period|Noncompliance to study drug admin|3
4810428|NCT01240863|16588939|P3|Open-label Titration Period|Protocol Violation|0
4810429|NCT01240863|16588940|P2|Open-label Titration Period|Protocol Violation|0
4810430|NCT01240863|16588941|P1|Open-label Titration Period|Protocol Violation|7
4810431|NCT01240863|16588939|P3|Open-label Titration Period|Withdrawal by Subject|0
4810432|NCT01240863|16588940|P2|Open-label Titration Period|Withdrawal by Subject|0
4810433|NCT01240863|16588941|P1|Open-label Titration Period|Withdrawal by Subject|9
4810434|NCT01240863|16588939|P3|Open-label Titration Period|Lack of Efficacy|0
4810435|NCT01240863|16588940|P2|Open-label Titration Period|Lack of Efficacy|0
4810436|NCT01240863|16588941|P1|Open-label Titration Period|Lack of Efficacy|19
4810437|NCT01240863|16588939|P3|Open-label Titration Period|Adverse Event|0
4810438|NCT01240863|16588940|P2|Open-label Titration Period|Adverse Event|0
4810439|NCT01240863|16588941|P1|Open-label Titration Period|Adverse Event|47
4810440|NCT01240811|16589003|P3|Overall Study|Withdrawal by Subject|1
4810441|NCT01240811|16589004|P2|Overall Study|Withdrawal by Subject|0
4810442|NCT01240811|16589005|P1|Overall Study|Withdrawal by Subject|0
4810443|NCT01240811|16589003|P3|Overall Study|Physician Decision|0
4810444|NCT01240811|16589004|P2|Overall Study|Physician Decision|1
4810445|NCT01240811|16589005|P1|Overall Study|Physician Decision|0
4810446|NCT01240785|16589021|P2|Overall Study|Protocol Violation|3
4810447|NCT01240785|16589022|P1|Overall Study|Protocol Violation|0
4810448|NCT01240785|16589021|P2|Overall Study|Lost to Follow-up|0
4810449|NCT01240785|16589022|P1|Overall Study|Lost to Follow-up|1
4810450|NCT01240746|16589053|P3|Overall Study|Withdrawal by Subject|59
4810451|NCT01240746|16589054|P2|Overall Study|Withdrawal by Subject|13
4810452|NCT01240746|16589055|P1|Overall Study|Withdrawal by Subject|10
4810453|NCT01240746|16589053|P3|Overall Study|Protocol Violation|72
4810454|NCT01240746|16589054|P2|Overall Study|Protocol Violation|15
4810455|NCT01240746|16589055|P1|Overall Study|Protocol Violation|24
4810456|NCT01240746|16589053|P3|Overall Study|Lost to Follow-up|102
4810457|NCT01240746|16589054|P2|Overall Study|Lost to Follow-up|20
4810458|NCT01240746|16589055|P1|Overall Study|Lost to Follow-up|23
4810459|NCT01240746|16589053|P3|Overall Study|Adverse Event|10
4810460|NCT01240746|16589054|P2|Overall Study|Adverse Event|0
4810461|NCT01240746|16589055|P1|Overall Study|Adverse Event|2
4810462|NCT01240590|16589110|P5|Phase II|Refused further treatment|1
4810463|NCT01240590|16589111|P4|Phase II|Refused further treatment|2
4810464|NCT01240590|16589112|P3|Phase II|Refused further treatment|0
4810465|NCT01240590|16589113|P2|Phase II|Refused further treatment|0
4810466|NCT01240590|16589114|P1|Phase II|Refused further treatment|0
4810467|NCT01240590|16589110|P5|Phase I|Refused further treatment|0
4810468|NCT01240590|16589111|P4|Phase I|Refused further treatment|0
4810469|NCT01240590|16589112|P3|Phase I|Refused further treatment|3
4810470|NCT01240590|16589113|P2|Phase I|Refused further treatment|0
4810471|NCT01240590|16589114|P1|Phase I|Refused further treatment|0
4810472|NCT01240551|16589142|P2|Overall Study|Lost to Follow-up|1
4810473|NCT01240551|16589143|P1|Overall Study|Lost to Follow-up|1
4810474|NCT01240551|16589142|P2|Overall Study|Refused further treatment|2
4810475|NCT01240551|16589143|P1|Overall Study|Refused further treatment|3
4810476|NCT01240382|16589153|P2|Overall Study|Fear of adverse events|1
4810477|NCT01240382|16589154|P1|Overall Study|Fear of adverse events|0
4810478|NCT01240382|16589153|P2|Overall Study|Lack of Efficacy|2
4810479|NCT01240382|16589154|P1|Overall Study|Lack of Efficacy|0
4810480|NCT01240382|16589153|P2|Overall Study|Adverse Event|1
4810481|NCT01240382|16589154|P1|Overall Study|Adverse Event|2
4810483|NCT01240356|16589165|P1|Overall Study|MRI contraindication|1
4810484|NCT01240356|16589164|P2|Overall Study|Withdrawal by Subject|0
4810485|NCT01240356|16589165|P1|Overall Study|Withdrawal by Subject|2
4810486|NCT01240200|16589188|P2|12-week Crossover Phase - Period 1|Withdrawal by Subject|1
4810487|NCT01240200|16589189|P1|12-week Crossover Phase - Period 1|Withdrawal by Subject|2
4810488|NCT01240135|16589207|P2|Period Two, 14 Days of Wear|Adverse Event|1
4810489|NCT01240135|16589208|P1|Period Two, 14 Days of Wear|Adverse Event|0
4810490|NCT01240135|16589207|P2|Period Two, 14 Days of Wear|Withdrawal by Subject|1
4810491|NCT01240135|16589208|P1|Period Two, 14 Days of Wear|Withdrawal by Subject|1
4810492|NCT01239992|16589225|P1|Overall Study|Withdrawal by Subject|2
4810493|NCT01239797|16589234|P2|Treated Participants|Poor/Non-compliance|1
4810494|NCT01239797|16589235|P1|Treated Participants|Poor/Non-compliance|0
4810495|NCT01239797|16589234|P2|Treated Participants|Subject No Longer Meets Study Criteria|1
4810496|NCT01239797|16589235|P1|Treated Participants|Subject No Longer Meets Study Criteria|1
4810497|NCT01239797|16589234|P2|Treated Participants|Death|1
4810498|NCT01239797|16589235|P1|Treated Participants|Death|1
4810499|NCT01239797|16589234|P2|Treated Participants|Non-specified|11
4810500|NCT01239797|16589235|P1|Treated Participants|Non-specified|1
4810501|NCT01239797|16589234|P2|Treated Participants|Withdrawal by Subject|23
4810502|NCT01239797|16589235|P1|Treated Participants|Withdrawal by Subject|27
4810503|NCT01239797|16589234|P2|Treated Participants|Adverse Event Unrelated to Study Drug|32
4810504|NCT01239797|16589235|P1|Treated Participants|Adverse Event Unrelated to Study Drug|22
4810505|NCT01239797|16589234|P2|Treated Participants|Study Drug Toxicity|44
4810506|NCT01239797|16589235|P1|Treated Participants|Study Drug Toxicity|30
4810507|NCT01239797|16589234|P2|Treated Participants|Disease Progression|161
4810508|NCT01239797|16589235|P1|Treated Participants|Disease Progression|153
4810509|NCT01239745|16589243|P1|Overall Study|Adverse Event|1
4810510|NCT01239745|16589243|P1|Overall Study|Study terminated by sponsor|45
4810511|NCT01239732|16589254|P1|Overall Study|Other|19
4810512|NCT01239732|16589254|P1|Overall Study|Treatment failure|2
4810513|NCT01239732|16589254|P1|Overall Study|Investigator's decision|4
4810514|NCT01239732|16589254|P1|Overall Study|Study termination by sponsor|2
4810515|NCT01239732|16589254|P1|Overall Study|Participant non compliance|5
4810516|NCT01239732|16589254|P1|Overall Study|Protocol Violation|3
4810517|NCT01239732|16589254|P1|Overall Study|Adverse Event|6
4810518|NCT01239732|16589254|P1|Overall Study|Withdrawal by Subject|87
4810519|NCT01239732|16589254|P1|Overall Study|Death|226
4810520|NCT01239732|16589254|P1|Overall Study|Termination of study per protocol|667
4810521|NCT01239680|16589267|P2|Overall Study|Withdrawal by Subject|0
4810522|NCT01239680|16589268|P1|Overall Study|Withdrawal by Subject|2
4810523|NCT01239472|16589293|P2|Overall Study|Lack of Efficacy|1
4810524|NCT01239472|16589294|P1|Overall Study|Lack of Efficacy|0
4810525|NCT01239472|16589293|P2|Overall Study|Adverse Event|1
4810526|NCT01239472|16589294|P1|Overall Study|Adverse Event|0
4810527|NCT01239472|16589293|P2|Overall Study|Withdrawal by Subject|1
4810528|NCT01239472|16589294|P1|Overall Study|Withdrawal by Subject|5
4810529|NCT01239394|16589302|P1|Overall Study|Adverse Event|1
4810530|NCT01239381|16589309|P1|Overall Study|Withdrawal by Subject|1
4810531|NCT01239381|16589309|P1|Overall Study|Protocol Violation|1
4810532|NCT01239368|16589329|P10|Overall Study|Death|0
4810533|NCT01239368|16589330|P9|Overall Study|Death|0
4810534|NCT01239368|16589331|P8|Overall Study|Death|0
4810535|NCT01239368|16589332|P7|Overall Study|Death|1
4810536|NCT01239368|16589333|P6|Overall Study|Death|0
4810537|NCT01239368|16589334|P5|Overall Study|Death|0
4810538|NCT01239368|16589335|P4|Overall Study|Death|0
4810539|NCT01239368|16589336|P3|Overall Study|Death|0
4810540|NCT01239368|16589337|P2|Overall Study|Death|0
4810541|NCT01239368|16589338|P1|Overall Study|Death|0
4810542|NCT01239368|16589329|P10|Overall Study|Refused further treatment|1
4810543|NCT01239368|16589330|P9|Overall Study|Refused further treatment|0
4810544|NCT01239368|16589331|P8|Overall Study|Refused further treatment|0
4810545|NCT01239368|16589332|P7|Overall Study|Refused further treatment|0
4810546|NCT01239368|16589333|P6|Overall Study|Refused further treatment|0
4810547|NCT01239368|16589334|P5|Overall Study|Refused further treatment|0
4810548|NCT01239368|16589335|P4|Overall Study|Refused further treatment|0
4810549|NCT01239368|16589336|P3|Overall Study|Refused further treatment|0
4810550|NCT01239368|16589337|P2|Overall Study|Refused further treatment|0
4810551|NCT01239368|16589338|P1|Overall Study|Refused further treatment|0
4810552|NCT01239368|16589329|P10|Overall Study|Disease progression on study|2
4810553|NCT01239368|16589330|P9|Overall Study|Disease progression on study|0
4810554|NCT01239368|16589331|P8|Overall Study|Disease progression on study|0
4810555|NCT01239368|16589332|P7|Overall Study|Disease progression on study|5
4810556|NCT01239368|16589333|P6|Overall Study|Disease progression on study|2
4810557|NCT01239368|16589334|P5|Overall Study|Disease progression on study|4
4810558|NCT01239368|16589335|P4|Overall Study|Disease progression on study|1
4810559|NCT01239368|16589336|P3|Overall Study|Disease progression on study|1
4810560|NCT01239368|16589337|P2|Overall Study|Disease progression on study|1
4810561|NCT01239368|16589338|P1|Overall Study|Disease progression on study|1
4810562|NCT01239368|16589329|P10|Overall Study|Principal investigator discretion|1
4810563|NCT01239368|16589330|P9|Overall Study|Principal investigator discretion|0
4810564|NCT01239368|16589331|P8|Overall Study|Principal investigator discretion|0
4810565|NCT01239368|16589332|P7|Overall Study|Principal investigator discretion|0
4810566|NCT01239368|16589333|P6|Overall Study|Principal investigator discretion|2
4810567|NCT01239368|16589334|P5|Overall Study|Principal investigator discretion|1
4810568|NCT01239368|16589335|P4|Overall Study|Principal investigator discretion|0
4810569|NCT01239368|16589336|P3|Overall Study|Principal investigator discretion|0
4810570|NCT01239368|16589337|P2|Overall Study|Principal investigator discretion|0
4810571|NCT01239368|16589338|P1|Overall Study|Principal investigator discretion|1
4810572|NCT01239342|16589390|P2|Overall Study|Reason Unknown|1
4810573|NCT01239342|16589391|P1|Overall Study|Reason Unknown|1
4810574|NCT01239342|16589390|P2|Overall Study|Withdrawal by Subject|5
4810575|NCT01239342|16589391|P1|Overall Study|Withdrawal by Subject|1
4810576|NCT01239342|16589390|P2|Overall Study|Adverse Event|0
4810577|NCT01239342|16589391|P1|Overall Study|Adverse Event|1
4810578|NCT01239316|16589407|P1|Overall Study|Adverse Event|1
4810579|NCT01239316|16589407|P1|Overall Study|Progression/Relapse|11
4810580|NCT01239160|16589421|P3|Overall Study|Early Termination Due to Study Closure|6
4810581|NCT01239160|16589422|P2|Overall Study|Early Termination Due to Study Closure|1
4810582|NCT01239160|16589423|P1|Overall Study|Early Termination Due to Study Closure|0
4810583|NCT01239160|16589421|P3|Overall Study|Physician Decision|2
4810584|NCT01239160|16589422|P2|Overall Study|Physician Decision|7
4810585|NCT01239160|16589423|P1|Overall Study|Physician Decision|5
4810586|NCT01239160|16589421|P3|Overall Study|Withdrawal by Subject|2
4810587|NCT01239160|16589422|P2|Overall Study|Withdrawal by Subject|6
4810588|NCT01239160|16589423|P1|Overall Study|Withdrawal by Subject|17
4810589|NCT01239160|16589421|P3|Overall Study|Lost to Follow-up|0
4810590|NCT01239160|16589422|P2|Overall Study|Lost to Follow-up|5
4810591|NCT01239160|16589423|P1|Overall Study|Lost to Follow-up|3
4810592|NCT01239121|16589436|P3|Overall Study|Withdrawal by Subject|0
4810593|NCT01239121|16589437|P2|Overall Study|Withdrawal by Subject|4
4810594|NCT01239121|16589438|P1|Overall Study|Withdrawal by Subject|2
4810595|NCT01239043|16589460|P2|Overall Study|Protocol Violation|1
4810596|NCT01239043|16589461|P1|Overall Study|Protocol Violation|2
4810597|NCT01238991|16589489|P10|Overall Study|Admission to a nursing home|0
4810598|NCT01238991|16589490|P9|Overall Study|Admission to a nursing home|0
4810599|NCT01238991|16589491|P8|Overall Study|Admission to a nursing home|0
4810600|NCT01238991|16589492|P7|Overall Study|Admission to a nursing home|0
4810601|NCT01238991|16589493|P6|Overall Study|Admission to a nursing home|0
4810602|NCT01238991|16589494|P5|Overall Study|Admission to a nursing home|0
4810603|NCT01238991|16589495|P4|Overall Study|Admission to a nursing home|0
4810604|NCT01238991|16589496|P3|Overall Study|Admission to a nursing home|1
4810605|NCT01238991|16589497|P2|Overall Study|Admission to a nursing home|0
4810606|NCT01238991|16589498|P1|Overall Study|Admission to a nursing home|1
4810607|NCT01238991|16589489|P10|Overall Study|Caregiver's request|0
4810608|NCT01238991|16589490|P9|Overall Study|Caregiver's request|1
4810609|NCT01238991|16589491|P8|Overall Study|Caregiver's request|0
4810610|NCT01238991|16589492|P7|Overall Study|Caregiver's request|0
4810611|NCT01238991|16589493|P6|Overall Study|Caregiver's request|0
4810612|NCT01238991|16589494|P5|Overall Study|Caregiver's request|0
4810613|NCT01238991|16589495|P4|Overall Study|Caregiver's request|0
4810614|NCT01238991|16589496|P3|Overall Study|Caregiver's request|0
4810615|NCT01238991|16589497|P2|Overall Study|Caregiver's request|0
4810616|NCT01238991|16589498|P1|Overall Study|Caregiver's request|0
4810617|NCT01238991|16589489|P10|Overall Study|Study Terminated by Sponsor|2
4810618|NCT01238991|16589490|P9|Overall Study|Study Terminated by Sponsor|2
4810619|NCT01238991|16589491|P8|Overall Study|Study Terminated by Sponsor|4
4810620|NCT01238991|16589492|P7|Overall Study|Study Terminated by Sponsor|7
4810621|NCT01238991|16589493|P6|Overall Study|Study Terminated by Sponsor|0
4810622|NCT01238991|16589494|P5|Overall Study|Study Terminated by Sponsor|1
4810623|NCT01238991|16589495|P4|Overall Study|Study Terminated by Sponsor|0
4810624|NCT01238991|16589496|P3|Overall Study|Study Terminated by Sponsor|0
4810625|NCT01238991|16589497|P2|Overall Study|Study Terminated by Sponsor|0
4810626|NCT01238991|16589498|P1|Overall Study|Study Terminated by Sponsor|0
4810627|NCT01238991|16589489|P10|Overall Study|Withdrawal by Subject|0
4810628|NCT01238991|16589490|P9|Overall Study|Withdrawal by Subject|0
4810629|NCT01238991|16589491|P8|Overall Study|Withdrawal by Subject|0
4810630|NCT01238991|16589492|P7|Overall Study|Withdrawal by Subject|0
4810631|NCT01238991|16589493|P6|Overall Study|Withdrawal by Subject|0
4810632|NCT01238991|16589494|P5|Overall Study|Withdrawal by Subject|0
4810633|NCT01238991|16589495|P4|Overall Study|Withdrawal by Subject|0
4810634|NCT01238991|16589496|P3|Overall Study|Withdrawal by Subject|1
4810635|NCT01238991|16589497|P2|Overall Study|Withdrawal by Subject|0
4810636|NCT01238991|16589498|P1|Overall Study|Withdrawal by Subject|0
4810637|NCT01238991|16589489|P10|Overall Study|Lack of Efficacy|0
4810638|NCT01238991|16589490|P9|Overall Study|Lack of Efficacy|1
4810639|NCT01238991|16589491|P8|Overall Study|Lack of Efficacy|0
4810640|NCT01238991|16589492|P7|Overall Study|Lack of Efficacy|0
4810641|NCT01238991|16589493|P6|Overall Study|Lack of Efficacy|0
4810642|NCT01238991|16589494|P5|Overall Study|Lack of Efficacy|0
4810643|NCT01238991|16589495|P4|Overall Study|Lack of Efficacy|0
4810644|NCT01238991|16589496|P3|Overall Study|Lack of Efficacy|1
4810645|NCT01238991|16589497|P2|Overall Study|Lack of Efficacy|0
4810646|NCT01238991|16589498|P1|Overall Study|Lack of Efficacy|0
4810647|NCT01238991|16589489|P10|Overall Study|Death|0
4810648|NCT01238991|16589490|P9|Overall Study|Death|0
4810649|NCT01238991|16589491|P8|Overall Study|Death|0
4810650|NCT01238991|16589492|P7|Overall Study|Death|0
4810651|NCT01238991|16589493|P6|Overall Study|Death|0
4810652|NCT01238991|16589494|P5|Overall Study|Death|0
4810653|NCT01238991|16589495|P4|Overall Study|Death|1
4810654|NCT01238991|16589496|P3|Overall Study|Death|0
4810655|NCT01238991|16589497|P2|Overall Study|Death|0
4810656|NCT01238991|16589498|P1|Overall Study|Death|0
4810657|NCT01238991|16589489|P10|Overall Study|Adverse Event|0
4810658|NCT01238991|16589490|P9|Overall Study|Adverse Event|0
4810659|NCT01238991|16589491|P8|Overall Study|Adverse Event|1
4810660|NCT01238991|16589492|P7|Overall Study|Adverse Event|1
4810661|NCT01238991|16589493|P6|Overall Study|Adverse Event|0
4810662|NCT01238991|16589494|P5|Overall Study|Adverse Event|1
4810663|NCT01238991|16589495|P4|Overall Study|Adverse Event|1
4810664|NCT01238991|16589496|P3|Overall Study|Adverse Event|3
4810665|NCT01238991|16589497|P2|Overall Study|Adverse Event|0
4810666|NCT01238991|16589498|P1|Overall Study|Adverse Event|1
4810667|NCT01238900|16589585|P1|<12 Months Post Stent Removal|persistent stricture after stenting|1
4810668|NCT01238900|16589585|P1|<12 Months Post Stent Removal|Lost to Follow-up|4
4810669|NCT01238861|16589599|P6|Overall Study|Withdrawal by Subject|9
4810670|NCT01238861|16589600|P5|Overall Study|Withdrawal by Subject|10
4810671|NCT01238861|16589601|P4|Overall Study|Withdrawal by Subject|8
4810672|NCT01238861|16589602|P3|Overall Study|Withdrawal by Subject|4
4810673|NCT01238861|16589603|P2|Overall Study|Withdrawal by Subject|5
4810674|NCT01238861|16589604|P1|Overall Study|Withdrawal by Subject|6
4810675|NCT01238861|16589599|P6|Overall Study|Adverse Event|0
4810676|NCT01238861|16589600|P5|Overall Study|Adverse Event|0
4810677|NCT01238861|16589601|P4|Overall Study|Adverse Event|0
4810678|NCT01238861|16589602|P3|Overall Study|Adverse Event|0
4810679|NCT01238861|16589603|P2|Overall Study|Adverse Event|1
4810680|NCT01238861|16589604|P1|Overall Study|Adverse Event|0
4810681|NCT01238861|16589599|P6|Overall Study|Lack of compliance|1
4810682|NCT01238861|16589600|P5|Overall Study|Lack of compliance|0
4810683|NCT01238861|16589601|P4|Overall Study|Lack of compliance|0
4810684|NCT01238861|16589602|P3|Overall Study|Lack of compliance|0
4810685|NCT01238861|16589603|P2|Overall Study|Lack of compliance|0
4810686|NCT01238861|16589604|P1|Overall Study|Lack of compliance|0
4810687|NCT01238861|16589599|P6|Overall Study|Serious adverse event|1
4810688|NCT01238861|16589600|P5|Overall Study|Serious adverse event|0
4810689|NCT01238861|16589601|P4|Overall Study|Serious adverse event|0
4810690|NCT01238861|16589602|P3|Overall Study|Serious adverse event|0
4810691|NCT01238861|16589603|P2|Overall Study|Serious adverse event|0
4810692|NCT01238861|16589604|P1|Overall Study|Serious adverse event|0
4810693|NCT01238861|16589599|P6|Overall Study|Unable to continue visits|1
4810694|NCT01238861|16589600|P5|Overall Study|Unable to continue visits|0
4810695|NCT01238861|16589601|P4|Overall Study|Unable to continue visits|1
4810696|NCT01238861|16589602|P3|Overall Study|Unable to continue visits|0
4810697|NCT01238861|16589603|P2|Overall Study|Unable to continue visits|0
4810698|NCT01238861|16589604|P1|Overall Study|Unable to continue visits|0
4810699|NCT01238861|16589599|P6|Overall Study|Personal problems|0
4810700|NCT01238861|16589600|P5|Overall Study|Personal problems|0
4810701|NCT01238861|16589601|P4|Overall Study|Personal problems|1
4810702|NCT01238861|16589602|P3|Overall Study|Personal problems|0
4810703|NCT01238861|16589603|P2|Overall Study|Personal problems|0
4810704|NCT01238861|16589604|P1|Overall Study|Personal problems|0
4810705|NCT01238861|16589599|P6|Overall Study|Strongyloides stercoralis antibodies +|0
4810706|NCT01238861|16589600|P5|Overall Study|Strongyloides stercoralis antibodies +|0
4810707|NCT01238861|16589601|P4|Overall Study|Strongyloides stercoralis antibodies +|1
4810708|NCT01238861|16589602|P3|Overall Study|Strongyloides stercoralis antibodies +|0
4810709|NCT01238861|16589603|P2|Overall Study|Strongyloides stercoralis antibodies +|0
4810710|NCT01238861|16589604|P1|Overall Study|Strongyloides stercoralis antibodies +|0
4810711|NCT01238861|16589599|P6|Overall Study|Subject moved out of state/area|0
4810712|NCT01238861|16589600|P5|Overall Study|Subject moved out of state/area|0
4810713|NCT01238861|16589601|P4|Overall Study|Subject moved out of state/area|1
4810714|NCT01238861|16589602|P3|Overall Study|Subject moved out of state/area|1
4810715|NCT01238861|16589603|P2|Overall Study|Subject moved out of state/area|0
4810716|NCT01238861|16589604|P1|Overall Study|Subject moved out of state/area|0
4810717|NCT01238861|16589599|P6|Overall Study|Subject traveled to Argentina by 1 year|0
4810718|NCT01238861|16589600|P5|Overall Study|Subject traveled to Argentina by 1 year|0
4810719|NCT01238861|16589601|P4|Overall Study|Subject traveled to Argentina by 1 year|0
4810720|NCT01238861|16589602|P3|Overall Study|Subject traveled to Argentina by 1 year|1
4810721|NCT01238861|16589603|P2|Overall Study|Subject traveled to Argentina by 1 year|0
4810722|NCT01238861|16589604|P1|Overall Study|Subject traveled to Argentina by 1 year|0
4810723|NCT01238861|16589599|P6|Overall Study|Incorrect enrollment/randomization|0
4810724|NCT01238861|16589600|P5|Overall Study|Incorrect enrollment/randomization|1
4810725|NCT01238861|16589601|P4|Overall Study|Incorrect enrollment/randomization|0
4810726|NCT01238861|16589602|P3|Overall Study|Incorrect enrollment/randomization|1
4810727|NCT01238861|16589603|P2|Overall Study|Incorrect enrollment/randomization|0
4810728|NCT01238861|16589604|P1|Overall Study|Incorrect enrollment/randomization|0
4810729|NCT01238861|16589599|P6|Overall Study|Did not meet entry ACQ-6 criteria|1
4810730|NCT01238861|16589600|P5|Overall Study|Did not meet entry ACQ-6 criteria|1
4810731|NCT01238861|16589601|P4|Overall Study|Did not meet entry ACQ-6 criteria|0
4810732|NCT01238861|16589602|P3|Overall Study|Did not meet entry ACQ-6 criteria|1
4810733|NCT01238861|16589603|P2|Overall Study|Did not meet entry ACQ-6 criteria|0
4810734|NCT01238861|16589604|P1|Overall Study|Did not meet entry ACQ-6 criteria|0
4810735|NCT01238861|16589599|P6|Overall Study|Unplanned surgery|0
4810736|NCT01238861|16589600|P5|Overall Study|Unplanned surgery|0
4810737|NCT01238861|16589601|P4|Overall Study|Unplanned surgery|0
4810738|NCT01238861|16589602|P3|Overall Study|Unplanned surgery|0
4810739|NCT01238861|16589603|P2|Overall Study|Unplanned surgery|0
4810740|NCT01238861|16589604|P1|Overall Study|Unplanned surgery|1
4810741|NCT01238861|16589599|P6|Overall Study|Lost to Follow-up|2
4810742|NCT01238861|16589600|P5|Overall Study|Lost to Follow-up|1
4810743|NCT01238861|16589601|P4|Overall Study|Lost to Follow-up|1
4810744|NCT01238861|16589602|P3|Overall Study|Lost to Follow-up|3
4810745|NCT01238861|16589603|P2|Overall Study|Lost to Follow-up|2
4810746|NCT01238861|16589604|P1|Overall Study|Lost to Follow-up|4
4810747|NCT01238848|16589684|P2|Overall Study|Physician Decision|5
4810748|NCT01238848|16589685|P1|Overall Study|Physician Decision|13
4810749|NCT01238822|16589693|P1|Overall Study|COULD NOT SWALLOW PILLS|3
4810750|NCT01238588|16589720|P1|Overall Study|Physician Decision|2
4810751|NCT01238588|16589720|P1|Overall Study|Withdrawal by Subject|1
4810752|NCT01238575|16589733|P2|Overall Study|Adverse Event|0
4810753|NCT01238575|16589734|P1|Overall Study|Adverse Event|2
4810754|NCT01238575|16589733|P2|Overall Study|Lack of Efficacy|4
4810755|NCT01238575|16589734|P1|Overall Study|Lack of Efficacy|2
4810756|NCT01238211|16589818|P1|Overall Study|Investigator/Patient Decision|3
4810757|NCT01238211|16589818|P1|Overall Study|Non-protocol treatment|4
4810758|NCT01238211|16589818|P1|Overall Study|Withdrawal by Subject|7
4810759|NCT01238211|16589818|P1|Overall Study|Relapse/Progression|2
4810760|NCT01238211|16589818|P1|Overall Study|Death|4
4810761|NCT01238211|16589818|P1|Overall Study|Adverse Event|7
4810762|NCT01238211|16589818|P1|Overall Study|Continues active treatment|31
4810763|NCT01238172|16589824|P2|Overall Study|Ineligible: based on Central Path Review|19
4810764|NCT01238172|16589825|P1|Overall Study|Ineligible: based on Central Path Review|9
4810765|NCT01238172|16589824|P2|Overall Study|Ineligible: based on Eligibility Review|5
4810766|NCT01238172|16589825|P1|Overall Study|Ineligible: based on Eligibility Review|2
4810767|NCT01237951|16589837|P1|Overall Study|Death|1
4810768|NCT01237899|16589855|P11|Washout Period of at Least 7 Days|Adverse Event|0
4810769|NCT01237899|16589856|P10|Washout Period of at Least 7 Days|Adverse Event|0
4810770|NCT01237899|16589857|P9|Washout Period of at Least 7 Days|Adverse Event|0
4810771|NCT01237899|16589858|P8|Washout Period of at Least 7 Days|Adverse Event|0
4810772|NCT01237899|16589859|P7|Washout Period of at Least 7 Days|Adverse Event|0
4810773|NCT01237899|16589860|P6|Washout Period of at Least 7 Days|Adverse Event|0
4810774|NCT01237899|16589861|P5|Washout Period of at Least 7 Days|Adverse Event|0
4810775|NCT01237899|16589862|P4|Washout Period of at Least 7 Days|Adverse Event|0
4810776|NCT01237899|16589863|P3|Washout Period of at Least 7 Days|Adverse Event|1
4810777|NCT01237899|16589864|P2|Washout Period of at Least 7 Days|Adverse Event|0
4810778|NCT01237899|16589865|P1|Washout Period of at Least 7 Days|Adverse Event|0
4810779|NCT01237678|16589945|P3|Phase II|Randomized but were not treated|3
4810780|NCT01237678|16589946|P2|Phase II|Randomized but were not treated|4
4810781|NCT01237678|16589947|P1|Phase II|Randomized but were not treated|0
4810782|NCT01237678|16589945|P3|Phase II|Sponsor Decision/Study Closed|7
4810783|NCT01237678|16589946|P2|Phase II|Sponsor Decision/Study Closed|18
4810784|NCT01237678|16589947|P1|Phase II|Sponsor Decision/Study Closed|0
4810785|NCT01237678|16589945|P3|Phase II|Completed Cycles 4-6|21
4810786|NCT01237678|16589946|P2|Phase II|Completed Cycles 4-6|11
4810787|NCT01237678|16589947|P1|Phase II|Completed Cycles 4-6|0
4810788|NCT01237678|16589945|P3|Phase II|Withdrawal by Subject|5
4810789|NCT01237678|16589946|P2|Phase II|Withdrawal by Subject|1
4810790|NCT01237678|16589947|P1|Phase II|Withdrawal by Subject|0
4810791|NCT01237678|16589945|P3|Phase II|Lack of Efficacy|3
4810792|NCT01237678|16589946|P2|Phase II|Lack of Efficacy|25
4810793|NCT01237678|16589947|P1|Phase II|Lack of Efficacy|0
4810794|NCT01237678|16589945|P3|Phase II|Death|2
4810795|NCT01237678|16589946|P2|Phase II|Death|0
4810796|NCT01237678|16589947|P1|Phase II|Death|0
4810797|NCT01237678|16589945|P3|Phase II|Adverse Event|9
4810798|NCT01237678|16589946|P2|Phase II|Adverse Event|39
4810799|NCT01237678|16589947|P1|Phase II|Adverse Event|0
4810800|NCT01237678|16589945|P3|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
4810801|NCT01237678|16589946|P2|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0
4810802|NCT01237678|16589947|P1|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1
4810803|NCT01237678|16589945|P3|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
4810804|NCT01237678|16589946|P2|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0
4810805|NCT01237678|16589947|P1|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3
4810806|NCT01237678|16589945|P3|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
4810807|NCT01237678|16589946|P2|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0
4810808|NCT01237678|16589947|P1|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24
4810809|NCT01237678|16589945|P3|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
4810810|NCT01237678|16589946|P2|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0
4810811|NCT01237678|16589947|P1|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5
4810812|NCT01237587|16589992|P2|Taper Phase|Withdrawal by Subject|1
4810813|NCT01237587|16589993|P1|Taper Phase|Withdrawal by Subject|0
4810814|NCT01237587|16589992|P2|Taper Phase|Sponsor Decision|0
4810815|NCT01237587|16589993|P1|Taper Phase|Sponsor Decision|1
4810816|NCT01237587|16589992|P2|Taper Phase|Parent/Guardian Decision|2
4810817|NCT01237587|16589993|P1|Taper Phase|Parent/Guardian Decision|0
4810818|NCT01237587|16589992|P2|Taper Phase|Lack of Efficacy|5
4810819|NCT01237587|16589993|P1|Taper Phase|Lack of Efficacy|2
4810820|NCT01237587|16589992|P2|Taper Phase|Protocol Violation|0
4810821|NCT01237587|16589993|P1|Taper Phase|Protocol Violation|2
4810822|NCT01237587|16589992|P2|Taper Phase|Adverse Event|2
4810823|NCT01237587|16589993|P1|Taper Phase|Adverse Event|0
4810824|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Physician Decision|4
4810825|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Physician Decision|4
4810826|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Sponsor Decision|0
4810827|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Sponsor Decision|1
4810828|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5
4810829|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0
4810830|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4
4810831|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2
4810832|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Lack of Efficacy|4
4810833|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Lack of Efficacy|2
4810834|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Adverse Event|5
4810835|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Adverse Event|5
4810836|NCT01237587|16589992|P2|Open Label Treatment (Extension Phase)|Lost to Follow-up|3
4810837|NCT01237587|16589993|P1|Open Label Treatment (Extension Phase)|Lost to Follow-up|4
4810838|NCT01237587|16589992|P2|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4
4810839|NCT01237587|16589993|P1|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3
4810840|NCT01237587|16589992|P2|Double Blind Treatment (Acute Phase)|Protocol Violation|3
4810841|NCT01237587|16589993|P1|Double Blind Treatment (Acute Phase)|Protocol Violation|4
4810842|NCT01237587|16589992|P2|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4
4810843|NCT01237587|16589993|P1|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2
4810844|NCT01237587|16589992|P2|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3
4810845|NCT01237587|16589993|P1|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2
4810846|NCT01237587|16589992|P2|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3
4810847|NCT01237587|16589993|P1|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1
4810848|NCT01237587|16589992|P2|Double Blind Treatment (Acute Phase)|Adverse Event|1
4810849|NCT01237587|16589993|P1|Double Blind Treatment (Acute Phase)|Adverse Event|5
4810850|NCT01237340|16590045|P1|Overall Study|Early termination of the trial|36
4810851|NCT01237340|16590045|P1|Overall Study|Withdrawal by Subject|1
4810852|NCT01237340|16590045|P1|Overall Study|Adverse Event|3
4810853|NCT01237327|16590059|P2|Overall Study|Lost to Follow-up|0
4810854|NCT01237327|16590060|P1|Overall Study|Lost to Follow-up|3
4810855|NCT01237327|16590059|P2|Overall Study|Withdrawal by Subject|3
4810856|NCT01237327|16590060|P1|Overall Study|Withdrawal by Subject|1
4810857|NCT01237327|16590059|P2|Overall Study|Protocol Specific Withdrawal Criteria|0
4810858|NCT01237327|16590060|P1|Overall Study|Protocol Specific Withdrawal Criteria|1
4810859|NCT01237327|16590059|P2|Overall Study|Progression of Disease: Extension Study|13
4810860|NCT01237327|16590060|P1|Overall Study|Progression of Disease: Extension Study|15
4810861|NCT01237327|16590059|P2|Overall Study|Progression of Disease: Core Study|22
4810862|NCT01237327|16590060|P1|Overall Study|Progression of Disease: Core Study|18
4810863|NCT01237327|16590059|P2|Overall Study|Completed 26 weeks treatment:Core Study|2
4810864|NCT01237327|16590060|P1|Overall Study|Completed 26 weeks treatment:Core Study|3
4810865|NCT01237327|16590059|P2|Overall Study|Protocol Violation: Core Study|0
4810866|NCT01237327|16590060|P1|Overall Study|Protocol Violation: Core Study|1
4810867|NCT01237223|16590095|P6|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4810868|NCT01237223|16590096|P5|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4810869|NCT01237223|16590097|P4|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2
4810870|NCT01237223|16590098|P3|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4810871|NCT01237223|16590099|P2|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1
4810872|NCT01237223|16590100|P1|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0
4810873|NCT01237223|16590095|P6|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1
4810874|NCT01237223|16590096|P5|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4810875|NCT01237223|16590097|P4|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4810876|NCT01237223|16590098|P3|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4810877|NCT01237223|16590099|P2|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4810878|NCT01237223|16590100|P1|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0
4810879|NCT01237223|16590095|P6|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
4810880|NCT01237223|16590096|P5|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
4810881|NCT01237223|16590097|P4|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0
4810882|NCT01237223|16590098|P3|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
4810883|NCT01237223|16590099|P2|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4
4810884|NCT01237223|16590100|P1|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1
4810885|NCT01237223|16590095|P6|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
4810886|NCT01237223|16590096|P5|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0
4810887|NCT01237223|16590097|P4|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1
4810888|NCT01237223|16590098|P3|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7
4810889|NCT01237223|16590099|P2|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6
4810890|NCT01237223|16590100|P1|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20
4810891|NCT01237223|16590095|P6|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1
4810892|NCT01237223|16590096|P5|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
4810893|NCT01237223|16590097|P4|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2
4810894|NCT01237223|16590098|P3|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3
4810895|NCT01237223|16590099|P2|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4
4810896|NCT01237223|16590100|P1|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12
4810897|NCT01237223|16590095|P6|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4810898|NCT01237223|16590096|P5|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4810899|NCT01237223|16590097|P4|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4810900|NCT01237223|16590098|P3|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4810901|NCT01237223|16590099|P2|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0
4810902|NCT01237223|16590100|P1|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8
4810903|NCT01237223|16590095|P6|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4810904|NCT01237223|16590096|P5|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4810905|NCT01237223|16590097|P4|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4810906|NCT01237223|16590098|P3|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4810907|NCT01237223|16590099|P2|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0
4810908|NCT01237223|16590100|P1|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28
4810909|NCT01237223|16590095|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4810910|NCT01237223|16590096|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4810911|NCT01237223|16590097|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4810912|NCT01237223|16590098|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4810913|NCT01237223|16590099|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0
4810914|NCT01237223|16590100|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308
4810915|NCT01237223|16590095|P6|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4810916|NCT01237223|16590096|P5|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4810917|NCT01237223|16590097|P4|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4810918|NCT01237223|16590098|P3|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4810919|NCT01237223|16590099|P2|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0
4810920|NCT01237223|16590100|P1|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25
4810921|NCT01237223|16590095|P6|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4810922|NCT01237223|16590096|P5|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4810923|NCT01237223|16590097|P4|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4810924|NCT01237223|16590098|P3|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4810925|NCT01237223|16590099|P2|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0
4810926|NCT01237223|16590100|P1|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29
4810927|NCT01237054|16590159|P1|Overall Study|imaging 10C0096|1
4810928|NCT01236755|16590228|P1|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3
4810929|NCT01236755|16590228|P1|Orthokeratology Wearing Phase|Withdrawal by Subject|5
4810930|NCT01236755|16590228|P1|Spectacles Wearing Phase|Lost to Follow-up|9
4810931|NCT01236755|16590228|P1|Spectacles Wearing Phase|Withdrawal by Subject|8
4810932|NCT01236534|16590251|P2|Overall Study|Adverse Event|0
4810933|NCT01236534|16590252|P1|Overall Study|Adverse Event|3
4810934|NCT01236365|16590270|P2|Overall Study|Dropped at Randomization due to high LFT|0
4810935|NCT01236365|16590271|P1|Overall Study|Dropped at Randomization due to high LFT|1
4810936|NCT01236365|16590270|P2|Overall Study|Moved Out of State|0
4810937|NCT01236365|16590271|P1|Overall Study|Moved Out of State|1
4810938|NCT01236365|16590270|P2|Overall Study|Lost to Follow-up|2
4810939|NCT01236365|16590271|P1|Overall Study|Lost to Follow-up|0
4810940|NCT01236339|16590295|P2|Overall Study|Termination of study by sponsor|13
4810941|NCT01236339|16590296|P1|Overall Study|Termination of study by sponsor|11
4810942|NCT01235793|16590325|P1|Overall Study|Death|6
4810943|NCT01236573|16590341|P11|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1
4810944|NCT01236573|16590342|P10|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810945|NCT01236573|16590343|P9|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810946|NCT01236573|16590344|P8|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810947|NCT01236573|16590345|P7|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810948|NCT01236573|16590346|P6|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810949|NCT01236573|16590347|P5|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810950|NCT01236573|16590348|P4|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810951|NCT01236573|16590349|P3|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810952|NCT01236573|16590350|P2|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810953|NCT01236573|16590351|P1|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0
4810954|NCT01236573|16590341|P11|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810955|NCT01236573|16590342|P10|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810956|NCT01236573|16590343|P9|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1
4810957|NCT01236573|16590344|P8|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810958|NCT01236573|16590345|P7|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810959|NCT01236573|16590346|P6|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810960|NCT01236573|16590347|P5|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810961|NCT01236573|16590348|P4|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810962|NCT01236573|16590349|P3|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810963|NCT01236573|16590350|P2|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810964|NCT01236573|16590351|P1|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0
4810965|NCT01236573|16590341|P11|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810966|NCT01236573|16590342|P10|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
4810967|NCT01236573|16590343|P9|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
4810968|NCT01236573|16590344|P8|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810969|NCT01236573|16590345|P7|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1
4810970|NCT01236573|16590346|P6|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810971|NCT01236573|16590347|P5|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810972|NCT01236573|16590348|P4|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810973|NCT01236573|16590349|P3|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810974|NCT01236573|16590350|P2|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810975|NCT01236573|16590351|P1|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0
4810976|NCT01236560|16590393|P6|Overall Study|Progressive disease|0
4810977|NCT01236560|16590394|P5|Overall Study|Progressive disease|0
4810978|NCT01236560|16590395|P4|Overall Study|Progressive disease|16
4810979|NCT01236560|16590396|P3|Overall Study|Progressive disease|9
4810980|NCT01236560|16590397|P2|Overall Study|Progressive disease|19
4810981|NCT01236560|16590398|P1|Overall Study|Progressive disease|5
4810982|NCT01236560|16590393|P6|Overall Study|Withdrawal by Subject|0
4810983|NCT01236560|16590394|P5|Overall Study|Withdrawal by Subject|0
4810984|NCT01236560|16590395|P4|Overall Study|Withdrawal by Subject|2
4810985|NCT01236560|16590396|P3|Overall Study|Withdrawal by Subject|1
4810986|NCT01236560|16590397|P2|Overall Study|Withdrawal by Subject|0
4810987|NCT01236560|16590398|P1|Overall Study|Withdrawal by Subject|0
4810988|NCT01236560|16590393|P6|Overall Study|Physician Decision|0
4810989|NCT01236560|16590394|P5|Overall Study|Physician Decision|0
4810990|NCT01236560|16590395|P4|Overall Study|Physician Decision|0
4810991|NCT01236560|16590396|P3|Overall Study|Physician Decision|8
4810992|NCT01236560|16590397|P2|Overall Study|Physician Decision|1
4810993|NCT01236560|16590398|P1|Overall Study|Physician Decision|0
4810994|NCT01236560|16590393|P6|Overall Study|Lost to Follow-up|0
4810995|NCT01236560|16590394|P5|Overall Study|Lost to Follow-up|0
4810996|NCT01236560|16590395|P4|Overall Study|Lost to Follow-up|0
4810997|NCT01236560|16590396|P3|Overall Study|Lost to Follow-up|1
4810998|NCT01236560|16590397|P2|Overall Study|Lost to Follow-up|1
4810999|NCT01236560|16590398|P1|Overall Study|Lost to Follow-up|0
4811000|NCT01236560|16590393|P6|Overall Study|Death|0
4811001|NCT01236560|16590394|P5|Overall Study|Death|0
4811002|NCT01236560|16590395|P4|Overall Study|Death|1
4811003|NCT01236560|16590396|P3|Overall Study|Death|0
4811004|NCT01236560|16590397|P2|Overall Study|Death|1
4811005|NCT01236560|16590398|P1|Overall Study|Death|0
4811006|NCT01236560|16590393|P6|Overall Study|Adverse Event|0
4811007|NCT01236560|16590394|P5|Overall Study|Adverse Event|0
4811008|NCT01236560|16590395|P4|Overall Study|Adverse Event|3
4811009|NCT01236560|16590396|P3|Overall Study|Adverse Event|1
4811010|NCT01236560|16590397|P2|Overall Study|Adverse Event|2
4811011|NCT01236560|16590398|P1|Overall Study|Adverse Event|0
4811012|NCT01236521|16590419|P2|Overall Study|Lost to Follow-up|7
4811013|NCT01236521|16590420|P1|Overall Study|Lost to Follow-up|7
4811014|NCT01236521|16590419|P2|Overall Study|Death|1
4811015|NCT01236521|16590420|P1|Overall Study|Death|2
4811016|NCT01236521|16590419|P2|Overall Study|Withdrawal by Subject|17
4811017|NCT01236521|16590420|P1|Overall Study|Withdrawal by Subject|12
4811018|NCT01236352|16590471|P11|Overall Study|Patient transferred to IST|6
4811019|NCT01236352|16590472|P10|Overall Study|Patient transferred to IST|2
4811020|NCT01236352|16590473|P9|Overall Study|Patient transferred to IST|0
4811021|NCT01236352|16590474|P8|Overall Study|Patient transferred to IST|0
4811022|NCT01236352|16590475|P7|Overall Study|Patient transferred to IST|0
4811023|NCT01236352|16590476|P6|Overall Study|Patient transferred to IST|0
4811024|NCT01236352|16590477|P5|Overall Study|Patient transferred to IST|0
4811025|NCT01236352|16590478|P4|Overall Study|Patient transferred to IST|0
4811026|NCT01236352|16590479|P3|Overall Study|Patient transferred to IST|0
4811027|NCT01236352|16590480|P2|Overall Study|Patient transferred to IST|0
4811028|NCT01236352|16590481|P1|Overall Study|Patient transferred to IST|0
4811029|NCT01236352|16590471|P11|Overall Study|Lack of response to drug|1
4811030|NCT01236352|16590472|P10|Overall Study|Lack of response to drug|1
4811031|NCT01236352|16590473|P9|Overall Study|Lack of response to drug|0
4811032|NCT01236352|16590474|P8|Overall Study|Lack of response to drug|0
4811033|NCT01236352|16590475|P7|Overall Study|Lack of response to drug|0
4811034|NCT01236352|16590476|P6|Overall Study|Lack of response to drug|0
4811035|NCT01236352|16590477|P5|Overall Study|Lack of response to drug|0
4811036|NCT01236352|16590478|P4|Overall Study|Lack of response to drug|0
4811037|NCT01236352|16590479|P3|Overall Study|Lack of response to drug|0
4811038|NCT01236352|16590480|P2|Overall Study|Lack of response to drug|0
4811039|NCT01236352|16590481|P1|Overall Study|Lack of response to drug|0
4811040|NCT01236352|16590471|P11|Overall Study|Relapse of Splenomegaly and symptoms|1
4811041|NCT01236352|16590472|P10|Overall Study|Relapse of Splenomegaly and symptoms|0
4811042|NCT01236352|16590473|P9|Overall Study|Relapse of Splenomegaly and symptoms|0
4811043|NCT01236352|16590474|P8|Overall Study|Relapse of Splenomegaly and symptoms|0
4811044|NCT01236352|16590475|P7|Overall Study|Relapse of Splenomegaly and symptoms|0
4811045|NCT01236352|16590476|P6|Overall Study|Relapse of Splenomegaly and symptoms|0
4811046|NCT01236352|16590477|P5|Overall Study|Relapse of Splenomegaly and symptoms|0
4811047|NCT01236352|16590478|P4|Overall Study|Relapse of Splenomegaly and symptoms|0
4811048|NCT01236352|16590479|P3|Overall Study|Relapse of Splenomegaly and symptoms|0
4811049|NCT01236352|16590480|P2|Overall Study|Relapse of Splenomegaly and symptoms|0
4811050|NCT01236352|16590481|P1|Overall Study|Relapse of Splenomegaly and symptoms|0
4811051|NCT01236352|16590471|P11|Overall Study|Patient moving to allogeneic transplant|0
4811052|NCT01236352|16590472|P10|Overall Study|Patient moving to allogeneic transplant|0
4811053|NCT01236352|16590473|P9|Overall Study|Patient moving to allogeneic transplant|0
4811054|NCT01236352|16590474|P8|Overall Study|Patient moving to allogeneic transplant|0
4811055|NCT01236352|16590475|P7|Overall Study|Patient moving to allogeneic transplant|1
4811056|NCT01236352|16590476|P6|Overall Study|Patient moving to allogeneic transplant|0
4811057|NCT01236352|16590477|P5|Overall Study|Patient moving to allogeneic transplant|0
4811058|NCT01236352|16590478|P4|Overall Study|Patient moving to allogeneic transplant|0
4811059|NCT01236352|16590479|P3|Overall Study|Patient moving to allogeneic transplant|0
4811060|NCT01236352|16590480|P2|Overall Study|Patient moving to allogeneic transplant|0
4811061|NCT01236352|16590481|P1|Overall Study|Patient moving to allogeneic transplant|0
4811062|NCT01236352|16590471|P11|Overall Study|Subject to receive drug via EAP|0
4811063|NCT01236352|16590472|P10|Overall Study|Subject to receive drug via EAP|4
4811064|NCT01236352|16590473|P9|Overall Study|Subject to receive drug via EAP|0
4811065|NCT01236352|16590474|P8|Overall Study|Subject to receive drug via EAP|2
4811066|NCT01236352|16590475|P7|Overall Study|Subject to receive drug via EAP|0
4811067|NCT01236352|16590476|P6|Overall Study|Subject to receive drug via EAP|0
4811068|NCT01236352|16590477|P5|Overall Study|Subject to receive drug via EAP|0
4811069|NCT01236352|16590478|P4|Overall Study|Subject to receive drug via EAP|0
4811070|NCT01236352|16590479|P3|Overall Study|Subject to receive drug via EAP|1
4811071|NCT01236352|16590480|P2|Overall Study|Subject to receive drug via EAP|1
4811072|NCT01236352|16590481|P1|Overall Study|Subject to receive drug via EAP|1
4811073|NCT01236352|16590471|P11|Overall Study|Subject request to discontinue treatment|4
4811074|NCT01236352|16590472|P10|Overall Study|Subject request to discontinue treatment|1
4811075|NCT01236352|16590473|P9|Overall Study|Subject request to discontinue treatment|0
4811076|NCT01236352|16590474|P8|Overall Study|Subject request to discontinue treatment|0
4811077|NCT01236352|16590475|P7|Overall Study|Subject request to discontinue treatment|0
4811078|NCT01236352|16590476|P6|Overall Study|Subject request to discontinue treatment|1
4811079|NCT01236352|16590477|P5|Overall Study|Subject request to discontinue treatment|0
4811080|NCT01236352|16590478|P4|Overall Study|Subject request to discontinue treatment|1
4811081|NCT01236352|16590479|P3|Overall Study|Subject request to discontinue treatment|1
4811082|NCT01236352|16590480|P2|Overall Study|Subject request to discontinue treatment|0
4811083|NCT01236352|16590481|P1|Overall Study|Subject request to discontinue treatment|0
4811084|NCT01236352|16590471|P11|Overall Study|Maximum clinical benefit|2
4811085|NCT01236352|16590472|P10|Overall Study|Maximum clinical benefit|4
4811086|NCT01236352|16590473|P9|Overall Study|Maximum clinical benefit|1
4811087|NCT01236352|16590474|P8|Overall Study|Maximum clinical benefit|1
4811088|NCT01236352|16590475|P7|Overall Study|Maximum clinical benefit|3
4811089|NCT01236352|16590476|P6|Overall Study|Maximum clinical benefit|0
4811090|NCT01236352|16590477|P5|Overall Study|Maximum clinical benefit|2
4811091|NCT01236352|16590478|P4|Overall Study|Maximum clinical benefit|0
4811092|NCT01236352|16590479|P3|Overall Study|Maximum clinical benefit|1
4811093|NCT01236352|16590480|P2|Overall Study|Maximum clinical benefit|1
4811094|NCT01236352|16590481|P1|Overall Study|Maximum clinical benefit|1
4811095|NCT01236352|16590471|P11|Overall Study|Poor/Non-compliance|0
4811096|NCT01236352|16590472|P10|Overall Study|Poor/Non-compliance|0
4811097|NCT01236352|16590473|P9|Overall Study|Poor/Non-compliance|0
4811098|NCT01236352|16590474|P8|Overall Study|Poor/Non-compliance|0
4811099|NCT01236352|16590475|P7|Overall Study|Poor/Non-compliance|0
4811100|NCT01236352|16590476|P6|Overall Study|Poor/Non-compliance|0
4811101|NCT01236352|16590477|P5|Overall Study|Poor/Non-compliance|0
4811102|NCT01236352|16590478|P4|Overall Study|Poor/Non-compliance|0
4811103|NCT01236352|16590479|P3|Overall Study|Poor/Non-compliance|0
4811104|NCT01236352|16590480|P2|Overall Study|Poor/Non-compliance|0
4811105|NCT01236352|16590481|P1|Overall Study|Poor/Non-compliance|1
4811106|NCT01236352|16590471|P11|Overall Study|Disease progression|2
4811107|NCT01236352|16590472|P10|Overall Study|Disease progression|2
4811108|NCT01236352|16590473|P9|Overall Study|Disease progression|2
4811109|NCT01236352|16590474|P8|Overall Study|Disease progression|3
4811110|NCT01236352|16590475|P7|Overall Study|Disease progression|1
4811111|NCT01236352|16590476|P6|Overall Study|Disease progression|2
4811112|NCT01236352|16590477|P5|Overall Study|Disease progression|2
4811113|NCT01236352|16590478|P4|Overall Study|Disease progression|2
4811114|NCT01236352|16590479|P3|Overall Study|Disease progression|1
4811115|NCT01236352|16590480|P2|Overall Study|Disease progression|2
4811116|NCT01236352|16590481|P1|Overall Study|Disease progression|1
4811117|NCT01236352|16590471|P11|Overall Study|Study drug toxicity|2
4811118|NCT01236352|16590472|P10|Overall Study|Study drug toxicity|2
4811119|NCT01236352|16590473|P9|Overall Study|Study drug toxicity|0
4811120|NCT01236352|16590474|P8|Overall Study|Study drug toxicity|0
4811121|NCT01236352|16590475|P7|Overall Study|Study drug toxicity|1
4811122|NCT01236352|16590476|P6|Overall Study|Study drug toxicity|1
4811123|NCT01236352|16590477|P5|Overall Study|Study drug toxicity|0
4811124|NCT01236352|16590478|P4|Overall Study|Study drug toxicity|0
4811125|NCT01236352|16590479|P3|Overall Study|Study drug toxicity|0
4811126|NCT01236352|16590480|P2|Overall Study|Study drug toxicity|0
4811127|NCT01236352|16590481|P1|Overall Study|Study drug toxicity|0
4811128|NCT01236352|16590471|P11|Overall Study|Adverse Event|1
4811129|NCT01236352|16590472|P10|Overall Study|Adverse Event|4
4811130|NCT01236352|16590473|P9|Overall Study|Adverse Event|0
4811131|NCT01236352|16590474|P8|Overall Study|Adverse Event|0
4811132|NCT01236352|16590475|P7|Overall Study|Adverse Event|2
4811133|NCT01236352|16590476|P6|Overall Study|Adverse Event|0
4811134|NCT01236352|16590477|P5|Overall Study|Adverse Event|0
4811135|NCT01236352|16590478|P4|Overall Study|Adverse Event|0
4811136|NCT01236352|16590479|P3|Overall Study|Adverse Event|0
4811137|NCT01236352|16590480|P2|Overall Study|Adverse Event|0
4811138|NCT01236352|16590481|P1|Overall Study|Adverse Event|0
4811139|NCT01236352|16590471|P11|Overall Study|Withdrawal by Subject|1
4811140|NCT01236352|16590472|P10|Overall Study|Withdrawal by Subject|2
4811141|NCT01236352|16590473|P9|Overall Study|Withdrawal by Subject|0
4811142|NCT01236352|16590474|P8|Overall Study|Withdrawal by Subject|0
4811143|NCT01236352|16590475|P7|Overall Study|Withdrawal by Subject|0
4811144|NCT01236352|16590476|P6|Overall Study|Withdrawal by Subject|0
4811145|NCT01236352|16590477|P5|Overall Study|Withdrawal by Subject|0
4811146|NCT01236352|16590478|P4|Overall Study|Withdrawal by Subject|0
4811147|NCT01236352|16590479|P3|Overall Study|Withdrawal by Subject|0
4811148|NCT01236352|16590480|P2|Overall Study|Withdrawal by Subject|0
4811149|NCT01236352|16590481|P1|Overall Study|Withdrawal by Subject|0
4811150|NCT01236352|16590471|P11|Overall Study|Death|0
4811151|NCT01236352|16590472|P10|Overall Study|Death|0
4811152|NCT01236352|16590473|P9|Overall Study|Death|0
4811153|NCT01236352|16590474|P8|Overall Study|Death|1
4811154|NCT01236352|16590475|P7|Overall Study|Death|0
4811155|NCT01236352|16590476|P6|Overall Study|Death|0
4811156|NCT01236352|16590477|P5|Overall Study|Death|0
4811157|NCT01236352|16590478|P4|Overall Study|Death|0
4811158|NCT01236352|16590479|P3|Overall Study|Death|0
4811159|NCT01236352|16590480|P2|Overall Study|Death|0
4811160|NCT01236352|16590481|P1|Overall Study|Death|0
4811161|NCT01236118|16590699|P3|Overall Study|Withdrawal by Subject|1
4811162|NCT01236118|16590700|P2|Overall Study|Withdrawal by Subject|0
4811163|NCT01236118|16590701|P1|Overall Study|Withdrawal by Subject|0
4811164|NCT01236118|16590699|P3|Overall Study|Physician Decision|0
4811165|NCT01236118|16590700|P2|Overall Study|Physician Decision|1
4811166|NCT01236118|16590701|P1|Overall Study|Physician Decision|0
4811167|NCT01236118|16590699|P3|Overall Study|Adverse Event|2
4811168|NCT01236118|16590700|P2|Overall Study|Adverse Event|0
4811169|NCT01236118|16590701|P1|Overall Study|Adverse Event|2
4811170|NCT01236001|16590902|P2|Overall Study|Planned Visit After End of Study|1
4811171|NCT01236001|16590903|P1|Overall Study|Planned Visit After End of Study|0
4811172|NCT01236001|16590902|P2|Overall Study|Incompliance|0
4811173|NCT01236001|16590903|P1|Overall Study|Incompliance|1
4811174|NCT01236001|16590902|P2|Overall Study|Lost to Follow-up|1
4811175|NCT01236001|16590903|P1|Overall Study|Lost to Follow-up|6
4811176|NCT01236001|16590902|P2|Overall Study|Lack of Efficacy|6
4811177|NCT01236001|16590903|P1|Overall Study|Lack of Efficacy|6
4811178|NCT01236001|16590902|P2|Overall Study|Adverse Event|14
4811179|NCT01236001|16590903|P1|Overall Study|Adverse Event|5
4811180|NCT01235975|16590935|P2|Overall Study|Lost to Follow-up|3
4811181|NCT01235975|16590936|P1|Overall Study|Lost to Follow-up|7
4811182|NCT01235975|16590935|P2|Overall Study|Migrated/moved from study area|1
4811183|NCT01235975|16590936|P1|Overall Study|Migrated/moved from study area|2
4811184|NCT01235975|16590935|P2|Overall Study|Withdrawal by Subject|2
4811185|NCT01235975|16590936|P1|Overall Study|Withdrawal by Subject|8
4811186|NCT01235975|16590935|P2|Overall Study|Serious Adverse Event|1
4811187|NCT01235975|16590936|P1|Overall Study|Serious Adverse Event|0
4811188|NCT01235949|16590986|P18|Booster Phase|Lost to Follow-up|1
4811189|NCT01235949|16590987|P17|Booster Phase|Lost to Follow-up|0
4811190|NCT01235949|16590988|P16|Booster Phase|Lost to Follow-up|0
4811191|NCT01235949|16590989|P15|Booster Phase|Lost to Follow-up|0
4811192|NCT01235949|16590990|P14|Booster Phase|Lost to Follow-up|0
4811193|NCT01235949|16590991|P13|Booster Phase|Lost to Follow-up|0
4811194|NCT01235949|16590992|P12|Booster Phase|Lost to Follow-up|1
4811195|NCT01235949|16590993|P11|Booster Phase|Lost to Follow-up|1
4811196|NCT01235949|16590994|P10|Booster Phase|Lost to Follow-up|1
4811197|NCT01235949|16590995|P9|Booster Phase|Lost to Follow-up|1
4811198|NCT01235949|16590996|P8|Booster Phase|Lost to Follow-up|0
4811199|NCT01235949|16590997|P7|Booster Phase|Lost to Follow-up|0
4811200|NCT01235949|16590998|P6|Booster Phase|Lost to Follow-up|0
4811201|NCT01235949|16590999|P5|Booster Phase|Lost to Follow-up|0
4811202|NCT01235949|16591000|P4|Booster Phase|Lost to Follow-up|0
4811203|NCT01235949|16591001|P3|Booster Phase|Lost to Follow-up|0
4811204|NCT01235949|16591002|P2|Booster Phase|Lost to Follow-up|0
4811205|NCT01235949|16591003|P1|Booster Phase|Lost to Follow-up|0
4811206|NCT01235949|16590986|P18|Booster Phase|Withdrawal by Subject|0
4811207|NCT01235949|16590987|P17|Booster Phase|Withdrawal by Subject|0
4811208|NCT01235949|16590988|P16|Booster Phase|Withdrawal by Subject|0
4811209|NCT01235949|16590989|P15|Booster Phase|Withdrawal by Subject|2
4811210|NCT01235949|16590990|P14|Booster Phase|Withdrawal by Subject|0
4811211|NCT01235949|16590991|P13|Booster Phase|Withdrawal by Subject|2
4811212|NCT01235949|16590992|P12|Booster Phase|Withdrawal by Subject|1
4811213|NCT01235949|16590993|P11|Booster Phase|Withdrawal by Subject|1
4811214|NCT01235949|16590994|P10|Booster Phase|Withdrawal by Subject|0
4811215|NCT01235949|16590995|P9|Booster Phase|Withdrawal by Subject|1
4811216|NCT01235949|16590996|P8|Booster Phase|Withdrawal by Subject|1
4811217|NCT01235949|16590997|P7|Booster Phase|Withdrawal by Subject|0
4811218|NCT01235949|16590998|P6|Booster Phase|Withdrawal by Subject|0
4811219|NCT01235949|16590999|P5|Booster Phase|Withdrawal by Subject|0
4811220|NCT01235949|16591000|P4|Booster Phase|Withdrawal by Subject|0
4811221|NCT01235949|16591001|P3|Booster Phase|Withdrawal by Subject|0
4811222|NCT01235949|16591002|P2|Booster Phase|Withdrawal by Subject|0
4811223|NCT01235949|16591003|P1|Booster Phase|Withdrawal by Subject|0
4811224|NCT01235949|16590986|P18|Booster Phase|Adverse Event|0
4811225|NCT01235949|16590987|P17|Booster Phase|Adverse Event|0
4811226|NCT01235949|16590988|P16|Booster Phase|Adverse Event|1
4811227|NCT01235949|16590989|P15|Booster Phase|Adverse Event|0
4811228|NCT01235949|16590990|P14|Booster Phase|Adverse Event|0
4811229|NCT01235949|16590991|P13|Booster Phase|Adverse Event|0
4811230|NCT01235949|16590992|P12|Booster Phase|Adverse Event|0
4811231|NCT01235949|16590993|P11|Booster Phase|Adverse Event|0
4811232|NCT01235949|16590994|P10|Booster Phase|Adverse Event|0
4811233|NCT01235949|16590995|P9|Booster Phase|Adverse Event|0
4811234|NCT01235949|16590996|P8|Booster Phase|Adverse Event|0
4811235|NCT01235949|16590997|P7|Booster Phase|Adverse Event|0
4811236|NCT01235949|16590998|P6|Booster Phase|Adverse Event|0
4811237|NCT01235949|16590999|P5|Booster Phase|Adverse Event|0
4811238|NCT01235949|16591000|P4|Booster Phase|Adverse Event|0
4811239|NCT01235949|16591001|P3|Booster Phase|Adverse Event|0
4811240|NCT01235949|16591002|P2|Booster Phase|Adverse Event|0
4811241|NCT01235949|16591003|P1|Booster Phase|Adverse Event|0
4811242|NCT01235949|16590986|P18|Booster Phase|Migrated/moved from study area|1
4811243|NCT01235949|16590987|P17|Booster Phase|Migrated/moved from study area|0
4811244|NCT01235949|16590988|P16|Booster Phase|Migrated/moved from study area|0
4811245|NCT01235949|16590989|P15|Booster Phase|Migrated/moved from study area|0
4811246|NCT01235949|16590990|P14|Booster Phase|Migrated/moved from study area|0
4811247|NCT01235949|16590991|P13|Booster Phase|Migrated/moved from study area|1
4811248|NCT01235949|16590992|P12|Booster Phase|Migrated/moved from study area|1
4811249|NCT01235949|16590993|P11|Booster Phase|Migrated/moved from study area|0
4811250|NCT01235949|16590994|P10|Booster Phase|Migrated/moved from study area|0
4811251|NCT01235949|16590995|P9|Booster Phase|Migrated/moved from study area|0
4811252|NCT01235949|16590996|P8|Booster Phase|Migrated/moved from study area|0
4811253|NCT01235949|16590997|P7|Booster Phase|Migrated/moved from study area|0
4811254|NCT01235949|16590998|P6|Booster Phase|Migrated/moved from study area|0
4811255|NCT01235949|16590999|P5|Booster Phase|Migrated/moved from study area|0
4811256|NCT01235949|16591000|P4|Booster Phase|Migrated/moved from study area|0
4811257|NCT01235949|16591001|P3|Booster Phase|Migrated/moved from study area|0
4811258|NCT01235949|16591002|P2|Booster Phase|Migrated/moved from study area|0
4811259|NCT01235949|16591003|P1|Booster Phase|Migrated/moved from study area|0
4811260|NCT01235949|16590986|P18|Primary Phase|Lost to Follow-up|0
4811261|NCT01235949|16590987|P17|Primary Phase|Lost to Follow-up|0
4811262|NCT01235949|16590988|P16|Primary Phase|Lost to Follow-up|0
4811263|NCT01235949|16590989|P15|Primary Phase|Lost to Follow-up|0
4811264|NCT01235949|16590990|P14|Primary Phase|Lost to Follow-up|0
4811265|NCT01235949|16590991|P13|Primary Phase|Lost to Follow-up|0
4811266|NCT01235949|16590992|P12|Primary Phase|Lost to Follow-up|0
4811267|NCT01235949|16590993|P11|Primary Phase|Lost to Follow-up|0
4811268|NCT01235949|16590994|P10|Primary Phase|Lost to Follow-up|0
4811269|NCT01235949|16590995|P9|Primary Phase|Lost to Follow-up|0
4811270|NCT01235949|16590996|P8|Primary Phase|Lost to Follow-up|0
4811271|NCT01235949|16590997|P7|Primary Phase|Lost to Follow-up|0
4811272|NCT01235949|16590998|P6|Primary Phase|Lost to Follow-up|2
4811273|NCT01235949|16590999|P5|Primary Phase|Lost to Follow-up|0
4811274|NCT01235949|16591000|P4|Primary Phase|Lost to Follow-up|1
4811275|NCT01235949|16591001|P3|Primary Phase|Lost to Follow-up|1
4811276|NCT01235949|16591002|P2|Primary Phase|Lost to Follow-up|0
4811277|NCT01235949|16591003|P1|Primary Phase|Lost to Follow-up|0
4811278|NCT01235949|16590986|P18|Primary Phase|Withdrawal by Subject|0
4811279|NCT01235949|16590987|P17|Primary Phase|Withdrawal by Subject|0
4811280|NCT01235949|16590988|P16|Primary Phase|Withdrawal by Subject|0
4811281|NCT01235949|16590989|P15|Primary Phase|Withdrawal by Subject|0
4811282|NCT01235949|16590990|P14|Primary Phase|Withdrawal by Subject|0
4811283|NCT01235949|16590991|P13|Primary Phase|Withdrawal by Subject|0
4811284|NCT01235949|16590992|P12|Primary Phase|Withdrawal by Subject|0
4811285|NCT01235949|16590993|P11|Primary Phase|Withdrawal by Subject|0
4811286|NCT01235949|16590994|P10|Primary Phase|Withdrawal by Subject|0
4811287|NCT01235949|16590995|P9|Primary Phase|Withdrawal by Subject|0
4811288|NCT01235949|16590996|P8|Primary Phase|Withdrawal by Subject|0
4811289|NCT01235949|16590997|P7|Primary Phase|Withdrawal by Subject|0
4811290|NCT01235949|16590998|P6|Primary Phase|Withdrawal by Subject|3
4811291|NCT01235949|16590999|P5|Primary Phase|Withdrawal by Subject|0
4811292|NCT01235949|16591000|P4|Primary Phase|Withdrawal by Subject|0
4811293|NCT01235949|16591001|P3|Primary Phase|Withdrawal by Subject|2
4811294|NCT01235949|16591002|P2|Primary Phase|Withdrawal by Subject|2
4811295|NCT01235949|16591003|P1|Primary Phase|Withdrawal by Subject|3
4811296|NCT01235949|16590986|P18|Primary Phase|Adverse Event|0
4811297|NCT01235949|16590987|P17|Primary Phase|Adverse Event|0
4811298|NCT01235949|16590988|P16|Primary Phase|Adverse Event|0
4811299|NCT01235949|16590989|P15|Primary Phase|Adverse Event|0
4811300|NCT01235949|16590990|P14|Primary Phase|Adverse Event|0
4811301|NCT01235949|16590991|P13|Primary Phase|Adverse Event|0
4811302|NCT01235949|16590992|P12|Primary Phase|Adverse Event|0
4811303|NCT01235949|16590993|P11|Primary Phase|Adverse Event|0
4811304|NCT01235949|16590994|P10|Primary Phase|Adverse Event|0
4811305|NCT01235949|16590995|P9|Primary Phase|Adverse Event|0
4811306|NCT01235949|16590996|P8|Primary Phase|Adverse Event|0
4811307|NCT01235949|16590997|P7|Primary Phase|Adverse Event|0
4811308|NCT01235949|16590998|P6|Primary Phase|Adverse Event|0
4811309|NCT01235949|16590999|P5|Primary Phase|Adverse Event|0
4811310|NCT01235949|16591000|P4|Primary Phase|Adverse Event|1
4811311|NCT01235949|16591001|P3|Primary Phase|Adverse Event|0
4811312|NCT01235949|16591002|P2|Primary Phase|Adverse Event|0
4811313|NCT01235949|16591003|P1|Primary Phase|Adverse Event|0
4811314|NCT01235949|16590986|P18|Primary Phase|Migrated/moved from study area|0
4811315|NCT01235949|16590987|P17|Primary Phase|Migrated/moved from study area|0
4811316|NCT01235949|16590988|P16|Primary Phase|Migrated/moved from study area|0
4811317|NCT01235949|16590989|P15|Primary Phase|Migrated/moved from study area|0
4811318|NCT01235949|16590990|P14|Primary Phase|Migrated/moved from study area|0
4811319|NCT01235949|16590991|P13|Primary Phase|Migrated/moved from study area|0
4811320|NCT01235949|16590992|P12|Primary Phase|Migrated/moved from study area|0
4811321|NCT01235949|16590993|P11|Primary Phase|Migrated/moved from study area|0
4811322|NCT01235949|16590994|P10|Primary Phase|Migrated/moved from study area|0
4811323|NCT01235949|16590995|P9|Primary Phase|Migrated/moved from study area|0
4811324|NCT01235949|16590996|P8|Primary Phase|Migrated/moved from study area|0
4811325|NCT01235949|16590997|P7|Primary Phase|Migrated/moved from study area|0
4811326|NCT01235949|16590998|P6|Primary Phase|Migrated/moved from study area|2
4811327|NCT01235949|16590999|P5|Primary Phase|Migrated/moved from study area|1
4811328|NCT01235949|16591000|P4|Primary Phase|Migrated/moved from study area|0
4811329|NCT01235949|16591001|P3|Primary Phase|Migrated/moved from study area|0
4811330|NCT01235949|16591002|P2|Primary Phase|Migrated/moved from study area|1
4811331|NCT01235949|16591003|P1|Primary Phase|Migrated/moved from study area|1
4811332|NCT01235741|16591253|P3|Follow-Up Post Treatment up to Month 6|Other|0
4811333|NCT01235741|16591254|P2|Follow-Up Post Treatment up to Month 6|Other|1
4811334|NCT01235741|16591255|P1|Follow-Up Post Treatment up to Month 6|Other|0
4811335|NCT01235741|16591253|P3|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1
4811336|NCT01235741|16591254|P2|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5
4811337|NCT01235741|16591255|P1|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0
4811338|NCT01235741|16591253|P3|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6
4811339|NCT01235741|16591254|P2|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3
4811340|NCT01235741|16591255|P1|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0
4811341|NCT01235741|16591253|P3|Randomized to Treatment|Sponsor terminated study|34
4811342|NCT01235741|16591254|P2|Randomized to Treatment|Sponsor terminated study|35
4811343|NCT01235741|16591255|P1|Randomized to Treatment|Sponsor terminated study|0
4811344|NCT01235741|16591253|P3|Randomized to Treatment|Adverse Event|1
4811345|NCT01235741|16591254|P2|Randomized to Treatment|Adverse Event|1
4811346|NCT01235741|16591255|P1|Randomized to Treatment|Adverse Event|0
4811347|NCT01235741|16591253|P3|Randomized to Treatment|Withdrawal by Subject|1
4811348|NCT01235741|16591254|P2|Randomized to Treatment|Withdrawal by Subject|0
4811349|NCT01235741|16591255|P1|Randomized to Treatment|Withdrawal by Subject|0
4811350|NCT01235741|16591253|P3|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
4811351|NCT01235741|16591254|P2|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0
4811352|NCT01235741|16591255|P1|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4
4811353|NCT01235741|16591253|P3|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
4811354|NCT01235741|16591254|P2|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0
4811355|NCT01235741|16591255|P1|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5
4811356|NCT01235741|16591253|P3|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
4811357|NCT01235741|16591254|P2|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0
4811358|NCT01235741|16591255|P1|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1
4811359|NCT01235741|16591253|P3|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
4811360|NCT01235741|16591254|P2|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0
4811361|NCT01235741|16591255|P1|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1
4811362|NCT01235741|16591253|P3|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
4811363|NCT01235741|16591254|P2|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0
4811364|NCT01235741|16591255|P1|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121
4811365|NCT01235741|16591253|P3|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
4811366|NCT01235741|16591254|P2|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0
4811367|NCT01235741|16591255|P1|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9
4811368|NCT01235728|16591282|P8|Overall Study|Protocol Violation|0
4811369|NCT01235728|16591283|P7|Overall Study|Protocol Violation|0
4811370|NCT01235728|16591284|P6|Overall Study|Protocol Violation|0
4811371|NCT01235728|16591285|P5|Overall Study|Protocol Violation|0
4811372|NCT01235728|16591286|P4|Overall Study|Protocol Violation|1
4811373|NCT01235728|16591287|P3|Overall Study|Protocol Violation|0
4811374|NCT01235728|16591288|P2|Overall Study|Protocol Violation|0
4811375|NCT01235728|16591289|P1|Overall Study|Protocol Violation|0
4811376|NCT01235715|16591299|P2|Overall Study|Physician Decision|2
4811377|NCT01235715|16591300|P1|Overall Study|Physician Decision|0
4811378|NCT01235689|16591340|P2|Overall Study|Miscellaneous|5
4811379|NCT01235689|16591341|P1|Overall Study|Miscellaneous|1
4811380|NCT01235689|16591340|P2|Overall Study|Lost to Follow-up|2
4811381|NCT01235689|16591341|P1|Overall Study|Lost to Follow-up|1
4811382|NCT01235689|16591340|P2|Overall Study|Withdrawal by Subject|4
4811383|NCT01235689|16591341|P1|Overall Study|Withdrawal by Subject|3
4811384|NCT01235689|16591340|P2|Overall Study|Lack of Efficacy|5
4811385|NCT01235689|16591341|P1|Overall Study|Lack of Efficacy|12
4811386|NCT01235689|16591340|P2|Overall Study|Adverse Event|16
4811387|NCT01235689|16591341|P1|Overall Study|Adverse Event|12
4811388|NCT01235598|16591413|P2|Overall Study|Withdrawal by Subject|0
4811389|NCT01235598|16591414|P1|Overall Study|Withdrawal by Subject|1
4811390|NCT01235598|16591413|P2|Overall Study|Lack of Efficacy|1
4811391|NCT01235598|16591414|P1|Overall Study|Lack of Efficacy|0
4811392|NCT01235598|16591413|P2|Overall Study|Adverse Event|3
4811393|NCT01235598|16591414|P1|Overall Study|Adverse Event|0
4811394|NCT01235546|16591459|P2|Overall Study|Protocol Violation|1
4811395|NCT01235546|16591460|P1|Overall Study|Protocol Violation|1
4811396|NCT01235546|16591459|P2|Overall Study|Staff error, medication not administered|0
4811397|NCT01235546|16591460|P1|Overall Study|Staff error, medication not administered|1
4811398|NCT01235507|16591484|P1|Overall Study|Withdrawal by Subject|1
4811399|NCT01235507|16591484|P1|Overall Study|Adverse Event|1
4811400|NCT01235442|16591498|P2|Overall Study|Other unspecified|2
4811401|NCT01235442|16591499|P1|Overall Study|Other unspecified|1
4811402|NCT01235442|16591498|P2|Overall Study|Administrative decision|2
4811403|NCT01235442|16591499|P1|Overall Study|Administrative decision|1
4811404|NCT01235442|16591498|P2|Overall Study|Noncompliance|2
4811405|NCT01235442|16591499|P1|Overall Study|Noncompliance|1
4811406|NCT01235442|16591498|P2|Overall Study|Lack of Efficacy|3
4811407|NCT01235442|16591499|P1|Overall Study|Lack of Efficacy|1
4811408|NCT01235442|16591498|P2|Overall Study|Withdrawal by Subject|9
4811409|NCT01235442|16591499|P1|Overall Study|Withdrawal by Subject|15
4811410|NCT01235442|16591498|P2|Overall Study|Adverse Event|6
4811411|NCT01235442|16591499|P1|Overall Study|Adverse Event|4
4811412|NCT01235442|16591498|P2|Overall Study|Protocol Violation|3
4811413|NCT01235442|16591499|P1|Overall Study|Protocol Violation|3
4811414|NCT01235442|16591498|P2|Overall Study|Ineligibility determined|4
4811415|NCT01235442|16591499|P1|Overall Study|Ineligibility determined|5
4811416|NCT01235442|16591498|P2|Overall Study|Pregnancy|1
4811417|NCT01235442|16591499|P1|Overall Study|Pregnancy|1
4811418|NCT01235442|16591498|P2|Overall Study|Death|2
4811419|NCT01235442|16591499|P1|Overall Study|Death|0
4811420|NCT01235442|16591498|P2|Overall Study|Lost to Follow-up|10
4811421|NCT01235442|16591499|P1|Overall Study|Lost to Follow-up|12
4811422|NCT01235403|16591517|P1|Overall Study|Other reasons for premature termination|4
4811423|NCT01235403|16591517|P1|Overall Study|Lack of Efficacy|2
4811424|NCT01235403|16591517|P1|Overall Study|Withdrawal by Subject|4
4811425|NCT01235403|16591517|P1|Overall Study|Lost to Follow-up|2
4811426|NCT01235403|16591517|P1|Overall Study|Adverse Event|14
4811427|NCT01235351|16591534|P2|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4
4811428|NCT01235351|16591535|P1|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10
4811429|NCT01235338|16591547|P2|Overall Study|Prohibited meds|0
4811430|NCT01235338|16591548|P1|Overall Study|Prohibited meds|1
4811431|NCT01235338|16591547|P2|Overall Study|Positive drug screen|1
4811432|NCT01235338|16591548|P1|Overall Study|Positive drug screen|0
4811433|NCT01235338|16591547|P2|Overall Study|Exclusion criteria violations|1
4811434|NCT01235338|16591548|P1|Overall Study|Exclusion criteria violations|1
4811435|NCT01235338|16591547|P2|Overall Study|Withdrawal by Subject|0
4811436|NCT01235338|16591548|P1|Overall Study|Withdrawal by Subject|5
4811437|NCT01235338|16591547|P2|Overall Study|Protocol Violation|1
4811438|NCT01235338|16591548|P1|Overall Study|Protocol Violation|1
4811439|NCT01235338|16591547|P2|Overall Study|Adverse Event|2
4811440|NCT01235338|16591548|P1|Overall Study|Adverse Event|3
4811441|NCT01235234|16591593|P3|Overall Study|Adverse Event|1
4811442|NCT01235234|16591594|P2|Overall Study|Adverse Event|2
4811443|NCT01235234|16591595|P1|Overall Study|Adverse Event|2
4811444|NCT01234883|16591643|P2|Overall Study|Inclusion/exclusion failure|0
4811445|NCT01234883|16591644|P1|Overall Study|Inclusion/exclusion failure|1
4811446|NCT01234883|16591643|P2|Overall Study|Technical difficulties with IV infusion|1
4811447|NCT01234883|16591644|P1|Overall Study|Technical difficulties with IV infusion|0
4811448|NCT01234883|16591643|P2|Overall Study|Parent/guardian withdrew consent|2
4811449|NCT01234883|16591644|P1|Overall Study|Parent/guardian withdrew consent|1
4811450|NCT01234883|16591643|P2|Overall Study|Early treatment release|10
4811451|NCT01234883|16591644|P1|Overall Study|Early treatment release|8
4811452|NCT01234675|16591687|P2|First Intervention (6 Weeks)|Withdrawal by Subject|0
4811453|NCT01234675|16591688|P1|First Intervention (6 Weeks)|Withdrawal by Subject|1
4811454|NCT01234675|16591687|P2|First Intervention (6 Weeks)|Adverse Event|1
4811455|NCT01234675|16591688|P1|First Intervention (6 Weeks)|Adverse Event|0
4811456|NCT01234649|16591720|P2|Overall Study|Lack of Efficacy|3
4811457|NCT01234649|16591721|P1|Overall Study|Lack of Efficacy|0
4811458|NCT01234649|16591720|P2|Overall Study|Allergic reaction|0
4811459|NCT01234649|16591721|P1|Overall Study|Allergic reaction|1
4811460|NCT01234649|16591720|P2|Overall Study|intolerant to side effects|3
4811461|NCT01234649|16591721|P1|Overall Study|intolerant to side effects|4
4811462|NCT01234649|16591720|P2|Overall Study|Pregnancy|6
4811463|NCT01234649|16591721|P1|Overall Study|Pregnancy|6
4811464|NCT01234649|16591720|P2|Overall Study|Withdrawal by Subject|26
4811465|NCT01234649|16591721|P1|Overall Study|Withdrawal by Subject|32
4811466|NCT01234467|16591769|P1|Overall Study|Other complicating disease (stroke)|1
4811467|NCT01234467|16591769|P1|Overall Study|Physician Decision|1
4811468|NCT01234467|16591769|P1|Overall Study|Clinical deterioration|1
4811469|NCT01234467|16591769|P1|Overall Study|Disease Progression|2
4811470|NCT01234467|16591769|P1|Overall Study|Withdrawal by Subject|2
4811471|NCT01234467|16591769|P1|Overall Study|Death|2
4811472|NCT01234467|16591769|P1|Overall Study|Adverse Event|3
4811473|NCT01234402|16591781|P3|Overall Study|Never treated: Insurance Denied Xeloda|0
4811474|NCT01234402|16591782|P2|Overall Study|Never treated: Insurance Denied Xeloda|1
4811475|NCT01234402|16591783|P1|Overall Study|Never treated: Insurance Denied Xeloda|0
4811476|NCT01234402|16591781|P3|Overall Study|Never treated: Withdrawal By Subject|0
4811477|NCT01234402|16591782|P2|Overall Study|Never treated: Withdrawal By Subject|1
4811478|NCT01234402|16591783|P1|Overall Study|Never treated: Withdrawal By Subject|0
4811479|NCT01234402|16591781|P3|Overall Study|Never treated: Death|1
4811480|NCT01234402|16591782|P2|Overall Study|Never treated: Death|0
4811481|NCT01234402|16591783|P1|Overall Study|Never treated: Death|0
4811482|NCT01234402|16591781|P3|Overall Study|Withdrawal by Subject|4
4811483|NCT01234402|16591782|P2|Overall Study|Withdrawal by Subject|3
4811484|NCT01234402|16591783|P1|Overall Study|Withdrawal by Subject|1
4811485|NCT01234402|16591781|P3|Overall Study|Lost to Follow-up|3
4811486|NCT01234402|16591782|P2|Overall Study|Lost to Follow-up|1
4811487|NCT01234402|16591783|P1|Overall Study|Lost to Follow-up|0
4811488|NCT01234350|16591824|P2|Overall Study|Covers a diverse set of reasons|92
4811489|NCT01234350|16591825|P1|Overall Study|Covers a diverse set of reasons|234
4811490|NCT01234350|16591824|P2|Overall Study|Lost to Follow-up|47
4811491|NCT01234350|16591825|P1|Overall Study|Lost to Follow-up|115
4811492|NCT01234350|16591824|P2|Overall Study|Withdrawal by Subject|36
4811493|NCT01234350|16591825|P1|Overall Study|Withdrawal by Subject|61
4811494|NCT01234350|16591824|P2|Overall Study|Adverse Event|92
4811495|NCT01234350|16591825|P1|Overall Study|Adverse Event|277
4811496|NCT01234337|16591851|P2|Overall Study|Switch to commercial drug|1
4811497|NCT01234337|16591852|P1|Overall Study|Switch to commercial drug|0
4811498|NCT01234337|16591851|P2|Overall Study|Death|1
4811499|NCT01234337|16591852|P1|Overall Study|Death|0
4811500|NCT01234337|16591851|P2|Overall Study|Withdrawal by Subject|9
4811501|NCT01234337|16591852|P1|Overall Study|Withdrawal by Subject|11
4811502|NCT01234337|16591851|P2|Overall Study|Protocol Violation|3
4811503|NCT01234337|16591852|P1|Overall Study|Protocol Violation|2
4811504|NCT01234337|16591851|P2|Overall Study|Lost to Follow-up|1
4811505|NCT01234337|16591852|P1|Overall Study|Lost to Follow-up|0
4811506|NCT01234337|16591851|P2|Overall Study|Randomized but not treated|4
4811507|NCT01234337|16591852|P1|Overall Study|Randomized but not treated|6
4811508|NCT01234337|16591851|P2|Overall Study|Non-compliant with study medication|2
4811509|NCT01234337|16591852|P1|Overall Study|Non-compliant with study medication|3
4811510|NCT01234337|16591851|P2|Overall Study|Investi. decision not protocol driven|6
4811511|NCT01234337|16591852|P1|Overall Study|Investi. decision not protocol driven|5
4811512|NCT01234337|16591851|P2|Overall Study|Disease progression/recurrence/relapse|223
4811513|NCT01234337|16591852|P1|Overall Study|Disease progression/recurrence/relapse|181
4811514|NCT01234337|16591851|P2|Overall Study|Adverse Event|21
4811515|NCT01234337|16591852|P1|Overall Study|Adverse Event|58
4811516|NCT01233999|16591912|P1|Overall Study|Lost to Follow-up|1
4811517|NCT01233999|16591912|P1|Overall Study|Withdrawal by Subject|1
4811518|NCT01233869|16591931|P4|Extended Treatment Period (46 Months)|Adverse Event|1
4811519|NCT01233869|16591932|P3|Extended Treatment Period (46 Months)|Adverse Event|0
4811520|NCT01233869|16591933|P2|Extended Treatment Period (46 Months)|Adverse Event|0
4811521|NCT01233869|16591934|P1|Extended Treatment Period (46 Months)|Adverse Event|1
4811522|NCT01233869|16591931|P4|Extended Treatment Period (46 Months)|Other|3
4811523|NCT01233869|16591932|P3|Extended Treatment Period (46 Months)|Other|0
4811524|NCT01233869|16591933|P2|Extended Treatment Period (46 Months)|Other|0
4811525|NCT01233869|16591934|P1|Extended Treatment Period (46 Months)|Other|3
4811526|NCT01233869|16591931|P4|Extended Treatment Period (46 Months)|Withdrawal by Subject|11
4811527|NCT01233869|16591932|P3|Extended Treatment Period (46 Months)|Withdrawal by Subject|5
4811528|NCT01233869|16591933|P2|Extended Treatment Period (46 Months)|Withdrawal by Subject|3
4811529|NCT01233869|16591934|P1|Extended Treatment Period (46 Months)|Withdrawal by Subject|10
4811530|NCT01233869|16591931|P4|Extended Treatment Period (46 Months)|Lost to Follow-up|1
4811531|NCT01233869|16591932|P3|Extended Treatment Period (46 Months)|Lost to Follow-up|0
4811532|NCT01233869|16591933|P2|Extended Treatment Period (46 Months)|Lost to Follow-up|0
4811533|NCT01233869|16591934|P1|Extended Treatment Period (46 Months)|Lost to Follow-up|0
4811534|NCT01233869|16591931|P4|Initial Treatment Period (24 Months)|Not Related to Study Drug|19
4811535|NCT01233869|16591932|P3|Initial Treatment Period (24 Months)|Not Related to Study Drug|2
4811536|NCT01233869|16591933|P2|Initial Treatment Period (24 Months)|Not Related to Study Drug|11
4811537|NCT01233869|16591934|P1|Initial Treatment Period (24 Months)|Not Related to Study Drug|14
4811538|NCT01233869|16591931|P4|Initial Treatment Period (24 Months)|Adverse Event|3
4811539|NCT01233869|16591932|P3|Initial Treatment Period (24 Months)|Adverse Event|0
4811540|NCT01233869|16591933|P2|Initial Treatment Period (24 Months)|Adverse Event|17
4811541|NCT01233869|16591934|P1|Initial Treatment Period (24 Months)|Adverse Event|9
4811542|NCT01233869|16591931|P4|Initial Treatment Period (24 Months)|Death|0
4811543|NCT01233869|16591932|P3|Initial Treatment Period (24 Months)|Death|0
4811544|NCT01233869|16591933|P2|Initial Treatment Period (24 Months)|Death|0
4811545|NCT01233869|16591934|P1|Initial Treatment Period (24 Months)|Death|1
4811546|NCT01233817|16592020|P1|Overall Study|Withdrawal by Subject|2
4811547|NCT01233817|16592020|P1|Overall Study|Lost to Follow-up|1
4811548|NCT01233687|16592067|P1|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1
4811549|NCT01233687|16592067|P1|Phase II AMG 102 + Erlotinib|Physician Decision|2
4811550|NCT01233687|16592067|P1|Phase II AMG 102 + Erlotinib|Death|1
4811551|NCT01233609|16592077|P2|Overall Study|Withdrawal by Subject|0
4811552|NCT01233609|16592078|P1|Overall Study|Withdrawal by Subject|3
4811553|NCT01233609|16592077|P2|Overall Study|Adverse Event|1
4811554|NCT01233609|16592078|P1|Overall Study|Adverse Event|2
4811555|NCT01233609|16592077|P2|Overall Study|Lost to Follow-up|1
4811556|NCT01233609|16592078|P1|Overall Study|Lost to Follow-up|3
4811557|NCT01233609|16592077|P2|Overall Study|Death|0
4811558|NCT01233609|16592078|P1|Overall Study|Death|1
4811559|NCT01233284|16592102|P5|Period 4 (4 Weeks)|Lost to Follow-up|0
4811560|NCT01233284|16592103|P4|Period 4 (4 Weeks)|Lost to Follow-up|1
4811561|NCT01233284|16592104|P3|Period 4 (4 Weeks)|Lost to Follow-up|0
4811562|NCT01233284|16592105|P2|Period 4 (4 Weeks)|Lost to Follow-up|0
4811563|NCT01233284|16592106|P1|Period 4 (4 Weeks)|Lost to Follow-up|0
4811564|NCT01233284|16592102|P5|Period 4 (4 Weeks)|Adverse Event|0
4811565|NCT01233284|16592103|P4|Period 4 (4 Weeks)|Adverse Event|0
4811566|NCT01233284|16592104|P3|Period 4 (4 Weeks)|Adverse Event|0
4811567|NCT01233284|16592105|P2|Period 4 (4 Weeks)|Adverse Event|1
4811568|NCT01233284|16592106|P1|Period 4 (4 Weeks)|Adverse Event|0
4811569|NCT01233284|16592102|P5|Period 3 (4 Weeks)|Other|0
4811570|NCT01233284|16592103|P4|Period 3 (4 Weeks)|Other|1
4811571|NCT01233284|16592104|P3|Period 3 (4 Weeks)|Other|0
4811572|NCT01233284|16592105|P2|Period 3 (4 Weeks)|Other|0
4811573|NCT01233284|16592106|P1|Period 3 (4 Weeks)|Other|0
4811574|NCT01233284|16592102|P5|Period 3 (4 Weeks)|Withdrawal by Subject|0
4811575|NCT01233284|16592103|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
4811576|NCT01233284|16592104|P3|Period 3 (4 Weeks)|Withdrawal by Subject|1
4811577|NCT01233284|16592105|P2|Period 3 (4 Weeks)|Withdrawal by Subject|0
4811578|NCT01233284|16592106|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
4811579|NCT01233284|16592102|P5|Period 2 (4 Weeks)|Withdrawal by Subject|0
4811580|NCT01233284|16592103|P4|Period 2 (4 Weeks)|Withdrawal by Subject|0
4811581|NCT01233284|16592104|P3|Period 2 (4 Weeks)|Withdrawal by Subject|1
4811582|NCT01233284|16592105|P2|Period 2 (4 Weeks)|Withdrawal by Subject|0
4811583|NCT01233284|16592106|P1|Period 2 (4 Weeks)|Withdrawal by Subject|0
4811584|NCT01233284|16592102|P5|Period 1 (4 Weeks)|Other|0
4811585|NCT01233284|16592103|P4|Period 1 (4 Weeks)|Other|0
4811586|NCT01233284|16592104|P3|Period 1 (4 Weeks)|Other|1
4811587|NCT01233284|16592105|P2|Period 1 (4 Weeks)|Other|0
4811588|NCT01233284|16592106|P1|Period 1 (4 Weeks)|Other|0
4811589|NCT01233284|16592102|P5|Period 1 (4 Weeks)|Withdrawal by Subject|0
4811590|NCT01233284|16592103|P4|Period 1 (4 Weeks)|Withdrawal by Subject|0
4811591|NCT01233284|16592104|P3|Period 1 (4 Weeks)|Withdrawal by Subject|0
4811592|NCT01233284|16592105|P2|Period 1 (4 Weeks)|Withdrawal by Subject|1
4811593|NCT01233284|16592106|P1|Period 1 (4 Weeks)|Withdrawal by Subject|0
4811594|NCT01233284|16592102|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
4811595|NCT01233284|16592103|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
4811596|NCT01233284|16592104|P3|Period 1 (4 Weeks)|Lost to Follow-up|0
4811597|NCT01233284|16592105|P2|Period 1 (4 Weeks)|Lost to Follow-up|0
4811598|NCT01233284|16592106|P1|Period 1 (4 Weeks)|Lost to Follow-up|1
4811599|NCT01233258|16592187|P6|First Intervention (6 Months)|Non-compliance with study medication|0
4811600|NCT01233258|16592188|P5|First Intervention (6 Months)|Non-compliance with study medication|0
4811601|NCT01233258|16592189|P4|First Intervention (6 Months)|Non-compliance with study medication|0
4811602|NCT01233258|16592190|P3|First Intervention (6 Months)|Non-compliance with study medication|0
4811603|NCT01233258|16592191|P2|First Intervention (6 Months)|Non-compliance with study medication|0
4811604|NCT01233258|16592192|P1|First Intervention (6 Months)|Non-compliance with study medication|1
4811605|NCT01233258|16592187|P6|First Intervention (6 Months)|Protocol Violation|0
4811606|NCT01233258|16592188|P5|First Intervention (6 Months)|Protocol Violation|0
4811607|NCT01233258|16592189|P4|First Intervention (6 Months)|Protocol Violation|0
4811608|NCT01233258|16592190|P3|First Intervention (6 Months)|Protocol Violation|1
4811609|NCT01233258|16592191|P2|First Intervention (6 Months)|Protocol Violation|0
4811610|NCT01233258|16592192|P1|First Intervention (6 Months)|Protocol Violation|0
4811611|NCT01233258|16592187|P6|First Intervention (6 Months)|Withdrawal by Subject|1
4811612|NCT01233258|16592188|P5|First Intervention (6 Months)|Withdrawal by Subject|0
4811613|NCT01233258|16592189|P4|First Intervention (6 Months)|Withdrawal by Subject|1
4811614|NCT01233258|16592190|P3|First Intervention (6 Months)|Withdrawal by Subject|0
4811615|NCT01233258|16592191|P2|First Intervention (6 Months)|Withdrawal by Subject|0
4811616|NCT01233258|16592192|P1|First Intervention (6 Months)|Withdrawal by Subject|0
4811617|NCT01233232|16592212|P3|Overall Study|Voluntary Discontinuation by Subject|0
4811618|NCT01233232|16592213|P2|Overall Study|Voluntary Discontinuation by Subject|0
4811619|NCT01233232|16592214|P1|Overall Study|Voluntary Discontinuation by Subject|1
4811620|NCT01233076|16592267|P2|Period 2, One Week|Lost to Follow-up|0
4811621|NCT01233076|16592268|P1|Period 2, One Week|Lost to Follow-up|1
4811622|NCT01233050|16592276|P2|Overall Study|protocol deviation (inclusion/exclusion)|6
4811623|NCT01233050|16592277|P1|Overall Study|protocol deviation (inclusion/exclusion)|8
4811624|NCT01232894|16592329|P2|Overall Study|Physician Decision|1
4811625|NCT01232894|16592330|P1|Overall Study|Physician Decision|2
4811626|NCT01232894|16592329|P2|Overall Study|Withdrawal by Subject|5
4811627|NCT01232894|16592330|P1|Overall Study|Withdrawal by Subject|8
4811628|NCT01232894|16592329|P2|Overall Study|Protocol Violation|1
4811629|NCT01232894|16592330|P1|Overall Study|Protocol Violation|1
4811630|NCT01232894|16592329|P2|Overall Study|Death|0
4811631|NCT01232894|16592330|P1|Overall Study|Death|1
4811632|NCT01232894|16592329|P2|Overall Study|Lost to Follow-up|1
4811633|NCT01232894|16592330|P1|Overall Study|Lost to Follow-up|0
4811634|NCT01232868|16592338|P2|Overall Study|Lost to Follow-up|4
4811635|NCT01232868|16592339|P1|Overall Study|Lost to Follow-up|2
4811636|NCT01232790|16592353|P2|Second Crossover|Withdrawal by Subject|2
4811637|NCT01232790|16592354|P1|Second Crossover|Withdrawal by Subject|1
4811638|NCT01232790|16592353|P2|First Crossover|Withdrawal by Subject|0
4811639|NCT01232790|16592354|P1|First Crossover|Withdrawal by Subject|1
4811640|NCT01232790|16592353|P2|Initial Assessment|Withdrawal by Subject|1
4811641|NCT01232790|16592354|P1|Initial Assessment|Withdrawal by Subject|0
4811642|NCT01232790|16592353|P2|Randomization|Physician Decision|1
4811643|NCT01232790|16592354|P1|Randomization|Physician Decision|0
4811644|NCT01232790|16592353|P2|Randomization|Protocol Violation|1
4811645|NCT01232790|16592354|P1|Randomization|Protocol Violation|0
4811646|NCT01232790|16592353|P2|Randomization|Withdrawal by Subject|0
4811647|NCT01232790|16592354|P1|Randomization|Withdrawal by Subject|2
4811648|NCT01232738|16592408|P1|Overall Study|Adverse Event|5
4811649|NCT01232738|16592408|P1|Overall Study|Withdrawal by Subject|2
4811650|NCT01232738|16592408|P1|Overall Study|Lost to Follow-up|1
4811651|NCT01232738|16592408|P1|Overall Study|Physician Decision|2
4811652|NCT01232738|16592408|P1|Overall Study|Death|3
4811653|NCT01232569|16592424|P4|Double-blind Treatment Period|Death|0
4811654|NCT01232569|16592425|P3|Double-blind Treatment Period|Death|0
4811655|NCT01232569|16592426|P2|Double-blind Treatment Period|Death|0
4811656|NCT01232569|16592427|P1|Double-blind Treatment Period|Death|2
4811657|NCT01232569|16592424|P4|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
4811658|NCT01232569|16592425|P3|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0
4811659|NCT01232569|16592426|P2|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3
4811660|NCT01232569|16592427|P1|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9
4811661|NCT01232569|16592424|P4|Double-blind Treatment Period|Physician Decision|0
4811662|NCT01232569|16592425|P3|Double-blind Treatment Period|Physician Decision|0
4811663|NCT01232569|16592426|P2|Double-blind Treatment Period|Physician Decision|0
4811664|NCT01232569|16592427|P1|Double-blind Treatment Period|Physician Decision|1
4811665|NCT01232569|16592424|P4|Double-blind Treatment Period|Lack of Efficacy|0
4811666|NCT01232569|16592425|P3|Double-blind Treatment Period|Lack of Efficacy|0
4811667|NCT01232569|16592426|P2|Double-blind Treatment Period|Lack of Efficacy|2
4811668|NCT01232569|16592427|P1|Double-blind Treatment Period|Lack of Efficacy|1
4811669|NCT01232569|16592424|P4|Double-blind Treatment Period|Lost to Follow-up|0
4811670|NCT01232569|16592425|P3|Double-blind Treatment Period|Lost to Follow-up|0
4811671|NCT01232569|16592426|P2|Double-blind Treatment Period|Lost to Follow-up|0
4811672|NCT01232569|16592427|P1|Double-blind Treatment Period|Lost to Follow-up|4
4811673|NCT01232569|16592424|P4|Double-blind Treatment Period|Escape|0
4811674|NCT01232569|16592425|P3|Double-blind Treatment Period|Escape|0
4811675|NCT01232569|16592426|P2|Double-blind Treatment Period|Escape|2
4811676|NCT01232569|16592427|P1|Double-blind Treatment Period|Escape|2
4811677|NCT01232569|16592424|P4|Double-blind Treatment Period|Withdrawal by Subject|0
4811678|NCT01232569|16592425|P3|Double-blind Treatment Period|Withdrawal by Subject|0
4811679|NCT01232569|16592426|P2|Double-blind Treatment Period|Withdrawal by Subject|2
4811680|NCT01232569|16592427|P1|Double-blind Treatment Period|Withdrawal by Subject|9
4811681|NCT01232556|16592470|P2|Overall Study|Other|4
4811682|NCT01232556|16592471|P1|Overall Study|Other|6
4811683|NCT01232556|16592470|P2|Overall Study|Terminated by Sponsor|51
4811684|NCT01232556|16592471|P1|Overall Study|Terminated by Sponsor|35
4811685|NCT01232556|16592470|P2|Overall Study|Lost to Follow-up|2
4811686|NCT01232556|16592471|P1|Overall Study|Lost to Follow-up|0
4811687|NCT01232556|16592470|P2|Overall Study|Death|97
4811688|NCT01232556|16592471|P1|Overall Study|Death|97
4811689|NCT01232556|16592470|P2|Overall Study|Withdrawal by Subject|17
4811690|NCT01232556|16592471|P1|Overall Study|Withdrawal by Subject|21
4811691|NCT01232491|16592530|P2|Overall Study|Other|18
4811692|NCT01232491|16592531|P1|Overall Study|Other|21
4811693|NCT01232491|16592530|P2|Overall Study|Withdrawal Criteria|21
4811694|NCT01232491|16592531|P1|Overall Study|Withdrawal Criteria|12
4811695|NCT01232491|16592530|P2|Overall Study|Protocol Violation|11
4811696|NCT01232491|16592531|P1|Overall Study|Protocol Violation|13
4811697|NCT01232491|16592530|P2|Overall Study|Lack of Efficacy|5
4811698|NCT01232491|16592531|P1|Overall Study|Lack of Efficacy|1
4811699|NCT01232491|16592530|P2|Overall Study|Adverse Event|8
4811700|NCT01232491|16592531|P1|Overall Study|Adverse Event|13
4811701|NCT01232452|16592560|P2|Overall Study|Protocol Violation|1
4811702|NCT01232452|16592561|P1|Overall Study|Protocol Violation|0
4811703|NCT01232452|16592560|P2|Overall Study|Sponsor Decision|1
4811704|NCT01232452|16592561|P1|Overall Study|Sponsor Decision|3
4811705|NCT01232452|16592560|P2|Overall Study|Protocol entry criterion not met|2
4811706|NCT01232452|16592561|P1|Overall Study|Protocol entry criterion not met|0
4811707|NCT01232452|16592560|P2|Overall Study|Physician Decision|12
4811708|NCT01232452|16592561|P1|Overall Study|Physician Decision|8
4811709|NCT01232452|16592560|P2|Overall Study|Withdrawal by Subject|8
4811710|NCT01232452|16592561|P1|Overall Study|Withdrawal by Subject|11
4811711|NCT01232452|16592560|P2|Overall Study|Adverse Event|15
4811712|NCT01232452|16592561|P1|Overall Study|Adverse Event|17
4811713|NCT01232296|16592587|P2|Overall Study|Death|6
4811714|NCT01232296|16592588|P1|Overall Study|Death|1
4811715|NCT01232296|16592587|P2|Overall Study|Subject/guardian decision|2
4811716|NCT01232296|16592588|P1|Overall Study|Subject/guardian decision|10
4811717|NCT01232296|16592587|P2|Overall Study|Technical problems|0
4811718|NCT01232296|16592588|P1|Overall Study|Technical problems|3
4811719|NCT01232296|16592587|P2|Overall Study|Study terminated by sponsor|1
4811720|NCT01232296|16592588|P1|Overall Study|Study terminated by sponsor|0
4811721|NCT01232296|16592587|P2|Overall Study|Progressive disease|61
4811722|NCT01232296|16592588|P1|Overall Study|Progressive disease|43
4811723|NCT01232296|16592587|P2|Overall Study|Physician Decision|1
4811724|NCT01232296|16592588|P1|Overall Study|Physician Decision|1
4811725|NCT01232296|16592587|P2|Overall Study|Adverse Event|12
4811726|NCT01232296|16592588|P1|Overall Study|Adverse Event|24
4811727|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3
4811728|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7
4811729|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811730|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811731|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811732|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811733|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811734|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811735|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811736|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0
4811737|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811738|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1
4811739|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811740|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811741|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811742|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811743|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811744|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811745|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811746|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0
4811747|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811748|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Death|1
4811749|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811750|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811751|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811752|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811753|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811754|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811755|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811756|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Death|0
4811757|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6
4811758|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9
4811759|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811760|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811761|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811762|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811763|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811764|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811765|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811766|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0
4811767|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14
4811768|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30
4811769|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811770|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811771|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811772|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811773|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811774|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811775|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811776|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0
4811777|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2
4811778|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3
4811779|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811780|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811781|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811782|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811783|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811784|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811785|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811786|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0
4811787|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30
4811788|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46
4811789|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811790|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811791|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811792|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811793|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811794|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811795|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811796|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0
4811797|NCT01232283|16592605|P10|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6
4811798|NCT01232283|16592606|P9|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11
4811799|NCT01232283|16592607|P8|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811800|NCT01232283|16592608|P7|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811801|NCT01232283|16592609|P6|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811802|NCT01232283|16592610|P5|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811803|NCT01232283|16592611|P4|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811804|NCT01232283|16592612|P3|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811805|NCT01232283|16592613|P2|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811806|NCT01232283|16592614|P1|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0
4811807|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811808|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811809|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811810|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811811|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Other|1
4811812|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811813|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811814|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811815|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811816|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Other|0
4811817|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811818|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811819|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1
4811820|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811821|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811822|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811823|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811824|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811825|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811826|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0
4811827|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811828|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811829|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
4811830|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1
4811831|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811832|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2
4811833|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811834|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811835|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811836|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0
4811837|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811838|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811839|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811840|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811841|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811842|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Death|1
4811843|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811844|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811845|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811846|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Death|0
4811847|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4811848|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4811849|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4
4811850|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
4811851|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
4811852|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3
4811853|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4811854|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4811855|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4811856|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0
4811857|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811858|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811859|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5
4811860|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13
4811861|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811862|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4
4811863|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811864|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811865|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811866|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0
4811867|NCT01232283|16592605|P10|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811868|NCT01232283|16592606|P9|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811869|NCT01232283|16592607|P8|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
4811870|NCT01232283|16592608|P7|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811871|NCT01232283|16592609|P6|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1
4811872|NCT01232283|16592610|P5|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2
4811873|NCT01232283|16592611|P4|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811874|NCT01232283|16592612|P3|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811875|NCT01232283|16592613|P2|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811876|NCT01232283|16592614|P1|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0
4811877|NCT01232283|16592605|P10|Maintenance Phase (Weeks16-32)|Other|0
4811878|NCT01232283|16592606|P9|Maintenance Phase (Weeks16-32)|Other|0
4811879|NCT01232283|16592607|P8|Maintenance Phase (Weeks16-32)|Other|0
4811880|NCT01232283|16592608|P7|Maintenance Phase (Weeks16-32)|Other|0
4811881|NCT01232283|16592609|P6|Maintenance Phase (Weeks16-32)|Other|0
4811882|NCT01232283|16592610|P5|Maintenance Phase (Weeks16-32)|Other|0
4811883|NCT01232283|16592611|P4|Maintenance Phase (Weeks16-32)|Other|0
4811884|NCT01232283|16592612|P3|Maintenance Phase (Weeks16-32)|Other|2
4811885|NCT01232283|16592613|P2|Maintenance Phase (Weeks16-32)|Other|0
4811886|NCT01232283|16592614|P1|Maintenance Phase (Weeks16-32)|Other|0
4811887|NCT01232283|16592605|P10|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811888|NCT01232283|16592606|P9|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811889|NCT01232283|16592607|P8|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811890|NCT01232283|16592608|P7|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811891|NCT01232283|16592609|P6|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811892|NCT01232283|16592610|P5|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811893|NCT01232283|16592611|P4|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2
4811894|NCT01232283|16592612|P3|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3
4811895|NCT01232283|16592613|P2|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811896|NCT01232283|16592614|P1|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0
4811897|NCT01232283|16592605|P10|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811898|NCT01232283|16592606|P9|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811899|NCT01232283|16592607|P8|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811900|NCT01232283|16592608|P7|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811901|NCT01232283|16592609|P6|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811902|NCT01232283|16592610|P5|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811903|NCT01232283|16592611|P4|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1
4811904|NCT01232283|16592612|P3|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7
4811905|NCT01232283|16592613|P2|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811906|NCT01232283|16592614|P1|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0
4811907|NCT01232283|16592605|P10|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811908|NCT01232283|16592606|P9|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811909|NCT01232283|16592607|P8|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811910|NCT01232283|16592608|P7|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811911|NCT01232283|16592609|P6|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811912|NCT01232283|16592610|P5|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811913|NCT01232283|16592611|P4|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811914|NCT01232283|16592612|P3|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1
4811915|NCT01232283|16592613|P2|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811916|NCT01232283|16592614|P1|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0
4811917|NCT01232283|16592605|P10|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811918|NCT01232283|16592606|P9|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811919|NCT01232283|16592607|P8|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811920|NCT01232283|16592608|P7|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811921|NCT01232283|16592609|P6|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811922|NCT01232283|16592610|P5|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811923|NCT01232283|16592611|P4|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3
4811924|NCT01232283|16592612|P3|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19
4811925|NCT01232283|16592613|P2|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811926|NCT01232283|16592614|P1|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0
4811927|NCT01232283|16592605|P10|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811928|NCT01232283|16592606|P9|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811929|NCT01232283|16592607|P8|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811930|NCT01232283|16592608|P7|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811931|NCT01232283|16592609|P6|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811932|NCT01232283|16592610|P5|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811933|NCT01232283|16592611|P4|Maintenance Phase (Weeks16-32)|Adverse Event|2
4811934|NCT01232283|16592612|P3|Maintenance Phase (Weeks16-32)|Adverse Event|8
4811935|NCT01232283|16592613|P2|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811936|NCT01232283|16592614|P1|Maintenance Phase (Weeks16-32)|Adverse Event|0
4811937|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811938|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811939|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811940|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811941|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811942|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811943|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811944|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Other|0
4811945|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Other|1
4811946|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Other|2
4811947|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811948|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811949|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811950|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811951|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811952|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811953|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811954|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0
4811955|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2
4811956|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3
4811957|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811958|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811959|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811960|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811961|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811962|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811963|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811964|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0
4811965|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
4811966|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6
4811967|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811968|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811969|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811970|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811971|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811972|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811973|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811974|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0
4811975|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7
4811976|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9
4811977|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811978|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811979|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811980|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811981|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811982|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811983|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811984|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811985|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0
4811986|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1
4811987|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811988|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811989|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811990|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811991|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811992|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811993|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811994|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0
4811995|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2
4811996|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3
4811997|NCT01232283|16592605|P10|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4811998|NCT01232283|16592606|P9|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4811999|NCT01232283|16592607|P8|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4812000|NCT01232283|16592608|P7|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4812001|NCT01232283|16592609|P6|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4812002|NCT01232283|16592610|P5|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4812003|NCT01232283|16592611|P4|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4812004|NCT01232283|16592612|P3|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0
4812005|NCT01232283|16592613|P2|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8
4812006|NCT01232283|16592614|P1|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12
4812007|NCT01232127|16592655|P3|Period 1: Days 1-10|Discontinued due to dosing error|0
4812096|NCT01231581|16592957|P2|Overall Study|Death|64
4812008|NCT01232127|16592656|P2|Period 1: Days 1-10|Discontinued due to dosing error|0
4812009|NCT01232127|16592657|P1|Period 1: Days 1-10|Discontinued due to dosing error|1
4812010|NCT01231984|16592681|P4|Study Period 2|Did not continue to meet I/E Criteria|1
4812011|NCT01231984|16592682|P3|Study Period 2|Did not continue to meet I/E Criteria|0
4812012|NCT01231984|16592683|P2|Study Period 2|Did not continue to meet I/E Criteria|1
4812013|NCT01231984|16592684|P1|Study Period 2|Did not continue to meet I/E Criteria|1
4812014|NCT01231984|16592681|P4|Study Period 2|Lost to Follow-up|3
4812015|NCT01231984|16592682|P3|Study Period 2|Lost to Follow-up|0
4812016|NCT01231984|16592683|P2|Study Period 2|Lost to Follow-up|0
4812017|NCT01231984|16592684|P1|Study Period 2|Lost to Follow-up|1
4812018|NCT01231984|16592681|P4|Study Period 2|Withdrawal by Subject|0
4812019|NCT01231984|16592682|P3|Study Period 2|Withdrawal by Subject|0
4812020|NCT01231984|16592683|P2|Study Period 2|Withdrawal by Subject|1
4812021|NCT01231984|16592684|P1|Study Period 2|Withdrawal by Subject|1
4812022|NCT01231984|16592681|P4|Study Period 1|Other|1
4812023|NCT01231984|16592682|P3|Study Period 1|Other|0
4812024|NCT01231984|16592683|P2|Study Period 1|Other|0
4812025|NCT01231984|16592684|P1|Study Period 1|Other|0
4812026|NCT01231984|16592681|P4|Study Period 1|Adverse Event|0
4812027|NCT01231984|16592682|P3|Study Period 1|Adverse Event|0
4812028|NCT01231984|16592683|P2|Study Period 1|Adverse Event|0
4812029|NCT01231984|16592684|P1|Study Period 1|Adverse Event|1
4812030|NCT01231984|16592681|P4|Study Period 1|Protocol Violation|3
4812031|NCT01231984|16592682|P3|Study Period 1|Protocol Violation|2
4812032|NCT01231984|16592683|P2|Study Period 1|Protocol Violation|4
4812033|NCT01231984|16592684|P1|Study Period 1|Protocol Violation|3
4812034|NCT01231984|16592681|P4|Study Period 1|Non-compliance with study requirements|1
4812035|NCT01231984|16592682|P3|Study Period 1|Non-compliance with study requirements|2
4812036|NCT01231984|16592683|P2|Study Period 1|Non-compliance with study requirements|0
4812037|NCT01231984|16592684|P1|Study Period 1|Non-compliance with study requirements|5
4812038|NCT01231984|16592681|P4|Study Period 1|Screen Failure|1
4812039|NCT01231984|16592682|P3|Study Period 1|Screen Failure|0
4812040|NCT01231984|16592683|P2|Study Period 1|Screen Failure|0
4812041|NCT01231984|16592684|P1|Study Period 1|Screen Failure|0
4812042|NCT01231984|16592681|P4|Study Period 1|Did not continue to meet I/E Criteria|2
4812043|NCT01231984|16592682|P3|Study Period 1|Did not continue to meet I/E Criteria|2
4812044|NCT01231984|16592683|P2|Study Period 1|Did not continue to meet I/E Criteria|2
4812045|NCT01231984|16592684|P1|Study Period 1|Did not continue to meet I/E Criteria|2
4812046|NCT01231984|16592681|P4|Study Period 1|Lost to Follow-up|0
4812047|NCT01231984|16592682|P3|Study Period 1|Lost to Follow-up|1
4812048|NCT01231984|16592683|P2|Study Period 1|Lost to Follow-up|1
4812049|NCT01231984|16592684|P1|Study Period 1|Lost to Follow-up|1
4812050|NCT01231984|16592681|P4|Study Period 1|Withdrawal by Subject|1
4812051|NCT01231984|16592682|P3|Study Period 1|Withdrawal by Subject|0
4812052|NCT01231984|16592683|P2|Study Period 1|Withdrawal by Subject|0
4812053|NCT01231984|16592684|P1|Study Period 1|Withdrawal by Subject|0
4812054|NCT01231620|16592753|P3|Overall Study|Lost to Follow-up|9
4812055|NCT01231620|16592754|P2|Overall Study|Lost to Follow-up|4
4812056|NCT01231620|16592755|P1|Overall Study|Lost to Follow-up|3
4812057|NCT01231620|16592753|P3|Overall Study|Withdrawal by Subject|8
4812058|NCT01231620|16592754|P2|Overall Study|Withdrawal by Subject|6
4812059|NCT01231620|16592755|P1|Overall Study|Withdrawal by Subject|6
4812060|NCT01231620|16592753|P3|Overall Study|Adverse Event|1
4812061|NCT01231620|16592754|P2|Overall Study|Adverse Event|2
4812062|NCT01231620|16592755|P1|Overall Study|Adverse Event|2
4812063|NCT01231620|16592753|P3|Overall Study|Death|11
4812064|NCT01231620|16592754|P2|Overall Study|Death|14
4812065|NCT01231620|16592755|P1|Overall Study|Death|12
4812066|NCT01231620|16592753|P3|Overall Study|Physician Decision|10
4812067|NCT01231620|16592754|P2|Overall Study|Physician Decision|5
4812068|NCT01231620|16592755|P1|Overall Study|Physician Decision|3
4812069|NCT01231607|16592861|P5|Overall Study|Withdrawal by Subject|9
4812070|NCT01231607|16592862|P4|Overall Study|Withdrawal by Subject|17
4812071|NCT01231607|16592863|P3|Overall Study|Withdrawal by Subject|14
4812072|NCT01231607|16592864|P2|Overall Study|Withdrawal by Subject|9
4812073|NCT01231607|16592865|P1|Overall Study|Withdrawal by Subject|9
4812074|NCT01231607|16592861|P5|Overall Study|Protocol Violation|2
4812075|NCT01231607|16592862|P4|Overall Study|Protocol Violation|2
4812076|NCT01231607|16592863|P3|Overall Study|Protocol Violation|0
4812077|NCT01231607|16592864|P2|Overall Study|Protocol Violation|2
4812078|NCT01231607|16592865|P1|Overall Study|Protocol Violation|3
4812079|NCT01231607|16592861|P5|Overall Study|Physician Decision|4
4812080|NCT01231607|16592862|P4|Overall Study|Physician Decision|5
4812081|NCT01231607|16592863|P3|Overall Study|Physician Decision|3
4812082|NCT01231607|16592864|P2|Overall Study|Physician Decision|4
4812083|NCT01231607|16592865|P1|Overall Study|Physician Decision|4
4812084|NCT01231607|16592861|P5|Overall Study|Lost to Follow-up|4
4812085|NCT01231607|16592862|P4|Overall Study|Lost to Follow-up|10
4812086|NCT01231607|16592863|P3|Overall Study|Lost to Follow-up|10
4812087|NCT01231607|16592864|P2|Overall Study|Lost to Follow-up|11
4812088|NCT01231607|16592865|P1|Overall Study|Lost to Follow-up|13
4812089|NCT01231607|16592861|P5|Overall Study|Adverse Event|5
4812090|NCT01231607|16592862|P4|Overall Study|Adverse Event|4
4812091|NCT01231607|16592863|P3|Overall Study|Adverse Event|4
4812092|NCT01231607|16592864|P2|Overall Study|Adverse Event|8
4812093|NCT01231607|16592865|P1|Overall Study|Adverse Event|0
4812094|NCT01231581|16592957|P2|Overall Study|Ongoing|0
4812095|NCT01231581|16592958|P1|Overall Study|Ongoing|1
4812097|NCT01231581|16592958|P1|Overall Study|Death|65
4812098|NCT01231581|16592957|P2|Overall Study|Study Closed/Terminated|5
4812099|NCT01231581|16592958|P1|Overall Study|Study Closed/Terminated|6
4812100|NCT01231581|16592957|P2|Overall Study|Withdrawal by Subject|9
4812101|NCT01231581|16592958|P1|Overall Study|Withdrawal by Subject|6
4812102|NCT01231581|16592957|P2|Overall Study|Lost to Follow-up|2
4812103|NCT01231581|16592958|P1|Overall Study|Lost to Follow-up|2
4812104|NCT01231555|16592979|P3|Overall Study|Withdrawal by Subject|0
4812105|NCT01231555|16592980|P2|Overall Study|Withdrawal by Subject|2
4812106|NCT01231555|16592981|P1|Overall Study|Withdrawal by Subject|0
4812107|NCT01231555|16592979|P3|Overall Study|Study terminated|8
4812108|NCT01231555|16592980|P2|Overall Study|Study terminated|5
4812109|NCT01231555|16592981|P1|Overall Study|Study terminated|8
4812110|NCT01231516|16593012|P2|Open-label Phase|Ongoing at the time of analysis|23
4812111|NCT01231516|16593013|P1|Open-label Phase|Ongoing at the time of analysis|282
4812112|NCT01231516|16593012|P2|Open-label Phase|Withdrawal by Subject|0
4812113|NCT01231516|16593013|P1|Open-label Phase|Withdrawal by Subject|1
4812114|NCT01231516|16593012|P2|Open-label Phase|Lost to Follow-up|0
4812115|NCT01231516|16593013|P1|Open-label Phase|Lost to Follow-up|3
4812116|NCT01231516|16593012|P2|Open-label Phase|Protocol Violation|0
4812117|NCT01231516|16593013|P1|Open-label Phase|Protocol Violation|2
4812118|NCT01231516|16593012|P2|Open-label Phase|Lack of Efficacy|3
4812119|NCT01231516|16593013|P1|Open-label Phase|Lack of Efficacy|7
4812120|NCT01231516|16593012|P2|48 Week Double-blind Phase|Site Closed|1
4812121|NCT01231516|16593013|P1|48 Week Double-blind Phase|Site Closed|3
4812122|NCT01231516|16593012|P2|48 Week Double-blind Phase|Withdrawal by Subject|5
4812123|NCT01231516|16593013|P1|48 Week Double-blind Phase|Withdrawal by Subject|11
4812124|NCT01231516|16593012|P2|48 Week Double-blind Phase|Physician Decision|1
4812125|NCT01231516|16593013|P1|48 Week Double-blind Phase|Physician Decision|1
4812126|NCT01231516|16593012|P2|48 Week Double-blind Phase|Lost to Follow-up|10
4812127|NCT01231516|16593013|P1|48 Week Double-blind Phase|Lost to Follow-up|5
4812128|NCT01231516|16593012|P2|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|3
4812129|NCT01231516|16593013|P1|48 Week Double-blind Phase|Met Protocol-Defined Stopping Criteria|5
4812130|NCT01231516|16593012|P2|48 Week Double-blind Phase|Protocol Violation|6
4812131|NCT01231516|16593013|P1|48 Week Double-blind Phase|Protocol Violation|9
4812132|NCT01231516|16593012|P2|48 Week Double-blind Phase|Lack of Efficacy|42
4812133|NCT01231516|16593013|P1|48 Week Double-blind Phase|Lack of Efficacy|20
4812134|NCT01231516|16593012|P2|48 Week Double-blind Phase|Adverse Event|11
4812135|NCT01231516|16593013|P1|48 Week Double-blind Phase|Adverse Event|4
4812136|NCT01231503|16593043|P8|Overall Study|Protocol Violation|0
4812137|NCT01231503|16593044|P7|Overall Study|Protocol Violation|0
4812138|NCT01231503|16593045|P6|Overall Study|Protocol Violation|0
4812139|NCT01231503|16593046|P5|Overall Study|Protocol Violation|0
4812140|NCT01231503|16593047|P4|Overall Study|Protocol Violation|1
4812141|NCT01231503|16593048|P3|Overall Study|Protocol Violation|0
4812142|NCT01231503|16593049|P2|Overall Study|Protocol Violation|0
4812143|NCT01231503|16593050|P1|Overall Study|Protocol Violation|0
4812144|NCT01231503|16593043|P8|Overall Study|Lost to Follow-up|6
4812145|NCT01231503|16593044|P7|Overall Study|Lost to Follow-up|6
4812146|NCT01231503|16593045|P6|Overall Study|Lost to Follow-up|9
4812147|NCT01231503|16593046|P5|Overall Study|Lost to Follow-up|7
4812148|NCT01231503|16593047|P4|Overall Study|Lost to Follow-up|5
4812149|NCT01231503|16593048|P3|Overall Study|Lost to Follow-up|8
4812150|NCT01231503|16593049|P2|Overall Study|Lost to Follow-up|10
4812151|NCT01231503|16593050|P1|Overall Study|Lost to Follow-up|8
4812152|NCT01231503|16593043|P8|Overall Study|Withdrawal by Subject|2
4812153|NCT01231503|16593044|P7|Overall Study|Withdrawal by Subject|1
4812154|NCT01231503|16593045|P6|Overall Study|Withdrawal by Subject|5
4812155|NCT01231503|16593046|P5|Overall Study|Withdrawal by Subject|3
4812156|NCT01231503|16593047|P4|Overall Study|Withdrawal by Subject|1
4812157|NCT01231503|16593048|P3|Overall Study|Withdrawal by Subject|3
4812158|NCT01231503|16593049|P2|Overall Study|Withdrawal by Subject|3
4812159|NCT01231503|16593050|P1|Overall Study|Withdrawal by Subject|6
4812160|NCT01231503|16593043|P8|Overall Study|Adverse event, serious fatal|0
4812161|NCT01231503|16593044|P7|Overall Study|Adverse event, serious fatal|0
4812162|NCT01231503|16593045|P6|Overall Study|Adverse event, serious fatal|1
4812163|NCT01231503|16593046|P5|Overall Study|Adverse event, serious fatal|0
4812164|NCT01231503|16593047|P4|Overall Study|Adverse event, serious fatal|1
4812165|NCT01231503|16593048|P3|Overall Study|Adverse event, serious fatal|1
4812166|NCT01231503|16593049|P2|Overall Study|Adverse event, serious fatal|0
4812167|NCT01231503|16593050|P1|Overall Study|Adverse event, serious fatal|0
4812168|NCT01231503|16593043|P8|Overall Study|Adverse Event|0
4812169|NCT01231503|16593044|P7|Overall Study|Adverse Event|0
4812170|NCT01231503|16593045|P6|Overall Study|Adverse Event|1
4812171|NCT01231503|16593046|P5|Overall Study|Adverse Event|0
4812172|NCT01231503|16593047|P4|Overall Study|Adverse Event|0
4812173|NCT01231503|16593048|P3|Overall Study|Adverse Event|0
4812174|NCT01231503|16593049|P2|Overall Study|Adverse Event|0
4812175|NCT01231503|16593050|P1|Overall Study|Adverse Event|0
4812176|NCT01231464|16593290|P2|Overall Study|Withdrawal by Subject|2
4812177|NCT01231464|16593291|P1|Overall Study|Withdrawal by Subject|3
4812178|NCT01231464|16593290|P2|Overall Study|Lost to Follow-up|2
4812179|NCT01231464|16593291|P1|Overall Study|Lost to Follow-up|1
4812180|NCT01231464|16593290|P2|Overall Study|Protocol Violation|2
4812181|NCT01231464|16593291|P1|Overall Study|Protocol Violation|1
4812182|NCT01231464|16593290|P2|Overall Study|Adverse Event|1
4812183|NCT01231464|16593291|P1|Overall Study|Adverse Event|0
4812184|NCT01231373|16593340|P4|Overall Study|Withdrew Consent|0
4812185|NCT01231373|16593341|P3|Overall Study|Withdrew Consent|0
4812186|NCT01231373|16593342|P2|Overall Study|Withdrew Consent|0
4812187|NCT01231373|16593343|P1|Overall Study|Withdrew Consent|1
4812188|NCT01231373|16593340|P4|Overall Study|Lost to Follow-up|1
4812189|NCT01231373|16593341|P3|Overall Study|Lost to Follow-up|0
4812190|NCT01231373|16593342|P2|Overall Study|Lost to Follow-up|0
4812191|NCT01231373|16593343|P1|Overall Study|Lost to Follow-up|0
4812192|NCT01231373|16593340|P4|Overall Study|Withdrew consent prior to randomization|0
4812193|NCT01231373|16593341|P3|Overall Study|Withdrew consent prior to randomization|0
4812194|NCT01231373|16593342|P2|Overall Study|Withdrew consent prior to randomization|1
4812195|NCT01231373|16593343|P1|Overall Study|Withdrew consent prior to randomization|2
4812196|NCT01231321|16593382|P1|Overall Study|Lack of Efficacy|2
4812197|NCT01231321|16593382|P1|Overall Study|Adverse Event|3
4812198|NCT01230892|16593430|P2|Overall Study|Lost to Follow-up|0
4812199|NCT01230892|16593431|P1|Overall Study|Lost to Follow-up|2
4812200|NCT01230892|16593430|P2|Overall Study|Withdrawal by Subject|1
4812201|NCT01230892|16593431|P1|Overall Study|Withdrawal by Subject|1
4812202|NCT01230827|16593441|P4|Overall Study|Study terminated by Sponsor|63
4812203|NCT01230827|16593442|P3|Overall Study|Study terminated by Sponsor|56
4812204|NCT01230827|16593443|P2|Overall Study|Study terminated by Sponsor|2
4812205|NCT01230827|16593444|P1|Overall Study|Study terminated by Sponsor|0
4812206|NCT01230827|16593441|P4|Overall Study|Recovery|0
4812207|NCT01230827|16593442|P3|Overall Study|Recovery|0
4812208|NCT01230827|16593443|P2|Overall Study|Recovery|6
4812209|NCT01230827|16593444|P1|Overall Study|Recovery|0
4812210|NCT01230827|16593441|P4|Overall Study|Adverse Event|7
4812211|NCT01230827|16593442|P3|Overall Study|Adverse Event|3
4812212|NCT01230827|16593443|P2|Overall Study|Adverse Event|2
4812213|NCT01230827|16593444|P1|Overall Study|Adverse Event|4
4812214|NCT01230827|16593441|P4|Overall Study|Lack of Efficacy|3
4812215|NCT01230827|16593442|P3|Overall Study|Lack of Efficacy|2
4812216|NCT01230827|16593443|P2|Overall Study|Lack of Efficacy|1
4812217|NCT01230827|16593444|P1|Overall Study|Lack of Efficacy|14
4812218|NCT01230827|16593441|P4|Overall Study|Withdrawal by Subject|2
4812219|NCT01230827|16593442|P3|Overall Study|Withdrawal by Subject|3
4812220|NCT01230827|16593443|P2|Overall Study|Withdrawal by Subject|0
4812221|NCT01230827|16593444|P1|Overall Study|Withdrawal by Subject|1
4812222|NCT01230827|16593441|P4|Overall Study|Lost to Follow-up|3
4812223|NCT01230827|16593442|P3|Overall Study|Lost to Follow-up|1
4812224|NCT01230827|16593443|P2|Overall Study|Lost to Follow-up|0
4812225|NCT01230827|16593444|P1|Overall Study|Lost to Follow-up|0
4812226|NCT01230814|16593460|P2|Overall Study|Discontinued (not due to adverse event)|1
4812227|NCT01230814|16593461|P1|Overall Study|Discontinued (not due to adverse event)|2
4812228|NCT01230814|16593460|P2|Overall Study|Lost to Follow-up|3
4812229|NCT01230814|16593461|P1|Overall Study|Lost to Follow-up|11
4812230|NCT01230788|16593511|P1|Overall Study|Prescribed exclusion drug|1
4812231|NCT01230749|16593523|P4|Overall Study|Fasting glucose more than 270 mg/dL|1
4812232|NCT01230749|16593524|P3|Overall Study|Fasting glucose more than 270 mg/dL|1
4812233|NCT01230749|16593525|P2|Overall Study|Fasting glucose more than 270 mg/dL|1
4812234|NCT01230749|16593526|P1|Overall Study|Fasting glucose more than 270 mg/dL|0
4812235|NCT01230749|16593523|P4|Overall Study|Withdrawal by Subject|0
4812236|NCT01230749|16593524|P3|Overall Study|Withdrawal by Subject|0
4812237|NCT01230749|16593525|P2|Overall Study|Withdrawal by Subject|1
4812238|NCT01230749|16593526|P1|Overall Study|Withdrawal by Subject|0
4812239|NCT01230749|16593523|P4|Overall Study|Physician Decision|0
4812240|NCT01230749|16593524|P3|Overall Study|Physician Decision|1
4812241|NCT01230749|16593525|P2|Overall Study|Physician Decision|0
4812242|NCT01230749|16593526|P1|Overall Study|Physician Decision|0
4812243|NCT01230749|16593523|P4|Overall Study|Adverse Event|1
4812244|NCT01230749|16593524|P3|Overall Study|Adverse Event|0
4812245|NCT01230749|16593525|P2|Overall Study|Adverse Event|0
4812246|NCT01230749|16593526|P1|Overall Study|Adverse Event|0
4812247|NCT01230710|16593561|P1|Overall Study|Withdrawal of Consent|1
4812248|NCT01230710|16593561|P1|Overall Study|Death|4
4812249|NCT01230710|16593561|P1|Overall Study|Lost to Follow-up|3
4812250|NCT01230710|16593561|P1|Overall Study|Disease Progression|41
4812251|NCT01230554|16593585|P1|Overall Study|Inability to maintain visit schedule|1
4812252|NCT01230554|16593585|P1|Overall Study|Lost to Follow-up|2
4812253|NCT01230489|16593608|P1|Overall Study|Treatment modality changed|1
4812254|NCT01230489|16593608|P1|Overall Study|Adverse Event|2
4812255|NCT01230489|16593608|P1|Overall Study|Death|2
4812256|NCT01230307|16593643|P2|Overall Study|LVAD Placement|2
4812257|NCT01230307|16593644|P1|Overall Study|LVAD Placement|0
4812258|NCT01230060|16593677|P1|Overall Study|Withdrawal by Subject|1
4812259|NCT01229735|16593750|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4812260|NCT01229735|16593751|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4812261|NCT01229735|16593750|P2|Overall Study|AE, non-serious non-fatal|17
4812262|NCT01229735|16593751|P1|Overall Study|AE, non-serious non-fatal|13
4812263|NCT01229735|16593750|P2|Overall Study|SAE, non-fatal|4
4812264|NCT01229735|16593751|P1|Overall Study|SAE, non-fatal|0
4812265|NCT01229735|16593750|P2|Overall Study|Other Reason|10
4812266|NCT01229735|16593751|P1|Overall Study|Other Reason|13
4812267|NCT01229735|16593750|P2|Overall Study|Withdrawal by Subject|17
4812268|NCT01229735|16593751|P1|Overall Study|Withdrawal by Subject|18
4812269|NCT01229735|16593750|P2|Overall Study|Lost to Follow-up|2
4812270|NCT01229735|16593751|P1|Overall Study|Lost to Follow-up|0
4812271|NCT01229735|16593750|P2|Overall Study|Protocol Violation|8
4812272|NCT01229735|16593751|P1|Overall Study|Protocol Violation|13
4812273|NCT01229735|16593750|P2|Overall Study|Lack of Efficacy|8
4812274|NCT01229735|16593751|P1|Overall Study|Lack of Efficacy|8
4812275|NCT01229449|16593808|P5|Overall Study|Physician Decision|0
4812276|NCT01229449|16593809|P4|Overall Study|Physician Decision|0
4812277|NCT01229449|16593810|P3|Overall Study|Physician Decision|1
4812278|NCT01229449|16593811|P2|Overall Study|Physician Decision|0
4812279|NCT01229449|16593812|P1|Overall Study|Physician Decision|0
4812280|NCT01229449|16593808|P5|Overall Study|Lost to Follow-up|0
4812281|NCT01229449|16593809|P4|Overall Study|Lost to Follow-up|0
4812282|NCT01229449|16593810|P3|Overall Study|Lost to Follow-up|1
4812283|NCT01229449|16593811|P2|Overall Study|Lost to Follow-up|1
4812284|NCT01229449|16593812|P1|Overall Study|Lost to Follow-up|1
4812285|NCT01229449|16593808|P5|Overall Study|Withdrawal by Subject|1
4812286|NCT01229449|16593809|P4|Overall Study|Withdrawal by Subject|1
4812287|NCT01229449|16593810|P3|Overall Study|Withdrawal by Subject|0
4812288|NCT01229449|16593811|P2|Overall Study|Withdrawal by Subject|3
4812289|NCT01229449|16593812|P1|Overall Study|Withdrawal by Subject|0
4812290|NCT01229436|16593869|P1|Overall Study|Lost to Follow-up|3
4812291|NCT01229436|16593869|P1|Overall Study|Withdrawal by Subject|2
4812292|NCT01229397|16593931|P2|Overall Study|Migrated/moved from study area|0
4812293|NCT01229397|16593932|P1|Overall Study|Migrated/moved from study area|1
4812294|NCT01229397|16593931|P2|Overall Study|Lost to Follow-up|6
4812295|NCT01229397|16593932|P1|Overall Study|Lost to Follow-up|7
4812296|NCT01229397|16593931|P2|Overall Study|Withdrawal by Subject|3
4812297|NCT01229397|16593932|P1|Overall Study|Withdrawal by Subject|3
4812298|NCT01229371|16593950|P4|Overall Study|Withdrawal by Subject|0
4812299|NCT01229371|16593951|P3|Overall Study|Withdrawal by Subject|0
4812300|NCT01229371|16593952|P2|Overall Study|Withdrawal by Subject|1
4812301|NCT01229371|16593953|P1|Overall Study|Withdrawal by Subject|0
4812302|NCT01229267|16593980|P5|Overall Study|Lost to Follow-up|22
4812303|NCT01229267|16593981|P4|Overall Study|Lost to Follow-up|3
4812304|NCT01229267|16593982|P3|Overall Study|Lost to Follow-up|8
4812305|NCT01229267|16593983|P2|Overall Study|Lost to Follow-up|5
4812306|NCT01229267|16593984|P1|Overall Study|Lost to Follow-up|6
4812307|NCT01229267|16593980|P5|Overall Study|Physician Decision|25
4812308|NCT01229267|16593981|P4|Overall Study|Physician Decision|3
4812309|NCT01229267|16593982|P3|Overall Study|Physician Decision|8
4812310|NCT01229267|16593983|P2|Overall Study|Physician Decision|11
4812311|NCT01229267|16593984|P1|Overall Study|Physician Decision|8
4812312|NCT01229267|16593980|P5|Overall Study|Progressive disease|1
4812313|NCT01229267|16593981|P4|Overall Study|Progressive disease|0
4812314|NCT01229267|16593982|P3|Overall Study|Progressive disease|0
4812315|NCT01229267|16593983|P2|Overall Study|Progressive disease|0
4812316|NCT01229267|16593984|P1|Overall Study|Progressive disease|0
4812317|NCT01229267|16593980|P5|Overall Study|Protocol Violation|0
4812318|NCT01229267|16593981|P4|Overall Study|Protocol Violation|0
4812319|NCT01229267|16593982|P3|Overall Study|Protocol Violation|0
4812320|NCT01229267|16593983|P2|Overall Study|Protocol Violation|1
4812321|NCT01229267|16593984|P1|Overall Study|Protocol Violation|0
4812322|NCT01229267|16593980|P5|Overall Study|Withdrawal by Subject|59
4812323|NCT01229267|16593981|P4|Overall Study|Withdrawal by Subject|14
4812324|NCT01229267|16593982|P3|Overall Study|Withdrawal by Subject|32
4812325|NCT01229267|16593983|P2|Overall Study|Withdrawal by Subject|22
4812326|NCT01229267|16593984|P1|Overall Study|Withdrawal by Subject|23
4812327|NCT01229267|16593980|P5|Overall Study|Death|103
4812328|NCT01229267|16593981|P4|Overall Study|Death|13
4812329|NCT01229267|16593982|P3|Overall Study|Death|35
4812330|NCT01229267|16593983|P2|Overall Study|Death|37
4812331|NCT01229267|16593984|P1|Overall Study|Death|40
4812332|NCT01229267|16593980|P5|Overall Study|Adverse Event|10
4812333|NCT01229267|16593981|P4|Overall Study|Adverse Event|2
4812334|NCT01229267|16593982|P3|Overall Study|Adverse Event|3
4812335|NCT01229267|16593983|P2|Overall Study|Adverse Event|6
4812336|NCT01229267|16593984|P1|Overall Study|Adverse Event|4
4812337|NCT01229254|16594003|P3|Overall Study|Non-compliance with Study Drug|1
4812338|NCT01229254|16594004|P2|Overall Study|Non-compliance with Study Drug|1
4812339|NCT01229254|16594005|P1|Overall Study|Non-compliance with Study Drug|0
4812340|NCT01229254|16594003|P3|Overall Study|Withdrawal by Subject|1
4812341|NCT01229254|16594004|P2|Overall Study|Withdrawal by Subject|0
4812342|NCT01229254|16594005|P1|Overall Study|Withdrawal by Subject|1
4812343|NCT01229254|16594003|P3|Overall Study|Protocol Violation|5
4812344|NCT01229254|16594004|P2|Overall Study|Protocol Violation|6
4812345|NCT01229254|16594005|P1|Overall Study|Protocol Violation|4
4812346|NCT01229254|16594003|P3|Overall Study|Physician Decision|0
4812347|NCT01229254|16594004|P2|Overall Study|Physician Decision|3
4812348|NCT01229254|16594005|P1|Overall Study|Physician Decision|0
4812349|NCT01229254|16594003|P3|Overall Study|Lost to Follow-up|1
4812350|NCT01229254|16594004|P2|Overall Study|Lost to Follow-up|0
4812351|NCT01229254|16594005|P1|Overall Study|Lost to Follow-up|3
4812352|NCT01229254|16594003|P3|Overall Study|Adverse Event|3
4812353|NCT01229254|16594004|P2|Overall Study|Adverse Event|5
4812354|NCT01229254|16594005|P1|Overall Study|Adverse Event|4
4812355|NCT01229254|16594003|P3|Overall Study|Not Continuing Into Safety Extension|1
4812356|NCT01229254|16594004|P2|Overall Study|Not Continuing Into Safety Extension|1
4812357|NCT01229254|16594005|P1|Overall Study|Not Continuing Into Safety Extension|3
4812358|NCT01229176|16594043|P8|Overall Study|Lost to Follow-up|2
4812359|NCT01229176|16594044|P7|Overall Study|Lost to Follow-up|0
4812360|NCT01229176|16594045|P6|Overall Study|Lost to Follow-up|1
4812361|NCT01229176|16594046|P5|Overall Study|Lost to Follow-up|1
4812362|NCT01229176|16594047|P4|Overall Study|Lost to Follow-up|0
4812363|NCT01229176|16594048|P3|Overall Study|Lost to Follow-up|0
4812364|NCT01229176|16594049|P2|Overall Study|Lost to Follow-up|3
4812365|NCT01229176|16594050|P1|Overall Study|Lost to Follow-up|0
4812366|NCT01229176|16594043|P8|Overall Study|Withdrawal by Subject|1
4812367|NCT01229176|16594044|P7|Overall Study|Withdrawal by Subject|0
4812368|NCT01229176|16594045|P6|Overall Study|Withdrawal by Subject|1
4812369|NCT01229176|16594046|P5|Overall Study|Withdrawal by Subject|1
4812370|NCT01229176|16594047|P4|Overall Study|Withdrawal by Subject|1
4812371|NCT01229176|16594048|P3|Overall Study|Withdrawal by Subject|0
4812372|NCT01229176|16594049|P2|Overall Study|Withdrawal by Subject|0
4812373|NCT01229176|16594050|P1|Overall Study|Withdrawal by Subject|0
4812374|NCT01229150|16594104|P4|Overall Study|Toxicity|0
4812375|NCT01229150|16594105|P3|Overall Study|Toxicity|0
4812376|NCT01229150|16594106|P2|Overall Study|Toxicity|2
4812377|NCT01229150|16594107|P1|Overall Study|Toxicity|2
4812378|NCT01229111|16594164|P1|Overall Study|Death|1
4812379|NCT01228747|16594213|P2|Overall Study|Other Reason|5
4812380|NCT01228747|16594214|P1|Overall Study|Other Reason|2
4812381|NCT01228747|16594213|P2|Overall Study|Withdrawal by Subject|1
4812382|NCT01228747|16594214|P1|Overall Study|Withdrawal by Subject|5
4812383|NCT01228747|16594213|P2|Overall Study|Lost to Follow-up|3
4812384|NCT01228747|16594214|P1|Overall Study|Lost to Follow-up|4
4812385|NCT01228747|16594213|P2|Overall Study|Protocol Violation|5
4812386|NCT01228747|16594214|P1|Overall Study|Protocol Violation|6
4812387|NCT01228747|16594213|P2|Overall Study|Lack of Efficacy|27
4812388|NCT01228747|16594214|P1|Overall Study|Lack of Efficacy|40
4812389|NCT01228747|16594213|P2|Overall Study|Adverse Event|4
4812390|NCT01228747|16594214|P1|Overall Study|Adverse Event|8
4812391|NCT01228734|16594230|P2|Overall Study|Randomized, but not treated|4
4812392|NCT01228734|16594231|P1|Overall Study|Randomized, but not treated|0
4812393|NCT01228591|16594245|P2|Baseline|Lack of Efficacy|2
4812394|NCT01228591|16594246|P1|Baseline|Lack of Efficacy|1
4812395|NCT01228318|16594275|P2|Overall Study|Incarcerated|0
4812396|NCT01228318|16594276|P1|Overall Study|Incarcerated|1
4812397|NCT01228318|16594275|P2|Overall Study|Moved|2
4812398|NCT01228318|16594276|P1|Overall Study|Moved|0
4812399|NCT01228318|16594275|P2|Overall Study|Unable to contact|5
4812400|NCT01228318|16594276|P1|Overall Study|Unable to contact|2
4812401|NCT01228318|16594275|P2|Overall Study|Clinic no show to receive intervention|0
4812402|NCT01228318|16594276|P1|Overall Study|Clinic no show to receive intervention|1
4812403|NCT01228175|16594292|P2|Overall Study|Physician Decision|1
4812404|NCT01228175|16594293|P1|Overall Study|Physician Decision|1
4812405|NCT01228175|16594292|P2|Overall Study|Withdrawal by Subject|2
4812406|NCT01228175|16594293|P1|Overall Study|Withdrawal by Subject|1
4812407|NCT01228175|16594292|P2|Overall Study|Lost to Follow-up|50
4812408|NCT01228175|16594293|P1|Overall Study|Lost to Follow-up|64
4812409|NCT01228071|16594335|P1|Overall Study|Withdrawal by Subject|1
4812410|NCT01228071|16594335|P1|Overall Study|Protocol Violation|1
4812411|NCT01228019|16594341|P1|Overall Study|Violation of Entry Criterion|9
4812412|NCT01228019|16594341|P1|Overall Study|Triglyceride Entry Criteria Not Met|152
4812413|NCT01228019|16594341|P1|Overall Study|Missing pre-treatment data|72
4812414|NCT01228019|16594341|P1|Overall Study|Duplicate enrollment|1
4812415|NCT01228019|16594341|P1|Overall Study|Dose Violation|70
4812416|NCT01227967|16594407|P2|Overall Study|Taking Additional Antiviral Drug|0
4812417|NCT01227967|16594408|P1|Overall Study|Taking Additional Antiviral Drug|1
4812418|NCT01227967|16594407|P2|Overall Study|Never Started Treatment|4
4812419|NCT01227967|16594408|P1|Overall Study|Never Started Treatment|0
4812420|NCT01227967|16594407|P2|Overall Study|Physician Decision|1
4812421|NCT01227967|16594408|P1|Overall Study|Physician Decision|0
4812422|NCT01227967|16594407|P2|Overall Study|Withdrawal by Subject|3
4812423|NCT01227967|16594408|P1|Overall Study|Withdrawal by Subject|4
4812424|NCT01227967|16594407|P2|Overall Study|Lost to Follow-up|3
4812425|NCT01227967|16594408|P1|Overall Study|Lost to Follow-up|8
4812426|NCT01227967|16594407|P2|Overall Study|Death|1
4812427|NCT01227967|16594408|P1|Overall Study|Death|0
4812428|NCT01227967|16594407|P2|Overall Study|Protocol Violation|1
4812429|NCT01227967|16594408|P1|Overall Study|Protocol Violation|3
4812430|NCT01227954|16594442|P1|Overall Study|No protocol treatment|7
4812431|NCT01227954|16594442|P1|Overall Study|Protocol Violation|6
4812432|NCT01227928|16594456|P2|Overall Study|Death|12
4812433|NCT01227928|16594457|P1|Overall Study|Death|14
4812434|NCT01227928|16594456|P2|Overall Study|Withdrawal by Subject|3
4812435|NCT01227928|16594457|P1|Overall Study|Withdrawal by Subject|4
4812436|NCT01227928|16594456|P2|Overall Study|Lost to Follow-up|2
4812437|NCT01227928|16594457|P1|Overall Study|Lost to Follow-up|4
4812438|NCT01227902|16594495|P4|Overall Study|Withdrawal by Subject|3
4812439|NCT01227902|16594496|P3|Overall Study|Withdrawal by Subject|4
4812440|NCT01227902|16594497|P2|Overall Study|Withdrawal by Subject|2
4812441|NCT01227902|16594498|P1|Overall Study|Withdrawal by Subject|4
4812442|NCT01227902|16594495|P4|Overall Study|Physician Decision|0
4812443|NCT01227902|16594496|P3|Overall Study|Physician Decision|1
4812444|NCT01227902|16594497|P2|Overall Study|Physician Decision|1
4812445|NCT01227902|16594498|P1|Overall Study|Physician Decision|0
4812446|NCT01227902|16594495|P4|Overall Study|Lost to Follow-up|2
4812447|NCT01227902|16594496|P3|Overall Study|Lost to Follow-up|1
4812448|NCT01227902|16594497|P2|Overall Study|Lost to Follow-up|0
4812449|NCT01227902|16594498|P1|Overall Study|Lost to Follow-up|0
4812450|NCT01227902|16594495|P4|Overall Study|Protocol Violation|0
4812451|NCT01227902|16594496|P3|Overall Study|Protocol Violation|0
4812452|NCT01227902|16594497|P2|Overall Study|Protocol Violation|0
4812453|NCT01227902|16594498|P1|Overall Study|Protocol Violation|1
4812454|NCT01227902|16594495|P4|Overall Study|Lack of Efficacy|1
4812455|NCT01227902|16594496|P3|Overall Study|Lack of Efficacy|2
4812456|NCT01227902|16594497|P2|Overall Study|Lack of Efficacy|2
4812457|NCT01227902|16594498|P1|Overall Study|Lack of Efficacy|1
4812458|NCT01227902|16594495|P4|Overall Study|Adverse Event|4
4812459|NCT01227902|16594496|P3|Overall Study|Adverse Event|11
4812460|NCT01227902|16594497|P2|Overall Study|Adverse Event|8
4812461|NCT01227902|16594498|P1|Overall Study|Adverse Event|12
4812462|NCT01227889|16594591|P2|Crossover Phase|Withdrawal by Subject|1
4812463|NCT01227889|16594592|P1|Crossover Phase|Withdrawal by Subject|0
4812464|NCT01227889|16594591|P2|Crossover Phase|Study Terminated By Sponsor|1
4812465|NCT01227889|16594592|P1|Crossover Phase|Study Terminated By Sponsor|0
4812466|NCT01227889|16594591|P2|Crossover Phase|Progressive Disease|31
4812467|NCT01227889|16594592|P1|Crossover Phase|Progressive Disease|0
4812468|NCT01227889|16594591|P2|Crossover Phase|Physician Decision|3
4812469|NCT01227889|16594592|P1|Crossover Phase|Physician Decision|0
4812470|NCT01227889|16594591|P2|Crossover Phase|Adverse Event|1
4812471|NCT01227889|16594592|P1|Crossover Phase|Adverse Event|0
4812472|NCT01227889|16594591|P2|Randomized Phase (RP)|Withdrawal by Subject|3
4812473|NCT01227889|16594592|P1|Randomized Phase (RP)|Withdrawal by Subject|15
4812474|NCT01227889|16594591|P2|Randomized Phase (RP)|Missing|3
4812475|NCT01227889|16594592|P1|Randomized Phase (RP)|Missing|1
4812476|NCT01227889|16594591|P2|Randomized Phase (RP)|Study terminated by sponsor|0
4812477|NCT01227889|16594592|P1|Randomized Phase (RP)|Study terminated by sponsor|10
4812478|NCT01227889|16594591|P2|Randomized Phase (RP)|Progressive Disease|52
4812479|NCT01227889|16594592|P1|Randomized Phase (RP)|Progressive Disease|135
4812480|NCT01227889|16594591|P2|Randomized Phase (RP)|Physician Decision|5
4812481|NCT01227889|16594592|P1|Randomized Phase (RP)|Physician Decision|13
4812482|NCT01227889|16594591|P2|Randomized Phase (RP)|Adverse Event|0
4812483|NCT01227889|16594592|P1|Randomized Phase (RP)|Adverse Event|13
4812484|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Physician Decision|3
4812485|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Physician Decision|0
4812486|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Physician Decision|0
4812487|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8
4812488|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
4812489|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0
4812490|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15
4812491|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
4812492|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0
4812493|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4
4812494|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
4812495|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0
4812496|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Protocol Violation|5
4812497|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Protocol Violation|0
4812498|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Protocol Violation|0
4812499|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5
4812500|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
4812501|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0
4812502|NCT01227824|16594619|P3|Open-label Phase: Median of 1267 Days|Adverse Event|4
4812503|NCT01227824|16594620|P2|Open-label Phase: Median of 1267 Days|Adverse Event|0
4812504|NCT01227824|16594621|P1|Open-label Phase: Median of 1267 Days|Adverse Event|0
4812505|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
4812506|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Physician Decision|0
4812507|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Physician Decision|3
4812508|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0
4812509|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14
4812510|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18
4812511|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0
4812512|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10
4812513|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22
4812514|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0
4812515|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4
4812516|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6
4812517|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0
4812518|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3
4812519|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6
4812520|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0
4812521|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16
4812522|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18
4812523|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0
4812524|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25
4812525|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22
4812526|NCT01227824|16594619|P3|Double-blind Phase: 96 Weeks Duration|Adverse Event|0
4812527|NCT01227824|16594620|P2|Double-blind Phase: 96 Weeks Duration|Adverse Event|7
4812528|NCT01227824|16594621|P1|Double-blind Phase: 96 Weeks Duration|Adverse Event|12
4812529|NCT01227707|16594716|P1|Overall Study|Death|1
4812530|NCT01227707|16594716|P1|Overall Study|Medical decision|6
4812531|NCT01227707|16594716|P1|Overall Study|Patient non-compliance|3
4812532|NCT01227707|16594716|P1|Overall Study|Withdrawal by Subject|1
4812533|NCT01227707|16594716|P1|Overall Study|Progression of disease|3
4812534|NCT01227707|16594716|P1|Overall Study|Adverse Event|10
4812535|NCT01227668|16594743|P2|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1
4812536|NCT01227668|16594744|P1|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0
4812537|NCT01227668|16594743|P2|Phase 2 (Randomization Phase)|Lack of Efficacy|23
4812538|NCT01227668|16594744|P1|Phase 2 (Randomization Phase)|Lack of Efficacy|13
4812539|NCT01227668|16594743|P2|Phase 2 (Randomization Phase)|Lost to Follow-up|0
4812540|NCT01227668|16594744|P1|Phase 2 (Randomization Phase)|Lost to Follow-up|1
4812541|NCT01227668|16594743|P2|Phase 2 (Randomization Phase)|Withdrawal by Subject|0
4812542|NCT01227668|16594744|P1|Phase 2 (Randomization Phase)|Withdrawal by Subject|5
4812543|NCT01227668|16594743|P2|Phase 2 (Randomization Phase)|Adverse Event|1
4812544|NCT01227668|16594744|P1|Phase 2 (Randomization Phase)|Adverse Event|0
4812545|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0
4812546|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2
4812547|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|Lack of Efficacy|0
4812548|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|Lack of Efficacy|25
4812549|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|No longer meets study criteria|0
4812550|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|No longer meets study criteria|7
4812551|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0
4812552|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11
4812553|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|Lost to Follow-up|0
4812554|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|Lost to Follow-up|8
4812555|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0
4812556|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7
4812557|NCT01227668|16594743|P2|Phase 1 (Stabilization Phase)|Adverse Event|0
4812558|NCT01227668|16594744|P1|Phase 1 (Stabilization Phase)|Adverse Event|12
4812559|NCT01227629|16594790|P10|Overall Study|Other|1
4812560|NCT01227629|16594791|P9|Overall Study|Other|2
4812561|NCT01227629|16594792|P8|Overall Study|Other|0
4812562|NCT01227629|16594793|P7|Overall Study|Other|0
4812563|NCT01227629|16594794|P6|Overall Study|Other|0
4812564|NCT01227629|16594795|P5|Overall Study|Other|0
4812565|NCT01227629|16594796|P4|Overall Study|Other|1
4812566|NCT01227629|16594797|P3|Overall Study|Other|0
4812567|NCT01227629|16594798|P2|Overall Study|Other|0
4812568|NCT01227629|16594799|P1|Overall Study|Other|0
4812569|NCT01227629|16594790|P10|Overall Study|Withdrawal by Subject|1
4812570|NCT01227629|16594791|P9|Overall Study|Withdrawal by Subject|0
4812571|NCT01227629|16594792|P8|Overall Study|Withdrawal by Subject|0
4812572|NCT01227629|16594793|P7|Overall Study|Withdrawal by Subject|2
4812573|NCT01227629|16594794|P6|Overall Study|Withdrawal by Subject|0
4812574|NCT01227629|16594795|P5|Overall Study|Withdrawal by Subject|0
4812575|NCT01227629|16594796|P4|Overall Study|Withdrawal by Subject|0
4812576|NCT01227629|16594797|P3|Overall Study|Withdrawal by Subject|0
4812577|NCT01227629|16594798|P2|Overall Study|Withdrawal by Subject|0
4812578|NCT01227629|16594799|P1|Overall Study|Withdrawal by Subject|0
4812579|NCT01227629|16594790|P10|Overall Study|Lost to Follow-up|0
4812580|NCT01227629|16594791|P9|Overall Study|Lost to Follow-up|0
4812581|NCT01227629|16594792|P8|Overall Study|Lost to Follow-up|0
4812582|NCT01227629|16594793|P7|Overall Study|Lost to Follow-up|0
4812583|NCT01227629|16594794|P6|Overall Study|Lost to Follow-up|0
4812584|NCT01227629|16594795|P5|Overall Study|Lost to Follow-up|1
4812585|NCT01227629|16594796|P4|Overall Study|Lost to Follow-up|0
4812586|NCT01227629|16594797|P3|Overall Study|Lost to Follow-up|0
4812587|NCT01227629|16594798|P2|Overall Study|Lost to Follow-up|0
4812588|NCT01227629|16594799|P1|Overall Study|Lost to Follow-up|0
4812589|NCT01227629|16594790|P10|Overall Study|Protocol Violation|0
4812590|NCT01227629|16594791|P9|Overall Study|Protocol Violation|0
4812591|NCT01227629|16594792|P8|Overall Study|Protocol Violation|0
4812592|NCT01227629|16594793|P7|Overall Study|Protocol Violation|0
4812593|NCT01227629|16594794|P6|Overall Study|Protocol Violation|0
4812594|NCT01227629|16594795|P5|Overall Study|Protocol Violation|0
4812595|NCT01227629|16594796|P4|Overall Study|Protocol Violation|1
4812596|NCT01227629|16594797|P3|Overall Study|Protocol Violation|0
4812597|NCT01227629|16594798|P2|Overall Study|Protocol Violation|0
4812598|NCT01227629|16594799|P1|Overall Study|Protocol Violation|0
4812599|NCT01227629|16594790|P10|Overall Study|Adverse Event|0
4812600|NCT01227629|16594791|P9|Overall Study|Adverse Event|4
4812601|NCT01227629|16594792|P8|Overall Study|Adverse Event|6
4812602|NCT01227629|16594793|P7|Overall Study|Adverse Event|6
4812603|NCT01227629|16594794|P6|Overall Study|Adverse Event|1
4812604|NCT01227629|16594795|P5|Overall Study|Adverse Event|1
4812605|NCT01227629|16594796|P4|Overall Study|Adverse Event|6
4812606|NCT01227629|16594797|P3|Overall Study|Adverse Event|1
4812607|NCT01227629|16594798|P2|Overall Study|Adverse Event|2
4812608|NCT01227629|16594799|P1|Overall Study|Adverse Event|2
4812609|NCT01227577|16595048|P1|Overall Study|Adverse Event|17
4812610|NCT01227577|16595048|P1|Overall Study|Lack of Efficacy|5
4812611|NCT01227577|16595048|P1|Overall Study|Withdrawal by Subject|4
4812612|NCT01227577|16595048|P1|Overall Study|Lost to Follow-up|1
4812613|NCT01227577|16595048|P1|Overall Study|Administrative problems|2
4812614|NCT01227577|16595048|P1|Overall Study|Death|3
4812615|NCT01227577|16595048|P1|Overall Study|Protocol deviation|3
4812616|NCT01227564|16595063|P3|Overall Study|Participant moved to another town|1
4812617|NCT01227564|16595064|P2|Overall Study|Participant moved to another town|0
4812618|NCT01227564|16595065|P1|Overall Study|Participant moved to another town|0
4812619|NCT01227564|16595063|P3|Overall Study|No Longer Willing to Participate|5
4812620|NCT01227564|16595064|P2|Overall Study|No Longer Willing to Participate|2
4812621|NCT01227564|16595065|P1|Overall Study|No Longer Willing to Participate|4
4812622|NCT01227512|16595203|P2|Overall Study|Participant met withdrawal criteria|1
4812623|NCT01227512|16595204|P1|Overall Study|Participant met withdrawal criteria|0
4812624|NCT01227512|16595203|P2|Overall Study|Withdrawal by Subject|0
4812625|NCT01227512|16595204|P1|Overall Study|Withdrawal by Subject|3
4812626|NCT01227512|16595203|P2|Overall Study|Adverse Event|3
4812627|NCT01227512|16595204|P1|Overall Study|Adverse Event|4
4812628|NCT01227512|16595203|P2|Overall Study|Physician Decision|6
4812629|NCT01227512|16595204|P1|Overall Study|Physician Decision|6
4812630|NCT01227421|16595238|P3|Overall Study|Randomized in error|0
4812631|NCT01227421|16595239|P2|Overall Study|Randomized in error|1
4812632|NCT01227421|16595240|P1|Overall Study|Randomized in error|1
4812633|NCT01227421|16595238|P3|Overall Study|Protocol Violation|2
4812634|NCT01227421|16595239|P2|Overall Study|Protocol Violation|1
4812635|NCT01227421|16595240|P1|Overall Study|Protocol Violation|1
4812636|NCT01227421|16595238|P3|Overall Study|Withdrawal by Subject|1
4812637|NCT01227421|16595239|P2|Overall Study|Withdrawal by Subject|2
4812638|NCT01227421|16595240|P1|Overall Study|Withdrawal by Subject|1
4812639|NCT01227421|16595238|P3|Overall Study|Adverse Event|2
4812640|NCT01227421|16595239|P2|Overall Study|Adverse Event|7
4812641|NCT01227421|16595240|P1|Overall Study|Adverse Event|2
4812642|NCT01227421|16595238|P3|Overall Study|Lost to Follow-up|5
4812643|NCT01227421|16595239|P2|Overall Study|Lost to Follow-up|7
4812644|NCT01227421|16595240|P1|Overall Study|Lost to Follow-up|6
4812645|NCT01227395|16595292|P2|Overall Study|Protocol Violation|1
4812646|NCT01227395|16595293|P1|Overall Study|Protocol Violation|0
4812647|NCT01227278|16595333|P2|Overall Study|Other|2
4812648|NCT01227278|16595334|P1|Overall Study|Other|1
4812649|NCT01227278|16595333|P2|Overall Study|Death|2
4812650|NCT01227278|16595334|P1|Overall Study|Death|0
4812651|NCT01227278|16595333|P2|Overall Study|Withdrawal by Subject|4
4812652|NCT01227278|16595334|P1|Overall Study|Withdrawal by Subject|4
4812653|NCT01227265|16595361|P3|Overall Study|Adverse Event|5
4812654|NCT01227265|16595362|P2|Overall Study|Adverse Event|10
4812655|NCT01227265|16595363|P1|Overall Study|Adverse Event|6
4812656|NCT01227265|16595361|P3|Overall Study|Lost to Follow-up|3
4812657|NCT01227265|16595362|P2|Overall Study|Lost to Follow-up|0
4812658|NCT01227265|16595363|P1|Overall Study|Lost to Follow-up|2
4812659|NCT01227265|16595361|P3|Overall Study|Withdrawal by Subject|3
4812660|NCT01227265|16595362|P2|Overall Study|Withdrawal by Subject|7
4812661|NCT01227265|16595363|P1|Overall Study|Withdrawal by Subject|7
4812662|NCT01227265|16595361|P3|Overall Study|Protocol Violation|0
4812663|NCT01227265|16595362|P2|Overall Study|Protocol Violation|1
4812664|NCT01227265|16595363|P1|Overall Study|Protocol Violation|2
4812665|NCT01227265|16595361|P3|Overall Study|Did Not Meet Protocol Eligibility|1
4812666|NCT01227265|16595362|P2|Overall Study|Did Not Meet Protocol Eligibility|0
4812667|NCT01227265|16595363|P1|Overall Study|Did Not Meet Protocol Eligibility|0
4812668|NCT01227265|16595361|P3|Overall Study|Administrative|2
4812669|NCT01227265|16595362|P2|Overall Study|Administrative|0
4812670|NCT01227265|16595363|P1|Overall Study|Administrative|1
4812671|NCT01227265|16595361|P3|Overall Study|Did Not Receive Treatment|0
4812672|NCT01227265|16595362|P2|Overall Study|Did Not Receive Treatment|2
4812673|NCT01227265|16595363|P1|Overall Study|Did Not Receive Treatment|1
4812674|NCT01227252|16595393|P4|Overall Study|Withdrawal by Subject|0
4812675|NCT01227252|16595394|P3|Overall Study|Withdrawal by Subject|0
4812676|NCT01227252|16595395|P2|Overall Study|Withdrawal by Subject|1
4812677|NCT01227252|16595396|P1|Overall Study|Withdrawal by Subject|0
4812678|NCT01227252|16595393|P4|Overall Study|Lost to Follow-up|0
4812679|NCT01227252|16595394|P3|Overall Study|Lost to Follow-up|0
4812680|NCT01227252|16595395|P2|Overall Study|Lost to Follow-up|1
4812681|NCT01227252|16595396|P1|Overall Study|Lost to Follow-up|0
4812682|NCT01227252|16595393|P4|Overall Study|Sponsor Decision|0
4812683|NCT01227252|16595394|P3|Overall Study|Sponsor Decision|0
4812684|NCT01227252|16595395|P2|Overall Study|Sponsor Decision|1
4812685|NCT01227252|16595396|P1|Overall Study|Sponsor Decision|0
4812686|NCT01227044|16595438|P2|Overall Study|Discontinued Intervention|2
4812687|NCT01227044|16595439|P1|Overall Study|Discontinued Intervention|1
4812688|NCT01227044|16595438|P2|Overall Study|Lost to Follow-up|7
4812689|NCT01227044|16595439|P1|Overall Study|Lost to Follow-up|5
4812690|NCT01227018|16595447|P1|Overall Study|Withdrew after beginning treatment|4
4812691|NCT01227018|16595447|P1|Overall Study|Toxicity|2
4812692|NCT01227018|16595447|P1|Overall Study|Disease progression|9
4812693|NCT01226745|16595492|P6|Overall Study|Other|1
4812694|NCT01226745|16595493|P5|Overall Study|Other|3
4812695|NCT01226745|16595494|P4|Overall Study|Other|4
4812696|NCT01226745|16595495|P3|Overall Study|Other|8
4812697|NCT01226745|16595496|P2|Overall Study|Other|7
4812698|NCT01226745|16595497|P1|Overall Study|Other|6
4812699|NCT01226745|16595492|P6|Overall Study|Death|1
4812700|NCT01226745|16595493|P5|Overall Study|Death|0
4812701|NCT01226745|16595494|P4|Overall Study|Death|0
4812702|NCT01226745|16595495|P3|Overall Study|Death|0
4812703|NCT01226745|16595496|P2|Overall Study|Death|0
4812704|NCT01226745|16595497|P1|Overall Study|Death|1
4812705|NCT01226745|16595492|P6|Overall Study|Lost to Follow-up|2
4812706|NCT01226745|16595493|P5|Overall Study|Lost to Follow-up|1
4812707|NCT01226745|16595494|P4|Overall Study|Lost to Follow-up|1
4812708|NCT01226745|16595495|P3|Overall Study|Lost to Follow-up|6
4812709|NCT01226745|16595496|P2|Overall Study|Lost to Follow-up|6
4812710|NCT01226745|16595497|P1|Overall Study|Lost to Follow-up|2
4812711|NCT01226745|16595492|P6|Overall Study|Did not complete schedule of assessments|1
4812712|NCT01226745|16595493|P5|Overall Study|Did not complete schedule of assessments|0
4812713|NCT01226745|16595494|P4|Overall Study|Did not complete schedule of assessments|0
4812714|NCT01226745|16595495|P3|Overall Study|Did not complete schedule of assessments|6
4812715|NCT01226745|16595496|P2|Overall Study|Did not complete schedule of assessments|3
4812716|NCT01226745|16595497|P1|Overall Study|Did not complete schedule of assessments|8
4812717|NCT01226511|16595693|P2|Taper Period|Parent/Caregiver Decision|1
4812718|NCT01226511|16595694|P1|Taper Period|Parent/Caregiver Decision|1
4812719|NCT01226511|16595693|P2|Taper Period|Protocol Violation|0
4812720|NCT01226511|16595694|P1|Taper Period|Protocol Violation|1
4812721|NCT01226511|16595693|P2|Taper Period|Lost to Follow-up|2
4812722|NCT01226511|16595694|P1|Taper Period|Lost to Follow-up|2
4812723|NCT01226511|16595693|P2|Taper Period|Adverse Event|0
4812724|NCT01226511|16595694|P1|Taper Period|Adverse Event|1
4812725|NCT01226511|16595693|P2|Extension Treatment Period|Sponsor Decision|1
4812726|NCT01226511|16595694|P1|Extension Treatment Period|Sponsor Decision|1
4812727|NCT01226511|16595693|P2|Extension Treatment Period|Parent/Caregiver Decision|8
4812728|NCT01226511|16595694|P1|Extension Treatment Period|Parent/Caregiver Decision|8
4812729|NCT01226511|16595693|P2|Extension Treatment Period|Withdrawal by Subject|3
4812730|NCT01226511|16595694|P1|Extension Treatment Period|Withdrawal by Subject|1
4812731|NCT01226511|16595693|P2|Extension Treatment Period|Protocol Violation|2
4812732|NCT01226511|16595694|P1|Extension Treatment Period|Protocol Violation|2
4812733|NCT01226511|16595693|P2|Extension Treatment Period|Lost to Follow-up|3
4812734|NCT01226511|16595694|P1|Extension Treatment Period|Lost to Follow-up|4
4812735|NCT01226511|16595693|P2|Extension Treatment Period|Lack of Efficacy|2
4812736|NCT01226511|16595694|P1|Extension Treatment Period|Lack of Efficacy|3
4812737|NCT01226511|16595693|P2|Extension Treatment Period|Adverse Event|8
4812738|NCT01226511|16595694|P1|Extension Treatment Period|Adverse Event|8
4812739|NCT01226511|16595693|P2|Acute Treatment Period|Withdrawal by Subject|6
4812740|NCT01226511|16595694|P1|Acute Treatment Period|Withdrawal by Subject|10
4812741|NCT01226511|16595693|P2|Acute Treatment Period|Protocol Violation|5
4812742|NCT01226511|16595694|P1|Acute Treatment Period|Protocol Violation|5
4812743|NCT01226511|16595693|P2|Acute Treatment Period|Parent/caregiver decision|7
4812744|NCT01226511|16595694|P1|Acute Treatment Period|Parent/caregiver decision|5
4812745|NCT01226511|16595693|P2|Acute Treatment Period|Lost to Follow-up|6
4812746|NCT01226511|16595694|P1|Acute Treatment Period|Lost to Follow-up|3
4812747|NCT01226511|16595693|P2|Acute Treatment Period|Lack of Efficacy|1
4812748|NCT01226511|16595694|P1|Acute Treatment Period|Lack of Efficacy|2
4812749|NCT01226511|16595693|P2|Acute Treatment Period|Adverse Event|6
4812750|NCT01226511|16595694|P1|Acute Treatment Period|Adverse Event|7
4812751|NCT01226459|16595794|P2|Overall Study|Pregnancy|0
4812752|NCT01226459|16595795|P1|Overall Study|Pregnancy|1
4812753|NCT01226459|16595794|P2|Overall Study|Lost to Follow-up|8
4812754|NCT01226459|16595795|P1|Overall Study|Lost to Follow-up|4
4812755|NCT01226459|16595794|P2|Overall Study|Withdrawal by Subject|13
4812756|NCT01226459|16595795|P1|Overall Study|Withdrawal by Subject|10
4812757|NCT01226459|16595794|P2|Overall Study|Protocol Violation|3
4812758|NCT01226459|16595795|P1|Overall Study|Protocol Violation|4
4812759|NCT01226459|16595794|P2|Overall Study|Adverse Event|8
4812760|NCT01226459|16595795|P1|Overall Study|Adverse Event|2
4812761|NCT01226121|16595813|P3|Overall Study|Lost to Follow-up|1
4812762|NCT01226121|16595814|P2|Overall Study|Lost to Follow-up|0
4812763|NCT01226121|16595815|P1|Overall Study|Lost to Follow-up|2
4812764|NCT01226095|16595826|P1|Overall Study|Poor compliance|1
4812765|NCT01226043|16595851|P4|30-week Observational Phase|Physician Decision|2
4812766|NCT01226043|16595852|P3|30-week Observational Phase|Physician Decision|2
4812767|NCT01226043|16595853|P2|30-week Observational Phase|Physician Decision|0
4812768|NCT01226043|16595854|P1|30-week Observational Phase|Physician Decision|0
4812769|NCT01226043|16595851|P4|30-week Observational Phase|Withdrawal by Subject|7
4812770|NCT01226043|16595852|P3|30-week Observational Phase|Withdrawal by Subject|1
4812771|NCT01226043|16595853|P2|30-week Observational Phase|Withdrawal by Subject|0
4812772|NCT01226043|16595854|P1|30-week Observational Phase|Withdrawal by Subject|0
4812773|NCT01226043|16595851|P4|30-week Observational Phase|Lost to Follow-up|2
4812774|NCT01226043|16595852|P3|30-week Observational Phase|Lost to Follow-up|2
4812775|NCT01226043|16595853|P2|30-week Observational Phase|Lost to Follow-up|0
4812776|NCT01226043|16595854|P1|30-week Observational Phase|Lost to Follow-up|0
4812777|NCT01226043|16595851|P4|30-week Observational Phase|Protocol Violation|1
4812778|NCT01226043|16595852|P3|30-week Observational Phase|Protocol Violation|0
4812779|NCT01226043|16595853|P2|30-week Observational Phase|Protocol Violation|0
4812780|NCT01226043|16595854|P1|30-week Observational Phase|Protocol Violation|0
4812781|NCT01226043|16595851|P4|30-week Observational Phase|Adverse Event|1
4812782|NCT01226043|16595852|P3|30-week Observational Phase|Adverse Event|1
4812783|NCT01226043|16595853|P2|30-week Observational Phase|Adverse Event|0
4812784|NCT01226043|16595854|P1|30-week Observational Phase|Adverse Event|0
4812785|NCT01226043|16595851|P4|6-week Re-randomization Phase|completed in error|1
4812786|NCT01226043|16595852|P3|6-week Re-randomization Phase|completed in error|0
4812787|NCT01226043|16595853|P2|6-week Re-randomization Phase|completed in error|0
4812788|NCT01226043|16595854|P1|6-week Re-randomization Phase|completed in error|0
4812789|NCT01226043|16595851|P4|6-week Re-randomization Phase|Physician Decision|2
4812790|NCT01226043|16595852|P3|6-week Re-randomization Phase|Physician Decision|3
4812791|NCT01226043|16595853|P2|6-week Re-randomization Phase|Physician Decision|0
4812792|NCT01226043|16595854|P1|6-week Re-randomization Phase|Physician Decision|0
4812793|NCT01226043|16595851|P4|6-week Re-randomization Phase|Withdrawal by Subject|3
4812794|NCT01226043|16595852|P3|6-week Re-randomization Phase|Withdrawal by Subject|1
4812795|NCT01226043|16595853|P2|6-week Re-randomization Phase|Withdrawal by Subject|0
4812796|NCT01226043|16595854|P1|6-week Re-randomization Phase|Withdrawal by Subject|0
4812797|NCT01226043|16595851|P4|6-week Re-randomization Phase|Lost to Follow-up|3
4812798|NCT01226043|16595852|P3|6-week Re-randomization Phase|Lost to Follow-up|1
4812799|NCT01226043|16595853|P2|6-week Re-randomization Phase|Lost to Follow-up|0
4812800|NCT01226043|16595854|P1|6-week Re-randomization Phase|Lost to Follow-up|0
4812801|NCT01226043|16595851|P4|6-week Re-randomization Phase|Protocol Violation|1
4812802|NCT01226043|16595852|P3|6-week Re-randomization Phase|Protocol Violation|1
4812803|NCT01226043|16595853|P2|6-week Re-randomization Phase|Protocol Violation|0
4812804|NCT01226043|16595854|P1|6-week Re-randomization Phase|Protocol Violation|0
4812805|NCT01226043|16595851|P4|6-week Re-randomization Phase|Adverse Event|1
4812806|NCT01226043|16595852|P3|6-week Re-randomization Phase|Adverse Event|1
4812807|NCT01226043|16595853|P2|6-week Re-randomization Phase|Adverse Event|0
4812808|NCT01226043|16595854|P1|6-week Re-randomization Phase|Adverse Event|0
4812809|NCT01226043|16595851|P4|4-week Crossover Phase - Period 2|Physician Decision|0
4812810|NCT01226043|16595852|P3|4-week Crossover Phase - Period 2|Physician Decision|0
4812811|NCT01226043|16595853|P2|4-week Crossover Phase - Period 2|Physician Decision|5
4812812|NCT01226043|16595854|P1|4-week Crossover Phase - Period 2|Physician Decision|4
4812813|NCT01226043|16595851|P4|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
4812814|NCT01226043|16595852|P3|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
4812815|NCT01226043|16595853|P2|4-week Crossover Phase - Period 2|Withdrawal by Subject|1
4812816|NCT01226043|16595854|P1|4-week Crossover Phase - Period 2|Withdrawal by Subject|0
4812817|NCT01226043|16595851|P4|4-week Crossover Phase - Period 1|Physician Decision|0
4812818|NCT01226043|16595852|P3|4-week Crossover Phase - Period 1|Physician Decision|0
4812819|NCT01226043|16595853|P2|4-week Crossover Phase - Period 1|Physician Decision|6
4812820|NCT01226043|16595854|P1|4-week Crossover Phase - Period 1|Physician Decision|0
4812821|NCT01226043|16595851|P4|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
4812822|NCT01226043|16595852|P3|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
4812823|NCT01226043|16595853|P2|4-week Crossover Phase - Period 1|Withdrawal by Subject|0
4812824|NCT01226043|16595854|P1|4-week Crossover Phase - Period 1|Withdrawal by Subject|2
4812825|NCT01226043|16595851|P4|4-week Crossover Phase - Period 1|Lost to Follow-up|0
4812826|NCT01226043|16595852|P3|4-week Crossover Phase - Period 1|Lost to Follow-up|0
4812827|NCT01226043|16595853|P2|4-week Crossover Phase - Period 1|Lost to Follow-up|1
4812828|NCT01226043|16595854|P1|4-week Crossover Phase - Period 1|Lost to Follow-up|0
4812829|NCT01226043|16595851|P4|4-week Crossover Phase - Period 1|Protocol Violation|0
4812830|NCT01226043|16595852|P3|4-week Crossover Phase - Period 1|Protocol Violation|0
4812831|NCT01226043|16595853|P2|4-week Crossover Phase - Period 1|Protocol Violation|2
4812832|NCT01226043|16595854|P1|4-week Crossover Phase - Period 1|Protocol Violation|1
4812833|NCT01225991|16595892|P1|Overall Study|Withdrawal by Subject|6
4812834|NCT01225952|16595903|P3|Overall Study|Surgical complications|0
4812835|NCT01225952|16595904|P2|Overall Study|Surgical complications|0
4812836|NCT01225952|16595905|P1|Overall Study|Surgical complications|1
4812837|NCT01225952|16595903|P3|Overall Study|Withdrawal by Subject|5
4812838|NCT01225952|16595904|P2|Overall Study|Withdrawal by Subject|4
4812839|NCT01225952|16595905|P1|Overall Study|Withdrawal by Subject|4
4812840|NCT01225952|16595903|P3|Overall Study|Study Eye Explanted|1
4812841|NCT01225952|16595904|P2|Overall Study|Study Eye Explanted|0
4812842|NCT01225952|16595905|P1|Overall Study|Study Eye Explanted|0
4812843|NCT01225952|16595903|P3|Overall Study|Lost to Follow-up|0
4812844|NCT01225952|16595904|P2|Overall Study|Lost to Follow-up|0
4812845|NCT01225952|16595905|P1|Overall Study|Lost to Follow-up|1
4812846|NCT01225887|16595997|P1|Overall Study|Ineligible:inadequate pathology|2
4812847|NCT01225887|16595997|P1|Overall Study|Ineligible;improper pre-protocol therapy|1
4812848|NCT01225887|16595997|P1|Overall Study|Ineligible:required test not done|2
4812849|NCT01225835|16596007|P2|Overall Study|Other|1
4812850|NCT01225835|16596008|P1|Overall Study|Other|1
4812851|NCT01225835|16596007|P2|Overall Study|Adverse Event|1
4812852|NCT01225835|16596008|P1|Overall Study|Adverse Event|2
4812853|NCT01225835|16596007|P2|Overall Study|Did not meet hCG criterion|0
4812854|NCT01225835|16596008|P1|Overall Study|Did not meet hCG criterion|2
4812855|NCT01225835|16596007|P2|Overall Study|Completed protocol|1
4812856|NCT01225835|16596008|P1|Overall Study|Completed protocol|2
4812857|NCT01225822|16596056|P5|Overall Study|Other|7
4812858|NCT01225822|16596057|P4|Overall Study|Other|10
4812859|NCT01225822|16596058|P3|Overall Study|Other|7
4812860|NCT01225822|16596059|P2|Overall Study|Other|10
4812861|NCT01225822|16596060|P1|Overall Study|Other|13
4812862|NCT01225822|16596056|P5|Overall Study|Withdrawal by Subject|6
4812863|NCT01225822|16596057|P4|Overall Study|Withdrawal by Subject|11
4812864|NCT01225822|16596058|P3|Overall Study|Withdrawal by Subject|7
4812865|NCT01225822|16596059|P2|Overall Study|Withdrawal by Subject|7
4812866|NCT01225822|16596060|P1|Overall Study|Withdrawal by Subject|6
4812867|NCT01225822|16596056|P5|Overall Study|Lost to Follow-up|0
4812868|NCT01225822|16596057|P4|Overall Study|Lost to Follow-up|1
4812869|NCT01225822|16596058|P3|Overall Study|Lost to Follow-up|0
4812870|NCT01225822|16596059|P2|Overall Study|Lost to Follow-up|0
4812871|NCT01225822|16596060|P1|Overall Study|Lost to Follow-up|0
4812872|NCT01225822|16596056|P5|Overall Study|Protocol Violation|4
4812873|NCT01225822|16596057|P4|Overall Study|Protocol Violation|7
4812874|NCT01225822|16596058|P3|Overall Study|Protocol Violation|6
4812875|NCT01225822|16596059|P2|Overall Study|Protocol Violation|8
4812876|NCT01225822|16596060|P1|Overall Study|Protocol Violation|6
4812877|NCT01225822|16596056|P5|Overall Study|Adverse Event|14
4812878|NCT01225822|16596057|P4|Overall Study|Adverse Event|23
4812879|NCT01225822|16596058|P3|Overall Study|Adverse Event|18
4812880|NCT01225822|16596059|P2|Overall Study|Adverse Event|31
4812881|NCT01225822|16596060|P1|Overall Study|Adverse Event|13
4812882|NCT01225731|16596127|P13|Part 3|Withdrawal by Subject|4
4812883|NCT01225731|16596128|P12|Part 3|Withdrawal by Subject|6
4812884|NCT01225731|16596129|P11|Part 3|Withdrawal by Subject|4
4812885|NCT01225731|16596130|P10|Part 3|Withdrawal by Subject|0
4812886|NCT01225731|16596131|P9|Part 3|Withdrawal by Subject|0
4812887|NCT01225731|16596132|P8|Part 3|Withdrawal by Subject|0
4812888|NCT01225731|16596133|P7|Part 3|Withdrawal by Subject|0
4812889|NCT01225731|16596134|P6|Part 3|Withdrawal by Subject|0
4812890|NCT01225731|16596135|P5|Part 3|Withdrawal by Subject|0
4812891|NCT01225731|16596136|P4|Part 3|Withdrawal by Subject|0
4812892|NCT01225731|16596137|P3|Part 3|Withdrawal by Subject|0
4812893|NCT01225731|16596138|P2|Part 3|Withdrawal by Subject|0
4812894|NCT01225731|16596139|P1|Part 3|Withdrawal by Subject|0
4812895|NCT01225731|16596127|P13|Part 3|Physician Decision|2
4812896|NCT01225731|16596128|P12|Part 3|Physician Decision|1
4812897|NCT01225731|16596129|P11|Part 3|Physician Decision|0
4812898|NCT01225731|16596130|P10|Part 3|Physician Decision|0
4812899|NCT01225731|16596131|P9|Part 3|Physician Decision|0
4812900|NCT01225731|16596132|P8|Part 3|Physician Decision|0
4812901|NCT01225731|16596133|P7|Part 3|Physician Decision|0
4812902|NCT01225731|16596134|P6|Part 3|Physician Decision|0
4812903|NCT01225731|16596135|P5|Part 3|Physician Decision|0
4812904|NCT01225731|16596136|P4|Part 3|Physician Decision|0
4812905|NCT01225731|16596137|P3|Part 3|Physician Decision|0
4812906|NCT01225731|16596138|P2|Part 3|Physician Decision|0
4812907|NCT01225731|16596139|P1|Part 3|Physician Decision|0
4812908|NCT01225731|16596127|P13|Part 3|Lost to Follow-up|1
4812909|NCT01225731|16596128|P12|Part 3|Lost to Follow-up|2
4812910|NCT01225731|16596129|P11|Part 3|Lost to Follow-up|1
4812911|NCT01225731|16596130|P10|Part 3|Lost to Follow-up|0
4812912|NCT01225731|16596131|P9|Part 3|Lost to Follow-up|0
4812913|NCT01225731|16596132|P8|Part 3|Lost to Follow-up|0
4812914|NCT01225731|16596133|P7|Part 3|Lost to Follow-up|0
4812915|NCT01225731|16596134|P6|Part 3|Lost to Follow-up|0
4812916|NCT01225731|16596135|P5|Part 3|Lost to Follow-up|0
4812917|NCT01225731|16596136|P4|Part 3|Lost to Follow-up|0
4812918|NCT01225731|16596137|P3|Part 3|Lost to Follow-up|0
4812919|NCT01225731|16596138|P2|Part 3|Lost to Follow-up|0
4812920|NCT01225731|16596139|P1|Part 3|Lost to Follow-up|0
4812921|NCT01225731|16596127|P13|Part 3|Adverse Event|0
4812922|NCT01225731|16596128|P12|Part 3|Adverse Event|1
4812923|NCT01225731|16596129|P11|Part 3|Adverse Event|1
4812924|NCT01225731|16596130|P10|Part 3|Adverse Event|0
4812925|NCT01225731|16596131|P9|Part 3|Adverse Event|0
4812926|NCT01225731|16596132|P8|Part 3|Adverse Event|0
4812927|NCT01225731|16596133|P7|Part 3|Adverse Event|0
4812928|NCT01225731|16596134|P6|Part 3|Adverse Event|0
4812929|NCT01225731|16596135|P5|Part 3|Adverse Event|0
4812930|NCT01225731|16596136|P4|Part 3|Adverse Event|0
4812931|NCT01225731|16596137|P3|Part 3|Adverse Event|0
4812932|NCT01225731|16596138|P2|Part 3|Adverse Event|0
4812933|NCT01225731|16596139|P1|Part 3|Adverse Event|0
4812934|NCT01225731|16596127|P13|Part 2|Withdrawal by Subject|0
4812935|NCT01225731|16596128|P12|Part 2|Withdrawal by Subject|0
4812936|NCT01225731|16596129|P11|Part 2|Withdrawal by Subject|0
4812937|NCT01225731|16596130|P10|Part 2|Withdrawal by Subject|0
4812938|NCT01225731|16596131|P9|Part 2|Withdrawal by Subject|1
4812939|NCT01225731|16596132|P8|Part 2|Withdrawal by Subject|4
4812940|NCT01225731|16596133|P7|Part 2|Withdrawal by Subject|3
4812941|NCT01225731|16596134|P6|Part 2|Withdrawal by Subject|1
4812942|NCT01225731|16596135|P5|Part 2|Withdrawal by Subject|0
4812943|NCT01225731|16596136|P4|Part 2|Withdrawal by Subject|0
4812944|NCT01225731|16596137|P3|Part 2|Withdrawal by Subject|0
4812945|NCT01225731|16596138|P2|Part 2|Withdrawal by Subject|0
4812946|NCT01225731|16596139|P1|Part 2|Withdrawal by Subject|0
4812947|NCT01225731|16596127|P13|Part 2|Physician Decision|0
4812948|NCT01225731|16596128|P12|Part 2|Physician Decision|0
4812949|NCT01225731|16596129|P11|Part 2|Physician Decision|0
4812950|NCT01225731|16596130|P10|Part 2|Physician Decision|0
4812951|NCT01225731|16596131|P9|Part 2|Physician Decision|2
4812952|NCT01225731|16596132|P8|Part 2|Physician Decision|2
4812953|NCT01225731|16596133|P7|Part 2|Physician Decision|0
4812954|NCT01225731|16596134|P6|Part 2|Physician Decision|0
4812955|NCT01225731|16596135|P5|Part 2|Physician Decision|0
4812956|NCT01225731|16596136|P4|Part 2|Physician Decision|0
4812957|NCT01225731|16596137|P3|Part 2|Physician Decision|0
4812958|NCT01225731|16596138|P2|Part 2|Physician Decision|0
4812959|NCT01225731|16596139|P1|Part 2|Physician Decision|0
4812960|NCT01225731|16596127|P13|Part 2|Lost to Follow-up|0
4812961|NCT01225731|16596128|P12|Part 2|Lost to Follow-up|0
4812962|NCT01225731|16596129|P11|Part 2|Lost to Follow-up|0
4812963|NCT01225731|16596130|P10|Part 2|Lost to Follow-up|0
4812964|NCT01225731|16596131|P9|Part 2|Lost to Follow-up|1
4812965|NCT01225731|16596132|P8|Part 2|Lost to Follow-up|3
4812966|NCT01225731|16596133|P7|Part 2|Lost to Follow-up|0
4812967|NCT01225731|16596134|P6|Part 2|Lost to Follow-up|0
4812968|NCT01225731|16596135|P5|Part 2|Lost to Follow-up|0
4812969|NCT01225731|16596136|P4|Part 2|Lost to Follow-up|0
4812970|NCT01225731|16596137|P3|Part 2|Lost to Follow-up|0
4812971|NCT01225731|16596138|P2|Part 2|Lost to Follow-up|0
4812972|NCT01225731|16596139|P1|Part 2|Lost to Follow-up|0
4812973|NCT01225731|16596127|P13|Part 2|Pregnancy|0
4812974|NCT01225731|16596128|P12|Part 2|Pregnancy|0
4812975|NCT01225731|16596129|P11|Part 2|Pregnancy|0
4812976|NCT01225731|16596130|P10|Part 2|Pregnancy|0
4812977|NCT01225731|16596131|P9|Part 2|Pregnancy|1
4812978|NCT01225731|16596132|P8|Part 2|Pregnancy|0
4812979|NCT01225731|16596133|P7|Part 2|Pregnancy|1
4812980|NCT01225731|16596134|P6|Part 2|Pregnancy|0
4812981|NCT01225731|16596135|P5|Part 2|Pregnancy|0
4812982|NCT01225731|16596136|P4|Part 2|Pregnancy|0
4812983|NCT01225731|16596137|P3|Part 2|Pregnancy|0
4812984|NCT01225731|16596138|P2|Part 2|Pregnancy|0
4812985|NCT01225731|16596139|P1|Part 2|Pregnancy|0
4812986|NCT01225731|16596127|P13|Part 2|Lack of Efficacy|0
4812987|NCT01225731|16596128|P12|Part 2|Lack of Efficacy|0
4812988|NCT01225731|16596129|P11|Part 2|Lack of Efficacy|0
4812989|NCT01225731|16596130|P10|Part 2|Lack of Efficacy|0
4812990|NCT01225731|16596131|P9|Part 2|Lack of Efficacy|3
4812991|NCT01225731|16596132|P8|Part 2|Lack of Efficacy|12
4812992|NCT01225731|16596133|P7|Part 2|Lack of Efficacy|0
4812993|NCT01225731|16596134|P6|Part 2|Lack of Efficacy|1
4812994|NCT01225731|16596135|P5|Part 2|Lack of Efficacy|0
4812995|NCT01225731|16596136|P4|Part 2|Lack of Efficacy|0
4812996|NCT01225731|16596137|P3|Part 2|Lack of Efficacy|0
4812997|NCT01225731|16596138|P2|Part 2|Lack of Efficacy|0
4812998|NCT01225731|16596139|P1|Part 2|Lack of Efficacy|0
4812999|NCT01225731|16596127|P13|Part 2|Adverse Event|0
4813000|NCT01225731|16596128|P12|Part 2|Adverse Event|0
4813001|NCT01225731|16596129|P11|Part 2|Adverse Event|0
4813002|NCT01225731|16596130|P10|Part 2|Adverse Event|0
4813003|NCT01225731|16596131|P9|Part 2|Adverse Event|2
4813004|NCT01225731|16596132|P8|Part 2|Adverse Event|4
4813005|NCT01225731|16596133|P7|Part 2|Adverse Event|4
4813006|NCT01225731|16596134|P6|Part 2|Adverse Event|0
4813007|NCT01225731|16596135|P5|Part 2|Adverse Event|0
4813008|NCT01225731|16596136|P4|Part 2|Adverse Event|0
4813009|NCT01225731|16596137|P3|Part 2|Adverse Event|0
4813010|NCT01225731|16596138|P2|Part 2|Adverse Event|0
4813011|NCT01225731|16596139|P1|Part 2|Adverse Event|0
4813012|NCT01225731|16596127|P13|Part 2|Protocol Violation|0
4813013|NCT01225731|16596128|P12|Part 2|Protocol Violation|0
4813014|NCT01225731|16596129|P11|Part 2|Protocol Violation|0
4813015|NCT01225731|16596130|P10|Part 2|Protocol Violation|0
4813016|NCT01225731|16596131|P9|Part 2|Protocol Violation|1
4813017|NCT01225731|16596132|P8|Part 2|Protocol Violation|0
4813018|NCT01225731|16596133|P7|Part 2|Protocol Violation|0
4813019|NCT01225731|16596134|P6|Part 2|Protocol Violation|1
4813020|NCT01225731|16596135|P5|Part 2|Protocol Violation|0
4813021|NCT01225731|16596136|P4|Part 2|Protocol Violation|0
4813022|NCT01225731|16596137|P3|Part 2|Protocol Violation|0
4813023|NCT01225731|16596138|P2|Part 2|Protocol Violation|0
4813024|NCT01225731|16596139|P1|Part 2|Protocol Violation|0
4813025|NCT01225731|16596127|P13|Part 1|Protocol Violation|0
4813026|NCT01225731|16596128|P12|Part 1|Protocol Violation|0
4813027|NCT01225731|16596129|P11|Part 1|Protocol Violation|0
4813028|NCT01225731|16596130|P10|Part 1|Protocol Violation|0
4813029|NCT01225731|16596131|P9|Part 1|Protocol Violation|0
4813030|NCT01225731|16596132|P8|Part 1|Protocol Violation|0
4813031|NCT01225731|16596133|P7|Part 1|Protocol Violation|0
4813032|NCT01225731|16596134|P6|Part 1|Protocol Violation|0
4813033|NCT01225731|16596135|P5|Part 1|Protocol Violation|0
4813034|NCT01225731|16596136|P4|Part 1|Protocol Violation|1
4813035|NCT01225731|16596137|P3|Part 1|Protocol Violation|0
4813036|NCT01225731|16596138|P2|Part 1|Protocol Violation|0
4813037|NCT01225731|16596139|P1|Part 1|Protocol Violation|0
4813038|NCT01225731|16596127|P13|Part 1|Withdrawal by Subject|0
4813039|NCT01225731|16596128|P12|Part 1|Withdrawal by Subject|0
4813040|NCT01225731|16596129|P11|Part 1|Withdrawal by Subject|0
4813041|NCT01225731|16596130|P10|Part 1|Withdrawal by Subject|0
4813042|NCT01225731|16596131|P9|Part 1|Withdrawal by Subject|0
4813043|NCT01225731|16596132|P8|Part 1|Withdrawal by Subject|0
4813044|NCT01225731|16596133|P7|Part 1|Withdrawal by Subject|0
4813045|NCT01225731|16596134|P6|Part 1|Withdrawal by Subject|0
4813046|NCT01225731|16596135|P5|Part 1|Withdrawal by Subject|4
4813047|NCT01225731|16596136|P4|Part 1|Withdrawal by Subject|0
4813048|NCT01225731|16596137|P3|Part 1|Withdrawal by Subject|0
4813049|NCT01225731|16596138|P2|Part 1|Withdrawal by Subject|3
4813050|NCT01225731|16596139|P1|Part 1|Withdrawal by Subject|0
4813051|NCT01225731|16596127|P13|Part 1|Adverse Event|0
4813052|NCT01225731|16596128|P12|Part 1|Adverse Event|0
4813053|NCT01225731|16596129|P11|Part 1|Adverse Event|0
4813054|NCT01225731|16596130|P10|Part 1|Adverse Event|0
4813055|NCT01225731|16596131|P9|Part 1|Adverse Event|0
4813056|NCT01225731|16596132|P8|Part 1|Adverse Event|0
4813057|NCT01225731|16596133|P7|Part 1|Adverse Event|0
4813058|NCT01225731|16596134|P6|Part 1|Adverse Event|0
4813059|NCT01225731|16596135|P5|Part 1|Adverse Event|1
4813060|NCT01225731|16596136|P4|Part 1|Adverse Event|1
4813061|NCT01225731|16596137|P3|Part 1|Adverse Event|1
4813062|NCT01225731|16596138|P2|Part 1|Adverse Event|2
4813063|NCT01225731|16596139|P1|Part 1|Adverse Event|1
4813064|NCT01225731|16596127|P13|Part 1|Did not meet eligibility criteria|0
4813065|NCT01225731|16596128|P12|Part 1|Did not meet eligibility criteria|0
4813066|NCT01225731|16596129|P11|Part 1|Did not meet eligibility criteria|0
4813067|NCT01225731|16596130|P10|Part 1|Did not meet eligibility criteria|0
4813068|NCT01225731|16596131|P9|Part 1|Did not meet eligibility criteria|0
4813069|NCT01225731|16596132|P8|Part 1|Did not meet eligibility criteria|0
4813070|NCT01225731|16596133|P7|Part 1|Did not meet eligibility criteria|0
4813071|NCT01225731|16596134|P6|Part 1|Did not meet eligibility criteria|0
4813072|NCT01225731|16596135|P5|Part 1|Did not meet eligibility criteria|1
4813073|NCT01225731|16596136|P4|Part 1|Did not meet eligibility criteria|0
4813074|NCT01225731|16596137|P3|Part 1|Did not meet eligibility criteria|0
4813075|NCT01225731|16596138|P2|Part 1|Did not meet eligibility criteria|0
4813076|NCT01225731|16596139|P1|Part 1|Did not meet eligibility criteria|1
4813077|NCT01225562|16596234|P3|Overall Study|Lost to Follow-up|1
4813078|NCT01225562|16596235|P2|Overall Study|Lost to Follow-up|6
4813079|NCT01225562|16596236|P1|Overall Study|Lost to Follow-up|3
4813080|NCT01225562|16596234|P3|Overall Study|Withdrawal by Subject|52
4813081|NCT01225562|16596235|P2|Overall Study|Withdrawal by Subject|50
4813082|NCT01225562|16596236|P1|Overall Study|Withdrawal by Subject|52
4813083|NCT01225549|16596253|P10|Period 6 - Washout|Disallowed medication|0
4813084|NCT01225549|16596254|P9|Period 6 - Washout|Disallowed medication|0
4813085|NCT01225549|16596255|P8|Period 6 - Washout|Disallowed medication|0
4813086|NCT01225549|16596256|P7|Period 6 - Washout|Disallowed medication|0
4813087|NCT01225549|16596257|P6|Period 6 - Washout|Disallowed medication|0
4813088|NCT01225549|16596258|P5|Period 6 - Washout|Disallowed medication|0
4813089|NCT01225549|16596259|P4|Period 6 - Washout|Disallowed medication|1
4813090|NCT01225549|16596260|P3|Period 6 - Washout|Disallowed medication|0
4813091|NCT01225549|16596261|P2|Period 6 - Washout|Disallowed medication|0
4813092|NCT01225549|16596262|P1|Period 6 - Washout|Disallowed medication|0
4813093|NCT01225549|16596253|P10|Period 4 - Washout|Disallowed medication|0
4813094|NCT01225549|16596254|P9|Period 4 - Washout|Disallowed medication|0
4813095|NCT01225549|16596255|P8|Period 4 - Washout|Disallowed medication|0
4813096|NCT01225549|16596256|P7|Period 4 - Washout|Disallowed medication|0
4813097|NCT01225549|16596257|P6|Period 4 - Washout|Disallowed medication|0
4813098|NCT01225549|16596258|P5|Period 4 - Washout|Disallowed medication|0
4813099|NCT01225549|16596259|P4|Period 4 - Washout|Disallowed medication|0
4813100|NCT01225549|16596260|P3|Period 4 - Washout|Disallowed medication|0
4813101|NCT01225549|16596261|P2|Period 4 - Washout|Disallowed medication|1
4813102|NCT01225549|16596262|P1|Period 4 - Washout|Disallowed medication|0
4813103|NCT01225211|16596345|P10|Overall Study|Other|1
4813104|NCT01225211|16596346|P9|Overall Study|Other|0
4813105|NCT01225211|16596347|P8|Overall Study|Other|0
4813106|NCT01225211|16596348|P7|Overall Study|Other|0
4813107|NCT01225211|16596349|P6|Overall Study|Other|0
4813108|NCT01225211|16596350|P5|Overall Study|Other|0
4813109|NCT01225211|16596351|P4|Overall Study|Other|0
4813110|NCT01225211|16596352|P3|Overall Study|Other|0
4813111|NCT01225211|16596353|P2|Overall Study|Other|0
4813112|NCT01225211|16596354|P1|Overall Study|Other|0
4813113|NCT01225211|16596345|P10|Overall Study|Withdrawal by Subject|3
4813114|NCT01225211|16596346|P9|Overall Study|Withdrawal by Subject|1
4813115|NCT01225211|16596347|P8|Overall Study|Withdrawal by Subject|0
4813116|NCT01225211|16596348|P7|Overall Study|Withdrawal by Subject|1
4813117|NCT01225211|16596349|P6|Overall Study|Withdrawal by Subject|0
4813118|NCT01225211|16596350|P5|Overall Study|Withdrawal by Subject|0
4813119|NCT01225211|16596351|P4|Overall Study|Withdrawal by Subject|0
4813120|NCT01225211|16596352|P3|Overall Study|Withdrawal by Subject|0
4813121|NCT01225211|16596353|P2|Overall Study|Withdrawal by Subject|0
4813122|NCT01225211|16596354|P1|Overall Study|Withdrawal by Subject|0
4813123|NCT01225211|16596345|P10|Overall Study|Adverse Event|1
4813124|NCT01225211|16596346|P9|Overall Study|Adverse Event|0
4813125|NCT01225211|16596347|P8|Overall Study|Adverse Event|0
4813126|NCT01225211|16596348|P7|Overall Study|Adverse Event|0
4813127|NCT01225211|16596349|P6|Overall Study|Adverse Event|0
4813128|NCT01225211|16596350|P5|Overall Study|Adverse Event|0
4813129|NCT01225211|16596351|P4|Overall Study|Adverse Event|0
4813130|NCT01225211|16596352|P3|Overall Study|Adverse Event|1
4813131|NCT01225211|16596353|P2|Overall Study|Adverse Event|0
4813132|NCT01225211|16596354|P1|Overall Study|Adverse Event|0
4813133|NCT01225172|16596457|P2|Overall Study|Withdrawal by Subject|0
4813134|NCT01225172|16596458|P1|Overall Study|Withdrawal by Subject|1
4813135|NCT01225172|16596457|P2|Overall Study|Subject no longer meets study criteria|0
4813136|NCT01225172|16596458|P1|Overall Study|Subject no longer meets study criteria|1
4813137|NCT01225172|16596457|P2|Overall Study|Subject request to discontinue treatment|1
4813138|NCT01225172|16596458|P1|Overall Study|Subject request to discontinue treatment|3
4813139|NCT01225172|16596457|P2|Overall Study|Subject decision to stop|0
4813140|NCT01225172|16596458|P1|Overall Study|Subject decision to stop|1
4813141|NCT01225159|16596480|P2|Overall Study|Change operation|0
4813142|NCT01225159|16596481|P1|Overall Study|Change operation|1
4813143|NCT01225146|16596491|P2|Overall Study|Sponsor discontinued making 2mg drug|2
4813144|NCT01225146|16596492|P1|Overall Study|Sponsor discontinued making 2mg drug|0
4813145|NCT01224925|16596560|P2|Overall Study|Lost to Follow-up|2
4813146|NCT01224925|16596561|P1|Overall Study|Lost to Follow-up|3
4813147|NCT01224821|16596569|P1|Long-Term Follow-Up|Completion of 10 Year Follow-up|9
4813148|NCT01224821|16596569|P1|Long-Term Follow-Up|Death|2
4813149|NCT01224821|16596569|P1|Dosimetric and Therapeutic Treatment|Started Other Treatment|1
4813150|NCT01224821|16596569|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1
4813151|NCT01224821|16596569|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2
4813152|NCT01224821|16596569|P1|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3
4813153|NCT01224821|16596569|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|38
4813154|NCT01224821|16596569|P1|Dosimetric and Therapeutic Treatment|Adverse Event|1
4813155|NCT01224782|16596588|P1|Overall Study|Transplantation|1
4813156|NCT01224782|16596588|P1|Overall Study|Deterioration|1
4813157|NCT01224782|16596588|P1|Overall Study|Financial Reasons|1
4813158|NCT01224782|16596588|P1|Overall Study|Change of Treatment|1
4813159|NCT01224782|16596588|P1|Overall Study|Start of Dialysis|3
4813160|NCT01224782|16596588|P1|Overall Study|Other|4
4813161|NCT01224782|16596588|P1|Overall Study|Noncompliance|10
4813162|NCT01224782|16596588|P1|Overall Study|Adverse Reaction|11
4813163|NCT01224782|16596588|P1|Overall Study|Adverse Event|12
4813164|NCT01224782|16596588|P1|Overall Study|Improvement|13
4813165|NCT01224782|16596588|P1|Overall Study|Death|14
4813166|NCT01224782|16596588|P1|Overall Study|Withdrawal by Subject|16
4813167|NCT01224782|16596588|P1|Overall Study|Lost to Follow-up|177
4813168|NCT01224639|16596614|P8|Overall Study|Adverse Event|1
4813169|NCT01224639|16596615|P7|Overall Study|Adverse Event|0
4813170|NCT01224639|16596616|P6|Overall Study|Adverse Event|0
4813171|NCT01224639|16596617|P5|Overall Study|Adverse Event|0
4813172|NCT01224639|16596618|P4|Overall Study|Adverse Event|0
4813173|NCT01224639|16596619|P3|Overall Study|Adverse Event|0
4813174|NCT01224639|16596620|P2|Overall Study|Adverse Event|0
4813175|NCT01224639|16596621|P1|Overall Study|Adverse Event|0
4813176|NCT01224639|16596614|P8|Overall Study|Withdrawal by Subject|1
4813177|NCT01224639|16596615|P7|Overall Study|Withdrawal by Subject|1
4813178|NCT01224639|16596616|P6|Overall Study|Withdrawal by Subject|0
4813179|NCT01224639|16596617|P5|Overall Study|Withdrawal by Subject|2
4813180|NCT01224639|16596618|P4|Overall Study|Withdrawal by Subject|0
4813181|NCT01224639|16596619|P3|Overall Study|Withdrawal by Subject|0
4813182|NCT01224639|16596620|P2|Overall Study|Withdrawal by Subject|0
4813183|NCT01224639|16596621|P1|Overall Study|Withdrawal by Subject|0
4813184|NCT01224431|16596739|P2|Overall Study|no video record|1
4813185|NCT01224431|16596740|P1|Overall Study|no video record|0
4813186|NCT01224431|16596739|P2|Overall Study|not randomized|4
4813187|NCT01224431|16596740|P1|Overall Study|not randomized|0
4813188|NCT01224171|16596761|P2|Overall Study|Lost to Follow-up|3
4813189|NCT01224171|16596762|P1|Overall Study|Lost to Follow-up|0
4813190|NCT01224171|16596761|P2|Overall Study|Withdrawal of Consent|4
4813191|NCT01224171|16596762|P1|Overall Study|Withdrawal of Consent|2
4813192|NCT01224171|16596761|P2|Overall Study|Lack of Efficacy|1
4813193|NCT01224171|16596762|P1|Overall Study|Lack of Efficacy|5
4813194|NCT01224171|16596761|P2|Overall Study|Protocol Violation|1
4813195|NCT01224171|16596762|P1|Overall Study|Protocol Violation|0
4813196|NCT01224171|16596761|P2|Overall Study|Adverse Event|4
4813197|NCT01224171|16596762|P1|Overall Study|Adverse Event|8
4813198|NCT01224158|16596784|P2|Overall Study|Withdrawal by Subject|0
4813199|NCT01224158|16596785|P1|Overall Study|Withdrawal by Subject|1
4813200|NCT01223937|16596821|P2|Overall Study|Other|1
4813201|NCT01223937|16596822|P1|Overall Study|Other|4
4813202|NCT01223937|16596821|P2|Overall Study|Protocol Violation|7
4813203|NCT01223937|16596822|P1|Overall Study|Protocol Violation|8
4813204|NCT01223937|16596821|P2|Overall Study|Adverse Event|4
4813205|NCT01223937|16596822|P1|Overall Study|Adverse Event|1
4813206|NCT01223937|16596821|P2|Overall Study|Lost to Follow-up|4
4813207|NCT01223937|16596822|P1|Overall Study|Lost to Follow-up|1
4813208|NCT01223937|16596821|P2|Overall Study|Withdrawal by Subject|2
4813209|NCT01223937|16596822|P1|Overall Study|Withdrawal by Subject|3
4813210|NCT01223404|16596868|P6|Third Intervention (1 Day)|Non-compliance (slept)|0
4813211|NCT01223404|16596869|P5|Third Intervention (1 Day)|Non-compliance (slept)|0
4813212|NCT01223404|16596870|P4|Third Intervention (1 Day)|Non-compliance (slept)|1
4813213|NCT01223404|16596871|P3|Third Intervention (1 Day)|Non-compliance (slept)|0
4813214|NCT01223404|16596872|P2|Third Intervention (1 Day)|Non-compliance (slept)|0
4813215|NCT01223404|16596873|P1|Third Intervention (1 Day)|Non-compliance (slept)|0
4813216|NCT01223404|16596868|P6|Second Intervention (1 Day)|Adverse Event|0
4813217|NCT01223404|16596869|P5|Second Intervention (1 Day)|Adverse Event|0
4813218|NCT01223404|16596870|P4|Second Intervention (1 Day)|Adverse Event|0
4813219|NCT01223404|16596871|P3|Second Intervention (1 Day)|Adverse Event|0
4813220|NCT01223404|16596872|P2|Second Intervention (1 Day)|Adverse Event|0
4813221|NCT01223404|16596873|P1|Second Intervention (1 Day)|Adverse Event|1
4813222|NCT01223404|16596868|P6|First Intervention (1 Day)|Adverse Event|0
4813223|NCT01223404|16596869|P5|First Intervention (1 Day)|Adverse Event|0
4813224|NCT01223404|16596870|P4|First Intervention (1 Day)|Adverse Event|1
4813225|NCT01223404|16596871|P3|First Intervention (1 Day)|Adverse Event|0
4813226|NCT01223404|16596872|P2|First Intervention (1 Day)|Adverse Event|0
4813227|NCT01223404|16596873|P1|First Intervention (1 Day)|Adverse Event|0
4813228|NCT01223365|16596937|P1|Open-label Treatment Period|Physician Decision|2
4813229|NCT01223365|16596937|P1|Open-label Treatment Period|Starting physical therapy|1
4813230|NCT01223365|16596937|P1|Open-label Treatment Period|"Out of window"|1
4813231|NCT01223365|16596937|P1|Open-label Treatment Period|Negative urine drug screen when on treat|1
4813232|NCT01223365|16596937|P1|Open-label Treatment Period|Moved out of area|2
4813233|NCT01223365|16596937|P1|Open-label Treatment Period|Noncompliance with study procedures|6
4813234|NCT01223365|16596937|P1|Open-label Treatment Period|Noncompliance with study drug admin|7
4813235|NCT01223365|16596937|P1|Open-label Treatment Period|Lost to Follow-up|7
4813236|NCT01223365|16596937|P1|Open-label Treatment Period|Protocol Violation|15
4813237|NCT01223365|16596937|P1|Open-label Treatment Period|Withdrawal by Subject|19
4813238|NCT01223365|16596937|P1|Open-label Treatment Period|Lack of Efficacy|2
4813239|NCT01223365|16596937|P1|Open-label Treatment Period|Adverse Event|39
4813240|NCT01223365|16596937|P1|Open-label Titration Period|Starting physical therapy|1
4813241|NCT01223365|16596937|P1|Open-label Titration Period|Noncompliance with study procedures|2
4813242|NCT01223365|16596937|P1|Open-label Titration Period|Noncompliance with study drug admin|1
4813243|NCT01223365|16596937|P1|Open-label Titration Period|Lost to Follow-up|2
4813244|NCT01223365|16596937|P1|Open-label Titration Period|Protocol Violation|1
4813245|NCT01223365|16596937|P1|Open-label Titration Period|Withdrawal by Subject|5
4813246|NCT01223365|16596937|P1|Open-label Titration Period|Lack of Efficacy|3
4813247|NCT01223365|16596937|P1|Open-label Titration Period|Adverse Event|23
4813248|NCT01223365|16596937|P1|Open-label Titration Period|Enrolled but not treated|1
4813249|NCT01223235|16597001|P1|Overall Study|Withdrawal by Subject|1
4813250|NCT01223196|16597009|P2|Overall Study|Withdrawal by Subject|0
4813251|NCT01223196|16597010|P1|Overall Study|Withdrawal by Subject|1
4813252|NCT01223196|16597009|P2|Overall Study|Physician Decision|0
4813253|NCT01223196|16597010|P1|Overall Study|Physician Decision|1
4813254|NCT01223196|16597009|P2|Overall Study|Lost to Follow-up|0
4813255|NCT01223196|16597010|P1|Overall Study|Lost to Follow-up|2
4813256|NCT01223183|16597022|P2|Washout Period (5-24 Days)|Physician Decision|0
4813257|NCT01223183|16597023|P1|Washout Period (5-24 Days)|Physician Decision|1
4813258|NCT01223183|16597022|P2|Washout Period (5-24 Days)|Lost to Follow-up|0
4813259|NCT01223183|16597023|P1|Washout Period (5-24 Days)|Lost to Follow-up|1
4813260|NCT01223183|16597022|P2|Imaging Day 1|Physician Decision|1
4813261|NCT01223183|16597023|P1|Imaging Day 1|Physician Decision|0
4813262|NCT01223027|16597033|P2|Overall Study|Study terminated by sponsor|8
4813263|NCT01223027|16597034|P1|Overall Study|Study terminated by sponsor|2
4813264|NCT01223027|16597033|P2|Overall Study|New therapy for study indication|8
4813265|NCT01223027|16597034|P1|Overall Study|New therapy for study indication|17
4813266|NCT01223027|16597033|P2|Overall Study|Subject/guardian decicion|16
4813267|NCT01223027|16597034|P1|Overall Study|Subject/guardian decicion|18
4813268|NCT01223027|16597033|P2|Overall Study|Protocol Violation|1
4813269|NCT01223027|16597034|P1|Overall Study|Protocol Violation|2
4813270|NCT01223027|16597033|P2|Overall Study|Progressive Disease|183
4813271|NCT01223027|16597034|P1|Overall Study|Progressive Disease|167
4813272|NCT01223027|16597033|P2|Overall Study|Physician Decision|8
4813273|NCT01223027|16597034|P1|Overall Study|Physician Decision|4
4813274|NCT01223027|16597033|P2|Overall Study|Lost to Follow-up|1
4813275|NCT01223027|16597034|P1|Overall Study|Lost to Follow-up|2
4813276|NCT01223027|16597033|P2|Overall Study|Death|42
4813277|NCT01223027|16597034|P1|Overall Study|Death|42
4813278|NCT01223027|16597033|P2|Overall Study|Adverse Event|10
4813279|NCT01223027|16597034|P1|Overall Study|Adverse Event|20
4813280|NCT01222715|16597096|P2|Overall Study|Surgery or radiation therapy in 1st 6 wk|0
4813281|NCT01222715|16597097|P1|Overall Study|Surgery or radiation therapy in 1st 6 wk|1
4813282|NCT01222715|16597096|P2|Overall Study|Ineligible|1
4813283|NCT01222715|16597097|P1|Overall Study|Ineligible|0
4813284|NCT01222715|16597096|P2|Overall Study|Pt cannot receive treatment for >9 wks|1
4813285|NCT01222715|16597097|P1|Overall Study|Pt cannot receive treatment for >9 wks|1
4813286|NCT01222715|16597096|P2|Overall Study|Refusal of further protocol therapy|4
4813287|NCT01222715|16597097|P1|Overall Study|Refusal of further protocol therapy|0
4813288|NCT01222715|16597096|P2|Overall Study|Physician Decision|2
4813289|NCT01222715|16597097|P1|Overall Study|Physician Decision|12
4813290|NCT01222715|16597096|P2|Overall Study|Lack of Efficacy|14
4813291|NCT01222715|16597097|P1|Overall Study|Lack of Efficacy|22
4813292|NCT01222715|16597096|P2|Overall Study|Death|1
4813293|NCT01222715|16597097|P1|Overall Study|Death|0
4813294|NCT01222715|16597096|P2|Overall Study|Adverse Event|4
4813295|NCT01222715|16597097|P1|Overall Study|Adverse Event|0
4813296|NCT01222533|16597136|P1|Overall Study|Other|4
4813297|NCT01222533|16597136|P1|Overall Study|Withdrawal by Subject|5
4813298|NCT01222533|16597136|P1|Overall Study|Adverse Event|5
4813299|NCT01222520|16597275|P2|Double-blind Period|Study medication stolen|0
4813300|NCT01222520|16597276|P1|Double-blind Period|Study medication stolen|1
4813301|NCT01222520|16597275|P2|Double-blind Period|Lack of Efficacy|1
4813302|NCT01222520|16597276|P1|Double-blind Period|Lack of Efficacy|0
4813303|NCT01222520|16597275|P2|Double-blind Period|Adverse Event|1
4813304|NCT01222520|16597276|P1|Double-blind Period|Adverse Event|0
4813305|NCT01222520|16597275|P2|Open-label run-in Period|Number of patients fulfilled|3
4813306|NCT01222520|16597276|P1|Open-label run-in Period|Number of patients fulfilled|0
4813307|NCT01222520|16597275|P2|Open-label run-in Period|Blood pressure criteria not met|18
4813308|NCT01222520|16597276|P1|Open-label run-in Period|Blood pressure criteria not met|0
4813309|NCT01222520|16597275|P2|Open-label run-in Period|Withdrawal by Subject|2
4813310|NCT01222520|16597276|P1|Open-label run-in Period|Withdrawal by Subject|0
4813311|NCT01222507|16597294|P1|Overall Study|Withdrawal by Subject|1
4813312|NCT01222507|16597294|P1|Overall Study|Physician Decision|1
4813313|NCT01222416|16597322|P2|Overall Study|Death|0
4813314|NCT01222416|16597323|P1|Overall Study|Death|1
4813315|NCT01222416|16597322|P2|Overall Study|missed view/scan|0
4813316|NCT01222416|16597323|P1|Overall Study|missed view/scan|1
4813317|NCT01222416|16597322|P2|Overall Study|scheduling|0
4813318|NCT01222416|16597323|P1|Overall Study|scheduling|6
4813319|NCT01222416|16597322|P2|Overall Study|Withdrawal by Subject|0
4813320|NCT01222416|16597323|P1|Overall Study|Withdrawal by Subject|5
4813321|NCT01222416|16597322|P2|Overall Study|Adverse Event|0
4813322|NCT01222416|16597323|P1|Overall Study|Adverse Event|4
4813323|NCT01222416|16597322|P2|Overall Study|ineligible;metastasis|0
4813324|NCT01222416|16597323|P1|Overall Study|ineligible;metastasis|3
4813325|NCT01222403|16597333|P2|Overall Study|Inappropriate enrollment|2
4813326|NCT01222403|16597334|P1|Overall Study|Inappropriate enrollment|0
4813327|NCT01222247|16597395|P2|Overall Study|Lost to Follow-up|2
4813328|NCT01222247|16597396|P1|Overall Study|Lost to Follow-up|2
4813329|NCT01222104|16597532|P1|Overall Study|Death|10
4813330|NCT01222104|16597532|P1|Overall Study|Lost to Follow-up|37
4813331|NCT01221948|16597555|P1|Overall Study|Protocol Violation|4
4813332|NCT01221948|16597555|P1|Overall Study|Death|1
4813333|NCT01221948|16597555|P1|Overall Study|not disclosed|2
4813334|NCT01221948|16597555|P1|Overall Study|Withdrawal by Subject|2
4813335|NCT01221948|16597555|P1|Overall Study|Physician Decision|5
4813336|NCT01221753|16597574|P1|Overall Study|Adverse Event|1
4813337|NCT01221727|16597581|P2|Overall Study|Withdrawal by Subject|1
4813338|NCT01221727|16597582|P1|Overall Study|Withdrawal by Subject|1
4813339|NCT01221727|16597581|P2|Overall Study|Physician Decision|0
4813340|NCT01221727|16597582|P1|Overall Study|Physician Decision|2
4813341|NCT01221623|16597603|P2|Overall Study|Other|2
4813342|NCT01221623|16597604|P1|Overall Study|Other|5
4813343|NCT01221623|16597603|P2|Overall Study|Death|0
4813344|NCT01221623|16597604|P1|Overall Study|Death|1
4813345|NCT01221623|16597603|P2|Overall Study|Adverse Event|3
4813346|NCT01221623|16597604|P1|Overall Study|Adverse Event|6
4813347|NCT01221623|16597603|P2|Overall Study|Lost to Follow-up|1
4813348|NCT01221623|16597604|P1|Overall Study|Lost to Follow-up|7
4813349|NCT01221623|16597603|P2|Overall Study|Withdrawal by Subject|8
4813350|NCT01221623|16597604|P1|Overall Study|Withdrawal by Subject|19
4813351|NCT01221597|16597628|P2|Overall Study|Death|0
4813352|NCT01221597|16597629|P1|Overall Study|Death|2
4813353|NCT01221597|16597628|P2|Overall Study|Other|4
4813354|NCT01221597|16597629|P1|Overall Study|Other|3
4813355|NCT01221597|16597628|P2|Overall Study|Protocol Violation|0
4813356|NCT01221597|16597629|P1|Overall Study|Protocol Violation|1
4813357|NCT01221597|16597628|P2|Overall Study|Lost to Follow-up|5
4813358|NCT01221597|16597629|P1|Overall Study|Lost to Follow-up|6
4813359|NCT01221597|16597628|P2|Overall Study|Withdrawal by Subject|6
4813360|NCT01221597|16597629|P1|Overall Study|Withdrawal by Subject|20
4813361|NCT01221597|16597628|P2|Overall Study|Adverse Event|1
4813362|NCT01221597|16597629|P1|Overall Study|Adverse Event|4
4813363|NCT01221363|16597686|P2|Overall Study|Withdrawal by Subject|5
4813364|NCT01221363|16597687|P1|Overall Study|Withdrawal by Subject|11
4813365|NCT01221363|16597686|P2|Overall Study|Pregnancy|0
4813366|NCT01221363|16597687|P1|Overall Study|Pregnancy|1
4813367|NCT01221350|16597697|P2|Overall Study|Withdrawal by Subject|2
4813368|NCT01221350|16597698|P1|Overall Study|Withdrawal by Subject|4
4813369|NCT01221350|16597697|P2|Overall Study|Exclusion criteria, asthma exacerbation|1
4813370|NCT01221350|16597698|P1|Overall Study|Exclusion criteria, asthma exacerbation|0
4813371|NCT01221350|16597697|P2|Overall Study|Discontinued intervention (GERD)|0
4813372|NCT01221350|16597698|P1|Overall Study|Discontinued intervention (GERD)|1
4813373|NCT01221285|16597757|P1|Overall Study|Withdrawal by Subject|1
4813374|NCT01221272|16597766|P2|Period 2|Adverse Event|2
4813375|NCT01221272|16597767|P1|Period 2|Adverse Event|0
4813376|NCT01221272|16597766|P2|Period 1|Significant Dosing Noncompliance|1
4813377|NCT01221272|16597767|P1|Period 1|Significant Dosing Noncompliance|0
4813378|NCT01221272|16597766|P2|Period 1|Consent Withdrawal|1
4813379|NCT01221272|16597767|P1|Period 1|Consent Withdrawal|0
4813380|NCT01221272|16597766|P2|Period 1|Adverse Event|0
4813381|NCT01221272|16597767|P1|Period 1|Adverse Event|2
4813382|NCT01221233|16597784|P2|Overall Study|Withdrawal by Subject|1
4813383|NCT01221233|16597785|P1|Overall Study|Withdrawal by Subject|3
4813384|NCT01221181|16597813|P1|Overall Study|Lost to Follow-up|1
4813385|NCT01221090|16597821|P4|Overall Study|Withdrawal by Subject|2
4813386|NCT01221090|16597822|P3|Overall Study|Withdrawal by Subject|27
4813387|NCT01221090|16597823|P2|Overall Study|Withdrawal by Subject|22
4813388|NCT01221090|16597824|P1|Overall Study|Withdrawal by Subject|0
4813389|NCT01221090|16597821|P4|Overall Study|Non-Compliant or Unable to Contact|20
4813390|NCT01221090|16597822|P3|Overall Study|Non-Compliant or Unable to Contact|15
4813391|NCT01221090|16597823|P2|Overall Study|Non-Compliant or Unable to Contact|12
4813392|NCT01221090|16597824|P1|Overall Study|Non-Compliant or Unable to Contact|15
4813393|NCT01220999|16597855|P5|Overall Study|Progressive disease|0
4813394|NCT01220999|16597856|P4|Overall Study|Progressive disease|0
4813395|NCT01220999|16597857|P3|Overall Study|Progressive disease|1
4813396|NCT01220999|16597858|P2|Overall Study|Progressive disease|0
4813397|NCT01220999|16597859|P1|Overall Study|Progressive disease|0
4813398|NCT01220609|16598009|P1|Overall Study|Ineligible-Never treated|1
4813399|NCT01220609|16598009|P1|Overall Study|Ineligible- Wrong cell type|1
4813400|NCT01220609|16598009|P1|Overall Study|Ineligible-Wrong primary cancer site|1
4813401|NCT01220557|16598023|P2|Overall Study|attended less than 6 lessons|2
4813402|NCT01220557|16598024|P1|Overall Study|attended less than 6 lessons|1
4813403|NCT01220557|16598023|P2|Overall Study|Lost to Follow-up|3
4813404|NCT01220557|16598024|P1|Overall Study|Lost to Follow-up|5
4813405|NCT01220414|16598057|P4|Overall Study|Withdrawal by Subject|1
4813406|NCT01220414|16598058|P3|Overall Study|Withdrawal by Subject|0
4813407|NCT01220414|16598059|P2|Overall Study|Withdrawal by Subject|0
4813408|NCT01220414|16598060|P1|Overall Study|Withdrawal by Subject|1
4813409|NCT01220401|16598067|P1|Overall Study|Protocol Violation|1
4813410|NCT01220401|16598067|P1|Overall Study|Withdrawal by Subject|2
4813411|NCT01220297|16598076|P1|Overall Study|Lost to Follow-up|1
4813412|NCT01220297|16598076|P1|Overall Study|Death|2
4813413|NCT01220180|16598093|P1|Overall Study|Randomized but not treated|1
4813414|NCT01220180|16598093|P1|Overall Study|Death|1
4813415|NCT01220180|16598093|P1|Overall Study|Lack of Efficacy|22
4813416|NCT01220180|16598093|P1|Overall Study|Adverse Event|35
4813417|NCT01220180|16598093|P1|Overall Study|Other|72
4813418|NCT01220180|16598093|P1|Overall Study|Lost to Follow-up|76
4813419|NCT01220167|16598119|P3|Period 3|Urine positive for substance abuse|0
4813420|NCT01220167|16598120|P2|Period 3|Urine positive for substance abuse|1
4813421|NCT01220167|16598121|P1|Period 3|Urine positive for substance abuse|0
4813422|NCT01220128|16598134|P7|Overall Study|Consent withdrawn by subject|0
4813423|NCT01220128|16598135|P6|Overall Study|Consent withdrawn by subject|0
4813424|NCT01220128|16598136|P5|Overall Study|Consent withdrawn by subject|0
4813425|NCT01220128|16598137|P4|Overall Study|Consent withdrawn by subject|0
4813426|NCT01220128|16598138|P3|Overall Study|Consent withdrawn by subject|0
4813427|NCT01220128|16598139|P2|Overall Study|Consent withdrawn by subject|0
4813428|NCT01220128|16598140|P1|Overall Study|Consent withdrawn by subject|1
4813429|NCT01220128|16598134|P7|Overall Study|Other|0
4813430|NCT01220128|16598135|P6|Overall Study|Other|0
4813431|NCT01220128|16598136|P5|Overall Study|Other|0
4813432|NCT01220128|16598137|P4|Overall Study|Other|0
4813433|NCT01220128|16598138|P3|Overall Study|Other|1
4813434|NCT01220128|16598139|P2|Overall Study|Other|0
4813435|NCT01220128|16598140|P1|Overall Study|Other|0
4813436|NCT01220128|16598134|P7|Overall Study|Adverse event, non-fatal|3
4813437|NCT01220128|16598135|P6|Overall Study|Adverse event, non-fatal|0
4813438|NCT01220128|16598136|P5|Overall Study|Adverse event, non-fatal|0
4813439|NCT01220128|16598137|P4|Overall Study|Adverse event, non-fatal|0
4813440|NCT01220128|16598138|P3|Overall Study|Adverse event, non-fatal|0
4813441|NCT01220128|16598139|P2|Overall Study|Adverse event, non-fatal|0
4813442|NCT01220128|16598140|P1|Overall Study|Adverse event, non-fatal|1
4813443|NCT01220128|16598134|P7|Overall Study|Adverse event, serious fatal|1
4813444|NCT01220128|16598135|P6|Overall Study|Adverse event, serious fatal|0
4813445|NCT01220128|16598136|P5|Overall Study|Adverse event, serious fatal|0
4813446|NCT01220128|16598137|P4|Overall Study|Adverse event, serious fatal|0
4813447|NCT01220128|16598138|P3|Overall Study|Adverse event, serious fatal|0
4813448|NCT01220128|16598139|P2|Overall Study|Adverse event, serious fatal|0
4813449|NCT01220128|16598140|P1|Overall Study|Adverse event, serious fatal|2
4813450|NCT01220128|16598134|P7|Overall Study|Sponsor study termination|1
4813451|NCT01220128|16598135|P6|Overall Study|Sponsor study termination|0
4813452|NCT01220128|16598136|P5|Overall Study|Sponsor study termination|0
4813453|NCT01220128|16598137|P4|Overall Study|Sponsor study termination|0
4813454|NCT01220128|16598138|P3|Overall Study|Sponsor study termination|0
4813455|NCT01220128|16598139|P2|Overall Study|Sponsor study termination|1
4813456|NCT01220128|16598140|P1|Overall Study|Sponsor study termination|0
4813457|NCT01220128|16598134|P7|Overall Study|Progressive disease|0
4813458|NCT01220128|16598135|P6|Overall Study|Progressive disease|0
4813459|NCT01220128|16598136|P5|Overall Study|Progressive disease|0
4813460|NCT01220128|16598137|P4|Overall Study|Progressive disease|0
4813461|NCT01220128|16598138|P3|Overall Study|Progressive disease|2
4813462|NCT01220128|16598139|P2|Overall Study|Progressive disease|0
4813463|NCT01220128|16598140|P1|Overall Study|Progressive disease|0
4813464|NCT01219985|16598345|P1|Overall Study|Physician Decision|20
4813465|NCT01219959|16598353|P2|Overall Study|Other|0
4813466|NCT01219959|16598354|P1|Overall Study|Other|1
4813467|NCT01219959|16598353|P2|Overall Study|Renal Transplantation|3
4813468|NCT01219959|16598354|P1|Overall Study|Renal Transplantation|0
4813469|NCT01219959|16598353|P2|Overall Study|Withdrawal by Subject|2
4813470|NCT01219959|16598354|P1|Overall Study|Withdrawal by Subject|0
4813471|NCT01219959|16598353|P2|Overall Study|Physician Decision|4
4813472|NCT01219959|16598354|P1|Overall Study|Physician Decision|0
4813473|NCT01219959|16598353|P2|Overall Study|Adverse Event|14
4813474|NCT01219959|16598354|P1|Overall Study|Adverse Event|6
4813475|NCT01219933|16598402|P1|Overall Study|Lack of Efficacy|1
4813476|NCT01219933|16598402|P1|Overall Study|Protocol Violation|8
4813477|NCT01219933|16598402|P1|Overall Study|Withdrawal by Subject|5
4813478|NCT01219933|16598402|P1|Overall Study|GC free|1
4813479|NCT01219933|16598402|P1|Overall Study|Lost to Follow-up|3
4813480|NCT01219933|16598402|P1|Overall Study|No LDA maintained|7
4813481|NCT01219933|16598402|P1|Overall Study|No LDA reached|5
4813482|NCT01219933|16598402|P1|Overall Study|Adverse Event|8
4813483|NCT01218867|16598612|P11|Overall Study|Death during treatment|0
4813484|NCT01218867|16598613|P10|Overall Study|Death during treatment|0
4813485|NCT01218867|16598614|P9|Overall Study|Death during treatment|0
4813486|NCT01218867|16598615|P8|Overall Study|Death during treatment|0
4813487|NCT01218867|16598616|P7|Overall Study|Death during treatment|1
4813488|NCT01218867|16598617|P6|Overall Study|Death during treatment|0
4813489|NCT01218867|16598618|P5|Overall Study|Death during treatment|0
4813490|NCT01218867|16598619|P4|Overall Study|Death during treatment|0
4813491|NCT01218867|16598620|P3|Overall Study|Death during treatment|0
4813492|NCT01218867|16598621|P2|Overall Study|Death during treatment|0
4813493|NCT01218867|16598622|P1|Overall Study|Death during treatment|0
4813494|NCT01218802|16598670|P2|Overall Study|Incarcerated|0
4813495|NCT01218802|16598671|P1|Overall Study|Incarcerated|2
4813496|NCT01218802|16598670|P2|Overall Study|Adverse Event|2
4813497|NCT01218802|16598671|P1|Overall Study|Adverse Event|0
4813498|NCT01218802|16598670|P2|Overall Study|Withdrawal by Subject|10
4813499|NCT01218802|16598671|P1|Overall Study|Withdrawal by Subject|3
4813500|NCT01218802|16598670|P2|Overall Study|Lost to Follow-up|6
4813501|NCT01218802|16598671|P1|Overall Study|Lost to Follow-up|5
4813502|NCT01218659|16598708|P3|12-Month OLE|Declined to participate in the OLE|4
4813503|NCT01218659|16598709|P2|12-Month OLE|Declined to participate in the OLE|0
4813504|NCT01218659|16598710|P1|12-Month OLE|Declined to participate in the OLE|0
4813505|NCT01218659|16598708|P3|12-Month OLE|Lack of Efficacy|1
4813506|NCT01218659|16598709|P2|12-Month OLE|Lack of Efficacy|0
4813507|NCT01218659|16598710|P1|12-Month OLE|Lack of Efficacy|0
4813508|NCT01218659|16598708|P3|12-Month OLE|Pregnancy|1
4813509|NCT01218659|16598709|P2|12-Month OLE|Pregnancy|0
4813510|NCT01218659|16598710|P1|12-Month OLE|Pregnancy|0
4813511|NCT01218659|16598708|P3|12-Month OLE|Lost to Follow-up|1
4813512|NCT01218659|16598709|P2|12-Month OLE|Lost to Follow-up|0
4813513|NCT01218659|16598710|P1|12-Month OLE|Lost to Follow-up|0
4813514|NCT01218659|16598708|P3|12-Month OLE|Physician Decision|1
4813515|NCT01218659|16598709|P2|12-Month OLE|Physician Decision|0
4813516|NCT01218659|16598710|P1|12-Month OLE|Physician Decision|0
4813517|NCT01218659|16598708|P3|12-Month OLE|Withdrawal by Subject|2
4813518|NCT01218659|16598709|P2|12-Month OLE|Withdrawal by Subject|0
4813519|NCT01218659|16598710|P1|12-Month OLE|Withdrawal by Subject|0
4813520|NCT01218659|16598708|P3|18-Month Randomized Period|Did not receive study drug|0
4813521|NCT01218659|16598709|P2|18-Month Randomized Period|Did not receive study drug|3
4813522|NCT01218659|16598710|P1|18-Month Randomized Period|Did not receive study drug|0
4813523|NCT01218659|16598708|P3|18-Month Randomized Period|Withdrawal by Subject|0
4813524|NCT01218659|16598709|P2|18-Month Randomized Period|Withdrawal by Subject|3
4813525|NCT01218659|16598710|P1|18-Month Randomized Period|Withdrawal by Subject|2
4813526|NCT01218646|16598725|P4|Overall Study|Protocol Violation|1
4813527|NCT01218646|16598726|P3|Overall Study|Protocol Violation|1
4813528|NCT01218646|16598727|P2|Overall Study|Protocol Violation|0
4813529|NCT01218646|16598728|P1|Overall Study|Protocol Violation|0
4813530|NCT01218646|16598725|P4|Overall Study|Lost to Follow-up|0
4813531|NCT01218646|16598726|P3|Overall Study|Lost to Follow-up|0
4813532|NCT01218646|16598727|P2|Overall Study|Lost to Follow-up|0
4813533|NCT01218646|16598728|P1|Overall Study|Lost to Follow-up|1
4813534|NCT01218646|16598725|P4|Overall Study|Adverse Event|0
4813535|NCT01218646|16598726|P3|Overall Study|Adverse Event|1
4813536|NCT01218646|16598727|P2|Overall Study|Adverse Event|0
4813537|NCT01218646|16598728|P1|Overall Study|Adverse Event|0
4813538|NCT01218594|16598766|P1|Overall Study|Physician Decision|6
4813539|NCT01218594|16598766|P1|Overall Study|Adverse Event|2
4813540|NCT01218594|16598766|P1|Overall Study|Withdrawal by Subject|3
4813541|NCT01218594|16598766|P1|Overall Study|Death|1
4813542|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
4813543|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0
4813544|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
4813545|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1
4813546|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
4813547|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0
4813548|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3
4813549|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2
4813550|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
4813551|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
4813552|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1
4813553|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0
4813554|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Other|0
4813555|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Other|0
4813556|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Other|4
4813557|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Other|3
4813558|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
4813559|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
4813560|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3
4813561|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0
4813562|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
4813563|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
4813564|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1
4813565|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0
4813566|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
4813567|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
4813568|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1
4813569|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0
4813570|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
4813571|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0
4813572|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15
4813573|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17
4813574|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
4813575|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
4813576|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0
4813577|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2
4813578|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Physician Decision|0
4813579|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Physician Decision|0
4813580|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Physician Decision|2
4813581|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Physician Decision|2
4813582|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
4813583|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
4813584|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3
4813585|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0
4813586|NCT01218516|16598772|P4|Combination Therapy (up to 4.5 Months)|Death|0
4813587|NCT01218516|16598773|P3|Combination Therapy (up to 4.5 Months)|Death|0
4813588|NCT01218516|16598774|P2|Combination Therapy (up to 4.5 Months)|Death|1
4813589|NCT01218516|16598775|P1|Combination Therapy (up to 4.5 Months)|Death|2
4813590|NCT01218477|16598797|P4|Overall Study|Maximum clinical benefit|0
4813591|NCT01218477|16598798|P3|Overall Study|Maximum clinical benefit|0
4813592|NCT01218477|16598799|P2|Overall Study|Maximum clinical benefit|2
4813593|NCT01218477|16598800|P1|Overall Study|Maximum clinical benefit|0
4813594|NCT01218477|16598797|P4|Overall Study|Administrative reason by sponsor|0
4813595|NCT01218477|16598798|P3|Overall Study|Administrative reason by sponsor|1
4813596|NCT01218477|16598799|P2|Overall Study|Administrative reason by sponsor|0
4813597|NCT01218477|16598800|P1|Overall Study|Administrative reason by sponsor|0
4813598|NCT01218477|16598797|P4|Overall Study|Prepared for cell transplantation|0
4813599|NCT01218477|16598798|P3|Overall Study|Prepared for cell transplantation|1
4813600|NCT01218477|16598799|P2|Overall Study|Prepared for cell transplantation|1
4813601|NCT01218477|16598800|P1|Overall Study|Prepared for cell transplantation|0
4813602|NCT01218477|16598797|P4|Overall Study|Withdrawal by Subject|0
4813603|NCT01218477|16598798|P3|Overall Study|Withdrawal by Subject|1
4813604|NCT01218477|16598799|P2|Overall Study|Withdrawal by Subject|0
4813605|NCT01218477|16598800|P1|Overall Study|Withdrawal by Subject|0
4813606|NCT01218477|16598797|P4|Overall Study|No longer meets study criteria|0
4813607|NCT01218477|16598798|P3|Overall Study|No longer meets study criteria|0
4813608|NCT01218477|16598799|P2|Overall Study|No longer meets study criteria|0
4813609|NCT01218477|16598800|P1|Overall Study|No longer meets study criteria|1
4813610|NCT01218477|16598797|P4|Overall Study|Study drug toxicity|0
4813611|NCT01218477|16598798|P3|Overall Study|Study drug toxicity|5
4813612|NCT01218477|16598799|P2|Overall Study|Study drug toxicity|2
4813613|NCT01218477|16598800|P1|Overall Study|Study drug toxicity|0
4813614|NCT01218477|16598797|P4|Overall Study|Disease progression|2
4813615|NCT01218477|16598798|P3|Overall Study|Disease progression|6
4813616|NCT01218477|16598799|P2|Overall Study|Disease progression|3
4813617|NCT01218477|16598800|P1|Overall Study|Disease progression|2
4813618|NCT01218438|16598817|P1|Epoch 4|Withdrawal by Subject|2
4813619|NCT01218438|16598817|P1|Epoch 4|Physician Decision|1
4813620|NCT01218438|16598817|P1|Epoch 3|Adverse Event|1
4813621|NCT01218438|16598817|P1|Epoch 3|Withdrawal by Subject|3
4813622|NCT01218438|16598817|P1|Epoch 1|Adverse Event|1
4813623|NCT01218438|16598817|P1|Epoch 1|Physician Decision|2
4813624|NCT01218308|16598983|P2|Overall Study|Other|21
4813625|NCT01218308|16598984|P1|Overall Study|Other|14
4813626|NCT01218308|16598983|P2|Overall Study|Lost to Follow-up|31
4813627|NCT01218308|16598984|P1|Overall Study|Lost to Follow-up|27
4813628|NCT01218308|16598983|P2|Overall Study|Withdrawal by Subject|64
4813629|NCT01218308|16598984|P1|Overall Study|Withdrawal by Subject|61
4813630|NCT01218308|16598983|P2|Overall Study|Protocol Violation|2
4813631|NCT01218308|16598984|P1|Overall Study|Protocol Violation|0
4813632|NCT01218308|16598983|P2|Overall Study|Adverse Event|2
4813633|NCT01218308|16598984|P1|Overall Study|Adverse Event|1
4813634|NCT01218243|16599028|P2|Overall Study|Protocol Violation|10
4813635|NCT01218243|16599029|P1|Overall Study|Protocol Violation|5
4813636|NCT01218243|16599028|P2|Overall Study|Lost to Follow-up|3
4813637|NCT01218243|16599029|P1|Overall Study|Lost to Follow-up|3
4813638|NCT01218243|16599028|P2|Overall Study|Lack of Efficacy|1
4813639|NCT01218243|16599029|P1|Overall Study|Lack of Efficacy|1
4813640|NCT01218204|16599045|P4|Part B Pooled Treatment Arm|Protocol Violation|1
4813641|NCT01218204|16599046|P3|Part B Pooled Treatment Arm|Protocol Violation|0
4813642|NCT01218204|16599047|P2|Part B Pooled Treatment Arm|Protocol Violation|0
4813643|NCT01218204|16599048|P1|Part B Pooled Treatment Arm|Protocol Violation|0
4813644|NCT01218204|16599045|P4|Part B Pooled Treatment Arm|Adverse Event|2
4813645|NCT01218204|16599046|P3|Part B Pooled Treatment Arm|Adverse Event|0
4813646|NCT01218204|16599047|P2|Part B Pooled Treatment Arm|Adverse Event|0
4813647|NCT01218204|16599048|P1|Part B Pooled Treatment Arm|Adverse Event|0
4813648|NCT01218204|16599045|P4|Part B Run-in|Withdrawal by Subject|0
4813649|NCT01218204|16599046|P3|Part B Run-in|Withdrawal by Subject|3
4813650|NCT01218204|16599047|P2|Part B Run-in|Withdrawal by Subject|0
4813651|NCT01218204|16599048|P1|Part B Run-in|Withdrawal by Subject|0
4813652|NCT01218204|16599045|P4|Part B Run-in|Protocol Violation|0
4813653|NCT01218204|16599046|P3|Part B Run-in|Protocol Violation|2
4813654|NCT01218204|16599047|P2|Part B Run-in|Protocol Violation|0
4813655|NCT01218204|16599048|P1|Part B Run-in|Protocol Violation|0
4813656|NCT01218204|16599045|P4|Part B Run-in|Adverse Event|0
4813657|NCT01218204|16599046|P3|Part B Run-in|Adverse Event|1
4813658|NCT01218204|16599047|P2|Part B Run-in|Adverse Event|0
4813659|NCT01218204|16599048|P1|Part B Run-in|Adverse Event|0
4813660|NCT01218204|16599045|P4|Part B Washout|Did not meet continuation criteria|0
4813661|NCT01218204|16599046|P3|Part B Washout|Did not meet continuation criteria|0
4813662|NCT01218204|16599047|P2|Part B Washout|Did not meet continuation criteria|112
4813663|NCT01218204|16599048|P1|Part B Washout|Did not meet continuation criteria|0
4813664|NCT01218204|16599045|P4|Part B Washout|Reached defined stopping criteria|0
4813665|NCT01218204|16599046|P3|Part B Washout|Reached defined stopping criteria|0
4813666|NCT01218204|16599047|P2|Part B Washout|Reached defined stopping criteria|2
4813667|NCT01218204|16599048|P1|Part B Washout|Reached defined stopping criteria|0
4813668|NCT01218204|16599045|P4|Part B Washout|Withdrawal by Subject|0
4813669|NCT01218204|16599046|P3|Part B Washout|Withdrawal by Subject|0
4813670|NCT01218204|16599047|P2|Part B Washout|Withdrawal by Subject|14
4813671|NCT01218204|16599048|P1|Part B Washout|Withdrawal by Subject|0
4813672|NCT01218204|16599045|P4|Part B Washout|Physician Decision|0
4813673|NCT01218204|16599046|P3|Part B Washout|Physician Decision|0
4813674|NCT01218204|16599047|P2|Part B Washout|Physician Decision|14
4813675|NCT01218204|16599048|P1|Part B Washout|Physician Decision|0
4813676|NCT01218204|16599045|P4|Part B Washout|Lost to Follow-up|0
4813677|NCT01218204|16599046|P3|Part B Washout|Lost to Follow-up|0
4813678|NCT01218204|16599047|P2|Part B Washout|Lost to Follow-up|2
4813679|NCT01218204|16599048|P1|Part B Washout|Lost to Follow-up|0
4813680|NCT01218204|16599045|P4|Part B Washout|Adverse Event|0
4813681|NCT01218204|16599046|P3|Part B Washout|Adverse Event|0
4813682|NCT01218204|16599047|P2|Part B Washout|Adverse Event|1
4813683|NCT01218204|16599048|P1|Part B Washout|Adverse Event|0
4813684|NCT01218126|16599312|P4|Overall Study|Withdrawal by Subject|6
4813685|NCT01218126|16599313|P3|Overall Study|Withdrawal by Subject|4
4813686|NCT01218126|16599314|P2|Overall Study|Withdrawal by Subject|5
4813687|NCT01218126|16599315|P1|Overall Study|Withdrawal by Subject|2
4813688|NCT01218126|16599312|P4|Overall Study|Physician Decision|2
4813689|NCT01218126|16599313|P3|Overall Study|Physician Decision|4
4813690|NCT01218126|16599314|P2|Overall Study|Physician Decision|2
4813691|NCT01218126|16599315|P1|Overall Study|Physician Decision|1
4813692|NCT01218126|16599312|P4|Overall Study|Lost to Follow-up|2
4813693|NCT01218126|16599313|P3|Overall Study|Lost to Follow-up|0
4813694|NCT01218126|16599314|P2|Overall Study|Lost to Follow-up|0
4813695|NCT01218126|16599315|P1|Overall Study|Lost to Follow-up|0
4813696|NCT01218126|16599312|P4|Overall Study|Protocol-defined stopping criteria|0
4813697|NCT01218126|16599313|P3|Overall Study|Protocol-defined stopping criteria|0
4813698|NCT01218126|16599314|P2|Overall Study|Protocol-defined stopping criteria|1
4813699|NCT01218126|16599315|P1|Overall Study|Protocol-defined stopping criteria|1
4813700|NCT01218126|16599312|P4|Overall Study|Protocol Violation|3
4813701|NCT01218126|16599313|P3|Overall Study|Protocol Violation|2
4813702|NCT01218126|16599314|P2|Overall Study|Protocol Violation|2
4813703|NCT01218126|16599315|P1|Overall Study|Protocol Violation|5
4813704|NCT01218126|16599312|P4|Overall Study|Lack of Efficacy|6
4813705|NCT01218126|16599313|P3|Overall Study|Lack of Efficacy|2
4813706|NCT01218126|16599314|P2|Overall Study|Lack of Efficacy|2
4813707|NCT01218126|16599315|P1|Overall Study|Lack of Efficacy|7
4813708|NCT01218126|16599312|P4|Overall Study|Adverse Event|16
4813709|NCT01218126|16599313|P3|Overall Study|Adverse Event|12
4813710|NCT01218126|16599314|P2|Overall Study|Adverse Event|10
4813711|NCT01218126|16599315|P1|Overall Study|Adverse Event|8
4813712|NCT01218113|16599356|P3|Overall Study|Protocol Deviation Eligibility Criteria|1
4813713|NCT01218113|16599357|P2|Overall Study|Protocol Deviation Eligibility Criteria|0
4813714|NCT01218113|16599358|P1|Overall Study|Protocol Deviation Eligibility Criteria|0
4813715|NCT01218113|16599356|P3|Overall Study|Lost to Follow-up|4
4813716|NCT01218113|16599357|P2|Overall Study|Lost to Follow-up|1
4813717|NCT01218113|16599358|P1|Overall Study|Lost to Follow-up|4
4813718|NCT01218113|16599356|P3|Overall Study|Withdrawal by Subject|1
4813719|NCT01218113|16599357|P2|Overall Study|Withdrawal by Subject|0
4813720|NCT01218113|16599358|P1|Overall Study|Withdrawal by Subject|1
4813721|NCT01218100|16599539|P4|Overall Study|Other Reason|4
4813722|NCT01218100|16599540|P3|Overall Study|Other Reason|6
4813723|NCT01218100|16599541|P2|Overall Study|Other Reason|2
4813724|NCT01218100|16599542|P1|Overall Study|Other Reason|2
4813725|NCT01218100|16599539|P4|Overall Study|Lost to Follow-up|1
4813726|NCT01218100|16599540|P3|Overall Study|Lost to Follow-up|2
4813727|NCT01218100|16599541|P2|Overall Study|Lost to Follow-up|8
4813728|NCT01218100|16599542|P1|Overall Study|Lost to Follow-up|3
4813729|NCT01218100|16599539|P4|Overall Study|Withdrawal by Subject|7
4813730|NCT01218100|16599540|P3|Overall Study|Withdrawal by Subject|6
4813731|NCT01218100|16599541|P2|Overall Study|Withdrawal by Subject|2
4813732|NCT01218100|16599542|P1|Overall Study|Withdrawal by Subject|5
4813733|NCT01218100|16599539|P4|Overall Study|Protocol Violation|1
4813734|NCT01218100|16599540|P3|Overall Study|Protocol Violation|1
4813735|NCT01218100|16599541|P2|Overall Study|Protocol Violation|0
4813736|NCT01218100|16599542|P1|Overall Study|Protocol Violation|0
4813737|NCT01218100|16599539|P4|Overall Study|Lack of Efficacy|12
4813738|NCT01218100|16599540|P3|Overall Study|Lack of Efficacy|5
4813739|NCT01218100|16599541|P2|Overall Study|Lack of Efficacy|6
4813740|NCT01218100|16599542|P1|Overall Study|Lack of Efficacy|9
4813741|NCT01218100|16599539|P4|Overall Study|Adverse Event|7
4813742|NCT01218100|16599540|P3|Overall Study|Adverse Event|6
4813743|NCT01218100|16599541|P2|Overall Study|Adverse Event|6
4813744|NCT01218100|16599542|P1|Overall Study|Adverse Event|4
4813745|NCT01218100|16599539|P4|Overall Study|Did not meet InclusionExclusion criteria|2
4813746|NCT01218100|16599540|P3|Overall Study|Did not meet InclusionExclusion criteria|1
4813747|NCT01218100|16599541|P2|Overall Study|Did not meet InclusionExclusion criteria|1
4813748|NCT01218100|16599542|P1|Overall Study|Did not meet InclusionExclusion criteria|1
4813749|NCT01218087|16599558|P2|Overall Study|Transferred|5
4813750|NCT01218087|16599559|P1|Overall Study|Transferred|8
4813751|NCT01218087|16599558|P2|Overall Study|Withdrawal by Subject|0
4813752|NCT01218087|16599559|P1|Overall Study|Withdrawal by Subject|5
4813753|NCT01218087|16599558|P2|Overall Study|Death|1
4813754|NCT01218087|16599559|P1|Overall Study|Death|2
4813755|NCT01218009|16599581|P2|Overall Study|Sponsor terminated study|163
4813756|NCT01218009|16599582|P1|Overall Study|Sponsor terminated study|161
4813757|NCT01218009|16599581|P2|Overall Study|Withdrawal by Subject|1
4813758|NCT01218009|16599582|P1|Overall Study|Withdrawal by Subject|3
4813759|NCT01218009|16599581|P2|Overall Study|Protocol Violation|1
4813760|NCT01218009|16599582|P1|Overall Study|Protocol Violation|2
4813761|NCT01217957|16599605|P5|Phase 2|Withdrawal by Patient|1
4813762|NCT01217957|16599606|P4|Phase 2|Withdrawal by Patient|0
4813763|NCT01217957|16599607|P3|Phase 2|Withdrawal by Patient|0
4813764|NCT01217957|16599608|P2|Phase 2|Withdrawal by Patient|0
4813765|NCT01217957|16599609|P1|Phase 2|Withdrawal by Patient|0
4813766|NCT01217957|16599605|P5|Phase 1|Withdrawal by Patient|0
4813767|NCT01217957|16599606|P4|Phase 1|Withdrawal by Patient|1
4813768|NCT01217957|16599607|P3|Phase 1|Withdrawal by Patient|1
4813769|NCT01217957|16599608|P2|Phase 1|Withdrawal by Patient|0
4813770|NCT01217957|16599609|P1|Phase 1|Withdrawal by Patient|1
4813771|NCT01217944|16599668|P3|Overall Study|Lack of Efficacy|0
4813772|NCT01217944|16599669|P2|Overall Study|Lack of Efficacy|0
4813773|NCT01217944|16599670|P1|Overall Study|Lack of Efficacy|1
4813774|NCT01217944|16599668|P3|Overall Study|Withdrawal by Subject|0
4813775|NCT01217944|16599669|P2|Overall Study|Withdrawal by Subject|2
4813776|NCT01217944|16599670|P1|Overall Study|Withdrawal by Subject|1
4813777|NCT01217944|16599668|P3|Overall Study|Lost to Follow-up|0
4813778|NCT01217944|16599669|P2|Overall Study|Lost to Follow-up|1
4813779|NCT01217944|16599670|P1|Overall Study|Lost to Follow-up|3
4813780|NCT01217944|16599668|P3|Overall Study|Protocol Violation|0
4813781|NCT01217944|16599669|P2|Overall Study|Protocol Violation|1
4813782|NCT01217944|16599670|P1|Overall Study|Protocol Violation|1
4813783|NCT01217892|16599713|P4|Overall Study|Poor/Non-Compliance|0
4813784|NCT01217892|16599714|P3|Overall Study|Poor/Non-Compliance|1
4813785|NCT01217892|16599715|P2|Overall Study|Poor/Non-Compliance|0
4813786|NCT01217892|16599716|P1|Overall Study|Poor/Non-Compliance|0
4813787|NCT01217892|16599713|P4|Overall Study|Incorrect enrollment|0
4813788|NCT01217892|16599714|P3|Overall Study|Incorrect enrollment|1
4813789|NCT01217892|16599715|P2|Overall Study|Incorrect enrollment|1
4813790|NCT01217892|16599716|P1|Overall Study|Incorrect enrollment|0
4813791|NCT01217892|16599713|P4|Overall Study|Subject no longer meets study criteria|8
4813792|NCT01217892|16599714|P3|Overall Study|Subject no longer meets study criteria|4
4813793|NCT01217892|16599715|P2|Overall Study|Subject no longer meets study criteria|2
4813794|NCT01217892|16599716|P1|Overall Study|Subject no longer meets study criteria|5
4813795|NCT01217892|16599713|P4|Overall Study|Lab value|0
4813796|NCT01217892|16599714|P3|Overall Study|Lab value|1
4813797|NCT01217892|16599715|P2|Overall Study|Lab value|0
4813798|NCT01217892|16599716|P1|Overall Study|Lab value|1
4813799|NCT01217892|16599713|P4|Overall Study|Withdrawal by Subject|0
4813800|NCT01217892|16599714|P3|Overall Study|Withdrawal by Subject|1
4813801|NCT01217892|16599715|P2|Overall Study|Withdrawal by Subject|2
4813802|NCT01217892|16599716|P1|Overall Study|Withdrawal by Subject|0
4813803|NCT01217892|16599713|P4|Overall Study|Adverse Event|0
4813804|NCT01217892|16599714|P3|Overall Study|Adverse Event|1
4813805|NCT01217892|16599715|P2|Overall Study|Adverse Event|1
4813806|NCT01217892|16599716|P1|Overall Study|Adverse Event|1
4813807|NCT01217814|16599779|P3|Overall Study|Lack of Efficacy|1
4813808|NCT01217814|16599780|P2|Overall Study|Lack of Efficacy|0
4813809|NCT01217814|16599781|P1|Overall Study|Lack of Efficacy|0
4813810|NCT01217814|16599779|P3|Overall Study|Adverse Event|0
4813811|NCT01217814|16599780|P2|Overall Study|Adverse Event|1
4813812|NCT01217814|16599781|P1|Overall Study|Adverse Event|1
4813813|NCT01217801|16599807|P2|Period 1|Withdrawal by Subject|1
4813814|NCT01217801|16599808|P1|Period 1|Withdrawal by Subject|0
4813815|NCT01217801|16599807|P2|Period 1|Protocol Violation|1
4813816|NCT01217801|16599808|P1|Period 1|Protocol Violation|1
4813817|NCT01217606|16599837|P2|9-Month Masked Extension|Lack of Efficacy|0
4813818|NCT01217606|16599838|P1|9-Month Masked Extension|Lack of Efficacy|2
4813819|NCT01217606|16599837|P2|9-Month Masked Extension|Pregnancy|0
4813820|NCT01217606|16599838|P1|9-Month Masked Extension|Pregnancy|1
4813821|NCT01217606|16599837|P2|9-Month Masked Extension|Lost to Follow-up|0
4813822|NCT01217606|16599838|P1|9-Month Masked Extension|Lost to Follow-up|1
4813823|NCT01217606|16599837|P2|9-Month Masked Extension|Personal Reasons|1
4813824|NCT01217606|16599838|P1|9-Month Masked Extension|Personal Reasons|2
4813825|NCT01217606|16599837|P2|9-Month Masked Extension|Other Reasons|4
4813826|NCT01217606|16599838|P1|9-Month Masked Extension|Other Reasons|4
4813827|NCT01217606|16599837|P2|9-Month Masked Extension|Adverse Event|6
4813828|NCT01217606|16599838|P1|9-Month Masked Extension|Adverse Event|3
4813829|NCT01217606|16599837|P2|Initial Treatment Phase|Adverse Event|6
4813830|NCT01217606|16599838|P1|Initial Treatment Phase|Adverse Event|10
4813831|NCT01217606|16599837|P2|Initial Treatment Phase|Lack of Efficacy|0
4813832|NCT01217606|16599838|P1|Initial Treatment Phase|Lack of Efficacy|1
4813833|NCT01217606|16599837|P2|Initial Treatment Phase|Personal Reasons|2
4813834|NCT01217606|16599838|P1|Initial Treatment Phase|Personal Reasons|0
4813835|NCT01217606|16599837|P2|Initial Treatment Phase|Protocol Violation|2
4813836|NCT01217606|16599838|P1|Initial Treatment Phase|Protocol Violation|3
4813837|NCT01217606|16599837|P2|Initial Treatment Phase|Other Reasons|2
4813838|NCT01217606|16599838|P1|Initial Treatment Phase|Other Reasons|0
4813839|NCT01217476|16599869|P2|Overall Study|Other|0
4813840|NCT01217476|16599870|P1|Overall Study|Other|2
4813841|NCT01217476|16599869|P2|Overall Study|Protocol Deviation|0
4813842|NCT01217476|16599870|P1|Overall Study|Protocol Deviation|1
4813843|NCT01217476|16599869|P2|Overall Study|Surgery on the Target Limb|2
4813844|NCT01217476|16599870|P1|Overall Study|Surgery on the Target Limb|0
4813845|NCT01217476|16599869|P2|Overall Study|Withdrawal by Subject|3
4813846|NCT01217476|16599870|P1|Overall Study|Withdrawal by Subject|3
4813847|NCT01217476|16599869|P2|Overall Study|Physician Decision|1
4813848|NCT01217476|16599870|P1|Overall Study|Physician Decision|0
4813849|NCT01217476|16599869|P2|Overall Study|Adverse Event|1
4813850|NCT01217476|16599870|P1|Overall Study|Adverse Event|6
4813851|NCT01217463|16599880|P2|Overall Study|Other|1
4813852|NCT01217463|16599881|P1|Overall Study|Other|1
4813853|NCT01217463|16599880|P2|Overall Study|Patient Non-compliant|0
4813854|NCT01217463|16599881|P1|Overall Study|Patient Non-compliant|1
4813855|NCT01217463|16599880|P2|Overall Study|Surgery on the Target Limb|1
4813856|NCT01217463|16599881|P1|Overall Study|Surgery on the Target Limb|0
4813857|NCT01217463|16599880|P2|Overall Study|Withdrawal by Subject|0
4813858|NCT01217463|16599881|P1|Overall Study|Withdrawal by Subject|3
4813859|NCT01217463|16599880|P2|Overall Study|Physician Decision|1
4813860|NCT01217463|16599881|P1|Overall Study|Physician Decision|0
4813861|NCT01217463|16599880|P2|Overall Study|Adverse Event|5
4813862|NCT01217463|16599881|P1|Overall Study|Adverse Event|8
4813863|NCT01217437|16599891|P2|Overall Study|Ineligible|1
4813864|NCT01217437|16599892|P1|Overall Study|Ineligible|1
4813865|NCT01217437|16599891|P2|Overall Study|Withdrawal by Subject|2
4813866|NCT01217437|16599892|P1|Overall Study|Withdrawal by Subject|0
4813867|NCT01217437|16599891|P2|Overall Study|Physician Decision|5
4813868|NCT01217437|16599892|P1|Overall Study|Physician Decision|8
4813869|NCT01217437|16599891|P2|Overall Study|Lack of Efficacy|25
4813870|NCT01217437|16599892|P1|Overall Study|Lack of Efficacy|29
4813871|NCT01217437|16599891|P2|Overall Study|Death|0
4813872|NCT01217437|16599892|P1|Overall Study|Death|5
4813873|NCT01217437|16599891|P2|Overall Study|Adverse Event|8
4813874|NCT01217437|16599892|P1|Overall Study|Adverse Event|0
4813875|NCT01217385|16599913|P1|Overall Study|Normal Breast TOI not available|10
4813876|NCT01217385|16599913|P1|Overall Study|Central Path not Available|1
4813877|NCT01217385|16599913|P1|Overall Study|DOSI not performed/not eval|12
4813878|NCT01217385|16599913|P1|Overall Study|Withdrawal by Subject|3
4813879|NCT01217307|16599925|P2|Overall Study|Withdrawal by Subject|1
4813880|NCT01217307|16599926|P1|Overall Study|Withdrawal by Subject|0
4813881|NCT01217229|16599932|P1|Overall Study|Disease progression not confirmed|2
4813882|NCT01217229|16599932|P1|Overall Study|Protocol Violation|1
4813883|NCT01217229|16599932|P1|Overall Study|Disease progression, Cheson criteria|14
4813884|NCT01217229|16599932|P1|Overall Study|Disease progression, deterioration|2
4813885|NCT01217229|16599932|P1|Overall Study|Adverse Event|1
4813886|NCT01217190|16599941|P2|Second Dosing|Withdrawal by Subject|2
4813887|NCT01217190|16599942|P1|Second Dosing|Withdrawal by Subject|0
4813888|NCT01217112|16599957|P5|Overall Study|Physician Decision|1
4813889|NCT01217112|16599958|P4|Overall Study|Physician Decision|0
4813890|NCT01217112|16599959|P3|Overall Study|Physician Decision|0
4813891|NCT01217112|16599960|P2|Overall Study|Physician Decision|0
4813892|NCT01217112|16599961|P1|Overall Study|Physician Decision|0
4813893|NCT01217112|16599957|P5|Overall Study|Withdrawal by Subject|0
4813894|NCT01217112|16599958|P4|Overall Study|Withdrawal by Subject|0
4813895|NCT01217112|16599959|P3|Overall Study|Withdrawal by Subject|1
4813896|NCT01217112|16599960|P2|Overall Study|Withdrawal by Subject|0
4813897|NCT01217112|16599961|P1|Overall Study|Withdrawal by Subject|0
4813898|NCT01217112|16599957|P5|Overall Study|Adverse Event|0
4813899|NCT01217112|16599958|P4|Overall Study|Adverse Event|2
4813900|NCT01217112|16599959|P3|Overall Study|Adverse Event|0
4813901|NCT01217112|16599960|P2|Overall Study|Adverse Event|2
4813902|NCT01217112|16599961|P1|Overall Study|Adverse Event|0
4813903|NCT01217073|16600194|P8|Extension Period|Withdrawal by Subject|8
4813904|NCT01217073|16600195|P7|Extension Period|Withdrawal by Subject|30
4813905|NCT01217073|16600196|P6|Extension Period|Withdrawal by Subject|0
4813906|NCT01217073|16600197|P5|Extension Period|Withdrawal by Subject|0
4813907|NCT01217073|16600198|P4|Extension Period|Withdrawal by Subject|0
4813908|NCT01217073|16600199|P3|Extension Period|Withdrawal by Subject|0
4813909|NCT01217073|16600200|P2|Extension Period|Withdrawal by Subject|0
4813910|NCT01217073|16600201|P1|Extension Period|Withdrawal by Subject|0
4813911|NCT01217073|16600194|P8|Extension Period|Site discontinued study participation|2
4813912|NCT01217073|16600195|P7|Extension Period|Site discontinued study participation|7
4813913|NCT01217073|16600196|P6|Extension Period|Site discontinued study participation|0
4813914|NCT01217073|16600197|P5|Extension Period|Site discontinued study participation|0
4813915|NCT01217073|16600198|P4|Extension Period|Site discontinued study participation|0
4813916|NCT01217073|16600199|P3|Extension Period|Site discontinued study participation|0
4813917|NCT01217073|16600200|P2|Extension Period|Site discontinued study participation|0
4813918|NCT01217073|16600201|P1|Extension Period|Site discontinued study participation|0
4813919|NCT01217073|16600194|P8|Extension Period|Protocol Violation|1
4813920|NCT01217073|16600195|P7|Extension Period|Protocol Violation|2
4813921|NCT01217073|16600196|P6|Extension Period|Protocol Violation|0
4813922|NCT01217073|16600197|P5|Extension Period|Protocol Violation|0
4813923|NCT01217073|16600198|P4|Extension Period|Protocol Violation|0
4813924|NCT01217073|16600199|P3|Extension Period|Protocol Violation|0
4813925|NCT01217073|16600200|P2|Extension Period|Protocol Violation|0
4813926|NCT01217073|16600201|P1|Extension Period|Protocol Violation|0
4813927|NCT01217073|16600194|P8|Extension Period|Physician Decision|1
4813928|NCT01217073|16600195|P7|Extension Period|Physician Decision|4
4813929|NCT01217073|16600196|P6|Extension Period|Physician Decision|0
4813930|NCT01217073|16600197|P5|Extension Period|Physician Decision|0
4813931|NCT01217073|16600198|P4|Extension Period|Physician Decision|0
4813932|NCT01217073|16600199|P3|Extension Period|Physician Decision|0
4813933|NCT01217073|16600200|P2|Extension Period|Physician Decision|0
4813934|NCT01217073|16600201|P1|Extension Period|Physician Decision|0
4813935|NCT01217073|16600194|P8|Extension Period|Non-compliance with study drug|1
4813936|NCT01217073|16600195|P7|Extension Period|Non-compliance with study drug|0
4813937|NCT01217073|16600196|P6|Extension Period|Non-compliance with study drug|0
4813938|NCT01217073|16600197|P5|Extension Period|Non-compliance with study drug|0
4813939|NCT01217073|16600198|P4|Extension Period|Non-compliance with study drug|0
4813940|NCT01217073|16600199|P3|Extension Period|Non-compliance with study drug|0
4813941|NCT01217073|16600200|P2|Extension Period|Non-compliance with study drug|0
4813942|NCT01217073|16600201|P1|Extension Period|Non-compliance with study drug|0
4813943|NCT01217073|16600194|P8|Extension Period|Lost to Follow-up|1
4813944|NCT01217073|16600195|P7|Extension Period|Lost to Follow-up|9
4813945|NCT01217073|16600196|P6|Extension Period|Lost to Follow-up|0
4813946|NCT01217073|16600197|P5|Extension Period|Lost to Follow-up|0
4813947|NCT01217073|16600198|P4|Extension Period|Lost to Follow-up|0
4813948|NCT01217073|16600199|P3|Extension Period|Lost to Follow-up|0
4813949|NCT01217073|16600200|P2|Extension Period|Lost to Follow-up|0
4813950|NCT01217073|16600201|P1|Extension Period|Lost to Follow-up|0
4813951|NCT01217073|16600194|P8|Extension Period|Lack of Efficacy|0
4813952|NCT01217073|16600195|P7|Extension Period|Lack of Efficacy|3
4813953|NCT01217073|16600196|P6|Extension Period|Lack of Efficacy|0
4813954|NCT01217073|16600197|P5|Extension Period|Lack of Efficacy|0
4813955|NCT01217073|16600198|P4|Extension Period|Lack of Efficacy|0
4813956|NCT01217073|16600199|P3|Extension Period|Lack of Efficacy|0
4813957|NCT01217073|16600200|P2|Extension Period|Lack of Efficacy|0
4813958|NCT01217073|16600201|P1|Extension Period|Lack of Efficacy|0
4813959|NCT01217073|16600194|P8|Extension Period|Excluded medication|0
4813960|NCT01217073|16600195|P7|Extension Period|Excluded medication|2
4813961|NCT01217073|16600196|P6|Extension Period|Excluded medication|0
4813962|NCT01217073|16600197|P5|Extension Period|Excluded medication|0
4813963|NCT01217073|16600198|P4|Extension Period|Excluded medication|0
4813964|NCT01217073|16600199|P3|Extension Period|Excluded medication|0
4813965|NCT01217073|16600200|P2|Extension Period|Excluded medication|0
4813966|NCT01217073|16600201|P1|Extension Period|Excluded medication|0
4813967|NCT01217073|16600194|P8|Extension Period|Death|0
4813968|NCT01217073|16600195|P7|Extension Period|Death|1
4813969|NCT01217073|16600196|P6|Extension Period|Death|0
4813970|NCT01217073|16600197|P5|Extension Period|Death|0
4813971|NCT01217073|16600198|P4|Extension Period|Death|0
4813972|NCT01217073|16600199|P3|Extension Period|Death|0
4813973|NCT01217073|16600200|P2|Extension Period|Death|0
4813974|NCT01217073|16600201|P1|Extension Period|Death|0
4813975|NCT01217073|16600194|P8|Extension Period|Creatinine/eGFR|1
4813976|NCT01217073|16600195|P7|Extension Period|Creatinine/eGFR|11
4813977|NCT01217073|16600196|P6|Extension Period|Creatinine/eGFR|0
4813978|NCT01217073|16600197|P5|Extension Period|Creatinine/eGFR|0
4813979|NCT01217073|16600198|P4|Extension Period|Creatinine/eGFR|0
4813980|NCT01217073|16600199|P3|Extension Period|Creatinine/eGFR|0
4813981|NCT01217073|16600200|P2|Extension Period|Creatinine/eGFR|0
4813982|NCT01217073|16600201|P1|Extension Period|Creatinine/eGFR|0
4813983|NCT01217073|16600194|P8|Extension Period|Contraindication to study medication|0
4813984|NCT01217073|16600195|P7|Extension Period|Contraindication to study medication|1
4813985|NCT01217073|16600196|P6|Extension Period|Contraindication to study medication|0
4813986|NCT01217073|16600197|P5|Extension Period|Contraindication to study medication|0
4813987|NCT01217073|16600198|P4|Extension Period|Contraindication to study medication|0
4813988|NCT01217073|16600199|P3|Extension Period|Contraindication to study medication|0
4813989|NCT01217073|16600200|P2|Extension Period|Contraindication to study medication|0
4813990|NCT01217073|16600201|P1|Extension Period|Contraindication to study medication|0
4813991|NCT01217073|16600194|P8|Extension Period|ALT/AST|0
4813992|NCT01217073|16600195|P7|Extension Period|ALT/AST|2
4813993|NCT01217073|16600196|P6|Extension Period|ALT/AST|0
4813994|NCT01217073|16600197|P5|Extension Period|ALT/AST|0
4813995|NCT01217073|16600198|P4|Extension Period|ALT/AST|0
4813996|NCT01217073|16600199|P3|Extension Period|ALT/AST|0
4813997|NCT01217073|16600200|P2|Extension Period|ALT/AST|0
4813998|NCT01217073|16600201|P1|Extension Period|ALT/AST|0
4813999|NCT01217073|16600194|P8|Extension Period|Adverse Event|5
4814000|NCT01217073|16600195|P7|Extension Period|Adverse Event|19
4814001|NCT01217073|16600196|P6|Extension Period|Adverse Event|0
4814002|NCT01217073|16600197|P5|Extension Period|Adverse Event|0
4814003|NCT01217073|16600198|P4|Extension Period|Adverse Event|0
4814004|NCT01217073|16600199|P3|Extension Period|Adverse Event|0
4814005|NCT01217073|16600200|P2|Extension Period|Adverse Event|0
4814006|NCT01217073|16600201|P1|Extension Period|Adverse Event|0
4814007|NCT01217073|16600194|P8|Base Period|Withdrawal by Subject|0
4814008|NCT01217073|16600195|P7|Base Period|Withdrawal by Subject|0
4814009|NCT01217073|16600196|P6|Base Period|Withdrawal by Subject|5
4814010|NCT01217073|16600197|P5|Base Period|Withdrawal by Subject|5
4814011|NCT01217073|16600198|P4|Base Period|Withdrawal by Subject|1
4814012|NCT01217073|16600199|P3|Base Period|Withdrawal by Subject|5
4814013|NCT01217073|16600200|P2|Base Period|Withdrawal by Subject|5
4814014|NCT01217073|16600201|P1|Base Period|Withdrawal by Subject|4
4814015|NCT01217073|16600194|P8|Base Period|Protocol Violation|0
4814016|NCT01217073|16600195|P7|Base Period|Protocol Violation|0
4814017|NCT01217073|16600196|P6|Base Period|Protocol Violation|2
4814018|NCT01217073|16600197|P5|Base Period|Protocol Violation|1
4814019|NCT01217073|16600198|P4|Base Period|Protocol Violation|0
4814020|NCT01217073|16600199|P3|Base Period|Protocol Violation|0
4814021|NCT01217073|16600200|P2|Base Period|Protocol Violation|0
4814022|NCT01217073|16600201|P1|Base Period|Protocol Violation|1
4814023|NCT01217073|16600194|P8|Base Period|Physician Decision|0
4814024|NCT01217073|16600195|P7|Base Period|Physician Decision|0
4814025|NCT01217073|16600196|P6|Base Period|Physician Decision|0
4814026|NCT01217073|16600197|P5|Base Period|Physician Decision|1
4814027|NCT01217073|16600198|P4|Base Period|Physician Decision|0
4814028|NCT01217073|16600199|P3|Base Period|Physician Decision|0
4814029|NCT01217073|16600200|P2|Base Period|Physician Decision|0
4814030|NCT01217073|16600201|P1|Base Period|Physician Decision|0
4814031|NCT01217073|16600194|P8|Base Period|Lost to Follow-up|0
4814032|NCT01217073|16600195|P7|Base Period|Lost to Follow-up|0
4814033|NCT01217073|16600196|P6|Base Period|Lost to Follow-up|0
4814034|NCT01217073|16600197|P5|Base Period|Lost to Follow-up|3
4814035|NCT01217073|16600198|P4|Base Period|Lost to Follow-up|1
4814036|NCT01217073|16600199|P3|Base Period|Lost to Follow-up|1
4814037|NCT01217073|16600200|P2|Base Period|Lost to Follow-up|0
4814038|NCT01217073|16600201|P1|Base Period|Lost to Follow-up|0
4814039|NCT01217073|16600194|P8|Base Period|Lack of Efficacy|0
4814040|NCT01217073|16600195|P7|Base Period|Lack of Efficacy|0
4814041|NCT01217073|16600196|P6|Base Period|Lack of Efficacy|1
4814042|NCT01217073|16600197|P5|Base Period|Lack of Efficacy|0
4814043|NCT01217073|16600198|P4|Base Period|Lack of Efficacy|0
4814044|NCT01217073|16600199|P3|Base Period|Lack of Efficacy|0
4814045|NCT01217073|16600200|P2|Base Period|Lack of Efficacy|0
4814046|NCT01217073|16600201|P1|Base Period|Lack of Efficacy|0
4814047|NCT01217073|16600194|P8|Base Period|Excluded medication|0
4814048|NCT01217073|16600195|P7|Base Period|Excluded medication|0
4814049|NCT01217073|16600196|P6|Base Period|Excluded medication|0
4814050|NCT01217073|16600197|P5|Base Period|Excluded medication|1
4814051|NCT01217073|16600198|P4|Base Period|Excluded medication|0
4814052|NCT01217073|16600199|P3|Base Period|Excluded medication|0
4814053|NCT01217073|16600200|P2|Base Period|Excluded medication|0
4814054|NCT01217073|16600201|P1|Base Period|Excluded medication|0
4814055|NCT01217073|16600194|P8|Base Period|Alanine aminotransferase (ALT)/AST|0
4814056|NCT01217073|16600195|P7|Base Period|Alanine aminotransferase (ALT)/AST|0
4814057|NCT01217073|16600196|P6|Base Period|Alanine aminotransferase (ALT)/AST|0
4814058|NCT01217073|16600197|P5|Base Period|Alanine aminotransferase (ALT)/AST|0
4814059|NCT01217073|16600198|P4|Base Period|Alanine aminotransferase (ALT)/AST|0
4814060|NCT01217073|16600199|P3|Base Period|Alanine aminotransferase (ALT)/AST|0
4814061|NCT01217073|16600200|P2|Base Period|Alanine aminotransferase (ALT)/AST|0
4814062|NCT01217073|16600201|P1|Base Period|Alanine aminotransferase (ALT)/AST|1
4814063|NCT01217073|16600194|P8|Base Period|Adverse Event|0
4814064|NCT01217073|16600195|P7|Base Period|Adverse Event|0
4814065|NCT01217073|16600196|P6|Base Period|Adverse Event|1
4814066|NCT01217073|16600197|P5|Base Period|Adverse Event|4
4814067|NCT01217073|16600198|P4|Base Period|Adverse Event|0
4814068|NCT01217073|16600199|P3|Base Period|Adverse Event|1
4814069|NCT01217073|16600200|P2|Base Period|Adverse Event|0
4814070|NCT01217073|16600201|P1|Base Period|Adverse Event|1
4814071|NCT01216332|16600392|P2|Overall Study|Withdrawal by Subject|0
4814072|NCT01216332|16600393|P1|Overall Study|Withdrawal by Subject|4
4814073|NCT01216319|16600411|P1|Overall Study|Unanticipated chemo for breast cancer|2
4814074|NCT01216319|16600411|P1|Overall Study|Lost to Follow-up|2
4814075|NCT01216176|16600428|P3|Overall Study|Physician Decision|1
4814076|NCT01216176|16600429|P2|Overall Study|Physician Decision|0
4814077|NCT01216176|16600430|P1|Overall Study|Physician Decision|0
4814078|NCT01216176|16600428|P3|Overall Study|Adverse Event|0
4814079|NCT01216176|16600429|P2|Overall Study|Adverse Event|8
4814080|NCT01216176|16600430|P1|Overall Study|Adverse Event|0
4814081|NCT01216163|16600453|P3|Overall Study|Withdrawal by Subject|0
4814082|NCT01216163|16600454|P2|Overall Study|Withdrawal by Subject|1
4814083|NCT01216163|16600455|P1|Overall Study|Withdrawal by Subject|1
4814084|NCT01216072|16600507|P2|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3
4814085|NCT01216072|16600508|P1|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0
4814086|NCT01216072|16600507|P2|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1
4814087|NCT01216072|16600508|P1|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0
4814088|NCT01216072|16600507|P2|Open-Label Extension Period (3 Months)|Adverse Event|10
4814089|NCT01216072|16600508|P1|Open-Label Extension Period (3 Months)|Adverse Event|0
4814090|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Protocol Deviation|4
4814091|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Protocol Deviation|11
4814092|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0
4814093|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5
4814094|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22
4814095|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12
4814096|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4
4814097|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3
4814098|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0
4814099|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3
4814100|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0
4814101|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2
4814102|NCT01216072|16600507|P2|Open-Label Core Period ( 6 Months)|Adverse Event|4
4814103|NCT01216072|16600508|P1|Open-Label Core Period ( 6 Months)|Adverse Event|40
4814104|NCT01215981|16600536|P2|Overall Study|Withdrawal by Subject|0
4814105|NCT01215981|16600537|P1|Overall Study|Withdrawal by Subject|1
4814106|NCT01215981|16600536|P2|Overall Study|Protocol Violation|0
4814107|NCT01215981|16600537|P1|Overall Study|Protocol Violation|1
4814108|NCT01215981|16600536|P2|Overall Study|Physician Decision|1
4814109|NCT01215981|16600537|P1|Overall Study|Physician Decision|0
4814110|NCT01215968|16600547|P2|Overall Study|Not received study drug|1
4814111|NCT01215968|16600548|P1|Overall Study|Not received study drug|0
4814112|NCT01215968|16600547|P2|Overall Study|Protocol Violation|4
4814113|NCT01215968|16600548|P1|Overall Study|Protocol Violation|2
4814114|NCT01215968|16600547|P2|Overall Study|Adverse Event|2
4814115|NCT01215968|16600548|P1|Overall Study|Adverse Event|0
4814116|NCT01215955|16600568|P4|Overall Study|Quality Issues|2
4814117|NCT01215955|16600569|P3|Overall Study|Quality Issues|3
4814118|NCT01215955|16600570|P2|Overall Study|Quality Issues|0
4814119|NCT01215955|16600571|P1|Overall Study|Quality Issues|0
4814120|NCT01215955|16600568|P4|Overall Study|Withdrawal by Subject|9
4814121|NCT01215955|16600569|P3|Overall Study|Withdrawal by Subject|13
4814122|NCT01215955|16600570|P2|Overall Study|Withdrawal by Subject|15
4814123|NCT01215955|16600571|P1|Overall Study|Withdrawal by Subject|14
4814124|NCT01215955|16600568|P4|Overall Study|Sponsor Decision|1
4814125|NCT01215955|16600569|P3|Overall Study|Sponsor Decision|0
4814126|NCT01215955|16600570|P2|Overall Study|Sponsor Decision|2
4814127|NCT01215955|16600571|P1|Overall Study|Sponsor Decision|1
4814128|NCT01215955|16600568|P4|Overall Study|Protocol Violation|8
4814129|NCT01215955|16600569|P3|Overall Study|Protocol Violation|8
4814130|NCT01215955|16600570|P2|Overall Study|Protocol Violation|13
4814131|NCT01215955|16600571|P1|Overall Study|Protocol Violation|17
4814132|NCT01215955|16600568|P4|Overall Study|Physician Decision|11
4814133|NCT01215955|16600569|P3|Overall Study|Physician Decision|8
4814134|NCT01215955|16600570|P2|Overall Study|Physician Decision|10
4814135|NCT01215955|16600571|P1|Overall Study|Physician Decision|4
4814136|NCT01215955|16600568|P4|Overall Study|Lost to Follow-up|9
4814137|NCT01215955|16600569|P3|Overall Study|Lost to Follow-up|8
4814138|NCT01215955|16600570|P2|Overall Study|Lost to Follow-up|4
4814139|NCT01215955|16600571|P1|Overall Study|Lost to Follow-up|4
4814140|NCT01215955|16600568|P4|Overall Study|Lack of Efficacy|0
4814141|NCT01215955|16600569|P3|Overall Study|Lack of Efficacy|1
4814142|NCT01215955|16600570|P2|Overall Study|Lack of Efficacy|2
4814143|NCT01215955|16600571|P1|Overall Study|Lack of Efficacy|1
4814144|NCT01215955|16600568|P4|Overall Study|Entry Criteria Not Met|7
4814145|NCT01215955|16600569|P3|Overall Study|Entry Criteria Not Met|4
4814146|NCT01215955|16600570|P2|Overall Study|Entry Criteria Not Met|3
4814147|NCT01215955|16600571|P1|Overall Study|Entry Criteria Not Met|1
4814148|NCT01215955|16600568|P4|Overall Study|Death|3
4814149|NCT01215955|16600569|P3|Overall Study|Death|1
4814150|NCT01215955|16600570|P2|Overall Study|Death|0
4814151|NCT01215955|16600571|P1|Overall Study|Death|2
4814152|NCT01215955|16600568|P4|Overall Study|Adverse Event|3
4814153|NCT01215955|16600569|P3|Overall Study|Adverse Event|2
4814154|NCT01215955|16600570|P2|Overall Study|Adverse Event|4
4814155|NCT01215955|16600571|P1|Overall Study|Adverse Event|1
4814156|NCT01215942|16600639|P2|Post-Treatment Follow-Up Period|Sponsor Decision|61
4814157|NCT01215942|16600640|P1|Post-Treatment Follow-Up Period|Sponsor Decision|28
4814158|NCT01215942|16600639|P2|Post-Treatment Follow-Up Period|Physician Decision|2
4814159|NCT01215942|16600640|P1|Post-Treatment Follow-Up Period|Physician Decision|1
4814160|NCT01215942|16600639|P2|Post-Treatment Follow-Up Period|Withdrawal by Subject|69
4814161|NCT01215942|16600640|P1|Post-Treatment Follow-Up Period|Withdrawal by Subject|43
4814162|NCT01215942|16600639|P2|Post-Treatment Follow-Up Period|Lost to Follow-up|13
4814163|NCT01215942|16600640|P1|Post-Treatment Follow-Up Period|Lost to Follow-up|13
4814164|NCT01215942|16600639|P2|Post-Treatment Follow-Up Period|Death|1
4814165|NCT01215942|16600640|P1|Post-Treatment Follow-Up Period|Death|0
4814166|NCT01215942|16600639|P2|Treatment Period|Sponsor Decision|530
4814167|NCT01215942|16600640|P1|Treatment Period|Sponsor Decision|349
4814168|NCT01215942|16600639|P2|Treatment Period|Protocol Violation|1
4814169|NCT01215942|16600640|P1|Treatment Period|Protocol Violation|0
4814170|NCT01215942|16600639|P2|Treatment Period|Physician Decision|5
4814171|NCT01215942|16600640|P1|Treatment Period|Physician Decision|5
4814172|NCT01215942|16600639|P2|Treatment Period|Withdrawal by Subject|40
4814173|NCT01215942|16600640|P1|Treatment Period|Withdrawal by Subject|17
4814174|NCT01215942|16600639|P2|Treatment Period|Lost to Follow-up|4
4814175|NCT01215942|16600640|P1|Treatment Period|Lost to Follow-up|3
4814176|NCT01215942|16600639|P2|Treatment Period|Lack of Efficacy|62
4814177|NCT01215942|16600640|P1|Treatment Period|Lack of Efficacy|23
4814178|NCT01215942|16600639|P2|Treatment Period|Death|4
4814179|NCT01215942|16600640|P1|Treatment Period|Death|2
4814180|NCT01215942|16600639|P2|Treatment Period|Adverse Event|26
4814181|NCT01215942|16600640|P1|Treatment Period|Adverse Event|15
4814182|NCT01215916|16600773|P9|Overall Study|Physician Decision|0
4814183|NCT01215916|16600774|P8|Overall Study|Physician Decision|0
4814184|NCT01215916|16600775|P7|Overall Study|Physician Decision|0
4814185|NCT01215916|16600776|P6|Overall Study|Physician Decision|0
4814186|NCT01215916|16600777|P5|Overall Study|Physician Decision|0
4814187|NCT01215916|16600778|P4|Overall Study|Physician Decision|1
4814188|NCT01215916|16600779|P3|Overall Study|Physician Decision|1
4814189|NCT01215916|16600780|P2|Overall Study|Physician Decision|0
4814190|NCT01215916|16600781|P1|Overall Study|Physician Decision|0
4814191|NCT01215916|16600773|P9|Overall Study|Death|1
4814192|NCT01215916|16600774|P8|Overall Study|Death|0
4814193|NCT01215916|16600775|P7|Overall Study|Death|0
4814194|NCT01215916|16600776|P6|Overall Study|Death|0
4814195|NCT01215916|16600777|P5|Overall Study|Death|1
4814196|NCT01215916|16600778|P4|Overall Study|Death|0
4814197|NCT01215916|16600779|P3|Overall Study|Death|0
4814198|NCT01215916|16600780|P2|Overall Study|Death|1
4814199|NCT01215916|16600781|P1|Overall Study|Death|0
4814200|NCT01215916|16600773|P9|Overall Study|Withdrawal by Subject|0
4814201|NCT01215916|16600774|P8|Overall Study|Withdrawal by Subject|0
4814202|NCT01215916|16600775|P7|Overall Study|Withdrawal by Subject|1
4814203|NCT01215916|16600776|P6|Overall Study|Withdrawal by Subject|0
4814204|NCT01215916|16600777|P5|Overall Study|Withdrawal by Subject|0
4814205|NCT01215916|16600778|P4|Overall Study|Withdrawal by Subject|2
4814206|NCT01215916|16600779|P3|Overall Study|Withdrawal by Subject|1
4814207|NCT01215916|16600780|P2|Overall Study|Withdrawal by Subject|1
4814208|NCT01215916|16600781|P1|Overall Study|Withdrawal by Subject|0
4814209|NCT01215916|16600773|P9|Overall Study|Adverse Event|0
4814210|NCT01215916|16600774|P8|Overall Study|Adverse Event|0
4814211|NCT01215916|16600775|P7|Overall Study|Adverse Event|3
4814212|NCT01215916|16600776|P6|Overall Study|Adverse Event|0
4814213|NCT01215916|16600777|P5|Overall Study|Adverse Event|0
4814214|NCT01215916|16600778|P4|Overall Study|Adverse Event|1
4814215|NCT01215916|16600779|P3|Overall Study|Adverse Event|0
4814216|NCT01215916|16600780|P2|Overall Study|Adverse Event|1
4814217|NCT01215916|16600781|P1|Overall Study|Adverse Event|1
4814218|NCT01215916|16600773|P9|Overall Study|Progressive Disease|1
4814219|NCT01215916|16600774|P8|Overall Study|Progressive Disease|3
4814220|NCT01215916|16600775|P7|Overall Study|Progressive Disease|5
4814221|NCT01215916|16600776|P6|Overall Study|Progressive Disease|4
4814222|NCT01215916|16600777|P5|Overall Study|Progressive Disease|5
4814223|NCT01215916|16600778|P4|Overall Study|Progressive Disease|2
4814224|NCT01215916|16600779|P3|Overall Study|Progressive Disease|1
4814225|NCT01215916|16600780|P2|Overall Study|Progressive Disease|2
4814226|NCT01215916|16600781|P1|Overall Study|Progressive Disease|0
4814227|NCT01215851|16600815|P6|Follow up Period|Lost to Follow-up|1
4814228|NCT01215851|16600816|P5|Follow up Period|Lost to Follow-up|0
4814229|NCT01215851|16600817|P4|Follow up Period|Lost to Follow-up|0
4814230|NCT01215851|16600818|P3|Follow up Period|Lost to Follow-up|0
4814231|NCT01215851|16600819|P2|Follow up Period|Lost to Follow-up|0
4814232|NCT01215851|16600820|P1|Follow up Period|Lost to Follow-up|0
4814233|NCT01215851|16600815|P6|Treatment Period|Adverse Event|1
4814234|NCT01215851|16600816|P5|Treatment Period|Adverse Event|0
4814235|NCT01215851|16600817|P4|Treatment Period|Adverse Event|3
4814236|NCT01215851|16600818|P3|Treatment Period|Adverse Event|1
4814237|NCT01215851|16600819|P2|Treatment Period|Adverse Event|1
4814238|NCT01215851|16600820|P1|Treatment Period|Adverse Event|1
4814239|NCT01215734|16600879|P2|Overall Study|Death|1
4814240|NCT01215734|16600880|P1|Overall Study|Death|0
4814241|NCT01215721|16600888|P1|Overall Study|Adverse Event|2
4814242|NCT01215513|16601020|P1|Overall Study|Miscellaneous reasons (CS42A)|2
4814243|NCT01215513|16601020|P1|Overall Study|Withdrawal by subject (CS42A)|5
4814244|NCT01215513|16601020|P1|Overall Study|Physician decision (CS42A)|6
4814245|NCT01215513|16601020|P1|Overall Study|Adverse event (CS42A)|2
4814246|NCT01215513|16601020|P1|Overall Study|Not enrolled from CS42 to CS42A|21
4814247|NCT01215513|16601020|P1|Overall Study|Not completed CS42|9
4814248|NCT01215435|16601029|P2|Overall Study|Unclassified|5
4814249|NCT01215435|16601030|P1|Overall Study|Unclassified|5
4814250|NCT01215435|16601029|P2|Overall Study|Lost to Follow-up|0
4814251|NCT01215435|16601030|P1|Overall Study|Lost to Follow-up|3
4814252|NCT01215435|16601029|P2|Overall Study|Withdrawal Criteria|11
4814253|NCT01215435|16601030|P1|Overall Study|Withdrawal Criteria|8
4814254|NCT01215435|16601029|P2|Overall Study|Protocol Violation|0
4814255|NCT01215435|16601030|P1|Overall Study|Protocol Violation|2
4814256|NCT01215435|16601029|P2|Overall Study|Adverse Event|0
4814257|NCT01215435|16601030|P1|Overall Study|Adverse Event|1
4814258|NCT01215422|16601044|P4|Overall Study|Did not complete all intubations|0
4814259|NCT01215422|16601045|P3|Overall Study|Did not complete all intubations|0
4814260|NCT01215422|16601046|P2|Overall Study|Did not complete all intubations|0
4814261|NCT01215422|16601047|P1|Overall Study|Did not complete all intubations|7
4814262|NCT01215422|16601044|P4|Overall Study|Failed intubations|8
4814263|NCT01215422|16601045|P3|Overall Study|Failed intubations|3
4814264|NCT01215422|16601046|P2|Overall Study|Failed intubations|0
4814265|NCT01215422|16601047|P1|Overall Study|Failed intubations|0
4814266|NCT01215422|16601044|P4|Overall Study|Relocation|0
4814267|NCT01215422|16601045|P3|Overall Study|Relocation|0
4814268|NCT01215422|16601046|P2|Overall Study|Relocation|0
4814269|NCT01215422|16601047|P1|Overall Study|Relocation|1
4814270|NCT01215357|16601069|P1|Overall Study|Protocol Violation|9
4814271|NCT01215357|16601069|P1|Overall Study|Withdrawal by Subject|3
4814272|NCT01215253|16601195|P2|Overall Study|Other|12
4814273|NCT01215253|16601196|P1|Overall Study|Other|14
4814274|NCT01215253|16601195|P2|Overall Study|Lost to Follow-up|4
4814275|NCT01215253|16601196|P1|Overall Study|Lost to Follow-up|6
4814276|NCT01215253|16601195|P2|Overall Study|Physician Decision|12
4814277|NCT01215253|16601196|P1|Overall Study|Physician Decision|9
4814278|NCT01215253|16601195|P2|Overall Study|Withdrawal by Subject|35
4814279|NCT01215253|16601196|P1|Overall Study|Withdrawal by Subject|57
4814280|NCT01215227|16601249|P6|Overall Study|Randomized but not treated|1
4814281|NCT01215227|16601250|P5|Overall Study|Randomized but not treated|0
4814282|NCT01215227|16601251|P4|Overall Study|Randomized but not treated|1
4814283|NCT01215227|16601252|P3|Overall Study|Randomized but not treated|1
4814284|NCT01215227|16601253|P2|Overall Study|Randomized but not treated|0
4814285|NCT01215227|16601254|P1|Overall Study|Randomized but not treated|0
4814286|NCT01215227|16601249|P6|Overall Study|Missing Status|0
4814287|NCT01215227|16601250|P5|Overall Study|Missing Status|0
4814288|NCT01215227|16601251|P4|Overall Study|Missing Status|0
4814289|NCT01215227|16601252|P3|Overall Study|Missing Status|0
4814290|NCT01215227|16601253|P2|Overall Study|Missing Status|1
4814291|NCT01215227|16601254|P1|Overall Study|Missing Status|0
4814292|NCT01215227|16601249|P6|Overall Study|Administrative|40
4814293|NCT01215227|16601250|P5|Overall Study|Administrative|28
4814294|NCT01215227|16601251|P4|Overall Study|Administrative|24
4814295|NCT01215227|16601252|P3|Overall Study|Administrative|42
4814296|NCT01215227|16601253|P2|Overall Study|Administrative|73
4814297|NCT01215227|16601254|P1|Overall Study|Administrative|83
4814298|NCT01215227|16601249|P6|Overall Study|Non-Compliance With Protocol|0
4814299|NCT01215227|16601250|P5|Overall Study|Non-Compliance With Protocol|0
4814300|NCT01215227|16601251|P4|Overall Study|Non-Compliance With Protocol|0
4814301|NCT01215227|16601252|P3|Overall Study|Non-Compliance With Protocol|1
4814302|NCT01215227|16601253|P2|Overall Study|Non-Compliance With Protocol|6
4814303|NCT01215227|16601254|P1|Overall Study|Non-Compliance With Protocol|2
4814304|NCT01215227|16601249|P6|Overall Study|Subject Withdrew Consent|8
4814305|NCT01215227|16601250|P5|Overall Study|Subject Withdrew Consent|11
4814306|NCT01215227|16601251|P4|Overall Study|Subject Withdrew Consent|10
4814307|NCT01215227|16601252|P3|Overall Study|Subject Withdrew Consent|7
4814308|NCT01215227|16601253|P2|Overall Study|Subject Withdrew Consent|20
4814309|NCT01215227|16601254|P1|Overall Study|Subject Withdrew Consent|16
4814310|NCT01215227|16601249|P6|Overall Study|Lost to Follow-up|2
4814311|NCT01215227|16601250|P5|Overall Study|Lost to Follow-up|1
4814312|NCT01215227|16601251|P4|Overall Study|Lost to Follow-up|1
4814313|NCT01215227|16601252|P3|Overall Study|Lost to Follow-up|1
4814314|NCT01215227|16601253|P2|Overall Study|Lost to Follow-up|4
4814315|NCT01215227|16601254|P1|Overall Study|Lost to Follow-up|1
4814316|NCT01215227|16601249|P6|Overall Study|Treatment Failure|1
4814317|NCT01215227|16601250|P5|Overall Study|Treatment Failure|1
4814318|NCT01215227|16601251|P4|Overall Study|Treatment Failure|5
4814319|NCT01215227|16601252|P3|Overall Study|Treatment Failure|1
4814320|NCT01215227|16601253|P2|Overall Study|Treatment Failure|4
4814321|NCT01215227|16601254|P1|Overall Study|Treatment Failure|8
4814322|NCT01215227|16601249|P6|Overall Study|Adverse Event|6
4814323|NCT01215227|16601250|P5|Overall Study|Adverse Event|7
4814324|NCT01215227|16601251|P4|Overall Study|Adverse Event|8
4814325|NCT01215227|16601252|P3|Overall Study|Adverse Event|4
4814326|NCT01215227|16601253|P2|Overall Study|Adverse Event|11
4814327|NCT01215227|16601254|P1|Overall Study|Adverse Event|11
4814328|NCT01215188|16601301|P3|Overall Study|Withdrawal by Subject|31
4814329|NCT01215188|16601302|P2|Overall Study|Withdrawal by Subject|34
4814330|NCT01215188|16601303|P1|Overall Study|Withdrawal by Subject|32
4814331|NCT01215188|16601301|P3|Overall Study|Protocol Violation|1
4814332|NCT01215188|16601302|P2|Overall Study|Protocol Violation|1
4814333|NCT01215188|16601303|P1|Overall Study|Protocol Violation|1
4814334|NCT01215188|16601301|P3|Overall Study|Lack of Efficacy|1
4814335|NCT01215188|16601302|P2|Overall Study|Lack of Efficacy|0
4814336|NCT01215188|16601303|P1|Overall Study|Lack of Efficacy|0
4814337|NCT01215188|16601301|P3|Overall Study|Physician Decision|0
4814338|NCT01215188|16601302|P2|Overall Study|Physician Decision|1
4814339|NCT01215188|16601303|P1|Overall Study|Physician Decision|2
4814340|NCT01215188|16601301|P3|Overall Study|Adverse Event|3
4814341|NCT01215188|16601302|P2|Overall Study|Adverse Event|1
4814342|NCT01215188|16601303|P1|Overall Study|Adverse Event|1
4814343|NCT01215188|16601301|P3|Overall Study|Lost to Follow-up|16
4814344|NCT01215188|16601302|P2|Overall Study|Lost to Follow-up|22
4814345|NCT01215188|16601303|P1|Overall Study|Lost to Follow-up|22
4814346|NCT01215175|16601355|P5|Overall Study|Lost to Follow-up|0
4814347|NCT01215175|16601356|P4|Overall Study|Lost to Follow-up|1
4814348|NCT01215175|16601357|P3|Overall Study|Lost to Follow-up|0
4814349|NCT01215175|16601358|P2|Overall Study|Lost to Follow-up|1
4814350|NCT01215175|16601359|P1|Overall Study|Lost to Follow-up|0
4814351|NCT01215097|16601476|P2|Overall Study|patient's private reason|1
4814352|NCT01215097|16601477|P1|Overall Study|patient's private reason|1
4814353|NCT01215097|16601476|P2|Overall Study|patient's refusal to come|2
4814354|NCT01215097|16601477|P1|Overall Study|patient's refusal to come|2
4814355|NCT01215097|16601476|P2|Overall Study|Lack of Efficacy|3
4814356|NCT01215097|16601477|P1|Overall Study|Lack of Efficacy|0
4814357|NCT01215097|16601476|P2|Overall Study|Withdrawal by Subject|3
4814358|NCT01215097|16601477|P1|Overall Study|Withdrawal by Subject|6
4814359|NCT01215097|16601476|P2|Overall Study|Lost to Follow-up|0
4814360|NCT01215097|16601477|P1|Overall Study|Lost to Follow-up|2
4814361|NCT01215097|16601476|P2|Overall Study|Protocol Violation|2
4814362|NCT01215097|16601477|P1|Overall Study|Protocol Violation|0
4814363|NCT01215097|16601476|P2|Overall Study|Adverse Event|3
4814364|NCT01215097|16601477|P1|Overall Study|Adverse Event|1
4814365|NCT01215032|16601509|P1|Overall Study|Lack of Efficacy|17
4814366|NCT01215032|16601509|P1|Overall Study|Adverse Event|3
4814367|NCT01214915|16601534|P1|Overall Study|Lack of Efficacy|3
4814368|NCT01214915|16601534|P1|Overall Study|Adverse Event|8
4814369|NCT01214850|16601545|P3|Overall Study|Unable to classify|1
4814370|NCT01214850|16601546|P2|Overall Study|Unable to classify|1
4814371|NCT01214850|16601547|P1|Overall Study|Unable to classify|2
4814372|NCT01214850|16601545|P3|Overall Study|Administrative reason|0
4814373|NCT01214850|16601546|P2|Overall Study|Administrative reason|0
4814374|NCT01214850|16601547|P1|Overall Study|Administrative reason|1
4814375|NCT01214850|16601545|P3|Overall Study|Inappropriate enrollment|0
4814376|NCT01214850|16601546|P2|Overall Study|Inappropriate enrollment|1
4814377|NCT01214850|16601547|P1|Overall Study|Inappropriate enrollment|2
4814378|NCT01214850|16601545|P3|Overall Study|Adverse event or death|3
4814379|NCT01214850|16601546|P2|Overall Study|Adverse event or death|8
4814380|NCT01214850|16601547|P1|Overall Study|Adverse event or death|11
4814381|NCT01214850|16601545|P3|Overall Study|Protocol Violation|6
4814382|NCT01214850|16601546|P2|Overall Study|Protocol Violation|5
4814383|NCT01214850|16601547|P1|Overall Study|Protocol Violation|5
4814384|NCT01214850|16601545|P3|Overall Study|Lost to Follow-up|123
4814385|NCT01214850|16601546|P2|Overall Study|Lost to Follow-up|98
4814386|NCT01214850|16601547|P1|Overall Study|Lost to Follow-up|124
4814387|NCT01214850|16601545|P3|Overall Study|Withdrawal by Subject|28
4814388|NCT01214850|16601546|P2|Overall Study|Withdrawal by Subject|31
4814389|NCT01214850|16601547|P1|Overall Study|Withdrawal by Subject|38
4814390|NCT01214837|16601631|P3|Overall Study|Unable to Classify|0
4814391|NCT01214837|16601632|P2|Overall Study|Unable to Classify|3
4814392|NCT01214837|16601633|P1|Overall Study|Unable to Classify|1
4814393|NCT01214837|16601631|P3|Overall Study|Protocol Violation|5
4814394|NCT01214837|16601632|P2|Overall Study|Protocol Violation|1
4814395|NCT01214837|16601633|P1|Overall Study|Protocol Violation|3
4814396|NCT01214837|16601631|P3|Overall Study|Administrative Reason|4
4814397|NCT01214837|16601632|P2|Overall Study|Administrative Reason|6
4814398|NCT01214837|16601633|P1|Overall Study|Administrative Reason|2
4814399|NCT01214837|16601631|P3|Overall Study|Inappropriate Enrolment|2
4814400|NCT01214837|16601632|P2|Overall Study|Inappropriate Enrolment|1
4814401|NCT01214837|16601633|P1|Overall Study|Inappropriate Enrolment|0
4814402|NCT01214837|16601631|P3|Overall Study|Lost to Follow-up|21
4814403|NCT01214837|16601632|P2|Overall Study|Lost to Follow-up|15
4814404|NCT01214837|16601633|P1|Overall Study|Lost to Follow-up|20
4814405|NCT01214837|16601631|P3|Overall Study|Withdrawal by Subject|28
4814406|NCT01214837|16601632|P2|Overall Study|Withdrawal by Subject|36
4814407|NCT01214837|16601633|P1|Overall Study|Withdrawal by Subject|27
4814408|NCT01214837|16601631|P3|Overall Study|Adverse Event|1
4814409|NCT01214837|16601632|P2|Overall Study|Adverse Event|2
4814410|NCT01214837|16601633|P1|Overall Study|Adverse Event|1
4814411|NCT01214837|16601631|P3|Overall Study|Death|1
4814412|NCT01214837|16601632|P2|Overall Study|Death|0
4814413|NCT01214837|16601633|P1|Overall Study|Death|0
4814414|NCT01214720|16601689|P2|Overall Study|Lost to Follow-up|2
4814415|NCT01214720|16601690|P1|Overall Study|Lost to Follow-up|6
4814416|NCT01214720|16601689|P2|Overall Study|Alive and in follow-up|48
4814417|NCT01214720|16601690|P1|Overall Study|Alive and in follow-up|45
4814418|NCT01214720|16601689|P2|Overall Study|Alive and still on treatment|18
4814419|NCT01214720|16601690|P1|Overall Study|Alive and still on treatment|34
4814420|NCT01214668|16601713|P6|Overall Study|Withdrawal by Subject|0
4814421|NCT01214668|16601714|P5|Overall Study|Withdrawal by Subject|1
4814422|NCT01214668|16601715|P4|Overall Study|Withdrawal by Subject|0
4814423|NCT01214668|16601716|P3|Overall Study|Withdrawal by Subject|0
4814424|NCT01214668|16601717|P2|Overall Study|Withdrawal by Subject|0
4814425|NCT01214668|16601718|P1|Overall Study|Withdrawal by Subject|0
4814426|NCT01214668|16601713|P6|Overall Study|Progressive Disease|5
4814427|NCT01214668|16601714|P5|Overall Study|Progressive Disease|4
4814428|NCT01214668|16601715|P4|Overall Study|Progressive Disease|4
4814429|NCT01214668|16601716|P3|Overall Study|Progressive Disease|5
4814430|NCT01214668|16601717|P2|Overall Study|Progressive Disease|2
4814431|NCT01214668|16601718|P1|Overall Study|Progressive Disease|4
4814432|NCT01214668|16601713|P6|Overall Study|Death|0
4814433|NCT01214668|16601714|P5|Overall Study|Death|0
4814434|NCT01214668|16601715|P4|Overall Study|Death|0
4814435|NCT01214668|16601716|P3|Overall Study|Death|1
4814436|NCT01214668|16601717|P2|Overall Study|Death|0
4814437|NCT01214668|16601718|P1|Overall Study|Death|0
4814438|NCT01214668|16601713|P6|Overall Study|Adverse Event|1
4814439|NCT01214668|16601714|P5|Overall Study|Adverse Event|1
4814440|NCT01214668|16601715|P4|Overall Study|Adverse Event|2
4814441|NCT01214668|16601716|P3|Overall Study|Adverse Event|0
4814442|NCT01214668|16601717|P2|Overall Study|Adverse Event|1
4814443|NCT01214668|16601718|P1|Overall Study|Adverse Event|0
4814444|NCT01214655|16601755|P3|Part C|Physician Decision|1
4814445|NCT01214655|16601756|P2|Part C|Physician Decision|0
4814446|NCT01214655|16601757|P1|Part C|Physician Decision|0
4814447|NCT01214655|16601755|P3|Part C|Death|1
4814448|NCT01214655|16601756|P2|Part C|Death|0
4814449|NCT01214655|16601757|P1|Part C|Death|0
4814450|NCT01214655|16601755|P3|Part C|Progressive Disease|5
4814451|NCT01214655|16601756|P2|Part C|Progressive Disease|0
4814452|NCT01214655|16601757|P1|Part C|Progressive Disease|0
4814453|NCT01214655|16601755|P3|Part B|Withdrawal by Subject|0
4814454|NCT01214655|16601756|P2|Part B|Withdrawal by Subject|2
4814455|NCT01214655|16601757|P1|Part B|Withdrawal by Subject|0
4814456|NCT01214655|16601755|P3|Part B|Death|0
4814457|NCT01214655|16601756|P2|Part B|Death|1
4814458|NCT01214655|16601757|P1|Part B|Death|0
4814459|NCT01214655|16601755|P3|Part B|Progressive disease|0
4814460|NCT01214655|16601756|P2|Part B|Progressive disease|10
4814461|NCT01214655|16601757|P1|Part B|Progressive disease|0
4814462|NCT01214655|16601755|P3|Part A|Physician Decision|0
4814463|NCT01214655|16601756|P2|Part A|Physician Decision|0
4814464|NCT01214655|16601757|P1|Part A|Physician Decision|1
4814465|NCT01214655|16601755|P3|Part A|Progressive Disease|0
4814466|NCT01214655|16601756|P2|Part A|Progressive Disease|0
4814467|NCT01214655|16601757|P1|Part A|Progressive Disease|7
4814468|NCT01214642|16601830|P12|Overall Study|Physician Decision|2
4814469|NCT01214642|16601831|P11|Overall Study|Physician Decision|0
4814470|NCT01214642|16601832|P10|Overall Study|Physician Decision|0
4814471|NCT01214642|16601833|P9|Overall Study|Physician Decision|0
4814472|NCT01214642|16601834|P8|Overall Study|Physician Decision|0
4814473|NCT01214642|16601835|P7|Overall Study|Physician Decision|0
4814474|NCT01214642|16601836|P6|Overall Study|Physician Decision|0
4814475|NCT01214642|16601837|P5|Overall Study|Physician Decision|1
4814476|NCT01214642|16601838|P4|Overall Study|Physician Decision|1
4814477|NCT01214642|16601839|P3|Overall Study|Physician Decision|1
4814478|NCT01214642|16601840|P2|Overall Study|Physician Decision|0
4814479|NCT01214642|16601841|P1|Overall Study|Physician Decision|0
4814480|NCT01214642|16601830|P12|Overall Study|Withdrawal by Subject|0
4814481|NCT01214642|16601831|P11|Overall Study|Withdrawal by Subject|1
4814482|NCT01214642|16601832|P10|Overall Study|Withdrawal by Subject|1
4814483|NCT01214642|16601833|P9|Overall Study|Withdrawal by Subject|3
4814484|NCT01214642|16601834|P8|Overall Study|Withdrawal by Subject|0
4814485|NCT01214642|16601835|P7|Overall Study|Withdrawal by Subject|0
4814486|NCT01214642|16601836|P6|Overall Study|Withdrawal by Subject|0
4814487|NCT01214642|16601837|P5|Overall Study|Withdrawal by Subject|0
4814488|NCT01214642|16601838|P4|Overall Study|Withdrawal by Subject|0
4814489|NCT01214642|16601839|P3|Overall Study|Withdrawal by Subject|1
4814490|NCT01214642|16601840|P2|Overall Study|Withdrawal by Subject|0
4814491|NCT01214642|16601841|P1|Overall Study|Withdrawal by Subject|0
4814492|NCT01214642|16601830|P12|Overall Study|Death|0
4814493|NCT01214642|16601831|P11|Overall Study|Death|1
4814494|NCT01214642|16601832|P10|Overall Study|Death|0
4814495|NCT01214642|16601833|P9|Overall Study|Death|0
4814496|NCT01214642|16601834|P8|Overall Study|Death|0
4814497|NCT01214642|16601835|P7|Overall Study|Death|0
4814498|NCT01214642|16601836|P6|Overall Study|Death|0
4814499|NCT01214642|16601837|P5|Overall Study|Death|0
4814500|NCT01214642|16601838|P4|Overall Study|Death|0
4814501|NCT01214642|16601839|P3|Overall Study|Death|1
4814502|NCT01214642|16601840|P2|Overall Study|Death|0
4814503|NCT01214642|16601841|P1|Overall Study|Death|0
4814504|NCT01214642|16601830|P12|Overall Study|Adverse Event|0
4814505|NCT01214642|16601831|P11|Overall Study|Adverse Event|1
4814506|NCT01214642|16601832|P10|Overall Study|Adverse Event|1
4814507|NCT01214642|16601833|P9|Overall Study|Adverse Event|0
4814508|NCT01214642|16601834|P8|Overall Study|Adverse Event|0
4814509|NCT01214642|16601835|P7|Overall Study|Adverse Event|1
4814510|NCT01214642|16601836|P6|Overall Study|Adverse Event|0
4814511|NCT01214642|16601837|P5|Overall Study|Adverse Event|0
4814512|NCT01214642|16601838|P4|Overall Study|Adverse Event|0
4814513|NCT01214642|16601839|P3|Overall Study|Adverse Event|0
4814514|NCT01214642|16601840|P2|Overall Study|Adverse Event|1
4814515|NCT01214642|16601841|P1|Overall Study|Adverse Event|0
4814516|NCT01214642|16601830|P12|Overall Study|Progressive Disease|4
4814517|NCT01214642|16601831|P11|Overall Study|Progressive Disease|1
4814518|NCT01214642|16601832|P10|Overall Study|Progressive Disease|2
4814519|NCT01214642|16601833|P9|Overall Study|Progressive Disease|10
4814520|NCT01214642|16601834|P8|Overall Study|Progressive Disease|3
4814521|NCT01214642|16601835|P7|Overall Study|Progressive Disease|5
4814522|NCT01214642|16601836|P6|Overall Study|Progressive Disease|3
4814523|NCT01214642|16601837|P5|Overall Study|Progressive Disease|5
4814524|NCT01214642|16601838|P4|Overall Study|Progressive Disease|5
4814525|NCT01214642|16601839|P3|Overall Study|Progressive Disease|3
4814526|NCT01214642|16601840|P2|Overall Study|Progressive Disease|2
4814527|NCT01214642|16601841|P1|Overall Study|Progressive Disease|3
4814528|NCT01214629|16601921|P11|Overall Study|Withdrawal by Subject|0
4814529|NCT01214629|16601922|P10|Overall Study|Withdrawal by Subject|1
4814530|NCT01214629|16601923|P9|Overall Study|Withdrawal by Subject|0
4814531|NCT01214629|16601924|P8|Overall Study|Withdrawal by Subject|0
4814532|NCT01214629|16601925|P7|Overall Study|Withdrawal by Subject|0
4814533|NCT01214629|16601926|P6|Overall Study|Withdrawal by Subject|0
4814534|NCT01214629|16601927|P5|Overall Study|Withdrawal by Subject|0
4814535|NCT01214629|16601928|P4|Overall Study|Withdrawal by Subject|0
4814536|NCT01214629|16601929|P3|Overall Study|Withdrawal by Subject|0
4814537|NCT01214629|16601930|P2|Overall Study|Withdrawal by Subject|0
4814538|NCT01214629|16601931|P1|Overall Study|Withdrawal by Subject|0
4814539|NCT01214629|16601921|P11|Overall Study|Physician Decision|1
4814540|NCT01214629|16601922|P10|Overall Study|Physician Decision|0
4814541|NCT01214629|16601923|P9|Overall Study|Physician Decision|0
4814542|NCT01214629|16601924|P8|Overall Study|Physician Decision|0
4814543|NCT01214629|16601925|P7|Overall Study|Physician Decision|0
4814544|NCT01214629|16601926|P6|Overall Study|Physician Decision|0
4814545|NCT01214629|16601927|P5|Overall Study|Physician Decision|0
4814546|NCT01214629|16601928|P4|Overall Study|Physician Decision|0
4814547|NCT01214629|16601929|P3|Overall Study|Physician Decision|0
4814548|NCT01214629|16601930|P2|Overall Study|Physician Decision|0
4814549|NCT01214629|16601931|P1|Overall Study|Physician Decision|0
4814550|NCT01214629|16601921|P11|Overall Study|Adverse Event|0
4814551|NCT01214629|16601922|P10|Overall Study|Adverse Event|1
4814552|NCT01214629|16601923|P9|Overall Study|Adverse Event|0
4814553|NCT01214629|16601924|P8|Overall Study|Adverse Event|0
4814554|NCT01214629|16601925|P7|Overall Study|Adverse Event|0
4814555|NCT01214629|16601926|P6|Overall Study|Adverse Event|1
4814556|NCT01214629|16601927|P5|Overall Study|Adverse Event|0
4814557|NCT01214629|16601928|P4|Overall Study|Adverse Event|1
4814558|NCT01214629|16601929|P3|Overall Study|Adverse Event|0
4814559|NCT01214629|16601930|P2|Overall Study|Adverse Event|0
4814560|NCT01214629|16601931|P1|Overall Study|Adverse Event|0
4814561|NCT01214629|16601921|P11|Overall Study|Progressive Disease|1
4814562|NCT01214629|16601922|P10|Overall Study|Progressive Disease|5
4814563|NCT01214629|16601923|P9|Overall Study|Progressive Disease|1
4814564|NCT01214629|16601924|P8|Overall Study|Progressive Disease|1
4814565|NCT01214629|16601925|P7|Overall Study|Progressive Disease|1
4814566|NCT01214629|16601926|P6|Overall Study|Progressive Disease|3
4814567|NCT01214629|16601927|P5|Overall Study|Progressive Disease|2
4814568|NCT01214629|16601928|P4|Overall Study|Progressive Disease|1
4814569|NCT01214629|16601929|P3|Overall Study|Progressive Disease|0
4814570|NCT01214629|16601930|P2|Overall Study|Progressive Disease|1
4814571|NCT01214629|16601931|P1|Overall Study|Progressive Disease|1
4814572|NCT01214616|16601996|P4|Overall Study|Withdrawal by Subject|1
4814573|NCT01214616|16601997|P3|Overall Study|Withdrawal by Subject|0
4814574|NCT01214616|16601998|P2|Overall Study|Withdrawal by Subject|0
4814575|NCT01214616|16601999|P1|Overall Study|Withdrawal by Subject|1
4814576|NCT01214616|16601996|P4|Overall Study|Other adverse events|1
4814577|NCT01214616|16601997|P3|Overall Study|Other adverse events|1
4814578|NCT01214616|16601998|P2|Overall Study|Other adverse events|1
4814579|NCT01214616|16601999|P1|Overall Study|Other adverse events|0
4814580|NCT01214616|16601996|P4|Overall Study|Dose limiting toxicity|0
4814581|NCT01214616|16601997|P3|Overall Study|Dose limiting toxicity|0
4814582|NCT01214616|16601998|P2|Overall Study|Dose limiting toxicity|2
4814583|NCT01214616|16601999|P1|Overall Study|Dose limiting toxicity|0
4814584|NCT01214616|16601996|P4|Overall Study|Progressive disease|4
4814585|NCT01214616|16601997|P3|Overall Study|Progressive disease|2
4814586|NCT01214616|16601998|P2|Overall Study|Progressive disease|2
4814587|NCT01214616|16601999|P1|Overall Study|Progressive disease|2
4814588|NCT01214603|16602036|P3|Overall Study|Progressive Disease|3
4814589|NCT01214603|16602037|P2|Overall Study|Progressive Disease|1
4814590|NCT01214603|16602038|P1|Overall Study|Progressive Disease|4
4814591|NCT01214603|16602036|P3|Overall Study|Death|0
4814592|NCT01214603|16602037|P2|Overall Study|Death|0
4814593|NCT01214603|16602038|P1|Overall Study|Death|1
4814594|NCT01214603|16602036|P3|Overall Study|Adverse Event|1
4814595|NCT01214603|16602037|P2|Overall Study|Adverse Event|0
4814596|NCT01214603|16602038|P1|Overall Study|Adverse Event|0
4814597|NCT01214434|16602061|P2|Overall Study|Site error|0
4814598|NCT01214434|16602062|P1|Overall Study|Site error|1
4814599|NCT01214434|16602061|P2|Overall Study|Lost to Follow-up|2
4814600|NCT01214434|16602062|P1|Overall Study|Lost to Follow-up|2
4814601|NCT01214434|16602061|P2|Overall Study|Withdrawal by Subject|0
4814602|NCT01214434|16602062|P1|Overall Study|Withdrawal by Subject|1
4814603|NCT01214395|16602078|P1|Overall Study|All patients had infection|5
4814604|NCT01214252|16602107|P1|Overall Study|Not eligible per protocol|82
4814605|NCT01214239|16602115|P2|Overall Study|patient's private reason|1
4814606|NCT01214239|16602116|P1|Overall Study|patient's private reason|1
4814607|NCT01214239|16602115|P2|Overall Study|Lack of Efficacy|2
4814608|NCT01214239|16602116|P1|Overall Study|Lack of Efficacy|1
4814609|NCT01214239|16602115|P2|Overall Study|Withdrawal by Subject|9
4814610|NCT01214239|16602116|P1|Overall Study|Withdrawal by Subject|4
4814611|NCT01214239|16602115|P2|Overall Study|Lost to Follow-up|1
4814612|NCT01214239|16602116|P1|Overall Study|Lost to Follow-up|1
4814613|NCT01214239|16602115|P2|Overall Study|Protocol Violation|1
4814614|NCT01214239|16602116|P1|Overall Study|Protocol Violation|2
4814615|NCT01214239|16602115|P2|Overall Study|Adverse Event|4
4814616|NCT01214239|16602116|P1|Overall Study|Adverse Event|3
4814617|NCT01214200|16602148|P1|Overall Study|Withdrawal by Subject|2
4814618|NCT01214200|16602148|P1|Overall Study|Did not meet inclusion/exclusion|9
4814619|NCT01214187|16602162|P2|Overall Study|Withdrawal by Subject|3
4814620|NCT01214187|16602163|P1|Overall Study|Withdrawal by Subject|0
4814621|NCT01214187|16602162|P2|Overall Study|Death|1
4814622|NCT01214187|16602163|P1|Overall Study|Death|1
4814623|NCT01214187|16602162|P2|Overall Study|Adverse Event|2
4814624|NCT01214187|16602163|P1|Overall Study|Adverse Event|6
4814625|NCT01214174|16602180|P3|Overall Study|Withdrawal by Subject|1
4814626|NCT01214174|16602181|P2|Overall Study|Withdrawal by Subject|0
4814627|NCT01214174|16602182|P1|Overall Study|Withdrawal by Subject|0
4814628|NCT01214044|16602332|P1|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1
4814629|NCT01214044|16602332|P1|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3
4814630|NCT01214044|16602332|P1|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3
4814631|NCT01214044|16602332|P1|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4
4814632|NCT01214044|16602332|P1|Visit 1: Screening and Consent, Washout|Ineligible|3
4814633|NCT01214044|16602332|P1|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5
4814634|NCT01213966|16602346|P4|Overall Study|Protocol Violation|1
4814635|NCT01213966|16602347|P3|Overall Study|Protocol Violation|3
4814636|NCT01213966|16602348|P2|Overall Study|Protocol Violation|0
4814637|NCT01213966|16602349|P1|Overall Study|Protocol Violation|1
4814638|NCT01213836|16602361|P2|Period 1, First Intervention|Withdrawal by Subject|1
4814639|NCT01213836|16602362|P1|Period 1, First Intervention|Withdrawal by Subject|1
4814640|NCT01213836|16602361|P2|Period 1, First Intervention|Protocol Violation|1
4814641|NCT01213836|16602362|P1|Period 1, First Intervention|Protocol Violation|0
4814642|NCT01213836|16602361|P2|Period 1, First Intervention|Adverse Event|1
4814643|NCT01213836|16602362|P1|Period 1, First Intervention|Adverse Event|2
4814644|NCT01213524|16602449|P1|Session 4|Withdrawal by Subject|2
4814645|NCT01213524|16602449|P1|Session 4|Physician Decision|1
4814646|NCT01213524|16602449|P1|Session 3|Withdrawal by Subject|4
4814647|NCT01213524|16602449|P1|Session 2|Withdrawal by Subject|5
4814648|NCT01213524|16602449|P1|Baseline|Physician Decision|1
4814649|NCT01213524|16602449|P1|Baseline|high breath alcohol levels|1
4814650|NCT01213524|16602449|P1|Baseline|Withdrawal by Subject|5
4814651|NCT01213472|16602463|P1|Overall Study|Physician Decision|1
4814652|NCT01213472|16602463|P1|Overall Study|Withdrawal by Subject|1
4814653|NCT01213472|16602463|P1|Overall Study|Recurrence/Progressive disease|25
4814654|NCT01213264|16602512|P3|Overall Study|Lost to Follow-up|6
4814655|NCT01213264|16602513|P2|Overall Study|Lost to Follow-up|2
4814656|NCT01213264|16602514|P1|Overall Study|Lost to Follow-up|1
4814657|NCT01213264|16602512|P3|Overall Study|Adverse Event|0
4814658|NCT01213264|16602513|P2|Overall Study|Adverse Event|0
4814659|NCT01213264|16602514|P1|Overall Study|Adverse Event|1
4814660|NCT01213251|16602534|P3|Overall Study|Missed 18-Month Follow-up|1
4814661|NCT01213251|16602535|P2|Overall Study|Missed 18-Month Follow-up|0
4814662|NCT01213251|16602536|P1|Overall Study|Missed 18-Month Follow-up|0
4814663|NCT01213251|16602534|P3|Overall Study|Protocol Violation|0
4814664|NCT01213251|16602535|P2|Overall Study|Protocol Violation|1
4814665|NCT01213251|16602536|P1|Overall Study|Protocol Violation|1
4814666|NCT01213251|16602534|P3|Overall Study|Exit|8
4814667|NCT01213251|16602535|P2|Overall Study|Exit|2
4814668|NCT01213251|16602536|P1|Overall Study|Exit|3
4814669|NCT01213251|16602534|P3|Overall Study|Death|2
4814670|NCT01213251|16602535|P2|Overall Study|Death|1
4814671|NCT01213251|16602536|P1|Overall Study|Death|2
4814672|NCT01213173|16602563|P2|Overall Study|Incorrect Enrollment|3
4814673|NCT01213173|16602564|P1|Overall Study|Incorrect Enrollment|1
4814674|NCT01213173|16602563|P2|Overall Study|Withdrawal by Subject|5
4814675|NCT01213173|16602564|P1|Overall Study|Withdrawal by Subject|5
4814676|NCT01213173|16602563|P2|Overall Study|Adverse Event|8
4814677|NCT01213173|16602564|P1|Overall Study|Adverse Event|4
4814678|NCT01213173|16602563|P2|Overall Study|Protocol Violation|0
4814679|NCT01213173|16602564|P1|Overall Study|Protocol Violation|2
4814680|NCT01213082|16602597|P3|Overall Study|Physician Decision|1
4814681|NCT01213082|16602598|P2|Overall Study|Physician Decision|0
4814682|NCT01213082|16602599|P1|Overall Study|Physician Decision|0
4814683|NCT01213082|16602597|P3|Overall Study|Lost to Follow-up|4
4814684|NCT01213082|16602598|P2|Overall Study|Lost to Follow-up|7
4814685|NCT01213082|16602599|P1|Overall Study|Lost to Follow-up|6
4814686|NCT01212991|16602641|P3|Open-label|Other|3
4814687|NCT01212991|16602642|P2|Open-label|Other|0
4814688|NCT01212991|16602643|P1|Open-label|Other|0
4814689|NCT01212991|16602641|P3|Open-label|Sponsor decision|53
4814690|NCT01212991|16602642|P2|Open-label|Sponsor decision|0
4814691|NCT01212991|16602643|P1|Open-label|Sponsor decision|0
4814692|NCT01212991|16602641|P3|Open-label|Withdrawal by Subject|7
4814693|NCT01212991|16602642|P2|Open-label|Withdrawal by Subject|0
4814694|NCT01212991|16602643|P1|Open-label|Withdrawal by Subject|0
4814695|NCT01212991|16602641|P3|Open-label|Lost to Follow-up|5
4814696|NCT01212991|16602642|P2|Open-label|Lost to Follow-up|0
4814697|NCT01212991|16602643|P1|Open-label|Lost to Follow-up|0
4814698|NCT01212991|16602641|P3|Open-label|Death|166
4814699|NCT01212991|16602642|P2|Open-label|Death|0
4814700|NCT01212991|16602643|P1|Open-label|Death|0
4814701|NCT01212991|16602641|P3|Double-blind|Sponsor decision|0
4814702|NCT01212991|16602642|P2|Double-blind|Sponsor decision|38
4814703|NCT01212991|16602643|P1|Double-blind|Sponsor decision|142
4814704|NCT01212991|16602641|P3|Double-blind|Other|0
4814705|NCT01212991|16602642|P2|Double-blind|Other|0
4814706|NCT01212991|16602643|P1|Double-blind|Other|7
4814707|NCT01212991|16602641|P3|Double-blind|Withdrawal by Subject|0
4814708|NCT01212991|16602642|P2|Double-blind|Withdrawal by Subject|19
4814709|NCT01212991|16602643|P1|Double-blind|Withdrawal by Subject|16
4814710|NCT01212991|16602641|P3|Double-blind|Death|0
4814711|NCT01212991|16602642|P2|Double-blind|Death|550
4814712|NCT01212991|16602643|P1|Double-blind|Death|699
4814713|NCT01212991|16602641|P3|Double-blind|Lost to Follow-up|0
4814714|NCT01212991|16602642|P2|Double-blind|Lost to Follow-up|4
4814715|NCT01212991|16602643|P1|Double-blind|Lost to Follow-up|8
4814716|NCT01212770|16602715|P9|Long-term Safety Phase (Year 5)|Death|0
4814717|NCT01212770|16602716|P8|Long-term Safety Phase (Year 5)|Death|1
4814718|NCT01212770|16602717|P7|Long-term Safety Phase (Year 5)|Death|0
4814719|NCT01212770|16602718|P6|Long-term Safety Phase (Year 5)|Death|0
4814720|NCT01212770|16602719|P5|Long-term Safety Phase (Year 5)|Death|0
4814721|NCT01212770|16602720|P4|Long-term Safety Phase (Year 5)|Death|0
4814722|NCT01212770|16602721|P3|Long-term Safety Phase (Year 5)|Death|0
4814723|NCT01212770|16602722|P2|Long-term Safety Phase (Year 5)|Death|0
4814724|NCT01212770|16602723|P1|Long-term Safety Phase (Year 5)|Death|0
4814725|NCT01212770|16602715|P9|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4814726|NCT01212770|16602716|P8|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
4814727|NCT01212770|16602717|P7|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4814728|NCT01212770|16602718|P6|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4814729|NCT01212770|16602719|P5|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4814730|NCT01212770|16602720|P4|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4814731|NCT01212770|16602721|P3|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1
4814732|NCT01212770|16602722|P2|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2
4814733|NCT01212770|16602723|P1|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0
4814734|NCT01212770|16602715|P9|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814735|NCT01212770|16602716|P8|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814736|NCT01212770|16602717|P7|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814737|NCT01212770|16602718|P6|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814738|NCT01212770|16602719|P5|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814739|NCT01212770|16602720|P4|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814740|NCT01212770|16602721|P3|Long-term Safety Phase (Year 5)|Lack of Efficacy|4
4814741|NCT01212770|16602722|P2|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814742|NCT01212770|16602723|P1|Long-term Safety Phase (Year 5)|Lack of Efficacy|0
4814743|NCT01212770|16602715|P9|Long-term Safety Phase (Year 5)|Adverse Event|1
4814744|NCT01212770|16602716|P8|Long-term Safety Phase (Year 5)|Adverse Event|0
4814745|NCT01212770|16602717|P7|Long-term Safety Phase (Year 5)|Adverse Event|0
4814746|NCT01212770|16602718|P6|Long-term Safety Phase (Year 5)|Adverse Event|0
4814747|NCT01212770|16602719|P5|Long-term Safety Phase (Year 5)|Adverse Event|0
4814748|NCT01212770|16602720|P4|Long-term Safety Phase (Year 5)|Adverse Event|0
4814749|NCT01212770|16602721|P3|Long-term Safety Phase (Year 5)|Adverse Event|2
4814750|NCT01212770|16602722|P2|Long-term Safety Phase (Year 5)|Adverse Event|0
4814751|NCT01212770|16602723|P1|Long-term Safety Phase (Year 5)|Adverse Event|0
4814752|NCT01212770|16602715|P9|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814753|NCT01212770|16602716|P8|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814754|NCT01212770|16602717|P7|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814755|NCT01212770|16602718|P6|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814756|NCT01212770|16602719|P5|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814757|NCT01212770|16602720|P4|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814758|NCT01212770|16602721|P3|Long-term Safety Phase (Year 5)|Miscellaneous|3
4814759|NCT01212770|16602722|P2|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814760|NCT01212770|16602723|P1|Long-term Safety Phase (Year 5)|Miscellaneous|0
4814761|NCT01212770|16602715|P9|Long-term Safety Phase (Year 5)|Missing|0
4814762|NCT01212770|16602716|P8|Long-term Safety Phase (Year 5)|Missing|0
4814763|NCT01212770|16602717|P7|Long-term Safety Phase (Year 5)|Missing|0
4814764|NCT01212770|16602718|P6|Long-term Safety Phase (Year 5)|Missing|0
4814765|NCT01212770|16602719|P5|Long-term Safety Phase (Year 5)|Missing|0
4814766|NCT01212770|16602720|P4|Long-term Safety Phase (Year 5)|Missing|0
4814767|NCT01212770|16602721|P3|Long-term Safety Phase (Year 5)|Missing|1
4814768|NCT01212770|16602722|P2|Long-term Safety Phase (Year 5)|Missing|0
4814769|NCT01212770|16602723|P1|Long-term Safety Phase (Year 5)|Missing|0
4814770|NCT01212770|16602715|P9|Long-term Safety Phase (Year 4)|Miscellaneous|1
4814771|NCT01212770|16602716|P8|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814772|NCT01212770|16602717|P7|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814773|NCT01212770|16602718|P6|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814774|NCT01212770|16602719|P5|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814775|NCT01212770|16602720|P4|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814776|NCT01212770|16602721|P3|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814777|NCT01212770|16602722|P2|Long-term Safety Phase (Year 4)|Miscellaneous|1
4814778|NCT01212770|16602723|P1|Long-term Safety Phase (Year 4)|Miscellaneous|0
4814779|NCT01212770|16602715|P9|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814780|NCT01212770|16602716|P8|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814781|NCT01212770|16602717|P7|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814782|NCT01212770|16602718|P6|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814783|NCT01212770|16602719|P5|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814784|NCT01212770|16602720|P4|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814785|NCT01212770|16602721|P3|Long-term Safety Phase (Year 4)|Lost to Follow-up|1
4814786|NCT01212770|16602722|P2|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814787|NCT01212770|16602723|P1|Long-term Safety Phase (Year 4)|Lost to Follow-up|0
4814788|NCT01212770|16602715|P9|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814789|NCT01212770|16602716|P8|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814790|NCT01212770|16602717|P7|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814791|NCT01212770|16602718|P6|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814792|NCT01212770|16602719|P5|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814793|NCT01212770|16602720|P4|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814794|NCT01212770|16602721|P3|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3
4814795|NCT01212770|16602722|P2|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2
4814796|NCT01212770|16602723|P1|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0
4814797|NCT01212770|16602715|P9|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4814798|NCT01212770|16602716|P8|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
4814799|NCT01212770|16602717|P7|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4814800|NCT01212770|16602718|P6|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4814801|NCT01212770|16602719|P5|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4814802|NCT01212770|16602720|P4|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4814803|NCT01212770|16602721|P3|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
4814804|NCT01212770|16602722|P2|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1
4814805|NCT01212770|16602723|P1|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0
4814806|NCT01212770|16602715|P9|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4814807|NCT01212770|16602716|P8|Long-term Safety Phase (Year 4)|Lack of Efficacy|2
4814808|NCT01212770|16602717|P7|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4814809|NCT01212770|16602718|P6|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4814810|NCT01212770|16602719|P5|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4814811|NCT01212770|16602720|P4|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4814812|NCT01212770|16602721|P3|Long-term Safety Phase (Year 4)|Lack of Efficacy|5
4814813|NCT01212770|16602722|P2|Long-term Safety Phase (Year 4)|Lack of Efficacy|1
4814814|NCT01212770|16602723|P1|Long-term Safety Phase (Year 4)|Lack of Efficacy|0
4814815|NCT01212770|16602715|P9|Long-term Safety Phase (Year 4)|Adverse Event|1
4814816|NCT01212770|16602716|P8|Long-term Safety Phase (Year 4)|Adverse Event|0
4814817|NCT01212770|16602717|P7|Long-term Safety Phase (Year 4)|Adverse Event|0
4814818|NCT01212770|16602718|P6|Long-term Safety Phase (Year 4)|Adverse Event|0
4814819|NCT01212770|16602719|P5|Long-term Safety Phase (Year 4)|Adverse Event|0
4814820|NCT01212770|16602720|P4|Long-term Safety Phase (Year 4)|Adverse Event|0
4814821|NCT01212770|16602721|P3|Long-term Safety Phase (Year 4)|Adverse Event|1
4814822|NCT01212770|16602722|P2|Long-term Safety Phase (Year 4)|Adverse Event|1
4814823|NCT01212770|16602723|P1|Long-term Safety Phase (Year 4)|Adverse Event|0
4814824|NCT01212770|16602715|P9|Long-term Safety Phase (Year 3)|Miscellaneous|1
4814825|NCT01212770|16602716|P8|Long-term Safety Phase (Year 3)|Miscellaneous|1
4814826|NCT01212770|16602717|P7|Long-term Safety Phase (Year 3)|Miscellaneous|0
4814827|NCT01212770|16602718|P6|Long-term Safety Phase (Year 3)|Miscellaneous|0
4814828|NCT01212770|16602719|P5|Long-term Safety Phase (Year 3)|Miscellaneous|0
4814829|NCT01212770|16602720|P4|Long-term Safety Phase (Year 3)|Miscellaneous|0
4814830|NCT01212770|16602721|P3|Long-term Safety Phase (Year 3)|Miscellaneous|1
4814831|NCT01212770|16602722|P2|Long-term Safety Phase (Year 3)|Miscellaneous|2
4814832|NCT01212770|16602723|P1|Long-term Safety Phase (Year 3)|Miscellaneous|0
4814833|NCT01212770|16602715|P9|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814834|NCT01212770|16602716|P8|Long-term Safety Phase (Year 3)|Protocol Violation|1
4814835|NCT01212770|16602717|P7|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814836|NCT01212770|16602718|P6|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814837|NCT01212770|16602719|P5|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814838|NCT01212770|16602720|P4|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814839|NCT01212770|16602721|P3|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814840|NCT01212770|16602722|P2|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814841|NCT01212770|16602723|P1|Long-term Safety Phase (Year 3)|Protocol Violation|0
4814842|NCT01212770|16602715|P9|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814843|NCT01212770|16602716|P8|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814844|NCT01212770|16602717|P7|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814845|NCT01212770|16602718|P6|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814846|NCT01212770|16602719|P5|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814847|NCT01212770|16602720|P4|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814848|NCT01212770|16602721|P3|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814849|NCT01212770|16602722|P2|Long-term Safety Phase (Year 3)|Lost to Follow-up|1
4814850|NCT01212770|16602723|P1|Long-term Safety Phase (Year 3)|Lost to Follow-up|0
4814851|NCT01212770|16602715|P9|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
4814852|NCT01212770|16602716|P8|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1
4814853|NCT01212770|16602717|P7|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4814854|NCT01212770|16602718|P6|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4814855|NCT01212770|16602719|P5|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4814856|NCT01212770|16602720|P4|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4814857|NCT01212770|16602721|P3|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4
4814858|NCT01212770|16602722|P2|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3
4814859|NCT01212770|16602723|P1|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0
4814860|NCT01212770|16602715|P9|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4814861|NCT01212770|16602716|P8|Long-term Safety Phase (Year 3)|Lack of Efficacy|2
4814862|NCT01212770|16602717|P7|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4814863|NCT01212770|16602718|P6|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4814864|NCT01212770|16602719|P5|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4814865|NCT01212770|16602720|P4|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4814866|NCT01212770|16602721|P3|Long-term Safety Phase (Year 3)|Lack of Efficacy|4
4814867|NCT01212770|16602722|P2|Long-term Safety Phase (Year 3)|Lack of Efficacy|3
4814868|NCT01212770|16602723|P1|Long-term Safety Phase (Year 3)|Lack of Efficacy|0
4814869|NCT01212770|16602715|P9|Long-term Safety Phase (Year 3)|Adverse Event|1
4814870|NCT01212770|16602716|P8|Long-term Safety Phase (Year 3)|Adverse Event|2
4814871|NCT01212770|16602717|P7|Long-term Safety Phase (Year 3)|Adverse Event|0
4814872|NCT01212770|16602718|P6|Long-term Safety Phase (Year 3)|Adverse Event|0
4814873|NCT01212770|16602719|P5|Long-term Safety Phase (Year 3)|Adverse Event|0
4814874|NCT01212770|16602720|P4|Long-term Safety Phase (Year 3)|Adverse Event|0
4814875|NCT01212770|16602721|P3|Long-term Safety Phase (Year 3)|Adverse Event|2
4814876|NCT01212770|16602722|P2|Long-term Safety Phase (Year 3)|Adverse Event|2
4814877|NCT01212770|16602723|P1|Long-term Safety Phase (Year 3)|Adverse Event|0
4814878|NCT01212770|16602715|P9|Long-term Safety Phase (Year 2)|Miscellaneous|1
4814879|NCT01212770|16602716|P8|Long-term Safety Phase (Year 2)|Miscellaneous|0
4814880|NCT01212770|16602717|P7|Long-term Safety Phase (Year 2)|Miscellaneous|0
4814881|NCT01212770|16602718|P6|Long-term Safety Phase (Year 2)|Miscellaneous|0
4814882|NCT01212770|16602719|P5|Long-term Safety Phase (Year 2)|Miscellaneous|0
4814883|NCT01212770|16602720|P4|Long-term Safety Phase (Year 2)|Miscellaneous|0
4814884|NCT01212770|16602721|P3|Long-term Safety Phase (Year 2)|Miscellaneous|1
4814885|NCT01212770|16602722|P2|Long-term Safety Phase (Year 2)|Miscellaneous|2
4814886|NCT01212770|16602723|P1|Long-term Safety Phase (Year 2)|Miscellaneous|0
4814887|NCT01212770|16602715|P9|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
4814888|NCT01212770|16602716|P8|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
4814889|NCT01212770|16602717|P7|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4814890|NCT01212770|16602718|P6|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4814891|NCT01212770|16602719|P5|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4814892|NCT01212770|16602720|P4|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4814893|NCT01212770|16602721|P3|Long-term Safety Phase (Year 2)|Lost to Follow-up|1
4814894|NCT01212770|16602722|P2|Long-term Safety Phase (Year 2)|Lost to Follow-up|2
4814895|NCT01212770|16602723|P1|Long-term Safety Phase (Year 2)|Lost to Follow-up|0
4814896|NCT01212770|16602715|P9|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
4814897|NCT01212770|16602716|P8|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4
4814898|NCT01212770|16602717|P7|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4814899|NCT01212770|16602718|P6|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4814900|NCT01212770|16602719|P5|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4814901|NCT01212770|16602720|P4|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4814902|NCT01212770|16602721|P3|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3
4814903|NCT01212770|16602722|P2|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9
4814904|NCT01212770|16602723|P1|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0
4814905|NCT01212770|16602715|P9|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814906|NCT01212770|16602716|P8|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814907|NCT01212770|16602717|P7|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814908|NCT01212770|16602718|P6|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814909|NCT01212770|16602719|P5|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814910|NCT01212770|16602720|P4|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814911|NCT01212770|16602721|P3|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814912|NCT01212770|16602722|P2|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1
4814913|NCT01212770|16602723|P1|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0
4814914|NCT01212770|16602715|P9|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
4814915|NCT01212770|16602716|P8|Long-term Safety Phase (Year 2)|Lack of Efficacy|4
4814916|NCT01212770|16602717|P7|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4814917|NCT01212770|16602718|P6|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4814918|NCT01212770|16602719|P5|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4814919|NCT01212770|16602720|P4|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4814920|NCT01212770|16602721|P3|Long-term Safety Phase (Year 2)|Lack of Efficacy|7
4814921|NCT01212770|16602722|P2|Long-term Safety Phase (Year 2)|Lack of Efficacy|6
4814922|NCT01212770|16602723|P1|Long-term Safety Phase (Year 2)|Lack of Efficacy|0
4814923|NCT01212770|16602715|P9|Long-term Safety Phase (Year 2)|Adverse Event|2
4814924|NCT01212770|16602716|P8|Long-term Safety Phase (Year 2)|Adverse Event|0
4814925|NCT01212770|16602717|P7|Long-term Safety Phase (Year 2)|Adverse Event|0
4814926|NCT01212770|16602718|P6|Long-term Safety Phase (Year 2)|Adverse Event|0
4814927|NCT01212770|16602719|P5|Long-term Safety Phase (Year 2)|Adverse Event|0
4814928|NCT01212770|16602720|P4|Long-term Safety Phase (Year 2)|Adverse Event|0
4814929|NCT01212770|16602721|P3|Long-term Safety Phase (Year 2)|Adverse Event|3
4814930|NCT01212770|16602722|P2|Long-term Safety Phase (Year 2)|Adverse Event|3
4814931|NCT01212770|16602723|P1|Long-term Safety Phase (Year 2)|Adverse Event|0
4814932|NCT01212770|16602715|P9|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814933|NCT01212770|16602716|P8|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814934|NCT01212770|16602717|P7|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814935|NCT01212770|16602718|P6|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814936|NCT01212770|16602719|P5|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814937|NCT01212770|16602720|P4|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
4814938|NCT01212770|16602721|P3|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1
4814939|NCT01212770|16602722|P2|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814940|NCT01212770|16602723|P1|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0
4814941|NCT01212770|16602715|P9|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814942|NCT01212770|16602716|P8|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814943|NCT01212770|16602717|P7|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814944|NCT01212770|16602718|P6|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814945|NCT01212770|16602719|P5|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814946|NCT01212770|16602720|P4|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1
4814947|NCT01212770|16602721|P3|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814948|NCT01212770|16602722|P2|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814949|NCT01212770|16602723|P1|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0
4814950|NCT01212770|16602715|P9|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814951|NCT01212770|16602716|P8|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814952|NCT01212770|16602717|P7|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814953|NCT01212770|16602718|P6|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814954|NCT01212770|16602719|P5|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814955|NCT01212770|16602720|P4|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814956|NCT01212770|16602721|P3|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1
4814957|NCT01212770|16602722|P2|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814958|NCT01212770|16602723|P1|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0
4814959|NCT01212770|16602715|P9|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
4814960|NCT01212770|16602716|P8|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
4814961|NCT01212770|16602717|P7|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
4814962|NCT01212770|16602718|P6|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
4814963|NCT01212770|16602719|P5|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1
4814964|NCT01212770|16602720|P4|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
4814965|NCT01212770|16602721|P3|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3
4814966|NCT01212770|16602722|P2|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6
4814967|NCT01212770|16602723|P1|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0
4814968|NCT01212770|16602715|P9|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4814969|NCT01212770|16602716|P8|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4814970|NCT01212770|16602717|P7|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4814971|NCT01212770|16602718|P6|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2
4814972|NCT01212770|16602719|P5|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1
4814973|NCT01212770|16602720|P4|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4
4814974|NCT01212770|16602721|P3|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5
4814975|NCT01212770|16602722|P2|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7
4814976|NCT01212770|16602723|P1|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0
4814977|NCT01212770|16602715|P9|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4814978|NCT01212770|16602716|P8|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4814979|NCT01212770|16602717|P7|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1
4814980|NCT01212770|16602718|P6|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4814981|NCT01212770|16602719|P5|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4814982|NCT01212770|16602720|P4|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
4814983|NCT01212770|16602721|P3|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2
4814984|NCT01212770|16602722|P2|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6
4814985|NCT01212770|16602723|P1|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0
4814986|NCT01212770|16602715|P9|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4814987|NCT01212770|16602716|P8|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4814988|NCT01212770|16602717|P7|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4814989|NCT01212770|16602718|P6|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4814990|NCT01212770|16602719|P5|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4814991|NCT01212770|16602720|P4|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0
4814992|NCT01212770|16602721|P3|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2
4814993|NCT01212770|16602722|P2|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1
4814994|NCT01212770|16602723|P1|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3
4814995|NCT01212770|16602715|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4814996|NCT01212770|16602716|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4814997|NCT01212770|16602717|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4814998|NCT01212770|16602718|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4814999|NCT01212770|16602719|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815000|NCT01212770|16602720|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815001|NCT01212770|16602721|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4815002|NCT01212770|16602722|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815003|NCT01212770|16602723|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815004|NCT01212770|16602715|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815005|NCT01212770|16602716|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815006|NCT01212770|16602717|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815007|NCT01212770|16602718|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815008|NCT01212770|16602719|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815009|NCT01212770|16602720|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815010|NCT01212770|16602721|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3
4815011|NCT01212770|16602722|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815012|NCT01212770|16602723|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4815013|NCT01212770|16602715|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815014|NCT01212770|16602716|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815015|NCT01212770|16602717|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815016|NCT01212770|16602718|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815017|NCT01212770|16602719|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815018|NCT01212770|16602720|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815019|NCT01212770|16602721|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1
4815020|NCT01212770|16602722|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4
4815021|NCT01212770|16602723|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
4815022|NCT01212770|16602715|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815023|NCT01212770|16602716|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815024|NCT01212770|16602717|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815025|NCT01212770|16602718|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815026|NCT01212770|16602719|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815027|NCT01212770|16602720|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815028|NCT01212770|16602721|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7
4815029|NCT01212770|16602722|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5
4815030|NCT01212770|16602723|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6
4815031|NCT01212770|16602715|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815032|NCT01212770|16602716|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815033|NCT01212770|16602717|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815034|NCT01212770|16602718|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815035|NCT01212770|16602719|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815036|NCT01212770|16602720|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815037|NCT01212770|16602721|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8
4815038|NCT01212770|16602722|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
4815039|NCT01212770|16602723|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10
4815040|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815041|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815042|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815043|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815044|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815045|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815046|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 5)|Miscellaneous|1
4815047|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 5)|Miscellaneous|1
4815048|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 5)|Miscellaneous|0
4815049|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815050|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815051|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815052|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815053|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815054|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815055|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815056|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1
4815057|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0
4815058|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
4815059|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
4815060|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4815061|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4815062|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4815063|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4815064|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2
4815065|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1
4815066|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0
4815067|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 5)|Adverse Event|0
4815068|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 5)|Adverse Event|2
4815069|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 5)|Adverse Event|0
4815070|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 5)|Adverse Event|0
4815071|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 5)|Adverse Event|0
4815072|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 5)|Adverse Event|0
4815073|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 5)|Adverse Event|2
4815074|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 5)|Adverse Event|2
4815075|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 5)|Adverse Event|0
4815076|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
4815077|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1
4815078|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4815079|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4815080|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4815081|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4815082|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
4815083|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3
4815084|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0
4815085|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815086|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1
4815087|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815088|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815089|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815090|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815091|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815092|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815093|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0
4815094|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 4)|Death|1
4815095|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 4)|Death|0
4815096|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 4)|Death|0
4815097|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 4)|Death|0
4815098|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 4)|Death|0
4815099|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 4)|Death|0
4815100|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 4)|Death|1
4815101|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 4)|Death|0
4815102|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 4)|Death|0
4815103|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3
4815104|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1
4815105|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4815106|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4815107|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4815108|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4815109|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2
4815110|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4
4815111|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0
4815112|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
4815113|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1
4815114|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4815115|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4815116|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4815117|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4815118|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
4815119|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2
4815120|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0
4815121|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 4)|Adverse Event|1
4815122|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 4)|Adverse Event|1
4815123|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 4)|Adverse Event|0
4815124|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 4)|Adverse Event|0
4815125|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 4)|Adverse Event|0
4815126|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 4)|Adverse Event|0
4815127|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 4)|Adverse Event|2
4815128|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 4)|Adverse Event|1
4815129|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 4)|Adverse Event|0
4815130|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 4)|Miscellaneous|1
4815131|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815132|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815133|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815134|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815135|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815136|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815137|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 4)|Miscellaneous|2
4815138|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 4)|Miscellaneous|0
4815139|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Miscellaneous|2
4815140|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815141|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815142|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815143|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815144|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815145|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Miscellaneous|3
4815146|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815147|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Miscellaneous|0
4815148|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815366|NCT01212588|16603132|P1|Overall Study|Protocol Violation|1
4815149|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815150|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815151|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815152|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815153|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815154|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815155|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Protocol Violation|1
4815156|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Protocol Violation|0
4815157|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1
4815158|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815159|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815160|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815161|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815162|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815163|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815164|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815165|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0
4815166|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
4815167|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
4815168|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4815169|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4815170|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4815171|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4815172|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1
4815173|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5
4815174|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0
4815175|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815176|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815177|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815178|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815179|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815180|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815181|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1
4815182|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815183|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0
4815184|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1
4815185|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3
4815186|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4815187|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4815188|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4815189|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4815190|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5
4815191|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8
4815192|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0
4815193|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 3)|Adverse Event|0
4815194|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 3)|Adverse Event|2
4815195|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 3)|Adverse Event|0
4815196|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 3)|Adverse Event|0
4815197|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 3)|Adverse Event|0
4815198|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 3)|Adverse Event|0
4815199|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 3)|Adverse Event|1
4815200|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 3)|Adverse Event|4
4815201|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 3)|Adverse Event|0
4815202|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815203|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815204|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815205|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815206|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815207|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815208|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2
4815209|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815210|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0
4815211|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6
4815212|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4
4815213|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4815214|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4815215|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4815216|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4815217|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9
4815218|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7
4815219|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0
4815220|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4815367|NCT01212588|16603131|P2|Overall Study|Physician Decision|1
4815221|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
4815222|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4815223|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4815224|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4815225|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4815226|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2
4815227|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4
4815228|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0
4815229|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 2)|Adverse Event|2
4815230|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 2)|Adverse Event|2
4815231|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 2)|Adverse Event|0
4815232|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 2)|Adverse Event|0
4815233|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 2)|Adverse Event|0
4815234|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 2)|Adverse Event|0
4815235|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 2)|Adverse Event|1
4815236|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 2)|Adverse Event|1
4815237|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 2)|Adverse Event|0
4815238|NCT01212757|16602920|P9|Long-Term Safety Phase (Year 2)|Miscellaneous|1
4815239|NCT01212757|16602921|P8|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815240|NCT01212757|16602922|P7|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815241|NCT01212757|16602923|P6|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815242|NCT01212757|16602924|P5|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815243|NCT01212757|16602925|P4|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815244|NCT01212757|16602926|P3|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815245|NCT01212757|16602927|P2|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815246|NCT01212757|16602928|P1|Long-Term Safety Phase (Year 2)|Miscellaneous|0
4815247|NCT01212757|16602920|P9|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815248|NCT01212757|16602921|P8|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815249|NCT01212757|16602922|P7|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815250|NCT01212757|16602923|P6|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815251|NCT01212757|16602924|P5|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815252|NCT01212757|16602925|P4|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815253|NCT01212757|16602926|P3|Active Treatment Phase (Weeks 24 - 52)|Other|1
4815254|NCT01212757|16602927|P2|Active Treatment Phase (Weeks 24 - 52)|Other|1
4815255|NCT01212757|16602928|P1|Active Treatment Phase (Weeks 24 - 52)|Other|0
4815256|NCT01212757|16602920|P9|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815257|NCT01212757|16602921|P8|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815258|NCT01212757|16602922|P7|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815259|NCT01212757|16602923|P6|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815260|NCT01212757|16602924|P5|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
4815261|NCT01212757|16602925|P4|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815262|NCT01212757|16602926|P3|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815263|NCT01212757|16602927|P2|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1
4815264|NCT01212757|16602928|P1|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0
4815265|NCT01212757|16602920|P9|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4815266|NCT01212757|16602921|P8|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4815267|NCT01212757|16602922|P7|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4815268|NCT01212757|16602923|P6|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
4815269|NCT01212757|16602924|P5|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1
4815270|NCT01212757|16602925|P4|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
4815271|NCT01212757|16602926|P3|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7
4815272|NCT01212757|16602927|P2|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3
4815273|NCT01212757|16602928|P1|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0
4815274|NCT01212757|16602920|P9|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815275|NCT01212757|16602921|P8|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815276|NCT01212757|16602922|P7|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815277|NCT01212757|16602923|P6|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815278|NCT01212757|16602924|P5|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815279|NCT01212757|16602925|P4|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815280|NCT01212757|16602926|P3|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2
4815281|NCT01212757|16602927|P2|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815282|NCT01212757|16602928|P1|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0
4815283|NCT01212757|16602920|P9|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4815284|NCT01212757|16602921|P8|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4815285|NCT01212757|16602922|P7|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4815286|NCT01212757|16602923|P6|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2
4815287|NCT01212757|16602924|P5|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4815288|NCT01212757|16602925|P4|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4
4815289|NCT01212757|16602926|P3|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7
4815290|NCT01212757|16602927|P2|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5
4815291|NCT01212757|16602928|P1|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0
4815292|NCT01212757|16602920|P9|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4815293|NCT01212757|16602921|P8|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4815294|NCT01212757|16602922|P7|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4815295|NCT01212757|16602923|P6|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
4815296|NCT01212757|16602924|P5|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4815297|NCT01212757|16602925|P4|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1
4815298|NCT01212757|16602926|P3|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3
4815299|NCT01212757|16602927|P2|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2
4815300|NCT01212757|16602928|P1|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0
4815301|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815302|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815303|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815304|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815305|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815306|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815307|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Other|0
4815308|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Other|2
4815309|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Other|1
4815310|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815311|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815312|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815313|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815314|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815315|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815316|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4815317|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1
4815318|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0
4815319|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815320|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815321|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815322|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815323|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815324|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0
4815325|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2
4815326|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4815327|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1
4815328|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815329|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815330|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815331|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815332|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815333|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815334|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1
4815335|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0
4815336|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3
4815337|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815338|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815339|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815340|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815341|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815342|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0
4815343|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3
4815344|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9
4815345|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7
4815346|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815347|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815348|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815349|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815350|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815351|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0
4815352|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
4815353|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2
4815354|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3
4815355|NCT01212757|16602920|P9|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815356|NCT01212757|16602921|P8|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815357|NCT01212757|16602922|P7|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815358|NCT01212757|16602923|P6|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815359|NCT01212757|16602924|P5|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815360|NCT01212757|16602925|P4|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0
4815361|NCT01212757|16602926|P3|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12
4815362|NCT01212757|16602927|P2|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5
4815363|NCT01212757|16602928|P1|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4
4815364|NCT01212744|16603112|P1|Overall Study|Withdrawal by Subject|1
4815365|NCT01212588|16603131|P2|Overall Study|Protocol Violation|1
4815368|NCT01212588|16603132|P1|Overall Study|Physician Decision|0
4815369|NCT01212185|16603230|P2|Overall Study|Protocol Violation|1
4815370|NCT01212185|16603231|P1|Overall Study|Protocol Violation|2
4815371|NCT01212159|16603250|P2|Overall Study|Withdrawal by Subject|12
4815372|NCT01212159|16603251|P1|Overall Study|Withdrawal by Subject|12
4815373|NCT01212094|16603350|P3|Years 2 & 3: Treatment Randomization|Adverse Event|1
4815374|NCT01212094|16603351|P2|Years 2 & 3: Treatment Randomization|Adverse Event|0
4815375|NCT01212094|16603352|P1|Years 2 & 3: Treatment Randomization|Adverse Event|0
4815376|NCT01212094|16603350|P3|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3
4815377|NCT01212094|16603351|P2|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
4815378|NCT01212094|16603352|P1|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0
4815379|NCT01212094|16603350|P3|Years 2 & 3: Treatment Randomization|Study terminated|7
4815380|NCT01212094|16603351|P2|Years 2 & 3: Treatment Randomization|Study terminated|4
4815381|NCT01212094|16603352|P1|Years 2 & 3: Treatment Randomization|Study terminated|0
4815382|NCT01212094|16603350|P3|Year 1: Baseline Monitoring|Started on DMT|0
4815383|NCT01212094|16603351|P2|Year 1: Baseline Monitoring|Started on DMT|0
4815384|NCT01212094|16603352|P1|Year 1: Baseline Monitoring|Started on DMT|2
4815385|NCT01212094|16603350|P3|Year 1: Baseline Monitoring|Withdrawal by Subject|0
4815386|NCT01212094|16603351|P2|Year 1: Baseline Monitoring|Withdrawal by Subject|0
4815387|NCT01212094|16603352|P1|Year 1: Baseline Monitoring|Withdrawal by Subject|7
4815388|NCT01212094|16603350|P3|Year 1: Baseline Monitoring|Study terminated|0
4815389|NCT01212094|16603351|P2|Year 1: Baseline Monitoring|Study terminated|0
4815390|NCT01212094|16603352|P1|Year 1: Baseline Monitoring|Study terminated|7
4815391|NCT01211769|16603411|P4|Overall Study|Adverse Event|1
4815392|NCT01211769|16603412|P3|Overall Study|Adverse Event|1
4815393|NCT01211769|16603413|P2|Overall Study|Adverse Event|1
4815394|NCT01211769|16603414|P1|Overall Study|Adverse Event|0
4815395|NCT01211769|16603411|P4|Overall Study|Physician Decision|1
4815396|NCT01211769|16603412|P3|Overall Study|Physician Decision|2
4815397|NCT01211769|16603413|P2|Overall Study|Physician Decision|0
4815398|NCT01211769|16603414|P1|Overall Study|Physician Decision|2
4815399|NCT01211769|16603411|P4|Overall Study|Lost to Follow-up|9
4815400|NCT01211769|16603412|P3|Overall Study|Lost to Follow-up|5
4815401|NCT01211769|16603413|P2|Overall Study|Lost to Follow-up|9
4815402|NCT01211769|16603414|P1|Overall Study|Lost to Follow-up|7
4815403|NCT01211665|16603469|P2|Overall Study|Death|0
4815404|NCT01211665|16603470|P1|Overall Study|Death|1
4815405|NCT01211665|16603469|P2|Overall Study|Withdrawal by Subject|0
4815406|NCT01211665|16603470|P1|Overall Study|Withdrawal by Subject|1
4815407|NCT01211613|16603497|P3|Overall Study|Withdrawal by Subject|0
4815408|NCT01211613|16603498|P2|Overall Study|Withdrawal by Subject|0
4815409|NCT01211613|16603499|P1|Overall Study|Withdrawal by Subject|1
4815410|NCT01211613|16603497|P3|Overall Study|Lost to Follow-up|2
4815411|NCT01211613|16603498|P2|Overall Study|Lost to Follow-up|2
4815412|NCT01211613|16603499|P1|Overall Study|Lost to Follow-up|2
4815413|NCT01211535|16603545|P2|Overall Study|Adverse Event|1
4815414|NCT01211535|16603546|P1|Overall Study|Adverse Event|0
4815415|NCT01211522|16603555|P3|Overall Study|Withdrawal by Subject|5
4815416|NCT01211522|16603556|P2|Overall Study|Withdrawal by Subject|7
4815417|NCT01211522|16603557|P1|Overall Study|Withdrawal by Subject|3
4815418|NCT01211288|16603607|P2|Overall Study|Lost to Follow-up|1
4815419|NCT01211288|16603608|P1|Overall Study|Lost to Follow-up|1
4815420|NCT01211262|16603626|P2|Overall Study|Other|1
4815421|NCT01211262|16603627|P1|Overall Study|Other|0
4815422|NCT01211262|16603626|P2|Overall Study|Withdrawal of Consent|0
4815423|NCT01211262|16603627|P1|Overall Study|Withdrawal of Consent|1
4815424|NCT01211262|16603626|P2|Overall Study|Adverse Event|0
4815425|NCT01211262|16603627|P1|Overall Study|Adverse Event|4
4815426|NCT01211262|16603626|P2|Overall Study|Progressive Disease|9
4815427|NCT01211262|16603627|P1|Overall Study|Progressive Disease|18
4815428|NCT01211197|16603667|P6|Washout Period 2 (7 Days)|Adverse Event|0
4815429|NCT01211197|16603668|P5|Washout Period 2 (7 Days)|Adverse Event|0
4815430|NCT01211197|16603669|P4|Washout Period 2 (7 Days)|Adverse Event|0
4815431|NCT01211197|16603670|P3|Washout Period 2 (7 Days)|Adverse Event|0
4815432|NCT01211197|16603671|P2|Washout Period 2 (7 Days)|Adverse Event|0
4815433|NCT01211197|16603672|P1|Washout Period 2 (7 Days)|Adverse Event|1
4815434|NCT01211197|16603667|P6|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4815435|NCT01211197|16603668|P5|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4815436|NCT01211197|16603669|P4|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4815437|NCT01211197|16603670|P3|Washout Period 1 (7 Days)|Withdrawal by Subject|1
4815438|NCT01211197|16603671|P2|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4815439|NCT01211197|16603672|P1|Washout Period 1 (7 Days)|Withdrawal by Subject|0
4815440|NCT01211184|16603719|P3|Overall Study|Withdrawal by Subject|1
4815441|NCT01211184|16603720|P2|Overall Study|Withdrawal by Subject|2
4815442|NCT01211184|16603721|P1|Overall Study|Withdrawal by Subject|0
4815443|NCT01211145|16603736|P4|Overall Study|Patient decision|2
4815444|NCT01211145|16603737|P3|Overall Study|Patient decision|0
4815445|NCT01211145|16603738|P2|Overall Study|Patient decision|1
4815446|NCT01211145|16603739|P1|Overall Study|Patient decision|2
4815447|NCT01211145|16603736|P4|Overall Study|Eligibility criteria not fulfilled|15
4815448|NCT01211145|16603737|P3|Overall Study|Eligibility criteria not fulfilled|10
4815449|NCT01211145|16603738|P2|Overall Study|Eligibility criteria not fulfilled|12
4815450|NCT01211145|16603739|P1|Overall Study|Eligibility criteria not fulfilled|16
4815451|NCT01211145|16603736|P4|Overall Study|Severe noncompliance to protocol|0
4815452|NCT01211145|16603737|P3|Overall Study|Severe noncompliance to protocol|0
4815453|NCT01211145|16603738|P2|Overall Study|Severe noncompliance to protocol|0
4815454|NCT01211145|16603739|P1|Overall Study|Severe noncompliance to protocol|1
4815455|NCT01211145|16603736|P4|Overall Study|Study-specific withdrawal criteria|0
4815456|NCT01211145|16603737|P3|Overall Study|Study-specific withdrawal criteria|0
4815457|NCT01211145|16603738|P2|Overall Study|Study-specific withdrawal criteria|0
4815458|NCT01211145|16603739|P1|Overall Study|Study-specific withdrawal criteria|1
4815459|NCT01211145|16603736|P4|Overall Study|Lost to Follow-up|2
4815460|NCT01211145|16603737|P3|Overall Study|Lost to Follow-up|1
4815461|NCT01211145|16603738|P2|Overall Study|Lost to Follow-up|2
4815462|NCT01211145|16603739|P1|Overall Study|Lost to Follow-up|3
4815463|NCT01211145|16603736|P4|Overall Study|Reason not specified|1
4815464|NCT01211145|16603737|P3|Overall Study|Reason not specified|2
4815465|NCT01211145|16603738|P2|Overall Study|Reason not specified|2
4815466|NCT01211145|16603739|P1|Overall Study|Reason not specified|3
4815467|NCT01210807|16603793|P2|Overall Study|Not implanted bilaterally|1
4815468|NCT01210807|16603794|P1|Overall Study|Not implanted bilaterally|2
4815469|NCT01210807|16603793|P2|Overall Study|Lost to Follow-up|2
4815470|NCT01210807|16603794|P1|Overall Study|Lost to Follow-up|1
4815471|NCT01210690|16603809|P1|Overall Study|Patient could not take glucose|1
4815472|NCT01210690|16603809|P1|Overall Study|Patient refused to swallow|1
4815473|NCT01210690|16603809|P1|Overall Study|Withdrawal by Subject|1
4815474|NCT01210690|16603809|P1|Overall Study|Disease Remission|1
4815475|NCT01210690|16603809|P1|Overall Study|Lost to Follow-up|3
4815476|NCT01210690|16603809|P1|Overall Study|Lack of Efficacy|12
4815477|NCT01210690|16603809|P1|Overall Study|Adverse Event|7
4815478|NCT01210664|16603822|P4|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1
4815479|NCT01210664|16603823|P3|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
4815480|NCT01210664|16603824|P2|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
4815481|NCT01210664|16603825|P1|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0
4815482|NCT01210664|16603822|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
4815483|NCT01210664|16603823|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1
4815484|NCT01210664|16603824|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
4815485|NCT01210664|16603825|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0
4815486|NCT01210664|16603822|P4|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
4815487|NCT01210664|16603823|P3|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1
4815488|NCT01210664|16603824|P2|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
4815489|NCT01210664|16603825|P1|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0
4815490|NCT01210651|16603853|P2|Overall Study|Injury outside study|0
4815491|NCT01210651|16603854|P1|Overall Study|Injury outside study|2
4815492|NCT01210651|16603853|P2|Overall Study|Withdrawal by Subject|1
4815493|NCT01210651|16603854|P1|Overall Study|Withdrawal by Subject|1
4815494|NCT01210651|16603853|P2|Overall Study|Withdrawn by PI for disruptive behavior|1
4815495|NCT01210651|16603854|P1|Overall Study|Withdrawn by PI for disruptive behavior|0
4815496|NCT01210651|16603853|P2|Overall Study|schedule conflicts|5
4815497|NCT01210651|16603854|P1|Overall Study|schedule conflicts|1
4815498|NCT01210651|16603853|P2|Overall Study|Lost to Follow-up|1
4815499|NCT01210651|16603854|P1|Overall Study|Lost to Follow-up|1
4815500|NCT01210495|16603974|P4|Overall Study|Other unspecified|0
4815501|NCT01210495|16603975|P3|Overall Study|Other unspecified|6
4815502|NCT01210495|16603976|P2|Overall Study|Other unspecified|0
4815503|NCT01210495|16603977|P1|Overall Study|Other unspecified|0
4815504|NCT01210495|16603974|P4|Overall Study|Lost to Follow-up|1
4815505|NCT01210495|16603975|P3|Overall Study|Lost to Follow-up|1
4815506|NCT01210495|16603976|P2|Overall Study|Lost to Follow-up|0
4815507|NCT01210495|16603977|P1|Overall Study|Lost to Follow-up|0
4815508|NCT01210495|16603974|P4|Overall Study|Study Terminated by Sponsor|11
4815509|NCT01210495|16603975|P3|Overall Study|Study Terminated by Sponsor|4
4815510|NCT01210495|16603976|P2|Overall Study|Study Terminated by Sponsor|0
4815511|NCT01210495|16603977|P1|Overall Study|Study Terminated by Sponsor|0
4815512|NCT01210495|16603974|P4|Overall Study|Death|54
4815513|NCT01210495|16603975|P3|Overall Study|Death|112
4815514|NCT01210495|16603976|P2|Overall Study|Death|7
4815515|NCT01210495|16603977|P1|Overall Study|Death|14
4815516|NCT01210495|16603974|P4|Overall Study|Participant Refused Further Follow-Up|2
4815517|NCT01210495|16603975|P3|Overall Study|Participant Refused Further Follow-Up|11
4815518|NCT01210495|16603976|P2|Overall Study|Participant Refused Further Follow-Up|0
4815519|NCT01210495|16603977|P1|Overall Study|Participant Refused Further Follow-Up|1
4815520|NCT01210443|16604039|P1|Overall Study|Study terminated by sponsor|2
4815521|NCT01210352|16604056|P9|Overall Study|Patient Discharged Early|0
4815522|NCT01210352|16604057|P8|Overall Study|Patient Discharged Early|0
4815523|NCT01210352|16604058|P7|Overall Study|Patient Discharged Early|0
4815524|NCT01210352|16604059|P6|Overall Study|Patient Discharged Early|0
4815525|NCT01210352|16604060|P5|Overall Study|Patient Discharged Early|0
4815526|NCT01210352|16604061|P4|Overall Study|Patient Discharged Early|0
4815527|NCT01210352|16604062|P3|Overall Study|Patient Discharged Early|1
4815528|NCT01210352|16604063|P2|Overall Study|Patient Discharged Early|0
4815529|NCT01210352|16604064|P1|Overall Study|Patient Discharged Early|0
4815530|NCT01210352|16604056|P9|Overall Study|Withdrawal by Subject|1
4815531|NCT01210352|16604057|P8|Overall Study|Withdrawal by Subject|0
4815532|NCT01210352|16604058|P7|Overall Study|Withdrawal by Subject|1
4815533|NCT01210352|16604059|P6|Overall Study|Withdrawal by Subject|0
4815534|NCT01210352|16604060|P5|Overall Study|Withdrawal by Subject|0
4815535|NCT01210352|16604061|P4|Overall Study|Withdrawal by Subject|0
4815536|NCT01210352|16604062|P3|Overall Study|Withdrawal by Subject|1
4815537|NCT01210352|16604063|P2|Overall Study|Withdrawal by Subject|0
4815538|NCT01210352|16604064|P1|Overall Study|Withdrawal by Subject|0
4815539|NCT01210352|16604056|P9|Overall Study|Physician Decision|2
4815540|NCT01210352|16604057|P8|Overall Study|Physician Decision|1
4815541|NCT01210352|16604058|P7|Overall Study|Physician Decision|0
4815542|NCT01210352|16604059|P6|Overall Study|Physician Decision|0
4815543|NCT01210352|16604060|P5|Overall Study|Physician Decision|0
4815544|NCT01210352|16604061|P4|Overall Study|Physician Decision|0
4815545|NCT01210352|16604062|P3|Overall Study|Physician Decision|0
4815546|NCT01210352|16604063|P2|Overall Study|Physician Decision|0
4815547|NCT01210352|16604064|P1|Overall Study|Physician Decision|0
4815548|NCT01210352|16604056|P9|Overall Study|Lack of Efficacy|0
4815549|NCT01210352|16604057|P8|Overall Study|Lack of Efficacy|0
4815550|NCT01210352|16604058|P7|Overall Study|Lack of Efficacy|1
4815551|NCT01210352|16604059|P6|Overall Study|Lack of Efficacy|0
4815552|NCT01210352|16604060|P5|Overall Study|Lack of Efficacy|0
4815553|NCT01210352|16604061|P4|Overall Study|Lack of Efficacy|0
4815554|NCT01210352|16604062|P3|Overall Study|Lack of Efficacy|0
4815555|NCT01210352|16604063|P2|Overall Study|Lack of Efficacy|0
4815556|NCT01210352|16604064|P1|Overall Study|Lack of Efficacy|0
4815557|NCT01210352|16604056|P9|Overall Study|Adverse Event|1
4815558|NCT01210352|16604057|P8|Overall Study|Adverse Event|2
4815559|NCT01210352|16604058|P7|Overall Study|Adverse Event|0
4815560|NCT01210352|16604059|P6|Overall Study|Adverse Event|0
4815561|NCT01210352|16604060|P5|Overall Study|Adverse Event|0
4815562|NCT01210352|16604061|P4|Overall Study|Adverse Event|0
4815563|NCT01210352|16604062|P3|Overall Study|Adverse Event|0
4815564|NCT01210352|16604063|P2|Overall Study|Adverse Event|0
4815565|NCT01210352|16604064|P1|Overall Study|Adverse Event|0
4815566|NCT01210222|16604255|P1|Overall Study|Never treated|1
4815567|NCT01210222|16604255|P1|Overall Study|Ineligible|2
4815568|NCT01210144|16604291|P2|Overall Study|No transfer|0
4815569|NCT01210144|16604292|P1|Overall Study|No transfer|1
4815570|NCT01210144|16604291|P2|Overall Study|No fertilization|0
4815571|NCT01210144|16604292|P1|Overall Study|No fertilization|1
4815572|NCT01210144|16604291|P2|Overall Study|Lack of ovarian response|0
4815573|NCT01210144|16604292|P1|Overall Study|Lack of ovarian response|1
4815574|NCT01210118|16604314|P2|Overall Study|Spontaneous abortion|3
4815575|NCT01210118|16604315|P1|Overall Study|Spontaneous abortion|1
4815576|NCT01210118|16604314|P2|Overall Study|Protocol Violation|1
4815577|NCT01210118|16604315|P1|Overall Study|Protocol Violation|1
4815578|NCT01210118|16604314|P2|Overall Study|Lost to Follow-up|1
4815579|NCT01210118|16604315|P1|Overall Study|Lost to Follow-up|1
4815580|NCT01210001|16604339|P3|Overall Study|Other reason not defined above|1
4815581|NCT01210001|16604340|P2|Overall Study|Other reason not defined above|2
4815582|NCT01210001|16604341|P1|Overall Study|Other reason not defined above|2
4815583|NCT01210001|16604339|P3|Overall Study|Patient refusal to continue,not due toAE|1
4815584|NCT01210001|16604340|P2|Overall Study|Patient refusal to continue,not due toAE|2
4815585|NCT01210001|16604341|P1|Overall Study|Patient refusal to continue,not due toAE|6
4815586|NCT01210001|16604339|P3|Overall Study|Lost to Follow-up|2
4815587|NCT01210001|16604340|P2|Overall Study|Lost to Follow-up|3
4815588|NCT01210001|16604341|P1|Overall Study|Lost to Follow-up|4
4815589|NCT01210001|16604339|P3|Overall Study|Non compliant with protocol|3
4815590|NCT01210001|16604340|P2|Overall Study|Non compliant with protocol|2
4815591|NCT01210001|16604341|P1|Overall Study|Non compliant with protocol|2
4815592|NCT01210001|16604339|P3|Overall Study|Adverse Event|5
4815593|NCT01210001|16604340|P2|Overall Study|Adverse Event|2
4815594|NCT01210001|16604341|P1|Overall Study|Adverse Event|4
4815595|NCT01210001|16604339|P3|Overall Study|Not treated|0
4815596|NCT01210001|16604340|P2|Overall Study|Not treated|0
4815597|NCT01210001|16604341|P1|Overall Study|Not treated|1
4815598|NCT01209949|16604361|P1|Overall Study|Lost to Follow-up|3
4815599|NCT01209832|16604367|P1|Period 2|Sponsor Decision|1
4815600|NCT01209832|16604367|P1|Period 1|Sponsor Decision and was not dosed|1
4815601|NCT01209780|16604386|P5|Overall Study|Inappropriate enrollment|1
4815602|NCT01209780|16604387|P4|Overall Study|Inappropriate enrollment|0
4815603|NCT01209780|16604388|P3|Overall Study|Inappropriate enrollment|0
4815604|NCT01209780|16604389|P2|Overall Study|Inappropriate enrollment|2
4815605|NCT01209780|16604390|P1|Overall Study|Inappropriate enrollment|0
4815606|NCT01209780|16604386|P5|Overall Study|Protocol Violation|0
4815607|NCT01209780|16604387|P4|Overall Study|Protocol Violation|0
4815608|NCT01209780|16604388|P3|Overall Study|Protocol Violation|0
4815609|NCT01209780|16604389|P2|Overall Study|Protocol Violation|1
4815610|NCT01209780|16604390|P1|Overall Study|Protocol Violation|0
4815611|NCT01209780|16604386|P5|Overall Study|Lost to Follow-up|4
4815612|NCT01209780|16604387|P4|Overall Study|Lost to Follow-up|9
4815613|NCT01209780|16604388|P3|Overall Study|Lost to Follow-up|3
4815614|NCT01209780|16604389|P2|Overall Study|Lost to Follow-up|12
4815615|NCT01209780|16604390|P1|Overall Study|Lost to Follow-up|17
4815616|NCT01209780|16604386|P5|Overall Study|Withdrawal by Subject|0
4815617|NCT01209780|16604387|P4|Overall Study|Withdrawal by Subject|1
4815618|NCT01209780|16604388|P3|Overall Study|Withdrawal by Subject|1
4815619|NCT01209780|16604389|P2|Overall Study|Withdrawal by Subject|2
4815620|NCT01209780|16604390|P1|Overall Study|Withdrawal by Subject|9
4815621|NCT01209780|16604386|P5|Overall Study|Adverse Event|0
4815622|NCT01209780|16604387|P4|Overall Study|Adverse Event|0
4815623|NCT01209780|16604388|P3|Overall Study|Adverse Event|0
4815624|NCT01209780|16604389|P2|Overall Study|Adverse Event|1
4815625|NCT01209780|16604390|P1|Overall Study|Adverse Event|0
4815626|NCT01209767|16604416|P1|Overall Study|Lost to Follow-up|3
4815627|NCT01209767|16604416|P1|Overall Study|Withdrawal by Subject|1
4815628|NCT01209689|16604485|P2|Overall Study|Sponsor's Decision to Stop the Study|17
4815629|NCT01209689|16604486|P1|Overall Study|Sponsor's Decision to Stop the Study|68
4815630|NCT01209689|16604485|P2|Overall Study|Failure to Return|0
4815631|NCT01209689|16604486|P1|Overall Study|Failure to Return|3
4815632|NCT01209689|16604485|P2|Overall Study|Violation of Selection Criteria at Entry|0
4815633|NCT01209689|16604486|P1|Overall Study|Violation of Selection Criteria at Entry|1
4815634|NCT01209689|16604485|P2|Overall Study|Adverse Event|0
4815635|NCT01209689|16604486|P1|Overall Study|Adverse Event|4
4815636|NCT01209689|16604485|P2|Overall Study|Refused Treatment|3
4815637|NCT01209689|16604486|P1|Overall Study|Refused Treatment|8
4815638|NCT01209689|16604485|P2|Overall Study|Insufficient Therapeutic Response|2
4815639|NCT01209689|16604486|P1|Overall Study|Insufficient Therapeutic Response|7
4815640|NCT01209624|16604492|P1|Overall Study|Other|4
4815641|NCT01209624|16604492|P1|Overall Study|Lost to Follow-up|290
4815642|NCT01209624|16604492|P1|Overall Study|Lack of Efficacy|17
4815643|NCT01209624|16604492|P1|Overall Study|Adverse Event|13
4815644|NCT01209624|16604492|P1|Overall Study|Death|2
4815645|NCT01209598|16604525|P2|Overall Study|Withdrawal by Subject|0
4815646|NCT01209598|16604526|P1|Overall Study|Withdrawal by Subject|1
4815647|NCT01209520|16604534|P1|Overall Study|Withdrawal by Subject|3
4815648|NCT01209325|16604544|P1|Overall Study|Incarceration|2
4815649|NCT01209325|16604544|P1|Overall Study|Refusal prior to therapy|1
4815650|NCT01209325|16604544|P1|Overall Study|Protocol Violation|4
4815651|NCT01209325|16604544|P1|Overall Study|Refusal after starting therapy|8
4815652|NCT01209325|16604544|P1|Overall Study|Relocated|3
4815653|NCT01209325|16604544|P1|Overall Study|Adverse Event|1
4815654|NCT01209325|16604544|P1|Overall Study|Lost to Follow-up|24
4815655|NCT01209286|16604599|P3|Overall Study|Other|0
4815656|NCT01209286|16604600|P2|Overall Study|Other|1
4815657|NCT01209286|16604601|P1|Overall Study|Other|0
4815658|NCT01209286|16604599|P3|Overall Study|Physician Decision|0
4815659|NCT01209286|16604600|P2|Overall Study|Physician Decision|2
4815660|NCT01209286|16604601|P1|Overall Study|Physician Decision|0
4815661|NCT01209286|16604599|P3|Overall Study|Remission Not Achieved in 2 Cycles|1
4815662|NCT01209286|16604600|P2|Overall Study|Remission Not Achieved in 2 Cycles|3
4815663|NCT01209286|16604601|P1|Overall Study|Remission Not Achieved in 2 Cycles|1
4815664|NCT01209286|16604599|P3|Overall Study|Hematological Relapse After Remission|1
4815665|NCT01209286|16604600|P2|Overall Study|Hematological Relapse After Remission|1
4815666|NCT01209286|16604601|P1|Overall Study|Hematological Relapse After Remission|0
4815667|NCT01209286|16604599|P3|Overall Study|Adverse Event|1
4815668|NCT01209286|16604600|P2|Overall Study|Adverse Event|3
4815669|NCT01209286|16604601|P1|Overall Study|Adverse Event|4
4815670|NCT01209143|16604721|P2|Overall Study|Disease progression|16
4815671|NCT01209143|16604722|P1|Overall Study|Disease progression|11
4815672|NCT01209143|16604721|P2|Overall Study|Withdrawal by Subject|1
4815673|NCT01209143|16604722|P1|Overall Study|Withdrawal by Subject|2
4815674|NCT01209143|16604721|P2|Overall Study|Lost to Follow-up|0
4815675|NCT01209143|16604722|P1|Overall Study|Lost to Follow-up|1
4815676|NCT01209143|16604721|P2|Overall Study|Physician Decision|1
4815677|NCT01209143|16604722|P1|Overall Study|Physician Decision|3
4815678|NCT01209143|16604721|P2|Overall Study|Death|1
4815679|NCT01209143|16604722|P1|Overall Study|Death|0
4815680|NCT01209143|16604721|P2|Overall Study|Adverse Event|1
4815681|NCT01209143|16604722|P1|Overall Study|Adverse Event|2
4815682|NCT01209078|16604732|P2|Overall Study|Withdrawal by Subject|1
4815683|NCT01209078|16604733|P1|Overall Study|Withdrawal by Subject|2
4815684|NCT01209078|16604732|P2|Overall Study|Physician Decision|2
4815685|NCT01209078|16604733|P1|Overall Study|Physician Decision|5
4815686|NCT01209078|16604732|P2|Overall Study|Lost to Follow-up|0
4815687|NCT01209078|16604733|P1|Overall Study|Lost to Follow-up|4
4815688|NCT01209078|16604732|P2|Overall Study|Adverse Event|0
4815689|NCT01209078|16604733|P1|Overall Study|Adverse Event|5
4815690|NCT01208961|16604808|P2|High-Fat Period III|Protocol Violation|0
4815691|NCT01208961|16604809|P1|High-Fat Period III|Protocol Violation|1
4815692|NCT01208870|16604831|P2|Overall Study|Lost to Follow-up|8
4815693|NCT01208870|16604832|P1|Overall Study|Lost to Follow-up|2
4815694|NCT01208415|16604848|P1|Overall Study|Still be eligible for follow-up|33
4815695|NCT01208415|16604848|P1|Overall Study|Device not placed|1
4815696|NCT01208415|16604848|P1|Overall Study|Withdrawal by Subject|3
4815697|NCT01208415|16604848|P1|Overall Study|Lost to Follow-up|2
4815698|NCT01208415|16604848|P1|Overall Study|Death|1
4815699|NCT01208402|16604854|P2|Overall Study|Withdrawal by Subject|0
4815700|NCT01208402|16604855|P1|Overall Study|Withdrawal by Subject|1
4815701|NCT01208337|16604871|P1|Overall Study|Death|3
4815702|NCT01208233|16604885|P6|Overall Study|Withdrawal by Subject|2
4815703|NCT01208233|16604886|P5|Overall Study|Withdrawal by Subject|4
4815704|NCT01208233|16604887|P4|Overall Study|Withdrawal by Subject|1
4815705|NCT01208233|16604888|P3|Overall Study|Withdrawal by Subject|1
4815706|NCT01208233|16604889|P2|Overall Study|Withdrawal by Subject|0
4815707|NCT01208233|16604890|P1|Overall Study|Withdrawal by Subject|1
4815708|NCT01208233|16604885|P6|Overall Study|Other|1
4815709|NCT01208233|16604886|P5|Overall Study|Other|0
4815710|NCT01208233|16604887|P4|Overall Study|Other|0
4815711|NCT01208233|16604888|P3|Overall Study|Other|0
4815712|NCT01208233|16604889|P2|Overall Study|Other|1
4815713|NCT01208233|16604890|P1|Overall Study|Other|2
4815714|NCT01208233|16604885|P6|Overall Study|Protocol Violation|0
4815715|NCT01208233|16604886|P5|Overall Study|Protocol Violation|3
4815716|NCT01208233|16604887|P4|Overall Study|Protocol Violation|0
4815717|NCT01208233|16604888|P3|Overall Study|Protocol Violation|0
4815718|NCT01208233|16604889|P2|Overall Study|Protocol Violation|0
4815719|NCT01208233|16604890|P1|Overall Study|Protocol Violation|0
4815720|NCT01208233|16604885|P6|Overall Study|Study terminated by sponsor|7
4815721|NCT01208233|16604886|P5|Overall Study|Study terminated by sponsor|10
4815722|NCT01208233|16604887|P4|Overall Study|Study terminated by sponsor|0
4815723|NCT01208233|16604888|P3|Overall Study|Study terminated by sponsor|0
4815724|NCT01208233|16604889|P2|Overall Study|Study terminated by sponsor|0
4815725|NCT01208233|16604890|P1|Overall Study|Study terminated by sponsor|0
4815726|NCT01208233|16604885|P6|Overall Study|Medication error without adverse event|1
4815727|NCT01208233|16604886|P5|Overall Study|Medication error without adverse event|0
4815728|NCT01208233|16604887|P4|Overall Study|Medication error without adverse event|0
4815729|NCT01208233|16604888|P3|Overall Study|Medication error without adverse event|0
4815730|NCT01208233|16604889|P2|Overall Study|Medication error without adverse event|0
4815731|NCT01208233|16604890|P1|Overall Study|Medication error without adverse event|0
4815732|NCT01208233|16604885|P6|Overall Study|Did not meet entrance criteria|0
4815733|NCT01208233|16604886|P5|Overall Study|Did not meet entrance criteria|1
4815734|NCT01208233|16604887|P4|Overall Study|Did not meet entrance criteria|0
4815735|NCT01208233|16604888|P3|Overall Study|Did not meet entrance criteria|1
4815736|NCT01208233|16604889|P2|Overall Study|Did not meet entrance criteria|1
4815737|NCT01208233|16604890|P1|Overall Study|Did not meet entrance criteria|2
4815738|NCT01208233|16604885|P6|Overall Study|Death|5
4815739|NCT01208233|16604886|P5|Overall Study|Death|3
4815740|NCT01208233|16604887|P4|Overall Study|Death|0
4815741|NCT01208233|16604888|P3|Overall Study|Death|0
4815742|NCT01208233|16604889|P2|Overall Study|Death|0
4815743|NCT01208233|16604890|P1|Overall Study|Death|0
4815744|NCT01208233|16604885|P6|Overall Study|Adverse Event|5
4815745|NCT01208233|16604886|P5|Overall Study|Adverse Event|3
4815746|NCT01208233|16604887|P4|Overall Study|Adverse Event|0
4815747|NCT01208233|16604888|P3|Overall Study|Adverse Event|2
4815748|NCT01208233|16604889|P2|Overall Study|Adverse Event|1
4815749|NCT01208233|16604890|P1|Overall Study|Adverse Event|0
4815750|NCT01208207|16605015|P7|Part II|Technical Problems|0
4815751|NCT01208207|16605016|P6|Part II|Technical Problems|1
4815752|NCT01208207|16605017|P5|Part II|Technical Problems|0
4815753|NCT01208207|16605018|P4|Part II|Technical Problems|1
4815754|NCT01208207|16605019|P3|Part II|Technical Problems|0
4815755|NCT01208207|16605020|P2|Part II|Technical Problems|0
4815756|NCT01208207|16605021|P1|Part II|Technical Problems|0
4815757|NCT01208207|16605015|P7|Part II|Protocol Violation|0
4815758|NCT01208207|16605016|P6|Part II|Protocol Violation|0
4815759|NCT01208207|16605017|P5|Part II|Protocol Violation|0
4815760|NCT01208207|16605018|P4|Part II|Protocol Violation|1
4815761|NCT01208207|16605019|P3|Part II|Protocol Violation|0
4815762|NCT01208207|16605020|P2|Part II|Protocol Violation|0
4815763|NCT01208207|16605021|P1|Part II|Protocol Violation|0
4815764|NCT01208207|16605015|P7|Part II|Physician Decision|0
4815765|NCT01208207|16605016|P6|Part II|Physician Decision|2
4815766|NCT01208207|16605017|P5|Part II|Physician Decision|0
4815767|NCT01208207|16605018|P4|Part II|Physician Decision|1
4815768|NCT01208207|16605019|P3|Part II|Physician Decision|0
4815769|NCT01208207|16605020|P2|Part II|Physician Decision|0
4815770|NCT01208207|16605021|P1|Part II|Physician Decision|0
4815771|NCT01208207|16605015|P7|Part II|Non-Compliance With Study Drug|0
4815772|NCT01208207|16605016|P6|Part II|Non-Compliance With Study Drug|1
4815773|NCT01208207|16605017|P5|Part II|Non-Compliance With Study Drug|1
4815774|NCT01208207|16605018|P4|Part II|Non-Compliance With Study Drug|4
4815775|NCT01208207|16605019|P3|Part II|Non-Compliance With Study Drug|0
4815776|NCT01208207|16605020|P2|Part II|Non-Compliance With Study Drug|0
4815777|NCT01208207|16605021|P1|Part II|Non-Compliance With Study Drug|0
4815778|NCT01208207|16605015|P7|Part II|Lost to Follow-up|1
4815779|NCT01208207|16605016|P6|Part II|Lost to Follow-up|2
4815780|NCT01208207|16605017|P5|Part II|Lost to Follow-up|0
4815781|NCT01208207|16605018|P4|Part II|Lost to Follow-up|4
4815782|NCT01208207|16605019|P3|Part II|Lost to Follow-up|0
4815783|NCT01208207|16605020|P2|Part II|Lost to Follow-up|0
4815784|NCT01208207|16605021|P1|Part II|Lost to Follow-up|0
4815785|NCT01208207|16605015|P7|Part II|Lack of Efficacy|3
4815786|NCT01208207|16605016|P6|Part II|Lack of Efficacy|3
4815787|NCT01208207|16605017|P5|Part II|Lack of Efficacy|4
4815788|NCT01208207|16605018|P4|Part II|Lack of Efficacy|6
4815789|NCT01208207|16605019|P3|Part II|Lack of Efficacy|0
4815790|NCT01208207|16605020|P2|Part II|Lack of Efficacy|0
4815791|NCT01208207|16605021|P1|Part II|Lack of Efficacy|0
4815792|NCT01208207|16605015|P7|Part II|Adverse Event|2
4815793|NCT01208207|16605016|P6|Part II|Adverse Event|4
4815794|NCT01208207|16605017|P5|Part II|Adverse Event|9
4815795|NCT01208207|16605018|P4|Part II|Adverse Event|5
4815796|NCT01208207|16605019|P3|Part II|Adverse Event|0
4815797|NCT01208207|16605020|P2|Part II|Adverse Event|0
4815798|NCT01208207|16605021|P1|Part II|Adverse Event|0
4815799|NCT01208207|16605015|P7|Part II|Withdrawal by Subject|5
4815800|NCT01208207|16605016|P6|Part II|Withdrawal by Subject|3
4815801|NCT01208207|16605017|P5|Part II|Withdrawal by Subject|9
4815802|NCT01208207|16605018|P4|Part II|Withdrawal by Subject|10
4815803|NCT01208207|16605019|P3|Part II|Withdrawal by Subject|0
4815804|NCT01208207|16605020|P2|Part II|Withdrawal by Subject|0
4815805|NCT01208207|16605021|P1|Part II|Withdrawal by Subject|0
4815806|NCT01208207|16605015|P7|Part I|Withdrawal by Subject|0
4815807|NCT01208207|16605016|P6|Part I|Withdrawal by Subject|0
4815808|NCT01208207|16605017|P5|Part I|Withdrawal by Subject|0
4815809|NCT01208207|16605018|P4|Part I|Withdrawal by Subject|0
4815810|NCT01208207|16605019|P3|Part I|Withdrawal by Subject|4
4815811|NCT01208207|16605020|P2|Part I|Withdrawal by Subject|4
4815812|NCT01208207|16605021|P1|Part I|Withdrawal by Subject|14
4815813|NCT01208207|16605015|P7|Part I|Protocol Violation|0
4815814|NCT01208207|16605016|P6|Part I|Protocol Violation|0
4815815|NCT01208207|16605017|P5|Part I|Protocol Violation|0
4815816|NCT01208207|16605018|P4|Part I|Protocol Violation|0
4815817|NCT01208207|16605019|P3|Part I|Protocol Violation|2
4815818|NCT01208207|16605020|P2|Part I|Protocol Violation|0
4815819|NCT01208207|16605021|P1|Part I|Protocol Violation|8
4815820|NCT01208207|16605015|P7|Part I|Progressive Disease|0
4815821|NCT01208207|16605016|P6|Part I|Progressive Disease|0
4815822|NCT01208207|16605017|P5|Part I|Progressive Disease|0
4815823|NCT01208207|16605018|P4|Part I|Progressive Disease|0
4815824|NCT01208207|16605019|P3|Part I|Progressive Disease|0
4815825|NCT01208207|16605020|P2|Part I|Progressive Disease|0
4815826|NCT01208207|16605021|P1|Part I|Progressive Disease|1
4815827|NCT01208207|16605015|P7|Part I|Physician Decision|0
4815828|NCT01208207|16605016|P6|Part I|Physician Decision|0
4815829|NCT01208207|16605017|P5|Part I|Physician Decision|0
4815830|NCT01208207|16605018|P4|Part I|Physician Decision|0
4815831|NCT01208207|16605019|P3|Part I|Physician Decision|0
4815832|NCT01208207|16605020|P2|Part I|Physician Decision|1
4815833|NCT01208207|16605021|P1|Part I|Physician Decision|0
4815834|NCT01208207|16605015|P7|Part I|Non-Compliance With Study Drug|0
4815835|NCT01208207|16605016|P6|Part I|Non-Compliance With Study Drug|0
4815836|NCT01208207|16605017|P5|Part I|Non-Compliance With Study Drug|0
4815837|NCT01208207|16605018|P4|Part I|Non-Compliance With Study Drug|0
4815838|NCT01208207|16605019|P3|Part I|Non-Compliance With Study Drug|1
4815839|NCT01208207|16605020|P2|Part I|Non-Compliance With Study Drug|0
4815840|NCT01208207|16605021|P1|Part I|Non-Compliance With Study Drug|1
4815841|NCT01208207|16605015|P7|Part I|Lost to Follow-up|0
4815842|NCT01208207|16605016|P6|Part I|Lost to Follow-up|0
4815843|NCT01208207|16605017|P5|Part I|Lost to Follow-up|0
4815844|NCT01208207|16605018|P4|Part I|Lost to Follow-up|0
4815845|NCT01208207|16605019|P3|Part I|Lost to Follow-up|0
4815846|NCT01208207|16605020|P2|Part I|Lost to Follow-up|1
4815847|NCT01208207|16605021|P1|Part I|Lost to Follow-up|6
4815848|NCT01208207|16605015|P7|Part I|Lack of Efficacy|0
4815849|NCT01208207|16605016|P6|Part I|Lack of Efficacy|0
4815850|NCT01208207|16605017|P5|Part I|Lack of Efficacy|0
4815851|NCT01208207|16605018|P4|Part I|Lack of Efficacy|0
4815852|NCT01208207|16605019|P3|Part I|Lack of Efficacy|2
4815853|NCT01208207|16605020|P2|Part I|Lack of Efficacy|3
4815854|NCT01208207|16605021|P1|Part I|Lack of Efficacy|21
4815855|NCT01208207|16605015|P7|Part I|Adverse Event|0
4815856|NCT01208207|16605016|P6|Part I|Adverse Event|0
4815857|NCT01208207|16605017|P5|Part I|Adverse Event|0
4815858|NCT01208207|16605018|P4|Part I|Adverse Event|0
4815859|NCT01208207|16605019|P3|Part I|Adverse Event|6
4815860|NCT01208207|16605020|P2|Part I|Adverse Event|2
4815861|NCT01208207|16605021|P1|Part I|Adverse Event|19
4815862|NCT01208181|16605048|P5|Part 2|Lack of Efficacy|0
4815863|NCT01208181|16605049|P4|Part 2|Lack of Efficacy|7
4815864|NCT01208181|16605050|P3|Part 2|Lack of Efficacy|5
4815865|NCT01208181|16605051|P2|Part 2|Lack of Efficacy|0
4815866|NCT01208181|16605052|P1|Part 2|Lack of Efficacy|0
4815867|NCT01208181|16605048|P5|Part 2|Lost to Follow-up|0
4815868|NCT01208181|16605049|P4|Part 2|Lost to Follow-up|2
4815869|NCT01208181|16605050|P3|Part 2|Lost to Follow-up|1
4815870|NCT01208181|16605051|P2|Part 2|Lost to Follow-up|0
4815871|NCT01208181|16605052|P1|Part 2|Lost to Follow-up|0
4815872|NCT01208181|16605048|P5|Part 2|Non-compliance with study drug|0
4815873|NCT01208181|16605049|P4|Part 2|Non-compliance with study drug|1
4815874|NCT01208181|16605050|P3|Part 2|Non-compliance with study drug|1
4815875|NCT01208181|16605051|P2|Part 2|Non-compliance with study drug|0
4815876|NCT01208181|16605052|P1|Part 2|Non-compliance with study drug|0
4815877|NCT01208181|16605048|P5|Part 2|Physician Decision|0
4815878|NCT01208181|16605049|P4|Part 2|Physician Decision|2
4815879|NCT01208181|16605050|P3|Part 2|Physician Decision|1
4815880|NCT01208181|16605051|P2|Part 2|Physician Decision|0
4815881|NCT01208181|16605052|P1|Part 2|Physician Decision|0
4815882|NCT01208181|16605048|P5|Part 2|Protocol Violation|0
4815883|NCT01208181|16605049|P4|Part 2|Protocol Violation|0
4815884|NCT01208181|16605050|P3|Part 2|Protocol Violation|1
4815885|NCT01208181|16605051|P2|Part 2|Protocol Violation|0
4815886|NCT01208181|16605052|P1|Part 2|Protocol Violation|0
4815887|NCT01208181|16605048|P5|Part 2|Withdrawal by Subject|0
4815888|NCT01208181|16605049|P4|Part 2|Withdrawal by Subject|1
4815889|NCT01208181|16605050|P3|Part 2|Withdrawal by Subject|1
4815890|NCT01208181|16605051|P2|Part 2|Withdrawal by Subject|0
4815891|NCT01208181|16605052|P1|Part 2|Withdrawal by Subject|0
4815892|NCT01208181|16605048|P5|Part 2|Adverse Event|0
4815893|NCT01208181|16605049|P4|Part 2|Adverse Event|7
4815894|NCT01208181|16605050|P3|Part 2|Adverse Event|6
4815895|NCT01208181|16605051|P2|Part 2|Adverse Event|0
4815896|NCT01208181|16605052|P1|Part 2|Adverse Event|0
4815897|NCT01208181|16605048|P5|Part 1|Adverse Event|4
4815898|NCT01208181|16605049|P4|Part 1|Adverse Event|0
4815899|NCT01208181|16605050|P3|Part 1|Adverse Event|0
4815900|NCT01208181|16605051|P2|Part 1|Adverse Event|24
4815901|NCT01208181|16605052|P1|Part 1|Adverse Event|26
4815902|NCT01208181|16605048|P5|Part 1|Lack of Efficacy|17
4815903|NCT01208181|16605049|P4|Part 1|Lack of Efficacy|0
4815904|NCT01208181|16605050|P3|Part 1|Lack of Efficacy|0
4815905|NCT01208181|16605051|P2|Part 1|Lack of Efficacy|12
4815906|NCT01208181|16605052|P1|Part 1|Lack of Efficacy|37
4815907|NCT01208181|16605048|P5|Part 1|Lost to Follow-up|1
4815908|NCT01208181|16605049|P4|Part 1|Lost to Follow-up|0
4815909|NCT01208181|16605050|P3|Part 1|Lost to Follow-up|0
4815910|NCT01208181|16605051|P2|Part 1|Lost to Follow-up|3
4815911|NCT01208181|16605052|P1|Part 1|Lost to Follow-up|5
4815912|NCT01208181|16605048|P5|Part 1|Non-compliance with study drug|0
4815913|NCT01208181|16605049|P4|Part 1|Non-compliance with study drug|0
4815914|NCT01208181|16605050|P3|Part 1|Non-compliance with study drug|0
4815915|NCT01208181|16605051|P2|Part 1|Non-compliance with study drug|1
4815916|NCT01208181|16605052|P1|Part 1|Non-compliance with study drug|1
4815917|NCT01208181|16605048|P5|Part 1|Physician Decision|0
4815918|NCT01208181|16605049|P4|Part 1|Physician Decision|0
4815919|NCT01208181|16605050|P3|Part 1|Physician Decision|0
4815920|NCT01208181|16605051|P2|Part 1|Physician Decision|0
4815921|NCT01208181|16605052|P1|Part 1|Physician Decision|4
4815922|NCT01208181|16605048|P5|Part 1|Protocol Violation|0
4815923|NCT01208181|16605049|P4|Part 1|Protocol Violation|0
4815924|NCT01208181|16605050|P3|Part 1|Protocol Violation|0
4815925|NCT01208181|16605051|P2|Part 1|Protocol Violation|5
4815926|NCT01208181|16605052|P1|Part 1|Protocol Violation|10
4815927|NCT01208181|16605048|P5|Part 1|Technical problem|0
4815928|NCT01208181|16605049|P4|Part 1|Technical problem|0
4815929|NCT01208181|16605050|P3|Part 1|Technical problem|0
4815930|NCT01208181|16605051|P2|Part 1|Technical problem|0
4815931|NCT01208181|16605052|P1|Part 1|Technical problem|5
4815932|NCT01208181|16605048|P5|Part 1|Withdrawal by Subject|0
4815933|NCT01208181|16605049|P4|Part 1|Withdrawal by Subject|0
4815934|NCT01208181|16605050|P3|Part 1|Withdrawal by Subject|0
4815935|NCT01208181|16605051|P2|Part 1|Withdrawal by Subject|10
4815936|NCT01208181|16605052|P1|Part 1|Withdrawal by Subject|11
4815937|NCT01208103|16605081|P1|Overall Study|Withdrawal by Subject|1
4815938|NCT01208103|16605081|P1|Overall Study|Adverse Event|1
4815939|NCT01208038|16605089|P1|Overall Study|Withdrawal by Subject|1
4815940|NCT01207687|16605145|P1|Overall Study|Withdrawal by Subject|1
4815941|NCT01207687|16605145|P1|Overall Study|Adverse Event|1
4815942|NCT01207596|16605183|P1|Overall Study|Withdrawal by Subject|1
4815943|NCT01207596|16605183|P1|Overall Study|Adverse Event|3
4815944|NCT01207596|16605183|P1|Overall Study|Lack of Efficacy|1
4815945|NCT01207596|16605183|P1|Overall Study|Physician Decision|4
4815946|NCT01207583|16605196|P3|Overall Study|Lost to Follow-up|0
4815947|NCT01207583|16605197|P2|Overall Study|Lost to Follow-up|2
4815948|NCT01207583|16605198|P1|Overall Study|Lost to Follow-up|0
4815949|NCT01207583|16605196|P3|Overall Study|Participant failed to return|0
4815950|NCT01207583|16605197|P2|Overall Study|Participant failed to return|0
4815951|NCT01207583|16605198|P1|Overall Study|Participant failed to return|1
4815952|NCT01207583|16605196|P3|Overall Study|Withdrawal by Subject|1
4815953|NCT01207583|16605197|P2|Overall Study|Withdrawal by Subject|3
4815954|NCT01207583|16605198|P1|Overall Study|Withdrawal by Subject|0
4815955|NCT01207492|16605251|P1|Overall Study|Toxicity|1
4815956|NCT01207492|16605251|P1|Overall Study|Progressive disease|3
4815957|NCT01207492|16605251|P1|Overall Study|Physician Decision|1
4815958|NCT01207492|16605251|P1|Overall Study|Withdrawal by Subject|9
4815959|NCT01207492|16605251|P1|Overall Study|Still on study|1
4815960|NCT01207453|16605266|P2|2nd Intervention|Lost to Follow-up|0
4815961|NCT01207453|16605267|P1|2nd Intervention|Lost to Follow-up|1
4815962|NCT01207453|16605266|P2|2nd Intervention|Adverse Event|2
4815963|NCT01207453|16605267|P1|2nd Intervention|Adverse Event|1
4815964|NCT01207453|16605266|P2|Washout|Lost to Follow-up|0
4815965|NCT01207453|16605267|P1|Washout|Lost to Follow-up|1
4815966|NCT01207453|16605266|P2|Washout|Adverse Event|0
4815967|NCT01207453|16605267|P1|Washout|Adverse Event|1
4815968|NCT01207453|16605266|P2|First Intervention|Adverse Event|1
4815969|NCT01207453|16605267|P1|First Intervention|Adverse Event|2
4815970|NCT01207440|16605293|P7|Overall Study|Reason Not Specified|0
4815971|NCT01207440|16605294|P6|Overall Study|Reason Not Specified|3
4815972|NCT01207440|16605295|P5|Overall Study|Reason Not Specified|4
4815973|NCT01207440|16605296|P4|Overall Study|Reason Not Specified|0
4815974|NCT01207440|16605297|P3|Overall Study|Reason Not Specified|7
4815975|NCT01207440|16605298|P2|Overall Study|Reason Not Specified|10
4815976|NCT01207440|16605299|P1|Overall Study|Reason Not Specified|10
4815977|NCT01207440|16605293|P7|Overall Study|Withdrawal by Subject|0
4815978|NCT01207440|16605294|P6|Overall Study|Withdrawal by Subject|2
4815979|NCT01207440|16605295|P5|Overall Study|Withdrawal by Subject|2
4815980|NCT01207440|16605296|P4|Overall Study|Withdrawal by Subject|3
4815981|NCT01207440|16605297|P3|Overall Study|Withdrawal by Subject|5
4815982|NCT01207440|16605298|P2|Overall Study|Withdrawal by Subject|4
4815983|NCT01207440|16605299|P1|Overall Study|Withdrawal by Subject|29
4815984|NCT01207440|16605293|P7|Overall Study|Site Terminated by Sponsor|2
4815985|NCT01207440|16605294|P6|Overall Study|Site Terminated by Sponsor|0
4815986|NCT01207440|16605295|P5|Overall Study|Site Terminated by Sponsor|3
4815987|NCT01207440|16605296|P4|Overall Study|Site Terminated by Sponsor|2
4815988|NCT01207440|16605297|P3|Overall Study|Site Terminated by Sponsor|12
4815989|NCT01207440|16605298|P2|Overall Study|Site Terminated by Sponsor|19
4815990|NCT01207440|16605299|P1|Overall Study|Site Terminated by Sponsor|69
4815991|NCT01207440|16605293|P7|Overall Study|Protocol Violation|0
4815992|NCT01207440|16605294|P6|Overall Study|Protocol Violation|0
4815993|NCT01207440|16605295|P5|Overall Study|Protocol Violation|0
4815994|NCT01207440|16605296|P4|Overall Study|Protocol Violation|0
4815995|NCT01207440|16605297|P3|Overall Study|Protocol Violation|0
4815996|NCT01207440|16605298|P2|Overall Study|Protocol Violation|0
4815997|NCT01207440|16605299|P1|Overall Study|Protocol Violation|2
4815998|NCT01207440|16605293|P7|Overall Study|Progressive Disease|0
4815999|NCT01207440|16605294|P6|Overall Study|Progressive Disease|27
4816000|NCT01207440|16605295|P5|Overall Study|Progressive Disease|23
4816001|NCT01207440|16605296|P4|Overall Study|Progressive Disease|7
4816002|NCT01207440|16605297|P3|Overall Study|Progressive Disease|19
4816003|NCT01207440|16605298|P2|Overall Study|Progressive Disease|10
4816004|NCT01207440|16605299|P1|Overall Study|Progressive Disease|19
4816005|NCT01207440|16605293|P7|Overall Study|Physician Decision|0
4816006|NCT01207440|16605294|P6|Overall Study|Physician Decision|0
4816007|NCT01207440|16605295|P5|Overall Study|Physician Decision|1
4816008|NCT01207440|16605296|P4|Overall Study|Physician Decision|0
4816009|NCT01207440|16605297|P3|Overall Study|Physician Decision|5
4816010|NCT01207440|16605298|P2|Overall Study|Physician Decision|5
4816011|NCT01207440|16605299|P1|Overall Study|Physician Decision|6
4816012|NCT01207440|16605293|P7|Overall Study|Non-compliance with Study Drug|0
4816013|NCT01207440|16605294|P6|Overall Study|Non-compliance with Study Drug|0
4816014|NCT01207440|16605295|P5|Overall Study|Non-compliance with Study Drug|0
4816015|NCT01207440|16605296|P4|Overall Study|Non-compliance with Study Drug|0
4816016|NCT01207440|16605297|P3|Overall Study|Non-compliance with Study Drug|1
4816017|NCT01207440|16605298|P2|Overall Study|Non-compliance with Study Drug|0
4816018|NCT01207440|16605299|P1|Overall Study|Non-compliance with Study Drug|3
4816019|NCT01207440|16605293|P7|Overall Study|Lost to Follow-up|0
4816020|NCT01207440|16605294|P6|Overall Study|Lost to Follow-up|0
4816021|NCT01207440|16605295|P5|Overall Study|Lost to Follow-up|0
4816022|NCT01207440|16605296|P4|Overall Study|Lost to Follow-up|1
4816023|NCT01207440|16605297|P3|Overall Study|Lost to Follow-up|2
4816024|NCT01207440|16605298|P2|Overall Study|Lost to Follow-up|0
4816025|NCT01207440|16605299|P1|Overall Study|Lost to Follow-up|0
4816026|NCT01207440|16605293|P7|Overall Study|Lack of Efficacy|0
4816027|NCT01207440|16605294|P6|Overall Study|Lack of Efficacy|3
4816028|NCT01207440|16605295|P5|Overall Study|Lack of Efficacy|2
4816029|NCT01207440|16605296|P4|Overall Study|Lack of Efficacy|1
4816030|NCT01207440|16605297|P3|Overall Study|Lack of Efficacy|5
4816031|NCT01207440|16605298|P2|Overall Study|Lack of Efficacy|2
4816032|NCT01207440|16605299|P1|Overall Study|Lack of Efficacy|13
4816033|NCT01207440|16605293|P7|Overall Study|Death|1
4816034|NCT01207440|16605294|P6|Overall Study|Death|5
4816035|NCT01207440|16605295|P5|Overall Study|Death|7
4816036|NCT01207440|16605296|P4|Overall Study|Death|2
4816037|NCT01207440|16605297|P3|Overall Study|Death|2
4816038|NCT01207440|16605298|P2|Overall Study|Death|3
4816039|NCT01207440|16605299|P1|Overall Study|Death|6
4816040|NCT01207440|16605293|P7|Overall Study|Adverse Event|2
4816041|NCT01207440|16605294|P6|Overall Study|Adverse Event|6
4816042|NCT01207440|16605295|P5|Overall Study|Adverse Event|6
4816043|NCT01207440|16605296|P4|Overall Study|Adverse Event|2
4816044|NCT01207440|16605297|P3|Overall Study|Adverse Event|7
4816045|NCT01207440|16605298|P2|Overall Study|Adverse Event|11
4816046|NCT01207440|16605299|P1|Overall Study|Adverse Event|46
4816047|NCT01207427|16605366|P3|Double-blind Treatment Period|Withdrawal by Subject|0
4816048|NCT01207427|16605367|P2|Double-blind Treatment Period|Withdrawal by Subject|0
4816049|NCT01207427|16605368|P1|Double-blind Treatment Period|Withdrawal by Subject|1
4816050|NCT01207427|16605366|P3|Double-blind Treatment Period|Protocol Violation|1
4816051|NCT01207427|16605367|P2|Double-blind Treatment Period|Protocol Violation|1
4816052|NCT01207427|16605368|P1|Double-blind Treatment Period|Protocol Violation|2
4816053|NCT01207427|16605366|P3|Double-blind Treatment Period|Lost to Follow-up|1
4816054|NCT01207427|16605367|P2|Double-blind Treatment Period|Lost to Follow-up|0
4816055|NCT01207427|16605368|P1|Double-blind Treatment Period|Lost to Follow-up|0
4816056|NCT01207427|16605366|P3|Double-blind Treatment Period|Adverse Event|0
4816057|NCT01207427|16605367|P2|Double-blind Treatment Period|Adverse Event|1
4816058|NCT01207427|16605368|P1|Double-blind Treatment Period|Adverse Event|0
4816059|NCT01207414|16605378|P2|Overall Study|Randomized in error|0
4816060|NCT01207414|16605379|P1|Overall Study|Randomized in error|1
4816061|NCT01207414|16605378|P2|Overall Study|Protocol deviation|9
4816062|NCT01207414|16605379|P1|Overall Study|Protocol deviation|12
4816063|NCT01207414|16605378|P2|Overall Study|Administrative problems|1
4816064|NCT01207414|16605379|P1|Overall Study|Administrative problems|1
4816065|NCT01207414|16605378|P2|Overall Study|Lost to Follow-up|17
4816066|NCT01207414|16605379|P1|Overall Study|Lost to Follow-up|15
4816067|NCT01207414|16605378|P2|Overall Study|Patient withdrew consent|11
4816068|NCT01207414|16605379|P1|Overall Study|Patient withdrew consent|14
4816069|NCT01207414|16605378|P2|Overall Study|Unsatisfactory therapeutic effect|4
4816070|NCT01207414|16605379|P1|Overall Study|Unsatisfactory therapeutic effect|5
4816071|NCT01207414|16605378|P2|Overall Study|Abnormal test procedure results|1
4816072|NCT01207414|16605379|P1|Overall Study|Abnormal test procedure results|0
4816073|NCT01207414|16605378|P2|Overall Study|Adverse Event|39
4816074|NCT01207414|16605379|P1|Overall Study|Adverse Event|25
4816075|NCT01207388|16605404|P1|Overall Study|Withdrawal by Subject|1
4816076|NCT01207388|16605404|P1|Overall Study|Death|67
4816077|NCT01207219|16605429|P3|Overall Study|Lost to Follow-up|6
4816078|NCT01207219|16605430|P2|Overall Study|Lost to Follow-up|8
4816079|NCT01207219|16605431|P1|Overall Study|Lost to Follow-up|6
4816080|NCT01207219|16605429|P3|Overall Study|changed diagnosis during study period|1
4816081|NCT01207219|16605430|P2|Overall Study|changed diagnosis during study period|3
4816082|NCT01207219|16605431|P1|Overall Study|changed diagnosis during study period|5
4816083|NCT01207102|16605451|P1|Overall Study|Withdrawal by Treating Physician|1
4816084|NCT01207102|16605451|P1|Overall Study|progression|2
4816085|NCT01207102|16605451|P1|Overall Study|Adverse Event|2
4816086|NCT01207102|16605451|P1|Overall Study|Withdrawal by Subject|5
4816087|NCT01206816|16605463|P7|Overall Study|other than stated above|1
4816088|NCT01206816|16605464|P6|Overall Study|other than stated above|0
4816089|NCT01206816|16605465|P5|Overall Study|other than stated above|0
4816090|NCT01206816|16605466|P4|Overall Study|other than stated above|0
4816091|NCT01206816|16605467|P3|Overall Study|other than stated above|1
4816092|NCT01206816|16605468|P2|Overall Study|other than stated above|0
4816093|NCT01206816|16605469|P1|Overall Study|other than stated above|0
4816094|NCT01206816|16605463|P7|Overall Study|Other AE|2
4816095|NCT01206816|16605464|P6|Overall Study|Other AE|3
4816096|NCT01206816|16605465|P5|Overall Study|Other AE|0
4816097|NCT01206816|16605466|P4|Overall Study|Other AE|0
4816098|NCT01206816|16605467|P3|Overall Study|Other AE|4
4816099|NCT01206816|16605468|P2|Overall Study|Other AE|0
4816100|NCT01206816|16605469|P1|Overall Study|Other AE|0
4816101|NCT01206816|16605463|P7|Overall Study|Progressive disease|3
4816102|NCT01206816|16605464|P6|Overall Study|Progressive disease|16
4816103|NCT01206816|16605465|P5|Overall Study|Progressive disease|3
4816104|NCT01206816|16605466|P4|Overall Study|Progressive disease|3
4816105|NCT01206816|16605467|P3|Overall Study|Progressive disease|13
4816106|NCT01206816|16605468|P2|Overall Study|Progressive disease|3
4816107|NCT01206816|16605469|P1|Overall Study|Progressive disease|3
4816108|NCT01206816|16605463|P7|Overall Study|Withdrawal by Subject|0
4816109|NCT01206816|16605464|P6|Overall Study|Withdrawal by Subject|0
4816110|NCT01206816|16605465|P5|Overall Study|Withdrawal by Subject|0
4816111|NCT01206816|16605466|P4|Overall Study|Withdrawal by Subject|0
4816112|NCT01206816|16605467|P3|Overall Study|Withdrawal by Subject|1
4816113|NCT01206816|16605468|P2|Overall Study|Withdrawal by Subject|0
4816114|NCT01206816|16605469|P1|Overall Study|Withdrawal by Subject|0
4816115|NCT01206816|16605463|P7|Overall Study|Protocol Violation|0
4816116|NCT01206816|16605464|P6|Overall Study|Protocol Violation|0
4816117|NCT01206816|16605465|P5|Overall Study|Protocol Violation|0
4816118|NCT01206816|16605466|P4|Overall Study|Protocol Violation|0
4816119|NCT01206816|16605467|P3|Overall Study|Protocol Violation|1
4816120|NCT01206816|16605468|P2|Overall Study|Protocol Violation|0
4816121|NCT01206816|16605469|P1|Overall Study|Protocol Violation|0
4816122|NCT01206777|16605515|P1|Overall Study|Adverse Event|1
4816123|NCT01206777|16605515|P1|Overall Study|Death|1
4816124|NCT01206764|16605521|P1|Overall Study|Protocol deviation|3
4816125|NCT01206764|16605521|P1|Overall Study|Disease progression|88
4816126|NCT01206764|16605521|P1|Overall Study|New cancer therapy|2
4816127|NCT01206764|16605521|P1|Overall Study|Death|11
4816128|NCT01206764|16605521|P1|Overall Study|Lost to Follow-up|6
4816129|NCT01206764|16605521|P1|Overall Study|Patient withdrew consent|5
4816130|NCT01206764|16605521|P1|Overall Study|Abnormal test procedure result|1
4816131|NCT01206764|16605521|P1|Overall Study|Abnormal laboratory value|2
4816132|NCT01206764|16605521|P1|Overall Study|Adverse Event|20
4816133|NCT01206582|16605579|P2|Overall Study|Discontinued intervention before week 8|2
4816134|NCT01206582|16605580|P1|Overall Study|Discontinued intervention before week 8|1
4816135|NCT01206582|16605579|P2|Overall Study|Withdrew prior to study|0
4816136|NCT01206582|16605580|P1|Overall Study|Withdrew prior to study|1
4816137|NCT01206517|16605612|P6|Overall Study|Withdrawal by Subject|0
4816138|NCT01206517|16605613|P5|Overall Study|Withdrawal by Subject|1
4816139|NCT01206517|16605614|P4|Overall Study|Withdrawal by Subject|0
4816140|NCT01206517|16605615|P3|Overall Study|Withdrawal by Subject|2
4816141|NCT01206517|16605616|P2|Overall Study|Withdrawal by Subject|0
4816142|NCT01206517|16605617|P1|Overall Study|Withdrawal by Subject|0
4816143|NCT01206439|16605697|P1|Overall Study|subject did not meet inclusion criteria|1
4816144|NCT01206322|16605720|P4|Overall Study|Adverse Event|1
4816145|NCT01206322|16605721|P3|Overall Study|Adverse Event|0
4816146|NCT01206322|16605722|P2|Overall Study|Adverse Event|0
4816147|NCT01206322|16605723|P1|Overall Study|Adverse Event|0
4816148|NCT01206140|16605739|P2|Overall Study|Deemed ineligible due to incorrect diag.|0
4816149|NCT01206140|16605740|P1|Overall Study|Deemed ineligible due to incorrect diag.|1
4816150|NCT01206101|16605752|P2|Overall Study|Unclassified|0
4816151|NCT01206101|16605753|P1|Overall Study|Unclassified|1
4816152|NCT01206101|16605752|P2|Overall Study|Physician Decision|1
4816153|NCT01206101|16605753|P1|Overall Study|Physician Decision|0
4816154|NCT01206101|16605752|P2|Overall Study|Adverse Event|0
4816155|NCT01206101|16605753|P1|Overall Study|Adverse Event|1
4816156|NCT01205776|16605794|P2|Overall Study|Withdrawal by Subject|34
4816157|NCT01205776|16605795|P1|Overall Study|Withdrawal by Subject|11
4816158|NCT01205776|16605794|P2|Overall Study|Lost to Follow-up|61
4816159|NCT01205776|16605795|P1|Overall Study|Lost to Follow-up|53
4816160|NCT01205685|16605983|P1|Overall Study|Withdrawal by Subject|1
4816161|NCT01205685|16605983|P1|Overall Study|Disease Progression|10
4816162|NCT01205581|16606003|P6|Overall Study|Withdrawal by Subject|0
4816163|NCT01205581|16606004|P5|Overall Study|Withdrawal by Subject|0
4816164|NCT01205581|16606005|P4|Overall Study|Withdrawal by Subject|0
4816165|NCT01205581|16606006|P3|Overall Study|Withdrawal by Subject|0
4816166|NCT01205581|16606007|P2|Overall Study|Withdrawal by Subject|0
4816167|NCT01205581|16606008|P1|Overall Study|Withdrawal by Subject|1
4816168|NCT01205529|16606078|P1|Overall Study|No longer met criteria|30
4816169|NCT01205529|16606078|P1|Overall Study|Unstable post op|15
4816170|NCT01205529|16606078|P1|Overall Study|Physician Decision|4
4816171|NCT01205529|16606078|P1|Overall Study|Withdrawal by Subject|2
4816172|NCT01205529|16606078|P1|Overall Study|Procedure Cancelled|4
4816173|NCT01205451|16606101|P2|Overall Study|Withdrawal by Subject|9
4816174|NCT01205451|16606102|P1|Overall Study|Withdrawal by Subject|5
4816175|NCT01205451|16606101|P2|Overall Study|Lost to Follow-up|1
4816176|NCT01205451|16606102|P1|Overall Study|Lost to Follow-up|1
4816177|NCT01205438|16606147|P3|Overall Study|Sponsor Decision|1
4816178|NCT01205438|16606148|P2|Overall Study|Sponsor Decision|1
4816179|NCT01205438|16606149|P1|Overall Study|Sponsor Decision|0
4816180|NCT01205438|16606147|P3|Overall Study|Protocol Violation|4
4816181|NCT01205438|16606148|P2|Overall Study|Protocol Violation|7
4816182|NCT01205438|16606149|P1|Overall Study|Protocol Violation|2
4816183|NCT01205438|16606147|P3|Overall Study|Physician Decision|2
4816184|NCT01205438|16606148|P2|Overall Study|Physician Decision|3
4816185|NCT01205438|16606149|P1|Overall Study|Physician Decision|0
4816186|NCT01205438|16606147|P3|Overall Study|Withdrawal by Subject|19
4816187|NCT01205438|16606148|P2|Overall Study|Withdrawal by Subject|25
4816188|NCT01205438|16606149|P1|Overall Study|Withdrawal by Subject|19
4816189|NCT01205438|16606147|P3|Overall Study|Lost to Follow-up|8
4816190|NCT01205438|16606148|P2|Overall Study|Lost to Follow-up|7
4816191|NCT01205438|16606149|P1|Overall Study|Lost to Follow-up|6
4816192|NCT01205438|16606147|P3|Overall Study|Lack of Efficacy|14
4816193|NCT01205438|16606148|P2|Overall Study|Lack of Efficacy|11
4816194|NCT01205438|16606149|P1|Overall Study|Lack of Efficacy|14
4816195|NCT01205438|16606147|P3|Overall Study|Entry Criteria Not Met|13
4816196|NCT01205438|16606148|P2|Overall Study|Entry Criteria Not Met|15
4816197|NCT01205438|16606149|P1|Overall Study|Entry Criteria Not Met|16
4816198|NCT01205438|16606147|P3|Overall Study|Death|3
4816199|NCT01205438|16606148|P2|Overall Study|Death|1
4816200|NCT01205438|16606149|P1|Overall Study|Death|1
4816201|NCT01205438|16606147|P3|Overall Study|Adverse Event|24
4816202|NCT01205438|16606148|P2|Overall Study|Adverse Event|17
4816203|NCT01205438|16606149|P1|Overall Study|Adverse Event|19
4816204|NCT01205269|16606205|P6|Period 4 - Washout|Eligibility criteria not fulfilled|0
4816205|NCT01205269|16606206|P5|Period 4 - Washout|Eligibility criteria not fulfilled|0
4816206|NCT01205269|16606207|P4|Period 4 - Washout|Eligibility criteria not fulfilled|1
4816207|NCT01205269|16606208|P3|Period 4 - Washout|Eligibility criteria not fulfilled|0
4816208|NCT01205269|16606209|P2|Period 4 - Washout|Eligibility criteria not fulfilled|0
4816209|NCT01205269|16606210|P1|Period 4 - Washout|Eligibility criteria not fulfilled|0
4816210|NCT01205230|16606250|P2|Overall Study|Physician Decision|0
4816211|NCT01205230|16606251|P1|Overall Study|Physician Decision|1
4816212|NCT01205230|16606250|P2|Overall Study|Adverse Event|0
4816213|NCT01205230|16606251|P1|Overall Study|Adverse Event|4
4816214|NCT01205165|16606294|P1|Overall Study|Lost to Follow-up|2
4816215|NCT01205152|16606307|P1|Overall Study|Death|1
4816216|NCT01205126|16606320|P2|Maintenance Phase|Withdrawal by Subject|11
4816217|NCT01205126|16606321|P1|Maintenance Phase|Withdrawal by Subject|8
4816218|NCT01205126|16606320|P2|Maintenance Phase|Lost to Follow-up|5
4816219|NCT01205126|16606321|P1|Maintenance Phase|Lost to Follow-up|5
4816220|NCT01205126|16606320|P2|Maintenance Phase|Other|8
4816221|NCT01205126|16606321|P1|Maintenance Phase|Other|11
4816222|NCT01205126|16606320|P2|Maintenance Phase|Prohibited drugs used|0
4816223|NCT01205126|16606321|P1|Maintenance Phase|Prohibited drugs used|1
4816224|NCT01205126|16606320|P2|Maintenance Phase|More than the maximum dosage required|5
4816225|NCT01205126|16606321|P1|Maintenance Phase|More than the maximum dosage required|5
4816226|NCT01205126|16606320|P2|Maintenance Phase|Death|4
4816227|NCT01205126|16606321|P1|Maintenance Phase|Death|4
4816228|NCT01205126|16606320|P2|Maintenance Phase|Adverse Event|7
4816229|NCT01205126|16606321|P1|Maintenance Phase|Adverse Event|3
4816230|NCT01205126|16606320|P2|Between Titration & Maintenance Phase|Other|4
4816231|NCT01205126|16606321|P1|Between Titration & Maintenance Phase|Other|0
4816232|NCT01205126|16606320|P2|Titration Phase|Other|6
4816233|NCT01205126|16606321|P1|Titration Phase|Other|8
4816234|NCT01205126|16606320|P2|Titration Phase|More than maximum dosage required|3
4816235|NCT01205126|16606321|P1|Titration Phase|More than maximum dosage required|2
4816236|NCT01205126|16606320|P2|Titration Phase|No stable titration dose|0
4816237|NCT01205126|16606321|P1|Titration Phase|No stable titration dose|1
4816238|NCT01205126|16606320|P2|Titration Phase|Lost to Follow-up|2
4816239|NCT01205126|16606321|P1|Titration Phase|Lost to Follow-up|2
4816240|NCT01205126|16606320|P2|Titration Phase|Withdrawal by Subject|5
4816241|NCT01205126|16606321|P1|Titration Phase|Withdrawal by Subject|5
4816242|NCT01205126|16606320|P2|Titration Phase|Adverse Event|3
4816243|NCT01205126|16606321|P1|Titration Phase|Adverse Event|5
4816244|NCT01205035|16606339|P2|Overall Study|Physician Decision|0
4816245|NCT01205035|16606340|P1|Overall Study|Physician Decision|1
4816246|NCT01205035|16606339|P2|Overall Study|Withdrawal by Subject|0
4816247|NCT01205035|16606340|P1|Overall Study|Withdrawal by Subject|1
4816248|NCT01204918|16606357|P3|Overall Study|Withdrawal by Subject|5
4816249|NCT01204918|16606358|P2|Overall Study|Withdrawal by Subject|10
4816250|NCT01204918|16606359|P1|Overall Study|Withdrawal by Subject|4
4816251|NCT01204775|16606402|P2|Overall Study|Withdrawal by Subject|0
4816252|NCT01204775|16606403|P1|Overall Study|Withdrawal by Subject|1
4816253|NCT01204775|16606402|P2|Overall Study|Poor/non-compliance|1
4816254|NCT01204775|16606403|P1|Overall Study|Poor/non-compliance|0
4816255|NCT01204710|16606428|P2|Optional Olaratumab Monotherapy|Withdrawal by Subject|1
4816256|NCT01204710|16606429|P1|Optional Olaratumab Monotherapy|Withdrawal by Subject|0
4816257|NCT01204710|16606428|P2|Optional Olaratumab Monotherapy|Physician Decision|1
4816258|NCT01204710|16606429|P1|Optional Olaratumab Monotherapy|Physician Decision|0
4816259|NCT01204710|16606428|P2|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1
4816260|NCT01204710|16606429|P1|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0
4816261|NCT01204710|16606428|P2|Randomization Treatment|Moved and Followed for Survival|1
4816262|NCT01204710|16606429|P1|Randomization Treatment|Moved and Followed for Survival|0
4816263|NCT01204710|16606428|P2|Randomization Treatment|Worsening of General condition|1
4816264|NCT01204710|16606429|P1|Randomization Treatment|Worsening of General condition|0
4816265|NCT01204710|16606428|P2|Randomization Treatment|Sponsor Decision|1
4816266|NCT01204710|16606429|P1|Randomization Treatment|Sponsor Decision|0
4816267|NCT01204710|16606428|P2|Randomization Treatment|Adverse Event|2
4816268|NCT01204710|16606429|P1|Randomization Treatment|Adverse Event|4
4816269|NCT01204710|16606428|P2|Randomization Treatment|Entry criteria not met|1
4816270|NCT01204710|16606429|P1|Randomization Treatment|Entry criteria not met|0
4816271|NCT01204710|16606428|P2|Randomization Treatment|Physician Decision|2
4816272|NCT01204710|16606429|P1|Randomization Treatment|Physician Decision|3
4816273|NCT01204710|16606428|P2|Randomization Treatment|Withdrawal by Subject|5
4816274|NCT01204710|16606429|P1|Randomization Treatment|Withdrawal by Subject|6
4816275|NCT01204710|16606428|P2|Randomization Treatment|Lost to Follow-up|0
4816276|NCT01204710|16606429|P1|Randomization Treatment|Lost to Follow-up|1
4816277|NCT01204697|16606465|P2|Overall Study|Randomized, but not treated|1
4816278|NCT01204697|16606466|P1|Overall Study|Randomized, but not treated|0
4816279|NCT01204697|16606465|P2|Overall Study|Withdrawal by Subject|4
4816280|NCT01204697|16606466|P1|Overall Study|Withdrawal by Subject|2
4816281|NCT01204697|16606465|P2|Overall Study|Lost to Follow-up|4
4816282|NCT01204697|16606466|P1|Overall Study|Lost to Follow-up|3
4816283|NCT01204697|16606465|P2|Overall Study|Death|27
4816284|NCT01204697|16606466|P1|Overall Study|Death|26
4816285|NCT01204671|16606487|P5|Overall Study|Physician Decision|0
4816286|NCT01204671|16606488|P4|Overall Study|Physician Decision|1
4816287|NCT01204671|16606489|P3|Overall Study|Physician Decision|0
4816288|NCT01204671|16606490|P2|Overall Study|Physician Decision|0
4816289|NCT01204671|16606491|P1|Overall Study|Physician Decision|0
4816290|NCT01204671|16606487|P5|Overall Study|Unknown Completion Status|0
4816291|NCT01204671|16606488|P4|Overall Study|Unknown Completion Status|0
4816292|NCT01204671|16606489|P3|Overall Study|Unknown Completion Status|0
4816293|NCT01204671|16606490|P2|Overall Study|Unknown Completion Status|1
4816294|NCT01204671|16606491|P1|Overall Study|Unknown Completion Status|1
4816295|NCT01204671|16606487|P5|Overall Study|Lost to Follow-up|0
4816296|NCT01204671|16606488|P4|Overall Study|Lost to Follow-up|4
4816297|NCT01204671|16606489|P3|Overall Study|Lost to Follow-up|6
4816298|NCT01204671|16606490|P2|Overall Study|Lost to Follow-up|8
4816299|NCT01204671|16606491|P1|Overall Study|Lost to Follow-up|7
4816300|NCT01204671|16606487|P5|Overall Study|Withdrawal by Subject|3
4816301|NCT01204671|16606488|P4|Overall Study|Withdrawal by Subject|5
4816302|NCT01204671|16606489|P3|Overall Study|Withdrawal by Subject|4
4816303|NCT01204671|16606490|P2|Overall Study|Withdrawal by Subject|3
4816304|NCT01204671|16606491|P1|Overall Study|Withdrawal by Subject|2
4816305|NCT01204671|16606487|P5|Overall Study|Adverse Event|1
4816306|NCT01204671|16606488|P4|Overall Study|Adverse Event|3
4816307|NCT01204671|16606489|P3|Overall Study|Adverse Event|3
4816308|NCT01204671|16606490|P2|Overall Study|Adverse Event|3
4816309|NCT01204671|16606491|P1|Overall Study|Adverse Event|4
4816310|NCT01204658|16606553|P4|Primary Phase|Adverse Event|0
4816311|NCT01204658|16606554|P3|Primary Phase|Adverse Event|1
4816312|NCT01204658|16606555|P2|Primary Phase|Adverse Event|0
4816313|NCT01204658|16606556|P1|Primary Phase|Adverse Event|0
4816314|NCT01204398|16606674|P1|Overall Study|Adverse Event|1
4816315|NCT01204294|16606691|P7|Overall Study|Other (house moving)|0
4816316|NCT01204294|16606692|P6|Overall Study|Other (house moving)|0
4816317|NCT01204294|16606693|P5|Overall Study|Other (house moving)|0
4816318|NCT01204294|16606694|P4|Overall Study|Other (house moving)|0
4816319|NCT01204294|16606695|P3|Overall Study|Other (house moving)|1
4816320|NCT01204294|16606696|P2|Overall Study|Other (house moving)|0
4816321|NCT01204294|16606697|P1|Overall Study|Other (house moving)|0
4816322|NCT01204294|16606691|P7|Overall Study|Lack of Efficacy|0
4816323|NCT01204294|16606692|P6|Overall Study|Lack of Efficacy|0
4816324|NCT01204294|16606693|P5|Overall Study|Lack of Efficacy|0
4816325|NCT01204294|16606694|P4|Overall Study|Lack of Efficacy|2
4816326|NCT01204294|16606695|P3|Overall Study|Lack of Efficacy|0
4816327|NCT01204294|16606696|P2|Overall Study|Lack of Efficacy|0
4816328|NCT01204294|16606697|P1|Overall Study|Lack of Efficacy|0
4816329|NCT01204294|16606691|P7|Overall Study|Withdrawal by Subject|2
4816330|NCT01204294|16606692|P6|Overall Study|Withdrawal by Subject|1
4816331|NCT01204294|16606693|P5|Overall Study|Withdrawal by Subject|1
4816332|NCT01204294|16606694|P4|Overall Study|Withdrawal by Subject|1
4816333|NCT01204294|16606695|P3|Overall Study|Withdrawal by Subject|2
4816334|NCT01204294|16606696|P2|Overall Study|Withdrawal by Subject|2
4816335|NCT01204294|16606697|P1|Overall Study|Withdrawal by Subject|0
4816336|NCT01204294|16606691|P7|Overall Study|Protocol Violation|0
4816337|NCT01204294|16606692|P6|Overall Study|Protocol Violation|0
4816338|NCT01204294|16606693|P5|Overall Study|Protocol Violation|0
4816339|NCT01204294|16606694|P4|Overall Study|Protocol Violation|1
4816340|NCT01204294|16606695|P3|Overall Study|Protocol Violation|2
4816341|NCT01204294|16606696|P2|Overall Study|Protocol Violation|0
4816342|NCT01204294|16606697|P1|Overall Study|Protocol Violation|1
4816343|NCT01204294|16606691|P7|Overall Study|Adverse Event|0
4816344|NCT01204294|16606692|P6|Overall Study|Adverse Event|4
4816345|NCT01204294|16606693|P5|Overall Study|Adverse Event|1
4816346|NCT01204294|16606694|P4|Overall Study|Adverse Event|7
4816347|NCT01204294|16606695|P3|Overall Study|Adverse Event|0
4816348|NCT01204294|16606696|P2|Overall Study|Adverse Event|6
4816349|NCT01204294|16606697|P1|Overall Study|Adverse Event|2
4816350|NCT01203956|16606731|P2|Second Two-week Period|Non-compliant: no evaluable results|6
4816351|NCT01203956|16606732|P1|Second Two-week Period|Non-compliant: no evaluable results|5
4816352|NCT01203930|16606741|P2|Overall Study|Adverse Event|5
4816353|NCT01203930|16606742|P1|Overall Study|Adverse Event|17
4816354|NCT01203930|16606741|P2|Overall Study|Poor tolerance of study drug|1
4816355|NCT01203930|16606742|P1|Overall Study|Poor tolerance of study drug|0
4816356|NCT01203930|16606741|P2|Overall Study|Study Terminated by Sponsor|12
4816357|NCT01203930|16606742|P1|Overall Study|Study Terminated by Sponsor|0
4816358|NCT01203930|16606741|P2|Overall Study|Investigator Request|8
4816359|NCT01203930|16606742|P1|Overall Study|Investigator Request|0
4816360|NCT01203930|16606741|P2|Overall Study|Withdrew Consent|10
4816361|NCT01203930|16606742|P1|Overall Study|Withdrew Consent|1
4816362|NCT01203930|16606741|P2|Overall Study|Death|1
4816363|NCT01203930|16606742|P1|Overall Study|Death|3
4816364|NCT01203930|16606741|P2|Overall Study|Disease Progression|4
4816365|NCT01203930|16606742|P1|Overall Study|Disease Progression|0
4816366|NCT01203917|16606764|P1|Overall Study|Due to EGFR M+I patient|1
4816367|NCT01203917|16606764|P1|Overall Study|Due to objective disease progression|1
4816368|NCT01203917|16606764|P1|Overall Study|Withdrawal by Subject|3
4816369|NCT01203917|16606764|P1|Overall Study|Lost to Follow-up|2
4816370|NCT01203917|16606764|P1|Overall Study|Death|29
4816371|NCT01203878|16606777|P3|Overall Study|Adverse Event|2
4816372|NCT01203878|16606778|P2|Overall Study|Adverse Event|0
4816373|NCT01203878|16606779|P1|Overall Study|Adverse Event|0
4816374|NCT01203878|16606777|P3|Overall Study|Withdrawal by Subject|1
4816375|NCT01203878|16606778|P2|Overall Study|Withdrawal by Subject|0
4816376|NCT01203878|16606779|P1|Overall Study|Withdrawal by Subject|0
4816377|NCT01203852|16606790|P1|Washout 2 Weeks|Physician Decision|46
4816378|NCT01203852|16606790|P1|Metoprolol 8 Weeks|Physician Decision|470
4816379|NCT01203787|16606808|P2|Overall Study|Adverse Event|15
4816380|NCT01203787|16606809|P1|Overall Study|Adverse Event|11
4816381|NCT01203787|16606808|P2|Overall Study|Lost to Follow-up|0
4816382|NCT01203787|16606809|P1|Overall Study|Lost to Follow-up|2
4816383|NCT01203787|16606808|P2|Overall Study|Withdrawal by Subject|2
4816384|NCT01203787|16606809|P1|Overall Study|Withdrawal by Subject|6
4816385|NCT01203787|16606808|P2|Overall Study|Death|10
4816386|NCT01203787|16606809|P1|Overall Study|Death|12
4816387|NCT01203098|16606880|P3|Overall Study|Withdrawal by Subject|3
4816388|NCT01203098|16606881|P2|Overall Study|Withdrawal by Subject|1
4816389|NCT01203098|16606882|P1|Overall Study|Withdrawal by Subject|1
4816390|NCT01203098|16606880|P3|Overall Study|Physician Decision|0
4816391|NCT01203098|16606881|P2|Overall Study|Physician Decision|2
4816392|NCT01203098|16606882|P1|Overall Study|Physician Decision|2
4816393|NCT01203098|16606880|P3|Overall Study|Lost to Follow-up|1
4816394|NCT01203098|16606881|P2|Overall Study|Lost to Follow-up|0
4816395|NCT01203098|16606882|P1|Overall Study|Lost to Follow-up|0
4816396|NCT01203098|16606880|P3|Overall Study|Adverse Event|7
4816397|NCT01203098|16606881|P2|Overall Study|Adverse Event|1
4816398|NCT01203098|16606882|P1|Overall Study|Adverse Event|3
4816399|NCT01203072|16606898|P5|Overall Study|Withdrawal by Subject|3
4816400|NCT01203072|16606899|P4|Overall Study|Withdrawal by Subject|2
4816401|NCT01203072|16606900|P3|Overall Study|Withdrawal by Subject|1
4816402|NCT01203072|16606901|P2|Overall Study|Withdrawal by Subject|2
4816403|NCT01203072|16606902|P1|Overall Study|Withdrawal by Subject|2
4816404|NCT01203072|16606898|P5|Overall Study|Protocol Violation|1
4816405|NCT01203072|16606899|P4|Overall Study|Protocol Violation|0
4816406|NCT01203072|16606900|P3|Overall Study|Protocol Violation|0
4816407|NCT01203072|16606901|P2|Overall Study|Protocol Violation|0
4816408|NCT01203072|16606902|P1|Overall Study|Protocol Violation|2
4816409|NCT01203072|16606898|P5|Overall Study|Lost to Follow-up|0
4816410|NCT01203072|16606899|P4|Overall Study|Lost to Follow-up|0
4816411|NCT01203072|16606900|P3|Overall Study|Lost to Follow-up|0
4816412|NCT01203072|16606901|P2|Overall Study|Lost to Follow-up|1
4816413|NCT01203072|16606902|P1|Overall Study|Lost to Follow-up|0
4816414|NCT01203072|16606898|P5|Overall Study|Lack of Efficacy|0
4816415|NCT01203072|16606899|P4|Overall Study|Lack of Efficacy|0
4816416|NCT01203072|16606900|P3|Overall Study|Lack of Efficacy|0
4816417|NCT01203072|16606901|P2|Overall Study|Lack of Efficacy|0
4816418|NCT01203072|16606902|P1|Overall Study|Lack of Efficacy|1
4816419|NCT01203072|16606898|P5|Overall Study|Adverse Event|2
4816420|NCT01203072|16606899|P4|Overall Study|Adverse Event|4
4816421|NCT01203072|16606900|P3|Overall Study|Adverse Event|2
4816422|NCT01203072|16606901|P2|Overall Study|Adverse Event|3
4816423|NCT01203072|16606902|P1|Overall Study|Adverse Event|5
4816424|NCT01202955|16606937|P2|Period 1: 10 Days|Withdrawal by Subject|2
4816425|NCT01202955|16606938|P1|Period 1: 10 Days|Withdrawal by Subject|0
4816426|NCT01202903|16606950|P2|Overall Study|Withdrawal by Subject|4
4816427|NCT01202903|16606951|P1|Overall Study|Withdrawal by Subject|4
4816428|NCT01202903|16606950|P2|Overall Study|Adverse Event|3
4816429|NCT01202903|16606951|P1|Overall Study|Adverse Event|3
4816430|NCT01202903|16606950|P2|Overall Study|Lack of Efficacy|3
4816431|NCT01202903|16606951|P1|Overall Study|Lack of Efficacy|1
4816432|NCT01202903|16606950|P2|Overall Study|Lost to Follow-up|1
4816433|NCT01202903|16606951|P1|Overall Study|Lost to Follow-up|1
4816434|NCT01202903|16606950|P2|Overall Study|Death|0
4816435|NCT01202903|16606951|P1|Overall Study|Death|1
4816436|NCT01202903|16606950|P2|Overall Study|Protocol Violation|1
4816437|NCT01202903|16606951|P1|Overall Study|Protocol Violation|0
4816438|NCT01202903|16606950|P2|Overall Study|Administrative Probelms|4
4816439|NCT01202903|16606951|P1|Overall Study|Administrative Probelms|1
4816440|NCT01202877|16606978|P3|Overall Study|Death|1
4816441|NCT01202877|16606979|P2|Overall Study|Death|0
4816442|NCT01202877|16606980|P1|Overall Study|Death|0
4816443|NCT01202877|16606978|P3|Overall Study|Withdrawal by Subject|1
4816444|NCT01202877|16606979|P2|Overall Study|Withdrawal by Subject|0
4816445|NCT01202877|16606980|P1|Overall Study|Withdrawal by Subject|0
4816446|NCT01202877|16606978|P3|Overall Study|Adverse Event|2
4816447|NCT01202877|16606979|P2|Overall Study|Adverse Event|0
4816448|NCT01202877|16606980|P1|Overall Study|Adverse Event|0
4816449|NCT01202877|16606978|P3|Overall Study|Disease Progression|2
4816450|NCT01202877|16606979|P2|Overall Study|Disease Progression|1
4816451|NCT01202877|16606980|P1|Overall Study|Disease Progression|0
4816452|NCT01202773|16606994|P3|Overall Study|Sponsor Decision|23
4816453|NCT01202773|16606995|P2|Overall Study|Sponsor Decision|20
4816454|NCT01202773|16606996|P1|Overall Study|Sponsor Decision|19
4816455|NCT01202773|16606994|P3|Overall Study|Protocol Violation|10
4816456|NCT01202773|16606995|P2|Overall Study|Protocol Violation|6
4816457|NCT01202773|16606996|P1|Overall Study|Protocol Violation|11
4816458|NCT01202773|16606994|P3|Overall Study|Physician Decision|0
4816459|NCT01202773|16606995|P2|Overall Study|Physician Decision|0
4816460|NCT01202773|16606996|P1|Overall Study|Physician Decision|2
4816461|NCT01202773|16606994|P3|Overall Study|Withdrawal by Subject|5
4816462|NCT01202773|16606995|P2|Overall Study|Withdrawal by Subject|6
4816463|NCT01202773|16606996|P1|Overall Study|Withdrawal by Subject|13
4816464|NCT01202773|16606994|P3|Overall Study|Lost to Follow-up|2
4816465|NCT01202773|16606995|P2|Overall Study|Lost to Follow-up|2
4816466|NCT01202773|16606996|P1|Overall Study|Lost to Follow-up|1
4816467|NCT01202773|16606994|P3|Overall Study|Entry Criteria Not Met|1
4816468|NCT01202773|16606995|P2|Overall Study|Entry Criteria Not Met|0
4816469|NCT01202773|16606996|P1|Overall Study|Entry Criteria Not Met|2
4816470|NCT01202773|16606994|P3|Overall Study|Lack of Efficacy|9
4816471|NCT01202773|16606995|P2|Overall Study|Lack of Efficacy|4
4816472|NCT01202773|16606996|P1|Overall Study|Lack of Efficacy|5
4816473|NCT01202773|16606994|P3|Overall Study|Adverse Event|5
4816474|NCT01202773|16606995|P2|Overall Study|Adverse Event|5
4816475|NCT01202773|16606996|P1|Overall Study|Adverse Event|4
4816476|NCT01202760|16607073|P3|Overall Study|Sponsor Decision|0
4816477|NCT01202760|16607074|P2|Overall Study|Sponsor Decision|4
4816478|NCT01202760|16607075|P1|Overall Study|Sponsor Decision|4
4816479|NCT01202760|16607073|P3|Overall Study|Protocol Violation|2
4816480|NCT01202760|16607074|P2|Overall Study|Protocol Violation|5
4816481|NCT01202760|16607075|P1|Overall Study|Protocol Violation|7
4816482|NCT01202760|16607073|P3|Overall Study|Physician Decision|0
4816483|NCT01202760|16607074|P2|Overall Study|Physician Decision|1
4816484|NCT01202760|16607075|P1|Overall Study|Physician Decision|0
4816485|NCT01202760|16607073|P3|Overall Study|Withdrawal by Subject|14
4816486|NCT01202760|16607074|P2|Overall Study|Withdrawal by Subject|18
4816487|NCT01202760|16607075|P1|Overall Study|Withdrawal by Subject|17
4816488|NCT01202760|16607073|P3|Overall Study|Parent / Caregiver Decision|0
4816489|NCT01202760|16607074|P2|Overall Study|Parent / Caregiver Decision|1
4816490|NCT01202760|16607075|P1|Overall Study|Parent / Caregiver Decision|0
4816491|NCT01202760|16607073|P3|Overall Study|Lost to Follow-up|1
4816492|NCT01202760|16607074|P2|Overall Study|Lost to Follow-up|2
4816493|NCT01202760|16607075|P1|Overall Study|Lost to Follow-up|0
4816494|NCT01202760|16607073|P3|Overall Study|Lack of Efficacy|7
4816495|NCT01202760|16607074|P2|Overall Study|Lack of Efficacy|8
4816496|NCT01202760|16607075|P1|Overall Study|Lack of Efficacy|6
4816497|NCT01202760|16607073|P3|Overall Study|Death|0
4816498|NCT01202760|16607074|P2|Overall Study|Death|1
4816499|NCT01202760|16607075|P1|Overall Study|Death|2
4816500|NCT01202760|16607073|P3|Overall Study|Adverse Event|10
4816501|NCT01202760|16607074|P2|Overall Study|Adverse Event|9
4816502|NCT01202760|16607075|P1|Overall Study|Adverse Event|11
4816503|NCT01202760|16607073|P3|Overall Study|Entry Criteria Not Met|1
4816504|NCT01202760|16607074|P2|Overall Study|Entry Criteria Not Met|3
4816505|NCT01202760|16607075|P1|Overall Study|Entry Criteria Not Met|0
4816506|NCT01202747|16607143|P1|Overall Study|Withdrawal by Subject|1
4816507|NCT01202591|16607196|P6|Overall Study|Objective Disease Progression|0
4816508|NCT01202591|16607197|P5|Overall Study|Objective Disease Progression|2
4816509|NCT01202591|16607198|P4|Overall Study|Objective Disease Progression|0
4816510|NCT01202591|16607199|P3|Overall Study|Objective Disease Progression|0
4816511|NCT01202591|16607200|P2|Overall Study|Objective Disease Progression|0
4816512|NCT01202591|16607201|P1|Overall Study|Objective Disease Progression|0
4816513|NCT01202591|16607196|P6|Overall Study|Withdrawal by Subject|1
4816514|NCT01202591|16607197|P5|Overall Study|Withdrawal by Subject|2
4816515|NCT01202591|16607198|P4|Overall Study|Withdrawal by Subject|0
4816516|NCT01202591|16607199|P3|Overall Study|Withdrawal by Subject|0
4816517|NCT01202591|16607200|P2|Overall Study|Withdrawal by Subject|0
4816518|NCT01202591|16607201|P1|Overall Study|Withdrawal by Subject|0
4816519|NCT01202591|16607196|P6|Overall Study|Other reason as per investigator|3
4816520|NCT01202591|16607197|P5|Overall Study|Other reason as per investigator|1
4816521|NCT01202591|16607198|P4|Overall Study|Other reason as per investigator|3
4816522|NCT01202591|16607199|P3|Overall Study|Other reason as per investigator|7
4816523|NCT01202591|16607200|P2|Overall Study|Other reason as per investigator|4
4816524|NCT01202591|16607201|P1|Overall Study|Other reason as per investigator|3
4816525|NCT01202591|16607196|P6|Overall Study|Adverse Event|0
4816526|NCT01202591|16607197|P5|Overall Study|Adverse Event|0
4816527|NCT01202591|16607198|P4|Overall Study|Adverse Event|4
4816528|NCT01202591|16607199|P3|Overall Study|Adverse Event|4
4816529|NCT01202591|16607200|P2|Overall Study|Adverse Event|1
4816530|NCT01202591|16607201|P1|Overall Study|Adverse Event|2
4816531|NCT01202409|16607245|P1|Overall Study|Ineligible - KRAS mutants|7
4816532|NCT01202409|16607245|P1|Overall Study|Adverse Event|1
4816533|NCT01202279|16607252|P2|Overall Study|study compliance|2
4816534|NCT01202279|16607253|P1|Overall Study|study compliance|5
4816535|NCT01202279|16607252|P2|Overall Study|Protocol Violation|1
4816536|NCT01202279|16607253|P1|Overall Study|Protocol Violation|1
4816537|NCT01202279|16607252|P2|Overall Study|Lost to Follow-up|7
4816538|NCT01202279|16607253|P1|Overall Study|Lost to Follow-up|10
4816539|NCT01202279|16607252|P2|Overall Study|Physician Decision|1
4816540|NCT01202279|16607253|P1|Overall Study|Physician Decision|0
4816541|NCT01202279|16607252|P2|Overall Study|Withdrawal by Subject|10
4816542|NCT01202279|16607253|P1|Overall Study|Withdrawal by Subject|13
4816543|NCT01202279|16607252|P2|Overall Study|Adverse Event|6
4816544|NCT01202279|16607253|P1|Overall Study|Adverse Event|8
4816545|NCT01202227|16607305|P1|Overall Study|Lack of Efficacy|1
4816546|NCT01202227|16607305|P1|Overall Study|Withdrawal by Subject|2
4816547|NCT01202227|16607305|P1|Overall Study|Adverse Event|16
4816548|NCT01202188|16607329|P5|Overall Study|Abnormal test procedure result (s)|0
4816549|NCT01202188|16607330|P4|Overall Study|Abnormal test procedure result (s)|0
4816550|NCT01202188|16607331|P3|Overall Study|Abnormal test procedure result (s)|2
4816551|NCT01202188|16607332|P2|Overall Study|Abnormal test procedure result (s)|0
4816552|NCT01202188|16607333|P1|Overall Study|Abnormal test procedure result (s)|0
4816553|NCT01202188|16607329|P5|Overall Study|Death|0
4816554|NCT01202188|16607330|P4|Overall Study|Death|1
4816555|NCT01202188|16607331|P3|Overall Study|Death|1
4816556|NCT01202188|16607332|P2|Overall Study|Death|1
4816557|NCT01202188|16607333|P1|Overall Study|Death|1
4816558|NCT01202188|16607329|P5|Overall Study|Lost to Follow-up|1
4816559|NCT01202188|16607330|P4|Overall Study|Lost to Follow-up|4
4816560|NCT01202188|16607331|P3|Overall Study|Lost to Follow-up|0
4816561|NCT01202188|16607332|P2|Overall Study|Lost to Follow-up|1
4816562|NCT01202188|16607333|P1|Overall Study|Lost to Follow-up|1
4816563|NCT01202188|16607329|P5|Overall Study|Unsatisfactory therapeutic effect|8
4816564|NCT01202188|16607330|P4|Overall Study|Unsatisfactory therapeutic effect|5
4816565|NCT01202188|16607331|P3|Overall Study|Unsatisfactory therapeutic effect|2
4816566|NCT01202188|16607332|P2|Overall Study|Unsatisfactory therapeutic effect|8
4816567|NCT01202188|16607333|P1|Overall Study|Unsatisfactory therapeutic effect|2
4816568|NCT01202188|16607329|P5|Overall Study|Administrative problems|2
4816569|NCT01202188|16607330|P4|Overall Study|Administrative problems|1
4816570|NCT01202188|16607331|P3|Overall Study|Administrative problems|1
4816571|NCT01202188|16607332|P2|Overall Study|Administrative problems|2
4816572|NCT01202188|16607333|P1|Overall Study|Administrative problems|3
4816573|NCT01202188|16607329|P5|Overall Study|Adverse Event|10
4816574|NCT01202188|16607330|P4|Overall Study|Adverse Event|10
4816575|NCT01202188|16607331|P3|Overall Study|Adverse Event|13
4816576|NCT01202188|16607332|P2|Overall Study|Adverse Event|23
4816577|NCT01202188|16607333|P1|Overall Study|Adverse Event|5
4816578|NCT01202188|16607329|P5|Overall Study|Subject withdrew consent|13
4816579|NCT01202188|16607330|P4|Overall Study|Subject withdrew consent|11
4816580|NCT01202188|16607331|P3|Overall Study|Subject withdrew consent|22
4816581|NCT01202188|16607332|P2|Overall Study|Subject withdrew consent|13
4816582|NCT01202188|16607333|P1|Overall Study|Subject withdrew consent|12
4816583|NCT01202188|16607329|P5|Overall Study|Protocol deviation|11
4816584|NCT01202188|16607330|P4|Overall Study|Protocol deviation|10
4816585|NCT01202188|16607331|P3|Overall Study|Protocol deviation|12
4816586|NCT01202188|16607332|P2|Overall Study|Protocol deviation|8
4816587|NCT01202188|16607333|P1|Overall Study|Protocol deviation|14
4816588|NCT01202175|16607441|P1|Overall Study|Adverse Event|2
4816589|NCT01202175|16607441|P1|Overall Study|Withdrawal by Subject|1
4816590|NCT01202175|16607441|P1|Overall Study|Lost to Follow-up|2
4816591|NCT01201967|16607509|P2|Overall Study|Lost to Follow-up|5
4816592|NCT01201967|16607510|P1|Overall Study|Lost to Follow-up|6
4816593|NCT01201915|16607535|P3|Overall Study|Target Lesion Progression|0
4816594|NCT01201915|16607536|P2|Overall Study|Target Lesion Progression|3
4816595|NCT01201915|16607537|P1|Overall Study|Target Lesion Progression|0
4816596|NCT01201915|16607535|P3|Overall Study|Subject Decision|5
4816597|NCT01201915|16607536|P2|Overall Study|Subject Decision|3
4816598|NCT01201915|16607537|P1|Overall Study|Subject Decision|3
4816599|NCT01201915|16607535|P3|Overall Study|Physician Decision|0
4816600|NCT01201915|16607536|P2|Overall Study|Physician Decision|0
4816601|NCT01201915|16607537|P1|Overall Study|Physician Decision|3
4816602|NCT01201915|16607535|P3|Overall Study|Lost to Follow-up|0
4816603|NCT01201915|16607536|P2|Overall Study|Lost to Follow-up|4
4816604|NCT01201915|16607537|P1|Overall Study|Lost to Follow-up|0
4816605|NCT01201915|16607535|P3|Overall Study|Adverse Event|1
4816606|NCT01201915|16607536|P2|Overall Study|Adverse Event|1
4816607|NCT01201915|16607537|P1|Overall Study|Adverse Event|2
4816608|NCT01201811|16607548|P1|Overall Study|Physician Decision|1
4816609|NCT01201811|16607548|P1|Overall Study|Treatment Failure|2
4816610|NCT01201811|16607548|P1|Overall Study|Death|4
4816611|NCT01201811|16607548|P1|Overall Study|Withdrawal by Subject|3
4816612|NCT01201811|16607548|P1|Overall Study|Disease progression|3
4816613|NCT01201811|16607548|P1|Overall Study|Adverse Event|6
4816614|NCT01201798|16607570|P2|Overall Study|Treatment Failure|8
4816615|NCT01201798|16607571|P1|Overall Study|Treatment Failure|1
4816616|NCT01201798|16607570|P2|Overall Study|Protocol Violation|1
4816617|NCT01201798|16607571|P1|Overall Study|Protocol Violation|1
4816618|NCT01201798|16607570|P2|Overall Study|Noncompliance|0
4816619|NCT01201798|16607571|P1|Overall Study|Noncompliance|1
4816620|NCT01201798|16607570|P2|Overall Study|Decision Unrelated to an Adverse Event|1
4816621|NCT01201798|16607571|P1|Overall Study|Decision Unrelated to an Adverse Event|1
4816622|NCT01201798|16607570|P2|Overall Study|Lost to Follow-up|5
4816623|NCT01201798|16607571|P1|Overall Study|Lost to Follow-up|3
4816624|NCT01201798|16607570|P2|Overall Study|Adverse Event|0
4816625|NCT01201798|16607571|P1|Overall Study|Adverse Event|2
4816626|NCT01201785|16607595|P1|Overall Study|Lost to Follow-up|16
4816627|NCT01201759|16607612|P2|Visit 4 Crossover|Lost to Follow-up|1
4816628|NCT01201759|16607613|P1|Visit 4 Crossover|Lost to Follow-up|0
4816629|NCT01201759|16607612|P2|Visit 3 - Washout|Lost to Follow-up|0
4816630|NCT01201759|16607613|P1|Visit 3 - Washout|Lost to Follow-up|1
4816631|NCT01201759|16607612|P2|Visit 3 - Washout|Adverse Event|3
4816632|NCT01201759|16607613|P1|Visit 3 - Washout|Adverse Event|0
4816633|NCT01201759|16607612|P2|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1
4816634|NCT01201759|16607613|P1|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2
4816635|NCT01201356|16607642|P1|Overall Study|Protocol Violation|12
4816636|NCT01201356|16607642|P1|Overall Study|Death|16
4816637|NCT01201356|16607642|P1|Overall Study|administrative problems|74
4816638|NCT01201356|16607642|P1|Overall Study|Lost to Follow-up|50
4816639|NCT01201356|16607642|P1|Overall Study|Withdrawal by Subject|144
4816640|NCT01201356|16607642|P1|Overall Study|Condition no longer requires study drug|12
4816641|NCT01201356|16607642|P1|Overall Study|Unsatisfactory therapeutic effect|112
4816642|NCT01201356|16607642|P1|Overall Study|Abnormal test procedure result(s)|3
4816643|NCT01201356|16607642|P1|Overall Study|Abnormal laboratory value(s)|51
4816644|NCT01201356|16607642|P1|Overall Study|Adverse Event|170
4816645|NCT01201343|16607656|P1|Overall Study|Randomized, not treated|3
4816646|NCT01201343|16607656|P1|Overall Study|Participant wrongly included in trial|1
4816647|NCT01201343|16607656|P1|Overall Study|Lack of Efficacy|2
4816648|NCT01201343|16607656|P1|Overall Study|Lost to Follow-up|2
4816649|NCT01201343|16607656|P1|Overall Study|Withdrawal by Subject|5
4816650|NCT01201343|16607656|P1|Overall Study|Adverse Event|6
4816651|NCT01201317|16607670|P3|Overall Study|Safety, possible history of tuberculosis|1
4816652|NCT01201317|16607671|P2|Overall Study|Safety, possible history of tuberculosis|0
4816653|NCT01201317|16607672|P1|Overall Study|Safety, possible history of tuberculosis|0
4816654|NCT01201317|16607670|P3|Overall Study|Lack of Efficacy|0
4816655|NCT01201317|16607671|P2|Overall Study|Lack of Efficacy|0
4816656|NCT01201317|16607672|P1|Overall Study|Lack of Efficacy|1
4816657|NCT01201317|16607670|P3|Overall Study|Decrease in renal function|0
4816658|NCT01201317|16607671|P2|Overall Study|Decrease in renal function|1
4816659|NCT01201317|16607672|P1|Overall Study|Decrease in renal function|0
4816660|NCT01201317|16607670|P3|Overall Study|Painful Diabetic Neuropathy worsening|0
4816661|NCT01201317|16607671|P2|Overall Study|Painful Diabetic Neuropathy worsening|1
4816662|NCT01201317|16607672|P1|Overall Study|Painful Diabetic Neuropathy worsening|0
4816663|NCT01201317|16607670|P3|Overall Study|Study-specific withdrawal criteria|1
4816664|NCT01201317|16607671|P2|Overall Study|Study-specific withdrawal criteria|0
4816665|NCT01201317|16607672|P1|Overall Study|Study-specific withdrawal criteria|0
4816666|NCT01201317|16607670|P3|Overall Study|Death|0
4816667|NCT01201317|16607671|P2|Overall Study|Death|1
4816668|NCT01201317|16607672|P1|Overall Study|Death|0
4816669|NCT01201317|16607670|P3|Overall Study|Protocol Violation|1
4816670|NCT01201317|16607671|P2|Overall Study|Protocol Violation|1
4816671|NCT01201317|16607672|P1|Overall Study|Protocol Violation|0
4816672|NCT01201317|16607670|P3|Overall Study|Screen failure|0
4816673|NCT01201317|16607671|P2|Overall Study|Screen failure|1
4816674|NCT01201317|16607672|P1|Overall Study|Screen failure|1
4816675|NCT01201317|16607670|P3|Overall Study|Adverse Event|2
4816676|NCT01201317|16607671|P2|Overall Study|Adverse Event|2
4816677|NCT01201317|16607672|P1|Overall Study|Adverse Event|2
4816678|NCT01201317|16607670|P3|Overall Study|Withdrawal by Subject|3
4816679|NCT01201317|16607671|P2|Overall Study|Withdrawal by Subject|0
4816680|NCT01201317|16607672|P1|Overall Study|Withdrawal by Subject|5
4816681|NCT01201265|16607692|P1|Overall Study|Disease Progression|4
4816682|NCT01201265|16607692|P1|Overall Study|Withdrawal by Subject|7
4816683|NCT01201265|16607692|P1|Overall Study|Lost to Follow-up|10
4816684|NCT01201265|16607692|P1|Overall Study|Insufficient Therapeutic Response|3
4816685|NCT01201265|16607692|P1|Overall Study|Death|14
4816686|NCT01200992|16607739|P2|Overall Study|Randomized but not treated|0
4816687|NCT01200992|16607740|P1|Overall Study|Randomized but not treated|2
4816688|NCT01200992|16607739|P2|Overall Study|Study terminated early|41
4816689|NCT01200992|16607740|P1|Overall Study|Study terminated early|35
4816690|NCT01200810|16607771|P2|Overall Study|Sponsor stopped making study drug|3
4816691|NCT01200810|16607772|P1|Overall Study|Sponsor stopped making study drug|3
4816692|NCT01200810|16607771|P2|Overall Study|Withdrawal by Subject|2
4816693|NCT01200810|16607772|P1|Overall Study|Withdrawal by Subject|1
4816694|NCT01200810|16607771|P2|Overall Study|Physician Decision|0
4816695|NCT01200810|16607772|P1|Overall Study|Physician Decision|1
4816696|NCT01200797|16607792|P1|Overall Study|Disease Progression|13
4816697|NCT01200797|16607792|P1|Overall Study|Adverse Event|4
4816698|NCT01200797|16607792|P1|Overall Study|symptomatic deterioration|2
4816699|NCT01200758|16607802|P4|Stage 2|Death|5
4816700|NCT01200758|16607803|P3|Stage 2|Death|3
4816701|NCT01200758|16607804|P2|Stage 2|Death|0
4816702|NCT01200758|16607805|P1|Stage 2|Death|0
4816703|NCT01200758|16607802|P4|Stage 2|Protocol Violation|4
4816704|NCT01200758|16607803|P3|Stage 2|Protocol Violation|1
4816705|NCT01200758|16607804|P2|Stage 2|Protocol Violation|0
4816706|NCT01200758|16607805|P1|Stage 2|Protocol Violation|0
4816707|NCT01200758|16607802|P4|Stage 2|Lost to Follow-up|1
4816708|NCT01200758|16607803|P3|Stage 2|Lost to Follow-up|3
4816709|NCT01200758|16607804|P2|Stage 2|Lost to Follow-up|0
4816710|NCT01200758|16607805|P1|Stage 2|Lost to Follow-up|0
4816711|NCT01200758|16607802|P4|Stage 2|Withdrawal by Subject|1
4816712|NCT01200758|16607803|P3|Stage 2|Withdrawal by Subject|4
4816713|NCT01200758|16607804|P2|Stage 2|Withdrawal by Subject|0
4816714|NCT01200758|16607805|P1|Stage 2|Withdrawal by Subject|0
4816715|NCT01200758|16607802|P4|Stage 2|Adverse Event|9
4816716|NCT01200758|16607803|P3|Stage 2|Adverse Event|5
4816717|NCT01200758|16607804|P2|Stage 2|Adverse Event|0
4816718|NCT01200758|16607805|P1|Stage 2|Adverse Event|0
4816719|NCT01200758|16607802|P4|Stage 2|Physician Decision|7
4816720|NCT01200758|16607803|P3|Stage 2|Physician Decision|5
4816721|NCT01200758|16607804|P2|Stage 2|Physician Decision|0
4816722|NCT01200758|16607805|P1|Stage 2|Physician Decision|0
4816723|NCT01200758|16607802|P4|Stage 2|Lack of Efficacy|2
4816724|NCT01200758|16607803|P3|Stage 2|Lack of Efficacy|4
4816725|NCT01200758|16607804|P2|Stage 2|Lack of Efficacy|0
4816726|NCT01200758|16607805|P1|Stage 2|Lack of Efficacy|0
4816727|NCT01200758|16607802|P4|Stage 2|Disease Progression|21
4816728|NCT01200758|16607803|P3|Stage 2|Disease Progression|16
4816729|NCT01200758|16607804|P2|Stage 2|Disease Progression|0
4816730|NCT01200758|16607805|P1|Stage 2|Disease Progression|0
4816731|NCT01200758|16607802|P4|Stage I|Disease Progression|0
4816732|NCT01200758|16607803|P3|Stage I|Disease Progression|0
4816733|NCT01200758|16607804|P2|Stage I|Disease Progression|7
4816734|NCT01200758|16607805|P1|Stage I|Disease Progression|9
4816735|NCT01200758|16607802|P4|Stage I|Withdrawal by Subject|0
4816736|NCT01200758|16607803|P3|Stage I|Withdrawal by Subject|0
4816737|NCT01200758|16607804|P2|Stage I|Withdrawal by Subject|2
4816738|NCT01200758|16607805|P1|Stage I|Withdrawal by Subject|1
4816739|NCT01200758|16607802|P4|Stage I|Adverse Event|0
4816740|NCT01200758|16607803|P3|Stage I|Adverse Event|0
4816741|NCT01200758|16607804|P2|Stage I|Adverse Event|5
4816742|NCT01200758|16607805|P1|Stage I|Adverse Event|5
4816743|NCT01200758|16607802|P4|Stage I|Lack of Efficacy|0
4816744|NCT01200758|16607803|P3|Stage I|Lack of Efficacy|0
4816745|NCT01200758|16607804|P2|Stage I|Lack of Efficacy|1
4816746|NCT01200758|16607805|P1|Stage I|Lack of Efficacy|2
4816747|NCT01200758|16607802|P4|Stage I|Physician Decision|0
4816748|NCT01200758|16607803|P3|Stage I|Physician Decision|0
4816749|NCT01200758|16607804|P2|Stage I|Physician Decision|1
4816750|NCT01200758|16607805|P1|Stage I|Physician Decision|1
4816751|NCT01200758|16607802|P4|Stage I|Death|0
4816752|NCT01200758|16607803|P3|Stage I|Death|0
4816753|NCT01200758|16607804|P2|Stage I|Death|1
4816754|NCT01200758|16607805|P1|Stage I|Death|0
4816755|NCT01200589|16607878|P2|Overall Study|Study terminated|172
4816756|NCT01200589|16607879|P1|Overall Study|Study terminated|170
4816757|NCT01200589|16607878|P2|Overall Study|Lost to Follow-up|4
4816758|NCT01200589|16607879|P1|Overall Study|Lost to Follow-up|5
4816759|NCT01200589|16607878|P2|Overall Study|Physician Decision|2
4816760|NCT01200589|16607879|P1|Overall Study|Physician Decision|2
4816761|NCT01200589|16607878|P2|Overall Study|Withdrawal by Subject|11
4816762|NCT01200589|16607879|P1|Overall Study|Withdrawal by Subject|13
4816763|NCT01200524|16607906|P3|Overall Study|Non availability of study nurse|1
4816764|NCT01200524|16607907|P2|Overall Study|Non availability of study nurse|0
4816765|NCT01200524|16607908|P1|Overall Study|Non availability of study nurse|0
4816766|NCT01200524|16607906|P3|Overall Study|Adverse Event|0
4816767|NCT01200524|16607907|P2|Overall Study|Adverse Event|0
4816768|NCT01200524|16607908|P1|Overall Study|Adverse Event|1
4816769|NCT01200524|16607906|P3|Overall Study|Withdrawal by Subject|3
4816770|NCT01200524|16607907|P2|Overall Study|Withdrawal by Subject|1
4816771|NCT01200524|16607908|P1|Overall Study|Withdrawal by Subject|1
4816772|NCT01200511|16607928|P1|Overall Study|Adverse Event|1
4816773|NCT01200511|16607928|P1|Overall Study|Withdrawal by Subject|1
4816774|NCT01200511|16607928|P1|Overall Study|Lost to Follow-up|3
4816775|NCT01200485|16607940|P3|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
4816776|NCT01200485|16607941|P2|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0
4816777|NCT01200485|16607942|P1|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2
4816778|NCT01200485|16607940|P3|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
4816779|NCT01200485|16607941|P2|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0
4816780|NCT01200485|16607942|P1|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1
4816781|NCT01200394|16607976|P2|Overall Study|Other|1
4816782|NCT01200394|16607977|P1|Overall Study|Other|0
4816783|NCT01200394|16607976|P2|Overall Study|Withdrawal by Subject|5
4816784|NCT01200394|16607977|P1|Overall Study|Withdrawal by Subject|0
4816785|NCT01200394|16607976|P2|Overall Study|Protocol Violation|3
4816786|NCT01200394|16607977|P1|Overall Study|Protocol Violation|0
4816787|NCT01200394|16607976|P2|Overall Study|Did Not Meet Entrance Criteria|4
4816788|NCT01200394|16607977|P1|Overall Study|Did Not Meet Entrance Criteria|1
4816789|NCT01200394|16607976|P2|Overall Study|Lost to Follow-up|1
4816790|NCT01200394|16607977|P1|Overall Study|Lost to Follow-up|0
4816791|NCT01200394|16607976|P2|Overall Study|Death|0
4816792|NCT01200394|16607977|P1|Overall Study|Death|1
4816793|NCT01200394|16607976|P2|Overall Study|Adverse Event|14
4816794|NCT01200394|16607977|P1|Overall Study|Adverse Event|0
4816795|NCT01200368|16608015|P3|Toddler Dose|Adverse Event|1
4816796|NCT01200368|16608016|P2|Toddler Dose|Adverse Event|3
4816797|NCT01200368|16608017|P1|Toddler Dose|Adverse Event|0
4816798|NCT01200368|16608015|P3|After Infant Series|Other|2
4816799|NCT01200368|16608016|P2|After Infant Series|Other|2
4816800|NCT01200368|16608017|P1|After Infant Series|Other|1
4816801|NCT01200368|16608015|P3|After Infant Series|Lost to Follow-up|0
4816802|NCT01200368|16608016|P2|After Infant Series|Lost to Follow-up|0
4816803|NCT01200368|16608017|P1|After Infant Series|Lost to Follow-up|1
4816804|NCT01200368|16608015|P3|After Infant Series|Withdrawal by Subject|4
4816805|NCT01200368|16608016|P2|After Infant Series|Withdrawal by Subject|8
4816806|NCT01200368|16608017|P1|After Infant Series|Withdrawal by Subject|10
4816807|NCT01200368|16608015|P3|After Infant Series|Adverse Event|3
4816808|NCT01200368|16608016|P2|After Infant Series|Adverse Event|6
4816809|NCT01200368|16608017|P1|After Infant Series|Adverse Event|6
4816810|NCT01200368|16608015|P3|Infant Series|Other|0
4816811|NCT01200368|16608016|P2|Infant Series|Other|0
4816812|NCT01200368|16608017|P1|Infant Series|Other|1
4816813|NCT01200368|16608015|P3|Infant Series|Randomized, not vaccinated|1
4816814|NCT01200368|16608016|P2|Infant Series|Randomized, not vaccinated|1
4816815|NCT01200368|16608017|P1|Infant Series|Randomized, not vaccinated|0
4816816|NCT01200368|16608015|P3|Infant Series|Did not meet entrance criteria|0
4816817|NCT01200368|16608016|P2|Infant Series|Did not meet entrance criteria|1
4816818|NCT01200368|16608017|P1|Infant Series|Did not meet entrance criteria|0
4816819|NCT01200368|16608015|P3|Infant Series|Withdrawal by Subject|2
4816820|NCT01200368|16608016|P2|Infant Series|Withdrawal by Subject|2
4816821|NCT01200368|16608017|P1|Infant Series|Withdrawal by Subject|0
4816822|NCT01200368|16608015|P3|Infant Series|Adverse Event|3
4816823|NCT01200368|16608016|P2|Infant Series|Adverse Event|2
4816824|NCT01200368|16608017|P1|Infant Series|Adverse Event|2
4816825|NCT01200355|16608083|P2|Overall Study|Death|2
4816826|NCT01200355|16608084|P1|Overall Study|Death|7
4816827|NCT01200342|16608098|P1|Overall Study|Disease Progression|1
4816828|NCT01200329|16608103|P1|Overall Study|Progressive disease|1
4816829|NCT01200329|16608103|P1|Overall Study|Lack of financial coverage|2
4816830|NCT01200290|16608108|P1|Post-Treatment Follow-Up Period|Death|2
4816831|NCT01200290|16608108|P1|Treatment Period|Adverse Event|1
4816832|NCT01200238|16608121|P2|Overall Study|Withdrawal by Subject|1
4816833|NCT01200238|16608122|P1|Overall Study|Withdrawal by Subject|0
4816834|NCT01200238|16608121|P2|Overall Study|Progressive Disease|8
4816835|NCT01200238|16608122|P1|Overall Study|Progressive Disease|5
4816836|NCT01200238|16608121|P2|Overall Study|Adverse Event|1
4816837|NCT01200238|16608122|P1|Overall Study|Adverse Event|2
4816838|NCT01200069|16608146|P2|Overall Study|Withdrawal by Subject|1
4816839|NCT01200069|16608147|P1|Overall Study|Withdrawal by Subject|0
4816840|NCT01199939|16608243|P1|Overall Study|Reached a virologic endpoint|4
4816841|NCT01199939|16608243|P1|Overall Study|Lost to Follow-up|2
4816842|NCT01199939|16608243|P1|Overall Study|Protocol Violation|3
4816843|NCT01199939|16608243|P1|Overall Study|Adverse Event|4
4816844|NCT01199861|16608275|P2|Overall Study|Adverse Event|0
4816845|NCT01199861|16608276|P1|Overall Study|Adverse Event|1
4816846|NCT01199861|16608275|P2|Overall Study|Administrative problems|0
4816847|NCT01199861|16608276|P1|Overall Study|Administrative problems|1
4816848|NCT01199822|16608297|P3|Overall Study|Investigator discontinued therapy|0
4816849|NCT01199822|16608298|P2|Overall Study|Investigator discontinued therapy|1
4816850|NCT01199822|16608299|P1|Overall Study|Investigator discontinued therapy|0
4816851|NCT01199731|16608348|P3|Overall Study|Withdrawal by Subject|0
4816852|NCT01199731|16608349|P2|Overall Study|Withdrawal by Subject|0
4816853|NCT01199731|16608350|P1|Overall Study|Withdrawal by Subject|2
4816854|NCT01199731|16608348|P3|Overall Study|Physician Decision|1
4816855|NCT01199731|16608349|P2|Overall Study|Physician Decision|1
4816856|NCT01199731|16608350|P1|Overall Study|Physician Decision|0
4816857|NCT01199731|16608348|P3|Overall Study|Lost to Follow-up|2
4816858|NCT01199731|16608349|P2|Overall Study|Lost to Follow-up|0
4816859|NCT01199731|16608350|P1|Overall Study|Lost to Follow-up|0
4816860|NCT01199731|16608348|P3|Overall Study|Study closed/terminated|7
4816861|NCT01199731|16608349|P2|Overall Study|Study closed/terminated|9
4816862|NCT01199731|16608350|P1|Overall Study|Study closed/terminated|7
4816863|NCT01199731|16608348|P3|Overall Study|Adverse Event|0
4816864|NCT01199731|16608349|P2|Overall Study|Adverse Event|1
4816865|NCT01199731|16608350|P1|Overall Study|Adverse Event|0
4816866|NCT01199705|16608388|P1|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1
4816867|NCT01199601|16608420|P2|Overall Study|Insecurity prevented staff interviewing.|9
4816868|NCT01199601|16608421|P1|Overall Study|Insecurity prevented staff interviewing.|7
4816869|NCT01199601|16608420|P2|Overall Study|Withdrawal by Subject|3
4816870|NCT01199601|16608421|P1|Overall Study|Withdrawal by Subject|15
4816871|NCT01199601|16608420|P2|Overall Study|Lost to Follow-up|66
4816872|NCT01199601|16608421|P1|Overall Study|Lost to Follow-up|47
4816873|NCT01199575|16608431|P1|Overall Study|Withdrawal by Subject|5
4816874|NCT01199471|16608436|P1|Overall Study|Physician Decision|1
4816875|NCT01199471|16608436|P1|Overall Study|Withdrawal by Subject|1
4816876|NCT01199471|16608436|P1|Overall Study|Protocol Violation|4
4816877|NCT01199263|16608456|P2|Overall Study|Never Treated|0
4816878|NCT01199263|16608457|P1|Overall Study|Never Treated|6
4816879|NCT01199263|16608456|P2|Overall Study|Ineligible|2
4816880|NCT01199263|16608457|P1|Overall Study|Ineligible|0
4816881|NCT01199198|16608490|P2|Overall Study|Hospice-care transfer|2
4816882|NCT01199198|16608491|P1|Overall Study|Hospice-care transfer|1
4816883|NCT01199198|16608490|P2|Overall Study|ICU Transfer|2
4816884|NCT01199198|16608491|P1|Overall Study|ICU Transfer|1
4816885|NCT01199198|16608490|P2|Overall Study|Withdrawal by Subject|2
4816886|NCT01199198|16608491|P1|Overall Study|Withdrawal by Subject|1
4816887|NCT01199198|16608490|P2|Overall Study|Lost to Follow-up|5
4816888|NCT01199198|16608491|P1|Overall Study|Lost to Follow-up|1
4816889|NCT01199198|16608490|P2|Overall Study|Adverse Event|0
4816890|NCT01199198|16608491|P1|Overall Study|Adverse Event|3
4816891|NCT01199068|16608508|P3|Overall Study|Withdrawal by Subject|1
4816892|NCT01199068|16608509|P2|Overall Study|Withdrawal by Subject|0
4816893|NCT01199068|16608510|P1|Overall Study|Withdrawal by Subject|0
4816894|NCT01199068|16608508|P3|Overall Study|Progressive disease|6
4816895|NCT01199068|16608509|P2|Overall Study|Progressive disease|3
4816896|NCT01199068|16608510|P1|Overall Study|Progressive disease|3
4816897|NCT01199068|16608508|P3|Overall Study|Unacceptable toxicity|2
4816898|NCT01199068|16608509|P2|Overall Study|Unacceptable toxicity|0
4816899|NCT01199068|16608510|P1|Overall Study|Unacceptable toxicity|0
4816900|NCT01199055|16608544|P3|Overall Study|Withdrawal by Subject|1
4816901|NCT01199055|16608545|P2|Overall Study|Withdrawal by Subject|0
4816902|NCT01199055|16608546|P1|Overall Study|Withdrawal by Subject|0
4816903|NCT01199055|16608544|P3|Overall Study|Progressive disease|2
4816904|NCT01199055|16608545|P2|Overall Study|Progressive disease|1
4816905|NCT01199055|16608546|P1|Overall Study|Progressive disease|2
4816906|NCT01199055|16608544|P3|Overall Study|Physician Decision|1
4816907|NCT01199055|16608545|P2|Overall Study|Physician Decision|1
4816908|NCT01199055|16608546|P1|Overall Study|Physician Decision|0
4816909|NCT01199055|16608544|P3|Overall Study|Death|0
4816910|NCT01199055|16608545|P2|Overall Study|Death|1
4816911|NCT01199055|16608546|P1|Overall Study|Death|0
4816912|NCT01199042|16608571|P1|At Home (3 Months)|Lost to Follow-up|1
4816913|NCT01199042|16608571|P1|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2
4816914|NCT01199016|16608580|P1|Overall Study|Lost to Follow-up|25
4816915|NCT01199016|16608580|P1|Overall Study|Withdrawal by Subject|21
4816916|NCT01199016|16608580|P1|Overall Study|Other|13
4816917|NCT01199016|16608580|P1|Overall Study|Protocol Violation|9
4816918|NCT01199016|16608580|P1|Overall Study|Entrance criteria|5
4816919|NCT01199016|16608580|P1|Overall Study|No longer meets eligibility criteria|4
4816920|NCT01198977|16608589|P2|Overall Study|Lost to Follow-up|0
4816921|NCT01198977|16608590|P1|Overall Study|Lost to Follow-up|1
4816922|NCT01198873|16608602|P2|Overall Study|Other than above|2
4816923|NCT01198873|16608603|P1|Overall Study|Other than above|4
4816924|NCT01198873|16608602|P2|Overall Study|Study closure|23
4816925|NCT01198873|16608603|P1|Overall Study|Study closure|29
4816926|NCT01198873|16608602|P2|Overall Study|Adverse Event|7
4816927|NCT01198873|16608603|P1|Overall Study|Adverse Event|4
4816928|NCT01198795|16608617|P1|Overall Study|Other Reason|4
4816929|NCT01198795|16608617|P1|Overall Study|Protocol Violation|2
4816930|NCT01198795|16608617|P1|Overall Study|Lack of Efficacy|5
4816931|NCT01198795|16608617|P1|Overall Study|Adverse Event|9
4816932|NCT01198795|16608617|P1|Overall Study|Lost to Follow-up|15
4816933|NCT01198795|16608617|P1|Overall Study|Withdrawal by Subject|17
4816934|NCT01198795|16608617|P1|Overall Study|Did not meet InclusionExclusion criteria|30
4816935|NCT01198756|16608634|P4|Overall Study|Lost to Follow-up|18
4816936|NCT01198756|16608635|P3|Overall Study|Lost to Follow-up|23
4816937|NCT01198756|16608636|P2|Overall Study|Lost to Follow-up|36
4816938|NCT01198756|16608637|P1|Overall Study|Lost to Follow-up|29
4816939|NCT01198756|16608634|P4|Overall Study|Withdrawal by Subject|5
4816940|NCT01198756|16608635|P3|Overall Study|Withdrawal by Subject|7
4816941|NCT01198756|16608636|P2|Overall Study|Withdrawal by Subject|4
4816942|NCT01198756|16608637|P1|Overall Study|Withdrawal by Subject|9
4816943|NCT01198756|16608634|P4|Overall Study|Protocol Violation|2
4816944|NCT01198756|16608635|P3|Overall Study|Protocol Violation|0
4816945|NCT01198756|16608636|P2|Overall Study|Protocol Violation|0
4816946|NCT01198756|16608637|P1|Overall Study|Protocol Violation|0
4816947|NCT01198756|16608634|P4|Overall Study|Adverse Event|1
4816948|NCT01198756|16608635|P3|Overall Study|Adverse Event|0
4816949|NCT01198756|16608636|P2|Overall Study|Adverse Event|0
4816950|NCT01198756|16608637|P1|Overall Study|Adverse Event|0
4816951|NCT01198600|16608748|P4|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
4816952|NCT01198600|16608749|P3|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1
4816953|NCT01198600|16608750|P2|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
4816954|NCT01198600|16608751|P1|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0
4816955|NCT01198600|16608748|P4|Phase 2: 56 Days of Wear|Relocation|0
4816956|NCT01198600|16608749|P3|Phase 2: 56 Days of Wear|Relocation|2
4816957|NCT01198600|16608750|P2|Phase 2: 56 Days of Wear|Relocation|0
4816958|NCT01198600|16608751|P1|Phase 2: 56 Days of Wear|Relocation|0
4816959|NCT01198600|16608748|P4|Phase 2: 56 Days of Wear|Inconvenience|0
4816960|NCT01198600|16608749|P3|Phase 2: 56 Days of Wear|Inconvenience|2
4816961|NCT01198600|16608750|P2|Phase 2: 56 Days of Wear|Inconvenience|0
4816962|NCT01198600|16608751|P1|Phase 2: 56 Days of Wear|Inconvenience|0
4816963|NCT01198600|16608748|P4|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
4816964|NCT01198600|16608749|P3|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
4816965|NCT01198600|16608750|P2|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1
4816966|NCT01198600|16608751|P1|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0
4816967|NCT01198600|16608748|P4|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
4816968|NCT01198600|16608749|P3|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
4816969|NCT01198600|16608750|P2|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1
4816970|NCT01198600|16608751|P1|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0
4816971|NCT01198600|16608748|P4|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
4816972|NCT01198600|16608749|P3|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
4816973|NCT01198600|16608750|P2|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0
4816974|NCT01198600|16608751|P1|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1
4816975|NCT01198600|16608748|P4|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
4816976|NCT01198600|16608749|P3|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
4816977|NCT01198600|16608750|P2|Phase 1: Period One, 30 Days of Wear|Inconvenience|0
4816978|NCT01198600|16608751|P1|Phase 1: Period One, 30 Days of Wear|Inconvenience|1
4816979|NCT01198587|16608777|P4|Overall Study|Lost to Follow-up|0
4816980|NCT01198587|16608778|P3|Overall Study|Lost to Follow-up|9
4816981|NCT01198587|16608779|P2|Overall Study|Lost to Follow-up|0
4816982|NCT01198587|16608780|P1|Overall Study|Lost to Follow-up|8
4816983|NCT01198574|16608802|P4|Overall Study|Resigned from schools|4
4816984|NCT01198574|16608803|P3|Overall Study|Resigned from schools|1
4816985|NCT01198574|16608804|P2|Overall Study|Resigned from schools|1
4816986|NCT01198574|16608805|P1|Overall Study|Resigned from schools|4
4816987|NCT01198548|16608823|P1|Overall Study|Administrative Decision|1
4816988|NCT01198548|16608823|P1|Overall Study|Disease Progression|9
4816989|NCT01198509|16608838|P6|Overall Study|Withdrawal by Subject|0
4816990|NCT01198509|16608839|P5|Overall Study|Withdrawal by Subject|0
4816991|NCT01198509|16608840|P4|Overall Study|Withdrawal by Subject|0
4816992|NCT01198509|16608841|P3|Overall Study|Withdrawal by Subject|0
4816993|NCT01198509|16608842|P2|Overall Study|Withdrawal by Subject|0
4816994|NCT01198509|16608843|P1|Overall Study|Withdrawal by Subject|1
4816995|NCT01198470|16608860|P1|Overall Study|Adverse Event|2
4816996|NCT01198275|16608926|P2|Overall Study|spontaneous return to sinus rhythm|2
4816997|NCT01198275|16608927|P1|Overall Study|spontaneous return to sinus rhythm|4
4816998|NCT01198275|16608926|P2|Overall Study|Adverse Event|3
4816999|NCT01198275|16608927|P1|Overall Study|Adverse Event|2
4817000|NCT01198145|16608950|P2|Overall Study|Withdrawal by Subject|1
4817001|NCT01198145|16608951|P1|Overall Study|Withdrawal by Subject|1
4817002|NCT01198132|16608973|P2|Overall Study|Protocol Violation|0
4817003|NCT01198132|16608974|P1|Overall Study|Protocol Violation|1
4817004|NCT01198132|16608973|P2|Overall Study|Adverse Event|1
4817005|NCT01198132|16608974|P1|Overall Study|Adverse Event|0
4817006|NCT01198132|16608973|P2|Overall Study|Abnormal/clinically significant biologic|1
4817007|NCT01198132|16608974|P1|Overall Study|Abnormal/clinically significant biologic|1
4817008|NCT01198132|16608973|P2|Overall Study|Sign/symptoms of underlying disease|1
4817009|NCT01198132|16608974|P1|Overall Study|Sign/symptoms of underlying disease|2
4817010|NCT01198132|16608973|P2|Overall Study|Lack of Efficacy|3
4817011|NCT01198132|16608974|P1|Overall Study|Lack of Efficacy|2
4817012|NCT01198132|16608973|P2|Overall Study|Other Unspecified|6
4817013|NCT01198132|16608974|P1|Overall Study|Other Unspecified|3
4817014|NCT01198132|16608973|P2|Overall Study|Physician Decision|4
4817015|NCT01198132|16608974|P1|Overall Study|Physician Decision|5
4817016|NCT01198132|16608973|P2|Overall Study|Withdrawal by Subject|5
4817017|NCT01198132|16608974|P1|Overall Study|Withdrawal by Subject|4
4817018|NCT01198028|16608998|P1|Overall Study|Physician Decision|2
4817019|NCT01198028|16608998|P1|Overall Study|Death|3
4817020|NCT01198028|16608998|P1|Overall Study|Adverse Event|5
4817021|NCT01198002|16609010|P3|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75
4817022|NCT01198002|16609011|P2|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70
4817023|NCT01198002|16609012|P1|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62
4817024|NCT01198002|16609010|P3|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
4817025|NCT01198002|16609011|P2|Treatment Period 2 (Weeks 52-100)|Physician Decision|0
4817026|NCT01198002|16609012|P1|Treatment Period 2 (Weeks 52-100)|Physician Decision|1
4817027|NCT01198002|16609010|P3|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
4817028|NCT01198002|16609011|P2|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2
4817029|NCT01198002|16609012|P1|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0
4817030|NCT01198002|16609010|P3|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
4817031|NCT01198002|16609011|P2|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0
4817032|NCT01198002|16609012|P1|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1
4817033|NCT01198002|16609010|P3|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
4817034|NCT01198002|16609011|P2|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1
4817035|NCT01198002|16609012|P1|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3
4817036|NCT01198002|16609010|P3|Treatment Period 2 (Weeks 52-100)|Adverse Event|1
4817037|NCT01198002|16609011|P2|Treatment Period 2 (Weeks 52-100)|Adverse Event|0
4817038|NCT01198002|16609012|P1|Treatment Period 2 (Weeks 52-100)|Adverse Event|2
4817039|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224
4817040|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216
4817041|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213
4817042|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
4817043|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10
4817044|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14
4817045|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
4817046|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Physician Decision|2
4817047|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Physician Decision|1
4817048|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12
4817049|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21
4817050|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16
4817051|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
4817052|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2
4817053|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0
4817054|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
4817055|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3
4817056|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1
4817057|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6
4817058|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9
4817059|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10
4817060|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Death|1
4817061|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Death|0
4817062|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Death|2
4817063|NCT01198002|16609010|P3|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
4817064|NCT01198002|16609011|P2|Treatment Period 1 (Weeks 0-52)|Adverse Event|11
4817065|NCT01198002|16609012|P1|Treatment Period 1 (Weeks 0-52)|Adverse Event|18
4817066|NCT01197911|16609127|P3|Overall Study|Adverse Event|1
4817067|NCT01197911|16609128|P2|Overall Study|Adverse Event|0
4817068|NCT01197911|16609129|P1|Overall Study|Adverse Event|0
4817069|NCT01197794|16609244|P7|Overall Study|Other|4
4817070|NCT01197794|16609245|P6|Overall Study|Other|2
4817071|NCT01197794|16609246|P5|Overall Study|Other|2
4817072|NCT01197794|16609247|P4|Overall Study|Other|0
4817073|NCT01197794|16609248|P3|Overall Study|Other|3
4817074|NCT01197794|16609249|P2|Overall Study|Other|1
4817075|NCT01197794|16609250|P1|Overall Study|Other|1
4817076|NCT01197794|16609244|P7|Overall Study|Lost to Follow-up|0
4817077|NCT01197794|16609245|P6|Overall Study|Lost to Follow-up|1
4817078|NCT01197794|16609246|P5|Overall Study|Lost to Follow-up|0
4817079|NCT01197794|16609247|P4|Overall Study|Lost to Follow-up|1
4817080|NCT01197794|16609248|P3|Overall Study|Lost to Follow-up|0
4817081|NCT01197794|16609249|P2|Overall Study|Lost to Follow-up|1
4817082|NCT01197794|16609250|P1|Overall Study|Lost to Follow-up|1
4817083|NCT01197794|16609244|P7|Overall Study|Withdrawal by Subject|6
4817084|NCT01197794|16609245|P6|Overall Study|Withdrawal by Subject|5
4817085|NCT01197794|16609246|P5|Overall Study|Withdrawal by Subject|1
4817086|NCT01197794|16609247|P4|Overall Study|Withdrawal by Subject|1
4817087|NCT01197794|16609248|P3|Overall Study|Withdrawal by Subject|4
4817088|NCT01197794|16609249|P2|Overall Study|Withdrawal by Subject|3
4817089|NCT01197794|16609250|P1|Overall Study|Withdrawal by Subject|3
4817090|NCT01197794|16609244|P7|Overall Study|Eligibility criteria not fulfilled|6
4817091|NCT01197794|16609245|P6|Overall Study|Eligibility criteria not fulfilled|9
4817092|NCT01197794|16609246|P5|Overall Study|Eligibility criteria not fulfilled|5
4817093|NCT01197794|16609247|P4|Overall Study|Eligibility criteria not fulfilled|5
4817094|NCT01197794|16609248|P3|Overall Study|Eligibility criteria not fulfilled|2
4817095|NCT01197794|16609249|P2|Overall Study|Eligibility criteria not fulfilled|8
4817096|NCT01197794|16609250|P1|Overall Study|Eligibility criteria not fulfilled|5
4817097|NCT01197794|16609244|P7|Overall Study|Development of study withdrawal criteria|1
4817098|NCT01197794|16609245|P6|Overall Study|Development of study withdrawal criteria|0
4817099|NCT01197794|16609246|P5|Overall Study|Development of study withdrawal criteria|0
4817100|NCT01197794|16609247|P4|Overall Study|Development of study withdrawal criteria|1
4817101|NCT01197794|16609248|P3|Overall Study|Development of study withdrawal criteria|0
4817102|NCT01197794|16609249|P2|Overall Study|Development of study withdrawal criteria|0
4817103|NCT01197794|16609250|P1|Overall Study|Development of study withdrawal criteria|3
4817104|NCT01197794|16609244|P7|Overall Study|Protocol Violation|1
4817105|NCT01197794|16609245|P6|Overall Study|Protocol Violation|0
4817106|NCT01197794|16609246|P5|Overall Study|Protocol Violation|2
4817107|NCT01197794|16609247|P4|Overall Study|Protocol Violation|0
4817108|NCT01197794|16609248|P3|Overall Study|Protocol Violation|0
4817109|NCT01197794|16609249|P2|Overall Study|Protocol Violation|0
4817110|NCT01197794|16609250|P1|Overall Study|Protocol Violation|0
4817111|NCT01197794|16609244|P7|Overall Study|Adverse Event|3
4817112|NCT01197794|16609245|P6|Overall Study|Adverse Event|2
4817113|NCT01197794|16609246|P5|Overall Study|Adverse Event|4
4817114|NCT01197794|16609247|P4|Overall Study|Adverse Event|4
4817115|NCT01197794|16609248|P3|Overall Study|Adverse Event|4
4817116|NCT01197794|16609249|P2|Overall Study|Adverse Event|2
4817117|NCT01197794|16609250|P1|Overall Study|Adverse Event|3
4817118|NCT01197755|16609332|P3|Overall Study|eg, change in circumstances|2
4817119|NCT01197755|16609333|P2|Overall Study|eg, change in circumstances|3
4817120|NCT01197755|16609334|P1|Overall Study|eg, change in circumstances|7
4817121|NCT01197755|16609332|P3|Overall Study|Lost to Follow-up|1
4817122|NCT01197755|16609333|P2|Overall Study|Lost to Follow-up|0
4817123|NCT01197755|16609334|P1|Overall Study|Lost to Follow-up|0
4817124|NCT01197755|16609332|P3|Overall Study|Withdrawal by Subject|0
4817125|NCT01197755|16609333|P2|Overall Study|Withdrawal by Subject|0
4817126|NCT01197755|16609334|P1|Overall Study|Withdrawal by Subject|1
4817127|NCT01197755|16609332|P3|Overall Study|Severe non-compliance to the protocol|2
4817128|NCT01197755|16609333|P2|Overall Study|Severe non-compliance to the protocol|1
4817129|NCT01197755|16609334|P1|Overall Study|Severe non-compliance to the protocol|2
4817130|NCT01197755|16609332|P3|Overall Study|Lack of therapeutic response|4
4817131|NCT01197755|16609333|P2|Overall Study|Lack of therapeutic response|7
4817132|NCT01197755|16609334|P1|Overall Study|Lack of therapeutic response|0
4817133|NCT01197755|16609332|P3|Overall Study|Entered the long-term extension study|35
4817134|NCT01197755|16609333|P2|Overall Study|Entered the long-term extension study|21
4817135|NCT01197755|16609334|P1|Overall Study|Entered the long-term extension study|18
4817136|NCT01197755|16609332|P3|Overall Study|Study-specific discontinuation criteria|0
4817137|NCT01197755|16609333|P2|Overall Study|Study-specific discontinuation criteria|1
4817138|NCT01197755|16609334|P1|Overall Study|Study-specific discontinuation criteria|2
4817139|NCT01197755|16609332|P3|Overall Study|Adverse Event|10
4817140|NCT01197755|16609333|P2|Overall Study|Adverse Event|10
4817141|NCT01197755|16609334|P1|Overall Study|Adverse Event|8
4817142|NCT01197560|16609406|P2|Overall Study|Missing|1
4817143|NCT01197560|16609407|P1|Overall Study|Missing|0
4817144|NCT01197560|16609406|P2|Overall Study|Miscellaneous|3
4817145|NCT01197560|16609407|P1|Overall Study|Miscellaneous|4
4817146|NCT01197560|16609406|P2|Overall Study|Disease progression|35
4817147|NCT01197560|16609407|P1|Overall Study|Disease progression|40
4817148|NCT01197560|16609406|P2|Overall Study|Withdrawal by Subject|1
4817149|NCT01197560|16609407|P1|Overall Study|Withdrawal by Subject|1
4817150|NCT01197560|16609406|P2|Overall Study|Death|5
4817151|NCT01197560|16609407|P1|Overall Study|Death|3
4817152|NCT01197560|16609406|P2|Overall Study|Adverse Event|8
4817153|NCT01197560|16609407|P1|Overall Study|Adverse Event|6
4817154|NCT01197534|16609454|P3|Overall Study|Adverse Event|24
4817155|NCT01197534|16609455|P2|Overall Study|Adverse Event|36
4817156|NCT01197534|16609456|P1|Overall Study|Adverse Event|35
4817157|NCT01197534|16609454|P3|Overall Study|Lost to Follow-up|2
4817158|NCT01197534|16609455|P2|Overall Study|Lost to Follow-up|4
4817159|NCT01197534|16609456|P1|Overall Study|Lost to Follow-up|1
4817160|NCT01197534|16609454|P3|Overall Study|Dev. of study specific discont. criteria|2
4817161|NCT01197534|16609455|P2|Overall Study|Dev. of study specific discont. criteria|6
4817162|NCT01197534|16609456|P1|Overall Study|Dev. of study specific discont. criteria|13
4817163|NCT01197534|16609454|P3|Overall Study|Lack of therapeutic response|9
4817164|NCT01197534|16609455|P2|Overall Study|Lack of therapeutic response|4
4817165|NCT01197534|16609456|P1|Overall Study|Lack of therapeutic response|9
4817166|NCT01197534|16609454|P3|Overall Study|Severe non-compliance to protocol|1
4817167|NCT01197534|16609455|P2|Overall Study|Severe non-compliance to protocol|4
4817168|NCT01197534|16609456|P1|Overall Study|Severe non-compliance to protocol|3
4817169|NCT01197534|16609454|P3|Overall Study|Enrolment in long term extension|119
4817170|NCT01197534|16609455|P2|Overall Study|Enrolment in long term extension|66
4817171|NCT01197534|16609456|P1|Overall Study|Enrolment in long term extension|57
4817172|NCT01197534|16609454|P3|Overall Study|Not reported|16
4817173|NCT01197534|16609455|P2|Overall Study|Not reported|10
4817174|NCT01197534|16609456|P1|Overall Study|Not reported|16
4817175|NCT01197521|16609500|P3|Overall Study|Adverse Event|24
4817176|NCT01197521|16609501|P2|Overall Study|Adverse Event|28
4817177|NCT01197521|16609502|P1|Overall Study|Adverse Event|25
4817178|NCT01197521|16609500|P3|Overall Study|Lost to Follow-up|2
4817179|NCT01197521|16609501|P2|Overall Study|Lost to Follow-up|2
4817180|NCT01197521|16609502|P1|Overall Study|Lost to Follow-up|3
4817181|NCT01197521|16609500|P3|Overall Study|Dev. of study specific discont. criteria|2
4817182|NCT01197521|16609501|P2|Overall Study|Dev. of study specific discont. criteria|16
4817183|NCT01197521|16609502|P1|Overall Study|Dev. of study specific discont. criteria|6
4817184|NCT01197521|16609500|P3|Overall Study|Lack of therapeutic response|4
4817185|NCT01197521|16609501|P2|Overall Study|Lack of therapeutic response|3
4817186|NCT01197521|16609502|P1|Overall Study|Lack of therapeutic response|2
4817187|NCT01197521|16609500|P3|Overall Study|Severe non-compliance to protocol|3
4817188|NCT01197521|16609501|P2|Overall Study|Severe non-compliance to protocol|3
4817189|NCT01197521|16609502|P1|Overall Study|Severe non-compliance to protocol|1
4817190|NCT01197521|16609500|P3|Overall Study|Enrolment in long term extension|87
4817191|NCT01197521|16609501|P2|Overall Study|Enrolment in long term extension|36
4817192|NCT01197521|16609502|P1|Overall Study|Enrolment in long term extension|42
4817193|NCT01197521|16609500|P3|Overall Study|Not reported|21
4817194|NCT01197521|16609501|P2|Overall Study|Not reported|25
4817195|NCT01197521|16609502|P1|Overall Study|Not reported|24
4817196|NCT01197508|16609547|P4|Overall Study|Other|2
4817197|NCT01197508|16609548|P3|Overall Study|Other|2
4817198|NCT01197508|16609549|P2|Overall Study|Other|3
4817199|NCT01197508|16609550|P1|Overall Study|Other|2
4817200|NCT01197508|16609547|P4|Overall Study|Lost to Follow-up|0
4817201|NCT01197508|16609548|P3|Overall Study|Lost to Follow-up|2
4817202|NCT01197508|16609549|P2|Overall Study|Lost to Follow-up|1
4817203|NCT01197508|16609550|P1|Overall Study|Lost to Follow-up|1
4817204|NCT01197508|16609547|P4|Overall Study|Study-specific withdrawal criteria|2
4817205|NCT01197508|16609548|P3|Overall Study|Study-specific withdrawal criteria|1
4817206|NCT01197508|16609549|P2|Overall Study|Study-specific withdrawal criteria|0
4817207|NCT01197508|16609550|P1|Overall Study|Study-specific withdrawal criteria|0
4817208|NCT01197508|16609547|P4|Overall Study|Lack of Efficacy|1
4817209|NCT01197508|16609548|P3|Overall Study|Lack of Efficacy|2
4817210|NCT01197508|16609549|P2|Overall Study|Lack of Efficacy|2
4817211|NCT01197508|16609550|P1|Overall Study|Lack of Efficacy|1
4817212|NCT01197508|16609547|P4|Overall Study|Condition under investigation worsened|1
4817213|NCT01197508|16609548|P3|Overall Study|Condition under investigation worsened|1
4817214|NCT01197508|16609549|P2|Overall Study|Condition under investigation worsened|1
4817215|NCT01197508|16609550|P1|Overall Study|Condition under investigation worsened|1
4817216|NCT01197508|16609547|P4|Overall Study|Severe non-compliance to protocol|3
4817217|NCT01197508|16609548|P3|Overall Study|Severe non-compliance to protocol|1
4817218|NCT01197508|16609549|P2|Overall Study|Severe non-compliance to protocol|3
4817219|NCT01197508|16609550|P1|Overall Study|Severe non-compliance to protocol|0
4817220|NCT01197508|16609547|P4|Overall Study|Adverse Event|3
4817221|NCT01197508|16609548|P3|Overall Study|Adverse Event|23
4817222|NCT01197508|16609549|P2|Overall Study|Adverse Event|13
4817223|NCT01197508|16609550|P1|Overall Study|Adverse Event|10
4817224|NCT01197508|16609547|P4|Overall Study|Eligiblity criteria not fulfilled|0
4817225|NCT01197508|16609548|P3|Overall Study|Eligiblity criteria not fulfilled|2
4817226|NCT01197508|16609549|P2|Overall Study|Eligiblity criteria not fulfilled|0
4817227|NCT01197508|16609550|P1|Overall Study|Eligiblity criteria not fulfilled|0
4817228|NCT01197508|16609547|P4|Overall Study|Withdrawal by Subject|4
4817229|NCT01197508|16609548|P3|Overall Study|Withdrawal by Subject|15
4817230|NCT01197508|16609549|P2|Overall Study|Withdrawal by Subject|7
4817231|NCT01197508|16609550|P1|Overall Study|Withdrawal by Subject|8
4817232|NCT01197417|16609671|P2|Overall Study|No 25-hour magnesium level|2
4817233|NCT01197417|16609672|P1|Overall Study|No 25-hour magnesium level|0
4817234|NCT01197417|16609671|P2|Overall Study|Found to be ineligible|5
4817235|NCT01197417|16609672|P1|Overall Study|Found to be ineligible|2
4817236|NCT01197417|16609671|P2|Overall Study|Hypotension|2
4817237|NCT01197417|16609672|P1|Overall Study|Hypotension|1
4817238|NCT01197417|16609671|P2|Overall Study|Not consented in time to receive drug|1
4817239|NCT01197417|16609672|P1|Overall Study|Not consented in time to receive drug|0
4817240|NCT01197417|16609671|P2|Overall Study|Subject transferred to intensive care|1
4817241|NCT01197417|16609672|P1|Overall Study|Subject transferred to intensive care|0
4817242|NCT01197417|16609671|P2|Overall Study|Site miscommunication|1
4817243|NCT01197417|16609672|P1|Overall Study|Site miscommunication|0
4817244|NCT01197417|16609671|P2|Overall Study|Withdrawal by Subject|4
4817245|NCT01197417|16609672|P1|Overall Study|Withdrawal by Subject|2
4817246|NCT01197417|16609671|P2|Overall Study|Physician Decision|2
4817247|NCT01197417|16609672|P1|Overall Study|Physician Decision|3
4817248|NCT01197378|16609690|P1|Overall Study|Other|2
4817249|NCT01197378|16609690|P1|Overall Study|Physician Decision|1
4817250|NCT01197378|16609690|P1|Overall Study|Withdrawal by Subject|1
4817251|NCT01197378|16609690|P1|Overall Study|Adverse Event|3
4817252|NCT01197300|16609709|P2|Overall Study|Protocol Violation|1
4817253|NCT01197300|16609710|P1|Overall Study|Protocol Violation|0
4817254|NCT01197300|16609709|P2|Overall Study|Lost to Follow-up|1
4817255|NCT01197300|16609710|P1|Overall Study|Lost to Follow-up|0
4817256|NCT01196988|16609742|P4|Overall Study|Other|0
4817257|NCT01196988|16609743|P3|Overall Study|Other|0
4817258|NCT01196988|16609744|P2|Overall Study|Other|0
4817259|NCT01196988|16609745|P1|Overall Study|Other|2
4817260|NCT01196988|16609742|P4|Overall Study|Lost to Follow-up|1
4817261|NCT01196988|16609743|P3|Overall Study|Lost to Follow-up|21
4817262|NCT01196988|16609744|P2|Overall Study|Lost to Follow-up|29
4817263|NCT01196988|16609745|P1|Overall Study|Lost to Follow-up|16
4817264|NCT01196988|16609742|P4|Overall Study|Withdrawal by Subject|0
4817265|NCT01196988|16609743|P3|Overall Study|Withdrawal by Subject|4
4817266|NCT01196988|16609744|P2|Overall Study|Withdrawal by Subject|1
4817267|NCT01196988|16609745|P1|Overall Study|Withdrawal by Subject|5
4817268|NCT01196988|16609742|P4|Overall Study|Adverse Event|0
4817269|NCT01196988|16609743|P3|Overall Study|Adverse Event|0
4817270|NCT01196988|16609744|P2|Overall Study|Adverse Event|2
4817271|NCT01196988|16609745|P1|Overall Study|Adverse Event|1
4817272|NCT01196975|16609839|P5|Overall Study|Lost to Follow-up|11
4817273|NCT01196975|16609840|P4|Overall Study|Lost to Follow-up|5
4817274|NCT01196975|16609841|P3|Overall Study|Lost to Follow-up|5
4817275|NCT01196975|16609842|P2|Overall Study|Lost to Follow-up|6
4817276|NCT01196975|16609843|P1|Overall Study|Lost to Follow-up|11
4817277|NCT01196975|16609839|P5|Overall Study|Withdrawal by Subject|0
4817278|NCT01196975|16609840|P4|Overall Study|Withdrawal by Subject|1
4817279|NCT01196975|16609841|P3|Overall Study|Withdrawal by Subject|0
4817280|NCT01196975|16609842|P2|Overall Study|Withdrawal by Subject|1
4817281|NCT01196975|16609843|P1|Overall Study|Withdrawal by Subject|2
4817282|NCT01196975|16609839|P5|Overall Study|Adverse Event|2
4817283|NCT01196975|16609840|P4|Overall Study|Adverse Event|0
4817284|NCT01196975|16609841|P3|Overall Study|Adverse Event|0
4817285|NCT01196975|16609842|P2|Overall Study|Adverse Event|2
4817286|NCT01196975|16609843|P1|Overall Study|Adverse Event|2
4817287|NCT01196741|16610127|P2|Overall Study|Protocol Violation|1
4817288|NCT01196741|16610128|P1|Overall Study|Protocol Violation|2
4817289|NCT01196741|16610127|P2|Overall Study|Other|2
4817290|NCT01196741|16610128|P1|Overall Study|Other|3
4817291|NCT01196741|16610127|P2|Overall Study|Other reason|3
4817292|NCT01196741|16610128|P1|Overall Study|Other reason|3
4817293|NCT01196741|16610127|P2|Overall Study|Withdrawal by Subject|0
4817294|NCT01196741|16610128|P1|Overall Study|Withdrawal by Subject|3
4817295|NCT01196741|16610127|P2|Overall Study|Dose limiting Adverse Event|1
4817296|NCT01196741|16610128|P1|Overall Study|Dose limiting Adverse Event|2
4817297|NCT01196741|16610127|P2|Overall Study|Serious Adverse Event|1
4817298|NCT01196741|16610128|P1|Overall Study|Serious Adverse Event|3
4817299|NCT01196741|16610127|P2|Overall Study|Adverse Event|6
4817300|NCT01196741|16610128|P1|Overall Study|Adverse Event|10
4817301|NCT01196741|16610127|P2|Overall Study|Disease progression|14
4817302|NCT01196741|16610128|P1|Overall Study|Disease progression|34
4817303|NCT01196429|16610158|P2|Overall Study|Refused - Never Treated|0
4817304|NCT01196429|16610159|P1|Overall Study|Refused - Never Treated|1
4817305|NCT01196429|16610158|P2|Overall Study|Ineligible - wrong cell type|0
4817306|NCT01196429|16610159|P1|Overall Study|Ineligible - wrong cell type|1
4817307|NCT01196429|16610158|P2|Overall Study|Ineligible - inadequate pathology|0
4817308|NCT01196429|16610159|P1|Overall Study|Ineligible - inadequate pathology|1
4817309|NCT01196416|16610175|P1|Overall Study|Withdrawal by Subject|2
4817310|NCT01196104|16610233|P2|Overall Study|Various|1
4817311|NCT01196104|16610234|P1|Overall Study|Various|0
4817312|NCT01196104|16610233|P2|Overall Study|Withdrawal by Subject|3
4817313|NCT01196104|16610234|P1|Overall Study|Withdrawal by Subject|3
4817314|NCT01196104|16610233|P2|Overall Study|Physician Decision|1
4817315|NCT01196104|16610234|P1|Overall Study|Physician Decision|0
4817316|NCT01196104|16610233|P2|Overall Study|Lost to Follow-up|0
4817317|NCT01196104|16610234|P1|Overall Study|Lost to Follow-up|1
4817318|NCT01196091|16610277|P3|Overall Study|Randomized, No Study Drug Received|1
4817319|NCT01196091|16610278|P2|Overall Study|Randomized, No Study Drug Received|0
4817320|NCT01196091|16610279|P1|Overall Study|Randomized, No Study Drug Received|1
4817321|NCT01196091|16610277|P3|Overall Study|Excluded Site|8
4817322|NCT01196091|16610278|P2|Overall Study|Excluded Site|11
4817323|NCT01196091|16610279|P1|Overall Study|Excluded Site|5
4817324|NCT01196091|16610277|P3|Overall Study|Sponsor Decision|4
4817325|NCT01196091|16610278|P2|Overall Study|Sponsor Decision|5
4817326|NCT01196091|16610279|P1|Overall Study|Sponsor Decision|6
4817327|NCT01196091|16610277|P3|Overall Study|Protocol Violation|3
4817328|NCT01196091|16610278|P2|Overall Study|Protocol Violation|3
4817329|NCT01196091|16610279|P1|Overall Study|Protocol Violation|1
4817330|NCT01196091|16610277|P3|Overall Study|Physician Decision|4
4817331|NCT01196091|16610278|P2|Overall Study|Physician Decision|3
4817332|NCT01196091|16610279|P1|Overall Study|Physician Decision|3
4817333|NCT01196091|16610277|P3|Overall Study|Withdrawal by Subject|22
4817334|NCT01196091|16610278|P2|Overall Study|Withdrawal by Subject|19
4817335|NCT01196091|16610279|P1|Overall Study|Withdrawal by Subject|16
4817336|NCT01196091|16610277|P3|Overall Study|Parent/Caregiver Decision|1
4817337|NCT01196091|16610278|P2|Overall Study|Parent/Caregiver Decision|0
4817338|NCT01196091|16610279|P1|Overall Study|Parent/Caregiver Decision|0
4817339|NCT01196091|16610277|P3|Overall Study|Lost to Follow-up|6
4817340|NCT01196091|16610278|P2|Overall Study|Lost to Follow-up|5
4817341|NCT01196091|16610279|P1|Overall Study|Lost to Follow-up|5
4817342|NCT01196091|16610277|P3|Overall Study|Lack of Efficacy|17
4817343|NCT01196091|16610278|P2|Overall Study|Lack of Efficacy|12
4817344|NCT01196091|16610279|P1|Overall Study|Lack of Efficacy|15
4817345|NCT01196091|16610277|P3|Overall Study|Entry Criteria Not Met|10
4817346|NCT01196091|16610278|P2|Overall Study|Entry Criteria Not Met|11
4817347|NCT01196091|16610279|P1|Overall Study|Entry Criteria Not Met|11
4817348|NCT01196091|16610277|P3|Overall Study|Death|2
4817349|NCT01196091|16610278|P2|Overall Study|Death|2
4817350|NCT01196091|16610279|P1|Overall Study|Death|3
4817351|NCT01196091|16610277|P3|Overall Study|Adverse Event|26
4817352|NCT01196091|16610278|P2|Overall Study|Adverse Event|27
4817353|NCT01196091|16610279|P1|Overall Study|Adverse Event|22
4817354|NCT01196078|16610331|P2|Overall Study|Death|4
4817355|NCT01196078|16610332|P1|Overall Study|Death|6
4817356|NCT01196078|16610331|P2|Overall Study|Lost to Follow-up|0
4817357|NCT01196078|16610332|P1|Overall Study|Lost to Follow-up|1
4817358|NCT01196078|16610331|P2|Overall Study|Lack of Efficacy|23
4817359|NCT01196078|16610332|P1|Overall Study|Lack of Efficacy|17
4817360|NCT01196078|16610331|P2|Overall Study|Protocol Violation|1
4817361|NCT01196078|16610332|P1|Overall Study|Protocol Violation|2
4817362|NCT01196078|16610331|P2|Overall Study|Adverse Event|4
4817363|NCT01196078|16610332|P1|Overall Study|Adverse Event|4
4817364|NCT01196078|16610331|P2|Overall Study|Withdrawal by Subject|5
4817365|NCT01196078|16610332|P1|Overall Study|Withdrawal by Subject|3
4817366|NCT01196052|16610360|P1|Overall Study|Withdrawal by Subject|6
4817367|NCT01196052|16610360|P1|Overall Study|Reason not Specified|5
4817368|NCT01196052|16610360|P1|Overall Study|Noncompliance to Protocol Requirements|2
4817369|NCT01196052|16610360|P1|Overall Study|Lost to Follow-up|1
4817370|NCT01196052|16610360|P1|Overall Study|Adverse Event|9
4817371|NCT01196026|16610377|P6|Overall Study|Other|0
4817372|NCT01196026|16610378|P5|Overall Study|Other|0
4817373|NCT01196026|16610379|P4|Overall Study|Other|0
4817374|NCT01196026|16610380|P3|Overall Study|Other|0
4817375|NCT01196026|16610381|P2|Overall Study|Other|1
4817376|NCT01196026|16610382|P1|Overall Study|Other|0
4817377|NCT01196026|16610377|P6|Overall Study|Lost to Follow-up|0
4817378|NCT01196026|16610378|P5|Overall Study|Lost to Follow-up|1
4817379|NCT01196026|16610379|P4|Overall Study|Lost to Follow-up|0
4817380|NCT01196026|16610380|P3|Overall Study|Lost to Follow-up|0
4817381|NCT01196026|16610381|P2|Overall Study|Lost to Follow-up|3
4817382|NCT01196026|16610382|P1|Overall Study|Lost to Follow-up|0
4817383|NCT01196026|16610377|P6|Overall Study|Withdrawal by Subject|0
4817384|NCT01196026|16610378|P5|Overall Study|Withdrawal by Subject|0
4817385|NCT01196026|16610379|P4|Overall Study|Withdrawal by Subject|0
4817386|NCT01196026|16610380|P3|Overall Study|Withdrawal by Subject|0
4817387|NCT01196026|16610381|P2|Overall Study|Withdrawal by Subject|4
4817388|NCT01196026|16610382|P1|Overall Study|Withdrawal by Subject|1
4817389|NCT01195948|16610616|P3|Overall Study|Lost to Follow-up|2
4817390|NCT01195948|16610617|P2|Overall Study|Lost to Follow-up|1
4817391|NCT01195948|16610618|P1|Overall Study|Lost to Follow-up|0
4817392|NCT01195844|16610671|P1|Overall Study|Fecal sample not collected|40
4817393|NCT01195831|16610688|P2|Overall Study|Protocol Violation|2
4817394|NCT01195831|16610689|P1|Overall Study|Protocol Violation|0
4817395|NCT01195831|16610688|P2|Overall Study|Adverse Event|2
4817396|NCT01195831|16610689|P1|Overall Study|Adverse Event|4
4817397|NCT01195831|16610688|P2|Overall Study|Withdrawal by Subject|2
4817398|NCT01195831|16610689|P1|Overall Study|Withdrawal by Subject|2
4817399|NCT01195831|16610688|P2|Overall Study|Lost to Follow-up|4
4817400|NCT01195831|16610689|P1|Overall Study|Lost to Follow-up|2
4817401|NCT01195675|16610732|P1|Overall Study|Withdrawal by Subject|2
4817402|NCT01195675|16610732|P1|Overall Study|Adverse Event|1
4817403|NCT01195662|16610765|P3|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
4817404|NCT01195662|16610766|P2|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0
4817405|NCT01195662|16610767|P1|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1
4817406|NCT01195662|16610765|P3|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1
4817407|NCT01195662|16610766|P2|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0
4817408|NCT01195662|16610767|P1|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2
4817409|NCT01195662|16610765|P3|Double Blind Treatment Period|Missing disposition information|1
4817410|NCT01195662|16610766|P2|Double Blind Treatment Period|Missing disposition information|1
4817411|NCT01195662|16610767|P1|Double Blind Treatment Period|Missing disposition information|0
4817412|NCT01195662|16610765|P3|Double Blind Treatment Period|Non-specified|0
4817413|NCT01195662|16610766|P2|Double Blind Treatment Period|Non-specified|0
4817414|NCT01195662|16610767|P1|Double Blind Treatment Period|Non-specified|3
4817415|NCT01195662|16610765|P3|Double Blind Treatment Period|Lack of Efficacy|0
4817416|NCT01195662|16610766|P2|Double Blind Treatment Period|Lack of Efficacy|0
4817417|NCT01195662|16610767|P1|Double Blind Treatment Period|Lack of Efficacy|2
4817418|NCT01195662|16610765|P3|Double Blind Treatment Period|No Longer Meets Criteria|2
4817419|NCT01195662|16610766|P2|Double Blind Treatment Period|No Longer Meets Criteria|5
4817420|NCT01195662|16610767|P1|Double Blind Treatment Period|No Longer Meets Criteria|1
4817421|NCT01195662|16610765|P3|Double Blind Treatment Period|Requested discontinue treatment|1
4817422|NCT01195662|16610766|P2|Double Blind Treatment Period|Requested discontinue treatment|0
4817423|NCT01195662|16610767|P1|Double Blind Treatment Period|Requested discontinue treatment|1
4817424|NCT01195662|16610765|P3|Double Blind Treatment Period|Administrative reason|1
4817425|NCT01195662|16610766|P2|Double Blind Treatment Period|Administrative reason|1
4817426|NCT01195662|16610767|P1|Double Blind Treatment Period|Administrative reason|2
4817427|NCT01195662|16610765|P3|Double Blind Treatment Period|Lost to Follow-up|3
4817428|NCT01195662|16610766|P2|Double Blind Treatment Period|Lost to Follow-up|2
4817429|NCT01195662|16610767|P1|Double Blind Treatment Period|Lost to Follow-up|3
4817430|NCT01195662|16610765|P3|Double Blind Treatment Period|Withdrawal by Subject|4
4817431|NCT01195662|16610766|P2|Double Blind Treatment Period|Withdrawal by Subject|4
4817432|NCT01195662|16610767|P1|Double Blind Treatment Period|Withdrawal by Subject|6
4817433|NCT01195662|16610765|P3|Double Blind Treatment Period|Adverse Event|2
4817434|NCT01195662|16610766|P2|Double Blind Treatment Period|Adverse Event|1
4817435|NCT01195662|16610767|P1|Double Blind Treatment Period|Adverse Event|4
4817436|NCT01195636|16610797|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|1
4817437|NCT01195636|16610798|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4817438|NCT01195636|16610797|P2|Second Intervention (3 Weeks)|Adverse Event|1
4817439|NCT01195636|16610798|P1|Second Intervention (3 Weeks)|Adverse Event|1
4817440|NCT01195636|16610797|P2|Washout Period (2 Weeks)|Withdrawal by Subject|2
4817441|NCT01195636|16610798|P1|Washout Period (2 Weeks)|Withdrawal by Subject|1
4817442|NCT01195636|16610797|P2|Washout Period (2 Weeks)|Adverse Event|1
4817443|NCT01195636|16610798|P1|Washout Period (2 Weeks)|Adverse Event|1
4817444|NCT01195636|16610797|P2|First Intervention (3 Weeks)|Lost to Follow-up|0
4817445|NCT01195636|16610798|P1|First Intervention (3 Weeks)|Lost to Follow-up|1
4817446|NCT01195636|16610797|P2|First Intervention (3 Weeks)|Withdrawal by Subject|0
4817447|NCT01195636|16610798|P1|First Intervention (3 Weeks)|Withdrawal by Subject|1
4817448|NCT01195636|16610797|P2|First Intervention (3 Weeks)|Protocol Violation|0
4817449|NCT01195636|16610798|P1|First Intervention (3 Weeks)|Protocol Violation|1
4817450|NCT01195636|16610797|P2|First Intervention (3 Weeks)|Adverse Event|3
4817451|NCT01195636|16610798|P1|First Intervention (3 Weeks)|Adverse Event|2
4817452|NCT01195623|16610824|P2|Overall Study|Lost to Follow-up|37
4817453|NCT01195623|16610825|P1|Overall Study|Lost to Follow-up|35
4817454|NCT01195545|16610854|P1|Overall Study|Protocol Violation|4
4817455|NCT01195415|16610866|P1|Overall Study|No repeat biopsy due to progression|2
4817456|NCT01195363|16610875|P2|Overall Study|incarceration|0
4817457|NCT01195363|16610876|P1|Overall Study|incarceration|1
4817458|NCT01195363|16610875|P2|Overall Study|Lack of Efficacy|4
4817459|NCT01195363|16610876|P1|Overall Study|Lack of Efficacy|0
4817460|NCT01195363|16610875|P2|Overall Study|Adverse Event|1
4817461|NCT01195363|16610876|P1|Overall Study|Adverse Event|3
4817462|NCT01195363|16610875|P2|Overall Study|Lost to Follow-up|4
4817463|NCT01195363|16610876|P1|Overall Study|Lost to Follow-up|7
4817464|NCT01195272|16610882|P1|Overall Study|Lack of Efficacy|3
4817465|NCT01195272|16610882|P1|Overall Study|Adverse Event|1
4817466|NCT01195103|16610911|P3|Overall Study|Withdrawal by Subject|0
4817467|NCT01195103|16610912|P2|Overall Study|Withdrawal by Subject|0
4817468|NCT01195103|16610913|P1|Overall Study|Withdrawal by Subject|1
4817469|NCT01195090|16610923|P2|Overall Study|Protocol Violation|4
4817470|NCT01195090|16610924|P1|Overall Study|Protocol Violation|3
4817471|NCT01195090|16610923|P2|Overall Study|Lost to Follow-up|2
4817472|NCT01195090|16610924|P1|Overall Study|Lost to Follow-up|2
4817473|NCT01195090|16610923|P2|Overall Study|Adverse Event|2
4817474|NCT01195090|16610924|P1|Overall Study|Adverse Event|1
4817475|NCT01194999|16610993|P1|Overall Study|Lost to Follow-up|17
4817476|NCT01194973|16610997|P1|26 Week Treatment Period|Pregnancy|1
4817477|NCT01194973|16610997|P1|26 Week Treatment Period|Lack of Efficacy|1
4817478|NCT01194973|16610997|P1|26 Week Treatment Period|Adverse Event|1
4817479|NCT01194973|16610997|P1|Screening Period|Screen Failure|3
4817480|NCT01194869|16611017|P1|Overall Study|Toxicity|2
4817481|NCT01194869|16611017|P1|Overall Study|Disease Progression|2
4817482|NCT01194830|16611048|P2|Overall Study|Other Reason|8
4817483|NCT01194830|16611049|P1|Overall Study|Other Reason|12
4817484|NCT01194830|16611048|P2|Overall Study|Non-compliance issues|4
4817485|NCT01194830|16611049|P1|Overall Study|Non-compliance issues|4
4817486|NCT01194830|16611048|P2|Overall Study|Lack of Efficacy|1
4817487|NCT01194830|16611049|P1|Overall Study|Lack of Efficacy|1
4817488|NCT01194830|16611048|P2|Overall Study|Withdrawal by Subject|1
4817489|NCT01194830|16611049|P1|Overall Study|Withdrawal by Subject|2
4817490|NCT01194830|16611048|P2|Overall Study|Lost to Follow-up|7
4817491|NCT01194830|16611049|P1|Overall Study|Lost to Follow-up|9
4817492|NCT01194830|16611048|P2|Overall Study|Protocol Violation|4
4817493|NCT01194830|16611049|P1|Overall Study|Protocol Violation|5
4817494|NCT01194830|16611048|P2|Overall Study|Adverse Event|2
4817495|NCT01194830|16611049|P1|Overall Study|Adverse Event|3
4817496|NCT01194804|16611071|P1|Overall Study|Withdrawal by Subject|1
4817497|NCT01194570|16611093|P2|Overall Study|Lost to Follow-up|4
4817498|NCT01194570|16611094|P1|Overall Study|Lost to Follow-up|1
4817499|NCT01194570|16611093|P2|Overall Study|Pregnancy|1
4817500|NCT01194570|16611094|P1|Overall Study|Pregnancy|1
4817501|NCT01194570|16611093|P2|Overall Study|Withdrawal by Subject|22
4817502|NCT01194570|16611094|P1|Overall Study|Withdrawal by Subject|21
4817503|NCT01194570|16611093|P2|Overall Study|Lack of Efficacy|21
4817504|NCT01194570|16611094|P1|Overall Study|Lack of Efficacy|27
4817505|NCT01194570|16611093|P2|Overall Study|Non-compliance|2
4817506|NCT01194570|16611094|P1|Overall Study|Non-compliance|2
4817507|NCT01194570|16611093|P2|Overall Study|Adverse Event|18
4817508|NCT01194570|16611094|P1|Overall Study|Adverse Event|12
4817509|NCT01194570|16611093|P2|Overall Study|Non-compliance with study drug|2
4817510|NCT01194570|16611094|P1|Overall Study|Non-compliance with study drug|2
4817511|NCT01194570|16611093|P2|Overall Study|Protocol Violation|2
4817512|NCT01194570|16611094|P1|Overall Study|Protocol Violation|0
4817513|NCT01194570|16611093|P2|Overall Study|Reason not specified|20
4817514|NCT01194570|16611094|P1|Overall Study|Reason not specified|13
4817515|NCT01194570|16611093|P2|Overall Study|Physician Decision|6
4817516|NCT01194570|16611094|P1|Overall Study|Physician Decision|2
4817517|NCT01194570|16611093|P2|Overall Study|Ongoing at CCOD|387
4817518|NCT01194570|16611094|P1|Overall Study|Ongoing at CCOD|162
4817519|NCT01194570|16611093|P2|Overall Study|Death|3
4817520|NCT01194570|16611094|P1|Overall Study|Death|1
4817521|NCT01194531|16611114|P2|Overall Study|Physician Decision|2
4817522|NCT01194531|16611115|P1|Overall Study|Physician Decision|0
4817523|NCT01194531|16611114|P2|Overall Study|Protocol Violation|1
4817524|NCT01194531|16611115|P1|Overall Study|Protocol Violation|4
4817525|NCT01194531|16611114|P2|Overall Study|Withdrawal by Subject|0
4817526|NCT01194531|16611115|P1|Overall Study|Withdrawal by Subject|1
4817527|NCT01194440|16611169|P1|6-months (2nd Dose)|Change in therapy|4
4817528|NCT01194440|16611169|P1|Baseline (First Dose)|Adverse Event|1
4817529|NCT01194440|16611169|P1|Baseline (First Dose)|Change in therapy|1
4817530|NCT01194440|16611169|P1|Baseline (First Dose)|Lack of Efficacy|1
4817531|NCT01194440|16611169|P1|Baseline (First Dose)|Reason not specified|4
4817532|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Death|2
4817533|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Death|0
4817534|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Death|2
4817535|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Death|1
4817536|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
4817537|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0
4817538|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
4817539|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1
4817540|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Adverse Event|12
4817541|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Adverse Event|2
4817542|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Adverse Event|21
4817543|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Adverse Event|35
4817544|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Protocol Violation|1
4817545|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Protocol Violation|0
4817546|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Protocol Violation|0
4817547|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Protocol Violation|0
4817548|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Other|0
4817549|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Other|0
4817550|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Other|1
4817551|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Other|2
4817552|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Pregnancy|1
4817553|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Pregnancy|1
4817554|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Pregnancy|3
4817555|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Pregnancy|1
4817556|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
4817557|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0
4817558|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5
4817559|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3
4817560|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Lost to Follow-up|1
4817561|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Lost to Follow-up|2
4817562|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Lost to Follow-up|3
4817563|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Lost to Follow-up|4
4817564|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3
4817565|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2
4817566|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11
4817567|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9
4817568|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6
4817569|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1
4817570|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14
4817571|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20
4817572|NCT01194414|16611182|P4|72 Weeks Open Label Extension|Randomized but not Treated|0
4817573|NCT01194414|16611183|P3|72 Weeks Open Label Extension|Randomized but not Treated|0
4817574|NCT01194414|16611184|P2|72 Weeks Open Label Extension|Randomized but not Treated|5
4817575|NCT01194414|16611185|P1|72 Weeks Open Label Extension|Randomized but not Treated|3
4817576|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Death|0
4817577|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Death|0
4817578|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Death|1
4817579|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Death|0
4817580|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
4817581|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0
4817582|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1
4817583|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2
4817584|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Adverse Event|0
4817585|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Adverse Event|0
4817586|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Adverse Event|40
4817587|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Adverse Event|28
4817588|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Other|0
4817589|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Other|0
4817590|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Other|1
4817591|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Other|0
4817592|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Lost to Follow-up|0
4817593|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Lost to Follow-up|0
4817594|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Lost to Follow-up|1
4817595|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Lost to Follow-up|2
4817596|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Pregnancy|0
4817597|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Pregnancy|0
4817598|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Pregnancy|2
4817599|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Pregnancy|2
4817600|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
4817601|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
4817602|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5
4817603|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0
4817604|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Protocol Violation|0
4817605|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Protocol Violation|0
4817606|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Protocol Violation|3
4817607|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Protocol Violation|5
4817608|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
4817609|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0
4817610|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5
4817611|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9
4817612|NCT01194414|16611182|P4|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
4817613|NCT01194414|16611183|P3|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0
4817614|NCT01194414|16611184|P2|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8
4817615|NCT01194414|16611185|P1|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11
4817616|NCT01194271|16611256|P1|Overall Study|Death|1
4817617|NCT01194271|16611256|P1|Overall Study|Ineligible, Screen Failure|1
4817618|NCT01194271|16611256|P1|Overall Study|Withdrawal by Subject|1
4817619|NCT01194258|16611260|P5|Period 2 (12 Weeks)|Withdrawal by Subject|0
4817620|NCT01194258|16611261|P4|Period 2 (12 Weeks)|Withdrawal by Subject|0
4817621|NCT01194258|16611262|P3|Period 2 (12 Weeks)|Withdrawal by Subject|1
4817622|NCT01194258|16611263|P2|Period 2 (12 Weeks)|Withdrawal by Subject|1
4817623|NCT01194258|16611264|P1|Period 2 (12 Weeks)|Withdrawal by Subject|0
4817624|NCT01194258|16611260|P5|Period 2 (12 Weeks)|Adverse Event|0
4817625|NCT01194258|16611261|P4|Period 2 (12 Weeks)|Adverse Event|0
4817626|NCT01194258|16611262|P3|Period 2 (12 Weeks)|Adverse Event|0
4817627|NCT01194258|16611263|P2|Period 2 (12 Weeks)|Adverse Event|1
4817628|NCT01194258|16611264|P1|Period 2 (12 Weeks)|Adverse Event|0
4817629|NCT01194258|16611260|P5|Period 2 (12 Weeks)|Lost to Follow-up|2
4817630|NCT01194258|16611261|P4|Period 2 (12 Weeks)|Lost to Follow-up|0
4817631|NCT01194258|16611262|P3|Period 2 (12 Weeks)|Lost to Follow-up|0
4817632|NCT01194258|16611263|P2|Period 2 (12 Weeks)|Lost to Follow-up|0
4817633|NCT01194258|16611264|P1|Period 2 (12 Weeks)|Lost to Follow-up|0
4817634|NCT01194258|16611260|P5|Period 1 (12 Weeks)|Death|1
4817635|NCT01194258|16611261|P4|Period 1 (12 Weeks)|Death|0
4817636|NCT01194258|16611262|P3|Period 1 (12 Weeks)|Death|0
4817637|NCT01194258|16611263|P2|Period 1 (12 Weeks)|Death|0
4817638|NCT01194258|16611264|P1|Period 1 (12 Weeks)|Death|0
4817639|NCT01194258|16611260|P5|Titration Period|Titration failure|0
4817640|NCT01194258|16611261|P4|Titration Period|Titration failure|0
4817641|NCT01194258|16611262|P3|Titration Period|Titration failure|0
4817642|NCT01194258|16611263|P2|Titration Period|Titration failure|0
4817643|NCT01194258|16611264|P1|Titration Period|Titration failure|3
4817644|NCT01194258|16611260|P5|Titration Period|Lost to Follow-up|0
4817645|NCT01194258|16611261|P4|Titration Period|Lost to Follow-up|0
4817646|NCT01194258|16611262|P3|Titration Period|Lost to Follow-up|0
4817647|NCT01194258|16611263|P2|Titration Period|Lost to Follow-up|0
4817648|NCT01194258|16611264|P1|Titration Period|Lost to Follow-up|2
4817649|NCT01194258|16611260|P5|Titration Period|Withdrawal by Subject|0
4817650|NCT01194258|16611261|P4|Titration Period|Withdrawal by Subject|0
4817651|NCT01194258|16611262|P3|Titration Period|Withdrawal by Subject|0
4817652|NCT01194258|16611263|P2|Titration Period|Withdrawal by Subject|0
4817653|NCT01194258|16611264|P1|Titration Period|Withdrawal by Subject|6
4817654|NCT01194245|16611288|P5|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
4817655|NCT01194245|16611289|P4|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
4817656|NCT01194245|16611290|P3|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1
4817657|NCT01194245|16611291|P2|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4817658|NCT01194245|16611292|P1|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0
4817659|NCT01194245|16611288|P5|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1
4817660|NCT01194245|16611289|P4|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4817661|NCT01194245|16611290|P3|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4817662|NCT01194245|16611291|P2|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4817663|NCT01194245|16611292|P1|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0
4817664|NCT01194245|16611288|P5|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4817665|NCT01194245|16611289|P4|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4817666|NCT01194245|16611290|P3|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4817667|NCT01194245|16611291|P2|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0
4817668|NCT01194245|16611292|P1|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7
4817669|NCT01194245|16611288|P5|Titration Period (4 to 6 Weeks)|Titration Failure|0
4817670|NCT01194245|16611289|P4|Titration Period (4 to 6 Weeks)|Titration Failure|0
4817671|NCT01194245|16611290|P3|Titration Period (4 to 6 Weeks)|Titration Failure|0
4817672|NCT01194245|16611291|P2|Titration Period (4 to 6 Weeks)|Titration Failure|0
4817673|NCT01194245|16611292|P1|Titration Period (4 to 6 Weeks)|Titration Failure|3
4817674|NCT01194245|16611288|P5|Titration Period (4 to 6 Weeks)|Physician Decision|0
4817675|NCT01194245|16611289|P4|Titration Period (4 to 6 Weeks)|Physician Decision|0
4817676|NCT01194245|16611290|P3|Titration Period (4 to 6 Weeks)|Physician Decision|0
4817677|NCT01194245|16611291|P2|Titration Period (4 to 6 Weeks)|Physician Decision|0
4817678|NCT01194245|16611292|P1|Titration Period (4 to 6 Weeks)|Physician Decision|3
4817679|NCT01194245|16611288|P5|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4817680|NCT01194245|16611289|P4|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4817681|NCT01194245|16611290|P3|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4817682|NCT01194245|16611291|P2|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0
4817683|NCT01194245|16611292|P1|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5
4817684|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Miscellaneous|2
4817685|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Miscellaneous|11
4817686|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817687|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817688|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817689|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817690|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817691|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817692|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817693|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Miscellaneous|0
4817694|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817695|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Protocol Violation|3
4817696|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817697|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817698|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817699|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817700|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817701|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817702|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817703|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Protocol Violation|0
4817704|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10
4817705|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24
4817706|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817707|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817708|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817709|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817710|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817711|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817712|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817713|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0
4817714|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Death|1
4817715|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Death|1
4817716|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Death|0
4817717|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Death|0
4817718|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Death|0
4817719|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Death|0
4817720|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Death|0
4817721|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Death|0
4817722|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Death|0
4817723|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Death|0
4817724|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32
4817725|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66
4817726|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817727|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817728|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817729|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817730|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817731|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817732|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817733|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0
4817734|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4
4817735|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9
4817736|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817737|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817738|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817739|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817740|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817741|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817742|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817743|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0
4817744|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49
4817745|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81
4817746|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817747|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817748|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817749|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817750|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817751|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817752|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817753|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0
4817754|NCT01194219|16611313|P10|Long-Term Extension Weeks 52 to 260|Adverse Event|14
4817755|NCT01194219|16611314|P9|Long-Term Extension Weeks 52 to 260|Adverse Event|25
4817756|NCT01194219|16611315|P8|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817757|NCT01194219|16611316|P7|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817758|NCT01194219|16611317|P6|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817759|NCT01194219|16611318|P5|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817760|NCT01194219|16611319|P4|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817761|NCT01194219|16611320|P3|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817762|NCT01194219|16611321|P2|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817763|NCT01194219|16611322|P1|Long-Term Extension Weeks 52 to 260|Adverse Event|0
4817764|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817765|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817766|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817767|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Other|1
4817768|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817769|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817770|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817771|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817772|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817773|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Other|0
4817774|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817775|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817776|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1
4817777|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817778|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817779|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817780|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817781|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817782|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817783|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0
4817784|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817785|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817786|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817787|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5
4817788|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2
4817789|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1
4817790|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817791|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817792|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817793|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0
4817794|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817795|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817796|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6
4817797|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12
4817798|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817799|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1
4817800|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817801|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817802|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817803|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0
4817804|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817805|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817806|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817807|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2
4817808|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817809|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1
4817810|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817811|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817812|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817813|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0
4817814|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4817815|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4817816|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33
4817817|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35
4817818|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
4817819|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1
4817820|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4817821|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4817822|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4817823|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0
4817824|NCT01194219|16611313|P10|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817825|NCT01194219|16611314|P9|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817826|NCT01194219|16611315|P8|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5
4817827|NCT01194219|16611316|P7|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6
4817828|NCT01194219|16611317|P6|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1
4817829|NCT01194219|16611318|P5|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817830|NCT01194219|16611319|P4|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817831|NCT01194219|16611320|P3|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817832|NCT01194219|16611321|P2|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817833|NCT01194219|16611322|P1|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0
4817834|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Other|0
4817835|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Other|0
4817836|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Other|0
4817837|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Other|0
4817838|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Other|0
4817839|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Other|0
4817840|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Other|1
4817841|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Other|2
4817842|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Other|0
4817843|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Other|0
4817844|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Protocol Violation|0
4817845|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Protocol Violation|0
4817846|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Protocol Violation|0
4817847|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Protocol Violation|0
4817848|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Protocol Violation|0
4817849|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Protocol Violation|0
4817850|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Protocol Violation|1
4817851|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Protocol Violation|0
4817852|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Protocol Violation|0
4817853|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Protocol Violation|0
4817854|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817855|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817856|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817857|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817858|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817859|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817860|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817861|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Lost to Follow-up|9
4817862|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817863|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Lost to Follow-up|0
4817864|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817865|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817866|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817867|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817868|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817869|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817870|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Withdrawal by Subject|3
4817871|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Withdrawal by Subject|12
4817872|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817873|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Withdrawal by Subject|0
4817874|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817875|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817876|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817877|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817878|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817879|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817880|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1
4817881|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2
4817882|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817883|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0
4817884|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817885|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817886|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817887|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817888|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817889|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817890|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Lack of Efficacy|15
4817891|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Lack of Efficacy|37
4817892|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817893|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Lack of Efficacy|0
4817894|NCT01194219|16611313|P10|Maintenance Phase Weeks16-32|Adverse Event|0
4817895|NCT01194219|16611314|P9|Maintenance Phase Weeks16-32|Adverse Event|0
4817896|NCT01194219|16611315|P8|Maintenance Phase Weeks16-32|Adverse Event|0
4817897|NCT01194219|16611316|P7|Maintenance Phase Weeks16-32|Adverse Event|0
4817898|NCT01194219|16611317|P6|Maintenance Phase Weeks16-32|Adverse Event|0
4817899|NCT01194219|16611318|P5|Maintenance Phase Weeks16-32|Adverse Event|0
4817900|NCT01194219|16611319|P4|Maintenance Phase Weeks16-32|Adverse Event|9
4817901|NCT01194219|16611320|P3|Maintenance Phase Weeks16-32|Adverse Event|8
4817902|NCT01194219|16611321|P2|Maintenance Phase Weeks16-32|Adverse Event|0
4817903|NCT01194219|16611322|P1|Maintenance Phase Weeks16-32|Adverse Event|0
4817904|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817905|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817906|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817907|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817908|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817909|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817910|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817911|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0
4817912|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
4817913|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1
4817914|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817915|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817916|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817917|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817918|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817919|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817920|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817921|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0
4817922|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1
4817923|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7
4817924|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817925|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817926|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817927|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817928|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817929|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817930|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817931|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0
4817932|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9
4817933|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7
4817934|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Death|0
4817935|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Death|0
4817936|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Death|0
4817937|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Death|0
4817938|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Death|0
4817939|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Death|0
4817940|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Death|0
4817941|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Death|0
4817942|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Death|1
4817943|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Death|0
4817944|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817945|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817946|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817947|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817948|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817949|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817950|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817951|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0
4817952|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9
4817953|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12
4817954|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817955|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817956|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817957|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817958|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817959|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817960|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817961|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817962|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0
4817963|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7
4817964|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817965|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817966|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817967|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817968|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817969|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817970|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817971|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0
4817972|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7
4817973|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2
4817974|NCT01194219|16611313|P10|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817975|NCT01194219|16611314|P9|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817976|NCT01194219|16611315|P8|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817977|NCT01194219|16611316|P7|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817978|NCT01194219|16611317|P6|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817979|NCT01194219|16611318|P5|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817980|NCT01194219|16611319|P4|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817981|NCT01194219|16611320|P3|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0
4817982|NCT01194219|16611321|P2|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5
4817983|NCT01194219|16611322|P1|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23
4817984|NCT01194154|16611356|P2|Overall Study|Did not receive study medication|4
4817985|NCT01194154|16611357|P1|Overall Study|Did not receive study medication|2
4817986|NCT01194154|16611356|P2|Overall Study|Other|0
4817987|NCT01194154|16611357|P1|Overall Study|Other|4
4817988|NCT01194154|16611356|P2|Overall Study|Treatment with prohibited medication|5
4817989|NCT01194154|16611357|P1|Overall Study|Treatment with prohibited medication|4
4817990|NCT01194154|16611356|P2|Overall Study|Skipping of CERA treatment at two visits|0
4817991|NCT01194154|16611357|P1|Overall Study|Skipping of CERA treatment at two visits|3
4817992|NCT01194154|16611356|P2|Overall Study|Hemoglobin increase|3
4817993|NCT01194154|16611357|P1|Overall Study|Hemoglobin increase|12
4817994|NCT01194154|16611356|P2|Overall Study|Hemoglobin decrease|1
4817995|NCT01194154|16611357|P1|Overall Study|Hemoglobin decrease|0
4817996|NCT01194154|16611356|P2|Overall Study|Blood pressure increase|3
4817997|NCT01194154|16611357|P1|Overall Study|Blood pressure increase|5
4817998|NCT01194154|16611356|P2|Overall Study|Withdrawal by Subject|6
4817999|NCT01194154|16611357|P1|Overall Study|Withdrawal by Subject|5
4818000|NCT01194154|16611356|P2|Overall Study|Protocol Violation|1
4818001|NCT01194154|16611357|P1|Overall Study|Protocol Violation|0
4818002|NCT01194154|16611356|P2|Overall Study|Lost to Follow-up|3
4818003|NCT01194154|16611357|P1|Overall Study|Lost to Follow-up|2
4818004|NCT01194154|16611356|P2|Overall Study|Adverse Event|7
4818005|NCT01194154|16611357|P1|Overall Study|Adverse Event|12
4818006|NCT01193920|16611398|P10|Overall Study|Unable to classify|0
4818007|NCT01193920|16611399|P9|Overall Study|Unable to classify|0
4818008|NCT01193920|16611400|P8|Overall Study|Unable to classify|1
4818009|NCT01193920|16611401|P7|Overall Study|Unable to classify|0
4818010|NCT01193920|16611402|P6|Overall Study|Unable to classify|0
4818011|NCT01193920|16611403|P5|Overall Study|Unable to classify|0
4818012|NCT01193920|16611404|P4|Overall Study|Unable to classify|1
4818013|NCT01193920|16611405|P3|Overall Study|Unable to classify|0
4818014|NCT01193920|16611406|P2|Overall Study|Unable to classify|0
4818015|NCT01193920|16611407|P1|Overall Study|Unable to classify|0
4818016|NCT01193920|16611398|P10|Overall Study|Death|4
4818017|NCT01193920|16611399|P9|Overall Study|Death|2
4818018|NCT01193920|16611400|P8|Overall Study|Death|3
4818019|NCT01193920|16611401|P7|Overall Study|Death|2
4818020|NCT01193920|16611402|P6|Overall Study|Death|0
4818021|NCT01193920|16611403|P5|Overall Study|Death|0
4818022|NCT01193920|16611404|P4|Overall Study|Death|1
4818023|NCT01193920|16611405|P3|Overall Study|Death|0
4818024|NCT01193920|16611406|P2|Overall Study|Death|0
4818025|NCT01193920|16611407|P1|Overall Study|Death|0
4818026|NCT01193920|16611398|P10|Overall Study|Protocol Violation|0
4818027|NCT01193920|16611399|P9|Overall Study|Protocol Violation|0
4818028|NCT01193920|16611400|P8|Overall Study|Protocol Violation|0
4818029|NCT01193920|16611401|P7|Overall Study|Protocol Violation|0
4818030|NCT01193920|16611402|P6|Overall Study|Protocol Violation|0
4818031|NCT01193920|16611403|P5|Overall Study|Protocol Violation|0
4818032|NCT01193920|16611404|P4|Overall Study|Protocol Violation|0
4818033|NCT01193920|16611405|P3|Overall Study|Protocol Violation|0
4818034|NCT01193920|16611406|P2|Overall Study|Protocol Violation|0
4818035|NCT01193920|16611407|P1|Overall Study|Protocol Violation|1
4818036|NCT01193920|16611398|P10|Overall Study|Lost to Follow-up|3
4818037|NCT01193920|16611399|P9|Overall Study|Lost to Follow-up|2
4818038|NCT01193920|16611400|P8|Overall Study|Lost to Follow-up|0
4818039|NCT01193920|16611401|P7|Overall Study|Lost to Follow-up|1
4818040|NCT01193920|16611402|P6|Overall Study|Lost to Follow-up|3
4818041|NCT01193920|16611403|P5|Overall Study|Lost to Follow-up|3
4818042|NCT01193920|16611404|P4|Overall Study|Lost to Follow-up|1
4818043|NCT01193920|16611405|P3|Overall Study|Lost to Follow-up|1
4818044|NCT01193920|16611406|P2|Overall Study|Lost to Follow-up|0
4818045|NCT01193920|16611407|P1|Overall Study|Lost to Follow-up|1
4818046|NCT01193920|16611398|P10|Overall Study|Withdrawal by Subject|0
4818047|NCT01193920|16611399|P9|Overall Study|Withdrawal by Subject|1
4818048|NCT01193920|16611400|P8|Overall Study|Withdrawal by Subject|0
4818049|NCT01193920|16611401|P7|Overall Study|Withdrawal by Subject|3
4818050|NCT01193920|16611402|P6|Overall Study|Withdrawal by Subject|1
4818051|NCT01193920|16611403|P5|Overall Study|Withdrawal by Subject|3
4818052|NCT01193920|16611404|P4|Overall Study|Withdrawal by Subject|1
4818053|NCT01193920|16611405|P3|Overall Study|Withdrawal by Subject|5
4818054|NCT01193920|16611406|P2|Overall Study|Withdrawal by Subject|0
4818055|NCT01193920|16611407|P1|Overall Study|Withdrawal by Subject|1
4818056|NCT01193842|16611503|P5|Phase II: Randomized Groups|Disease progression/relapse on treatment|3
4818057|NCT01193842|16611504|P4|Phase II: Randomized Groups|Disease progression/relapse on treatment|5
4818058|NCT01193842|16611505|P3|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
4818059|NCT01193842|16611506|P2|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
4818060|NCT01193842|16611507|P1|Phase II: Randomized Groups|Disease progression/relapse on treatment|0
4818061|NCT01193842|16611503|P5|Phase II: Randomized Groups|Ineligible|1
4818062|NCT01193842|16611504|P4|Phase II: Randomized Groups|Ineligible|0
4818063|NCT01193842|16611505|P3|Phase II: Randomized Groups|Ineligible|0
4818064|NCT01193842|16611506|P2|Phase II: Randomized Groups|Ineligible|0
4818065|NCT01193842|16611507|P1|Phase II: Randomized Groups|Ineligible|0
4818066|NCT01193842|16611503|P5|Phase II: Randomized Groups|Withdrawal by Subject|2
4818067|NCT01193842|16611504|P4|Phase II: Randomized Groups|Withdrawal by Subject|1
4818068|NCT01193842|16611505|P3|Phase II: Randomized Groups|Withdrawal by Subject|0
4818069|NCT01193842|16611506|P2|Phase II: Randomized Groups|Withdrawal by Subject|0
4818070|NCT01193842|16611507|P1|Phase II: Randomized Groups|Withdrawal by Subject|0
4818071|NCT01193842|16611503|P5|Phase II: Randomized Groups|Adverse Event|3
4818072|NCT01193842|16611504|P4|Phase II: Randomized Groups|Adverse Event|5
4818073|NCT01193842|16611505|P3|Phase II: Randomized Groups|Adverse Event|0
4818074|NCT01193842|16611506|P2|Phase II: Randomized Groups|Adverse Event|0
4818075|NCT01193842|16611507|P1|Phase II: Randomized Groups|Adverse Event|0
4818076|NCT01193842|16611503|P5|Phase II: Randomized Groups|Death|1
4818077|NCT01193842|16611504|P4|Phase II: Randomized Groups|Death|1
4818078|NCT01193842|16611505|P3|Phase II: Randomized Groups|Death|0
4818079|NCT01193842|16611506|P2|Phase II: Randomized Groups|Death|0
4818080|NCT01193842|16611507|P1|Phase II: Randomized Groups|Death|0
4818081|NCT01193842|16611503|P5|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4818082|NCT01193842|16611504|P4|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4818083|NCT01193842|16611505|P3|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1
4818084|NCT01193842|16611506|P2|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4818085|NCT01193842|16611507|P1|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0
4818086|NCT01193842|16611503|P5|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4818087|NCT01193842|16611504|P4|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4818088|NCT01193842|16611505|P3|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4818089|NCT01193842|16611506|P2|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0
4818090|NCT01193842|16611507|P1|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1
4818091|NCT01193842|16611503|P5|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4818092|NCT01193842|16611504|P4|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4818093|NCT01193842|16611505|P3|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4818094|NCT01193842|16611506|P2|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1
4818095|NCT01193842|16611507|P1|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0
4818096|NCT01193686|16611542|P2|Overall Study|Removed by Investigators; unable to matc|0
4818097|NCT01193686|16611543|P1|Overall Study|Removed by Investigators; unable to matc|3
4818098|NCT01193686|16611542|P2|Overall Study|Withdrawal by Subject|1
4818099|NCT01193686|16611543|P1|Overall Study|Withdrawal by Subject|4
4818100|NCT01193660|16611560|P3|Overall Study|Physician Decision|1
4818101|NCT01193660|16611561|P2|Overall Study|Physician Decision|0
4818102|NCT01193660|16611562|P1|Overall Study|Physician Decision|1
4818103|NCT01193660|16611560|P3|Overall Study|Death|0
4818104|NCT01193660|16611561|P2|Overall Study|Death|0
4818105|NCT01193660|16611562|P1|Overall Study|Death|1
4818106|NCT01193660|16611560|P3|Overall Study|Withdrawal by Subject|1
4818107|NCT01193660|16611561|P2|Overall Study|Withdrawal by Subject|3
4818108|NCT01193660|16611562|P1|Overall Study|Withdrawal by Subject|2
4818109|NCT01193608|16611606|P6|Overall Study|Adverse Event|0
4818110|NCT01193608|16611607|P5|Overall Study|Adverse Event|1
4818111|NCT01193608|16611608|P4|Overall Study|Adverse Event|0
4818112|NCT01193608|16611609|P3|Overall Study|Adverse Event|0
4818113|NCT01193608|16611610|P2|Overall Study|Adverse Event|0
4818114|NCT01193608|16611611|P1|Overall Study|Adverse Event|0
4818115|NCT01193608|16611606|P6|Overall Study|Lost to Follow-up|2
4818116|NCT01193608|16611607|P5|Overall Study|Lost to Follow-up|1
4818117|NCT01193608|16611608|P4|Overall Study|Lost to Follow-up|0
4818118|NCT01193608|16611609|P3|Overall Study|Lost to Follow-up|0
4818119|NCT01193608|16611610|P2|Overall Study|Lost to Follow-up|0
4818120|NCT01193608|16611611|P1|Overall Study|Lost to Follow-up|0
4818121|NCT01193608|16611606|P6|Overall Study|Withdrawal by Subject|0
4818122|NCT01193608|16611607|P5|Overall Study|Withdrawal by Subject|3
4818123|NCT01193608|16611608|P4|Overall Study|Withdrawal by Subject|3
4818124|NCT01193608|16611609|P3|Overall Study|Withdrawal by Subject|2
4818125|NCT01193608|16611610|P2|Overall Study|Withdrawal by Subject|1
4818126|NCT01193608|16611611|P1|Overall Study|Withdrawal by Subject|0
4818127|NCT01193608|16611606|P6|Overall Study|Other|0
4818128|NCT01193608|16611607|P5|Overall Study|Other|0
4818129|NCT01193608|16611608|P4|Overall Study|Other|0
4818130|NCT01193608|16611609|P3|Overall Study|Other|0
4818131|NCT01193608|16611610|P2|Overall Study|Other|1
4818132|NCT01193608|16611611|P1|Overall Study|Other|0
4818133|NCT01193582|16611848|P4|12 Month Follow-up|Withdrawal by Subject|11
4818134|NCT01193582|16611849|P3|12 Month Follow-up|Withdrawal by Subject|3
4818135|NCT01193582|16611850|P2|12 Month Follow-up|Withdrawal by Subject|0
4818136|NCT01193582|16611851|P1|12 Month Follow-up|Withdrawal by Subject|6
4818137|NCT01193582|16611848|P4|12 Month Follow-up|Death|0
4818138|NCT01193582|16611849|P3|12 Month Follow-up|Death|1
4818139|NCT01193582|16611850|P2|12 Month Follow-up|Death|0
4818140|NCT01193582|16611851|P1|12 Month Follow-up|Death|0
4818141|NCT01193582|16611848|P4|Vaccination Series|Withdrawal by Subject|3
4818142|NCT01193582|16611849|P3|Vaccination Series|Withdrawal by Subject|8
4818143|NCT01193582|16611850|P2|Vaccination Series|Withdrawal by Subject|13
4818144|NCT01193582|16611851|P1|Vaccination Series|Withdrawal by Subject|11
4818145|NCT01193556|16611881|P2|Overall Study|Study termination|25
4818146|NCT01193556|16611882|P1|Overall Study|Study termination|26
4818147|NCT01193530|16611892|P2|Overall Study|Non-Compliance|1
4818148|NCT01193530|16611893|P1|Overall Study|Non-Compliance|0
4818149|NCT01193530|16611892|P2|Overall Study|Returned home - out of state|1
4818150|NCT01193530|16611893|P1|Overall Study|Returned home - out of state|0
4818151|NCT01193530|16611892|P2|Overall Study|Lost Light Box|1
4818152|NCT01193530|16611893|P1|Overall Study|Lost Light Box|0
4818153|NCT01193530|16611892|P2|Overall Study|Began Contraindicated Therapy|0
4818154|NCT01193530|16611893|P1|Overall Study|Began Contraindicated Therapy|1
4818155|NCT01193530|16611892|P2|Overall Study|Withdrawal by Subject|2
4818156|NCT01193530|16611893|P1|Overall Study|Withdrawal by Subject|2
4818157|NCT01193517|16611902|P3|Overall Study|Early Progression|0
4818158|NCT01193517|16611903|P2|Overall Study|Early Progression|0
4818159|NCT01193517|16611904|P1|Overall Study|Early Progression|1
4818248|NCT01193218|16612147|P3|0-12 Weeks|Adverse Event|1
4818160|NCT01193348|16611913|P1|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2
4818161|NCT01193348|16611913|P1|Extension Treatment Period|Physician Decision|1
4818162|NCT01193348|16611913|P1|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1
4818163|NCT01193348|16611913|P1|Treatment Period (26 Weeks)|Serious Adverse Event|1
4818164|NCT01193348|16611913|P1|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1
4818165|NCT01193348|16611913|P1|Screening Period|Screen Failure|5
4818166|NCT01193335|16611933|P2|2-Year Follow-up|No Longer Met Eligibility Criteria|2
4818167|NCT01193335|16611934|P1|2-Year Follow-up|No Longer Met Eligibility Criteria|2
4818168|NCT01193335|16611933|P2|2-Year Follow-up|No Longer Willing to Participate|6
4818169|NCT01193335|16611934|P1|2-Year Follow-up|No Longer Willing to Participate|5
4818170|NCT01193335|16611933|P2|1-Year Follow-up|Lost to Follow-up|0
4818171|NCT01193335|16611934|P1|1-Year Follow-up|Lost to Follow-up|4
4818172|NCT01193335|16611933|P2|1-Year Follow-up|No Longer Willing to Participate|9
4818173|NCT01193335|16611934|P1|1-Year Follow-up|No Longer Willing to Participate|7
4818174|NCT01193335|16611933|P2|After Infant Series|No Longer Met Eligibility Criteria|1
4818175|NCT01193335|16611934|P1|After Infant Series|No Longer Met Eligibility Criteria|0
4818176|NCT01193335|16611933|P2|After Infant Series|Lost to Follow-up|2
4818177|NCT01193335|16611934|P1|After Infant Series|Lost to Follow-up|1
4818178|NCT01193283|16612029|P1|Overall Study|Death|1
4818179|NCT01193257|16612035|P2|Overall Study|Unblinded due to futility|251
4818180|NCT01193257|16612036|P1|Overall Study|Unblinded due to futility|135
4818181|NCT01193257|16612035|P2|Overall Study|Lost to Follow-up|3
4818182|NCT01193257|16612036|P1|Overall Study|Lost to Follow-up|2
4818183|NCT01193257|16612035|P2|Overall Study|Withdrawal by Subject|86
4818184|NCT01193257|16612036|P1|Overall Study|Withdrawal by Subject|26
4818185|NCT01193257|16612035|P2|Overall Study|Study termination by sponsor|3
4818186|NCT01193257|16612036|P1|Overall Study|Study termination by sponsor|0
4818187|NCT01193257|16612035|P2|Overall Study|Death|391
4818188|NCT01193257|16612036|P1|Overall Study|Death|202
4818189|NCT01193244|16612086|P2|Overall Study|Lost to Follow-up|15
4818190|NCT01193244|16612087|P1|Overall Study|Lost to Follow-up|6
4818191|NCT01193244|16612086|P2|Overall Study|Other|278
4818192|NCT01193244|16612087|P1|Overall Study|Other|303
4818193|NCT01193244|16612086|P2|Overall Study|Withdrawal by Subject|97
4818194|NCT01193244|16612087|P1|Overall Study|Withdrawal by Subject|79
4818195|NCT01193218|16612142|P8|12-52 Weeks|Other reason than above|0
4818196|NCT01193218|16612143|P7|12-52 Weeks|Other reason than above|0
4818197|NCT01193218|16612144|P6|12-52 Weeks|Other reason than above|0
4818198|NCT01193218|16612145|P5|12-52 Weeks|Other reason than above|1
4818199|NCT01193218|16612146|P4|12-52 Weeks|Other reason than above|1
4818200|NCT01193218|16612147|P3|12-52 Weeks|Other reason than above|0
4818201|NCT01193218|16612148|P2|12-52 Weeks|Other reason than above|0
4818202|NCT01193218|16612149|P1|12-52 Weeks|Other reason than above|1
4818203|NCT01193218|16612142|P8|12-52 Weeks|Withdrawal by Subject|2
4818204|NCT01193218|16612143|P7|12-52 Weeks|Withdrawal by Subject|1
4818205|NCT01193218|16612144|P6|12-52 Weeks|Withdrawal by Subject|2
4818206|NCT01193218|16612145|P5|12-52 Weeks|Withdrawal by Subject|0
4818207|NCT01193218|16612146|P4|12-52 Weeks|Withdrawal by Subject|0
4818208|NCT01193218|16612147|P3|12-52 Weeks|Withdrawal by Subject|3
4818209|NCT01193218|16612148|P2|12-52 Weeks|Withdrawal by Subject|0
4818210|NCT01193218|16612149|P1|12-52 Weeks|Withdrawal by Subject|3
4818211|NCT01193218|16612142|P8|12-52 Weeks|Lack of Efficacy|0
4818212|NCT01193218|16612143|P7|12-52 Weeks|Lack of Efficacy|1
4818213|NCT01193218|16612144|P6|12-52 Weeks|Lack of Efficacy|0
4818214|NCT01193218|16612145|P5|12-52 Weeks|Lack of Efficacy|0
4818215|NCT01193218|16612146|P4|12-52 Weeks|Lack of Efficacy|0
4818216|NCT01193218|16612147|P3|12-52 Weeks|Lack of Efficacy|0
4818217|NCT01193218|16612148|P2|12-52 Weeks|Lack of Efficacy|0
4818218|NCT01193218|16612149|P1|12-52 Weeks|Lack of Efficacy|0
4818219|NCT01193218|16612142|P8|12-52 Weeks|Adverse Event|2
4818220|NCT01193218|16612143|P7|12-52 Weeks|Adverse Event|1
4818221|NCT01193218|16612144|P6|12-52 Weeks|Adverse Event|3
4818222|NCT01193218|16612145|P5|12-52 Weeks|Adverse Event|3
4818223|NCT01193218|16612146|P4|12-52 Weeks|Adverse Event|2
4818224|NCT01193218|16612147|P3|12-52 Weeks|Adverse Event|1
4818225|NCT01193218|16612148|P2|12-52 Weeks|Adverse Event|0
4818226|NCT01193218|16612149|P1|12-52 Weeks|Adverse Event|1
4818227|NCT01193218|16612142|P8|0-12 Weeks|Withdrawal by Subject|0
4818228|NCT01193218|16612143|P7|0-12 Weeks|Withdrawal by Subject|1
4818229|NCT01193218|16612144|P6|0-12 Weeks|Withdrawal by Subject|0
4818230|NCT01193218|16612145|P5|0-12 Weeks|Withdrawal by Subject|0
4818231|NCT01193218|16612146|P4|0-12 Weeks|Withdrawal by Subject|0
4818232|NCT01193218|16612147|P3|0-12 Weeks|Withdrawal by Subject|2
4818233|NCT01193218|16612148|P2|0-12 Weeks|Withdrawal by Subject|0
4818234|NCT01193218|16612149|P1|0-12 Weeks|Withdrawal by Subject|3
4818235|NCT01193218|16612142|P8|0-12 Weeks|Protocol Violation|0
4818236|NCT01193218|16612143|P7|0-12 Weeks|Protocol Violation|0
4818237|NCT01193218|16612144|P6|0-12 Weeks|Protocol Violation|1
4818238|NCT01193218|16612145|P5|0-12 Weeks|Protocol Violation|1
4818239|NCT01193218|16612146|P4|0-12 Weeks|Protocol Violation|0
4818240|NCT01193218|16612147|P3|0-12 Weeks|Protocol Violation|0
4818241|NCT01193218|16612148|P2|0-12 Weeks|Protocol Violation|0
4818242|NCT01193218|16612149|P1|0-12 Weeks|Protocol Violation|0
4818243|NCT01193218|16612142|P8|0-12 Weeks|Adverse Event|0
4818244|NCT01193218|16612143|P7|0-12 Weeks|Adverse Event|2
4818245|NCT01193218|16612144|P6|0-12 Weeks|Adverse Event|2
4818246|NCT01193218|16612145|P5|0-12 Weeks|Adverse Event|0
4818247|NCT01193218|16612146|P4|0-12 Weeks|Adverse Event|0
4818249|NCT01193218|16612148|P2|0-12 Weeks|Adverse Event|0
4818250|NCT01193218|16612149|P1|0-12 Weeks|Adverse Event|6
4818251|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3
4818252|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1
4818253|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Experienced Relapse|57
4818254|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Experienced Relapse|25
4818255|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Withdrawal by Subject|30
4818256|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Withdrawal by Subject|19
4818257|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Pregnancy|0
4818258|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Pregnancy|1
4818259|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Lost to Follow-up|9
4818260|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Lost to Follow-up|2
4818261|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Death|0
4818262|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Death|2
4818263|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Adverse Event|3
4818264|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Adverse Event|12
4818265|NCT01193153|16612180|P2|Double Blind Relapse Prevention Period|Other|3
4818266|NCT01193153|16612181|P1|Double Blind Relapse Prevention Period|Other|2
4818267|NCT01193153|16612180|P2|Open-label Stabilization Period|Other|0
4818268|NCT01193153|16612181|P1|Open-label Stabilization Period|Other|8
4818269|NCT01193153|16612180|P2|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0
4818270|NCT01193153|16612181|P1|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35
4818271|NCT01193153|16612180|P2|Open-label Stabilization Period|Withdrawal by Subject|0
4818272|NCT01193153|16612181|P1|Open-label Stabilization Period|Withdrawal by Subject|29
4818273|NCT01193153|16612180|P2|Open-label Stabilization Period|Lack of Efficacy|0
4818274|NCT01193153|16612181|P1|Open-label Stabilization Period|Lack of Efficacy|5
4818275|NCT01193153|16612180|P2|Open-label Stabilization Period|Lost to Follow-up|0
4818276|NCT01193153|16612181|P1|Open-label Stabilization Period|Lost to Follow-up|10
4818277|NCT01193153|16612180|P2|Open-label Stabilization Period|Death|0
4818278|NCT01193153|16612181|P1|Open-label Stabilization Period|Death|2
4818279|NCT01193153|16612180|P2|Open-label Stabilization Period|Adverse Event|0
4818280|NCT01193153|16612181|P1|Open-label Stabilization Period|Adverse Event|9
4818281|NCT01193153|16612180|P2|Open-label Lead in Period|Lack of Efficacy|0
4818282|NCT01193153|16612181|P1|Open-label Lead in Period|Lack of Efficacy|26
4818283|NCT01193153|16612180|P2|Open-label Lead in Period|Death|0
4818284|NCT01193153|16612181|P1|Open-label Lead in Period|Death|1
4818285|NCT01193153|16612180|P2|Open-label Lead in Period|Adverse Event|0
4818286|NCT01193153|16612181|P1|Open-label Lead in Period|Adverse Event|41
4818287|NCT01193153|16612180|P2|Open-label Lead in Period|Subject Failed Stabilization Criteria|0
4818288|NCT01193153|16612181|P1|Open-label Lead in Period|Subject Failed Stabilization Criteria|47
4818289|NCT01193153|16612180|P2|Open-label Lead in Period|Other|0
4818290|NCT01193153|16612181|P1|Open-label Lead in Period|Other|14
4818291|NCT01193153|16612180|P2|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0
4818292|NCT01193153|16612181|P1|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4
4818293|NCT01193153|16612180|P2|Open-label Lead in Period|Withdrawal by Subject|0
4818294|NCT01193153|16612181|P1|Open-label Lead in Period|Withdrawal by Subject|69
4818295|NCT01193153|16612180|P2|Open-label Lead in Period|Pregnancy|0
4818296|NCT01193153|16612181|P1|Open-label Lead in Period|Pregnancy|1
4818297|NCT01193153|16612180|P2|Open-label Lead in Period|Lost to Follow-up|0
4818298|NCT01193153|16612181|P1|Open-label Lead in Period|Lost to Follow-up|32
4818299|NCT01193127|16612216|P4|Treated|Withdrawal by Subject|1
4818300|NCT01193127|16612217|P3|Treated|Withdrawal by Subject|0
4818301|NCT01193127|16612218|P2|Treated|Withdrawal by Subject|0
4818302|NCT01193127|16612219|P1|Treated|Withdrawal by Subject|0
4818303|NCT01193127|16612216|P4|Randomized|Surgery Cancelled|1
4818304|NCT01193127|16612217|P3|Randomized|Surgery Cancelled|0
4818305|NCT01193127|16612218|P2|Randomized|Surgery Cancelled|0
4818306|NCT01193127|16612219|P1|Randomized|Surgery Cancelled|0
4818307|NCT01193101|16612544|P4|Overall Study|Abnormal test procedure results|0
4818308|NCT01193101|16612545|P3|Overall Study|Abnormal test procedure results|0
4818309|NCT01193101|16612546|P2|Overall Study|Abnormal test procedure results|1
4818310|NCT01193101|16612547|P1|Overall Study|Abnormal test procedure results|0
4818311|NCT01193101|16612544|P4|Overall Study|Administrative problems|0
4818312|NCT01193101|16612545|P3|Overall Study|Administrative problems|1
4818313|NCT01193101|16612546|P2|Overall Study|Administrative problems|0
4818314|NCT01193101|16612547|P1|Overall Study|Administrative problems|0
4818315|NCT01193101|16612544|P4|Overall Study|Withdrawal by Subject|1
4818316|NCT01193101|16612545|P3|Overall Study|Withdrawal by Subject|1
4818317|NCT01193101|16612546|P2|Overall Study|Withdrawal by Subject|4
4818318|NCT01193101|16612547|P1|Overall Study|Withdrawal by Subject|2
4818319|NCT01193101|16612544|P4|Overall Study|Lack of Efficacy|8
4818320|NCT01193101|16612545|P3|Overall Study|Lack of Efficacy|0
4818321|NCT01193101|16612546|P2|Overall Study|Lack of Efficacy|1
4818322|NCT01193101|16612547|P1|Overall Study|Lack of Efficacy|3
4818323|NCT01193101|16612544|P4|Overall Study|Adverse Event|3
4818324|NCT01193101|16612545|P3|Overall Study|Adverse Event|1
4818325|NCT01193101|16612546|P2|Overall Study|Adverse Event|1
4818326|NCT01193101|16612547|P1|Overall Study|Adverse Event|0
4818327|NCT01192815|16612664|P1|Overall Study|Lack of Efficacy|1
4818328|NCT01192815|16612664|P1|Overall Study|Withdrawal by Subject|1
4818329|NCT01192776|16612679|P4|Overall Study|Lost to Follow-up|5
4818330|NCT01192776|16612680|P3|Overall Study|Lost to Follow-up|3
4818331|NCT01192776|16612681|P2|Overall Study|Lost to Follow-up|6
4818332|NCT01192776|16612682|P1|Overall Study|Lost to Follow-up|3
4818333|NCT01192776|16612679|P4|Overall Study|Death|15
4818334|NCT01192776|16612680|P3|Overall Study|Death|18
4818335|NCT01192776|16612681|P2|Overall Study|Death|15
4818336|NCT01192776|16612682|P1|Overall Study|Death|8
4818337|NCT01192516|16612760|P3|Overall Study|Unable to follow Actiwatch instructions|0
4818338|NCT01192516|16612761|P2|Overall Study|Unable to follow Actiwatch instructions|2
4818339|NCT01192516|16612762|P1|Overall Study|Unable to follow Actiwatch instructions|4
4818340|NCT01192516|16612760|P3|Overall Study|started new treatment|0
4818341|NCT01192516|16612761|P2|Overall Study|started new treatment|1
4818342|NCT01192516|16612762|P1|Overall Study|started new treatment|5
4818343|NCT01192516|16612760|P3|Overall Study|Withdrawal by Subject|1
4818344|NCT01192516|16612761|P2|Overall Study|Withdrawal by Subject|4
4818345|NCT01192516|16612762|P1|Overall Study|Withdrawal by Subject|4
4818346|NCT01192516|16612760|P3|Overall Study|Lost to Follow-up|7
4818347|NCT01192516|16612761|P2|Overall Study|Lost to Follow-up|10
4818348|NCT01192516|16612762|P1|Overall Study|Lost to Follow-up|7
4818349|NCT01192412|16612796|P2|Overall Study|Withdrawal by Subject|1
4818350|NCT01192412|16612797|P1|Overall Study|Withdrawal by Subject|2
4818351|NCT01192412|16612796|P2|Overall Study|Lost to Follow-up|1
4818352|NCT01192412|16612797|P1|Overall Study|Lost to Follow-up|2
4818353|NCT01192399|16612805|P1|Overall Study|Lack of Efficacy|2
4818354|NCT01192347|16612815|P1|Overall Study|Patient did not show up for visits|1
4818355|NCT01192347|16612815|P1|Overall Study|Patient not visiting hospital regularly|1
4818356|NCT01192347|16612815|P1|Overall Study|Patient seen in different hospital|1
4818357|NCT01192347|16612815|P1|Overall Study|Suspected serious adverse drug reaction|1
4818358|NCT01192347|16612815|P1|Overall Study|Adverse Event|1
4818359|NCT01192347|16612815|P1|Overall Study|Withdrawal by Subject|1
4818360|NCT01192347|16612815|P1|Overall Study|Lost to Follow-up|3
4818361|NCT01192347|16612815|P1|Overall Study|Death|3
4818362|NCT01192295|16612838|P2|Overall Study|Administrative|6
4818363|NCT01192295|16612839|P1|Overall Study|Administrative|4
4818364|NCT01192295|16612838|P2|Overall Study|Lack of Efficacy|5
4818365|NCT01192295|16612839|P1|Overall Study|Lack of Efficacy|0
4818366|NCT01192295|16612838|P2|Overall Study|Lost to Follow-up|1
4818367|NCT01192295|16612839|P1|Overall Study|Lost to Follow-up|0
4818368|NCT01192295|16612838|P2|Overall Study|Withdrawal by Subject|4
4818369|NCT01192295|16612839|P1|Overall Study|Withdrawal by Subject|3
4818370|NCT01192295|16612838|P2|Overall Study|Adverse Event|7
4818371|NCT01192295|16612839|P1|Overall Study|Adverse Event|3
4818372|NCT01192204|16612877|P2|Overall Study|could not keep recall appointments|0
4818373|NCT01192204|16612878|P1|Overall Study|could not keep recall appointments|1
4818374|NCT01192191|16612890|P2|Overall Study|Withdrawal by Subject|6
4818375|NCT01192191|16612891|P1|Overall Study|Withdrawal by Subject|1
4818376|NCT01192191|16612890|P2|Overall Study|Lost to Follow-up|1
4818377|NCT01192191|16612891|P1|Overall Study|Lost to Follow-up|0
4818378|NCT01192191|16612890|P2|Overall Study|Participants Reached Stopping Criteria|2
4818379|NCT01192191|16612891|P1|Overall Study|Participants Reached Stopping Criteria|3
4818380|NCT01192191|16612890|P2|Overall Study|Adverse Event|12
4818381|NCT01192191|16612891|P1|Overall Study|Adverse Event|7
4818382|NCT01192178|16612917|P2|Overall Study|Lack of Efficacy|2
4818383|NCT01192178|16612918|P1|Overall Study|Lack of Efficacy|1
4818384|NCT01192178|16612917|P2|Overall Study|Adverse Event|1
4818385|NCT01192178|16612918|P1|Overall Study|Adverse Event|2
4818386|NCT01192178|16612917|P2|Overall Study|Lost to Follow-up|3
4818387|NCT01192178|16612918|P1|Overall Study|Lost to Follow-up|3
4818388|NCT01192178|16612917|P2|Overall Study|Physician Decision|4
4818389|NCT01192178|16612918|P1|Overall Study|Physician Decision|2
4818390|NCT01192178|16612917|P2|Overall Study|Protocol Violation|3
4818391|NCT01192178|16612918|P1|Overall Study|Protocol Violation|10
4818392|NCT01192178|16612917|P2|Overall Study|Withdrawal by Subject|10
4818393|NCT01192178|16612918|P1|Overall Study|Withdrawal by Subject|6
4818394|NCT01192152|16612938|P2|Period 3|family emergency|0
4818395|NCT01192152|16612939|P1|Period 3|family emergency|1
4818396|NCT01192152|16612938|P2|Period 1|left prematurely (while on treatment B)|1
4818397|NCT01192152|16612939|P1|Period 1|left prematurely (while on treatment B)|0
4818398|NCT01192126|16613110|P2|First Intervention (1 Week)|Lost to Follow-up|1
4818399|NCT01192126|16613111|P1|First Intervention (1 Week)|Lost to Follow-up|1
4818400|NCT01192126|16613110|P2|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0
4818401|NCT01192126|16613111|P1|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1
4818402|NCT01192100|16613119|P6|Overall Study|Protocol Violation|0
4818403|NCT01192100|16613120|P5|Overall Study|Protocol Violation|0
4818404|NCT01192100|16613121|P4|Overall Study|Protocol Violation|1
4818405|NCT01192100|16613122|P3|Overall Study|Protocol Violation|0
4818406|NCT01192100|16613123|P2|Overall Study|Protocol Violation|0
4818407|NCT01192100|16613124|P1|Overall Study|Protocol Violation|0
4818408|NCT01192100|16613119|P6|Overall Study|Withdrawal by Subject|0
4818409|NCT01192100|16613120|P5|Overall Study|Withdrawal by Subject|1
4818410|NCT01192100|16613121|P4|Overall Study|Withdrawal by Subject|0
4818411|NCT01192100|16613122|P3|Overall Study|Withdrawal by Subject|0
4818412|NCT01192100|16613123|P2|Overall Study|Withdrawal by Subject|0
4818413|NCT01192100|16613124|P1|Overall Study|Withdrawal by Subject|0
4818414|NCT01192022|16613144|P5|Overall Study|Parents did not allow all follow up|0
4818415|NCT01192022|16613145|P4|Overall Study|Parents did not allow all follow up|1
4818416|NCT01192022|16613146|P3|Overall Study|Parents did not allow all follow up|0
4818417|NCT01192022|16613147|P2|Overall Study|Parents did not allow all follow up|0
4818418|NCT01192022|16613148|P1|Overall Study|Parents did not allow all follow up|0
4818419|NCT01192022|16613144|P5|Overall Study|Patient needed surgery|0
4818420|NCT01192022|16613145|P4|Overall Study|Patient needed surgery|0
4818421|NCT01192022|16613146|P3|Overall Study|Patient needed surgery|0
4818422|NCT01192022|16613147|P2|Overall Study|Patient needed surgery|1
4818423|NCT01192022|16613148|P1|Overall Study|Patient needed surgery|0
4818424|NCT01192022|16613144|P5|Overall Study|Patient too sick from chemotherapy|0
4818425|NCT01192022|16613145|P4|Overall Study|Patient too sick from chemotherapy|0
4818426|NCT01192022|16613146|P3|Overall Study|Patient too sick from chemotherapy|0
4818427|NCT01192022|16613147|P2|Overall Study|Patient too sick from chemotherapy|1
4818428|NCT01192022|16613148|P1|Overall Study|Patient too sick from chemotherapy|0
4818429|NCT01192022|16613144|P5|Overall Study|Physician withdrew-patient hardship|0
4818430|NCT01192022|16613145|P4|Overall Study|Physician withdrew-patient hardship|0
4818431|NCT01192022|16613146|P3|Overall Study|Physician withdrew-patient hardship|0
4818432|NCT01192022|16613147|P2|Overall Study|Physician withdrew-patient hardship|0
4818433|NCT01192022|16613148|P1|Overall Study|Physician withdrew-patient hardship|1
4818434|NCT01192022|16613144|P5|Overall Study|Fatal Adverse Event|1
4818435|NCT01192022|16613145|P4|Overall Study|Fatal Adverse Event|0
4818436|NCT01192022|16613146|P3|Overall Study|Fatal Adverse Event|0
4818437|NCT01192022|16613147|P2|Overall Study|Fatal Adverse Event|6
4818438|NCT01192022|16613148|P1|Overall Study|Fatal Adverse Event|4
4818439|NCT01192022|16613144|P5|Overall Study|Adverse Event|0
4818440|NCT01192022|16613145|P4|Overall Study|Adverse Event|0
4818441|NCT01192022|16613146|P3|Overall Study|Adverse Event|0
4818442|NCT01192022|16613147|P2|Overall Study|Adverse Event|0
4818443|NCT01192022|16613148|P1|Overall Study|Adverse Event|1
4818444|NCT01192022|16613144|P5|Overall Study|Lost to Follow-up|0
4818445|NCT01192022|16613145|P4|Overall Study|Lost to Follow-up|1
4818446|NCT01192022|16613146|P3|Overall Study|Lost to Follow-up|1
4818447|NCT01192022|16613147|P2|Overall Study|Lost to Follow-up|2
4818448|NCT01192022|16613148|P1|Overall Study|Lost to Follow-up|4
4818449|NCT01192022|16613144|P5|Overall Study|Withdrawal of Consent|0
4818450|NCT01192022|16613145|P4|Overall Study|Withdrawal of Consent|0
4818451|NCT01192022|16613146|P3|Overall Study|Withdrawal of Consent|0
4818452|NCT01192022|16613147|P2|Overall Study|Withdrawal of Consent|1
4818453|NCT01192022|16613148|P1|Overall Study|Withdrawal of Consent|3
4818454|NCT01191944|16613171|P2|Overall Study|Other|3
4818455|NCT01191944|16613172|P1|Overall Study|Other|1
4818456|NCT01191944|16613171|P2|Overall Study|Withdrawal by Subject|2
4818457|NCT01191944|16613172|P1|Overall Study|Withdrawal by Subject|4
4818458|NCT01191944|16613171|P2|Overall Study|Protocol Violation|2
4818459|NCT01191944|16613172|P1|Overall Study|Protocol Violation|1
4818460|NCT01191944|16613171|P2|Overall Study|Adverse Event|12
4818461|NCT01191944|16613172|P1|Overall Study|Adverse Event|11
4818462|NCT01191840|16613218|P2|Overall Study|Withdrawal by Subject|0
4818463|NCT01191840|16613219|P1|Overall Study|Withdrawal by Subject|2
4818464|NCT01191840|16613218|P2|Overall Study|lab error speciation - non Staph infecti|1
4818465|NCT01191840|16613219|P1|Overall Study|lab error speciation - non Staph infecti|0
4818466|NCT01191840|16613218|P2|Overall Study|IRB approval lapse|2
4818467|NCT01191840|16613219|P1|Overall Study|IRB approval lapse|0
4818468|NCT01191840|16613218|P2|Overall Study|ineligible at enrollment|0
4818469|NCT01191840|16613219|P1|Overall Study|ineligible at enrollment|1
4818470|NCT01191840|16613218|P2|Overall Study|Non Staph Infection|3
4818471|NCT01191840|16613219|P1|Overall Study|Non Staph Infection|4
4818472|NCT01191840|16613218|P2|Overall Study|Lost to Follow-up|6
4818473|NCT01191840|16613219|P1|Overall Study|Lost to Follow-up|4
4818474|NCT01191840|16613218|P2|Overall Study|Subject discontinued treatment|2
4818475|NCT01191840|16613219|P1|Overall Study|Subject discontinued treatment|1
4818476|NCT01191840|16613218|P2|Overall Study|withdrew consent|1
4818477|NCT01191840|16613219|P1|Overall Study|withdrew consent|2
4818478|NCT01191801|16613244|P2|Overall Study|Not Provided|27
4818479|NCT01191801|16613245|P1|Overall Study|Not Provided|45
4818480|NCT01191801|16613244|P2|Overall Study|Withdrawal by Subject|4
4818481|NCT01191801|16613245|P1|Overall Study|Withdrawal by Subject|1
4818482|NCT01191801|16613244|P2|Overall Study|Physician Decision|24
4818483|NCT01191801|16613245|P1|Overall Study|Physician Decision|47
4818484|NCT01191801|16613244|P2|Overall Study|Protocol Violation|4
4818485|NCT01191801|16613245|P1|Overall Study|Protocol Violation|2
4818486|NCT01191801|16613244|P2|Overall Study|Adverse Event|8
4818487|NCT01191801|16613245|P1|Overall Study|Adverse Event|9
4818488|NCT01191801|16613244|P2|Overall Study|Lack of Efficacy|258
4818489|NCT01191801|16613245|P1|Overall Study|Lack of Efficacy|176
4818490|NCT01191801|16613244|P2|Overall Study|Death|12
4818491|NCT01191801|16613245|P1|Overall Study|Death|36
4818492|NCT01191788|16613265|P2|Overall Study|Lost to Follow-up|22
4818493|NCT01191788|16613266|P1|Overall Study|Lost to Follow-up|21
4818494|NCT01191762|16613276|P2|Overall Study|Adverse Event|0
4818495|NCT01191762|16613277|P1|Overall Study|Adverse Event|1
4818496|NCT01191268|16613435|P3|Overall Study|Sponsor Decision|0
4818497|NCT01191268|16613436|P2|Overall Study|Sponsor Decision|2
4818498|NCT01191268|16613437|P1|Overall Study|Sponsor Decision|0
4818499|NCT01191268|16613435|P3|Overall Study|Protocol Violation|1
4818500|NCT01191268|16613436|P2|Overall Study|Protocol Violation|0
4818501|NCT01191268|16613437|P1|Overall Study|Protocol Violation|1
4818502|NCT01191268|16613435|P3|Overall Study|Death|3
4818503|NCT01191268|16613436|P2|Overall Study|Death|1
4818504|NCT01191268|16613437|P1|Overall Study|Death|0
4818505|NCT01191268|16613435|P3|Overall Study|Entry Criteria Not Met|1
4818506|NCT01191268|16613436|P2|Overall Study|Entry Criteria Not Met|1
4818507|NCT01191268|16613437|P1|Overall Study|Entry Criteria Not Met|3
4818508|NCT01191268|16613435|P3|Overall Study|Lost to Follow-up|9
4818509|NCT01191268|16613436|P2|Overall Study|Lost to Follow-up|5
4818510|NCT01191268|16613437|P1|Overall Study|Lost to Follow-up|8
4818511|NCT01191268|16613435|P3|Overall Study|Physician Decision|9
4818512|NCT01191268|16613436|P2|Overall Study|Physician Decision|8
4818513|NCT01191268|16613437|P1|Overall Study|Physician Decision|6
4818514|NCT01191268|16613435|P3|Overall Study|Adverse Event|8
4818515|NCT01191268|16613436|P2|Overall Study|Adverse Event|13
4818516|NCT01191268|16613437|P1|Overall Study|Adverse Event|21
4818517|NCT01191268|16613435|P3|Overall Study|Withdrawal by Subject|21
4818518|NCT01191268|16613436|P2|Overall Study|Withdrawal by Subject|25
4818519|NCT01191268|16613437|P1|Overall Study|Withdrawal by Subject|19
4818520|NCT01191190|16613578|P1|Overall Study|Withdrawal by Subject|1
4818521|NCT01191086|16613591|P1|Overall Study|Other|1
4818522|NCT01191086|16613591|P1|Overall Study|Discontinuation criterion met|1
4818523|NCT01191086|16613591|P1|Overall Study|Withdrawal by Subject|24
4818524|NCT01191086|16613591|P1|Overall Study|Physician Decision|2
4818525|NCT01191086|16613591|P1|Overall Study|Lost to Follow-up|4
4818526|NCT01191086|16613591|P1|Overall Study|Lack of Efficacy|10
4818527|NCT01191086|16613591|P1|Overall Study|Adverse Event|20
4818528|NCT01191008|16613595|P1|Overall Study|Lost to Follow-up|8
4818529|NCT01191008|16613595|P1|Overall Study|Protocol Violation|7
4818530|NCT01190930|16613603|P10|Maintenance|Still on therapy|0
4818531|NCT01190930|16613604|P9|Maintenance|Still on therapy|0
4818532|NCT01190930|16613605|P8|Maintenance|Still on therapy|0
4818533|NCT01190930|16613606|P7|Maintenance|Still on therapy|0
4818534|NCT01190930|16613607|P6|Maintenance|Still on therapy|0
4818535|NCT01190930|16613608|P5|Maintenance|Still on therapy|0
4818536|NCT01190930|16613609|P4|Maintenance|Still on therapy|29
4818537|NCT01190930|16613610|P3|Maintenance|Still on therapy|0
4818538|NCT01190930|16613611|P2|Maintenance|Still on therapy|8
4818539|NCT01190930|16613612|P1|Maintenance|Still on therapy|0
4818540|NCT01190930|16613603|P10|Maintenance|Relapse|11
4818541|NCT01190930|16613604|P9|Maintenance|Relapse|11
4818542|NCT01190930|16613605|P8|Maintenance|Relapse|13
4818543|NCT01190930|16613606|P7|Maintenance|Relapse|6
4818544|NCT01190930|16613607|P6|Maintenance|Relapse|1
4818545|NCT01190930|16613608|P5|Maintenance|Relapse|0
4818546|NCT01190930|16613609|P4|Maintenance|Relapse|2
4818547|NCT01190930|16613610|P3|Maintenance|Relapse|0
4818548|NCT01190930|16613611|P2|Maintenance|Relapse|0
4818549|NCT01190930|16613612|P1|Maintenance|Relapse|0
4818550|NCT01190930|16613603|P10|Maintenance|Enrollment onto another COG Protocol|0
4818551|NCT01190930|16613604|P9|Maintenance|Enrollment onto another COG Protocol|1
4818552|NCT01190930|16613605|P8|Maintenance|Enrollment onto another COG Protocol|0
4818553|NCT01190930|16613606|P7|Maintenance|Enrollment onto another COG Protocol|0
4818554|NCT01190930|16613607|P6|Maintenance|Enrollment onto another COG Protocol|0
4818555|NCT01190930|16613608|P5|Maintenance|Enrollment onto another COG Protocol|0
4818556|NCT01190930|16613609|P4|Maintenance|Enrollment onto another COG Protocol|0
4818557|NCT01190930|16613610|P3|Maintenance|Enrollment onto another COG Protocol|0
4818558|NCT01190930|16613611|P2|Maintenance|Enrollment onto another COG Protocol|0
4818559|NCT01190930|16613612|P1|Maintenance|Enrollment onto another COG Protocol|0
4818560|NCT01190930|16613603|P10|Maintenance|Inevaluable|0
4818561|NCT01190930|16613604|P9|Maintenance|Inevaluable|0
4818562|NCT01190930|16613605|P8|Maintenance|Inevaluable|1
4818563|NCT01190930|16613606|P7|Maintenance|Inevaluable|1
4818564|NCT01190930|16613607|P6|Maintenance|Inevaluable|1
4818565|NCT01190930|16613608|P5|Maintenance|Inevaluable|0
4818566|NCT01190930|16613609|P4|Maintenance|Inevaluable|0
4818567|NCT01190930|16613610|P3|Maintenance|Inevaluable|0
4818568|NCT01190930|16613611|P2|Maintenance|Inevaluable|0
4818569|NCT01190930|16613612|P1|Maintenance|Inevaluable|0
4818570|NCT01190930|16613603|P10|Maintenance|second malignant neoplasm|0
4818571|NCT01190930|16613604|P9|Maintenance|second malignant neoplasm|1
4818572|NCT01190930|16613605|P8|Maintenance|second malignant neoplasm|0
4818573|NCT01190930|16613606|P7|Maintenance|second malignant neoplasm|0
4818574|NCT01190930|16613607|P6|Maintenance|second malignant neoplasm|1
4818575|NCT01190930|16613608|P5|Maintenance|second malignant neoplasm|0
4818576|NCT01190930|16613609|P4|Maintenance|second malignant neoplasm|1
4818577|NCT01190930|16613610|P3|Maintenance|second malignant neoplasm|0
4818578|NCT01190930|16613611|P2|Maintenance|second malignant neoplasm|0
4818579|NCT01190930|16613612|P1|Maintenance|second malignant neoplasm|0
4818580|NCT01190930|16613603|P10|Maintenance|Refusal|6
4818581|NCT01190930|16613604|P9|Maintenance|Refusal|13
4818582|NCT01190930|16613605|P8|Maintenance|Refusal|17
4818583|NCT01190930|16613606|P7|Maintenance|Refusal|5
4818584|NCT01190930|16613607|P6|Maintenance|Refusal|4
4818585|NCT01190930|16613608|P5|Maintenance|Refusal|0
4818586|NCT01190930|16613609|P4|Maintenance|Refusal|2
4818587|NCT01190930|16613610|P3|Maintenance|Refusal|0
4818588|NCT01190930|16613611|P2|Maintenance|Refusal|1
4818589|NCT01190930|16613612|P1|Maintenance|Refusal|0
4818590|NCT01190930|16613603|P10|Maintenance|Withdrawal by Subject|1
4818591|NCT01190930|16613604|P9|Maintenance|Withdrawal by Subject|4
4818592|NCT01190930|16613605|P8|Maintenance|Withdrawal by Subject|1
4818593|NCT01190930|16613606|P7|Maintenance|Withdrawal by Subject|2
4818594|NCT01190930|16613607|P6|Maintenance|Withdrawal by Subject|0
4818595|NCT01190930|16613608|P5|Maintenance|Withdrawal by Subject|0
4818596|NCT01190930|16613609|P4|Maintenance|Withdrawal by Subject|0
4818597|NCT01190930|16613610|P3|Maintenance|Withdrawal by Subject|0
4818598|NCT01190930|16613611|P2|Maintenance|Withdrawal by Subject|0
4818599|NCT01190930|16613612|P1|Maintenance|Withdrawal by Subject|0
4818600|NCT01190930|16613603|P10|Maintenance|Physician Decision|17
4818601|NCT01190930|16613604|P9|Maintenance|Physician Decision|10
4818602|NCT01190930|16613605|P8|Maintenance|Physician Decision|8
4818603|NCT01190930|16613606|P7|Maintenance|Physician Decision|8
4818604|NCT01190930|16613607|P6|Maintenance|Physician Decision|4
4818605|NCT01190930|16613608|P5|Maintenance|Physician Decision|9
4818606|NCT01190930|16613609|P4|Maintenance|Physician Decision|5
4818607|NCT01190930|16613610|P3|Maintenance|Physician Decision|0
4818608|NCT01190930|16613611|P2|Maintenance|Physician Decision|1
4818609|NCT01190930|16613612|P1|Maintenance|Physician Decision|0
4818610|NCT01190930|16613603|P10|Maintenance|Lost to Follow-up|0
4818611|NCT01190930|16613604|P9|Maintenance|Lost to Follow-up|1
4818612|NCT01190930|16613605|P8|Maintenance|Lost to Follow-up|1
4818613|NCT01190930|16613606|P7|Maintenance|Lost to Follow-up|1
4818614|NCT01190930|16613607|P6|Maintenance|Lost to Follow-up|0
4818615|NCT01190930|16613608|P5|Maintenance|Lost to Follow-up|0
4818616|NCT01190930|16613609|P4|Maintenance|Lost to Follow-up|0
4818617|NCT01190930|16613610|P3|Maintenance|Lost to Follow-up|0
4818618|NCT01190930|16613611|P2|Maintenance|Lost to Follow-up|0
4818619|NCT01190930|16613612|P1|Maintenance|Lost to Follow-up|0
4818620|NCT01190930|16613603|P10|Maintenance|Death|2
4818621|NCT01190930|16613604|P9|Maintenance|Death|2
4818622|NCT01190930|16613605|P8|Maintenance|Death|2
4818623|NCT01190930|16613606|P7|Maintenance|Death|2
4818624|NCT01190930|16613607|P6|Maintenance|Death|0
4818625|NCT01190930|16613608|P5|Maintenance|Death|0
4818626|NCT01190930|16613609|P4|Maintenance|Death|1
4818627|NCT01190930|16613610|P3|Maintenance|Death|0
4818628|NCT01190930|16613611|P2|Maintenance|Death|0
4818629|NCT01190930|16613612|P1|Maintenance|Death|0
4818630|NCT01190930|16613603|P10|Maintenance|Adverse Event|0
4818631|NCT01190930|16613604|P9|Maintenance|Adverse Event|3
4818632|NCT01190930|16613605|P8|Maintenance|Adverse Event|3
4818633|NCT01190930|16613606|P7|Maintenance|Adverse Event|1
4818634|NCT01190930|16613607|P6|Maintenance|Adverse Event|1
4818635|NCT01190930|16613608|P5|Maintenance|Adverse Event|0
4818636|NCT01190930|16613609|P4|Maintenance|Adverse Event|0
4818637|NCT01190930|16613610|P3|Maintenance|Adverse Event|0
4818638|NCT01190930|16613611|P2|Maintenance|Adverse Event|0
4818639|NCT01190930|16613612|P1|Maintenance|Adverse Event|0
4818640|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Relapse|0
4818641|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Relapse|0
4818642|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Relapse|0
4818643|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Relapse|0
4818644|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Relapse|0
4818645|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Relapse|0
4818646|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Relapse|0
4818647|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Relapse|1
4818648|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Relapse|0
4818649|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Relapse|0
4818650|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Progressive disease|0
4818651|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Progressive disease|0
4818652|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Progressive disease|0
4818653|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Progressive disease|0
4818654|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Progressive disease|0
4818655|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Progressive disease|0
4818656|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Progressive disease|0
4818657|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Progressive disease|1
4818658|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Progressive disease|0
4818659|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Progressive disease|0
4818660|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818661|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818662|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818663|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818664|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818665|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818666|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818667|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818668|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1
4818669|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0
4818670|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Inevaluable|0
4818671|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Inevaluable|0
4818672|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Inevaluable|0
4818673|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Inevaluable|0
4818674|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Inevaluable|0
4818675|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Inevaluable|0
4818676|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Inevaluable|0
4818677|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Inevaluable|6
4818678|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Inevaluable|0
4818679|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Inevaluable|0
4818680|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Refusal|0
4818681|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Refusal|0
4818682|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Refusal|0
4818683|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Refusal|0
4818684|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Refusal|3
4818685|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Refusal|0
4818686|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Refusal|4
4818687|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Refusal|694
4818688|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Refusal|2
4818689|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Refusal|0
4818690|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818691|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818692|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818693|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818694|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818695|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818696|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Withdrawal by Subject|2
4818697|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Withdrawal by Subject|5
4818698|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Withdrawal by Subject|1
4818699|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Withdrawal by Subject|0
4818700|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Physician Decision|0
4818701|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Physician Decision|0
4818702|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Physician Decision|0
4818703|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Physician Decision|0
4818704|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Physician Decision|3
4818705|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Physician Decision|5
4818706|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Physician Decision|7
4818707|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Physician Decision|35
4818708|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Physician Decision|2
4818709|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Physician Decision|0
4818710|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Death|0
4818711|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Death|0
4818712|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Death|0
4818713|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Death|0
4818714|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Death|0
4818715|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Death|0
4818716|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Death|4
4818717|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Death|8
4818718|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Death|0
4818719|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Death|0
4818720|NCT01190930|16613603|P10|Post Induction Pre-Maintenance|Adverse Event|0
4818721|NCT01190930|16613604|P9|Post Induction Pre-Maintenance|Adverse Event|0
4818722|NCT01190930|16613605|P8|Post Induction Pre-Maintenance|Adverse Event|0
4818723|NCT01190930|16613606|P7|Post Induction Pre-Maintenance|Adverse Event|0
4818724|NCT01190930|16613607|P6|Post Induction Pre-Maintenance|Adverse Event|0
4818725|NCT01190930|16613608|P5|Post Induction Pre-Maintenance|Adverse Event|0
4818726|NCT01190930|16613609|P4|Post Induction Pre-Maintenance|Adverse Event|0
4818727|NCT01190930|16613610|P3|Post Induction Pre-Maintenance|Adverse Event|8
4818728|NCT01190930|16613611|P2|Post Induction Pre-Maintenance|Adverse Event|0
4818729|NCT01190930|16613612|P1|Post Induction Pre-Maintenance|Adverse Event|0
4818730|NCT01190930|16613603|P10|Induction|Ineligible|0
4818731|NCT01190930|16613604|P9|Induction|Ineligible|0
4818732|NCT01190930|16613605|P8|Induction|Ineligible|0
4818733|NCT01190930|16613606|P7|Induction|Ineligible|0
4818734|NCT01190930|16613607|P6|Induction|Ineligible|0
4818735|NCT01190930|16613608|P5|Induction|Ineligible|0
4818736|NCT01190930|16613609|P4|Induction|Ineligible|0
4818737|NCT01190930|16613610|P3|Induction|Ineligible|0
4818738|NCT01190930|16613611|P2|Induction|Ineligible|4
4818739|NCT01190930|16613612|P1|Induction|Ineligible|69
4818740|NCT01190930|16613603|P10|Induction|No treatment|0
4818741|NCT01190930|16613604|P9|Induction|No treatment|0
4818742|NCT01190930|16613605|P8|Induction|No treatment|0
4818743|NCT01190930|16613606|P7|Induction|No treatment|0
4818744|NCT01190930|16613607|P6|Induction|No treatment|0
4818745|NCT01190930|16613608|P5|Induction|No treatment|0
4818746|NCT01190930|16613609|P4|Induction|No treatment|0
4818747|NCT01190930|16613610|P3|Induction|No treatment|0
4818748|NCT01190930|16613611|P2|Induction|No treatment|0
4818749|NCT01190930|16613612|P1|Induction|No treatment|3
4818750|NCT01190930|16613603|P10|Induction|Progressive disease|0
4818751|NCT01190930|16613604|P9|Induction|Progressive disease|0
4818752|NCT01190930|16613605|P8|Induction|Progressive disease|0
4818753|NCT01190930|16613606|P7|Induction|Progressive disease|0
4818754|NCT01190930|16613607|P6|Induction|Progressive disease|0
4818755|NCT01190930|16613608|P5|Induction|Progressive disease|0
4818756|NCT01190930|16613609|P4|Induction|Progressive disease|0
4818757|NCT01190930|16613610|P3|Induction|Progressive disease|0
4818758|NCT01190930|16613611|P2|Induction|Progressive disease|1
4818759|NCT01190930|16613612|P1|Induction|Progressive disease|0
4818760|NCT01190930|16613603|P10|Induction|Incomplete Induction data|0
4818761|NCT01190930|16613604|P9|Induction|Incomplete Induction data|0
4818762|NCT01190930|16613605|P8|Induction|Incomplete Induction data|0
4818763|NCT01190930|16613606|P7|Induction|Incomplete Induction data|0
4818764|NCT01190930|16613607|P6|Induction|Incomplete Induction data|0
4818765|NCT01190930|16613608|P5|Induction|Incomplete Induction data|0
4818766|NCT01190930|16613609|P4|Induction|Incomplete Induction data|0
4818767|NCT01190930|16613610|P3|Induction|Incomplete Induction data|0
4818768|NCT01190930|16613611|P2|Induction|Incomplete Induction data|0
4818769|NCT01190930|16613612|P1|Induction|Incomplete Induction data|63
4818770|NCT01190930|16613603|P10|Induction|Philadelphia chromosome-positive|0
4818771|NCT01190930|16613604|P9|Induction|Philadelphia chromosome-positive|0
4818772|NCT01190930|16613605|P8|Induction|Philadelphia chromosome-positive|0
4818773|NCT01190930|16613606|P7|Induction|Philadelphia chromosome-positive|0
4818774|NCT01190930|16613607|P6|Induction|Philadelphia chromosome-positive|0
4818775|NCT01190930|16613608|P5|Induction|Philadelphia chromosome-positive|0
4818776|NCT01190930|16613609|P4|Induction|Philadelphia chromosome-positive|0
4818777|NCT01190930|16613610|P3|Induction|Philadelphia chromosome-positive|0
4818778|NCT01190930|16613611|P2|Induction|Philadelphia chromosome-positive|0
4818779|NCT01190930|16613612|P1|Induction|Philadelphia chromosome-positive|99
4818780|NCT01190930|16613603|P10|Induction|Very High Risk|0
4818781|NCT01190930|16613604|P9|Induction|Very High Risk|0
4818782|NCT01190930|16613605|P8|Induction|Very High Risk|0
4818783|NCT01190930|16613606|P7|Induction|Very High Risk|0
4818784|NCT01190930|16613607|P6|Induction|Very High Risk|0
4818785|NCT01190930|16613608|P5|Induction|Very High Risk|0
4818786|NCT01190930|16613609|P4|Induction|Very High Risk|0
4818787|NCT01190930|16613610|P3|Induction|Very High Risk|0
4818788|NCT01190930|16613611|P2|Induction|Very High Risk|0
4818789|NCT01190930|16613612|P1|Induction|Very High Risk|1012
4818790|NCT01190930|16613603|P10|Induction|Low Risk|0
4818791|NCT01190930|16613604|P9|Induction|Low Risk|0
4818792|NCT01190930|16613605|P8|Induction|Low Risk|0
4818793|NCT01190930|16613606|P7|Induction|Low Risk|0
4818794|NCT01190930|16613607|P6|Induction|Low Risk|0
4818795|NCT01190930|16613608|P5|Induction|Low Risk|0
4818796|NCT01190930|16613609|P4|Induction|Low Risk|0
4818797|NCT01190930|16613610|P3|Induction|Low Risk|0
4818798|NCT01190930|16613611|P2|Induction|Low Risk|0
4818799|NCT01190930|16613612|P1|Induction|Low Risk|443
4818800|NCT01190930|16613603|P10|Induction|High Risk|0
4818801|NCT01190930|16613604|P9|Induction|High Risk|0
4818802|NCT01190930|16613605|P8|Induction|High Risk|0
4818803|NCT01190930|16613606|P7|Induction|High Risk|0
4818804|NCT01190930|16613607|P6|Induction|High Risk|0
4818805|NCT01190930|16613608|P5|Induction|High Risk|0
4818806|NCT01190930|16613609|P4|Induction|High Risk|0
4818807|NCT01190930|16613610|P3|Induction|High Risk|0
4818808|NCT01190930|16613611|P2|Induction|High Risk|0
4818809|NCT01190930|16613612|P1|Induction|High Risk|1227
4818810|NCT01190930|16613603|P10|Induction|Average Risk|0
4818811|NCT01190930|16613604|P9|Induction|Average Risk|0
4818812|NCT01190930|16613605|P8|Induction|Average Risk|0
4818813|NCT01190930|16613606|P7|Induction|Average Risk|0
4818814|NCT01190930|16613607|P6|Induction|Average Risk|0
4818815|NCT01190930|16613608|P5|Induction|Average Risk|0
4818816|NCT01190930|16613609|P4|Induction|Average Risk|0
4818817|NCT01190930|16613610|P3|Induction|Average Risk|0
4818818|NCT01190930|16613611|P2|Induction|Average Risk|0
4818819|NCT01190930|16613612|P1|Induction|Average Risk|1847
4818820|NCT01190930|16613603|P10|Induction|Enrollment onto another COG Protocol|0
4818821|NCT01190930|16613604|P9|Induction|Enrollment onto another COG Protocol|0
4818822|NCT01190930|16613605|P8|Induction|Enrollment onto another COG Protocol|0
4818823|NCT01190930|16613606|P7|Induction|Enrollment onto another COG Protocol|0
4818824|NCT01190930|16613607|P6|Induction|Enrollment onto another COG Protocol|0
4818825|NCT01190930|16613608|P5|Induction|Enrollment onto another COG Protocol|0
4818826|NCT01190930|16613609|P4|Induction|Enrollment onto another COG Protocol|0
4818827|NCT01190930|16613610|P3|Induction|Enrollment onto another COG Protocol|0
4818828|NCT01190930|16613611|P2|Induction|Enrollment onto another COG Protocol|0
4818829|NCT01190930|16613612|P1|Induction|Enrollment onto another COG Protocol|1
4818830|NCT01190930|16613603|P10|Induction|High Risk Downs|0
4818831|NCT01190930|16613604|P9|Induction|High Risk Downs|0
4818832|NCT01190930|16613605|P8|Induction|High Risk Downs|0
4818833|NCT01190930|16613606|P7|Induction|High Risk Downs|0
4818834|NCT01190930|16613607|P6|Induction|High Risk Downs|0
4818835|NCT01190930|16613608|P5|Induction|High Risk Downs|0
4818836|NCT01190930|16613609|P4|Induction|High Risk Downs|0
4818837|NCT01190930|16613610|P3|Induction|High Risk Downs|0
4818838|NCT01190930|16613611|P2|Induction|High Risk Downs|0
4818839|NCT01190930|16613612|P1|Induction|High Risk Downs|80
4818840|NCT01190930|16613603|P10|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818841|NCT01190930|16613604|P9|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818842|NCT01190930|16613605|P8|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818843|NCT01190930|16613606|P7|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818844|NCT01190930|16613607|P6|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818845|NCT01190930|16613608|P5|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818846|NCT01190930|16613609|P4|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818847|NCT01190930|16613610|P3|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818848|NCT01190930|16613611|P2|Induction|BM MRD >= 0.01% on Day 29 of Induction|0
4818849|NCT01190930|16613612|P1|Induction|BM MRD >= 0.01% on Day 29 of Induction|61
4818850|NCT01190930|16613603|P10|Induction|Inevaluable|0
4818851|NCT01190930|16613604|P9|Induction|Inevaluable|0
4818852|NCT01190930|16613605|P8|Induction|Inevaluable|0
4818853|NCT01190930|16613606|P7|Induction|Inevaluable|0
4818854|NCT01190930|16613607|P6|Induction|Inevaluable|0
4818855|NCT01190930|16613608|P5|Induction|Inevaluable|0
4818856|NCT01190930|16613609|P4|Induction|Inevaluable|0
4818857|NCT01190930|16613610|P3|Induction|Inevaluable|0
4818858|NCT01190930|16613611|P2|Induction|Inevaluable|1
4818859|NCT01190930|16613612|P1|Induction|Inevaluable|23
4818860|NCT01190930|16613603|P10|Induction|Refusal|0
4818861|NCT01190930|16613604|P9|Induction|Refusal|0
4818862|NCT01190930|16613605|P8|Induction|Refusal|0
4818863|NCT01190930|16613606|P7|Induction|Refusal|0
4818864|NCT01190930|16613607|P6|Induction|Refusal|0
4818865|NCT01190930|16613608|P5|Induction|Refusal|0
4818866|NCT01190930|16613609|P4|Induction|Refusal|0
4818867|NCT01190930|16613610|P3|Induction|Refusal|0
4818868|NCT01190930|16613611|P2|Induction|Refusal|0
4818869|NCT01190930|16613612|P1|Induction|Refusal|235
4818870|NCT01190930|16613603|P10|Induction|Withdrawal by Subject|0
4818871|NCT01190930|16613604|P9|Induction|Withdrawal by Subject|0
4818872|NCT01190930|16613605|P8|Induction|Withdrawal by Subject|0
4818873|NCT01190930|16613606|P7|Induction|Withdrawal by Subject|0
4818874|NCT01190930|16613607|P6|Induction|Withdrawal by Subject|0
4818875|NCT01190930|16613608|P5|Induction|Withdrawal by Subject|0
4818876|NCT01190930|16613609|P4|Induction|Withdrawal by Subject|0
4818877|NCT01190930|16613610|P3|Induction|Withdrawal by Subject|0
4818878|NCT01190930|16613611|P2|Induction|Withdrawal by Subject|0
4818879|NCT01190930|16613612|P1|Induction|Withdrawal by Subject|9
4818880|NCT01190930|16613603|P10|Induction|Physician Decision|0
4818881|NCT01190930|16613604|P9|Induction|Physician Decision|0
4818882|NCT01190930|16613605|P8|Induction|Physician Decision|0
4818883|NCT01190930|16613606|P7|Induction|Physician Decision|0
4818884|NCT01190930|16613607|P6|Induction|Physician Decision|0
4818885|NCT01190930|16613608|P5|Induction|Physician Decision|0
4818886|NCT01190930|16613609|P4|Induction|Physician Decision|0
4818887|NCT01190930|16613610|P3|Induction|Physician Decision|0
4818888|NCT01190930|16613611|P2|Induction|Physician Decision|3
4818889|NCT01190930|16613612|P1|Induction|Physician Decision|125
4818890|NCT01190930|16613603|P10|Induction|Lost to Follow-up|0
4818891|NCT01190930|16613604|P9|Induction|Lost to Follow-up|0
4818892|NCT01190930|16613605|P8|Induction|Lost to Follow-up|0
4818893|NCT01190930|16613606|P7|Induction|Lost to Follow-up|0
4818894|NCT01190930|16613607|P6|Induction|Lost to Follow-up|0
4818895|NCT01190930|16613608|P5|Induction|Lost to Follow-up|0
4818896|NCT01190930|16613609|P4|Induction|Lost to Follow-up|0
4818897|NCT01190930|16613610|P3|Induction|Lost to Follow-up|0
4818898|NCT01190930|16613611|P2|Induction|Lost to Follow-up|0
4818899|NCT01190930|16613612|P1|Induction|Lost to Follow-up|1
4818900|NCT01190930|16613603|P10|Induction|Death|0
4818901|NCT01190930|16613604|P9|Induction|Death|0
4818902|NCT01190930|16613605|P8|Induction|Death|0
4818903|NCT01190930|16613606|P7|Induction|Death|0
4818904|NCT01190930|16613607|P6|Induction|Death|0
4818905|NCT01190930|16613608|P5|Induction|Death|0
4818906|NCT01190930|16613609|P4|Induction|Death|0
4818907|NCT01190930|16613610|P3|Induction|Death|0
4818908|NCT01190930|16613611|P2|Induction|Death|0
4818909|NCT01190930|16613612|P1|Induction|Death|34
4818910|NCT01190930|16613603|P10|Induction|Adverse Event|0
4818911|NCT01190930|16613604|P9|Induction|Adverse Event|0
4818912|NCT01190930|16613605|P8|Induction|Adverse Event|0
4818913|NCT01190930|16613606|P7|Induction|Adverse Event|0
4818914|NCT01190930|16613607|P6|Induction|Adverse Event|0
4818915|NCT01190930|16613608|P5|Induction|Adverse Event|0
4818916|NCT01190930|16613609|P4|Induction|Adverse Event|0
4818917|NCT01190930|16613610|P3|Induction|Adverse Event|0
4818918|NCT01190930|16613611|P2|Induction|Adverse Event|0
4818919|NCT01190930|16613612|P1|Induction|Adverse Event|17
4818920|NCT01190891|16613636|P2|Overall Study|Withdrawal by Subject|0
4818921|NCT01190891|16613637|P1|Overall Study|Withdrawal by Subject|5
4818922|NCT01190891|16613636|P2|Overall Study|Protocol Violation|0
4818923|NCT01190891|16613637|P1|Overall Study|Protocol Violation|1
4818924|NCT01190865|16613662|P1|Overall Study|Non-compliance|2
4818925|NCT01190865|16613662|P1|Overall Study|Withdrawal by Subject|1
4818926|NCT01190839|16613669|P2|Overall Study|Randomized but not treated|4
4818927|NCT01190839|16613670|P1|Overall Study|Randomized but not treated|2
4818928|NCT01190839|16613669|P2|Overall Study|Undefined|31
4818929|NCT01190839|16613670|P1|Overall Study|Undefined|35
4818930|NCT01190839|16613669|P2|Overall Study|Trial stopped by Sponsor|68
4818931|NCT01190839|16613670|P1|Overall Study|Trial stopped by Sponsor|71
4818932|NCT01190839|16613669|P2|Overall Study|Death|0
4818933|NCT01190839|16613670|P1|Overall Study|Death|1
4818934|NCT01190839|16613669|P2|Overall Study|Lost to Follow-up|1
4818935|NCT01190839|16613670|P1|Overall Study|Lost to Follow-up|7
4818936|NCT01190839|16613669|P2|Overall Study|Protocol Violation|2
4818937|NCT01190839|16613670|P1|Overall Study|Protocol Violation|2
4818938|NCT01190839|16613669|P2|Overall Study|Adverse Event|41
4818939|NCT01190839|16613670|P1|Overall Study|Adverse Event|32
4818940|NCT01190813|16613684|P2|Overall Study|Adverse Event|1
4818941|NCT01190813|16613685|P1|Overall Study|Adverse Event|0
4818942|NCT01190813|16613684|P2|Overall Study|Refused study treatment after randomized|0
4818943|NCT01190813|16613685|P1|Overall Study|Refused study treatment after randomized|1
4818944|NCT01190813|16613684|P2|Overall Study|Withdrawal by Subject|1
4818945|NCT01190813|16613685|P1|Overall Study|Withdrawal by Subject|2
4818946|NCT01190813|16613684|P2|Overall Study|Lost to Follow-up|2
4818947|NCT01190813|16613685|P1|Overall Study|Lost to Follow-up|1
4818948|NCT01190514|16613806|P4|Third Intervention (Period 3)|Adverse Event|0
4818949|NCT01190514|16613807|P3|Third Intervention (Period 3)|Adverse Event|0
4818950|NCT01190514|16613808|P2|Third Intervention (Period 3)|Adverse Event|0
4818951|NCT01190514|16613809|P1|Third Intervention (Period 3)|Adverse Event|1
4818952|NCT01190514|16613806|P4|First Intervention (Period 1)|Adverse Event|0
4818953|NCT01190514|16613807|P3|First Intervention (Period 1)|Adverse Event|0
4818954|NCT01190514|16613808|P2|First Intervention (Period 1)|Adverse Event|0
4818955|NCT01190514|16613809|P1|First Intervention (Period 1)|Adverse Event|1
4818956|NCT01190475|16613842|P3|Overall Study|Withdrawal by Subject|1
4818957|NCT01190475|16613843|P2|Overall Study|Withdrawal by Subject|0
4818958|NCT01190475|16613844|P1|Overall Study|Withdrawal by Subject|0
4818959|NCT01190449|16613860|P2|Overall Study|Ineligible|4
4818960|NCT01190449|16613861|P1|Overall Study|Ineligible|0
4818961|NCT01190436|16613869|P1|Overall Study|Other|4
4818962|NCT01190436|16613869|P1|Overall Study|Lost to Follow-up|35
4818963|NCT01190410|16613885|P2|Overall Study|PI discretion|2
4818964|NCT01190410|16613886|P1|Overall Study|PI discretion|0
4818965|NCT01190410|16613885|P2|Overall Study|Administrative decision|0
4818966|NCT01190410|16613886|P1|Overall Study|Administrative decision|1
4818967|NCT01190410|16613885|P2|Overall Study|Withdrawal by Subject|2
4818968|NCT01190410|16613886|P1|Overall Study|Withdrawal by Subject|0
4818969|NCT01190410|16613885|P2|Overall Study|Lack of Efficacy|2
4818970|NCT01190410|16613886|P1|Overall Study|Lack of Efficacy|0
4818971|NCT01190410|16613885|P2|Overall Study|Adverse Event|3
4818972|NCT01190410|16613886|P1|Overall Study|Adverse Event|0
4818973|NCT01190267|16613914|P2|Overall Study|Protocol Violation|1
4818974|NCT01190267|16613915|P1|Overall Study|Protocol Violation|8
4818975|NCT01190267|16613914|P2|Overall Study|Withdrawal by Subject|1
4818976|NCT01190267|16613915|P1|Overall Study|Withdrawal by Subject|13
4818977|NCT01190267|16613914|P2|Overall Study|Lost to Follow-up|0
4818978|NCT01190267|16613915|P1|Overall Study|Lost to Follow-up|2
4818979|NCT01190267|16613914|P2|Overall Study|Treatment Failure|2
4818980|NCT01190267|16613915|P1|Overall Study|Treatment Failure|8
4818981|NCT01190267|16613914|P2|Overall Study|Adverse Event|0
4818982|NCT01190267|16613915|P1|Overall Study|Adverse Event|10
4818983|NCT01190254|16613926|P3|Overall Study|Did not meet protocol eligibility|0
4818984|NCT01190254|16613927|P2|Overall Study|Did not meet protocol eligibility|0
4818985|NCT01190254|16613928|P1|Overall Study|Did not meet protocol eligibility|1
4818986|NCT01190254|16613926|P3|Overall Study|Protocol Violation|2
4818987|NCT01190254|16613927|P2|Overall Study|Protocol Violation|0
4818988|NCT01190254|16613928|P1|Overall Study|Protocol Violation|2
4818989|NCT01190254|16613926|P3|Overall Study|Withdrawal by Subject|7
4818990|NCT01190254|16613927|P2|Overall Study|Withdrawal by Subject|5
4818991|NCT01190254|16613928|P1|Overall Study|Withdrawal by Subject|4
4818992|NCT01190254|16613926|P3|Overall Study|Lost to Follow-up|0
4818993|NCT01190254|16613927|P2|Overall Study|Lost to Follow-up|2
4818994|NCT01190254|16613928|P1|Overall Study|Lost to Follow-up|4
4818995|NCT01190254|16613926|P3|Overall Study|Lack of Efficacy|5
4818996|NCT01190254|16613927|P2|Overall Study|Lack of Efficacy|4
4818997|NCT01190254|16613928|P1|Overall Study|Lack of Efficacy|7
4818998|NCT01190254|16613926|P3|Overall Study|Adverse Event|8
4818999|NCT01190254|16613927|P2|Overall Study|Adverse Event|6
4819000|NCT01190254|16613928|P1|Overall Study|Adverse Event|3
4819001|NCT01190228|16613993|P3|Overall Study|Withdrawal by Subject|0
4819002|NCT01190228|16613994|P2|Overall Study|Withdrawal by Subject|0
4819003|NCT01190228|16613995|P1|Overall Study|Withdrawal by Subject|1
4819004|NCT01190228|16613993|P3|Overall Study|Protocol Violation|0
4819005|NCT01190228|16613994|P2|Overall Study|Protocol Violation|0
4819006|NCT01190228|16613995|P1|Overall Study|Protocol Violation|4
4819007|NCT01190215|16614018|P2|Up to Month 6|Lost to Follow-up|0
4819008|NCT01190215|16614019|P1|Up to Month 6|Lost to Follow-up|2
4819009|NCT01190189|16614352|P1|Overall Study|Migrated/moved from study area|1
4819010|NCT01190189|16614352|P1|Overall Study|Withdrawal by Subject|1
4819011|NCT01190189|16614352|P1|Overall Study|Lost to Follow-up|4
4819012|NCT01190176|16614359|P1|Overall Study|Lost to Follow-up|1
4819013|NCT01190176|16614359|P1|Overall Study|Withdrawal by Subject|1
4819014|NCT01190150|16614380|P2|Washout|Difficulty in adherence|1
4819015|NCT01190150|16614381|P1|Washout|Difficulty in adherence|0
4819016|NCT01190150|16614380|P2|Washout|Withdrawal by Subject|1
4819017|NCT01190150|16614381|P1|Washout|Withdrawal by Subject|0
4819018|NCT01190150|16614380|P2|First Treatment|Withdrawal by Subject|0
4819019|NCT01190150|16614381|P1|First Treatment|Withdrawal by Subject|1
4819020|NCT01190124|16614408|P3|Overall Study|Lost to Follow-up|0
4819021|NCT01190124|16614409|P2|Overall Study|Lost to Follow-up|0
4819022|NCT01190124|16614410|P1|Overall Study|Lost to Follow-up|2
4819023|NCT01190124|16614408|P3|Overall Study|Therapeutic Failure|1
4819024|NCT01190124|16614409|P2|Overall Study|Therapeutic Failure|0
4819025|NCT01190124|16614410|P1|Overall Study|Therapeutic Failure|12
4819026|NCT01190124|16614408|P3|Overall Study|Death|0
4819027|NCT01190124|16614409|P2|Overall Study|Death|0
4819028|NCT01190124|16614410|P1|Overall Study|Death|3
4819029|NCT01190098|16614448|P2|Overall Study|Other|1
4819030|NCT01190098|16614449|P1|Overall Study|Other|0
4819031|NCT01190098|16614448|P2|Overall Study|Lack of transportation|0
4819032|NCT01190098|16614449|P1|Overall Study|Lack of transportation|1
4819033|NCT01190098|16614448|P2|Overall Study|Patient coomorbidity|1
4819034|NCT01190098|16614449|P1|Overall Study|Patient coomorbidity|0
4819035|NCT01190098|16614448|P2|Overall Study|Adverse Event|0
4819036|NCT01190098|16614449|P1|Overall Study|Adverse Event|2
4819037|NCT01190020|16614490|P2|Overall Study|Withdrawal by Subject|0
4819038|NCT01190020|16614491|P1|Overall Study|Withdrawal by Subject|3
4819039|NCT01190020|16614490|P2|Overall Study|Lost to Follow-up|0
4819040|NCT01190020|16614491|P1|Overall Study|Lost to Follow-up|2
4819041|NCT01190020|16614490|P2|Overall Study|Adverse Event|0
4819042|NCT01190020|16614491|P1|Overall Study|Adverse Event|2
4819043|NCT01190007|16614503|P1|Overall Study|Participant was arrested|1
4819044|NCT01190007|16614503|P1|Overall Study|Difficulty of visit for complications|1
4819045|NCT01190007|16614503|P1|Overall Study|Adverse Event|8
4819046|NCT01190007|16614503|P1|Overall Study|Withdrawal by Subject|4
4819047|NCT01189890|16614520|P2|Overall Study|Hyperglycemia Discontinuation Criteria|5
4819048|NCT01189890|16614521|P1|Overall Study|Hyperglycemia Discontinuation Criteria|5
4819049|NCT01189890|16614520|P2|Overall Study|Physician Decision|4
4819050|NCT01189890|16614521|P1|Overall Study|Physician Decision|5
4819051|NCT01189890|16614520|P2|Overall Study|Non Compliance|1
4819052|NCT01189890|16614521|P1|Overall Study|Non Compliance|0
4819053|NCT01189890|16614520|P2|Overall Study|Withdrawal by Subject|11
4819054|NCT01189890|16614521|P1|Overall Study|Withdrawal by Subject|15
4819055|NCT01189890|16614520|P2|Overall Study|Protocol Violation|5
4819056|NCT01189890|16614521|P1|Overall Study|Protocol Violation|1
4819057|NCT01189890|16614520|P2|Overall Study|Lost to Follow-up|7
4819058|NCT01189890|16614521|P1|Overall Study|Lost to Follow-up|1
4819059|NCT01189890|16614520|P2|Overall Study|Lack of Efficacy|2
4819060|NCT01189890|16614521|P1|Overall Study|Lack of Efficacy|7
4819061|NCT01189890|16614520|P2|Overall Study|Adverse Event|4
4819062|NCT01189890|16614521|P1|Overall Study|Adverse Event|3
4819063|NCT01189812|16614543|P2|Overall Study|Moved out of State|2
4819064|NCT01189812|16614544|P1|Overall Study|Moved out of State|1
4819065|NCT01189812|16614543|P2|Overall Study|Out of Window|3
4819066|NCT01189812|16614544|P1|Overall Study|Out of Window|4
4819067|NCT01189812|16614543|P2|Overall Study|Adverse Event|0
4819068|NCT01189812|16614544|P1|Overall Study|Adverse Event|1
4819069|NCT01189812|16614543|P2|Overall Study|Withdrawal by Subject|3
4819070|NCT01189812|16614544|P1|Overall Study|Withdrawal by Subject|2
4819071|NCT01189604|16614628|P7|Overall Study|Withdrawal by Subject|0
4819072|NCT01189604|16614629|P6|Overall Study|Withdrawal by Subject|0
4819073|NCT01189604|16614630|P5|Overall Study|Withdrawal by Subject|0
4819074|NCT01189604|16614631|P4|Overall Study|Withdrawal by Subject|0
4819075|NCT01189604|16614632|P3|Overall Study|Withdrawal by Subject|0
4819076|NCT01189604|16614633|P2|Overall Study|Withdrawal by Subject|0
4819077|NCT01189604|16614634|P1|Overall Study|Withdrawal by Subject|1
4819078|NCT01189604|16614628|P7|Overall Study|Adverse Event|1
4819079|NCT01189604|16614629|P6|Overall Study|Adverse Event|0
4819080|NCT01189604|16614630|P5|Overall Study|Adverse Event|2
4819081|NCT01189604|16614631|P4|Overall Study|Adverse Event|0
4819082|NCT01189604|16614632|P3|Overall Study|Adverse Event|0
4819083|NCT01189604|16614633|P2|Overall Study|Adverse Event|1
4819084|NCT01189604|16614634|P1|Overall Study|Adverse Event|0
4819085|NCT01189604|16614628|P7|Overall Study|Impossible to visit|0
4819086|NCT01189604|16614629|P6|Overall Study|Impossible to visit|1
4819087|NCT01189604|16614630|P5|Overall Study|Impossible to visit|0
4819088|NCT01189604|16614631|P4|Overall Study|Impossible to visit|0
4819089|NCT01189604|16614632|P3|Overall Study|Impossible to visit|0
4819090|NCT01189604|16614633|P2|Overall Study|Impossible to visit|0
4819091|NCT01189604|16614634|P1|Overall Study|Impossible to visit|0
4819092|NCT01189500|16614678|P1|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1
4819093|NCT01189500|16614678|P1|Period 1: TAMOX Alone|Adverse Event|1
4819094|NCT01189487|16614739|P1|Overall Study|Adverse Event|1
4819095|NCT01189487|16614739|P1|Overall Study|Lack of Efficacy|2
4819096|NCT01189461|16614747|P1|Overall Study|Other|8
4819097|NCT01189461|16614747|P1|Overall Study|Did not meet entrance criteria|3
4819098|NCT01189461|16614747|P1|Overall Study|Adverse Event|2
4819099|NCT01189461|16614747|P1|Overall Study|Protocol Violation|1
4819100|NCT01189461|16614747|P1|Overall Study|Withdrawal by Subject|6
4819101|NCT01189461|16614747|P1|Overall Study|Lost to Follow-up|1
4819102|NCT01189461|16614747|P1|Overall Study|Lack of Efficacy|13
4819103|NCT01189435|16614754|P1|Overall Study|Physician Decision|1
4819104|NCT01189435|16614754|P1|Overall Study|Withdrawal by Subject|1
4819105|NCT01189266|16614834|P3|Overall Study|No treatment|1
4819106|NCT01189266|16614835|P2|Overall Study|No treatment|0
4819107|NCT01189266|16614836|P1|Overall Study|No treatment|0
4819108|NCT01189266|16614834|P3|Overall Study|Patient refuses further therapy|7
4819109|NCT01189266|16614835|P2|Overall Study|Patient refuses further therapy|0
4819110|NCT01189266|16614836|P1|Overall Study|Patient refuses further therapy|1
4819111|NCT01189266|16614834|P3|Overall Study|Withdrawal by Subject|1
4819112|NCT01189266|16614835|P2|Overall Study|Withdrawal by Subject|0
4819113|NCT01189266|16614836|P1|Overall Study|Withdrawal by Subject|0
4819114|NCT01189266|16614834|P3|Overall Study|Protocol Violation|1
4819115|NCT01189266|16614835|P2|Overall Study|Protocol Violation|1
4819116|NCT01189266|16614836|P1|Overall Study|Protocol Violation|0
4819117|NCT01189266|16614834|P3|Overall Study|Physician Decision|1
4819118|NCT01189266|16614835|P2|Overall Study|Physician Decision|0
4819119|NCT01189266|16614836|P1|Overall Study|Physician Decision|0
4819120|NCT01189266|16614834|P3|Overall Study|Lack of Efficacy|44
4819121|NCT01189266|16614835|P2|Overall Study|Lack of Efficacy|5
4819122|NCT01189266|16614836|P1|Overall Study|Lack of Efficacy|4
4819123|NCT01189266|16614834|P3|Overall Study|Death|5
4819124|NCT01189266|16614835|P2|Overall Study|Death|0
4819125|NCT01189266|16614836|P1|Overall Study|Death|0
4819126|NCT01189266|16614834|P3|Overall Study|Adverse Event|5
4819127|NCT01189266|16614835|P2|Overall Study|Adverse Event|0
4819128|NCT01189266|16614836|P1|Overall Study|Adverse Event|1
4819129|NCT01189227|16614886|P2|Overall Study|Study terminated due to low accrual|3
4819130|NCT01189227|16614887|P1|Overall Study|Study terminated due to low accrual|6
4819131|NCT01189201|16614893|P1|Overall Study|Adverse Event|1
4819132|NCT01189032|16614996|P3|Overall Study|Protocol Violation|1
4819133|NCT01189032|16614997|P2|Overall Study|Protocol Violation|1
4819134|NCT01189032|16614998|P1|Overall Study|Protocol Violation|1
4819135|NCT01189032|16614996|P3|Overall Study|Withdrawal by Subject|1
4819136|NCT01189032|16614997|P2|Overall Study|Withdrawal by Subject|0
4819137|NCT01189032|16614998|P1|Overall Study|Withdrawal by Subject|1
4819138|NCT01189032|16614996|P3|Overall Study|Lack of Efficacy|0
4819139|NCT01189032|16614997|P2|Overall Study|Lack of Efficacy|3
4819140|NCT01189032|16614998|P1|Overall Study|Lack of Efficacy|2
4819141|NCT01189032|16614996|P3|Overall Study|Adverse Event|4
4819142|NCT01189032|16614997|P2|Overall Study|Adverse Event|3
4819143|NCT01189032|16614998|P1|Overall Study|Adverse Event|1
4819144|NCT01188967|16615008|P2|Overall Study|Lost to Follow-up|2
4819145|NCT01188967|16615009|P1|Overall Study|Lost to Follow-up|3
4819146|NCT01188967|16615008|P2|Overall Study|Physician Decision|1
4819147|NCT01188967|16615009|P1|Overall Study|Physician Decision|1
4819148|NCT01188967|16615008|P2|Overall Study|Withdrawal by Subject|1
4819149|NCT01188967|16615009|P1|Overall Study|Withdrawal by Subject|1
4819150|NCT01188811|16615062|P2|Overall Study|Adverse Event|0
4819151|NCT01188811|16615063|P1|Overall Study|Adverse Event|6
4819152|NCT01188811|16615062|P2|Overall Study|Withdrawal by Subject|2
4819153|NCT01188811|16615063|P1|Overall Study|Withdrawal by Subject|0
4819154|NCT01188798|16615075|P2|Overall Study|Protocol closure|1
4819155|NCT01188798|16615076|P1|Overall Study|Protocol closure|1
4819156|NCT01188798|16615075|P2|Overall Study|Required additional transplant|1
4819157|NCT01188798|16615076|P1|Overall Study|Required additional transplant|1
4819158|NCT01188798|16615075|P2|Overall Study|Death|1
4819159|NCT01188798|16615076|P1|Overall Study|Death|0
4819160|NCT01188772|16615088|P4|Overall Study|Withdrawal by Subject|0
4819161|NCT01188772|16615089|P3|Overall Study|Withdrawal by Subject|2
4819162|NCT01188772|16615090|P2|Overall Study|Withdrawal by Subject|0
4819163|NCT01188772|16615091|P1|Overall Study|Withdrawal by Subject|0
4819164|NCT01188772|16615088|P4|Overall Study|Virologic Failure|0
4819165|NCT01188772|16615089|P3|Overall Study|Virologic Failure|0
4819166|NCT01188772|16615090|P2|Overall Study|Virologic Failure|0
4819167|NCT01188772|16615091|P1|Overall Study|Virologic Failure|1
4819168|NCT01188772|16615088|P4|Overall Study|Treatment Failure|0
4819169|NCT01188772|16615089|P3|Overall Study|Treatment Failure|1
4819170|NCT01188772|16615090|P2|Overall Study|Treatment Failure|0
4819171|NCT01188772|16615091|P1|Overall Study|Treatment Failure|0
4819172|NCT01188772|16615088|P4|Overall Study|Terminated by Sponsor|0
4819173|NCT01188772|16615089|P3|Overall Study|Terminated by Sponsor|1
4819174|NCT01188772|16615090|P2|Overall Study|Terminated by Sponsor|0
4819175|NCT01188772|16615091|P1|Overall Study|Terminated by Sponsor|0
4819176|NCT01188772|16615088|P4|Overall Study|Physician Decision|0
4819177|NCT01188772|16615089|P3|Overall Study|Physician Decision|1
4819178|NCT01188772|16615090|P2|Overall Study|Physician Decision|0
4819179|NCT01188772|16615091|P1|Overall Study|Physician Decision|0
4819180|NCT01188772|16615088|P4|Overall Study|Non-responder|0
4819181|NCT01188772|16615089|P3|Overall Study|Non-responder|3
4819182|NCT01188772|16615090|P2|Overall Study|Non-responder|0
4819183|NCT01188772|16615091|P1|Overall Study|Non-responder|0
4819184|NCT01188772|16615088|P4|Overall Study|Lost to Follow-up|1
4819185|NCT01188772|16615089|P3|Overall Study|Lost to Follow-up|1
4819186|NCT01188772|16615090|P2|Overall Study|Lost to Follow-up|1
4819187|NCT01188772|16615091|P1|Overall Study|Lost to Follow-up|4
4819188|NCT01188772|16615088|P4|Overall Study|Adverse Event|0
4819189|NCT01188772|16615089|P3|Overall Study|Adverse Event|2
4819190|NCT01188772|16615090|P2|Overall Study|Adverse Event|1
4819191|NCT01188772|16615091|P1|Overall Study|Adverse Event|0
4819192|NCT01188772|16615088|P4|Overall Study|Randomized but Not Treated|0
4819193|NCT01188772|16615089|P3|Overall Study|Randomized but Not Treated|0
4819194|NCT01188772|16615090|P2|Overall Study|Randomized but Not Treated|1
4819195|NCT01188772|16615091|P1|Overall Study|Randomized but Not Treated|0
4819196|NCT01188681|16615163|P4|Overall Study|Withdrawal by Subject|1
4819197|NCT01188681|16615164|P3|Overall Study|Withdrawal by Subject|0
4819198|NCT01188681|16615165|P2|Overall Study|Withdrawal by Subject|0
4819199|NCT01188681|16615166|P1|Overall Study|Withdrawal by Subject|0
4819200|NCT01188681|16615163|P4|Overall Study|bladder cancer|0
4819201|NCT01188681|16615164|P3|Overall Study|bladder cancer|1
4819202|NCT01188681|16615165|P2|Overall Study|bladder cancer|0
4819203|NCT01188681|16615166|P1|Overall Study|bladder cancer|0
4819204|NCT01188668|16615180|P1|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1
4819205|NCT01188668|16615180|P1|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2
4819206|NCT01188668|16615180|P1|Period 1: ARIP Alone|Protocol Violation|2
4819207|NCT01188655|16615213|P1|Overall Study|Other|11
4819208|NCT01188655|16615213|P1|Overall Study|Lost to Follow-up|1
4819209|NCT01188655|16615213|P1|Overall Study|Lack of Efficacy|1
4819210|NCT01188564|16615257|P2|Double-blind Phase|randomized not treated|0
4819211|NCT01188564|16615258|P1|Double-blind Phase|randomized not treated|1
4819212|NCT01188551|16615270|P4|Overall Study|Pharmacy issues|0
4819213|NCT01188551|16615271|P3|Overall Study|Pharmacy issues|0
4819214|NCT01188551|16615272|P2|Overall Study|Pharmacy issues|0
4819215|NCT01188551|16615273|P1|Overall Study|Pharmacy issues|1
4819216|NCT01188538|16615289|P2|Overall Study|Lost to Follow-up|1
4819217|NCT01188538|16615290|P1|Overall Study|Lost to Follow-up|0
4819218|NCT01188343|16615386|P3|Overall Study|Withdrawal by Subject|0
4819219|NCT01188343|16615387|P2|Overall Study|Withdrawal by Subject|24
4819220|NCT01188343|16615388|P1|Overall Study|Withdrawal by Subject|1
4819221|NCT01188343|16615386|P3|Overall Study|Not vaccinated|1
4819222|NCT01188343|16615387|P2|Overall Study|Not vaccinated|2
4819223|NCT01188343|16615388|P1|Overall Study|Not vaccinated|0
4819224|NCT01188226|16615414|P1|Overall Study|Withdrawal by Subject|4
4819225|NCT01187953|16615460|P2|Overall Study|Withdrawal by Subject|3
4819226|NCT01187953|16615461|P1|Overall Study|Withdrawal by Subject|3
4819227|NCT01187953|16615460|P2|Overall Study|Lost to Follow-up|3
4819228|NCT01187953|16615461|P1|Overall Study|Lost to Follow-up|0
4819229|NCT01187953|16615460|P2|Overall Study|Adverse Event|2
4819230|NCT01187953|16615461|P1|Overall Study|Adverse Event|1
4819231|NCT01187953|16615460|P2|Overall Study|Death|13
4819232|NCT01187953|16615461|P1|Overall Study|Death|11
4819233|NCT01187901|16615475|P2|Overall Study|Pregnancy|2
4819234|NCT01187901|16615476|P1|Overall Study|Pregnancy|0
4819235|NCT01187901|16615475|P2|Overall Study|No Endpoint due to Early Study Halt|3
4819236|NCT01187901|16615476|P1|Overall Study|No Endpoint due to Early Study Halt|2
4819237|NCT01187901|16615475|P2|Overall Study|Adverse Event|0
4819238|NCT01187901|16615476|P1|Overall Study|Adverse Event|3
4819239|NCT01187901|16615475|P2|Overall Study|Suspected Allergic Reaction|1
4819240|NCT01187901|16615476|P1|Overall Study|Suspected Allergic Reaction|1
4819241|NCT01187901|16615475|P2|Overall Study|Unrelated Health Reasons|2
4819242|NCT01187901|16615476|P1|Overall Study|Unrelated Health Reasons|1
4819243|NCT01187901|16615475|P2|Overall Study|Lost to Follow-up|2
4819244|NCT01187901|16615476|P1|Overall Study|Lost to Follow-up|1
4819245|NCT01187901|16615475|P2|Overall Study|Protocol Violation|0
4819246|NCT01187901|16615476|P1|Overall Study|Protocol Violation|1
4819247|NCT01187550|16615517|P2|Overall Study|Randomized but not treated|0
4819248|NCT01187550|16615518|P1|Overall Study|Randomized but not treated|8
4819249|NCT01187550|16615517|P2|Overall Study|Other|0
4819250|NCT01187550|16615518|P1|Overall Study|Other|3
4819251|NCT01187550|16615517|P2|Overall Study|Protocol Violation|1
4819252|NCT01187550|16615518|P1|Overall Study|Protocol Violation|3
4819253|NCT01187446|16615674|P2|Overall Study|Patient started non-protocol therapy|1
4819254|NCT01187446|16615675|P1|Overall Study|Patient started non-protocol therapy|0
4819255|NCT01187433|16615691|P2|Overall Study|Withdrawal by Subject|2
4819256|NCT01187433|16615692|P1|Overall Study|Withdrawal by Subject|5
4819257|NCT01187433|16615691|P2|Overall Study|Protocol Violation|2
4819258|NCT01187433|16615692|P1|Overall Study|Protocol Violation|6
4819259|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
4819260|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4819261|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4819262|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4819263|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4819264|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22
4819265|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11
4819266|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
4819267|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
4819268|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
4819269|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10
4819270|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3
4819271|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4819272|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6
4819273|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
4819274|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
4819275|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4819276|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4819277|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4819278|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4819279|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
4819280|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
4819281|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
4819282|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
4819283|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4819284|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13
4819285|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5
4819286|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
4819287|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3
4819288|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
4819289|NCT01187407|16615722|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12
4819290|NCT01187407|16615723|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5
4819291|NCT01187407|16615724|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6
4819292|NCT01187407|16615725|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
4819293|NCT01187407|16615726|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
4819294|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819295|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819296|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819297|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819298|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4
4819299|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819300|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819301|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819302|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819303|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29
4819304|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819305|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819306|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819307|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819308|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13
4819309|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819310|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819311|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819312|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819313|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
4819314|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819315|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819316|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819317|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819318|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9
4819319|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819320|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819321|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819322|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819323|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4
4819324|NCT01187407|16615722|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819325|NCT01187407|16615723|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819326|NCT01187407|16615724|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819327|NCT01187407|16615725|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819328|NCT01187407|16615726|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29
4819329|NCT01187043|16615839|P5|Overall Study|Unable to make scheduled visits|1
4819330|NCT01187043|16615840|P4|Overall Study|Unable to make scheduled visits|0
4819331|NCT01187043|16615841|P3|Overall Study|Unable to make scheduled visits|4
4819332|NCT01187043|16615842|P2|Overall Study|Unable to make scheduled visits|0
4819333|NCT01187043|16615843|P1|Overall Study|Unable to make scheduled visits|1
4819334|NCT01187043|16615839|P5|Overall Study|Adverse Event|1
4819335|NCT01187043|16615840|P4|Overall Study|Adverse Event|0
4819336|NCT01187043|16615841|P3|Overall Study|Adverse Event|0
4819337|NCT01187043|16615842|P2|Overall Study|Adverse Event|0
4819338|NCT01187043|16615843|P1|Overall Study|Adverse Event|0
4819339|NCT01186978|16615869|P1|Overall Study|Withdrawal by Subject|1
4819340|NCT01186939|16615876|P1|Overall Study|Transformation to AML|1
4819341|NCT01186939|16615876|P1|Overall Study|Bone marrow transplant|1
4819342|NCT01186939|16615876|P1|Overall Study|Myocardial infarction|1
4819343|NCT01186939|16615876|P1|Overall Study|NCI CTC Grade 3 or 4 toxicity|1
4819344|NCT01186939|16615876|P1|Overall Study|Started additional treatment|1
4819345|NCT01186939|16615876|P1|Overall Study|Sponsor decision|4
4819346|NCT01186939|16615876|P1|Overall Study|Program closed|5
4819347|NCT01186939|16615876|P1|Overall Study|No longer receiving clinical benefit|17
4819348|NCT01186939|16615876|P1|Overall Study|Withdrawal by Subject|2
4819349|NCT01186939|16615876|P1|Overall Study|Death|7
4819350|NCT01186848|16615880|P1|Overall Study|Adverse Event|2
4819351|NCT01186848|16615880|P1|Overall Study|Withdrawal by Subject|2
4819352|NCT01186848|16615880|P1|Overall Study|Lost to Follow-up|4
4819353|NCT01186809|16615886|P1|Overall Study|Death|30
4819354|NCT01186796|16615892|P2|Overall Study|Protocol Violation|1
4819355|NCT01186796|16615893|P1|Overall Study|Protocol Violation|0
4819356|NCT01186796|16615892|P2|Overall Study|Withdrawal by Subject|1
4819357|NCT01186796|16615893|P1|Overall Study|Withdrawal by Subject|1
4819358|NCT01186796|16615892|P2|Overall Study|Adverse Event|0
4819359|NCT01186796|16615893|P1|Overall Study|Adverse Event|3
4819360|NCT01186770|16615911|P4|Overall Study|Other than specified|2
4819361|NCT01186770|16615912|P3|Overall Study|Other than specified|1
4819362|NCT01186770|16615913|P2|Overall Study|Other than specified|1
4819363|NCT01186770|16615914|P1|Overall Study|Other than specified|0
4819364|NCT01186770|16615911|P4|Overall Study|Insufficient response to treatment|7
4819365|NCT01186770|16615912|P3|Overall Study|Insufficient response to treatment|5
4819366|NCT01186770|16615913|P2|Overall Study|Insufficient response to treatment|8
4819367|NCT01186770|16615914|P1|Overall Study|Insufficient response to treatment|7
4819368|NCT01186770|16615911|P4|Overall Study|Lost to Follow-up|9
4819369|NCT01186770|16615912|P3|Overall Study|Lost to Follow-up|14
4819370|NCT01186770|16615913|P2|Overall Study|Lost to Follow-up|6
4819371|NCT01186770|16615914|P1|Overall Study|Lost to Follow-up|10
4819372|NCT01186770|16615911|P4|Overall Study|Withdrawal by Subject|17
4819373|NCT01186770|16615912|P3|Overall Study|Withdrawal by Subject|11
4819374|NCT01186770|16615913|P2|Overall Study|Withdrawal by Subject|13
4819375|NCT01186770|16615914|P1|Overall Study|Withdrawal by Subject|15
4819376|NCT01186770|16615911|P4|Overall Study|Adverse Event|9
4819377|NCT01186770|16615912|P3|Overall Study|Adverse Event|7
4819378|NCT01186770|16615913|P2|Overall Study|Adverse Event|9
4819379|NCT01186770|16615914|P1|Overall Study|Adverse Event|2
4819380|NCT01186770|16615911|P4|Overall Study|Protocol Violation|14
4819381|NCT01186770|16615912|P3|Overall Study|Protocol Violation|12
4819382|NCT01186770|16615913|P2|Overall Study|Protocol Violation|9
4819383|NCT01186770|16615914|P1|Overall Study|Protocol Violation|7
4819384|NCT01186770|16615911|P4|Overall Study|Ineligibility|0
4819385|NCT01186770|16615912|P3|Overall Study|Ineligibility|2
4819386|NCT01186770|16615913|P2|Overall Study|Ineligibility|0
4819387|NCT01186770|16615914|P1|Overall Study|Ineligibility|0
4819388|NCT01186744|16615938|P6|Overall Study|Death|0
4819389|NCT01186744|16615939|P5|Overall Study|Death|0
4819390|NCT01186744|16615940|P4|Overall Study|Death|0
4819391|NCT01186744|16615941|P3|Overall Study|Death|0
4819392|NCT01186744|16615942|P2|Overall Study|Death|0
4819393|NCT01186744|16615943|P1|Overall Study|Death|1
4819394|NCT01186744|16615938|P6|Overall Study|Adverse Event|4
4819395|NCT01186744|16615939|P5|Overall Study|Adverse Event|1
4819396|NCT01186744|16615940|P4|Overall Study|Adverse Event|0
4819397|NCT01186744|16615941|P3|Overall Study|Adverse Event|1
4819398|NCT01186744|16615942|P2|Overall Study|Adverse Event|14
4819399|NCT01186744|16615943|P1|Overall Study|Adverse Event|10
4819400|NCT01186744|16615938|P6|Overall Study|Other|5
4819401|NCT01186744|16615939|P5|Overall Study|Other|1
4819402|NCT01186744|16615940|P4|Overall Study|Other|2
4819403|NCT01186744|16615941|P3|Overall Study|Other|1
4819404|NCT01186744|16615942|P2|Overall Study|Other|10
4819405|NCT01186744|16615943|P1|Overall Study|Other|9
4819406|NCT01186744|16615938|P6|Overall Study|Study terminated by Sponsor|0
4819407|NCT01186744|16615939|P5|Overall Study|Study terminated by Sponsor|0
4819408|NCT01186744|16615940|P4|Overall Study|Study terminated by Sponsor|0
4819409|NCT01186744|16615941|P3|Overall Study|Study terminated by Sponsor|0
4819410|NCT01186744|16615942|P2|Overall Study|Study terminated by Sponsor|0
4819411|NCT01186744|16615943|P1|Overall Study|Study terminated by Sponsor|1
4819412|NCT01186744|16615938|P6|Overall Study|Withdrawal by Subject|6
4819413|NCT01186744|16615939|P5|Overall Study|Withdrawal by Subject|0
4819414|NCT01186744|16615940|P4|Overall Study|Withdrawal by Subject|5
4819415|NCT01186744|16615941|P3|Overall Study|Withdrawal by Subject|2
4819416|NCT01186744|16615942|P2|Overall Study|Withdrawal by Subject|10
4819417|NCT01186744|16615943|P1|Overall Study|Withdrawal by Subject|14
4819418|NCT01186744|16615938|P6|Overall Study|Screen failure|0
4819419|NCT01186744|16615939|P5|Overall Study|Screen failure|0
4819420|NCT01186744|16615940|P4|Overall Study|Screen failure|1
4819421|NCT01186744|16615941|P3|Overall Study|Screen failure|0
4819422|NCT01186744|16615942|P2|Overall Study|Screen failure|1
4819423|NCT01186744|16615943|P1|Overall Study|Screen failure|1
4819424|NCT01186744|16615938|P6|Overall Study|Lost to Follow-up|4
4819425|NCT01186744|16615939|P5|Overall Study|Lost to Follow-up|1
4819426|NCT01186744|16615940|P4|Overall Study|Lost to Follow-up|1
4819427|NCT01186744|16615941|P3|Overall Study|Lost to Follow-up|2
4819428|NCT01186744|16615942|P2|Overall Study|Lost to Follow-up|16
4819429|NCT01186744|16615943|P1|Overall Study|Lost to Follow-up|15
4819430|NCT01186744|16615938|P6|Overall Study|Protocol Violation|2
4819431|NCT01186744|16615939|P5|Overall Study|Protocol Violation|1
4819432|NCT01186744|16615940|P4|Overall Study|Protocol Violation|1
4819433|NCT01186744|16615941|P3|Overall Study|Protocol Violation|0
4819434|NCT01186744|16615942|P2|Overall Study|Protocol Violation|2
4819435|NCT01186744|16615943|P1|Overall Study|Protocol Violation|1
4819436|NCT01186744|16615938|P6|Overall Study|Lack of Efficacy|5
4819437|NCT01186744|16615939|P5|Overall Study|Lack of Efficacy|2
4819438|NCT01186744|16615940|P4|Overall Study|Lack of Efficacy|2
4819439|NCT01186744|16615941|P3|Overall Study|Lack of Efficacy|0
4819440|NCT01186744|16615942|P2|Overall Study|Lack of Efficacy|99
4819441|NCT01186744|16615943|P1|Overall Study|Lack of Efficacy|156
4819442|NCT01186692|16616363|P1|Overall Study|Adverse Event|2
4819443|NCT01186692|16616363|P1|Overall Study|Futher testing contraindicated implant|19
4819444|NCT01186692|16616363|P1|Overall Study|Not Catheterized|11
4819445|NCT01186458|16616390|P1|Overall Study|Adverse Event|1
4819446|NCT01186419|16616399|P2|Overall Study|Other|1
4819447|NCT01186419|16616400|P1|Overall Study|Other|1
4819448|NCT01186419|16616399|P2|Overall Study|Physician Decision|3
4819449|NCT01186419|16616400|P1|Overall Study|Physician Decision|0
4819450|NCT01186419|16616399|P2|Overall Study|Adverse Event|2
4819451|NCT01186419|16616400|P1|Overall Study|Adverse Event|1
4819452|NCT01186419|16616399|P2|Overall Study|Withdrawal by Subject|3
4819453|NCT01186419|16616400|P1|Overall Study|Withdrawal by Subject|5
4819454|NCT01186328|16616414|P3|Overall Study|Death|0
4819455|NCT01186328|16616415|P2|Overall Study|Death|0
4819456|NCT01186328|16616416|P1|Overall Study|Death|1
4819457|NCT01185964|16616446|P4|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2
4819458|NCT01185964|16616447|P3|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
4819459|NCT01185964|16616448|P2|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
4819460|NCT01185964|16616449|P1|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0
4819461|NCT01185964|16616446|P4|Optional Olaratumab Monotherapy on Dox|Adverse Event|1
4819462|NCT01185964|16616447|P3|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
4819463|NCT01185964|16616448|P2|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
4819464|NCT01185964|16616449|P1|Optional Olaratumab Monotherapy on Dox|Adverse Event|0
4819465|NCT01185964|16616446|P4|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2
4819466|NCT01185964|16616447|P3|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
4819467|NCT01185964|16616448|P2|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
4819468|NCT01185964|16616449|P1|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0
4819469|NCT01185964|16616446|P4|Phase 1b and Phase 2|Off Treatment but alive and on study|0
4819470|NCT01185964|16616447|P3|Phase 1b and Phase 2|Off Treatment but alive and on study|1
4819471|NCT01185964|16616448|P2|Phase 1b and Phase 2|Off Treatment but alive and on study|1
4819472|NCT01185964|16616449|P1|Phase 1b and Phase 2|Off Treatment but alive and on study|0
4819473|NCT01185964|16616446|P4|Phase 1b and Phase 2|Adverse Event|0
4819474|NCT01185964|16616447|P3|Phase 1b and Phase 2|Adverse Event|2
4819475|NCT01185964|16616448|P2|Phase 1b and Phase 2|Adverse Event|0
4819476|NCT01185964|16616449|P1|Phase 1b and Phase 2|Adverse Event|1
4819477|NCT01185964|16616446|P4|Phase 1b and Phase 2|Participant was beyond maximum weight|0
4819478|NCT01185964|16616447|P3|Phase 1b and Phase 2|Participant was beyond maximum weight|1
4819479|NCT01185964|16616448|P2|Phase 1b and Phase 2|Participant was beyond maximum weight|0
4819480|NCT01185964|16616449|P1|Phase 1b and Phase 2|Participant was beyond maximum weight|0
4819481|NCT01185964|16616446|P4|Phase 1b and Phase 2|Other Therapy Started|0
4819482|NCT01185964|16616447|P3|Phase 1b and Phase 2|Other Therapy Started|3
4819483|NCT01185964|16616448|P2|Phase 1b and Phase 2|Other Therapy Started|3
4819484|NCT01185964|16616449|P1|Phase 1b and Phase 2|Other Therapy Started|0
4819485|NCT01185964|16616446|P4|Phase 1b and Phase 2|Withdrawal by Subject|0
4819486|NCT01185964|16616447|P3|Phase 1b and Phase 2|Withdrawal by Subject|2
4819487|NCT01185964|16616448|P2|Phase 1b and Phase 2|Withdrawal by Subject|6
4819488|NCT01185964|16616449|P1|Phase 1b and Phase 2|Withdrawal by Subject|1
4819489|NCT01185834|16616475|P1|Overall Study|Early exit - Site error|2
4819490|NCT01185834|16616475|P1|Overall Study|Time/Job Conflict|2
4819491|NCT01185834|16616475|P1|Overall Study|Biomicroscopy|4
4819492|NCT01185834|16616475|P1|Overall Study|Discomfort|4
4819493|NCT01185834|16616475|P1|Overall Study|Lost to Follow-up|2
4819494|NCT01185821|16616485|P5|Overall Study|Administrative problems|2
4819495|NCT01185821|16616486|P4|Overall Study|Administrative problems|1
4819496|NCT01185821|16616487|P3|Overall Study|Administrative problems|1
4819497|NCT01185821|16616488|P2|Overall Study|Administrative problems|0
4819498|NCT01185821|16616489|P1|Overall Study|Administrative problems|0
4819499|NCT01185821|16616485|P5|Overall Study|Lost to Follow-up|2
4819500|NCT01185821|16616486|P4|Overall Study|Lost to Follow-up|1
4819501|NCT01185821|16616487|P3|Overall Study|Lost to Follow-up|2
4819502|NCT01185821|16616488|P2|Overall Study|Lost to Follow-up|1
4819503|NCT01185821|16616489|P1|Overall Study|Lost to Follow-up|1
4819504|NCT01185821|16616485|P5|Overall Study|Withdrawal by Subject|3
4819505|NCT01185821|16616486|P4|Overall Study|Withdrawal by Subject|1
4819506|NCT01185821|16616487|P3|Overall Study|Withdrawal by Subject|2
4819507|NCT01185821|16616488|P2|Overall Study|Withdrawal by Subject|2
4819508|NCT01185821|16616489|P1|Overall Study|Withdrawal by Subject|3
4819509|NCT01185821|16616485|P5|Overall Study|Lack of Efficacy|9
4819510|NCT01185821|16616486|P4|Overall Study|Lack of Efficacy|0
4819511|NCT01185821|16616487|P3|Overall Study|Lack of Efficacy|3
4819512|NCT01185821|16616488|P2|Overall Study|Lack of Efficacy|0
4819513|NCT01185821|16616489|P1|Overall Study|Lack of Efficacy|0
4819514|NCT01185821|16616485|P5|Overall Study|Adverse Event|5
4819515|NCT01185821|16616486|P4|Overall Study|Adverse Event|2
4819516|NCT01185821|16616487|P3|Overall Study|Adverse Event|1
4819517|NCT01185821|16616488|P2|Overall Study|Adverse Event|3
4819518|NCT01185821|16616489|P1|Overall Study|Adverse Event|2
4819519|NCT01185821|16616485|P5|Overall Study|Condition no longer required study drug|1
4819520|NCT01185821|16616486|P4|Overall Study|Condition no longer required study drug|0
4819521|NCT01185821|16616487|P3|Overall Study|Condition no longer required study drug|0
4819522|NCT01185821|16616488|P2|Overall Study|Condition no longer required study drug|0
4819523|NCT01185821|16616489|P1|Overall Study|Condition no longer required study drug|0
4819524|NCT01185821|16616485|P5|Overall Study|Death|0
4819525|NCT01185821|16616486|P4|Overall Study|Death|0
4819526|NCT01185821|16616487|P3|Overall Study|Death|0
4819527|NCT01185821|16616488|P2|Overall Study|Death|1
4819528|NCT01185821|16616489|P1|Overall Study|Death|0
4819529|NCT01185821|16616485|P5|Overall Study|Abnormal test procedure result|1
4819530|NCT01185821|16616486|P4|Overall Study|Abnormal test procedure result|0
4819531|NCT01185821|16616487|P3|Overall Study|Abnormal test procedure result|0
4819532|NCT01185821|16616488|P2|Overall Study|Abnormal test procedure result|0
4819533|NCT01185821|16616489|P1|Overall Study|Abnormal test procedure result|0
4819534|NCT01185821|16616485|P5|Overall Study|Protocol Violation|1
4819535|NCT01185821|16616486|P4|Overall Study|Protocol Violation|1
4819536|NCT01185821|16616487|P3|Overall Study|Protocol Violation|0
4819537|NCT01185821|16616488|P2|Overall Study|Protocol Violation|0
4819538|NCT01185821|16616489|P1|Overall Study|Protocol Violation|0
4819539|NCT01185821|16616485|P5|Overall Study|Abnormal laboratory value(s)|0
4819540|NCT01185821|16616486|P4|Overall Study|Abnormal laboratory value(s)|0
4819541|NCT01185821|16616487|P3|Overall Study|Abnormal laboratory value(s)|1
4819542|NCT01185821|16616488|P2|Overall Study|Abnormal laboratory value(s)|2
4819543|NCT01185821|16616489|P1|Overall Study|Abnormal laboratory value(s)|1
4819544|NCT01185782|16616540|P2|Overall Study|Randomized but not treated|4
4819545|NCT01185782|16616541|P1|Overall Study|Randomized but not treated|0
4819546|NCT01185782|16616540|P2|Overall Study|Other|5
4819547|NCT01185782|16616541|P1|Overall Study|Other|2
4819548|NCT01185782|16616540|P2|Overall Study|Poor Response to Treatment|1
4819549|NCT01185782|16616541|P1|Overall Study|Poor Response to Treatment|3
4819550|NCT01185782|16616540|P2|Overall Study|Protocol Violation|0
4819551|NCT01185782|16616541|P1|Overall Study|Protocol Violation|1
4819552|NCT01185782|16616540|P2|Overall Study|Adverse Event|1
4819553|NCT01185782|16616541|P1|Overall Study|Adverse Event|0
4819554|NCT01185704|16616569|P2|Overall Study|Ectopic pregnancy|1
4819555|NCT01185704|16616570|P1|Overall Study|Ectopic pregnancy|0
4819556|NCT01185704|16616569|P2|Overall Study|Ovarian hyperstimulation syndrome risk|3
4819557|NCT01185704|16616570|P1|Overall Study|Ovarian hyperstimulation syndrome risk|5
4819558|NCT01185704|16616569|P2|Overall Study|Lack of ovarian response|1
4819559|NCT01185704|16616570|P1|Overall Study|Lack of ovarian response|5
4819560|NCT01185704|16616569|P2|Overall Study|Randomized but not treated|3
4819561|NCT01185704|16616570|P1|Overall Study|Randomized but not treated|3
4819562|NCT01185639|16616604|P1|Overall Study|Progressed and didn't receive therapy|2
4819563|NCT01185600|16616614|P2|Overall Study|Hold by DSMB|2
4819564|NCT01185600|16616615|P1|Overall Study|Hold by DSMB|1
4819565|NCT01185600|16616614|P2|Overall Study|Withdrawal by Subject|1
4819566|NCT01185600|16616615|P1|Overall Study|Withdrawal by Subject|1
4819567|NCT01185600|16616614|P2|Overall Study|Physician Decision|35
4819568|NCT01185600|16616615|P1|Overall Study|Physician Decision|29
4819569|NCT01185600|16616614|P2|Overall Study|Lost to Follow-up|5
4819570|NCT01185600|16616615|P1|Overall Study|Lost to Follow-up|0
4819571|NCT01185600|16616614|P2|Overall Study|Death|1
4819572|NCT01185600|16616615|P1|Overall Study|Death|0
4819573|NCT01185600|16616614|P2|Overall Study|Adverse Event|1
4819574|NCT01185600|16616615|P1|Overall Study|Adverse Event|1
4819575|NCT01185561|16616637|P2|Overall Study|Withdrawal by Subject|8
4819576|NCT01185561|16616638|P1|Overall Study|Withdrawal by Subject|2
4819577|NCT01185561|16616637|P2|Overall Study|Lost to Follow-up|4
4819578|NCT01185561|16616638|P1|Overall Study|Lost to Follow-up|0
4819579|NCT01185548|16616650|P1|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2
4819580|NCT01185522|16616663|P1|Overall Study|Other reasons|12
4819581|NCT01185522|16616663|P1|Overall Study|Poor tolerance|39
4819582|NCT01185522|16616663|P1|Overall Study|Withdrawal by Subject|10
4819583|NCT01185522|16616663|P1|Overall Study|Lost to Follow-up|19
4819584|NCT01185522|16616663|P1|Overall Study|Lack of Efficacy|28
4819585|NCT01185509|16616689|P2|Overall Study|Intercurrent Illness|1
4819586|NCT01185509|16616690|P1|Overall Study|Intercurrent Illness|0
4819587|NCT01185509|16616689|P2|Overall Study|Death|1
4819588|NCT01185509|16616690|P1|Overall Study|Death|0
4819589|NCT01185509|16616689|P2|Overall Study|Withdrawal by Subject|1
4819590|NCT01185509|16616690|P1|Overall Study|Withdrawal by Subject|0
4819591|NCT01185509|16616689|P2|Overall Study|Physician Decision|2
4819592|NCT01185509|16616690|P1|Overall Study|Physician Decision|2
4819593|NCT01185509|16616689|P2|Overall Study|Progression/Relapse|15
4819594|NCT01185509|16616690|P1|Overall Study|Progression/Relapse|9
4819595|NCT01185353|16616706|P10|Part D (Weeks 76 Through 128)|Adverse Event|0
4819596|NCT01185353|16616707|P9|Part D (Weeks 76 Through 128)|Adverse Event|2
4819597|NCT01185353|16616708|P8|Part D (Weeks 76 Through 128)|Adverse Event|1
4819598|NCT01185353|16616709|P7|Part D (Weeks 76 Through 128)|Adverse Event|0
4819599|NCT01185353|16616710|P6|Part D (Weeks 76 Through 128)|Adverse Event|0
4819600|NCT01185353|16616711|P5|Part D (Weeks 76 Through 128)|Adverse Event|0
4819601|NCT01185353|16616712|P4|Part D (Weeks 76 Through 128)|Adverse Event|0
4819602|NCT01185353|16616713|P3|Part D (Weeks 76 Through 128)|Adverse Event|0
4819603|NCT01185353|16616714|P2|Part D (Weeks 76 Through 128)|Adverse Event|0
4819604|NCT01185353|16616715|P1|Part D (Weeks 76 Through 128)|Adverse Event|0
4819605|NCT01185353|16616706|P10|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
4819606|NCT01185353|16616707|P9|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2
4819607|NCT01185353|16616708|P8|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1
4819608|NCT01185353|16616709|P7|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819609|NCT01185353|16616710|P6|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819610|NCT01185353|16616711|P5|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819611|NCT01185353|16616712|P4|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819612|NCT01185353|16616713|P3|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819613|NCT01185353|16616714|P2|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819614|NCT01185353|16616715|P1|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0
4819615|NCT01185353|16616706|P10|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819616|NCT01185353|16616707|P9|Part D (Weeks 76 Through 128)|Lost to Follow-up|3
4819617|NCT01185353|16616708|P8|Part D (Weeks 76 Through 128)|Lost to Follow-up|1
4819618|NCT01185353|16616709|P7|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819619|NCT01185353|16616710|P6|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819620|NCT01185353|16616711|P5|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819621|NCT01185353|16616712|P4|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819622|NCT01185353|16616713|P3|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819623|NCT01185353|16616714|P2|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819624|NCT01185353|16616715|P1|Part D (Weeks 76 Through 128)|Lost to Follow-up|0
4819625|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Reason missing|0
4819626|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Reason missing|1
4819627|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Reason missing|0
4819628|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Reason missing|0
4819629|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Reason missing|0
4819630|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Reason missing|0
4819631|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Reason missing|0
4819632|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Reason missing|0
4819633|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Reason missing|0
4819634|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Reason missing|0
4819635|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Physician Decision|1
4819636|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Physician Decision|0
4819637|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Physician Decision|0
4819638|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Physician Decision|0
4819639|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Physician Decision|0
4819640|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Physician Decision|0
4819641|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Physician Decision|0
4819642|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Physician Decision|0
4819643|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Physician Decision|0
4819644|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Physician Decision|0
4819645|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1
4819646|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819647|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819648|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819649|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819650|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819651|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819652|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819653|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819654|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0
4819655|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Death|1
4819656|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Death|0
4819657|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Death|0
4819658|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Death|0
4819659|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Death|0
4819660|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Death|0
4819661|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Death|0
4819662|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Death|0
4819663|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Death|0
4819664|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Death|0
4819665|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819666|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Lack of Efficacy|2
4819667|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819668|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819669|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819670|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819671|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819672|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819673|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819674|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Lack of Efficacy|0
4819675|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
4819676|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Lost to Follow-up|1
4819677|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Lost to Follow-up|2
4819678|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819679|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819680|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819681|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819682|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819683|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819684|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Lost to Follow-up|0
4819685|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
4819686|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2
4819687|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6
4819688|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819689|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819690|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819691|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819692|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819693|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819694|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0
4819695|NCT01185353|16616706|P10|Part C (Weeks 24 Through 76)|Adverse Event|2
4819696|NCT01185353|16616707|P9|Part C (Weeks 24 Through 76)|Adverse Event|2
4819697|NCT01185353|16616708|P8|Part C (Weeks 24 Through 76)|Adverse Event|8
4819698|NCT01185353|16616709|P7|Part C (Weeks 24 Through 76)|Adverse Event|0
4819699|NCT01185353|16616710|P6|Part C (Weeks 24 Through 76)|Adverse Event|0
4819700|NCT01185353|16616711|P5|Part C (Weeks 24 Through 76)|Adverse Event|0
4819701|NCT01185353|16616712|P4|Part C (Weeks 24 Through 76)|Adverse Event|0
4819702|NCT01185353|16616713|P3|Part C (Weeks 24 Through 76)|Adverse Event|0
4819703|NCT01185353|16616714|P2|Part C (Weeks 24 Through 76)|Adverse Event|0
4819704|NCT01185353|16616715|P1|Part C (Weeks 24 Through 76)|Adverse Event|0
4819705|NCT01185353|16616706|P10|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819706|NCT01185353|16616707|P9|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819707|NCT01185353|16616708|P8|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819708|NCT01185353|16616709|P7|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1
4819709|NCT01185353|16616710|P6|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819710|NCT01185353|16616711|P5|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819787|NCT01185353|16616708|P8|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819711|NCT01185353|16616712|P4|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819712|NCT01185353|16616713|P3|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819713|NCT01185353|16616714|P2|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819714|NCT01185353|16616715|P1|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0
4819715|NCT01185353|16616706|P10|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4819716|NCT01185353|16616707|P9|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4819717|NCT01185353|16616708|P8|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4819718|NCT01185353|16616709|P7|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4
4819719|NCT01185353|16616710|P6|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3
4819720|NCT01185353|16616711|P5|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4819721|NCT01185353|16616712|P4|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2
4819722|NCT01185353|16616713|P3|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1
4819723|NCT01185353|16616714|P2|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4819724|NCT01185353|16616715|P1|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0
4819725|NCT01185353|16616706|P10|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819726|NCT01185353|16616707|P9|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819727|NCT01185353|16616708|P8|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819728|NCT01185353|16616709|P7|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
4819729|NCT01185353|16616710|P6|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819730|NCT01185353|16616711|P5|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819731|NCT01185353|16616712|P4|Part B (Weeks 12 Through 24)|Lost to Follow-up|1
4819732|NCT01185353|16616713|P3|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819733|NCT01185353|16616714|P2|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819734|NCT01185353|16616715|P1|Part B (Weeks 12 Through 24)|Lost to Follow-up|0
4819735|NCT01185353|16616706|P10|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819736|NCT01185353|16616707|P9|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819737|NCT01185353|16616708|P8|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819738|NCT01185353|16616709|P7|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819739|NCT01185353|16616710|P6|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819740|NCT01185353|16616711|P5|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819741|NCT01185353|16616712|P4|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
4819742|NCT01185353|16616713|P3|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819743|NCT01185353|16616714|P2|Part B (Weeks 12 Through 24)|Lack of Efficacy|1
4819744|NCT01185353|16616715|P1|Part B (Weeks 12 Through 24)|Lack of Efficacy|0
4819745|NCT01185353|16616706|P10|Part B (Weeks 12 Through 24)|Adverse Event|0
4819746|NCT01185353|16616707|P9|Part B (Weeks 12 Through 24)|Adverse Event|0
4819747|NCT01185353|16616708|P8|Part B (Weeks 12 Through 24)|Adverse Event|0
4819748|NCT01185353|16616709|P7|Part B (Weeks 12 Through 24)|Adverse Event|0
4819749|NCT01185353|16616710|P6|Part B (Weeks 12 Through 24)|Adverse Event|1
4819750|NCT01185353|16616711|P5|Part B (Weeks 12 Through 24)|Adverse Event|0
4819751|NCT01185353|16616712|P4|Part B (Weeks 12 Through 24)|Adverse Event|0
4819752|NCT01185353|16616713|P3|Part B (Weeks 12 Through 24)|Adverse Event|1
4819753|NCT01185353|16616714|P2|Part B (Weeks 12 Through 24)|Adverse Event|0
4819754|NCT01185353|16616715|P1|Part B (Weeks 12 Through 24)|Adverse Event|0
4819755|NCT01185353|16616706|P10|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819756|NCT01185353|16616707|P9|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819757|NCT01185353|16616708|P8|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819758|NCT01185353|16616709|P7|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819759|NCT01185353|16616710|P6|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819760|NCT01185353|16616711|P5|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3
4819761|NCT01185353|16616712|P4|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819762|NCT01185353|16616713|P3|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819763|NCT01185353|16616714|P2|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0
4819764|NCT01185353|16616715|P1|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2
4819765|NCT01185353|16616706|P10|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819766|NCT01185353|16616707|P9|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819767|NCT01185353|16616708|P8|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819768|NCT01185353|16616709|P7|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819769|NCT01185353|16616710|P6|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819770|NCT01185353|16616711|P5|Part A (Weeks 0 Through 12)|Protocol Violation|1
4819771|NCT01185353|16616712|P4|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819772|NCT01185353|16616713|P3|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819773|NCT01185353|16616714|P2|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819774|NCT01185353|16616715|P1|Part A (Weeks 0 Through 12)|Protocol Violation|0
4819775|NCT01185353|16616706|P10|Part A (Weeks 0 Through 12)|Physician Decision|0
4819776|NCT01185353|16616707|P9|Part A (Weeks 0 Through 12)|Physician Decision|0
4819777|NCT01185353|16616708|P8|Part A (Weeks 0 Through 12)|Physician Decision|0
4819778|NCT01185353|16616709|P7|Part A (Weeks 0 Through 12)|Physician Decision|0
4819779|NCT01185353|16616710|P6|Part A (Weeks 0 Through 12)|Physician Decision|0
4819780|NCT01185353|16616711|P5|Part A (Weeks 0 Through 12)|Physician Decision|2
4819781|NCT01185353|16616712|P4|Part A (Weeks 0 Through 12)|Physician Decision|0
4819782|NCT01185353|16616713|P3|Part A (Weeks 0 Through 12)|Physician Decision|1
4819783|NCT01185353|16616714|P2|Part A (Weeks 0 Through 12)|Physician Decision|0
4819784|NCT01185353|16616715|P1|Part A (Weeks 0 Through 12)|Physician Decision|0
4819785|NCT01185353|16616706|P10|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819786|NCT01185353|16616707|P9|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819788|NCT01185353|16616709|P7|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819789|NCT01185353|16616710|P6|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819790|NCT01185353|16616711|P5|Part A (Weeks 0 Through 12)|Lack of Efficacy|1
4819791|NCT01185353|16616712|P4|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819792|NCT01185353|16616713|P3|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819793|NCT01185353|16616714|P2|Part A (Weeks 0 Through 12)|Lack of Efficacy|0
4819794|NCT01185353|16616715|P1|Part A (Weeks 0 Through 12)|Lack of Efficacy|2
4819795|NCT01185353|16616706|P10|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819796|NCT01185353|16616707|P9|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819797|NCT01185353|16616708|P8|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819798|NCT01185353|16616709|P7|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819799|NCT01185353|16616710|P6|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819800|NCT01185353|16616711|P5|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4
4819801|NCT01185353|16616712|P4|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819802|NCT01185353|16616713|P3|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819803|NCT01185353|16616714|P2|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819804|NCT01185353|16616715|P1|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0
4819805|NCT01185353|16616706|P10|Part A (Weeks 0 Through 12)|Adverse Event|0
4819806|NCT01185353|16616707|P9|Part A (Weeks 0 Through 12)|Adverse Event|0
4819807|NCT01185353|16616708|P8|Part A (Weeks 0 Through 12)|Adverse Event|0
4819808|NCT01185353|16616709|P7|Part A (Weeks 0 Through 12)|Adverse Event|0
4819809|NCT01185353|16616710|P6|Part A (Weeks 0 Through 12)|Adverse Event|0
4819810|NCT01185353|16616711|P5|Part A (Weeks 0 Through 12)|Adverse Event|5
4819811|NCT01185353|16616712|P4|Part A (Weeks 0 Through 12)|Adverse Event|1
4819812|NCT01185353|16616713|P3|Part A (Weeks 0 Through 12)|Adverse Event|1
4819813|NCT01185353|16616714|P2|Part A (Weeks 0 Through 12)|Adverse Event|1
4819814|NCT01185353|16616715|P1|Part A (Weeks 0 Through 12)|Adverse Event|1
4819815|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7
4819816|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3
4819817|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4819818|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4819819|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
4819820|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
4819821|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8
4819822|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
4819823|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4819824|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2
4819825|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4819826|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
4819827|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4819828|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4819829|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4819830|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4819831|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7
4819832|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5
4819833|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4
4819834|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4819835|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
4819836|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7
4819837|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4
4819838|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
4819839|NCT01185340|16616876|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
4819840|NCT01185340|16616877|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8
4819841|NCT01185340|16616878|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13
4819842|NCT01185340|16616879|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
4819843|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819844|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819845|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4819846|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3
4819847|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819848|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819849|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4819850|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32
4819851|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819852|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819853|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4819854|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16
4819855|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819856|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819857|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4819858|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2
4819859|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819860|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819861|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4819862|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5
4819863|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819864|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819865|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4819866|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6
4819867|NCT01185340|16616876|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819868|NCT01185340|16616877|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819869|NCT01185340|16616878|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4819870|NCT01185340|16616879|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24
4819871|NCT01185301|16616931|P4|Overall Study|Other Reason|2
4819872|NCT01185301|16616932|P3|Overall Study|Other Reason|2
4819873|NCT01185301|16616933|P2|Overall Study|Other Reason|2
4819874|NCT01185301|16616934|P1|Overall Study|Other Reason|3
4819875|NCT01185301|16616931|P4|Overall Study|Lost to Follow-up|1
4819876|NCT01185301|16616932|P3|Overall Study|Lost to Follow-up|0
4819877|NCT01185301|16616933|P2|Overall Study|Lost to Follow-up|0
4819878|NCT01185301|16616934|P1|Overall Study|Lost to Follow-up|2
4819879|NCT01185301|16616931|P4|Overall Study|Withdrawal by Subject|3
4819880|NCT01185301|16616932|P3|Overall Study|Withdrawal by Subject|2
4819881|NCT01185301|16616933|P2|Overall Study|Withdrawal by Subject|5
4819882|NCT01185301|16616934|P1|Overall Study|Withdrawal by Subject|7
4819883|NCT01185301|16616931|P4|Overall Study|Adverse Event|3
4819884|NCT01185301|16616932|P3|Overall Study|Adverse Event|2
4819885|NCT01185301|16616933|P2|Overall Study|Adverse Event|0
4819886|NCT01185301|16616934|P1|Overall Study|Adverse Event|3
4819887|NCT01185288|16616994|P2|Overall Study|Noncompliance|1
4819888|NCT01185288|16616995|P1|Overall Study|Noncompliance|0
4819889|NCT01185288|16616994|P2|Overall Study|Did not meet inclusion criteria|0
4819890|NCT01185288|16616995|P1|Overall Study|Did not meet inclusion criteria|1
4819891|NCT01185288|16616994|P2|Overall Study|Investigator discretion|0
4819892|NCT01185288|16616995|P1|Overall Study|Investigator discretion|1
4819893|NCT01185288|16616994|P2|Overall Study|Lack of Efficacy|0
4819894|NCT01185288|16616995|P1|Overall Study|Lack of Efficacy|2
4819895|NCT01185288|16616994|P2|Overall Study|Lost to Follow-up|5
4819896|NCT01185288|16616995|P1|Overall Study|Lost to Follow-up|2
4819897|NCT01185288|16616994|P2|Overall Study|Withdrawal by Subject|4
4819898|NCT01185288|16616995|P1|Overall Study|Withdrawal by Subject|6
4819899|NCT01185288|16616994|P2|Overall Study|Adverse Event|6
4819900|NCT01185288|16616995|P1|Overall Study|Adverse Event|7
4819901|NCT01185249|16617013|P1|Overall Study|Patients discharged or change in status|42
4819902|NCT01185171|16617018|P1|Maintenance|Disease Recurrence|1
4819903|NCT01185171|16617018|P1|Maintenance|Withdrawal by Subject|1
4819904|NCT01185171|16617018|P1|Maintenance|Comorbid Illness|2
4819905|NCT01185171|16617018|P1|Maintenance|Nausea|1
4819906|NCT01185171|16617018|P1|Maintenance|Xerostomia|1
4819907|NCT01185171|16617018|P1|Maintenance|Diarrhea|1
4819908|NCT01185171|16617018|P1|Maintenance|Rush|2
4819909|NCT01185171|16617018|P1|Maintenance|Elevated liver transaminases|3
4819910|NCT01185171|16617018|P1|Concurrent Chemo and Radiation Treatment|Death|3
4819911|NCT01185171|16617018|P1|Induction Chemotherapy|Duodenal Ulcer|1
4819912|NCT01185171|16617018|P1|Induction Chemotherapy|Withdrawal by Subject|1
4819913|NCT01185080|16617028|P3|Overall Study|Personal reasons|1
4819914|NCT01185080|16617029|P2|Overall Study|Personal reasons|0
4819915|NCT01185080|16617030|P1|Overall Study|Personal reasons|0
4819916|NCT01185080|16617028|P3|Overall Study|Adverse Event|0
4819917|NCT01185080|16617029|P2|Overall Study|Adverse Event|1
4819918|NCT01185080|16617030|P1|Overall Study|Adverse Event|1
4819919|NCT01184989|16617082|P1|Overall Study|Withdrawal by Subject|1
4819920|NCT01184989|16617082|P1|Overall Study|Adverse Event|11
4819921|NCT01184872|16617102|P2|Overall Study|Protocol deviation|0
4819922|NCT01184872|16617103|P1|Overall Study|Protocol deviation|1
4819923|NCT01184872|16617102|P2|Overall Study|Administrative problems|1
4819924|NCT01184872|16617103|P1|Overall Study|Administrative problems|1
4819925|NCT01184872|16617102|P2|Overall Study|Lost to Follow-up|1
4819926|NCT01184872|16617103|P1|Overall Study|Lost to Follow-up|0
4819927|NCT01184872|16617102|P2|Overall Study|Withdrawal by Subject|0
4819928|NCT01184872|16617103|P1|Overall Study|Withdrawal by Subject|2
4819929|NCT01184872|16617102|P2|Overall Study|Unsatisfactory therapeutic effect|2
4819930|NCT01184872|16617103|P1|Overall Study|Unsatisfactory therapeutic effect|3
4819931|NCT01184872|16617102|P2|Overall Study|Adverse Event|4
4819932|NCT01184872|16617103|P1|Overall Study|Adverse Event|3
4819933|NCT01184859|16617122|P5|Period 2: Daily Dose for 28 Days|Adverse Event|0
4819934|NCT01184859|16617123|P4|Period 2: Daily Dose for 28 Days|Adverse Event|0
4819935|NCT01184859|16617124|P3|Period 2: Daily Dose for 28 Days|Adverse Event|0
4819936|NCT01184859|16617125|P2|Period 2: Daily Dose for 28 Days|Adverse Event|0
4819937|NCT01184859|16617126|P1|Period 2: Daily Dose for 28 Days|Adverse Event|1
4819938|NCT01184859|16617122|P5|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1
4819939|NCT01184859|16617123|P4|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4819940|NCT01184859|16617124|P3|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4819941|NCT01184859|16617125|P2|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4819942|NCT01184859|16617126|P1|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0
4819943|NCT01184859|16617122|P5|Period 1: Single Dose|Adverse Event|1
4819944|NCT01184859|16617123|P4|Period 1: Single Dose|Adverse Event|0
4819945|NCT01184859|16617124|P3|Period 1: Single Dose|Adverse Event|0
4819946|NCT01184859|16617125|P2|Period 1: Single Dose|Adverse Event|0
4819947|NCT01184859|16617126|P1|Period 1: Single Dose|Adverse Event|0
4819948|NCT01184859|16617122|P5|Period 1: Single Dose|Protocol Violation|0
4819949|NCT01184859|16617123|P4|Period 1: Single Dose|Protocol Violation|0
4819950|NCT01184859|16617124|P3|Period 1: Single Dose|Protocol Violation|0
4819951|NCT01184859|16617125|P2|Period 1: Single Dose|Protocol Violation|1
4819952|NCT01184859|16617126|P1|Period 1: Single Dose|Protocol Violation|0
4819953|NCT01184859|16617122|P5|Period 1: Single Dose|Insufficient urine production|0
4819954|NCT01184859|16617123|P4|Period 1: Single Dose|Insufficient urine production|0
4819955|NCT01184859|16617124|P3|Period 1: Single Dose|Insufficient urine production|0
4819956|NCT01184859|16617125|P2|Period 1: Single Dose|Insufficient urine production|1
4819957|NCT01184859|16617126|P1|Period 1: Single Dose|Insufficient urine production|0
4819958|NCT01184846|16617218|P1|Overall Study|Insufficient response|1
4819959|NCT01184846|16617218|P1|Overall Study|Adverse Event|2
4819960|NCT01184508|16617251|P2|Overall Study|Randomized, Not Treated|1
4819961|NCT01184508|16617252|P1|Overall Study|Randomized, Not Treated|0
4819962|NCT01184508|16617251|P2|Overall Study|Withdrawal by Subject|3
4819963|NCT01184508|16617252|P1|Overall Study|Withdrawal by Subject|1
4819964|NCT01184508|16617251|P2|Overall Study|Sponsor Decision|2
4819965|NCT01184508|16617252|P1|Overall Study|Sponsor Decision|5
4819966|NCT01184508|16617251|P2|Overall Study|Protocol Violation|1
4819967|NCT01184508|16617252|P1|Overall Study|Protocol Violation|3
4819968|NCT01184508|16617251|P2|Overall Study|Physician Decision|0
4819969|NCT01184508|16617252|P1|Overall Study|Physician Decision|1
4819970|NCT01184508|16617251|P2|Overall Study|Lost to Follow-up|1
4819971|NCT01184508|16617252|P1|Overall Study|Lost to Follow-up|1
4819972|NCT01184508|16617251|P2|Overall Study|Lack of Efficacy|1
4819973|NCT01184508|16617252|P1|Overall Study|Lack of Efficacy|1
4819974|NCT01184508|16617251|P2|Overall Study|Adverse Event|6
4819975|NCT01184508|16617252|P1|Overall Study|Adverse Event|4
4819976|NCT01184326|16617312|P3|Overall Study|Disease Progression|12
4819977|NCT01184326|16617313|P2|Overall Study|Disease Progression|3
4819978|NCT01184326|16617314|P1|Overall Study|Disease Progression|1
4819979|NCT01184326|16617312|P3|Overall Study|Physician Decision|0
4819980|NCT01184326|16617313|P2|Overall Study|Physician Decision|1
4819981|NCT01184326|16617314|P1|Overall Study|Physician Decision|1
4819982|NCT01184326|16617312|P3|Overall Study|Withdrawal by Subject|1
4819983|NCT01184326|16617313|P2|Overall Study|Withdrawal by Subject|0
4819984|NCT01184326|16617314|P1|Overall Study|Withdrawal by Subject|0
4819985|NCT01184326|16617312|P3|Overall Study|Death|1
4819986|NCT01184326|16617313|P2|Overall Study|Death|0
4819987|NCT01184326|16617314|P1|Overall Study|Death|0
4819988|NCT01184326|16617312|P3|Overall Study|Adverse Event|0
4819989|NCT01184326|16617313|P2|Overall Study|Adverse Event|2
4819990|NCT01184326|16617314|P1|Overall Study|Adverse Event|1
4819991|NCT01184118|16617328|P1|Overall Study|Withdrawal by Subject|5
4819992|NCT01184118|16617328|P1|Overall Study|Exclusionary medical condition|2
4819993|NCT01184118|16617328|P1|Overall Study|FEV1 <60% predicted|2
4819994|NCT01184118|16617328|P1|Overall Study|No physiologic confirmation of asthma|8
4819995|NCT01184118|16617328|P1|Overall Study|Only asthma step 1 - screen fail|1
4819996|NCT01184079|16617336|P2|Overall Study|Lost to Follow-up|2
4819997|NCT01184079|16617337|P1|Overall Study|Lost to Follow-up|14
4819998|NCT01184053|16617347|P1|Overall Study|progression while on treatment|3
4819999|NCT01183975|16617363|P1|Overall Study|Lost to Follow-up|73
4820000|NCT01183884|16617380|P1|Overall Study|Other|4
4820001|NCT01183884|16617380|P1|Overall Study|Not Treated|1
4820002|NCT01183884|16617380|P1|Overall Study|Other Complicating Disease|3
4820003|NCT01183884|16617380|P1|Overall Study|Withdrawal by Subject|1
4820004|NCT01183884|16617380|P1|Overall Study|Adverse Event|3
4820005|NCT01183884|16617380|P1|Overall Study|Progressive Disease|26
4820006|NCT01183858|16617388|P2|Overall Study|Lost to Follow-up|1
4820007|NCT01183858|16617389|P1|Overall Study|Lost to Follow-up|1
4820008|NCT01183858|16617388|P2|Overall Study|Death related to Progressive Disease|5
4820009|NCT01183858|16617389|P1|Overall Study|Death related to Progressive Disease|4
4820010|NCT01183858|16617388|P2|Overall Study|Progressive Disease|115
4820011|NCT01183858|16617389|P1|Overall Study|Progressive Disease|112
4820012|NCT01183858|16617388|P2|Overall Study|Administrative/Other|6
4820013|NCT01183858|16617389|P1|Overall Study|Administrative/Other|6
4820014|NCT01183858|16617388|P2|Overall Study|Protocol Violation|0
4820015|NCT01183858|16617389|P1|Overall Study|Protocol Violation|1
4820016|NCT01183858|16617388|P2|Overall Study|Discontinued Smoking|1
4820017|NCT01183858|16617389|P1|Overall Study|Discontinued Smoking|3
4820018|NCT01183858|16617388|P2|Overall Study|Withdrew Consent|4
4820019|NCT01183858|16617389|P1|Overall Study|Withdrew Consent|4
4820020|NCT01183858|16617388|P2|Overall Study|Refused Treatment|4
4820021|NCT01183858|16617389|P1|Overall Study|Refused Treatment|1
4820022|NCT01183858|16617388|P2|Overall Study|Insufficient Therapeutic Response|0
4820023|NCT01183858|16617389|P1|Overall Study|Insufficient Therapeutic Response|2
4820024|NCT01183858|16617388|P2|Overall Study|Investigator's Decision|3
4820025|NCT01183858|16617389|P1|Overall Study|Investigator's Decision|0
4820026|NCT01183858|16617388|P2|Overall Study|Adverse Event|11
4820027|NCT01183858|16617389|P1|Overall Study|Adverse Event|14
4820028|NCT01183858|16617388|P2|Overall Study|Death not related to Progressive Disease|6
4820029|NCT01183858|16617389|P1|Overall Study|Death not related to Progressive Disease|5
4820030|NCT01183780|16617411|P2|Overall Study|Lost to Follow-up|11
4820031|NCT01183780|16617412|P1|Overall Study|Lost to Follow-up|6
4820032|NCT01183780|16617411|P2|Overall Study|Withdrawal by Subject|14
4820033|NCT01183780|16617412|P1|Overall Study|Withdrawal by Subject|25
4820034|NCT01183468|16617545|P4|Overall Study|Withdrawal by Subject|0
4820035|NCT01183468|16617546|P3|Overall Study|Withdrawal by Subject|0
4820036|NCT01183468|16617547|P2|Overall Study|Withdrawal by Subject|1
4820037|NCT01183468|16617548|P1|Overall Study|Withdrawal by Subject|0
4820038|NCT01183468|16617545|P4|Overall Study|Physician Decision|0
4820039|NCT01183468|16617546|P3|Overall Study|Physician Decision|0
4820040|NCT01183468|16617547|P2|Overall Study|Physician Decision|0
4820041|NCT01183468|16617548|P1|Overall Study|Physician Decision|1
4820042|NCT01183468|16617545|P4|Overall Study|Lost to Follow-up|0
4820043|NCT01183468|16617546|P3|Overall Study|Lost to Follow-up|0
4820044|NCT01183468|16617547|P2|Overall Study|Lost to Follow-up|1
4820045|NCT01183468|16617548|P1|Overall Study|Lost to Follow-up|2
4820046|NCT01183390|16617570|P2|First Intervention|Adverse Event|1
4820047|NCT01183390|16617571|P1|First Intervention|Adverse Event|0
4820048|NCT01183260|16617604|P2|Overall Study|Death|0
4820049|NCT01183260|16617605|P1|Overall Study|Death|1
4820050|NCT01183260|16617604|P2|Overall Study|Revised within 30 days|1
4820051|NCT01183260|16617605|P1|Overall Study|Revised within 30 days|0
4820052|NCT01183260|16617604|P2|Overall Study|Withdrawal by Subject|1
4820053|NCT01183260|16617605|P1|Overall Study|Withdrawal by Subject|1
4820054|NCT01183260|16617604|P2|Overall Study|Intraop screen failure|0
4820055|NCT01183260|16617605|P1|Overall Study|Intraop screen failure|2
4820056|NCT01183234|16617615|P2|First Intervention|Adverse Event|0
4820057|NCT01183234|16617616|P1|First Intervention|Adverse Event|1
4820058|NCT01183143|16617708|P1|Overall Study|Subjects enrolled, but not treated|11
4820059|NCT01183143|16617708|P1|Overall Study|Subject Questionnaires not returned|5
4820060|NCT01183143|16617708|P1|Overall Study|Withdrawal by Subject|19
4820061|NCT01183143|16617708|P1|Overall Study|Protocol Violation|115
4820062|NCT01183104|16617724|P2|Overall Study|Did not receive study drug|9
4820063|NCT01183104|16617725|P1|Overall Study|Did not receive study drug|5
4820064|NCT01183104|16617724|P2|Overall Study|Nonparticipation in Extension Study|50
4820065|NCT01183104|16617725|P1|Overall Study|Nonparticipation in Extension Study|39
4820066|NCT01183104|16617724|P2|Overall Study|Withdrawal by Subject|11
4820067|NCT01183104|16617725|P1|Overall Study|Withdrawal by Subject|6
4820068|NCT01183104|16617724|P2|Overall Study|Physician Decision|8
4820069|NCT01183104|16617725|P1|Overall Study|Physician Decision|5
4820070|NCT01183104|16617724|P2|Overall Study|Lost to Follow-up|7
4820071|NCT01183104|16617725|P1|Overall Study|Lost to Follow-up|14
4820072|NCT01183104|16617724|P2|Overall Study|Death|1
4820073|NCT01183104|16617725|P1|Overall Study|Death|0
4820074|NCT01183104|16617724|P2|Overall Study|Adverse Event|6
4820075|NCT01183104|16617725|P1|Overall Study|Adverse Event|8
4820076|NCT01183065|16617741|P1|Overall Study|Patient no longer fits eligibility crite|1
4820077|NCT01183013|16617752|P7|Overall Study|Reasons other than stated above|13
4820078|NCT01183013|16617753|P6|Overall Study|Reasons other than stated above|15
4820079|NCT01183013|16617754|P5|Overall Study|Reasons other than stated above|12
4820080|NCT01183013|16617755|P4|Overall Study|Reasons other than stated above|12
4820081|NCT01183013|16617756|P3|Overall Study|Reasons other than stated above|17
4820082|NCT01183013|16617757|P2|Overall Study|Reasons other than stated above|11
4820083|NCT01183013|16617758|P1|Overall Study|Reasons other than stated above|15
4820084|NCT01183013|16617752|P7|Overall Study|Withdrawal by Subject|10
4820085|NCT01183013|16617753|P6|Overall Study|Withdrawal by Subject|9
4820086|NCT01183013|16617754|P5|Overall Study|Withdrawal by Subject|7
4820087|NCT01183013|16617755|P4|Overall Study|Withdrawal by Subject|8
4820088|NCT01183013|16617756|P3|Overall Study|Withdrawal by Subject|10
4820089|NCT01183013|16617757|P2|Overall Study|Withdrawal by Subject|13
4820090|NCT01183013|16617758|P1|Overall Study|Withdrawal by Subject|9
4820091|NCT01183013|16617752|P7|Overall Study|Lost to Follow-up|5
4820092|NCT01183013|16617753|P6|Overall Study|Lost to Follow-up|6
4820093|NCT01183013|16617754|P5|Overall Study|Lost to Follow-up|2
4820094|NCT01183013|16617755|P4|Overall Study|Lost to Follow-up|3
4820095|NCT01183013|16617756|P3|Overall Study|Lost to Follow-up|4
4820096|NCT01183013|16617757|P2|Overall Study|Lost to Follow-up|3
4820097|NCT01183013|16617758|P1|Overall Study|Lost to Follow-up|7
4820098|NCT01183013|16617752|P7|Overall Study|Protocol Violation|3
4820099|NCT01183013|16617753|P6|Overall Study|Protocol Violation|3
4820100|NCT01183013|16617754|P5|Overall Study|Protocol Violation|4
4820101|NCT01183013|16617755|P4|Overall Study|Protocol Violation|0
4820102|NCT01183013|16617756|P3|Overall Study|Protocol Violation|4
4820103|NCT01183013|16617757|P2|Overall Study|Protocol Violation|2
4820104|NCT01183013|16617758|P1|Overall Study|Protocol Violation|5
4820105|NCT01183013|16617752|P7|Overall Study|Lack of Efficacy|0
4820106|NCT01183013|16617753|P6|Overall Study|Lack of Efficacy|2
4820107|NCT01183013|16617754|P5|Overall Study|Lack of Efficacy|1
4820108|NCT01183013|16617755|P4|Overall Study|Lack of Efficacy|2
4820109|NCT01183013|16617756|P3|Overall Study|Lack of Efficacy|1
4820110|NCT01183013|16617757|P2|Overall Study|Lack of Efficacy|2
4820111|NCT01183013|16617758|P1|Overall Study|Lack of Efficacy|3
4820112|NCT01183013|16617752|P7|Overall Study|Adverse Event|6
4820113|NCT01183013|16617753|P6|Overall Study|Adverse Event|10
4820114|NCT01183013|16617754|P5|Overall Study|Adverse Event|10
4820115|NCT01183013|16617755|P4|Overall Study|Adverse Event|5
4820116|NCT01183013|16617756|P3|Overall Study|Adverse Event|5
4820117|NCT01183013|16617757|P2|Overall Study|Adverse Event|8
4820118|NCT01183013|16617758|P1|Overall Study|Adverse Event|6
4820119|NCT01182844|16617839|P2|Overall Study|Withdrawal by Subject|2
4820120|NCT01182844|16617840|P1|Overall Study|Withdrawal by Subject|0
4820121|NCT01182441|16617925|P2|Overall Study|Physician Decision|1
4820122|NCT01182441|16617926|P1|Overall Study|Physician Decision|1
4820123|NCT01182441|16617925|P2|Overall Study|Adverse Event|0
4820124|NCT01182441|16617926|P1|Overall Study|Adverse Event|2
4820125|NCT01182441|16617925|P2|Overall Study|Implant Not Attempted|0
4820126|NCT01182441|16617926|P1|Overall Study|Implant Not Attempted|4
4820127|NCT01182441|16617925|P2|Overall Study|Withdrawal by Subject|13
4820128|NCT01182441|16617926|P1|Overall Study|Withdrawal by Subject|6
4820129|NCT01182441|16617925|P2|Overall Study|Lost to Follow-up|8
4820130|NCT01182441|16617926|P1|Overall Study|Lost to Follow-up|5
4820131|NCT01182441|16617925|P2|Overall Study|Implant Attempt Unsuccessful|0
4820132|NCT01182441|16617926|P1|Overall Study|Implant Attempt Unsuccessful|13
4820133|NCT01182441|16617925|P2|Overall Study|Death|25
4820134|NCT01182441|16617926|P1|Overall Study|Death|37
4820135|NCT01182441|16617925|P2|Overall Study|Patient Still in Follow-up|72
4820136|NCT01182441|16617926|P1|Overall Study|Patient Still in Follow-up|152
4820137|NCT01182428|16617937|P2|Overall Study|Withdrawal by Subject|0
4820138|NCT01182428|16617938|P1|Overall Study|Withdrawal by Subject|1
4820139|NCT01182428|16617937|P2|Overall Study|Lost to Follow-up|1
4820140|NCT01182428|16617938|P1|Overall Study|Lost to Follow-up|9
4820141|NCT01182428|16617937|P2|Overall Study|Physician Decision|0
4820142|NCT01182428|16617938|P1|Overall Study|Physician Decision|1
4820143|NCT01182415|16618002|P1|Overall Study|Lost to Follow-up|1
4820144|NCT01182350|16618018|P5|Overall Study|Unevaluable for Biopsy|3
4820145|NCT01182350|16618019|P4|Overall Study|Unevaluable for Biopsy|0
4820146|NCT01182350|16618020|P3|Overall Study|Unevaluable for Biopsy|0
4820147|NCT01182350|16618021|P2|Overall Study|Unevaluable for Biopsy|0
4820148|NCT01182350|16618022|P1|Overall Study|Unevaluable for Biopsy|0
4820149|NCT01182350|16618018|P5|Overall Study|Travel Issue/Prefer Treatment at Home|0
4820150|NCT01182350|16618019|P4|Overall Study|Travel Issue/Prefer Treatment at Home|1
4820151|NCT01182350|16618020|P3|Overall Study|Travel Issue/Prefer Treatment at Home|1
4820152|NCT01182350|16618021|P2|Overall Study|Travel Issue/Prefer Treatment at Home|0
4820153|NCT01182350|16618022|P1|Overall Study|Travel Issue/Prefer Treatment at Home|2
4820154|NCT01182350|16618018|P5|Overall Study|Alternative Therapy|0
4820155|NCT01182350|16618019|P4|Overall Study|Alternative Therapy|0
4820156|NCT01182350|16618020|P3|Overall Study|Alternative Therapy|1
4820157|NCT01182350|16618021|P2|Overall Study|Alternative Therapy|0
4820158|NCT01182350|16618022|P1|Overall Study|Alternative Therapy|2
4820159|NCT01182350|16618018|P5|Overall Study|Withdrawal by Subject|0
4820160|NCT01182350|16618019|P4|Overall Study|Withdrawal by Subject|1
4820161|NCT01182350|16618020|P3|Overall Study|Withdrawal by Subject|0
4820162|NCT01182350|16618021|P2|Overall Study|Withdrawal by Subject|1
4820163|NCT01182350|16618022|P1|Overall Study|Withdrawal by Subject|3
4820164|NCT01182350|16618018|P5|Overall Study|Death|0
4820165|NCT01182350|16618019|P4|Overall Study|Death|0
4820166|NCT01182350|16618020|P3|Overall Study|Death|1
4820167|NCT01182350|16618021|P2|Overall Study|Death|1
4820168|NCT01182350|16618022|P1|Overall Study|Death|0
4820169|NCT01182350|16618018|P5|Overall Study|Disease Progression|0
4820170|NCT01182350|16618019|P4|Overall Study|Disease Progression|1
4820171|NCT01182350|16618020|P3|Overall Study|Disease Progression|0
4820172|NCT01182350|16618021|P2|Overall Study|Disease Progression|12
4820173|NCT01182350|16618022|P1|Overall Study|Disease Progression|15
4820174|NCT01182350|16618018|P5|Overall Study|Adverse Event|0
4820175|NCT01182350|16618019|P4|Overall Study|Adverse Event|0
4820176|NCT01182350|16618020|P3|Overall Study|Adverse Event|0
4820177|NCT01182350|16618021|P2|Overall Study|Adverse Event|0
4820178|NCT01182350|16618022|P1|Overall Study|Adverse Event|5
4820179|NCT01182337|16618044|P2|Overall Study|Lost to Follow-up|1
4820180|NCT01182337|16618045|P1|Overall Study|Lost to Follow-up|0
4820181|NCT01182337|16618044|P2|Overall Study|Withdrawal by Subject|1
4820182|NCT01182337|16618045|P1|Overall Study|Withdrawal by Subject|3
4820183|NCT01182298|16618063|P1|Overall Study|Withdrawal by Subject|2
4820184|NCT01182298|16618063|P1|Overall Study|Lack of Efficacy|4
4820185|NCT01182285|16618067|P3|Third Intervention Week 11-52|Other|2
4820186|NCT01182285|16618068|P2|Third Intervention Week 11-52|Other|0
4820187|NCT01182285|16618069|P1|Third Intervention Week 11-52|Other|0
4820188|NCT01182285|16618067|P3|Third Intervention Week 11-52|Disease Progression|6
4820189|NCT01182285|16618068|P2|Third Intervention Week 11-52|Disease Progression|0
4820190|NCT01182285|16618069|P1|Third Intervention Week 11-52|Disease Progression|0
4820191|NCT01182285|16618067|P3|First Intervention Week 1-10|Non-compliance|0
4820192|NCT01182285|16618068|P2|First Intervention Week 1-10|Non-compliance|0
4820193|NCT01182285|16618069|P1|First Intervention Week 1-10|Non-compliance|1
4820194|NCT01182285|16618067|P3|First Intervention Week 1-10|Adverse Event|0
4820195|NCT01182285|16618068|P2|First Intervention Week 1-10|Adverse Event|0
4820196|NCT01182285|16618069|P1|First Intervention Week 1-10|Adverse Event|1
4820197|NCT01182285|16618067|P3|First Intervention Week 1-10|Disease progression|0
4820198|NCT01182285|16618068|P2|First Intervention Week 1-10|Disease progression|0
4820199|NCT01182285|16618069|P1|First Intervention Week 1-10|Disease progression|1
4820200|NCT01182207|16618079|P2|Second Intervention|Emeses within 1 hour of dosing|0
4820201|NCT01182207|16618080|P1|Second Intervention|Emeses within 1 hour of dosing|1
4820202|NCT01182207|16618079|P2|First Intervention|Positive Hepatitis Results|1
4820203|NCT01182207|16618080|P1|First Intervention|Positive Hepatitis Results|0
4820204|NCT01182194|16618098|P2|Washout of 28 Days|Withdrawal by Subject|0
4820205|NCT01182194|16618099|P1|Washout of 28 Days|Withdrawal by Subject|1
4820206|NCT01182181|16618117|P2|Washout of 21 Days|Withdrawal by Subject|1
4820207|NCT01182181|16618118|P1|Washout of 21 Days|Withdrawal by Subject|0
4820208|NCT01182181|16618117|P2|First Intervention|Adverse Event|0
4820209|NCT01182181|16618118|P1|First Intervention|Adverse Event|1
4820210|NCT01181986|16618143|P3|Phase 2|Medical condition|0
4820211|NCT01181986|16618144|P2|Phase 2|Medical condition|1
4820212|NCT01181986|16618145|P1|Phase 2|Medical condition|0
4820213|NCT01181986|16618143|P3|Phase 2|Adverse Event|0
4820214|NCT01181986|16618144|P2|Phase 2|Adverse Event|3
4820215|NCT01181986|16618145|P1|Phase 2|Adverse Event|0
4820216|NCT01181986|16618143|P3|Phase 1|Protocol Violation|0
4820217|NCT01181986|16618144|P2|Phase 1|Protocol Violation|0
4820218|NCT01181986|16618145|P1|Phase 1|Protocol Violation|1
4820219|NCT01181986|16618143|P3|Phase 1|Adverse Event|1
4820220|NCT01181986|16618144|P2|Phase 1|Adverse Event|0
4820221|NCT01181986|16618145|P1|Phase 1|Adverse Event|0
4820222|NCT01181986|16618143|P3|Phase 1|Lost to Follow-up|1
4820223|NCT01181986|16618144|P2|Phase 1|Lost to Follow-up|1
4820224|NCT01181986|16618145|P1|Phase 1|Lost to Follow-up|0
4820225|NCT01181921|16618166|P1|Overall Study|Lost to Follow-up|1
4820226|NCT01181895|16618173|P3|Overall Study|Withdrawal by Subject|5
4820227|NCT01181895|16618174|P2|Overall Study|Withdrawal by Subject|0
4820228|NCT01181895|16618175|P1|Overall Study|Withdrawal by Subject|3
4820229|NCT01181895|16618173|P3|Overall Study|Investigator Discretion|1
4820230|NCT01181895|16618174|P2|Overall Study|Investigator Discretion|2
4820231|NCT01181895|16618175|P1|Overall Study|Investigator Discretion|1
4820232|NCT01181895|16618173|P3|Overall Study|Lost to Follow-up|2
4820233|NCT01181895|16618174|P2|Overall Study|Lost to Follow-up|1
4820234|NCT01181895|16618175|P1|Overall Study|Lost to Follow-up|0
4820235|NCT01181895|16618173|P3|Overall Study|Protocol Violation|0
4820236|NCT01181895|16618174|P2|Overall Study|Protocol Violation|1
4820237|NCT01181895|16618175|P1|Overall Study|Protocol Violation|2
4820238|NCT01181895|16618173|P3|Overall Study|Lack of Efficacy|9
4820239|NCT01181895|16618174|P2|Overall Study|Lack of Efficacy|9
4820240|NCT01181895|16618175|P1|Overall Study|Lack of Efficacy|8
4820241|NCT01181895|16618173|P3|Overall Study|Adverse Event|1
4820242|NCT01181895|16618174|P2|Overall Study|Adverse Event|1
4820243|NCT01181895|16618175|P1|Overall Study|Adverse Event|3
4820244|NCT01181778|16618233|P1|Overall Study|Physician Decision|48
4820245|NCT01181726|16618241|P2|First Intervention|Adverse Event|0
4820246|NCT01181726|16618242|P1|First Intervention|Adverse Event|1
4820247|NCT01181609|16618322|P1|Overall Study|Death|50
4820248|NCT01181609|16618322|P1|Overall Study|Lost to Follow-up|1
4820249|NCT01181609|16618322|P1|Overall Study|Withdrawal by Subject|1
4820250|NCT01181609|16618322|P1|Overall Study|Adverse Event|1
4820251|NCT01181531|16618340|P2|Overall Study|Adverse Event|1
4820252|NCT01181531|16618341|P1|Overall Study|Adverse Event|0
4820253|NCT01181531|16618340|P2|Overall Study|Death|12
4820254|NCT01181531|16618341|P1|Overall Study|Death|9
4820255|NCT01181531|16618340|P2|Overall Study|Protocol Violation|6
4820256|NCT01181531|16618341|P1|Overall Study|Protocol Violation|6
4820257|NCT01181531|16618340|P2|Overall Study|Withdrawal by Subject|7
4820258|NCT01181531|16618341|P1|Overall Study|Withdrawal by Subject|8
4820259|NCT01181531|16618340|P2|Overall Study|Pregnancy|1
4820260|NCT01181531|16618341|P1|Overall Study|Pregnancy|0
4820261|NCT01181531|16618340|P2|Overall Study|Protocol Specified Criteria|8
4820262|NCT01181531|16618341|P1|Overall Study|Protocol Specified Criteria|15
4820263|NCT01181531|16618340|P2|Overall Study|Ineligibility determined|2
4820264|NCT01181531|16618341|P1|Overall Study|Ineligibility determined|1
4820265|NCT01181531|16618340|P2|Overall Study|Noncompliance|2
4820266|NCT01181531|16618341|P1|Overall Study|Noncompliance|2
4820267|NCT01181531|16618340|P2|Overall Study|Physician Decision|1
4820268|NCT01181531|16618341|P1|Overall Study|Physician Decision|3
4820269|NCT01181531|16618340|P2|Overall Study|Partial consent by subject withdrawn|1
4820270|NCT01181531|16618341|P1|Overall Study|Partial consent by subject withdrawn|0
4820271|NCT01181531|16618340|P2|Overall Study|Other|12
4820272|NCT01181531|16618341|P1|Overall Study|Other|17
4820273|NCT01181271|16618483|P1|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1
4820274|NCT01181271|16618483|P1|Evaluation for Allogeneic Transplant|No suitable donor|2
4820275|NCT01181271|16618483|P1|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4
4820276|NCT01181271|16618483|P1|Evaluation for Allogeneic Transplant|Lack of Efficacy|6
4820277|NCT01181167|16618507|P2|Overall Study|Withdrawal by Subject|8
4820278|NCT01181167|16618508|P1|Overall Study|Withdrawal by Subject|6
4820279|NCT01181167|16618507|P2|Overall Study|Protocol Violation|0
4820280|NCT01181167|16618508|P1|Overall Study|Protocol Violation|3
4820281|NCT01181167|16618507|P2|Overall Study|Physician Decision|3
4820282|NCT01181167|16618508|P1|Overall Study|Physician Decision|2
4820283|NCT01181167|16618507|P2|Overall Study|Lost to Follow-up|0
4820284|NCT01181167|16618508|P1|Overall Study|Lost to Follow-up|1
4820285|NCT01181167|16618507|P2|Overall Study|Adverse Event|21
4820286|NCT01181167|16618508|P1|Overall Study|Adverse Event|11
4820287|NCT01181141|16618518|P2|Overall Study|Withdrawal by Subject|1
4820288|NCT01181141|16618519|P1|Overall Study|Withdrawal by Subject|3
4820289|NCT01181141|16618518|P2|Overall Study|Protocol Violation|1
4820290|NCT01181141|16618519|P1|Overall Study|Protocol Violation|3
4820291|NCT01181141|16618518|P2|Overall Study|Physician Decision|0
4820292|NCT01181141|16618519|P1|Overall Study|Physician Decision|2
4820293|NCT01181141|16618518|P2|Overall Study|Lost to Follow-up|1
4820294|NCT01181141|16618519|P1|Overall Study|Lost to Follow-up|1
4820295|NCT01181141|16618518|P2|Overall Study|Lack of Efficacy|0
4820296|NCT01181141|16618519|P1|Overall Study|Lack of Efficacy|1
4820297|NCT01181141|16618518|P2|Overall Study|Adverse Event|1
4820298|NCT01181141|16618519|P1|Overall Study|Adverse Event|2
4820299|NCT01181128|16618528|P3|Overall Study|Other|1
4820300|NCT01181128|16618529|P2|Overall Study|Other|1
4820301|NCT01181128|16618530|P1|Overall Study|Other|1
4820302|NCT01181128|16618528|P3|Overall Study|Adverse Event|0
4820303|NCT01181128|16618529|P2|Overall Study|Adverse Event|2
4820304|NCT01181128|16618530|P1|Overall Study|Adverse Event|0
4820305|NCT01181128|16618528|P3|Overall Study|Physician Decision|0
4820306|NCT01181128|16618529|P2|Overall Study|Physician Decision|0
4820307|NCT01181128|16618530|P1|Overall Study|Physician Decision|2
4820308|NCT01181128|16618528|P3|Overall Study|Death|0
4820309|NCT01181128|16618529|P2|Overall Study|Death|0
4820310|NCT01181128|16618530|P1|Overall Study|Death|1
4820311|NCT01181128|16618528|P3|Overall Study|Withdrawal by Subject|0
4820312|NCT01181128|16618529|P2|Overall Study|Withdrawal by Subject|2
4820313|NCT01181128|16618530|P1|Overall Study|Withdrawal by Subject|2
4820314|NCT01181102|16618618|P2|Overall Study|Withdrawal by Subject|12
4820315|NCT01181102|16618619|P1|Overall Study|Withdrawal by Subject|10
4820316|NCT01181102|16618618|P2|Overall Study|Protocol Violation|6
4820317|NCT01181102|16618619|P1|Overall Study|Protocol Violation|5
4820318|NCT01181102|16618618|P2|Overall Study|Physician Decision|1
4820319|NCT01181102|16618619|P1|Overall Study|Physician Decision|3
4820320|NCT01181102|16618618|P2|Overall Study|Lost to Follow-up|0
4820321|NCT01181102|16618619|P1|Overall Study|Lost to Follow-up|2
4820322|NCT01181102|16618618|P2|Overall Study|Lack of Efficacy|1
4820323|NCT01181102|16618619|P1|Overall Study|Lack of Efficacy|3
4820324|NCT01181102|16618618|P2|Overall Study|Adverse Event|26
4820325|NCT01181102|16618619|P1|Overall Study|Adverse Event|28
4820326|NCT01181011|16618663|P1|Overall Study|Lost to Follow-up|1
4820327|NCT01181011|16618663|P1|Overall Study|Adverse Event|2
4820328|NCT01180998|16618713|P3|Overall Study|Poor lens handling|2
4820329|NCT01180998|16618714|P2|Overall Study|Poor lens handling|0
4820330|NCT01180998|16618715|P1|Overall Study|Poor lens handling|0
4820331|NCT01180998|16618713|P3|Overall Study|Poor comfort|4
4820332|NCT01180998|16618714|P2|Overall Study|Poor comfort|0
4820333|NCT01180998|16618715|P1|Overall Study|Poor comfort|3
4820334|NCT01180998|16618713|P3|Overall Study|Withdrawal by Subject|1
4820335|NCT01180998|16618714|P2|Overall Study|Withdrawal by Subject|0
4820336|NCT01180998|16618715|P1|Overall Study|Withdrawal by Subject|0
4820337|NCT01180998|16618713|P3|Overall Study|Protocol Violation|0
4820338|NCT01180998|16618714|P2|Overall Study|Protocol Violation|2
4820339|NCT01180998|16618715|P1|Overall Study|Protocol Violation|1
4820340|NCT01180998|16618713|P3|Overall Study|Lost to Follow-up|1
4820341|NCT01180998|16618714|P2|Overall Study|Lost to Follow-up|0
4820342|NCT01180998|16618715|P1|Overall Study|Lost to Follow-up|0
4820343|NCT01180998|16618713|P3|Overall Study|Poor Vision|2
4820344|NCT01180998|16618714|P2|Overall Study|Poor Vision|2
4820345|NCT01180998|16618715|P1|Overall Study|Poor Vision|0
4820346|NCT01180985|16618729|P2|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0
4820347|NCT01180985|16618730|P1|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1
4820348|NCT01180790|16618769|P7|Overall Study|Severe coronary atherosclerosis (death)|0
4820349|NCT01180790|16618770|P6|Overall Study|Severe coronary atherosclerosis (death)|0
4820350|NCT01180790|16618771|P5|Overall Study|Severe coronary atherosclerosis (death)|0
4820351|NCT01180790|16618772|P4|Overall Study|Severe coronary atherosclerosis (death)|0
4820352|NCT01180790|16618773|P3|Overall Study|Severe coronary atherosclerosis (death)|1
4820353|NCT01180790|16618774|P2|Overall Study|Severe coronary atherosclerosis (death)|0
4820354|NCT01180790|16618775|P1|Overall Study|Severe coronary atherosclerosis (death)|0
4820355|NCT01180790|16618769|P7|Overall Study|compliance|0
4820356|NCT01180790|16618770|P6|Overall Study|compliance|0
4820357|NCT01180790|16618771|P5|Overall Study|compliance|0
4820358|NCT01180790|16618772|P4|Overall Study|compliance|0
4820359|NCT01180790|16618773|P3|Overall Study|compliance|0
4820360|NCT01180790|16618774|P2|Overall Study|compliance|1
4820361|NCT01180790|16618775|P1|Overall Study|compliance|0
4820362|NCT01180790|16618769|P7|Overall Study|Lack of Efficacy|0
4820363|NCT01180790|16618770|P6|Overall Study|Lack of Efficacy|3
4820364|NCT01180790|16618771|P5|Overall Study|Lack of Efficacy|1
4820365|NCT01180790|16618772|P4|Overall Study|Lack of Efficacy|6
4820366|NCT01180790|16618773|P3|Overall Study|Lack of Efficacy|5
4820367|NCT01180790|16618774|P2|Overall Study|Lack of Efficacy|2
4820368|NCT01180790|16618775|P1|Overall Study|Lack of Efficacy|1
4820369|NCT01180790|16618769|P7|Overall Study|Physician Decision|0
4820370|NCT01180790|16618770|P6|Overall Study|Physician Decision|0
4820371|NCT01180790|16618771|P5|Overall Study|Physician Decision|0
4820372|NCT01180790|16618772|P4|Overall Study|Physician Decision|1
4820373|NCT01180790|16618773|P3|Overall Study|Physician Decision|0
4820374|NCT01180790|16618774|P2|Overall Study|Physician Decision|0
4820375|NCT01180790|16618775|P1|Overall Study|Physician Decision|1
4820376|NCT01180790|16618769|P7|Overall Study|Lost to Follow-up|1
4820377|NCT01180790|16618770|P6|Overall Study|Lost to Follow-up|0
4820378|NCT01180790|16618771|P5|Overall Study|Lost to Follow-up|1
4820379|NCT01180790|16618772|P4|Overall Study|Lost to Follow-up|2
4820380|NCT01180790|16618773|P3|Overall Study|Lost to Follow-up|0
4820381|NCT01180790|16618774|P2|Overall Study|Lost to Follow-up|1
4820382|NCT01180790|16618775|P1|Overall Study|Lost to Follow-up|3
4820383|NCT01180790|16618769|P7|Overall Study|Withdrawal by Subject|0
4820384|NCT01180790|16618770|P6|Overall Study|Withdrawal by Subject|1
4820385|NCT01180790|16618771|P5|Overall Study|Withdrawal by Subject|2
4820386|NCT01180790|16618772|P4|Overall Study|Withdrawal by Subject|0
4820387|NCT01180790|16618773|P3|Overall Study|Withdrawal by Subject|5
4820388|NCT01180790|16618774|P2|Overall Study|Withdrawal by Subject|0
4820389|NCT01180790|16618775|P1|Overall Study|Withdrawal by Subject|3
4820390|NCT01180790|16618769|P7|Overall Study|Adverse Event|0
4820391|NCT01180790|16618770|P6|Overall Study|Adverse Event|3
4820392|NCT01180790|16618771|P5|Overall Study|Adverse Event|1
4820393|NCT01180790|16618772|P4|Overall Study|Adverse Event|0
4820394|NCT01180790|16618773|P3|Overall Study|Adverse Event|2
4820395|NCT01180790|16618774|P2|Overall Study|Adverse Event|1
4820396|NCT01180790|16618775|P1|Overall Study|Adverse Event|1
4820397|NCT01180777|16618840|P1|Overall Study|Adverse Event|1
4820398|NCT01180777|16618840|P1|Overall Study|Lost to Follow-up|1
4820399|NCT01180777|16618840|P1|Overall Study|Poor lens fit|4
4820400|NCT01180777|16618840|P1|Overall Study|Protocol Violation|6
4820401|NCT01180660|16618854|P2|Overall Study|Changed to open surgery|0
4820402|NCT01180660|16618855|P1|Overall Study|Changed to open surgery|1
4820403|NCT01180647|16618865|P2|Overall Study|Lost to Follow-up|6
4820404|NCT01180647|16618866|P1|Overall Study|Lost to Follow-up|5
4820405|NCT01180400|16618901|P2|Overall Study|Other|1
4820406|NCT01180400|16618902|P1|Overall Study|Other|0
4820407|NCT01180400|16618901|P2|Overall Study|Lost to Follow-up|3
4820408|NCT01180400|16618902|P1|Overall Study|Lost to Follow-up|2
4820409|NCT01180400|16618901|P2|Overall Study|Study-specific withdrawal criteria|2
4820410|NCT01180400|16618902|P1|Overall Study|Study-specific withdrawal criteria|1
4820411|NCT01180400|16618901|P2|Overall Study|Lack of Efficacy|0
4820412|NCT01180400|16618902|P1|Overall Study|Lack of Efficacy|2
4820413|NCT01180400|16618901|P2|Overall Study|Condition under investigation worsened|1
4820414|NCT01180400|16618902|P1|Overall Study|Condition under investigation worsened|2
4820415|NCT01180400|16618901|P2|Overall Study|Severe non-compliance to protocol|2
4820416|NCT01180400|16618902|P1|Overall Study|Severe non-compliance to protocol|1
4820417|NCT01180400|16618901|P2|Overall Study|Adverse Event|10
4820418|NCT01180400|16618902|P1|Overall Study|Adverse Event|12
4820419|NCT01180400|16618901|P2|Overall Study|Eligibility criteria not fulfilled|2
4820420|NCT01180400|16618902|P1|Overall Study|Eligibility criteria not fulfilled|0
4820421|NCT01180400|16618901|P2|Overall Study|Withdrawal by Subject|6
4820422|NCT01180400|16618902|P1|Overall Study|Withdrawal by Subject|5
4820423|NCT01180296|16618950|P2|Overall Study|Protocol Violation|2
4820424|NCT01180296|16618951|P1|Overall Study|Protocol Violation|1
4820425|NCT01180244|16618961|P2|Overall Study|Lost to Follow-up|0
4820426|NCT01180244|16618962|P1|Overall Study|Lost to Follow-up|1
4820427|NCT01180244|16618961|P2|Overall Study|Protocol Violation|0
4820428|NCT01180244|16618962|P1|Overall Study|Protocol Violation|1
4820429|NCT01180244|16618961|P2|Overall Study|Withdrawal by Subject|1
4820430|NCT01180244|16618962|P1|Overall Study|Withdrawal by Subject|0
4820431|NCT01180244|16618961|P2|Overall Study|Adverse Event|0
4820432|NCT01180244|16618962|P1|Overall Study|Adverse Event|1
4820433|NCT01180244|16618961|P2|Overall Study|Physician Decision|0
4820434|NCT01180244|16618962|P1|Overall Study|Physician Decision|3
4820435|NCT01180244|16618961|P2|Overall Study|Lack of Efficacy|7
4820436|NCT01180244|16618962|P1|Overall Study|Lack of Efficacy|0
4820437|NCT01180049|16619007|P2|Overall Study|Death|35
4820438|NCT01180049|16619008|P1|Overall Study|Death|36
4820439|NCT01180049|16619007|P2|Overall Study|Lost to Follow-up|6
4820440|NCT01180049|16619008|P1|Overall Study|Lost to Follow-up|8
4820441|NCT01180049|16619007|P2|Overall Study|Other|7
4820442|NCT01180049|16619008|P1|Overall Study|Other|9
4820443|NCT01179919|16619045|P1|Overall Study|Adverse Event|1
4820444|NCT01179919|16619045|P1|Overall Study|Protocol Violation|1
4820445|NCT01179737|16619054|P4|Extension|The study was terminated|0
4820446|NCT01179737|16619055|P3|Extension|The study was terminated|0
4820447|NCT01179737|16619056|P2|Extension|The study was terminated|0
4820448|NCT01179737|16619057|P1|Extension|The study was terminated|3
4820449|NCT01179737|16619054|P4|Cohort 1 & Cohort 2 Expansion|Death|0
4820450|NCT01179737|16619055|P3|Cohort 1 & Cohort 2 Expansion|Death|0
4820451|NCT01179737|16619056|P2|Cohort 1 & Cohort 2 Expansion|Death|0
4820452|NCT01179737|16619057|P1|Cohort 1 & Cohort 2 Expansion|Death|1
4820453|NCT01179737|16619054|P4|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
4820454|NCT01179737|16619055|P3|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
4820455|NCT01179737|16619056|P2|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1
4820456|NCT01179737|16619057|P1|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0
4820457|NCT01179737|16619054|P4|Cohort 1 & Cohort 2|Death|0
4820458|NCT01179737|16619055|P3|Cohort 1 & Cohort 2|Death|1
4820459|NCT01179737|16619056|P2|Cohort 1 & Cohort 2|Death|0
4820460|NCT01179737|16619057|P1|Cohort 1 & Cohort 2|Death|0
4820461|NCT01179737|16619054|P4|Cohort 1 & Cohort 2|Administrative problems|4
4820462|NCT01179737|16619055|P3|Cohort 1 & Cohort 2|Administrative problems|2
4820463|NCT01179737|16619056|P2|Cohort 1 & Cohort 2|Administrative problems|0
4820464|NCT01179737|16619057|P1|Cohort 1 & Cohort 2|Administrative problems|0
4820465|NCT01179737|16619054|P4|Cohort 1 & Cohort 2|Withdrew consent|0
4820466|NCT01179737|16619055|P3|Cohort 1 & Cohort 2|Withdrew consent|0
4820467|NCT01179737|16619056|P2|Cohort 1 & Cohort 2|Withdrew consent|0
4820468|NCT01179737|16619057|P1|Cohort 1 & Cohort 2|Withdrew consent|2
4820469|NCT01179737|16619054|P4|Cohort 1 & Cohort 2|Adverse Event|0
4820470|NCT01179737|16619055|P3|Cohort 1 & Cohort 2|Adverse Event|1
4820471|NCT01179737|16619056|P2|Cohort 1 & Cohort 2|Adverse Event|1
4820472|NCT01179737|16619057|P1|Cohort 1 & Cohort 2|Adverse Event|3
4820473|NCT01179672|16619068|P2|Overall Study|Physician Decision|1
4820474|NCT01179672|16619069|P1|Overall Study|Physician Decision|1
4820475|NCT01179672|16619068|P2|Overall Study|Protocol Violation|2
4820476|NCT01179672|16619069|P1|Overall Study|Protocol Violation|2
4820477|NCT01179672|16619068|P2|Overall Study|Lost to Follow-up|1
4820478|NCT01179672|16619069|P1|Overall Study|Lost to Follow-up|0
4820479|NCT01179672|16619068|P2|Overall Study|Entry Criteria Not Met|2
4820480|NCT01179672|16619069|P1|Overall Study|Entry Criteria Not Met|0
4820481|NCT01179672|16619068|P2|Overall Study|Withdrawal by Subject|12
4820482|NCT01179672|16619069|P1|Overall Study|Withdrawal by Subject|10
4820483|NCT01179672|16619068|P2|Overall Study|Adverse Event|8
4820484|NCT01179672|16619069|P1|Overall Study|Adverse Event|17
4820485|NCT01179516|16619125|P3|Overall Study|Other|2
4820486|NCT01179516|16619126|P2|Overall Study|Other|0
4820487|NCT01179516|16619127|P1|Overall Study|Other|2
4820488|NCT01179516|16619125|P3|Overall Study|Lost to Follow-up|3
4820489|NCT01179516|16619126|P2|Overall Study|Lost to Follow-up|7
4820490|NCT01179516|16619127|P1|Overall Study|Lost to Follow-up|7
4820491|NCT01179516|16619125|P3|Overall Study|Withdrawal of Consent|10
4820492|NCT01179516|16619126|P2|Overall Study|Withdrawal of Consent|6
4820493|NCT01179516|16619127|P1|Overall Study|Withdrawal of Consent|2
4820494|NCT01179516|16619125|P3|Overall Study|Protocol Deviations|3
4820495|NCT01179516|16619126|P2|Overall Study|Protocol Deviations|3
4820496|NCT01179516|16619127|P1|Overall Study|Protocol Deviations|4
4820497|NCT01179516|16619125|P3|Overall Study|Noncompliance with Study Drug|1
4820498|NCT01179516|16619126|P2|Overall Study|Noncompliance with Study Drug|0
4820499|NCT01179516|16619127|P1|Overall Study|Noncompliance with Study Drug|2
4820500|NCT01179516|16619125|P3|Overall Study|Lack of Efficacy|0
4820501|NCT01179516|16619126|P2|Overall Study|Lack of Efficacy|2
4820502|NCT01179516|16619127|P1|Overall Study|Lack of Efficacy|4
4820503|NCT01179516|16619125|P3|Overall Study|Pretreatment Event or Adverse Event|12
4820504|NCT01179516|16619126|P2|Overall Study|Pretreatment Event or Adverse Event|8
4820505|NCT01179516|16619127|P1|Overall Study|Pretreatment Event or Adverse Event|6
4820506|NCT01179477|16619171|P1|Overall Study|Did not complete final visit|27
4820507|NCT01179477|16619171|P1|Overall Study|Non-death withdrawal|438
4820508|NCT01179477|16619171|P1|Overall Study|Unsuccessful implant|80
4820509|NCT01179477|16619171|P1|Overall Study|Death|542
4820510|NCT01179399|16619176|P1|Overall Study|Withdrawal by Subject|1
4820511|NCT01179399|16619176|P1|Overall Study|Lack of Efficacy|30
4820512|NCT01179399|16619176|P1|Overall Study|Adverse Event|1
4820513|NCT01179347|16619182|P2|Open-label Period (12 Weeks)|Other|4
4820514|NCT01179347|16619183|P1|Open-label Period (12 Weeks)|Other|7
4820515|NCT01179347|16619182|P2|Open-label Period (12 Weeks)|Protocol Violation|0
4820516|NCT01179347|16619183|P1|Open-label Period (12 Weeks)|Protocol Violation|1
4820517|NCT01179347|16619182|P2|Open-label Period (12 Weeks)|Withdrawal by Subject|1
4820518|NCT01179347|16619183|P1|Open-label Period (12 Weeks)|Withdrawal by Subject|1
4820519|NCT01179347|16619182|P2|Open-label Period (12 Weeks)|Lost to Follow-up|0
4820520|NCT01179347|16619183|P1|Open-label Period (12 Weeks)|Lost to Follow-up|1
4820521|NCT01179347|16619182|P2|Open-label Period (12 Weeks)|Lack of Efficacy|2
4820522|NCT01179347|16619183|P1|Open-label Period (12 Weeks)|Lack of Efficacy|0
4820523|NCT01179347|16619182|P2|Open-label Period (12 Weeks)|Adverse Event|9
4820524|NCT01179347|16619183|P1|Open-label Period (12 Weeks)|Adverse Event|5
4820525|NCT01179347|16619182|P2|Double-blind Period (12 Weeks)|Other|4
4820526|NCT01179347|16619183|P1|Double-blind Period (12 Weeks)|Other|2
4820527|NCT01179347|16619182|P2|Double-blind Period (12 Weeks)|Withdrawal by Subject|2
4820528|NCT01179347|16619183|P1|Double-blind Period (12 Weeks)|Withdrawal by Subject|1
4820529|NCT01179347|16619182|P2|Double-blind Period (12 Weeks)|Lost to Follow-up|2
4820530|NCT01179347|16619183|P1|Double-blind Period (12 Weeks)|Lost to Follow-up|1
4820531|NCT01179347|16619182|P2|Double-blind Period (12 Weeks)|Protocol Violation|0
4820532|NCT01179347|16619183|P1|Double-blind Period (12 Weeks)|Protocol Violation|2
4820533|NCT01179347|16619182|P2|Double-blind Period (12 Weeks)|Adverse Event|6
4820534|NCT01179347|16619183|P1|Double-blind Period (12 Weeks)|Adverse Event|2
4820535|NCT01179334|16619205|P2|Long-term Extension (LTE) Period|Adverse Event|4
4820536|NCT01179334|16619206|P1|Long-term Extension (LTE) Period|Adverse Event|2
4820537|NCT01179334|16619205|P2|Long-term Extension (LTE) Period|Death|0
4820538|NCT01179334|16619206|P1|Long-term Extension (LTE) Period|Death|3
4820539|NCT01179334|16619205|P2|Long-term Extension (LTE) Period|Study terminated by sponsor|2
4820540|NCT01179334|16619206|P1|Long-term Extension (LTE) Period|Study terminated by sponsor|6
4820541|NCT01179334|16619205|P2|Treatment Period|Adverse Event|0
4820542|NCT01179334|16619206|P1|Treatment Period|Adverse Event|1
4820543|NCT01179191|16619261|P1|Maintenance Phase (8 Weeks)|Other|66
4820544|NCT01179191|16619261|P1|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29
4820545|NCT01179191|16619261|P1|Maintenance Phase (8 Weeks)|Physician Decision|3
4820546|NCT01179191|16619261|P1|Maintenance Phase (8 Weeks)|Lost to Follow-up|9
4820547|NCT01179191|16619261|P1|Maintenance Phase (8 Weeks)|Adverse Event|10
4820548|NCT01179191|16619261|P1|Titration Phase (up to 6 Weeks)|Other|62
4820549|NCT01179191|16619261|P1|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13
4820550|NCT01179191|16619261|P1|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162
4820551|NCT01179191|16619261|P1|Titration Phase (up to 6 Weeks)|Physician Decision|30
4820552|NCT01179191|16619261|P1|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19
4820553|NCT01179191|16619261|P1|Titration Phase (up to 6 Weeks)|Adverse Event|47
4820554|NCT01179048|16619293|P2|Overall Study|Alive|142
4820555|NCT01179048|16619294|P1|Overall Study|Alive|127
4820556|NCT01179048|16619293|P2|Overall Study|Lost to Follow-up|9
4820557|NCT01179048|16619294|P1|Overall Study|Lost to Follow-up|8
4820558|NCT01179048|16619293|P2|Overall Study|Withdrawn - does not allow contact|8
4820559|NCT01179048|16619294|P1|Overall Study|Withdrawn - does not allow contact|4
4820560|NCT01178853|16619321|P2|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1
4820561|NCT01178853|16619322|P1|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0
4820562|NCT01178853|16619321|P2|Period 4 (Warfarin + Study Drug)|Adverse Event|2
4820563|NCT01178853|16619322|P1|Period 4 (Warfarin + Study Drug)|Adverse Event|0
4820564|NCT01178853|16619321|P2|Period 3 (Warfarin Titration)|Adverse Event|0
4820565|NCT01178853|16619322|P1|Period 3 (Warfarin Titration)|Adverse Event|1
4820566|NCT01178853|16619321|P2|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0
4820567|NCT01178853|16619322|P1|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1
4820568|NCT01178853|16619321|P2|Period 1 (Warfarin Titration)|INR Out of Range|2
4820569|NCT01178853|16619322|P1|Period 1 (Warfarin Titration)|INR Out of Range|1
4820570|NCT01178762|16619362|P1|Overall Study|Lost to Follow-up|15
4820571|NCT01178671|16619368|P2|Overall Study|Physician Decision|6
4820572|NCT01178671|16619369|P1|Overall Study|Physician Decision|4
4820573|NCT01178671|16619368|P2|Overall Study|Lost to Follow-up|1
4820574|NCT01178671|16619369|P1|Overall Study|Lost to Follow-up|3
4820575|NCT01178671|16619368|P2|Overall Study|Lack of Efficacy|1
4820576|NCT01178671|16619369|P1|Overall Study|Lack of Efficacy|0
4820577|NCT01178671|16619368|P2|Overall Study|Protocol Violation|1
4820578|NCT01178671|16619369|P1|Overall Study|Protocol Violation|1
4820579|NCT01178671|16619368|P2|Overall Study|Adverse Event|6
4820580|NCT01178671|16619369|P1|Overall Study|Adverse Event|4
4820581|NCT01178385|16619417|P2|Overall Study|Withdrawal by Subject|0
4820582|NCT01178385|16619418|P1|Overall Study|Withdrawal by Subject|2
4820583|NCT01178294|16619487|P1|Overall Study|Completion status could not be verified|1
4820584|NCT01178294|16619487|P1|Overall Study|Subject status is terminal|1
4820585|NCT01178294|16619487|P1|Overall Study|Development of inhibitors to OBI-1|1
4820586|NCT01178294|16619487|P1|Overall Study|Death|1
4820587|NCT01178294|16619487|P1|Overall Study|Lack of Efficacy|1
4820588|NCT01178294|16619487|P1|Overall Study|Lost to Follow-up|2
4820589|NCT01178294|16619487|P1|Overall Study|Adverse Event|4
4820590|NCT01178138|16619767|P1|Overall Study|Physician Decision|8
4820591|NCT01178138|16619767|P1|Overall Study|Withdrawal by Subject|7
4820592|NCT01178138|16619767|P1|Overall Study|Lost to Follow-up|8
4820593|NCT01178125|16619788|P1|Overall Study|Investigator Decision|5
4820594|NCT01178125|16619788|P1|Overall Study|Protocol Violation|17
4820595|NCT01178125|16619788|P1|Overall Study|Sponsor Decision|28
4820596|NCT01178125|16619788|P1|Overall Study|Other Reason|39
4820597|NCT01178125|16619788|P1|Overall Study|Pregnancy|55
4820598|NCT01178125|16619788|P1|Overall Study|Noncompliance|184
4820599|NCT01178125|16619788|P1|Overall Study|Withdrawal by Subject|209
4820600|NCT01178125|16619788|P1|Overall Study|Adverse Event|244
4820601|NCT01178125|16619788|P1|Overall Study|Lost to Follow-up|397
4820602|NCT01178099|16619819|P2|Overall Study|Physician Decision|1
4820603|NCT01178099|16619820|P1|Overall Study|Physician Decision|0
4820604|NCT01178086|16619860|P1|Overall Study|Excluded from EAS|20
4820605|NCT01178086|16619860|P1|Overall Study|Other unspecified|89
4820606|NCT01178086|16619860|P1|Overall Study|Death|59
4820607|NCT01178086|16619860|P1|Overall Study|Switch to other CLL therapy|113
4820608|NCT01178086|16619860|P1|Overall Study|Physician Decision|44
4820609|NCT01178086|16619860|P1|Overall Study|Participant refusal|7
4820610|NCT01178073|16619887|P3|Overall Study|Missing Completion Status|0
4820611|NCT01178073|16619888|P2|Overall Study|Missing Completion Status|0
4820612|NCT01178073|16619889|P1|Overall Study|Missing Completion Status|1
4820613|NCT01178073|16619887|P3|Overall Study|Withdrawal by Subject|8
4820614|NCT01178073|16619888|P2|Overall Study|Withdrawal by Subject|6
4820615|NCT01178073|16619889|P1|Overall Study|Withdrawal by Subject|10
4820616|NCT01178073|16619887|P3|Overall Study|Physician Decision|10
4820617|NCT01178073|16619888|P2|Overall Study|Physician Decision|10
4820618|NCT01178073|16619889|P1|Overall Study|Physician Decision|14
4820619|NCT01178073|16619887|P3|Overall Study|Lost to Follow-up|3
4820620|NCT01178073|16619888|P2|Overall Study|Lost to Follow-up|0
4820621|NCT01178073|16619889|P1|Overall Study|Lost to Follow-up|2
4820622|NCT01178073|16619887|P3|Overall Study|Protocol Violation|1
4820623|NCT01178073|16619888|P2|Overall Study|Protocol Violation|1
4820624|NCT01178073|16619889|P1|Overall Study|Protocol Violation|1
4820625|NCT01178073|16619887|P3|Overall Study|Adverse Event|24
4820626|NCT01178073|16619888|P2|Overall Study|Adverse Event|27
4820627|NCT01178073|16619889|P1|Overall Study|Adverse Event|34
4820628|NCT01177969|16619920|P2|Overall Study|Withdrawal by Subject|2
4820629|NCT01177969|16619921|P1|Overall Study|Withdrawal by Subject|1
4820630|NCT01177969|16619920|P2|Overall Study|Protocol Violation|1
4820631|NCT01177969|16619921|P1|Overall Study|Protocol Violation|2
4820632|NCT01177943|16619944|P2|First Intervention|Withdrawal by Subject|0
4820633|NCT01177943|16619945|P1|First Intervention|Withdrawal by Subject|2
4820634|NCT01177813|16619958|P5|Overall Study|Other reason not defined above|2
4820635|NCT01177813|16619959|P4|Overall Study|Other reason not defined above|3
4820636|NCT01177813|16619960|P3|Overall Study|Other reason not defined above|2
4820637|NCT01177813|16619961|P2|Overall Study|Other reason not defined above|2
4820638|NCT01177813|16619962|P1|Overall Study|Other reason not defined above|5
4820639|NCT01177813|16619958|P5|Overall Study|Withdrawal by Subject|3
4820640|NCT01177813|16619959|P4|Overall Study|Withdrawal by Subject|5
4820641|NCT01177813|16619960|P3|Overall Study|Withdrawal by Subject|6
4820642|NCT01177813|16619961|P2|Overall Study|Withdrawal by Subject|7
4820643|NCT01177813|16619962|P1|Overall Study|Withdrawal by Subject|12
4820644|NCT01177813|16619958|P5|Overall Study|Lost to Follow-up|0
4820645|NCT01177813|16619959|P4|Overall Study|Lost to Follow-up|3
4820646|NCT01177813|16619960|P3|Overall Study|Lost to Follow-up|6
4820647|NCT01177813|16619961|P2|Overall Study|Lost to Follow-up|5
4820648|NCT01177813|16619962|P1|Overall Study|Lost to Follow-up|12
4820649|NCT01177813|16619958|P5|Overall Study|Protocol Violation|1
4820650|NCT01177813|16619959|P4|Overall Study|Protocol Violation|0
4820651|NCT01177813|16619960|P3|Overall Study|Protocol Violation|2
4820652|NCT01177813|16619961|P2|Overall Study|Protocol Violation|2
4820653|NCT01177813|16619962|P1|Overall Study|Protocol Violation|3
4820654|NCT01177813|16619958|P5|Overall Study|Lack of Efficacy|0
4820655|NCT01177813|16619959|P4|Overall Study|Lack of Efficacy|0
4820656|NCT01177813|16619960|P3|Overall Study|Lack of Efficacy|0
4820657|NCT01177813|16619961|P2|Overall Study|Lack of Efficacy|0
4820658|NCT01177813|16619962|P1|Overall Study|Lack of Efficacy|1
4820659|NCT01177813|16619958|P5|Overall Study|Adverse Event|3
4820660|NCT01177813|16619959|P4|Overall Study|Adverse Event|6
4820661|NCT01177813|16619960|P3|Overall Study|Adverse Event|4
4820662|NCT01177813|16619961|P2|Overall Study|Adverse Event|2
4820663|NCT01177813|16619962|P1|Overall Study|Adverse Event|8
4820664|NCT01177800|16619991|P2|Overall Study|Withdrawal of informed consent|1
4820665|NCT01177800|16619992|P1|Overall Study|Withdrawal of informed consent|0
4820666|NCT01177800|16619991|P2|Overall Study|Physician Decision|0
4820667|NCT01177800|16619992|P1|Overall Study|Physician Decision|1
4820668|NCT01177800|16619991|P2|Overall Study|Protocol Violation|1
4820669|NCT01177800|16619992|P1|Overall Study|Protocol Violation|0
4820670|NCT01177800|16619991|P2|Overall Study|Adverse Event|3
4820671|NCT01177800|16619992|P1|Overall Study|Adverse Event|9
4820672|NCT01177722|16620014|P4|Overall Study|Withdrawal by Subject|6
4820673|NCT01177722|16620015|P3|Overall Study|Withdrawal by Subject|4
4820674|NCT01177722|16620016|P2|Overall Study|Withdrawal by Subject|6
4820675|NCT01177722|16620017|P1|Overall Study|Withdrawal by Subject|10
4820676|NCT01177722|16620014|P4|Overall Study|Lost to Follow-up|1
4820677|NCT01177722|16620015|P3|Overall Study|Lost to Follow-up|3
4820678|NCT01177722|16620016|P2|Overall Study|Lost to Follow-up|4
4820679|NCT01177722|16620017|P1|Overall Study|Lost to Follow-up|3
4820680|NCT01177722|16620014|P4|Overall Study|Protocol Violation|0
4820681|NCT01177722|16620015|P3|Overall Study|Protocol Violation|1
4820682|NCT01177722|16620016|P2|Overall Study|Protocol Violation|0
4820683|NCT01177722|16620017|P1|Overall Study|Protocol Violation|0
4820684|NCT01177722|16620014|P4|Overall Study|Serious Adverse Event|0
4820685|NCT01177722|16620015|P3|Overall Study|Serious Adverse Event|1
4820686|NCT01177722|16620016|P2|Overall Study|Serious Adverse Event|0
4820687|NCT01177722|16620017|P1|Overall Study|Serious Adverse Event|0
4820688|NCT01177670|16620049|P1|Overall Study|Withdrawal by Subject|4
4820689|NCT01177670|16620049|P1|Overall Study|Physician Decision|50
4820690|NCT01177670|16620049|P1|Overall Study|Study Terminated|115
4820691|NCT01177553|16620056|P2|Overall Study|babies not yet 6 months of age|0
4820692|NCT01177553|16620057|P1|Overall Study|babies not yet 6 months of age|1
4820693|NCT01177410|16620066|P3|Overall Study|Lost to Follow-up|0
4820694|NCT01177410|16620067|P2|Overall Study|Lost to Follow-up|1
4820695|NCT01177410|16620068|P1|Overall Study|Lost to Follow-up|0
4820696|NCT01177410|16620066|P3|Overall Study|Withdrawal by Subject|3
4820697|NCT01177410|16620067|P2|Overall Study|Withdrawal by Subject|4
4820698|NCT01177410|16620068|P1|Overall Study|Withdrawal by Subject|1
4820699|NCT01177410|16620066|P3|Overall Study|Adverse Event|2
4820700|NCT01177410|16620067|P2|Overall Study|Adverse Event|2
4820701|NCT01177410|16620068|P1|Overall Study|Adverse Event|0
4820702|NCT01177384|16620081|P2|Overall Study|Withdrawal by Subject|12
4820703|NCT01177384|16620082|P1|Overall Study|Withdrawal by Subject|5
4820704|NCT01177384|16620081|P2|Overall Study|Protocol Violation|2
4820705|NCT01177384|16620082|P1|Overall Study|Protocol Violation|0
4820706|NCT01177384|16620081|P2|Overall Study|Physician Decision|3
4820707|NCT01177384|16620082|P1|Overall Study|Physician Decision|0
4820708|NCT01177384|16620081|P2|Overall Study|Lost to Follow-up|4
4820709|NCT01177384|16620082|P1|Overall Study|Lost to Follow-up|3
4820710|NCT01177384|16620081|P2|Overall Study|Lack of Efficacy|1
4820711|NCT01177384|16620082|P1|Overall Study|Lack of Efficacy|0
4820712|NCT01177384|16620081|P2|Overall Study|Adverse Event|4
4820713|NCT01177384|16620082|P1|Overall Study|Adverse Event|6
4820714|NCT01177293|16620094|P2|Washout Period (of 14 Days)|Lost to Follow-up|1
4820715|NCT01177293|16620095|P1|Washout Period (of 14 Days)|Lost to Follow-up|0
4820716|NCT01177228|16620113|P4|Overall Study|Withdrawal by Subject|0
4820717|NCT01177228|16620114|P3|Overall Study|Withdrawal by Subject|0
4820718|NCT01177228|16620115|P2|Overall Study|Withdrawal by Subject|1
4820719|NCT01177228|16620116|P1|Overall Study|Withdrawal by Subject|0
4820720|NCT01177228|16620113|P4|Overall Study|Worsening disease activity|0
4820721|NCT01177228|16620114|P3|Overall Study|Worsening disease activity|0
4820722|NCT01177228|16620115|P2|Overall Study|Worsening disease activity|0
4820723|NCT01177228|16620116|P1|Overall Study|Worsening disease activity|1
4820724|NCT01177228|16620113|P4|Overall Study|Positive tuberculosis test|0
4820725|NCT01177228|16620114|P3|Overall Study|Positive tuberculosis test|0
4820726|NCT01177228|16620115|P2|Overall Study|Positive tuberculosis test|1
4820727|NCT01177228|16620116|P1|Overall Study|Positive tuberculosis test|0
4820728|NCT01177137|16620170|P3|Overall Study|Withdrawal by Subject|2
4820729|NCT01177137|16620171|P2|Overall Study|Withdrawal by Subject|10
4820730|NCT01177137|16620172|P1|Overall Study|Withdrawal by Subject|10
4820731|NCT01177059|16620256|P1|Overall Study|Lost to Follow-up|18
4820732|NCT01177059|16620256|P1|Overall Study|Withdrew consent|2
4820733|NCT01177059|16620256|P1|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30
4820734|NCT01177007|16620262|P1|Overall Study|Change in treatment modality|21
4820735|NCT01177007|16620262|P1|Overall Study|Required additional Y90 treatment|6
4820736|NCT01177007|16620262|P1|Overall Study|Entered hospice care|5
4820737|NCT01177007|16620262|P1|Overall Study|Death|4
4820738|NCT01177007|16620262|P1|Overall Study|Lost to Follow-up|2
4820739|NCT01176968|16620276|P2|Overall Study|Reason not defined|3
4820740|NCT01176968|16620277|P1|Overall Study|Reason not defined|5
4820741|NCT01176968|16620276|P2|Overall Study|Study terminated by sponsor|1
4820742|NCT01176968|16620277|P1|Overall Study|Study terminated by sponsor|0
4820743|NCT01176968|16620276|P2|Overall Study|Did Not Meet Entrance Criteria|0
4820744|NCT01176968|16620277|P1|Overall Study|Did Not Meet Entrance Criteria|1
4820745|NCT01176968|16620276|P2|Overall Study|Protocol Violation|1
4820746|NCT01176968|16620277|P1|Overall Study|Protocol Violation|2
4820747|NCT01176968|16620276|P2|Overall Study|Withdrawal by Subject|48
4820748|NCT01176968|16620277|P1|Overall Study|Withdrawal by Subject|48
4820749|NCT01176968|16620276|P2|Overall Study|Lost to Follow-up|14
4820750|NCT01176968|16620277|P1|Overall Study|Lost to Follow-up|16
4820751|NCT01176968|16620276|P2|Overall Study|Lack of Efficacy|1
4820752|NCT01176968|16620277|P1|Overall Study|Lack of Efficacy|0
4820753|NCT01176968|16620276|P2|Overall Study|Death|3
4820754|NCT01176968|16620277|P1|Overall Study|Death|2
4820755|NCT01176968|16620276|P2|Overall Study|Adverse Event|11
4820756|NCT01176968|16620277|P1|Overall Study|Adverse Event|10
4820757|NCT01176916|16620323|P1|Overall Study|Withdrawal prior to Treatment|6
4820758|NCT01176916|16620323|P1|Overall Study|Other|6
4820759|NCT01176916|16620323|P1|Overall Study|Withdrawal by Subject|37
4820760|NCT01176916|16620323|P1|Overall Study|Protocol Violation|24
4820761|NCT01176916|16620323|P1|Overall Study|Objective progression or relapse|17
4820762|NCT01176916|16620323|P1|Overall Study|Lost to Follow-up|15
4820763|NCT01176916|16620323|P1|Overall Study|Death|1
4820764|NCT01176916|16620323|P1|Overall Study|Adverse Event|61
4820765|NCT01176773|16620338|P1|Overall Study|Withdrew consent|1
4820766|NCT01176773|16620338|P1|Overall Study|Screen Failure|2
4820767|NCT01176565|16620381|P2|Overall Study|Not Analyzed (any other reason)|2
4820768|NCT01176565|16620382|P1|Overall Study|Not Analyzed (any other reason)|1
4820769|NCT01176565|16620381|P2|Overall Study|Withdrawal by Subject|1
4820770|NCT01176565|16620382|P1|Overall Study|Withdrawal by Subject|7
4820771|NCT01176565|16620381|P2|Overall Study|Lost to Follow-up|16
4820772|NCT01176565|16620382|P1|Overall Study|Lost to Follow-up|12
4820773|NCT01176513|16620400|P1|Overall Study|Withdrew subjects prior to dosing|3
4820774|NCT01176292|16620428|P2|Overall Study|Has not scheduled one-year visit yet|2
4820775|NCT01176292|16620429|P1|Overall Study|Has not scheduled one-year visit yet|2
4820776|NCT01176292|16620428|P2|Overall Study|Physician Decision|2
4820777|NCT01176292|16620429|P1|Overall Study|Physician Decision|0
4820778|NCT01176292|16620428|P2|Overall Study|Adverse Event|1
4820779|NCT01176292|16620429|P1|Overall Study|Adverse Event|1
4820780|NCT01176292|16620428|P2|Overall Study|Lost to Follow-up|4
4820781|NCT01176292|16620429|P1|Overall Study|Lost to Follow-up|2
4820782|NCT01176266|16620447|P1|Overall Study|Withdrawal by Subject|3
4820783|NCT01176266|16620447|P1|Overall Study|Death|6
4820784|NCT01176240|16620471|P2|Study 306B|withdrew prior to dosing|1
4820785|NCT01176240|16620472|P1|Study 306B|withdrew prior to dosing|2
4820786|NCT01176240|16620471|P2|Study 306B|Lost to Follow-up|1
4820787|NCT01176240|16620472|P1|Study 306B|Lost to Follow-up|0
4820788|NCT01176240|16620471|P2|Study 306B|Supine Hypertension|2
4820789|NCT01176240|16620472|P1|Study 306B|Supine Hypertension|1
4820790|NCT01176240|16620471|P2|Study 306B|Physician Decision|1
4820791|NCT01176240|16620472|P1|Study 306B|Physician Decision|2
4820792|NCT01176240|16620471|P2|Study 306B|Withdrawal by Subject|1
4820793|NCT01176240|16620472|P1|Study 306B|Withdrawal by Subject|4
4820794|NCT01176240|16620471|P2|Study 306B|Protocol Violation|3
4820795|NCT01176240|16620472|P1|Study 306B|Protocol Violation|2
4820796|NCT01176240|16620471|P2|Study 306B|Adverse Event|5
4820797|NCT01176240|16620472|P1|Study 306B|Adverse Event|10
4820798|NCT01176240|16620471|P2|Study 306B|Lack of Efficacy|3
4820799|NCT01176240|16620472|P1|Study 306B|Lack of Efficacy|5
4820800|NCT01176240|16620471|P2|Study 306A|Stop due to diverse problems|0
4820801|NCT01176240|16620472|P1|Study 306A|Stop due to diverse problems|1
4820802|NCT01176240|16620471|P2|Study 306A|Withdrawal by Subject|1
4820803|NCT01176240|16620472|P1|Study 306A|Withdrawal by Subject|0
4820804|NCT01176240|16620471|P2|Study 306A|Protocol Violation|1
4820805|NCT01176240|16620472|P1|Study 306A|Protocol Violation|0
4820806|NCT01176240|16620471|P2|Study 306A|Lack of Efficacy|1
4820807|NCT01176240|16620472|P1|Study 306A|Lack of Efficacy|2
4820808|NCT01176058|16620498|P2|Overall Study|Withdrawal by Subject|0
4820809|NCT01176058|16620499|P1|Overall Study|Withdrawal by Subject|1
4820810|NCT01176058|16620498|P2|Overall Study|Insufficient mycological response|1
4820811|NCT01176058|16620499|P1|Overall Study|Insufficient mycological response|0
4820812|NCT01176058|16620498|P2|Overall Study|Insufficient clinical response|2
4820813|NCT01176058|16620499|P1|Overall Study|Insufficient clinical response|2
4820814|NCT01176058|16620498|P2|Overall Study|Adverse Event|0
4820815|NCT01176058|16620499|P1|Overall Study|Adverse Event|1
4820816|NCT01176032|16620523|P2|Overall Study|Other|0
4820817|NCT01176032|16620524|P1|Overall Study|Other|1
4820818|NCT01176032|16620523|P2|Overall Study|Informed consent withdrawn|0
4820819|NCT01176032|16620524|P1|Overall Study|Informed consent withdrawn|3
4820820|NCT01176032|16620523|P2|Overall Study|Protocol Violation|0
4820821|NCT01176032|16620524|P1|Overall Study|Protocol Violation|1
4820822|NCT01176032|16620523|P2|Overall Study|Unsatisfactory therapeutic effect|1
4820823|NCT01176032|16620524|P1|Overall Study|Unsatisfactory therapeutic effect|0
4820824|NCT01176032|16620523|P2|Overall Study|Adverse Event|0
4820825|NCT01176032|16620524|P1|Overall Study|Adverse Event|1
4820826|NCT01175824|16620665|P2|Overall Study|Entry Criteria Not Met|4
4820827|NCT01175824|16620666|P1|Overall Study|Entry Criteria Not Met|6
4820828|NCT01175824|16620665|P2|Overall Study|Sponsor Decision|0
4820829|NCT01175824|16620666|P1|Overall Study|Sponsor Decision|1
4820830|NCT01175824|16620665|P2|Overall Study|Withdrawal by Subject|7
4820831|NCT01175824|16620666|P1|Overall Study|Withdrawal by Subject|3
4820832|NCT01175824|16620665|P2|Overall Study|Protocol Violation|5
4820833|NCT01175824|16620666|P1|Overall Study|Protocol Violation|2
4820834|NCT01175824|16620665|P2|Overall Study|Physician Decision|4
4820835|NCT01175824|16620666|P1|Overall Study|Physician Decision|0
4820836|NCT01175824|16620665|P2|Overall Study|Lost to Follow-up|1
4820837|NCT01175824|16620666|P1|Overall Study|Lost to Follow-up|0
4820838|NCT01175824|16620665|P2|Overall Study|Lack of Efficacy|0
4820839|NCT01175824|16620666|P1|Overall Study|Lack of Efficacy|2
4820840|NCT01175824|16620665|P2|Overall Study|Adverse Event|1
4820841|NCT01175824|16620666|P1|Overall Study|Adverse Event|2
4820842|NCT01175811|16620700|P2|Overall Study|Withdrawal by Subject|7
4820843|NCT01175811|16620701|P1|Overall Study|Withdrawal by Subject|6
4820844|NCT01175811|16620700|P2|Overall Study|Protocol Violation|2
4820845|NCT01175811|16620701|P1|Overall Study|Protocol Violation|1
4820846|NCT01175811|16620700|P2|Overall Study|Physician Decision|1
4820847|NCT01175811|16620701|P1|Overall Study|Physician Decision|1
4820848|NCT01175811|16620700|P2|Overall Study|Lost to Follow-up|2
4820849|NCT01175811|16620701|P1|Overall Study|Lost to Follow-up|3
4820850|NCT01175811|16620700|P2|Overall Study|Lack of Efficacy|0
4820851|NCT01175811|16620701|P1|Overall Study|Lack of Efficacy|1
4820852|NCT01175811|16620700|P2|Overall Study|Entry criteria not met|1
4820853|NCT01175811|16620701|P1|Overall Study|Entry criteria not met|3
4820854|NCT01175811|16620700|P2|Overall Study|Adverse Event|1
4820855|NCT01175811|16620701|P1|Overall Study|Adverse Event|1
4820856|NCT01175707|16620736|P2|Overall Study|Adverse Event|6
4820857|NCT01175707|16620737|P1|Overall Study|Adverse Event|4
4820858|NCT01175668|16620773|P2|Overall Study|Withdrawal by Subject|0
4820859|NCT01175668|16620774|P1|Overall Study|Withdrawal by Subject|2
4820860|NCT01175590|16620784|P2|Overall Study|Protocol Violation|1
4820861|NCT01175590|16620785|P1|Overall Study|Protocol Violation|0
4820862|NCT01175590|16620784|P2|Overall Study|Herpes Simplex Dermatitis|0
4820863|NCT01175590|16620785|P1|Overall Study|Herpes Simplex Dermatitis|1
4820864|NCT01175590|16620784|P2|Overall Study|Treated not as randomized|2
4820865|NCT01175590|16620785|P1|Overall Study|Treated not as randomized|3
4820866|NCT01175590|16620784|P2|Overall Study|Residual Bacterial Conjunctivitis|0
4820867|NCT01175590|16620785|P1|Overall Study|Residual Bacterial Conjunctivitis|1
4820868|NCT01175590|16620784|P2|Overall Study|Lack of Efficacy|1
4820869|NCT01175590|16620785|P1|Overall Study|Lack of Efficacy|1
4820870|NCT01175590|16620784|P2|Overall Study|Physician Decision|4
4820871|NCT01175590|16620785|P1|Overall Study|Physician Decision|1
4820872|NCT01175590|16620784|P2|Overall Study|Adverse Event|0
4820873|NCT01175590|16620785|P1|Overall Study|Adverse Event|4
4820874|NCT01175590|16620784|P2|Overall Study|Withdrawal by Subject|2
4820875|NCT01175590|16620785|P1|Overall Study|Withdrawal by Subject|0
4820876|NCT01175590|16620784|P2|Overall Study|Lost to Follow-up|0
4820877|NCT01175590|16620785|P1|Overall Study|Lost to Follow-up|1
4820878|NCT01175473|16620819|P2|Overall Study|Adverse Event|2
4820879|NCT01175473|16620820|P1|Overall Study|Adverse Event|2
4820880|NCT01175382|16620861|P3|Overall Study|Unable to tolerate study meds|1
4820881|NCT01175382|16620862|P2|Overall Study|Unable to tolerate study meds|1
4820882|NCT01175382|16620863|P1|Overall Study|Unable to tolerate study meds|0
4820883|NCT01175382|16620861|P3|Overall Study|Unwilling to follow protocol|0
4820884|NCT01175382|16620862|P2|Overall Study|Unwilling to follow protocol|1
4820885|NCT01175382|16620863|P1|Overall Study|Unwilling to follow protocol|0
4820886|NCT01175382|16620861|P3|Overall Study|Unable/unwilling to attend visits|2
4820887|NCT01175382|16620862|P2|Overall Study|Unable/unwilling to attend visits|1
4820888|NCT01175382|16620863|P1|Overall Study|Unable/unwilling to attend visits|3
4820889|NCT01175382|16620861|P3|Overall Study|No longer having problem|1
4820890|NCT01175382|16620862|P2|Overall Study|No longer having problem|0
4820891|NCT01175382|16620863|P1|Overall Study|No longer having problem|1
4820892|NCT01175382|16620861|P3|Overall Study|Withdrawal by Subject|1
4820893|NCT01175382|16620862|P2|Overall Study|Withdrawal by Subject|0
4820894|NCT01175382|16620863|P1|Overall Study|Withdrawal by Subject|0
4820895|NCT01175382|16620861|P3|Overall Study|Physician Decision|0
4820896|NCT01175382|16620862|P2|Overall Study|Physician Decision|1
4820897|NCT01175382|16620863|P1|Overall Study|Physician Decision|0
4820898|NCT01175382|16620861|P3|Overall Study|Lost to Follow-up|1
4820899|NCT01175382|16620862|P2|Overall Study|Lost to Follow-up|3
4820900|NCT01175382|16620863|P1|Overall Study|Lost to Follow-up|4
4820901|NCT01175356|16620949|P1|Overall Study|Initiation other tx prior to completion|9
4820902|NCT01175356|16620949|P1|Overall Study|Inadequate stem cell for transplant|1
4820903|NCT01175356|16620949|P1|Overall Study|On other COG study w/tumor tx intent|7
4820904|NCT01175356|16620949|P1|Overall Study|Pts MIBG non-avid after enrollment|2
4820905|NCT01175356|16620949|P1|Overall Study|Refusal by patient/parent/guardian|6
4820906|NCT01175356|16620949|P1|Overall Study|Treatment Slot Not Available|18
4820907|NCT01175356|16620949|P1|Overall Study|Ineligible|1
4820908|NCT01175356|16620949|P1|Overall Study|Physician Decision|23
4820909|NCT01175356|16620949|P1|Overall Study|Lost to Follow-up|1
4820910|NCT01175356|16620949|P1|Overall Study|Lack of Efficacy|12
4820911|NCT01175356|16620949|P1|Overall Study|Death|1
4820912|NCT01175213|16620989|P2|Safety Follow-up|Adverse Event|0
4820913|NCT01175213|16620990|P1|Safety Follow-up|Adverse Event|1
4820914|NCT01175213|16620989|P2|IGSC, 10%/rHuPH20|site elected to exit study|0
4820915|NCT01175213|16620990|P1|IGSC, 10%/rHuPH20|site elected to exit study|3
4820916|NCT01175213|16620989|P2|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0
4820917|NCT01175213|16620990|P1|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6
4820918|NCT01175213|16620989|P2|IGSC, 10%/rHuPH20|bone marrow transplant|0
4820919|NCT01175213|16620990|P1|IGSC, 10%/rHuPH20|bone marrow transplant|1
4820920|NCT01175213|16620989|P2|IGSC, 10%/rHuPH20|Death|0
4820921|NCT01175213|16620990|P1|IGSC, 10%/rHuPH20|Death|1
4820922|NCT01175213|16620989|P2|IGSC, 10%/rHuPH20|Withdrawal by Subject|0
4820923|NCT01175213|16620990|P1|IGSC, 10%/rHuPH20|Withdrawal by Subject|4
4820924|NCT01175135|16621047|P4|Overall Study|Randomized But Not Treated|0
4820925|NCT01175135|16621048|P3|Overall Study|Randomized But Not Treated|1
4820926|NCT01175135|16621049|P2|Overall Study|Randomized But Not Treated|0
4820927|NCT01175135|16621050|P1|Overall Study|Randomized But Not Treated|0
4820928|NCT01175135|16621047|P4|Overall Study|Other|0
4820929|NCT01175135|16621048|P3|Overall Study|Other|3
4820930|NCT01175135|16621049|P2|Overall Study|Other|1
4820931|NCT01175135|16621050|P1|Overall Study|Other|3
4820932|NCT01175135|16621047|P4|Overall Study|Withdrawal by Subject|5
4820933|NCT01175135|16621048|P3|Overall Study|Withdrawal by Subject|5
4820934|NCT01175135|16621049|P2|Overall Study|Withdrawal by Subject|8
4820935|NCT01175135|16621050|P1|Overall Study|Withdrawal by Subject|4
4820936|NCT01175135|16621047|P4|Overall Study|Protocol Violation|0
4820937|NCT01175135|16621048|P3|Overall Study|Protocol Violation|0
4820938|NCT01175135|16621049|P2|Overall Study|Protocol Violation|1
4820939|NCT01175135|16621050|P1|Overall Study|Protocol Violation|1
4820940|NCT01175135|16621047|P4|Overall Study|Lost to Follow-up|0
4820941|NCT01175135|16621048|P3|Overall Study|Lost to Follow-up|0
4820942|NCT01175135|16621049|P2|Overall Study|Lost to Follow-up|2
4820943|NCT01175135|16621050|P1|Overall Study|Lost to Follow-up|1
4820944|NCT01175135|16621047|P4|Overall Study|Lack of Efficacy|5
4820945|NCT01175135|16621048|P3|Overall Study|Lack of Efficacy|0
4820946|NCT01175135|16621049|P2|Overall Study|Lack of Efficacy|5
4820947|NCT01175135|16621050|P1|Overall Study|Lack of Efficacy|4
4820948|NCT01175135|16621047|P4|Overall Study|Death|0
4820949|NCT01175135|16621048|P3|Overall Study|Death|0
4820950|NCT01175135|16621049|P2|Overall Study|Death|0
4820951|NCT01175135|16621050|P1|Overall Study|Death|1
4820952|NCT01175135|16621047|P4|Overall Study|Adverse Event|4
4820953|NCT01175135|16621048|P3|Overall Study|Adverse Event|3
4820954|NCT01175135|16621049|P2|Overall Study|Adverse Event|5
4820955|NCT01175135|16621050|P1|Overall Study|Adverse Event|2
4820956|NCT01175083|16621138|P6|Booster Epoch|Withdrawal by Subject|0
4820957|NCT01175083|16621139|P5|Booster Epoch|Withdrawal by Subject|0
4820958|NCT01175083|16621140|P4|Booster Epoch|Withdrawal by Subject|1
4820959|NCT01175083|16621141|P3|Booster Epoch|Withdrawal by Subject|0
4820960|NCT01175083|16621142|P2|Booster Epoch|Withdrawal by Subject|0
4820961|NCT01175083|16621143|P1|Booster Epoch|Withdrawal by Subject|0
4820962|NCT01175083|16621138|P6|Booster Epoch|Death|0
4820963|NCT01175083|16621139|P5|Booster Epoch|Death|0
4820964|NCT01175083|16621140|P4|Booster Epoch|Death|0
4820965|NCT01175083|16621141|P3|Booster Epoch|Death|1
4820966|NCT01175083|16621142|P2|Booster Epoch|Death|0
4820967|NCT01175083|16621143|P1|Booster Epoch|Death|0
4820968|NCT01175083|16621138|P6|Primary Epoch|Lost to Follow-up|1
4820969|NCT01175083|16621139|P5|Primary Epoch|Lost to Follow-up|0
4820970|NCT01175083|16621140|P4|Primary Epoch|Lost to Follow-up|0
4820971|NCT01175083|16621141|P3|Primary Epoch|Lost to Follow-up|0
4820972|NCT01175083|16621142|P2|Primary Epoch|Lost to Follow-up|0
4820973|NCT01175083|16621143|P1|Primary Epoch|Lost to Follow-up|0
4820974|NCT01175083|16621138|P6|Primary Epoch|Withdrawal by Subject|2
4820975|NCT01175083|16621139|P5|Primary Epoch|Withdrawal by Subject|0
4820976|NCT01175083|16621140|P4|Primary Epoch|Withdrawal by Subject|0
4820977|NCT01175083|16621141|P3|Primary Epoch|Withdrawal by Subject|0
4820978|NCT01175083|16621142|P2|Primary Epoch|Withdrawal by Subject|0
4820979|NCT01175083|16621143|P1|Primary Epoch|Withdrawal by Subject|0
4820980|NCT01175018|16621235|P2|Overall Study|Adverse Event|1
4820981|NCT01175018|16621236|P1|Overall Study|Adverse Event|3
4820982|NCT01174784|16621298|P1|Overall Study|Screen fails|4
4820983|NCT01174563|16621344|P1|Overall Study|Sponsor's decision|1
4820984|NCT01174563|16621344|P1|Overall Study|Rash Adverse Event|1
4820985|NCT01174563|16621344|P1|Overall Study|Participant Withdrew Consent|3
4820986|NCT01174563|16621344|P1|Overall Study|Investigator's Discretion|5
4820987|NCT01174563|16621344|P1|Overall Study|Death|5
4820988|NCT01174563|16621344|P1|Overall Study|Progressive Disease|45
4820989|NCT01174550|16621352|P2|Overall Study|Withdrawal by Subject|289
4820990|NCT01174550|16621353|P1|Overall Study|Withdrawal by Subject|543
4820991|NCT01174550|16621352|P2|Overall Study|Lost to Follow-up|510
4820992|NCT01174550|16621353|P1|Overall Study|Lost to Follow-up|652
4820993|NCT01174550|16621352|P2|Overall Study|Death|74
4820994|NCT01174550|16621353|P1|Overall Study|Death|75
4820995|NCT01174459|16621381|P1|Overall Study|case report form (CRF) not collected|5
4820996|NCT01174446|16621386|P4|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
4820997|NCT01174446|16621387|P3|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
4820998|NCT01174446|16621388|P2|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1
4820999|NCT01174446|16621389|P1|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0
4821000|NCT01174446|16621386|P4|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
4821001|NCT01174446|16621387|P3|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
4821002|NCT01174446|16621388|P2|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0
4821003|NCT01174446|16621389|P1|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1
4821004|NCT01174446|16621386|P4|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
4821005|NCT01174446|16621387|P3|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1
4821006|NCT01174446|16621388|P2|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
4821007|NCT01174446|16621389|P1|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0
4821008|NCT01174446|16621386|P4|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
4821009|NCT01174446|16621387|P3|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1
4821010|NCT01174446|16621388|P2|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
4821011|NCT01174446|16621389|P1|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0
4821012|NCT01174368|16621576|P1|Overall Study|Withdrawal by Subject|1
4821013|NCT01174342|16621582|P1|Overall Study|Conversion to cesarean section|4
4821014|NCT01174264|16621589|P3|Steady-state Pharmacokinetics|Not evaluable|2
4821015|NCT01174264|16621590|P2|Steady-state Pharmacokinetics|Not evaluable|0
4821016|NCT01174264|16621591|P1|Steady-state Pharmacokinetics|Not evaluable|6
4821017|NCT01174264|16621589|P3|Single Dose Pharmacokinetics|Patient entered hospice care|1
4821018|NCT01174264|16621590|P2|Single Dose Pharmacokinetics|Patient entered hospice care|0
4821019|NCT01174264|16621591|P1|Single Dose Pharmacokinetics|Patient entered hospice care|0
4821020|NCT01174264|16621589|P3|Single Dose Pharmacokinetics|Early progressive disease|1
4821021|NCT01174264|16621590|P2|Single Dose Pharmacokinetics|Early progressive disease|0
4821022|NCT01174264|16621591|P1|Single Dose Pharmacokinetics|Early progressive disease|1
4821023|NCT01174238|16621623|P1|Overall Study|Lost to Follow-up|2
4821024|NCT01174186|16621634|P2|Overall Study|Withdrawal by Subject|2
4821025|NCT01174186|16621635|P1|Overall Study|Withdrawal by Subject|0
4821026|NCT01174186|16621634|P2|Overall Study|Lost to Follow-up|1
4821027|NCT01174186|16621635|P1|Overall Study|Lost to Follow-up|0
4821028|NCT01174173|16621642|P1|Overall Study|drug-drug interaction|1
4821029|NCT01174160|16621653|P2|Overall Study|Withdrawal by Subject|0
4821030|NCT01174160|16621654|P1|Overall Study|Withdrawal by Subject|1
4821031|NCT01174160|16621653|P2|Overall Study|Protocol Violation|6
4821032|NCT01174160|16621654|P1|Overall Study|Protocol Violation|4
4821033|NCT01174160|16621653|P2|Overall Study|Physician Decision|0
4821034|NCT01174160|16621654|P1|Overall Study|Physician Decision|1
4821035|NCT01174160|16621653|P2|Overall Study|Lost to Follow-up|0
4821036|NCT01174160|16621654|P1|Overall Study|Lost to Follow-up|1
4821037|NCT01174160|16621653|P2|Overall Study|Adverse Event|0
4821038|NCT01174160|16621654|P1|Overall Study|Adverse Event|1
4821039|NCT01174043|16621669|P1|Overall Study|Withdrawal by Subject|2
4821040|NCT01174043|16621669|P1|Overall Study|Death|1
4821041|NCT01174043|16621669|P1|Overall Study|Adverse Event|3
4821042|NCT01174043|16621669|P1|Overall Study|Disease progression|5
4821043|NCT01174004|16621708|P2|Overall Study|Physician Decision|0
4821044|NCT01174004|16621709|P1|Overall Study|Physician Decision|1
4821045|NCT01174004|16621708|P2|Overall Study|Protocol Violation|1
4821046|NCT01174004|16621709|P1|Overall Study|Protocol Violation|0
4821047|NCT01174004|16621708|P2|Overall Study|At Discretion of Sponsor|2
4821048|NCT01174004|16621709|P1|Overall Study|At Discretion of Sponsor|2
4821049|NCT01174004|16621708|P2|Overall Study|Withdrawal by Subject|3
4821050|NCT01174004|16621709|P1|Overall Study|Withdrawal by Subject|2
4821051|NCT01174004|16621708|P2|Overall Study|Adverse Event|10
4821052|NCT01174004|16621709|P1|Overall Study|Adverse Event|2
4821053|NCT01173718|16621740|P1|Overall Study|Abandonment of study graft|27
4821054|NCT01173718|16621740|P1|Overall Study|Death|17
4821055|NCT01173679|16621749|P1|Overall Study|Death|1
4821056|NCT01173653|16621757|P2|Overall Study|Pts unwilling to provide follow-up|41
4821057|NCT01173653|16621758|P1|Overall Study|Pts unwilling to provide follow-up|53
4821058|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6
4821059|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2
4821060|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4821061|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4821062|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0
4821063|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24
4821064|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5
4821065|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7
4821066|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9
4821067|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0
4821068|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4821069|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4
4821070|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5
4821071|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1
4821072|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0
4821073|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1
4821074|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
4821075|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4821076|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2
4821077|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0
4821078|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9
4821079|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2
4821080|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4821081|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3
4821082|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0
4821083|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9
4821084|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8
4821085|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6
4821086|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10
4821087|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0
4821088|NCT01173601|16621768|P5|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14
4821089|NCT01173601|16621769|P4|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7
4821090|NCT01173601|16621770|P3|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15
4821091|NCT01173601|16621771|P2|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10
4821092|NCT01173601|16621772|P1|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0
4821093|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4821094|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4821095|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4821096|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0
4821097|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6
4821098|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4821099|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4821100|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4821101|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0
4821102|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25
4821103|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4821104|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4821105|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4821106|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0
4821107|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15
4821108|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4821109|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4821110|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4821111|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0
4821112|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3
4821113|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4821114|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4821115|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4821116|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0
4821117|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7
4821118|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4821119|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4821120|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4821121|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0
4821122|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9
4821123|NCT01173601|16621768|P5|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4821124|NCT01173601|16621769|P4|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4821125|NCT01173601|16621770|P3|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4821126|NCT01173601|16621771|P2|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0
4821127|NCT01173601|16621772|P1|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23
4821128|NCT01173523|16621849|P2|Overall Study|Other|3
4821129|NCT01173523|16621850|P1|Overall Study|Other|2
4821130|NCT01173523|16621849|P2|Overall Study|Progressive Disease|8
4821131|NCT01173523|16621850|P1|Overall Study|Progressive Disease|10
4821132|NCT01173523|16621849|P2|Overall Study|Clinical Progression|1
4821133|NCT01173523|16621850|P1|Overall Study|Clinical Progression|1
4821134|NCT01173471|16621866|P4|Overall Study|Reason given as Other|0
4821135|NCT01173471|16621867|P3|Overall Study|Reason given as Other|1
4821136|NCT01173471|16621868|P2|Overall Study|Reason given as Other|0
4821137|NCT01173471|16621869|P1|Overall Study|Reason given as Other|0
4821138|NCT01173471|16621866|P4|Overall Study|Lost to Follow-up|0
4821139|NCT01173471|16621867|P3|Overall Study|Lost to Follow-up|1
4821140|NCT01173471|16621868|P2|Overall Study|Lost to Follow-up|0
4821141|NCT01173471|16621869|P1|Overall Study|Lost to Follow-up|0
4821142|NCT01173471|16621866|P4|Overall Study|Condition under investigation worsened|0
4821143|NCT01173471|16621867|P3|Overall Study|Condition under investigation worsened|0
4821144|NCT01173471|16621868|P2|Overall Study|Condition under investigation worsened|0
4821145|NCT01173471|16621869|P1|Overall Study|Condition under investigation worsened|2
4821146|NCT01173471|16621866|P4|Overall Study|Eligibility criteria not fulfilled|1
4821147|NCT01173471|16621867|P3|Overall Study|Eligibility criteria not fulfilled|1
4821148|NCT01173471|16621868|P2|Overall Study|Eligibility criteria not fulfilled|0
4821149|NCT01173471|16621869|P1|Overall Study|Eligibility criteria not fulfilled|0
4821150|NCT01173120|16622009|P1|Overall Study|Switch-Difficulty With Device|12
4821151|NCT01173120|16622009|P1|Overall Study|Switch-Participant Decision|12
4821152|NCT01173120|16622009|P1|Overall Study|Switch-Administrative Reason By Sponsor|33
4821153|NCT01173120|16622009|P1|Overall Study|Participant Decision|2
4821154|NCT01173120|16622009|P1|Overall Study|Lost to Follow-up|1
4821155|NCT01173120|16622009|P1|Overall Study|Lack of Efficacy|2
4821156|NCT01173055|16622027|P2|Period 2 - Day 64 to 112|Adverse Event|1
4821157|NCT01173055|16622028|P1|Period 2 - Day 64 to 112|Adverse Event|0
4821158|NCT01173055|16622027|P2|Period 1 - Day 1 to 49|Withdrawal by Subject|2
4821159|NCT01173055|16622028|P1|Period 1 - Day 1 to 49|Withdrawal by Subject|2
4821160|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1
4821161|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821162|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821163|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821164|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821165|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821166|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821167|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821168|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0
4821169|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821170|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821171|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821172|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821173|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821174|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821175|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1
4821176|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821177|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0
4821178|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Death|0
4821179|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Death|0
4821180|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Death|0
4821181|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Death|0
4821182|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Death|0
4821183|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Death|0
4821184|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Death|1
4821185|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Death|0
4821186|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Death|0
4821187|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4821188|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1
4821189|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4821190|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4821191|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4821192|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4821193|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3
4821194|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2
4821195|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0
4821196|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821197|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
4821198|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821199|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821200|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821201|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821202|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821203|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1
4821204|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0
4821205|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821206|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821207|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821208|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821209|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821210|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821211|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2
4821212|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821213|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0
4821214|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
4821215|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
4821216|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4821217|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4821218|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4821219|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4821220|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1
4821221|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4821222|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0
4821223|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821224|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1
4821225|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821226|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821227|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821228|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821229|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821230|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821231|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0
4821232|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
4821233|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821234|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821235|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821236|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821237|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821238|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1
4821239|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821240|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0
4821241|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
4821242|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
4821243|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4821244|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4821245|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4821246|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4821247|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2
4821248|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4
4821249|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0
4821250|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2
4821251|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3
4821252|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4821253|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4821254|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4821255|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4821256|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
4821257|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1
4821258|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0
4821259|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4821260|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3
4821261|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4821262|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4821263|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4821264|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4821265|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1
4821266|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4
4821267|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0
4821268|NCT01172938|16622079|P9|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821269|NCT01172938|16622080|P8|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821270|NCT01172938|16622081|P7|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821271|NCT01172938|16622082|P6|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821272|NCT01172938|16622083|P5|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821273|NCT01172938|16622084|P4|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821274|NCT01172938|16622085|P3|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2
4821275|NCT01172938|16622086|P2|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821276|NCT01172938|16622087|P1|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0
4821277|NCT01172938|16622079|P9|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821278|NCT01172938|16622080|P8|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821279|NCT01172938|16622081|P7|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821280|NCT01172938|16622082|P6|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821281|NCT01172938|16622083|P5|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821282|NCT01172938|16622084|P4|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821283|NCT01172938|16622085|P3|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821284|NCT01172938|16622086|P2|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1
4821285|NCT01172938|16622087|P1|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0
4821286|NCT01172938|16622079|P9|Active-Treatment Phase Weeks (104-156)|Death|0
4821287|NCT01172938|16622080|P8|Active-Treatment Phase Weeks (104-156)|Death|1
4821288|NCT01172938|16622081|P7|Active-Treatment Phase Weeks (104-156)|Death|0
4821289|NCT01172938|16622082|P6|Active-Treatment Phase Weeks (104-156)|Death|0
4821290|NCT01172938|16622083|P5|Active-Treatment Phase Weeks (104-156)|Death|0
4821291|NCT01172938|16622084|P4|Active-Treatment Phase Weeks (104-156)|Death|0
4821292|NCT01172938|16622085|P3|Active-Treatment Phase Weeks (104-156)|Death|0
4821293|NCT01172938|16622086|P2|Active-Treatment Phase Weeks (104-156)|Death|0
4821294|NCT01172938|16622087|P1|Active-Treatment Phase Weeks (104-156)|Death|0
4821295|NCT01172938|16622079|P9|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1
4821296|NCT01172938|16622080|P8|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2
4821297|NCT01172938|16622081|P7|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4821298|NCT01172938|16622082|P6|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4821299|NCT01172938|16622083|P5|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4821300|NCT01172938|16622084|P4|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4821301|NCT01172938|16622085|P3|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3
4821302|NCT01172938|16622086|P2|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6
4821303|NCT01172938|16622087|P1|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0
4821304|NCT01172938|16622079|P9|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
4821305|NCT01172938|16622080|P8|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
4821306|NCT01172938|16622081|P7|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4821307|NCT01172938|16622082|P6|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4821308|NCT01172938|16622083|P5|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4821309|NCT01172938|16622084|P4|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4821310|NCT01172938|16622085|P3|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2
4821311|NCT01172938|16622086|P2|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4
4821312|NCT01172938|16622087|P1|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0
4821313|NCT01172938|16622079|P9|Active-Treatment Phase Weeks (104-156)|Adverse Event|1
4821314|NCT01172938|16622080|P8|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821315|NCT01172938|16622081|P7|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821316|NCT01172938|16622082|P6|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821317|NCT01172938|16622083|P5|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821318|NCT01172938|16622084|P4|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821319|NCT01172938|16622085|P3|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821320|NCT01172938|16622086|P2|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821321|NCT01172938|16622087|P1|Active-Treatment Phase Weeks (104-156)|Adverse Event|0
4821322|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821323|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821324|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821325|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821326|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821327|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821328|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821329|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Missing|1
4821330|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Missing|0
4821331|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1
4821332|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821333|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821334|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821335|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821336|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821337|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821338|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2
4821339|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0
4821340|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4821341|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3
4821342|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4821343|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4821344|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4821345|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4821346|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
4821347|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1
4821348|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0
4821349|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Death|0
4821350|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Death|0
4821351|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Death|0
4821352|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Death|0
4821353|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Death|0
4821354|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Death|0
4821355|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Death|1
4821356|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Death|0
4821357|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Death|0
4821358|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2
4821359|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5
4821360|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4821361|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4821362|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4821363|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4821364|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8
4821365|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10
4821366|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0
4821367|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821368|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821369|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821370|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821371|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821372|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821373|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2
4821374|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821375|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0
4821376|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4821377|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4
4821378|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4821379|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4821380|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4821381|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4821382|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8
4821383|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7
4821384|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0
4821385|NCT01172938|16622079|P9|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
4821386|NCT01172938|16622080|P8|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3
4821387|NCT01172938|16622081|P7|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4821388|NCT01172938|16622082|P6|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4821389|NCT01172938|16622083|P5|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4821390|NCT01172938|16622084|P4|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4821391|NCT01172938|16622085|P3|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1
4821392|NCT01172938|16622086|P2|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2
4821393|NCT01172938|16622087|P1|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0
4821394|NCT01172938|16622079|P9|Active Treatment Phase (Weeks 25-52)|Other|0
4821395|NCT01172938|16622080|P8|Active Treatment Phase (Weeks 25-52)|Other|0
4821396|NCT01172938|16622081|P7|Active Treatment Phase (Weeks 25-52)|Other|1
4821397|NCT01172938|16622082|P6|Active Treatment Phase (Weeks 25-52)|Other|1
4821398|NCT01172938|16622083|P5|Active Treatment Phase (Weeks 25-52)|Other|0
4821399|NCT01172938|16622084|P4|Active Treatment Phase (Weeks 25-52)|Other|0
4821400|NCT01172938|16622085|P3|Active Treatment Phase (Weeks 25-52)|Other|0
4821401|NCT01172938|16622086|P2|Active Treatment Phase (Weeks 25-52)|Other|0
4821402|NCT01172938|16622087|P1|Active Treatment Phase (Weeks 25-52)|Other|0
4821403|NCT01172938|16622079|P9|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4821404|NCT01172938|16622080|P8|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4821405|NCT01172938|16622081|P7|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4821406|NCT01172938|16622082|P6|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4821407|NCT01172938|16622083|P5|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4821408|NCT01172938|16622084|P4|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
4821409|NCT01172938|16622085|P3|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
4821410|NCT01172938|16622086|P2|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1
4821411|NCT01172938|16622087|P1|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0
4821412|NCT01172938|16622079|P9|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
4821413|NCT01172938|16622080|P8|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
4821414|NCT01172938|16622081|P7|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
4821415|NCT01172938|16622082|P6|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9
4821416|NCT01172938|16622083|P5|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
4821417|NCT01172938|16622084|P4|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2
4821418|NCT01172938|16622085|P3|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1
4821419|NCT01172938|16622086|P2|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5
4821420|NCT01172938|16622087|P1|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0
4821421|NCT01172938|16622079|P9|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821422|NCT01172938|16622080|P8|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821423|NCT01172938|16622081|P7|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821424|NCT01172938|16622082|P6|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821425|NCT01172938|16622083|P5|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821426|NCT01172938|16622084|P4|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821427|NCT01172938|16622085|P3|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1
4821428|NCT01172938|16622086|P2|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821429|NCT01172938|16622087|P1|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0
4821430|NCT01172938|16622079|P9|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4821431|NCT01172938|16622080|P8|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4821432|NCT01172938|16622081|P7|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4821433|NCT01172938|16622082|P6|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
4821434|NCT01172938|16622083|P5|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1
4821435|NCT01172938|16622084|P4|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3
4821436|NCT01172938|16622085|P3|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7
4821437|NCT01172938|16622086|P2|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4
4821438|NCT01172938|16622087|P1|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0
4821439|NCT01172938|16622079|P9|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4821440|NCT01172938|16622080|P8|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4821441|NCT01172938|16622081|P7|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4821442|NCT01172938|16622082|P6|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
4821443|NCT01172938|16622083|P5|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
4821444|NCT01172938|16622084|P4|Active Treatment Phase (Weeks 25-52)|Adverse Event|1
4821445|NCT01172938|16622085|P3|Active Treatment Phase (Weeks 25-52)|Adverse Event|5
4821446|NCT01172938|16622086|P2|Active Treatment Phase (Weeks 25-52)|Adverse Event|2
4821447|NCT01172938|16622087|P1|Active Treatment Phase (Weeks 25-52)|Adverse Event|0
4821448|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Other|0
4821449|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Other|0
4821450|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Other|0
4821451|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Other|0
4821452|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Other|0
4821453|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Other|0
4821454|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Other|1
4821455|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Other|2
4821456|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Other|0
4821457|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821458|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821459|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821460|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821461|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821462|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821463|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821464|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0
4821465|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1
4821466|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Death|0
4821467|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Death|0
4821468|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Death|0
4821469|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Death|0
4821470|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Death|0
4821471|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Death|0
4821472|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Death|0
4821473|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Death|1
4821474|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Death|0
4821475|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4821476|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4821477|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4821478|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4821479|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4821480|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0
4821481|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3
4821482|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5
4821483|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2
4821484|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821485|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821486|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821487|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821488|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821489|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821490|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2
4821491|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1
4821492|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0
4821493|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4821494|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4821495|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4821496|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4821497|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4821498|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0
4821499|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
4821500|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5
4821501|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4
4821502|NCT01172938|16622079|P9|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4821503|NCT01172938|16622080|P8|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4821504|NCT01172938|16622081|P7|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4821505|NCT01172938|16622082|P6|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4821506|NCT01172938|16622083|P5|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4821507|NCT01172938|16622084|P4|Placebo-controlled Phase (Week 0-24)|Adverse Event|0
4821508|NCT01172938|16622085|P3|Placebo-controlled Phase (Week 0-24)|Adverse Event|10
4821509|NCT01172938|16622086|P2|Placebo-controlled Phase (Week 0-24)|Adverse Event|8
4821510|NCT01172938|16622087|P1|Placebo-controlled Phase (Week 0-24)|Adverse Event|11
4821511|NCT01172873|16622273|P2|Overall Study|Withdrawal by Subject|2
4821512|NCT01172873|16622274|P1|Overall Study|Withdrawal by Subject|3
4821513|NCT01172847|16622284|P1|Overall Study|Withdrawal by Subject|3
4821514|NCT01172821|16622313|P4|Overall Study|Other|3
4821515|NCT01172821|16622314|P3|Overall Study|Other|5
4821516|NCT01172821|16622315|P2|Overall Study|Other|4
4821517|NCT01172821|16622316|P1|Overall Study|Other|3
4821518|NCT01172821|16622313|P4|Overall Study|Withdrawal by Subject|3
4821519|NCT01172821|16622314|P3|Overall Study|Withdrawal by Subject|3
4821520|NCT01172821|16622315|P2|Overall Study|Withdrawal by Subject|3
4821521|NCT01172821|16622316|P1|Overall Study|Withdrawal by Subject|2
4821522|NCT01172821|16622313|P4|Overall Study|Lost to Follow-up|2
4821523|NCT01172821|16622314|P3|Overall Study|Lost to Follow-up|2
4821524|NCT01172821|16622315|P2|Overall Study|Lost to Follow-up|1
4821525|NCT01172821|16622316|P1|Overall Study|Lost to Follow-up|4
4821526|NCT01172821|16622313|P4|Overall Study|Protocol Violation|2
4821527|NCT01172821|16622314|P3|Overall Study|Protocol Violation|1
4821528|NCT01172821|16622315|P2|Overall Study|Protocol Violation|2
4821529|NCT01172821|16622316|P1|Overall Study|Protocol Violation|0
4821530|NCT01172821|16622313|P4|Overall Study|Adverse Event|7
4821531|NCT01172821|16622314|P3|Overall Study|Adverse Event|2
4821532|NCT01172821|16622315|P2|Overall Study|Adverse Event|2
4821533|NCT01172821|16622316|P1|Overall Study|Adverse Event|5
4821534|NCT01172808|16622406|P4|Overall Study|Other|7
4821535|NCT01172808|16622407|P3|Overall Study|Other|9
4821536|NCT01172808|16622408|P2|Overall Study|Other|5
4821537|NCT01172808|16622409|P1|Overall Study|Other|6
4821538|NCT01172808|16622406|P4|Overall Study|Withdrawal by Subject|2
4821539|NCT01172808|16622407|P3|Overall Study|Withdrawal by Subject|3
4821540|NCT01172808|16622408|P2|Overall Study|Withdrawal by Subject|1
4821541|NCT01172808|16622409|P1|Overall Study|Withdrawal by Subject|4
4821542|NCT01172808|16622406|P4|Overall Study|Lost to Follow-up|3
4821543|NCT01172808|16622407|P3|Overall Study|Lost to Follow-up|1
4821544|NCT01172808|16622408|P2|Overall Study|Lost to Follow-up|1
4821545|NCT01172808|16622409|P1|Overall Study|Lost to Follow-up|0
4821546|NCT01172808|16622406|P4|Overall Study|Protocol Violation|0
4821547|NCT01172808|16622407|P3|Overall Study|Protocol Violation|2
4821548|NCT01172808|16622408|P2|Overall Study|Protocol Violation|2
4821549|NCT01172808|16622409|P1|Overall Study|Protocol Violation|2
4821550|NCT01172808|16622406|P4|Overall Study|Lack of Efficacy|0
4821551|NCT01172808|16622407|P3|Overall Study|Lack of Efficacy|0
4821552|NCT01172808|16622408|P2|Overall Study|Lack of Efficacy|0
4821553|NCT01172808|16622409|P1|Overall Study|Lack of Efficacy|1
4821554|NCT01172808|16622406|P4|Overall Study|Adverse Event|3
4821555|NCT01172808|16622407|P3|Overall Study|Adverse Event|8
4821556|NCT01172808|16622408|P2|Overall Study|Adverse Event|4
4821557|NCT01172808|16622409|P1|Overall Study|Adverse Event|8
4821558|NCT01172639|16622500|P5|Overall Study|Withdrawal by Subject|0
4821559|NCT01172639|16622501|P4|Overall Study|Withdrawal by Subject|5
4821560|NCT01172639|16622502|P3|Overall Study|Withdrawal by Subject|5
4821561|NCT01172639|16622503|P2|Overall Study|Withdrawal by Subject|3
4821562|NCT01172639|16622504|P1|Overall Study|Withdrawal by Subject|3
4821563|NCT01172639|16622500|P5|Overall Study|Lost to Follow-up|6
4821564|NCT01172639|16622501|P4|Overall Study|Lost to Follow-up|6
4821565|NCT01172639|16622502|P3|Overall Study|Lost to Follow-up|11
4821566|NCT01172639|16622503|P2|Overall Study|Lost to Follow-up|7
4821567|NCT01172639|16622504|P1|Overall Study|Lost to Follow-up|9
4821568|NCT01172639|16622500|P5|Overall Study|Death|0
4821569|NCT01172639|16622501|P4|Overall Study|Death|0
4821570|NCT01172639|16622502|P3|Overall Study|Death|0
4821571|NCT01172639|16622503|P2|Overall Study|Death|1
4821572|NCT01172639|16622504|P1|Overall Study|Death|1
4821573|NCT01172535|16622579|P1|Overall Study|Unwilling to adhere to study requirement|1
4821574|NCT01172535|16622579|P1|Overall Study|Ineligible at study entry|1
4821575|NCT01172535|16622579|P1|Overall Study|Lost to Follow-up|1
4821576|NCT01172535|16622579|P1|Overall Study|Withdrawal by Subject|2
4821577|NCT01172535|16622579|P1|Overall Study|Death|3
4821578|NCT01172288|16622632|P2|Overall Study|Protocol Violation|1
4821579|NCT01172288|16622633|P1|Overall Study|Protocol Violation|0
4821580|NCT01172288|16622632|P2|Overall Study|Adverse Event|0
4821581|NCT01172288|16622633|P1|Overall Study|Adverse Event|1
4821582|NCT01172275|16622649|P2|Overall Study|Protocol Violation|0
4821583|NCT01172275|16622650|P1|Overall Study|Protocol Violation|1
4821584|NCT01172275|16622649|P2|Overall Study|Lost to Follow-up|0
4821585|NCT01172275|16622650|P1|Overall Study|Lost to Follow-up|1
4821586|NCT01171989|16622708|P3|Overall Study|Lost to Follow-up|1
4821587|NCT01171989|16622709|P2|Overall Study|Lost to Follow-up|0
4821588|NCT01171989|16622710|P1|Overall Study|Lost to Follow-up|0
4821589|NCT01171976|16622784|P3|Overall Study|Adverse Event|5
4821590|NCT01171976|16622785|P2|Overall Study|Adverse Event|2
4821591|NCT01171976|16622786|P1|Overall Study|Adverse Event|6
4821592|NCT01171976|16622784|P3|Overall Study|Abnormal test result|0
4821593|NCT01171976|16622785|P2|Overall Study|Abnormal test result|0
4821594|NCT01171976|16622786|P1|Overall Study|Abnormal test result|1
4821595|NCT01171976|16622784|P3|Overall Study|Withdrawal by Subject|6
4821596|NCT01171976|16622785|P2|Overall Study|Withdrawal by Subject|5
4821597|NCT01171976|16622786|P1|Overall Study|Withdrawal by Subject|1
4821598|NCT01171976|16622784|P3|Overall Study|Lost to Follow-up|2
4821599|NCT01171976|16622785|P2|Overall Study|Lost to Follow-up|0
4821600|NCT01171976|16622786|P1|Overall Study|Lost to Follow-up|4
4821601|NCT01171976|16622784|P3|Overall Study|Death|1
4821602|NCT01171976|16622785|P2|Overall Study|Death|4
4821603|NCT01171976|16622786|P1|Overall Study|Death|2
4821604|NCT01171976|16622784|P3|Overall Study|Protocol Violation|1
4821605|NCT01171976|16622785|P2|Overall Study|Protocol Violation|0
4821606|NCT01171976|16622786|P1|Overall Study|Protocol Violation|0
4821607|NCT01171963|16622823|P2|Overall Study|Withdrawal by Subject|129
4821608|NCT01171963|16622824|P1|Overall Study|Withdrawal by Subject|114
4821609|NCT01171963|16622823|P2|Overall Study|Other - diarrhoea|0
4821610|NCT01171963|16622824|P1|Overall Study|Other - diarrhoea|1
4821611|NCT01171963|16622823|P2|Overall Study|Lost to Follow-up|24
4821612|NCT01171963|16622824|P1|Overall Study|Lost to Follow-up|23
4821613|NCT01171963|16622823|P2|Overall Study|Adverse Event|15
4821614|NCT01171963|16622824|P1|Overall Study|Adverse Event|10
4821615|NCT01171898|16622893|P4|Overall Study|Other|2
4821616|NCT01171898|16622894|P3|Overall Study|Other|0
4821617|NCT01171898|16622895|P2|Overall Study|Other|5
4821618|NCT01171898|16622896|P1|Overall Study|Other|1
4821619|NCT01171898|16622893|P4|Overall Study|Ongoing|0
4821620|NCT01171898|16622894|P3|Overall Study|Ongoing|3
4821621|NCT01171898|16622895|P2|Overall Study|Ongoing|9
4821622|NCT01171898|16622896|P1|Overall Study|Ongoing|1
4821623|NCT01171898|16622893|P4|Overall Study|Terminated by Sponsor|0
4821624|NCT01171898|16622894|P3|Overall Study|Terminated by Sponsor|0
4821625|NCT01171898|16622895|P2|Overall Study|Terminated by Sponsor|0
4821626|NCT01171898|16622896|P1|Overall Study|Terminated by Sponsor|1
4821627|NCT01171898|16622893|P4|Overall Study|Withdrawal by Subject|3
4821628|NCT01171898|16622894|P3|Overall Study|Withdrawal by Subject|6
4821629|NCT01171898|16622895|P2|Overall Study|Withdrawal by Subject|4
4821630|NCT01171898|16622896|P1|Overall Study|Withdrawal by Subject|1
4821631|NCT01171898|16622893|P4|Overall Study|Lost to Follow-up|1
4821632|NCT01171898|16622894|P3|Overall Study|Lost to Follow-up|1
4821633|NCT01171898|16622895|P2|Overall Study|Lost to Follow-up|1
4821634|NCT01171898|16622896|P1|Overall Study|Lost to Follow-up|0
4821635|NCT01171898|16622893|P4|Overall Study|Death|0
4821636|NCT01171898|16622894|P3|Overall Study|Death|2
4821637|NCT01171898|16622895|P2|Overall Study|Death|0
4821638|NCT01171898|16622896|P1|Overall Study|Death|0
4821639|NCT01171820|16622920|P2|Overall Study|1-Year Missed Visit|1
4821640|NCT01171820|16622921|P1|Overall Study|1-Year Missed Visit|1
4821641|NCT01171820|16622920|P2|Overall Study|Physician Decision|1
4821642|NCT01171820|16622921|P1|Overall Study|Physician Decision|0
4821643|NCT01171820|16622920|P2|Overall Study|Withdrawal by Subject|0
4821644|NCT01171820|16622921|P1|Overall Study|Withdrawal by Subject|2
4821645|NCT01171820|16622920|P2|Overall Study|Lost to Follow-up|1
4821646|NCT01171820|16622921|P1|Overall Study|Lost to Follow-up|0
4821647|NCT01171820|16622920|P2|Overall Study|Death|3
4821648|NCT01171820|16622921|P1|Overall Study|Death|3
4821649|NCT01171677|16622999|P2|Overall Study|completed <70% IntenSati classes|0
4821650|NCT01171677|16623000|P1|Overall Study|completed <70% IntenSati classes|5
4821651|NCT01171677|16622999|P2|Overall Study|Adverse Event|0
4821652|NCT01171677|16623000|P1|Overall Study|Adverse Event|1
4821653|NCT01171677|16622999|P2|Overall Study|Withdrawal by Subject|3
4821654|NCT01171677|16623000|P1|Overall Study|Withdrawal by Subject|0
4821655|NCT01171625|16623032|P1|Overall Study|Consented but did not receive device|25
4821656|NCT01171625|16623032|P1|Overall Study|Other|1
4821657|NCT01171625|16623032|P1|Overall Study|Patient received valve-in-valve|3
4821658|NCT01171625|16623032|P1|Overall Study|Lost to Follow-up|5
4821659|NCT01171625|16623032|P1|Overall Study|Explanted|10
4821660|NCT01171625|16623032|P1|Overall Study|Withdrawal by Subject|31
4821661|NCT01171625|16623032|P1|Overall Study|Death|38
4821662|NCT01171625|16623032|P1|Overall Study|On-Protocol|67
4821663|NCT01171612|16623065|P1|Overall Study|Lost to Follow-up|51
4821664|NCT01171534|16623075|P2|Overall Study|screen failure|1
4821665|NCT01171534|16623076|P1|Overall Study|screen failure|0
4821666|NCT01171534|16623075|P2|Overall Study|Lost to Follow-up|2
4821667|NCT01171534|16623076|P1|Overall Study|Lost to Follow-up|0
4821668|NCT01171521|16623088|P1|Overall Study|screen failure|1
4821669|NCT01171521|16623088|P1|Overall Study|Lost to Follow-up|5
4821670|NCT01171183|16623095|P2|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0
4821671|NCT01171183|16623096|P1|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1
4821672|NCT01171183|16623095|P2|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3
4821673|NCT01171183|16623096|P1|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7
4821674|NCT01171183|16623095|P2|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
4821675|NCT01171183|16623096|P1|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2
4821676|NCT01171183|16623095|P2|Residential Facility (Weeks 1-2)|BP outside of study parameters|3
4821677|NCT01171183|16623096|P1|Residential Facility (Weeks 1-2)|BP outside of study parameters|0
4821678|NCT01171183|16623095|P2|Residential Facility (Weeks 1-2)|Protocol Violation|1
4821679|NCT01171183|16623096|P1|Residential Facility (Weeks 1-2)|Protocol Violation|0
4821680|NCT01171183|16623095|P2|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
4821681|NCT01171183|16623096|P1|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2
4821682|NCT01170962|16623117|P3|Follow up Period|Others|3
4821683|NCT01170962|16623118|P2|Follow up Period|Others|7
4821684|NCT01170962|16623119|P1|Follow up Period|Others|10
4821685|NCT01170962|16623117|P3|Follow up Period|Death|0
4821686|NCT01170962|16623118|P2|Follow up Period|Death|2
4821687|NCT01170962|16623119|P1|Follow up Period|Death|2
4821688|NCT01170962|16623117|P3|Follow up Period|Lost to Follow-up|1
4821689|NCT01170962|16623118|P2|Follow up Period|Lost to Follow-up|8
4821690|NCT01170962|16623119|P1|Follow up Period|Lost to Follow-up|13
4821691|NCT01170962|16623117|P3|Follow up Period|Withdrawal by Subject|2
4821692|NCT01170962|16623118|P2|Follow up Period|Withdrawal by Subject|10
4821693|NCT01170962|16623119|P1|Follow up Period|Withdrawal by Subject|14
4821694|NCT01170962|16623117|P3|Treatment Period|Completed 24 Week treatment period only|0
4821695|NCT01170962|16623118|P2|Treatment Period|Completed 24 Week treatment period only|2
4821696|NCT01170962|16623119|P1|Treatment Period|Completed 24 Week treatment period only|10
4821697|NCT01170962|16623117|P3|Treatment Period|Request to discontinue treatment|1
4821698|NCT01170962|16623118|P2|Treatment Period|Request to discontinue treatment|3
4821699|NCT01170962|16623119|P1|Treatment Period|Request to discontinue treatment|7
4821700|NCT01170962|16623117|P3|Treatment Period|Participant no longer meets criteria|0
4821701|NCT01170962|16623118|P2|Treatment Period|Participant no longer meets criteria|1
4821702|NCT01170962|16623119|P1|Treatment Period|Participant no longer meets criteria|0
4821703|NCT01170962|16623117|P3|Treatment Period|Lost to Follow-up|1
4821704|NCT01170962|16623118|P2|Treatment Period|Lost to Follow-up|1
4821705|NCT01170962|16623119|P1|Treatment Period|Lost to Follow-up|1
4821706|NCT01170962|16623117|P3|Treatment Period|Withdrawal by Subject|0
4821707|NCT01170962|16623118|P2|Treatment Period|Withdrawal by Subject|1
4821708|NCT01170962|16623119|P1|Treatment Period|Withdrawal by Subject|2
4821709|NCT01170962|16623117|P3|Treatment Period|Adverse Event|3
4821710|NCT01170962|16623118|P2|Treatment Period|Adverse Event|12
4821711|NCT01170962|16623119|P1|Treatment Period|Adverse Event|11
4821712|NCT01170962|16623117|P3|Treatment Period|Lack of Efficacy|7
4821713|NCT01170962|16623118|P2|Treatment Period|Lack of Efficacy|91
4821714|NCT01170962|16623119|P1|Treatment Period|Lack of Efficacy|96
4821715|NCT01170663|16623214|P2|Overall Study|Withdrawal of consent without follow-up|11
4821716|NCT01170663|16623215|P1|Overall Study|Withdrawal of consent without follow-up|11
4821717|NCT01170663|16623214|P2|Overall Study|Lost to Follow-up|9
4821718|NCT01170663|16623215|P1|Overall Study|Lost to Follow-up|3
4821719|NCT01170598|16623243|P1|Overall Study|Refused|1
4821720|NCT01170598|16623243|P1|Overall Study|Lost to Follow-up|1
4821721|NCT01170598|16623243|P1|Overall Study|Death|3
4821722|NCT01170598|16623243|P1|Overall Study|Withdrawal by Subject|1
4821723|NCT01170364|16623306|P2|Overall Study|Protocol Violation|1
4821724|NCT01170364|16623307|P1|Overall Study|Protocol Violation|4
4821725|NCT01170273|16623315|P2|Overall Study|Adverse Event|1
4821726|NCT01170273|16623316|P1|Overall Study|Adverse Event|0
4821727|NCT01170273|16623315|P2|Overall Study|Death|0
4821728|NCT01170273|16623316|P1|Overall Study|Death|1
4821729|NCT01170273|16623315|P2|Overall Study|Protocol Violation|0
4821730|NCT01170273|16623316|P1|Overall Study|Protocol Violation|1
4821731|NCT01170273|16623315|P2|Overall Study|Lost to Follow-up|8
4821732|NCT01170273|16623316|P1|Overall Study|Lost to Follow-up|6
4821733|NCT01170221|16623333|P2|Overall Study|Randomized but not treated|0
4821734|NCT01170221|16623334|P1|Overall Study|Randomized but not treated|1
4821735|NCT01170221|16623333|P2|Overall Study|Subject completed only screening and LFU|0
4821736|NCT01170221|16623334|P1|Overall Study|Subject completed only screening and LFU|1
4821737|NCT01170221|16623333|P2|Overall Study|Withdrawal by Subject|7
4821738|NCT01170221|16623334|P1|Overall Study|Withdrawal by Subject|9
4821739|NCT01170221|16623333|P2|Overall Study|Lost to Follow-up|21
4821740|NCT01170221|16623334|P1|Overall Study|Lost to Follow-up|22
4821741|NCT01170208|16623357|P3|Overall Study|Protocol Violation|1
4821742|NCT01170208|16623358|P2|Overall Study|Protocol Violation|0
4821743|NCT01170208|16623359|P1|Overall Study|Protocol Violation|1
4821744|NCT01170208|16623357|P3|Overall Study|Withdrawal by Subject|1
4821745|NCT01170208|16623358|P2|Overall Study|Withdrawal by Subject|0
4821746|NCT01170208|16623359|P1|Overall Study|Withdrawal by Subject|5
4821747|NCT01170091|16623387|P1|Overall Study|Treatment duration is less than 4 weeks|21
4821748|NCT01170091|16623387|P1|Overall Study|Missing efficacy evaluation|3
4821749|NCT01170065|16623397|P3|Overall Study|Ongoing after planned observation time|10
4821750|NCT01170065|16623398|P2|Overall Study|Ongoing after planned observation time|26
4821751|NCT01170065|16623399|P1|Overall Study|Ongoing after planned observation time|5
4821752|NCT01170065|16623397|P3|Overall Study|Reason other than specified|3
4821753|NCT01170065|16623398|P2|Overall Study|Reason other than specified|8
4821754|NCT01170065|16623399|P1|Overall Study|Reason other than specified|3
4821755|NCT01170065|16623397|P3|Overall Study|Consent withdrawn, not due to AE|2
4821756|NCT01170065|16623398|P2|Overall Study|Consent withdrawn, not due to AE|4
4821757|NCT01170065|16623399|P1|Overall Study|Consent withdrawn, not due to AE|2
4821758|NCT01170065|16623397|P3|Overall Study|Lost to Follow-up|1
4821759|NCT01170065|16623398|P2|Overall Study|Lost to Follow-up|4
4821760|NCT01170065|16623399|P1|Overall Study|Lost to Follow-up|1
4821761|NCT01170065|16623397|P3|Overall Study|Adverse Event|10
4821762|NCT01170065|16623398|P2|Overall Study|Adverse Event|50
4821763|NCT01170065|16623399|P1|Overall Study|Adverse Event|17
4821764|NCT01170039|16623430|P2|Overall Study|Lack of funding, drug not available|3
4821765|NCT01170039|16623431|P1|Overall Study|Lack of funding, drug not available|3
4821766|NCT01170039|16623430|P2|Overall Study|Withdrawal by Subject|3
4821767|NCT01170039|16623431|P1|Overall Study|Withdrawal by Subject|5
4821768|NCT01169987|16623443|P1|Overall Study|Other|4
4821769|NCT01169987|16623443|P1|Overall Study|Lost to Follow-up|24
4821770|NCT01169987|16623443|P1|Overall Study|Withdrawal by Subject|3
4821771|NCT01169779|16623509|P2|Overall Study|Familial and personal reasons|3
4821772|NCT01169779|16623510|P1|Overall Study|Familial and personal reasons|3
4821773|NCT01169779|16623509|P2|Overall Study|Withdrawal by Subject|2
4821774|NCT01169779|16623510|P1|Overall Study|Withdrawal by Subject|3
4821775|NCT01169779|16623509|P2|Overall Study|Protocol Violation|1
4821776|NCT01169779|16623510|P1|Overall Study|Protocol Violation|1
4821777|NCT01169779|16623509|P2|Overall Study|Lack of Efficacy|0
4821778|NCT01169779|16623510|P1|Overall Study|Lack of Efficacy|1
4821779|NCT01169779|16623509|P2|Overall Study|Adverse Event|11
4821780|NCT01169779|16623510|P1|Overall Study|Adverse Event|3
4821781|NCT01169701|16623545|P2|Overall Study|Sponsor decision|1
4821782|NCT01169701|16623546|P1|Overall Study|Sponsor decision|0
4821783|NCT01169701|16623545|P2|Overall Study|Serious adverse event|1
4821784|NCT01169701|16623546|P1|Overall Study|Serious adverse event|0
4821785|NCT01169701|16623545|P2|Overall Study|Administrative problems|1
4821786|NCT01169701|16623546|P1|Overall Study|Administrative problems|0
4821787|NCT01169701|16623545|P2|Overall Study|Death|1
4821788|NCT01169701|16623546|P1|Overall Study|Death|0
4821789|NCT01169701|16623545|P2|Overall Study|Exclusion criteria|0
4821790|NCT01169701|16623546|P1|Overall Study|Exclusion criteria|2
4821791|NCT01169701|16623545|P2|Overall Study|Adverse Event|2
4821792|NCT01169701|16623546|P1|Overall Study|Adverse Event|1
4821793|NCT01169701|16623545|P2|Overall Study|Withdrawal by Subject|3
4821794|NCT01169701|16623546|P1|Overall Study|Withdrawal by Subject|1
4821795|NCT01169701|16623545|P2|Overall Study|Lost to Follow-up|1
4821796|NCT01169701|16623546|P1|Overall Study|Lost to Follow-up|1
4821797|NCT01169675|16623583|P5|Overall Study|Other Reason Not Defined Above|1
4821798|NCT01169675|16623584|P4|Overall Study|Other Reason Not Defined Above|1
4821799|NCT01169675|16623585|P3|Overall Study|Other Reason Not Defined Above|0
4821800|NCT01169675|16623586|P2|Overall Study|Other Reason Not Defined Above|0
4821801|NCT01169675|16623587|P1|Overall Study|Other Reason Not Defined Above|0
4821802|NCT01169675|16623583|P5|Overall Study|Withdrawal by Subject|2
4821803|NCT01169675|16623584|P4|Overall Study|Withdrawal by Subject|1
4821804|NCT01169675|16623585|P3|Overall Study|Withdrawal by Subject|0
4821805|NCT01169675|16623586|P2|Overall Study|Withdrawal by Subject|0
4821806|NCT01169675|16623587|P1|Overall Study|Withdrawal by Subject|1
4821807|NCT01169675|16623583|P5|Overall Study|Adverse Event|0
4821808|NCT01169675|16623584|P4|Overall Study|Adverse Event|0
4821809|NCT01169675|16623585|P3|Overall Study|Adverse Event|2
4821810|NCT01169675|16623586|P2|Overall Study|Adverse Event|1
4821811|NCT01169675|16623587|P1|Overall Study|Adverse Event|5
4821812|NCT01169675|16623583|P5|Overall Study|Dose Limiting Toxicity (DLT)|2
4821813|NCT01169675|16623584|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
4821814|NCT01169675|16623585|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
4821815|NCT01169675|16623586|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
4821816|NCT01169675|16623587|P1|Overall Study|Dose Limiting Toxicity (DLT)|1
4821817|NCT01169675|16623583|P5|Overall Study|Progressive disease|1
4821818|NCT01169675|16623584|P4|Overall Study|Progressive disease|15
4821819|NCT01169675|16623585|P3|Overall Study|Progressive disease|5
4821820|NCT01169675|16623586|P2|Overall Study|Progressive disease|2
4821821|NCT01169675|16623587|P1|Overall Study|Progressive disease|13
4821822|NCT01169649|16623624|P1|Overall Study|Patient Not Treated|3
4821823|NCT01169558|16623636|P1|Overall Study|Partial response|2
4821824|NCT01169558|16623636|P1|Overall Study|Protocol Violation|2
4821825|NCT01169558|16623636|P1|Overall Study|Non-compliance|2
4821826|NCT01169558|16623636|P1|Overall Study|Need for Surgery|4
4821827|NCT01169558|16623636|P1|Overall Study|Lost to Follow-up|4
4821828|NCT01169558|16623636|P1|Overall Study|Stable Disease|4
4821829|NCT01169558|16623636|P1|Overall Study|Medical Decision|7
4821830|NCT01169558|16623636|P1|Overall Study|Withdrawal of Consent|8
4821831|NCT01169558|16623636|P1|Overall Study|Adverse Event|25
4821832|NCT01169558|16623636|P1|Overall Study|Disease progression|98
4821833|NCT01169493|16623661|P6|Period 3 (6 Months)|Physician Decision|0
4821834|NCT01169493|16623662|P5|Period 3 (6 Months)|Physician Decision|0
4821835|NCT01169493|16623663|P4|Period 3 (6 Months)|Physician Decision|0
4821836|NCT01169493|16623664|P3|Period 3 (6 Months)|Physician Decision|1
4821837|NCT01169493|16623665|P2|Period 3 (6 Months)|Physician Decision|1
4821838|NCT01169493|16623666|P1|Period 3 (6 Months)|Physician Decision|0
4821839|NCT01169493|16623661|P6|Period 3 (6 Months)|Adverse Event|0
4821840|NCT01169493|16623662|P5|Period 3 (6 Months)|Adverse Event|0
4821841|NCT01169493|16623663|P4|Period 3 (6 Months)|Adverse Event|0
4821842|NCT01169493|16623664|P3|Period 3 (6 Months)|Adverse Event|0
4821843|NCT01169493|16623665|P2|Period 3 (6 Months)|Adverse Event|1
4821844|NCT01169493|16623666|P1|Period 3 (6 Months)|Adverse Event|0
4821845|NCT01169493|16623661|P6|Period 1 (6 Months)|Withdrawal by Subject|3
4821846|NCT01169493|16623662|P5|Period 1 (6 Months)|Withdrawal by Subject|0
4821847|NCT01169493|16623663|P4|Period 1 (6 Months)|Withdrawal by Subject|0
4821848|NCT01169493|16623664|P3|Period 1 (6 Months)|Withdrawal by Subject|2
4821849|NCT01169493|16623665|P2|Period 1 (6 Months)|Withdrawal by Subject|1
4821850|NCT01169493|16623666|P1|Period 1 (6 Months)|Withdrawal by Subject|0
4821851|NCT01169350|16623712|P1|Overall Study|Lost to Follow-up|2
4821852|NCT01169350|16623712|P1|Overall Study|Physician Decision|3
4821853|NCT01169103|16623850|P2|Overall Study|Withdrawal by Subject|1
4821854|NCT01169103|16623851|P1|Overall Study|Withdrawal by Subject|3
4821855|NCT01169103|16623850|P2|Overall Study|Lost to Follow-up|3
4821856|NCT01169103|16623851|P1|Overall Study|Lost to Follow-up|3
4821857|NCT01169038|16623878|P1|Overall Study|Required antibiotic administration|1
4821858|NCT01169038|16623878|P1|Overall Study|Adverse Event|5
4821859|NCT01169038|16623878|P1|Overall Study|Death|1
4821860|NCT01168999|16623886|P4|Overall Study|Lost to Follow-up|0
4821861|NCT01168999|16623887|P3|Overall Study|Lost to Follow-up|0
4821862|NCT01168999|16623888|P2|Overall Study|Lost to Follow-up|1
4821863|NCT01168999|16623889|P1|Overall Study|Lost to Follow-up|2
4821864|NCT01168973|16623955|P2|Overall Study|Protocol Criterion Not Met and Deviation|9
4821865|NCT01168973|16623956|P1|Overall Study|Protocol Criterion Not Met and Deviation|7
4821866|NCT01168973|16623955|P2|Overall Study|Sponsor Decision|1
4821867|NCT01168973|16623956|P1|Overall Study|Sponsor Decision|2
4821868|NCT01168973|16623955|P2|Overall Study|Physician Decision|19
4821869|NCT01168973|16623956|P1|Overall Study|Physician Decision|37
4821870|NCT01168973|16623955|P2|Overall Study|Death|45
4821871|NCT01168973|16623956|P1|Overall Study|Death|42
4821872|NCT01168973|16623955|P2|Overall Study|Withdrawal by Subject|53
4821873|NCT01168973|16623956|P1|Overall Study|Withdrawal by Subject|90
4821874|NCT01168973|16623955|P2|Overall Study|Adverse Event|55
4821875|NCT01168973|16623956|P1|Overall Study|Adverse Event|94
4821876|NCT01168973|16623955|P2|Overall Study|Progressive Disease|429
4821877|NCT01168973|16623956|P1|Overall Study|Progressive Disease|341
4821878|NCT01168856|16624031|P2|Overall Study|Protocol Violation|6
4821879|NCT01168856|16624032|P1|Overall Study|Protocol Violation|4
4821880|NCT01168856|16624031|P2|Overall Study|Other|291
4821881|NCT01168856|16624032|P1|Overall Study|Other|1
4821882|NCT01168856|16624031|P2|Overall Study|Death|2
4821883|NCT01168856|16624032|P1|Overall Study|Death|0
4821884|NCT01168856|16624031|P2|Overall Study|Participant received anti-HCV treatment|0
4821885|NCT01168856|16624032|P1|Overall Study|Participant received anti-HCV treatment|1
4821886|NCT01168856|16624031|P2|Overall Study|Confirmed Quantifiable HCV RNA|1
4821887|NCT01168856|16624032|P1|Overall Study|Confirmed Quantifiable HCV RNA|0
4821888|NCT01168856|16624031|P2|Overall Study|Physician Decision|1
4821889|NCT01168856|16624032|P1|Overall Study|Physician Decision|2
4821890|NCT01168856|16624031|P2|Overall Study|Withdrawal by Subject|8
4821891|NCT01168856|16624032|P1|Overall Study|Withdrawal by Subject|6
4821892|NCT01168856|16624031|P2|Overall Study|Lost to Follow-up|34
4821893|NCT01168856|16624032|P1|Overall Study|Lost to Follow-up|4
4821894|NCT01168596|16624130|P2|Overall Study|Withdrawal by Subject|1
4821895|NCT01168596|16624131|P1|Overall Study|Withdrawal by Subject|3
4821896|NCT01168427|16624175|P1|Overall Study|Patient exited prior to implant|1
4821897|NCT01168401|16624191|P11|Overall Study|Withdrawal by Subject|0
4821898|NCT01168401|16624192|P10|Overall Study|Withdrawal by Subject|0
4821899|NCT01168401|16624193|P9|Overall Study|Withdrawal by Subject|0
4821900|NCT01168401|16624194|P8|Overall Study|Withdrawal by Subject|0
4821901|NCT01168401|16624195|P7|Overall Study|Withdrawal by Subject|0
4821902|NCT01168401|16624196|P6|Overall Study|Withdrawal by Subject|0
4821903|NCT01168401|16624197|P5|Overall Study|Withdrawal by Subject|0
4821904|NCT01168401|16624198|P4|Overall Study|Withdrawal by Subject|1
4821905|NCT01168401|16624199|P3|Overall Study|Withdrawal by Subject|0
4821906|NCT01168401|16624200|P2|Overall Study|Withdrawal by Subject|0
4821907|NCT01168401|16624201|P1|Overall Study|Withdrawal by Subject|0
4821908|NCT01168401|16624191|P11|Overall Study|Lost to Follow-up|0
4821909|NCT01168401|16624192|P10|Overall Study|Lost to Follow-up|0
4821910|NCT01168401|16624193|P9|Overall Study|Lost to Follow-up|0
4821911|NCT01168401|16624194|P8|Overall Study|Lost to Follow-up|0
4821912|NCT01168401|16624195|P7|Overall Study|Lost to Follow-up|0
4821913|NCT01168401|16624196|P6|Overall Study|Lost to Follow-up|0
4821914|NCT01168401|16624197|P5|Overall Study|Lost to Follow-up|0
4821915|NCT01168401|16624198|P4|Overall Study|Lost to Follow-up|1
4821916|NCT01168401|16624199|P3|Overall Study|Lost to Follow-up|2
4821917|NCT01168401|16624200|P2|Overall Study|Lost to Follow-up|1
4821918|NCT01168401|16624201|P1|Overall Study|Lost to Follow-up|1
4821919|NCT01168349|16624434|P1|Overall Study|Protocol Violation|76
4821920|NCT01168349|16624434|P1|Overall Study|Other|22
4821921|NCT01168349|16624434|P1|Overall Study|Kidney transplantation|3
4821922|NCT01168349|16624434|P1|Overall Study|Withdrawal by Subject|9
4821923|NCT01168349|16624434|P1|Overall Study|Lost to Follow-up|34
4821924|NCT01168349|16624434|P1|Overall Study|Death|157
4821925|NCT01168232|16624540|P1|Overall Study|Ineligible-Inadequate pathology|1
4821926|NCT01168232|16624540|P1|Overall Study|Ineligible- Wrong cell type|6
4821927|NCT01168232|16624540|P1|Overall Study|Ineligible-Second primary cancer site|1
4821928|NCT01168219|16624547|P1|Overall Study|ineligible due to CML|2
4821929|NCT01168219|16624547|P1|Overall Study|withdrew before transplant|1
4821930|NCT01168219|16624547|P1|Overall Study|off study before starting treatment|2
4821931|NCT01167907|16624570|P2|Overall Study|saphenous catheter dislodged before comp|1
4821932|NCT01167907|16624571|P1|Overall Study|saphenous catheter dislodged before comp|1
4821933|NCT01167907|16624570|P2|Overall Study|Protocol Violation|0
4821934|NCT01167907|16624571|P1|Overall Study|Protocol Violation|1
4821935|NCT01167881|16624589|P2|Overall Study|Other not defined above|55
4821936|NCT01167881|16624590|P1|Overall Study|Other not defined above|31
4821937|NCT01167881|16624589|P2|Overall Study|Not treated|0
4821938|NCT01167881|16624590|P1|Overall Study|Not treated|4
4821939|NCT01167881|16624589|P2|Overall Study|Patient refusal to cont., not due to AE|40
4821940|NCT01167881|16624590|P1|Overall Study|Patient refusal to cont., not due to AE|45
4821941|NCT01167881|16624589|P2|Overall Study|Lost to Follow-up|20
4821942|NCT01167881|16624590|P1|Overall Study|Lost to Follow-up|19
4821943|NCT01167881|16624589|P2|Overall Study|Non compliant with protocol|18
4821944|NCT01167881|16624590|P1|Overall Study|Non compliant with protocol|9
4821945|NCT01167881|16624589|P2|Overall Study|Lack of Efficacy|7
4821946|NCT01167881|16624590|P1|Overall Study|Lack of Efficacy|4
4821947|NCT01167881|16624589|P2|Overall Study|Adverse Event|51
4821948|NCT01167881|16624590|P1|Overall Study|Adverse Event|47
4821949|NCT01167634|16624644|P4|Overall Study|Withdrawal by Subject|0
4821950|NCT01167634|16624645|P3|Overall Study|Withdrawal by Subject|0
4821951|NCT01167634|16624646|P2|Overall Study|Withdrawal by Subject|1
4821952|NCT01167634|16624647|P1|Overall Study|Withdrawal by Subject|1
4821953|NCT01167634|16624644|P4|Overall Study|Lost to Follow-up|4
4821954|NCT01167634|16624645|P3|Overall Study|Lost to Follow-up|3
4821955|NCT01167634|16624646|P2|Overall Study|Lost to Follow-up|3
4821956|NCT01167634|16624647|P1|Overall Study|Lost to Follow-up|1
4821957|NCT01167582|16624668|P2|Overall Study|Lost to Follow-up|1
4821958|NCT01167582|16624669|P1|Overall Study|Lost to Follow-up|0
4821959|NCT01167426|16624720|P1|Overall Study|Sponsor Decision|1
4821960|NCT01167426|16624720|P1|Overall Study|Withdrawal by Subject|2
4821961|NCT01167426|16624720|P1|Overall Study|Protocol Violation|1
4821962|NCT01167426|16624720|P1|Overall Study|Lost to Follow-up|6
4821963|NCT01167257|16624728|P2|Overall Study|Withdrew consent|1
4821964|NCT01167257|16624729|P1|Overall Study|Withdrew consent|1
4821965|NCT01167257|16624728|P2|Overall Study|Lost to Follow-up|2
4821966|NCT01167257|16624729|P1|Overall Study|Lost to Follow-up|2
4821967|NCT01167192|16624751|P1|Overall Study|Insurance denial|1
4821968|NCT01167192|16624751|P1|Overall Study|Withdrawal by Subject|1
4821969|NCT01167192|16624751|P1|Overall Study|Death|1
4821970|NCT01167192|16624751|P1|Overall Study|Adverse Event|1
4821971|NCT01167179|16624768|P2|Overall Study|diverse|5
4821972|NCT01167179|16624769|P1|Overall Study|diverse|6
4821973|NCT01167179|16624768|P2|Overall Study|Withdrawal by Subject|2
4821974|NCT01167179|16624769|P1|Overall Study|Withdrawal by Subject|1
4821975|NCT01167179|16624768|P2|Overall Study|Death|10
4821976|NCT01167179|16624769|P1|Overall Study|Death|4
4821977|NCT01167179|16624768|P2|Overall Study|disease recurrence|4
4821978|NCT01167179|16624769|P1|Overall Study|disease recurrence|4
4821979|NCT01167153|16624779|P2|Overall Study|Subject initiation withdrawal, Other|8
4821980|NCT01167153|16624780|P1|Overall Study|Subject initiation withdrawal, Other|5
4821981|NCT01167153|16624779|P2|Overall Study|Withdrawal consent|1
4821982|NCT01167153|16624780|P1|Overall Study|Withdrawal consent|1
4821983|NCT01167153|16624779|P2|Overall Study|Investigator initiation withdrawal,Other|1
4821984|NCT01167153|16624780|P1|Overall Study|Investigator initiation withdrawal,Other|1
4821985|NCT01167153|16624779|P2|Overall Study|Non-compliance to concomitant medication|2
4821986|NCT01167153|16624780|P1|Overall Study|Non-compliance to concomitant medication|0
4821987|NCT01167153|16624779|P2|Overall Study|Lost to Follow-up|9
4821988|NCT01167153|16624780|P1|Overall Study|Lost to Follow-up|7
4821989|NCT01167153|16624779|P2|Overall Study|Hypotension|0
4821990|NCT01167153|16624780|P1|Overall Study|Hypotension|1
4821991|NCT01167153|16624779|P2|Overall Study|AE including clinical laboratory AE|8
4821992|NCT01167153|16624780|P1|Overall Study|AE including clinical laboratory AE|2
4821993|NCT01167153|16624779|P2|Overall Study|Non-effective therapy|4
4821994|NCT01167153|16624780|P1|Overall Study|Non-effective therapy|1
4821995|NCT01167140|16624798|P1|Overall Study|Withdrawal by Subject|1
4821996|NCT01167023|16624806|P3|Overall Study|Withdrawal by Subject|1
4821997|NCT01167023|16624807|P2|Overall Study|Withdrawal by Subject|0
4821998|NCT01167023|16624808|P1|Overall Study|Withdrawal by Subject|0
4821999|NCT01167023|16624806|P3|Overall Study|Sponsor Decision|0
4822000|NCT01167023|16624807|P2|Overall Study|Sponsor Decision|1
4822001|NCT01167023|16624808|P1|Overall Study|Sponsor Decision|0
4822002|NCT01167023|16624806|P3|Overall Study|Screen Failure|0
4822003|NCT01167023|16624807|P2|Overall Study|Screen Failure|1
4822004|NCT01167023|16624808|P1|Overall Study|Screen Failure|0
4822005|NCT01167023|16624806|P3|Overall Study|Lost to Follow-up|1
4822006|NCT01167023|16624807|P2|Overall Study|Lost to Follow-up|1
4822007|NCT01167023|16624808|P1|Overall Study|Lost to Follow-up|0
4822008|NCT01166958|16624848|P2|Overall Study|Withdrawal by Subject|0
4822009|NCT01166958|16624849|P1|Overall Study|Withdrawal by Subject|1
4822010|NCT01166945|16624865|P2|Day 30|Lost to Follow-up|3
4822011|NCT01166945|16624866|P1|Day 30|Lost to Follow-up|4
4822012|NCT01166945|16624865|P2|Day 15|NonCompliance/Lost to Follow Up|1
4822013|NCT01166945|16624866|P1|Day 15|NonCompliance/Lost to Follow Up|2
4822014|NCT01166945|16624865|P2|Day 10|NonCompliance/Lost to Follow Up|2
4822015|NCT01166945|16624866|P1|Day 10|NonCompliance/Lost to Follow Up|3
4822016|NCT01166945|16624865|P2|Randomized|diagnosed with Group A strep|4
4822017|NCT01166945|16624866|P1|Randomized|diagnosed with Group A strep|4
4822018|NCT01166763|16624874|P1|Overall Study|Withdrawal by Subject|3
4822019|NCT01166750|16624882|P2|Overall Study|Lost to Follow-up|0
4822020|NCT01166750|16624883|P1|Overall Study|Lost to Follow-up|1
4822021|NCT01166659|16624900|P1|Overall Study|Study Closed at Site|1
4822022|NCT01166659|16624900|P1|Overall Study|Lost to Follow-up|1
4822023|NCT01166659|16624900|P1|Overall Study|Death|1
4822024|NCT01166659|16624900|P1|Overall Study|Investigator Decision|2
4822025|NCT01166659|16624900|P1|Overall Study|Subject Decision|8
4822026|NCT01166646|16624909|P2|Overall Study|Adverse Event|0
4822027|NCT01166646|16624910|P1|Overall Study|Adverse Event|1
4822028|NCT01166646|16624909|P2|Overall Study|Protocol Violation|1
4822029|NCT01166646|16624910|P1|Overall Study|Protocol Violation|0
4822030|NCT01166568|16624929|P3|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1
4822031|NCT01166568|16624930|P2|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0
4822032|NCT01166568|16624931|P1|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7
4822033|NCT01166568|16624929|P3|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0
4822034|NCT01166568|16624930|P2|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1
4822035|NCT01166568|16624931|P1|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7
4822036|NCT01166568|16624929|P3|Deferred Implantation- Randomized|Withdrawal by Subject|1
4822037|NCT01166568|16624930|P2|Deferred Implantation- Randomized|Withdrawal by Subject|0
4822038|NCT01166568|16624931|P1|Deferred Implantation- Randomized|Withdrawal by Subject|0
4822039|NCT01166438|16624944|P2|Off Treatment Follow-up Phase|Lack of Efficacy|52
4822040|NCT01166438|16624945|P1|Off Treatment Follow-up Phase|Lack of Efficacy|29
4822041|NCT01166438|16624944|P2|Off Treatment Follow-up Phase|Lost to Follow-up|2
4822042|NCT01166438|16624945|P1|Off Treatment Follow-up Phase|Lost to Follow-up|4
4822043|NCT01166438|16624944|P2|Off Treatment Follow-up Phase|Withdrawal by Subject|2
4822044|NCT01166438|16624945|P1|Off Treatment Follow-up Phase|Withdrawal by Subject|1
4822045|NCT01166438|16624944|P2|Double-blind Phase: 1st 6 Months|Not treated|1
4822046|NCT01166438|16624945|P1|Double-blind Phase: 1st 6 Months|Not treated|1
4822047|NCT01166438|16624944|P2|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4
4822048|NCT01166438|16624945|P1|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0
4822049|NCT01166438|16624944|P2|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4
4822050|NCT01166438|16624945|P1|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8
4822051|NCT01166373|16624963|P4|Overall Study|Physician Decision|0
4822052|NCT01166373|16624964|P3|Overall Study|Physician Decision|0
4822053|NCT01166373|16624965|P2|Overall Study|Physician Decision|0
4822054|NCT01166373|16624966|P1|Overall Study|Physician Decision|1
4822055|NCT01166373|16624963|P4|Overall Study|Withdrawal by Subject|3
4822056|NCT01166373|16624964|P3|Overall Study|Withdrawal by Subject|2
4822057|NCT01166373|16624965|P2|Overall Study|Withdrawal by Subject|2
4822058|NCT01166373|16624966|P1|Overall Study|Withdrawal by Subject|1
4822059|NCT01166373|16624963|P4|Overall Study|Lost to Follow-up|2
4822060|NCT01166373|16624964|P3|Overall Study|Lost to Follow-up|2
4822061|NCT01166373|16624965|P2|Overall Study|Lost to Follow-up|2
4822062|NCT01166373|16624966|P1|Overall Study|Lost to Follow-up|3
4822063|NCT01166282|16625099|P3|Open-label Period|Irregular Compliance|1
4822064|NCT01166282|16625100|P2|Open-label Period|Irregular Compliance|0
4822065|NCT01166282|16625101|P1|Open-label Period|Irregular Compliance|0
4822066|NCT01166282|16625099|P3|Open-label Period|Remission|4
4822067|NCT01166282|16625100|P2|Open-label Period|Remission|0
4822068|NCT01166282|16625101|P1|Open-label Period|Remission|0
4822069|NCT01166282|16625099|P3|Open-label Period|Lack of Efficacy|2
4822070|NCT01166282|16625100|P2|Open-label Period|Lack of Efficacy|0
4822071|NCT01166282|16625101|P1|Open-label Period|Lack of Efficacy|0
4822072|NCT01166282|16625099|P3|Open-label Period|Withdrawal by Subject|4
4822073|NCT01166282|16625100|P2|Open-label Period|Withdrawal by Subject|0
4822074|NCT01166282|16625101|P1|Open-label Period|Withdrawal by Subject|0
4822075|NCT01166282|16625099|P3|Open-label Period|Adverse Event|6
4822076|NCT01166282|16625100|P2|Open-label Period|Adverse Event|0
4822077|NCT01166282|16625101|P1|Open-label Period|Adverse Event|0
4822078|NCT01166178|16625140|P2|Overall Study|Study was terminated|8
4822079|NCT01166178|16625141|P1|Overall Study|Study was terminated|20
4822080|NCT01166178|16625140|P2|Overall Study|Withdrawal by Subject|0
4822081|NCT01166178|16625141|P1|Overall Study|Withdrawal by Subject|1
4822082|NCT01165996|16625180|P1|Overall Study|Physician Decision|1
4822083|NCT01165996|16625180|P1|Overall Study|Death|1
4822084|NCT01165684|16625251|P2|Overall Study|Unclassified|22
4822085|NCT01165684|16625252|P1|Overall Study|Unclassified|16
4822086|NCT01165684|16625251|P2|Overall Study|Withdrawal Criteria|13
4822087|NCT01165684|16625252|P1|Overall Study|Withdrawal Criteria|2
4822088|NCT01165684|16625251|P2|Overall Study|Protocol Violation|15
4822089|NCT01165684|16625252|P1|Overall Study|Protocol Violation|7
4822090|NCT01165684|16625251|P2|Overall Study|Lack of Efficacy|1
4822091|NCT01165684|16625252|P1|Overall Study|Lack of Efficacy|2
4822092|NCT01165684|16625251|P2|Overall Study|Adverse Event|1
4822093|NCT01165684|16625252|P1|Overall Study|Adverse Event|1
4822094|NCT01165554|16625286|P1|Overall Study|Withdrawal by Subject|23
4822095|NCT01165424|16625309|P1|Overall Study|Participant moved (relocated)|1
4822096|NCT01165424|16625309|P1|Overall Study|Did not meet entry criteria|1
4822097|NCT01165424|16625309|P1|Overall Study|Laboratory adverse experiences|1
4822098|NCT01165424|16625309|P1|Overall Study|Clinical adverse experiences|1
4822099|NCT01165320|16625316|P3|Overall Study|Reason unknown|0
4822100|NCT01165320|16625317|P2|Overall Study|Reason unknown|1
4822101|NCT01165320|16625318|P1|Overall Study|Reason unknown|0
4822102|NCT01165320|16625316|P3|Overall Study|Lack of Efficacy|0
4822103|NCT01165320|16625317|P2|Overall Study|Lack of Efficacy|2
4822104|NCT01165320|16625318|P1|Overall Study|Lack of Efficacy|0
4822105|NCT01165320|16625316|P3|Overall Study|Laboratory adverse experience|0
4822106|NCT01165320|16625317|P2|Overall Study|Laboratory adverse experience|0
4822107|NCT01165320|16625318|P1|Overall Study|Laboratory adverse experience|1
4822108|NCT01165320|16625316|P3|Overall Study|Clinical adverse experience|0
4822109|NCT01165320|16625317|P2|Overall Study|Clinical adverse experience|1
4822110|NCT01165320|16625318|P1|Overall Study|Clinical adverse experience|2
4822111|NCT01165307|16625328|P2|Overall Study|Subject not available for contact|0
4822112|NCT01165307|16625329|P1|Overall Study|Subject not available for contact|1
4822113|NCT01165307|16625328|P2|Overall Study|Withdrawal by Subject|0
4822114|NCT01165307|16625329|P1|Overall Study|Withdrawal by Subject|2
4822115|NCT01165307|16625328|P2|Overall Study|Lost to Follow-up|3
4822116|NCT01165307|16625329|P1|Overall Study|Lost to Follow-up|11
4822117|NCT01165281|16625359|P2|Overall Study|Other|0
4822118|NCT01165281|16625360|P1|Overall Study|Other|6
4822119|NCT01165281|16625359|P2|Overall Study|Progressive Disease|14
4822120|NCT01165281|16625360|P1|Overall Study|Progressive Disease|10
4822121|NCT01165281|16625359|P2|Overall Study|Noncompliance with Study Drug|4
4822122|NCT01165281|16625360|P1|Overall Study|Noncompliance with Study Drug|1
4822123|NCT01165281|16625359|P2|Overall Study|Withdrawal by Subject|7
4822124|NCT01165281|16625360|P1|Overall Study|Withdrawal by Subject|8
4822125|NCT01165281|16625359|P2|Overall Study|Protocol Violation|5
4822126|NCT01165281|16625360|P1|Overall Study|Protocol Violation|6
4822127|NCT01165281|16625359|P2|Overall Study|Physician Decision|1
4822128|NCT01165281|16625360|P1|Overall Study|Physician Decision|8
4822129|NCT01165281|16625359|P2|Overall Study|Lost to Follow-up|1
4822130|NCT01165281|16625360|P1|Overall Study|Lost to Follow-up|0
4822131|NCT01165281|16625359|P2|Overall Study|Lack of Efficacy|1
4822132|NCT01165281|16625360|P1|Overall Study|Lack of Efficacy|4
4822133|NCT01165281|16625359|P2|Overall Study|Death|4
4822134|NCT01165281|16625360|P1|Overall Study|Death|3
4822135|NCT01165281|16625359|P2|Overall Study|Adverse Event|14
4822136|NCT01165281|16625360|P1|Overall Study|Adverse Event|12
4822137|NCT01165242|16625381|P3|Overall Study|Lost to Follow-up|10
4822138|NCT01165242|16625382|P2|Overall Study|Lost to Follow-up|7
4822139|NCT01165242|16625383|P1|Overall Study|Lost to Follow-up|9
4822140|NCT01165242|16625381|P3|Overall Study|Extended Holiday|1
4822141|NCT01165242|16625382|P2|Overall Study|Extended Holiday|0
4822142|NCT01165242|16625383|P1|Overall Study|Extended Holiday|0
4822143|NCT01165242|16625381|P3|Overall Study|Withdrawal by Subject|2
4822144|NCT01165242|16625382|P2|Overall Study|Withdrawal by Subject|2
4822145|NCT01165242|16625383|P1|Overall Study|Withdrawal by Subject|0
4822146|NCT01165242|16625381|P3|Overall Study|Visit 2 Declined by Subject|1
4822147|NCT01165242|16625382|P2|Overall Study|Visit 2 Declined by Subject|0
4822148|NCT01165242|16625383|P1|Overall Study|Visit 2 Declined by Subject|0
4822149|NCT01165242|16625381|P3|Overall Study|Incarcerated Subjects|0
4822150|NCT01165242|16625382|P2|Overall Study|Incarcerated Subjects|1
4822151|NCT01165242|16625383|P1|Overall Study|Incarcerated Subjects|0
4822152|NCT01165242|16625381|P3|Overall Study|Unreachable Subjects|0
4822153|NCT01165242|16625382|P2|Overall Study|Unreachable Subjects|0
4822154|NCT01165242|16625383|P1|Overall Study|Unreachable Subjects|1
4822155|NCT01165229|16625417|P2|Overall Study|Unknown completion status|1
4822156|NCT01165229|16625418|P1|Overall Study|Unknown completion status|0
4822157|NCT01165229|16625417|P2|Overall Study|No reason from the subject|102
4822158|NCT01165229|16625418|P1|Overall Study|No reason from the subject|108
4822159|NCT01165229|16625417|P2|Overall Study|Suspected HZ Episode|2
4822160|NCT01165229|16625418|P1|Overall Study|Suspected HZ Episode|2
4822161|NCT01165229|16625417|P2|Overall Study|Lost to Follow-up|133
4822162|NCT01165229|16625418|P1|Overall Study|Lost to Follow-up|123
4822163|NCT01165229|16625417|P2|Overall Study|Migrated/moved from study area|46
4822164|NCT01165229|16625418|P1|Overall Study|Migrated/moved from study area|51
4822165|NCT01165229|16625417|P2|Overall Study|Withdrawal by Subject|396
4822166|NCT01165229|16625418|P1|Overall Study|Withdrawal by Subject|387
4822167|NCT01165229|16625417|P2|Overall Study|Protocol Violation|8
4822168|NCT01165229|16625418|P1|Overall Study|Protocol Violation|6
4822169|NCT01165229|16625417|P2|Overall Study|Non-Serious Adverse Event|15
4822170|NCT01165229|16625418|P1|Overall Study|Non-Serious Adverse Event|47
4822171|NCT01165229|16625417|P2|Overall Study|Serious Adverse Event|487
4822172|NCT01165229|16625418|P1|Overall Study|Serious Adverse Event|456
4822173|NCT01165216|16625552|P2|Overall Study|Disease progression|3
4822174|NCT01165216|16625553|P1|Overall Study|Disease progression|1
4822175|NCT01165216|16625552|P2|Overall Study|Withdrawal by Subject|1
4822176|NCT01165216|16625553|P1|Overall Study|Withdrawal by Subject|1
4822177|NCT01165216|16625552|P2|Overall Study|Adverse Event|3
4822178|NCT01165216|16625553|P1|Overall Study|Adverse Event|6
4822179|NCT01165203|16625575|P2|Extended Safety Follow-up Phase|Other-subjects business reasons|1
4822180|NCT01165203|16625576|P1|Extended Safety Follow-up Phase|Other-subjects business reasons|0
4822181|NCT01165203|16625575|P2|Extended Safety Follow-up Phase|Lost to Follow-up|0
4822182|NCT01165203|16625576|P1|Extended Safety Follow-up Phase|Lost to Follow-up|2
4822183|NCT01165203|16625575|P2|Extended Safety Follow-up Phase|Migrated/moved from study area|1
4822184|NCT01165203|16625576|P1|Extended Safety Follow-up Phase|Migrated/moved from study area|2
4822185|NCT01165203|16625575|P2|Extended Safety Follow-up Phase|Withdrawal by Subject|2
4822186|NCT01165203|16625576|P1|Extended Safety Follow-up Phase|Withdrawal by Subject|2
4822187|NCT01165203|16625575|P2|Extended Safety Follow-up Phase|Serious Adverse Event|0
4822188|NCT01165203|16625576|P1|Extended Safety Follow-up Phase|Serious Adverse Event|1
4822189|NCT01165203|16625575|P2|Active Phase|Lost to Follow-up|0
4822190|NCT01165203|16625576|P1|Active Phase|Lost to Follow-up|2
4822191|NCT01165203|16625575|P2|Active Phase|Migrated/moved from study area|1
4822192|NCT01165203|16625576|P1|Active Phase|Migrated/moved from study area|0
4822193|NCT01165203|16625575|P2|Active Phase|Withdrawal by Subject|1
4822194|NCT01165203|16625576|P1|Active Phase|Withdrawal by Subject|2
4822195|NCT01165203|16625575|P2|Active Phase|Serious Adverse Event|0
4822196|NCT01165203|16625576|P1|Active Phase|Serious Adverse Event|1
4822197|NCT01165177|16625666|P2|Overall Study|Migrated/ moved from study area|43
4822198|NCT01165177|16625667|P1|Overall Study|Migrated/ moved from study area|48
4822199|NCT01165177|16625666|P2|Overall Study|Lost to Follow-up|194
4822200|NCT01165177|16625667|P1|Overall Study|Lost to Follow-up|183
4822201|NCT01165177|16625666|P2|Overall Study|Suspected HZ episode|2
4822202|NCT01165177|16625667|P1|Overall Study|Suspected HZ episode|0
4822203|NCT01165177|16625666|P2|Overall Study|Other unspecified reasons|35
4822204|NCT01165177|16625667|P1|Overall Study|Other unspecified reasons|47
4822205|NCT01165177|16625666|P2|Overall Study|Non-serious adverse event|18
4822206|NCT01165177|16625667|P1|Overall Study|Non-serious adverse event|30
4822207|NCT01165177|16625666|P2|Overall Study|Protocol Violation|21
4822208|NCT01165177|16625667|P1|Overall Study|Protocol Violation|19
4822209|NCT01165177|16625666|P2|Overall Study|Withdrawal by Subject|354
4822210|NCT01165177|16625667|P1|Overall Study|Withdrawal by Subject|368
4822211|NCT01165177|16625666|P2|Overall Study|Serious Adverse Event|235
4822212|NCT01165177|16625667|P1|Overall Study|Serious Adverse Event|227
4822213|NCT01165138|16625796|P4|Overall Study|Withdrawal by Subject|3
4822214|NCT01165138|16625797|P3|Overall Study|Withdrawal by Subject|6
4822215|NCT01165138|16625798|P2|Overall Study|Withdrawal by Subject|6
4822216|NCT01165138|16625799|P1|Overall Study|Withdrawal by Subject|0
4822217|NCT01165138|16625796|P4|Overall Study|Physician Decision|6
4822218|NCT01165138|16625797|P3|Overall Study|Physician Decision|7
4822219|NCT01165138|16625798|P2|Overall Study|Physician Decision|6
4822220|NCT01165138|16625799|P1|Overall Study|Physician Decision|0
4822221|NCT01165138|16625796|P4|Overall Study|Lost to Follow-up|2
4822222|NCT01165138|16625797|P3|Overall Study|Lost to Follow-up|1
4822223|NCT01165138|16625798|P2|Overall Study|Lost to Follow-up|0
4822224|NCT01165138|16625799|P1|Overall Study|Lost to Follow-up|0
4822225|NCT01165138|16625796|P4|Overall Study|Protocol Violation|2
4822226|NCT01165138|16625797|P3|Overall Study|Protocol Violation|0
4822227|NCT01165138|16625798|P2|Overall Study|Protocol Violation|7
4822228|NCT01165138|16625799|P1|Overall Study|Protocol Violation|0
4822229|NCT01165138|16625796|P4|Overall Study|Lack of Efficacy|7
4822230|NCT01165138|16625797|P3|Overall Study|Lack of Efficacy|6
4822231|NCT01165138|16625798|P2|Overall Study|Lack of Efficacy|32
4822232|NCT01165138|16625799|P1|Overall Study|Lack of Efficacy|0
4822233|NCT01165138|16625796|P4|Overall Study|Adverse Event|2
4822234|NCT01165138|16625797|P3|Overall Study|Adverse Event|0
4822235|NCT01165138|16625798|P2|Overall Study|Adverse Event|1
4822236|NCT01165138|16625799|P1|Overall Study|Adverse Event|0
4822237|NCT01165021|16625869|P1|Overall Study|Death|1
4822238|NCT01164956|16625877|P3|Overall Study|Side Effects|1
4822239|NCT01164956|16625878|P2|Overall Study|Side Effects|0
4822240|NCT01164956|16625879|P1|Overall Study|Side Effects|1
4822241|NCT01164891|16625887|P1|Overall Study|Adverse Event|1
4822242|NCT01164891|16625887|P1|Overall Study|Disease Progression|5
4822243|NCT01164865|16625907|P2|Overall Study|Lost to Follow-up|1
4822244|NCT01164865|16625908|P1|Overall Study|Lost to Follow-up|2
4822245|NCT01164722|16625918|P2|Overall Study|enrolled on other study, concomitant med|3
4822246|NCT01164722|16625919|P1|Overall Study|enrolled on other study, concomitant med|1
4822247|NCT01164722|16625918|P2|Overall Study|met protocol criteria for non-treatment|1
4822248|NCT01164722|16625919|P1|Overall Study|met protocol criteria for non-treatment|11
4822249|NCT01164722|16625918|P2|Overall Study|Lost to Follow-up|6
4822250|NCT01164722|16625919|P1|Overall Study|Lost to Follow-up|3
4822251|NCT01164722|16625918|P2|Overall Study|Withdrawal by Subject|4
4822252|NCT01164722|16625919|P1|Overall Study|Withdrawal by Subject|3
4822253|NCT01164722|16625918|P2|Overall Study|Adverse Event|1
4822254|NCT01164722|16625919|P1|Overall Study|Adverse Event|0
4822255|NCT01164579|16625949|P3|Overall Study|Reason not specified|0
4822256|NCT01164579|16625950|P2|Overall Study|Reason not specified|0
4822257|NCT01164579|16625951|P1|Overall Study|Reason not specified|1
4822258|NCT01164579|16625949|P3|Overall Study|Adverse Event|5
4822259|NCT01164579|16625950|P2|Overall Study|Adverse Event|2
4822260|NCT01164579|16625951|P1|Overall Study|Adverse Event|4
4822261|NCT01164579|16625949|P3|Overall Study|Protocol Violation|2
4822262|NCT01164579|16625950|P2|Overall Study|Protocol Violation|1
4822263|NCT01164579|16625951|P1|Overall Study|Protocol Violation|0
4822264|NCT01164579|16625949|P3|Overall Study|Withdrawal by Subject|3
4822265|NCT01164579|16625950|P2|Overall Study|Withdrawal by Subject|5
4822266|NCT01164579|16625951|P1|Overall Study|Withdrawal by Subject|2
4822267|NCT01164579|16625949|P3|Overall Study|Lost to Follow-up|0
4822268|NCT01164579|16625950|P2|Overall Study|Lost to Follow-up|1
4822269|NCT01164579|16625951|P1|Overall Study|Lost to Follow-up|1
4822270|NCT01164579|16625949|P3|Overall Study|Lack of Efficacy|6
4822271|NCT01164579|16625950|P2|Overall Study|Lack of Efficacy|0
4822272|NCT01164579|16625951|P1|Overall Study|Lack of Efficacy|0
4822273|NCT01164501|16626031|P3|Overall Study|Other reason not defined above|4
4822274|NCT01164501|16626032|P2|Overall Study|Other reason not defined above|1
4822275|NCT01164501|16626033|P1|Overall Study|Other reason not defined above|9
4822276|NCT01164501|16626031|P3|Overall Study|Patient refusal to continue,not due toAE|8
4822277|NCT01164501|16626032|P2|Overall Study|Patient refusal to continue,not due toAE|4
4822278|NCT01164501|16626033|P1|Overall Study|Patient refusal to continue,not due toAE|10
4822279|NCT01164501|16626031|P3|Overall Study|Lost to Follow-up|3
4822280|NCT01164501|16626032|P2|Overall Study|Lost to Follow-up|0
4822281|NCT01164501|16626033|P1|Overall Study|Lost to Follow-up|3
4822282|NCT01164501|16626031|P3|Overall Study|Non compliant with protocol|4
4822283|NCT01164501|16626032|P2|Overall Study|Non compliant with protocol|1
4822284|NCT01164501|16626033|P1|Overall Study|Non compliant with protocol|1
4822285|NCT01164501|16626031|P3|Overall Study|Lack of Efficacy|1
4822286|NCT01164501|16626032|P2|Overall Study|Lack of Efficacy|0
4822287|NCT01164501|16626033|P1|Overall Study|Lack of Efficacy|0
4822288|NCT01164501|16626031|P3|Overall Study|Adverse Event|21
4822289|NCT01164501|16626032|P2|Overall Study|Adverse Event|4
4822290|NCT01164501|16626033|P1|Overall Study|Adverse Event|18
4822291|NCT01164501|16626031|P3|Overall Study|Not treated|1
4822292|NCT01164501|16626032|P2|Overall Study|Not treated|0
4822293|NCT01164501|16626033|P1|Overall Study|Not treated|2
4822294|NCT01164475|16626050|P2|Overall Study|Protocol Violation|0
4822295|NCT01164475|16626051|P1|Overall Study|Protocol Violation|1
4822296|NCT01164475|16626050|P2|Overall Study|Progressive disease|1
4822297|NCT01164475|16626051|P1|Overall Study|Progressive disease|0
4822298|NCT01164475|16626050|P2|Overall Study|Other|1
4822299|NCT01164475|16626051|P1|Overall Study|Other|0
4822300|NCT01164475|16626050|P2|Overall Study|Lack of Efficacy|0
4822301|NCT01164475|16626051|P1|Overall Study|Lack of Efficacy|1
4822302|NCT01164007|16626105|P1|Overall Study|Medical Decision|3
4822303|NCT01164007|16626105|P1|Overall Study|Withdrawal by Subject|1
4822304|NCT01164007|16626105|P1|Overall Study|Protocol Violation|1
4822305|NCT01164007|16626105|P1|Overall Study|Progression of Disease|30
4822306|NCT01164007|16626105|P1|Overall Study|Adverse Event|5
4822307|NCT01163916|16626131|P3|Overall Study|Other|16
4822308|NCT01163916|16626132|P2|Overall Study|Other|4
4822309|NCT01163916|16626133|P1|Overall Study|Other|24
4822310|NCT01163916|16626131|P3|Overall Study|Lack of Efficacy|1
4822311|NCT01163916|16626132|P2|Overall Study|Lack of Efficacy|0
4822312|NCT01163916|16626133|P1|Overall Study|Lack of Efficacy|2
4822313|NCT01163916|16626131|P3|Overall Study|Adverse Event|1
4822314|NCT01163916|16626132|P2|Overall Study|Adverse Event|0
4822315|NCT01163916|16626133|P1|Overall Study|Adverse Event|2
4822316|NCT01163916|16626131|P3|Overall Study|Withdrawal by Subject|2
4822317|NCT01163916|16626132|P2|Overall Study|Withdrawal by Subject|0
4822318|NCT01163916|16626133|P1|Overall Study|Withdrawal by Subject|2
4822319|NCT01163851|16626171|P2|Overall Study|Enrolled but not treated|0
4822320|NCT01163851|16626172|P1|Overall Study|Enrolled but not treated|1
4822321|NCT01163851|16626171|P2|Overall Study|Site Closure|1
4822322|NCT01163851|16626172|P1|Overall Study|Site Closure|0
4822323|NCT01163786|16626250|P1|Completed Follow up (Visit 9 and 10)|Other|1
4822324|NCT01163786|16626250|P1|Treatment With Bortezomib|Adverse Event|2
4822325|NCT01163786|16626250|P1|Treatment With Bortezomib|Withdrawal by Subject|1
4822326|NCT01163747|16626273|P2|Overall Study|Refused Treatment|4
4822327|NCT01163747|16626274|P1|Overall Study|Refused Treatment|6
4822328|NCT01163747|16626273|P2|Overall Study|Protocol Violation|1
4822329|NCT01163747|16626274|P1|Overall Study|Protocol Violation|0
4822330|NCT01163747|16626273|P2|Overall Study|Insufficient Therapeutic Response|1
4822331|NCT01163747|16626274|P1|Overall Study|Insufficient Therapeutic Response|0
4822332|NCT01163747|16626273|P2|Overall Study|Adverse Event|5
4822333|NCT01163747|16626274|P1|Overall Study|Adverse Event|0
4822334|NCT01163721|16626294|P2|Overall Study|Physician Decision|1
4822335|NCT01163721|16626295|P1|Overall Study|Physician Decision|0
4822336|NCT01163721|16626294|P2|Overall Study|Lost to Follow-up|1
4822337|NCT01163721|16626295|P1|Overall Study|Lost to Follow-up|0
4822338|NCT01163721|16626294|P2|Overall Study|Withdrawal by Subject|4
4822339|NCT01163721|16626295|P1|Overall Study|Withdrawal by Subject|3
4822340|NCT01163721|16626294|P2|Overall Study|Adverse Event|6
4822341|NCT01163721|16626295|P1|Overall Study|Adverse Event|5
4822342|NCT01163617|16626345|P8|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822343|NCT01163617|16626346|P7|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822344|NCT01163617|16626347|P6|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822345|NCT01163617|16626348|P5|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822346|NCT01163617|16626349|P4|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822347|NCT01163617|16626350|P3|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1
4822348|NCT01163617|16626351|P2|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822349|NCT01163617|16626352|P1|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0
4822350|NCT01163617|16626345|P8|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822351|NCT01163617|16626346|P7|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822352|NCT01163617|16626347|P6|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822353|NCT01163617|16626348|P5|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822354|NCT01163617|16626349|P4|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822355|NCT01163617|16626350|P3|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822356|NCT01163617|16626351|P2|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1
4822357|NCT01163617|16626352|P1|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0
4822358|NCT01163617|16626345|P8|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822359|NCT01163617|16626346|P7|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822360|NCT01163617|16626347|P6|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822361|NCT01163617|16626348|P5|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822362|NCT01163617|16626349|P4|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822363|NCT01163617|16626350|P3|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822364|NCT01163617|16626351|P2|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1
4822365|NCT01163617|16626352|P1|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0
4822366|NCT01163474|16626381|P1|Overall Study|Lost to Follow-up|3
4822367|NCT01163474|16626381|P1|Overall Study|Tech barriers to videoteleconference vis|12
4822368|NCT01163474|16626381|P1|Overall Study|Withdrawal by Subject|1
4822369|NCT01163318|16626393|P1|Overall Study|Multiple Reasons Per Participant|224
4822370|NCT01163318|16626393|P1|Overall Study|Participants Without Case Report Form|7
4822371|NCT01163318|16626393|P1|Overall Study|History/comorbidity of malignant tumor|3
4822372|NCT01163318|16626393|P1|Overall Study|Did Not Continue Use of Adalimumab|26
4822373|NCT01163318|16626393|P1|Overall Study|Off-Label Use of Adalimumab|8
4822374|NCT01163292|16626402|P2|Overall Study|No further visits|7
4822375|NCT01163292|16626403|P1|Overall Study|No further visits|5
4822376|NCT01163292|16626402|P2|Overall Study|Economic reasons|0
4822377|NCT01163292|16626403|P1|Overall Study|Economic reasons|6
4822378|NCT01163292|16626402|P2|Overall Study|Refusal to receive adalimumab|0
4822379|NCT01163292|16626403|P1|Overall Study|Refusal to receive adalimumab|7
4822380|NCT01163292|16626402|P2|Overall Study|Sufficient response to adalimumab|0
4822381|NCT01163292|16626403|P1|Overall Study|Sufficient response to adalimumab|8
4822382|NCT01163292|16626402|P2|Overall Study|Initiation of biological therapy|15
4822383|NCT01163292|16626403|P1|Overall Study|Initiation of biological therapy|0
4822384|NCT01163292|16626402|P2|Overall Study|Adverse Event|0
4822385|NCT01163292|16626403|P1|Overall Study|Adverse Event|6
4822386|NCT01163292|16626402|P2|Overall Study|Lack of Efficacy|0
4822387|NCT01163292|16626403|P1|Overall Study|Lack of Efficacy|9
4822388|NCT01163279|16626419|P2|Overall Study|Withdrawal by Subject|0
4822389|NCT01163279|16626420|P1|Overall Study|Withdrawal by Subject|2
4822390|NCT01163266|16626449|P3|Overall Study|Other|2
4822391|NCT01163266|16626450|P2|Overall Study|Other|1
4822392|NCT01163266|16626451|P1|Overall Study|Other|1
4822393|NCT01163266|16626449|P3|Overall Study|Lost to Follow-up|10
4822394|NCT01163266|16626450|P2|Overall Study|Lost to Follow-up|7
4822395|NCT01163266|16626451|P1|Overall Study|Lost to Follow-up|7
4822396|NCT01163266|16626449|P3|Overall Study|Withdrawal of Consent|3
4822397|NCT01163266|16626450|P2|Overall Study|Withdrawal of Consent|7
4822398|NCT01163266|16626451|P1|Overall Study|Withdrawal of Consent|5
4822399|NCT01163266|16626449|P3|Overall Study|Protocol Deviations|5
4822400|NCT01163266|16626450|P2|Overall Study|Protocol Deviations|2
4822401|NCT01163266|16626451|P1|Overall Study|Protocol Deviations|2
4822402|NCT01163266|16626449|P3|Overall Study|Noncompliance with Study Drug|0
4822403|NCT01163266|16626450|P2|Overall Study|Noncompliance with Study Drug|2
4822404|NCT01163266|16626451|P1|Overall Study|Noncompliance with Study Drug|0
4822405|NCT01163266|16626449|P3|Overall Study|Lack of Efficacy|1
4822406|NCT01163266|16626450|P2|Overall Study|Lack of Efficacy|3
4822407|NCT01163266|16626451|P1|Overall Study|Lack of Efficacy|1
4822408|NCT01163266|16626449|P3|Overall Study|Pretreatment Event or Adverse Event|7
4822409|NCT01163266|16626450|P2|Overall Study|Pretreatment Event or Adverse Event|9
4822410|NCT01163266|16626451|P1|Overall Study|Pretreatment Event or Adverse Event|2
4822411|NCT01163253|16626476|P2|Overall Study|Other Unspecified|34
4822412|NCT01163253|16626477|P1|Overall Study|Other Unspecified|170
4822413|NCT01163253|16626476|P2|Overall Study|Ongoing|4
4822414|NCT01163253|16626477|P1|Overall Study|Ongoing|13
4822415|NCT01163253|16626476|P2|Overall Study|Death|5
4822416|NCT01163253|16626477|P1|Overall Study|Death|17
4822417|NCT01163253|16626476|P2|Overall Study|Adverse Event|78
4822418|NCT01163253|16626477|P1|Overall Study|Adverse Event|300
4822419|NCT01163253|16626476|P2|Overall Study|Insufficient Clinical Response|29
4822420|NCT01163253|16626477|P1|Overall Study|Insufficient Clinical Response|423
4822421|NCT01163253|16626476|P2|Overall Study|Lost to Follow-up|23
4822422|NCT01163253|16626477|P1|Overall Study|Lost to Follow-up|125
4822423|NCT01163253|16626476|P2|Overall Study|Medication Error|0
4822424|NCT01163253|16626477|P1|Overall Study|Medication Error|1
4822425|NCT01163253|16626476|P2|Overall Study|Withdrawal by Subject|50
4822426|NCT01163253|16626477|P1|Overall Study|Withdrawal by Subject|199
4822427|NCT01163253|16626476|P2|Overall Study|Protocol Violation|12
4822428|NCT01163253|16626477|P1|Overall Study|Protocol Violation|43
4822429|NCT01163253|16626476|P2|Overall Study|Study Terminated by Sponsor|349
4822430|NCT01163253|16626477|P1|Overall Study|Study Terminated by Sponsor|978
4822431|NCT01163253|16626476|P2|Overall Study|Withdrawn Due to Pregnancy|2
4822432|NCT01163253|16626477|P1|Overall Study|Withdrawn Due to Pregnancy|12
4822433|NCT01163149|16626665|P3|Extension Treatment Period|Noncompliance|1
4822434|NCT01163149|16626666|P2|Extension Treatment Period|Noncompliance|0
4822435|NCT01163149|16626667|P1|Extension Treatment Period|Noncompliance|0
4822436|NCT01163149|16626665|P3|Extension Treatment Period|Adverse Event|0
4822437|NCT01163149|16626666|P2|Extension Treatment Period|Adverse Event|1
4822438|NCT01163149|16626667|P1|Extension Treatment Period|Adverse Event|0
4822439|NCT01163149|16626665|P3|Extension Treatment Period|Withdrawal by Subject|1
4822440|NCT01163149|16626666|P2|Extension Treatment Period|Withdrawal by Subject|0
4822441|NCT01163149|16626667|P1|Extension Treatment Period|Withdrawal by Subject|2
4822442|NCT01163032|16626776|P3|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2
4822443|NCT01163032|16626777|P2|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
4822444|NCT01163032|16626778|P1|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0
4822445|NCT01163032|16626776|P3|Open Label Extension Phase|Study Termination|7
4822446|NCT01163032|16626777|P2|Open Label Extension Phase|Study Termination|0
4822447|NCT01163032|16626778|P1|Open Label Extension Phase|Study Termination|0
4822448|NCT01163032|16626776|P3|Open Label Extension Phase|Protocol Violation|1
4822449|NCT01163032|16626777|P2|Open Label Extension Phase|Protocol Violation|0
4822450|NCT01163032|16626778|P1|Open Label Extension Phase|Protocol Violation|0
4822451|NCT01163032|16626776|P3|Open Label Extension Phase|Withdrawal by Subject|3
4822452|NCT01163032|16626777|P2|Open Label Extension Phase|Withdrawal by Subject|0
4822453|NCT01163032|16626778|P1|Open Label Extension Phase|Withdrawal by Subject|0
4822454|NCT01163032|16626776|P3|Open Label Extension Phase|Adverse Event|3
4822455|NCT01163032|16626777|P2|Open Label Extension Phase|Adverse Event|0
4822456|NCT01163032|16626778|P1|Open Label Extension Phase|Adverse Event|0
4822457|NCT01163032|16626776|P3|Randomization Phase|Unsatisfactory Therapeutic Effect|0
4822458|NCT01163032|16626777|P2|Randomization Phase|Unsatisfactory Therapeutic Effect|1
4822459|NCT01163032|16626778|P1|Randomization Phase|Unsatisfactory Therapeutic Effect|0
4822460|NCT01163032|16626776|P3|Randomization Phase|Various*|0
4822461|NCT01163032|16626777|P2|Randomization Phase|Various*|4
4822462|NCT01163032|16626778|P1|Randomization Phase|Various*|5
4822463|NCT01163032|16626776|P3|Randomization Phase|Protocol Violation|0
4822464|NCT01163032|16626777|P2|Randomization Phase|Protocol Violation|1
4822465|NCT01163032|16626778|P1|Randomization Phase|Protocol Violation|0
4822466|NCT01163032|16626776|P3|Randomization Phase|Adverse Event|0
4822467|NCT01163032|16626777|P2|Randomization Phase|Adverse Event|3
4822468|NCT01163032|16626778|P1|Randomization Phase|Adverse Event|3
4822469|NCT01163032|16626776|P3|Randomization Phase|Withdrawal by Subject|0
4822470|NCT01163032|16626777|P2|Randomization Phase|Withdrawal by Subject|3
4822471|NCT01163032|16626778|P1|Randomization Phase|Withdrawal by Subject|2
4822472|NCT01162863|16626811|P3|Overall Study|Adverse Event|0
4822473|NCT01162863|16626812|P2|Overall Study|Adverse Event|1
4822474|NCT01162863|16626813|P1|Overall Study|Adverse Event|0
4822475|NCT01162863|16626811|P3|Overall Study|Lack of Efficacy|0
4822476|NCT01162863|16626812|P2|Overall Study|Lack of Efficacy|0
4822477|NCT01162863|16626813|P1|Overall Study|Lack of Efficacy|1
4822478|NCT01162499|16626843|P2|Intervention 1 (4 Hours)|Unable to establish IV access|1
4822479|NCT01162499|16626844|P1|Intervention 1 (4 Hours)|Unable to establish IV access|0
4822480|NCT01162486|16626869|P5|Overall Study|Pregnancy|0
4822481|NCT01162486|16626870|P4|Overall Study|Pregnancy|1
4822482|NCT01162486|16626871|P3|Overall Study|Pregnancy|0
4822483|NCT01162486|16626872|P2|Overall Study|Pregnancy|0
4822484|NCT01162486|16626873|P1|Overall Study|Pregnancy|0
4822485|NCT01162486|16626869|P5|Overall Study|elevated LFTs|0
4822486|NCT01162486|16626870|P4|Overall Study|elevated LFTs|0
4822487|NCT01162486|16626871|P3|Overall Study|elevated LFTs|1
4822488|NCT01162486|16626872|P2|Overall Study|elevated LFTs|0
4822489|NCT01162486|16626873|P1|Overall Study|elevated LFTs|0
4822490|NCT01162486|16626869|P5|Overall Study|vomited Rifampin/ gagged with midazolam|0
4822491|NCT01162486|16626870|P4|Overall Study|vomited Rifampin/ gagged with midazolam|0
4822492|NCT01162486|16626871|P3|Overall Study|vomited Rifampin/ gagged with midazolam|0
4822493|NCT01162486|16626872|P2|Overall Study|vomited Rifampin/ gagged with midazolam|0
4822494|NCT01162486|16626873|P1|Overall Study|vomited Rifampin/ gagged with midazolam|1
4822495|NCT01162486|16626869|P5|Overall Study|low ANC|0
4822496|NCT01162486|16626870|P4|Overall Study|low ANC|0
4822497|NCT01162486|16626871|P3|Overall Study|low ANC|0
4822498|NCT01162486|16626872|P2|Overall Study|low ANC|0
4822499|NCT01162486|16626873|P1|Overall Study|low ANC|1
4822500|NCT01162473|16626906|P2|Overall Study|Withdrawal by Subject|4
4822501|NCT01162473|16626907|P1|Overall Study|Withdrawal by Subject|0
4822502|NCT01162473|16626906|P2|Overall Study|Adverse Event|1
4822503|NCT01162473|16626907|P1|Overall Study|Adverse Event|2
4822504|NCT01162421|16626915|P2|Overall Study|Other|3
4822505|NCT01162421|16626916|P1|Overall Study|Other|2
4822506|NCT01162421|16626915|P2|Overall Study|Lack of Efficacy|2
4822507|NCT01162421|16626916|P1|Overall Study|Lack of Efficacy|2
4822508|NCT01162421|16626915|P2|Overall Study|Lost to Follow-up|2
4822509|NCT01162421|16626916|P1|Overall Study|Lost to Follow-up|0
4822510|NCT01162421|16626915|P2|Overall Study|Adverse Event|5
4822511|NCT01162421|16626916|P1|Overall Study|Adverse Event|2
4822512|NCT01162421|16626915|P2|Overall Study|Did not receive study drug|1
4822513|NCT01162421|16626916|P1|Overall Study|Did not receive study drug|2
4822514|NCT01162343|16626999|P1|Overall Study|Refused psychiatrist assessment|12
4822515|NCT01162343|16626999|P1|Overall Study|Left ED prior to psychiatrist assessment|80
4822516|NCT01162304|16627014|P1|Overall Study|Beck scale to high|11
4822517|NCT01162135|16627028|P1|Overall Study|Ineligible|1
4822518|NCT01162135|16627028|P1|Overall Study|Severe back pain|1
4822519|NCT01162135|16627028|P1|Overall Study|Withdrawal by Subject|1
4822520|NCT01162122|16627034|P2|Overall Study|Missing primary reason|0
4822521|NCT01162122|16627035|P1|Overall Study|Missing primary reason|1
4822522|NCT01162122|16627034|P2|Overall Study|Unable to classify|7
4822523|NCT01162122|16627035|P1|Overall Study|Unable to classify|3
4822524|NCT01162122|16627034|P2|Overall Study|Administrative reason|1
4822525|NCT01162122|16627035|P1|Overall Study|Administrative reason|1
4822526|NCT01162122|16627034|P2|Overall Study|Inappropriate enrollment|4
4822527|NCT01162122|16627035|P1|Overall Study|Inappropriate enrollment|5
4822528|NCT01162122|16627034|P2|Overall Study|Protocol Violation|2
4822529|NCT01162122|16627035|P1|Overall Study|Protocol Violation|2
4822530|NCT01162122|16627034|P2|Overall Study|Death|46
4822531|NCT01162122|16627035|P1|Overall Study|Death|51
4822532|NCT01162122|16627034|P2|Overall Study|Adverse Event|2
4822533|NCT01162122|16627035|P1|Overall Study|Adverse Event|3
4822534|NCT01162122|16627034|P2|Overall Study|Lost to Follow-up|91
4822535|NCT01162122|16627035|P1|Overall Study|Lost to Follow-up|73
4822536|NCT01162122|16627034|P2|Overall Study|Withdrawal by Subject|43
4822537|NCT01162122|16627035|P1|Overall Study|Withdrawal by Subject|52
4822538|NCT01161628|16627141|P1|Overall Study|Lack of Efficacy|2
4822539|NCT01161628|16627141|P1|Overall Study|Death|6
4822540|NCT01161537|16627164|P1|Part B|Withdrawal by Subject|2
4822541|NCT01161524|16627182|P3|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4
4822542|NCT01161524|16627183|P2|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
4822543|NCT01161524|16627184|P1|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0
4822544|NCT01161524|16627182|P3|Extension Phase (Approximately 83 Weeks)|Subject Choice|5
4822545|NCT01161524|16627183|P2|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
4822546|NCT01161524|16627184|P1|Extension Phase (Approximately 83 Weeks)|Subject Choice|0
4822547|NCT01161524|16627182|P3|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1
4822548|NCT01161524|16627183|P2|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
4822549|NCT01161524|16627184|P1|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0
4822550|NCT01161524|16627182|P3|Extension Phase (Approximately 83 Weeks)|Other|6
4822551|NCT01161524|16627183|P2|Extension Phase (Approximately 83 Weeks)|Other|0
4822552|NCT01161524|16627184|P1|Extension Phase (Approximately 83 Weeks)|Other|0
4822553|NCT01161524|16627182|P3|Extension Phase (Approximately 83 Weeks)|Adverse Event|8
4822554|NCT01161524|16627183|P2|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
4822555|NCT01161524|16627184|P1|Extension Phase (Approximately 83 Weeks)|Adverse Event|0
4822556|NCT01161524|16627182|P3|Core Study (23 Weeks)|Subject Choice|0
4822557|NCT01161524|16627183|P2|Core Study (23 Weeks)|Subject Choice|2
4822558|NCT01161524|16627184|P1|Core Study (23 Weeks)|Subject Choice|3
4822559|NCT01161524|16627182|P3|Core Study (23 Weeks)|Lost to Follow-up|0
4822560|NCT01161524|16627183|P2|Core Study (23 Weeks)|Lost to Follow-up|2
4822561|NCT01161524|16627184|P1|Core Study (23 Weeks)|Lost to Follow-up|1
4822562|NCT01161524|16627182|P3|Core Study (23 Weeks)|Withdrawal of Consent|0
4822563|NCT01161524|16627183|P2|Core Study (23 Weeks)|Withdrawal of Consent|1
4822564|NCT01161524|16627184|P1|Core Study (23 Weeks)|Withdrawal of Consent|1
4822565|NCT01161524|16627182|P3|Core Study (23 Weeks)|Other|0
4822566|NCT01161524|16627183|P2|Core Study (23 Weeks)|Other|0
4822567|NCT01161524|16627184|P1|Core Study (23 Weeks)|Other|1
4822568|NCT01161524|16627182|P3|Core Study (23 Weeks)|Adverse Event|0
4822569|NCT01161524|16627183|P2|Core Study (23 Weeks)|Adverse Event|0
4822570|NCT01161524|16627184|P1|Core Study (23 Weeks)|Adverse Event|3
4822571|NCT01161498|16627223|P2|Overall Study|Disease Progression|1
4822572|NCT01161498|16627224|P1|Overall Study|Disease Progression|0
4822573|NCT01161472|16627248|P4|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
4822574|NCT01161472|16627249|P3|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
4822575|NCT01161472|16627250|P2|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0
4822576|NCT01161472|16627251|P1|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1
4822577|NCT01161446|16627307|P2|Overall Study|Withdrawal by Subject|1
4822578|NCT01161446|16627308|P1|Overall Study|Withdrawal by Subject|0
4822579|NCT01161446|16627307|P2|Overall Study|Lost to Follow-up|14
4822580|NCT01161446|16627308|P1|Overall Study|Lost to Follow-up|18
4822581|NCT01161407|16627334|P2|Overall Study|Protocol Violation|1
4822582|NCT01161407|16627335|P1|Overall Study|Protocol Violation|3
4822583|NCT01161173|16627390|P1|Overall Study|Reasons Not Specified|23
4822584|NCT01161173|16627390|P1|Overall Study|End of Study|2
4822585|NCT01161173|16627390|P1|Overall Study|Death|194
4822586|NCT01161173|16627390|P1|Overall Study|Unacceptable Toxicity|21
4822587|NCT01161173|16627390|P1|Overall Study|Withdrawal of Consent|5
4822588|NCT01161173|16627390|P1|Overall Study|Progressive Disease|82
4822589|NCT01161173|16627390|P1|Overall Study|Lost to Follow-up|7
4822590|NCT01161173|16627390|P1|Overall Study|Protocol Violation|13
4822591|NCT01161043|16627485|P1|Overall Study|Withdrawal by Subject|3
4822592|NCT01160822|16627522|P7|Overall Study|Protocol deviation|0
4822593|NCT01160822|16627523|P6|Overall Study|Protocol deviation|0
4822594|NCT01160822|16627524|P5|Overall Study|Protocol deviation|2
4822595|NCT01160822|16627525|P4|Overall Study|Protocol deviation|0
4822596|NCT01160822|16627526|P3|Overall Study|Protocol deviation|0
4822597|NCT01160822|16627527|P2|Overall Study|Protocol deviation|0
4822598|NCT01160822|16627528|P1|Overall Study|Protocol deviation|0
4822599|NCT01160822|16627522|P7|Overall Study|Administrative problems|0
4822600|NCT01160822|16627523|P6|Overall Study|Administrative problems|0
4822601|NCT01160822|16627524|P5|Overall Study|Administrative problems|1
4822602|NCT01160822|16627525|P4|Overall Study|Administrative problems|0
4822603|NCT01160822|16627526|P3|Overall Study|Administrative problems|0
4822604|NCT01160822|16627527|P2|Overall Study|Administrative problems|0
4822605|NCT01160822|16627528|P1|Overall Study|Administrative problems|0
4822606|NCT01160822|16627522|P7|Overall Study|Lost to Follow-up|0
4822607|NCT01160822|16627523|P6|Overall Study|Lost to Follow-up|0
4822608|NCT01160822|16627524|P5|Overall Study|Lost to Follow-up|1
4822609|NCT01160822|16627525|P4|Overall Study|Lost to Follow-up|0
4822610|NCT01160822|16627526|P3|Overall Study|Lost to Follow-up|0
4822611|NCT01160822|16627527|P2|Overall Study|Lost to Follow-up|0
4822612|NCT01160822|16627528|P1|Overall Study|Lost to Follow-up|0
4822613|NCT01160822|16627522|P7|Overall Study|Withdrawal by Subject|1
4822614|NCT01160822|16627523|P6|Overall Study|Withdrawal by Subject|0
4822615|NCT01160822|16627524|P5|Overall Study|Withdrawal by Subject|0
4822616|NCT01160822|16627525|P4|Overall Study|Withdrawal by Subject|0
4822617|NCT01160822|16627526|P3|Overall Study|Withdrawal by Subject|0
4822618|NCT01160822|16627527|P2|Overall Study|Withdrawal by Subject|0
4822619|NCT01160822|16627528|P1|Overall Study|Withdrawal by Subject|0
4822620|NCT01160822|16627522|P7|Overall Study|Unsatisfactory therapeutic effect|3
4822621|NCT01160822|16627523|P6|Overall Study|Unsatisfactory therapeutic effect|5
4822622|NCT01160822|16627524|P5|Overall Study|Unsatisfactory therapeutic effect|4
4822623|NCT01160822|16627525|P4|Overall Study|Unsatisfactory therapeutic effect|0
4822624|NCT01160822|16627526|P3|Overall Study|Unsatisfactory therapeutic effect|0
4822625|NCT01160822|16627527|P2|Overall Study|Unsatisfactory therapeutic effect|0
4822626|NCT01160822|16627528|P1|Overall Study|Unsatisfactory therapeutic effect|0
4822627|NCT01160822|16627522|P7|Overall Study|Adverse Event|5
4822628|NCT01160822|16627523|P6|Overall Study|Adverse Event|2
4822629|NCT01160822|16627524|P5|Overall Study|Adverse Event|1
4822630|NCT01160822|16627525|P4|Overall Study|Adverse Event|0
4822631|NCT01160822|16627526|P3|Overall Study|Adverse Event|0
4822632|NCT01160822|16627527|P2|Overall Study|Adverse Event|0
4822633|NCT01160822|16627528|P1|Overall Study|Adverse Event|0
4822634|NCT01160770|16627617|P1|Overall Study|Other Reasons|1
4822635|NCT01160770|16627617|P1|Overall Study|Lack of Efficacy|15
4822636|NCT01160770|16627617|P1|Overall Study|Death|9
4822637|NCT01160770|16627617|P1|Overall Study|Study termination or sponsor request|1
4822638|NCT01160770|16627617|P1|Overall Study|Lost to Follow-up|7
4822639|NCT01160770|16627617|P1|Overall Study|Physician Decision|1
4822640|NCT01160770|16627617|P1|Overall Study|Subject/parent/caregiver request|33
4822641|NCT01160770|16627617|P1|Overall Study|Protocol Violation|2
4822642|NCT01160770|16627617|P1|Overall Study|Adverse Event|10
4822643|NCT01160744|16627630|P4|Overall Study|Not meet inclusion/exclusion criteria|0
4822644|NCT01160744|16627631|P3|Overall Study|Not meet inclusion/exclusion criteria|1
4822645|NCT01160744|16627632|P2|Overall Study|Not meet inclusion/exclusion criteria|0
4822646|NCT01160744|16627633|P1|Overall Study|Not meet inclusion/exclusion criteria|0
4822647|NCT01160744|16627630|P4|Overall Study|Withdrawal by Subject|4
4822648|NCT01160744|16627631|P3|Overall Study|Withdrawal by Subject|6
4822649|NCT01160744|16627632|P2|Overall Study|Withdrawal by Subject|5
4822650|NCT01160744|16627633|P1|Overall Study|Withdrawal by Subject|11
4822651|NCT01160640|16627669|P2|Overall Study|Withdrawal by Subject|3
4822652|NCT01160640|16627670|P1|Overall Study|Withdrawal by Subject|0
4822653|NCT01160640|16627669|P2|Overall Study|Incarceration|0
4822654|NCT01160640|16627670|P1|Overall Study|Incarceration|1
4822655|NCT01160640|16627669|P2|Overall Study|Physician Decision|3
4822656|NCT01160640|16627670|P1|Overall Study|Physician Decision|3
4822657|NCT01160614|16627686|P2|Overall Study|Withdrawal by Subject|2
4822658|NCT01160614|16627687|P1|Overall Study|Withdrawal by Subject|0
4822659|NCT01160484|16627735|P1|Overall Study|inclusion/exclusion criteria failure|1
4822660|NCT01160484|16627735|P1|Overall Study|Withdrawal by Subject|2
4822661|NCT01160484|16627735|P1|Overall Study|Adverse Event|6
4822662|NCT01160484|16627735|P1|Overall Study|Lack of Efficacy|9
4822663|NCT01160354|16627788|P3|Overall Study|Death|1
4822664|NCT01160354|16627789|P2|Overall Study|Death|1
4822665|NCT01160354|16627790|P1|Overall Study|Death|0
4822666|NCT01160289|16627809|P6|Post-Randomization Period|Sponsor Decision|0
4822667|NCT01160289|16627810|P5|Post-Randomization Period|Sponsor Decision|0
4822668|NCT01160289|16627811|P4|Post-Randomization Period|Sponsor Decision|0
4822669|NCT01160289|16627812|P3|Post-Randomization Period|Sponsor Decision|0
4822670|NCT01160289|16627813|P2|Post-Randomization Period|Sponsor Decision|1
4822671|NCT01160289|16627814|P1|Post-Randomization Period|Sponsor Decision|0
4822672|NCT01160289|16627809|P6|Post-Randomization Period|Entry Criteria Not Met|0
4822673|NCT01160289|16627810|P5|Post-Randomization Period|Entry Criteria Not Met|0
4822674|NCT01160289|16627811|P4|Post-Randomization Period|Entry Criteria Not Met|2
4822675|NCT01160289|16627812|P3|Post-Randomization Period|Entry Criteria Not Met|2
4822676|NCT01160289|16627813|P2|Post-Randomization Period|Entry Criteria Not Met|2
4822677|NCT01160289|16627814|P1|Post-Randomization Period|Entry Criteria Not Met|0
4822678|NCT01160289|16627809|P6|Post-Randomization Period|Withdrawal by Subject|7
4822679|NCT01160289|16627810|P5|Post-Randomization Period|Withdrawal by Subject|5
4822680|NCT01160289|16627811|P4|Post-Randomization Period|Withdrawal by Subject|8
4822681|NCT01160289|16627812|P3|Post-Randomization Period|Withdrawal by Subject|13
4822682|NCT01160289|16627813|P2|Post-Randomization Period|Withdrawal by Subject|5
4822683|NCT01160289|16627814|P1|Post-Randomization Period|Withdrawal by Subject|0
4822684|NCT01160289|16627809|P6|Post-Randomization Period|Protocol Violation|3
4822685|NCT01160289|16627810|P5|Post-Randomization Period|Protocol Violation|1
4822686|NCT01160289|16627811|P4|Post-Randomization Period|Protocol Violation|0
4822687|NCT01160289|16627812|P3|Post-Randomization Period|Protocol Violation|2
4822688|NCT01160289|16627813|P2|Post-Randomization Period|Protocol Violation|4
4822689|NCT01160289|16627814|P1|Post-Randomization Period|Protocol Violation|0
4822690|NCT01160289|16627809|P6|Post-Randomization Period|Physician Decision|0
4822691|NCT01160289|16627810|P5|Post-Randomization Period|Physician Decision|0
4822692|NCT01160289|16627811|P4|Post-Randomization Period|Physician Decision|0
4822693|NCT01160289|16627812|P3|Post-Randomization Period|Physician Decision|1
4822694|NCT01160289|16627813|P2|Post-Randomization Period|Physician Decision|0
4822695|NCT01160289|16627814|P1|Post-Randomization Period|Physician Decision|0
4822696|NCT01160289|16627809|P6|Post-Randomization Period|Lost to Follow-up|4
4822697|NCT01160289|16627810|P5|Post-Randomization Period|Lost to Follow-up|3
4822698|NCT01160289|16627811|P4|Post-Randomization Period|Lost to Follow-up|5
4822699|NCT01160289|16627812|P3|Post-Randomization Period|Lost to Follow-up|2
4822700|NCT01160289|16627813|P2|Post-Randomization Period|Lost to Follow-up|3
4822701|NCT01160289|16627814|P1|Post-Randomization Period|Lost to Follow-up|0
4822702|NCT01160289|16627809|P6|Post-Randomization Period|Lack of Efficacy|0
4822703|NCT01160289|16627810|P5|Post-Randomization Period|Lack of Efficacy|0
4822704|NCT01160289|16627811|P4|Post-Randomization Period|Lack of Efficacy|3
4822705|NCT01160289|16627812|P3|Post-Randomization Period|Lack of Efficacy|0
4822706|NCT01160289|16627813|P2|Post-Randomization Period|Lack of Efficacy|1
4822707|NCT01160289|16627814|P1|Post-Randomization Period|Lack of Efficacy|0
4822708|NCT01160289|16627809|P6|Post-Randomization Period|Death|0
4822709|NCT01160289|16627810|P5|Post-Randomization Period|Death|0
4822710|NCT01160289|16627811|P4|Post-Randomization Period|Death|1
4822711|NCT01160289|16627812|P3|Post-Randomization Period|Death|0
4822712|NCT01160289|16627813|P2|Post-Randomization Period|Death|0
4822713|NCT01160289|16627814|P1|Post-Randomization Period|Death|0
4822714|NCT01160289|16627809|P6|Post-Randomization Period|Adverse Event|0
4822715|NCT01160289|16627810|P5|Post-Randomization Period|Adverse Event|0
4822716|NCT01160289|16627811|P4|Post-Randomization Period|Adverse Event|2
4822717|NCT01160289|16627812|P3|Post-Randomization Period|Adverse Event|4
4822718|NCT01160289|16627813|P2|Post-Randomization Period|Adverse Event|4
4822719|NCT01160289|16627814|P1|Post-Randomization Period|Adverse Event|0
4822720|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4822721|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4822722|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4822723|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4822724|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0
4822725|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64
4822726|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4822727|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4822728|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4822729|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4822730|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0
4822731|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67
4822732|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Protocol Violation|0
4822733|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Protocol Violation|0
4822734|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Protocol Violation|0
4822735|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Protocol Violation|0
4822736|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Protocol Violation|0
4822737|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Protocol Violation|1
4822738|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Physician Decision|0
4822739|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Physician Decision|0
4822740|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Physician Decision|0
4822741|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Physician Decision|0
4822742|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Physician Decision|0
4822743|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Physician Decision|26
4822744|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4822745|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4822746|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4822747|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4822748|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Lost to Follow-up|0
4822749|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Lost to Follow-up|9
4822750|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4822751|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4822752|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4822753|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4822754|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Lack of Efficacy|0
4822755|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Lack of Efficacy|1
4822756|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4822757|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4822758|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4822759|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4822760|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0
4822761|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308
4822762|NCT01160289|16627809|P6|Screening, Washout, and Lead-In Period|Adverse Event|0
4822763|NCT01160289|16627810|P5|Screening, Washout, and Lead-In Period|Adverse Event|0
4822764|NCT01160289|16627811|P4|Screening, Washout, and Lead-In Period|Adverse Event|0
4822765|NCT01160289|16627812|P3|Screening, Washout, and Lead-In Period|Adverse Event|0
4822766|NCT01160289|16627813|P2|Screening, Washout, and Lead-In Period|Adverse Event|0
4822767|NCT01160289|16627814|P1|Screening, Washout, and Lead-In Period|Adverse Event|8
4822768|NCT01160211|16627903|P3|Overall Study|Lost to Follow-up|5
4822769|NCT01160211|16627904|P2|Overall Study|Lost to Follow-up|7
4822770|NCT01160211|16627905|P1|Overall Study|Lost to Follow-up|4
4822771|NCT01160211|16627903|P3|Overall Study|Physician Decision|0
4822772|NCT01160211|16627904|P2|Overall Study|Physician Decision|0
4822773|NCT01160211|16627905|P1|Overall Study|Physician Decision|2
4822774|NCT01160211|16627903|P3|Overall Study|Withdrawal by Subject|3
4822775|NCT01160211|16627904|P2|Overall Study|Withdrawal by Subject|5
4822776|NCT01160211|16627905|P1|Overall Study|Withdrawal by Subject|3
4822777|NCT01160211|16627903|P3|Overall Study|ongoing|79
4822778|NCT01160211|16627904|P2|Overall Study|ongoing|75
4822779|NCT01160211|16627905|P1|Overall Study|ongoing|90
4822780|NCT01160198|16627938|P3|Overall Study|Participant lost drug; withdrew consent|1
4822781|NCT01160198|16627939|P2|Overall Study|Participant lost drug; withdrew consent|0
4822782|NCT01160198|16627940|P1|Overall Study|Participant lost drug; withdrew consent|0
4822783|NCT01160198|16627938|P3|Overall Study|Lost to Follow-up|0
4822784|NCT01160198|16627939|P2|Overall Study|Lost to Follow-up|1
4822785|NCT01160198|16627940|P1|Overall Study|Lost to Follow-up|0
4822786|NCT01160198|16627938|P3|Overall Study|Adverse Event|0
4822787|NCT01160198|16627939|P2|Overall Study|Adverse Event|1
4822788|NCT01160198|16627940|P1|Overall Study|Adverse Event|0
4822789|NCT01160198|16627938|P3|Overall Study|Withdrawal by Subject|0
4822790|NCT01160198|16627939|P2|Overall Study|Withdrawal by Subject|1
4822791|NCT01160198|16627940|P1|Overall Study|Withdrawal by Subject|2
4822792|NCT01159938|16627962|P5|First Study Period|Protocol Violation (Microalbuminuria)|0
4822793|NCT01159938|16627963|P4|First Study Period|Protocol Violation (Microalbuminuria)|0
4822794|NCT01159938|16627964|P3|First Study Period|Protocol Violation (Microalbuminuria)|1
4822795|NCT01159938|16627965|P2|First Study Period|Protocol Violation (Microalbuminuria)|0
4822796|NCT01159938|16627966|P1|First Study Period|Protocol Violation (Microalbuminuria)|0
4822797|NCT01159912|16628029|P3|Overall Study|Withdrawal by Subject|3
4822798|NCT01159912|16628030|P2|Overall Study|Withdrawal by Subject|3
4822799|NCT01159912|16628031|P1|Overall Study|Withdrawal by Subject|10
4822800|NCT01159912|16628029|P3|Overall Study|Physician Decision|3
4822801|NCT01159912|16628030|P2|Overall Study|Physician Decision|0
4822802|NCT01159912|16628031|P1|Overall Study|Physician Decision|0
4822803|NCT01159912|16628029|P3|Overall Study|Lost to Follow-up|0
4822804|NCT01159912|16628030|P2|Overall Study|Lost to Follow-up|0
4822805|NCT01159912|16628031|P1|Overall Study|Lost to Follow-up|4
4822806|NCT01159912|16628029|P3|Overall Study|Protocol Violation|3
4822807|NCT01159912|16628030|P2|Overall Study|Protocol Violation|2
4822808|NCT01159912|16628031|P1|Overall Study|Protocol Violation|1
4822809|NCT01159912|16628029|P3|Overall Study|Lack of Efficacy|14
4822810|NCT01159912|16628030|P2|Overall Study|Lack of Efficacy|15
4822811|NCT01159912|16628031|P1|Overall Study|Lack of Efficacy|23
4822812|NCT01159912|16628029|P3|Overall Study|Adverse Event|3
4822813|NCT01159912|16628030|P2|Overall Study|Adverse Event|2
4822814|NCT01159912|16628031|P1|Overall Study|Adverse Event|2
4822815|NCT01159769|16628054|P1|Overall Study|Adverse Event|1
4822816|NCT01159691|16628074|P1|Overall Study|Disc. Neupro lack of efficacy & unknown|1
4822817|NCT01159691|16628074|P1|Overall Study|Disc. Neupro due to AE & unknown reasons|2
4822818|NCT01159691|16628074|P1|Overall Study|Disc. Neupro other & unknown reasons|7
4822819|NCT01159691|16628074|P1|Overall Study|Disc. Neupro other & lost to follow-up|2
4822820|NCT01159691|16628074|P1|Overall Study|Discontinued Neupro due to other reasons|1
4822821|NCT01159691|16628074|P1|Overall Study|Discontinued Neupro due to Adverse Event|6
4822822|NCT01159691|16628074|P1|Overall Study|Unknown reasons|1
4822823|NCT01159691|16628074|P1|Overall Study|Lost to Follow-up|2
4822824|NCT01159665|16628087|P6|Overall Study|Withdrawal by Subject|0
4822825|NCT01159665|16628088|P5|Overall Study|Withdrawal by Subject|0
4822826|NCT01159665|16628089|P4|Overall Study|Withdrawal by Subject|0
4822827|NCT01159665|16628090|P3|Overall Study|Withdrawal by Subject|0
4822828|NCT01159665|16628091|P2|Overall Study|Withdrawal by Subject|1
4822829|NCT01159665|16628092|P1|Overall Study|Withdrawal by Subject|0
4822830|NCT01159600|16628120|P8|Overall Study|Other reason not defined above|3
4822831|NCT01159600|16628121|P7|Overall Study|Other reason not defined above|3
4822832|NCT01159600|16628122|P6|Overall Study|Other reason not defined above|7
4822833|NCT01159600|16628123|P5|Overall Study|Other reason not defined above|5
4822834|NCT01159600|16628124|P4|Overall Study|Other reason not defined above|2
4822835|NCT01159600|16628125|P3|Overall Study|Other reason not defined above|4
4822836|NCT01159600|16628126|P2|Overall Study|Other reason not defined above|0
4822837|NCT01159600|16628127|P1|Overall Study|Other reason not defined above|3
4822838|NCT01159600|16628120|P8|Overall Study|Patient refusal to continue,not due toAE|5
4822839|NCT01159600|16628121|P7|Overall Study|Patient refusal to continue,not due toAE|2
4822840|NCT01159600|16628122|P6|Overall Study|Patient refusal to continue,not due toAE|4
4822841|NCT01159600|16628123|P5|Overall Study|Patient refusal to continue,not due toAE|4
4822842|NCT01159600|16628124|P4|Overall Study|Patient refusal to continue,not due toAE|5
4822843|NCT01159600|16628125|P3|Overall Study|Patient refusal to continue,not due toAE|4
4822844|NCT01159600|16628126|P2|Overall Study|Patient refusal to continue,not due toAE|2
4822845|NCT01159600|16628127|P1|Overall Study|Patient refusal to continue,not due toAE|7
4822846|NCT01159600|16628120|P8|Overall Study|Lost to Follow-up|2
4822847|NCT01159600|16628121|P7|Overall Study|Lost to Follow-up|3
4822848|NCT01159600|16628122|P6|Overall Study|Lost to Follow-up|0
4822849|NCT01159600|16628123|P5|Overall Study|Lost to Follow-up|3
4822850|NCT01159600|16628124|P4|Overall Study|Lost to Follow-up|3
4822851|NCT01159600|16628125|P3|Overall Study|Lost to Follow-up|4
4822852|NCT01159600|16628126|P2|Overall Study|Lost to Follow-up|3
4822853|NCT01159600|16628127|P1|Overall Study|Lost to Follow-up|2
4822854|NCT01159600|16628120|P8|Overall Study|Non compliant with protocol|0
4822855|NCT01159600|16628121|P7|Overall Study|Non compliant with protocol|2
4822856|NCT01159600|16628122|P6|Overall Study|Non compliant with protocol|0
4822857|NCT01159600|16628123|P5|Overall Study|Non compliant with protocol|2
4822858|NCT01159600|16628124|P4|Overall Study|Non compliant with protocol|0
4822859|NCT01159600|16628125|P3|Overall Study|Non compliant with protocol|0
4822860|NCT01159600|16628126|P2|Overall Study|Non compliant with protocol|1
4822861|NCT01159600|16628127|P1|Overall Study|Non compliant with protocol|2
4822862|NCT01159600|16628120|P8|Overall Study|Lack of Efficacy|1
4822863|NCT01159600|16628121|P7|Overall Study|Lack of Efficacy|0
4822864|NCT01159600|16628122|P6|Overall Study|Lack of Efficacy|0
4822865|NCT01159600|16628123|P5|Overall Study|Lack of Efficacy|2
4822866|NCT01159600|16628124|P4|Overall Study|Lack of Efficacy|0
4822867|NCT01159600|16628125|P3|Overall Study|Lack of Efficacy|0
4822868|NCT01159600|16628126|P2|Overall Study|Lack of Efficacy|0
4822869|NCT01159600|16628127|P1|Overall Study|Lack of Efficacy|0
4822870|NCT01159600|16628120|P8|Overall Study|Adverse Event|5
4822871|NCT01159600|16628121|P7|Overall Study|Adverse Event|7
4822872|NCT01159600|16628122|P6|Overall Study|Adverse Event|6
4822873|NCT01159600|16628123|P5|Overall Study|Adverse Event|8
4822874|NCT01159600|16628124|P4|Overall Study|Adverse Event|1
4822875|NCT01159600|16628125|P3|Overall Study|Adverse Event|5
4822876|NCT01159600|16628126|P2|Overall Study|Adverse Event|2
4822877|NCT01159600|16628127|P1|Overall Study|Adverse Event|7
4822878|NCT01159600|16628120|P8|Overall Study|Not treated|2
4822879|NCT01159600|16628121|P7|Overall Study|Not treated|2
4822880|NCT01159600|16628122|P6|Overall Study|Not treated|1
4822881|NCT01159600|16628123|P5|Overall Study|Not treated|0
4822882|NCT01159600|16628124|P4|Overall Study|Not treated|0
4822883|NCT01159600|16628125|P3|Overall Study|Not treated|1
4822884|NCT01159600|16628126|P2|Overall Study|Not treated|0
4822885|NCT01159600|16628127|P1|Overall Study|Not treated|0
4822886|NCT01159574|16628169|P1|Follow Up Phase|still being followed for overall surviva|18
4822887|NCT01159574|16628169|P1|Follow Up Phase|Lost to Follow-up|2
4822888|NCT01159574|16628169|P1|Treatment Phase|still on treatment|2
4822889|NCT01159574|16628169|P1|Treatment Phase|Withdrawal by Subject|7
4822890|NCT01159574|16628169|P1|Treatment Phase|Physician Decision|2
4822891|NCT01159574|16628169|P1|Treatment Phase|Death|6
4822892|NCT01159574|16628169|P1|Treatment Phase|Adverse Event|3
4822893|NCT01159574|16628169|P1|Treatment Phase|non-evaluable/not included in analysis|1
4822894|NCT01159431|16628190|P2|Overall Study|Lack of Efficacy|3
4822895|NCT01159431|16628191|P1|Overall Study|Lack of Efficacy|0
4822896|NCT01159431|16628190|P2|Overall Study|non-compliance|1
4822897|NCT01159431|16628191|P1|Overall Study|non-compliance|1
4822898|NCT01159431|16628190|P2|Overall Study|Adverse Event|2
4822899|NCT01159431|16628191|P1|Overall Study|Adverse Event|1
4822900|NCT01159171|16628244|P1|Overall Study|Death|1
4822901|NCT01159171|16628244|P1|Overall Study|Medical Decision|4
4822902|NCT01159171|16628244|P1|Overall Study|Need for Surgery|5
4822903|NCT01159171|16628244|P1|Overall Study|Protocol Violation|1
4822904|NCT01159171|16628244|P1|Overall Study|Progression of Disease|28
4822905|NCT01159171|16628244|P1|Overall Study|Adverse Event|11
4822906|NCT01158924|16628334|P2|Overall Study|Lost to Follow-up|1
4822907|NCT01158924|16628335|P1|Overall Study|Lost to Follow-up|0
4822908|NCT01158924|16628334|P2|Overall Study|Withdrawal by Subject|2
4822909|NCT01158924|16628335|P1|Overall Study|Withdrawal by Subject|1
4822910|NCT01158534|16628440|P1|Overall Study|Other|1
4822911|NCT01158534|16628440|P1|Overall Study|Death|1
4822912|NCT01158534|16628440|P1|Overall Study|Withdrawal by Subject|1
4822913|NCT01158404|16628465|P8|Overall Study|Progressive Disease|0
4822914|NCT01158404|16628466|P7|Overall Study|Progressive Disease|1
4822915|NCT01158404|16628467|P6|Overall Study|Progressive Disease|0
4822916|NCT01158404|16628468|P5|Overall Study|Progressive Disease|0
4822917|NCT01158404|16628469|P4|Overall Study|Progressive Disease|0
4822918|NCT01158404|16628470|P3|Overall Study|Progressive Disease|0
4822919|NCT01158404|16628471|P2|Overall Study|Progressive Disease|0
4822920|NCT01158404|16628472|P1|Overall Study|Progressive Disease|0
4822921|NCT01158404|16628465|P8|Overall Study|Physician Decision|1
4822922|NCT01158404|16628466|P7|Overall Study|Physician Decision|0
4822923|NCT01158404|16628467|P6|Overall Study|Physician Decision|0
4822924|NCT01158404|16628468|P5|Overall Study|Physician Decision|0
4822925|NCT01158404|16628469|P4|Overall Study|Physician Decision|0
4822926|NCT01158404|16628470|P3|Overall Study|Physician Decision|0
4822927|NCT01158404|16628471|P2|Overall Study|Physician Decision|0
4822928|NCT01158404|16628472|P1|Overall Study|Physician Decision|0
4822929|NCT01158404|16628465|P8|Overall Study|Withdrawal by Subject|1
4822930|NCT01158404|16628466|P7|Overall Study|Withdrawal by Subject|0
4822931|NCT01158404|16628467|P6|Overall Study|Withdrawal by Subject|1
4822932|NCT01158404|16628468|P5|Overall Study|Withdrawal by Subject|3
4822933|NCT01158404|16628469|P4|Overall Study|Withdrawal by Subject|0
4822934|NCT01158404|16628470|P3|Overall Study|Withdrawal by Subject|0
4822935|NCT01158404|16628471|P2|Overall Study|Withdrawal by Subject|1
4822936|NCT01158404|16628472|P1|Overall Study|Withdrawal by Subject|0
4822937|NCT01158378|16628514|P2|Overall Study|Withdrawal by Subject|0
4822938|NCT01158378|16628515|P1|Overall Study|Withdrawal by Subject|4
4822939|NCT01158378|16628514|P2|Overall Study|Lost to Follow-up|4
4822940|NCT01158378|16628515|P1|Overall Study|Lost to Follow-up|2
4822941|NCT01158378|16628514|P2|Overall Study|Death|5
4822942|NCT01158378|16628515|P1|Overall Study|Death|4
4822943|NCT01158261|16628527|P1|Overall Study|Withdrawal by Subject|1
4822944|NCT01158261|16628527|P1|Overall Study|Death|7
4822945|NCT01158261|16628527|P1|Overall Study|Lost to Follow-up|9
4822946|NCT01158222|16628531|P1|Overall Study|Not eligible for intermediate phase|17
4822947|NCT01158118|16628543|P2|Overall Study|Death|1
4822948|NCT01158118|16628544|P1|Overall Study|Death|0
4822949|NCT01158118|16628543|P2|Overall Study|Suffered stroke prior to transplant|1
4822950|NCT01158118|16628544|P1|Overall Study|Suffered stroke prior to transplant|0
4822951|NCT01158118|16628543|P2|Overall Study|Donor match was a screen failure|1
4822952|NCT01158118|16628544|P1|Overall Study|Donor match was a screen failure|0
4822953|NCT01158118|16628543|P2|Overall Study|Screen failure|0
4822954|NCT01158118|16628544|P1|Overall Study|Screen failure|1
4822955|NCT01157897|16628564|P4|Overall Study|Relocated|0
4822956|NCT01157897|16628565|P3|Overall Study|Relocated|0
4822957|NCT01157897|16628566|P2|Overall Study|Relocated|2
4822958|NCT01157897|16628567|P1|Overall Study|Relocated|0
4822959|NCT01157897|16628564|P4|Overall Study|Lost to Follow-up|1
4822960|NCT01157897|16628565|P3|Overall Study|Lost to Follow-up|0
4822961|NCT01157897|16628566|P2|Overall Study|Lost to Follow-up|0
4822962|NCT01157897|16628567|P1|Overall Study|Lost to Follow-up|2
4822963|NCT01157845|16628592|P1|Overall Study|Device malfunction|1
4822964|NCT01157845|16628592|P1|Overall Study|Study was ended|1
4822965|NCT01157845|16628592|P1|Overall Study|Protocol Violation|13
4822966|NCT01157845|16628592|P1|Overall Study|Physician Decision|3
4822967|NCT01157845|16628592|P1|Overall Study|Withdrawal by Subject|12
4822968|NCT01157845|16628592|P1|Overall Study|Lost to Follow-up|5
4822969|NCT01157676|16628599|P2|Surgery|underwent robotic cystectomy|0
4822970|NCT01157676|16628600|P1|Surgery|underwent robotic cystectomy|1
4822971|NCT01157676|16628599|P2|Surgery|converted to open procedure|5
4822972|NCT01157676|16628600|P1|Surgery|converted to open procedure|0
4822973|NCT01157676|16628599|P2|Surgery|underwent open cystectomy|4
4822974|NCT01157676|16628600|P1|Surgery|underwent open cystectomy|0
4822975|NCT01157676|16628599|P2|Randomization|Physician Decision|0
4822976|NCT01157676|16628600|P1|Randomization|Physician Decision|1
4822977|NCT01157676|16628599|P2|Randomization|Withdrawal by Subject|13
4822978|NCT01157676|16628600|P1|Randomization|Withdrawal by Subject|17
4822979|NCT01157676|16628599|P2|Randomization|unresectable|3
4822980|NCT01157676|16628600|P1|Randomization|unresectable|2
4822981|NCT01157676|16628599|P2|Randomization|Death|1
4822982|NCT01157676|16628600|P1|Randomization|Death|1
4822983|NCT01157377|16628675|P7|Overall Study|Other Miscellaneous Reasons|1
4822984|NCT01157377|16628676|P6|Overall Study|Other Miscellaneous Reasons|1
4822985|NCT01157377|16628677|P5|Overall Study|Other Miscellaneous Reasons|1
4822986|NCT01157377|16628678|P4|Overall Study|Other Miscellaneous Reasons|0
4822987|NCT01157377|16628679|P3|Overall Study|Other Miscellaneous Reasons|0
4822988|NCT01157377|16628680|P2|Overall Study|Other Miscellaneous Reasons|2
4822989|NCT01157377|16628681|P1|Overall Study|Other Miscellaneous Reasons|0
4822990|NCT01157377|16628675|P7|Overall Study|Lack of Efficacy|1
4822991|NCT01157377|16628676|P6|Overall Study|Lack of Efficacy|0
4822992|NCT01157377|16628677|P5|Overall Study|Lack of Efficacy|0
4822993|NCT01157377|16628678|P4|Overall Study|Lack of Efficacy|0
4822994|NCT01157377|16628679|P3|Overall Study|Lack of Efficacy|0
4822995|NCT01157377|16628680|P2|Overall Study|Lack of Efficacy|0
4822996|NCT01157377|16628681|P1|Overall Study|Lack of Efficacy|0
4822997|NCT01157377|16628675|P7|Overall Study|Protocol Violation|0
4822998|NCT01157377|16628676|P6|Overall Study|Protocol Violation|1
4822999|NCT01157377|16628677|P5|Overall Study|Protocol Violation|0
4823000|NCT01157377|16628678|P4|Overall Study|Protocol Violation|0
4823001|NCT01157377|16628679|P3|Overall Study|Protocol Violation|0
4823002|NCT01157377|16628680|P2|Overall Study|Protocol Violation|0
4823003|NCT01157377|16628681|P1|Overall Study|Protocol Violation|0
4823004|NCT01157377|16628675|P7|Overall Study|Personal Reasons|0
4823005|NCT01157377|16628676|P6|Overall Study|Personal Reasons|0
4823006|NCT01157377|16628677|P5|Overall Study|Personal Reasons|0
4823007|NCT01157377|16628678|P4|Overall Study|Personal Reasons|1
4823008|NCT01157377|16628679|P3|Overall Study|Personal Reasons|0
4823009|NCT01157377|16628680|P2|Overall Study|Personal Reasons|1
4823010|NCT01157377|16628681|P1|Overall Study|Personal Reasons|2
4823011|NCT01157377|16628675|P7|Overall Study|Lost to Follow-up|0
4823012|NCT01157377|16628676|P6|Overall Study|Lost to Follow-up|1
4823013|NCT01157377|16628677|P5|Overall Study|Lost to Follow-up|1
4823014|NCT01157377|16628678|P4|Overall Study|Lost to Follow-up|0
4823015|NCT01157377|16628679|P3|Overall Study|Lost to Follow-up|1
4823016|NCT01157377|16628680|P2|Overall Study|Lost to Follow-up|0
4823017|NCT01157377|16628681|P1|Overall Study|Lost to Follow-up|0
4823018|NCT01157364|16628703|P6|Overall Study|Adverse Event|0
4823019|NCT01157364|16628704|P5|Overall Study|Adverse Event|1
4823020|NCT01157364|16628705|P4|Overall Study|Adverse Event|0
4823021|NCT01157364|16628706|P3|Overall Study|Adverse Event|1
4823022|NCT01157364|16628707|P2|Overall Study|Adverse Event|1
4823023|NCT01157364|16628708|P1|Overall Study|Adverse Event|0
4823024|NCT01157364|16628703|P6|Overall Study|Lack of Efficacy|0
4823025|NCT01157364|16628704|P5|Overall Study|Lack of Efficacy|0
4823026|NCT01157364|16628705|P4|Overall Study|Lack of Efficacy|1
4823027|NCT01157364|16628706|P3|Overall Study|Lack of Efficacy|0
4823028|NCT01157364|16628707|P2|Overall Study|Lack of Efficacy|0
4823029|NCT01157364|16628708|P1|Overall Study|Lack of Efficacy|0
4823030|NCT01157364|16628703|P6|Overall Study|Lost to Follow-up|0
4823031|NCT01157364|16628704|P5|Overall Study|Lost to Follow-up|0
4823032|NCT01157364|16628705|P4|Overall Study|Lost to Follow-up|0
4823033|NCT01157364|16628706|P3|Overall Study|Lost to Follow-up|1
4823034|NCT01157364|16628707|P2|Overall Study|Lost to Follow-up|0
4823035|NCT01157364|16628708|P1|Overall Study|Lost to Follow-up|1
4823036|NCT01157364|16628703|P6|Overall Study|Personal Reasons|1
4823037|NCT01157364|16628704|P5|Overall Study|Personal Reasons|1
4823038|NCT01157364|16628705|P4|Overall Study|Personal Reasons|0
4823039|NCT01157364|16628706|P3|Overall Study|Personal Reasons|0
4823040|NCT01157364|16628707|P2|Overall Study|Personal Reasons|2
4823041|NCT01157364|16628708|P1|Overall Study|Personal Reasons|0
4823042|NCT01157364|16628703|P6|Overall Study|Other Reasons|0
4823043|NCT01157364|16628704|P5|Overall Study|Other Reasons|0
4823044|NCT01157364|16628705|P4|Overall Study|Other Reasons|1
4823045|NCT01157364|16628706|P3|Overall Study|Other Reasons|2
4823046|NCT01157364|16628707|P2|Overall Study|Other Reasons|1
4823047|NCT01157364|16628708|P1|Overall Study|Other Reasons|1
4823048|NCT01157351|16628742|P2|Overall Study|Randomized but not Treated|2
4823049|NCT01157351|16628743|P1|Overall Study|Randomized but not Treated|4
4823050|NCT01157351|16628742|P2|Overall Study|Noncompliance with Study Drug|3
4823051|NCT01157351|16628743|P1|Overall Study|Noncompliance with Study Drug|0
4823052|NCT01157351|16628742|P2|Overall Study|Other|36
4823053|NCT01157351|16628743|P1|Overall Study|Other|32
4823054|NCT01157351|16628742|P2|Overall Study|Protocol Violation|1
4823055|NCT01157351|16628743|P1|Overall Study|Protocol Violation|0
4823056|NCT01157351|16628742|P2|Overall Study|Physician Decision|4
4823057|NCT01157351|16628743|P1|Overall Study|Physician Decision|5
4823058|NCT01157351|16628742|P2|Overall Study|Withdrawal by Subject|27
4823059|NCT01157351|16628743|P1|Overall Study|Withdrawal by Subject|37
4823060|NCT01157351|16628742|P2|Overall Study|Lost to Follow-up|55
4823061|NCT01157351|16628743|P1|Overall Study|Lost to Follow-up|53
4823062|NCT01157351|16628742|P2|Overall Study|Death|0
4823063|NCT01157351|16628743|P1|Overall Study|Death|1
4823064|NCT01157351|16628742|P2|Overall Study|Adverse Event|4
4823065|NCT01157351|16628743|P1|Overall Study|Adverse Event|5
4823066|NCT01157234|16628761|P2|Overall Study|Withdrawal by Subject|0
4823067|NCT01157234|16628762|P1|Overall Study|Withdrawal by Subject|1
4823068|NCT01157182|16628794|P2|Washout of 28 Days|Adverse Event|0
4823069|NCT01157182|16628795|P1|Washout of 28 Days|Adverse Event|2
4823070|NCT01157169|16628843|P2|Second Intervention|Emesis Within 4 hrs of Administration|1
4823071|NCT01157169|16628844|P1|Second Intervention|Emesis Within 4 hrs of Administration|0
4823072|NCT01157169|16628843|P2|First Intervention|Emesis Within 4 hrs of Administration|2
4823073|NCT01157169|16628844|P1|First Intervention|Emesis Within 4 hrs of Administration|4
4823074|NCT01157117|16628863|P3|Overall Study|Unknown (Pending Final Form Submission)|13
4823075|NCT01157117|16628864|P2|Overall Study|Unknown (Pending Final Form Submission)|5
4823076|NCT01157117|16628865|P1|Overall Study|Unknown (Pending Final Form Submission)|4
4823077|NCT01157117|16628863|P3|Overall Study|Lost to Follow-up|1
4823078|NCT01157117|16628864|P2|Overall Study|Lost to Follow-up|0
4823079|NCT01157117|16628865|P1|Overall Study|Lost to Follow-up|0
4823080|NCT01157117|16628863|P3|Overall Study|Lack of Efficacy|0
4823081|NCT01157117|16628864|P2|Overall Study|Lack of Efficacy|1
4823082|NCT01157117|16628865|P1|Overall Study|Lack of Efficacy|1
4823083|NCT01157117|16628863|P3|Overall Study|Withdrawal by Subject|1
4823084|NCT01157117|16628864|P2|Overall Study|Withdrawal by Subject|1
4823085|NCT01157117|16628865|P1|Overall Study|Withdrawal by Subject|4
4823086|NCT01157117|16628863|P3|Overall Study|Dosing Symptoms|0
4823087|NCT01157117|16628864|P2|Overall Study|Dosing Symptoms|4
4823088|NCT01157117|16628865|P1|Overall Study|Dosing Symptoms|0
4823089|NCT01157078|16628906|P2|Overall Study|Other|4
4823090|NCT01157078|16628907|P1|Overall Study|Other|2
4823091|NCT01157078|16628906|P2|Overall Study|Lost to Follow-up|5
4823092|NCT01157078|16628907|P1|Overall Study|Lost to Follow-up|7
4823093|NCT01157078|16628906|P2|Overall Study|Study-specific withdrawal criteria|2
4823094|NCT01157078|16628907|P1|Overall Study|Study-specific withdrawal criteria|2
4823095|NCT01157078|16628906|P2|Overall Study|Lack of Efficacy|0
4823096|NCT01157078|16628907|P1|Overall Study|Lack of Efficacy|2
4823097|NCT01157078|16628906|P2|Overall Study|Condition under investigation worsened|1
4823098|NCT01157078|16628907|P1|Overall Study|Condition under investigation worsened|0
4823099|NCT01157078|16628906|P2|Overall Study|Severe non-compliance to protocol|4
4823100|NCT01157078|16628907|P1|Overall Study|Severe non-compliance to protocol|2
4823101|NCT01157078|16628906|P2|Overall Study|Adverse Event|6
4823102|NCT01157078|16628907|P1|Overall Study|Adverse Event|6
4823103|NCT01157078|16628906|P2|Overall Study|Eligibility criteria not fulfilled|0
4823104|NCT01157078|16628907|P1|Overall Study|Eligibility criteria not fulfilled|2
4823105|NCT01157078|16628906|P2|Overall Study|Withdrawal by Subject|14
4823106|NCT01157078|16628907|P1|Overall Study|Withdrawal by Subject|12
4823107|NCT01157065|16628957|P2|Overall Study|Death|1
4823108|NCT01157065|16628958|P1|Overall Study|Death|0
4823109|NCT01156844|16628979|P4|Overall Study|Protocol deviation|0
4823110|NCT01156844|16628980|P3|Overall Study|Protocol deviation|0
4823111|NCT01156844|16628981|P2|Overall Study|Protocol deviation|0
4823112|NCT01156844|16628982|P1|Overall Study|Protocol deviation|2
4823113|NCT01156844|16628979|P4|Overall Study|Administrative problems|1
4823114|NCT01156844|16628980|P3|Overall Study|Administrative problems|0
4823115|NCT01156844|16628981|P2|Overall Study|Administrative problems|1
4823116|NCT01156844|16628982|P1|Overall Study|Administrative problems|0
4823117|NCT01156844|16628979|P4|Overall Study|Lost to Follow-up|0
4823118|NCT01156844|16628980|P3|Overall Study|Lost to Follow-up|1
4823119|NCT01156844|16628981|P2|Overall Study|Lost to Follow-up|0
4823120|NCT01156844|16628982|P1|Overall Study|Lost to Follow-up|0
4823121|NCT01156844|16628979|P4|Overall Study|Withdrawal by Subject|2
4823122|NCT01156844|16628980|P3|Overall Study|Withdrawal by Subject|2
4823123|NCT01156844|16628981|P2|Overall Study|Withdrawal by Subject|0
4823124|NCT01156844|16628982|P1|Overall Study|Withdrawal by Subject|0
4823125|NCT01156844|16628979|P4|Overall Study|Abnormal test procedure result(s)|2
4823126|NCT01156844|16628980|P3|Overall Study|Abnormal test procedure result(s)|2
4823127|NCT01156844|16628981|P2|Overall Study|Abnormal test procedure result(s)|1
4823128|NCT01156844|16628982|P1|Overall Study|Abnormal test procedure result(s)|0
4823129|NCT01156844|16628979|P4|Overall Study|Adverse Event|1
4823130|NCT01156844|16628980|P3|Overall Study|Adverse Event|1
4823131|NCT01156844|16628981|P2|Overall Study|Adverse Event|0
4823132|NCT01156844|16628982|P1|Overall Study|Adverse Event|0
4823133|NCT01156792|16629016|P1|Overall Study|other Sponsor Decision (Protocol Amendme|11
4823134|NCT01156792|16629016|P1|Overall Study|Withdrawal by Subject|9
4823135|NCT01156792|16629016|P1|Overall Study|Physician Decision|3
4823136|NCT01156792|16629016|P1|Overall Study|Lost to Follow-up|3
4823137|NCT01156792|16629016|P1|Overall Study|Protocol Violation|6
4823138|NCT01156792|16629016|P1|Overall Study|Lack of Efficacy|36
4823139|NCT01156792|16629016|P1|Overall Study|Adverse Event|1
4823140|NCT01156714|16629084|P3|Overall Study|Withdrawal by Subject|3
4823141|NCT01156714|16629085|P2|Overall Study|Withdrawal by Subject|4
4823142|NCT01156714|16629086|P1|Overall Study|Withdrawal by Subject|9
4823143|NCT01156675|16629149|P3|Overall Study|No data|2
4823144|NCT01156675|16629150|P2|Overall Study|No data|22
4823145|NCT01156675|16629151|P1|Overall Study|No data|29
4823146|NCT01156675|16629149|P3|Overall Study|Death|0
4823147|NCT01156675|16629150|P2|Overall Study|Death|3
4823148|NCT01156675|16629151|P1|Overall Study|Death|5
4823149|NCT01156532|16629209|P1|Overall Study|Lost to Follow-up|1
4823150|NCT01156532|16629209|P1|Overall Study|Family Reasons|1
4823151|NCT01156480|16629221|P2|Overall Study|change in diagnosis|1
4823152|NCT01156480|16629222|P1|Overall Study|change in diagnosis|0
4823153|NCT01156376|16629251|P3|Overall Study|Withdrawal by Subject|3
4823154|NCT01156376|16629252|P2|Overall Study|Withdrawal by Subject|0
4823155|NCT01156376|16629253|P1|Overall Study|Withdrawal by Subject|0
4823156|NCT01156376|16629251|P3|Overall Study|Adverse Event|1
4823157|NCT01156376|16629252|P2|Overall Study|Adverse Event|0
4823158|NCT01156376|16629253|P1|Overall Study|Adverse Event|1
4823159|NCT01156363|16629474|P1|Overall Study|Other|6
4823160|NCT01156363|16629474|P1|Overall Study|Refused Treatment|4
4823161|NCT01156363|16629474|P1|Overall Study|Failure to Return|1
4823162|NCT01156363|16629474|P1|Overall Study|Insufficient Therapeutic Response|5
4823163|NCT01156363|16629474|P1|Overall Study|Adverse Event|6
4823164|NCT01156311|16629496|P4|6-month Add-on Therapy Period|Other|2
4823165|NCT01156311|16629497|P3|6-month Add-on Therapy Period|Other|1
4823166|NCT01156311|16629498|P2|6-month Add-on Therapy Period|Other|0
4823167|NCT01156311|16629499|P1|6-month Add-on Therapy Period|Other|0
4823168|NCT01156311|16629496|P4|6-month Add-on Therapy Period|Physician Decision|0
4823169|NCT01156311|16629497|P3|6-month Add-on Therapy Period|Physician Decision|1
4823170|NCT01156311|16629498|P2|6-month Add-on Therapy Period|Physician Decision|0
4823171|NCT01156311|16629499|P1|6-month Add-on Therapy Period|Physician Decision|0
4823172|NCT01156311|16629496|P4|6-month Add-on Therapy Period|Disease Activity|2
4823173|NCT01156311|16629497|P3|6-month Add-on Therapy Period|Disease Activity|1
4823174|NCT01156311|16629498|P2|6-month Add-on Therapy Period|Disease Activity|0
4823175|NCT01156311|16629499|P1|6-month Add-on Therapy Period|Disease Activity|0
4823176|NCT01156311|16629496|P4|6-month Add-on Therapy Period|Lost to Follow-up|0
4823177|NCT01156311|16629497|P3|6-month Add-on Therapy Period|Lost to Follow-up|2
4823178|NCT01156311|16629498|P2|6-month Add-on Therapy Period|Lost to Follow-up|0
4823179|NCT01156311|16629499|P1|6-month Add-on Therapy Period|Lost to Follow-up|0
4823180|NCT01156311|16629496|P4|6-month Add-on Therapy Period|Adverse Event|6
4823181|NCT01156311|16629497|P3|6-month Add-on Therapy Period|Adverse Event|7
4823182|NCT01156311|16629498|P2|6-month Add-on Therapy Period|Adverse Event|0
4823183|NCT01156311|16629499|P1|6-month Add-on Therapy Period|Adverse Event|0
4823184|NCT01156311|16629496|P4|2-Month Monotherapy Period|Other|0
4823185|NCT01156311|16629497|P3|2-Month Monotherapy Period|Other|0
4823186|NCT01156311|16629498|P2|2-Month Monotherapy Period|Other|0
4823187|NCT01156311|16629499|P1|2-Month Monotherapy Period|Other|1
4823188|NCT01156311|16629496|P4|2-Month Monotherapy Period|Physician Decision|0
4823189|NCT01156311|16629497|P3|2-Month Monotherapy Period|Physician Decision|0
4823190|NCT01156311|16629498|P2|2-Month Monotherapy Period|Physician Decision|1
4823191|NCT01156311|16629499|P1|2-Month Monotherapy Period|Physician Decision|0
4823192|NCT01156311|16629496|P4|2-Month Monotherapy Period|Withdrawal by Subject|0
4823193|NCT01156311|16629497|P3|2-Month Monotherapy Period|Withdrawal by Subject|0
4823194|NCT01156311|16629498|P2|2-Month Monotherapy Period|Withdrawal by Subject|1
4823195|NCT01156311|16629499|P1|2-Month Monotherapy Period|Withdrawal by Subject|1
4823196|NCT01156142|16629523|P2|Overall Study|Ineligible|1
4823197|NCT01156142|16629524|P1|Overall Study|Ineligible|0
4823198|NCT01156142|16629523|P2|Overall Study|Withdrawal by Subject|6
4823199|NCT01156142|16629524|P1|Overall Study|Withdrawal by Subject|8
4823200|NCT01156116|16629542|P2|Overall Study|CPAP intolerance|0
4823201|NCT01156116|16629543|P1|Overall Study|CPAP intolerance|2
4823202|NCT01156116|16629542|P2|Overall Study|Withdrawal by Subject|1
4823203|NCT01156116|16629543|P1|Overall Study|Withdrawal by Subject|3
4823204|NCT01156051|16629557|P2|Overall Study|patient not compliant with protocol|1
4823205|NCT01156051|16629558|P1|Overall Study|patient not compliant with protocol|0
4823206|NCT01156051|16629557|P2|Overall Study|Lost to Follow-up|0
4823207|NCT01156051|16629558|P1|Overall Study|Lost to Follow-up|1
4823208|NCT01156012|16629572|P2|Overall Study|Non respect of one of inclusion criteria|1
4823209|NCT01156012|16629573|P1|Overall Study|Non respect of one of inclusion criteria|2
4823298|NCT01155479|16629875|P2|Part II|Adverse Event|6
4823210|NCT01156012|16629572|P2|Overall Study|use of commercial drug instead of study|1
4823211|NCT01156012|16629573|P1|Overall Study|use of commercial drug instead of study|0
4823212|NCT01156012|16629572|P2|Overall Study|Withdrawal by Subject|0
4823213|NCT01156012|16629573|P1|Overall Study|Withdrawal by Subject|1
4823214|NCT01156012|16629572|P2|Overall Study|Lost to Follow-up|0
4823215|NCT01156012|16629573|P1|Overall Study|Lost to Follow-up|1
4823216|NCT01156012|16629572|P2|Overall Study|Adverse Event|1
4823217|NCT01156012|16629573|P1|Overall Study|Adverse Event|3
4823218|NCT01155869|16629590|P2|Overall Study|Lost to Follow-up|1
4823219|NCT01155869|16629591|P1|Overall Study|Lost to Follow-up|3
4823220|NCT01155726|16629700|P4|Period 1, 3 Days (Masked)|Inconvenience|0
4823221|NCT01155726|16629701|P3|Period 1, 3 Days (Masked)|Inconvenience|2
4823222|NCT01155726|16629702|P2|Period 1, 3 Days (Masked)|Inconvenience|0
4823223|NCT01155726|16629703|P1|Period 1, 3 Days (Masked)|Inconvenience|1
4823224|NCT01155661|16629725|P1|Overall Study|Sponsor Decision|13
4823225|NCT01155661|16629725|P1|Overall Study|Withdrawal by Subject|73
4823226|NCT01155661|16629725|P1|Overall Study|Protocol Violation|35
4823227|NCT01155661|16629725|P1|Overall Study|Physician Decision|3
4823228|NCT01155661|16629725|P1|Overall Study|Lost to Follow-up|22
4823229|NCT01155661|16629725|P1|Overall Study|Lack of Efficacy|32
4823230|NCT01155661|16629725|P1|Overall Study|Death|1
4823231|NCT01155661|16629725|P1|Overall Study|Adverse Event|101
4823232|NCT01155583|16629760|P9|Phase I|Withdrawal by Subject|0
4823233|NCT01155583|16629761|P8|Phase I|Withdrawal by Subject|1
4823234|NCT01155583|16629762|P7|Phase I|Withdrawal by Subject|0
4823235|NCT01155583|16629763|P6|Phase I|Withdrawal by Subject|0
4823236|NCT01155583|16629764|P5|Phase I|Withdrawal by Subject|0
4823237|NCT01155583|16629765|P4|Phase I|Withdrawal by Subject|0
4823238|NCT01155583|16629766|P3|Phase I|Withdrawal by Subject|0
4823239|NCT01155583|16629767|P2|Phase I|Withdrawal by Subject|0
4823240|NCT01155583|16629768|P1|Phase I|Withdrawal by Subject|0
4823241|NCT01155583|16629760|P9|Phase I|Screen failure - did not start treatment|0
4823242|NCT01155583|16629761|P8|Phase I|Screen failure - did not start treatment|2
4823243|NCT01155583|16629762|P7|Phase I|Screen failure - did not start treatment|0
4823244|NCT01155583|16629763|P6|Phase I|Screen failure - did not start treatment|0
4823245|NCT01155583|16629764|P5|Phase I|Screen failure - did not start treatment|1
4823246|NCT01155583|16629765|P4|Phase I|Screen failure - did not start treatment|0
4823247|NCT01155583|16629766|P3|Phase I|Screen failure - did not start treatment|0
4823248|NCT01155583|16629767|P2|Phase I|Screen failure - did not start treatment|0
4823249|NCT01155583|16629768|P1|Phase I|Screen failure - did not start treatment|0
4823250|NCT01155570|16629787|P1|Overall Study|Other Reasons|23
4823251|NCT01155570|16629787|P1|Overall Study|Participant's Economic Reasons + Other|1
4823252|NCT01155570|16629787|P1|Overall Study|Adverse Event + Other Reasons|7
4823253|NCT01155570|16629787|P1|Overall Study|Adverse Event + Lack of Efficacy|2
4823254|NCT01155570|16629787|P1|Overall Study|No Hospital Visits|7
4823255|NCT01155570|16629787|P1|Overall Study|Participant's Economic Reasons|17
4823256|NCT01155570|16629787|P1|Overall Study|Lack of Efficacy|46
4823257|NCT01155570|16629787|P1|Overall Study|Adverse Event|39
4823258|NCT01155531|16629821|P4|Overall Study|Withdrawal by Subject|0
4823259|NCT01155531|16629822|P3|Overall Study|Withdrawal by Subject|1
4823260|NCT01155531|16629823|P2|Overall Study|Withdrawal by Subject|0
4823261|NCT01155531|16629824|P1|Overall Study|Withdrawal by Subject|1
4823262|NCT01155531|16629821|P4|Overall Study|Lost to Follow-up|1
4823263|NCT01155531|16629822|P3|Overall Study|Lost to Follow-up|0
4823264|NCT01155531|16629823|P2|Overall Study|Lost to Follow-up|0
4823265|NCT01155531|16629824|P1|Overall Study|Lost to Follow-up|0
4823266|NCT01155531|16629821|P4|Overall Study|Adverse Event|0
4823267|NCT01155531|16629822|P3|Overall Study|Adverse Event|1
4823268|NCT01155531|16629823|P2|Overall Study|Adverse Event|0
4823269|NCT01155531|16629824|P1|Overall Study|Adverse Event|0
4823270|NCT01155479|16629872|P5|Part II|Non-Compliance with Protocol|0
4823271|NCT01155479|16629873|P4|Part II|Non-Compliance with Protocol|2
4823272|NCT01155479|16629874|P3|Part II|Non-Compliance with Protocol|0
4823273|NCT01155479|16629875|P2|Part II|Non-Compliance with Protocol|1
4823274|NCT01155479|16629876|P1|Part II|Non-Compliance with Protocol|0
4823275|NCT01155479|16629872|P5|Part II|Treatment Failure|1
4823276|NCT01155479|16629873|P4|Part II|Treatment Failure|0
4823277|NCT01155479|16629874|P3|Part II|Treatment Failure|2
4823278|NCT01155479|16629875|P2|Part II|Treatment Failure|1
4823279|NCT01155479|16629876|P1|Part II|Treatment Failure|0
4823280|NCT01155479|16629872|P5|Part II|Lost to Follow-up|1
4823281|NCT01155479|16629873|P4|Part II|Lost to Follow-up|0
4823282|NCT01155479|16629874|P3|Part II|Lost to Follow-up|0
4823283|NCT01155479|16629875|P2|Part II|Lost to Follow-up|0
4823284|NCT01155479|16629876|P1|Part II|Lost to Follow-up|1
4823285|NCT01155479|16629872|P5|Part II|Withdrawal by Subject|3
4823286|NCT01155479|16629873|P4|Part II|Withdrawal by Subject|7
4823287|NCT01155479|16629874|P3|Part II|Withdrawal by Subject|12
4823288|NCT01155479|16629875|P2|Part II|Withdrawal by Subject|4
4823289|NCT01155479|16629876|P1|Part II|Withdrawal by Subject|8
4823290|NCT01155479|16629872|P5|Part II|Administrative|46
4823291|NCT01155479|16629873|P4|Part II|Administrative|38
4823292|NCT01155479|16629874|P3|Part II|Administrative|36
4823293|NCT01155479|16629875|P2|Part II|Administrative|49
4823294|NCT01155479|16629876|P1|Part II|Administrative|43
4823295|NCT01155479|16629872|P5|Part II|Adverse Event|4
4823296|NCT01155479|16629873|P4|Part II|Adverse Event|3
4823297|NCT01155479|16629874|P3|Part II|Adverse Event|8
4823299|NCT01155479|16629876|P1|Part II|Adverse Event|7
4823300|NCT01155479|16629872|P5|Part I|Non-Compliance with Protocol|2
4823301|NCT01155479|16629873|P4|Part I|Non-Compliance with Protocol|3
4823302|NCT01155479|16629874|P3|Part I|Non-Compliance with Protocol|3
4823303|NCT01155479|16629875|P2|Part I|Non-Compliance with Protocol|1
4823304|NCT01155479|16629876|P1|Part I|Non-Compliance with Protocol|2
4823305|NCT01155479|16629872|P5|Part I|Did Not Receive Treatment|1
4823306|NCT01155479|16629873|P4|Part I|Did Not Receive Treatment|6
4823307|NCT01155479|16629874|P3|Part I|Did Not Receive Treatment|2
4823308|NCT01155479|16629875|P2|Part I|Did Not Receive Treatment|2
4823309|NCT01155479|16629876|P1|Part I|Did Not Receive Treatment|4
4823310|NCT01155479|16629872|P5|Part I|Treatment Failure|2
4823311|NCT01155479|16629873|P4|Part I|Treatment Failure|1
4823312|NCT01155479|16629874|P3|Part I|Treatment Failure|3
4823313|NCT01155479|16629875|P2|Part I|Treatment Failure|0
4823314|NCT01155479|16629876|P1|Part I|Treatment Failure|3
4823315|NCT01155479|16629872|P5|Part I|Lost to Follow-up|0
4823316|NCT01155479|16629873|P4|Part I|Lost to Follow-up|1
4823317|NCT01155479|16629874|P3|Part I|Lost to Follow-up|1
4823318|NCT01155479|16629875|P2|Part I|Lost to Follow-up|0
4823319|NCT01155479|16629876|P1|Part I|Lost to Follow-up|0
4823320|NCT01155479|16629872|P5|Part I|Withdrawal by Subject|9
4823321|NCT01155479|16629873|P4|Part I|Withdrawal by Subject|8
4823322|NCT01155479|16629874|P3|Part I|Withdrawal by Subject|8
4823323|NCT01155479|16629875|P2|Part I|Withdrawal by Subject|13
4823324|NCT01155479|16629876|P1|Part I|Withdrawal by Subject|11
4823325|NCT01155479|16629872|P5|Part I|Did Not Meet Protocol Eligibility|3
4823326|NCT01155479|16629873|P4|Part I|Did Not Meet Protocol Eligibility|1
4823327|NCT01155479|16629874|P3|Part I|Did Not Meet Protocol Eligibility|2
4823328|NCT01155479|16629875|P2|Part I|Did Not Meet Protocol Eligibility|1
4823329|NCT01155479|16629876|P1|Part I|Did Not Meet Protocol Eligibility|3
4823330|NCT01155479|16629872|P5|Part I|Administrative|0
4823331|NCT01155479|16629873|P4|Part I|Administrative|0
4823332|NCT01155479|16629874|P3|Part I|Administrative|2
4823333|NCT01155479|16629875|P2|Part I|Administrative|2
4823334|NCT01155479|16629876|P1|Part I|Administrative|2
4823335|NCT01155479|16629872|P5|Part I|Adverse Event|6
4823336|NCT01155479|16629873|P4|Part I|Adverse Event|7
4823337|NCT01155479|16629874|P3|Part I|Adverse Event|18
4823338|NCT01155479|16629875|P2|Part I|Adverse Event|8
4823339|NCT01155479|16629876|P1|Part I|Adverse Event|13
4823340|NCT01155466|16629928|P5|Overall Study|Randomized not treated|2
4823341|NCT01155466|16629929|P4|Overall Study|Randomized not treated|0
4823342|NCT01155466|16629930|P3|Overall Study|Randomized not treated|3
4823343|NCT01155466|16629931|P2|Overall Study|Randomized not treated|2
4823344|NCT01155466|16629932|P1|Overall Study|Randomized not treated|2
4823345|NCT01155466|16629928|P5|Overall Study|Administrative|0
4823346|NCT01155466|16629929|P4|Overall Study|Administrative|0
4823347|NCT01155466|16629930|P3|Overall Study|Administrative|0
4823348|NCT01155466|16629931|P2|Overall Study|Administrative|3
4823349|NCT01155466|16629932|P1|Overall Study|Administrative|0
4823350|NCT01155466|16629928|P5|Overall Study|Protocol Violation|1
4823351|NCT01155466|16629929|P4|Overall Study|Protocol Violation|0
4823352|NCT01155466|16629930|P3|Overall Study|Protocol Violation|2
4823353|NCT01155466|16629931|P2|Overall Study|Protocol Violation|0
4823354|NCT01155466|16629932|P1|Overall Study|Protocol Violation|0
4823355|NCT01155466|16629928|P5|Overall Study|Withdrawal by Subject|4
4823356|NCT01155466|16629929|P4|Overall Study|Withdrawal by Subject|4
4823357|NCT01155466|16629930|P3|Overall Study|Withdrawal by Subject|9
4823358|NCT01155466|16629931|P2|Overall Study|Withdrawal by Subject|5
4823359|NCT01155466|16629932|P1|Overall Study|Withdrawal by Subject|7
4823360|NCT01155466|16629928|P5|Overall Study|Lost to Follow-up|2
4823361|NCT01155466|16629929|P4|Overall Study|Lost to Follow-up|0
4823362|NCT01155466|16629930|P3|Overall Study|Lost to Follow-up|0
4823363|NCT01155466|16629931|P2|Overall Study|Lost to Follow-up|0
4823364|NCT01155466|16629932|P1|Overall Study|Lost to Follow-up|0
4823365|NCT01155466|16629928|P5|Overall Study|Adverse Event|18
4823366|NCT01155466|16629929|P4|Overall Study|Adverse Event|17
4823367|NCT01155466|16629930|P3|Overall Study|Adverse Event|6
4823368|NCT01155466|16629931|P2|Overall Study|Adverse Event|15
4823369|NCT01155466|16629932|P1|Overall Study|Adverse Event|13
4823370|NCT01155388|16629986|P2|Overall Study|Adverse Event|0
4823371|NCT01155388|16629987|P1|Overall Study|Adverse Event|1
4823372|NCT01155375|16629997|P2|Overall Study|Adverse Event|0
4823373|NCT01155375|16629998|P1|Overall Study|Adverse Event|1
4823374|NCT01155323|16630017|P2|Second Intervention|Lost to Follow-up|1
4823375|NCT01155323|16630018|P1|Second Intervention|Lost to Follow-up|1
4823376|NCT01155323|16630017|P2|First Intervention|exclusion criteria|1
4823377|NCT01155323|16630018|P1|First Intervention|exclusion criteria|1
4823378|NCT01155284|16630036|P2|Overall Study|Adverse Event|0
4823379|NCT01155284|16630037|P1|Overall Study|Adverse Event|1
4823380|NCT01155284|16630036|P2|Overall Study|Physician Decision|0
4823381|NCT01155284|16630037|P1|Overall Study|Physician Decision|1
4823382|NCT01155284|16630036|P2|Overall Study|Lost to Follow-up|2
4823383|NCT01155284|16630037|P1|Overall Study|Lost to Follow-up|1
4823384|NCT01155284|16630036|P2|Overall Study|Withdrawal by Subject|3
4823385|NCT01155284|16630037|P1|Overall Study|Withdrawal by Subject|4
4823386|NCT01155219|16630047|P2|Overall Study|non-medical reason|2
4823387|NCT01155219|16630048|P1|Overall Study|non-medical reason|1
4823388|NCT01155219|16630047|P2|Overall Study|Adverse Event|1
4823389|NCT01155219|16630048|P1|Overall Study|Adverse Event|3
4823390|NCT01155167|16630097|P2|Overall Study|Access site changed to femoral artery|0
4823391|NCT01155167|16630098|P1|Overall Study|Access site changed to femoral artery|1
4823392|NCT01155167|16630097|P2|Overall Study|Insufficient ultrasound data|0
4823393|NCT01155167|16630098|P1|Overall Study|Insufficient ultrasound data|2
4823394|NCT01155141|16630121|P1|Overall Study|Screen Failure|1
4823395|NCT01155141|16630121|P1|Overall Study|Withdrawal by Subject|1
4823396|NCT01155063|16630133|P1|Overall Study|Study terminated by sponsor|87
4823397|NCT01155063|16630133|P1|Overall Study|Withdrawal by Subject|1
4823398|NCT01155063|16630133|P1|Overall Study|Adverse Event|1
4823399|NCT01155024|16630143|P2|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2
4823400|NCT01155024|16630144|P1|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0
4823401|NCT01155024|16630143|P2|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2
4823402|NCT01155024|16630144|P1|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0
4823403|NCT01155024|16630143|P2|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2
4823404|NCT01155024|16630144|P1|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0
4823405|NCT01155011|16630154|P2|6 to 12 Months|Death|5
4823406|NCT01155011|16630155|P1|6 to 12 Months|Death|1
4823407|NCT01155011|16630154|P2|6 to 12 Months|Withdrawal by Subject|5
4823408|NCT01155011|16630155|P1|6 to 12 Months|Withdrawal by Subject|8
4823409|NCT01155011|16630154|P2|Baseline to 6 Months|Death|1
4823410|NCT01155011|16630155|P1|Baseline to 6 Months|Death|0
4823411|NCT01155011|16630154|P2|Baseline to 6 Months|investigator decision, moved|5
4823412|NCT01155011|16630155|P1|Baseline to 6 Months|investigator decision, moved|4
4823413|NCT01155011|16630154|P2|Baseline to 6 Months|Withdrawal by Subject|19
4823414|NCT01155011|16630155|P1|Baseline to 6 Months|Withdrawal by Subject|18
4823415|NCT01154816|16630196|P12|Overall Study|Adverse Event|0
4823416|NCT01154816|16630197|P11|Overall Study|Adverse Event|0
4823417|NCT01154816|16630198|P10|Overall Study|Adverse Event|0
4823418|NCT01154816|16630199|P9|Overall Study|Adverse Event|0
4823419|NCT01154816|16630200|P8|Overall Study|Adverse Event|1
4823420|NCT01154816|16630201|P7|Overall Study|Adverse Event|1
4823421|NCT01154816|16630202|P6|Overall Study|Adverse Event|0
4823422|NCT01154816|16630203|P5|Overall Study|Adverse Event|0
4823423|NCT01154816|16630204|P4|Overall Study|Adverse Event|0
4823424|NCT01154816|16630205|P3|Overall Study|Adverse Event|0
4823425|NCT01154816|16630206|P2|Overall Study|Adverse Event|2
4823426|NCT01154816|16630207|P1|Overall Study|Adverse Event|5
4823427|NCT01154816|16630196|P12|Overall Study|Physician Decision|1
4823428|NCT01154816|16630197|P11|Overall Study|Physician Decision|1
4823429|NCT01154816|16630198|P10|Overall Study|Physician Decision|1
4823430|NCT01154816|16630199|P9|Overall Study|Physician Decision|0
4823431|NCT01154816|16630200|P8|Overall Study|Physician Decision|0
4823432|NCT01154816|16630201|P7|Overall Study|Physician Decision|0
4823433|NCT01154816|16630202|P6|Overall Study|Physician Decision|0
4823434|NCT01154816|16630203|P5|Overall Study|Physician Decision|2
4823435|NCT01154816|16630204|P4|Overall Study|Physician Decision|0
4823436|NCT01154816|16630205|P3|Overall Study|Physician Decision|1
4823437|NCT01154816|16630206|P2|Overall Study|Physician Decision|0
4823438|NCT01154816|16630207|P1|Overall Study|Physician Decision|1
4823439|NCT01154816|16630196|P12|Overall Study|Progressive Disease|3
4823440|NCT01154816|16630197|P11|Overall Study|Progressive Disease|10
4823441|NCT01154816|16630198|P10|Overall Study|Progressive Disease|6
4823442|NCT01154816|16630199|P9|Overall Study|Progressive Disease|8
4823443|NCT01154816|16630200|P8|Overall Study|Progressive Disease|6
4823444|NCT01154816|16630201|P7|Overall Study|Progressive Disease|5
4823445|NCT01154816|16630202|P6|Overall Study|Progressive Disease|8
4823446|NCT01154816|16630203|P5|Overall Study|Progressive Disease|8
4823447|NCT01154816|16630204|P4|Overall Study|Progressive Disease|9
4823448|NCT01154816|16630205|P3|Overall Study|Progressive Disease|9
4823449|NCT01154816|16630206|P2|Overall Study|Progressive Disease|8
4823450|NCT01154816|16630207|P1|Overall Study|Progressive Disease|13
4823451|NCT01154816|16630196|P12|Overall Study|Withdrawal by Subject|0
4823452|NCT01154816|16630197|P11|Overall Study|Withdrawal by Subject|0
4823453|NCT01154816|16630198|P10|Overall Study|Withdrawal by Subject|3
4823454|NCT01154816|16630199|P9|Overall Study|Withdrawal by Subject|1
4823455|NCT01154816|16630200|P8|Overall Study|Withdrawal by Subject|0
4823456|NCT01154816|16630201|P7|Overall Study|Withdrawal by Subject|0
4823457|NCT01154816|16630202|P6|Overall Study|Withdrawal by Subject|0
4823458|NCT01154816|16630203|P5|Overall Study|Withdrawal by Subject|0
4823459|NCT01154816|16630204|P4|Overall Study|Withdrawal by Subject|1
4823460|NCT01154816|16630205|P3|Overall Study|Withdrawal by Subject|0
4823461|NCT01154816|16630206|P2|Overall Study|Withdrawal by Subject|0
4823462|NCT01154816|16630207|P1|Overall Study|Withdrawal by Subject|1
4823463|NCT01154673|16630284|P2|Overall Study|moved out of province|0
4823464|NCT01154673|16630285|P1|Overall Study|moved out of province|1
4823465|NCT01154673|16630284|P2|Overall Study|Lost to Follow-up|0
4823466|NCT01154673|16630285|P1|Overall Study|Lost to Follow-up|1
4823467|NCT01154452|16630340|P4|Phase II|Adverse Event|4
4823468|NCT01154452|16630341|P3|Phase II|Adverse Event|4
4823469|NCT01154452|16630342|P2|Phase II|Adverse Event|0
4823470|NCT01154452|16630343|P1|Phase II|Adverse Event|0
4823471|NCT01154452|16630340|P4|Phase II|Withdrawal by Subject|2
4823472|NCT01154452|16630341|P3|Phase II|Withdrawal by Subject|1
4823473|NCT01154452|16630342|P2|Phase II|Withdrawal by Subject|0
4823474|NCT01154452|16630343|P1|Phase II|Withdrawal by Subject|0
4823475|NCT01154452|16630340|P4|Phase Ib|Adverse Event|0
4823476|NCT01154452|16630341|P3|Phase Ib|Adverse Event|0
4823477|NCT01154452|16630342|P2|Phase Ib|Adverse Event|1
4823478|NCT01154452|16630343|P1|Phase Ib|Adverse Event|2
4823479|NCT01154452|16630340|P4|Phase Ib|Not Treated|0
4823480|NCT01154452|16630341|P3|Phase Ib|Not Treated|0
4823481|NCT01154452|16630342|P2|Phase Ib|Not Treated|0
4823482|NCT01154452|16630343|P1|Phase Ib|Not Treated|1
4823483|NCT01154296|16630375|P2|6-month Follow-up|Declined by Study Coordinator|4
4823484|NCT01154296|16630376|P1|6-month Follow-up|Declined by Study Coordinator|5
4823485|NCT01154296|16630375|P2|6-month Follow-up|Death|2
4823486|NCT01154296|16630376|P1|6-month Follow-up|Death|3
4823487|NCT01154296|16630375|P2|6-month Follow-up|Withdrew consent|15
4823488|NCT01154296|16630376|P1|6-month Follow-up|Withdrew consent|14
4823489|NCT01154296|16630375|P2|6-month Follow-up|Incarcerated|32
4823490|NCT01154296|16630376|P1|6-month Follow-up|Incarcerated|37
4823491|NCT01154296|16630375|P2|6-month Follow-up|Lost contact|275
4823492|NCT01154296|16630376|P1|6-month Follow-up|Lost contact|269
4823493|NCT01154296|16630375|P2|Randomization and Intervention|Left clinic early|0
4823494|NCT01154296|16630376|P1|Randomization and Intervention|Left clinic early|2
4823495|NCT01154296|16630375|P2|Randomization and Intervention|Left before test|1
4823496|NCT01154296|16630376|P1|Randomization and Intervention|Left before test|0
4823497|NCT01154296|16630375|P2|Randomization and Intervention|Did not return|0
4823498|NCT01154296|16630376|P1|Randomization and Intervention|Did not return|1
4823499|NCT01154296|16630375|P2|Randomization and Intervention|Declined by staff|0
4823500|NCT01154296|16630376|P1|Randomization and Intervention|Declined by staff|1
4823501|NCT01154296|16630375|P2|Randomization and Intervention|Decided to decline|1
4823502|NCT01154296|16630376|P1|Randomization and Intervention|Decided to decline|1
4823503|NCT01154283|16630394|P2|7-12 Weeks|Withdrawal by Subject|1
4823504|NCT01154283|16630395|P1|7-12 Weeks|Withdrawal by Subject|0
4823505|NCT01154283|16630394|P2|7-12 Weeks|Death|0
4823506|NCT01154283|16630395|P1|7-12 Weeks|Death|1
4823507|NCT01154283|16630394|P2|0-6 Weeks|Death|1
4823508|NCT01154283|16630395|P1|0-6 Weeks|Death|0
4823509|NCT01154283|16630394|P2|0-6 Weeks|Withdrawal by Subject|2
4823510|NCT01154283|16630395|P1|0-6 Weeks|Withdrawal by Subject|7
4823511|NCT01154231|16630407|P1|Overall Study|No Info. After 1st Day, No Drug Admin.|1
4823512|NCT01154231|16630407|P1|Overall Study|Safety Unassessable, No Drug Admin.|1
4823513|NCT01154218|16630413|P4|Fourth Intervention Period|Withdrawal by Subject|0
4823514|NCT01154218|16630414|P3|Fourth Intervention Period|Withdrawal by Subject|0
4823515|NCT01154218|16630415|P2|Fourth Intervention Period|Withdrawal by Subject|0
4823516|NCT01154218|16630416|P1|Fourth Intervention Period|Withdrawal by Subject|1
4823517|NCT01154218|16630413|P4|Washout Period (at Least 14 Days)|Withdrawal by Subject|1
4823518|NCT01154218|16630414|P3|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4823519|NCT01154218|16630415|P2|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4823520|NCT01154218|16630416|P1|Washout Period (at Least 14 Days)|Withdrawal by Subject|0
4823521|NCT01154218|16630413|P4|Third Intervention Period|Adverse Event|0
4823522|NCT01154218|16630414|P3|Third Intervention Period|Adverse Event|0
4823523|NCT01154218|16630415|P2|Third Intervention Period|Adverse Event|1
4823524|NCT01154218|16630416|P1|Third Intervention Period|Adverse Event|0
4823525|NCT01154166|16630490|P2|Overall Study|Poor Compliance|0
4823526|NCT01154166|16630491|P1|Overall Study|Poor Compliance|1
4823527|NCT01154166|16630490|P2|Overall Study|Disease Progression|0
4823528|NCT01154166|16630491|P1|Overall Study|Disease Progression|1
4823529|NCT01154166|16630490|P2|Overall Study|Lack of Efficacy|0
4823530|NCT01154166|16630491|P1|Overall Study|Lack of Efficacy|3
4823531|NCT01154166|16630490|P2|Overall Study|Withdrawal by Subject|1
4823532|NCT01154166|16630491|P1|Overall Study|Withdrawal by Subject|10
4823533|NCT01154166|16630490|P2|Overall Study|Protocol Violation|1
4823534|NCT01154166|16630491|P1|Overall Study|Protocol Violation|4
4823535|NCT01154166|16630490|P2|Overall Study|Lost to Follow-up|1
4823536|NCT01154166|16630491|P1|Overall Study|Lost to Follow-up|1
4823537|NCT01154166|16630490|P2|Overall Study|Adverse Event|9
4823538|NCT01154166|16630491|P1|Overall Study|Adverse Event|14
4823539|NCT01154153|16630523|P2|Overall Study|Withdrew consent|0
4823540|NCT01154153|16630524|P1|Overall Study|Withdrew consent|1
4823541|NCT01154153|16630523|P2|Overall Study|Unable to use labs|3
4823542|NCT01154153|16630524|P1|Overall Study|Unable to use labs|2
4823543|NCT01154153|16630523|P2|Overall Study|Poor compliance to protocol|0
4823544|NCT01154153|16630524|P1|Overall Study|Poor compliance to protocol|2
4823545|NCT01154140|16630542|P2|Overall Study|Randomized but not treated|2
4823546|NCT01154140|16630543|P1|Overall Study|Randomized but not treated|1
4823547|NCT01154140|16630542|P2|Overall Study|Other|1
4823548|NCT01154140|16630543|P1|Overall Study|Other|3
4823549|NCT01154140|16630542|P2|Overall Study|Withdrawal by Subject|13
4823550|NCT01154140|16630543|P1|Overall Study|Withdrawal by Subject|12
4823551|NCT01154140|16630542|P2|Overall Study|Lost to Follow-up|5
4823552|NCT01154140|16630543|P1|Overall Study|Lost to Follow-up|4
4823553|NCT01154140|16630542|P2|Overall Study|Death|81
4823554|NCT01154140|16630543|P1|Overall Study|Death|71
4823555|NCT01154127|16630596|P2|Period 2 (21 Days)|Protocol Deviation|1
4823556|NCT01154127|16630597|P1|Period 2 (21 Days)|Protocol Deviation|0
4823557|NCT01154127|16630596|P2|Washout (14 - 28 Days)|Abnormal Test Procedure|0
4823558|NCT01154127|16630597|P1|Washout (14 - 28 Days)|Abnormal Test Procedure|1
4823559|NCT01154127|16630596|P2|Washout (14 - 28 Days)|Adverse Event|0
4823560|NCT01154127|16630597|P1|Washout (14 - 28 Days)|Adverse Event|2
4823561|NCT01154127|16630596|P2|Period 1 (21 Days)|Withdrawal by Subject|2
4823562|NCT01154127|16630597|P1|Period 1 (21 Days)|Withdrawal by Subject|0
4823563|NCT01154127|16630596|P2|Period 1 (21 Days)|Adverse Event|4
4823564|NCT01154127|16630597|P1|Period 1 (21 Days)|Adverse Event|3
4823565|NCT01154101|16630624|P5|Overall Study|Withdrawal by Subject|1
4823566|NCT01154101|16630625|P4|Overall Study|Withdrawal by Subject|0
4823567|NCT01154101|16630626|P3|Overall Study|Withdrawal by Subject|2
4823568|NCT01154101|16630627|P2|Overall Study|Withdrawal by Subject|1
4823569|NCT01154101|16630628|P1|Overall Study|Withdrawal by Subject|0
4823570|NCT01154101|16630624|P5|Overall Study|Lost to Follow-up|0
4823571|NCT01154101|16630625|P4|Overall Study|Lost to Follow-up|1
4823572|NCT01154101|16630626|P3|Overall Study|Lost to Follow-up|0
4823573|NCT01154101|16630627|P2|Overall Study|Lost to Follow-up|1
4823574|NCT01154101|16630628|P1|Overall Study|Lost to Follow-up|0
4823575|NCT01154101|16630624|P5|Overall Study|Adverse Event|0
4823576|NCT01154101|16630625|P4|Overall Study|Adverse Event|1
4823577|NCT01154101|16630626|P3|Overall Study|Adverse Event|1
4823578|NCT01154101|16630627|P2|Overall Study|Adverse Event|2
4823579|NCT01154101|16630628|P1|Overall Study|Adverse Event|0
4823580|NCT01154088|16630683|P3|Overall Study|Lost to Follow-up|7
4823581|NCT01154088|16630684|P2|Overall Study|Lost to Follow-up|6
4823582|NCT01154088|16630685|P1|Overall Study|Lost to Follow-up|4
4823583|NCT01154036|16630725|P8|Phase II|Withdrawal by Subject|4
4823584|NCT01154036|16630726|P7|Phase II|Withdrawal by Subject|5
4823585|NCT01154036|16630727|P6|Phase II|Withdrawal by Subject|2
4823586|NCT01154036|16630728|P5|Phase II|Withdrawal by Subject|4
4823587|NCT01154036|16630729|P4|Phase II|Withdrawal by Subject|0
4823588|NCT01154036|16630730|P3|Phase II|Withdrawal by Subject|0
4823589|NCT01154036|16630731|P2|Phase II|Withdrawal by Subject|0
4823590|NCT01154036|16630732|P1|Phase II|Withdrawal by Subject|0
4823591|NCT01154036|16630725|P8|Phase II|Protocol Violation|0
4823592|NCT01154036|16630726|P7|Phase II|Protocol Violation|0
4823593|NCT01154036|16630727|P6|Phase II|Protocol Violation|2
4823594|NCT01154036|16630728|P5|Phase II|Protocol Violation|1
4823595|NCT01154036|16630729|P4|Phase II|Protocol Violation|0
4823596|NCT01154036|16630730|P3|Phase II|Protocol Violation|0
4823597|NCT01154036|16630731|P2|Phase II|Protocol Violation|0
4823598|NCT01154036|16630732|P1|Phase II|Protocol Violation|0
4823599|NCT01154036|16630725|P8|Phase II|Lost to Follow-up|1
4823600|NCT01154036|16630726|P7|Phase II|Lost to Follow-up|2
4823601|NCT01154036|16630727|P6|Phase II|Lost to Follow-up|0
4823602|NCT01154036|16630728|P5|Phase II|Lost to Follow-up|2
4823603|NCT01154036|16630729|P4|Phase II|Lost to Follow-up|1
4823604|NCT01154036|16630730|P3|Phase II|Lost to Follow-up|0
4823605|NCT01154036|16630731|P2|Phase II|Lost to Follow-up|0
4823606|NCT01154036|16630732|P1|Phase II|Lost to Follow-up|0
4823607|NCT01154036|16630725|P8|Phase II|Physician Decision|0
4823608|NCT01154036|16630726|P7|Phase II|Physician Decision|1
4823609|NCT01154036|16630727|P6|Phase II|Physician Decision|0
4823610|NCT01154036|16630728|P5|Phase II|Physician Decision|0
4823611|NCT01154036|16630729|P4|Phase II|Physician Decision|0
4823612|NCT01154036|16630730|P3|Phase II|Physician Decision|0
4823613|NCT01154036|16630731|P2|Phase II|Physician Decision|0
4823614|NCT01154036|16630732|P1|Phase II|Physician Decision|0
4823615|NCT01154036|16630725|P8|Phase II|Adverse Event|1
4823616|NCT01154036|16630726|P7|Phase II|Adverse Event|1
4823617|NCT01154036|16630727|P6|Phase II|Adverse Event|1
4823618|NCT01154036|16630728|P5|Phase II|Adverse Event|1
4823619|NCT01154036|16630729|P4|Phase II|Adverse Event|0
4823620|NCT01154036|16630730|P3|Phase II|Adverse Event|0
4823621|NCT01154036|16630731|P2|Phase II|Adverse Event|0
4823622|NCT01154036|16630732|P1|Phase II|Adverse Event|0
4823623|NCT01154036|16630725|P8|Phase I|Adverse Event|0
4823624|NCT01154036|16630726|P7|Phase I|Adverse Event|0
4823625|NCT01154036|16630727|P6|Phase I|Adverse Event|0
4823626|NCT01154036|16630728|P5|Phase I|Adverse Event|0
4823627|NCT01154036|16630729|P4|Phase I|Adverse Event|0
4823628|NCT01154036|16630730|P3|Phase I|Adverse Event|12
4823629|NCT01154036|16630731|P2|Phase I|Adverse Event|11
4823630|NCT01154036|16630732|P1|Phase I|Adverse Event|1
4823631|NCT01154036|16630725|P8|Phase I|Withdrawal by Subject|0
4823632|NCT01154036|16630726|P7|Phase I|Withdrawal by Subject|0
4823633|NCT01154036|16630727|P6|Phase I|Withdrawal by Subject|0
4823634|NCT01154036|16630728|P5|Phase I|Withdrawal by Subject|0
4823635|NCT01154036|16630729|P4|Phase I|Withdrawal by Subject|0
4823636|NCT01154036|16630730|P3|Phase I|Withdrawal by Subject|29
4823637|NCT01154036|16630731|P2|Phase I|Withdrawal by Subject|10
4823638|NCT01154036|16630732|P1|Phase I|Withdrawal by Subject|2
4823639|NCT01154036|16630725|P8|Phase I|Protocol Violation|0
4823640|NCT01154036|16630726|P7|Phase I|Protocol Violation|0
4823641|NCT01154036|16630727|P6|Phase I|Protocol Violation|0
4823642|NCT01154036|16630728|P5|Phase I|Protocol Violation|0
4823643|NCT01154036|16630729|P4|Phase I|Protocol Violation|0
4823644|NCT01154036|16630730|P3|Phase I|Protocol Violation|9
4823645|NCT01154036|16630731|P2|Phase I|Protocol Violation|3
4823646|NCT01154036|16630732|P1|Phase I|Protocol Violation|0
4823647|NCT01154036|16630725|P8|Phase I|Lost to Follow-up|0
4823648|NCT01154036|16630726|P7|Phase I|Lost to Follow-up|0
4823649|NCT01154036|16630727|P6|Phase I|Lost to Follow-up|0
4823650|NCT01154036|16630728|P5|Phase I|Lost to Follow-up|0
4823651|NCT01154036|16630729|P4|Phase I|Lost to Follow-up|0
4823652|NCT01154036|16630730|P3|Phase I|Lost to Follow-up|6
4823653|NCT01154036|16630731|P2|Phase I|Lost to Follow-up|3
4823654|NCT01154036|16630732|P1|Phase I|Lost to Follow-up|0
4823655|NCT01154036|16630725|P8|Phase I|Physician Decision|0
4823656|NCT01154036|16630726|P7|Phase I|Physician Decision|0
4823657|NCT01154036|16630727|P6|Phase I|Physician Decision|0
4823658|NCT01154036|16630728|P5|Phase I|Physician Decision|0
4823659|NCT01154036|16630729|P4|Phase I|Physician Decision|0
4823660|NCT01154036|16630730|P3|Phase I|Physician Decision|0
4823661|NCT01154036|16630731|P2|Phase I|Physician Decision|1
4823662|NCT01154036|16630732|P1|Phase I|Physician Decision|0
4823663|NCT01154010|16630856|P2|Overall Study|Lost to Follow-up|1
4823664|NCT01154010|16630857|P1|Overall Study|Lost to Follow-up|0
4823665|NCT01153984|16630863|P1|Overall Study|Adverse Event|1
4823666|NCT01153984|16630863|P1|Overall Study|Withdrawal by Subject|1
4823667|NCT01153971|16630874|P1|Follow-up (Months 17-40 of Study)|Disease progression|2
4823668|NCT01153971|16630874|P1|Follow-up (Months 17-40 of Study)|Protocol Violation|1
4823669|NCT01153971|16630874|P1|Follow-up (Months 17-40 of Study)|Adverse Event|1
4823670|NCT01153971|16630874|P1|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1
4823671|NCT01153971|16630874|P1|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2
4823672|NCT01153971|16630874|P1|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1
4823673|NCT01153971|16630874|P1|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2
4823674|NCT01153958|16630897|P2|Overall Study|Study Terminated|32
4823675|NCT01153958|16630898|P1|Overall Study|Study Terminated|36
4823676|NCT01153893|16630916|P2|Overall Study|Adverse Event|0
4823677|NCT01153893|16630917|P1|Overall Study|Adverse Event|1
4823678|NCT01153841|16630943|P2|Overall Study|Lost to Follow-up|0
4823679|NCT01153841|16630944|P1|Overall Study|Lost to Follow-up|2
4823680|NCT01153841|16630943|P2|Overall Study|Protocol Violation|0
4823681|NCT01153841|16630944|P1|Overall Study|Protocol Violation|2
4823682|NCT01153841|16630943|P2|Overall Study|Withdrawal by Subject|0
4823683|NCT01153841|16630944|P1|Overall Study|Withdrawal by Subject|1
4823684|NCT01153841|16630943|P2|Overall Study|Adverse Event|0
4823685|NCT01153841|16630944|P1|Overall Study|Adverse Event|1
4823686|NCT01153815|16630960|P2|Overall Study|Withdrawal by Subject|4
4823687|NCT01153815|16630961|P1|Overall Study|Withdrawal by Subject|6
4823688|NCT01153815|16630960|P2|Overall Study|Adverse Event|1
4823689|NCT01153815|16630961|P1|Overall Study|Adverse Event|3
4823690|NCT01153763|16630983|P1|Overall Study|Withdrawal by Subject|2
4823691|NCT01153763|16630983|P1|Overall Study|Physician Decision|2
4823692|NCT01153763|16630983|P1|Overall Study|Lost to Follow-up|1
4823693|NCT01153763|16630983|P1|Overall Study|Study Closed|16
4823694|NCT01153724|16630999|P1|Treatment Period 2|Other reason not defined above|1
4823695|NCT01153724|16630999|P1|Treatment Period 2|Adverse Event|1
4823696|NCT01153724|16630999|P1|Treatment Period 1|Withdrawal by Subject|1
4823697|NCT01153698|16631039|P1|Overall Study|Not treated with Pradaxa|5
4823698|NCT01153698|16631039|P1|Overall Study|Other|2
4823699|NCT01153698|16631039|P1|Overall Study|Switch to other anticoagulants|4
4823700|NCT01153698|16631039|P1|Overall Study|Withdrawal by Subject|2
4823701|NCT01153698|16631039|P1|Overall Study|Lost to Follow-up|4
4823702|NCT01153698|16631039|P1|Overall Study|Adverse Event|12
4823703|NCT01153633|16631090|P2|Overall Study|Therapeutic failure|3
4823704|NCT01153633|16631091|P1|Overall Study|Therapeutic failure|3
4823705|NCT01153633|16631090|P2|Overall Study|Protocol Violation|1
4823706|NCT01153633|16631091|P1|Overall Study|Protocol Violation|1
4823707|NCT01153516|16631128|P2|Overall Study|Both subjects refused surgery|0
4823708|NCT01153516|16631129|P1|Overall Study|Both subjects refused surgery|2
4823709|NCT01153425|16631154|P2|Overall Study|Withdrawal by Subject|3
4823710|NCT01153425|16631155|P1|Overall Study|Withdrawal by Subject|3
4823711|NCT01153347|16631167|P4|Overall Study|Death|0
4823712|NCT01153347|16631168|P3|Overall Study|Death|0
4823713|NCT01153347|16631169|P2|Overall Study|Death|0
4823714|NCT01153347|16631170|P1|Overall Study|Death|1
4823715|NCT01153347|16631167|P4|Overall Study|Other|0
4823716|NCT01153347|16631168|P3|Overall Study|Other|4
4823717|NCT01153347|16631169|P2|Overall Study|Other|5
4823718|NCT01153347|16631170|P1|Overall Study|Other|5
4823719|NCT01153347|16631167|P4|Overall Study|Lost to Follow-up|8
4823720|NCT01153347|16631168|P3|Overall Study|Lost to Follow-up|11
4823721|NCT01153347|16631169|P2|Overall Study|Lost to Follow-up|9
4823722|NCT01153347|16631170|P1|Overall Study|Lost to Follow-up|4
4823723|NCT01153347|16631167|P4|Overall Study|Study-specific withdrawal criteria|2
4823724|NCT01153347|16631168|P3|Overall Study|Study-specific withdrawal criteria|1
4823725|NCT01153347|16631169|P2|Overall Study|Study-specific withdrawal criteria|3
4823726|NCT01153347|16631170|P1|Overall Study|Study-specific withdrawal criteria|4
4823727|NCT01153347|16631167|P4|Overall Study|Lack of Efficacy|4
4823728|NCT01153347|16631168|P3|Overall Study|Lack of Efficacy|0
4823729|NCT01153347|16631169|P2|Overall Study|Lack of Efficacy|2
4823730|NCT01153347|16631170|P1|Overall Study|Lack of Efficacy|2
4823731|NCT01153347|16631167|P4|Overall Study|Condition under investigation worsened|0
4823732|NCT01153347|16631168|P3|Overall Study|Condition under investigation worsened|0
4823733|NCT01153347|16631169|P2|Overall Study|Condition under investigation worsened|1
4823734|NCT01153347|16631170|P1|Overall Study|Condition under investigation worsened|1
4823735|NCT01153347|16631167|P4|Overall Study|Severe non-compliance to protocol|3
4823736|NCT01153347|16631168|P3|Overall Study|Severe non-compliance to protocol|4
4823737|NCT01153347|16631169|P2|Overall Study|Severe non-compliance to protocol|7
4823738|NCT01153347|16631170|P1|Overall Study|Severe non-compliance to protocol|6
4823739|NCT01153347|16631167|P4|Overall Study|Adverse Event|7
4823740|NCT01153347|16631168|P3|Overall Study|Adverse Event|21
4823741|NCT01153347|16631169|P2|Overall Study|Adverse Event|9
4823742|NCT01153347|16631170|P1|Overall Study|Adverse Event|3
4823743|NCT01153347|16631167|P4|Overall Study|Eligibility criteria not fulfilled|1
4823744|NCT01153347|16631168|P3|Overall Study|Eligibility criteria not fulfilled|2
4823745|NCT01153347|16631169|P2|Overall Study|Eligibility criteria not fulfilled|1
4823746|NCT01153347|16631170|P1|Overall Study|Eligibility criteria not fulfilled|0
4823747|NCT01153347|16631167|P4|Overall Study|Withdrawal by Subject|7
4823748|NCT01153347|16631168|P3|Overall Study|Withdrawal by Subject|7
4823749|NCT01153347|16631169|P2|Overall Study|Withdrawal by Subject|7
4823750|NCT01153347|16631170|P1|Overall Study|Withdrawal by Subject|7
4823751|NCT01153321|16631270|P2|Overall Study|Adverse Event|1
4823752|NCT01153321|16631271|P1|Overall Study|Adverse Event|1
4823753|NCT01153321|16631270|P2|Overall Study|Withdrawal by Subject|1
4823754|NCT01153321|16631271|P1|Overall Study|Withdrawal by Subject|0
4823755|NCT01153321|16631270|P2|Overall Study|Development of study withdrawal criteria|1
4823756|NCT01153321|16631271|P1|Overall Study|Development of study withdrawal criteria|0
4823757|NCT01153269|16631383|P1|Overall Study|Antiretroviral therapy break|1
4823758|NCT01153269|16631383|P1|Overall Study|Withdrawal by Subject|1
4823759|NCT01153009|16631446|P4|Overall Study|Other|2
4823760|NCT01153009|16631447|P3|Overall Study|Other|3
4823761|NCT01153009|16631448|P2|Overall Study|Other|1
4823762|NCT01153009|16631449|P1|Overall Study|Other|1
4823763|NCT01153009|16631446|P4|Overall Study|Lost to Follow-up|15
4823764|NCT01153009|16631447|P3|Overall Study|Lost to Follow-up|11
4823765|NCT01153009|16631448|P2|Overall Study|Lost to Follow-up|8
4823766|NCT01153009|16631449|P1|Overall Study|Lost to Follow-up|8
4823767|NCT01153009|16631446|P4|Overall Study|Withdrawal of Consent|6
4823768|NCT01153009|16631447|P3|Overall Study|Withdrawal of Consent|4
4823769|NCT01153009|16631448|P2|Overall Study|Withdrawal of Consent|5
4823770|NCT01153009|16631449|P1|Overall Study|Withdrawal of Consent|5
4823771|NCT01153009|16631446|P4|Overall Study|Protocol Deviations|2
4823772|NCT01153009|16631447|P3|Overall Study|Protocol Deviations|3
4823773|NCT01153009|16631448|P2|Overall Study|Protocol Deviations|3
4823774|NCT01153009|16631449|P1|Overall Study|Protocol Deviations|4
4823775|NCT01153009|16631446|P4|Overall Study|Noncompliance with Study Medication|1
4823776|NCT01153009|16631447|P3|Overall Study|Noncompliance with Study Medication|4
4823777|NCT01153009|16631448|P2|Overall Study|Noncompliance with Study Medication|3
4823778|NCT01153009|16631449|P1|Overall Study|Noncompliance with Study Medication|1
4823779|NCT01153009|16631446|P4|Overall Study|Lack of Efficacy|1
4823780|NCT01153009|16631447|P3|Overall Study|Lack of Efficacy|2
4823781|NCT01153009|16631448|P2|Overall Study|Lack of Efficacy|0
4823782|NCT01153009|16631449|P1|Overall Study|Lack of Efficacy|9
4823783|NCT01153009|16631446|P4|Overall Study|Adverse Event|10
4823784|NCT01153009|16631447|P3|Overall Study|Adverse Event|14
4823785|NCT01153009|16631448|P2|Overall Study|Adverse Event|14
4823786|NCT01153009|16631449|P1|Overall Study|Adverse Event|4
4823787|NCT01152996|16631479|P1|Overall Study|Elevated liver enzymes|1
4823788|NCT01152996|16631479|P1|Overall Study|Protocol Violation|22
4823789|NCT01152996|16631479|P1|Overall Study|Other|36
4823790|NCT01152996|16631479|P1|Overall Study|Noncompliance|41
4823791|NCT01152996|16631479|P1|Overall Study|Lack of Efficacy|68
4823792|NCT01152996|16631479|P1|Overall Study|Lost to Follow-up|112
4823793|NCT01152996|16631479|P1|Overall Study|Adverse Event|115
4823794|NCT01152996|16631479|P1|Overall Study|Withdrawal by Subject|142
4823795|NCT01152814|16631492|P1|Overall Study|Lost to Follow-up|2
4823796|NCT01152788|16631501|P2|Overall Study|No treatment|1
4823797|NCT01152788|16631502|P1|Overall Study|No treatment|0
4823798|NCT01152788|16631501|P2|Overall Study|Withdrawal by Subject|3
4823799|NCT01152788|16631502|P1|Overall Study|Withdrawal by Subject|0
4823800|NCT01152580|16631539|P2|Overall Study|Withdrawal by Subject|1
4823801|NCT01152580|16631540|P1|Overall Study|Withdrawal by Subject|0
4823802|NCT01152554|16631562|P2|Overall Study|Death|1
4823803|NCT01152554|16631563|P1|Overall Study|Death|1
4823804|NCT01152554|16631562|P2|Overall Study|Other|8
4823805|NCT01152554|16631563|P1|Overall Study|Other|28
4823806|NCT01152554|16631562|P2|Overall Study|Lost to Follow-up|32
4823807|NCT01152554|16631563|P1|Overall Study|Lost to Follow-up|87
4823808|NCT01152554|16631562|P2|Overall Study|Study-specific withdrawal criteria|8
4823809|NCT01152554|16631563|P1|Overall Study|Study-specific withdrawal criteria|17
4823810|NCT01152554|16631562|P2|Overall Study|Lack of Efficacy|3
4823811|NCT01152554|16631563|P1|Overall Study|Lack of Efficacy|20
4823812|NCT01152554|16631562|P2|Overall Study|Condition under investigation worsened|2
4823813|NCT01152554|16631563|P1|Overall Study|Condition under investigation worsened|5
4823814|NCT01152554|16631562|P2|Overall Study|Severe non-compliance to protocol|14
4823815|NCT01152554|16631563|P1|Overall Study|Severe non-compliance to protocol|36
4823816|NCT01152554|16631562|P2|Overall Study|Adverse Event|14
4823817|NCT01152554|16631563|P1|Overall Study|Adverse Event|67
4823818|NCT01152554|16631562|P2|Overall Study|Eligiblity criteria not fulfilled|1
4823819|NCT01152554|16631563|P1|Overall Study|Eligiblity criteria not fulfilled|0
4823820|NCT01152554|16631562|P2|Overall Study|Withdrawal by Subject|28
4823821|NCT01152554|16631563|P1|Overall Study|Withdrawal by Subject|73
4823822|NCT01152450|16631602|P6|Period 1 (4 Weeks)|Lost to Follow-up|0
4823823|NCT01152450|16631603|P5|Period 1 (4 Weeks)|Lost to Follow-up|0
4823824|NCT01152450|16631604|P4|Period 1 (4 Weeks)|Lost to Follow-up|0
4823825|NCT01152450|16631605|P3|Period 1 (4 Weeks)|Lost to Follow-up|1
4823826|NCT01152450|16631606|P2|Period 1 (4 Weeks)|Lost to Follow-up|1
4823827|NCT01152450|16631607|P1|Period 1 (4 Weeks)|Lost to Follow-up|0
4823828|NCT01152450|16631602|P6|Period 1 (4 Weeks)|Protocol Violation|0
4823829|NCT01152450|16631603|P5|Period 1 (4 Weeks)|Protocol Violation|1
4823830|NCT01152450|16631604|P4|Period 1 (4 Weeks)|Protocol Violation|0
4823831|NCT01152450|16631605|P3|Period 1 (4 Weeks)|Protocol Violation|0
4823832|NCT01152450|16631606|P2|Period 1 (4 Weeks)|Protocol Violation|0
4823833|NCT01152450|16631607|P1|Period 1 (4 Weeks)|Protocol Violation|0
4823834|NCT01152450|16631602|P6|Period 1 (4 Weeks)|Adverse Event|1
4823835|NCT01152450|16631603|P5|Period 1 (4 Weeks)|Adverse Event|1
4823836|NCT01152450|16631604|P4|Period 1 (4 Weeks)|Adverse Event|0
4823837|NCT01152450|16631605|P3|Period 1 (4 Weeks)|Adverse Event|0
4823838|NCT01152450|16631606|P2|Period 1 (4 Weeks)|Adverse Event|0
4823839|NCT01152450|16631607|P1|Period 1 (4 Weeks)|Adverse Event|0
4823840|NCT01152437|16631678|P3|Overall Study|Refusal to continue taking trial medicat|2
4823841|NCT01152437|16631679|P2|Overall Study|Refusal to continue taking trial medicat|0
4823842|NCT01152437|16631680|P1|Overall Study|Refusal to continue taking trial medicat|1
4823843|NCT01152437|16631678|P3|Overall Study|Progressive disease|32
4823844|NCT01152437|16631679|P2|Overall Study|Progressive disease|13
4823845|NCT01152437|16631680|P1|Overall Study|Progressive disease|27
4823846|NCT01152437|16631678|P3|Overall Study|Not treated|2
4823847|NCT01152437|16631679|P2|Overall Study|Not treated|1
4823848|NCT01152437|16631680|P1|Overall Study|Not treated|0
4823849|NCT01152437|16631678|P3|Overall Study|Other Adverse Event|7
4823850|NCT01152437|16631679|P2|Overall Study|Other Adverse Event|1
4823851|NCT01152437|16631680|P1|Overall Study|Other Adverse Event|8
4823852|NCT01152385|16631700|P4|Overall Study|Other|3
4823853|NCT01152385|16631701|P3|Overall Study|Other|2
4823854|NCT01152385|16631702|P2|Overall Study|Other|3
4823855|NCT01152385|16631703|P1|Overall Study|Other|4
4823856|NCT01152385|16631700|P4|Overall Study|Study-specific withdrawal criteria|0
4823857|NCT01152385|16631701|P3|Overall Study|Study-specific withdrawal criteria|2
4823858|NCT01152385|16631702|P2|Overall Study|Study-specific withdrawal criteria|1
4823859|NCT01152385|16631703|P1|Overall Study|Study-specific withdrawal criteria|1
4823860|NCT01152385|16631700|P4|Overall Study|Adverse Event|0
4823861|NCT01152385|16631701|P3|Overall Study|Adverse Event|0
4823862|NCT01152385|16631702|P2|Overall Study|Adverse Event|1
4823863|NCT01152385|16631703|P1|Overall Study|Adverse Event|1
4823864|NCT01152385|16631700|P4|Overall Study|Protocol Violation|1
4823865|NCT01152385|16631701|P3|Overall Study|Protocol Violation|0
4823866|NCT01152385|16631702|P2|Overall Study|Protocol Violation|0
4823867|NCT01152385|16631703|P1|Overall Study|Protocol Violation|0
4823868|NCT01152385|16631700|P4|Overall Study|Withdrawal by Subject|1
4823869|NCT01152385|16631701|P3|Overall Study|Withdrawal by Subject|1
4823870|NCT01152385|16631702|P2|Overall Study|Withdrawal by Subject|1
4823871|NCT01152385|16631703|P1|Overall Study|Withdrawal by Subject|3
4823872|NCT01152190|16631774|P2|Overall Study|Withdrawal by Subject|3
4823873|NCT01152190|16631775|P1|Overall Study|Withdrawal by Subject|1
4823874|NCT01152190|16631774|P2|Overall Study|Protocol Violation|1
4823875|NCT01152190|16631775|P1|Overall Study|Protocol Violation|1
4823876|NCT01152190|16631774|P2|Overall Study|Death|0
4823877|NCT01152190|16631775|P1|Overall Study|Death|1
4823878|NCT01152190|16631774|P2|Overall Study|Adverse Event|4
4823879|NCT01152190|16631775|P1|Overall Study|Adverse Event|2
4823880|NCT01152021|16631798|P2|Overall Study|No access to study drug in Pharmacy|1
4823881|NCT01152021|16631799|P1|Overall Study|No access to study drug in Pharmacy|0
4823882|NCT01152021|16631798|P2|Overall Study|Physician Decision|1
4823883|NCT01152021|16631799|P1|Overall Study|Physician Decision|1
4823884|NCT01152021|16631798|P2|Overall Study|Study drug had expired|0
4823885|NCT01152021|16631799|P1|Overall Study|Study drug had expired|1
4823886|NCT01152021|16631798|P2|Overall Study|Adverse Event|4
4823887|NCT01152021|16631799|P1|Overall Study|Adverse Event|4
4823888|NCT01151618|16631856|P1|Overall Study|Withdrawal by Subject|7
4823889|NCT01151618|16631856|P1|Overall Study|Adverse Event|2
4823890|NCT01151579|16631864|P2|Overall Study|Not meet inclusion criteria|4
4823891|NCT01151579|16631865|P1|Overall Study|Not meet inclusion criteria|6
4823892|NCT01151579|16631864|P2|Overall Study|Withdrawal by Subject|2
4823893|NCT01151579|16631865|P1|Overall Study|Withdrawal by Subject|3
4823894|NCT01151579|16631864|P2|Overall Study|Physician Decision|1
4823895|NCT01151579|16631865|P1|Overall Study|Physician Decision|3
4823896|NCT01151540|16631879|P1|Overall Study|Withdrawal by Subject|7
4823897|NCT01151540|16631879|P1|Overall Study|Adverse event, non-fatal|4
4823898|NCT01151540|16631879|P1|Overall Study|Other|2
4823899|NCT01151423|16631928|P2|Overall Study|Participated in other clinical trial|0
4823900|NCT01151423|16631929|P1|Overall Study|Participated in other clinical trial|1
4823901|NCT01151423|16631928|P2|Overall Study|Diagnosed as non-TTP patient|1
4823902|NCT01151423|16631929|P1|Overall Study|Diagnosed as non-TTP patient|0
4823903|NCT01151423|16631928|P2|Overall Study|Lost to Follow-up|0
4823904|NCT01151423|16631929|P1|Overall Study|Lost to Follow-up|1
4823905|NCT01151423|16631928|P2|Overall Study|Withdrawal by Subject|3
4823906|NCT01151423|16631929|P1|Overall Study|Withdrawal by Subject|1
4823907|NCT01151423|16631928|P2|Overall Study|Adverse Event|0
4823908|NCT01151423|16631929|P1|Overall Study|Adverse Event|3
4823909|NCT01151423|16631928|P2|Overall Study|Death|1
4823910|NCT01151423|16631929|P1|Overall Study|Death|0
4823911|NCT01151423|16631928|P2|Overall Study|Pregnancy|1
4823912|NCT01151423|16631929|P1|Overall Study|Pregnancy|0
4823913|NCT01151423|16631928|P2|Overall Study|Physician Decision|1
4823914|NCT01151423|16631929|P1|Overall Study|Physician Decision|1
4823915|NCT01151423|16631928|P2|Overall Study|Protocol Violation|1
4823916|NCT01151423|16631929|P1|Overall Study|Protocol Violation|0
4823917|NCT01151423|16631928|P2|Overall Study|Study terminated by Sponsor|10
4823918|NCT01151423|16631929|P1|Overall Study|Study terminated by Sponsor|9
4823919|NCT01151410|16631977|P2|Overall Study|Abnormal laboratory value(s)|1
4823920|NCT01151410|16631978|P1|Overall Study|Abnormal laboratory value(s)|0
4823921|NCT01151410|16631977|P2|Overall Study|Unsatisfactory therapeutic effect|1
4823922|NCT01151410|16631978|P1|Overall Study|Unsatisfactory therapeutic effect|1
4823923|NCT01151410|16631977|P2|Overall Study|Administrative problems|1
4823924|NCT01151410|16631978|P1|Overall Study|Administrative problems|1
4823925|NCT01151410|16631977|P2|Overall Study|Protocol deviation|1
4823926|NCT01151410|16631978|P1|Overall Study|Protocol deviation|2
4823927|NCT01151410|16631977|P2|Overall Study|Adverse Event|2
4823928|NCT01151410|16631978|P1|Overall Study|Adverse Event|1
4823929|NCT01151410|16631977|P2|Overall Study|Lost to Follow-up|4
4823930|NCT01151410|16631978|P1|Overall Study|Lost to Follow-up|3
4823931|NCT01151410|16631977|P2|Overall Study|Withdrawal by Subject|5
4823932|NCT01151410|16631978|P1|Overall Study|Withdrawal by Subject|3
4823933|NCT01151345|16632022|P2|First Intervention Period|Protocol Violation|1
4823934|NCT01151345|16632023|P1|First Intervention Period|Protocol Violation|0
4823935|NCT01151280|16632037|P1|Overall Study|Lack of Efficacy|3
4823936|NCT01151280|16632037|P1|Overall Study|Adverse Event|1
4823937|NCT01151215|16632050|P3|Overall Study|Safety as judged by the investigator|1
4823938|NCT01151215|16632051|P2|Overall Study|Safety as judged by the investigator|0
4823939|NCT01151215|16632052|P1|Overall Study|Safety as judged by the investigator|0
4823940|NCT01151215|16632050|P3|Overall Study|Disease progression|1
4823941|NCT01151215|16632051|P2|Overall Study|Disease progression|1
4823942|NCT01151215|16632052|P1|Overall Study|Disease progression|0
4823943|NCT01151215|16632050|P3|Overall Study|Withdrawal by Subject|2
4823944|NCT01151215|16632051|P2|Overall Study|Withdrawal by Subject|1
4823945|NCT01151215|16632052|P1|Overall Study|Withdrawal by Subject|3
4823946|NCT01151215|16632050|P3|Overall Study|Lost to Follow-up|3
4823947|NCT01151215|16632051|P2|Overall Study|Lost to Follow-up|0
4823948|NCT01151215|16632052|P1|Overall Study|Lost to Follow-up|0
4823949|NCT01151215|16632050|P3|Overall Study|Death|11
4823950|NCT01151215|16632051|P2|Overall Study|Death|20
4823951|NCT01151215|16632052|P1|Overall Study|Death|16
4823952|NCT01151215|16632050|P3|Overall Study|Worsening of condition under study|1
4823953|NCT01151215|16632051|P2|Overall Study|Worsening of condition under study|1
4823954|NCT01151215|16632052|P1|Overall Study|Worsening of condition under study|1
4823955|NCT01151137|16632090|P2|Overall Study|Lost to Follow-up|1
4823956|NCT01151137|16632091|P1|Overall Study|Lost to Follow-up|1
4823957|NCT01151137|16632090|P2|Overall Study|Death|27
4823958|NCT01151137|16632091|P1|Overall Study|Death|15
4823959|NCT01151098|16632109|P1|Overall Study|Miscellaneous|13
4823960|NCT01151098|16632109|P1|Overall Study|Protocol Violation|1
4823961|NCT01151098|16632109|P1|Overall Study|Lack of Efficacy|15
4823962|NCT01151098|16632109|P1|Overall Study|Lost to Follow-up|6
4823963|NCT01151098|16632109|P1|Overall Study|Adverse Event|82
4823964|NCT01151085|16632113|P1|Overall Study|Protocol Violation|25
4823965|NCT01151085|16632113|P1|Overall Study|Lost to Follow-up|31
4823966|NCT01151020|16632144|P1|Overall Study|Still be eligible for follow-up|79
4823967|NCT01151020|16632144|P1|Overall Study|Patients did not receive the device|2
4823968|NCT01151020|16632144|P1|Overall Study|Withdrawal by Subject|12
4823969|NCT01151020|16632144|P1|Overall Study|Lost to Follow-up|1
4823970|NCT01151020|16632144|P1|Overall Study|Conversion to open repair|1
4823971|NCT01151020|16632144|P1|Overall Study|Death|15
4823972|NCT01150474|16632223|P2|Overall Study|Surgery Changed|0
4823973|NCT01150474|16632224|P1|Overall Study|Surgery Changed|1
4823974|NCT01150474|16632223|P2|Overall Study|Drug not administered|0
4823975|NCT01150474|16632224|P1|Overall Study|Drug not administered|1
4823976|NCT01150474|16632223|P2|Overall Study|Drug did not arrive in time|0
4823977|NCT01150474|16632224|P1|Overall Study|Drug did not arrive in time|1
4823978|NCT01150474|16632223|P2|Overall Study|Rectotomy|0
4823979|NCT01150474|16632224|P1|Overall Study|Rectotomy|1
4823980|NCT01150474|16632223|P2|Overall Study|Multiple Studies|1
4823981|NCT01150474|16632224|P1|Overall Study|Multiple Studies|0
4823982|NCT01150474|16632223|P2|Overall Study|Cancer found|0
4823983|NCT01150474|16632224|P1|Overall Study|Cancer found|1
4823984|NCT01150474|16632223|P2|Overall Study|Withdrawal by Subject|2
4823985|NCT01150474|16632224|P1|Overall Study|Withdrawal by Subject|5
4823986|NCT01150357|16632269|P3|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
4823987|NCT01150357|16632270|P2|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0
4823988|NCT01150357|16632271|P1|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1
4823989|NCT01150357|16632269|P3|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
4823990|NCT01150357|16632270|P2|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0
4823991|NCT01150357|16632271|P1|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2
4823992|NCT01150357|16632269|P3|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2
4823993|NCT01150357|16632270|P2|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
4823994|NCT01150357|16632271|P1|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0
4823995|NCT01150357|16632269|P3|Dose Response Phase (Phase 1)|Withdrawal by Participants|1
4823996|NCT01150357|16632270|P2|Dose Response Phase (Phase 1)|Withdrawal by Participants|2
4823997|NCT01150357|16632271|P1|Dose Response Phase (Phase 1)|Withdrawal by Participants|0
4823998|NCT01150357|16632269|P3|Dose Response Phase (Phase 1)|Adverse Event|1
4823999|NCT01150357|16632270|P2|Dose Response Phase (Phase 1)|Adverse Event|0
4824000|NCT01150357|16632271|P1|Dose Response Phase (Phase 1)|Adverse Event|0
4824001|NCT01150357|16632269|P3|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
4824002|NCT01150357|16632270|P2|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0
4824003|NCT01150357|16632271|P1|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1
4824004|NCT01150357|16632269|P3|Dose Response Phase (Phase 1)|Protocol Violation|1
4824005|NCT01150357|16632270|P2|Dose Response Phase (Phase 1)|Protocol Violation|1
4824006|NCT01150357|16632271|P1|Dose Response Phase (Phase 1)|Protocol Violation|0
4824007|NCT01150123|16632351|P18|Overall Study|Lost to Follow-up|0
4824008|NCT01150123|16632352|P17|Overall Study|Lost to Follow-up|0
4824009|NCT01150123|16632353|P16|Overall Study|Lost to Follow-up|0
4824010|NCT01150123|16632354|P15|Overall Study|Lost to Follow-up|0
4824011|NCT01150123|16632355|P14|Overall Study|Lost to Follow-up|0
4824012|NCT01150123|16632356|P13|Overall Study|Lost to Follow-up|2
4824013|NCT01150123|16632357|P12|Overall Study|Lost to Follow-up|1
4824014|NCT01150123|16632358|P11|Overall Study|Lost to Follow-up|1
4824015|NCT01150123|16632359|P10|Overall Study|Lost to Follow-up|1
4824016|NCT01150123|16632360|P9|Overall Study|Lost to Follow-up|3
4824017|NCT01150123|16632361|P8|Overall Study|Lost to Follow-up|0
4824018|NCT01150123|16632362|P7|Overall Study|Lost to Follow-up|0
4824019|NCT01150123|16632363|P6|Overall Study|Lost to Follow-up|5
4824020|NCT01150123|16632364|P5|Overall Study|Lost to Follow-up|2
4824021|NCT01150123|16632365|P4|Overall Study|Lost to Follow-up|2
4824022|NCT01150123|16632366|P3|Overall Study|Lost to Follow-up|2
4824023|NCT01150123|16632367|P2|Overall Study|Lost to Follow-up|1
4824024|NCT01150123|16632368|P1|Overall Study|Lost to Follow-up|2
4824025|NCT01150123|16632351|P18|Overall Study|Withdrawal by Subject|1
4824026|NCT01150123|16632352|P17|Overall Study|Withdrawal by Subject|0
4824027|NCT01150123|16632353|P16|Overall Study|Withdrawal by Subject|1
4824028|NCT01150123|16632354|P15|Overall Study|Withdrawal by Subject|0
4824029|NCT01150123|16632355|P14|Overall Study|Withdrawal by Subject|0
4824030|NCT01150123|16632356|P13|Overall Study|Withdrawal by Subject|1
4824031|NCT01150123|16632357|P12|Overall Study|Withdrawal by Subject|0
4824032|NCT01150123|16632358|P11|Overall Study|Withdrawal by Subject|1
4824033|NCT01150123|16632359|P10|Overall Study|Withdrawal by Subject|0
4824034|NCT01150123|16632360|P9|Overall Study|Withdrawal by Subject|2
4824035|NCT01150123|16632361|P8|Overall Study|Withdrawal by Subject|3
4824036|NCT01150123|16632362|P7|Overall Study|Withdrawal by Subject|0
4824037|NCT01150123|16632363|P6|Overall Study|Withdrawal by Subject|1
4824038|NCT01150123|16632364|P5|Overall Study|Withdrawal by Subject|1
4824039|NCT01150123|16632365|P4|Overall Study|Withdrawal by Subject|1
4824040|NCT01150123|16632366|P3|Overall Study|Withdrawal by Subject|2
4824041|NCT01150123|16632367|P2|Overall Study|Withdrawal by Subject|1
4824042|NCT01150123|16632368|P1|Overall Study|Withdrawal by Subject|1
4824043|NCT01150097|16632544|P3|Months 24 to 48 Post-transplantation|Death|0
4824044|NCT01150097|16632545|P2|Months 24 to 48 Post-transplantation|Death|0
4824045|NCT01150097|16632546|P1|Months 24 to 48 Post-transplantation|Death|2
4824046|NCT01150097|16632544|P3|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
4824047|NCT01150097|16632545|P2|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0
4824048|NCT01150097|16632546|P1|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4
4824049|NCT01150097|16632544|P3|Months 24 to 48 Post-transplantation|Administrative problems|0
4824050|NCT01150097|16632545|P2|Months 24 to 48 Post-transplantation|Administrative problems|4
4824051|NCT01150097|16632546|P1|Months 24 to 48 Post-transplantation|Administrative problems|5
4824052|NCT01150097|16632544|P3|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
4824053|NCT01150097|16632545|P2|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0
4824054|NCT01150097|16632546|P1|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3
4824055|NCT01150097|16632544|P3|Months 24 to 36 Post-transplantation|Lost to Follow-up|3
4824056|NCT01150097|16632545|P2|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
4824057|NCT01150097|16632546|P1|Months 24 to 36 Post-transplantation|Lost to Follow-up|0
4824058|NCT01150097|16632544|P3|Months 24 to 36 Post-transplantation|Administrative problems|2
4824059|NCT01150097|16632545|P2|Months 24 to 36 Post-transplantation|Administrative problems|2
4824060|NCT01150097|16632546|P1|Months 24 to 36 Post-transplantation|Administrative problems|5
4824061|NCT01150097|16632544|P3|Months 24 to 36 Post-transplantation|Death|0
4824062|NCT01150097|16632545|P2|Months 24 to 36 Post-transplantation|Death|0
4824063|NCT01150097|16632546|P1|Months 24 to 36 Post-transplantation|Death|2
4824064|NCT01149863|16632590|P1|Overall Study|Missing data or Not receiveing studydrug|3
4824065|NCT01149681|16632665|P1|Overall Study|adverse events nonrelated study drug|2
4824066|NCT01149681|16632665|P1|Overall Study|Physician Decision|2
4824067|NCT01149681|16632665|P1|Overall Study|Progressive disease|1
4824068|NCT01149681|16632665|P1|Overall Study|Withdrawal by Subject|7
4824069|NCT01149655|16632673|P4|Period 3-DB Maintenance Phase|Relapse With AE|18
4824070|NCT01149655|16632674|P3|Period 3-DB Maintenance Phase|Relapse With AE|19
4824071|NCT01149655|16632675|P2|Period 3-DB Maintenance Phase|Relapse With AE|0
4824072|NCT01149655|16632676|P1|Period 3-DB Maintenance Phase|Relapse With AE|0
4824073|NCT01149655|16632673|P4|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
4824074|NCT01149655|16632674|P3|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1
4824075|NCT01149655|16632675|P2|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
4824076|NCT01149655|16632676|P1|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0
4824077|NCT01149655|16632673|P4|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
4824078|NCT01149655|16632674|P3|Period 3-DB Maintenance Phase|Withdrawal by Subject|4
4824079|NCT01149655|16632675|P2|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
4824080|NCT01149655|16632676|P1|Period 3-DB Maintenance Phase|Withdrawal by Subject|0
4824081|NCT01149655|16632673|P4|Period 3-DB Maintenance Phase|Physician Decision|0
4824082|NCT01149655|16632674|P3|Period 3-DB Maintenance Phase|Physician Decision|1
4824083|NCT01149655|16632675|P2|Period 3-DB Maintenance Phase|Physician Decision|0
4824084|NCT01149655|16632676|P1|Period 3-DB Maintenance Phase|Physician Decision|0
4824085|NCT01149655|16632673|P4|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19
4824086|NCT01149655|16632674|P3|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58
4824087|NCT01149655|16632675|P2|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
4824088|NCT01149655|16632676|P1|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0
4824089|NCT01149655|16632673|P4|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
4824090|NCT01149655|16632674|P3|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
4824091|NCT01149655|16632675|P2|Period 2-Stabilization Phase|Adverse Event Without Relapse|6
4824092|NCT01149655|16632676|P1|Period 2-Stabilization Phase|Adverse Event Without Relapse|0
4824093|NCT01149655|16632673|P4|Period 2-Stabilization Phase|Withdrawal by Subject|0
4824094|NCT01149655|16632674|P3|Period 2-Stabilization Phase|Withdrawal by Subject|0
4824095|NCT01149655|16632675|P2|Period 2-Stabilization Phase|Withdrawal by Subject|5
4824096|NCT01149655|16632676|P1|Period 2-Stabilization Phase|Withdrawal by Subject|0
4824097|NCT01149655|16632673|P4|Period 2-Stabilization Phase|Physician Decision|0
4824098|NCT01149655|16632674|P3|Period 2-Stabilization Phase|Physician Decision|0
4824099|NCT01149655|16632675|P2|Period 2-Stabilization Phase|Physician Decision|3
4824100|NCT01149655|16632676|P1|Period 2-Stabilization Phase|Physician Decision|0
4824101|NCT01149655|16632673|P4|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
4824102|NCT01149655|16632674|P3|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
4824103|NCT01149655|16632675|P2|Period 2-Stabilization Phase|Met Withdrawal Criteria|7
4824104|NCT01149655|16632676|P1|Period 2-Stabilization Phase|Met Withdrawal Criteria|0
4824105|NCT01149655|16632673|P4|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
4824106|NCT01149655|16632674|P3|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
4824107|NCT01149655|16632675|P2|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16
4824108|NCT01149655|16632676|P1|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0
4824109|NCT01149655|16632673|P4|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
4824110|NCT01149655|16632674|P3|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
4824111|NCT01149655|16632675|P2|Period 1 - Conversion Phase|Adverse Event Without Relapse|0
4824112|NCT01149655|16632676|P1|Period 1 - Conversion Phase|Adverse Event Without Relapse|3
4824113|NCT01149655|16632673|P4|Period 1 - Conversion Phase|Withdrawal by Subject|0
4824114|NCT01149655|16632674|P3|Period 1 - Conversion Phase|Withdrawal by Subject|0
4824115|NCT01149655|16632675|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
4824116|NCT01149655|16632676|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
4824117|NCT01149655|16632673|P4|Period 1 - Conversion Phase|Physician Decision|0
4824118|NCT01149655|16632674|P3|Period 1 - Conversion Phase|Physician Decision|0
4824119|NCT01149655|16632675|P2|Period 1 - Conversion Phase|Physician Decision|0
4824120|NCT01149655|16632676|P1|Period 1 - Conversion Phase|Physician Decision|2
4824121|NCT01149655|16632673|P4|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4824122|NCT01149655|16632674|P3|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4824123|NCT01149655|16632675|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4824124|NCT01149655|16632676|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
4824125|NCT01149655|16632673|P4|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
4824126|NCT01149655|16632674|P3|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
4824127|NCT01149655|16632675|P2|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0
4824128|NCT01149655|16632676|P1|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4
4824129|NCT01149655|16632673|P4|Period 1 - Conversion Phase|Lost to Follow-up|0
4824130|NCT01149655|16632674|P3|Period 1 - Conversion Phase|Lost to Follow-up|0
4824131|NCT01149655|16632675|P2|Period 1 - Conversion Phase|Lost to Follow-up|0
4824132|NCT01149655|16632676|P1|Period 1 - Conversion Phase|Lost to Follow-up|1
4824133|NCT01149538|16632719|P2|Overall Study|Withdrawal by Subject|3
4824134|NCT01149538|16632720|P1|Overall Study|Withdrawal by Subject|5
4824135|NCT01149538|16632719|P2|Overall Study|Lost to Follow-up|1
4824136|NCT01149538|16632720|P1|Overall Study|Lost to Follow-up|0
4824137|NCT01149486|16632741|P2|First Intervention|Adverse Event|1
4824138|NCT01149486|16632742|P1|First Intervention|Adverse Event|0
4824139|NCT01149473|16632766|P2|Washout of 7 Days|Withdrawal by Subject|1
4824140|NCT01149473|16632767|P1|Washout of 7 Days|Withdrawal by Subject|1
4824141|NCT01149473|16632766|P2|First Intervention|Adverse Event|1
4824142|NCT01149473|16632767|P1|First Intervention|Adverse Event|1
4824143|NCT01149460|16632785|P2|Overall Study|Withdrawal by Subject|2
4824144|NCT01149460|16632786|P1|Overall Study|Withdrawal by Subject|0
4824145|NCT01149421|16632819|P3|Overall Study|Protocol Violation|6
4824146|NCT01149421|16632820|P2|Overall Study|Protocol Violation|2
4824147|NCT01149421|16632821|P1|Overall Study|Protocol Violation|2
4824148|NCT01149421|16632819|P3|Overall Study|Entry Criteria Not Met|2
4824149|NCT01149421|16632820|P2|Overall Study|Entry Criteria Not Met|1
4824150|NCT01149421|16632821|P1|Overall Study|Entry Criteria Not Met|1
4824151|NCT01149421|16632819|P3|Overall Study|Physician Decision|6
4824152|NCT01149421|16632820|P2|Overall Study|Physician Decision|3
4824153|NCT01149421|16632821|P1|Overall Study|Physician Decision|5
4824154|NCT01149421|16632819|P3|Overall Study|Lost to Follow-up|5
4824155|NCT01149421|16632820|P2|Overall Study|Lost to Follow-up|4
4824156|NCT01149421|16632821|P1|Overall Study|Lost to Follow-up|2
4824157|NCT01149421|16632819|P3|Overall Study|Sponsor Decision|1
4824158|NCT01149421|16632820|P2|Overall Study|Sponsor Decision|1
4824159|NCT01149421|16632821|P1|Overall Study|Sponsor Decision|0
4824160|NCT01149421|16632819|P3|Overall Study|Withdrawal by Subject|13
4824161|NCT01149421|16632820|P2|Overall Study|Withdrawal by Subject|12
4824162|NCT01149421|16632821|P1|Overall Study|Withdrawal by Subject|20
4824163|NCT01149421|16632819|P3|Overall Study|Adverse Event|11
4824164|NCT01149421|16632820|P2|Overall Study|Adverse Event|6
4824165|NCT01149421|16632821|P1|Overall Study|Adverse Event|22
4824166|NCT01149369|16632902|P2|Overall Study|Adverse Event|3
4824167|NCT01149369|16632903|P1|Overall Study|Adverse Event|6
4824168|NCT01149343|16633071|P4|Overall Study|Recurrence / Progressive disease|0
4824169|NCT01149343|16633072|P3|Overall Study|Recurrence / Progressive disease|1
4824170|NCT01149343|16633073|P2|Overall Study|Recurrence / Progressive disease|0
4824171|NCT01149343|16633074|P1|Overall Study|Recurrence / Progressive disease|0
4824172|NCT01149343|16633071|P4|Overall Study|Sponsor study termination|2
4824173|NCT01149343|16633072|P3|Overall Study|Sponsor study termination|0
4824174|NCT01149343|16633073|P2|Overall Study|Sponsor study termination|0
4824175|NCT01149343|16633074|P1|Overall Study|Sponsor study termination|0
4824176|NCT01149343|16633071|P4|Overall Study|Other|14
4824177|NCT01149343|16633072|P3|Overall Study|Other|2
4824178|NCT01149343|16633073|P2|Overall Study|Other|10
4824179|NCT01149343|16633074|P1|Overall Study|Other|8
4824180|NCT01149343|16633071|P4|Overall Study|Lost to Follow-up|1
4824181|NCT01149343|16633072|P3|Overall Study|Lost to Follow-up|0
4824182|NCT01149343|16633073|P2|Overall Study|Lost to Follow-up|0
4824183|NCT01149343|16633074|P1|Overall Study|Lost to Follow-up|1
4824184|NCT01149343|16633071|P4|Overall Study|Death|18
4824185|NCT01149343|16633072|P3|Overall Study|Death|18
4824186|NCT01149343|16633073|P2|Overall Study|Death|13
4824187|NCT01149343|16633074|P1|Overall Study|Death|10
4824188|NCT01149343|16633071|P4|Overall Study|Withdrawal by Subject|5
4824189|NCT01149343|16633072|P3|Overall Study|Withdrawal by Subject|1
4824190|NCT01149343|16633073|P2|Overall Study|Withdrawal by Subject|1
4824191|NCT01149343|16633074|P1|Overall Study|Withdrawal by Subject|1
4824192|NCT01149148|16633159|P2|Overall Study|Death|0
4824193|NCT01149148|16633160|P1|Overall Study|Death|1
4824194|NCT01149148|16633159|P2|Overall Study|Lost to Follow-up|2
4824195|NCT01149148|16633160|P1|Overall Study|Lost to Follow-up|1
4824196|NCT01149096|16633170|P2|Overall Study|Lost to Follow-up|1
4824197|NCT01149096|16633171|P1|Overall Study|Lost to Follow-up|0
4824198|NCT01149057|16633195|P1|Overall Study|Other|6
4824199|NCT01149057|16633195|P1|Overall Study|High Parathyroid Hormone Value|1
4824200|NCT01149057|16633195|P1|Overall Study|Lost to Follow-up|1
4824201|NCT01149057|16633195|P1|Overall Study|Participant Non-Compliance|2
4824202|NCT01149057|16633195|P1|Overall Study|B Cell Depletion|4
4824203|NCT01149057|16633195|P1|Overall Study|Positive Hepatitis B Core Antibody|5
4824204|NCT01149057|16633195|P1|Overall Study|Withdrawal by Subject|9
4824205|NCT01149057|16633195|P1|Overall Study|Adverse Event|13
4824206|NCT01149057|16633195|P1|Overall Study|Lack of Efficacy|16
4824207|NCT01148979|16633222|P2|Overall Study|Lost to Follow-up|1
4824208|NCT01148979|16633223|P1|Overall Study|Lost to Follow-up|0
4824209|NCT01148862|16633241|P2|Second Intervention|Withdrawal by Subject|2
4824210|NCT01148862|16633242|P1|Second Intervention|Withdrawal by Subject|0
4824211|NCT01148810|16633274|P2|Overall Study|Protocol Violation|0
4824212|NCT01148810|16633275|P1|Overall Study|Protocol Violation|1
4824213|NCT01148810|16633274|P2|Overall Study|Withdrawal by Subject|2
4824214|NCT01148810|16633275|P1|Overall Study|Withdrawal by Subject|0
4824215|NCT01148810|16633274|P2|Overall Study|Lack of Efficacy|1
4824216|NCT01148810|16633275|P1|Overall Study|Lack of Efficacy|0
4824217|NCT01148810|16633274|P2|Overall Study|Adverse Event|2
4824218|NCT01148810|16633275|P1|Overall Study|Adverse Event|0
4824219|NCT01148771|16633302|P2|Washout Period|Withdrawal by Subject|1
4824220|NCT01148771|16633303|P1|Washout Period|Withdrawal by Subject|0
4824221|NCT01148693|16633323|P2|Overall Study|Attempts for cannulation were failed|10
4824222|NCT01148693|16633324|P1|Overall Study|Attempts for cannulation were failed|13
4824223|NCT01148537|16633344|P3|Overall Study|Adverse Event|1
4824224|NCT01148537|16633345|P2|Overall Study|Adverse Event|0
4824225|NCT01148537|16633346|P1|Overall Study|Adverse Event|2
4824226|NCT01148537|16633344|P3|Overall Study|Withdrawal by Subject|2
4824227|NCT01148537|16633345|P2|Overall Study|Withdrawal by Subject|0
4824228|NCT01148537|16633346|P1|Overall Study|Withdrawal by Subject|1
4824229|NCT01148511|16633432|P3|Randomized|Other|1
4824230|NCT01148511|16633433|P2|Randomized|Other|1
4824231|NCT01148511|16633434|P1|Randomized|Other|0
4824232|NCT01148511|16633432|P3|Randomized|Consent withdrawal|3
4824233|NCT01148511|16633433|P2|Randomized|Consent withdrawal|5
4824234|NCT01148511|16633434|P1|Randomized|Consent withdrawal|0
4824235|NCT01148511|16633432|P3|Randomized|Lost to Follow-up|1
4824236|NCT01148511|16633433|P2|Randomized|Lost to Follow-up|1
4824237|NCT01148511|16633434|P1|Randomized|Lost to Follow-up|0
4824238|NCT01148511|16633432|P3|Randomized|Protocol Violation|1
4824239|NCT01148511|16633433|P2|Randomized|Protocol Violation|2
4824240|NCT01148511|16633434|P1|Randomized|Protocol Violation|0
4824241|NCT01148511|16633432|P3|Randomized|Adverse Event|0
4824242|NCT01148511|16633433|P2|Randomized|Adverse Event|1
4824243|NCT01148511|16633434|P1|Randomized|Adverse Event|0
4824244|NCT01148511|16633432|P3|Exposed to Study Drug|Lost to Follow-up|0
4824245|NCT01148511|16633433|P2|Exposed to Study Drug|Lost to Follow-up|0
4824246|NCT01148511|16633434|P1|Exposed to Study Drug|Lost to Follow-up|4
4824247|NCT01148511|16633432|P3|Exposed to Study Drug|Protocol Violation|0
4824248|NCT01148511|16633433|P2|Exposed to Study Drug|Protocol Violation|0
4824249|NCT01148511|16633434|P1|Exposed to Study Drug|Protocol Violation|2
4824250|NCT01148459|16633455|P2|Overall Study|Failure to comply with study procedures|1
4824251|NCT01148459|16633456|P1|Overall Study|Failure to comply with study procedures|0
4824252|NCT01148459|16633455|P2|Overall Study|Refusal|0
4824253|NCT01148459|16633456|P1|Overall Study|Refusal|1
4824254|NCT01148459|16633455|P2|Overall Study|Lost to Follow-up|0
4824255|NCT01148459|16633456|P1|Overall Study|Lost to Follow-up|2
4824256|NCT01148459|16633455|P2|Overall Study|Migrated/moved from study area|6
4824257|NCT01148459|16633456|P1|Overall Study|Migrated/moved from study area|3
4824258|NCT01148459|16633455|P2|Overall Study|Withdrawal by Subject|0
4824259|NCT01148459|16633456|P1|Overall Study|Withdrawal by Subject|1
4824260|NCT01148459|16633455|P2|Overall Study|Serious Adverse Event|4
4824261|NCT01148459|16633456|P1|Overall Study|Serious Adverse Event|5
4824262|NCT01148225|16633504|P1|Overall Study|Other|185
4824263|NCT01148017|16633555|P4|Overall Study|Unable to classify|0
4824264|NCT01148017|16633556|P3|Overall Study|Unable to classify|0
4824265|NCT01148017|16633557|P2|Overall Study|Unable to classify|1
4824266|NCT01148017|16633558|P1|Overall Study|Unable to classify|3
4824267|NCT01148017|16633555|P4|Overall Study|Administrative reason|0
4824268|NCT01148017|16633556|P3|Overall Study|Administrative reason|0
4824269|NCT01148017|16633557|P2|Overall Study|Administrative reason|9
4824270|NCT01148017|16633558|P1|Overall Study|Administrative reason|22
4824271|NCT01148017|16633555|P4|Overall Study|Inappropriate enrollment|0
4824272|NCT01148017|16633556|P3|Overall Study|Inappropriate enrollment|0
4824273|NCT01148017|16633557|P2|Overall Study|Inappropriate enrollment|0
4824274|NCT01148017|16633558|P1|Overall Study|Inappropriate enrollment|1
4824275|NCT01148017|16633555|P4|Overall Study|Lost to Follow-up|0
4824276|NCT01148017|16633556|P3|Overall Study|Lost to Follow-up|0
4824277|NCT01148017|16633557|P2|Overall Study|Lost to Follow-up|10
4824278|NCT01148017|16633558|P1|Overall Study|Lost to Follow-up|23
4824279|NCT01148017|16633555|P4|Overall Study|Withdrawal by Subject|0
4824280|NCT01148017|16633556|P3|Overall Study|Withdrawal by Subject|0
4824281|NCT01148017|16633557|P2|Overall Study|Withdrawal by Subject|14
4824282|NCT01148017|16633558|P1|Overall Study|Withdrawal by Subject|31
4824283|NCT01147926|16633597|P2|Overall Study|Colonoscopy result|1
4824284|NCT01147926|16633598|P1|Overall Study|Colonoscopy result|0
4824285|NCT01147926|16633597|P2|Overall Study|Went on holiday|1
4824286|NCT01147926|16633598|P1|Overall Study|Went on holiday|0
4824287|NCT01147926|16633597|P2|Overall Study|Too busy, no time for study|0
4824288|NCT01147926|16633598|P1|Overall Study|Too busy, no time for study|1
4824289|NCT01147926|16633597|P2|Overall Study|Lack of Efficacy|0
4824290|NCT01147926|16633598|P1|Overall Study|Lack of Efficacy|1
4824291|NCT01147926|16633597|P2|Overall Study|Sponsor's Decision|1
4824292|NCT01147926|16633598|P1|Overall Study|Sponsor's Decision|0
4824293|NCT01147926|16633597|P2|Overall Study|Lost to Follow-up|2
4824294|NCT01147926|16633598|P1|Overall Study|Lost to Follow-up|0
4824295|NCT01147926|16633597|P2|Overall Study|Selection criteria not met|1
4824296|NCT01147926|16633598|P1|Overall Study|Selection criteria not met|3
4824297|NCT01147926|16633597|P2|Overall Study|Principal investigator left hospital|3
4824298|NCT01147926|16633598|P1|Overall Study|Principal investigator left hospital|1
4824299|NCT01147926|16633597|P2|Overall Study|Subject Non-Compliant|4
4824300|NCT01147926|16633598|P1|Overall Study|Subject Non-Compliant|5
4824301|NCT01147926|16633597|P2|Overall Study|Adverse Event|6
4824302|NCT01147926|16633598|P1|Overall Study|Adverse Event|7
4824303|NCT01147926|16633597|P2|Overall Study|Subject Withdrew Consent|10
4824304|NCT01147926|16633598|P1|Overall Study|Subject Withdrew Consent|9
4824305|NCT01147900|16633633|P3|At Year 10|Lost to Follow-up|0
4824306|NCT01147900|16633634|P2|At Year 10|Lost to Follow-up|1
4824307|NCT01147900|16633635|P1|At Year 10|Lost to Follow-up|0
4824308|NCT01147874|16633694|P1|Overall Study|Withdrawal by Subject|24
4824309|NCT01147874|16633694|P1|Overall Study|Sponsor's Decision|2
4824310|NCT01147874|16633694|P1|Overall Study|Protocol Violation|5
4824311|NCT01147874|16633694|P1|Overall Study|Other|5
4824312|NCT01147874|16633694|P1|Overall Study|Lost to Follow-up|25
4824313|NCT01147874|16633694|P1|Overall Study|Investigator's Request|1
4824314|NCT01147874|16633694|P1|Overall Study|Adverse Event|5
4824315|NCT01147848|16633702|P3|Randomized Phase|Withdrawal by Subject|9
4824316|NCT01147848|16633703|P2|Randomized Phase|Withdrawal by Subject|7
4824317|NCT01147848|16633704|P1|Randomized Phase|Withdrawal by Subject|0
4824318|NCT01147848|16633702|P3|Randomized Phase|Physician Decision|1
4824319|NCT01147848|16633703|P2|Randomized Phase|Physician Decision|0
4824320|NCT01147848|16633704|P1|Randomized Phase|Physician Decision|0
4824321|NCT01147848|16633702|P3|Randomized Phase|Lost to Follow-up|7
4824322|NCT01147848|16633703|P2|Randomized Phase|Lost to Follow-up|5
4824323|NCT01147848|16633704|P1|Randomized Phase|Lost to Follow-up|0
4824324|NCT01147848|16633702|P3|Randomized Phase|Protocol Violation|10
4824325|NCT01147848|16633703|P2|Randomized Phase|Protocol Violation|7
4824326|NCT01147848|16633704|P1|Randomized Phase|Protocol Violation|0
4824327|NCT01147848|16633702|P3|Randomized Phase|Lack of Efficacy|11
4824328|NCT01147848|16633703|P2|Randomized Phase|Lack of Efficacy|20
4824329|NCT01147848|16633704|P1|Randomized Phase|Lack of Efficacy|0
4824330|NCT01147848|16633702|P3|Randomized Phase|Adverse Event|8
4824331|NCT01147848|16633703|P2|Randomized Phase|Adverse Event|6
4824332|NCT01147848|16633704|P1|Randomized Phase|Adverse Event|0
4824333|NCT01147848|16633702|P3|Run-in Period|Run-in Failure|0
4824334|NCT01147848|16633703|P2|Run-in Period|Run-in Failure|0
4824335|NCT01147848|16633704|P1|Run-in Period|Run-in Failure|135
4824336|NCT01147848|16633702|P3|Run-in Period|Screen Failure|0
4824337|NCT01147848|16633703|P2|Run-in Period|Screen Failure|0
4824338|NCT01147848|16633704|P1|Run-in Period|Screen Failure|623
4824339|NCT01147822|16633736|P2|Overall Study|Not Completed/Ongoing|102
4824340|NCT01147822|16633737|P1|Overall Study|Not Completed/Ongoing|111
4824341|NCT01147822|16633736|P2|Overall Study|Withdrawal by Subject|13
4824342|NCT01147822|16633737|P1|Overall Study|Withdrawal by Subject|8
4824343|NCT01147822|16633736|P2|Overall Study|Physician Decision|2
4824344|NCT01147822|16633737|P1|Overall Study|Physician Decision|0
4824345|NCT01147822|16633736|P2|Overall Study|Lost to Follow-up|2
4824346|NCT01147822|16633737|P1|Overall Study|Lost to Follow-up|3
4824347|NCT01147822|16633736|P2|Overall Study|Protocol Violation|1
4824348|NCT01147822|16633737|P1|Overall Study|Protocol Violation|0
4824349|NCT01147822|16633736|P2|Overall Study|Death|59
4824350|NCT01147822|16633737|P1|Overall Study|Death|66
4824351|NCT01147809|16633757|P6|Phase II (168 Days)|Ongoing|0
4824352|NCT01147809|16633758|P5|Phase II (168 Days)|Ongoing|1
4824353|NCT01147809|16633759|P4|Phase II (168 Days)|Ongoing|0
4824354|NCT01147809|16633760|P3|Phase II (168 Days)|Ongoing|0
4824355|NCT01147809|16633761|P2|Phase II (168 Days)|Ongoing|0
4824356|NCT01147809|16633762|P1|Phase II (168 Days)|Ongoing|0
4824357|NCT01147809|16633757|P6|Phase II (168 Days)|Withdrawal by Subject|15
4824358|NCT01147809|16633758|P5|Phase II (168 Days)|Withdrawal by Subject|7
4824359|NCT01147809|16633759|P4|Phase II (168 Days)|Withdrawal by Subject|0
4824360|NCT01147809|16633760|P3|Phase II (168 Days)|Withdrawal by Subject|0
4824361|NCT01147809|16633761|P2|Phase II (168 Days)|Withdrawal by Subject|0
4824362|NCT01147809|16633762|P1|Phase II (168 Days)|Withdrawal by Subject|0
4824363|NCT01147809|16633757|P6|Phase II (168 Days)|Physician Decision|11
4824364|NCT01147809|16633758|P5|Phase II (168 Days)|Physician Decision|5
4824365|NCT01147809|16633759|P4|Phase II (168 Days)|Physician Decision|0
4824366|NCT01147809|16633760|P3|Phase II (168 Days)|Physician Decision|0
4824367|NCT01147809|16633761|P2|Phase II (168 Days)|Physician Decision|0
4824368|NCT01147809|16633762|P1|Phase II (168 Days)|Physician Decision|0
4824369|NCT01147809|16633757|P6|Phase II (168 Days)|Protocol Violation|1
4824370|NCT01147809|16633758|P5|Phase II (168 Days)|Protocol Violation|0
4824371|NCT01147809|16633759|P4|Phase II (168 Days)|Protocol Violation|0
4824372|NCT01147809|16633760|P3|Phase II (168 Days)|Protocol Violation|0
4824373|NCT01147809|16633761|P2|Phase II (168 Days)|Protocol Violation|0
4824374|NCT01147809|16633762|P1|Phase II (168 Days)|Protocol Violation|0
4824375|NCT01147809|16633757|P6|Phase II (168 Days)|Adverse Event|6
4824376|NCT01147809|16633758|P5|Phase II (168 Days)|Adverse Event|3
4824377|NCT01147809|16633759|P4|Phase II (168 Days)|Adverse Event|0
4824378|NCT01147809|16633760|P3|Phase II (168 Days)|Adverse Event|0
4824379|NCT01147809|16633761|P2|Phase II (168 Days)|Adverse Event|0
4824380|NCT01147809|16633762|P1|Phase II (168 Days)|Adverse Event|0
4824381|NCT01147809|16633757|P6|Phase I (168 Days)|Withdrawal by Subject|0
4824382|NCT01147809|16633758|P5|Phase I (168 Days)|Withdrawal by Subject|0
4824383|NCT01147809|16633759|P4|Phase I (168 Days)|Withdrawal by Subject|3
4824384|NCT01147809|16633760|P3|Phase I (168 Days)|Withdrawal by Subject|0
4824385|NCT01147809|16633761|P2|Phase I (168 Days)|Withdrawal by Subject|0
4824386|NCT01147809|16633762|P1|Phase I (168 Days)|Withdrawal by Subject|0
4824387|NCT01147809|16633757|P6|Phase I (168 Days)|Physician Decision|0
4824388|NCT01147809|16633758|P5|Phase I (168 Days)|Physician Decision|0
4824389|NCT01147809|16633759|P4|Phase I (168 Days)|Physician Decision|0
4824390|NCT01147809|16633760|P3|Phase I (168 Days)|Physician Decision|2
4824391|NCT01147809|16633761|P2|Phase I (168 Days)|Physician Decision|1
4824392|NCT01147809|16633762|P1|Phase I (168 Days)|Physician Decision|0
4824393|NCT01147809|16633757|P6|Phase I (168 Days)|Lost to Follow-up|0
4824394|NCT01147809|16633758|P5|Phase I (168 Days)|Lost to Follow-up|0
4824395|NCT01147809|16633759|P4|Phase I (168 Days)|Lost to Follow-up|1
4824396|NCT01147809|16633760|P3|Phase I (168 Days)|Lost to Follow-up|0
4824397|NCT01147809|16633761|P2|Phase I (168 Days)|Lost to Follow-up|0
4824398|NCT01147809|16633762|P1|Phase I (168 Days)|Lost to Follow-up|1
4824399|NCT01147809|16633757|P6|Phase I (168 Days)|Adverse Event|0
4824400|NCT01147809|16633758|P5|Phase I (168 Days)|Adverse Event|0
4824401|NCT01147809|16633759|P4|Phase I (168 Days)|Adverse Event|1
4824402|NCT01147809|16633760|P3|Phase I (168 Days)|Adverse Event|0
4824403|NCT01147809|16633761|P2|Phase I (168 Days)|Adverse Event|0
4824404|NCT01147809|16633762|P1|Phase I (168 Days)|Adverse Event|0
4824405|NCT01147744|16633883|P7|Overall Study|Met Protocol-defined Stopping Criteria|0
4824406|NCT01147744|16633884|P6|Overall Study|Met Protocol-defined Stopping Criteria|1
4824407|NCT01147744|16633885|P5|Overall Study|Met Protocol-defined Stopping Criteria|0
4824408|NCT01147744|16633886|P4|Overall Study|Met Protocol-defined Stopping Criteria|0
4824409|NCT01147744|16633887|P3|Overall Study|Met Protocol-defined Stopping Criteria|0
4824410|NCT01147744|16633888|P2|Overall Study|Met Protocol-defined Stopping Criteria|0
4824411|NCT01147744|16633889|P1|Overall Study|Met Protocol-defined Stopping Criteria|1
4824412|NCT01147744|16633883|P7|Overall Study|Sponsor decision to amend protocol|6
4824413|NCT01147744|16633884|P6|Overall Study|Sponsor decision to amend protocol|2
4824414|NCT01147744|16633885|P5|Overall Study|Sponsor decision to amend protocol|7
4824415|NCT01147744|16633886|P4|Overall Study|Sponsor decision to amend protocol|5
4824416|NCT01147744|16633887|P3|Overall Study|Sponsor decision to amend protocol|2
4824417|NCT01147744|16633888|P2|Overall Study|Sponsor decision to amend protocol|4
4824418|NCT01147744|16633889|P1|Overall Study|Sponsor decision to amend protocol|7
4824419|NCT01147744|16633883|P7|Overall Study|Lost to Follow-up|0
4824420|NCT01147744|16633884|P6|Overall Study|Lost to Follow-up|0
4824421|NCT01147744|16633885|P5|Overall Study|Lost to Follow-up|0
4824422|NCT01147744|16633886|P4|Overall Study|Lost to Follow-up|0
4824423|NCT01147744|16633887|P3|Overall Study|Lost to Follow-up|0
4824424|NCT01147744|16633888|P2|Overall Study|Lost to Follow-up|1
4824425|NCT01147744|16633889|P1|Overall Study|Lost to Follow-up|0
4824426|NCT01147744|16633883|P7|Overall Study|Withdrawal by Subject|2
4824427|NCT01147744|16633884|P6|Overall Study|Withdrawal by Subject|5
4824428|NCT01147744|16633885|P5|Overall Study|Withdrawal by Subject|2
4824429|NCT01147744|16633886|P4|Overall Study|Withdrawal by Subject|2
4824430|NCT01147744|16633887|P3|Overall Study|Withdrawal by Subject|2
4824431|NCT01147744|16633888|P2|Overall Study|Withdrawal by Subject|4
4824432|NCT01147744|16633889|P1|Overall Study|Withdrawal by Subject|8
4824433|NCT01147744|16633883|P7|Overall Study|Adverse Event|2
4824434|NCT01147744|16633884|P6|Overall Study|Adverse Event|1
4824435|NCT01147744|16633885|P5|Overall Study|Adverse Event|2
4824436|NCT01147744|16633886|P4|Overall Study|Adverse Event|0
4824437|NCT01147744|16633887|P3|Overall Study|Adverse Event|3
4824438|NCT01147744|16633888|P2|Overall Study|Adverse Event|2
4824439|NCT01147744|16633889|P1|Overall Study|Adverse Event|1
4824440|NCT01147744|16633883|P7|Overall Study|Lack of Efficacy|7
4824441|NCT01147744|16633884|P6|Overall Study|Lack of Efficacy|8
4824442|NCT01147744|16633885|P5|Overall Study|Lack of Efficacy|13
4824443|NCT01147744|16633886|P4|Overall Study|Lack of Efficacy|11
4824444|NCT01147744|16633887|P3|Overall Study|Lack of Efficacy|9
4824445|NCT01147744|16633888|P2|Overall Study|Lack of Efficacy|11
4824446|NCT01147744|16633889|P1|Overall Study|Lack of Efficacy|11
4824447|NCT01147744|16633883|P7|Overall Study|Physician Decision|1
4824448|NCT01147744|16633884|P6|Overall Study|Physician Decision|0
4824449|NCT01147744|16633885|P5|Overall Study|Physician Decision|0
4824450|NCT01147744|16633886|P4|Overall Study|Physician Decision|0
4824451|NCT01147744|16633887|P3|Overall Study|Physician Decision|1
4824452|NCT01147744|16633888|P2|Overall Study|Physician Decision|1
4824453|NCT01147744|16633889|P1|Overall Study|Physician Decision|0
4824454|NCT01147744|16633883|P7|Overall Study|Protocol Violation|1
4824455|NCT01147744|16633884|P6|Overall Study|Protocol Violation|3
4824456|NCT01147744|16633885|P5|Overall Study|Protocol Violation|1
4824457|NCT01147744|16633886|P4|Overall Study|Protocol Violation|0
4824458|NCT01147744|16633887|P3|Overall Study|Protocol Violation|1
4824459|NCT01147744|16633888|P2|Overall Study|Protocol Violation|0
4824460|NCT01147744|16633889|P1|Overall Study|Protocol Violation|1
4824461|NCT01147653|16633984|P2|Year 2|Withdrawal by Subject|3
4824462|NCT01147653|16633985|P1|Year 2|Withdrawal by Subject|2
4824463|NCT01147640|16634046|P2|Overall Study|Didn't meet eligibility criteria|0
4824464|NCT01147640|16634047|P1|Overall Study|Didn't meet eligibility criteria|1
4824465|NCT01147640|16634046|P2|Overall Study|Lost to Follow-up|1
4824466|NCT01147640|16634047|P1|Overall Study|Lost to Follow-up|0
4824467|NCT01147640|16634046|P2|Overall Study|Withdrawal by Subject|0
4824468|NCT01147640|16634047|P1|Overall Study|Withdrawal by Subject|1
4824469|NCT01147640|16634046|P2|Overall Study|Physician Decision|0
4824470|NCT01147640|16634047|P1|Overall Study|Physician Decision|1
4824471|NCT01147640|16634046|P2|Overall Study|Adverse Event|0
4824472|NCT01147640|16634047|P1|Overall Study|Adverse Event|2
4824473|NCT01147497|16634079|P2|Overall Study|failed insertion|0
4824474|NCT01147497|16634080|P1|Overall Study|failed insertion|2
4824475|NCT01147471|16634100|P2|6 Month Follow Up|Lost to Follow-up|2
4824476|NCT01147471|16634101|P1|6 Month Follow Up|Lost to Follow-up|4
4824477|NCT01147471|16634100|P2|3 Month Follow Up|Physician Decision|1
4824478|NCT01147471|16634101|P1|3 Month Follow Up|Physician Decision|0
4824479|NCT01147471|16634100|P2|3 Month Follow Up|Lost to Follow-up|1
4824480|NCT01147471|16634101|P1|3 Month Follow Up|Lost to Follow-up|1
4824481|NCT01147471|16634100|P2|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1
4824482|NCT01147471|16634101|P1|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0
4824483|NCT01147471|16634100|P2|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1
4824484|NCT01147471|16634101|P1|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0
4824485|NCT01147471|16634100|P2|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1
4824486|NCT01147471|16634101|P1|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0
4824487|NCT01147458|16634115|P4|Second Intervention|Other|0
4824488|NCT01147458|16634116|P3|Second Intervention|Other|1
4824489|NCT01147458|16634117|P2|Second Intervention|Other|0
4824490|NCT01147458|16634118|P1|Second Intervention|Other|0
4824491|NCT01147458|16634115|P4|Second Intervention|Adverse Event|1
4824492|NCT01147458|16634116|P3|Second Intervention|Adverse Event|1
4824493|NCT01147458|16634117|P2|Second Intervention|Adverse Event|0
4824494|NCT01147458|16634118|P1|Second Intervention|Adverse Event|2
4824495|NCT01147458|16634115|P4|Second Intervention|Withdrawal by Subject|0
4824496|NCT01147458|16634116|P3|Second Intervention|Withdrawal by Subject|0
4824497|NCT01147458|16634117|P2|Second Intervention|Withdrawal by Subject|1
4824498|NCT01147458|16634118|P1|Second Intervention|Withdrawal by Subject|0
4824499|NCT01147458|16634115|P4|Second Intervention|Protocol Violation|0
4824500|NCT01147458|16634116|P3|Second Intervention|Protocol Violation|1
4824501|NCT01147458|16634117|P2|Second Intervention|Protocol Violation|1
4824502|NCT01147458|16634118|P1|Second Intervention|Protocol Violation|0
4824503|NCT01147458|16634115|P4|Second Intervention|Study terminated by sponsor|3
4824504|NCT01147458|16634116|P3|Second Intervention|Study terminated by sponsor|5
4824505|NCT01147458|16634117|P2|Second Intervention|Study terminated by sponsor|5
4824506|NCT01147458|16634118|P1|Second Intervention|Study terminated by sponsor|7
4824507|NCT01147458|16634115|P4|First Intervention|Other|0
4824508|NCT01147458|16634116|P3|First Intervention|Other|0
4824509|NCT01147458|16634117|P2|First Intervention|Other|2
4824510|NCT01147458|16634118|P1|First Intervention|Other|1
4824511|NCT01147458|16634115|P4|First Intervention|Adverse Event|3
4824512|NCT01147458|16634116|P3|First Intervention|Adverse Event|2
4824513|NCT01147458|16634117|P2|First Intervention|Adverse Event|3
4824514|NCT01147458|16634118|P1|First Intervention|Adverse Event|0
4824515|NCT01147458|16634115|P4|First Intervention|Withdrawal by Subject|0
4824516|NCT01147458|16634116|P3|First Intervention|Withdrawal by Subject|1
4824517|NCT01147458|16634117|P2|First Intervention|Withdrawal by Subject|0
4824518|NCT01147458|16634118|P1|First Intervention|Withdrawal by Subject|3
4824519|NCT01147458|16634115|P4|First Intervention|Protocol Violation|3
4824520|NCT01147458|16634116|P3|First Intervention|Protocol Violation|2
4824521|NCT01147458|16634117|P2|First Intervention|Protocol Violation|3
4824522|NCT01147458|16634118|P1|First Intervention|Protocol Violation|2
4824523|NCT01147458|16634115|P4|First Intervention|Study terminated by sponsor|8
4824524|NCT01147458|16634116|P3|First Intervention|Study terminated by sponsor|7
4824525|NCT01147458|16634117|P2|First Intervention|Study terminated by sponsor|8
4824526|NCT01147458|16634118|P1|First Intervention|Study terminated by sponsor|8
4824527|NCT01147393|16634197|P1|Dose Level -1|Dose Limited Toxicity|1
4824528|NCT01147393|16634197|P1|Dose Level 1|Dose limiting Toxicity|2
4824529|NCT01147341|16634218|P2|Open Label Period|Subject moved|0
4824530|NCT01147341|16634219|P1|Open Label Period|Subject moved|1
4824531|NCT01147341|16634218|P2|Open Label Period|Lack of Efficacy|0
4824532|NCT01147341|16634219|P1|Open Label Period|Lack of Efficacy|3
4824533|NCT01147341|16634218|P2|Double Blind Period|Withdrawal by Subject|1
4824534|NCT01147341|16634219|P1|Double Blind Period|Withdrawal by Subject|0
4824535|NCT01147341|16634218|P2|Double Blind Period|Lack of Efficacy|1
4824536|NCT01147341|16634219|P1|Double Blind Period|Lack of Efficacy|1
4824537|NCT01147250|16634282|P2|Overall Study|Other than specified|1
4824538|NCT01147250|16634283|P1|Overall Study|Other than specified|0
4824539|NCT01147250|16634282|P2|Overall Study|Site termination by sponsor|5
4824540|NCT01147250|16634283|P1|Overall Study|Site termination by sponsor|13
4824541|NCT01147250|16634282|P2|Overall Study|Withdrawal by Subject|88
4824542|NCT01147250|16634283|P1|Overall Study|Withdrawal by Subject|83
4824543|NCT01147250|16634282|P2|Overall Study|Lost to Follow-up|11
4824544|NCT01147250|16634283|P1|Overall Study|Lost to Follow-up|14
4824545|NCT01147172|16634295|P1|Overall Study|Lost to Follow-up|2
4824546|NCT01147172|16634295|P1|Overall Study|Withdrawal by Subject|2
4824547|NCT01147068|16634313|P7|Subjects That Completed Safety Follow-up|Ineligible|0
4824548|NCT01147068|16634314|P6|Subjects That Completed Safety Follow-up|Ineligible|0
4824549|NCT01147068|16634315|P5|Subjects That Completed Safety Follow-up|Ineligible|0
4824550|NCT01147068|16634316|P4|Subjects That Completed Safety Follow-up|Ineligible|0
4824551|NCT01147068|16634317|P3|Subjects That Completed Safety Follow-up|Ineligible|0
4824552|NCT01147068|16634318|P2|Subjects That Completed Safety Follow-up|Ineligible|1
4824553|NCT01147068|16634319|P1|Subjects That Completed Safety Follow-up|Ineligible|0
4824554|NCT01147068|16634313|P7|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4824555|NCT01147068|16634314|P6|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4824556|NCT01147068|16634315|P5|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4824557|NCT01147068|16634316|P4|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2
4824558|NCT01147068|16634317|P3|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4824559|NCT01147068|16634318|P2|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4824560|NCT01147068|16634319|P1|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0
4824561|NCT01147068|16634313|P7|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
4824562|NCT01147068|16634314|P6|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
4824563|NCT01147068|16634315|P5|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4824564|NCT01147068|16634316|P4|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4824565|NCT01147068|16634317|P3|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4824566|NCT01147068|16634318|P2|Subjects That Completed Safety Follow-up|Lost to Follow-up|0
4824567|NCT01147068|16634319|P1|Subjects That Completed Safety Follow-up|Lost to Follow-up|1
4824568|NCT01147068|16634313|P7|Subjects That Received 2nd Dose|Other|0
4824569|NCT01147068|16634314|P6|Subjects That Received 2nd Dose|Other|0
4824570|NCT01147068|16634315|P5|Subjects That Received 2nd Dose|Other|1
4824571|NCT01147068|16634316|P4|Subjects That Received 2nd Dose|Other|0
4824572|NCT01147068|16634317|P3|Subjects That Received 2nd Dose|Other|3
4824573|NCT01147068|16634318|P2|Subjects That Received 2nd Dose|Other|3
4824574|NCT01147068|16634319|P1|Subjects That Received 2nd Dose|Other|0
4824575|NCT01147068|16634313|P7|Subjects That Received 2nd Dose|Did not complete the study|0
4824576|NCT01147068|16634314|P6|Subjects That Received 2nd Dose|Did not complete the study|1
4824577|NCT01147068|16634315|P5|Subjects That Received 2nd Dose|Did not complete the study|0
4824578|NCT01147068|16634316|P4|Subjects That Received 2nd Dose|Did not complete the study|0
4824579|NCT01147068|16634317|P3|Subjects That Received 2nd Dose|Did not complete the study|0
4824580|NCT01147068|16634318|P2|Subjects That Received 2nd Dose|Did not complete the study|1
4824581|NCT01147068|16634319|P1|Subjects That Received 2nd Dose|Did not complete the study|0
4824582|NCT01147068|16634313|P7|Subjects That Received 2nd Dose|Ineligible|0
4824583|NCT01147068|16634314|P6|Subjects That Received 2nd Dose|Ineligible|0
4824584|NCT01147068|16634315|P5|Subjects That Received 2nd Dose|Ineligible|0
4824585|NCT01147068|16634316|P4|Subjects That Received 2nd Dose|Ineligible|0
4824586|NCT01147068|16634317|P3|Subjects That Received 2nd Dose|Ineligible|0
4824587|NCT01147068|16634318|P2|Subjects That Received 2nd Dose|Ineligible|1
4824588|NCT01147068|16634319|P1|Subjects That Received 2nd Dose|Ineligible|0
4824589|NCT01147068|16634313|P7|Subjects That Received 2nd Dose|Lost to Follow-up|0
4824590|NCT01147068|16634314|P6|Subjects That Received 2nd Dose|Lost to Follow-up|1
4824591|NCT01147068|16634315|P5|Subjects That Received 2nd Dose|Lost to Follow-up|0
4824592|NCT01147068|16634316|P4|Subjects That Received 2nd Dose|Lost to Follow-up|0
4824593|NCT01147068|16634317|P3|Subjects That Received 2nd Dose|Lost to Follow-up|0
4824594|NCT01147068|16634318|P2|Subjects That Received 2nd Dose|Lost to Follow-up|0
4824595|NCT01147068|16634319|P1|Subjects That Received 2nd Dose|Lost to Follow-up|1
4824596|NCT01147055|16634349|P2|First Intervention Period|Lost to Follow-up|0
4824597|NCT01147055|16634350|P1|First Intervention Period|Lost to Follow-up|1
4824598|NCT01146951|16634392|P2|Overall Study|Adverse Event|1
4824599|NCT01146951|16634393|P1|Overall Study|Adverse Event|4
4824600|NCT01146912|16634414|P8|Overall Study|Duplicate patient|0
4824601|NCT01146912|16634415|P7|Overall Study|Duplicate patient|0
4824602|NCT01146912|16634416|P6|Overall Study|Duplicate patient|0
4824603|NCT01146912|16634417|P5|Overall Study|Duplicate patient|0
4824604|NCT01146912|16634418|P4|Overall Study|Duplicate patient|0
4824605|NCT01146912|16634419|P3|Overall Study|Duplicate patient|1
4824606|NCT01146912|16634420|P2|Overall Study|Duplicate patient|0
4824607|NCT01146912|16634421|P1|Overall Study|Duplicate patient|0
4824608|NCT01146912|16634414|P8|Overall Study|< 14 weeks gestational age|0
4824609|NCT01146912|16634415|P7|Overall Study|< 14 weeks gestational age|0
4824610|NCT01146912|16634416|P6|Overall Study|< 14 weeks gestational age|0
4824611|NCT01146912|16634417|P5|Overall Study|< 14 weeks gestational age|0
4824612|NCT01146912|16634418|P4|Overall Study|< 14 weeks gestational age|2
4824613|NCT01146912|16634419|P3|Overall Study|< 14 weeks gestational age|3
4824614|NCT01146912|16634420|P2|Overall Study|< 14 weeks gestational age|0
4824615|NCT01146912|16634421|P1|Overall Study|< 14 weeks gestational age|0
4824616|NCT01146912|16634414|P8|Overall Study|Already received influenza vaccination|0
4824617|NCT01146912|16634415|P7|Overall Study|Already received influenza vaccination|56
4824618|NCT01146912|16634416|P6|Overall Study|Already received influenza vaccination|61
4824619|NCT01146912|16634417|P5|Overall Study|Already received influenza vaccination|41
4824620|NCT01146912|16634418|P4|Overall Study|Already received influenza vaccination|15
4824621|NCT01146912|16634419|P3|Overall Study|Already received influenza vaccination|13
4824622|NCT01146912|16634420|P2|Overall Study|Already received influenza vaccination|822
4824623|NCT01146912|16634421|P1|Overall Study|Already received influenza vaccination|817
4824624|NCT01146873|16634443|P2|Overall Study|Transfer out|6
4824625|NCT01146873|16634444|P1|Overall Study|Transfer out|0
4824626|NCT01146860|16634460|P2|Overall Study|Withdrawal by Subject|1
4824627|NCT01146860|16634461|P1|Overall Study|Withdrawal by Subject|0
4824628|NCT01146782|16634512|P1|Primary Endpoint Cohort|Physician Decision|1
4824629|NCT01146782|16634512|P1|Primary Endpoint Cohort|Withdrawal by Subject|5
4824630|NCT01146782|16634512|P1|Safety Cohort|TST <4 hrs|14
4824631|NCT01146782|16634512|P1|Safety Cohort|Control AHI <5|4
4824632|NCT01146782|16634512|P1|Safety Cohort|Withdrawal by Subject|4
4824633|NCT01146782|16634512|P1|Safety Cohort|Screen Failure|61
4824634|NCT01146782|16634512|P1|Screening Cohort|Withdrawal by Subject|29
4824635|NCT01146782|16634512|P1|Screening Cohort|Physician Decision|1
4824636|NCT01146782|16634512|P1|Screening Cohort|Lost to Follow-up|4
4824637|NCT01146782|16634512|P1|Screening Cohort|Screen Failure|187
4824638|NCT01146665|16634530|P2|Overall Study|Withdrawal by Subject|16
4824639|NCT01146665|16634531|P1|Overall Study|Withdrawal by Subject|10
4824640|NCT01146613|16634563|P2|Overall Study|Outpatient detox|0
4824641|NCT01146613|16634564|P1|Overall Study|Outpatient detox|1
4824642|NCT01146613|16634563|P2|Overall Study|schedule conflict|0
4824643|NCT01146613|16634564|P1|Overall Study|schedule conflict|1
4824644|NCT01146613|16634563|P2|Overall Study|Withdrawal by Subject|3
4824645|NCT01146613|16634564|P1|Overall Study|Withdrawal by Subject|0
4824646|NCT01146613|16634563|P2|Overall Study|Physician Decision|0
4824647|NCT01146613|16634564|P1|Overall Study|Physician Decision|1
4824648|NCT01146613|16634563|P2|Overall Study|Death|0
4824649|NCT01146613|16634564|P1|Overall Study|Death|1
4824650|NCT01146613|16634563|P2|Overall Study|Lack of Efficacy|1
4824651|NCT01146613|16634564|P1|Overall Study|Lack of Efficacy|0
4824652|NCT01146613|16634563|P2|Overall Study|Lost to Follow-up|8
4824653|NCT01146613|16634564|P1|Overall Study|Lost to Follow-up|3
4824654|NCT01146288|16634674|P2|First Intervention(1 Day)|Adverse Event|1
4824655|NCT01146288|16634675|P1|First Intervention(1 Day)|Adverse Event|0
4824656|NCT01146054|16634689|P1|Overall Study|Lost to Follow-up|1
4824657|NCT01146054|16634689|P1|Overall Study|Other illness precluded treatment|2
4824658|NCT01146054|16634689|P1|Overall Study|Rapid tumor progression|2
4824659|NCT01146054|16634689|P1|Overall Study|Did not meet dose constraints for SBRT|5
4824660|NCT01145898|16634699|P2|3-year Treatment|medication change by treating physician|16
4824661|NCT01145898|16634700|P1|3-year Treatment|medication change by treating physician|3
4824662|NCT01145885|16634731|P1|Overall Study|Progressive Disease|7
4824663|NCT01145755|16634777|P3|Overall Study|Positive urine ethanol|0
4824664|NCT01145755|16634778|P2|Overall Study|Positive urine ethanol|1
4824665|NCT01145755|16634779|P1|Overall Study|Positive urine ethanol|0
4824666|NCT01145755|16634777|P3|Overall Study|Withdrawal by Subject|1
4824667|NCT01145755|16634778|P2|Overall Study|Withdrawal by Subject|0
4824668|NCT01145755|16634779|P1|Overall Study|Withdrawal by Subject|0
4824669|NCT01145755|16634777|P3|Overall Study|Patient could not swollow medication|1
4824670|NCT01145755|16634778|P2|Overall Study|Patient could not swollow medication|0
4824671|NCT01145755|16634779|P1|Overall Study|Patient could not swollow medication|0
4824672|NCT01145755|16634777|P3|Overall Study|Lack of Efficacy|0
4824673|NCT01145755|16634778|P2|Overall Study|Lack of Efficacy|1
4824674|NCT01145755|16634779|P1|Overall Study|Lack of Efficacy|0
4824675|NCT01145755|16634777|P3|Overall Study|Study Closure|17
4824676|NCT01145755|16634778|P2|Overall Study|Study Closure|14
4824677|NCT01145755|16634779|P1|Overall Study|Study Closure|14
4824678|NCT01145755|16634777|P3|Overall Study|Protocol Violation|1
4824679|NCT01145755|16634778|P2|Overall Study|Protocol Violation|3
4824680|NCT01145755|16634779|P1|Overall Study|Protocol Violation|0
4824681|NCT01145755|16634777|P3|Overall Study|Lost to Follow-up|1
4824682|NCT01145755|16634778|P2|Overall Study|Lost to Follow-up|3
4824683|NCT01145755|16634779|P1|Overall Study|Lost to Follow-up|2
4824684|NCT01145755|16634777|P3|Overall Study|Withdrawal by Subject|2
4824685|NCT01145755|16634778|P2|Overall Study|Withdrawal by Subject|2
4824686|NCT01145755|16634779|P1|Overall Study|Withdrawal by Subject|2
4824687|NCT01145755|16634777|P3|Overall Study|Adverse Event|2
4824688|NCT01145755|16634778|P2|Overall Study|Adverse Event|4
4824689|NCT01145755|16634779|P1|Overall Study|Adverse Event|2
4824690|NCT01145625|16634806|P2|Overall Study|Pregnancy|1
4824691|NCT01145625|16634807|P1|Overall Study|Pregnancy|0
4824692|NCT01145625|16634806|P2|Overall Study|Withdrawal by Subject|16
4824693|NCT01145625|16634807|P1|Overall Study|Withdrawal by Subject|7
4824694|NCT01145625|16634806|P2|Overall Study|Protocol Violation|1
4824695|NCT01145625|16634807|P1|Overall Study|Protocol Violation|3
4824696|NCT01145625|16634806|P2|Overall Study|Adverse Event|4
4824697|NCT01145625|16634807|P1|Overall Study|Adverse Event|6
4824698|NCT01145625|16634806|P2|Overall Study|Lost to Follow-up|9
4824699|NCT01145625|16634807|P1|Overall Study|Lost to Follow-up|8
4824700|NCT01145560|16634820|P3|Overall Study|Withdrawal of therapy|1
4824701|NCT01145560|16634821|P2|Overall Study|Withdrawal of therapy|0
4824702|NCT01145560|16634822|P1|Overall Study|Withdrawal of therapy|0
4824703|NCT01145560|16634820|P3|Overall Study|False insurance information|0
4824704|NCT01145560|16634821|P2|Overall Study|False insurance information|1
4824705|NCT01145560|16634822|P1|Overall Study|False insurance information|0
4824706|NCT01145560|16634820|P3|Overall Study|Accidental unblinding of study treatment|0
4824707|NCT01145560|16634821|P2|Overall Study|Accidental unblinding of study treatment|1
4824708|NCT01145560|16634822|P1|Overall Study|Accidental unblinding of study treatment|0
4824709|NCT01145560|16634820|P3|Overall Study|No study drug by 24h after organ failure|0
4824710|NCT01145560|16634821|P2|Overall Study|No study drug by 24h after organ failure|0
4824711|NCT01145560|16634822|P1|Overall Study|No study drug by 24h after organ failure|1
4824712|NCT01145560|16634820|P3|Overall Study|Lost to Follow-up|1
4824713|NCT01145560|16634821|P2|Overall Study|Lost to Follow-up|1
4824714|NCT01145560|16634822|P1|Overall Study|Lost to Follow-up|1
4824715|NCT01145560|16634820|P3|Overall Study|Withdrawal by Subject|0
4824716|NCT01145560|16634821|P2|Overall Study|Withdrawal by Subject|1
4824717|NCT01145560|16634822|P1|Overall Study|Withdrawal by Subject|2
4824718|NCT01145508|16634848|P2|Overall Study|Never started treatment|1
4824719|NCT01145508|16634849|P1|Overall Study|Never started treatment|1
4824720|NCT01145508|16634848|P2|Overall Study|Physician Decision|1
4824721|NCT01145508|16634849|P1|Overall Study|Physician Decision|2
4824722|NCT01145508|16634848|P2|Overall Study|Death|0
4824723|NCT01145508|16634849|P1|Overall Study|Death|1
4824724|NCT01145508|16634848|P2|Overall Study|Adverse Event|0
4824725|NCT01145508|16634849|P1|Overall Study|Adverse Event|1
4824726|NCT01145495|16634855|P1|Overall Study|Disease progression after respone|1
4824727|NCT01145495|16634855|P1|Overall Study|Withdrawal by Subject|5
4824728|NCT01145495|16634855|P1|Overall Study|Adverse Event|6
4824729|NCT01145482|16634861|P2|First Intervention (1 Day)|Withdrawal by Subject|1
4824730|NCT01145482|16634862|P1|First Intervention (1 Day)|Withdrawal by Subject|0
4824731|NCT01145417|16634872|P2|Overall Study|Other|0
4824732|NCT01145417|16634873|P1|Overall Study|Other|1
4824733|NCT01145417|16634872|P2|Overall Study|Study terminated by sponsor|43
4824734|NCT01145417|16634873|P1|Overall Study|Study terminated by sponsor|35
4824735|NCT01145417|16634872|P2|Overall Study|Adverse Event|1
4824736|NCT01145417|16634873|P1|Overall Study|Adverse Event|0
4824737|NCT01145417|16634872|P2|Overall Study|Pregnancy|0
4824738|NCT01145417|16634873|P1|Overall Study|Pregnancy|1
4824739|NCT01145417|16634872|P2|Overall Study|Withdrawal by Subject|2
4824740|NCT01145417|16634873|P1|Overall Study|Withdrawal by Subject|1
4824741|NCT01145417|16634872|P2|Overall Study|Lost to Follow-up|1
4824742|NCT01145417|16634873|P1|Overall Study|Lost to Follow-up|2
4824743|NCT01145417|16634872|P2|Overall Study|Death|0
4824744|NCT01145417|16634873|P1|Overall Study|Death|1
4824745|NCT01145352|16634906|P1|Overall Study|Syringe formulation was used|1
4824746|NCT01145352|16634906|P1|Overall Study|Treated before marketing approval|4
4824747|NCT01145352|16634906|P1|Overall Study|Found to have been registered twice|6
4824748|NCT01145222|16634918|P4|Overall Study|Poor bowel preparation|1
4824749|NCT01145222|16634919|P3|Overall Study|Poor bowel preparation|0
4824750|NCT01145222|16634920|P2|Overall Study|Poor bowel preparation|0
4824751|NCT01145222|16634921|P1|Overall Study|Poor bowel preparation|0
4824752|NCT01145222|16634918|P4|Overall Study|Procedure not done (no anesthesiologist)|0
4824753|NCT01145222|16634919|P3|Overall Study|Procedure not done (no anesthesiologist)|1
4824754|NCT01145222|16634920|P2|Overall Study|Procedure not done (no anesthesiologist)|0
4824755|NCT01145222|16634921|P1|Overall Study|Procedure not done (no anesthesiologist)|0
4824756|NCT01145066|16634968|P3|Overall Study|Low platelet count|0
4824757|NCT01145066|16634969|P2|Overall Study|Low platelet count|1
4824758|NCT01145066|16634970|P1|Overall Study|Low platelet count|0
4824759|NCT01145066|16634968|P3|Overall Study|Abdominal discomfort|0
4824760|NCT01145066|16634969|P2|Overall Study|Abdominal discomfort|1
4824761|NCT01145066|16634970|P1|Overall Study|Abdominal discomfort|0
4824762|NCT01145066|16634968|P3|Overall Study|problems swallowing capsule|0
4824763|NCT01145066|16634969|P2|Overall Study|problems swallowing capsule|0
4824764|NCT01145066|16634970|P1|Overall Study|problems swallowing capsule|1
4824765|NCT01145066|16634968|P3|Overall Study|To start new med|0
4824766|NCT01145066|16634969|P2|Overall Study|To start new med|0
4824767|NCT01145066|16634970|P1|Overall Study|To start new med|1
4824768|NCT01145066|16634968|P3|Overall Study|Withdrawal by Subject|2
4824769|NCT01145066|16634969|P2|Overall Study|Withdrawal by Subject|0
4824770|NCT01145066|16634970|P1|Overall Study|Withdrawal by Subject|0
4824771|NCT01145066|16634968|P3|Overall Study|Non-related surgery|1
4824772|NCT01145066|16634969|P2|Overall Study|Non-related surgery|0
4824773|NCT01145066|16634970|P1|Overall Study|Non-related surgery|0
4824774|NCT01145066|16634968|P3|Overall Study|To resume NSAIDs|1
4824775|NCT01145066|16634969|P2|Overall Study|To resume NSAIDs|2
4824776|NCT01145066|16634970|P1|Overall Study|To resume NSAIDs|2
4824777|NCT01145053|16635038|P1|Overall Study|Other|18
4824778|NCT01145053|16635038|P1|Overall Study|Withdrawal by Subject|25
4824779|NCT01145053|16635038|P1|Overall Study|Lost to Follow-up|28
4824780|NCT01145053|16635038|P1|Overall Study|Adverse Event|22
4824781|NCT01144715|16635090|P2|Overall Study|Adverse Event|1
4824782|NCT01144715|16635091|P1|Overall Study|Adverse Event|0
4824783|NCT01144715|16635090|P2|Overall Study|Withdrawal by Subject|1
4824784|NCT01144715|16635091|P1|Overall Study|Withdrawal by Subject|2
4824785|NCT01144715|16635090|P2|Overall Study|Lost to Follow-up|1
4824786|NCT01144715|16635091|P1|Overall Study|Lost to Follow-up|2
4824787|NCT01144663|16635107|P4|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0
4824788|NCT01144663|16635108|P3|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5
4824789|NCT01144663|16635109|P2|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6
4824790|NCT01144663|16635110|P1|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4
4824791|NCT01144663|16635107|P4|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0
4824792|NCT01144663|16635108|P3|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
4824793|NCT01144663|16635109|P2|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3
4824794|NCT01144663|16635110|P1|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1
4824795|NCT01144663|16635107|P4|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
4824796|NCT01144663|16635108|P3|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1
4824797|NCT01144663|16635109|P2|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
4824798|NCT01144663|16635110|P1|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0
4824799|NCT01144663|16635107|P4|Booster Vaccination Phase|Lost to Follow-up|0
4824800|NCT01144663|16635108|P3|Booster Vaccination Phase|Lost to Follow-up|3
4824801|NCT01144663|16635109|P2|Booster Vaccination Phase|Lost to Follow-up|1
4824802|NCT01144663|16635110|P1|Booster Vaccination Phase|Lost to Follow-up|2
4824803|NCT01144663|16635107|P4|Booster Vaccination Phase|Migrated/moved from study area|0
4824804|NCT01144663|16635108|P3|Booster Vaccination Phase|Migrated/moved from study area|1
4824805|NCT01144663|16635109|P2|Booster Vaccination Phase|Migrated/moved from study area|1
4824806|NCT01144663|16635110|P1|Booster Vaccination Phase|Migrated/moved from study area|1
4824807|NCT01144663|16635107|P4|Booster Vaccination Phase|Withdrawal by Subject|1
4824808|NCT01144663|16635108|P3|Booster Vaccination Phase|Withdrawal by Subject|1
4824809|NCT01144663|16635109|P2|Booster Vaccination Phase|Withdrawal by Subject|0
4824810|NCT01144663|16635110|P1|Booster Vaccination Phase|Withdrawal by Subject|0
4824811|NCT01144663|16635107|P4|Primary Vaccination Phase|Other|2
4824812|NCT01144663|16635108|P3|Primary Vaccination Phase|Other|0
4824813|NCT01144663|16635109|P2|Primary Vaccination Phase|Other|1
4824814|NCT01144663|16635110|P1|Primary Vaccination Phase|Other|0
4824815|NCT01144663|16635107|P4|Primary Vaccination Phase|Lost to Follow-up|2
4824816|NCT01144663|16635108|P3|Primary Vaccination Phase|Lost to Follow-up|1
4824817|NCT01144663|16635109|P2|Primary Vaccination Phase|Lost to Follow-up|0
4824818|NCT01144663|16635110|P1|Primary Vaccination Phase|Lost to Follow-up|2
4824819|NCT01144663|16635107|P4|Primary Vaccination Phase|Migrated/moved from study area|3
4824820|NCT01144663|16635108|P3|Primary Vaccination Phase|Migrated/moved from study area|2
4824821|NCT01144663|16635109|P2|Primary Vaccination Phase|Migrated/moved from study area|1
4824822|NCT01144663|16635110|P1|Primary Vaccination Phase|Migrated/moved from study area|4
4824823|NCT01144663|16635107|P4|Primary Vaccination Phase|Withdrawal by Subject|10
4824824|NCT01144663|16635108|P3|Primary Vaccination Phase|Withdrawal by Subject|3
4824825|NCT01144663|16635109|P2|Primary Vaccination Phase|Withdrawal by Subject|5
4824826|NCT01144663|16635110|P1|Primary Vaccination Phase|Withdrawal by Subject|9
4824827|NCT01144663|16635107|P4|Primary Vaccination Phase|Protocol Violation|0
4824828|NCT01144663|16635108|P3|Primary Vaccination Phase|Protocol Violation|1
4824829|NCT01144663|16635109|P2|Primary Vaccination Phase|Protocol Violation|0
4824830|NCT01144663|16635110|P1|Primary Vaccination Phase|Protocol Violation|2
4824831|NCT01144663|16635107|P4|Primary Vaccination Phase|Adverse Event|1
4824832|NCT01144663|16635108|P3|Primary Vaccination Phase|Adverse Event|0
4824833|NCT01144663|16635109|P2|Primary Vaccination Phase|Adverse Event|0
4824834|NCT01144663|16635110|P1|Primary Vaccination Phase|Adverse Event|1
4824835|NCT01144663|16635107|P4|Primary Vaccination Phase|Serious adverse event, fatal|0
4824836|NCT01144663|16635108|P3|Primary Vaccination Phase|Serious adverse event, fatal|1
4824837|NCT01144663|16635109|P2|Primary Vaccination Phase|Serious adverse event, fatal|0
4824916|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Death|2
4824838|NCT01144663|16635110|P1|Primary Vaccination Phase|Serious adverse event, fatal|2
4824839|NCT01144416|16635448|P2|Intervention Period|Other|5
4824840|NCT01144416|16635449|P1|Intervention Period|Other|7
4824841|NCT01144416|16635448|P2|Intervention Period|No/too few/bad quality embryos|3
4824842|NCT01144416|16635449|P1|Intervention Period|No/too few/bad quality embryos|3
4824843|NCT01144416|16635448|P2|Intervention Period|No or abnormal fertilization|10
4824844|NCT01144416|16635449|P1|Intervention Period|No or abnormal fertilization|25
4824845|NCT01144416|16635448|P2|Intervention Period|No/too few/bad oocytes|5
4824846|NCT01144416|16635449|P1|Intervention Period|No/too few/bad oocytes|7
4824847|NCT01144416|16635448|P2|Intervention Period|Too high ovarian response|2
4824848|NCT01144416|16635449|P1|Intervention Period|Too high ovarian response|4
4824849|NCT01144416|16635448|P2|Intervention Period|Risk of OHSS|1
4824850|NCT01144416|16635449|P1|Intervention Period|Risk of OHSS|0
4824851|NCT01144416|16635448|P2|Intervention Period|Insufficient ovarian response|17
4824852|NCT01144416|16635449|P1|Intervention Period|Insufficient ovarian response|11
4824853|NCT01144416|16635448|P2|Intervention Period|Adverse Event|6
4824854|NCT01144416|16635449|P1|Intervention Period|Adverse Event|5
4824855|NCT01144403|16635465|P1|Overall Study|Adverse Event|1
4824856|NCT01144403|16635465|P1|Overall Study|Death|1
4824857|NCT01144403|16635465|P1|Overall Study|Lost to Follow-up|3
4824858|NCT01144377|16635477|P5|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4824859|NCT01144377|16635478|P4|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4824860|NCT01144377|16635479|P3|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4824861|NCT01144377|16635480|P2|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0
4824862|NCT01144377|16635481|P1|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1
4824863|NCT01144377|16635477|P5|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1
4824864|NCT01144377|16635478|P4|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4824865|NCT01144377|16635479|P3|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4824866|NCT01144377|16635480|P2|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4824867|NCT01144377|16635481|P1|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0
4824868|NCT01144377|16635477|P5|Optional 40 Week Safety Follow-up Period|Adverse Event|1
4824869|NCT01144377|16635478|P4|Optional 40 Week Safety Follow-up Period|Adverse Event|0
4824870|NCT01144377|16635479|P3|Optional 40 Week Safety Follow-up Period|Adverse Event|0
4824871|NCT01144377|16635480|P2|Optional 40 Week Safety Follow-up Period|Adverse Event|1
4824872|NCT01144377|16635481|P1|Optional 40 Week Safety Follow-up Period|Adverse Event|0
4824873|NCT01144377|16635477|P5|52 Week Treatment Period|Sponsor Decision|1
4824874|NCT01144377|16635478|P4|52 Week Treatment Period|Sponsor Decision|0
4824875|NCT01144377|16635479|P3|52 Week Treatment Period|Sponsor Decision|0
4824876|NCT01144377|16635480|P2|52 Week Treatment Period|Sponsor Decision|0
4824877|NCT01144377|16635481|P1|52 Week Treatment Period|Sponsor Decision|0
4824878|NCT01144377|16635477|P5|52 Week Treatment Period|Withdrawal by Subject|0
4824879|NCT01144377|16635478|P4|52 Week Treatment Period|Withdrawal by Subject|1
4824880|NCT01144377|16635479|P3|52 Week Treatment Period|Withdrawal by Subject|1
4824881|NCT01144377|16635480|P2|52 Week Treatment Period|Withdrawal by Subject|1
4824882|NCT01144377|16635481|P1|52 Week Treatment Period|Withdrawal by Subject|4
4824883|NCT01144377|16635477|P5|52 Week Treatment Period|Lost to Follow-up|0
4824884|NCT01144377|16635478|P4|52 Week Treatment Period|Lost to Follow-up|0
4824885|NCT01144377|16635479|P3|52 Week Treatment Period|Lost to Follow-up|0
4824886|NCT01144377|16635480|P2|52 Week Treatment Period|Lost to Follow-up|0
4824887|NCT01144377|16635481|P1|52 Week Treatment Period|Lost to Follow-up|1
4824888|NCT01144377|16635477|P5|52 Week Treatment Period|Protocol Violation|1
4824889|NCT01144377|16635478|P4|52 Week Treatment Period|Protocol Violation|0
4824890|NCT01144377|16635479|P3|52 Week Treatment Period|Protocol Violation|0
4824891|NCT01144377|16635480|P2|52 Week Treatment Period|Protocol Violation|0
4824892|NCT01144377|16635481|P1|52 Week Treatment Period|Protocol Violation|0
4824893|NCT01144377|16635477|P5|52 Week Treatment Period|Entry Criteria Not Met|0
4824894|NCT01144377|16635478|P4|52 Week Treatment Period|Entry Criteria Not Met|1
4824895|NCT01144377|16635479|P3|52 Week Treatment Period|Entry Criteria Not Met|1
4824896|NCT01144377|16635480|P2|52 Week Treatment Period|Entry Criteria Not Met|0
4824897|NCT01144377|16635481|P1|52 Week Treatment Period|Entry Criteria Not Met|0
4824898|NCT01144377|16635477|P5|52 Week Treatment Period|Adverse Event|1
4824899|NCT01144377|16635478|P4|52 Week Treatment Period|Adverse Event|2
4824900|NCT01144377|16635479|P3|52 Week Treatment Period|Adverse Event|3
4824901|NCT01144377|16635480|P2|52 Week Treatment Period|Adverse Event|0
4824902|NCT01144377|16635481|P1|52 Week Treatment Period|Adverse Event|0
4824903|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Physician Decision|1
4824904|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Physician Decision|0
4824905|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Physician Decision|0
4824906|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Relapse|5
4824907|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Relapse|5
4824908|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Relapse|0
4824909|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Lost to Follow-up|4
4824910|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Lost to Follow-up|1
4824911|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Lost to Follow-up|0
4824912|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
4824913|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Withdrawal by Subject|1
4824914|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Withdrawal by Subject|0
4824915|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Death|0
4824917|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Death|0
4824918|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Adverse Event|1
4824919|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Adverse Event|3
4824920|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Adverse Event|0
4824921|NCT01144364|16635530|P3|Follow-Up/Maintenance Phase|Disease progression|29
4824922|NCT01144364|16635531|P2|Follow-Up/Maintenance Phase|Disease progression|23
4824923|NCT01144364|16635532|P1|Follow-Up/Maintenance Phase|Disease progression|0
4824924|NCT01144364|16635530|P3|Induction Phase|Protocol Violation|0
4824925|NCT01144364|16635531|P2|Induction Phase|Protocol Violation|0
4824926|NCT01144364|16635532|P1|Induction Phase|Protocol Violation|1
4824927|NCT01144364|16635530|P3|Induction Phase|Secondary neoplasia|0
4824928|NCT01144364|16635531|P2|Induction Phase|Secondary neoplasia|0
4824929|NCT01144364|16635532|P1|Induction Phase|Secondary neoplasia|1
4824930|NCT01144364|16635530|P3|Induction Phase|Stable disease|0
4824931|NCT01144364|16635531|P2|Induction Phase|Stable disease|0
4824932|NCT01144364|16635532|P1|Induction Phase|Stable disease|2
4824933|NCT01144364|16635530|P3|Induction Phase|Physician Decision|0
4824934|NCT01144364|16635531|P2|Induction Phase|Physician Decision|0
4824935|NCT01144364|16635532|P1|Induction Phase|Physician Decision|1
4824936|NCT01144364|16635530|P3|Induction Phase|Lost to Follow-up|0
4824937|NCT01144364|16635531|P2|Induction Phase|Lost to Follow-up|0
4824938|NCT01144364|16635532|P1|Induction Phase|Lost to Follow-up|2
4824939|NCT01144364|16635530|P3|Induction Phase|Withdrawal by Subject|0
4824940|NCT01144364|16635531|P2|Induction Phase|Withdrawal by Subject|0
4824941|NCT01144364|16635532|P1|Induction Phase|Withdrawal by Subject|1
4824942|NCT01144364|16635530|P3|Induction Phase|Death|0
4824943|NCT01144364|16635531|P2|Induction Phase|Death|0
4824944|NCT01144364|16635532|P1|Induction Phase|Death|1
4824945|NCT01144364|16635530|P3|Induction Phase|Adverse Event|0
4824946|NCT01144364|16635531|P2|Induction Phase|Adverse Event|0
4824947|NCT01144364|16635532|P1|Induction Phase|Adverse Event|9
4824948|NCT01144364|16635530|P3|Induction Phase|Disease progression|0
4824949|NCT01144364|16635531|P2|Induction Phase|Disease progression|0
4824950|NCT01144364|16635532|P1|Induction Phase|Disease progression|14
4824951|NCT01144299|16635581|P2|Overall Study|Withdrawal by Subject|0
4824952|NCT01144299|16635582|P1|Overall Study|Withdrawal by Subject|1
4824953|NCT01144299|16635581|P2|Overall Study|Lost to Follow-up|0
4824954|NCT01144299|16635582|P1|Overall Study|Lost to Follow-up|1
4824955|NCT01144182|16635627|P2|Overall Study|Lost to Follow-up|9
4824956|NCT01144182|16635628|P1|Overall Study|Lost to Follow-up|9
4824957|NCT01144182|16635627|P2|Overall Study|Withdrawal by Subject|6
4824958|NCT01144182|16635628|P1|Overall Study|Withdrawal by Subject|3
4824959|NCT01144182|16635627|P2|Overall Study|Death|6
4824960|NCT01144182|16635628|P1|Overall Study|Death|5
4824961|NCT01144052|16635688|P2|Overall Study|Withdrawal by Subject|1
4824962|NCT01144052|16635689|P1|Overall Study|Withdrawal by Subject|1
4824963|NCT01143896|16635720|P2|Overall Study|Death|3
4824964|NCT01143896|16635721|P1|Overall Study|Death|6
4824965|NCT01143896|16635720|P2|Overall Study|Withdrawal by Subject|5
4824966|NCT01143896|16635721|P1|Overall Study|Withdrawal by Subject|13
4824967|NCT01143896|16635720|P2|Overall Study|Lost to Follow-up|13
4824968|NCT01143896|16635721|P1|Overall Study|Lost to Follow-up|18
4824969|NCT01143896|16635720|P2|Overall Study|Did not complete Baseline Interview|4
4824970|NCT01143896|16635721|P1|Overall Study|Did not complete Baseline Interview|5
4824971|NCT01143714|16635833|P2|Overall Study|wound size increased|0
4824972|NCT01143714|16635834|P1|Overall Study|wound size increased|1
4824973|NCT01143714|16635833|P2|Overall Study|wound closed = deemed healed|0
4824974|NCT01143714|16635834|P1|Overall Study|wound closed = deemed healed|1
4824975|NCT01143714|16635833|P2|Overall Study|Subject non-compliance|1
4824976|NCT01143714|16635834|P1|Overall Study|Subject non-compliance|0
4824977|NCT01143714|16635833|P2|Overall Study|Withdrawal by Subject|0
4824978|NCT01143714|16635834|P1|Overall Study|Withdrawal by Subject|1
4824979|NCT01143714|16635833|P2|Overall Study|Adverse Event|2
4824980|NCT01143714|16635834|P1|Overall Study|Adverse Event|4
4824981|NCT01143402|16635939|P3|Overall Study|Not Treated|1
4824982|NCT01143402|16635940|P2|Overall Study|Not Treated|0
4824983|NCT01143402|16635941|P1|Overall Study|Not Treated|0
4824984|NCT01143402|16635939|P3|Overall Study|Rapid clinical decline|0
4824985|NCT01143402|16635940|P2|Overall Study|Rapid clinical decline|1
4824986|NCT01143402|16635941|P1|Overall Study|Rapid clinical decline|1
4824987|NCT01143389|16635952|P2|Overall Study|Lost to Follow-up|25
4824988|NCT01143389|16635953|P1|Overall Study|Lost to Follow-up|26
4824989|NCT01143337|16635967|P3|Overall Study|Other reason|5
4824990|NCT01143337|16635968|P2|Overall Study|Other reason|0
4824991|NCT01143337|16635969|P1|Overall Study|Other reason|0
4824992|NCT01143337|16635967|P3|Overall Study|Withdrawal by Subject|1
4824993|NCT01143337|16635968|P2|Overall Study|Withdrawal by Subject|0
4824994|NCT01143337|16635969|P1|Overall Study|Withdrawal by Subject|0
4824995|NCT01143337|16635967|P3|Overall Study|Protocol Violation|0
4824996|NCT01143337|16635968|P2|Overall Study|Protocol Violation|0
4824997|NCT01143337|16635969|P1|Overall Study|Protocol Violation|1
4824998|NCT01143337|16635967|P3|Overall Study|Lack of Efficacy|1
4824999|NCT01143337|16635968|P2|Overall Study|Lack of Efficacy|2
4825000|NCT01143337|16635969|P1|Overall Study|Lack of Efficacy|6
4825001|NCT01143337|16635967|P3|Overall Study|Adverse Event|5
4825002|NCT01143337|16635968|P2|Overall Study|Adverse Event|9
4825003|NCT01143337|16635969|P1|Overall Study|Adverse Event|3
4825004|NCT01143324|16635983|P1|Overall Study|Explant of the device|4
4825005|NCT01143324|16635983|P1|Overall Study|Withdrawal by Subject|4
4825006|NCT01143324|16635983|P1|Overall Study|Lost to Follow-up|11
4825007|NCT01143259|16636022|P2|Overall Study|Screen Failure|9
4825008|NCT01143259|16636023|P1|Overall Study|Screen Failure|7
4825009|NCT01143259|16636022|P2|Overall Study|Protocol Violation|9
4825010|NCT01143259|16636023|P1|Overall Study|Protocol Violation|13
4825011|NCT01143259|16636022|P2|Overall Study|Withdrawal by Subject|2
4825012|NCT01143259|16636023|P1|Overall Study|Withdrawal by Subject|3
4825013|NCT01143207|16636031|P1|Overall Study|Lost to Follow-up|2
4825014|NCT01143090|16636051|P1|Overall Study|Administrative|1
4825015|NCT01143090|16636051|P1|Overall Study|Failure to meet eligibility criteria|1
4825016|NCT01143090|16636051|P1|Overall Study|Non-compliance with study drug|1
4825017|NCT01143090|16636051|P1|Overall Study|Withdrawal by Subject|18
4825018|NCT01143090|16636051|P1|Overall Study|Protocol Violation|2
4825019|NCT01143090|16636051|P1|Overall Study|Lost to Follow-up|9
4825020|NCT01143090|16636051|P1|Overall Study|Adverse Event|17
4825021|NCT01143090|16636051|P1|Overall Study|Lack of Efficacy|2
4825022|NCT01143077|16636058|P3|Overall Study|Principal Investigator Decision|1
4825023|NCT01143077|16636059|P2|Overall Study|Principal Investigator Decision|0
4825024|NCT01143077|16636060|P1|Overall Study|Principal Investigator Decision|2
4825025|NCT01143077|16636058|P3|Overall Study|Administrative|0
4825026|NCT01143077|16636059|P2|Overall Study|Administrative|0
4825027|NCT01143077|16636060|P1|Overall Study|Administrative|1
4825028|NCT01143077|16636058|P3|Overall Study|Non-compliance with study drug|1
4825029|NCT01143077|16636059|P2|Overall Study|Non-compliance with study drug|1
4825030|NCT01143077|16636060|P1|Overall Study|Non-compliance with study drug|0
4825031|NCT01143077|16636058|P3|Overall Study|Withdrawal by Subject|3
4825032|NCT01143077|16636059|P2|Overall Study|Withdrawal by Subject|3
4825033|NCT01143077|16636060|P1|Overall Study|Withdrawal by Subject|4
4825034|NCT01143077|16636058|P3|Overall Study|Protocol Violation|0
4825035|NCT01143077|16636059|P2|Overall Study|Protocol Violation|0
4825036|NCT01143077|16636060|P1|Overall Study|Protocol Violation|2
4825037|NCT01143077|16636058|P3|Overall Study|Lost to Follow-up|4
4825038|NCT01143077|16636059|P2|Overall Study|Lost to Follow-up|3
4825039|NCT01143077|16636060|P1|Overall Study|Lost to Follow-up|2
4825040|NCT01143077|16636058|P3|Overall Study|Adverse Event|5
4825041|NCT01143077|16636059|P2|Overall Study|Adverse Event|6
4825042|NCT01143077|16636060|P1|Overall Study|Adverse Event|5
4825043|NCT01143077|16636058|P3|Overall Study|Lack of Efficacy|1
4825044|NCT01143077|16636059|P2|Overall Study|Lack of Efficacy|2
4825045|NCT01143077|16636060|P1|Overall Study|Lack of Efficacy|0
4825046|NCT01143051|16636077|P6|3-14 Day Washout|Withdrawal by Subject|1
4825047|NCT01143051|16636078|P5|3-14 Day Washout|Withdrawal by Subject|0
4825048|NCT01143051|16636079|P4|3-14 Day Washout|Withdrawal by Subject|0
4825049|NCT01143051|16636080|P3|3-14 Day Washout|Withdrawal by Subject|0
4825050|NCT01143051|16636081|P2|3-14 Day Washout|Withdrawal by Subject|0
4825051|NCT01143051|16636082|P1|3-14 Day Washout|Withdrawal by Subject|0
4825052|NCT01143051|16636077|P6|3-14 Day Washout|Withdrawal by Subject|0
4825053|NCT01143051|16636078|P5|3-14 Day Washout|Withdrawal by Subject|0
4825054|NCT01143051|16636079|P4|3-14 Day Washout|Withdrawal by Subject|0
4825055|NCT01143051|16636080|P3|3-14 Day Washout|Withdrawal by Subject|1
4825056|NCT01143051|16636081|P2|3-14 Day Washout|Withdrawal by Subject|0
4825057|NCT01143051|16636082|P1|3-14 Day Washout|Withdrawal by Subject|0
4825058|NCT01143038|16636131|P1|Overall Study|Death|1
4825059|NCT01143038|16636131|P1|Overall Study|Protocol Deviation|1
4825060|NCT01143038|16636131|P1|Overall Study|Lost to Follow-up|2
4825061|NCT01143038|16636131|P1|Overall Study|Adverse Event|3
4825062|NCT01143038|16636131|P1|Overall Study|Requirement for alternative therapy|5
4825063|NCT01143038|16636131|P1|Overall Study|Withdrawal by Subject|4
4825064|NCT01142908|16636145|P2|Overall Study|Withdrawal by Subject|0
4825065|NCT01142908|16636146|P1|Overall Study|Withdrawal by Subject|3
4825066|NCT01142908|16636145|P2|Overall Study|Excluded - did not meet criteria|5
4825067|NCT01142908|16636146|P1|Overall Study|Excluded - did not meet criteria|9
4825068|NCT01142908|16636145|P2|Overall Study|Death|4
4825069|NCT01142908|16636146|P1|Overall Study|Death|1
4825070|NCT01142908|16636145|P2|Overall Study|Lost to Follow-up|13
4825071|NCT01142908|16636146|P1|Overall Study|Lost to Follow-up|19
4825072|NCT01142791|16636192|P2|Overall Study|Received only 1 sonication|6
4825073|NCT01142791|16636193|P1|Overall Study|Received only 1 sonication|0
4825074|NCT01142791|16636192|P2|Overall Study|Withdrawal by Subject|0
4825075|NCT01142791|16636193|P1|Overall Study|Withdrawal by Subject|5
4825076|NCT01142791|16636192|P2|Overall Study|Lost to Follow-up|0
4825077|NCT01142791|16636193|P1|Overall Study|Lost to Follow-up|1
4825078|NCT01142791|16636192|P2|Overall Study|Alternative Treatment|0
4825079|NCT01142791|16636193|P1|Overall Study|Alternative Treatment|1
4825080|NCT01142726|16636200|P3|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
4825081|NCT01142726|16636201|P2|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1
4825082|NCT01142726|16636202|P1|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0
4825083|NCT01142726|16636200|P3|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1
4825084|NCT01142726|16636201|P2|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
4825085|NCT01142726|16636202|P1|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0
4825086|NCT01142726|16636200|P3|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
4825087|NCT01142726|16636201|P2|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
4825088|NCT01142726|16636202|P1|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1
4825089|NCT01142726|16636200|P3|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1
4825090|NCT01142726|16636201|P2|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
4825091|NCT01142726|16636202|P1|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0
4825092|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|non-specified|1
4825093|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|non-specified|1
4825094|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|non-specified|0
4825095|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53
4825096|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54
4825097|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65
4825098|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
4825099|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0
4825100|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1
4825101|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
4825102|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0
4825103|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2
4825104|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
4825105|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|Pregnancy|0
4825106|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|Pregnancy|1
4825107|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2
4825108|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
4825109|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1
4825110|NCT01142726|16636200|P3|Withdrawal Phase: Months 12 up to 24|Adverse Event|1
4825111|NCT01142726|16636201|P2|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
4825112|NCT01142726|16636202|P1|Withdrawal Phase: Months 12 up to 24|Adverse Event|0
4825113|NCT01142726|16636200|P3|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11
4825114|NCT01142726|16636201|P2|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6
4825115|NCT01142726|16636202|P1|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5
4825116|NCT01142726|16636200|P3|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
4825117|NCT01142726|16636201|P2|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0
4825118|NCT01142726|16636202|P1|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1
4825119|NCT01142726|16636200|P3|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
4825120|NCT01142726|16636201|P2|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2
4825121|NCT01142726|16636202|P1|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1
4825122|NCT01142726|16636200|P3|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3
4825123|NCT01142726|16636201|P2|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9
4825124|NCT01142726|16636202|P1|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4
4825125|NCT01142726|16636200|P3|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
4825126|NCT01142726|16636201|P2|Treatment Phase: Day 1 Through Month 12|Adverse Event|8
4825127|NCT01142726|16636202|P1|Treatment Phase: Day 1 Through Month 12|Adverse Event|5
4825128|NCT01142661|16636265|P1|Overall Study|Physician Decision|1
4825129|NCT01142661|16636265|P1|Overall Study|Withdrawal by Subject|1
4825130|NCT01142661|16636265|P1|Overall Study|Adverse Event|2
4825131|NCT01142596|16636272|P2|Overall Study|Other reason (not specified)|4
4825132|NCT01142596|16636273|P1|Overall Study|Other reason (not specified)|5
4825133|NCT01142596|16636272|P2|Overall Study|Lost to Follow-up|3
4825134|NCT01142596|16636273|P1|Overall Study|Lost to Follow-up|2
4825135|NCT01142596|16636272|P2|Overall Study|Lack of Efficacy|9
4825136|NCT01142596|16636273|P1|Overall Study|Lack of Efficacy|5
4825137|NCT01142596|16636272|P2|Overall Study|Adverse Event|35
4825138|NCT01142596|16636273|P1|Overall Study|Adverse Event|8
4825139|NCT01142596|16636272|P2|Overall Study|Withdrawal by Subject|35
4825140|NCT01142596|16636273|P1|Overall Study|Withdrawal by Subject|9
4825141|NCT01142466|16636325|P2|Overall Study|Withdrawal by Subject|1
4825142|NCT01142466|16636326|P1|Overall Study|Withdrawal by Subject|1
4825143|NCT01142466|16636325|P2|Overall Study|Adverse Event|1
4825144|NCT01142466|16636326|P1|Overall Study|Adverse Event|2
4825145|NCT01142388|16636346|P2|Overall Study|Never started therapy|3
4825146|NCT01142388|16636347|P1|Overall Study|Never started therapy|7
4825147|NCT01142388|16636346|P2|Overall Study|Other|1
4825148|NCT01142388|16636347|P1|Overall Study|Other|1
4825149|NCT01142388|16636346|P2|Overall Study|Other complications|2
4825150|NCT01142388|16636347|P1|Overall Study|Other complications|0
4825151|NCT01142388|16636346|P2|Overall Study|Alternative therapy|0
4825152|NCT01142388|16636347|P1|Overall Study|Alternative therapy|1
4825153|NCT01142388|16636346|P2|Overall Study|Withdrawal by Subject|3
4825154|NCT01142388|16636347|P1|Overall Study|Withdrawal by Subject|5
4825155|NCT01142388|16636346|P2|Overall Study|Death|2
4825156|NCT01142388|16636347|P1|Overall Study|Death|3
4825157|NCT01142388|16636346|P2|Overall Study|Adverse Event|5
4825158|NCT01142388|16636347|P1|Overall Study|Adverse Event|9
4825159|NCT01142388|16636346|P2|Overall Study|Lack of Efficacy|31
4825160|NCT01142388|16636347|P1|Overall Study|Lack of Efficacy|21
4825161|NCT01142336|16636359|P2|Overall Study|Lost to Follow-up|1
4825162|NCT01142336|16636360|P1|Overall Study|Lost to Follow-up|0
4825163|NCT01142336|16636359|P2|Overall Study|Adverse Event|1
4825164|NCT01142336|16636360|P1|Overall Study|Adverse Event|1
4825165|NCT01142232|16636397|P5|Overall Study|Noncompliance|2
4825166|NCT01142232|16636398|P4|Overall Study|Noncompliance|0
4825167|NCT01142232|16636399|P3|Overall Study|Noncompliance|0
4825168|NCT01142232|16636400|P2|Overall Study|Noncompliance|0
4825169|NCT01142232|16636401|P1|Overall Study|Noncompliance|0
4825170|NCT01142232|16636397|P5|Overall Study|Off Trt for other complicating disease|1
4825171|NCT01142232|16636398|P4|Overall Study|Off Trt for other complicating disease|0
4825172|NCT01142232|16636399|P3|Overall Study|Off Trt for other complicating disease|0
4825173|NCT01142232|16636400|P2|Overall Study|Off Trt for other complicating disease|0
4825174|NCT01142232|16636401|P1|Overall Study|Off Trt for other complicating disease|0
4825175|NCT01142232|16636397|P5|Overall Study|Alternative Therapy|1
4825176|NCT01142232|16636398|P4|Overall Study|Alternative Therapy|0
4825177|NCT01142232|16636399|P3|Overall Study|Alternative Therapy|1
4825178|NCT01142232|16636400|P2|Overall Study|Alternative Therapy|1
4825179|NCT01142232|16636401|P1|Overall Study|Alternative Therapy|0
4825180|NCT01142232|16636397|P5|Overall Study|Physician Decision|10
4825181|NCT01142232|16636398|P4|Overall Study|Physician Decision|2
4825182|NCT01142232|16636399|P3|Overall Study|Physician Decision|0
4825183|NCT01142232|16636400|P2|Overall Study|Physician Decision|1
4825184|NCT01142232|16636401|P1|Overall Study|Physician Decision|0
4825185|NCT01142232|16636397|P5|Overall Study|Withdrawal by Subject|3
4825186|NCT01142232|16636398|P4|Overall Study|Withdrawal by Subject|1
4825187|NCT01142232|16636399|P3|Overall Study|Withdrawal by Subject|0
4825188|NCT01142232|16636400|P2|Overall Study|Withdrawal by Subject|0
4825189|NCT01142232|16636401|P1|Overall Study|Withdrawal by Subject|0
4825190|NCT01142232|16636397|P5|Overall Study|Disease Progression|12
4825191|NCT01142232|16636398|P4|Overall Study|Disease Progression|2
4825192|NCT01142232|16636399|P3|Overall Study|Disease Progression|1
4825193|NCT01142232|16636400|P2|Overall Study|Disease Progression|0
4825194|NCT01142232|16636401|P1|Overall Study|Disease Progression|2
4825195|NCT01142232|16636397|P5|Overall Study|Death|1
4825196|NCT01142232|16636398|P4|Overall Study|Death|0
4825197|NCT01142232|16636399|P3|Overall Study|Death|0
4825198|NCT01142232|16636400|P2|Overall Study|Death|0
4825199|NCT01142232|16636401|P1|Overall Study|Death|0
4825200|NCT01142232|16636397|P5|Overall Study|Adverse Event|4
4825201|NCT01142232|16636398|P4|Overall Study|Adverse Event|0
4825202|NCT01142232|16636399|P3|Overall Study|Adverse Event|1
4825203|NCT01142232|16636400|P2|Overall Study|Adverse Event|2
4825204|NCT01142232|16636401|P1|Overall Study|Adverse Event|1
4825205|NCT01142193|16636416|P2|Overall Study|Other|2
4825206|NCT01142193|16636417|P1|Overall Study|Other|1
4825207|NCT01142193|16636416|P2|Overall Study|Protocol Discontinuation Criterion Met|0
4825208|NCT01142193|16636417|P1|Overall Study|Protocol Discontinuation Criterion Met|1
4825209|NCT01142193|16636416|P2|Overall Study|Withdrawal by Subject|3
4825210|NCT01142193|16636417|P1|Overall Study|Withdrawal by Subject|4
4825211|NCT01142193|16636416|P2|Overall Study|Physician Decision|1
4825212|NCT01142193|16636417|P1|Overall Study|Physician Decision|1
4825213|NCT01142193|16636416|P2|Overall Study|Lack of Efficacy|1
4825214|NCT01142193|16636417|P1|Overall Study|Lack of Efficacy|2
4825215|NCT01142193|16636416|P2|Overall Study|Adverse Event|4
4825216|NCT01142193|16636417|P1|Overall Study|Adverse Event|12
4825217|NCT01142128|16636445|P1|Overall Study|Withdrawal by Subject|2
4825218|NCT01142128|16636445|P1|Overall Study|Lost to Follow-up|1
4825219|NCT01142128|16636445|P1|Overall Study|Physician Decision|1
4825220|NCT01142115|16636455|P2|First Intervention|Adverse Event|0
4825221|NCT01142115|16636456|P1|First Intervention|Adverse Event|1
4825222|NCT01142115|16636455|P2|First Intervention|Lack of Efficacy|1
4825223|NCT01142115|16636456|P1|First Intervention|Lack of Efficacy|1
4825224|NCT01142089|16636473|P2|Overall Study|Patient required rescue medication|17
4825225|NCT01142089|16636474|P1|Overall Study|Patient required rescue medication|8
4825226|NCT01142089|16636473|P2|Overall Study|Noncompliance with study procedures|1
4825227|NCT01142089|16636474|P1|Overall Study|Noncompliance with study procedures|2
4825228|NCT01142089|16636473|P2|Overall Study|Use of prohibited medications|1
4825229|NCT01142089|16636474|P1|Overall Study|Use of prohibited medications|0
4825230|NCT01142089|16636473|P2|Overall Study|Withdrawal by Subject|2
4825231|NCT01142089|16636474|P1|Overall Study|Withdrawal by Subject|1
4825232|NCT01142089|16636473|P2|Overall Study|Physician Decision|0
4825233|NCT01142089|16636474|P1|Overall Study|Physician Decision|1
4825234|NCT01141712|16636505|P1|Overall Study|Disease progression|3
4825235|NCT01141660|16636526|P2|Overall Study|Physician Decision|12
4825236|NCT01141660|16636527|P1|Overall Study|Physician Decision|0
4825237|NCT01141283|16636595|P1|Overall Study|Lack of Efficacy|10
4825238|NCT01141283|16636595|P1|Overall Study|Administrative|4
4825239|NCT01141283|16636595|P1|Overall Study|Withdrawal by Subject|14
4825240|NCT01141283|16636595|P1|Overall Study|Lost to Follow-up|4
4825241|NCT01141283|16636595|P1|Overall Study|Adverse Event|56
4825242|NCT01141205|16636601|P2|Overall Study|Withdrawal by Subject|1
4825243|NCT01141205|16636602|P1|Overall Study|Withdrawal by Subject|1
4825244|NCT01141205|16636601|P2|Overall Study|Lost to Follow-up|0
4825245|NCT01141205|16636602|P1|Overall Study|Lost to Follow-up|1
4825246|NCT01141205|16636601|P2|Overall Study|Physician Decision|1
4825247|NCT01141205|16636602|P1|Overall Study|Physician Decision|1
4825248|NCT01140906|16636641|P4|Overall Study|Administrative or other reason|2
4825249|NCT01140906|16636642|P3|Overall Study|Administrative or other reason|3
4825250|NCT01140906|16636643|P2|Overall Study|Administrative or other reason|5
4825251|NCT01140906|16636644|P1|Overall Study|Administrative or other reason|0
4825252|NCT01140906|16636641|P4|Overall Study|Lost to Follow-up|2
4825253|NCT01140906|16636642|P3|Overall Study|Lost to Follow-up|0
4825254|NCT01140906|16636643|P2|Overall Study|Lost to Follow-up|1
4825255|NCT01140906|16636644|P1|Overall Study|Lost to Follow-up|1
4825256|NCT01140906|16636641|P4|Overall Study|Withdrawal of consent|2
4825257|NCT01140906|16636642|P3|Overall Study|Withdrawal of consent|2
4825258|NCT01140906|16636643|P2|Overall Study|Withdrawal of consent|6
4825259|NCT01140906|16636644|P1|Overall Study|Withdrawal of consent|6
4825260|NCT01140906|16636641|P4|Overall Study|Protocol Violation|1
4825261|NCT01140906|16636642|P3|Overall Study|Protocol Violation|2
4825262|NCT01140906|16636643|P2|Overall Study|Protocol Violation|3
4825263|NCT01140906|16636644|P1|Overall Study|Protocol Violation|5
4825264|NCT01140906|16636641|P4|Overall Study|Non-compliance|1
4825265|NCT01140906|16636642|P3|Overall Study|Non-compliance|0
4825266|NCT01140906|16636643|P2|Overall Study|Non-compliance|1
4825267|NCT01140906|16636644|P1|Overall Study|Non-compliance|0
4825268|NCT01140906|16636641|P4|Overall Study|Lack of Efficacy|1
4825269|NCT01140906|16636642|P3|Overall Study|Lack of Efficacy|2
4825270|NCT01140906|16636643|P2|Overall Study|Lack of Efficacy|8
4825271|NCT01140906|16636644|P1|Overall Study|Lack of Efficacy|6
4825272|NCT01140906|16636641|P4|Overall Study|Adverse Event|7
4825273|NCT01140906|16636642|P3|Overall Study|Adverse Event|17
4825274|NCT01140906|16636643|P2|Overall Study|Adverse Event|10
4825275|NCT01140906|16636644|P1|Overall Study|Adverse Event|7
4825276|NCT01140880|16636684|P2|Overall Study|Protocol Violation|30
4825277|NCT01140880|16636685|P1|Overall Study|Protocol Violation|0
4825278|NCT01140880|16636684|P2|Overall Study|Lost to Follow-up|10
4825279|NCT01140880|16636685|P1|Overall Study|Lost to Follow-up|8
4825280|NCT01140880|16636684|P2|Overall Study|Withdrawal by Subject|3
4825281|NCT01140880|16636685|P1|Overall Study|Withdrawal by Subject|6
4825282|NCT01140880|16636684|P2|Overall Study|Death|1
4825283|NCT01140880|16636685|P1|Overall Study|Death|0
4825284|NCT01140867|16636697|P1|Overall Study|Medication Noncompliance|2
4825285|NCT01140867|16636697|P1|Overall Study|Uncooperative patient|2
4825286|NCT01140867|16636697|P1|Overall Study|Protocol Violation|1
4825287|NCT01140867|16636697|P1|Overall Study|Withdrawal by Subject|1
4825288|NCT01140867|16636697|P1|Overall Study|Lost to Follow-up|2
4825289|NCT01140867|16636697|P1|Overall Study|Lack of Efficacy|3
4825290|NCT01140867|16636697|P1|Overall Study|Adverse Event|22
4825291|NCT01140646|16636737|P1|Overall Study|Refused Further Treatment|5
4825292|NCT01140646|16636737|P1|Overall Study|Adverse Event|4
4825293|NCT01140568|16636745|P1|Overall Study|Screen Fail|4
4825294|NCT01140568|16636745|P1|Overall Study|Withdrawal by Subject|1
4825295|NCT01140568|16636745|P1|Overall Study|disease progression|31
4825296|NCT01140503|16636750|P1|Overall Study|Withdrawal by Subject|1
4825297|NCT01140477|16636758|P2|Overall Study|Subject explanted|1
4825298|NCT01140477|16636759|P1|Overall Study|Subject explanted|0
4825299|NCT01140477|16636758|P2|Overall Study|Death|1
4825300|NCT01140477|16636759|P1|Overall Study|Death|1
4825301|NCT01140477|16636758|P2|Overall Study|Surgical complication preventing implant|0
4825302|NCT01140477|16636759|P1|Overall Study|Surgical complication preventing implant|2
4825303|NCT01140477|16636758|P2|Overall Study|Withdrawal by Subject|4
4825304|NCT01140477|16636759|P1|Overall Study|Withdrawal by Subject|1
4825305|NCT01140477|16636758|P2|Overall Study|Lost to Follow-up|0
4825306|NCT01140477|16636759|P1|Overall Study|Lost to Follow-up|4
4825307|NCT01140451|16636770|P2|Overall Study|Participants Planning Pregnancy|0
4825308|NCT01140451|16636771|P1|Overall Study|Participants Planning Pregnancy|3
4825309|NCT01140451|16636770|P2|Overall Study|Lost to Follow-up|0
4825310|NCT01140451|16636771|P1|Overall Study|Lost to Follow-up|2
4825311|NCT01140451|16636770|P2|Overall Study|Physician Decision|3
4825312|NCT01140451|16636771|P1|Overall Study|Physician Decision|5
4825313|NCT01140451|16636770|P2|Overall Study|Adverse Event|6
4825314|NCT01140451|16636771|P1|Overall Study|Adverse Event|2
4825315|NCT01140451|16636770|P2|Overall Study|Withdrawal by Subject|33
4825316|NCT01140451|16636771|P1|Overall Study|Withdrawal by Subject|26
4825317|NCT01140347|16636836|P2|Overall Study|Withdrawal by Subject|8
4825318|NCT01140347|16636837|P1|Overall Study|Withdrawal by Subject|13
4825319|NCT01140347|16636836|P2|Overall Study|Lost to Follow-up|6
4825320|NCT01140347|16636837|P1|Overall Study|Lost to Follow-up|5
4825321|NCT01140061|16636890|P10|Extension|Laboratory Adverse Event|1
4825322|NCT01140061|16636891|P9|Extension|Laboratory Adverse Event|0
4825323|NCT01140061|16636892|P8|Extension|Laboratory Adverse Event|0
4825324|NCT01140061|16636893|P7|Extension|Laboratory Adverse Event|0
4825325|NCT01140061|16636894|P6|Extension|Laboratory Adverse Event|0
4825326|NCT01140061|16636895|P5|Extension|Laboratory Adverse Event|0
4825327|NCT01140061|16636896|P4|Extension|Laboratory Adverse Event|0
4825328|NCT01140061|16636897|P3|Extension|Laboratory Adverse Event|0
4825329|NCT01140061|16636898|P2|Extension|Laboratory Adverse Event|0
4825330|NCT01140061|16636899|P1|Extension|Laboratory Adverse Event|0
4825331|NCT01140061|16636890|P10|Part I|Adverse Event|0
4825332|NCT01140061|16636891|P9|Part I|Adverse Event|0
4825333|NCT01140061|16636892|P8|Part I|Adverse Event|0
4825334|NCT01140061|16636893|P7|Part I|Adverse Event|0
4825335|NCT01140061|16636894|P6|Part I|Adverse Event|0
4825336|NCT01140061|16636895|P5|Part I|Adverse Event|0
4825337|NCT01140061|16636896|P4|Part I|Adverse Event|0
4825338|NCT01140061|16636897|P3|Part I|Adverse Event|0
4825339|NCT01140061|16636898|P2|Part I|Adverse Event|0
4825340|NCT01140061|16636899|P1|Part I|Adverse Event|1
4825341|NCT01140048|16636926|P1|Overall Study|Lost to Follow-up|31
4825342|NCT01140048|16636926|P1|Overall Study|Withdrawal by Subject|13
4825343|NCT01140048|16636926|P1|Overall Study|Physician Decision|1
4825344|NCT01139775|16636966|P3|Overall Study|Physician Decision|2
4825345|NCT01139775|16636967|P2|Overall Study|Physician Decision|2
4825346|NCT01139775|16636968|P1|Overall Study|Physician Decision|0
4825347|NCT01139775|16636966|P3|Overall Study|Withdrawal by Subject|2
4825348|NCT01139775|16636967|P2|Overall Study|Withdrawal by Subject|0
4825349|NCT01139775|16636968|P1|Overall Study|Withdrawal by Subject|1
4825350|NCT01139775|16636966|P3|Overall Study|Protocol Violation|0
4825351|NCT01139775|16636967|P2|Overall Study|Protocol Violation|5
4825352|NCT01139775|16636968|P1|Overall Study|Protocol Violation|0
4825353|NCT01139775|16636966|P3|Overall Study|Adverse Event|2
4825354|NCT01139775|16636967|P2|Overall Study|Adverse Event|6
4825355|NCT01139775|16636968|P1|Overall Study|Adverse Event|0
4825356|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Lost to Follow-up|4
4825357|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Lost to Follow-up|3
4825358|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Lost to Follow-up|0
4825359|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Lack of Efficacy|5
4825360|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Lack of Efficacy|3
4825361|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Lack of Efficacy|0
4825362|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Sponsor Decision|6
4825363|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Sponsor Decision|5
4825364|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Sponsor Decision|0
4825365|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Physician Decision|0
4825366|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Physician Decision|2
4825367|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Physician Decision|0
4825368|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13
4825369|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6
4825370|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0
4825371|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Protocol Violation|8
4825372|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Protocol Violation|2
4825373|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Protocol Violation|0
4825374|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17
4825375|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14
4825376|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0
4825377|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Death|1
4825378|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Death|1
4825379|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Death|0
4825380|NCT01139762|16637000|P3|Double-Blind Randomized Active Treatment|Adverse Event|10
4825381|NCT01139762|16637001|P2|Double-Blind Randomized Active Treatment|Adverse Event|4
4825382|NCT01139762|16637002|P1|Double-Blind Randomized Active Treatment|Adverse Event|0
4825383|NCT01139762|16637000|P3|Washout and Placebo Lead-In Period|Lost to Follow-up|0
4825384|NCT01139762|16637001|P2|Washout and Placebo Lead-In Period|Lost to Follow-up|0
4825385|NCT01139762|16637002|P1|Washout and Placebo Lead-In Period|Lost to Follow-up|10
4825386|NCT01139762|16637000|P3|Washout and Placebo Lead-In Period|Sponsor Decision|0
4825387|NCT01139762|16637001|P2|Washout and Placebo Lead-In Period|Sponsor Decision|0
4825388|NCT01139762|16637002|P1|Washout and Placebo Lead-In Period|Sponsor Decision|10
4825389|NCT01139762|16637000|P3|Washout and Placebo Lead-In Period|Physician Decision|0
4825390|NCT01139762|16637001|P2|Washout and Placebo Lead-In Period|Physician Decision|0
4825391|NCT01139762|16637002|P1|Washout and Placebo Lead-In Period|Physician Decision|12
4825392|NCT01139762|16637000|P3|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
4825393|NCT01139762|16637001|P2|Washout and Placebo Lead-In Period|Withdrawal by Subject|0
4825394|NCT01139762|16637002|P1|Washout and Placebo Lead-In Period|Withdrawal by Subject|83
4825395|NCT01139762|16637000|P3|Washout and Placebo Lead-In Period|Adverse Event|0
4825396|NCT01139762|16637001|P2|Washout and Placebo Lead-In Period|Adverse Event|0
4825397|NCT01139762|16637002|P1|Washout and Placebo Lead-In Period|Adverse Event|1
4825398|NCT01139762|16637000|P3|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
4825399|NCT01139762|16637001|P2|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0
4825400|NCT01139762|16637002|P1|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258
4825401|NCT01139658|16637037|P2|Overall Study|Other|75
4825402|NCT01139658|16637038|P1|Overall Study|Other|28
4825403|NCT01139658|16637037|P2|Overall Study|No documentation of treatment|0
4825404|NCT01139658|16637038|P1|Overall Study|No documentation of treatment|1
4825405|NCT01139658|16637037|P2|Overall Study|Withdrawal by Subject|4
4825406|NCT01139658|16637038|P1|Overall Study|Withdrawal by Subject|2
4825407|NCT01139658|16637037|P2|Overall Study|Lack of Efficacy|7
4825408|NCT01139658|16637038|P1|Overall Study|Lack of Efficacy|15
4825409|NCT01139658|16637037|P2|Overall Study|Adverse Event|27
4825410|NCT01139658|16637038|P1|Overall Study|Adverse Event|10
4825411|NCT01139580|16637076|P2|Overall Study|Participant Randomization in Error|1
4825412|NCT01139580|16637077|P1|Overall Study|Participant Randomization in Error|0
4825413|NCT01139580|16637076|P2|Overall Study|Beginning Study Exclusion Treatment|1
4825414|NCT01139580|16637077|P1|Overall Study|Beginning Study Exclusion Treatment|0
4825415|NCT01139580|16637076|P2|Overall Study|Misrandomized|0
4825416|NCT01139580|16637077|P1|Overall Study|Misrandomized|1
4825417|NCT01139580|16637076|P2|Overall Study|Did Not Meet Exclusion Criteria|0
4825418|NCT01139580|16637077|P1|Overall Study|Did Not Meet Exclusion Criteria|1
4825419|NCT01139580|16637076|P2|Overall Study|Used Excluded Medicine After Enrollment|0
4825420|NCT01139580|16637077|P1|Overall Study|Used Excluded Medicine After Enrollment|1
4825421|NCT01139580|16637076|P2|Overall Study|Withdrawal by Subject|9
4825422|NCT01139580|16637077|P1|Overall Study|Withdrawal by Subject|6
4825423|NCT01139580|16637076|P2|Overall Study|Lack of Efficacy|2
4825424|NCT01139580|16637077|P1|Overall Study|Lack of Efficacy|0
4825425|NCT01139580|16637076|P2|Overall Study|Lost to Follow-up|1
4825426|NCT01139580|16637077|P1|Overall Study|Lost to Follow-up|9
4825427|NCT01139580|16637076|P2|Overall Study|Adverse Event|4
4825428|NCT01139580|16637077|P1|Overall Study|Adverse Event|5
4825429|NCT01139450|16637125|P3|Overall Study|Adverse Event|3
4825430|NCT01139450|16637126|P2|Overall Study|Adverse Event|2
4825431|NCT01139450|16637127|P1|Overall Study|Adverse Event|2
4825432|NCT01139450|16637125|P3|Overall Study|Administrative|1
4825433|NCT01139450|16637126|P2|Overall Study|Administrative|0
4825434|NCT01139450|16637127|P1|Overall Study|Administrative|0
4825435|NCT01139450|16637125|P3|Overall Study|Lost to Follow-up|11
4825436|NCT01139450|16637126|P2|Overall Study|Lost to Follow-up|7
4825437|NCT01139450|16637127|P1|Overall Study|Lost to Follow-up|9
4825438|NCT01139450|16637125|P3|Overall Study|Protocol Violation|2
4825439|NCT01139450|16637126|P2|Overall Study|Protocol Violation|5
4825440|NCT01139450|16637127|P1|Overall Study|Protocol Violation|6
4825441|NCT01139450|16637125|P3|Overall Study|Lack of Efficacy|8
4825442|NCT01139450|16637126|P2|Overall Study|Lack of Efficacy|1
4825443|NCT01139450|16637127|P1|Overall Study|Lack of Efficacy|3
4825444|NCT01139450|16637125|P3|Overall Study|Withdrawal by Subject|13
4825445|NCT01139450|16637126|P2|Overall Study|Withdrawal by Subject|10
4825446|NCT01139450|16637127|P1|Overall Study|Withdrawal by Subject|7
4825447|NCT01139164|16637179|P3|Overall Study|Withdrawn prior to study start|0
4825448|NCT01139164|16637180|P2|Overall Study|Withdrawn prior to study start|2
4825449|NCT01139164|16637181|P1|Overall Study|Withdrawn prior to study start|0
4825450|NCT01139125|16637195|P1|Overall Study|Withdrawal by Subject|1
4825451|NCT01139047|16637199|P1|Overall Study|Withdrawal by Subject|1
4825452|NCT01139021|16637214|P6|Overall Study|Withdrawal by Subject|0
4825453|NCT01139021|16637215|P5|Overall Study|Withdrawal by Subject|4
4825454|NCT01139021|16637216|P4|Overall Study|Withdrawal by Subject|1
4825455|NCT01139021|16637217|P3|Overall Study|Withdrawal by Subject|0
4825456|NCT01139021|16637218|P2|Overall Study|Withdrawal by Subject|0
4825457|NCT01139021|16637219|P1|Overall Study|Withdrawal by Subject|0
4825458|NCT01139021|16637214|P6|Overall Study|Protocol Violation|0
4825459|NCT01139021|16637215|P5|Overall Study|Protocol Violation|2
4825460|NCT01139021|16637216|P4|Overall Study|Protocol Violation|0
4825461|NCT01139021|16637217|P3|Overall Study|Protocol Violation|0
4825462|NCT01139021|16637218|P2|Overall Study|Protocol Violation|0
4825463|NCT01139021|16637219|P1|Overall Study|Protocol Violation|1
4825464|NCT01139021|16637214|P6|Overall Study|Lost to Follow-up|0
4825465|NCT01139021|16637215|P5|Overall Study|Lost to Follow-up|2
4825466|NCT01139021|16637216|P4|Overall Study|Lost to Follow-up|0
4825467|NCT01139021|16637217|P3|Overall Study|Lost to Follow-up|0
4825468|NCT01139021|16637218|P2|Overall Study|Lost to Follow-up|0
4825469|NCT01139021|16637219|P1|Overall Study|Lost to Follow-up|0
4825470|NCT01139021|16637214|P6|Overall Study|Adverse Event|0
4825471|NCT01139021|16637215|P5|Overall Study|Adverse Event|1
4825472|NCT01139021|16637216|P4|Overall Study|Adverse Event|0
4825473|NCT01139021|16637217|P3|Overall Study|Adverse Event|0
4825474|NCT01139021|16637218|P2|Overall Study|Adverse Event|0
4825475|NCT01139021|16637219|P1|Overall Study|Adverse Event|0
4825476|NCT01139008|16637255|P1|Overall Study|Non-compliant, lost product|1
4825477|NCT01139008|16637255|P1|Overall Study|Withdrawal by Subject|5
4825478|NCT01138826|16637302|P6|Washout Period I (of 16 Days)|Lost to Follow-up|0
4825479|NCT01138826|16637303|P5|Washout Period I (of 16 Days)|Lost to Follow-up|1
4825480|NCT01138826|16637304|P4|Washout Period I (of 16 Days)|Lost to Follow-up|0
4825481|NCT01138826|16637305|P3|Washout Period I (of 16 Days)|Lost to Follow-up|0
4825482|NCT01138826|16637306|P2|Washout Period I (of 16 Days)|Lost to Follow-up|1
4825483|NCT01138826|16637307|P1|Washout Period I (of 16 Days)|Lost to Follow-up|1
4825484|NCT01138657|16637344|P2|Overall Study|Miscellaneous Reasons|4
4825485|NCT01138657|16637345|P1|Overall Study|Miscellaneous Reasons|3
4825486|NCT01138657|16637344|P2|Overall Study|Lost to Follow-up|3
4825487|NCT01138657|16637345|P1|Overall Study|Lost to Follow-up|0
4825488|NCT01138657|16637344|P2|Overall Study|Lack of Efficacy|1
4825489|NCT01138657|16637345|P1|Overall Study|Lack of Efficacy|2
4825490|NCT01138657|16637344|P2|Overall Study|Adverse Event|10
4825491|NCT01138657|16637345|P1|Overall Study|Adverse Event|3
4825492|NCT01138501|16637408|P1|Overall Study|Withdrawal by Subject|3
4825493|NCT01138501|16637408|P1|Overall Study|Protocol Violation|2
4825494|NCT01138150|16637452|P2|Overall Study|Physician Decision|0
4825495|NCT01138150|16637453|P1|Overall Study|Physician Decision|1
4825496|NCT01138150|16637452|P2|Overall Study|blood unable to be processed|1
4825497|NCT01138150|16637453|P1|Overall Study|blood unable to be processed|0
4825498|NCT01138111|16637534|P1|Overall Study|Lost to Follow-up|2
4825499|NCT01138111|16637534|P1|Overall Study|Death|1
4825500|NCT01138111|16637534|P1|Overall Study|Adverse Event|1
4825501|NCT01138111|16637534|P1|Overall Study|Withdrawal by Subject|5
4825502|NCT01138046|16637588|P1|Overall Study|Withdrawal due to death|6
4825503|NCT01138007|16637608|P3|Overall Study|Withdrawal by Subject|15
4825504|NCT01138007|16637609|P2|Overall Study|Withdrawal by Subject|6
4825505|NCT01138007|16637610|P1|Overall Study|Withdrawal by Subject|5
4825506|NCT01138007|16637608|P3|Overall Study|Physician Decision|3
4825507|NCT01138007|16637609|P2|Overall Study|Physician Decision|5
4825508|NCT01138007|16637610|P1|Overall Study|Physician Decision|0
4825509|NCT01138007|16637608|P3|Overall Study|Lost to Follow-up|5
4825510|NCT01138007|16637609|P2|Overall Study|Lost to Follow-up|3
4825511|NCT01138007|16637610|P1|Overall Study|Lost to Follow-up|3
4825512|NCT01138007|16637608|P3|Overall Study|Protocol-Defined Stopping Criteria|8
4825513|NCT01138007|16637609|P2|Overall Study|Protocol-Defined Stopping Criteria|1
4825514|NCT01138007|16637610|P1|Overall Study|Protocol-Defined Stopping Criteria|6
4825515|NCT01138007|16637608|P3|Overall Study|Protocol Violation|2
4825516|NCT01138007|16637609|P2|Overall Study|Protocol Violation|3
4825517|NCT01138007|16637610|P1|Overall Study|Protocol Violation|2
4825518|NCT01138007|16637608|P3|Overall Study|Lack of Efficacy|6
4825519|NCT01138007|16637609|P2|Overall Study|Lack of Efficacy|0
4825520|NCT01138007|16637610|P1|Overall Study|Lack of Efficacy|2
4825521|NCT01138007|16637608|P3|Overall Study|Adverse Event|9
4825522|NCT01138007|16637609|P2|Overall Study|Adverse Event|12
4825523|NCT01138007|16637610|P1|Overall Study|Adverse Event|4
4825524|NCT01137812|16637717|P2|Overall Study|Other|27
4825525|NCT01137812|16637718|P1|Overall Study|Other|19
4825526|NCT01137812|16637717|P2|Overall Study|Patient met glycemic withdrawal criteria|85
4825527|NCT01137812|16637718|P1|Overall Study|Patient met glycemic withdrawal criteria|40
4825528|NCT01137812|16637717|P2|Overall Study|Death|0
4825529|NCT01137812|16637718|P1|Overall Study|Death|2
4825530|NCT01137812|16637717|P2|Overall Study|Withdrawal by Subject|13
4825531|NCT01137812|16637718|P1|Overall Study|Withdrawal by Subject|5
4825532|NCT01137812|16637717|P2|Overall Study|Protocol Violation|4
4825533|NCT01137812|16637718|P1|Overall Study|Protocol Violation|5
4825534|NCT01137812|16637717|P2|Overall Study|Physician Decision|17
4825535|NCT01137812|16637718|P1|Overall Study|Physician Decision|25
4825536|NCT01137812|16637717|P2|Overall Study|Lost to Follow-up|8
4825537|NCT01137812|16637718|P1|Overall Study|Lost to Follow-up|6
4825538|NCT01137812|16637717|P2|Overall Study|Adverse Event|14
4825539|NCT01137812|16637718|P1|Overall Study|Adverse Event|21
4825540|NCT01137786|16637738|P2|Overall Study|Withdrawal by Subject|1
4825541|NCT01137786|16637739|P1|Overall Study|Withdrawal by Subject|1
4825542|NCT01137786|16637738|P2|Overall Study|Lost to Follow-up|2
4825543|NCT01137786|16637739|P1|Overall Study|Lost to Follow-up|0
4825544|NCT01137773|16637749|P2|Overall Study|Lost to Follow-up|0
4825545|NCT01137773|16637750|P1|Overall Study|Lost to Follow-up|6
4825546|NCT01137773|16637749|P2|Overall Study|Death|3
4825547|NCT01137773|16637750|P1|Overall Study|Death|3
4825548|NCT01137682|16637761|P3|Overall Study|Did not receive treatment in extension|1
4825549|NCT01137682|16637762|P2|Overall Study|Did not receive treatment in extension|0
4825550|NCT01137682|16637763|P1|Overall Study|Did not receive treatment in extension|0
4825551|NCT01137682|16637761|P3|Overall Study|Did not enter extension|2
4825552|NCT01137682|16637762|P2|Overall Study|Did not enter extension|3
4825553|NCT01137682|16637763|P1|Overall Study|Did not enter extension|2
4825554|NCT01137682|16637761|P3|Overall Study|Protocol Violation-Extension|0
4825555|NCT01137682|16637762|P2|Overall Study|Protocol Violation-Extension|1
4825556|NCT01137682|16637763|P1|Overall Study|Protocol Violation-Extension|2
4825557|NCT01137682|16637761|P3|Overall Study|Death-Extension|0
4825558|NCT01137682|16637762|P2|Overall Study|Death-Extension|0
4825559|NCT01137682|16637763|P1|Overall Study|Death-Extension|2
4825560|NCT01137682|16637761|P3|Overall Study|Administrative problems-Extension|0
4825561|NCT01137682|16637762|P2|Overall Study|Administrative problems-Extension|2
4825562|NCT01137682|16637763|P1|Overall Study|Administrative problems-Extension|0
4825563|NCT01137682|16637761|P3|Overall Study|Lost to Follow Up-Extension|0
4825564|NCT01137682|16637762|P2|Overall Study|Lost to Follow Up-Extension|1
4825565|NCT01137682|16637763|P1|Overall Study|Lost to Follow Up-Extension|0
4825566|NCT01137682|16637761|P3|Overall Study|Withdrawal by Subject-Extension|8
4825567|NCT01137682|16637762|P2|Overall Study|Withdrawal by Subject-Extension|8
4825568|NCT01137682|16637763|P1|Overall Study|Withdrawal by Subject-Extension|6
4825569|NCT01137682|16637761|P3|Overall Study|Lack of Efficacy-Extension|13
4825570|NCT01137682|16637762|P2|Overall Study|Lack of Efficacy-Extension|9
4825571|NCT01137682|16637763|P1|Overall Study|Lack of Efficacy-Extension|15
4825572|NCT01137682|16637761|P3|Overall Study|Adverse Event-Extension|7
4825573|NCT01137682|16637762|P2|Overall Study|Adverse Event-Extension|8
4825574|NCT01137682|16637763|P1|Overall Study|Adverse Event-Extension|4
4825575|NCT01137682|16637761|P3|Overall Study|Protocol Violation-CORE|1
4825576|NCT01137682|16637762|P2|Overall Study|Protocol Violation-CORE|1
4825577|NCT01137682|16637763|P1|Overall Study|Protocol Violation-CORE|0
4825578|NCT01137682|16637761|P3|Overall Study|Administrative problems-CORE|0
4825579|NCT01137682|16637762|P2|Overall Study|Administrative problems-CORE|1
4825580|NCT01137682|16637763|P1|Overall Study|Administrative problems-CORE|2
4825581|NCT01137682|16637761|P3|Overall Study|Withdrawal by Subject-CORE|2
4825582|NCT01137682|16637762|P2|Overall Study|Withdrawal by Subject-CORE|2
4825583|NCT01137682|16637763|P1|Overall Study|Withdrawal by Subject-CORE|2
4825584|NCT01137682|16637761|P3|Overall Study|Adverse Event-CORE|0
4825585|NCT01137682|16637762|P2|Overall Study|Adverse Event-CORE|4
4825586|NCT01137682|16637763|P1|Overall Study|Adverse Event-CORE|2
4825587|NCT01137604|16637813|P4|Overall Study|Clinical Decline|1
4825588|NCT01137604|16637814|P3|Overall Study|Clinical Decline|1
4825589|NCT01137604|16637815|P2|Overall Study|Clinical Decline|0
4825590|NCT01137604|16637816|P1|Overall Study|Clinical Decline|0
4825591|NCT01137604|16637813|P4|Overall Study|Participant's Decision|0
4825592|NCT01137604|16637814|P3|Overall Study|Participant's Decision|0
4825593|NCT01137604|16637815|P2|Overall Study|Participant's Decision|0
4825594|NCT01137604|16637816|P1|Overall Study|Participant's Decision|1
4825595|NCT01137604|16637813|P4|Overall Study|Clinical Progression|0
4825596|NCT01137604|16637814|P3|Overall Study|Clinical Progression|1
4825597|NCT01137604|16637815|P2|Overall Study|Clinical Progression|2
4825598|NCT01137604|16637816|P1|Overall Study|Clinical Progression|0
4825599|NCT01137604|16637813|P4|Overall Study|Withdrawal by Subject|1
4825600|NCT01137604|16637814|P3|Overall Study|Withdrawal by Subject|2
4825601|NCT01137604|16637815|P2|Overall Study|Withdrawal by Subject|2
4825602|NCT01137604|16637816|P1|Overall Study|Withdrawal by Subject|0
4825603|NCT01137604|16637813|P4|Overall Study|Adverse Event|9
4825604|NCT01137604|16637814|P3|Overall Study|Adverse Event|9
4825605|NCT01137604|16637815|P2|Overall Study|Adverse Event|6
4825606|NCT01137604|16637816|P1|Overall Study|Adverse Event|1
4825607|NCT01137578|16637850|P3|Overall Study|Other|6
4825608|NCT01137578|16637851|P2|Overall Study|Other|2
4825609|NCT01137578|16637852|P1|Overall Study|Other|12
4825610|NCT01137578|16637850|P3|Overall Study|Withdrawal by Subject|0
4825611|NCT01137578|16637851|P2|Overall Study|Withdrawal by Subject|0
4825612|NCT01137578|16637852|P1|Overall Study|Withdrawal by Subject|1
4825613|NCT01137578|16637850|P3|Overall Study|Participant requested to Discontinue|0
4825614|NCT01137578|16637851|P2|Overall Study|Participant requested to Discontinue|0
4825615|NCT01137578|16637852|P1|Overall Study|Participant requested to Discontinue|3
4825616|NCT01137474|16637901|P4|Overall Study|Administrative reason by sponsor|0
4825617|NCT01137474|16637902|P3|Overall Study|Administrative reason by sponsor|0
4825618|NCT01137474|16637903|P2|Overall Study|Administrative reason by sponsor|1
4825619|NCT01137474|16637904|P1|Overall Study|Administrative reason by sponsor|0
4825620|NCT01137474|16637901|P4|Overall Study|Pregnancy|0
4825621|NCT01137474|16637902|P3|Overall Study|Pregnancy|0
4825622|NCT01137474|16637903|P2|Overall Study|Pregnancy|1
4825623|NCT01137474|16637904|P1|Overall Study|Pregnancy|0
4825624|NCT01137474|16637901|P4|Overall Study|Other|0
4825625|NCT01137474|16637902|P3|Overall Study|Other|0
4825626|NCT01137474|16637903|P2|Overall Study|Other|1
4825627|NCT01137474|16637904|P1|Overall Study|Other|3
4825628|NCT01137474|16637901|P4|Overall Study|Lack of Efficacy|2
4825629|NCT01137474|16637902|P3|Overall Study|Lack of Efficacy|0
4825630|NCT01137474|16637903|P2|Overall Study|Lack of Efficacy|0
4825631|NCT01137474|16637904|P1|Overall Study|Lack of Efficacy|0
4825632|NCT01137474|16637901|P4|Overall Study|Lost to Follow-up|2
4825633|NCT01137474|16637902|P3|Overall Study|Lost to Follow-up|0
4825634|NCT01137474|16637903|P2|Overall Study|Lost to Follow-up|1
4825635|NCT01137474|16637904|P1|Overall Study|Lost to Follow-up|5
4825636|NCT01137474|16637901|P4|Overall Study|No longer met study criteria|5
4825637|NCT01137474|16637902|P3|Overall Study|No longer met study criteria|0
4825638|NCT01137474|16637903|P2|Overall Study|No longer met study criteria|1
4825639|NCT01137474|16637904|P1|Overall Study|No longer met study criteria|6
4825640|NCT01137474|16637901|P4|Overall Study|Withdrawal by Subject|9
4825641|NCT01137474|16637902|P3|Overall Study|Withdrawal by Subject|6
4825642|NCT01137474|16637903|P2|Overall Study|Withdrawal by Subject|2
4825643|NCT01137474|16637904|P1|Overall Study|Withdrawal by Subject|7
4825644|NCT01137474|16637901|P4|Overall Study|Adverse Event|3
4825645|NCT01137474|16637902|P3|Overall Study|Adverse Event|1
4825646|NCT01137474|16637903|P2|Overall Study|Adverse Event|5
4825647|NCT01137474|16637904|P1|Overall Study|Adverse Event|3
4825648|NCT01137435|16637922|P1|Overall Study|Off label usage|4
4825649|NCT01137435|16637922|P1|Overall Study|Lost to Follow-up|24
4825650|NCT01137292|16637949|P1|Overall Study|Other|7
4825651|NCT01137292|16637949|P1|Overall Study|Lost to Follow-up|1
4825652|NCT01137292|16637949|P1|Overall Study|Lack of Efficacy|13
4825653|NCT01137292|16637949|P1|Overall Study|Adverse Event|3
4825654|NCT01137292|16637949|P1|Overall Study|Death|30
4825655|NCT01137110|16637958|P2|Overall Study|Protocol Violation|0
4825656|NCT01137110|16637959|P1|Overall Study|Protocol Violation|1
4825657|NCT01137071|16637965|P1|Overall Study|Wrongly Included|1
4825658|NCT01137071|16637965|P1|Overall Study|Withdrawal by Subject|2
4825659|NCT01137071|16637965|P1|Overall Study|Disease Progression|11
4825660|NCT01136967|16638121|P2|Overall Study|Diagnosis of Second Primary Cancer|1
4825661|NCT01136967|16638122|P1|Overall Study|Diagnosis of Second Primary Cancer|0
4825662|NCT01136967|16638121|P2|Overall Study|Increase in Lesion Size|2
4825663|NCT01136967|16638122|P1|Overall Study|Increase in Lesion Size|0
4825664|NCT01136967|16638121|P2|Overall Study|Investigator's Choice|1
4825665|NCT01136967|16638122|P1|Overall Study|Investigator's Choice|1
4825666|NCT01136967|16638121|P2|Overall Study|Non-compliance|0
4825667|NCT01136967|16638122|P1|Overall Study|Non-compliance|1
4825668|NCT01136967|16638121|P2|Overall Study|Radiation|0
4825669|NCT01136967|16638122|P1|Overall Study|Radiation|1
4825670|NCT01136967|16638121|P2|Overall Study|Clinical Progression|5
4825671|NCT01136967|16638122|P1|Overall Study|Clinical Progression|3
4825672|NCT01136967|16638121|P2|Overall Study|Withdrawal by Subject|2
4825673|NCT01136967|16638122|P1|Overall Study|Withdrawal by Subject|1
4825674|NCT01136967|16638121|P2|Overall Study|Lost to Follow-up|1
4825675|NCT01136967|16638122|P1|Overall Study|Lost to Follow-up|0
4825676|NCT01136967|16638121|P2|Overall Study|Participant Choice|3
4825677|NCT01136967|16638122|P1|Overall Study|Participant Choice|8
4825678|NCT01136967|16638121|P2|Overall Study|Adverse Event|12
4825679|NCT01136967|16638122|P1|Overall Study|Adverse Event|9
4825680|NCT01136954|16638144|P2|Overall Study|Other|3
4825681|NCT01136954|16638145|P1|Overall Study|Other|1
4825682|NCT01136954|16638144|P2|Overall Study|Physician Decision|1
4825683|NCT01136954|16638145|P1|Overall Study|Physician Decision|0
4825684|NCT01136954|16638144|P2|Overall Study|Lack of Efficacy|13
4825685|NCT01136954|16638145|P1|Overall Study|Lack of Efficacy|14
4825686|NCT01136954|16638144|P2|Overall Study|Withdrawal by Subject|2
4825687|NCT01136954|16638145|P1|Overall Study|Withdrawal by Subject|6
4825688|NCT01136954|16638144|P2|Overall Study|Adverse Event|2
4825689|NCT01136954|16638145|P1|Overall Study|Adverse Event|3
4825690|NCT01136915|16638159|P2|Overall Study|Exclusion criterion met|1
4825691|NCT01136915|16638160|P1|Overall Study|Exclusion criterion met|0
4825692|NCT01136915|16638159|P2|Overall Study|Lost to Follow-up|0
4825693|NCT01136915|16638160|P1|Overall Study|Lost to Follow-up|2
4825694|NCT01136876|16638170|P2|Overall Study|Missing NGAL measurement|5
4825695|NCT01136876|16638171|P1|Overall Study|Missing NGAL measurement|2
4825696|NCT01136876|16638170|P2|Overall Study|Physician Decision|5
4825697|NCT01136876|16638171|P1|Overall Study|Physician Decision|3
4825698|NCT01136876|16638170|P2|Overall Study|Lost to Follow-up|1
4825699|NCT01136876|16638171|P1|Overall Study|Lost to Follow-up|0
4825700|NCT01136785|16638200|P2|Overall Study|Protocol Violation|1
4825701|NCT01136785|16638201|P1|Overall Study|Protocol Violation|2
4825702|NCT01136772|16638216|P2|Overall Study|Did not follow up after first injection|2
4825703|NCT01136772|16638217|P1|Overall Study|Did not follow up after first injection|2
4825704|NCT01136772|16638216|P2|Overall Study|Did not receive injection|7
4825705|NCT01136772|16638217|P1|Overall Study|Did not receive injection|10
4825706|NCT01136772|16638216|P2|Overall Study|Withdrawal by Subject|36
4825707|NCT01136772|16638217|P1|Overall Study|Withdrawal by Subject|33
4825708|NCT01136772|16638216|P2|Overall Study|Administrative|12
4825709|NCT01136772|16638217|P1|Overall Study|Administrative|14
4825710|NCT01136772|16638216|P2|Overall Study|Lack of Efficacy|39
4825711|NCT01136772|16638217|P1|Overall Study|Lack of Efficacy|42
4825712|NCT01136772|16638216|P2|Overall Study|Adverse Event|14
4825713|NCT01136772|16638217|P1|Overall Study|Adverse Event|15
4825714|NCT01136746|16638227|P2|Overall Study|Death|0
4825715|NCT01136746|16638228|P1|Overall Study|Death|1
4825716|NCT01136746|16638227|P2|Overall Study|Protocol Violation|1
4825717|NCT01136746|16638228|P1|Overall Study|Protocol Violation|2
4825718|NCT01136746|16638227|P2|Overall Study|Lost to Follow-up|2
4825719|NCT01136746|16638228|P1|Overall Study|Lost to Follow-up|0
4825720|NCT01136733|16638295|P7|Phase 2|Other|6
4825721|NCT01136733|16638296|P6|Phase 2|Other|7
4825722|NCT01136733|16638297|P5|Phase 2|Other|6
4825723|NCT01136733|16638298|P4|Phase 2|Other|0
4825724|NCT01136733|16638299|P3|Phase 2|Other|0
4825725|NCT01136733|16638300|P2|Phase 2|Other|0
4825726|NCT01136733|16638301|P1|Phase 2|Other|0
4825727|NCT01136733|16638295|P7|Phase 2|Administrative-Withdrew Consent|0
4825728|NCT01136733|16638296|P6|Phase 2|Administrative-Withdrew Consent|0
4825729|NCT01136733|16638297|P5|Phase 2|Administrative-Withdrew Consent|1
4825730|NCT01136733|16638298|P4|Phase 2|Administrative-Withdrew Consent|0
4825731|NCT01136733|16638299|P3|Phase 2|Administrative-Withdrew Consent|0
4825732|NCT01136733|16638300|P2|Phase 2|Administrative-Withdrew Consent|0
4825733|NCT01136733|16638301|P1|Phase 2|Administrative-Withdrew Consent|0
4825734|NCT01136733|16638295|P7|Phase 2|Participant Choice|1
4825735|NCT01136733|16638296|P6|Phase 2|Participant Choice|0
4825736|NCT01136733|16638297|P5|Phase 2|Participant Choice|3
4825737|NCT01136733|16638298|P4|Phase 2|Participant Choice|0
4825738|NCT01136733|16638299|P3|Phase 2|Participant Choice|0
4825739|NCT01136733|16638300|P2|Phase 2|Participant Choice|0
4825740|NCT01136733|16638301|P1|Phase 2|Participant Choice|0
4825741|NCT01136733|16638295|P7|Phase 2|Adverse Event|5
4825742|NCT01136733|16638296|P6|Phase 2|Adverse Event|13
4825743|NCT01136733|16638297|P5|Phase 2|Adverse Event|11
4825744|NCT01136733|16638298|P4|Phase 2|Adverse Event|0
4825745|NCT01136733|16638299|P3|Phase 2|Adverse Event|0
4825746|NCT01136733|16638300|P2|Phase 2|Adverse Event|0
4825747|NCT01136733|16638301|P1|Phase 2|Adverse Event|0
4825748|NCT01136733|16638295|P7|Phase 2|Disease Progression|38
4825749|NCT01136733|16638296|P6|Phase 2|Disease Progression|32
4825750|NCT01136733|16638297|P5|Phase 2|Disease Progression|30
4825751|NCT01136733|16638298|P4|Phase 2|Disease Progression|0
4825752|NCT01136733|16638299|P3|Phase 2|Disease Progression|0
4825753|NCT01136733|16638300|P2|Phase 2|Disease Progression|0
4825754|NCT01136733|16638301|P1|Phase 2|Disease Progression|0
4825755|NCT01136733|16638295|P7|Phase 1b|Clinical Progression|0
4825756|NCT01136733|16638296|P6|Phase 1b|Clinical Progression|0
4825757|NCT01136733|16638297|P5|Phase 1b|Clinical Progression|0
4825758|NCT01136733|16638298|P4|Phase 1b|Clinical Progression|0
4825759|NCT01136733|16638299|P3|Phase 1b|Clinical Progression|0
4825760|NCT01136733|16638300|P2|Phase 1b|Clinical Progression|1
4825761|NCT01136733|16638301|P1|Phase 1b|Clinical Progression|1
4825762|NCT01136733|16638295|P7|Phase 1b|Administrative-Withdrew Consent|0
4825763|NCT01136733|16638296|P6|Phase 1b|Administrative-Withdrew Consent|0
4825764|NCT01136733|16638297|P5|Phase 1b|Administrative-Withdrew Consent|0
4825765|NCT01136733|16638298|P4|Phase 1b|Administrative-Withdrew Consent|0
4825766|NCT01136733|16638299|P3|Phase 1b|Administrative-Withdrew Consent|0
4825767|NCT01136733|16638300|P2|Phase 1b|Administrative-Withdrew Consent|1
4825768|NCT01136733|16638301|P1|Phase 1b|Administrative-Withdrew Consent|0
4825769|NCT01136733|16638295|P7|Phase 1b|Participant Choice|0
4825770|NCT01136733|16638296|P6|Phase 1b|Participant Choice|0
4825771|NCT01136733|16638297|P5|Phase 1b|Participant Choice|0
4825772|NCT01136733|16638298|P4|Phase 1b|Participant Choice|0
4825773|NCT01136733|16638299|P3|Phase 1b|Participant Choice|1
4825774|NCT01136733|16638300|P2|Phase 1b|Participant Choice|0
4825775|NCT01136733|16638301|P1|Phase 1b|Participant Choice|0
4825776|NCT01136733|16638295|P7|Phase 1b|Adverse Event|0
4825777|NCT01136733|16638296|P6|Phase 1b|Adverse Event|0
4825778|NCT01136733|16638297|P5|Phase 1b|Adverse Event|0
4825779|NCT01136733|16638298|P4|Phase 1b|Adverse Event|0
4825780|NCT01136733|16638299|P3|Phase 1b|Adverse Event|1
4825781|NCT01136733|16638300|P2|Phase 1b|Adverse Event|3
4825782|NCT01136733|16638301|P1|Phase 1b|Adverse Event|0
4825783|NCT01136655|16638384|P1|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1
4825784|NCT01136655|16638384|P1|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1
4825785|NCT01136655|16638384|P1|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1
4825786|NCT01136655|16638384|P1|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1
4825787|NCT01136408|16638417|P3|Overall Study|Protocol Violation|1
4825788|NCT01136408|16638418|P2|Overall Study|Protocol Violation|1
4825789|NCT01136408|16638419|P1|Overall Study|Protocol Violation|1
4825790|NCT01136408|16638417|P3|Overall Study|Adverse Event|4
4825791|NCT01136408|16638418|P2|Overall Study|Adverse Event|8
4825792|NCT01136408|16638419|P1|Overall Study|Adverse Event|4
4825793|NCT01136382|16638476|P2|Overall Study|Withdrawal by Subject|1
4825794|NCT01136382|16638477|P1|Overall Study|Withdrawal by Subject|4
4825795|NCT01136382|16638476|P2|Overall Study|Severe Non-Compliance to Protocol|2
4825796|NCT01136382|16638477|P1|Overall Study|Severe Non-Compliance to Protocol|0
4825797|NCT01136382|16638476|P2|Overall Study|Study-Specific Withdrawal Criteria|25
4825798|NCT01136382|16638477|P1|Overall Study|Study-Specific Withdrawal Criteria|48
4825799|NCT01136382|16638476|P2|Overall Study|Other|3
4825800|NCT01136382|16638477|P1|Overall Study|Other|8
4825801|NCT01136356|16638503|P2|Second 18-day Withdrawal|Withdrawal by Subject|1
4825802|NCT01136356|16638504|P1|Second 18-day Withdrawal|Withdrawal by Subject|0
4825803|NCT01136356|16638503|P2|First 18-day Withdrawal|Physician Decision|0
4825804|NCT01136356|16638504|P1|First 18-day Withdrawal|Physician Decision|1
4825805|NCT01136356|16638503|P2|First 18-day Withdrawal|Withdrawal by Subject|0
4825806|NCT01136356|16638504|P1|First 18-day Withdrawal|Withdrawal by Subject|3
4825807|NCT01136291|16638515|P2|Overall Study|Lost to Follow-up|1
4825808|NCT01136291|16638516|P1|Overall Study|Lost to Follow-up|1
4825809|NCT01136174|16638535|P4|Overall Study|Adverse Event|4
4825810|NCT01136174|16638536|P3|Overall Study|Adverse Event|0
4825811|NCT01136174|16638537|P2|Overall Study|Adverse Event|0
4825812|NCT01136174|16638538|P1|Overall Study|Adverse Event|0
4825813|NCT01135992|16638618|P1|Overall Study|Unclassified|7
4825814|NCT01135992|16638618|P1|Overall Study|Withdrawal criteria|10
4825815|NCT01135992|16638618|P1|Overall Study|Protocol Violation|2
4825816|NCT01135992|16638618|P1|Overall Study|Lack of Efficacy|1
4825817|NCT01135992|16638618|P1|Overall Study|Adverse Event|1
4825818|NCT01135914|16638630|P3|Overall Study|Adverse Event|2
4825819|NCT01135914|16638631|P2|Overall Study|Adverse Event|1
4825820|NCT01135914|16638632|P1|Overall Study|Adverse Event|0
4825821|NCT01135914|16638630|P3|Overall Study|Lack of Efficacy|10
4825822|NCT01135914|16638631|P2|Overall Study|Lack of Efficacy|1
4825823|NCT01135914|16638632|P1|Overall Study|Lack of Efficacy|2
4825824|NCT01135914|16638630|P3|Overall Study|Protocol Violation|3
4825825|NCT01135914|16638631|P2|Overall Study|Protocol Violation|0
4825826|NCT01135914|16638632|P1|Overall Study|Protocol Violation|0
4825827|NCT01135914|16638630|P3|Overall Study|Lost to Follow-up|1
4825828|NCT01135914|16638631|P2|Overall Study|Lost to Follow-up|0
4825829|NCT01135914|16638632|P1|Overall Study|Lost to Follow-up|1
4825830|NCT01135914|16638630|P3|Overall Study|Withdrawal by Subject|6
4825831|NCT01135914|16638631|P2|Overall Study|Withdrawal by Subject|3
4825832|NCT01135914|16638632|P1|Overall Study|Withdrawal by Subject|1
4825833|NCT01135524|16638665|P1|Overall Study|Lack of Efficacy|8
4825834|NCT01135524|16638665|P1|Overall Study|Administrative|151
4825835|NCT01135524|16638665|P1|Overall Study|Lost to Follow-up|3
4825836|NCT01135524|16638665|P1|Overall Study|Adverse Event|20
4825837|NCT01135524|16638665|P1|Overall Study|Withdrawal by Subject|14
4825838|NCT01135511|16638678|P9|Overall Study|Withdrawal by Subject|1
4825839|NCT01135511|16638679|P8|Overall Study|Withdrawal by Subject|0
4825840|NCT01135511|16638680|P7|Overall Study|Withdrawal by Subject|1
4825841|NCT01135511|16638681|P6|Overall Study|Withdrawal by Subject|0
4825842|NCT01135511|16638682|P5|Overall Study|Withdrawal by Subject|0
4825843|NCT01135511|16638683|P4|Overall Study|Withdrawal by Subject|0
4825844|NCT01135511|16638684|P3|Overall Study|Withdrawal by Subject|0
4825845|NCT01135511|16638685|P2|Overall Study|Withdrawal by Subject|0
4825846|NCT01135511|16638686|P1|Overall Study|Withdrawal by Subject|0
4825847|NCT01135511|16638678|P9|Overall Study|noncompliance with study drug taken|0
4825848|NCT01135511|16638679|P8|Overall Study|noncompliance with study drug taken|0
4825849|NCT01135511|16638680|P7|Overall Study|noncompliance with study drug taken|0
4825850|NCT01135511|16638681|P6|Overall Study|noncompliance with study drug taken|0
4825851|NCT01135511|16638682|P5|Overall Study|noncompliance with study drug taken|1
4825852|NCT01135511|16638683|P4|Overall Study|noncompliance with study drug taken|0
4825853|NCT01135511|16638684|P3|Overall Study|noncompliance with study drug taken|0
4825854|NCT01135511|16638685|P2|Overall Study|noncompliance with study drug taken|0
4825855|NCT01135511|16638686|P1|Overall Study|noncompliance with study drug taken|0
4825856|NCT01135511|16638678|P9|Overall Study|could not visit the clinic|0
4825857|NCT01135511|16638679|P8|Overall Study|could not visit the clinic|0
4825858|NCT01135511|16638680|P7|Overall Study|could not visit the clinic|0
4825859|NCT01135511|16638681|P6|Overall Study|could not visit the clinic|0
4825860|NCT01135511|16638682|P5|Overall Study|could not visit the clinic|0
4825861|NCT01135511|16638683|P4|Overall Study|could not visit the clinic|0
4825862|NCT01135511|16638684|P3|Overall Study|could not visit the clinic|2
4825863|NCT01135511|16638685|P2|Overall Study|could not visit the clinic|1
4825864|NCT01135511|16638686|P1|Overall Study|could not visit the clinic|0
4825865|NCT01135511|16638678|P9|Overall Study|Pregnancy|0
4825866|NCT01135511|16638679|P8|Overall Study|Pregnancy|0
4825867|NCT01135511|16638680|P7|Overall Study|Pregnancy|0
4825868|NCT01135511|16638681|P6|Overall Study|Pregnancy|0
4825869|NCT01135511|16638682|P5|Overall Study|Pregnancy|0
4825870|NCT01135511|16638683|P4|Overall Study|Pregnancy|1
4825871|NCT01135511|16638684|P3|Overall Study|Pregnancy|0
4825872|NCT01135511|16638685|P2|Overall Study|Pregnancy|0
4825873|NCT01135511|16638686|P1|Overall Study|Pregnancy|0
4825874|NCT01135511|16638678|P9|Overall Study|Protocol Violation|0
4825875|NCT01135511|16638679|P8|Overall Study|Protocol Violation|0
4825876|NCT01135511|16638680|P7|Overall Study|Protocol Violation|0
4825877|NCT01135511|16638681|P6|Overall Study|Protocol Violation|0
4825878|NCT01135511|16638682|P5|Overall Study|Protocol Violation|0
4825879|NCT01135511|16638683|P4|Overall Study|Protocol Violation|0
4825880|NCT01135511|16638684|P3|Overall Study|Protocol Violation|3
4825881|NCT01135511|16638685|P2|Overall Study|Protocol Violation|0
4825882|NCT01135511|16638686|P1|Overall Study|Protocol Violation|0
4825883|NCT01135511|16638678|P9|Overall Study|Lack of Efficacy|0
4825884|NCT01135511|16638679|P8|Overall Study|Lack of Efficacy|0
4825885|NCT01135511|16638680|P7|Overall Study|Lack of Efficacy|0
4825886|NCT01135511|16638681|P6|Overall Study|Lack of Efficacy|0
4825887|NCT01135511|16638682|P5|Overall Study|Lack of Efficacy|0
4825888|NCT01135511|16638683|P4|Overall Study|Lack of Efficacy|2
4825889|NCT01135511|16638684|P3|Overall Study|Lack of Efficacy|1
4825890|NCT01135511|16638685|P2|Overall Study|Lack of Efficacy|1
4825891|NCT01135511|16638686|P1|Overall Study|Lack of Efficacy|0
4825892|NCT01135511|16638678|P9|Overall Study|Adverse Event|0
4825893|NCT01135511|16638679|P8|Overall Study|Adverse Event|1
4825894|NCT01135511|16638680|P7|Overall Study|Adverse Event|0
4825895|NCT01135511|16638681|P6|Overall Study|Adverse Event|1
4825896|NCT01135511|16638682|P5|Overall Study|Adverse Event|0
4825897|NCT01135511|16638683|P4|Overall Study|Adverse Event|0
4825898|NCT01135511|16638684|P3|Overall Study|Adverse Event|2
4825899|NCT01135511|16638685|P2|Overall Study|Adverse Event|1
4825900|NCT01135511|16638686|P1|Overall Study|Adverse Event|0
4825901|NCT01135498|16638968|P1|Overall Study|Ongoing at time of analysis|2
4825902|NCT01135498|16638968|P1|Overall Study|Death|1
4825903|NCT01135498|16638968|P1|Overall Study|Withdrawal by Subject|4
4825904|NCT01135498|16638968|P1|Overall Study|Investigator judgement|25
4825905|NCT01135498|16638968|P1|Overall Study|Progressive disease|38
4825906|NCT01135498|16638968|P1|Overall Study|Adverse Event|20
4825907|NCT01135134|16639147|P2|Overall Study|Did not meet protocol eligibility|0
4825908|NCT01135134|16639148|P1|Overall Study|Did not meet protocol eligibility|1
4825909|NCT01135134|16639147|P2|Overall Study|Adverse Event|1
4825910|NCT01135134|16639148|P1|Overall Study|Adverse Event|1
4825911|NCT01135017|16639171|P2|Overall Study|Other than above|4
4825912|NCT01135017|16639172|P1|Overall Study|Other than above|3
4825913|NCT01135017|16639171|P2|Overall Study|Adverse Event|8
4825914|NCT01135017|16639172|P1|Overall Study|Adverse Event|3
4825915|NCT01134939|16639210|P8|Overall Study|Termination page not available|0
4825916|NCT01134939|16639211|P7|Overall Study|Termination page not available|7
4825917|NCT01134939|16639212|P6|Overall Study|Termination page not available|3
4825918|NCT01134939|16639213|P5|Overall Study|Termination page not available|0
4825919|NCT01134939|16639214|P4|Overall Study|Termination page not available|8
4825920|NCT01134939|16639215|P3|Overall Study|Termination page not available|5
4825921|NCT01134939|16639216|P2|Overall Study|Termination page not available|6
4825922|NCT01134939|16639217|P1|Overall Study|Termination page not available|4
4825923|NCT01134939|16639210|P8|Overall Study|Death|0
4825924|NCT01134939|16639211|P7|Overall Study|Death|0
4825925|NCT01134939|16639212|P6|Overall Study|Death|0
4825926|NCT01134939|16639213|P5|Overall Study|Death|0
4825927|NCT01134939|16639214|P4|Overall Study|Death|0
4825928|NCT01134939|16639215|P3|Overall Study|Death|0
4825929|NCT01134939|16639216|P2|Overall Study|Death|1
4825930|NCT01134939|16639217|P1|Overall Study|Death|0
4825931|NCT01134939|16639210|P8|Overall Study|Lost to Follow-up|0
4825932|NCT01134939|16639211|P7|Overall Study|Lost to Follow-up|0
4825933|NCT01134939|16639212|P6|Overall Study|Lost to Follow-up|1
4825934|NCT01134939|16639213|P5|Overall Study|Lost to Follow-up|2
4825935|NCT01134939|16639214|P4|Overall Study|Lost to Follow-up|1
4825936|NCT01134939|16639215|P3|Overall Study|Lost to Follow-up|0
4825937|NCT01134939|16639216|P2|Overall Study|Lost to Follow-up|3
4825938|NCT01134939|16639217|P1|Overall Study|Lost to Follow-up|2
4825939|NCT01134939|16639210|P8|Overall Study|Lack of Efficacy|0
4825940|NCT01134939|16639211|P7|Overall Study|Lack of Efficacy|1
4825941|NCT01134939|16639212|P6|Overall Study|Lack of Efficacy|0
4825942|NCT01134939|16639213|P5|Overall Study|Lack of Efficacy|3
4825943|NCT01134939|16639214|P4|Overall Study|Lack of Efficacy|0
4825944|NCT01134939|16639215|P3|Overall Study|Lack of Efficacy|1
4825945|NCT01134939|16639216|P2|Overall Study|Lack of Efficacy|5
4825946|NCT01134939|16639217|P1|Overall Study|Lack of Efficacy|2
4825947|NCT01134939|16639210|P8|Overall Study|Adverse Event|0
4825948|NCT01134939|16639211|P7|Overall Study|Adverse Event|1
4825949|NCT01134939|16639212|P6|Overall Study|Adverse Event|5
4825950|NCT01134939|16639213|P5|Overall Study|Adverse Event|5
4825951|NCT01134939|16639214|P4|Overall Study|Adverse Event|5
4825952|NCT01134939|16639215|P3|Overall Study|Adverse Event|4
4825953|NCT01134939|16639216|P2|Overall Study|Adverse Event|3
4825954|NCT01134939|16639217|P1|Overall Study|Adverse Event|9
4825955|NCT01134783|16639355|P2|Overall Study|Lost to Follow-up|20
4825956|NCT01134783|16639356|P1|Overall Study|Lost to Follow-up|5
4825957|NCT01134783|16639355|P2|Overall Study|Withdrawal by Subject|9
4825958|NCT01134783|16639356|P1|Overall Study|Withdrawal by Subject|15
4825959|NCT01134783|16639355|P2|Overall Study|Pregnancy|8
4825960|NCT01134783|16639356|P1|Overall Study|Pregnancy|16
4825961|NCT01134731|16639375|P3|Overall Study|Lost to Follow-up|3
4825962|NCT01134731|16639376|P2|Overall Study|Lost to Follow-up|4
4825963|NCT01134731|16639377|P1|Overall Study|Lost to Follow-up|5
4825964|NCT01134731|16639375|P3|Overall Study|Withdrawal by Subject|1
4825965|NCT01134731|16639376|P2|Overall Study|Withdrawal by Subject|3
4825966|NCT01134731|16639377|P1|Overall Study|Withdrawal by Subject|3
4825967|NCT01134731|16639375|P3|Overall Study|Lack of Efficacy|1
4825968|NCT01134731|16639376|P2|Overall Study|Lack of Efficacy|0
4825969|NCT01134731|16639377|P1|Overall Study|Lack of Efficacy|0
4825970|NCT01134731|16639375|P3|Overall Study|Physician Decision|2
4825971|NCT01134731|16639376|P2|Overall Study|Physician Decision|2
4825972|NCT01134731|16639377|P1|Overall Study|Physician Decision|2
4825973|NCT01134731|16639375|P3|Overall Study|Adverse Event|1
4825974|NCT01134731|16639376|P2|Overall Study|Adverse Event|2
4825975|NCT01134731|16639377|P1|Overall Study|Adverse Event|3
4825976|NCT01134705|16639390|P2|Overall Study|Other|6
4825977|NCT01134705|16639391|P1|Overall Study|Other|1
4825978|NCT01134705|16639390|P2|Overall Study|Protocol Violation|1
4825979|NCT01134705|16639391|P1|Overall Study|Protocol Violation|1
4825980|NCT01134705|16639390|P2|Overall Study|Lost to Follow-up|2
4825981|NCT01134705|16639391|P1|Overall Study|Lost to Follow-up|5
4825982|NCT01134705|16639390|P2|Overall Study|Pregnancy|0
4825983|NCT01134705|16639391|P1|Overall Study|Pregnancy|1
4825984|NCT01134705|16639390|P2|Overall Study|Withdrawal by Subject|6
4825985|NCT01134705|16639391|P1|Overall Study|Withdrawal by Subject|6
4825986|NCT01134705|16639390|P2|Overall Study|Adverse Event|7
4825987|NCT01134705|16639391|P1|Overall Study|Adverse Event|1
4825988|NCT01134627|16639403|P2|Overall Study|Other|14
4825989|NCT01134627|16639404|P1|Overall Study|Other|11
4825990|NCT01134627|16639403|P2|Overall Study|Planning to become pregnant/pregnancy|0
4825991|NCT01134627|16639404|P1|Overall Study|Planning to become pregnant/pregnancy|1
4825992|NCT01134627|16639403|P2|Overall Study|Withdrawal by Subject|3
4825993|NCT01134627|16639404|P1|Overall Study|Withdrawal by Subject|4
4825994|NCT01134627|16639403|P2|Overall Study|Lack of Efficacy|12
4825995|NCT01134627|16639404|P1|Overall Study|Lack of Efficacy|2
4825996|NCT01134627|16639403|P2|Overall Study|Protocol Violation|5
4825997|NCT01134627|16639404|P1|Overall Study|Protocol Violation|3
4825998|NCT01134627|16639403|P2|Overall Study|Lost to Follow-up|2
4825999|NCT01134627|16639404|P1|Overall Study|Lost to Follow-up|1
4826000|NCT01134627|16639403|P2|Overall Study|Adverse Event|31
4826001|NCT01134627|16639404|P1|Overall Study|Adverse Event|47
4826002|NCT01134614|16639434|P2|Overall Study|Patient in hospice care|1
4826003|NCT01134614|16639435|P1|Overall Study|Patient in hospice care|0
4826004|NCT01134614|16639434|P2|Overall Study|Symptomatic deterioration|1
4826005|NCT01134614|16639435|P1|Overall Study|Symptomatic deterioration|0
4826006|NCT01134614|16639434|P2|Overall Study|Pt received tx not allowed on study|1
4826007|NCT01134614|16639435|P1|Overall Study|Pt received tx not allowed on study|0
4826008|NCT01134614|16639434|P2|Overall Study|Never started treatment|1
4826009|NCT01134614|16639435|P1|Overall Study|Never started treatment|4
4826010|NCT01134614|16639434|P2|Overall Study|Physician's decision|1
4826011|NCT01134614|16639435|P1|Overall Study|Physician's decision|0
4826012|NCT01134614|16639434|P2|Overall Study|Complicating disease|1
4826013|NCT01134614|16639435|P1|Overall Study|Complicating disease|2
4826014|NCT01134614|16639434|P2|Overall Study|Alternative therapy|0
4826015|NCT01134614|16639435|P1|Overall Study|Alternative therapy|2
4826016|NCT01134614|16639434|P2|Overall Study|Withdrawal by Subject|2
4826017|NCT01134614|16639435|P1|Overall Study|Withdrawal by Subject|3
4826018|NCT01134614|16639434|P2|Overall Study|Death|8
4826019|NCT01134614|16639435|P1|Overall Study|Death|5
4826020|NCT01134614|16639434|P2|Overall Study|Adverse Event|39
4826021|NCT01134614|16639435|P1|Overall Study|Adverse Event|26
4826022|NCT01134614|16639434|P2|Overall Study|Progressive disease|54
4826023|NCT01134614|16639435|P1|Overall Study|Progressive disease|60
4826024|NCT01134614|16639434|P2|Overall Study|Still on treatment as of March 2013|13
4826025|NCT01134614|16639435|P1|Overall Study|Still on treatment as of March 2013|21
4826026|NCT01134562|16639463|P5|Overall Study|Adverse Event|0
4826027|NCT01134562|16639464|P4|Overall Study|Adverse Event|0
4826028|NCT01134562|16639465|P3|Overall Study|Adverse Event|0
4826029|NCT01134562|16639466|P2|Overall Study|Adverse Event|1
4826030|NCT01134562|16639467|P1|Overall Study|Adverse Event|0
4826031|NCT01134393|16639639|P1|Overall Study|Other|6
4826032|NCT01134393|16639639|P1|Overall Study|Withdrawal by Subject|11
4826033|NCT01134393|16639639|P1|Overall Study|Lost to Follow-up|3
4826034|NCT01134393|16639639|P1|Overall Study|Protocol Violation|12
4826035|NCT01134393|16639639|P1|Overall Study|Lack of Efficacy|2
4826036|NCT01134393|16639639|P1|Overall Study|Adverse Event|18
4826037|NCT01134315|16639760|P2|Overall Study|Other Reason|17
4826038|NCT01134315|16639761|P1|Overall Study|Other Reason|8
4826039|NCT01134315|16639760|P2|Overall Study|Adverse Event|2
4826040|NCT01134315|16639761|P1|Overall Study|Adverse Event|1
4826041|NCT01134263|16639799|P5|Overall Study|Enrolled, but not treated|0
4826042|NCT01134263|16639800|P4|Overall Study|Enrolled, but not treated|1
4826043|NCT01134263|16639801|P3|Overall Study|Enrolled, but not treated|0
4826044|NCT01134263|16639802|P2|Overall Study|Enrolled, but not treated|1
4826045|NCT01134263|16639803|P1|Overall Study|Enrolled, but not treated|1
4826046|NCT01134263|16639799|P5|Overall Study|Withdrawal by Subject|5
4826047|NCT01134263|16639800|P4|Overall Study|Withdrawal by Subject|7
4826048|NCT01134263|16639801|P3|Overall Study|Withdrawal by Subject|16
4826049|NCT01134263|16639802|P2|Overall Study|Withdrawal by Subject|6
4826050|NCT01134263|16639803|P1|Overall Study|Withdrawal by Subject|8
4826051|NCT01134263|16639799|P5|Overall Study|Lost to Follow-up|1
4826052|NCT01134263|16639800|P4|Overall Study|Lost to Follow-up|3
4826053|NCT01134263|16639801|P3|Overall Study|Lost to Follow-up|5
4826054|NCT01134263|16639802|P2|Overall Study|Lost to Follow-up|3
4826055|NCT01134263|16639803|P1|Overall Study|Lost to Follow-up|4
4826056|NCT01134263|16639799|P5|Overall Study|Protocol Violation|2
4826057|NCT01134263|16639800|P4|Overall Study|Protocol Violation|4
4826058|NCT01134263|16639801|P3|Overall Study|Protocol Violation|2
4826059|NCT01134263|16639802|P2|Overall Study|Protocol Violation|7
4826060|NCT01134263|16639803|P1|Overall Study|Protocol Violation|8
4826061|NCT01134263|16639799|P5|Overall Study|Other adverse event|0
4826062|NCT01134263|16639800|P4|Overall Study|Other adverse event|3
4826063|NCT01134263|16639801|P3|Overall Study|Other adverse event|5
4826064|NCT01134263|16639802|P2|Overall Study|Other adverse event|2
4826065|NCT01134263|16639803|P1|Overall Study|Other adverse event|1
4826066|NCT01134263|16639799|P5|Overall Study|Serious adverse event|1
4826067|NCT01134263|16639800|P4|Overall Study|Serious adverse event|1
4826068|NCT01134263|16639801|P3|Overall Study|Serious adverse event|1
4826069|NCT01134263|16639802|P2|Overall Study|Serious adverse event|1
4826070|NCT01134263|16639803|P1|Overall Study|Serious adverse event|2
4826071|NCT01134107|16639836|P2|Period 2-Second Treatment Intervention|Sponsor Decision|0
4826072|NCT01134107|16639837|P1|Period 2-Second Treatment Intervention|Sponsor Decision|1
4826073|NCT01134107|16639836|P2|Period 2-Second Treatment Intervention|Physician Decision|0
4826074|NCT01134107|16639837|P1|Period 2-Second Treatment Intervention|Physician Decision|1
4826075|NCT01134107|16639836|P2|Period 2-Second Treatment Intervention|Withdrawal by Subject|0
4826076|NCT01134107|16639837|P1|Period 2-Second Treatment Intervention|Withdrawal by Subject|2
4826077|NCT01134107|16639836|P2|Period 1-First Treatment Intervention|Physician Decision|0
4826078|NCT01134107|16639837|P1|Period 1-First Treatment Intervention|Physician Decision|1
4826079|NCT01134107|16639836|P2|Period 1-First Treatment Intervention|Withdrawal by Subject|4
4826080|NCT01134107|16639837|P1|Period 1-First Treatment Intervention|Withdrawal by Subject|3
4826081|NCT01134107|16639836|P2|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
4826082|NCT01134107|16639837|P1|Period 1-First Treatment Intervention|Entry Criteria Not Met|1
4826083|NCT01134107|16639836|P2|Period 1-First Treatment Intervention|Adverse Event|0
4826084|NCT01134107|16639837|P1|Period 1-First Treatment Intervention|Adverse Event|1
4826085|NCT01134055|16639884|P7|Overall Study|Physician Decision|1
4826086|NCT01134055|16639885|P6|Overall Study|Physician Decision|0
4826087|NCT01134055|16639886|P5|Overall Study|Physician Decision|0
4826088|NCT01134055|16639887|P4|Overall Study|Physician Decision|0
4826089|NCT01134055|16639888|P3|Overall Study|Physician Decision|0
4826090|NCT01134055|16639889|P2|Overall Study|Physician Decision|0
4826091|NCT01134055|16639890|P1|Overall Study|Physician Decision|0
4826092|NCT01134055|16639884|P7|Overall Study|Protocol Violation|0
4826093|NCT01134055|16639885|P6|Overall Study|Protocol Violation|0
4826094|NCT01134055|16639886|P5|Overall Study|Protocol Violation|1
4826095|NCT01134055|16639887|P4|Overall Study|Protocol Violation|1
4826096|NCT01134055|16639888|P3|Overall Study|Protocol Violation|0
4826097|NCT01134055|16639889|P2|Overall Study|Protocol Violation|0
4826098|NCT01134055|16639890|P1|Overall Study|Protocol Violation|0
4826099|NCT01134055|16639884|P7|Overall Study|Withdrawal by Subject|8
4826100|NCT01134055|16639885|P6|Overall Study|Withdrawal by Subject|0
4826101|NCT01134055|16639886|P5|Overall Study|Withdrawal by Subject|0
4826102|NCT01134055|16639887|P4|Overall Study|Withdrawal by Subject|2
4826103|NCT01134055|16639888|P3|Overall Study|Withdrawal by Subject|1
4826104|NCT01134055|16639889|P2|Overall Study|Withdrawal by Subject|3
4826105|NCT01134055|16639890|P1|Overall Study|Withdrawal by Subject|3
4826106|NCT01134055|16639884|P7|Overall Study|Lost to Follow-up|0
4826107|NCT01134055|16639885|P6|Overall Study|Lost to Follow-up|0
4826108|NCT01134055|16639886|P5|Overall Study|Lost to Follow-up|0
4826109|NCT01134055|16639887|P4|Overall Study|Lost to Follow-up|1
4826110|NCT01134055|16639888|P3|Overall Study|Lost to Follow-up|0
4826111|NCT01134055|16639889|P2|Overall Study|Lost to Follow-up|1
4826112|NCT01134055|16639890|P1|Overall Study|Lost to Follow-up|0
4826113|NCT01134055|16639884|P7|Overall Study|Adverse Event|2
4826114|NCT01134055|16639885|P6|Overall Study|Adverse Event|7
4826115|NCT01134055|16639886|P5|Overall Study|Adverse Event|5
4826116|NCT01134055|16639887|P4|Overall Study|Adverse Event|2
4826117|NCT01134055|16639888|P3|Overall Study|Adverse Event|2
4826118|NCT01134055|16639889|P2|Overall Study|Adverse Event|2
4826119|NCT01134055|16639890|P1|Overall Study|Adverse Event|5
4826120|NCT01134042|16640024|P3|Overall Study|Withdrawal by Subject|7
4826121|NCT01134042|16640025|P2|Overall Study|Withdrawal by Subject|4
4826122|NCT01134042|16640026|P1|Overall Study|Withdrawal by Subject|13
4826123|NCT01134042|16640024|P3|Overall Study|Physician Decision|1
4826124|NCT01134042|16640025|P2|Overall Study|Physician Decision|8
4826125|NCT01134042|16640026|P1|Overall Study|Physician Decision|4
4826126|NCT01134042|16640024|P3|Overall Study|Lost to Follow-up|1
4826127|NCT01134042|16640025|P2|Overall Study|Lost to Follow-up|0
4826128|NCT01134042|16640026|P1|Overall Study|Lost to Follow-up|2
4826129|NCT01134042|16640024|P3|Overall Study|Protocol Violation|5
4826130|NCT01134042|16640025|P2|Overall Study|Protocol Violation|3
4826131|NCT01134042|16640026|P1|Overall Study|Protocol Violation|5
4826132|NCT01134042|16640024|P3|Overall Study|Lack of Efficacy|18
4826133|NCT01134042|16640025|P2|Overall Study|Lack of Efficacy|6
4826134|NCT01134042|16640026|P1|Overall Study|Lack of Efficacy|21
4826135|NCT01134042|16640024|P3|Overall Study|Adverse Event|2
4826136|NCT01134042|16640025|P2|Overall Study|Adverse Event|7
4826137|NCT01134042|16640026|P1|Overall Study|Adverse Event|3
4826138|NCT01133977|16640102|P5|Overall Study|Withdrawal by Subject|1
4826139|NCT01133977|16640103|P4|Overall Study|Withdrawal by Subject|5
4826140|NCT01133977|16640104|P3|Overall Study|Withdrawal by Subject|0
4826141|NCT01133977|16640105|P2|Overall Study|Withdrawal by Subject|0
4826142|NCT01133977|16640106|P1|Overall Study|Withdrawal by Subject|0
4826143|NCT01133977|16640102|P5|Overall Study|Lost to Follow-up|1
4826144|NCT01133977|16640103|P4|Overall Study|Lost to Follow-up|2
4826145|NCT01133977|16640104|P3|Overall Study|Lost to Follow-up|0
4826146|NCT01133977|16640105|P2|Overall Study|Lost to Follow-up|0
4826147|NCT01133977|16640106|P1|Overall Study|Lost to Follow-up|0
4826148|NCT01133977|16640102|P5|Overall Study|Started a New Line of Therapy|33
4826149|NCT01133977|16640103|P4|Overall Study|Started a New Line of Therapy|25
4826150|NCT01133977|16640104|P3|Overall Study|Started a New Line of Therapy|4
4826151|NCT01133977|16640105|P2|Overall Study|Started a New Line of Therapy|6
4826152|NCT01133977|16640106|P1|Overall Study|Started a New Line of Therapy|2
4826153|NCT01133977|16640102|P5|Overall Study|Death|3
4826154|NCT01133977|16640103|P4|Overall Study|Death|7
4826155|NCT01133977|16640104|P3|Overall Study|Death|1
4826156|NCT01133977|16640105|P2|Overall Study|Death|1
4826157|NCT01133977|16640106|P1|Overall Study|Death|1
4826158|NCT01133977|16640102|P5|Overall Study|Adverse Event|0
4826159|NCT01133977|16640103|P4|Overall Study|Adverse Event|0
4826160|NCT01133977|16640104|P3|Overall Study|Adverse Event|1
4826161|NCT01133977|16640105|P2|Overall Study|Adverse Event|0
4826162|NCT01133977|16640106|P1|Overall Study|Adverse Event|0
4826163|NCT01133847|16640133|P3|Follow-Up Phase|Lost to Follow-up|7
4826164|NCT01133847|16640134|P2|Follow-Up Phase|Lost to Follow-up|3
4826165|NCT01133847|16640135|P1|Follow-Up Phase|Lost to Follow-up|1
4826166|NCT01133847|16640133|P3|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3
4826167|NCT01133847|16640134|P2|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1
4826168|NCT01133847|16640135|P1|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5
4826169|NCT01133821|16640175|P2|Overall Study|Refused participation|3
4826170|NCT01133821|16640176|P1|Overall Study|Refused participation|1
4826171|NCT01133821|16640175|P2|Overall Study|Protocol Violation|1
4826172|NCT01133821|16640176|P1|Overall Study|Protocol Violation|0
4826173|NCT01133821|16640175|P2|Overall Study|preferred other treatment|1
4826174|NCT01133821|16640176|P1|Overall Study|preferred other treatment|1
4826175|NCT01133821|16640175|P2|Overall Study|Withdrawal by Subject|3
4826176|NCT01133821|16640176|P1|Overall Study|Withdrawal by Subject|8
4826177|NCT01133821|16640175|P2|Overall Study|Lost to Follow-up|11
4826178|NCT01133821|16640176|P1|Overall Study|Lost to Follow-up|8
4826179|NCT01133756|16640187|P3|Overall Study|Progression of Disease|1
4826180|NCT01133756|16640188|P2|Overall Study|Progression of Disease|0
4826181|NCT01133756|16640189|P1|Overall Study|Progression of Disease|0
4826182|NCT01133756|16640187|P3|Overall Study|Withdrawal by Subject|0
4826183|NCT01133756|16640188|P2|Overall Study|Withdrawal by Subject|1
4826184|NCT01133756|16640189|P1|Overall Study|Withdrawal by Subject|0
4826185|NCT01133756|16640187|P3|Overall Study|Investigator Decision|0
4826186|NCT01133756|16640188|P2|Overall Study|Investigator Decision|0
4826187|NCT01133756|16640189|P1|Overall Study|Investigator Decision|1
4826188|NCT01133756|16640187|P3|Overall Study|Adverse Event|1
4826189|NCT01133756|16640188|P2|Overall Study|Adverse Event|2
4826190|NCT01133756|16640189|P1|Overall Study|Adverse Event|1
4826191|NCT01133704|16640205|P2|Overall Study|Study Closure|0
4826192|NCT01133704|16640206|P1|Overall Study|Study Closure|1
4826193|NCT01133704|16640205|P2|Overall Study|Patient refused to continue|0
4826194|NCT01133704|16640206|P1|Overall Study|Patient refused to continue|4
4826195|NCT01133704|16640205|P2|Overall Study|Death|26
4826196|NCT01133704|16640206|P1|Overall Study|Death|44
4826197|NCT01133678|16640216|P2|Overall Study|Death|1
4826198|NCT01133678|16640217|P1|Overall Study|Death|1
4826199|NCT01133665|16640223|P1|Overall Study|Physician Decision|2
4826200|NCT01133626|16640283|P3|Overall Study|Other|0
4826201|NCT01133626|16640284|P2|Overall Study|Other|2
4826202|NCT01133626|16640285|P1|Overall Study|Other|0
4826203|NCT01133626|16640283|P3|Overall Study|Withdrawal by Subject|2
4826204|NCT01133626|16640284|P2|Overall Study|Withdrawal by Subject|2
4826205|NCT01133626|16640285|P1|Overall Study|Withdrawal by Subject|1
4826206|NCT01133626|16640283|P3|Overall Study|Adverse Event|0
4826207|NCT01133626|16640284|P2|Overall Study|Adverse Event|1
4826208|NCT01133626|16640285|P1|Overall Study|Adverse Event|0
4826209|NCT01133522|16640303|P10|Overall Study|Physician Decision|0
4826210|NCT01133522|16640304|P9|Overall Study|Physician Decision|0
4826211|NCT01133522|16640305|P8|Overall Study|Physician Decision|0
4826212|NCT01133522|16640306|P7|Overall Study|Physician Decision|0
4826213|NCT01133522|16640307|P6|Overall Study|Physician Decision|0
4826214|NCT01133522|16640308|P5|Overall Study|Physician Decision|1
4826215|NCT01133522|16640309|P4|Overall Study|Physician Decision|0
4826216|NCT01133522|16640310|P3|Overall Study|Physician Decision|0
4826217|NCT01133522|16640311|P2|Overall Study|Physician Decision|0
4826218|NCT01133522|16640312|P1|Overall Study|Physician Decision|0
4826219|NCT01133522|16640303|P10|Overall Study|Withdrawal by Subject|0
4826220|NCT01133522|16640304|P9|Overall Study|Withdrawal by Subject|0
4826221|NCT01133522|16640305|P8|Overall Study|Withdrawal by Subject|0
4826222|NCT01133522|16640306|P7|Overall Study|Withdrawal by Subject|0
4826223|NCT01133522|16640307|P6|Overall Study|Withdrawal by Subject|0
4826224|NCT01133522|16640308|P5|Overall Study|Withdrawal by Subject|0
4826225|NCT01133522|16640309|P4|Overall Study|Withdrawal by Subject|1
4826226|NCT01133522|16640310|P3|Overall Study|Withdrawal by Subject|0
4826227|NCT01133522|16640311|P2|Overall Study|Withdrawal by Subject|1
4826228|NCT01133522|16640312|P1|Overall Study|Withdrawal by Subject|0
4826229|NCT01133418|16640380|P2|Overall Study|Lost to Follow-up|6
4826230|NCT01133418|16640381|P1|Overall Study|Lost to Follow-up|5
4826231|NCT01133405|16640403|P10|Period 2|Physician Decision|0
4826232|NCT01133405|16640404|P9|Period 2|Physician Decision|0
4826233|NCT01133405|16640405|P8|Period 2|Physician Decision|0
4826234|NCT01133405|16640406|P7|Period 2|Physician Decision|0
4826235|NCT01133405|16640407|P6|Period 2|Physician Decision|1
4826236|NCT01133405|16640408|P5|Period 2|Physician Decision|0
4826237|NCT01133405|16640409|P4|Period 2|Physician Decision|0
4826238|NCT01133405|16640410|P3|Period 2|Physician Decision|0
4826239|NCT01133405|16640411|P2|Period 2|Physician Decision|0
4826240|NCT01133405|16640412|P1|Period 2|Physician Decision|0
4826241|NCT01133405|16640403|P10|Period 2|Entry Criteria Not Met|0
4826242|NCT01133405|16640404|P9|Period 2|Entry Criteria Not Met|0
4826243|NCT01133405|16640405|P8|Period 2|Entry Criteria Not Met|0
4826244|NCT01133405|16640406|P7|Period 2|Entry Criteria Not Met|0
4826245|NCT01133405|16640407|P6|Period 2|Entry Criteria Not Met|0
4826246|NCT01133405|16640408|P5|Period 2|Entry Criteria Not Met|0
4826247|NCT01133405|16640409|P4|Period 2|Entry Criteria Not Met|0
4826248|NCT01133405|16640410|P3|Period 2|Entry Criteria Not Met|0
4826249|NCT01133405|16640411|P2|Period 2|Entry Criteria Not Met|1
4826250|NCT01133405|16640412|P1|Period 2|Entry Criteria Not Met|0
4826251|NCT01133405|16640403|P10|Period 2|Withdrawal by Subject|0
4826252|NCT01133405|16640404|P9|Period 2|Withdrawal by Subject|0
4826253|NCT01133405|16640405|P8|Period 2|Withdrawal by Subject|0
4826254|NCT01133405|16640406|P7|Period 2|Withdrawal by Subject|0
4826255|NCT01133405|16640407|P6|Period 2|Withdrawal by Subject|1
4826256|NCT01133405|16640408|P5|Period 2|Withdrawal by Subject|0
4826257|NCT01133405|16640409|P4|Period 2|Withdrawal by Subject|1
4826258|NCT01133405|16640410|P3|Period 2|Withdrawal by Subject|0
4826259|NCT01133405|16640411|P2|Period 2|Withdrawal by Subject|0
4826260|NCT01133405|16640412|P1|Period 2|Withdrawal by Subject|0
4826261|NCT01133405|16640403|P10|Period 2|Adverse Event|0
4826262|NCT01133405|16640404|P9|Period 2|Adverse Event|0
4826263|NCT01133405|16640405|P8|Period 2|Adverse Event|0
4826264|NCT01133405|16640406|P7|Period 2|Adverse Event|0
4826265|NCT01133405|16640407|P6|Period 2|Adverse Event|0
4826266|NCT01133405|16640408|P5|Period 2|Adverse Event|0
4826267|NCT01133405|16640409|P4|Period 2|Adverse Event|0
4826268|NCT01133405|16640410|P3|Period 2|Adverse Event|1
4826269|NCT01133405|16640411|P2|Period 2|Adverse Event|0
4826270|NCT01133405|16640412|P1|Period 2|Adverse Event|0
4826271|NCT01133405|16640403|P10|Period 1|Received drug only in period 3|0
4826272|NCT01133405|16640404|P9|Period 1|Received drug only in period 3|0
4826273|NCT01133405|16640405|P8|Period 1|Received drug only in period 3|0
4826274|NCT01133405|16640406|P7|Period 1|Received drug only in period 3|0
4826275|NCT01133405|16640407|P6|Period 1|Received drug only in period 3|0
4826276|NCT01133405|16640408|P5|Period 1|Received drug only in period 3|0
4826277|NCT01133405|16640409|P4|Period 1|Received drug only in period 3|0
4826278|NCT01133405|16640410|P3|Period 1|Received drug only in period 3|1
4826279|NCT01133405|16640411|P2|Period 1|Received drug only in period 3|1
4826280|NCT01133405|16640412|P1|Period 1|Received drug only in period 3|0
4826281|NCT01133405|16640403|P10|Period 1|Received drug only in period 2|0
4826282|NCT01133405|16640404|P9|Period 1|Received drug only in period 2|0
4826283|NCT01133405|16640405|P8|Period 1|Received drug only in period 2|0
4826284|NCT01133405|16640406|P7|Period 1|Received drug only in period 2|0
4826285|NCT01133405|16640407|P6|Period 1|Received drug only in period 2|1
4826286|NCT01133405|16640408|P5|Period 1|Received drug only in period 2|0
4826287|NCT01133405|16640409|P4|Period 1|Received drug only in period 2|2
4826288|NCT01133405|16640410|P3|Period 1|Received drug only in period 2|0
4826289|NCT01133405|16640411|P2|Period 1|Received drug only in period 2|1
4826290|NCT01133405|16640412|P1|Period 1|Received drug only in period 2|0
4826291|NCT01133405|16640403|P10|Period 1|Discontinued after randomization|0
4826292|NCT01133405|16640404|P9|Period 1|Discontinued after randomization|0
4826293|NCT01133405|16640405|P8|Period 1|Discontinued after randomization|0
4826294|NCT01133405|16640406|P7|Period 1|Discontinued after randomization|1
4826295|NCT01133405|16640407|P6|Period 1|Discontinued after randomization|0
4826296|NCT01133405|16640408|P5|Period 1|Discontinued after randomization|0
4826297|NCT01133405|16640409|P4|Period 1|Discontinued after randomization|0
4826298|NCT01133405|16640410|P3|Period 1|Discontinued after randomization|0
4826299|NCT01133405|16640411|P2|Period 1|Discontinued after randomization|0
4826300|NCT01133405|16640412|P1|Period 1|Discontinued after randomization|1
4826301|NCT01133405|16640403|P10|Period 1|Physician Decision|0
4826302|NCT01133405|16640404|P9|Period 1|Physician Decision|0
4826303|NCT01133405|16640405|P8|Period 1|Physician Decision|0
4826304|NCT01133405|16640406|P7|Period 1|Physician Decision|0
4826305|NCT01133405|16640407|P6|Period 1|Physician Decision|0
4826306|NCT01133405|16640408|P5|Period 1|Physician Decision|0
4826307|NCT01133405|16640409|P4|Period 1|Physician Decision|1
4826308|NCT01133405|16640410|P3|Period 1|Physician Decision|0
4826309|NCT01133405|16640411|P2|Period 1|Physician Decision|0
4826310|NCT01133405|16640412|P1|Period 1|Physician Decision|0
4826311|NCT01133405|16640403|P10|Period 1|Withdrawal by Subject|0
4826312|NCT01133405|16640404|P9|Period 1|Withdrawal by Subject|0
4826313|NCT01133405|16640405|P8|Period 1|Withdrawal by Subject|0
4826314|NCT01133405|16640406|P7|Period 1|Withdrawal by Subject|0
4826315|NCT01133405|16640407|P6|Period 1|Withdrawal by Subject|1
4826316|NCT01133405|16640408|P5|Period 1|Withdrawal by Subject|0
4826317|NCT01133405|16640409|P4|Period 1|Withdrawal by Subject|1
4826318|NCT01133405|16640410|P3|Period 1|Withdrawal by Subject|0
4826319|NCT01133405|16640411|P2|Period 1|Withdrawal by Subject|1
4826320|NCT01133405|16640412|P1|Period 1|Withdrawal by Subject|0
4826321|NCT01133392|16640463|P2|Interval Between Dosing (4-7 Days)|Protocol Violation|1
4826322|NCT01133392|16640464|P1|Interval Between Dosing (4-7 Days)|Protocol Violation|0
4826323|NCT01133392|16640463|P2|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1
4826324|NCT01133392|16640464|P1|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0
4826325|NCT01133379|16640481|P3|Overall Study|Lost to Follow-up|1
4826326|NCT01133379|16640482|P2|Overall Study|Lost to Follow-up|1
4826327|NCT01133379|16640483|P1|Overall Study|Lost to Follow-up|1
4826328|NCT01133379|16640481|P3|Overall Study|Withdrawal by Subject|1
4826329|NCT01133379|16640482|P2|Overall Study|Withdrawal by Subject|1
4826330|NCT01133379|16640483|P1|Overall Study|Withdrawal by Subject|0
4826331|NCT01133288|16640536|P1|Intervention Allocation|study terminated|2
4826332|NCT01133288|16640536|P1|Eligibility Assessment|met exclusion criteria|5
4826333|NCT01133275|16640541|P1|Overall Study|Cerebrovascular accident (CVA)|1
4826334|NCT01133275|16640541|P1|Overall Study|Withdrawal by Subject|1
4826335|NCT01133171|16640549|P3|Overall Study|Withdrawal by Subject|0
4826336|NCT01133171|16640550|P2|Overall Study|Withdrawal by Subject|2
4826337|NCT01133171|16640551|P1|Overall Study|Withdrawal by Subject|1
4826338|NCT01133067|16640567|P1|Overall Study|Lost to Follow-up|3
4826339|NCT01133067|16640567|P1|Overall Study|Death|136
4826340|NCT01132820|16640627|P1|Overall Study|Inadequate data|1
4826341|NCT01132820|16640627|P1|Overall Study|Never treated|1
4826342|NCT01132820|16640627|P1|Overall Study|Ineligible:Inadequate pathology|1
4826343|NCT01132820|16640627|P1|Overall Study|Ineligible:Improper pre-protocol therapy|1
4826344|NCT01132820|16640627|P1|Overall Study|Ineligible: wrong cell type|1
4826345|NCT01132755|16640636|P1|Overall Study|Withdrawal by Subject|4
4826346|NCT01132755|16640636|P1|Overall Study|Protocol Violation|15
4826347|NCT01132755|16640636|P1|Overall Study|Procedure not done due to medical reason|23
4826348|NCT01132664|16640665|P5|BM Cohort|Withdrawal by Subject|1
4826349|NCT01132664|16640666|P4|BM Cohort|Withdrawal by Subject|0
4826350|NCT01132664|16640667|P3|BM Cohort|Withdrawal by Subject|0
4826351|NCT01132664|16640668|P2|BM Cohort|Withdrawal by Subject|0
4826352|NCT01132664|16640669|P1|BM Cohort|Withdrawal by Subject|0
4826353|NCT01132664|16640665|P5|BM Cohort|Adverse Event|1
4826354|NCT01132664|16640666|P4|BM Cohort|Adverse Event|0
4826355|NCT01132664|16640667|P3|BM Cohort|Adverse Event|0
4826356|NCT01132664|16640668|P2|BM Cohort|Adverse Event|0
4826357|NCT01132664|16640669|P1|BM Cohort|Adverse Event|0
4826358|NCT01132664|16640665|P5|BM Cohort|Disease progression|4
4826359|NCT01132664|16640666|P4|BM Cohort|Disease progression|3
4826360|NCT01132664|16640667|P3|BM Cohort|Disease progression|0
4826361|NCT01132664|16640668|P2|BM Cohort|Disease progression|0
4826362|NCT01132664|16640669|P1|BM Cohort|Disease progression|0
4826363|NCT01132664|16640665|P5|Phase ll|Disease progression|0
4826364|NCT01132664|16640666|P4|Phase ll|Disease progression|0
4826365|NCT01132664|16640667|P3|Phase ll|Disease progression|35
4826366|NCT01132664|16640668|P2|Phase ll|Disease progression|0
4826367|NCT01132664|16640669|P1|Phase ll|Disease progression|0
4826368|NCT01132664|16640665|P5|Phase ll|Withdrawal by Subject|0
4826369|NCT01132664|16640666|P4|Phase ll|Withdrawal by Subject|0
4826370|NCT01132664|16640667|P3|Phase ll|Withdrawal by Subject|3
4826371|NCT01132664|16640668|P2|Phase ll|Withdrawal by Subject|0
4826372|NCT01132664|16640669|P1|Phase ll|Withdrawal by Subject|0
4826373|NCT01132664|16640665|P5|Phase ll|Adverse Event|0
4826374|NCT01132664|16640666|P4|Phase ll|Adverse Event|0
4826375|NCT01132664|16640667|P3|Phase ll|Adverse Event|10
4826376|NCT01132664|16640668|P2|Phase ll|Adverse Event|0
4826377|NCT01132664|16640669|P1|Phase ll|Adverse Event|0
4826378|NCT01132664|16640665|P5|Phase ll|Death|0
4826379|NCT01132664|16640666|P4|Phase ll|Death|0
4826380|NCT01132664|16640667|P3|Phase ll|Death|2
4826381|NCT01132664|16640668|P2|Phase ll|Death|0
4826382|NCT01132664|16640669|P1|Phase ll|Death|0
4826383|NCT01132664|16640665|P5|Phase lb|Disease Progression|0
4826384|NCT01132664|16640666|P4|Phase lb|Disease Progression|0
4826385|NCT01132664|16640667|P3|Phase lb|Disease Progression|0
4826386|NCT01132664|16640668|P2|Phase lb|Disease Progression|9
4826387|NCT01132664|16640669|P1|Phase lb|Disease Progression|4
4826388|NCT01132664|16640665|P5|Phase lb|Withdrawal by Subject|0
4826389|NCT01132664|16640666|P4|Phase lb|Withdrawal by Subject|0
4826390|NCT01132664|16640667|P3|Phase lb|Withdrawal by Subject|0
4826391|NCT01132664|16640668|P2|Phase lb|Withdrawal by Subject|2
4826392|NCT01132664|16640669|P1|Phase lb|Withdrawal by Subject|1
4826393|NCT01132664|16640665|P5|Phase lb|Adverse Event|0
4826394|NCT01132664|16640666|P4|Phase lb|Adverse Event|0
4826395|NCT01132664|16640667|P3|Phase lb|Adverse Event|0
4826396|NCT01132664|16640668|P2|Phase lb|Adverse Event|1
4826397|NCT01132664|16640669|P1|Phase lb|Adverse Event|0
4826398|NCT01132651|16640703|P2|Overall Study|Lost to Follow-up|1
4826399|NCT01132651|16640704|P1|Overall Study|Lost to Follow-up|1
4826400|NCT01132612|16640715|P3|Overall Study|Lack of Efficacy|73
4826401|NCT01132612|16640716|P2|Overall Study|Lack of Efficacy|22
4826402|NCT01132612|16640717|P1|Overall Study|Lack of Efficacy|23
4826403|NCT01132612|16640715|P3|Overall Study|Administrative problems|52
4826404|NCT01132612|16640716|P2|Overall Study|Administrative problems|1
4826405|NCT01132612|16640717|P1|Overall Study|Administrative problems|5
4826406|NCT01132612|16640715|P3|Overall Study|Withdrawal by Subject|19
4826407|NCT01132612|16640716|P2|Overall Study|Withdrawal by Subject|8
4826408|NCT01132612|16640717|P1|Overall Study|Withdrawal by Subject|5
4826409|NCT01132612|16640715|P3|Overall Study|Adverse Event|15
4826410|NCT01132612|16640716|P2|Overall Study|Adverse Event|2
4826411|NCT01132612|16640717|P1|Overall Study|Adverse Event|5
4826412|NCT01132612|16640715|P3|Overall Study|Lost to Follow-up|7
4826413|NCT01132612|16640716|P2|Overall Study|Lost to Follow-up|2
4826414|NCT01132612|16640717|P1|Overall Study|Lost to Follow-up|2
4826415|NCT01132612|16640715|P3|Overall Study|Protocol deviation|3
4826416|NCT01132612|16640716|P2|Overall Study|Protocol deviation|0
4826417|NCT01132612|16640717|P1|Overall Study|Protocol deviation|0
4826418|NCT01132612|16640715|P3|Overall Study|Death|1
4826419|NCT01132612|16640716|P2|Overall Study|Death|0
4826420|NCT01132612|16640717|P1|Overall Study|Death|0
4826421|NCT01132547|16640733|P2|Overall Study|Death|0
4826422|NCT01132547|16640734|P1|Overall Study|Death|1
4826423|NCT01132547|16640733|P2|Overall Study|Withdrawal by Subject|1
4826424|NCT01132547|16640734|P1|Overall Study|Withdrawal by Subject|3
4826425|NCT01132495|16640804|P4|Overall Study|Various reasons|12
4826426|NCT01132495|16640805|P3|Overall Study|Various reasons|20
4826427|NCT01132495|16640806|P2|Overall Study|Various reasons|38
4826428|NCT01132495|16640807|P1|Overall Study|Various reasons|40
4826429|NCT01132482|16640820|P2|Overall Study|Adverse Event|0
4826430|NCT01132482|16640821|P1|Overall Study|Adverse Event|1
4826431|NCT01132326|16640844|P1|Overall Study|Subject Unable to Come To Visits|1
4826432|NCT01132326|16640844|P1|Overall Study|Death|5
4826433|NCT01132326|16640844|P1|Overall Study|Caregiver Withdrew Consent|1
4826434|NCT01132326|16640844|P1|Overall Study|Pregnancy|1
4826435|NCT01132326|16640844|P1|Overall Study|Declining Health|1
4826436|NCT01132326|16640844|P1|Overall Study|Study Termination|80
4826437|NCT01132326|16640844|P1|Overall Study|Physician Decision|10
4826438|NCT01132326|16640844|P1|Overall Study|Withdrawal by Subject|40
4826439|NCT01132326|16640844|P1|Overall Study|Lost to Follow-up|16
4826440|NCT01132326|16640844|P1|Overall Study|Protocol Violation|1
4826441|NCT01132326|16640844|P1|Overall Study|Adverse Event|37
4826442|NCT01132326|16640844|P1|Overall Study|Lack of Efficacy|25
4826443|NCT01132313|16640860|P12|Overall Study|Other reason not defined above|0
4826444|NCT01132313|16640861|P11|Overall Study|Other reason not defined above|0
4826445|NCT01132313|16640862|P10|Overall Study|Other reason not defined above|0
4826446|NCT01132313|16640863|P9|Overall Study|Other reason not defined above|0
4826447|NCT01132313|16640864|P8|Overall Study|Other reason not defined above|1
4826448|NCT01132313|16640865|P7|Overall Study|Other reason not defined above|0
4826449|NCT01132313|16640866|P6|Overall Study|Other reason not defined above|0
4826450|NCT01132313|16640867|P5|Overall Study|Other reason not defined above|0
4826451|NCT01132313|16640868|P4|Overall Study|Other reason not defined above|0
4826452|NCT01132313|16640869|P3|Overall Study|Other reason not defined above|0
4826453|NCT01132313|16640870|P2|Overall Study|Other reason not defined above|0
4826454|NCT01132313|16640871|P1|Overall Study|Other reason not defined above|0
4826455|NCT01132313|16640860|P12|Overall Study|Lack of antiviral response|0
4826456|NCT01132313|16640861|P11|Overall Study|Lack of antiviral response|1
4826457|NCT01132313|16640862|P10|Overall Study|Lack of antiviral response|0
4826458|NCT01132313|16640863|P9|Overall Study|Lack of antiviral response|0
4826459|NCT01132313|16640864|P8|Overall Study|Lack of antiviral response|0
4826460|NCT01132313|16640865|P7|Overall Study|Lack of antiviral response|21
4826461|NCT01132313|16640866|P6|Overall Study|Lack of antiviral response|18
4826462|NCT01132313|16640867|P5|Overall Study|Lack of antiviral response|18
4826463|NCT01132313|16640868|P4|Overall Study|Lack of antiviral response|18
4826464|NCT01132313|16640869|P3|Overall Study|Lack of antiviral response|12
4826465|NCT01132313|16640870|P2|Overall Study|Lack of antiviral response|0
4826466|NCT01132313|16640871|P1|Overall Study|Lack of antiviral response|0
4826467|NCT01132313|16640860|P12|Overall Study|Withdrawal by Subject|0
4826468|NCT01132313|16640861|P11|Overall Study|Withdrawal by Subject|0
4826469|NCT01132313|16640862|P10|Overall Study|Withdrawal by Subject|2
4826470|NCT01132313|16640863|P9|Overall Study|Withdrawal by Subject|0
4826471|NCT01132313|16640864|P8|Overall Study|Withdrawal by Subject|0
4826472|NCT01132313|16640865|P7|Overall Study|Withdrawal by Subject|1
4826473|NCT01132313|16640866|P6|Overall Study|Withdrawal by Subject|0
4826474|NCT01132313|16640867|P5|Overall Study|Withdrawal by Subject|6
4826475|NCT01132313|16640868|P4|Overall Study|Withdrawal by Subject|3
4826476|NCT01132313|16640869|P3|Overall Study|Withdrawal by Subject|3
4826477|NCT01132313|16640870|P2|Overall Study|Withdrawal by Subject|0
4826478|NCT01132313|16640871|P1|Overall Study|Withdrawal by Subject|0
4826479|NCT01132313|16640860|P12|Overall Study|Lost to Follow-up|0
4826480|NCT01132313|16640861|P11|Overall Study|Lost to Follow-up|0
4826481|NCT01132313|16640862|P10|Overall Study|Lost to Follow-up|0
4826482|NCT01132313|16640863|P9|Overall Study|Lost to Follow-up|0
4826483|NCT01132313|16640864|P8|Overall Study|Lost to Follow-up|1
4826484|NCT01132313|16640865|P7|Overall Study|Lost to Follow-up|0
4826485|NCT01132313|16640866|P6|Overall Study|Lost to Follow-up|0
4826486|NCT01132313|16640867|P5|Overall Study|Lost to Follow-up|0
4826487|NCT01132313|16640868|P4|Overall Study|Lost to Follow-up|0
4826488|NCT01132313|16640869|P3|Overall Study|Lost to Follow-up|1
4826489|NCT01132313|16640870|P2|Overall Study|Lost to Follow-up|0
4826490|NCT01132313|16640871|P1|Overall Study|Lost to Follow-up|0
4826491|NCT01132313|16640860|P12|Overall Study|Protocol Violation|0
4826492|NCT01132313|16640861|P11|Overall Study|Protocol Violation|0
4826493|NCT01132313|16640862|P10|Overall Study|Protocol Violation|0
4826494|NCT01132313|16640863|P9|Overall Study|Protocol Violation|0
4826495|NCT01132313|16640864|P8|Overall Study|Protocol Violation|0
4826496|NCT01132313|16640865|P7|Overall Study|Protocol Violation|0
4826497|NCT01132313|16640866|P6|Overall Study|Protocol Violation|0
4826498|NCT01132313|16640867|P5|Overall Study|Protocol Violation|0
4826499|NCT01132313|16640868|P4|Overall Study|Protocol Violation|1
4826500|NCT01132313|16640869|P3|Overall Study|Protocol Violation|0
4826501|NCT01132313|16640870|P2|Overall Study|Protocol Violation|0
4826502|NCT01132313|16640871|P1|Overall Study|Protocol Violation|0
4826503|NCT01132313|16640860|P12|Overall Study|Adverse Event|0
4826504|NCT01132313|16640861|P11|Overall Study|Adverse Event|0
4826505|NCT01132313|16640862|P10|Overall Study|Adverse Event|2
4826506|NCT01132313|16640863|P9|Overall Study|Adverse Event|7
4826507|NCT01132313|16640864|P8|Overall Study|Adverse Event|3
4826508|NCT01132313|16640865|P7|Overall Study|Adverse Event|5
4826509|NCT01132313|16640866|P6|Overall Study|Adverse Event|6
4826510|NCT01132313|16640867|P5|Overall Study|Adverse Event|19
4826511|NCT01132313|16640868|P4|Overall Study|Adverse Event|10
4826512|NCT01132313|16640869|P3|Overall Study|Adverse Event|4
4826513|NCT01132313|16640870|P2|Overall Study|Adverse Event|0
4826514|NCT01132313|16640871|P1|Overall Study|Adverse Event|0
4826515|NCT01132313|16640860|P12|Overall Study|Not treated|0
4826516|NCT01132313|16640861|P11|Overall Study|Not treated|0
4826517|NCT01132313|16640862|P10|Overall Study|Not treated|0
4826518|NCT01132313|16640863|P9|Overall Study|Not treated|0
4826519|NCT01132313|16640864|P8|Overall Study|Not treated|0
4826520|NCT01132313|16640865|P7|Overall Study|Not treated|3
4826521|NCT01132313|16640866|P6|Overall Study|Not treated|1
4826522|NCT01132313|16640867|P5|Overall Study|Not treated|2
4826523|NCT01132313|16640868|P4|Overall Study|Not treated|0
4826524|NCT01132313|16640869|P3|Overall Study|Not treated|0
4826525|NCT01132313|16640870|P2|Overall Study|Not treated|0
4826526|NCT01132313|16640871|P1|Overall Study|Not treated|2
4826527|NCT01132313|16640860|P12|Overall Study|Lack of Efficacy|0
4826528|NCT01132313|16640861|P11|Overall Study|Lack of Efficacy|0
4826529|NCT01132313|16640862|P10|Overall Study|Lack of Efficacy|16
4826530|NCT01132313|16640863|P9|Overall Study|Lack of Efficacy|14
4826531|NCT01132313|16640864|P8|Overall Study|Lack of Efficacy|3
4826532|NCT01132313|16640865|P7|Overall Study|Lack of Efficacy|0
4826533|NCT01132313|16640866|P6|Overall Study|Lack of Efficacy|0
4826534|NCT01132313|16640867|P5|Overall Study|Lack of Efficacy|0
4826535|NCT01132313|16640868|P4|Overall Study|Lack of Efficacy|0
4826536|NCT01132313|16640869|P3|Overall Study|Lack of Efficacy|0
4826537|NCT01132313|16640870|P2|Overall Study|Lack of Efficacy|0
4826538|NCT01132313|16640871|P1|Overall Study|Lack of Efficacy|1
4826539|NCT01132118|16640951|P2|Second Intervention (8 Weeks)|Adverse Event|1
4826540|NCT01132118|16640952|P1|Second Intervention (8 Weeks)|Adverse Event|0
4826541|NCT01132118|16640951|P2|First Intervention (8 Weeks)|Withdrawal by Subject|3
4826542|NCT01132118|16640952|P1|First Intervention (8 Weeks)|Withdrawal by Subject|2
4826543|NCT01132118|16640951|P2|First Intervention (8 Weeks)|Adverse Event|0
4826544|NCT01132118|16640952|P1|First Intervention (8 Weeks)|Adverse Event|1
4826545|NCT01131676|16640982|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2
4826546|NCT01131676|16640983|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
4826547|NCT01131676|16640984|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4
4826548|NCT01131676|16640982|P3|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5
4826549|NCT01131676|16640983|P2|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6
4826550|NCT01131676|16640984|P1|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7
4826551|NCT01131676|16640982|P3|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7
4826552|NCT01131676|16640983|P2|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9
4826553|NCT01131676|16640984|P1|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5
4826554|NCT01131676|16640982|P3|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19
4826555|NCT01131676|16640983|P2|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21
4826556|NCT01131676|16640984|P1|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20
4826557|NCT01131676|16640982|P3|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5
4826558|NCT01131676|16640983|P2|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6
4826559|NCT01131676|16640984|P1|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8
4826560|NCT01131676|16640982|P3|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25
4826561|NCT01131676|16640983|P2|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35
4826562|NCT01131676|16640984|P1|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23
4826563|NCT01131676|16640982|P3|Discontinuation From Treatment|Adverse Event|273
4826564|NCT01131676|16640983|P2|Discontinuation From Treatment|Adverse Event|267
4826565|NCT01131676|16640984|P1|Discontinuation From Treatment|Adverse Event|303
4826566|NCT01131676|16640982|P3|Discontinuation From Treatment|Other than those specified|125
4826567|NCT01131676|16640983|P2|Discontinuation From Treatment|Other than those specified|142
4826568|NCT01131676|16640984|P1|Discontinuation From Treatment|Other than those specified|162
4826569|NCT01131676|16640982|P3|Discontinuation From Treatment|Refusal to continue, not due to AE|122
4826570|NCT01131676|16640983|P2|Discontinuation From Treatment|Refusal to continue, not due to AE|118
4826571|NCT01131676|16640984|P1|Discontinuation From Treatment|Refusal to continue, not due to AE|172
4826572|NCT01131676|16640982|P3|Discontinuation From Treatment|Lost to Follow-up|6
4826573|NCT01131676|16640983|P2|Discontinuation From Treatment|Lost to Follow-up|9
4826574|NCT01131676|16640984|P1|Discontinuation From Treatment|Lost to Follow-up|15
4826575|NCT01131676|16640982|P3|Discontinuation From Treatment|Non compliant with protocol|12
4826576|NCT01131676|16640983|P2|Discontinuation From Treatment|Non compliant with protocol|15
4826577|NCT01131676|16640984|P1|Discontinuation From Treatment|Non compliant with protocol|15
4826578|NCT01131676|16640982|P3|Discontinuation From Treatment|Lack of Efficacy|0
4826579|NCT01131676|16640983|P2|Discontinuation From Treatment|Lack of Efficacy|1
4826580|NCT01131676|16640984|P1|Discontinuation From Treatment|Lack of Efficacy|11
4826581|NCT01131676|16640982|P3|Discontinuation From Treatment|Not treated|2
4826582|NCT01131676|16640983|P2|Discontinuation From Treatment|Not treated|2
4826583|NCT01131676|16640984|P1|Discontinuation From Treatment|Not treated|4
4826584|NCT01131676|16640982|P3|Discontinuation From Treatment|Study drug stopped, reason missing|4
4826585|NCT01131676|16640983|P2|Discontinuation From Treatment|Study drug stopped, reason missing|3
4826586|NCT01131676|16640984|P1|Discontinuation From Treatment|Study drug stopped, reason missing|5
4826587|NCT01131585|16641019|P2|Overall Study|Study termination|32
4826588|NCT01131585|16641020|P1|Overall Study|Study termination|78
4826589|NCT01131585|16641019|P2|Overall Study|Administrative problems|1
4826590|NCT01131585|16641020|P1|Overall Study|Administrative problems|1
4826591|NCT01131585|16641019|P2|Overall Study|Lost to Follow-up|1
4826592|NCT01131585|16641020|P1|Overall Study|Lost to Follow-up|0
4826593|NCT01131585|16641019|P2|Overall Study|Withdrawal by Subject|3
4826594|NCT01131585|16641020|P1|Overall Study|Withdrawal by Subject|3
4826595|NCT01131585|16641019|P2|Overall Study|Protocol Violation|1
4826596|NCT01131585|16641020|P1|Overall Study|Protocol Violation|2
4826597|NCT01131585|16641019|P2|Overall Study|Unsatisfactory therapeutic effect|3
4826598|NCT01131585|16641020|P1|Overall Study|Unsatisfactory therapeutic effect|0
4826599|NCT01131585|16641019|P2|Overall Study|Abnormal laboratory value|0
4826600|NCT01131585|16641020|P1|Overall Study|Abnormal laboratory value|1
4826601|NCT01131585|16641019|P2|Overall Study|Adverse Event|2
4826602|NCT01131585|16641020|P1|Overall Study|Adverse Event|0
4826603|NCT01131520|16641028|P2|Overall Study|Subject changed history after enrollment|1
4826604|NCT01131520|16641029|P1|Overall Study|Subject changed history after enrollment|0
4826605|NCT01131520|16641028|P2|Overall Study|Counselor not available|3
4826606|NCT01131520|16641029|P1|Overall Study|Counselor not available|0
4826607|NCT01131520|16641028|P2|Overall Study|Computer problem|0
4826608|NCT01131520|16641029|P1|Overall Study|Computer problem|1
4826609|NCT01131507|16641051|P1|Overall Study|Withdrawal by Subject|1
4826610|NCT01131507|16641051|P1|Overall Study|Lost to Follow-up|1
4826611|NCT01131507|16641051|P1|Overall Study|Adverse Event|1
4826612|NCT01131494|16641056|P1|Overall Study|Withdrawal by Subject|2
4826613|NCT01131455|16641066|P3|Overall Study|Death of PI|0
4826614|NCT01131455|16641067|P2|Overall Study|Death of PI|4
4826615|NCT01131455|16641068|P1|Overall Study|Death of PI|6
4826616|NCT01131312|16641079|P3|Overall Study|Lost to Follow-up|351
4826617|NCT01131312|16641080|P2|Overall Study|Lost to Follow-up|229
4826618|NCT01131312|16641081|P1|Overall Study|Lost to Follow-up|425
4826619|NCT01131299|16641092|P2|Overall Study|Withdrawal by Subject|7
4826620|NCT01131299|16641093|P1|Overall Study|Withdrawal by Subject|4
4826621|NCT01131260|16641106|P2|Overall Study|Ineligible|2
4826622|NCT01131260|16641107|P1|Overall Study|Ineligible|0
4826623|NCT01131260|16641106|P2|Overall Study|Staff error|1
4826624|NCT01131260|16641107|P1|Overall Study|Staff error|2
4826625|NCT01131260|16641106|P2|Overall Study|Technical problems|6
4826626|NCT01131260|16641107|P1|Overall Study|Technical problems|7
4826627|NCT01131260|16641106|P2|Overall Study|Physician Decision|24
4826628|NCT01131260|16641107|P1|Overall Study|Physician Decision|22
4826629|NCT01131260|16641106|P2|Overall Study|Declined to continue participation|13
4826630|NCT01131260|16641107|P1|Overall Study|Declined to continue participation|8
4826631|NCT01131260|16641106|P2|Overall Study|Randomization error|1
4826632|NCT01131260|16641107|P1|Overall Study|Randomization error|5
4826633|NCT01131182|16641155|P2|Overall Study|Other Reason|0
4826634|NCT01131182|16641156|P1|Overall Study|Other Reason|1
4826635|NCT01131182|16641155|P2|Overall Study|Lost to Follow-up|15
4826636|NCT01131182|16641156|P1|Overall Study|Lost to Follow-up|14
4826637|NCT01131182|16641155|P2|Overall Study|Withdrawal by Subject|1
4826638|NCT01131182|16641156|P1|Overall Study|Withdrawal by Subject|1
4826639|NCT01131130|16641164|P1|Period 3- Crossover|+ Slit lamp finding|1
4826640|NCT01131130|16641164|P1|Period 1 - Baseline|Pregnancy|1
4826641|NCT01131104|16641177|P1|Overall Study|No Information on Index Date of Onset|1
4826642|NCT01131104|16641177|P1|Overall Study|Information Not Available|5
4826643|NCT01131104|16641177|P1|Overall Study|Physician Decision|4
4826644|NCT01131104|16641177|P1|Overall Study|Withdrawal by Subject|3
4826645|NCT01131078|16641184|P3|Overall Study|Other|0
4826646|NCT01131078|16641185|P2|Overall Study|Other|1
4826647|NCT01131078|16641186|P1|Overall Study|Other|0
4826648|NCT01131078|16641184|P3|Overall Study|Death|2
4826649|NCT01131078|16641185|P2|Overall Study|Death|0
4826650|NCT01131078|16641186|P1|Overall Study|Death|4
4826651|NCT01131078|16641184|P3|Overall Study|Physician Decision|8
4826652|NCT01131078|16641185|P2|Overall Study|Physician Decision|6
4826653|NCT01131078|16641186|P1|Overall Study|Physician Decision|10
4826654|NCT01131078|16641184|P3|Overall Study|Non-compliance|0
4826655|NCT01131078|16641185|P2|Overall Study|Non-compliance|0
4826656|NCT01131078|16641186|P1|Overall Study|Non-compliance|3
4826657|NCT01131078|16641184|P3|Overall Study|Withdrawal by Subject|3
4826658|NCT01131078|16641185|P2|Overall Study|Withdrawal by Subject|4
4826659|NCT01131078|16641186|P1|Overall Study|Withdrawal by Subject|2
4826660|NCT01131078|16641184|P3|Overall Study|Lost to Follow-up|1
4826661|NCT01131078|16641185|P2|Overall Study|Lost to Follow-up|1
4826662|NCT01131078|16641186|P1|Overall Study|Lost to Follow-up|1
4826663|NCT01131078|16641184|P3|Overall Study|Protocol Violation|0
4826664|NCT01131078|16641185|P2|Overall Study|Protocol Violation|0
4826665|NCT01131078|16641186|P1|Overall Study|Protocol Violation|1
4826666|NCT01131078|16641184|P3|Overall Study|Progressive Disease|71
4826667|NCT01131078|16641185|P2|Overall Study|Progressive Disease|77
4826668|NCT01131078|16641186|P1|Overall Study|Progressive Disease|58
4826669|NCT01131078|16641184|P3|Overall Study|Adverse Event|17
4826670|NCT01131078|16641185|P2|Overall Study|Adverse Event|12
4826671|NCT01131078|16641186|P1|Overall Study|Adverse Event|22
4826672|NCT01130974|16641273|P2|Overall Study|Ineligibility criteria|2
4826673|NCT01130974|16641274|P1|Overall Study|Ineligibility criteria|5
4826674|NCT01130974|16641273|P2|Overall Study|Withdrawal by Subject|1
4826675|NCT01130974|16641274|P1|Overall Study|Withdrawal by Subject|0
4826676|NCT01130974|16641273|P2|Overall Study|Protocol Violation|10
4826677|NCT01130974|16641274|P1|Overall Study|Protocol Violation|10
4826678|NCT01130883|16641300|P1|Overall Study|Adverse Event|3
4826679|NCT01130883|16641300|P1|Overall Study|Reason Unknown|1
4826680|NCT01130883|16641300|P1|Overall Study|Patient Noncompliance|6
4826681|NCT01130831|16641357|P1|Overall Study|Information was missing|3
4826682|NCT01130831|16641357|P1|Overall Study|Death|4
4826683|NCT01130831|16641357|P1|Overall Study|Withdrawal by Subject|7
4826684|NCT01130597|16641396|P1|Overall Study|Protocol Violation|1
4826685|NCT01130597|16641396|P1|Overall Study|Death|1
4826686|NCT01130597|16641396|P1|Overall Study|Adverse Event|4
4826687|NCT01130597|16641396|P1|Overall Study|Protocol-specified (High K+)|1
4826688|NCT01130532|16641421|P4|Period IV (Weeks 13-16)|Withdrawal by Subject|3
4826689|NCT01130532|16641422|P3|Period IV (Weeks 13-16)|Withdrawal by Subject|0
4826690|NCT01130532|16641423|P2|Period IV (Weeks 13-16)|Withdrawal by Subject|0
4826691|NCT01130532|16641424|P1|Period IV (Weeks 13-16)|Withdrawal by Subject|0
4826692|NCT01130532|16641421|P4|Period IV (Weeks 13-16)|Lost to Follow-up|5
4826693|NCT01130532|16641422|P3|Period IV (Weeks 13-16)|Lost to Follow-up|0
4826694|NCT01130532|16641423|P2|Period IV (Weeks 13-16)|Lost to Follow-up|0
4826695|NCT01130532|16641424|P1|Period IV (Weeks 13-16)|Lost to Follow-up|0
4826696|NCT01130532|16641421|P4|Period IV (Weeks 13-16)|Entry Criteria Not Met|1
4826697|NCT01130532|16641422|P3|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
4826698|NCT01130532|16641423|P2|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
4826699|NCT01130532|16641424|P1|Period IV (Weeks 13-16)|Entry Criteria Not Met|0
4826700|NCT01130532|16641421|P4|Period IV (Weeks 13-16)|Adverse Event|1
4826701|NCT01130532|16641422|P3|Period IV (Weeks 13-16)|Adverse Event|0
4826702|NCT01130532|16641423|P2|Period IV (Weeks 13-16)|Adverse Event|0
4826703|NCT01130532|16641424|P1|Period IV (Weeks 13-16)|Adverse Event|0
4826704|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Withdrawal by Subject|0
4826705|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Withdrawal by Subject|6
4826706|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Withdrawal by Subject|7
4826707|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Withdrawal by Subject|7
4826708|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Sponsor Decision|0
4826709|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Sponsor Decision|2
4826710|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Sponsor Decision|4
4826711|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Sponsor Decision|3
4826712|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Protocol Violation|0
4826713|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Protocol Violation|1
4826714|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Protocol Violation|0
4826715|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Protocol Violation|0
4826716|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Lost to Follow-up|0
4826717|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Lost to Follow-up|3
4826718|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Lost to Follow-up|2
4826719|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Lost to Follow-up|2
4826720|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Lack of Efficacy|0
4826721|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Lack of Efficacy|1
4826722|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Lack of Efficacy|0
4826723|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Lack of Efficacy|2
4826724|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Entry Criteria Not Met|0
4826725|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Entry Criteria Not Met|4
4826726|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Entry Criteria Not Met|2
4826727|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Entry Criteria Not Met|4
4826728|NCT01130532|16641421|P4|Period III (Weeks 0-12)|Adverse Event|0
4826729|NCT01130532|16641422|P3|Period III (Weeks 0-12)|Adverse Event|2
4826730|NCT01130532|16641423|P2|Period III (Weeks 0-12)|Adverse Event|3
4826731|NCT01130532|16641424|P1|Period III (Weeks 0-12)|Adverse Event|3
4826732|NCT01130493|16641469|P3|Part 2: OLE|Withdrawal by Subject|4
4826733|NCT01130493|16641470|P2|Part 2: OLE|Withdrawal by Subject|1
4826734|NCT01130493|16641471|P1|Part 2: OLE|Withdrawal by Subject|0
4826735|NCT01130493|16641469|P3|Part 2: OLE|Adverse Event|1
4826736|NCT01130493|16641470|P2|Part 2: OLE|Adverse Event|2
4826737|NCT01130493|16641471|P1|Part 2: OLE|Adverse Event|0
4826738|NCT01130493|16641469|P3|Part 1: Double-blind Treatment Period 2|Noncompliance|1
4826739|NCT01130493|16641470|P2|Part 1: Double-blind Treatment Period 2|Noncompliance|0
4826740|NCT01130493|16641471|P1|Part 1: Double-blind Treatment Period 2|Noncompliance|0
4826741|NCT01130493|16641469|P3|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1
4826742|NCT01130493|16641470|P2|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
4826743|NCT01130493|16641471|P1|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0
4826744|NCT01130493|16641469|P3|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1
4826745|NCT01130493|16641470|P2|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
4826746|NCT01130493|16641471|P1|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0
4826747|NCT01130493|16641469|P3|Part 1: Open-Label IPX066 Washout|Adverse Event|1
4826748|NCT01130493|16641470|P2|Part 1: Open-Label IPX066 Washout|Adverse Event|0
4826749|NCT01130493|16641471|P1|Part 1: Open-Label IPX066 Washout|Adverse Event|0
4826750|NCT01130493|16641469|P3|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
4826751|NCT01130493|16641470|P2|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1
4826752|NCT01130493|16641471|P1|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0
4826753|NCT01130493|16641469|P3|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
4826754|NCT01130493|16641470|P2|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1
4826755|NCT01130493|16641471|P1|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0
4826756|NCT01130493|16641469|P3|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
4826757|NCT01130493|16641470|P2|Part 1: Double-blind Treatment Period 1|Protocol Violation|1
4826758|NCT01130493|16641471|P1|Part 1: Double-blind Treatment Period 1|Protocol Violation|0
4826759|NCT01130493|16641469|P3|Open-label Dose Conversion to IPX066|Diary imcomplete|0
4826760|NCT01130493|16641470|P2|Open-label Dose Conversion to IPX066|Diary imcomplete|0
4826761|NCT01130493|16641471|P1|Open-label Dose Conversion to IPX066|Diary imcomplete|1
4826762|NCT01130493|16641469|P3|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
4826763|NCT01130493|16641470|P2|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0
4826764|NCT01130493|16641471|P1|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7
4826765|NCT01130493|16641469|P3|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
4826766|NCT01130493|16641470|P2|Open-label Dose Conversion to IPX066|Lack of Efficacy|0
4826767|NCT01130493|16641471|P1|Open-label Dose Conversion to IPX066|Lack of Efficacy|7
4826768|NCT01130493|16641469|P3|Open-label Dose Conversion to IPX066|Protocol Violation|0
4826769|NCT01130493|16641470|P2|Open-label Dose Conversion to IPX066|Protocol Violation|0
4826770|NCT01130493|16641471|P1|Open-label Dose Conversion to IPX066|Protocol Violation|3
4826771|NCT01130493|16641469|P3|Open-label Dose Conversion to IPX066|Adverse Event|0
4826772|NCT01130493|16641470|P2|Open-label Dose Conversion to IPX066|Adverse Event|0
4826773|NCT01130493|16641471|P1|Open-label Dose Conversion to IPX066|Adverse Event|1
4826774|NCT01130337|16641488|P1|Overall Study|Surgical resection (R2)|1
4826775|NCT01130337|16641488|P1|Overall Study|Toxicity, AE/intercurrent disease|7
4826776|NCT01130337|16641488|P1|Overall Study|Disease progression|1
4826777|NCT01130337|16641488|P1|Overall Study|Death|1
4826778|NCT01130337|16641488|P1|Overall Study|Principal investigator decision|1
4826779|NCT01130337|16641488|P1|Overall Study|Withdrawal by Subject|3
4826780|NCT01130272|16641500|P5|Overall Study|Study arm discontinued|0
4826781|NCT01130272|16641501|P4|Overall Study|Study arm discontinued|0
4826782|NCT01130272|16641502|P3|Overall Study|Study arm discontinued|0
4826783|NCT01130272|16641503|P2|Overall Study|Study arm discontinued|0
4826784|NCT01130272|16641504|P1|Overall Study|Study arm discontinued|38
4826785|NCT01130272|16641500|P5|Overall Study|Sponsor decision|16
4826786|NCT01130272|16641501|P4|Overall Study|Sponsor decision|13
4826787|NCT01130272|16641502|P3|Overall Study|Sponsor decision|16
4826788|NCT01130272|16641503|P2|Overall Study|Sponsor decision|15
4826789|NCT01130272|16641504|P1|Overall Study|Sponsor decision|6
4826790|NCT01130272|16641500|P5|Overall Study|Physician Decision|2
4826791|NCT01130272|16641501|P4|Overall Study|Physician Decision|1
4826792|NCT01130272|16641502|P3|Overall Study|Physician Decision|0
4826793|NCT01130272|16641503|P2|Overall Study|Physician Decision|1
4826794|NCT01130272|16641504|P1|Overall Study|Physician Decision|1
4826795|NCT01130272|16641500|P5|Overall Study|Withdrawal by Subject|8
4826796|NCT01130272|16641501|P4|Overall Study|Withdrawal by Subject|9
4826797|NCT01130272|16641502|P3|Overall Study|Withdrawal by Subject|10
4826798|NCT01130272|16641503|P2|Overall Study|Withdrawal by Subject|11
4826799|NCT01130272|16641504|P1|Overall Study|Withdrawal by Subject|4
4826800|NCT01130272|16641500|P5|Overall Study|Lost to Follow-up|6
4826801|NCT01130272|16641501|P4|Overall Study|Lost to Follow-up|7
4826802|NCT01130272|16641502|P3|Overall Study|Lost to Follow-up|4
4826803|NCT01130272|16641503|P2|Overall Study|Lost to Follow-up|3
4826804|NCT01130272|16641504|P1|Overall Study|Lost to Follow-up|4
4826805|NCT01130272|16641500|P5|Overall Study|Protocol Violation|5
4826806|NCT01130272|16641501|P4|Overall Study|Protocol Violation|5
4826807|NCT01130272|16641502|P3|Overall Study|Protocol Violation|3
4826808|NCT01130272|16641503|P2|Overall Study|Protocol Violation|0
4826809|NCT01130272|16641504|P1|Overall Study|Protocol Violation|0
4826810|NCT01130272|16641500|P5|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4826811|NCT01130272|16641501|P4|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1
4826812|NCT01130272|16641502|P3|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4826813|NCT01130272|16641503|P2|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4826814|NCT01130272|16641504|P1|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0
4826815|NCT01130272|16641500|P5|Overall Study|Lack of efficacy- uncontrolled diarrhea|2
4826816|NCT01130272|16641501|P4|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
4826817|NCT01130272|16641502|P3|Overall Study|Lack of efficacy- uncontrolled diarrhea|0
4826818|NCT01130272|16641503|P2|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
4826819|NCT01130272|16641504|P1|Overall Study|Lack of efficacy- uncontrolled diarrhea|1
4826820|NCT01130272|16641500|P5|Overall Study|Rescue medications due to diarrhea|6
4826821|NCT01130272|16641501|P4|Overall Study|Rescue medications due to diarrhea|8
4826822|NCT01130272|16641502|P3|Overall Study|Rescue medications due to diarrhea|8
4826823|NCT01130272|16641503|P2|Overall Study|Rescue medications due to diarrhea|5
4826824|NCT01130272|16641504|P1|Overall Study|Rescue medications due to diarrhea|3
4826825|NCT01130272|16641500|P5|Overall Study|IVRS-confirmed constipation|0
4826826|NCT01130272|16641501|P4|Overall Study|IVRS-confirmed constipation|2
4826827|NCT01130272|16641502|P3|Overall Study|IVRS-confirmed constipation|1
4826828|NCT01130272|16641503|P2|Overall Study|IVRS-confirmed constipation|1
4826829|NCT01130272|16641504|P1|Overall Study|IVRS-confirmed constipation|0
4826830|NCT01130272|16641500|P5|Overall Study|Adverse Event|7
4826831|NCT01130272|16641501|P4|Overall Study|Adverse Event|22
4826832|NCT01130272|16641502|P3|Overall Study|Adverse Event|6
4826833|NCT01130272|16641503|P2|Overall Study|Adverse Event|5
4826834|NCT01130272|16641504|P1|Overall Study|Adverse Event|2
4826835|NCT01130168|16641541|P6|Period 1|Adverse Event|0
4826836|NCT01130168|16641542|P5|Period 1|Adverse Event|0
4826837|NCT01130168|16641543|P4|Period 1|Adverse Event|1
4826838|NCT01130168|16641544|P3|Period 1|Adverse Event|0
4826839|NCT01130168|16641545|P2|Period 1|Adverse Event|0
4826840|NCT01130168|16641546|P1|Period 1|Adverse Event|0
4826841|NCT01130168|16641541|P6|Period 1|Discontinued For Other Reason|0
4826842|NCT01130168|16641542|P5|Period 1|Discontinued For Other Reason|0
4826843|NCT01130168|16641543|P4|Period 1|Discontinued For Other Reason|1
4826844|NCT01130168|16641544|P3|Period 1|Discontinued For Other Reason|1
4826845|NCT01130168|16641545|P2|Period 1|Discontinued For Other Reason|0
4826846|NCT01130168|16641546|P1|Period 1|Discontinued For Other Reason|0
4826847|NCT01130168|16641541|P6|Period 1|Withdrawal by Subject|0
4826848|NCT01130168|16641542|P5|Period 1|Withdrawal by Subject|0
4826849|NCT01130168|16641543|P4|Period 1|Withdrawal by Subject|1
4826850|NCT01130168|16641544|P3|Period 1|Withdrawal by Subject|0
4826851|NCT01130168|16641545|P2|Period 1|Withdrawal by Subject|1
4826852|NCT01130168|16641546|P1|Period 1|Withdrawal by Subject|0
4826853|NCT01130103|16641583|P2|Maintenance Treatment|Withdrawal by Subject|0
4826854|NCT01130103|16641584|P1|Maintenance Treatment|Withdrawal by Subject|1
4826855|NCT01130103|16641583|P2|Maintenance Treatment|Lost to Follow-up|1
4826856|NCT01130103|16641584|P1|Maintenance Treatment|Lost to Follow-up|1
4826857|NCT01130103|16641583|P2|Maintenance Treatment|Lack of Efficacy|1
4826858|NCT01130103|16641584|P1|Maintenance Treatment|Lack of Efficacy|0
4826859|NCT01130103|16641583|P2|Randomized Treatment|Withdrawal by Subject|2
4826860|NCT01130103|16641584|P1|Randomized Treatment|Withdrawal by Subject|1
4826861|NCT01130103|16641583|P2|Randomized Treatment|Protocol Violation|2
4826862|NCT01130103|16641584|P1|Randomized Treatment|Protocol Violation|3
4826863|NCT01130103|16641583|P2|Randomized Treatment|Lost to Follow-up|0
4826864|NCT01130103|16641584|P1|Randomized Treatment|Lost to Follow-up|1
4826865|NCT01130103|16641583|P2|Randomized Treatment|Adverse Event|1
4826866|NCT01130103|16641584|P1|Randomized Treatment|Adverse Event|1
4826867|NCT01130051|16641598|P2|Washout Period of 14 Days|Protocol Violation|1
4826868|NCT01130051|16641599|P1|Washout Period of 14 Days|Protocol Violation|1
4826869|NCT01130051|16641598|P2|Washout Period of 14 Days|Withdrawal by Subject|1
4826870|NCT01130051|16641599|P1|Washout Period of 14 Days|Withdrawal by Subject|0
4826871|NCT01129960|16641613|P4|Overall Study|Pregnancy|0
4826872|NCT01129960|16641614|P3|Overall Study|Pregnancy|0
4826873|NCT01129960|16641615|P2|Overall Study|Pregnancy|0
4826874|NCT01129960|16641616|P1|Overall Study|Pregnancy|1
4826875|NCT01129960|16641613|P4|Overall Study|Physician Decision|0
4826876|NCT01129960|16641614|P3|Overall Study|Physician Decision|0
4826877|NCT01129960|16641615|P2|Overall Study|Physician Decision|0
4826878|NCT01129960|16641616|P1|Overall Study|Physician Decision|1
4826879|NCT01129960|16641613|P4|Overall Study|Discontinuation of the study by Sponsor|0
4826880|NCT01129960|16641614|P3|Overall Study|Discontinuation of the study by Sponsor|0
4826881|NCT01129960|16641615|P2|Overall Study|Discontinuation of the study by Sponsor|1
4826882|NCT01129960|16641616|P1|Overall Study|Discontinuation of the study by Sponsor|0
4826883|NCT01129960|16641613|P4|Overall Study|Lost to Follow-up|3
4826884|NCT01129960|16641614|P3|Overall Study|Lost to Follow-up|3
4826885|NCT01129960|16641615|P2|Overall Study|Lost to Follow-up|2
4826886|NCT01129960|16641616|P1|Overall Study|Lost to Follow-up|0
4826887|NCT01129960|16641613|P4|Overall Study|Protocol Violation|0
4826888|NCT01129960|16641614|P3|Overall Study|Protocol Violation|3
4826889|NCT01129960|16641615|P2|Overall Study|Protocol Violation|2
4826890|NCT01129960|16641616|P1|Overall Study|Protocol Violation|1
4826891|NCT01129960|16641613|P4|Overall Study|Adverse Event|7
4826892|NCT01129960|16641614|P3|Overall Study|Adverse Event|16
4826893|NCT01129960|16641615|P2|Overall Study|Adverse Event|16
4826894|NCT01129960|16641616|P1|Overall Study|Adverse Event|23
4826895|NCT01129960|16641613|P4|Overall Study|Lack of Efficacy|1
4826896|NCT01129960|16641614|P3|Overall Study|Lack of Efficacy|1
4826897|NCT01129960|16641615|P2|Overall Study|Lack of Efficacy|1
4826898|NCT01129960|16641616|P1|Overall Study|Lack of Efficacy|1
4826899|NCT01129960|16641613|P4|Overall Study|Withdrawal by Subject|2
4826900|NCT01129960|16641614|P3|Overall Study|Withdrawal by Subject|3
4826901|NCT01129960|16641615|P2|Overall Study|Withdrawal by Subject|0
4826902|NCT01129960|16641616|P1|Overall Study|Withdrawal by Subject|3
4826903|NCT01129921|16641628|P2|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1
4826904|NCT01129921|16641629|P1|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0
4826905|NCT01129921|16641628|P2|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4
4826906|NCT01129921|16641629|P1|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0
4826907|NCT01129921|16641628|P2|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1
4826908|NCT01129921|16641629|P1|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0
4826909|NCT01129921|16641628|P2|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1
4826910|NCT01129921|16641629|P1|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2
4826911|NCT01129882|16641639|P1|Overall Study|Withdrawal by Subject|160
4826912|NCT01129882|16641639|P1|Overall Study|Trial Termination by Sponsor|6
4826913|NCT01129882|16641639|P1|Overall Study|Withdrawal Criteria Met|19
4826914|NCT01129882|16641639|P1|Overall Study|Protocol Deviation|3
4826915|NCT01129882|16641639|P1|Overall Study|Physician Decision|27
4826916|NCT01129882|16641639|P1|Overall Study|Lost to Follow-up|13
4826917|NCT01129882|16641639|P1|Overall Study|Lack of Efficacy|5
4826918|NCT01129882|16641639|P1|Overall Study|Death|6
4826919|NCT01129882|16641639|P1|Overall Study|Adverse Event|39
4826920|NCT01129622|16641658|P1|Overall Study|Withdrawal by Subject|2
4826921|NCT01129583|16641669|P2|Overall Study|Ipsilateral Upper Extremity Injury|1
4826922|NCT01129583|16641670|P1|Overall Study|Ipsilateral Upper Extremity Injury|1
4826923|NCT01129583|16641669|P2|Overall Study|Lost to Follow-up|1
4826924|NCT01129583|16641670|P1|Overall Study|Lost to Follow-up|1
4826925|NCT01129583|16641669|P2|Overall Study|Death|0
4826926|NCT01129583|16641670|P1|Overall Study|Death|1
4826927|NCT01129557|16641683|P3|Overall Study|Novartis terminated study early|2
4826928|NCT01129557|16641684|P2|Overall Study|Novartis terminated study early|3
4826929|NCT01129557|16641685|P1|Overall Study|Novartis terminated study early|3
4826930|NCT01129557|16641683|P3|Overall Study|Adverse Event|2
4826931|NCT01129557|16641684|P2|Overall Study|Adverse Event|2
4826932|NCT01129557|16641685|P1|Overall Study|Adverse Event|1
4826933|NCT01129336|16641798|P2|Overall Study|Death|4
4826934|NCT01129336|16641799|P1|Overall Study|Death|0
4826935|NCT01129336|16641798|P2|Overall Study|Missing Study Completion Status|3
4826936|NCT01129336|16641799|P1|Overall Study|Missing Study Completion Status|2
4826937|NCT01129336|16641798|P2|Overall Study|Adverse Event|1
4826938|NCT01129336|16641799|P1|Overall Study|Adverse Event|0
4826939|NCT01129336|16641798|P2|Overall Study|Withdrawal by Subject|4
4826940|NCT01129336|16641799|P1|Overall Study|Withdrawal by Subject|7
4826941|NCT01129336|16641798|P2|Overall Study|Lost to Follow-up|0
4826942|NCT01129336|16641799|P1|Overall Study|Lost to Follow-up|1
4826943|NCT01129336|16641798|P2|Overall Study|Disease Progression|4
4826944|NCT01129336|16641799|P1|Overall Study|Disease Progression|1
4826945|NCT01129336|16641798|P2|Overall Study|Protocol Violation|0
4826946|NCT01129336|16641799|P1|Overall Study|Protocol Violation|1
4826947|NCT01129284|16641814|P3|Overall Study|Adverse Event|1
4826948|NCT01129284|16641815|P2|Overall Study|Adverse Event|0
4826949|NCT01129284|16641816|P1|Overall Study|Adverse Event|2
4826950|NCT01129128|16641864|P3|Overall Study|Physician Decision|0
4826951|NCT01129128|16641865|P2|Overall Study|Physician Decision|0
4826952|NCT01129128|16641866|P1|Overall Study|Physician Decision|1
4826953|NCT01129128|16641864|P3|Overall Study|Withdrawal by Subject|3
4826954|NCT01129128|16641865|P2|Overall Study|Withdrawal by Subject|1
4826955|NCT01129128|16641866|P1|Overall Study|Withdrawal by Subject|0
4826956|NCT01129128|16641864|P3|Overall Study|Protocol Violation|0
4826957|NCT01129128|16641865|P2|Overall Study|Protocol Violation|1
4826958|NCT01129128|16641866|P1|Overall Study|Protocol Violation|0
4826959|NCT01129128|16641864|P3|Overall Study|Lost to Follow-up|1
4826960|NCT01129128|16641865|P2|Overall Study|Lost to Follow-up|2
4826961|NCT01129128|16641866|P1|Overall Study|Lost to Follow-up|2
4826962|NCT01129115|16641890|P4|Overall Study|Protocol Violation|2
4826963|NCT01129115|16641891|P3|Overall Study|Protocol Violation|2
4826964|NCT01129115|16641892|P2|Overall Study|Protocol Violation|2
4826965|NCT01129115|16641893|P1|Overall Study|Protocol Violation|0
4826966|NCT01129115|16641890|P4|Overall Study|Withdrawal by Subject|4
4826967|NCT01129115|16641891|P3|Overall Study|Withdrawal by Subject|1
4826968|NCT01129115|16641892|P2|Overall Study|Withdrawal by Subject|3
4826969|NCT01129115|16641893|P1|Overall Study|Withdrawal by Subject|1
4826970|NCT01129115|16641890|P4|Overall Study|Adverse Event|3
4826971|NCT01129115|16641891|P3|Overall Study|Adverse Event|3
4826972|NCT01129115|16641892|P2|Overall Study|Adverse Event|2
4826973|NCT01129115|16641893|P1|Overall Study|Adverse Event|1
4826974|NCT01129102|16641930|P3|Overall Study|Lost to Follow-up|0
4826975|NCT01129102|16641931|P2|Overall Study|Lost to Follow-up|0
4826976|NCT01129102|16641932|P1|Overall Study|Lost to Follow-up|2
4826977|NCT01129102|16641930|P3|Overall Study|Adverse Event|1
4826978|NCT01129102|16641931|P2|Overall Study|Adverse Event|2
4826979|NCT01129102|16641932|P1|Overall Study|Adverse Event|2
4826980|NCT01129102|16641930|P3|Overall Study|Pregnancy|1
4826981|NCT01129102|16641931|P2|Overall Study|Pregnancy|0
4826982|NCT01129102|16641932|P1|Overall Study|Pregnancy|0
4826983|NCT01129102|16641930|P3|Overall Study|Protocol Violation|1
4826984|NCT01129102|16641931|P2|Overall Study|Protocol Violation|1
4826985|NCT01129102|16641932|P1|Overall Study|Protocol Violation|0
4826986|NCT01129102|16641930|P3|Overall Study|Withdrawal by Subject|3
4826987|NCT01129102|16641931|P2|Overall Study|Withdrawal by Subject|0
4826988|NCT01129102|16641932|P1|Overall Study|Withdrawal by Subject|2
4826989|NCT01129102|16641930|P3|Overall Study|No study drug treatment|1
4826990|NCT01129102|16641931|P2|Overall Study|No study drug treatment|3
4826991|NCT01129102|16641932|P1|Overall Study|No study drug treatment|2
4826992|NCT01129011|16641943|P2|Overall Study|misc|4
4826993|NCT01129011|16641944|P1|Overall Study|misc|7
4826994|NCT01129011|16641943|P2|Overall Study|Duodenal Ulcer|8
4826995|NCT01129011|16641944|P1|Overall Study|Duodenal Ulcer|2
4826996|NCT01129011|16641943|P2|Overall Study|Lost to Follow-up|7
4826997|NCT01129011|16641944|P1|Overall Study|Lost to Follow-up|6
4826998|NCT01129011|16641943|P2|Overall Study|Withdrawal by Subject|8
4826999|NCT01129011|16641944|P1|Overall Study|Withdrawal by Subject|24
4827000|NCT01129011|16641943|P2|Overall Study|Adverse Event|30
4827001|NCT01129011|16641944|P1|Overall Study|Adverse Event|20
4827002|NCT01128959|16641999|P1|Treatment Period|Withdrawal by Subject|1
4827003|NCT01128959|16641999|P1|Treatment Period|Adverse Event|3
4827004|NCT01128959|16641999|P1|Lead in Period|Adverse Event|3
4827005|NCT01128946|16642005|P4|Period III|Protocol Violation|0
4827006|NCT01128946|16642006|P3|Period III|Protocol Violation|0
4827007|NCT01128946|16642007|P2|Period III|Protocol Violation|0
4827008|NCT01128946|16642008|P1|Period III|Protocol Violation|1
4827009|NCT01128946|16642005|P4|Period II|Withdrawal by Subject|1
4827010|NCT01128946|16642006|P3|Period II|Withdrawal by Subject|0
4827011|NCT01128946|16642007|P2|Period II|Withdrawal by Subject|0
4827012|NCT01128946|16642008|P1|Period II|Withdrawal by Subject|0
4827013|NCT01128946|16642005|P4|Period II|Protocol Violation|0
4827014|NCT01128946|16642006|P3|Period II|Protocol Violation|0
4827015|NCT01128946|16642007|P2|Period II|Protocol Violation|1
4827016|NCT01128946|16642008|P1|Period II|Protocol Violation|0
4827017|NCT01128946|16642005|P4|Period I|Withdrawal by Subject|1
4827018|NCT01128946|16642006|P3|Period I|Withdrawal by Subject|1
4827019|NCT01128946|16642007|P2|Period I|Withdrawal by Subject|0
4827020|NCT01128946|16642008|P1|Period I|Withdrawal by Subject|0
4827021|NCT01128946|16642005|P4|Period I|Protocol Violation|0
4827022|NCT01128946|16642006|P3|Period I|Protocol Violation|0
4827023|NCT01128946|16642007|P2|Period I|Protocol Violation|1
4827024|NCT01128946|16642008|P1|Period I|Protocol Violation|0
4827025|NCT01128894|16642026|P2|Overall Study|Conflicting HbA1c Results at Screening|0
4827026|NCT01128894|16642027|P1|Overall Study|Conflicting HbA1c Results at Screening|1
4827027|NCT01128894|16642026|P2|Overall Study|Physician Decision|1
4827028|NCT01128894|16642027|P1|Overall Study|Physician Decision|2
4827029|NCT01128894|16642026|P2|Overall Study|Withdrawal by Subject|12
4827030|NCT01128894|16642027|P1|Overall Study|Withdrawal by Subject|10
4827031|NCT01128894|16642026|P2|Overall Study|Lost to Follow-up|8
4827032|NCT01128894|16642027|P1|Overall Study|Lost to Follow-up|8
4827033|NCT01128894|16642026|P2|Overall Study|Noncompliance|5
4827034|NCT01128894|16642027|P1|Overall Study|Noncompliance|4
4827035|NCT01128894|16642026|P2|Overall Study|Protocol Violation|1
4827036|NCT01128894|16642027|P1|Overall Study|Protocol Violation|2
4827037|NCT01128894|16642026|P2|Overall Study|Adverse Event|41
4827038|NCT01128894|16642027|P1|Overall Study|Adverse Event|31
4827039|NCT01128842|16642045|P1|Overall Study|Disease Progression|6
4827040|NCT01128842|16642045|P1|Overall Study|Adverse Event|1
4827041|NCT01128738|16642062|P2|Second TP|Withdrawal by Subject|2
4827042|NCT01128738|16642063|P1|Second TP|Withdrawal by Subject|0
4827043|NCT01128738|16642062|P2|Second TP|Lost to Follow-up|1
4827044|NCT01128738|16642063|P1|Second TP|Lost to Follow-up|0
4827045|NCT01128738|16642062|P2|First Treatment Phase (TP)|Withdrawal by Subject|1
4827046|NCT01128738|16642063|P1|First Treatment Phase (TP)|Withdrawal by Subject|3
4827047|NCT01128738|16642062|P2|First Treatment Phase (TP)|Lost to Follow-up|0
4827048|NCT01128738|16642063|P1|First Treatment Phase (TP)|Lost to Follow-up|1
4827049|NCT01128621|16642188|P2|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2
4827050|NCT01128621|16642189|P1|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0
4827051|NCT01128595|16642310|P4|Treatment Period 3|Withdrawal by Subject|0
4827052|NCT01128595|16642311|P3|Treatment Period 3|Withdrawal by Subject|0
4827053|NCT01128595|16642312|P2|Treatment Period 3|Withdrawal by Subject|1
4827054|NCT01128595|16642313|P1|Treatment Period 3|Withdrawal by Subject|0
4827055|NCT01128569|16642343|P6|Treatment Period 2|Withdrawal by Subject|0
4827056|NCT01128569|16642344|P5|Treatment Period 2|Withdrawal by Subject|0
4827057|NCT01128569|16642345|P4|Treatment Period 2|Withdrawal by Subject|0
4827058|NCT01128569|16642346|P3|Treatment Period 2|Withdrawal by Subject|0
4827059|NCT01128569|16642347|P2|Treatment Period 2|Withdrawal by Subject|1
4827060|NCT01128569|16642348|P1|Treatment Period 2|Withdrawal by Subject|0
4827061|NCT01128569|16642343|P6|Washout Period 1|Adverse Event|0
4827062|NCT01128569|16642344|P5|Washout Period 1|Adverse Event|0
4827063|NCT01128569|16642345|P4|Washout Period 1|Adverse Event|0
4827064|NCT01128569|16642346|P3|Washout Period 1|Adverse Event|1
4827065|NCT01128569|16642347|P2|Washout Period 1|Adverse Event|0
4827066|NCT01128569|16642348|P1|Washout Period 1|Adverse Event|0
4827067|NCT01128543|16642365|P1|Overall Study|Protocol Violation|1
4827068|NCT01128543|16642365|P1|Overall Study|Withdrawal by Subject|3
4827069|NCT01128413|16642391|P2|Overall Study|Pt made DNR|0
4827070|NCT01128413|16642392|P1|Overall Study|Pt made DNR|1
4827071|NCT01128413|16642391|P2|Overall Study|NICOM Monitor Problems|1
4827072|NCT01128413|16642392|P1|Overall Study|NICOM Monitor Problems|2
4827073|NCT01128413|16642391|P2|Overall Study|Withdrawal by Subject|0
4827074|NCT01128413|16642392|P1|Overall Study|Withdrawal by Subject|1
4827075|NCT01128400|16642401|P3|Overall Study|Excluded due to sinus problems|0
4827076|NCT01128400|16642402|P2|Overall Study|Excluded due to sinus problems|1
4827077|NCT01128400|16642403|P1|Overall Study|Excluded due to sinus problems|0
4827078|NCT01128400|16642401|P3|Overall Study|were not invited to participate on taste|15
4827079|NCT01128400|16642402|P2|Overall Study|were not invited to participate on taste|0
4827080|NCT01128400|16642403|P1|Overall Study|were not invited to participate on taste|0
4827081|NCT01128400|16642401|P3|Overall Study|Screening failure|0
4827082|NCT01128400|16642402|P2|Overall Study|Screening failure|0
4827083|NCT01128400|16642403|P1|Overall Study|Screening failure|1
4827084|NCT01128400|16642401|P3|Overall Study|Lost to Follow-up|1
4827085|NCT01128400|16642402|P2|Overall Study|Lost to Follow-up|0
4827086|NCT01128400|16642403|P1|Overall Study|Lost to Follow-up|1
4827087|NCT01128387|16642416|P2|Overall Study|Physician Decision|1
4827088|NCT01128387|16642417|P1|Overall Study|Physician Decision|0
4827089|NCT01128361|16642427|P2|Overall Study|Withdrawal by Subject|2
4827090|NCT01128361|16642428|P1|Overall Study|Withdrawal by Subject|5
4827091|NCT01128361|16642427|P2|Overall Study|Lost to Follow-up|1
4827092|NCT01128361|16642428|P1|Overall Study|Lost to Follow-up|0
4827093|NCT01128296|16642440|P6|Overall Study|Withdrawal by Subject|2
4827094|NCT01128296|16642441|P5|Overall Study|Withdrawal by Subject|0
4827095|NCT01128296|16642442|P4|Overall Study|Withdrawal by Subject|0
4827096|NCT01128296|16642443|P3|Overall Study|Withdrawal by Subject|0
4827097|NCT01128296|16642444|P2|Overall Study|Withdrawal by Subject|0
4827098|NCT01128296|16642445|P1|Overall Study|Withdrawal by Subject|0
4827099|NCT01128296|16642440|P6|Overall Study|Physician Decision|3
4827100|NCT01128296|16642441|P5|Overall Study|Physician Decision|0
4827101|NCT01128296|16642442|P4|Overall Study|Physician Decision|0
4827102|NCT01128296|16642443|P3|Overall Study|Physician Decision|0
4827103|NCT01128296|16642444|P2|Overall Study|Physician Decision|0
4827104|NCT01128296|16642445|P1|Overall Study|Physician Decision|0
4827105|NCT01128244|16642476|P1|Overall Study|Scheduling conflict|2
4827106|NCT01128244|16642476|P1|Overall Study|Adverse Event|1
4827107|NCT01128179|16642517|P2|Overall Study|Protocol Violation|0
4827108|NCT01128179|16642518|P1|Overall Study|Protocol Violation|1
4827109|NCT01128179|16642517|P2|Overall Study|Death|0
4827110|NCT01128179|16642518|P1|Overall Study|Death|1
4827111|NCT01128153|16642538|P2|Overall Study|Developed discontinuation criteria|1
4827112|NCT01128153|16642539|P1|Overall Study|Developed discontinuation criteria|1
4827113|NCT01128153|16642538|P2|Overall Study|Protocol Violation|0
4827114|NCT01128153|16642539|P1|Overall Study|Protocol Violation|2
4827115|NCT01128153|16642538|P2|Overall Study|Incorrect enrolment to study|1
4827116|NCT01128153|16642539|P1|Overall Study|Incorrect enrolment to study|2
4827117|NCT01128153|16642538|P2|Overall Study|Withdrawal by Subject|3
4827118|NCT01128153|16642539|P1|Overall Study|Withdrawal by Subject|2
4827119|NCT01128153|16642538|P2|Overall Study|Condition under investigation worsened|7
4827120|NCT01128153|16642539|P1|Overall Study|Condition under investigation worsened|8
4827121|NCT01128153|16642538|P2|Overall Study|Adverse Event|3
4827122|NCT01128153|16642539|P1|Overall Study|Adverse Event|1
4827123|NCT01128114|16642555|P1|Overall Study|Screening Failed|2
4827124|NCT01128114|16642555|P1|Overall Study|Treatment Withdrawn|6
4827125|NCT01127763|16642572|P1|Overall Study|Physician Decision|2
4827126|NCT01127763|16642572|P1|Overall Study|Withdrawal by Subject|1
4827127|NCT01127763|16642572|P1|Overall Study|Adverse Event|2
4827128|NCT01127646|16642617|P2|Overall Study|Protocol Violation|1
4827129|NCT01127646|16642618|P1|Overall Study|Protocol Violation|0
4827130|NCT01127646|16642617|P2|Overall Study|Entry Criteria Not Met|0
4827131|NCT01127646|16642618|P1|Overall Study|Entry Criteria Not Met|1
4827132|NCT01127633|16642652|P2|Overall Study|Not treated|0
4827133|NCT01127633|16642653|P1|Overall Study|Not treated|1
4827134|NCT01127633|16642652|P2|Overall Study|Abnormal Lab/ECG Result|1
4827135|NCT01127633|16642653|P1|Overall Study|Abnormal Lab/ECG Result|0
4827136|NCT01127633|16642652|P2|Overall Study|Protocol Violation|16
4827137|NCT01127633|16642653|P1|Overall Study|Protocol Violation|8
4827138|NCT01127633|16642652|P2|Overall Study|Sponsor Decision|195
4827139|NCT01127633|16642653|P1|Overall Study|Sponsor Decision|163
4827140|NCT01127633|16642652|P2|Overall Study|Withdrawal by Subject|72
4827141|NCT01127633|16642653|P1|Overall Study|Withdrawal by Subject|57
4827142|NCT01127633|16642652|P2|Overall Study|Physician Decision|45
4827143|NCT01127633|16642653|P1|Overall Study|Physician Decision|60
4827144|NCT01127633|16642652|P2|Overall Study|Parent/Caregiver Decision|228
4827145|NCT01127633|16642653|P1|Overall Study|Parent/Caregiver Decision|246
4827146|NCT01127633|16642652|P2|Overall Study|Lost to Follow-up|0
4827147|NCT01127633|16642653|P1|Overall Study|Lost to Follow-up|4
4827148|NCT01127633|16642652|P2|Overall Study|Death|43
4827149|NCT01127633|16642653|P1|Overall Study|Death|40
4827150|NCT01127633|16642652|P2|Overall Study|Adverse Event|73
4827151|NCT01127633|16642653|P1|Overall Study|Adverse Event|74
4827152|NCT01127607|16642685|P2|Phase II (Between Subjects)|Withdrawal by Subject|0
4827153|NCT01127607|16642686|P1|Phase II (Between Subjects)|Withdrawal by Subject|1
4827154|NCT01127607|16642685|P2|Phase II (Between Subjects)|Lost to Follow-up|2
4827155|NCT01127607|16642686|P1|Phase II (Between Subjects)|Lost to Follow-up|0
4827156|NCT01127256|16642863|P2|Overall Study|Protocol Violation|0
4827157|NCT01127256|16642864|P1|Overall Study|Protocol Violation|1
4827158|NCT01127256|16642863|P2|Overall Study|Withdrawal by Subject|9
4827159|NCT01127256|16642864|P1|Overall Study|Withdrawal by Subject|5
4827160|NCT01127256|16642863|P2|Overall Study|Lost to Follow-up|17
4827161|NCT01127256|16642864|P1|Overall Study|Lost to Follow-up|16
4827162|NCT01127256|16642863|P2|Overall Study|Lack of Efficacy|0
4827163|NCT01127256|16642864|P1|Overall Study|Lack of Efficacy|4
4827164|NCT01127256|16642863|P2|Overall Study|Adverse Event|13
4827165|NCT01127256|16642864|P1|Overall Study|Adverse Event|13
4827166|NCT01127165|16642876|P2|Overall Study|Protocol Violation|1
4827167|NCT01127165|16642877|P1|Overall Study|Protocol Violation|0
4827168|NCT01127165|16642876|P2|Overall Study|Withdrawal by Subject|3
4827169|NCT01127165|16642877|P1|Overall Study|Withdrawal by Subject|1
4827170|NCT01127165|16642876|P2|Overall Study|Lost to Follow-up|5
4827171|NCT01127165|16642877|P1|Overall Study|Lost to Follow-up|3
4827172|NCT01127165|16642876|P2|Overall Study|Lack of Efficacy|8
4827173|NCT01127165|16642877|P1|Overall Study|Lack of Efficacy|10
4827174|NCT01127165|16642876|P2|Overall Study|Adverse Event|2
4827175|NCT01127165|16642877|P1|Overall Study|Adverse Event|2
4827176|NCT01127139|16642889|P1|Overall Study|Reason not specified|1
4827177|NCT01127139|16642889|P1|Overall Study|Lack of Efficacy|4
4827178|NCT01127139|16642889|P1|Overall Study|Incompliance|12
4827179|NCT01127139|16642889|P1|Overall Study|Adverse Event|40
4827180|NCT01127061|16642917|P2|Overall Study|Physician Decision|3
4827181|NCT01127061|16642918|P1|Overall Study|Physician Decision|3
4827182|NCT01127061|16642917|P2|Overall Study|Lost to Follow-up|10
4827183|NCT01127061|16642918|P1|Overall Study|Lost to Follow-up|7
4827184|NCT01126879|16642955|P2|Overall Study|Physician Decision|0
4827185|NCT01126879|16642956|P1|Overall Study|Physician Decision|1
4827186|NCT01126879|16642955|P2|Overall Study|Adverse Event|1
4827187|NCT01126879|16642956|P1|Overall Study|Adverse Event|0
4827188|NCT01126879|16642955|P2|Overall Study|Withdrawal by Subject|0
4827189|NCT01126879|16642956|P1|Overall Study|Withdrawal by Subject|1
4827190|NCT01126879|16642955|P2|Overall Study|Progressive Disease|1
4827191|NCT01126879|16642956|P1|Overall Study|Progressive Disease|3
4827192|NCT01126619|16643003|P1|Overall Study|Non-compliance|1
4827193|NCT01126619|16643003|P1|Overall Study|Withdrawal by Subject|9
4827194|NCT01126619|16643003|P1|Overall Study|Serious adverse event|1
4827195|NCT01126619|16643003|P1|Overall Study|Investigator decision|4
4827196|NCT01126619|16643003|P1|Overall Study|Not eligible for the study|2
4827197|NCT01126580|16643031|P3|Overall Study|Treatment Non-compliance|3
4827198|NCT01126580|16643032|P2|Overall Study|Treatment Non-compliance|2
4827199|NCT01126580|16643033|P1|Overall Study|Treatment Non-compliance|0
4827200|NCT01126580|16643031|P3|Overall Study|Lost to Follow-up|9
4827201|NCT01126580|16643032|P2|Overall Study|Lost to Follow-up|13
4827202|NCT01126580|16643033|P1|Overall Study|Lost to Follow-up|15
4827203|NCT01126580|16643031|P3|Overall Study|Protocol Violation|2
4827204|NCT01126580|16643032|P2|Overall Study|Protocol Violation|1
4827205|NCT01126580|16643033|P1|Overall Study|Protocol Violation|0
4827206|NCT01126580|16643031|P3|Overall Study|Lack of Efficacy|4
4827207|NCT01126580|16643032|P2|Overall Study|Lack of Efficacy|3
4827208|NCT01126580|16643033|P1|Overall Study|Lack of Efficacy|2
4827209|NCT01126580|16643031|P3|Overall Study|Entry Criteria Not Met|2
4827210|NCT01126580|16643032|P2|Overall Study|Entry Criteria Not Met|1
4827211|NCT01126580|16643033|P1|Overall Study|Entry Criteria Not Met|1
4827212|NCT01126580|16643031|P3|Overall Study|Physician Decision|2
4827213|NCT01126580|16643032|P2|Overall Study|Physician Decision|1
4827214|NCT01126580|16643033|P1|Overall Study|Physician Decision|1
4827215|NCT01126580|16643031|P3|Overall Study|Sponsor Decision|7
4827216|NCT01126580|16643032|P2|Overall Study|Sponsor Decision|4
4827217|NCT01126580|16643033|P1|Overall Study|Sponsor Decision|5
4827218|NCT01126580|16643031|P3|Overall Study|Withdrawal by Subject|14
4827219|NCT01126580|16643032|P2|Overall Study|Withdrawal by Subject|19
4827220|NCT01126580|16643033|P1|Overall Study|Withdrawal by Subject|11
4827221|NCT01126580|16643031|P3|Overall Study|Adverse Event|12
4827222|NCT01126580|16643032|P2|Overall Study|Adverse Event|8
4827223|NCT01126580|16643033|P1|Overall Study|Adverse Event|14
4827224|NCT01126541|16643128|P3|Overall Study|Administrative reason or other|2
4827225|NCT01126541|16643129|P2|Overall Study|Administrative reason or other|1
4827226|NCT01126541|16643130|P1|Overall Study|Administrative reason or other|1
4827227|NCT01126541|16643128|P3|Overall Study|Protocol Violation|1
4827228|NCT01126541|16643129|P2|Overall Study|Protocol Violation|0
4827229|NCT01126541|16643130|P1|Overall Study|Protocol Violation|0
4827230|NCT01126541|16643128|P3|Overall Study|Withdrawal by Subject|6
4827231|NCT01126541|16643129|P2|Overall Study|Withdrawal by Subject|5
4827232|NCT01126541|16643130|P1|Overall Study|Withdrawal by Subject|2
4827233|NCT01126541|16643128|P3|Overall Study|Lost to Follow-up|2
4827234|NCT01126541|16643129|P2|Overall Study|Lost to Follow-up|2
4827235|NCT01126541|16643130|P1|Overall Study|Lost to Follow-up|1
4827236|NCT01126541|16643128|P3|Overall Study|Lack of Efficacy|11
4827237|NCT01126541|16643129|P2|Overall Study|Lack of Efficacy|1
4827238|NCT01126541|16643130|P1|Overall Study|Lack of Efficacy|6
4827239|NCT01126541|16643128|P3|Overall Study|Death|0
4827240|NCT01126541|16643129|P2|Overall Study|Death|1
4827241|NCT01126541|16643130|P1|Overall Study|Death|0
4827242|NCT01126541|16643128|P3|Overall Study|Adverse Event|4
4827243|NCT01126541|16643129|P2|Overall Study|Adverse Event|2
4827244|NCT01126541|16643130|P1|Overall Study|Adverse Event|0
4827245|NCT01126437|16643214|P3|Overall Study|Other reason not specified|178
4827246|NCT01126437|16643215|P2|Overall Study|Other reason not specified|176
4827247|NCT01126437|16643216|P1|Overall Study|Other reason not specified|210
4827248|NCT01126437|16643214|P3|Overall Study|Withdrawal by Subject|319
4827249|NCT01126437|16643215|P2|Overall Study|Withdrawal by Subject|335
4827250|NCT01126437|16643216|P1|Overall Study|Withdrawal by Subject|331
4827251|NCT01126437|16643214|P3|Overall Study|Lost to Follow-up|55
4827252|NCT01126437|16643215|P2|Overall Study|Lost to Follow-up|63
4827253|NCT01126437|16643216|P1|Overall Study|Lost to Follow-up|52
4827254|NCT01126437|16643214|P3|Overall Study|Protocol Violation|41
4827255|NCT01126437|16643215|P2|Overall Study|Protocol Violation|66
4827256|NCT01126437|16643216|P1|Overall Study|Protocol Violation|64
4827257|NCT01126437|16643214|P3|Overall Study|Lack of Efficacy|59
4827258|NCT01126437|16643215|P2|Overall Study|Lack of Efficacy|60
4827259|NCT01126437|16643216|P1|Overall Study|Lack of Efficacy|65
4827260|NCT01126437|16643214|P3|Overall Study|Adverse Event|635
4827261|NCT01126437|16643215|P2|Overall Study|Adverse Event|606
4827262|NCT01126437|16643216|P1|Overall Study|Adverse Event|602
4827263|NCT01126437|16643214|P3|Overall Study|Sites with data irregularities/fraud|7
4827264|NCT01126437|16643215|P2|Overall Study|Sites with data irregularities/fraud|6
4827265|NCT01126437|16643216|P1|Overall Study|Sites with data irregularities/fraud|6
4827266|NCT01126437|16643214|P3|Overall Study|Not treated|19
4827267|NCT01126437|16643215|P2|Overall Study|Not treated|18
4827268|NCT01126437|16643216|P1|Overall Study|Not treated|11
4827269|NCT01126424|16643254|P6|Overall Study|Withdrawal by Subject|0
4827270|NCT01126424|16643255|P5|Overall Study|Withdrawal by Subject|1
4827271|NCT01126424|16643256|P4|Overall Study|Withdrawal by Subject|3
4827272|NCT01126424|16643257|P3|Overall Study|Withdrawal by Subject|1
4827273|NCT01126424|16643258|P2|Overall Study|Withdrawal by Subject|0
4827274|NCT01126424|16643259|P1|Overall Study|Withdrawal by Subject|0
4827275|NCT01126424|16643254|P6|Overall Study|Adverse Event|0
4827276|NCT01126424|16643255|P5|Overall Study|Adverse Event|1
4827277|NCT01126424|16643256|P4|Overall Study|Adverse Event|0
4827278|NCT01126424|16643257|P3|Overall Study|Adverse Event|0
4827279|NCT01126424|16643258|P2|Overall Study|Adverse Event|0
4827280|NCT01126424|16643259|P1|Overall Study|Adverse Event|0
4827281|NCT01126359|16643282|P2|First Intervention (20-minutes)|Physician Decision|1
4827282|NCT01126359|16643283|P1|First Intervention (20-minutes)|Physician Decision|0
4827283|NCT01126268|16643295|P1|Overall Study|Adverse Event|1
4827284|NCT01126060|16643334|P2|Overall Study|Protocol Violation|2
4827285|NCT01126060|16643335|P1|Overall Study|Protocol Violation|0
4827286|NCT01125930|16643343|P2|Overall Study|Lost to Follow-up|2
4827287|NCT01125930|16643344|P1|Overall Study|Lost to Follow-up|0
4827288|NCT01125930|16643343|P2|Overall Study|Protocol Violation|1
4827289|NCT01125930|16643344|P1|Overall Study|Protocol Violation|0
4827290|NCT01125930|16643343|P2|Overall Study|Withdrawal by Subject|6
4827291|NCT01125930|16643344|P1|Overall Study|Withdrawal by Subject|1
4827292|NCT01125930|16643343|P2|Overall Study|Adverse Event|1
4827293|NCT01125930|16643344|P1|Overall Study|Adverse Event|0
4827294|NCT01125917|16643498|P1|Overall Study|Lack of Efficacy|19
4827295|NCT01125917|16643498|P1|Overall Study|Administrative|223
4827296|NCT01125917|16643498|P1|Overall Study|Withdrawal by Subject|31
4827297|NCT01125917|16643498|P1|Overall Study|Lost to Follow-up|23
4827298|NCT01125917|16643498|P1|Overall Study|Adverse Event|43
4827299|NCT01125813|16643502|P1|Overall Study|Screen Failures|4
4827300|NCT01125813|16643502|P1|Overall Study|Withdrawal by Subject|1
4827301|NCT01125813|16643502|P1|Overall Study|Death|1
4827302|NCT01125800|16643512|P5|Phase II|Disease progression|8
4827303|NCT01125800|16643513|P4|Phase II|Disease progression|1
4827304|NCT01125800|16643514|P3|Phase II|Disease progression|0
4827305|NCT01125800|16643515|P2|Phase II|Disease progression|0
4827306|NCT01125800|16643516|P1|Phase II|Disease progression|0
4827307|NCT01125800|16643512|P5|Phase II|Adverse Event|2
4827308|NCT01125800|16643513|P4|Phase II|Adverse Event|0
4827309|NCT01125800|16643514|P3|Phase II|Adverse Event|0
4827310|NCT01125800|16643515|P2|Phase II|Adverse Event|0
4827311|NCT01125800|16643516|P1|Phase II|Adverse Event|0
4827312|NCT01125800|16643512|P5|Phase II|Protocol Violation|1
4827313|NCT01125800|16643513|P4|Phase II|Protocol Violation|0
4827314|NCT01125800|16643514|P3|Phase II|Protocol Violation|0
4827315|NCT01125800|16643515|P2|Phase II|Protocol Violation|0
4827316|NCT01125800|16643516|P1|Phase II|Protocol Violation|0
4827317|NCT01125800|16643512|P5|Phase I|Disease progression|0
4827318|NCT01125800|16643513|P4|Phase I|Disease progression|3
4827319|NCT01125800|16643514|P3|Phase I|Disease progression|1
4827320|NCT01125800|16643515|P2|Phase I|Disease progression|4
4827321|NCT01125800|16643516|P1|Phase I|Disease progression|5
4827322|NCT01125800|16643512|P5|Phase I|Withdrawal by Subject|0
4827323|NCT01125800|16643513|P4|Phase I|Withdrawal by Subject|0
4827324|NCT01125800|16643514|P3|Phase I|Withdrawal by Subject|1
4827325|NCT01125800|16643515|P2|Phase I|Withdrawal by Subject|0
4827326|NCT01125800|16643516|P1|Phase I|Withdrawal by Subject|0
4827327|NCT01125800|16643512|P5|Phase I|Administrative problems|0
4827328|NCT01125800|16643513|P4|Phase I|Administrative problems|0
4827329|NCT01125800|16643514|P3|Phase I|Administrative problems|0
4827330|NCT01125800|16643515|P2|Phase I|Administrative problems|0
4827331|NCT01125800|16643516|P1|Phase I|Administrative problems|1
4827332|NCT01125800|16643512|P5|Phase I|Adverse Event|0
4827333|NCT01125800|16643513|P4|Phase I|Adverse Event|7
4827334|NCT01125800|16643514|P3|Phase I|Adverse Event|1
4827335|NCT01125800|16643515|P2|Phase I|Adverse Event|2
4827336|NCT01125800|16643516|P1|Phase I|Adverse Event|2
4827337|NCT01125800|16643512|P5|Phase I|Protocol Violation|0
4827338|NCT01125800|16643513|P4|Phase I|Protocol Violation|1
4827339|NCT01125800|16643514|P3|Phase I|Protocol Violation|1
4827340|NCT01125800|16643515|P2|Phase I|Protocol Violation|3
4827341|NCT01125800|16643516|P1|Phase I|Protocol Violation|0
4827342|NCT01125748|16643582|P2|Overall Study|Patient Decision to Withdraw|4
4827343|NCT01125748|16643583|P1|Overall Study|Patient Decision to Withdraw|2
4827344|NCT01125748|16643582|P2|Overall Study|Physician Decision|7
4827345|NCT01125748|16643583|P1|Overall Study|Physician Decision|8
4827346|NCT01125748|16643582|P2|Overall Study|Lost to Follow-up|1
4827347|NCT01125748|16643583|P1|Overall Study|Lost to Follow-up|0
4827348|NCT01125748|16643582|P2|Overall Study|Adverse Event|2
4827349|NCT01125748|16643583|P1|Overall Study|Adverse Event|0
4827350|NCT01125722|16643593|P2|Overall Study|Lost to Follow-up|0
4827351|NCT01125722|16643594|P1|Overall Study|Lost to Follow-up|1
4827352|NCT01125722|16643593|P2|Overall Study|Withdrawal by Subject|1
4827353|NCT01125722|16643594|P1|Overall Study|Withdrawal by Subject|2
4827354|NCT01125566|16643641|P3|Patients Who Switched From AV to TV|Other than listed above|4
4827355|NCT01125566|16643642|P2|Patients Who Switched From AV to TV|Other than listed above|0
4827356|NCT01125566|16643643|P1|Patients Who Switched From AV to TV|Other than listed above|0
4827357|NCT01125566|16643641|P3|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3
4827358|NCT01125566|16643642|P2|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
4827359|NCT01125566|16643643|P1|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0
4827360|NCT01125566|16643641|P3|Patients Who Switched From AV to TV|Refused to continue taking medication|7
4827361|NCT01125566|16643642|P2|Patients Who Switched From AV to TV|Refused to continue taking medication|0
4827362|NCT01125566|16643643|P1|Patients Who Switched From AV to TV|Refused to continue taking medication|0
4827363|NCT01125566|16643641|P3|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59
4827364|NCT01125566|16643642|P2|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
4827365|NCT01125566|16643643|P1|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0
4827366|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0
4827367|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
4827368|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1
4827369|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Other than listed above|0
4827370|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Other than listed above|13
4827371|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Other than listed above|25
4827372|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Not treated|0
4827373|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Not treated|0
4827374|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Not treated|2
4827375|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0
4827376|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23
4827377|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24
4827378|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Protocol Violation|0
4827379|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Protocol Violation|2
4827380|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Protocol Violation|0
4827381|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Adverse Event|0
4827382|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Adverse Event|5
4827383|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Adverse Event|25
4827384|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0
4827385|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
4827386|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6
4827387|NCT01125566|16643641|P3|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0
4827388|NCT01125566|16643642|P2|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119
4827389|NCT01125566|16643643|P1|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182
4827390|NCT01125514|16643656|P1|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1
4827391|NCT01125514|16643656|P1|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1
4827392|NCT01125514|16643656|P1|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2
4827393|NCT01125514|16643656|P1|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3
4827394|NCT01125514|16643656|P1|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1
4827395|NCT01125514|16643656|P1|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1
4827396|NCT01125189|16643756|P3|Follow up Period|Other reasons|5
4827397|NCT01125189|16643757|P2|Follow up Period|Other reasons|4
4827398|NCT01125189|16643758|P1|Follow up Period|Other reasons|4
4827399|NCT01125189|16643756|P3|Follow up Period|Lost to Follow-up|6
4827400|NCT01125189|16643757|P2|Follow up Period|Lost to Follow-up|9
4827401|NCT01125189|16643758|P1|Follow up Period|Lost to Follow-up|12
4827402|NCT01125189|16643756|P3|Follow up Period|Death|0
4827403|NCT01125189|16643757|P2|Follow up Period|Death|0
4827404|NCT01125189|16643758|P1|Follow up Period|Death|1
4827405|NCT01125189|16643756|P3|Follow up Period|Withdrawal by Subject|5
4827406|NCT01125189|16643757|P2|Follow up Period|Withdrawal by Subject|2
4827407|NCT01125189|16643758|P1|Follow up Period|Withdrawal by Subject|3
4827408|NCT01125189|16643756|P3|Treatment Period|Completed 24 week treatment period only|2
4827409|NCT01125189|16643757|P2|Treatment Period|Completed 24 week treatment period only|1
4827410|NCT01125189|16643758|P1|Treatment Period|Completed 24 week treatment period only|2
4827411|NCT01125189|16643756|P3|Treatment Period|Other reasons|0
4827412|NCT01125189|16643757|P2|Treatment Period|Other reasons|1
4827413|NCT01125189|16643758|P1|Treatment Period|Other reasons|1
4827414|NCT01125189|16643756|P3|Treatment Period|Participants requested to discontinue|4
4827415|NCT01125189|16643757|P2|Treatment Period|Participants requested to discontinue|3
4827416|NCT01125189|16643758|P1|Treatment Period|Participants requested to discontinue|1
4827417|NCT01125189|16643756|P3|Treatment Period|Poor compliance/noncompliance|0
4827418|NCT01125189|16643757|P2|Treatment Period|Poor compliance/noncompliance|1
4827419|NCT01125189|16643758|P1|Treatment Period|Poor compliance/noncompliance|0
4827420|NCT01125189|16643756|P3|Treatment Period|Lost to Follow-up|1
4827421|NCT01125189|16643757|P2|Treatment Period|Lost to Follow-up|2
4827422|NCT01125189|16643758|P1|Treatment Period|Lost to Follow-up|1
4827423|NCT01125189|16643756|P3|Treatment Period|Death|0
4827424|NCT01125189|16643757|P2|Treatment Period|Death|0
4827425|NCT01125189|16643758|P1|Treatment Period|Death|1
4827426|NCT01125189|16643756|P3|Treatment Period|Withdrawal by Subject|1
4827427|NCT01125189|16643757|P2|Treatment Period|Withdrawal by Subject|1
4827428|NCT01125189|16643758|P1|Treatment Period|Withdrawal by Subject|3
4827429|NCT01125189|16643756|P3|Treatment Period|Adverse Event|8
4827430|NCT01125189|16643757|P2|Treatment Period|Adverse Event|8
4827431|NCT01125189|16643758|P1|Treatment Period|Adverse Event|7
4827432|NCT01125189|16643756|P3|Treatment Period|Lack of Efficacy|25
4827433|NCT01125189|16643757|P2|Treatment Period|Lack of Efficacy|18
4827434|NCT01125189|16643758|P1|Treatment Period|Lack of Efficacy|15
4827435|NCT01124916|16643827|P2|Overall Study|Lost to Follow-up|2
4827436|NCT01124916|16643828|P1|Overall Study|Lost to Follow-up|3
4827437|NCT01124864|16643842|P6|Overall Study|Protocol Violation|0
4827438|NCT01124864|16643843|P5|Overall Study|Protocol Violation|1
4827439|NCT01124864|16643844|P4|Overall Study|Protocol Violation|0
4827440|NCT01124864|16643845|P3|Overall Study|Protocol Violation|0
4827441|NCT01124864|16643846|P2|Overall Study|Protocol Violation|0
4827442|NCT01124864|16643847|P1|Overall Study|Protocol Violation|1
4827443|NCT01124864|16643842|P6|Overall Study|Lost to Follow-up|0
4827444|NCT01124864|16643843|P5|Overall Study|Lost to Follow-up|0
4827445|NCT01124864|16643844|P4|Overall Study|Lost to Follow-up|1
4827446|NCT01124864|16643845|P3|Overall Study|Lost to Follow-up|0
4827447|NCT01124864|16643846|P2|Overall Study|Lost to Follow-up|1
4827448|NCT01124864|16643847|P1|Overall Study|Lost to Follow-up|1
4827449|NCT01124864|16643842|P6|Overall Study|Withdrawal by Subject|1
4827450|NCT01124864|16643843|P5|Overall Study|Withdrawal by Subject|2
4827451|NCT01124864|16643844|P4|Overall Study|Withdrawal by Subject|0
4827452|NCT01124864|16643845|P3|Overall Study|Withdrawal by Subject|4
4827453|NCT01124864|16643846|P2|Overall Study|Withdrawal by Subject|3
4827454|NCT01124864|16643847|P1|Overall Study|Withdrawal by Subject|2
4827455|NCT01124864|16643842|P6|Overall Study|Death|0
4827456|NCT01124864|16643843|P5|Overall Study|Death|1
4827457|NCT01124864|16643844|P4|Overall Study|Death|2
4827458|NCT01124864|16643845|P3|Overall Study|Death|6
4827459|NCT01124864|16643846|P2|Overall Study|Death|9
4827460|NCT01124864|16643847|P1|Overall Study|Death|6
4827461|NCT01124864|16643842|P6|Overall Study|Follow up phase competed as per protocol|2
4827462|NCT01124864|16643843|P5|Overall Study|Follow up phase competed as per protocol|26
4827463|NCT01124864|16643844|P4|Overall Study|Follow up phase competed as per protocol|18
4827464|NCT01124864|16643845|P3|Overall Study|Follow up phase competed as per protocol|24
4827465|NCT01124864|16643846|P2|Overall Study|Follow up phase competed as per protocol|22
4827466|NCT01124864|16643847|P1|Overall Study|Follow up phase competed as per protocol|18
4827467|NCT01124838|16643881|P2|Overall Study|Lost to Follow-up|0
4827468|NCT01124838|16643882|P1|Overall Study|Lost to Follow-up|2
4827469|NCT01124838|16643881|P2|Overall Study|Withdrawal by Subject|2
4827470|NCT01124838|16643882|P1|Overall Study|Withdrawal by Subject|3
4827471|NCT01124838|16643881|P2|Overall Study|Lack of Efficacy|0
4827472|NCT01124838|16643882|P1|Overall Study|Lack of Efficacy|2
4827473|NCT01124838|16643881|P2|Overall Study|Adverse Event|11
4827474|NCT01124838|16643882|P1|Overall Study|Adverse Event|7
4827475|NCT01124838|16643881|P2|Overall Study|Miscellaneous|2
4827476|NCT01124838|16643882|P1|Overall Study|Miscellaneous|4
4827477|NCT01124734|16643949|P1|Overall Study|Elected for alternative treatment|2
4827478|NCT01124734|16643949|P1|Overall Study|Withdrawal by Subject|1
4827479|NCT01124734|16643949|P1|Overall Study|Adverse Event|1
4827480|NCT01124734|16643949|P1|Overall Study|Disease progression|13
4827481|NCT01124643|16643960|P1|Overall Study|Death|1
4827482|NCT01124617|16643974|P2|Overall Study|Other|1
4827483|NCT01124617|16643975|P1|Overall Study|Other|2
4827484|NCT01124617|16643974|P2|Overall Study|Withdrawal by Subject|1
4827485|NCT01124617|16643975|P1|Overall Study|Withdrawal by Subject|9
4827486|NCT01124617|16643974|P2|Overall Study|Protocol Violation|1
4827487|NCT01124617|16643975|P1|Overall Study|Protocol Violation|1
4827488|NCT01124617|16643974|P2|Overall Study|Lack of Efficacy|1
4827489|NCT01124617|16643975|P1|Overall Study|Lack of Efficacy|2
4827490|NCT01124617|16643974|P2|Overall Study|Adverse Event|2
4827491|NCT01124617|16643975|P1|Overall Study|Adverse Event|5
4827492|NCT01124604|16644007|P2|Overall Study|Disease Progression|1
4827493|NCT01124604|16644008|P1|Overall Study|Disease Progression|0
4827494|NCT01124604|16644007|P2|Overall Study|Withdrawal by Subject|0
4827495|NCT01124604|16644008|P1|Overall Study|Withdrawal by Subject|4
4827496|NCT01124604|16644007|P2|Overall Study|Lack of Efficacy|0
4827497|NCT01124604|16644008|P1|Overall Study|Lack of Efficacy|1
4827498|NCT01124604|16644007|P2|Overall Study|Adverse Event|1
4827499|NCT01124604|16644008|P1|Overall Study|Adverse Event|10
4827500|NCT01124448|16644047|P2|Overall Study|Protocol Violation|0
4827501|NCT01124448|16644048|P1|Overall Study|Protocol Violation|2
4827502|NCT01124448|16644047|P2|Overall Study|Lost to Follow-up|3
4827503|NCT01124448|16644048|P1|Overall Study|Lost to Follow-up|0
4827504|NCT01124422|16644056|P3|4-Week Double-blind Treatment Phase|Lost to Follow-up|1
4827505|NCT01124422|16644057|P2|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
4827506|NCT01124422|16644058|P1|4-Week Double-blind Treatment Phase|Lost to Follow-up|0
4827507|NCT01124422|16644056|P3|4-Week Double-blind Treatment Phase|Physician Decision|2
4827508|NCT01124422|16644057|P2|4-Week Double-blind Treatment Phase|Physician Decision|5
4827509|NCT01124422|16644058|P1|4-Week Double-blind Treatment Phase|Physician Decision|0
4827510|NCT01124422|16644056|P3|4-Week Double-blind Treatment Phase|Adverse Event|3
4827511|NCT01124422|16644057|P2|4-Week Double-blind Treatment Phase|Adverse Event|6
4827512|NCT01124422|16644058|P1|4-Week Double-blind Treatment Phase|Adverse Event|0
4827513|NCT01124422|16644056|P3|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3
4827514|NCT01124422|16644057|P2|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
4827515|NCT01124422|16644058|P1|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0
4827516|NCT01124422|16644056|P3|4-Week Open-label Run-in Phase|Protocol Violation|0
4827517|NCT01124422|16644057|P2|4-Week Open-label Run-in Phase|Protocol Violation|0
4827518|NCT01124422|16644058|P1|4-Week Open-label Run-in Phase|Protocol Violation|5
4827519|NCT01124422|16644056|P3|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
4827520|NCT01124422|16644057|P2|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0
4827521|NCT01124422|16644058|P1|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61
4827522|NCT01124422|16644056|P3|4-Week Open-label Run-in Phase|Lost to Follow-up|0
4827523|NCT01124422|16644057|P2|4-Week Open-label Run-in Phase|Lost to Follow-up|0
4827524|NCT01124422|16644058|P1|4-Week Open-label Run-in Phase|Lost to Follow-up|1
4827525|NCT01124422|16644056|P3|4-Week Open-label Run-in Phase|Physician Decision|0
4827526|NCT01124422|16644057|P2|4-Week Open-label Run-in Phase|Physician Decision|0
4827527|NCT01124422|16644058|P1|4-Week Open-label Run-in Phase|Physician Decision|4
4827528|NCT01124422|16644056|P3|4-Week Open-label Run-in Phase|Adverse Event|0
4827529|NCT01124422|16644057|P2|4-Week Open-label Run-in Phase|Adverse Event|0
4827530|NCT01124422|16644058|P1|4-Week Open-label Run-in Phase|Adverse Event|7
4827531|NCT01124422|16644056|P3|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
4827532|NCT01124422|16644057|P2|4-Week Open-label Run-in Phase|Withdrawal by Subject|0
4827533|NCT01124422|16644058|P1|4-Week Open-label Run-in Phase|Withdrawal by Subject|5
4827534|NCT01124292|16644128|P3|Overall Study|piercing track closed|1
4827535|NCT01124292|16644129|P2|Overall Study|piercing track closed|2
4827536|NCT01124292|16644130|P1|Overall Study|piercing track closed|0
4827537|NCT01124292|16644128|P3|Overall Study|medical issue unrelated to the study|2
4827538|NCT01124292|16644129|P2|Overall Study|medical issue unrelated to the study|0
4827539|NCT01124292|16644130|P1|Overall Study|medical issue unrelated to the study|0
4827540|NCT01124292|16644128|P3|Overall Study|Withdrawal by Subject|2
4827541|NCT01124292|16644129|P2|Overall Study|Withdrawal by Subject|6
4827542|NCT01124292|16644130|P1|Overall Study|Withdrawal by Subject|0
4827543|NCT01124292|16644128|P3|Overall Study|Physician Decision|2
4827544|NCT01124292|16644129|P2|Overall Study|Physician Decision|3
4827545|NCT01124292|16644130|P1|Overall Study|Physician Decision|0
4827546|NCT01124292|16644128|P3|Overall Study|Lost to Follow-up|3
4827547|NCT01124292|16644129|P2|Overall Study|Lost to Follow-up|4
4827548|NCT01124292|16644130|P1|Overall Study|Lost to Follow-up|2
4827549|NCT01124175|16644201|P2|Washout of 7 Days|Withdrawal by Subject|2
4827550|NCT01124175|16644202|P1|Washout of 7 Days|Withdrawal by Subject|0
4827551|NCT01124162|16644220|P2|Washout of 7 Days|Withdrawal by Subject|0
4827552|NCT01124162|16644221|P1|Washout of 7 Days|Withdrawal by Subject|1
4827553|NCT01124162|16644220|P2|First Intervention|Adverse Event|0
4827554|NCT01124162|16644221|P1|First Intervention|Adverse Event|2
4827555|NCT01124149|16644237|P1|Maintenance Phase|Non-compliance|1
4827556|NCT01124149|16644237|P1|Maintenance Phase|Coordinator error|1
4827557|NCT01124149|16644237|P1|Maintenance Phase|Protocol Violation|5
4827558|NCT01124149|16644237|P1|Maintenance Phase|Withdrawal by Subject|10
4827559|NCT01124149|16644237|P1|Maintenance Phase|Lost to Follow-up|15
4827560|NCT01124149|16644237|P1|Maintenance Phase|Adverse Event|24
4827561|NCT01124149|16644237|P1|Maintenance Phase|Lack of Efficacy|40
4827562|NCT01124149|16644237|P1|Acute Phase|Sponsor decision|1
4827563|NCT01124149|16644237|P1|Acute Phase|Travelling to another country|1
4827564|NCT01124149|16644237|P1|Acute Phase|Low hemoglobin|1
4827565|NCT01124149|16644237|P1|Acute Phase|Non-compliance|1
4827566|NCT01124149|16644237|P1|Acute Phase|UC symptoms not ameliorated|1
4827567|NCT01124149|16644237|P1|Acute Phase|Sponsor request|1
4827568|NCT01124149|16644237|P1|Acute Phase|Prolonged antibiotic therapy|1
4827569|NCT01124149|16644237|P1|Acute Phase|Lost to Follow-up|2
4827570|NCT01124149|16644237|P1|Acute Phase|Protocol Violation|14
4827571|NCT01124149|16644237|P1|Acute Phase|Lack of Efficacy|17
4827572|NCT01124149|16644237|P1|Acute Phase|Adverse Event|21
4827573|NCT01124149|16644237|P1|Acute Phase|Withdrawal by Subject|22
4827574|NCT01124097|16644257|P4|Overall Study|Physician Decision|0
4827575|NCT01124097|16644258|P3|Overall Study|Physician Decision|0
4827576|NCT01124097|16644259|P2|Overall Study|Physician Decision|1
4827577|NCT01124097|16644260|P1|Overall Study|Physician Decision|2
4827578|NCT01124097|16644257|P4|Overall Study|Protocol Violation|1
4827579|NCT01124097|16644258|P3|Overall Study|Protocol Violation|2
4827580|NCT01124097|16644259|P2|Overall Study|Protocol Violation|0
4827581|NCT01124097|16644260|P1|Overall Study|Protocol Violation|2
4827582|NCT01124097|16644257|P4|Overall Study|Adverse Event|7
4827583|NCT01124097|16644258|P3|Overall Study|Adverse Event|15
4827584|NCT01124097|16644259|P2|Overall Study|Adverse Event|15
4827585|NCT01124097|16644260|P1|Overall Study|Adverse Event|24
4827586|NCT01124097|16644257|P4|Overall Study|Lack of Efficacy|3
4827587|NCT01124097|16644258|P3|Overall Study|Lack of Efficacy|1
4827588|NCT01124097|16644259|P2|Overall Study|Lack of Efficacy|3
4827589|NCT01124097|16644260|P1|Overall Study|Lack of Efficacy|2
4827590|NCT01124097|16644257|P4|Overall Study|Withdrawal by Subject|3
4827591|NCT01124097|16644258|P3|Overall Study|Withdrawal by Subject|2
4827592|NCT01124097|16644259|P2|Overall Study|Withdrawal by Subject|3
4827593|NCT01124097|16644260|P1|Overall Study|Withdrawal by Subject|4
4827594|NCT01124045|16644272|P2|Overall Study|Physician Decision|2
4827595|NCT01124045|16644273|P1|Overall Study|Physician Decision|0
4827596|NCT01124045|16644272|P2|Overall Study|Lost to Follow-up|1
4827597|NCT01124045|16644273|P1|Overall Study|Lost to Follow-up|0
4827598|NCT01124006|16644306|P3|Overall Study|Other|1
4827599|NCT01124006|16644307|P2|Overall Study|Other|0
4827600|NCT01124006|16644308|P1|Overall Study|Other|0
4827601|NCT01124006|16644306|P3|Overall Study|Lost to Follow-up|1
4827602|NCT01124006|16644307|P2|Overall Study|Lost to Follow-up|0
4827603|NCT01124006|16644308|P1|Overall Study|Lost to Follow-up|1
4827604|NCT01124006|16644306|P3|Overall Study|Withdrawal by Subject|0
4827605|NCT01124006|16644307|P2|Overall Study|Withdrawal by Subject|2
4827606|NCT01124006|16644308|P1|Overall Study|Withdrawal by Subject|2
4827607|NCT01123980|16644336|P2|Overall Study|Unclassified|7
4827608|NCT01123980|16644337|P1|Overall Study|Unclassified|6
4827609|NCT01123980|16644336|P2|Overall Study|Withdrawal by Subject|3
4827610|NCT01123980|16644337|P1|Overall Study|Withdrawal by Subject|5
4827611|NCT01123980|16644336|P2|Overall Study|Protocol Violation|6
4827612|NCT01123980|16644337|P1|Overall Study|Protocol Violation|6
4827613|NCT01123980|16644336|P2|Overall Study|Lost to Follow-up|6
4827614|NCT01123980|16644337|P1|Overall Study|Lost to Follow-up|0
4827615|NCT01123980|16644336|P2|Overall Study|Physician Decision|1
4827616|NCT01123980|16644337|P1|Overall Study|Physician Decision|0
4827617|NCT01123980|16644336|P2|Overall Study|Lack of Efficacy|0
4827618|NCT01123980|16644337|P1|Overall Study|Lack of Efficacy|1
4827619|NCT01123980|16644336|P2|Overall Study|Adverse Event|1
4827620|NCT01123980|16644337|P1|Overall Study|Adverse Event|1
4827621|NCT01123941|16644357|P2|Overall Study|Lost to Follow-up|1
4827622|NCT01123941|16644358|P1|Overall Study|Lost to Follow-up|2
4827623|NCT01123889|16644393|P2|Overall Study|Lost to Follow-up|1
4827624|NCT01123889|16644394|P1|Overall Study|Lost to Follow-up|3
4827625|NCT01123850|16644404|P1|Overall Study|Slow enrollment|45
4827626|NCT01123655|16644411|P3|Overall Study|began prohibitive drug|1
4827627|NCT01123655|16644412|P2|Overall Study|began prohibitive drug|0
4827628|NCT01123655|16644413|P1|Overall Study|began prohibitive drug|0
4827629|NCT01123655|16644411|P3|Overall Study|new illness|0
4827630|NCT01123655|16644412|P2|Overall Study|new illness|1
4827631|NCT01123655|16644413|P1|Overall Study|new illness|0
4827632|NCT01123655|16644411|P3|Overall Study|Medication for RA had to be changed|0
4827633|NCT01123655|16644412|P2|Overall Study|Medication for RA had to be changed|0
4827634|NCT01123655|16644413|P1|Overall Study|Medication for RA had to be changed|1
4827635|NCT01123642|16644485|P1|Overall Study|ineligible at baseline assessment|36
4827636|NCT01123642|16644485|P1|Overall Study|Withdrawal by Subject|9
4827637|NCT01123642|16644485|P1|Overall Study|Lost to Follow-up|23
4827638|NCT01123395|16644501|P2|Washout Period of 14 Days|Withdrawal by Subject|1
4827639|NCT01123395|16644502|P1|Washout Period of 14 Days|Withdrawal by Subject|0
4827640|NCT01123382|16644514|P2|Overall Study|Lost to Follow-up|2
4827641|NCT01123382|16644515|P1|Overall Study|Lost to Follow-up|1
4827642|NCT01123382|16644514|P2|Overall Study|Withdrawal by Subject|4
4827643|NCT01123382|16644515|P1|Overall Study|Withdrawal by Subject|1
4827644|NCT01123356|16644537|P1|Overall Study|Withdrawal by Subject|1
4827645|NCT01123356|16644537|P1|Overall Study|Lack of Efficacy|4
4827646|NCT01123356|16644537|P1|Overall Study|Adverse Event|2
4827647|NCT01123200|16644545|P1|Overall Study|Withdrawal by Subject|1
4827648|NCT01123161|16644552|P2|Overall Study|Withdrawal by Subject|0
4827649|NCT01123161|16644553|P1|Overall Study|Withdrawal by Subject|1
4827650|NCT01123161|16644552|P2|Overall Study|Lost to Follow-up|0
4827651|NCT01123161|16644553|P1|Overall Study|Lost to Follow-up|1
4827652|NCT01123148|16644571|P1|Overall Study|Didn't meet milestone criteria|1
4827653|NCT01123148|16644571|P1|Overall Study|Coughing caused unacceptable EEG quality|1
4827654|NCT01123083|16644577|P2|Overall Study|Participant/legal representative request|3
4827655|NCT01123083|16644578|P1|Overall Study|Participant/legal representative request|7
4827656|NCT01123083|16644577|P2|Overall Study|Withdrew for another reason not covered|1
4827657|NCT01123083|16644578|P1|Overall Study|Withdrew for another reason not covered|0
4827658|NCT01123083|16644577|P2|Overall Study|Adverse Event|0
4827659|NCT01123083|16644578|P1|Overall Study|Adverse Event|1
4827660|NCT01123083|16644577|P2|Overall Study|Lost to Follow-up|6
4827661|NCT01123083|16644578|P1|Overall Study|Lost to Follow-up|2
4827662|NCT01123083|16644577|P2|Overall Study|Administrative reasons|4
4827663|NCT01123083|16644578|P1|Overall Study|Administrative reasons|0
4827664|NCT01123083|16644577|P2|Overall Study|Investigator recommendation|1
4827665|NCT01123083|16644578|P1|Overall Study|Investigator recommendation|1
4827666|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Lack of Efficacy|7
4827667|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Lack of Efficacy|0
4827668|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65
4827669|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0
4827670|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Physician Decision|12
4827671|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Physician Decision|0
4827672|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9
4827673|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0
4827674|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165
4827675|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0
4827676|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Adverse Event|33
4827677|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Adverse Event|0
4827678|NCT01122927|16644602|P2|Period 2- Open-label Treatment Phase|Lost to Follow-up|21
4827679|NCT01122927|16644603|P1|Period 2- Open-label Treatment Phase|Lost to Follow-up|0
4827680|NCT01122927|16644602|P2|Period 1 - Conversion Phase|Protocol Deviation|0
4827681|NCT01122927|16644603|P1|Period 1 - Conversion Phase|Protocol Deviation|1
4827682|NCT01122927|16644602|P2|Period 1 - Conversion Phase|Withdrawal by Subject|0
4827683|NCT01122927|16644603|P1|Period 1 - Conversion Phase|Withdrawal by Subject|7
4827684|NCT01122927|16644602|P2|Period 1 - Conversion Phase|Physician Decision|0
4827685|NCT01122927|16644603|P1|Period 1 - Conversion Phase|Physician Decision|2
4827686|NCT01122927|16644602|P2|Period 1 - Conversion Phase|Met Withdrawal Criteria|0
4827687|NCT01122927|16644603|P1|Period 1 - Conversion Phase|Met Withdrawal Criteria|1
4827688|NCT01122927|16644602|P2|Period 1 - Conversion Phase|Adverse Event|0
4827689|NCT01122927|16644603|P1|Period 1 - Conversion Phase|Adverse Event|3
4827690|NCT01122862|16644655|P3|Period 2|Adverse Event|1
4827691|NCT01122862|16644656|P2|Period 2|Adverse Event|0
4827692|NCT01122862|16644657|P1|Period 2|Adverse Event|0
4827693|NCT01122862|16644655|P3|Period 1|Protocol Violation|0
4827694|NCT01122862|16644656|P2|Period 1|Protocol Violation|1
4827695|NCT01122862|16644657|P1|Period 1|Protocol Violation|0
4827696|NCT01122680|16644763|P4|Period 3 (4 Weeks)|Withdrawal by Subject|0
4827697|NCT01122680|16644764|P3|Period 3 (4 Weeks)|Withdrawal by Subject|0
4827698|NCT01122680|16644765|P2|Period 3 (4 Weeks)|Withdrawal by Subject|1
4827699|NCT01122680|16644766|P1|Period 3 (4 Weeks)|Withdrawal by Subject|0
4827700|NCT01122680|16644763|P4|Period 3 (4 Weeks)|Adverse Event|0
4827701|NCT01122680|16644764|P3|Period 3 (4 Weeks)|Adverse Event|0
4827702|NCT01122680|16644765|P2|Period 3 (4 Weeks)|Adverse Event|0
4827703|NCT01122680|16644766|P1|Period 3 (4 Weeks)|Adverse Event|1
4827704|NCT01122680|16644763|P4|Period 2 (4 Weeks)|Other|0
4827705|NCT01122680|16644764|P3|Period 2 (4 Weeks)|Other|0
4827706|NCT01122680|16644765|P2|Period 2 (4 Weeks)|Other|0
4827707|NCT01122680|16644766|P1|Period 2 (4 Weeks)|Other|1
4827708|NCT01122680|16644763|P4|Period 2 (4 Weeks)|Protocol Violation|1
4827709|NCT01122680|16644764|P3|Period 2 (4 Weeks)|Protocol Violation|0
4827710|NCT01122680|16644765|P2|Period 2 (4 Weeks)|Protocol Violation|0
4827711|NCT01122680|16644766|P1|Period 2 (4 Weeks)|Protocol Violation|0
4827712|NCT01122680|16644763|P4|Period 1 (4 Weeks)|Other|0
4827713|NCT01122680|16644764|P3|Period 1 (4 Weeks)|Other|0
4827714|NCT01122680|16644765|P2|Period 1 (4 Weeks)|Other|1
4827715|NCT01122680|16644766|P1|Period 1 (4 Weeks)|Other|1
4827716|NCT01122680|16644763|P4|Period 1 (4 Weeks)|Protocol Violation|0
4827717|NCT01122680|16644764|P3|Period 1 (4 Weeks)|Protocol Violation|0
4827718|NCT01122680|16644765|P2|Period 1 (4 Weeks)|Protocol Violation|0
4827719|NCT01122680|16644766|P1|Period 1 (4 Weeks)|Protocol Violation|1
4827720|NCT01122680|16644763|P4|Period 1 (4 Weeks)|Adverse Event|0
4827721|NCT01122680|16644764|P3|Period 1 (4 Weeks)|Adverse Event|0
4827722|NCT01122680|16644765|P2|Period 1 (4 Weeks)|Adverse Event|0
4827723|NCT01122680|16644766|P1|Period 1 (4 Weeks)|Adverse Event|1
4827724|NCT01122576|16644831|P3|Post-Cataract Surgery|Fellow Eye Explanted|1
4827725|NCT01122576|16644832|P2|Post-Cataract Surgery|Fellow Eye Explanted|0
4827726|NCT01122576|16644833|P1|Post-Cataract Surgery|Fellow Eye Explanted|0
4827727|NCT01122576|16644831|P3|Post-Cataract Surgery|Central Macular Edema|1
4827728|NCT01122576|16644832|P2|Post-Cataract Surgery|Central Macular Edema|0
4827729|NCT01122576|16644833|P1|Post-Cataract Surgery|Central Macular Edema|0
4827730|NCT01122576|16644831|P3|Pre-Cataract Surgery|Withdrawal by Subject|2
4827731|NCT01122576|16644832|P2|Pre-Cataract Surgery|Withdrawal by Subject|1
4827732|NCT01122576|16644833|P1|Pre-Cataract Surgery|Withdrawal by Subject|0
4827733|NCT01122394|16645014|P2|Overall Study|Adverse Event|1
4827734|NCT01122394|16645015|P1|Overall Study|Adverse Event|0
4827735|NCT01122394|16645014|P2|Overall Study|Lost to Follow-up|2
4827736|NCT01122394|16645015|P1|Overall Study|Lost to Follow-up|2
4827737|NCT01122394|16645014|P2|Overall Study|Withdrawal by Subject|1
4827738|NCT01122394|16645015|P1|Overall Study|Withdrawal by Subject|1
4827739|NCT01122381|16645031|P2|Overall Study|study terminated early|1
4827740|NCT01122381|16645032|P1|Overall Study|study terminated early|0
4827741|NCT01122264|16645048|P3|Overall Study|Lack of Efficacy|1
4827742|NCT01122264|16645049|P2|Overall Study|Lack of Efficacy|1
4827743|NCT01122264|16645050|P1|Overall Study|Lack of Efficacy|3
4827744|NCT01122264|16645048|P3|Overall Study|Physician Decision|1
4827745|NCT01122264|16645049|P2|Overall Study|Physician Decision|1
4827746|NCT01122264|16645050|P1|Overall Study|Physician Decision|3
4827747|NCT01122264|16645048|P3|Overall Study|Withdrawal by Subject|16
4827748|NCT01122264|16645049|P2|Overall Study|Withdrawal by Subject|6
4827749|NCT01122264|16645050|P1|Overall Study|Withdrawal by Subject|6
4827750|NCT01122264|16645048|P3|Overall Study|Protocol Violation|9
4827751|NCT01122264|16645049|P2|Overall Study|Protocol Violation|7
4827752|NCT01122264|16645050|P1|Overall Study|Protocol Violation|7
4827753|NCT01122264|16645048|P3|Overall Study|Entry Criteria Not Met|0
4827754|NCT01122264|16645049|P2|Overall Study|Entry Criteria Not Met|0
4827755|NCT01122264|16645050|P1|Overall Study|Entry Criteria Not Met|1
4827756|NCT01122264|16645048|P3|Overall Study|Lost to Follow-up|13
4827757|NCT01122264|16645049|P2|Overall Study|Lost to Follow-up|9
4827758|NCT01122264|16645050|P1|Overall Study|Lost to Follow-up|5
4827759|NCT01122264|16645048|P3|Overall Study|Death|0
4827760|NCT01122264|16645049|P2|Overall Study|Death|0
4827761|NCT01122264|16645050|P1|Overall Study|Death|1
4827762|NCT01122264|16645048|P3|Overall Study|Adverse Event|7
4827763|NCT01122264|16645049|P2|Overall Study|Adverse Event|5
4827764|NCT01122264|16645050|P1|Overall Study|Adverse Event|6
4827765|NCT01122173|16645160|P1|Overall Study|Left study for other reasons|3
4827766|NCT01122173|16645160|P1|Overall Study|Withdrawal by Subject|3
4827767|NCT01122173|16645160|P1|Overall Study|Lost to Follow-up|3
4827768|NCT01121991|16645383|P1|Overall Study|No Fertilization|1
4827769|NCT01121991|16645383|P1|Overall Study|No Oocytes Retrieved|3
4827770|NCT01121991|16645383|P1|Overall Study|Lack of Ovarian Response|2
4827771|NCT01121926|16645408|P2|Washout Period|Positive pregnancy test|1
4827772|NCT01121926|16645409|P1|Washout Period|Positive pregnancy test|0
4827773|NCT01121926|16645408|P2|Washout Period|Adverse Event|1
4827774|NCT01121926|16645409|P1|Washout Period|Adverse Event|0
4827775|NCT01121926|16645408|P2|First Intervention Period|Adverse Event|0
4827776|NCT01121926|16645409|P1|First Intervention Period|Adverse Event|1
4827777|NCT01121913|16645427|P4|Third Washout Period|Adverse Event|0
4827778|NCT01121913|16645428|P3|Third Washout Period|Adverse Event|0
4827779|NCT01121913|16645429|P2|Third Washout Period|Adverse Event|0
4827780|NCT01121913|16645430|P1|Third Washout Period|Adverse Event|1
4827781|NCT01121913|16645427|P4|Second Washout Period|Withdrawal by Subject|0
4827782|NCT01121913|16645428|P3|Second Washout Period|Withdrawal by Subject|1
4827783|NCT01121913|16645429|P2|Second Washout Period|Withdrawal by Subject|0
4827784|NCT01121913|16645430|P1|Second Washout Period|Withdrawal by Subject|0
4827785|NCT01121913|16645427|P4|Second Intervention Period|Adverse Event|0
4827786|NCT01121913|16645428|P3|Second Intervention Period|Adverse Event|1
4827787|NCT01121913|16645429|P2|Second Intervention Period|Adverse Event|0
4827788|NCT01121913|16645430|P1|Second Intervention Period|Adverse Event|0
4827789|NCT01121913|16645427|P4|First Washout Period|Withdrawal by Subject|0
4827790|NCT01121913|16645428|P3|First Washout Period|Withdrawal by Subject|0
4827791|NCT01121913|16645429|P2|First Washout Period|Withdrawal by Subject|0
4827792|NCT01121913|16645430|P1|First Washout Period|Withdrawal by Subject|1
4827793|NCT01121913|16645427|P4|First Intervention Period|Adverse Event|0
4827794|NCT01121913|16645428|P3|First Intervention Period|Adverse Event|1
4827795|NCT01121913|16645429|P2|First Intervention Period|Adverse Event|0
4827796|NCT01121913|16645430|P1|First Intervention Period|Adverse Event|0
4827797|NCT01121900|16645460|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4827798|NCT01121900|16645461|P1|Washout Period of 7 Days|Withdrawal by Subject|0
4827799|NCT01121900|16645460|P2|First Intervention Period|Adverse Event|1
4827800|NCT01121900|16645461|P1|First Intervention Period|Adverse Event|1
4827801|NCT01121757|16645481|P2|Combination|Disease Progression|0
4827802|NCT01121757|16645482|P1|Combination|Disease Progression|2
4827803|NCT01121757|16645481|P2|Combination|Physician Decision|1
4827804|NCT01121757|16645482|P1|Combination|Physician Decision|0
4827805|NCT01121757|16645481|P2|First Drug|Disease Progression|2
4827806|NCT01121757|16645482|P1|First Drug|Disease Progression|0
4827807|NCT01121757|16645481|P2|First Drug|Death|0
4827808|NCT01121757|16645482|P1|First Drug|Death|1
4827809|NCT01121666|16645498|P2|Overall Study|Protocol Violation|10
4827810|NCT01121666|16645499|P1|Overall Study|Protocol Violation|29
4827811|NCT01121575|16645555|P6|Overall Study|Death|1
4827812|NCT01121575|16645556|P5|Overall Study|Death|7
4827813|NCT01121575|16645557|P4|Overall Study|Death|1
4827814|NCT01121575|16645558|P3|Overall Study|Death|0
4827815|NCT01121575|16645559|P2|Overall Study|Death|0
4827816|NCT01121575|16645560|P1|Overall Study|Death|6
4827817|NCT01121575|16645555|P6|Overall Study|Unspecified Reasons|10
4827818|NCT01121575|16645556|P5|Overall Study|Unspecified Reasons|13
4827819|NCT01121575|16645557|P4|Overall Study|Unspecified Reasons|5
4827820|NCT01121575|16645558|P3|Overall Study|Unspecified Reasons|7
4827821|NCT01121575|16645559|P2|Overall Study|Unspecified Reasons|6
4827822|NCT01121575|16645560|P1|Overall Study|Unspecified Reasons|8
4827823|NCT01121575|16645555|P6|Overall Study|Participant Refused Further Follow-Up|1
4827824|NCT01121575|16645556|P5|Overall Study|Participant Refused Further Follow-Up|5
4827825|NCT01121575|16645557|P4|Overall Study|Participant Refused Further Follow-Up|0
4827826|NCT01121575|16645558|P3|Overall Study|Participant Refused Further Follow-Up|0
4827827|NCT01121575|16645559|P2|Overall Study|Participant Refused Further Follow-Up|0
4827828|NCT01121575|16645560|P1|Overall Study|Participant Refused Further Follow-Up|0
4827829|NCT01121562|16645684|P1|Overall Study|Met study discontinuation criteria|1
4827830|NCT01121562|16645684|P1|Overall Study|Sponsor Decision|1
4827831|NCT01121562|16645684|P1|Overall Study|Adverse Event|1
4827832|NCT01121562|16645684|P1|Overall Study|Withdrawal by Subject|1
4827833|NCT01121562|16645684|P1|Overall Study|Objective progression or relapse|8
4827834|NCT01121549|16645693|P1|Overall Study|Other|58
4827835|NCT01121549|16645693|P1|Overall Study|Withdrawal by Subject|16
4827836|NCT01121549|16645693|P1|Overall Study|Protocol Violation|33
4827837|NCT01121549|16645693|P1|Overall Study|Pregnancy|1
4827838|NCT01121549|16645693|P1|Overall Study|Study terminated by sponsor|197
4827839|NCT01121549|16645693|P1|Overall Study|Did not meet entrance criteria|9
4827840|NCT01121549|16645693|P1|Overall Study|Lost to Follow-up|12
4827841|NCT01121549|16645693|P1|Overall Study|Lack of Efficacy|11
4827842|NCT01121549|16645693|P1|Overall Study|Adverse Event|10
4827843|NCT01121536|16645704|P1|Overall Study|Other|118
4827844|NCT01121536|16645704|P1|Overall Study|Lost to Follow-up|39
4827845|NCT01121536|16645704|P1|Overall Study|Noncompliance with study procedures|9
4827846|NCT01121536|16645704|P1|Overall Study|Noncompliance with study medication|12
4827847|NCT01121536|16645704|P1|Overall Study|Protocol Violation|20
4827848|NCT01121536|16645704|P1|Overall Study|Withdrawal by Subject|65
4827849|NCT01121536|16645704|P1|Overall Study|Lack of Efficacy|35
4827850|NCT01121536|16645704|P1|Overall Study|Adverse Event|63
4827851|NCT01121484|16645725|P2|Overall Study|Randomized, not treated|4
4827852|NCT01121484|16645726|P1|Overall Study|Randomized, not treated|1
4827853|NCT01121484|16645725|P2|Overall Study|Other|3
4827854|NCT01121484|16645726|P1|Overall Study|Other|3
4827855|NCT01121484|16645725|P2|Overall Study|Discontinuation of study by sponsor|1
4827856|NCT01121484|16645726|P1|Overall Study|Discontinuation of study by sponsor|0
4827857|NCT01121484|16645725|P2|Overall Study|Withdrawal by Subject|7
4827858|NCT01121484|16645726|P1|Overall Study|Withdrawal by Subject|8
4827859|NCT01121484|16645725|P2|Overall Study|Protocol Violation|0
4827860|NCT01121484|16645726|P1|Overall Study|Protocol Violation|1
4827861|NCT01121484|16645725|P2|Overall Study|Physician Decision|3
4827862|NCT01121484|16645726|P1|Overall Study|Physician Decision|0
4827863|NCT01121484|16645725|P2|Overall Study|Lost to Follow-up|9
4827864|NCT01121484|16645726|P1|Overall Study|Lost to Follow-up|5
4827865|NCT01121484|16645725|P2|Overall Study|Lack of Efficacy|11
4827866|NCT01121484|16645726|P1|Overall Study|Lack of Efficacy|3
4827867|NCT01121484|16645725|P2|Overall Study|Adverse Event|5
4827868|NCT01121484|16645726|P1|Overall Study|Adverse Event|12
4827869|NCT01121406|16645744|P2|Overall Study|Not treated|0
4827870|NCT01121406|16645745|P1|Overall Study|Not treated|1
4827871|NCT01121406|16645744|P2|Overall Study|Reason other than specified above|6
4827872|NCT01121406|16645745|P1|Overall Study|Reason other than specified above|2
4827873|NCT01121406|16645744|P2|Overall Study|Refused continuation of study med.|2
4827874|NCT01121406|16645745|P1|Overall Study|Refused continuation of study med.|1
4827875|NCT01121406|16645744|P2|Overall Study|Lost to Follow-up|1
4827876|NCT01121406|16645745|P1|Overall Study|Lost to Follow-up|0
4827877|NCT01121406|16645744|P2|Overall Study|Non-compliant with protocol|2
4827878|NCT01121406|16645745|P1|Overall Study|Non-compliant with protocol|0
4827879|NCT01121406|16645744|P2|Overall Study|Other AE|10
4827880|NCT01121406|16645745|P1|Overall Study|Other AE|3
4827881|NCT01121406|16645744|P2|Overall Study|Wors. or AE of underlying cancer disease|6
4827882|NCT01121406|16645745|P1|Overall Study|Wors. or AE of underlying cancer disease|4
4827883|NCT01121406|16645744|P2|Overall Study|Progressive disease RECIST|28
4827884|NCT01121406|16645745|P1|Overall Study|Progressive disease RECIST|44
4827885|NCT01121393|16645795|P2|Overall Study|Other than listed|0
4827886|NCT01121393|16645796|P1|Overall Study|Other than listed|6
4827887|NCT01121393|16645795|P2|Overall Study|Not treated|9
4827888|NCT01121393|16645796|P1|Overall Study|Not treated|3
4827889|NCT01121393|16645795|P2|Overall Study|Refused cont. medication|7
4827890|NCT01121393|16645796|P1|Overall Study|Refused cont. medication|7
4827891|NCT01121393|16645795|P2|Overall Study|Lost to Follow-up|0
4827892|NCT01121393|16645796|P1|Overall Study|Lost to Follow-up|1
4827893|NCT01121393|16645795|P2|Overall Study|Non-compliant with protocol|3
4827894|NCT01121393|16645796|P1|Overall Study|Non-compliant with protocol|0
4827895|NCT01121393|16645795|P2|Overall Study|Other Adverse events|45
4827896|NCT01121393|16645796|P1|Overall Study|Other Adverse events|24
4827897|NCT01121393|16645795|P2|Overall Study|Progressive disease|20
4827898|NCT01121393|16645796|P1|Overall Study|Progressive disease|201
4827899|NCT01121263|16645841|P2|Overall Study|Withdrawal by Subject|1
4827900|NCT01121263|16645842|P1|Overall Study|Withdrawal by Subject|0
4827901|NCT01121263|16645841|P2|Overall Study|Lost to Follow-up|12
4827902|NCT01121263|16645842|P1|Overall Study|Lost to Follow-up|22
4827903|NCT01121263|16645841|P2|Overall Study|Death|2
4827904|NCT01121263|16645842|P1|Overall Study|Death|3
4827905|NCT01121185|16645933|P2|Overall Study|Not transplanted|0
4827906|NCT01121185|16645934|P1|Overall Study|Not transplanted|1
4827907|NCT01121185|16645933|P2|Overall Study|Not infused|1
4827908|NCT01121185|16645934|P1|Overall Study|Not infused|0
4827909|NCT01121146|16645968|P2|Overall Study|Lost to Follow-up|16
4827910|NCT01121146|16645969|P1|Overall Study|Lost to Follow-up|7
4827911|NCT01121146|16645968|P2|Overall Study|Adverse Event|11
4827912|NCT01121146|16645969|P1|Overall Study|Adverse Event|2
4827913|NCT01121146|16645968|P2|Overall Study|Death|15
4827914|NCT01121146|16645969|P1|Overall Study|Death|17
4827915|NCT01120899|16645990|P1|Overall Study|Withdrawal by Subject|3
4827916|NCT01120782|16646018|P1|Overall Study|Test article shipping error|11
4827917|NCT01120756|16646024|P2|Overall Study|Withdrawal by Subject|1
4827918|NCT01120756|16646025|P1|Overall Study|Withdrawal by Subject|1
4827919|NCT01120717|16646035|P2|Overall Study|Abnormal Test Procedure Result(s)|0
4827920|NCT01120717|16646036|P1|Overall Study|Abnormal Test Procedure Result(s)|1
4827921|NCT01120717|16646035|P2|Overall Study|Death|1
4827922|NCT01120717|16646036|P1|Overall Study|Death|3
4827923|NCT01120717|16646035|P2|Overall Study|Lost to Follow-up|3
4827924|NCT01120717|16646036|P1|Overall Study|Lost to Follow-up|2
4827925|NCT01120717|16646035|P2|Overall Study|Unsatisfactory Therapeutic Effect|3
4827926|NCT01120717|16646036|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
4827927|NCT01120717|16646035|P2|Overall Study|Protocol Deviation|5
4827928|NCT01120717|16646036|P1|Overall Study|Protocol Deviation|2
4827929|NCT01120717|16646035|P2|Overall Study|Adverse Event|6
4827930|NCT01120717|16646036|P1|Overall Study|Adverse Event|10
4827931|NCT01120717|16646035|P2|Overall Study|Withdrawal by Subject|6
4827932|NCT01120717|16646036|P1|Overall Study|Withdrawal by Subject|11
4827933|NCT01120691|16646142|P3|Overall Study|Abnormal laboratory value(s)|4
4827934|NCT01120691|16646143|P2|Overall Study|Abnormal laboratory value(s)|3
4827935|NCT01120691|16646144|P1|Overall Study|Abnormal laboratory value(s)|1
4827936|NCT01120691|16646142|P3|Overall Study|Patient's inability to use the device|0
4827937|NCT01120691|16646143|P2|Overall Study|Patient's inability to use the device|1
4827938|NCT01120691|16646144|P1|Overall Study|Patient's inability to use the device|3
4827939|NCT01120691|16646142|P3|Overall Study|Abnormal test procedure result(s)|1
4827940|NCT01120691|16646143|P2|Overall Study|Abnormal test procedure result(s)|2
4827941|NCT01120691|16646144|P1|Overall Study|Abnormal test procedure result(s)|3
4827942|NCT01120691|16646142|P3|Overall Study|Lost to Follow-up|4
4827943|NCT01120691|16646143|P2|Overall Study|Lost to Follow-up|6
4827944|NCT01120691|16646144|P1|Overall Study|Lost to Follow-up|5
4827945|NCT01120691|16646142|P3|Overall Study|Protocol deviation|12
4827946|NCT01120691|16646143|P2|Overall Study|Protocol deviation|12
4827947|NCT01120691|16646144|P1|Overall Study|Protocol deviation|13
4827948|NCT01120691|16646142|P3|Overall Study|Administrative problems|9
4827949|NCT01120691|16646143|P2|Overall Study|Administrative problems|8
4827950|NCT01120691|16646144|P1|Overall Study|Administrative problems|15
4827951|NCT01120691|16646142|P3|Overall Study|Unsatisfactory therapeutic effect|38
4827952|NCT01120691|16646143|P2|Overall Study|Unsatisfactory therapeutic effect|32
4827953|NCT01120691|16646144|P1|Overall Study|Unsatisfactory therapeutic effect|18
4827954|NCT01120691|16646142|P3|Overall Study|Death|24
4827955|NCT01120691|16646143|P2|Overall Study|Death|22
4827956|NCT01120691|16646144|P1|Overall Study|Death|21
4827957|NCT01120691|16646142|P3|Overall Study|Subject withdrew consent|44
4827958|NCT01120691|16646143|P2|Overall Study|Subject withdrew consent|50
4827959|NCT01120691|16646144|P1|Overall Study|Subject withdrew consent|33
4827960|NCT01120691|16646142|P3|Overall Study|Adverse Event|47
4827961|NCT01120691|16646143|P2|Overall Study|Adverse Event|67
4827962|NCT01120691|16646144|P1|Overall Study|Adverse Event|59
4827963|NCT01120626|16646241|P2|Overall Study|Withdrawal by Subject|0
4827964|NCT01120626|16646242|P1|Overall Study|Withdrawal by Subject|1
4827965|NCT01120600|16646252|P2|Overall Study|Withdrawal by Subject|11
4827966|NCT01120600|16646253|P1|Overall Study|Withdrawal by Subject|10
4827967|NCT01120600|16646252|P2|Overall Study|Protocol Violation|4
4827968|NCT01120600|16646253|P1|Overall Study|Protocol Violation|0
4827969|NCT01120600|16646252|P2|Overall Study|Physician Decision|3
4827970|NCT01120600|16646253|P1|Overall Study|Physician Decision|1
4827971|NCT01120600|16646252|P2|Overall Study|Lost to Follow-up|3
4827972|NCT01120600|16646253|P1|Overall Study|Lost to Follow-up|1
4827973|NCT01120600|16646252|P2|Overall Study|Excessive Bone Loss|4
4827974|NCT01120600|16646253|P1|Overall Study|Excessive Bone Loss|0
4827975|NCT01120600|16646252|P2|Overall Study|Adverse Event|7
4827976|NCT01120600|16646253|P1|Overall Study|Adverse Event|7
4827977|NCT01120379|16646308|P1|Four Year Timepoint|Any other reason for early termination|217
4827978|NCT01120379|16646308|P1|Four Year Timepoint|Physician Decision|5
4827979|NCT01120379|16646308|P1|Four Year Timepoint|Death|131
4827980|NCT01120379|16646308|P1|Four Year Timepoint|Lost to Follow-up|10
4827981|NCT01120379|16646308|P1|Four Year Timepoint|Withdrawal by Subject|5
4827982|NCT01120379|16646308|P1|Three Year Timepoint|Any other reason for early termination|17
4827983|NCT01120379|16646308|P1|Three Year Timepoint|Physician Decision|9
4827984|NCT01120379|16646308|P1|Three Year Timepoint|Death|120
4827985|NCT01120379|16646308|P1|Three Year Timepoint|Lost to Follow-up|43
4827986|NCT01120379|16646308|P1|Three Year Timepoint|Withdrawal by Subject|25
4827987|NCT01120379|16646308|P1|Two Year Timepoint|Any other reason for early termination|4
4827988|NCT01120379|16646308|P1|Two Year Timepoint|Physician Decision|12
4827989|NCT01120379|16646308|P1|Two Year Timepoint|Death|123
4827990|NCT01120379|16646308|P1|Two Year Timepoint|Lost to Follow-up|87
4827991|NCT01120379|16646308|P1|Two Year Timepoint|Withdrawal by Subject|11
4827992|NCT01120379|16646308|P1|One Year Timepoint|Any other reason for early termination|5
4827993|NCT01120379|16646308|P1|One Year Timepoint|Physician Decision|9
4827994|NCT01120379|16646308|P1|One Year Timepoint|Death|108
4827995|NCT01120379|16646308|P1|One Year Timepoint|Lost to Follow-up|115
4827996|NCT01120379|16646308|P1|One Year Timepoint|Withdrawal by Subject|41
4827997|NCT01120275|16646344|P1|Overall Study|Not specific|1
4827998|NCT01120275|16646344|P1|Overall Study|Refusal|1
4827999|NCT01120275|16646344|P1|Overall Study|Withdrawal by Subject|1
4828000|NCT01120275|16646344|P1|Overall Study|Ineligible|3
4828001|NCT01120275|16646344|P1|Overall Study|Progression|27
4828002|NCT01120275|16646344|P1|Overall Study|Adverse Event|3
4828003|NCT01120210|16646411|P2|MAIN INFUSION|Withdrawal by Subject|1
4828004|NCT01120210|16646412|P1|MAIN INFUSION|Withdrawal by Subject|0
4828005|NCT01120210|16646411|P2|MAIN INFUSION|Adverse Event|0
4828006|NCT01120210|16646412|P1|MAIN INFUSION|Adverse Event|1
4828007|NCT01120184|16646462|P3|Overall Study|Death|169
4828008|NCT01120184|16646463|P2|Overall Study|Death|176
4828009|NCT01120184|16646464|P1|Overall Study|Death|170
4828010|NCT01120184|16646462|P3|Overall Study|Subject/ Guardian Decision to Withdraw|25
4828011|NCT01120184|16646463|P2|Overall Study|Subject/ Guardian Decision to Withdraw|29
4828012|NCT01120184|16646464|P1|Overall Study|Subject/ Guardian Decision to Withdraw|32
4828013|NCT01120184|16646462|P3|Overall Study|Sponsor Decision to Terminate Study|143
4828014|NCT01120184|16646463|P2|Overall Study|Sponsor Decision to Terminate Study|144
4828015|NCT01120184|16646464|P1|Overall Study|Sponsor Decision to Terminate Study|133
4828016|NCT01120184|16646462|P3|Overall Study|Reason not Specified|12
4828017|NCT01120184|16646463|P2|Overall Study|Reason not Specified|3
4828018|NCT01120184|16646464|P1|Overall Study|Reason not Specified|8
4828019|NCT01120184|16646462|P3|Overall Study|Physician Decision|3
4828020|NCT01120184|16646463|P2|Overall Study|Physician Decision|1
4828021|NCT01120184|16646464|P1|Overall Study|Physician Decision|9
4828022|NCT01120184|16646462|P3|Overall Study|Lost to Follow-up|11
4828023|NCT01120184|16646463|P2|Overall Study|Lost to Follow-up|13
4828024|NCT01120184|16646464|P1|Overall Study|Lost to Follow-up|13
4828025|NCT01120184|16646462|P3|Overall Study|Adverse Event|0
4828026|NCT01120184|16646463|P2|Overall Study|Adverse Event|1
4828027|NCT01120184|16646464|P1|Overall Study|Adverse Event|0
4828028|NCT01120093|16646586|P5|Treatment Period 5|Adverse Event|0
4828029|NCT01120093|16646587|P4|Treatment Period 5|Adverse Event|1
4828030|NCT01120093|16646588|P3|Treatment Period 5|Adverse Event|0
4828031|NCT01120093|16646589|P2|Treatment Period 5|Adverse Event|1
4828032|NCT01120093|16646590|P1|Treatment Period 5|Adverse Event|0
4828033|NCT01120093|16646586|P5|Treatment Period 4|Adverse Event|0
4828034|NCT01120093|16646587|P4|Treatment Period 4|Adverse Event|0
4828035|NCT01120093|16646588|P3|Treatment Period 4|Adverse Event|0
4828036|NCT01120093|16646589|P2|Treatment Period 4|Adverse Event|0
4828037|NCT01120093|16646590|P1|Treatment Period 4|Adverse Event|1
4828038|NCT01120093|16646586|P5|Treatment Period 3|Withdrawal by Subject|0
4828039|NCT01120093|16646587|P4|Treatment Period 3|Withdrawal by Subject|0
4828040|NCT01120093|16646588|P3|Treatment Period 3|Withdrawal by Subject|1
4828041|NCT01120093|16646589|P2|Treatment Period 3|Withdrawal by Subject|0
4828042|NCT01120093|16646590|P1|Treatment Period 3|Withdrawal by Subject|0
4828043|NCT01120093|16646586|P5|Treatment Period 3|Adverse Event|1
4828044|NCT01120093|16646587|P4|Treatment Period 3|Adverse Event|0
4828045|NCT01120093|16646588|P3|Treatment Period 3|Adverse Event|0
4828046|NCT01120093|16646589|P2|Treatment Period 3|Adverse Event|0
4828047|NCT01120093|16646590|P1|Treatment Period 3|Adverse Event|0
4828048|NCT01120093|16646586|P5|Treatment Period 3|Lack of Efficacy|0
4828049|NCT01120093|16646587|P4|Treatment Period 3|Lack of Efficacy|1
4828050|NCT01120093|16646588|P3|Treatment Period 3|Lack of Efficacy|0
4828051|NCT01120093|16646589|P2|Treatment Period 3|Lack of Efficacy|0
4828052|NCT01120093|16646590|P1|Treatment Period 3|Lack of Efficacy|0
4828053|NCT01120093|16646586|P5|Treatment Period 2|Withdrawal by Subject|1
4828054|NCT01120093|16646587|P4|Treatment Period 2|Withdrawal by Subject|0
4828055|NCT01120093|16646588|P3|Treatment Period 2|Withdrawal by Subject|0
4828056|NCT01120093|16646589|P2|Treatment Period 2|Withdrawal by Subject|0
4828057|NCT01120093|16646590|P1|Treatment Period 2|Withdrawal by Subject|0
4828058|NCT01120093|16646586|P5|Treatment Period 2|Adverse Event|0
4828059|NCT01120093|16646587|P4|Treatment Period 2|Adverse Event|1
4828060|NCT01120093|16646588|P3|Treatment Period 2|Adverse Event|0
4828061|NCT01120093|16646589|P2|Treatment Period 2|Adverse Event|0
4828062|NCT01120093|16646590|P1|Treatment Period 2|Adverse Event|0
4828063|NCT01120093|16646586|P5|Treatment Period 1|Withdrawal by Subject|0
4828064|NCT01120093|16646587|P4|Treatment Period 1|Withdrawal by Subject|0
4828065|NCT01120093|16646588|P3|Treatment Period 1|Withdrawal by Subject|0
4828066|NCT01120093|16646589|P2|Treatment Period 1|Withdrawal by Subject|1
4828067|NCT01120093|16646590|P1|Treatment Period 1|Withdrawal by Subject|0
4828068|NCT01120093|16646586|P5|Treatment Period 1|Adverse Event|1
4828069|NCT01120093|16646587|P4|Treatment Period 1|Adverse Event|0
4828070|NCT01120093|16646588|P3|Treatment Period 1|Adverse Event|1
4828071|NCT01120093|16646589|P2|Treatment Period 1|Adverse Event|0
4828072|NCT01120093|16646590|P1|Treatment Period 1|Adverse Event|0
4828073|NCT01120067|16646619|P2|Overall Study|fail to engage >3 sessions|0
4828074|NCT01120067|16646620|P1|Overall Study|fail to engage >3 sessions|2
4828075|NCT01120067|16646619|P2|Overall Study|Lost to Follow-up|1
4828076|NCT01120067|16646620|P1|Overall Study|Lost to Follow-up|3
4828077|NCT01120028|16646630|P4|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
4828078|NCT01120028|16646631|P3|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0
4828079|NCT01120028|16646632|P2|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18
4828080|NCT01120028|16646633|P1|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14
4828081|NCT01120028|16646630|P4|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
4828082|NCT01120028|16646631|P3|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
4828083|NCT01120028|16646632|P2|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5
4828084|NCT01120028|16646633|P1|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0
4828085|NCT01119963|16646657|P2|Overall Study|Lost to Follow-up|1
4828086|NCT01119963|16646658|P1|Overall Study|Lost to Follow-up|1
4828087|NCT01119950|16646668|P1|Overall Study|Death|1
4828088|NCT01119950|16646668|P1|Overall Study|Abnormal lab value|1
4828089|NCT01119950|16646668|P1|Overall Study|Administrative|2
4828090|NCT01119950|16646668|P1|Overall Study|Lost to Follow-up|4
4828091|NCT01119950|16646668|P1|Overall Study|Protocol Violation|5
4828092|NCT01119950|16646668|P1|Overall Study|Withdrawal by Subject|9
4828093|NCT01119950|16646668|P1|Overall Study|Adverse Event|25
4828094|NCT01119937|16646915|P2|Overall Study|Withdrawal by Subject|1
4828095|NCT01119937|16646916|P1|Overall Study|Withdrawal by Subject|2
4828096|NCT01119937|16646915|P2|Overall Study|Unsatisfactory therapeutic effect|0
4828097|NCT01119937|16646916|P1|Overall Study|Unsatisfactory therapeutic effect|3
4828098|NCT01119937|16646915|P2|Overall Study|Protocol deviation|1
4828099|NCT01119937|16646916|P1|Overall Study|Protocol deviation|3
4828100|NCT01119937|16646915|P2|Overall Study|Adverse Event|5
4828101|NCT01119937|16646916|P1|Overall Study|Adverse Event|11
4828102|NCT01119898|16646944|P2|Overall Study|Randomized in error did not participate|0
4828103|NCT01119898|16646945|P1|Overall Study|Randomized in error did not participate|1
4828104|NCT01119898|16646944|P2|Overall Study|Medical procedure|0
4828105|NCT01119898|16646945|P1|Overall Study|Medical procedure|1
4828106|NCT01119898|16646944|P2|Overall Study|Protocol Violation|1
4828107|NCT01119898|16646945|P1|Overall Study|Protocol Violation|1
4828108|NCT01119898|16646944|P2|Overall Study|Lack of Efficacy|2
4828109|NCT01119898|16646945|P1|Overall Study|Lack of Efficacy|0
4828110|NCT01119898|16646944|P2|Overall Study|Withdrawal by Subject|4
4828111|NCT01119898|16646945|P1|Overall Study|Withdrawal by Subject|1
4828112|NCT01119898|16646944|P2|Overall Study|Adverse Event|5
4828113|NCT01119898|16646945|P1|Overall Study|Adverse Event|4
4828114|NCT01119859|16646971|P2|Overall Study|Failure to return|0
4828115|NCT01119859|16646972|P1|Overall Study|Failure to return|3
4828116|NCT01119859|16646971|P2|Overall Study|Refused treatment|6
4828117|NCT01119859|16646972|P1|Overall Study|Refused treatment|3
4828118|NCT01119859|16646971|P2|Overall Study|Insufficient therapeutic response|14
4828119|NCT01119859|16646972|P1|Overall Study|Insufficient therapeutic response|7
4828120|NCT01119859|16646971|P2|Overall Study|Death|0
4828121|NCT01119859|16646972|P1|Overall Study|Death|2
4828122|NCT01119859|16646971|P2|Overall Study|Adverse Event|10
4828123|NCT01119859|16646972|P1|Overall Study|Adverse Event|9
4828124|NCT01119846|16646991|P3|Overall Study|Withdrawal by Subject|4
4828125|NCT01119846|16646992|P2|Overall Study|Withdrawal by Subject|0
4828126|NCT01119846|16646993|P1|Overall Study|Withdrawal by Subject|0
4828127|NCT01119846|16646991|P3|Overall Study|Protocol Violation|1
4828128|NCT01119846|16646992|P2|Overall Study|Protocol Violation|0
4828129|NCT01119846|16646993|P1|Overall Study|Protocol Violation|0
4828130|NCT01119846|16646991|P3|Overall Study|Physician Decision|0
4828131|NCT01119846|16646992|P2|Overall Study|Physician Decision|0
4828132|NCT01119846|16646993|P1|Overall Study|Physician Decision|1
4828133|NCT01119846|16646991|P3|Overall Study|Adverse Event|6
4828134|NCT01119846|16646992|P2|Overall Study|Adverse Event|0
4828135|NCT01119846|16646993|P1|Overall Study|Adverse Event|1
4828136|NCT01119768|16647207|P2|Treatment Period|Lack of Efficacy|25
4828137|NCT01119768|16647208|P1|Treatment Period|Lack of Efficacy|18
4828138|NCT01119703|16647264|P2|Overall Study|Adverse Event|1
4828139|NCT01119703|16647265|P1|Overall Study|Adverse Event|0
4828140|NCT01119625|16647279|P2|Overall Study|Other|1
4828141|NCT01119625|16647280|P1|Overall Study|Other|0
4828142|NCT01119625|16647279|P2|Overall Study|Withdrawal by Subject|1
4828143|NCT01119625|16647280|P1|Overall Study|Withdrawal by Subject|2
4828144|NCT01119625|16647279|P2|Overall Study|Lost to Follow-up|2
4828145|NCT01119625|16647280|P1|Overall Study|Lost to Follow-up|1
4828146|NCT01119508|16647320|P1|Overall Study|Died before tumor response evaluation|1
4828147|NCT01119508|16647320|P1|Overall Study|Withdrawal by Subject|2
4828148|NCT01119508|16647320|P1|Overall Study|Adverse Event|56
4828149|NCT01119443|16647400|P2|Crossover Period 1 (5 Days)|Adverse Event|1
4828150|NCT01119443|16647401|P1|Crossover Period 1 (5 Days)|Adverse Event|0
4828151|NCT01119287|16647444|P6|Overall Study|Patient Decision, not related to AE|0
4828152|NCT01119287|16647445|P5|Overall Study|Patient Decision, not related to AE|1
4828153|NCT01119287|16647446|P4|Overall Study|Patient Decision, not related to AE|2
4828154|NCT01119287|16647447|P3|Overall Study|Patient Decision, not related to AE|2
4828155|NCT01119287|16647448|P2|Overall Study|Patient Decision, not related to AE|0
4828156|NCT01119287|16647449|P1|Overall Study|Patient Decision, not related to AE|0
4828157|NCT01119248|16647462|P1|Overall Study|Physician Decision|5
4828158|NCT01119131|16647512|P3|Overall Study|Physician Decision|1
4828159|NCT01119131|16647513|P2|Overall Study|Physician Decision|0
4828160|NCT01119131|16647514|P1|Overall Study|Physician Decision|0
4828161|NCT01119131|16647512|P3|Overall Study|Non-Compliance|4
4828162|NCT01119131|16647513|P2|Overall Study|Non-Compliance|0
4828163|NCT01119131|16647514|P1|Overall Study|Non-Compliance|1
4828164|NCT01119131|16647512|P3|Overall Study|Adverse Event|1
4828165|NCT01119131|16647513|P2|Overall Study|Adverse Event|1
4828166|NCT01119131|16647514|P1|Overall Study|Adverse Event|1
4828167|NCT01119118|16647543|P1|Overall Study|Adverse Event|1
4828168|NCT01119105|16647554|P3|Overall Study|Other|0
4828169|NCT01119105|16647555|P2|Overall Study|Other|1
4828170|NCT01119105|16647556|P1|Overall Study|Other|1
4828171|NCT01119105|16647554|P3|Overall Study|study drug missed on 2 consecutive days|1
4828172|NCT01119105|16647555|P2|Overall Study|study drug missed on 2 consecutive days|2
4828173|NCT01119105|16647556|P1|Overall Study|study drug missed on 2 consecutive days|1
4828174|NCT01119105|16647554|P3|Overall Study|Adverse Event|1
4828175|NCT01119105|16647555|P2|Overall Study|Adverse Event|0
4828176|NCT01119105|16647556|P1|Overall Study|Adverse Event|1
4828177|NCT01119105|16647554|P3|Overall Study|Lost to Follow-up|5
4828178|NCT01119105|16647555|P2|Overall Study|Lost to Follow-up|2
4828179|NCT01119105|16647556|P1|Overall Study|Lost to Follow-up|0
4828180|NCT01119105|16647554|P3|Overall Study|Withdrawal by Subject|1
4828181|NCT01119105|16647555|P2|Overall Study|Withdrawal by Subject|1
4828182|NCT01119105|16647556|P1|Overall Study|Withdrawal by Subject|1
4828183|NCT01119001|16647571|P1|Overall Study|Withdrawal by Subject|2
4828184|NCT01118975|16647615|P2|Overall Study|Adverse Event|1
4828185|NCT01118975|16647616|P1|Overall Study|Adverse Event|0
4828186|NCT01118962|16647622|P1|Overall Study|Non-compliance with Medicinal Product|1
4828187|NCT01118962|16647622|P1|Overall Study|Pregnancy|1
4828188|NCT01118962|16647622|P1|Overall Study|Withdrawal by Subject|4
4828189|NCT01118962|16647622|P1|Overall Study|Protocol Violation|1
4828190|NCT01118962|16647622|P1|Overall Study|Lack of Efficacy|1
4828191|NCT01118962|16647622|P1|Overall Study|Adverse Event|2
4828192|NCT01118949|16647627|P1|Overall Study|Withdrawal by Subject|4
4828193|NCT01118949|16647627|P1|Overall Study|Adverse Event|5
4828194|NCT01118780|16647657|P2|Overall Study|Withdrawal by Subject|8
4828195|NCT01118780|16647658|P1|Overall Study|Withdrawal by Subject|13
4828196|NCT01118780|16647657|P2|Overall Study|Protocol Violation|6
4828197|NCT01118780|16647658|P1|Overall Study|Protocol Violation|3
4828198|NCT01118780|16647657|P2|Overall Study|Physician Decision|0
4828199|NCT01118780|16647658|P1|Overall Study|Physician Decision|2
4828200|NCT01118780|16647657|P2|Overall Study|Lack of Efficacy|6
4828201|NCT01118780|16647658|P1|Overall Study|Lack of Efficacy|2
4828202|NCT01118780|16647657|P2|Overall Study|Death|0
4828203|NCT01118780|16647658|P1|Overall Study|Death|1
4828204|NCT01118780|16647657|P2|Overall Study|Adverse Event|15
4828205|NCT01118780|16647658|P1|Overall Study|Adverse Event|15
4828206|NCT01118728|16647716|P1|Overall Study|Lost to Follow-up|4
4828207|NCT01118728|16647716|P1|Overall Study|Withdrawal by Subject|3
4828208|NCT01118728|16647716|P1|Overall Study|Sponsor's decision to discontinue study|172
4828209|NCT01118728|16647716|P1|Overall Study|Lack of Efficacy|27
4828210|NCT01118728|16647716|P1|Overall Study|Adverse Event|17
4828211|NCT01118663|16647723|P2|Overall Study|Withdrawal by Subject|1
4828212|NCT01118663|16647724|P1|Overall Study|Withdrawal by Subject|0
4828213|NCT01118663|16647723|P2|Overall Study|Adverse Event|1
4828214|NCT01118663|16647724|P1|Overall Study|Adverse Event|2
4828215|NCT01118455|16647747|P2|Baseline [Visits 1 & 2]|Adverse Event|0
4828216|NCT01118455|16647748|P1|Baseline [Visits 1 & 2]|Adverse Event|1
4828217|NCT01118377|16647776|P1|Overall Study|Failure to Return|3
4828218|NCT01118377|16647776|P1|Overall Study|Death|38
4828219|NCT01118377|16647776|P1|Overall Study|Did Not Receive Study Medication|1
4828220|NCT01118351|16647782|P1|Overall Study|Withdrawal by Subject|1
4828221|NCT01118351|16647782|P1|Overall Study|Adverse Event|3
4828222|NCT01118325|16647806|P3|Overall Study|Adverse Event|1
4828223|NCT01118325|16647807|P2|Overall Study|Adverse Event|0
4828224|NCT01118325|16647808|P1|Overall Study|Adverse Event|1
4828225|NCT01118312|16647854|P2|Overall Study|Withdrawal by Subject|3
4828226|NCT01118312|16647855|P1|Overall Study|Withdrawal by Subject|1
4828227|NCT01118312|16647854|P2|Overall Study|Lost to Follow-up|32
4828228|NCT01118312|16647855|P1|Overall Study|Lost to Follow-up|33
4828229|NCT01118299|16647865|P2|Overall Study|Enrollment Closure, Protocol Amendment|15
4828230|NCT01118299|16647866|P1|Overall Study|Enrollment Closure, Protocol Amendment|6
4828231|NCT01118299|16647865|P2|Overall Study|Lost to Follow-up|1
4828232|NCT01118299|16647866|P1|Overall Study|Lost to Follow-up|2
4828233|NCT01118299|16647865|P2|Overall Study|Withdrawal by Subject|8
4828234|NCT01118299|16647866|P1|Overall Study|Withdrawal by Subject|8
4828235|NCT01118299|16647865|P2|Overall Study|Death|5
4828236|NCT01118299|16647866|P1|Overall Study|Death|7
4828237|NCT01118143|16648063|P2|Overall Study|Withdrawal by Subject|5
4828238|NCT01118143|16648064|P1|Overall Study|Withdrawal by Subject|2
4828239|NCT01118117|16648074|P2|Overall Study|Missed 12 Month Visit|0
4828240|NCT01118117|16648075|P1|Overall Study|Missed 12 Month Visit|7
4828241|NCT01118117|16648074|P2|Overall Study|Lost to Follow-up|0
4828242|NCT01118117|16648075|P1|Overall Study|Lost to Follow-up|6
4828243|NCT01118117|16648074|P2|Overall Study|Death|0
4828244|NCT01118117|16648075|P1|Overall Study|Death|8
4828245|NCT01118052|16648107|P1|Overall Study|Never treated|2
4828246|NCT01117987|16648130|P2|Overall Study|Administrative problems|22
4828247|NCT01117987|16648131|P1|Overall Study|Administrative problems|25
4828248|NCT01117987|16648130|P2|Overall Study|Adverse Event|26
4828249|NCT01117987|16648131|P1|Overall Study|Adverse Event|19
4828250|NCT01117987|16648130|P2|Overall Study|Withdrawal by Subject|10
4828251|NCT01117987|16648131|P1|Overall Study|Withdrawal by Subject|5
4828252|NCT01117987|16648130|P2|Overall Study|Death|10
4828253|NCT01117987|16648131|P1|Overall Study|Death|5
4828254|NCT01117987|16648130|P2|Overall Study|Lack of Efficacy|4
4828255|NCT01117987|16648131|P1|Overall Study|Lack of Efficacy|3
4828256|NCT01117987|16648130|P2|Overall Study|Abnormal test procedure result|0
4828257|NCT01117987|16648131|P1|Overall Study|Abnormal test procedure result|2
4828258|NCT01117987|16648130|P2|Overall Study|Lost to Follow-up|1
4828259|NCT01117987|16648131|P1|Overall Study|Lost to Follow-up|1
4828260|NCT01117987|16648130|P2|Overall Study|Subject no longer requires study drug|0
4828261|NCT01117987|16648131|P1|Overall Study|Subject no longer requires study drug|1
4828262|NCT01117987|16648130|P2|Overall Study|Protocol deviation|1
4828263|NCT01117987|16648131|P1|Overall Study|Protocol deviation|0
4828264|NCT01117870|16648152|P2|Overall Study|Inability to place needle|0
4828265|NCT01117870|16648153|P1|Overall Study|Inability to place needle|1
4828266|NCT01117857|16648167|P1|Overall Study|Physician Decision|1
4828267|NCT01117857|16648167|P1|Overall Study|Withdrawal by Subject|4
4828268|NCT01117857|16648167|P1|Overall Study|Lost to Follow-up|4
4828269|NCT01117766|16648175|P2|Second Intervention|Withdrawal by Subject|1
4828270|NCT01117766|16648176|P1|Second Intervention|Withdrawal by Subject|0
4828271|NCT01117766|16648175|P2|Second Intervention|Adverse Event|2
4828272|NCT01117766|16648176|P1|Second Intervention|Adverse Event|0
4828273|NCT01117766|16648175|P2|Second Intervention|Other|2
4828274|NCT01117766|16648176|P1|Second Intervention|Other|1
4828275|NCT01117766|16648175|P2|Second Intervention|Lost to Follow-up|0
4828276|NCT01117766|16648176|P1|Second Intervention|Lost to Follow-up|1
4828277|NCT01117766|16648175|P2|Washout Period|Protocol Violation|2
4828278|NCT01117766|16648176|P1|Washout Period|Protocol Violation|0
4828279|NCT01117766|16648175|P2|First Intervention|Protocol Violation|0
4828280|NCT01117766|16648176|P1|First Intervention|Protocol Violation|1
4828281|NCT01117766|16648175|P2|First Intervention|Adverse Event|1
4828282|NCT01117766|16648176|P1|First Intervention|Adverse Event|0
4828283|NCT01117623|16648213|P8|Overall Study|Invest. text: completed all planned txs|0
4828284|NCT01117623|16648214|P7|Overall Study|Invest. text: completed all planned txs|0
4828285|NCT01117623|16648215|P6|Overall Study|Invest. text: completed all planned txs|1
4828286|NCT01117623|16648216|P5|Overall Study|Invest. text: completed all planned txs|0
4828287|NCT01117623|16648217|P4|Overall Study|Invest. text: completed all planned txs|0
4828288|NCT01117623|16648218|P3|Overall Study|Invest. text: completed all planned txs|0
4828289|NCT01117623|16648219|P2|Overall Study|Invest. text: completed all planned txs|0
4828290|NCT01117623|16648220|P1|Overall Study|Invest. text: completed all planned txs|0
4828291|NCT01117623|16648213|P8|Overall Study|Non-compliance with study medication|1
4828292|NCT01117623|16648214|P7|Overall Study|Non-compliance with study medication|0
4828293|NCT01117623|16648215|P6|Overall Study|Non-compliance with study medication|0
4828294|NCT01117623|16648216|P5|Overall Study|Non-compliance with study medication|0
4828295|NCT01117623|16648217|P4|Overall Study|Non-compliance with study medication|0
4828296|NCT01117623|16648218|P3|Overall Study|Non-compliance with study medication|0
4828297|NCT01117623|16648219|P2|Overall Study|Non-compliance with study medication|0
4828298|NCT01117623|16648220|P1|Overall Study|Non-compliance with study medication|0
4828299|NCT01117623|16648213|P8|Overall Study|Withdrawal by Subject|1
4828300|NCT01117623|16648214|P7|Overall Study|Withdrawal by Subject|1
4828301|NCT01117623|16648215|P6|Overall Study|Withdrawal by Subject|1
4828302|NCT01117623|16648216|P5|Overall Study|Withdrawal by Subject|0
4828303|NCT01117623|16648217|P4|Overall Study|Withdrawal by Subject|0
4828304|NCT01117623|16648218|P3|Overall Study|Withdrawal by Subject|2
4828305|NCT01117623|16648219|P2|Overall Study|Withdrawal by Subject|0
4828306|NCT01117623|16648220|P1|Overall Study|Withdrawal by Subject|0
4828307|NCT01117623|16648213|P8|Overall Study|Disease progression, recurrence, relapse|22
4828308|NCT01117623|16648214|P7|Overall Study|Disease progression, recurrence, relapse|5
4828309|NCT01117623|16648215|P6|Overall Study|Disease progression, recurrence, relapse|14
4828310|NCT01117623|16648216|P5|Overall Study|Disease progression, recurrence, relapse|8
4828311|NCT01117623|16648217|P4|Overall Study|Disease progression, recurrence, relapse|6
4828312|NCT01117623|16648218|P3|Overall Study|Disease progression, recurrence, relapse|5
4828313|NCT01117623|16648219|P2|Overall Study|Disease progression, recurrence, relapse|6
4828314|NCT01117623|16648220|P1|Overall Study|Disease progression, recurrence, relapse|3
4828315|NCT01117623|16648213|P8|Overall Study|Adverse Event|2
4828316|NCT01117623|16648214|P7|Overall Study|Adverse Event|0
4828317|NCT01117623|16648215|P6|Overall Study|Adverse Event|0
4828318|NCT01117623|16648216|P5|Overall Study|Adverse Event|2
4828319|NCT01117623|16648217|P4|Overall Study|Adverse Event|0
4828320|NCT01117623|16648218|P3|Overall Study|Adverse Event|4
4828321|NCT01117623|16648219|P2|Overall Study|Adverse Event|2
4828322|NCT01117623|16648220|P1|Overall Study|Adverse Event|0
4828323|NCT01117480|16648372|P1|Overall Study|Did Not Start Adalimumab Therapy|20
4828324|NCT01117480|16648372|P1|Overall Study|Protocol Violation|8
4828325|NCT01117454|16648380|P2|Overall Study|Pregnancy|1
4828326|NCT01117454|16648381|P1|Overall Study|Pregnancy|0
4828327|NCT01117428|16648393|P6|Overall Study|Progressive disease|17
4828328|NCT01117428|16648394|P5|Overall Study|Progressive disease|16
4828329|NCT01117428|16648395|P4|Overall Study|Progressive disease|12
4828330|NCT01117428|16648396|P3|Overall Study|Progressive disease|10
4828331|NCT01117428|16648397|P2|Overall Study|Progressive disease|27
4828332|NCT01117428|16648398|P1|Overall Study|Progressive disease|15
4828333|NCT01117428|16648393|P6|Overall Study|Withdrawal by Subject|0
4828334|NCT01117428|16648394|P5|Overall Study|Withdrawal by Subject|0
4828335|NCT01117428|16648395|P4|Overall Study|Withdrawal by Subject|0
4828336|NCT01117428|16648396|P3|Overall Study|Withdrawal by Subject|1
4828337|NCT01117428|16648397|P2|Overall Study|Withdrawal by Subject|0
4828338|NCT01117428|16648398|P1|Overall Study|Withdrawal by Subject|0
4828339|NCT01117428|16648393|P6|Overall Study|Physician Decision|0
4828340|NCT01117428|16648394|P5|Overall Study|Physician Decision|0
4828341|NCT01117428|16648395|P4|Overall Study|Physician Decision|0
4828342|NCT01117428|16648396|P3|Overall Study|Physician Decision|0
4828343|NCT01117428|16648397|P2|Overall Study|Physician Decision|1
4828344|NCT01117428|16648398|P1|Overall Study|Physician Decision|0
4828345|NCT01117428|16648393|P6|Overall Study|Death|1
4828346|NCT01117428|16648394|P5|Overall Study|Death|0
4828347|NCT01117428|16648395|P4|Overall Study|Death|0
4828348|NCT01117428|16648396|P3|Overall Study|Death|2
4828349|NCT01117428|16648397|P2|Overall Study|Death|1
4828350|NCT01117428|16648398|P1|Overall Study|Death|0
4828351|NCT01117428|16648393|P6|Overall Study|Adverse Event|2
4828352|NCT01117428|16648394|P5|Overall Study|Adverse Event|1
4828353|NCT01117428|16648395|P4|Overall Study|Adverse Event|0
4828354|NCT01117428|16648396|P3|Overall Study|Adverse Event|0
4828355|NCT01117428|16648397|P2|Overall Study|Adverse Event|0
4828356|NCT01117428|16648398|P1|Overall Study|Adverse Event|4
4828357|NCT01117428|16648393|P6|Overall Study|Lack of Efficacy|0
4828358|NCT01117428|16648394|P5|Overall Study|Lack of Efficacy|0
4828359|NCT01117428|16648395|P4|Overall Study|Lack of Efficacy|0
4828360|NCT01117428|16648396|P3|Overall Study|Lack of Efficacy|0
4828361|NCT01117428|16648397|P2|Overall Study|Lack of Efficacy|0
4828362|NCT01117428|16648398|P1|Overall Study|Lack of Efficacy|1
4828363|NCT01117350|16648432|P2|Extension Period|Prohibited medication|1
4828364|NCT01117350|16648433|P1|Extension Period|Prohibited medication|0
4828365|NCT01117350|16648432|P2|Extension Period|Inclusion criteria not respected|1
4828366|NCT01117350|16648433|P1|Extension Period|Inclusion criteria not respected|0
4828367|NCT01117350|16648432|P2|Extension Period|Lack of Efficacy|2
4828368|NCT01117350|16648433|P1|Extension Period|Lack of Efficacy|0
4828369|NCT01117350|16648432|P2|Extension Period|Withdrawal by Subject|3
4828370|NCT01117350|16648433|P1|Extension Period|Withdrawal by Subject|0
4828371|NCT01117350|16648432|P2|Extension Period|Lost to Follow-up|2
4828372|NCT01117350|16648433|P1|Extension Period|Lost to Follow-up|0
4828373|NCT01117350|16648432|P2|Extension Period|Protocol Violation|2
4828374|NCT01117350|16648433|P1|Extension Period|Protocol Violation|0
4828375|NCT01117350|16648432|P2|Extension Period|Adverse Event|2
4828376|NCT01117350|16648433|P1|Extension Period|Adverse Event|0
4828377|NCT01117350|16648432|P2|Extension Period|Not included in extension, not treated|50
4828378|NCT01117350|16648433|P1|Extension Period|Not included in extension, not treated|0
4828379|NCT01117350|16648432|P2|Comparative Period|Move to another city/country|1
4828380|NCT01117350|16648433|P1|Comparative Period|Move to another city/country|2
4828381|NCT01117350|16648432|P2|Comparative Period|Physician Decision|1
4828382|NCT01117350|16648433|P1|Comparative Period|Physician Decision|0
4828383|NCT01117350|16648432|P2|Comparative Period|Lack of Efficacy|0
4828384|NCT01117350|16648433|P1|Comparative Period|Lack of Efficacy|1
4828385|NCT01117350|16648432|P2|Comparative Period|Protocol Violation|12
4828386|NCT01117350|16648433|P1|Comparative Period|Protocol Violation|8
4828387|NCT01117350|16648432|P2|Comparative Period|Withdrawal by Subject|13
4828388|NCT01117350|16648433|P1|Comparative Period|Withdrawal by Subject|9
4828389|NCT01117350|16648432|P2|Comparative Period|Lost to Follow-up|7
4828390|NCT01117350|16648433|P1|Comparative Period|Lost to Follow-up|11
4828391|NCT01117350|16648432|P2|Comparative Period|Adverse Event|33
4828392|NCT01117350|16648433|P1|Comparative Period|Adverse Event|6
4828393|NCT01117350|16648432|P2|Comparative Period|Not Treated|8
4828394|NCT01117350|16648433|P1|Comparative Period|Not Treated|5
4828395|NCT01117337|16648465|P2|Overall Study|Lost to Follow-up|0
4828396|NCT01117337|16648466|P1|Overall Study|Lost to Follow-up|4
4828397|NCT01117181|16648487|P2|Overall Study|Withdrawal by Subject|2
4828398|NCT01117181|16648488|P1|Overall Study|Withdrawal by Subject|0
4828399|NCT01117181|16648487|P2|Overall Study|Lost to Follow-up|0
4828400|NCT01117181|16648488|P1|Overall Study|Lost to Follow-up|1
4828401|NCT01117051|16648521|P2|Overall Study|Convenience issue|0
4828402|NCT01117051|16648522|P1|Overall Study|Convenience issue|1
4828403|NCT01117051|16648521|P2|Overall Study|Randomized by mistake|1
4828404|NCT01117051|16648522|P1|Overall Study|Randomized by mistake|0
4828405|NCT01117051|16648521|P2|Overall Study|Surgical procedure|1
4828406|NCT01117051|16648522|P1|Overall Study|Surgical procedure|0
4828407|NCT01117051|16648521|P2|Overall Study|Sponsor's decision|1
4828408|NCT01117051|16648522|P1|Overall Study|Sponsor's decision|3
4828409|NCT01117051|16648521|P2|Overall Study|Did not meet in-/exclusion criteria|1
4828410|NCT01117051|16648522|P1|Overall Study|Did not meet in-/exclusion criteria|0
4828411|NCT01117051|16648521|P2|Overall Study|Lost to Follow-up|1
4828412|NCT01117051|16648522|P1|Overall Study|Lost to Follow-up|0
4828413|NCT01117051|16648521|P2|Overall Study|Adverse Event|3
4828414|NCT01117051|16648522|P1|Overall Study|Adverse Event|4
4828415|NCT01117051|16648521|P2|Overall Study|Withdrawal by Subject|3
4828416|NCT01117051|16648522|P1|Overall Study|Withdrawal by Subject|5
4828417|NCT01117012|16648532|P2|Overall Study|Undefined|3
4828418|NCT01117012|16648533|P1|Overall Study|Undefined|4
4828419|NCT01117012|16648532|P2|Overall Study|Withdrawal by Subject|0
4828420|NCT01117012|16648533|P1|Overall Study|Withdrawal by Subject|3
4828421|NCT01117012|16648532|P2|Overall Study|Death|1
4828422|NCT01117012|16648533|P1|Overall Study|Death|1
4828423|NCT01117012|16648532|P2|Overall Study|Adverse Event|1
4828424|NCT01117012|16648533|P1|Overall Study|Adverse Event|0
4828425|NCT01116882|16648707|P2|12-month|Withdrawal by Subject|8
4828426|NCT01116882|16648708|P1|12-month|Withdrawal by Subject|5
4828427|NCT01116882|16648707|P2|12-month|Other Reasons|49
4828428|NCT01116882|16648708|P1|12-month|Other Reasons|151
4828429|NCT01116882|16648707|P2|12-month|Lost to Follow-up|42
4828430|NCT01116882|16648708|P1|12-month|Lost to Follow-up|111
4828431|NCT01116882|16648707|P2|30-day|Other Reasons|6
4828432|NCT01116882|16648708|P1|30-day|Other Reasons|16
4828433|NCT01116882|16648707|P2|30-day|Withdrawal by Subject|4
4828434|NCT01116882|16648708|P1|30-day|Withdrawal by Subject|2
4828435|NCT01116882|16648707|P2|30-day|Lost to Follow-up|21
4828436|NCT01116882|16648708|P1|30-day|Lost to Follow-up|50
4828437|NCT01116687|16648746|P1|Overall Study|Withdrawal by Subject|4
4828438|NCT01116648|16648773|P15|Phase 1 Dose Level 3|Adverse Event|0
4828439|NCT01116648|16648774|P14|Phase 1 Dose Level 3|Adverse Event|0
4828440|NCT01116648|16648775|P13|Phase 1 Dose Level 3|Adverse Event|0
4828441|NCT01116648|16648776|P12|Phase 1 Dose Level 3|Adverse Event|0
4828442|NCT01116648|16648777|P11|Phase 1 Dose Level 3|Adverse Event|0
4828443|NCT01116648|16648778|P10|Phase 1 Dose Level 3|Adverse Event|0
4828444|NCT01116648|16648779|P9|Phase 1 Dose Level 3|Adverse Event|0
4828445|NCT01116648|16648780|P8|Phase 1 Dose Level 3|Adverse Event|0
4828446|NCT01116648|16648781|P7|Phase 1 Dose Level 3|Adverse Event|0
4828447|NCT01116648|16648782|P6|Phase 1 Dose Level 3|Adverse Event|0
4828448|NCT01116648|16648783|P5|Phase 1 Dose Level 3|Adverse Event|0
4828449|NCT01116648|16648784|P4|Phase 1 Dose Level 3|Adverse Event|2
4828450|NCT01116648|16648785|P3|Phase 1 Dose Level 3|Adverse Event|0
4828451|NCT01116648|16648786|P2|Phase 1 Dose Level 3|Adverse Event|0
4828452|NCT01116648|16648787|P1|Phase 1 Dose Level 3|Adverse Event|0
4828453|NCT01116544|16648814|P2|Overall Study|Withdrawal by Subject|1
4828454|NCT01116544|16648815|P1|Overall Study|Withdrawal by Subject|1
4828455|NCT01116544|16648814|P2|Overall Study|Protocol Violation|0
4828456|NCT01116544|16648815|P1|Overall Study|Protocol Violation|1
4828457|NCT01116427|16648841|P2|Extension Phase|Not using appropriate birth control|0
4828458|NCT01116427|16648842|P1|Extension Phase|Not using appropriate birth control|1
4828459|NCT01116427|16648841|P2|Extension Phase|Withdrawal by Subject|1
4828460|NCT01116427|16648842|P1|Extension Phase|Withdrawal by Subject|5
4828461|NCT01116427|16648841|P2|Extension Phase|Lost to Follow-up|0
4828462|NCT01116427|16648842|P1|Extension Phase|Lost to Follow-up|2
4828463|NCT01116427|16648841|P2|Extension Phase|Adverse Event|1
4828464|NCT01116427|16648842|P1|Extension Phase|Adverse Event|1
4828465|NCT01116427|16648841|P2|Core Phase|Worsening Multiple Sclerosis|0
4828466|NCT01116427|16648842|P1|Core Phase|Worsening Multiple Sclerosis|1
4828467|NCT01116427|16648841|P2|Core Phase|Withdrawal by Subject|0
4828468|NCT01116427|16648842|P1|Core Phase|Withdrawal by Subject|3
4828469|NCT01116427|16648841|P2|Core Phase|Lost to Follow-up|0
4828470|NCT01116427|16648842|P1|Core Phase|Lost to Follow-up|1
4828471|NCT01116427|16648841|P2|Core Phase|Adverse Event|1
4828472|NCT01116427|16648842|P1|Core Phase|Adverse Event|0
4828473|NCT01116232|16648883|P1|Overall Study|Progressive diease|4
4828474|NCT01115998|16648997|P2|Overall Study|Lost to Follow-up|6
4828475|NCT01115998|16648998|P1|Overall Study|Lost to Follow-up|6
4828476|NCT01115933|16649008|P1|Overall Study|Did not receive XIENCE PRIME SV|1
4828477|NCT01115855|16649105|P2|Overall Study|Other|6
4828478|NCT01115855|16649106|P1|Overall Study|Other|8
4828479|NCT01115855|16649105|P2|Overall Study|Withdrawal by Subject|5
4828480|NCT01115855|16649106|P1|Overall Study|Withdrawal by Subject|5
4828481|NCT01115855|16649105|P2|Overall Study|Protocol Violation|1
4828482|NCT01115855|16649106|P1|Overall Study|Protocol Violation|0
4828483|NCT01115855|16649105|P2|Overall Study|Lab Abnormality|1
4828484|NCT01115855|16649106|P1|Overall Study|Lab Abnormality|1
4828485|NCT01115855|16649105|P2|Overall Study|Death|5
4828486|NCT01115855|16649106|P1|Overall Study|Death|6
4828487|NCT01115855|16649105|P2|Overall Study|Adverse Event|18
4828488|NCT01115855|16649106|P1|Overall Study|Adverse Event|16
4828489|NCT01115803|16649161|P7|Overall Study|Progressive Disease during Cycle1|1
4828490|NCT01115803|16649162|P6|Overall Study|Progressive Disease during Cycle1|0
4828491|NCT01115803|16649163|P5|Overall Study|Progressive Disease during Cycle1|0
4828492|NCT01115803|16649164|P4|Overall Study|Progressive Disease during Cycle1|0
4828493|NCT01115803|16649165|P3|Overall Study|Progressive Disease during Cycle1|0
4828494|NCT01115803|16649166|P2|Overall Study|Progressive Disease during Cycle1|0
4828495|NCT01115803|16649167|P1|Overall Study|Progressive Disease during Cycle1|0
4828496|NCT01115803|16649161|P7|Overall Study|Lost to Follow-up|0
4828497|NCT01115803|16649162|P6|Overall Study|Lost to Follow-up|0
4828498|NCT01115803|16649163|P5|Overall Study|Lost to Follow-up|0
4828499|NCT01115803|16649164|P4|Overall Study|Lost to Follow-up|0
4828500|NCT01115803|16649165|P3|Overall Study|Lost to Follow-up|1
4828501|NCT01115803|16649166|P2|Overall Study|Lost to Follow-up|0
4828502|NCT01115803|16649167|P1|Overall Study|Lost to Follow-up|0
4828503|NCT01115803|16649161|P7|Overall Study|Withdrawal by Subject|1
4828504|NCT01115803|16649162|P6|Overall Study|Withdrawal by Subject|0
4828505|NCT01115803|16649163|P5|Overall Study|Withdrawal by Subject|0
4828506|NCT01115803|16649164|P4|Overall Study|Withdrawal by Subject|0
4828507|NCT01115803|16649165|P3|Overall Study|Withdrawal by Subject|0
4828508|NCT01115803|16649166|P2|Overall Study|Withdrawal by Subject|0
4828509|NCT01115803|16649167|P1|Overall Study|Withdrawal by Subject|0
4828510|NCT01115738|16649230|P3|Overall Study|Withdrawal by Subject|9
4828511|NCT01115738|16649231|P2|Overall Study|Withdrawal by Subject|6
4828512|NCT01115738|16649232|P1|Overall Study|Withdrawal by Subject|6
4828513|NCT01115738|16649230|P3|Overall Study|Physician Decision|17
4828514|NCT01115738|16649231|P2|Overall Study|Physician Decision|15
4828515|NCT01115738|16649232|P1|Overall Study|Physician Decision|18
4828516|NCT01115738|16649230|P3|Overall Study|Lost to Follow-up|1
4828517|NCT01115738|16649231|P2|Overall Study|Lost to Follow-up|0
4828518|NCT01115738|16649232|P1|Overall Study|Lost to Follow-up|0
4828519|NCT01115738|16649230|P3|Overall Study|Death|0
4828520|NCT01115738|16649231|P2|Overall Study|Death|0
4828521|NCT01115738|16649232|P1|Overall Study|Death|1
4828522|NCT01115569|16649430|P2|Maintenance Phase|Administrative|1
4828523|NCT01115569|16649431|P1|Maintenance Phase|Administrative|0
4828524|NCT01115569|16649430|P2|Maintenance Phase|Non-Compliance with Study Drug|48
4828525|NCT01115569|16649431|P1|Maintenance Phase|Non-Compliance with Study Drug|0
4828526|NCT01115569|16649430|P2|Maintenance Phase|Withdrawal by Subject|27
4828527|NCT01115569|16649431|P1|Maintenance Phase|Withdrawal by Subject|0
4828528|NCT01115569|16649430|P2|Maintenance Phase|Protocol Violation|9
4828529|NCT01115569|16649431|P1|Maintenance Phase|Protocol Violation|0
4828530|NCT01115569|16649430|P2|Maintenance Phase|Physician Decision|3
4828531|NCT01115569|16649431|P1|Maintenance Phase|Physician Decision|0
4828532|NCT01115569|16649430|P2|Maintenance Phase|Lost to Follow-up|8
4828533|NCT01115569|16649431|P1|Maintenance Phase|Lost to Follow-up|0
4828534|NCT01115569|16649430|P2|Maintenance Phase|Adverse Event|43
4828535|NCT01115569|16649431|P1|Maintenance Phase|Adverse Event|0
4828536|NCT01115569|16649430|P2|Conversion/Titration Phase|Non-Compliance with Study Drug|0
4828537|NCT01115569|16649431|P1|Conversion/Titration Phase|Non-Compliance with Study Drug|53
4828538|NCT01115569|16649430|P2|Conversion/Titration Phase|Withdrawal by Subject|0
4828539|NCT01115569|16649431|P1|Conversion/Titration Phase|Withdrawal by Subject|26
4828540|NCT01115569|16649430|P2|Conversion/Titration Phase|Protocol Violation|0
4828541|NCT01115569|16649431|P1|Conversion/Titration Phase|Protocol Violation|68
4828542|NCT01115569|16649430|P2|Conversion/Titration Phase|Physician Decision|0
4828543|NCT01115569|16649431|P1|Conversion/Titration Phase|Physician Decision|5
4828544|NCT01115569|16649430|P2|Conversion/Titration Phase|Lost to Follow-up|0
4828545|NCT01115569|16649431|P1|Conversion/Titration Phase|Lost to Follow-up|3
4828546|NCT01115569|16649430|P2|Conversion/Titration Phase|Adverse Event|0
4828547|NCT01115569|16649431|P1|Conversion/Titration Phase|Adverse Event|59
4828548|NCT01115491|16649460|P1|Overall Study|Physician Decision|1
4828549|NCT01115491|16649460|P1|Overall Study|Withdrawal by Subject|1
4828550|NCT01115491|16649460|P1|Overall Study|Lost to Follow-up|3
4828551|NCT01115491|16649460|P1|Overall Study|Adverse Event|3
4828552|NCT01115491|16649460|P1|Overall Study|Death|22
4828553|NCT01115309|16649519|P1|Long-term Follow-up|Lost to Follow-up|6
4828554|NCT01115309|16649519|P1|Procedure Safety (1-Month)|Withdrawal by Subject|1
4828555|NCT01115309|16649519|P1|Procedure Safety (1-Month)|Lost to Follow-up|2
4828556|NCT01114880|16649686|P2|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2
4828557|NCT01114880|16649687|P1|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0
4828558|NCT01114880|16649686|P2|Period 2 (Week 12 to Week 24)|Adverse Event|0
4828559|NCT01114880|16649687|P1|Period 2 (Week 12 to Week 24)|Adverse Event|3
4828560|NCT01114880|16649686|P2|Period 1 (Week 0 to Week 12)|Poor subject compliance|1
4828561|NCT01114880|16649687|P1|Period 1 (Week 0 to Week 12)|Poor subject compliance|0
4828562|NCT01114880|16649686|P2|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1
4828563|NCT01114880|16649687|P1|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0
4828564|NCT01114880|16649686|P2|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0
4828565|NCT01114880|16649687|P1|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1
4828566|NCT01114880|16649686|P2|Period 1 (Week 0 to Week 12)|Adverse Event|0
4828567|NCT01114880|16649687|P1|Period 1 (Week 0 to Week 12)|Adverse Event|4
4828568|NCT01114828|16649739|P2|Overall Study|Withdrawal by Subject|1
4828569|NCT01114828|16649740|P1|Overall Study|Withdrawal by Subject|0
4828570|NCT01114828|16649739|P2|Overall Study|Protocol Violation|0
4828571|NCT01114828|16649740|P1|Overall Study|Protocol Violation|2
4828572|NCT01114828|16649739|P2|Overall Study|Lack of Efficacy|2
4828573|NCT01114828|16649740|P1|Overall Study|Lack of Efficacy|0
4828574|NCT01114828|16649739|P2|Overall Study|Adverse Event|1
4828575|NCT01114828|16649740|P1|Overall Study|Adverse Event|1
4828576|NCT01114737|16649750|P2|Open-Label Treatment Period|Difficult Personal Events|0
4828577|NCT01114737|16649751|P1|Open-Label Treatment Period|Difficult Personal Events|1
4828578|NCT01114737|16649750|P2|Open-Label Treatment Period|Lost to Follow-up|1
4828579|NCT01114737|16649751|P1|Open-Label Treatment Period|Lost to Follow-up|3
4828580|NCT01114737|16649750|P2|Open-Label Treatment Period|Withdrawal by Subject|1
4828581|NCT01114737|16649751|P1|Open-Label Treatment Period|Withdrawal by Subject|1
4828582|NCT01114737|16649750|P2|Randomized Treatment Period|Pregnancy|0
4828583|NCT01114737|16649751|P1|Randomized Treatment Period|Pregnancy|1
4828584|NCT01114737|16649750|P2|Randomized Treatment Period|Lost to Follow-up|1
4828585|NCT01114737|16649751|P1|Randomized Treatment Period|Lost to Follow-up|1
4828586|NCT01114737|16649750|P2|Randomized Treatment Period|Withdrawal by Subject|0
4828587|NCT01114737|16649751|P1|Randomized Treatment Period|Withdrawal by Subject|1
4828588|NCT01114724|16649799|P1|Overall Study|Withdrawal by Subject|1
4828589|NCT01114724|16649799|P1|Overall Study|Lost to Follow-up|1
4828590|NCT01114724|16649799|P1|Overall Study|Death|8
4828591|NCT01114672|16649819|P2|Overall Study|transplanted|0
4828592|NCT01114672|16649820|P1|Overall Study|transplanted|1
4828593|NCT01114672|16649819|P2|Overall Study|Lost to Follow-up|0
4828594|NCT01114672|16649820|P1|Overall Study|Lost to Follow-up|1
4828595|NCT01114672|16649819|P2|Overall Study|Withdrawal by Subject|1
4828596|NCT01114672|16649820|P1|Overall Study|Withdrawal by Subject|2
4828597|NCT01114672|16649819|P2|Overall Study|Death|1
4828598|NCT01114672|16649820|P1|Overall Study|Death|0
4828599|NCT01114646|16649828|P2|Overall Study|Withdrawal by Subject|2
4828600|NCT01114646|16649829|P1|Overall Study|Withdrawal by Subject|3
4828601|NCT01114529|16649889|P3|Completed Study Phase at Month 24|Missing|0
4828602|NCT01114529|16649890|P2|Completed Study Phase at Month 24|Missing|0
4828603|NCT01114529|16649891|P1|Completed Study Phase at Month 24|Missing|2
4828604|NCT01114529|16649889|P3|Completed Study Phase at Month 24|Other|0
4828605|NCT01114529|16649890|P2|Completed Study Phase at Month 24|Other|0
4828606|NCT01114529|16649891|P1|Completed Study Phase at Month 24|Other|2
4828607|NCT01114529|16649889|P3|Completed Study Phase at Month 24|Death|4
4828608|NCT01114529|16649890|P2|Completed Study Phase at Month 24|Death|5
4828609|NCT01114529|16649891|P1|Completed Study Phase at Month 24|Death|8
4828610|NCT01114529|16649889|P3|Completed Study Phase at Month 24|Lost to Follow-up|7
4828611|NCT01114529|16649890|P2|Completed Study Phase at Month 24|Lost to Follow-up|5
4828612|NCT01114529|16649891|P1|Completed Study Phase at Month 24|Lost to Follow-up|10
4828613|NCT01114529|16649889|P3|Completed Study Phase at Month 24|Withdrawal by Subject|3
4828614|NCT01114529|16649890|P2|Completed Study Phase at Month 24|Withdrawal by Subject|6
4828615|NCT01114529|16649891|P1|Completed Study Phase at Month 24|Withdrawal by Subject|18
4828616|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Missing|0
4828617|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Missing|0
4828618|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Missing|2
4828619|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Protocol Violation|2
4828620|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Protocol Violation|5
4828621|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Protocol Violation|0
4828622|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Graft loss|0
4828623|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Graft loss|2
4828624|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Graft loss|0
4828625|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Death|2
4828626|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Death|1
4828627|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Death|2
4828628|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Administrative problems|2
4828629|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Administrative problems|1
4828630|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Administrative problems|2
4828631|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Lost to Follow-up|2
4828632|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Lost to Follow-up|4
4828633|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Lost to Follow-up|1
4828634|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Withdrawal by Subject|2
4828635|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Withdrawal by Subject|8
4828636|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Withdrawal by Subject|18
4828637|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Subject's no longer required drug|1
4828638|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Subject's no longer required drug|1
4828639|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Subject's no longer required drug|1
4828640|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Lack of Efficacy|2
4828641|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Lack of Efficacy|1
4828642|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Lack of Efficacy|2
4828643|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1
4828644|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0
4828645|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3
4828646|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1
4828647|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0
4828648|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6
4828649|NCT01114529|16649889|P3|Completed Study Medication at Month 24|Adverse Event|17
4828650|NCT01114529|16649890|P2|Completed Study Medication at Month 24|Adverse Event|18
4828651|NCT01114529|16649891|P1|Completed Study Medication at Month 24|Adverse Event|87
4828652|NCT01114516|16649910|P2|Overall Study|Lost to Follow-up|1
4828653|NCT01114516|16649911|P1|Overall Study|Lost to Follow-up|2
4828654|NCT01114438|16649925|P1|Overall Study|Withdrawal by Subject|2
4828655|NCT01114438|16649925|P1|Overall Study|Physician Decision|1
4828656|NCT01114438|16649925|P1|Overall Study|concomitant medication|1
4828657|NCT01114438|16649925|P1|Overall Study|Adverse Event|10
4828658|NCT01114373|16649935|P2|Intervention 2 (4 Weeks)|Lost to Follow-up|1
4828659|NCT01114373|16649936|P1|Intervention 2 (4 Weeks)|Lost to Follow-up|0
4828660|NCT01114373|16649935|P2|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0
4828661|NCT01114373|16649936|P1|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1
4828662|NCT01114373|16649935|P2|Intervention 1 (4 Weeks)|Incarceration|0
4828663|NCT01114373|16649936|P1|Intervention 1 (4 Weeks)|Incarceration|1
4828664|NCT01114373|16649935|P2|Intervention 1 (4 Weeks)|Lost to Follow-up|0
4828665|NCT01114373|16649936|P1|Intervention 1 (4 Weeks)|Lost to Follow-up|1
4828666|NCT01114360|16649968|P2|Intervention 1 (4 Weeks)|Physician Decision|1
4828667|NCT01114360|16649969|P1|Intervention 1 (4 Weeks)|Physician Decision|0
4828668|NCT01114217|16650020|P2|Overall Study|Other-Withdrawal by Subject|1
4828669|NCT01114217|16650021|P1|Overall Study|Other-Withdrawal by Subject|1
4828670|NCT01114217|16650020|P2|Overall Study|Other-Lost to Follow-up|0
4828671|NCT01114217|16650021|P1|Overall Study|Other-Lost to Follow-up|1
4828672|NCT01114217|16650020|P2|Overall Study|Other-Site Stopped Communicating|0
4828673|NCT01114217|16650021|P1|Overall Study|Other-Site Stopped Communicating|2
4828674|NCT01114217|16650020|P2|Overall Study|Other-Study Withdrawn|1
4828675|NCT01114217|16650021|P1|Overall Study|Other-Study Withdrawn|1
4828676|NCT01114217|16650020|P2|Overall Study|Other-Study Termination|1
4828677|NCT01114217|16650021|P1|Overall Study|Other-Study Termination|0
4828678|NCT01114217|16650020|P2|Overall Study|Other-Sponsor Decision|12
4828679|NCT01114217|16650021|P1|Overall Study|Other-Sponsor Decision|10
4828680|NCT01114217|16650020|P2|Overall Study|Other-Physician Decision|1
4828681|NCT01114217|16650021|P1|Overall Study|Other-Physician Decision|1
4828682|NCT01114217|16650020|P2|Overall Study|Other-Non Compliance|0
4828683|NCT01114217|16650021|P1|Overall Study|Other-Non Compliance|2
4828684|NCT01114217|16650020|P2|Overall Study|Other-Lack of Efficacy|0
4828685|NCT01114217|16650021|P1|Overall Study|Other-Lack of Efficacy|1
4828686|NCT01114217|16650020|P2|Overall Study|Other-Protocol Violation|3
4828687|NCT01114217|16650021|P1|Overall Study|Other-Protocol Violation|1
4828688|NCT01114217|16650020|P2|Overall Study|Other-Pregnancy|4
4828689|NCT01114217|16650021|P1|Overall Study|Other-Pregnancy|2
4828690|NCT01114217|16650020|P2|Overall Study|Other-Procedure|1
4828691|NCT01114217|16650021|P1|Overall Study|Other-Procedure|1
4828692|NCT01114217|16650020|P2|Overall Study|Other-Early termination|10
4828693|NCT01114217|16650021|P1|Overall Study|Other-Early termination|6
4828694|NCT01114217|16650020|P2|Overall Study|Other-Clerical Error|0
4828695|NCT01114217|16650021|P1|Overall Study|Other-Clerical Error|3
4828696|NCT01114217|16650020|P2|Overall Study|Withdrawal by Subject|28
4828697|NCT01114217|16650021|P1|Overall Study|Withdrawal by Subject|21
4828698|NCT01114217|16650020|P2|Overall Study|Lost to Follow-up|33
4828699|NCT01114217|16650021|P1|Overall Study|Lost to Follow-up|17
4828700|NCT01114217|16650020|P2|Overall Study|Adverse Event|3
4828701|NCT01114217|16650021|P1|Overall Study|Adverse Event|5
4828702|NCT01114204|16650033|P2|Overall Study|Other-Protocol Violation|0
4828703|NCT01114204|16650034|P1|Overall Study|Other-Protocol Violation|1
4828704|NCT01114204|16650033|P2|Overall Study|Other-Participant request|0
4828705|NCT01114204|16650034|P1|Overall Study|Other-Participant request|2
4828706|NCT01114204|16650033|P2|Overall Study|Other-Medical monitor request|0
4828707|NCT01114204|16650034|P1|Overall Study|Other-Medical monitor request|1
4828708|NCT01114204|16650033|P2|Overall Study|Other-Personal reasons|0
4828709|NCT01114204|16650034|P1|Overall Study|Other-Personal reasons|2
4828710|NCT01114204|16650033|P2|Overall Study|Death|0
4828711|NCT01114204|16650034|P1|Overall Study|Death|1
4828712|NCT01114204|16650033|P2|Overall Study|Withdrawal by Subject|6
4828713|NCT01114204|16650034|P1|Overall Study|Withdrawal by Subject|10
4828714|NCT01114204|16650033|P2|Overall Study|Lost to Follow-up|0
4828715|NCT01114204|16650034|P1|Overall Study|Lost to Follow-up|1
4828716|NCT01114204|16650033|P2|Overall Study|Adverse Event|2
4828717|NCT01114204|16650034|P1|Overall Study|Adverse Event|3
4828718|NCT01114139|16650052|P2|Overall Study|Other-Withdrew prior to receiving dose|3
4828719|NCT01114139|16650053|P1|Overall Study|Other-Withdrew prior to receiving dose|1
4828720|NCT01114139|16650052|P2|Overall Study|Other-Physician changed treatment|0
4828721|NCT01114139|16650053|P1|Overall Study|Other-Physician changed treatment|1
4828722|NCT01114139|16650052|P2|Overall Study|Other-Participant went on hospice|1
4828723|NCT01114139|16650053|P1|Overall Study|Other-Participant went on hospice|0
4828724|NCT01114139|16650052|P2|Overall Study|Other-Participant falsified records|1
4828725|NCT01114139|16650053|P1|Overall Study|Other-Participant falsified records|0
4828726|NCT01114139|16650052|P2|Overall Study|Other-Out of window for study drug dose|0
4828727|NCT01114139|16650053|P1|Overall Study|Other-Out of window for study drug dose|1
4828728|NCT01114139|16650052|P2|Overall Study|Other-Protocol Violation|0
4828729|NCT01114139|16650053|P1|Overall Study|Other-Protocol Violation|1
4828730|NCT01114139|16650052|P2|Overall Study|Other-Missed 1 visit|0
4828731|NCT01114139|16650053|P1|Overall Study|Other-Missed 1 visit|1
4828732|NCT01114139|16650052|P2|Overall Study|Withdrawal by Subject|6
4828733|NCT01114139|16650053|P1|Overall Study|Withdrawal by Subject|17
4828734|NCT01114139|16650052|P2|Overall Study|Lost to Follow-up|3
4828735|NCT01114139|16650053|P1|Overall Study|Lost to Follow-up|15
4828736|NCT01114139|16650052|P2|Overall Study|Adverse Event|2
4828737|NCT01114139|16650053|P1|Overall Study|Adverse Event|3
4828738|NCT01113931|16650082|P2|Overall Study|Withdrawal by Subject|0
4828739|NCT01113931|16650083|P1|Overall Study|Withdrawal by Subject|3
4828740|NCT01113931|16650082|P2|Overall Study|Various|4
4828741|NCT01113931|16650083|P1|Overall Study|Various|2
4828742|NCT01113931|16650082|P2|Overall Study|Lost to Follow-up|9
4828743|NCT01113931|16650083|P1|Overall Study|Lost to Follow-up|12
4828744|NCT01113931|16650082|P2|Overall Study|Physician Decision|2
4828745|NCT01113931|16650083|P1|Overall Study|Physician Decision|0
4828746|NCT01113931|16650082|P2|Overall Study|Adverse Event|2
4828747|NCT01113931|16650083|P1|Overall Study|Adverse Event|2
4828748|NCT01113892|16650097|P2|Overall Study|Graft no longer evaluable|9
4828749|NCT01113892|16650098|P1|Overall Study|Graft no longer evaluable|9
4828750|NCT01113892|16650097|P2|Overall Study|Death|4
4828751|NCT01113892|16650098|P1|Overall Study|Death|2
4828752|NCT01113892|16650097|P2|Overall Study|Withdrawal by Subject|1
4828753|NCT01113892|16650098|P1|Overall Study|Withdrawal by Subject|1
4828754|NCT01113892|16650097|P2|Overall Study|Lost to Follow-up|2
4828755|NCT01113892|16650098|P1|Overall Study|Lost to Follow-up|2
4828756|NCT01113879|16650126|P2|Period 1: Block 1|Withdrawal by Subject|0
4828757|NCT01113879|16650127|P1|Period 1: Block 1|Withdrawal by Subject|2
4828758|NCT01113801|16650139|P4|Overall Study|Clinical Endpoint (ESRD)|5
4828759|NCT01113801|16650140|P3|Overall Study|Clinical Endpoint (ESRD)|2
4828760|NCT01113801|16650141|P2|Overall Study|Clinical Endpoint (ESRD)|4
4828761|NCT01113801|16650142|P1|Overall Study|Clinical Endpoint (ESRD)|7
4828762|NCT01113801|16650139|P4|Overall Study|Sponsor Decision|15
4828763|NCT01113801|16650140|P3|Overall Study|Sponsor Decision|20
4828764|NCT01113801|16650141|P2|Overall Study|Sponsor Decision|21
4828765|NCT01113801|16650142|P1|Overall Study|Sponsor Decision|15
4828766|NCT01113801|16650139|P4|Overall Study|Physician Decision|3
4828767|NCT01113801|16650140|P3|Overall Study|Physician Decision|3
4828768|NCT01113801|16650141|P2|Overall Study|Physician Decision|2
4828769|NCT01113801|16650142|P1|Overall Study|Physician Decision|2
4828770|NCT01113801|16650139|P4|Overall Study|Withdrawal by Subject|8
4828771|NCT01113801|16650140|P3|Overall Study|Withdrawal by Subject|7
4828772|NCT01113801|16650141|P2|Overall Study|Withdrawal by Subject|7
4828773|NCT01113801|16650142|P1|Overall Study|Withdrawal by Subject|9
4828774|NCT01113801|16650139|P4|Overall Study|Protocol Violation|0
4828775|NCT01113801|16650140|P3|Overall Study|Protocol Violation|0
4828776|NCT01113801|16650141|P2|Overall Study|Protocol Violation|1
4828777|NCT01113801|16650142|P1|Overall Study|Protocol Violation|0
4828778|NCT01113801|16650139|P4|Overall Study|Death|4
4828779|NCT01113801|16650140|P3|Overall Study|Death|3
4828780|NCT01113801|16650141|P2|Overall Study|Death|5
4828781|NCT01113801|16650142|P1|Overall Study|Death|4
4828782|NCT01113801|16650139|P4|Overall Study|Adverse Event|6
4828783|NCT01113801|16650140|P3|Overall Study|Adverse Event|2
4828784|NCT01113801|16650141|P2|Overall Study|Adverse Event|0
4828785|NCT01113801|16650142|P1|Overall Study|Adverse Event|4
4828786|NCT01113749|16650170|P2|Overall Study|Lost to Follow-up|2
4828787|NCT01113749|16650171|P1|Overall Study|Lost to Follow-up|1
4828788|NCT01113710|16650194|P1|Overall Study|Subject Did Not Receive Neupro|3
4828789|NCT01113710|16650194|P1|Overall Study|Compliance/Subject Withdrawal/AE|1
4828790|NCT01113710|16650194|P1|Overall Study|Lack of Patient's Compliance/Other|1
4828791|NCT01113710|16650194|P1|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1
4828792|NCT01113710|16650194|P1|Overall Study|Compliance/Efficacy/Subject Withdrawal|1
4828793|NCT01113710|16650194|P1|Overall Study|Compliance/Efficacy/AE/Other|1
4828794|NCT01113710|16650194|P1|Overall Study|Compliance/Efficacy/Adverse Event|1
4828795|NCT01113710|16650194|P1|Overall Study|Efficacy/Withdrawal by Subject/Other|1
4828796|NCT01113710|16650194|P1|Overall Study|Lost to Follow up/Withdrawal by Subject|2
4828797|NCT01113710|16650194|P1|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2
4828798|NCT01113710|16650194|P1|Overall Study|Efficacy/Subject Withdrawal/AE|2
4828799|NCT01113710|16650194|P1|Overall Study|Lack of Efficacy/Adverse Event|3
4828800|NCT01113710|16650194|P1|Overall Study|Patient Compliance/Withdrawal by Subject|4
4828801|NCT01113710|16650194|P1|Overall Study|Lack of Efficacy/Other|4
4828802|NCT01113710|16650194|P1|Overall Study|Patient's Compliance/Lost to Follow up|5
4828803|NCT01113710|16650194|P1|Overall Study|Adverse Event/Other|5
4828804|NCT01113710|16650194|P1|Overall Study|Other|7
4828805|NCT01113710|16650194|P1|Overall Study|Lack of Patient's Compliance|8
4828806|NCT01113710|16650194|P1|Overall Study|Withdrawal by Subject/Adverse Event|11
4828807|NCT01113710|16650194|P1|Overall Study|Lack of Efficacy/Withdrawal by Subject|13
4828808|NCT01113710|16650194|P1|Overall Study|Lost to Follow-up|20
4828809|NCT01113710|16650194|P1|Overall Study|Withdrawal by Subject|28
4828810|NCT01113710|16650194|P1|Overall Study|No Information Available|40
4828811|NCT01113710|16650194|P1|Overall Study|Lack of Efficacy|41
4828812|NCT01113710|16650194|P1|Overall Study|Adverse Event|64
4828813|NCT01113580|16650222|P2|Overall Study|Protocol Violation|0
4828814|NCT01113580|16650223|P1|Overall Study|Protocol Violation|1
4828815|NCT01113541|16650237|P1|Overall Study|Adverse Event|4
4828816|NCT01113541|16650237|P1|Overall Study|Study Terminated by Sponsor|7
4828817|NCT01113541|16650237|P1|Overall Study|Protocol Violation|1
4828818|NCT01113541|16650237|P1|Overall Study|Withdrawal by Subject|1
4828819|NCT01113463|16650270|P1|Overall Study|Physician Decision|5
4828820|NCT01112982|16650300|P1|Overall Study|exceeded weight limit to complete MRI|1
4828821|NCT01112982|16650300|P1|Overall Study|Withdrawal by Subject|1
4828822|NCT01112917|16650312|P2|Overall Study|Unable to Convert Filter|0
4828823|NCT01112917|16650313|P1|Overall Study|Unable to Convert Filter|3
4828824|NCT01112917|16650312|P2|Overall Study|Withdrawal by Subject|3
4828825|NCT01112917|16650313|P1|Overall Study|Withdrawal by Subject|1
4828826|NCT01112917|16650312|P2|Overall Study|Lost to Follow-up|1
4828827|NCT01112917|16650313|P1|Overall Study|Lost to Follow-up|1
4828828|NCT01112917|16650312|P2|Overall Study|Death|11
4828829|NCT01112917|16650313|P1|Overall Study|Death|2
4828830|NCT01112579|16650417|P2|Overall Study|Death|2
4828831|NCT01112579|16650418|P1|Overall Study|Death|0
4828832|NCT01112579|16650417|P2|Overall Study|Missed Visit|1
4828833|NCT01112579|16650418|P1|Overall Study|Missed Visit|1
4828834|NCT01112514|16650428|P1|Overall Study|Lost to Follow-up|1
4828835|NCT01112267|16650484|P2|Overall Study|Participants not receive any study drug|2
4828836|NCT01112267|16650485|P1|Overall Study|Participants not receive any study drug|1
4828837|NCT01112267|16650484|P2|Overall Study|Participants not compliant|2
4828838|NCT01112267|16650485|P1|Overall Study|Participants not compliant|1
4828839|NCT01112267|16650484|P2|Overall Study|Protocol Violation|3
4828840|NCT01112267|16650485|P1|Overall Study|Protocol Violation|5
4828841|NCT01112267|16650484|P2|Overall Study|Withdrawal by Subject|5
4828842|NCT01112267|16650485|P1|Overall Study|Withdrawal by Subject|3
4828843|NCT01112267|16650484|P2|Overall Study|Adverse Event|6
4828844|NCT01112267|16650485|P1|Overall Study|Adverse Event|24
4828845|NCT01112059|16650524|P2|Overall Study|Withdrawal by Subject|0
4828846|NCT01112059|16650525|P1|Overall Study|Withdrawal by Subject|1
4828847|NCT01111851|16650539|P2|Overall Study|All planned PET scans were not obtained.|0
4828848|NCT01111851|16650540|P1|Overall Study|All planned PET scans were not obtained.|2
4828849|NCT01111838|16650552|P1|Overall Study|Other Complicating Disease|1
4828850|NCT01111838|16650552|P1|Overall Study|Clinical deterioration|1
4828851|NCT01111838|16650552|P1|Overall Study|Not Treated|3
4828852|NCT01111838|16650552|P1|Overall Study|Patient Ineligible|2
4828853|NCT01111825|16650560|P4|Overall Study|Discontinuation by Sponsor|20
4828854|NCT01111825|16650561|P3|Overall Study|Discontinuation by Sponsor|0
4828855|NCT01111825|16650562|P2|Overall Study|Discontinuation by Sponsor|0
4828856|NCT01111825|16650563|P1|Overall Study|Discontinuation by Sponsor|0
4828857|NCT01111825|16650560|P4|Overall Study|Disease Progression|0
4828858|NCT01111825|16650561|P3|Overall Study|Disease Progression|0
4828859|NCT01111825|16650562|P2|Overall Study|Disease Progression|0
4828860|NCT01111825|16650563|P1|Overall Study|Disease Progression|1
4828861|NCT01111825|16650560|P4|Overall Study|Adverse Event|0
4828862|NCT01111825|16650561|P3|Overall Study|Adverse Event|4
4828863|NCT01111825|16650562|P2|Overall Study|Adverse Event|1
4828864|NCT01111825|16650563|P1|Overall Study|Adverse Event|2
4828865|NCT01111825|16650560|P4|Overall Study|Lost to Follow-up|1
4828866|NCT01111825|16650561|P3|Overall Study|Lost to Follow-up|3
4828867|NCT01111825|16650562|P2|Overall Study|Lost to Follow-up|0
4828868|NCT01111825|16650563|P1|Overall Study|Lost to Follow-up|0
4828869|NCT01111825|16650560|P4|Overall Study|Withdrawal by Subject|0
4828870|NCT01111825|16650561|P3|Overall Study|Withdrawal by Subject|1
4828871|NCT01111825|16650562|P2|Overall Study|Withdrawal by Subject|0
4828872|NCT01111825|16650563|P1|Overall Study|Withdrawal by Subject|0
4828873|NCT01111604|16650585|P3|Overall Study|Met Exclusion Criteria|0
4828874|NCT01111604|16650586|P2|Overall Study|Met Exclusion Criteria|0
4828875|NCT01111604|16650587|P1|Overall Study|Met Exclusion Criteria|2
4828876|NCT01111604|16650585|P3|Overall Study|Death|0
4828877|NCT01111604|16650586|P2|Overall Study|Death|0
4828878|NCT01111604|16650587|P1|Overall Study|Death|1
4828879|NCT01111604|16650585|P3|Overall Study|Withdrawal by Subject|0
4828880|NCT01111604|16650586|P2|Overall Study|Withdrawal by Subject|0
4828881|NCT01111604|16650587|P1|Overall Study|Withdrawal by Subject|2
4828882|NCT01111604|16650585|P3|Overall Study|Withdrew Consent|2
4828883|NCT01111604|16650586|P2|Overall Study|Withdrew Consent|0
4828884|NCT01111604|16650587|P1|Overall Study|Withdrew Consent|3
4828885|NCT01111604|16650585|P3|Overall Study|Lost to Follow-up|1
4828886|NCT01111604|16650586|P2|Overall Study|Lost to Follow-up|0
4828887|NCT01111604|16650587|P1|Overall Study|Lost to Follow-up|0
4828888|NCT01111526|16650625|P3|Overall Study|GVHD Disease Progression|2
4828889|NCT01111526|16650626|P2|Overall Study|GVHD Disease Progression|1
4828890|NCT01111526|16650627|P1|Overall Study|GVHD Disease Progression|0
4828891|NCT01111474|16650639|P1|Overall Study|Lost to Follow-up|12
4828892|NCT01111461|16650647|P1|Overall Study|Other|6
4828893|NCT01111461|16650647|P1|Overall Study|Withdrawal by Subject|1
4828894|NCT01111461|16650647|P1|Overall Study|Lost to Follow-up|1
4828895|NCT01111461|16650647|P1|Overall Study|Participant choice|11
4828896|NCT01111461|16650647|P1|Overall Study|Adverse Event|32
4828897|NCT01111292|16650827|P2|Treatment|Physician Decision|1
4828898|NCT01111292|16650828|P1|Treatment|Physician Decision|1
4828899|NCT01111240|16650834|P1|Overall Study|Other|312
4828900|NCT01111240|16650834|P1|Overall Study|Lack of Efficacy and Adverse Event|19
4828901|NCT01111240|16650834|P1|Overall Study|Lack of Efficacy|545
4828902|NCT01111240|16650834|P1|Overall Study|Adverse Event|190
4828903|NCT01111149|16650864|P3|Overall Study|Withdrawal by Subject|2
4828904|NCT01111149|16650865|P2|Overall Study|Withdrawal by Subject|0
4828905|NCT01111149|16650866|P1|Overall Study|Withdrawal by Subject|1
4828906|NCT01111149|16650864|P3|Overall Study|Protocol Violation|2
4828907|NCT01111149|16650865|P2|Overall Study|Protocol Violation|1
4828908|NCT01111149|16650866|P1|Overall Study|Protocol Violation|1
4828909|NCT01111123|16650942|P2|Maintenance Phase|Lost to Follow-up|2
4828910|NCT01111123|16650943|P1|Maintenance Phase|Lost to Follow-up|0
4828911|NCT01111123|16650942|P2|Open- Label Phase|Failed to be clear or almost cleared|0
4828912|NCT01111123|16650943|P1|Open- Label Phase|Failed to be clear or almost cleared|14
4828913|NCT01111019|16650989|P1|Overall Study|Other|1
4828914|NCT01111019|16650989|P1|Overall Study|Withdrew Prematurely|2
4828915|NCT01110915|16651021|P2|Overall Study|Withdrawal by Subject|1
4828916|NCT01110915|16651022|P1|Overall Study|Withdrawal by Subject|7
4828917|NCT01110915|16651021|P2|Overall Study|Lost to Follow-up|0
4828918|NCT01110915|16651022|P1|Overall Study|Lost to Follow-up|1
4828919|NCT01110915|16651021|P2|Overall Study|Death|1
4828920|NCT01110915|16651022|P1|Overall Study|Death|2
4828921|NCT01110707|16651039|P2|Overall Study|Protocol Violation|3
4828922|NCT01110707|16651040|P1|Overall Study|Protocol Violation|0
4828923|NCT01110408|16651141|P2|Overall Study|Protocol Violation|0
4828924|NCT01110408|16651142|P1|Overall Study|Protocol Violation|1
4828925|NCT01110382|16651166|P2|Overall Study|Protocol Violation|1
4828926|NCT01110382|16651167|P1|Overall Study|Protocol Violation|0
4828927|NCT01110382|16651166|P2|Overall Study|Withdrawal by Subject|1
4828928|NCT01110382|16651167|P1|Overall Study|Withdrawal by Subject|0
4828929|NCT01110330|16651188|P3|Overall Study|Other|1
4828930|NCT01110330|16651189|P2|Overall Study|Other|1
4828931|NCT01110330|16651190|P1|Overall Study|Other|1
4828932|NCT01110330|16651188|P3|Overall Study|Withdrawal by Subject|2
4828933|NCT01110330|16651189|P2|Overall Study|Withdrawal by Subject|6
4828934|NCT01110330|16651190|P1|Overall Study|Withdrawal by Subject|0
4828935|NCT01110330|16651188|P3|Overall Study|Protocol Violation|4
4828936|NCT01110330|16651189|P2|Overall Study|Protocol Violation|0
4828937|NCT01110330|16651190|P1|Overall Study|Protocol Violation|2
4828938|NCT01110330|16651188|P3|Overall Study|Physician Decision|0
4828939|NCT01110330|16651189|P2|Overall Study|Physician Decision|1
4828940|NCT01110330|16651190|P1|Overall Study|Physician Decision|0
4828941|NCT01110330|16651188|P3|Overall Study|Lost to Follow-up|15
4828942|NCT01110330|16651189|P2|Overall Study|Lost to Follow-up|10
4828943|NCT01110330|16651190|P1|Overall Study|Lost to Follow-up|9
4828944|NCT01110330|16651188|P3|Overall Study|Lack of Efficacy|1
4828945|NCT01110330|16651189|P2|Overall Study|Lack of Efficacy|1
4828946|NCT01110330|16651190|P1|Overall Study|Lack of Efficacy|3
4828947|NCT01110330|16651188|P3|Overall Study|Adverse Event|3
4828948|NCT01110330|16651189|P2|Overall Study|Adverse Event|4
4828949|NCT01110330|16651190|P1|Overall Study|Adverse Event|0
4828950|NCT01110239|16651218|P4|7.5 Min Ischemia|Withdrawal by Subject|0
4828951|NCT01110239|16651219|P3|7.5 Min Ischemia|Withdrawal by Subject|1
4828952|NCT01110239|16651220|P2|7.5 Min Ischemia|Withdrawal by Subject|0
4828953|NCT01110239|16651221|P1|7.5 Min Ischemia|Withdrawal by Subject|0
4828954|NCT01110239|16651218|P4|Sham Preconditioning|Withdrawal by Subject|0
4828955|NCT01110239|16651219|P3|Sham Preconditioning|Withdrawal by Subject|1
4828956|NCT01110239|16651220|P2|Sham Preconditioning|Withdrawal by Subject|0
4828957|NCT01110239|16651221|P1|Sham Preconditioning|Withdrawal by Subject|0
4828958|NCT01110200|16651237|P2|Overall Study|Lost to Follow-up|7
4828959|NCT01110200|16651238|P1|Overall Study|Lost to Follow-up|10
4828960|NCT01110200|16651237|P2|Overall Study|Physician Decision|17
4828961|NCT01110200|16651238|P1|Overall Study|Physician Decision|13
4828962|NCT01110200|16651237|P2|Overall Study|Protocol Violation|12
4828963|NCT01110200|16651238|P1|Overall Study|Protocol Violation|14
4828964|NCT01110200|16651237|P2|Overall Study|Lack of Efficacy|25
4828965|NCT01110200|16651238|P1|Overall Study|Lack of Efficacy|16
4828966|NCT01110200|16651237|P2|Overall Study|Withdrawal by Subject|32
4828967|NCT01110200|16651238|P1|Overall Study|Withdrawal by Subject|25
4828968|NCT01110200|16651237|P2|Overall Study|Adverse Event|28
4828969|NCT01110200|16651238|P1|Overall Study|Adverse Event|28
4828970|NCT01110005|16651274|P2|Overall Study|Withdrawal by Subject|1
4828971|NCT01110005|16651275|P1|Overall Study|Withdrawal by Subject|0
4828972|NCT01110005|16651274|P2|Overall Study|missing consent|2
4828973|NCT01110005|16651275|P1|Overall Study|missing consent|3
4828974|NCT01110005|16651274|P2|Overall Study|ineligible|2
4828975|NCT01110005|16651275|P1|Overall Study|ineligible|1
4828976|NCT01109992|16651287|P2|Overall Study|Movement during rest scan.|1
4828977|NCT01109992|16651288|P1|Overall Study|Movement during rest scan.|0
4828978|NCT01109992|16651287|P2|Overall Study|Withdrawal by Subject|1
4828979|NCT01109992|16651288|P1|Overall Study|Withdrawal by Subject|0
4828980|NCT01109979|16651302|P2|Overall Study|Withdrawal by Subject|1
4828981|NCT01109979|16651303|P1|Overall Study|Withdrawal by Subject|0
4828982|NCT01109979|16651302|P2|Overall Study|Physician Decision|0
4828983|NCT01109979|16651303|P1|Overall Study|Physician Decision|2
4828984|NCT01109849|16651311|P5|Adaptive Randomization: Weight Recovery|moved away|0
4828985|NCT01109849|16651312|P4|Adaptive Randomization: Weight Recovery|moved away|2
4828986|NCT01109849|16651313|P3|Adaptive Randomization: Weight Recovery|moved away|0
4828987|NCT01109849|16651314|P2|Adaptive Randomization: Weight Recovery|moved away|0
4828988|NCT01109849|16651315|P1|Adaptive Randomization: Weight Recovery|moved away|0
4828989|NCT01109849|16651311|P5|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
4828990|NCT01109849|16651312|P4|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
4828991|NCT01109849|16651313|P3|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1
4828992|NCT01109849|16651314|P2|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
4828993|NCT01109849|16651315|P1|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0
4828994|NCT01109849|16651311|P5|Initial Randomization: ADHD Treatment|move away|0
4828995|NCT01109849|16651312|P4|Initial Randomization: ADHD Treatment|move away|0
4828996|NCT01109849|16651313|P3|Initial Randomization: ADHD Treatment|move away|0
4828997|NCT01109849|16651314|P2|Initial Randomization: ADHD Treatment|move away|7
4828998|NCT01109849|16651315|P1|Initial Randomization: ADHD Treatment|move away|2
4828999|NCT01109849|16651311|P5|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
4829000|NCT01109849|16651312|P4|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
4829001|NCT01109849|16651313|P3|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0
4829002|NCT01109849|16651314|P2|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7
4829003|NCT01109849|16651315|P1|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6
4829004|NCT01109849|16651311|P5|Initial Randomization: ADHD Treatment|Protocol Violation|0
4829005|NCT01109849|16651312|P4|Initial Randomization: ADHD Treatment|Protocol Violation|0
4829006|NCT01109849|16651313|P3|Initial Randomization: ADHD Treatment|Protocol Violation|0
4829007|NCT01109849|16651314|P2|Initial Randomization: ADHD Treatment|Protocol Violation|0
4829008|NCT01109849|16651315|P1|Initial Randomization: ADHD Treatment|Protocol Violation|1
4829009|NCT01109849|16651311|P5|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
4829010|NCT01109849|16651312|P4|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
4829011|NCT01109849|16651313|P3|Initial Randomization: ADHD Treatment|Lost to Follow-up|0
4829012|NCT01109849|16651314|P2|Initial Randomization: ADHD Treatment|Lost to Follow-up|35
4829013|NCT01109849|16651315|P1|Initial Randomization: ADHD Treatment|Lost to Follow-up|9
4829014|NCT01109524|16651384|P1|Overall Study|Other|5
4829015|NCT01109524|16651384|P1|Overall Study|Participant requested to end treatment|4
4829016|NCT01109524|16651384|P1|Overall Study|No longer meets criteria|2
4829017|NCT01109524|16651384|P1|Overall Study|Death|2
4829018|NCT01109524|16651384|P1|Overall Study|Maximum clinical benefit|3
4829019|NCT01109524|16651384|P1|Overall Study|Withdrawal by Subject|2
4829020|NCT01109524|16651384|P1|Overall Study|Adverse Event|4
4829021|NCT01109524|16651384|P1|Overall Study|Study Drug toxicity|6
4829022|NCT01109524|16651384|P1|Overall Study|Disease Progression|29
4829023|NCT01109316|16651406|P6|Study Period 3|Withdrawal by Subject|0
4829024|NCT01109316|16651407|P5|Study Period 3|Withdrawal by Subject|1
4829025|NCT01109316|16651408|P4|Study Period 3|Withdrawal by Subject|0
4829026|NCT01109316|16651409|P3|Study Period 3|Withdrawal by Subject|0
4829027|NCT01109316|16651410|P2|Study Period 3|Withdrawal by Subject|0
4829028|NCT01109316|16651411|P1|Study Period 3|Withdrawal by Subject|1
4829029|NCT01109316|16651406|P6|Study Period 3|Lost to Follow-up|0
4829030|NCT01109316|16651407|P5|Study Period 3|Lost to Follow-up|1
4829031|NCT01109316|16651408|P4|Study Period 3|Lost to Follow-up|0
4829032|NCT01109316|16651409|P3|Study Period 3|Lost to Follow-up|0
4829033|NCT01109316|16651410|P2|Study Period 3|Lost to Follow-up|0
4829034|NCT01109316|16651411|P1|Study Period 3|Lost to Follow-up|0
4829035|NCT01109316|16651406|P6|Study Period 2|Withdrawal by Subject|1
4829036|NCT01109316|16651407|P5|Study Period 2|Withdrawal by Subject|0
4829037|NCT01109316|16651408|P4|Study Period 2|Withdrawal by Subject|0
4829038|NCT01109316|16651409|P3|Study Period 2|Withdrawal by Subject|1
4829039|NCT01109316|16651410|P2|Study Period 2|Withdrawal by Subject|0
4829040|NCT01109316|16651411|P1|Study Period 2|Withdrawal by Subject|0
4829041|NCT01109316|16651406|P6|Study Period 2|Protocol Violation|0
4829042|NCT01109316|16651407|P5|Study Period 2|Protocol Violation|0
4829043|NCT01109316|16651408|P4|Study Period 2|Protocol Violation|0
4829044|NCT01109316|16651409|P3|Study Period 2|Protocol Violation|0
4829045|NCT01109316|16651410|P2|Study Period 2|Protocol Violation|0
4829046|NCT01109316|16651411|P1|Study Period 2|Protocol Violation|1
4829047|NCT01109316|16651406|P6|Study Period 2|Physician Decision|0
4829048|NCT01109316|16651407|P5|Study Period 2|Physician Decision|0
4829049|NCT01109316|16651408|P4|Study Period 2|Physician Decision|1
4829050|NCT01109316|16651409|P3|Study Period 2|Physician Decision|0
4829051|NCT01109316|16651410|P2|Study Period 2|Physician Decision|0
4829052|NCT01109316|16651411|P1|Study Period 2|Physician Decision|0
4829053|NCT01109316|16651406|P6|Study Period 2|Entry Criteria Not Met|0
4829054|NCT01109316|16651407|P5|Study Period 2|Entry Criteria Not Met|0
4829055|NCT01109316|16651408|P4|Study Period 2|Entry Criteria Not Met|0
4829056|NCT01109316|16651409|P3|Study Period 2|Entry Criteria Not Met|0
4829057|NCT01109316|16651410|P2|Study Period 2|Entry Criteria Not Met|1
4829058|NCT01109316|16651411|P1|Study Period 2|Entry Criteria Not Met|0
4829059|NCT01109316|16651406|P6|Study Period 1|Sponsor Decision|2
4829060|NCT01109316|16651407|P5|Study Period 1|Sponsor Decision|0
4829061|NCT01109316|16651408|P4|Study Period 1|Sponsor Decision|0
4829062|NCT01109316|16651409|P3|Study Period 1|Sponsor Decision|0
4829063|NCT01109316|16651410|P2|Study Period 1|Sponsor Decision|0
4829064|NCT01109316|16651411|P1|Study Period 1|Sponsor Decision|0
4829065|NCT01109316|16651406|P6|Study Period 1|Withdrawal by Subject|0
4829066|NCT01109316|16651407|P5|Study Period 1|Withdrawal by Subject|2
4829067|NCT01109316|16651408|P4|Study Period 1|Withdrawal by Subject|0
4829068|NCT01109316|16651409|P3|Study Period 1|Withdrawal by Subject|1
4829069|NCT01109316|16651410|P2|Study Period 1|Withdrawal by Subject|0
4829070|NCT01109316|16651411|P1|Study Period 1|Withdrawal by Subject|0
4829071|NCT01109316|16651406|P6|Study Period 1|Lost to Follow-up|0
4829072|NCT01109316|16651407|P5|Study Period 1|Lost to Follow-up|0
4829073|NCT01109316|16651408|P4|Study Period 1|Lost to Follow-up|1
4829074|NCT01109316|16651409|P3|Study Period 1|Lost to Follow-up|1
4829075|NCT01109316|16651410|P2|Study Period 1|Lost to Follow-up|0
4829076|NCT01109316|16651411|P1|Study Period 1|Lost to Follow-up|0
4829077|NCT01109316|16651406|P6|Study Period 1|Adverse Event|0
4829078|NCT01109316|16651407|P5|Study Period 1|Adverse Event|0
4829079|NCT01109316|16651408|P4|Study Period 1|Adverse Event|0
4829080|NCT01109316|16651409|P3|Study Period 1|Adverse Event|1
4829081|NCT01109316|16651410|P2|Study Period 1|Adverse Event|0
4829082|NCT01109316|16651411|P1|Study Period 1|Adverse Event|0
4829083|NCT01109173|16651459|P4|Overall Study|Not Specifiied|14
4829084|NCT01109173|16651460|P3|Overall Study|Not Specifiied|9
4829085|NCT01109173|16651461|P2|Overall Study|Not Specifiied|4
4829086|NCT01109173|16651462|P1|Overall Study|Not Specifiied|5
4829087|NCT01109173|16651459|P4|Overall Study|Patient Did Not Use Study Medication|7
4829088|NCT01109173|16651460|P3|Overall Study|Patient Did Not Use Study Medication|11
4829089|NCT01109173|16651461|P2|Overall Study|Patient Did Not Use Study Medication|26
4829090|NCT01109173|16651462|P1|Overall Study|Patient Did Not Use Study Medication|34
4829091|NCT01109173|16651459|P4|Overall Study|Protocol Violation|2
4829092|NCT01109173|16651460|P3|Overall Study|Protocol Violation|1
4829093|NCT01109173|16651461|P2|Overall Study|Protocol Violation|5
4829094|NCT01109173|16651462|P1|Overall Study|Protocol Violation|4
4829095|NCT01109173|16651459|P4|Overall Study|Treatment Failure|64
4829096|NCT01109173|16651460|P3|Overall Study|Treatment Failure|69
4829097|NCT01109173|16651461|P2|Overall Study|Treatment Failure|32
4829098|NCT01109173|16651462|P1|Overall Study|Treatment Failure|25
4829099|NCT01109173|16651459|P4|Overall Study|Noncompliance|0
4829100|NCT01109173|16651460|P3|Overall Study|Noncompliance|0
4829101|NCT01109173|16651461|P2|Overall Study|Noncompliance|1
4829102|NCT01109173|16651462|P1|Overall Study|Noncompliance|0
4829103|NCT01109173|16651459|P4|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
4829104|NCT01109173|16651460|P3|Overall Study|Patient Decision Unrelated to Advrs Evnt|2
4829105|NCT01109173|16651461|P2|Overall Study|Patient Decision Unrelated to Advrs Evnt|0
4829106|NCT01109173|16651462|P1|Overall Study|Patient Decision Unrelated to Advrs Evnt|5
4829107|NCT01109173|16651459|P4|Overall Study|Lost to Follow-up|0
4829108|NCT01109173|16651460|P3|Overall Study|Lost to Follow-up|0
4829109|NCT01109173|16651461|P2|Overall Study|Lost to Follow-up|1
4829110|NCT01109173|16651462|P1|Overall Study|Lost to Follow-up|0
4829111|NCT01109173|16651459|P4|Overall Study|Adverse Event|6
4829112|NCT01109173|16651460|P3|Overall Study|Adverse Event|9
4829113|NCT01109173|16651461|P2|Overall Study|Adverse Event|17
4829114|NCT01109173|16651462|P1|Overall Study|Adverse Event|15
4829115|NCT01108809|16651575|P1|Overall Study|Lost to Follow-up|1
4829116|NCT01108809|16651575|P1|Overall Study|Adverse Event|3
4829117|NCT01108796|16651592|P2|Overall Study|Lost to Follow-up|6
4829118|NCT01108796|16651593|P1|Overall Study|Lost to Follow-up|7
4829119|NCT01108796|16651592|P2|Overall Study|Adverse Event|1
4829120|NCT01108796|16651593|P1|Overall Study|Adverse Event|0
4829121|NCT01108731|16651636|P2|Overall Study|Adverse Event|3
4829122|NCT01108731|16651637|P1|Overall Study|Adverse Event|3
4829123|NCT01108731|16651636|P2|Overall Study|Withdrawal by Subject|1
4829124|NCT01108731|16651637|P1|Overall Study|Withdrawal by Subject|1
4829125|NCT01108718|16651649|P2|Received Second Intervention (2 Months)|Withdrawal by Subject|0
4829126|NCT01108718|16651650|P1|Received Second Intervention (2 Months)|Withdrawal by Subject|1
4829127|NCT01108523|16651662|P1|Overall Study|Protocol Violation|4
4829128|NCT01108510|16651669|P2|Overall Study|Death|1
4829129|NCT01108510|16651670|P1|Overall Study|Death|1
4829130|NCT01108510|16651669|P2|Overall Study|Pregnancy|3
4829131|NCT01108510|16651670|P1|Overall Study|Pregnancy|0
4829132|NCT01108510|16651669|P2|Overall Study|Lack of Efficacy|0
4829133|NCT01108510|16651670|P1|Overall Study|Lack of Efficacy|3
4829134|NCT01108510|16651669|P2|Overall Study|Participant Noncompliance|7
4829135|NCT01108510|16651670|P1|Overall Study|Participant Noncompliance|5
4829136|NCT01108510|16651669|P2|Overall Study|Investigator's Discretion|10
4829137|NCT01108510|16651670|P1|Overall Study|Investigator's Discretion|12
4829138|NCT01108510|16651669|P2|Overall Study|Withdrew Consent|15
4829139|NCT01108510|16651670|P1|Overall Study|Withdrew Consent|21
4829140|NCT01108510|16651669|P2|Overall Study|Lost to Follow-up|17
4829141|NCT01108510|16651670|P1|Overall Study|Lost to Follow-up|20
4829142|NCT01108510|16651669|P2|Overall Study|Adverse Event|19
4829143|NCT01108510|16651670|P1|Overall Study|Adverse Event|26
4829144|NCT01108510|16651669|P2|Overall Study|Joined Another Gilead-sponsored Study|195
4829145|NCT01108510|16651670|P1|Overall Study|Joined Another Gilead-sponsored Study|186
4829146|NCT01108510|16651669|P2|Overall Study|Randomized but Not Treated|1
4829147|NCT01108510|16651670|P1|Overall Study|Randomized but Not Treated|5
4829148|NCT01108458|16651690|P1|Overall Study|Withdrawal by Subject|1
4829149|NCT01108341|16651742|P1|Overall Study|Other|1
4829150|NCT01108341|16651742|P1|Overall Study|Lost to Follow-up|1
4829151|NCT01108341|16651742|P1|Overall Study|Withdrawal by Subject|1
4829152|NCT01108341|16651742|P1|Overall Study|Death|2
4829153|NCT01108263|16651749|P2|Overall Study|Adverse Event|1
4829154|NCT01108263|16651750|P1|Overall Study|Adverse Event|0
4829155|NCT01108237|16651760|P2|Overall Study|Did not meet criteria for analysis|0
4829156|NCT01108237|16651761|P1|Overall Study|Did not meet criteria for analysis|7
4829157|NCT01108237|16651760|P2|Overall Study|No alignment data|17
4829158|NCT01108237|16651761|P1|Overall Study|No alignment data|2
4829159|NCT01108185|16651767|P1|Overall Study|Lost to Follow-up|12
4829160|NCT01108185|16651767|P1|Overall Study|Non-compliance|15
4829161|NCT01108094|16651784|P4|Overall Study|Withdrawal by Subject|0
4829162|NCT01108094|16651785|P3|Overall Study|Withdrawal by Subject|0
4829163|NCT01108094|16651786|P2|Overall Study|Withdrawal by Subject|0
4829164|NCT01108094|16651787|P1|Overall Study|Withdrawal by Subject|1
4829165|NCT01108094|16651784|P4|Overall Study|Adverse Event|0
4829166|NCT01108094|16651785|P3|Overall Study|Adverse Event|0
4829167|NCT01108094|16651786|P2|Overall Study|Adverse Event|0
4829168|NCT01108094|16651787|P1|Overall Study|Adverse Event|2
4829169|NCT01108068|16651831|P2|Overall Study|5 not started, 1 stop due to side effect|0
4829170|NCT01108068|16651832|P1|Overall Study|5 not started, 1 stop due to side effect|6
4829171|NCT01108055|16651839|P1|Overall Study|Not evaluable- didn't complete treatment|4
4829172|NCT01108055|16651839|P1|Overall Study|Ineligible|11
4829173|NCT01107925|16651877|P6|Period 2|Withdrawal by Subject|1
4829174|NCT01107925|16651878|P5|Period 2|Withdrawal by Subject|0
4829175|NCT01107925|16651879|P4|Period 2|Withdrawal by Subject|0
4829176|NCT01107925|16651880|P3|Period 2|Withdrawal by Subject|0
4829177|NCT01107925|16651881|P2|Period 2|Withdrawal by Subject|1
4829178|NCT01107925|16651882|P1|Period 2|Withdrawal by Subject|0
4829179|NCT01107925|16651877|P6|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4829180|NCT01107925|16651878|P5|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
4829181|NCT01107925|16651879|P4|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4829182|NCT01107925|16651880|P3|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4829183|NCT01107925|16651881|P2|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0
4829184|NCT01107925|16651882|P1|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1
4829185|NCT01107912|16651920|P6|Period 3|Withdrawal by Subject|0
4829186|NCT01107912|16651921|P5|Period 3|Withdrawal by Subject|0
4829187|NCT01107912|16651922|P4|Period 3|Withdrawal by Subject|1
4829188|NCT01107912|16651923|P3|Period 3|Withdrawal by Subject|0
4829189|NCT01107912|16651924|P2|Period 3|Withdrawal by Subject|0
4829190|NCT01107912|16651925|P1|Period 3|Withdrawal by Subject|0
4829191|NCT01107912|16651920|P6|Period 3|Adverse Event|0
4829192|NCT01107912|16651921|P5|Period 3|Adverse Event|0
4829193|NCT01107912|16651922|P4|Period 3|Adverse Event|0
4829194|NCT01107912|16651923|P3|Period 3|Adverse Event|1
4829195|NCT01107912|16651924|P2|Period 3|Adverse Event|1
4829196|NCT01107912|16651925|P1|Period 3|Adverse Event|0
4829197|NCT01107912|16651920|P6|Period 2|Physician Decision|0
4829198|NCT01107912|16651921|P5|Period 2|Physician Decision|0
4829199|NCT01107912|16651922|P4|Period 2|Physician Decision|0
4829200|NCT01107912|16651923|P3|Period 2|Physician Decision|1
4829201|NCT01107912|16651924|P2|Period 2|Physician Decision|0
4829202|NCT01107912|16651925|P1|Period 2|Physician Decision|0
4829203|NCT01107912|16651920|P6|Period 1|Withdrawal by Subject|0
4829204|NCT01107912|16651921|P5|Period 1|Withdrawal by Subject|0
4829205|NCT01107912|16651922|P4|Period 1|Withdrawal by Subject|0
4829206|NCT01107912|16651923|P3|Period 1|Withdrawal by Subject|0
4829207|NCT01107912|16651924|P2|Period 1|Withdrawal by Subject|0
4829208|NCT01107912|16651925|P1|Period 1|Withdrawal by Subject|1
4829209|NCT01107912|16651920|P6|Period 1|Physician Decision|0
4829210|NCT01107912|16651921|P5|Period 1|Physician Decision|1
4829211|NCT01107912|16651922|P4|Period 1|Physician Decision|0
4829212|NCT01107912|16651923|P3|Period 1|Physician Decision|0
4829213|NCT01107912|16651924|P2|Period 1|Physician Decision|0
4829214|NCT01107912|16651925|P1|Period 1|Physician Decision|0
4829215|NCT01107912|16651920|P6|Period 1|Adverse Event|0
4829216|NCT01107912|16651921|P5|Period 1|Adverse Event|2
4829217|NCT01107912|16651922|P4|Period 1|Adverse Event|0
4829218|NCT01107912|16651923|P3|Period 1|Adverse Event|0
4829219|NCT01107912|16651924|P2|Period 1|Adverse Event|0
4829220|NCT01107912|16651925|P1|Period 1|Adverse Event|0
4829221|NCT01107899|16651962|P3|Overall Study|Withdrawal by Subject|1
4829222|NCT01107899|16651963|P2|Overall Study|Withdrawal by Subject|0
4829223|NCT01107899|16651964|P1|Overall Study|Withdrawal by Subject|0
4829224|NCT01107899|16651962|P3|Overall Study|Physician Decision|3
4829225|NCT01107899|16651963|P2|Overall Study|Physician Decision|0
4829226|NCT01107899|16651964|P1|Overall Study|Physician Decision|5
4829227|NCT01107886|16652010|P2|Overall Study|Administrative withdrawal of consent|5
4829228|NCT01107886|16652011|P1|Overall Study|Administrative withdrawal of consent|7
4829229|NCT01107886|16652010|P2|Overall Study|Withdrawal by Subject|196
4829230|NCT01107886|16652011|P1|Overall Study|Withdrawal by Subject|180
4829231|NCT01107886|16652010|P2|Overall Study|Lost to Follow-up|13
4829232|NCT01107886|16652011|P1|Overall Study|Lost to Follow-up|15
4829233|NCT01107743|16652044|P1|Overall Study|Protocol Violation|46
4829234|NCT01107535|16652158|P1|Overall Study|Death|5
4829235|NCT01107457|16652171|P6|Part B and C|Clinical Relapse|4
4829236|NCT01107457|16652172|P5|Part B and C|Clinical Relapse|0
4829237|NCT01107457|16652173|P4|Part B and C|Clinical Relapse|0
4829238|NCT01107457|16652174|P3|Part B and C|Clinical Relapse|0
4829239|NCT01107457|16652175|P2|Part B and C|Clinical Relapse|0
4829240|NCT01107457|16652176|P1|Part B and C|Clinical Relapse|0
4829241|NCT01107457|16652171|P6|Part B and C|Withdrawal by Subject|16
4829242|NCT01107457|16652172|P5|Part B and C|Withdrawal by Subject|0
4829243|NCT01107457|16652173|P4|Part B and C|Withdrawal by Subject|0
4829244|NCT01107457|16652174|P3|Part B and C|Withdrawal by Subject|0
4829245|NCT01107457|16652175|P2|Part B and C|Withdrawal by Subject|0
4829246|NCT01107457|16652176|P1|Part B and C|Withdrawal by Subject|0
4829247|NCT01107457|16652171|P6|Part B and C|Sponsor Decision|66
4829248|NCT01107457|16652172|P5|Part B and C|Sponsor Decision|0
4829249|NCT01107457|16652173|P4|Part B and C|Sponsor Decision|0
4829250|NCT01107457|16652174|P3|Part B and C|Sponsor Decision|0
4829251|NCT01107457|16652175|P2|Part B and C|Sponsor Decision|0
4829252|NCT01107457|16652176|P1|Part B and C|Sponsor Decision|0
4829253|NCT01107457|16652171|P6|Part B and C|Protocol Violation|1
4829254|NCT01107457|16652172|P5|Part B and C|Protocol Violation|0
4829255|NCT01107457|16652173|P4|Part B and C|Protocol Violation|0
4829256|NCT01107457|16652174|P3|Part B and C|Protocol Violation|0
4829257|NCT01107457|16652175|P2|Part B and C|Protocol Violation|0
4829258|NCT01107457|16652176|P1|Part B and C|Protocol Violation|0
4829259|NCT01107457|16652171|P6|Part B and C|Lost to Follow-up|10
4829260|NCT01107457|16652172|P5|Part B and C|Lost to Follow-up|0
4829261|NCT01107457|16652173|P4|Part B and C|Lost to Follow-up|0
4829262|NCT01107457|16652174|P3|Part B and C|Lost to Follow-up|0
4829263|NCT01107457|16652175|P2|Part B and C|Lost to Follow-up|0
4829264|NCT01107457|16652176|P1|Part B and C|Lost to Follow-up|0
4829265|NCT01107457|16652171|P6|Part B and C|Lack of Efficacy|7
4829266|NCT01107457|16652172|P5|Part B and C|Lack of Efficacy|0
4829267|NCT01107457|16652173|P4|Part B and C|Lack of Efficacy|0
4829268|NCT01107457|16652174|P3|Part B and C|Lack of Efficacy|0
4829269|NCT01107457|16652175|P2|Part B and C|Lack of Efficacy|0
4829270|NCT01107457|16652176|P1|Part B and C|Lack of Efficacy|0
4829271|NCT01107457|16652171|P6|Part B and C|Physician Decision|3
4829272|NCT01107457|16652172|P5|Part B and C|Physician Decision|0
4829273|NCT01107457|16652173|P4|Part B and C|Physician Decision|0
4829274|NCT01107457|16652174|P3|Part B and C|Physician Decision|0
4829275|NCT01107457|16652175|P2|Part B and C|Physician Decision|0
4829276|NCT01107457|16652176|P1|Part B and C|Physician Decision|0
4829277|NCT01107457|16652171|P6|Part B and C|Inclusion/Exclusion Criteria Not Met|1
4829278|NCT01107457|16652172|P5|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4829279|NCT01107457|16652173|P4|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4829280|NCT01107457|16652174|P3|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4829281|NCT01107457|16652175|P2|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4829282|NCT01107457|16652176|P1|Part B and C|Inclusion/Exclusion Criteria Not Met|0
4829283|NCT01107457|16652171|P6|Part B and C|Adverse Event|12
4829284|NCT01107457|16652172|P5|Part B and C|Adverse Event|0
4829285|NCT01107457|16652173|P4|Part B and C|Adverse Event|0
4829286|NCT01107457|16652174|P3|Part B and C|Adverse Event|0
4829287|NCT01107457|16652175|P2|Part B and C|Adverse Event|0
4829288|NCT01107457|16652176|P1|Part B and C|Adverse Event|0
4829289|NCT01107457|16652171|P6|Part A|Protocol Violation|0
4829290|NCT01107457|16652172|P5|Part A|Protocol Violation|0
4829291|NCT01107457|16652173|P4|Part A|Protocol Violation|0
4829292|NCT01107457|16652174|P3|Part A|Protocol Violation|0
4829293|NCT01107457|16652175|P2|Part A|Protocol Violation|1
4829294|NCT01107457|16652176|P1|Part A|Protocol Violation|0
4829295|NCT01107457|16652171|P6|Part A|Lack of Efficacy|0
4829296|NCT01107457|16652172|P5|Part A|Lack of Efficacy|0
4829297|NCT01107457|16652173|P4|Part A|Lack of Efficacy|0
4829298|NCT01107457|16652174|P3|Part A|Lack of Efficacy|0
4829299|NCT01107457|16652175|P2|Part A|Lack of Efficacy|0
4829300|NCT01107457|16652176|P1|Part A|Lack of Efficacy|1
4829301|NCT01107457|16652171|P6|Part A|Lost to Follow-up|0
4829302|NCT01107457|16652172|P5|Part A|Lost to Follow-up|0
4829303|NCT01107457|16652173|P4|Part A|Lost to Follow-up|0
4829304|NCT01107457|16652174|P3|Part A|Lost to Follow-up|0
4829305|NCT01107457|16652175|P2|Part A|Lost to Follow-up|1
4829306|NCT01107457|16652176|P1|Part A|Lost to Follow-up|0
4829307|NCT01107457|16652171|P6|Part A|Withdrawal by Subject|0
4829308|NCT01107457|16652172|P5|Part A|Withdrawal by Subject|1
4829309|NCT01107457|16652173|P4|Part A|Withdrawal by Subject|3
4829310|NCT01107457|16652174|P3|Part A|Withdrawal by Subject|0
4829311|NCT01107457|16652175|P2|Part A|Withdrawal by Subject|3
4829312|NCT01107457|16652176|P1|Part A|Withdrawal by Subject|3
4829313|NCT01107457|16652171|P6|Part A|Adverse Event|0
4829314|NCT01107457|16652172|P5|Part A|Adverse Event|0
4829315|NCT01107457|16652173|P4|Part A|Adverse Event|0
4829316|NCT01107457|16652174|P3|Part A|Adverse Event|1
4829317|NCT01107457|16652175|P2|Part A|Adverse Event|2
4829318|NCT01107457|16652176|P1|Part A|Adverse Event|1
4829319|NCT01107444|16652304|P2|Overall Study|Protocol Entry Criteria Not Met|1
4829320|NCT01107444|16652305|P1|Overall Study|Protocol Entry Criteria Not Met|0
4829321|NCT01107444|16652304|P2|Overall Study|Withdrawal by Subject|12
4829322|NCT01107444|16652305|P1|Overall Study|Withdrawal by Subject|8
4829323|NCT01107418|16652339|P1|Overall Study|Entered Extension Study|1
4829324|NCT01107418|16652339|P1|Overall Study|Started Other Therapy|1
4829325|NCT01107418|16652339|P1|Overall Study|Study Closing|1
4829326|NCT01107418|16652339|P1|Overall Study|Withdrawal by Subject|1
4829327|NCT01107418|16652339|P1|Overall Study|Adverse Event|3
4829328|NCT01107418|16652339|P1|Overall Study|Disease Progression|45
4829329|NCT01107405|16652412|P5|Overall Study|Protocol Violation|0
4829330|NCT01107405|16652413|P4|Overall Study|Protocol Violation|1
4829331|NCT01107405|16652414|P3|Overall Study|Protocol Violation|1
4829332|NCT01107405|16652415|P2|Overall Study|Protocol Violation|0
4829333|NCT01107405|16652416|P1|Overall Study|Protocol Violation|0
4829334|NCT01107405|16652412|P5|Overall Study|Withdrawal by Subject|1
4829335|NCT01107405|16652413|P4|Overall Study|Withdrawal by Subject|2
4829336|NCT01107405|16652414|P3|Overall Study|Withdrawal by Subject|1
4829337|NCT01107405|16652415|P2|Overall Study|Withdrawal by Subject|0
4829338|NCT01107405|16652416|P1|Overall Study|Withdrawal by Subject|1
4829339|NCT01107405|16652412|P5|Overall Study|Adverse Event|2
4829340|NCT01107405|16652413|P4|Overall Study|Adverse Event|0
4829341|NCT01107405|16652414|P3|Overall Study|Adverse Event|0
4829342|NCT01107405|16652415|P2|Overall Study|Adverse Event|1
4829343|NCT01107405|16652416|P1|Overall Study|Adverse Event|1
4829344|NCT01107392|16652455|P2|Overall Study|Administrative decision|0
4829345|NCT01107392|16652456|P1|Overall Study|Administrative decision|1
4829346|NCT01107392|16652455|P2|Overall Study|Personal Reasons|3
4829347|NCT01107392|16652456|P1|Overall Study|Personal Reasons|2
4829348|NCT01107392|16652455|P2|Overall Study|Adverse Event|0
4829349|NCT01107392|16652456|P1|Overall Study|Adverse Event|2
4829350|NCT01107379|16652468|P1|Overall Study|Lost to Follow-up|3
4829351|NCT01107379|16652468|P1|Overall Study|Withdrawal by Subject|18
4829352|NCT01107353|16652479|P2|Overall Study|Positive Drug Screen|0
4829353|NCT01107353|16652480|P1|Overall Study|Positive Drug Screen|1
4829354|NCT01107197|16652488|P2|Overall Study|Withdrawal by Subject|5
4829355|NCT01107197|16652489|P1|Overall Study|Withdrawal by Subject|3
4829356|NCT01107197|16652488|P2|Overall Study|Lost to Follow-up|8
4829357|NCT01107197|16652489|P1|Overall Study|Lost to Follow-up|5
4829358|NCT01107197|16652488|P2|Overall Study|Death|10
4829359|NCT01107197|16652489|P1|Overall Study|Death|12
4829360|NCT01106976|16652524|P1|Overall Study|Lost to Follow-up|8
4829361|NCT01106911|16652538|P1|Overall Study|deemed ineligible after screening|3
4829362|NCT01106911|16652538|P1|Overall Study|Physician Decision|2
4829363|NCT01106898|16652542|P1|Overall Study|Adverse Event|6
4829364|NCT01106846|16652587|P2|Overall Study|Change in surgical procedure|1
4829365|NCT01106846|16652588|P1|Overall Study|Change in surgical procedure|0
4829366|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4829367|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4829368|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
4829369|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Other|4
4829370|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Other|3
4829371|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Other|8
4829372|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4829373|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4829374|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4829375|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
4829376|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4829377|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4829378|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
4829379|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Physician Decision|2
4829380|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
4829381|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4829382|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4829383|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4829384|NCT01106690|16652638|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
4829385|NCT01106690|16652639|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
4829386|NCT01106690|16652640|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
4829387|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Other|6
4829388|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Other|2
4829389|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Other|10
4829390|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4829391|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4829392|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
4829393|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4829394|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4829395|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
4829396|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4829397|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4829398|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4829399|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
4829400|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
4829401|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0
4829402|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|0
4829403|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|1
4829404|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
4829405|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Protocol Violation|0
4829406|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Protocol Violation|0
4829407|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Protocol Violation|1
4829408|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Lost to Follow-up|2
4829409|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
4829410|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Lost to Follow-up|1
4829411|NCT01106690|16652638|P3|Core Period: Baseline to Week 26|Adverse Event|4
4829412|NCT01106690|16652639|P2|Core Period: Baseline to Week 26|Adverse Event|1
4829413|NCT01106690|16652640|P1|Core Period: Baseline to Week 26|Adverse Event|6
4829414|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Other|5
4829415|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Other|8
4829416|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Other|5
4829417|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Other|6
4829418|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4829419|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4829420|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4829421|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4829422|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
4829423|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3
4829424|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
4829425|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
4829426|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4829427|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
4829428|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3
4829429|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4829430|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
4829431|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
4829432|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Protocol Violation|0
4829433|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
4829434|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Physician Decision|3
4829435|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Physician Decision|2
4829436|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Physician Decision|3
4829437|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
4829438|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4829439|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4829440|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4829441|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4829442|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Lack of Efficacy|4
4829443|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
4829444|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Lack of Efficacy|0
4829445|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Lack of Efficacy|2
4829446|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Death|1
4829447|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Death|0
4829448|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Death|0
4829449|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Death|0
4829450|NCT01106677|16652676|P4|Extension Period: Week 26 to Week 52|Adverse Event|9
4829451|NCT01106677|16652677|P3|Extension Period: Week 26 to Week 52|Adverse Event|5
4829452|NCT01106677|16652678|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
4829453|NCT01106677|16652679|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
4829454|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Pregnancy|0
4829455|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Pregnancy|0
4829456|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Pregnancy|1
4829457|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Pregnancy|0
4829458|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Other|23
4829459|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Other|8
4829460|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Other|14
4829461|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Other|8
4829462|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Product quality complaint|0
4829463|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Product quality complaint|1
4829464|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Product quality complaint|1
4829465|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Product quality complaint|0
4829466|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Study terminated by sponsor|0
4829467|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Study terminated by sponsor|2
4829468|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Study terminated by sponsor|1
4829469|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Study terminated by sponsor|0
4829470|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4829471|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4829472|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|3
4829473|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4829474|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3
4829475|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
4829476|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2
4829477|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1
4829478|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|6
4829479|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|15
4829480|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
4829481|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|5
4829482|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Protocol Violation|3
4829483|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Protocol Violation|0
4829484|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Protocol Violation|1
4829485|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Protocol Violation|0
4829486|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Physician Decision|1
4829487|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Physician Decision|3
4829488|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Physician Decision|1
4829489|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Physician Decision|2
4829490|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Lost to Follow-up|3
4829491|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Lost to Follow-up|6
4829492|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Lost to Follow-up|1
4829493|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Lost to Follow-up|3
4829494|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Lack of Efficacy|0
4829495|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Lack of Efficacy|0
4829496|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Lack of Efficacy|0
4829497|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Lack of Efficacy|1
4829498|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Death|0
4829499|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Death|1
4829500|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Death|0
4829501|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Death|0
4829502|NCT01106677|16652676|P4|Core Period: Baseline to Week 26|Adverse Event|8
4829503|NCT01106677|16652677|P3|Core Period: Baseline to Week 26|Adverse Event|6
4829504|NCT01106677|16652678|P2|Core Period: Baseline to Week 26|Adverse Event|18
4829505|NCT01106677|16652679|P1|Core Period: Baseline to Week 26|Adverse Event|7
4829506|NCT01106651|16652742|P3|Overall Study|Death|0
4829507|NCT01106651|16652743|P2|Overall Study|Death|3
4829508|NCT01106651|16652744|P1|Overall Study|Death|0
4829509|NCT01106651|16652742|P3|Overall Study|Other|21
4829510|NCT01106651|16652743|P2|Overall Study|Other|31
4829511|NCT01106651|16652744|P1|Overall Study|Other|34
4829512|NCT01106651|16652742|P3|Overall Study|Noncompliance with study drug|2
4829513|NCT01106651|16652743|P2|Overall Study|Noncompliance with study drug|0
4829514|NCT01106651|16652744|P1|Overall Study|Noncompliance with study drug|1
4829515|NCT01106651|16652742|P3|Overall Study|Withdrawal by Subject|4
4829516|NCT01106651|16652743|P2|Overall Study|Withdrawal by Subject|7
4829517|NCT01106651|16652744|P1|Overall Study|Withdrawal by Subject|14
4829518|NCT01106651|16652742|P3|Overall Study|Protocol Violation|1
4829519|NCT01106651|16652743|P2|Overall Study|Protocol Violation|2
4829520|NCT01106651|16652744|P1|Overall Study|Protocol Violation|1
4829521|NCT01106651|16652742|P3|Overall Study|Physician Decision|1
4829522|NCT01106651|16652743|P2|Overall Study|Physician Decision|3
4829523|NCT01106651|16652744|P1|Overall Study|Physician Decision|4
4829524|NCT01106651|16652742|P3|Overall Study|Lost to Follow-up|6
4829525|NCT01106651|16652743|P2|Overall Study|Lost to Follow-up|2
4829526|NCT01106651|16652744|P1|Overall Study|Lost to Follow-up|8
4829527|NCT01106651|16652742|P3|Overall Study|Adverse Event|23
4829528|NCT01106651|16652743|P2|Overall Study|Adverse Event|9
4829529|NCT01106651|16652744|P1|Overall Study|Adverse Event|17
4829530|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Other|4
4829531|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Other|5
4829532|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Other|5
4829533|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2
4829534|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
4829535|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
4829536|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4
4829537|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5
4829538|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14
4829539|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4829540|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4829541|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4
4829542|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
4829543|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
4829544|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
4829545|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Physician Decision|1
4829546|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
4829547|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Physician Decision|2
4829548|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|2
4829549|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|3
4829550|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
4829551|NCT01106625|16652797|P3|Extension Period: Week 26 to Week 52|Adverse Event|3
4829552|NCT01106625|16652798|P2|Extension Period: Week 26 to Week 52|Adverse Event|2
4829553|NCT01106625|16652799|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
4829554|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Other|4
4829555|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Other|7
4829556|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Other|8
4829557|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4829558|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4829559|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4829560|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
4829561|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1
4829562|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0
4829563|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4829564|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
4829565|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|4
4829566|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|7
4829567|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|9
4829568|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|6
4829569|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Protocol Violation|3
4829570|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Protocol Violation|1
4829571|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Protocol Violation|2
4829572|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Physician Decision|0
4829573|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Physician Decision|0
4829574|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Physician Decision|1
4829575|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Lost to Follow-up|4
4829576|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Lost to Follow-up|0
4829577|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Lost to Follow-up|5
4829578|NCT01106625|16652797|P3|Core Period: Baseline to Week 26|Adverse Event|8
4829579|NCT01106625|16652798|P2|Core Period: Baseline to Week 26|Adverse Event|8
4829580|NCT01106625|16652799|P1|Core Period: Baseline to Week 26|Adverse Event|6
4829581|NCT01106586|16652830|P2|Overall Study|Participant Transferred to Another Study|197
4829582|NCT01106586|16652831|P1|Overall Study|Participant Transferred to Another Study|212
4829583|NCT01106586|16652830|P2|Overall Study|Protocol Violation|0
4829584|NCT01106586|16652831|P1|Overall Study|Protocol Violation|1
4829585|NCT01106586|16652830|P2|Overall Study|Participant Noncompliance|10
4829586|NCT01106586|16652831|P1|Overall Study|Participant Noncompliance|12
4829587|NCT01106586|16652830|P2|Overall Study|Lost to Follow-up|20
4829588|NCT01106586|16652831|P1|Overall Study|Lost to Follow-up|24
4829589|NCT01106586|16652830|P2|Overall Study|Withdrew Consent|30
4829590|NCT01106586|16652831|P1|Overall Study|Withdrew Consent|18
4829591|NCT01106586|16652830|P2|Overall Study|Investigator's Discretion|8
4829592|NCT01106586|16652831|P1|Overall Study|Investigator's Discretion|5
4829593|NCT01106586|16652830|P2|Overall Study|Lack of Efficacy|0
4829594|NCT01106586|16652831|P1|Overall Study|Lack of Efficacy|1
4829595|NCT01106586|16652830|P2|Overall Study|Pregnancy|2
4829596|NCT01106586|16652831|P1|Overall Study|Pregnancy|2
4829597|NCT01106586|16652830|P2|Overall Study|Death|3
4829598|NCT01106586|16652831|P1|Overall Study|Death|1
4829599|NCT01106586|16652830|P2|Overall Study|Adverse Event|15
4829600|NCT01106586|16652831|P1|Overall Study|Adverse Event|9
4829601|NCT01106534|16652849|P1|Overall Study|Physician Decision|1
4829602|NCT01106534|16652849|P1|Overall Study|Death|16
4829603|NCT01106534|16652849|P1|Overall Study|Lost to Follow-up|2
4829604|NCT01106534|16652849|P1|Overall Study|Withdrawal by Subject|18
4829605|NCT01106430|16652881|P2|Overall Study|Withdrawal by Subject|4
4829606|NCT01106430|16652882|P1|Overall Study|Withdrawal by Subject|8
4829607|NCT01106430|16652881|P2|Overall Study|Protocol Violation|2
4829608|NCT01106430|16652882|P1|Overall Study|Protocol Violation|7
4829609|NCT01106430|16652881|P2|Overall Study|Previous Use Of Marijuana|0
4829610|NCT01106430|16652882|P1|Overall Study|Previous Use Of Marijuana|1
4829611|NCT01106430|16652881|P2|Overall Study|Hard Time Swallowing The Pills|0
4829612|NCT01106430|16652882|P1|Overall Study|Hard Time Swallowing The Pills|1
4829613|NCT01106430|16652881|P2|Overall Study|Noncompliance|1
4829614|NCT01106430|16652882|P1|Overall Study|Noncompliance|0
4829615|NCT01106430|16652881|P2|Overall Study|Refused To Take Medication|1
4829616|NCT01106430|16652882|P1|Overall Study|Refused To Take Medication|0
4829617|NCT01106430|16652881|P2|Overall Study|Moved Out Of State|1
4829618|NCT01106430|16652882|P1|Overall Study|Moved Out Of State|0
4829619|NCT01106430|16652881|P2|Overall Study|Early Termination Requested By Sponsor|0
4829620|NCT01106430|16652882|P1|Overall Study|Early Termination Requested By Sponsor|1
4829621|NCT01106430|16652881|P2|Overall Study|Lost to Follow-up|1
4829622|NCT01106430|16652882|P1|Overall Study|Lost to Follow-up|5
4829623|NCT01106430|16652881|P2|Overall Study|Lack of Efficacy|13
4829624|NCT01106430|16652882|P1|Overall Study|Lack of Efficacy|2
4829625|NCT01106430|16652881|P2|Overall Study|Adverse Event|10
4829626|NCT01106430|16652882|P1|Overall Study|Adverse Event|8
4829627|NCT01106404|16652904|P2|Period I (First 6 Weeks)|Lack of Efficacy|1
4829628|NCT01106404|16652905|P1|Period I (First 6 Weeks)|Lack of Efficacy|0
4829629|NCT01106404|16652904|P2|Period I (First 6 Weeks)|Lost to Follow-up|1
4829630|NCT01106404|16652905|P1|Period I (First 6 Weeks)|Lost to Follow-up|0
4829631|NCT01106404|16652904|P2|Period I (First 6 Weeks)|Physician Decision|0
4829632|NCT01106404|16652905|P1|Period I (First 6 Weeks)|Physician Decision|1
4829633|NCT01106404|16652904|P2|Period I (First 6 Weeks)|Adverse Event|0
4829634|NCT01106404|16652905|P1|Period I (First 6 Weeks)|Adverse Event|2
4829635|NCT01106352|16652928|P5|Overall Study|Home hospice since July 2013|0
4829636|NCT01106352|16652929|P4|Overall Study|Home hospice since July 2013|1
4829637|NCT01106352|16652930|P3|Overall Study|Home hospice since July 2013|0
4829638|NCT01106352|16652931|P2|Overall Study|Home hospice since July 2013|0
4829639|NCT01106352|16652932|P1|Overall Study|Home hospice since July 2013|0
4829640|NCT01106352|16652928|P5|Overall Study|Subject entered hospice|0
4829641|NCT01106352|16652929|P4|Overall Study|Subject entered hospice|1
4829642|NCT01106352|16652930|P3|Overall Study|Subject entered hospice|0
4829643|NCT01106352|16652931|P2|Overall Study|Subject entered hospice|0
4829644|NCT01106352|16652932|P1|Overall Study|Subject entered hospice|0
4829645|NCT01106352|16652928|P5|Overall Study|Went on hospice|0
4829646|NCT01106352|16652929|P4|Overall Study|Went on hospice|1
4829647|NCT01106352|16652930|P3|Overall Study|Went on hospice|0
4829648|NCT01106352|16652931|P2|Overall Study|Went on hospice|0
4829649|NCT01106352|16652932|P1|Overall Study|Went on hospice|0
4829650|NCT01106352|16652928|P5|Overall Study|Withdrawal by Subject|2
4829651|NCT01106352|16652929|P4|Overall Study|Withdrawal by Subject|3
4829652|NCT01106352|16652930|P3|Overall Study|Withdrawal by Subject|0
4829653|NCT01106352|16652931|P2|Overall Study|Withdrawal by Subject|0
4829654|NCT01106352|16652932|P1|Overall Study|Withdrawal by Subject|0
4829655|NCT01106352|16652928|P5|Overall Study|Disease progression|0
4829656|NCT01106352|16652929|P4|Overall Study|Disease progression|1
4829657|NCT01106352|16652930|P3|Overall Study|Disease progression|0
4829658|NCT01106352|16652931|P2|Overall Study|Disease progression|0
4829659|NCT01106352|16652932|P1|Overall Study|Disease progression|0
4829660|NCT01106352|16652928|P5|Overall Study|Death|1
4829661|NCT01106352|16652929|P4|Overall Study|Death|3
4829662|NCT01106352|16652930|P3|Overall Study|Death|1
4829663|NCT01106352|16652931|P2|Overall Study|Death|0
4829664|NCT01106352|16652932|P1|Overall Study|Death|0
4829665|NCT01106352|16652928|P5|Overall Study|Lost to Follow-up|1
4829666|NCT01106352|16652929|P4|Overall Study|Lost to Follow-up|0
4829667|NCT01106352|16652930|P3|Overall Study|Lost to Follow-up|0
4829668|NCT01106352|16652931|P2|Overall Study|Lost to Follow-up|0
4829669|NCT01106352|16652932|P1|Overall Study|Lost to Follow-up|0
4829670|NCT01106352|16652928|P5|Overall Study|Too ill to come in for the visit|0
4829671|NCT01106352|16652929|P4|Overall Study|Too ill to come in for the visit|0
4829672|NCT01106352|16652930|P3|Overall Study|Too ill to come in for the visit|1
4829673|NCT01106352|16652931|P2|Overall Study|Too ill to come in for the visit|0
4829674|NCT01106352|16652932|P1|Overall Study|Too ill to come in for the visit|0
4829675|NCT01106352|16652928|P5|Overall Study|Sponsor Decision|0
4829676|NCT01106352|16652929|P4|Overall Study|Sponsor Decision|0
4829677|NCT01106352|16652930|P3|Overall Study|Sponsor Decision|0
4829678|NCT01106352|16652931|P2|Overall Study|Sponsor Decision|0
4829679|NCT01106352|16652932|P1|Overall Study|Sponsor Decision|1
4829680|NCT01106352|16652928|P5|Overall Study|Subjects untreated|4
4829681|NCT01106352|16652929|P4|Overall Study|Subjects untreated|3
4829682|NCT01106352|16652930|P3|Overall Study|Subjects untreated|0
4829683|NCT01106352|16652931|P2|Overall Study|Subjects untreated|0
4829684|NCT01106352|16652932|P1|Overall Study|Subjects untreated|0
4829685|NCT01106287|16653028|P4|Overall Study|Adverse Event|0
4829686|NCT01106287|16653029|P3|Overall Study|Adverse Event|0
4829687|NCT01106287|16653030|P2|Overall Study|Adverse Event|0
4829688|NCT01106287|16653031|P1|Overall Study|Adverse Event|1
4829689|NCT01106248|16653051|P1|Overall Study|Administrative|2
4829690|NCT01106248|16653051|P1|Overall Study|Adverse Event|1
4829691|NCT01106157|16653059|P2|Overall Study|Withdrawal by Subject|0
4829692|NCT01106157|16653060|P1|Overall Study|Withdrawal by Subject|1
4829693|NCT01106092|16653088|P4|Overall Study|Withdrawal by Subject|1
4829694|NCT01106092|16653089|P3|Overall Study|Withdrawal by Subject|0
4829695|NCT01106092|16653090|P2|Overall Study|Withdrawal by Subject|0
4829696|NCT01106092|16653091|P1|Overall Study|Withdrawal by Subject|0
4829697|NCT01106027|16653174|P1|Overall Study|Lost graft early, discontinued|1
4829698|NCT01106014|16653180|P2|Overall Study|Lost to Follow-up|3
4829699|NCT01106014|16653181|P1|Overall Study|Lost to Follow-up|2
4829700|NCT01106014|16653180|P2|Overall Study|Administrative reason|6
4829701|NCT01106014|16653181|P1|Overall Study|Administrative reason|7
4829702|NCT01106014|16653180|P2|Overall Study|Withdrawal by Subject|37
4829703|NCT01106014|16653181|P1|Overall Study|Withdrawal by Subject|43
4829704|NCT01106014|16653180|P2|Overall Study|Adverse Event|42
4829705|NCT01106014|16653181|P1|Overall Study|Adverse Event|78
4829706|NCT01106014|16653180|P2|Overall Study|Morbidity or Mortality primary endpoint|242
4829707|NCT01106014|16653181|P1|Overall Study|Morbidity or Mortality primary endpoint|155
4829708|NCT01105975|16653201|P10|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4829709|NCT01105975|16653202|P9|Overall Study|Abnormal Lab/Electrocardiogram Result|2
4829710|NCT01105975|16653203|P8|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4829711|NCT01105975|16653204|P7|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4829712|NCT01105975|16653205|P6|Overall Study|Abnormal Lab/Electrocardiogram Result|2
4829713|NCT01105975|16653206|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4829714|NCT01105975|16653207|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4829715|NCT01105975|16653208|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4829716|NCT01105975|16653209|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4829717|NCT01105975|16653210|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4829718|NCT01105975|16653201|P10|Overall Study|Protocol Violation|2
4829719|NCT01105975|16653202|P9|Overall Study|Protocol Violation|2
4829720|NCT01105975|16653203|P8|Overall Study|Protocol Violation|1
4829721|NCT01105975|16653204|P7|Overall Study|Protocol Violation|1
4829722|NCT01105975|16653205|P6|Overall Study|Protocol Violation|1
4829723|NCT01105975|16653206|P5|Overall Study|Protocol Violation|1
4829724|NCT01105975|16653207|P4|Overall Study|Protocol Violation|0
4829725|NCT01105975|16653208|P3|Overall Study|Protocol Violation|2
4829726|NCT01105975|16653209|P2|Overall Study|Protocol Violation|2
4829727|NCT01105975|16653210|P1|Overall Study|Protocol Violation|0
4829728|NCT01105975|16653201|P10|Overall Study|Physician Decision|0
4829729|NCT01105975|16653202|P9|Overall Study|Physician Decision|0
4829730|NCT01105975|16653203|P8|Overall Study|Physician Decision|0
4829731|NCT01105975|16653204|P7|Overall Study|Physician Decision|2
4829732|NCT01105975|16653205|P6|Overall Study|Physician Decision|0
4829733|NCT01105975|16653206|P5|Overall Study|Physician Decision|0
4829734|NCT01105975|16653207|P4|Overall Study|Physician Decision|0
4829735|NCT01105975|16653208|P3|Overall Study|Physician Decision|0
4829736|NCT01105975|16653209|P2|Overall Study|Physician Decision|0
4829737|NCT01105975|16653210|P1|Overall Study|Physician Decision|0
4829738|NCT01105975|16653201|P10|Overall Study|Lost to Follow-up|0
4829739|NCT01105975|16653202|P9|Overall Study|Lost to Follow-up|1
4829740|NCT01105975|16653203|P8|Overall Study|Lost to Follow-up|0
4829741|NCT01105975|16653204|P7|Overall Study|Lost to Follow-up|0
4829742|NCT01105975|16653205|P6|Overall Study|Lost to Follow-up|0
4829743|NCT01105975|16653206|P5|Overall Study|Lost to Follow-up|1
4829744|NCT01105975|16653207|P4|Overall Study|Lost to Follow-up|1
4829745|NCT01105975|16653208|P3|Overall Study|Lost to Follow-up|0
4829746|NCT01105975|16653209|P2|Overall Study|Lost to Follow-up|0
4829747|NCT01105975|16653210|P1|Overall Study|Lost to Follow-up|1
4829748|NCT01105975|16653201|P10|Overall Study|Withdrawal by Subject|3
4829749|NCT01105975|16653202|P9|Overall Study|Withdrawal by Subject|0
4829750|NCT01105975|16653203|P8|Overall Study|Withdrawal by Subject|1
4829751|NCT01105975|16653204|P7|Overall Study|Withdrawal by Subject|2
4829752|NCT01105975|16653205|P6|Overall Study|Withdrawal by Subject|1
4829753|NCT01105975|16653206|P5|Overall Study|Withdrawal by Subject|4
4829754|NCT01105975|16653207|P4|Overall Study|Withdrawal by Subject|0
4829755|NCT01105975|16653208|P3|Overall Study|Withdrawal by Subject|2
4829756|NCT01105975|16653209|P2|Overall Study|Withdrawal by Subject|2
4829757|NCT01105975|16653210|P1|Overall Study|Withdrawal by Subject|2
4829758|NCT01105975|16653201|P10|Overall Study|Adverse Event|4
4829759|NCT01105975|16653202|P9|Overall Study|Adverse Event|1
4829760|NCT01105975|16653203|P8|Overall Study|Adverse Event|4
4829761|NCT01105975|16653204|P7|Overall Study|Adverse Event|2
4829762|NCT01105975|16653205|P6|Overall Study|Adverse Event|1
4829763|NCT01105975|16653206|P5|Overall Study|Adverse Event|0
4829764|NCT01105975|16653207|P4|Overall Study|Adverse Event|1
4829765|NCT01105975|16653208|P3|Overall Study|Adverse Event|5
4829766|NCT01105975|16653209|P2|Overall Study|Adverse Event|1
4829767|NCT01105975|16653210|P1|Overall Study|Adverse Event|2
4829768|NCT01105936|16653358|P4|Period 3|Protocol Violation|0
4829769|NCT01105936|16653359|P3|Period 3|Protocol Violation|0
4829770|NCT01105936|16653360|P2|Period 3|Protocol Violation|2
4829771|NCT01105936|16653361|P1|Period 3|Protocol Violation|0
4829772|NCT01105936|16653358|P4|Period 2|Adverse Event|0
4829773|NCT01105936|16653359|P3|Period 2|Adverse Event|0
4829774|NCT01105936|16653360|P2|Period 2|Adverse Event|0
4829775|NCT01105936|16653361|P1|Period 2|Adverse Event|1
4829776|NCT01105936|16653358|P4|Period 1|Adverse Event|1
4829777|NCT01105936|16653359|P3|Period 1|Adverse Event|0
4829778|NCT01105936|16653360|P2|Period 1|Adverse Event|0
4829779|NCT01105936|16653361|P1|Period 1|Adverse Event|0
4829780|NCT01105767|16653390|P3|Overall Study|Lost to Follow-up|1184
4829781|NCT01105767|16653391|P2|Overall Study|Lost to Follow-up|1614
4829782|NCT01105767|16653392|P1|Overall Study|Lost to Follow-up|1160
4829783|NCT01105533|16653444|P9|Overall Study|Physician Decision|0
4829784|NCT01105533|16653445|P8|Overall Study|Physician Decision|1
4829785|NCT01105533|16653446|P7|Overall Study|Physician Decision|0
4829786|NCT01105533|16653447|P6|Overall Study|Physician Decision|0
4829787|NCT01105533|16653448|P5|Overall Study|Physician Decision|0
4829788|NCT01105533|16653449|P4|Overall Study|Physician Decision|0
4829789|NCT01105533|16653450|P3|Overall Study|Physician Decision|0
4829790|NCT01105533|16653451|P2|Overall Study|Physician Decision|0
4829791|NCT01105533|16653452|P1|Overall Study|Physician Decision|0
4829792|NCT01105533|16653444|P9|Overall Study|Other|2
4829793|NCT01105533|16653445|P8|Overall Study|Other|1
4829794|NCT01105533|16653446|P7|Overall Study|Other|3
4829795|NCT01105533|16653447|P6|Overall Study|Other|0
4829796|NCT01105533|16653448|P5|Overall Study|Other|1
4829797|NCT01105533|16653449|P4|Overall Study|Other|0
4829798|NCT01105533|16653450|P3|Overall Study|Other|0
4829799|NCT01105533|16653451|P2|Overall Study|Other|0
4829800|NCT01105533|16653452|P1|Overall Study|Other|0
4829801|NCT01105533|16653444|P9|Overall Study|Adverse Event|1
4829802|NCT01105533|16653445|P8|Overall Study|Adverse Event|0
4829803|NCT01105533|16653446|P7|Overall Study|Adverse Event|2
4829804|NCT01105533|16653447|P6|Overall Study|Adverse Event|2
4829805|NCT01105533|16653448|P5|Overall Study|Adverse Event|1
4829806|NCT01105533|16653449|P4|Overall Study|Adverse Event|0
4829807|NCT01105533|16653450|P3|Overall Study|Adverse Event|0
4829808|NCT01105533|16653451|P2|Overall Study|Adverse Event|0
4829809|NCT01105533|16653452|P1|Overall Study|Adverse Event|0
4829810|NCT01105533|16653444|P9|Overall Study|Lack of Efficacy|9
4829811|NCT01105533|16653445|P8|Overall Study|Lack of Efficacy|2
4829812|NCT01105533|16653446|P7|Overall Study|Lack of Efficacy|3
4829813|NCT01105533|16653447|P6|Overall Study|Lack of Efficacy|5
4829814|NCT01105533|16653448|P5|Overall Study|Lack of Efficacy|4
4829815|NCT01105533|16653449|P4|Overall Study|Lack of Efficacy|3
4829816|NCT01105533|16653450|P3|Overall Study|Lack of Efficacy|3
4829817|NCT01105533|16653451|P2|Overall Study|Lack of Efficacy|1
4829818|NCT01105533|16653452|P1|Overall Study|Lack of Efficacy|1
4829819|NCT01105533|16653444|P9|Overall Study|Death|0
4829820|NCT01105533|16653445|P8|Overall Study|Death|0
4829821|NCT01105533|16653446|P7|Overall Study|Death|0
4829822|NCT01105533|16653447|P6|Overall Study|Death|0
4829823|NCT01105533|16653448|P5|Overall Study|Death|1
4829824|NCT01105533|16653449|P4|Overall Study|Death|0
4829825|NCT01105533|16653450|P3|Overall Study|Death|0
4829826|NCT01105533|16653451|P2|Overall Study|Death|0
4829827|NCT01105533|16653452|P1|Overall Study|Death|0
4829828|NCT01105377|16653542|P2|Overall Study|Withdrawal by Subject|1
4829829|NCT01105377|16653543|P1|Overall Study|Withdrawal by Subject|0
4829830|NCT01105130|16653591|P3|Overall Study|Multiple Reasons|2
4829831|NCT01105130|16653592|P2|Overall Study|Multiple Reasons|0
4829832|NCT01105130|16653593|P1|Overall Study|Multiple Reasons|3
4829833|NCT01105130|16653591|P3|Overall Study|Toxicity|2
4829834|NCT01105130|16653592|P2|Overall Study|Toxicity|3
4829835|NCT01105130|16653593|P1|Overall Study|Toxicity|1
4829836|NCT01105130|16653591|P3|Overall Study|Never Started|4
4829837|NCT01105130|16653592|P2|Overall Study|Never Started|2
4829838|NCT01105130|16653593|P1|Overall Study|Never Started|2
4829839|NCT01105130|16653591|P3|Overall Study|Withdrawal by Subject|2
4829840|NCT01105130|16653592|P2|Overall Study|Withdrawal by Subject|6
4829841|NCT01105130|16653593|P1|Overall Study|Withdrawal by Subject|4
4829842|NCT01105091|16653623|P2|Overall Study|Death|0
4829843|NCT01105091|16653624|P1|Overall Study|Death|2
4829844|NCT01105065|16653648|P1|Overall Study|Technical Problems|1
4829845|NCT01105065|16653648|P1|Overall Study|Adverse Event|5
4829846|NCT01104870|16653657|P3|Overall Study|Withdrawal by Subject|1
4829847|NCT01104870|16653658|P2|Overall Study|Withdrawal by Subject|0
4829848|NCT01104870|16653659|P1|Overall Study|Withdrawal by Subject|0
4829849|NCT01104870|16653657|P3|Overall Study|Death|1
4829850|NCT01104870|16653658|P2|Overall Study|Death|0
4829851|NCT01104870|16653659|P1|Overall Study|Death|0
4829852|NCT01104870|16653657|P3|Overall Study|Adverse Event|0
4829853|NCT01104870|16653658|P2|Overall Study|Adverse Event|1
4829854|NCT01104870|16653659|P1|Overall Study|Adverse Event|1
4829855|NCT01104792|16653688|P1|Overall Study|Did Not Meet Eligibility Criteria|133
4829856|NCT01104792|16653688|P1|Overall Study|Reasons Not Specified|27
4829857|NCT01104792|16653688|P1|Overall Study|Lost to Follow-up|43
4829858|NCT01104792|16653688|P1|Overall Study|Withdrawal of Consent|179
4829859|NCT01104792|16653688|P1|Overall Study|Protocol Violation|45
4829860|NCT01104792|16653688|P1|Overall Study|Insufficient Therapeutic Response|22
4829861|NCT01104792|16653688|P1|Overall Study|Adverse Event|77
4829862|NCT01104779|16653696|P3|Overall Study|Withdrawal by Subject|32
4829863|NCT01104779|16653697|P2|Overall Study|Withdrawal by Subject|25
4829864|NCT01104779|16653698|P1|Overall Study|Withdrawal by Subject|16
4829865|NCT01104779|16653696|P3|Overall Study|Lost to Follow-up|1
4829866|NCT01104779|16653697|P2|Overall Study|Lost to Follow-up|0
4829867|NCT01104779|16653698|P1|Overall Study|Lost to Follow-up|2
4829868|NCT01104779|16653696|P3|Overall Study|Other reasons|0
4829869|NCT01104779|16653697|P2|Overall Study|Other reasons|1
4829870|NCT01104779|16653698|P1|Overall Study|Other reasons|0
4829871|NCT01104779|16653696|P3|Overall Study|Did not meet inc/exc criteria|1
4829872|NCT01104779|16653697|P2|Overall Study|Did not meet inc/exc criteria|1
4829873|NCT01104779|16653698|P1|Overall Study|Did not meet inc/exc criteria|1
4829874|NCT01104779|16653696|P3|Overall Study|Adverse Event|13
4829875|NCT01104779|16653697|P2|Overall Study|Adverse Event|14
4829876|NCT01104779|16653698|P1|Overall Study|Adverse Event|13
4829877|NCT01104779|16653696|P3|Overall Study|Lack of Efficacy|13
4829878|NCT01104779|16653697|P2|Overall Study|Lack of Efficacy|12
4829879|NCT01104779|16653698|P1|Overall Study|Lack of Efficacy|26
4829880|NCT01104779|16653696|P3|Overall Study|Protocol Violation|2
4829881|NCT01104779|16653697|P2|Overall Study|Protocol Violation|2
4829882|NCT01104779|16653698|P1|Overall Study|Protocol Violation|1
4829883|NCT01104766|16653713|P4|Overall Study|Lost to Follow-up|1
4829884|NCT01104766|16653714|P3|Overall Study|Lost to Follow-up|1
4829885|NCT01104766|16653715|P2|Overall Study|Lost to Follow-up|2
4829886|NCT01104766|16653716|P1|Overall Study|Lost to Follow-up|1
4829887|NCT01104766|16653713|P4|Overall Study|Withdrawal by Subject|15
4829888|NCT01104766|16653714|P3|Overall Study|Withdrawal by Subject|25
4829889|NCT01104766|16653715|P2|Overall Study|Withdrawal by Subject|19
4829890|NCT01104766|16653716|P1|Overall Study|Withdrawal by Subject|17
4829891|NCT01104766|16653713|P4|Overall Study|Protocol Violation|0
4829892|NCT01104766|16653714|P3|Overall Study|Protocol Violation|0
4829893|NCT01104766|16653715|P2|Overall Study|Protocol Violation|0
4829894|NCT01104766|16653716|P1|Overall Study|Protocol Violation|2
4829895|NCT01104766|16653713|P4|Overall Study|Lack of Efficacy|8
4829896|NCT01104766|16653714|P3|Overall Study|Lack of Efficacy|14
4829897|NCT01104766|16653715|P2|Overall Study|Lack of Efficacy|15
4829898|NCT01104766|16653716|P1|Overall Study|Lack of Efficacy|20
4829899|NCT01104766|16653713|P4|Overall Study|Adverse Event|14
4829900|NCT01104766|16653714|P3|Overall Study|Adverse Event|20
4829901|NCT01104766|16653715|P2|Overall Study|Adverse Event|15
4829902|NCT01104766|16653716|P1|Overall Study|Adverse Event|17
4829903|NCT01104766|16653713|P4|Overall Study|Did not meet inc/exc criteria|0
4829904|NCT01104766|16653714|P3|Overall Study|Did not meet inc/exc criteria|0
4829905|NCT01104766|16653715|P2|Overall Study|Did not meet inc/exc criteria|0
4829906|NCT01104766|16653716|P1|Overall Study|Did not meet inc/exc criteria|1
4829907|NCT01104701|16653734|P4|Overall Study|Physician Decision|0
4829908|NCT01104701|16653735|P3|Overall Study|Physician Decision|0
4829909|NCT01104701|16653736|P2|Overall Study|Physician Decision|2
4829910|NCT01104701|16653737|P1|Overall Study|Physician Decision|0
4829911|NCT01104701|16653734|P4|Overall Study|Adverse Event|1
4829912|NCT01104701|16653735|P3|Overall Study|Adverse Event|0
4829913|NCT01104701|16653736|P2|Overall Study|Adverse Event|0
4829914|NCT01104701|16653737|P1|Overall Study|Adverse Event|0
4829915|NCT01104701|16653734|P4|Overall Study|Withdrawal by Subject|1
4829916|NCT01104701|16653735|P3|Overall Study|Withdrawal by Subject|2
4829917|NCT01104701|16653736|P2|Overall Study|Withdrawal by Subject|1
4829918|NCT01104701|16653737|P1|Overall Study|Withdrawal by Subject|0
4829919|NCT01104662|16653799|P8|Overall Study|Randomized but not treated|0
4829920|NCT01104662|16653800|P7|Overall Study|Randomized but not treated|0
4829921|NCT01104662|16653801|P6|Overall Study|Randomized but not treated|1
4829922|NCT01104662|16653802|P5|Overall Study|Randomized but not treated|0
4829923|NCT01104662|16653803|P4|Overall Study|Randomized but not treated|0
4829924|NCT01104662|16653804|P3|Overall Study|Randomized but not treated|1
4829925|NCT01104662|16653805|P2|Overall Study|Randomized but not treated|4
4829926|NCT01104662|16653806|P1|Overall Study|Randomized but not treated|3
4829927|NCT01104662|16653799|P8|Overall Study|Reason not specified|0
4829928|NCT01104662|16653800|P7|Overall Study|Reason not specified|0
4829929|NCT01104662|16653801|P6|Overall Study|Reason not specified|1
4829930|NCT01104662|16653802|P5|Overall Study|Reason not specified|0
4829931|NCT01104662|16653803|P4|Overall Study|Reason not specified|0
4829932|NCT01104662|16653804|P3|Overall Study|Reason not specified|0
4829933|NCT01104662|16653805|P2|Overall Study|Reason not specified|3
4829934|NCT01104662|16653806|P1|Overall Study|Reason not specified|3
4829935|NCT01104662|16653799|P8|Overall Study|Participant left investigator's care|0
4829936|NCT01104662|16653800|P7|Overall Study|Participant left investigator's care|0
4829937|NCT01104662|16653801|P6|Overall Study|Participant left investigator's care|0
4829938|NCT01104662|16653802|P5|Overall Study|Participant left investigator's care|0
4829939|NCT01104662|16653803|P4|Overall Study|Participant left investigator's care|0
4829940|NCT01104662|16653804|P3|Overall Study|Participant left investigator's care|0
4829941|NCT01104662|16653805|P2|Overall Study|Participant left investigator's care|1
4829942|NCT01104662|16653806|P1|Overall Study|Participant left investigator's care|1
4829943|NCT01104662|16653799|P8|Overall Study|Clinical Failure|0
4829944|NCT01104662|16653800|P7|Overall Study|Clinical Failure|0
4829945|NCT01104662|16653801|P6|Overall Study|Clinical Failure|1
4829946|NCT01104662|16653802|P5|Overall Study|Clinical Failure|0
4829947|NCT01104662|16653803|P4|Overall Study|Clinical Failure|0
4829948|NCT01104662|16653804|P3|Overall Study|Clinical Failure|0
4829949|NCT01104662|16653805|P2|Overall Study|Clinical Failure|0
4829950|NCT01104662|16653806|P1|Overall Study|Clinical Failure|1
4829951|NCT01104662|16653799|P8|Overall Study|Adverse Event|0
4829952|NCT01104662|16653800|P7|Overall Study|Adverse Event|0
4829953|NCT01104662|16653801|P6|Overall Study|Adverse Event|1
4829954|NCT01104662|16653802|P5|Overall Study|Adverse Event|1
4829955|NCT01104662|16653803|P4|Overall Study|Adverse Event|1
4829956|NCT01104662|16653804|P3|Overall Study|Adverse Event|0
4829957|NCT01104662|16653805|P2|Overall Study|Adverse Event|2
4829958|NCT01104662|16653806|P1|Overall Study|Adverse Event|2
4829959|NCT01104636|16653832|P1|Overall Study|Ongoing|21
4829960|NCT01104636|16653832|P1|Overall Study|Adverse Event|40
4829961|NCT01104636|16653832|P1|Overall Study|Pregnancy|2
4829962|NCT01104636|16653832|P1|Overall Study|Study terminated by sponsor|1
4829963|NCT01104636|16653832|P1|Overall Study|Other|43
4829964|NCT01104636|16653832|P1|Overall Study|Withdrawal by Subject|4
4829965|NCT01104636|16653832|P1|Overall Study|Lost to Follow-up|24
4829966|NCT01104636|16653832|P1|Overall Study|Lack of Efficacy|43
4829967|NCT01104584|16653837|P1|Overall Study|Study prematurely discontinued|2
4829968|NCT01104584|16653837|P1|Overall Study|Study drug never administered|21
4829969|NCT01104558|16653907|P1|Overall Study|Missing of genetic analysis results|1
4829970|NCT01104558|16653907|P1|Overall Study|Missing of primary efficacy assessment|10
4829971|NCT01104558|16653907|P1|Overall Study|Protocol Violation|6
4829972|NCT01104545|16653951|P3|Overall Study|Adverse Event|2
4829973|NCT01104545|16653952|P2|Overall Study|Adverse Event|1
4829974|NCT01104545|16653953|P1|Overall Study|Adverse Event|0
4829975|NCT01104493|16654110|P2|Overall Study|Lost to Follow-up|2
4829976|NCT01104493|16654111|P1|Overall Study|Lost to Follow-up|0
4829977|NCT01104415|16654129|P2|Extension Period|Heart surgery/feeling miserable|1
4829978|NCT01104415|16654130|P1|Extension Period|Heart surgery/feeling miserable|0
4829979|NCT01104415|16654129|P2|Extension Period|Transition to Study LX1606.302|4
4829980|NCT01104415|16654130|P1|Extension Period|Transition to Study LX1606.302|0
4829981|NCT01104415|16654129|P2|Extension Period|Physician Decision|1
4829982|NCT01104415|16654130|P1|Extension Period|Physician Decision|0
4829983|NCT01104415|16654129|P2|Extension Period|Death|1
4829984|NCT01104415|16654130|P1|Extension Period|Death|0
4829985|NCT01104415|16654129|P2|Extension Period|Progressive disease|4
4829986|NCT01104415|16654130|P1|Extension Period|Progressive disease|0
4829987|NCT01104415|16654129|P2|Core Phase|Consent withdrawn by subjects|0
4829988|NCT01104415|16654130|P1|Core Phase|Consent withdrawn by subjects|1
4829989|NCT01104376|16654174|P1|Overall Study|Consented but excluded after labs|13
4829990|NCT01104376|16654174|P1|Overall Study|Withdrawal by Subject|15
4829991|NCT01104311|16654180|P2|Overall Study|Adverse Event|2
4829992|NCT01104311|16654181|P1|Overall Study|Adverse Event|1
4829993|NCT01104311|16654180|P2|Overall Study|low compliance|1
4829994|NCT01104311|16654181|P1|Overall Study|low compliance|1
4829995|NCT01104311|16654180|P2|Overall Study|Physician Decision|2
4829996|NCT01104311|16654181|P1|Overall Study|Physician Decision|2
4829997|NCT01104311|16654180|P2|Overall Study|Protocol Violation|1
4829998|NCT01104311|16654181|P1|Overall Study|Protocol Violation|0
4829999|NCT01104311|16654180|P2|Overall Study|Withdrawal by Subject|6
4830000|NCT01104311|16654181|P1|Overall Study|Withdrawal by Subject|6
4830001|NCT01104246|16654208|P1|Overall Study|did not meet inclusion criteria|4
4830002|NCT01104246|16654208|P1|Overall Study|Withdrawal by Subject|1
4830003|NCT01104155|16654223|P2|Overall Study|Other|4
4830004|NCT01104155|16654224|P1|Overall Study|Other|3
4830005|NCT01104155|16654223|P2|Overall Study|Withdrawal of consent|1
4830006|NCT01104155|16654224|P1|Overall Study|Withdrawal of consent|1
4830007|NCT01104155|16654223|P2|Overall Study|Participant choice|5
4830008|NCT01104155|16654224|P1|Overall Study|Participant choice|6
4830009|NCT01104155|16654223|P2|Overall Study|Adverse Event|8
4830010|NCT01104155|16654224|P1|Overall Study|Adverse Event|15
4830011|NCT01103960|16654276|P2|Overall Study|Other|0
4830012|NCT01103960|16654277|P1|Overall Study|Other|1
4830013|NCT01103960|16654276|P2|Overall Study|Withdrawal by Subject|1
4830014|NCT01103960|16654277|P1|Overall Study|Withdrawal by Subject|2
4830015|NCT01103960|16654276|P2|Overall Study|Adverse Event|1
4830016|NCT01103960|16654277|P1|Overall Study|Adverse Event|2
4830017|NCT01103778|16654312|P1|Overall Study|Screen failure|1
4830018|NCT01103778|16654312|P1|Overall Study|Proteinuria improved prior to enrollment|1
4830019|NCT01103778|16654312|P1|Overall Study|Lost to Follow-up|1
4830020|NCT01103713|16654319|P1|Overall Study|Other|1
4830021|NCT01103713|16654319|P1|Overall Study|Study terminated by sponsor|2
4830022|NCT01103713|16654319|P1|Overall Study|Withdrawal by Subject|8
4830023|NCT01103713|16654319|P1|Overall Study|Lost to Follow-up|2
4830024|NCT01103479|16654369|P3|Overall Study|Saw non-study physician|0
4830025|NCT01103479|16654370|P2|Overall Study|Saw non-study physician|0
4830026|NCT01103479|16654371|P1|Overall Study|Saw non-study physician|2
4830027|NCT01103479|16654369|P3|Overall Study|Active cancer|0
4830028|NCT01103479|16654370|P2|Overall Study|Active cancer|0
4830029|NCT01103479|16654371|P1|Overall Study|Active cancer|1
4830030|NCT01103479|16654369|P3|Overall Study|Family history of CRC|2
4830031|NCT01103479|16654370|P2|Overall Study|Family history of CRC|0
4830032|NCT01103479|16654371|P1|Overall Study|Family history of CRC|1
4830033|NCT01103479|16654369|P3|Overall Study|Up to date with CRC screening|12
4830034|NCT01103479|16654370|P2|Overall Study|Up to date with CRC screening|9
4830035|NCT01103479|16654371|P1|Overall Study|Up to date with CRC screening|1
4830036|NCT01103466|16654384|P3|Third Period (14 +/- 3 Days)|not satisfied with product|1
4830037|NCT01103466|16654385|P2|Third Period (14 +/- 3 Days)|not satisfied with product|0
4830038|NCT01103466|16654386|P1|Third Period (14 +/- 3 Days)|not satisfied with product|0
4830039|NCT01103466|16654384|P3|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
4830040|NCT01103466|16654385|P2|Third Period (14 +/- 3 Days)|Lack of Efficacy|0
4830041|NCT01103466|16654386|P1|Third Period (14 +/- 3 Days)|Lack of Efficacy|1
4830042|NCT01103466|16654384|P3|Third Period (14 +/- 3 Days)|Adverse Event|0
4830043|NCT01103466|16654385|P2|Third Period (14 +/- 3 Days)|Adverse Event|0
4830044|NCT01103466|16654386|P1|Third Period (14 +/- 3 Days)|Adverse Event|1
4830045|NCT01103466|16654384|P3|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
4830046|NCT01103466|16654385|P2|Second Period (14 +/- 3 Days)|Lack of Efficacy|1
4830047|NCT01103466|16654386|P1|Second Period (14 +/- 3 Days)|Lack of Efficacy|0
4830048|NCT01103466|16654384|P3|Second Period (14 +/- 3 Days)|Adverse Event|0
4830049|NCT01103466|16654385|P2|Second Period (14 +/- 3 Days)|Adverse Event|1
4830050|NCT01103466|16654386|P1|Second Period (14 +/- 3 Days)|Adverse Event|2
4830051|NCT01103466|16654384|P3|First Period (14 +/- 3 Days)|Protocol Violation|0
4830052|NCT01103466|16654385|P2|First Period (14 +/- 3 Days)|Protocol Violation|0
4830053|NCT01103466|16654386|P1|First Period (14 +/- 3 Days)|Protocol Violation|2
4830054|NCT01103362|16654476|P1|Overall Study|study terminated|596
4830055|NCT01103323|16654482|P2|Switched From Placebo to Regorafenib|Adverse Event|1
4830056|NCT01103323|16654483|P1|Switched From Placebo to Regorafenib|Adverse Event|0
4830057|NCT01103323|16654482|P2|Without/Before Drug Switch|Switch to Regorafenib|4
4830058|NCT01103323|16654483|P1|Without/Before Drug Switch|Switch to Regorafenib|0
4830059|NCT01103323|16654482|P2|Without/Before Drug Switch|did not receive study treatment|2
4830060|NCT01103323|16654483|P1|Without/Before Drug Switch|did not receive study treatment|5
4830061|NCT01103323|16654482|P2|Without/Before Drug Switch|Physician Decision|0
4830062|NCT01103323|16654483|P1|Without/Before Drug Switch|Physician Decision|2
4830063|NCT01103323|16654482|P2|Without/Before Drug Switch|Protocol Violation|0
4830064|NCT01103323|16654483|P1|Without/Before Drug Switch|Protocol Violation|2
4830065|NCT01103323|16654482|P2|Without/Before Drug Switch|Withdrawal by Subject|5
4830066|NCT01103323|16654483|P1|Without/Before Drug Switch|Withdrawal by Subject|17
4830067|NCT01103323|16654482|P2|Without/Before Drug Switch|Adverse Event|7
4830068|NCT01103323|16654483|P1|Without/Before Drug Switch|Adverse Event|50
4830069|NCT01103284|16654500|P2|Overall Study|Missing CRF entries for study completion|2
4830070|NCT01103284|16654501|P1|Overall Study|Missing CRF entries for study completion|0
4830071|NCT01103284|16654500|P2|Overall Study|Not described|1
4830072|NCT01103284|16654501|P1|Overall Study|Not described|2
4830073|NCT01103284|16654500|P2|Overall Study|Termination by the Sponsor|1
4830074|NCT01103284|16654501|P1|Overall Study|Termination by the Sponsor|0
4830075|NCT01103284|16654500|P2|Overall Study|Dermal Hypersensitivity|1
4830076|NCT01103284|16654501|P1|Overall Study|Dermal Hypersensitivity|0
4830077|NCT01103284|16654500|P2|Overall Study|Withdrawal by Subject|18
4830078|NCT01103284|16654501|P1|Overall Study|Withdrawal by Subject|14
4830079|NCT01103284|16654500|P2|Overall Study|Adverse Event|5
4830080|NCT01103284|16654501|P1|Overall Study|Adverse Event|0
4830081|NCT01103284|16654500|P2|Overall Study|Protocol Violation|5
4830082|NCT01103284|16654501|P1|Overall Study|Protocol Violation|12
4830083|NCT01103284|16654500|P2|Overall Study|Pregnancy|1
4830084|NCT01103284|16654501|P1|Overall Study|Pregnancy|3
4830085|NCT01103284|16654500|P2|Overall Study|Lost to Follow-up|10
4830086|NCT01103284|16654501|P1|Overall Study|Lost to Follow-up|9
4830087|NCT01103284|16654500|P2|Overall Study|Death|0
4830088|NCT01103284|16654501|P1|Overall Study|Death|2
4830089|NCT01103245|16654529|P4|Overall Study|Physician Decision|0
4830090|NCT01103245|16654530|P3|Overall Study|Physician Decision|0
4830091|NCT01103245|16654531|P2|Overall Study|Physician Decision|0
4830092|NCT01103245|16654532|P1|Overall Study|Physician Decision|1
4830093|NCT01103245|16654529|P4|Overall Study|Adverse Event|0
4830094|NCT01103245|16654530|P3|Overall Study|Adverse Event|1
4830095|NCT01103245|16654531|P2|Overall Study|Adverse Event|2
4830096|NCT01103245|16654532|P1|Overall Study|Adverse Event|0
4830097|NCT01103245|16654529|P4|Overall Study|Inadequate IV access|0
4830098|NCT01103245|16654530|P3|Overall Study|Inadequate IV access|0
4830099|NCT01103245|16654531|P2|Overall Study|Inadequate IV access|0
4830100|NCT01103245|16654532|P1|Overall Study|Inadequate IV access|1
4830101|NCT01103245|16654529|P4|Overall Study|Withdrawal by Subject|0
4830102|NCT01103245|16654530|P3|Overall Study|Withdrawal by Subject|3
4830103|NCT01103245|16654531|P2|Overall Study|Withdrawal by Subject|0
4830104|NCT01103245|16654532|P1|Overall Study|Withdrawal by Subject|1
4830105|NCT01103232|16654548|P2|Overall Study|Protocol Violation|1
4830106|NCT01103232|16654549|P1|Overall Study|Protocol Violation|0
4830107|NCT01103232|16654548|P2|Overall Study|Withdrawal by Subject|1
4830108|NCT01103232|16654549|P1|Overall Study|Withdrawal by Subject|1
4830109|NCT01103180|16654557|P2|Overall Study|Protocol Violation|1
4830110|NCT01103180|16654558|P1|Overall Study|Protocol Violation|0
4830111|NCT01103180|16654557|P2|Overall Study|Physician Decision|0
4830112|NCT01103180|16654558|P1|Overall Study|Physician Decision|1
4830113|NCT01103180|16654557|P2|Overall Study|Lost to Follow-up|7
4830114|NCT01103180|16654558|P1|Overall Study|Lost to Follow-up|13
4830115|NCT01103180|16654557|P2|Overall Study|Withdrawal by Subject|13
4830116|NCT01103180|16654558|P1|Overall Study|Withdrawal by Subject|8
4830117|NCT01103141|16654568|P2|Overall Study|Lost to Follow-up|1
4830118|NCT01103141|16654569|P1|Overall Study|Lost to Follow-up|2
4830119|NCT01103141|16654568|P2|Overall Study|Death|1
4830120|NCT01103141|16654569|P1|Overall Study|Death|0
4830121|NCT01103063|16654577|P2|Overall Study|Death|1
4830122|NCT01103063|16654578|P1|Overall Study|Death|3
4830123|NCT01103063|16654577|P2|Overall Study|Study terminated by Sponsor|342
4830124|NCT01103063|16654578|P1|Overall Study|Study terminated by Sponsor|326
4830125|NCT01103063|16654577|P2|Overall Study|Protocol Violation|0
4830126|NCT01103063|16654578|P1|Overall Study|Protocol Violation|1
4830127|NCT01103063|16654577|P2|Overall Study|Other|11
4830128|NCT01103063|16654578|P1|Overall Study|Other|16
4830129|NCT01103063|16654577|P2|Overall Study|Withdrawal by Subject|15
4830130|NCT01103063|16654578|P1|Overall Study|Withdrawal by Subject|60
4830131|NCT01103063|16654577|P2|Overall Study|Lost to Follow-up|51
4830132|NCT01103063|16654578|P1|Overall Study|Lost to Follow-up|68
4830133|NCT01103063|16654577|P2|Overall Study|Adverse Event|1
4830134|NCT01103063|16654578|P1|Overall Study|Adverse Event|3
4830135|NCT01102972|16654646|P2|Overall Study|Withdrawal by Subject|6
4830136|NCT01102972|16654647|P1|Overall Study|Withdrawal by Subject|6
4830137|NCT01102972|16654646|P2|Overall Study|Investigator Discretion|0
4830138|NCT01102972|16654647|P1|Overall Study|Investigator Discretion|2
4830139|NCT01102972|16654646|P2|Overall Study|Lost to Follow-up|5
4830140|NCT01102972|16654647|P1|Overall Study|Lost to Follow-up|10
4830141|NCT01102972|16654646|P2|Overall Study|Protocol Violation|0
4830142|NCT01102972|16654647|P1|Overall Study|Protocol Violation|1
4830143|NCT01102972|16654646|P2|Overall Study|Lack of Efficacy|1
4830144|NCT01102972|16654647|P1|Overall Study|Lack of Efficacy|2
4830145|NCT01102972|16654646|P2|Overall Study|Adverse Event|2
4830146|NCT01102972|16654647|P1|Overall Study|Adverse Event|8
4830147|NCT01102803|16654711|P2|Post to Follow-Up|Lost to Follow-up|3
4830148|NCT01102803|16654712|P1|Post to Follow-Up|Lost to Follow-up|1
4830149|NCT01102803|16654711|P2|Baseline to Post-Treatment|Lost to Follow-up|0
4830150|NCT01102803|16654712|P1|Baseline to Post-Treatment|Lost to Follow-up|3
4830151|NCT01102777|16654726|P2|Overall Study|Lost to Follow-up|10
4830152|NCT01102777|16654727|P1|Overall Study|Lost to Follow-up|7
4830153|NCT01102777|16654726|P2|Overall Study|Death|6
4830154|NCT01102777|16654727|P1|Overall Study|Death|2
4830155|NCT01102491|16654786|P2|Overall Study|Protocol Violation|12
4830156|NCT01102491|16654787|P1|Overall Study|Protocol Violation|11
4830157|NCT01102426|16654795|P2|Overall Study|Death (non-related to the study|8
4830158|NCT01102426|16654796|P1|Overall Study|Death (non-related to the study|19
4830159|NCT01102426|16654795|P2|Overall Study|Death (due to adverse events|1
4830160|NCT01102426|16654796|P1|Overall Study|Death (due to adverse events|0
4830161|NCT01102426|16654795|P2|Overall Study|Patient Refusal|12
4830162|NCT01102426|16654796|P1|Overall Study|Patient Refusal|24
4830163|NCT01102426|16654795|P2|Overall Study|Adverse Events (unrelated to|1
4830164|NCT01102426|16654796|P1|Overall Study|Adverse Events (unrelated to|9
4830165|NCT01102426|16654795|P2|Overall Study|Progressive Disease|44
4830166|NCT01102426|16654796|P1|Overall Study|Progressive Disease|85
4830167|NCT01102426|16654795|P2|Overall Study|Physician Decision|6
4830168|NCT01102426|16654796|P1|Overall Study|Physician Decision|9
4830169|NCT01102426|16654795|P2|Overall Study|Adverse Events (treatment-related)|8
4830170|NCT01102426|16654796|P1|Overall Study|Adverse Events (treatment-related)|15
4830171|NCT01102426|16654795|P2|Overall Study|Randomized but not treated|1
4830172|NCT01102426|16654796|P1|Overall Study|Randomized but not treated|4
4830173|NCT01102374|16654847|P2|Overall Study|Lost to Follow-up|6
4830174|NCT01102374|16654848|P1|Overall Study|Lost to Follow-up|7
4830175|NCT01102374|16654847|P2|Overall Study|Death|13
4830176|NCT01102374|16654848|P1|Overall Study|Death|9
4830177|NCT01102257|16654897|P2|Overall Study|Adverse Event|0
4830178|NCT01102257|16654898|P1|Overall Study|Adverse Event|1
4830179|NCT01102257|16654897|P2|Overall Study|Adverse Event|0
4830180|NCT01102257|16654898|P1|Overall Study|Adverse Event|1
4830181|NCT01102140|16654915|P2|Overall Study|Investigator terminated study|2
4830182|NCT01102140|16654916|P1|Overall Study|Investigator terminated study|2
4830183|NCT01102140|16654915|P2|Overall Study|Lost to Follow-up|0
4830184|NCT01102140|16654916|P1|Overall Study|Lost to Follow-up|1
4830185|NCT01101841|16654971|P2|Overall Study|Eligibility Criteria|2
4830186|NCT01101841|16654972|P1|Overall Study|Eligibility Criteria|1
4830187|NCT01101841|16654971|P2|Overall Study|Suicidality Tracking Scale|1
4830188|NCT01101841|16654972|P1|Overall Study|Suicidality Tracking Scale|3
4830189|NCT01101841|16654971|P2|Overall Study|Other|1
4830190|NCT01101841|16654972|P1|Overall Study|Other|0
4830191|NCT01101841|16654971|P2|Overall Study|Lack of Efficacy|2
4830192|NCT01101841|16654972|P1|Overall Study|Lack of Efficacy|0
4830193|NCT01101841|16654971|P2|Overall Study|Physician Decision|2
4830194|NCT01101841|16654972|P1|Overall Study|Physician Decision|0
4830195|NCT01101841|16654971|P2|Overall Study|Protocol Violation|1
4830196|NCT01101841|16654972|P1|Overall Study|Protocol Violation|1
4830197|NCT01101841|16654971|P2|Overall Study|Withdrawal by Subject|40
4830198|NCT01101841|16654972|P1|Overall Study|Withdrawal by Subject|21
4830199|NCT01101841|16654971|P2|Overall Study|Lost to Follow-up|3
4830200|NCT01101841|16654972|P1|Overall Study|Lost to Follow-up|9
4830201|NCT01101841|16654971|P2|Overall Study|Adverse Event|15
4830202|NCT01101841|16654972|P1|Overall Study|Adverse Event|15
4830203|NCT01101542|16655010|P1|Year 6 Surveillance Period|Withdrawal by Subject|4
4830204|NCT01101542|16655010|P1|Year 6 Surveillance Period|Pregnancy|1
4830205|NCT01101542|16655010|P1|Year 6 Surveillance Period|Lost to Follow-up|986
4830206|NCT01101542|16655010|P1|Year 5 Surveillance Period|Pregnancy|1
4830207|NCT01101542|16655010|P1|Year 5 Surveillance Period|Lost to Follow-up|140
4830208|NCT01101542|16655010|P1|Year 4 Surveillance Period|Other|287
4830209|NCT01101542|16655010|P1|Year 3 Surveillance Period|Withdrawal by Subject|4
4830210|NCT01101542|16655010|P1|Year 3 Surveillance Period|Lost to Follow-up|7
4830211|NCT01101477|16655026|P3|Overall Study|Protocol Violation|1
4830212|NCT01101477|16655027|P2|Overall Study|Protocol Violation|3
4830213|NCT01101477|16655028|P1|Overall Study|Protocol Violation|5
4830214|NCT01101334|16655051|P2|Overall Study|Other|1
4830215|NCT01101334|16655052|P1|Overall Study|Other|2
4830216|NCT01101334|16655051|P2|Overall Study|Progressive Disease|35
4830217|NCT01101334|16655052|P1|Overall Study|Progressive Disease|22
4830218|NCT01101334|16655051|P2|Overall Study|Withdrawal by Sponsor|1
4830219|NCT01101334|16655052|P1|Overall Study|Withdrawal by Sponsor|1
4830220|NCT01101334|16655051|P2|Overall Study|Withdrawal by Subject|3
4830221|NCT01101334|16655052|P1|Overall Study|Withdrawal by Subject|4
4830222|NCT01101334|16655051|P2|Overall Study|Death|1
4830223|NCT01101334|16655052|P1|Overall Study|Death|7
4830224|NCT01101334|16655051|P2|Overall Study|Adverse Event|4
4830225|NCT01101334|16655052|P1|Overall Study|Adverse Event|9
4830226|NCT01101321|16655064|P2|Period 1|Adverse Event|3
4830227|NCT01101321|16655065|P1|Period 1|Adverse Event|3
4830228|NCT01101321|16655064|P2|Period 1|Withdrawal by Subject|1
4830229|NCT01101321|16655065|P1|Period 1|Withdrawal by Subject|1
4830230|NCT01101308|16655075|P2|Period 1|Positive for cotinine|0
4830231|NCT01101308|16655076|P1|Period 1|Positive for cotinine|1
4830232|NCT01101308|16655075|P2|Period 1|Adverse Event|1
4830233|NCT01101308|16655076|P1|Period 1|Adverse Event|2
4830234|NCT01101191|16655087|P2|Period 1|Adverse Event|2
4830235|NCT01101191|16655088|P1|Period 1|Adverse Event|1
4830236|NCT01101191|16655087|P2|Period 1|Withdrawal by Subject|0
4830237|NCT01101191|16655088|P1|Period 1|Withdrawal by Subject|1
4830238|NCT01101178|16655099|P2|Period 2|Withdrawal by Subject|1
4830239|NCT01101178|16655100|P1|Period 2|Withdrawal by Subject|0
4830240|NCT01101178|16655099|P2|Period 1|Adverse Event|1
4830241|NCT01101178|16655100|P1|Period 1|Adverse Event|2
4830242|NCT01101178|16655099|P2|Period 1|Positive drug screen|1
4830243|NCT01101178|16655100|P1|Period 1|Positive drug screen|1
4830244|NCT01101178|16655099|P2|Period 1|Withdrawal by Subject|2
4830245|NCT01101178|16655100|P1|Period 1|Withdrawal by Subject|1
4830246|NCT01101165|16655111|P2|Period 2|Adverse Event|0
4830247|NCT01101165|16655112|P1|Period 2|Adverse Event|1
4830248|NCT01101165|16655111|P2|Period 2|Withdrawal by Subject|1
4830249|NCT01101165|16655112|P1|Period 2|Withdrawal by Subject|3
4830250|NCT01101165|16655111|P2|Period 1|Lost to Follow-up|0
4830251|NCT01101165|16655112|P1|Period 1|Lost to Follow-up|1
4830252|NCT01101165|16655111|P2|Period 1|Positive Drug Screen|1
4830253|NCT01101165|16655112|P1|Period 1|Positive Drug Screen|0
4830254|NCT01101165|16655111|P2|Period 1|Withdrawal by Subject|2
4830255|NCT01101165|16655112|P1|Period 1|Withdrawal by Subject|0
4830256|NCT01101165|16655111|P2|Period 1|Adverse Event|2
4830257|NCT01101165|16655112|P1|Period 1|Adverse Event|1
4830258|NCT01101061|16655133|P6|Overall Study|Adverse Event|0
4830259|NCT01101061|16655134|P5|Overall Study|Adverse Event|0
4830260|NCT01101061|16655135|P4|Overall Study|Adverse Event|0
4830261|NCT01101061|16655136|P3|Overall Study|Adverse Event|1
4830262|NCT01101061|16655137|P2|Overall Study|Adverse Event|0
4830263|NCT01101061|16655138|P1|Overall Study|Adverse Event|0
4830264|NCT01101035|16655218|P2|Overall Study|Reason not Specified|363
4830265|NCT01101035|16655219|P1|Overall Study|Reason not Specified|333
4830266|NCT01101035|16655218|P2|Overall Study|Voluntary Withdrawal|587
4830267|NCT01101035|16655219|P1|Overall Study|Voluntary Withdrawal|595
4830268|NCT01101035|16655218|P2|Overall Study|Lost to Follow-up|223
4830269|NCT01101035|16655219|P1|Overall Study|Lost to Follow-up|226
4830270|NCT01101035|16655218|P2|Overall Study|Major Protocol Deviation|46
4830271|NCT01101035|16655219|P1|Overall Study|Major Protocol Deviation|52
4830272|NCT01101035|16655218|P2|Overall Study|Adverse Event|172
4830273|NCT01101035|16655219|P1|Overall Study|Adverse Event|191
4830274|NCT01101022|16655239|P2|Overall Study|Vacation|1
4830275|NCT01101022|16655240|P1|Overall Study|Vacation|0
4830276|NCT01101022|16655239|P2|Overall Study|Work schedule|1
4830277|NCT01101022|16655240|P1|Overall Study|Work schedule|1
4830278|NCT01101022|16655239|P2|Overall Study|Non-compliance|0
4830279|NCT01101022|16655240|P1|Overall Study|Non-compliance|1
4830280|NCT01101022|16655239|P2|Overall Study|Sponsor decision|1
4830281|NCT01101022|16655240|P1|Overall Study|Sponsor decision|1
4830282|NCT01101022|16655239|P2|Overall Study|Lack of Efficacy|7
4830283|NCT01101022|16655240|P1|Overall Study|Lack of Efficacy|0
4830284|NCT01101022|16655239|P2|Overall Study|Lost to Follow-up|4
4830285|NCT01101022|16655240|P1|Overall Study|Lost to Follow-up|1
4830286|NCT01101022|16655239|P2|Overall Study|Withdrawal by Subject|8
4830287|NCT01101022|16655240|P1|Overall Study|Withdrawal by Subject|3
4830288|NCT01101022|16655239|P2|Overall Study|Protocol Violation|3
4830289|NCT01101022|16655240|P1|Overall Study|Protocol Violation|4
4830290|NCT01101022|16655239|P2|Overall Study|Adverse Event|2
4830291|NCT01101022|16655240|P1|Overall Study|Adverse Event|6
4830292|NCT01100944|16655274|P3|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
4830293|NCT01100944|16655275|P2|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2
4830294|NCT01100944|16655276|P1|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0
4830295|NCT01100944|16655274|P3|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
4830296|NCT01100944|16655275|P2|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0
4830297|NCT01100944|16655276|P1|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1
4830298|NCT01100944|16655274|P3|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
4830299|NCT01100944|16655275|P2|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0
4830300|NCT01100944|16655276|P1|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1
4830301|NCT01100944|16655274|P3|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
4830302|NCT01100944|16655275|P2|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0
4830303|NCT01100944|16655276|P1|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2
4830304|NCT01100853|16655334|P2|Overall Study|Withdrawal by Subject|4
4830305|NCT01100853|16655335|P1|Overall Study|Withdrawal by Subject|6
4830306|NCT01100853|16655334|P2|Overall Study|Received <4 study injections|13
4830307|NCT01100853|16655335|P1|Overall Study|Received <4 study injections|10
4830308|NCT01100853|16655334|P2|Overall Study|Lost to Follow-up|6
4830309|NCT01100853|16655335|P1|Overall Study|Lost to Follow-up|11
4830310|NCT01100658|16655381|P1|Overall Study|Withdrawal by Subject|1
4830311|NCT01100567|16655413|P2|Overall Study|Deemed ineligible after consent|1
4830312|NCT01100567|16655414|P1|Overall Study|Deemed ineligible after consent|0
4830313|NCT01100567|16655413|P2|Overall Study|Physician Decision|1
4830314|NCT01100567|16655414|P1|Overall Study|Physician Decision|0
4830315|NCT01100567|16655413|P2|Overall Study|Lost to Follow-up|2
4830316|NCT01100567|16655414|P1|Overall Study|Lost to Follow-up|1
4830317|NCT01100567|16655413|P2|Overall Study|Early Hospital Discharge|4
4830318|NCT01100567|16655414|P1|Overall Study|Early Hospital Discharge|6
4830319|NCT01100567|16655413|P2|Overall Study|Withdrawal by Subject|8
4830320|NCT01100567|16655414|P1|Overall Study|Withdrawal by Subject|5
4830321|NCT01100528|16655422|P1|Overall Study|Withdrawal by Subject|2
4830322|NCT01100528|16655422|P1|Overall Study|Death|1
4830323|NCT01100502|16655430|P2|Long-Term Follow-up|Continuing in long-term follow-up|129
4830324|NCT01100502|16655431|P1|Long-Term Follow-up|Continuing in long-term follow-up|122
4830325|NCT01100502|16655430|P2|Long-Term Follow-up|Lost to Follow-up|2
4830326|NCT01100502|16655431|P1|Long-Term Follow-up|Lost to Follow-up|5
4830327|NCT01100502|16655430|P2|Long-Term Follow-up|Withdrawal by Subject|8
4830328|NCT01100502|16655431|P1|Long-Term Follow-up|Withdrawal by Subject|10
4830329|NCT01100502|16655430|P2|Treatment Period|Progressive Disease|69
4830330|NCT01100502|16655431|P1|Treatment Period|Progressive Disease|24
4830331|NCT01100502|16655430|P2|Treatment Period|Withdrawal by Subject|4
4830332|NCT01100502|16655431|P1|Treatment Period|Withdrawal by Subject|9
4830333|NCT01100502|16655430|P2|Treatment Period|Adverse Event|10
4830334|NCT01100502|16655431|P1|Treatment Period|Adverse Event|54
4830335|NCT01100437|16655441|P3|Maintenance|Sponsor termination of study|1
4830336|NCT01100437|16655442|P2|Maintenance|Sponsor termination of study|0
4830337|NCT01100437|16655443|P1|Maintenance|Sponsor termination of study|0
4830338|NCT01100437|16655441|P3|Maintenance|Withdrawal by Subject|1
4830339|NCT01100437|16655442|P2|Maintenance|Withdrawal by Subject|0
4830340|NCT01100437|16655443|P1|Maintenance|Withdrawal by Subject|0
4830341|NCT01100437|16655441|P3|Titration/Stabilization|Sponsor canceled study|1
4830342|NCT01100437|16655442|P2|Titration/Stabilization|Sponsor canceled study|0
4830343|NCT01100437|16655443|P1|Titration/Stabilization|Sponsor canceled study|0
4830344|NCT01100437|16655441|P3|Titration/Stabilization|Non-compliance|1
4830345|NCT01100437|16655442|P2|Titration/Stabilization|Non-compliance|0
4830346|NCT01100437|16655443|P1|Titration/Stabilization|Non-compliance|0
4830347|NCT01100437|16655441|P3|Titration/Stabilization|Adverse Event|4
4830348|NCT01100437|16655442|P2|Titration/Stabilization|Adverse Event|0
4830349|NCT01100437|16655443|P1|Titration/Stabilization|Adverse Event|0
4830350|NCT01100320|16655480|P2|Period 2|Withdrawal by Subject|1
4830351|NCT01100320|16655481|P1|Period 2|Withdrawal by Subject|1
4830352|NCT01100320|16655480|P2|Period 1|Adverse Event|2
4830353|NCT01100320|16655481|P1|Period 1|Adverse Event|2
4830354|NCT01100320|16655480|P2|Period 1|Positive Drug Screen|1
4830355|NCT01100320|16655481|P1|Period 1|Positive Drug Screen|1
4830356|NCT01100320|16655480|P2|Period 1|Withdrawal by Subject|4
4830357|NCT01100320|16655481|P1|Period 1|Withdrawal by Subject|2
4830358|NCT01100307|16655493|P2|Open Phase (Week 24 up to Week 54)|Adverse Event|8
4830359|NCT01100307|16655494|P1|Open Phase (Week 24 up to Week 54)|Adverse Event|3
4830360|NCT01100307|16655493|P2|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3
4830361|NCT01100307|16655494|P1|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2
4830362|NCT01100307|16655493|P2|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2
4830363|NCT01100307|16655494|P1|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1
4830364|NCT01100307|16655493|P2|Double Masked Phase (Up to Week 24)|Adverse Event|2
4830365|NCT01100307|16655494|P1|Double Masked Phase (Up to Week 24)|Adverse Event|5
4830366|NCT01100307|16655493|P2|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1
4830367|NCT01100307|16655494|P1|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0
4830368|NCT01100307|16655493|P2|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
4830369|NCT01100307|16655494|P1|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1
4830370|NCT01100086|16655563|P2|Period 1|Withdrawal by Subject|0
4830371|NCT01100086|16655564|P1|Period 1|Withdrawal by Subject|1
4830372|NCT01100073|16655574|P1|Overall Study|Missing|5
4830373|NCT01100073|16655574|P1|Overall Study|Other|8
4830374|NCT01100073|16655574|P1|Overall Study|Insufficient tolerability +patients wish|8
4830375|NCT01100073|16655574|P1|Overall Study|Lack of effect + patient's wish|2
4830376|NCT01100073|16655574|P1|Overall Study|Lost to Follow-up|39
4830377|NCT01100073|16655574|P1|Overall Study|Withdrawal by Subject|13
4830378|NCT01100073|16655574|P1|Overall Study|Insufficient Tolerability|21
4830379|NCT01100073|16655574|P1|Overall Study|Lack of Efficacy|4
4830380|NCT01100034|16655589|P1|Overall Study|Site closed due to non-responsiveness|1
4830381|NCT01100034|16655589|P1|Overall Study|Participants moved to another hospital|4
4830382|NCT01100034|16655589|P1|Overall Study|Participated in another clinical trial|1
4830383|NCT01100034|16655589|P1|Overall Study|Sponsor decision|21
4830384|NCT01100034|16655589|P1|Overall Study|Withdrawal by Subject|4
4830385|NCT01100034|16655589|P1|Overall Study|Withdrawal of parent/guardian consent|1
4830386|NCT01100034|16655589|P1|Overall Study|Lost to Follow-up|11
4830387|NCT01099917|16655627|P1|Overall Study|Not Treated|24
4830388|NCT01099917|16655627|P1|Overall Study|Adverse Event|3
4830389|NCT01099709|16655689|P2|Period 1|Adverse Event|0
4830390|NCT01099709|16655690|P1|Period 1|Adverse Event|1
4830391|NCT01099709|16655689|P2|Period 1|Positive cotinine test|1
4830392|NCT01099709|16655690|P1|Period 1|Positive cotinine test|0
4830393|NCT01099709|16655689|P2|Period 1|Withdrawal by Subject|1
4830394|NCT01099709|16655690|P1|Period 1|Withdrawal by Subject|0
4830395|NCT01099579|16655759|P3|Stage 2 (ATV Capsule)|Adverse Event|0
4830396|NCT01099579|16655760|P2|Stage 2 (ATV Capsule)|Adverse Event|1
4830397|NCT01099579|16655761|P1|Stage 2 (ATV Capsule)|Adverse Event|0
4830398|NCT01099579|16655759|P3|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1
4830399|NCT01099579|16655760|P2|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0
4830400|NCT01099579|16655761|P1|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2
4830401|NCT01099579|16655759|P3|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
4830402|NCT01099579|16655760|P2|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
4830403|NCT01099579|16655761|P1|Stage 2 (ATV Capsule)|Withdrawal by Subject|1
4830404|NCT01099579|16655759|P3|Stage 2 (ATV Capsule)|Lack of Efficacy|2
4830405|NCT01099579|16655760|P2|Stage 2 (ATV Capsule)|Lack of Efficacy|0
4830406|NCT01099579|16655761|P1|Stage 2 (ATV Capsule)|Lack of Efficacy|0
4830407|NCT01099579|16655759|P3|Stage 2 (ATV Capsule)|Lost to Follow-up|1
4830408|NCT01099579|16655760|P2|Stage 2 (ATV Capsule)|Lost to Follow-up|1
4830409|NCT01099579|16655761|P1|Stage 2 (ATV Capsule)|Lost to Follow-up|1
4830410|NCT01099579|16655759|P3|Stage 2 (ATV Capsule)|No longer met study criteria|1
4830411|NCT01099579|16655760|P2|Stage 2 (ATV Capsule)|No longer met study criteria|2
4830412|NCT01099579|16655761|P1|Stage 2 (ATV Capsule)|No longer met study criteria|2
4830413|NCT01099579|16655759|P3|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
4830414|NCT01099579|16655760|P2|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2
4830415|NCT01099579|16655761|P1|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0
4830416|NCT01099579|16655759|P3|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
4830417|NCT01099579|16655760|P2|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2
4830418|NCT01099579|16655761|P1|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0
4830419|NCT01099579|16655759|P3|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1
4830420|NCT01099579|16655760|P2|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
4830421|NCT01099579|16655761|P1|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0
4830422|NCT01099579|16655759|P3|Stage 1 (ATV Powder Formulation)|Adverse Event|0
4830423|NCT01099579|16655760|P2|Stage 1 (ATV Powder Formulation)|Adverse Event|1
4830424|NCT01099579|16655761|P1|Stage 1 (ATV Powder Formulation)|Adverse Event|4
4830425|NCT01099397|16655870|P1|Overall Study|Withdrawal by Subject|5
4830426|NCT01099397|16655870|P1|Overall Study|Protocol Violation|4
4830427|NCT01099397|16655870|P1|Overall Study|Lost to Follow-up|4
4830428|NCT01099267|16655897|P1|MDS-003 Study|Secondary Malign Disease|1
4830429|NCT01099267|16655897|P1|MDS-003 Study|Loss of Response|1
4830430|NCT01099267|16655897|P1|MDS-003 Study|Non-Compliance|2
4830431|NCT01099267|16655897|P1|MDS-003 Study|Investigator Decision|2
4830432|NCT01099267|16655897|P1|MDS-003 Study|Disease Progression|7
4830433|NCT01099267|16655897|P1|MDS-003 Study|Study Closed by Sponsor|2
4830434|NCT01099267|16655897|P1|MDS-003 Study|Death|11
4830435|NCT01099267|16655897|P1|MDS-003 Study|Lost to Follow-up|1
4830436|NCT01099267|16655897|P1|MDS-003 Study|Withdrawal by Subject|8
4830437|NCT01099267|16655897|P1|MDS-003 Study|Lack of Efficacy|52
4830438|NCT01099267|16655897|P1|MDS-003 Study|Adverse Event|37
4830439|NCT01099215|16655907|P2|Overall Study|Adverse Event|1
4830440|NCT01099215|16655908|P1|Overall Study|Adverse Event|0
4830441|NCT01099215|16655907|P2|Overall Study|Withdrawal by Subject|0
4830442|NCT01099215|16655908|P1|Overall Study|Withdrawal by Subject|1
4830443|NCT01098851|16655978|P2|Overall Study|Equipment failure|0
4830444|NCT01098851|16655979|P1|Overall Study|Equipment failure|1
4830445|NCT01098812|16655990|P3|Overall Study|Lost to Follow-up|0
4830446|NCT01098812|16655991|P2|Overall Study|Lost to Follow-up|1
4830447|NCT01098812|16655992|P1|Overall Study|Lost to Follow-up|0
4830448|NCT01098812|16655990|P3|Overall Study|Death|1
4830449|NCT01098812|16655991|P2|Overall Study|Death|0
4830450|NCT01098812|16655992|P1|Overall Study|Death|2
4830451|NCT01098539|16656068|P2|Overall Study|Physician Decision|3
4830452|NCT01098539|16656069|P1|Overall Study|Physician Decision|5
4830453|NCT01098539|16656068|P2|Overall Study|Withdrawal by Subject|26
4830454|NCT01098539|16656069|P1|Overall Study|Withdrawal by Subject|12
4830455|NCT01098539|16656068|P2|Overall Study|Lost to Follow-up|4
4830456|NCT01098539|16656069|P1|Overall Study|Lost to Follow-up|4
4830457|NCT01098539|16656068|P2|Overall Study|Noncompliance|5
4830458|NCT01098539|16656069|P1|Overall Study|Noncompliance|3
4830459|NCT01098539|16656068|P2|Overall Study|Protocol Violation|4
4830460|NCT01098539|16656069|P1|Overall Study|Protocol Violation|1
4830461|NCT01098539|16656068|P2|Overall Study|Adverse Event|26
4830462|NCT01098539|16656069|P1|Overall Study|Adverse Event|26
4830463|NCT01098487|16656120|P1|Overall Study|Physician Decision|1
4830464|NCT01098487|16656120|P1|Overall Study|Lost to Follow-up|3
4830465|NCT01098487|16656120|P1|Overall Study|Withdrawal by Subject|7
4830466|NCT01098487|16656120|P1|Overall Study|Lack of Efficacy|11
4830467|NCT01098487|16656120|P1|Overall Study|Adverse Event|22
4830468|NCT01098474|16656138|P6|Follow Up Phase|Lost to Follow-up|0
4830469|NCT01098474|16656139|P5|Follow Up Phase|Lost to Follow-up|1
4830470|NCT01098474|16656140|P4|Follow Up Phase|Lost to Follow-up|0
4830471|NCT01098474|16656141|P3|Follow Up Phase|Lost to Follow-up|0
4830472|NCT01098474|16656142|P2|Follow Up Phase|Lost to Follow-up|0
4830473|NCT01098474|16656143|P1|Follow Up Phase|Lost to Follow-up|0
4830474|NCT01098474|16656138|P6|Follow Up Phase|Withdrawal by Subject|1
4830475|NCT01098474|16656139|P5|Follow Up Phase|Withdrawal by Subject|0
4830476|NCT01098474|16656140|P4|Follow Up Phase|Withdrawal by Subject|2
4830477|NCT01098474|16656141|P3|Follow Up Phase|Withdrawal by Subject|0
4830478|NCT01098474|16656142|P2|Follow Up Phase|Withdrawal by Subject|0
4830479|NCT01098474|16656143|P1|Follow Up Phase|Withdrawal by Subject|0
4830480|NCT01098474|16656138|P6|Follow Up Phase|Other|4
4830481|NCT01098474|16656139|P5|Follow Up Phase|Other|0
4830482|NCT01098474|16656140|P4|Follow Up Phase|Other|0
4830483|NCT01098474|16656141|P3|Follow Up Phase|Other|0
4830484|NCT01098474|16656142|P2|Follow Up Phase|Other|0
4830485|NCT01098474|16656143|P1|Follow Up Phase|Other|0
4830486|NCT01098474|16656138|P6|Follow Up Phase|Travelled out of study area|0
4830487|NCT01098474|16656139|P5|Follow Up Phase|Travelled out of study area|1
4830488|NCT01098474|16656140|P4|Follow Up Phase|Travelled out of study area|0
4830489|NCT01098474|16656141|P3|Follow Up Phase|Travelled out of study area|0
4830490|NCT01098474|16656142|P2|Follow Up Phase|Travelled out of study area|0
4830491|NCT01098474|16656143|P1|Follow Up Phase|Travelled out of study area|0
4830492|NCT01098474|16656138|P6|Active Phase|Lost to Follow-up|0
4830493|NCT01098474|16656139|P5|Active Phase|Lost to Follow-up|0
4830494|NCT01098474|16656140|P4|Active Phase|Lost to Follow-up|0
4830495|NCT01098474|16656141|P3|Active Phase|Lost to Follow-up|0
4830496|NCT01098474|16656142|P2|Active Phase|Lost to Follow-up|0
4830497|NCT01098474|16656143|P1|Active Phase|Lost to Follow-up|1
4830498|NCT01098474|16656138|P6|Active Phase|Withdrawal by Subject|0
4830499|NCT01098474|16656139|P5|Active Phase|Withdrawal by Subject|0
4830500|NCT01098474|16656140|P4|Active Phase|Withdrawal by Subject|0
4830501|NCT01098474|16656141|P3|Active Phase|Withdrawal by Subject|2
4830502|NCT01098474|16656142|P2|Active Phase|Withdrawal by Subject|1
4830503|NCT01098474|16656143|P1|Active Phase|Withdrawal by Subject|1
4830504|NCT01098474|16656138|P6|Active Phase|Other|0
4830505|NCT01098474|16656139|P5|Active Phase|Other|0
4830506|NCT01098474|16656140|P4|Active Phase|Other|0
4830507|NCT01098474|16656141|P3|Active Phase|Other|3
4830508|NCT01098474|16656142|P2|Active Phase|Other|0
4830509|NCT01098474|16656143|P1|Active Phase|Other|0
4830510|NCT01098461|16656377|P4|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
4830511|NCT01098461|16656378|P3|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
4830512|NCT01098461|16656379|P2|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1
4830513|NCT01098461|16656380|P1|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0
4830514|NCT01098461|16656377|P4|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
4830515|NCT01098461|16656378|P3|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
4830516|NCT01098461|16656379|P2|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1
4830517|NCT01098461|16656380|P1|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0
4830518|NCT01098461|16656377|P4|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
4830519|NCT01098461|16656378|P3|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
4830520|NCT01098461|16656379|P2|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1
4830521|NCT01098461|16656380|P1|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0
4830522|NCT01098461|16656377|P4|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
4830523|NCT01098461|16656378|P3|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
4830524|NCT01098461|16656379|P2|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1
4830525|NCT01098461|16656380|P1|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0
4830526|NCT01098461|16656377|P4|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
4830527|NCT01098461|16656378|P3|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0
4830528|NCT01098461|16656379|P2|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2
4830529|NCT01098461|16656380|P1|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1
4830530|NCT01098461|16656377|P4|Treatment Period (TP) (16 Weeks)|Adverse Event|3
4830531|NCT01098461|16656378|P3|Treatment Period (TP) (16 Weeks)|Adverse Event|1
4830532|NCT01098461|16656379|P2|Treatment Period (TP) (16 Weeks)|Adverse Event|2
4830533|NCT01098461|16656380|P1|Treatment Period (TP) (16 Weeks)|Adverse Event|1
4830534|NCT01098461|16656377|P4|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
4830535|NCT01098461|16656378|P3|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0
4830536|NCT01098461|16656379|P2|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2
4830537|NCT01098461|16656380|P1|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10
4830538|NCT01098305|16656440|P2|Overall Study|Lost to Follow-up|33
4830539|NCT01098305|16656441|P1|Overall Study|Lost to Follow-up|31
4830540|NCT01098266|16656451|P2|Overall Study|Withdrawal by Subject|5
4830541|NCT01098266|16656452|P1|Overall Study|Withdrawal by Subject|3
4830542|NCT01098266|16656451|P2|Overall Study|Death|2
4830543|NCT01098266|16656452|P1|Overall Study|Death|3
4830544|NCT01098266|16656451|P2|Overall Study|Physician Decision|0
4830545|NCT01098266|16656452|P1|Overall Study|Physician Decision|1
4830546|NCT01098240|16656481|P3|Double-Blind Phase|Adverse Event|3
4830547|NCT01098240|16656482|P2|Double-Blind Phase|Adverse Event|3
4830548|NCT01098240|16656483|P1|Double-Blind Phase|Adverse Event|0
4830549|NCT01098240|16656481|P3|Double-Blind Phase|Withdrawal by Subject|3
4830550|NCT01098240|16656482|P2|Double-Blind Phase|Withdrawal by Subject|1
4830551|NCT01098240|16656483|P1|Double-Blind Phase|Withdrawal by Subject|0
4830552|NCT01098240|16656481|P3|Double-Blind Phase|Insufficient Clinical Response|2
4830553|NCT01098240|16656482|P2|Double-Blind Phase|Insufficient Clinical Response|1
4830554|NCT01098240|16656483|P1|Double-Blind Phase|Insufficient Clinical Response|0
4830555|NCT01098240|16656481|P3|Double-Blind Phase|Did Not Meet Entrance Criteria|0
4830556|NCT01098240|16656482|P2|Double-Blind Phase|Did Not Meet Entrance Criteria|1
4830557|NCT01098240|16656483|P1|Double-Blind Phase|Did Not Meet Entrance Criteria|0
4830558|NCT01098240|16656481|P3|Double-Blind Phase|Other|2
4830559|NCT01098240|16656482|P2|Double-Blind Phase|Other|2
4830560|NCT01098240|16656483|P1|Double-Blind Phase|Other|0
4830561|NCT01098240|16656481|P3|Double-Blind Phase|Lost to Follow-up|0
4830562|NCT01098240|16656482|P2|Double-Blind Phase|Lost to Follow-up|2
4830563|NCT01098240|16656483|P1|Double-Blind Phase|Lost to Follow-up|0
4830564|NCT01098240|16656481|P3|Double-Blind Phase|Protocol Violation|4
4830565|NCT01098240|16656482|P2|Double-Blind Phase|Protocol Violation|2
4830566|NCT01098240|16656483|P1|Double-Blind Phase|Protocol Violation|0
4830567|NCT01098240|16656481|P3|Double-Blind Phase|Study Terminated by Sponsor|8
4830568|NCT01098240|16656482|P2|Double-Blind Phase|Study Terminated by Sponsor|5
4830569|NCT01098240|16656483|P1|Double-Blind Phase|Study Terminated by Sponsor|0
4830570|NCT01098240|16656481|P3|Open-Label Phase|Adverse Event|0
4830571|NCT01098240|16656482|P2|Open-Label Phase|Adverse Event|0
4830572|NCT01098240|16656483|P1|Open-Label Phase|Adverse Event|12
4830573|NCT01098240|16656481|P3|Open-Label Phase|Withdrawal by Subject|0
4830574|NCT01098240|16656482|P2|Open-Label Phase|Withdrawal by Subject|0
4830575|NCT01098240|16656483|P1|Open-Label Phase|Withdrawal by Subject|9
4830576|NCT01098240|16656481|P3|Open-Label Phase|Pregnancy|0
4830577|NCT01098240|16656482|P2|Open-Label Phase|Pregnancy|0
4830578|NCT01098240|16656483|P1|Open-Label Phase|Pregnancy|1
4830579|NCT01098240|16656481|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
4830580|NCT01098240|16656482|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
4830581|NCT01098240|16656483|P1|Open-Label Phase|Did Not Meet Entrance Criteria|50
4830582|NCT01098240|16656481|P3|Open-Label Phase|Other|0
4830583|NCT01098240|16656482|P2|Open-Label Phase|Other|0
4830584|NCT01098240|16656483|P1|Open-Label Phase|Other|19
4830585|NCT01098240|16656481|P3|Open-Label Phase|Lost to Follow-up|0
4830586|NCT01098240|16656482|P2|Open-Label Phase|Lost to Follow-up|0
4830587|NCT01098240|16656483|P1|Open-Label Phase|Lost to Follow-up|13
4830588|NCT01098240|16656481|P3|Open-Label Phase|Protocol Violation|0
4830589|NCT01098240|16656482|P2|Open-Label Phase|Protocol Violation|0
4830590|NCT01098240|16656483|P1|Open-Label Phase|Protocol Violation|4
4830591|NCT01098240|16656481|P3|Open-Label Phase|Study Terminated by Sponsor|0
4830592|NCT01098240|16656482|P2|Open-Label Phase|Study Terminated by Sponsor|0
4830593|NCT01098240|16656483|P1|Open-Label Phase|Study Terminated by Sponsor|27
4830594|NCT01098162|16656513|P1|Overall Study|Reason Unknown|26
4830595|NCT01098162|16656513|P1|Overall Study|Other Reason|1
4830596|NCT01098162|16656513|P1|Overall Study|Wish of Patient & Lost to Follow-up|1
4830597|NCT01098162|16656513|P1|Overall Study|AE & Lack of Efficacy & Wish of Patient|1
4830598|NCT01098162|16656513|P1|Overall Study|Adverse Event & Lost to Follow-up|2
4830599|NCT01098162|16656513|P1|Overall Study|Adverse Event & Wish of Patient|13
4830600|NCT01098162|16656513|P1|Overall Study|Adverse Event & Lack of Efficacy|6
4830601|NCT01098162|16656513|P1|Overall Study|Lack of Efficacy & Wish of Patient|5
4830602|NCT01098162|16656513|P1|Overall Study|Lost to Follow-up|9
4830603|NCT01098162|16656513|P1|Overall Study|Wish of Patient|7
4830604|NCT01098162|16656513|P1|Overall Study|Lack of Efficacy|4
4830605|NCT01098162|16656513|P1|Overall Study|Adverse Event|37
4830606|NCT01098110|16656525|P3|Overall Study|Untreated|0
4830607|NCT01098110|16656526|P2|Overall Study|Untreated|1
4830608|NCT01098110|16656527|P1|Overall Study|Untreated|1
4830609|NCT01098110|16656525|P3|Overall Study|Other|5
4830610|NCT01098110|16656526|P2|Overall Study|Other|7
4830611|NCT01098110|16656527|P1|Overall Study|Other|4
4830612|NCT01098110|16656525|P3|Overall Study|Lack of Efficacy|27
4830613|NCT01098110|16656526|P2|Overall Study|Lack of Efficacy|9
4830614|NCT01098110|16656527|P1|Overall Study|Lack of Efficacy|13
4830615|NCT01098110|16656525|P3|Overall Study|Adverse Event|43
4830616|NCT01098110|16656526|P2|Overall Study|Adverse Event|32
4830617|NCT01098110|16656527|P1|Overall Study|Adverse Event|30
4830618|NCT01098110|16656525|P3|Overall Study|Withdrawal by Subject|19
4830619|NCT01098110|16656526|P2|Overall Study|Withdrawal by Subject|24
4830620|NCT01098110|16656527|P1|Overall Study|Withdrawal by Subject|14
4830621|NCT01098097|16656568|P1|Overall Study|No reason reported|31
4830622|NCT01098097|16656568|P1|Overall Study|Status unknown|16
4830623|NCT01098097|16656568|P1|Overall Study|Lost to Follow-up|18
4830624|NCT01098097|16656568|P1|Overall Study|Adverse Event|17
4830625|NCT01098071|16656577|P1|Overall Study|Lost to Follow-up|13
4830626|NCT01098071|16656577|P1|Overall Study|Surgery (adenoidectomy)|2
4830627|NCT01098032|16656590|P2|Overall Study|Withdrawal by Subject|1
4830628|NCT01098032|16656591|P1|Overall Study|Withdrawal by Subject|1
4830629|NCT01097863|16656708|P3|Overall Study|Did not return for final visit|1
4830630|NCT01097863|16656709|P2|Overall Study|Did not return for final visit|0
4830631|NCT01097863|16656710|P1|Overall Study|Did not return for final visit|0
4830632|NCT01097863|16656708|P3|Overall Study|Discomfort|1
4830633|NCT01097863|16656709|P2|Overall Study|Discomfort|0
4830634|NCT01097863|16656710|P1|Overall Study|Discomfort|1
4830635|NCT01097707|16656734|P5|Overall Study|Reason unknown|1
4830636|NCT01097707|16656735|P4|Overall Study|Reason unknown|0
4830637|NCT01097707|16656736|P3|Overall Study|Reason unknown|0
4830638|NCT01097707|16656737|P2|Overall Study|Reason unknown|0
4830639|NCT01097707|16656738|P1|Overall Study|Reason unknown|0
4830640|NCT01097707|16656734|P5|Overall Study|Withdrawal by Subject|3
4830641|NCT01097707|16656735|P4|Overall Study|Withdrawal by Subject|4
4830642|NCT01097707|16656736|P3|Overall Study|Withdrawal by Subject|1
4830643|NCT01097707|16656737|P2|Overall Study|Withdrawal by Subject|6
4830644|NCT01097707|16656738|P1|Overall Study|Withdrawal by Subject|3
4830645|NCT01097707|16656734|P5|Overall Study|Sponsor Decision|36
4830646|NCT01097707|16656735|P4|Overall Study|Sponsor Decision|35
4830647|NCT01097707|16656736|P3|Overall Study|Sponsor Decision|34
4830648|NCT01097707|16656737|P2|Overall Study|Sponsor Decision|31
4830649|NCT01097707|16656738|P1|Overall Study|Sponsor Decision|31
4830650|NCT01097707|16656734|P5|Overall Study|Protocol Violation|2
4830651|NCT01097707|16656735|P4|Overall Study|Protocol Violation|2
4830652|NCT01097707|16656736|P3|Overall Study|Protocol Violation|3
4830653|NCT01097707|16656737|P2|Overall Study|Protocol Violation|2
4830654|NCT01097707|16656738|P1|Overall Study|Protocol Violation|2
4830655|NCT01097707|16656734|P5|Overall Study|Lost to Follow-up|3
4830656|NCT01097707|16656735|P4|Overall Study|Lost to Follow-up|0
4830657|NCT01097707|16656736|P3|Overall Study|Lost to Follow-up|2
4830658|NCT01097707|16656737|P2|Overall Study|Lost to Follow-up|1
4830659|NCT01097707|16656738|P1|Overall Study|Lost to Follow-up|1
4830660|NCT01097707|16656734|P5|Overall Study|Lack of Efficacy|0
4830661|NCT01097707|16656735|P4|Overall Study|Lack of Efficacy|1
4830662|NCT01097707|16656736|P3|Overall Study|Lack of Efficacy|0
4830663|NCT01097707|16656737|P2|Overall Study|Lack of Efficacy|0
4830664|NCT01097707|16656738|P1|Overall Study|Lack of Efficacy|1
4830665|NCT01097707|16656734|P5|Overall Study|Entry Criteria Not Met|1
4830666|NCT01097707|16656735|P4|Overall Study|Entry Criteria Not Met|0
4830667|NCT01097707|16656736|P3|Overall Study|Entry Criteria Not Met|1
4830668|NCT01097707|16656737|P2|Overall Study|Entry Criteria Not Met|1
4830669|NCT01097707|16656738|P1|Overall Study|Entry Criteria Not Met|2
4830670|NCT01097707|16656734|P5|Overall Study|Adverse Event|3
4830671|NCT01097707|16656735|P4|Overall Study|Adverse Event|1
4830672|NCT01097707|16656736|P3|Overall Study|Adverse Event|3
4830673|NCT01097707|16656737|P2|Overall Study|Adverse Event|2
4830674|NCT01097707|16656738|P1|Overall Study|Adverse Event|4
4830675|NCT01097707|16656734|P5|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4830676|NCT01097707|16656735|P4|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4830677|NCT01097707|16656736|P3|Overall Study|Abnormal Lab/Electrocardiogram Result|1
4830678|NCT01097707|16656737|P2|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4830679|NCT01097707|16656738|P1|Overall Study|Abnormal Lab/Electrocardiogram Result|0
4830680|NCT01097694|16656787|P2|Overall Study|Withdrawal by Subject|1
4830681|NCT01097694|16656788|P1|Overall Study|Withdrawal by Subject|3
4830682|NCT01097694|16656787|P2|Overall Study|Lost to Follow-up|3
4830683|NCT01097694|16656788|P1|Overall Study|Lost to Follow-up|0
4830684|NCT01097694|16656787|P2|Overall Study|Adverse Event|0
4830685|NCT01097694|16656788|P1|Overall Study|Adverse Event|5
4830686|NCT01097668|16656850|P2|Overall Study|Lost to Follow-up|0
4830687|NCT01097668|16656851|P1|Overall Study|Lost to Follow-up|1
4830688|NCT01097668|16656850|P2|Overall Study|Withdrawal by Subject|2
4830689|NCT01097668|16656851|P1|Overall Study|Withdrawal by Subject|1
4830690|NCT01097655|16656861|P1|Overall Study|Did Not Meet Inclusion Criteria|8
4830691|NCT01097655|16656861|P1|Overall Study|Subject Documented Twice|1
4830692|NCT01097655|16656861|P1|Overall Study|Withdrawal by Subject|1
4830693|NCT01097629|16656871|P8|DB RO Phase|Lost to Follow-up|0
4830694|NCT01097629|16656872|P7|DB RO Phase|Lost to Follow-up|2
4830695|NCT01097629|16656873|P6|DB RO Phase|Lost to Follow-up|0
4830696|NCT01097629|16656874|P5|DB RO Phase|Lost to Follow-up|0
4830697|NCT01097629|16656875|P4|DB RO Phase|Lost to Follow-up|0
4830698|NCT01097629|16656876|P3|DB RO Phase|Lost to Follow-up|0
4830699|NCT01097629|16656877|P2|DB RO Phase|Lost to Follow-up|0
4830700|NCT01097629|16656878|P1|DB RO Phase|Lost to Follow-up|0
4830701|NCT01097629|16656871|P8|DB RO Phase|Protocol Violation|0
4830702|NCT01097629|16656872|P7|DB RO Phase|Protocol Violation|1
4830703|NCT01097629|16656873|P6|DB RO Phase|Protocol Violation|1
4830704|NCT01097629|16656874|P5|DB RO Phase|Protocol Violation|0
4830705|NCT01097629|16656875|P4|DB RO Phase|Protocol Violation|1
4830706|NCT01097629|16656876|P3|DB RO Phase|Protocol Violation|0
4830707|NCT01097629|16656877|P2|DB RO Phase|Protocol Violation|0
4830708|NCT01097629|16656878|P1|DB RO Phase|Protocol Violation|0
4830709|NCT01097629|16656871|P8|DB RO Phase|Withdrawal by Subject|1
4830710|NCT01097629|16656872|P7|DB RO Phase|Withdrawal by Subject|0
4830711|NCT01097629|16656873|P6|DB RO Phase|Withdrawal by Subject|0
4830712|NCT01097629|16656874|P5|DB RO Phase|Withdrawal by Subject|0
4830713|NCT01097629|16656875|P4|DB RO Phase|Withdrawal by Subject|0
4830714|NCT01097629|16656876|P3|DB RO Phase|Withdrawal by Subject|0
4830715|NCT01097629|16656877|P2|DB RO Phase|Withdrawal by Subject|0
4830716|NCT01097629|16656878|P1|DB RO Phase|Withdrawal by Subject|0
4830717|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830718|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830719|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830720|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830721|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830722|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4
4830723|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5
4830724|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
4830725|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830726|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830727|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830728|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830729|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830730|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830731|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1
4830732|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2
4830733|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830734|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830735|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830736|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830737|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830738|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8
4830739|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4
4830740|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
4830741|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830742|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830743|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830744|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830745|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830746|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
4830747|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4
4830748|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2
4830749|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830750|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830751|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830752|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830753|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830754|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8
4830755|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4
4830756|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
4830757|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830758|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830759|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830760|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830761|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830762|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19
4830763|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9
4830764|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
4830765|NCT01097629|16656871|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830766|NCT01097629|16656872|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830767|NCT01097629|16656873|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830768|NCT01097629|16656874|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830769|NCT01097629|16656875|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830770|NCT01097629|16656876|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17
4830771|NCT01097629|16656877|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19
4830772|NCT01097629|16656878|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10
4830773|NCT01097616|16656929|P8|DB RO Phase|Not Treated in RO|0
4830774|NCT01097616|16656930|P7|DB RO Phase|Not Treated in RO|0
4830775|NCT01097616|16656931|P6|DB RO Phase|Not Treated in RO|1
4830776|NCT01097616|16656932|P5|DB RO Phase|Not Treated in RO|0
4830777|NCT01097616|16656933|P4|DB RO Phase|Not Treated in RO|0
4830778|NCT01097616|16656934|P3|DB RO Phase|Not Treated in RO|0
4830779|NCT01097616|16656935|P2|DB RO Phase|Not Treated in RO|0
4830780|NCT01097616|16656936|P1|DB RO Phase|Not Treated in RO|0
4830781|NCT01097616|16656929|P8|DB RO Phase|Lost to Follow-up|1
4830782|NCT01097616|16656930|P7|DB RO Phase|Lost to Follow-up|0
4830783|NCT01097616|16656931|P6|DB RO Phase|Lost to Follow-up|0
4830784|NCT01097616|16656932|P5|DB RO Phase|Lost to Follow-up|1
4830785|NCT01097616|16656933|P4|DB RO Phase|Lost to Follow-up|1
4830786|NCT01097616|16656934|P3|DB RO Phase|Lost to Follow-up|0
4830787|NCT01097616|16656935|P2|DB RO Phase|Lost to Follow-up|0
4830788|NCT01097616|16656936|P1|DB RO Phase|Lost to Follow-up|0
4830789|NCT01097616|16656929|P8|DB RO Phase|Withdrawal by Subject|0
4830790|NCT01097616|16656930|P7|DB RO Phase|Withdrawal by Subject|0
4830791|NCT01097616|16656931|P6|DB RO Phase|Withdrawal by Subject|1
4830792|NCT01097616|16656932|P5|DB RO Phase|Withdrawal by Subject|0
4830793|NCT01097616|16656933|P4|DB RO Phase|Withdrawal by Subject|0
4830794|NCT01097616|16656934|P3|DB RO Phase|Withdrawal by Subject|0
4830795|NCT01097616|16656935|P2|DB RO Phase|Withdrawal by Subject|0
4830796|NCT01097616|16656936|P1|DB RO Phase|Withdrawal by Subject|0
4830797|NCT01097616|16656929|P8|DB RO Phase|Adverse Event|0
4830798|NCT01097616|16656930|P7|DB RO Phase|Adverse Event|1
4830799|NCT01097616|16656931|P6|DB RO Phase|Adverse Event|0
4830800|NCT01097616|16656932|P5|DB RO Phase|Adverse Event|0
4830801|NCT01097616|16656933|P4|DB RO Phase|Adverse Event|0
4830802|NCT01097616|16656934|P3|DB RO Phase|Adverse Event|0
4830803|NCT01097616|16656935|P2|DB RO Phase|Adverse Event|0
4830804|NCT01097616|16656936|P1|DB RO Phase|Adverse Event|0
4830805|NCT01097616|16656929|P8|Optional DB EXT Phase|Physician Decision|0
4830806|NCT01097616|16656930|P7|Optional DB EXT Phase|Physician Decision|0
4830807|NCT01097616|16656931|P6|Optional DB EXT Phase|Physician Decision|0
4830808|NCT01097616|16656932|P5|Optional DB EXT Phase|Physician Decision|0
4830809|NCT01097616|16656933|P4|Optional DB EXT Phase|Physician Decision|0
4830810|NCT01097616|16656934|P3|Optional DB EXT Phase|Physician Decision|0
4830811|NCT01097616|16656935|P2|Optional DB EXT Phase|Physician Decision|0
4830812|NCT01097616|16656936|P1|Optional DB EXT Phase|Physician Decision|1
4830813|NCT01097616|16656929|P8|Optional DB EXT Phase|Lack of Efficacy|0
4830814|NCT01097616|16656930|P7|Optional DB EXT Phase|Lack of Efficacy|0
4830815|NCT01097616|16656931|P6|Optional DB EXT Phase|Lack of Efficacy|0
4830816|NCT01097616|16656932|P5|Optional DB EXT Phase|Lack of Efficacy|0
4830817|NCT01097616|16656933|P4|Optional DB EXT Phase|Lack of Efficacy|0
4830818|NCT01097616|16656934|P3|Optional DB EXT Phase|Lack of Efficacy|1
4830819|NCT01097616|16656935|P2|Optional DB EXT Phase|Lack of Efficacy|1
4830820|NCT01097616|16656936|P1|Optional DB EXT Phase|Lack of Efficacy|1
4830821|NCT01097616|16656929|P8|Optional DB EXT Phase|Lost to Follow-up|0
4830822|NCT01097616|16656930|P7|Optional DB EXT Phase|Lost to Follow-up|0
4830823|NCT01097616|16656931|P6|Optional DB EXT Phase|Lost to Follow-up|0
4830824|NCT01097616|16656932|P5|Optional DB EXT Phase|Lost to Follow-up|0
4830825|NCT01097616|16656933|P4|Optional DB EXT Phase|Lost to Follow-up|0
4830826|NCT01097616|16656934|P3|Optional DB EXT Phase|Lost to Follow-up|1
4830827|NCT01097616|16656935|P2|Optional DB EXT Phase|Lost to Follow-up|5
4830828|NCT01097616|16656936|P1|Optional DB EXT Phase|Lost to Follow-up|1
4830829|NCT01097616|16656929|P8|Optional DB EXT Phase|Protocol Violation|0
4830830|NCT01097616|16656930|P7|Optional DB EXT Phase|Protocol Violation|0
4830831|NCT01097616|16656931|P6|Optional DB EXT Phase|Protocol Violation|0
4830832|NCT01097616|16656932|P5|Optional DB EXT Phase|Protocol Violation|0
4830833|NCT01097616|16656933|P4|Optional DB EXT Phase|Protocol Violation|0
4830834|NCT01097616|16656934|P3|Optional DB EXT Phase|Protocol Violation|3
4830835|NCT01097616|16656935|P2|Optional DB EXT Phase|Protocol Violation|2
4830836|NCT01097616|16656936|P1|Optional DB EXT Phase|Protocol Violation|0
4830837|NCT01097616|16656929|P8|Optional DB EXT Phase|Withdrawal by Subject|0
4830838|NCT01097616|16656930|P7|Optional DB EXT Phase|Withdrawal by Subject|0
4830839|NCT01097616|16656931|P6|Optional DB EXT Phase|Withdrawal by Subject|0
4830840|NCT01097616|16656932|P5|Optional DB EXT Phase|Withdrawal by Subject|0
4830841|NCT01097616|16656933|P4|Optional DB EXT Phase|Withdrawal by Subject|0
4830842|NCT01097616|16656934|P3|Optional DB EXT Phase|Withdrawal by Subject|3
4830843|NCT01097616|16656935|P2|Optional DB EXT Phase|Withdrawal by Subject|6
4830844|NCT01097616|16656936|P1|Optional DB EXT Phase|Withdrawal by Subject|12
4830845|NCT01097616|16656929|P8|Optional DB EXT Phase|Adverse Event|0
4830846|NCT01097616|16656930|P7|Optional DB EXT Phase|Adverse Event|0
4830847|NCT01097616|16656931|P6|Optional DB EXT Phase|Adverse Event|0
4830848|NCT01097616|16656932|P5|Optional DB EXT Phase|Adverse Event|0
4830849|NCT01097616|16656933|P4|Optional DB EXT Phase|Adverse Event|0
4830850|NCT01097616|16656934|P3|Optional DB EXT Phase|Adverse Event|2
4830851|NCT01097616|16656935|P2|Optional DB EXT Phase|Adverse Event|7
4830852|NCT01097616|16656936|P1|Optional DB EXT Phase|Adverse Event|0
4830853|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830854|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830855|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830856|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830857|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830858|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1
4830859|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830860|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0
4830861|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830862|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830863|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830864|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830865|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830866|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0
4830867|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3
4830868|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4
4830869|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4830870|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4830871|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4830872|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4830873|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4830874|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0
4830875|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
4830876|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1
4830877|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830878|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830879|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830880|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830881|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0
4830882|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9
4830883|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7
4830884|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1
4830885|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830886|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830887|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830888|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830889|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830890|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0
4830891|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
4830892|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1
4830893|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830894|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830895|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830896|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830897|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0
4830898|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1
4830899|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3
4830900|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5
4830901|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830902|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830903|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830904|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830905|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0
4830906|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12
4830907|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8
4830908|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6
4830909|NCT01097616|16656929|P8|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830910|NCT01097616|16656930|P7|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830911|NCT01097616|16656931|P6|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830912|NCT01097616|16656932|P5|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830913|NCT01097616|16656933|P4|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0
4830914|NCT01097616|16656934|P3|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21
4830915|NCT01097616|16656935|P2|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15
4830916|NCT01097616|16656936|P1|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6
4830917|NCT01097421|16657011|P1|Overall Study|Withdrawal by Subject|3
4830918|NCT01097421|16657011|P1|Overall Study|Lost to Follow-up|1
4830919|NCT01097421|16657011|P1|Overall Study|Protocol Violation|2
4830920|NCT01097421|16657011|P1|Overall Study|Adverse Event|8
4830921|NCT01097330|16657030|P2|Overall Study|Study terminated early|5
4830922|NCT01097330|16657031|P1|Overall Study|Study terminated early|7
4830923|NCT01097057|16657048|P1|Overall Study|Physician Decision|3
4830924|NCT01097044|16657057|P2|Overall Study|Withdrawal by Sponsor|1
4830925|NCT01097044|16657058|P1|Overall Study|Withdrawal by Sponsor|0
4830926|NCT01097044|16657057|P2|Overall Study|Lost to Follow-up|0
4830927|NCT01097044|16657058|P1|Overall Study|Lost to Follow-up|1
4830928|NCT01097044|16657057|P2|Overall Study|Withdrawal by Subject|4
4830929|NCT01097044|16657058|P1|Overall Study|Withdrawal by Subject|4
4830930|NCT01097005|16657076|P1|Overall Study|Discontinuance by complication|50
4830931|NCT01097005|16657076|P1|Overall Study|Adverse Event|14
4830932|NCT01097005|16657076|P1|Overall Study|Deviation from exclusion criteria|37
4830933|NCT01097005|16657076|P1|Overall Study|No examination data available|244
4830934|NCT01097005|16657076|P1|Overall Study|Poor medication compliance|1
4830935|NCT01097005|16657076|P1|Overall Study|Subjects cannot visit the hospital|1
4830936|NCT01097005|16657076|P1|Overall Study|Case Report Form not collected|18
4830937|NCT01096849|16657122|P3|Overall Study|Lost to Follow-up|1
4830938|NCT01096849|16657123|P2|Overall Study|Lost to Follow-up|3
4830939|NCT01096849|16657124|P1|Overall Study|Lost to Follow-up|1
4830940|NCT01096849|16657122|P3|Overall Study|Administrative Reasons|2
4830941|NCT01096849|16657123|P2|Overall Study|Administrative Reasons|1
4830942|NCT01096849|16657124|P1|Overall Study|Administrative Reasons|0
4830943|NCT01096849|16657122|P3|Overall Study|Investigator or Medical Monitor Decision|0
4830944|NCT01096849|16657123|P2|Overall Study|Investigator or Medical Monitor Decision|1
4830945|NCT01096849|16657124|P1|Overall Study|Investigator or Medical Monitor Decision|0
4830946|NCT01096849|16657122|P3|Overall Study|Unacceptable/ Intolerable AE(s)|1
4830947|NCT01096849|16657123|P2|Overall Study|Unacceptable/ Intolerable AE(s)|1
4830948|NCT01096849|16657124|P1|Overall Study|Unacceptable/ Intolerable AE(s)|0
4830949|NCT01096849|16657122|P3|Overall Study|Lack of Efficacy|0
4830950|NCT01096849|16657123|P2|Overall Study|Lack of Efficacy|2
4830951|NCT01096849|16657124|P1|Overall Study|Lack of Efficacy|0
4830952|NCT01096849|16657122|P3|Overall Study|Consent Withdrawn|2
4830953|NCT01096849|16657123|P2|Overall Study|Consent Withdrawn|4
4830954|NCT01096849|16657124|P1|Overall Study|Consent Withdrawn|1
4830955|NCT01096784|16657200|P2|Overall Study|Other Unspecified|1
4830956|NCT01096784|16657201|P1|Overall Study|Other Unspecified|0
4830957|NCT01096784|16657200|P2|Overall Study|Administrative Decision|1
4830958|NCT01096784|16657201|P1|Overall Study|Administrative Decision|0
4830959|NCT01096784|16657200|P2|Overall Study|Protocol Deviation|2
4830960|NCT01096784|16657201|P1|Overall Study|Protocol Deviation|2
4830961|NCT01096784|16657200|P2|Overall Study|Adverse Event|9
4830962|NCT01096784|16657201|P1|Overall Study|Adverse Event|11
4830963|NCT01096784|16657200|P2|Overall Study|Withdrawal by Subject|1
4830964|NCT01096784|16657201|P1|Overall Study|Withdrawal by Subject|2
4830965|NCT01096667|16657306|P5|Overall Study|Not treated|0
4830966|NCT01096667|16657307|P4|Overall Study|Not treated|0
4830967|NCT01096667|16657308|P3|Overall Study|Not treated|0
4830968|NCT01096667|16657309|P2|Overall Study|Not treated|0
4830969|NCT01096667|16657310|P1|Overall Study|Not treated|1
4830970|NCT01096667|16657306|P5|Overall Study|Protocol Violation|0
4830971|NCT01096667|16657307|P4|Overall Study|Protocol Violation|1
4830972|NCT01096667|16657308|P3|Overall Study|Protocol Violation|0
4830973|NCT01096667|16657309|P2|Overall Study|Protocol Violation|0
4830974|NCT01096667|16657310|P1|Overall Study|Protocol Violation|0
4830975|NCT01096667|16657306|P5|Overall Study|Reason not available|0
4830976|NCT01096667|16657307|P4|Overall Study|Reason not available|1
4830977|NCT01096667|16657308|P3|Overall Study|Reason not available|1
4830978|NCT01096667|16657309|P2|Overall Study|Reason not available|1
4830979|NCT01096667|16657310|P1|Overall Study|Reason not available|0
4830980|NCT01096667|16657306|P5|Overall Study|Withdrawal by Subject|0
4830981|NCT01096667|16657307|P4|Overall Study|Withdrawal by Subject|1
4830982|NCT01096667|16657308|P3|Overall Study|Withdrawal by Subject|0
4830983|NCT01096667|16657309|P2|Overall Study|Withdrawal by Subject|0
4830984|NCT01096667|16657310|P1|Overall Study|Withdrawal by Subject|1
4830985|NCT01096667|16657306|P5|Overall Study|Lost to Follow-up|0
4830986|NCT01096667|16657307|P4|Overall Study|Lost to Follow-up|0
4830987|NCT01096667|16657308|P3|Overall Study|Lost to Follow-up|1
4830988|NCT01096667|16657309|P2|Overall Study|Lost to Follow-up|1
4830989|NCT01096667|16657310|P1|Overall Study|Lost to Follow-up|1
4830990|NCT01096589|16657452|P4|Overall Study|found treatment exhausting|1
4830991|NCT01096589|16657453|P3|Overall Study|found treatment exhausting|0
4830992|NCT01096589|16657454|P2|Overall Study|found treatment exhausting|0
4830993|NCT01096589|16657455|P1|Overall Study|found treatment exhausting|0
4830994|NCT01096589|16657452|P4|Overall Study|Compliance with protocol|0
4830995|NCT01096589|16657453|P3|Overall Study|Compliance with protocol|1
4830996|NCT01096589|16657454|P2|Overall Study|Compliance with protocol|0
4830997|NCT01096589|16657455|P1|Overall Study|Compliance with protocol|0
4830998|NCT01096589|16657452|P4|Overall Study|Withdrawal by Subject|1
4830999|NCT01096589|16657453|P3|Overall Study|Withdrawal by Subject|1
4831000|NCT01096589|16657454|P2|Overall Study|Withdrawal by Subject|1
4831001|NCT01096589|16657455|P1|Overall Study|Withdrawal by Subject|2
4831002|NCT01096589|16657452|P4|Overall Study|Adverse Event|1
4831003|NCT01096589|16657453|P3|Overall Study|Adverse Event|2
4831004|NCT01096589|16657454|P2|Overall Study|Adverse Event|1
4831005|NCT01096589|16657455|P1|Overall Study|Adverse Event|2
4831006|NCT01096550|16657471|P2|Overall Study|Lost to Follow-up|9
4831007|NCT01096550|16657472|P1|Overall Study|Lost to Follow-up|12
4831008|NCT01096550|16657471|P2|Overall Study|non-African American participant|6
4831009|NCT01096550|16657472|P1|Overall Study|non-African American participant|13
4831010|NCT01096550|16657471|P2|Overall Study|Withdrawal by Subject|1
4831011|NCT01096550|16657472|P1|Overall Study|Withdrawal by Subject|0
4831012|NCT01096550|16657471|P2|Overall Study|clinic readmission|1
4831013|NCT01096550|16657472|P1|Overall Study|clinic readmission|1
4831014|NCT01096550|16657471|P2|Overall Study|non-regular treatment track at clinic|1
4831015|NCT01096550|16657472|P1|Overall Study|non-regular treatment track at clinic|1
4831016|NCT01096550|16657471|P2|Overall Study|discontinued site|11
4831017|NCT01096550|16657472|P1|Overall Study|discontinued site|10
4831018|NCT01096446|16657480|P2|Overall Study|Protocol Violation|0
4831019|NCT01096446|16657481|P1|Overall Study|Protocol Violation|2
4831020|NCT01096446|16657480|P2|Overall Study|Death|0
4831021|NCT01096446|16657481|P1|Overall Study|Death|1
4831022|NCT01096342|16657486|P1|Overall Study|Protocol Violation|1
4831023|NCT01096316|16657494|P2|Overall Study|Lost to Follow-up|9
4831024|NCT01096316|16657495|P1|Overall Study|Lost to Follow-up|15
4831025|NCT01096186|16657514|P1|Overall Study|Noncompliance with study drug|1
4831026|NCT01096186|16657514|P1|Overall Study|Physician Decision|1
4831027|NCT01096186|16657514|P1|Overall Study|Withdrawal by Subject|22
4831028|NCT01096186|16657514|P1|Overall Study|Lost to Follow-up|2
4831029|NCT01096186|16657514|P1|Overall Study|Lack of Efficacy|4
4831030|NCT01096186|16657514|P1|Overall Study|Death|4
4831031|NCT01096186|16657514|P1|Overall Study|Adverse Event|16
4831032|NCT01096160|16657530|P10|Overall Study|Met stopping criteria per protocol|0
4831033|NCT01096160|16657531|P9|Overall Study|Met stopping criteria per protocol|2
4831034|NCT01096160|16657532|P8|Overall Study|Met stopping criteria per protocol|0
4831035|NCT01096160|16657533|P7|Overall Study|Met stopping criteria per protocol|2
4831036|NCT01096160|16657534|P6|Overall Study|Met stopping criteria per protocol|0
4831037|NCT01096160|16657535|P5|Overall Study|Met stopping criteria per protocol|1
4831038|NCT01096160|16657536|P4|Overall Study|Met stopping criteria per protocol|0
4831039|NCT01096160|16657537|P3|Overall Study|Met stopping criteria per protocol|0
4831040|NCT01096160|16657538|P2|Overall Study|Met stopping criteria per protocol|0
4831041|NCT01096160|16657539|P1|Overall Study|Met stopping criteria per protocol|0
4831042|NCT01096160|16657530|P10|Overall Study|Adverse Event|1
4831043|NCT01096160|16657531|P9|Overall Study|Adverse Event|0
4831044|NCT01096160|16657532|P8|Overall Study|Adverse Event|0
4831045|NCT01096160|16657533|P7|Overall Study|Adverse Event|0
4831046|NCT01096160|16657534|P6|Overall Study|Adverse Event|0
4831047|NCT01096160|16657535|P5|Overall Study|Adverse Event|0
4831048|NCT01096160|16657536|P4|Overall Study|Adverse Event|0
4831049|NCT01096160|16657537|P3|Overall Study|Adverse Event|1
4831050|NCT01096160|16657538|P2|Overall Study|Adverse Event|0
4831051|NCT01096160|16657539|P1|Overall Study|Adverse Event|0
4831052|NCT01096056|16657597|P2|Overall Study|Lost to Follow-up|1
4831053|NCT01096056|16657598|P1|Overall Study|Lost to Follow-up|0
4831054|NCT01096017|16657630|P2|Treatment Period 2|Eligibility criteria not fulfilled|1
4831143|NCT01094808|16657916|P1|Overall Study|Withdrawal by Subject|1
4831055|NCT01096017|16657631|P1|Treatment Period 2|Eligibility criteria not fulfilled|1
4831056|NCT01095978|16657659|P1|Overall Study|Adverse Event|1
4831057|NCT01095978|16657659|P1|Overall Study|Did not take Klacid SR|2
4831058|NCT01095835|16657693|P3|Overall Study|Protocol Violation|0
4831059|NCT01095835|16657694|P2|Overall Study|Protocol Violation|2
4831060|NCT01095835|16657695|P1|Overall Study|Protocol Violation|1
4831061|NCT01095835|16657693|P3|Overall Study|Non study compliance|1
4831062|NCT01095835|16657694|P2|Overall Study|Non study compliance|0
4831063|NCT01095835|16657695|P1|Overall Study|Non study compliance|0
4831064|NCT01095835|16657693|P3|Overall Study|Withdrawal by Subject|0
4831065|NCT01095835|16657694|P2|Overall Study|Withdrawal by Subject|3
4831066|NCT01095835|16657695|P1|Overall Study|Withdrawal by Subject|1
4831067|NCT01095835|16657693|P3|Overall Study|Physician Decision|1
4831068|NCT01095835|16657694|P2|Overall Study|Physician Decision|0
4831069|NCT01095835|16657695|P1|Overall Study|Physician Decision|0
4831070|NCT01095835|16657693|P3|Overall Study|Lack of Efficacy|0
4831071|NCT01095835|16657694|P2|Overall Study|Lack of Efficacy|1
4831072|NCT01095835|16657695|P1|Overall Study|Lack of Efficacy|0
4831073|NCT01095835|16657693|P3|Overall Study|Adverse Event|6
4831074|NCT01095835|16657694|P2|Overall Study|Adverse Event|6
4831075|NCT01095835|16657695|P1|Overall Study|Adverse Event|8
4831076|NCT01095796|16657733|P2|Overall Study|Participant Transferred to Another Study|200
4831077|NCT01095796|16657734|P1|Overall Study|Participant Transferred to Another Study|215
4831078|NCT01095796|16657733|P2|Overall Study|Protocol Violation|0
4831079|NCT01095796|16657734|P1|Overall Study|Protocol Violation|1
4831080|NCT01095796|16657733|P2|Overall Study|Participant Noncompliance|10
4831081|NCT01095796|16657734|P1|Overall Study|Participant Noncompliance|5
4831082|NCT01095796|16657733|P2|Overall Study|Lost to Follow-up|29
4831083|NCT01095796|16657734|P1|Overall Study|Lost to Follow-up|27
4831084|NCT01095796|16657733|P2|Overall Study|Withdrew Consent|22
4831085|NCT01095796|16657734|P1|Overall Study|Withdrew Consent|16
4831086|NCT01095796|16657733|P2|Overall Study|Investigator's Discretion|2
4831087|NCT01095796|16657734|P1|Overall Study|Investigator's Discretion|7
4831088|NCT01095796|16657733|P2|Overall Study|Lack of Efficacy|3
4831089|NCT01095796|16657734|P1|Overall Study|Lack of Efficacy|5
4831090|NCT01095796|16657733|P2|Overall Study|Pregnancy|0
4831091|NCT01095796|16657734|P1|Overall Study|Pregnancy|2
4831092|NCT01095796|16657733|P2|Overall Study|Death|2
4831093|NCT01095796|16657734|P1|Overall Study|Death|3
4831094|NCT01095796|16657733|P2|Overall Study|Adverse Event|19
4831095|NCT01095796|16657734|P1|Overall Study|Adverse Event|9
4831096|NCT01095796|16657733|P2|Overall Study|Randomized but Not Treated|2
4831097|NCT01095796|16657734|P1|Overall Study|Randomized but Not Treated|5
4831098|NCT01095666|16657764|P3|Overall Study|Non-compliance, not met criteria etc.|2
4831099|NCT01095666|16657765|P2|Overall Study|Non-compliance, not met criteria etc.|2
4831100|NCT01095666|16657766|P1|Overall Study|Non-compliance, not met criteria etc.|7
4831101|NCT01095666|16657764|P3|Overall Study|Withdrawal by Subject|1
4831102|NCT01095666|16657765|P2|Overall Study|Withdrawal by Subject|6
4831103|NCT01095666|16657766|P1|Overall Study|Withdrawal by Subject|6
4831104|NCT01095666|16657764|P3|Overall Study|Lost to Follow-up|0
4831105|NCT01095666|16657765|P2|Overall Study|Lost to Follow-up|2
4831106|NCT01095666|16657766|P1|Overall Study|Lost to Follow-up|2
4831107|NCT01095666|16657764|P3|Overall Study|Adverse Event|3
4831108|NCT01095666|16657765|P2|Overall Study|Adverse Event|1
4831109|NCT01095666|16657766|P1|Overall Study|Adverse Event|2
4831110|NCT01095666|16657764|P3|Overall Study|Lack of Efficacy|1
4831111|NCT01095666|16657765|P2|Overall Study|Lack of Efficacy|0
4831112|NCT01095666|16657766|P1|Overall Study|Lack of Efficacy|0
4831113|NCT01095653|16657789|P3|Overall Study|non-compliance, not met criteria, etc.|5
4831114|NCT01095653|16657790|P2|Overall Study|non-compliance, not met criteria, etc.|6
4831115|NCT01095653|16657791|P1|Overall Study|non-compliance, not met criteria, etc.|10
4831116|NCT01095653|16657789|P3|Overall Study|Withdrawal by Subject|3
4831117|NCT01095653|16657790|P2|Overall Study|Withdrawal by Subject|5
4831118|NCT01095653|16657791|P1|Overall Study|Withdrawal by Subject|4
4831119|NCT01095653|16657789|P3|Overall Study|Lost to Follow-up|4
4831120|NCT01095653|16657790|P2|Overall Study|Lost to Follow-up|0
4831121|NCT01095653|16657791|P1|Overall Study|Lost to Follow-up|1
4831122|NCT01095653|16657789|P3|Overall Study|Adverse Event|4
4831123|NCT01095653|16657790|P2|Overall Study|Adverse Event|4
4831124|NCT01095653|16657791|P1|Overall Study|Adverse Event|1
4831125|NCT01095653|16657789|P3|Overall Study|Lack of Efficacy|0
4831126|NCT01095653|16657790|P2|Overall Study|Lack of Efficacy|0
4831127|NCT01095653|16657791|P1|Overall Study|Lack of Efficacy|3
4831128|NCT01095250|16657849|P4|Overall Study|Withdrawal by Subject|0
4831129|NCT01095250|16657850|P3|Overall Study|Withdrawal by Subject|1
4831130|NCT01095250|16657851|P2|Overall Study|Withdrawal by Subject|0
4831131|NCT01095250|16657852|P1|Overall Study|Withdrawal by Subject|0
4831132|NCT01095250|16657849|P4|Overall Study|administrative reasons|5
4831133|NCT01095250|16657850|P3|Overall Study|administrative reasons|7
4831134|NCT01095250|16657851|P2|Overall Study|administrative reasons|10
4831135|NCT01095250|16657852|P1|Overall Study|administrative reasons|8
4831136|NCT01095094|16657882|P1|Overall Study|Physician Decision|1
4831137|NCT01095094|16657882|P1|Overall Study|Death|1
4831138|NCT01095094|16657882|P1|Overall Study|Withdrawal by Subject|1
4831139|NCT01094886|16657904|P1|Overall Study|Withdrawal by Subject|5
4831140|NCT01094886|16657904|P1|Overall Study|Adverse Event|2
4831141|NCT01094808|16657914|P3|Overall Study|Withdrawal by Subject|0
4831142|NCT01094808|16657915|P2|Overall Study|Withdrawal by Subject|1
4831144|NCT01094782|16657957|P6|Overall Study|Noncompliance With Study Schedule|0
4831145|NCT01094782|16657958|P5|Overall Study|Noncompliance With Study Schedule|0
4831146|NCT01094782|16657959|P4|Overall Study|Noncompliance With Study Schedule|1
4831147|NCT01094782|16657960|P3|Overall Study|Noncompliance With Study Schedule|0
4831148|NCT01094782|16657961|P2|Overall Study|Noncompliance With Study Schedule|0
4831149|NCT01094782|16657962|P1|Overall Study|Noncompliance With Study Schedule|0
4831150|NCT01094782|16657957|P6|Overall Study|Low Visual Analog Scale (VAS) Score|0
4831151|NCT01094782|16657958|P5|Overall Study|Low Visual Analog Scale (VAS) Score|1
4831152|NCT01094782|16657959|P4|Overall Study|Low Visual Analog Scale (VAS) Score|0
4831153|NCT01094782|16657960|P3|Overall Study|Low Visual Analog Scale (VAS) Score|0
4831154|NCT01094782|16657961|P2|Overall Study|Low Visual Analog Scale (VAS) Score|0
4831155|NCT01094782|16657962|P1|Overall Study|Low Visual Analog Scale (VAS) Score|0
4831156|NCT01094782|16657957|P6|Overall Study|Recent Interventional Injection|1
4831157|NCT01094782|16657958|P5|Overall Study|Recent Interventional Injection|0
4831158|NCT01094782|16657959|P4|Overall Study|Recent Interventional Injection|0
4831159|NCT01094782|16657960|P3|Overall Study|Recent Interventional Injection|0
4831160|NCT01094782|16657961|P2|Overall Study|Recent Interventional Injection|0
4831161|NCT01094782|16657962|P1|Overall Study|Recent Interventional Injection|0
4831162|NCT01094782|16657957|P6|Overall Study|Wrong Pain Condition|1
4831163|NCT01094782|16657958|P5|Overall Study|Wrong Pain Condition|1
4831164|NCT01094782|16657959|P4|Overall Study|Wrong Pain Condition|2
4831165|NCT01094782|16657960|P3|Overall Study|Wrong Pain Condition|0
4831166|NCT01094782|16657961|P2|Overall Study|Wrong Pain Condition|0
4831167|NCT01094782|16657962|P1|Overall Study|Wrong Pain Condition|0
4831168|NCT01094782|16657957|P6|Overall Study|Hypertension|0
4831169|NCT01094782|16657958|P5|Overall Study|Hypertension|0
4831170|NCT01094782|16657959|P4|Overall Study|Hypertension|0
4831171|NCT01094782|16657960|P3|Overall Study|Hypertension|1
4831172|NCT01094782|16657961|P2|Overall Study|Hypertension|0
4831173|NCT01094782|16657962|P1|Overall Study|Hypertension|0
4831174|NCT01094782|16657957|P6|Overall Study|Healthy Subject Had Pain|0
4831175|NCT01094782|16657958|P5|Overall Study|Healthy Subject Had Pain|0
4831176|NCT01094782|16657959|P4|Overall Study|Healthy Subject Had Pain|0
4831177|NCT01094782|16657960|P3|Overall Study|Healthy Subject Had Pain|0
4831178|NCT01094782|16657961|P2|Overall Study|Healthy Subject Had Pain|1
4831179|NCT01094782|16657962|P1|Overall Study|Healthy Subject Had Pain|0
4831180|NCT01094782|16657957|P6|Overall Study|Unable to Complete Questionnaires|0
4831181|NCT01094782|16657958|P5|Overall Study|Unable to Complete Questionnaires|0
4831182|NCT01094782|16657959|P4|Overall Study|Unable to Complete Questionnaires|0
4831183|NCT01094782|16657960|P3|Overall Study|Unable to Complete Questionnaires|0
4831184|NCT01094782|16657961|P2|Overall Study|Unable to Complete Questionnaires|1
4831185|NCT01094782|16657962|P1|Overall Study|Unable to Complete Questionnaires|0
4831186|NCT01094782|16657957|P6|Overall Study|Sensory Deficit at Site of QST|0
4831187|NCT01094782|16657958|P5|Overall Study|Sensory Deficit at Site of QST|0
4831188|NCT01094782|16657959|P4|Overall Study|Sensory Deficit at Site of QST|0
4831189|NCT01094782|16657960|P3|Overall Study|Sensory Deficit at Site of QST|0
4831190|NCT01094782|16657961|P2|Overall Study|Sensory Deficit at Site of QST|1
4831191|NCT01094782|16657962|P1|Overall Study|Sensory Deficit at Site of QST|0
4831192|NCT01094782|16657957|P6|Overall Study|Positive Drug Screen|2
4831193|NCT01094782|16657958|P5|Overall Study|Positive Drug Screen|3
4831194|NCT01094782|16657959|P4|Overall Study|Positive Drug Screen|1
4831195|NCT01094782|16657960|P3|Overall Study|Positive Drug Screen|1
4831196|NCT01094782|16657961|P2|Overall Study|Positive Drug Screen|2
4831197|NCT01094782|16657962|P1|Overall Study|Positive Drug Screen|2
4831198|NCT01094782|16657957|P6|Overall Study|Lost to Follow-up|4
4831199|NCT01094782|16657958|P5|Overall Study|Lost to Follow-up|1
4831200|NCT01094782|16657959|P4|Overall Study|Lost to Follow-up|2
4831201|NCT01094782|16657960|P3|Overall Study|Lost to Follow-up|0
4831202|NCT01094782|16657961|P2|Overall Study|Lost to Follow-up|0
4831203|NCT01094782|16657962|P1|Overall Study|Lost to Follow-up|1
4831204|NCT01094782|16657957|P6|Overall Study|Withdrawal by Subject|0
4831205|NCT01094782|16657958|P5|Overall Study|Withdrawal by Subject|5
4831206|NCT01094782|16657959|P4|Overall Study|Withdrawal by Subject|5
4831207|NCT01094782|16657960|P3|Overall Study|Withdrawal by Subject|1
4831208|NCT01094782|16657961|P2|Overall Study|Withdrawal by Subject|5
4831209|NCT01094782|16657962|P1|Overall Study|Withdrawal by Subject|5
4831210|NCT01094743|16658006|P1|Period 1|Unsatisfactory comfort at lens fitting|2
4831211|NCT01094730|16658023|P2|Period 2 (14 Days)|Unsatisfactory lens fitting|1
4831212|NCT01094730|16658024|P1|Period 2 (14 Days)|Unsatisfactory lens fitting|0
4831213|NCT01094730|16658023|P2|Period 2 (14 Days)|Adverse Event|1
4831214|NCT01094730|16658024|P1|Period 2 (14 Days)|Adverse Event|0
4831215|NCT01094730|16658023|P2|Period 2 (14 Days)|No time for the follow-up visit|0
4831216|NCT01094730|16658024|P1|Period 2 (14 Days)|No time for the follow-up visit|1
4831217|NCT01094730|16658023|P2|Period 2 (14 Days)|Protocol Violation|0
4831218|NCT01094730|16658024|P1|Period 2 (14 Days)|Protocol Violation|2
4831219|NCT01094730|16658023|P2|Period 1 (14 Days)|Unsatisfactory visual response|0
4831220|NCT01094730|16658024|P1|Period 1 (14 Days)|Unsatisfactory visual response|1
4831221|NCT01094730|16658023|P2|Period 1 (14 Days)|No time for the follow-up visit|0
4831222|NCT01094730|16658024|P1|Period 1 (14 Days)|No time for the follow-up visit|1
4831223|NCT01094730|16658023|P2|Period 1 (14 Days)|Withdrawal by Subject|1
4831224|NCT01094730|16658024|P1|Period 1 (14 Days)|Withdrawal by Subject|0
4831225|NCT01094730|16658023|P2|Period 1 (14 Days)|Lost to Follow-up|1
4831226|NCT01094730|16658024|P1|Period 1 (14 Days)|Lost to Follow-up|0
4831227|NCT01094301|16658160|P1|Implant Stage|No return of pain|4
4831228|NCT01094301|16658160|P1|Implant Stage|Withdrawal by Subject|2
4831229|NCT01094301|16658160|P1|Implant Stage|Protocol Violation|1
4831230|NCT01094301|16658160|P1|Implant Stage|Adverse Event|1
4831231|NCT01094301|16658160|P1|Trial Stage|Withdrawal by Subject|1
4831232|NCT01094288|16658190|P8|Overall Study|Ongoing Participants|0
4831233|NCT01094288|16658191|P7|Overall Study|Ongoing Participants|0
4831234|NCT01094288|16658192|P6|Overall Study|Ongoing Participants|0
4831235|NCT01094288|16658193|P5|Overall Study|Ongoing Participants|0
4831236|NCT01094288|16658194|P4|Overall Study|Ongoing Participants|0
4831237|NCT01094288|16658195|P3|Overall Study|Ongoing Participants|0
4831238|NCT01094288|16658196|P2|Overall Study|Ongoing Participants|3
4831239|NCT01094288|16658197|P1|Overall Study|Ongoing Participants|0
4831240|NCT01094288|16658190|P8|Overall Study|Reason not Specified|0
4831241|NCT01094288|16658191|P7|Overall Study|Reason not Specified|0
4831242|NCT01094288|16658192|P6|Overall Study|Reason not Specified|0
4831243|NCT01094288|16658193|P5|Overall Study|Reason not Specified|0
4831244|NCT01094288|16658194|P4|Overall Study|Reason not Specified|1
4831245|NCT01094288|16658195|P3|Overall Study|Reason not Specified|0
4831246|NCT01094288|16658196|P2|Overall Study|Reason not Specified|3
4831247|NCT01094288|16658197|P1|Overall Study|Reason not Specified|2
4831248|NCT01094288|16658190|P8|Overall Study|Initiation of Alternative Therapy|0
4831249|NCT01094288|16658191|P7|Overall Study|Initiation of Alternative Therapy|0
4831250|NCT01094288|16658192|P6|Overall Study|Initiation of Alternative Therapy|0
4831251|NCT01094288|16658193|P5|Overall Study|Initiation of Alternative Therapy|0
4831252|NCT01094288|16658194|P4|Overall Study|Initiation of Alternative Therapy|0
4831253|NCT01094288|16658195|P3|Overall Study|Initiation of Alternative Therapy|1
4831254|NCT01094288|16658196|P2|Overall Study|Initiation of Alternative Therapy|0
4831255|NCT01094288|16658197|P1|Overall Study|Initiation of Alternative Therapy|0
4831256|NCT01094288|16658190|P8|Overall Study|Withdrawal by Subject|2
4831257|NCT01094288|16658191|P7|Overall Study|Withdrawal by Subject|0
4831258|NCT01094288|16658192|P6|Overall Study|Withdrawal by Subject|0
4831259|NCT01094288|16658193|P5|Overall Study|Withdrawal by Subject|0
4831260|NCT01094288|16658194|P4|Overall Study|Withdrawal by Subject|0
4831261|NCT01094288|16658195|P3|Overall Study|Withdrawal by Subject|2
4831262|NCT01094288|16658196|P2|Overall Study|Withdrawal by Subject|1
4831263|NCT01094288|16658197|P1|Overall Study|Withdrawal by Subject|0
4831264|NCT01094288|16658190|P8|Overall Study|Adverse Event|0
4831265|NCT01094288|16658191|P7|Overall Study|Adverse Event|0
4831266|NCT01094288|16658192|P6|Overall Study|Adverse Event|0
4831267|NCT01094288|16658193|P5|Overall Study|Adverse Event|0
4831268|NCT01094288|16658194|P4|Overall Study|Adverse Event|1
4831269|NCT01094288|16658195|P3|Overall Study|Adverse Event|1
4831270|NCT01094288|16658196|P2|Overall Study|Adverse Event|3
4831271|NCT01094288|16658197|P1|Overall Study|Adverse Event|0
4831272|NCT01094184|16658309|P2|Overall Study|Death|11
4831273|NCT01094184|16658310|P1|Overall Study|Death|35
4831274|NCT01094171|16658544|P1|Overall Study|Other|1
4831275|NCT01094171|16658544|P1|Overall Study|Migration from the study area|3
4831276|NCT01094171|16658544|P1|Overall Study|Informed consent withdrawal|4
4831277|NCT01094171|16658544|P1|Overall Study|Lost to Follow-up|2
4831278|NCT01094119|16658553|P2|Overall Study|Lack of Efficacy|4
4831279|NCT01094119|16658554|P1|Overall Study|Lack of Efficacy|2
4831280|NCT01093885|16658579|P1|Overall Study|Lost to Follow-up|1
4831281|NCT01093885|16658579|P1|Overall Study|Adverse Event|4
4831282|NCT01093846|16658587|P3|Overall Study|Administrative Problems|15
4831283|NCT01093846|16658588|P2|Overall Study|Administrative Problems|17
4831284|NCT01093846|16658589|P1|Overall Study|Administrative Problems|18
4831285|NCT01093846|16658587|P3|Overall Study|Condition no longer required study drug|1
4831286|NCT01093846|16658588|P2|Overall Study|Condition no longer required study drug|1
4831287|NCT01093846|16658589|P1|Overall Study|Condition no longer required study drug|1
4831288|NCT01093846|16658587|P3|Overall Study|Lack of Efficacy|4
4831289|NCT01093846|16658588|P2|Overall Study|Lack of Efficacy|0
4831290|NCT01093846|16658589|P1|Overall Study|Lack of Efficacy|0
4831291|NCT01093846|16658587|P3|Overall Study|Adverse Event|1
4831292|NCT01093846|16658588|P2|Overall Study|Adverse Event|0
4831293|NCT01093846|16658589|P1|Overall Study|Adverse Event|0
4831294|NCT01093755|16658614|P2|Overall Study|Withdrawal by Subject|4
4831295|NCT01093755|16658615|P1|Overall Study|Withdrawal by Subject|3
4831296|NCT01093625|16658655|P2|1-Year Visit|Lost to Follow-up|3
4831297|NCT01093625|16658656|P1|1-Year Visit|Lost to Follow-up|5
4831298|NCT01093625|16658655|P2|6-Month Visit|Lost to Follow-up|2
4831299|NCT01093625|16658656|P1|6-Month Visit|Lost to Follow-up|2
4831300|NCT01093625|16658655|P2|6-Month Visit|Withdrawal by Subject|7
4831301|NCT01093625|16658656|P1|6-Month Visit|Withdrawal by Subject|6
4831302|NCT01093625|16658655|P2|3-Month Visit|Lost to Follow-up|0
4831303|NCT01093625|16658656|P1|3-Month Visit|Lost to Follow-up|2
4831304|NCT01093625|16658655|P2|1-Month Visit|Lost to Follow-up|0
4831305|NCT01093625|16658656|P1|1-Month Visit|Lost to Follow-up|2
4831306|NCT01093625|16658655|P2|2-Week Visit|Withdrawal by Subject|0
4831307|NCT01093625|16658656|P1|2-Week Visit|Withdrawal by Subject|1
4831308|NCT01093625|16658655|P2|Baseline and Dispensed|Withdrawal by Subject|0
4831309|NCT01093625|16658656|P1|Baseline and Dispensed|Withdrawal by Subject|2
4831310|NCT01093599|16658676|P2|Overall Study|Lost to Follow-up|46
4831311|NCT01093599|16658677|P1|Overall Study|Lost to Follow-up|32
4831312|NCT01093586|16658683|P1|Overall Study|Failed to engraft|3
4831313|NCT01093573|16658704|P3|Overall Study|Insurance Denied|1
4831314|NCT01093573|16658705|P2|Overall Study|Insurance Denied|0
4831315|NCT01093573|16658706|P1|Overall Study|Insurance Denied|0
4831316|NCT01093573|16658704|P3|Overall Study|Physician Decision|1
4831317|NCT01093573|16658705|P2|Overall Study|Physician Decision|0
4831318|NCT01093573|16658706|P1|Overall Study|Physician Decision|0
4831319|NCT01093534|16658723|P3|Overall Study|Other|4
4831320|NCT01093534|16658724|P2|Overall Study|Other|3
4831321|NCT01093534|16658725|P1|Overall Study|Other|1
4831322|NCT01093534|16658723|P3|Overall Study|Withdrawal by Subject|2
4831323|NCT01093534|16658724|P2|Overall Study|Withdrawal by Subject|7
4831324|NCT01093534|16658725|P1|Overall Study|Withdrawal by Subject|5
4831325|NCT01093534|16658723|P3|Overall Study|Lack of Efficacy|1
4831326|NCT01093534|16658724|P2|Overall Study|Lack of Efficacy|1
4831327|NCT01093534|16658725|P1|Overall Study|Lack of Efficacy|2
4831328|NCT01093534|16658723|P3|Overall Study|Adverse Event|2
4831329|NCT01093534|16658724|P2|Overall Study|Adverse Event|5
4831330|NCT01093534|16658725|P1|Overall Study|Adverse Event|2
4831331|NCT01093222|16658873|P1|Overall Study|Not protocol specified|1
4831332|NCT01093222|16658873|P1|Overall Study|Death|2
4831333|NCT01093222|16658873|P1|Overall Study|Progression/relapse|24
4831334|NCT01093222|16658873|P1|Overall Study|Adverse Event|7
4831335|NCT01093222|16658873|P1|Overall Study|Ineligible|6
4831336|NCT01092832|16658949|P2|Overall Study|Other|0
4831337|NCT01092832|16658950|P1|Overall Study|Other|1
4831338|NCT01092780|16658962|P4|Washout Period 2|Adverse Event|0
4831339|NCT01092780|16658963|P3|Washout Period 2|Adverse Event|1
4831340|NCT01092780|16658964|P2|Washout Period 2|Adverse Event|1
4831341|NCT01092780|16658965|P1|Washout Period 2|Adverse Event|0
4831342|NCT01092780|16658962|P4|Washout Period 1|Noncompliance with nCPAP|0
4831343|NCT01092780|16658963|P3|Washout Period 1|Noncompliance with nCPAP|0
4831344|NCT01092780|16658964|P2|Washout Period 1|Noncompliance with nCPAP|0
4831345|NCT01092780|16658965|P1|Washout Period 1|Noncompliance with nCPAP|1
4831346|NCT01092780|16658962|P4|Washout Period 1|Adverse Event|0
4831347|NCT01092780|16658963|P3|Washout Period 1|Adverse Event|0
4831348|NCT01092780|16658964|P2|Washout Period 1|Adverse Event|1
4831349|NCT01092780|16658965|P1|Washout Period 1|Adverse Event|0
4831350|NCT01092728|16659001|P2|Overall Study|Prohibited Concomitant Medications|0
4831351|NCT01092728|16659002|P1|Overall Study|Prohibited Concomitant Medications|1
4831352|NCT01092728|16659001|P2|Overall Study|Disease Progression|13
4831353|NCT01092728|16659002|P1|Overall Study|Disease Progression|1
4831354|NCT01092728|16659001|P2|Overall Study|Adverse Event|1
4831355|NCT01092728|16659002|P1|Overall Study|Adverse Event|0
4831356|NCT01092728|16659001|P2|Overall Study|Withdrawal by Subject|0
4831357|NCT01092728|16659002|P1|Overall Study|Withdrawal by Subject|2
4831358|NCT01092702|16659010|P1|Overall Study|Lost to Follow-up|2
4831359|NCT01092702|16659010|P1|Overall Study|Withdrawal by Subject|7
4831360|NCT01092663|16659027|P2|Overall Study|Protocol Violation|1
4831361|NCT01092663|16659028|P1|Overall Study|Protocol Violation|0
4831362|NCT01092663|16659027|P2|Overall Study|Adverse Event|1
4831363|NCT01092663|16659028|P1|Overall Study|Adverse Event|1
4831364|NCT01092663|16659027|P2|Overall Study|High fasting triglyceride|0
4831365|NCT01092663|16659028|P1|Overall Study|High fasting triglyceride|2
4831366|NCT01092663|16659027|P2|Overall Study|Glucose >300mg/dL|0
4831367|NCT01092663|16659028|P1|Overall Study|Glucose >300mg/dL|1
4831368|NCT01092663|16659027|P2|Overall Study|Withdrawal by Subject|2
4831369|NCT01092663|16659028|P1|Overall Study|Withdrawal by Subject|3
4831370|NCT01092637|16659076|P2|Overall Study|Death|49
4831371|NCT01092637|16659077|P1|Overall Study|Death|47
4831372|NCT01092546|16659092|P1|Overall Study|Subjects withdrawn prior to dosing|4
4831373|NCT01092507|16659099|P2|Overall Study|Withdrawal by Subject|0
4831374|NCT01092507|16659100|P1|Overall Study|Withdrawal by Subject|2
4831375|NCT01092416|16659135|P1|12-Month Follow-up|Data collected after close of 1Y window|2
4831376|NCT01092416|16659135|P1|12-Month Follow-up|Missed 1-year follow-up|1
4831377|NCT01092416|16659135|P1|12-Month Follow-up|Withdrawal by Subject|2
4831378|NCT01092416|16659135|P1|12-Month Follow-up|Lost to Follow-up|4
4831379|NCT01092416|16659135|P1|12-Month Follow-up|Death|16
4831380|NCT01092416|16659135|P1|30-Day Follow-up|Data collected after close of 30D window|5
4831381|NCT01092416|16659135|P1|30-Day Follow-up|Missed 30-day follow-up|3
4831382|NCT01092416|16659135|P1|30-Day Follow-up|Death|2
4831383|NCT01092416|16659135|P1|Enrollment|Atherectomy device not inserted|3
4831384|NCT01091974|16659185|P4|Overall Study|side-effects|2
4831385|NCT01091974|16659186|P3|Overall Study|side-effects|0
4831386|NCT01091974|16659187|P2|Overall Study|side-effects|1
4831387|NCT01091974|16659188|P1|Overall Study|side-effects|1
4831388|NCT01091974|16659185|P4|Overall Study|Withdrawal by Subject|2
4831389|NCT01091974|16659186|P3|Overall Study|Withdrawal by Subject|2
4831390|NCT01091974|16659187|P2|Overall Study|Withdrawal by Subject|3
4831391|NCT01091974|16659188|P1|Overall Study|Withdrawal by Subject|1
4831392|NCT01091974|16659185|P4|Overall Study|resumed sleep medication|2
4831393|NCT01091974|16659186|P3|Overall Study|resumed sleep medication|1
4831394|NCT01091974|16659187|P2|Overall Study|resumed sleep medication|0
4831395|NCT01091974|16659188|P1|Overall Study|resumed sleep medication|0
4831396|NCT01091974|16659185|P4|Overall Study|Did not start intervention|1
4831397|NCT01091974|16659186|P3|Overall Study|Did not start intervention|3
4831398|NCT01091974|16659187|P2|Overall Study|Did not start intervention|1
4831399|NCT01091974|16659188|P1|Overall Study|Did not start intervention|3
4831400|NCT01091675|16659223|P1|Overall Study|Lack of Efficacy|27
4831401|NCT01091675|16659223|P1|Overall Study|Adverse Event|7
4831402|NCT01091662|16659229|P2|Overall Study|unable to swallow capsule|1
4831403|NCT01091662|16659230|P1|Overall Study|unable to swallow capsule|0
4831404|NCT01091662|16659229|P2|Overall Study|Protocol Violation|2
4831405|NCT01091662|16659230|P1|Overall Study|Protocol Violation|0
4831406|NCT01091662|16659229|P2|Overall Study|Pregnancy|1
4831407|NCT01091662|16659230|P1|Overall Study|Pregnancy|0
4831408|NCT01091662|16659229|P2|Overall Study|Lost to Follow-up|1
4831409|NCT01091662|16659230|P1|Overall Study|Lost to Follow-up|0
4831410|NCT01091662|16659229|P2|Overall Study|met exclusion criteria|0
4831411|NCT01091662|16659230|P1|Overall Study|met exclusion criteria|1
4831412|NCT01091662|16659229|P2|Overall Study|met exit criteria|13
4831413|NCT01091662|16659230|P1|Overall Study|met exit criteria|7
4831414|NCT01091662|16659229|P2|Overall Study|Withdrawal by Subject|6
4831415|NCT01091662|16659230|P1|Overall Study|Withdrawal by Subject|7
4831416|NCT01091662|16659229|P2|Overall Study|Physician Decision|1
4831417|NCT01091662|16659230|P1|Overall Study|Physician Decision|1
4831418|NCT01091662|16659229|P2|Overall Study|Adverse Event|9
4831419|NCT01091662|16659230|P1|Overall Study|Adverse Event|1
4831420|NCT01091519|16659268|P2|Overall Study|Randomized not treated|4
4831421|NCT01091519|16659269|P1|Overall Study|Randomized not treated|4
4831422|NCT01091519|16659268|P2|Overall Study|Other|8
4831423|NCT01091519|16659269|P1|Overall Study|Other|6
4831424|NCT01091519|16659268|P2|Overall Study|Withdrawal by Subject|2
4831425|NCT01091519|16659269|P1|Overall Study|Withdrawal by Subject|2
4831426|NCT01091519|16659268|P2|Overall Study|Lost to Follow-up|24
4831427|NCT01091519|16659269|P1|Overall Study|Lost to Follow-up|14
4831428|NCT01091519|16659268|P2|Overall Study|Lack of Efficacy|19
4831429|NCT01091519|16659269|P1|Overall Study|Lack of Efficacy|16
4831430|NCT01091519|16659268|P2|Overall Study|Death|0
4831431|NCT01091519|16659269|P1|Overall Study|Death|1
4831432|NCT01091519|16659268|P2|Overall Study|Adverse Event|16
4831433|NCT01091519|16659269|P1|Overall Study|Adverse Event|12
4831434|NCT01091454|16659281|P1|Overall Study|Ineligible|1
4831435|NCT01091428|16659294|P4|Phase 2|Physician Decision|0
4831436|NCT01091428|16659295|P3|Phase 2|Physician Decision|2
4831437|NCT01091428|16659296|P2|Phase 2|Physician Decision|0
4831438|NCT01091428|16659297|P1|Phase 2|Physician Decision|0
4831439|NCT01091428|16659294|P4|Phase 2|Reason not specified|3
4831440|NCT01091428|16659295|P3|Phase 2|Reason not specified|4
4831441|NCT01091428|16659296|P2|Phase 2|Reason not specified|0
4831442|NCT01091428|16659297|P1|Phase 2|Reason not specified|0
4831443|NCT01091428|16659294|P4|Phase 2|Unsatisfactory Therapeutic Response|1
4831444|NCT01091428|16659295|P3|Phase 2|Unsatisfactory Therapeutic Response|1
4831445|NCT01091428|16659296|P2|Phase 2|Unsatisfactory Therapeutic Response|0
4831446|NCT01091428|16659297|P1|Phase 2|Unsatisfactory Therapeutic Response|0
4831447|NCT01091428|16659294|P4|Phase 2|Withdrawal by Subject|8
4831448|NCT01091428|16659295|P3|Phase 2|Withdrawal by Subject|9
4831449|NCT01091428|16659296|P2|Phase 2|Withdrawal by Subject|0
4831450|NCT01091428|16659297|P1|Phase 2|Withdrawal by Subject|0
4831451|NCT01091428|16659294|P4|Phase 2|Adverse Event|5
4831452|NCT01091428|16659295|P3|Phase 2|Adverse Event|12
4831453|NCT01091428|16659296|P2|Phase 2|Adverse Event|0
4831454|NCT01091428|16659297|P1|Phase 2|Adverse Event|0
4831455|NCT01091428|16659294|P4|Phase 2|Symptomatic Deterioration|6
4831456|NCT01091428|16659295|P3|Phase 2|Symptomatic Deterioration|1
4831457|NCT01091428|16659296|P2|Phase 2|Symptomatic Deterioration|0
4831458|NCT01091428|16659297|P1|Phase 2|Symptomatic Deterioration|0
4831459|NCT01091428|16659294|P4|Phase 2|Progressive Disease|46
4831460|NCT01091428|16659295|P3|Phase 2|Progressive Disease|44
4831461|NCT01091428|16659296|P2|Phase 2|Progressive Disease|0
4831462|NCT01091428|16659297|P1|Phase 2|Progressive Disease|0
4831463|NCT01091428|16659294|P4|Phase 1|Single-Patient IND|0
4831464|NCT01091428|16659295|P3|Phase 1|Single-Patient IND|0
4831465|NCT01091428|16659296|P2|Phase 1|Single-Patient IND|0
4831466|NCT01091428|16659297|P1|Phase 1|Single-Patient IND|2
4831467|NCT01091428|16659294|P4|Phase 1|Reason not specified|0
4831468|NCT01091428|16659295|P3|Phase 1|Reason not specified|0
4831469|NCT01091428|16659296|P2|Phase 1|Reason not specified|1
4831470|NCT01091428|16659297|P1|Phase 1|Reason not specified|0
4831471|NCT01091428|16659294|P4|Phase 1|Withdrawal by Subject|0
4831472|NCT01091428|16659295|P3|Phase 1|Withdrawal by Subject|0
4831473|NCT01091428|16659296|P2|Phase 1|Withdrawal by Subject|0
4831474|NCT01091428|16659297|P1|Phase 1|Withdrawal by Subject|7
4831475|NCT01091428|16659294|P4|Phase 1|Adverse Event|0
4831476|NCT01091428|16659295|P3|Phase 1|Adverse Event|0
4831477|NCT01091428|16659296|P2|Phase 1|Adverse Event|0
4831478|NCT01091428|16659297|P1|Phase 1|Adverse Event|2
4831479|NCT01091428|16659294|P4|Phase 1|Symptomatic Deterioration|0
4831480|NCT01091428|16659295|P3|Phase 1|Symptomatic Deterioration|0
4831481|NCT01091428|16659296|P2|Phase 1|Symptomatic Deterioration|2
4831482|NCT01091428|16659297|P1|Phase 1|Symptomatic Deterioration|3
4831483|NCT01091428|16659294|P4|Phase 1|Progressive Disease|0
4831484|NCT01091428|16659295|P3|Phase 1|Progressive Disease|0
4831485|NCT01091428|16659296|P2|Phase 1|Progressive Disease|8
4831486|NCT01091428|16659297|P1|Phase 1|Progressive Disease|24
4831487|NCT01091363|16659400|P2|Overall Study|Lost to Follow-up|2
4831488|NCT01091363|16659401|P1|Overall Study|Lost to Follow-up|2
4831489|NCT01091363|16659400|P2|Overall Study|Withdrawal by Subject|15
4831490|NCT01091363|16659401|P1|Overall Study|Withdrawal by Subject|11
4831491|NCT01091259|16659411|P1|Overall Study|Lack of Efficacy|2
4831492|NCT01091259|16659411|P1|Overall Study|Adverse Event|3
4831493|NCT01091246|16659422|P3|Overall Study|Subject not dosed|1
4831494|NCT01091246|16659423|P2|Overall Study|Subject not dosed|0
4831495|NCT01091246|16659424|P1|Overall Study|Subject not dosed|2
4831496|NCT01091246|16659422|P3|Overall Study|Withdrawal by Subject|4
4831497|NCT01091246|16659423|P2|Overall Study|Withdrawal by Subject|5
4831498|NCT01091246|16659424|P1|Overall Study|Withdrawal by Subject|9
4831499|NCT01091246|16659422|P3|Overall Study|Adverse Event|1
4831500|NCT01091246|16659423|P2|Overall Study|Adverse Event|0
4831501|NCT01091246|16659424|P1|Overall Study|Adverse Event|1
4831502|NCT01091246|16659422|P3|Overall Study|Lost to Follow-up|7
4831503|NCT01091246|16659423|P2|Overall Study|Lost to Follow-up|11
4831504|NCT01091246|16659424|P1|Overall Study|Lost to Follow-up|23
4831505|NCT01091168|16659500|P2|Overall Study|Physician, patient's decision, other|37
4831506|NCT01091168|16659501|P1|Overall Study|Physician, patient's decision, other|27
4831507|NCT01091168|16659500|P2|Overall Study|Lost to Follow-up|1
4831508|NCT01091168|16659501|P1|Overall Study|Lost to Follow-up|0
4831509|NCT01091168|16659500|P2|Overall Study|Adverse Event|24
4831510|NCT01091168|16659501|P1|Overall Study|Adverse Event|21
4831511|NCT01091168|16659500|P2|Overall Study|Progressive disease|234
4831512|NCT01091168|16659501|P1|Overall Study|Progressive disease|250
4831513|NCT01091103|16659576|P1|Overall Study|Progressive Disease|3
4831514|NCT01091103|16659576|P1|Overall Study|Adverse Event|1
4831515|NCT01090973|16659596|P1|Overall Study|Disease progression|1
4831516|NCT01090765|16659617|P6|Overall Study|Vasovagal reaction with first infusion|0
4831517|NCT01090765|16659618|P5|Overall Study|Vasovagal reaction with first infusion|1
4831518|NCT01090765|16659619|P4|Overall Study|Vasovagal reaction with first infusion|0
4831519|NCT01090765|16659620|P3|Overall Study|Vasovagal reaction with first infusion|0
4831520|NCT01090765|16659621|P2|Overall Study|Vasovagal reaction with first infusion|0
4831521|NCT01090765|16659622|P1|Overall Study|Vasovagal reaction with first infusion|0
4831522|NCT01090765|16659617|P6|Overall Study|Developed a DVT, needed anticoagulation|0
4831523|NCT01090765|16659618|P5|Overall Study|Developed a DVT, needed anticoagulation|0
4831524|NCT01090765|16659619|P4|Overall Study|Developed a DVT, needed anticoagulation|1
4831525|NCT01090765|16659620|P3|Overall Study|Developed a DVT, needed anticoagulation|0
4831526|NCT01090765|16659621|P2|Overall Study|Developed a DVT, needed anticoagulation|0
4831527|NCT01090765|16659622|P1|Overall Study|Developed a DVT, needed anticoagulation|0
4831528|NCT01090765|16659617|P6|Overall Study|Patient withdrew consent|1
4831529|NCT01090765|16659618|P5|Overall Study|Patient withdrew consent|1
4831530|NCT01090765|16659619|P4|Overall Study|Patient withdrew consent|0
4831531|NCT01090765|16659620|P3|Overall Study|Patient withdrew consent|0
4831532|NCT01090765|16659621|P2|Overall Study|Patient withdrew consent|0
4831533|NCT01090765|16659622|P1|Overall Study|Patient withdrew consent|0
4831534|NCT01090739|16659668|P1|36 Month Follow-up|Visit still pending|17
4831535|NCT01090739|16659668|P1|36 Month Follow-up|Withdrawal by Subject|6
4831536|NCT01090739|16659668|P1|24 Month Follow-up|Death|1
4831537|NCT01090739|16659668|P1|24 Month Follow-up|Lost to Follow-up|1
4831538|NCT01090739|16659668|P1|24 Month Follow-up|Withdrawal by Subject|7
4831539|NCT01090739|16659668|P1|12 Month Follow-up|Death|1
4831540|NCT01090739|16659668|P1|12 Month Follow-up|Physician Decision|1
4831541|NCT01090739|16659668|P1|12 Month Follow-up|Lost to Follow-up|1
4831542|NCT01090739|16659668|P1|12 Month Follow-up|Withdrawal by Subject|2
4831543|NCT01090739|16659668|P1|Enrollment|Adverse Event|1
4831544|NCT01090739|16659668|P1|Enrollment|Study implant limit reached|2
4831545|NCT01090739|16659668|P1|Enrollment|Sponsor termination of site|4
4831546|NCT01090739|16659668|P1|Enrollment|Physician Decision|5
4831547|NCT01090739|16659668|P1|Enrollment|Lost to Follow-up|5
4831548|NCT01090739|16659668|P1|Enrollment|Protocol Violation|14
4831549|NCT01090739|16659668|P1|Enrollment|Withdrawal by Subject|24
4831550|NCT01090492|16659693|P8|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831551|NCT01090492|16659694|P7|Second Intervention Period (4 Weeks)|Lost to Follow-up|1
4831552|NCT01090492|16659695|P6|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831553|NCT01090492|16659696|P5|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831554|NCT01090492|16659697|P4|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831555|NCT01090492|16659698|P3|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831556|NCT01090492|16659699|P2|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831557|NCT01090492|16659700|P1|Second Intervention Period (4 Weeks)|Lost to Follow-up|0
4831558|NCT01090492|16659693|P8|Second Intervention Period (4 Weeks)|Adverse Event|1
4831559|NCT01090492|16659694|P7|Second Intervention Period (4 Weeks)|Adverse Event|7
4831560|NCT01090492|16659695|P6|Second Intervention Period (4 Weeks)|Adverse Event|1
4831561|NCT01090492|16659696|P5|Second Intervention Period (4 Weeks)|Adverse Event|1
4831562|NCT01090492|16659697|P4|Second Intervention Period (4 Weeks)|Adverse Event|0
4831563|NCT01090492|16659698|P3|Second Intervention Period (4 Weeks)|Adverse Event|1
4831564|NCT01090492|16659699|P2|Second Intervention Period (4 Weeks)|Adverse Event|0
4831565|NCT01090492|16659700|P1|Second Intervention Period (4 Weeks)|Adverse Event|0
4831566|NCT01090492|16659693|P8|Second Intervention Period (4 Weeks)|Other|0
4831567|NCT01090492|16659694|P7|Second Intervention Period (4 Weeks)|Other|0
4831568|NCT01090492|16659695|P6|Second Intervention Period (4 Weeks)|Other|0
4831569|NCT01090492|16659696|P5|Second Intervention Period (4 Weeks)|Other|0
4831570|NCT01090492|16659697|P4|Second Intervention Period (4 Weeks)|Other|0
4831571|NCT01090492|16659698|P3|Second Intervention Period (4 Weeks)|Other|1
4831572|NCT01090492|16659699|P2|Second Intervention Period (4 Weeks)|Other|1
4831573|NCT01090492|16659700|P1|Second Intervention Period (4 Weeks)|Other|0
4831574|NCT01090492|16659693|P8|Second Intervention Period (4 Weeks)|Non-compliance|0
4831575|NCT01090492|16659694|P7|Second Intervention Period (4 Weeks)|Non-compliance|0
4831576|NCT01090492|16659695|P6|Second Intervention Period (4 Weeks)|Non-compliance|0
4831577|NCT01090492|16659696|P5|Second Intervention Period (4 Weeks)|Non-compliance|0
4831578|NCT01090492|16659697|P4|Second Intervention Period (4 Weeks)|Non-compliance|0
4831579|NCT01090492|16659698|P3|Second Intervention Period (4 Weeks)|Non-compliance|0
4831580|NCT01090492|16659699|P2|Second Intervention Period (4 Weeks)|Non-compliance|1
4831581|NCT01090492|16659700|P1|Second Intervention Period (4 Weeks)|Non-compliance|0
4831582|NCT01090492|16659693|P8|Second Intervention Period (4 Weeks)|Protocol Violation|1
4831583|NCT01090492|16659694|P7|Second Intervention Period (4 Weeks)|Protocol Violation|1
4831584|NCT01090492|16659695|P6|Second Intervention Period (4 Weeks)|Protocol Violation|0
4831585|NCT01090492|16659696|P5|Second Intervention Period (4 Weeks)|Protocol Violation|1
4831586|NCT01090492|16659697|P4|Second Intervention Period (4 Weeks)|Protocol Violation|0
4831587|NCT01090492|16659698|P3|Second Intervention Period (4 Weeks)|Protocol Violation|0
4831588|NCT01090492|16659699|P2|Second Intervention Period (4 Weeks)|Protocol Violation|0
4831589|NCT01090492|16659700|P1|Second Intervention Period (4 Weeks)|Protocol Violation|1
4831590|NCT01090492|16659693|P8|First Intervention Period (4 Weeks)|Adverse Event|5
4831591|NCT01090492|16659694|P7|First Intervention Period (4 Weeks)|Adverse Event|0
4831592|NCT01090492|16659695|P6|First Intervention Period (4 Weeks)|Adverse Event|2
4831593|NCT01090492|16659696|P5|First Intervention Period (4 Weeks)|Adverse Event|1
4831594|NCT01090492|16659697|P4|First Intervention Period (4 Weeks)|Adverse Event|3
4831595|NCT01090492|16659698|P3|First Intervention Period (4 Weeks)|Adverse Event|0
4831596|NCT01090492|16659699|P2|First Intervention Period (4 Weeks)|Adverse Event|2
4831597|NCT01090492|16659700|P1|First Intervention Period (4 Weeks)|Adverse Event|0
4831598|NCT01090492|16659693|P8|First Intervention Period (4 Weeks)|Pregnancy|0
4831599|NCT01090492|16659694|P7|First Intervention Period (4 Weeks)|Pregnancy|0
4831600|NCT01090492|16659695|P6|First Intervention Period (4 Weeks)|Pregnancy|0
4831601|NCT01090492|16659696|P5|First Intervention Period (4 Weeks)|Pregnancy|1
4831602|NCT01090492|16659697|P4|First Intervention Period (4 Weeks)|Pregnancy|0
4831603|NCT01090492|16659698|P3|First Intervention Period (4 Weeks)|Pregnancy|0
4831604|NCT01090492|16659699|P2|First Intervention Period (4 Weeks)|Pregnancy|0
4831605|NCT01090492|16659700|P1|First Intervention Period (4 Weeks)|Pregnancy|0
4831606|NCT01090492|16659693|P8|First Intervention Period (4 Weeks)|Other|0
4831607|NCT01090492|16659694|P7|First Intervention Period (4 Weeks)|Other|0
4831608|NCT01090492|16659695|P6|First Intervention Period (4 Weeks)|Other|0
4831609|NCT01090492|16659696|P5|First Intervention Period (4 Weeks)|Other|2
4831610|NCT01090492|16659697|P4|First Intervention Period (4 Weeks)|Other|1
4831611|NCT01090492|16659698|P3|First Intervention Period (4 Weeks)|Other|1
4831612|NCT01090492|16659699|P2|First Intervention Period (4 Weeks)|Other|0
4831613|NCT01090492|16659700|P1|First Intervention Period (4 Weeks)|Other|0
4831614|NCT01090492|16659693|P8|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831615|NCT01090492|16659694|P7|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831616|NCT01090492|16659695|P6|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831617|NCT01090492|16659696|P5|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831618|NCT01090492|16659697|P4|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831619|NCT01090492|16659698|P3|First Intervention Period (4 Weeks)|Lost to Follow-up|1
4831620|NCT01090492|16659699|P2|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831621|NCT01090492|16659700|P1|First Intervention Period (4 Weeks)|Lost to Follow-up|0
4831622|NCT01090492|16659693|P8|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1
4831623|NCT01090492|16659694|P7|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4831624|NCT01090492|16659695|P6|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4831625|NCT01090492|16659696|P5|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4831626|NCT01090492|16659697|P4|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4831627|NCT01090492|16659698|P3|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4831628|NCT01090492|16659699|P2|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2
4831629|NCT01090492|16659700|P1|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0
4831630|NCT01090492|16659693|P8|First Intervention Period (4 Weeks)|Protocol Violation|0
4831631|NCT01090492|16659694|P7|First Intervention Period (4 Weeks)|Protocol Violation|1
4831632|NCT01090492|16659695|P6|First Intervention Period (4 Weeks)|Protocol Violation|0
4831633|NCT01090492|16659696|P5|First Intervention Period (4 Weeks)|Protocol Violation|0
4831634|NCT01090492|16659697|P4|First Intervention Period (4 Weeks)|Protocol Violation|2
4831635|NCT01090492|16659698|P3|First Intervention Period (4 Weeks)|Protocol Violation|1
4831636|NCT01090492|16659699|P2|First Intervention Period (4 Weeks)|Protocol Violation|1
4831637|NCT01090492|16659700|P1|First Intervention Period (4 Weeks)|Protocol Violation|1
4831638|NCT01090453|16659768|P2|Overall Study|Eligibility Criteria|1
4831639|NCT01090453|16659769|P1|Overall Study|Eligibility Criteria|0
4831640|NCT01090453|16659768|P2|Overall Study|Other|4
4831641|NCT01090453|16659769|P1|Overall Study|Other|2
4831642|NCT01090453|16659768|P2|Overall Study|Protocol Violation|0
4831643|NCT01090453|16659769|P1|Overall Study|Protocol Violation|2
4831644|NCT01090453|16659768|P2|Overall Study|Non serious AEs|0
4831645|NCT01090453|16659769|P1|Overall Study|Non serious AEs|1
4831646|NCT01090453|16659768|P2|Overall Study|Lost to Follow-up|7
4831647|NCT01090453|16659769|P1|Overall Study|Lost to Follow-up|7
4831648|NCT01090453|16659768|P2|Overall Study|Withdrawal by Subject|2
4831649|NCT01090453|16659769|P1|Overall Study|Withdrawal by Subject|1
4831650|NCT01090427|16659820|P7|After Controlled Period|Adverse Event|0
4831651|NCT01090427|16659821|P6|After Controlled Period|Adverse Event|1
4831652|NCT01090427|16659822|P5|After Controlled Period|Adverse Event|0
4831653|NCT01090427|16659823|P4|After Controlled Period|Adverse Event|2
4831654|NCT01090427|16659824|P3|After Controlled Period|Adverse Event|0
4831655|NCT01090427|16659825|P2|After Controlled Period|Adverse Event|0
4831656|NCT01090427|16659826|P1|After Controlled Period|Adverse Event|0
4831657|NCT01090427|16659820|P7|After Controlled Period|Lack of Efficacy|2
4831658|NCT01090427|16659821|P6|After Controlled Period|Lack of Efficacy|3
4831659|NCT01090427|16659822|P5|After Controlled Period|Lack of Efficacy|0
4831660|NCT01090427|16659823|P4|After Controlled Period|Lack of Efficacy|0
4831661|NCT01090427|16659824|P3|After Controlled Period|Lack of Efficacy|0
4831662|NCT01090427|16659825|P2|After Controlled Period|Lack of Efficacy|0
4831663|NCT01090427|16659826|P1|After Controlled Period|Lack of Efficacy|0
4831664|NCT01090427|16659820|P7|After Controlled Period|Death|0
4831665|NCT01090427|16659821|P6|After Controlled Period|Death|1
4831666|NCT01090427|16659822|P5|After Controlled Period|Death|0
4831667|NCT01090427|16659823|P4|After Controlled Period|Death|0
4831668|NCT01090427|16659824|P3|After Controlled Period|Death|0
4831669|NCT01090427|16659825|P2|After Controlled Period|Death|0
4831670|NCT01090427|16659826|P1|After Controlled Period|Death|0
4831671|NCT01090414|16659863|P4|Study 101-99|Participant Request|0
4831672|NCT01090414|16659864|P3|Study 101-99|Participant Request|0
4831673|NCT01090414|16659865|P2|Study 101-99|Participant Request|1
4831674|NCT01090414|16659866|P1|Study 101-99|Participant Request|3
4831675|NCT01090414|16659863|P4|Study 101-99|Withdrew Consent|1
4831676|NCT01090414|16659864|P3|Study 101-99|Withdrew Consent|3
4831677|NCT01090414|16659865|P2|Study 101-99|Withdrew Consent|2
4831678|NCT01090414|16659866|P1|Study 101-99|Withdrew Consent|0
4831679|NCT01090414|16659863|P4|Study 101-99|Other (Unknown Reasons)|0
4831680|NCT01090414|16659864|P3|Study 101-99|Other (Unknown Reasons)|0
4831681|NCT01090414|16659865|P2|Study 101-99|Other (Unknown Reasons)|3
4831682|NCT01090414|16659866|P1|Study 101-99|Other (Unknown Reasons)|3
4831683|NCT01090414|16659863|P4|Study 101-99|Sponsor Discontinued Study|0
4831684|NCT01090414|16659864|P3|Study 101-99|Sponsor Discontinued Study|5
4831685|NCT01090414|16659865|P2|Study 101-99|Sponsor Discontinued Study|7
4831686|NCT01090414|16659866|P1|Study 101-99|Sponsor Discontinued Study|0
4831687|NCT01090414|16659863|P4|Study 101-99|Death|0
4831688|NCT01090414|16659864|P3|Study 101-99|Death|1
4831689|NCT01090414|16659865|P2|Study 101-99|Death|8
4831690|NCT01090414|16659866|P1|Study 101-99|Death|3
4831691|NCT01090414|16659863|P4|Study 101-99|Investigator Request|0
4831692|NCT01090414|16659864|P3|Study 101-99|Investigator Request|4
4831693|NCT01090414|16659865|P2|Study 101-99|Investigator Request|11
4831694|NCT01090414|16659866|P1|Study 101-99|Investigator Request|1
4831695|NCT01090414|16659863|P4|Study 101-99|Adverse Event|0
4831696|NCT01090414|16659864|P3|Study 101-99|Adverse Event|18
4831697|NCT01090414|16659865|P2|Study 101-99|Adverse Event|28
4831698|NCT01090414|16659866|P1|Study 101-99|Adverse Event|10
4831699|NCT01090414|16659863|P4|Study 101-99|Progressive Disease|4
4831700|NCT01090414|16659864|P3|Study 101-99|Progressive Disease|10
4831701|NCT01090414|16659865|P2|Study 101-99|Progressive Disease|48
4831702|NCT01090414|16659866|P1|Study 101-99|Progressive Disease|28
4831703|NCT01090323|16659933|P2|Overall Study|Stopped end of extension 1#|1
4831704|NCT01090323|16659934|P1|Overall Study|Stopped end of extension 1#|3
4831705|NCT01090323|16659933|P2|Overall Study|Stopped end of core|0
4831706|NCT01090323|16659934|P1|Overall Study|Stopped end of core|7
4831707|NCT01090323|16659933|P2|Overall Study|Death|2
4831708|NCT01090323|16659934|P1|Overall Study|Death|1
4831709|NCT01090323|16659933|P2|Overall Study|Administrative problems|4
4831710|NCT01090323|16659934|P1|Overall Study|Administrative problems|6
4831711|NCT01090323|16659933|P2|Overall Study|Lost to Follow-up|6
4831712|NCT01090323|16659934|P1|Overall Study|Lost to Follow-up|11
4831713|NCT01090323|16659933|P2|Overall Study|Withdrew consent|11
4831714|NCT01090323|16659934|P1|Overall Study|Withdrew consent|33
4831715|NCT01090323|16659933|P2|Overall Study|Protocol Violation|1
4831716|NCT01090323|16659934|P1|Overall Study|Protocol Violation|2
4831717|NCT01090323|16659933|P2|Overall Study|Condition no longer requires drug|4
4831718|NCT01090323|16659934|P1|Overall Study|Condition no longer requires drug|5
4831719|NCT01090323|16659933|P2|Overall Study|Unsatisfactory therapeutic effect|2
4831720|NCT01090323|16659934|P1|Overall Study|Unsatisfactory therapeutic effect|4
4831721|NCT01090323|16659933|P2|Overall Study|Abnormal Test Procedure Results|0
4831722|NCT01090323|16659934|P1|Overall Study|Abnormal Test Procedure Results|2
4831723|NCT01090323|16659933|P2|Overall Study|Abnormal Lab Values|1
4831724|NCT01090323|16659934|P1|Overall Study|Abnormal Lab Values|3
4831725|NCT01090323|16659933|P2|Overall Study|Adverse Event|2
4831726|NCT01090323|16659934|P1|Overall Study|Adverse Event|12
4831727|NCT01090310|16659946|P4|Extension Study|Subject withdrew consent|0
4831728|NCT01090310|16659947|P3|Extension Study|Subject withdrew consent|0
4831729|NCT01090310|16659948|P2|Extension Study|Subject withdrew consent|1
4831730|NCT01090310|16659949|P1|Extension Study|Subject withdrew consent|0
4831731|NCT01090310|16659946|P4|Extension Study|Unsatisfactory therapeutic effect|1
4831732|NCT01090310|16659947|P3|Extension Study|Unsatisfactory therapeutic effect|1
4831733|NCT01090310|16659948|P2|Extension Study|Unsatisfactory therapeutic effect|0
4831734|NCT01090310|16659949|P1|Extension Study|Unsatisfactory therapeutic effect|1
4831735|NCT01090310|16659946|P4|Extension Study|Adverse Event|1
4831736|NCT01090310|16659947|P3|Extension Study|Adverse Event|0
4831737|NCT01090310|16659948|P2|Extension Study|Adverse Event|0
4831738|NCT01090310|16659949|P1|Extension Study|Adverse Event|0
4831739|NCT01090310|16659946|P4|Extension Study|Aministrative problems|18
4831740|NCT01090310|16659947|P3|Extension Study|Aministrative problems|14
4831741|NCT01090310|16659948|P2|Extension Study|Aministrative problems|15
4831742|NCT01090310|16659949|P1|Extension Study|Aministrative problems|13
4831743|NCT01090310|16659946|P4|Core Study|Protocol deviation|1
4831744|NCT01090310|16659947|P3|Core Study|Protocol deviation|0
4831745|NCT01090310|16659948|P2|Core Study|Protocol deviation|0
4831746|NCT01090310|16659949|P1|Core Study|Protocol deviation|1
4831747|NCT01090310|16659946|P4|Core Study|Administrative reasons|4
4831748|NCT01090310|16659947|P3|Core Study|Administrative reasons|4
4831749|NCT01090310|16659948|P2|Core Study|Administrative reasons|6
4831750|NCT01090310|16659949|P1|Core Study|Administrative reasons|5
4831751|NCT01090310|16659946|P4|Core Study|Abnormal test procedure result|0
4831752|NCT01090310|16659947|P3|Core Study|Abnormal test procedure result|1
4831753|NCT01090310|16659948|P2|Core Study|Abnormal test procedure result|0
4831754|NCT01090310|16659949|P1|Core Study|Abnormal test procedure result|0
4831755|NCT01090310|16659946|P4|Core Study|Subject withdrew consent|1
4831756|NCT01090310|16659947|P3|Core Study|Subject withdrew consent|1
4831757|NCT01090310|16659948|P2|Core Study|Subject withdrew consent|3
4831758|NCT01090310|16659949|P1|Core Study|Subject withdrew consent|0
4831759|NCT01090310|16659946|P4|Core Study|Adverse Event|1
4831760|NCT01090310|16659947|P3|Core Study|Adverse Event|1
4831761|NCT01090310|16659948|P2|Core Study|Adverse Event|2
4831762|NCT01090310|16659949|P1|Core Study|Adverse Event|2
4831763|NCT01090102|16659988|P2|Second 12 Weeks|Withdrawal by Subject|1
4831764|NCT01090102|16659989|P1|Second 12 Weeks|Withdrawal by Subject|0
4831765|NCT01090102|16659988|P2|First 12 Weeks|Death|1
4831766|NCT01090102|16659989|P1|First 12 Weeks|Death|1
4831767|NCT01090102|16659988|P2|First 12 Weeks|Adverse Event|0
4831768|NCT01090102|16659989|P1|First 12 Weeks|Adverse Event|2
4831769|NCT01090102|16659988|P2|First 12 Weeks|Withdrawal by Subject|1
4831770|NCT01090102|16659989|P1|First 12 Weeks|Withdrawal by Subject|1
4831771|NCT01090076|16659999|P2|Overall Study|Withdrawal by Subject|1
4831772|NCT01090076|16660000|P1|Overall Study|Withdrawal by Subject|0
4831773|NCT01090076|16659999|P2|Overall Study|Death|1
4831774|NCT01090076|16660000|P1|Overall Study|Death|1
4831775|NCT01090063|16660010|P1|Treatment|Withdrawal by Subject|4
4831776|NCT01090063|16660010|P1|Screen|Screen Failed|4
4831777|NCT01090050|16660026|P2|Overall Study|Physician Decision|1
4831778|NCT01090050|16660027|P1|Overall Study|Physician Decision|0
4831779|NCT01090050|16660026|P2|Overall Study|Lack of Efficacy|5
4831780|NCT01090050|16660027|P1|Overall Study|Lack of Efficacy|1
4831781|NCT01090050|16660026|P2|Overall Study|Lost to Follow-up|1
4831782|NCT01090050|16660027|P1|Overall Study|Lost to Follow-up|0
4831783|NCT01090011|16660047|P1|Overall Study|Other reason not defined above|5
4831784|NCT01090011|16660047|P1|Overall Study|Refusal to start/continue medication|5
4831785|NCT01090011|16660047|P1|Overall Study|Protocol Violation|1
4831786|NCT01090011|16660047|P1|Overall Study|Adverse Event|32
4831787|NCT01090011|16660047|P1|Overall Study|Progressive disease|128
4831788|NCT01089647|16660140|P2|Overall Study|Adverse Event|1
4831789|NCT01089647|16660141|P1|Overall Study|Adverse Event|0
4831790|NCT01089647|16660140|P2|Overall Study|Withdrawal by Subject|1
4831791|NCT01089647|16660141|P1|Overall Study|Withdrawal by Subject|2
4831792|NCT01089647|16660140|P2|Overall Study|Lost to Follow-up|2
4831793|NCT01089647|16660141|P1|Overall Study|Lost to Follow-up|2
4831794|NCT01089608|16660149|P2|Overall Study|Lost to Follow-up|2
4831795|NCT01089608|16660150|P1|Overall Study|Lost to Follow-up|0
4831796|NCT01089608|16660149|P2|Overall Study|Adverse Event|4
4831797|NCT01089608|16660150|P1|Overall Study|Adverse Event|0
4831798|NCT01089582|16660167|P1|Overall Study|Withdrawal by Subject|1
4831799|NCT01089582|16660167|P1|Overall Study|Other|4
4831800|NCT01089582|16660167|P1|Overall Study|Lost to Follow-up|8
4831801|NCT01089582|16660167|P1|Overall Study|Adverse Event|15
4831802|NCT01089582|16660167|P1|Overall Study|Death|2
4831803|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Withdrawal by Subject|2
4831804|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Withdrawal by Subject|1
4831805|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
4831806|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Withdrawal by Subject|3
4831807|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
4831808|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Withdrawal by Subject|0
4831809|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Satisfactory Response|1
4831810|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Satisfactory Response|4
4831811|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Satisfactory Response|3
4831812|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Satisfactory Response|4
4831813|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Satisfactory Response|0
4831814|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Satisfactory Response|0
4831815|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Protocol Violation|0
4831816|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Protocol Violation|1
4831817|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Protocol Violation|1
4831818|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Protocol Violation|1
4831819|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Protocol Violation|0
4831820|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Protocol Violation|0
4831821|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4831822|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4831823|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4831824|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Lost to Follow-up|1
4831825|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4831826|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Lost to Follow-up|0
4831827|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4831828|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Lack of Efficacy|1
4831829|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Lack of Efficacy|2
4831830|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4831831|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4831832|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Lack of Efficacy|0
4831833|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4831834|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4831835|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4831836|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1
4831837|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
4831838|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0
4831839|NCT01089556|16660210|P6|Study Period III (Weeks 9-16)|Adverse Event|3
4831840|NCT01089556|16660211|P5|Study Period III (Weeks 9-16)|Adverse Event|4
4831841|NCT01089556|16660212|P4|Study Period III (Weeks 9-16)|Adverse Event|2
4831842|NCT01089556|16660213|P3|Study Period III (Weeks 9-16)|Adverse Event|4
4831843|NCT01089556|16660214|P2|Study Period III (Weeks 9-16)|Adverse Event|0
4831844|NCT01089556|16660215|P1|Study Period III (Weeks 9-16)|Adverse Event|0
4831845|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Not received any study drug|0
4831846|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Not received any study drug|0
4831847|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Not received any study drug|0
4831848|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Not received any study drug|0
4831849|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Not received any study drug|4
4831850|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Not received any study drug|3
4831851|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4831852|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4831853|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4831854|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Withdrawal by Subject|0
4831855|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Withdrawal by Subject|14
4831856|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Withdrawal by Subject|12
4831857|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Protocol Violation|0
4831858|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Protocol Violation|0
4831859|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Protocol Violation|0
4831860|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Protocol Violation|0
4831861|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Protocol Violation|4
4831862|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Protocol Violation|4
4831863|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Physician Decision|0
4831864|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Physician Decision|0
4831865|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Physician Decision|0
4831866|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Physician Decision|0
4831867|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Physician Decision|0
4831868|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Physician Decision|4
4831869|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4831870|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4831871|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4831872|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4831873|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Lost to Follow-up|3
4831874|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Lost to Follow-up|0
4831875|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4831876|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4831877|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4831878|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Lack of Efficacy|0
4831879|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Lack of Efficacy|2
4831880|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Lack of Efficacy|1
4831881|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4831882|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4831883|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4831884|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0
4831885|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8
4831886|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12
4831887|NCT01089556|16660210|P6|Study Period II (Weeks 1-8)|Adverse Event|0
4831888|NCT01089556|16660211|P5|Study Period II (Weeks 1-8)|Adverse Event|0
4831889|NCT01089556|16660212|P4|Study Period II (Weeks 1-8)|Adverse Event|0
4831890|NCT01089556|16660213|P3|Study Period II (Weeks 1-8)|Adverse Event|0
4831891|NCT01089556|16660214|P2|Study Period II (Weeks 1-8)|Adverse Event|39
4831892|NCT01089556|16660215|P1|Study Period II (Weeks 1-8)|Adverse Event|35
4831893|NCT01089543|16660289|P4|Overall Study|Adverse Event|0
4831894|NCT01089543|16660290|P3|Overall Study|Adverse Event|0
4831895|NCT01089543|16660291|P2|Overall Study|Adverse Event|1
4831896|NCT01089543|16660292|P1|Overall Study|Adverse Event|0
4831897|NCT01089543|16660289|P4|Overall Study|Physician Decision|1
4831898|NCT01089543|16660290|P3|Overall Study|Physician Decision|0
4831899|NCT01089543|16660291|P2|Overall Study|Physician Decision|0
4831900|NCT01089543|16660292|P1|Overall Study|Physician Decision|1
4831901|NCT01089543|16660289|P4|Overall Study|Withdrawal by Subject|1
4831902|NCT01089543|16660290|P3|Overall Study|Withdrawal by Subject|3
4831903|NCT01089543|16660291|P2|Overall Study|Withdrawal by Subject|3
4831904|NCT01089543|16660292|P1|Overall Study|Withdrawal by Subject|2
4831905|NCT01089504|16660327|P2|Overall Study|Withdrawal by Subject|0
4831906|NCT01089504|16660328|P1|Overall Study|Withdrawal by Subject|2
4831907|NCT01089504|16660327|P2|Overall Study|Lost to Follow-up|1
4831908|NCT01089504|16660328|P1|Overall Study|Lost to Follow-up|1
4831909|NCT01089413|16660341|P1|Overall Study|Other|71
4831910|NCT01089413|16660341|P1|Overall Study|Metastasectomy|13
4831911|NCT01089413|16660341|P1|Overall Study|Death|10
4831912|NCT01089413|16660341|P1|Overall Study|Unacceptable Toxicity|12
4831913|NCT01089413|16660341|P1|Overall Study|Participant Withdrew Consent|1
4831914|NCT01089413|16660341|P1|Overall Study|Progressive Disease|93
4831915|NCT01089413|16660341|P1|Overall Study|Lost to Follow-up|1
4831916|NCT01089361|16660360|P2|Overall Study|Death|0
4831917|NCT01089361|16660361|P1|Overall Study|Death|1
4831918|NCT01089127|16660410|P6|Overall Study|Protocol deviation|0
4831919|NCT01089127|16660411|P5|Overall Study|Protocol deviation|1
4831920|NCT01089127|16660412|P4|Overall Study|Protocol deviation|0
4831921|NCT01089127|16660413|P3|Overall Study|Protocol deviation|0
4831922|NCT01089127|16660414|P2|Overall Study|Protocol deviation|1
4831923|NCT01089127|16660415|P1|Overall Study|Protocol deviation|0
4831924|NCT01089127|16660410|P6|Overall Study|Lost to Follow-up|0
4831925|NCT01089127|16660411|P5|Overall Study|Lost to Follow-up|1
4831926|NCT01089127|16660412|P4|Overall Study|Lost to Follow-up|0
4831927|NCT01089127|16660413|P3|Overall Study|Lost to Follow-up|0
4831928|NCT01089127|16660414|P2|Overall Study|Lost to Follow-up|1
4831929|NCT01089127|16660415|P1|Overall Study|Lost to Follow-up|1
4831930|NCT01089127|16660410|P6|Overall Study|Abnormal test procedure result(s)|0
4831931|NCT01089127|16660411|P5|Overall Study|Abnormal test procedure result(s)|0
4831932|NCT01089127|16660412|P4|Overall Study|Abnormal test procedure result(s)|0
4831933|NCT01089127|16660413|P3|Overall Study|Abnormal test procedure result(s)|0
4831934|NCT01089127|16660414|P2|Overall Study|Abnormal test procedure result(s)|1
4831935|NCT01089127|16660415|P1|Overall Study|Abnormal test procedure result(s)|2
4831936|NCT01089127|16660410|P6|Overall Study|Subject withdrew consent|2
4831937|NCT01089127|16660411|P5|Overall Study|Subject withdrew consent|0
4831938|NCT01089127|16660412|P4|Overall Study|Subject withdrew consent|1
4831939|NCT01089127|16660413|P3|Overall Study|Subject withdrew consent|1
4831940|NCT01089127|16660414|P2|Overall Study|Subject withdrew consent|1
4831941|NCT01089127|16660415|P1|Overall Study|Subject withdrew consent|0
4831942|NCT01089127|16660410|P6|Overall Study|Adverse Event|1
4831943|NCT01089127|16660411|P5|Overall Study|Adverse Event|0
4831944|NCT01089127|16660412|P4|Overall Study|Adverse Event|0
4831945|NCT01089127|16660413|P3|Overall Study|Adverse Event|1
4831946|NCT01089127|16660414|P2|Overall Study|Adverse Event|1
4831947|NCT01089127|16660415|P1|Overall Study|Adverse Event|5
4831948|NCT01089023|16660469|P1|Overall Study|Lack of Efficacy|1
4831949|NCT01089023|16660469|P1|Overall Study|Protocol Violation|1
4831950|NCT01089023|16660469|P1|Overall Study|Withdrawal by Subject|1
4831951|NCT01089023|16660469|P1|Overall Study|Adverse Event|1
4831952|NCT01089023|16660469|P1|Overall Study|Lost to Follow-up|3
4831953|NCT01088997|16660483|P2|Overall Study|Excluded prior to receiving drug|1
4831954|NCT01088997|16660484|P1|Overall Study|Excluded prior to receiving drug|1
4831955|NCT01088997|16660483|P2|Overall Study|Req. Extracorporeal membrane oxygenation|1
4831956|NCT01088997|16660484|P1|Overall Study|Req. Extracorporeal membrane oxygenation|1
4831957|NCT01088997|16660483|P2|Overall Study|Physician Decision|1
4831958|NCT01088997|16660484|P1|Overall Study|Physician Decision|1
4831959|NCT01088984|16660495|P2|Phase 2|Other|1
4831960|NCT01088984|16660496|P1|Phase 2|Other|0
4831961|NCT01088984|16660495|P2|Phase 2|DIsease Progression|25
4831962|NCT01088984|16660496|P1|Phase 2|DIsease Progression|0
4831963|NCT01088984|16660495|P2|Phase 2|Withdrawal by Subject|1
4831964|NCT01088984|16660496|P1|Phase 2|Withdrawal by Subject|0
4831965|NCT01088984|16660495|P2|Phase 2|Death|5
4831966|NCT01088984|16660496|P1|Phase 2|Death|0
4831967|NCT01088984|16660495|P2|Phase 1|Other|1
4831968|NCT01088984|16660496|P1|Phase 1|Other|1
4831969|NCT01088984|16660495|P2|Phase 1|Disease Progression|4
4831970|NCT01088984|16660496|P1|Phase 1|Disease Progression|2
4831971|NCT01088984|16660495|P2|Phase 1|Death|1
4831972|NCT01088984|16660496|P1|Phase 1|Death|2
4831973|NCT01088529|16660567|P2|Overall Study|Did not receive study treatment|1
4831974|NCT01088529|16660568|P1|Overall Study|Did not receive study treatment|0
4831975|NCT01088503|16660581|P3|Overall Study|Death|7
4831976|NCT01088503|16660582|P2|Overall Study|Death|358
4831977|NCT01088503|16660583|P1|Overall Study|Death|64
4831978|NCT01088503|16660581|P3|Overall Study|Withdrawal by Subject|10
4831979|NCT01088503|16660582|P2|Overall Study|Withdrawal by Subject|327
4831980|NCT01088503|16660583|P1|Overall Study|Withdrawal by Subject|118
4831981|NCT01088438|16660661|P2|Overall Study|Lost to Follow-up|30
4831982|NCT01088438|16660662|P1|Overall Study|Lost to Follow-up|18
4831983|NCT01088438|16660661|P2|Overall Study|Withdrawal by Subject|6
4831984|NCT01088438|16660662|P1|Overall Study|Withdrawal by Subject|11
4831985|NCT01088412|16660675|P3|Overall Study|Study Summary Not Completed|22
4831986|NCT01088412|16660676|P2|Overall Study|Study Summary Not Completed|64
4831987|NCT01088412|16660677|P1|Overall Study|Study Summary Not Completed|4360
4831988|NCT01088412|16660675|P3|Overall Study|Lost to Follow-up|11
4831989|NCT01088412|16660676|P2|Overall Study|Lost to Follow-up|130
4831990|NCT01088412|16660677|P1|Overall Study|Lost to Follow-up|3052
4831991|NCT01088412|16660675|P3|Overall Study|Third Party Required to Change Brand|0
4831992|NCT01088412|16660676|P2|Overall Study|Third Party Required to Change Brand|0
4831993|NCT01088412|16660677|P1|Overall Study|Third Party Required to Change Brand|487
4831994|NCT01088412|16660675|P3|Overall Study|Sponsor Decision|23
4831995|NCT01088412|16660676|P2|Overall Study|Sponsor Decision|79
4831996|NCT01088412|16660677|P1|Overall Study|Sponsor Decision|4467
4831997|NCT01088412|16660675|P3|Overall Study|Physician Decision|4
4831998|NCT01088412|16660676|P2|Overall Study|Physician Decision|8
4831999|NCT01088412|16660677|P1|Overall Study|Physician Decision|1041
4832000|NCT01088412|16660675|P3|Overall Study|Participant Moved|2
4832001|NCT01088412|16660676|P2|Overall Study|Participant Moved|21
4832002|NCT01088412|16660677|P1|Overall Study|Participant Moved|601
4832003|NCT01088412|16660675|P3|Overall Study|Received Another GH Product|0
4832004|NCT01088412|16660676|P2|Overall Study|Received Another GH Product|0
4832005|NCT01088412|16660677|P1|Overall Study|Received Another GH Product|79
4832006|NCT01088412|16660675|P3|Overall Study|Withdrawal by Subject|1
4832007|NCT01088412|16660676|P2|Overall Study|Withdrawal by Subject|25
4832008|NCT01088412|16660677|P1|Overall Study|Withdrawal by Subject|1761
4832009|NCT01088412|16660675|P3|Overall Study|Other Reason per Case Report Form|9
4832010|NCT01088412|16660676|P2|Overall Study|Other Reason per Case Report Form|103
4832011|NCT01088412|16660677|P1|Overall Study|Other Reason per Case Report Form|2089
4832012|NCT01088412|16660675|P3|Overall Study|Death|0
4832013|NCT01088412|16660676|P2|Overall Study|Death|6
4832014|NCT01088412|16660677|P1|Overall Study|Death|42
4832015|NCT01088412|16660675|P3|Overall Study|Adverse Event|0
4832016|NCT01088412|16660676|P2|Overall Study|Adverse Event|0
4832017|NCT01088412|16660677|P1|Overall Study|Adverse Event|38
4832018|NCT01088399|16660696|P3|Overall Study|Study summary visit not completed|80
4832019|NCT01088399|16660697|P2|Overall Study|Study summary visit not completed|283
4832020|NCT01088399|16660698|P1|Overall Study|Study summary visit not completed|2398
4832021|NCT01088399|16660696|P3|Overall Study|Enrollment criteria not met|70
4832022|NCT01088399|16660697|P2|Overall Study|Enrollment criteria not met|119
4832023|NCT01088399|16660698|P1|Overall Study|Enrollment criteria not met|48
4832024|NCT01088399|16660696|P3|Overall Study|Protocol Violation|0
4832025|NCT01088399|16660697|P2|Overall Study|Protocol Violation|1
4832026|NCT01088399|16660698|P1|Overall Study|Protocol Violation|10
4832027|NCT01088399|16660696|P3|Overall Study|Sponsor decision|7
4832028|NCT01088399|16660697|P2|Overall Study|Sponsor decision|298
4832029|NCT01088399|16660698|P1|Overall Study|Sponsor decision|1573
4832030|NCT01088399|16660696|P3|Overall Study|Change to or start of somatropin therapy|12
4832031|NCT01088399|16660697|P2|Overall Study|Change to or start of somatropin therapy|17
4832032|NCT01088399|16660698|P1|Overall Study|Change to or start of somatropin therapy|234
4832033|NCT01088399|16660696|P3|Overall Study|Withdrawal by Subject|33
4832034|NCT01088399|16660697|P2|Overall Study|Withdrawal by Subject|195
4832035|NCT01088399|16660698|P1|Overall Study|Withdrawal by Subject|544
4832036|NCT01088399|16660696|P3|Overall Study|Physician Decision|16
4832037|NCT01088399|16660697|P2|Overall Study|Physician Decision|88
4832038|NCT01088399|16660698|P1|Overall Study|Physician Decision|531
4832039|NCT01088399|16660696|P3|Overall Study|Lost to Follow-up|58
4832040|NCT01088399|16660697|P2|Overall Study|Lost to Follow-up|278
4832041|NCT01088399|16660698|P1|Overall Study|Lost to Follow-up|1070
4832042|NCT01088399|16660696|P3|Overall Study|Lack of Efficacy|5
4832043|NCT01088399|16660697|P2|Overall Study|Lack of Efficacy|7
4832044|NCT01088399|16660698|P1|Overall Study|Lack of Efficacy|298
4832045|NCT01088399|16660696|P3|Overall Study|Death|0
4832046|NCT01088399|16660697|P2|Overall Study|Death|45
4832047|NCT01088399|16660698|P1|Overall Study|Death|204
4832048|NCT01088399|16660696|P3|Overall Study|Adverse Event|0
4832049|NCT01088399|16660697|P2|Overall Study|Adverse Event|16
4832050|NCT01088399|16660698|P1|Overall Study|Adverse Event|211
4832051|NCT01088243|16660727|P2|Overall Study|Adverse Event|0
4832052|NCT01088243|16660728|P1|Overall Study|Adverse Event|1
4832053|NCT01087970|16660769|P1|Overall Study|Protocol Violation|2
4832054|NCT01087957|16660781|P2|Overall Study|Physician Decision|9
4832055|NCT01087957|16660782|P1|Overall Study|Physician Decision|5
4832056|NCT01087957|16660781|P2|Overall Study|Withdrawal by Subject|15
4832057|NCT01087957|16660782|P1|Overall Study|Withdrawal by Subject|18
4832058|NCT01087957|16660781|P2|Overall Study|Protocol Violation|25
4832059|NCT01087957|16660782|P1|Overall Study|Protocol Violation|13
4832060|NCT01087957|16660781|P2|Overall Study|Lost to Follow-up|4
4832061|NCT01087957|16660782|P1|Overall Study|Lost to Follow-up|3
4832062|NCT01087957|16660781|P2|Overall Study|Death|2
4832063|NCT01087957|16660782|P1|Overall Study|Death|2
4832064|NCT01087944|16660808|P2|Period 2 (Week 4-6)|Adverse Event|2
4832065|NCT01087944|16660809|P1|Period 2 (Week 4-6)|Adverse Event|0
4832066|NCT01087944|16660808|P2|Period 1 (Week 1-3)|Adverse Event|0
4832067|NCT01087944|16660809|P1|Period 1 (Week 1-3)|Adverse Event|1
4832068|NCT01087905|16660889|P8|Overall Study|Withdrawal by Subject|5
4832069|NCT01087905|16660890|P7|Overall Study|Withdrawal by Subject|3
4832070|NCT01087905|16660891|P6|Overall Study|Withdrawal by Subject|3
4832071|NCT01087905|16660892|P5|Overall Study|Withdrawal by Subject|4
4832072|NCT01087905|16660893|P4|Overall Study|Withdrawal by Subject|5
4832073|NCT01087905|16660894|P3|Overall Study|Withdrawal by Subject|4
4832074|NCT01087905|16660895|P2|Overall Study|Withdrawal by Subject|4
4832075|NCT01087905|16660896|P1|Overall Study|Withdrawal by Subject|5
4832076|NCT01087905|16660889|P8|Overall Study|Lost to Follow-up|24
4832077|NCT01087905|16660890|P7|Overall Study|Lost to Follow-up|20
4832078|NCT01087905|16660891|P6|Overall Study|Lost to Follow-up|25
4832079|NCT01087905|16660892|P5|Overall Study|Lost to Follow-up|27
4832080|NCT01087905|16660893|P4|Overall Study|Lost to Follow-up|31
4832081|NCT01087905|16660894|P3|Overall Study|Lost to Follow-up|18
4832082|NCT01087905|16660895|P2|Overall Study|Lost to Follow-up|28
4832083|NCT01087905|16660896|P1|Overall Study|Lost to Follow-up|24
4832084|NCT01087814|16660918|P2|Second Intervention (5 Days)|Physician Decision|0
4832085|NCT01087814|16660919|P1|Second Intervention (5 Days)|Physician Decision|1
4832086|NCT01087814|16660918|P2|First Intervention (5 Days)|Withdrawal by Subject|1
4832087|NCT01087814|16660919|P1|First Intervention (5 Days)|Withdrawal by Subject|3
4832088|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Personal reasons|1
4832089|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Personal reasons|0
4832090|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Personal reasons|0
4832091|NCT01087788|16660937|P3|Open-Label Period (OL-P)|No participation in study extension|1
4832092|NCT01087788|16660938|P2|Open-Label Period (OL-P)|No participation in study extension|0
4832093|NCT01087788|16660939|P1|Open-Label Period (OL-P)|No participation in study extension|0
4832094|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Principal investigator decision|2
4832095|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Principal investigator decision|1
4832096|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Principal investigator decision|0
4832097|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Sponsor request|0
4832098|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Sponsor request|0
4832099|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Sponsor request|1
4832100|NCT01087788|16660937|P3|Open-Label Period (OL-P)|AE, non-serious unknown|0
4832101|NCT01087788|16660938|P2|Open-Label Period (OL-P)|AE, non-serious unknown|0
4832102|NCT01087788|16660939|P1|Open-Label Period (OL-P)|AE, non-serious unknown|1
4832103|NCT01087788|16660937|P3|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
4832104|NCT01087788|16660938|P2|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1
4832105|NCT01087788|16660939|P1|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0
4832106|NCT01087788|16660937|P3|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
4832107|NCT01087788|16660938|P2|Open-Label Period (OL-P)|AE, non-serious non-fatal|4
4832108|NCT01087788|16660939|P1|Open-Label Period (OL-P)|AE, non-serious non-fatal|6
4832109|NCT01087788|16660937|P3|Open-Label Period (OL-P)|AE, serious non-fatal|4
4832110|NCT01087788|16660938|P2|Open-Label Period (OL-P)|AE, serious non-fatal|3
4832111|NCT01087788|16660939|P1|Open-Label Period (OL-P)|AE, serious non-fatal|1
4832112|NCT01087788|16660937|P3|Open-Label Period (OL-P)|AE, serious fatal|1
4832113|NCT01087788|16660938|P2|Open-Label Period (OL-P)|AE, serious fatal|0
4832114|NCT01087788|16660939|P1|Open-Label Period (OL-P)|AE, serious fatal|2
4832115|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Withdrawal by Subject|10
4832116|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Withdrawal by Subject|8
4832117|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Withdrawal by Subject|13
4832118|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Lost to Follow-up|2
4832119|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Lost to Follow-up|4
4832120|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Lost to Follow-up|0
4832121|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Protocol Violation|0
4832122|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Protocol Violation|1
4832123|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Protocol Violation|2
4832124|NCT01087788|16660937|P3|Open-Label Period (OL-P)|Lack of Efficacy|3
4832125|NCT01087788|16660938|P2|Open-Label Period (OL-P)|Lack of Efficacy|2
4832126|NCT01087788|16660939|P1|Open-Label Period (OL-P)|Lack of Efficacy|4
4832127|NCT01087788|16660937|P3|24-weeks Dose-blind Period|Patient moved|1
4832128|NCT01087788|16660938|P2|24-weeks Dose-blind Period|Patient moved|0
4832129|NCT01087788|16660939|P1|24-weeks Dose-blind Period|Patient moved|0
4832130|NCT01087788|16660937|P3|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
4832131|NCT01087788|16660938|P2|24-weeks Dose-blind Period|Sponsor decision following missed visits|0
4832132|NCT01087788|16660939|P1|24-weeks Dose-blind Period|Sponsor decision following missed visits|1
4832133|NCT01087788|16660937|P3|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
4832134|NCT01087788|16660938|P2|24-weeks Dose-blind Period|AE, non-serious non-fatal|1
4832135|NCT01087788|16660939|P1|24-weeks Dose-blind Period|AE, non-serious non-fatal|2
4832136|NCT01087788|16660937|P3|24-weeks Dose-blind Period|AE, serious non-fatal|2
4832137|NCT01087788|16660938|P2|24-weeks Dose-blind Period|AE, serious non-fatal|1
4832138|NCT01087788|16660939|P1|24-weeks Dose-blind Period|AE, serious non-fatal|2
4832139|NCT01087788|16660937|P3|24-weeks Dose-blind Period|AE, serious fatal|0
4832140|NCT01087788|16660938|P2|24-weeks Dose-blind Period|AE, serious fatal|1
4832141|NCT01087788|16660939|P1|24-weeks Dose-blind Period|AE, serious fatal|0
4832142|NCT01087788|16660937|P3|24-weeks Dose-blind Period|Withdrawal by Subject|0
4832143|NCT01087788|16660938|P2|24-weeks Dose-blind Period|Withdrawal by Subject|0
4832144|NCT01087788|16660939|P1|24-weeks Dose-blind Period|Withdrawal by Subject|1
4832145|NCT01087788|16660937|P3|24-weeks Dose-blind Period|Lost to Follow-up|1
4832146|NCT01087788|16660938|P2|24-weeks Dose-blind Period|Lost to Follow-up|0
4832147|NCT01087788|16660939|P1|24-weeks Dose-blind Period|Lost to Follow-up|1
4832148|NCT01087788|16660937|P3|24-weeks Dose-blind Period|Lack of Efficacy|1
4832149|NCT01087788|16660938|P2|24-weeks Dose-blind Period|Lack of Efficacy|2
4832150|NCT01087788|16660939|P1|24-weeks Dose-blind Period|Lack of Efficacy|0
4832300|NCT01087489|16661112|P1|Overall Study|enrolled in another VA study|0
4832151|NCT01087788|16660937|P3|24-weeks Double-blind Period|P cannot comply with scheduled visits|1
4832152|NCT01087788|16660938|P2|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
4832153|NCT01087788|16660939|P1|24-weeks Double-blind Period|P cannot comply with scheduled visits|0
4832154|NCT01087788|16660937|P3|24-weeks Double-blind Period|Exclusion criteria were not met|0
4832155|NCT01087788|16660938|P2|24-weeks Double-blind Period|Exclusion criteria were not met|1
4832156|NCT01087788|16660939|P1|24-weeks Double-blind Period|Exclusion criteria were not met|0
4832157|NCT01087788|16660937|P3|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
4832158|NCT01087788|16660938|P2|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1
4832159|NCT01087788|16660939|P1|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0
4832160|NCT01087788|16660937|P3|24-weeks Double-blind Period|Patient (P) does not want to attend|0
4832161|NCT01087788|16660938|P2|24-weeks Double-blind Period|Patient (P) does not want to attend|0
4832162|NCT01087788|16660939|P1|24-weeks Double-blind Period|Patient (P) does not want to attend|1
4832163|NCT01087788|16660937|P3|24-weeks Double-blind Period|AE, unknown type|1
4832164|NCT01087788|16660938|P2|24-weeks Double-blind Period|AE, unknown type|0
4832165|NCT01087788|16660939|P1|24-weeks Double-blind Period|AE, unknown type|0
4832166|NCT01087788|16660937|P3|24-weeks Double-blind Period|AE, non-serious non-fatal|2
4832167|NCT01087788|16660938|P2|24-weeks Double-blind Period|AE, non-serious non-fatal|1
4832168|NCT01087788|16660939|P1|24-weeks Double-blind Period|AE, non-serious non-fatal|2
4832169|NCT01087788|16660937|P3|24-weeks Double-blind Period|AE, serious non-fatal|3
4832170|NCT01087788|16660938|P2|24-weeks Double-blind Period|AE, serious non-fatal|2
4832171|NCT01087788|16660939|P1|24-weeks Double-blind Period|AE, serious non-fatal|0
4832172|NCT01087788|16660937|P3|24-weeks Double-blind Period|AE, serious fatal|1
4832173|NCT01087788|16660938|P2|24-weeks Double-blind Period|AE, serious fatal|1
4832174|NCT01087788|16660939|P1|24-weeks Double-blind Period|AE, serious fatal|0
4832175|NCT01087788|16660937|P3|24-weeks Double-blind Period|Withdrawal by Subject|5
4832176|NCT01087788|16660938|P2|24-weeks Double-blind Period|Withdrawal by Subject|2
4832177|NCT01087788|16660939|P1|24-weeks Double-blind Period|Withdrawal by Subject|7
4832178|NCT01087788|16660937|P3|24-weeks Double-blind Period|Lost to Follow-up|1
4832179|NCT01087788|16660938|P2|24-weeks Double-blind Period|Lost to Follow-up|1
4832180|NCT01087788|16660939|P1|24-weeks Double-blind Period|Lost to Follow-up|4
4832181|NCT01087788|16660937|P3|24-weeks Double-blind Period|Protocol Violation|0
4832182|NCT01087788|16660938|P2|24-weeks Double-blind Period|Protocol Violation|1
4832183|NCT01087788|16660939|P1|24-weeks Double-blind Period|Protocol Violation|0
4832184|NCT01087788|16660937|P3|24-weeks Double-blind Period|Lack of Efficacy|1
4832185|NCT01087788|16660938|P2|24-weeks Double-blind Period|Lack of Efficacy|0
4832186|NCT01087788|16660939|P1|24-weeks Double-blind Period|Lack of Efficacy|2
4832187|NCT01087775|16660966|P1|Overall Study|failed inclusion criteria|2
4832188|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4
4832189|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2
4832190|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
4832191|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
4832192|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0
4832193|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13
4832194|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16
4832195|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
4832196|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
4832197|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0
4832198|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4
4832199|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7
4832200|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
4832201|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
4832202|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0
4832203|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|Other|4
4832204|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|Other|2
4832205|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|Other|0
4832206|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|Other|0
4832207|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|Other|0
4832208|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15
4832209|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22
4832210|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
4832211|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
4832212|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0
4832213|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2
4832214|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5
4832215|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
4832216|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
4832217|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0
4832218|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|Protocol Violation|1
4832219|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|Protocol Violation|1
4832220|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|Protocol Violation|0
4832221|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|Protocol Violation|0
4832222|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|Protocol Violation|0
4832223|NCT01087762|16660974|P5|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14
4832224|NCT01087762|16660975|P4|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4
4832225|NCT01087762|16660976|P3|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
4832226|NCT01087762|16660977|P2|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
4832227|NCT01087762|16660978|P1|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0
4832228|NCT01087762|16660974|P5|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
4832229|NCT01087762|16660975|P4|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0
4832230|NCT01087762|16660976|P3|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3
4832231|NCT01087762|16660977|P2|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
4832232|NCT01087762|16660978|P1|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2
4832233|NCT01087762|16660974|P5|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
4832234|NCT01087762|16660975|P4|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0
4832235|NCT01087762|16660976|P3|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
4832236|NCT01087762|16660977|P2|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2
4832237|NCT01087762|16660978|P1|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1
4832238|NCT01087762|16660974|P5|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
4832239|NCT01087762|16660975|P4|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0
4832240|NCT01087762|16660976|P3|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
4832241|NCT01087762|16660977|P2|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2
4832242|NCT01087762|16660978|P1|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1
4832243|NCT01087762|16660974|P5|Double Blind Period (Weeks 0-24)|Protocol Violation|0
4832244|NCT01087762|16660975|P4|Double Blind Period (Weeks 0-24)|Protocol Violation|0
4832245|NCT01087762|16660976|P3|Double Blind Period (Weeks 0-24)|Protocol Violation|1
4832246|NCT01087762|16660977|P2|Double Blind Period (Weeks 0-24)|Protocol Violation|0
4832247|NCT01087762|16660978|P1|Double Blind Period (Weeks 0-24)|Protocol Violation|6
4832248|NCT01087762|16660974|P5|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
4832249|NCT01087762|16660975|P4|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
4832250|NCT01087762|16660976|P3|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3
4832251|NCT01087762|16660977|P2|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0
4832252|NCT01087762|16660978|P1|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2
4832253|NCT01087736|16661026|P2|Overall Study|Withdrawal by Subject|1
4832254|NCT01087736|16661027|P1|Overall Study|Withdrawal by Subject|0
4832255|NCT01087736|16661026|P2|Overall Study|Death|1
4832256|NCT01087736|16661027|P1|Overall Study|Death|0
4832257|NCT01087736|16661026|P2|Overall Study|Lost to Follow-up|0
4832258|NCT01087736|16661027|P1|Overall Study|Lost to Follow-up|1
4832259|NCT01087723|16661037|P2|Overall Study|Reason Not Specified|2
4832260|NCT01087723|16661038|P1|Overall Study|Reason Not Specified|1
4832261|NCT01087723|16661037|P2|Overall Study|Lost to Follow-up|4
4832262|NCT01087723|16661038|P1|Overall Study|Lost to Follow-up|1
4832263|NCT01087723|16661037|P2|Overall Study|Physician Decision|0
4832264|NCT01087723|16661038|P1|Overall Study|Physician Decision|2
4832265|NCT01087723|16661037|P2|Overall Study|Withdrawal by Subject|13
4832266|NCT01087723|16661038|P1|Overall Study|Withdrawal by Subject|10
4832267|NCT01087723|16661037|P2|Overall Study|1 Year Visit Too Early (<335 days)|1
4832268|NCT01087723|16661038|P1|Overall Study|1 Year Visit Too Early (<335 days)|0
4832269|NCT01087528|16661079|P1|Overall Study|Incomplete CE procedure|6
4832270|NCT01087528|16661079|P1|Overall Study|Withdrawal by Subject|1
4832271|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Other reason not described above|4
4832272|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Other reason not described above|5
4832273|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Study site excluded from analysis|5
4832274|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Study site excluded from analysis|1
4832275|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Withdrawal by Subject|2
4832276|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Withdrawal by Subject|3
4832277|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Lost to Follow-up|0
4832278|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Lost to Follow-up|2
4832279|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Protocol Violation|0
4832280|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Protocol Violation|4
4832281|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Lack of Efficacy|2
4832282|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Lack of Efficacy|1
4832283|NCT01087502|16661091|P2|Up to Final Analysis (Week 52)|Adverse Event|10
4832284|NCT01087502|16661092|P1|Up to Final Analysis (Week 52)|Adverse Event|17
4832285|NCT01087502|16661091|P2|Up to Interim Analysis (Week 12)|Other reason not described above|2
4832286|NCT01087502|16661092|P1|Up to Interim Analysis (Week 12)|Other reason not described above|1
4832287|NCT01087502|16661091|P2|Up to Interim Analysis (Week 12)|Lack of Efficacy|0
4832288|NCT01087502|16661092|P1|Up to Interim Analysis (Week 12)|Lack of Efficacy|1
4832289|NCT01087502|16661091|P2|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
4832290|NCT01087502|16661092|P1|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1
4832291|NCT01087502|16661091|P2|Up to Interim Analysis (Week 12)|Protocol Violation|1
4832292|NCT01087502|16661092|P1|Up to Interim Analysis (Week 12)|Protocol Violation|1
4832293|NCT01087502|16661091|P2|Up to Interim Analysis (Week 12)|Adverse Event|4
4832294|NCT01087502|16661092|P1|Up to Interim Analysis (Week 12)|Adverse Event|5
4832295|NCT01087489|16661111|P2|Overall Study|unable to survey by telephone|1
4832296|NCT01087489|16661112|P1|Overall Study|unable to survey by telephone|0
4832297|NCT01087489|16661111|P2|Overall Study|Death|1
4832298|NCT01087489|16661112|P1|Overall Study|Death|0
4832299|NCT01087489|16661111|P2|Overall Study|enrolled in another VA study|1
4832301|NCT01086969|16661125|P3|Overall Study|Withdrawal by Subject|0
4832302|NCT01086969|16661126|P2|Overall Study|Withdrawal by Subject|2
4832303|NCT01086969|16661127|P1|Overall Study|Withdrawal by Subject|1
4832304|NCT01086540|16661223|P2|Overall Study|Addition of new therapy for PAH|0
4832305|NCT01086540|16661224|P1|Overall Study|Addition of new therapy for PAH|1
4832306|NCT01086540|16661223|P2|Overall Study|Physician Decision|1
4832307|NCT01086540|16661224|P1|Overall Study|Physician Decision|2
4832308|NCT01086540|16661223|P2|Overall Study|Death|1
4832309|NCT01086540|16661224|P1|Overall Study|Death|3
4832310|NCT01086423|16661282|P3|Overall Study|Lost to Follow-up|1
4832311|NCT01086423|16661283|P2|Overall Study|Lost to Follow-up|0
4832312|NCT01086423|16661284|P1|Overall Study|Lost to Follow-up|0
4832313|NCT01086423|16661282|P3|Overall Study|Withdrawal by Subject|3
4832314|NCT01086423|16661283|P2|Overall Study|Withdrawal by Subject|1
4832315|NCT01086423|16661284|P1|Overall Study|Withdrawal by Subject|5
4832316|NCT01086423|16661282|P3|Overall Study|Adverse event, non-fatal|0
4832317|NCT01086423|16661283|P2|Overall Study|Adverse event, non-fatal|1
4832318|NCT01086423|16661284|P1|Overall Study|Adverse event, non-fatal|2
4832319|NCT01086423|16661282|P3|Overall Study|Adverse event, fatal|0
4832320|NCT01086423|16661283|P2|Overall Study|Adverse event, fatal|1
4832321|NCT01086423|16661284|P1|Overall Study|Adverse event, fatal|1
4832322|NCT01086423|16661282|P3|Overall Study|Migrated/moved from study area|4
4832323|NCT01086423|16661283|P2|Overall Study|Migrated/moved from study area|0
4832324|NCT01086423|16661284|P1|Overall Study|Migrated/moved from study area|2
4832325|NCT01086423|16661282|P3|Overall Study|Protocol Violation|1
4832326|NCT01086423|16661283|P2|Overall Study|Protocol Violation|0
4832327|NCT01086423|16661284|P1|Overall Study|Protocol Violation|0
4832328|NCT01086410|16661329|P4|Overall Study|Lost to Follow-up|0
4832329|NCT01086410|16661330|P3|Overall Study|Lost to Follow-up|1
4832330|NCT01086410|16661331|P2|Overall Study|Lost to Follow-up|0
4832331|NCT01086410|16661332|P1|Overall Study|Lost to Follow-up|0
4832332|NCT01086410|16661329|P4|Overall Study|Protocol Violation|0
4832333|NCT01086410|16661330|P3|Overall Study|Protocol Violation|0
4832334|NCT01086410|16661331|P2|Overall Study|Protocol Violation|1
4832335|NCT01086410|16661332|P1|Overall Study|Protocol Violation|1
4832336|NCT01086410|16661329|P4|Overall Study|Lack of Efficacy|0
4832337|NCT01086410|16661330|P3|Overall Study|Lack of Efficacy|0
4832338|NCT01086410|16661331|P2|Overall Study|Lack of Efficacy|1
4832339|NCT01086410|16661332|P1|Overall Study|Lack of Efficacy|1
4832340|NCT01086410|16661329|P4|Overall Study|Adverse Event|2
4832341|NCT01086410|16661330|P3|Overall Study|Adverse Event|0
4832342|NCT01086410|16661331|P2|Overall Study|Adverse Event|0
4832343|NCT01086410|16661332|P1|Overall Study|Adverse Event|1
4832344|NCT01086384|16661428|P3|Treatment Period|Received Treatment in Error|0
4832345|NCT01086384|16661429|P2|Treatment Period|Received Treatment in Error|1
4832346|NCT01086384|16661430|P1|Treatment Period|Received Treatment in Error|0
4832347|NCT01086384|16661428|P3|Treatment Period|Protocol-Defined Stopping Criteria|1
4832348|NCT01086384|16661429|P2|Treatment Period|Protocol-Defined Stopping Criteria|0
4832349|NCT01086384|16661430|P1|Treatment Period|Protocol-Defined Stopping Criteria|0
4832350|NCT01086384|16661428|P3|Treatment Period|Study Closed/Terminated|8
4832351|NCT01086384|16661429|P2|Treatment Period|Study Closed/Terminated|7
4832352|NCT01086384|16661430|P1|Treatment Period|Study Closed/Terminated|0
4832353|NCT01086384|16661428|P3|Treatment Period|Physician Decision|6
4832354|NCT01086384|16661429|P2|Treatment Period|Physician Decision|9
4832355|NCT01086384|16661430|P1|Treatment Period|Physician Decision|0
4832356|NCT01086384|16661428|P3|Treatment Period|Lost to Follow-up|9
4832357|NCT01086384|16661429|P2|Treatment Period|Lost to Follow-up|11
4832358|NCT01086384|16661430|P1|Treatment Period|Lost to Follow-up|0
4832359|NCT01086384|16661428|P3|Treatment Period|Adverse Event|15
4832360|NCT01086384|16661429|P2|Treatment Period|Adverse Event|19
4832361|NCT01086384|16661430|P1|Treatment Period|Adverse Event|0
4832362|NCT01086384|16661428|P3|Treatment Period|Lack of Efficacy|13
4832363|NCT01086384|16661429|P2|Treatment Period|Lack of Efficacy|22
4832364|NCT01086384|16661430|P1|Treatment Period|Lack of Efficacy|0
4832365|NCT01086384|16661428|P3|Treatment Period|Protocol Violation|17
4832366|NCT01086384|16661429|P2|Treatment Period|Protocol Violation|26
4832367|NCT01086384|16661430|P1|Treatment Period|Protocol Violation|0
4832368|NCT01086384|16661428|P3|Treatment Period|Withdrawal by Subject|55
4832369|NCT01086384|16661429|P2|Treatment Period|Withdrawal by Subject|53
4832370|NCT01086384|16661430|P1|Treatment Period|Withdrawal by Subject|0
4832371|NCT01086384|16661428|P3|2-week Run-in Period|Randomized in Error|0
4832372|NCT01086384|16661429|P2|2-week Run-in Period|Randomized in Error|0
4832373|NCT01086384|16661430|P1|2-week Run-in Period|Randomized in Error|1
4832374|NCT01086384|16661428|P3|2-week Run-in Period|Continuation Criteria Not Met|0
4832375|NCT01086384|16661429|P2|2-week Run-in Period|Continuation Criteria Not Met|0
4832376|NCT01086384|16661430|P1|2-week Run-in Period|Continuation Criteria Not Met|92
4832377|NCT01086384|16661428|P3|2-week Run-in Period|Study Closed/Terminated|0
4832378|NCT01086384|16661429|P2|2-week Run-in Period|Study Closed/Terminated|0
4832379|NCT01086384|16661430|P1|2-week Run-in Period|Study Closed/Terminated|42
4832380|NCT01086384|16661428|P3|2-week Run-in Period|Withdrawal by Subject|0
4832381|NCT01086384|16661429|P2|2-week Run-in Period|Withdrawal by Subject|0
4832382|NCT01086384|16661430|P1|2-week Run-in Period|Withdrawal by Subject|19
4832383|NCT01086384|16661428|P3|2-week Run-in Period|Physician Decision|0
4832384|NCT01086384|16661429|P2|2-week Run-in Period|Physician Decision|0
4832385|NCT01086384|16661430|P1|2-week Run-in Period|Physician Decision|6
4832386|NCT01086384|16661428|P3|2-week Run-in Period|Lost to Follow-up|0
4832387|NCT01086384|16661429|P2|2-week Run-in Period|Lost to Follow-up|0
4832388|NCT01086384|16661430|P1|2-week Run-in Period|Lost to Follow-up|1
4832389|NCT01086384|16661428|P3|2-week Run-in Period|Protocol Violation|0
4832390|NCT01086384|16661429|P2|2-week Run-in Period|Protocol Violation|0
4832391|NCT01086384|16661430|P1|2-week Run-in Period|Protocol Violation|1
4832392|NCT01086384|16661428|P3|2-week Run-in Period|Adverse Event|0
4832393|NCT01086384|16661429|P2|2-week Run-in Period|Adverse Event|0
4832394|NCT01086384|16661430|P1|2-week Run-in Period|Adverse Event|1
4832395|NCT01086358|16661440|P2|Second Intervention|Lost to Follow-up|4
4832396|NCT01086358|16661441|P1|Second Intervention|Lost to Follow-up|4
4832397|NCT01086358|16661440|P2|First Intervention|Withdrawal by Subject|1
4832398|NCT01086358|16661441|P1|First Intervention|Withdrawal by Subject|0
4832399|NCT01086358|16661440|P2|First Intervention|Lost to Follow-up|4
4832400|NCT01086358|16661441|P1|First Intervention|Lost to Follow-up|9
4832401|NCT01086215|16661511|P4|Overall Study|Lost to Follow-up|2
4832402|NCT01086215|16661512|P3|Overall Study|Lost to Follow-up|18
4832403|NCT01086215|16661513|P2|Overall Study|Lost to Follow-up|39
4832404|NCT01086215|16661514|P1|Overall Study|Lost to Follow-up|22
4832405|NCT01086215|16661511|P4|Overall Study|Death|1
4832406|NCT01086215|16661512|P3|Overall Study|Death|8
4832407|NCT01086215|16661513|P2|Overall Study|Death|8
4832408|NCT01086215|16661514|P1|Overall Study|Death|14
4832409|NCT01086150|16661535|P3|Overall Study|Screen Failure|0
4832410|NCT01086150|16661536|P2|Overall Study|Screen Failure|1
4832411|NCT01086150|16661537|P1|Overall Study|Screen Failure|0
4832412|NCT01086150|16661535|P3|Overall Study|Lost to Follow-up|0
4832413|NCT01086150|16661536|P2|Overall Study|Lost to Follow-up|1
4832414|NCT01086150|16661537|P1|Overall Study|Lost to Follow-up|0
4832415|NCT01086150|16661535|P3|Overall Study|Withdrawal by Subject|1
4832416|NCT01086150|16661536|P2|Overall Study|Withdrawal by Subject|4
4832417|NCT01086150|16661537|P1|Overall Study|Withdrawal by Subject|0
4832418|NCT01086033|16661548|P1|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1
4832419|NCT01086033|16661548|P1|Overall Study|AE and Other Reason|1
4832420|NCT01086033|16661548|P1|Overall Study|AE and Lost to Follow-up|1
4832421|NCT01086033|16661548|P1|Overall Study|Death|1
4832422|NCT01086033|16661548|P1|Overall Study|AE and Lack of Efficacy|4
4832423|NCT01086033|16661548|P1|Overall Study|Withdrew consent and Other Reason|4
4832424|NCT01086033|16661548|P1|Overall Study|Withdrew Consent and Lack of Efficacy|5
4832425|NCT01086033|16661548|P1|Overall Study|AE and Withdrew Consent|5
4832426|NCT01086033|16661548|P1|Overall Study|Other|13
4832427|NCT01086033|16661548|P1|Overall Study|Other|14
4832428|NCT01086033|16661548|P1|Overall Study|Withdrawal by Subject|41
4832429|NCT01086033|16661548|P1|Overall Study|Adverse Event|42
4832430|NCT01086033|16661548|P1|Overall Study|Lost to Follow-up|86
4832431|NCT01086033|16661548|P1|Overall Study|Lack of efficacy/Exacerbation of RA|86
4832432|NCT01085812|16661614|P2|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2
4832433|NCT01085812|16661615|P1|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0
4832434|NCT01085812|16661614|P2|Double-blind Intent-to-treat Population|Lost to Follow-up|17
4832435|NCT01085812|16661615|P1|Double-blind Intent-to-treat Population|Lost to Follow-up|4
4832436|NCT01085812|16661614|P2|Double-blind Intent-to-treat Population|Withdrawal by Subject|22
4832437|NCT01085812|16661615|P1|Double-blind Intent-to-treat Population|Withdrawal by Subject|11
4832438|NCT01085812|16661614|P2|Double-blind Intent-to-treat Population|Protocol Violation|7
4832439|NCT01085812|16661615|P1|Double-blind Intent-to-treat Population|Protocol Violation|2
4832440|NCT01085812|16661614|P2|Double-blind Intent-to-treat Population|Adverse Event|8
4832441|NCT01085812|16661615|P1|Double-blind Intent-to-treat Population|Adverse Event|3
4832442|NCT01085812|16661614|P2|Double-Blind Period|Other Reasons|2
4832443|NCT01085812|16661615|P1|Double-Blind Period|Other Reasons|0
4832444|NCT01085812|16661614|P2|Double-Blind Period|Lost to Follow-up|17
4832445|NCT01085812|16661615|P1|Double-Blind Period|Lost to Follow-up|5
4832446|NCT01085812|16661614|P2|Double-Blind Period|Withdrawal by Subject|24
4832447|NCT01085812|16661615|P1|Double-Blind Period|Withdrawal by Subject|11
4832448|NCT01085812|16661614|P2|Double-Blind Period|Protocol Violation|7
4832449|NCT01085812|16661615|P1|Double-Blind Period|Protocol Violation|2
4832450|NCT01085812|16661614|P2|Double-Blind Period|Adverse Event|8
4832451|NCT01085812|16661615|P1|Double-Blind Period|Adverse Event|3
4832452|NCT01085812|16661614|P2|Open-Label Period|Lost to Follow-up|42
4832453|NCT01085812|16661615|P1|Open-Label Period|Lost to Follow-up|0
4832454|NCT01085812|16661614|P2|Open-Label Period|Withdrawal by Subject|53
4832455|NCT01085812|16661615|P1|Open-Label Period|Withdrawal by Subject|0
4832456|NCT01085812|16661614|P2|Open-Label Period|Protocol Violation|39
4832457|NCT01085812|16661615|P1|Open-Label Period|Protocol Violation|0
4832458|NCT01085812|16661614|P2|Open-Label Period|Lack of Efficacy|26
4832459|NCT01085812|16661615|P1|Open-Label Period|Lack of Efficacy|0
4832460|NCT01085812|16661614|P2|Open-Label Period|Adverse Event|80
4832461|NCT01085812|16661615|P1|Open-Label Period|Adverse Event|0
4832462|NCT01085734|16661662|P2|Overall Study|Withdrawal by Subject|1
4832463|NCT01085734|16661663|P1|Overall Study|Withdrawal by Subject|0
4832464|NCT01085734|16661662|P2|Overall Study|Lost to Follow-up|1
4832465|NCT01085734|16661663|P1|Overall Study|Lost to Follow-up|0
4832466|NCT01085734|16661662|P2|Overall Study|Death|0
4832467|NCT01085734|16661663|P1|Overall Study|Death|1
4832468|NCT01085734|16661662|P2|Overall Study|Adverse Event|2
4832469|NCT01085734|16661663|P1|Overall Study|Adverse Event|0
4832470|NCT01085682|16661675|P2|Overall Study|Withdrawal by Subject|25
4832471|NCT01085682|16661676|P1|Overall Study|Withdrawal by Subject|25
4832472|NCT01085630|16661693|P2|Overall Study|Ineligible|0
4832473|NCT01085630|16661694|P1|Overall Study|Ineligible|3
4832474|NCT01085630|16661693|P2|Overall Study|Insufficient data|0
4832475|NCT01085630|16661694|P1|Overall Study|Insufficient data|1
4832476|NCT01085591|16661707|P3|Overall Study|Not Properly Consented|0
4832477|NCT01085591|16661708|P2|Overall Study|Not Properly Consented|0
4832478|NCT01085591|16661709|P1|Overall Study|Not Properly Consented|1
4832479|NCT01085591|16661707|P3|Overall Study|Other|0
4832480|NCT01085591|16661708|P2|Overall Study|Other|1
4832481|NCT01085591|16661709|P1|Overall Study|Other|0
4832482|NCT01085591|16661707|P3|Overall Study|Protocol Violation|1
4832483|NCT01085591|16661708|P2|Overall Study|Protocol Violation|1
4832484|NCT01085591|16661709|P1|Overall Study|Protocol Violation|1
4832485|NCT01085591|16661707|P3|Overall Study|Lost to Follow-up|1
4832486|NCT01085591|16661708|P2|Overall Study|Lost to Follow-up|1
4832487|NCT01085591|16661709|P1|Overall Study|Lost to Follow-up|0
4832488|NCT01085591|16661707|P3|Overall Study|Withdrawal by Subject|1
4832489|NCT01085591|16661708|P2|Overall Study|Withdrawal by Subject|2
4832490|NCT01085591|16661709|P1|Overall Study|Withdrawal by Subject|0
4832491|NCT01085591|16661707|P3|Overall Study|Physician Decision|1
4832492|NCT01085591|16661708|P2|Overall Study|Physician Decision|0
4832493|NCT01085591|16661709|P1|Overall Study|Physician Decision|1
4832494|NCT01085591|16661707|P3|Overall Study|Adverse Event|3
4832495|NCT01085591|16661708|P2|Overall Study|Adverse Event|1
4832496|NCT01085591|16661709|P1|Overall Study|Adverse Event|0
4832497|NCT01085357|16661762|P2|Overall Study|Lost to Follow-up|0
4832498|NCT01085357|16661763|P1|Overall Study|Lost to Follow-up|2
4832499|NCT01085357|16661762|P2|Overall Study|Death|1
4832500|NCT01085357|16661763|P1|Overall Study|Death|11
4832501|NCT01085357|16661762|P2|Overall Study|Investigator Decision|1
4832502|NCT01085357|16661763|P1|Overall Study|Investigator Decision|1
4832503|NCT01085357|16661762|P2|Overall Study|Subject Decision|3
4832504|NCT01085357|16661763|P1|Overall Study|Subject Decision|4
4832505|NCT01085357|16661762|P2|Overall Study|Adverse Event|1
4832506|NCT01085357|16661763|P1|Overall Study|Adverse Event|1
4832507|NCT01085214|16661836|P1|Overall Study|Alternate treatment required|1
4832508|NCT01085201|16661848|P5|Overall Study|Fond ineligible after consent|0
4832509|NCT01085201|16661849|P4|Overall Study|Fond ineligible after consent|0
4832510|NCT01085201|16661850|P3|Overall Study|Fond ineligible after consent|1
4832511|NCT01085201|16661851|P2|Overall Study|Fond ineligible after consent|1
4832512|NCT01085201|16661852|P1|Overall Study|Fond ineligible after consent|0
4832513|NCT01085201|16661848|P5|Overall Study|Unknown- no study drug|0
4832514|NCT01085201|16661849|P4|Overall Study|Unknown- no study drug|0
4832515|NCT01085201|16661850|P3|Overall Study|Unknown- no study drug|0
4832516|NCT01085201|16661851|P2|Overall Study|Unknown- no study drug|0
4832517|NCT01085201|16661852|P1|Overall Study|Unknown- no study drug|2
4832518|NCT01085201|16661848|P5|Overall Study|Scheduling conflict|0
4832519|NCT01085201|16661849|P4|Overall Study|Scheduling conflict|0
4832520|NCT01085201|16661850|P3|Overall Study|Scheduling conflict|1
4832521|NCT01085201|16661851|P2|Overall Study|Scheduling conflict|0
4832522|NCT01085201|16661852|P1|Overall Study|Scheduling conflict|1
4832523|NCT01085136|16661874|P3|Part B|Other reason not defined above|3
4832524|NCT01085136|16661875|P2|Part B|Other reason not defined above|6
4832525|NCT01085136|16661876|P1|Part B|Other reason not defined above|0
4832526|NCT01085136|16661874|P3|Part B|Not treated|8
4832527|NCT01085136|16661875|P2|Part B|Not treated|4
4832528|NCT01085136|16661876|P1|Part B|Not treated|0
4832529|NCT01085136|16661874|P3|Part B|Refusal to continue trial medication|7
4832530|NCT01085136|16661875|P2|Part B|Refusal to continue trial medication|12
4832531|NCT01085136|16661876|P1|Part B|Refusal to continue trial medication|0
4832532|NCT01085136|16661874|P3|Part B|Other AE|8
4832533|NCT01085136|16661875|P2|Part B|Other AE|29
4832534|NCT01085136|16661876|P1|Part B|Other AE|0
4832535|NCT01085136|16661874|P3|Part A|Other reason not defined above|0
4832536|NCT01085136|16661875|P2|Part A|Other reason not defined above|0
4832537|NCT01085136|16661876|P1|Part A|Other reason not defined above|30
4832538|NCT01085136|16661874|P3|Part A|Refusal to continue trial medication|0
4832539|NCT01085136|16661875|P2|Part A|Refusal to continue trial medication|0
4832540|NCT01085136|16661876|P1|Part A|Refusal to continue trial medication|64
4832541|NCT01085136|16661874|P3|Part A|Lost to Follow-up|0
4832542|NCT01085136|16661875|P2|Part A|Lost to Follow-up|0
4832543|NCT01085136|16661876|P1|Part A|Lost to Follow-up|3
4832544|NCT01085136|16661874|P3|Part A|Protocol Violation|0
4832545|NCT01085136|16661875|P2|Part A|Protocol Violation|0
4832546|NCT01085136|16661876|P1|Part A|Protocol Violation|3
4832547|NCT01085136|16661874|P3|Part A|Other Adverse event|0
4832548|NCT01085136|16661875|P2|Part A|Other Adverse event|0
4832549|NCT01085136|16661876|P1|Part A|Other Adverse event|223
4832550|NCT01085045|16661892|P1|Part B|Adverse Event|6
4832551|NCT01085045|16661892|P1|Part B|Lost to Follow-up|1
4832552|NCT01085045|16661892|P1|Part B|Protocol Specified Criteria|6
4832553|NCT01085045|16661892|P1|Part B|Withdrawal by Subject|2
4832554|NCT01085045|16661892|P1|Part A|Protocol Specified Criteria|7
4832555|NCT01085045|16661892|P1|Part A|Protocol Violation|1
4832556|NCT01085045|16661892|P1|Part A|Adverse Event|6
4832557|NCT01085045|16661892|P1|Part A|Withdrawal by Subject|4
4832558|NCT01084772|16662003|P2|2 Years|Study Termination|2
4832559|NCT01084772|16662004|P1|2 Years|Study Termination|3
4832560|NCT01084772|16662003|P2|2 Years|Lost to Follow-up|2
4832561|NCT01084772|16662004|P1|2 Years|Lost to Follow-up|5
4832562|NCT01084772|16662003|P2|2 Years|Withdrawal by Subject|0
4832563|NCT01084772|16662004|P1|2 Years|Withdrawal by Subject|1
4832564|NCT01084772|16662003|P2|1 Year|Study Termination|7
4832565|NCT01084772|16662004|P1|1 Year|Study Termination|0
4832566|NCT01084772|16662003|P2|1 Year|Lost to Follow-up|0
4832567|NCT01084772|16662004|P1|1 Year|Lost to Follow-up|3
4832568|NCT01084772|16662003|P2|1 Year|Withdrawal by Subject|1
4832569|NCT01084772|16662004|P1|1 Year|Withdrawal by Subject|0
4832570|NCT01084772|16662003|P2|3 Months|Study Termination|2
4832571|NCT01084772|16662004|P1|3 Months|Study Termination|2
4832572|NCT01084772|16662003|P2|3 Months|Death|0
4832573|NCT01084772|16662004|P1|3 Months|Death|1
4832574|NCT01084772|16662003|P2|Baseline|Withdrawal by Subject|6
4832575|NCT01084772|16662004|P1|Baseline|Withdrawal by Subject|7
4832576|NCT01084707|16662040|P1|Overall Study|Withdrawal by Subject|6
4832577|NCT01084694|16662076|P2|Overall Study|eligibility not maintained|7
4832578|NCT01084694|16662077|P1|Overall Study|eligibility not maintained|2
4832579|NCT01084694|16662076|P2|Overall Study|Death|12
4832580|NCT01084694|16662077|P1|Overall Study|Death|2
4832581|NCT01084694|16662076|P2|Overall Study|Withdrawal by Subject|1
4832582|NCT01084694|16662077|P1|Overall Study|Withdrawal by Subject|2
4832583|NCT01084668|16662093|P1|Overall Study|Non-compliance|1
4832584|NCT01084668|16662093|P1|Overall Study|Pregnancy|1
4832585|NCT01084668|16662093|P1|Overall Study|Withdrawal by Subject|2
4832586|NCT01084668|16662093|P1|Overall Study|Lack of Efficacy|5
4832587|NCT01084655|16662105|P3|Overall Study|Prostate-specificAntigen(PSA)progression|1
4832588|NCT01084655|16662106|P2|Overall Study|Prostate-specificAntigen(PSA)progression|0
4832589|NCT01084655|16662107|P1|Overall Study|Prostate-specificAntigen(PSA)progression|0
4832590|NCT01084655|16662105|P3|Overall Study|Symptomatic deterioration|2
4832591|NCT01084655|16662106|P2|Overall Study|Symptomatic deterioration|0
4832592|NCT01084655|16662107|P1|Overall Study|Symptomatic deterioration|0
4832593|NCT01084655|16662105|P3|Overall Study|Other|2
4832594|NCT01084655|16662106|P2|Overall Study|Other|3
4832595|NCT01084655|16662107|P1|Overall Study|Other|0
4832596|NCT01084655|16662105|P3|Overall Study|Adverse Event|2
4832597|NCT01084655|16662106|P2|Overall Study|Adverse Event|1
4832598|NCT01084655|16662107|P1|Overall Study|Adverse Event|2
4832599|NCT01084655|16662105|P3|Overall Study|Withdrawal by Subject|4
4832600|NCT01084655|16662106|P2|Overall Study|Withdrawal by Subject|0
4832601|NCT01084655|16662107|P1|Overall Study|Withdrawal by Subject|1
4832602|NCT01084655|16662105|P3|Overall Study|Radiographic disease progression|8
4832603|NCT01084655|16662106|P2|Overall Study|Radiographic disease progression|2
4832604|NCT01084655|16662107|P1|Overall Study|Radiographic disease progression|3
4832605|NCT01084603|16662142|P1|Washout Period 4|Adverse Event|1
4832606|NCT01084603|16662142|P1|Oral Nicotine 1|Withdrawal by Subject|1
4832607|NCT01084603|16662142|P1|Nicorette® Gum|Withdrawal by Subject|1
4832608|NCT01084603|16662142|P1|NiQuitinTM Lozenge|Withdrawal by Subject|1
4832609|NCT01084603|16662142|P1|Baseline|Withdrawal by Subject|2
4832610|NCT01084551|16662178|P3|Overall Study|Physician Decision|0
4832611|NCT01084551|16662179|P2|Overall Study|Physician Decision|0
4832612|NCT01084551|16662180|P1|Overall Study|Physician Decision|1
4832613|NCT01084551|16662178|P3|Overall Study|Lost to Follow-up|3
4832614|NCT01084551|16662179|P2|Overall Study|Lost to Follow-up|0
4832615|NCT01084551|16662180|P1|Overall Study|Lost to Follow-up|0
4832616|NCT01084551|16662178|P3|Overall Study|Protocol Violation|0
4832617|NCT01084551|16662179|P2|Overall Study|Protocol Violation|4
4832618|NCT01084551|16662180|P1|Overall Study|Protocol Violation|2
4832619|NCT01084551|16662178|P3|Overall Study|Withdrawal by Subject|0
4832620|NCT01084551|16662179|P2|Overall Study|Withdrawal by Subject|1
4832621|NCT01084551|16662180|P1|Overall Study|Withdrawal by Subject|2
4832622|NCT01084551|16662178|P3|Overall Study|Lack of Efficacy|1
4832623|NCT01084551|16662179|P2|Overall Study|Lack of Efficacy|0
4832624|NCT01084551|16662180|P1|Overall Study|Lack of Efficacy|2
4832625|NCT01084551|16662178|P3|Overall Study|Adverse Event|4
4832626|NCT01084551|16662179|P2|Overall Study|Adverse Event|9
4832627|NCT01084551|16662180|P1|Overall Study|Adverse Event|2
4832628|NCT01084538|16662218|P1|Overall Study|Reason unknown|8
4832629|NCT01084538|16662218|P1|Overall Study|Over-suppression of parathyroid gland|2
4832630|NCT01084538|16662218|P1|Overall Study|Change of residence|2
4832631|NCT01084538|16662218|P1|Overall Study|Nodular hyperplasia of parathyroid gland|2
4832632|NCT01084538|16662218|P1|Overall Study|Hyperphosphatemia|2
4832633|NCT01084538|16662218|P1|Overall Study|Patient noncompliance|2
4832634|NCT01084538|16662218|P1|Overall Study|Lack of effectiveness|2
4832635|NCT01084538|16662218|P1|Overall Study|Serious Adverse Event|3
4832636|NCT01084538|16662218|P1|Overall Study|Kidney transplant|6
4832637|NCT01084538|16662218|P1|Overall Study|Adverse Event|9
4832638|NCT01084538|16662218|P1|Overall Study|Drug not available|30
4832639|NCT01084252|16662352|P14|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832640|NCT01084252|16662353|P13|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|1
4832641|NCT01084252|16662354|P12|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832642|NCT01084252|16662355|P11|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832643|NCT01084252|16662356|P10|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832644|NCT01084252|16662357|P9|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832645|NCT01084252|16662358|P8|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832646|NCT01084252|16662359|P7|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832647|NCT01084252|16662360|P6|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832793|NCT01084252|16662352|P14|Phase 1 (120 Weeks)|Progressive disease|0
4832648|NCT01084252|16662361|P5|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832649|NCT01084252|16662362|P4|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832650|NCT01084252|16662363|P3|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832651|NCT01084252|16662364|P2|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832652|NCT01084252|16662365|P1|Phase 2 Stage 2 (97 Weeks)|Enrolled, but not treated|0
4832653|NCT01084252|16662352|P14|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|15
4832654|NCT01084252|16662353|P13|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|13
4832655|NCT01084252|16662354|P12|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832656|NCT01084252|16662355|P11|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832657|NCT01084252|16662356|P10|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832658|NCT01084252|16662357|P9|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832659|NCT01084252|16662358|P8|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832660|NCT01084252|16662359|P7|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832661|NCT01084252|16662360|P6|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832662|NCT01084252|16662361|P5|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832663|NCT01084252|16662362|P4|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832664|NCT01084252|16662363|P3|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832665|NCT01084252|16662364|P2|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832666|NCT01084252|16662365|P1|Phase 2 Stage 2 (97 Weeks)|Ongoing treatment|0
4832667|NCT01084252|16662352|P14|Phase 2 Stage 2 (97 Weeks)|Other than specified above|2
4832668|NCT01084252|16662353|P13|Phase 2 Stage 2 (97 Weeks)|Other than specified above|12
4832669|NCT01084252|16662354|P12|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832670|NCT01084252|16662355|P11|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832671|NCT01084252|16662356|P10|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832672|NCT01084252|16662357|P9|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832673|NCT01084252|16662358|P8|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832674|NCT01084252|16662359|P7|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832675|NCT01084252|16662360|P6|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832676|NCT01084252|16662361|P5|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832677|NCT01084252|16662362|P4|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832678|NCT01084252|16662363|P3|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832679|NCT01084252|16662364|P2|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832680|NCT01084252|16662365|P1|Phase 2 Stage 2 (97 Weeks)|Other than specified above|0
4832681|NCT01084252|16662352|P14|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832682|NCT01084252|16662353|P13|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|1
4832683|NCT01084252|16662354|P12|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832684|NCT01084252|16662355|P11|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832685|NCT01084252|16662356|P10|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832686|NCT01084252|16662357|P9|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832687|NCT01084252|16662358|P8|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832688|NCT01084252|16662359|P7|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832689|NCT01084252|16662360|P6|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832690|NCT01084252|16662361|P5|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832691|NCT01084252|16662362|P4|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832692|NCT01084252|16662363|P3|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832693|NCT01084252|16662364|P2|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832694|NCT01084252|16662365|P1|Phase 2 Stage 2 (97 Weeks)|Poor compliance to protocol|0
4832695|NCT01084252|16662352|P14|Phase 2 Stage 2 (97 Weeks)|Progressive disease|33
4832696|NCT01084252|16662353|P13|Phase 2 Stage 2 (97 Weeks)|Progressive disease|70
4832697|NCT01084252|16662354|P12|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832698|NCT01084252|16662355|P11|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832699|NCT01084252|16662356|P10|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832700|NCT01084252|16662357|P9|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832701|NCT01084252|16662358|P8|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832702|NCT01084252|16662359|P7|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832703|NCT01084252|16662360|P6|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832704|NCT01084252|16662361|P5|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832705|NCT01084252|16662362|P4|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832706|NCT01084252|16662363|P3|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832707|NCT01084252|16662364|P2|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832708|NCT01084252|16662365|P1|Phase 2 Stage 2 (97 Weeks)|Progressive disease|0
4832709|NCT01084252|16662352|P14|Phase 2 Stage 2 (97 Weeks)|Adverse Event|5
4832710|NCT01084252|16662353|P13|Phase 2 Stage 2 (97 Weeks)|Adverse Event|13
4832711|NCT01084252|16662354|P12|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832712|NCT01084252|16662355|P11|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832713|NCT01084252|16662356|P10|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832714|NCT01084252|16662357|P9|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832715|NCT01084252|16662358|P8|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832716|NCT01084252|16662359|P7|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832717|NCT01084252|16662360|P6|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832718|NCT01084252|16662361|P5|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832719|NCT01084252|16662362|P4|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832720|NCT01084252|16662363|P3|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832721|NCT01084252|16662364|P2|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832722|NCT01084252|16662365|P1|Phase 2 Stage 2 (97 Weeks)|Adverse Event|0
4832723|NCT01084252|16662352|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832724|NCT01084252|16662353|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832725|NCT01084252|16662354|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
4832726|NCT01084252|16662355|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|2
4832727|NCT01084252|16662356|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|4
4832728|NCT01084252|16662357|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|1
4832729|NCT01084252|16662358|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832730|NCT01084252|16662359|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832731|NCT01084252|16662360|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832732|NCT01084252|16662361|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832733|NCT01084252|16662362|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832734|NCT01084252|16662363|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832735|NCT01084252|16662364|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832736|NCT01084252|16662365|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Ongoing treatment|0
4832737|NCT01084252|16662352|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832738|NCT01084252|16662353|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832739|NCT01084252|16662354|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|3
4832740|NCT01084252|16662355|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|4
4832741|NCT01084252|16662356|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832742|NCT01084252|16662357|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|2
4832743|NCT01084252|16662358|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832744|NCT01084252|16662359|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832745|NCT01084252|16662360|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832746|NCT01084252|16662361|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832747|NCT01084252|16662362|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832748|NCT01084252|16662363|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832749|NCT01084252|16662364|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832750|NCT01084252|16662365|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Other than specified above|0
4832751|NCT01084252|16662352|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832752|NCT01084252|16662353|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832753|NCT01084252|16662354|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|19
4832754|NCT01084252|16662355|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|17
4832755|NCT01084252|16662356|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|18
4832756|NCT01084252|16662357|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|20
4832757|NCT01084252|16662358|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832758|NCT01084252|16662359|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832759|NCT01084252|16662360|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832760|NCT01084252|16662361|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832761|NCT01084252|16662362|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832762|NCT01084252|16662363|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832763|NCT01084252|16662364|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832764|NCT01084252|16662365|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Progressive disease|0
4832765|NCT01084252|16662352|P14|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832766|NCT01084252|16662353|P13|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832767|NCT01084252|16662354|P12|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|1
4832768|NCT01084252|16662355|P11|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
4832769|NCT01084252|16662356|P10|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|2
4832770|NCT01084252|16662357|P9|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832771|NCT01084252|16662358|P8|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832772|NCT01084252|16662359|P7|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832773|NCT01084252|16662360|P6|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832774|NCT01084252|16662361|P5|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832775|NCT01084252|16662362|P4|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832776|NCT01084252|16662363|P3|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832777|NCT01084252|16662364|P2|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832778|NCT01084252|16662365|P1|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Adverse Event|0
4832779|NCT01084252|16662352|P14|Phase 1 (120 Weeks)|Other than specified above|0
4832780|NCT01084252|16662353|P13|Phase 1 (120 Weeks)|Other than specified above|0
4832781|NCT01084252|16662354|P12|Phase 1 (120 Weeks)|Other than specified above|0
4832782|NCT01084252|16662355|P11|Phase 1 (120 Weeks)|Other than specified above|0
4832783|NCT01084252|16662356|P10|Phase 1 (120 Weeks)|Other than specified above|0
4832784|NCT01084252|16662357|P9|Phase 1 (120 Weeks)|Other than specified above|0
4832785|NCT01084252|16662358|P8|Phase 1 (120 Weeks)|Other than specified above|1
4832786|NCT01084252|16662359|P7|Phase 1 (120 Weeks)|Other than specified above|1
4832787|NCT01084252|16662360|P6|Phase 1 (120 Weeks)|Other than specified above|0
4832788|NCT01084252|16662361|P5|Phase 1 (120 Weeks)|Other than specified above|1
4832789|NCT01084252|16662362|P4|Phase 1 (120 Weeks)|Other than specified above|3
4832790|NCT01084252|16662363|P3|Phase 1 (120 Weeks)|Other than specified above|0
4832791|NCT01084252|16662364|P2|Phase 1 (120 Weeks)|Other than specified above|1
4832792|NCT01084252|16662365|P1|Phase 1 (120 Weeks)|Other than specified above|1
4832794|NCT01084252|16662353|P13|Phase 1 (120 Weeks)|Progressive disease|0
4832795|NCT01084252|16662354|P12|Phase 1 (120 Weeks)|Progressive disease|0
4832796|NCT01084252|16662355|P11|Phase 1 (120 Weeks)|Progressive disease|0
4832797|NCT01084252|16662356|P10|Phase 1 (120 Weeks)|Progressive disease|0
4832798|NCT01084252|16662357|P9|Phase 1 (120 Weeks)|Progressive disease|0
4832799|NCT01084252|16662358|P8|Phase 1 (120 Weeks)|Progressive disease|6
4832800|NCT01084252|16662359|P7|Phase 1 (120 Weeks)|Progressive disease|5
4832801|NCT01084252|16662360|P6|Phase 1 (120 Weeks)|Progressive disease|6
4832802|NCT01084252|16662361|P5|Phase 1 (120 Weeks)|Progressive disease|16
4832803|NCT01084252|16662362|P4|Phase 1 (120 Weeks)|Progressive disease|22
4832804|NCT01084252|16662363|P3|Phase 1 (120 Weeks)|Progressive disease|2
4832805|NCT01084252|16662364|P2|Phase 1 (120 Weeks)|Progressive disease|5
4832806|NCT01084252|16662365|P1|Phase 1 (120 Weeks)|Progressive disease|15
4832807|NCT01084252|16662352|P14|Phase 1 (120 Weeks)|Adverse Event|0
4832808|NCT01084252|16662353|P13|Phase 1 (120 Weeks)|Adverse Event|0
4832809|NCT01084252|16662354|P12|Phase 1 (120 Weeks)|Adverse Event|0
4832810|NCT01084252|16662355|P11|Phase 1 (120 Weeks)|Adverse Event|0
4832811|NCT01084252|16662356|P10|Phase 1 (120 Weeks)|Adverse Event|0
4832812|NCT01084252|16662357|P9|Phase 1 (120 Weeks)|Adverse Event|0
4832813|NCT01084252|16662358|P8|Phase 1 (120 Weeks)|Adverse Event|0
4832814|NCT01084252|16662359|P7|Phase 1 (120 Weeks)|Adverse Event|1
4832815|NCT01084252|16662360|P6|Phase 1 (120 Weeks)|Adverse Event|0
4832816|NCT01084252|16662361|P5|Phase 1 (120 Weeks)|Adverse Event|1
4832817|NCT01084252|16662362|P4|Phase 1 (120 Weeks)|Adverse Event|1
4832818|NCT01084252|16662363|P3|Phase 1 (120 Weeks)|Adverse Event|1
4832819|NCT01084252|16662364|P2|Phase 1 (120 Weeks)|Adverse Event|0
4832820|NCT01084252|16662365|P1|Phase 1 (120 Weeks)|Adverse Event|0
4832821|NCT01084239|16662549|P2|28-Day Follow-up|Lost to Follow-up|9
4832822|NCT01084239|16662550|P1|28-Day Follow-up|Lost to Follow-up|4
4832823|NCT01084174|16662568|P2|Overall Study|Participant noncompliance|1
4832824|NCT01084174|16662569|P1|Overall Study|Participant noncompliance|0
4832825|NCT01084174|16662568|P2|Overall Study|Anaphylaxis|1
4832826|NCT01084174|16662569|P1|Overall Study|Anaphylaxis|0
4832827|NCT01084174|16662568|P2|Overall Study|Eosinophilic esophagitis|1
4832828|NCT01084174|16662569|P1|Overall Study|Eosinophilic esophagitis|0
4832829|NCT01084174|16662568|P2|Overall Study|gastrointestinal symptoms|1
4832830|NCT01084174|16662569|P1|Overall Study|gastrointestinal symptoms|1
4832831|NCT01084135|16662602|P2|20 Week|Physician Decision|1
4832832|NCT01084135|16662603|P1|20 Week|Physician Decision|0
4832833|NCT01084083|16662613|P1|Overall Study|Never started assigned therapy|1
4832834|NCT01084083|16662613|P1|Overall Study|Other|2
4832835|NCT01084083|16662613|P1|Overall Study|Complicating disease|1
4832836|NCT01084083|16662613|P1|Overall Study|Withdrawal by Subject|2
4832837|NCT01084083|16662613|P1|Overall Study|Death|1
4832838|NCT01084083|16662613|P1|Overall Study|Adverse Event|5
4832839|NCT01084005|16662621|P2|Overall Study|Withdrawal by Subject|1
4832840|NCT01084005|16662622|P1|Overall Study|Withdrawal by Subject|1
4832841|NCT01084005|16662621|P2|Overall Study|Protocol Violation|7
4832842|NCT01084005|16662622|P1|Overall Study|Protocol Violation|3
4832843|NCT01084005|16662621|P2|Overall Study|Adverse Event|8
4832844|NCT01084005|16662622|P1|Overall Study|Adverse Event|1
4832845|NCT01083810|16662703|P3|Overall Study|Virologic failure|0
4832846|NCT01083810|16662704|P2|Overall Study|Virologic failure|8
4832847|NCT01083810|16662705|P1|Overall Study|Virologic failure|1
4832848|NCT01083810|16662703|P3|Overall Study|Therapy break|2
4832849|NCT01083810|16662704|P2|Overall Study|Therapy break|2
4832850|NCT01083810|16662705|P1|Overall Study|Therapy break|1
4832851|NCT01083810|16662703|P3|Overall Study|Participation in study|0
4832852|NCT01083810|16662704|P2|Overall Study|Participation in study|0
4832853|NCT01083810|16662705|P1|Overall Study|Participation in study|1
4832854|NCT01083810|16662703|P3|Overall Study|Co-morbidities|0
4832855|NCT01083810|16662704|P2|Overall Study|Co-morbidities|0
4832856|NCT01083810|16662705|P1|Overall Study|Co-morbidities|1
4832857|NCT01083810|16662703|P3|Overall Study|Death|3
4832858|NCT01083810|16662704|P2|Overall Study|Death|2
4832859|NCT01083810|16662705|P1|Overall Study|Death|2
4832860|NCT01083810|16662703|P3|Overall Study|Simplification|0
4832861|NCT01083810|16662704|P2|Overall Study|Simplification|1
4832862|NCT01083810|16662705|P1|Overall Study|Simplification|4
4832863|NCT01083810|16662703|P3|Overall Study|Non-compliance|2
4832864|NCT01083810|16662704|P2|Overall Study|Non-compliance|7
4832865|NCT01083810|16662705|P1|Overall Study|Non-compliance|4
4832866|NCT01083810|16662703|P3|Overall Study|Reason not reported|1
4832867|NCT01083810|16662704|P2|Overall Study|Reason not reported|1
4832868|NCT01083810|16662705|P1|Overall Study|Reason not reported|6
4832869|NCT01083810|16662703|P3|Overall Study|Withdrawal by Subject|4
4832870|NCT01083810|16662704|P2|Overall Study|Withdrawal by Subject|2
4832871|NCT01083810|16662705|P1|Overall Study|Withdrawal by Subject|7
4832872|NCT01083810|16662703|P3|Overall Study|Adverse Event|4
4832873|NCT01083810|16662704|P2|Overall Study|Adverse Event|11
4832874|NCT01083810|16662705|P1|Overall Study|Adverse Event|15
4832875|NCT01083810|16662703|P3|Overall Study|Lost to Follow-up|4
4832876|NCT01083810|16662704|P2|Overall Study|Lost to Follow-up|11
4832877|NCT01083810|16662705|P1|Overall Study|Lost to Follow-up|23
4832878|NCT01083771|16662726|P1|Overall Study|Withdrawal by Subject|3
4832879|NCT01083771|16662726|P1|Overall Study|non-compliant|2
4832880|NCT01083693|16662827|P3|Overall Study|Reason unknown|1
4832881|NCT01083693|16662828|P2|Overall Study|Reason unknown|0
4832882|NCT01083693|16662829|P1|Overall Study|Reason unknown|0
4832883|NCT01083693|16662827|P3|Overall Study|Withdrawal by Subject|2
4832884|NCT01083693|16662828|P2|Overall Study|Withdrawal by Subject|0
4832885|NCT01083693|16662829|P1|Overall Study|Withdrawal by Subject|3
4832886|NCT01083693|16662827|P3|Overall Study|Other medical condition/surgery|0
4832887|NCT01083693|16662828|P2|Overall Study|Other medical condition/surgery|1
4832888|NCT01083693|16662829|P1|Overall Study|Other medical condition/surgery|1
4832889|NCT01083693|16662827|P3|Overall Study|Complete remission|0
4832890|NCT01083693|16662828|P2|Overall Study|Complete remission|1
4832891|NCT01083693|16662829|P1|Overall Study|Complete remission|0
4832892|NCT01083693|16662827|P3|Overall Study|Patient Moved|0
4832893|NCT01083693|16662828|P2|Overall Study|Patient Moved|1
4832894|NCT01083693|16662829|P1|Overall Study|Patient Moved|0
4832895|NCT01083693|16662827|P3|Overall Study|Lack of effectiveness|2
4832896|NCT01083693|16662828|P2|Overall Study|Lack of effectiveness|2
4832897|NCT01083693|16662829|P1|Overall Study|Lack of effectiveness|13
4832898|NCT01083693|16662827|P3|Overall Study|Lost to Follow-up|2
4832899|NCT01083693|16662828|P2|Overall Study|Lost to Follow-up|0
4832900|NCT01083693|16662829|P1|Overall Study|Lost to Follow-up|2
4832901|NCT01083693|16662827|P3|Overall Study|Adverse Event|0
4832902|NCT01083693|16662828|P2|Overall Study|Adverse Event|1
4832903|NCT01083693|16662829|P1|Overall Study|Adverse Event|1
4832904|NCT01083680|16662864|P1|Overall Study|Withdrawal by Subject|1086
4832905|NCT01083680|16662864|P1|Overall Study|Lost to Follow-up|2758
4832906|NCT01083641|16662887|P1|Overall Study|Withdrawal by Subject|2
4832907|NCT01083602|16662907|P1|Overall Study|Lack of Efficacy|36
4832908|NCT01083602|16662907|P1|Overall Study|Withdrawal by Subject|5
4832909|NCT01083602|16662907|P1|Overall Study|Death|1
4832910|NCT01083602|16662907|P1|Overall Study|New Cancer Therapy|2
4832911|NCT01083602|16662907|P1|Overall Study|Adverse Event|11
4832912|NCT01083576|16662918|P2|Overall Study|Treatment Failure|1
4832913|NCT01083576|16662919|P1|Overall Study|Treatment Failure|6
4832914|NCT01083485|16662949|P2|Overall Study|Other|0
4832915|NCT01083485|16662950|P1|Overall Study|Other|1
4832916|NCT01083485|16662949|P2|Overall Study|Withdrawal by Subject|2
4832917|NCT01083485|16662950|P1|Overall Study|Withdrawal by Subject|5
4832918|NCT01083485|16662949|P2|Overall Study|Protocol Violation|0
4832919|NCT01083485|16662950|P1|Overall Study|Protocol Violation|1
4832920|NCT01083485|16662949|P2|Overall Study|Adverse Event|1
4832921|NCT01083485|16662950|P1|Overall Study|Adverse Event|0
4832922|NCT01083316|16662982|P1|Overall Study|Withdrawal by Subject|1
4832923|NCT01083316|16662982|P1|Overall Study|Adverse Event|2
4832924|NCT01083186|16662994|P1|Overall Study|Non-compliance to Study Treatment|1
4832925|NCT01083186|16662994|P1|Overall Study|Administrative Reasons|2
4832926|NCT01083186|16662994|P1|Overall Study|Hemodialysis Initiation|28
4832927|NCT01083186|16662994|P1|Overall Study|Lack of Efficacy|2
4832928|NCT01083186|16662994|P1|Overall Study|Adverse Event|3
4832929|NCT01083186|16662994|P1|Overall Study|Death|3
4832930|NCT01083186|16662994|P1|Overall Study|Consent Withdrawal|7
4832931|NCT01083186|16662994|P1|Overall Study|Lost to Follow-up|48
4832932|NCT01083173|16663035|P2|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46
4832933|NCT01083173|16663036|P1|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0
4832934|NCT01083173|16663035|P2|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136
4832935|NCT01083173|16663036|P1|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0
4832936|NCT01083173|16663035|P2|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195
4832937|NCT01083173|16663036|P1|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0
4832938|NCT01083173|16663035|P2|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101
4832939|NCT01083173|16663036|P1|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0
4832940|NCT01083173|16663035|P2|Long-term Surveillance: Safety Group|Violation of the dosage|1
4832941|NCT01083173|16663036|P1|Long-term Surveillance: Safety Group|Violation of the dosage|0
4832942|NCT01083173|16663035|P2|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
4832943|NCT01083173|16663036|P1|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
4832944|NCT01083173|16663035|P2|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0
4832945|NCT01083173|16663036|P1|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13
4832946|NCT01083173|16663035|P2|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0
4832947|NCT01083173|16663036|P1|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168
4832948|NCT01083173|16663035|P2|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0
4832949|NCT01083173|16663036|P1|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201
4832950|NCT01083173|16663035|P2|Main Surveillance: Safety Group|Violation of the use/dosage|0
4832951|NCT01083173|16663036|P1|Main Surveillance: Safety Group|Violation of the use/dosage|1
4832952|NCT01083173|16663035|P2|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0
4832953|NCT01083173|16663036|P1|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14
4832954|NCT01083160|16663054|P1|Overall Study|Adverse Event|1
4832955|NCT01083121|16663061|P1|Overall Study|Use of Humira outside the approved label|81
4832956|NCT01082965|16663071|P2|Overall Study|Other|1
4832957|NCT01082965|16663072|P1|Overall Study|Other|1
4832958|NCT01082965|16663071|P2|Overall Study|Protocol Violation|1
4832959|NCT01082965|16663072|P1|Overall Study|Protocol Violation|0
4832960|NCT01082874|16663109|P4|Overall Study|Withdrawal by Subject|3
4832961|NCT01082874|16663110|P3|Overall Study|Withdrawal by Subject|5
4832962|NCT01082874|16663111|P2|Overall Study|Withdrawal by Subject|2
4832963|NCT01082874|16663112|P1|Overall Study|Withdrawal by Subject|1
4832964|NCT01082874|16663109|P4|Overall Study|Lost to Follow-up|10
4832965|NCT01082874|16663110|P3|Overall Study|Lost to Follow-up|6
4832966|NCT01082874|16663111|P2|Overall Study|Lost to Follow-up|10
4832967|NCT01082874|16663112|P1|Overall Study|Lost to Follow-up|10
4832968|NCT01082640|16663125|P3|Overall Study|Other|3
4832969|NCT01082640|16663126|P2|Overall Study|Other|1
4832970|NCT01082640|16663127|P1|Overall Study|Other|2
4832971|NCT01082640|16663125|P3|Overall Study|Lost to Follow-up|0
4832972|NCT01082640|16663126|P2|Overall Study|Lost to Follow-up|3
4832973|NCT01082640|16663127|P1|Overall Study|Lost to Follow-up|0
4832974|NCT01082640|16663125|P3|Overall Study|Major protocol deviation|0
4832975|NCT01082640|16663126|P2|Overall Study|Major protocol deviation|3
4832976|NCT01082640|16663127|P1|Overall Study|Major protocol deviation|3
4832977|NCT01082640|16663125|P3|Overall Study|Withdrawal by Subject|2
4832978|NCT01082640|16663126|P2|Overall Study|Withdrawal by Subject|3
4832979|NCT01082640|16663127|P1|Overall Study|Withdrawal by Subject|3
4832980|NCT01082640|16663125|P3|Overall Study|Adverse Event|3
4832981|NCT01082640|16663126|P2|Overall Study|Adverse Event|5
4832982|NCT01082640|16663127|P1|Overall Study|Adverse Event|9
4832983|NCT01082614|16663149|P2|Overall Study|Physician Decision|0
4832984|NCT01082614|16663150|P1|Overall Study|Physician Decision|2
4832985|NCT01082614|16663149|P2|Overall Study|Equipment Malfunction|1
4832986|NCT01082614|16663150|P1|Overall Study|Equipment Malfunction|0
4832987|NCT01082614|16663149|P2|Overall Study|Adverse Event|4
4832988|NCT01082614|16663150|P1|Overall Study|Adverse Event|1
4832989|NCT01082367|16663221|P2|Follow-up (F-U) Period|Adverse Event|1
4832990|NCT01082367|16663222|P1|Follow-up (F-U) Period|Adverse Event|0
4832991|NCT01082367|16663221|P2|Follow-up (F-U) Period|Abnormal lab values|0
4832992|NCT01082367|16663222|P1|Follow-up (F-U) Period|Abnormal lab values|1
4832993|NCT01082367|16663221|P2|Follow-up (F-U) Period|Administrative problems|0
4832994|NCT01082367|16663222|P1|Follow-up (F-U) Period|Administrative problems|1
4832995|NCT01082367|16663221|P2|Double-blind Period|Adverse Event|1
4832996|NCT01082367|16663222|P1|Double-blind Period|Adverse Event|0
4832997|NCT01082367|16663221|P2|Double-blind Period|Lack of Efficacy|11
4832998|NCT01082367|16663222|P1|Double-blind Period|Lack of Efficacy|5
4832999|NCT01082367|16663221|P2|Double-blind Period|Administrative problems|1
4833000|NCT01082367|16663222|P1|Double-blind Period|Administrative problems|0
4833001|NCT01082328|16663236|P1|Overall Study|Adverse Event|1
4833002|NCT01082211|16663245|P1|Overall Study|No protocol treatment received|3
4833003|NCT01082211|16663245|P1|Overall Study|Protocol Violation|4
4833004|NCT01082081|16663272|P3|Overall Study|Other Reason|0
4833005|NCT01082081|16663273|P2|Overall Study|Other Reason|1
4833006|NCT01082081|16663274|P1|Overall Study|Other Reason|0
4833007|NCT01082081|16663272|P3|Overall Study|Withdrawal by Subject|1
4833008|NCT01082081|16663273|P2|Overall Study|Withdrawal by Subject|0
4833009|NCT01082081|16663274|P1|Overall Study|Withdrawal by Subject|0
4833010|NCT01082081|16663272|P3|Overall Study|Lost to Follow-up|1
4833011|NCT01082081|16663273|P2|Overall Study|Lost to Follow-up|0
4833012|NCT01082081|16663274|P1|Overall Study|Lost to Follow-up|0
4833013|NCT01081951|16663326|P2|Overall Study|Lost to Follow-up|1
4833014|NCT01081951|16663327|P1|Overall Study|Lost to Follow-up|0
4833015|NCT01081951|16663326|P2|Overall Study|Allocated treatment but did not take it|1
4833016|NCT01081951|16663327|P1|Overall Study|Allocated treatment but did not take it|0
4833017|NCT01081951|16663326|P2|Overall Study|Withdrawal by Subject|6
4833018|NCT01081951|16663327|P1|Overall Study|Withdrawal by Subject|2
4833019|NCT01081951|16663326|P2|Overall Study|Death|47
4833020|NCT01081951|16663327|P1|Overall Study|Death|54
4833021|NCT01081912|16663337|P3|Maintenance Treatment|Withdrawal by Medical Monitor|1
4833022|NCT01081912|16663338|P2|Maintenance Treatment|Withdrawal by Medical Monitor|0
4833023|NCT01081912|16663339|P1|Maintenance Treatment|Withdrawal by Medical Monitor|0
4833024|NCT01081912|16663337|P3|Maintenance Treatment|Non-Compliance|7
4833025|NCT01081912|16663338|P2|Maintenance Treatment|Non-Compliance|4
4833026|NCT01081912|16663339|P1|Maintenance Treatment|Non-Compliance|0
4833027|NCT01081912|16663337|P3|Maintenance Treatment|Withdrawal by Subject|5
4833028|NCT01081912|16663338|P2|Maintenance Treatment|Withdrawal by Subject|5
4833029|NCT01081912|16663339|P1|Maintenance Treatment|Withdrawal by Subject|0
4833030|NCT01081912|16663337|P3|Maintenance Treatment|Protocol Violation|2
4833031|NCT01081912|16663338|P2|Maintenance Treatment|Protocol Violation|1
4833032|NCT01081912|16663339|P1|Maintenance Treatment|Protocol Violation|0
4833033|NCT01081912|16663337|P3|Maintenance Treatment|Physician Decision|1
4833034|NCT01081912|16663338|P2|Maintenance Treatment|Physician Decision|0
4833035|NCT01081912|16663339|P1|Maintenance Treatment|Physician Decision|0
4833036|NCT01081912|16663337|P3|Maintenance Treatment|Lost to Follow-up|0
4833037|NCT01081912|16663338|P2|Maintenance Treatment|Lost to Follow-up|1
4833038|NCT01081912|16663339|P1|Maintenance Treatment|Lost to Follow-up|0
4833039|NCT01081912|16663337|P3|Maintenance Treatment|Lack of Efficacy|64
4833040|NCT01081912|16663338|P2|Maintenance Treatment|Lack of Efficacy|14
4833041|NCT01081912|16663339|P1|Maintenance Treatment|Lack of Efficacy|0
4833042|NCT01081912|16663337|P3|Maintenance Treatment|Adverse Event|12
4833043|NCT01081912|16663338|P2|Maintenance Treatment|Adverse Event|2
4833044|NCT01081912|16663339|P1|Maintenance Treatment|Adverse Event|0
4833045|NCT01081912|16663337|P3|Conversion/Titration|Non-Compliance|0
4833046|NCT01081912|16663338|P2|Conversion/Titration|Non-Compliance|0
4833047|NCT01081912|16663339|P1|Conversion/Titration|Non-Compliance|47
4833048|NCT01081912|16663337|P3|Conversion/Titration|Withdrawal by Subject|0
4833049|NCT01081912|16663338|P2|Conversion/Titration|Withdrawal by Subject|0
4833050|NCT01081912|16663339|P1|Conversion/Titration|Withdrawal by Subject|23
4833051|NCT01081912|16663337|P3|Conversion/Titration|Protocol Violation|0
4833052|NCT01081912|16663338|P2|Conversion/Titration|Protocol Violation|0
4833053|NCT01081912|16663339|P1|Conversion/Titration|Protocol Violation|67
4833054|NCT01081912|16663337|P3|Conversion/Titration|Physician Decision|0
4833055|NCT01081912|16663338|P2|Conversion/Titration|Physician Decision|0
4833056|NCT01081912|16663339|P1|Conversion/Titration|Physician Decision|2
4833057|NCT01081912|16663337|P3|Conversion/Titration|Lost to Follow-up|0
4833058|NCT01081912|16663338|P2|Conversion/Titration|Lost to Follow-up|0
4833059|NCT01081912|16663339|P1|Conversion/Titration|Lost to Follow-up|5
4833060|NCT01081912|16663337|P3|Conversion/Titration|Lack of Efficacy|0
4833061|NCT01081912|16663338|P2|Conversion/Titration|Lack of Efficacy|0
4833062|NCT01081912|16663339|P1|Conversion/Titration|Lack of Efficacy|17
4833063|NCT01081912|16663337|P3|Conversion/Titration|Adverse Event|0
4833064|NCT01081912|16663338|P2|Conversion/Titration|Adverse Event|0
4833065|NCT01081912|16663339|P1|Conversion/Titration|Adverse Event|47
4833066|NCT01081886|16663348|P2|Overall Study|Study termination|13
4833067|NCT01081886|16663349|P1|Overall Study|Study termination|11
4833068|NCT01081873|16663357|P1|Overall Study|Other|47
4833069|NCT01081873|16663357|P1|Overall Study|Progression of prostate cancer|13
4833070|NCT01081873|16663357|P1|Overall Study|Lost to Follow-up|142
4833071|NCT01081873|16663357|P1|Overall Study|Withdrawal by Subject|10
4833072|NCT01081873|16663357|P1|Overall Study|Death|86
4833073|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Physician Decision|0
4833074|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Physician Decision|0
4833075|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
4833076|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Physician Decision|1
4833077|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Physician Decision|0
4833078|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
4833079|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
4833080|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0
4833081|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1
4833082|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7
4833083|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Other|0
4833084|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Other|0
4833085|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Other|4
4833086|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Other|5
4833087|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Other|4
4833088|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
4833089|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
4833090|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0
4833091|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4
4833092|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1
4833093|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4833094|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4833095|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4833096|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0
4833097|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1
4833098|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4833099|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4833100|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4833101|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2
4833102|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4833103|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Protocol Violation|0
4833104|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Protocol Violation|0
4833105|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Protocol Violation|0
4833106|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
4833107|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Protocol Violation|0
4833108|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4833109|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4833110|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4833111|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
4833112|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|4
4833113|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Death|0
4833114|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Death|0
4833115|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Death|0
4833116|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Death|0
4833117|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Death|1
4833118|NCT01081834|16663429|P5|Extension Period: Week 26 to Week 52|Adverse Event|0
4833119|NCT01081834|16663430|P4|Extension Period: Week 26 to Week 52|Adverse Event|0
4833120|NCT01081834|16663431|P3|Extension Period: Week 26 to Week 52|Adverse Event|0
4833121|NCT01081834|16663432|P2|Extension Period: Week 26 to Week 52|Adverse Event|0
4833122|NCT01081834|16663433|P1|Extension Period: Week 26 to Week 52|Adverse Event|1
4833123|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4833124|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4833125|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0
4833126|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1
4833127|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3
4833128|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Other|0
4833129|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Other|1
4833130|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Other|3
4833131|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Other|4
4833132|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Other|4
4833133|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4833134|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4833135|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4833136|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Unable to take rescue therapy|0
4833137|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Unable to take rescue therapy|1
4833138|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4833139|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Noncompliance with study drug|2
4833140|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|2
4833141|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|4
4833142|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|3
4833143|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Withdrawal by Subject|1
4833144|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Withdrawal by Subject|3
4833145|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|9
4833146|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|3
4833147|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|15
4833148|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Protocol Violation|2
4833149|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Protocol Violation|0
4833150|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Protocol Violation|0
4833151|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Protocol Violation|4
4833152|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Protocol Violation|0
4833153|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Lost to Follow-up|0
4833154|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Lost to Follow-up|0
4833155|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Lost to Follow-up|5
4833156|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Lost to Follow-up|2
4833157|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Lost to Follow-up|2
4833158|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Death|0
4833159|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Death|0
4833160|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Death|0
4833161|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Death|0
4833162|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Death|1
4833163|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Adverse Event|1
4833164|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Adverse Event|1
4833165|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Adverse Event|3
4833166|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Adverse Event|5
4833167|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Adverse Event|2
4833168|NCT01081834|16663429|P5|Core Period: Baseline to Week 26|Pregnancy|0
4833169|NCT01081834|16663430|P4|Core Period: Baseline to Week 26|Pregnancy|0
4833170|NCT01081834|16663431|P3|Core Period: Baseline to Week 26|Pregnancy|0
4833171|NCT01081834|16663432|P2|Core Period: Baseline to Week 26|Pregnancy|0
4833172|NCT01081834|16663433|P1|Core Period: Baseline to Week 26|Pregnancy|1
4833173|NCT01081795|16663494|P3|Overall Study|Other|0
4833174|NCT01081795|16663495|P2|Overall Study|Other|2
4833175|NCT01081795|16663496|P1|Overall Study|Other|1
4833176|NCT01081795|16663494|P3|Overall Study|Using drug with restricted days of use|2
4833177|NCT01081795|16663495|P2|Overall Study|Using drug with restricted days of use|3
4833178|NCT01081795|16663496|P1|Overall Study|Using drug with restricted days of use|2
4833179|NCT01081795|16663494|P3|Overall Study|Use of a prohibited concomitant drug|1
4833180|NCT01081795|16663495|P2|Overall Study|Use of a prohibited concomitant drug|1
4833181|NCT01081795|16663496|P1|Overall Study|Use of a prohibited concomitant drug|1
4833182|NCT01081795|16663494|P3|Overall Study|Ineligible for participation|0
4833183|NCT01081795|16663495|P2|Overall Study|Ineligible for participation|0
4833184|NCT01081795|16663496|P1|Overall Study|Ineligible for participation|1
4833185|NCT01081795|16663494|P3|Overall Study|Revocation of informed consent|0
4833186|NCT01081795|16663495|P2|Overall Study|Revocation of informed consent|0
4833187|NCT01081795|16663496|P1|Overall Study|Revocation of informed consent|2
4833188|NCT01081795|16663494|P3|Overall Study|Subject's schedule|2
4833189|NCT01081795|16663495|P2|Overall Study|Subject's schedule|1
4833190|NCT01081795|16663496|P1|Overall Study|Subject's schedule|1
4833191|NCT01081795|16663494|P3|Overall Study|Lack of Efficacy|19
4833192|NCT01081795|16663495|P2|Overall Study|Lack of Efficacy|5
4833193|NCT01081795|16663496|P1|Overall Study|Lack of Efficacy|7
4833194|NCT01081795|16663494|P3|Overall Study|Adverse Event|6
4833195|NCT01081795|16663495|P2|Overall Study|Adverse Event|23
4833196|NCT01081795|16663496|P1|Overall Study|Adverse Event|18
4833197|NCT01081769|16663533|P2|CORE Intent-To-Treat|Patient Moved|2
4833198|NCT01081769|16663534|P1|CORE Intent-To-Treat|Patient Moved|2
4833199|NCT01081769|16663533|P2|CORE Intent-To-Treat|Visit Schedule Issues|2
4833200|NCT01081769|16663534|P1|CORE Intent-To-Treat|Visit Schedule Issues|1
4833201|NCT01081769|16663533|P2|CORE Intent-To-Treat|Ineligibility|4
4833202|NCT01081769|16663534|P1|CORE Intent-To-Treat|Ineligibility|3
4833203|NCT01081769|16663533|P2|CORE Intent-To-Treat|Other|1
4833204|NCT01081769|16663534|P1|CORE Intent-To-Treat|Other|0
4833205|NCT01081769|16663533|P2|CORE Intent-To-Treat|Noncompliance With Study Drug|5
4833206|NCT01081769|16663534|P1|CORE Intent-To-Treat|Noncompliance With Study Drug|0
4833207|NCT01081769|16663533|P2|CORE Intent-To-Treat|Withdrawal by Subject|60
4833208|NCT01081769|16663534|P1|CORE Intent-To-Treat|Withdrawal by Subject|52
4833209|NCT01081769|16663533|P2|CORE Intent-To-Treat|Pregnancy|0
4833210|NCT01081769|16663534|P1|CORE Intent-To-Treat|Pregnancy|1
4833211|NCT01081769|16663533|P2|CORE Intent-To-Treat|Lost to Follow-up|5
4833212|NCT01081769|16663534|P1|CORE Intent-To-Treat|Lost to Follow-up|4
4833213|NCT01081769|16663533|P2|CORE Intent-To-Treat|Lack of Efficacy|6
4833214|NCT01081769|16663534|P1|CORE Intent-To-Treat|Lack of Efficacy|2
4833215|NCT01081769|16663533|P2|CORE Intent-To-Treat|Death|1
4833216|NCT01081769|16663534|P1|CORE Intent-To-Treat|Death|1
4833217|NCT01081769|16663533|P2|CORE Intent-To-Treat|Adverse Event|11
4833218|NCT01081769|16663534|P1|CORE Intent-To-Treat|Adverse Event|14
4833219|NCT01081769|16663533|P2|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0
4833220|NCT01081769|16663534|P1|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2
4833221|NCT01081769|16663533|P2|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7
4833222|NCT01081769|16663534|P1|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6
4833223|NCT01081769|16663533|P2|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
4833224|NCT01081769|16663534|P1|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6
4833225|NCT01081769|16663533|P2|Whole Intent-to-Treat|Missing Responder Assessment|12
4833226|NCT01081769|16663534|P1|Whole Intent-to-Treat|Missing Responder Assessment|10
4833227|NCT01081678|16663572|P4|Overall Study|Other|0
4833228|NCT01081678|16663573|P3|Overall Study|Other|0
4833229|NCT01081678|16663574|P2|Overall Study|Other|1
4833230|NCT01081678|16663575|P1|Overall Study|Other|0
4833231|NCT01081678|16663572|P4|Overall Study|Death|6
4833232|NCT01081678|16663573|P3|Overall Study|Death|2
4833233|NCT01081678|16663574|P2|Overall Study|Death|2
4833234|NCT01081678|16663575|P1|Overall Study|Death|2
4833235|NCT01081678|16663572|P4|Overall Study|Lost to Follow-up|3
4833236|NCT01081678|16663573|P3|Overall Study|Lost to Follow-up|4
4833237|NCT01081678|16663574|P2|Overall Study|Lost to Follow-up|1
4833238|NCT01081678|16663575|P1|Overall Study|Lost to Follow-up|4
4833239|NCT01081678|16663572|P4|Overall Study|Administrative Decision|1
4833240|NCT01081678|16663573|P3|Overall Study|Administrative Decision|0
4833241|NCT01081678|16663574|P2|Overall Study|Administrative Decision|0
4833242|NCT01081678|16663575|P1|Overall Study|Administrative Decision|1
4833243|NCT01081678|16663572|P4|Overall Study|Withdrawal by Subject|14
4833244|NCT01081678|16663573|P3|Overall Study|Withdrawal by Subject|17
4833245|NCT01081678|16663574|P2|Overall Study|Withdrawal by Subject|7
4833246|NCT01081678|16663575|P1|Overall Study|Withdrawal by Subject|15
4833247|NCT01081678|16663572|P4|Overall Study|Adverse Event|2
4833248|NCT01081678|16663573|P3|Overall Study|Adverse Event|2
4833249|NCT01081678|16663574|P2|Overall Study|Adverse Event|1
4833250|NCT01081678|16663575|P1|Overall Study|Adverse Event|2
4833251|NCT01081678|16663572|P4|Overall Study|Noncompliance|2
4833252|NCT01081678|16663573|P3|Overall Study|Noncompliance|5
4833253|NCT01081678|16663574|P2|Overall Study|Noncompliance|4
4833254|NCT01081678|16663575|P1|Overall Study|Noncompliance|3
4833255|NCT01081678|16663572|P4|Overall Study|Ineligibility Determined|1
4833256|NCT01081678|16663573|P3|Overall Study|Ineligibility Determined|1
4833257|NCT01081678|16663574|P2|Overall Study|Ineligibility Determined|0
4833258|NCT01081678|16663575|P1|Overall Study|Ineligibility Determined|0
4833259|NCT01081665|16663605|P1|Overall Study|Lack of Efficacy|1
4833260|NCT01081665|16663605|P1|Overall Study|Adverse Event|1
4833261|NCT01081665|16663605|P1|Overall Study|Change in renal replacement therapy|2
4833262|NCT01081665|16663605|P1|Overall Study|Regulation of iPTH|5
4833263|NCT01081665|16663605|P1|Overall Study|Change of dialysis unit|10
4833264|NCT01081665|16663605|P1|Overall Study|Withdrawal by Subject|17
4833265|NCT01081665|16663605|P1|Overall Study|Lost to Follow-up|18
4833266|NCT01081665|16663605|P1|Overall Study|Death|41
4833267|NCT01081626|16663617|P2|Overall Study|Other|30
4833268|NCT01081626|16663618|P1|Overall Study|Other|33
4833269|NCT01081626|16663617|P2|Overall Study|Lost to Follow-up|1
4833270|NCT01081626|16663618|P1|Overall Study|Lost to Follow-up|0
4833271|NCT01081626|16663617|P2|Overall Study|Overstimulation|1
4833272|NCT01081626|16663618|P1|Overall Study|Overstimulation|0
4833273|NCT01081626|16663617|P2|Overall Study|Low antral follicle count|0
4833274|NCT01081626|16663618|P1|Overall Study|Low antral follicle count|1
4833275|NCT01081626|16663617|P2|Overall Study|Missing Estradiol|28
4833276|NCT01081626|16663618|P1|Overall Study|Missing Estradiol|25
4833277|NCT01081626|16663617|P2|Overall Study|Dosing error|1
4833278|NCT01081626|16663618|P1|Overall Study|Dosing error|1
4833279|NCT01081301|16663644|P1|Overall Study|Lost to Follow-up|4
4833280|NCT01081301|16663644|P1|Overall Study|Patient too ill|2
4833281|NCT01081301|16663644|P1|Overall Study|Too busy|5
4833282|NCT01081301|16663644|P1|Overall Study|Bereaved|3
4833283|NCT01081249|16663719|P2|Overall Study|Diagnosed with Bipolar Disorder|1
4833284|NCT01081249|16663720|P1|Overall Study|Diagnosed with Bipolar Disorder|0
4833285|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Other|3
4833286|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Other|4
4833287|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71
4833288|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47
4833289|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20
4833290|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13
4833291|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2
4833292|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3
4833293|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8
4833294|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10
4833295|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0
4833296|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1
4833297|NCT01081145|16663726|P2|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2
4833298|NCT01081145|16663727|P1|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3
4833299|NCT01081145|16663726|P2|Open-Label Phase|Protocol Violation|0
4833300|NCT01081145|16663727|P1|Open-Label Phase|Protocol Violation|4
4833301|NCT01081145|16663726|P2|Open-Label Phase|Lost to Follow-up|0
4833302|NCT01081145|16663727|P1|Open-Label Phase|Lost to Follow-up|11
4833303|NCT01081145|16663726|P2|Open-Label Phase|Other|0
4833304|NCT01081145|16663727|P1|Open-Label Phase|Other|12
4833305|NCT01081145|16663726|P2|Open-Label Phase|Withdrawal by Subject|0
4833306|NCT01081145|16663727|P1|Open-Label Phase|Withdrawal by Subject|41
4833307|NCT01081145|16663726|P2|Open-Label Phase|Adverse Event|0
4833308|NCT01081145|16663727|P1|Open-Label Phase|Adverse Event|42
4833309|NCT01081145|16663726|P2|Open-Label Phase|Response criteria not met|0
4833310|NCT01081145|16663727|P1|Open-Label Phase|Response criteria not met|46
4833311|NCT01081145|16663726|P2|Open-Label Phase|Lack of Efficacy|0
4833312|NCT01081145|16663727|P1|Open-Label Phase|Lack of Efficacy|56
4833313|NCT01081132|16663755|P2|Overall Study|Protocol Violation|1
4833314|NCT01081132|16663756|P1|Overall Study|Protocol Violation|3
4833315|NCT01081132|16663755|P2|Overall Study|Declined Taper Phase|1
4833316|NCT01081132|16663756|P1|Overall Study|Declined Taper Phase|0
4833317|NCT01081132|16663755|P2|Overall Study|Patient Did Not Complete Wk14 and 15|1
4833318|NCT01081132|16663756|P1|Overall Study|Patient Did Not Complete Wk14 and 15|0
4833319|NCT01081132|16663755|P2|Overall Study|Stopped Taking Meds|0
4833320|NCT01081132|16663756|P1|Overall Study|Stopped Taking Meds|2
4833321|NCT01081132|16663755|P2|Overall Study|Missed Visits|1
4833322|NCT01081132|16663756|P1|Overall Study|Missed Visits|1
4833323|NCT01081132|16663755|P2|Overall Study|Lack Of Compliance|1
4833324|NCT01081132|16663756|P1|Overall Study|Lack Of Compliance|0
4833325|NCT01081132|16663755|P2|Overall Study|Non Compliance|2
4833326|NCT01081132|16663756|P1|Overall Study|Non Compliance|4
4833327|NCT01081132|16663755|P2|Overall Study|Adverse Event|9
4833328|NCT01081132|16663756|P1|Overall Study|Adverse Event|3
4833329|NCT01081132|16663755|P2|Overall Study|Lost to Follow-up|11
4833330|NCT01081132|16663756|P1|Overall Study|Lost to Follow-up|4
4833331|NCT01081132|16663755|P2|Overall Study|Withdrawal by Subject|16
4833332|NCT01081132|16663756|P1|Overall Study|Withdrawal by Subject|13
4833333|NCT01081132|16663755|P2|Overall Study|Lack of Efficacy|9
4833334|NCT01081132|16663756|P1|Overall Study|Lack of Efficacy|25
4833335|NCT01080807|16663840|P2|Overall Study|Moved away without notifying center|0
4833336|NCT01080807|16663841|P1|Overall Study|Moved away without notifying center|1
4833337|NCT01080807|16663840|P2|Overall Study|Switched to first shift|0
4833338|NCT01080807|16663841|P1|Overall Study|Switched to first shift|1
4833339|NCT01080807|16663840|P2|Overall Study|Work schedule and travel|1
4833340|NCT01080807|16663841|P1|Overall Study|Work schedule and travel|0
4833341|NCT01080807|16663840|P2|Overall Study|Work schedule changing|1
4833342|NCT01080807|16663841|P1|Overall Study|Work schedule changing|1
4833343|NCT01080807|16663840|P2|Overall Study|Stopped working consistent night shifts|1
4833344|NCT01080807|16663841|P1|Overall Study|Stopped working consistent night shifts|0
4833345|NCT01080807|16663840|P2|Overall Study|Laid off or terminated from job|2
4833346|NCT01080807|16663841|P1|Overall Study|Laid off or terminated from job|1
4833347|NCT01080807|16663840|P2|Overall Study|Began working day shift|2
4833348|NCT01080807|16663841|P1|Overall Study|Began working day shift|0
4833349|NCT01080807|16663840|P2|Overall Study|Noncompliance to study procedures|1
4833350|NCT01080807|16663841|P1|Overall Study|Noncompliance to study procedures|1
4833351|NCT01080807|16663840|P2|Overall Study|Noncompliance with drug administration|1
4833352|NCT01080807|16663841|P1|Overall Study|Noncompliance with drug administration|1
4833353|NCT01080807|16663840|P2|Overall Study|Lost to Follow-up|4
4833354|NCT01080807|16663841|P1|Overall Study|Lost to Follow-up|6
4833355|NCT01080807|16663840|P2|Overall Study|Protocol Violation|6
4833356|NCT01080807|16663841|P1|Overall Study|Protocol Violation|7
4833357|NCT01080807|16663840|P2|Overall Study|Withdrawal by Subject|2
4833358|NCT01080807|16663841|P1|Overall Study|Withdrawal by Subject|7
4833359|NCT01080807|16663840|P2|Overall Study|Lack of Efficacy|1
4833360|NCT01080807|16663841|P1|Overall Study|Lack of Efficacy|0
4833361|NCT01080807|16663840|P2|Overall Study|Adverse Event|1
4833362|NCT01080807|16663841|P1|Overall Study|Adverse Event|9
4833363|NCT01080768|16663950|P2|Overall Study|Protocol Deviation|1
4833364|NCT01080768|16663951|P1|Overall Study|Protocol Deviation|2
4833365|NCT01080716|16663961|P4|Part 1|Physician Decision|0
4833366|NCT01080716|16663962|P3|Part 1|Physician Decision|0
4833367|NCT01080716|16663963|P2|Part 1|Physician Decision|0
4833368|NCT01080716|16663964|P1|Part 1|Physician Decision|1
4833369|NCT01080625|16664003|P3|Overall Study|Physician Decision|1
4833370|NCT01080625|16664004|P2|Overall Study|Physician Decision|2
4833371|NCT01080625|16664005|P1|Overall Study|Physician Decision|0
4833372|NCT01080391|16664015|P2|Overall Study|Randomized but not treated|4
4833373|NCT01080391|16664016|P1|Overall Study|Randomized but not treated|7
4833374|NCT01080326|16664034|P1|Overall Study|Surgeon decision|1
4833375|NCT01080326|16664034|P1|Overall Study|Patient deterioration prior to procedure|3
4833376|NCT01080300|16664040|P2|Overall Study|Reasons not specified|6
4833377|NCT01080300|16664041|P1|Overall Study|Reasons not specified|4
4833378|NCT01080300|16664040|P2|Overall Study|Withdrawal by Subject|28
4833379|NCT01080300|16664041|P1|Overall Study|Withdrawal by Subject|12
4833380|NCT01080300|16664040|P2|Overall Study|Death|1
4833381|NCT01080300|16664041|P1|Overall Study|Death|0
4833382|NCT01080300|16664040|P2|Overall Study|Lost to Follow-up|6
4833383|NCT01080300|16664041|P1|Overall Study|Lost to Follow-up|10
4833384|NCT01080300|16664040|P2|Overall Study|Protocol Violation|13
4833385|NCT01080300|16664041|P1|Overall Study|Protocol Violation|7
4833386|NCT01080300|16664040|P2|Overall Study|Lack of Efficacy|15
4833387|NCT01080300|16664041|P1|Overall Study|Lack of Efficacy|12
4833388|NCT01080300|16664040|P2|Overall Study|Adverse Event|35
4833389|NCT01080300|16664041|P1|Overall Study|Adverse Event|49
4833390|NCT01080131|16664146|P2|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5
4833391|NCT01080131|16664147|P1|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4
4833392|NCT01080131|16664146|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4
4833393|NCT01080131|16664147|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3
4833394|NCT01080131|16664146|P2|Extension Study 2 (25-72 Weeks)|Adverse Event|2
4833395|NCT01080131|16664147|P1|Extension Study 2 (25-72 Weeks)|Adverse Event|1
4833396|NCT01080131|16664146|P2|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0
4833397|NCT01080131|16664147|P1|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1
4833398|NCT01080131|16664146|P2|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3
4833399|NCT01080131|16664147|P1|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4
4833400|NCT01080131|16664146|P2|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1
4833401|NCT01080131|16664147|P1|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0
4833402|NCT01080131|16664146|P2|Extension Study 1 (12 -24 Weeks)|Adverse Event|0
4833403|NCT01080131|16664147|P1|Extension Study 1 (12 -24 Weeks)|Adverse Event|1
4833404|NCT01080131|16664146|P2|Core Study (0- 12 Weeks)|Protocol deviation|2
4833405|NCT01080131|16664147|P1|Core Study (0- 12 Weeks)|Protocol deviation|0
4833406|NCT01080131|16664146|P2|Core Study (0- 12 Weeks)|Death|0
4833407|NCT01080131|16664147|P1|Core Study (0- 12 Weeks)|Death|1
4833408|NCT01080131|16664146|P2|Core Study (0- 12 Weeks)|Administrative problems|1
4833409|NCT01080131|16664147|P1|Core Study (0- 12 Weeks)|Administrative problems|0
4833410|NCT01080131|16664146|P2|Core Study (0- 12 Weeks)|Lost to Follow-up|3
4833411|NCT01080131|16664147|P1|Core Study (0- 12 Weeks)|Lost to Follow-up|5
4833412|NCT01080131|16664146|P2|Core Study (0- 12 Weeks)|Patient withdrew consent|4
4833413|NCT01080131|16664147|P1|Core Study (0- 12 Weeks)|Patient withdrew consent|6
4833414|NCT01080131|16664146|P2|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
4833415|NCT01080131|16664147|P1|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1
4833416|NCT01079988|16664242|P5|Overall Study|Other|1
4833417|NCT01079988|16664243|P4|Overall Study|Other|2
4833418|NCT01079988|16664244|P3|Overall Study|Other|0
4833419|NCT01079988|16664245|P2|Overall Study|Other|0
4833420|NCT01079988|16664246|P1|Overall Study|Other|0
4833421|NCT01079988|16664242|P5|Overall Study|Lack of Efficacy|0
4833422|NCT01079988|16664243|P4|Overall Study|Lack of Efficacy|0
4833423|NCT01079988|16664244|P3|Overall Study|Lack of Efficacy|0
4833424|NCT01079988|16664245|P2|Overall Study|Lack of Efficacy|0
4833425|NCT01079988|16664246|P1|Overall Study|Lack of Efficacy|1
4833426|NCT01079988|16664242|P5|Overall Study|Lost to Follow-up|0
4833427|NCT01079988|16664243|P4|Overall Study|Lost to Follow-up|1
4833428|NCT01079988|16664244|P3|Overall Study|Lost to Follow-up|0
4833429|NCT01079988|16664245|P2|Overall Study|Lost to Follow-up|0
4833430|NCT01079988|16664246|P1|Overall Study|Lost to Follow-up|0
4833431|NCT01079962|16664265|P2|Overall Study|Due to arrhythmia/bradycardia|1
4833432|NCT01079962|16664266|P1|Overall Study|Due to arrhythmia/bradycardia|1
4833433|NCT01079962|16664265|P2|Overall Study|Participant not returning for next visit|0
4833434|NCT01079962|16664266|P1|Overall Study|Participant not returning for next visit|1
4833435|NCT01079962|16664265|P2|Overall Study|Inclusion/exclusion criteria|3
4833436|NCT01079962|16664266|P1|Overall Study|Inclusion/exclusion criteria|1
4833437|NCT01079962|16664265|P2|Overall Study|No blood pressure (BP) control|0
4833438|NCT01079962|16664266|P1|Overall Study|No blood pressure (BP) control|3
4833439|NCT01079962|16664265|P2|Overall Study|Protocol Violation|2
4833440|NCT01079962|16664266|P1|Overall Study|Protocol Violation|2
4833441|NCT01079962|16664265|P2|Overall Study|Withdrawal by Subject|7
4833442|NCT01079962|16664266|P1|Overall Study|Withdrawal by Subject|5
4833443|NCT01079962|16664265|P2|Overall Study|Adverse Event|2
4833444|NCT01079962|16664266|P1|Overall Study|Adverse Event|2
4833445|NCT01079949|16664294|P2|Overall Study|Randomized but not treated|0
4833446|NCT01079949|16664295|P1|Overall Study|Randomized but not treated|1
4833447|NCT01079949|16664294|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
4833448|NCT01079949|16664295|P1|Overall Study|Withdrawal between OPU - embryo transfer|8
4833449|NCT01079949|16664294|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8
4833450|NCT01079949|16664295|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4
4833451|NCT01079949|16664294|P2|Overall Study|Withdrawal before r-hCG administration|3
4833452|NCT01079949|16664295|P1|Overall Study|Withdrawal before r-hCG administration|2
4833453|NCT01079936|16664341|P5|Phase II|Insurance Issue|1
4833454|NCT01079936|16664342|P4|Phase II|Insurance Issue|0
4833455|NCT01079936|16664343|P3|Phase II|Insurance Issue|0
4833456|NCT01079936|16664344|P2|Phase II|Insurance Issue|0
4833457|NCT01079936|16664345|P1|Phase II|Insurance Issue|0
4833458|NCT01079936|16664341|P5|Phase II|Adverse Event|0
4833459|NCT01079936|16664342|P4|Phase II|Adverse Event|0
4833460|NCT01079936|16664343|P3|Phase II|Adverse Event|1
4833461|NCT01079936|16664344|P2|Phase II|Adverse Event|0
4833462|NCT01079936|16664345|P1|Phase II|Adverse Event|0
4833463|NCT01079936|16664341|P5|Phase I: MTD|No Stem Cell Transplantation|0
4833464|NCT01079936|16664342|P4|Phase I: MTD|No Stem Cell Transplantation|0
4833465|NCT01079936|16664343|P3|Phase I: MTD|No Stem Cell Transplantation|0
4833466|NCT01079936|16664344|P2|Phase I: MTD|No Stem Cell Transplantation|0
4833467|NCT01079936|16664345|P1|Phase I: MTD|No Stem Cell Transplantation|2
4833468|NCT01079936|16664341|P5|Phase I: MTD|First Remission Status|0
4833469|NCT01079936|16664342|P4|Phase I: MTD|First Remission Status|0
4833470|NCT01079936|16664343|P3|Phase I: MTD|First Remission Status|0
4833471|NCT01079936|16664344|P2|Phase I: MTD|First Remission Status|0
4833472|NCT01079936|16664345|P1|Phase I: MTD|First Remission Status|2
4833473|NCT01079832|16664364|P1|Overall Study|Withdrawal by Subject|1
4833474|NCT01079806|16664374|P2|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
4833475|NCT01079806|16664375|P1|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6
4833476|NCT01079806|16664374|P2|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1
4833477|NCT01079806|16664375|P1|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0
4833478|NCT01079806|16664374|P2|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8
4833479|NCT01079806|16664375|P1|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13
4833480|NCT01079806|16664374|P2|Day 1 to Week 96|Removal by Medical Monitor|1
4833481|NCT01079806|16664375|P1|Day 1 to Week 96|Removal by Medical Monitor|0
4833482|NCT01079806|16664374|P2|Day 1 to Week 96|Subject request to stop study treatment|0
4833483|NCT01079806|16664375|P1|Day 1 to Week 96|Subject request to stop study treatment|1
4833484|NCT01079806|16664374|P2|Day 1 to Week 96|Lost to Follow-up|0
4833485|NCT01079806|16664375|P1|Day 1 to Week 96|Lost to Follow-up|1
4833486|NCT01079806|16664374|P2|Day 1 to Week 96|Poor compliance or noncompliance|0
4833487|NCT01079806|16664375|P1|Day 1 to Week 96|Poor compliance or noncompliance|2
4833488|NCT01079806|16664374|P2|Day 1 to Week 96|Pregnancy|1
4833489|NCT01079806|16664375|P1|Day 1 to Week 96|Pregnancy|0
4833490|NCT01079806|16664374|P2|Day 1 to Week 96|Withdrawal by Subject|2
4833491|NCT01079806|16664375|P1|Day 1 to Week 96|Withdrawal by Subject|3
4833492|NCT01079806|16664374|P2|Day 1 to Week 96|Adverse Event|3
4833493|NCT01079806|16664375|P1|Day 1 to Week 96|Adverse Event|0
4833494|NCT01079741|16664410|P5|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3
4833495|NCT01079741|16664411|P4|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4833496|NCT01079741|16664412|P3|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4833497|NCT01079741|16664413|P2|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4833498|NCT01079741|16664414|P1|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0
4833499|NCT01079741|16664410|P5|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4833500|NCT01079741|16664411|P4|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4833501|NCT01079741|16664412|P3|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4833502|NCT01079741|16664413|P2|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1
4833503|NCT01079741|16664414|P1|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0
4833504|NCT01079234|16664462|P4|Extension: Week 27 to 52|Unclassified|7
4833505|NCT01079234|16664463|P3|Extension: Week 27 to 52|Unclassified|4
4833506|NCT01079234|16664464|P2|Extension: Week 27 to 52|Unclassified|0
4833507|NCT01079234|16664465|P1|Extension: Week 27 to 52|Unclassified|0
4833508|NCT01079234|16664462|P4|Extension: Week 27 to 52|Withdrawal criteria|2
4833509|NCT01079234|16664463|P3|Extension: Week 27 to 52|Withdrawal criteria|4
4833510|NCT01079234|16664464|P2|Extension: Week 27 to 52|Withdrawal criteria|0
4833511|NCT01079234|16664465|P1|Extension: Week 27 to 52|Withdrawal criteria|0
4833512|NCT01079234|16664462|P4|Extension: Week 27 to 52|Protocol Violation|5
4833513|NCT01079234|16664463|P3|Extension: Week 27 to 52|Protocol Violation|2
4833514|NCT01079234|16664464|P2|Extension: Week 27 to 52|Protocol Violation|0
4833515|NCT01079234|16664465|P1|Extension: Week 27 to 52|Protocol Violation|0
4833516|NCT01079234|16664462|P4|Extension: Week 27 to 52|Lack of Efficacy|2
4833517|NCT01079234|16664463|P3|Extension: Week 27 to 52|Lack of Efficacy|0
4833518|NCT01079234|16664464|P2|Extension: Week 27 to 52|Lack of Efficacy|0
4833519|NCT01079234|16664465|P1|Extension: Week 27 to 52|Lack of Efficacy|0
4833520|NCT01079234|16664462|P4|Extension: Week 27 to 52|Adverse Event|0
4833521|NCT01079234|16664463|P3|Extension: Week 27 to 52|Adverse Event|1
4833522|NCT01079234|16664464|P2|Extension: Week 27 to 52|Adverse Event|0
4833523|NCT01079234|16664465|P1|Extension: Week 27 to 52|Adverse Event|0
4833524|NCT01079234|16664462|P4|Main: Week 0 to 26|Unclassified|0
4833525|NCT01079234|16664463|P3|Main: Week 0 to 26|Unclassified|4
4833526|NCT01079234|16664464|P2|Main: Week 0 to 26|Unclassified|13
4833527|NCT01079234|16664465|P1|Main: Week 0 to 26|Unclassified|7
4833528|NCT01079234|16664462|P4|Main: Week 0 to 26|Withdrawal criteria|0
4833529|NCT01079234|16664463|P3|Main: Week 0 to 26|Withdrawal criteria|2
4833530|NCT01079234|16664464|P2|Main: Week 0 to 26|Withdrawal criteria|6
4833531|NCT01079234|16664465|P1|Main: Week 0 to 26|Withdrawal criteria|6
4833532|NCT01079234|16664462|P4|Main: Week 0 to 26|Protocol Violation|0
4833533|NCT01079234|16664463|P3|Main: Week 0 to 26|Protocol Violation|4
4833534|NCT01079234|16664464|P2|Main: Week 0 to 26|Protocol Violation|2
4833535|NCT01079234|16664465|P1|Main: Week 0 to 26|Protocol Violation|6
4833536|NCT01079234|16664462|P4|Main: Week 0 to 26|Lack of Efficacy|0
4833537|NCT01079234|16664463|P3|Main: Week 0 to 26|Lack of Efficacy|1
4833538|NCT01079234|16664464|P2|Main: Week 0 to 26|Lack of Efficacy|1
4833539|NCT01079234|16664465|P1|Main: Week 0 to 26|Lack of Efficacy|2
4833540|NCT01079234|16664462|P4|Main: Week 0 to 26|Adverse Event|0
4833541|NCT01079234|16664463|P3|Main: Week 0 to 26|Adverse Event|1
4833542|NCT01079234|16664464|P2|Main: Week 0 to 26|Adverse Event|4
4833543|NCT01079234|16664465|P1|Main: Week 0 to 26|Adverse Event|5
4833544|NCT01079195|16664483|P1|Overall Study|Non-compliance|2
4833545|NCT01079195|16664483|P1|Overall Study|No Follow-up Documentation Available|4
4833546|NCT01079195|16664483|P1|Overall Study|Improved Status of Participant|4
4833547|NCT01079195|16664483|P1|Overall Study|Physician Decision|4
4833548|NCT01079195|16664483|P1|Overall Study|Lack of Effectiveness|12
4833549|NCT01079195|16664483|P1|Overall Study|Financial Reasons|15
4833550|NCT01079195|16664483|P1|Overall Study|Withdrawal by Subject|18
4833551|NCT01079195|16664483|P1|Overall Study|Reason Unknown|39
4833552|NCT01079195|16664483|P1|Overall Study|Adverse Event|157
4833553|NCT01079195|16664483|P1|Overall Study|No Documentation Available|437
4833554|NCT01079195|16664483|P1|Overall Study|No Documentation of Tarka Therapy|739
4833555|NCT01079182|16664489|P1|Overall Study|Reasons not Evaluated|271
4833556|NCT01079182|16664489|P1|Overall Study|ADR and Lack of Effectiveness|39
4833557|NCT01079182|16664489|P1|Overall Study|Lack of Efficacy|514
4833558|NCT01079182|16664489|P1|Overall Study|Adverse Drug Reaction (ADR)|261
4833559|NCT01079182|16664489|P1|Overall Study|Lost to Follow-up|1634
4833560|NCT01079130|16664597|P6|Overall Study|Lost to Follow-up|0
4833561|NCT01079130|16664598|P5|Overall Study|Lost to Follow-up|1
4833562|NCT01079130|16664599|P4|Overall Study|Lost to Follow-up|0
4833563|NCT01079130|16664600|P3|Overall Study|Lost to Follow-up|0
4833564|NCT01079130|16664601|P2|Overall Study|Lost to Follow-up|0
4833565|NCT01079130|16664602|P1|Overall Study|Lost to Follow-up|0
4833566|NCT01079130|16664597|P6|Overall Study|Unsatisfactory therapeutic effect|0
4833567|NCT01079130|16664598|P5|Overall Study|Unsatisfactory therapeutic effect|0
4833568|NCT01079130|16664599|P4|Overall Study|Unsatisfactory therapeutic effect|2
4833569|NCT01079130|16664600|P3|Overall Study|Unsatisfactory therapeutic effect|0
4833570|NCT01079130|16664601|P2|Overall Study|Unsatisfactory therapeutic effect|0
4833571|NCT01079130|16664602|P1|Overall Study|Unsatisfactory therapeutic effect|0
4833572|NCT01079130|16664597|P6|Overall Study|Abnormal test procedure result(s)|0
4833573|NCT01079130|16664598|P5|Overall Study|Abnormal test procedure result(s)|1
4833574|NCT01079130|16664599|P4|Overall Study|Abnormal test procedure result(s)|0
4833575|NCT01079130|16664600|P3|Overall Study|Abnormal test procedure result(s)|0
4833576|NCT01079130|16664601|P2|Overall Study|Abnormal test procedure result(s)|0
4833577|NCT01079130|16664602|P1|Overall Study|Abnormal test procedure result(s)|0
4833578|NCT01079130|16664597|P6|Overall Study|Protocol deviation|0
4833579|NCT01079130|16664598|P5|Overall Study|Protocol deviation|0
4833580|NCT01079130|16664599|P4|Overall Study|Protocol deviation|2
4833581|NCT01079130|16664600|P3|Overall Study|Protocol deviation|1
4833582|NCT01079130|16664601|P2|Overall Study|Protocol deviation|2
4833583|NCT01079130|16664602|P1|Overall Study|Protocol deviation|0
4833584|NCT01079130|16664597|P6|Overall Study|Withdrawal by Subject|3
4833585|NCT01079130|16664598|P5|Overall Study|Withdrawal by Subject|1
4833586|NCT01079130|16664599|P4|Overall Study|Withdrawal by Subject|0
4833587|NCT01079130|16664600|P3|Overall Study|Withdrawal by Subject|0
4833588|NCT01079130|16664601|P2|Overall Study|Withdrawal by Subject|1
4833589|NCT01079130|16664602|P1|Overall Study|Withdrawal by Subject|0
4833590|NCT01079130|16664597|P6|Overall Study|Administrative problems|1
4833591|NCT01079130|16664598|P5|Overall Study|Administrative problems|0
4833592|NCT01079130|16664599|P4|Overall Study|Administrative problems|0
4833593|NCT01079130|16664600|P3|Overall Study|Administrative problems|0
4833594|NCT01079130|16664601|P2|Overall Study|Administrative problems|3
4833595|NCT01079130|16664602|P1|Overall Study|Administrative problems|1
4833596|NCT01079130|16664597|P6|Overall Study|Adverse Event|1
4833597|NCT01079130|16664598|P5|Overall Study|Adverse Event|5
4833598|NCT01079130|16664599|P4|Overall Study|Adverse Event|1
4833599|NCT01079130|16664600|P3|Overall Study|Adverse Event|0
4833600|NCT01079130|16664601|P2|Overall Study|Adverse Event|1
4833601|NCT01079130|16664602|P1|Overall Study|Adverse Event|1
4833602|NCT01078974|16664622|P1|Overall Study|Adverse Event|3
4833603|NCT01078922|16664627|P1|Overall Study|Adverse Event|1
4833604|NCT01078805|16664668|P1|Overall Study|Didn't take study drug|82
4833605|NCT01078805|16664668|P1|Overall Study|Other|173
4833606|NCT01078805|16664668|P1|Overall Study|Withdrawal by Subject|739
4833607|NCT01078805|16664668|P1|Overall Study|Sponsor decision|46
4833608|NCT01078805|16664668|P1|Overall Study|Serious adverse event|26
4833609|NCT01078805|16664668|P1|Overall Study|Physician Decision|169
4833610|NCT01078805|16664668|P1|Overall Study|Lost to Follow-up|676
4833611|NCT01078805|16664668|P1|Overall Study|Death|134
4833612|NCT01078805|16664668|P1|Overall Study|Clinically significant abnormal lab|5
4833613|NCT01078675|16664695|P2|Overall Study|Adverse Event|0
4833614|NCT01078675|16664696|P1|Overall Study|Adverse Event|3
4833615|NCT01078675|16664695|P2|Overall Study|Provided in CRF for specific reasons|3
4833616|NCT01078675|16664696|P1|Overall Study|Provided in CRF for specific reasons|2
4833617|NCT01078675|16664695|P2|Overall Study|Protocol Violation|0
4833618|NCT01078675|16664696|P1|Overall Study|Protocol Violation|56
4833619|NCT01078675|16664695|P2|Overall Study|Withdrawal by Subject|3
4833620|NCT01078675|16664696|P1|Overall Study|Withdrawal by Subject|7
4833621|NCT01078662|16664718|P5|Overall Study|Lost to Follow-up|0
4833622|NCT01078662|16664719|P4|Overall Study|Lost to Follow-up|0
4833623|NCT01078662|16664720|P3|Overall Study|Lost to Follow-up|0
4833624|NCT01078662|16664721|P2|Overall Study|Lost to Follow-up|0
4833625|NCT01078662|16664722|P1|Overall Study|Lost to Follow-up|1
4833626|NCT01078662|16664718|P5|Overall Study|Protocol Violation|0
4833627|NCT01078662|16664719|P4|Overall Study|Protocol Violation|0
4833628|NCT01078662|16664720|P3|Overall Study|Protocol Violation|0
4833629|NCT01078662|16664721|P2|Overall Study|Protocol Violation|1
4833630|NCT01078662|16664722|P1|Overall Study|Protocol Violation|0
4833631|NCT01078662|16664718|P5|Overall Study|Withdrawal by Subject|0
4833632|NCT01078662|16664719|P4|Overall Study|Withdrawal by Subject|0
4833633|NCT01078662|16664720|P3|Overall Study|Withdrawal by Subject|1
4833634|NCT01078662|16664721|P2|Overall Study|Withdrawal by Subject|11
4833635|NCT01078662|16664722|P1|Overall Study|Withdrawal by Subject|4
4833636|NCT01078662|16664718|P5|Overall Study|Patients reached data cut-off|3
4833637|NCT01078662|16664719|P4|Overall Study|Patients reached data cut-off|2
4833638|NCT01078662|16664720|P3|Overall Study|Patients reached data cut-off|2
4833639|NCT01078662|16664721|P2|Overall Study|Patients reached data cut-off|53
4833640|NCT01078662|16664722|P1|Overall Study|Patients reached data cut-off|12
4833641|NCT01078662|16664718|P5|Overall Study|Death|8
4833642|NCT01078662|16664719|P4|Overall Study|Death|5
4833643|NCT01078662|16664720|P3|Overall Study|Death|18
4833644|NCT01078662|16664721|P2|Overall Study|Death|103
4833645|NCT01078662|16664722|P1|Overall Study|Death|41
4833646|NCT01078623|16664761|P20|Treatment Period 4|Withdrawal by Subject|0
4833647|NCT01078623|16664762|P19|Treatment Period 4|Withdrawal by Subject|0
4833648|NCT01078623|16664763|P18|Treatment Period 4|Withdrawal by Subject|0
4833649|NCT01078623|16664764|P17|Treatment Period 4|Withdrawal by Subject|0
4833650|NCT01078623|16664765|P16|Treatment Period 4|Withdrawal by Subject|1
4833651|NCT01078623|16664766|P15|Treatment Period 4|Withdrawal by Subject|0
4833652|NCT01078623|16664767|P14|Treatment Period 4|Withdrawal by Subject|0
4833653|NCT01078623|16664768|P13|Treatment Period 4|Withdrawal by Subject|0
4833654|NCT01078623|16664769|P12|Treatment Period 4|Withdrawal by Subject|0
4833655|NCT01078623|16664770|P11|Treatment Period 4|Withdrawal by Subject|0
4833656|NCT01078623|16664771|P10|Treatment Period 4|Withdrawal by Subject|0
4833657|NCT01078623|16664772|P9|Treatment Period 4|Withdrawal by Subject|0
4833658|NCT01078623|16664773|P8|Treatment Period 4|Withdrawal by Subject|0
4833659|NCT01078623|16664774|P7|Treatment Period 4|Withdrawal by Subject|0
4833660|NCT01078623|16664775|P6|Treatment Period 4|Withdrawal by Subject|0
4833661|NCT01078623|16664776|P5|Treatment Period 4|Withdrawal by Subject|0
4833662|NCT01078623|16664777|P4|Treatment Period 4|Withdrawal by Subject|0
4833663|NCT01078623|16664778|P3|Treatment Period 4|Withdrawal by Subject|0
4833664|NCT01078623|16664779|P2|Treatment Period 4|Withdrawal by Subject|0
4833665|NCT01078623|16664780|P1|Treatment Period 4|Withdrawal by Subject|0
4833666|NCT01078623|16664761|P20|Treatment Period 4|Adverse Event|0
4833667|NCT01078623|16664762|P19|Treatment Period 4|Adverse Event|0
4833668|NCT01078623|16664763|P18|Treatment Period 4|Adverse Event|0
4833669|NCT01078623|16664764|P17|Treatment Period 4|Adverse Event|0
4833670|NCT01078623|16664765|P16|Treatment Period 4|Adverse Event|0
4833671|NCT01078623|16664766|P15|Treatment Period 4|Adverse Event|0
4833672|NCT01078623|16664767|P14|Treatment Period 4|Adverse Event|0
4833673|NCT01078623|16664768|P13|Treatment Period 4|Adverse Event|0
4833674|NCT01078623|16664769|P12|Treatment Period 4|Adverse Event|0
4833675|NCT01078623|16664770|P11|Treatment Period 4|Adverse Event|0
4833676|NCT01078623|16664771|P10|Treatment Period 4|Adverse Event|0
4833677|NCT01078623|16664772|P9|Treatment Period 4|Adverse Event|0
4833678|NCT01078623|16664773|P8|Treatment Period 4|Adverse Event|0
4833679|NCT01078623|16664774|P7|Treatment Period 4|Adverse Event|0
4833680|NCT01078623|16664775|P6|Treatment Period 4|Adverse Event|0
4833681|NCT01078623|16664776|P5|Treatment Period 4|Adverse Event|0
4833682|NCT01078623|16664777|P4|Treatment Period 4|Adverse Event|0
4833683|NCT01078623|16664778|P3|Treatment Period 4|Adverse Event|1
4833684|NCT01078623|16664779|P2|Treatment Period 4|Adverse Event|0
4833685|NCT01078623|16664780|P1|Treatment Period 4|Adverse Event|0
4833686|NCT01078623|16664761|P20|Treatment Period 3|Adverse Event|0
4833687|NCT01078623|16664762|P19|Treatment Period 3|Adverse Event|0
4833688|NCT01078623|16664763|P18|Treatment Period 3|Adverse Event|0
4833689|NCT01078623|16664764|P17|Treatment Period 3|Adverse Event|0
4833690|NCT01078623|16664765|P16|Treatment Period 3|Adverse Event|0
4833691|NCT01078623|16664766|P15|Treatment Period 3|Adverse Event|0
4833692|NCT01078623|16664767|P14|Treatment Period 3|Adverse Event|1
4833693|NCT01078623|16664768|P13|Treatment Period 3|Adverse Event|0
4833694|NCT01078623|16664769|P12|Treatment Period 3|Adverse Event|0
4833695|NCT01078623|16664770|P11|Treatment Period 3|Adverse Event|0
4833696|NCT01078623|16664771|P10|Treatment Period 3|Adverse Event|0
4833697|NCT01078623|16664772|P9|Treatment Period 3|Adverse Event|0
4833698|NCT01078623|16664773|P8|Treatment Period 3|Adverse Event|0
4833699|NCT01078623|16664774|P7|Treatment Period 3|Adverse Event|0
4833700|NCT01078623|16664775|P6|Treatment Period 3|Adverse Event|0
4833701|NCT01078623|16664776|P5|Treatment Period 3|Adverse Event|1
4833702|NCT01078623|16664777|P4|Treatment Period 3|Adverse Event|0
4833703|NCT01078623|16664778|P3|Treatment Period 3|Adverse Event|0
4833704|NCT01078623|16664779|P2|Treatment Period 3|Adverse Event|0
4833705|NCT01078623|16664780|P1|Treatment Period 3|Adverse Event|0
4833706|NCT01078623|16664761|P20|Treatment Period 2|Withdrawal by Subject|0
4833707|NCT01078623|16664762|P19|Treatment Period 2|Withdrawal by Subject|0
4833708|NCT01078623|16664763|P18|Treatment Period 2|Withdrawal by Subject|0
4833709|NCT01078623|16664764|P17|Treatment Period 2|Withdrawal by Subject|0
4833710|NCT01078623|16664765|P16|Treatment Period 2|Withdrawal by Subject|0
4833711|NCT01078623|16664766|P15|Treatment Period 2|Withdrawal by Subject|0
4833712|NCT01078623|16664767|P14|Treatment Period 2|Withdrawal by Subject|0
4833713|NCT01078623|16664768|P13|Treatment Period 2|Withdrawal by Subject|0
4833714|NCT01078623|16664769|P12|Treatment Period 2|Withdrawal by Subject|0
4833715|NCT01078623|16664770|P11|Treatment Period 2|Withdrawal by Subject|0
4833716|NCT01078623|16664771|P10|Treatment Period 2|Withdrawal by Subject|0
4833717|NCT01078623|16664772|P9|Treatment Period 2|Withdrawal by Subject|0
4833718|NCT01078623|16664773|P8|Treatment Period 2|Withdrawal by Subject|0
4833719|NCT01078623|16664774|P7|Treatment Period 2|Withdrawal by Subject|0
4833720|NCT01078623|16664775|P6|Treatment Period 2|Withdrawal by Subject|1
4833721|NCT01078623|16664776|P5|Treatment Period 2|Withdrawal by Subject|0
4833722|NCT01078623|16664777|P4|Treatment Period 2|Withdrawal by Subject|0
4833723|NCT01078623|16664778|P3|Treatment Period 2|Withdrawal by Subject|0
4833724|NCT01078623|16664779|P2|Treatment Period 2|Withdrawal by Subject|0
4833725|NCT01078623|16664780|P1|Treatment Period 2|Withdrawal by Subject|0
4833726|NCT01078623|16664761|P20|Treatment Period 2|Adverse Event|0
4833727|NCT01078623|16664762|P19|Treatment Period 2|Adverse Event|1
4833728|NCT01078623|16664763|P18|Treatment Period 2|Adverse Event|0
4833729|NCT01078623|16664764|P17|Treatment Period 2|Adverse Event|0
4833730|NCT01078623|16664765|P16|Treatment Period 2|Adverse Event|0
4833731|NCT01078623|16664766|P15|Treatment Period 2|Adverse Event|0
4833732|NCT01078623|16664767|P14|Treatment Period 2|Adverse Event|0
4833733|NCT01078623|16664768|P13|Treatment Period 2|Adverse Event|0
4833734|NCT01078623|16664769|P12|Treatment Period 2|Adverse Event|0
4833735|NCT01078623|16664770|P11|Treatment Period 2|Adverse Event|0
4833736|NCT01078623|16664771|P10|Treatment Period 2|Adverse Event|0
4833737|NCT01078623|16664772|P9|Treatment Period 2|Adverse Event|0
4833738|NCT01078623|16664773|P8|Treatment Period 2|Adverse Event|0
4833739|NCT01078623|16664774|P7|Treatment Period 2|Adverse Event|1
4833740|NCT01078623|16664775|P6|Treatment Period 2|Adverse Event|0
4833741|NCT01078623|16664776|P5|Treatment Period 2|Adverse Event|0
4833742|NCT01078623|16664777|P4|Treatment Period 2|Adverse Event|0
4833743|NCT01078623|16664778|P3|Treatment Period 2|Adverse Event|0
4833744|NCT01078623|16664779|P2|Treatment Period 2|Adverse Event|0
4833745|NCT01078623|16664780|P1|Treatment Period 2|Adverse Event|0
4833746|NCT01078623|16664761|P20|Treatment Period 1|Protocol Violation|0
4833747|NCT01078623|16664762|P19|Treatment Period 1|Protocol Violation|0
4833748|NCT01078623|16664763|P18|Treatment Period 1|Protocol Violation|0
4833749|NCT01078623|16664764|P17|Treatment Period 1|Protocol Violation|0
4833750|NCT01078623|16664765|P16|Treatment Period 1|Protocol Violation|0
4833751|NCT01078623|16664766|P15|Treatment Period 1|Protocol Violation|0
4833752|NCT01078623|16664767|P14|Treatment Period 1|Protocol Violation|0
4833753|NCT01078623|16664768|P13|Treatment Period 1|Protocol Violation|0
4833754|NCT01078623|16664769|P12|Treatment Period 1|Protocol Violation|0
4833755|NCT01078623|16664770|P11|Treatment Period 1|Protocol Violation|0
4833756|NCT01078623|16664771|P10|Treatment Period 1|Protocol Violation|0
4833757|NCT01078623|16664772|P9|Treatment Period 1|Protocol Violation|0
4833758|NCT01078623|16664773|P8|Treatment Period 1|Protocol Violation|0
4833759|NCT01078623|16664774|P7|Treatment Period 1|Protocol Violation|0
4833760|NCT01078623|16664775|P6|Treatment Period 1|Protocol Violation|1
4833761|NCT01078623|16664776|P5|Treatment Period 1|Protocol Violation|0
4833762|NCT01078623|16664777|P4|Treatment Period 1|Protocol Violation|0
4833763|NCT01078623|16664778|P3|Treatment Period 1|Protocol Violation|0
4833764|NCT01078623|16664779|P2|Treatment Period 1|Protocol Violation|0
4833765|NCT01078623|16664780|P1|Treatment Period 1|Protocol Violation|0
4833766|NCT01078623|16664761|P20|Treatment Period 1|Withdrawal by Subject|0
4833767|NCT01078623|16664762|P19|Treatment Period 1|Withdrawal by Subject|0
4833768|NCT01078623|16664763|P18|Treatment Period 1|Withdrawal by Subject|0
4833769|NCT01078623|16664764|P17|Treatment Period 1|Withdrawal by Subject|0
4833770|NCT01078623|16664765|P16|Treatment Period 1|Withdrawal by Subject|0
4833771|NCT01078623|16664766|P15|Treatment Period 1|Withdrawal by Subject|0
4833772|NCT01078623|16664767|P14|Treatment Period 1|Withdrawal by Subject|0
4833773|NCT01078623|16664768|P13|Treatment Period 1|Withdrawal by Subject|0
4833774|NCT01078623|16664769|P12|Treatment Period 1|Withdrawal by Subject|0
4833775|NCT01078623|16664770|P11|Treatment Period 1|Withdrawal by Subject|1
4833776|NCT01078623|16664771|P10|Treatment Period 1|Withdrawal by Subject|0
4833777|NCT01078623|16664772|P9|Treatment Period 1|Withdrawal by Subject|0
4833778|NCT01078623|16664773|P8|Treatment Period 1|Withdrawal by Subject|1
4833779|NCT01078623|16664774|P7|Treatment Period 1|Withdrawal by Subject|0
4833780|NCT01078623|16664775|P6|Treatment Period 1|Withdrawal by Subject|0
4833781|NCT01078623|16664776|P5|Treatment Period 1|Withdrawal by Subject|0
4833782|NCT01078623|16664777|P4|Treatment Period 1|Withdrawal by Subject|0
4833783|NCT01078623|16664778|P3|Treatment Period 1|Withdrawal by Subject|0
4833784|NCT01078623|16664779|P2|Treatment Period 1|Withdrawal by Subject|0
4833785|NCT01078623|16664780|P1|Treatment Period 1|Withdrawal by Subject|0
4833786|NCT01078623|16664761|P20|Treatment Period 1|Adverse Event|0
4833787|NCT01078623|16664762|P19|Treatment Period 1|Adverse Event|0
4833788|NCT01078623|16664763|P18|Treatment Period 1|Adverse Event|0
4833789|NCT01078623|16664764|P17|Treatment Period 1|Adverse Event|0
4833790|NCT01078623|16664765|P16|Treatment Period 1|Adverse Event|0
4833791|NCT01078623|16664766|P15|Treatment Period 1|Adverse Event|0
4833792|NCT01078623|16664767|P14|Treatment Period 1|Adverse Event|0
4833793|NCT01078623|16664768|P13|Treatment Period 1|Adverse Event|0
4833794|NCT01078623|16664769|P12|Treatment Period 1|Adverse Event|0
4833795|NCT01078623|16664770|P11|Treatment Period 1|Adverse Event|0
4833796|NCT01078623|16664771|P10|Treatment Period 1|Adverse Event|1
4833797|NCT01078623|16664772|P9|Treatment Period 1|Adverse Event|1
4833798|NCT01078623|16664773|P8|Treatment Period 1|Adverse Event|0
4833799|NCT01078623|16664774|P7|Treatment Period 1|Adverse Event|1
4833800|NCT01078623|16664775|P6|Treatment Period 1|Adverse Event|0
4833801|NCT01078623|16664776|P5|Treatment Period 1|Adverse Event|0
4833802|NCT01078623|16664777|P4|Treatment Period 1|Adverse Event|0
4833803|NCT01078623|16664778|P3|Treatment Period 1|Adverse Event|1
4833804|NCT01078623|16664779|P2|Treatment Period 1|Adverse Event|1
4833805|NCT01078623|16664780|P1|Treatment Period 1|Adverse Event|1
4833806|NCT01078584|16664802|P1|Overall Study|Multiple Reasons|2
4833807|NCT01078584|16664802|P1|Overall Study|Serious Adverse Event|27
4833808|NCT01078584|16664802|P1|Overall Study|Protocol Violation|75
4833809|NCT01078584|16664802|P1|Overall Study|Lack of Efficacy|98
4833810|NCT01078584|16664802|P1|Overall Study|Physician Discontinued Patient|12
4833811|NCT01078584|16664802|P1|Overall Study|Physician Switched Medication|26
4833812|NCT01078584|16664802|P1|Overall Study|Blood Pressure Controlled|49
4833813|NCT01078584|16664802|P1|Overall Study|Non-compliance|67
4833814|NCT01078584|16664802|P1|Overall Study|Physician Withdrew from Study|90
4833815|NCT01078584|16664802|P1|Overall Study|Withdrawal of Consent|244
4833816|NCT01078584|16664802|P1|Overall Study|Non-serious Adverse Event|577
4833817|NCT01078584|16664802|P1|Overall Study|Lost to Follow-up|670
4833818|NCT01078584|16664802|P1|Overall Study|Final Status Unknown|1073
4833819|NCT01078571|16664883|P1|Overall Study|Protocol Violation|2
4833820|NCT01078571|16664883|P1|Overall Study|Lost to Follow-up|8
4833821|NCT01078571|16664883|P1|Overall Study|Withdrawal by Subject|12
4833822|NCT01078571|16664883|P1|Overall Study|Reason not reported|21
4833823|NCT01078571|16664883|P1|Overall Study|Lack of effectiveness|36
4833824|NCT01078571|16664883|P1|Overall Study|Adverse Event|36
4833825|NCT01078545|16664934|P1|Overall Study|Participant moved to another physician|1
4833826|NCT01078545|16664934|P1|Overall Study|Death|3
4833827|NCT01078545|16664934|P1|Overall Study|Withdrawal by Subject|3
4833828|NCT01078545|16664934|P1|Overall Study|Physician Decision|6
4833829|NCT01078545|16664934|P1|Overall Study|Lost to Follow-up|13
4833830|NCT01078454|16664944|P2|Overall Study|Death|1
4833831|NCT01078454|16664945|P1|Overall Study|Death|0
4833832|NCT01078454|16664944|P2|Overall Study|Adverse Event|1
4833833|NCT01078454|16664945|P1|Overall Study|Adverse Event|1
4833834|NCT01078441|16664951|P1|Overall Study|Withdrawal by Subject|1
4833835|NCT01078389|16664991|P2|Overall Study|Other|2
4833836|NCT01078389|16664992|P1|Overall Study|Other|9
4833837|NCT01078389|16664991|P2|Overall Study|Voluntary Withdrawal|36
4833838|NCT01078389|16664992|P1|Overall Study|Voluntary Withdrawal|20
4833839|NCT01078389|16664991|P2|Overall Study|Lost to Follow-up|23
4833840|NCT01078389|16664992|P1|Overall Study|Lost to Follow-up|23
4833841|NCT01078389|16664991|P2|Overall Study|Major Protocol Deviation|0
4833842|NCT01078389|16664992|P1|Overall Study|Major Protocol Deviation|2
4833843|NCT01078389|16664991|P2|Overall Study|Adverse Event|6
4833844|NCT01078389|16664992|P1|Overall Study|Adverse Event|10
4833845|NCT01078298|16665153|P2|Overall Study|Other|32
4833846|NCT01078298|16665154|P1|Overall Study|Other|24
4833847|NCT01078298|16665153|P2|Overall Study|Did not meet entrance criteria|1
4833848|NCT01078298|16665154|P1|Overall Study|Did not meet entrance criteria|0
4833849|NCT01078298|16665153|P2|Overall Study|Death|0
4833850|NCT01078298|16665154|P1|Overall Study|Death|2
4833851|NCT01078298|16665153|P2|Overall Study|Adverse Event|5
4833852|NCT01078298|16665154|P1|Overall Study|Adverse Event|6
4833853|NCT01078298|16665153|P2|Overall Study|Protocol Violation|6
4833854|NCT01078298|16665154|P1|Overall Study|Protocol Violation|6
4833855|NCT01078298|16665153|P2|Overall Study|Withdrawal by Subject|33
4833856|NCT01078298|16665154|P1|Overall Study|Withdrawal by Subject|31
4833857|NCT01078298|16665153|P2|Overall Study|Lost to Follow-up|13
4833858|NCT01078298|16665154|P1|Overall Study|Lost to Follow-up|12
4833859|NCT01078168|16665264|P2|Overall Study|Physician Decision|1
4833860|NCT01078168|16665265|P1|Overall Study|Physician Decision|0
4833861|NCT01078155|16665271|P1|Overall Study|Lost to Follow-up|15
4833862|NCT01078155|16665271|P1|Overall Study|Participant's Decision|6
4833863|NCT01078155|16665271|P1|Overall Study|Lack of Efficacy|16
4833864|NCT01078155|16665271|P1|Overall Study|Adverse Event|7
4833865|NCT01078116|16665287|P1|Overall Study|Case report form not completed|3
4833866|NCT01078116|16665287|P1|Overall Study|Lack of effectiveness|15
4833867|NCT01078116|16665287|P1|Overall Study|Withdrawal by Subject|8
4833868|NCT01078116|16665287|P1|Overall Study|Adverse Event|5
4833869|NCT01078116|16665287|P1|Overall Study|Lost to Follow-up|17
4833870|NCT01078090|16665295|P1|Overall Study|Other|523
4833871|NCT01078090|16665295|P1|Overall Study|ADR and lack of efficacy|61
4833872|NCT01078090|16665295|P1|Overall Study|Lack of Efficacy|1193
4833873|NCT01078090|16665295|P1|Overall Study|Adverse drug reaction (ADR)|453
4833874|NCT01078090|16665295|P1|Overall Study|Lost to Follow-up|2363
4833875|NCT01077960|16665389|P1|Overall Study|Reason unspecified|1
4833876|NCT01077960|16665389|P1|Overall Study|Subject decision|1
4833877|NCT01077960|16665389|P1|Overall Study|Lost to Follow-up|5
4833878|NCT01077960|16665389|P1|Overall Study|Protocol Violation|3
4833879|NCT01077960|16665389|P1|Overall Study|Adverse Event|6
4833880|NCT01077804|16665639|P1|Overall Study|Other|18
4833881|NCT01077804|16665639|P1|Overall Study|Refused to continue|79
4833882|NCT01077804|16665639|P1|Overall Study|Unreachable|102
4833883|NCT01077739|16665648|P2|Overall Study|Other|2
4833884|NCT01077739|16665649|P1|Overall Study|Other|2
4833885|NCT01077739|16665648|P2|Overall Study|Unacceptable toxicity|2
4833886|NCT01077739|16665649|P1|Overall Study|Unacceptable toxicity|1
4833887|NCT01077739|16665648|P2|Overall Study|Death|3
4833888|NCT01077739|16665649|P1|Overall Study|Death|0
4833889|NCT01077739|16665648|P2|Overall Study|Withdrawal by Subject|0
4833890|NCT01077739|16665649|P1|Overall Study|Withdrawal by Subject|1
4833891|NCT01077739|16665648|P2|Overall Study|Premature withdrawal|3
4833892|NCT01077739|16665649|P1|Overall Study|Premature withdrawal|1
4833893|NCT01077713|16665663|P2|Overall Study|Other|2
4833894|NCT01077713|16665664|P1|Overall Study|Other|4
4833895|NCT01077713|16665663|P2|Overall Study|Adverse Event|1
4833896|NCT01077713|16665664|P1|Overall Study|Adverse Event|2
4833897|NCT01077713|16665663|P2|Overall Study|Lost to Follow-up|1
4833898|NCT01077713|16665664|P1|Overall Study|Lost to Follow-up|1
4833899|NCT01077713|16665663|P2|Overall Study|Death|29
4833900|NCT01077713|16665664|P1|Overall Study|Death|28
4833901|NCT01077713|16665663|P2|Overall Study|Progressive Disease (PD)|1
4833902|NCT01077713|16665664|P1|Overall Study|Progressive Disease (PD)|0
4833903|NCT01077713|16665663|P2|Overall Study|Withdrawal by Subject|2
4833904|NCT01077713|16665664|P1|Overall Study|Withdrawal by Subject|1
4833905|NCT01077622|16665688|P1|Overall Study|Withdrawal by Subject|1
4833906|NCT01077622|16665688|P1|Overall Study|Physician Decision|2
4833907|NCT01077544|16665808|P2|Overall Study|Disease Progression|1
4833908|NCT01077544|16665809|P1|Overall Study|Disease Progression|0
4833909|NCT01077544|16665808|P2|Overall Study|Adverse Event|1
4833910|NCT01077544|16665809|P1|Overall Study|Adverse Event|0
4833911|NCT01077544|16665808|P2|Overall Study|New Cancer Therapy|3
4833912|NCT01077544|16665809|P1|Overall Study|New Cancer Therapy|3
4833913|NCT01077518|16665837|P3|Optional Ofa Phase|Withdrawal by Subject|3
4833914|NCT01077518|16665838|P2|Optional Ofa Phase|Withdrawal by Subject|0
4833915|NCT01077518|16665839|P1|Optional Ofa Phase|Withdrawal by Subject|0
4833916|NCT01077518|16665837|P3|Optional Ofa Phase|Study Terminated by Sponsor|12
4833917|NCT01077518|16665838|P2|Optional Ofa Phase|Study Terminated by Sponsor|0
4833918|NCT01077518|16665839|P1|Optional Ofa Phase|Study Terminated by Sponsor|0
4833919|NCT01077518|16665837|P3|Optional Ofa Phase|Physician Decision|1
4833920|NCT01077518|16665838|P2|Optional Ofa Phase|Physician Decision|0
4833921|NCT01077518|16665839|P1|Optional Ofa Phase|Physician Decision|0
4833922|NCT01077518|16665837|P3|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0
4833923|NCT01077518|16665838|P2|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28
4833924|NCT01077518|16665839|P1|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32
4833925|NCT01077518|16665837|P3|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0
4833926|NCT01077518|16665838|P2|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22
4833927|NCT01077518|16665839|P1|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28
4833928|NCT01077518|16665837|P3|Treatment Phase - no Optional Ofa|Physician Decision|0
4833929|NCT01077518|16665838|P2|Treatment Phase - no Optional Ofa|Physician Decision|11
4833930|NCT01077518|16665839|P1|Treatment Phase - no Optional Ofa|Physician Decision|10
4833931|NCT01077518|16665837|P3|Treatment Phase - no Optional Ofa|Lost to Follow-up|0
4833932|NCT01077518|16665838|P2|Treatment Phase - no Optional Ofa|Lost to Follow-up|4
4833933|NCT01077518|16665839|P1|Treatment Phase - no Optional Ofa|Lost to Follow-up|8
4833934|NCT01077375|16665912|P2|Overall Study|Other Reason|1
4833935|NCT01077375|16665913|P1|Overall Study|Other Reason|0
4833936|NCT01077375|16665912|P2|Overall Study|Lost to Follow-up|5
4833937|NCT01077375|16665913|P1|Overall Study|Lost to Follow-up|2
4833938|NCT01077375|16665912|P2|Overall Study|Withdrawal by Subject|6
4833939|NCT01077375|16665913|P1|Overall Study|Withdrawal by Subject|0
4833940|NCT01077375|16665912|P2|Overall Study|Lack of Efficacy|8
4833941|NCT01077375|16665913|P1|Overall Study|Lack of Efficacy|6
4833942|NCT01077375|16665912|P2|Overall Study|Adverse Event|15
4833943|NCT01077375|16665913|P1|Overall Study|Adverse Event|2
4833944|NCT01077362|16665924|P3|Overall Study|Other|2
4833945|NCT01077362|16665925|P2|Overall Study|Other|1
4833946|NCT01077362|16665926|P1|Overall Study|Other|0
4833947|NCT01077362|16665924|P3|Overall Study|Withdrawal by Subject|5
4833948|NCT01077362|16665925|P2|Overall Study|Withdrawal by Subject|3
4833949|NCT01077362|16665926|P1|Overall Study|Withdrawal by Subject|5
4833950|NCT01077362|16665924|P3|Overall Study|Adverse Event|4
4833951|NCT01077362|16665925|P2|Overall Study|Adverse Event|7
4833952|NCT01077362|16665926|P1|Overall Study|Adverse Event|12
4833953|NCT01077362|16665924|P3|Overall Study|Lost to Follow-up|3
4833954|NCT01077362|16665925|P2|Overall Study|Lost to Follow-up|0
4833955|NCT01077362|16665926|P1|Overall Study|Lost to Follow-up|1
4833956|NCT01077362|16665924|P3|Overall Study|Lack of Efficacy|10
4833957|NCT01077362|16665925|P2|Overall Study|Lack of Efficacy|8
4833958|NCT01077362|16665926|P1|Overall Study|Lack of Efficacy|13
4833959|NCT01077323|16665962|P3|Overall Study|Baseline diagnosis of pancreatic disease|120
4833960|NCT01077323|16665963|P2|Overall Study|Baseline diagnosis of pancreatic disease|2080
4833961|NCT01077323|16665964|P1|Overall Study|Baseline diagnosis of pancreatic disease|152
4833962|NCT01077323|16665962|P3|Overall Study|Dispensing of drug in baseline period|256446
4833963|NCT01077323|16665963|P2|Overall Study|Dispensing of drug in baseline period|120229
4833964|NCT01077323|16665964|P1|Overall Study|Dispensing of drug in baseline period|0
4833965|NCT01077323|16665962|P3|Overall Study|<9 months enroll before drug dispensed|11655523
4833966|NCT01077323|16665963|P2|Overall Study|<9 months enroll before drug dispensed|263954
4833967|NCT01077323|16665964|P1|Overall Study|<9 months enroll before drug dispensed|11226
4833968|NCT01077284|16666007|P3|Overall Study|Other|1
4833969|NCT01077284|16666008|P2|Overall Study|Other|0
4833970|NCT01077284|16666009|P1|Overall Study|Other|0
4833971|NCT01077284|16666007|P3|Overall Study|Withdrawal by Subject|1
4833972|NCT01077284|16666008|P2|Overall Study|Withdrawal by Subject|3
4833973|NCT01077284|16666009|P1|Overall Study|Withdrawal by Subject|2
4833974|NCT01077284|16666007|P3|Overall Study|Lost to Follow-up|0
4833975|NCT01077284|16666008|P2|Overall Study|Lost to Follow-up|2
4833976|NCT01077284|16666009|P1|Overall Study|Lost to Follow-up|1
4833977|NCT01077284|16666007|P3|Overall Study|Adverse Event|1
4833978|NCT01077284|16666008|P2|Overall Study|Adverse Event|0
4833979|NCT01077284|16666009|P1|Overall Study|Adverse Event|2
4833980|NCT01077271|16666030|P1|Overall Study|Mother unconvinced of the necessity|1
4833981|NCT01077271|16666030|P1|Overall Study|End of RSV season nearly reached|1
4833982|NCT01077271|16666030|P1|Overall Study|Parents thought too many injections|2
4833983|NCT01077271|16666030|P1|Overall Study|Changed doctors|2
4833984|NCT01077271|16666030|P1|Overall Study|Quota used up (insurance reimb issue)|2
4833985|NCT01077271|16666030|P1|Overall Study|Noncompliance|2
4833986|NCT01077271|16666030|P1|Overall Study|Screen failure, did not take palivizumab|4
4833987|NCT01077271|16666030|P1|Overall Study|Parental desire|8
4833988|NCT01077258|16666068|P1|Overall Study|Other reasons|260
4833989|NCT01077258|16666068|P1|Overall Study|Clinical remission|37
4833990|NCT01077258|16666068|P1|Overall Study|Lack of Efficacy|663
4833991|NCT01077258|16666068|P1|Overall Study|Adverse drug reaction|218
4833992|NCT01077258|16666068|P1|Overall Study|Lost to Follow-up|1390
4833993|NCT01077193|16666104|P1|Overall Study|Study Terminated by Sponsor|40
4833994|NCT01077193|16666104|P1|Overall Study|Lack of Efficacy|1
4833995|NCT01077193|16666104|P1|Overall Study|Withdrawal by Subject|2
4833996|NCT01077193|16666104|P1|Overall Study|Lost to Follow-up|1
4833997|NCT01077154|16666110|P2|Overall Study|Protocol Deviation|0
4833998|NCT01077154|16666111|P1|Overall Study|Protocol Deviation|1
4833999|NCT01077154|16666110|P2|Overall Study|Administrative Decision|6
4834000|NCT01077154|16666111|P1|Overall Study|Administrative Decision|1
4834001|NCT01077154|16666110|P2|Overall Study|Adverse Event|9
4834002|NCT01077154|16666111|P1|Overall Study|Adverse Event|9
4834003|NCT01077154|16666110|P2|Overall Study|Other|11
4834004|NCT01077154|16666111|P1|Overall Study|Other|14
4834005|NCT01077154|16666110|P2|Overall Study|Ineligibility Determined|14
4834006|NCT01077154|16666111|P1|Overall Study|Ineligibility Determined|10
4834007|NCT01077154|16666110|P2|Overall Study|Disease Progression|20
4834008|NCT01077154|16666111|P1|Overall Study|Disease Progression|18
4834009|NCT01077154|16666110|P2|Overall Study|Noncompliance|20
4834010|NCT01077154|16666111|P1|Overall Study|Noncompliance|22
4834011|NCT01077154|16666110|P2|Overall Study|Lost to Follow-up|35
4834012|NCT01077154|16666111|P1|Overall Study|Lost to Follow-up|43
4834013|NCT01077154|16666110|P2|Overall Study|Death|214
4834014|NCT01077154|16666111|P1|Overall Study|Death|215
4834015|NCT01077154|16666110|P2|Overall Study|Withdrawal by Subject|385
4834016|NCT01077154|16666111|P1|Overall Study|Withdrawal by Subject|369
4834017|NCT01077154|16666110|P2|Overall Study|Protocol-specified Criteria: Study Ended|1514
4834018|NCT01077154|16666111|P1|Overall Study|Protocol-specified Criteria: Study Ended|1524
4834019|NCT01077128|16666125|P1|Overall Study|Other|54
4834020|NCT01077128|16666125|P1|Overall Study|Lack of efficacy/disease exacerbation|1
4834021|NCT01077128|16666125|P1|Overall Study|Adverse event and disease exacerbation|1
4834022|NCT01077128|16666125|P1|Overall Study|Adverse event and consent withdrawal|1
4834023|NCT01077128|16666125|P1|Overall Study|Disease exacerbation|1
4834024|NCT01077128|16666125|P1|Overall Study|Lack of Efficacy|1
4834025|NCT01077128|16666125|P1|Overall Study|Adverse Event|8
4834026|NCT01077076|16666183|P6|Third Intervention|Death in the participant's family|1
4834027|NCT01077076|16666184|P5|Third Intervention|Death in the participant's family|0
4834028|NCT01077076|16666185|P4|Third Intervention|Death in the participant's family|0
4834029|NCT01077076|16666186|P3|Third Intervention|Death in the participant's family|0
4834030|NCT01077076|16666187|P2|Third Intervention|Death in the participant's family|0
4834031|NCT01077076|16666188|P1|Third Intervention|Death in the participant's family|0
4834032|NCT01077076|16666183|P6|First Intervention|Withdrawal by Subject|0
4834033|NCT01077076|16666184|P5|First Intervention|Withdrawal by Subject|0
4834034|NCT01077076|16666185|P4|First Intervention|Withdrawal by Subject|0
4834035|NCT01077076|16666186|P3|First Intervention|Withdrawal by Subject|0
4834036|NCT01077076|16666187|P2|First Intervention|Withdrawal by Subject|0
4834037|NCT01077076|16666188|P1|First Intervention|Withdrawal by Subject|1
4834038|NCT01077063|16666198|P2|Overall Study|Withdrawal by Subject|2
4834039|NCT01077063|16666199|P1|Overall Study|Withdrawal by Subject|0
4834040|NCT01077063|16666198|P2|Overall Study|Death|1
4834041|NCT01077063|16666199|P1|Overall Study|Death|1
4834042|NCT01077063|16666198|P2|Overall Study|Adverse Event|0
4834043|NCT01077063|16666199|P1|Overall Study|Adverse Event|3
4834044|NCT01077050|16666205|P1|Overall Study|Screen failure|8
4834045|NCT01077050|16666205|P1|Overall Study|Subjects signed ICF could not be located|1
4834046|NCT01077024|16666211|P2|Overall Study|Other|4
4834047|NCT01077024|16666212|P1|Overall Study|Other|4
4834048|NCT01077024|16666211|P2|Overall Study|Incarcerated|8
4834049|NCT01077024|16666212|P1|Overall Study|Incarcerated|7
4834050|NCT01077024|16666211|P2|Overall Study|Withdrawal by Subject|2
4834051|NCT01077024|16666212|P1|Overall Study|Withdrawal by Subject|0
4834052|NCT01077024|16666211|P2|Overall Study|Lost to Follow-up|14
4834053|NCT01077024|16666212|P1|Overall Study|Lost to Follow-up|20
4834054|NCT01076959|16666251|P1|Overall Study|Other|119
4834055|NCT01076959|16666251|P1|Overall Study|Lost to Follow-up|241
4834056|NCT01076959|16666251|P1|Overall Study|Non-compliance|274
4834057|NCT01076959|16666251|P1|Overall Study|Lack of Efficacy|849
4834058|NCT01076959|16666251|P1|Overall Study|Adverse Event|767
4834059|NCT01076647|16666287|P2|Overall Study|Unclassified|12
4834060|NCT01076647|16666288|P1|Overall Study|Unclassified|12
4834061|NCT01076647|16666287|P2|Overall Study|Withdrawal criteria|2
4834062|NCT01076647|16666288|P1|Overall Study|Withdrawal criteria|2
4834063|NCT01076647|16666287|P2|Overall Study|Protocol Violation|9
4834064|NCT01076647|16666288|P1|Overall Study|Protocol Violation|7
4834065|NCT01076647|16666287|P2|Overall Study|Lack of Efficacy|1
4834066|NCT01076647|16666288|P1|Overall Study|Lack of Efficacy|0
4834067|NCT01076647|16666287|P2|Overall Study|Adverse Event|1
4834068|NCT01076647|16666288|P1|Overall Study|Adverse Event|4
4834069|NCT01076543|16666302|P6|Overall Study|Withdrawal by Subject|0
4834070|NCT01076543|16666303|P5|Overall Study|Withdrawal by Subject|0
4834071|NCT01076543|16666304|P4|Overall Study|Withdrawal by Subject|0
4834072|NCT01076543|16666305|P3|Overall Study|Withdrawal by Subject|0
4834073|NCT01076543|16666306|P2|Overall Study|Withdrawal by Subject|0
4834074|NCT01076543|16666307|P1|Overall Study|Withdrawal by Subject|2
4834075|NCT01076400|16666368|P3|Overall Study|Progressive Disease|0
4834076|NCT01076400|16666369|P2|Overall Study|Progressive Disease|0
4834077|NCT01076400|16666370|P1|Overall Study|Progressive Disease|5
4834078|NCT01076400|16666368|P3|Overall Study|Adverse Event|0
4834079|NCT01076400|16666369|P2|Overall Study|Adverse Event|0
4834080|NCT01076400|16666370|P1|Overall Study|Adverse Event|2
4834081|NCT01076361|16666376|P1|Overall Study|22 leads were excluded from analysis|21
4834082|NCT01076335|16666384|P1|Overall Study|Withdrawal without treatment|1
4834083|NCT01076335|16666384|P1|Overall Study|Withdrawal by Subject|3
4834084|NCT01076205|16666436|P1|Overall Study|Lost to Follow-up|3151
4834085|NCT01076205|16666436|P1|Overall Study|Unknown Reason|71
4834086|NCT01076205|16666436|P1|Overall Study|Other Reason|1075
4834087|NCT01076205|16666436|P1|Overall Study|Lack of Effectiveness|1423
4834088|NCT01076205|16666436|P1|Overall Study|Adverse Drug Reaction|299
4834089|NCT01076192|16666489|P1|Overall Study|Other|197
4834090|NCT01076179|16666504|P1|Overall Study|Withdrawal by Subject|1
4834091|NCT01076166|16666527|P1|Overall Study|Symptoms improved/resolved|6
4834092|NCT01076166|16666527|P1|Overall Study|Adverse Event|3
4834093|NCT01076153|16666534|P1|Overall Study|Adverse Event|1
4834094|NCT01076153|16666534|P1|Overall Study|Symptoms improved/resolved|10
4834095|NCT01076088|16666548|P6|Overall Study|Other protocol specified criteria|1
4834096|NCT01076088|16666549|P5|Overall Study|Other protocol specified criteria|0
4834097|NCT01076088|16666550|P4|Overall Study|Other protocol specified criteria|0
4834098|NCT01076088|16666551|P3|Overall Study|Other protocol specified criteria|0
4834099|NCT01076088|16666552|P2|Overall Study|Other protocol specified criteria|0
4834100|NCT01076088|16666553|P1|Overall Study|Other protocol specified criteria|0
4834101|NCT01076088|16666548|P6|Overall Study|Withdrawal by Subject|17
4834102|NCT01076088|16666549|P5|Overall Study|Withdrawal by Subject|11
4834103|NCT01076088|16666550|P4|Overall Study|Withdrawal by Subject|10
4834104|NCT01076088|16666551|P3|Overall Study|Withdrawal by Subject|14
4834105|NCT01076088|16666552|P2|Overall Study|Withdrawal by Subject|8
4834106|NCT01076088|16666553|P1|Overall Study|Withdrawal by Subject|8
4834107|NCT01076088|16666548|P6|Overall Study|Physician Decision|0
4834108|NCT01076088|16666549|P5|Overall Study|Physician Decision|1
4834109|NCT01076088|16666550|P4|Overall Study|Physician Decision|1
4834110|NCT01076088|16666551|P3|Overall Study|Physician Decision|0
4834111|NCT01076088|16666552|P2|Overall Study|Physician Decision|3
4834112|NCT01076088|16666553|P1|Overall Study|Physician Decision|1
4834113|NCT01076088|16666548|P6|Overall Study|Non-compliance with study drug|0
4834114|NCT01076088|16666549|P5|Overall Study|Non-compliance with study drug|0
4834115|NCT01076088|16666550|P4|Overall Study|Non-compliance with study drug|1
4834116|NCT01076088|16666551|P3|Overall Study|Non-compliance with study drug|0
4834117|NCT01076088|16666552|P2|Overall Study|Non-compliance with study drug|0
4834118|NCT01076088|16666553|P1|Overall Study|Non-compliance with study drug|0
4834119|NCT01076088|16666548|P6|Overall Study|Lost to Follow-up|2
4834120|NCT01076088|16666549|P5|Overall Study|Lost to Follow-up|1
4834121|NCT01076088|16666550|P4|Overall Study|Lost to Follow-up|1
4834122|NCT01076088|16666551|P3|Overall Study|Lost to Follow-up|0
4834123|NCT01076088|16666552|P2|Overall Study|Lost to Follow-up|1
4834124|NCT01076088|16666553|P1|Overall Study|Lost to Follow-up|1
4834125|NCT01076088|16666548|P6|Overall Study|Adverse Event|3
4834126|NCT01076088|16666549|P5|Overall Study|Adverse Event|3
4834127|NCT01076088|16666550|P4|Overall Study|Adverse Event|2
4834128|NCT01076088|16666551|P3|Overall Study|Adverse Event|3
4834129|NCT01076088|16666552|P2|Overall Study|Adverse Event|6
4834130|NCT01076088|16666553|P1|Overall Study|Adverse Event|1
4834131|NCT01076075|16666581|P2|Overall Study|Withdrawal by Subject|19
4834132|NCT01076075|16666582|P1|Overall Study|Withdrawal by Subject|8
4834133|NCT01076075|16666581|P2|Overall Study|Protocol Violation|1
4834134|NCT01076075|16666582|P1|Overall Study|Protocol Violation|0
4834135|NCT01076075|16666581|P2|Overall Study|other|9
4834136|NCT01076075|16666582|P1|Overall Study|other|19
4834137|NCT01076075|16666581|P2|Overall Study|Lost to Follow-up|5
4834138|NCT01076075|16666582|P1|Overall Study|Lost to Follow-up|6
4834139|NCT01076075|16666581|P2|Overall Study|Lack of Efficacy|4
4834140|NCT01076075|16666582|P1|Overall Study|Lack of Efficacy|5
4834141|NCT01076075|16666581|P2|Overall Study|Adverse Event|9
4834142|NCT01076075|16666582|P1|Overall Study|Adverse Event|3
4834143|NCT01076036|16666596|P1|Overall Study|Didn't meet inclusion/exclusion criteria|2
4834144|NCT01076010|16666604|P3|Overall Study|Other|0
4834145|NCT01076010|16666605|P2|Overall Study|Other|2
4834146|NCT01076010|16666606|P1|Overall Study|Other|5
4834147|NCT01076010|16666604|P3|Overall Study|Withdrawal by Subject|1
4834148|NCT01076010|16666605|P2|Overall Study|Withdrawal by Subject|0
4834149|NCT01076010|16666606|P1|Overall Study|Withdrawal by Subject|3
4834150|NCT01076010|16666604|P3|Overall Study|Noncompliance|0
4834151|NCT01076010|16666605|P2|Overall Study|Noncompliance|1
4834152|NCT01076010|16666606|P1|Overall Study|Noncompliance|1
4834153|NCT01076010|16666604|P3|Overall Study|Protocol Violation|0
4834154|NCT01076010|16666605|P2|Overall Study|Protocol Violation|1
4834155|NCT01076010|16666606|P1|Overall Study|Protocol Violation|0
4834156|NCT01076010|16666604|P3|Overall Study|Significant Surgical Procedure|0
4834157|NCT01076010|16666605|P2|Overall Study|Significant Surgical Procedure|1
4834158|NCT01076010|16666606|P1|Overall Study|Significant Surgical Procedure|0
4834159|NCT01076010|16666604|P3|Overall Study|Treatment Interruption for > 2 Weeks|0
4834160|NCT01076010|16666605|P2|Overall Study|Treatment Interruption for > 2 Weeks|1
4834161|NCT01076010|16666606|P1|Overall Study|Treatment Interruption for > 2 Weeks|0
4834162|NCT01076010|16666604|P3|Overall Study|Lack of Efficacy|0
4834163|NCT01076010|16666605|P2|Overall Study|Lack of Efficacy|0
4834164|NCT01076010|16666606|P1|Overall Study|Lack of Efficacy|4
4834165|NCT01076010|16666604|P3|Overall Study|Progressive disease|1
4834166|NCT01076010|16666605|P2|Overall Study|Progressive disease|30
4834167|NCT01076010|16666606|P1|Overall Study|Progressive disease|90
4834168|NCT01076010|16666604|P3|Overall Study|Adverse Event|0
4834169|NCT01076010|16666605|P2|Overall Study|Adverse Event|2
4834170|NCT01076010|16666606|P1|Overall Study|Adverse Event|7
4834171|NCT01076010|16666604|P3|Overall Study|Death|0
4834172|NCT01076010|16666605|P2|Overall Study|Death|1
4834173|NCT01076010|16666606|P1|Overall Study|Death|15
4834174|NCT01075984|16666646|P5|Follow-up Phase|Treatment failure|4
4834175|NCT01075984|16666647|P4|Follow-up Phase|Treatment failure|0
4834176|NCT01075984|16666648|P3|Follow-up Phase|Treatment failure|0
4834177|NCT01075984|16666649|P2|Follow-up Phase|Treatment failure|0
4834178|NCT01075984|16666650|P1|Follow-up Phase|Treatment failure|0
4834179|NCT01075984|16666646|P5|Follow-up Phase|Progression of disease|2
4834180|NCT01075984|16666647|P4|Follow-up Phase|Progression of disease|0
4834181|NCT01075984|16666648|P3|Follow-up Phase|Progression of disease|0
4834182|NCT01075984|16666649|P2|Follow-up Phase|Progression of disease|0
4834183|NCT01075984|16666650|P1|Follow-up Phase|Progression of disease|0
4834184|NCT01075984|16666646|P5|Follow-up Phase|Withdrawal by Subject|10
4834185|NCT01075984|16666647|P4|Follow-up Phase|Withdrawal by Subject|0
4834186|NCT01075984|16666648|P3|Follow-up Phase|Withdrawal by Subject|0
4834187|NCT01075984|16666649|P2|Follow-up Phase|Withdrawal by Subject|0
4834188|NCT01075984|16666650|P1|Follow-up Phase|Withdrawal by Subject|0
4834189|NCT01075984|16666646|P5|Follow-up Phase|Administrative|1
4834190|NCT01075984|16666647|P4|Follow-up Phase|Administrative|0
4834191|NCT01075984|16666648|P3|Follow-up Phase|Administrative|0
4834192|NCT01075984|16666649|P2|Follow-up Phase|Administrative|0
4834193|NCT01075984|16666650|P1|Follow-up Phase|Administrative|0
4834194|NCT01075984|16666646|P5|Follow-up Phase|Adverse Event|27
4834195|NCT01075984|16666647|P4|Follow-up Phase|Adverse Event|2
4834196|NCT01075984|16666648|P3|Follow-up Phase|Adverse Event|0
4834197|NCT01075984|16666649|P2|Follow-up Phase|Adverse Event|0
4834198|NCT01075984|16666650|P1|Follow-up Phase|Adverse Event|0
4834199|NCT01075984|16666646|P5|Follow-up Phase|Protocol Violation|3
4834200|NCT01075984|16666647|P4|Follow-up Phase|Protocol Violation|0
4834201|NCT01075984|16666648|P3|Follow-up Phase|Protocol Violation|1
4834202|NCT01075984|16666649|P2|Follow-up Phase|Protocol Violation|0
4834203|NCT01075984|16666650|P1|Follow-up Phase|Protocol Violation|0
4834204|NCT01075984|16666646|P5|Treatment Phase|Progression of disease|2
4834205|NCT01075984|16666647|P4|Treatment Phase|Progression of disease|0
4834206|NCT01075984|16666648|P3|Treatment Phase|Progression of disease|0
4834207|NCT01075984|16666649|P2|Treatment Phase|Progression of disease|0
4834208|NCT01075984|16666650|P1|Treatment Phase|Progression of disease|0
4834209|NCT01075984|16666646|P5|Treatment Phase|Treatment Failure|5
4834210|NCT01075984|16666647|P4|Treatment Phase|Treatment Failure|0
4834211|NCT01075984|16666648|P3|Treatment Phase|Treatment Failure|1
4834212|NCT01075984|16666649|P2|Treatment Phase|Treatment Failure|0
4834213|NCT01075984|16666650|P1|Treatment Phase|Treatment Failure|0
4834214|NCT01075984|16666646|P5|Treatment Phase|Withdrawal by Subject|15
4834215|NCT01075984|16666647|P4|Treatment Phase|Withdrawal by Subject|0
4834216|NCT01075984|16666648|P3|Treatment Phase|Withdrawal by Subject|2
4834217|NCT01075984|16666649|P2|Treatment Phase|Withdrawal by Subject|0
4834218|NCT01075984|16666650|P1|Treatment Phase|Withdrawal by Subject|0
4834219|NCT01075984|16666646|P5|Treatment Phase|Protocol Violation|3
4834220|NCT01075984|16666647|P4|Treatment Phase|Protocol Violation|0
4834221|NCT01075984|16666648|P3|Treatment Phase|Protocol Violation|1
4834222|NCT01075984|16666649|P2|Treatment Phase|Protocol Violation|0
4834223|NCT01075984|16666650|P1|Treatment Phase|Protocol Violation|0
4834224|NCT01075984|16666646|P5|Treatment Phase|Adverse Event|35
4834225|NCT01075984|16666647|P4|Treatment Phase|Adverse Event|7
4834226|NCT01075984|16666648|P3|Treatment Phase|Adverse Event|3
4834227|NCT01075984|16666649|P2|Treatment Phase|Adverse Event|1
4834228|NCT01075984|16666650|P1|Treatment Phase|Adverse Event|0
4834229|NCT01075958|16666708|P1|Overall Study|Blood sample could not be obtained|44
4834230|NCT01075815|16666724|P2|Overall Study|Withdrawal between OPU - embryo transfer|2
4834231|NCT01075815|16666725|P1|Overall Study|Withdrawal between OPU - embryo transfer|3
4834232|NCT01075815|16666724|P2|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
4834233|NCT01075815|16666725|P1|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1
4834234|NCT01075815|16666724|P2|Overall Study|Withdrawal before r-hCG administration|1
4834235|NCT01075815|16666725|P1|Overall Study|Withdrawal before r-hCG administration|6
4834236|NCT01075763|16666763|P2|Overall Study|Withdrawal by Subject|2
4834237|NCT01075763|16666764|P1|Overall Study|Withdrawal by Subject|2
4834238|NCT01075763|16666763|P2|Overall Study|Lack of Efficacy|1
4834239|NCT01075763|16666764|P1|Overall Study|Lack of Efficacy|0
4834240|NCT01075763|16666763|P2|Overall Study|Lost to Follow-up|1
4834241|NCT01075763|16666764|P1|Overall Study|Lost to Follow-up|2
4834242|NCT01075685|16666788|P2|Overall Study|Lost to Follow-up|220
4834243|NCT01075685|16666789|P1|Overall Study|Lost to Follow-up|563
4834244|NCT01075685|16666788|P2|Overall Study|Withdrawal by Subject|5
4834245|NCT01075685|16666789|P1|Overall Study|Withdrawal by Subject|20
4834246|NCT01075685|16666788|P2|Overall Study|Protocol Violation|1
4834247|NCT01075685|16666789|P1|Overall Study|Protocol Violation|9
4834248|NCT01075646|16666805|P4|Overall Study|Lost to Follow-up|2
4834249|NCT01075646|16666806|P3|Overall Study|Lost to Follow-up|1
4834250|NCT01075646|16666807|P2|Overall Study|Lost to Follow-up|3
4834251|NCT01075646|16666808|P1|Overall Study|Lost to Follow-up|4
4834252|NCT01075412|16666840|P2|Overall Study|Withdrawal by Subject|1
4834253|NCT01075412|16666841|P1|Overall Study|Withdrawal by Subject|0
4834254|NCT01075321|16666866|P4|Overall Study|Ineligible (miscalculated lab value)|1
4834255|NCT01075321|16666867|P3|Overall Study|Ineligible (miscalculated lab value)|0
4834256|NCT01075321|16666868|P2|Overall Study|Ineligible (miscalculated lab value)|0
4834257|NCT01075321|16666869|P1|Overall Study|Ineligible (miscalculated lab value)|0
4834258|NCT01075321|16666866|P4|Overall Study|Treatment Incomplete due to progression|0
4834259|NCT01075321|16666867|P3|Overall Study|Treatment Incomplete due to progression|0
4834260|NCT01075321|16666868|P2|Overall Study|Treatment Incomplete due to progression|0
4834261|NCT01075321|16666869|P1|Overall Study|Treatment Incomplete due to progression|1
4834262|NCT01075321|16666866|P4|Overall Study|Protocol Violation|0
4834263|NCT01075321|16666867|P3|Overall Study|Protocol Violation|1
4834264|NCT01075321|16666868|P2|Overall Study|Protocol Violation|0
4834265|NCT01075321|16666869|P1|Overall Study|Protocol Violation|0
4834266|NCT01075321|16666866|P4|Overall Study|Withdrawal by Subject|1
4834267|NCT01075321|16666867|P3|Overall Study|Withdrawal by Subject|1
4834268|NCT01075321|16666868|P2|Overall Study|Withdrawal by Subject|0
4834269|NCT01075321|16666869|P1|Overall Study|Withdrawal by Subject|0
4834270|NCT01075282|16666887|P3|Overall Study|Death|2
4834271|NCT01075282|16666888|P2|Overall Study|Death|1
4834272|NCT01075282|16666889|P1|Overall Study|Death|0
4834273|NCT01075282|16666887|P3|Overall Study|Protocol Violation|1
4834274|NCT01075282|16666888|P2|Overall Study|Protocol Violation|2
4834275|NCT01075282|16666889|P1|Overall Study|Protocol Violation|0
4834276|NCT01075282|16666887|P3|Overall Study|Treatment Non-compliance|2
4834277|NCT01075282|16666888|P2|Overall Study|Treatment Non-compliance|2
4834278|NCT01075282|16666889|P1|Overall Study|Treatment Non-compliance|1
4834279|NCT01075282|16666887|P3|Overall Study|Lack of Efficacy|0
4834280|NCT01075282|16666888|P2|Overall Study|Lack of Efficacy|1
4834281|NCT01075282|16666889|P1|Overall Study|Lack of Efficacy|1
4834282|NCT01075282|16666887|P3|Overall Study|Physician Decision|3
4834283|NCT01075282|16666888|P2|Overall Study|Physician Decision|3
4834284|NCT01075282|16666889|P1|Overall Study|Physician Decision|3
4834285|NCT01075282|16666887|P3|Overall Study|Lost to Follow-up|3
4834286|NCT01075282|16666888|P2|Overall Study|Lost to Follow-up|3
4834287|NCT01075282|16666889|P1|Overall Study|Lost to Follow-up|3
4834288|NCT01075282|16666887|P3|Overall Study|Entry Criteria Not Met|0
4834289|NCT01075282|16666888|P2|Overall Study|Entry Criteria Not Met|2
4834290|NCT01075282|16666889|P1|Overall Study|Entry Criteria Not Met|3
4834291|NCT01075282|16666887|P3|Overall Study|Adverse Event|5
4834292|NCT01075282|16666888|P2|Overall Study|Adverse Event|8
4834293|NCT01075282|16666889|P1|Overall Study|Adverse Event|9
4834294|NCT01075282|16666887|P3|Overall Study|Withdrawal by Subject|11
4834295|NCT01075282|16666888|P2|Overall Study|Withdrawal by Subject|7
4834296|NCT01075282|16666889|P1|Overall Study|Withdrawal by Subject|11
4834297|NCT01075256|16666972|P3|Overall Study|Withdrawal by Subject|0
4834298|NCT01075256|16666973|P2|Overall Study|Withdrawal by Subject|0
4834299|NCT01075256|16666974|P1|Overall Study|Withdrawal by Subject|1
4834300|NCT01075243|16667006|P3|Overall Study|Withdrawal by Subject|0
4834301|NCT01075243|16667007|P2|Overall Study|Withdrawal by Subject|1
4834302|NCT01075243|16667008|P1|Overall Study|Withdrawal by Subject|1
4834303|NCT01075243|16667006|P3|Overall Study|Lost to Follow-up|0
4834304|NCT01075243|16667007|P2|Overall Study|Lost to Follow-up|2
4834305|NCT01075243|16667008|P1|Overall Study|Lost to Follow-up|5
4834306|NCT01075217|16667060|P2|Overall Study|Physician Decision|0
4834307|NCT01075217|16667061|P1|Overall Study|Physician Decision|1
4834308|NCT01075217|16667060|P2|Overall Study|Adverse Event|1
4834309|NCT01075217|16667061|P1|Overall Study|Adverse Event|1
4834310|NCT01075191|16667094|P1|Overall Study|Unknown Reasons|1
4834311|NCT01075191|16667094|P1|Overall Study|Patient's Wish|2
4834312|NCT01075191|16667094|P1|Overall Study|Therapy Break|3
4834313|NCT01075191|16667094|P1|Overall Study|Noncompliance|3
4834314|NCT01075191|16667094|P1|Overall Study|Adverse Event|4
4834315|NCT01075191|16667094|P1|Overall Study|Co-morbidities|1
4834316|NCT01075191|16667094|P1|Overall Study|Intensification|3
4834317|NCT01075191|16667094|P1|Overall Study|Death|1
4834318|NCT01075178|16667105|P2|Subject Chart Review|matched partner excluded (reasons above)|3
4834319|NCT01075178|16667106|P1|Subject Chart Review|matched partner excluded (reasons above)|6
4834320|NCT01075178|16667105|P2|Subject Chart Review|no data collected due to site closure|4
4834321|NCT01075178|16667106|P1|Subject Chart Review|no data collected due to site closure|3
4834322|NCT01075178|16667105|P2|Subject Chart Review|died before chart review period|2
4834323|NCT01075178|16667106|P1|Subject Chart Review|died before chart review period|0
4834324|NCT01075178|16667105|P2|Subject Matching|eligible but not matched|403
4834325|NCT01075178|16667106|P1|Subject Matching|eligible but not matched|130
4834326|NCT01075152|16667120|P2|Overall Study|Withdrawal by Subject|0
4834327|NCT01075152|16667121|P1|Overall Study|Withdrawal by Subject|1
4834328|NCT01075100|16667147|P2|Overall Study|Other|1
4834329|NCT01075100|16667148|P1|Overall Study|Other|3
4834330|NCT01075100|16667147|P2|Overall Study|Disease Progression|29
4834331|NCT01075100|16667148|P1|Overall Study|Disease Progression|25
4834332|NCT01075100|16667147|P2|Overall Study|Investigator Request|1
4834333|NCT01075100|16667148|P1|Overall Study|Investigator Request|2
4834334|NCT01075100|16667147|P2|Overall Study|Patient Request|4
4834335|NCT01075100|16667148|P1|Overall Study|Patient Request|4
4834336|NCT01075100|16667147|P2|Overall Study|Adverse Event|18
4834337|NCT01075100|16667148|P1|Overall Study|Adverse Event|15
4834338|NCT01075074|16667178|P3|Overall Study|Surgeon changed to open incisional case|2
4834339|NCT01075074|16667179|P2|Overall Study|Surgeon changed to open incisional case|2
4834340|NCT01075074|16667180|P1|Overall Study|Surgeon changed to open incisional case|1
4834341|NCT01075048|16667200|P3|Overall Study|Lost to Follow-up|1
4834342|NCT01075048|16667201|P2|Overall Study|Lost to Follow-up|1
4834343|NCT01075048|16667202|P1|Overall Study|Lost to Follow-up|0
4834344|NCT01075048|16667200|P3|Overall Study|Withdrawal by Subject|3
4834345|NCT01075048|16667201|P2|Overall Study|Withdrawal by Subject|6
4834346|NCT01075048|16667202|P1|Overall Study|Withdrawal by Subject|1
4834347|NCT01075048|16667200|P3|Overall Study|Start of other or new therapy|46
4834348|NCT01075048|16667201|P2|Overall Study|Start of other or new therapy|36
4834349|NCT01075048|16667202|P1|Overall Study|Start of other or new therapy|4
4834350|NCT01075048|16667200|P3|Overall Study|Death|12
4834351|NCT01075048|16667201|P2|Overall Study|Death|17
4834352|NCT01075048|16667202|P1|Overall Study|Death|4
4834353|NCT01074944|16667225|P5|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3
4834354|NCT01074944|16667226|P4|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4834355|NCT01074944|16667227|P3|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4834356|NCT01074944|16667228|P2|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4834357|NCT01074944|16667229|P1|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0
4834358|NCT01074944|16667225|P5|Extended Treatment (up to 42 Months)|Pregnancy|2
4834359|NCT01074944|16667226|P4|Extended Treatment (up to 42 Months)|Pregnancy|0
4834360|NCT01074944|16667227|P3|Extended Treatment (up to 42 Months)|Pregnancy|0
4834361|NCT01074944|16667228|P2|Extended Treatment (up to 42 Months)|Pregnancy|0
4834362|NCT01074944|16667229|P1|Extended Treatment (up to 42 Months)|Pregnancy|0
4834363|NCT01074944|16667225|P5|Long Term Treatment|Withdrawal by Subject|0
4834364|NCT01074944|16667226|P4|Long Term Treatment|Withdrawal by Subject|2
4834365|NCT01074944|16667227|P3|Long Term Treatment|Withdrawal by Subject|0
4834366|NCT01074944|16667228|P2|Long Term Treatment|Withdrawal by Subject|0
4834367|NCT01074944|16667229|P1|Long Term Treatment|Withdrawal by Subject|0
4834368|NCT01074944|16667225|P5|Long Term Treatment|Entered in Period, But Not Treated|0
4834369|NCT01074944|16667226|P4|Long Term Treatment|Entered in Period, But Not Treated|1
4834370|NCT01074944|16667227|P3|Long Term Treatment|Entered in Period, But Not Treated|0
4834371|NCT01074944|16667228|P2|Long Term Treatment|Entered in Period, But Not Treated|0
4834372|NCT01074944|16667229|P1|Long Term Treatment|Entered in Period, But Not Treated|0
4834373|NCT01074944|16667225|P5|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4834374|NCT01074944|16667226|P4|Long Term Treatment|Transitioned to Commercial Eliglustat|18
4834375|NCT01074944|16667227|P3|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4834376|NCT01074944|16667228|P2|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4834377|NCT01074944|16667229|P1|Long Term Treatment|Transitioned to Commercial Eliglustat|0
4834378|NCT01074944|16667225|P5|Long Term Treatment|Lost to Follow-up|0
4834379|NCT01074944|16667226|P4|Long Term Treatment|Lost to Follow-up|2
4834380|NCT01074944|16667227|P3|Long Term Treatment|Lost to Follow-up|0
4834381|NCT01074944|16667228|P2|Long Term Treatment|Lost to Follow-up|0
4834382|NCT01074944|16667229|P1|Long Term Treatment|Lost to Follow-up|0
4834383|NCT01074944|16667225|P5|Long Term Treatment|Adverse Event|0
4834384|NCT01074944|16667226|P4|Long Term Treatment|Adverse Event|3
4834385|NCT01074944|16667227|P3|Long Term Treatment|Adverse Event|0
4834386|NCT01074944|16667228|P2|Long Term Treatment|Adverse Event|0
4834387|NCT01074944|16667229|P1|Long Term Treatment|Adverse Event|0
4834388|NCT01074944|16667225|P5|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
4834389|NCT01074944|16667226|P4|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
4834390|NCT01074944|16667227|P3|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
4834391|NCT01074944|16667228|P2|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1
4834392|NCT01074944|16667229|P1|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0
4834393|NCT01074944|16667225|P5|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4834394|NCT01074944|16667226|P4|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4834395|NCT01074944|16667227|P3|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4834396|NCT01074944|16667228|P2|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1
4834397|NCT01074944|16667229|P1|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0
4834398|NCT01074944|16667225|P5|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
4834399|NCT01074944|16667226|P4|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
4834400|NCT01074944|16667227|P3|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
4834401|NCT01074944|16667228|P2|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1
4834402|NCT01074944|16667229|P1|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0
4834403|NCT01074944|16667225|P5|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
4834404|NCT01074944|16667226|P4|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
4834405|NCT01074944|16667227|P3|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1
4834406|NCT01074944|16667228|P2|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6
4834407|NCT01074944|16667229|P1|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0
4834408|NCT01074944|16667225|P5|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
4834409|NCT01074944|16667226|P4|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
4834410|NCT01074944|16667227|P3|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3
4834411|NCT01074944|16667228|P2|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2
4834412|NCT01074944|16667229|P1|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0
4834413|NCT01074944|16667225|P5|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4834414|NCT01074944|16667226|P4|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4834415|NCT01074944|16667227|P3|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4834416|NCT01074944|16667228|P2|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0
4834417|NCT01074944|16667229|P1|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6
4834418|NCT01074944|16667225|P5|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4834419|NCT01074944|16667226|P4|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4834420|NCT01074944|16667227|P3|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4834421|NCT01074944|16667228|P2|Lead-in Period (up to 78 Weeks)|Pregnancy|0
4834422|NCT01074944|16667229|P1|Lead-in Period (up to 78 Weeks)|Pregnancy|4
4834423|NCT01074944|16667225|P5|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4834424|NCT01074944|16667226|P4|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4834425|NCT01074944|16667227|P3|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4834426|NCT01074944|16667228|P2|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0
4834427|NCT01074944|16667229|P1|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1
4834428|NCT01074944|16667225|P5|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4834429|NCT01074944|16667226|P4|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4834430|NCT01074944|16667227|P3|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4834431|NCT01074944|16667228|P2|Lead-in Period (up to 78 Weeks)|Adverse Event|0
4834432|NCT01074944|16667229|P1|Lead-in Period (up to 78 Weeks)|Adverse Event|2
4834433|NCT01074931|16667283|P1|Overall Study|Death|5
4834434|NCT01074931|16667283|P1|Overall Study|Economic reasons|1
4834435|NCT01074658|16667295|P1|Overall Study|No implant attempted|19
4834436|NCT01074554|16667303|P2|Overall Study|Lost to Follow-up|1
4834437|NCT01074554|16667304|P1|Overall Study|Lost to Follow-up|0
4834438|NCT01074554|16667303|P2|Overall Study|Adverse Event|3
4834439|NCT01074554|16667304|P1|Overall Study|Adverse Event|3
4834440|NCT01074502|16667314|P1|Overall Study|Withdrawal by Subject|1
4834441|NCT01074450|16667338|P2|Second Intervention|Physician Decision|1
4834442|NCT01074450|16667339|P1|Second Intervention|Physician Decision|0
4834443|NCT01074450|16667338|P2|Second Intervention|Protocol Violation|0
4834444|NCT01074450|16667339|P1|Second Intervention|Protocol Violation|1
4834445|NCT01074450|16667338|P2|First Intervention|Emesis in Dosing Interval|2
4834446|NCT01074450|16667339|P1|First Intervention|Emesis in Dosing Interval|0
4834447|NCT01074307|16667368|P2|Overall Study|Protocol Violation|5
4834448|NCT01074307|16667369|P1|Overall Study|Protocol Violation|8
4834449|NCT01074307|16667368|P2|Overall Study|Exclusion criterion|1
4834450|NCT01074307|16667369|P1|Overall Study|Exclusion criterion|0
4834451|NCT01074307|16667368|P2|Overall Study|No primary endpoint evaluation|6
4834452|NCT01074307|16667369|P1|Overall Study|No primary endpoint evaluation|14
4834453|NCT01074268|16667391|P2|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2
4834454|NCT01074268|16667392|P1|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3
4834455|NCT01074268|16667391|P2|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
4834456|NCT01074268|16667392|P1|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2
4834457|NCT01074268|16667391|P2|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2
4834458|NCT01074268|16667392|P1|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0
4834459|NCT01074268|16667391|P2|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
4834460|NCT01074268|16667392|P1|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1
4834461|NCT01074268|16667391|P2|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5
4834462|NCT01074268|16667392|P1|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8
4834463|NCT01074268|16667391|P2|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3
4834464|NCT01074268|16667392|P1|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6
4834465|NCT01074268|16667391|P2|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4
4834466|NCT01074268|16667392|P1|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3
4834467|NCT01074268|16667391|P2|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2
4834468|NCT01074268|16667392|P1|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0
4834469|NCT01074268|16667391|P2|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1
4834470|NCT01074268|16667392|P1|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3
4834471|NCT01074255|16667418|P1|Overall Study|Did not receive EMEND|2
4834472|NCT01074242|16667422|P1|Overall Study|Duplicate Case Report Form|5
4834473|NCT01074242|16667422|P1|Overall Study|Violation of vaccine dose or dosage|351
4834474|NCT01074242|16667422|P1|Overall Study|Case report unclear|6
4834475|NCT01074242|16667422|P1|Overall Study|Lost to Follow-up|1
4834476|NCT01074242|16667422|P1|Overall Study|Case report before date of contract|40
4834477|NCT01074229|16667430|P3|Overall Study|Change to open surgical procedure|4
4834478|NCT01074229|16667431|P2|Overall Study|Change to open surgical procedure|3
4834479|NCT01074229|16667432|P1|Overall Study|Change to open surgical procedure|1
4834480|NCT01074229|16667430|P3|Overall Study|Lost to Follow-up|0
4834481|NCT01074229|16667431|P2|Overall Study|Lost to Follow-up|0
4834482|NCT01074229|16667432|P1|Overall Study|Lost to Follow-up|1
4834483|NCT01074216|16667443|P1|Overall Study|Not Treated|12
4834484|NCT01074216|16667443|P1|Overall Study|Physician Decision|1
4834485|NCT01074047|16667507|P2|Extension Phase|Death|0
4834486|NCT01074047|16667508|P1|Extension Phase|Death|5
4834487|NCT01074047|16667507|P2|Extension Phase|Withdrawal by Subject|0
4834488|NCT01074047|16667508|P1|Extension Phase|Withdrawal by Subject|2
4834489|NCT01074047|16667507|P2|Extension Phase|Disease Progression|0
4834490|NCT01074047|16667508|P1|Extension Phase|Disease Progression|9
4834491|NCT01074047|16667507|P2|Extension Phase|Adverse Event|0
4834492|NCT01074047|16667508|P1|Extension Phase|Adverse Event|5
4834493|NCT01074047|16667507|P2|Extension Phase|Physician Decision|0
4834494|NCT01074047|16667508|P1|Extension Phase|Physician Decision|1
4834495|NCT01074047|16667507|P2|Survival Follow-Up Phase|Alive at study closure|3
4834496|NCT01074047|16667508|P1|Survival Follow-Up Phase|Alive at study closure|1
4834497|NCT01074047|16667507|P2|Survival Follow-Up Phase|Death|124
4834498|NCT01074047|16667508|P1|Survival Follow-Up Phase|Death|116
4834499|NCT01074047|16667507|P2|Survival Follow-Up Phase|Lost to Follow-up|1
4834500|NCT01074047|16667508|P1|Survival Follow-Up Phase|Lost to Follow-up|2
4834501|NCT01074047|16667507|P2|Survival Follow-Up Phase|Withdrawal by Subject|8
4834502|NCT01074047|16667508|P1|Survival Follow-Up Phase|Withdrawal by Subject|5
4834503|NCT01074047|16667507|P2|Treatment Phase|Miscellaneous|39
4834504|NCT01074047|16667508|P1|Treatment Phase|Miscellaneous|32
4834505|NCT01074047|16667507|P2|Treatment Phase|Protocol Violation|1
4834506|NCT01074047|16667508|P1|Treatment Phase|Protocol Violation|0
4834507|NCT01074047|16667507|P2|Treatment Phase|Lost to Follow-up|1
4834508|NCT01074047|16667508|P1|Treatment Phase|Lost to Follow-up|0
4834509|NCT01074047|16667507|P2|Treatment Phase|Death|58
4834510|NCT01074047|16667508|P1|Treatment Phase|Death|53
4834511|NCT01074047|16667507|P2|Treatment Phase|Withdrawal by Subject|48
4834512|NCT01074047|16667508|P1|Treatment Phase|Withdrawal by Subject|27
4834513|NCT01074047|16667507|P2|Treatment Phase|Disease Progression|21
4834514|NCT01074047|16667508|P1|Treatment Phase|Disease Progression|16
4834515|NCT01074047|16667507|P2|Treatment Phase|Adverse Event|66
4834516|NCT01074047|16667508|P1|Treatment Phase|Adverse Event|89
4834517|NCT01074008|16667596|P9|Overall Study|Lost to Follow-up|4
4834518|NCT01074008|16667597|P8|Overall Study|Lost to Follow-up|0
4834519|NCT01074008|16667598|P7|Overall Study|Lost to Follow-up|1
4834520|NCT01074008|16667599|P6|Overall Study|Lost to Follow-up|0
4834521|NCT01074008|16667600|P5|Overall Study|Lost to Follow-up|1
4834522|NCT01074008|16667601|P4|Overall Study|Lost to Follow-up|1
4834523|NCT01074008|16667602|P3|Overall Study|Lost to Follow-up|1
4834524|NCT01074008|16667603|P2|Overall Study|Lost to Follow-up|1
4834525|NCT01074008|16667604|P1|Overall Study|Lost to Follow-up|0
4834526|NCT01074008|16667596|P9|Overall Study|Withdrawal by Subject|0
4834527|NCT01074008|16667597|P8|Overall Study|Withdrawal by Subject|0
4834528|NCT01074008|16667598|P7|Overall Study|Withdrawal by Subject|0
4834529|NCT01074008|16667599|P6|Overall Study|Withdrawal by Subject|0
4834530|NCT01074008|16667600|P5|Overall Study|Withdrawal by Subject|1
4834531|NCT01074008|16667601|P4|Overall Study|Withdrawal by Subject|0
4834532|NCT01074008|16667602|P3|Overall Study|Withdrawal by Subject|1
4834533|NCT01074008|16667603|P2|Overall Study|Withdrawal by Subject|1
4834534|NCT01074008|16667604|P1|Overall Study|Withdrawal by Subject|1
4834535|NCT01074008|16667596|P9|Overall Study|Adverse Event|0
4834536|NCT01074008|16667597|P8|Overall Study|Adverse Event|0
4834537|NCT01074008|16667598|P7|Overall Study|Adverse Event|0
4834538|NCT01074008|16667599|P6|Overall Study|Adverse Event|0
4834539|NCT01074008|16667600|P5|Overall Study|Adverse Event|0
4834540|NCT01074008|16667601|P4|Overall Study|Adverse Event|0
4834541|NCT01074008|16667602|P3|Overall Study|Adverse Event|0
4834542|NCT01074008|16667603|P2|Overall Study|Adverse Event|1
4834543|NCT01074008|16667604|P1|Overall Study|Adverse Event|0
4834544|NCT01073943|16667714|P2|Overall Study|Could not tolerate prep|0
4834545|NCT01073943|16667715|P1|Overall Study|Could not tolerate prep|1
4834546|NCT01073943|16667714|P2|Overall Study|Unable to return for follow-up|1
4834547|NCT01073943|16667715|P1|Overall Study|Unable to return for follow-up|0
4834548|NCT01073943|16667714|P2|Overall Study|Subject forgot|1
4834549|NCT01073943|16667715|P1|Overall Study|Subject forgot|0
4834550|NCT01073943|16667714|P2|Overall Study|Power outage; colonoscopy not done|0
4834551|NCT01073943|16667715|P1|Overall Study|Power outage; colonoscopy not done|1
4834552|NCT01073943|16667714|P2|Overall Study|Lost to Follow-up|2
4834553|NCT01073943|16667715|P1|Overall Study|Lost to Follow-up|0
4834554|NCT01073943|16667714|P2|Overall Study|Adverse Event|1
4834555|NCT01073943|16667715|P1|Overall Study|Adverse Event|1
4834556|NCT01073943|16667714|P2|Overall Study|Protocol Violation|1
4834557|NCT01073943|16667715|P1|Overall Study|Protocol Violation|2
4834558|NCT01073943|16667714|P2|Overall Study|Withdrawal by Subject|2
4834559|NCT01073943|16667715|P1|Overall Study|Withdrawal by Subject|8
4834560|NCT01073930|16667741|P2|Overall Study|Inadequate prep; unable to do procedure|1
4834561|NCT01073930|16667742|P1|Overall Study|Inadequate prep; unable to do procedure|0
4834562|NCT01073930|16667741|P2|Overall Study|Noncompliance with study drug|1
4834563|NCT01073930|16667742|P1|Overall Study|Noncompliance with study drug|0
4834564|NCT01073930|16667741|P2|Overall Study|Adverse Event|1
4834565|NCT01073930|16667742|P1|Overall Study|Adverse Event|0
4834566|NCT01073930|16667741|P2|Overall Study|Lost to Follow-up|1
4834567|NCT01073930|16667742|P1|Overall Study|Lost to Follow-up|0
4834568|NCT01073930|16667741|P2|Overall Study|Withdrawal by Subject|2
4834569|NCT01073930|16667742|P1|Overall Study|Withdrawal by Subject|3
4834570|NCT01073865|16667766|P2|Overall Study|Withdrawal by Subject|5
4834571|NCT01073865|16667767|P1|Overall Study|Withdrawal by Subject|5
4834572|NCT01073865|16667766|P2|Overall Study|Death|2
4834573|NCT01073865|16667767|P1|Overall Study|Death|3
4834574|NCT01073865|16667766|P2|Overall Study|Lost to Follow-up|1
4834575|NCT01073865|16667767|P1|Overall Study|Lost to Follow-up|1
4834576|NCT01073865|16667766|P2|Overall Study|Reasons other than below|31
4834577|NCT01073865|16667767|P1|Overall Study|Reasons other than below|19
4834578|NCT01073631|16667786|P1|Overall Study|Other|63
4834579|NCT01073631|16667786|P1|Overall Study|Adverse Event|24
4834580|NCT01073631|16667786|P1|Overall Study|Death|82
4834581|NCT01073618|16667791|P1|Overall Study|Other|80
4834582|NCT01073618|16667791|P1|Overall Study|Adverse Event|19
4834583|NCT01073618|16667791|P1|Overall Study|Death|208
4834584|NCT01073605|16667799|P3|Overall Study|Randomized But Not Treated|1
4834585|NCT01073605|16667800|P2|Overall Study|Randomized But Not Treated|1
4834586|NCT01073605|16667801|P1|Overall Study|Randomized But Not Treated|0
4834587|NCT01073605|16667799|P3|Overall Study|Withdrawal by Subject|22
4834588|NCT01073605|16667800|P2|Overall Study|Withdrawal by Subject|39
4834589|NCT01073605|16667801|P1|Overall Study|Withdrawal by Subject|31
4834590|NCT01073605|16667799|P3|Overall Study|Other|29
4834591|NCT01073605|16667800|P2|Overall Study|Other|21
4834592|NCT01073605|16667801|P1|Overall Study|Other|25
4834593|NCT01073605|16667799|P3|Overall Study|Lost to Follow-up|9
4834594|NCT01073605|16667800|P2|Overall Study|Lost to Follow-up|4
4834595|NCT01073605|16667801|P1|Overall Study|Lost to Follow-up|3
4834596|NCT01073605|16667799|P3|Overall Study|Adverse Event|0
4834597|NCT01073605|16667800|P2|Overall Study|Adverse Event|1
4834598|NCT01073605|16667801|P1|Overall Study|Adverse Event|2
4834599|NCT01073605|16667799|P3|Overall Study|Ongoing at Cutoff Date|0
4834600|NCT01073605|16667800|P2|Overall Study|Ongoing at Cutoff Date|1
4834601|NCT01073605|16667801|P1|Overall Study|Ongoing at Cutoff Date|1
4834602|NCT01073566|16667847|P2|Period 2 (6 Weeks)|Adverse Event|0
4834603|NCT01073566|16667848|P1|Period 2 (6 Weeks)|Adverse Event|1
4834604|NCT01073462|16667860|P1|Overall Study|Lost to Follow-up|7
4834605|NCT01073462|16667860|P1|Overall Study|Serious adverse event|2
4834606|NCT01073462|16667860|P1|Overall Study|Low parathyroid hormone levels|8
4834607|NCT01073462|16667860|P1|Overall Study|Kidney transplant|10
4834608|NCT01073462|16667860|P1|Overall Study|Death|14
4834609|NCT01073293|16667879|P2|Overall Study|Withdrawal by Subject|10
4834610|NCT01073293|16667880|P1|Overall Study|Withdrawal by Subject|5
4834611|NCT01073293|16667879|P2|Overall Study|Lost to Follow-up|1
4834612|NCT01073293|16667880|P1|Overall Study|Lost to Follow-up|0
4834613|NCT01073267|16667902|P1|Overall Study|Disease Progression|3
4834614|NCT01073163|16667906|P1|Overall Study|Early termination|1
4834615|NCT01073163|16667906|P1|Overall Study|Disease Progression|1
4834616|NCT01073163|16667906|P1|Overall Study|Adverse Event|1
4834617|NCT01072929|16667929|P3|Overall Study|Other|0
4834618|NCT01072929|16667930|P2|Overall Study|Other|3
4834619|NCT01072929|16667931|P1|Overall Study|Other|0
4834620|NCT01072929|16667929|P3|Overall Study|Noncompliance with study procedures|1
4834621|NCT01072929|16667930|P2|Overall Study|Noncompliance with study procedures|0
4834622|NCT01072929|16667931|P1|Overall Study|Noncompliance with study procedures|1
4834623|NCT01072929|16667929|P3|Overall Study|Noncompliance with study medication|0
4834624|NCT01072929|16667930|P2|Overall Study|Noncompliance with study medication|3
4834625|NCT01072929|16667931|P1|Overall Study|Noncompliance with study medication|0
4834626|NCT01072929|16667929|P3|Overall Study|Lost to Follow-up|1
4834627|NCT01072929|16667930|P2|Overall Study|Lost to Follow-up|4
4834628|NCT01072929|16667931|P1|Overall Study|Lost to Follow-up|8
4834629|NCT01072929|16667929|P3|Overall Study|Protocol Violation|2
4834630|NCT01072929|16667930|P2|Overall Study|Protocol Violation|11
4834631|NCT01072929|16667931|P1|Overall Study|Protocol Violation|13
4834632|NCT01072929|16667929|P3|Overall Study|Withdrawal by Subject|3
4834633|NCT01072929|16667930|P2|Overall Study|Withdrawal by Subject|15
4834634|NCT01072929|16667931|P1|Overall Study|Withdrawal by Subject|7
4834635|NCT01072929|16667929|P3|Overall Study|Lack of Efficacy|0
4834636|NCT01072929|16667930|P2|Overall Study|Lack of Efficacy|4
4834637|NCT01072929|16667931|P1|Overall Study|Lack of Efficacy|7
4834638|NCT01072929|16667929|P3|Overall Study|Adverse Event|2
4834639|NCT01072929|16667930|P2|Overall Study|Adverse Event|11
4834640|NCT01072929|16667931|P1|Overall Study|Adverse Event|8
4834641|NCT01072877|16668010|P5|Overall Study|Lost to Follow-up|0
4834642|NCT01072877|16668011|P4|Overall Study|Lost to Follow-up|2
4834643|NCT01072877|16668012|P3|Overall Study|Lost to Follow-up|0
4834644|NCT01072877|16668013|P2|Overall Study|Lost to Follow-up|1
4834645|NCT01072877|16668014|P1|Overall Study|Lost to Follow-up|1
4834646|NCT01072630|16668093|P3|Overall Study|Other|1
4834647|NCT01072630|16668094|P2|Overall Study|Other|2
4834648|NCT01072630|16668095|P1|Overall Study|Other|3
4834649|NCT01072630|16668093|P3|Overall Study|Noncompliance with study procedures|1
4834650|NCT01072630|16668094|P2|Overall Study|Noncompliance with study procedures|2
4834651|NCT01072630|16668095|P1|Overall Study|Noncompliance with study procedures|1
4834652|NCT01072630|16668093|P3|Overall Study|Noncompliance with study medication|1
4834653|NCT01072630|16668094|P2|Overall Study|Noncompliance with study medication|1
4834654|NCT01072630|16668095|P1|Overall Study|Noncompliance with study medication|1
4834655|NCT01072630|16668093|P3|Overall Study|Lost to Follow-up|1
4834656|NCT01072630|16668094|P2|Overall Study|Lost to Follow-up|11
4834657|NCT01072630|16668095|P1|Overall Study|Lost to Follow-up|11
4834658|NCT01072630|16668093|P3|Overall Study|Protocol Violation|4
4834659|NCT01072630|16668094|P2|Overall Study|Protocol Violation|8
4834660|NCT01072630|16668095|P1|Overall Study|Protocol Violation|10
4834661|NCT01072630|16668093|P3|Overall Study|Withdrawal by Subject|2
4834662|NCT01072630|16668094|P2|Overall Study|Withdrawal by Subject|7
4834663|NCT01072630|16668095|P1|Overall Study|Withdrawal by Subject|8
4834664|NCT01072630|16668093|P3|Overall Study|Lack of Efficacy|1
4834665|NCT01072630|16668094|P2|Overall Study|Lack of Efficacy|10
4834666|NCT01072630|16668095|P1|Overall Study|Lack of Efficacy|10
4834667|NCT01072630|16668093|P3|Overall Study|Adverse Event|2
4834668|NCT01072630|16668094|P2|Overall Study|Adverse Event|19
4834669|NCT01072630|16668095|P1|Overall Study|Adverse Event|11
4834670|NCT01072539|16668176|P1|Overall Study|Protocol Violation|2
4834671|NCT01072539|16668176|P1|Overall Study|Treated prior to the Site Initiation|1
4834672|NCT01072500|16668200|P2|Overall Study|Withdrawal by Subject|10
4834673|NCT01072500|16668201|P1|Overall Study|Withdrawal by Subject|17
4834674|NCT01072500|16668200|P2|Overall Study|Lost to Follow-up|2
4834675|NCT01072500|16668201|P1|Overall Study|Lost to Follow-up|5
4834676|NCT01072500|16668200|P2|Overall Study|Death|2
4834677|NCT01072500|16668201|P1|Overall Study|Death|2
4834678|NCT01072448|16668211|P2|Overall Study|Death|2
4834679|NCT01072448|16668212|P1|Overall Study|Death|0
4834680|NCT01072448|16668211|P2|Overall Study|Abnormal laboratory value(s)|1
4834681|NCT01072448|16668212|P1|Overall Study|Abnormal laboratory value(s)|0
4834682|NCT01072448|16668211|P2|Overall Study|Lost to Follow-up|1
4834683|NCT01072448|16668212|P1|Overall Study|Lost to Follow-up|1
4834684|NCT01072448|16668211|P2|Overall Study|Unsatisfactory therapeutic effect|3
4834685|NCT01072448|16668212|P1|Overall Study|Unsatisfactory therapeutic effect|1
4834686|NCT01072448|16668211|P2|Overall Study|Abnormal test procedure result(s)|0
4834687|NCT01072448|16668212|P1|Overall Study|Abnormal test procedure result(s)|1
4834688|NCT01072448|16668211|P2|Overall Study|Protocol deviation|4
4834689|NCT01072448|16668212|P1|Overall Study|Protocol deviation|3
4834690|NCT01072448|16668211|P2|Overall Study|Subject withdrew consent|9
4834691|NCT01072448|16668212|P1|Overall Study|Subject withdrew consent|4
4834692|NCT01072448|16668211|P2|Overall Study|Adverse Event|10
4834693|NCT01072448|16668212|P1|Overall Study|Adverse Event|9
4834694|NCT01072396|16668226|P2|Period Two|Lost to Follow-up|0
4834695|NCT01072396|16668227|P1|Period Two|Lost to Follow-up|1
4834696|NCT01072396|16668226|P2|Period Two|Adverse Event|3
4834697|NCT01072396|16668227|P1|Period Two|Adverse Event|0
4834698|NCT01072396|16668226|P2|Washout Period|Missing termination information|1
4834699|NCT01072396|16668227|P1|Washout Period|Missing termination information|0
4834700|NCT01072396|16668226|P2|Period One|Withdrawal by Subject|0
4834701|NCT01072396|16668227|P1|Period One|Withdrawal by Subject|2
4834702|NCT01072396|16668226|P2|Period One|Protocol Violation|1
4834703|NCT01072396|16668227|P1|Period One|Protocol Violation|2
4834704|NCT01072396|16668226|P2|Period One|Adverse Event|1
4834705|NCT01072396|16668227|P1|Period One|Adverse Event|1
4834706|NCT01072357|16668239|P2|Overall Study|Lost to Follow-up|1
4834707|NCT01072357|16668240|P1|Overall Study|Lost to Follow-up|0
4834708|NCT01072344|16668250|P2|Overall Study|Lost to Follow-up|4
4834709|NCT01072344|16668251|P1|Overall Study|Lost to Follow-up|3
4834710|NCT01072344|16668250|P2|Overall Study|Protocol Violation|2
4834711|NCT01072344|16668251|P1|Overall Study|Protocol Violation|1
4834712|NCT01072344|16668250|P2|Overall Study|Relasped-reached end point|12
4834713|NCT01072344|16668251|P1|Overall Study|Relasped-reached end point|7
4834714|NCT01072201|16668289|P2|Overall Study|Lost to Follow-up|1
4834715|NCT01072201|16668290|P1|Overall Study|Lost to Follow-up|0
4834716|NCT01072175|16668323|P13|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834717|NCT01072175|16668324|P12|Part D (HPMC Capsules)|Withdrawal by Subject|3
4834718|NCT01072175|16668325|P11|Part D (HPMC Capsules)|Withdrawal by Subject|1
4834719|NCT01072175|16668326|P10|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834720|NCT01072175|16668327|P9|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834721|NCT01072175|16668328|P8|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834722|NCT01072175|16668329|P7|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834723|NCT01072175|16668330|P6|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834724|NCT01072175|16668331|P5|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834725|NCT01072175|16668332|P4|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834726|NCT01072175|16668333|P3|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834727|NCT01072175|16668334|P2|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834728|NCT01072175|16668335|P1|Part D (HPMC Capsules)|Withdrawal by Subject|0
4834729|NCT01072175|16668323|P13|Part D (HPMC Capsules)|Study closed/terminated|9
4834730|NCT01072175|16668324|P12|Part D (HPMC Capsules)|Study closed/terminated|10
4834731|NCT01072175|16668325|P11|Part D (HPMC Capsules)|Study closed/terminated|1
4834732|NCT01072175|16668326|P10|Part D (HPMC Capsules)|Study closed/terminated|2
4834733|NCT01072175|16668327|P9|Part D (HPMC Capsules)|Study closed/terminated|0
4834734|NCT01072175|16668328|P8|Part D (HPMC Capsules)|Study closed/terminated|0
4834735|NCT01072175|16668329|P7|Part D (HPMC Capsules)|Study closed/terminated|0
4834736|NCT01072175|16668330|P6|Part D (HPMC Capsules)|Study closed/terminated|0
4834737|NCT01072175|16668331|P5|Part D (HPMC Capsules)|Study closed/terminated|0
4834738|NCT01072175|16668332|P4|Part D (HPMC Capsules)|Study closed/terminated|0
4834739|NCT01072175|16668333|P3|Part D (HPMC Capsules)|Study closed/terminated|0
4834740|NCT01072175|16668334|P2|Part D (HPMC Capsules)|Study closed/terminated|0
4834741|NCT01072175|16668335|P1|Part D (HPMC Capsules)|Study closed/terminated|0
4834742|NCT01072175|16668323|P13|Part D (HPMC Capsules)|Lost to Follow-up|3
4834743|NCT01072175|16668324|P12|Part D (HPMC Capsules)|Lost to Follow-up|1
4834744|NCT01072175|16668325|P11|Part D (HPMC Capsules)|Lost to Follow-up|1
4834745|NCT01072175|16668326|P10|Part D (HPMC Capsules)|Lost to Follow-up|0
4834746|NCT01072175|16668327|P9|Part D (HPMC Capsules)|Lost to Follow-up|0
4834747|NCT01072175|16668328|P8|Part D (HPMC Capsules)|Lost to Follow-up|0
4834748|NCT01072175|16668329|P7|Part D (HPMC Capsules)|Lost to Follow-up|0
4834749|NCT01072175|16668330|P6|Part D (HPMC Capsules)|Lost to Follow-up|0
4834750|NCT01072175|16668331|P5|Part D (HPMC Capsules)|Lost to Follow-up|0
4834751|NCT01072175|16668332|P4|Part D (HPMC Capsules)|Lost to Follow-up|0
4834752|NCT01072175|16668333|P3|Part D (HPMC Capsules)|Lost to Follow-up|0
4834753|NCT01072175|16668334|P2|Part D (HPMC Capsules)|Lost to Follow-up|0
4834754|NCT01072175|16668335|P1|Part D (HPMC Capsules)|Lost to Follow-up|0
4834755|NCT01072175|16668323|P13|Part D (HPMC Capsules)|Physician Decision|1
4834756|NCT01072175|16668324|P12|Part D (HPMC Capsules)|Physician Decision|1
4834757|NCT01072175|16668325|P11|Part D (HPMC Capsules)|Physician Decision|1
4834758|NCT01072175|16668326|P10|Part D (HPMC Capsules)|Physician Decision|0
4834759|NCT01072175|16668327|P9|Part D (HPMC Capsules)|Physician Decision|0
4834760|NCT01072175|16668328|P8|Part D (HPMC Capsules)|Physician Decision|0
4834761|NCT01072175|16668329|P7|Part D (HPMC Capsules)|Physician Decision|0
4834762|NCT01072175|16668330|P6|Part D (HPMC Capsules)|Physician Decision|0
4834763|NCT01072175|16668331|P5|Part D (HPMC Capsules)|Physician Decision|0
4834764|NCT01072175|16668332|P4|Part D (HPMC Capsules)|Physician Decision|0
4834765|NCT01072175|16668333|P3|Part D (HPMC Capsules)|Physician Decision|0
4834766|NCT01072175|16668334|P2|Part D (HPMC Capsules)|Physician Decision|0
4834767|NCT01072175|16668335|P1|Part D (HPMC Capsules)|Physician Decision|0
4834768|NCT01072175|16668323|P13|Part D (HPMC Capsules)|Death|26
4834769|NCT01072175|16668324|P12|Part D (HPMC Capsules)|Death|28
4834770|NCT01072175|16668325|P11|Part D (HPMC Capsules)|Death|12
4834771|NCT01072175|16668326|P10|Part D (HPMC Capsules)|Death|10
4834772|NCT01072175|16668327|P9|Part D (HPMC Capsules)|Death|0
4834773|NCT01072175|16668328|P8|Part D (HPMC Capsules)|Death|0
4834774|NCT01072175|16668329|P7|Part D (HPMC Capsules)|Death|0
4834775|NCT01072175|16668330|P6|Part D (HPMC Capsules)|Death|0
4834776|NCT01072175|16668331|P5|Part D (HPMC Capsules)|Death|0
4834777|NCT01072175|16668332|P4|Part D (HPMC Capsules)|Death|0
4834778|NCT01072175|16668333|P3|Part D (HPMC Capsules)|Death|0
4834779|NCT01072175|16668334|P2|Part D (HPMC Capsules)|Death|0
4834780|NCT01072175|16668335|P1|Part D (HPMC Capsules)|Death|0
4834781|NCT01072175|16668323|P13|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834782|NCT01072175|16668324|P12|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834783|NCT01072175|16668325|P11|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834784|NCT01072175|16668326|P10|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834785|NCT01072175|16668327|P9|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3
4834786|NCT01072175|16668328|P8|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834787|NCT01072175|16668329|P7|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834788|NCT01072175|16668330|P6|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834789|NCT01072175|16668331|P5|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834790|NCT01072175|16668332|P4|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834791|NCT01072175|16668333|P3|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834792|NCT01072175|16668334|P2|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834793|NCT01072175|16668335|P1|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0
4834794|NCT01072175|16668323|P13|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834795|NCT01072175|16668324|P12|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834796|NCT01072175|16668325|P11|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834797|NCT01072175|16668326|P10|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834798|NCT01072175|16668327|P9|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4
4834799|NCT01072175|16668328|P8|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834800|NCT01072175|16668329|P7|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834801|NCT01072175|16668330|P6|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834802|NCT01072175|16668331|P5|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834803|NCT01072175|16668332|P4|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834804|NCT01072175|16668333|P3|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834805|NCT01072175|16668334|P2|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834806|NCT01072175|16668335|P1|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0
4834807|NCT01072175|16668323|P13|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834808|NCT01072175|16668324|P12|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834809|NCT01072175|16668325|P11|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834810|NCT01072175|16668326|P10|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834811|NCT01072175|16668327|P9|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1
4834812|NCT01072175|16668328|P8|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834813|NCT01072175|16668329|P7|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834814|NCT01072175|16668330|P6|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834815|NCT01072175|16668331|P5|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834816|NCT01072175|16668332|P4|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834817|NCT01072175|16668333|P3|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834818|NCT01072175|16668334|P2|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834819|NCT01072175|16668335|P1|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0
4834820|NCT01072175|16668323|P13|Part C (Phase II: Crossover Phase [CP])|Death|0
4834821|NCT01072175|16668324|P12|Part C (Phase II: Crossover Phase [CP])|Death|0
4834822|NCT01072175|16668325|P11|Part C (Phase II: Crossover Phase [CP])|Death|0
4834823|NCT01072175|16668326|P10|Part C (Phase II: Crossover Phase [CP])|Death|0
4834824|NCT01072175|16668327|P9|Part C (Phase II: Crossover Phase [CP])|Death|37
4834825|NCT01072175|16668328|P8|Part C (Phase II: Crossover Phase [CP])|Death|0
4834826|NCT01072175|16668329|P7|Part C (Phase II: Crossover Phase [CP])|Death|0
4834827|NCT01072175|16668330|P6|Part C (Phase II: Crossover Phase [CP])|Death|0
4834828|NCT01072175|16668331|P5|Part C (Phase II: Crossover Phase [CP])|Death|0
4834829|NCT01072175|16668332|P4|Part C (Phase II: Crossover Phase [CP])|Death|0
4834830|NCT01072175|16668333|P3|Part C (Phase II: Crossover Phase [CP])|Death|0
4834831|NCT01072175|16668334|P2|Part C (Phase II: Crossover Phase [CP])|Death|0
4834832|NCT01072175|16668335|P1|Part C (Phase II: Crossover Phase [CP])|Death|0
4834833|NCT01072175|16668323|P13|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834834|NCT01072175|16668324|P12|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834835|NCT01072175|16668325|P11|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834836|NCT01072175|16668326|P10|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834837|NCT01072175|16668327|P9|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834838|NCT01072175|16668328|P8|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834839|NCT01072175|16668329|P7|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7
4834840|NCT01072175|16668330|P6|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3
4834841|NCT01072175|16668331|P5|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834842|NCT01072175|16668332|P4|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834843|NCT01072175|16668333|P3|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834844|NCT01072175|16668334|P2|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834845|NCT01072175|16668335|P1|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0
4834846|NCT01072175|16668323|P13|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834847|NCT01072175|16668324|P12|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834848|NCT01072175|16668325|P11|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834849|NCT01072175|16668326|P10|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834850|NCT01072175|16668327|P9|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834851|NCT01072175|16668328|P8|Part C (Phase II: Randomized Phase)|Study closed/terminated|11
4834852|NCT01072175|16668329|P7|Part C (Phase II: Randomized Phase)|Study closed/terminated|9
4834853|NCT01072175|16668330|P6|Part C (Phase II: Randomized Phase)|Study closed/terminated|6
4834854|NCT01072175|16668331|P5|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834855|NCT01072175|16668332|P4|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834856|NCT01072175|16668333|P3|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834857|NCT01072175|16668334|P2|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834858|NCT01072175|16668335|P1|Part C (Phase II: Randomized Phase)|Study closed/terminated|0
4834859|NCT01072175|16668323|P13|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834860|NCT01072175|16668324|P12|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834861|NCT01072175|16668325|P11|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834862|NCT01072175|16668326|P10|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834863|NCT01072175|16668327|P9|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834864|NCT01072175|16668328|P8|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
4834865|NCT01072175|16668329|P7|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3
4834866|NCT01072175|16668330|P6|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834867|NCT01072175|16668331|P5|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834868|NCT01072175|16668332|P4|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834869|NCT01072175|16668333|P3|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834870|NCT01072175|16668334|P2|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834871|NCT01072175|16668335|P1|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0
4834872|NCT01072175|16668323|P13|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834873|NCT01072175|16668324|P12|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834874|NCT01072175|16668325|P11|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834875|NCT01072175|16668326|P10|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834876|NCT01072175|16668327|P9|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834877|NCT01072175|16668328|P8|Part C (Phase II: Randomized Phase)|Physician Decision|1
4834878|NCT01072175|16668329|P7|Part C (Phase II: Randomized Phase)|Physician Decision|1
4834879|NCT01072175|16668330|P6|Part C (Phase II: Randomized Phase)|Physician Decision|1
4834880|NCT01072175|16668331|P5|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834881|NCT01072175|16668332|P4|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834882|NCT01072175|16668333|P3|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834883|NCT01072175|16668334|P2|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834884|NCT01072175|16668335|P1|Part C (Phase II: Randomized Phase)|Physician Decision|0
4834885|NCT01072175|16668323|P13|Part C (Phase II: Randomized Phase)|Death|0
4834886|NCT01072175|16668324|P12|Part C (Phase II: Randomized Phase)|Death|0
4834887|NCT01072175|16668325|P11|Part C (Phase II: Randomized Phase)|Death|0
4834888|NCT01072175|16668326|P10|Part C (Phase II: Randomized Phase)|Death|0
4834889|NCT01072175|16668327|P9|Part C (Phase II: Randomized Phase)|Death|0
4834890|NCT01072175|16668328|P8|Part C (Phase II: Randomized Phase)|Death|39
4834891|NCT01072175|16668329|P7|Part C (Phase II: Randomized Phase)|Death|34
4834892|NCT01072175|16668330|P6|Part C (Phase II: Randomized Phase)|Death|44
4834893|NCT01072175|16668331|P5|Part C (Phase II: Randomized Phase)|Death|0
4834894|NCT01072175|16668332|P4|Part C (Phase II: Randomized Phase)|Death|0
4834895|NCT01072175|16668333|P3|Part C (Phase II: Randomized Phase)|Death|0
4834896|NCT01072175|16668334|P2|Part C (Phase II: Randomized Phase)|Death|0
4834897|NCT01072175|16668335|P1|Part C (Phase II: Randomized Phase)|Death|0
4834898|NCT01072175|16668323|P13|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834899|NCT01072175|16668324|P12|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834900|NCT01072175|16668325|P11|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834901|NCT01072175|16668326|P10|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834902|NCT01072175|16668327|P9|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834903|NCT01072175|16668328|P8|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834904|NCT01072175|16668329|P7|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834905|NCT01072175|16668330|P6|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834906|NCT01072175|16668331|P5|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6
4834907|NCT01072175|16668332|P4|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3
4834908|NCT01072175|16668333|P3|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834909|NCT01072175|16668334|P2|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1
4834910|NCT01072175|16668335|P1|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0
4834911|NCT01072175|16668323|P13|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834912|NCT01072175|16668324|P12|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834913|NCT01072175|16668325|P11|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834914|NCT01072175|16668326|P10|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834915|NCT01072175|16668327|P9|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834916|NCT01072175|16668328|P8|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834917|NCT01072175|16668329|P7|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834918|NCT01072175|16668330|P6|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834919|NCT01072175|16668331|P5|Part B (Dose Escalation and Expansion)|Study closed/terminated|10
4834920|NCT01072175|16668332|P4|Part B (Dose Escalation and Expansion)|Study closed/terminated|2
4834921|NCT01072175|16668333|P3|Part B (Dose Escalation and Expansion)|Study closed/terminated|3
4834922|NCT01072175|16668334|P2|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834923|NCT01072175|16668335|P1|Part B (Dose Escalation and Expansion)|Study closed/terminated|0
4834924|NCT01072175|16668323|P13|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834925|NCT01072175|16668324|P12|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834926|NCT01072175|16668325|P11|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834927|NCT01072175|16668326|P10|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834928|NCT01072175|16668327|P9|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834929|NCT01072175|16668328|P8|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834930|NCT01072175|16668329|P7|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834931|NCT01072175|16668330|P6|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834932|NCT01072175|16668331|P5|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6
4834933|NCT01072175|16668332|P4|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
4834934|NCT01072175|16668333|P3|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834935|NCT01072175|16668334|P2|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1
4834936|NCT01072175|16668335|P1|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0
4834937|NCT01072175|16668323|P13|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834938|NCT01072175|16668324|P12|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834939|NCT01072175|16668325|P11|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834940|NCT01072175|16668326|P10|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834941|NCT01072175|16668327|P9|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834942|NCT01072175|16668328|P8|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834943|NCT01072175|16668329|P7|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834944|NCT01072175|16668330|P6|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834945|NCT01072175|16668331|P5|Part B (Dose Escalation and Expansion)|Physician Decision|4
4834946|NCT01072175|16668332|P4|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834947|NCT01072175|16668333|P3|Part B (Dose Escalation and Expansion)|Physician Decision|2
4834948|NCT01072175|16668334|P2|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834949|NCT01072175|16668335|P1|Part B (Dose Escalation and Expansion)|Physician Decision|0
4834950|NCT01072175|16668323|P13|Part B (Dose Escalation and Expansion)|Death|0
4834951|NCT01072175|16668324|P12|Part B (Dose Escalation and Expansion)|Death|0
4834952|NCT01072175|16668325|P11|Part B (Dose Escalation and Expansion)|Death|0
4834953|NCT01072175|16668326|P10|Part B (Dose Escalation and Expansion)|Death|0
4834954|NCT01072175|16668327|P9|Part B (Dose Escalation and Expansion)|Death|0
4834955|NCT01072175|16668328|P8|Part B (Dose Escalation and Expansion)|Death|0
4834956|NCT01072175|16668329|P7|Part B (Dose Escalation and Expansion)|Death|0
4834957|NCT01072175|16668330|P6|Part B (Dose Escalation and Expansion)|Death|0
4834958|NCT01072175|16668331|P5|Part B (Dose Escalation and Expansion)|Death|68
4834959|NCT01072175|16668332|P4|Part B (Dose Escalation and Expansion)|Death|21
4834960|NCT01072175|16668333|P3|Part B (Dose Escalation and Expansion)|Death|18
4834961|NCT01072175|16668334|P2|Part B (Dose Escalation and Expansion)|Death|4
4834962|NCT01072175|16668335|P1|Part B (Dose Escalation and Expansion)|Death|0
4834963|NCT01072175|16668323|P13|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834964|NCT01072175|16668324|P12|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834965|NCT01072175|16668325|P11|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834966|NCT01072175|16668326|P10|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834967|NCT01072175|16668327|P9|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834968|NCT01072175|16668328|P8|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834969|NCT01072175|16668329|P7|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834970|NCT01072175|16668330|P6|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834971|NCT01072175|16668331|P5|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834972|NCT01072175|16668332|P4|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834973|NCT01072175|16668333|P3|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834974|NCT01072175|16668334|P2|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0
4834975|NCT01072175|16668335|P1|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1
4834976|NCT01072175|16668323|P13|Part A (Drug-Drug Interaction)|Physician Decision|0
4834977|NCT01072175|16668324|P12|Part A (Drug-Drug Interaction)|Physician Decision|0
4834978|NCT01072175|16668325|P11|Part A (Drug-Drug Interaction)|Physician Decision|0
4834979|NCT01072175|16668326|P10|Part A (Drug-Drug Interaction)|Physician Decision|0
4834980|NCT01072175|16668327|P9|Part A (Drug-Drug Interaction)|Physician Decision|0
4834981|NCT01072175|16668328|P8|Part A (Drug-Drug Interaction)|Physician Decision|0
4834982|NCT01072175|16668329|P7|Part A (Drug-Drug Interaction)|Physician Decision|0
4834983|NCT01072175|16668330|P6|Part A (Drug-Drug Interaction)|Physician Decision|0
4834984|NCT01072175|16668331|P5|Part A (Drug-Drug Interaction)|Physician Decision|0
4834985|NCT01072175|16668332|P4|Part A (Drug-Drug Interaction)|Physician Decision|0
4834986|NCT01072175|16668333|P3|Part A (Drug-Drug Interaction)|Physician Decision|0
4834987|NCT01072175|16668334|P2|Part A (Drug-Drug Interaction)|Physician Decision|0
4834988|NCT01072175|16668335|P1|Part A (Drug-Drug Interaction)|Physician Decision|6
4834989|NCT01072175|16668323|P13|Part A (Drug-Drug Interaction)|Death|0
4834990|NCT01072175|16668324|P12|Part A (Drug-Drug Interaction)|Death|0
4834991|NCT01072175|16668325|P11|Part A (Drug-Drug Interaction)|Death|0
4834992|NCT01072175|16668326|P10|Part A (Drug-Drug Interaction)|Death|0
4834993|NCT01072175|16668327|P9|Part A (Drug-Drug Interaction)|Death|0
4834994|NCT01072175|16668328|P8|Part A (Drug-Drug Interaction)|Death|0
4834995|NCT01072175|16668329|P7|Part A (Drug-Drug Interaction)|Death|0
4834996|NCT01072175|16668330|P6|Part A (Drug-Drug Interaction)|Death|0
4834997|NCT01072175|16668331|P5|Part A (Drug-Drug Interaction)|Death|0
4834998|NCT01072175|16668332|P4|Part A (Drug-Drug Interaction)|Death|0
4834999|NCT01072175|16668333|P3|Part A (Drug-Drug Interaction)|Death|0
4835000|NCT01072175|16668334|P2|Part A (Drug-Drug Interaction)|Death|0
4835001|NCT01072175|16668335|P1|Part A (Drug-Drug Interaction)|Death|1
4835002|NCT01072149|16668544|P18|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835003|NCT01072149|16668545|P17|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835004|NCT01072149|16668546|P16|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835005|NCT01072149|16668547|P15|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835006|NCT01072149|16668548|P14|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
4835007|NCT01072149|16668549|P13|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835008|NCT01072149|16668550|P12|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835009|NCT01072149|16668551|P11|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835010|NCT01072149|16668552|P10|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835011|NCT01072149|16668553|P9|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835012|NCT01072149|16668554|P8|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835013|NCT01072149|16668555|P7|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835014|NCT01072149|16668556|P6|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835015|NCT01072149|16668557|P5|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835016|NCT01072149|16668558|P4|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835017|NCT01072149|16668559|P3|Treatment Period 3 (28 Days)|Withdrawal by Subject|1
4835018|NCT01072149|16668560|P2|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835019|NCT01072149|16668561|P1|Treatment Period 3 (28 Days)|Withdrawal by Subject|0
4835020|NCT01072149|16668544|P18|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835021|NCT01072149|16668545|P17|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835022|NCT01072149|16668546|P16|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835023|NCT01072149|16668547|P15|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835024|NCT01072149|16668548|P14|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835025|NCT01072149|16668549|P13|Washout Period 2 (14 Days)|Lack of Efficacy|1
4835026|NCT01072149|16668550|P12|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835027|NCT01072149|16668551|P11|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835028|NCT01072149|16668552|P10|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835029|NCT01072149|16668553|P9|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835030|NCT01072149|16668554|P8|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835031|NCT01072149|16668555|P7|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835032|NCT01072149|16668556|P6|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835033|NCT01072149|16668557|P5|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835034|NCT01072149|16668558|P4|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835035|NCT01072149|16668559|P3|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835036|NCT01072149|16668560|P2|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835037|NCT01072149|16668561|P1|Washout Period 2 (14 Days)|Lack of Efficacy|0
4835038|NCT01072149|16668544|P18|Washout Period 2 (14 Days)|Adverse Event|0
4835039|NCT01072149|16668545|P17|Washout Period 2 (14 Days)|Adverse Event|0
4835040|NCT01072149|16668546|P16|Washout Period 2 (14 Days)|Adverse Event|1
4835041|NCT01072149|16668547|P15|Washout Period 2 (14 Days)|Adverse Event|0
4835042|NCT01072149|16668548|P14|Washout Period 2 (14 Days)|Adverse Event|0
4835043|NCT01072149|16668549|P13|Washout Period 2 (14 Days)|Adverse Event|0
4835044|NCT01072149|16668550|P12|Washout Period 2 (14 Days)|Adverse Event|0
4835045|NCT01072149|16668551|P11|Washout Period 2 (14 Days)|Adverse Event|0
4835046|NCT01072149|16668552|P10|Washout Period 2 (14 Days)|Adverse Event|0
4835047|NCT01072149|16668553|P9|Washout Period 2 (14 Days)|Adverse Event|0
4835048|NCT01072149|16668554|P8|Washout Period 2 (14 Days)|Adverse Event|0
4835049|NCT01072149|16668555|P7|Washout Period 2 (14 Days)|Adverse Event|0
4835050|NCT01072149|16668556|P6|Washout Period 2 (14 Days)|Adverse Event|0
4835051|NCT01072149|16668557|P5|Washout Period 2 (14 Days)|Adverse Event|0
4835052|NCT01072149|16668558|P4|Washout Period 2 (14 Days)|Adverse Event|0
4835053|NCT01072149|16668559|P3|Washout Period 2 (14 Days)|Adverse Event|0
4835054|NCT01072149|16668560|P2|Washout Period 2 (14 Days)|Adverse Event|0
4835055|NCT01072149|16668561|P1|Washout Period 2 (14 Days)|Adverse Event|0
4835056|NCT01072149|16668544|P18|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835057|NCT01072149|16668545|P17|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835058|NCT01072149|16668546|P16|Washout Period 2 (14 Days)|Withdrawal by Subject|1
4835059|NCT01072149|16668547|P15|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835060|NCT01072149|16668548|P14|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835061|NCT01072149|16668549|P13|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835062|NCT01072149|16668550|P12|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835063|NCT01072149|16668551|P11|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835064|NCT01072149|16668552|P10|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835065|NCT01072149|16668553|P9|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835066|NCT01072149|16668554|P8|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835067|NCT01072149|16668555|P7|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835068|NCT01072149|16668556|P6|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835069|NCT01072149|16668557|P5|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835070|NCT01072149|16668558|P4|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835071|NCT01072149|16668559|P3|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835072|NCT01072149|16668560|P2|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835073|NCT01072149|16668561|P1|Washout Period 2 (14 Days)|Withdrawal by Subject|0
4835074|NCT01072149|16668544|P18|Washout Period 2 (14 Days)|Physician Decision|0
4835075|NCT01072149|16668545|P17|Washout Period 2 (14 Days)|Physician Decision|0
4835076|NCT01072149|16668546|P16|Washout Period 2 (14 Days)|Physician Decision|0
4835077|NCT01072149|16668547|P15|Washout Period 2 (14 Days)|Physician Decision|0
4835078|NCT01072149|16668548|P14|Washout Period 2 (14 Days)|Physician Decision|0
4835079|NCT01072149|16668549|P13|Washout Period 2 (14 Days)|Physician Decision|0
4835080|NCT01072149|16668550|P12|Washout Period 2 (14 Days)|Physician Decision|0
4835081|NCT01072149|16668551|P11|Washout Period 2 (14 Days)|Physician Decision|0
4835082|NCT01072149|16668552|P10|Washout Period 2 (14 Days)|Physician Decision|0
4835083|NCT01072149|16668553|P9|Washout Period 2 (14 Days)|Physician Decision|0
4835084|NCT01072149|16668554|P8|Washout Period 2 (14 Days)|Physician Decision|0
4835085|NCT01072149|16668555|P7|Washout Period 2 (14 Days)|Physician Decision|0
4835086|NCT01072149|16668556|P6|Washout Period 2 (14 Days)|Physician Decision|0
4835087|NCT01072149|16668557|P5|Washout Period 2 (14 Days)|Physician Decision|0
4835088|NCT01072149|16668558|P4|Washout Period 2 (14 Days)|Physician Decision|0
4835089|NCT01072149|16668559|P3|Washout Period 2 (14 Days)|Physician Decision|0
4835090|NCT01072149|16668560|P2|Washout Period 2 (14 Days)|Physician Decision|0
4835091|NCT01072149|16668561|P1|Washout Period 2 (14 Days)|Physician Decision|1
4835092|NCT01072149|16668544|P18|Treatment Period 2 (28 Days)|Physician Decision|0
4835093|NCT01072149|16668545|P17|Treatment Period 2 (28 Days)|Physician Decision|0
4835094|NCT01072149|16668546|P16|Treatment Period 2 (28 Days)|Physician Decision|0
4835095|NCT01072149|16668547|P15|Treatment Period 2 (28 Days)|Physician Decision|0
4835096|NCT01072149|16668548|P14|Treatment Period 2 (28 Days)|Physician Decision|0
4835097|NCT01072149|16668549|P13|Treatment Period 2 (28 Days)|Physician Decision|0
4835098|NCT01072149|16668550|P12|Treatment Period 2 (28 Days)|Physician Decision|0
4835099|NCT01072149|16668551|P11|Treatment Period 2 (28 Days)|Physician Decision|0
4835100|NCT01072149|16668552|P10|Treatment Period 2 (28 Days)|Physician Decision|0
4835101|NCT01072149|16668553|P9|Treatment Period 2 (28 Days)|Physician Decision|0
4835102|NCT01072149|16668554|P8|Treatment Period 2 (28 Days)|Physician Decision|1
4835103|NCT01072149|16668555|P7|Treatment Period 2 (28 Days)|Physician Decision|0
4835104|NCT01072149|16668556|P6|Treatment Period 2 (28 Days)|Physician Decision|0
4835105|NCT01072149|16668557|P5|Treatment Period 2 (28 Days)|Physician Decision|0
4835106|NCT01072149|16668558|P4|Treatment Period 2 (28 Days)|Physician Decision|0
4835107|NCT01072149|16668559|P3|Treatment Period 2 (28 Days)|Physician Decision|0
4835108|NCT01072149|16668560|P2|Treatment Period 2 (28 Days)|Physician Decision|0
4835109|NCT01072149|16668561|P1|Treatment Period 2 (28 Days)|Physician Decision|0
4835110|NCT01072149|16668544|P18|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835111|NCT01072149|16668545|P17|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835112|NCT01072149|16668546|P16|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835113|NCT01072149|16668547|P15|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835114|NCT01072149|16668548|P14|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835115|NCT01072149|16668549|P13|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835116|NCT01072149|16668550|P12|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835117|NCT01072149|16668551|P11|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835118|NCT01072149|16668552|P10|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835119|NCT01072149|16668553|P9|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835120|NCT01072149|16668554|P8|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835121|NCT01072149|16668555|P7|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835122|NCT01072149|16668556|P6|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835123|NCT01072149|16668557|P5|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835124|NCT01072149|16668558|P4|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835125|NCT01072149|16668559|P3|Treatment Period 2 (28 Days)|Withdrawal by Subject|1
4835126|NCT01072149|16668560|P2|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835127|NCT01072149|16668561|P1|Treatment Period 2 (28 Days)|Withdrawal by Subject|0
4835128|NCT01072149|16668544|P18|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835129|NCT01072149|16668545|P17|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835130|NCT01072149|16668546|P16|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835131|NCT01072149|16668547|P15|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835132|NCT01072149|16668548|P14|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835133|NCT01072149|16668549|P13|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835134|NCT01072149|16668550|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835135|NCT01072149|16668551|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835136|NCT01072149|16668552|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835137|NCT01072149|16668553|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835138|NCT01072149|16668554|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835139|NCT01072149|16668555|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835140|NCT01072149|16668556|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835141|NCT01072149|16668557|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835142|NCT01072149|16668558|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835143|NCT01072149|16668559|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835144|NCT01072149|16668560|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|1
4835145|NCT01072149|16668561|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4835146|NCT01072149|16668544|P18|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835147|NCT01072149|16668545|P17|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835148|NCT01072149|16668546|P16|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835149|NCT01072149|16668547|P15|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835150|NCT01072149|16668548|P14|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835151|NCT01072149|16668549|P13|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835152|NCT01072149|16668550|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835153|NCT01072149|16668551|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|1
4835154|NCT01072149|16668552|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835155|NCT01072149|16668553|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835156|NCT01072149|16668554|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835157|NCT01072149|16668555|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835158|NCT01072149|16668556|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835159|NCT01072149|16668557|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835160|NCT01072149|16668558|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835161|NCT01072149|16668559|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835162|NCT01072149|16668560|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835163|NCT01072149|16668561|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4835164|NCT01072149|16668544|P18|Treatment Period 1 (28 Days)|Protocol Violation|1
4835165|NCT01072149|16668545|P17|Treatment Period 1 (28 Days)|Protocol Violation|0
4835166|NCT01072149|16668546|P16|Treatment Period 1 (28 Days)|Protocol Violation|0
4835167|NCT01072149|16668547|P15|Treatment Period 1 (28 Days)|Protocol Violation|0
4835168|NCT01072149|16668548|P14|Treatment Period 1 (28 Days)|Protocol Violation|0
4835169|NCT01072149|16668549|P13|Treatment Period 1 (28 Days)|Protocol Violation|0
4835170|NCT01072149|16668550|P12|Treatment Period 1 (28 Days)|Protocol Violation|0
4835171|NCT01072149|16668551|P11|Treatment Period 1 (28 Days)|Protocol Violation|0
4835172|NCT01072149|16668552|P10|Treatment Period 1 (28 Days)|Protocol Violation|0
4835173|NCT01072149|16668553|P9|Treatment Period 1 (28 Days)|Protocol Violation|0
4835174|NCT01072149|16668554|P8|Treatment Period 1 (28 Days)|Protocol Violation|0
4835175|NCT01072149|16668555|P7|Treatment Period 1 (28 Days)|Protocol Violation|0
4835176|NCT01072149|16668556|P6|Treatment Period 1 (28 Days)|Protocol Violation|0
4835177|NCT01072149|16668557|P5|Treatment Period 1 (28 Days)|Protocol Violation|0
4835178|NCT01072149|16668558|P4|Treatment Period 1 (28 Days)|Protocol Violation|0
4835179|NCT01072149|16668559|P3|Treatment Period 1 (28 Days)|Protocol Violation|0
4835180|NCT01072149|16668560|P2|Treatment Period 1 (28 Days)|Protocol Violation|0
4835181|NCT01072149|16668561|P1|Treatment Period 1 (28 Days)|Protocol Violation|0
4835182|NCT01072149|16668544|P18|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835183|NCT01072149|16668545|P17|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835184|NCT01072149|16668546|P16|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835185|NCT01072149|16668547|P15|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835186|NCT01072149|16668548|P14|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835187|NCT01072149|16668549|P13|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835188|NCT01072149|16668550|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835189|NCT01072149|16668551|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835190|NCT01072149|16668552|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835191|NCT01072149|16668553|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835192|NCT01072149|16668554|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835193|NCT01072149|16668555|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835194|NCT01072149|16668556|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835195|NCT01072149|16668557|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835196|NCT01072149|16668558|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835197|NCT01072149|16668559|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4835198|NCT01072149|16668560|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835199|NCT01072149|16668561|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4835200|NCT01071954|16668650|P1|Overall Study|Protocol Specified Criteria|1
4835201|NCT01071954|16668650|P1|Overall Study|Administrative Decision|5
4835202|NCT01071954|16668650|P1|Overall Study|Requirement for Alternative Therapy|5
4835203|NCT01071954|16668650|P1|Overall Study|Withdrawal by Subject|11
4835204|NCT01071954|16668650|P1|Overall Study|Adverse Event|1
4835205|NCT01071954|16668650|P1|Overall Study|Noncompliance|4
4835206|NCT01071915|16668659|P1|Overall Study|Miscellaneous Reasons|2
4835207|NCT01071915|16668659|P1|Overall Study|Withdrawal by Subject|2
4835208|NCT01071915|16668659|P1|Overall Study|Physician Decision|2
4835209|NCT01071915|16668659|P1|Overall Study|Adverse Event|3
4835210|NCT01071798|16668669|P1|Subpopulation Who Received Two Cycles|Patient Requirement|7
4835211|NCT01071798|16668669|P1|Subpopulation Who Received Two Cycles|Lack of Tolerability|4
4835212|NCT01071798|16668669|P1|Subpopulation Who Received Two Cycles|Lack of Efficacy|3
4835213|NCT01071798|16668669|P1|Subpopulation Who Received Two Cycles|Remission|1
4835214|NCT01071798|16668669|P1|Participants Who Received One Cycle|Severe concomitant disease|2
4835215|NCT01071798|16668669|P1|Participants Who Received One Cycle|Change of therapy|6
4835216|NCT01071798|16668669|P1|Participants Who Received One Cycle|Death|5
4835217|NCT01071798|16668669|P1|Participants Who Received One Cycle|Patient requirement|20
4835218|NCT01071798|16668669|P1|Participants Who Received One Cycle|Lack of tolerability|14
4835219|NCT01071798|16668669|P1|Participants Who Received One Cycle|Lack of Efficacy|18
4835220|NCT01071512|16668699|P1|Overall Study|positive anti-JC virus antibody test|2
4835221|NCT01071512|16668699|P1|Overall Study|Development of antibodies to drug|2
4835222|NCT01071512|16668699|P1|Overall Study|Adverse Event|1
4835223|NCT01071395|16668709|P2|Overall Study|Adverse Event|1
4835224|NCT01071395|16668710|P1|Overall Study|Adverse Event|3
4835225|NCT01071395|16668709|P2|Overall Study|Withdrawal by Subject|1
4835226|NCT01071395|16668710|P1|Overall Study|Withdrawal by Subject|2
4835227|NCT01071317|16668729|P2|Overall Study|Lost to Follow-up|2
4835228|NCT01071317|16668730|P1|Overall Study|Lost to Follow-up|2
4835229|NCT01071278|16668742|P1|Overall Study|Completion Status Unknown|459
4835230|NCT01071278|16668742|P1|Overall Study|Premature Discontinuation|254
4835231|NCT01071252|16668753|P5|Overall Study|Death|1
4835232|NCT01071252|16668754|P4|Overall Study|Death|0
4835233|NCT01071252|16668755|P3|Overall Study|Death|0
4835234|NCT01071252|16668756|P2|Overall Study|Death|0
4835235|NCT01071252|16668757|P1|Overall Study|Death|0
4835236|NCT01071252|16668753|P5|Overall Study|Adverse Event|0
4835237|NCT01071252|16668754|P4|Overall Study|Adverse Event|1
4835238|NCT01071252|16668755|P3|Overall Study|Adverse Event|0
4835239|NCT01071252|16668756|P2|Overall Study|Adverse Event|1
4835240|NCT01071252|16668757|P1|Overall Study|Adverse Event|1
4835241|NCT01071252|16668753|P5|Overall Study|Lost to Follow-up|0
4835242|NCT01071252|16668754|P4|Overall Study|Lost to Follow-up|2
4835243|NCT01071252|16668755|P3|Overall Study|Lost to Follow-up|1
4835244|NCT01071252|16668756|P2|Overall Study|Lost to Follow-up|0
4835245|NCT01071252|16668757|P1|Overall Study|Lost to Follow-up|1
4835246|NCT01071252|16668753|P5|Overall Study|administrative problems|1
4835247|NCT01071252|16668754|P4|Overall Study|administrative problems|2
4835248|NCT01071252|16668755|P3|Overall Study|administrative problems|0
4835249|NCT01071252|16668756|P2|Overall Study|administrative problems|1
4835250|NCT01071252|16668757|P1|Overall Study|administrative problems|1
4835251|NCT01071252|16668753|P5|Overall Study|Withdrawal by Subject|3
4835252|NCT01071252|16668754|P4|Overall Study|Withdrawal by Subject|2
4835253|NCT01071252|16668755|P3|Overall Study|Withdrawal by Subject|1
4835254|NCT01071252|16668756|P2|Overall Study|Withdrawal by Subject|2
4835255|NCT01071252|16668757|P1|Overall Study|Withdrawal by Subject|8
4835256|NCT01071252|16668753|P5|Overall Study|unsatisfactory therapeutic effect|6
4835257|NCT01071252|16668754|P4|Overall Study|unsatisfactory therapeutic effect|0
4835258|NCT01071252|16668755|P3|Overall Study|unsatisfactory therapeutic effect|2
4835259|NCT01071252|16668756|P2|Overall Study|unsatisfactory therapeutic effect|6
4835260|NCT01071252|16668757|P1|Overall Study|unsatisfactory therapeutic effect|4
4835261|NCT01071200|16668785|P2|Overall Study|No viable embryos|1
4835262|NCT01071200|16668786|P1|Overall Study|No viable embryos|0
4835263|NCT01071200|16668785|P2|Overall Study|Ovarian Hyper Stimulation Syndrome|0
4835264|NCT01071200|16668786|P1|Overall Study|Ovarian Hyper Stimulation Syndrome|1
4835265|NCT01071200|16668785|P2|Overall Study|No oocytes retrieved|1
4835266|NCT01071200|16668786|P1|Overall Study|No oocytes retrieved|1
4835267|NCT01071200|16668785|P2|Overall Study|No fertilization|0
4835268|NCT01071200|16668786|P1|Overall Study|No fertilization|4
4835269|NCT01071200|16668785|P2|Overall Study|Lack of ovarian response|1
4835270|NCT01071200|16668786|P1|Overall Study|Lack of ovarian response|1
4835271|NCT01071096|16668818|P2|First Intervention (90 Days)|Lost to Follow-up|0
4835272|NCT01071096|16668819|P1|First Intervention (90 Days)|Lost to Follow-up|1
4835273|NCT01071083|16668843|P5|Overall Study|Subject Refused to Continue|0
4835274|NCT01071083|16668844|P4|Overall Study|Subject Refused to Continue|0
4835275|NCT01071083|16668845|P3|Overall Study|Subject Refused to Continue|0
4835276|NCT01071083|16668846|P2|Overall Study|Subject Refused to Continue|0
4835277|NCT01071083|16668847|P1|Overall Study|Subject Refused to Continue|1
4835278|NCT01071083|16668843|P5|Overall Study|Did Not Want Per Protocol Treatment|1
4835279|NCT01071083|16668844|P4|Overall Study|Did Not Want Per Protocol Treatment|0
4835280|NCT01071083|16668845|P3|Overall Study|Did Not Want Per Protocol Treatment|1
4835281|NCT01071083|16668846|P2|Overall Study|Did Not Want Per Protocol Treatment|0
4835282|NCT01071083|16668847|P1|Overall Study|Did Not Want Per Protocol Treatment|0
4835283|NCT01071083|16668843|P5|Overall Study|Did Not Meet Eligibility Criteria|1
4835284|NCT01071083|16668844|P4|Overall Study|Did Not Meet Eligibility Criteria|1
4835285|NCT01071083|16668845|P3|Overall Study|Did Not Meet Eligibility Criteria|1
4835286|NCT01071083|16668846|P2|Overall Study|Did Not Meet Eligibility Criteria|0
4835287|NCT01071083|16668847|P1|Overall Study|Did Not Meet Eligibility Criteria|0
4835288|NCT01071083|16668843|P5|Overall Study|Images Not Usable (Motion)|0
4835289|NCT01071083|16668844|P4|Overall Study|Images Not Usable (Motion)|0
4835290|NCT01071083|16668845|P3|Overall Study|Images Not Usable (Motion)|0
4835291|NCT01071083|16668846|P2|Overall Study|Images Not Usable (Motion)|1
4835292|NCT01071083|16668847|P1|Overall Study|Images Not Usable (Motion)|0
4835293|NCT01071083|16668843|P5|Overall Study|Subject Moved|0
4835294|NCT01071083|16668844|P4|Overall Study|Subject Moved|0
4835295|NCT01071083|16668845|P3|Overall Study|Subject Moved|0
4835296|NCT01071083|16668846|P2|Overall Study|Subject Moved|1
4835297|NCT01071083|16668847|P1|Overall Study|Subject Moved|0
4835298|NCT01071083|16668843|P5|Overall Study|Early Rescue|1
4835299|NCT01071083|16668844|P4|Overall Study|Early Rescue|0
4835300|NCT01071083|16668845|P3|Overall Study|Early Rescue|0
4835301|NCT01071083|16668846|P2|Overall Study|Early Rescue|0
4835302|NCT01071083|16668847|P1|Overall Study|Early Rescue|1
4835303|NCT01071083|16668843|P5|Overall Study|Physician Decision|1
4835304|NCT01071083|16668844|P4|Overall Study|Physician Decision|1
4835305|NCT01071083|16668845|P3|Overall Study|Physician Decision|0
4835306|NCT01071083|16668846|P2|Overall Study|Physician Decision|0
4835307|NCT01071083|16668847|P1|Overall Study|Physician Decision|1
4835308|NCT01071083|16668843|P5|Overall Study|Withdrawal by Subject|3
4835309|NCT01071083|16668844|P4|Overall Study|Withdrawal by Subject|0
4835310|NCT01071083|16668845|P3|Overall Study|Withdrawal by Subject|2
4835311|NCT01071083|16668846|P2|Overall Study|Withdrawal by Subject|0
4835312|NCT01071083|16668847|P1|Overall Study|Withdrawal by Subject|3
4835313|NCT01071083|16668843|P5|Overall Study|Adverse Event|1
4835314|NCT01071083|16668844|P4|Overall Study|Adverse Event|0
4835315|NCT01071083|16668845|P3|Overall Study|Adverse Event|1
4835316|NCT01071083|16668846|P2|Overall Study|Adverse Event|0
4835317|NCT01071083|16668847|P1|Overall Study|Adverse Event|1
4835318|NCT01071070|16668866|P2|Overall Study|Hypercalcemia|0
4835319|NCT01071070|16668867|P1|Overall Study|Hypercalcemia|1
4835320|NCT01071070|16668866|P2|Overall Study|Missed 3 consecutive doses of study drug|0
4835321|NCT01071070|16668867|P1|Overall Study|Missed 3 consecutive doses of study drug|2
4835322|NCT01071070|16668866|P2|Overall Study|Withdrawal by Subject|0
4835323|NCT01071070|16668867|P1|Overall Study|Withdrawal by Subject|1
4835324|NCT01071070|16668866|P2|Overall Study|Adverse Event|3
4835325|NCT01071070|16668867|P1|Overall Study|Adverse Event|0
4835326|NCT01070979|16668913|P3|Overall Study|No study drug taken|0
4835327|NCT01070979|16668914|P2|Overall Study|No study drug taken|1
4835328|NCT01070979|16668915|P1|Overall Study|No study drug taken|0
4835329|NCT01070979|16668913|P3|Overall Study|Withdrawal by Subject|1
4835330|NCT01070979|16668914|P2|Overall Study|Withdrawal by Subject|1
4835331|NCT01070979|16668915|P1|Overall Study|Withdrawal by Subject|3
4835332|NCT01070979|16668913|P3|Overall Study|Surgery, moving, personal, abn. labs|2
4835333|NCT01070979|16668914|P2|Overall Study|Surgery, moving, personal, abn. labs|4
4835334|NCT01070979|16668915|P1|Overall Study|Surgery, moving, personal, abn. labs|4
4835335|NCT01070979|16668913|P3|Overall Study|Protocol Violation|6
4835336|NCT01070979|16668914|P2|Overall Study|Protocol Violation|2
4835337|NCT01070979|16668915|P1|Overall Study|Protocol Violation|0
4835338|NCT01070979|16668913|P3|Overall Study|Lost to Follow-up|1
4835339|NCT01070979|16668914|P2|Overall Study|Lost to Follow-up|1
4835340|NCT01070979|16668915|P1|Overall Study|Lost to Follow-up|2
4835341|NCT01070979|16668913|P3|Overall Study|Adverse Event|3
4835342|NCT01070979|16668914|P2|Overall Study|Adverse Event|3
4835343|NCT01070979|16668915|P1|Overall Study|Adverse Event|2
4835344|NCT01070966|16668941|P1|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2
4835345|NCT01070966|16668941|P1|Participants for Efficacy Evaluation|No efficacy evaluation|19
4835346|NCT01070966|16668941|P1|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61
4835347|NCT01070966|16668941|P1|Participants for Safety Evaluation|TMT given before date of contract|3
4835348|NCT01070966|16668941|P1|Participants for Safety Evaluation|Violation inclusion criteria/off label|3
4835349|NCT01070966|16668941|P1|Participants for Safety Evaluation|Duplicate Participants|4
4835350|NCT01070966|16668941|P1|Participants for Safety Evaluation|Off-label use|9
4835351|NCT01070966|16668941|P1|Participants for Safety Evaluation|Violation of inclusion criteria|59
4835352|NCT01070953|16668952|P1|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2
4835353|NCT01070953|16668952|P1|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106
4835354|NCT01070953|16668952|P1|Participants for Efficacy Evaluation|No efficacy evaluation|119
4835355|NCT01070953|16668952|P1|Participants for Safety Evaluation|Duplicated participants & off-label use|1
4835356|NCT01070953|16668952|P1|Participants for Safety Evaluation|Violation of inclusions & off label use|1
4835357|NCT01070953|16668952|P1|Participants for Safety Evaluation|Uncontracted participants|4
4835358|NCT01070953|16668952|P1|Participants for Safety Evaluation|Treatment prior to date of contract|8
4835359|NCT01070953|16668952|P1|Participants for Safety Evaluation|Duplicated participants|22
4835360|NCT01070953|16668952|P1|Participants for Safety Evaluation|Off-label use|283
4835361|NCT01070953|16668952|P1|Participants for Safety Evaluation|Violation of inclusion criteria|612
4835362|NCT01070888|16668965|P2|Washout (14 Days)|Physician Decision|0
4835363|NCT01070888|16668966|P1|Washout (14 Days)|Physician Decision|1
4835364|NCT01070888|16668965|P2|First Intervention (14 Days)|Lost to Follow-up|1
4835365|NCT01070888|16668966|P1|First Intervention (14 Days)|Lost to Follow-up|0
4835366|NCT01070888|16668965|P2|First Intervention (14 Days)|Adverse Event|1
4835367|NCT01070888|16668966|P1|First Intervention (14 Days)|Adverse Event|0
4835368|NCT01070784|16668991|P2|Overall Study|Adverse Event|9
4835369|NCT01070784|16668992|P1|Overall Study|Adverse Event|14
4835370|NCT01070784|16668991|P2|Overall Study|Withdrawal by Subject|9
4835371|NCT01070784|16668992|P1|Overall Study|Withdrawal by Subject|6
4835372|NCT01070771|16669080|P1|Overall Study|Protocol Violation|1
4835373|NCT01070771|16669080|P1|Overall Study|Adverse Event|2
4835374|NCT01070550|16669100|P6|Overall Study|Withdrawal by Subject|0
4835375|NCT01070550|16669101|P5|Overall Study|Withdrawal by Subject|0
4835376|NCT01070550|16669102|P4|Overall Study|Withdrawal by Subject|0
4835377|NCT01070550|16669103|P3|Overall Study|Withdrawal by Subject|3
4835378|NCT01070550|16669104|P2|Overall Study|Withdrawal by Subject|0
4835379|NCT01070550|16669105|P1|Overall Study|Withdrawal by Subject|35
4835380|NCT01070550|16669100|P6|Overall Study|Other|0
4835381|NCT01070550|16669101|P5|Overall Study|Other|0
4835382|NCT01070550|16669102|P4|Overall Study|Other|1
4835383|NCT01070550|16669103|P3|Overall Study|Other|0
4835384|NCT01070550|16669104|P2|Overall Study|Other|0
4835385|NCT01070550|16669105|P1|Overall Study|Other|5
4835386|NCT01070550|16669100|P6|Overall Study|Treatment was stopped early|0
4835387|NCT01070550|16669101|P5|Overall Study|Treatment was stopped early|0
4835388|NCT01070550|16669102|P4|Overall Study|Treatment was stopped early|0
4835389|NCT01070550|16669103|P3|Overall Study|Treatment was stopped early|0
4835390|NCT01070550|16669104|P2|Overall Study|Treatment was stopped early|0
4835391|NCT01070550|16669105|P1|Overall Study|Treatment was stopped early|7
4835392|NCT01070550|16669100|P6|Overall Study|Treatment unavailable|0
4835393|NCT01070550|16669101|P5|Overall Study|Treatment unavailable|0
4835394|NCT01070550|16669102|P4|Overall Study|Treatment unavailable|0
4835395|NCT01070550|16669103|P3|Overall Study|Treatment unavailable|0
4835396|NCT01070550|16669104|P2|Overall Study|Treatment unavailable|0
4835397|NCT01070550|16669105|P1|Overall Study|Treatment unavailable|1
4835398|NCT01070550|16669100|P6|Overall Study|Treatment stopped|0
4835399|NCT01070550|16669101|P5|Overall Study|Treatment stopped|0
4835400|NCT01070550|16669102|P4|Overall Study|Treatment stopped|0
4835401|NCT01070550|16669103|P3|Overall Study|Treatment stopped|0
4835402|NCT01070550|16669104|P2|Overall Study|Treatment stopped|0
4835403|NCT01070550|16669105|P1|Overall Study|Treatment stopped|3
4835404|NCT01070550|16669100|P6|Overall Study|Treatment restarted|0
4835405|NCT01070550|16669101|P5|Overall Study|Treatment restarted|0
4835406|NCT01070550|16669102|P4|Overall Study|Treatment restarted|0
4835407|NCT01070550|16669103|P3|Overall Study|Treatment restarted|0
4835408|NCT01070550|16669104|P2|Overall Study|Treatment restarted|1
4835409|NCT01070550|16669105|P1|Overall Study|Treatment restarted|0
4835410|NCT01070550|16669100|P6|Overall Study|Treatment not started|0
4835411|NCT01070550|16669101|P5|Overall Study|Treatment not started|0
4835412|NCT01070550|16669102|P4|Overall Study|Treatment not started|0
4835413|NCT01070550|16669103|P3|Overall Study|Treatment not started|4
4835414|NCT01070550|16669104|P2|Overall Study|Treatment not started|2
4835415|NCT01070550|16669105|P1|Overall Study|Treatment not started|14
4835416|NCT01070550|16669100|P6|Overall Study|Treatment interrupted|0
4835417|NCT01070550|16669101|P5|Overall Study|Treatment interrupted|0
4835418|NCT01070550|16669102|P4|Overall Study|Treatment interrupted|1
4835419|NCT01070550|16669103|P3|Overall Study|Treatment interrupted|1
4835420|NCT01070550|16669104|P2|Overall Study|Treatment interrupted|0
4835421|NCT01070550|16669105|P1|Overall Study|Treatment interrupted|7
4835422|NCT01070550|16669100|P6|Overall Study|Treatment duration shortened|0
4835423|NCT01070550|16669101|P5|Overall Study|Treatment duration shortened|0
4835424|NCT01070550|16669102|P4|Overall Study|Treatment duration shortened|0
4835425|NCT01070550|16669103|P3|Overall Study|Treatment duration shortened|0
4835426|NCT01070550|16669104|P2|Overall Study|Treatment duration shortened|0
4835427|NCT01070550|16669105|P1|Overall Study|Treatment duration shortened|1
4835428|NCT01070550|16669100|P6|Overall Study|Sponsor decision|0
4835429|NCT01070550|16669101|P5|Overall Study|Sponsor decision|0
4835430|NCT01070550|16669102|P4|Overall Study|Sponsor decision|0
4835431|NCT01070550|16669103|P3|Overall Study|Sponsor decision|0
4835432|NCT01070550|16669104|P2|Overall Study|Sponsor decision|0
4835433|NCT01070550|16669105|P1|Overall Study|Sponsor decision|1
4835434|NCT01070550|16669100|P6|Overall Study|Screen failure|0
4835435|NCT01070550|16669101|P5|Overall Study|Screen failure|0
4835436|NCT01070550|16669102|P4|Overall Study|Screen failure|0
4835437|NCT01070550|16669103|P3|Overall Study|Screen failure|0
4835438|NCT01070550|16669104|P2|Overall Study|Screen failure|0
4835439|NCT01070550|16669105|P1|Overall Study|Screen failure|1
4835440|NCT01070550|16669100|P6|Overall Study|Result not available|0
4835441|NCT01070550|16669101|P5|Overall Study|Result not available|0
4835442|NCT01070550|16669102|P4|Overall Study|Result not available|0
4835443|NCT01070550|16669103|P3|Overall Study|Result not available|3
4835444|NCT01070550|16669104|P2|Overall Study|Result not available|1
4835445|NCT01070550|16669105|P1|Overall Study|Result not available|3
4835446|NCT01070550|16669100|P6|Overall Study|Relapse|0
4835447|NCT01070550|16669101|P5|Overall Study|Relapse|0
4835448|NCT01070550|16669102|P4|Overall Study|Relapse|4
4835449|NCT01070550|16669103|P3|Overall Study|Relapse|14
4835450|NCT01070550|16669104|P2|Overall Study|Relapse|5
4835451|NCT01070550|16669105|P1|Overall Study|Relapse|44
4835452|NCT01070550|16669100|P6|Overall Study|Protocol Violation|0
4835453|NCT01070550|16669101|P5|Overall Study|Protocol Violation|0
4835454|NCT01070550|16669102|P4|Overall Study|Protocol Violation|1
4835455|NCT01070550|16669103|P3|Overall Study|Protocol Violation|1
4835456|NCT01070550|16669104|P2|Overall Study|Protocol Violation|1
4835457|NCT01070550|16669105|P1|Overall Study|Protocol Violation|15
4835458|NCT01070550|16669100|P6|Overall Study|Not categorized|1
4835459|NCT01070550|16669101|P5|Overall Study|Not categorized|0
4835460|NCT01070550|16669102|P4|Overall Study|Not categorized|1
4835461|NCT01070550|16669103|P3|Overall Study|Not categorized|6
4835462|NCT01070550|16669104|P2|Overall Study|Not categorized|2
4835463|NCT01070550|16669105|P1|Overall Study|Not categorized|33
4835464|NCT01070550|16669100|P6|Overall Study|Non-responders|2
4835465|NCT01070550|16669101|P5|Overall Study|Non-responders|0
4835466|NCT01070550|16669102|P4|Overall Study|Non-responders|20
4835467|NCT01070550|16669103|P3|Overall Study|Non-responders|21
4835468|NCT01070550|16669104|P2|Overall Study|Non-responders|4
4835469|NCT01070550|16669105|P1|Overall Study|Non-responders|493
4835470|NCT01070550|16669100|P6|Overall Study|New treatment started|0
4835471|NCT01070550|16669101|P5|Overall Study|New treatment started|0
4835472|NCT01070550|16669102|P4|Overall Study|New treatment started|2
4835473|NCT01070550|16669103|P3|Overall Study|New treatment started|0
4835474|NCT01070550|16669104|P2|Overall Study|New treatment started|1
4835475|NCT01070550|16669105|P1|Overall Study|New treatment started|3
4835476|NCT01070550|16669100|P6|Overall Study|Miscellaneous|0
4835477|NCT01070550|16669101|P5|Overall Study|Miscellaneous|0
4835478|NCT01070550|16669102|P4|Overall Study|Miscellaneous|1
4835479|NCT01070550|16669103|P3|Overall Study|Miscellaneous|3
4835480|NCT01070550|16669104|P2|Overall Study|Miscellaneous|2
4835481|NCT01070550|16669105|P1|Overall Study|Miscellaneous|12
4835482|NCT01070550|16669100|P6|Overall Study|Lack of Efficacy|1
4835483|NCT01070550|16669101|P5|Overall Study|Lack of Efficacy|0
4835484|NCT01070550|16669102|P4|Overall Study|Lack of Efficacy|5
4835485|NCT01070550|16669103|P3|Overall Study|Lack of Efficacy|5
4835486|NCT01070550|16669104|P2|Overall Study|Lack of Efficacy|1
4835487|NCT01070550|16669105|P1|Overall Study|Lack of Efficacy|65
4835488|NCT01070550|16669100|P6|Overall Study|Lab test not done|1
4835489|NCT01070550|16669101|P5|Overall Study|Lab test not done|0
4835490|NCT01070550|16669102|P4|Overall Study|Lab test not done|1
4835491|NCT01070550|16669103|P3|Overall Study|Lab test not done|4
4835492|NCT01070550|16669104|P2|Overall Study|Lab test not done|3
4835493|NCT01070550|16669105|P1|Overall Study|Lab test not done|22
4835494|NCT01070550|16669100|P6|Overall Study|Incomplete treatment|0
4835495|NCT01070550|16669101|P5|Overall Study|Incomplete treatment|0
4835496|NCT01070550|16669102|P4|Overall Study|Incomplete treatment|0
4835497|NCT01070550|16669103|P3|Overall Study|Incomplete treatment|0
4835498|NCT01070550|16669104|P2|Overall Study|Incomplete treatment|0
4835499|NCT01070550|16669105|P1|Overall Study|Incomplete treatment|2
4835500|NCT01070550|16669100|P6|Overall Study|Failed to return|2
4835501|NCT01070550|16669101|P5|Overall Study|Failed to return|1
4835502|NCT01070550|16669102|P4|Overall Study|Failed to return|40
4835503|NCT01070550|16669103|P3|Overall Study|Failed to return|144
4835504|NCT01070550|16669104|P2|Overall Study|Failed to return|33
4835505|NCT01070550|16669105|P1|Overall Study|Failed to return|450
4835506|NCT01070550|16669100|P6|Overall Study|Early termination|0
4835507|NCT01070550|16669101|P5|Overall Study|Early termination|0
4835508|NCT01070550|16669102|P4|Overall Study|Early termination|0
4835509|NCT01070550|16669103|P3|Overall Study|Early termination|0
4835510|NCT01070550|16669104|P2|Overall Study|Early termination|0
4835511|NCT01070550|16669105|P1|Overall Study|Early termination|3
4835512|NCT01070550|16669100|P6|Overall Study|Not meeting inclusion/exclusion criteria|0
4835513|NCT01070550|16669101|P5|Overall Study|Not meeting inclusion/exclusion criteria|0
4835514|NCT01070550|16669102|P4|Overall Study|Not meeting inclusion/exclusion criteria|0
4835515|NCT01070550|16669103|P3|Overall Study|Not meeting inclusion/exclusion criteria|1
4835516|NCT01070550|16669104|P2|Overall Study|Not meeting inclusion/exclusion criteria|1
4835517|NCT01070550|16669105|P1|Overall Study|Not meeting inclusion/exclusion criteria|2
4835518|NCT01070550|16669100|P6|Overall Study|Death|0
4835519|NCT01070550|16669101|P5|Overall Study|Death|0
4835520|NCT01070550|16669102|P4|Overall Study|Death|0
4835521|NCT01070550|16669103|P3|Overall Study|Death|3
4835522|NCT01070550|16669104|P2|Overall Study|Death|4
4835523|NCT01070550|16669105|P1|Overall Study|Death|20
4835524|NCT01070550|16669100|P6|Overall Study|Adverse Event|0
4835525|NCT01070550|16669101|P5|Overall Study|Adverse Event|0
4835526|NCT01070550|16669102|P4|Overall Study|Adverse Event|0
4835527|NCT01070550|16669103|P3|Overall Study|Adverse Event|3
4835528|NCT01070550|16669104|P2|Overall Study|Adverse Event|1
4835529|NCT01070550|16669105|P1|Overall Study|Adverse Event|43
4835530|NCT01070394|16669245|P1|Overall Study|Withdrawal by Subject|1
4835531|NCT01070394|16669245|P1|Overall Study|Adverse Event|6
4835532|NCT01070381|16669256|P2|Period 2, 1 Week of Wear|Unacceptable Vision|0
4835533|NCT01070381|16669257|P1|Period 2, 1 Week of Wear|Unacceptable Vision|1
4835534|NCT01070381|16669256|P2|Period 2, 1 Week of Wear|Handling|1
4835535|NCT01070381|16669257|P1|Period 2, 1 Week of Wear|Handling|0
4835536|NCT01070329|16669265|P2|Overall Study|Sponsor Decision|1
4835537|NCT01070329|16669266|P1|Overall Study|Sponsor Decision|0
4835538|NCT01070329|16669265|P2|Overall Study|Entry Criteria Not Met|0
4835539|NCT01070329|16669266|P1|Overall Study|Entry Criteria Not Met|1
4835540|NCT01070329|16669265|P2|Overall Study|Physician Decision|1
4835541|NCT01070329|16669266|P1|Overall Study|Physician Decision|2
4835542|NCT01070329|16669265|P2|Overall Study|Lack of Efficacy|6
4835543|NCT01070329|16669266|P1|Overall Study|Lack of Efficacy|2
4835544|NCT01070329|16669265|P2|Overall Study|Protocol Violation|8
4835545|NCT01070329|16669266|P1|Overall Study|Protocol Violation|3
4835546|NCT01070329|16669265|P2|Overall Study|Withdrawal by Subject|11
4835547|NCT01070329|16669266|P1|Overall Study|Withdrawal by Subject|9
4835548|NCT01070329|16669265|P2|Overall Study|Lost to Follow-up|12
4835549|NCT01070329|16669266|P1|Overall Study|Lost to Follow-up|22
4835550|NCT01070329|16669265|P2|Overall Study|Adverse Event|10
4835551|NCT01070329|16669266|P1|Overall Study|Adverse Event|13
4835552|NCT01070316|16669298|P1|Extension Phase|Withdrawal by Subject|1
4835553|NCT01070316|16669298|P1|Extension Phase|Lack of Efficacy|3
4835554|NCT01070303|16669305|P1|Overall Study|Other|18
4835555|NCT01070303|16669305|P1|Overall Study|Administrative Reason|1
4835556|NCT01070303|16669305|P1|Overall Study|Lack of Efficacy|2
4835557|NCT01070303|16669305|P1|Overall Study|Protocol Violation|0
4835558|NCT01070303|16669305|P1|Overall Study|Lost to Follow-up|9
4835559|NCT01070303|16669305|P1|Overall Study|Withdrawal by Subject|20
4835560|NCT01070303|16669305|P1|Overall Study|Adverse Event|39
4835561|NCT01070043|16669400|P3|Double-Blind Treatment|Adverse Event|2
4835562|NCT01070043|16669401|P2|Double-Blind Treatment|Adverse Event|0
4835563|NCT01070043|16669402|P1|Double-Blind Treatment|Adverse Event|0
4835564|NCT01070043|16669400|P3|Run-In Phase|Did not Meet Inclusion Criteria|0
4835565|NCT01070043|16669401|P2|Run-In Phase|Did not Meet Inclusion Criteria|0
4835566|NCT01070043|16669402|P1|Run-In Phase|Did not Meet Inclusion Criteria|18
4835567|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Removal|0
4835568|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Removal|1
4835569|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Physician Decision|2
4835570|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Physician Decision|0
4835571|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2
4835572|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4
4835573|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3
4835574|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4
4835575|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33
4835576|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7
4835577|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Lack of Efficacy|1
4835578|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Lack of Efficacy|0
4835579|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Protocol Violation|1
4835580|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Protocol Violation|0
4835581|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Lost to Follow-up|1
4835582|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Lost to Follow-up|1
4835583|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Withdrawal by Subject|12
4835584|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Withdrawal by Subject|15
4835585|NCT01069939|16669418|P2|Randomised and Included in the Analyses|Adverse Event|22
4835586|NCT01069939|16669419|P1|Randomised and Included in the Analyses|Adverse Event|17
4835587|NCT01069900|16669445|P2|Overall Study|Insufficient Therapeutic effect|0
4835588|NCT01069900|16669446|P1|Overall Study|Insufficient Therapeutic effect|1
4835589|NCT01069900|16669445|P2|Overall Study|Protocol Violation|1
4835590|NCT01069900|16669446|P1|Overall Study|Protocol Violation|4
4835591|NCT01069900|16669445|P2|Overall Study|Withdrawal by Subject|1
4835592|NCT01069900|16669446|P1|Overall Study|Withdrawal by Subject|6
4835593|NCT01069900|16669445|P2|Overall Study|Lost to Follow-up|1
4835594|NCT01069900|16669446|P1|Overall Study|Lost to Follow-up|7
4835595|NCT01069900|16669445|P2|Overall Study|Technical problems|1
4835596|NCT01069900|16669446|P1|Overall Study|Technical problems|0
4835597|NCT01069861|16669490|P1|Overall Study|Did not meet entrance criteria|1
4835598|NCT01069861|16669490|P1|Overall Study|Adverse Event|1
4835599|NCT01069861|16669490|P1|Overall Study|Death|1
4835600|NCT01069627|16669503|P1|Overall Study|Protocol Violation|1
4835601|NCT01069627|16669503|P1|Overall Study|Adverse Event|12
4835602|NCT01069627|16669503|P1|Overall Study|Disease progression|7
4835603|NCT01069523|16669553|P2|Overall Study|Withdrawal by Subject|7
4835604|NCT01069523|16669554|P1|Overall Study|Withdrawal by Subject|4
4835605|NCT01069484|16669577|P2|Overall Study|Illness mother or child|1
4835606|NCT01069484|16669578|P1|Overall Study|Illness mother or child|3
4835607|NCT01069484|16669577|P2|Overall Study|No specific reason|2
4835608|NCT01069484|16669578|P1|Overall Study|No specific reason|8
4835609|NCT01069484|16669577|P2|Overall Study|Death-in-near-family|0
4835610|NCT01069484|16669578|P1|Overall Study|Death-in-near-family|1
4835611|NCT01069419|16669586|P1|Overall Study|Missing termination information|13
4835612|NCT01069419|16669586|P1|Overall Study|Other Reason|43
4835613|NCT01069419|16669586|P1|Overall Study|Withdrawal by Subject|34
4835614|NCT01069419|16669586|P1|Overall Study|Remission of disease|11
4835615|NCT01069419|16669586|P1|Overall Study|Lost to Follow-up|49
4835616|NCT01069419|16669586|P1|Overall Study|Lack of Efficacy|332
4835617|NCT01069419|16669586|P1|Overall Study|Adverse Event|233
4835618|NCT01069341|16669615|P1|Overall Study|Lost to Follow-up|1
4835619|NCT01069289|16669657|P2|Overall Study|Due to deteriorating health condition|0
4835620|NCT01069289|16669658|P1|Overall Study|Due to deteriorating health condition|1
4835621|NCT01069289|16669657|P2|Overall Study|Severe non-compliance to protocol|2
4835622|NCT01069289|16669658|P1|Overall Study|Severe non-compliance to protocol|3
4835623|NCT01069289|16669657|P2|Overall Study|Eligibility criteria not fulfilled|0
4835624|NCT01069289|16669658|P1|Overall Study|Eligibility criteria not fulfilled|2
4835625|NCT01069289|16669657|P2|Overall Study|Adverse Event|28
4835626|NCT01069289|16669658|P1|Overall Study|Adverse Event|21
4835627|NCT01069289|16669657|P2|Overall Study|Withdrawal by Subject|26
4835628|NCT01069289|16669658|P1|Overall Study|Withdrawal by Subject|15
4835629|NCT01069172|16669707|P2|Overall Study|Withdrawal by Subject|0
4835630|NCT01069172|16669708|P1|Overall Study|Withdrawal by Subject|1
4835631|NCT01069120|16669718|P1|Overall Study|Study prematurely terminated|27
4835632|NCT01068912|16669755|P3|Overall Study|other underlying illness|3
4835633|NCT01068912|16669756|P2|Overall Study|other underlying illness|3
4835634|NCT01068912|16669757|P1|Overall Study|other underlying illness|0
4835635|NCT01068912|16669755|P3|Overall Study|aggravation influenza|1
4835636|NCT01068912|16669756|P2|Overall Study|aggravation influenza|1
4835637|NCT01068912|16669757|P1|Overall Study|aggravation influenza|1
4835638|NCT01068912|16669755|P3|Overall Study|Protocol Violation|0
4835639|NCT01068912|16669756|P2|Overall Study|Protocol Violation|2
4835640|NCT01068912|16669757|P1|Overall Study|Protocol Violation|0
4835641|NCT01068912|16669755|P3|Overall Study|Lost to Follow-up|3
4835642|NCT01068912|16669756|P2|Overall Study|Lost to Follow-up|7
4835643|NCT01068912|16669757|P1|Overall Study|Lost to Follow-up|3
4835644|NCT01068912|16669755|P3|Overall Study|Withdrawal by Subject|6
4835645|NCT01068912|16669756|P2|Overall Study|Withdrawal by Subject|6
4835646|NCT01068912|16669757|P1|Overall Study|Withdrawal by Subject|5
4835647|NCT01068912|16669755|P3|Overall Study|Adverse Event|2
4835648|NCT01068912|16669756|P2|Overall Study|Adverse Event|3
4835649|NCT01068912|16669757|P1|Overall Study|Adverse Event|2
4835650|NCT01068860|16669775|P10|Overall Study|Lost to Follow-up|0
4835651|NCT01068860|16669776|P9|Overall Study|Lost to Follow-up|0
4835652|NCT01068860|16669777|P8|Overall Study|Lost to Follow-up|0
4835653|NCT01068860|16669778|P7|Overall Study|Lost to Follow-up|0
4835654|NCT01068860|16669779|P6|Overall Study|Lost to Follow-up|0
4835655|NCT01068860|16669780|P5|Overall Study|Lost to Follow-up|0
4835656|NCT01068860|16669781|P4|Overall Study|Lost to Follow-up|0
4835657|NCT01068860|16669782|P3|Overall Study|Lost to Follow-up|0
4835658|NCT01068860|16669783|P2|Overall Study|Lost to Follow-up|1
4835659|NCT01068860|16669784|P1|Overall Study|Lost to Follow-up|0
4835660|NCT01068860|16669775|P10|Overall Study|Administrative problems; misrandomized|1
4835661|NCT01068860|16669776|P9|Overall Study|Administrative problems; misrandomized|0
4835662|NCT01068860|16669777|P8|Overall Study|Administrative problems; misrandomized|0
4835663|NCT01068860|16669778|P7|Overall Study|Administrative problems; misrandomized|0
4835664|NCT01068860|16669779|P6|Overall Study|Administrative problems; misrandomized|0
4835665|NCT01068860|16669780|P5|Overall Study|Administrative problems; misrandomized|0
4835666|NCT01068860|16669781|P4|Overall Study|Administrative problems; misrandomized|1
4835667|NCT01068860|16669782|P3|Overall Study|Administrative problems; misrandomized|0
4835668|NCT01068860|16669783|P2|Overall Study|Administrative problems; misrandomized|0
4835669|NCT01068860|16669784|P1|Overall Study|Administrative problems; misrandomized|0
4835670|NCT01068860|16669775|P10|Overall Study|Withdrawal by Subject|3
4835671|NCT01068860|16669776|P9|Overall Study|Withdrawal by Subject|0
4835672|NCT01068860|16669777|P8|Overall Study|Withdrawal by Subject|0
4835673|NCT01068860|16669778|P7|Overall Study|Withdrawal by Subject|0
4835674|NCT01068860|16669779|P6|Overall Study|Withdrawal by Subject|2
4835675|NCT01068860|16669780|P5|Overall Study|Withdrawal by Subject|0
4835676|NCT01068860|16669781|P4|Overall Study|Withdrawal by Subject|0
4835677|NCT01068860|16669782|P3|Overall Study|Withdrawal by Subject|0
4835678|NCT01068860|16669783|P2|Overall Study|Withdrawal by Subject|0
4835679|NCT01068860|16669784|P1|Overall Study|Withdrawal by Subject|0
4835680|NCT01068769|16669967|P1|Overall Study|Ineligible|1
4835681|NCT01068743|16669972|P4|Period 3|Adverse Event|0
4835682|NCT01068743|16669973|P3|Period 3|Adverse Event|0
4835683|NCT01068743|16669974|P2|Period 3|Adverse Event|1
4835684|NCT01068743|16669975|P1|Period 3|Adverse Event|0
4835685|NCT01068730|16670049|P4|Period 4|Family emergency|0
4835686|NCT01068730|16670050|P3|Period 4|Family emergency|0
4835687|NCT01068730|16670051|P2|Period 4|Family emergency|1
4835688|NCT01068730|16670052|P1|Period 4|Family emergency|0
4835689|NCT01068730|16670049|P4|Period 3|Personal reason|0
4835690|NCT01068730|16670050|P3|Period 3|Personal reason|0
4835691|NCT01068730|16670051|P2|Period 3|Personal reason|0
4835692|NCT01068730|16670052|P1|Period 3|Personal reason|1
4835693|NCT01068717|16670106|P4|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
4835694|NCT01068717|16670107|P3|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
4835695|NCT01068717|16670108|P2|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0
4835696|NCT01068717|16670109|P1|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1
4835697|NCT01068678|16670165|P2|Overall Study|Unclassified|15
4835698|NCT01068678|16670166|P1|Overall Study|Unclassified|18
4835699|NCT01068678|16670165|P2|Overall Study|Withdrawal criteria|6
4835700|NCT01068678|16670166|P1|Overall Study|Withdrawal criteria|12
4835701|NCT01068678|16670165|P2|Overall Study|Protocol Violation|1
4835702|NCT01068678|16670166|P1|Overall Study|Protocol Violation|5
4835703|NCT01068678|16670165|P2|Overall Study|Lack of Efficacy|2
4835704|NCT01068678|16670166|P1|Overall Study|Lack of Efficacy|3
4835705|NCT01068665|16670176|P2|Overall Study|Other|12
4835706|NCT01068665|16670177|P1|Overall Study|Other|17
4835707|NCT01068665|16670176|P2|Overall Study|Withdrawal Criteria|9
4835708|NCT01068665|16670177|P1|Overall Study|Withdrawal Criteria|3
4835709|NCT01068665|16670176|P2|Overall Study|Protocol Violation|2
4835710|NCT01068665|16670177|P1|Overall Study|Protocol Violation|5
4835711|NCT01068665|16670176|P2|Overall Study|Lack of Efficacy|2
4835712|NCT01068665|16670177|P1|Overall Study|Lack of Efficacy|0
4835713|NCT01068665|16670176|P2|Overall Study|Adverse Event|4
4835714|NCT01068665|16670177|P1|Overall Study|Adverse Event|5
4835715|NCT01068652|16670187|P2|Overall Study|Unclassified|4
4835716|NCT01068652|16670188|P1|Overall Study|Unclassified|7
4835717|NCT01068652|16670187|P2|Overall Study|Patient was not eligible|0
4835718|NCT01068652|16670188|P1|Overall Study|Patient was not eligible|1
4835719|NCT01068652|16670187|P2|Overall Study|Withdrawal criteria|2
4835720|NCT01068652|16670188|P1|Overall Study|Withdrawal criteria|1
4835721|NCT01068652|16670187|P2|Overall Study|Protocol Violation|6
4835722|NCT01068652|16670188|P1|Overall Study|Protocol Violation|3
4835723|NCT01068652|16670187|P2|Overall Study|Lost to Follow-up|1
4835724|NCT01068652|16670188|P1|Overall Study|Lost to Follow-up|2
4835725|NCT01068652|16670187|P2|Overall Study|Lack of Efficacy|2
4835726|NCT01068652|16670188|P1|Overall Study|Lack of Efficacy|0
4835727|NCT01068652|16670187|P2|Overall Study|Adverse Event|0
4835728|NCT01068652|16670188|P1|Overall Study|Adverse Event|4
4835729|NCT01068626|16670228|P2|Overall Study|Withdrawal by Subject|2
4835730|NCT01068626|16670229|P1|Overall Study|Withdrawal by Subject|0
4835731|NCT01068626|16670228|P2|Overall Study|Adverse Event|0
4835732|NCT01068626|16670229|P1|Overall Study|Adverse Event|3
4835733|NCT01068600|16670247|P2|Overall Study|Administrative problems|1
4835734|NCT01068600|16670248|P1|Overall Study|Administrative problems|0
4835735|NCT01068600|16670247|P2|Overall Study|Unsatisfactory therapeutic effect|4
4835736|NCT01068600|16670248|P1|Overall Study|Unsatisfactory therapeutic effect|0
4835737|NCT01068600|16670247|P2|Overall Study|Protocol deviation|1
4835738|NCT01068600|16670248|P1|Overall Study|Protocol deviation|1
4835739|NCT01068600|16670247|P2|Overall Study|Lost to Follow-up|2
4835740|NCT01068600|16670248|P1|Overall Study|Lost to Follow-up|1
4835741|NCT01068600|16670247|P2|Overall Study|Abnormal laboratory value(s)|0
4835742|NCT01068600|16670248|P1|Overall Study|Abnormal laboratory value(s)|1
4835743|NCT01068600|16670247|P2|Overall Study|Adverse Event|3
4835744|NCT01068600|16670248|P1|Overall Study|Adverse Event|3
4835745|NCT01068600|16670247|P2|Overall Study|Withdrawal by Subject|6
4835746|NCT01068600|16670248|P1|Overall Study|Withdrawal by Subject|5
4835747|NCT01068509|16670270|P3|Overall Study|Reason Not Specified|0
4835748|NCT01068509|16670271|P2|Overall Study|Reason Not Specified|1
4835749|NCT01068509|16670272|P1|Overall Study|Reason Not Specified|0
4835750|NCT01068509|16670270|P3|Overall Study|Withdrew Consent|2
4835751|NCT01068509|16670271|P2|Overall Study|Withdrew Consent|1
4835752|NCT01068509|16670272|P1|Overall Study|Withdrew Consent|0
4835753|NCT01068509|16670270|P3|Overall Study|Lost to Follow-up|0
4835754|NCT01068509|16670271|P2|Overall Study|Lost to Follow-up|0
4835755|NCT01068509|16670272|P1|Overall Study|Lost to Follow-up|1
4835756|NCT01068509|16670270|P3|Overall Study|Disease Progression|18
4835757|NCT01068509|16670271|P2|Overall Study|Disease Progression|20
4835758|NCT01068509|16670272|P1|Overall Study|Disease Progression|5
4835759|NCT01068509|16670270|P3|Overall Study|Death|1
4835760|NCT01068509|16670271|P2|Overall Study|Death|0
4835761|NCT01068509|16670272|P1|Overall Study|Death|0
4835762|NCT01068418|16670285|P1|Overall Study|Physician Decision|12
4835763|NCT01068262|16670294|P4|Overall Study|Withdrawal by Subject|0
4835764|NCT01068262|16670295|P3|Overall Study|Withdrawal by Subject|0
4835765|NCT01068262|16670296|P2|Overall Study|Withdrawal by Subject|1
4835766|NCT01068262|16670297|P1|Overall Study|Withdrawal by Subject|0
4835767|NCT01068262|16670294|P4|Overall Study|Protocol Violation|0
4835768|NCT01068262|16670295|P3|Overall Study|Protocol Violation|0
4835769|NCT01068262|16670296|P2|Overall Study|Protocol Violation|0
4835770|NCT01068262|16670297|P1|Overall Study|Protocol Violation|1
4835771|NCT01068262|16670294|P4|Overall Study|Adverse Event|0
4835772|NCT01068262|16670295|P3|Overall Study|Adverse Event|1
4835773|NCT01068262|16670296|P2|Overall Study|Adverse Event|0
4835774|NCT01068262|16670297|P1|Overall Study|Adverse Event|2
4835775|NCT01068158|16670327|P2|Overall Study|Protocol Violation|2
4835776|NCT01068158|16670328|P1|Overall Study|Protocol Violation|0
4835777|NCT01068158|16670327|P2|Overall Study|Lost to Follow-up|0
4835778|NCT01068158|16670328|P1|Overall Study|Lost to Follow-up|7
4835779|NCT01068158|16670327|P2|Overall Study|Withdrawal by Subject|2
4835780|NCT01068158|16670328|P1|Overall Study|Withdrawal by Subject|1
4835781|NCT01067976|16670340|P1|Overall Study|Study prematurely discontinued|2
4835782|NCT01067976|16670340|P1|Overall Study|Study drug never administered|20
4835783|NCT01067846|16670401|P2|Overall Study|participation in other tx study|0
4835784|NCT01067846|16670402|P1|Overall Study|participation in other tx study|1
4835785|NCT01067846|16670401|P2|Overall Study|Withdrawal by Subject|0
4835786|NCT01067846|16670402|P1|Overall Study|Withdrawal by Subject|1
4835787|NCT01067846|16670401|P2|Overall Study|Lost to Follow-up|19
4835788|NCT01067846|16670402|P1|Overall Study|Lost to Follow-up|17
4835789|NCT01067521|16670472|P2|Open-Label Period|Lost to Follow-up|20
4835790|NCT01067521|16670473|P1|Open-Label Period|Lost to Follow-up|21
4835791|NCT01067521|16670472|P2|Open-Label Period|Teva requested subject to be withdrawn|2
4835792|NCT01067521|16670473|P1|Open-Label Period|Teva requested subject to be withdrawn|5
4835793|NCT01067521|16670472|P2|Open-Label Period|Pregnancy|8
4835794|NCT01067521|16670473|P1|Open-Label Period|Pregnancy|14
4835795|NCT01067521|16670472|P2|Open-Label Period|Protocol Violation|0
4835796|NCT01067521|16670473|P1|Open-Label Period|Protocol Violation|3
4835797|NCT01067521|16670472|P2|Open-Label Period|Non-compliance with study drug|0
4835798|NCT01067521|16670473|P1|Open-Label Period|Non-compliance with study drug|5
4835799|NCT01067521|16670472|P2|Open-Label Period|Physician Decision|11
4835800|NCT01067521|16670473|P1|Open-Label Period|Physician Decision|13
4835801|NCT01067521|16670472|P2|Open-Label Period|Withdrawal by Subject|88
4835802|NCT01067521|16670473|P1|Open-Label Period|Withdrawal by Subject|160
4835803|NCT01067521|16670472|P2|Open-Label Period|Adverse Event|28
4835804|NCT01067521|16670473|P1|Open-Label Period|Adverse Event|30
4835805|NCT01067521|16670472|P2|Open-Label Period|Death|1
4835806|NCT01067521|16670473|P1|Open-Label Period|Death|3
4835807|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1
4835808|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5
4835809|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Pregnancy|4
4835810|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Pregnancy|7
4835811|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Protocol Violation|0
4835812|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Protocol Violation|2
4835813|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0
4835814|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2
4835815|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1
4835816|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4
4835817|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Physician Decision|1
4835818|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Physician Decision|1
4835819|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17
4835820|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34
4835821|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Adverse Event|6
4835822|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Adverse Event|29
4835823|NCT01067521|16670472|P2|Double-Blind Placebo-Controlled Period|Death|1
4835824|NCT01067521|16670473|P1|Double-Blind Placebo-Controlled Period|Death|0
4835825|NCT01067508|16670499|P2|Overall Study|Withdrawal by Subject|1
4835826|NCT01067508|16670500|P1|Overall Study|Withdrawal by Subject|0
4835827|NCT01067508|16670499|P2|Overall Study|Physician Decision|1
4835828|NCT01067508|16670500|P1|Overall Study|Physician Decision|0
4835829|NCT01067469|16670508|P2|Overall Study|Disease Progression|1
4835830|NCT01067469|16670509|P1|Overall Study|Disease Progression|0
4835831|NCT01067469|16670508|P2|Overall Study|Withdrawal by Subject|1
4835832|NCT01067469|16670509|P1|Overall Study|Withdrawal by Subject|0
4835833|NCT01067352|16670541|P3|Overall Study|Physician Decision|0
4835834|NCT01067352|16670542|P2|Overall Study|Physician Decision|1
4835835|NCT01067352|16670543|P1|Overall Study|Physician Decision|0
4835836|NCT01067352|16670541|P3|Overall Study|Withdrawal by Subject|1
4835837|NCT01067352|16670542|P2|Overall Study|Withdrawal by Subject|2
4835838|NCT01067352|16670543|P1|Overall Study|Withdrawal by Subject|1
4835839|NCT01067339|16670559|P2|Overall Study|Withdrawal by Subject|5
4835840|NCT01067339|16670560|P1|Overall Study|Withdrawal by Subject|6
4835841|NCT01067326|16670570|P2|Overall Study|Early Study Termination|1
4835842|NCT01067326|16670571|P1|Overall Study|Early Study Termination|1
4835843|NCT01067326|16670570|P2|Overall Study|Withdrawal by Subject|0
4835844|NCT01067326|16670571|P1|Overall Study|Withdrawal by Subject|1
4835845|NCT01067326|16670570|P2|Overall Study|Adverse Event|2
4835846|NCT01067326|16670571|P1|Overall Study|Adverse Event|0
4835847|NCT01067144|16670585|P2|Follow-up|Death|1
4835848|NCT01067144|16670586|P1|Follow-up|Death|0
4835849|NCT01067144|16670585|P2|Follow-up|Surgery cancelled|1
4835850|NCT01067144|16670586|P1|Follow-up|Surgery cancelled|0
4835851|NCT01067144|16670585|P2|Follow-up|Withdrawal by Subject|14
4835852|NCT01067144|16670586|P1|Follow-up|Withdrawal by Subject|18
4835853|NCT01067144|16670585|P2|Follow-up|Censored owing to second surgery|28
4835854|NCT01067144|16670586|P1|Follow-up|Censored owing to second surgery|19
4835855|NCT01067144|16670585|P2|Follow-up|Lost to Follow-up|12
4835856|NCT01067144|16670586|P1|Follow-up|Lost to Follow-up|22
4835857|NCT01067144|16670585|P2|Treatment|Did not receive allocated intervention|7
4835858|NCT01067144|16670586|P1|Treatment|Did not receive allocated intervention|4
4835859|NCT01067105|16670602|P1|Overall Study|Other|31
4835860|NCT01067105|16670602|P1|Overall Study|Physician Decision|6
4835861|NCT01067105|16670602|P1|Overall Study|Lost to Follow-up|6
4835862|NCT01067105|16670602|P1|Overall Study|Withdrawal by Subject|36
4835863|NCT01067105|16670602|P1|Overall Study|Protocol Violation|48
4835864|NCT01067105|16670602|P1|Overall Study|Adverse Event|14
4835865|NCT01066936|16670619|P1|Overall Study|Withdrawal by Subject|4
4835866|NCT01066936|16670619|P1|Overall Study|Lost to Follow-up|3
4835867|NCT01066936|16670619|P1|Overall Study|Device revised/removed|1
4835868|NCT01066936|16670619|P1|Overall Study|Death|2
4835869|NCT01066923|16670655|P4|Overall Study|Withdrawal by Subject|8
4835870|NCT01066923|16670656|P3|Overall Study|Withdrawal by Subject|8
4835871|NCT01066923|16670657|P2|Overall Study|Withdrawal by Subject|3
4835872|NCT01066923|16670658|P1|Overall Study|Withdrawal by Subject|3
4835873|NCT01066897|16670682|P2|Overall Study|stopped study after developing the flu.|0
4835874|NCT01066897|16670683|P1|Overall Study|stopped study after developing the flu.|1
4835875|NCT01066897|16670682|P2|Overall Study|Withdrawal by Subject|0
4835876|NCT01066897|16670683|P1|Overall Study|Withdrawal by Subject|1
4835877|NCT01066871|16670697|P4|Overall Study|Other|2
4835878|NCT01066871|16670698|P3|Overall Study|Other|1
4835879|NCT01066871|16670699|P2|Overall Study|Other|2
4835880|NCT01066871|16670700|P1|Overall Study|Other|0
4835881|NCT01066871|16670697|P4|Overall Study|Withdrawal by Subject|0
4835882|NCT01066871|16670698|P3|Overall Study|Withdrawal by Subject|0
4835883|NCT01066871|16670699|P2|Overall Study|Withdrawal by Subject|1
4835884|NCT01066871|16670700|P1|Overall Study|Withdrawal by Subject|3
4835885|NCT01066871|16670697|P4|Overall Study|Lack of Efficacy|1
4835886|NCT01066871|16670698|P3|Overall Study|Lack of Efficacy|0
4835887|NCT01066871|16670699|P2|Overall Study|Lack of Efficacy|0
4835888|NCT01066871|16670700|P1|Overall Study|Lack of Efficacy|0
4835889|NCT01066871|16670697|P4|Overall Study|Protocol Violation|2
4835890|NCT01066871|16670698|P3|Overall Study|Protocol Violation|3
4835891|NCT01066871|16670699|P2|Overall Study|Protocol Violation|0
4835892|NCT01066871|16670700|P1|Overall Study|Protocol Violation|1
4835893|NCT01066871|16670697|P4|Overall Study|Lost to Follow-up|0
4835894|NCT01066871|16670698|P3|Overall Study|Lost to Follow-up|2
4835895|NCT01066871|16670699|P2|Overall Study|Lost to Follow-up|2
4835896|NCT01066871|16670700|P1|Overall Study|Lost to Follow-up|0
4835897|NCT01066819|16670764|P6|Overall Study|Other|0
4835898|NCT01066819|16670765|P5|Overall Study|Other|0
4835899|NCT01066819|16670766|P4|Overall Study|Other|0
4835900|NCT01066819|16670767|P3|Overall Study|Other|1
4835901|NCT01066819|16670768|P2|Overall Study|Other|1
4835902|NCT01066819|16670769|P1|Overall Study|Other|5
4835903|NCT01066819|16670764|P6|Overall Study|Treatment stopped|0
4835904|NCT01066819|16670765|P5|Overall Study|Treatment stopped|0
4835905|NCT01066819|16670766|P4|Overall Study|Treatment stopped|1
4835906|NCT01066819|16670767|P3|Overall Study|Treatment stopped|2
4835907|NCT01066819|16670768|P2|Overall Study|Treatment stopped|1
4835908|NCT01066819|16670769|P1|Overall Study|Treatment stopped|12
4835909|NCT01066819|16670764|P6|Overall Study|Treatment never started|2
4835910|NCT01066819|16670765|P5|Overall Study|Treatment never started|2
4835911|NCT01066819|16670766|P4|Overall Study|Treatment never started|3
4835912|NCT01066819|16670767|P3|Overall Study|Treatment never started|19
4835913|NCT01066819|16670768|P2|Overall Study|Treatment never started|19
4835914|NCT01066819|16670769|P1|Overall Study|Treatment never started|85
4835915|NCT01066819|16670764|P6|Overall Study|Spontaneous cure|0
4835916|NCT01066819|16670765|P5|Overall Study|Spontaneous cure|0
4835917|NCT01066819|16670766|P4|Overall Study|Spontaneous cure|0
4835918|NCT01066819|16670767|P3|Overall Study|Spontaneous cure|0
4835919|NCT01066819|16670768|P2|Overall Study|Spontaneous cure|0
4835920|NCT01066819|16670769|P1|Overall Study|Spontaneous cure|1
4835921|NCT01066819|16670764|P6|Overall Study|Screen failure|0
4835922|NCT01066819|16670765|P5|Overall Study|Screen failure|0
4835923|NCT01066819|16670766|P4|Overall Study|Screen failure|0
4835924|NCT01066819|16670767|P3|Overall Study|Screen failure|0
4835925|NCT01066819|16670768|P2|Overall Study|Screen failure|0
4835926|NCT01066819|16670769|P1|Overall Study|Screen failure|1
4835927|NCT01066819|16670764|P6|Overall Study|Results not available|0
4835928|NCT01066819|16670765|P5|Overall Study|Results not available|0
4835929|NCT01066819|16670766|P4|Overall Study|Results not available|0
4835930|NCT01066819|16670767|P3|Overall Study|Results not available|0
4835931|NCT01066819|16670768|P2|Overall Study|Results not available|0
4835932|NCT01066819|16670769|P1|Overall Study|Results not available|1
4835933|NCT01066819|16670764|P6|Overall Study|Relapse|0
4835934|NCT01066819|16670765|P5|Overall Study|Relapse|0
4835935|NCT01066819|16670766|P4|Overall Study|Relapse|0
4835936|NCT01066819|16670767|P3|Overall Study|Relapse|3
4835937|NCT01066819|16670768|P2|Overall Study|Relapse|4
4835938|NCT01066819|16670769|P1|Overall Study|Relapse|16
4835939|NCT01066819|16670764|P6|Overall Study|Not categorised|0
4835940|NCT01066819|16670765|P5|Overall Study|Not categorised|0
4835941|NCT01066819|16670766|P4|Overall Study|Not categorised|1
4835942|NCT01066819|16670767|P3|Overall Study|Not categorised|6
4835943|NCT01066819|16670768|P2|Overall Study|Not categorised|2
4835944|NCT01066819|16670769|P1|Overall Study|Not categorised|9
4835945|NCT01066819|16670764|P6|Overall Study|Non responders|1
4835946|NCT01066819|16670765|P5|Overall Study|Non responders|0
4835947|NCT01066819|16670766|P4|Overall Study|Non responders|2
4835948|NCT01066819|16670767|P3|Overall Study|Non responders|7
4835949|NCT01066819|16670768|P2|Overall Study|Non responders|2
4835950|NCT01066819|16670769|P1|Overall Study|Non responders|123
4835951|NCT01066819|16670764|P6|Overall Study|Miscellaneous|0
4835952|NCT01066819|16670765|P5|Overall Study|Miscellaneous|0
4835953|NCT01066819|16670766|P4|Overall Study|Miscellaneous|1
4835954|NCT01066819|16670767|P3|Overall Study|Miscellaneous|18
4835955|NCT01066819|16670768|P2|Overall Study|Miscellaneous|10
4835956|NCT01066819|16670769|P1|Overall Study|Miscellaneous|28
4835957|NCT01066819|16670764|P6|Overall Study|Lab test not done|0
4835958|NCT01066819|16670765|P5|Overall Study|Lab test not done|0
4835959|NCT01066819|16670766|P4|Overall Study|Lab test not done|1
4835960|NCT01066819|16670767|P3|Overall Study|Lab test not done|2
4835961|NCT01066819|16670768|P2|Overall Study|Lab test not done|0
4835962|NCT01066819|16670769|P1|Overall Study|Lab test not done|9
4835963|NCT01066819|16670764|P6|Overall Study|Failed to return|3
4835964|NCT01066819|16670765|P5|Overall Study|Failed to return|2
4835965|NCT01066819|16670766|P4|Overall Study|Failed to return|7
4835966|NCT01066819|16670767|P3|Overall Study|Failed to return|68
4835967|NCT01066819|16670768|P2|Overall Study|Failed to return|107
4835968|NCT01066819|16670769|P1|Overall Study|Failed to return|298
4835969|NCT01066819|16670764|P6|Overall Study|Early termination|0
4835970|NCT01066819|16670765|P5|Overall Study|Early termination|0
4835971|NCT01066819|16670766|P4|Overall Study|Early termination|0
4835972|NCT01066819|16670767|P3|Overall Study|Early termination|0
4835973|NCT01066819|16670768|P2|Overall Study|Early termination|0
4835974|NCT01066819|16670769|P1|Overall Study|Early termination|2
4835975|NCT01066819|16670764|P6|Overall Study|Not met inclusion/exclusion criteria|0
4835976|NCT01066819|16670765|P5|Overall Study|Not met inclusion/exclusion criteria|0
4835977|NCT01066819|16670766|P4|Overall Study|Not met inclusion/exclusion criteria|0
4835978|NCT01066819|16670767|P3|Overall Study|Not met inclusion/exclusion criteria|0
4835979|NCT01066819|16670768|P2|Overall Study|Not met inclusion/exclusion criteria|0
4835980|NCT01066819|16670769|P1|Overall Study|Not met inclusion/exclusion criteria|1
4835981|NCT01066819|16670764|P6|Overall Study|Administrative|0
4835982|NCT01066819|16670765|P5|Overall Study|Administrative|0
4835983|NCT01066819|16670766|P4|Overall Study|Administrative|0
4835984|NCT01066819|16670767|P3|Overall Study|Administrative|2
4835985|NCT01066819|16670768|P2|Overall Study|Administrative|4
4835986|NCT01066819|16670769|P1|Overall Study|Administrative|6
4835987|NCT01066819|16670764|P6|Overall Study|Withdrawal by Subject|0
4835988|NCT01066819|16670765|P5|Overall Study|Withdrawal by Subject|0
4835989|NCT01066819|16670766|P4|Overall Study|Withdrawal by Subject|0
4835990|NCT01066819|16670767|P3|Overall Study|Withdrawal by Subject|6
4835991|NCT01066819|16670768|P2|Overall Study|Withdrawal by Subject|11
4835992|NCT01066819|16670769|P1|Overall Study|Withdrawal by Subject|29
4835993|NCT01066819|16670764|P6|Overall Study|Protocol Violation|0
4835994|NCT01066819|16670765|P5|Overall Study|Protocol Violation|0
4835995|NCT01066819|16670766|P4|Overall Study|Protocol Violation|0
4835996|NCT01066819|16670767|P3|Overall Study|Protocol Violation|0
4835997|NCT01066819|16670768|P2|Overall Study|Protocol Violation|6
4835998|NCT01066819|16670769|P1|Overall Study|Protocol Violation|12
4835999|NCT01066819|16670764|P6|Overall Study|Physician Decision|0
4836000|NCT01066819|16670765|P5|Overall Study|Physician Decision|0
4836001|NCT01066819|16670766|P4|Overall Study|Physician Decision|0
4836002|NCT01066819|16670767|P3|Overall Study|Physician Decision|3
4836003|NCT01066819|16670768|P2|Overall Study|Physician Decision|2
4836004|NCT01066819|16670769|P1|Overall Study|Physician Decision|6
4836005|NCT01066819|16670764|P6|Overall Study|Lack of Efficacy|0
4836006|NCT01066819|16670765|P5|Overall Study|Lack of Efficacy|0
4836007|NCT01066819|16670766|P4|Overall Study|Lack of Efficacy|1
4836008|NCT01066819|16670767|P3|Overall Study|Lack of Efficacy|2
4836009|NCT01066819|16670768|P2|Overall Study|Lack of Efficacy|1
4836010|NCT01066819|16670769|P1|Overall Study|Lack of Efficacy|22
4836011|NCT01066819|16670764|P6|Overall Study|Death|0
4836012|NCT01066819|16670765|P5|Overall Study|Death|0
4836013|NCT01066819|16670766|P4|Overall Study|Death|0
4836014|NCT01066819|16670767|P3|Overall Study|Death|1
4836015|NCT01066819|16670768|P2|Overall Study|Death|0
4836016|NCT01066819|16670769|P1|Overall Study|Death|5
4836017|NCT01066819|16670764|P6|Overall Study|Adverse Event|0
4836018|NCT01066819|16670765|P5|Overall Study|Adverse Event|0
4836019|NCT01066819|16670766|P4|Overall Study|Adverse Event|0
4836020|NCT01066819|16670767|P3|Overall Study|Adverse Event|6
4836021|NCT01066819|16670768|P2|Overall Study|Adverse Event|1
4836022|NCT01066819|16670769|P1|Overall Study|Adverse Event|18
4836023|NCT01066793|16670910|P6|Overall Study|Treatment Stopped|0
4836024|NCT01066793|16670911|P5|Overall Study|Treatment Stopped|0
4836025|NCT01066793|16670912|P4|Overall Study|Treatment Stopped|1
4836026|NCT01066793|16670913|P3|Overall Study|Treatment Stopped|0
4836027|NCT01066793|16670914|P2|Overall Study|Treatment Stopped|1
4836028|NCT01066793|16670915|P1|Overall Study|Treatment Stopped|2
4836029|NCT01066793|16670910|P6|Overall Study|Treatment Never Started|0
4836030|NCT01066793|16670911|P5|Overall Study|Treatment Never Started|0
4836031|NCT01066793|16670912|P4|Overall Study|Treatment Never Started|1
4836032|NCT01066793|16670913|P3|Overall Study|Treatment Never Started|4
4836033|NCT01066793|16670914|P2|Overall Study|Treatment Never Started|5
4836034|NCT01066793|16670915|P1|Overall Study|Treatment Never Started|18
4836035|NCT01066793|16670910|P6|Overall Study|Treatment Interrupted|0
4836036|NCT01066793|16670911|P5|Overall Study|Treatment Interrupted|0
4836037|NCT01066793|16670912|P4|Overall Study|Treatment Interrupted|0
4836038|NCT01066793|16670913|P3|Overall Study|Treatment Interrupted|0
4836039|NCT01066793|16670914|P2|Overall Study|Treatment Interrupted|1
4836040|NCT01066793|16670915|P1|Overall Study|Treatment Interrupted|1
4836041|NCT01066793|16670910|P6|Overall Study|Result Not Available|0
4836042|NCT01066793|16670911|P5|Overall Study|Result Not Available|0
4836043|NCT01066793|16670912|P4|Overall Study|Result Not Available|0
4836044|NCT01066793|16670913|P3|Overall Study|Result Not Available|0
4836045|NCT01066793|16670914|P2|Overall Study|Result Not Available|0
4836046|NCT01066793|16670915|P1|Overall Study|Result Not Available|1
4836047|NCT01066793|16670910|P6|Overall Study|Relapse|0
4836048|NCT01066793|16670911|P5|Overall Study|Relapse|0
4836049|NCT01066793|16670912|P4|Overall Study|Relapse|3
4836050|NCT01066793|16670913|P3|Overall Study|Relapse|2
4836051|NCT01066793|16670914|P2|Overall Study|Relapse|8
4836052|NCT01066793|16670915|P1|Overall Study|Relapse|20
4836053|NCT01066793|16670910|P6|Overall Study|Other|0
4836054|NCT01066793|16670911|P5|Overall Study|Other|0
4836055|NCT01066793|16670912|P4|Overall Study|Other|2
4836056|NCT01066793|16670913|P3|Overall Study|Other|6
4836057|NCT01066793|16670914|P2|Overall Study|Other|5
4836058|NCT01066793|16670915|P1|Overall Study|Other|15
4836059|NCT01066793|16670910|P6|Overall Study|Non-responders|0
4836060|NCT01066793|16670911|P5|Overall Study|Non-responders|0
4836061|NCT01066793|16670912|P4|Overall Study|Non-responders|25
4836062|NCT01066793|16670913|P3|Overall Study|Non-responders|11
4836063|NCT01066793|16670914|P2|Overall Study|Non-responders|5
4836064|NCT01066793|16670915|P1|Overall Study|Non-responders|104
4836065|NCT01066793|16670910|P6|Overall Study|Miscellaneous|0
4836066|NCT01066793|16670911|P5|Overall Study|Miscellaneous|0
4836067|NCT01066793|16670912|P4|Overall Study|Miscellaneous|0
4836068|NCT01066793|16670913|P3|Overall Study|Miscellaneous|6
4836069|NCT01066793|16670914|P2|Overall Study|Miscellaneous|5
4836070|NCT01066793|16670915|P1|Overall Study|Miscellaneous|4
4836071|NCT01066793|16670910|P6|Overall Study|Lab test not done|0
4836072|NCT01066793|16670911|P5|Overall Study|Lab test not done|0
4836073|NCT01066793|16670912|P4|Overall Study|Lab test not done|1
4836074|NCT01066793|16670913|P3|Overall Study|Lab test not done|0
4836075|NCT01066793|16670914|P2|Overall Study|Lab test not done|0
4836076|NCT01066793|16670915|P1|Overall Study|Lab test not done|7
4836077|NCT01066793|16670910|P6|Overall Study|Early Termination|0
4836078|NCT01066793|16670911|P5|Overall Study|Early Termination|0
4836079|NCT01066793|16670912|P4|Overall Study|Early Termination|0
4836080|NCT01066793|16670913|P3|Overall Study|Early Termination|0
4836081|NCT01066793|16670914|P2|Overall Study|Early Termination|0
4836082|NCT01066793|16670915|P1|Overall Study|Early Termination|3
4836083|NCT01066793|16670910|P6|Overall Study|Withdrawal by Subject|0
4836084|NCT01066793|16670911|P5|Overall Study|Withdrawal by Subject|0
4836085|NCT01066793|16670912|P4|Overall Study|Withdrawal by Subject|0
4836086|NCT01066793|16670913|P3|Overall Study|Withdrawal by Subject|1
4836087|NCT01066793|16670914|P2|Overall Study|Withdrawal by Subject|4
4836088|NCT01066793|16670915|P1|Overall Study|Withdrawal by Subject|7
4836089|NCT01066793|16670910|P6|Overall Study|Protocol Violation|0
4836090|NCT01066793|16670911|P5|Overall Study|Protocol Violation|0
4836091|NCT01066793|16670912|P4|Overall Study|Protocol Violation|0
4836092|NCT01066793|16670913|P3|Overall Study|Protocol Violation|2
4836093|NCT01066793|16670914|P2|Overall Study|Protocol Violation|2
4836094|NCT01066793|16670915|P1|Overall Study|Protocol Violation|3
4836095|NCT01066793|16670910|P6|Overall Study|Physician Decision|0
4836096|NCT01066793|16670911|P5|Overall Study|Physician Decision|0
4836097|NCT01066793|16670912|P4|Overall Study|Physician Decision|0
4836098|NCT01066793|16670913|P3|Overall Study|Physician Decision|0
4836099|NCT01066793|16670914|P2|Overall Study|Physician Decision|0
4836100|NCT01066793|16670915|P1|Overall Study|Physician Decision|3
4836101|NCT01066793|16670910|P6|Overall Study|Lost to Follow-up|1
4836102|NCT01066793|16670911|P5|Overall Study|Lost to Follow-up|0
4836103|NCT01066793|16670912|P4|Overall Study|Lost to Follow-up|16
4836104|NCT01066793|16670913|P3|Overall Study|Lost to Follow-up|82
4836105|NCT01066793|16670914|P2|Overall Study|Lost to Follow-up|39
4836106|NCT01066793|16670915|P1|Overall Study|Lost to Follow-up|180
4836107|NCT01066793|16670910|P6|Overall Study|Lack of Efficacy|0
4836108|NCT01066793|16670911|P5|Overall Study|Lack of Efficacy|0
4836109|NCT01066793|16670912|P4|Overall Study|Lack of Efficacy|0
4836110|NCT01066793|16670913|P3|Overall Study|Lack of Efficacy|0
4836111|NCT01066793|16670914|P2|Overall Study|Lack of Efficacy|1
4836112|NCT01066793|16670915|P1|Overall Study|Lack of Efficacy|2
4836113|NCT01066793|16670910|P6|Overall Study|Death|0
4836114|NCT01066793|16670911|P5|Overall Study|Death|0
4836115|NCT01066793|16670912|P4|Overall Study|Death|0
4836116|NCT01066793|16670913|P3|Overall Study|Death|1
4836117|NCT01066793|16670914|P2|Overall Study|Death|1
4836118|NCT01066793|16670915|P1|Overall Study|Death|4
4836119|NCT01066780|16671055|P2|Overall Study|Withdrawn prior to ClearVoice exposure.|1
4836120|NCT01066780|16671056|P1|Overall Study|Withdrawn prior to ClearVoice exposure.|1
4836121|NCT01066585|16671086|P2|Overall Study|Withdrawal by Subject|3
4836122|NCT01066585|16671087|P1|Overall Study|Withdrawal by Subject|0
4836123|NCT01066585|16671086|P2|Overall Study|Protocol Violation|0
4836124|NCT01066585|16671087|P1|Overall Study|Protocol Violation|1
4836125|NCT01066546|16671099|P1|Overall Study|Study terminated by sponsor|5
4836126|NCT01066156|16671144|P1|Overall Study|Withdrawal by Subject|1
4836127|NCT01066156|16671144|P1|Overall Study|Lost to Follow-up|7
4836128|NCT01066156|16671144|P1|Overall Study|ineligible|2
4836129|NCT01066143|16671148|P1|Overall Study|ineligible for the study|8
4836130|NCT01066104|16671154|P2|Overall Study|Protocol Violation|0
4836131|NCT01066104|16671155|P1|Overall Study|Protocol Violation|1
4836132|NCT01066104|16671154|P2|Overall Study|Adverse Event|1
4836133|NCT01066104|16671155|P1|Overall Study|Adverse Event|1
4836134|NCT01066052|16671165|P2|Overall Study|Enrolled But Not Treated|0
4836135|NCT01066052|16671166|P1|Overall Study|Enrolled But Not Treated|3
4836136|NCT01066039|16671177|P1|Overall Study|Drug/Dose Adjustment Required|1
4836137|NCT01066039|16671177|P1|Overall Study|Failure to Control Blood Pressure|1
4836138|NCT01066039|16671177|P1|Overall Study|Volunteer Failed to Make the Next Visit|2
4836139|NCT01066039|16671177|P1|Overall Study|Additional Antihypertensive Required|4
4836140|NCT01066039|16671177|P1|Overall Study|Dropout due to Insulin Administration|1
4836141|NCT01066039|16671177|P1|Overall Study|Investigator's Request|1
4836142|NCT01066039|16671177|P1|Overall Study|Inclusion/Exclusion Criteria Violation|9
4836143|NCT01066039|16671177|P1|Overall Study|Protocol Violation|2
4836144|NCT01066039|16671177|P1|Overall Study|Withdrawal by Subject|17
4836145|NCT01066039|16671177|P1|Overall Study|Adverse Event|6
4836146|NCT01066000|16671202|P1|Overall Study|Adverse Event|1
4836147|NCT01066000|16671202|P1|Overall Study|Withdrawal by Subject|1
4836148|NCT01066000|16671202|P1|Overall Study|Death|3
4836149|NCT01066000|16671202|P1|Overall Study|Protocol Violation|4
4836150|NCT01065844|16671213|P1|Overall Study|Adverse Event|5
4836151|NCT01065818|16671217|P1|Overall Study|Not a candidate for surgery|1
4836152|NCT01065818|16671217|P1|Overall Study|Withdrawal by Subject|1
4836153|NCT01065779|16671221|P1|Overall Study|Inclusion Criteria Violation|7
4836154|NCT01065779|16671221|P1|Overall Study|Failed to Follow-up|10
4836155|NCT01065779|16671221|P1|Overall Study|Not Administered With Study Drug|17
4836156|NCT01065779|16671221|P1|Overall Study|Non-enrollment Period Administration|10
4836157|NCT01065779|16671221|P1|Overall Study|Investigation Before Contract Date|37
4836158|NCT01065779|16671221|P1|Overall Study|Duplicate Investigation|1
4836159|NCT01065766|16671232|P1|Overall Study|Violated dosage/administration|25
4836160|NCT01065766|16671232|P1|Overall Study|Contraindication to administration|6
4836161|NCT01065766|16671232|P1|Overall Study|Assessed before the contracted date|1
4836162|NCT01065597|16671251|P1|Overall Study|Adverse Event|1
4836163|NCT01065454|16671298|P4|Follow up|study ongoing|41
4836164|NCT01065454|16671299|P3|Follow up|study ongoing|15
4836165|NCT01065454|16671300|P2|Follow up|study ongoing|22
4836166|NCT01065454|16671301|P1|Follow up|study ongoing|37
4836167|NCT01065454|16671298|P4|Follow up|Withdrawal by Subject|0
4836168|NCT01065454|16671299|P3|Follow up|Withdrawal by Subject|1
4836169|NCT01065454|16671300|P2|Follow up|Withdrawal by Subject|1
4836170|NCT01065454|16671301|P1|Follow up|Withdrawal by Subject|1
4836171|NCT01065454|16671298|P4|Follow up|Progressive disease|1
4836172|NCT01065454|16671299|P3|Follow up|Progressive disease|0
4836173|NCT01065454|16671300|P2|Follow up|Progressive disease|0
4836174|NCT01065454|16671301|P1|Follow up|Progressive disease|0
4836175|NCT01065454|16671298|P4|Follow up|Lost to Follow-up|1
4836176|NCT01065454|16671299|P3|Follow up|Lost to Follow-up|0
4836177|NCT01065454|16671300|P2|Follow up|Lost to Follow-up|0
4836178|NCT01065454|16671301|P1|Follow up|Lost to Follow-up|0
4836179|NCT01065454|16671298|P4|Follow up|Death|0
4836180|NCT01065454|16671299|P3|Follow up|Death|1
4836181|NCT01065454|16671300|P2|Follow up|Death|1
4836182|NCT01065454|16671301|P1|Follow up|Death|0
4836183|NCT01065454|16671298|P4|Follow up|Adverse Event|1
4836184|NCT01065454|16671299|P3|Follow up|Adverse Event|0
4836185|NCT01065454|16671300|P2|Follow up|Adverse Event|0
4836186|NCT01065454|16671301|P1|Follow up|Adverse Event|1
4836187|NCT01065454|16671298|P4|Treatment|Withdrawal by Subject|3
4836188|NCT01065454|16671299|P3|Treatment|Withdrawal by Subject|2
4836189|NCT01065454|16671300|P2|Treatment|Withdrawal by Subject|1
4836190|NCT01065454|16671301|P1|Treatment|Withdrawal by Subject|3
4836191|NCT01065454|16671298|P4|Treatment|Protocol Violation|0
4836192|NCT01065454|16671299|P3|Treatment|Protocol Violation|1
4836193|NCT01065454|16671300|P2|Treatment|Protocol Violation|0
4836194|NCT01065454|16671301|P1|Treatment|Protocol Violation|1
4836195|NCT01065454|16671298|P4|Treatment|Protocol Decision|2
4836196|NCT01065454|16671299|P3|Treatment|Protocol Decision|3
4836197|NCT01065454|16671300|P2|Treatment|Protocol Decision|0
4836198|NCT01065454|16671301|P1|Treatment|Protocol Decision|0
4836199|NCT01065454|16671298|P4|Treatment|Non-compliance|1
4836200|NCT01065454|16671299|P3|Treatment|Non-compliance|0
4836201|NCT01065454|16671300|P2|Treatment|Non-compliance|0
4836202|NCT01065454|16671301|P1|Treatment|Non-compliance|1
4836203|NCT01065454|16671298|P4|Treatment|Death|0
4836204|NCT01065454|16671299|P3|Treatment|Death|0
4836205|NCT01065454|16671300|P2|Treatment|Death|0
4836206|NCT01065454|16671301|P1|Treatment|Death|1
4836207|NCT01065454|16671298|P4|Treatment|Adverse Event|6
4836208|NCT01065454|16671299|P3|Treatment|Adverse Event|3
4836209|NCT01065454|16671300|P2|Treatment|Adverse Event|4
4836210|NCT01065454|16671301|P1|Treatment|Adverse Event|7
4836211|NCT01065350|16671424|P2|Overall Study|Received incorrect drug allocation|1
4836212|NCT01065350|16671425|P1|Overall Study|Received incorrect drug allocation|0
4836213|NCT01064947|16671486|P1|Overall Study|negative culture|41
4836214|NCT01064856|16671527|P4|Open-label (OL) Period|Other|7
4836215|NCT01064856|16671528|P3|Open-label (OL) Period|Other|7
4836216|NCT01064856|16671529|P2|Open-label (OL) Period|Other|0
4836217|NCT01064856|16671530|P1|Open-label (OL) Period|Other|0
4836218|NCT01064856|16671527|P4|Open-label (OL) Period|Lost to Follow-up|1
4836219|NCT01064856|16671528|P3|Open-label (OL) Period|Lost to Follow-up|2
4836220|NCT01064856|16671529|P2|Open-label (OL) Period|Lost to Follow-up|0
4836221|NCT01064856|16671530|P1|Open-label (OL) Period|Lost to Follow-up|0
4836222|NCT01064856|16671527|P4|Open-label (OL) Period|Consent withdrawn by participant|6
4836223|NCT01064856|16671528|P3|Open-label (OL) Period|Consent withdrawn by participant|5
4836224|NCT01064856|16671529|P2|Open-label (OL) Period|Consent withdrawn by participant|0
4836225|NCT01064856|16671530|P1|Open-label (OL) Period|Consent withdrawn by participant|0
4836226|NCT01064856|16671527|P4|Open-label (OL) Period|Adverse Event|6
4836227|NCT01064856|16671528|P3|Open-label (OL) Period|Adverse Event|12
4836228|NCT01064856|16671529|P2|Open-label (OL) Period|Adverse Event|0
4836229|NCT01064856|16671530|P1|Open-label (OL) Period|Adverse Event|0
4836230|NCT01064856|16671527|P4|Double-blind (DB) Period|Consent withdrawn by participant|0
4836231|NCT01064856|16671528|P3|Double-blind (DB) Period|Consent withdrawn by participant|0
4836232|NCT01064856|16671529|P2|Double-blind (DB) Period|Consent withdrawn by participant|0
4836233|NCT01064856|16671530|P1|Double-blind (DB) Period|Consent withdrawn by participant|1
4836234|NCT01064856|16671527|P4|Double-blind (DB) Period|Adverse Event|0
4836235|NCT01064856|16671528|P3|Double-blind (DB) Period|Adverse Event|0
4836236|NCT01064856|16671529|P2|Double-blind (DB) Period|Adverse Event|0
4836237|NCT01064856|16671530|P1|Double-blind (DB) Period|Adverse Event|1
4836238|NCT01064817|16671574|P2|Study Completion|Withdrawal by Subject|0
4836239|NCT01064817|16671575|P1|Study Completion|Withdrawal by Subject|1
4836240|NCT01064817|16671574|P2|Study Completion|Physician Decision|0
4836241|NCT01064817|16671575|P1|Study Completion|Physician Decision|1
4836242|NCT01064739|16671587|P1|Fixed Sodium Diet + Fava Beans|Adverse Event|1
4836243|NCT01064687|16671658|P4|Overall Study|Treatment Noncompliance|0
4836244|NCT01064687|16671659|P3|Overall Study|Treatment Noncompliance|1
4836245|NCT01064687|16671660|P2|Overall Study|Treatment Noncompliance|1
4836246|NCT01064687|16671661|P1|Overall Study|Treatment Noncompliance|1
4836247|NCT01064687|16671658|P4|Overall Study|Withdrawal by Subject|5
4836248|NCT01064687|16671659|P3|Overall Study|Withdrawal by Subject|12
4836249|NCT01064687|16671660|P2|Overall Study|Withdrawal by Subject|7
4836250|NCT01064687|16671661|P1|Overall Study|Withdrawal by Subject|9
4836251|NCT01064687|16671658|P4|Overall Study|Sponsor Decision|0
4836252|NCT01064687|16671659|P3|Overall Study|Sponsor Decision|3
4836253|NCT01064687|16671660|P2|Overall Study|Sponsor Decision|0
4836254|NCT01064687|16671661|P1|Overall Study|Sponsor Decision|0
4836255|NCT01064687|16671658|P4|Overall Study|Protocol Violation|1
4836256|NCT01064687|16671659|P3|Overall Study|Protocol Violation|0
4836257|NCT01064687|16671660|P2|Overall Study|Protocol Violation|1
4836258|NCT01064687|16671661|P1|Overall Study|Protocol Violation|1
4836259|NCT01064687|16671658|P4|Overall Study|Physician Decision|0
4836260|NCT01064687|16671659|P3|Overall Study|Physician Decision|0
4836261|NCT01064687|16671660|P2|Overall Study|Physician Decision|2
4836262|NCT01064687|16671661|P1|Overall Study|Physician Decision|2
4836263|NCT01064687|16671658|P4|Overall Study|Lost to Follow-up|5
4836264|NCT01064687|16671659|P3|Overall Study|Lost to Follow-up|13
4836265|NCT01064687|16671660|P2|Overall Study|Lost to Follow-up|10
4836266|NCT01064687|16671661|P1|Overall Study|Lost to Follow-up|7
4836267|NCT01064687|16671658|P4|Overall Study|Lack of Efficacy|3
4836268|NCT01064687|16671659|P3|Overall Study|Lack of Efficacy|2
4836269|NCT01064687|16671660|P2|Overall Study|Lack of Efficacy|0
4836270|NCT01064687|16671661|P1|Overall Study|Lack of Efficacy|1
4836271|NCT01064687|16671658|P4|Overall Study|Entry Criteria Not Met|0
4836272|NCT01064687|16671659|P3|Overall Study|Entry Criteria Not Met|0
4836273|NCT01064687|16671660|P2|Overall Study|Entry Criteria Not Met|0
4836274|NCT01064687|16671661|P1|Overall Study|Entry Criteria Not Met|3
4836275|NCT01064687|16671658|P4|Overall Study|Death|0
4836276|NCT01064687|16671659|P3|Overall Study|Death|0
4836277|NCT01064687|16671660|P2|Overall Study|Death|1
4836278|NCT01064687|16671661|P1|Overall Study|Death|1
4836279|NCT01064687|16671658|P4|Overall Study|Adverse Event|3
4836280|NCT01064687|16671659|P3|Overall Study|Adverse Event|10
4836281|NCT01064687|16671660|P2|Overall Study|Adverse Event|4
4836282|NCT01064687|16671661|P1|Overall Study|Adverse Event|9
4836283|NCT01064648|16671841|P4|Phase II|Under Review|0
4836284|NCT01064648|16671842|P3|Phase II|Under Review|2
4836285|NCT01064648|16671843|P2|Phase II|Under Review|0
4836286|NCT01064648|16671844|P1|Phase II|Under Review|0
4836287|NCT01064648|16671841|P4|Phase II|Non-protocol specified|3
4836288|NCT01064648|16671842|P3|Phase II|Non-protocol specified|5
4836289|NCT01064648|16671843|P2|Phase II|Non-protocol specified|0
4836290|NCT01064648|16671844|P1|Phase II|Non-protocol specified|0
4836291|NCT01064648|16671841|P4|Phase II|Progression|27
4836292|NCT01064648|16671842|P3|Phase II|Progression|21
4836293|NCT01064648|16671843|P2|Phase II|Progression|0
4836294|NCT01064648|16671844|P1|Phase II|Progression|0
4836295|NCT01064648|16671841|P4|Phase II|Withdrawal by Subject|5
4836296|NCT01064648|16671842|P3|Phase II|Withdrawal by Subject|2
4836297|NCT01064648|16671843|P2|Phase II|Withdrawal by Subject|0
4836298|NCT01064648|16671844|P1|Phase II|Withdrawal by Subject|0
4836299|NCT01064648|16671841|P4|Phase II|Death|5
4836300|NCT01064648|16671842|P3|Phase II|Death|4
4836301|NCT01064648|16671843|P2|Phase II|Death|0
4836302|NCT01064648|16671844|P1|Phase II|Death|0
4836303|NCT01064648|16671841|P4|Phase II|Adverse Event|8
4836304|NCT01064648|16671842|P3|Phase II|Adverse Event|15
4836305|NCT01064648|16671843|P2|Phase II|Adverse Event|0
4836306|NCT01064648|16671844|P1|Phase II|Adverse Event|0
4836307|NCT01064648|16671841|P4|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
4836308|NCT01064648|16671842|P3|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
4836309|NCT01064648|16671843|P2|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4
4836310|NCT01064648|16671844|P1|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0
4836311|NCT01064648|16671841|P4|Phase I Cohort 2: Dose Level 2|Progression|0
4836312|NCT01064648|16671842|P3|Phase I Cohort 2: Dose Level 2|Progression|0
4836313|NCT01064648|16671843|P2|Phase I Cohort 2: Dose Level 2|Progression|5
4836314|NCT01064648|16671844|P1|Phase I Cohort 2: Dose Level 2|Progression|0
4836315|NCT01064648|16671841|P4|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
4836316|NCT01064648|16671842|P3|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
4836317|NCT01064648|16671843|P2|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1
4836318|NCT01064648|16671844|P1|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0
4836319|NCT01064648|16671841|P4|Phase I Cohort 2: Dose Level 2|Adverse Event|0
4836320|NCT01064648|16671842|P3|Phase I Cohort 2: Dose Level 2|Adverse Event|0
4836321|NCT01064648|16671843|P2|Phase I Cohort 2: Dose Level 2|Adverse Event|3
4836322|NCT01064648|16671844|P1|Phase I Cohort 2: Dose Level 2|Adverse Event|0
4836323|NCT01064648|16671841|P4|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
4836324|NCT01064648|16671842|P3|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
4836325|NCT01064648|16671843|P2|Phase I Cohort1: Dose Level 1|Non-protocol specified|0
4836326|NCT01064648|16671844|P1|Phase I Cohort1: Dose Level 1|Non-protocol specified|2
4836327|NCT01064648|16671841|P4|Phase I Cohort1: Dose Level 1|Progression|0
4836328|NCT01064648|16671842|P3|Phase I Cohort1: Dose Level 1|Progression|0
4836329|NCT01064648|16671843|P2|Phase I Cohort1: Dose Level 1|Progression|0
4836330|NCT01064648|16671844|P1|Phase I Cohort1: Dose Level 1|Progression|5
4836331|NCT01064622|16671870|P2|Randomized Phase II|Protocol Violation|1
4836332|NCT01064622|16671871|P1|Randomized Phase II|Protocol Violation|0
4836333|NCT01064622|16671870|P2|Randomized Phase II|Withdrawal by Subject|2
4836334|NCT01064622|16671871|P1|Randomized Phase II|Withdrawal by Subject|2
4836335|NCT01064531|16671894|P2|Overall Study|Death|1
4836336|NCT01064531|16671895|P1|Overall Study|Death|0
4836337|NCT01064531|16671894|P2|Overall Study|Revision due to dislocation|1
4836338|NCT01064531|16671895|P1|Overall Study|Revision due to dislocation|0
4836339|NCT01064531|16671894|P2|Overall Study|Revision due to femoral stem loosening|0
4836340|NCT01064531|16671895|P1|Overall Study|Revision due to femoral stem loosening|1
4836341|NCT01064531|16671894|P2|Overall Study|Withdrawal by Subject|2
4836342|NCT01064531|16671895|P1|Overall Study|Withdrawal by Subject|2
4836343|NCT01064531|16671894|P2|Overall Study|Physician Decision|1
4836344|NCT01064531|16671895|P1|Overall Study|Physician Decision|0
4836345|NCT01064531|16671894|P2|Overall Study|Lost to Follow-up|2
4836346|NCT01064531|16671895|P1|Overall Study|Lost to Follow-up|0
4836347|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Other|1
4836348|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Other|2
4836349|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Other|5
4836350|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Protocol Violation|1
4836351|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Protocol Violation|1
4836352|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Protocol Violation|1
4836353|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4836354|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0
4836355|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1
4836356|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4836357|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0
4836358|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1
4836359|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Physician Decision|0
4836360|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Physician Decision|0
4836361|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Physician Decision|1
4836362|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4836363|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Lost to Follow-up|0
4836364|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Lost to Follow-up|1
4836365|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Death|0
4836366|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Death|1
4836367|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Death|0
4836368|NCT01064414|16671942|P3|Extension Period: Week 26 to Week 52|Adverse Event|2
4836369|NCT01064414|16671943|P2|Extension Period: Week 26 to Week 52|Adverse Event|1
4836370|NCT01064414|16671944|P1|Extension Period: Week 26 to Week 52|Adverse Event|2
4836371|NCT01064414|16671942|P3|Core Period: Baseline to Week 26|Other|2
4836372|NCT01064414|16671943|P2|Core Period: Baseline to Week 26|Other|7
4836373|NCT01064414|16671944|P1|Core Period: Baseline to Week 26|Other|4
4836374|NCT01064414|16671942|P3|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4836375|NCT01064414|16671943|P2|Core Period: Baseline to Week 26|Noncompliance with study drug|1
4836376|NCT01064414|16671944|P1|Core Period: Baseline to Week 26|Noncompliance with study drug|0
4836377|NCT01064414|16671942|P3|Core Period: Baseline to Week 26|Withdrawal by Subject|2
4836378|NCT01064414|16671943|P2|Core Period: Baseline to Week 26|Withdrawal by Subject|2
4836379|NCT01064414|16671944|P1|Core Period: Baseline to Week 26|Withdrawal by Subject|4
4836380|NCT01064414|16671942|P3|Core Period: Baseline to Week 26|Protocol Violation|1
4836381|NCT01064414|16671943|P2|Core Period: Baseline to Week 26|Protocol Violation|0
4836382|NCT01064414|16671944|P1|Core Period: Baseline to Week 26|Protocol Violation|1
4836383|NCT01064414|16671942|P3|Core Period: Baseline to Week 26|Death|0
4836384|NCT01064414|16671943|P2|Core Period: Baseline to Week 26|Death|1
4836385|NCT01064414|16671944|P1|Core Period: Baseline to Week 26|Death|0
4836386|NCT01064414|16671942|P3|Core Period: Baseline to Week 26|Adverse Event|2
4836387|NCT01064414|16671943|P2|Core Period: Baseline to Week 26|Adverse Event|4
4836388|NCT01064414|16671944|P1|Core Period: Baseline to Week 26|Adverse Event|4
4836389|NCT01064401|16671963|P2|Overall Study|Other|1
4836390|NCT01064401|16671964|P1|Overall Study|Other|2
4836391|NCT01064401|16671963|P2|Overall Study|Site Closure|5
4836392|NCT01064401|16671964|P1|Overall Study|Site Closure|4
4836393|NCT01064401|16671963|P2|Overall Study|Noncompliance|8
4836394|NCT01064401|16671964|P1|Overall Study|Noncompliance|7
4836395|NCT01064401|16671963|P2|Overall Study|Pregnancy|7
4836396|NCT01064401|16671964|P1|Overall Study|Pregnancy|4
4836397|NCT01064401|16671963|P2|Overall Study|Death|0
4836398|NCT01064401|16671964|P1|Overall Study|Death|4
4836399|NCT01064401|16671963|P2|Overall Study|Investigator Decision|6
4836400|NCT01064401|16671964|P1|Overall Study|Investigator Decision|4
4836401|NCT01064401|16671963|P2|Overall Study|Consent Withdrawn|80
4836402|NCT01064401|16671964|P1|Overall Study|Consent Withdrawn|98
4836403|NCT01064401|16671963|P2|Overall Study|Lost to Follow-up|9
4836404|NCT01064401|16671964|P1|Overall Study|Lost to Follow-up|12
4836405|NCT01064401|16671963|P2|Overall Study|Lack of Efficacy|23
4836406|NCT01064401|16671964|P1|Overall Study|Lack of Efficacy|46
4836407|NCT01064401|16671963|P2|Overall Study|Adverse Event|56
4836408|NCT01064401|16671964|P1|Overall Study|Adverse Event|47
4836409|NCT01064310|16672013|P3|Open Label Pazopinib|Physician Decision|20
4836410|NCT01064310|16672014|P2|Open Label Pazopinib|Physician Decision|0
4836411|NCT01064310|16672015|P1|Open Label Pazopinib|Physician Decision|0
4836412|NCT01064310|16672013|P3|Open Label Pazopinib|Lack of Efficacy|51
4836413|NCT01064310|16672014|P2|Open Label Pazopinib|Lack of Efficacy|0
4836414|NCT01064310|16672015|P1|Open Label Pazopinib|Lack of Efficacy|0
4836415|NCT01064310|16672013|P3|Open Label Pazopinib|Adverse Event|12
4836416|NCT01064310|16672014|P2|Open Label Pazopinib|Adverse Event|0
4836417|NCT01064310|16672015|P1|Open Label Pazopinib|Adverse Event|0
4836418|NCT01064310|16672013|P3|Open Label Pazopinib|Withdrawal by Subject|1
4836419|NCT01064310|16672014|P2|Open Label Pazopinib|Withdrawal by Subject|0
4836420|NCT01064310|16672015|P1|Open Label Pazopinib|Withdrawal by Subject|0
4836421|NCT01064310|16672013|P3|Period 2|Lack of Efficacy|0
4836422|NCT01064310|16672014|P2|Period 2|Lack of Efficacy|4
4836423|NCT01064310|16672015|P1|Period 2|Lack of Efficacy|1
4836424|NCT01064310|16672013|P3|Period 2|Entered Open-label Period|0
4836425|NCT01064310|16672014|P2|Period 2|Entered Open-label Period|0
4836426|NCT01064310|16672015|P1|Period 2|Entered Open-label Period|1
4836427|NCT01064310|16672013|P3|Period 2|Physician Decision|0
4836428|NCT01064310|16672014|P2|Period 2|Physician Decision|1
4836429|NCT01064310|16672015|P1|Period 2|Physician Decision|0
4836430|NCT01064310|16672013|P3|Period 2|Adverse Event|0
4836431|NCT01064310|16672014|P2|Period 2|Adverse Event|1
4836432|NCT01064310|16672015|P1|Period 2|Adverse Event|2
4836433|NCT01064310|16672013|P3|Period 1|Entered Open-label Period|0
4836434|NCT01064310|16672014|P2|Period 1|Entered Open-label Period|1
4836435|NCT01064310|16672015|P1|Period 1|Entered Open-label Period|1
4836436|NCT01064310|16672013|P3|Period 1|Lack of Efficacy|0
4836437|NCT01064310|16672014|P2|Period 1|Lack of Efficacy|5
4836438|NCT01064310|16672015|P1|Period 1|Lack of Efficacy|3
4836439|NCT01064310|16672013|P3|Period 1|Withdrawal by Subject|0
4836440|NCT01064310|16672014|P2|Period 1|Withdrawal by Subject|2
4836441|NCT01064310|16672015|P1|Period 1|Withdrawal by Subject|2
4836442|NCT01064310|16672013|P3|Period 1|Physician Decision|0
4836443|NCT01064310|16672014|P2|Period 1|Physician Decision|0
4836444|NCT01064310|16672015|P1|Period 1|Physician Decision|1
4836445|NCT01064310|16672013|P3|Period 1|Adverse Event|0
4836446|NCT01064310|16672014|P2|Period 1|Adverse Event|10
4836447|NCT01064310|16672015|P1|Period 1|Adverse Event|7
4836448|NCT01064297|16672045|P3|Overall Study|Lost to Follow-up|133
4836449|NCT01064297|16672046|P2|Overall Study|Lost to Follow-up|48
4836450|NCT01064297|16672047|P1|Overall Study|Lost to Follow-up|791
4836451|NCT01064167|16672116|P2|Overall Study|Protocol Violation|15
4836452|NCT01064167|16672117|P1|Overall Study|Protocol Violation|14
4836453|NCT01063972|16672132|P2|Overall Study|Incarcerated|1
4836454|NCT01063972|16672133|P1|Overall Study|Incarcerated|2
4836455|NCT01063972|16672132|P2|Overall Study|Death|11
4836456|NCT01063972|16672133|P1|Overall Study|Death|12
4836457|NCT01063881|16672183|P3|Overall Study|Reason for not completed not specified|0
4836458|NCT01063881|16672184|P2|Overall Study|Reason for not completed not specified|1
4836459|NCT01063881|16672185|P1|Overall Study|Reason for not completed not specified|5
4836460|NCT01063881|16672183|P3|Overall Study|Withdrawal by Subject|0
4836461|NCT01063881|16672184|P2|Overall Study|Withdrawal by Subject|1
4836462|NCT01063881|16672185|P1|Overall Study|Withdrawal by Subject|25
4836463|NCT01063881|16672183|P3|Overall Study|Lost to Follow-up|1
4836464|NCT01063881|16672184|P2|Overall Study|Lost to Follow-up|7
4836465|NCT01063881|16672185|P1|Overall Study|Lost to Follow-up|13
4836466|NCT01063881|16672183|P3|Overall Study|Adverse Event|0
4836467|NCT01063881|16672184|P2|Overall Study|Adverse Event|2
4836468|NCT01063881|16672185|P1|Overall Study|Adverse Event|12
4836469|NCT01063868|16672209|P2|Overall Study|Study Terminated By Sponsor|4
4836470|NCT01063868|16672210|P1|Overall Study|Study Terminated By Sponsor|23
4836471|NCT01063868|16672209|P2|Overall Study|Withdrawal by Subject|1
4836472|NCT01063868|16672210|P1|Overall Study|Withdrawal by Subject|3
4836473|NCT01063868|16672209|P2|Overall Study|Adverse Event|7
4836474|NCT01063868|16672210|P1|Overall Study|Adverse Event|9
4836475|NCT01063855|16672218|P2|Overall Study|Reason not specified|11
4836476|NCT01063855|16672219|P1|Overall Study|Reason not specified|13
4836477|NCT01063855|16672218|P2|Overall Study|Withdrawal by Subject|8
4836478|NCT01063855|16672219|P1|Overall Study|Withdrawal by Subject|11
4836479|NCT01063855|16672218|P2|Overall Study|Lack of Efficacy|1
4836480|NCT01063855|16672219|P1|Overall Study|Lack of Efficacy|0
4836481|NCT01063855|16672218|P2|Overall Study|Pregnancy|0
4836482|NCT01063855|16672219|P1|Overall Study|Pregnancy|1
4836483|NCT01063855|16672218|P2|Overall Study|Lost to Follow-up|4
4836484|NCT01063855|16672219|P1|Overall Study|Lost to Follow-up|8
4836485|NCT01063855|16672218|P2|Overall Study|Death|1
4836486|NCT01063855|16672219|P1|Overall Study|Death|0
4836487|NCT01063855|16672218|P2|Overall Study|Adverse Event|4
4836488|NCT01063855|16672219|P1|Overall Study|Adverse Event|4
4836489|NCT01063764|16672266|P1|2nd Period (Week 22 to the End of Study)|Protocol Violation|1
4836490|NCT01063764|16672266|P1|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7
4836491|NCT01063764|16672266|P1|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9
4836492|NCT01063764|16672266|P1|2nd Period (Week 22 to the End of Study)|Adverse Event|3
4836493|NCT01063764|16672266|P1|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1
4836494|NCT01063764|16672266|P1|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6
4836495|NCT01063764|16672266|P1|1st Period (From Week 8 to Week 22)|Adverse Event|4
4836496|NCT01063595|16672285|P2|First Intervention|Reason not Specified|1
4836497|NCT01063595|16672286|P1|First Intervention|Reason not Specified|0
4836498|NCT01063595|16672285|P2|First Intervention|Withdrawal by Subject|0
4836499|NCT01063595|16672286|P1|First Intervention|Withdrawal by Subject|1
4836500|NCT01063595|16672285|P2|First Intervention|Adverse Event|4
4836501|NCT01063595|16672286|P1|First Intervention|Adverse Event|1
4836502|NCT01063595|16672285|P2|Enrolled in Study and Randomized|Withdrawn by the Investigator|1
4836503|NCT01063595|16672286|P1|Enrolled in Study and Randomized|Withdrawn by the Investigator|0
4836504|NCT01063595|16672285|P2|Enrolled in Study and Randomized|Adverse Event|1
4836505|NCT01063595|16672286|P1|Enrolled in Study and Randomized|Adverse Event|0
4836506|NCT01063595|16672285|P2|Enrolled in Study and Randomized|Reason not Specified|0
4836507|NCT01063595|16672286|P1|Enrolled in Study and Randomized|Reason not Specified|1
4836508|NCT01063517|16672298|P2|Overall Study|Death|48
4836509|NCT01063517|16672299|P1|Overall Study|Death|33
4836510|NCT01063517|16672298|P2|Overall Study|Withdrawal by Subject|2
4836511|NCT01063517|16672299|P1|Overall Study|Withdrawal by Subject|1
4836512|NCT01063517|16672298|P2|Overall Study|Lost to Follow-up|3
4836513|NCT01063517|16672299|P1|Overall Study|Lost to Follow-up|4
4836514|NCT01063517|16672298|P2|Overall Study|Study reached data cut-off|7
4836515|NCT01063517|16672299|P1|Overall Study|Study reached data cut-off|19
4836516|NCT01063517|16672298|P2|Overall Study|Consent withdrawal|0
4836517|NCT01063517|16672299|P1|Overall Study|Consent withdrawal|1
4836518|NCT01063348|16672339|P2|Overall Study|Lost to Follow-up|10
4836519|NCT01063348|16672340|P1|Overall Study|Lost to Follow-up|3
4836520|NCT01063283|16672350|P3|Cycle 1|Technical failure in data collection|0
4836521|NCT01063283|16672351|P2|Cycle 1|Technical failure in data collection|0
4836522|NCT01063283|16672352|P1|Cycle 1|Technical failure in data collection|1
4836523|NCT01063283|16672350|P3|Cycle 1|Adverse Event|0
4836524|NCT01063283|16672351|P2|Cycle 1|Adverse Event|0
4836525|NCT01063283|16672352|P1|Cycle 1|Adverse Event|2
4836526|NCT01063153|16672366|P2|Overall Study|Physician Decision|4
4836527|NCT01063153|16672367|P1|Overall Study|Physician Decision|0
4836528|NCT01063153|16672366|P2|Overall Study|Withdrawal by Subject|1
4836529|NCT01063153|16672367|P1|Overall Study|Withdrawal by Subject|0
4836530|NCT01063153|16672366|P2|Overall Study|Lost to Follow-up|7
4836531|NCT01063153|16672367|P1|Overall Study|Lost to Follow-up|0
4836532|NCT01063153|16672366|P2|Overall Study|Found Ineligible During Screening|0
4836533|NCT01063153|16672367|P1|Overall Study|Found Ineligible During Screening|2
4836534|NCT01063062|16672398|P2|Overall Study|Miscellaneous reason|1
4836535|NCT01063062|16672399|P1|Overall Study|Miscellaneous reason|0
4836536|NCT01063062|16672398|P2|Overall Study|Lost to Follow-up|2
4836537|NCT01063062|16672399|P1|Overall Study|Lost to Follow-up|0
4836538|NCT01063062|16672398|P2|Overall Study|Investigator's request|0
4836539|NCT01063062|16672399|P1|Overall Study|Investigator's request|1
4836540|NCT01063062|16672398|P2|Overall Study|Protocol Violation|4
4836541|NCT01063062|16672399|P1|Overall Study|Protocol Violation|5
4836542|NCT01063062|16672398|P2|Overall Study|Adverse Event|4
4836543|NCT01063062|16672399|P1|Overall Study|Adverse Event|2
4836544|NCT01063062|16672398|P2|Overall Study|Patient withdrew consent|1
4836545|NCT01063062|16672399|P1|Overall Study|Patient withdrew consent|0
4836546|NCT01063036|16672453|P1|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32
4836547|NCT01063036|16672453|P1|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6
4836548|NCT01063036|16672453|P1|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1
4836549|NCT01063036|16672453|P1|Participants Treated With Study Drug|Pregnancy|1
4836550|NCT01063036|16672453|P1|Participants Treated With Study Drug|Lost to Follow-up|1
4836551|NCT01063036|16672453|P1|Participants Treated With Study Drug|Withdrawal by Subject|2
4836552|NCT01063036|16672453|P1|Participants Treated With Study Drug|Protocol Violation|1
4836553|NCT01063036|16672453|P1|Participants Treated With Study Drug|Adverse Event|1
4836554|NCT01062971|16672469|P2|Overall Study|Lost to Follow-up|4
4836555|NCT01062971|16672470|P1|Overall Study|Lost to Follow-up|3
4836556|NCT01062971|16672469|P2|Overall Study|Protocol Violation|3
4836557|NCT01062971|16672470|P1|Overall Study|Protocol Violation|1
4836558|NCT01062841|16672509|P2|Overall Study|Withdrawal by Study|0
4836559|NCT01062841|16672510|P1|Overall Study|Withdrawal by Study|3
4836560|NCT01062841|16672509|P2|Overall Study|Withdrawal by Subject|0
4836561|NCT01062841|16672510|P1|Overall Study|Withdrawal by Subject|2
4836562|NCT01062841|16672509|P2|Overall Study|Death|5
4836563|NCT01062841|16672510|P1|Overall Study|Death|3
4836564|NCT01062841|16672509|P2|Overall Study|Indwelling Device Removed|48
4836565|NCT01062841|16672510|P1|Overall Study|Indwelling Device Removed|41
4836566|NCT01062763|16672540|P2|Overall Study|Adverse Event|4
4836567|NCT01062763|16672541|P1|Overall Study|Adverse Event|3
4836568|NCT01062425|16672567|P2|Overall Study|Protocol Violation|6
4836569|NCT01062425|16672568|P1|Overall Study|Protocol Violation|3
4836570|NCT01062399|16672585|P5|Overall Study|Protocol Violation|4
4836571|NCT01062399|16672586|P4|Overall Study|Protocol Violation|6
4836572|NCT01062399|16672587|P3|Overall Study|Protocol Violation|0
4836573|NCT01062399|16672588|P2|Overall Study|Protocol Violation|1
4836574|NCT01062399|16672589|P1|Overall Study|Protocol Violation|0
4836575|NCT01062256|16672633|P3|Overall Study|Administrative|0
4836576|NCT01062256|16672634|P2|Overall Study|Administrative|2
4836577|NCT01062256|16672635|P1|Overall Study|Administrative|0
4836578|NCT01062256|16672633|P3|Overall Study|Ineligible|3
4836579|NCT01062256|16672634|P2|Overall Study|Ineligible|4
4836580|NCT01062256|16672635|P1|Overall Study|Ineligible|1
4836581|NCT01062256|16672633|P3|Overall Study|Withdrawal by Subject|1
4836582|NCT01062256|16672634|P2|Overall Study|Withdrawal by Subject|1
4836583|NCT01062256|16672635|P1|Overall Study|Withdrawal by Subject|1
4836584|NCT01062256|16672633|P3|Overall Study|Adverse Event|0
4836585|NCT01062256|16672634|P2|Overall Study|Adverse Event|0
4836586|NCT01062256|16672635|P1|Overall Study|Adverse Event|1
4836587|NCT01062126|16672666|P1|Overall Study|All Withdrawals|324
4836588|NCT01062126|16672666|P1|Overall Study|Death|209
4836589|NCT01062113|16672673|P3|Overall Study|Withdrawal by Subject|0
4836590|NCT01062113|16672674|P2|Overall Study|Withdrawal by Subject|0
4836591|NCT01062113|16672675|P1|Overall Study|Withdrawal by Subject|1
4836592|NCT01062113|16672673|P3|Overall Study|Lack of Efficacy|31
4836593|NCT01062113|16672674|P2|Overall Study|Lack of Efficacy|22
4836594|NCT01062113|16672675|P1|Overall Study|Lack of Efficacy|38
4836595|NCT01062113|16672673|P3|Overall Study|Adverse Event|0
4836596|NCT01062113|16672674|P2|Overall Study|Adverse Event|0
4836597|NCT01062113|16672675|P1|Overall Study|Adverse Event|1
4836598|NCT01062061|16672693|P1|Overall Study|Failed to meet inclusion criteria|2
4836599|NCT01062061|16672693|P1|Overall Study|Outside chief indications|10
4836600|NCT01062061|16672693|P1|Overall Study|Investigated before study start|13
4836601|NCT01062061|16672693|P1|Overall Study|Enrolled more than once|2
4836602|NCT01061866|16672732|P1|Overall Study|Adverse Event|2
4836603|NCT01061775|16672736|P1|Overall Study|Lost to Follow-up|1
4836604|NCT01061775|16672736|P1|Overall Study|Physician Decision|2
4836605|NCT01061736|16672753|P10|Overall Study|Other than specified above|21
4836606|NCT01061736|16672754|P9|Overall Study|Other than specified above|15
4836607|NCT01061736|16672755|P8|Overall Study|Other than specified above|18
4836608|NCT01061736|16672756|P7|Overall Study|Other than specified above|0
4836609|NCT01061736|16672757|P6|Overall Study|Other than specified above|0
4836610|NCT01061736|16672758|P5|Overall Study|Other than specified above|1
4836611|NCT01061736|16672759|P4|Overall Study|Other than specified above|0
4836612|NCT01061736|16672760|P3|Overall Study|Other than specified above|2
4836613|NCT01061736|16672761|P2|Overall Study|Other than specified above|1
4836614|NCT01061736|16672762|P1|Overall Study|Other than specified above|0
4836615|NCT01061736|16672753|P10|Overall Study|Not treated|0
4836616|NCT01061736|16672754|P9|Overall Study|Not treated|1
4836617|NCT01061736|16672755|P8|Overall Study|Not treated|2
4836618|NCT01061736|16672756|P7|Overall Study|Not treated|0
4836619|NCT01061736|16672757|P6|Overall Study|Not treated|0
4836620|NCT01061736|16672758|P5|Overall Study|Not treated|1
4836621|NCT01061736|16672759|P4|Overall Study|Not treated|0
4836622|NCT01061736|16672760|P3|Overall Study|Not treated|0
4836623|NCT01061736|16672761|P2|Overall Study|Not treated|0
4836624|NCT01061736|16672762|P1|Overall Study|Not treated|0
4836625|NCT01061736|16672753|P10|Overall Study|Poor compliance to protocol|9
4836626|NCT01061736|16672754|P9|Overall Study|Poor compliance to protocol|5
4836627|NCT01061736|16672755|P8|Overall Study|Poor compliance to protocol|2
4836628|NCT01061736|16672756|P7|Overall Study|Poor compliance to protocol|0
4836629|NCT01061736|16672757|P6|Overall Study|Poor compliance to protocol|0
4836630|NCT01061736|16672758|P5|Overall Study|Poor compliance to protocol|0
4836631|NCT01061736|16672759|P4|Overall Study|Poor compliance to protocol|0
4836632|NCT01061736|16672760|P3|Overall Study|Poor compliance to protocol|0
4836633|NCT01061736|16672761|P2|Overall Study|Poor compliance to protocol|0
4836634|NCT01061736|16672762|P1|Overall Study|Poor compliance to protocol|0
4836635|NCT01061736|16672753|P10|Overall Study|Lack of Efficacy|10
4836636|NCT01061736|16672754|P9|Overall Study|Lack of Efficacy|9
4836637|NCT01061736|16672755|P8|Overall Study|Lack of Efficacy|9
4836638|NCT01061736|16672756|P7|Overall Study|Lack of Efficacy|1
4836639|NCT01061736|16672757|P6|Overall Study|Lack of Efficacy|2
4836640|NCT01061736|16672758|P5|Overall Study|Lack of Efficacy|1
4836641|NCT01061736|16672759|P4|Overall Study|Lack of Efficacy|1
4836642|NCT01061736|16672760|P3|Overall Study|Lack of Efficacy|1
4836643|NCT01061736|16672761|P2|Overall Study|Lack of Efficacy|2
4836644|NCT01061736|16672762|P1|Overall Study|Lack of Efficacy|0
4836645|NCT01061736|16672753|P10|Overall Study|Adverse Event|34
4836646|NCT01061736|16672754|P9|Overall Study|Adverse Event|67
4836647|NCT01061736|16672755|P8|Overall Study|Adverse Event|63
4836648|NCT01061736|16672756|P7|Overall Study|Adverse Event|4
4836649|NCT01061736|16672757|P6|Overall Study|Adverse Event|1
4836650|NCT01061736|16672758|P5|Overall Study|Adverse Event|4
4836651|NCT01061736|16672759|P4|Overall Study|Adverse Event|2
4836652|NCT01061736|16672760|P3|Overall Study|Adverse Event|3
4836653|NCT01061736|16672761|P2|Overall Study|Adverse Event|1
4836654|NCT01061736|16672762|P1|Overall Study|Adverse Event|13
4836655|NCT01061736|16672753|P10|Overall Study|Dose regimen not selected|0
4836656|NCT01061736|16672754|P9|Overall Study|Dose regimen not selected|0
4836657|NCT01061736|16672755|P8|Overall Study|Dose regimen not selected|0
4836658|NCT01061736|16672756|P7|Overall Study|Dose regimen not selected|79
4836659|NCT01061736|16672757|P6|Overall Study|Dose regimen not selected|0
4836660|NCT01061736|16672758|P5|Overall Study|Dose regimen not selected|0
4836661|NCT01061736|16672759|P4|Overall Study|Dose regimen not selected|0
4836662|NCT01061736|16672760|P3|Overall Study|Dose regimen not selected|0
4836663|NCT01061736|16672761|P2|Overall Study|Dose regimen not selected|0
4836664|NCT01061736|16672762|P1|Overall Study|Dose regimen not selected|0
4836665|NCT01061723|16672801|P6|Overall Study|Other than specified above|1
4836666|NCT01061723|16672802|P5|Overall Study|Other than specified above|0
4836667|NCT01061723|16672803|P4|Overall Study|Other than specified above|1
4836668|NCT01061723|16672804|P3|Overall Study|Other than specified above|1
4836669|NCT01061723|16672805|P2|Overall Study|Other than specified above|1
4836670|NCT01061723|16672806|P1|Overall Study|Other than specified above|2
4836671|NCT01061723|16672801|P6|Overall Study|Randomized but not treated|1
4836672|NCT01061723|16672802|P5|Overall Study|Randomized but not treated|0
4836673|NCT01061723|16672803|P4|Overall Study|Randomized but not treated|0
4836674|NCT01061723|16672804|P3|Overall Study|Randomized but not treated|0
4836675|NCT01061723|16672805|P2|Overall Study|Randomized but not treated|0
4836676|NCT01061723|16672806|P1|Overall Study|Randomized but not treated|0
4836677|NCT01061723|16672801|P6|Overall Study|Lack of Efficacy|1
4836678|NCT01061723|16672802|P5|Overall Study|Lack of Efficacy|1
4836679|NCT01061723|16672803|P4|Overall Study|Lack of Efficacy|2
4836680|NCT01061723|16672804|P3|Overall Study|Lack of Efficacy|4
4836681|NCT01061723|16672805|P2|Overall Study|Lack of Efficacy|3
4836682|NCT01061723|16672806|P1|Overall Study|Lack of Efficacy|2
4836683|NCT01061723|16672801|P6|Overall Study|Adverse Event|6
4836684|NCT01061723|16672802|P5|Overall Study|Adverse Event|2
4836685|NCT01061723|16672803|P4|Overall Study|Adverse Event|5
4836686|NCT01061723|16672804|P3|Overall Study|Adverse Event|5
4836687|NCT01061723|16672805|P2|Overall Study|Adverse Event|2
4836688|NCT01061723|16672806|P1|Overall Study|Adverse Event|0
4836689|NCT01061710|16672886|P1|Overall Study|Protocol Violation|14
4836690|NCT01061671|16672896|P2|Overall Study|Death|30
4836691|NCT01061671|16672897|P1|Overall Study|Death|28
4836692|NCT01061671|16672896|P2|Overall Study|Lost to Follow-up|5
4836693|NCT01061671|16672897|P1|Overall Study|Lost to Follow-up|3
4836694|NCT01061671|16672896|P2|Overall Study|Withdrawal by Subject|20
4836695|NCT01061671|16672897|P1|Overall Study|Withdrawal by Subject|16
4836696|NCT01061606|16672909|P1|Overall Study|alternative therapy|2
4836697|NCT01061606|16672909|P1|Overall Study|Disease Progression|4
4836698|NCT01061606|16672909|P1|Overall Study|Death|1
4836699|NCT01061606|16672909|P1|Overall Study|Adverse Event|1
4836700|NCT01061567|16672918|P1|Overall Study|Other reason than stated above|3
4836701|NCT01061567|16672918|P1|Overall Study|Withdrawal by Subject|11
4836702|NCT01061567|16672918|P1|Overall Study|Protocol Violation|1
4836703|NCT01061567|16672918|P1|Overall Study|Lost to Follow-up|24
4836704|NCT01061567|16672918|P1|Overall Study|Lack of Efficacy|3
4836705|NCT01061567|16672918|P1|Overall Study|Death|2
4836706|NCT01061567|16672918|P1|Overall Study|Adverse Event|32
4836707|NCT01061385|16672942|P2|Overall Study|subject decision not related to AE|1
4836708|NCT01061385|16672943|P1|Overall Study|subject decision not related to AE|0
4836709|NCT01061385|16672942|P2|Overall Study|Lost to Follow-up|0
4836710|NCT01061385|16672943|P1|Overall Study|Lost to Follow-up|1
4836711|NCT01061359|16672951|P1|Overall Study|Secondary neoplasm|11
4836712|NCT01061359|16672951|P1|Overall Study|Relapse|187
4836713|NCT01061359|16672951|P1|Overall Study|Lost to Follow-up|1072
4836714|NCT01061359|16672951|P1|Overall Study|Death|32
4836715|NCT01061333|16672957|P2|Period 4: 20-day Washout|Discontinued by Study Team|1
4836716|NCT01061333|16672958|P1|Period 4: 20-day Washout|Discontinued by Study Team|0
4836717|NCT01061177|16672996|P1|Overall Study|Death|4
4836718|NCT01061177|16672996|P1|Overall Study|Administratie problems|4
4836719|NCT01061177|16672996|P1|Overall Study|Abnormal test procedure results|4
4836720|NCT01061177|16672996|P1|Overall Study|Abnormal laboratory values|6
4836721|NCT01061177|16672996|P1|Overall Study|New cancer therapy|9
4836722|NCT01061177|16672996|P1|Overall Study|Lost to Follow-up|9
4836723|NCT01061177|16672996|P1|Overall Study|Protocol Violation|11
4836724|NCT01061177|16672996|P1|Overall Study|Disease progression|17
4836725|NCT01061177|16672996|P1|Overall Study|Withdrawal by Subject|27
4836726|NCT01061177|16672996|P1|Overall Study|Adverse Event|117
4836727|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3
4836728|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1
4836729|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8
4836730|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5
4836731|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5
4836732|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15
4836733|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26
4836734|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28
4836735|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0
4836736|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2
4836737|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11
4836738|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12
4836739|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4
4836740|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25
4836741|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36
4836742|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49
4836743|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3
4836744|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31
4836745|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52
4836746|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54
4836747|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Death|1
4836748|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Death|1
4836749|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Death|5
4836750|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Death|3
4836751|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
4836752|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
4836753|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0
4836754|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1
4836755|NCT01061151|16673019|P4|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4
4836756|NCT01061151|16673020|P3|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2
4836757|NCT01061151|16673021|P2|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
4836758|NCT01061151|16673022|P1|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0
4836759|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0
4836760|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1
4836761|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5
4836762|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3
4836763|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5
4836764|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2
4836765|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61
4836766|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44
4836767|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0
4836768|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1
4836769|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19
4836770|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15
4836771|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10
4836772|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2
4836773|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65
4836774|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73
4836775|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10
4836776|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2
4836777|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82
4836778|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89
4836779|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Death|2
4836780|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Death|1
4836781|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Death|9
4836782|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Death|6
4836783|NCT01061151|16673019|P4|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1
4836784|NCT01061151|16673020|P3|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
4836785|NCT01061151|16673021|P2|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0
4836786|NCT01061151|16673022|P1|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2
4836787|NCT01061008|16673081|P2|Overall Study|Adverse Event|1
4836788|NCT01061008|16673082|P1|Overall Study|Adverse Event|0
4836789|NCT01061008|16673081|P2|Overall Study|Unable to exercise following surgery|0
4836790|NCT01061008|16673082|P1|Overall Study|Unable to exercise following surgery|1
4836791|NCT01061008|16673081|P2|Overall Study|Withdrawal by Subject|3
4836792|NCT01061008|16673082|P1|Overall Study|Withdrawal by Subject|1
4836793|NCT01061008|16673081|P2|Overall Study|Death|0
4836794|NCT01061008|16673082|P1|Overall Study|Death|1
4836795|NCT01061008|16673081|P2|Overall Study|Badiocephalic fistula failed|2
4836796|NCT01061008|16673082|P1|Overall Study|Badiocephalic fistula failed|3
4836797|NCT01060670|16673090|P2|Run In|screen failure|238
4836798|NCT01060670|16673091|P1|Run In|screen failure|0
4836799|NCT01060553|16673126|P2|Overall Study|Lack of Efficacy|0
4836800|NCT01060553|16673127|P1|Overall Study|Lack of Efficacy|1
4836801|NCT01060553|16673126|P2|Overall Study|Withdrawal by Subject|5
4836802|NCT01060553|16673127|P1|Overall Study|Withdrawal by Subject|5
4836803|NCT01060553|16673126|P2|Overall Study|Lost to Follow-up|5
4836804|NCT01060553|16673127|P1|Overall Study|Lost to Follow-up|3
4836805|NCT01060540|16673134|P2|Overall Study|Physician Decision|1
4836806|NCT01060540|16673135|P1|Overall Study|Physician Decision|0
4836807|NCT01060540|16673134|P2|Overall Study|Death|1
4836808|NCT01060540|16673135|P1|Overall Study|Death|2
4836809|NCT01060540|16673134|P2|Overall Study|Lost to Follow-up|43
4836810|NCT01060540|16673135|P1|Overall Study|Lost to Follow-up|52
4836811|NCT01060540|16673134|P2|Overall Study|Withdrawal by Subject|20
4836812|NCT01060540|16673135|P1|Overall Study|Withdrawal by Subject|10
4836813|NCT01060384|16673149|P5|Overall Study|Intercurrent illness|1
4836814|NCT01060384|16673150|P4|Overall Study|Intercurrent illness|0
4836815|NCT01060384|16673151|P3|Overall Study|Intercurrent illness|0
4836816|NCT01060384|16673152|P2|Overall Study|Intercurrent illness|0
4836817|NCT01060384|16673153|P1|Overall Study|Intercurrent illness|0
4836818|NCT01060384|16673149|P5|Overall Study|Death|1
4836819|NCT01060384|16673150|P4|Overall Study|Death|0
4836820|NCT01060384|16673151|P3|Overall Study|Death|0
4836821|NCT01060384|16673152|P2|Overall Study|Death|0
4836822|NCT01060384|16673153|P1|Overall Study|Death|0
4836823|NCT01060384|16673149|P5|Overall Study|Withdrawal by Subject|0
4836824|NCT01060384|16673150|P4|Overall Study|Withdrawal by Subject|0
4836825|NCT01060384|16673151|P3|Overall Study|Withdrawal by Subject|0
4836826|NCT01060384|16673152|P2|Overall Study|Withdrawal by Subject|1
4836827|NCT01060384|16673153|P1|Overall Study|Withdrawal by Subject|0
4836828|NCT01060150|16673172|P1|Overall Study|Enrolled, but not treated|2
4836829|NCT01060150|16673172|P1|Overall Study|Withdrawal by Subject|8
4836830|NCT01060150|16673172|P1|Overall Study|Protocol Violation|6
4836831|NCT01060150|16673172|P1|Overall Study|Lost to Follow-up|1
4836832|NCT01060150|16673172|P1|Overall Study|Adverse Event|6
4836833|NCT01060124|16673187|P1|Overall Study|Withdrawal by Subject|7
4836834|NCT01060124|16673187|P1|Overall Study|Adverse Event|14
4836835|NCT01060124|16673187|P1|Overall Study|Other|16
4836836|NCT01060111|16673198|P3|Overall Study|Other|4
4836837|NCT01060111|16673199|P2|Overall Study|Other|3
4836838|NCT01060111|16673200|P1|Overall Study|Other|2
4836839|NCT01060111|16673198|P3|Overall Study|Participants' non-cooperation|0
4836840|NCT01060111|16673199|P2|Overall Study|Participants' non-cooperation|0
4836841|NCT01060111|16673200|P1|Overall Study|Participants' non-cooperation|1
4836842|NCT01060111|16673198|P3|Overall Study|Adverse event and insufficient effect|0
4836843|NCT01060111|16673199|P2|Overall Study|Adverse event and insufficient effect|1
4836844|NCT01060111|16673200|P1|Overall Study|Adverse event and insufficient effect|0
4836845|NCT01060111|16673198|P3|Overall Study|Participants' non-cooperation|6
4836846|NCT01060111|16673199|P2|Overall Study|Participants' non-cooperation|6
4836847|NCT01060111|16673200|P1|Overall Study|Participants' non-cooperation|8
4836848|NCT01060111|16673198|P3|Overall Study|Participants' evasion for hospital visit|2
4836849|NCT01060111|16673199|P2|Overall Study|Participants' evasion for hospital visit|3
4836850|NCT01060111|16673200|P1|Overall Study|Participants' evasion for hospital visit|0
4836851|NCT01060111|16673198|P3|Overall Study|Inappropriate participant|5
4836852|NCT01060111|16673199|P2|Overall Study|Inappropriate participant|4
4836853|NCT01060111|16673200|P1|Overall Study|Inappropriate participant|5
4836854|NCT01060111|16673198|P3|Overall Study|Lack of Efficacy|0
4836855|NCT01060111|16673199|P2|Overall Study|Lack of Efficacy|1
4836856|NCT01060111|16673200|P1|Overall Study|Lack of Efficacy|2
4836857|NCT01060111|16673198|P3|Overall Study|Adverse Event|18
4836858|NCT01060111|16673199|P2|Overall Study|Adverse Event|5
4836859|NCT01060111|16673200|P1|Overall Study|Adverse Event|9
4836860|NCT01060072|16673232|P2|Overall Study|Excluded Medications|1
4836861|NCT01060072|16673233|P1|Overall Study|Excluded Medications|0
4836862|NCT01060072|16673232|P2|Overall Study|Acute cholecystitis|0
4836863|NCT01060072|16673233|P1|Overall Study|Acute cholecystitis|1
4836864|NCT01060072|16673232|P2|Overall Study|Protocol Violation|1
4836865|NCT01060072|16673233|P1|Overall Study|Protocol Violation|0
4836866|NCT01060072|16673232|P2|Overall Study|Physician Decision|2
4836867|NCT01060072|16673233|P1|Overall Study|Physician Decision|0
4836868|NCT01060072|16673232|P2|Overall Study|Adverse Event|1
4836869|NCT01060072|16673233|P1|Overall Study|Adverse Event|1
4836870|NCT01060059|16673249|P2|Overall Study|lack of compliance|2
4836871|NCT01060059|16673250|P1|Overall Study|lack of compliance|5
4836872|NCT01060059|16673249|P2|Overall Study|lack of glycemic control|1
4836873|NCT01060059|16673250|P1|Overall Study|lack of glycemic control|2
4836874|NCT01060059|16673249|P2|Overall Study|Withdrawal by Subject|23
4836875|NCT01060059|16673250|P1|Overall Study|Withdrawal by Subject|35
4836876|NCT01060059|16673249|P2|Overall Study|entry criteria not met|3
4836877|NCT01060059|16673250|P1|Overall Study|entry criteria not met|4
4836878|NCT01060059|16673249|P2|Overall Study|Lost to Follow-up|34
4836879|NCT01060059|16673250|P1|Overall Study|Lost to Follow-up|18
4836880|NCT01060059|16673249|P2|Overall Study|Death|3
4836881|NCT01060059|16673250|P1|Overall Study|Death|2
4836882|NCT01060059|16673249|P2|Overall Study|Adverse Event|1
4836883|NCT01060059|16673250|P1|Overall Study|Adverse Event|1
4836884|NCT01060007|16673308|P1|Overall Study|Inevaluable for response at surgery|3
4836885|NCT01060007|16673308|P1|Overall Study|Withdrawal by Subject|1
4836886|NCT01059903|16673376|P2|Period 1: First Intervention- 24 Hours|Adverse Event|1
4836887|NCT01059903|16673377|P1|Period 1: First Intervention- 24 Hours|Adverse Event|1
4836888|NCT01059864|16673420|P3|Double-Blind Treatment Phase|Adverse Event|3
4836889|NCT01059864|16673421|P2|Double-Blind Treatment Phase|Adverse Event|3
4836890|NCT01059864|16673422|P1|Double-Blind Treatment Phase|Adverse Event|0
4836891|NCT01059864|16673420|P3|Open-Label Run-In Phase|Protocol Violation|0
4836892|NCT01059864|16673421|P2|Open-Label Run-In Phase|Protocol Violation|0
4836893|NCT01059864|16673422|P1|Open-Label Run-In Phase|Protocol Violation|2
4836894|NCT01059864|16673420|P3|Open-Label Run-In Phase|Withdrawal by Subject|0
4836895|NCT01059864|16673421|P2|Open-Label Run-In Phase|Withdrawal by Subject|0
4836896|NCT01059864|16673422|P1|Open-Label Run-In Phase|Withdrawal by Subject|1
4836897|NCT01059864|16673420|P3|Open-Label Run-In Phase|Lost to Follow-up|0
4836898|NCT01059864|16673421|P2|Open-Label Run-In Phase|Lost to Follow-up|0
4836899|NCT01059864|16673422|P1|Open-Label Run-In Phase|Lost to Follow-up|2
4836900|NCT01059864|16673420|P3|Open-Label Run-In Phase|Lack of Efficacy|0
4836901|NCT01059864|16673421|P2|Open-Label Run-In Phase|Lack of Efficacy|0
4836902|NCT01059864|16673422|P1|Open-Label Run-In Phase|Lack of Efficacy|1
4836903|NCT01059864|16673420|P3|Open-Label Run-In Phase|Adverse Event|0
4836904|NCT01059864|16673421|P2|Open-Label Run-In Phase|Adverse Event|0
4836905|NCT01059864|16673422|P1|Open-Label Run-In Phase|Adverse Event|7
4836906|NCT01059825|16673496|P7|Treatment Period|Adverse event not related to study drug|0
4836907|NCT01059825|16673497|P6|Treatment Period|Adverse event not related to study drug|1
4836908|NCT01059825|16673498|P5|Treatment Period|Adverse event not related to study drug|1
4836909|NCT01059825|16673499|P4|Treatment Period|Adverse event not related to study drug|1
4836910|NCT01059825|16673500|P3|Treatment Period|Adverse event not related to study drug|2
4836911|NCT01059825|16673501|P2|Treatment Period|Adverse event not related to study drug|1
4836912|NCT01059825|16673502|P1|Treatment Period|Adverse event not related to study drug|0
4836913|NCT01059825|16673496|P7|Treatment Period|Insufficient clinical response|0
4836914|NCT01059825|16673497|P6|Treatment Period|Insufficient clinical response|0
4836915|NCT01059825|16673498|P5|Treatment Period|Insufficient clinical response|0
4836916|NCT01059825|16673499|P4|Treatment Period|Insufficient clinical response|0
4836917|NCT01059825|16673500|P3|Treatment Period|Insufficient clinical response|0
4836918|NCT01059825|16673501|P2|Treatment Period|Insufficient clinical response|0
4836919|NCT01059825|16673502|P1|Treatment Period|Insufficient clinical response|3
4836920|NCT01059825|16673496|P7|Treatment Period|Adverse event related to study drug|0
4836921|NCT01059825|16673497|P6|Treatment Period|Adverse event related to study drug|0
4836922|NCT01059825|16673498|P5|Treatment Period|Adverse event related to study drug|0
4836923|NCT01059825|16673499|P4|Treatment Period|Adverse event related to study drug|1
4836924|NCT01059825|16673500|P3|Treatment Period|Adverse event related to study drug|1
4836925|NCT01059825|16673501|P2|Treatment Period|Adverse event related to study drug|0
4836926|NCT01059825|16673502|P1|Treatment Period|Adverse event related to study drug|1
4836927|NCT01059825|16673496|P7|Treatment Period|Protocol Violation|0
4836928|NCT01059825|16673497|P6|Treatment Period|Protocol Violation|1
4836929|NCT01059825|16673498|P5|Treatment Period|Protocol Violation|1
4836930|NCT01059825|16673499|P4|Treatment Period|Protocol Violation|1
4836931|NCT01059825|16673500|P3|Treatment Period|Protocol Violation|1
4836932|NCT01059825|16673501|P2|Treatment Period|Protocol Violation|0
4836933|NCT01059825|16673502|P1|Treatment Period|Protocol Violation|0
4836934|NCT01059825|16673496|P7|Treatment Period|Other reason not specified|0
4836935|NCT01059825|16673497|P6|Treatment Period|Other reason not specified|0
4836936|NCT01059825|16673498|P5|Treatment Period|Other reason not specified|0
4836937|NCT01059825|16673499|P4|Treatment Period|Other reason not specified|2
4836938|NCT01059825|16673500|P3|Treatment Period|Other reason not specified|1
4836939|NCT01059825|16673501|P2|Treatment Period|Other reason not specified|2
4836940|NCT01059825|16673502|P1|Treatment Period|Other reason not specified|1
4836941|NCT01059825|16673496|P7|Treatment Period|Withdrawal by Subject|0
4836942|NCT01059825|16673497|P6|Treatment Period|Withdrawal by Subject|1
4836943|NCT01059825|16673498|P5|Treatment Period|Withdrawal by Subject|4
4836944|NCT01059825|16673499|P4|Treatment Period|Withdrawal by Subject|5
4836945|NCT01059825|16673500|P3|Treatment Period|Withdrawal by Subject|1
4836946|NCT01059825|16673501|P2|Treatment Period|Withdrawal by Subject|0
4836947|NCT01059825|16673502|P1|Treatment Period|Withdrawal by Subject|3
4836948|NCT01059825|16673496|P7|Treatment Period|Lost to Follow-up|0
4836949|NCT01059825|16673497|P6|Treatment Period|Lost to Follow-up|0
4836950|NCT01059825|16673498|P5|Treatment Period|Lost to Follow-up|2
4836951|NCT01059825|16673499|P4|Treatment Period|Lost to Follow-up|1
4836952|NCT01059825|16673500|P3|Treatment Period|Lost to Follow-up|0
4836953|NCT01059825|16673501|P2|Treatment Period|Lost to Follow-up|1
4836954|NCT01059825|16673502|P1|Treatment Period|Lost to Follow-up|2
4836955|NCT01059825|16673496|P7|Enrolled, Run-in Period|Protocol Violation|5
4836956|NCT01059825|16673497|P6|Enrolled, Run-in Period|Protocol Violation|0
4836957|NCT01059825|16673498|P5|Enrolled, Run-in Period|Protocol Violation|0
4836958|NCT01059825|16673499|P4|Enrolled, Run-in Period|Protocol Violation|0
4836959|NCT01059825|16673500|P3|Enrolled, Run-in Period|Protocol Violation|0
4836960|NCT01059825|16673501|P2|Enrolled, Run-in Period|Protocol Violation|0
4836961|NCT01059825|16673502|P1|Enrolled, Run-in Period|Protocol Violation|0
4836962|NCT01059825|16673496|P7|Enrolled, Run-in Period|Other reason not specified|7
4836963|NCT01059825|16673497|P6|Enrolled, Run-in Period|Other reason not specified|0
4836964|NCT01059825|16673498|P5|Enrolled, Run-in Period|Other reason not specified|0
4836965|NCT01059825|16673499|P4|Enrolled, Run-in Period|Other reason not specified|0
4836966|NCT01059825|16673500|P3|Enrolled, Run-in Period|Other reason not specified|0
4836967|NCT01059825|16673501|P2|Enrolled, Run-in Period|Other reason not specified|0
4836968|NCT01059825|16673502|P1|Enrolled, Run-in Period|Other reason not specified|0
4836969|NCT01059825|16673496|P7|Enrolled, Run-in Period|Withdrawal by Subject|13
4836970|NCT01059825|16673497|P6|Enrolled, Run-in Period|Withdrawal by Subject|0
4836971|NCT01059825|16673498|P5|Enrolled, Run-in Period|Withdrawal by Subject|0
4836972|NCT01059825|16673499|P4|Enrolled, Run-in Period|Withdrawal by Subject|0
4836973|NCT01059825|16673500|P3|Enrolled, Run-in Period|Withdrawal by Subject|0
4836974|NCT01059825|16673501|P2|Enrolled, Run-in Period|Withdrawal by Subject|0
4836975|NCT01059825|16673502|P1|Enrolled, Run-in Period|Withdrawal by Subject|0
4836976|NCT01059825|16673496|P7|Enrolled, Run-in Period|Lost to Follow-up|5
4836977|NCT01059825|16673497|P6|Enrolled, Run-in Period|Lost to Follow-up|0
4836978|NCT01059825|16673498|P5|Enrolled, Run-in Period|Lost to Follow-up|0
4836979|NCT01059825|16673499|P4|Enrolled, Run-in Period|Lost to Follow-up|0
4836980|NCT01059825|16673500|P3|Enrolled, Run-in Period|Lost to Follow-up|0
4836981|NCT01059825|16673501|P2|Enrolled, Run-in Period|Lost to Follow-up|0
4836982|NCT01059825|16673502|P1|Enrolled, Run-in Period|Lost to Follow-up|0
4836983|NCT01059825|16673496|P7|Enrolled, Run-in Period|Did not meet entrance criteria|14
4836984|NCT01059825|16673497|P6|Enrolled, Run-in Period|Did not meet entrance criteria|0
4836985|NCT01059825|16673498|P5|Enrolled, Run-in Period|Did not meet entrance criteria|0
4836986|NCT01059825|16673499|P4|Enrolled, Run-in Period|Did not meet entrance criteria|0
4836987|NCT01059825|16673500|P3|Enrolled, Run-in Period|Did not meet entrance criteria|0
4836988|NCT01059825|16673501|P2|Enrolled, Run-in Period|Did not meet entrance criteria|0
4836989|NCT01059825|16673502|P1|Enrolled, Run-in Period|Did not meet entrance criteria|0
4836990|NCT01059825|16673496|P7|Enrolled, Run-in Period|Adverse event not related to study drug|3
4836991|NCT01059825|16673497|P6|Enrolled, Run-in Period|Adverse event not related to study drug|0
4836992|NCT01059825|16673498|P5|Enrolled, Run-in Period|Adverse event not related to study drug|0
4836993|NCT01059825|16673499|P4|Enrolled, Run-in Period|Adverse event not related to study drug|0
4836994|NCT01059825|16673500|P3|Enrolled, Run-in Period|Adverse event not related to study drug|0
4836995|NCT01059825|16673501|P2|Enrolled, Run-in Period|Adverse event not related to study drug|0
4836996|NCT01059825|16673502|P1|Enrolled, Run-in Period|Adverse event not related to study drug|0
4836997|NCT01059812|16673689|P2|Overall Study|Unclassified|4
4836998|NCT01059812|16673690|P1|Overall Study|Unclassified|14
4836999|NCT01059812|16673689|P2|Overall Study|Withdrawal Criteria|4
4837000|NCT01059812|16673690|P1|Overall Study|Withdrawal Criteria|9
4837001|NCT01059812|16673689|P2|Overall Study|Protocol Violation|1
4837002|NCT01059812|16673690|P1|Overall Study|Protocol Violation|3
4837003|NCT01059812|16673689|P2|Overall Study|Lack of Efficacy|2
4837004|NCT01059812|16673690|P1|Overall Study|Lack of Efficacy|2
4837005|NCT01059812|16673689|P2|Overall Study|Adverse Event|5
4837006|NCT01059812|16673690|P1|Overall Study|Adverse Event|9
4837007|NCT01059799|16673706|P2|Overall Study|Other|3
4837008|NCT01059799|16673707|P1|Overall Study|Other|12
4837009|NCT01059799|16673706|P2|Overall Study|Withdrawal criteria|2
4837010|NCT01059799|16673707|P1|Overall Study|Withdrawal criteria|13
4837011|NCT01059799|16673706|P2|Overall Study|Protocol Violation|2
4837012|NCT01059799|16673707|P1|Overall Study|Protocol Violation|3
4837013|NCT01059799|16673706|P2|Overall Study|Lack of Efficacy|0
4837014|NCT01059799|16673707|P1|Overall Study|Lack of Efficacy|1
4837015|NCT01059799|16673706|P2|Overall Study|Adverse Event|3
4837016|NCT01059799|16673707|P1|Overall Study|Adverse Event|2
4837017|NCT01059773|16673721|P2|Overall Study|Other|3
4837018|NCT01059773|16673722|P1|Overall Study|Other|1
4837019|NCT01059773|16673721|P2|Overall Study|Ineligible follow TB screening criteria|1
4837020|NCT01059773|16673722|P1|Overall Study|Ineligible follow TB screening criteria|0
4837021|NCT01059773|16673721|P2|Overall Study|Malignancy including squamous cell skin|1
4837022|NCT01059773|16673722|P1|Overall Study|Malignancy including squamous cell skin|0
4837023|NCT01059773|16673721|P2|Overall Study|Death|1
4837024|NCT01059773|16673722|P1|Overall Study|Death|0
4837025|NCT01059773|16673721|P2|Overall Study|Lack of Efficacy|3
4837026|NCT01059773|16673722|P1|Overall Study|Lack of Efficacy|3
4837027|NCT01059773|16673721|P2|Overall Study|Physician Decision|4
4837028|NCT01059773|16673722|P1|Overall Study|Physician Decision|5
4837029|NCT01059773|16673721|P2|Overall Study|Protocol Violation|2
4837030|NCT01059773|16673722|P1|Overall Study|Protocol Violation|6
4837031|NCT01059773|16673721|P2|Overall Study|Pregnancy|1
4837032|NCT01059773|16673722|P1|Overall Study|Pregnancy|1
4837033|NCT01059773|16673721|P2|Overall Study|Lost to Follow-up|1
4837034|NCT01059773|16673722|P1|Overall Study|Lost to Follow-up|1
4837035|NCT01059773|16673721|P2|Overall Study|Withdrawal by Subject|5
4837036|NCT01059773|16673722|P1|Overall Study|Withdrawal by Subject|1
4837037|NCT01059773|16673721|P2|Overall Study|Adverse Event|2
4837038|NCT01059773|16673722|P1|Overall Study|Adverse Event|2
4837039|NCT01059643|16673878|P1|Overall Study|Physician Decision|1
4837040|NCT01059643|16673878|P1|Overall Study|Withdrawal by Subject|2
4837041|NCT01059643|16673878|P1|Overall Study|Adverse Event|3
4837042|NCT01059630|16673893|P2|Overall Study|Withdrawal by Subject|14
4837043|NCT01059630|16673894|P1|Overall Study|Withdrawal by Subject|21
4837044|NCT01059630|16673893|P2|Overall Study|Physician Decision|4
4837045|NCT01059630|16673894|P1|Overall Study|Physician Decision|2
4837046|NCT01059630|16673893|P2|Overall Study|Lost to Follow-up|1
4837047|NCT01059630|16673894|P1|Overall Study|Lost to Follow-up|4
4837048|NCT01059630|16673893|P2|Overall Study|Death|84
4837049|NCT01059630|16673894|P1|Overall Study|Death|100
4837050|NCT01059617|16673968|P4|Overall Study|Other|6
4837051|NCT01059617|16673969|P3|Overall Study|Other|8
4837052|NCT01059617|16673970|P2|Overall Study|Other|1
4837053|NCT01059617|16673971|P1|Overall Study|Other|7
4837054|NCT01059565|16674141|P2|24-Week Open-Label Phase|Pulmonologist/participant decision|1
4837055|NCT01059565|16674142|P1|24-Week Open-Label Phase|Pulmonologist/participant decision|0
4837056|NCT01059565|16674141|P2|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1
4837057|NCT01059565|16674142|P1|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0
4837058|NCT01059565|16674141|P2|24-Week Open-Label Phase|Subject noncompliance|0
4837059|NCT01059565|16674142|P1|24-Week Open-Label Phase|Subject noncompliance|1
4837060|NCT01059565|16674141|P2|24-Week Open-Label Phase|Withdrawal by Subject|0
4837061|NCT01059565|16674142|P1|24-Week Open-Label Phase|Withdrawal by Subject|1
4837062|NCT01059565|16674141|P2|24-Week Open-Label Phase|Worsening health (physician decision)|1
4837063|NCT01059565|16674142|P1|24-Week Open-Label Phase|Worsening health (physician decision)|1
4837064|NCT01059565|16674141|P2|24-Week Open-Label Phase|Adverse Event|0
4837065|NCT01059565|16674142|P1|24-Week Open-Label Phase|Adverse Event|2
4837066|NCT01059565|16674141|P2|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5
4837067|NCT01059565|16674142|P1|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1
4837068|NCT01059565|16674141|P2|24-Week Randomized Phase|Lost to Follow-up|1
4837069|NCT01059565|16674142|P1|24-Week Randomized Phase|Lost to Follow-up|0
4837070|NCT01059565|16674141|P2|24-Week Randomized Phase|Withdrawal by Subject|1
4837071|NCT01059565|16674142|P1|24-Week Randomized Phase|Withdrawal by Subject|3
4837072|NCT01059565|16674141|P2|24-Week Randomized Phase|Adverse Event|0
4837073|NCT01059565|16674142|P1|24-Week Randomized Phase|Adverse Event|5
4837074|NCT01059565|16674141|P2|24-Week Randomized Phase|Randomized but not treated|0
4837075|NCT01059565|16674142|P1|24-Week Randomized Phase|Randomized but not treated|1
4837076|NCT01059539|16674176|P1|Overall Study|Reason Not Specified|2
4837077|NCT01059539|16674176|P1|Overall Study|Lost to Follow-up|42
4837078|NCT01059539|16674176|P1|Overall Study|Withdrawal of Consent|80
4837079|NCT01059539|16674176|P1|Overall Study|Protocol Violation|55
4837080|NCT01059539|16674176|P1|Overall Study|Insufficient Therapeutic Response|26
4837081|NCT01059539|16674176|P1|Overall Study|Adverse Event|66
4837082|NCT01059526|16674183|P2|Overall Study|Patient found to be dermatographic|0
4837083|NCT01059526|16674184|P1|Overall Study|Patient found to be dermatographic|1
4837084|NCT01059526|16674183|P2|Overall Study|Lost to Follow-up|1
4837085|NCT01059526|16674184|P1|Overall Study|Lost to Follow-up|4
4837086|NCT01059526|16674183|P2|Overall Study|Withdrawal by Subject|1
4837087|NCT01059526|16674184|P1|Overall Study|Withdrawal by Subject|3
4837088|NCT01059526|16674183|P2|Overall Study|Protocol Violation|1
4837089|NCT01059526|16674184|P1|Overall Study|Protocol Violation|0
4837090|NCT01059526|16674183|P2|Overall Study|Adverse Event|2
4837091|NCT01059526|16674184|P1|Overall Study|Adverse Event|2
4837092|NCT01059526|16674183|P2|Overall Study|Patient enrolled but not treated|17
4837093|NCT01059526|16674184|P1|Overall Study|Patient enrolled but not treated|20
4837094|NCT01059344|16674530|P2|Overall Study|Other|6
4837095|NCT01059344|16674531|P1|Overall Study|Other|3
4837096|NCT01059344|16674530|P2|Overall Study|Lost to Follow-up|1
4837097|NCT01059344|16674531|P1|Overall Study|Lost to Follow-up|1
4837098|NCT01059344|16674530|P2|Overall Study|Withdrawal by Subject|9
4837099|NCT01059344|16674531|P1|Overall Study|Withdrawal by Subject|6
4837100|NCT01059344|16674530|P2|Overall Study|Adverse Event|30
4837101|NCT01059344|16674531|P1|Overall Study|Adverse Event|12
4837102|NCT01059175|16674555|P2|Overall Study|Lost to Follow-up|1
4837103|NCT01059175|16674556|P1|Overall Study|Lost to Follow-up|0
4837104|NCT01059175|16674555|P2|Overall Study|Adverse Event|2
4837105|NCT01059175|16674556|P1|Overall Study|Adverse Event|4
4837106|NCT01059175|16674555|P2|Overall Study|Death|17
4837107|NCT01059175|16674556|P1|Overall Study|Death|17
4837108|NCT01059071|16674578|P4|Overall Study|Physician Decision|1
4837109|NCT01059071|16674579|P3|Overall Study|Physician Decision|0
4837110|NCT01059071|16674580|P2|Overall Study|Physician Decision|0
4837111|NCT01059071|16674581|P1|Overall Study|Physician Decision|0
4837112|NCT01059071|16674578|P4|Overall Study|Withdrawal by Subject|2
4837113|NCT01059071|16674579|P3|Overall Study|Withdrawal by Subject|0
4837114|NCT01059071|16674580|P2|Overall Study|Withdrawal by Subject|0
4837115|NCT01059071|16674581|P1|Overall Study|Withdrawal by Subject|1
4837116|NCT01059071|16674578|P4|Overall Study|Lack of Efficacy|3
4837117|NCT01059071|16674579|P3|Overall Study|Lack of Efficacy|2
4837118|NCT01059071|16674580|P2|Overall Study|Lack of Efficacy|4
4837119|NCT01059071|16674581|P1|Overall Study|Lack of Efficacy|1
4837120|NCT01058863|16674608|P1|Overall Study|Randomized in error|1
4837121|NCT01058863|16674608|P1|Overall Study|Sponsor requested withdrawal|1
4837122|NCT01058863|16674608|P1|Overall Study|Withdrawal by Subject|1
4837123|NCT01058863|16674608|P1|Overall Study|Lost to Follow-up|1
4837124|NCT01058707|16674633|P7|Overall Study|Reason Not Specified|7
4837125|NCT01058707|16674634|P6|Overall Study|Reason Not Specified|1
4837126|NCT01058707|16674635|P5|Overall Study|Reason Not Specified|7
4837127|NCT01058707|16674636|P4|Overall Study|Reason Not Specified|0
4837128|NCT01058707|16674637|P3|Overall Study|Reason Not Specified|2
4837129|NCT01058707|16674638|P2|Overall Study|Reason Not Specified|3
4837130|NCT01058707|16674639|P1|Overall Study|Reason Not Specified|0
4837131|NCT01058707|16674633|P7|Overall Study|Lost to Follow-up|0
4837132|NCT01058707|16674634|P6|Overall Study|Lost to Follow-up|0
4837133|NCT01058707|16674635|P5|Overall Study|Lost to Follow-up|0
4837134|NCT01058707|16674636|P4|Overall Study|Lost to Follow-up|0
4837135|NCT01058707|16674637|P3|Overall Study|Lost to Follow-up|1
4837136|NCT01058707|16674638|P2|Overall Study|Lost to Follow-up|0
4837137|NCT01058707|16674639|P1|Overall Study|Lost to Follow-up|0
4837138|NCT01058707|16674633|P7|Overall Study|Subject Decision|6
4837139|NCT01058707|16674634|P6|Overall Study|Subject Decision|3
4837140|NCT01058707|16674635|P5|Overall Study|Subject Decision|2
4837141|NCT01058707|16674636|P4|Overall Study|Subject Decision|1
4837142|NCT01058707|16674637|P3|Overall Study|Subject Decision|3
4837143|NCT01058707|16674638|P2|Overall Study|Subject Decision|3
4837144|NCT01058707|16674639|P1|Overall Study|Subject Decision|5
4837145|NCT01058707|16674633|P7|Overall Study|Adverse Event|1
4837146|NCT01058707|16674634|P6|Overall Study|Adverse Event|3
4837147|NCT01058707|16674635|P5|Overall Study|Adverse Event|7
4837148|NCT01058707|16674636|P4|Overall Study|Adverse Event|6
4837149|NCT01058707|16674637|P3|Overall Study|Adverse Event|7
4837150|NCT01058707|16674638|P2|Overall Study|Adverse Event|4
4837151|NCT01058707|16674639|P1|Overall Study|Adverse Event|11
4837152|NCT01058707|16674633|P7|Overall Study|Disease Progression|12
4837153|NCT01058707|16674634|P6|Overall Study|Disease Progression|10
4837154|NCT01058707|16674635|P5|Overall Study|Disease Progression|23
4837155|NCT01058707|16674636|P4|Overall Study|Disease Progression|15
4837156|NCT01058707|16674637|P3|Overall Study|Disease Progression|20
4837157|NCT01058707|16674638|P2|Overall Study|Disease Progression|20
4837158|NCT01058707|16674639|P1|Overall Study|Disease Progression|15
4837159|NCT01058668|16674805|P3|Double-blind Treatment Phase|Other Unspecified|0
4837160|NCT01058668|16674806|P2|Double-blind Treatment Phase|Other Unspecified|1
4837161|NCT01058668|16674807|P1|Double-blind Treatment Phase|Other Unspecified|1
4837162|NCT01058668|16674805|P3|Double-blind Treatment Phase|Lost to Follow-up|1
4837163|NCT01058668|16674806|P2|Double-blind Treatment Phase|Lost to Follow-up|1
4837164|NCT01058668|16674807|P1|Double-blind Treatment Phase|Lost to Follow-up|0
4837165|NCT01058668|16674805|P3|Double-blind Treatment Phase|Withdrawal of Consent|17
4837166|NCT01058668|16674806|P2|Double-blind Treatment Phase|Withdrawal of Consent|18
4837167|NCT01058668|16674807|P1|Double-blind Treatment Phase|Withdrawal of Consent|14
4837168|NCT01058668|16674805|P3|Double-blind Treatment Phase|Protocol Violation|2
4837169|NCT01058668|16674806|P2|Double-blind Treatment Phase|Protocol Violation|1
4837170|NCT01058668|16674807|P1|Double-blind Treatment Phase|Protocol Violation|1
4837171|NCT01058668|16674805|P3|Double-blind Treatment Phase|Insufficient Therapeutic Response|5
4837172|NCT01058668|16674806|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|2
4837173|NCT01058668|16674807|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|15
4837174|NCT01058668|16674805|P3|Double-blind Treatment Phase|Adverse Event|25
4837175|NCT01058668|16674806|P2|Double-blind Treatment Phase|Adverse Event|15
4837176|NCT01058668|16674807|P1|Double-blind Treatment Phase|Adverse Event|8
4837177|NCT01058655|16674822|P4|Overall Study|Other|4
4837178|NCT01058655|16674823|P3|Overall Study|Other|0
4837179|NCT01058655|16674824|P2|Overall Study|Other|0
4837180|NCT01058655|16674825|P1|Overall Study|Other|0
4837181|NCT01058655|16674822|P4|Overall Study|Disease Progression|24
4837182|NCT01058655|16674823|P3|Overall Study|Disease Progression|4
4837183|NCT01058655|16674824|P2|Overall Study|Disease Progression|2
4837184|NCT01058655|16674825|P1|Overall Study|Disease Progression|1
4837185|NCT01058655|16674822|P4|Overall Study|Death|0
4837186|NCT01058655|16674823|P3|Overall Study|Death|1
4837187|NCT01058655|16674824|P2|Overall Study|Death|1
4837188|NCT01058655|16674825|P1|Overall Study|Death|0
4837189|NCT01058655|16674822|P4|Overall Study|Clinical Progression (non-RECIST)|7
4837190|NCT01058655|16674823|P3|Overall Study|Clinical Progression (non-RECIST)|0
4837191|NCT01058655|16674824|P2|Overall Study|Clinical Progression (non-RECIST)|0
4837192|NCT01058655|16674825|P1|Overall Study|Clinical Progression (non-RECIST)|1
4837193|NCT01058655|16674822|P4|Overall Study|Symptomatic Deterioration|1
4837194|NCT01058655|16674823|P3|Overall Study|Symptomatic Deterioration|0
4837195|NCT01058655|16674824|P2|Overall Study|Symptomatic Deterioration|0
4837196|NCT01058655|16674825|P1|Overall Study|Symptomatic Deterioration|0
4837197|NCT01058655|16674822|P4|Overall Study|Prolonged Treatment Delay|2
4837198|NCT01058655|16674823|P3|Overall Study|Prolonged Treatment Delay|0
4837199|NCT01058655|16674824|P2|Overall Study|Prolonged Treatment Delay|0
4837200|NCT01058655|16674825|P1|Overall Study|Prolonged Treatment Delay|0
4837201|NCT01058655|16674822|P4|Overall Study|Withdrawal by Subject|4
4837202|NCT01058655|16674823|P3|Overall Study|Withdrawal by Subject|3
4837203|NCT01058655|16674824|P2|Overall Study|Withdrawal by Subject|0
4837204|NCT01058655|16674825|P1|Overall Study|Withdrawal by Subject|1
4837205|NCT01058642|16674843|P4|Treatment Period 1|Lack of Compliance with Study Drug|0
4837206|NCT01058642|16674844|P3|Treatment Period 1|Lack of Compliance with Study Drug|0
4837207|NCT01058642|16674845|P2|Treatment Period 1|Lack of Compliance with Study Drug|0
4837208|NCT01058642|16674846|P1|Treatment Period 1|Lack of Compliance with Study Drug|1
4837209|NCT01058642|16674843|P4|Treatment Period 1|Protocol Violation|1
4837210|NCT01058642|16674844|P3|Treatment Period 1|Protocol Violation|0
4837211|NCT01058642|16674845|P2|Treatment Period 1|Protocol Violation|0
4837212|NCT01058642|16674846|P1|Treatment Period 1|Protocol Violation|0
4837213|NCT01058642|16674843|P4|Treatment Period 1|Lack of Efficacy|1
4837214|NCT01058642|16674844|P3|Treatment Period 1|Lack of Efficacy|0
4837215|NCT01058642|16674845|P2|Treatment Period 1|Lack of Efficacy|0
4837216|NCT01058642|16674846|P1|Treatment Period 1|Lack of Efficacy|0
4837217|NCT01058642|16674843|P4|Treatment Period 1|Withdrawal by Subject|0
4837218|NCT01058642|16674844|P3|Treatment Period 1|Withdrawal by Subject|0
4837219|NCT01058642|16674845|P2|Treatment Period 1|Withdrawal by Subject|0
4837220|NCT01058642|16674846|P1|Treatment Period 1|Withdrawal by Subject|1
4837221|NCT01058642|16674843|P4|Treatment Period 1|Physician Decision|0
4837222|NCT01058642|16674844|P3|Treatment Period 1|Physician Decision|1
4837223|NCT01058642|16674845|P2|Treatment Period 1|Physician Decision|0
4837224|NCT01058642|16674846|P1|Treatment Period 1|Physician Decision|0
4837225|NCT01058642|16674843|P4|Treatment Period 1|Adverse Event|0
4837226|NCT01058642|16674844|P3|Treatment Period 1|Adverse Event|1
4837227|NCT01058642|16674845|P2|Treatment Period 1|Adverse Event|1
4837228|NCT01058642|16674846|P1|Treatment Period 1|Adverse Event|0
4837229|NCT01058421|16674856|P2|6 Month Outcomes|Remained in Other Facility|3
4837230|NCT01058421|16674857|P1|6 Month Outcomes|Remained in Other Facility|1
4837231|NCT01058421|16674856|P2|6 Month Outcomes|Lost to Follow-up|21
4837232|NCT01058421|16674857|P1|6 Month Outcomes|Lost to Follow-up|16
4837233|NCT01058421|16674856|P2|6 Month Outcomes|Death|2
4837234|NCT01058421|16674857|P1|6 Month Outcomes|Death|2
4837235|NCT01058421|16674856|P2|3 Month Outcomes|Remained in Other Facility|8
4837236|NCT01058421|16674857|P1|3 Month Outcomes|Remained in Other Facility|5
4837237|NCT01058421|16674856|P2|3 Month Outcomes|Remained in Hospital|2
4837238|NCT01058421|16674857|P1|3 Month Outcomes|Remained in Hospital|0
4837239|NCT01058421|16674856|P2|3 Month Outcomes|Lost to Follow-up|11
4837240|NCT01058421|16674857|P1|3 Month Outcomes|Lost to Follow-up|12
4837241|NCT01058421|16674856|P2|3 Month Outcomes|Death|5
4837242|NCT01058421|16674857|P1|3 Month Outcomes|Death|3
4837243|NCT01058421|16674856|P2|1 Month Outcomes|Remained in Other Facility|17
4837244|NCT01058421|16674857|P1|1 Month Outcomes|Remained in Other Facility|16
4837245|NCT01058421|16674856|P2|1 Month Outcomes|Remained in Hospital|12
4837246|NCT01058421|16674857|P1|1 Month Outcomes|Remained in Hospital|5
4837247|NCT01058421|16674856|P2|1 Month Outcomes|Lost to Follow-up|7
4837248|NCT01058421|16674857|P1|1 Month Outcomes|Lost to Follow-up|8
4837249|NCT01058421|16674856|P2|1 Month Outcomes|Death|6
4837250|NCT01058421|16674857|P1|1 Month Outcomes|Death|10
4837251|NCT01058395|16674881|P2|Overall Study|Lost to Follow-up|0
4837252|NCT01058395|16674882|P1|Overall Study|Lost to Follow-up|1
4837253|NCT01058395|16674881|P2|Overall Study|Death|1
4837254|NCT01058395|16674882|P1|Overall Study|Death|2
4837255|NCT01058369|16674891|P1|Overall Study|Early termination study|1
4837256|NCT01058369|16674891|P1|Overall Study|Adverse Event|1
4837257|NCT01058356|16674895|P1|Overall Study|Lost to Follow-up|4
4837258|NCT01058356|16674895|P1|Overall Study|Withdrawal by Subject|21
4837259|NCT01058356|16674895|P1|Overall Study|Administration of contraindicated drugs|12
4837260|NCT01058356|16674895|P1|Overall Study|Adverse Event|5
4837261|NCT01058304|16674902|P2|Overall Study|Developed exclusion criterion|12
4837262|NCT01058304|16674903|P1|Overall Study|Developed exclusion criterion|6
4837263|NCT01058304|16674902|P2|Overall Study|Lost to Follow-up|16
4837264|NCT01058304|16674903|P1|Overall Study|Lost to Follow-up|13
4837265|NCT01058304|16674902|P2|Overall Study|Withdrawal by Subject|5
4837266|NCT01058304|16674903|P1|Overall Study|Withdrawal by Subject|8
4837267|NCT01058265|16674913|P2|Overall Study|Lost to Follow-up|12
4837268|NCT01058265|16674914|P1|Overall Study|Lost to Follow-up|11
4837269|NCT01058096|16674933|P2|Double-blind Treatment Phase|Other Unspecified|0
4837270|NCT01058096|16674934|P1|Double-blind Treatment Phase|Other Unspecified|2
4837271|NCT01058096|16674933|P2|Double-blind Treatment Phase|Lost to Follow-up|1
4837272|NCT01058096|16674934|P1|Double-blind Treatment Phase|Lost to Follow-up|0
4837273|NCT01058096|16674933|P2|Double-blind Treatment Phase|Withdrawal of Consent|26
4837274|NCT01058096|16674934|P1|Double-blind Treatment Phase|Withdrawal of Consent|17
4837275|NCT01058096|16674933|P2|Double-blind Treatment Phase|Protocol Violation|1
4837276|NCT01058096|16674934|P1|Double-blind Treatment Phase|Protocol Violation|2
4837277|NCT01058096|16674933|P2|Double-blind Treatment Phase|Insufficient Therapeutic Response|7
4837278|NCT01058096|16674934|P1|Double-blind Treatment Phase|Insufficient Therapeutic Response|16
4837279|NCT01058096|16674933|P2|Double-blind Treatment Phase|Adverse Event|15
4837280|NCT01058096|16674934|P1|Double-blind Treatment Phase|Adverse Event|11
4837281|NCT01058005|16674950|P3|Overall Study|Reason Missing|1
4837282|NCT01058005|16674951|P2|Overall Study|Reason Missing|3
4837283|NCT01058005|16674952|P1|Overall Study|Reason Missing|5
4837284|NCT01058005|16674950|P3|Overall Study|Withdrawn Due to Study Termination|7
4837285|NCT01058005|16674951|P2|Overall Study|Withdrawn Due to Study Termination|13
4837286|NCT01058005|16674952|P1|Overall Study|Withdrawn Due to Study Termination|27
4837287|NCT01058005|16674950|P3|Overall Study|Withdrawal by Subject|11
4837288|NCT01058005|16674951|P2|Overall Study|Withdrawal by Subject|5
4837289|NCT01058005|16674952|P1|Overall Study|Withdrawal by Subject|4
4837290|NCT01058005|16674950|P3|Overall Study|Physician Decision|0
4837291|NCT01058005|16674951|P2|Overall Study|Physician Decision|2
4837292|NCT01058005|16674952|P1|Overall Study|Physician Decision|2
4837293|NCT01058005|16674950|P3|Overall Study|Adverse Event|1
4837294|NCT01058005|16674951|P2|Overall Study|Adverse Event|2
4837295|NCT01058005|16674952|P1|Overall Study|Adverse Event|0
4837296|NCT01057862|16674987|P2|Overall Study|Withdrawal by Subject|2
4837297|NCT01057862|16674988|P1|Overall Study|Withdrawal by Subject|1
4837298|NCT01057810|16674998|P2|Overall Study|Other|14
4837299|NCT01057810|16674999|P1|Overall Study|Other|7
4837300|NCT01057810|16674998|P2|Overall Study|No longer met study criteria|1
4837301|NCT01057810|16674999|P1|Overall Study|No longer met study criteria|0
4837302|NCT01057810|16674998|P2|Overall Study|Poor/non-compliance|1
4837303|NCT01057810|16674999|P1|Overall Study|Poor/non-compliance|0
4837304|NCT01057810|16674998|P2|Overall Study|Maximum clinical benefit|5
4837305|NCT01057810|16674999|P1|Overall Study|Maximum clinical benefit|5
4837306|NCT01057810|16674998|P2|Overall Study|Death|12
4837307|NCT01057810|16674999|P1|Overall Study|Death|2
4837308|NCT01057810|16674998|P2|Overall Study|Withdrawal by Subject|25
4837309|NCT01057810|16674999|P1|Overall Study|Withdrawal by Subject|10
4837310|NCT01057810|16674998|P2|Overall Study|Adverse event unrelated to study drug|29
4837311|NCT01057810|16674999|P1|Overall Study|Adverse event unrelated to study drug|13
4837312|NCT01057810|16674998|P2|Overall Study|Study drug toxicity|114
4837313|NCT01057810|16674999|P1|Overall Study|Study drug toxicity|5
4837314|NCT01057810|16674998|P2|Overall Study|Disease progression|197
4837315|NCT01057810|16674999|P1|Overall Study|Disease progression|156
4837316|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2
4837317|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
4837318|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0
4837319|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Other|0
4837320|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Other|1
4837321|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Other|0
4837322|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6
4837323|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8
4837324|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0
4837325|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4
4837326|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
4837327|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0
4837328|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5
4837329|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2
4837330|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0
4837331|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8
4837332|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3
4837333|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0
4837334|NCT01057693|16675015|P3|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11
4837335|NCT01057693|16675016|P2|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8
4837336|NCT01057693|16675017|P1|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0
4837337|NCT01057693|16675015|P3|Between Single-Blind and Double-Blind|Other|0
4837338|NCT01057693|16675016|P2|Between Single-Blind and Double-Blind|Other|0
4837339|NCT01057693|16675017|P1|Between Single-Blind and Double-Blind|Other|6
4837340|NCT01057693|16675015|P3|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
4837341|NCT01057693|16675016|P2|Between Single-Blind and Double-Blind|Withdrawal by Subject|0
4837342|NCT01057693|16675017|P1|Between Single-Blind and Double-Blind|Withdrawal by Subject|4
4837343|NCT01057693|16675015|P3|Between Single-Blind and Double-Blind|Protocol Violation|0
4837344|NCT01057693|16675016|P2|Between Single-Blind and Double-Blind|Protocol Violation|0
4837345|NCT01057693|16675017|P1|Between Single-Blind and Double-Blind|Protocol Violation|7
4837346|NCT01057693|16675015|P3|Between Single-Blind and Double-Blind|Lost to Follow-up|0
4837347|NCT01057693|16675016|P2|Between Single-Blind and Double-Blind|Lost to Follow-up|0
4837348|NCT01057693|16675017|P1|Between Single-Blind and Double-Blind|Lost to Follow-up|1
4837349|NCT01057693|16675015|P3|Between Single-Blind and Double-Blind|Lack of Efficacy|0
4837350|NCT01057693|16675016|P2|Between Single-Blind and Double-Blind|Lack of Efficacy|0
4837351|NCT01057693|16675017|P1|Between Single-Blind and Double-Blind|Lack of Efficacy|247
4837352|NCT01057693|16675015|P3|Between Single-Blind and Double-Blind|Adverse Event|0
4837353|NCT01057693|16675016|P2|Between Single-Blind and Double-Blind|Adverse Event|0
4837354|NCT01057693|16675017|P1|Between Single-Blind and Double-Blind|Adverse Event|5
4837355|NCT01057693|16675015|P3|Single-Blind Phase (Up to Week 6)|Other|0
4837356|NCT01057693|16675016|P2|Single-Blind Phase (Up to Week 6)|Other|0
4837357|NCT01057693|16675017|P1|Single-Blind Phase (Up to Week 6)|Other|2
4837358|NCT01057693|16675015|P3|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
4837359|NCT01057693|16675016|P2|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0
4837360|NCT01057693|16675017|P1|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22
4837361|NCT01057693|16675015|P3|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
4837362|NCT01057693|16675016|P2|Single-Blind Phase (Up to Week 6)|Protocol Violation|0
4837363|NCT01057693|16675017|P1|Single-Blind Phase (Up to Week 6)|Protocol Violation|9
4837364|NCT01057693|16675015|P3|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
4837365|NCT01057693|16675016|P2|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0
4837366|NCT01057693|16675017|P1|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14
4837367|NCT01057693|16675015|P3|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
4837368|NCT01057693|16675016|P2|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0
4837369|NCT01057693|16675017|P1|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7
4837370|NCT01057693|16675015|P3|Single-Blind Phase (Up to Week 6)|Adverse Event|0
4837371|NCT01057693|16675016|P2|Single-Blind Phase (Up to Week 6)|Adverse Event|0
4837372|NCT01057693|16675017|P1|Single-Blind Phase (Up to Week 6)|Adverse Event|45
4837373|NCT01057589|16675063|P1|Overall Study|Lost to Follow-up|1
4837374|NCT01057589|16675063|P1|Overall Study|Death|8
4837375|NCT01057589|16675063|P1|Overall Study|Sponsor Decision|1
4837376|NCT01057589|16675063|P1|Overall Study|Withdrawal by Subject|3
4837377|NCT01057589|16675063|P1|Overall Study|Physician Decision|8
4837378|NCT01057589|16675063|P1|Overall Study|Adverse Event|10
4837379|NCT01057589|16675063|P1|Overall Study|Disease Progression|35
4837380|NCT01057433|16675072|P1|Overall Study|Adverse Event|1
4837381|NCT01057394|16675076|P2|Overall Study|Not eligible|2
4837382|NCT01057394|16675077|P1|Overall Study|Not eligible|0
4837383|NCT01057251|16675087|P2|Overall Study|Other Reason|1
4837384|NCT01057251|16675088|P1|Overall Study|Other Reason|1
4837385|NCT01057251|16675087|P2|Overall Study|Lost to Follow-up|6
4837386|NCT01057251|16675088|P1|Overall Study|Lost to Follow-up|7
4837387|NCT01057251|16675087|P2|Overall Study|Withdrawal by Subject|5
4837388|NCT01057251|16675088|P1|Overall Study|Withdrawal by Subject|4
4837389|NCT01057251|16675087|P2|Overall Study|Protocol Violation|2
4837390|NCT01057251|16675088|P1|Overall Study|Protocol Violation|6
4837391|NCT01057251|16675087|P2|Overall Study|Lack of Efficacy|11
4837392|NCT01057251|16675088|P1|Overall Study|Lack of Efficacy|2
4837393|NCT01057251|16675087|P2|Overall Study|Adverse Event|2
4837394|NCT01057251|16675088|P1|Overall Study|Adverse Event|4
4837395|NCT01057251|16675087|P2|Overall Study|Did not meet InclusionExclusion criteria|2
4837396|NCT01057251|16675088|P1|Overall Study|Did not meet InclusionExclusion criteria|4
4837397|NCT01056822|16675166|P2|Overall Study|Lost to Follow-up|0
4837398|NCT01056822|16675167|P1|Overall Study|Lost to Follow-up|1
4837399|NCT01056822|16675166|P2|Overall Study|Withdrawal by Subject|1
4837400|NCT01056822|16675167|P1|Overall Study|Withdrawal by Subject|1
4837401|NCT01056822|16675166|P2|Overall Study|Protocol Violation|5
4837402|NCT01056822|16675167|P1|Overall Study|Protocol Violation|6
4837403|NCT01056822|16675166|P2|Overall Study|Adverse Event|1
4837404|NCT01056822|16675167|P1|Overall Study|Adverse Event|0
4837405|NCT01056718|16675216|P1|Overall Study|Ischemia on baseline stress test|1
4837406|NCT01056718|16675216|P1|Overall Study|Withdrawal by Subject|2
4837407|NCT01056653|16675249|P3|Overall Study|Lost to Follow-up|2
4837408|NCT01056653|16675250|P2|Overall Study|Lost to Follow-up|0
4837409|NCT01056653|16675251|P1|Overall Study|Lost to Follow-up|0
4837410|NCT01056640|16675267|P2|Overall Study|Death|4
4837411|NCT01056640|16675268|P1|Overall Study|Death|15
4837412|NCT01056640|16675267|P2|Overall Study|Withdrawal by Subject|8
4837413|NCT01056640|16675268|P1|Overall Study|Withdrawal by Subject|11
4837414|NCT01056536|16675283|P3|Overall Study|Lost to Follow-up|248
4837415|NCT01056536|16675284|P2|Overall Study|Lost to Follow-up|116
4837416|NCT01056536|16675285|P1|Overall Study|Lost to Follow-up|202
4837417|NCT01056523|16675296|P7|Overall Study|Death|1
4837418|NCT01056523|16675297|P6|Overall Study|Death|0
4837419|NCT01056523|16675298|P5|Overall Study|Death|0
4837420|NCT01056523|16675299|P4|Overall Study|Death|3
4837421|NCT01056523|16675300|P3|Overall Study|Death|2
4837422|NCT01056523|16675301|P2|Overall Study|Death|0
4837423|NCT01056523|16675302|P1|Overall Study|Death|1
4837424|NCT01056510|16675312|P2|Overall Study|Missing|1
4837425|NCT01056510|16675313|P1|Overall Study|Missing|0
4837426|NCT01056510|16675312|P2|Overall Study|Other|12
4837427|NCT01056510|16675313|P1|Overall Study|Other|10
4837428|NCT01056510|16675312|P2|Overall Study|Lost to Follow-up|6
4837429|NCT01056510|16675313|P1|Overall Study|Lost to Follow-up|5
4837430|NCT01056510|16675312|P2|Overall Study|Physician Decision|5
4837431|NCT01056510|16675313|P1|Overall Study|Physician Decision|4
4837432|NCT01056510|16675312|P2|Overall Study|Noncompliance|3
4837433|NCT01056510|16675313|P1|Overall Study|Noncompliance|1
4837434|NCT01056510|16675312|P2|Overall Study|Death|34
4837435|NCT01056510|16675313|P1|Overall Study|Death|29
4837436|NCT01056510|16675312|P2|Overall Study|Withdrawal by Subject|2
4837437|NCT01056510|16675313|P1|Overall Study|Withdrawal by Subject|4
4837438|NCT01056510|16675312|P2|Overall Study|Dropout Before Start of Treatment|1
4837439|NCT01056510|16675313|P1|Overall Study|Dropout Before Start of Treatment|1
4837440|NCT01056484|16675359|P2|Follow up - Non-randomized|Withdrawal by Subject|2
4837441|NCT01056484|16675360|P1|Follow up - Non-randomized|Withdrawal by Subject|0
4837442|NCT01056484|16675359|P2|Randomized Controlled Trial|Physician Decision|0
4837443|NCT01056484|16675360|P1|Randomized Controlled Trial|Physician Decision|1
4837444|NCT01056484|16675359|P2|Randomized Controlled Trial|Withdrawal by Subject|1
4837445|NCT01056484|16675360|P1|Randomized Controlled Trial|Withdrawal by Subject|6
4837446|NCT01056380|16675376|P2|Overall Study|Lost to Follow-up|3
4837447|NCT01056380|16675377|P1|Overall Study|Lost to Follow-up|2
4837448|NCT01056341|16675404|P5|Overall Study|Other reasons|5
4837449|NCT01056341|16675405|P4|Overall Study|Other reasons|9
4837450|NCT01056341|16675406|P3|Overall Study|Other reasons|8
4837451|NCT01056341|16675407|P2|Overall Study|Other reasons|4
4837452|NCT01056341|16675408|P1|Overall Study|Other reasons|4
4837453|NCT01056341|16675404|P5|Overall Study|Lack of Efficacy|9
4837454|NCT01056341|16675405|P4|Overall Study|Lack of Efficacy|25
4837455|NCT01056341|16675406|P3|Overall Study|Lack of Efficacy|7
4837456|NCT01056341|16675407|P2|Overall Study|Lack of Efficacy|30
4837457|NCT01056341|16675408|P1|Overall Study|Lack of Efficacy|32
4837458|NCT01056341|16675404|P5|Overall Study|Treatment Intolerance|0
4837459|NCT01056341|16675405|P4|Overall Study|Treatment Intolerance|2
4837460|NCT01056341|16675406|P3|Overall Study|Treatment Intolerance|0
4837461|NCT01056341|16675407|P2|Overall Study|Treatment Intolerance|2
4837462|NCT01056341|16675408|P1|Overall Study|Treatment Intolerance|0
4837463|NCT01056289|16675487|P4|Double-blind Phase|Physician Decision|0
4837464|NCT01056289|16675488|P3|Double-blind Phase|Physician Decision|1
4837465|NCT01056289|16675489|P2|Double-blind Phase|Physician Decision|0
4837466|NCT01056289|16675490|P1|Double-blind Phase|Physician Decision|0
4837467|NCT01056289|16675487|P4|Double-blind Phase|Discontinuation symptom|2
4837468|NCT01056289|16675488|P3|Double-blind Phase|Discontinuation symptom|2
4837469|NCT01056289|16675489|P2|Double-blind Phase|Discontinuation symptom|1
4837470|NCT01056289|16675490|P1|Double-blind Phase|Discontinuation symptom|0
4837471|NCT01056289|16675487|P4|Double-blind Phase|Withdrawal by Subject|2
4837472|NCT01056289|16675488|P3|Double-blind Phase|Withdrawal by Subject|4
4837473|NCT01056289|16675489|P2|Double-blind Phase|Withdrawal by Subject|0
4837474|NCT01056289|16675490|P1|Double-blind Phase|Withdrawal by Subject|0
4837475|NCT01056289|16675487|P4|Double-blind Phase|Protocol Violation|1
4837476|NCT01056289|16675488|P3|Double-blind Phase|Protocol Violation|1
4837477|NCT01056289|16675489|P2|Double-blind Phase|Protocol Violation|0
4837478|NCT01056289|16675490|P1|Double-blind Phase|Protocol Violation|0
4837479|NCT01056289|16675487|P4|Double-blind Phase|Other|2
4837480|NCT01056289|16675488|P3|Double-blind Phase|Other|1
4837481|NCT01056289|16675489|P2|Double-blind Phase|Other|0
4837482|NCT01056289|16675490|P1|Double-blind Phase|Other|0
4837483|NCT01056289|16675487|P4|Double-blind Phase|Lost to Follow-up|2
4837484|NCT01056289|16675488|P3|Double-blind Phase|Lost to Follow-up|2
4837485|NCT01056289|16675489|P2|Double-blind Phase|Lost to Follow-up|2
4837486|NCT01056289|16675490|P1|Double-blind Phase|Lost to Follow-up|0
4837487|NCT01056289|16675487|P4|Double-blind Phase|Adverse Event|1
4837488|NCT01056289|16675488|P3|Double-blind Phase|Adverse Event|2
4837489|NCT01056289|16675489|P2|Double-blind Phase|Adverse Event|1
4837490|NCT01056289|16675490|P1|Double-blind Phase|Adverse Event|0
4837491|NCT01056289|16675487|P4|Open-label Phase|Not randomized to Double-blind phase|0
4837492|NCT01056289|16675488|P3|Open-label Phase|Not randomized to Double-blind phase|0
4837493|NCT01056289|16675489|P2|Open-label Phase|Not randomized to Double-blind phase|0
4837494|NCT01056289|16675490|P1|Open-label Phase|Not randomized to Double-blind phase|1
4837495|NCT01056289|16675487|P4|Open-label Phase|Lack of Efficacy|0
4837496|NCT01056289|16675488|P3|Open-label Phase|Lack of Efficacy|0
4837497|NCT01056289|16675489|P2|Open-label Phase|Lack of Efficacy|0
4837498|NCT01056289|16675490|P1|Open-label Phase|Lack of Efficacy|18
4837499|NCT01056289|16675487|P4|Open-label Phase|Withdrawal by Subject|0
4837500|NCT01056289|16675488|P3|Open-label Phase|Withdrawal by Subject|0
4837501|NCT01056289|16675489|P2|Open-label Phase|Withdrawal by Subject|0
4837502|NCT01056289|16675490|P1|Open-label Phase|Withdrawal by Subject|26
4837503|NCT01056289|16675487|P4|Open-label Phase|Protocol Violation|0
4837504|NCT01056289|16675488|P3|Open-label Phase|Protocol Violation|0
4837505|NCT01056289|16675489|P2|Open-label Phase|Protocol Violation|0
4837506|NCT01056289|16675490|P1|Open-label Phase|Protocol Violation|6
4837507|NCT01056289|16675487|P4|Open-label Phase|Other|0
4837508|NCT01056289|16675488|P3|Open-label Phase|Other|0
4837509|NCT01056289|16675489|P2|Open-label Phase|Other|0
4837510|NCT01056289|16675490|P1|Open-label Phase|Other|9
4837511|NCT01056289|16675487|P4|Open-label Phase|Lost to Follow-up|0
4837512|NCT01056289|16675488|P3|Open-label Phase|Lost to Follow-up|0
4837513|NCT01056289|16675489|P2|Open-label Phase|Lost to Follow-up|0
4837514|NCT01056289|16675490|P1|Open-label Phase|Lost to Follow-up|30
4837515|NCT01056289|16675487|P4|Open-label Phase|Adverse Event|0
4837516|NCT01056289|16675488|P3|Open-label Phase|Adverse Event|0
4837517|NCT01056289|16675489|P2|Open-label Phase|Adverse Event|0
4837518|NCT01056289|16675490|P1|Open-label Phase|Adverse Event|29
4837519|NCT01056276|16675507|P2|Maintenance Therapy|Continuing maintenance therapy|14
4837520|NCT01056276|16675508|P1|Maintenance Therapy|Continuing maintenance therapy|0
4837521|NCT01056276|16675507|P2|Maintenance Therapy|Intercurrent Illness|1
4837522|NCT01056276|16675508|P1|Maintenance Therapy|Intercurrent Illness|0
4837523|NCT01056276|16675507|P2|Maintenance Therapy|Withdrawal by Subject|1
4837524|NCT01056276|16675508|P1|Maintenance Therapy|Withdrawal by Subject|0
4837525|NCT01056276|16675507|P2|Maintenance Therapy|Physician Decision|1
4837526|NCT01056276|16675508|P1|Maintenance Therapy|Physician Decision|0
4837527|NCT01056276|16675507|P2|Maintenance Therapy|Progressive Disease|9
4837528|NCT01056276|16675508|P1|Maintenance Therapy|Progressive Disease|0
4837529|NCT01056276|16675507|P2|Maintenance Therapy|Toxicity|2
4837530|NCT01056276|16675508|P1|Maintenance Therapy|Toxicity|0
4837531|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Lost to Follow-up|0
4837532|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Lost to Follow-up|1
4837533|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Death|1
4837534|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Death|3
4837535|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Physician Decision|0
4837536|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Physician Decision|3
4837537|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Intercurrent Illness|2
4837538|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Intercurrent Illness|1
4837539|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Disease Progression|2
4837540|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Disease Progression|2
4837541|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Withdrawal by Subject|2
4837542|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Withdrawal by Subject|1
4837543|NCT01056276|16675507|P2|Treatment Period-Cycles 1-8|Toxicity|1
4837544|NCT01056276|16675508|P1|Treatment Period-Cycles 1-8|Toxicity|2
4837545|NCT01056263|16675522|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|5
4837546|NCT01056263|16675522|P1|Overall Study|Objective progression or relapse|1
4837547|NCT01056263|16675522|P1|Overall Study|Neoplasm progression|1
4837548|NCT01056263|16675522|P1|Overall Study|Progressive disease|2
4837549|NCT01056263|16675522|P1|Overall Study|Lack of Efficacy|29
4837550|NCT01056263|16675522|P1|Overall Study|Withdrawal by Subject|1
4837551|NCT01056263|16675522|P1|Overall Study|Death|1
4837552|NCT01056263|16675522|P1|Overall Study|Adverse Event|12
4837553|NCT01056107|16675545|P4|Overall Study|Withdrawal by Subject|0
4837554|NCT01056107|16675546|P3|Overall Study|Withdrawal by Subject|3
4837555|NCT01056107|16675547|P2|Overall Study|Withdrawal by Subject|1
4837556|NCT01056107|16675548|P1|Overall Study|Withdrawal by Subject|0
4837557|NCT01055886|16675605|P2|Overall Study|Withdrawal by PI|1
4837558|NCT01055886|16675606|P1|Overall Study|Withdrawal by PI|0
4837559|NCT01055886|16675605|P2|Overall Study|Lost to Follow-up|1
4837560|NCT01055886|16675606|P1|Overall Study|Lost to Follow-up|1
4837561|NCT01055886|16675605|P2|Overall Study|Withdrawal by Subject|9
4837562|NCT01055886|16675606|P1|Overall Study|Withdrawal by Subject|4
4837563|NCT01055834|16675618|P2|Treatment Period I|Adverse Event|0
4837564|NCT01055834|16675619|P1|Treatment Period I|Adverse Event|1
4837565|NCT01055639|16675704|P2|Overall Study|Withdrawal by Subject|11
4837566|NCT01055639|16675705|P1|Overall Study|Withdrawal by Subject|8
4837567|NCT01055639|16675704|P2|Overall Study|Protocol Violation|5
4837568|NCT01055639|16675705|P1|Overall Study|Protocol Violation|5
4837569|NCT01055639|16675704|P2|Overall Study|Lost to Follow-up|11
4837570|NCT01055639|16675705|P1|Overall Study|Lost to Follow-up|8
4837571|NCT01055639|16675704|P2|Overall Study|Lack of Efficacy|1
4837572|NCT01055639|16675705|P1|Overall Study|Lack of Efficacy|0
4837573|NCT01055639|16675704|P2|Overall Study|Adverse Event|1
4837574|NCT01055639|16675705|P1|Overall Study|Adverse Event|0
4837575|NCT01055613|16675729|P2|Overall Study|Subject Disinterest|1
4837576|NCT01055613|16675730|P1|Overall Study|Subject Disinterest|1
4837577|NCT01055613|16675729|P2|Overall Study|Protocol Violation|1
4837578|NCT01055613|16675730|P1|Overall Study|Protocol Violation|1
4837579|NCT01055613|16675729|P2|Overall Study|Lost to Follow-up|1
4837580|NCT01055613|16675730|P1|Overall Study|Lost to Follow-up|1
4837581|NCT01055613|16675729|P2|Overall Study|Discomfort|1
4837582|NCT01055613|16675730|P1|Overall Study|Discomfort|2
4837583|NCT01055613|16675729|P2|Overall Study|Unacceptable lens fit|0
4837584|NCT01055613|16675730|P1|Overall Study|Unacceptable lens fit|1
4837585|NCT01055613|16675729|P2|Overall Study|No Longer Meets Eligibility Criteria|0
4837586|NCT01055613|16675730|P1|Overall Study|No Longer Meets Eligibility Criteria|3
4837587|NCT01055496|16675740|P2|Overall Study|Other - Unspecified|1
4837588|NCT01055496|16675741|P1|Overall Study|Other - Unspecified|0
4837589|NCT01055496|16675740|P2|Overall Study|Lost to Follow-up|2
4837590|NCT01055496|16675741|P1|Overall Study|Lost to Follow-up|0
4837591|NCT01055496|16675740|P2|Overall Study|Death|23
4837592|NCT01055496|16675741|P1|Overall Study|Death|13
4837593|NCT01055496|16675740|P2|Overall Study|Withdrawal by Subject|4
4837594|NCT01055496|16675741|P1|Overall Study|Withdrawal by Subject|2
4837595|NCT01055457|16675798|P10|Overall Study|Adverse Event|0
4837596|NCT01055457|16675799|P9|Overall Study|Adverse Event|0
4837597|NCT01055457|16675800|P8|Overall Study|Adverse Event|0
4837598|NCT01055457|16675801|P7|Overall Study|Adverse Event|0
4837599|NCT01055457|16675802|P6|Overall Study|Adverse Event|0
4837600|NCT01055457|16675803|P5|Overall Study|Adverse Event|0
4837601|NCT01055457|16675804|P4|Overall Study|Adverse Event|1
4837602|NCT01055457|16675805|P3|Overall Study|Adverse Event|0
4837603|NCT01055457|16675806|P2|Overall Study|Adverse Event|0
4837604|NCT01055457|16675807|P1|Overall Study|Adverse Event|0
4837605|NCT01055457|16675798|P10|Overall Study|Pregnancy|0
4837606|NCT01055457|16675799|P9|Overall Study|Pregnancy|0
4837607|NCT01055457|16675800|P8|Overall Study|Pregnancy|0
4837608|NCT01055457|16675801|P7|Overall Study|Pregnancy|0
4837609|NCT01055457|16675802|P6|Overall Study|Pregnancy|0
4837610|NCT01055457|16675803|P5|Overall Study|Pregnancy|0
4837611|NCT01055457|16675804|P4|Overall Study|Pregnancy|1
4837612|NCT01055457|16675805|P3|Overall Study|Pregnancy|0
4837613|NCT01055457|16675806|P2|Overall Study|Pregnancy|0
4837614|NCT01055457|16675807|P1|Overall Study|Pregnancy|0
4837615|NCT01055457|16675798|P10|Overall Study|Discomfort|0
4837616|NCT01055457|16675799|P9|Overall Study|Discomfort|0
4837617|NCT01055457|16675800|P8|Overall Study|Discomfort|0
4837618|NCT01055457|16675801|P7|Overall Study|Discomfort|0
4837619|NCT01055457|16675802|P6|Overall Study|Discomfort|0
4837620|NCT01055457|16675803|P5|Overall Study|Discomfort|1
4837621|NCT01055457|16675804|P4|Overall Study|Discomfort|0
4837622|NCT01055457|16675805|P3|Overall Study|Discomfort|0
4837623|NCT01055457|16675806|P2|Overall Study|Discomfort|0
4837624|NCT01055457|16675807|P1|Overall Study|Discomfort|0
4837625|NCT01055457|16675798|P10|Overall Study|Subject Ineligible|0
4837626|NCT01055457|16675799|P9|Overall Study|Subject Ineligible|0
4837627|NCT01055457|16675800|P8|Overall Study|Subject Ineligible|0
4837628|NCT01055457|16675801|P7|Overall Study|Subject Ineligible|0
4837629|NCT01055457|16675802|P6|Overall Study|Subject Ineligible|0
4837630|NCT01055457|16675803|P5|Overall Study|Subject Ineligible|1
4837631|NCT01055457|16675804|P4|Overall Study|Subject Ineligible|0
4837632|NCT01055457|16675805|P3|Overall Study|Subject Ineligible|1
4837633|NCT01055457|16675806|P2|Overall Study|Subject Ineligible|0
4837634|NCT01055457|16675807|P1|Overall Study|Subject Ineligible|1
4837635|NCT01055457|16675798|P10|Overall Study|Subject Disinterest|0
4837636|NCT01055457|16675799|P9|Overall Study|Subject Disinterest|0
4837637|NCT01055457|16675800|P8|Overall Study|Subject Disinterest|1
4837638|NCT01055457|16675801|P7|Overall Study|Subject Disinterest|0
4837639|NCT01055457|16675802|P6|Overall Study|Subject Disinterest|0
4837640|NCT01055457|16675803|P5|Overall Study|Subject Disinterest|0
4837641|NCT01055457|16675804|P4|Overall Study|Subject Disinterest|0
4837642|NCT01055457|16675805|P3|Overall Study|Subject Disinterest|0
4837643|NCT01055457|16675806|P2|Overall Study|Subject Disinterest|0
4837644|NCT01055457|16675807|P1|Overall Study|Subject Disinterest|0
4837645|NCT01055457|16675798|P10|Overall Study|Protocol Violation|1
4837646|NCT01055457|16675799|P9|Overall Study|Protocol Violation|0
4837647|NCT01055457|16675800|P8|Overall Study|Protocol Violation|0
4837648|NCT01055457|16675801|P7|Overall Study|Protocol Violation|1
4837649|NCT01055457|16675802|P6|Overall Study|Protocol Violation|2
4837650|NCT01055457|16675803|P5|Overall Study|Protocol Violation|1
4837651|NCT01055457|16675804|P4|Overall Study|Protocol Violation|1
4837652|NCT01055457|16675805|P3|Overall Study|Protocol Violation|1
4837653|NCT01055457|16675806|P2|Overall Study|Protocol Violation|0
4837654|NCT01055457|16675807|P1|Overall Study|Protocol Violation|0
4837655|NCT01055457|16675798|P10|Overall Study|Lost to Follow-up|0
4837656|NCT01055457|16675799|P9|Overall Study|Lost to Follow-up|0
4837657|NCT01055457|16675800|P8|Overall Study|Lost to Follow-up|0
4837658|NCT01055457|16675801|P7|Overall Study|Lost to Follow-up|0
4837659|NCT01055457|16675802|P6|Overall Study|Lost to Follow-up|1
4837660|NCT01055457|16675803|P5|Overall Study|Lost to Follow-up|0
4837661|NCT01055457|16675804|P4|Overall Study|Lost to Follow-up|0
4837662|NCT01055457|16675805|P3|Overall Study|Lost to Follow-up|0
4837663|NCT01055457|16675806|P2|Overall Study|Lost to Follow-up|1
4837664|NCT01055457|16675807|P1|Overall Study|Lost to Follow-up|0
4837665|NCT01055314|16675841|P2|Overall Study|No treatment|0
4837666|NCT01055314|16675842|P1|Overall Study|No treatment|1
4837667|NCT01055314|16675841|P2|Overall Study|Refusal of further protocol therapy|4
4837668|NCT01055314|16675842|P1|Overall Study|Refusal of further protocol therapy|10
4837669|NCT01055314|16675841|P2|Overall Study|Ineligible|5
4837670|NCT01055314|16675842|P1|Overall Study|Ineligible|3
4837671|NCT01055314|16675841|P2|Overall Study|Withdrawal by Subject|0
4837672|NCT01055314|16675842|P1|Overall Study|Withdrawal by Subject|1
4837673|NCT01055314|16675841|P2|Overall Study|Physician Decision|5
4837674|NCT01055314|16675842|P1|Overall Study|Physician Decision|10
4837675|NCT01055314|16675841|P2|Overall Study|Lack of Efficacy|19
4837676|NCT01055314|16675842|P1|Overall Study|Lack of Efficacy|11
4837677|NCT01055314|16675841|P2|Overall Study|Death|1
4837678|NCT01055314|16675842|P1|Overall Study|Death|2
4837679|NCT01055314|16675841|P2|Overall Study|Adverse Event|4
4837680|NCT01055314|16675842|P1|Overall Study|Adverse Event|7
4837681|NCT01055262|16675854|P1|Overall Study|Uncooperativeness|1
4837682|NCT01055262|16675854|P1|Overall Study|Protocol Violation|3
4837683|NCT01055262|16675854|P1|Overall Study|Adverse Event|5
4837684|NCT01055197|16675895|P2|Overall Study|Withdrawal by Subject|0
4837685|NCT01055197|16675896|P1|Overall Study|Withdrawal by Subject|2
4837686|NCT01055197|16675895|P2|Overall Study|Protocol Violation|2
4837687|NCT01055197|16675896|P1|Overall Study|Protocol Violation|7
4837688|NCT01055132|16675931|P2|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1
4837689|NCT01055132|16675932|P1|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0
4837690|NCT01055132|16675931|P2|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0
4837691|NCT01055132|16675932|P1|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1
4837692|NCT01055028|16675957|P2|Inter-treatment Period|Did not start Cycle 4|3
4837693|NCT01055028|16675958|P1|Inter-treatment Period|Did not start Cycle 4|0
4837694|NCT01055028|16675957|P2|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
4837695|NCT01055028|16675958|P1|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2
4837696|NCT01055028|16675957|P2|Treatment Cycles 1 to 3|Adverse Event|1
4837697|NCT01055028|16675958|P1|Treatment Cycles 1 to 3|Adverse Event|0
4837698|NCT01055028|16675957|P2|Screening|Screen Failure|1
4837699|NCT01055028|16675958|P1|Screening|Screen Failure|1
4837700|NCT01054976|16675972|P1|Overall Study|Other|8
4837701|NCT01054976|16675972|P1|Overall Study|Withdrawal by Subject|4
4837702|NCT01054976|16675972|P1|Overall Study|Uncooperative participations to study|7
4837703|NCT01054976|16675972|P1|Overall Study|Adverse Event|16
4837704|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Withdrawal by Subject|2
4837705|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4837706|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|3
4837707|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
4837708|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4837709|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|8
4837710|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4837711|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Physician Decision|1
4837712|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Physician Decision|1
4837713|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Physician Decision|3
4837714|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Physician Decision|6
4837715|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Physician Decision|1
4837716|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Physician Decision|4
4837717|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Physician Decision|0
4837718|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4837719|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4837720|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4837721|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4837722|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4837723|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|3
4837724|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4837725|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
4837726|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4837727|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4837728|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4837729|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1
4837730|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4837731|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0
4837732|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
4837885|NCT01054560|16676328|P1|Overall Study|Lost to Follow-up|2
4837733|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15
4837734|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
4837735|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
4837736|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12
4837737|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7
4837738|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0
4837739|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Protocol Violation|4
4837740|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Protocol Violation|8
4837741|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Protocol Violation|3
4837742|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
4837743|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Protocol Violation|7
4837744|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Protocol Violation|7
4837745|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
4837746|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
4837747|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7
4837748|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11
4837749|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5
4837750|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2
4837751|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
4837752|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
4837753|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4837754|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
4837755|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4837756|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1
4837757|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
4837758|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4837759|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4837760|NCT01054885|16675993|P7|24-week, Double-blind Treatment Period|Adverse Event|19
4837761|NCT01054885|16675994|P6|24-week, Double-blind Treatment Period|Adverse Event|17
4837762|NCT01054885|16675995|P5|24-week, Double-blind Treatment Period|Adverse Event|15
4837763|NCT01054885|16675996|P4|24-week, Double-blind Treatment Period|Adverse Event|15
4837764|NCT01054885|16675997|P3|24-week, Double-blind Treatment Period|Adverse Event|12
4837765|NCT01054885|16675998|P2|24-week, Double-blind Treatment Period|Adverse Event|18
4837766|NCT01054885|16675999|P1|24-week, Double-blind Treatment Period|Adverse Event|0
4837767|NCT01054885|16675993|P7|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837768|NCT01054885|16675994|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837769|NCT01054885|16675995|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837770|NCT01054885|16675996|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837771|NCT01054885|16675997|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837772|NCT01054885|16675998|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837773|NCT01054885|16675999|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|68
4837774|NCT01054885|16675993|P7|2-week, Single-blind Run-In Period|Adverse Event|0
4837775|NCT01054885|16675994|P6|2-week, Single-blind Run-In Period|Adverse Event|0
4837776|NCT01054885|16675995|P5|2-week, Single-blind Run-In Period|Adverse Event|0
4837777|NCT01054885|16675996|P4|2-week, Single-blind Run-In Period|Adverse Event|0
4837778|NCT01054885|16675997|P3|2-week, Single-blind Run-In Period|Adverse Event|0
4837779|NCT01054885|16675998|P2|2-week, Single-blind Run-In Period|Adverse Event|0
4837780|NCT01054885|16675999|P1|2-week, Single-blind Run-In Period|Adverse Event|7
4837781|NCT01054885|16675993|P7|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837782|NCT01054885|16675994|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837783|NCT01054885|16675995|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837784|NCT01054885|16675996|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837785|NCT01054885|16675997|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837786|NCT01054885|16675998|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837787|NCT01054885|16675999|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
4837788|NCT01054885|16675993|P7|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837789|NCT01054885|16675994|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837790|NCT01054885|16675995|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837791|NCT01054885|16675996|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837792|NCT01054885|16675997|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837793|NCT01054885|16675998|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837794|NCT01054885|16675999|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|23
4837795|NCT01054885|16675993|P7|2-week, Single-blind Run-In Period|Physician Decision|0
4837796|NCT01054885|16675994|P6|2-week, Single-blind Run-In Period|Physician Decision|0
4837797|NCT01054885|16675995|P5|2-week, Single-blind Run-In Period|Physician Decision|0
4837798|NCT01054885|16675996|P4|2-week, Single-blind Run-In Period|Physician Decision|0
4837799|NCT01054885|16675997|P3|2-week, Single-blind Run-In Period|Physician Decision|0
4837800|NCT01054885|16675998|P2|2-week, Single-blind Run-In Period|Physician Decision|0
4837801|NCT01054885|16675999|P1|2-week, Single-blind Run-In Period|Physician Decision|6
4837802|NCT01054885|16675993|P7|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837803|NCT01054885|16675994|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837804|NCT01054885|16675995|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837805|NCT01054885|16675996|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837806|NCT01054885|16675997|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837807|NCT01054885|16675998|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837808|NCT01054885|16675999|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246
4837809|NCT01054846|16676039|P2|Overall Study|Lost to Follow-up|17
4837810|NCT01054846|16676040|P1|Overall Study|Lost to Follow-up|76
4837811|NCT01054820|16676047|P1|Overall Study|Withdrawal by Subject|2
4837812|NCT01054729|16676069|P4|Overall Study|Lack of Efficacy|1
4837813|NCT01054729|16676070|P3|Overall Study|Lack of Efficacy|0
4837814|NCT01054729|16676071|P2|Overall Study|Lack of Efficacy|0
4837815|NCT01054729|16676072|P1|Overall Study|Lack of Efficacy|0
4837816|NCT01054729|16676069|P4|Overall Study|Subject moved|0
4837817|NCT01054729|16676070|P3|Overall Study|Subject moved|1
4837818|NCT01054729|16676071|P2|Overall Study|Subject moved|0
4837819|NCT01054729|16676072|P1|Overall Study|Subject moved|0
4837820|NCT01054729|16676069|P4|Overall Study|Personal/Obligations|0
4837821|NCT01054729|16676070|P3|Overall Study|Personal/Obligations|0
4837822|NCT01054729|16676071|P2|Overall Study|Personal/Obligations|1
4837823|NCT01054729|16676072|P1|Overall Study|Personal/Obligations|0
4837824|NCT01054729|16676069|P4|Overall Study|PEG/RBV Non-responder|0
4837825|NCT01054729|16676070|P3|Overall Study|PEG/RBV Non-responder|1
4837826|NCT01054729|16676071|P2|Overall Study|PEG/RBV Non-responder|0
4837827|NCT01054729|16676072|P1|Overall Study|PEG/RBV Non-responder|1
4837828|NCT01054729|16676069|P4|Overall Study|Non-responder|1
4837829|NCT01054729|16676070|P3|Overall Study|Non-responder|1
4837830|NCT01054729|16676071|P2|Overall Study|Non-responder|0
4837831|NCT01054729|16676072|P1|Overall Study|Non-responder|1
4837832|NCT01054729|16676069|P4|Overall Study|Lost to Follow-up, Later Contacted Site|0
4837833|NCT01054729|16676070|P3|Overall Study|Lost to Follow-up, Later Contacted Site|0
4837834|NCT01054729|16676071|P2|Overall Study|Lost to Follow-up, Later Contacted Site|1
4837835|NCT01054729|16676072|P1|Overall Study|Lost to Follow-up, Later Contacted Site|0
4837836|NCT01054729|16676069|P4|Overall Study|Lost to Follow-up|0
4837837|NCT01054729|16676070|P3|Overall Study|Lost to Follow-up|0
4837838|NCT01054729|16676071|P2|Overall Study|Lost to Follow-up|1
4837839|NCT01054729|16676072|P1|Overall Study|Lost to Follow-up|0
4837840|NCT01054729|16676069|P4|Overall Study|Withdrawal by Subject|0
4837841|NCT01054729|16676070|P3|Overall Study|Withdrawal by Subject|1
4837842|NCT01054729|16676071|P2|Overall Study|Withdrawal by Subject|0
4837843|NCT01054729|16676072|P1|Overall Study|Withdrawal by Subject|1
4837844|NCT01054729|16676069|P4|Overall Study|Adverse Event|1
4837845|NCT01054729|16676070|P3|Overall Study|Adverse Event|2
4837846|NCT01054729|16676071|P2|Overall Study|Adverse Event|1
4837847|NCT01054729|16676072|P1|Overall Study|Adverse Event|1
4837848|NCT01054729|16676069|P4|Overall Study|Randomized but Not Treated|0
4837849|NCT01054729|16676070|P3|Overall Study|Randomized but Not Treated|0
4837850|NCT01054729|16676071|P2|Overall Study|Randomized but Not Treated|1
4837851|NCT01054729|16676072|P1|Overall Study|Randomized but Not Treated|0
4837852|NCT01054599|16676170|P2|Overall Study|Withdrawal by Subject|1
4837853|NCT01054599|16676171|P1|Overall Study|Withdrawal by Subject|0
4837854|NCT01054599|16676170|P2|Overall Study|Adverse Event|1
4837855|NCT01054599|16676171|P1|Overall Study|Adverse Event|0
4837856|NCT01054599|16676170|P2|Overall Study|Lost to Follow-up|2
4837857|NCT01054599|16676171|P1|Overall Study|Lost to Follow-up|0
4837858|NCT01054599|16676170|P2|Overall Study|Visual impairment, WTAR <80|1
4837859|NCT01054599|16676171|P1|Overall Study|Visual impairment, WTAR <80|0
4837860|NCT01054599|16676170|P2|Overall Study|Timing/scheduling difficulties|1
4837861|NCT01054599|16676171|P1|Overall Study|Timing/scheduling difficulties|1
4837862|NCT01054599|16676170|P2|Overall Study|Spells/seizure-like episodes|1
4837863|NCT01054599|16676171|P1|Overall Study|Spells/seizure-like episodes|1
4837864|NCT01054599|16676170|P2|Overall Study|Protocol Violation|0
4837865|NCT01054599|16676171|P1|Overall Study|Protocol Violation|1
4837866|NCT01054599|16676170|P2|Overall Study|Dizziness due to phenytoin toxicity|0
4837867|NCT01054599|16676171|P1|Overall Study|Dizziness due to phenytoin toxicity|1
4837868|NCT01054573|16676278|P4|Overall Study|Withdrawal by Subject|1
4837869|NCT01054573|16676279|P3|Overall Study|Withdrawal by Subject|2
4837870|NCT01054573|16676280|P2|Overall Study|Withdrawal by Subject|2
4837871|NCT01054573|16676281|P1|Overall Study|Withdrawal by Subject|0
4837872|NCT01054573|16676278|P4|Overall Study|Lost to Follow-up|0
4837873|NCT01054573|16676279|P3|Overall Study|Lost to Follow-up|0
4837874|NCT01054573|16676280|P2|Overall Study|Lost to Follow-up|2
4837875|NCT01054573|16676281|P1|Overall Study|Lost to Follow-up|0
4837876|NCT01054573|16676278|P4|Overall Study|Adverse Event|1
4837877|NCT01054573|16676279|P3|Overall Study|Adverse Event|1
4837878|NCT01054573|16676280|P2|Overall Study|Adverse Event|0
4837879|NCT01054573|16676281|P1|Overall Study|Adverse Event|1
4837880|NCT01054560|16676327|P2|Overall Study|Physician Decision|0
4837881|NCT01054560|16676328|P1|Overall Study|Physician Decision|1
4837882|NCT01054560|16676327|P2|Overall Study|Withdrawal by Subject|2
4837883|NCT01054560|16676328|P1|Overall Study|Withdrawal by Subject|0
4837884|NCT01054560|16676327|P2|Overall Study|Lost to Follow-up|5
4837886|NCT01054560|16676327|P2|Overall Study|Death|21
4837887|NCT01054560|16676328|P1|Overall Study|Death|10
4837888|NCT01054300|16676380|P4|Period 2|Withdrawal by Subject|0
4837889|NCT01054300|16676381|P3|Period 2|Withdrawal by Subject|1
4837890|NCT01054300|16676382|P2|Period 2|Withdrawal by Subject|0
4837891|NCT01054300|16676383|P1|Period 2|Withdrawal by Subject|0
4837892|NCT01054300|16676380|P4|Period 1|Adverse Event|0
4837893|NCT01054300|16676381|P3|Period 1|Adverse Event|0
4837894|NCT01054300|16676382|P2|Period 1|Adverse Event|0
4837895|NCT01054300|16676383|P1|Period 1|Adverse Event|1
4837896|NCT01054222|16676433|P1|Overall Study|Withdrawal by Subject|6
4837897|NCT01054222|16676433|P1|Overall Study|Lost to Follow-up|4
4837898|NCT01054222|16676433|P1|Overall Study|Lack of Efficacy|1
4837899|NCT01054170|16676474|P2|Overall Study|Adverse Event|4
4837900|NCT01054170|16676475|P1|Overall Study|Adverse Event|0
4837901|NCT01054170|16676474|P2|Overall Study|Withdrawal by Subject|2
4837902|NCT01054170|16676475|P1|Overall Study|Withdrawal by Subject|3
4837903|NCT01054170|16676474|P2|Overall Study|Protocol Violation|0
4837904|NCT01054170|16676475|P1|Overall Study|Protocol Violation|1
4837905|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4837906|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Withdrawal by Subject|10
4837907|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Withdrawal by Subject|7
4837908|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Withdrawal by Subject|9
4837909|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Withdrawal by Subject|11
4837910|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Withdrawal by Subject|0
4837911|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Physician Decision|4
4837912|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Physician Decision|5
4837913|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Physician Decision|5
4837914|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Physician Decision|2
4837915|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Physician Decision|5
4837916|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Physician Decision|0
4837917|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Lost to Follow-up|3
4837918|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Lost to Follow-up|1
4837919|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Lost to Follow-up|2
4837920|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4837921|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Lost to Follow-up|4
4837922|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Lost to Follow-up|0
4837923|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
4837924|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
4837925|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8
4837926|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5
4837927|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
4837928|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4837929|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Protocol Violation|4
4837930|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Protocol Violation|1
4837931|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Protocol Violation|2
4837932|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Protocol Violation|4
4837933|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Protocol Violation|3
4837934|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Protocol Violation|0
4837935|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12
4837936|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9
4837937|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13
4837938|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16
4837939|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17
4837940|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0
4837941|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4837942|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
4837943|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
4837944|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2
4837945|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3
4837946|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0
4837947|NCT01053988|16676540|P6|24-week, Double-blind Treatment Period|Adverse Event|14
4837948|NCT01053988|16676541|P5|24-week, Double-blind Treatment Period|Adverse Event|17
4837949|NCT01053988|16676542|P4|24-week, Double-blind Treatment Period|Adverse Event|24
4837950|NCT01053988|16676543|P3|24-week, Double-blind Treatment Period|Adverse Event|23
4837951|NCT01053988|16676544|P2|24-week, Double-blind Treatment Period|Adverse Event|15
4837952|NCT01053988|16676545|P1|24-week, Double-blind Treatment Period|Adverse Event|0
4837953|NCT01053988|16676540|P6|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837954|NCT01053988|16676541|P5|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837955|NCT01053988|16676542|P4|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837956|NCT01053988|16676543|P3|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837957|NCT01053988|16676544|P2|2-week, Single-blind Run-In Period|Lost to Follow-up|0
4837958|NCT01053988|16676545|P1|2-week, Single-blind Run-In Period|Lost to Follow-up|1
4837959|NCT01053988|16676540|P6|2-week, Single-blind Run-In Period|Physician Decision|0
4837960|NCT01053988|16676541|P5|2-week, Single-blind Run-In Period|Physician Decision|0
4837961|NCT01053988|16676542|P4|2-week, Single-blind Run-In Period|Physician Decision|0
4837962|NCT01053988|16676543|P3|2-week, Single-blind Run-In Period|Physician Decision|0
4837963|NCT01053988|16676544|P2|2-week, Single-blind Run-In Period|Physician Decision|0
4837964|NCT01053988|16676545|P1|2-week, Single-blind Run-In Period|Physician Decision|5
4837965|NCT01053988|16676540|P6|2-week, Single-blind Run-In Period|Adverse Event|0
4837966|NCT01053988|16676541|P5|2-week, Single-blind Run-In Period|Adverse Event|0
4837967|NCT01053988|16676542|P4|2-week, Single-blind Run-In Period|Adverse Event|0
4837968|NCT01053988|16676543|P3|2-week, Single-blind Run-In Period|Adverse Event|0
4837969|NCT01053988|16676544|P2|2-week, Single-blind Run-In Period|Adverse Event|0
4837970|NCT01053988|16676545|P1|2-week, Single-blind Run-In Period|Adverse Event|6
4837971|NCT01053988|16676540|P6|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837972|NCT01053988|16676541|P5|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837973|NCT01053988|16676542|P4|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837974|NCT01053988|16676543|P3|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837975|NCT01053988|16676544|P2|2-week, Single-blind Run-In Period|Withdrawal by Subject|0
4837976|NCT01053988|16676545|P1|2-week, Single-blind Run-In Period|Withdrawal by Subject|30
4837977|NCT01053988|16676540|P6|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837978|NCT01053988|16676541|P5|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837979|NCT01053988|16676542|P4|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837980|NCT01053988|16676543|P3|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837981|NCT01053988|16676544|P2|2-week, Single-blind Run-In Period|Study Closed/Terminated|0
4837982|NCT01053988|16676545|P1|2-week, Single-blind Run-In Period|Study Closed/Terminated|98
4837983|NCT01053988|16676540|P6|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837984|NCT01053988|16676541|P5|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837985|NCT01053988|16676542|P4|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837986|NCT01053988|16676543|P3|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837987|NCT01053988|16676544|P2|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0
4837988|NCT01053988|16676545|P1|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220
4837989|NCT01053962|16676582|P5|Treatment Period|Noncompliance with protocol|0
4837990|NCT01053962|16676583|P4|Treatment Period|Noncompliance with protocol|0
4837991|NCT01053962|16676584|P3|Treatment Period|Noncompliance with protocol|0
4837992|NCT01053962|16676585|P2|Treatment Period|Noncompliance with protocol|0
4837993|NCT01053962|16676586|P1|Treatment Period|Noncompliance with protocol|1
4837994|NCT01053962|16676582|P5|Treatment Period|Withdrawal by Subject|1
4837995|NCT01053962|16676583|P4|Treatment Period|Withdrawal by Subject|0
4837996|NCT01053962|16676584|P3|Treatment Period|Withdrawal by Subject|0
4837997|NCT01053962|16676585|P2|Treatment Period|Withdrawal by Subject|0
4837998|NCT01053962|16676586|P1|Treatment Period|Withdrawal by Subject|0
4837999|NCT01053962|16676582|P5|Treatment Period|Adverse Event|1
4838000|NCT01053962|16676583|P4|Treatment Period|Adverse Event|0
4838001|NCT01053962|16676584|P3|Treatment Period|Adverse Event|0
4838002|NCT01053962|16676585|P2|Treatment Period|Adverse Event|0
4838003|NCT01053962|16676586|P1|Treatment Period|Adverse Event|0
4838004|NCT01053962|16676582|P5|Treatment Period|Lack of Efficacy|1
4838005|NCT01053962|16676583|P4|Treatment Period|Lack of Efficacy|0
4838006|NCT01053962|16676584|P3|Treatment Period|Lack of Efficacy|0
4838007|NCT01053962|16676585|P2|Treatment Period|Lack of Efficacy|0
4838008|NCT01053962|16676586|P1|Treatment Period|Lack of Efficacy|0
4838009|NCT01053962|16676582|P5|Pretreatment Period|Abnormal Lab values Exl 16|0
4838010|NCT01053962|16676583|P4|Pretreatment Period|Abnormal Lab values Exl 16|1
4838011|NCT01053962|16676584|P3|Pretreatment Period|Abnormal Lab values Exl 16|0
4838012|NCT01053962|16676585|P2|Pretreatment Period|Abnormal Lab values Exl 16|0
4838013|NCT01053962|16676586|P1|Pretreatment Period|Abnormal Lab values Exl 16|0
4838014|NCT01053962|16676582|P5|Pretreatment Period|Failed Urine drug screen Day 1|0
4838015|NCT01053962|16676583|P4|Pretreatment Period|Failed Urine drug screen Day 1|0
4838016|NCT01053962|16676584|P3|Pretreatment Period|Failed Urine drug screen Day 1|0
4838017|NCT01053962|16676585|P2|Pretreatment Period|Failed Urine drug screen Day 1|1
4838018|NCT01053962|16676586|P1|Pretreatment Period|Failed Urine drug screen Day 1|0
4838019|NCT01053962|16676582|P5|Pretreatment Period|Venipuncture Failure|0
4838020|NCT01053962|16676583|P4|Pretreatment Period|Venipuncture Failure|0
4838021|NCT01053962|16676584|P3|Pretreatment Period|Venipuncture Failure|1
4838022|NCT01053962|16676585|P2|Pretreatment Period|Venipuncture Failure|0
4838023|NCT01053962|16676586|P1|Pretreatment Period|Venipuncture Failure|0
4838024|NCT01053962|16676582|P5|Pretreatment Period|Withdrew Consent (Patient/PI)|2
4838025|NCT01053962|16676583|P4|Pretreatment Period|Withdrew Consent (Patient/PI)|1
4838026|NCT01053962|16676584|P3|Pretreatment Period|Withdrew Consent (Patient/PI)|0
4838027|NCT01053962|16676585|P2|Pretreatment Period|Withdrew Consent (Patient/PI)|0
4838028|NCT01053962|16676586|P1|Pretreatment Period|Withdrew Consent (Patient/PI)|0
4838029|NCT01053741|16676637|P2|2nd Study Intervention|Physician Decision|1
4838030|NCT01053741|16676638|P1|2nd Study Intervention|Physician Decision|0
4838031|NCT01053663|16676647|P1|Overall Study|Negative Influenza Diagnosis|1
4838032|NCT01053663|16676647|P1|Overall Study|Transferred to Another Hospital|1
4838033|NCT01053663|16676647|P1|Overall Study|Poor IV Access|1
4838034|NCT01053663|16676647|P1|Overall Study|Lost to Follow-up|1
4838035|NCT01053663|16676647|P1|Overall Study|Death|2
4838036|NCT01053429|16676705|P1|Overall Study|Other|309
4838037|NCT01053429|16676705|P1|Overall Study|Adverse Event|64
4838038|NCT01053247|16676735|P3|Overall Study|Adverse Event|3
4838039|NCT01053247|16676736|P2|Overall Study|Adverse Event|9
4838040|NCT01053247|16676737|P1|Overall Study|Adverse Event|0
4838041|NCT01053247|16676735|P3|Overall Study|Lost to Follow-up|7
4838042|NCT01053247|16676736|P2|Overall Study|Lost to Follow-up|5
4838043|NCT01053247|16676737|P1|Overall Study|Lost to Follow-up|8
4838044|NCT01053247|16676735|P3|Overall Study|Protocol Violation|2
4838045|NCT01053247|16676736|P2|Overall Study|Protocol Violation|1
4838046|NCT01053247|16676737|P1|Overall Study|Protocol Violation|2
4838047|NCT01053247|16676735|P3|Overall Study|Lack of Efficacy|1
4838048|NCT01053247|16676736|P2|Overall Study|Lack of Efficacy|0
4838049|NCT01053247|16676737|P1|Overall Study|Lack of Efficacy|1
4838050|NCT01053247|16676735|P3|Overall Study|Withdrawal by Subject|15
4838051|NCT01053247|16676736|P2|Overall Study|Withdrawal by Subject|4
4838052|NCT01053247|16676737|P1|Overall Study|Withdrawal by Subject|9
4838053|NCT01053221|16676747|P2|Overall Study|The study was closed prematurely|9
4838054|NCT01053221|16676748|P1|Overall Study|The study was closed prematurely|5
4838055|NCT01052844|16676850|P2|Overall Study|Adverse Event|1
4838056|NCT01052844|16676851|P1|Overall Study|Adverse Event|0
4838057|NCT01052779|16676872|P2|Overall Study|Other-Missed Week 5 Visit|0
4838058|NCT01052779|16676873|P1|Overall Study|Other-Missed Week 5 Visit|2
4838059|NCT01052779|16676872|P2|Overall Study|Other-Surgery|2
4838060|NCT01052779|16676873|P1|Overall Study|Other-Surgery|0
4838061|NCT01052779|16676872|P2|Overall Study|Other-Protocol Violation|1
4838062|NCT01052779|16676873|P1|Overall Study|Other-Protocol Violation|1
4838063|NCT01052779|16676872|P2|Overall Study|Withdrawal by Subject|2
4838064|NCT01052779|16676873|P1|Overall Study|Withdrawal by Subject|1
4838065|NCT01052779|16676872|P2|Overall Study|Adverse Event|4
4838066|NCT01052779|16676873|P1|Overall Study|Adverse Event|1
4838067|NCT01052714|16676883|P3|Overall Study|Withdrawal by Subject|1
4838068|NCT01052714|16676884|P2|Overall Study|Withdrawal by Subject|12
4838069|NCT01052714|16676885|P1|Overall Study|Withdrawal by Subject|7
4838070|NCT01052714|16676883|P3|Overall Study|Physician Decision|1
4838071|NCT01052714|16676884|P2|Overall Study|Physician Decision|9
4838072|NCT01052714|16676885|P1|Overall Study|Physician Decision|9
4838073|NCT01052714|16676883|P3|Overall Study|Lost to Follow-up|0
4838074|NCT01052714|16676884|P2|Overall Study|Lost to Follow-up|3
4838075|NCT01052714|16676885|P1|Overall Study|Lost to Follow-up|2
4838076|NCT01052714|16676883|P3|Overall Study|Death|0
4838077|NCT01052714|16676884|P2|Overall Study|Death|2
4838078|NCT01052714|16676885|P1|Overall Study|Death|1
4838079|NCT01052714|16676883|P3|Overall Study|Adverse Event|0
4838080|NCT01052714|16676884|P2|Overall Study|Adverse Event|3
4838081|NCT01052714|16676885|P1|Overall Study|Adverse Event|6
4838082|NCT01052662|16676939|P3|Overall Study|Administrative|0
4838083|NCT01052662|16676940|P2|Overall Study|Administrative|3
4838084|NCT01052662|16676941|P1|Overall Study|Administrative|0
4838085|NCT01052662|16676939|P3|Overall Study|Legal Problem|0
4838086|NCT01052662|16676940|P2|Overall Study|Legal Problem|0
4838087|NCT01052662|16676941|P1|Overall Study|Legal Problem|2
4838088|NCT01052662|16676939|P3|Overall Study|Adverse Event|0
4838089|NCT01052662|16676940|P2|Overall Study|Adverse Event|1
4838090|NCT01052662|16676941|P1|Overall Study|Adverse Event|1
4838091|NCT01052662|16676939|P3|Overall Study|Pharmacy issue|3
4838092|NCT01052662|16676940|P2|Overall Study|Pharmacy issue|3
4838093|NCT01052662|16676941|P1|Overall Study|Pharmacy issue|1
4838094|NCT01052662|16676939|P3|Overall Study|Withdrawal by Subject|1
4838095|NCT01052662|16676940|P2|Overall Study|Withdrawal by Subject|2
4838096|NCT01052662|16676941|P1|Overall Study|Withdrawal by Subject|3
4838097|NCT01052662|16676939|P3|Overall Study|Lost to Follow-up|18
4838098|NCT01052662|16676940|P2|Overall Study|Lost to Follow-up|13
4838099|NCT01052662|16676941|P1|Overall Study|Lost to Follow-up|15
4838100|NCT01052480|16676982|P2|Overall Study|Death|5
4838101|NCT01052480|16676983|P1|Overall Study|Death|1
4838102|NCT01052480|16676982|P2|Overall Study|Physician Decision|2
4838103|NCT01052480|16676983|P1|Overall Study|Physician Decision|0
4838104|NCT01052480|16676982|P2|Overall Study|Withdrawal by Subject|7
4838105|NCT01052480|16676983|P1|Overall Study|Withdrawal by Subject|3
4838106|NCT01052480|16676982|P2|Overall Study|Protocol Violation|0
4838107|NCT01052480|16676983|P1|Overall Study|Protocol Violation|1
4838108|NCT01052480|16676982|P2|Overall Study|Lost to Follow-up|3
4838109|NCT01052480|16676983|P1|Overall Study|Lost to Follow-up|3
4838110|NCT01052428|16677033|P2|Overall Study|Withdrawal by Subject|1
4838111|NCT01052428|16677034|P1|Overall Study|Withdrawal by Subject|0
4838112|NCT01052428|16677033|P2|Overall Study|Death|0
4838113|NCT01052428|16677034|P1|Overall Study|Death|1
4838114|NCT01052272|16677056|P4|Overall Study|decline in health|0
4838115|NCT01052272|16677057|P3|Overall Study|decline in health|1
4838116|NCT01052272|16677058|P2|Overall Study|decline in health|0
4838117|NCT01052272|16677059|P1|Overall Study|decline in health|0
4838118|NCT01052272|16677056|P4|Overall Study|placed in long-term care|0
4838119|NCT01052272|16677057|P3|Overall Study|placed in long-term care|1
4838120|NCT01052272|16677058|P2|Overall Study|placed in long-term care|0
4838121|NCT01052272|16677059|P1|Overall Study|placed in long-term care|0
4838122|NCT01052272|16677056|P4|Overall Study|Withdrawal by Subject|2
4838123|NCT01052272|16677057|P3|Overall Study|Withdrawal by Subject|3
4838124|NCT01052272|16677058|P2|Overall Study|Withdrawal by Subject|2
4838125|NCT01052272|16677059|P1|Overall Study|Withdrawal by Subject|0
4838126|NCT01052272|16677056|P4|Overall Study|patient refuses follow-up|4
4838127|NCT01052272|16677057|P3|Overall Study|patient refuses follow-up|2
4838128|NCT01052272|16677058|P2|Overall Study|patient refuses follow-up|4
4838129|NCT01052272|16677059|P1|Overall Study|patient refuses follow-up|5
4838130|NCT01052272|16677056|P4|Overall Study|Physician Decision|0
4838131|NCT01052272|16677057|P3|Overall Study|Physician Decision|0
4838132|NCT01052272|16677058|P2|Overall Study|Physician Decision|1
4838133|NCT01052272|16677059|P1|Overall Study|Physician Decision|0
4838134|NCT01052272|16677056|P4|Overall Study|Death|1
4838135|NCT01052272|16677057|P3|Overall Study|Death|1
4838136|NCT01052272|16677058|P2|Overall Study|Death|0
4838137|NCT01052272|16677059|P1|Overall Study|Death|0
4838138|NCT01052116|16677104|P2|Overall Study|Spirometry not performed|4
4838139|NCT01052116|16677105|P1|Overall Study|Spirometry not performed|0
4838140|NCT01052116|16677104|P2|Overall Study|Withdrawal by Subject|6
4838141|NCT01052116|16677105|P1|Overall Study|Withdrawal by Subject|3
4838142|NCT01052116|16677104|P2|Overall Study|Lost to Follow-up|17
4838143|NCT01052116|16677105|P1|Overall Study|Lost to Follow-up|11
4838144|NCT01052077|16677113|P4|Phase A+|Withdrawal by Subject|7
4838145|NCT01052077|16677114|P3|Phase A+|Withdrawal by Subject|0
4838146|NCT01052077|16677115|P2|Phase A+|Withdrawal by Subject|0
4838147|NCT01052077|16677116|P1|Phase A+|Withdrawal by Subject|0
4838148|NCT01052077|16677113|P4|Phase A+|Met Withdrawal Criteria|2
4838149|NCT01052077|16677114|P3|Phase A+|Met Withdrawal Criteria|0
4838150|NCT01052077|16677115|P2|Phase A+|Met Withdrawal Criteria|0
4838151|NCT01052077|16677116|P1|Phase A+|Met Withdrawal Criteria|0
4838152|NCT01052077|16677113|P4|Phase A+|Adverse Event|4
4838153|NCT01052077|16677114|P3|Phase A+|Adverse Event|0
4838154|NCT01052077|16677115|P2|Phase A+|Adverse Event|0
4838155|NCT01052077|16677116|P1|Phase A+|Adverse Event|0
4838156|NCT01052077|16677113|P4|Phase A+|Lost to Follow-up|8
4838157|NCT01052077|16677114|P3|Phase A+|Lost to Follow-up|0
4838158|NCT01052077|16677115|P2|Phase A+|Lost to Follow-up|0
4838159|NCT01052077|16677116|P1|Phase A+|Lost to Follow-up|0
4838160|NCT01052077|16677113|P4|Phase B|Lack of Efficacy|0
4838161|NCT01052077|16677114|P3|Phase B|Lack of Efficacy|0
4838162|NCT01052077|16677115|P2|Phase B|Lack of Efficacy|1
4838163|NCT01052077|16677116|P1|Phase B|Lack of Efficacy|0
4838164|NCT01052077|16677113|P4|Phase B|Protocol Deviation|0
4838165|NCT01052077|16677114|P3|Phase B|Protocol Deviation|4
4838166|NCT01052077|16677115|P2|Phase B|Protocol Deviation|3
4838167|NCT01052077|16677116|P1|Phase B|Protocol Deviation|0
4838168|NCT01052077|16677113|P4|Phase B|Withdrawal by Subject|0
4838169|NCT01052077|16677114|P3|Phase B|Withdrawal by Subject|5
4838170|NCT01052077|16677115|P2|Phase B|Withdrawal by Subject|0
4838171|NCT01052077|16677116|P1|Phase B|Withdrawal by Subject|0
4838172|NCT01052077|16677113|P4|Phase B|Physician Decision|0
4838173|NCT01052077|16677114|P3|Phase B|Physician Decision|1
4838174|NCT01052077|16677115|P2|Phase B|Physician Decision|1
4838175|NCT01052077|16677116|P1|Phase B|Physician Decision|0
4838176|NCT01052077|16677113|P4|Phase B|Met Withdrawal Criteria|0
4838177|NCT01052077|16677114|P3|Phase B|Met Withdrawal Criteria|1
4838178|NCT01052077|16677115|P2|Phase B|Met Withdrawal Criteria|2
4838179|NCT01052077|16677116|P1|Phase B|Met Withdrawal Criteria|0
4838180|NCT01052077|16677113|P4|Phase B|Adverse Event|0
4838181|NCT01052077|16677114|P3|Phase B|Adverse Event|2
4838182|NCT01052077|16677115|P2|Phase B|Adverse Event|9
4838183|NCT01052077|16677116|P1|Phase B|Adverse Event|0
4838184|NCT01052077|16677113|P4|Phase B|Lost to Follow-up|0
4838185|NCT01052077|16677114|P3|Phase B|Lost to Follow-up|3
4838186|NCT01052077|16677115|P2|Phase B|Lost to Follow-up|2
4838187|NCT01052077|16677116|P1|Phase B|Lost to Follow-up|0
4838188|NCT01052077|16677113|P4|Phase A|Protocol Deviation|0
4838189|NCT01052077|16677114|P3|Phase A|Protocol Deviation|0
4838190|NCT01052077|16677115|P2|Phase A|Protocol Deviation|0
4838191|NCT01052077|16677116|P1|Phase A|Protocol Deviation|27
4838192|NCT01052077|16677113|P4|Phase A|Withdrawal by Subject|0
4838193|NCT01052077|16677114|P3|Phase A|Withdrawal by Subject|0
4838194|NCT01052077|16677115|P2|Phase A|Withdrawal by Subject|0
4838195|NCT01052077|16677116|P1|Phase A|Withdrawal by Subject|29
4838196|NCT01052077|16677113|P4|Phase A|Physician Decision|0
4838197|NCT01052077|16677114|P3|Phase A|Physician Decision|0
4838198|NCT01052077|16677115|P2|Phase A|Physician Decision|0
4838199|NCT01052077|16677116|P1|Phase A|Physician Decision|10
4838200|NCT01052077|16677113|P4|Phase A|Met Withdrawal Criteria|0
4838201|NCT01052077|16677114|P3|Phase A|Met Withdrawal Criteria|0
4838202|NCT01052077|16677115|P2|Phase A|Met Withdrawal Criteria|0
4838203|NCT01052077|16677116|P1|Phase A|Met Withdrawal Criteria|26
4838204|NCT01052077|16677113|P4|Phase A|Adverse Event|0
4838205|NCT01052077|16677114|P3|Phase A|Adverse Event|0
4838206|NCT01052077|16677115|P2|Phase A|Adverse Event|0
4838207|NCT01052077|16677116|P1|Phase A|Adverse Event|32
4838208|NCT01052077|16677113|P4|Phase A|Lost to Follow-up|0
4838209|NCT01052077|16677114|P3|Phase A|Lost to Follow-up|0
4838210|NCT01052077|16677115|P2|Phase A|Lost to Follow-up|0
4838211|NCT01052077|16677116|P1|Phase A|Lost to Follow-up|22
4838212|NCT01052038|16677143|P3|Overall Study|Protocol Violation|3
4838213|NCT01052038|16677144|P2|Overall Study|Protocol Violation|3
4838214|NCT01052038|16677145|P1|Overall Study|Protocol Violation|2
4838215|NCT01052038|16677143|P3|Overall Study|Lost to Follow-up|1
4838216|NCT01052038|16677144|P2|Overall Study|Lost to Follow-up|3
4838217|NCT01052038|16677145|P1|Overall Study|Lost to Follow-up|2
4838218|NCT01051986|16677167|P2|Overall Study|Protocol Violation|3
4838219|NCT01051986|16677168|P1|Overall Study|Protocol Violation|2
4838220|NCT01051986|16677167|P2|Overall Study|Withdrawal by Subject|1
4838221|NCT01051986|16677168|P1|Overall Study|Withdrawal by Subject|2
4838222|NCT01051986|16677167|P2|Overall Study|Death|0
4838223|NCT01051986|16677168|P1|Overall Study|Death|1
4838224|NCT01051921|16677182|P1|Overall Study|patient moved|1
4838225|NCT01051921|16677182|P1|Overall Study|virological failure|1
4838226|NCT01051921|16677182|P1|Overall Study|Lost to Follow-up|4
4838227|NCT01051921|16677182|P1|Overall Study|Withdrawal by Subject|7
4838228|NCT01051921|16677182|P1|Overall Study|Adverse Event|8
4838229|NCT01051921|16677182|P1|Overall Study|Physician Decision|9
4838230|NCT01051856|16677189|P2|Overall Study|Withdrawal by Subject|0
4838231|NCT01051856|16677190|P1|Overall Study|Withdrawal by Subject|1
4838232|NCT01051817|16677200|P2|Overall Study|Protocol Violation|1
4838233|NCT01051817|16677201|P1|Overall Study|Protocol Violation|0
4838234|NCT01051817|16677200|P2|Overall Study|Withdrawal by Subject|5
4838235|NCT01051817|16677201|P1|Overall Study|Withdrawal by Subject|3
4838236|NCT01051817|16677200|P2|Overall Study|Abnormal Test Proceedure reults|1
4838237|NCT01051817|16677201|P1|Overall Study|Abnormal Test Proceedure reults|0
4838238|NCT01051817|16677200|P2|Overall Study|Adverse Event|2
4838239|NCT01051817|16677201|P1|Overall Study|Adverse Event|0
4838240|NCT01051791|16677211|P1|Overall Study|Withdrawal by Subject|1
4838241|NCT01051791|16677211|P1|Overall Study|Failed screening|3
4838242|NCT01051739|16677229|P2|Overall Study|Withdrawal by Subject|10
4838243|NCT01051739|16677230|P1|Overall Study|Withdrawal by Subject|25
4838244|NCT01051739|16677229|P2|Overall Study|Death|3
4838245|NCT01051739|16677230|P1|Overall Study|Death|3
4838246|NCT01051661|16677242|P6|Overall Study|Withdrawal by Subject|34
4838247|NCT01051661|16677243|P5|Overall Study|Withdrawal by Subject|12
4838248|NCT01051661|16677244|P4|Overall Study|Withdrawal by Subject|28
4838249|NCT01051661|16677245|P3|Overall Study|Withdrawal by Subject|13
4838250|NCT01051661|16677246|P2|Overall Study|Withdrawal by Subject|30
4838251|NCT01051661|16677247|P1|Overall Study|Withdrawal by Subject|16
4838252|NCT01051661|16677242|P6|Overall Study|Protocol Violation|1
4838253|NCT01051661|16677243|P5|Overall Study|Protocol Violation|2
4838254|NCT01051661|16677244|P4|Overall Study|Protocol Violation|1
4838255|NCT01051661|16677245|P3|Overall Study|Protocol Violation|0
4838256|NCT01051661|16677246|P2|Overall Study|Protocol Violation|0
4838257|NCT01051661|16677247|P1|Overall Study|Protocol Violation|0
4838258|NCT01051661|16677242|P6|Overall Study|Subject lost legal representation|0
4838259|NCT01051661|16677243|P5|Overall Study|Subject lost legal representation|1
4838260|NCT01051661|16677244|P4|Overall Study|Subject lost legal representation|0
4838261|NCT01051661|16677245|P3|Overall Study|Subject lost legal representation|0
4838262|NCT01051661|16677246|P2|Overall Study|Subject lost legal representation|0
4838263|NCT01051661|16677247|P1|Overall Study|Subject lost legal representation|0
4838264|NCT01051661|16677242|P6|Overall Study|Failure to comply with protocol|0
4838265|NCT01051661|16677243|P5|Overall Study|Failure to comply with protocol|0
4838266|NCT01051661|16677244|P4|Overall Study|Failure to comply with protocol|0
4838267|NCT01051661|16677245|P3|Overall Study|Failure to comply with protocol|2
4838268|NCT01051661|16677246|P2|Overall Study|Failure to comply with protocol|0
4838269|NCT01051661|16677247|P1|Overall Study|Failure to comply with protocol|0
4838270|NCT01051661|16677242|P6|Overall Study|Consent not received from both parents|1
4838271|NCT01051661|16677243|P5|Overall Study|Consent not received from both parents|0
4838272|NCT01051661|16677244|P4|Overall Study|Consent not received from both parents|0
4838273|NCT01051661|16677245|P3|Overall Study|Consent not received from both parents|0
4838274|NCT01051661|16677246|P2|Overall Study|Consent not received from both parents|0
4838275|NCT01051661|16677247|P1|Overall Study|Consent not received from both parents|0
4838276|NCT01051661|16677242|P6|Overall Study|Unable to attend visit(s)|2
4838277|NCT01051661|16677243|P5|Overall Study|Unable to attend visit(s)|3
4838278|NCT01051661|16677244|P4|Overall Study|Unable to attend visit(s)|1
4838279|NCT01051661|16677245|P3|Overall Study|Unable to attend visit(s)|2
4838280|NCT01051661|16677246|P2|Overall Study|Unable to attend visit(s)|4
4838281|NCT01051661|16677247|P1|Overall Study|Unable to attend visit(s)|2
4838282|NCT01051661|16677242|P6|Overall Study|Data not reliable|1
4838283|NCT01051661|16677243|P5|Overall Study|Data not reliable|0
4838284|NCT01051661|16677244|P4|Overall Study|Data not reliable|0
4838285|NCT01051661|16677245|P3|Overall Study|Data not reliable|0
4838286|NCT01051661|16677246|P2|Overall Study|Data not reliable|0
4838287|NCT01051661|16677247|P1|Overall Study|Data not reliable|1
4838288|NCT01051661|16677242|P6|Overall Study|Refused blood sampling|1
4838289|NCT01051661|16677243|P5|Overall Study|Refused blood sampling|0
4838290|NCT01051661|16677244|P4|Overall Study|Refused blood sampling|0
4838291|NCT01051661|16677245|P3|Overall Study|Refused blood sampling|0
4838292|NCT01051661|16677246|P2|Overall Study|Refused blood sampling|0
4838293|NCT01051661|16677247|P1|Overall Study|Refused blood sampling|0
4838294|NCT01051661|16677242|P6|Overall Study|Migrated/moved from study area|3
4838295|NCT01051661|16677243|P5|Overall Study|Migrated/moved from study area|7
4838296|NCT01051661|16677244|P4|Overall Study|Migrated/moved from study area|8
4838297|NCT01051661|16677245|P3|Overall Study|Migrated/moved from study area|6
4838298|NCT01051661|16677246|P2|Overall Study|Migrated/moved from study area|6
4838299|NCT01051661|16677247|P1|Overall Study|Migrated/moved from study area|1
4838300|NCT01051661|16677242|P6|Overall Study|Lost to Follow-up|24
4838301|NCT01051661|16677243|P5|Overall Study|Lost to Follow-up|10
4838302|NCT01051661|16677244|P4|Overall Study|Lost to Follow-up|17
4838303|NCT01051661|16677245|P3|Overall Study|Lost to Follow-up|15
4838304|NCT01051661|16677246|P2|Overall Study|Lost to Follow-up|22
4838305|NCT01051661|16677247|P1|Overall Study|Lost to Follow-up|13
4838306|NCT01051661|16677242|P6|Overall Study|Adverse Event|0
4838307|NCT01051661|16677243|P5|Overall Study|Adverse Event|0
4838308|NCT01051661|16677244|P4|Overall Study|Adverse Event|1
4838309|NCT01051661|16677245|P3|Overall Study|Adverse Event|1
4838310|NCT01051661|16677246|P2|Overall Study|Adverse Event|1
4838311|NCT01051661|16677247|P1|Overall Study|Adverse Event|1
4838312|NCT01051557|16677444|P7|Overall Study|Adverse Event|4
4838313|NCT01051557|16677445|P6|Overall Study|Adverse Event|3
4838314|NCT01051557|16677446|P5|Overall Study|Adverse Event|1
4838315|NCT01051557|16677447|P4|Overall Study|Adverse Event|1
4838316|NCT01051557|16677448|P3|Overall Study|Adverse Event|0
4838317|NCT01051557|16677449|P2|Overall Study|Adverse Event|0
4838318|NCT01051557|16677450|P1|Overall Study|Adverse Event|0
4838319|NCT01051557|16677444|P7|Overall Study|Withdrawal by Subject|1
4838320|NCT01051557|16677445|P6|Overall Study|Withdrawal by Subject|0
4838321|NCT01051557|16677446|P5|Overall Study|Withdrawal by Subject|2
4838322|NCT01051557|16677447|P4|Overall Study|Withdrawal by Subject|0
4838323|NCT01051557|16677448|P3|Overall Study|Withdrawal by Subject|1
4838324|NCT01051557|16677449|P2|Overall Study|Withdrawal by Subject|0
4838325|NCT01051557|16677450|P1|Overall Study|Withdrawal by Subject|0
4838326|NCT01051557|16677444|P7|Overall Study|disease progression|1
4838327|NCT01051557|16677445|P6|Overall Study|disease progression|3
4838328|NCT01051557|16677446|P5|Overall Study|disease progression|4
4838329|NCT01051557|16677447|P4|Overall Study|disease progression|2
4838330|NCT01051557|16677448|P3|Overall Study|disease progression|5
4838331|NCT01051557|16677449|P2|Overall Study|disease progression|3
4838332|NCT01051557|16677450|P1|Overall Study|disease progression|3
4838333|NCT01051557|16677444|P7|Overall Study|Physician Decision|0
4838334|NCT01051557|16677445|P6|Overall Study|Physician Decision|0
4838335|NCT01051557|16677446|P5|Overall Study|Physician Decision|0
4838336|NCT01051557|16677447|P4|Overall Study|Physician Decision|0
4838337|NCT01051557|16677448|P3|Overall Study|Physician Decision|0
4838338|NCT01051557|16677449|P2|Overall Study|Physician Decision|0
4838339|NCT01051557|16677450|P1|Overall Study|Physician Decision|1
4838340|NCT01051466|16677481|P2|Overall Study|Physician Decision|0
4838341|NCT01051466|16677482|P1|Overall Study|Physician Decision|1
4838342|NCT01051466|16677481|P2|Overall Study|Entry Criteria Not Met|3
4838343|NCT01051466|16677482|P1|Overall Study|Entry Criteria Not Met|0
4838344|NCT01051466|16677481|P2|Overall Study|Withdrawal by Subject|1
4838345|NCT01051466|16677482|P1|Overall Study|Withdrawal by Subject|5
4838346|NCT01051466|16677481|P2|Overall Study|Lost to Follow-up|1
4838347|NCT01051466|16677482|P1|Overall Study|Lost to Follow-up|1
4838348|NCT01051466|16677481|P2|Overall Study|Adverse Event|0
4838349|NCT01051466|16677482|P1|Overall Study|Adverse Event|1
4838350|NCT01051349|16677527|P1|Overall Study|Reason not Specified|12
4838351|NCT01051349|16677527|P1|Overall Study|Subject non-compliance|7
4838352|NCT01051349|16677527|P1|Overall Study|Lost to Follow-up|6
4838353|NCT01051349|16677527|P1|Overall Study|Investigator Decision|6
4838354|NCT01051349|16677527|P1|Overall Study|Consent Withdrawn|54
4838355|NCT01051349|16677527|P1|Overall Study|Adverse Event|88
4838356|NCT01051323|16677556|P1|Overall Study|Missing|37
4838357|NCT01051323|16677556|P1|Overall Study|Other|148
4838358|NCT01051323|16677556|P1|Overall Study|Hospitalization|28
4838359|NCT01051323|16677556|P1|Overall Study|Death|129
4838360|NCT01051323|16677556|P1|Overall Study|Lost to Follow-up|31
4838361|NCT01051323|16677556|P1|Overall Study|Withdrawal by Subject|13
4838362|NCT01051323|16677556|P1|Overall Study|Dialysis dependency|22
4838363|NCT01051323|16677556|P1|Overall Study|Transplantation|28
4838364|NCT01051323|16677556|P1|Overall Study|Discontinuation of treatment|103
4838365|NCT01051063|16677585|P2|Overall Study|Lost to Follow-up|1
4838366|NCT01051063|16677586|P1|Overall Study|Lost to Follow-up|0
4838367|NCT01051063|16677585|P2|Overall Study|Other|0
4838368|NCT01051063|16677586|P1|Overall Study|Other|1
4838369|NCT01051063|16677585|P2|Overall Study|Moved from the study site area|0
4838370|NCT01051063|16677586|P1|Overall Study|Moved from the study site area|1
4838371|NCT01051063|16677585|P2|Overall Study|Termination of the study|0
4838372|NCT01051063|16677586|P1|Overall Study|Termination of the study|5
4838373|NCT01051063|16677585|P2|Overall Study|Withdrawal by Subject|1
4838374|NCT01051063|16677586|P1|Overall Study|Withdrawal by Subject|1
4838375|NCT01051063|16677585|P2|Overall Study|Death|2
4838376|NCT01051063|16677586|P1|Overall Study|Death|2
4838377|NCT01050998|16677606|P5|Overall Study|Data integrity issues|4
4838378|NCT01050998|16677607|P4|Overall Study|Data integrity issues|1
4838379|NCT01050998|16677608|P3|Overall Study|Data integrity issues|1
4838380|NCT01050998|16677609|P2|Overall Study|Data integrity issues|0
4838381|NCT01050998|16677610|P1|Overall Study|Data integrity issues|0
4838382|NCT01050998|16677606|P5|Overall Study|Other|5
4838383|NCT01050998|16677607|P4|Overall Study|Other|1
4838384|NCT01050998|16677608|P3|Overall Study|Other|1
4838385|NCT01050998|16677609|P2|Overall Study|Other|2
4838386|NCT01050998|16677610|P1|Overall Study|Other|3
4838387|NCT01050998|16677606|P5|Overall Study|Withdrawal by Subject|3
4838388|NCT01050998|16677607|P4|Overall Study|Withdrawal by Subject|1
4838389|NCT01050998|16677608|P3|Overall Study|Withdrawal by Subject|0
4838390|NCT01050998|16677609|P2|Overall Study|Withdrawal by Subject|0
4838391|NCT01050998|16677610|P1|Overall Study|Withdrawal by Subject|0
4838392|NCT01050998|16677606|P5|Overall Study|Adverse Event|2
4838393|NCT01050998|16677607|P4|Overall Study|Adverse Event|0
4838394|NCT01050998|16677608|P3|Overall Study|Adverse Event|1
4838395|NCT01050998|16677609|P2|Overall Study|Adverse Event|0
4838396|NCT01050998|16677610|P1|Overall Study|Adverse Event|1
4838397|NCT01050816|16677949|P1|Overall Study|patient's refusal|2
4838398|NCT01050816|16677949|P1|Overall Study|Lost to Follow-up|2
4838399|NCT01050790|16677955|P1|Overall Study|Adverse Event|1
4838400|NCT01050764|16677965|P1|Overall Study|Death after HSCT, before T-cell infusion|1
4838401|NCT01050764|16677965|P1|Overall Study|Donor mobilization failure, death|1
4838402|NCT01050764|16677965|P1|Overall Study|Death, before HSCT|1
4838403|NCT01050673|16677976|P2|Overall Study|Physician Decision|5
4838404|NCT01050673|16677977|P1|Overall Study|Physician Decision|4
4838405|NCT01050634|16678045|P1|Overall Study|Ongoing at Date of Cut-Off|5
4838406|NCT01050634|16678045|P1|Overall Study|Other|21
4838407|NCT01050634|16678045|P1|Overall Study|Lost to Follow-up|2
4838408|NCT01050634|16678045|P1|Overall Study|Adverse Event|42
4838409|NCT01050634|16678045|P1|Overall Study|Death|2
4838410|NCT01050634|16678045|P1|Overall Study|Enrolled, but Not Treated|56
4838411|NCT01050569|16678069|P3|Overall Study|Physician Decision|3
4838412|NCT01050569|16678070|P2|Overall Study|Physician Decision|3
4838413|NCT01050569|16678071|P1|Overall Study|Physician Decision|3
4838414|NCT01050569|16678069|P3|Overall Study|Adverse Event|0
4838415|NCT01050569|16678070|P2|Overall Study|Adverse Event|0
4838416|NCT01050569|16678071|P1|Overall Study|Adverse Event|1
4838417|NCT01050569|16678069|P3|Overall Study|Lack of Efficacy|3
4838418|NCT01050569|16678070|P2|Overall Study|Lack of Efficacy|4
4838419|NCT01050569|16678071|P1|Overall Study|Lack of Efficacy|5
4838420|NCT01050569|16678069|P3|Overall Study|Withdrawal by Subject|11
4838421|NCT01050569|16678070|P2|Overall Study|Withdrawal by Subject|3
4838422|NCT01050569|16678071|P1|Overall Study|Withdrawal by Subject|9
4838423|NCT01050569|16678069|P3|Overall Study|Lost to Follow-up|16
4838424|NCT01050569|16678070|P2|Overall Study|Lost to Follow-up|14
4838425|NCT01050569|16678071|P1|Overall Study|Lost to Follow-up|20
4838426|NCT01050543|16678090|P2|Overall Study|Administrative|1
4838427|NCT01050543|16678091|P1|Overall Study|Administrative|4
4838428|NCT01050543|16678090|P2|Overall Study|Protocol Violation|1
4838429|NCT01050543|16678091|P1|Overall Study|Protocol Violation|0
4838430|NCT01050543|16678090|P2|Overall Study|Withdrawal by Subject|2
4838431|NCT01050543|16678091|P1|Overall Study|Withdrawal by Subject|0
4838432|NCT01050530|16678099|P2|Overall Study|Protocol Violation|0
4838433|NCT01050530|16678100|P1|Overall Study|Protocol Violation|1
4838434|NCT01050530|16678099|P2|Overall Study|Withdrawal by Subject|3
4838435|NCT01050530|16678100|P1|Overall Study|Withdrawal by Subject|0
4838436|NCT01050530|16678099|P2|Overall Study|Lack of Efficacy|4
4838437|NCT01050530|16678100|P1|Overall Study|Lack of Efficacy|1
4838438|NCT01050530|16678099|P2|Overall Study|Adverse Event|3
4838439|NCT01050530|16678100|P1|Overall Study|Adverse Event|6
4838440|NCT01050257|16678111|P3|Overall Study|Death|1
4838441|NCT01050257|16678112|P2|Overall Study|Death|0
4838442|NCT01050257|16678113|P1|Overall Study|Death|0
4838443|NCT01050257|16678111|P3|Overall Study|Failure to return|0
4838444|NCT01050257|16678112|P2|Overall Study|Failure to return|2
4838445|NCT01050257|16678113|P1|Overall Study|Failure to return|0
4838446|NCT01050257|16678111|P3|Overall Study|Violation criteria|0
4838447|NCT01050257|16678112|P2|Overall Study|Violation criteria|1
4838448|NCT01050257|16678113|P1|Overall Study|Violation criteria|0
4838449|NCT01050257|16678111|P3|Overall Study|Refused treatment/ Did not Cooperate|0
4838450|NCT01050257|16678112|P2|Overall Study|Refused treatment/ Did not Cooperate|1
4838451|NCT01050257|16678113|P1|Overall Study|Refused treatment/ Did not Cooperate|1
4838452|NCT01050257|16678111|P3|Overall Study|No reason specified|2
4838453|NCT01050257|16678112|P2|Overall Study|No reason specified|0
4838454|NCT01050257|16678113|P1|Overall Study|No reason specified|0
4838455|NCT01050257|16678111|P3|Overall Study|Withdrawal by Subject|0
4838456|NCT01050257|16678112|P2|Overall Study|Withdrawal by Subject|3
4838457|NCT01050257|16678113|P1|Overall Study|Withdrawal by Subject|0
4838458|NCT01050257|16678111|P3|Overall Study|Admin/Other (did not switch to oral)|2
4838459|NCT01050257|16678112|P2|Overall Study|Admin/Other (did not switch to oral)|2
4838460|NCT01050257|16678113|P1|Overall Study|Admin/Other (did not switch to oral)|6
4838461|NCT01050257|16678111|P3|Overall Study|Adverse Event|2
4838462|NCT01050257|16678112|P2|Overall Study|Adverse Event|4
4838463|NCT01050257|16678113|P1|Overall Study|Adverse Event|4
4838464|NCT01050218|16678148|P1|Overall Study|Family emergency|1
4838465|NCT01050218|16678148|P1|Overall Study|Serious Adverse Event|1
4838466|NCT01050218|16678148|P1|Overall Study|Failed to return|7
4838467|NCT01050218|16678148|P1|Overall Study|Compliance|2
4838468|NCT01050218|16678148|P1|Overall Study|Discontinued by sponsor|18
4838469|NCT01050218|16678148|P1|Overall Study|Withdrawal by Subject|18
4838470|NCT01050218|16678148|P1|Overall Study|Protocol Violation|3
4838471|NCT01050218|16678148|P1|Overall Study|Lack of Efficacy|8
4838472|NCT01050218|16678148|P1|Overall Study|Adverse Event|37
4838473|NCT01050205|16678154|P2|Overall Study|Discontinued Intervention|0
4838474|NCT01050205|16678155|P1|Overall Study|Discontinued Intervention|2
4838475|NCT01050205|16678154|P2|Overall Study|Relocated from area|2
4838476|NCT01050205|16678155|P1|Overall Study|Relocated from area|1
4838477|NCT01050205|16678154|P2|Overall Study|Withdrawal by Subject|1
4838478|NCT01050205|16678155|P1|Overall Study|Withdrawal by Subject|1
4838479|NCT01050205|16678154|P2|Overall Study|Lost to Follow-up|1
4838480|NCT01050205|16678155|P1|Overall Study|Lost to Follow-up|7
4838481|NCT01050062|16678212|P2|Overall Study|Others|11
4838482|NCT01050062|16678213|P1|Overall Study|Others|17
4838483|NCT01050062|16678212|P2|Overall Study|Physician Decision|9
4838484|NCT01050062|16678213|P1|Overall Study|Physician Decision|74
4838485|NCT01050062|16678212|P2|Overall Study|Lack of Efficacy|35
4838486|NCT01050062|16678213|P1|Overall Study|Lack of Efficacy|22
4838487|NCT01050062|16678212|P2|Overall Study|Lost to Follow-up|35
4838488|NCT01050062|16678213|P1|Overall Study|Lost to Follow-up|83
4838489|NCT01050062|16678212|P2|Overall Study|Adverse Event|22
4838490|NCT01050062|16678213|P1|Overall Study|Adverse Event|75
4838491|NCT01049984|16678235|P2|Overall Study|Treatment failure|2
4838492|NCT01049984|16678236|P1|Overall Study|Treatment failure|0
4838493|NCT01049984|16678235|P2|Overall Study|Adverse Event|7
4838494|NCT01049984|16678236|P1|Overall Study|Adverse Event|13
4838495|NCT01049984|16678235|P2|Overall Study|Lost to Follow-up|1
4838496|NCT01049984|16678236|P1|Overall Study|Lost to Follow-up|2
4838497|NCT01049984|16678235|P2|Overall Study|Protocol Violation|4
4838498|NCT01049984|16678236|P1|Overall Study|Protocol Violation|3
4838499|NCT01049984|16678235|P2|Overall Study|Withdrawal by Subject|5
4838500|NCT01049984|16678236|P1|Overall Study|Withdrawal by Subject|1
4838501|NCT01049581|16678300|P2|Overall Study|Lost to Follow-up|1
4838502|NCT01049581|16678301|P1|Overall Study|Lost to Follow-up|2
4838503|NCT01049503|16678316|P6|Overall Study|Lost to Follow-up|8
4838504|NCT01049503|16678317|P5|Overall Study|Lost to Follow-up|27
4838505|NCT01049503|16678318|P4|Overall Study|Lost to Follow-up|26
4838506|NCT01049503|16678319|P3|Overall Study|Lost to Follow-up|24
4838507|NCT01049503|16678320|P2|Overall Study|Lost to Follow-up|12
4838508|NCT01049503|16678321|P1|Overall Study|Lost to Follow-up|11
4838509|NCT01049412|16678352|P2|Period II|Lost to Follow-up|0
4838510|NCT01049412|16678353|P1|Period II|Lost to Follow-up|1
4838511|NCT01049412|16678352|P2|Period II|Adverse Event|0
4838512|NCT01049412|16678353|P1|Period II|Adverse Event|1
4838513|NCT01049412|16678352|P2|Period II|Withdrawal by Subject|3
4838514|NCT01049412|16678353|P1|Period II|Withdrawal by Subject|2
4838515|NCT01049412|16678352|P2|Period I|Adverse Event|0
4838516|NCT01049412|16678353|P1|Period I|Adverse Event|1
4838517|NCT01049412|16678352|P2|Period I|Protocol Violation|2
4838518|NCT01049412|16678353|P1|Period I|Protocol Violation|1
4838519|NCT01049412|16678352|P2|Period I|Physician Decision|3
4838520|NCT01049412|16678353|P1|Period I|Physician Decision|0
4838521|NCT01049412|16678352|P2|Period I|Lost to Follow-up|2
4838522|NCT01049412|16678353|P1|Period I|Lost to Follow-up|2
4838523|NCT01049412|16678352|P2|Period I|Withdrawal by Subject|6
4838524|NCT01049412|16678353|P1|Period I|Withdrawal by Subject|4
4838525|NCT01049373|16678382|P2|Overall Study|Non-cooperation|1
4838526|NCT01049373|16678383|P1|Overall Study|Non-cooperation|0
4838527|NCT01049373|16678382|P2|Overall Study|Other|1
4838528|NCT01049373|16678383|P1|Overall Study|Other|1
4838529|NCT01049373|16678382|P2|Overall Study|no evaluable study values|21
4838530|NCT01049373|16678383|P1|Overall Study|no evaluable study values|9
4838531|NCT01049373|16678382|P2|Overall Study|Lost to Follow-up|4
4838532|NCT01049373|16678383|P1|Overall Study|Lost to Follow-up|9
4838533|NCT01049373|16678382|P2|Overall Study|Adverse Event|3
4838534|NCT01049373|16678383|P1|Overall Study|Adverse Event|3
4838535|NCT01049373|16678382|P2|Overall Study|Withdrawal by Subject|5
4838536|NCT01049373|16678383|P1|Overall Study|Withdrawal by Subject|8
4838537|NCT01049373|16678382|P2|Overall Study|Protocol Violation|9
4838538|NCT01049373|16678383|P1|Overall Study|Protocol Violation|9
4838539|NCT01049360|16678397|P20|Period 4|Withdrawal by Subject|0
4838540|NCT01049360|16678398|P19|Period 4|Withdrawal by Subject|0
4838541|NCT01049360|16678399|P18|Period 4|Withdrawal by Subject|0
4838542|NCT01049360|16678400|P17|Period 4|Withdrawal by Subject|0
4838543|NCT01049360|16678401|P16|Period 4|Withdrawal by Subject|0
4838544|NCT01049360|16678402|P15|Period 4|Withdrawal by Subject|0
4838545|NCT01049360|16678403|P14|Period 4|Withdrawal by Subject|0
4838546|NCT01049360|16678404|P13|Period 4|Withdrawal by Subject|0
4838547|NCT01049360|16678405|P12|Period 4|Withdrawal by Subject|0
4838548|NCT01049360|16678406|P11|Period 4|Withdrawal by Subject|0
4838549|NCT01049360|16678407|P10|Period 4|Withdrawal by Subject|0
4838550|NCT01049360|16678408|P9|Period 4|Withdrawal by Subject|0
4838551|NCT01049360|16678409|P8|Period 4|Withdrawal by Subject|0
4838552|NCT01049360|16678410|P7|Period 4|Withdrawal by Subject|0
4838553|NCT01049360|16678411|P6|Period 4|Withdrawal by Subject|0
4838554|NCT01049360|16678412|P5|Period 4|Withdrawal by Subject|0
4838555|NCT01049360|16678413|P4|Period 4|Withdrawal by Subject|1
4838556|NCT01049360|16678414|P3|Period 4|Withdrawal by Subject|0
4838557|NCT01049360|16678415|P2|Period 4|Withdrawal by Subject|0
4838558|NCT01049360|16678416|P1|Period 4|Withdrawal by Subject|0
4838559|NCT01049360|16678397|P20|Period 4|Protocol Violation|0
4838560|NCT01049360|16678398|P19|Period 4|Protocol Violation|0
4838561|NCT01049360|16678399|P18|Period 4|Protocol Violation|1
4838562|NCT01049360|16678400|P17|Period 4|Protocol Violation|0
4838563|NCT01049360|16678401|P16|Period 4|Protocol Violation|0
4838564|NCT01049360|16678402|P15|Period 4|Protocol Violation|0
4838565|NCT01049360|16678403|P14|Period 4|Protocol Violation|0
4838566|NCT01049360|16678404|P13|Period 4|Protocol Violation|0
4838567|NCT01049360|16678405|P12|Period 4|Protocol Violation|0
4838568|NCT01049360|16678406|P11|Period 4|Protocol Violation|0
4838569|NCT01049360|16678407|P10|Period 4|Protocol Violation|0
4838570|NCT01049360|16678408|P9|Period 4|Protocol Violation|0
4838571|NCT01049360|16678409|P8|Period 4|Protocol Violation|0
4838572|NCT01049360|16678410|P7|Period 4|Protocol Violation|0
4838573|NCT01049360|16678411|P6|Period 4|Protocol Violation|0
4838574|NCT01049360|16678412|P5|Period 4|Protocol Violation|0
4838575|NCT01049360|16678413|P4|Period 4|Protocol Violation|0
4838576|NCT01049360|16678414|P3|Period 4|Protocol Violation|0
4838577|NCT01049360|16678415|P2|Period 4|Protocol Violation|0
4838578|NCT01049360|16678416|P1|Period 4|Protocol Violation|0
4838579|NCT01049360|16678397|P20|Period 2|Lack of Efficacy|0
4838580|NCT01049360|16678398|P19|Period 2|Lack of Efficacy|0
4838581|NCT01049360|16678399|P18|Period 2|Lack of Efficacy|0
4838582|NCT01049360|16678400|P17|Period 2|Lack of Efficacy|0
4838583|NCT01049360|16678401|P16|Period 2|Lack of Efficacy|0
4838584|NCT01049360|16678402|P15|Period 2|Lack of Efficacy|0
4838585|NCT01049360|16678403|P14|Period 2|Lack of Efficacy|0
4838586|NCT01049360|16678404|P13|Period 2|Lack of Efficacy|0
4838587|NCT01049360|16678405|P12|Period 2|Lack of Efficacy|0
4838588|NCT01049360|16678406|P11|Period 2|Lack of Efficacy|0
4838589|NCT01049360|16678407|P10|Period 2|Lack of Efficacy|0
4838590|NCT01049360|16678408|P9|Period 2|Lack of Efficacy|0
4838591|NCT01049360|16678409|P8|Period 2|Lack of Efficacy|0
4838592|NCT01049360|16678410|P7|Period 2|Lack of Efficacy|0
4838593|NCT01049360|16678411|P6|Period 2|Lack of Efficacy|1
4838594|NCT01049360|16678412|P5|Period 2|Lack of Efficacy|0
4838595|NCT01049360|16678413|P4|Period 2|Lack of Efficacy|0
4838596|NCT01049360|16678414|P3|Period 2|Lack of Efficacy|0
4838597|NCT01049360|16678415|P2|Period 2|Lack of Efficacy|0
4838598|NCT01049360|16678416|P1|Period 2|Lack of Efficacy|0
4838599|NCT01049360|16678397|P20|Period 2|Withdrawal by Subject|1
4838600|NCT01049360|16678398|P19|Period 2|Withdrawal by Subject|0
4838601|NCT01049360|16678399|P18|Period 2|Withdrawal by Subject|0
4838602|NCT01049360|16678400|P17|Period 2|Withdrawal by Subject|0
4838603|NCT01049360|16678401|P16|Period 2|Withdrawal by Subject|0
4838604|NCT01049360|16678402|P15|Period 2|Withdrawal by Subject|1
4838605|NCT01049360|16678403|P14|Period 2|Withdrawal by Subject|0
4838606|NCT01049360|16678404|P13|Period 2|Withdrawal by Subject|0
4838607|NCT01049360|16678405|P12|Period 2|Withdrawal by Subject|0
4838608|NCT01049360|16678406|P11|Period 2|Withdrawal by Subject|0
4838609|NCT01049360|16678407|P10|Period 2|Withdrawal by Subject|0
4838610|NCT01049360|16678408|P9|Period 2|Withdrawal by Subject|0
4838611|NCT01049360|16678409|P8|Period 2|Withdrawal by Subject|0
4838612|NCT01049360|16678410|P7|Period 2|Withdrawal by Subject|0
4838613|NCT01049360|16678411|P6|Period 2|Withdrawal by Subject|0
4838614|NCT01049360|16678412|P5|Period 2|Withdrawal by Subject|0
4838615|NCT01049360|16678413|P4|Period 2|Withdrawal by Subject|1
4838616|NCT01049360|16678414|P3|Period 2|Withdrawal by Subject|0
4838617|NCT01049360|16678415|P2|Period 2|Withdrawal by Subject|0
4838618|NCT01049360|16678416|P1|Period 2|Withdrawal by Subject|0
4838619|NCT01049360|16678397|P20|Period 2|Adverse Event|1
4838620|NCT01049360|16678398|P19|Period 2|Adverse Event|0
4838621|NCT01049360|16678399|P18|Period 2|Adverse Event|0
4838622|NCT01049360|16678400|P17|Period 2|Adverse Event|0
4838623|NCT01049360|16678401|P16|Period 2|Adverse Event|0
4838624|NCT01049360|16678402|P15|Period 2|Adverse Event|0
4838625|NCT01049360|16678403|P14|Period 2|Adverse Event|0
4838626|NCT01049360|16678404|P13|Period 2|Adverse Event|0
4838627|NCT01049360|16678405|P12|Period 2|Adverse Event|0
4838628|NCT01049360|16678406|P11|Period 2|Adverse Event|0
4838629|NCT01049360|16678407|P10|Period 2|Adverse Event|0
4838630|NCT01049360|16678408|P9|Period 2|Adverse Event|1
4838631|NCT01049360|16678409|P8|Period 2|Adverse Event|0
4838632|NCT01049360|16678410|P7|Period 2|Adverse Event|0
4838633|NCT01049360|16678411|P6|Period 2|Adverse Event|0
4838634|NCT01049360|16678412|P5|Period 2|Adverse Event|0
4838635|NCT01049360|16678413|P4|Period 2|Adverse Event|0
4838636|NCT01049360|16678414|P3|Period 2|Adverse Event|0
4838637|NCT01049360|16678415|P2|Period 2|Adverse Event|1
4838638|NCT01049360|16678416|P1|Period 2|Adverse Event|0
4838639|NCT01049360|16678397|P20|Period 2|Protocol Violation|0
4838640|NCT01049360|16678398|P19|Period 2|Protocol Violation|0
4838641|NCT01049360|16678399|P18|Period 2|Protocol Violation|0
4838642|NCT01049360|16678400|P17|Period 2|Protocol Violation|0
4838643|NCT01049360|16678401|P16|Period 2|Protocol Violation|1
4838644|NCT01049360|16678402|P15|Period 2|Protocol Violation|1
4838645|NCT01049360|16678403|P14|Period 2|Protocol Violation|0
4838646|NCT01049360|16678404|P13|Period 2|Protocol Violation|0
4838647|NCT01049360|16678405|P12|Period 2|Protocol Violation|0
4838648|NCT01049360|16678406|P11|Period 2|Protocol Violation|0
4838649|NCT01049360|16678407|P10|Period 2|Protocol Violation|0
4838650|NCT01049360|16678408|P9|Period 2|Protocol Violation|0
4838651|NCT01049360|16678409|P8|Period 2|Protocol Violation|0
4838652|NCT01049360|16678410|P7|Period 2|Protocol Violation|0
4838653|NCT01049360|16678411|P6|Period 2|Protocol Violation|0
4838654|NCT01049360|16678412|P5|Period 2|Protocol Violation|0
4838655|NCT01049360|16678413|P4|Period 2|Protocol Violation|1
4838656|NCT01049360|16678414|P3|Period 2|Protocol Violation|0
4838657|NCT01049360|16678415|P2|Period 2|Protocol Violation|0
4838658|NCT01049360|16678416|P1|Period 2|Protocol Violation|0
4838659|NCT01049360|16678397|P20|Period 1|Withdrawal by Subject|0
4838660|NCT01049360|16678398|P19|Period 1|Withdrawal by Subject|0
4838661|NCT01049360|16678399|P18|Period 1|Withdrawal by Subject|0
4838662|NCT01049360|16678400|P17|Period 1|Withdrawal by Subject|0
4838663|NCT01049360|16678401|P16|Period 1|Withdrawal by Subject|0
4838664|NCT01049360|16678402|P15|Period 1|Withdrawal by Subject|0
4838665|NCT01049360|16678403|P14|Period 1|Withdrawal by Subject|0
4838666|NCT01049360|16678404|P13|Period 1|Withdrawal by Subject|1
4838667|NCT01049360|16678405|P12|Period 1|Withdrawal by Subject|0
4838668|NCT01049360|16678406|P11|Period 1|Withdrawal by Subject|1
4838669|NCT01049360|16678407|P10|Period 1|Withdrawal by Subject|0
4838670|NCT01049360|16678408|P9|Period 1|Withdrawal by Subject|1
4838671|NCT01049360|16678409|P8|Period 1|Withdrawal by Subject|0
4838672|NCT01049360|16678410|P7|Period 1|Withdrawal by Subject|0
4838673|NCT01049360|16678411|P6|Period 1|Withdrawal by Subject|0
4838674|NCT01049360|16678412|P5|Period 1|Withdrawal by Subject|0
4838675|NCT01049360|16678413|P4|Period 1|Withdrawal by Subject|0
4838676|NCT01049360|16678414|P3|Period 1|Withdrawal by Subject|0
4838677|NCT01049360|16678415|P2|Period 1|Withdrawal by Subject|0
4838678|NCT01049360|16678416|P1|Period 1|Withdrawal by Subject|0
4838679|NCT01049360|16678397|P20|Period 1|Did not meet inc/exc criteria|0
4838680|NCT01049360|16678398|P19|Period 1|Did not meet inc/exc criteria|0
4838681|NCT01049360|16678399|P18|Period 1|Did not meet inc/exc criteria|0
4838682|NCT01049360|16678400|P17|Period 1|Did not meet inc/exc criteria|0
4838683|NCT01049360|16678401|P16|Period 1|Did not meet inc/exc criteria|0
4838684|NCT01049360|16678402|P15|Period 1|Did not meet inc/exc criteria|0
4838685|NCT01049360|16678403|P14|Period 1|Did not meet inc/exc criteria|0
4838686|NCT01049360|16678404|P13|Period 1|Did not meet inc/exc criteria|0
4838687|NCT01049360|16678405|P12|Period 1|Did not meet inc/exc criteria|0
4838688|NCT01049360|16678406|P11|Period 1|Did not meet inc/exc criteria|0
4838689|NCT01049360|16678407|P10|Period 1|Did not meet inc/exc criteria|0
4838690|NCT01049360|16678408|P9|Period 1|Did not meet inc/exc criteria|1
4838691|NCT01049360|16678409|P8|Period 1|Did not meet inc/exc criteria|1
4838692|NCT01049360|16678410|P7|Period 1|Did not meet inc/exc criteria|0
4838693|NCT01049360|16678411|P6|Period 1|Did not meet inc/exc criteria|0
4838694|NCT01049360|16678412|P5|Period 1|Did not meet inc/exc criteria|0
4838695|NCT01049360|16678413|P4|Period 1|Did not meet inc/exc criteria|0
4838696|NCT01049360|16678414|P3|Period 1|Did not meet inc/exc criteria|0
4838697|NCT01049360|16678415|P2|Period 1|Did not meet inc/exc criteria|0
4838698|NCT01049360|16678416|P1|Period 1|Did not meet inc/exc criteria|0
4838699|NCT01049360|16678397|P20|Period 1|Adverse Event|0
4838700|NCT01049360|16678398|P19|Period 1|Adverse Event|1
4838701|NCT01049360|16678399|P18|Period 1|Adverse Event|0
4838702|NCT01049360|16678400|P17|Period 1|Adverse Event|1
4838703|NCT01049360|16678401|P16|Period 1|Adverse Event|0
4838704|NCT01049360|16678402|P15|Period 1|Adverse Event|0
4838705|NCT01049360|16678403|P14|Period 1|Adverse Event|1
4838706|NCT01049360|16678404|P13|Period 1|Adverse Event|1
4838707|NCT01049360|16678405|P12|Period 1|Adverse Event|0
4838708|NCT01049360|16678406|P11|Period 1|Adverse Event|0
4838709|NCT01049360|16678407|P10|Period 1|Adverse Event|0
4838710|NCT01049360|16678408|P9|Period 1|Adverse Event|0
4838711|NCT01049360|16678409|P8|Period 1|Adverse Event|1
4838712|NCT01049360|16678410|P7|Period 1|Adverse Event|0
4838713|NCT01049360|16678411|P6|Period 1|Adverse Event|0
4838714|NCT01049360|16678412|P5|Period 1|Adverse Event|0
4838715|NCT01049360|16678413|P4|Period 1|Adverse Event|1
4838716|NCT01049360|16678414|P3|Period 1|Adverse Event|0
4838717|NCT01049360|16678415|P2|Period 1|Adverse Event|1
4838718|NCT01049360|16678416|P1|Period 1|Adverse Event|0
4838719|NCT01049334|16678440|P2|Overall Study|Protocol Violation|1
4838720|NCT01049334|16678441|P1|Overall Study|Protocol Violation|0
4838721|NCT01049334|16678440|P2|Overall Study|Physician Decision|0
4838722|NCT01049334|16678441|P1|Overall Study|Physician Decision|2
4838723|NCT01049334|16678440|P2|Overall Study|Adverse Event|3
4838724|NCT01049334|16678441|P1|Overall Study|Adverse Event|2
4838725|NCT01049334|16678440|P2|Overall Study|Withdrawal by Subject|3
4838726|NCT01049334|16678441|P1|Overall Study|Withdrawal by Subject|5
4838727|NCT01049308|16678477|P1|Pill Counts|Withdrawal by Subject|83
4838728|NCT01049217|16678491|P2|Overall Study|Randomized but not Treated|2
4838729|NCT01049217|16678492|P1|Overall Study|Randomized but not Treated|0
4838730|NCT01049217|16678491|P2|Overall Study|Other|2
4838731|NCT01049217|16678492|P1|Overall Study|Other|1
4838732|NCT01049217|16678491|P2|Overall Study|Study Terminated by Sponsor|43
4838733|NCT01049217|16678492|P1|Overall Study|Study Terminated by Sponsor|43
4838734|NCT01049217|16678491|P2|Overall Study|Pregnancy|0
4838735|NCT01049217|16678492|P1|Overall Study|Pregnancy|1
4838736|NCT01049217|16678491|P2|Overall Study|Protocol Violation|3
4838737|NCT01049217|16678492|P1|Overall Study|Protocol Violation|1
4838738|NCT01049217|16678491|P2|Overall Study|Withdrawal by Subject|3
4838739|NCT01049217|16678492|P1|Overall Study|Withdrawal by Subject|4
4838740|NCT01049217|16678491|P2|Overall Study|Lost to Follow-up|8
4838741|NCT01049217|16678492|P1|Overall Study|Lost to Follow-up|3
4838742|NCT01049217|16678491|P2|Overall Study|Lack of Efficacy|1
4838743|NCT01049217|16678492|P1|Overall Study|Lack of Efficacy|1
4838744|NCT01049217|16678491|P2|Overall Study|Adverse Event|1
4838745|NCT01049217|16678492|P1|Overall Study|Adverse Event|2
4838746|NCT01049035|16678569|P7|Overall Study|Voluntary withdrawal not due to an AE|2
4838747|NCT01049035|16678570|P6|Overall Study|Voluntary withdrawal not due to an AE|5
4838748|NCT01049035|16678571|P5|Overall Study|Voluntary withdrawal not due to an AE|1
4838749|NCT01049035|16678572|P4|Overall Study|Voluntary withdrawal not due to an AE|2
4838750|NCT01049035|16678573|P3|Overall Study|Voluntary withdrawal not due to an AE|8
4838751|NCT01049035|16678574|P2|Overall Study|Voluntary withdrawal not due to an AE|10
4838752|NCT01049035|16678575|P1|Overall Study|Voluntary withdrawal not due to an AE|16
4838753|NCT01049035|16678569|P7|Overall Study|Lost to Follow-up|3
4838754|NCT01049035|16678570|P6|Overall Study|Lost to Follow-up|3
4838755|NCT01049035|16678571|P5|Overall Study|Lost to Follow-up|0
4838756|NCT01049035|16678572|P4|Overall Study|Lost to Follow-up|1
4838757|NCT01049035|16678573|P3|Overall Study|Lost to Follow-up|4
4838758|NCT01049035|16678574|P2|Overall Study|Lost to Follow-up|4
4838759|NCT01049035|16678575|P1|Overall Study|Lost to Follow-up|5
4838760|NCT01049035|16678569|P7|Overall Study|Non-compliance with the protocol|10
4838761|NCT01049035|16678570|P6|Overall Study|Non-compliance with the protocol|4
4838762|NCT01049035|16678571|P5|Overall Study|Non-compliance with the protocol|3
4838763|NCT01049035|16678572|P4|Overall Study|Non-compliance with the protocol|5
4838764|NCT01049035|16678573|P3|Overall Study|Non-compliance with the protocol|14
4838765|NCT01049035|16678574|P2|Overall Study|Non-compliance with the protocol|6
4838766|NCT01049035|16678575|P1|Overall Study|Non-compliance with the protocol|12
4838767|NCT01049035|16678569|P7|Overall Study|Other adverse event (AE)|0
4838768|NCT01049035|16678570|P6|Overall Study|Other adverse event (AE)|0
4838769|NCT01049035|16678571|P5|Overall Study|Other adverse event (AE)|0
4838770|NCT01049035|16678572|P4|Overall Study|Other adverse event (AE)|1
4838771|NCT01049035|16678573|P3|Overall Study|Other adverse event (AE)|0
4838772|NCT01049035|16678574|P2|Overall Study|Other adverse event (AE)|0
4838773|NCT01049035|16678575|P1|Overall Study|Other adverse event (AE)|0
4838774|NCT01049035|16678569|P7|Overall Study|Serious adverse event|0
4838775|NCT01049035|16678570|P6|Overall Study|Serious adverse event|0
4838776|NCT01049035|16678571|P5|Overall Study|Serious adverse event|0
4838777|NCT01049035|16678572|P4|Overall Study|Serious adverse event|2
4838778|NCT01049035|16678573|P3|Overall Study|Serious adverse event|1
4838779|NCT01049035|16678574|P2|Overall Study|Serious adverse event|1
4838780|NCT01049035|16678575|P1|Overall Study|Serious adverse event|0
4838781|NCT01049009|16678734|P2|Treatment Period 2 (12 Weeks)|Protocol Violation|7
4838782|NCT01049009|16678735|P1|Treatment Period 2 (12 Weeks)|Protocol Violation|8
4838783|NCT01049009|16678734|P2|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3
4838784|NCT01049009|16678735|P1|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2
4838785|NCT01049009|16678734|P2|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1
4838786|NCT01049009|16678735|P1|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0
4838787|NCT01049009|16678734|P2|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4838788|NCT01049009|16678735|P1|Treatment Period 1 (12 Weeks)|Protocol Violation|2
4838789|NCT01048944|16678747|P4|Overall Study|Protocol Violation|2
4838790|NCT01048944|16678748|P3|Overall Study|Protocol Violation|10
4838791|NCT01048944|16678749|P2|Overall Study|Protocol Violation|10
4838792|NCT01048944|16678750|P1|Overall Study|Protocol Violation|8
4838793|NCT01048866|16678782|P2|Overall Study|Other|1
4838794|NCT01048866|16678783|P1|Overall Study|Other|1
4838795|NCT01048866|16678782|P2|Overall Study|Lost to Follow-up|2
4838796|NCT01048866|16678783|P1|Overall Study|Lost to Follow-up|0
4838797|NCT01048866|16678782|P2|Overall Study|Withdrawal by Subject|2
4838798|NCT01048866|16678783|P1|Overall Study|Withdrawal by Subject|0
4838799|NCT01048866|16678782|P2|Overall Study|Physician Decision|0
4838800|NCT01048866|16678783|P1|Overall Study|Physician Decision|1
4838801|NCT01048866|16678782|P2|Overall Study|Protocol Violation|0
4838802|NCT01048866|16678783|P1|Overall Study|Protocol Violation|1
4838803|NCT01048866|16678782|P2|Overall Study|Adverse Event|0
4838804|NCT01048866|16678783|P1|Overall Study|Adverse Event|1
4838805|NCT01048788|16678828|P3|Overall Study|Withdrawal by Subject|0
4838806|NCT01048788|16678829|P2|Overall Study|Withdrawal by Subject|1
4838807|NCT01048788|16678830|P1|Overall Study|Withdrawal by Subject|0
4838808|NCT01048788|16678828|P3|Overall Study|Lack of Efficacy|1
4838809|NCT01048788|16678829|P2|Overall Study|Lack of Efficacy|0
4838810|NCT01048788|16678830|P1|Overall Study|Lack of Efficacy|0
4838811|NCT01048788|16678828|P3|Overall Study|Adverse Event|1
4838812|NCT01048788|16678829|P2|Overall Study|Adverse Event|1
4838813|NCT01048788|16678830|P1|Overall Study|Adverse Event|5
4838814|NCT01048671|16678852|P3|Overall Study|Protocol Violation|1
4838815|NCT01048671|16678853|P2|Overall Study|Protocol Violation|1
4838816|NCT01048671|16678854|P1|Overall Study|Protocol Violation|0
4838817|NCT01048541|16678934|P2|Overall Study|Withdrawal by Subject|0
4838818|NCT01048541|16678935|P1|Overall Study|Withdrawal by Subject|1
4838819|NCT01048502|16678945|P4|Overall Study|Physician Decision|1
4838820|NCT01048502|16678946|P3|Overall Study|Physician Decision|0
4838821|NCT01048502|16678947|P2|Overall Study|Physician Decision|3
4838822|NCT01048502|16678948|P1|Overall Study|Physician Decision|0
4838823|NCT01048502|16678945|P4|Overall Study|Withdrawal by Subject|3
4838824|NCT01048502|16678946|P3|Overall Study|Withdrawal by Subject|5
4838825|NCT01048502|16678947|P2|Overall Study|Withdrawal by Subject|4
4838826|NCT01048502|16678948|P1|Overall Study|Withdrawal by Subject|1
4838827|NCT01048502|16678945|P4|Overall Study|Adverse Event|0
4838828|NCT01048502|16678946|P3|Overall Study|Adverse Event|0
4838829|NCT01048502|16678947|P2|Overall Study|Adverse Event|0
4838830|NCT01048502|16678948|P1|Overall Study|Adverse Event|1
4838831|NCT01048502|16678945|P4|Overall Study|Lost to Follow-up|0
4838832|NCT01048502|16678946|P3|Overall Study|Lost to Follow-up|0
4838833|NCT01048502|16678947|P2|Overall Study|Lost to Follow-up|0
4838834|NCT01048502|16678948|P1|Overall Study|Lost to Follow-up|2
4838835|NCT01048333|16678984|P6|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4838836|NCT01048333|16678985|P5|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4838837|NCT01048333|16678986|P4|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4838838|NCT01048333|16678987|P3|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4838839|NCT01048333|16678988|P2|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1
4838840|NCT01048333|16678989|P1|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0
4838841|NCT01048242|16679011|P2|Overall Study|See study flow chart|2
4838842|NCT01048242|16679012|P1|Overall Study|See study flow chart|4
4838843|NCT01048099|16679027|P1|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202
4838844|NCT01048099|16679027|P1|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57
4838845|NCT01047553|16679075|P2|Overall Study|PI's decision|1
4838846|NCT01047553|16679076|P1|Overall Study|PI's decision|0
4838847|NCT01047553|16679075|P2|Overall Study|Sever Non-Compliance to Protocol|0
4838848|NCT01047553|16679076|P1|Overall Study|Sever Non-Compliance to Protocol|1
4838849|NCT01047553|16679075|P2|Overall Study|Lost to Follow-up|0
4838850|NCT01047553|16679076|P1|Overall Study|Lost to Follow-up|1
4838851|NCT01047553|16679075|P2|Overall Study|Development of Study-Specific Withdrawal|1
4838852|NCT01047553|16679076|P1|Overall Study|Development of Study-Specific Withdrawal|1
4838853|NCT01047553|16679075|P2|Overall Study|Withdrawal by Subject|2
4838854|NCT01047553|16679076|P1|Overall Study|Withdrawal by Subject|4
4838855|NCT01047553|16679075|P2|Overall Study|Adverse Event|5
4838856|NCT01047553|16679076|P1|Overall Study|Adverse Event|10
4838857|NCT01047436|16679183|P2|Overall Study|Protocol Violation|0
4838858|NCT01047436|16679184|P1|Overall Study|Protocol Violation|1
4838859|NCT01047345|16679209|P3|Extension|Lost to Follow-up|5
4838860|NCT01047345|16679210|P2|Extension|Lost to Follow-up|0
4838861|NCT01047345|16679211|P1|Extension|Lost to Follow-up|0
4838862|NCT01047345|16679209|P3|Extension|Withdrawal by Subject|1
4838863|NCT01047345|16679210|P2|Extension|Withdrawal by Subject|0
4838864|NCT01047345|16679211|P1|Extension|Withdrawal by Subject|0
4838865|NCT01047345|16679209|P3|Base Study|Withdrawal by Subject|0
4838866|NCT01047345|16679210|P2|Base Study|Withdrawal by Subject|4
4838867|NCT01047345|16679211|P1|Base Study|Withdrawal by Subject|12
4838868|NCT01047345|16679209|P3|Base Study|Protocol Violation|0
4838869|NCT01047345|16679210|P2|Base Study|Protocol Violation|1
4838870|NCT01047345|16679211|P1|Base Study|Protocol Violation|3
4838871|NCT01047345|16679209|P3|Base Study|Lost to Follow-up|0
4838872|NCT01047345|16679210|P2|Base Study|Lost to Follow-up|1
4838873|NCT01047345|16679211|P1|Base Study|Lost to Follow-up|4
4838874|NCT01047345|16679209|P3|Base Study|Adverse Event|0
4838875|NCT01047345|16679210|P2|Base Study|Adverse Event|0
4838876|NCT01047345|16679211|P1|Base Study|Adverse Event|3
4838877|NCT01047332|16679233|P2|Overall Study|Lost to Follow-up|3
4838878|NCT01047332|16679234|P1|Overall Study|Lost to Follow-up|8
4838879|NCT01047332|16679233|P2|Overall Study|Died Unobstructed|41
4838880|NCT01047332|16679234|P1|Overall Study|Died Unobstructed|38
4838881|NCT01047332|16679233|P2|Overall Study|SEMS Obstruction|20
4838882|NCT01047332|16679234|P1|Overall Study|SEMS Obstruction|11
4838883|NCT01047319|16679249|P3|Overall Study|Study terminated by Sponsor|203
4838884|NCT01047319|16679250|P2|Overall Study|Study terminated by Sponsor|215
4838885|NCT01047319|16679251|P1|Overall Study|Study terminated by Sponsor|198
4838886|NCT01047319|16679249|P3|Overall Study|Withdrawal by Subject|87
4838887|NCT01047319|16679250|P2|Overall Study|Withdrawal by Subject|75
4838888|NCT01047319|16679251|P1|Overall Study|Withdrawal by Subject|77
4838889|NCT01047319|16679249|P3|Overall Study|Adverse Event|21
4838890|NCT01047319|16679250|P2|Overall Study|Adverse Event|27
4838891|NCT01047319|16679251|P1|Overall Study|Adverse Event|16
4838892|NCT01047319|16679249|P3|Overall Study|Lost to Follow-up|10
4838893|NCT01047319|16679250|P2|Overall Study|Lost to Follow-up|10
4838894|NCT01047319|16679251|P1|Overall Study|Lost to Follow-up|14
4838895|NCT01047319|16679249|P3|Overall Study|Physician Decision|10
4838896|NCT01047319|16679250|P2|Overall Study|Physician Decision|9
4838897|NCT01047319|16679251|P1|Overall Study|Physician Decision|12
4838898|NCT01047319|16679249|P3|Overall Study|Pregnancy|8
4838899|NCT01047319|16679250|P2|Overall Study|Pregnancy|8
4838900|NCT01047319|16679251|P1|Overall Study|Pregnancy|13
4838901|NCT01047319|16679249|P3|Overall Study|Death|5
4838902|NCT01047319|16679250|P2|Overall Study|Death|1
4838903|NCT01047319|16679251|P1|Overall Study|Death|5
4838904|NCT01047319|16679249|P3|Overall Study|Lack of Efficacy|3
4838905|NCT01047319|16679250|P2|Overall Study|Lack of Efficacy|3
4838906|NCT01047319|16679251|P1|Overall Study|Lack of Efficacy|4
4838907|NCT01047319|16679249|P3|Overall Study|Protocol Violation|4
4838908|NCT01047319|16679250|P2|Overall Study|Protocol Violation|2
4838909|NCT01047319|16679251|P1|Overall Study|Protocol Violation|3
4838910|NCT01047319|16679249|P3|Overall Study|Teva requested participant withdrawal|1
4838911|NCT01047319|16679250|P2|Overall Study|Teva requested participant withdrawal|0
4838912|NCT01047319|16679251|P1|Overall Study|Teva requested participant withdrawal|3
4838913|NCT01047306|16679273|P2|Overall Study|Lost to Follow-up|0
4838914|NCT01047306|16679274|P1|Overall Study|Lost to Follow-up|1
4838915|NCT01047306|16679273|P2|Overall Study|Withdrawal by Subject|0
4838916|NCT01047306|16679274|P1|Overall Study|Withdrawal by Subject|2
4838917|NCT01047293|16679348|P4|Overall Study|DLT criteria not fulfilled|0
4838918|NCT01047293|16679349|P3|Overall Study|DLT criteria not fulfilled|0
4838919|NCT01047293|16679350|P2|Overall Study|DLT criteria not fulfilled|1
4838920|NCT01047293|16679351|P1|Overall Study|DLT criteria not fulfilled|1
4838921|NCT01047007|16679382|P4|Overall Study|Progressive Disease|0
4838922|NCT01047007|16679383|P3|Overall Study|Progressive Disease|1
4838923|NCT01047007|16679384|P2|Overall Study|Progressive Disease|4
4838924|NCT01047007|16679385|P1|Overall Study|Progressive Disease|2
4838925|NCT01047007|16679382|P4|Overall Study|Adverse Event|0
4838926|NCT01047007|16679383|P3|Overall Study|Adverse Event|1
4838927|NCT01047007|16679384|P2|Overall Study|Adverse Event|2
4838928|NCT01047007|16679385|P1|Overall Study|Adverse Event|0
4838929|NCT01046903|16679396|P1|Overall Study|Other|5
4838930|NCT01046903|16679396|P1|Overall Study|Withdrawal by Subject|3
4838931|NCT01046903|16679396|P1|Overall Study|Adverse Event|4
4838932|NCT01046903|16679396|P1|Overall Study|Lost to Follow-up|16
4838933|NCT01046877|16679409|P1|Overall Study|Exited voluntarily after tube extrusion|11
4838934|NCT01046877|16679409|P1|Overall Study|Exited voluntarily before tube extrusion|7
4838935|NCT01046695|16679425|P2|Overall Study|TENS interfered with the cardiac monitor|1
4838936|NCT01046695|16679426|P1|Overall Study|TENS interfered with the cardiac monitor|0
4838937|NCT01046695|16679425|P2|Overall Study|Subject had a pacemaker|1
4838938|NCT01046695|16679426|P1|Overall Study|Subject had a pacemaker|0
4838939|NCT01046682|16679438|P2|Overall Study|Adverse Event|0
4838940|NCT01046682|16679439|P1|Overall Study|Adverse Event|2
4838941|NCT01046643|16679456|P4|First Period Treatment or Placebo|Withdrawal by Subject|0
4838942|NCT01046643|16679457|P3|First Period Treatment or Placebo|Withdrawal by Subject|0
4838943|NCT01046643|16679458|P2|First Period Treatment or Placebo|Withdrawal by Subject|1
4838944|NCT01046643|16679459|P1|First Period Treatment or Placebo|Withdrawal by Subject|0
4838945|NCT01046565|16679481|P1|Overall Study|Withdrawal by Subject|7
4838946|NCT01046565|16679481|P1|Overall Study|Adverse Event|2
4838947|NCT01046396|16679490|P1|Overall Study|Withdrawal by Subject|5
4838948|NCT01046253|16679501|P2|Second Intervention|Protocol Violation|1
4838949|NCT01046253|16679502|P1|Second Intervention|Protocol Violation|0
4838950|NCT01046253|16679501|P2|Second Intervention|Adverse Event|1
4838951|NCT01046253|16679502|P1|Second Intervention|Adverse Event|0
4838952|NCT01046136|16679514|P2|Overall Study|Lost to Follow-up|3
4838953|NCT01046136|16679515|P1|Overall Study|Lost to Follow-up|3
4838954|NCT01046136|16679514|P2|Overall Study|Physician Decision|1
4838955|NCT01046136|16679515|P1|Overall Study|Physician Decision|1
4838956|NCT01046136|16679514|P2|Overall Study|Withdrawal by Subject|4
4838957|NCT01046136|16679515|P1|Overall Study|Withdrawal by Subject|0
4838958|NCT01046110|16679527|P2|Overall Study|Unclassified|35
4838959|NCT01046110|16679528|P1|Overall Study|Unclassified|36
4838960|NCT01046110|16679527|P2|Overall Study|Withdrawal Criteria|5
4838961|NCT01046110|16679528|P1|Overall Study|Withdrawal Criteria|3
4838962|NCT01046110|16679527|P2|Overall Study|Protocol Violation|12
4838963|NCT01046110|16679528|P1|Overall Study|Protocol Violation|7
4838964|NCT01046110|16679527|P2|Overall Study|Lack of Efficacy|1
4838965|NCT01046110|16679528|P1|Overall Study|Lack of Efficacy|0
4838966|NCT01046110|16679527|P2|Overall Study|Adverse Event|2
4838967|NCT01046110|16679528|P1|Overall Study|Adverse Event|9
4838968|NCT01046084|16679538|P2|Third Washout of 7 Days|Withdrawal by Subject|0
4838969|NCT01046084|16679539|P1|Third Washout of 7 Days|Withdrawal by Subject|2
4838970|NCT01045993|16679553|P4|Overall Study|Treated-later found eligibility not met|0
4838971|NCT01045993|16679554|P3|Overall Study|Treated-later found eligibility not met|0
4838972|NCT01045993|16679555|P2|Overall Study|Treated-later found eligibility not met|1
4838973|NCT01045993|16679556|P1|Overall Study|Treated-later found eligibility not met|0
4838974|NCT01045967|16679632|P2|Second Intervention|Protocol Violation|1
4838975|NCT01045967|16679633|P1|Second Intervention|Protocol Violation|0
4838976|NCT01045798|16679645|P2|Overall Study|Received Systemic Antifungal Prestudy|1
4838977|NCT01045798|16679646|P1|Overall Study|Received Systemic Antifungal Prestudy|0
4838978|NCT01045798|16679645|P2|Overall Study|Changed to Other Antifungal Therapy|2
4838979|NCT01045798|16679646|P1|Overall Study|Changed to Other Antifungal Therapy|1
4838980|NCT01045798|16679645|P2|Overall Study|Invasive Fungal Infection at Baseline|1
4838981|NCT01045798|16679646|P1|Overall Study|Invasive Fungal Infection at Baseline|0
4838982|NCT01045798|16679645|P2|Overall Study|Changed to Open-Label Caspofungin|0
4838983|NCT01045798|16679646|P1|Overall Study|Changed to Open-Label Caspofungin|1
4838984|NCT01045707|16679654|P2|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5
4838985|NCT01045707|16679655|P1|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6
4838986|NCT01045707|16679654|P2|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1
4838987|NCT01045707|16679655|P1|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2
4838988|NCT01045707|16679654|P2|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3
4838989|NCT01045707|16679655|P1|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2
4838990|NCT01045707|16679654|P2|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
4838991|NCT01045707|16679655|P1|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3
4838992|NCT01045707|16679654|P2|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11
4838993|NCT01045707|16679655|P1|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10
4838994|NCT01045707|16679654|P2|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11
4838995|NCT01045707|16679655|P1|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22
4838996|NCT01045707|16679654|P2|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5
4838997|NCT01045707|16679655|P1|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6
4838998|NCT01045707|16679654|P2|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2
4838999|NCT01045707|16679655|P1|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4
4839000|NCT01045707|16679654|P2|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3
4839001|NCT01045707|16679655|P1|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5
4839002|NCT01045694|16679671|P1|Overall Study|Withdrawal by Subject|2
4839003|NCT01045460|16679692|P2|Overall Study|Lack of Efficacy|0
4839004|NCT01045460|16679693|P1|Overall Study|Lack of Efficacy|3
4839005|NCT01045460|16679692|P2|Overall Study|Lost to Follow-up|1
4839006|NCT01045460|16679693|P1|Overall Study|Lost to Follow-up|0
4839007|NCT01045460|16679692|P2|Overall Study|Physician Decision|2
4839008|NCT01045460|16679693|P1|Overall Study|Physician Decision|3
4839009|NCT01045447|16679705|P2|Overall Study|Unclassified|13
4839010|NCT01045447|16679706|P1|Overall Study|Unclassified|17
4839011|NCT01045447|16679705|P2|Overall Study|Withdrawal Criteria|10
4839012|NCT01045447|16679706|P1|Overall Study|Withdrawal Criteria|10
4839013|NCT01045447|16679705|P2|Overall Study|Protocol Violation|3
4839014|NCT01045447|16679706|P1|Overall Study|Protocol Violation|6
4839015|NCT01045447|16679705|P2|Overall Study|Lack of Efficacy|1
4839016|NCT01045447|16679706|P1|Overall Study|Lack of Efficacy|3
4839017|NCT01045447|16679705|P2|Overall Study|Adverse Event|1
4839018|NCT01045447|16679706|P1|Overall Study|Adverse Event|0
4839019|NCT01045421|16679720|P11|Phase 2|Other|1
4839020|NCT01045421|16679721|P10|Phase 2|Other|0
4839021|NCT01045421|16679722|P9|Phase 2|Other|0
4839022|NCT01045421|16679723|P8|Phase 2|Other|3
4839023|NCT01045421|16679724|P7|Phase 2|Other|0
4839024|NCT01045421|16679725|P6|Phase 2|Other|0
4839025|NCT01045421|16679726|P5|Phase 2|Other|0
4839026|NCT01045421|16679727|P4|Phase 2|Other|0
4839027|NCT01045421|16679728|P3|Phase 2|Other|0
4839028|NCT01045421|16679729|P2|Phase 2|Other|0
4839029|NCT01045421|16679730|P1|Phase 2|Other|0
4839030|NCT01045421|16679720|P11|Phase 2|Death|0
4839031|NCT01045421|16679721|P10|Phase 2|Death|2
4839032|NCT01045421|16679722|P9|Phase 2|Death|1
4839033|NCT01045421|16679723|P8|Phase 2|Death|1
4839034|NCT01045421|16679724|P7|Phase 2|Death|0
4839035|NCT01045421|16679725|P6|Phase 2|Death|0
4839036|NCT01045421|16679726|P5|Phase 2|Death|0
4839037|NCT01045421|16679727|P4|Phase 2|Death|0
4839038|NCT01045421|16679728|P3|Phase 2|Death|0
4839039|NCT01045421|16679729|P2|Phase 2|Death|0
4839040|NCT01045421|16679730|P1|Phase 2|Death|0
4839041|NCT01045421|16679720|P11|Phase 2|Progressive Disease|1
4839042|NCT01045421|16679721|P10|Phase 2|Progressive Disease|1
4839043|NCT01045421|16679722|P9|Phase 2|Progressive Disease|1
4839044|NCT01045421|16679723|P8|Phase 2|Progressive Disease|1
4839045|NCT01045421|16679724|P7|Phase 2|Progressive Disease|0
4839046|NCT01045421|16679725|P6|Phase 2|Progressive Disease|0
4839047|NCT01045421|16679726|P5|Phase 2|Progressive Disease|0
4839048|NCT01045421|16679727|P4|Phase 2|Progressive Disease|0
4839049|NCT01045421|16679728|P3|Phase 2|Progressive Disease|0
4839050|NCT01045421|16679729|P2|Phase 2|Progressive Disease|0
4839051|NCT01045421|16679730|P1|Phase 2|Progressive Disease|0
4839052|NCT01045421|16679720|P11|Phase 1|Withdrawal by Subject|0
4839053|NCT01045421|16679721|P10|Phase 1|Withdrawal by Subject|0
4839054|NCT01045421|16679722|P9|Phase 1|Withdrawal by Subject|0
4839055|NCT01045421|16679723|P8|Phase 1|Withdrawal by Subject|0
4839056|NCT01045421|16679724|P7|Phase 1|Withdrawal by Subject|0
4839057|NCT01045421|16679725|P6|Phase 1|Withdrawal by Subject|0
4839058|NCT01045421|16679726|P5|Phase 1|Withdrawal by Subject|0
4839059|NCT01045421|16679727|P4|Phase 1|Withdrawal by Subject|1
4839060|NCT01045421|16679728|P3|Phase 1|Withdrawal by Subject|0
4839061|NCT01045421|16679729|P2|Phase 1|Withdrawal by Subject|0
4839062|NCT01045421|16679730|P1|Phase 1|Withdrawal by Subject|0
4839063|NCT01045421|16679720|P11|Phase 1|Progressive Disease|0
4839064|NCT01045421|16679721|P10|Phase 1|Progressive Disease|0
4839065|NCT01045421|16679722|P9|Phase 1|Progressive Disease|0
4839066|NCT01045421|16679723|P8|Phase 1|Progressive Disease|0
4839067|NCT01045421|16679724|P7|Phase 1|Progressive Disease|0
4839068|NCT01045421|16679725|P6|Phase 1|Progressive Disease|0
4839069|NCT01045421|16679726|P5|Phase 1|Progressive Disease|1
4839070|NCT01045421|16679727|P4|Phase 1|Progressive Disease|0
4839071|NCT01045421|16679728|P3|Phase 1|Progressive Disease|0
4839072|NCT01045421|16679729|P2|Phase 1|Progressive Disease|0
4839073|NCT01045421|16679730|P1|Phase 1|Progressive Disease|0
4839074|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6
4839075|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1
4839076|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5
4839077|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
4839078|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|Protocol Violation|6
4839079|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|Protocol Violation|3
4839080|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|Other Reason|1
4839081|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|Other Reason|2
4839082|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|Other Reason|4
4839083|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
4839084|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5
4839085|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1
4839086|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
4839087|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5
4839088|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3
4839089|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|Adverse Event|7
4839090|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|Adverse Event|10
4839091|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|Adverse Event|10
4839092|NCT01045161|16679824|P3|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9
4839093|NCT01045161|16679825|P2|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7
4839094|NCT01045161|16679826|P1|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10
4839095|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2
4839096|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
4839097|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3
4839098|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
4839099|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4
4839100|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3
4839101|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
4839102|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
4839103|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|Other Reason|3
4839104|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6
4839105|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1
4839106|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4
4839107|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2
4839108|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3
4839109|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6
4839110|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8
4839111|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3
4839112|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4
4839113|NCT01045161|16679824|P3|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6
4839114|NCT01045161|16679825|P2|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12
4839115|NCT01045161|16679826|P1|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8
4839116|NCT01045096|16679863|P3|Overall Study|Other|0
4839117|NCT01045096|16679864|P2|Overall Study|Other|0
4839118|NCT01045096|16679865|P1|Overall Study|Other|1
4839119|NCT01045096|16679863|P3|Overall Study|Withdrawal by Subject|0
4839120|NCT01045096|16679864|P2|Overall Study|Withdrawal by Subject|0
4839121|NCT01045096|16679865|P1|Overall Study|Withdrawal by Subject|2
4839122|NCT01044745|16679982|P1|Overall Study|Ineiligible|2
4839123|NCT01044732|16679991|P2|Overall Study|Technical error or malfunction|14
4839124|NCT01044732|16679992|P1|Overall Study|Technical error or malfunction|15
4839125|NCT01044732|16679991|P2|Overall Study|Inability to reach cecum|2
4839126|NCT01044732|16679992|P1|Overall Study|Inability to reach cecum|5
4839127|NCT01044732|16679991|P2|Overall Study|Inadequate bowel preparation|17
4839128|NCT01044732|16679992|P1|Overall Study|Inadequate bowel preparation|11
4839129|NCT01044732|16679991|P2|Overall Study|Withdrawal by Subject|1
4839130|NCT01044732|16679992|P1|Overall Study|Withdrawal by Subject|0
4839131|NCT01044732|16679991|P2|Overall Study|Protocol Violation|12
4839132|NCT01044732|16679992|P1|Overall Study|Protocol Violation|11
4839133|NCT01044732|16679991|P2|Overall Study|Physician Decision|3
4839134|NCT01044732|16679992|P1|Overall Study|Physician Decision|5
4839135|NCT01044732|16679991|P2|Overall Study|Lost to Follow-up|1
4839136|NCT01044732|16679992|P1|Overall Study|Lost to Follow-up|2
4839137|NCT01044498|16680181|P2|Overall Study|Other|0
4839138|NCT01044498|16680182|P1|Overall Study|Other|1
4839139|NCT01044498|16680181|P2|Overall Study|Adverse Event|1
4839140|NCT01044498|16680182|P1|Overall Study|Adverse Event|1
4839141|NCT01044498|16680181|P2|Overall Study|Withdrew consent|1
4839142|NCT01044498|16680182|P1|Overall Study|Withdrew consent|1
4839143|NCT01044459|16680208|P2|Overall Study|Lost to Follow-up|12
4839144|NCT01044459|16680209|P1|Overall Study|Lost to Follow-up|18
4839145|NCT01044459|16680208|P2|Overall Study|COPD exacerbation|8
4839146|NCT01044459|16680209|P1|Overall Study|COPD exacerbation|9
4839147|NCT01044459|16680208|P2|Overall Study|Other Reason|14
4839148|NCT01044459|16680209|P1|Overall Study|Other Reason|7
4839149|NCT01044459|16680208|P2|Overall Study|Protocol Violation|16
4839150|NCT01044459|16680209|P1|Overall Study|Protocol Violation|11
4839151|NCT01044459|16680208|P2|Overall Study|Lack of Efficacy|12
4839152|NCT01044459|16680209|P1|Overall Study|Lack of Efficacy|23
4839153|NCT01044459|16680208|P2|Overall Study|Adverse Event|20
4839154|NCT01044459|16680209|P1|Overall Study|Adverse Event|22
4839155|NCT01044459|16680208|P2|Overall Study|Terminated by Sponsor|21
4839156|NCT01044459|16680209|P1|Overall Study|Terminated by Sponsor|22
4839157|NCT01044459|16680208|P2|Overall Study|Withdrawal by Subject|28
4839158|NCT01044459|16680209|P1|Overall Study|Withdrawal by Subject|21
4839159|NCT01044433|16680217|P1|Overall Study|Withdrawal by Subject|3
4839160|NCT01044433|16680217|P1|Overall Study|Lost to Follow-up|3
4839161|NCT01044303|16680225|P1|Overall Study|Lost to Follow-up|2
4839162|NCT01044290|16680235|P3|Follow-Up 2|Withdrawal by Subject|1
4839163|NCT01044290|16680236|P2|Follow-Up 2|Withdrawal by Subject|1
4839164|NCT01044290|16680237|P1|Follow-Up 2|Withdrawal by Subject|0
4839165|NCT01044290|16680235|P3|Follow-Up 2|Death|1
4839166|NCT01044290|16680236|P2|Follow-Up 2|Death|1
4839167|NCT01044290|16680237|P1|Follow-Up 2|Death|0
4839168|NCT01044290|16680235|P3|Follow-up 1|Withdrawal by Subject|0
4839169|NCT01044290|16680236|P2|Follow-up 1|Withdrawal by Subject|2
4839170|NCT01044290|16680237|P1|Follow-up 1|Withdrawal by Subject|2
4839171|NCT01044290|16680235|P3|Follow-up 1|Death|1
4839172|NCT01044290|16680236|P2|Follow-up 1|Death|3
4839173|NCT01044290|16680237|P1|Follow-up 1|Death|3
4839174|NCT01043874|16680357|P1|Overall Study|Administrative Problems|1
4839175|NCT01043874|16680357|P1|Overall Study|Lack of Efficacy|1
4839176|NCT01043874|16680357|P1|Overall Study|Withdrawal by Subject|1
4839177|NCT01043874|16680357|P1|Overall Study|Adverse Event|3
4839178|NCT01043705|16680367|P3|Overall Study|Other|25
4839179|NCT01043705|16680368|P2|Overall Study|Other|19
4839180|NCT01043705|16680369|P1|Overall Study|Other|0
4839181|NCT01043705|16680367|P3|Overall Study|Screen Fail|0
4839182|NCT01043705|16680368|P2|Overall Study|Screen Fail|0
4839183|NCT01043705|16680369|P1|Overall Study|Screen Fail|21
4839184|NCT01043705|16680367|P3|Overall Study|Adverse Event|0
4839185|NCT01043705|16680368|P2|Overall Study|Adverse Event|2
4839186|NCT01043705|16680369|P1|Overall Study|Adverse Event|0
4839187|NCT01043705|16680367|P3|Overall Study|Subsequent Procedure|29
4839188|NCT01043705|16680368|P2|Overall Study|Subsequent Procedure|24
4839189|NCT01043705|16680369|P1|Overall Study|Subsequent Procedure|9
4839190|NCT01043705|16680367|P3|Overall Study|Site Closure|0
4839191|NCT01043705|16680368|P2|Overall Study|Site Closure|0
4839192|NCT01043705|16680369|P1|Overall Study|Site Closure|8
4839193|NCT01043705|16680367|P3|Overall Study|Withdrawal by Subject|0
4839194|NCT01043705|16680368|P2|Overall Study|Withdrawal by Subject|6
4839195|NCT01043705|16680369|P1|Overall Study|Withdrawal by Subject|8
4839196|NCT01043705|16680367|P3|Overall Study|Protocol Violation|0
4839197|NCT01043705|16680368|P2|Overall Study|Protocol Violation|1
4839198|NCT01043705|16680369|P1|Overall Study|Protocol Violation|2
4839199|NCT01043705|16680367|P3|Overall Study|Multiple Reasons|0
4839200|NCT01043705|16680368|P2|Overall Study|Multiple Reasons|7
4839201|NCT01043705|16680369|P1|Overall Study|Multiple Reasons|4
4839202|NCT01043705|16680367|P3|Overall Study|Lost to Follow-up|0
4839203|NCT01043705|16680368|P2|Overall Study|Lost to Follow-up|12
4839204|NCT01043705|16680369|P1|Overall Study|Lost to Follow-up|27
4839205|NCT01043705|16680367|P3|Overall Study|Death|26
4839206|NCT01043705|16680368|P2|Overall Study|Death|60
4839207|NCT01043705|16680369|P1|Overall Study|Death|28
4839208|NCT01043185|16680458|P10|Period 6 - Third Washout Period|Protocol Violation|0
4839209|NCT01043185|16680459|P9|Period 6 - Third Washout Period|Protocol Violation|1
4839210|NCT01043185|16680460|P8|Period 6 - Third Washout Period|Protocol Violation|0
4839211|NCT01043185|16680461|P7|Period 6 - Third Washout Period|Protocol Violation|0
4839212|NCT01043185|16680462|P6|Period 6 - Third Washout Period|Protocol Violation|0
4839213|NCT01043185|16680463|P5|Period 6 - Third Washout Period|Protocol Violation|0
4839214|NCT01043185|16680464|P4|Period 6 - Third Washout Period|Protocol Violation|0
4839215|NCT01043185|16680465|P3|Period 6 - Third Washout Period|Protocol Violation|0
4839216|NCT01043185|16680466|P2|Period 6 - Third Washout Period|Protocol Violation|0
4839217|NCT01043185|16680467|P1|Period 6 - Third Washout Period|Protocol Violation|0
4839218|NCT01042977|16680543|P2|Overall Study|Various|0
4839219|NCT01042977|16680544|P1|Overall Study|Various|3
4839220|NCT01042977|16680543|P2|Overall Study|Administrative reason by sponsor|1
4839221|NCT01042977|16680544|P1|Overall Study|Administrative reason by sponsor|0
4839222|NCT01042977|16680543|P2|Overall Study|Safety|2
4839223|NCT01042977|16680544|P1|Overall Study|Safety|0
4839224|NCT01042977|16680543|P2|Overall Study|Incorrect enrollment|4
4839225|NCT01042977|16680544|P1|Overall Study|Incorrect enrollment|6
4839226|NCT01042977|16680543|P2|Overall Study|Subject no longer meets study criteria|13
4839227|NCT01042977|16680544|P1|Overall Study|Subject no longer meets study criteria|15
4839228|NCT01042977|16680543|P2|Overall Study|Poor/non-compliance|4
4839229|NCT01042977|16680544|P1|Overall Study|Poor/non-compliance|3
4839230|NCT01042977|16680543|P2|Overall Study|Lost to Follow-up|2
4839231|NCT01042977|16680544|P1|Overall Study|Lost to Follow-up|0
4839232|NCT01042977|16680543|P2|Overall Study|Withdrawal by Subject|16
4839233|NCT01042977|16680544|P1|Overall Study|Withdrawal by Subject|8
4839234|NCT01042977|16680543|P2|Overall Study|Death|1
4839235|NCT01042977|16680544|P1|Overall Study|Death|2
4839236|NCT01042977|16680543|P2|Overall Study|Adverse Event|12
4839237|NCT01042977|16680544|P1|Overall Study|Adverse Event|4
4839238|NCT01042938|16680564|P2|Overall Study|Ineligible: RTOG study conflict|0
4839239|NCT01042938|16680565|P1|Overall Study|Ineligible: RTOG study conflict|1
4839240|NCT01042938|16680564|P2|Overall Study|Protocol Violation|1
4839241|NCT01042938|16680565|P1|Overall Study|Protocol Violation|1
4839242|NCT01042938|16680564|P2|Overall Study|Withdrawal by Subject|1
4839243|NCT01042938|16680565|P1|Overall Study|Withdrawal by Subject|1
4839244|NCT01042678|16680584|P6|Overall Study|Physician Decision|0
4839245|NCT01042678|16680585|P5|Overall Study|Physician Decision|0
4839246|NCT01042678|16680586|P4|Overall Study|Physician Decision|0
4839247|NCT01042678|16680587|P3|Overall Study|Physician Decision|0
4839248|NCT01042678|16680588|P2|Overall Study|Physician Decision|0
4839249|NCT01042678|16680589|P1|Overall Study|Physician Decision|1
4839250|NCT01042600|16680627|P2|Overall Study|Ineligible|0
4839251|NCT01042600|16680628|P1|Overall Study|Ineligible|1
4839252|NCT01042535|16680648|P1|Overall Study|complications from other disease|2
4839253|NCT01042535|16680648|P1|Overall Study|disease progression during treatment|3
4839254|NCT01042535|16680648|P1|Overall Study|disease progression prior to treatment|3
4839255|NCT01042392|16680682|P4|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
4839256|NCT01042392|16680683|P3|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
4839257|NCT01042392|16680684|P2|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1
4839258|NCT01042392|16680685|P1|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0
4839259|NCT01042392|16680682|P4|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
4839260|NCT01042392|16680683|P3|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2
4839261|NCT01042392|16680684|P2|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
4839262|NCT01042392|16680685|P1|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0
4839263|NCT01042392|16680682|P4|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
4839264|NCT01042392|16680683|P3|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
4839265|NCT01042392|16680684|P2|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0
4839266|NCT01042392|16680685|P1|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2
4839267|NCT01042392|16680682|P4|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
4839268|NCT01042392|16680683|P3|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1
4839269|NCT01042392|16680684|P2|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
4839270|NCT01042392|16680685|P1|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0
4839271|NCT01042392|16680682|P4|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
4839272|NCT01042392|16680683|P3|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
4839273|NCT01042392|16680684|P2|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0
4839274|NCT01042392|16680685|P1|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2
4839275|NCT01042392|16680682|P4|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
4839276|NCT01042392|16680683|P3|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1
4839277|NCT01042392|16680684|P2|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
4839278|NCT01042392|16680685|P1|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0
4839279|NCT01042392|16680682|P4|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
4839280|NCT01042392|16680683|P3|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2
4839281|NCT01042392|16680684|P2|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0
4839282|NCT01042392|16680685|P1|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1
4839283|NCT01042392|16680682|P4|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
4839284|NCT01042392|16680683|P3|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
4839285|NCT01042392|16680684|P2|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0
4839286|NCT01042392|16680685|P1|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1
4839287|NCT01042392|16680682|P4|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
4839288|NCT01042392|16680683|P3|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5
4839289|NCT01042392|16680684|P2|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0
4839290|NCT01042392|16680685|P1|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6
4839291|NCT01042236|16680733|P6|Treatment Period 3|Protocol Violation|0
4839292|NCT01042236|16680734|P5|Treatment Period 3|Protocol Violation|0
4839293|NCT01042236|16680735|P4|Treatment Period 3|Protocol Violation|1
4839294|NCT01042236|16680736|P3|Treatment Period 3|Protocol Violation|0
4839295|NCT01042236|16680737|P2|Treatment Period 3|Protocol Violation|0
4839296|NCT01042236|16680738|P1|Treatment Period 3|Protocol Violation|0
4839297|NCT01042236|16680733|P6|Treatment Period 3|Adverse Event|0
4839298|NCT01042236|16680734|P5|Treatment Period 3|Adverse Event|0
4839299|NCT01042236|16680735|P4|Treatment Period 3|Adverse Event|1
4839300|NCT01042236|16680736|P3|Treatment Period 3|Adverse Event|0
4839301|NCT01042236|16680737|P2|Treatment Period 3|Adverse Event|0
4839302|NCT01042236|16680738|P1|Treatment Period 3|Adverse Event|0
4839303|NCT01042236|16680733|P6|Treatment Period 1|Adverse Event|0
4839304|NCT01042236|16680734|P5|Treatment Period 1|Adverse Event|1
4839305|NCT01042236|16680735|P4|Treatment Period 1|Adverse Event|0
4839306|NCT01042236|16680736|P3|Treatment Period 1|Adverse Event|0
4839307|NCT01042236|16680737|P2|Treatment Period 1|Adverse Event|1
4839308|NCT01042236|16680738|P1|Treatment Period 1|Adverse Event|0
4839309|NCT01042158|16680775|P1|Overall Study|Physician Decision|1
4839310|NCT01042093|16680805|P4|Overall Study|Withdrawal by Subject|1
4839311|NCT01042093|16680806|P3|Overall Study|Withdrawal by Subject|0
4839312|NCT01042093|16680807|P2|Overall Study|Withdrawal by Subject|0
4839313|NCT01042093|16680808|P1|Overall Study|Withdrawal by Subject|0
4839314|NCT01042093|16680805|P4|Overall Study|Protocol Violation|3
4839315|NCT01042093|16680806|P3|Overall Study|Protocol Violation|2
4839316|NCT01042093|16680807|P2|Overall Study|Protocol Violation|2
4839317|NCT01042093|16680808|P1|Overall Study|Protocol Violation|2
4839318|NCT01041976|16680828|P2|Overall Study|Death|4
4839319|NCT01041976|16680829|P1|Overall Study|Death|0
4839320|NCT01041976|16680828|P2|Overall Study|Incarceration|0
4839321|NCT01041976|16680829|P1|Overall Study|Incarceration|2
4839322|NCT01041976|16680828|P2|Overall Study|Withdrawal by Subject|0
4839323|NCT01041976|16680829|P1|Overall Study|Withdrawal by Subject|3
4839324|NCT01041859|16680839|P3|Double-Blind Maintenance|Withdrawal by Subject|9
4839325|NCT01041859|16680840|P2|Double-Blind Maintenance|Withdrawal by Subject|8
4839326|NCT01041859|16680841|P1|Double-Blind Maintenance|Withdrawal by Subject|0
4839327|NCT01041859|16680839|P3|Double-Blind Maintenance|Noncompliance With Study Drug|6
4839328|NCT01041859|16680840|P2|Double-Blind Maintenance|Noncompliance With Study Drug|2
4839329|NCT01041859|16680841|P1|Double-Blind Maintenance|Noncompliance With Study Drug|0
4839330|NCT01041859|16680839|P3|Double-Blind Maintenance|Other|2
4839331|NCT01041859|16680840|P2|Double-Blind Maintenance|Other|6
4839332|NCT01041859|16680841|P1|Double-Blind Maintenance|Other|0
4839333|NCT01041859|16680839|P3|Double-Blind Maintenance|Protocol Violation|3
4839334|NCT01041859|16680840|P2|Double-Blind Maintenance|Protocol Violation|1
4839335|NCT01041859|16680841|P1|Double-Blind Maintenance|Protocol Violation|0
4839336|NCT01041859|16680839|P3|Double-Blind Maintenance|Physician Decision|1
4839337|NCT01041859|16680840|P2|Double-Blind Maintenance|Physician Decision|2
4839338|NCT01041859|16680841|P1|Double-Blind Maintenance|Physician Decision|0
4839339|NCT01041859|16680839|P3|Double-Blind Maintenance|Lost to Follow-up|0
4839340|NCT01041859|16680840|P2|Double-Blind Maintenance|Lost to Follow-up|1
4839341|NCT01041859|16680841|P1|Double-Blind Maintenance|Lost to Follow-up|0
4839342|NCT01041859|16680839|P3|Double-Blind Maintenance|Lack of Efficacy|11
4839343|NCT01041859|16680840|P2|Double-Blind Maintenance|Lack of Efficacy|3
4839344|NCT01041859|16680841|P1|Double-Blind Maintenance|Lack of Efficacy|0
4839345|NCT01041859|16680839|P3|Double-Blind Maintenance|Adverse Event|13
4839346|NCT01041859|16680840|P2|Double-Blind Maintenance|Adverse Event|23
4839347|NCT01041859|16680841|P1|Double-Blind Maintenance|Adverse Event|0
4839348|NCT01041859|16680839|P3|Open-Label Titration|Withdrawal by Subject|0
4839349|NCT01041859|16680840|P2|Open-Label Titration|Withdrawal by Subject|0
4839350|NCT01041859|16680841|P1|Open-Label Titration|Withdrawal by Subject|11
4839351|NCT01041859|16680839|P3|Open-Label Titration|Noncompliance With Study Drug|0
4839352|NCT01041859|16680840|P2|Open-Label Titration|Noncompliance With Study Drug|0
4839353|NCT01041859|16680841|P1|Open-Label Titration|Noncompliance With Study Drug|8
4839354|NCT01041859|16680839|P3|Open-Label Titration|Other|0
4839355|NCT01041859|16680840|P2|Open-Label Titration|Other|0
4839356|NCT01041859|16680841|P1|Open-Label Titration|Other|7
4839357|NCT01041859|16680839|P3|Open-Label Titration|Protocol Violation|0
4839358|NCT01041859|16680840|P2|Open-Label Titration|Protocol Violation|0
4839359|NCT01041859|16680841|P1|Open-Label Titration|Protocol Violation|1
4839360|NCT01041859|16680839|P3|Open-Label Titration|Physician Decision|0
4839361|NCT01041859|16680840|P2|Open-Label Titration|Physician Decision|0
4839362|NCT01041859|16680841|P1|Open-Label Titration|Physician Decision|1
4839363|NCT01041859|16680839|P3|Open-Label Titration|Lost to Follow-up|0
4839364|NCT01041859|16680840|P2|Open-Label Titration|Lost to Follow-up|0
4839365|NCT01041859|16680841|P1|Open-Label Titration|Lost to Follow-up|1
4839366|NCT01041859|16680839|P3|Open-Label Titration|Lack of Efficacy|0
4839367|NCT01041859|16680840|P2|Open-Label Titration|Lack of Efficacy|0
4839368|NCT01041859|16680841|P1|Open-Label Titration|Lack of Efficacy|3
4839369|NCT01041859|16680839|P3|Open-Label Titration|Adverse Event|0
4839370|NCT01041859|16680840|P2|Open-Label Titration|Adverse Event|0
4839371|NCT01041859|16680841|P1|Open-Label Titration|Adverse Event|69
4839372|NCT01041638|16680877|P1|Overall Study|Withdrawal by Subject|11
4839373|NCT01041638|16680877|P1|Overall Study|Physician Decision|4
4839374|NCT01041638|16680877|P1|Overall Study|Lack of Efficacy|7
4839375|NCT01041638|16680877|P1|Overall Study|Death|1
4839376|NCT01041638|16680877|P1|Overall Study|Adverse Event|4
4839377|NCT01041573|16680887|P4|Overall Study|positive to anti-HCV|0
4839378|NCT01041573|16680888|P3|Overall Study|positive to anti-HCV|0
4839379|NCT01041573|16680889|P2|Overall Study|positive to anti-HCV|0
4839380|NCT01041573|16680890|P1|Overall Study|positive to anti-HCV|1
4839381|NCT01041573|16680887|P4|Overall Study|further blood extraction|0
4839382|NCT01041573|16680888|P3|Overall Study|further blood extraction|0
4839383|NCT01041573|16680889|P2|Overall Study|further blood extraction|1
4839384|NCT01041573|16680890|P1|Overall Study|further blood extraction|0
4839385|NCT01041573|16680887|P4|Overall Study|relocation|1
4839386|NCT01041573|16680888|P3|Overall Study|relocation|3
4839387|NCT01041573|16680889|P2|Overall Study|relocation|4
4839388|NCT01041573|16680890|P1|Overall Study|relocation|1
4839389|NCT01041573|16680887|P4|Overall Study|Adverse Event|0
4839390|NCT01041573|16680888|P3|Overall Study|Adverse Event|0
4839391|NCT01041573|16680889|P2|Overall Study|Adverse Event|2
4839392|NCT01041573|16680890|P1|Overall Study|Adverse Event|0
4839393|NCT01041573|16680887|P4|Overall Study|Lost to Follow-up|1
4839394|NCT01041573|16680888|P3|Overall Study|Lost to Follow-up|2
4839395|NCT01041573|16680889|P2|Overall Study|Lost to Follow-up|1
4839396|NCT01041573|16680890|P1|Overall Study|Lost to Follow-up|0
4839397|NCT01041573|16680887|P4|Overall Study|Death|0
4839398|NCT01041573|16680888|P3|Overall Study|Death|0
4839399|NCT01041573|16680889|P2|Overall Study|Death|0
4839400|NCT01041573|16680890|P1|Overall Study|Death|1
4839401|NCT01041573|16680887|P4|Overall Study|Withdrawal by Subject|0
4839402|NCT01041573|16680888|P3|Overall Study|Withdrawal by Subject|2
4839403|NCT01041573|16680889|P2|Overall Study|Withdrawal by Subject|5
4839404|NCT01041573|16680890|P1|Overall Study|Withdrawal by Subject|2
4839405|NCT01041417|16680913|P2|Overall Study|Death|0
4839406|NCT01041417|16680914|P1|Overall Study|Death|1
4839407|NCT01041417|16680913|P2|Overall Study|Lost to Follow-up|1
4839408|NCT01041417|16680914|P1|Overall Study|Lost to Follow-up|1
4839409|NCT01041417|16680913|P2|Overall Study|Adverse Event|2
4839410|NCT01041417|16680914|P1|Overall Study|Adverse Event|5
4839411|NCT01041404|16680952|P2|Overall Study|Other|23
4839412|NCT01041404|16680953|P1|Overall Study|Other|11
4839413|NCT01041404|16680952|P2|Overall Study|Failure to Return|2
4839414|NCT01041404|16680953|P1|Overall Study|Failure to Return|1
4839415|NCT01041404|16680952|P2|Overall Study|Withdrawal by Subject|23
4839416|NCT01041404|16680953|P1|Overall Study|Withdrawal by Subject|29
4839417|NCT01041404|16680952|P2|Overall Study|Protocol Violation|0
4839418|NCT01041404|16680953|P1|Overall Study|Protocol Violation|4
4839419|NCT01041404|16680952|P2|Overall Study|Violation of Selection Criteria|1
4839420|NCT01041404|16680953|P1|Overall Study|Violation of Selection Criteria|0
4839421|NCT01041404|16680952|P2|Overall Study|Lack of Efficacy|210
4839422|NCT01041404|16680953|P1|Overall Study|Lack of Efficacy|200
4839423|NCT01041404|16680952|P2|Overall Study|Adverse Event|35
4839424|NCT01041404|16680953|P1|Overall Study|Adverse Event|45
4839425|NCT01041287|16680994|P2|Treatment Period 2 (3 Months)|Adverse Event|2
4839426|NCT01041287|16680995|P1|Treatment Period 2 (3 Months)|Adverse Event|0
4839427|NCT01041287|16680994|P2|Treatment Period 2 (3 Months)|Lost to Follow-up|3
4839428|NCT01041287|16680995|P1|Treatment Period 2 (3 Months)|Lost to Follow-up|3
4839429|NCT01040871|16681035|P2|Overall Study|Randomized and Not Treated|1
4839430|NCT01040871|16681036|P1|Overall Study|Randomized and Not Treated|2
4839431|NCT01040871|16681035|P2|Overall Study|drug supply issue|0
4839432|NCT01040871|16681036|P1|Overall Study|drug supply issue|1
4839433|NCT01040871|16681035|P2|Overall Study|Lack of Efficacy|1
4839434|NCT01040871|16681036|P1|Overall Study|Lack of Efficacy|1
4839435|NCT01040871|16681035|P2|Overall Study|Death|3
4839436|NCT01040871|16681036|P1|Overall Study|Death|1
4839437|NCT01040871|16681035|P2|Overall Study|Withdrawal by Subject|0
4839438|NCT01040871|16681036|P1|Overall Study|Withdrawal by Subject|2
4839439|NCT01040871|16681035|P2|Overall Study|Adverse Event|2
4839440|NCT01040871|16681036|P1|Overall Study|Adverse Event|6
4839441|NCT01040845|16681087|P2|Overall Study|Physician Decision|0
4839442|NCT01040845|16681088|P1|Overall Study|Physician Decision|1
4839443|NCT01040845|16681087|P2|Overall Study|Withdrawal by Subject|1
4839444|NCT01040845|16681088|P1|Overall Study|Withdrawal by Subject|1
4839445|NCT01040832|16681103|P2|Overall Study|Other|1
4839446|NCT01040832|16681104|P1|Overall Study|Other|2
4839447|NCT01040832|16681103|P2|Overall Study|Symptomatic deterioration|5
4839448|NCT01040832|16681104|P1|Overall Study|Symptomatic deterioration|2
4839449|NCT01040832|16681103|P2|Overall Study|Progressive disease|17
4839450|NCT01040832|16681104|P1|Overall Study|Progressive disease|32
4839451|NCT01040832|16681103|P2|Overall Study|Withdrawal by Subject|3
4839452|NCT01040832|16681104|P1|Overall Study|Withdrawal by Subject|2
4839453|NCT01040832|16681103|P2|Overall Study|Death|6
4839454|NCT01040832|16681104|P1|Overall Study|Death|4
4839455|NCT01040832|16681103|P2|Overall Study|Adverse Event|5
4839456|NCT01040832|16681104|P1|Overall Study|Adverse Event|4
4839457|NCT01040793|16681127|P6|Overall Study|Other reasons not listed above|0
4839458|NCT01040793|16681128|P5|Overall Study|Other reasons not listed above|1
4839459|NCT01040793|16681129|P4|Overall Study|Other reasons not listed above|0
4839460|NCT01040793|16681130|P3|Overall Study|Other reasons not listed above|1
4839461|NCT01040793|16681131|P2|Overall Study|Other reasons not listed above|0
4839462|NCT01040793|16681132|P1|Overall Study|Other reasons not listed above|0
4839463|NCT01040793|16681127|P6|Overall Study|Withdrawal by Subject|0
4839464|NCT01040793|16681128|P5|Overall Study|Withdrawal by Subject|0
4839465|NCT01040793|16681129|P4|Overall Study|Withdrawal by Subject|2
4839466|NCT01040793|16681130|P3|Overall Study|Withdrawal by Subject|0
4839467|NCT01040793|16681131|P2|Overall Study|Withdrawal by Subject|0
4839468|NCT01040793|16681132|P1|Overall Study|Withdrawal by Subject|0
4839469|NCT01040793|16681127|P6|Overall Study|Lost to Follow-up|0
4839470|NCT01040793|16681128|P5|Overall Study|Lost to Follow-up|0
4839471|NCT01040793|16681129|P4|Overall Study|Lost to Follow-up|0
4839472|NCT01040793|16681130|P3|Overall Study|Lost to Follow-up|1
4839473|NCT01040793|16681131|P2|Overall Study|Lost to Follow-up|1
4839474|NCT01040793|16681132|P1|Overall Study|Lost to Follow-up|0
4839475|NCT01040793|16681127|P6|Overall Study|Protocol Violation|0
4839476|NCT01040793|16681128|P5|Overall Study|Protocol Violation|1
4839477|NCT01040793|16681129|P4|Overall Study|Protocol Violation|0
4839478|NCT01040793|16681130|P3|Overall Study|Protocol Violation|1
4839479|NCT01040793|16681131|P2|Overall Study|Protocol Violation|1
4839480|NCT01040793|16681132|P1|Overall Study|Protocol Violation|1
4839481|NCT01040793|16681127|P6|Overall Study|Adverse Event|1
4839482|NCT01040793|16681128|P5|Overall Study|Adverse Event|2
4839483|NCT01040793|16681129|P4|Overall Study|Adverse Event|2
4839484|NCT01040793|16681130|P3|Overall Study|Adverse Event|0
4839485|NCT01040793|16681131|P2|Overall Study|Adverse Event|3
4839486|NCT01040793|16681132|P1|Overall Study|Adverse Event|5
4839487|NCT01040780|16681211|P2|Overall Study|Protocol Violation|3
4839488|NCT01040780|16681212|P1|Overall Study|Protocol Violation|1
4839489|NCT01040728|16681226|P4|Overall Study|Other reasons not listed above|0
4839490|NCT01040728|16681227|P3|Overall Study|Other reasons not listed above|0
4839491|NCT01040728|16681228|P2|Overall Study|Other reasons not listed above|1
4839492|NCT01040728|16681229|P1|Overall Study|Other reasons not listed above|0
4839493|NCT01040728|16681226|P4|Overall Study|Lack of Efficacy|1
4839494|NCT01040728|16681227|P3|Overall Study|Lack of Efficacy|0
4839495|NCT01040728|16681228|P2|Overall Study|Lack of Efficacy|1
4839496|NCT01040728|16681229|P1|Overall Study|Lack of Efficacy|0
4839497|NCT01040728|16681226|P4|Overall Study|Protocol Violation|1
4839498|NCT01040728|16681227|P3|Overall Study|Protocol Violation|0
4839499|NCT01040728|16681228|P2|Overall Study|Protocol Violation|0
4839500|NCT01040728|16681229|P1|Overall Study|Protocol Violation|0
4839501|NCT01040728|16681226|P4|Overall Study|Withdrawal by Subject|0
4839502|NCT01040728|16681227|P3|Overall Study|Withdrawal by Subject|1
4839503|NCT01040728|16681228|P2|Overall Study|Withdrawal by Subject|1
4839504|NCT01040728|16681229|P1|Overall Study|Withdrawal by Subject|0
4839505|NCT01040728|16681226|P4|Overall Study|Adverse Event|4
4839506|NCT01040728|16681227|P3|Overall Study|Adverse Event|0
4839507|NCT01040728|16681228|P2|Overall Study|Adverse Event|8
4839508|NCT01040728|16681229|P1|Overall Study|Adverse Event|4
4839509|NCT01040689|16681299|P4|Overall Study|Other reasons not listed above|0
4839510|NCT01040689|16681300|P3|Overall Study|Other reasons not listed above|0
4839511|NCT01040689|16681301|P2|Overall Study|Other reasons not listed above|1
4839512|NCT01040689|16681302|P1|Overall Study|Other reasons not listed above|0
4839513|NCT01040689|16681299|P4|Overall Study|Withdrawal by Subject|0
4839514|NCT01040689|16681300|P3|Overall Study|Withdrawal by Subject|1
4839515|NCT01040689|16681301|P2|Overall Study|Withdrawal by Subject|1
4839516|NCT01040689|16681302|P1|Overall Study|Withdrawal by Subject|2
4839517|NCT01040689|16681299|P4|Overall Study|Lost to Follow-up|0
4839518|NCT01040689|16681300|P3|Overall Study|Lost to Follow-up|0
4839519|NCT01040689|16681301|P2|Overall Study|Lost to Follow-up|0
4839520|NCT01040689|16681302|P1|Overall Study|Lost to Follow-up|1
4839521|NCT01040689|16681299|P4|Overall Study|Lack of Efficacy|0
4839522|NCT01040689|16681300|P3|Overall Study|Lack of Efficacy|1
4839523|NCT01040689|16681301|P2|Overall Study|Lack of Efficacy|0
4839524|NCT01040689|16681302|P1|Overall Study|Lack of Efficacy|0
4839525|NCT01040689|16681299|P4|Overall Study|Adverse Event|4
4839526|NCT01040689|16681300|P3|Overall Study|Adverse Event|2
4839527|NCT01040689|16681301|P2|Overall Study|Adverse Event|0
4839528|NCT01040689|16681302|P1|Overall Study|Adverse Event|0
4839529|NCT01040403|16681381|P1|Overall Study|Other reason not defined above|6
4839530|NCT01040403|16681381|P1|Overall Study|Not treated|1
4839531|NCT01040403|16681381|P1|Overall Study|Lost to Follow-up|1
4839532|NCT01040403|16681381|P1|Overall Study|Protocol Violation|2
4839533|NCT01040403|16681381|P1|Overall Study|Adverse Event|10
4839534|NCT01040351|16681569|P2|Overall Study|poor ovarian response|2
4839535|NCT01040351|16681570|P1|Overall Study|poor ovarian response|1
4839536|NCT01040260|16681580|P2|Overall Study|Lost to Follow-up|5
4839537|NCT01040260|16681581|P1|Overall Study|Lost to Follow-up|3
4839538|NCT01040260|16681580|P2|Overall Study|Withdrawal by Subject|6
4839539|NCT01040260|16681581|P1|Overall Study|Withdrawal by Subject|12
4839540|NCT01040169|16681608|P2|Overall Study|Lost to Follow-up|8
4839541|NCT01040169|16681609|P1|Overall Study|Lost to Follow-up|3
4839542|NCT01040130|16681617|P6|Overall Study|Other reasons not listed above|0
4839543|NCT01040130|16681618|P5|Overall Study|Other reasons not listed above|0
4839544|NCT01040130|16681619|P4|Overall Study|Other reasons not listed above|0
4839545|NCT01040130|16681620|P3|Overall Study|Other reasons not listed above|0
4839546|NCT01040130|16681621|P2|Overall Study|Other reasons not listed above|0
4839547|NCT01040130|16681622|P1|Overall Study|Other reasons not listed above|2
4839548|NCT01040130|16681617|P6|Overall Study|Withdrawal by Subject|1
4839549|NCT01040130|16681618|P5|Overall Study|Withdrawal by Subject|0
4839550|NCT01040130|16681619|P4|Overall Study|Withdrawal by Subject|0
4839551|NCT01040130|16681620|P3|Overall Study|Withdrawal by Subject|0
4839552|NCT01040130|16681621|P2|Overall Study|Withdrawal by Subject|2
4839553|NCT01040130|16681622|P1|Overall Study|Withdrawal by Subject|0
4839554|NCT01040130|16681617|P6|Overall Study|Protocol Violation|0
4839555|NCT01040130|16681618|P5|Overall Study|Protocol Violation|0
4839556|NCT01040130|16681619|P4|Overall Study|Protocol Violation|0
4839557|NCT01040130|16681620|P3|Overall Study|Protocol Violation|2
4839558|NCT01040130|16681621|P2|Overall Study|Protocol Violation|0
4839559|NCT01040130|16681622|P1|Overall Study|Protocol Violation|0
4839560|NCT01040130|16681617|P6|Overall Study|Adverse Event|3
4839561|NCT01040130|16681618|P5|Overall Study|Adverse Event|0
4839562|NCT01040130|16681619|P4|Overall Study|Adverse Event|5
4839563|NCT01040130|16681620|P3|Overall Study|Adverse Event|0
4839564|NCT01040130|16681621|P2|Overall Study|Adverse Event|1
4839565|NCT01040130|16681622|P1|Overall Study|Adverse Event|1
4839566|NCT01039688|16681715|P3|Overall Study|Death|0
4839567|NCT01039688|16681716|P2|Overall Study|Death|0
4839568|NCT01039688|16681717|P1|Overall Study|Death|2
4839569|NCT01039688|16681715|P3|Overall Study|Withdrawal by Subject|13
4839570|NCT01039688|16681716|P2|Overall Study|Withdrawal by Subject|27
4839571|NCT01039688|16681717|P1|Overall Study|Withdrawal by Subject|23
4839572|NCT01039688|16681715|P3|Overall Study|Other|12
4839573|NCT01039688|16681716|P2|Overall Study|Other|25
4839574|NCT01039688|16681717|P1|Overall Study|Other|13
4839575|NCT01039688|16681715|P3|Overall Study|Lost to Follow-up|5
4839576|NCT01039688|16681716|P2|Overall Study|Lost to Follow-up|9
4839577|NCT01039688|16681717|P1|Overall Study|Lost to Follow-up|11
4839578|NCT01039688|16681715|P3|Overall Study|Lack of Efficacy|26
4839579|NCT01039688|16681716|P2|Overall Study|Lack of Efficacy|11
4839580|NCT01039688|16681717|P1|Overall Study|Lack of Efficacy|20
4839581|NCT01039688|16681715|P3|Overall Study|Adverse Event|24
4839582|NCT01039688|16681716|P2|Overall Study|Adverse Event|39
4839583|NCT01039688|16681717|P1|Overall Study|Adverse Event|38
4839584|NCT01039675|16681988|P2|Overall Study|Physician Decision|1
4839585|NCT01039675|16681989|P1|Overall Study|Physician Decision|0
4839586|NCT01039675|16681988|P2|Overall Study|Lost to Follow-up|1
4839587|NCT01039675|16681989|P1|Overall Study|Lost to Follow-up|0
4839588|NCT01039675|16681988|P2|Overall Study|Withdrawal by Subject|1
4839589|NCT01039675|16681989|P1|Overall Study|Withdrawal by Subject|0
4839590|NCT01039675|16681988|P2|Overall Study|Lack of Efficacy|2
4839591|NCT01039675|16681989|P1|Overall Study|Lack of Efficacy|0
4839592|NCT01039675|16681988|P2|Overall Study|Adverse Event|2
4839593|NCT01039675|16681989|P1|Overall Study|Adverse Event|0
4839594|NCT01039584|16682002|P3|Overall Study|Positive for Chlamydia or gonorrhea|8
4839595|NCT01039584|16682003|P2|Overall Study|Positive for Chlamydia or gonorrhea|10
4839596|NCT01039584|16682004|P1|Overall Study|Positive for Chlamydia or gonorrhea|7
4839597|NCT01039584|16682002|P3|Overall Study|Pap smear with significant pathology|3
4839598|NCT01039584|16682003|P2|Overall Study|Pap smear with significant pathology|10
4839599|NCT01039584|16682004|P1|Overall Study|Pap smear with significant pathology|10
4839600|NCT01039584|16682002|P3|Overall Study|other|1
4839601|NCT01039584|16682003|P2|Overall Study|other|3
4839602|NCT01039584|16682004|P1|Overall Study|other|1
4839603|NCT01039584|16682002|P3|Overall Study|Lack of Efficacy|10
4839604|NCT01039584|16682003|P2|Overall Study|Lack of Efficacy|6
4839605|NCT01039584|16682004|P1|Overall Study|Lack of Efficacy|7
4839606|NCT01039584|16682002|P3|Overall Study|Negative Baseline culture for Candida|24
4839607|NCT01039584|16682003|P2|Overall Study|Negative Baseline culture for Candida|59
4839608|NCT01039584|16682004|P1|Overall Study|Negative Baseline culture for Candida|59
4839609|NCT01039584|16682002|P3|Overall Study|Lost to Follow-up|4
4839610|NCT01039584|16682003|P2|Overall Study|Lost to Follow-up|3
4839611|NCT01039584|16682004|P1|Overall Study|Lost to Follow-up|5
4839612|NCT01039584|16682002|P3|Overall Study|Protocol Violation|6
4839613|NCT01039584|16682003|P2|Overall Study|Protocol Violation|4
4839614|NCT01039584|16682004|P1|Overall Study|Protocol Violation|10
4839615|NCT01039584|16682002|P3|Overall Study|Withdrawal by Subject|1
4839616|NCT01039584|16682003|P2|Overall Study|Withdrawal by Subject|2
4839617|NCT01039584|16682004|P1|Overall Study|Withdrawal by Subject|4
4839618|NCT01039519|16682018|P1|Survival Follow-up|Sponsor decision|4
4839619|NCT01039519|16682018|P1|Survival Follow-up|Death|23
4839620|NCT01039519|16682018|P1|Treatment|Physician Decision|2
4839621|NCT01039519|16682018|P1|Treatment|Adverse Event|3
4839622|NCT01039519|16682018|P1|Treatment|Treatment failure|2
4839623|NCT01039519|16682018|P1|Treatment|Progressive disease|20
4839624|NCT01039428|16682054|P2|Overall Study|Withdrawal by Subject|0
4839625|NCT01039428|16682055|P1|Overall Study|Withdrawal by Subject|1
4839626|NCT01039428|16682054|P2|Overall Study|Protocol Violation|0
4839627|NCT01039428|16682055|P1|Overall Study|Protocol Violation|1
4839628|NCT01039376|16682079|P2|Overall Study|Study terminated by Sponsor|72
4839629|NCT01039376|16682080|P1|Overall Study|Study terminated by Sponsor|90
4839630|NCT01039376|16682079|P2|Overall Study|Withdrawal by Subject|32
4839631|NCT01039376|16682080|P1|Overall Study|Withdrawal by Subject|20
4839632|NCT01039376|16682079|P2|Overall Study|Physician Decision|10
4839633|NCT01039376|16682080|P1|Overall Study|Physician Decision|15
4839634|NCT01039376|16682079|P2|Overall Study|Lost to Follow-up|12
4839635|NCT01039376|16682080|P1|Overall Study|Lost to Follow-up|5
4839636|NCT01038921|16682149|P2|Overall Study|Physician Decision|0
4839637|NCT01038921|16682150|P1|Overall Study|Physician Decision|1
4839638|NCT01038921|16682149|P2|Overall Study|Withdrawal by Subject|0
4839639|NCT01038921|16682150|P1|Overall Study|Withdrawal by Subject|1
4839640|NCT01038869|16682156|P1|Overall Study|Lost to Follow-up|6
4839641|NCT01038869|16682156|P1|Overall Study|Withdrawal by Subject|1
4839642|NCT01038856|16682164|P1|Overall Study|Adverse Event|2
4839643|NCT01038752|16682173|P2|Overall Study|Lost to Follow-up|3
4839644|NCT01038752|16682174|P1|Overall Study|Lost to Follow-up|3
4839645|NCT01038752|16682173|P2|Overall Study|Tumor Progression|2
4839646|NCT01038752|16682174|P1|Overall Study|Tumor Progression|2
4839647|NCT01038713|16682197|P3|Overall Study|Autoimmune Pancreatitis|0
4839648|NCT01038713|16682198|P2|Overall Study|Autoimmune Pancreatitis|0
4839649|NCT01038713|16682199|P1|Overall Study|Autoimmune Pancreatitis|1
4839650|NCT01038713|16682197|P3|Overall Study|died from PEP|0
4839651|NCT01038713|16682198|P2|Overall Study|died from PEP|1
4839652|NCT01038713|16682199|P1|Overall Study|died from PEP|0
4839653|NCT01038713|16682197|P3|Overall Study|Neuroendocrine Tumor|0
4839654|NCT01038713|16682198|P2|Overall Study|Neuroendocrine Tumor|1
4839655|NCT01038713|16682199|P1|Overall Study|Neuroendocrine Tumor|0
4839656|NCT01038713|16682197|P3|Overall Study|Lost to Follow-up|0
4839657|NCT01038713|16682198|P2|Overall Study|Lost to Follow-up|0
4839658|NCT01038713|16682199|P1|Overall Study|Lost to Follow-up|3
4839659|NCT01038713|16682197|P3|Overall Study|Patient to hospice|1
4839660|NCT01038713|16682198|P2|Overall Study|Patient to hospice|1
4839661|NCT01038713|16682199|P1|Overall Study|Patient to hospice|1
4839662|NCT01038687|16682222|P3|Overall Study|Adverse Event|1
4839663|NCT01038687|16682223|P2|Overall Study|Adverse Event|2
4839664|NCT01038687|16682224|P1|Overall Study|Adverse Event|0
4839665|NCT01038635|16682265|P9|Overall Study|Death|2
4839666|NCT01038635|16682266|P8|Overall Study|Death|1
4839667|NCT01038635|16682267|P7|Overall Study|Death|1
4839668|NCT01038635|16682268|P6|Overall Study|Death|0
4839669|NCT01038635|16682269|P5|Overall Study|Death|1
4839670|NCT01038635|16682270|P4|Overall Study|Death|0
4839671|NCT01038635|16682271|P3|Overall Study|Death|0
4839672|NCT01038635|16682272|P2|Overall Study|Death|0
4839673|NCT01038635|16682273|P1|Overall Study|Death|0
4839674|NCT01038635|16682265|P9|Overall Study|Disease Progression|0
4839675|NCT01038635|16682266|P8|Overall Study|Disease Progression|4
4839676|NCT01038635|16682267|P7|Overall Study|Disease Progression|1
4839677|NCT01038635|16682268|P6|Overall Study|Disease Progression|0
4839678|NCT01038635|16682269|P5|Overall Study|Disease Progression|0
4839679|NCT01038635|16682270|P4|Overall Study|Disease Progression|0
4839680|NCT01038635|16682271|P3|Overall Study|Disease Progression|0
4839681|NCT01038635|16682272|P2|Overall Study|Disease Progression|0
4839682|NCT01038635|16682273|P1|Overall Study|Disease Progression|2
4839683|NCT01038609|16682299|P5|Overall Study|Refusal of Blood Draws|0
4839684|NCT01038609|16682300|P4|Overall Study|Refusal of Blood Draws|0
4839685|NCT01038609|16682301|P3|Overall Study|Refusal of Blood Draws|0
4839686|NCT01038609|16682302|P2|Overall Study|Refusal of Blood Draws|1
4839687|NCT01038609|16682303|P1|Overall Study|Refusal of Blood Draws|0
4839688|NCT01038609|16682299|P5|Overall Study|Death in the Family|0
4839689|NCT01038609|16682300|P4|Overall Study|Death in the Family|0
4839690|NCT01038609|16682301|P3|Overall Study|Death in the Family|0
4839691|NCT01038609|16682302|P2|Overall Study|Death in the Family|0
4839692|NCT01038609|16682303|P1|Overall Study|Death in the Family|1
4839693|NCT01038609|16682299|P5|Overall Study|Dosing Error|1
4839694|NCT01038609|16682300|P4|Overall Study|Dosing Error|1
4839695|NCT01038609|16682301|P3|Overall Study|Dosing Error|0
4839696|NCT01038609|16682302|P2|Overall Study|Dosing Error|0
4839697|NCT01038609|16682303|P1|Overall Study|Dosing Error|0
4839698|NCT01038609|16682299|P5|Overall Study|Adverse Event|0
4839699|NCT01038609|16682300|P4|Overall Study|Adverse Event|0
4839700|NCT01038609|16682301|P3|Overall Study|Adverse Event|1
4839701|NCT01038609|16682302|P2|Overall Study|Adverse Event|0
4839702|NCT01038609|16682303|P1|Overall Study|Adverse Event|0
4839703|NCT01038323|16682422|P3|Overall Study|Withdrawal by Subject|4
4839704|NCT01038323|16682423|P2|Overall Study|Withdrawal by Subject|2
4839705|NCT01038323|16682424|P1|Overall Study|Withdrawal by Subject|3
4839706|NCT01038128|16682438|P1|Overall Study|Withdrawal by Subject|2
4839707|NCT01038128|16682438|P1|Overall Study|Lost to Follow-up|1
4839708|NCT01038128|16682438|P1|Overall Study|Lack of Efficacy|1
4839709|NCT01037244|16682602|P4|Overall Study|Various|1
4839710|NCT01037244|16682603|P3|Overall Study|Various|1
4839711|NCT01037244|16682604|P2|Overall Study|Various|2
4839712|NCT01037244|16682605|P1|Overall Study|Various|3
4839713|NCT01037244|16682602|P4|Overall Study|Partner Withdrew Consent|0
4839714|NCT01037244|16682603|P3|Overall Study|Partner Withdrew Consent|0
4839715|NCT01037244|16682604|P2|Overall Study|Partner Withdrew Consent|1
4839716|NCT01037244|16682605|P1|Overall Study|Partner Withdrew Consent|2
4839717|NCT01037244|16682602|P4|Overall Study|Withdrawal by Subject|5
4839718|NCT01037244|16682603|P3|Overall Study|Withdrawal by Subject|3
4839719|NCT01037244|16682604|P2|Overall Study|Withdrawal by Subject|5
4839720|NCT01037244|16682605|P1|Overall Study|Withdrawal by Subject|1
4839721|NCT01037244|16682602|P4|Overall Study|Lost to Follow-up|4
4839722|NCT01037244|16682603|P3|Overall Study|Lost to Follow-up|4
4839723|NCT01037244|16682604|P2|Overall Study|Lost to Follow-up|3
4839724|NCT01037244|16682605|P1|Overall Study|Lost to Follow-up|3
4839725|NCT01037244|16682602|P4|Overall Study|Lack of Efficacy|1
4839726|NCT01037244|16682603|P3|Overall Study|Lack of Efficacy|0
4839727|NCT01037244|16682604|P2|Overall Study|Lack of Efficacy|1
4839728|NCT01037244|16682605|P1|Overall Study|Lack of Efficacy|1
4839729|NCT01037244|16682602|P4|Overall Study|Adverse Event|3
4839730|NCT01037244|16682603|P3|Overall Study|Adverse Event|6
4839731|NCT01037244|16682604|P2|Overall Study|Adverse Event|2
4839732|NCT01037244|16682605|P1|Overall Study|Adverse Event|3
4839733|NCT01037218|16682667|P4|Overall Study|Various|1
4839734|NCT01037218|16682668|P3|Overall Study|Various|3
4839735|NCT01037218|16682669|P2|Overall Study|Various|2
4839736|NCT01037218|16682670|P1|Overall Study|Various|3
4839737|NCT01037218|16682667|P4|Overall Study|Protocol Violation|2
4839738|NCT01037218|16682668|P3|Overall Study|Protocol Violation|2
4839739|NCT01037218|16682669|P2|Overall Study|Protocol Violation|0
4839740|NCT01037218|16682670|P1|Overall Study|Protocol Violation|0
4839741|NCT01037218|16682667|P4|Overall Study|Partner Withdrew Consent|1
4839742|NCT01037218|16682668|P3|Overall Study|Partner Withdrew Consent|2
4839743|NCT01037218|16682669|P2|Overall Study|Partner Withdrew Consent|3
4839744|NCT01037218|16682670|P1|Overall Study|Partner Withdrew Consent|0
4839745|NCT01037218|16682667|P4|Overall Study|Withdrawal by Subject|4
4839746|NCT01037218|16682668|P3|Overall Study|Withdrawal by Subject|7
4839747|NCT01037218|16682669|P2|Overall Study|Withdrawal by Subject|7
4839748|NCT01037218|16682670|P1|Overall Study|Withdrawal by Subject|6
4839749|NCT01037218|16682667|P4|Overall Study|Lost to Follow-up|2
4839750|NCT01037218|16682668|P3|Overall Study|Lost to Follow-up|4
4839751|NCT01037218|16682669|P2|Overall Study|Lost to Follow-up|5
4839752|NCT01037218|16682670|P1|Overall Study|Lost to Follow-up|3
4839753|NCT01037218|16682667|P4|Overall Study|Lack of Efficacy|5
4839754|NCT01037218|16682668|P3|Overall Study|Lack of Efficacy|1
4839755|NCT01037218|16682669|P2|Overall Study|Lack of Efficacy|2
4839756|NCT01037218|16682670|P1|Overall Study|Lack of Efficacy|0
4839757|NCT01037218|16682667|P4|Overall Study|Adverse Event|1
4839758|NCT01037218|16682668|P3|Overall Study|Adverse Event|2
4839759|NCT01037218|16682669|P2|Overall Study|Adverse Event|2
4839760|NCT01037218|16682670|P1|Overall Study|Adverse Event|4
4839761|NCT01037127|16682741|P2|Overall Study|Study Closed Terminated|17
4839762|NCT01037127|16682742|P1|Overall Study|Study Closed Terminated|2
4839763|NCT01037127|16682741|P2|Overall Study|Physician Decision|0
4839764|NCT01037127|16682742|P1|Overall Study|Physician Decision|1
4839765|NCT01037127|16682741|P2|Overall Study|Lost to Follow-up|4
4839766|NCT01037127|16682742|P1|Overall Study|Lost to Follow-up|2
4839767|NCT01037114|16682774|P1|Year 20|Others|1
4839768|NCT01037088|16682787|P1|Overall Study|Withdrawal by Subject|3
4839769|NCT01036763|16682819|P1|Overall Study|Other reason (not specified)|40
4839770|NCT01036763|16682819|P1|Overall Study|Lost to Follow-up|28
4839771|NCT01036763|16682819|P1|Overall Study|Adverse Event|25
4839772|NCT01036724|16682831|P2|Overall Study|Protocol Violation|5
4839773|NCT01036724|16682832|P1|Overall Study|Protocol Violation|4
4839774|NCT01036724|16682831|P2|Overall Study|Lack of Efficacy|1
4839775|NCT01036724|16682832|P1|Overall Study|Lack of Efficacy|1
4839776|NCT01036724|16682831|P2|Overall Study|Adverse Event|2
4839777|NCT01036724|16682832|P1|Overall Study|Adverse Event|1
4839778|NCT01036594|16682840|P2|Treatment Regiments Post Week 12|Lack of Efficacy|1
4839779|NCT01036594|16682841|P1|Treatment Regiments Post Week 12|Lack of Efficacy|0
4839780|NCT01036594|16682840|P2|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1
4839781|NCT01036594|16682841|P1|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0
4839782|NCT01036594|16682840|P2|Treatment Regiments Post Week 12|Adverse Event|1
4839783|NCT01036594|16682841|P1|Treatment Regiments Post Week 12|Adverse Event|0
4839784|NCT01036594|16682840|P2|Treatment Regiments Post Week 12|Withdrawal by Subject|0
4839785|NCT01036594|16682841|P1|Treatment Regiments Post Week 12|Withdrawal by Subject|1
4839786|NCT01036594|16682840|P2|Treatment Regiments Post Week 12|Physician Decision|1
4839787|NCT01036594|16682841|P1|Treatment Regiments Post Week 12|Physician Decision|1
4839788|NCT01036594|16682840|P2|Week 12 Evaluation|Physician Decision|0
4839789|NCT01036594|16682841|P1|Week 12 Evaluation|Physician Decision|1
4839790|NCT01036594|16682840|P2|Week 12 Evaluation|Adverse Event|0
4839791|NCT01036594|16682841|P1|Week 12 Evaluation|Adverse Event|5
4839792|NCT01036594|16682840|P2|First Treatment Regimen|Withdrawal by Subject|0
4839793|NCT01036594|16682841|P1|First Treatment Regimen|Withdrawal by Subject|1
4839794|NCT01036594|16682840|P2|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0
4839795|NCT01036594|16682841|P1|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1
4839796|NCT01036529|16682865|P2|Overall Study|Sponsor study termination|12
4839797|NCT01036529|16682866|P1|Overall Study|Sponsor study termination|11
4839798|NCT01036529|16682865|P2|Overall Study|Withdrawal by Subject|1
4839799|NCT01036529|16682866|P1|Overall Study|Withdrawal by Subject|1
4839800|NCT01036529|16682865|P2|Overall Study|Physician Decision|0
4839801|NCT01036529|16682866|P1|Overall Study|Physician Decision|1
4839802|NCT01036529|16682865|P2|Overall Study|Lost to Follow-up|1
4839803|NCT01036529|16682866|P1|Overall Study|Lost to Follow-up|0
4839804|NCT01036529|16682865|P2|Overall Study|Adverse Event|1
4839805|NCT01036529|16682866|P1|Overall Study|Adverse Event|0
4839806|NCT01036438|16682893|P2|Overall Study|No effect of study treatment|1
4839807|NCT01036438|16682894|P1|Overall Study|No effect of study treatment|3
4839808|NCT01036438|16682893|P2|Overall Study|Death|1
4839809|NCT01036438|16682894|P1|Overall Study|Death|0
4839810|NCT01036438|16682893|P2|Overall Study|Adverse Event|8
4839811|NCT01036438|16682894|P1|Overall Study|Adverse Event|7
4839812|NCT01036321|16682902|P2|Overall Study|Adverse Event|1
4839813|NCT01036321|16682903|P1|Overall Study|Adverse Event|2
4839814|NCT01036321|16682902|P2|Overall Study|Withdrawal by Subject|2
4839815|NCT01036321|16682903|P1|Overall Study|Withdrawal by Subject|3
4839816|NCT01036321|16682902|P2|Overall Study|Ineligible after randomization|1
4839817|NCT01036321|16682903|P1|Overall Study|Ineligible after randomization|0
4839818|NCT01036165|16682927|P1|Overall Study|Problems finding proper area to inject|1
4839819|NCT01036165|16682927|P1|Overall Study|Device Related Issues|3
4839820|NCT01036165|16682927|P1|Overall Study|Withdrawal by Subject|3
4839821|NCT01036165|16682927|P1|Overall Study|Lost to Follow-up|2
4839822|NCT01036165|16682927|P1|Overall Study|Adverse Event|6
4839823|NCT01036022|16682938|P6|Overall Study|Withdrawal by Subject|0
4839824|NCT01036022|16682939|P5|Overall Study|Withdrawal by Subject|2
4839825|NCT01036022|16682940|P4|Overall Study|Withdrawal by Subject|1
4839826|NCT01036022|16682941|P3|Overall Study|Withdrawal by Subject|0
4839827|NCT01036022|16682942|P2|Overall Study|Withdrawal by Subject|0
4839828|NCT01036022|16682943|P1|Overall Study|Withdrawal by Subject|0
4839829|NCT01036022|16682938|P6|Overall Study|Physician Decision|0
4839830|NCT01036022|16682939|P5|Overall Study|Physician Decision|0
4839831|NCT01036022|16682940|P4|Overall Study|Physician Decision|0
4839832|NCT01036022|16682941|P3|Overall Study|Physician Decision|1
4839833|NCT01036022|16682942|P2|Overall Study|Physician Decision|0
4839834|NCT01036022|16682943|P1|Overall Study|Physician Decision|0
4839835|NCT01036022|16682938|P6|Overall Study|Lack of Efficacy|1
4839836|NCT01036022|16682939|P5|Overall Study|Lack of Efficacy|1
4839837|NCT01036022|16682940|P4|Overall Study|Lack of Efficacy|0
4839838|NCT01036022|16682941|P3|Overall Study|Lack of Efficacy|1
4839839|NCT01036022|16682942|P2|Overall Study|Lack of Efficacy|1
4839840|NCT01036022|16682943|P1|Overall Study|Lack of Efficacy|1
4839841|NCT01036022|16682938|P6|Overall Study|Adverse Event|2
4839842|NCT01036022|16682939|P5|Overall Study|Adverse Event|0
4839843|NCT01036022|16682940|P4|Overall Study|Adverse Event|1
4839844|NCT01036022|16682941|P3|Overall Study|Adverse Event|2
4839845|NCT01036022|16682942|P2|Overall Study|Adverse Event|3
4839846|NCT01036022|16682943|P1|Overall Study|Adverse Event|1
4839847|NCT01035905|16683079|P2|Overall Study|Lack of Efficacy|1
4839848|NCT01035905|16683080|P1|Overall Study|Lack of Efficacy|1
4839849|NCT01035606|16683253|P3|Overall Study|change in health, job demands,family|4
4839850|NCT01035606|16683254|P2|Overall Study|change in health, job demands,family|3
4839851|NCT01035606|16683255|P1|Overall Study|change in health, job demands,family|3
4839852|NCT01035463|16683271|P6|Overall Study|Other|2
4839853|NCT01035463|16683272|P5|Overall Study|Other|0
4839854|NCT01035463|16683273|P4|Overall Study|Other|1
4839855|NCT01035463|16683274|P3|Overall Study|Other|0
4839856|NCT01035463|16683275|P2|Overall Study|Other|0
4839857|NCT01035463|16683276|P1|Overall Study|Other|0
4839858|NCT01035463|16683271|P6|Overall Study|Other Malignancy|2
4839859|NCT01035463|16683272|P5|Overall Study|Other Malignancy|0
4839860|NCT01035463|16683273|P4|Overall Study|Other Malignancy|0
4839861|NCT01035463|16683274|P3|Overall Study|Other Malignancy|0
4839862|NCT01035463|16683275|P2|Overall Study|Other Malignancy|0
4839863|NCT01035463|16683276|P1|Overall Study|Other Malignancy|0
4839864|NCT01035463|16683271|P6|Overall Study|Disease progression|3
4839865|NCT01035463|16683272|P5|Overall Study|Disease progression|0
4839866|NCT01035463|16683273|P4|Overall Study|Disease progression|0
4839867|NCT01035463|16683274|P3|Overall Study|Disease progression|0
4839868|NCT01035463|16683275|P2|Overall Study|Disease progression|0
4839869|NCT01035463|16683276|P1|Overall Study|Disease progression|0
4839870|NCT01035463|16683271|P6|Overall Study|Withdrawal by Subject|4
4839871|NCT01035463|16683272|P5|Overall Study|Withdrawal by Subject|1
4839872|NCT01035463|16683273|P4|Overall Study|Withdrawal by Subject|0
4839873|NCT01035463|16683274|P3|Overall Study|Withdrawal by Subject|1
4839874|NCT01035463|16683275|P2|Overall Study|Withdrawal by Subject|2
4839875|NCT01035463|16683276|P1|Overall Study|Withdrawal by Subject|0
4839876|NCT01035463|16683271|P6|Overall Study|Adverse Event|7
4839877|NCT01035463|16683272|P5|Overall Study|Adverse Event|5
4839878|NCT01035463|16683273|P4|Overall Study|Adverse Event|1
4839879|NCT01035463|16683274|P3|Overall Study|Adverse Event|4
4839880|NCT01035463|16683275|P2|Overall Study|Adverse Event|0
4839881|NCT01035463|16683276|P1|Overall Study|Adverse Event|0
4839882|NCT01035255|16683313|P2|Overall Study|patient's request|13
4839883|NCT01035255|16683314|P1|Overall Study|patient's request|15
4839884|NCT01035255|16683313|P2|Overall Study|Lost to Follow-up|5
4839885|NCT01035255|16683314|P1|Overall Study|Lost to Follow-up|2
4839886|NCT01035255|16683313|P2|Overall Study|Death|844
4839887|NCT01035255|16683314|P1|Overall Study|Death|724
4839888|NCT01035229|16683332|P2|Overall Study|Disease Progression|152
4839889|NCT01035229|16683333|P1|Overall Study|Disease Progression|261
4839890|NCT01035229|16683332|P2|Overall Study|Sponsor's decision to end study|3
4839891|NCT01035229|16683333|P1|Overall Study|Sponsor's decision to end study|3
4839892|NCT01035229|16683332|P2|Overall Study|Protocol Violation|2
4839893|NCT01035229|16683333|P1|Overall Study|Protocol Violation|0
4839894|NCT01035229|16683332|P2|Overall Study|New cancer therapy|0
4839895|NCT01035229|16683333|P1|Overall Study|New cancer therapy|2
4839896|NCT01035229|16683332|P2|Overall Study|Death|5
4839897|NCT01035229|16683333|P1|Overall Study|Death|13
4839898|NCT01035229|16683332|P2|Overall Study|Administrative problems|1
4839899|NCT01035229|16683333|P1|Overall Study|Administrative problems|1
4839900|NCT01035229|16683332|P2|Overall Study|Lost to Follow-up|0
4839901|NCT01035229|16683333|P1|Overall Study|Lost to Follow-up|1
4839902|NCT01035229|16683332|P2|Overall Study|Withdrawal by Subject|7
4839903|NCT01035229|16683333|P1|Overall Study|Withdrawal by Subject|20
4839904|NCT01035229|16683332|P2|Overall Study|Adverse Event|14
4839905|NCT01035229|16683333|P1|Overall Study|Adverse Event|61
4839906|NCT01035138|16683363|P3|Overall Study|Lost to Follow-up|1
4839907|NCT01035138|16683364|P2|Overall Study|Lost to Follow-up|0
4839908|NCT01035138|16683365|P1|Overall Study|Lost to Follow-up|0
4839909|NCT01035138|16683363|P3|Overall Study|Sponsor Decision|42
4839910|NCT01035138|16683364|P2|Overall Study|Sponsor Decision|60
4839911|NCT01035138|16683365|P1|Overall Study|Sponsor Decision|66
4839912|NCT01035138|16683363|P3|Overall Study|Physician Decision|1
4839913|NCT01035138|16683364|P2|Overall Study|Physician Decision|0
4839914|NCT01035138|16683365|P1|Overall Study|Physician Decision|0
4839915|NCT01035138|16683363|P3|Overall Study|Withdrawal by Subject|0
4839916|NCT01035138|16683364|P2|Overall Study|Withdrawal by Subject|0
4839917|NCT01035138|16683365|P1|Overall Study|Withdrawal by Subject|1
4839918|NCT01035138|16683363|P3|Overall Study|Caregiver Decision|1
4839919|NCT01035138|16683364|P2|Overall Study|Caregiver Decision|0
4839920|NCT01035138|16683365|P1|Overall Study|Caregiver Decision|2
4839921|NCT01035138|16683363|P3|Overall Study|Adverse Event|2
4839922|NCT01035138|16683364|P2|Overall Study|Adverse Event|0
4839923|NCT01035138|16683365|P1|Overall Study|Adverse Event|4
4839924|NCT01035060|16683465|P2|Overall Study|Physician Decision|0
4839925|NCT01035060|16683466|P1|Overall Study|Physician Decision|2
4839926|NCT01035060|16683465|P2|Overall Study|Withdrawal by Subject|6
4839927|NCT01035060|16683466|P1|Overall Study|Withdrawal by Subject|8
4839928|NCT01035060|16683465|P2|Overall Study|Did not quality after 2nd screening|1
4839929|NCT01035060|16683466|P1|Overall Study|Did not quality after 2nd screening|14
4839930|NCT01035060|16683465|P2|Overall Study|Lost to Follow-up|7
4839931|NCT01035060|16683466|P1|Overall Study|Lost to Follow-up|0
4839932|NCT01034709|16683491|P2|Overall Study|Protocol Violation|16
4839933|NCT01034709|16683492|P1|Overall Study|Protocol Violation|9
4839934|NCT01034657|16683498|P3|Randomized Phase|Adverse Event|1
4839935|NCT01034657|16683499|P2|Randomized Phase|Adverse Event|2
4839936|NCT01034657|16683500|P1|Randomized Phase|Adverse Event|0
4839937|NCT01034657|16683498|P3|Randomized Phase|Abnormal laboratory value|0
4839938|NCT01034657|16683499|P2|Randomized Phase|Abnormal laboratory value|1
4839939|NCT01034657|16683500|P1|Randomized Phase|Abnormal laboratory value|0
4839940|NCT01034657|16683498|P3|Randomized Phase|Lack of Efficacy|0
4839941|NCT01034657|16683499|P2|Randomized Phase|Lack of Efficacy|1
4839942|NCT01034657|16683500|P1|Randomized Phase|Lack of Efficacy|5
4839943|NCT01034657|16683498|P3|Randomized Phase|Withdrawal by Subject|0
4839944|NCT01034657|16683499|P2|Randomized Phase|Withdrawal by Subject|2
4839945|NCT01034657|16683500|P1|Randomized Phase|Withdrawal by Subject|0
4839946|NCT01034657|16683498|P3|Core Phase|Protocol Violation|0
4839947|NCT01034657|16683499|P2|Core Phase|Protocol Violation|0
4839948|NCT01034657|16683500|P1|Core Phase|Protocol Violation|2
4839949|NCT01034657|16683498|P3|Core Phase|Adverse Event|0
4839950|NCT01034657|16683499|P2|Core Phase|Adverse Event|0
4839951|NCT01034657|16683500|P1|Core Phase|Adverse Event|8
4839952|NCT01034657|16683498|P3|Core Phase|Abnormal laboratory value|0
4839953|NCT01034657|16683499|P2|Core Phase|Abnormal laboratory value|0
4839954|NCT01034657|16683500|P1|Core Phase|Abnormal laboratory value|1
4839955|NCT01034657|16683498|P3|Core Phase|Lack of Efficacy|0
4839956|NCT01034657|16683499|P2|Core Phase|Lack of Efficacy|0
4839957|NCT01034657|16683500|P1|Core Phase|Lack of Efficacy|2
4839958|NCT01034657|16683498|P3|Core Phase|Withdrawal by Subject|0
4839959|NCT01034657|16683499|P2|Core Phase|Withdrawal by Subject|0
4839960|NCT01034657|16683500|P1|Core Phase|Withdrawal by Subject|1
4839961|NCT01034631|16683541|P3|Phase II|Determined Ineligible per protocol|0
4839962|NCT01034631|16683542|P2|Phase II|Determined Ineligible per protocol|1
4839963|NCT01034631|16683543|P1|Phase II|Determined Ineligible per protocol|0
4839964|NCT01034631|16683541|P3|Phase II|Not Evaluable per protocol|2
4839965|NCT01034631|16683542|P2|Phase II|Not Evaluable per protocol|0
4839966|NCT01034631|16683543|P1|Phase II|Not Evaluable per protocol|0
4839967|NCT01034631|16683541|P3|Phase I|Symptomatic Deterioration before Treatme|0
4839968|NCT01034631|16683542|P2|Phase I|Symptomatic Deterioration before Treatme|0
4839969|NCT01034631|16683543|P1|Phase I|Symptomatic Deterioration before Treatme|3
4839970|NCT01034540|16683610|P2|Overall Study|Adverse Event|1
4839971|NCT01034540|16683611|P1|Overall Study|Adverse Event|0
4839972|NCT01034462|16683630|P2|Overall Study|Other reasons|2
4839973|NCT01034462|16683631|P1|Overall Study|Other reasons|1
4839974|NCT01034462|16683630|P2|Overall Study|Lost to Follow-up|16
4839975|NCT01034462|16683631|P1|Overall Study|Lost to Follow-up|14
4839976|NCT01034462|16683630|P2|Overall Study|Withdrawal by Subject|8
4839977|NCT01034462|16683631|P1|Overall Study|Withdrawal by Subject|9
4839978|NCT01034462|16683630|P2|Overall Study|Protocol Violation|7
4839979|NCT01034462|16683631|P1|Overall Study|Protocol Violation|10
4839980|NCT01034462|16683630|P2|Overall Study|Lack of Efficacy|4
4839981|NCT01034462|16683631|P1|Overall Study|Lack of Efficacy|4
4839982|NCT01034462|16683630|P2|Overall Study|Adverse Event|17
4839983|NCT01034462|16683631|P1|Overall Study|Adverse Event|7
4839984|NCT01034397|16683641|P2|Overall Study|Other|1
4839985|NCT01034397|16683642|P1|Overall Study|Other|0
4839986|NCT01034397|16683641|P2|Overall Study|Adverse Event|0
4839987|NCT01034397|16683642|P1|Overall Study|Adverse Event|4
4839988|NCT01034397|16683641|P2|Overall Study|Lack of Efficacy|0
4839989|NCT01034397|16683642|P1|Overall Study|Lack of Efficacy|3
4839990|NCT01034397|16683641|P2|Overall Study|Lack of compliance|1
4839991|NCT01034397|16683642|P1|Overall Study|Lack of compliance|0
4839992|NCT01034358|16683791|P1|Overall Study|Protocol Violation|1
4839993|NCT01034358|16683791|P1|Overall Study|Withdrawal by Subject|1
4839994|NCT01034306|16683797|P2|Overall Study|Noncomplience|0
4839995|NCT01034306|16683798|P1|Overall Study|Noncomplience|1
4839996|NCT01034306|16683797|P2|Overall Study|hospitalized and decided to stop|0
4839997|NCT01034306|16683798|P1|Overall Study|hospitalized and decided to stop|1
4839998|NCT01034306|16683797|P2|Overall Study|Withdrawal by Subject|2
4839999|NCT01034306|16683798|P1|Overall Study|Withdrawal by Subject|2
4840000|NCT01034306|16683797|P2|Overall Study|Lost to Follow-up|1
4840001|NCT01034306|16683798|P1|Overall Study|Lost to Follow-up|0
4840002|NCT01034306|16683797|P2|Overall Study|Adverse Event|0
4840003|NCT01034306|16683798|P1|Overall Study|Adverse Event|1
4840004|NCT01034176|16683806|P2|Overall Study|Lost to Follow-up|1
4840005|NCT01034176|16683807|P1|Overall Study|Lost to Follow-up|0
4840006|NCT01034176|16683806|P2|Overall Study|Withdrawal by Subject|1
4840007|NCT01034176|16683807|P1|Overall Study|Withdrawal by Subject|0
4840008|NCT01034176|16683806|P2|Overall Study|Physician Decision|0
4840009|NCT01034176|16683807|P1|Overall Study|Physician Decision|2
4840010|NCT01034163|16683817|P2|Overall Study|Abnormal laboratory value|0
4840011|NCT01034163|16683818|P1|Overall Study|Abnormal laboratory value|1
4840012|NCT01034163|16683817|P2|Overall Study|Administrative problems|1
4840013|NCT01034163|16683818|P1|Overall Study|Administrative problems|0
4840014|NCT01034163|16683817|P2|Overall Study|Adverse Event|0
4840015|NCT01034163|16683818|P1|Overall Study|Adverse Event|6
4840016|NCT01034163|16683817|P2|Overall Study|Disease progression|4
4840017|NCT01034163|16683818|P1|Overall Study|Disease progression|3
4840018|NCT01034163|16683817|P2|Overall Study|Protocol deviation|0
4840019|NCT01034163|16683818|P1|Overall Study|Protocol deviation|1
4840020|NCT01034163|16683817|P2|Overall Study|Withdrawal by Subject|2
4840021|NCT01034163|16683818|P1|Overall Study|Withdrawal by Subject|8
4840022|NCT01034163|16683817|P2|Overall Study|Treatment completed as per protocol|7
4840023|NCT01034163|16683818|P1|Overall Study|Treatment completed as per protocol|8
4840024|NCT01034137|16683827|P3|Overall Study|Administrative or other|4
4840025|NCT01034137|16683828|P2|Overall Study|Administrative or other|3
4840026|NCT01034137|16683829|P1|Overall Study|Administrative or other|2
4840027|NCT01034137|16683827|P3|Overall Study|Refused treatment or did not cooperate|1
4840028|NCT01034137|16683828|P2|Overall Study|Refused treatment or did not cooperate|0
4840029|NCT01034137|16683829|P1|Overall Study|Refused treatment or did not cooperate|2
4840030|NCT01034137|16683827|P3|Overall Study|Protocol Violation|1
4840031|NCT01034137|16683828|P2|Overall Study|Protocol Violation|2
4840032|NCT01034137|16683829|P1|Overall Study|Protocol Violation|2
4840033|NCT01034137|16683827|P3|Overall Study|Lack of Efficacy|13
4840034|NCT01034137|16683828|P2|Overall Study|Lack of Efficacy|4
4840035|NCT01034137|16683829|P1|Overall Study|Lack of Efficacy|9
4840036|NCT01034137|16683827|P3|Overall Study|Withdrawal by Subject|3
4840037|NCT01034137|16683828|P2|Overall Study|Withdrawal by Subject|3
4840038|NCT01034137|16683829|P1|Overall Study|Withdrawal by Subject|4
4840039|NCT01034137|16683827|P3|Overall Study|Adverse Event|8
4840040|NCT01034137|16683828|P2|Overall Study|Adverse Event|10
4840041|NCT01034137|16683829|P1|Overall Study|Adverse Event|9
4840042|NCT01033942|16683968|P3|Overall Study|Enrolled in Extension Study|0
4840043|NCT01033942|16683969|P2|Overall Study|Enrolled in Extension Study|3
4840044|NCT01033942|16683970|P1|Overall Study|Enrolled in Extension Study|0
4840045|NCT01033942|16683968|P3|Overall Study|Lost to Follow-up|0
4840046|NCT01033942|16683969|P2|Overall Study|Lost to Follow-up|0
4840047|NCT01033942|16683970|P1|Overall Study|Lost to Follow-up|1
4840048|NCT01033942|16683968|P3|Overall Study|Withdrawal by Subject|1
4840049|NCT01033942|16683969|P2|Overall Study|Withdrawal by Subject|1
4840050|NCT01033942|16683970|P1|Overall Study|Withdrawal by Subject|1
4840051|NCT01033851|16684268|P2|Overall Study|Withdrawal by Subject|7
4840052|NCT01033851|16684269|P1|Overall Study|Withdrawal by Subject|3
4840053|NCT01033825|16684284|P7|Overall Study|Other|0
4840054|NCT01033825|16684285|P6|Overall Study|Other|0
4840055|NCT01033825|16684286|P5|Overall Study|Other|1
4840056|NCT01033825|16684287|P4|Overall Study|Other|0
4840057|NCT01033825|16684288|P3|Overall Study|Other|0
4840058|NCT01033825|16684289|P2|Overall Study|Other|0
4840059|NCT01033825|16684290|P1|Overall Study|Other|0
4840060|NCT01033825|16684284|P7|Overall Study|Protocol Violation|0
4840061|NCT01033825|16684285|P6|Overall Study|Protocol Violation|0
4840062|NCT01033825|16684286|P5|Overall Study|Protocol Violation|0
4840063|NCT01033825|16684287|P4|Overall Study|Protocol Violation|0
4840064|NCT01033825|16684288|P3|Overall Study|Protocol Violation|0
4840065|NCT01033825|16684289|P2|Overall Study|Protocol Violation|0
4840066|NCT01033825|16684290|P1|Overall Study|Protocol Violation|1
4840067|NCT01033825|16684284|P7|Overall Study|Adverse Event|0
4840068|NCT01033825|16684285|P6|Overall Study|Adverse Event|0
4840069|NCT01033825|16684286|P5|Overall Study|Adverse Event|0
4840070|NCT01033825|16684287|P4|Overall Study|Adverse Event|1
4840071|NCT01033825|16684288|P3|Overall Study|Adverse Event|0
4840072|NCT01033825|16684289|P2|Overall Study|Adverse Event|0
4840073|NCT01033825|16684290|P1|Overall Study|Adverse Event|0
4840074|NCT01033825|16684284|P7|Overall Study|Withdrawal by Subject|0
4840075|NCT01033825|16684285|P6|Overall Study|Withdrawal by Subject|0
4840076|NCT01033825|16684286|P5|Overall Study|Withdrawal by Subject|1
4840077|NCT01033825|16684287|P4|Overall Study|Withdrawal by Subject|1
4840078|NCT01033825|16684288|P3|Overall Study|Withdrawal by Subject|2
4840079|NCT01033825|16684289|P2|Overall Study|Withdrawal by Subject|3
4840080|NCT01033825|16684290|P1|Overall Study|Withdrawal by Subject|2
4840081|NCT01033747|16684517|P2|Overall Study|Stopped at end of Extension 1|0
4840082|NCT01033747|16684518|P1|Overall Study|Stopped at end of Extension 1|2
4840083|NCT01033747|16684517|P2|Overall Study|Stopped at end of prolongation visit 1|0
4840084|NCT01033747|16684518|P1|Overall Study|Stopped at end of prolongation visit 1|1
4840085|NCT01033747|16684517|P2|Overall Study|Withdrawal by Subject|6
4840086|NCT01033747|16684518|P1|Overall Study|Withdrawal by Subject|9
4840087|NCT01033747|16684517|P2|Overall Study|Protocol Violation|0
4840088|NCT01033747|16684518|P1|Overall Study|Protocol Violation|1
4840089|NCT01033747|16684517|P2|Overall Study|Unsatisfactory therapeutic effect|4
4840090|NCT01033747|16684518|P1|Overall Study|Unsatisfactory therapeutic effect|14
4840091|NCT01033747|16684517|P2|Overall Study|Abnormal test procedure|1
4840092|NCT01033747|16684518|P1|Overall Study|Abnormal test procedure|0
4840093|NCT01033747|16684517|P2|Overall Study|Abnormal Laboratory Value|0
4840094|NCT01033747|16684518|P1|Overall Study|Abnormal Laboratory Value|1
4840095|NCT01033747|16684517|P2|Overall Study|Adverse Event|4
4840096|NCT01033747|16684518|P1|Overall Study|Adverse Event|9
4840097|NCT01033734|16684526|P1|Overall Study|Withdrawal by Subject|1
4840098|NCT01033487|16684582|P10|Fourth Intervention Period|Adverse Event|0
4840099|NCT01033487|16684583|P9|Fourth Intervention Period|Adverse Event|1
4840100|NCT01033487|16684584|P8|Fourth Intervention Period|Adverse Event|0
4840101|NCT01033487|16684585|P7|Fourth Intervention Period|Adverse Event|0
4840102|NCT01033487|16684586|P6|Fourth Intervention Period|Adverse Event|0
4840103|NCT01033487|16684587|P5|Fourth Intervention Period|Adverse Event|0
4840104|NCT01033487|16684588|P4|Fourth Intervention Period|Adverse Event|0
4840105|NCT01033487|16684589|P3|Fourth Intervention Period|Adverse Event|0
4840106|NCT01033487|16684590|P2|Fourth Intervention Period|Adverse Event|0
4840107|NCT01033487|16684591|P1|Fourth Intervention Period|Adverse Event|0
4840108|NCT01033448|16684645|P1|Overall Study|Unknown disposition|1
4840109|NCT01033448|16684645|P1|Overall Study|Withdrew due to other reasons|3
4840110|NCT01033448|16684645|P1|Overall Study|Lost to Follow-up|3
4840111|NCT01033448|16684645|P1|Overall Study|Positive HCV-RNA at week 48|1
4840112|NCT01033448|16684645|P1|Overall Study|Withdrawal by Subject|4
4840113|NCT01033136|16684704|P2|Follow-Up (3 Month)|Lost to Follow-up|2
4840114|NCT01033136|16684705|P1|Follow-Up (3 Month)|Lost to Follow-up|2
4840115|NCT01033071|16684716|P3|Overall Study|Other|3
4840116|NCT01033071|16684717|P2|Overall Study|Other|4
4840117|NCT01033071|16684718|P1|Overall Study|Other|6
4840118|NCT01033071|16684716|P3|Overall Study|Lack of Efficacy|1
4840119|NCT01033071|16684717|P2|Overall Study|Lack of Efficacy|1
4840120|NCT01033071|16684718|P1|Overall Study|Lack of Efficacy|0
4840121|NCT01033071|16684716|P3|Overall Study|Withdrawal by Subject|11
4840122|NCT01033071|16684717|P2|Overall Study|Withdrawal by Subject|14
4840123|NCT01033071|16684718|P1|Overall Study|Withdrawal by Subject|17
4840124|NCT01033071|16684716|P3|Overall Study|Lost to Follow-up|5
4840125|NCT01033071|16684717|P2|Overall Study|Lost to Follow-up|5
4840126|NCT01033071|16684718|P1|Overall Study|Lost to Follow-up|4
4840127|NCT01033071|16684716|P3|Overall Study|Protocol Violation|1
4840128|NCT01033071|16684717|P2|Overall Study|Protocol Violation|2
4840129|NCT01033071|16684718|P1|Overall Study|Protocol Violation|0
4840130|NCT01033071|16684716|P3|Overall Study|Adverse Event|26
4840131|NCT01033071|16684717|P2|Overall Study|Adverse Event|51
4840132|NCT01033071|16684718|P1|Overall Study|Adverse Event|28
4840133|NCT01033019|16684789|P2|Overall Study|Withdrawal by Subject|0
4840134|NCT01033019|16684790|P1|Overall Study|Withdrawal by Subject|1
4840135|NCT01032915|16684847|P4|Overall Study|Protocol Violation|1
4840136|NCT01032915|16684848|P3|Overall Study|Protocol Violation|0
4840137|NCT01032915|16684849|P2|Overall Study|Protocol Violation|0
4840138|NCT01032915|16684850|P1|Overall Study|Protocol Violation|1
4840139|NCT01032915|16684847|P4|Overall Study|Administrative reasons|4
4840140|NCT01032915|16684848|P3|Overall Study|Administrative reasons|4
4840141|NCT01032915|16684849|P2|Overall Study|Administrative reasons|6
4840142|NCT01032915|16684850|P1|Overall Study|Administrative reasons|5
4840143|NCT01032915|16684847|P4|Overall Study|Withdrawal by Subject|1
4840144|NCT01032915|16684848|P3|Overall Study|Withdrawal by Subject|1
4840145|NCT01032915|16684849|P2|Overall Study|Withdrawal by Subject|3
4840146|NCT01032915|16684850|P1|Overall Study|Withdrawal by Subject|0
4840147|NCT01032915|16684847|P4|Overall Study|Abnormal test procedure result|0
4840148|NCT01032915|16684848|P3|Overall Study|Abnormal test procedure result|1
4840149|NCT01032915|16684849|P2|Overall Study|Abnormal test procedure result|0
4840150|NCT01032915|16684850|P1|Overall Study|Abnormal test procedure result|0
4840151|NCT01032915|16684847|P4|Overall Study|Adverse Event|1
4840152|NCT01032915|16684848|P3|Overall Study|Adverse Event|1
4840153|NCT01032915|16684849|P2|Overall Study|Adverse Event|2
4840154|NCT01032915|16684850|P1|Overall Study|Adverse Event|2
4840155|NCT01032889|16684875|P3|Overall Study|Miscellaneous Reasons|1
4840156|NCT01032889|16684876|P2|Overall Study|Miscellaneous Reasons|1
4840157|NCT01032889|16684877|P1|Overall Study|Miscellaneous Reasons|2
4840158|NCT01032889|16684875|P3|Overall Study|Lack of Submental Fat|1
4840159|NCT01032889|16684876|P2|Overall Study|Lack of Submental Fat|8
4840160|NCT01032889|16684877|P1|Overall Study|Lack of Submental Fat|2
4840161|NCT01032889|16684875|P3|Overall Study|Lost to Follow-up|0
4840162|NCT01032889|16684876|P2|Overall Study|Lost to Follow-up|1
4840163|NCT01032889|16684877|P1|Overall Study|Lost to Follow-up|1
4840164|NCT01032889|16684875|P3|Overall Study|Patient Request|0
4840165|NCT01032889|16684876|P2|Overall Study|Patient Request|1
4840166|NCT01032889|16684877|P1|Overall Study|Patient Request|0
4840167|NCT01032889|16684875|P3|Overall Study|Withdrawal of Consent|1
4840168|NCT01032889|16684876|P2|Overall Study|Withdrawal of Consent|2
4840169|NCT01032889|16684877|P1|Overall Study|Withdrawal of Consent|1
4840170|NCT01032889|16684875|P3|Overall Study|Adverse Event|0
4840171|NCT01032889|16684876|P2|Overall Study|Adverse Event|2
4840172|NCT01032889|16684877|P1|Overall Study|Adverse Event|2
4840173|NCT01032837|16684908|P4|Overall Study|Refused treatment|1
4840174|NCT01032837|16684909|P3|Overall Study|Refused treatment|0
4840175|NCT01032837|16684910|P2|Overall Study|Refused treatment|0
4840176|NCT01032837|16684911|P1|Overall Study|Refused treatment|0
4840177|NCT01032837|16684908|P4|Overall Study|Failed to return|0
4840178|NCT01032837|16684909|P3|Overall Study|Failed to return|1
4840179|NCT01032837|16684910|P2|Overall Study|Failed to return|0
4840180|NCT01032837|16684911|P1|Overall Study|Failed to return|0
4840181|NCT01032837|16684908|P4|Overall Study|Withdrew consent|1
4840182|NCT01032837|16684909|P3|Overall Study|Withdrew consent|0
4840183|NCT01032837|16684910|P2|Overall Study|Withdrew consent|2
4840184|NCT01032837|16684911|P1|Overall Study|Withdrew consent|0
4840185|NCT01032837|16684908|P4|Overall Study|Adverse event/internal illness|1
4840186|NCT01032837|16684909|P3|Overall Study|Adverse event/internal illness|0
4840187|NCT01032837|16684910|P2|Overall Study|Adverse event/internal illness|1
4840188|NCT01032837|16684911|P1|Overall Study|Adverse event/internal illness|0
4840189|NCT01032629|16685011|P3|Overall Study|Lost to Follow-up|37
4840190|NCT01032629|16685012|P2|Overall Study|Lost to Follow-up|47
4840191|NCT01032629|16685013|P1|Overall Study|Lost to Follow-up|74
4840192|NCT01032629|16685011|P3|Overall Study|Withdrawal by Subject|35
4840193|NCT01032629|16685012|P2|Overall Study|Withdrawal by Subject|36
4840194|NCT01032629|16685013|P1|Overall Study|Withdrawal by Subject|50
4840195|NCT01032629|16685011|P3|Overall Study|Closed Site|16
4840196|NCT01032629|16685012|P2|Overall Study|Closed Site|18
4840197|NCT01032629|16685013|P1|Overall Study|Closed Site|21
4840198|NCT01032382|16685125|P2|Overall Study|Index lesion relapse|3
4840199|NCT01032382|16685126|P1|Overall Study|Index lesion relapse|1
4840200|NCT01032382|16685125|P2|Overall Study|Treatment failure|1
4840201|NCT01032382|16685126|P1|Overall Study|Treatment failure|3
4840202|NCT01032382|16685125|P2|Overall Study|Disease dissemination|1
4840203|NCT01032382|16685126|P1|Overall Study|Disease dissemination|1
4840204|NCT01032291|16685214|P3|Proof of Concept|Never Received Study Drug|0
4840205|NCT01032291|16685215|P2|Proof of Concept|Never Received Study Drug|1
4840206|NCT01032291|16685216|P1|Proof of Concept|Never Received Study Drug|0
4840207|NCT01032291|16685214|P3|Proof of Concept|Lack of Efficacy|0
4840208|NCT01032291|16685215|P2|Proof of Concept|Lack of Efficacy|1
4840209|NCT01032291|16685216|P1|Proof of Concept|Lack of Efficacy|0
4840210|NCT01032291|16685214|P3|Proof of Concept|Death|2
4840211|NCT01032291|16685215|P2|Proof of Concept|Death|1
4840212|NCT01032291|16685216|P1|Proof of Concept|Death|0
4840213|NCT01032291|16685214|P3|Proof of Concept|Adverse Event|1
4840214|NCT01032291|16685215|P2|Proof of Concept|Adverse Event|5
4840215|NCT01032291|16685216|P1|Proof of Concept|Adverse Event|0
4840216|NCT01032291|16685214|P3|Safety Lead-in|Death|0
4840217|NCT01032291|16685215|P2|Safety Lead-in|Death|0
4840218|NCT01032291|16685216|P1|Safety Lead-in|Death|1
4840219|NCT01032291|16685214|P3|Safety Lead-in|Adverse Event|0
4840220|NCT01032291|16685215|P2|Safety Lead-in|Adverse Event|0
4840221|NCT01032291|16685216|P1|Safety Lead-in|Adverse Event|1
4840222|NCT01032239|16685263|P2|Overall Study|Protocol Violation|0
4840223|NCT01032239|16685264|P1|Overall Study|Protocol Violation|1
4840224|NCT01032239|16685263|P2|Overall Study|Death|0
4840225|NCT01032239|16685264|P1|Overall Study|Death|1
4840226|NCT01032239|16685263|P2|Overall Study|Withdrawal by Subject|3
4840227|NCT01032239|16685264|P1|Overall Study|Withdrawal by Subject|2
4840228|NCT01032239|16685263|P2|Overall Study|Lost to Follow-up|2
4840229|NCT01032239|16685264|P1|Overall Study|Lost to Follow-up|3
4840230|NCT01032200|16685294|P2|Overall Study|Multiple|1
4840231|NCT01032200|16685295|P1|Overall Study|Multiple|1
4840232|NCT01032200|16685294|P2|Overall Study|Progression|0
4840233|NCT01032200|16685295|P1|Overall Study|Progression|1
4840234|NCT01032200|16685294|P2|Overall Study|Toxicity|2
4840235|NCT01032200|16685295|P1|Overall Study|Toxicity|0
4840236|NCT01032200|16685294|P2|Overall Study|Withdrawal by Subject|3
4840237|NCT01032200|16685295|P1|Overall Study|Withdrawal by Subject|1
4840238|NCT01032200|16685294|P2|Overall Study|Death|1
4840239|NCT01032200|16685295|P1|Overall Study|Death|1
4840240|NCT01032174|16685311|P2|Overall Study|Adverse Event|1
4840241|NCT01032174|16685312|P1|Overall Study|Adverse Event|0
4840242|NCT01032070|16685552|P2|Overall Study|Withdrawal by Subject|2
4840243|NCT01032070|16685553|P1|Overall Study|Withdrawal by Subject|0
4840244|NCT01032070|16685552|P2|Overall Study|Medical or ethical reasons|2
4840245|NCT01032070|16685553|P1|Overall Study|Medical or ethical reasons|0
4840246|NCT01032070|16685552|P2|Overall Study|Disease progression|8
4840247|NCT01032070|16685553|P1|Overall Study|Disease progression|13
4840248|NCT01032044|16685582|P2|Overall Study|Lost to Follow-up|11
4840249|NCT01032044|16685583|P1|Overall Study|Lost to Follow-up|11
4840250|NCT01032044|16685582|P2|Overall Study|Adverse Event|1
4840251|NCT01032044|16685583|P1|Overall Study|Adverse Event|0
4840252|NCT01032044|16685582|P2|Overall Study|Protocol Violation|8
4840253|NCT01032044|16685583|P1|Overall Study|Protocol Violation|14
4840254|NCT01032018|16685591|P2|Overall Study|Death|1
4840255|NCT01032018|16685592|P1|Overall Study|Death|0
4840256|NCT01032018|16685591|P2|Overall Study|Lost to Follow-up|5
4840257|NCT01032018|16685592|P1|Overall Study|Lost to Follow-up|6
4840258|NCT01031979|16685602|P2|Overall Study|Lost to Follow-up|4
4840259|NCT01031979|16685603|P1|Overall Study|Lost to Follow-up|5
4840260|NCT01031836|16685636|P6|Stage II|Other|0
4840261|NCT01031836|16685637|P5|Stage II|Other|1
4840262|NCT01031836|16685638|P4|Stage II|Other|1
4840263|NCT01031836|16685639|P3|Stage II|Other|0
4840264|NCT01031836|16685640|P2|Stage II|Other|0
4840265|NCT01031836|16685641|P1|Stage II|Other|2
4840266|NCT01031836|16685636|P6|Stage II|Adverse Event|1
4840267|NCT01031836|16685637|P5|Stage II|Adverse Event|1
4840268|NCT01031836|16685638|P4|Stage II|Adverse Event|2
4840269|NCT01031836|16685639|P3|Stage II|Adverse Event|2
4840270|NCT01031836|16685640|P2|Stage II|Adverse Event|0
4840271|NCT01031836|16685641|P1|Stage II|Adverse Event|0
4840272|NCT01031836|16685636|P6|Stage I|Other|1
4840273|NCT01031836|16685637|P5|Stage I|Other|0
4840274|NCT01031836|16685638|P4|Stage I|Other|0
4840275|NCT01031836|16685639|P3|Stage I|Other|0
4840276|NCT01031836|16685640|P2|Stage I|Other|1
4840277|NCT01031836|16685641|P1|Stage I|Other|0
4840278|NCT01031836|16685636|P6|Stage I|Adverse Event|0
4840279|NCT01031836|16685637|P5|Stage I|Adverse Event|0
4840280|NCT01031836|16685638|P4|Stage I|Adverse Event|0
4840281|NCT01031836|16685639|P3|Stage I|Adverse Event|0
4840282|NCT01031836|16685640|P2|Stage I|Adverse Event|1
4840283|NCT01031836|16685641|P1|Stage I|Adverse Event|1
4840284|NCT01031706|16685702|P2|Overall Study|Withdrawal by Subject|1
4840285|NCT01031706|16685703|P1|Overall Study|Withdrawal by Subject|1
4840286|NCT01031706|16685702|P2|Overall Study|Adverse Event|0
4840287|NCT01031706|16685703|P1|Overall Study|Adverse Event|1
4840288|NCT01031680|16685713|P2|Overall Study|Various|2
4840289|NCT01031680|16685714|P1|Overall Study|Various|0
4840290|NCT01031680|16685713|P2|Overall Study|Administrative Reason by Sponsor|1
4840291|NCT01031680|16685714|P1|Overall Study|Administrative Reason by Sponsor|0
4840292|NCT01031680|16685713|P2|Overall Study|Incorrect Enrolment|2
4840293|NCT01031680|16685714|P1|Overall Study|Incorrect Enrolment|1
4840294|NCT01031680|16685713|P2|Overall Study|Safety|0
4840295|NCT01031680|16685714|P1|Overall Study|Safety|1
4840296|NCT01031680|16685713|P2|Overall Study|Poor/Non-compliance|6
4840297|NCT01031680|16685714|P1|Overall Study|Poor/Non-compliance|5
4840298|NCT01031680|16685713|P2|Overall Study|Subject No Longer Meets Study Criteria|17
4840299|NCT01031680|16685714|P1|Overall Study|Subject No Longer Meets Study Criteria|26
4840300|NCT01031680|16685713|P2|Overall Study|Death|1
4840301|NCT01031680|16685714|P1|Overall Study|Death|2
4840302|NCT01031680|16685713|P2|Overall Study|Withdrawal by Subject|16
4840303|NCT01031680|16685714|P1|Overall Study|Withdrawal by Subject|12
4840304|NCT01031680|16685713|P2|Overall Study|Lost to Follow-up|10
4840305|NCT01031680|16685714|P1|Overall Study|Lost to Follow-up|2
4840306|NCT01031680|16685713|P2|Overall Study|Adverse Event|3
4840307|NCT01031680|16685714|P1|Overall Study|Adverse Event|8
4840308|NCT01031628|16685734|P4|Overall Study|Study terminated early|0
4840309|NCT01031628|16685735|P3|Overall Study|Study terminated early|3
4840310|NCT01031628|16685736|P2|Overall Study|Study terminated early|1
4840311|NCT01031628|16685737|P1|Overall Study|Study terminated early|0
4840312|NCT01031537|16685762|P1|Overall Study|PI removal, no longer met eligibility|12
4840313|NCT01031537|16685762|P1|Overall Study|Withdrawal by Subject|5
4840314|NCT01031537|16685762|P1|Overall Study|moved, met exclusion criteria|10
4840315|NCT01031537|16685762|P1|Overall Study|retired from NIH, met exclusion criteria|1
4840316|NCT01031537|16685762|P1|Overall Study|Lack of Efficacy|1
4840317|NCT01031537|16685762|P1|Overall Study|medical reasons not related to study|3
4840318|NCT01031446|16685780|P1|Overall Study|Still on treatment|1
4840319|NCT01031446|16685780|P1|Overall Study|Withdrawal by Subject|3
4840320|NCT01031446|16685780|P1|Overall Study|Physician Decision|4
4840321|NCT01031446|16685780|P1|Overall Study|Adverse Event|9
4840322|NCT01031446|16685780|P1|Overall Study|Disease Progression|38
4840323|NCT01031381|16685794|P1|Overall Study|Withdrawal by Subject|6
4840324|NCT01031381|16685794|P1|Overall Study|Physician Decision|3
4840325|NCT01031069|16685823|P4|Overall Study|Other|0
4840326|NCT01031069|16685824|P3|Overall Study|Other|1
4840327|NCT01031069|16685825|P2|Overall Study|Other|0
4840328|NCT01031069|16685826|P1|Overall Study|Other|0
4840329|NCT01031069|16685823|P4|Overall Study|Lost to Follow-up|15
4840330|NCT01031069|16685824|P3|Overall Study|Lost to Follow-up|21
4840331|NCT01031069|16685825|P2|Overall Study|Lost to Follow-up|5
4840332|NCT01031069|16685826|P1|Overall Study|Lost to Follow-up|9
4840333|NCT01031069|16685823|P4|Overall Study|Migrated/moved from study area|1
4840334|NCT01031069|16685824|P3|Overall Study|Migrated/moved from study area|1
4840335|NCT01031069|16685825|P2|Overall Study|Migrated/moved from study area|2
4840336|NCT01031069|16685826|P1|Overall Study|Migrated/moved from study area|1
4840337|NCT01031069|16685823|P4|Overall Study|Withdrawal by Subject|18
4840338|NCT01031069|16685824|P3|Overall Study|Withdrawal by Subject|18
4840339|NCT01031069|16685825|P2|Overall Study|Withdrawal by Subject|3
4840340|NCT01031069|16685826|P1|Overall Study|Withdrawal by Subject|2
4840341|NCT01031069|16685823|P4|Overall Study|Serious Adverse Event|0
4840342|NCT01031069|16685824|P3|Overall Study|Serious Adverse Event|0
4840343|NCT01031069|16685825|P2|Overall Study|Serious Adverse Event|1
4840344|NCT01031069|16685826|P1|Overall Study|Serious Adverse Event|0
4840345|NCT01031004|16685928|P2|Overall Study|Lost to Follow-up|0
4840346|NCT01031004|16685929|P1|Overall Study|Lost to Follow-up|1
4840347|NCT01031004|16685928|P2|Overall Study|Protocol Violation|1
4840348|NCT01031004|16685929|P1|Overall Study|Protocol Violation|0
4840349|NCT01030965|16685973|P4|Overall Study|Withdrawal by Subject|2
4840350|NCT01030965|16685974|P3|Overall Study|Withdrawal by Subject|0
4840351|NCT01030965|16685975|P2|Overall Study|Withdrawal by Subject|1
4840352|NCT01030965|16685976|P1|Overall Study|Withdrawal by Subject|0
4840353|NCT01030965|16685973|P4|Overall Study|Protocol-defined Stopping Criteria|0
4840354|NCT01030965|16685974|P3|Overall Study|Protocol-defined Stopping Criteria|1
4840355|NCT01030965|16685975|P2|Overall Study|Protocol-defined Stopping Criteria|1
4840356|NCT01030965|16685976|P1|Overall Study|Protocol-defined Stopping Criteria|0
4840357|NCT01030965|16685973|P4|Overall Study|Adverse Event|1
4840358|NCT01030965|16685974|P3|Overall Study|Adverse Event|2
4840359|NCT01030965|16685975|P2|Overall Study|Adverse Event|1
4840360|NCT01030965|16685976|P1|Overall Study|Adverse Event|0
4840361|NCT01030965|16685973|P4|Overall Study|Protocol Violation|1
4840362|NCT01030965|16685974|P3|Overall Study|Protocol Violation|1
4840363|NCT01030965|16685975|P2|Overall Study|Protocol Violation|1
4840364|NCT01030965|16685976|P1|Overall Study|Protocol Violation|1
4840365|NCT01030965|16685973|P4|Overall Study|Lack of Efficacy|3
4840366|NCT01030965|16685974|P3|Overall Study|Lack of Efficacy|0
4840367|NCT01030965|16685975|P2|Overall Study|Lack of Efficacy|2
4840368|NCT01030965|16685976|P1|Overall Study|Lack of Efficacy|3
4840369|NCT01030952|16685996|P2|Overall Study|Unexplained|1
4840370|NCT01030952|16685997|P1|Overall Study|Unexplained|1
4840371|NCT01030952|16685996|P2|Overall Study|Lost to Follow-up|1
4840372|NCT01030952|16685997|P1|Overall Study|Lost to Follow-up|0
4840373|NCT01030952|16685996|P2|Overall Study|Informed consent withdrawal|0
4840374|NCT01030952|16685997|P1|Overall Study|Informed consent withdrawal|1
4840375|NCT01030952|16685996|P2|Overall Study|Protocol Violation|1
4840376|NCT01030952|16685997|P1|Overall Study|Protocol Violation|0
4840377|NCT01030822|16686045|P3|Overall Study|Lost to Follow-up|7
4840378|NCT01030822|16686046|P2|Overall Study|Lost to Follow-up|4
4840379|NCT01030822|16686047|P1|Overall Study|Lost to Follow-up|9
4840380|NCT01030822|16686045|P3|Overall Study|Withdrawal by Subject|16
4840381|NCT01030822|16686046|P2|Overall Study|Withdrawal by Subject|13
4840382|NCT01030822|16686047|P1|Overall Study|Withdrawal by Subject|16
4840383|NCT01030822|16686045|P3|Overall Study|Moved/migrated from study area|3
4840384|NCT01030822|16686046|P2|Overall Study|Moved/migrated from study area|7
4840385|NCT01030822|16686047|P1|Overall Study|Moved/migrated from study area|6
4840386|NCT01030718|16686122|P3|Study CA180-036 Only|Other Reasons|0
4840387|NCT01030718|16686123|P2|Study CA180-036 Only|Other Reasons|2
4840388|NCT01030718|16686124|P1|Study CA180-036 Only|Other Reasons|0
4840389|NCT01030718|16686122|P3|Study CA180-036 Only|Death|0
4840390|NCT01030718|16686123|P2|Study CA180-036 Only|Death|1
4840391|NCT01030718|16686124|P1|Study CA180-036 Only|Death|0
4840392|NCT01030718|16686122|P3|Study CA180-036 Only|Adverse Event|0
4840393|NCT01030718|16686123|P2|Study CA180-036 Only|Adverse Event|3
4840394|NCT01030718|16686124|P1|Study CA180-036 Only|Adverse Event|2
4840395|NCT01030718|16686122|P3|Study CA180-036 Only|insufficient effect|5
4840396|NCT01030718|16686123|P2|Study CA180-036 Only|insufficient effect|1
4840397|NCT01030718|16686124|P1|Study CA180-036 Only|insufficient effect|1
4840398|NCT01030718|16686122|P3|Studies CA180-031 and -036 Combined|other reasons|0
4840399|NCT01030718|16686123|P2|Studies CA180-031 and -036 Combined|other reasons|2
4840400|NCT01030718|16686124|P1|Studies CA180-031 and -036 Combined|other reasons|0
4840401|NCT01030718|16686122|P3|Studies CA180-031 and -036 Combined|Death|0
4840402|NCT01030718|16686123|P2|Studies CA180-031 and -036 Combined|Death|1
4840403|NCT01030718|16686124|P1|Studies CA180-031 and -036 Combined|Death|0
4840404|NCT01030718|16686122|P3|Studies CA180-031 and -036 Combined|Adverse Event|1
4840405|NCT01030718|16686123|P2|Studies CA180-031 and -036 Combined|Adverse Event|5
4840406|NCT01030718|16686124|P1|Studies CA180-031 and -036 Combined|Adverse Event|3
4840407|NCT01030718|16686122|P3|Studies CA180-031 and -036 Combined|Insufficient effect|11
4840408|NCT01030718|16686123|P2|Studies CA180-031 and -036 Combined|Insufficient effect|1
4840409|NCT01030718|16686124|P1|Studies CA180-031 and -036 Combined|Insufficient effect|1
4840410|NCT01030666|16686185|P2|Overall Study|Lost to Follow-up|2
4840411|NCT01030666|16686186|P1|Overall Study|Lost to Follow-up|3
4840412|NCT01030536|16686211|P5|Overall Study|Death|0
4840413|NCT01030536|16686212|P4|Overall Study|Death|0
4840414|NCT01030536|16686213|P3|Overall Study|Death|0
4840415|NCT01030536|16686214|P2|Overall Study|Death|1
4840416|NCT01030536|16686215|P1|Overall Study|Death|0
4840417|NCT01030536|16686211|P5|Overall Study|Progressive disease|0
4840418|NCT01030536|16686212|P4|Overall Study|Progressive disease|2
4840419|NCT01030536|16686213|P3|Overall Study|Progressive disease|3
4840420|NCT01030536|16686214|P2|Overall Study|Progressive disease|2
4840421|NCT01030536|16686215|P1|Overall Study|Progressive disease|6
4840422|NCT01030536|16686211|P5|Overall Study|Adverse Event|1
4840423|NCT01030536|16686212|P4|Overall Study|Adverse Event|0
4840424|NCT01030536|16686213|P3|Overall Study|Adverse Event|1
4840425|NCT01030536|16686214|P2|Overall Study|Adverse Event|3
4840426|NCT01030536|16686215|P1|Overall Study|Adverse Event|0
4840427|NCT01030536|16686211|P5|Overall Study|undefined|0
4840428|NCT01030536|16686212|P4|Overall Study|undefined|1
4840429|NCT01030536|16686213|P3|Overall Study|undefined|1
4840430|NCT01030536|16686214|P2|Overall Study|undefined|0
4840431|NCT01030536|16686215|P1|Overall Study|undefined|1
4840432|NCT01030536|16686211|P5|Overall Study|Withdrawal by Subject|0
4840433|NCT01030536|16686212|P4|Overall Study|Withdrawal by Subject|0
4840434|NCT01030536|16686213|P3|Overall Study|Withdrawal by Subject|1
4840435|NCT01030536|16686214|P2|Overall Study|Withdrawal by Subject|0
4840436|NCT01030536|16686215|P1|Overall Study|Withdrawal by Subject|0
4840437|NCT01030523|16686320|P2|Overall Study|Withdrawal by Subject|1
4840438|NCT01030523|16686321|P1|Overall Study|Withdrawal by Subject|0
4840439|NCT01030523|16686320|P2|Overall Study|Implant failure|0
4840440|NCT01030523|16686321|P1|Overall Study|Implant failure|1
4840441|NCT01030523|16686320|P2|Overall Study|Lost to Follow-up|4
4840442|NCT01030523|16686321|P1|Overall Study|Lost to Follow-up|4
4840443|NCT01030523|16686320|P2|Overall Study|Death|0
4840444|NCT01030523|16686321|P1|Overall Study|Death|1
4840445|NCT01030458|16686335|P2|Overall Study|Side effect of medication|1
4840446|NCT01030458|16686336|P1|Overall Study|Side effect of medication|1
4840447|NCT01030458|16686335|P2|Overall Study|Moved or changed job|13
4840448|NCT01030458|16686336|P1|Overall Study|Moved or changed job|6
4840449|NCT01030458|16686335|P2|Overall Study|Logistical reasons|5
4840450|NCT01030458|16686336|P1|Overall Study|Logistical reasons|9
4840451|NCT01030458|16686335|P2|Overall Study|Withdrawal by Subject|3
4840452|NCT01030458|16686336|P1|Overall Study|Withdrawal by Subject|2
4840453|NCT01030458|16686335|P2|Overall Study|Lost to Follow-up|10
4840454|NCT01030458|16686336|P1|Overall Study|Lost to Follow-up|9
4840455|NCT01030341|16686369|P1|Overall Study|Lost to Follow-up|2
4840456|NCT01030341|16686369|P1|Overall Study|Withdrawal by Subject|1
4840457|NCT01030133|16686392|P2|Overall Study|failed to experience pain at level 7/10|2
4840458|NCT01030133|16686393|P1|Overall Study|failed to experience pain at level 7/10|2
4840459|NCT01029925|16686405|P1|Completion of Cycle 2 (56 Days)|off study due to disease progression|1
4840460|NCT01029925|16686405|P1|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2
4840461|NCT01029925|16686405|P1|Completion of Cycle 1 (28 Days)|Death|2
4840462|NCT01029886|16686424|P2|Overall Study|Loss Glucose Control|1
4840463|NCT01029886|16686425|P1|Overall Study|Loss Glucose Control|7
4840464|NCT01029886|16686424|P2|Overall Study|Sponsor Decision|0
4840465|NCT01029886|16686425|P1|Overall Study|Sponsor Decision|1
4840466|NCT01029886|16686424|P2|Overall Study|Entry Criteria Not Met|5
4840467|NCT01029886|16686425|P1|Overall Study|Entry Criteria Not Met|13
4840468|NCT01029886|16686424|P2|Overall Study|Withdrawal by Subject|18
4840469|NCT01029886|16686425|P1|Overall Study|Withdrawal by Subject|8
4840470|NCT01029886|16686424|P2|Overall Study|Protocol Violation|5
4840471|NCT01029886|16686425|P1|Overall Study|Protocol Violation|17
4840472|NCT01029886|16686424|P2|Overall Study|Physician Decision|6
4840473|NCT01029886|16686425|P1|Overall Study|Physician Decision|2
4840474|NCT01029886|16686424|P2|Overall Study|Lost to Follow-up|0
4840475|NCT01029886|16686425|P1|Overall Study|Lost to Follow-up|1
4840476|NCT01029886|16686424|P2|Overall Study|Adverse Event|25
4840477|NCT01029886|16686425|P1|Overall Study|Adverse Event|12
4840478|NCT01029795|16686453|P2|Overall Study|Withdrawal by Subject|3
4840479|NCT01029795|16686454|P1|Overall Study|Withdrawal by Subject|1
4840480|NCT01029795|16686453|P2|Overall Study|Sponsor Decision|17
4840481|NCT01029795|16686454|P1|Overall Study|Sponsor Decision|11
4840482|NCT01029795|16686453|P2|Overall Study|Physician Decision|1
4840483|NCT01029795|16686454|P1|Overall Study|Physician Decision|2
4840484|NCT01029795|16686453|P2|Overall Study|Entry Criteria Not Met|1
4840485|NCT01029795|16686454|P1|Overall Study|Entry Criteria Not Met|2
4840486|NCT01029782|16686508|P2|Overall Study|Withdrawal by Subject|1
4840487|NCT01029782|16686509|P1|Overall Study|Withdrawal by Subject|0
4840488|NCT01029782|16686508|P2|Overall Study|Protocol Violation|2
4840489|NCT01029782|16686509|P1|Overall Study|Protocol Violation|0
4840490|NCT01029782|16686508|P2|Overall Study|Physician Decision|1
4840491|NCT01029782|16686509|P1|Overall Study|Physician Decision|0
4840492|NCT01029782|16686508|P2|Overall Study|Adverse Event|1
4840493|NCT01029782|16686509|P1|Overall Study|Adverse Event|0
4840494|NCT01029782|16686508|P2|Overall Study|Diagnosis changed|1
4840495|NCT01029782|16686509|P1|Overall Study|Diagnosis changed|1
4840496|NCT01029782|16686508|P2|Overall Study|Lost to Follow-up|2
4840497|NCT01029782|16686509|P1|Overall Study|Lost to Follow-up|2
4840498|NCT01029691|16686561|P3|Continued APAP to Delivery|Death|1
4840499|NCT01029691|16686562|P2|Continued APAP to Delivery|Death|0
4840500|NCT01029691|16686563|P1|Continued APAP to Delivery|Death|0
4840501|NCT01029652|16686588|P2|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1
4840502|NCT01029652|16686589|P1|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0
4840503|NCT01029652|16686588|P2|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1
4840504|NCT01029652|16686589|P1|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0
4840505|NCT01029652|16686588|P2|Extension Study 2 (25-72 Weeks)|Death|1
4840506|NCT01029652|16686589|P1|Extension Study 2 (25-72 Weeks)|Death|1
4840507|NCT01029652|16686588|P2|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1
4840508|NCT01029652|16686589|P1|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0
4840509|NCT01029652|16686588|P2|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0
4840510|NCT01029652|16686589|P1|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1
4840511|NCT01029652|16686588|P2|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3
4840512|NCT01029652|16686589|P1|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2
4840513|NCT01029652|16686588|P2|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1
4840514|NCT01029652|16686589|P1|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0
4840515|NCT01029652|16686588|P2|Core Study (0-12 Weeks)|Death|1
4840516|NCT01029652|16686589|P1|Core Study (0-12 Weeks)|Death|0
4840517|NCT01029652|16686588|P2|Core Study (0-12 Weeks)|Administrative problems|1
4840518|NCT01029652|16686589|P1|Core Study (0-12 Weeks)|Administrative problems|2
4840519|NCT01029652|16686588|P2|Core Study (0-12 Weeks)|Lost to Follow-up|1
4840520|NCT01029652|16686589|P1|Core Study (0-12 Weeks)|Lost to Follow-up|3
4840521|NCT01029652|16686588|P2|Core Study (0-12 Weeks)|Patient Withdrew Consent|3
4840522|NCT01029652|16686589|P1|Core Study (0-12 Weeks)|Patient Withdrew Consent|1
4840523|NCT01029652|16686588|P2|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4
4840524|NCT01029652|16686589|P1|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0
4840525|NCT01029535|16686673|P1|Overall Study|Death|1
4840526|NCT01029535|16686673|P1|Overall Study|Use of Another Treatment|1
4840527|NCT01029535|16686673|P1|Overall Study|Adverse Event|1
4840528|NCT01029535|16686673|P1|Overall Study|Participant Withdrew Consent|2
4840529|NCT01029535|16686673|P1|Overall Study|Protocol Violation|2
4840530|NCT01029535|16686673|P1|Overall Study|Lost to Follow-up|24
4840531|NCT01029405|16686702|P4|Overall Study|Other|1
4840532|NCT01029405|16686703|P3|Overall Study|Other|0
4840533|NCT01029405|16686704|P2|Overall Study|Other|1
4840534|NCT01029405|16686705|P1|Overall Study|Other|0
4840535|NCT01029405|16686702|P4|Overall Study|Lost to Follow-up|2
4840536|NCT01029405|16686703|P3|Overall Study|Lost to Follow-up|1
4840537|NCT01029405|16686704|P2|Overall Study|Lost to Follow-up|1
4840538|NCT01029405|16686705|P1|Overall Study|Lost to Follow-up|2
4840539|NCT01029405|16686702|P4|Overall Study|Adverse Event|1
4840540|NCT01029405|16686703|P3|Overall Study|Adverse Event|1
4840541|NCT01029405|16686704|P2|Overall Study|Adverse Event|0
4840542|NCT01029405|16686705|P1|Overall Study|Adverse Event|0
4840543|NCT01029405|16686702|P4|Overall Study|Protocol Violation|1
4840544|NCT01029405|16686703|P3|Overall Study|Protocol Violation|0
4840545|NCT01029405|16686704|P2|Overall Study|Protocol Violation|0
4840546|NCT01029405|16686705|P1|Overall Study|Protocol Violation|0
4840547|NCT01029405|16686702|P4|Overall Study|Withdrawal by Subject|0
4840548|NCT01029405|16686703|P3|Overall Study|Withdrawal by Subject|2
4840549|NCT01029405|16686704|P2|Overall Study|Withdrawal by Subject|1
4840550|NCT01029405|16686705|P1|Overall Study|Withdrawal by Subject|0
4840551|NCT01029392|16686717|P2|Overall Study|Physician Decision|0
4840552|NCT01029392|16686718|P1|Overall Study|Physician Decision|2
4840553|NCT01029392|16686717|P2|Overall Study|Withdrawal by Subject|11
4840554|NCT01029392|16686718|P1|Overall Study|Withdrawal by Subject|18
4840555|NCT01029366|16686728|P2|Overall Study|manufacturing failure|1
4840556|NCT01029366|16686729|P1|Overall Study|manufacturing failure|0
4840557|NCT01029366|16686728|P2|Overall Study|disease progression|0
4840558|NCT01029366|16686729|P1|Overall Study|disease progression|2
4840559|NCT01029366|16686728|P2|Overall Study|Death|1
4840560|NCT01029366|16686729|P1|Overall Study|Death|1
4840561|NCT01029366|16686728|P2|Overall Study|Withdrawal by Subject|0
4840562|NCT01029366|16686729|P1|Overall Study|Withdrawal by Subject|1
4840563|NCT01029340|16686741|P6|Extension Period|Physician Decision|1
4840564|NCT01029340|16686742|P5|Extension Period|Physician Decision|0
4840565|NCT01029340|16686743|P4|Extension Period|Physician Decision|0
4840566|NCT01029340|16686744|P3|Extension Period|Physician Decision|0
4840567|NCT01029340|16686745|P2|Extension Period|Physician Decision|0
4840568|NCT01029340|16686746|P1|Extension Period|Physician Decision|0
4840569|NCT01029340|16686741|P6|Extension Period|Withdrawal by Subject|1
4840570|NCT01029340|16686742|P5|Extension Period|Withdrawal by Subject|0
4840571|NCT01029340|16686743|P4|Extension Period|Withdrawal by Subject|0
4840572|NCT01029340|16686744|P3|Extension Period|Withdrawal by Subject|0
4840573|NCT01029340|16686745|P2|Extension Period|Withdrawal by Subject|0
4840574|NCT01029340|16686746|P1|Extension Period|Withdrawal by Subject|0
4840575|NCT01029340|16686741|P6|Extension Period|non-compliance|1
4840576|NCT01029340|16686742|P5|Extension Period|non-compliance|0
4840577|NCT01029340|16686743|P4|Extension Period|non-compliance|0
4840578|NCT01029340|16686744|P3|Extension Period|non-compliance|0
4840579|NCT01029340|16686745|P2|Extension Period|non-compliance|0
4840580|NCT01029340|16686746|P1|Extension Period|non-compliance|0
4840581|NCT01029340|16686741|P6|Extension Period|starting another study|8
4840582|NCT01029340|16686742|P5|Extension Period|starting another study|0
4840583|NCT01029340|16686743|P4|Extension Period|starting another study|0
4840584|NCT01029340|16686744|P3|Extension Period|starting another study|0
4840585|NCT01029340|16686745|P2|Extension Period|starting another study|0
4840586|NCT01029340|16686746|P1|Extension Period|starting another study|0
4840587|NCT01029340|16686741|P6|Extension Period|Adverse Event|1
4840588|NCT01029340|16686742|P5|Extension Period|Adverse Event|0
4840589|NCT01029340|16686743|P4|Extension Period|Adverse Event|0
4840590|NCT01029340|16686744|P3|Extension Period|Adverse Event|0
4840591|NCT01029340|16686745|P2|Extension Period|Adverse Event|0
4840592|NCT01029340|16686746|P1|Extension Period|Adverse Event|0
4840593|NCT01029340|16686741|P6|Part B Treatment Period|Protocol Violation|0
4840594|NCT01029340|16686742|P5|Part B Treatment Period|Protocol Violation|0
4840595|NCT01029340|16686743|P4|Part B Treatment Period|Protocol Violation|0
4840596|NCT01029340|16686744|P3|Part B Treatment Period|Protocol Violation|1
4840597|NCT01029340|16686745|P2|Part B Treatment Period|Protocol Violation|0
4840598|NCT01029340|16686746|P1|Part B Treatment Period|Protocol Violation|0
4840599|NCT01029340|16686741|P6|Part B Treatment Period|Withdrawal by Subject|0
4840600|NCT01029340|16686742|P5|Part B Treatment Period|Withdrawal by Subject|0
4840601|NCT01029340|16686743|P4|Part B Treatment Period|Withdrawal by Subject|0
4840602|NCT01029340|16686744|P3|Part B Treatment Period|Withdrawal by Subject|1
4840603|NCT01029340|16686745|P2|Part B Treatment Period|Withdrawal by Subject|0
4840604|NCT01029340|16686746|P1|Part B Treatment Period|Withdrawal by Subject|0
4840605|NCT01029262|16686777|P2|Overall Study|Death|3
4840606|NCT01029262|16686778|P1|Overall Study|Death|0
4840607|NCT01029262|16686777|P2|Overall Study|Miscellaneous|9
4840608|NCT01029262|16686778|P1|Overall Study|Miscellaneous|1
4840609|NCT01029262|16686777|P2|Overall Study|Protocol Violation|3
4840610|NCT01029262|16686778|P1|Overall Study|Protocol Violation|2
4840611|NCT01029262|16686777|P2|Overall Study|Withdrawal by Subject|17
4840612|NCT01029262|16686778|P1|Overall Study|Withdrawal by Subject|10
4840613|NCT01029262|16686777|P2|Overall Study|Lack of therapeutic effect|76
4840614|NCT01029262|16686778|P1|Overall Study|Lack of therapeutic effect|57
4840615|NCT01029262|16686777|P2|Overall Study|Adverse Event|52
4840616|NCT01029262|16686778|P1|Overall Study|Adverse Event|9
4840617|NCT01028651|16686947|P1|Overall Study|Adverse Event|1
4840618|NCT01028651|16686947|P1|Overall Study|Death|2
4840619|NCT01028560|16686970|P2|Overall Study|Withdrawal by Subject|12
4840620|NCT01028560|16686971|P1|Overall Study|Withdrawal by Subject|7
4840621|NCT01028560|16686970|P2|Overall Study|Lack of Efficacy|6
4840622|NCT01028560|16686971|P1|Overall Study|Lack of Efficacy|3
4840623|NCT01028391|16686985|P2|Overall Study|Needed excluded medication|1
4840624|NCT01028391|16686986|P1|Overall Study|Needed excluded medication|1
4840625|NCT01028391|16686985|P2|Overall Study|Withdrawal by Subject|3
4840626|NCT01028391|16686986|P1|Overall Study|Withdrawal by Subject|6
4840627|NCT01028391|16686985|P2|Overall Study|Physician Decision|1
4840628|NCT01028391|16686986|P1|Overall Study|Physician Decision|0
4840629|NCT01028391|16686985|P2|Overall Study|Lost to Follow-up|4
4840630|NCT01028391|16686986|P1|Overall Study|Lost to Follow-up|3
4840631|NCT01028391|16686985|P2|Overall Study|Lack of Efficacy|2
4840632|NCT01028391|16686986|P1|Overall Study|Lack of Efficacy|0
4840633|NCT01028391|16686985|P2|Overall Study|Adverse Event|0
4840634|NCT01028391|16686986|P1|Overall Study|Adverse Event|4
4840635|NCT01028378|16686994|P1|Overall Study|Adminstrative Reasons|4
4840636|NCT01028378|16686994|P1|Overall Study|Withdrawal by Subject|1
4840637|NCT01028378|16686994|P1|Overall Study|Lost to Follow-up|12
4840638|NCT01028352|16687006|P1|Overall Study|Withdrawal by Subject|1
4840639|NCT01028352|16687006|P1|Overall Study|Ineligible due to baseline average pain|5
4840640|NCT01028300|16687011|P1|Overall Study|Study Terminated|4
4840641|NCT01028222|16687020|P2|Overall Study|Adverse Event|0
4840642|NCT01028222|16687021|P1|Overall Study|Adverse Event|2
4840643|NCT01028222|16687020|P2|Overall Study|Crossover to nilotinib w/out progression|2
4840644|NCT01028222|16687021|P1|Overall Study|Crossover to nilotinib w/out progression|0
4840645|NCT01028222|16687020|P2|Overall Study|Withdrawal by Subject|0
4840646|NCT01028222|16687021|P1|Overall Study|Withdrawal by Subject|1
4840647|NCT01028222|16687020|P2|Overall Study|Lost to Follow-up|1
4840648|NCT01028222|16687021|P1|Overall Study|Lost to Follow-up|0
4840649|NCT01028222|16687020|P2|Overall Study|Administrative problems|1
4840650|NCT01028222|16687021|P1|Overall Study|Administrative problems|1
4840651|NCT01028222|16687020|P2|Overall Study|Disease progression|9
4840652|NCT01028222|16687021|P1|Overall Study|Disease progression|33
4840653|NCT01028222|16687020|P2|Overall Study|Protocol deviation|0
4840654|NCT01028222|16687021|P1|Overall Study|Protocol deviation|1
4840655|NCT01028053|16687063|P1|Overall Study|Various reasons|4
4840656|NCT01028053|16687063|P1|Overall Study|Terminated by Sponsor|1
4840657|NCT01028053|16687063|P1|Overall Study|Technical Problem|1
4840658|NCT01028053|16687063|P1|Overall Study|Physician Decision|2
4840659|NCT01028053|16687063|P1|Overall Study|Protocol Violation|1
4840660|NCT01028053|16687063|P1|Overall Study|Patient Request|11
4840661|NCT01028053|16687063|P1|Overall Study|Screen Failure|113
4840662|NCT01028027|16687071|P2|Overall Study|Lack of Efficacy|1
4840663|NCT01028027|16687072|P1|Overall Study|Lack of Efficacy|0
4840664|NCT01028027|16687071|P2|Overall Study|Protocol Violation|1
4840665|NCT01028027|16687072|P1|Overall Study|Protocol Violation|3
4840666|NCT01028027|16687071|P2|Overall Study|Adverse Event|7
4840667|NCT01028027|16687072|P1|Overall Study|Adverse Event|4
4840668|NCT01028027|16687071|P2|Overall Study|Withdrawal by Subject|3
4840669|NCT01028027|16687072|P1|Overall Study|Withdrawal by Subject|5
4840670|NCT01028027|16687071|P2|Overall Study|Lost to Follow-up|1
4840671|NCT01028027|16687072|P1|Overall Study|Lost to Follow-up|4
4840672|NCT01028014|16687094|P6|Overall Study|Lost to Follow-up|2
4840673|NCT01028014|16687095|P5|Overall Study|Lost to Follow-up|1
4840674|NCT01028014|16687096|P4|Overall Study|Lost to Follow-up|1
4840675|NCT01028014|16687097|P3|Overall Study|Lost to Follow-up|0
4840676|NCT01028014|16687098|P2|Overall Study|Lost to Follow-up|2
4840677|NCT01028014|16687099|P1|Overall Study|Lost to Follow-up|1
4840678|NCT01027897|16687140|P1|Overall Study|Withdrawal by Subject|1
4840679|NCT01027897|16687140|P1|Overall Study|Protocol Violation|1
4840680|NCT01027884|16687148|P2|Overall Study|Spinal fixation surgery|3
4840681|NCT01027884|16687149|P1|Overall Study|Spinal fixation surgery|0
4840682|NCT01027884|16687148|P2|Overall Study|Lost to Follow-up|1
4840683|NCT01027884|16687149|P1|Overall Study|Lost to Follow-up|0
4840684|NCT01027884|16687148|P2|Overall Study|Withdrawal by Subject|1
4840685|NCT01027884|16687149|P1|Overall Study|Withdrawal by Subject|0
4840686|NCT01027884|16687148|P2|Overall Study|Non-compliance|1
4840687|NCT01027884|16687149|P1|Overall Study|Non-compliance|1
4840688|NCT01027884|16687148|P2|Overall Study|Protocol Violation|0
4840689|NCT01027884|16687149|P1|Overall Study|Protocol Violation|1
4840690|NCT01027884|16687148|P2|Overall Study|Adverse Event|1
4840691|NCT01027884|16687149|P1|Overall Study|Adverse Event|2
4840692|NCT01027871|16687166|P3|Overall Study|Discontinued Prior to Treatment|1
4840693|NCT01027871|16687167|P2|Overall Study|Discontinued Prior to Treatment|0
4840694|NCT01027871|16687168|P1|Overall Study|Discontinued Prior to Treatment|0
4840695|NCT01027871|16687166|P3|Overall Study|Sponsor Decision|0
4840696|NCT01027871|16687167|P2|Overall Study|Sponsor Decision|2
4840697|NCT01027871|16687168|P1|Overall Study|Sponsor Decision|0
4840698|NCT01027871|16687166|P3|Overall Study|Adverse Event|2
4840699|NCT01027871|16687167|P2|Overall Study|Adverse Event|2
4840700|NCT01027871|16687168|P1|Overall Study|Adverse Event|0
4840701|NCT01027871|16687166|P3|Overall Study|Withdrawal by Subject|2
4840702|NCT01027871|16687167|P2|Overall Study|Withdrawal by Subject|2
4840703|NCT01027871|16687168|P1|Overall Study|Withdrawal by Subject|1
4840704|NCT01027871|16687166|P3|Overall Study|Protocol Violation|2
4840705|NCT01027871|16687167|P2|Overall Study|Protocol Violation|2
4840706|NCT01027871|16687168|P1|Overall Study|Protocol Violation|0
4840707|NCT01027871|16687166|P3|Overall Study|Physician Decision|0
4840708|NCT01027871|16687167|P2|Overall Study|Physician Decision|5
4840709|NCT01027871|16687168|P1|Overall Study|Physician Decision|1
4840710|NCT01027845|16687227|P4|Booster Vaccination Phase|Migrated/moved from study area|0
4840711|NCT01027845|16687228|P3|Booster Vaccination Phase|Migrated/moved from study area|0
4840712|NCT01027845|16687229|P2|Booster Vaccination Phase|Migrated/moved from study area|0
4840713|NCT01027845|16687230|P1|Booster Vaccination Phase|Migrated/moved from study area|1
4840714|NCT01027845|16687227|P4|Booster Vaccination Phase|Withdrawal by Subject|0
4840715|NCT01027845|16687228|P3|Booster Vaccination Phase|Withdrawal by Subject|0
4840716|NCT01027845|16687229|P2|Booster Vaccination Phase|Withdrawal by Subject|0
4840717|NCT01027845|16687230|P1|Booster Vaccination Phase|Withdrawal by Subject|1
4840718|NCT01027845|16687227|P4|Primary Vaccination Phase|Migrated/moved from study area|0
4840719|NCT01027845|16687228|P3|Primary Vaccination Phase|Migrated/moved from study area|0
4840720|NCT01027845|16687229|P2|Primary Vaccination Phase|Migrated/moved from study area|1
4840721|NCT01027845|16687230|P1|Primary Vaccination Phase|Migrated/moved from study area|0
4840722|NCT01027845|16687227|P4|Primary Vaccination Phase|Protocol Violation|0
4840723|NCT01027845|16687228|P3|Primary Vaccination Phase|Protocol Violation|0
4840724|NCT01027845|16687229|P2|Primary Vaccination Phase|Protocol Violation|0
4840725|NCT01027845|16687230|P1|Primary Vaccination Phase|Protocol Violation|1
4840726|NCT01027845|16687227|P4|Primary Vaccination Phase|Adverse Event|0
4840727|NCT01027845|16687228|P3|Primary Vaccination Phase|Adverse Event|0
4840728|NCT01027845|16687229|P2|Primary Vaccination Phase|Adverse Event|0
4840729|NCT01027845|16687230|P1|Primary Vaccination Phase|Adverse Event|1
4840730|NCT01027845|16687227|P4|Primary Vaccination Phase|Serious Adverse Event|0
4840731|NCT01027845|16687228|P3|Primary Vaccination Phase|Serious Adverse Event|0
4840732|NCT01027845|16687229|P2|Primary Vaccination Phase|Serious Adverse Event|0
4840733|NCT01027845|16687230|P1|Primary Vaccination Phase|Serious Adverse Event|2
4840734|NCT01027754|16687313|P2|Overall Study|Withdrawal by Subject|5
4840735|NCT01027754|16687314|P1|Overall Study|Withdrawal by Subject|0
4840736|NCT01027754|16687313|P2|Overall Study|withdrew/lost to follow-up after interve|3
4840737|NCT01027754|16687314|P1|Overall Study|withdrew/lost to follow-up after interve|2
4840738|NCT01027702|16687348|P7|Overall Study|Death|0
4840739|NCT01027702|16687349|P6|Overall Study|Death|0
4840740|NCT01027702|16687350|P5|Overall Study|Death|0
4840741|NCT01027702|16687351|P4|Overall Study|Death|0
4840742|NCT01027702|16687352|P3|Overall Study|Death|1
4840743|NCT01027702|16687353|P2|Overall Study|Death|0
4840744|NCT01027702|16687354|P1|Overall Study|Death|0
4840745|NCT01027702|16687348|P7|Overall Study|Received subsequent therapy|1
4840746|NCT01027702|16687349|P6|Overall Study|Received subsequent therapy|0
4840747|NCT01027702|16687350|P5|Overall Study|Received subsequent therapy|1
4840748|NCT01027702|16687351|P4|Overall Study|Received subsequent therapy|4
4840749|NCT01027702|16687352|P3|Overall Study|Received subsequent therapy|0
4840750|NCT01027702|16687353|P2|Overall Study|Received subsequent therapy|2
4840751|NCT01027702|16687354|P1|Overall Study|Received subsequent therapy|1
4840752|NCT01027650|16687380|P8|Overall Study|Lack of Efficacy|0
4840753|NCT01027650|16687381|P7|Overall Study|Lack of Efficacy|0
4840754|NCT01027650|16687382|P6|Overall Study|Lack of Efficacy|1
4840755|NCT01027650|16687383|P5|Overall Study|Lack of Efficacy|0
4840756|NCT01027650|16687384|P4|Overall Study|Lack of Efficacy|0
4840757|NCT01027650|16687385|P3|Overall Study|Lack of Efficacy|0
4840758|NCT01027650|16687386|P2|Overall Study|Lack of Efficacy|0
4840759|NCT01027650|16687387|P1|Overall Study|Lack of Efficacy|0
4840760|NCT01027650|16687380|P8|Overall Study|Lost to Follow-up|0
4840761|NCT01027650|16687381|P7|Overall Study|Lost to Follow-up|1
4840762|NCT01027650|16687382|P6|Overall Study|Lost to Follow-up|0
4840763|NCT01027650|16687383|P5|Overall Study|Lost to Follow-up|0
4840764|NCT01027650|16687384|P4|Overall Study|Lost to Follow-up|0
4840765|NCT01027650|16687385|P3|Overall Study|Lost to Follow-up|0
4840766|NCT01027650|16687386|P2|Overall Study|Lost to Follow-up|0
4840767|NCT01027650|16687387|P1|Overall Study|Lost to Follow-up|0
4840768|NCT01027650|16687380|P8|Overall Study|Personal Reasons|0
4840769|NCT01027650|16687381|P7|Overall Study|Personal Reasons|0
4840770|NCT01027650|16687382|P6|Overall Study|Personal Reasons|1
4840771|NCT01027650|16687383|P5|Overall Study|Personal Reasons|2
4840772|NCT01027650|16687384|P4|Overall Study|Personal Reasons|0
4840773|NCT01027650|16687385|P3|Overall Study|Personal Reasons|0
4840774|NCT01027650|16687386|P2|Overall Study|Personal Reasons|0
4840775|NCT01027650|16687387|P1|Overall Study|Personal Reasons|0
4840776|NCT01027416|16687465|P2|Overall Study|Physician Decision|4
4840777|NCT01027416|16687466|P1|Overall Study|Physician Decision|1
4840778|NCT01027416|16687465|P2|Overall Study|Withdrawal by Subject|1
4840779|NCT01027416|16687466|P1|Overall Study|Withdrawal by Subject|0
4840780|NCT01027364|16687478|P4|Overall Study|Withdrawal by Subject|0
4840781|NCT01027364|16687479|P3|Overall Study|Withdrawal by Subject|0
4840782|NCT01027364|16687480|P2|Overall Study|Withdrawal by Subject|2
4840783|NCT01027364|16687481|P1|Overall Study|Withdrawal by Subject|1
4840784|NCT01027364|16687478|P4|Overall Study|Protocol Violation|1
4840785|NCT01027364|16687479|P3|Overall Study|Protocol Violation|0
4840786|NCT01027364|16687480|P2|Overall Study|Protocol Violation|0
4840787|NCT01027364|16687481|P1|Overall Study|Protocol Violation|1
4840788|NCT01027364|16687478|P4|Overall Study|Lost to Follow-up|0
4840789|NCT01027364|16687479|P3|Overall Study|Lost to Follow-up|0
4840790|NCT01027364|16687480|P2|Overall Study|Lost to Follow-up|0
4840791|NCT01027364|16687481|P1|Overall Study|Lost to Follow-up|1
4840792|NCT01027364|16687478|P4|Overall Study|Adverse Event|0
4840793|NCT01027364|16687479|P3|Overall Study|Adverse Event|1
4840794|NCT01027364|16687480|P2|Overall Study|Adverse Event|0
4840795|NCT01027364|16687481|P1|Overall Study|Adverse Event|1
4840796|NCT01027351|16687576|P6|Overall Study|Protocol Violation|0
4840797|NCT01027351|16687577|P5|Overall Study|Protocol Violation|1
4840798|NCT01027351|16687578|P4|Overall Study|Protocol Violation|1
4840799|NCT01027351|16687579|P3|Overall Study|Protocol Violation|0
4840800|NCT01027351|16687580|P2|Overall Study|Protocol Violation|0
4840801|NCT01027351|16687581|P1|Overall Study|Protocol Violation|1
4840802|NCT01027351|16687576|P6|Overall Study|Inappropriate enrollment|0
4840803|NCT01027351|16687577|P5|Overall Study|Inappropriate enrollment|1
4840804|NCT01027351|16687578|P4|Overall Study|Inappropriate enrollment|0
4840805|NCT01027351|16687579|P3|Overall Study|Inappropriate enrollment|0
4840806|NCT01027351|16687580|P2|Overall Study|Inappropriate enrollment|0
4840807|NCT01027351|16687581|P1|Overall Study|Inappropriate enrollment|0
4840808|NCT01027351|16687576|P6|Overall Study|Lost to Follow-up|0
4840809|NCT01027351|16687577|P5|Overall Study|Lost to Follow-up|6
4840810|NCT01027351|16687578|P4|Overall Study|Lost to Follow-up|1
4840811|NCT01027351|16687579|P3|Overall Study|Lost to Follow-up|0
4840812|NCT01027351|16687580|P2|Overall Study|Lost to Follow-up|1
4840813|NCT01027351|16687581|P1|Overall Study|Lost to Follow-up|1
4840814|NCT01027351|16687576|P6|Overall Study|Withdrawal by Subject|5
4840815|NCT01027351|16687577|P5|Overall Study|Withdrawal by Subject|3
4840816|NCT01027351|16687578|P4|Overall Study|Withdrawal by Subject|0
4840817|NCT01027351|16687579|P3|Overall Study|Withdrawal by Subject|1
4840818|NCT01027351|16687580|P2|Overall Study|Withdrawal by Subject|0
4840819|NCT01027351|16687581|P1|Overall Study|Withdrawal by Subject|1
4840820|NCT01027286|16687665|P2|Overall Study|Lost to Follow-up|1
4840821|NCT01027286|16687666|P1|Overall Study|Lost to Follow-up|0
4840822|NCT01027286|16687665|P2|Overall Study|Unable to Obtain Required Blood Volume|0
4840823|NCT01027286|16687666|P1|Overall Study|Unable to Obtain Required Blood Volume|1
4840824|NCT01027273|16687686|P2|Overall Study|Death|2
4840825|NCT01027273|16687687|P1|Overall Study|Death|2
4840826|NCT01027273|16687686|P2|Overall Study|Lost to Follow-up|31
4840827|NCT01027273|16687687|P1|Overall Study|Lost to Follow-up|57
4840828|NCT01026974|16687734|P4|Overall Study|Inappropriate enrollment|0
4840829|NCT01026974|16687735|P3|Overall Study|Inappropriate enrollment|1
4840830|NCT01026974|16687736|P2|Overall Study|Inappropriate enrollment|0
4840831|NCT01026974|16687737|P1|Overall Study|Inappropriate enrollment|0
4840832|NCT01026974|16687734|P4|Overall Study|Adverse Event|1
4840833|NCT01026974|16687735|P3|Overall Study|Adverse Event|0
4840834|NCT01026974|16687736|P2|Overall Study|Adverse Event|0
4840835|NCT01026974|16687737|P1|Overall Study|Adverse Event|0
4840836|NCT01026974|16687734|P4|Overall Study|Lost to Follow-up|0
4840837|NCT01026974|16687735|P3|Overall Study|Lost to Follow-up|4
4840838|NCT01026974|16687736|P2|Overall Study|Lost to Follow-up|1
4840839|NCT01026974|16687737|P1|Overall Study|Lost to Follow-up|1
4840840|NCT01026974|16687734|P4|Overall Study|Withdrawal by Subject|2
4840841|NCT01026974|16687735|P3|Overall Study|Withdrawal by Subject|7
4840842|NCT01026974|16687736|P2|Overall Study|Withdrawal by Subject|1
4840843|NCT01026974|16687737|P1|Overall Study|Withdrawal by Subject|0
4840844|NCT01026948|16687794|P1|Overall Study|Physician Decision|8
4840845|NCT01026831|16687827|P2|Overall Study|Withdrawal by Subject|5
4840846|NCT01026831|16687828|P1|Overall Study|Withdrawal by Subject|7
4840847|NCT01026831|16687827|P2|Overall Study|Protocol Violation|2
4840848|NCT01026831|16687828|P1|Overall Study|Protocol Violation|0
4840849|NCT01026831|16687827|P2|Overall Study|Physician Decision|1
4840850|NCT01026831|16687828|P1|Overall Study|Physician Decision|1
4840851|NCT01026831|16687827|P2|Overall Study|Lost to Follow-up|0
4840852|NCT01026831|16687828|P1|Overall Study|Lost to Follow-up|2
4840853|NCT01026831|16687827|P2|Overall Study|Adverse Event|3
4840854|NCT01026831|16687828|P1|Overall Study|Adverse Event|4
4840855|NCT01026818|16687839|P4|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1
4840856|NCT01026818|16687840|P3|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
4840857|NCT01026818|16687841|P2|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2
4840858|NCT01026818|16687842|P1|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0
4840859|NCT01026818|16687839|P4|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
4840860|NCT01026818|16687840|P3|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3
4840861|NCT01026818|16687841|P2|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1
4840862|NCT01026818|16687842|P1|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0
4840863|NCT01026818|16687839|P4|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
4840864|NCT01026818|16687840|P3|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2
4840865|NCT01026818|16687841|P2|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1
4840866|NCT01026818|16687842|P1|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0
4840867|NCT01026818|16687839|P4|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
4840868|NCT01026818|16687840|P3|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
4840869|NCT01026818|16687841|P2|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1
4840870|NCT01026818|16687842|P1|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0
4840871|NCT01026818|16687839|P4|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
4840872|NCT01026818|16687840|P3|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
4840873|NCT01026818|16687841|P2|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2
4840874|NCT01026818|16687842|P1|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0
4840875|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Death|1
4840876|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Death|0
4840877|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Death|0
4840878|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Death|0
4840879|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
4840880|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2
4840881|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1
4840882|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0
4840883|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
4840884|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
4840885|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1
4840886|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0
4840887|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
4840888|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
4840889|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1
4840890|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0
4840891|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2
4840892|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
4840893|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1
4840894|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0
4840895|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
4840896|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
4840897|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1
4840898|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0
4840899|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
4840900|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1
4840901|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2
4840902|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0
4840903|NCT01026818|16687839|P4|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
4840904|NCT01026818|16687840|P3|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1
4840905|NCT01026818|16687841|P2|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2
4840906|NCT01026818|16687842|P1|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0
4840907|NCT01026818|16687839|P4|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2
4840908|NCT01026818|16687840|P3|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1
4840909|NCT01026818|16687841|P2|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
4840910|NCT01026818|16687842|P1|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0
4840911|NCT01026818|16687839|P4|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7
4840912|NCT01026818|16687840|P3|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9
4840913|NCT01026818|16687841|P2|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2
4840914|NCT01026818|16687842|P1|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0
4840915|NCT01026818|16687839|P4|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4
4840916|NCT01026818|16687840|P3|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
4840917|NCT01026818|16687841|P2|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3
4840918|NCT01026818|16687842|P1|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0
4840919|NCT01026818|16687839|P4|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6
4840920|NCT01026818|16687840|P3|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2
4840921|NCT01026818|16687841|P2|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3
4840922|NCT01026818|16687842|P1|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0
4840923|NCT01026818|16687839|P4|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
4840924|NCT01026818|16687840|P3|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3
4840925|NCT01026818|16687841|P2|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7
4840926|NCT01026818|16687842|P1|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0
4840927|NCT01026818|16687839|P4|DB Treatment Period (Month 0 - 9)|Adverse Event|4
4840928|NCT01026818|16687840|P3|DB Treatment Period (Month 0 - 9)|Adverse Event|6
4840929|NCT01026818|16687841|P2|DB Treatment Period (Month 0 - 9)|Adverse Event|10
4840930|NCT01026818|16687842|P1|DB Treatment Period (Month 0 - 9)|Adverse Event|0
4840931|NCT01026818|16687839|P4|Screening Period|Physician Decision|0
4840932|NCT01026818|16687840|P3|Screening Period|Physician Decision|0
4840933|NCT01026818|16687841|P2|Screening Period|Physician Decision|0
4840934|NCT01026818|16687842|P1|Screening Period|Physician Decision|1
4840935|NCT01026818|16687839|P4|Screening Period|Adverse Event|0
4840936|NCT01026818|16687840|P3|Screening Period|Adverse Event|0
4840937|NCT01026818|16687841|P2|Screening Period|Adverse Event|0
4840938|NCT01026818|16687842|P1|Screening Period|Adverse Event|2
4840939|NCT01026818|16687839|P4|Screening Period|Protocol Deviation|0
4840940|NCT01026818|16687840|P3|Screening Period|Protocol Deviation|0
4840941|NCT01026818|16687841|P2|Screening Period|Protocol Deviation|0
4840942|NCT01026818|16687842|P1|Screening Period|Protocol Deviation|3
4840943|NCT01026818|16687839|P4|Screening Period|Withdrawal by Subject|0
4840944|NCT01026818|16687840|P3|Screening Period|Withdrawal by Subject|0
4840945|NCT01026818|16687841|P2|Screening Period|Withdrawal by Subject|0
4840946|NCT01026818|16687842|P1|Screening Period|Withdrawal by Subject|49
4840947|NCT01026818|16687839|P4|Screening Period|Entry Criteria Not Met|0
4840948|NCT01026818|16687840|P3|Screening Period|Entry Criteria Not Met|0
4840949|NCT01026818|16687841|P2|Screening Period|Entry Criteria Not Met|0
4840950|NCT01026818|16687842|P1|Screening Period|Entry Criteria Not Met|105
4840951|NCT01026792|16687930|P1|Overall Study|Protocol Violation|1
4840952|NCT01026493|16687973|P8|Overall Study|Protocol Violation|1
4840953|NCT01026493|16687974|P7|Overall Study|Protocol Violation|4
4840954|NCT01026493|16687975|P6|Overall Study|Protocol Violation|3
4840955|NCT01026493|16687976|P5|Overall Study|Protocol Violation|2
4840956|NCT01026493|16687977|P4|Overall Study|Protocol Violation|0
4840957|NCT01026493|16687978|P3|Overall Study|Protocol Violation|0
4840958|NCT01026493|16687979|P2|Overall Study|Protocol Violation|1
4840959|NCT01026493|16687980|P1|Overall Study|Protocol Violation|0
4840960|NCT01026454|16688008|P2|Second Intervention|Pregnancy|1
4840961|NCT01026454|16688009|P1|Second Intervention|Pregnancy|1
4840962|NCT01026389|16688358|P2|Overall Study|change of treatment, patient moved|2
4840963|NCT01026389|16688359|P1|Overall Study|change of treatment, patient moved|4
4840964|NCT01026389|16688358|P2|Overall Study|Withdrawal by Subject|3
4840965|NCT01026389|16688359|P1|Overall Study|Withdrawal by Subject|1
4840966|NCT01026324|16688374|P3|Follow up/Survival|Withdrawal by Subject|0
4840967|NCT01026324|16688375|P2|Follow up/Survival|Withdrawal by Subject|0
4840968|NCT01026324|16688376|P1|Follow up/Survival|Withdrawal by Subject|1
4840969|NCT01026220|16688386|P3|Consolidation Maintenance|Withdrawal by Subject|6
4840970|NCT01026220|16688387|P2|Consolidation Maintenance|Withdrawal by Subject|2
4840971|NCT01026220|16688388|P1|Consolidation Maintenance|Withdrawal by Subject|0
4840972|NCT01026220|16688386|P3|Consolidation Maintenance|Physician Decision|7
4840973|NCT01026220|16688387|P2|Consolidation Maintenance|Physician Decision|2
4840974|NCT01026220|16688388|P1|Consolidation Maintenance|Physician Decision|0
4840975|NCT01026220|16688386|P3|Consolidation Maintenance|Lack of Efficacy|1
4840976|NCT01026220|16688387|P2|Consolidation Maintenance|Lack of Efficacy|1
4840977|NCT01026220|16688388|P1|Consolidation Maintenance|Lack of Efficacy|0
4840978|NCT01026220|16688386|P3|Consolidation Maintenance|Death|0
4840979|NCT01026220|16688387|P2|Consolidation Maintenance|Death|1
4840980|NCT01026220|16688388|P1|Consolidation Maintenance|Death|0
4840981|NCT01026220|16688386|P3|Induction|Ineligible|0
4840982|NCT01026220|16688387|P2|Induction|Ineligible|0
4840983|NCT01026220|16688388|P1|Induction|Ineligible|1
4840984|NCT01026220|16688386|P3|Induction|Withdrawal by Subject|0
4840985|NCT01026220|16688387|P2|Induction|Withdrawal by Subject|0
4840986|NCT01026220|16688388|P1|Induction|Withdrawal by Subject|9
4840987|NCT01026220|16688386|P3|Induction|Physician Decision|0
4840988|NCT01026220|16688387|P2|Induction|Physician Decision|0
4840989|NCT01026220|16688388|P1|Induction|Physician Decision|12
4840990|NCT01026220|16688386|P3|Induction|Lack of Efficacy|0
4840991|NCT01026220|16688387|P2|Induction|Lack of Efficacy|0
4840992|NCT01026220|16688388|P1|Induction|Lack of Efficacy|2
4840993|NCT01026220|16688386|P3|Induction|Death|0
4840994|NCT01026220|16688387|P2|Induction|Death|0
4840995|NCT01026220|16688388|P1|Induction|Death|1
4840996|NCT01026194|16688412|P2|Period 2：Open-label Period|Withdrawal by Subject|4
4840997|NCT01026194|16688413|P1|Period 2：Open-label Period|Withdrawal by Subject|0
4840998|NCT01026194|16688412|P2|Period 2：Open-label Period|Physician Decision|1
4840999|NCT01026194|16688413|P1|Period 2：Open-label Period|Physician Decision|3
4841000|NCT01026194|16688412|P2|Period 2：Open-label Period|Adverse Event|5
4841001|NCT01026194|16688413|P1|Period 2：Open-label Period|Adverse Event|4
4841002|NCT01026194|16688412|P2|Period 1：Double Blind Period|Physician Decision|4
4841003|NCT01026194|16688413|P1|Period 1：Double Blind Period|Physician Decision|0
4841004|NCT01026194|16688412|P2|Period 1：Double Blind Period|Lack of Efficacy|0
4841005|NCT01026194|16688413|P1|Period 1：Double Blind Period|Lack of Efficacy|1
4841006|NCT01026194|16688412|P2|Period 1：Double Blind Period|Adverse Event|1
4841007|NCT01026194|16688413|P1|Period 1：Double Blind Period|Adverse Event|2
4841008|NCT01026142|16688445|P2|Overall Study|Withdrew consent or lost to follow-up|29
4841009|NCT01026142|16688446|P1|Overall Study|Withdrew consent or lost to follow-up|36
4841010|NCT01026142|16688445|P2|Overall Study|Death|134
4841011|NCT01026142|16688446|P1|Overall Study|Death|136
4841012|NCT01026103|16688468|P1|Overall Study|did not receive study device bc of error|1
4841013|NCT01026103|16688468|P1|Overall Study|Physician Decision|1
4841014|NCT01026038|16688478|P3|Overall Study|Lost to Follow-up|0
4841015|NCT01026038|16688479|P2|Overall Study|Lost to Follow-up|1
4841016|NCT01026038|16688480|P1|Overall Study|Lost to Follow-up|1
4841017|NCT01025843|16688529|P10|Washout 4|Withdrawal by Subject|0
4841018|NCT01025843|16688530|P9|Washout 4|Withdrawal by Subject|0
4841019|NCT01025843|16688531|P8|Washout 4|Withdrawal by Subject|0
4841020|NCT01025843|16688532|P7|Washout 4|Withdrawal by Subject|0
4841021|NCT01025843|16688533|P6|Washout 4|Withdrawal by Subject|0
4841022|NCT01025843|16688534|P5|Washout 4|Withdrawal by Subject|0
4841023|NCT01025843|16688535|P4|Washout 4|Withdrawal by Subject|1
4841024|NCT01025843|16688536|P3|Washout 4|Withdrawal by Subject|1
4841025|NCT01025843|16688537|P2|Washout 4|Withdrawal by Subject|0
4841026|NCT01025843|16688538|P1|Washout 4|Withdrawal by Subject|0
4841027|NCT01025817|16688632|P2|Completed Study|Lost to Follow-up|1
4841028|NCT01025817|16688633|P1|Completed Study|Lost to Follow-up|0
4841029|NCT01025817|16688632|P2|Completed Study|Missing|0
4841030|NCT01025817|16688633|P1|Completed Study|Missing|2
4841031|NCT01025817|16688632|P2|Completed Study|Death|5
4841032|NCT01025817|16688633|P1|Completed Study|Death|6
4841033|NCT01025817|16688632|P2|Completed Study|Withdrawal by Subject|16
4841034|NCT01025817|16688633|P1|Completed Study|Withdrawal by Subject|8
4841035|NCT01025817|16688632|P2|Completed Study Medication|Lost to Follow-up|1
4841036|NCT01025817|16688633|P1|Completed Study Medication|Lost to Follow-up|0
4841037|NCT01025817|16688632|P2|Completed Study Medication|Subject no longer required study drug|1
4841038|NCT01025817|16688633|P1|Completed Study Medication|Subject no longer required study drug|0
4841039|NCT01025817|16688632|P2|Completed Study Medication|Abnormal lab values|2
4841040|NCT01025817|16688633|P1|Completed Study Medication|Abnormal lab values|0
4841041|NCT01025817|16688632|P2|Completed Study Medication|Death|2
4841042|NCT01025817|16688633|P1|Completed Study Medication|Death|2
4841043|NCT01025817|16688632|P2|Completed Study Medication|Graft loss|5
4841044|NCT01025817|16688633|P1|Completed Study Medication|Graft loss|2
4841045|NCT01025817|16688632|P2|Completed Study Medication|Abnormal test procedure|0
4841046|NCT01025817|16688633|P1|Completed Study Medication|Abnormal test procedure|4
4841047|NCT01025817|16688632|P2|Completed Study Medication|Unsatisfactory therapeutic effect|0
4841048|NCT01025817|16688633|P1|Completed Study Medication|Unsatisfactory therapeutic effect|7
4841049|NCT01025817|16688632|P2|Completed Study Medication|Administrative problems|5
4841050|NCT01025817|16688633|P1|Completed Study Medication|Administrative problems|7
4841051|NCT01025817|16688632|P2|Completed Study Medication|Withdrawal by Subject|9
4841052|NCT01025817|16688633|P1|Completed Study Medication|Withdrawal by Subject|8
4841053|NCT01025817|16688632|P2|Completed Study Medication|Protocol Deviation|8
4841054|NCT01025817|16688633|P1|Completed Study Medication|Protocol Deviation|9
4841055|NCT01025817|16688632|P2|Completed Study Medication|Adverse Event|39
4841056|NCT01025817|16688633|P1|Completed Study Medication|Adverse Event|66
4841057|NCT01025752|16688799|P2|Overall Study|Physician Decision|3
4841058|NCT01025752|16688800|P1|Overall Study|Physician Decision|1
4841059|NCT01025752|16688799|P2|Overall Study|Lost to Follow-up|10
4841060|NCT01025752|16688800|P1|Overall Study|Lost to Follow-up|7
4841061|NCT01025635|16688820|P2|Overall Study|Reason not known|2
4841062|NCT01025635|16688821|P1|Overall Study|Reason not known|4
4841063|NCT01025635|16688820|P2|Overall Study|Lost to Follow-up|13
4841064|NCT01025635|16688821|P1|Overall Study|Lost to Follow-up|9
4841065|NCT01025635|16688820|P2|Overall Study|Lack of Efficacy|1
4841066|NCT01025635|16688821|P1|Overall Study|Lack of Efficacy|0
4841067|NCT01025635|16688820|P2|Overall Study|Protocol Violation|2
4841068|NCT01025635|16688821|P1|Overall Study|Protocol Violation|4
4841069|NCT01025635|16688820|P2|Overall Study|Withdrawal by Subject|7
4841070|NCT01025635|16688821|P1|Overall Study|Withdrawal by Subject|6
4841071|NCT01025336|16688853|P5|Overall Study|Protocol Violation|0
4841072|NCT01025336|16688854|P4|Overall Study|Protocol Violation|2
4841073|NCT01025336|16688855|P3|Overall Study|Protocol Violation|0
4841074|NCT01025336|16688856|P2|Overall Study|Protocol Violation|0
4841075|NCT01025336|16688857|P1|Overall Study|Protocol Violation|0
4841076|NCT01025284|16688912|P3|Overall Study|Withdrawal by Subject|0
4841077|NCT01025284|16688913|P2|Overall Study|Withdrawal by Subject|1
4841078|NCT01025284|16688914|P1|Overall Study|Withdrawal by Subject|0
4841079|NCT01025284|16688912|P3|Overall Study|Investigator Decision|0
4841080|NCT01025284|16688913|P2|Overall Study|Investigator Decision|1
4841081|NCT01025284|16688914|P1|Overall Study|Investigator Decision|0
4841082|NCT01025232|16688939|P2|Overall Study|Study drug no longer available|6
4841083|NCT01025232|16688940|P1|Overall Study|Study drug no longer available|3
4841084|NCT01025193|16688958|P1|Overall Study|Adverse Event|3
4841085|NCT01025193|16688958|P1|Overall Study|Protocol Violation|1
4841086|NCT01025154|16688968|P1|Overall Study|Withdrawal by Subject|1
4841087|NCT01025154|16688968|P1|Overall Study|Lost to Follow-up|1
4841088|NCT01025037|16688977|P1|Overall Study|Withdrawal by Subject|1
4841089|NCT01025037|16688977|P1|Overall Study|Lost to Follow-up|7
4841090|NCT01025037|16688977|P1|Overall Study|Adverse Event|3
4841091|NCT01024959|16688999|P1|Overall Study|missing results required for analysis|17
4841092|NCT01024959|16688999|P1|Overall Study|results not evaluable|12
4841093|NCT01024959|16688999|P1|Overall Study|ineligible|12
4841094|NCT01024946|16689008|P1|Overall Study|Adverse Event|1
4841095|NCT01024946|16689008|P1|Overall Study|Withdrawal by Subject|1
4841096|NCT01024946|16689008|P1|Overall Study|Screen Failure|3
4841097|NCT01024920|16689014|P2|Overall Study|Not treated|0
4841098|NCT01024920|16689015|P1|Overall Study|Not treated|3
4841099|NCT01024920|16689014|P2|Overall Study|Other reason|13
4841100|NCT01024920|16689015|P1|Overall Study|Other reason|21
4841101|NCT01024920|16689014|P2|Overall Study|Withdrawal by Subject|0
4841102|NCT01024920|16689015|P1|Overall Study|Withdrawal by Subject|2
4841103|NCT01024920|16689014|P2|Overall Study|Lost to Follow-up|4
4841104|NCT01024920|16689015|P1|Overall Study|Lost to Follow-up|4
4841105|NCT01024920|16689014|P2|Overall Study|Adverse Event|2
4841106|NCT01024920|16689015|P1|Overall Study|Adverse Event|4
4841107|NCT01024920|16689014|P2|Overall Study|Progressive disease|3
4841108|NCT01024920|16689015|P1|Overall Study|Progressive disease|11
4841109|NCT01024855|16689033|P1|Overall Study|Inclusion/exclusion criteria|1
4841110|NCT01024751|16689040|P2|Eligible Participants|Ineligible|1
4841111|NCT01024751|16689041|P1|Eligible Participants|Ineligible|0
4841112|NCT01024751|16689040|P2|Eligible Participants|Lost to Follow-up|1
4841113|NCT01024751|16689041|P1|Eligible Participants|Lost to Follow-up|0
4841114|NCT01024751|16689040|P2|Eligible Participants|Withdrawal by Subject|1
4841115|NCT01024751|16689041|P1|Eligible Participants|Withdrawal by Subject|0
4841116|NCT01024751|16689040|P2|Enrolled Participants|Ineligible at baseline|4
4841117|NCT01024751|16689041|P1|Enrolled Participants|Ineligible at baseline|3
4841118|NCT01024608|16689098|P2|Overall Study|Never received study treatment|0
4841119|NCT01024608|16689099|P1|Overall Study|Never received study treatment|2
4841120|NCT01024608|16689098|P2|Overall Study|Protocol Violation|3
4841121|NCT01024608|16689099|P1|Overall Study|Protocol Violation|0
4841122|NCT01024608|16689098|P2|Overall Study|Lost to Follow-up|1
4841123|NCT01024608|16689099|P1|Overall Study|Lost to Follow-up|0
4841124|NCT01024608|16689098|P2|Overall Study|Withdrawal by Subject|0
4841125|NCT01024608|16689099|P1|Overall Study|Withdrawal by Subject|1
4841126|NCT01024608|16689098|P2|Overall Study|Adverse Event|0
4841127|NCT01024608|16689099|P1|Overall Study|Adverse Event|1
4841128|NCT01024465|16689128|P1|Overall Study|Physician Decision|1
4841129|NCT01024465|16689128|P1|Overall Study|Adverse Event|2
4841130|NCT01024387|16689132|P1|Overall Study|Other|5
4841131|NCT01024387|16689132|P1|Overall Study|Adverse Event|3
4841132|NCT01024387|16689132|P1|Overall Study|Prolonged Treatment Delay|1
4841133|NCT01024387|16689132|P1|Overall Study|Death|2
4841134|NCT01024387|16689132|P1|Overall Study|Withdrawal by Subject|5
4841135|NCT01024387|16689132|P1|Overall Study|Physician Decision|5
4841136|NCT01024387|16689132|P1|Overall Study|Symptomatic Progression|10
4841137|NCT01024387|16689132|P1|Overall Study|Radiographic Progression|29
4841138|NCT01024309|16689153|P2|Overall Study|Withdrawal by Subject|4
4841139|NCT01024309|16689154|P1|Overall Study|Withdrawal by Subject|4
4841140|NCT01024309|16689153|P2|Overall Study|Physician Decision|0
4841141|NCT01024309|16689154|P1|Overall Study|Physician Decision|4
4841142|NCT01024244|16689186|P5|Overall Study|Withdrawal by Subject|0
4841143|NCT01024244|16689187|P4|Overall Study|Withdrawal by Subject|0
4841144|NCT01024244|16689188|P3|Overall Study|Withdrawal by Subject|0
4841145|NCT01024244|16689189|P2|Overall Study|Withdrawal by Subject|1
4841146|NCT01024244|16689190|P1|Overall Study|Withdrawal by Subject|0
4841147|NCT01024244|16689186|P5|Overall Study|Sponsor Decision|10
4841148|NCT01024244|16689187|P4|Overall Study|Sponsor Decision|12
4841149|NCT01024244|16689188|P3|Overall Study|Sponsor Decision|14
4841150|NCT01024244|16689189|P2|Overall Study|Sponsor Decision|7
4841151|NCT01024244|16689190|P1|Overall Study|Sponsor Decision|14
4841152|NCT01024244|16689186|P5|Overall Study|Protocol Violation|2
4841153|NCT01024244|16689187|P4|Overall Study|Protocol Violation|0
4841154|NCT01024244|16689188|P3|Overall Study|Protocol Violation|0
4841155|NCT01024244|16689189|P2|Overall Study|Protocol Violation|0
4841156|NCT01024244|16689190|P1|Overall Study|Protocol Violation|1
4841157|NCT01024244|16689186|P5|Overall Study|Lack of Efficacy|0
4841158|NCT01024244|16689187|P4|Overall Study|Lack of Efficacy|0
4841159|NCT01024244|16689188|P3|Overall Study|Lack of Efficacy|0
4841160|NCT01024244|16689189|P2|Overall Study|Lack of Efficacy|0
4841161|NCT01024244|16689190|P1|Overall Study|Lack of Efficacy|1
4841162|NCT01024244|16689186|P5|Overall Study|Entry Criteria Not Met|0
4841163|NCT01024244|16689187|P4|Overall Study|Entry Criteria Not Met|0
4841164|NCT01024244|16689188|P3|Overall Study|Entry Criteria Not Met|0
4841165|NCT01024244|16689189|P2|Overall Study|Entry Criteria Not Met|1
4841166|NCT01024244|16689190|P1|Overall Study|Entry Criteria Not Met|0
4841167|NCT01024244|16689186|P5|Overall Study|Adverse Event|2
4841168|NCT01024244|16689187|P4|Overall Study|Adverse Event|1
4841169|NCT01024244|16689188|P3|Overall Study|Adverse Event|0
4841170|NCT01024244|16689189|P2|Overall Study|Adverse Event|2
4841171|NCT01024244|16689190|P1|Overall Study|Adverse Event|1
4841172|NCT01024036|16689304|P2|Follow-Up Period|Adverse Event|1
4841173|NCT01024036|16689305|P1|Follow-Up Period|Adverse Event|4
4841174|NCT01024036|16689304|P2|Follow-Up Period|Withdrawal by Subject|1
4841175|NCT01024036|16689305|P1|Follow-Up Period|Withdrawal by Subject|0
4841176|NCT01024036|16689304|P2|Follow-Up Period|Lost to Follow-up|1
4841177|NCT01024036|16689305|P1|Follow-Up Period|Lost to Follow-up|1
4841178|NCT01024036|16689304|P2|Unblinded Treatment|Lack of Efficacy|2
4841179|NCT01024036|16689305|P1|Unblinded Treatment|Lack of Efficacy|0
4841180|NCT01024036|16689304|P2|Unblinded Treatment|Adverse Event|1
4841181|NCT01024036|16689305|P1|Unblinded Treatment|Adverse Event|0
4841182|NCT01024036|16689304|P2|Blinded Treatment|Withdrawal by Subject|3
4841183|NCT01024036|16689305|P1|Blinded Treatment|Withdrawal by Subject|4
4841184|NCT01024036|16689304|P2|Blinded Treatment|Death|2
4841185|NCT01024036|16689305|P1|Blinded Treatment|Death|0
4841186|NCT01024036|16689304|P2|Blinded Treatment|Physician Decision|0
4841187|NCT01024036|16689305|P1|Blinded Treatment|Physician Decision|1
4841188|NCT01024036|16689304|P2|Blinded Treatment|Lack of Efficacy|14
4841189|NCT01024036|16689305|P1|Blinded Treatment|Lack of Efficacy|16
4841190|NCT01024036|16689304|P2|Blinded Treatment|Adverse Event|1
4841191|NCT01024036|16689305|P1|Blinded Treatment|Adverse Event|1
4841192|NCT01023958|16689352|P1|Overall Study|Refused to continue medication|1
4841193|NCT01023958|16689352|P1|Overall Study|Other adverse event|1
4841194|NCT01023958|16689352|P1|Overall Study|Progressive disease|48
4841195|NCT01023815|16689400|P4|Randomized Period (Day 90 to Month 12)|Graft Loss|0
4841196|NCT01023815|16689401|P3|Randomized Period (Day 90 to Month 12)|Graft Loss|0
4841197|NCT01023815|16689402|P2|Randomized Period (Day 90 to Month 12)|Graft Loss|1
4841198|NCT01023815|16689403|P1|Randomized Period (Day 90 to Month 12)|Graft Loss|0
4841199|NCT01023815|16689400|P4|Randomized Period (Day 90 to Month 12)|Administrative Problems|2
4841200|NCT01023815|16689401|P3|Randomized Period (Day 90 to Month 12)|Administrative Problems|6
4841201|NCT01023815|16689402|P2|Randomized Period (Day 90 to Month 12)|Administrative Problems|1
4841202|NCT01023815|16689403|P1|Randomized Period (Day 90 to Month 12)|Administrative Problems|0
4841203|NCT01023815|16689400|P4|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
4841204|NCT01023815|16689401|P3|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
4841205|NCT01023815|16689402|P2|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1
4841206|NCT01023815|16689403|P1|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0
4841207|NCT01023815|16689400|P4|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
4841208|NCT01023815|16689401|P3|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1
4841209|NCT01023815|16689402|P2|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
4841210|NCT01023815|16689403|P1|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0
4841211|NCT01023815|16689400|P4|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
4841212|NCT01023815|16689401|P3|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
4841213|NCT01023815|16689402|P2|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0
4841214|NCT01023815|16689403|P1|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144
4841215|NCT01023789|16689422|P1|3 - Year Visit|Lost to Follow-up|13
4841216|NCT01023789|16689422|P1|3 - Year Visit|Withdrawal of consent|1
4841217|NCT01023789|16689422|P1|3 - Year Visit|Death|29
4841218|NCT01023672|16689508|P1|Overall Study|Death|1
4841219|NCT01023672|16689508|P1|Overall Study|Worsening disease|2
4841220|NCT01023659|16689515|P3|Overall Study|Lost to Follow-up|99
4841221|NCT01023659|16689516|P2|Overall Study|Lost to Follow-up|228
4841222|NCT01023659|16689517|P1|Overall Study|Lost to Follow-up|73
4841223|NCT01023581|16689544|P7|Overall Study|Other|0
4841224|NCT01023581|16689545|P6|Overall Study|Other|0
4841225|NCT01023581|16689546|P5|Overall Study|Other|1
4841226|NCT01023581|16689547|P4|Overall Study|Other|0
4841227|NCT01023581|16689548|P3|Overall Study|Other|1
4841228|NCT01023581|16689549|P2|Overall Study|Other|0
4841229|NCT01023581|16689550|P1|Overall Study|Other|1
4841230|NCT01023581|16689544|P7|Overall Study|Physician Decision|1
4841231|NCT01023581|16689545|P6|Overall Study|Physician Decision|1
4841232|NCT01023581|16689546|P5|Overall Study|Physician Decision|1
4841233|NCT01023581|16689547|P4|Overall Study|Physician Decision|1
4841234|NCT01023581|16689548|P3|Overall Study|Physician Decision|2
4841235|NCT01023581|16689549|P2|Overall Study|Physician Decision|0
4841236|NCT01023581|16689550|P1|Overall Study|Physician Decision|2
4841237|NCT01023581|16689544|P7|Overall Study|Lack of Efficacy|1
4841238|NCT01023581|16689545|P6|Overall Study|Lack of Efficacy|2
4841239|NCT01023581|16689546|P5|Overall Study|Lack of Efficacy|1
4841240|NCT01023581|16689547|P4|Overall Study|Lack of Efficacy|2
4841241|NCT01023581|16689548|P3|Overall Study|Lack of Efficacy|6
4841242|NCT01023581|16689549|P2|Overall Study|Lack of Efficacy|3
4841243|NCT01023581|16689550|P1|Overall Study|Lack of Efficacy|9
4841244|NCT01023581|16689544|P7|Overall Study|Pregnancy|0
4841245|NCT01023581|16689545|P6|Overall Study|Pregnancy|1
4841246|NCT01023581|16689546|P5|Overall Study|Pregnancy|0
4841247|NCT01023581|16689547|P4|Overall Study|Pregnancy|2
4841248|NCT01023581|16689548|P3|Overall Study|Pregnancy|0
4841249|NCT01023581|16689549|P2|Overall Study|Pregnancy|0
4841250|NCT01023581|16689550|P1|Overall Study|Pregnancy|0
4841251|NCT01023581|16689544|P7|Overall Study|Withdrawal by Subject|5
4841252|NCT01023581|16689545|P6|Overall Study|Withdrawal by Subject|8
4841253|NCT01023581|16689546|P5|Overall Study|Withdrawal by Subject|6
4841254|NCT01023581|16689547|P4|Overall Study|Withdrawal by Subject|10
4841255|NCT01023581|16689548|P3|Overall Study|Withdrawal by Subject|16
4841256|NCT01023581|16689549|P2|Overall Study|Withdrawal by Subject|8
4841257|NCT01023581|16689550|P1|Overall Study|Withdrawal by Subject|13
4841258|NCT01023581|16689544|P7|Overall Study|Lost to Follow-up|2
4841259|NCT01023581|16689545|P6|Overall Study|Lost to Follow-up|2
4841260|NCT01023581|16689546|P5|Overall Study|Lost to Follow-up|5
4841261|NCT01023581|16689547|P4|Overall Study|Lost to Follow-up|2
4841262|NCT01023581|16689548|P3|Overall Study|Lost to Follow-up|7
4841263|NCT01023581|16689549|P2|Overall Study|Lost to Follow-up|8
4841264|NCT01023581|16689550|P1|Overall Study|Lost to Follow-up|4
4841265|NCT01023581|16689544|P7|Overall Study|Major protocol deviation|0
4841266|NCT01023581|16689545|P6|Overall Study|Major protocol deviation|0
4841267|NCT01023581|16689546|P5|Overall Study|Major protocol deviation|0
4841268|NCT01023581|16689547|P4|Overall Study|Major protocol deviation|0
4841269|NCT01023581|16689548|P3|Overall Study|Major protocol deviation|3
4841270|NCT01023581|16689549|P2|Overall Study|Major protocol deviation|0
4841271|NCT01023581|16689550|P1|Overall Study|Major protocol deviation|2
4841272|NCT01023581|16689544|P7|Overall Study|Adverse Event|11
4841273|NCT01023581|16689545|P6|Overall Study|Adverse Event|5
4841274|NCT01023581|16689546|P5|Overall Study|Adverse Event|2
4841275|NCT01023581|16689547|P4|Overall Study|Adverse Event|3
4841276|NCT01023581|16689548|P3|Overall Study|Adverse Event|7
4841277|NCT01023581|16689549|P2|Overall Study|Adverse Event|4
4841278|NCT01023581|16689550|P1|Overall Study|Adverse Event|4
4841279|NCT01023516|16689607|P2|Overall Study|Incorrect enrolment|2
4841280|NCT01023516|16689608|P1|Overall Study|Incorrect enrolment|4
4841281|NCT01023516|16689607|P2|Overall Study|Study-specific criteria|2
4841282|NCT01023516|16689608|P1|Overall Study|Study-specific criteria|4
4841283|NCT01023516|16689607|P2|Overall Study|Safety reason|3
4841284|NCT01023516|16689608|P1|Overall Study|Safety reason|0
4841285|NCT01023516|16689607|P2|Overall Study|Adverse Event|6
4841286|NCT01023516|16689608|P1|Overall Study|Adverse Event|9
4841287|NCT01023516|16689607|P2|Overall Study|Voluntary discontinuation|5
4841288|NCT01023516|16689608|P1|Overall Study|Voluntary discontinuation|7
4841289|NCT01023308|16689690|P2|Overall Study|Withdrawal by Subject|18
4841290|NCT01023308|16689691|P1|Overall Study|Withdrawal by Subject|34
4841291|NCT01023308|16689690|P2|Overall Study|Lost to Follow-up|0
4841292|NCT01023308|16689691|P1|Overall Study|Lost to Follow-up|1
4841293|NCT01023308|16689690|P2|Overall Study|Untreated|5
4841294|NCT01023308|16689691|P1|Overall Study|Untreated|5
4841295|NCT01023308|16689690|P2|Overall Study|Protocol Violation|4
4841296|NCT01023308|16689691|P1|Overall Study|Protocol Violation|3
4841297|NCT01023308|16689690|P2|Overall Study|New Cancer therapy|7
4841298|NCT01023308|16689691|P1|Overall Study|New Cancer therapy|4
4841299|NCT01023308|16689690|P2|Overall Study|Disease progression|153
4841300|NCT01023308|16689691|P1|Overall Study|Disease progression|82
4841301|NCT01023308|16689690|P2|Overall Study|Death|17
4841302|NCT01023308|16689691|P1|Overall Study|Death|21
4841303|NCT01023308|16689690|P2|Overall Study|Adverse Event|66
4841304|NCT01023308|16689691|P1|Overall Study|Adverse Event|130
4841305|NCT01023308|16689690|P2|Overall Study|Administrative problems|1
4841306|NCT01023308|16689691|P1|Overall Study|Administrative problems|2
4841307|NCT01023308|16689690|P2|Overall Study|Abnormal test proceedure results|8
4841308|NCT01023308|16689691|P1|Overall Study|Abnormal test proceedure results|3
4841309|NCT01023269|16689717|P2|Overall Study|early termination of the study|0
4841310|NCT01023269|16689718|P1|Overall Study|early termination of the study|2
4841311|NCT01023256|16689726|P4|Overall Study|Withdrawal by Subject|2
4841312|NCT01023256|16689727|P3|Overall Study|Withdrawal by Subject|0
4841313|NCT01023256|16689728|P2|Overall Study|Withdrawal by Subject|0
4841314|NCT01023256|16689729|P1|Overall Study|Withdrawal by Subject|0
4841315|NCT01023256|16689726|P4|Overall Study|Adverse Event|1
4841316|NCT01023256|16689727|P3|Overall Study|Adverse Event|0
4841317|NCT01023256|16689728|P2|Overall Study|Adverse Event|0
4841318|NCT01023256|16689729|P1|Overall Study|Adverse Event|0
4841319|NCT01023256|16689726|P4|Overall Study|Other|2
4841320|NCT01023256|16689727|P3|Overall Study|Other|0
4841321|NCT01023256|16689728|P2|Overall Study|Other|0
4841322|NCT01023256|16689729|P1|Overall Study|Other|1
4841323|NCT01023256|16689726|P4|Overall Study|Randomized but not treated|0
4841324|NCT01023256|16689727|P3|Overall Study|Randomized but not treated|1
4841325|NCT01023256|16689728|P2|Overall Study|Randomized but not treated|0
4841326|NCT01023256|16689729|P1|Overall Study|Randomized but not treated|1
4841327|NCT01023256|16689726|P4|Overall Study|Protocol Violation|0
4841328|NCT01023256|16689727|P3|Overall Study|Protocol Violation|0
4841329|NCT01023256|16689728|P2|Overall Study|Protocol Violation|3
4841330|NCT01023256|16689729|P1|Overall Study|Protocol Violation|2
4841331|NCT01023217|16689771|P2|Overall Study|Withdrawal by Subject|0
4841332|NCT01023217|16689772|P1|Overall Study|Withdrawal by Subject|1
4841333|NCT01023061|16689810|P1|Overall Study|Withdrawal prior to treatment|2
4841334|NCT01023035|16689819|P3|Follow-up Period (up to Week 72)|Non-medical Reason|38
4841335|NCT01023035|16689820|P2|Follow-up Period (up to Week 72)|Non-medical Reason|28
4841336|NCT01023035|16689821|P1|Follow-up Period (up to Week 72)|Non-medical Reason|26
4841337|NCT01023035|16689819|P3|Follow-up Period (up to Week 72)|Adverse Event|1
4841338|NCT01023035|16689820|P2|Follow-up Period (up to Week 72)|Adverse Event|0
4841339|NCT01023035|16689821|P1|Follow-up Period (up to Week 72)|Adverse Event|2
4841340|NCT01023035|16689819|P3|Treatment Period|Treatment Failure|24
4841341|NCT01023035|16689820|P2|Treatment Period|Treatment Failure|31
4841342|NCT01023035|16689821|P1|Treatment Period|Treatment Failure|26
4841343|NCT01023035|16689819|P3|Treatment Period|Non-Medical Reasons|44
4841344|NCT01023035|16689820|P2|Treatment Period|Non-Medical Reasons|22
4841345|NCT01023035|16689821|P1|Treatment Period|Non-Medical Reasons|19
4841346|NCT01023035|16689819|P3|Treatment Period|Adverse Event|50
4841347|NCT01023035|16689820|P2|Treatment Period|Adverse Event|32
4841348|NCT01023035|16689821|P1|Treatment Period|Adverse Event|27
4841349|NCT01023022|16689831|P1|Overall Study|due to technical issues|2
4841350|NCT01023022|16689831|P1|Overall Study|Lost to Follow-up|7
4841351|NCT01023022|16689831|P1|Overall Study|Death|5
4841352|NCT01022996|16689837|P1|Overall Study|Protocol Violation|1
4841353|NCT01022996|16689837|P1|Overall Study|Disease Progression|32
4841354|NCT01022996|16689837|P1|Overall Study|Administrative problems|6
4841355|NCT01022996|16689837|P1|Overall Study|Lost to Follow-up|1
4841356|NCT01022996|16689837|P1|Overall Study|Withdrawal by Subject|3
4841357|NCT01022996|16689837|P1|Overall Study|Adverse Event|14
4841358|NCT01022853|16689851|P5|Overall Study|Other not stated above|0
4841359|NCT01022853|16689852|P4|Overall Study|Other not stated above|0
4841360|NCT01022853|16689853|P3|Overall Study|Other not stated above|1
4841361|NCT01022853|16689854|P2|Overall Study|Other not stated above|0
4841362|NCT01022853|16689855|P1|Overall Study|Other not stated above|1
4841363|NCT01022853|16689851|P5|Overall Study|Withdrawal by Subject|0
4841364|NCT01022853|16689852|P4|Overall Study|Withdrawal by Subject|1
4841365|NCT01022853|16689853|P3|Overall Study|Withdrawal by Subject|1
4841366|NCT01022853|16689854|P2|Overall Study|Withdrawal by Subject|1
4841367|NCT01022853|16689855|P1|Overall Study|Withdrawal by Subject|0
4841368|NCT01022853|16689851|P5|Overall Study|Dose-limiting toxicity|1
4841369|NCT01022853|16689852|P4|Overall Study|Dose-limiting toxicity|0
4841370|NCT01022853|16689853|P3|Overall Study|Dose-limiting toxicity|0
4841371|NCT01022853|16689854|P2|Overall Study|Dose-limiting toxicity|0
4841372|NCT01022853|16689855|P1|Overall Study|Dose-limiting toxicity|0
4841373|NCT01022853|16689851|P5|Overall Study|Progressive disease|1
4841374|NCT01022853|16689852|P4|Overall Study|Progressive disease|7
4841375|NCT01022853|16689853|P3|Overall Study|Progressive disease|11
4841376|NCT01022853|16689854|P2|Overall Study|Progressive disease|3
4841377|NCT01022853|16689855|P1|Overall Study|Progressive disease|2
4841378|NCT01022762|16689934|P2|Overall Study|Unclassified|20
4841379|NCT01022762|16689935|P1|Overall Study|Unclassified|12
4841380|NCT01022762|16689934|P2|Overall Study|Protocol Violation|6
4841381|NCT01022762|16689935|P1|Overall Study|Protocol Violation|7
4841382|NCT01022762|16689934|P2|Overall Study|Lack of Efficacy|1
4841383|NCT01022762|16689935|P1|Overall Study|Lack of Efficacy|0
4841384|NCT01022762|16689934|P2|Overall Study|Adverse Event|1
4841385|NCT01022762|16689935|P1|Overall Study|Adverse Event|3
4841386|NCT01022502|16689970|P1|Overall Study|Withdrawal by Subject|1
4841387|NCT01022502|16689970|P1|Overall Study|employment related reasons|1
4841388|NCT01022502|16689970|P1|Overall Study|Adverse Event|1
4841389|NCT01022424|16689984|P1|Overall Study|eGFR under the withdrawal criteria|2
4841390|NCT01022424|16689984|P1|Overall Study|Physician Decision|1
4841391|NCT01022424|16689984|P1|Overall Study|Adverse Event|1
4841392|NCT01022398|16689999|P2|Overall Study|Study terminated|2
4841393|NCT01022398|16690000|P1|Overall Study|Study terminated|2
4841394|NCT01022203|16690025|P2|Follow-Up Assessment|Lost to Follow-up|2
4841395|NCT01022203|16690026|P1|Follow-Up Assessment|Lost to Follow-up|2
4841396|NCT01022203|16690025|P2|Post Treatment Assessment|Adverse Event|2
4841397|NCT01022203|16690026|P1|Post Treatment Assessment|Adverse Event|0
4841398|NCT01022203|16690025|P2|Post Treatment Assessment|Physician Decision|0
4841399|NCT01022203|16690026|P1|Post Treatment Assessment|Physician Decision|2
4841400|NCT01022203|16690025|P2|Post Treatment Assessment|Withdrawal by Subject|12
4841401|NCT01022203|16690026|P1|Post Treatment Assessment|Withdrawal by Subject|12
4841402|NCT01022112|16690045|P5|Overall Study|Fasting plasma glucose level increased|7
4841403|NCT01022112|16690046|P4|Overall Study|Fasting plasma glucose level increased|0
4841404|NCT01022112|16690047|P3|Overall Study|Fasting plasma glucose level increased|0
4841405|NCT01022112|16690048|P2|Overall Study|Fasting plasma glucose level increased|0
4841406|NCT01022112|16690049|P1|Overall Study|Fasting plasma glucose level increased|1
4841407|NCT01022112|16690045|P5|Overall Study|Withdrawal by Subject|1
4841408|NCT01022112|16690046|P4|Overall Study|Withdrawal by Subject|2
4841409|NCT01022112|16690047|P3|Overall Study|Withdrawal by Subject|2
4841410|NCT01022112|16690048|P2|Overall Study|Withdrawal by Subject|1
4841411|NCT01022112|16690049|P1|Overall Study|Withdrawal by Subject|0
4841412|NCT01022112|16690045|P5|Overall Study|Physician Decision|1
4841413|NCT01022112|16690046|P4|Overall Study|Physician Decision|0
4841414|NCT01022112|16690047|P3|Overall Study|Physician Decision|1
4841415|NCT01022112|16690048|P2|Overall Study|Physician Decision|0
4841416|NCT01022112|16690049|P1|Overall Study|Physician Decision|0
4841417|NCT01022112|16690045|P5|Overall Study|Lack of Efficacy|1
4841418|NCT01022112|16690046|P4|Overall Study|Lack of Efficacy|0
4841419|NCT01022112|16690047|P3|Overall Study|Lack of Efficacy|0
4841420|NCT01022112|16690048|P2|Overall Study|Lack of Efficacy|0
4841421|NCT01022112|16690049|P1|Overall Study|Lack of Efficacy|1
4841422|NCT01022112|16690045|P5|Overall Study|Adverse Event|0
4841423|NCT01022112|16690046|P4|Overall Study|Adverse Event|1
4841424|NCT01022112|16690047|P3|Overall Study|Adverse Event|0
4841425|NCT01022112|16690048|P2|Overall Study|Adverse Event|2
4841426|NCT01022112|16690049|P1|Overall Study|Adverse Event|1
4841427|NCT01021878|16690098|P2|Overall Study|Transplantation|1
4841428|NCT01021878|16690099|P1|Overall Study|Transplantation|6
4841429|NCT01021878|16690098|P2|Overall Study|Adverse Event|5
4841430|NCT01021878|16690099|P1|Overall Study|Adverse Event|6
4841431|NCT01021878|16690098|P2|Overall Study|Death|1
4841432|NCT01021878|16690099|P1|Overall Study|Death|0
4841433|NCT01021878|16690098|P2|Overall Study|Lost to Follow-up|3
4841434|NCT01021878|16690099|P1|Overall Study|Lost to Follow-up|4
4841435|NCT01021852|16690121|P8|Treatment Period 2|Withdrawal by Subject|2
4841436|NCT01021852|16690122|P7|Treatment Period 2|Withdrawal by Subject|1
4841437|NCT01021852|16690123|P6|Treatment Period 2|Withdrawal by Subject|0
4841438|NCT01021852|16690124|P5|Treatment Period 2|Withdrawal by Subject|0
4841439|NCT01021852|16690125|P4|Treatment Period 2|Withdrawal by Subject|0
4841440|NCT01021852|16690126|P3|Treatment Period 2|Withdrawal by Subject|0
4841441|NCT01021852|16690127|P2|Treatment Period 2|Withdrawal by Subject|0
4841442|NCT01021852|16690128|P1|Treatment Period 2|Withdrawal by Subject|0
4841443|NCT01021852|16690121|P8|Treatment Period 2|Protocol Violation|0
4841444|NCT01021852|16690122|P7|Treatment Period 2|Protocol Violation|1
4841445|NCT01021852|16690123|P6|Treatment Period 2|Protocol Violation|0
4841446|NCT01021852|16690124|P5|Treatment Period 2|Protocol Violation|1
4841447|NCT01021852|16690125|P4|Treatment Period 2|Protocol Violation|0
4841448|NCT01021852|16690126|P3|Treatment Period 2|Protocol Violation|0
4841449|NCT01021852|16690127|P2|Treatment Period 2|Protocol Violation|0
4841450|NCT01021852|16690128|P1|Treatment Period 2|Protocol Violation|0
4841451|NCT01021852|16690121|P8|Treatment Period 2|Physician Decision|0
4841452|NCT01021852|16690122|P7|Treatment Period 2|Physician Decision|0
4841453|NCT01021852|16690123|P6|Treatment Period 2|Physician Decision|0
4841454|NCT01021852|16690124|P5|Treatment Period 2|Physician Decision|0
4841455|NCT01021852|16690125|P4|Treatment Period 2|Physician Decision|0
4841456|NCT01021852|16690126|P3|Treatment Period 2|Physician Decision|1
4841457|NCT01021852|16690127|P2|Treatment Period 2|Physician Decision|0
4841458|NCT01021852|16690128|P1|Treatment Period 2|Physician Decision|0
4841459|NCT01021852|16690121|P8|Treatment Period 2|Lack of Efficacy|0
4841460|NCT01021852|16690122|P7|Treatment Period 2|Lack of Efficacy|0
4841461|NCT01021852|16690123|P6|Treatment Period 2|Lack of Efficacy|1
4841462|NCT01021852|16690124|P5|Treatment Period 2|Lack of Efficacy|0
4841463|NCT01021852|16690125|P4|Treatment Period 2|Lack of Efficacy|0
4841464|NCT01021852|16690126|P3|Treatment Period 2|Lack of Efficacy|0
4841465|NCT01021852|16690127|P2|Treatment Period 2|Lack of Efficacy|0
4841466|NCT01021852|16690128|P1|Treatment Period 2|Lack of Efficacy|0
4841467|NCT01021852|16690121|P8|Treatment Period 2|Adverse Event|0
4841468|NCT01021852|16690122|P7|Treatment Period 2|Adverse Event|1
4841469|NCT01021852|16690123|P6|Treatment Period 2|Adverse Event|0
4841470|NCT01021852|16690124|P5|Treatment Period 2|Adverse Event|1
4841471|NCT01021852|16690125|P4|Treatment Period 2|Adverse Event|0
4841472|NCT01021852|16690126|P3|Treatment Period 2|Adverse Event|0
4841473|NCT01021852|16690127|P2|Treatment Period 2|Adverse Event|1
4841474|NCT01021852|16690128|P1|Treatment Period 2|Adverse Event|0
4841475|NCT01021852|16690121|P8|Washout Period-No Drug|Adverse Event|0
4841476|NCT01021852|16690122|P7|Washout Period-No Drug|Adverse Event|0
4841477|NCT01021852|16690123|P6|Washout Period-No Drug|Adverse Event|1
4841478|NCT01021852|16690124|P5|Washout Period-No Drug|Adverse Event|0
4841479|NCT01021852|16690125|P4|Washout Period-No Drug|Adverse Event|0
4841480|NCT01021852|16690126|P3|Washout Period-No Drug|Adverse Event|0
4841481|NCT01021852|16690127|P2|Washout Period-No Drug|Adverse Event|0
4841482|NCT01021852|16690128|P1|Washout Period-No Drug|Adverse Event|1
4841483|NCT01021852|16690121|P8|Washout Period-Placebo|Protocol Violation|0
4841484|NCT01021852|16690122|P7|Washout Period-Placebo|Protocol Violation|1
4841485|NCT01021852|16690123|P6|Washout Period-Placebo|Protocol Violation|0
4841486|NCT01021852|16690124|P5|Washout Period-Placebo|Protocol Violation|0
4841487|NCT01021852|16690125|P4|Washout Period-Placebo|Protocol Violation|0
4841488|NCT01021852|16690126|P3|Washout Period-Placebo|Protocol Violation|0
4841489|NCT01021852|16690127|P2|Washout Period-Placebo|Protocol Violation|0
4841490|NCT01021852|16690128|P1|Washout Period-Placebo|Protocol Violation|0
4841491|NCT01021852|16690121|P8|Washout Period-Placebo|Lost to Follow-up|0
4841492|NCT01021852|16690122|P7|Washout Period-Placebo|Lost to Follow-up|0
4841493|NCT01021852|16690123|P6|Washout Period-Placebo|Lost to Follow-up|0
4841494|NCT01021852|16690124|P5|Washout Period-Placebo|Lost to Follow-up|1
4841495|NCT01021852|16690125|P4|Washout Period-Placebo|Lost to Follow-up|0
4841496|NCT01021852|16690126|P3|Washout Period-Placebo|Lost to Follow-up|0
4841497|NCT01021852|16690127|P2|Washout Period-Placebo|Lost to Follow-up|0
4841498|NCT01021852|16690128|P1|Washout Period-Placebo|Lost to Follow-up|0
4841499|NCT01021852|16690121|P8|Washout Period-Placebo|Adverse Event|0
4841500|NCT01021852|16690122|P7|Washout Period-Placebo|Adverse Event|0
4841501|NCT01021852|16690123|P6|Washout Period-Placebo|Adverse Event|1
4841502|NCT01021852|16690124|P5|Washout Period-Placebo|Adverse Event|0
4841503|NCT01021852|16690125|P4|Washout Period-Placebo|Adverse Event|1
4841504|NCT01021852|16690126|P3|Washout Period-Placebo|Adverse Event|0
4841505|NCT01021852|16690127|P2|Washout Period-Placebo|Adverse Event|0
4841506|NCT01021852|16690128|P1|Washout Period-Placebo|Adverse Event|0
4841507|NCT01021852|16690121|P8|Treatment Period 1|Not Treated|0
4841508|NCT01021852|16690122|P7|Treatment Period 1|Not Treated|0
4841509|NCT01021852|16690123|P6|Treatment Period 1|Not Treated|0
4841510|NCT01021852|16690124|P5|Treatment Period 1|Not Treated|0
4841511|NCT01021852|16690125|P4|Treatment Period 1|Not Treated|2
4841512|NCT01021852|16690126|P3|Treatment Period 1|Not Treated|0
4841513|NCT01021852|16690127|P2|Treatment Period 1|Not Treated|0
4841514|NCT01021852|16690128|P1|Treatment Period 1|Not Treated|0
4841515|NCT01021852|16690121|P8|Treatment Period 1|Withdrawal by Subject|1
4841516|NCT01021852|16690122|P7|Treatment Period 1|Withdrawal by Subject|0
4841517|NCT01021852|16690123|P6|Treatment Period 1|Withdrawal by Subject|0
4841518|NCT01021852|16690124|P5|Treatment Period 1|Withdrawal by Subject|1
4841519|NCT01021852|16690125|P4|Treatment Period 1|Withdrawal by Subject|0
4841520|NCT01021852|16690126|P3|Treatment Period 1|Withdrawal by Subject|0
4841521|NCT01021852|16690127|P2|Treatment Period 1|Withdrawal by Subject|0
4841522|NCT01021852|16690128|P1|Treatment Period 1|Withdrawal by Subject|0
4841523|NCT01021852|16690121|P8|Treatment Period 1|Pregnancy|0
4841524|NCT01021852|16690122|P7|Treatment Period 1|Pregnancy|0
4841525|NCT01021852|16690123|P6|Treatment Period 1|Pregnancy|0
4841526|NCT01021852|16690124|P5|Treatment Period 1|Pregnancy|0
4841527|NCT01021852|16690125|P4|Treatment Period 1|Pregnancy|0
4841528|NCT01021852|16690126|P3|Treatment Period 1|Pregnancy|1
4841529|NCT01021852|16690127|P2|Treatment Period 1|Pregnancy|0
4841530|NCT01021852|16690128|P1|Treatment Period 1|Pregnancy|0
4841531|NCT01021852|16690121|P8|Treatment Period 1|Adverse Event|0
4841532|NCT01021852|16690122|P7|Treatment Period 1|Adverse Event|0
4841533|NCT01021852|16690123|P6|Treatment Period 1|Adverse Event|2
4841534|NCT01021852|16690124|P5|Treatment Period 1|Adverse Event|2
4841535|NCT01021852|16690125|P4|Treatment Period 1|Adverse Event|0
4841536|NCT01021852|16690126|P3|Treatment Period 1|Adverse Event|1
4841537|NCT01021852|16690127|P2|Treatment Period 1|Adverse Event|1
4841538|NCT01021852|16690128|P1|Treatment Period 1|Adverse Event|3
4841539|NCT01021813|16690164|P5|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
4841540|NCT01021813|16690165|P4|DB Randomized Discontinuation Phase|Withdrawal by Subject|1
4841541|NCT01021813|16690166|P3|DB Randomized Discontinuation Phase|Withdrawal by Subject|3
4841542|NCT01021813|16690167|P2|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
4841543|NCT01021813|16690168|P1|DB Randomized Discontinuation Phase|Withdrawal by Subject|0
4841544|NCT01021813|16690164|P5|DB Randomized Discontinuation Phase|Protocol Violation|0
4841545|NCT01021813|16690165|P4|DB Randomized Discontinuation Phase|Protocol Violation|0
4841546|NCT01021813|16690166|P3|DB Randomized Discontinuation Phase|Protocol Violation|1
4841547|NCT01021813|16690167|P2|DB Randomized Discontinuation Phase|Protocol Violation|0
4841548|NCT01021813|16690168|P1|DB Randomized Discontinuation Phase|Protocol Violation|0
4841549|NCT01021813|16690164|P5|DB Randomized Discontinuation Phase|Lost to Follow-up|1
4841550|NCT01021813|16690165|P4|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4841551|NCT01021813|16690166|P3|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4841552|NCT01021813|16690167|P2|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4841553|NCT01021813|16690168|P1|DB Randomized Discontinuation Phase|Lost to Follow-up|0
4841554|NCT01021813|16690164|P5|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4841555|NCT01021813|16690165|P4|DB Randomized Discontinuation Phase|Lack of Efficacy|1
4841556|NCT01021813|16690166|P3|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4841557|NCT01021813|16690167|P2|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4841558|NCT01021813|16690168|P1|DB Randomized Discontinuation Phase|Lack of Efficacy|0
4841559|NCT01021813|16690164|P5|DB Randomized Discontinuation Phase|Adverse Event|1
4841560|NCT01021813|16690165|P4|DB Randomized Discontinuation Phase|Adverse Event|3
4841561|NCT01021813|16690166|P3|DB Randomized Discontinuation Phase|Adverse Event|0
4841562|NCT01021813|16690167|P2|DB Randomized Discontinuation Phase|Adverse Event|0
4841563|NCT01021813|16690168|P1|DB Randomized Discontinuation Phase|Adverse Event|0
4841564|NCT01021813|16690164|P5|DB Treatment Phase|Withdrawal by Subject|0
4841565|NCT01021813|16690165|P4|DB Treatment Phase|Withdrawal by Subject|0
4841566|NCT01021813|16690166|P3|DB Treatment Phase|Withdrawal by Subject|0
4841567|NCT01021813|16690167|P2|DB Treatment Phase|Withdrawal by Subject|24
4841568|NCT01021813|16690168|P1|DB Treatment Phase|Withdrawal by Subject|60
4841569|NCT01021813|16690164|P5|DB Treatment Phase|Protocol Violation|0
4841570|NCT01021813|16690165|P4|DB Treatment Phase|Protocol Violation|0
4841571|NCT01021813|16690166|P3|DB Treatment Phase|Protocol Violation|0
4841572|NCT01021813|16690167|P2|DB Treatment Phase|Protocol Violation|3
4841573|NCT01021813|16690168|P1|DB Treatment Phase|Protocol Violation|4
4841574|NCT01021813|16690164|P5|DB Treatment Phase|Pregnancy|0
4841575|NCT01021813|16690165|P4|DB Treatment Phase|Pregnancy|0
4841576|NCT01021813|16690166|P3|DB Treatment Phase|Pregnancy|0
4841577|NCT01021813|16690167|P2|DB Treatment Phase|Pregnancy|0
4841578|NCT01021813|16690168|P1|DB Treatment Phase|Pregnancy|1
4841579|NCT01021813|16690164|P5|DB Treatment Phase|Physician Decision|0
4841580|NCT01021813|16690165|P4|DB Treatment Phase|Physician Decision|0
4841581|NCT01021813|16690166|P3|DB Treatment Phase|Physician Decision|0
4841582|NCT01021813|16690167|P2|DB Treatment Phase|Physician Decision|8
4841583|NCT01021813|16690168|P1|DB Treatment Phase|Physician Decision|17
4841584|NCT01021813|16690164|P5|DB Treatment Phase|Lost to Follow-up|0
4841585|NCT01021813|16690165|P4|DB Treatment Phase|Lost to Follow-up|0
4841586|NCT01021813|16690166|P3|DB Treatment Phase|Lost to Follow-up|0
4841587|NCT01021813|16690167|P2|DB Treatment Phase|Lost to Follow-up|12
4841588|NCT01021813|16690168|P1|DB Treatment Phase|Lost to Follow-up|14
4841589|NCT01021813|16690164|P5|DB Treatment Phase|Lack of Efficacy|0
4841590|NCT01021813|16690165|P4|DB Treatment Phase|Lack of Efficacy|0
4841591|NCT01021813|16690166|P3|DB Treatment Phase|Lack of Efficacy|0
4841592|NCT01021813|16690167|P2|DB Treatment Phase|Lack of Efficacy|28
4841593|NCT01021813|16690168|P1|DB Treatment Phase|Lack of Efficacy|44
4841594|NCT01021813|16690164|P5|DB Treatment Phase|Adverse Event|0
4841595|NCT01021813|16690165|P4|DB Treatment Phase|Adverse Event|0
4841596|NCT01021813|16690166|P3|DB Treatment Phase|Adverse Event|0
4841597|NCT01021813|16690167|P2|DB Treatment Phase|Adverse Event|22
4841598|NCT01021813|16690168|P1|DB Treatment Phase|Adverse Event|60
4841599|NCT01021748|16690229|P9|Overall Study|Not Treated|0
4841600|NCT01021748|16690230|P8|Overall Study|Not Treated|0
4841601|NCT01021748|16690231|P7|Overall Study|Not Treated|0
4841602|NCT01021748|16690232|P6|Overall Study|Not Treated|0
4841603|NCT01021748|16690233|P5|Overall Study|Not Treated|0
4841604|NCT01021748|16690234|P4|Overall Study|Not Treated|0
4841605|NCT01021748|16690235|P3|Overall Study|Not Treated|0
4841606|NCT01021748|16690236|P2|Overall Study|Not Treated|1
4841607|NCT01021748|16690237|P1|Overall Study|Not Treated|0
4841608|NCT01021748|16690229|P9|Overall Study|Withdrawal by Subject|1
4841609|NCT01021748|16690230|P8|Overall Study|Withdrawal by Subject|0
4841610|NCT01021748|16690231|P7|Overall Study|Withdrawal by Subject|1
4841611|NCT01021748|16690232|P6|Overall Study|Withdrawal by Subject|0
4841612|NCT01021748|16690233|P5|Overall Study|Withdrawal by Subject|0
4841613|NCT01021748|16690234|P4|Overall Study|Withdrawal by Subject|0
4841614|NCT01021748|16690235|P3|Overall Study|Withdrawal by Subject|0
4841615|NCT01021748|16690236|P2|Overall Study|Withdrawal by Subject|0
4841616|NCT01021748|16690237|P1|Overall Study|Withdrawal by Subject|0
4841617|NCT01021748|16690229|P9|Overall Study|Progressive Disease|6
4841618|NCT01021748|16690230|P8|Overall Study|Progressive Disease|5
4841619|NCT01021748|16690231|P7|Overall Study|Progressive Disease|0
4841620|NCT01021748|16690232|P6|Overall Study|Progressive Disease|3
4841621|NCT01021748|16690233|P5|Overall Study|Progressive Disease|7
4841622|NCT01021748|16690234|P4|Overall Study|Progressive Disease|6
4841623|NCT01021748|16690235|P3|Overall Study|Progressive Disease|4
4841624|NCT01021748|16690236|P2|Overall Study|Progressive Disease|3
4841625|NCT01021748|16690237|P1|Overall Study|Progressive Disease|3
4841626|NCT01021748|16690229|P9|Overall Study|Physician Decision|2
4841627|NCT01021748|16690230|P8|Overall Study|Physician Decision|1
4841628|NCT01021748|16690231|P7|Overall Study|Physician Decision|1
4841629|NCT01021748|16690232|P6|Overall Study|Physician Decision|0
4841630|NCT01021748|16690233|P5|Overall Study|Physician Decision|0
4841631|NCT01021748|16690234|P4|Overall Study|Physician Decision|1
4841632|NCT01021748|16690235|P3|Overall Study|Physician Decision|1
4841633|NCT01021748|16690236|P2|Overall Study|Physician Decision|0
4841634|NCT01021748|16690237|P1|Overall Study|Physician Decision|1
4841635|NCT01021748|16690229|P9|Overall Study|Adverse Event|7
4841636|NCT01021748|16690230|P8|Overall Study|Adverse Event|0
4841637|NCT01021748|16690231|P7|Overall Study|Adverse Event|1
4841638|NCT01021748|16690232|P6|Overall Study|Adverse Event|0
4841639|NCT01021748|16690233|P5|Overall Study|Adverse Event|2
4841640|NCT01021748|16690234|P4|Overall Study|Adverse Event|0
4841641|NCT01021748|16690235|P3|Overall Study|Adverse Event|2
4841642|NCT01021748|16690236|P2|Overall Study|Adverse Event|1
4841643|NCT01021748|16690237|P1|Overall Study|Adverse Event|2
4841644|NCT01021683|16690284|P1|Overall Study|Other|8
4841645|NCT01021683|16690284|P1|Overall Study|Recovery of neutrophil count|51
4841646|NCT01021683|16690284|P1|Overall Study|Lack of Efficacy|12
4841647|NCT01021553|16690310|P3|Overall Study|Withdrawal by Subject|0
4841648|NCT01021553|16690311|P2|Overall Study|Withdrawal by Subject|1
4841649|NCT01021553|16690312|P1|Overall Study|Withdrawal by Subject|1
4841650|NCT01021553|16690310|P3|Overall Study|Lost to Follow-up|1
4841651|NCT01021553|16690311|P2|Overall Study|Lost to Follow-up|0
4841652|NCT01021553|16690312|P1|Overall Study|Lost to Follow-up|0
4841653|NCT01021553|16690310|P3|Overall Study|Protocol Violation|2
4841654|NCT01021553|16690311|P2|Overall Study|Protocol Violation|2
4841655|NCT01021553|16690312|P1|Overall Study|Protocol Violation|0
4841656|NCT01021553|16690310|P3|Overall Study|Lack of Efficacy|0
4841657|NCT01021553|16690311|P2|Overall Study|Lack of Efficacy|2
4841658|NCT01021553|16690312|P1|Overall Study|Lack of Efficacy|2
4841659|NCT01021553|16690310|P3|Overall Study|Adverse Event|0
4841660|NCT01021553|16690311|P2|Overall Study|Adverse Event|0
4841661|NCT01021553|16690312|P1|Overall Study|Adverse Event|1
4841662|NCT01021423|16690366|P2|Overall Study|Study terminated|5
4841663|NCT01021423|16690367|P1|Overall Study|Study terminated|4
4841664|NCT01021332|16690383|P1|Overall Study|Miscellaneous|3
4841665|NCT01021332|16690383|P1|Overall Study|Protocol Violation|9
4841666|NCT01021332|16690383|P1|Overall Study|Lost to Follow-up|4
4841667|NCT01021332|16690383|P1|Overall Study|Withdrawal of Consent|23
4841668|NCT01021332|16690383|P1|Overall Study|Lack of Efficacy|19
4841669|NCT01021332|16690383|P1|Overall Study|Adverse Event|43
4841670|NCT01021332|16690383|P1|Overall Study|Not fulfilling incl./excl.criteria|5
4841671|NCT01021293|16690444|P2|Overall Study|Lost to Follow-up|1
4841672|NCT01021293|16690445|P1|Overall Study|Lost to Follow-up|1
4841673|NCT01021293|16690444|P2|Overall Study|Migrated/moved from study area|18
4841674|NCT01021293|16690445|P1|Overall Study|Migrated/moved from study area|6
4841675|NCT01021293|16690444|P2|Overall Study|Withdrawal by Subject|3
4841676|NCT01021293|16690445|P1|Overall Study|Withdrawal by Subject|1
4841677|NCT01021293|16690444|P2|Overall Study|Adverse Event|1
4841678|NCT01021293|16690445|P1|Overall Study|Adverse Event|2
4841679|NCT01021293|16690444|P2|Overall Study|Serious Adverse Event|1
4841680|NCT01021293|16690445|P1|Overall Study|Serious Adverse Event|2
4841681|NCT01021215|16690464|P2|Overall Study|Lost to Follow-up|0
4841682|NCT01021215|16690465|P1|Overall Study|Lost to Follow-up|3
4841683|NCT01021137|16690479|P4|Overall Study|Withdrawal by Subject|3
4841684|NCT01021137|16690480|P3|Overall Study|Withdrawal by Subject|0
4841685|NCT01021137|16690481|P2|Overall Study|Withdrawal by Subject|0
4841686|NCT01021137|16690482|P1|Overall Study|Withdrawal by Subject|1
4841687|NCT01021137|16690479|P4|Overall Study|Lost to Follow-up|6
4841688|NCT01021137|16690480|P3|Overall Study|Lost to Follow-up|2
4841689|NCT01021137|16690481|P2|Overall Study|Lost to Follow-up|4
4841690|NCT01021137|16690482|P1|Overall Study|Lost to Follow-up|9
4841691|NCT01021020|16690525|P1|14 Day Washout Period A|Physician Decision|1
4841692|NCT01021020|16690525|P1|Period I|Withdrawal by Subject|1
4841693|NCT01021020|16690525|P1|Period I|Protocol Violation|1
4841694|NCT01021007|16690541|P2|Overall Study|Adverse Event|3
4841695|NCT01021007|16690542|P1|Overall Study|Adverse Event|1
4841696|NCT01021007|16690541|P2|Overall Study|Lost to Follow-up|1
4841697|NCT01021007|16690542|P1|Overall Study|Lost to Follow-up|1
4841698|NCT01020981|16690554|P2|Overall Study|Participant declined to complete survey|0
4841699|NCT01020981|16690555|P1|Overall Study|Participant declined to complete survey|2
4841700|NCT01020981|16690554|P2|Overall Study|Survey returned undeliverable|32
4841701|NCT01020981|16690555|P1|Overall Study|Survey returned undeliverable|8
4841702|NCT01020981|16690554|P2|Overall Study|Did not return mailed survey|58
4841703|NCT01020981|16690555|P1|Overall Study|Did not return mailed survey|74
4841704|NCT01020877|16690576|P2|Second Intervention|Withdrawal by Subject|0
4841705|NCT01020877|16690577|P1|Second Intervention|Withdrawal by Subject|1
4841706|NCT01020838|16690587|P1|Overall Study|Most common: Study ended by sponsor|77
4841707|NCT01020838|16690587|P1|Overall Study|Lost to Follow-up|6
4841708|NCT01020838|16690587|P1|Overall Study|Withdrawal by Subject|9
4841709|NCT01020838|16690587|P1|Overall Study|Adverse Event|1
4841710|NCT01020838|16690587|P1|Overall Study|Death|90
4841711|NCT01020812|16690602|P1|Overall Study|Protocol Violation|1
4841712|NCT01020812|16690602|P1|Overall Study|Withdrawal by Subject|1
4841713|NCT01020812|16690602|P1|Overall Study|Physician Decision|1
4841714|NCT01020799|16690612|P3|Overall Study|Lost to Follow-up|2
4841715|NCT01020799|16690613|P2|Overall Study|Lost to Follow-up|4
4841716|NCT01020799|16690614|P1|Overall Study|Lost to Follow-up|6
4841717|NCT01020799|16690612|P3|Overall Study|Withdrawal by Subject|3
4841718|NCT01020799|16690613|P2|Overall Study|Withdrawal by Subject|2
4841719|NCT01020799|16690614|P1|Overall Study|Withdrawal by Subject|2
4841720|NCT01020799|16690612|P3|Overall Study|Protocol Violation|0
4841721|NCT01020799|16690613|P2|Overall Study|Protocol Violation|2
4841722|NCT01020799|16690614|P1|Overall Study|Protocol Violation|3
4841723|NCT01020799|16690612|P3|Overall Study|non-compliance; lack of efficacy; etc.|0
4841724|NCT01020799|16690613|P2|Overall Study|non-compliance; lack of efficacy; etc.|3
4841725|NCT01020799|16690614|P1|Overall Study|non-compliance; lack of efficacy; etc.|4
4841726|NCT01020799|16690612|P3|Overall Study|Adverse Event|2
4841727|NCT01020799|16690613|P2|Overall Study|Adverse Event|3
4841728|NCT01020799|16690614|P1|Overall Study|Adverse Event|4
4841729|NCT01020786|16690637|P1|Maintenance Period|Sponsor Decision|1
4841730|NCT01020786|16690637|P1|Maintenance Period|Withdrawal by Subject|8
4841731|NCT01020786|16690637|P1|Maintenance Period|Progressive Disease|43
4841732|NCT01020786|16690637|P1|Maintenance Period|Adverse Event|8
4841733|NCT01020786|16690637|P1|Induction Period|Withdrawal by Subject|3
4841734|NCT01020786|16690637|P1|Induction Period|Investigator Decision|3
4841735|NCT01020786|16690637|P1|Induction Period|Progressive Disease|31
4841736|NCT01020786|16690637|P1|Induction Period|Adverse Event|10
4841737|NCT01020786|16690637|P1|Induction Period|Entry Criteria Not Met|2
4841738|NCT01020773|16690651|P2|Overall Study|Withdrawal by Subject|3
4841739|NCT01020773|16690652|P1|Overall Study|Withdrawal by Subject|4
4841740|NCT01020747|16690658|P1|Overall Study|Withdrawal by Subject|1
4841741|NCT01020526|16690674|P1|Overall Study|Adverse Event|2
4841742|NCT01020526|16690674|P1|Overall Study|Lost to Follow-up|1
4841743|NCT01020526|16690674|P1|Overall Study|Insufficient clinical response|3
4841744|NCT01020526|16690674|P1|Overall Study|Other reasons|3
4841745|NCT01020526|16690674|P1|Overall Study|Withdrawal by Subject|5
4841746|NCT01020474|16690680|P2|Overall Study|Insufficient Clinical Response|3
4841747|NCT01020474|16690681|P1|Overall Study|Insufficient Clinical Response|0
4841748|NCT01020474|16690680|P2|Overall Study|Other Reasons|1
4841749|NCT01020474|16690681|P1|Overall Study|Other Reasons|1
4841750|NCT01020474|16690680|P2|Overall Study|Withdrawal by Subject|7
4841751|NCT01020474|16690681|P1|Overall Study|Withdrawal by Subject|5
4841752|NCT01020474|16690680|P2|Overall Study|Protocol Violation|2
4841753|NCT01020474|16690681|P1|Overall Study|Protocol Violation|0
4841754|NCT01020474|16690680|P2|Overall Study|Adverse Event|4
4841755|NCT01020474|16690681|P1|Overall Study|Adverse Event|4
4841756|NCT01020448|16690701|P1|Treatment|Lost to Follow-up|2
4841757|NCT01020448|16690701|P1|Treatment|Lack of Efficacy|8
4841758|NCT01020448|16690701|P1|Treatment|Disease Progression|2
4841759|NCT01020448|16690701|P1|Treatment|Consent Withdrawn|3
4841760|NCT01020448|16690701|P1|Treatment|Adverse Event|11
4841761|NCT01020448|16690701|P1|Pre-assignment|Does Not Meet Entry Criteria|2
4841762|NCT01020448|16690701|P1|Pre-assignment|Withdrawal by Subject|5
4841763|NCT01020448|16690701|P1|Pre-assignment|Adverse Event|6
4841764|NCT01020435|16690712|P2|Overall Study|Lost to Follow-up|1
4841765|NCT01020435|16690713|P1|Overall Study|Lost to Follow-up|0
4841766|NCT01020305|16690721|P1|Overall Study|Adverse Event|2
4841767|NCT01020123|16690732|P7|Extention Period|Lost to Follow-up|0
4841768|NCT01020123|16690733|P6|Extention Period|Lost to Follow-up|2
4841769|NCT01020123|16690734|P5|Extention Period|Lost to Follow-up|0
4841770|NCT01020123|16690735|P4|Extention Period|Lost to Follow-up|0
4841771|NCT01020123|16690736|P3|Extention Period|Lost to Follow-up|0
4841772|NCT01020123|16690737|P2|Extention Period|Lost to Follow-up|0
4841773|NCT01020123|16690738|P1|Extention Period|Lost to Follow-up|0
4841774|NCT01020123|16690732|P7|Extention Period|Protocol Violation|1
4841775|NCT01020123|16690733|P6|Extention Period|Protocol Violation|0
4841776|NCT01020123|16690734|P5|Extention Period|Protocol Violation|0
4841777|NCT01020123|16690735|P4|Extention Period|Protocol Violation|0
4841778|NCT01020123|16690736|P3|Extention Period|Protocol Violation|1
4841779|NCT01020123|16690737|P2|Extention Period|Protocol Violation|1
4841780|NCT01020123|16690738|P1|Extention Period|Protocol Violation|1
4841781|NCT01020123|16690732|P7|Extention Period|Adverse Event|0
4841782|NCT01020123|16690733|P6|Extention Period|Adverse Event|0
4841783|NCT01020123|16690734|P5|Extention Period|Adverse Event|0
4841784|NCT01020123|16690735|P4|Extention Period|Adverse Event|1
4841785|NCT01020123|16690736|P3|Extention Period|Adverse Event|0
4841786|NCT01020123|16690737|P2|Extention Period|Adverse Event|0
4841787|NCT01020123|16690738|P1|Extention Period|Adverse Event|0
4841788|NCT01020123|16690732|P7|Extention Period|Withdrawal by Subject|0
4841789|NCT01020123|16690733|P6|Extention Period|Withdrawal by Subject|0
4841790|NCT01020123|16690734|P5|Extention Period|Withdrawal by Subject|0
4841791|NCT01020123|16690735|P4|Extention Period|Withdrawal by Subject|0
4841792|NCT01020123|16690736|P3|Extention Period|Withdrawal by Subject|1
4841793|NCT01020123|16690737|P2|Extention Period|Withdrawal by Subject|1
4841794|NCT01020123|16690738|P1|Extention Period|Withdrawal by Subject|2
4841795|NCT01020123|16690732|P7|Main Period|Unclasified|6
4841796|NCT01020123|16690733|P6|Main Period|Unclasified|3
4841797|NCT01020123|16690734|P5|Main Period|Unclasified|1
4841798|NCT01020123|16690735|P4|Main Period|Unclasified|0
4841799|NCT01020123|16690736|P3|Main Period|Unclasified|1
4841800|NCT01020123|16690737|P2|Main Period|Unclasified|0
4841801|NCT01020123|16690738|P1|Main Period|Unclasified|2
4841802|NCT01020123|16690732|P7|Main Period|Lost to Follow-up|0
4841803|NCT01020123|16690733|P6|Main Period|Lost to Follow-up|0
4841804|NCT01020123|16690734|P5|Main Period|Lost to Follow-up|0
4841805|NCT01020123|16690735|P4|Main Period|Lost to Follow-up|0
4841806|NCT01020123|16690736|P3|Main Period|Lost to Follow-up|0
4841807|NCT01020123|16690737|P2|Main Period|Lost to Follow-up|2
4841808|NCT01020123|16690738|P1|Main Period|Lost to Follow-up|0
4841809|NCT01020123|16690732|P7|Main Period|Protocol Violation|2
4841810|NCT01020123|16690733|P6|Main Period|Protocol Violation|3
4841811|NCT01020123|16690734|P5|Main Period|Protocol Violation|2
4841812|NCT01020123|16690735|P4|Main Period|Protocol Violation|5
4841813|NCT01020123|16690736|P3|Main Period|Protocol Violation|2
4841814|NCT01020123|16690737|P2|Main Period|Protocol Violation|4
4841815|NCT01020123|16690738|P1|Main Period|Protocol Violation|4
4841816|NCT01020123|16690732|P7|Main Period|Adverse Event|1
4841817|NCT01020123|16690733|P6|Main Period|Adverse Event|2
4841818|NCT01020123|16690734|P5|Main Period|Adverse Event|1
4841819|NCT01020123|16690735|P4|Main Period|Adverse Event|1
4841820|NCT01020123|16690736|P3|Main Period|Adverse Event|2
4841821|NCT01020123|16690737|P2|Main Period|Adverse Event|2
4841822|NCT01020123|16690738|P1|Main Period|Adverse Event|5
4841823|NCT01020123|16690732|P7|Main Period|Eligibility Criteria not fullfilled|0
4841824|NCT01020123|16690733|P6|Main Period|Eligibility Criteria not fullfilled|0
4841825|NCT01020123|16690734|P5|Main Period|Eligibility Criteria not fullfilled|1
4841826|NCT01020123|16690735|P4|Main Period|Eligibility Criteria not fullfilled|0
4841827|NCT01020123|16690736|P3|Main Period|Eligibility Criteria not fullfilled|0
4841828|NCT01020123|16690737|P2|Main Period|Eligibility Criteria not fullfilled|1
4841829|NCT01020123|16690738|P1|Main Period|Eligibility Criteria not fullfilled|0
4841830|NCT01020123|16690732|P7|Main Period|Withdrawal by Subject|2
4841831|NCT01020123|16690733|P6|Main Period|Withdrawal by Subject|3
4841832|NCT01020123|16690734|P5|Main Period|Withdrawal by Subject|6
4841833|NCT01020123|16690735|P4|Main Period|Withdrawal by Subject|1
4841834|NCT01020123|16690736|P3|Main Period|Withdrawal by Subject|3
4841835|NCT01020123|16690737|P2|Main Period|Withdrawal by Subject|5
4841836|NCT01020123|16690738|P1|Main Period|Withdrawal by Subject|6
4841837|NCT01020019|16690933|P2|Overall Study|moving|2
4841838|NCT01020019|16690934|P1|Overall Study|moving|0
4841839|NCT01020019|16690933|P2|Overall Study|not interested in treatment|4
4841840|NCT01020019|16690934|P1|Overall Study|not interested in treatment|4
4841841|NCT01020019|16690933|P2|Overall Study|Adverse Event|5
4841842|NCT01020019|16690934|P1|Overall Study|Adverse Event|1
4841843|NCT01020019|16690933|P2|Overall Study|Lost to Follow-up|18
4841844|NCT01020019|16690934|P1|Overall Study|Lost to Follow-up|21
4841845|NCT01019980|16690955|P2|Overall Study|Drug not available.|0
4841846|NCT01019980|16690956|P1|Overall Study|Drug not available.|2
4841847|NCT01019694|16691019|P3|Overall Study|Other reason (not specified)|6
4841848|NCT01019694|16691020|P2|Overall Study|Other reason (not specified)|5
4841849|NCT01019694|16691021|P1|Overall Study|Other reason (not specified)|1
4841850|NCT01019694|16691019|P3|Overall Study|Not treated|3
4841851|NCT01019694|16691020|P2|Overall Study|Not treated|2
4841852|NCT01019694|16691021|P1|Overall Study|Not treated|0
4841853|NCT01019694|16691019|P3|Overall Study|Withdrawal by Subject|12
4841854|NCT01019694|16691020|P2|Overall Study|Withdrawal by Subject|6
4841855|NCT01019694|16691021|P1|Overall Study|Withdrawal by Subject|4
4841856|NCT01019694|16691019|P3|Overall Study|Lost to Follow-up|3
4841857|NCT01019694|16691020|P2|Overall Study|Lost to Follow-up|3
4841858|NCT01019694|16691021|P1|Overall Study|Lost to Follow-up|5
4841859|NCT01019694|16691019|P3|Overall Study|Protocol Violation|4
4841860|NCT01019694|16691020|P2|Overall Study|Protocol Violation|6
4841861|NCT01019694|16691021|P1|Overall Study|Protocol Violation|2
4841862|NCT01019694|16691019|P3|Overall Study|Adverse Event|19
4841863|NCT01019694|16691020|P2|Overall Study|Adverse Event|16
4841864|NCT01019694|16691021|P1|Overall Study|Adverse Event|12
4841865|NCT01019486|16691146|P3|Overall Study|Withdrawal by Subject|1
4841866|NCT01019486|16691147|P2|Overall Study|Withdrawal by Subject|1
4841867|NCT01019486|16691148|P1|Overall Study|Withdrawal by Subject|1
4841868|NCT01019369|16691162|P2|Overall Study|Withdrawal by Subject|1
4841869|NCT01019369|16691163|P1|Overall Study|Withdrawal by Subject|0
4841870|NCT01019369|16691162|P2|Overall Study|Lost to Follow-up|6
4841871|NCT01019369|16691163|P1|Overall Study|Lost to Follow-up|10
4841872|NCT01019317|16691179|P1|Overall Study|Not Eligible|4
4841873|NCT01019252|16691185|P2|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5
4841874|NCT01019252|16691186|P1|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0
4841875|NCT01019252|16691185|P2|Wait List Cross-over to CBT for ADHD|Time constraints|2
4841876|NCT01019252|16691186|P1|Wait List Cross-over to CBT for ADHD|Time constraints|0
4841877|NCT01019252|16691185|P2|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0
4841878|NCT01019252|16691186|P1|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1
4841879|NCT01019252|16691185|P2|Initial CBT for ADHD vs. Wait List|Time constraints|0
4841880|NCT01019252|16691186|P1|Initial CBT for ADHD vs. Wait List|Time constraints|2
4841881|NCT01019135|16691199|P3|Overall Study|Did not attend CR|6
4841882|NCT01019135|16691200|P2|Overall Study|Did not attend CR|13
4841883|NCT01019135|16691201|P1|Overall Study|Did not attend CR|8
4841884|NCT01019135|16691199|P3|Overall Study|Did not receive allocated intervention|25
4841885|NCT01019135|16691200|P2|Overall Study|Did not receive allocated intervention|6
4841886|NCT01019135|16691201|P1|Overall Study|Did not receive allocated intervention|12
4841887|NCT01018992|16691229|P2|Overall Study|Lost to Follow-up|1
4841888|NCT01018992|16691230|P1|Overall Study|Lost to Follow-up|5
4841889|NCT01018992|16691229|P2|Overall Study|Protocol Violation|4
4841890|NCT01018992|16691230|P1|Overall Study|Protocol Violation|0
4841891|NCT01018992|16691229|P2|Overall Study|Withdrawal by Subject|8
4841892|NCT01018992|16691230|P1|Overall Study|Withdrawal by Subject|3
4841893|NCT01018992|16691229|P2|Overall Study|Adverse Event|3
4841894|NCT01018992|16691230|P1|Overall Study|Adverse Event|8
4841895|NCT01018979|16691244|P2|Overall Study|Not received at least one dose|1
4841896|NCT01018979|16691245|P1|Overall Study|Not received at least one dose|0
4841897|NCT01018979|16691244|P2|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9
4841898|NCT01018979|16691245|P1|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3
4841899|NCT01018953|16691275|P1|Overall Study|Study termination by sponsor|5
4841900|NCT01018953|16691275|P1|Overall Study|Withdrawal by Subject|1
4841901|NCT01018953|16691275|P1|Overall Study|Adverse Event|2
4841902|NCT01018862|16691288|P3|Overall Study|administrative problems|4
4841903|NCT01018862|16691289|P2|Overall Study|administrative problems|4
4841904|NCT01018862|16691290|P1|Overall Study|administrative problems|5
4841905|NCT01018862|16691288|P3|Overall Study|Withdrawal by Subject|1
4841906|NCT01018862|16691289|P2|Overall Study|Withdrawal by Subject|2
4841907|NCT01018862|16691290|P1|Overall Study|Withdrawal by Subject|1
4841908|NCT01018862|16691288|P3|Overall Study|Protocol Violation|3
4841909|NCT01018862|16691289|P2|Overall Study|Protocol Violation|3
4841910|NCT01018862|16691290|P1|Overall Study|Protocol Violation|1
4841911|NCT01018862|16691288|P3|Overall Study|Lost to Follow-up|0
4841912|NCT01018862|16691289|P2|Overall Study|Lost to Follow-up|1
4841913|NCT01018862|16691290|P1|Overall Study|Lost to Follow-up|3
4841914|NCT01018862|16691288|P3|Overall Study|Lack of Efficacy|2
4841915|NCT01018862|16691289|P2|Overall Study|Lack of Efficacy|0
4841916|NCT01018862|16691290|P1|Overall Study|Lack of Efficacy|1
4841917|NCT01018862|16691288|P3|Overall Study|Adverse Event|6
4841918|NCT01018862|16691289|P2|Overall Study|Adverse Event|0
4841919|NCT01018862|16691290|P1|Overall Study|Adverse Event|2
4841920|NCT01018810|16691312|P5|Overall Study|Sponsor Decision|1
4841921|NCT01018810|16691313|P4|Overall Study|Sponsor Decision|1
4841922|NCT01018810|16691314|P3|Overall Study|Sponsor Decision|1
4841923|NCT01018810|16691315|P2|Overall Study|Sponsor Decision|0
4841924|NCT01018810|16691316|P1|Overall Study|Sponsor Decision|2
4841925|NCT01018810|16691312|P5|Overall Study|Withdrawal by Subject|0
4841926|NCT01018810|16691313|P4|Overall Study|Withdrawal by Subject|0
4841927|NCT01018810|16691314|P3|Overall Study|Withdrawal by Subject|0
4841928|NCT01018810|16691315|P2|Overall Study|Withdrawal by Subject|1
4841929|NCT01018810|16691316|P1|Overall Study|Withdrawal by Subject|0
4841930|NCT01018732|16691376|P3|Overall Study|Unable to Classify|1
4841931|NCT01018732|16691377|P2|Overall Study|Unable to Classify|0
4841932|NCT01018732|16691378|P1|Overall Study|Unable to Classify|0
4841933|NCT01018732|16691376|P3|Overall Study|Inappropriate Enrollment|0
4841934|NCT01018732|16691377|P2|Overall Study|Inappropriate Enrollment|1
4841935|NCT01018732|16691378|P1|Overall Study|Inappropriate Enrollment|0
4841936|NCT01018732|16691376|P3|Overall Study|Protocol Violation|0
4841937|NCT01018732|16691377|P2|Overall Study|Protocol Violation|1
4841938|NCT01018732|16691378|P1|Overall Study|Protocol Violation|1
4841939|NCT01018732|16691376|P3|Overall Study|Lost to Follow-up|3
4841940|NCT01018732|16691377|P2|Overall Study|Lost to Follow-up|0
4841941|NCT01018732|16691378|P1|Overall Study|Lost to Follow-up|0
4841942|NCT01018680|16691412|P2|Overall Study|Physician Decision|1
4841943|NCT01018680|16691413|P1|Overall Study|Physician Decision|3
4841944|NCT01018680|16691412|P2|Overall Study|Entry Criteria Not Met|4
4841945|NCT01018680|16691413|P1|Overall Study|Entry Criteria Not Met|1
4841946|NCT01018680|16691412|P2|Overall Study|Lost to Follow-up|3
4841947|NCT01018680|16691413|P1|Overall Study|Lost to Follow-up|5
4841948|NCT01018680|16691412|P2|Overall Study|Lack of Efficacy|2
4841949|NCT01018680|16691413|P1|Overall Study|Lack of Efficacy|8
4841950|NCT01018680|16691412|P2|Overall Study|Sponsor Decision|7
4841951|NCT01018680|16691413|P1|Overall Study|Sponsor Decision|6
4841952|NCT01018680|16691412|P2|Overall Study|Protocol Violation|8
4841953|NCT01018680|16691413|P1|Overall Study|Protocol Violation|5
4841954|NCT01018680|16691412|P2|Overall Study|Withdrawal by Subject|10
4841955|NCT01018680|16691413|P1|Overall Study|Withdrawal by Subject|10
4841956|NCT01018680|16691412|P2|Overall Study|Adverse Event|40
4841957|NCT01018680|16691413|P1|Overall Study|Adverse Event|23
4841958|NCT01020487|16691456|P3|Part 2 Open-label Period|Adverse Event|1
4841959|NCT01020487|16691457|P2|Part 2 Open-label Period|Adverse Event|4
4841960|NCT01020487|16691458|P1|Part 2 Open-label Period|Adverse Event|0
4841961|NCT01020487|16691456|P3|Part 2 Double-blind Treatment Period|Randomized in Error|1
4841962|NCT01020487|16691457|P2|Part 2 Double-blind Treatment Period|Randomized in Error|0
4841963|NCT01020487|16691458|P1|Part 2 Double-blind Treatment Period|Randomized in Error|0
4841964|NCT01020487|16691456|P3|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3
4841965|NCT01020487|16691457|P2|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
4841966|NCT01020487|16691458|P1|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0
4841967|NCT01020487|16691456|P3|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1
4841968|NCT01020487|16691457|P2|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
4841969|NCT01020487|16691458|P1|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0
4841970|NCT01020487|16691456|P3|Part 2 Double-blind Treatment Period|Adverse Event|1
4841971|NCT01020487|16691457|P2|Part 2 Double-blind Treatment Period|Adverse Event|2
4841972|NCT01020487|16691458|P1|Part 2 Double-blind Treatment Period|Adverse Event|0
4841973|NCT01018511|16691483|P4|Overall Study|Miscellaneous|0
4841974|NCT01018511|16691484|P3|Overall Study|Miscellaneous|0
4841975|NCT01018511|16691485|P2|Overall Study|Miscellaneous|2
4841976|NCT01018511|16691486|P1|Overall Study|Miscellaneous|0
4841977|NCT01018511|16691483|P4|Overall Study|Protocol Violation|9
4841978|NCT01018511|16691484|P3|Overall Study|Protocol Violation|7
4841979|NCT01018511|16691485|P2|Overall Study|Protocol Violation|8
4841980|NCT01018511|16691486|P1|Overall Study|Protocol Violation|5
4841981|NCT01018511|16691483|P4|Overall Study|Lost to Follow-up|0
4841982|NCT01018511|16691484|P3|Overall Study|Lost to Follow-up|1
4841983|NCT01018511|16691485|P2|Overall Study|Lost to Follow-up|0
4841984|NCT01018511|16691486|P1|Overall Study|Lost to Follow-up|0
4841985|NCT01018511|16691483|P4|Overall Study|Withdrawal by Subject|9
4841986|NCT01018511|16691484|P3|Overall Study|Withdrawal by Subject|11
4841987|NCT01018511|16691485|P2|Overall Study|Withdrawal by Subject|5
4841988|NCT01018511|16691486|P1|Overall Study|Withdrawal by Subject|6
4841989|NCT01018511|16691483|P4|Overall Study|Lack of Efficacy|2
4841990|NCT01018511|16691484|P3|Overall Study|Lack of Efficacy|1
4841991|NCT01018511|16691485|P2|Overall Study|Lack of Efficacy|1
4841992|NCT01018511|16691486|P1|Overall Study|Lack of Efficacy|4
4841993|NCT01018511|16691483|P4|Overall Study|Adverse Event|10
4841994|NCT01018511|16691484|P3|Overall Study|Adverse Event|13
4841995|NCT01018511|16691485|P2|Overall Study|Adverse Event|9
4841996|NCT01018511|16691486|P1|Overall Study|Adverse Event|5
4841997|NCT01018511|16691483|P4|Overall Study|Not fulfilling eligibility criteria|3
4841998|NCT01018511|16691484|P3|Overall Study|Not fulfilling eligibility criteria|7
4841999|NCT01018511|16691485|P2|Overall Study|Not fulfilling eligibility criteria|7
4842000|NCT01018511|16691486|P1|Overall Study|Not fulfilling eligibility criteria|6
4842001|NCT01018394|16691683|P2|Overall Study|Lost to Follow-up|3
4842002|NCT01018394|16691684|P1|Overall Study|Lost to Follow-up|4
4842003|NCT01018394|16691683|P2|Overall Study|Withdrawal by Subject|5
4842004|NCT01018394|16691684|P1|Overall Study|Withdrawal by Subject|5
4842005|NCT01018264|16691694|P2|Overall Study|Lost to Follow-up|1
4842006|NCT01018264|16691695|P1|Overall Study|Lost to Follow-up|0
4842007|NCT01018264|16691694|P2|Overall Study|Withdrawal by Subject|0
4842008|NCT01018264|16691695|P1|Overall Study|Withdrawal by Subject|1
4842009|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Withdrawal by Subject|9
4842010|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|7
4842011|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|10
4842012|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
4842013|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Physician Decision|3
4842014|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Physician Decision|0
4842015|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Physician Decision|1
4842016|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Physician Decision|0
4842017|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Lost to Follow-up|4
4842018|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Lost to Follow-up|3
4842019|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Lost to Follow-up|1
4842020|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
4842021|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4
4842022|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16
4842023|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14
4842024|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0
4842025|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Protocol Violation|2
4842026|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Protocol Violation|8
4842027|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Protocol Violation|8
4842028|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Protocol Violation|0
4842029|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Lack of Efficacy|1
4842030|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Lack of Efficacy|4
4842031|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Lack of Efficacy|1
4842032|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
4842033|NCT01018186|16691712|P4|52-week Double-blind Treatment Period|Adverse Event|6
4842034|NCT01018186|16691713|P3|52-week Double-blind Treatment Period|Adverse Event|3
4842035|NCT01018186|16691714|P2|52-week Double-blind Treatment Period|Adverse Event|5
4842036|NCT01018186|16691715|P1|52-week Double-blind Treatment Period|Adverse Event|0
4842037|NCT01018186|16691712|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4842038|NCT01018186|16691713|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4842039|NCT01018186|16691714|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4842040|NCT01018186|16691715|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|97
4842041|NCT01018186|16691712|P4|2-week Run-in Period|Withdrawal by Subject|0
4842042|NCT01018186|16691713|P3|2-week Run-in Period|Withdrawal by Subject|0
4842043|NCT01018186|16691714|P2|2-week Run-in Period|Withdrawal by Subject|0
4842044|NCT01018186|16691715|P1|2-week Run-in Period|Withdrawal by Subject|11
4842045|NCT01018186|16691712|P4|2-week Run-in Period|Physician Decision|0
4842046|NCT01018186|16691713|P3|2-week Run-in Period|Physician Decision|0
4842047|NCT01018186|16691714|P2|2-week Run-in Period|Physician Decision|0
4842048|NCT01018186|16691715|P1|2-week Run-in Period|Physician Decision|3
4842049|NCT01018186|16691712|P4|2-week Run-in Period|Lost to Follow-up|0
4842050|NCT01018186|16691713|P3|2-week Run-in Period|Lost to Follow-up|0
4842051|NCT01018186|16691714|P2|2-week Run-in Period|Lost to Follow-up|0
4842052|NCT01018186|16691715|P1|2-week Run-in Period|Lost to Follow-up|2
4842053|NCT01018186|16691712|P4|2-week Run-in Period|Protocol Violation|0
4842054|NCT01018186|16691713|P3|2-week Run-in Period|Protocol Violation|0
4842055|NCT01018186|16691714|P2|2-week Run-in Period|Protocol Violation|0
4842056|NCT01018186|16691715|P1|2-week Run-in Period|Protocol Violation|1
4842057|NCT01018030|16691916|P3|Overall Study|Did Not Receive Study Drug|0
4842058|NCT01018030|16691917|P2|Overall Study|Did Not Receive Study Drug|3
4842059|NCT01018030|16691918|P1|Overall Study|Did Not Receive Study Drug|1
4842060|NCT01018030|16691916|P3|Overall Study|Lack of Efficacy|0
4842061|NCT01018030|16691917|P2|Overall Study|Lack of Efficacy|0
4842062|NCT01018030|16691918|P1|Overall Study|Lack of Efficacy|1
4842063|NCT01018030|16691916|P3|Overall Study|Physician Decision|1
4842064|NCT01018030|16691917|P2|Overall Study|Physician Decision|0
4842065|NCT01018030|16691918|P1|Overall Study|Physician Decision|1
4842066|NCT01018030|16691916|P3|Overall Study|Protocol Violation|0
4842067|NCT01018030|16691917|P2|Overall Study|Protocol Violation|1
4842068|NCT01018030|16691918|P1|Overall Study|Protocol Violation|2
4842069|NCT01018030|16691916|P3|Overall Study|Lost to Follow-up|3
4842070|NCT01018030|16691917|P2|Overall Study|Lost to Follow-up|0
4842071|NCT01018030|16691918|P1|Overall Study|Lost to Follow-up|2
4842072|NCT01018030|16691916|P3|Overall Study|Withdrawal by Subject|4
4842073|NCT01018030|16691917|P2|Overall Study|Withdrawal by Subject|2
4842074|NCT01018030|16691918|P1|Overall Study|Withdrawal by Subject|2
4842075|NCT01018030|16691916|P3|Overall Study|Adverse Event|5
4842076|NCT01018030|16691917|P2|Overall Study|Adverse Event|5
4842077|NCT01018030|16691918|P1|Overall Study|Adverse Event|10
4842078|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Physician Decision|7
4842079|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Physician Decision|9
4842080|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Physician Decision|8
4842081|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Physician Decision|10
4842082|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Physician Decision|0
4842083|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|10
4842084|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
4842085|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|8
4842086|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|6
4842087|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
4842088|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4842089|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4842090|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
4842091|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
4842092|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4842093|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9
4842094|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12
4842095|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
4842096|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11
4842097|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4842098|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Protocol Violation|8
4842099|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Protocol Violation|9
4842100|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Protocol Violation|11
4842101|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Protocol Violation|7
4842102|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
4842103|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|14
4842104|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|16
4842105|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|14
4842185|NCT01017146|16692226|P2|Overall Study|Change in Work Situation|0
4842106|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|35
4842107|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
4842108|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
4842109|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|25
4842110|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
4842111|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|30
4842112|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
4842113|NCT01017952|16691969|P5|52-week, Double-blind Treatment Period|Adverse Event|30
4842114|NCT01017952|16691970|P4|52-week, Double-blind Treatment Period|Adverse Event|35
4842115|NCT01017952|16691971|P3|52-week, Double-blind Treatment Period|Adverse Event|32
4842116|NCT01017952|16691972|P2|52-week, Double-blind Treatment Period|Adverse Event|25
4842117|NCT01017952|16691973|P1|52-week, Double-blind Treatment Period|Adverse Event|0
4842118|NCT01017952|16691969|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4842119|NCT01017952|16691970|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4842120|NCT01017952|16691971|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4842121|NCT01017952|16691972|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4842122|NCT01017952|16691973|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|63
4842123|NCT01017952|16691969|P5|4-week, Open-label Run-In Period|Physician Decision|0
4842124|NCT01017952|16691970|P4|4-week, Open-label Run-In Period|Physician Decision|0
4842125|NCT01017952|16691971|P3|4-week, Open-label Run-In Period|Physician Decision|0
4842126|NCT01017952|16691972|P2|4-week, Open-label Run-In Period|Physician Decision|0
4842127|NCT01017952|16691973|P1|4-week, Open-label Run-In Period|Physician Decision|10
4842128|NCT01017952|16691969|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
4842129|NCT01017952|16691970|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
4842130|NCT01017952|16691971|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
4842131|NCT01017952|16691972|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
4842132|NCT01017952|16691973|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
4842133|NCT01017952|16691969|P5|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4842134|NCT01017952|16691970|P4|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4842135|NCT01017952|16691971|P3|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4842136|NCT01017952|16691972|P2|4-week, Open-label Run-In Period|Study Closed/Tterminated|0
4842137|NCT01017952|16691973|P1|4-week, Open-label Run-In Period|Study Closed/Tterminated|1
4842138|NCT01017952|16691969|P5|4-week, Open-label Run-In Period|Adverse Event|0
4842139|NCT01017952|16691970|P4|4-week, Open-label Run-In Period|Adverse Event|0
4842140|NCT01017952|16691971|P3|4-week, Open-label Run-In Period|Adverse Event|0
4842141|NCT01017952|16691972|P2|4-week, Open-label Run-In Period|Adverse Event|0
4842142|NCT01017952|16691973|P1|4-week, Open-label Run-In Period|Adverse Event|23
4842143|NCT01017952|16691969|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4842144|NCT01017952|16691970|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4842145|NCT01017952|16691971|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4842146|NCT01017952|16691972|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4842147|NCT01017952|16691973|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356
4842148|NCT01017874|16691997|P2|Overall Study|Physician Decision|3
4842149|NCT01017874|16691998|P1|Overall Study|Physician Decision|1
4842150|NCT01017874|16691997|P2|Overall Study|Lost to Follow-up|2
4842151|NCT01017874|16691998|P1|Overall Study|Lost to Follow-up|3
4842152|NCT01017874|16691997|P2|Overall Study|Sponsor decision|1
4842153|NCT01017874|16691998|P1|Overall Study|Sponsor decision|3
4842154|NCT01017874|16691997|P2|Overall Study|Withdrawal by Subject|20
4842155|NCT01017874|16691998|P1|Overall Study|Withdrawal by Subject|23
4842156|NCT01017731|16692016|P1|Overall Study|Adverse Event|1
4842157|NCT01017731|16692016|P1|Overall Study|Physician Decision|2
4842158|NCT01017731|16692016|P1|Overall Study|Withdrawal by Subject|3
4842159|NCT01017731|16692016|P1|Overall Study|Lost to Follow-up|2
4842160|NCT01017601|16692045|P2|Overall Study|Withdrawal by Subject|1
4842161|NCT01017601|16692046|P1|Overall Study|Withdrawal by Subject|0
4842162|NCT01017601|16692045|P2|Overall Study|Disease Progression|12
4842163|NCT01017601|16692046|P1|Overall Study|Disease Progression|12
4842164|NCT01017575|16692073|P5|Overall Study|Withdrawal by Subject|0
4842165|NCT01017575|16692074|P4|Overall Study|Withdrawal by Subject|0
4842166|NCT01017575|16692075|P3|Overall Study|Withdrawal by Subject|0
4842167|NCT01017575|16692076|P2|Overall Study|Withdrawal by Subject|0
4842168|NCT01017575|16692077|P1|Overall Study|Withdrawal by Subject|1
4842169|NCT01017575|16692073|P5|Overall Study|Adverse Event|2
4842170|NCT01017575|16692074|P4|Overall Study|Adverse Event|0
4842171|NCT01017575|16692075|P3|Overall Study|Adverse Event|0
4842172|NCT01017575|16692076|P2|Overall Study|Adverse Event|1
4842173|NCT01017575|16692077|P1|Overall Study|Adverse Event|0
4842174|NCT01017575|16692073|P5|Overall Study|Lack of Efficacy|1
4842175|NCT01017575|16692074|P4|Overall Study|Lack of Efficacy|1
4842176|NCT01017575|16692075|P3|Overall Study|Lack of Efficacy|0
4842177|NCT01017575|16692076|P2|Overall Study|Lack of Efficacy|1
4842178|NCT01017575|16692077|P1|Overall Study|Lack of Efficacy|0
4842179|NCT01017549|16692114|P1|5 Year Follow-up|Mastectomy|3
4842180|NCT01017549|16692114|P1|5 Year Follow-up|Lost to Follow-up|9
4842181|NCT01017549|16692114|P1|One-year Follow-up|Withdrawal by Subject|5
4842182|NCT01017549|16692114|P1|One-year Follow-up|Lost to Follow-up|2
4842183|NCT01017549|16692114|P1|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1
4842184|NCT01017263|16692145|P1|Overall Study|not eligible|12
4842186|NCT01017146|16692227|P1|Overall Study|Change in Work Situation|1
4842187|NCT01017146|16692226|P2|Overall Study|Did Not Meet Eligibility Criteria|2
4842188|NCT01017146|16692227|P1|Overall Study|Did Not Meet Eligibility Criteria|1
4842189|NCT01017146|16692226|P2|Overall Study|Took Excluded Medication|0
4842190|NCT01017146|16692227|P1|Overall Study|Took Excluded Medication|2
4842191|NCT01017146|16692226|P2|Overall Study|Protocol Violation|0
4842192|NCT01017146|16692227|P1|Overall Study|Protocol Violation|2
4842193|NCT01017146|16692226|P2|Overall Study|Pregnancy|1
4842194|NCT01017146|16692227|P1|Overall Study|Pregnancy|2
4842195|NCT01017146|16692226|P2|Overall Study|Relocation|4
4842196|NCT01017146|16692227|P1|Overall Study|Relocation|0
4842197|NCT01017146|16692226|P2|Overall Study|Withdrawal by Subject|16
4842198|NCT01017146|16692227|P1|Overall Study|Withdrawal by Subject|32
4842199|NCT01017146|16692226|P2|Overall Study|Noncompliance with Study Product|1
4842200|NCT01017146|16692227|P1|Overall Study|Noncompliance with Study Product|1
4842201|NCT01017146|16692226|P2|Overall Study|Lost to Follow-up|14
4842202|NCT01017146|16692227|P1|Overall Study|Lost to Follow-up|14
4842203|NCT01017146|16692226|P2|Overall Study|Adverse Event|1
4842204|NCT01017146|16692227|P1|Overall Study|Adverse Event|11
4842205|NCT01017120|16692265|P2|Overall Study|Parent Unable to Provide Transportation|0
4842206|NCT01017120|16692266|P1|Overall Study|Parent Unable to Provide Transportation|1
4842207|NCT01017120|16692265|P2|Overall Study|Protocol Violation|0
4842208|NCT01017120|16692266|P1|Overall Study|Protocol Violation|1
4842209|NCT01017120|16692265|P2|Overall Study|Relocated Out of Town|2
4842210|NCT01017120|16692266|P1|Overall Study|Relocated Out of Town|0
4842211|NCT01017120|16692265|P2|Overall Study|Did Not Meet Eligibility Criteria|0
4842212|NCT01017120|16692266|P1|Overall Study|Did Not Meet Eligibility Criteria|1
4842213|NCT01017120|16692265|P2|Overall Study|Pregnancy|1
4842214|NCT01017120|16692266|P1|Overall Study|Pregnancy|1
4842215|NCT01017120|16692265|P2|Overall Study|Withdrawal by Subject|21
4842216|NCT01017120|16692266|P1|Overall Study|Withdrawal by Subject|39
4842217|NCT01017120|16692265|P2|Overall Study|Lack of Efficacy|0
4842218|NCT01017120|16692266|P1|Overall Study|Lack of Efficacy|1
4842219|NCT01017120|16692265|P2|Overall Study|Lost to Follow-up|11
4842220|NCT01017120|16692266|P1|Overall Study|Lost to Follow-up|13
4842221|NCT01017120|16692265|P2|Overall Study|Adverse Event|0
4842222|NCT01017120|16692266|P1|Overall Study|Adverse Event|9
4842223|NCT01017029|16692327|P2|Overall Study|Death|1
4842224|NCT01017029|16692328|P1|Overall Study|Death|3
4842225|NCT01017029|16692327|P2|Overall Study|Administrative problem|1
4842226|NCT01017029|16692328|P1|Overall Study|Administrative problem|0
4842227|NCT01017029|16692327|P2|Overall Study|Lost to Follow-up|0
4842228|NCT01017029|16692328|P1|Overall Study|Lost to Follow-up|1
4842229|NCT01016977|16692356|P2|Overall Study|Withdrawal by Subject|2
4842230|NCT01016977|16692357|P1|Overall Study|Withdrawal by Subject|2
4842231|NCT01016977|16692356|P2|Overall Study|Lost to Follow-up|0
4842232|NCT01016977|16692357|P1|Overall Study|Lost to Follow-up|1
4842233|NCT01016964|16692393|P2|Overall Study|Lost to Follow-up|3
4842234|NCT01016964|16692394|P1|Overall Study|Lost to Follow-up|3
4842235|NCT01016912|16692410|P5|Follow-up Period|Other reason|0
4842236|NCT01016912|16692411|P4|Follow-up Period|Other reason|1
4842237|NCT01016912|16692412|P3|Follow-up Period|Other reason|1
4842238|NCT01016912|16692413|P2|Follow-up Period|Other reason|0
4842239|NCT01016912|16692414|P1|Follow-up Period|Other reason|0
4842240|NCT01016912|16692410|P5|End of Treatment Period|Completed double-blind period only|0
4842241|NCT01016912|16692411|P4|End of Treatment Period|Completed double-blind period only|0
4842242|NCT01016912|16692412|P3|End of Treatment Period|Completed double-blind period only|0
4842243|NCT01016912|16692413|P2|End of Treatment Period|Completed double-blind period only|1
4842244|NCT01016912|16692414|P1|End of Treatment Period|Completed double-blind period only|0
4842245|NCT01016912|16692410|P5|End of Treatment Period|Adverse Event|0
4842246|NCT01016912|16692411|P4|End of Treatment Period|Adverse Event|0
4842247|NCT01016912|16692412|P3|End of Treatment Period|Adverse Event|1
4842248|NCT01016912|16692413|P2|End of Treatment Period|Adverse Event|1
4842249|NCT01016912|16692414|P1|End of Treatment Period|Adverse Event|0
4842250|NCT01016912|16692410|P5|End of Treatment Period|Lack of Efficacy|4
4842251|NCT01016912|16692411|P4|End of Treatment Period|Lack of Efficacy|4
4842252|NCT01016912|16692412|P3|End of Treatment Period|Lack of Efficacy|0
4842253|NCT01016912|16692413|P2|End of Treatment Period|Lack of Efficacy|1
4842254|NCT01016912|16692414|P1|End of Treatment Period|Lack of Efficacy|0
4842255|NCT01016600|16692593|P4|Overall Study|Did not start treatment|0
4842256|NCT01016600|16692594|P3|Overall Study|Did not start treatment|0
4842257|NCT01016600|16692595|P2|Overall Study|Did not start treatment|0
4842258|NCT01016600|16692596|P1|Overall Study|Did not start treatment|1
4842259|NCT01016262|16692784|P6|Open-Label Phase|Withdrawal of Informed Consent|0
4842260|NCT01016262|16692785|P5|Open-Label Phase|Withdrawal of Informed Consent|1
4842261|NCT01016262|16692786|P4|Open-Label Phase|Withdrawal of Informed Consent|0
4842262|NCT01016262|16692787|P3|Open-Label Phase|Withdrawal of Informed Consent|0
4842263|NCT01016262|16692788|P2|Open-Label Phase|Withdrawal of Informed Consent|0
4842264|NCT01016262|16692789|P1|Open-Label Phase|Withdrawal of Informed Consent|0
4842265|NCT01016262|16692784|P6|Open-Label Phase|Lack of Efficacy|0
4842266|NCT01016262|16692785|P5|Open-Label Phase|Lack of Efficacy|0
4842267|NCT01016262|16692786|P4|Open-Label Phase|Lack of Efficacy|1
4842268|NCT01016262|16692787|P3|Open-Label Phase|Lack of Efficacy|0
4842269|NCT01016262|16692788|P2|Open-Label Phase|Lack of Efficacy|0
4842270|NCT01016262|16692789|P1|Open-Label Phase|Lack of Efficacy|0
4842271|NCT01016262|16692784|P6|Open-Label Phase|Lost to Follow-up|0
4842272|NCT01016262|16692785|P5|Open-Label Phase|Lost to Follow-up|1
4842273|NCT01016262|16692786|P4|Open-Label Phase|Lost to Follow-up|0
4842274|NCT01016262|16692787|P3|Open-Label Phase|Lost to Follow-up|0
4842275|NCT01016262|16692788|P2|Open-Label Phase|Lost to Follow-up|0
4842276|NCT01016262|16692789|P1|Open-Label Phase|Lost to Follow-up|0
4842277|NCT01016262|16692784|P6|Open-Label Phase|Adverse Event|0
4842278|NCT01016262|16692785|P5|Open-Label Phase|Adverse Event|0
4842279|NCT01016262|16692786|P4|Open-Label Phase|Adverse Event|1
4842280|NCT01016262|16692787|P3|Open-Label Phase|Adverse Event|0
4842281|NCT01016262|16692788|P2|Open-Label Phase|Adverse Event|0
4842282|NCT01016262|16692789|P1|Open-Label Phase|Adverse Event|0
4842283|NCT01016262|16692784|P6|Double-blind Phase|Withdrawal of Informed Consent|0
4842284|NCT01016262|16692785|P5|Double-blind Phase|Withdrawal of Informed Consent|0
4842285|NCT01016262|16692786|P4|Double-blind Phase|Withdrawal of Informed Consent|0
4842286|NCT01016262|16692787|P3|Double-blind Phase|Withdrawal of Informed Consent|1
4842287|NCT01016262|16692788|P2|Double-blind Phase|Withdrawal of Informed Consent|0
4842288|NCT01016262|16692789|P1|Double-blind Phase|Withdrawal of Informed Consent|0
4842289|NCT01016262|16692784|P6|Double-blind Phase|Disease Progression|0
4842290|NCT01016262|16692785|P5|Double-blind Phase|Disease Progression|0
4842291|NCT01016262|16692786|P4|Double-blind Phase|Disease Progression|0
4842292|NCT01016262|16692787|P3|Double-blind Phase|Disease Progression|2
4842293|NCT01016262|16692788|P2|Double-blind Phase|Disease Progression|1
4842294|NCT01016262|16692789|P1|Double-blind Phase|Disease Progression|0
4842295|NCT01016262|16692784|P6|Double-blind Phase|Lack of Efficacy|0
4842296|NCT01016262|16692785|P5|Double-blind Phase|Lack of Efficacy|0
4842297|NCT01016262|16692786|P4|Double-blind Phase|Lack of Efficacy|0
4842298|NCT01016262|16692787|P3|Double-blind Phase|Lack of Efficacy|5
4842299|NCT01016262|16692788|P2|Double-blind Phase|Lack of Efficacy|0
4842300|NCT01016262|16692789|P1|Double-blind Phase|Lack of Efficacy|1
4842301|NCT01016262|16692784|P6|Double-blind Phase|Adverse Event|0
4842302|NCT01016262|16692785|P5|Double-blind Phase|Adverse Event|0
4842303|NCT01016262|16692786|P4|Double-blind Phase|Adverse Event|0
4842304|NCT01016262|16692787|P3|Double-blind Phase|Adverse Event|1
4842305|NCT01016262|16692788|P2|Double-blind Phase|Adverse Event|0
4842306|NCT01016262|16692789|P1|Double-blind Phase|Adverse Event|0
4842307|NCT01016132|16692812|P1|Overall Study|Discomfort|1
4842308|NCT01016067|16692827|P2|Overall Study|Withdrew due to Relocation|1
4842309|NCT01016067|16692828|P1|Overall Study|Withdrew due to Relocation|0
4842310|NCT01016067|16692827|P2|Overall Study|Physician Decision|1
4842311|NCT01016067|16692828|P1|Overall Study|Physician Decision|1
4842312|NCT01016067|16692827|P2|Overall Study|Lost to Follow-up|2
4842313|NCT01016067|16692828|P1|Overall Study|Lost to Follow-up|1
4842314|NCT01016015|16692846|P1|Overall Study|Adverse Event|15
4842315|NCT01016015|16692846|P1|Overall Study|Withdrawal by Subject|1
4842316|NCT01016015|16692846|P1|Overall Study|Not Treated|3
4842317|NCT01015833|16692857|P2|Overall Study|Did not start treatment|0
4842318|NCT01015833|16692858|P1|Overall Study|Did not start treatment|1
4842319|NCT01015833|16692857|P2|Overall Study|Motor Vehicle Accidents|0
4842320|NCT01015833|16692858|P1|Overall Study|Motor Vehicle Accidents|1
4842321|NCT01015833|16692857|P2|Overall Study|Other|1
4842322|NCT01015833|16692858|P1|Overall Study|Other|5
4842323|NCT01015833|16692857|P2|Overall Study|Symptomatic deterioration|1
4842324|NCT01015833|16692858|P1|Overall Study|Symptomatic deterioration|0
4842325|NCT01015833|16692857|P2|Overall Study|Physician Decision|0
4842326|NCT01015833|16692858|P1|Overall Study|Physician Decision|2
4842327|NCT01015833|16692857|P2|Overall Study|Adverse Event|1
4842328|NCT01015833|16692858|P1|Overall Study|Adverse Event|0
4842329|NCT01015833|16692857|P2|Overall Study|Withdrawal by Subject|2
4842330|NCT01015833|16692858|P1|Overall Study|Withdrawal by Subject|3
4842331|NCT01015833|16692857|P2|Overall Study|Death|0
4842332|NCT01015833|16692858|P1|Overall Study|Death|1
4842333|NCT01015820|16692874|P2|Overall Study|Suboptimal measurements|0
4842334|NCT01015820|16692875|P1|Overall Study|Suboptimal measurements|1
4842335|NCT01015768|16692905|P2|Overall Study|Some subject data unuseable|4
4842336|NCT01015768|16692906|P1|Overall Study|Some subject data unuseable|4
4842337|NCT01015703|16692921|P5|Overall Study|Protocol Violation|0
4842338|NCT01015703|16692922|P4|Overall Study|Protocol Violation|0
4842339|NCT01015703|16692923|P3|Overall Study|Protocol Violation|0
4842340|NCT01015703|16692924|P2|Overall Study|Protocol Violation|0
4842341|NCT01015703|16692925|P1|Overall Study|Protocol Violation|1
4842342|NCT01015703|16692921|P5|Overall Study|Adverse Event|0
4842343|NCT01015703|16692922|P4|Overall Study|Adverse Event|0
4842344|NCT01015703|16692923|P3|Overall Study|Adverse Event|0
4842345|NCT01015703|16692924|P2|Overall Study|Adverse Event|0
4842346|NCT01015703|16692925|P1|Overall Study|Adverse Event|1
4842347|NCT01015703|16692921|P5|Overall Study|Withdrawal by Subject|0
4842348|NCT01015703|16692922|P4|Overall Study|Withdrawal by Subject|0
4842349|NCT01015703|16692923|P3|Overall Study|Withdrawal by Subject|0
4842350|NCT01015703|16692924|P2|Overall Study|Withdrawal by Subject|1
4842351|NCT01015703|16692925|P1|Overall Study|Withdrawal by Subject|0
4842352|NCT01015677|16692940|P3|Overall Study|Withdrawal by Subject|0
4842353|NCT01015677|16692941|P2|Overall Study|Withdrawal by Subject|1
4842354|NCT01015677|16692942|P1|Overall Study|Withdrawal by Subject|1
4842355|NCT01015677|16692940|P3|Overall Study|Protocol Violation|0
4842356|NCT01015677|16692941|P2|Overall Study|Protocol Violation|1
4842357|NCT01015677|16692942|P1|Overall Study|Protocol Violation|0
4842358|NCT01015677|16692940|P3|Overall Study|Lack of Efficacy|0
4842359|NCT01015677|16692941|P2|Overall Study|Lack of Efficacy|1
4842360|NCT01015677|16692942|P1|Overall Study|Lack of Efficacy|0
4842361|NCT01015677|16692940|P3|Overall Study|Adverse Event|0
4842362|NCT01015677|16692941|P2|Overall Study|Adverse Event|1
4842363|NCT01015677|16692942|P1|Overall Study|Adverse Event|0
4842364|NCT01015638|16692964|P2|Overall Study|Withdrawal by Subject|0
4842365|NCT01015638|16692965|P1|Overall Study|Withdrawal by Subject|1
4842366|NCT01015612|16692993|P1|Overall Study|Withdrawal by Subject|40
4842367|NCT01015612|16692993|P1|Overall Study|Death|113
4842368|NCT01015560|16693024|P1|Overall Study|Withdrawal by Subject|1
4842369|NCT01015560|16693024|P1|Overall Study|Not protocol specified|1
4842370|NCT01015560|16693024|P1|Overall Study|Adverse Event|1
4842371|NCT01015287|16693073|P2|Overall Study|Protocol Violation|1
4842372|NCT01015287|16693074|P1|Overall Study|Protocol Violation|1
4842373|NCT01015287|16693073|P2|Overall Study|Lost to Follow-up|1
4842374|NCT01015287|16693074|P1|Overall Study|Lost to Follow-up|2
4842375|NCT01015287|16693073|P2|Overall Study|Entry Criteria not Met|14
4842376|NCT01015287|16693074|P1|Overall Study|Entry Criteria not Met|11
4842377|NCT01015287|16693073|P2|Overall Study|Withdrawal by Subject|19
4842378|NCT01015287|16693074|P1|Overall Study|Withdrawal by Subject|14
4842379|NCT01015287|16693073|P2|Overall Study|Physician Decision|21
4842380|NCT01015287|16693074|P1|Overall Study|Physician Decision|19
4842381|NCT01015287|16693073|P2|Overall Study|Sponsor Decision|7
4842382|NCT01015287|16693074|P1|Overall Study|Sponsor Decision|3
4842383|NCT01015287|16693073|P2|Overall Study|Adverse Event|0
4842384|NCT01015287|16693074|P1|Overall Study|Adverse Event|1
4842385|NCT01015287|16693073|P2|Overall Study|Death|16
4842386|NCT01015287|16693074|P1|Overall Study|Death|21
4842387|NCT01015131|16693106|P1|Overall Study|Other Protocol Specified Criteria|4
4842388|NCT01015131|16693106|P1|Overall Study|Withdrawal by Subject|2
4842389|NCT01015131|16693106|P1|Overall Study|Protocol Violation|1
4842390|NCT01015131|16693106|P1|Overall Study|Physician Decision|1
4842391|NCT01015118|16693122|P2|Overall Study|Other than stated above|23
4842392|NCT01015118|16693123|P1|Overall Study|Other than stated above|42
4842393|NCT01015118|16693122|P2|Overall Study|Not treated|5
4842394|NCT01015118|16693123|P1|Overall Study|Not treated|9
4842395|NCT01015118|16693122|P2|Overall Study|Progressive disease|229
4842396|NCT01015118|16693123|P1|Overall Study|Progressive disease|364
4842397|NCT01015118|16693122|P2|Overall Study|Worsening or AE of underlying disease|4
4842398|NCT01015118|16693123|P1|Overall Study|Worsening or AE of underlying disease|5
4842399|NCT01015118|16693122|P2|Overall Study|Other Adverse Event (AE)|33
4842400|NCT01015118|16693123|P1|Overall Study|Other Adverse Event (AE)|141
4842401|NCT01015118|16693122|P2|Overall Study|Withdrawal by Subject|27
4842402|NCT01015118|16693123|P1|Overall Study|Withdrawal by Subject|103
4842403|NCT01015118|16693122|P2|Overall Study|Protocol Violation|6
4842404|NCT01015118|16693123|P1|Overall Study|Protocol Violation|5
4842405|NCT01014988|16693151|P6|Overall Study|Withdrawal by Subject|0
4842406|NCT01014988|16693152|P5|Overall Study|Withdrawal by Subject|0
4842407|NCT01014988|16693153|P4|Overall Study|Withdrawal by Subject|0
4842408|NCT01014988|16693154|P3|Overall Study|Withdrawal by Subject|0
4842409|NCT01014988|16693155|P2|Overall Study|Withdrawal by Subject|0
4842410|NCT01014988|16693156|P1|Overall Study|Withdrawal by Subject|1
4842411|NCT01014988|16693151|P6|Overall Study|Physician Decision|0
4842412|NCT01014988|16693152|P5|Overall Study|Physician Decision|0
4842413|NCT01014988|16693153|P4|Overall Study|Physician Decision|0
4842414|NCT01014988|16693154|P3|Overall Study|Physician Decision|0
4842415|NCT01014988|16693155|P2|Overall Study|Physician Decision|0
4842416|NCT01014988|16693156|P1|Overall Study|Physician Decision|1
4842417|NCT01014988|16693151|P6|Overall Study|Lost to Follow-up|0
4842418|NCT01014988|16693152|P5|Overall Study|Lost to Follow-up|0
4842419|NCT01014988|16693153|P4|Overall Study|Lost to Follow-up|0
4842420|NCT01014988|16693154|P3|Overall Study|Lost to Follow-up|1
4842421|NCT01014988|16693155|P2|Overall Study|Lost to Follow-up|0
4842422|NCT01014988|16693156|P1|Overall Study|Lost to Follow-up|1
4842423|NCT01014988|16693151|P6|Overall Study|Adverse Event|3
4842424|NCT01014988|16693152|P5|Overall Study|Adverse Event|1
4842425|NCT01014988|16693153|P4|Overall Study|Adverse Event|0
4842426|NCT01014988|16693154|P3|Overall Study|Adverse Event|1
4842427|NCT01014988|16693155|P2|Overall Study|Adverse Event|0
4842428|NCT01014988|16693156|P1|Overall Study|Adverse Event|20
4842429|NCT01014975|16693328|P3|Overall Study|Lost to Follow-up|1
4842430|NCT01014975|16693329|P2|Overall Study|Lost to Follow-up|0
4842431|NCT01014975|16693330|P1|Overall Study|Lost to Follow-up|0
4842432|NCT01014975|16693328|P3|Overall Study|Death|4
4842433|NCT01014975|16693329|P2|Overall Study|Death|3
4842434|NCT01014975|16693330|P1|Overall Study|Death|3
4842435|NCT01014975|16693328|P3|Overall Study|Withdrawal by Subject|1
4842436|NCT01014975|16693329|P2|Overall Study|Withdrawal by Subject|0
4842437|NCT01014975|16693330|P1|Overall Study|Withdrawal by Subject|1
4842438|NCT01014910|16693835|P2|Overall Study|Withdrawal by Subject|2
4842439|NCT01014910|16693836|P1|Overall Study|Withdrawal by Subject|0
4842440|NCT01014767|16693854|P4|Overall Study|PI left institution, data unavailable|1
4842441|NCT01014767|16693855|P3|Overall Study|PI left institution, data unavailable|4
4842442|NCT01014767|16693856|P2|Overall Study|PI left institution, data unavailable|1
4842443|NCT01014767|16693857|P1|Overall Study|PI left institution, data unavailable|12
4842444|NCT01014689|16693901|P2|Overall Study|Pregnancy|0
4842445|NCT01014689|16693902|P1|Overall Study|Pregnancy|1
4842446|NCT01014689|16693901|P2|Overall Study|Lost to Follow-up|7
4842447|NCT01014689|16693902|P1|Overall Study|Lost to Follow-up|3
4842448|NCT01014689|16693901|P2|Overall Study|Protocol Violation|1
4842449|NCT01014689|16693902|P1|Overall Study|Protocol Violation|1
4842450|NCT01014689|16693901|P2|Overall Study|Withdrawal by Subject|4
4842451|NCT01014689|16693902|P1|Overall Study|Withdrawal by Subject|5
4842452|NCT01014689|16693901|P2|Overall Study|Adverse Event|0
4842453|NCT01014689|16693902|P1|Overall Study|Adverse Event|3
4842454|NCT01014689|16693901|P2|Overall Study|Lack of Efficacy|1
4842455|NCT01014689|16693902|P1|Overall Study|Lack of Efficacy|0
4842456|NCT01014585|16693937|P4|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
4842457|NCT01014585|16693938|P3|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22
4842458|NCT01014585|16693939|P2|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23
4842459|NCT01014585|16693940|P1|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18
4842460|NCT01014585|16693937|P4|Overall Study|Lost to Follow-up|2
4842461|NCT01014585|16693938|P3|Overall Study|Lost to Follow-up|0
4842462|NCT01014585|16693939|P2|Overall Study|Lost to Follow-up|0
4842463|NCT01014585|16693940|P1|Overall Study|Lost to Follow-up|0
4842464|NCT01014585|16693937|P4|Overall Study|Withdrawal by Subject|3
4842465|NCT01014585|16693938|P3|Overall Study|Withdrawal by Subject|1
4842466|NCT01014585|16693939|P2|Overall Study|Withdrawal by Subject|0
4842467|NCT01014585|16693940|P1|Overall Study|Withdrawal by Subject|2
4842468|NCT01014585|16693937|P4|Overall Study|Adverse Event|3
4842469|NCT01014585|16693938|P3|Overall Study|Adverse Event|0
4842470|NCT01014585|16693939|P2|Overall Study|Adverse Event|2
4842471|NCT01014585|16693940|P1|Overall Study|Adverse Event|0
4842472|NCT01014533|16693960|P2|Overall Study|unable to come to appointment|3
4842473|NCT01014533|16693961|P1|Overall Study|unable to come to appointment|0
4842474|NCT01014533|16693960|P2|Overall Study|Withdrawal by Subject|0
4842475|NCT01014533|16693961|P1|Overall Study|Withdrawal by Subject|2
4842476|NCT01014533|16693960|P2|Overall Study|Protocol Violation|2
4842477|NCT01014533|16693961|P1|Overall Study|Protocol Violation|3
4842478|NCT01014442|16693982|P2|Overall Study|Unspecified Reason|1
4842479|NCT01014442|16693983|P1|Overall Study|Unspecified Reason|1
4842480|NCT01014442|16693982|P2|Overall Study|Lack of Compliance|1
4842481|NCT01014442|16693983|P1|Overall Study|Lack of Compliance|0
4842482|NCT01014442|16693982|P2|Overall Study|Protocol Violation|5
4842483|NCT01014442|16693983|P1|Overall Study|Protocol Violation|2
4842484|NCT01014442|16693982|P2|Overall Study|Withdrawal by Subject|4
4842485|NCT01014442|16693983|P1|Overall Study|Withdrawal by Subject|4
4842486|NCT01014442|16693982|P2|Overall Study|Adverse Event|8
4842487|NCT01014442|16693983|P1|Overall Study|Adverse Event|0
4842488|NCT01014208|16694107|P2|Overall Study|Study Closed/terminated|83
4842489|NCT01014208|16694108|P1|Overall Study|Study Closed/terminated|78
4842490|NCT01014208|16694107|P2|Overall Study|Did Not Receive Study Drug|0
4842491|NCT01014208|16694108|P1|Overall Study|Did Not Receive Study Drug|2
4842492|NCT01014208|16694107|P2|Overall Study|Participant Withdrew Consent|12
4842493|NCT01014208|16694108|P1|Overall Study|Participant Withdrew Consent|12
4842494|NCT01014208|16694107|P2|Overall Study|Lost to Follow-up|5
4842495|NCT01014208|16694108|P1|Overall Study|Lost to Follow-up|2
4842496|NCT01014143|16694150|P3|Second Intervention|Lost to Follow-up|0
4842497|NCT01014143|16694151|P2|Second Intervention|Lost to Follow-up|0
4842498|NCT01014143|16694152|P1|Second Intervention|Lost to Follow-up|2
4842499|NCT01014013|16694247|P2|Overall Study|Inappropriate therapy duration, < 7 Days|1
4842500|NCT01014013|16694248|P1|Overall Study|Inappropriate therapy duration, < 7 Days|0
4842501|NCT01014013|16694247|P2|Overall Study|Appendectomy|0
4842502|NCT01014013|16694248|P1|Overall Study|Appendectomy|1
4842503|NCT01014013|16694247|P2|Overall Study|Another antibiotic therapy required|1
4842504|NCT01014013|16694248|P1|Overall Study|Another antibiotic therapy required|0
4842505|NCT01014013|16694247|P2|Overall Study|Physician Decision|1
4842506|NCT01014013|16694248|P1|Overall Study|Physician Decision|0
4842507|NCT01014013|16694247|P2|Overall Study|Pathogen resistant|4
4842508|NCT01014013|16694248|P1|Overall Study|Pathogen resistant|7
4842509|NCT01014013|16694247|P2|Overall Study|Negative urine culture|0
4842510|NCT01014013|16694248|P1|Overall Study|Negative urine culture|2
4842511|NCT01014013|16694247|P2|Overall Study|Pathogen culture = no growth|34
4842512|NCT01014013|16694248|P1|Overall Study|Pathogen culture = no growth|26
4842513|NCT01014013|16694247|P2|Overall Study|Clinical/microbiologic failure|2
4842514|NCT01014013|16694248|P1|Overall Study|Clinical/microbiologic failure|1
4842515|NCT01014013|16694247|P2|Overall Study|Withdrawal by Subject|4
4842516|NCT01014013|16694248|P1|Overall Study|Withdrawal by Subject|7
4842517|NCT01014013|16694247|P2|Overall Study|Protocol Violation|3
4842518|NCT01014013|16694248|P1|Overall Study|Protocol Violation|1
4842519|NCT01014013|16694247|P2|Overall Study|Laboratory adverse experience|1
4842520|NCT01014013|16694248|P1|Overall Study|Laboratory adverse experience|1
4842521|NCT01014013|16694247|P2|Overall Study|Clinical adverse experience|2
4842522|NCT01014013|16694248|P1|Overall Study|Clinical adverse experience|4
4842523|NCT01014013|16694247|P2|Overall Study|Inclusion/Exclusion criteria not met|3
4842524|NCT01014013|16694248|P1|Overall Study|Inclusion/Exclusion criteria not met|1
4842525|NCT01013961|16694260|P2|Overall Study|Physician Decision|1
4842526|NCT01013961|16694261|P1|Overall Study|Physician Decision|0
4842527|NCT01013961|16694260|P2|Overall Study|Withdrawal by Subject|0
4842528|NCT01013961|16694261|P1|Overall Study|Withdrawal by Subject|1
4842529|NCT01013961|16694260|P2|Overall Study|Adverse Event|2
4842530|NCT01013961|16694261|P1|Overall Study|Adverse Event|2
4842531|NCT01013883|16694279|P2|Overall Study|Lost to Follow-up|2
4842532|NCT01013883|16694280|P1|Overall Study|Lost to Follow-up|2
4842533|NCT01013870|16694292|P2|Overall Study|Lost to Follow-up|3
4842534|NCT01013870|16694293|P1|Overall Study|Lost to Follow-up|1
4842535|NCT01013792|16694342|P2|Overall Study|Lost to Follow-up|1
4842536|NCT01013792|16694343|P1|Overall Study|Lost to Follow-up|0
4842537|NCT01013792|16694342|P2|Overall Study|Adverse Event|3
4842538|NCT01013792|16694343|P1|Overall Study|Adverse Event|0
4842539|NCT01013792|16694342|P2|Overall Study|Study suspended|1
4842540|NCT01013792|16694343|P1|Overall Study|Study suspended|2
4842541|NCT01013753|16694349|P1|Overall Study|Other|2
4842542|NCT01013753|16694349|P1|Overall Study|Withdrawal by Subject|2
4842543|NCT01013753|16694349|P1|Overall Study|Lost to Follow-up|1
4842544|NCT01013753|16694349|P1|Overall Study|Protocol Violation|3
4842545|NCT01013753|16694349|P1|Overall Study|Adverse Event|8
4842546|NCT01013740|16694545|P2|Overall Study|Ongoing: Study records not completed|2
4842547|NCT01013740|16694546|P1|Overall Study|Ongoing: Study records not completed|0
4842548|NCT01013740|16694545|P2|Overall Study|Missing|1
4842549|NCT01013740|16694546|P1|Overall Study|Missing|2
4842550|NCT01013740|16694545|P2|Overall Study|study close / terminated : done in error|1
4842551|NCT01013740|16694546|P1|Overall Study|study close / terminated : done in error|2
4842552|NCT01013740|16694545|P2|Overall Study|Withdrawal by Subject|10
4842553|NCT01013740|16694546|P1|Overall Study|Withdrawal by Subject|2
4842554|NCT01013740|16694545|P2|Overall Study|Physician Decision|0
4842555|NCT01013740|16694546|P1|Overall Study|Physician Decision|2
4842556|NCT01013740|16694545|P2|Overall Study|Lost to Follow-up|5
4842557|NCT01013740|16694546|P1|Overall Study|Lost to Follow-up|3
4842558|NCT01013701|16694570|P1|Overall Study|study prematurely terminated|7
4842559|NCT01013597|16694577|P1|Overall Study|Withdrawal by Subject|1
4842560|NCT01013350|16694589|P2|Overall Study|Other|25
4842561|NCT01013350|16694590|P1|Overall Study|Other|1
4842562|NCT01013350|16694589|P2|Overall Study|Participant entered interventional study|8
4842563|NCT01013350|16694590|P1|Overall Study|Participant entered interventional study|0
4842564|NCT01013350|16694589|P2|Overall Study|Death|5
4842565|NCT01013350|16694590|P1|Overall Study|Death|3
4842566|NCT01013350|16694589|P2|Overall Study|Withdrawal by Subject|38
4842567|NCT01013350|16694590|P1|Overall Study|Withdrawal by Subject|15
4842568|NCT01013350|16694589|P2|Overall Study|Physician Decision|20
4842569|NCT01013350|16694590|P1|Overall Study|Physician Decision|4
4842570|NCT01013350|16694589|P2|Overall Study|Adverse Event|1
4842571|NCT01013350|16694590|P1|Overall Study|Adverse Event|0
4842572|NCT01013350|16694589|P2|Overall Study|Lost to Follow-up|95
4842573|NCT01013350|16694590|P1|Overall Study|Lost to Follow-up|15
4842574|NCT01013285|16694603|P2|Overall Study|Death|89
4842575|NCT01013285|16694604|P1|Overall Study|Death|48
4842576|NCT01013207|16694617|P1|CPAP Post Nexus (S9)|Lost to Follow-up|6
4842577|NCT01012999|16694635|P1|Overall Study|Protocol Violation|1
4842578|NCT01012973|16694641|P2|Overall Study|Withdrawal by Subject|6
4842579|NCT01012973|16694642|P1|Overall Study|Withdrawal by Subject|4
4842580|NCT01012973|16694641|P2|Overall Study|Protocol Violation|2
4842581|NCT01012973|16694642|P1|Overall Study|Protocol Violation|5
4842582|NCT01012973|16694641|P2|Overall Study|Increase in vis. acuity, never injected|1
4842583|NCT01012973|16694642|P1|Overall Study|Increase in vis. acuity, never injected|0
4842584|NCT01012973|16694641|P2|Overall Study|(Overseas travel - indefinite period)|0
4842585|NCT01012973|16694642|P1|Overall Study|(Overseas travel - indefinite period)|1
4842586|NCT01012973|16694641|P2|Overall Study|Lost to Follow-up|0
4842587|NCT01012973|16694642|P1|Overall Study|Lost to Follow-up|1
4842588|NCT01012973|16694641|P2|Overall Study|Lack of Efficacy|5
4842589|NCT01012973|16694642|P1|Overall Study|Lack of Efficacy|0
4842590|NCT01012973|16694641|P2|Overall Study|Adverse Event|5
4842591|NCT01012973|16694642|P1|Overall Study|Adverse Event|5
4842592|NCT01012947|16694667|P5|Overall Study|Lost to Follow-up|142
4842593|NCT01012947|16694668|P4|Overall Study|Lost to Follow-up|118
4842594|NCT01012947|16694669|P3|Overall Study|Lost to Follow-up|130
4842595|NCT01012947|16694670|P2|Overall Study|Lost to Follow-up|135
4842596|NCT01012947|16694671|P1|Overall Study|Lost to Follow-up|131
4842597|NCT01012765|16694692|P6|Treatment Period 2|Unsatisfactory therapeutic effect|0
4842598|NCT01012765|16694693|P5|Treatment Period 2|Unsatisfactory therapeutic effect|0
4842599|NCT01012765|16694694|P4|Treatment Period 2|Unsatisfactory therapeutic effect|0
4842600|NCT01012765|16694695|P3|Treatment Period 2|Unsatisfactory therapeutic effect|1
4842601|NCT01012765|16694696|P2|Treatment Period 2|Unsatisfactory therapeutic effect|1
4842602|NCT01012765|16694697|P1|Treatment Period 2|Unsatisfactory therapeutic effect|0
4842603|NCT01012765|16694692|P6|Treatment Period 2|Adverse Event|0
4842604|NCT01012765|16694693|P5|Treatment Period 2|Adverse Event|0
4842605|NCT01012765|16694694|P4|Treatment Period 2|Adverse Event|0
4842606|NCT01012765|16694695|P3|Treatment Period 2|Adverse Event|1
4842607|NCT01012765|16694696|P2|Treatment Period 2|Adverse Event|1
4842608|NCT01012765|16694697|P1|Treatment Period 2|Adverse Event|0
4842609|NCT01012765|16694692|P6|Treatment Period 2|Abnormal laboratory value(s)|1
4842610|NCT01012765|16694693|P5|Treatment Period 2|Abnormal laboratory value(s)|0
4842611|NCT01012765|16694694|P4|Treatment Period 2|Abnormal laboratory value(s)|0
4842612|NCT01012765|16694695|P3|Treatment Period 2|Abnormal laboratory value(s)|0
4842613|NCT01012765|16694696|P2|Treatment Period 2|Abnormal laboratory value(s)|0
4842614|NCT01012765|16694697|P1|Treatment Period 2|Abnormal laboratory value(s)|0
4842615|NCT01012765|16694692|P6|Treatment Period 2|Withdrawal by Subject|0
4842616|NCT01012765|16694693|P5|Treatment Period 2|Withdrawal by Subject|1
4842617|NCT01012765|16694694|P4|Treatment Period 2|Withdrawal by Subject|0
4842618|NCT01012765|16694695|P3|Treatment Period 2|Withdrawal by Subject|1
4842619|NCT01012765|16694696|P2|Treatment Period 2|Withdrawal by Subject|0
4842620|NCT01012765|16694697|P1|Treatment Period 2|Withdrawal by Subject|1
4842621|NCT01012765|16694692|P6|Treatment Period 1|Unsatisfactory therapeutic effect|0
4842622|NCT01012765|16694693|P5|Treatment Period 1|Unsatisfactory therapeutic effect|1
4842623|NCT01012765|16694694|P4|Treatment Period 1|Unsatisfactory therapeutic effect|0
4842624|NCT01012765|16694695|P3|Treatment Period 1|Unsatisfactory therapeutic effect|0
4842625|NCT01012765|16694696|P2|Treatment Period 1|Unsatisfactory therapeutic effect|0
4842626|NCT01012765|16694697|P1|Treatment Period 1|Unsatisfactory therapeutic effect|0
4842627|NCT01012765|16694692|P6|Treatment Period 1|Protocol Violation|0
4842628|NCT01012765|16694693|P5|Treatment Period 1|Protocol Violation|1
4842629|NCT01012765|16694694|P4|Treatment Period 1|Protocol Violation|2
4842630|NCT01012765|16694695|P3|Treatment Period 1|Protocol Violation|0
4842631|NCT01012765|16694696|P2|Treatment Period 1|Protocol Violation|0
4842632|NCT01012765|16694697|P1|Treatment Period 1|Protocol Violation|0
4842633|NCT01012765|16694692|P6|Treatment Period 1|Administrative problems|0
4842634|NCT01012765|16694693|P5|Treatment Period 1|Administrative problems|1
4842635|NCT01012765|16694694|P4|Treatment Period 1|Administrative problems|1
4842636|NCT01012765|16694695|P3|Treatment Period 1|Administrative problems|1
4842637|NCT01012765|16694696|P2|Treatment Period 1|Administrative problems|0
4842638|NCT01012765|16694697|P1|Treatment Period 1|Administrative problems|0
4842639|NCT01012765|16694692|P6|Treatment Period 1|Withdrawal by Subject|0
4842640|NCT01012765|16694693|P5|Treatment Period 1|Withdrawal by Subject|0
4842641|NCT01012765|16694694|P4|Treatment Period 1|Withdrawal by Subject|0
4842642|NCT01012765|16694695|P3|Treatment Period 1|Withdrawal by Subject|0
4842643|NCT01012765|16694696|P2|Treatment Period 1|Withdrawal by Subject|0
4842644|NCT01012765|16694697|P1|Treatment Period 1|Withdrawal by Subject|2
4842645|NCT01012765|16694692|P6|Treatment Period 1|Adverse Event|0
4842646|NCT01012765|16694693|P5|Treatment Period 1|Adverse Event|0
4842647|NCT01012765|16694694|P4|Treatment Period 1|Adverse Event|0
4842648|NCT01012765|16694695|P3|Treatment Period 1|Adverse Event|1
4842649|NCT01012765|16694696|P2|Treatment Period 1|Adverse Event|0
4842650|NCT01012765|16694697|P1|Treatment Period 1|Adverse Event|1
4842651|NCT01012739|16694726|P4|Treatment Period 2|Abnormal test procedure results|1
4842652|NCT01012739|16694727|P3|Treatment Period 2|Abnormal test procedure results|0
4842653|NCT01012739|16694728|P2|Treatment Period 2|Abnormal test procedure results|0
4842654|NCT01012739|16694729|P1|Treatment Period 2|Abnormal test procedure results|0
4842655|NCT01012739|16694726|P4|Treatment Period 1|Adverse Event|1
4842656|NCT01012739|16694727|P3|Treatment Period 1|Adverse Event|0
4842657|NCT01012739|16694728|P2|Treatment Period 1|Adverse Event|0
4842658|NCT01012739|16694729|P1|Treatment Period 1|Adverse Event|0
4842659|NCT01012713|16694757|P1|Overall Study|Lack of Efficacy|3
4842660|NCT01012622|16694783|P1|Overall Study|withdrawal of consent by a parent|2
4842661|NCT01012622|16694783|P1|Overall Study|screening failure|1
4842662|NCT01012622|16694783|P1|Overall Study|Other|1
4842663|NCT01012622|16694783|P1|Overall Study|non-compliance with the drug|9
4842664|NCT01012622|16694783|P1|Overall Study|Adverse Event|7
4842665|NCT01012622|16694783|P1|Overall Study|Lost to Follow-up|5
4842666|NCT01012622|16694783|P1|Overall Study|Withdrawal by Subject|6
4842667|NCT01012440|16694809|P1|Overall Study|Withdrawal by Subject|2
4842668|NCT01012414|16694813|P1|Overall Study|Trial was stopped before completed|7
4842669|NCT01012414|16694813|P1|Overall Study|Lost to Follow-up|1
4842670|NCT01012414|16694813|P1|Overall Study|Withdrawal by Subject|2
4842671|NCT01012323|16694854|P1|Overall Study|Investigator Judgment|1
4842672|NCT01012258|16694891|P1|Overall Study|Ongoing|29
4842673|NCT01012258|16694891|P1|Overall Study|Another Tumor Discovered|1
4842674|NCT01012258|16694891|P1|Overall Study|Another Anti-cancer Drug Received|1
4842675|NCT01012258|16694891|P1|Overall Study|Symptomatic Deterioration|1
4842676|NCT01012258|16694891|P1|Overall Study|Progressive Disease (PD)|18
4842677|NCT01012258|16694891|P1|Overall Study|Adverse Event|1
4842678|NCT01012258|16694891|P1|Overall Study|Lost to Follow-up|1
4842679|NCT01012258|16694891|P1|Overall Study|Death|14
4842680|NCT01012219|16694938|P1|Period 2|Withdrawal by Subject|1
4842681|NCT01012219|16694938|P1|Period 1|Withdrawal by Subject|1
4842682|NCT01012037|16695229|P3|Overall Study|Other reason (not specified)|1
4842683|NCT01012037|16695230|P2|Overall Study|Other reason (not specified)|1
4842684|NCT01012037|16695231|P1|Overall Study|Other reason (not specified)|1
4842685|NCT01012037|16695229|P3|Overall Study|Withdrawal by Subject|1
4842686|NCT01012037|16695230|P2|Overall Study|Withdrawal by Subject|4
4842687|NCT01012037|16695231|P1|Overall Study|Withdrawal by Subject|0
4842688|NCT01012037|16695229|P3|Overall Study|Protocol Violation|5
4842689|NCT01012037|16695230|P2|Overall Study|Protocol Violation|3
4842690|NCT01012037|16695231|P1|Overall Study|Protocol Violation|0
4842691|NCT01012037|16695229|P3|Overall Study|Adverse Event|3
4842692|NCT01012037|16695230|P2|Overall Study|Adverse Event|8
4842693|NCT01012037|16695231|P1|Overall Study|Adverse Event|0
4842694|NCT01011946|16695266|P1|Overall Study|No pathological lab value|1
4842695|NCT01011946|16695266|P1|Overall Study|Transferred to another hospital|2
4842696|NCT01011933|16695270|P1|Overall Study|Never treated|1
4842697|NCT01011933|16695270|P1|Overall Study|Inadequate pathology|1
4842698|NCT01011933|16695270|P1|Overall Study|Improper pre-protocol Rx|1
4842699|NCT01011933|16695270|P1|Overall Study|Wrong cell type|1
4842700|NCT01011907|16695287|P2|Overall Study|Adverse Event|4
4842701|NCT01011907|16695288|P1|Overall Study|Adverse Event|1
4842702|NCT01011907|16695287|P2|Overall Study|Withdrawal by Subject|11
4842703|NCT01011907|16695288|P1|Overall Study|Withdrawal by Subject|13
4842704|NCT01011868|16695305|P3|After Week 78 Follow-up|Other reason not defined above|16
4842705|NCT01011868|16695306|P2|After Week 78 Follow-up|Other reason not defined above|5
4842706|NCT01011868|16695307|P1|After Week 78 Follow-up|Other reason not defined above|5
4842707|NCT01011868|16695305|P3|After Week 78 Follow-up|Withdrawal by Subject|1
4842708|NCT01011868|16695306|P2|After Week 78 Follow-up|Withdrawal by Subject|8
4842709|NCT01011868|16695307|P1|After Week 78 Follow-up|Withdrawal by Subject|9
4842710|NCT01011868|16695305|P3|After Week 78 Follow-up|Lost to Follow-up|4
4842711|NCT01011868|16695306|P2|After Week 78 Follow-up|Lost to Follow-up|6
4842712|NCT01011868|16695307|P1|After Week 78 Follow-up|Lost to Follow-up|11
4842713|NCT01011868|16695305|P3|After Week 78 Follow-up|Protocol Violation|2
4842714|NCT01011868|16695306|P2|After Week 78 Follow-up|Protocol Violation|1
4842715|NCT01011868|16695307|P1|After Week 78 Follow-up|Protocol Violation|9
4842716|NCT01011868|16695305|P3|After Week 78 Follow-up|Lack of Efficacy|0
4842717|NCT01011868|16695306|P2|After Week 78 Follow-up|Lack of Efficacy|0
4842718|NCT01011868|16695307|P1|After Week 78 Follow-up|Lack of Efficacy|4
4842719|NCT01011868|16695305|P3|After Week 78 Follow-up|Adverse Event|21
4842720|NCT01011868|16695306|P2|After Week 78 Follow-up|Adverse Event|18
4842721|NCT01011868|16695307|P1|After Week 78 Follow-up|Adverse Event|14
4842722|NCT01011868|16695305|P3|After Week 18 Follow-up|Other reason not defined above|12
4842723|NCT01011868|16695306|P2|After Week 18 Follow-up|Other reason not defined above|3
4842724|NCT01011868|16695307|P1|After Week 18 Follow-up|Other reason not defined above|2
4842725|NCT01011868|16695305|P3|After Week 18 Follow-up|Withdrawal by Subject|0
4842726|NCT01011868|16695306|P2|After Week 18 Follow-up|Withdrawal by Subject|3
4842727|NCT01011868|16695307|P1|After Week 18 Follow-up|Withdrawal by Subject|6
4842728|NCT01011868|16695305|P3|After Week 18 Follow-up|Lost to Follow-up|0
4842729|NCT01011868|16695306|P2|After Week 18 Follow-up|Lost to Follow-up|3
4842730|NCT01011868|16695307|P1|After Week 18 Follow-up|Lost to Follow-up|5
4842731|NCT01011868|16695305|P3|After Week 18 Follow-up|Protocol Violation|1
4842732|NCT01011868|16695306|P2|After Week 18 Follow-up|Protocol Violation|1
4842733|NCT01011868|16695307|P1|After Week 18 Follow-up|Protocol Violation|1
4842734|NCT01011868|16695305|P3|After Week 18 Follow-up|Lack of Efficacy|0
4842735|NCT01011868|16695306|P2|After Week 18 Follow-up|Lack of Efficacy|0
4842736|NCT01011868|16695307|P1|After Week 18 Follow-up|Lack of Efficacy|1
4842737|NCT01011868|16695305|P3|After Week 18 Follow-up|Adverse Event|13
4842738|NCT01011868|16695306|P2|After Week 18 Follow-up|Adverse Event|6
4842739|NCT01011868|16695307|P1|After Week 18 Follow-up|Adverse Event|8
4842740|NCT01011738|16695369|P3|Overall Study|Unknown reasons|17
4842741|NCT01011738|16695370|P2|Overall Study|Unknown reasons|291
4842742|NCT01011738|16695371|P1|Overall Study|Unknown reasons|312
4842743|NCT01011738|16695369|P3|Overall Study|Death|0
4842744|NCT01011738|16695370|P2|Overall Study|Death|3
4842745|NCT01011738|16695371|P1|Overall Study|Death|12
4842746|NCT01011673|16695411|P2|24 Hour Follow-up|Lost to Follow-up|3
4842747|NCT01011673|16695412|P1|24 Hour Follow-up|Lost to Follow-up|3
4842748|NCT01011673|16695411|P2|Randomized|Secondary headache|1
4842749|NCT01011673|16695412|P1|Randomized|Secondary headache|2
4842750|NCT01011556|16695435|P4|Overall Study|Inclusion/exclusion criteria not met|5
4842751|NCT01011556|16695436|P3|Overall Study|Inclusion/exclusion criteria not met|3
4842752|NCT01011556|16695437|P2|Overall Study|Inclusion/exclusion criteria not met|1
4842753|NCT01011556|16695438|P1|Overall Study|Inclusion/exclusion criteria not met|2
4842754|NCT01011556|16695435|P4|Overall Study|Sponsor decision|2
4842755|NCT01011556|16695436|P3|Overall Study|Sponsor decision|1
4842756|NCT01011556|16695437|P2|Overall Study|Sponsor decision|1
4842757|NCT01011556|16695438|P1|Overall Study|Sponsor decision|0
4842758|NCT01011556|16695435|P4|Overall Study|Withdrawal by Subject|4
4842759|NCT01011556|16695436|P3|Overall Study|Withdrawal by Subject|4
4842760|NCT01011556|16695437|P2|Overall Study|Withdrawal by Subject|2
4842761|NCT01011556|16695438|P1|Overall Study|Withdrawal by Subject|1
4842762|NCT01011556|16695435|P4|Overall Study|Protocol Violation|0
4842763|NCT01011556|16695436|P3|Overall Study|Protocol Violation|0
4842764|NCT01011556|16695437|P2|Overall Study|Protocol Violation|1
4842765|NCT01011556|16695438|P1|Overall Study|Protocol Violation|0
4842766|NCT01011556|16695435|P4|Overall Study|Physician Decision|1
4842767|NCT01011556|16695436|P3|Overall Study|Physician Decision|0
4842768|NCT01011556|16695437|P2|Overall Study|Physician Decision|0
4842769|NCT01011556|16695438|P1|Overall Study|Physician Decision|1
4842770|NCT01011556|16695435|P4|Overall Study|Lost to Follow-up|0
4842771|NCT01011556|16695436|P3|Overall Study|Lost to Follow-up|0
4842772|NCT01011556|16695437|P2|Overall Study|Lost to Follow-up|0
4842773|NCT01011556|16695438|P1|Overall Study|Lost to Follow-up|1
4842774|NCT01011556|16695435|P4|Overall Study|Adverse Event|1
4842775|NCT01011556|16695436|P3|Overall Study|Adverse Event|2
4842776|NCT01011556|16695437|P2|Overall Study|Adverse Event|3
4842777|NCT01011556|16695438|P1|Overall Study|Adverse Event|1
4842778|NCT01011465|16695516|P8|Overall Study|Withdrawal by Subject|0
4842779|NCT01011465|16695517|P7|Overall Study|Withdrawal by Subject|1
4842780|NCT01011465|16695518|P6|Overall Study|Withdrawal by Subject|0
4842781|NCT01011465|16695519|P5|Overall Study|Withdrawal by Subject|1
4842782|NCT01011465|16695520|P4|Overall Study|Withdrawal by Subject|0
4842783|NCT01011465|16695521|P3|Overall Study|Withdrawal by Subject|0
4842784|NCT01011465|16695522|P2|Overall Study|Withdrawal by Subject|1
4842785|NCT01011465|16695523|P1|Overall Study|Withdrawal by Subject|2
4842786|NCT01011439|16695551|P1|Overall Study|Sponsor's decision|15
4842787|NCT01011439|16695551|P1|Overall Study|Withdrawal by Subject|1
4842788|NCT01011439|16695551|P1|Overall Study|Lost to Follow-up|4
4842789|NCT01011439|16695551|P1|Overall Study|Death|37
4842790|NCT01011387|16695588|P1|Overall Study|Protocol Violation|1
4842791|NCT01011387|16695588|P1|Overall Study|Adverse Event|2
4842792|NCT01011387|16695588|P1|Overall Study|Withdrawal by Subject|3
4842793|NCT01011335|16695596|P13|Overall Study|Adverse Event|1
4842794|NCT01011335|16695597|P12|Overall Study|Adverse Event|0
4842795|NCT01011335|16695598|P11|Overall Study|Adverse Event|4
4842796|NCT01011335|16695599|P10|Overall Study|Adverse Event|0
4842797|NCT01011335|16695600|P9|Overall Study|Adverse Event|0
4842798|NCT01011335|16695601|P8|Overall Study|Adverse Event|0
4842799|NCT01011335|16695602|P7|Overall Study|Adverse Event|0
4842800|NCT01011335|16695603|P6|Overall Study|Adverse Event|0
4842801|NCT01011335|16695604|P5|Overall Study|Adverse Event|0
4842802|NCT01011335|16695605|P4|Overall Study|Adverse Event|0
4842803|NCT01011335|16695606|P3|Overall Study|Adverse Event|0
4842804|NCT01011335|16695607|P2|Overall Study|Adverse Event|0
4842805|NCT01011335|16695608|P1|Overall Study|Adverse Event|0
4842806|NCT01011335|16695596|P13|Overall Study|Moved/deployed or no booster|0
4842807|NCT01011335|16695597|P12|Overall Study|Moved/deployed or no booster|0
4842808|NCT01011335|16695598|P11|Overall Study|Moved/deployed or no booster|2
4842809|NCT01011335|16695599|P10|Overall Study|Moved/deployed or no booster|0
4842810|NCT01011335|16695600|P9|Overall Study|Moved/deployed or no booster|1
4842811|NCT01011335|16695601|P8|Overall Study|Moved/deployed or no booster|0
4842812|NCT01011335|16695602|P7|Overall Study|Moved/deployed or no booster|1
4842813|NCT01011335|16695603|P6|Overall Study|Moved/deployed or no booster|0
4842814|NCT01011335|16695604|P5|Overall Study|Moved/deployed or no booster|0
4842815|NCT01011335|16695605|P4|Overall Study|Moved/deployed or no booster|1
4842816|NCT01011335|16695606|P3|Overall Study|Moved/deployed or no booster|0
4842817|NCT01011335|16695607|P2|Overall Study|Moved/deployed or no booster|0
4842818|NCT01011335|16695608|P1|Overall Study|Moved/deployed or no booster|1
4842819|NCT01011335|16695596|P13|Overall Study|Protocol Violation|0
4842820|NCT01011335|16695597|P12|Overall Study|Protocol Violation|0
4842821|NCT01011335|16695598|P11|Overall Study|Protocol Violation|0
4842822|NCT01011335|16695599|P10|Overall Study|Protocol Violation|0
4842823|NCT01011335|16695600|P9|Overall Study|Protocol Violation|0
4842824|NCT01011335|16695601|P8|Overall Study|Protocol Violation|0
4842825|NCT01011335|16695602|P7|Overall Study|Protocol Violation|0
4842826|NCT01011335|16695603|P6|Overall Study|Protocol Violation|0
4842827|NCT01011335|16695604|P5|Overall Study|Protocol Violation|0
4842828|NCT01011335|16695605|P4|Overall Study|Protocol Violation|0
4842829|NCT01011335|16695606|P3|Overall Study|Protocol Violation|0
4842830|NCT01011335|16695607|P2|Overall Study|Protocol Violation|1
4842831|NCT01011335|16695608|P1|Overall Study|Protocol Violation|0
4842832|NCT01011335|16695596|P13|Overall Study|Lost to Follow-up|2
4842833|NCT01011335|16695597|P12|Overall Study|Lost to Follow-up|1
4842834|NCT01011335|16695598|P11|Overall Study|Lost to Follow-up|0
4842835|NCT01011335|16695599|P10|Overall Study|Lost to Follow-up|0
4842836|NCT01011335|16695600|P9|Overall Study|Lost to Follow-up|1
4842837|NCT01011335|16695601|P8|Overall Study|Lost to Follow-up|2
4842838|NCT01011335|16695602|P7|Overall Study|Lost to Follow-up|2
4842839|NCT01011335|16695603|P6|Overall Study|Lost to Follow-up|1
4842840|NCT01011335|16695604|P5|Overall Study|Lost to Follow-up|1
4842841|NCT01011335|16695605|P4|Overall Study|Lost to Follow-up|1
4842842|NCT01011335|16695606|P3|Overall Study|Lost to Follow-up|1
4842843|NCT01011335|16695607|P2|Overall Study|Lost to Follow-up|0
4842844|NCT01011335|16695608|P1|Overall Study|Lost to Follow-up|0
4842845|NCT01011309|16695648|P3|Overall Study|Protocol Violation|3
4842846|NCT01011309|16695649|P2|Overall Study|Protocol Violation|1
4842847|NCT01011309|16695650|P1|Overall Study|Protocol Violation|0
4842848|NCT01011309|16695648|P3|Overall Study|Lack of Efficacy|0
4842849|NCT01011309|16695649|P2|Overall Study|Lack of Efficacy|1
4842850|NCT01011309|16695650|P1|Overall Study|Lack of Efficacy|0
4842851|NCT01011309|16695648|P3|Overall Study|Adverse Event|2
4842852|NCT01011309|16695649|P2|Overall Study|Adverse Event|1
4842853|NCT01011309|16695650|P1|Overall Study|Adverse Event|2
4842854|NCT01011283|16695666|P2|Overall Study|Other|2
4842855|NCT01011283|16695667|P1|Overall Study|Other|2
4842856|NCT01011283|16695666|P2|Overall Study|Terminated by Sponsor|5
4842857|NCT01011283|16695667|P1|Overall Study|Terminated by Sponsor|5
4842858|NCT01011283|16695666|P2|Overall Study|Progressive Disease|2
4842859|NCT01011283|16695667|P1|Overall Study|Progressive Disease|0
4842860|NCT01011283|16695666|P2|Overall Study|Adverse Event|2
4842861|NCT01011283|16695667|P1|Overall Study|Adverse Event|4
4842862|NCT01011153|16695716|P3|Overall Study|Less than 78 cases completed|9
4842863|NCT01011153|16695717|P2|Overall Study|Less than 78 cases completed|11
4842864|NCT01011153|16695718|P1|Overall Study|Less than 78 cases completed|8
4842865|NCT01011049|16695747|P4|Overall Study|Withdrawal by Subject|0
4842866|NCT01011049|16695748|P3|Overall Study|Withdrawal by Subject|1
4842867|NCT01011049|16695749|P2|Overall Study|Withdrawal by Subject|0
4842868|NCT01011049|16695750|P1|Overall Study|Withdrawal by Subject|0
4842869|NCT01011049|16695747|P4|Overall Study|Lost to Follow-up|0
4842870|NCT01011049|16695748|P3|Overall Study|Lost to Follow-up|1
4842871|NCT01011049|16695749|P2|Overall Study|Lost to Follow-up|2
4842872|NCT01011049|16695750|P1|Overall Study|Lost to Follow-up|1
4842873|NCT01011049|16695747|P4|Overall Study|Protocol Violation|0
4842874|NCT01011049|16695748|P3|Overall Study|Protocol Violation|2
4842875|NCT01011049|16695749|P2|Overall Study|Protocol Violation|0
4842876|NCT01011049|16695750|P1|Overall Study|Protocol Violation|0
4842877|NCT01010971|16695780|P3|Overall Study|Other|2
4842878|NCT01010971|16695781|P2|Overall Study|Other|0
4842879|NCT01010971|16695782|P1|Overall Study|Other|1
4842880|NCT01010971|16695780|P3|Overall Study|Lost to Follow-up|3
4842881|NCT01010971|16695781|P2|Overall Study|Lost to Follow-up|2
4842882|NCT01010971|16695782|P1|Overall Study|Lost to Follow-up|0
4842883|NCT01010971|16695780|P3|Overall Study|Withdrawal by Subject|5
4842884|NCT01010971|16695781|P2|Overall Study|Withdrawal by Subject|2
4842885|NCT01010971|16695782|P1|Overall Study|Withdrawal by Subject|0
4842886|NCT01010971|16695780|P3|Overall Study|Adverse Event|3
4842887|NCT01010971|16695781|P2|Overall Study|Adverse Event|4
4842888|NCT01010971|16695782|P1|Overall Study|Adverse Event|2
4842889|NCT01010867|16695910|P1|Overall Study|< 50% adherence to probiotic|1
4842890|NCT01010776|16695922|P1|Extension Phase|Other|3
4842891|NCT01010776|16695922|P1|In-Between Main Phase & Extension Phase|Extension phase was optional|15
4842892|NCT01010776|16695922|P1|Main Phase|Did not received study medication|5
4842893|NCT01010776|16695922|P1|Main Phase|Other|1
4842894|NCT01010776|16695922|P1|Main Phase|Inform consent withdrawal|1
4842895|NCT01010776|16695922|P1|Main Phase|Selection failure|2
4842896|NCT01010776|16695922|P1|Main Phase|Non-compliance to study medication|5
4842897|NCT01010776|16695922|P1|Main Phase|Lost to Follow-up|6
4842898|NCT01010776|16695922|P1|Main Phase|Adverse Event|7
4842899|NCT01010776|16695922|P1|Main Phase|Lack of Efficacy|8
4842900|NCT01010776|16695922|P1|Main Phase|Withdrawal by Subject|14
4842901|NCT01010750|16695979|P6|Second Intervention|Adverse Event|0
4842902|NCT01010750|16695980|P5|Second Intervention|Adverse Event|0
4842903|NCT01010750|16695981|P4|Second Intervention|Adverse Event|0
4842904|NCT01010750|16695982|P3|Second Intervention|Adverse Event|0
4842905|NCT01010750|16695983|P2|Second Intervention|Adverse Event|1
4842906|NCT01010750|16695984|P1|Second Intervention|Adverse Event|0
4842907|NCT01010633|16696009|P2|Overall Study|Investigator decision|1
4842908|NCT01010633|16696010|P1|Overall Study|Investigator decision|0
4842909|NCT01010633|16696009|P2|Overall Study|Withdrawal by Subject|1
4842910|NCT01010633|16696010|P1|Overall Study|Withdrawal by Subject|2
4842911|NCT01010633|16696009|P2|Overall Study|Protocol Violation|2
4842912|NCT01010633|16696010|P1|Overall Study|Protocol Violation|1
4842913|NCT01010633|16696009|P2|Overall Study|Adverse Event|1
4842914|NCT01010633|16696010|P1|Overall Study|Adverse Event|1
4842915|NCT01010503|16696037|P1|Overall Study|Death|1
4842916|NCT01010503|16696037|P1|Overall Study|Adverse Event|1
4842917|NCT01010230|16696096|P2|Overall Study|Lost to Follow-up|2
4842918|NCT01010230|16696097|P1|Overall Study|Lost to Follow-up|4
4842919|NCT01010230|16696096|P2|Overall Study|Withdrawal by Subject|5
4842920|NCT01010230|16696097|P1|Overall Study|Withdrawal by Subject|6
4842921|NCT01010217|16696132|P5|Overall Study|Physician Decision|3
4842922|NCT01010217|16696133|P4|Overall Study|Physician Decision|6
4842923|NCT01010217|16696134|P3|Overall Study|Physician Decision|0
4842924|NCT01010217|16696135|P2|Overall Study|Physician Decision|0
4842925|NCT01010217|16696136|P1|Overall Study|Physician Decision|0
4842926|NCT01010217|16696132|P5|Overall Study|Withdrawal by Subject|0
4842927|NCT01010217|16696133|P4|Overall Study|Withdrawal by Subject|0
4842928|NCT01010217|16696134|P3|Overall Study|Withdrawal by Subject|0
4842929|NCT01010217|16696135|P2|Overall Study|Withdrawal by Subject|0
4842930|NCT01010217|16696136|P1|Overall Study|Withdrawal by Subject|1
4842931|NCT01010217|16696132|P5|Overall Study|Lost to Follow-up|0
4842932|NCT01010217|16696133|P4|Overall Study|Lost to Follow-up|0
4842933|NCT01010217|16696134|P3|Overall Study|Lost to Follow-up|1
4842934|NCT01010217|16696135|P2|Overall Study|Lost to Follow-up|5
4842935|NCT01010217|16696136|P1|Overall Study|Lost to Follow-up|4
4842936|NCT01010204|16696175|P2|Overall Study|psychiatric hospitalization|1
4842937|NCT01010204|16696176|P1|Overall Study|psychiatric hospitalization|2
4842938|NCT01010204|16696175|P2|Overall Study|Withdrawal by Subject|3
4842939|NCT01010204|16696176|P1|Overall Study|Withdrawal by Subject|2
4842940|NCT01010204|16696175|P2|Overall Study|Adverse Event|3
4842941|NCT01010204|16696176|P1|Overall Study|Adverse Event|1
4842942|NCT01010204|16696175|P2|Overall Study|Lost to Follow-up|2
4842943|NCT01010204|16696176|P1|Overall Study|Lost to Follow-up|2
4842944|NCT01010126|16696192|P6|Overall Study|Withdrawal by Subject|0
4842945|NCT01010126|16696193|P5|Overall Study|Withdrawal by Subject|3
4842946|NCT01010126|16696194|P4|Overall Study|Withdrawal by Subject|0
4842947|NCT01010126|16696195|P3|Overall Study|Withdrawal by Subject|1
4842948|NCT01010126|16696196|P2|Overall Study|Withdrawal by Subject|0
4842949|NCT01010126|16696197|P1|Overall Study|Withdrawal by Subject|1
4842950|NCT01010061|16696249|P2|Overall Study|Did Not Receive Treatment|2
4842951|NCT01010061|16696250|P1|Overall Study|Did Not Receive Treatment|2
4842952|NCT01010061|16696249|P2|Overall Study|Violation of Selection Criteria|1
4842953|NCT01010061|16696250|P1|Overall Study|Violation of Selection Criteria|0
4842954|NCT01010061|16696249|P2|Overall Study|Insufficient Therapeutic Response|5
4842955|NCT01010061|16696250|P1|Overall Study|Insufficient Therapeutic Response|1
4842956|NCT01010061|16696249|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
4842957|NCT01010061|16696250|P1|Overall Study|Refused Treatment/Did Not Cooperate|2
4842958|NCT01010061|16696249|P2|Overall Study|Administrative/Other|1
4842959|NCT01010061|16696250|P1|Overall Study|Administrative/Other|0
4842960|NCT01010061|16696249|P2|Overall Study|Death|6
4842961|NCT01010061|16696250|P1|Overall Study|Death|3
4842962|NCT01010061|16696249|P2|Overall Study|Withdrew Consent|1
4842963|NCT01010061|16696250|P1|Overall Study|Withdrew Consent|5
4842964|NCT01010061|16696249|P2|Overall Study|Disease Progression|8
4842965|NCT01010061|16696250|P1|Overall Study|Disease Progression|2
4842966|NCT01010061|16696249|P2|Overall Study|Adverse Events or Intercurrent Illness|16
4842967|NCT01010061|16696250|P1|Overall Study|Adverse Events or Intercurrent Illness|33
4842968|NCT01009983|16696301|P1|Overall Study|necessary scans not completed|1
4842969|NCT01009840|16696314|P1|Overall Study|Subject Withdrew Consent to Participate|1
4842970|NCT01009840|16696314|P1|Overall Study|Subject was Withdrawn by Investigator|1
4842971|NCT01009840|16696314|P1|Overall Study|Subject Met Withdrawal Criteria|7
4842972|NCT01009840|16696314|P1|Overall Study|Adverse Event|4
4842973|NCT01009840|16696314|P1|Overall Study|Lost to Follow-up|1
4842974|NCT01009814|16696332|P5|Overall Study|No longer met study criteria|0
4842975|NCT01009814|16696333|P4|Overall Study|No longer met study criteria|0
4842976|NCT01009814|16696334|P3|Overall Study|No longer met study criteria|0
4842977|NCT01009814|16696335|P2|Overall Study|No longer met study criteria|1
4842978|NCT01009814|16696336|P1|Overall Study|No longer met study criteria|1
4842979|NCT01009645|16696460|P4|Overall Study|Lost to Follow-up|5
4842980|NCT01009645|16696461|P3|Overall Study|Lost to Follow-up|4
4842981|NCT01009645|16696462|P2|Overall Study|Lost to Follow-up|8
4842982|NCT01009645|16696463|P1|Overall Study|Lost to Follow-up|2
4842983|NCT01009580|16696500|P2|Overall Study|Unclassified|21
4842984|NCT01009580|16696501|P1|Overall Study|Unclassified|17
4842985|NCT01009580|16696500|P2|Overall Study|Withdrawal Criteria|6
4842986|NCT01009580|16696501|P1|Overall Study|Withdrawal Criteria|4
4842987|NCT01009580|16696500|P2|Overall Study|Protocol Violation|3
4842988|NCT01009580|16696501|P1|Overall Study|Protocol Violation|2
4842989|NCT01009580|16696500|P2|Overall Study|Lack of Efficacy|1
4842990|NCT01009580|16696501|P1|Overall Study|Lack of Efficacy|0
4842991|NCT01009580|16696500|P2|Overall Study|Adverse Event|4
4842992|NCT01009580|16696501|P1|Overall Study|Adverse Event|4
4842993|NCT01009554|16696515|P2|Overall Study|Noncompliant with Study Product|3
4842994|NCT01009554|16696516|P1|Overall Study|Noncompliant with Study Product|0
4842995|NCT01009554|16696515|P2|Overall Study|Withdrawal by Subject|3
4842996|NCT01009554|16696516|P1|Overall Study|Withdrawal by Subject|1
4842997|NCT01009554|16696515|P2|Overall Study|Adverse Event|1
4842998|NCT01009554|16696516|P1|Overall Study|Adverse Event|1
4842999|NCT01009515|16696648|P1|Overall Study|Withdrawal by Subject|3
4843000|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Physician Decision|8
4843001|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Physician Decision|6
4843002|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Physician Decision|6
4843003|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Physician Decision|4
4843004|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Physician Decision|0
4843005|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Lost to Follow-up|5
4843006|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Lost to Follow-up|6
4843007|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Lost to Follow-up|7
4843008|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Lost to Follow-up|11
4843009|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Lost to Follow-up|0
4843010|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4843011|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Study Closed/Terminated|1
4843012|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4843013|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Study Closed/Terminated|2
4843014|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Study Closed/Terminated|0
4843015|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
4843016|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13
4843017|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14
4843018|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10
4843019|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0
4843020|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Protocol Violation|7
4843021|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Protocol Violation|8
4843022|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Protocol Violation|7
4843023|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Protocol Violation|8
4843024|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Protocol Violation|0
4843025|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Lack of Efficacy|18
4843026|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Lack of Efficacy|11
4843027|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Lack of Efficacy|16
4843028|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Lack of Efficacy|24
4843029|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Lack of Efficacy|0
4843030|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Withdrawal by Subject|22
4843031|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Withdrawal by Subject|17
4843032|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Withdrawal by Subject|18
4843033|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Withdrawal by Subject|34
4843034|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Withdrawal by Subject|0
4843035|NCT01009463|16696659|P5|52-week, Double-blind Treatment Period|Adverse Event|31
4843036|NCT01009463|16696660|P4|52-week, Double-blind Treatment Period|Adverse Event|29
4843037|NCT01009463|16696661|P3|52-week, Double-blind Treatment Period|Adverse Event|25
4843038|NCT01009463|16696662|P2|52-week, Double-blind Treatment Period|Adverse Event|22
4843039|NCT01009463|16696663|P1|52-week, Double-blind Treatment Period|Adverse Event|0
4843040|NCT01009463|16696659|P5|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4843041|NCT01009463|16696660|P4|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4843042|NCT01009463|16696661|P3|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4843043|NCT01009463|16696662|P2|4-week, Open-label Run-In Period|Withdrawal by Subject|0
4843044|NCT01009463|16696663|P1|4-week, Open-label Run-In Period|Withdrawal by Subject|50
4843045|NCT01009463|16696659|P5|4-week, Open-label Run-In Period|Physician Decision|0
4843046|NCT01009463|16696660|P4|4-week, Open-label Run-In Period|Physician Decision|0
4843047|NCT01009463|16696661|P3|4-week, Open-label Run-In Period|Physician Decision|0
4843048|NCT01009463|16696662|P2|4-week, Open-label Run-In Period|Physician Decision|0
4843049|NCT01009463|16696663|P1|4-week, Open-label Run-In Period|Physician Decision|10
4843050|NCT01009463|16696659|P5|4-week, Open-label Run-In Period|Lost to Follow-up|0
4843051|NCT01009463|16696660|P4|4-week, Open-label Run-In Period|Lost to Follow-up|0
4843052|NCT01009463|16696661|P3|4-week, Open-label Run-In Period|Lost to Follow-up|0
4843053|NCT01009463|16696662|P2|4-week, Open-label Run-In Period|Lost to Follow-up|0
4843054|NCT01009463|16696663|P1|4-week, Open-label Run-In Period|Lost to Follow-up|6
4843055|NCT01009463|16696659|P5|4-week, Open-label Run-In Period|Adverse Event|0
4843056|NCT01009463|16696660|P4|4-week, Open-label Run-In Period|Adverse Event|0
4843057|NCT01009463|16696661|P3|4-week, Open-label Run-In Period|Adverse Event|0
4843058|NCT01009463|16696662|P2|4-week, Open-label Run-In Period|Adverse Event|0
4843059|NCT01009463|16696663|P1|4-week, Open-label Run-In Period|Adverse Event|10
4843060|NCT01009463|16696659|P5|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4843061|NCT01009463|16696660|P4|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4843062|NCT01009463|16696661|P3|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4843063|NCT01009463|16696662|P2|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0
4843064|NCT01009463|16696663|P1|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373
4843065|NCT01009346|16696685|P1|Overall Study|Adverse Event|4
4843066|NCT01009294|16696709|P1|Overall Study|Study discontinued by Sponsor|6
4843067|NCT01009203|16696730|P1|Overall Study|Treatment-unrelated death|1
4843068|NCT01009203|16696730|P1|Overall Study|Adverse Event|5
4843069|NCT01009203|16696730|P1|Overall Study|Withdrawal by Subject|1
4843070|NCT01009099|16696770|P2|Overall Study|Death|1
4843071|NCT01009099|16696771|P1|Overall Study|Death|0
4843072|NCT01009099|16696770|P2|Overall Study|Withdrawal by Subject|1
4843073|NCT01009099|16696771|P1|Overall Study|Withdrawal by Subject|1
4843074|NCT01009099|16696770|P2|Overall Study|Physician Decision|2
4843075|NCT01009099|16696771|P1|Overall Study|Physician Decision|3
4843076|NCT01009099|16696770|P2|Overall Study|Lost to Follow-up|0
4843077|NCT01009099|16696771|P1|Overall Study|Lost to Follow-up|1
4843078|NCT01009086|16696780|P3|Overall Study|Other|1
4843079|NCT01009086|16696781|P2|Overall Study|Other|5
4843080|NCT01009086|16696782|P1|Overall Study|Other|3
4843081|NCT01009086|16696780|P3|Overall Study|Withdrawal by Subject|13
4843082|NCT01009086|16696781|P2|Overall Study|Withdrawal by Subject|11
4843083|NCT01009086|16696782|P1|Overall Study|Withdrawal by Subject|9
4843084|NCT01009086|16696780|P3|Overall Study|Adverse Event|8
4843085|NCT01009086|16696781|P2|Overall Study|Adverse Event|11
4843086|NCT01009086|16696782|P1|Overall Study|Adverse Event|12
4843087|NCT01009086|16696780|P3|Overall Study|Lost to Follow-up|3
4843088|NCT01009086|16696781|P2|Overall Study|Lost to Follow-up|5
4843089|NCT01009086|16696782|P1|Overall Study|Lost to Follow-up|4
4843090|NCT01009086|16696780|P3|Overall Study|Lack of Efficacy|9
4843091|NCT01009086|16696781|P2|Overall Study|Lack of Efficacy|15
4843092|NCT01009086|16696782|P1|Overall Study|Lack of Efficacy|16
4843093|NCT01009060|16696817|P2|Overall Study|Withdrawal by Subject|1
4843094|NCT01009060|16696818|P1|Overall Study|Withdrawal by Subject|1
4843095|NCT01009060|16696817|P2|Overall Study|Physician Decision|1
4843096|NCT01009060|16696818|P1|Overall Study|Physician Decision|1
4843097|NCT01009060|16696817|P2|Overall Study|Lost to Follow-up|0
4843098|NCT01009060|16696818|P1|Overall Study|Lost to Follow-up|1
4843099|NCT01009060|16696817|P2|Overall Study|Protocol Violation|1
4843100|NCT01009060|16696818|P1|Overall Study|Protocol Violation|0
4843101|NCT01009060|16696817|P2|Overall Study|Adverse Event|2
4843102|NCT01009060|16696818|P1|Overall Study|Adverse Event|1
4843103|NCT01009047|16696856|P2|Overall Study|Other|2
4843104|NCT01009047|16696857|P1|Overall Study|Other|3
4843105|NCT01009047|16696856|P2|Overall Study|Withdrawal by consent|11
4843106|NCT01009047|16696857|P1|Overall Study|Withdrawal by consent|16
4843107|NCT01009047|16696856|P2|Overall Study|Lack of Efficacy|11
4843108|NCT01009047|16696857|P1|Overall Study|Lack of Efficacy|4
4843109|NCT01009047|16696856|P2|Overall Study|Lost to Follow-up|2
4843110|NCT01009047|16696857|P1|Overall Study|Lost to Follow-up|0
4843111|NCT01009047|16696856|P2|Overall Study|Adverse Event|0
4843112|NCT01009047|16696857|P1|Overall Study|Adverse Event|5
4843113|NCT01009034|16696879|P1|Overall Study|Withdrawal by Subject|2
4843114|NCT01009034|16696879|P1|Overall Study|Lost to Follow-up|2
4843115|NCT01008995|16696887|P4|After Controlled Period|Other|0
4843116|NCT01008995|16696888|P3|After Controlled Period|Other|1
4843117|NCT01008995|16696889|P2|After Controlled Period|Other|0
4843118|NCT01008995|16696890|P1|After Controlled Period|Other|0
4843119|NCT01008995|16696887|P4|After Controlled Period|Adverse Event|1
4843120|NCT01008995|16696888|P3|After Controlled Period|Adverse Event|1
4843121|NCT01008995|16696889|P2|After Controlled Period|Adverse Event|0
4843122|NCT01008995|16696890|P1|After Controlled Period|Adverse Event|0
4843123|NCT01008995|16696887|P4|Controlled Period|Other|0
4843124|NCT01008995|16696888|P3|Controlled Period|Other|0
4843125|NCT01008995|16696889|P2|Controlled Period|Other|1
4843126|NCT01008995|16696890|P1|Controlled Period|Other|2
4843127|NCT01008995|16696887|P4|Controlled Period|Adverse Event|0
4843128|NCT01008995|16696888|P3|Controlled Period|Adverse Event|0
4843129|NCT01008995|16696889|P2|Controlled Period|Adverse Event|2
4843130|NCT01008995|16696890|P1|Controlled Period|Adverse Event|1
4843131|NCT01008943|16696907|P1|Overall Study|Withdrawal by Subject|1
4843132|NCT01008904|16696914|P1|Overall Study|unexpected unrelated surgery|1
4843133|NCT01008904|16696914|P1|Overall Study|Adverse Event|2
4843134|NCT01008904|16696914|P1|Overall Study|Lost to Follow-up|1
4843135|NCT01008748|16696919|P1|Overall Study|Other|1
4843136|NCT01008748|16696919|P1|Overall Study|Lost to Follow-up|80
4843137|NCT01008696|16696944|P2|Overall Study|Other|2
4843138|NCT01008696|16696945|P1|Overall Study|Other|0
4843139|NCT01008696|16696944|P2|Overall Study|Other|3
4843140|NCT01008696|16696945|P1|Overall Study|Other|2
4843141|NCT01008696|16696944|P2|Overall Study|Participants' non-cooperation|3
4843142|NCT01008696|16696945|P1|Overall Study|Participants' non-cooperation|2
4843143|NCT01008696|16696944|P2|Overall Study|Adverse Event|0
4843144|NCT01008696|16696945|P1|Overall Study|Adverse Event|1
4843145|NCT01008696|16696944|P2|Overall Study|Physician Decision|1
4843146|NCT01008696|16696945|P1|Overall Study|Physician Decision|5
4843147|NCT01008696|16696944|P2|Overall Study|Withdrawal by Subject|4
4843148|NCT01008696|16696945|P1|Overall Study|Withdrawal by Subject|2
4843149|NCT01008696|16696944|P2|Overall Study|Participant's evasion of hospital visit|4
4843150|NCT01008696|16696945|P1|Overall Study|Participant's evasion of hospital visit|5
4843151|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|Not appropriate for this study|1
4843152|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|Not appropriate for this study|0
4843153|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|Not appropriate for this study|0
4843154|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29
4843155|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21
4843156|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
4843157|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
4843158|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4843159|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4843160|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3
4843161|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
4843162|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
4843163|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|Physician Decision|0
4843164|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|Physician Decision|1
4843165|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|Physician Decision|0
4843166|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
4843167|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|3
4843168|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
4843169|NCT01008618|16696955|P3|Period 2 (Double-Blind Period)|Adverse Event|2
4843170|NCT01008618|16696956|P2|Period 2 (Double-Blind Period)|Adverse Event|11
4843171|NCT01008618|16696957|P1|Period 2 (Double-Blind Period)|Adverse Event|0
4843172|NCT01008618|16696955|P3|Period 1 (Titration Period)|Aggravated symptom|0
4843173|NCT01008618|16696956|P2|Period 1 (Titration Period)|Aggravated symptom|0
4843174|NCT01008618|16696957|P1|Period 1 (Titration Period)|Aggravated symptom|2
4843175|NCT01008618|16696955|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4843176|NCT01008618|16696956|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4843177|NCT01008618|16696957|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20
4843178|NCT01008618|16696955|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
4843179|NCT01008618|16696956|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
4843180|NCT01008618|16696957|P1|Period 1 (Titration Period)|Withdrawal by Subject|11
4843181|NCT01008618|16696955|P3|Period 1 (Titration Period)|Adverse Event|0
4843182|NCT01008618|16696956|P2|Period 1 (Titration Period)|Adverse Event|0
4843183|NCT01008618|16696957|P1|Period 1 (Titration Period)|Adverse Event|33
4843184|NCT01008618|16696955|P3|Period 1 (Titration Period)|Physician Decision|0
4843185|NCT01008618|16696956|P2|Period 1 (Titration Period)|Physician Decision|0
4843186|NCT01008618|16696957|P1|Period 1 (Titration Period)|Physician Decision|2
4843187|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35
4843188|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18
4843189|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0
4843190|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1
4843191|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4843192|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0
4843193|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3
4843194|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
4843195|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0
4843196|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4
4843197|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1
4843198|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0
4843199|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
4843200|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|Impossible to perform required tests|1
4843201|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|Impossible to perform required tests|0
4843202|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
4843203|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|Withdrawal by Subject|2
4843204|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|Withdrawal by Subject|0
4843205|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|Adverse Event|4
4843206|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|Adverse Event|14
4843207|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|Adverse Event|0
4843208|NCT01008553|16697006|P3|Period 2 (Double-Blind Period)|Physician Decision|2
4843209|NCT01008553|16697007|P2|Period 2 (Double-Blind Period)|Physician Decision|1
4843210|NCT01008553|16697008|P1|Period 2 (Double-Blind Period)|Physician Decision|0
4843211|NCT01008553|16697006|P3|Period 1 (Titration Period)|Not appropriate for this study|0
4843212|NCT01008553|16697007|P2|Period 1 (Titration Period)|Not appropriate for this study|0
4843213|NCT01008553|16697008|P1|Period 1 (Titration Period)|Not appropriate for this study|1
4843214|NCT01008553|16697006|P3|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4843215|NCT01008553|16697007|P2|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0
4843216|NCT01008553|16697008|P1|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50
4843217|NCT01008553|16697006|P3|Period 1 (Titration Period)|Determined to increase dosage|0
4843218|NCT01008553|16697007|P2|Period 1 (Titration Period)|Determined to increase dosage|0
4843219|NCT01008553|16697008|P1|Period 1 (Titration Period)|Determined to increase dosage|3
4843220|NCT01008553|16697006|P3|Period 1 (Titration Period)|Withdrawal by Subject|0
4843221|NCT01008553|16697007|P2|Period 1 (Titration Period)|Withdrawal by Subject|0
4843222|NCT01008553|16697008|P1|Period 1 (Titration Period)|Withdrawal by Subject|6
4843223|NCT01008553|16697006|P3|Period 1 (Titration Period)|Adverse Event|0
4843224|NCT01008553|16697007|P2|Period 1 (Titration Period)|Adverse Event|0
4843225|NCT01008553|16697008|P1|Period 1 (Titration Period)|Adverse Event|33
4843226|NCT01008553|16697006|P3|Period 1 (Titration Period)|Physician Decision|0
4843227|NCT01008553|16697007|P2|Period 1 (Titration Period)|Physician Decision|0
4843228|NCT01008553|16697008|P1|Period 1 (Titration Period)|Physician Decision|2
4843229|NCT01008475|16697040|P7|Overall Study|Ongoing treatment at data cut-off date|4
4843230|NCT01008475|16697041|P6|Overall Study|Ongoing treatment at data cut-off date|6
4843231|NCT01008475|16697042|P5|Overall Study|Ongoing treatment at data cut-off date|5
4843232|NCT01008475|16697043|P4|Overall Study|Ongoing treatment at data cut-off date|0
4843233|NCT01008475|16697044|P3|Overall Study|Ongoing treatment at data cut-off date|0
4843234|NCT01008475|16697045|P2|Overall Study|Ongoing treatment at data cut-off date|0
4843235|NCT01008475|16697046|P1|Overall Study|Ongoing treatment at data cut-off date|0
4843236|NCT01008449|16697086|P2|Overall Study|Lost to Follow-up|19
4843237|NCT01008449|16697087|P1|Overall Study|Lost to Follow-up|29
4843238|NCT01008423|16697109|P2|Overall Study|Other|1
4843239|NCT01008423|16697110|P1|Overall Study|Other|0
4843240|NCT01008423|16697109|P2|Overall Study|Personal Conflict|0
4843241|NCT01008423|16697110|P1|Overall Study|Personal Conflict|1
4843242|NCT01008423|16697109|P2|Overall Study|Disease Extent 70 centimeters (cm)|0
4843243|NCT01008423|16697110|P1|Overall Study|Disease Extent 70 centimeters (cm)|1
4843244|NCT01008423|16697109|P2|Overall Study|Lack of Efficacy|5
4843245|NCT01008423|16697110|P1|Overall Study|Lack of Efficacy|0
4843246|NCT01008423|16697109|P2|Overall Study|Low Cortisol|1
4843247|NCT01008423|16697110|P1|Overall Study|Low Cortisol|0
4843248|NCT01008423|16697109|P2|Overall Study|Lost to Follow-up|2
4843249|NCT01008423|16697110|P1|Overall Study|Lost to Follow-up|0
4843250|NCT01008423|16697109|P2|Overall Study|Withdrawal by Subject|7
4843251|NCT01008423|16697110|P1|Overall Study|Withdrawal by Subject|4
4843252|NCT01008423|16697109|P2|Overall Study|Adverse Event|6
4843253|NCT01008423|16697110|P1|Overall Study|Adverse Event|13
4843254|NCT01008410|16697136|P2|Overall Study|Met Exclusion Criterion|1
4843255|NCT01008410|16697137|P1|Overall Study|Met Exclusion Criterion|0
4843256|NCT01008410|16697136|P2|Overall Study|Lack of Efficacy|6
4843257|NCT01008410|16697137|P1|Overall Study|Lack of Efficacy|2
4843258|NCT01008410|16697136|P2|Overall Study|Low Cortisol|0
4843259|NCT01008410|16697137|P1|Overall Study|Low Cortisol|2
4843260|NCT01008410|16697136|P2|Overall Study|Noncompliance|0
4843261|NCT01008410|16697137|P1|Overall Study|Noncompliance|1
4843262|NCT01008410|16697136|P2|Overall Study|Lost to Follow-up|0
4843263|NCT01008410|16697137|P1|Overall Study|Lost to Follow-up|1
4843264|NCT01008410|16697136|P2|Overall Study|Withdrawal by Subject|2
4843265|NCT01008410|16697137|P1|Overall Study|Withdrawal by Subject|6
4843266|NCT01008410|16697136|P2|Overall Study|Adverse Event|7
4843267|NCT01008410|16697137|P1|Overall Study|Adverse Event|13
4843268|NCT01008150|16697191|P4|Overall Study|did not receive study drug|0
4843269|NCT01008150|16697192|P3|Overall Study|did not receive study drug|1
4843270|NCT01008150|16697193|P2|Overall Study|did not receive study drug|1
4843271|NCT01008150|16697194|P1|Overall Study|did not receive study drug|1
4843272|NCT01007916|16697242|P2|Period 2, 4 Weeks of Wear|Relocation|0
4843273|NCT01007916|16697243|P1|Period 2, 4 Weeks of Wear|Relocation|1
4843274|NCT01007916|16697242|P2|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0
4843275|NCT01007916|16697243|P1|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1
4843276|NCT01007942|16697251|P2|Overall Study|Patients untreated|3
4843277|NCT01007942|16697252|P1|Overall Study|Patients untreated|4
4843278|NCT01007942|16697251|P2|Overall Study|Death|2
4843279|NCT01007942|16697252|P1|Overall Study|Death|3
4843280|NCT01007942|16697251|P2|Overall Study|Administrative problems|0
4843281|NCT01007942|16697252|P1|Overall Study|Administrative problems|2
4843282|NCT01007942|16697251|P2|Overall Study|Lost to Follow-up|0
4843283|NCT01007942|16697252|P1|Overall Study|Lost to Follow-up|1
4843284|NCT01007942|16697251|P2|Overall Study|Withdrawal by Subject|14
4843285|NCT01007942|16697252|P1|Overall Study|Withdrawal by Subject|19
4843286|NCT01007942|16697251|P2|Overall Study|Protocol Violation|1
4843287|NCT01007942|16697252|P1|Overall Study|Protocol Violation|1
4843288|NCT01007942|16697251|P2|Overall Study|New cancer therapy|1
4843289|NCT01007942|16697252|P1|Overall Study|New cancer therapy|5
4843290|NCT01007942|16697251|P2|Overall Study|Disease progression|242
4843291|NCT01007942|16697252|P1|Overall Study|Disease progression|217
4843292|NCT01007942|16697251|P2|Overall Study|Abnormal test procedure|1
4843293|NCT01007942|16697252|P1|Overall Study|Abnormal test procedure|0
4843294|NCT01007942|16697251|P2|Overall Study|Adverse Event|14
4843295|NCT01007942|16697252|P1|Overall Study|Adverse Event|29
4843296|NCT01007838|16697278|P4|Overall Study|Started home haemodialysis|0
4843297|NCT01007838|16697279|P3|Overall Study|Started home haemodialysis|0
4843298|NCT01007838|16697280|P2|Overall Study|Started home haemodialysis|0
4843299|NCT01007838|16697281|P1|Overall Study|Started home haemodialysis|1
4843300|NCT01007838|16697278|P4|Overall Study|Physician Decision|0
4843301|NCT01007838|16697279|P3|Overall Study|Physician Decision|0
4843302|NCT01007838|16697280|P2|Overall Study|Physician Decision|0
4843303|NCT01007838|16697281|P1|Overall Study|Physician Decision|1
4843304|NCT01007838|16697278|P4|Overall Study|Withdrawal by Subject|0
4843305|NCT01007838|16697279|P3|Overall Study|Withdrawal by Subject|0
4843306|NCT01007838|16697280|P2|Overall Study|Withdrawal by Subject|0
4843307|NCT01007838|16697281|P1|Overall Study|Withdrawal by Subject|1
4843308|NCT01007812|16697291|P2|Period 1, One Week|Discomfort|0
4843309|NCT01007812|16697292|P1|Period 1, One Week|Discomfort|1
4843310|NCT01007812|16697291|P2|Period 1, One Week|Lost to Follow-up|1
4843311|NCT01007812|16697292|P1|Period 1, One Week|Lost to Follow-up|0
4843312|NCT01007552|16697342|P1|Overall Study|Withdrawal by Subject|1
4843313|NCT01007448|16697358|P2|Overall Study|Adverse Event|4
4843314|NCT01007448|16697359|P1|Overall Study|Adverse Event|1
4843315|NCT01007448|16697358|P2|Overall Study|Withdrawal by Subject|3
4843316|NCT01007448|16697359|P1|Overall Study|Withdrawal by Subject|2
4843317|NCT01007448|16697358|P2|Overall Study|Lack of Efficacy|0
4843318|NCT01007448|16697359|P1|Overall Study|Lack of Efficacy|2
4843319|NCT01007448|16697358|P2|Overall Study|Progressive Disease|2
4843320|NCT01007448|16697359|P1|Overall Study|Progressive Disease|1
4843321|NCT01007448|16697358|P2|Overall Study|Participant Given Prohibited Medication|0
4843322|NCT01007448|16697359|P1|Overall Study|Participant Given Prohibited Medication|1
4843323|NCT01007448|16697358|P2|Overall Study|Participant Leaving the Country|0
4843324|NCT01007448|16697359|P1|Overall Study|Participant Leaving the Country|1
4843325|NCT01007448|16697358|P2|Overall Study|Staph Skin Infection Flare|0
4843326|NCT01007448|16697359|P1|Overall Study|Staph Skin Infection Flare|1
4843327|NCT01007448|16697358|P2|Overall Study|Continuing Prohibited Systemic Drugs|0
4843328|NCT01007448|16697359|P1|Overall Study|Continuing Prohibited Systemic Drugs|1
4843329|NCT01007435|16697391|P4|Overall Study|Reason not Specified|1
4843330|NCT01007435|16697392|P3|Overall Study|Reason not Specified|2
4843331|NCT01007435|16697393|P2|Overall Study|Reason not Specified|1
4843332|NCT01007435|16697394|P1|Overall Study|Reason not Specified|1
4843333|NCT01007435|16697391|P4|Overall Study|Failure to Return|6
4843334|NCT01007435|16697392|P3|Overall Study|Failure to Return|3
4843335|NCT01007435|16697393|P2|Overall Study|Failure to Return|4
4843336|NCT01007435|16697394|P1|Overall Study|Failure to Return|5
4843337|NCT01007435|16697391|P4|Overall Study|Refused Treatment|8
4843338|NCT01007435|16697392|P3|Overall Study|Refused Treatment|5
4843339|NCT01007435|16697393|P2|Overall Study|Refused Treatment|13
4843340|NCT01007435|16697394|P1|Overall Study|Refused Treatment|13
4843341|NCT01007435|16697391|P4|Overall Study|Other Protocol Violation|0
4843342|NCT01007435|16697392|P3|Overall Study|Other Protocol Violation|1
4843343|NCT01007435|16697393|P2|Overall Study|Other Protocol Violation|0
4843344|NCT01007435|16697394|P1|Overall Study|Other Protocol Violation|2
4843345|NCT01007435|16697391|P4|Overall Study|Violation of Selection Criteria at Entry|0
4843346|NCT01007435|16697392|P3|Overall Study|Violation of Selection Criteria at Entry|2
4843347|NCT01007435|16697393|P2|Overall Study|Violation of Selection Criteria at Entry|5
4843348|NCT01007435|16697394|P1|Overall Study|Violation of Selection Criteria at Entry|3
4843349|NCT01007435|16697391|P4|Overall Study|Insufficient Therapeutic Response|9
4843350|NCT01007435|16697392|P3|Overall Study|Insufficient Therapeutic Response|2
4843351|NCT01007435|16697393|P2|Overall Study|Insufficient Therapeutic Response|7
4843352|NCT01007435|16697394|P1|Overall Study|Insufficient Therapeutic Response|21
4843353|NCT01007435|16697391|P4|Overall Study|Death|1
4843354|NCT01007435|16697392|P3|Overall Study|Death|2
4843355|NCT01007435|16697393|P2|Overall Study|Death|4
4843356|NCT01007435|16697394|P1|Overall Study|Death|2
4843357|NCT01007435|16697391|P4|Overall Study|Adverse Event|31
4843358|NCT01007435|16697392|P3|Overall Study|Adverse Event|47
4843359|NCT01007435|16697393|P2|Overall Study|Adverse Event|25
4843360|NCT01007435|16697394|P1|Overall Study|Adverse Event|16
4843361|NCT01007396|16697436|P1|Overall Study|Lost to Follow-up|47
4843362|NCT01007253|16697441|P4|Washout Period (2 Weeks) # 3|Physician Decision|0
4843363|NCT01007253|16697442|P3|Washout Period (2 Weeks) # 3|Physician Decision|0
4843364|NCT01007253|16697443|P2|Washout Period (2 Weeks) # 3|Physician Decision|0
4843365|NCT01007253|16697444|P1|Washout Period (2 Weeks) # 3|Physician Decision|1
4843366|NCT01007149|16697476|P2|Overall Study|Administrative problems|1
4843367|NCT01007149|16697477|P1|Overall Study|Administrative problems|0
4843368|NCT01007123|16697551|P4|Overall Study|Lost to Follow-up|0
4843369|NCT01007123|16697552|P3|Overall Study|Lost to Follow-up|0
4843370|NCT01007123|16697553|P2|Overall Study|Lost to Follow-up|1
4843371|NCT01007123|16697554|P1|Overall Study|Lost to Follow-up|0
4843372|NCT01007123|16697551|P4|Overall Study|Withdrawal by Subject|0
4843373|NCT01007123|16697552|P3|Overall Study|Withdrawal by Subject|1
4843374|NCT01007123|16697553|P2|Overall Study|Withdrawal by Subject|0
4843375|NCT01007123|16697554|P1|Overall Study|Withdrawal by Subject|1
4843376|NCT01007123|16697551|P4|Overall Study|Protocol Violation|1
4843377|NCT01007123|16697552|P3|Overall Study|Protocol Violation|2
4843378|NCT01007123|16697553|P2|Overall Study|Protocol Violation|1
4843379|NCT01007123|16697554|P1|Overall Study|Protocol Violation|1
4843380|NCT01007123|16697551|P4|Overall Study|Lack of Efficacy|4
4843381|NCT01007123|16697552|P3|Overall Study|Lack of Efficacy|1
4843382|NCT01007123|16697553|P2|Overall Study|Lack of Efficacy|0
4843383|NCT01007123|16697554|P1|Overall Study|Lack of Efficacy|1
4843384|NCT01007123|16697551|P4|Overall Study|Adverse Event|1
4843385|NCT01007123|16697552|P3|Overall Study|Adverse Event|7
4843386|NCT01007123|16697553|P2|Overall Study|Adverse Event|4
4843387|NCT01007123|16697554|P1|Overall Study|Adverse Event|3
4843388|NCT01007032|16697615|P4|Overall Study|Withdrawal by Subject|1
4843389|NCT01007032|16697616|P3|Overall Study|Withdrawal by Subject|0
4843390|NCT01007032|16697617|P2|Overall Study|Withdrawal by Subject|0
4843391|NCT01007032|16697618|P1|Overall Study|Withdrawal by Subject|0
4843392|NCT01007032|16697615|P4|Overall Study|On Study Treatment at Cut-off Date|0
4843393|NCT01007032|16697616|P3|Overall Study|On Study Treatment at Cut-off Date|1
4843394|NCT01007032|16697617|P2|Overall Study|On Study Treatment at Cut-off Date|1
4843395|NCT01007032|16697618|P1|Overall Study|On Study Treatment at Cut-off Date|0
4843396|NCT01006980|16697662|P2|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10
4843397|NCT01006980|16697663|P1|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0
4843398|NCT01006980|16697662|P2|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1
4843399|NCT01006980|16697663|P1|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0
4843400|NCT01006980|16697662|P2|Crossover: Dacarbazine to Vemurafenib|Progression|65
4843401|NCT01006980|16697663|P1|Crossover: Dacarbazine to Vemurafenib|Progression|0
4843402|NCT01006980|16697662|P2|Crossover: Dacarbazine to Vemurafenib|Death|4
4843403|NCT01006980|16697663|P1|Crossover: Dacarbazine to Vemurafenib|Death|0
4843404|NCT01006980|16697662|P2|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4
4843405|NCT01006980|16697663|P1|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0
4843406|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Reason Not Specified|43
4843407|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Reason Not Specified|26
4843408|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Protocol Violation|3
4843409|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Protocol Violation|2
4843410|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Refuse Treatment|6
4843411|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Refuse Treatment|9
4843412|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Withdrawal of Consent|6
4843413|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Withdrawal of Consent|4
4843414|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Progression|218
4843415|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Progression|257
4843416|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Death|12
4843417|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Death|13
4843418|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Adverse Event|5
4843419|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Adverse Event|25
4843420|NCT01006980|16697662|P2|Vemurafenib and Dacarbazine|Randomized but Not Treated|45
4843421|NCT01006980|16697663|P1|Vemurafenib and Dacarbazine|Randomized but Not Treated|1
4843422|NCT01006889|16697702|P1|Overall Study|Withdrawal by Subject|3
4843423|NCT01006707|16697713|P3|Study Session 1|Could not tolerate withdrawal in scanner|0
4843424|NCT01006707|16697714|P2|Study Session 1|Could not tolerate withdrawal in scanner|0
4843425|NCT01006707|16697715|P1|Study Session 1|Could not tolerate withdrawal in scanner|3
4843426|NCT01006707|16697713|P3|Study Session 1|Lost to Follow-up|0
4843427|NCT01006707|16697714|P2|Study Session 1|Lost to Follow-up|0
4843428|NCT01006707|16697715|P1|Study Session 1|Lost to Follow-up|2
4843429|NCT01006629|16697735|P1|Overall Study|Parent unable to perform site visit|4
4843430|NCT01006629|16697735|P1|Overall Study|Parent refused to continue participation|1
4843431|NCT01006629|16697735|P1|Overall Study|Adverse Event|1
4843432|NCT01006616|16697750|P4|Period 2 (18 Months)|Study Terminated|70
4843433|NCT01006616|16697751|P3|Period 2 (18 Months)|Study Terminated|44
4843434|NCT01006616|16697752|P2|Period 2 (18 Months)|Study Terminated|46
4843435|NCT01006616|16697753|P1|Period 2 (18 Months)|Study Terminated|63
4843436|NCT01006616|16697750|P4|Period 2 (18 Months)|Noncompliance With Protocol|1
4843437|NCT01006616|16697751|P3|Period 2 (18 Months)|Noncompliance With Protocol|0
4843438|NCT01006616|16697752|P2|Period 2 (18 Months)|Noncompliance With Protocol|1
4843439|NCT01006616|16697753|P1|Period 2 (18 Months)|Noncompliance With Protocol|0
4843440|NCT01006616|16697750|P4|Period 2 (18 Months)|Withdrawal by Subject|1
4843441|NCT01006616|16697751|P3|Period 2 (18 Months)|Withdrawal by Subject|0
4843442|NCT01006616|16697752|P2|Period 2 (18 Months)|Withdrawal by Subject|4
4843443|NCT01006616|16697753|P1|Period 2 (18 Months)|Withdrawal by Subject|1
4843444|NCT01006616|16697750|P4|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2
4843445|NCT01006616|16697751|P3|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1
4843446|NCT01006616|16697752|P2|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6
4843447|NCT01006616|16697753|P1|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0
4843448|NCT01006616|16697750|P4|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2
4843449|NCT01006616|16697751|P3|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
4843450|NCT01006616|16697752|P2|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0
4843451|NCT01006616|16697753|P1|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3
4843452|NCT01006616|16697750|P4|Period 2 (18 Months)|Lost to Follow-up|0
4843453|NCT01006616|16697751|P3|Period 2 (18 Months)|Lost to Follow-up|0
4843454|NCT01006616|16697752|P2|Period 2 (18 Months)|Lost to Follow-up|0
4843455|NCT01006616|16697753|P1|Period 2 (18 Months)|Lost to Follow-up|2
4843456|NCT01006616|16697750|P4|Period 2 (18 Months)|Lack of Efficacy|2
4843457|NCT01006616|16697751|P3|Period 2 (18 Months)|Lack of Efficacy|1
4843458|NCT01006616|16697752|P2|Period 2 (18 Months)|Lack of Efficacy|0
4843459|NCT01006616|16697753|P1|Period 2 (18 Months)|Lack of Efficacy|0
4843460|NCT01006616|16697750|P4|Period 2 (18 Months)|Adverse Event|4
4843461|NCT01006616|16697751|P3|Period 2 (18 Months)|Adverse Event|6
4843462|NCT01006616|16697752|P2|Period 2 (18 Months)|Adverse Event|6
4843463|NCT01006616|16697753|P1|Period 2 (18 Months)|Adverse Event|6
4843464|NCT01006616|16697750|P4|Period 1 (6 Months)|Not Treated|1
4843465|NCT01006616|16697751|P3|Period 1 (6 Months)|Not Treated|1
4843466|NCT01006616|16697752|P2|Period 1 (6 Months)|Not Treated|0
4843467|NCT01006616|16697753|P1|Period 1 (6 Months)|Not Treated|0
4843468|NCT01006616|16697750|P4|Period 1 (6 Months)|Noncompliance With Protocol|3
4843469|NCT01006616|16697751|P3|Period 1 (6 Months)|Noncompliance With Protocol|2
4843470|NCT01006616|16697752|P2|Period 1 (6 Months)|Noncompliance With Protocol|2
4843471|NCT01006616|16697753|P1|Period 1 (6 Months)|Noncompliance With Protocol|0
4843472|NCT01006616|16697750|P4|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
4843473|NCT01006616|16697751|P3|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
4843474|NCT01006616|16697752|P2|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7
4843475|NCT01006616|16697753|P1|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5
4843476|NCT01006616|16697750|P4|Period 1 (6 Months)|Withdrawal by Subject|0
4843477|NCT01006616|16697751|P3|Period 1 (6 Months)|Withdrawal by Subject|2
4843478|NCT01006616|16697752|P2|Period 1 (6 Months)|Withdrawal by Subject|2
4843479|NCT01006616|16697753|P1|Period 1 (6 Months)|Withdrawal by Subject|2
4843480|NCT01006616|16697750|P4|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2
4843481|NCT01006616|16697751|P3|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1
4843482|NCT01006616|16697752|P2|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3
4843483|NCT01006616|16697753|P1|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0
4843484|NCT01006616|16697750|P4|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3
4843485|NCT01006616|16697751|P3|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2
4843486|NCT01006616|16697752|P2|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5
4843487|NCT01006616|16697753|P1|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6
4843488|NCT01006616|16697750|P4|Period 1 (6 Months)|Lost to Follow-up|0
4843489|NCT01006616|16697751|P3|Period 1 (6 Months)|Lost to Follow-up|1
4843490|NCT01006616|16697752|P2|Period 1 (6 Months)|Lost to Follow-up|0
4843491|NCT01006616|16697753|P1|Period 1 (6 Months)|Lost to Follow-up|0
4843492|NCT01006616|16697750|P4|Period 1 (6 Months)|Lack of Efficacy|4
4843493|NCT01006616|16697751|P3|Period 1 (6 Months)|Lack of Efficacy|0
4843494|NCT01006616|16697752|P2|Period 1 (6 Months)|Lack of Efficacy|4
4843495|NCT01006616|16697753|P1|Period 1 (6 Months)|Lack of Efficacy|3
4843496|NCT01006616|16697750|P4|Period 1 (6 Months)|Adverse Event|9
4843497|NCT01006616|16697751|P3|Period 1 (6 Months)|Adverse Event|37
4843498|NCT01006616|16697752|P2|Period 1 (6 Months)|Adverse Event|31
4843499|NCT01006616|16697753|P1|Period 1 (6 Months)|Adverse Event|10
4843500|NCT01006603|16697889|P2|Overall Study|Other|7
4843501|NCT01006603|16697890|P1|Overall Study|Other|3
4843502|NCT01006603|16697889|P2|Overall Study|Study specific discontinuation criteria|34
4843503|NCT01006603|16697890|P1|Overall Study|Study specific discontinuation criteria|33
4843504|NCT01006603|16697889|P2|Overall Study|Death|1
4843505|NCT01006603|16697890|P1|Overall Study|Death|1
4843506|NCT01006603|16697889|P2|Overall Study|Adverse Event|7
4843507|NCT01006603|16697890|P1|Overall Study|Adverse Event|15
4843508|NCT01006603|16697889|P2|Overall Study|Incorrect enrolment|2
4843509|NCT01006603|16697890|P1|Overall Study|Incorrect enrolment|0
4843510|NCT01006603|16697889|P2|Overall Study|Protocol Violation|3
4843511|NCT01006603|16697890|P1|Overall Study|Protocol Violation|1
4843512|NCT01006603|16697889|P2|Overall Study|Safety reason|1
4843513|NCT01006603|16697890|P1|Overall Study|Safety reason|1
4843514|NCT01006603|16697889|P2|Overall Study|Lost to Follow-up|1
4843515|NCT01006603|16697890|P1|Overall Study|Lost to Follow-up|0
4843516|NCT01006603|16697889|P2|Overall Study|Withdrawal by Subject|19
4843517|NCT01006603|16697890|P1|Overall Study|Withdrawal by Subject|17
4843518|NCT01006590|16697910|P2|Overall Study|Other|2
4843519|NCT01006590|16697911|P1|Overall Study|Other|3
4843520|NCT01006590|16697910|P2|Overall Study|Study specific discontinuation criteria|23
4843521|NCT01006590|16697911|P1|Overall Study|Study specific discontinuation criteria|16
4843522|NCT01006590|16697910|P2|Overall Study|Withdrawal by Subject|2
4843523|NCT01006590|16697911|P1|Overall Study|Withdrawal by Subject|4
4843524|NCT01006590|16697910|P2|Overall Study|Protocol Violation|0
4843525|NCT01006590|16697911|P1|Overall Study|Protocol Violation|1
4843526|NCT01006590|16697910|P2|Overall Study|Lost to Follow-up|1
4843527|NCT01006590|16697911|P1|Overall Study|Lost to Follow-up|1
4843528|NCT01006590|16697910|P2|Overall Study|Death|1
4843529|NCT01006590|16697911|P1|Overall Study|Death|1
4843530|NCT01006590|16697910|P2|Overall Study|Adverse Event|3
4843531|NCT01006590|16697911|P1|Overall Study|Adverse Event|2
4843532|NCT01006356|16697950|P1|Overall Study|Other|23
4843533|NCT01006356|16697950|P1|Overall Study|Protocol Violation|3
4843534|NCT01006356|16697950|P1|Overall Study|Choice by participants|2
4843535|NCT01006356|16697950|P1|Overall Study|Withdrawal by Subject|1
4843536|NCT01006356|16697950|P1|Overall Study|Paticipants did not cooperate|6
4843537|NCT01006356|16697950|P1|Overall Study|Physician Decision|1
4843538|NCT01006356|16697950|P1|Overall Study|Adverse Event|6
4843539|NCT01006291|16697965|P3|Overall Study|Other|17
4843540|NCT01006291|16697966|P2|Overall Study|Other|14
4843541|NCT01006291|16697967|P1|Overall Study|Other|14
4843542|NCT01006291|16697965|P3|Overall Study|Withdrawal criteria|4
4843543|NCT01006291|16697966|P2|Overall Study|Withdrawal criteria|4
4843544|NCT01006291|16697967|P1|Overall Study|Withdrawal criteria|5
4843545|NCT01006291|16697965|P3|Overall Study|Protocol Violation|3
4843546|NCT01006291|16697966|P2|Overall Study|Protocol Violation|3
4843547|NCT01006291|16697967|P1|Overall Study|Protocol Violation|3
4843548|NCT01006291|16697965|P3|Overall Study|Lack of Efficacy|1
4843549|NCT01006291|16697966|P2|Overall Study|Lack of Efficacy|2
4843550|NCT01006291|16697967|P1|Overall Study|Lack of Efficacy|2
4843551|NCT01006291|16697965|P3|Overall Study|Adverse Event|2
4843552|NCT01006291|16697966|P2|Overall Study|Adverse Event|1
4843553|NCT01006291|16697967|P1|Overall Study|Adverse Event|2
4843554|NCT01006135|16698017|P1|Overall Study|Other|72
4843555|NCT01006135|16698017|P1|Overall Study|Lost to Follow-up|32
4843556|NCT01006135|16698017|P1|Overall Study|Protocol Violation|14
4843557|NCT01006135|16698017|P1|Overall Study|Adverse Event|22
4843558|NCT01006122|16698024|P2|Second Double-blind Intervention Period|Death|1
4843559|NCT01006122|16698025|P1|Second Double-blind Intervention Period|Death|0
4843560|NCT01006122|16698024|P2|Second Double-blind Intervention Period|Withdrawal by Subject|2
4843561|NCT01006122|16698025|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
4843562|NCT01006122|16698024|P2|Second Double-blind Intervention Period|Lost to Follow-up|3
4843563|NCT01006122|16698025|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
4843564|NCT01006122|16698024|P2|Second Double-blind Intervention Period|Protocol Violation|0
4843565|NCT01006122|16698025|P1|Second Double-blind Intervention Period|Protocol Violation|1
4843566|NCT01006122|16698024|P2|Second Double-blind Intervention Period|Adverse Event|1
4843567|NCT01006122|16698025|P1|Second Double-blind Intervention Period|Adverse Event|1
4843568|NCT01006122|16698024|P2|First Double-blind Intervention Period|Adverse Event|4
4843569|NCT01006122|16698025|P1|First Double-blind Intervention Period|Adverse Event|0
4843570|NCT01006122|16698024|P2|First Double-blind Intervention Period|Other|0
4843571|NCT01006122|16698025|P1|First Double-blind Intervention Period|Other|3
4843572|NCT01006122|16698024|P2|First Double-blind Intervention Period|Lack of Efficacy|1
4843573|NCT01006122|16698025|P1|First Double-blind Intervention Period|Lack of Efficacy|2
4843574|NCT01006122|16698024|P2|First Double-blind Intervention Period|Does not meet entrance criteria|0
4843575|NCT01006122|16698025|P1|First Double-blind Intervention Period|Does not meet entrance criteria|1
4843576|NCT01006122|16698024|P2|First Double-blind Intervention Period|Withdrawal by Subject|8
4843577|NCT01006122|16698025|P1|First Double-blind Intervention Period|Withdrawal by Subject|9
4843578|NCT01006122|16698024|P2|First Double-blind Intervention Period|Pregnancy|1
4843579|NCT01006122|16698025|P1|First Double-blind Intervention Period|Pregnancy|0
4843580|NCT01006122|16698024|P2|First Double-blind Intervention Period|Protocol Violation|1
4843581|NCT01006122|16698025|P1|First Double-blind Intervention Period|Protocol Violation|1
4843582|NCT01006122|16698024|P2|First Double-blind Intervention Period|Lost to Follow-up|2
4843583|NCT01006122|16698025|P1|First Double-blind Intervention Period|Lost to Follow-up|0
4843584|NCT01005966|16698076|P5|Treatment Period 4 (14 Days)|Other Reason|1
4843585|NCT01005966|16698077|P4|Treatment Period 4 (14 Days)|Other Reason|0
4843586|NCT01005966|16698078|P3|Treatment Period 4 (14 Days)|Other Reason|0
4843587|NCT01005966|16698079|P2|Treatment Period 4 (14 Days)|Other Reason|0
4843588|NCT01005966|16698080|P1|Treatment Period 4 (14 Days)|Other Reason|0
4843589|NCT01005966|16698076|P5|Treatment Period 4 (14 Days)|Protocol Violation|0
4843590|NCT01005966|16698077|P4|Treatment Period 4 (14 Days)|Protocol Violation|0
4843591|NCT01005966|16698078|P3|Treatment Period 4 (14 Days)|Protocol Violation|0
4843592|NCT01005966|16698079|P2|Treatment Period 4 (14 Days)|Protocol Violation|1
4843593|NCT01005966|16698080|P1|Treatment Period 4 (14 Days)|Protocol Violation|0
4843594|NCT01005966|16698076|P5|Treatment Period 3 (14 Days)|Protocol Violation|1
4843595|NCT01005966|16698077|P4|Treatment Period 3 (14 Days)|Protocol Violation|0
4843596|NCT01005966|16698078|P3|Treatment Period 3 (14 Days)|Protocol Violation|0
4843597|NCT01005966|16698079|P2|Treatment Period 3 (14 Days)|Protocol Violation|1
4843598|NCT01005966|16698080|P1|Treatment Period 3 (14 Days)|Protocol Violation|0
4843599|NCT01005966|16698076|P5|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4843600|NCT01005966|16698077|P4|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4843601|NCT01005966|16698078|P3|Treatment Period 2 (14 Days)|Withdrawal by Subject|1
4843602|NCT01005966|16698079|P2|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4843603|NCT01005966|16698080|P1|Treatment Period 2 (14 Days)|Withdrawal by Subject|0
4843604|NCT01005966|16698076|P5|Treatment Period 2 (14 Days)|Protocol Violation|0
4843605|NCT01005966|16698077|P4|Treatment Period 2 (14 Days)|Protocol Violation|1
4843606|NCT01005966|16698078|P3|Treatment Period 2 (14 Days)|Protocol Violation|0
4843607|NCT01005966|16698079|P2|Treatment Period 2 (14 Days)|Protocol Violation|0
4843608|NCT01005966|16698080|P1|Treatment Period 2 (14 Days)|Protocol Violation|0
4843609|NCT01005966|16698076|P5|Treatment Period 2 (14 Days)|Adverse Event|0
4843610|NCT01005966|16698077|P4|Treatment Period 2 (14 Days)|Adverse Event|0
4843611|NCT01005966|16698078|P3|Treatment Period 2 (14 Days)|Adverse Event|1
4843612|NCT01005966|16698079|P2|Treatment Period 2 (14 Days)|Adverse Event|1
4843613|NCT01005966|16698080|P1|Treatment Period 2 (14 Days)|Adverse Event|0
4843614|NCT01005966|16698076|P5|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4843615|NCT01005966|16698077|P4|Washout Period 1 (4 Days)|Withdrawal by Subject|1
4843616|NCT01005966|16698078|P3|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4843617|NCT01005966|16698079|P2|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4843618|NCT01005966|16698080|P1|Washout Period 1 (4 Days)|Withdrawal by Subject|0
4843619|NCT01005966|16698076|P5|Treatment Period 1 (14 Days)|Protocol Violation|0
4843620|NCT01005966|16698077|P4|Treatment Period 1 (14 Days)|Protocol Violation|0
4843621|NCT01005966|16698078|P3|Treatment Period 1 (14 Days)|Protocol Violation|1
4843622|NCT01005966|16698079|P2|Treatment Period 1 (14 Days)|Protocol Violation|0
4843623|NCT01005966|16698080|P1|Treatment Period 1 (14 Days)|Protocol Violation|1
4843624|NCT01005966|16698076|P5|Treatment Period 1 (14 Days)|Adverse Event|0
4843625|NCT01005966|16698077|P4|Treatment Period 1 (14 Days)|Adverse Event|0
4843626|NCT01005966|16698078|P3|Treatment Period 1 (14 Days)|Adverse Event|0
4843627|NCT01005966|16698079|P2|Treatment Period 1 (14 Days)|Adverse Event|0
4843628|NCT01005966|16698080|P1|Treatment Period 1 (14 Days)|Adverse Event|1
4843629|NCT01005914|16698100|P1|Overall Study|Withdrawal by Subject|1
4843630|NCT01005914|16698100|P1|Overall Study|Lack of Efficacy|1
4843631|NCT01005914|16698100|P1|Overall Study|Death|4
4843632|NCT01005914|16698100|P1|Overall Study|Adverse Event|4
4843633|NCT01005901|16698106|P2|Overall Study|No longer requires study drug|1
4843634|NCT01005901|16698107|P1|Overall Study|No longer requires study drug|0
4843635|NCT01005901|16698106|P2|Overall Study|Patient's inability to use the device|1
4843636|NCT01005901|16698107|P1|Overall Study|Patient's inability to use the device|1
4843637|NCT01005901|16698106|P2|Overall Study|Lost to Follow-up|2
4843638|NCT01005901|16698107|P1|Overall Study|Lost to Follow-up|1
4843639|NCT01005901|16698106|P2|Overall Study|Death|3
4843640|NCT01005901|16698107|P1|Overall Study|Death|2
4843641|NCT01005901|16698106|P2|Overall Study|Protocol Violation|3
4843642|NCT01005901|16698107|P1|Overall Study|Protocol Violation|4
4843643|NCT01005901|16698106|P2|Overall Study|Unsatisfactory therapeutic effect|5
4843644|NCT01005901|16698107|P1|Overall Study|Unsatisfactory therapeutic effect|5
4843645|NCT01005901|16698106|P2|Overall Study|Administrative problems|13
4843646|NCT01005901|16698107|P1|Overall Study|Administrative problems|21
4843647|NCT01005901|16698106|P2|Overall Study|Adverse Event|16
4843648|NCT01005901|16698107|P1|Overall Study|Adverse Event|30
4843649|NCT01005901|16698106|P2|Overall Study|Withdrawal by Subject|14
4843650|NCT01005901|16698107|P1|Overall Study|Withdrawal by Subject|38
4843651|NCT01005875|16698170|P1|Overall Study|Death|3
4843652|NCT01005745|16698187|P1|Overall Study|Inappropriate antidiuretic hormone|1
4843653|NCT01005745|16698187|P1|Overall Study|Death prior to treatment|1
4843654|NCT01005745|16698187|P1|Overall Study|Disease progressed during TIL growth|3
4843655|NCT01005745|16698187|P1|Overall Study|No TIL growth|1
4843656|NCT01005732|16698192|P1|Overall Study|Death|1
4843657|NCT01005732|16698192|P1|Overall Study|Lost to Follow-up|10
4843658|NCT01005719|16698208|P6|Period 2|Adverse Event|1
4843659|NCT01005719|16698209|P5|Period 2|Adverse Event|1
4843660|NCT01005719|16698210|P4|Period 2|Adverse Event|0
4843661|NCT01005719|16698211|P3|Period 2|Adverse Event|0
4843662|NCT01005719|16698212|P2|Period 2|Adverse Event|0
4843663|NCT01005719|16698213|P1|Period 2|Adverse Event|0
4843664|NCT01005719|16698208|P6|Period 1|Delay in completing study procedures|1
4843665|NCT01005719|16698209|P5|Period 1|Delay in completing study procedures|0
4843666|NCT01005719|16698210|P4|Period 1|Delay in completing study procedures|0
4843667|NCT01005719|16698211|P3|Period 1|Delay in completing study procedures|0
4843668|NCT01005719|16698212|P2|Period 1|Delay in completing study procedures|0
4843669|NCT01005719|16698213|P1|Period 1|Delay in completing study procedures|0
4843670|NCT01005719|16698208|P6|Period 1|Adverse Event|0
4843671|NCT01005719|16698209|P5|Period 1|Adverse Event|0
4843672|NCT01005719|16698210|P4|Period 1|Adverse Event|1
4843673|NCT01005719|16698211|P3|Period 1|Adverse Event|0
4843674|NCT01005719|16698212|P2|Period 1|Adverse Event|0
4843675|NCT01005719|16698213|P1|Period 1|Adverse Event|0
4843676|NCT01005680|16698280|P2|Overall Study|Physician Decision|1
4843677|NCT01005680|16698281|P1|Overall Study|Physician Decision|1
4843678|NCT01005680|16698280|P2|Overall Study|Withdrawal by Subject|4
4843679|NCT01005680|16698281|P1|Overall Study|Withdrawal by Subject|1
4843680|NCT01005680|16698280|P2|Overall Study|Lost to Follow-up|6
4843681|NCT01005680|16698281|P1|Overall Study|Lost to Follow-up|4
4843682|NCT01005602|16698305|P2|Overall Study|Excluded due to unreliable clinical data|0
4843683|NCT01005602|16698306|P1|Overall Study|Excluded due to unreliable clinical data|1
4843684|NCT01005329|16698394|P1|Overall Study|Ineligible or received no protocol trt.|4
4843685|NCT01005316|16698407|P4|Overall Study|Retransplanted|0
4843686|NCT01005316|16698408|P3|Overall Study|Retransplanted|0
4843687|NCT01005316|16698409|P2|Overall Study|Retransplanted|1
4843688|NCT01005316|16698410|P1|Overall Study|Retransplanted|0
4843689|NCT01005316|16698407|P4|Overall Study|Transferred Care|3
4843690|NCT01005316|16698408|P3|Overall Study|Transferred Care|1
4843691|NCT01005316|16698409|P2|Overall Study|Transferred Care|0
4843692|NCT01005316|16698410|P1|Overall Study|Transferred Care|1
4843693|NCT01005316|16698407|P4|Overall Study|Delisted|0
4843694|NCT01005316|16698408|P3|Overall Study|Delisted|0
4843695|NCT01005316|16698409|P2|Overall Study|Delisted|0
4843696|NCT01005316|16698410|P1|Overall Study|Delisted|8
4843697|NCT01005316|16698407|P4|Overall Study|Consented to Another Study|0
4843698|NCT01005316|16698408|P3|Overall Study|Consented to Another Study|0
4843699|NCT01005316|16698409|P2|Overall Study|Consented to Another Study|0
4843700|NCT01005316|16698410|P1|Overall Study|Consented to Another Study|2
4843701|NCT01005316|16698407|P4|Overall Study|Withdrawal by Subject|2
4843702|NCT01005316|16698408|P3|Overall Study|Withdrawal by Subject|0
4843703|NCT01005316|16698409|P2|Overall Study|Withdrawal by Subject|1
4843704|NCT01005316|16698410|P1|Overall Study|Withdrawal by Subject|1
4843705|NCT01005316|16698407|P4|Overall Study|Sponsor Decision|0
4843706|NCT01005316|16698408|P3|Overall Study|Sponsor Decision|0
4843707|NCT01005316|16698409|P2|Overall Study|Sponsor Decision|3
4843708|NCT01005316|16698410|P1|Overall Study|Sponsor Decision|6
4843709|NCT01005316|16698407|P4|Overall Study|Physician Decision|0
4843710|NCT01005316|16698408|P3|Overall Study|Physician Decision|0
4843711|NCT01005316|16698409|P2|Overall Study|Physician Decision|0
4843712|NCT01005316|16698410|P1|Overall Study|Physician Decision|6
4843713|NCT01005316|16698407|P4|Overall Study|Lost to Follow-up|2
4843714|NCT01005316|16698408|P3|Overall Study|Lost to Follow-up|0
4843715|NCT01005316|16698409|P2|Overall Study|Lost to Follow-up|3
4843716|NCT01005316|16698410|P1|Overall Study|Lost to Follow-up|1
4843717|NCT01005316|16698407|P4|Overall Study|Study Termination|85
4843718|NCT01005316|16698408|P3|Overall Study|Study Termination|9
4843719|NCT01005316|16698409|P2|Overall Study|Study Termination|63
4843720|NCT01005316|16698410|P1|Overall Study|Study Termination|5
4843721|NCT01005316|16698407|P4|Overall Study|Death|15
4843722|NCT01005316|16698408|P3|Overall Study|Death|1
4843723|NCT01005316|16698409|P2|Overall Study|Death|5
4843724|NCT01005316|16698410|P1|Overall Study|Death|20
4843725|NCT01005316|16698407|P4|Overall Study|Adverse Event|1
4843726|NCT01005316|16698408|P3|Overall Study|Adverse Event|0
4843727|NCT01005316|16698409|P2|Overall Study|Adverse Event|0
4843728|NCT01005316|16698410|P1|Overall Study|Adverse Event|0
4843729|NCT01005251|16698477|P5|Overall Study|Lack of Efficacy|0
4843730|NCT01005251|16698478|P4|Overall Study|Lack of Efficacy|1
4843731|NCT01005251|16698479|P3|Overall Study|Lack of Efficacy|1
4843732|NCT01005251|16698480|P2|Overall Study|Lack of Efficacy|0
4843733|NCT01005251|16698481|P1|Overall Study|Lack of Efficacy|0
4843734|NCT01005251|16698477|P5|Overall Study|Randomized in error|0
4843735|NCT01005251|16698478|P4|Overall Study|Randomized in error|1
4843736|NCT01005251|16698479|P3|Overall Study|Randomized in error|1
4843737|NCT01005251|16698480|P2|Overall Study|Randomized in error|0
4843738|NCT01005251|16698481|P1|Overall Study|Randomized in error|0
4843739|NCT01005251|16698477|P5|Overall Study|Wrong drug dispensed|0
4843740|NCT01005251|16698478|P4|Overall Study|Wrong drug dispensed|0
4843741|NCT01005251|16698479|P3|Overall Study|Wrong drug dispensed|0
4843742|NCT01005251|16698480|P2|Overall Study|Wrong drug dispensed|1
4843743|NCT01005251|16698481|P1|Overall Study|Wrong drug dispensed|0
4843744|NCT01005251|16698477|P5|Overall Study|Patient moved|0
4843745|NCT01005251|16698478|P4|Overall Study|Patient moved|0
4843746|NCT01005251|16698479|P3|Overall Study|Patient moved|0
4843747|NCT01005251|16698480|P2|Overall Study|Patient moved|0
4843748|NCT01005251|16698481|P1|Overall Study|Patient moved|1
4843749|NCT01005251|16698477|P5|Overall Study|Physician Decision|2
4843750|NCT01005251|16698478|P4|Overall Study|Physician Decision|0
4843751|NCT01005251|16698479|P3|Overall Study|Physician Decision|0
4843752|NCT01005251|16698480|P2|Overall Study|Physician Decision|0
4843753|NCT01005251|16698481|P1|Overall Study|Physician Decision|0
4843754|NCT01005251|16698477|P5|Overall Study|Lost to Follow-up|0
4843755|NCT01005251|16698478|P4|Overall Study|Lost to Follow-up|0
4843756|NCT01005251|16698479|P3|Overall Study|Lost to Follow-up|2
4843757|NCT01005251|16698480|P2|Overall Study|Lost to Follow-up|4
4843758|NCT01005251|16698481|P1|Overall Study|Lost to Follow-up|1
4843759|NCT01005251|16698477|P5|Overall Study|Developed study-specific withdrawal crit|1
4843760|NCT01005251|16698478|P4|Overall Study|Developed study-specific withdrawal crit|0
4843761|NCT01005251|16698479|P3|Overall Study|Developed study-specific withdrawal crit|3
4843762|NCT01005251|16698480|P2|Overall Study|Developed study-specific withdrawal crit|0
4843763|NCT01005251|16698481|P1|Overall Study|Developed study-specific withdrawal crit|2
4843764|NCT01005251|16698477|P5|Overall Study|Protocol Violation|2
4843765|NCT01005251|16698478|P4|Overall Study|Protocol Violation|0
4843766|NCT01005251|16698479|P3|Overall Study|Protocol Violation|0
4843767|NCT01005251|16698480|P2|Overall Study|Protocol Violation|0
4843768|NCT01005251|16698481|P1|Overall Study|Protocol Violation|1
4843769|NCT01005251|16698477|P5|Overall Study|Adverse Event|4
4843770|NCT01005251|16698478|P4|Overall Study|Adverse Event|5
4843771|NCT01005251|16698479|P3|Overall Study|Adverse Event|8
4843772|NCT01005251|16698480|P2|Overall Study|Adverse Event|6
4843773|NCT01005251|16698481|P1|Overall Study|Adverse Event|2
4843774|NCT01005251|16698477|P5|Overall Study|Eligibility criteria not fulfilled|0
4843775|NCT01005251|16698478|P4|Overall Study|Eligibility criteria not fulfilled|1
4843776|NCT01005251|16698479|P3|Overall Study|Eligibility criteria not fulfilled|4
4843777|NCT01005251|16698480|P2|Overall Study|Eligibility criteria not fulfilled|0
4843778|NCT01005251|16698481|P1|Overall Study|Eligibility criteria not fulfilled|4
4843779|NCT01005251|16698477|P5|Overall Study|Withdrawal by Subject|9
4843780|NCT01005251|16698478|P4|Overall Study|Withdrawal by Subject|4
4843781|NCT01005251|16698479|P3|Overall Study|Withdrawal by Subject|3
4843782|NCT01005251|16698480|P2|Overall Study|Withdrawal by Subject|5
4843783|NCT01005251|16698481|P1|Overall Study|Withdrawal by Subject|2
4843784|NCT01004861|16698565|P13|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843785|NCT01004861|16698566|P12|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843786|NCT01004861|16698567|P11|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843787|NCT01004861|16698568|P10|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843788|NCT01004861|16698569|P9|Overall Study|Ongoing (as of 31 Jan 2018)|13
4843789|NCT01004861|16698570|P8|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843790|NCT01004861|16698571|P7|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843791|NCT01004861|16698572|P6|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843792|NCT01004861|16698573|P5|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843793|NCT01004861|16698574|P4|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843794|NCT01004861|16698575|P3|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843795|NCT01004861|16698576|P2|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843796|NCT01004861|16698577|P1|Overall Study|Ongoing (as of 31 Jan 2018)|0
4843797|NCT01004861|16698565|P13|Overall Study|Other|3
4843798|NCT01004861|16698566|P12|Overall Study|Other|2
4843799|NCT01004861|16698567|P11|Overall Study|Other|1
4843800|NCT01004861|16698568|P10|Overall Study|Other|2
4843801|NCT01004861|16698569|P9|Overall Study|Other|1
4843802|NCT01004861|16698570|P8|Overall Study|Other|0
4843803|NCT01004861|16698571|P7|Overall Study|Other|0
4843804|NCT01004861|16698572|P6|Overall Study|Other|0
4843805|NCT01004861|16698573|P5|Overall Study|Other|0
4843806|NCT01004861|16698574|P4|Overall Study|Other|0
4843807|NCT01004861|16698575|P3|Overall Study|Other|0
4843808|NCT01004861|16698576|P2|Overall Study|Other|0
4843809|NCT01004861|16698577|P1|Overall Study|Other|0
4843810|NCT01004861|16698565|P13|Overall Study|Non-compliance|1
4843811|NCT01004861|16698566|P12|Overall Study|Non-compliance|0
4843812|NCT01004861|16698567|P11|Overall Study|Non-compliance|0
4843813|NCT01004861|16698568|P10|Overall Study|Non-compliance|0
4843814|NCT01004861|16698569|P9|Overall Study|Non-compliance|5
4843815|NCT01004861|16698570|P8|Overall Study|Non-compliance|0
4843816|NCT01004861|16698571|P7|Overall Study|Non-compliance|0
4843817|NCT01004861|16698572|P6|Overall Study|Non-compliance|0
4843818|NCT01004861|16698573|P5|Overall Study|Non-compliance|0
4843819|NCT01004861|16698574|P4|Overall Study|Non-compliance|0
4843820|NCT01004861|16698575|P3|Overall Study|Non-compliance|0
4843821|NCT01004861|16698576|P2|Overall Study|Non-compliance|0
4843822|NCT01004861|16698577|P1|Overall Study|Non-compliance|0
4843823|NCT01004861|16698565|P13|Overall Study|Lost to Follow-up|0
4843824|NCT01004861|16698566|P12|Overall Study|Lost to Follow-up|1
4843825|NCT01004861|16698567|P11|Overall Study|Lost to Follow-up|0
4843826|NCT01004861|16698568|P10|Overall Study|Lost to Follow-up|0
4843827|NCT01004861|16698569|P9|Overall Study|Lost to Follow-up|1
4843828|NCT01004861|16698570|P8|Overall Study|Lost to Follow-up|1
4843829|NCT01004861|16698571|P7|Overall Study|Lost to Follow-up|0
4843830|NCT01004861|16698572|P6|Overall Study|Lost to Follow-up|0
4843831|NCT01004861|16698573|P5|Overall Study|Lost to Follow-up|0
4843832|NCT01004861|16698574|P4|Overall Study|Lost to Follow-up|0
4843833|NCT01004861|16698575|P3|Overall Study|Lost to Follow-up|0
4843834|NCT01004861|16698576|P2|Overall Study|Lost to Follow-up|0
4843835|NCT01004861|16698577|P1|Overall Study|Lost to Follow-up|0
4843836|NCT01004861|16698565|P13|Overall Study|Withdrawal by Subject|3
4843837|NCT01004861|16698566|P12|Overall Study|Withdrawal by Subject|2
4843838|NCT01004861|16698567|P11|Overall Study|Withdrawal by Subject|1
4843839|NCT01004861|16698568|P10|Overall Study|Withdrawal by Subject|1
4843840|NCT01004861|16698569|P9|Overall Study|Withdrawal by Subject|2
4843841|NCT01004861|16698570|P8|Overall Study|Withdrawal by Subject|0
4843842|NCT01004861|16698571|P7|Overall Study|Withdrawal by Subject|1
4843843|NCT01004861|16698572|P6|Overall Study|Withdrawal by Subject|0
4843844|NCT01004861|16698573|P5|Overall Study|Withdrawal by Subject|1
4843845|NCT01004861|16698574|P4|Overall Study|Withdrawal by Subject|0
4843846|NCT01004861|16698575|P3|Overall Study|Withdrawal by Subject|0
4843847|NCT01004861|16698576|P2|Overall Study|Withdrawal by Subject|0
4843848|NCT01004861|16698577|P1|Overall Study|Withdrawal by Subject|0
4843849|NCT01004861|16698565|P13|Overall Study|Protocol Violation|0
4843850|NCT01004861|16698566|P12|Overall Study|Protocol Violation|0
4843851|NCT01004861|16698567|P11|Overall Study|Protocol Violation|0
4843852|NCT01004861|16698568|P10|Overall Study|Protocol Violation|0
4843853|NCT01004861|16698569|P9|Overall Study|Protocol Violation|0
4843854|NCT01004861|16698570|P8|Overall Study|Protocol Violation|0
4843855|NCT01004861|16698571|P7|Overall Study|Protocol Violation|0
4843856|NCT01004861|16698572|P6|Overall Study|Protocol Violation|0
4843857|NCT01004861|16698573|P5|Overall Study|Protocol Violation|1
4843858|NCT01004861|16698574|P4|Overall Study|Protocol Violation|0
4843859|NCT01004861|16698575|P3|Overall Study|Protocol Violation|0
4843860|NCT01004861|16698576|P2|Overall Study|Protocol Violation|0
4843861|NCT01004861|16698577|P1|Overall Study|Protocol Violation|0
4843862|NCT01004861|16698565|P13|Overall Study|Adverse Event|2
4843863|NCT01004861|16698566|P12|Overall Study|Adverse Event|0
4843864|NCT01004861|16698567|P11|Overall Study|Adverse Event|1
4843865|NCT01004861|16698568|P10|Overall Study|Adverse Event|1
4843866|NCT01004861|16698569|P9|Overall Study|Adverse Event|13
4843867|NCT01004861|16698570|P8|Overall Study|Adverse Event|1
4843868|NCT01004861|16698571|P7|Overall Study|Adverse Event|1
4843869|NCT01004861|16698572|P6|Overall Study|Adverse Event|2
4843870|NCT01004861|16698573|P5|Overall Study|Adverse Event|0
4843871|NCT01004861|16698574|P4|Overall Study|Adverse Event|1
4843872|NCT01004861|16698575|P3|Overall Study|Adverse Event|0
4843873|NCT01004861|16698576|P2|Overall Study|Adverse Event|0
4843874|NCT01004861|16698577|P1|Overall Study|Adverse Event|0
4843875|NCT01004861|16698565|P13|Overall Study|Physician Decision|3
4843876|NCT01004861|16698566|P12|Overall Study|Physician Decision|0
4843877|NCT01004861|16698567|P11|Overall Study|Physician Decision|0
4843878|NCT01004861|16698568|P10|Overall Study|Physician Decision|0
4843879|NCT01004861|16698569|P9|Overall Study|Physician Decision|0
4843880|NCT01004861|16698570|P8|Overall Study|Physician Decision|1
4843881|NCT01004861|16698571|P7|Overall Study|Physician Decision|0
4843882|NCT01004861|16698572|P6|Overall Study|Physician Decision|0
4843883|NCT01004861|16698573|P5|Overall Study|Physician Decision|1
4843884|NCT01004861|16698574|P4|Overall Study|Physician Decision|1
4843885|NCT01004861|16698575|P3|Overall Study|Physician Decision|1
4843886|NCT01004861|16698576|P2|Overall Study|Physician Decision|2
4843887|NCT01004861|16698577|P1|Overall Study|Physician Decision|0
4843888|NCT01004861|16698565|P13|Overall Study|Disease progression|8
4843889|NCT01004861|16698566|P12|Overall Study|Disease progression|3
4843890|NCT01004861|16698567|P11|Overall Study|Disease progression|6
4843891|NCT01004861|16698568|P10|Overall Study|Disease progression|7
4843892|NCT01004861|16698569|P9|Overall Study|Disease progression|4
4843893|NCT01004861|16698570|P8|Overall Study|Disease progression|1
4843894|NCT01004861|16698571|P7|Overall Study|Disease progression|5
4843895|NCT01004861|16698572|P6|Overall Study|Disease progression|4
4843896|NCT01004861|16698573|P5|Overall Study|Disease progression|4
4843897|NCT01004861|16698574|P4|Overall Study|Disease progression|4
4843898|NCT01004861|16698575|P3|Overall Study|Disease progression|5
4843899|NCT01004861|16698576|P2|Overall Study|Disease progression|4
4843900|NCT01004861|16698577|P1|Overall Study|Disease progression|3
4843901|NCT01004848|16698643|P2|Overall Study|Lost to Follow-up|45
4843902|NCT01004848|16698644|P1|Overall Study|Lost to Follow-up|55
4843903|NCT01004822|16698682|P8|Overall Study|Other|0
4843904|NCT01004822|16698683|P7|Overall Study|Other|0
4843905|NCT01004822|16698684|P6|Overall Study|Other|1
4843906|NCT01004822|16698685|P5|Overall Study|Other|0
4843907|NCT01004822|16698686|P4|Overall Study|Other|1
4843908|NCT01004822|16698687|P3|Overall Study|Other|4
4843909|NCT01004822|16698688|P2|Overall Study|Other|0
4843910|NCT01004822|16698689|P1|Overall Study|Other|0
4843911|NCT01004822|16698682|P8|Overall Study|Adverse Event|1
4843912|NCT01004822|16698683|P7|Overall Study|Adverse Event|1
4843913|NCT01004822|16698684|P6|Overall Study|Adverse Event|0
4843914|NCT01004822|16698685|P5|Overall Study|Adverse Event|0
4843915|NCT01004822|16698686|P4|Overall Study|Adverse Event|0
4843916|NCT01004822|16698687|P3|Overall Study|Adverse Event|0
4843917|NCT01004822|16698688|P2|Overall Study|Adverse Event|0
4843918|NCT01004822|16698689|P1|Overall Study|Adverse Event|0
4843919|NCT01004822|16698682|P8|Overall Study|No longer willing to continue|0
4843920|NCT01004822|16698683|P7|Overall Study|No longer willing to continue|1
4843921|NCT01004822|16698684|P6|Overall Study|No longer willing to continue|1
4843922|NCT01004822|16698685|P5|Overall Study|No longer willing to continue|2
4843923|NCT01004822|16698686|P4|Overall Study|No longer willing to continue|1
4843924|NCT01004822|16698687|P3|Overall Study|No longer willing to continue|0
4843925|NCT01004822|16698688|P2|Overall Study|No longer willing to continue|0
4843926|NCT01004822|16698689|P1|Overall Study|No longer willing to continue|0
4843927|NCT01004822|16698682|P8|Overall Study|Global deterioration of health status|0
4843928|NCT01004822|16698683|P7|Overall Study|Global deterioration of health status|1
4843929|NCT01004822|16698684|P6|Overall Study|Global deterioration of health status|0
4843930|NCT01004822|16698685|P5|Overall Study|Global deterioration of health status|0
4843931|NCT01004822|16698686|P4|Overall Study|Global deterioration of health status|1
4843932|NCT01004822|16698687|P3|Overall Study|Global deterioration of health status|0
4843933|NCT01004822|16698688|P2|Overall Study|Global deterioration of health status|0
4843934|NCT01004822|16698689|P1|Overall Study|Global deterioration of health status|0
4843935|NCT01004822|16698682|P8|Overall Study|Objective progression or relapse|4
4843936|NCT01004822|16698683|P7|Overall Study|Objective progression or relapse|1
4843937|NCT01004822|16698684|P6|Overall Study|Objective progression or relapse|2
4843938|NCT01004822|16698685|P5|Overall Study|Objective progression or relapse|2
4843939|NCT01004822|16698686|P4|Overall Study|Objective progression or relapse|1
4843940|NCT01004822|16698687|P3|Overall Study|Objective progression or relapse|0
4843941|NCT01004822|16698688|P2|Overall Study|Objective progression or relapse|3
4843942|NCT01004822|16698689|P1|Overall Study|Objective progression or relapse|3
4843943|NCT01004614|16698854|P4|Washout|Withdrawal by Subject|0
4843944|NCT01004614|16698855|P3|Washout|Withdrawal by Subject|0
4843945|NCT01004614|16698856|P2|Washout|Withdrawal by Subject|1
4843946|NCT01004614|16698857|P1|Washout|Withdrawal by Subject|0
4843947|NCT01004510|16698891|P1|Overall Study|Adverse Event|1
4843948|NCT01004432|16698895|P5|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10
4843949|NCT01004432|16698896|P4|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4843950|NCT01004432|16698897|P3|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4843951|NCT01004432|16698898|P2|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4843952|NCT01004432|16698899|P1|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0
4843953|NCT01004432|16698895|P5|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2
4843954|NCT01004432|16698896|P4|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4843955|NCT01004432|16698897|P3|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4843956|NCT01004432|16698898|P2|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4843957|NCT01004432|16698899|P1|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0
4843958|NCT01004432|16698895|P5|OL Study Extension (Week 52 - 76)|Protocol Violation|4
4843959|NCT01004432|16698896|P4|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4843960|NCT01004432|16698897|P3|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4843961|NCT01004432|16698898|P2|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4843962|NCT01004432|16698899|P1|OL Study Extension (Week 52 - 76)|Protocol Violation|0
4843963|NCT01004432|16698895|P5|OL Study Extension (Week 52 - 76)|Adverse Event|2
4843964|NCT01004432|16698896|P4|OL Study Extension (Week 52 - 76)|Adverse Event|0
4843965|NCT01004432|16698897|P3|OL Study Extension (Week 52 - 76)|Adverse Event|0
4843966|NCT01004432|16698898|P2|OL Study Extension (Week 52 - 76)|Adverse Event|0
4843967|NCT01004432|16698899|P1|OL Study Extension (Week 52 - 76)|Adverse Event|0
4843968|NCT01004432|16698895|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
4843969|NCT01004432|16698896|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
4843970|NCT01004432|16698897|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1
4843971|NCT01004432|16698898|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3
4843972|NCT01004432|16698899|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0
4843973|NCT01004432|16698895|P5|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
4843974|NCT01004432|16698896|P4|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37
4843975|NCT01004432|16698897|P3|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24
4843976|NCT01004432|16698898|P2|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2
4843977|NCT01004432|16698899|P1|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0
4843978|NCT01004432|16698895|P5|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4843979|NCT01004432|16698896|P4|OL/Double-Blind (DB) Period (Week 16-52)|Death|1
4843980|NCT01004432|16698897|P3|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4843981|NCT01004432|16698898|P2|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4843982|NCT01004432|16698899|P1|OL/Double-Blind (DB) Period (Week 16-52)|Death|0
4843983|NCT01004432|16698895|P5|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
4843984|NCT01004432|16698896|P4|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7
4843985|NCT01004432|16698897|P3|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4
4843986|NCT01004432|16698898|P2|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1
4843987|NCT01004432|16698899|P1|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0
4843988|NCT01004432|16698895|P5|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
4843989|NCT01004432|16698896|P4|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4
4843990|NCT01004432|16698897|P3|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
4843991|NCT01004432|16698898|P2|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3
4843992|NCT01004432|16698899|P1|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0
4843993|NCT01004432|16698895|P5|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
4843994|NCT01004432|16698896|P4|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6
4843995|NCT01004432|16698897|P3|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5
4843996|NCT01004432|16698898|P2|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1
4843997|NCT01004432|16698899|P1|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0
4843998|NCT01004432|16698895|P5|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4843999|NCT01004432|16698896|P4|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4844000|NCT01004432|16698897|P3|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4844001|NCT01004432|16698898|P2|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0
4844002|NCT01004432|16698899|P1|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2
4844003|NCT01004432|16698895|P5|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4844004|NCT01004432|16698896|P4|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4844005|NCT01004432|16698897|P3|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4844006|NCT01004432|16698898|P2|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0
4844007|NCT01004432|16698899|P1|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15
4844008|NCT01004432|16698895|P5|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4844009|NCT01004432|16698896|P4|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4844010|NCT01004432|16698897|P3|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4844011|NCT01004432|16698898|P2|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0
4844012|NCT01004432|16698899|P1|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17
4844013|NCT01004432|16698895|P5|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4844014|NCT01004432|16698896|P4|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4844015|NCT01004432|16698897|P3|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4844016|NCT01004432|16698898|P2|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0
4844017|NCT01004432|16698899|P1|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29
4844018|NCT01004432|16698895|P5|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4844019|NCT01004432|16698896|P4|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4844020|NCT01004432|16698897|P3|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4844021|NCT01004432|16698898|P2|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0
4844022|NCT01004432|16698899|P1|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20
4844023|NCT01004406|16698921|P2|Overall Study|Lost to Follow-up|0
4844024|NCT01004406|16698922|P1|Overall Study|Lost to Follow-up|1
4844025|NCT01004406|16698921|P2|Overall Study|Withdrawal by Subject|0
4844026|NCT01004406|16698922|P1|Overall Study|Withdrawal by Subject|2
4844027|NCT01004263|16698957|P1|Overall Study|Lack of Qualifying Event|2
4844028|NCT01004263|16698957|P1|Overall Study|Physician Decision|15
4844029|NCT01004263|16698957|P1|Overall Study|Pregnancy|2
4844030|NCT01004263|16698957|P1|Overall Study|Lack of Efficacy|13
4844031|NCT01004263|16698957|P1|Overall Study|Lost to Follow-up|64
4844032|NCT01004263|16698957|P1|Overall Study|Protocol Violation|10
4844033|NCT01004263|16698957|P1|Overall Study|Withdrawal by Subject|58
4844034|NCT01004263|16698957|P1|Overall Study|Adverse Event|15
4844035|NCT01004250|16698965|P1|Follow-Up (FU) Period|Lost to Follow-up|1
4844036|NCT01004250|16698965|P1|Maintenance Therapy Period|Physician Decision|4
4844037|NCT01004250|16698965|P1|Maintenance Therapy Period|Withdrawal by Subject|5
4844038|NCT01004250|16698965|P1|Maintenance Therapy Period|Protocol Violation|1
4844039|NCT01004250|16698965|P1|Maintenance Therapy Period|Lost to Follow-up|1
4844040|NCT01004250|16698965|P1|Maintenance Therapy Period|Adverse Event|15
4844041|NCT01004250|16698965|P1|Induction Therapy Period|Physician Decision|2
4844042|NCT01004250|16698965|P1|Induction Therapy Period|Withdrawal by Subject|2
4844043|NCT01004250|16698965|P1|Induction Therapy Period|Entry Criteria Not Met|1
4844044|NCT01004250|16698965|P1|Induction Therapy Period|Adverse Event|10
4844045|NCT01004185|16698977|P2|Overall Study|Withdrawal by Subject|1
4844046|NCT01004185|16698978|P1|Overall Study|Withdrawal by Subject|2
4844047|NCT01004185|16698977|P2|Overall Study|Sponsor Terminated Study|5
4844048|NCT01004185|16698978|P1|Overall Study|Sponsor Terminated Study|4
4844049|NCT01004185|16698977|P2|Overall Study|Lack of Efficacy|1
4844050|NCT01004185|16698978|P1|Overall Study|Lack of Efficacy|2
4844051|NCT01004185|16698977|P2|Overall Study|Lost to Follow-up|1
4844052|NCT01004185|16698978|P1|Overall Study|Lost to Follow-up|0
4844053|NCT01004185|16698977|P2|Overall Study|Adverse Event|1
4844054|NCT01004185|16698978|P1|Overall Study|Adverse Event|1
4844055|NCT01004172|16698986|P1|Overall Study|Symptomatic Deterioration|2
4844056|NCT01004172|16698986|P1|Overall Study|Physician Decision|1
4844057|NCT01004172|16698986|P1|Overall Study|Adverse Event|1
4844058|NCT01004172|16698986|P1|Overall Study|Progressive Disease in CNS and Non-CNS|2
4844059|NCT01004172|16698986|P1|Overall Study|Progressive Disease in Non-CNS Only|16
4844060|NCT01004172|16698986|P1|Overall Study|Progressive Disease in CNS Only|16
4844061|NCT01004159|16698994|P1|Overall Study|Disease Progression|18
4844062|NCT01004159|16698994|P1|Overall Study|Adverse Event|2
4844063|NCT01004146|16699001|P2|Overall Study|Withdrawal by Subject|5
4844064|NCT01004146|16699002|P1|Overall Study|Withdrawal by Subject|4
4844065|NCT01004003|16699096|P9|Overall Study|Other|0
4844066|NCT01004003|16699097|P8|Overall Study|Other|0
4844067|NCT01004003|16699098|P7|Overall Study|Other|0
4844068|NCT01004003|16699099|P6|Overall Study|Other|1
4844069|NCT01004003|16699100|P5|Overall Study|Other|0
4844070|NCT01004003|16699101|P4|Overall Study|Other|0
4844071|NCT01004003|16699102|P3|Overall Study|Other|0
4844072|NCT01004003|16699103|P2|Overall Study|Other|0
4844073|NCT01004003|16699104|P1|Overall Study|Other|0
4844074|NCT01004003|16699096|P9|Overall Study|Refused to continue taking trial med.|2
4844075|NCT01004003|16699097|P8|Overall Study|Refused to continue taking trial med.|0
4844076|NCT01004003|16699098|P7|Overall Study|Refused to continue taking trial med.|0
4844077|NCT01004003|16699099|P6|Overall Study|Refused to continue taking trial med.|0
4844078|NCT01004003|16699100|P5|Overall Study|Refused to continue taking trial med.|0
4844079|NCT01004003|16699101|P4|Overall Study|Refused to continue taking trial med.|0
4844080|NCT01004003|16699102|P3|Overall Study|Refused to continue taking trial med.|0
4844081|NCT01004003|16699103|P2|Overall Study|Refused to continue taking trial med.|0
4844082|NCT01004003|16699104|P1|Overall Study|Refused to continue taking trial med.|0
4844083|NCT01004003|16699096|P9|Overall Study|Adverse Event|6
4844084|NCT01004003|16699097|P8|Overall Study|Adverse Event|21
4844085|NCT01004003|16699098|P7|Overall Study|Adverse Event|7
4844086|NCT01004003|16699099|P6|Overall Study|Adverse Event|2
4844087|NCT01004003|16699100|P5|Overall Study|Adverse Event|2
4844088|NCT01004003|16699101|P4|Overall Study|Adverse Event|3
4844089|NCT01004003|16699102|P3|Overall Study|Adverse Event|3
4844090|NCT01004003|16699103|P2|Overall Study|Adverse Event|2
4844091|NCT01004003|16699104|P1|Overall Study|Adverse Event|4
4844092|NCT01004003|16699096|P9|Overall Study|Progressive disease|22
4844093|NCT01004003|16699097|P8|Overall Study|Progressive disease|39
4844094|NCT01004003|16699098|P7|Overall Study|Progressive disease|1
4844095|NCT01004003|16699099|P6|Overall Study|Progressive disease|1
4844096|NCT01004003|16699100|P5|Overall Study|Progressive disease|2
4844097|NCT01004003|16699101|P4|Overall Study|Progressive disease|0
4844098|NCT01004003|16699102|P3|Overall Study|Progressive disease|1
4844099|NCT01004003|16699103|P2|Overall Study|Progressive disease|1
4844100|NCT01004003|16699104|P1|Overall Study|Progressive disease|2
4844101|NCT01003990|16699135|P3|Overall Study|Subject Withdrew Consent|7
4844102|NCT01003990|16699136|P2|Overall Study|Subject Withdrew Consent|5
4844103|NCT01003990|16699137|P1|Overall Study|Subject Withdrew Consent|12
4844104|NCT01003990|16699135|P3|Overall Study|No Longer Met Study Criteria|0
4844105|NCT01003990|16699136|P2|Overall Study|No Longer Met Study Criteria|1
4844106|NCT01003990|16699137|P1|Overall Study|No Longer Met Study Criteria|4
4844107|NCT01003990|16699135|P3|Overall Study|Pregnancy|4
4844108|NCT01003990|16699136|P2|Overall Study|Pregnancy|2
4844109|NCT01003990|16699137|P1|Overall Study|Pregnancy|10
4844110|NCT01003990|16699135|P3|Overall Study|Poor/Non-compliance|2
4844111|NCT01003990|16699136|P2|Overall Study|Poor/Non-compliance|3
4844112|NCT01003990|16699137|P1|Overall Study|Poor/Non-compliance|4
4844113|NCT01003990|16699135|P3|Overall Study|Reasons Not Identified|8
4844114|NCT01003990|16699136|P2|Overall Study|Reasons Not Identified|13
4844115|NCT01003990|16699137|P1|Overall Study|Reasons Not Identified|14
4844116|NCT01003990|16699135|P3|Overall Study|Lost to Follow-up|7
4844117|NCT01003990|16699136|P2|Overall Study|Lost to Follow-up|12
4844118|NCT01003990|16699137|P1|Overall Study|Lost to Follow-up|30
4844119|NCT01003990|16699135|P3|Overall Study|Lack of Efficacy|3
4844120|NCT01003990|16699136|P2|Overall Study|Lack of Efficacy|2
4844121|NCT01003990|16699137|P1|Overall Study|Lack of Efficacy|10
4844122|NCT01003990|16699135|P3|Overall Study|Death|1
4844123|NCT01003990|16699136|P2|Overall Study|Death|8
4844124|NCT01003990|16699137|P1|Overall Study|Death|0
4844125|NCT01003990|16699135|P3|Overall Study|Adverse Event|11
4844126|NCT01003990|16699136|P2|Overall Study|Adverse Event|5
4844127|NCT01003990|16699137|P1|Overall Study|Adverse Event|8
4844128|NCT01003899|16699154|P1|Overall Study|Progressive disease|34
4844129|NCT01003899|16699154|P1|Overall Study|Not treated|1
4844130|NCT01003899|16699154|P1|Overall Study|Not entered|4
4844131|NCT01003899|16699154|P1|Overall Study|Other Adverse Event|8
4844132|NCT01003886|16699163|P1|Overall Study|Adverse Event|3
4844133|NCT01003886|16699163|P1|Overall Study|Other|14
4844134|NCT01003886|16699163|P1|Overall Study|Withdrawal by Subject|39
4844135|NCT01003886|16699163|P1|Overall Study|Lost to Follow-up|169
4844136|NCT01003886|16699163|P1|Overall Study|Lack of Efficacy|5
4844137|NCT01003639|16699184|P2|Overall Study|Physician Decision|0
4844138|NCT01003639|16699185|P1|Overall Study|Physician Decision|1
4844139|NCT01003639|16699184|P2|Overall Study|Protocol Violation|1
4844140|NCT01003639|16699185|P1|Overall Study|Protocol Violation|0
4844141|NCT01003639|16699184|P2|Overall Study|Adverse Event|1
4844142|NCT01003639|16699185|P1|Overall Study|Adverse Event|0
4844143|NCT01003639|16699184|P2|Overall Study|Lack of Efficacy|6
4844144|NCT01003639|16699185|P1|Overall Study|Lack of Efficacy|1
4844145|NCT01003639|16699184|P2|Overall Study|Withdrawal by Subject|5
4844146|NCT01003639|16699185|P1|Overall Study|Withdrawal by Subject|9
4844147|NCT01003639|16699184|P2|Overall Study|Lost to Follow-up|9
4844148|NCT01003639|16699185|P1|Overall Study|Lost to Follow-up|6
4844149|NCT01003249|16699241|P2|Second Intervention (4 Weeks)|Adverse Event|0
4844150|NCT01003249|16699242|P1|Second Intervention (4 Weeks)|Adverse Event|1
4844151|NCT01003249|16699241|P2|Second Intervention (4 Weeks)|Withdrawal by Subject|1
4844152|NCT01003249|16699242|P1|Second Intervention (4 Weeks)|Withdrawal by Subject|0
4844153|NCT01003249|16699241|P2|First Intervention (4 Weeks)|Non-Serious Event|1
4844154|NCT01003249|16699242|P1|First Intervention (4 Weeks)|Non-Serious Event|1
4844155|NCT01003249|16699241|P2|First Intervention (4 Weeks)|Withdrawal by Subject|1
4844156|NCT01003249|16699242|P1|First Intervention (4 Weeks)|Withdrawal by Subject|1
4844157|NCT01003210|16699260|P2|Overall Study|Lost to Follow-up|3
4844158|NCT01003210|16699261|P1|Overall Study|Lost to Follow-up|1
4844159|NCT01003184|16699273|P2|Overall Study|Physician Decision|0
4844160|NCT01003184|16699274|P1|Overall Study|Physician Decision|1
4844161|NCT01003184|16699273|P2|Overall Study|Withdrawal by Subject|6
4844162|NCT01003184|16699274|P1|Overall Study|Withdrawal by Subject|1
4844163|NCT01003184|16699273|P2|Overall Study|Protocol Violation|0
4844164|NCT01003184|16699274|P1|Overall Study|Protocol Violation|3
4844165|NCT01003184|16699273|P2|Overall Study|Loss of glucose control|1
4844166|NCT01003184|16699274|P1|Overall Study|Loss of glucose control|1
4844167|NCT01003184|16699273|P2|Overall Study|Lost to Follow-up|0
4844168|NCT01003184|16699274|P1|Overall Study|Lost to Follow-up|1
4844169|NCT01003184|16699273|P2|Overall Study|Adverse Event|5
4844170|NCT01003184|16699274|P1|Overall Study|Adverse Event|12
4844171|NCT01002989|16699357|P1|Overall Study|exclusion criteria, no consent|5
4844172|NCT01002742|16699372|P2|Overall Study|Determined to be ineligible|1
4844173|NCT01002742|16699373|P1|Overall Study|Determined to be ineligible|0
4844174|NCT01002573|16699409|P2|Overall Study|Subject did not receive at least 1 dose|7
4844175|NCT01002573|16699410|P1|Overall Study|Subject did not receive at least 1 dose|11
4844176|NCT01002547|16699431|P3|Overall Study|Adverse Event|0
4844177|NCT01002547|16699432|P2|Overall Study|Adverse Event|0
4844178|NCT01002547|16699433|P1|Overall Study|Adverse Event|1
4844179|NCT01002547|16699431|P3|Overall Study|Death|2
4844180|NCT01002547|16699432|P2|Overall Study|Death|2
4844181|NCT01002547|16699433|P1|Overall Study|Death|0
4844182|NCT01002547|16699431|P3|Overall Study|Physician Decision|0
4844183|NCT01002547|16699432|P2|Overall Study|Physician Decision|0
4844184|NCT01002547|16699433|P1|Overall Study|Physician Decision|1
4844185|NCT01002547|16699431|P3|Overall Study|Lost to Follow-up|1
4844186|NCT01002547|16699432|P2|Overall Study|Lost to Follow-up|1
4844187|NCT01002547|16699433|P1|Overall Study|Lost to Follow-up|2
4844188|NCT01002547|16699431|P3|Overall Study|Withdrawal by Subject|5
4844189|NCT01002547|16699432|P2|Overall Study|Withdrawal by Subject|0
4844190|NCT01002547|16699433|P1|Overall Study|Withdrawal by Subject|4
4844191|NCT01002482|16699491|P2|Overall Study|Included twice|0
4844192|NCT01002482|16699492|P1|Overall Study|Included twice|1
4844193|NCT01002482|16699491|P2|Overall Study|Withdrawal by Subject|21
4844194|NCT01002482|16699492|P1|Overall Study|Withdrawal by Subject|14
4844195|NCT01002339|16699526|P3|Overall Study|Randomized. Not transplanted|1
4844196|NCT01002339|16699527|P2|Overall Study|Randomized. Not transplanted|0
4844197|NCT01002339|16699528|P1|Overall Study|Randomized. Not transplanted|0
4844198|NCT01002339|16699526|P3|Overall Study|Lung cancer detected before transplant|1
4844199|NCT01002339|16699527|P2|Overall Study|Lung cancer detected before transplant|0
4844200|NCT01002339|16699528|P1|Overall Study|Lung cancer detected before transplant|0
4844201|NCT01002339|16699526|P3|Overall Study|Protocol Violation|2
4844202|NCT01002339|16699527|P2|Overall Study|Protocol Violation|0
4844203|NCT01002339|16699528|P1|Overall Study|Protocol Violation|0
4844204|NCT01002339|16699526|P3|Overall Study|Incorrect treatment assignment|1
4844205|NCT01002339|16699527|P2|Overall Study|Incorrect treatment assignment|0
4844206|NCT01002339|16699528|P1|Overall Study|Incorrect treatment assignment|0
4844207|NCT01002339|16699526|P3|Overall Study|Withdrawal by Subject|0
4844208|NCT01002339|16699527|P2|Overall Study|Withdrawal by Subject|1
4844209|NCT01002339|16699528|P1|Overall Study|Withdrawal by Subject|0
4844210|NCT01002105|16699604|P2|Overall Study|condition worsened|2
4844211|NCT01002105|16699605|P1|Overall Study|condition worsened|4
4844212|NCT01002105|16699604|P2|Overall Study|non compliance|3
4844213|NCT01002105|16699605|P1|Overall Study|non compliance|5
4844214|NCT01002105|16699604|P2|Overall Study|Lost to Follow-up|16
4844215|NCT01002105|16699605|P1|Overall Study|Lost to Follow-up|10
4844216|NCT01001988|16699621|P1|Overall Study|Lost to Follow-up|15
4844217|NCT01001988|16699621|P1|Overall Study|Withdrawal by Subject|18
4844218|NCT01001988|16699621|P1|Overall Study|Protocol Violation|84
4844219|NCT01001832|16699639|P2|Follow-up Period|Other|1
4844220|NCT01001832|16699640|P1|Follow-up Period|Other|2
4844221|NCT01001832|16699639|P2|Follow-up Period|Follow-up no longer required /protocol|20
4844222|NCT01001832|16699640|P1|Follow-up Period|Follow-up no longer required /protocol|15
4844223|NCT01001832|16699639|P2|Follow-up Period|Withdrawal by Subject|0
4844224|NCT01001832|16699640|P1|Follow-up Period|Withdrawal by Subject|1
4844225|NCT01001832|16699639|P2|Long-term Period|Other|2
4844226|NCT01001832|16699640|P1|Long-term Period|Other|1
4844227|NCT01001832|16699639|P2|Long-term Period|Lack of Efficacy|2
4844228|NCT01001832|16699640|P1|Long-term Period|Lack of Efficacy|0
4844229|NCT01001832|16699639|P2|Long-term Period|Withdrawal by Subject|0
4844230|NCT01001832|16699640|P1|Long-term Period|Withdrawal by Subject|1
4844231|NCT01001832|16699639|P2|Long-term Period|Adverse Event|1
4844232|NCT01001832|16699640|P1|Long-term Period|Adverse Event|2
4844233|NCT01001832|16699639|P2|Short-term Period|Adverse Event|3
4844234|NCT01001832|16699640|P1|Short-term Period|Adverse Event|2
4844235|NCT01001767|16699698|P2|Overall Study|Physician Decision|0
4844236|NCT01001767|16699699|P1|Overall Study|Physician Decision|1
4844237|NCT01001767|16699698|P2|Overall Study|Lost to Follow-up|0
4844238|NCT01001767|16699699|P1|Overall Study|Lost to Follow-up|1
4844239|NCT01001767|16699698|P2|Overall Study|Protocol Violation|0
4844240|NCT01001767|16699699|P1|Overall Study|Protocol Violation|1
4844241|NCT01001767|16699698|P2|Overall Study|no baseline study performed|0
4844242|NCT01001767|16699699|P1|Overall Study|no baseline study performed|1
4844243|NCT01001702|16699705|P1|Overall Study|Lack of Efficacy per Investigator|3
4844244|NCT01001702|16699705|P1|Overall Study|Withdrawal by Subject|19
4844245|NCT01001702|16699705|P1|Overall Study|Investigator withdrew Subject|10
4844246|NCT01001702|16699705|P1|Overall Study|Subject met Withdrawal Criteria|22
4844247|NCT01001702|16699705|P1|Overall Study|Sponsor Discontinued Study|4
4844248|NCT01001702|16699705|P1|Overall Study|Adverse Event|7
4844249|NCT01001702|16699705|P1|Overall Study|Lost to Follow-up|7
4844250|NCT01001598|16699716|P1|Overall Study|Adverse Event|1
4844251|NCT01001598|16699716|P1|Overall Study|Hematopoietic Stem Cell Transplant|1
4844252|NCT01001572|16699724|P3|Double-Blind Treatment Phase|Lost to Follow-up|1
4844253|NCT01001572|16699725|P2|Double-Blind Treatment Phase|Lost to Follow-up|0
4844254|NCT01001572|16699726|P1|Double-Blind Treatment Phase|Lost to Follow-up|0
4844255|NCT01001572|16699724|P3|Double-Blind Treatment Phase|Protocol deviation|1
4844256|NCT01001572|16699725|P2|Double-Blind Treatment Phase|Protocol deviation|0
4844257|NCT01001572|16699726|P1|Double-Blind Treatment Phase|Protocol deviation|0
4844258|NCT01001572|16699724|P3|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1
4844259|NCT01001572|16699725|P2|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
4844260|NCT01001572|16699726|P1|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
4844261|NCT01001572|16699724|P3|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1
4844262|NCT01001572|16699725|P2|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
4844263|NCT01001572|16699726|P1|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0
4844264|NCT01001572|16699724|P3|Double-Blind Treatment Phase|Withdrawal by Subject|13
4844265|NCT01001572|16699725|P2|Double-Blind Treatment Phase|Withdrawal by Subject|8
4844266|NCT01001572|16699726|P1|Double-Blind Treatment Phase|Withdrawal by Subject|0
4844267|NCT01001572|16699724|P3|Double-Blind Treatment Phase|Adverse Event|2
4844268|NCT01001572|16699725|P2|Double-Blind Treatment Phase|Adverse Event|2
4844269|NCT01001572|16699726|P1|Double-Blind Treatment Phase|Adverse Event|0
4844270|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
4844271|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0
4844272|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45
4844273|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Administrative problems|0
4844274|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Administrative problems|0
4844275|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Administrative problems|82
4844276|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
4844277|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Lost to Follow-up|0
4844278|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Lost to Follow-up|4
4844279|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
4844280|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0
4844281|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1
4844282|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
4844283|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0
4844284|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7
4844285|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
4844286|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0
4844287|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96
4844288|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Adverse Event|0
4844289|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Adverse Event|0
4844290|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Adverse Event|11
4844291|NCT01001572|16699724|P3|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
4844292|NCT01001572|16699725|P2|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0
4844293|NCT01001572|16699726|P1|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32
4844294|NCT01001520|16699764|P2|Medication Period 2|Withdrawal by Subject|3
4844295|NCT01001520|16699765|P1|Medication Period 2|Withdrawal by Subject|0
4844296|NCT01001520|16699764|P2|Washout Period|Withdrawal by Subject|1
4844297|NCT01001520|16699765|P1|Washout Period|Withdrawal by Subject|2
4844298|NCT01001520|16699764|P2|Medication Period 1|Ineligible: Claustrophobia in fMRI|0
4844299|NCT01001520|16699765|P1|Medication Period 1|Ineligible: Claustrophobia in fMRI|2
4844300|NCT01001520|16699764|P2|Medication Period 1|Ineligible: fMRI contraindicated metal|2
4844301|NCT01001520|16699765|P1|Medication Period 1|Ineligible: fMRI contraindicated metal|0
4844302|NCT01001520|16699764|P2|Medication Period 1|Ineligible: Positive Urine Drug Screen|3
4844303|NCT01001520|16699765|P1|Medication Period 1|Ineligible: Positive Urine Drug Screen|0
4844304|NCT01001520|16699764|P2|Medication Period 1|Withdrawal by Subject|2
4844305|NCT01001520|16699765|P1|Medication Period 1|Withdrawal by Subject|2
4844306|NCT01001494|16699792|P3|Overall Study|Other|3
4844307|NCT01001494|16699793|P2|Overall Study|Other|1
4844308|NCT01001494|16699794|P1|Overall Study|Other|0
4844309|NCT01001494|16699792|P3|Overall Study|Lack of Efficacy|8
4844310|NCT01001494|16699793|P2|Overall Study|Lack of Efficacy|0
4844311|NCT01001494|16699794|P1|Overall Study|Lack of Efficacy|2
4844312|NCT01001494|16699792|P3|Overall Study|COPD exacerbation|5
4844313|NCT01001494|16699793|P2|Overall Study|COPD exacerbation|4
4844314|NCT01001494|16699794|P1|Overall Study|COPD exacerbation|3
4844315|NCT01001494|16699792|P3|Overall Study|Withdrawal by Subject|17
4844316|NCT01001494|16699793|P2|Overall Study|Withdrawal by Subject|7
4844317|NCT01001494|16699794|P1|Overall Study|Withdrawal by Subject|9
4844318|NCT01001494|16699792|P3|Overall Study|Lost to Follow-up|1
4844319|NCT01001494|16699793|P2|Overall Study|Lost to Follow-up|0
4844320|NCT01001494|16699794|P1|Overall Study|Lost to Follow-up|2
4844321|NCT01001494|16699792|P3|Overall Study|Protocol Violation|1
4844322|NCT01001494|16699793|P2|Overall Study|Protocol Violation|1
4844323|NCT01001494|16699794|P1|Overall Study|Protocol Violation|0
4844324|NCT01001494|16699792|P3|Overall Study|Adverse Event|6
4844325|NCT01001494|16699793|P2|Overall Study|Adverse Event|4
4844326|NCT01001494|16699794|P1|Overall Study|Adverse Event|8
4844327|NCT01001429|16699879|P2|Overall Study|surgery cancelled|1
4844328|NCT01001429|16699880|P1|Overall Study|surgery cancelled|0
4844329|NCT01001390|16699919|P2|Overall Study|Failure to wear AFO device|0
4844330|NCT01001390|16699920|P1|Overall Study|Failure to wear AFO device|2
4844331|NCT01001377|16699928|P2|Overall Study|Death|384
4844332|NCT01001377|16699929|P1|Overall Study|Death|391
4844333|NCT01001377|16699928|P2|Overall Study|Lost to Follow-up|17
4844334|NCT01001377|16699929|P1|Overall Study|Lost to Follow-up|14
4844335|NCT01001377|16699928|P2|Overall Study|Withdrawal by Subject|20
4844336|NCT01001377|16699929|P1|Overall Study|Withdrawal by Subject|19
4844337|NCT01001377|16699928|P2|Overall Study|Ineligibility determined|0
4844338|NCT01001377|16699929|P1|Overall Study|Ineligibility determined|2
4844339|NCT01001325|16699959|P2|Overall Study|Protocol Violation|0
4844340|NCT01001325|16699960|P1|Overall Study|Protocol Violation|2
4844341|NCT01001325|16699959|P2|Overall Study|Lost to Follow-up|10
4844342|NCT01001325|16699960|P1|Overall Study|Lost to Follow-up|16
4844343|NCT01001299|16699966|P1|Overall Study|Withdrew Consent|1
4844344|NCT01001299|16699966|P1|Overall Study|Began Taking Commercially Available Drug|2
4844345|NCT01001299|16699966|P1|Overall Study|Death|1
4844346|NCT01001299|16699966|P1|Overall Study|Adverse event or Intercurrent Illness|1
4844347|NCT01001299|16699966|P1|Overall Study|Insufficient Therapeutic Response|20
4844348|NCT01001234|16699995|P5|Overall Study|Not Treated: Lack of Qualifying Event|0
4844349|NCT01001234|16699996|P4|Overall Study|Not Treated: Lack of Qualifying Event|0
4844350|NCT01001234|16699997|P3|Overall Study|Not Treated: Lack of Qualifying Event|0
4844351|NCT01001234|16699998|P2|Overall Study|Not Treated: Lack of Qualifying Event|13
4844352|NCT01001234|16699999|P1|Overall Study|Not Treated: Lack of Qualifying Event|248
4844353|NCT01001234|16699995|P5|Overall Study|Not Treated: Physician Decision|0
4844354|NCT01001234|16699996|P4|Overall Study|Not Treated: Physician Decision|0
4844355|NCT01001234|16699997|P3|Overall Study|Not Treated: Physician Decision|0
4844356|NCT01001234|16699998|P2|Overall Study|Not Treated: Physician Decision|4
4844357|NCT01001234|16699999|P1|Overall Study|Not Treated: Physician Decision|37
4844358|NCT01001234|16699995|P5|Overall Study|Not Treated: Pregnancy|0
4844359|NCT01001234|16699996|P4|Overall Study|Not Treated: Pregnancy|0
4844360|NCT01001234|16699997|P3|Overall Study|Not Treated: Pregnancy|0
4844361|NCT01001234|16699998|P2|Overall Study|Not Treated: Pregnancy|0
4844362|NCT01001234|16699999|P1|Overall Study|Not Treated: Pregnancy|3
4844363|NCT01001234|16699995|P5|Overall Study|Not Treated: Lost to Follow-up|0
4844364|NCT01001234|16699996|P4|Overall Study|Not Treated: Lost to Follow-up|5
4844365|NCT01001234|16699997|P3|Overall Study|Not Treated: Lost to Follow-up|7
4844366|NCT01001234|16699998|P2|Overall Study|Not Treated: Lost to Follow-up|4
4844367|NCT01001234|16699999|P1|Overall Study|Not Treated: Lost to Follow-up|53
4844368|NCT01001234|16699995|P5|Overall Study|Not Treated: Protocol Violation|0
4844369|NCT01001234|16699996|P4|Overall Study|Not Treated: Protocol Violation|0
4844370|NCT01001234|16699997|P3|Overall Study|Not Treated: Protocol Violation|0
4844371|NCT01001234|16699998|P2|Overall Study|Not Treated: Protocol Violation|0
4844372|NCT01001234|16699999|P1|Overall Study|Not Treated: Protocol Violation|3
4844373|NCT01001234|16699995|P5|Overall Study|Not Treated: Withdrawal by Subject|0
4844374|NCT01001234|16699996|P4|Overall Study|Not Treated: Withdrawal by Subject|0
4844375|NCT01001234|16699997|P3|Overall Study|Not Treated: Withdrawal by Subject|2
4844376|NCT01001234|16699998|P2|Overall Study|Not Treated: Withdrawal by Subject|2
4844377|NCT01001234|16699999|P1|Overall Study|Not Treated: Withdrawal by Subject|23
4844378|NCT01001234|16699995|P5|Overall Study|Not Treated: Adverse Event|0
4844379|NCT01001234|16699996|P4|Overall Study|Not Treated: Adverse Event|0
4844380|NCT01001234|16699997|P3|Overall Study|Not Treated: Adverse Event|0
4844381|NCT01001234|16699998|P2|Overall Study|Not Treated: Adverse Event|0
4844382|NCT01001234|16699999|P1|Overall Study|Not Treated: Adverse Event|1
4844383|NCT01001234|16699995|P5|Overall Study|Physician Decision|0
4844384|NCT01001234|16699996|P4|Overall Study|Physician Decision|0
4844385|NCT01001234|16699997|P3|Overall Study|Physician Decision|0
4844386|NCT01001234|16699998|P2|Overall Study|Physician Decision|0
4844387|NCT01001234|16699999|P1|Overall Study|Physician Decision|1
4844388|NCT01001234|16699995|P5|Overall Study|Lost to Follow-up|0
4844389|NCT01001234|16699996|P4|Overall Study|Lost to Follow-up|2
4844390|NCT01001234|16699997|P3|Overall Study|Lost to Follow-up|1
4844391|NCT01001234|16699998|P2|Overall Study|Lost to Follow-up|0
4844392|NCT01001234|16699999|P1|Overall Study|Lost to Follow-up|0
4844393|NCT01001234|16699995|P5|Overall Study|Protocol Violation|0
4844394|NCT01001234|16699996|P4|Overall Study|Protocol Violation|18
4844395|NCT01001234|16699997|P3|Overall Study|Protocol Violation|19
4844396|NCT01001234|16699998|P2|Overall Study|Protocol Violation|3
4844397|NCT01001234|16699999|P1|Overall Study|Protocol Violation|34
4844398|NCT01001234|16699995|P5|Overall Study|Withdrawal by Subject|0
4844399|NCT01001234|16699996|P4|Overall Study|Withdrawal by Subject|0
4844400|NCT01001234|16699997|P3|Overall Study|Withdrawal by Subject|3
4844401|NCT01001234|16699998|P2|Overall Study|Withdrawal by Subject|0
4844402|NCT01001234|16699999|P1|Overall Study|Withdrawal by Subject|2
4844403|NCT01001221|16700015|P5|Overall Study|Not treated; protocol exclusion|0
4844404|NCT01001221|16700016|P4|Overall Study|Not treated; protocol exclusion|0
4844405|NCT01001221|16700017|P3|Overall Study|Not treated; protocol exclusion|1
4844406|NCT01001221|16700018|P2|Overall Study|Not treated; protocol exclusion|0
4844407|NCT01001221|16700019|P1|Overall Study|Not treated; protocol exclusion|0
4844408|NCT01001221|16700015|P5|Overall Study|Other|0
4844409|NCT01001221|16700016|P4|Overall Study|Other|0
4844410|NCT01001221|16700017|P3|Overall Study|Other|0
4844411|NCT01001221|16700018|P2|Overall Study|Other|1
4844412|NCT01001221|16700019|P1|Overall Study|Other|1
4844413|NCT01001221|16700015|P5|Overall Study|Disease progression|0
4844414|NCT01001221|16700016|P4|Overall Study|Disease progression|4
4844415|NCT01001221|16700017|P3|Overall Study|Disease progression|2
4844416|NCT01001221|16700018|P2|Overall Study|Disease progression|2
4844417|NCT01001221|16700019|P1|Overall Study|Disease progression|3
4844418|NCT01001221|16700015|P5|Overall Study|Adverse Event|0
4844419|NCT01001221|16700016|P4|Overall Study|Adverse Event|2
4844420|NCT01001221|16700017|P3|Overall Study|Adverse Event|0
4844421|NCT01001221|16700018|P2|Overall Study|Adverse Event|2
4844422|NCT01001221|16700019|P1|Overall Study|Adverse Event|1
4844423|NCT01001208|16700194|P2|Overall Study|Other|2
4844424|NCT01001208|16700195|P1|Overall Study|Other|0
4844425|NCT01001208|16700194|P2|Overall Study|Disease Progression|3
4844426|NCT01001208|16700195|P1|Overall Study|Disease Progression|0
4844427|NCT01001208|16700194|P2|Overall Study|Noncompliance|7
4844428|NCT01001208|16700195|P1|Overall Study|Noncompliance|4
4844429|NCT01001208|16700194|P2|Overall Study|Ineligibility Determined|2
4844430|NCT01001208|16700195|P1|Overall Study|Ineligibility Determined|4
4844431|NCT01001208|16700194|P2|Overall Study|Withdrawal by Subject|5
4844432|NCT01001208|16700195|P1|Overall Study|Withdrawal by Subject|4
4844433|NCT01001208|16700194|P2|Overall Study|Physician Decision|0
4844434|NCT01001208|16700195|P1|Overall Study|Physician Decision|1
4844435|NCT01001208|16700194|P2|Overall Study|Lost to Follow-up|9
4844436|NCT01001208|16700195|P1|Overall Study|Lost to Follow-up|5
4844437|NCT01001208|16700194|P2|Overall Study|Adverse Event|5
4844438|NCT01001208|16700195|P1|Overall Study|Adverse Event|10
4844439|NCT01001169|16700238|P2|Overall Study|Withdrawal by Subject|1
4844440|NCT01001169|16700239|P1|Overall Study|Withdrawal by Subject|2
4844441|NCT01001104|16700347|P4|Overall Study|Withdrawal by Subject|2
4844442|NCT01001104|16700348|P3|Overall Study|Withdrawal by Subject|0
4844443|NCT01001104|16700349|P2|Overall Study|Withdrawal by Subject|0
4844444|NCT01001104|16700350|P1|Overall Study|Withdrawal by Subject|0
4844445|NCT01001104|16700347|P4|Overall Study|Entry Criteria Not Met|1
4844446|NCT01001104|16700348|P3|Overall Study|Entry Criteria Not Met|0
4844447|NCT01001104|16700349|P2|Overall Study|Entry Criteria Not Met|0
4844448|NCT01001104|16700350|P1|Overall Study|Entry Criteria Not Met|0
4844449|NCT01001104|16700347|P4|Overall Study|Lost to Follow-up|0
4844450|NCT01001104|16700348|P3|Overall Study|Lost to Follow-up|1
4844451|NCT01001104|16700349|P2|Overall Study|Lost to Follow-up|0
4844452|NCT01001104|16700350|P1|Overall Study|Lost to Follow-up|0
4844453|NCT01001104|16700347|P4|Overall Study|Adverse Event|0
4844454|NCT01001104|16700348|P3|Overall Study|Adverse Event|0
4844455|NCT01001104|16700349|P2|Overall Study|Adverse Event|1
4844456|NCT01001104|16700350|P1|Overall Study|Adverse Event|2
4844457|NCT01000974|16700441|P3|Booster Vaccination Phase|Other|4
4844458|NCT01000974|16700442|P2|Booster Vaccination Phase|Other|6
4844459|NCT01000974|16700443|P1|Booster Vaccination Phase|Other|24
4844460|NCT01000974|16700441|P3|Booster Vaccination Phase|Lost to Follow-up|7
4844461|NCT01000974|16700442|P2|Booster Vaccination Phase|Lost to Follow-up|5
4844462|NCT01000974|16700443|P1|Booster Vaccination Phase|Lost to Follow-up|40
4844463|NCT01000974|16700441|P3|Booster Vaccination Phase|Withdrawal by Subject|1
4844464|NCT01000974|16700442|P2|Booster Vaccination Phase|Withdrawal by Subject|1
4844465|NCT01000974|16700443|P1|Booster Vaccination Phase|Withdrawal by Subject|3
4844466|NCT01000974|16700441|P3|Booster Vaccination Phase|Protocol Violation|2
4844467|NCT01000974|16700442|P2|Booster Vaccination Phase|Protocol Violation|0
4844468|NCT01000974|16700443|P1|Booster Vaccination Phase|Protocol Violation|0
4844469|NCT01000974|16700441|P3|Primary Vaccination Phase|Other|12
4844470|NCT01000974|16700442|P2|Primary Vaccination Phase|Other|9
4844471|NCT01000974|16700443|P1|Primary Vaccination Phase|Other|4
4844472|NCT01000974|16700441|P3|Primary Vaccination Phase|Adverse Event|2
4844473|NCT01000974|16700442|P2|Primary Vaccination Phase|Adverse Event|2
4844474|NCT01000974|16700443|P1|Primary Vaccination Phase|Adverse Event|14
4844475|NCT01000974|16700441|P3|Primary Vaccination Phase|Protocol Violation|2
4844476|NCT01000974|16700442|P2|Primary Vaccination Phase|Protocol Violation|3
4844477|NCT01000974|16700443|P1|Primary Vaccination Phase|Protocol Violation|40
4844478|NCT01000974|16700441|P3|Primary Vaccination Phase|Lost to Follow-up|26
4844479|NCT01000974|16700442|P2|Primary Vaccination Phase|Lost to Follow-up|19
4844480|NCT01000974|16700443|P1|Primary Vaccination Phase|Lost to Follow-up|171
4844481|NCT01000974|16700441|P3|Primary Vaccination Phase|Withdrawal by Subject|21
4844482|NCT01000974|16700442|P2|Primary Vaccination Phase|Withdrawal by Subject|17
4844483|NCT01000974|16700443|P1|Primary Vaccination Phase|Withdrawal by Subject|109
4844484|NCT01000961|16700550|P2|First Intervention (3 Weeks)|Infection after pre-planned surgery|1
4844485|NCT01000961|16700551|P1|First Intervention (3 Weeks)|Infection after pre-planned surgery|0
4844486|NCT01000961|16700550|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
4844487|NCT01000961|16700551|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
4844488|NCT01000805|16700574|P2|Overall Study|Sponsor Decision|1
4844489|NCT01000805|16700575|P1|Overall Study|Sponsor Decision|0
4844490|NCT01000805|16700574|P2|Overall Study|Withdrawal by Subject|6
4844491|NCT01000805|16700575|P1|Overall Study|Withdrawal by Subject|16
4844492|NCT01000805|16700574|P2|Overall Study|Protocol Violation|8
4844493|NCT01000805|16700575|P1|Overall Study|Protocol Violation|12
4844494|NCT01000805|16700574|P2|Overall Study|Physician Decision|1
4844495|NCT01000805|16700575|P1|Overall Study|Physician Decision|0
4844496|NCT01000805|16700574|P2|Overall Study|Lost to Follow-up|21
4844497|NCT01000805|16700575|P1|Overall Study|Lost to Follow-up|16
4844498|NCT01000805|16700574|P2|Overall Study|Lack of Efficacy|16
4844499|NCT01000805|16700575|P1|Overall Study|Lack of Efficacy|5
4844500|NCT01000805|16700574|P2|Overall Study|Adverse Event|9
4844501|NCT01000805|16700575|P1|Overall Study|Adverse Event|21
4844502|NCT01000727|16700609|P2|Overall Study|Study closed/terminated|24
4844503|NCT01000727|16700610|P1|Overall Study|Study closed/terminated|23
4844504|NCT01000727|16700609|P2|Overall Study|Withdrawal by Subject|109
4844505|NCT01000727|16700610|P1|Overall Study|Withdrawal by Subject|111
4844506|NCT01000727|16700609|P2|Overall Study|Lost to Follow-up|43
4844507|NCT01000727|16700610|P1|Overall Study|Lost to Follow-up|41
4844508|NCT01000649|16700675|P4|Overall Study|Lost to Follow-up|2
4844509|NCT01000649|16700676|P3|Overall Study|Lost to Follow-up|0
4844510|NCT01000649|16700677|P2|Overall Study|Lost to Follow-up|2
4844511|NCT01000649|16700678|P1|Overall Study|Lost to Follow-up|0
4844512|NCT01000649|16700675|P4|Overall Study|Adverse Event|4
4844513|NCT01000649|16700676|P3|Overall Study|Adverse Event|2
4844514|NCT01000649|16700677|P2|Overall Study|Adverse Event|1
4844515|NCT01000649|16700678|P1|Overall Study|Adverse Event|5
4844516|NCT01000610|16700759|P1|Overall Study|Treatment failure|1
4844517|NCT01000610|16700759|P1|Overall Study|Lost to Follow-up|4
4844518|NCT01000610|16700759|P1|Overall Study|Adverse Event|1
4844519|NCT01000506|16700770|P4|Overall Study|Withdrawal by Subject|7
4844520|NCT01000506|16700771|P3|Overall Study|Withdrawal by Subject|2
4844521|NCT01000506|16700772|P2|Overall Study|Withdrawal by Subject|8
4844522|NCT01000506|16700773|P1|Overall Study|Withdrawal by Subject|11
4844523|NCT01000506|16700770|P4|Overall Study|Physician Decision|3
4844524|NCT01000506|16700771|P3|Overall Study|Physician Decision|3
4844525|NCT01000506|16700772|P2|Overall Study|Physician Decision|3
4844526|NCT01000506|16700773|P1|Overall Study|Physician Decision|1
4844527|NCT01000506|16700770|P4|Overall Study|Lost to Follow-up|0
4844528|NCT01000506|16700771|P3|Overall Study|Lost to Follow-up|4
4844529|NCT01000506|16700772|P2|Overall Study|Lost to Follow-up|1
4844530|NCT01000506|16700773|P1|Overall Study|Lost to Follow-up|1
4844531|NCT01000506|16700770|P4|Overall Study|Protocol Violation|0
4844532|NCT01000506|16700771|P3|Overall Study|Protocol Violation|0
4844533|NCT01000506|16700772|P2|Overall Study|Protocol Violation|1
4844534|NCT01000506|16700773|P1|Overall Study|Protocol Violation|1
4844535|NCT01000506|16700770|P4|Overall Study|Lack of Efficacy|4
4844536|NCT01000506|16700771|P3|Overall Study|Lack of Efficacy|4
4844537|NCT01000506|16700772|P2|Overall Study|Lack of Efficacy|6
4844538|NCT01000506|16700773|P1|Overall Study|Lack of Efficacy|8
4844539|NCT01000506|16700770|P4|Overall Study|Adverse Event|9
4844540|NCT01000506|16700771|P3|Overall Study|Adverse Event|8
4844541|NCT01000506|16700772|P2|Overall Study|Adverse Event|5
4844542|NCT01000506|16700773|P1|Overall Study|Adverse Event|6
4844543|NCT01000493|16700817|P2|Overall Study|Withdrawal by Subject|7
4844544|NCT01000493|16700818|P1|Overall Study|Withdrawal by Subject|3
4844545|NCT01000493|16700817|P2|Overall Study|Physician Decision|1
4844546|NCT01000493|16700818|P1|Overall Study|Physician Decision|1
4844547|NCT01000493|16700817|P2|Overall Study|Lost to Follow-up|9
4844548|NCT01000493|16700818|P1|Overall Study|Lost to Follow-up|5
4844549|NCT01000493|16700817|P2|Overall Study|Study closed/terminated|23
4844550|NCT01000493|16700818|P1|Overall Study|Study closed/terminated|25
4844551|NCT01000493|16700817|P2|Overall Study|Protocol Violation|8
4844552|NCT01000493|16700818|P1|Overall Study|Protocol Violation|1
4844553|NCT01000493|16700817|P2|Overall Study|Lack of Efficacy|1
4844554|NCT01000493|16700818|P1|Overall Study|Lack of Efficacy|1
4844555|NCT01000493|16700817|P2|Overall Study|Adverse Event|6
4844556|NCT01000493|16700818|P1|Overall Study|Adverse Event|3
4844557|NCT01000480|16700868|P1|Concurrent Therapy Phase|Physician Decision|1
4844558|NCT01000480|16700868|P1|Concurrent Therapy Phase|Withdrawal by Subject|3
4844559|NCT01000480|16700868|P1|Concurrent Therapy Phase|Protocol Violation|2
4844560|NCT01000480|16700868|P1|Concurrent Therapy Phase|Adverse Event|4
4844561|NCT01000480|16700868|P1|Induction Phase|Entry Criteria Not Met|3
4844562|NCT01000480|16700868|P1|Induction Phase|Physician Decision|1
4844563|NCT01000480|16700868|P1|Induction Phase|Lost to Follow-up|1
4844564|NCT01000480|16700868|P1|Induction Phase|Adverse Event|2
4844565|NCT01000376|16700876|P2|Cycle 1 Day 1|Progressive Disease|0
4844566|NCT01000376|16700877|P1|Cycle 1 Day 1|Progressive Disease|1
4844567|NCT01000376|16700876|P2|Cycle 1 Day 1|Adverse Event|0
4844568|NCT01000376|16700877|P1|Cycle 1 Day 1|Adverse Event|1
4844569|NCT01000337|16700887|P2|Overall Study|Lost to Follow-up|3
4844570|NCT01000337|16700888|P1|Overall Study|Lost to Follow-up|4
4844571|NCT01000311|16700906|P2|Overall Study|Administrative reason|15
4844572|NCT01000311|16700907|P1|Overall Study|Administrative reason|9
4844573|NCT01000311|16700906|P2|Overall Study|Inappropriate enrollment|0
4844574|NCT01000311|16700907|P1|Overall Study|Inappropriate enrollment|2
4844575|NCT01000311|16700906|P2|Overall Study|Protocol Violation|2
4844576|NCT01000311|16700907|P1|Overall Study|Protocol Violation|1
4844577|NCT01000311|16700906|P2|Overall Study|Lost to Follow-up|24
4844578|NCT01000311|16700907|P1|Overall Study|Lost to Follow-up|15
4844579|NCT01000311|16700906|P2|Overall Study|Withdrawal by Subject|24
4844580|NCT01000311|16700907|P1|Overall Study|Withdrawal by Subject|16
4844581|NCT01000311|16700906|P2|Overall Study|Adverse Event|5
4844582|NCT01000311|16700907|P1|Overall Study|Adverse Event|2
4844583|NCT01000155|16700957|P1|Overall Study|Adverse Event|1
4844584|NCT01000155|16700957|P1|Overall Study|Withdrawal by Subject|1
4844585|NCT01000064|16700963|P2|Overall Study|Withdrawal by Subject|1
4844586|NCT01000064|16700964|P1|Overall Study|Withdrawal by Subject|1
4844587|NCT01000051|16700987|P2|Overall Study|Serious noncompliance|0
4844588|NCT01000051|16700988|P1|Overall Study|Serious noncompliance|1
4844589|NCT01000051|16700987|P2|Overall Study|Disease Progression|0
4844590|NCT01000051|16700988|P1|Overall Study|Disease Progression|1
4844591|NCT01000051|16700987|P2|Overall Study|Withdrawal by Subject|1
4844592|NCT01000051|16700988|P1|Overall Study|Withdrawal by Subject|1
4844593|NCT01000025|16700996|P2|Overall Study|Intercurrent Illness|7
4844594|NCT01000025|16700997|P1|Overall Study|Intercurrent Illness|26
4844595|NCT01000025|16700996|P2|Overall Study|Lack of Efficacy|208
4844596|NCT01000025|16700997|P1|Overall Study|Lack of Efficacy|363
4844597|NCT01000025|16700996|P2|Overall Study|Death|13
4844598|NCT01000025|16700997|P1|Overall Study|Death|23
4844599|NCT01000025|16700996|P2|Overall Study|Withdrawal by Subject|8
4844600|NCT01000025|16700997|P1|Overall Study|Withdrawal by Subject|13
4844601|NCT01000025|16700996|P2|Overall Study|Adverse Event|2
4844602|NCT01000025|16700997|P1|Overall Study|Adverse Event|43
4844603|NCT00999921|16701015|P2|Overall Study|Lost to Follow-up|19
4844604|NCT00999921|16701016|P1|Overall Study|Lost to Follow-up|10
4844605|NCT00999908|16701026|P3|Treatment Period 2|Protocol Violation|0
4844606|NCT00999908|16701027|P2|Treatment Period 2|Protocol Violation|0
4844607|NCT00999908|16701028|P1|Treatment Period 2|Protocol Violation|1
4844608|NCT00999908|16701026|P3|Treatment Period 1|Subject withdrew consent|0
4844609|NCT00999908|16701027|P2|Treatment Period 1|Subject withdrew consent|0
4844610|NCT00999908|16701028|P1|Treatment Period 1|Subject withdrew consent|2
4844611|NCT00999804|16701057|P2|Overall Study|Ineligible|0
4844612|NCT00999804|16701058|P1|Overall Study|Ineligible|3
4844613|NCT00999804|16701057|P2|Overall Study|Death|0
4844614|NCT00999804|16701058|P1|Overall Study|Death|1
4844615|NCT00999804|16701057|P2|Overall Study|Withdrawal by Subject|0
4844616|NCT00999804|16701058|P1|Overall Study|Withdrawal by Subject|4
4844617|NCT00999804|16701057|P2|Overall Study|Adverse Event|3
4844618|NCT00999804|16701058|P1|Overall Study|Adverse Event|4
4844619|NCT00999804|16701057|P2|Overall Study|Lack of Efficacy|2
4844620|NCT00999804|16701058|P1|Overall Study|Lack of Efficacy|9
4844621|NCT00999713|16701072|P2|Overall Study|Physician Decision|0
4844622|NCT00999713|16701073|P1|Overall Study|Physician Decision|2
4844623|NCT00999687|16701087|P1|Second Intervention|Lack of Efficacy|1
4844624|NCT00999687|16701087|P1|Second Intervention|Withdrawal by Subject|2
4844625|NCT00999687|16701087|P1|First Intervention|Withdrawal by Subject|1
4844626|NCT00999661|16701094|P1|Overall Study|Not meeting eligibility criteria|9
4844627|NCT00999661|16701094|P1|Overall Study|Withdrawal by Subject|1
4844628|NCT00999661|16701094|P1|Overall Study|Adverse Event|1
4844629|NCT00999661|16701094|P1|Overall Study|Lost to Follow-up|59
4844630|NCT00999596|16701115|P1|Overall Study|Statistical population not required|101
4844631|NCT00999544|16701120|P1|Overall Study|Withdrawal by Subject|1
4844632|NCT00999466|16701156|P3|Main Part|Adverse Event|2
4844633|NCT00999466|16701157|P2|Main Part|Adverse Event|4
4844634|NCT00999466|16701158|P1|Main Part|Adverse Event|0
4844635|NCT00999466|16701156|P3|Main Part|Withdrawal by Subject|2
4844636|NCT00999466|16701157|P2|Main Part|Withdrawal by Subject|0
4844637|NCT00999466|16701158|P1|Main Part|Withdrawal by Subject|0
4844638|NCT00999167|16701435|P3|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
4844639|NCT00999167|16701436|P2|Part B: Randomized, Placebo Controlled|Physician stopped drug|1
4844640|NCT00999167|16701437|P1|Part B: Randomized, Placebo Controlled|Physician stopped drug|0
4844641|NCT00999167|16701435|P3|Part B: Randomized, Placebo Controlled|Physician Decision|0
4844642|NCT00999167|16701436|P2|Part B: Randomized, Placebo Controlled|Physician Decision|1
4844643|NCT00999167|16701437|P1|Part B: Randomized, Placebo Controlled|Physician Decision|0
4844644|NCT00999167|16701435|P3|Part B: Randomized, Placebo Controlled|Noncompliance|0
4844645|NCT00999167|16701436|P2|Part B: Randomized, Placebo Controlled|Noncompliance|1
4844646|NCT00999167|16701437|P1|Part B: Randomized, Placebo Controlled|Noncompliance|0
4844647|NCT00999167|16701435|P3|Part B: Randomized, Placebo Controlled|Adverse Event|1
4844648|NCT00999167|16701436|P2|Part B: Randomized, Placebo Controlled|Adverse Event|6
4844649|NCT00999167|16701437|P1|Part B: Randomized, Placebo Controlled|Adverse Event|0
4844650|NCT00999167|16701435|P3|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4
4844651|NCT00999167|16701436|P2|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7
4844652|NCT00999167|16701437|P1|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0
4844653|NCT00999167|16701435|P3|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16
4844654|NCT00999167|16701436|P2|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19
4844655|NCT00999167|16701437|P1|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0
4844656|NCT00999167|16701435|P3|Part A: Open Label Safety run-in|Adverse Event|0
4844657|NCT00999167|16701436|P2|Part A: Open Label Safety run-in|Adverse Event|0
4844658|NCT00999167|16701437|P1|Part A: Open Label Safety run-in|Adverse Event|3
4844659|NCT00999167|16701435|P3|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
4844660|NCT00999167|16701436|P2|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0
4844661|NCT00999167|16701437|P1|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4
4844662|NCT00998985|16701575|P14|Overall Study|Protocol Violation|0
4844663|NCT00998985|16701576|P13|Overall Study|Protocol Violation|0
4844664|NCT00998985|16701577|P12|Overall Study|Protocol Violation|0
4844665|NCT00998985|16701578|P11|Overall Study|Protocol Violation|0
4844666|NCT00998985|16701579|P10|Overall Study|Protocol Violation|0
4844667|NCT00998985|16701580|P9|Overall Study|Protocol Violation|0
4844668|NCT00998985|16701581|P8|Overall Study|Protocol Violation|0
4844669|NCT00998985|16701582|P7|Overall Study|Protocol Violation|0
4844670|NCT00998985|16701583|P6|Overall Study|Protocol Violation|1
4844671|NCT00998985|16701584|P5|Overall Study|Protocol Violation|0
4844672|NCT00998985|16701585|P4|Overall Study|Protocol Violation|0
4844673|NCT00998985|16701586|P3|Overall Study|Protocol Violation|0
4844674|NCT00998985|16701587|P2|Overall Study|Protocol Violation|0
4844675|NCT00998985|16701588|P1|Overall Study|Protocol Violation|0
4844676|NCT00998985|16701575|P14|Overall Study|Withdrawal by Subject|0
4844677|NCT00998985|16701576|P13|Overall Study|Withdrawal by Subject|0
4844678|NCT00998985|16701577|P12|Overall Study|Withdrawal by Subject|0
4844679|NCT00998985|16701578|P11|Overall Study|Withdrawal by Subject|0
4844680|NCT00998985|16701579|P10|Overall Study|Withdrawal by Subject|0
4844681|NCT00998985|16701580|P9|Overall Study|Withdrawal by Subject|1
4844682|NCT00998985|16701581|P8|Overall Study|Withdrawal by Subject|0
4844683|NCT00998985|16701582|P7|Overall Study|Withdrawal by Subject|0
4844684|NCT00998985|16701583|P6|Overall Study|Withdrawal by Subject|0
4844685|NCT00998985|16701584|P5|Overall Study|Withdrawal by Subject|0
4844686|NCT00998985|16701585|P4|Overall Study|Withdrawal by Subject|0
4844687|NCT00998985|16701586|P3|Overall Study|Withdrawal by Subject|0
4844688|NCT00998985|16701587|P2|Overall Study|Withdrawal by Subject|0
4844689|NCT00998985|16701588|P1|Overall Study|Withdrawal by Subject|0
4844690|NCT00998881|16701656|P2|Overall Study|Personal matter|0
4844691|NCT00998881|16701657|P1|Overall Study|Personal matter|1
4844692|NCT00998881|16701656|P2|Overall Study|Withdrawal by Subject|0
4844693|NCT00998881|16701657|P1|Overall Study|Withdrawal by Subject|1
4844694|NCT00998881|16701656|P2|Overall Study|Physician Decision|0
4844695|NCT00998881|16701657|P1|Overall Study|Physician Decision|3
4844696|NCT00998881|16701656|P2|Overall Study|Lack of Efficacy|0
4844697|NCT00998881|16701657|P1|Overall Study|Lack of Efficacy|1
4844698|NCT00998881|16701656|P2|Overall Study|Adverse Event|2
4844699|NCT00998881|16701657|P1|Overall Study|Adverse Event|2
4844700|NCT00998790|16701676|P1|Overall Study|Withdrawal by Subject|21
4844701|NCT00998764|16701686|P2|Overall Study|Recurrent Episode of vasogenic edema|0
4844702|NCT00998764|16701687|P1|Overall Study|Recurrent Episode of vasogenic edema|1
4844703|NCT00998764|16701686|P2|Overall Study|Other|4
4844704|NCT00998764|16701687|P1|Overall Study|Other|4
4844705|NCT00998764|16701686|P2|Overall Study|Loss of Caregiver|3
4844706|NCT00998764|16701687|P1|Overall Study|Loss of Caregiver|0
4844707|NCT00998764|16701686|P2|Overall Study|Lost to Follow-up|1
4844708|NCT00998764|16701687|P1|Overall Study|Lost to Follow-up|1
4844709|NCT00998764|16701686|P2|Overall Study|Failed to Return|1
4844710|NCT00998764|16701687|P1|Overall Study|Failed to Return|1
4844711|NCT00998764|16701686|P2|Overall Study|Protocol Violation|1
4844712|NCT00998764|16701687|P1|Overall Study|Protocol Violation|0
4844713|NCT00998764|16701686|P2|Overall Study|Discontinuation of Study by Sponsor|217
4844714|NCT00998764|16701687|P1|Overall Study|Discontinuation of Study by Sponsor|164
4844715|NCT00998764|16701686|P2|Overall Study|Death|1
4844716|NCT00998764|16701687|P1|Overall Study|Death|3
4844717|NCT00998764|16701686|P2|Overall Study|Physician Decision|3
4844718|NCT00998764|16701687|P1|Overall Study|Physician Decision|3
4844719|NCT00998764|16701686|P2|Overall Study|Withdrawal by Subject|25
4844720|NCT00998764|16701687|P1|Overall Study|Withdrawal by Subject|19
4844721|NCT00998764|16701686|P2|Overall Study|Adverse Event|12
4844722|NCT00998764|16701687|P1|Overall Study|Adverse Event|17
4844723|NCT00998764|16701686|P2|Overall Study|Lack of Efficacy|6
4844724|NCT00998764|16701687|P1|Overall Study|Lack of Efficacy|3
4844725|NCT00998738|16701709|P1|Overall Study|Uknown|1
4844726|NCT00998400|16701777|P2|Overall Study|Logistical problems|0
4844727|NCT00998400|16701778|P1|Overall Study|Logistical problems|1
4844728|NCT00998400|16701777|P2|Overall Study|Lack of interest/motivation|2
4844729|NCT00998400|16701778|P1|Overall Study|Lack of interest/motivation|1
4844730|NCT00998335|16701823|P2|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2
4844731|NCT00998335|16701824|P1|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0
4844732|NCT00998309|16701852|P1|Overall Study|Protocol Violation|4
4844733|NCT00998296|16701919|P11|Overall Study|Reason other than those specified above|0
4844734|NCT00998296|16701920|P10|Overall Study|Reason other than those specified above|1
4844735|NCT00998296|16701921|P9|Overall Study|Reason other than those specified above|0
4844736|NCT00998296|16701922|P8|Overall Study|Reason other than those specified above|0
4844737|NCT00998296|16701923|P7|Overall Study|Reason other than those specified above|0
4844738|NCT00998296|16701924|P6|Overall Study|Reason other than those specified above|0
4844739|NCT00998296|16701925|P5|Overall Study|Reason other than those specified above|0
4844740|NCT00998296|16701926|P4|Overall Study|Reason other than those specified above|0
4844741|NCT00998296|16701927|P3|Overall Study|Reason other than those specified above|0
4844742|NCT00998296|16701928|P2|Overall Study|Reason other than those specified above|0
4844743|NCT00998296|16701929|P1|Overall Study|Reason other than those specified above|0
4844744|NCT00998296|16701919|P11|Overall Study|Refused to continue taking trial med.|0
4844745|NCT00998296|16701920|P10|Overall Study|Refused to continue taking trial med.|2
4844746|NCT00998296|16701921|P9|Overall Study|Refused to continue taking trial med.|0
4844747|NCT00998296|16701922|P8|Overall Study|Refused to continue taking trial med.|0
4844748|NCT00998296|16701923|P7|Overall Study|Refused to continue taking trial med.|0
4844749|NCT00998296|16701924|P6|Overall Study|Refused to continue taking trial med.|0
4844750|NCT00998296|16701925|P5|Overall Study|Refused to continue taking trial med.|0
4844751|NCT00998296|16701926|P4|Overall Study|Refused to continue taking trial med.|0
4844752|NCT00998296|16701927|P3|Overall Study|Refused to continue taking trial med.|0
4844753|NCT00998296|16701928|P2|Overall Study|Refused to continue taking trial med.|0
4844754|NCT00998296|16701929|P1|Overall Study|Refused to continue taking trial med.|0
4844755|NCT00998296|16701919|P11|Overall Study|Other adverse event|2
4844756|NCT00998296|16701920|P10|Overall Study|Other adverse event|1
4844757|NCT00998296|16701921|P9|Overall Study|Other adverse event|0
4844758|NCT00998296|16701922|P8|Overall Study|Other adverse event|0
4844759|NCT00998296|16701923|P7|Overall Study|Other adverse event|0
4844760|NCT00998296|16701924|P6|Overall Study|Other adverse event|0
4844761|NCT00998296|16701925|P5|Overall Study|Other adverse event|1
4844762|NCT00998296|16701926|P4|Overall Study|Other adverse event|0
4844763|NCT00998296|16701927|P3|Overall Study|Other adverse event|0
4844764|NCT00998296|16701928|P2|Overall Study|Other adverse event|0
4844765|NCT00998296|16701929|P1|Overall Study|Other adverse event|0
4844766|NCT00998296|16701919|P11|Overall Study|Dose limiting or dose reducing toxicity|0
4844767|NCT00998296|16701920|P10|Overall Study|Dose limiting or dose reducing toxicity|0
4844768|NCT00998296|16701921|P9|Overall Study|Dose limiting or dose reducing toxicity|2
4844769|NCT00998296|16701922|P8|Overall Study|Dose limiting or dose reducing toxicity|2
4844770|NCT00998296|16701923|P7|Overall Study|Dose limiting or dose reducing toxicity|0
4844771|NCT00998296|16701924|P6|Overall Study|Dose limiting or dose reducing toxicity|0
4844772|NCT00998296|16701925|P5|Overall Study|Dose limiting or dose reducing toxicity|1
4844773|NCT00998296|16701926|P4|Overall Study|Dose limiting or dose reducing toxicity|0
4844774|NCT00998296|16701927|P3|Overall Study|Dose limiting or dose reducing toxicity|0
4844775|NCT00998296|16701928|P2|Overall Study|Dose limiting or dose reducing toxicity|0
4844776|NCT00998296|16701929|P1|Overall Study|Dose limiting or dose reducing toxicity|0
4844777|NCT00998296|16701919|P11|Overall Study|Progressive disease|5
4844778|NCT00998296|16701920|P10|Overall Study|Progressive disease|14
4844779|NCT00998296|16701921|P9|Overall Study|Progressive disease|0
4844780|NCT00998296|16701922|P8|Overall Study|Progressive disease|0
4844781|NCT00998296|16701923|P7|Overall Study|Progressive disease|1
4844782|NCT00998296|16701924|P6|Overall Study|Progressive disease|0
4844783|NCT00998296|16701925|P5|Overall Study|Progressive disease|0
4844784|NCT00998296|16701926|P4|Overall Study|Progressive disease|0
4844785|NCT00998296|16701927|P3|Overall Study|Progressive disease|0
4844786|NCT00998296|16701928|P2|Overall Study|Progressive disease|1
4844787|NCT00998296|16701929|P1|Overall Study|Progressive disease|0
4844788|NCT00997984|16702032|P3|Overall Study|Work schedule|2
4844789|NCT00997984|16702033|P2|Overall Study|Work schedule|0
4844790|NCT00997984|16702034|P1|Overall Study|Work schedule|0
4844791|NCT00997984|16702032|P3|Overall Study|Suicidal ideation|1
4844792|NCT00997984|16702033|P2|Overall Study|Suicidal ideation|0
4844793|NCT00997984|16702034|P1|Overall Study|Suicidal ideation|0
4844794|NCT00997984|16702032|P3|Overall Study|Wrong medication dispensed|0
4844795|NCT00997984|16702033|P2|Overall Study|Wrong medication dispensed|1
4844796|NCT00997984|16702034|P1|Overall Study|Wrong medication dispensed|0
4844797|NCT00997984|16702032|P3|Overall Study|non-compliance|3
4844798|NCT00997984|16702033|P2|Overall Study|non-compliance|2
4844799|NCT00997984|16702034|P1|Overall Study|non-compliance|0
4844800|NCT00997984|16702032|P3|Overall Study|Met exclusion criteria|0
4844801|NCT00997984|16702033|P2|Overall Study|Met exclusion criteria|0
4844802|NCT00997984|16702034|P1|Overall Study|Met exclusion criteria|1
4844803|NCT00997984|16702032|P3|Overall Study|Lack of Efficacy|3
4844804|NCT00997984|16702033|P2|Overall Study|Lack of Efficacy|6
4844805|NCT00997984|16702034|P1|Overall Study|Lack of Efficacy|20
4844806|NCT00997984|16702032|P3|Overall Study|Lost to Follow-up|4
4844807|NCT00997984|16702033|P2|Overall Study|Lost to Follow-up|5
4844808|NCT00997984|16702034|P1|Overall Study|Lost to Follow-up|8
4844809|NCT00997984|16702032|P3|Overall Study|Withdrawal by Subject|5
4844810|NCT00997984|16702033|P2|Overall Study|Withdrawal by Subject|9
4844811|NCT00997984|16702034|P1|Overall Study|Withdrawal by Subject|6
4844812|NCT00997984|16702032|P3|Overall Study|Protocol Violation|0
4844813|NCT00997984|16702033|P2|Overall Study|Protocol Violation|3
4844814|NCT00997984|16702034|P1|Overall Study|Protocol Violation|1
4844815|NCT00997984|16702032|P3|Overall Study|Adverse Event|8
4844816|NCT00997984|16702033|P2|Overall Study|Adverse Event|8
4844817|NCT00997984|16702034|P1|Overall Study|Adverse Event|1
4844818|NCT00997503|16702192|P1|Overall Study|Other reason|13
4844819|NCT00997503|16702192|P1|Overall Study|Missed 12-month follow-up|85
4844820|NCT00997503|16702192|P1|Overall Study|Physician Decision|10
4844821|NCT00997503|16702192|P1|Overall Study|Adverse Event|3
4844822|NCT00997503|16702192|P1|Overall Study|Lost to Follow-up|33
4844823|NCT00997503|16702192|P1|Overall Study|Withdrawal by Subject|76
4844824|NCT00997503|16702192|P1|Overall Study|Death|53
4844825|NCT00997438|16702235|P3|Overall Study|Exclusion criteria at visit 1|3
4844826|NCT00997438|16702236|P2|Overall Study|Exclusion criteria at visit 1|2
4844827|NCT00997438|16702237|P1|Overall Study|Exclusion criteria at visit 1|2
4844828|NCT00997438|16702235|P3|Overall Study|Withdrawal by Subject|0
4844829|NCT00997438|16702236|P2|Overall Study|Withdrawal by Subject|1
4844830|NCT00997438|16702237|P1|Overall Study|Withdrawal by Subject|1
4844831|NCT00997438|16702235|P3|Overall Study|Blood draw difficulty|1
4844832|NCT00997438|16702236|P2|Overall Study|Blood draw difficulty|0
4844833|NCT00997438|16702237|P1|Overall Study|Blood draw difficulty|2
4844834|NCT00997386|16702277|P1|Overall Study|Death|7
4844835|NCT00997373|16702286|P2|Overall Study|could not have hysterectomy|0
4844836|NCT00997373|16702287|P1|Overall Study|could not have hysterectomy|6
4844837|NCT00997373|16702286|P2|Overall Study|wrong tumor type|0
4844838|NCT00997373|16702287|P1|Overall Study|wrong tumor type|4
4844839|NCT00997373|16702286|P2|Overall Study|Withdrawal by Subject|0
4844840|NCT00997373|16702287|P1|Overall Study|Withdrawal by Subject|5
4844841|NCT00997334|16702293|P1|Overall Study|Ineligible|1
4844842|NCT00997334|16702293|P1|Overall Study|No lesion amenable|1
4844843|NCT00997334|16702293|P1|Overall Study|Urgent Palliative Care|2
4844844|NCT00997334|16702293|P1|Overall Study|Death|2
4844845|NCT00997334|16702293|P1|Overall Study|Withdrawal by Subject|3
4844846|NCT00997334|16702293|P1|Overall Study|Patient non-compliance|1
4844847|NCT00997334|16702293|P1|Overall Study|Adverse Event|3
4844848|NCT00997334|16702293|P1|Overall Study|still on therapy|12
4844849|NCT00997321|16702302|P2|Overall Study|did not undergo sedation after enrollmen|3
4844850|NCT00997321|16702303|P1|Overall Study|did not undergo sedation after enrollmen|0
4844851|NCT00997243|16702315|P1|Overall Study|Early termination of study by sponsor|7
4844852|NCT00997126|16702347|P2|Overall Study|Physician Decision|11
4844853|NCT00997126|16702348|P1|Overall Study|Physician Decision|7
4844854|NCT00997035|16702377|P2|3-month Follow-up Visit|Lost to Follow-up|6
4844855|NCT00997035|16702378|P1|3-month Follow-up Visit|Lost to Follow-up|12
4844856|NCT00997035|16702377|P2|3-week Followup Visit|Lost to Follow-up|6
4844857|NCT00997035|16702378|P1|3-week Followup Visit|Lost to Follow-up|9
4844858|NCT00996996|16702402|P1|Overall Study|Did Not Receive Study Medications|1
4844859|NCT00996996|16702402|P1|Overall Study|Death|5
4844860|NCT00996996|16702402|P1|Overall Study|Lost to Follow-up|9
4844861|NCT00996996|16702402|P1|Overall Study|Non-compliance|8
4844862|NCT00996996|16702402|P1|Overall Study|Progressive Disease|10
4844863|NCT00996944|16702436|P2|Long-term Treatment Period|Study Closed/Terminated|5
4844864|NCT00996944|16702437|P1|Long-term Treatment Period|Study Closed/Terminated|12
4844865|NCT00996944|16702436|P2|Double-blind Treatment Period|Withdrawal by Subject|1
4844866|NCT00996944|16702437|P1|Double-blind Treatment Period|Withdrawal by Subject|1
4844867|NCT00996944|16702436|P2|Double-blind Treatment Period|Study Closed/Terminated|5
4844868|NCT00996944|16702437|P1|Double-blind Treatment Period|Study Closed/Terminated|6
4844869|NCT00996944|16702436|P2|Double-blind Treatment Period|Protocol Violation|0
4844870|NCT00996944|16702437|P1|Double-blind Treatment Period|Protocol Violation|1
4844871|NCT00996944|16702436|P2|Double-blind Treatment Period|Adverse Event|1
4844872|NCT00996944|16702437|P1|Double-blind Treatment Period|Adverse Event|2
4844873|NCT00996918|16702489|P5|Overall Study|Other|0
4844874|NCT00996918|16702490|P4|Overall Study|Other|0
4844875|NCT00996918|16702491|P3|Overall Study|Other|0
4844876|NCT00996918|16702492|P2|Overall Study|Other|1
4844877|NCT00996918|16702493|P1|Overall Study|Other|3
4844878|NCT00996918|16702489|P5|Overall Study|Loss of Caregiver|0
4844879|NCT00996918|16702490|P4|Overall Study|Loss of Caregiver|0
4844880|NCT00996918|16702491|P3|Overall Study|Loss of Caregiver|0
4844881|NCT00996918|16702492|P2|Overall Study|Loss of Caregiver|1
4844882|NCT00996918|16702493|P1|Overall Study|Loss of Caregiver|0
4844883|NCT00996918|16702489|P5|Overall Study|Discontinuation of Study by Sponsor|2
4844884|NCT00996918|16702490|P4|Overall Study|Discontinuation of Study by Sponsor|45
4844885|NCT00996918|16702491|P3|Overall Study|Discontinuation of Study by Sponsor|30
4844886|NCT00996918|16702492|P2|Overall Study|Discontinuation of Study by Sponsor|54
4844887|NCT00996918|16702493|P1|Overall Study|Discontinuation of Study by Sponsor|31
4844888|NCT00996918|16702489|P5|Overall Study|Physician Decision|0
4844889|NCT00996918|16702490|P4|Overall Study|Physician Decision|0
4844890|NCT00996918|16702491|P3|Overall Study|Physician Decision|0
4844891|NCT00996918|16702492|P2|Overall Study|Physician Decision|0
4844892|NCT00996918|16702493|P1|Overall Study|Physician Decision|1
4844893|NCT00996918|16702489|P5|Overall Study|Withdrawal by Subject|2
4844894|NCT00996918|16702490|P4|Overall Study|Withdrawal by Subject|3
4844895|NCT00996918|16702491|P3|Overall Study|Withdrawal by Subject|3
4844896|NCT00996918|16702492|P2|Overall Study|Withdrawal by Subject|4
4844897|NCT00996918|16702493|P1|Overall Study|Withdrawal by Subject|1
4844898|NCT00996918|16702489|P5|Overall Study|Adverse Event|0
4844899|NCT00996918|16702490|P4|Overall Study|Adverse Event|6
4844900|NCT00996918|16702491|P3|Overall Study|Adverse Event|2
4844901|NCT00996918|16702492|P2|Overall Study|Adverse Event|5
4844902|NCT00996918|16702493|P1|Overall Study|Adverse Event|2
4844903|NCT00996918|16702489|P5|Overall Study|Lack of Efficacy|0
4844904|NCT00996918|16702490|P4|Overall Study|Lack of Efficacy|2
4844905|NCT00996918|16702491|P3|Overall Study|Lack of Efficacy|2
4844906|NCT00996918|16702492|P2|Overall Study|Lack of Efficacy|1
4844907|NCT00996918|16702493|P1|Overall Study|Lack of Efficacy|1
4844908|NCT00996892|16702537|P20|Expansion Stage 2A|Disease Progression|31
4844909|NCT00996892|16702538|P19|Expansion Stage 2A|Disease Progression|0
4844910|NCT00996892|16702539|P18|Expansion Stage 2A|Disease Progression|0
4844911|NCT00996892|16702540|P17|Expansion Stage 2A|Disease Progression|0
4844912|NCT00996892|16702541|P16|Expansion Stage 2A|Disease Progression|0
4844913|NCT00996892|16702542|P15|Expansion Stage 2A|Disease Progression|0
4844914|NCT00996892|16702543|P14|Expansion Stage 2A|Disease Progression|0
4844915|NCT00996892|16702544|P13|Expansion Stage 2A|Disease Progression|0
4844916|NCT00996892|16702545|P12|Expansion Stage 2A|Disease Progression|0
4844917|NCT00996892|16702546|P11|Expansion Stage 2A|Disease Progression|0
4844918|NCT00996892|16702547|P10|Expansion Stage 2A|Disease Progression|0
4844919|NCT00996892|16702548|P9|Expansion Stage 2A|Disease Progression|0
4844920|NCT00996892|16702549|P8|Expansion Stage 2A|Disease Progression|0
4844921|NCT00996892|16702550|P7|Expansion Stage 2A|Disease Progression|0
4844922|NCT00996892|16702551|P6|Expansion Stage 2A|Disease Progression|0
4844923|NCT00996892|16702552|P5|Expansion Stage 2A|Disease Progression|0
4844924|NCT00996892|16702553|P4|Expansion Stage 2A|Disease Progression|0
4844925|NCT00996892|16702554|P3|Expansion Stage 2A|Disease Progression|0
4844926|NCT00996892|16702555|P2|Expansion Stage 2A|Disease Progression|0
4844927|NCT00996892|16702556|P1|Expansion Stage 2A|Disease Progression|0
4844928|NCT00996892|16702537|P20|Expansion Stage 2A|Withdrawal by Subject|4
4844929|NCT00996892|16702538|P19|Expansion Stage 2A|Withdrawal by Subject|0
4844930|NCT00996892|16702539|P18|Expansion Stage 2A|Withdrawal by Subject|0
4844931|NCT00996892|16702540|P17|Expansion Stage 2A|Withdrawal by Subject|0
4844932|NCT00996892|16702541|P16|Expansion Stage 2A|Withdrawal by Subject|0
4844933|NCT00996892|16702542|P15|Expansion Stage 2A|Withdrawal by Subject|0
4844934|NCT00996892|16702543|P14|Expansion Stage 2A|Withdrawal by Subject|0
4844935|NCT00996892|16702544|P13|Expansion Stage 2A|Withdrawal by Subject|0
4844936|NCT00996892|16702545|P12|Expansion Stage 2A|Withdrawal by Subject|0
4844937|NCT00996892|16702546|P11|Expansion Stage 2A|Withdrawal by Subject|0
4844938|NCT00996892|16702547|P10|Expansion Stage 2A|Withdrawal by Subject|0
4844939|NCT00996892|16702548|P9|Expansion Stage 2A|Withdrawal by Subject|0
4844940|NCT00996892|16702549|P8|Expansion Stage 2A|Withdrawal by Subject|0
4844941|NCT00996892|16702550|P7|Expansion Stage 2A|Withdrawal by Subject|0
4844942|NCT00996892|16702551|P6|Expansion Stage 2A|Withdrawal by Subject|0
4844943|NCT00996892|16702552|P5|Expansion Stage 2A|Withdrawal by Subject|0
4844944|NCT00996892|16702553|P4|Expansion Stage 2A|Withdrawal by Subject|0
4844945|NCT00996892|16702554|P3|Expansion Stage 2A|Withdrawal by Subject|0
4844946|NCT00996892|16702555|P2|Expansion Stage 2A|Withdrawal by Subject|0
4844947|NCT00996892|16702556|P1|Expansion Stage 2A|Withdrawal by Subject|0
4844948|NCT00996892|16702537|P20|Expansion Stage 2A|Physician Decision|2
4844949|NCT00996892|16702538|P19|Expansion Stage 2A|Physician Decision|0
4844950|NCT00996892|16702539|P18|Expansion Stage 2A|Physician Decision|0
4844951|NCT00996892|16702540|P17|Expansion Stage 2A|Physician Decision|0
4844952|NCT00996892|16702541|P16|Expansion Stage 2A|Physician Decision|0
4844953|NCT00996892|16702542|P15|Expansion Stage 2A|Physician Decision|0
4844954|NCT00996892|16702543|P14|Expansion Stage 2A|Physician Decision|0
4844955|NCT00996892|16702544|P13|Expansion Stage 2A|Physician Decision|0
4844956|NCT00996892|16702545|P12|Expansion Stage 2A|Physician Decision|0
4844957|NCT00996892|16702546|P11|Expansion Stage 2A|Physician Decision|0
4844958|NCT00996892|16702547|P10|Expansion Stage 2A|Physician Decision|0
4844959|NCT00996892|16702548|P9|Expansion Stage 2A|Physician Decision|0
4844960|NCT00996892|16702549|P8|Expansion Stage 2A|Physician Decision|0
4844961|NCT00996892|16702550|P7|Expansion Stage 2A|Physician Decision|0
4844962|NCT00996892|16702551|P6|Expansion Stage 2A|Physician Decision|0
4844963|NCT00996892|16702552|P5|Expansion Stage 2A|Physician Decision|0
4844964|NCT00996892|16702553|P4|Expansion Stage 2A|Physician Decision|0
4844965|NCT00996892|16702554|P3|Expansion Stage 2A|Physician Decision|0
4844966|NCT00996892|16702555|P2|Expansion Stage 2A|Physician Decision|0
4844967|NCT00996892|16702556|P1|Expansion Stage 2A|Physician Decision|0
4844968|NCT00996892|16702537|P20|Expansion Stage 2A|Adverse Event|8
4844969|NCT00996892|16702538|P19|Expansion Stage 2A|Adverse Event|0
4844970|NCT00996892|16702539|P18|Expansion Stage 2A|Adverse Event|0
4844971|NCT00996892|16702540|P17|Expansion Stage 2A|Adverse Event|0
4844972|NCT00996892|16702541|P16|Expansion Stage 2A|Adverse Event|0
4844973|NCT00996892|16702542|P15|Expansion Stage 2A|Adverse Event|0
4844974|NCT00996892|16702543|P14|Expansion Stage 2A|Adverse Event|0
4844975|NCT00996892|16702544|P13|Expansion Stage 2A|Adverse Event|0
4844976|NCT00996892|16702545|P12|Expansion Stage 2A|Adverse Event|0
4844977|NCT00996892|16702546|P11|Expansion Stage 2A|Adverse Event|0
4844978|NCT00996892|16702547|P10|Expansion Stage 2A|Adverse Event|0
4844979|NCT00996892|16702548|P9|Expansion Stage 2A|Adverse Event|0
4844980|NCT00996892|16702549|P8|Expansion Stage 2A|Adverse Event|0
4844981|NCT00996892|16702550|P7|Expansion Stage 2A|Adverse Event|0
4844982|NCT00996892|16702551|P6|Expansion Stage 2A|Adverse Event|0
4844983|NCT00996892|16702552|P5|Expansion Stage 2A|Adverse Event|0
4844984|NCT00996892|16702553|P4|Expansion Stage 2A|Adverse Event|0
4844985|NCT00996892|16702554|P3|Expansion Stage 2A|Adverse Event|0
4844986|NCT00996892|16702555|P2|Expansion Stage 2A|Adverse Event|0
4844987|NCT00996892|16702556|P1|Expansion Stage 2A|Adverse Event|0
4844988|NCT00996892|16702537|P20|Expansion Stage 2|Disease Progression|0
4844989|NCT00996892|16702538|P19|Expansion Stage 2|Disease Progression|28
4844990|NCT00996892|16702539|P18|Expansion Stage 2|Disease Progression|0
4844991|NCT00996892|16702540|P17|Expansion Stage 2|Disease Progression|0
4844992|NCT00996892|16702541|P16|Expansion Stage 2|Disease Progression|0
4844993|NCT00996892|16702542|P15|Expansion Stage 2|Disease Progression|0
4844994|NCT00996892|16702543|P14|Expansion Stage 2|Disease Progression|0
4844995|NCT00996892|16702544|P13|Expansion Stage 2|Disease Progression|0
4844996|NCT00996892|16702545|P12|Expansion Stage 2|Disease Progression|0
4844997|NCT00996892|16702546|P11|Expansion Stage 2|Disease Progression|0
4844998|NCT00996892|16702547|P10|Expansion Stage 2|Disease Progression|0
4844999|NCT00996892|16702548|P9|Expansion Stage 2|Disease Progression|0
4845000|NCT00996892|16702549|P8|Expansion Stage 2|Disease Progression|0
4845001|NCT00996892|16702550|P7|Expansion Stage 2|Disease Progression|0
4845002|NCT00996892|16702551|P6|Expansion Stage 2|Disease Progression|0
4845003|NCT00996892|16702552|P5|Expansion Stage 2|Disease Progression|0
4845004|NCT00996892|16702553|P4|Expansion Stage 2|Disease Progression|0
4845005|NCT00996892|16702554|P3|Expansion Stage 2|Disease Progression|0
4845006|NCT00996892|16702555|P2|Expansion Stage 2|Disease Progression|0
4845007|NCT00996892|16702556|P1|Expansion Stage 2|Disease Progression|0
4845008|NCT00996892|16702537|P20|Expansion Stage 2|Withdrawal by Subject|0
4845009|NCT00996892|16702538|P19|Expansion Stage 2|Withdrawal by Subject|1
4845010|NCT00996892|16702539|P18|Expansion Stage 2|Withdrawal by Subject|0
4845011|NCT00996892|16702540|P17|Expansion Stage 2|Withdrawal by Subject|0
4845012|NCT00996892|16702541|P16|Expansion Stage 2|Withdrawal by Subject|0
4845013|NCT00996892|16702542|P15|Expansion Stage 2|Withdrawal by Subject|0
4845014|NCT00996892|16702543|P14|Expansion Stage 2|Withdrawal by Subject|0
4845015|NCT00996892|16702544|P13|Expansion Stage 2|Withdrawal by Subject|0
4845016|NCT00996892|16702545|P12|Expansion Stage 2|Withdrawal by Subject|0
4845017|NCT00996892|16702546|P11|Expansion Stage 2|Withdrawal by Subject|0
4845018|NCT00996892|16702547|P10|Expansion Stage 2|Withdrawal by Subject|0
4845019|NCT00996892|16702548|P9|Expansion Stage 2|Withdrawal by Subject|0
4845020|NCT00996892|16702549|P8|Expansion Stage 2|Withdrawal by Subject|0
4845021|NCT00996892|16702550|P7|Expansion Stage 2|Withdrawal by Subject|0
4845022|NCT00996892|16702551|P6|Expansion Stage 2|Withdrawal by Subject|0
4845023|NCT00996892|16702552|P5|Expansion Stage 2|Withdrawal by Subject|0
4845024|NCT00996892|16702553|P4|Expansion Stage 2|Withdrawal by Subject|0
4845025|NCT00996892|16702554|P3|Expansion Stage 2|Withdrawal by Subject|0
4845026|NCT00996892|16702555|P2|Expansion Stage 2|Withdrawal by Subject|0
4845027|NCT00996892|16702556|P1|Expansion Stage 2|Withdrawal by Subject|0
4845028|NCT00996892|16702537|P20|Expansion Stage 2|Physician Decision|0
4845029|NCT00996892|16702538|P19|Expansion Stage 2|Physician Decision|1
4845030|NCT00996892|16702539|P18|Expansion Stage 2|Physician Decision|0
4845031|NCT00996892|16702540|P17|Expansion Stage 2|Physician Decision|0
4845032|NCT00996892|16702541|P16|Expansion Stage 2|Physician Decision|0
4845033|NCT00996892|16702542|P15|Expansion Stage 2|Physician Decision|0
4845034|NCT00996892|16702543|P14|Expansion Stage 2|Physician Decision|0
4845035|NCT00996892|16702544|P13|Expansion Stage 2|Physician Decision|0
4845036|NCT00996892|16702545|P12|Expansion Stage 2|Physician Decision|0
4845037|NCT00996892|16702546|P11|Expansion Stage 2|Physician Decision|0
4845038|NCT00996892|16702547|P10|Expansion Stage 2|Physician Decision|0
4845039|NCT00996892|16702548|P9|Expansion Stage 2|Physician Decision|0
4845040|NCT00996892|16702549|P8|Expansion Stage 2|Physician Decision|0
4845041|NCT00996892|16702550|P7|Expansion Stage 2|Physician Decision|0
4845042|NCT00996892|16702551|P6|Expansion Stage 2|Physician Decision|0
4845043|NCT00996892|16702552|P5|Expansion Stage 2|Physician Decision|0
4845044|NCT00996892|16702553|P4|Expansion Stage 2|Physician Decision|0
4845045|NCT00996892|16702554|P3|Expansion Stage 2|Physician Decision|0
4845046|NCT00996892|16702555|P2|Expansion Stage 2|Physician Decision|0
4845047|NCT00996892|16702556|P1|Expansion Stage 2|Physician Decision|0
4845048|NCT00996892|16702537|P20|Expansion Stage 2|Death|0
4845049|NCT00996892|16702538|P19|Expansion Stage 2|Death|2
4845050|NCT00996892|16702539|P18|Expansion Stage 2|Death|0
4845051|NCT00996892|16702540|P17|Expansion Stage 2|Death|0
4845052|NCT00996892|16702541|P16|Expansion Stage 2|Death|0
4845053|NCT00996892|16702542|P15|Expansion Stage 2|Death|0
4845054|NCT00996892|16702543|P14|Expansion Stage 2|Death|0
4845055|NCT00996892|16702544|P13|Expansion Stage 2|Death|0
4845056|NCT00996892|16702545|P12|Expansion Stage 2|Death|0
4845057|NCT00996892|16702546|P11|Expansion Stage 2|Death|0
4845058|NCT00996892|16702547|P10|Expansion Stage 2|Death|0
4845059|NCT00996892|16702548|P9|Expansion Stage 2|Death|0
4845060|NCT00996892|16702549|P8|Expansion Stage 2|Death|0
4845061|NCT00996892|16702550|P7|Expansion Stage 2|Death|0
4845062|NCT00996892|16702551|P6|Expansion Stage 2|Death|0
4845063|NCT00996892|16702552|P5|Expansion Stage 2|Death|0
4845064|NCT00996892|16702553|P4|Expansion Stage 2|Death|0
4845065|NCT00996892|16702554|P3|Expansion Stage 2|Death|0
4845066|NCT00996892|16702555|P2|Expansion Stage 2|Death|0
4845067|NCT00996892|16702556|P1|Expansion Stage 2|Death|0
4845068|NCT00996892|16702537|P20|Expansion Stage 2|Adverse Event|0
4845069|NCT00996892|16702538|P19|Expansion Stage 2|Adverse Event|3
4845070|NCT00996892|16702539|P18|Expansion Stage 2|Adverse Event|0
4845071|NCT00996892|16702540|P17|Expansion Stage 2|Adverse Event|0
4845072|NCT00996892|16702541|P16|Expansion Stage 2|Adverse Event|0
4845073|NCT00996892|16702542|P15|Expansion Stage 2|Adverse Event|0
4845074|NCT00996892|16702543|P14|Expansion Stage 2|Adverse Event|0
4845075|NCT00996892|16702544|P13|Expansion Stage 2|Adverse Event|0
4845076|NCT00996892|16702545|P12|Expansion Stage 2|Adverse Event|0
4845077|NCT00996892|16702546|P11|Expansion Stage 2|Adverse Event|0
4845078|NCT00996892|16702547|P10|Expansion Stage 2|Adverse Event|0
4845079|NCT00996892|16702548|P9|Expansion Stage 2|Adverse Event|0
4845080|NCT00996892|16702549|P8|Expansion Stage 2|Adverse Event|0
4845081|NCT00996892|16702550|P7|Expansion Stage 2|Adverse Event|0
4845082|NCT00996892|16702551|P6|Expansion Stage 2|Adverse Event|0
4845083|NCT00996892|16702552|P5|Expansion Stage 2|Adverse Event|0
4845084|NCT00996892|16702553|P4|Expansion Stage 2|Adverse Event|0
4845085|NCT00996892|16702554|P3|Expansion Stage 2|Adverse Event|0
4845086|NCT00996892|16702555|P2|Expansion Stage 2|Adverse Event|0
4845087|NCT00996892|16702556|P1|Expansion Stage 2|Adverse Event|0
4845088|NCT00996892|16702537|P20|Dose-Escalation Stage 1B|Disease Progression|0
4845089|NCT00996892|16702538|P19|Dose-Escalation Stage 1B|Disease Progression|0
4845090|NCT00996892|16702539|P18|Dose-Escalation Stage 1B|Disease Progression|3
4845091|NCT00996892|16702540|P17|Dose-Escalation Stage 1B|Disease Progression|3
4845092|NCT00996892|16702541|P16|Dose-Escalation Stage 1B|Disease Progression|3
4845093|NCT00996892|16702542|P15|Dose-Escalation Stage 1B|Disease Progression|4
4845094|NCT00996892|16702543|P14|Dose-Escalation Stage 1B|Disease Progression|0
4845095|NCT00996892|16702544|P13|Dose-Escalation Stage 1B|Disease Progression|0
4845096|NCT00996892|16702545|P12|Dose-Escalation Stage 1B|Disease Progression|0
4845097|NCT00996892|16702546|P11|Dose-Escalation Stage 1B|Disease Progression|0
4845098|NCT00996892|16702547|P10|Dose-Escalation Stage 1B|Disease Progression|0
4845099|NCT00996892|16702548|P9|Dose-Escalation Stage 1B|Disease Progression|0
4845100|NCT00996892|16702549|P8|Dose-Escalation Stage 1B|Disease Progression|0
4845101|NCT00996892|16702550|P7|Dose-Escalation Stage 1B|Disease Progression|0
4845102|NCT00996892|16702551|P6|Dose-Escalation Stage 1B|Disease Progression|0
4845103|NCT00996892|16702552|P5|Dose-Escalation Stage 1B|Disease Progression|0
4845104|NCT00996892|16702553|P4|Dose-Escalation Stage 1B|Disease Progression|0
4845105|NCT00996892|16702554|P3|Dose-Escalation Stage 1B|Disease Progression|0
4845106|NCT00996892|16702555|P2|Dose-Escalation Stage 1B|Disease Progression|0
4845107|NCT00996892|16702556|P1|Dose-Escalation Stage 1B|Disease Progression|0
4845108|NCT00996892|16702537|P20|Dose-Escalation Stage 1B|Physician Decision|0
4845109|NCT00996892|16702538|P19|Dose-Escalation Stage 1B|Physician Decision|0
4845110|NCT00996892|16702539|P18|Dose-Escalation Stage 1B|Physician Decision|2
4845111|NCT00996892|16702540|P17|Dose-Escalation Stage 1B|Physician Decision|0
4845112|NCT00996892|16702541|P16|Dose-Escalation Stage 1B|Physician Decision|0
4845113|NCT00996892|16702542|P15|Dose-Escalation Stage 1B|Physician Decision|0
4845114|NCT00996892|16702543|P14|Dose-Escalation Stage 1B|Physician Decision|0
4845115|NCT00996892|16702544|P13|Dose-Escalation Stage 1B|Physician Decision|0
4845116|NCT00996892|16702545|P12|Dose-Escalation Stage 1B|Physician Decision|0
4845117|NCT00996892|16702546|P11|Dose-Escalation Stage 1B|Physician Decision|0
4845118|NCT00996892|16702547|P10|Dose-Escalation Stage 1B|Physician Decision|0
4845119|NCT00996892|16702548|P9|Dose-Escalation Stage 1B|Physician Decision|0
4845120|NCT00996892|16702549|P8|Dose-Escalation Stage 1B|Physician Decision|0
4845121|NCT00996892|16702550|P7|Dose-Escalation Stage 1B|Physician Decision|0
4845122|NCT00996892|16702551|P6|Dose-Escalation Stage 1B|Physician Decision|0
4845123|NCT00996892|16702552|P5|Dose-Escalation Stage 1B|Physician Decision|0
4845124|NCT00996892|16702553|P4|Dose-Escalation Stage 1B|Physician Decision|0
4845125|NCT00996892|16702554|P3|Dose-Escalation Stage 1B|Physician Decision|0
4845126|NCT00996892|16702555|P2|Dose-Escalation Stage 1B|Physician Decision|0
4845127|NCT00996892|16702556|P1|Dose-Escalation Stage 1B|Physician Decision|0
4845208|NCT00996892|16702537|P20|Dose-Escalation Stage 1A|Adverse Event|0
4845128|NCT00996892|16702537|P20|Dose-Escalation Stage 1A|Disease Progression|0
4845129|NCT00996892|16702538|P19|Dose-Escalation Stage 1A|Disease Progression|0
4845130|NCT00996892|16702539|P18|Dose-Escalation Stage 1A|Disease Progression|0
4845131|NCT00996892|16702540|P17|Dose-Escalation Stage 1A|Disease Progression|0
4845132|NCT00996892|16702541|P16|Dose-Escalation Stage 1A|Disease Progression|0
4845133|NCT00996892|16702542|P15|Dose-Escalation Stage 1A|Disease Progression|0
4845134|NCT00996892|16702543|P14|Dose-Escalation Stage 1A|Disease Progression|4
4845135|NCT00996892|16702544|P13|Dose-Escalation Stage 1A|Disease Progression|6
4845136|NCT00996892|16702545|P12|Dose-Escalation Stage 1A|Disease Progression|7
4845137|NCT00996892|16702546|P11|Dose-Escalation Stage 1A|Disease Progression|5
4845138|NCT00996892|16702547|P10|Dose-Escalation Stage 1A|Disease Progression|1
4845139|NCT00996892|16702548|P9|Dose-Escalation Stage 1A|Disease Progression|3
4845140|NCT00996892|16702549|P8|Dose-Escalation Stage 1A|Disease Progression|2
4845141|NCT00996892|16702550|P7|Dose-Escalation Stage 1A|Disease Progression|0
4845142|NCT00996892|16702551|P6|Dose-Escalation Stage 1A|Disease Progression|0
4845143|NCT00996892|16702552|P5|Dose-Escalation Stage 1A|Disease Progression|0
4845144|NCT00996892|16702553|P4|Dose-Escalation Stage 1A|Disease Progression|0
4845145|NCT00996892|16702554|P3|Dose-Escalation Stage 1A|Disease Progression|0
4845146|NCT00996892|16702555|P2|Dose-Escalation Stage 1A|Disease Progression|0
4845147|NCT00996892|16702556|P1|Dose-Escalation Stage 1A|Disease Progression|0
4845148|NCT00996892|16702537|P20|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845149|NCT00996892|16702538|P19|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845150|NCT00996892|16702539|P18|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845151|NCT00996892|16702540|P17|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845152|NCT00996892|16702541|P16|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845153|NCT00996892|16702542|P15|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845154|NCT00996892|16702543|P14|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845155|NCT00996892|16702544|P13|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4845156|NCT00996892|16702545|P12|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4845157|NCT00996892|16702546|P11|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4845158|NCT00996892|16702547|P10|Dose-Escalation Stage 1A|Withdrawal by Subject|1
4845159|NCT00996892|16702548|P9|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845160|NCT00996892|16702549|P8|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845161|NCT00996892|16702550|P7|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845162|NCT00996892|16702551|P6|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845163|NCT00996892|16702552|P5|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845164|NCT00996892|16702553|P4|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845165|NCT00996892|16702554|P3|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845166|NCT00996892|16702555|P2|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845167|NCT00996892|16702556|P1|Dose-Escalation Stage 1A|Withdrawal by Subject|0
4845168|NCT00996892|16702537|P20|Dose-Escalation Stage 1A|Physician Decision|0
4845169|NCT00996892|16702538|P19|Dose-Escalation Stage 1A|Physician Decision|0
4845170|NCT00996892|16702539|P18|Dose-Escalation Stage 1A|Physician Decision|0
4845171|NCT00996892|16702540|P17|Dose-Escalation Stage 1A|Physician Decision|0
4845172|NCT00996892|16702541|P16|Dose-Escalation Stage 1A|Physician Decision|0
4845173|NCT00996892|16702542|P15|Dose-Escalation Stage 1A|Physician Decision|0
4845174|NCT00996892|16702543|P14|Dose-Escalation Stage 1A|Physician Decision|0
4845175|NCT00996892|16702544|P13|Dose-Escalation Stage 1A|Physician Decision|0
4845176|NCT00996892|16702545|P12|Dose-Escalation Stage 1A|Physician Decision|0
4845177|NCT00996892|16702546|P11|Dose-Escalation Stage 1A|Physician Decision|0
4845178|NCT00996892|16702547|P10|Dose-Escalation Stage 1A|Physician Decision|0
4845179|NCT00996892|16702548|P9|Dose-Escalation Stage 1A|Physician Decision|0
4845180|NCT00996892|16702549|P8|Dose-Escalation Stage 1A|Physician Decision|1
4845181|NCT00996892|16702550|P7|Dose-Escalation Stage 1A|Physician Decision|0
4845182|NCT00996892|16702551|P6|Dose-Escalation Stage 1A|Physician Decision|0
4845183|NCT00996892|16702552|P5|Dose-Escalation Stage 1A|Physician Decision|0
4845184|NCT00996892|16702553|P4|Dose-Escalation Stage 1A|Physician Decision|0
4845185|NCT00996892|16702554|P3|Dose-Escalation Stage 1A|Physician Decision|0
4845186|NCT00996892|16702555|P2|Dose-Escalation Stage 1A|Physician Decision|0
4845187|NCT00996892|16702556|P1|Dose-Escalation Stage 1A|Physician Decision|0
4845188|NCT00996892|16702537|P20|Dose-Escalation Stage 1A|Death|0
4845189|NCT00996892|16702538|P19|Dose-Escalation Stage 1A|Death|0
4845190|NCT00996892|16702539|P18|Dose-Escalation Stage 1A|Death|0
4845191|NCT00996892|16702540|P17|Dose-Escalation Stage 1A|Death|0
4845192|NCT00996892|16702541|P16|Dose-Escalation Stage 1A|Death|0
4845193|NCT00996892|16702542|P15|Dose-Escalation Stage 1A|Death|0
4845194|NCT00996892|16702543|P14|Dose-Escalation Stage 1A|Death|0
4845195|NCT00996892|16702544|P13|Dose-Escalation Stage 1A|Death|1
4845196|NCT00996892|16702545|P12|Dose-Escalation Stage 1A|Death|1
4845197|NCT00996892|16702546|P11|Dose-Escalation Stage 1A|Death|0
4845198|NCT00996892|16702547|P10|Dose-Escalation Stage 1A|Death|2
4845199|NCT00996892|16702548|P9|Dose-Escalation Stage 1A|Death|0
4845200|NCT00996892|16702549|P8|Dose-Escalation Stage 1A|Death|0
4845201|NCT00996892|16702550|P7|Dose-Escalation Stage 1A|Death|0
4845202|NCT00996892|16702551|P6|Dose-Escalation Stage 1A|Death|0
4845203|NCT00996892|16702552|P5|Dose-Escalation Stage 1A|Death|0
4845204|NCT00996892|16702553|P4|Dose-Escalation Stage 1A|Death|0
4845205|NCT00996892|16702554|P3|Dose-Escalation Stage 1A|Death|0
4845206|NCT00996892|16702555|P2|Dose-Escalation Stage 1A|Death|0
4845207|NCT00996892|16702556|P1|Dose-Escalation Stage 1A|Death|0
4845209|NCT00996892|16702538|P19|Dose-Escalation Stage 1A|Adverse Event|0
4845210|NCT00996892|16702539|P18|Dose-Escalation Stage 1A|Adverse Event|0
4845211|NCT00996892|16702540|P17|Dose-Escalation Stage 1A|Adverse Event|0
4845212|NCT00996892|16702541|P16|Dose-Escalation Stage 1A|Adverse Event|0
4845213|NCT00996892|16702542|P15|Dose-Escalation Stage 1A|Adverse Event|0
4845214|NCT00996892|16702543|P14|Dose-Escalation Stage 1A|Adverse Event|1
4845215|NCT00996892|16702544|P13|Dose-Escalation Stage 1A|Adverse Event|0
4845216|NCT00996892|16702545|P12|Dose-Escalation Stage 1A|Adverse Event|0
4845217|NCT00996892|16702546|P11|Dose-Escalation Stage 1A|Adverse Event|1
4845218|NCT00996892|16702547|P10|Dose-Escalation Stage 1A|Adverse Event|0
4845219|NCT00996892|16702548|P9|Dose-Escalation Stage 1A|Adverse Event|0
4845220|NCT00996892|16702549|P8|Dose-Escalation Stage 1A|Adverse Event|0
4845221|NCT00996892|16702550|P7|Dose-Escalation Stage 1A|Adverse Event|0
4845222|NCT00996892|16702551|P6|Dose-Escalation Stage 1A|Adverse Event|0
4845223|NCT00996892|16702552|P5|Dose-Escalation Stage 1A|Adverse Event|0
4845224|NCT00996892|16702553|P4|Dose-Escalation Stage 1A|Adverse Event|0
4845225|NCT00996892|16702554|P3|Dose-Escalation Stage 1A|Adverse Event|0
4845226|NCT00996892|16702555|P2|Dose-Escalation Stage 1A|Adverse Event|0
4845227|NCT00996892|16702556|P1|Dose-Escalation Stage 1A|Adverse Event|0
4845228|NCT00996892|16702537|P20|Dose-Escalation Stage 1|Disease Progression|0
4845229|NCT00996892|16702538|P19|Dose-Escalation Stage 1|Disease Progression|0
4845230|NCT00996892|16702539|P18|Dose-Escalation Stage 1|Disease Progression|0
4845231|NCT00996892|16702540|P17|Dose-Escalation Stage 1|Disease Progression|0
4845232|NCT00996892|16702541|P16|Dose-Escalation Stage 1|Disease Progression|0
4845233|NCT00996892|16702542|P15|Dose-Escalation Stage 1|Disease Progression|0
4845234|NCT00996892|16702543|P14|Dose-Escalation Stage 1|Disease Progression|0
4845235|NCT00996892|16702544|P13|Dose-Escalation Stage 1|Disease Progression|0
4845236|NCT00996892|16702545|P12|Dose-Escalation Stage 1|Disease Progression|0
4845237|NCT00996892|16702546|P11|Dose-Escalation Stage 1|Disease Progression|0
4845238|NCT00996892|16702547|P10|Dose-Escalation Stage 1|Disease Progression|0
4845239|NCT00996892|16702548|P9|Dose-Escalation Stage 1|Disease Progression|0
4845240|NCT00996892|16702549|P8|Dose-Escalation Stage 1|Disease Progression|0
4845241|NCT00996892|16702550|P7|Dose-Escalation Stage 1|Disease Progression|0
4845242|NCT00996892|16702551|P6|Dose-Escalation Stage 1|Disease Progression|7
4845243|NCT00996892|16702552|P5|Dose-Escalation Stage 1|Disease Progression|10
4845244|NCT00996892|16702553|P4|Dose-Escalation Stage 1|Disease Progression|4
4845245|NCT00996892|16702554|P3|Dose-Escalation Stage 1|Disease Progression|3
4845246|NCT00996892|16702555|P2|Dose-Escalation Stage 1|Disease Progression|2
4845247|NCT00996892|16702556|P1|Dose-Escalation Stage 1|Disease Progression|2
4845248|NCT00996892|16702537|P20|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845249|NCT00996892|16702538|P19|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845250|NCT00996892|16702539|P18|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845251|NCT00996892|16702540|P17|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845252|NCT00996892|16702541|P16|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845253|NCT00996892|16702542|P15|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845254|NCT00996892|16702543|P14|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845255|NCT00996892|16702544|P13|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845256|NCT00996892|16702545|P12|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845257|NCT00996892|16702546|P11|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845258|NCT00996892|16702547|P10|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845259|NCT00996892|16702548|P9|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845260|NCT00996892|16702549|P8|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845261|NCT00996892|16702550|P7|Dose-Escalation Stage 1|Withdrawal by Subject|1
4845262|NCT00996892|16702551|P6|Dose-Escalation Stage 1|Withdrawal by Subject|1
4845263|NCT00996892|16702552|P5|Dose-Escalation Stage 1|Withdrawal by Subject|1
4845264|NCT00996892|16702553|P4|Dose-Escalation Stage 1|Withdrawal by Subject|2
4845265|NCT00996892|16702554|P3|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845266|NCT00996892|16702555|P2|Dose-Escalation Stage 1|Withdrawal by Subject|1
4845267|NCT00996892|16702556|P1|Dose-Escalation Stage 1|Withdrawal by Subject|0
4845268|NCT00996892|16702537|P20|Dose-Escalation Stage 1|Physician Decision|0
4845269|NCT00996892|16702538|P19|Dose-Escalation Stage 1|Physician Decision|0
4845270|NCT00996892|16702539|P18|Dose-Escalation Stage 1|Physician Decision|0
4845271|NCT00996892|16702540|P17|Dose-Escalation Stage 1|Physician Decision|0
4845272|NCT00996892|16702541|P16|Dose-Escalation Stage 1|Physician Decision|0
4845273|NCT00996892|16702542|P15|Dose-Escalation Stage 1|Physician Decision|0
4845274|NCT00996892|16702543|P14|Dose-Escalation Stage 1|Physician Decision|0
4845275|NCT00996892|16702544|P13|Dose-Escalation Stage 1|Physician Decision|0
4845276|NCT00996892|16702545|P12|Dose-Escalation Stage 1|Physician Decision|0
4845277|NCT00996892|16702546|P11|Dose-Escalation Stage 1|Physician Decision|0
4845278|NCT00996892|16702547|P10|Dose-Escalation Stage 1|Physician Decision|0
4845279|NCT00996892|16702548|P9|Dose-Escalation Stage 1|Physician Decision|0
4845280|NCT00996892|16702549|P8|Dose-Escalation Stage 1|Physician Decision|0
4845281|NCT00996892|16702550|P7|Dose-Escalation Stage 1|Physician Decision|2
4845282|NCT00996892|16702551|P6|Dose-Escalation Stage 1|Physician Decision|1
4845283|NCT00996892|16702552|P5|Dose-Escalation Stage 1|Physician Decision|0
4845284|NCT00996892|16702553|P4|Dose-Escalation Stage 1|Physician Decision|1
4845285|NCT00996892|16702554|P3|Dose-Escalation Stage 1|Physician Decision|0
4845286|NCT00996892|16702555|P2|Dose-Escalation Stage 1|Physician Decision|0
4845287|NCT00996892|16702556|P1|Dose-Escalation Stage 1|Physician Decision|1
4845288|NCT00996892|16702537|P20|Dose-Escalation Stage 1|Death|0
4845289|NCT00996892|16702538|P19|Dose-Escalation Stage 1|Death|0
4845290|NCT00996892|16702539|P18|Dose-Escalation Stage 1|Death|0
4845291|NCT00996892|16702540|P17|Dose-Escalation Stage 1|Death|0
4845292|NCT00996892|16702541|P16|Dose-Escalation Stage 1|Death|0
4845293|NCT00996892|16702542|P15|Dose-Escalation Stage 1|Death|0
4845294|NCT00996892|16702543|P14|Dose-Escalation Stage 1|Death|0
4845295|NCT00996892|16702544|P13|Dose-Escalation Stage 1|Death|0
4845296|NCT00996892|16702545|P12|Dose-Escalation Stage 1|Death|0
4845297|NCT00996892|16702546|P11|Dose-Escalation Stage 1|Death|0
4845298|NCT00996892|16702547|P10|Dose-Escalation Stage 1|Death|0
4845299|NCT00996892|16702548|P9|Dose-Escalation Stage 1|Death|0
4845300|NCT00996892|16702549|P8|Dose-Escalation Stage 1|Death|0
4845301|NCT00996892|16702550|P7|Dose-Escalation Stage 1|Death|0
4845302|NCT00996892|16702551|P6|Dose-Escalation Stage 1|Death|1
4845303|NCT00996892|16702552|P5|Dose-Escalation Stage 1|Death|0
4845304|NCT00996892|16702553|P4|Dose-Escalation Stage 1|Death|0
4845305|NCT00996892|16702554|P3|Dose-Escalation Stage 1|Death|0
4845306|NCT00996892|16702555|P2|Dose-Escalation Stage 1|Death|0
4845307|NCT00996892|16702556|P1|Dose-Escalation Stage 1|Death|1
4845308|NCT00996892|16702537|P20|Dose-Escalation Stage 1|Adverse Event|0
4845309|NCT00996892|16702538|P19|Dose-Escalation Stage 1|Adverse Event|0
4845310|NCT00996892|16702539|P18|Dose-Escalation Stage 1|Adverse Event|0
4845311|NCT00996892|16702540|P17|Dose-Escalation Stage 1|Adverse Event|0
4845312|NCT00996892|16702541|P16|Dose-Escalation Stage 1|Adverse Event|0
4845313|NCT00996892|16702542|P15|Dose-Escalation Stage 1|Adverse Event|0
4845314|NCT00996892|16702543|P14|Dose-Escalation Stage 1|Adverse Event|0
4845315|NCT00996892|16702544|P13|Dose-Escalation Stage 1|Adverse Event|0
4845316|NCT00996892|16702545|P12|Dose-Escalation Stage 1|Adverse Event|0
4845317|NCT00996892|16702546|P11|Dose-Escalation Stage 1|Adverse Event|0
4845318|NCT00996892|16702547|P10|Dose-Escalation Stage 1|Adverse Event|0
4845319|NCT00996892|16702548|P9|Dose-Escalation Stage 1|Adverse Event|0
4845320|NCT00996892|16702549|P8|Dose-Escalation Stage 1|Adverse Event|0
4845321|NCT00996892|16702550|P7|Dose-Escalation Stage 1|Adverse Event|1
4845322|NCT00996892|16702551|P6|Dose-Escalation Stage 1|Adverse Event|0
4845323|NCT00996892|16702552|P5|Dose-Escalation Stage 1|Adverse Event|0
4845324|NCT00996892|16702553|P4|Dose-Escalation Stage 1|Adverse Event|2
4845325|NCT00996892|16702554|P3|Dose-Escalation Stage 1|Adverse Event|0
4845326|NCT00996892|16702555|P2|Dose-Escalation Stage 1|Adverse Event|0
4845327|NCT00996892|16702556|P1|Dose-Escalation Stage 1|Adverse Event|0
4845328|NCT00996840|16703150|P5|Overall Study|Withdrawal by Subject|0
4845329|NCT00996840|16703151|P4|Overall Study|Withdrawal by Subject|0
4845330|NCT00996840|16703152|P3|Overall Study|Withdrawal by Subject|0
4845331|NCT00996840|16703153|P2|Overall Study|Withdrawal by Subject|1
4845332|NCT00996840|16703154|P1|Overall Study|Withdrawal by Subject|1
4845333|NCT00996840|16703150|P5|Overall Study|Physician Decision|2
4845334|NCT00996840|16703151|P4|Overall Study|Physician Decision|1
4845335|NCT00996840|16703152|P3|Overall Study|Physician Decision|1
4845336|NCT00996840|16703153|P2|Overall Study|Physician Decision|0
4845337|NCT00996840|16703154|P1|Overall Study|Physician Decision|0
4845338|NCT00996840|16703150|P5|Overall Study|Adverse Event|0
4845339|NCT00996840|16703151|P4|Overall Study|Adverse Event|0
4845340|NCT00996840|16703152|P3|Overall Study|Adverse Event|0
4845341|NCT00996840|16703153|P2|Overall Study|Adverse Event|1
4845342|NCT00996840|16703154|P1|Overall Study|Adverse Event|0
4845343|NCT00996801|16703304|P6|Overall Study|Withdrawal by Subject|9
4845344|NCT00996801|16703305|P5|Overall Study|Withdrawal by Subject|5
4845345|NCT00996801|16703306|P4|Overall Study|Withdrawal by Subject|5
4845346|NCT00996801|16703307|P3|Overall Study|Withdrawal by Subject|9
4845347|NCT00996801|16703308|P2|Overall Study|Withdrawal by Subject|6
4845348|NCT00996801|16703309|P1|Overall Study|Withdrawal by Subject|8
4845349|NCT00996801|16703304|P6|Overall Study|Study Terminated by Sponsor|0
4845350|NCT00996801|16703305|P5|Overall Study|Study Terminated by Sponsor|46
4845351|NCT00996801|16703306|P4|Overall Study|Study Terminated by Sponsor|0
4845352|NCT00996801|16703307|P3|Overall Study|Study Terminated by Sponsor|0
4845353|NCT00996801|16703308|P2|Overall Study|Study Terminated by Sponsor|1
4845354|NCT00996801|16703309|P1|Overall Study|Study Terminated by Sponsor|0
4845355|NCT00996801|16703304|P6|Overall Study|Protocol Violation|4
4845356|NCT00996801|16703305|P5|Overall Study|Protocol Violation|3
4845357|NCT00996801|16703306|P4|Overall Study|Protocol Violation|2
4845358|NCT00996801|16703307|P3|Overall Study|Protocol Violation|1
4845359|NCT00996801|16703308|P2|Overall Study|Protocol Violation|4
4845360|NCT00996801|16703309|P1|Overall Study|Protocol Violation|3
4845361|NCT00996801|16703304|P6|Overall Study|Progressive Disease|0
4845362|NCT00996801|16703305|P5|Overall Study|Progressive Disease|0
4845363|NCT00996801|16703306|P4|Overall Study|Progressive Disease|0
4845364|NCT00996801|16703307|P3|Overall Study|Progressive Disease|0
4845365|NCT00996801|16703308|P2|Overall Study|Progressive Disease|1
4845366|NCT00996801|16703309|P1|Overall Study|Progressive Disease|0
4845367|NCT00996801|16703304|P6|Overall Study|Physician Decision|0
4845368|NCT00996801|16703305|P5|Overall Study|Physician Decision|0
4845369|NCT00996801|16703306|P4|Overall Study|Physician Decision|1
4845370|NCT00996801|16703307|P3|Overall Study|Physician Decision|0
4845371|NCT00996801|16703308|P2|Overall Study|Physician Decision|0
4845372|NCT00996801|16703309|P1|Overall Study|Physician Decision|0
4845373|NCT00996801|16703304|P6|Overall Study|Lost to Follow-up|2
4845374|NCT00996801|16703305|P5|Overall Study|Lost to Follow-up|3
4845375|NCT00996801|16703306|P4|Overall Study|Lost to Follow-up|3
4845376|NCT00996801|16703307|P3|Overall Study|Lost to Follow-up|0
4845377|NCT00996801|16703308|P2|Overall Study|Lost to Follow-up|0
4845378|NCT00996801|16703309|P1|Overall Study|Lost to Follow-up|0
4845379|NCT00996801|16703304|P6|Overall Study|Lack of Efficacy|1
4845380|NCT00996801|16703305|P5|Overall Study|Lack of Efficacy|0
4845381|NCT00996801|16703306|P4|Overall Study|Lack of Efficacy|3
4845382|NCT00996801|16703307|P3|Overall Study|Lack of Efficacy|1
4845383|NCT00996801|16703308|P2|Overall Study|Lack of Efficacy|0
4845384|NCT00996801|16703309|P1|Overall Study|Lack of Efficacy|3
4845385|NCT00996801|16703304|P6|Overall Study|Adverse Event|3
4845386|NCT00996801|16703305|P5|Overall Study|Adverse Event|31
4845387|NCT00996801|16703306|P4|Overall Study|Adverse Event|17
4845388|NCT00996801|16703307|P3|Overall Study|Adverse Event|12
4845389|NCT00996801|16703308|P2|Overall Study|Adverse Event|4
4845390|NCT00996801|16703309|P1|Overall Study|Adverse Event|6
4845391|NCT00996736|16703421|P2|Overall Study|Visit not within 3-month window|3
4845392|NCT00996736|16703422|P1|Overall Study|Visit not within 3-month window|5
4845393|NCT00996736|16703421|P2|Overall Study|Lost to Follow-up|14
4845394|NCT00996736|16703422|P1|Overall Study|Lost to Follow-up|15
4845395|NCT00996736|16703421|P2|Overall Study|Death|1
4845396|NCT00996736|16703422|P1|Overall Study|Death|1
4845397|NCT00996658|16703442|P2|Overall Study|Other|7
4845398|NCT00996658|16703443|P1|Overall Study|Other|9
4845399|NCT00996658|16703442|P2|Overall Study|Non-compliance issues|3
4845400|NCT00996658|16703443|P1|Overall Study|Non-compliance issues|3
4845401|NCT00996658|16703442|P2|Overall Study|Lost to Follow-up|5
4845402|NCT00996658|16703443|P1|Overall Study|Lost to Follow-up|2
4845403|NCT00996658|16703442|P2|Overall Study|Protocol Violation|1
4845404|NCT00996658|16703443|P1|Overall Study|Protocol Violation|0
4845405|NCT00996658|16703442|P2|Overall Study|Adverse Event|5
4845406|NCT00996658|16703443|P1|Overall Study|Adverse Event|2
4845407|NCT00996632|16703471|P2|Overall Study|Physician Decision|0
4845408|NCT00996632|16703472|P1|Overall Study|Physician Decision|0
4845409|NCT00996606|16703480|P1|Overall Study|Withdrawal by Subject|3
4845410|NCT00996606|16703480|P1|Overall Study|Protocol Violation|1
4845411|NCT00996606|16703480|P1|Overall Study|Insufficient Therapeutic Response|2
4845412|NCT00996606|16703480|P1|Overall Study|Adverse Event or Intercurrent Illness|2
4845413|NCT00996593|16703574|P1|Long-Term Follow-Up|Site Closed|1
4845414|NCT00996593|16703574|P1|Long-Term Follow-Up|Withdrawal by Subject|2
4845415|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Non-compliance|1
4845416|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3
4845417|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6
4845418|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Death|1
4845419|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|22
4845420|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3
4845421|NCT00996593|16703574|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7
4845422|NCT00996580|16703602|P1|Overall Study|Other|29
4845423|NCT00996580|16703602|P1|Overall Study|Withdrawal by Subject|217
4845424|NCT00996580|16703602|P1|Overall Study|Sponsor requested participant withdrawal|35
4845425|NCT00996580|16703602|P1|Overall Study|Protocol Violation|16
4845426|NCT00996580|16703602|P1|Overall Study|Pregnancy|68
4845427|NCT00996580|16703602|P1|Overall Study|Physician Decision|5
4845428|NCT00996580|16703602|P1|Overall Study|Noncompliance with the protocol|137
4845429|NCT00996580|16703602|P1|Overall Study|Lost to Follow-up|480
4845430|NCT00996580|16703602|P1|Overall Study|Adverse Event|466
4845431|NCT00996489|16703637|P1|Overall Study|Discontinued|116
4845432|NCT00996489|16703637|P1|Overall Study|Device failure|45
4845433|NCT00996476|16703657|P5|Overall Study|Adverse Event|1
4845434|NCT00996476|16703658|P4|Overall Study|Adverse Event|0
4845435|NCT00996476|16703659|P3|Overall Study|Adverse Event|0
4845436|NCT00996476|16703660|P2|Overall Study|Adverse Event|1
4845437|NCT00996476|16703661|P1|Overall Study|Adverse Event|0
4845438|NCT00996476|16703657|P5|Overall Study|Withdrawal by Subject|1
4845439|NCT00996476|16703658|P4|Overall Study|Withdrawal by Subject|0
4845440|NCT00996476|16703659|P3|Overall Study|Withdrawal by Subject|1
4845441|NCT00996476|16703660|P2|Overall Study|Withdrawal by Subject|2
4845442|NCT00996476|16703661|P1|Overall Study|Withdrawal by Subject|1
4845443|NCT00996437|16703729|P2|Overall Study|Missed|5
4845444|NCT00996437|16703730|P1|Overall Study|Missed|2
4845445|NCT00996437|16703729|P2|Overall Study|Dropped|2
4845446|NCT00996437|16703730|P1|Overall Study|Dropped|2
4845447|NCT00996437|16703729|P2|Overall Study|Death|0
4845448|NCT00996437|16703730|P1|Overall Study|Death|1
4845449|NCT00996333|16703775|P1|Overall Study|Other|5
4845450|NCT00996333|16703775|P1|Overall Study|Physician Decision|1
4845451|NCT00996333|16703775|P1|Overall Study|Adverse Event|1
4845452|NCT00996333|16703775|P1|Overall Study|Death|4
4845453|NCT00996333|16703775|P1|Overall Study|Withdrawal by Subject|1
4845454|NCT00996333|16703775|P1|Overall Study|Screen failure|1
4845455|NCT00996307|16703785|P4|Overall Study|Unable to classify|1
4845456|NCT00996307|16703786|P3|Overall Study|Unable to classify|2
4845457|NCT00996307|16703787|P2|Overall Study|Unable to classify|0
4845458|NCT00996307|16703788|P1|Overall Study|Unable to classify|4
4845459|NCT00996307|16703785|P4|Overall Study|Administrative reason|0
4845460|NCT00996307|16703786|P3|Overall Study|Administrative reason|0
4845461|NCT00996307|16703787|P2|Overall Study|Administrative reason|1
4845462|NCT00996307|16703788|P1|Overall Study|Administrative reason|0
4845463|NCT00996307|16703785|P4|Overall Study|Lost to Follow-up|15
4845464|NCT00996307|16703786|P3|Overall Study|Lost to Follow-up|7
4845465|NCT00996307|16703787|P2|Overall Study|Lost to Follow-up|13
4845466|NCT00996307|16703788|P1|Overall Study|Lost to Follow-up|13
4845467|NCT00996307|16703785|P4|Overall Study|Withdrawal by Subject|5
4845468|NCT00996307|16703786|P3|Overall Study|Withdrawal by Subject|5
4845469|NCT00996307|16703787|P2|Overall Study|Withdrawal by Subject|2
4845470|NCT00996307|16703788|P1|Overall Study|Withdrawal by Subject|3
4845471|NCT00996307|16703785|P4|Overall Study|Adverse Event|0
4845472|NCT00996307|16703786|P3|Overall Study|Adverse Event|0
4845473|NCT00996307|16703787|P2|Overall Study|Adverse Event|1
4845474|NCT00996307|16703788|P1|Overall Study|Adverse Event|0
4845475|NCT00996281|16703848|P2|Overall Study|Other|7
4845476|NCT00996281|16703849|P1|Overall Study|Other|5
4845477|NCT00996281|16703848|P2|Overall Study|Lack of Efficacy|2
4845478|NCT00996281|16703849|P1|Overall Study|Lack of Efficacy|0
4845479|NCT00996281|16703848|P2|Overall Study|Withdrawal by Subject|20
4845480|NCT00996281|16703849|P1|Overall Study|Withdrawal by Subject|31
4845481|NCT00996281|16703848|P2|Overall Study|Lost to Follow-up|16
4845482|NCT00996281|16703849|P1|Overall Study|Lost to Follow-up|14
4845483|NCT00996281|16703848|P2|Overall Study|Major Protocol Deviation|7
4845484|NCT00996281|16703849|P1|Overall Study|Major Protocol Deviation|6
4845485|NCT00996281|16703848|P2|Overall Study|Adverse Event|37
4845486|NCT00996281|16703849|P1|Overall Study|Adverse Event|75
4845487|NCT00996216|16703857|P1|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1
4845488|NCT00996216|16703857|P1|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3
4845489|NCT00996216|16703857|P1|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1
4845490|NCT00996203|16703873|P1|Overall Study|Protocol Violation|2
4845491|NCT00996203|16703873|P1|Overall Study|Lack of Efficacy|1
4845492|NCT00996203|16703873|P1|Overall Study|Lost to Follow-up|1
4845493|NCT00996203|16703873|P1|Overall Study|Adverse Event|3
4845494|NCT00996125|16703905|P2|Overall Study|Withdrawal by Subject|3
4845495|NCT00996125|16703906|P1|Overall Study|Withdrawal by Subject|4
4845496|NCT00996125|16703905|P2|Overall Study|Lost to Follow-up|6
4845497|NCT00996125|16703906|P1|Overall Study|Lost to Follow-up|1
4845498|NCT00996125|16703905|P2|Overall Study|Adverse Event|2
4845499|NCT00996125|16703906|P1|Overall Study|Adverse Event|0
4845500|NCT00996034|16703926|P1|Overall Study|withdrawn by PI|1
4845501|NCT00996034|16703926|P1|Overall Study|Lost to Follow-up|2
4845502|NCT00995930|16703932|P2|Overall Study|Adverse Event|14
4845503|NCT00995930|16703933|P1|Overall Study|Adverse Event|11
4845504|NCT00995930|16703932|P2|Overall Study|Withdrawal by Subject|4
4845505|NCT00995930|16703933|P1|Overall Study|Withdrawal by Subject|3
4845506|NCT00995930|16703932|P2|Overall Study|Lost to Follow-up|2
4845507|NCT00995930|16703933|P1|Overall Study|Lost to Follow-up|1
4845508|NCT00995930|16703932|P2|Overall Study|Administrative problems|2
4845509|NCT00995930|16703933|P1|Overall Study|Administrative problems|4
4845510|NCT00995930|16703932|P2|Overall Study|Death|1
4845511|NCT00995930|16703933|P1|Overall Study|Death|0
4845512|NCT00995930|16703932|P2|Overall Study|Protocol deviation|5
4845513|NCT00995930|16703933|P1|Overall Study|Protocol deviation|2
4845514|NCT00995865|16703984|P3|Overall Study|Lost to Follow-up|1
4845515|NCT00995865|16703985|P2|Overall Study|Lost to Follow-up|0
4845516|NCT00995865|16703986|P1|Overall Study|Lost to Follow-up|0
4845517|NCT00995865|16703984|P3|Overall Study|Protocol Violation|0
4845518|NCT00995865|16703985|P2|Overall Study|Protocol Violation|0
4845519|NCT00995865|16703986|P1|Overall Study|Protocol Violation|2
4845520|NCT00995774|16704008|P2|Training Period 2|Withdrawal by Subject|0
4845521|NCT00995774|16704009|P1|Training Period 2|Withdrawal by Subject|2
4845522|NCT00995709|16704043|P3|Overall Study|Protocol Violation|0
4845523|NCT00995709|16704044|P2|Overall Study|Protocol Violation|1
4845524|NCT00995709|16704045|P1|Overall Study|Protocol Violation|2
4845525|NCT00995709|16704043|P3|Overall Study|Death|0
4845526|NCT00995709|16704044|P2|Overall Study|Death|1
4845527|NCT00995709|16704045|P1|Overall Study|Death|0
4845528|NCT00995709|16704043|P3|Overall Study|Lost to Follow-up|0
4845529|NCT00995709|16704044|P2|Overall Study|Lost to Follow-up|0
4845530|NCT00995709|16704045|P1|Overall Study|Lost to Follow-up|1
4845531|NCT00995709|16704043|P3|Overall Study|Withdrawal by Subject|1
4845532|NCT00995709|16704044|P2|Overall Study|Withdrawal by Subject|4
4845533|NCT00995709|16704045|P1|Overall Study|Withdrawal by Subject|0
4845534|NCT00995709|16704043|P3|Overall Study|Lack of Efficacy|4
4845535|NCT00995709|16704044|P2|Overall Study|Lack of Efficacy|1
4845536|NCT00995709|16704045|P1|Overall Study|Lack of Efficacy|0
4845537|NCT00995709|16704043|P3|Overall Study|Adverse Event|0
4845538|NCT00995709|16704044|P2|Overall Study|Adverse Event|2
4845539|NCT00995709|16704045|P1|Overall Study|Adverse Event|4
4845540|NCT00995670|16704071|P3|Overall Study|Failed arterial cannulation|3
4845541|NCT00995670|16704072|P2|Overall Study|Failed arterial cannulation|0
4845542|NCT00995670|16704073|P1|Overall Study|Failed arterial cannulation|1
4845543|NCT00995566|16704081|P1|Overall Study|Early study termination|52
4845544|NCT00995566|16704081|P1|Overall Study|Adverse Event|2
4845545|NCT00995553|16704095|P2|Overall Study|Withdrawal by Subject|6
4845546|NCT00995553|16704096|P1|Overall Study|Withdrawal by Subject|2
4845547|NCT00995488|16704145|P1|Overall Study|Withdrawal by Subject|1
4845548|NCT00995436|16704179|P3|Overall Study|Withdrawal by Subject|0
4845549|NCT00995436|16704180|P2|Overall Study|Withdrawal by Subject|5
4845550|NCT00995436|16704181|P1|Overall Study|Withdrawal by Subject|2
4845551|NCT00995410|16704189|P1|Overall Study|Misc|28
4845552|NCT00995410|16704189|P1|Overall Study|Lost to Follow-up|2
4845553|NCT00995410|16704189|P1|Overall Study|Withdrawal by Subject|7
4845554|NCT00995410|16704189|P1|Overall Study|Adverse Event|51
4845555|NCT00995371|16704196|P2|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
4845556|NCT00995371|16704197|P1|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5
4845557|NCT00995345|16704215|P5|Overall Study|all other reasons combined|3
4845558|NCT00995345|16704216|P4|Overall Study|all other reasons combined|1
4845559|NCT00995345|16704217|P3|Overall Study|all other reasons combined|2
4845560|NCT00995345|16704218|P2|Overall Study|all other reasons combined|2
4845561|NCT00995345|16704219|P1|Overall Study|all other reasons combined|2
4845562|NCT00995345|16704215|P5|Overall Study|Lost to Follow-up|0
4845563|NCT00995345|16704216|P4|Overall Study|Lost to Follow-up|1
4845564|NCT00995345|16704217|P3|Overall Study|Lost to Follow-up|2
4845565|NCT00995345|16704218|P2|Overall Study|Lost to Follow-up|2
4845566|NCT00995345|16704219|P1|Overall Study|Lost to Follow-up|2
4845567|NCT00995345|16704215|P5|Overall Study|Adverse Event|1
4845568|NCT00995345|16704216|P4|Overall Study|Adverse Event|0
4845569|NCT00995345|16704217|P3|Overall Study|Adverse Event|2
4845570|NCT00995345|16704218|P2|Overall Study|Adverse Event|1
4845571|NCT00995345|16704219|P1|Overall Study|Adverse Event|3
4845572|NCT00995345|16704215|P5|Overall Study|Withdrawal by Subject|1
4845573|NCT00995345|16704216|P4|Overall Study|Withdrawal by Subject|3
4845574|NCT00995345|16704217|P3|Overall Study|Withdrawal by Subject|1
4845575|NCT00995345|16704218|P2|Overall Study|Withdrawal by Subject|2
4845576|NCT00995345|16704219|P1|Overall Study|Withdrawal by Subject|4
4845577|NCT00995085|16704251|P1|Overall Study|Withdrawal by Subject|5
4845578|NCT00995020|16704268|P2|Overall Study|specimen fragmentation, thermal damage|2
4845579|NCT00995020|16704269|P1|Overall Study|specimen fragmentation, thermal damage|1
4845580|NCT00995020|16704268|P2|Overall Study|margin analysis not performed|5
4845581|NCT00995020|16704269|P1|Overall Study|margin analysis not performed|2
4845582|NCT00995007|16704279|P2|Overall Study|Toxicity|0
4845583|NCT00995007|16704280|P1|Overall Study|Toxicity|8
4845584|NCT00995007|16704279|P2|Overall Study|Refused further treatment|2
4845585|NCT00995007|16704280|P1|Overall Study|Refused further treatment|8
4845586|NCT00995007|16704279|P2|Overall Study|Withdrew consent|0
4845587|NCT00995007|16704280|P1|Overall Study|Withdrew consent|1
4845588|NCT00994682|16704343|P2|Pioglitazone Open Label|Physician Decision|1
4845589|NCT00994682|16704344|P1|Pioglitazone Open Label|Physician Decision|6
4845590|NCT00994682|16704343|P2|Pioglitazone Open Label|Lost to Follow-up|2
4845591|NCT00994682|16704344|P1|Pioglitazone Open Label|Lost to Follow-up|3
4845592|NCT00994682|16704343|P2|Pioglitazone Open Label|Withdrawal by Subject|4
4845593|NCT00994682|16704344|P1|Pioglitazone Open Label|Withdrawal by Subject|4
4845594|NCT00994682|16704343|P2|Double Bilnd|Adverse Event|0
4845595|NCT00994682|16704344|P1|Double Bilnd|Adverse Event|1
4845596|NCT00994682|16704343|P2|Double Bilnd|Lost to Follow-up|3
4845597|NCT00994682|16704344|P1|Double Bilnd|Lost to Follow-up|3
4845598|NCT00994682|16704343|P2|Double Bilnd|Withdrawal by Subject|6
4845599|NCT00994682|16704344|P1|Double Bilnd|Withdrawal by Subject|5
4845600|NCT00994643|16704388|P1|Overall Study|Withdrawal by Subject|1
4845601|NCT00994461|16704402|P3|Overall Study|Adverse Event|0
4845602|NCT00994461|16704403|P2|Overall Study|Adverse Event|1
4845603|NCT00994461|16704404|P1|Overall Study|Adverse Event|2
4845604|NCT00994448|16704432|P2|Overall Study|Physician Decision|0
4845605|NCT00994448|16704433|P1|Overall Study|Physician Decision|1
4845606|NCT00994448|16704432|P2|Overall Study|Withdrawal by Subject|1
4845607|NCT00994448|16704433|P1|Overall Study|Withdrawal by Subject|1
4845608|NCT00994448|16704432|P2|Overall Study|Lost to Follow-up|1
4845609|NCT00994448|16704433|P1|Overall Study|Lost to Follow-up|5
4845610|NCT00994448|16704432|P2|Overall Study|Adverse Event|0
4845611|NCT00994448|16704433|P1|Overall Study|Adverse Event|1
4845612|NCT00994422|16704441|P2|Overall Study|Lost to Follow-up|1
4845613|NCT00994422|16704442|P1|Overall Study|Lost to Follow-up|7
4845614|NCT00994279|16704467|P2|Overall Study|Multiple reasons|3
4845615|NCT00994279|16704468|P1|Overall Study|Multiple reasons|1
4845616|NCT00994279|16704467|P2|Overall Study|Toxicity|0
4845617|NCT00994279|16704468|P1|Overall Study|Toxicity|1
4845618|NCT00994279|16704467|P2|Overall Study|Withdrawal by Subject|2
4845619|NCT00994279|16704468|P1|Overall Study|Withdrawal by Subject|2
4845620|NCT00994240|16704478|P2|Overall Study|study termination|3
4845621|NCT00994240|16704479|P1|Overall Study|study termination|2
4845622|NCT00994240|16704478|P2|Overall Study|Withdrawal by Subject|0
4845623|NCT00994240|16704479|P1|Overall Study|Withdrawal by Subject|1
4845624|NCT00994240|16704478|P2|Overall Study|Lost to Follow-up|2
4845625|NCT00994240|16704479|P1|Overall Study|Lost to Follow-up|3
4845626|NCT00994214|16704489|P4|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
4845627|NCT00994214|16704490|P3|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2
4845628|NCT00994214|16704491|P2|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3
4845629|NCT00994214|16704492|P1|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4
4845630|NCT00994214|16704489|P4|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1
4845631|NCT00994214|16704490|P3|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
4845632|NCT00994214|16704491|P2|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
4845633|NCT00994214|16704492|P1|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0
4845634|NCT00994214|16704489|P4|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14
4845635|NCT00994214|16704490|P3|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
4845794|NCT00993421|16704871|P3|Overall Study|Physician Decision|0
4845636|NCT00994214|16704491|P2|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12
4845637|NCT00994214|16704492|P1|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13
4845638|NCT00994214|16704489|P4|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
4845639|NCT00994214|16704490|P3|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
4845640|NCT00994214|16704491|P2|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0
4845641|NCT00994214|16704492|P1|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1
4845642|NCT00994214|16704489|P4|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1
4845643|NCT00994214|16704490|P3|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
4845644|NCT00994214|16704491|P2|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
4845645|NCT00994214|16704492|P1|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0
4845646|NCT00994214|16704489|P4|ITT (Intention-to-Treat) - Part A|Adverse Event|0
4845647|NCT00994214|16704490|P3|ITT (Intention-to-Treat) - Part A|Adverse Event|0
4845648|NCT00994214|16704491|P2|ITT (Intention-to-Treat) - Part A|Adverse Event|1
4845649|NCT00994214|16704492|P1|ITT (Intention-to-Treat) - Part A|Adverse Event|0
4845650|NCT00994110|16704571|P2|Overall Study|Pt not eligible|5
4845651|NCT00994110|16704572|P1|Overall Study|Pt not eligible|10
4845652|NCT00994110|16704571|P2|Overall Study|Patient not resected|52
4845653|NCT00994110|16704572|P1|Overall Study|Patient not resected|41
4845654|NCT00994110|16704571|P2|Overall Study|Adverse Event|0
4845655|NCT00994110|16704572|P1|Overall Study|Adverse Event|1
4845656|NCT00994110|16704571|P2|Overall Study|Not Treated|8
4845657|NCT00994110|16704572|P1|Overall Study|Not Treated|4
4845658|NCT00994110|16704571|P2|Overall Study|Withdrawal by Subject|9
4845659|NCT00994110|16704572|P1|Overall Study|Withdrawal by Subject|9
4845660|NCT00993967|16704578|P1|Overall Study|Protocol Violation|2
4845661|NCT00993967|16704578|P1|Overall Study|Withdrawal by Subject|36
4845662|NCT00993967|16704578|P1|Overall Study|Lost to Follow-up|14
4845663|NCT00993967|16704578|P1|Overall Study|Death|1
4845664|NCT00993967|16704578|P1|Overall Study|Adverse Event|8
4845665|NCT00993954|16704585|P2|Overall Study|Protocol Violation|2
4845666|NCT00993954|16704586|P1|Overall Study|Protocol Violation|21
4845667|NCT00993928|16704599|P2|Overall Study|ineligible|0
4845668|NCT00993928|16704600|P1|Overall Study|ineligible|1
4845669|NCT00993928|16704599|P2|Overall Study|Withdrawal by Subject|7
4845670|NCT00993928|16704600|P1|Overall Study|Withdrawal by Subject|4
4845671|NCT00993915|16704614|P1|Overall Study|Ongoing|3
4845672|NCT00993915|16704614|P1|Overall Study|Other|1
4845673|NCT00993915|16704614|P1|Overall Study|Withdrawal by Subject|2
4845674|NCT00993915|16704614|P1|Overall Study|Insufficient clinical response|3
4845675|NCT00993668|16704640|P2|Open-Label Period|Lost to Follow-up|1
4845676|NCT00993668|16704641|P1|Open-Label Period|Lost to Follow-up|6
4845677|NCT00993668|16704640|P2|Open-Label Period|Withdrawal by Subject|3
4845678|NCT00993668|16704641|P1|Open-Label Period|Withdrawal by Subject|4
4845679|NCT00993668|16704640|P2|Open-Label Period|Lack of Efficacy|3
4845680|NCT00993668|16704641|P1|Open-Label Period|Lack of Efficacy|4
4845681|NCT00993668|16704640|P2|Open-Label Period|Adverse Event|8
4845682|NCT00993668|16704641|P1|Open-Label Period|Adverse Event|9
4845683|NCT00993668|16704640|P2|Single-Blind Period|Lost to Follow-up|1
4845684|NCT00993668|16704641|P1|Single-Blind Period|Lost to Follow-up|3
4845685|NCT00993668|16704640|P2|Single-Blind Period|Lack of Efficacy|1
4845686|NCT00993668|16704641|P1|Single-Blind Period|Lack of Efficacy|0
4845687|NCT00993668|16704640|P2|Single-Blind Period|Adverse Event|1
4845688|NCT00993668|16704641|P1|Single-Blind Period|Adverse Event|1
4845689|NCT00993616|16704685|P1|Overall Study|Never treated|1
4845690|NCT00993616|16704685|P1|Overall Study|No tumor at entry|1
4845691|NCT00993499|16704703|P6|Discontinued After Starting Course 3|Other adverse event|0
4845692|NCT00993499|16704704|P5|Discontinued After Starting Course 3|Other adverse event|0
4845693|NCT00993499|16704705|P4|Discontinued After Starting Course 3|Other adverse event|0
4845694|NCT00993499|16704706|P3|Discontinued After Starting Course 3|Other adverse event|1
4845695|NCT00993499|16704707|P2|Discontinued After Starting Course 3|Other adverse event|0
4845696|NCT00993499|16704708|P1|Discontinued After Starting Course 3|Other adverse event|1
4845697|NCT00993499|16704703|P6|Discontinued After Starting Course 3|DLT|0
4845698|NCT00993499|16704704|P5|Discontinued After Starting Course 3|DLT|0
4845699|NCT00993499|16704705|P4|Discontinued After Starting Course 3|DLT|1
4845700|NCT00993499|16704706|P3|Discontinued After Starting Course 3|DLT|2
4845701|NCT00993499|16704707|P2|Discontinued After Starting Course 3|DLT|0
4845702|NCT00993499|16704708|P1|Discontinued After Starting Course 3|DLT|1
4845703|NCT00993499|16704703|P6|Discontinued After Starting Course 3|Progressive Disease|3
4845704|NCT00993499|16704704|P5|Discontinued After Starting Course 3|Progressive Disease|3
4845705|NCT00993499|16704705|P4|Discontinued After Starting Course 3|Progressive Disease|1
4845706|NCT00993499|16704706|P3|Discontinued After Starting Course 3|Progressive Disease|3
4845707|NCT00993499|16704707|P2|Discontinued After Starting Course 3|Progressive Disease|4
4845708|NCT00993499|16704708|P1|Discontinued After Starting Course 3|Progressive Disease|6
4845709|NCT00993499|16704703|P6|Discontinued After Starting Course 3|Withdrawal by Subject|0
4845710|NCT00993499|16704704|P5|Discontinued After Starting Course 3|Withdrawal by Subject|0
4845711|NCT00993499|16704705|P4|Discontinued After Starting Course 3|Withdrawal by Subject|0
4845712|NCT00993499|16704706|P3|Discontinued After Starting Course 3|Withdrawal by Subject|0
4845713|NCT00993499|16704707|P2|Discontinued After Starting Course 3|Withdrawal by Subject|1
4845714|NCT00993499|16704708|P1|Discontinued After Starting Course 3|Withdrawal by Subject|0
4845715|NCT00993499|16704703|P6|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4845716|NCT00993499|16704704|P5|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4845717|NCT00993499|16704705|P4|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4845718|NCT00993499|16704706|P3|Discontinued Before Starting Course 3|Non compliance with the protocol|2
4845719|NCT00993499|16704707|P2|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4845720|NCT00993499|16704708|P1|Discontinued Before Starting Course 3|Non compliance with the protocol|0
4845721|NCT00993499|16704703|P6|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4845722|NCT00993499|16704704|P5|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4845723|NCT00993499|16704705|P4|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
4845724|NCT00993499|16704706|P3|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1
4845725|NCT00993499|16704707|P2|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4845726|NCT00993499|16704708|P1|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0
4845727|NCT00993499|16704703|P6|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4845728|NCT00993499|16704704|P5|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4845729|NCT00993499|16704705|P4|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4845730|NCT00993499|16704706|P3|Discontinued Before Starting Course 3|Withdrawal by Subject|0
4845731|NCT00993499|16704707|P2|Discontinued Before Starting Course 3|Withdrawal by Subject|2
4845732|NCT00993499|16704708|P1|Discontinued Before Starting Course 3|Withdrawal by Subject|2
4845733|NCT00993499|16704703|P6|Discontinued Before Starting Course 3|Progressive Disease|0
4845734|NCT00993499|16704704|P5|Discontinued Before Starting Course 3|Progressive Disease|0
4845735|NCT00993499|16704705|P4|Discontinued Before Starting Course 3|Progressive Disease|0
4845736|NCT00993499|16704706|P3|Discontinued Before Starting Course 3|Progressive Disease|0
4845737|NCT00993499|16704707|P2|Discontinued Before Starting Course 3|Progressive Disease|2
4845738|NCT00993499|16704708|P1|Discontinued Before Starting Course 3|Progressive Disease|2
4845739|NCT00993499|16704703|P6|Run-in Period (8 Days)|Progressive disease|0
4845740|NCT00993499|16704704|P5|Run-in Period (8 Days)|Progressive disease|0
4845741|NCT00993499|16704705|P4|Run-in Period (8 Days)|Progressive disease|0
4845742|NCT00993499|16704706|P3|Run-in Period (8 Days)|Progressive disease|1
4845743|NCT00993499|16704707|P2|Run-in Period (8 Days)|Progressive disease|1
4845744|NCT00993499|16704708|P1|Run-in Period (8 Days)|Progressive disease|0
4845745|NCT00993499|16704703|P6|Run-in Period (8 Days)|Consent withdrawn|0
4845746|NCT00993499|16704704|P5|Run-in Period (8 Days)|Consent withdrawn|0
4845747|NCT00993499|16704705|P4|Run-in Period (8 Days)|Consent withdrawn|0
4845748|NCT00993499|16704706|P3|Run-in Period (8 Days)|Consent withdrawn|0
4845749|NCT00993499|16704707|P2|Run-in Period (8 Days)|Consent withdrawn|1
4845750|NCT00993499|16704708|P1|Run-in Period (8 Days)|Consent withdrawn|0
4845751|NCT00993499|16704703|P6|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4845752|NCT00993499|16704704|P5|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4845753|NCT00993499|16704705|P4|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4845754|NCT00993499|16704706|P3|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4845755|NCT00993499|16704707|P2|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0
4845756|NCT00993499|16704708|P1|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1
4845757|NCT00993499|16704703|P6|Run-in Period (8 Days)|Adverse Event|0
4845758|NCT00993499|16704704|P5|Run-in Period (8 Days)|Adverse Event|0
4845759|NCT00993499|16704705|P4|Run-in Period (8 Days)|Adverse Event|0
4845760|NCT00993499|16704706|P3|Run-in Period (8 Days)|Adverse Event|0
4845761|NCT00993499|16704707|P2|Run-in Period (8 Days)|Adverse Event|1
4845762|NCT00993499|16704708|P1|Run-in Period (8 Days)|Adverse Event|0
4845763|NCT00993473|16704790|P2|Overall Study|Family event|0
4845764|NCT00993473|16704791|P1|Overall Study|Family event|1
4845765|NCT00993473|16704790|P2|Overall Study|Technical problem with CGM device|1
4845766|NCT00993473|16704791|P1|Overall Study|Technical problem with CGM device|0
4845767|NCT00993473|16704790|P2|Overall Study|Withdrawal by Subject|5
4845768|NCT00993473|16704791|P1|Overall Study|Withdrawal by Subject|1
4845769|NCT00993473|16704790|P2|Overall Study|Lost to Follow-up|0
4845770|NCT00993473|16704791|P1|Overall Study|Lost to Follow-up|1
4845771|NCT00993473|16704790|P2|Overall Study|Protocol Violation|2
4845772|NCT00993473|16704791|P1|Overall Study|Protocol Violation|1
4845773|NCT00993473|16704790|P2|Overall Study|Adverse Event|2
4845774|NCT00993473|16704791|P1|Overall Study|Adverse Event|0
4845775|NCT00993447|16704829|P2|Overall Study|Adverse Event|0
4845776|NCT00993447|16704830|P1|Overall Study|Adverse Event|1
4845777|NCT00993447|16704829|P2|Overall Study|Lost to Follow-up|3
4845778|NCT00993447|16704830|P1|Overall Study|Lost to Follow-up|1
4845779|NCT00993447|16704829|P2|Overall Study|Protocol Violation|8
4845780|NCT00993447|16704830|P1|Overall Study|Protocol Violation|12
4845781|NCT00993447|16704829|P2|Overall Study|Withdrawal by Subject|8
4845782|NCT00993447|16704830|P1|Overall Study|Withdrawal by Subject|23
4845783|NCT00993421|16704867|P7|Overall Study|Protocol Violation|1
4845784|NCT00993421|16704868|P6|Overall Study|Protocol Violation|2
4845785|NCT00993421|16704869|P5|Overall Study|Protocol Violation|0
4845786|NCT00993421|16704870|P4|Overall Study|Protocol Violation|0
4845787|NCT00993421|16704871|P3|Overall Study|Protocol Violation|0
4845788|NCT00993421|16704872|P2|Overall Study|Protocol Violation|0
4845789|NCT00993421|16704873|P1|Overall Study|Protocol Violation|0
4845790|NCT00993421|16704867|P7|Overall Study|Physician Decision|1
4845791|NCT00993421|16704868|P6|Overall Study|Physician Decision|1
4845792|NCT00993421|16704869|P5|Overall Study|Physician Decision|0
4845793|NCT00993421|16704870|P4|Overall Study|Physician Decision|0
4845795|NCT00993421|16704872|P2|Overall Study|Physician Decision|0
4845796|NCT00993421|16704873|P1|Overall Study|Physician Decision|0
4845797|NCT00993421|16704867|P7|Overall Study|Entry Criteria Exclusion|0
4845798|NCT00993421|16704868|P6|Overall Study|Entry Criteria Exclusion|1
4845799|NCT00993421|16704869|P5|Overall Study|Entry Criteria Exclusion|0
4845800|NCT00993421|16704870|P4|Overall Study|Entry Criteria Exclusion|3
4845801|NCT00993421|16704871|P3|Overall Study|Entry Criteria Exclusion|1
4845802|NCT00993421|16704872|P2|Overall Study|Entry Criteria Exclusion|0
4845803|NCT00993421|16704873|P1|Overall Study|Entry Criteria Exclusion|0
4845804|NCT00993421|16704867|P7|Overall Study|Death|1
4845805|NCT00993421|16704868|P6|Overall Study|Death|0
4845806|NCT00993421|16704869|P5|Overall Study|Death|0
4845807|NCT00993421|16704870|P4|Overall Study|Death|0
4845808|NCT00993421|16704871|P3|Overall Study|Death|0
4845809|NCT00993421|16704872|P2|Overall Study|Death|0
4845810|NCT00993421|16704873|P1|Overall Study|Death|0
4845811|NCT00993421|16704867|P7|Overall Study|Withdrawal by Subject|3
4845812|NCT00993421|16704868|P6|Overall Study|Withdrawal by Subject|5
4845813|NCT00993421|16704869|P5|Overall Study|Withdrawal by Subject|3
4845814|NCT00993421|16704870|P4|Overall Study|Withdrawal by Subject|3
4845815|NCT00993421|16704871|P3|Overall Study|Withdrawal by Subject|3
4845816|NCT00993421|16704872|P2|Overall Study|Withdrawal by Subject|2
4845817|NCT00993421|16704873|P1|Overall Study|Withdrawal by Subject|3
4845818|NCT00993421|16704867|P7|Overall Study|Lost to Follow-up|6
4845819|NCT00993421|16704868|P6|Overall Study|Lost to Follow-up|0
4845820|NCT00993421|16704869|P5|Overall Study|Lost to Follow-up|0
4845821|NCT00993421|16704870|P4|Overall Study|Lost to Follow-up|0
4845822|NCT00993421|16704871|P3|Overall Study|Lost to Follow-up|5
4845823|NCT00993421|16704872|P2|Overall Study|Lost to Follow-up|5
4845824|NCT00993421|16704873|P1|Overall Study|Lost to Follow-up|3
4845825|NCT00993421|16704867|P7|Overall Study|Sponsor Decision|29
4845826|NCT00993421|16704868|P6|Overall Study|Sponsor Decision|30
4845827|NCT00993421|16704869|P5|Overall Study|Sponsor Decision|38
4845828|NCT00993421|16704870|P4|Overall Study|Sponsor Decision|30
4845829|NCT00993421|16704871|P3|Overall Study|Sponsor Decision|28
4845830|NCT00993421|16704872|P2|Overall Study|Sponsor Decision|31
4845831|NCT00993421|16704873|P1|Overall Study|Sponsor Decision|36
4845832|NCT00993421|16704867|P7|Overall Study|Adverse Event|1
4845833|NCT00993421|16704868|P6|Overall Study|Adverse Event|7
4845834|NCT00993421|16704869|P5|Overall Study|Adverse Event|5
4845835|NCT00993421|16704870|P4|Overall Study|Adverse Event|9
4845836|NCT00993421|16704871|P3|Overall Study|Adverse Event|6
4845837|NCT00993421|16704872|P2|Overall Study|Adverse Event|7
4845838|NCT00993421|16704873|P1|Overall Study|Adverse Event|2
4845839|NCT00993317|16705024|P2|Overall Study|Early study termination at the site|0
4845840|NCT00993317|16705025|P1|Overall Study|Early study termination at the site|1
4845841|NCT00993317|16705024|P2|Overall Study|Investigator's opinion|1
4845842|NCT00993317|16705025|P1|Overall Study|Investigator's opinion|0
4845843|NCT00993317|16705024|P2|Overall Study|Withdrawal by Subject|2
4845844|NCT00993317|16705025|P1|Overall Study|Withdrawal by Subject|0
4845845|NCT00993317|16705024|P2|Overall Study|Lack of Efficacy|18
4845846|NCT00993317|16705025|P1|Overall Study|Lack of Efficacy|18
4845847|NCT00993317|16705024|P2|Overall Study|Adverse Event|4
4845848|NCT00993317|16705025|P1|Overall Study|Adverse Event|2
4845849|NCT00993291|16705043|P1|Overall Study|Withdrawal by Subject|1
4845850|NCT00993265|16705049|P2|Overall Study|Non-compliant with study medication|0
4845851|NCT00993265|16705050|P1|Overall Study|Non-compliant with study medication|1
4845852|NCT00993265|16705049|P2|Overall Study|Changed dose of concomitant drug|0
4845853|NCT00993265|16705050|P1|Overall Study|Changed dose of concomitant drug|2
4845854|NCT00993265|16705049|P2|Overall Study|Adverse Event|0
4845855|NCT00993265|16705050|P1|Overall Study|Adverse Event|1
4845856|NCT00993148|16705102|P1|Overall Study|never initiated treatment|1
4845857|NCT00993148|16705102|P1|Overall Study|Lost to Follow-up|2
4845858|NCT00993044|16705114|P1|Irinotecan 50 mg|Physician Decision|1
4845859|NCT00993031|16705121|P2|Overall Study|Lost to Follow-up|13
4845860|NCT00993031|16705122|P1|Overall Study|Lost to Follow-up|19
4845861|NCT00993031|16705121|P2|Overall Study|Withdrawal by Subject|3
4845862|NCT00993031|16705122|P1|Overall Study|Withdrawal by Subject|3
4845863|NCT00993031|16705121|P2|Overall Study|Physician Decision|2
4845864|NCT00993031|16705122|P1|Overall Study|Physician Decision|0
4845865|NCT00993031|16705121|P2|Overall Study|Death|1
4845866|NCT00993031|16705122|P1|Overall Study|Death|0
4845867|NCT00992992|16705154|P1|Overall Study|Sponsor Closed the Study|4
4845868|NCT00992992|16705154|P1|Overall Study|GlaxoSmithKline Closed the Study|2
4845869|NCT00992992|16705154|P1|Overall Study|Death|16
4845870|NCT00992992|16705154|P1|Overall Study|Lost to Follow-up|3
4845871|NCT00992836|16705185|P1|Overall Study|Protocol Violation|2
4845872|NCT00992836|16705185|P1|Overall Study|Withdrawal by Subject|2
4845873|NCT00992836|16705185|P1|Overall Study|Lost to Follow-up|1
4845874|NCT00992784|16705200|P3|Overall Study|Withdrawal by Subject|1
4845875|NCT00992784|16705201|P2|Overall Study|Withdrawal by Subject|1
4845876|NCT00992784|16705202|P1|Overall Study|Withdrawal by Subject|1
4845877|NCT00992784|16705200|P3|Overall Study|Adverse Event|0
4845878|NCT00992784|16705201|P2|Overall Study|Adverse Event|1
4845879|NCT00992784|16705202|P1|Overall Study|Adverse Event|2
4845880|NCT00992589|16705314|P4|Double-Blind Phase|Other|3
4845881|NCT00992589|16705315|P3|Double-Blind Phase|Other|6
4845882|NCT00992589|16705316|P2|Double-Blind Phase|Other|1
4845883|NCT00992589|16705317|P1|Double-Blind Phase|Other|0
4845884|NCT00992589|16705314|P4|Double-Blind Phase|Lost to Follow-up|2
4845885|NCT00992589|16705315|P3|Double-Blind Phase|Lost to Follow-up|0
4845886|NCT00992589|16705316|P2|Double-Blind Phase|Lost to Follow-up|0
4845887|NCT00992589|16705317|P1|Double-Blind Phase|Lost to Follow-up|0
4845888|NCT00992589|16705314|P4|Double-Blind Phase|Withdrawal by Subject|2
4845889|NCT00992589|16705315|P3|Double-Blind Phase|Withdrawal by Subject|5
4845890|NCT00992589|16705316|P2|Double-Blind Phase|Withdrawal by Subject|6
4845891|NCT00992589|16705317|P1|Double-Blind Phase|Withdrawal by Subject|0
4845892|NCT00992589|16705314|P4|Double-Blind Phase|Adverse Event|3
4845893|NCT00992589|16705315|P3|Double-Blind Phase|Adverse Event|2
4845894|NCT00992589|16705316|P2|Double-Blind Phase|Adverse Event|6
4845895|NCT00992589|16705317|P1|Double-Blind Phase|Adverse Event|0
4845896|NCT00992589|16705314|P4|Open-Label Phase|Other|0
4845897|NCT00992589|16705315|P3|Open-Label Phase|Other|0
4845898|NCT00992589|16705316|P2|Open-Label Phase|Other|0
4845899|NCT00992589|16705317|P1|Open-Label Phase|Other|45
4845900|NCT00992589|16705314|P4|Open-Label Phase|Physician Decision|0
4845901|NCT00992589|16705315|P3|Open-Label Phase|Physician Decision|0
4845902|NCT00992589|16705316|P2|Open-Label Phase|Physician Decision|0
4845903|NCT00992589|16705317|P1|Open-Label Phase|Physician Decision|4
4845904|NCT00992589|16705314|P4|Open-Label Phase|Protocol Violation|0
4845905|NCT00992589|16705315|P3|Open-Label Phase|Protocol Violation|0
4845906|NCT00992589|16705316|P2|Open-Label Phase|Protocol Violation|0
4845907|NCT00992589|16705317|P1|Open-Label Phase|Protocol Violation|3
4845908|NCT00992589|16705314|P4|Open-Label Phase|Lost to Follow-up|0
4845909|NCT00992589|16705315|P3|Open-Label Phase|Lost to Follow-up|0
4845910|NCT00992589|16705316|P2|Open-Label Phase|Lost to Follow-up|0
4845911|NCT00992589|16705317|P1|Open-Label Phase|Lost to Follow-up|1
4845912|NCT00992589|16705314|P4|Open-Label Phase|Withdrawal by Subject|0
4845913|NCT00992589|16705315|P3|Open-Label Phase|Withdrawal by Subject|0
4845914|NCT00992589|16705316|P2|Open-Label Phase|Withdrawal by Subject|0
4845915|NCT00992589|16705317|P1|Open-Label Phase|Withdrawal by Subject|20
4845916|NCT00992589|16705314|P4|Open-Label Phase|Adverse Event|0
4845917|NCT00992589|16705315|P3|Open-Label Phase|Adverse Event|0
4845918|NCT00992589|16705316|P2|Open-Label Phase|Adverse Event|0
4845919|NCT00992589|16705317|P1|Open-Label Phase|Adverse Event|4
4845920|NCT00992511|16705363|P4|Overall Study|Withdrawal by Subject|1
4845921|NCT00992511|16705364|P3|Overall Study|Withdrawal by Subject|1
4845922|NCT00992511|16705365|P2|Overall Study|Withdrawal by Subject|0
4845923|NCT00992511|16705366|P1|Overall Study|Withdrawal by Subject|0
4845924|NCT00992511|16705363|P4|Overall Study|Lost to Follow-up|2
4845925|NCT00992511|16705364|P3|Overall Study|Lost to Follow-up|0
4845926|NCT00992511|16705365|P2|Overall Study|Lost to Follow-up|0
4845927|NCT00992511|16705366|P1|Overall Study|Lost to Follow-up|1
4845928|NCT00992511|16705363|P4|Overall Study|Migrated/moved from study area|2
4845929|NCT00992511|16705364|P3|Overall Study|Migrated/moved from study area|1
4845930|NCT00992511|16705365|P2|Overall Study|Migrated/moved from study area|0
4845931|NCT00992511|16705366|P1|Overall Study|Migrated/moved from study area|1
4845932|NCT00992459|16705450|P2|Overall Study|Adverse Event|0
4845933|NCT00992459|16705451|P1|Overall Study|Adverse Event|1
4845934|NCT00992459|16705450|P2|Overall Study|Withdrawal by Subject|1
4845935|NCT00992459|16705451|P1|Overall Study|Withdrawal by Subject|0
4845936|NCT00992446|16705475|P1|Overall Study|Maintenance Therapy Screen Fail|5
4845937|NCT00992446|16705475|P1|Overall Study|Withdrawal by Subject|2
4845938|NCT00992446|16705475|P1|Overall Study|Disease Progression|1
4845939|NCT00992407|16705550|P2|Overall Study|Study medication not administered|13
4845940|NCT00992407|16705551|P1|Overall Study|Study medication not administered|17
4845941|NCT00992407|16705550|P2|Overall Study|Loss of follow-up & Adverse events|1
4845942|NCT00992407|16705551|P1|Overall Study|Loss of follow-up & Adverse events|2
4845943|NCT00992407|16705550|P2|Overall Study|Other|0
4845944|NCT00992407|16705551|P1|Overall Study|Other|2
4845945|NCT00992407|16705550|P2|Overall Study|protocol Violation & Adverse events|4
4845946|NCT00992407|16705551|P1|Overall Study|protocol Violation & Adverse events|2
4845947|NCT00992407|16705550|P2|Overall Study|Adverse Event|2
4845948|NCT00992407|16705551|P1|Overall Study|Adverse Event|3
4845949|NCT00992407|16705550|P2|Overall Study|Lost to Follow-up|3
4845950|NCT00992407|16705551|P1|Overall Study|Lost to Follow-up|3
4845951|NCT00992407|16705550|P2|Overall Study|Protocol Violation|1
4845952|NCT00992407|16705551|P1|Overall Study|Protocol Violation|2
4845953|NCT00992394|16705601|P2|Overall Study|Other event|0
4845954|NCT00992394|16705602|P1|Overall Study|Other event|1
4845955|NCT00992394|16705601|P2|Overall Study|Lost to Follow-up|0
4845956|NCT00992394|16705602|P1|Overall Study|Lost to Follow-up|2
4845957|NCT00992394|16705601|P2|Overall Study|Protocol Violation|4
4845958|NCT00992394|16705602|P1|Overall Study|Protocol Violation|2
4845959|NCT00992394|16705601|P2|Overall Study|Physician Decision|0
4845960|NCT00992394|16705602|P1|Overall Study|Physician Decision|1
4845961|NCT00992394|16705601|P2|Overall Study|Withdrawal by Subject|2
4845962|NCT00992394|16705602|P1|Overall Study|Withdrawal by Subject|8
4845963|NCT00992394|16705601|P2|Overall Study|Adverse Event|5
4845964|NCT00992394|16705602|P1|Overall Study|Adverse Event|4
4845965|NCT00992394|16705601|P2|Overall Study|Lack of Efficacy|3
4845966|NCT00992394|16705602|P1|Overall Study|Lack of Efficacy|6
4845967|NCT00992225|16705689|P1|Overall Study|Adverse Event|2
4845968|NCT00992225|16705689|P1|Overall Study|Entry Criteria Not Met|8
4845969|NCT00992186|16705699|P1|Overall Study|Refusal To Receive Study Agent|3
4845970|NCT00992186|16705699|P1|Overall Study|Progressive Disease|30
4845971|NCT00992186|16705699|P1|Overall Study|Adverse Event|9
4845972|NCT00992186|16705699|P1|Overall Study|Physician Decision|1
4845973|NCT00992186|16705699|P1|Overall Study|Protocol Violation|1
4845974|NCT00992186|16705699|P1|Overall Study|Withdrawal by Subject|2
4845975|NCT00992108|16705718|P2|Overall Study|Lost to Follow-up|1
4845976|NCT00992108|16705719|P1|Overall Study|Lost to Follow-up|0
4845977|NCT00992056|16705733|P2|Washout Period (2 Weeks)|Physician Decision|0
4845978|NCT00992056|16705734|P1|Washout Period (2 Weeks)|Physician Decision|1
4845979|NCT00992056|16705733|P2|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2
4845980|NCT00992056|16705734|P1|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1
4845981|NCT00992017|16705740|P1|Overall Study|Not adhere to study requirements|1
4845982|NCT00992017|16705740|P1|Overall Study|Unable to get to clinic|5
4845983|NCT00992017|16705740|P1|Overall Study|Withdrawal by Subject|2
4845984|NCT00992017|16705740|P1|Overall Study|Lost to Follow-up|2
4845985|NCT00991952|16705755|P2|Overall Study|Adverse Event|1
4845986|NCT00991952|16705756|P1|Overall Study|Adverse Event|0
4845987|NCT00991939|16705764|P2|Overall Study|Entire study terminated|1
4845988|NCT00991939|16705765|P1|Overall Study|Entire study terminated|4
4845989|NCT00991939|16705764|P2|Overall Study|Withdrawal by Subject|0
4845990|NCT00991939|16705765|P1|Overall Study|Withdrawal by Subject|1
4845991|NCT00991939|16705764|P2|Overall Study|Lost to Follow-up|1
4845992|NCT00991939|16705765|P1|Overall Study|Lost to Follow-up|0
4845993|NCT00991887|16705799|P2|Overall Study|Lost to Follow-up|1
4845994|NCT00991887|16705800|P1|Overall Study|Lost to Follow-up|2
4845995|NCT00991510|16705819|P2|Period III (Days 29-112)|Adverse Event|1
4845996|NCT00991510|16705820|P1|Period III (Days 29-112)|Adverse Event|1
4845997|NCT00991510|16705819|P2|Period I (Days 1-14)|Adverse Event|0
4845998|NCT00991510|16705820|P1|Period I (Days 1-14)|Adverse Event|1
4845999|NCT00991406|16705864|P1|Overall Study|One participant did not respond to FES.|1
4846000|NCT00991341|16705873|P2|Overall Study|Withdrawal by Subject|4
4846001|NCT00991341|16705874|P1|Overall Study|Withdrawal by Subject|3
4846002|NCT00991341|16705873|P2|Overall Study|Physician Decision|2
4846003|NCT00991341|16705874|P1|Overall Study|Physician Decision|1
4846004|NCT00991341|16705873|P2|Overall Study|no RBCs received 96hrs after randomized|155
4846005|NCT00991341|16705874|P1|Overall Study|no RBCs received 96hrs after randomized|186
4846006|NCT00991341|16705873|P2|Overall Study|Death|0
4846007|NCT00991341|16705874|P1|Overall Study|Death|3
4846008|NCT00991341|16705873|P2|Overall Study|no surgery w/in 30 days of randomization|18
4846009|NCT00991341|16705874|P1|Overall Study|no surgery w/in 30 days of randomization|11
4846010|NCT00991302|16705912|P2|Overall Study|Lost to Follow-up|12
4846011|NCT00991302|16705913|P1|Overall Study|Lost to Follow-up|14
4846012|NCT00991302|16705912|P2|Overall Study|Death|1
4846013|NCT00991302|16705913|P1|Overall Study|Death|0
4846014|NCT00991289|16705929|P1|Overall Study|Protocol Violation|2
4846015|NCT00991289|16705929|P1|Overall Study|Lost to Follow-up|4
4846016|NCT00991289|16705929|P1|Overall Study|Withdrawal by Subject|3
4846017|NCT00991289|16705929|P1|Overall Study|Physician Decision|2
4846018|NCT00991289|16705929|P1|Overall Study|Adverse Event|1
4846019|NCT00991276|16705949|P6|Third Intervention Period|Withdrawal by Subject|0
4846020|NCT00991276|16705950|P5|Third Intervention Period|Withdrawal by Subject|0
4846021|NCT00991276|16705951|P4|Third Intervention Period|Withdrawal by Subject|1
4846022|NCT00991276|16705952|P3|Third Intervention Period|Withdrawal by Subject|0
4846023|NCT00991276|16705953|P2|Third Intervention Period|Withdrawal by Subject|0
4846024|NCT00991276|16705954|P1|Third Intervention Period|Withdrawal by Subject|0
4846025|NCT00991276|16705949|P6|Third Intervention Period|Adverse Event|0
4846026|NCT00991276|16705950|P5|Third Intervention Period|Adverse Event|0
4846027|NCT00991276|16705951|P4|Third Intervention Period|Adverse Event|0
4846028|NCT00991276|16705952|P3|Third Intervention Period|Adverse Event|1
4846029|NCT00991276|16705953|P2|Third Intervention Period|Adverse Event|0
4846030|NCT00991276|16705954|P1|Third Intervention Period|Adverse Event|0
4846031|NCT00991276|16705949|P6|Third Intervention Period|Other|1
4846032|NCT00991276|16705950|P5|Third Intervention Period|Other|0
4846033|NCT00991276|16705951|P4|Third Intervention Period|Other|0
4846034|NCT00991276|16705952|P3|Third Intervention Period|Other|0
4846035|NCT00991276|16705953|P2|Third Intervention Period|Other|0
4846036|NCT00991276|16705954|P1|Third Intervention Period|Other|0
4846037|NCT00991276|16705949|P6|Third Intervention Period|Protocol Violation|0
4846038|NCT00991276|16705950|P5|Third Intervention Period|Protocol Violation|0
4846039|NCT00991276|16705951|P4|Third Intervention Period|Protocol Violation|0
4846040|NCT00991276|16705952|P3|Third Intervention Period|Protocol Violation|0
4846041|NCT00991276|16705953|P2|Third Intervention Period|Protocol Violation|0
4846042|NCT00991276|16705954|P1|Third Intervention Period|Protocol Violation|1
4846043|NCT00991276|16705949|P6|Second Intervention Period|Other|1
4846044|NCT00991276|16705950|P5|Second Intervention Period|Other|0
4846045|NCT00991276|16705951|P4|Second Intervention Period|Other|1
4846046|NCT00991276|16705952|P3|Second Intervention Period|Other|0
4846047|NCT00991276|16705953|P2|Second Intervention Period|Other|0
4846048|NCT00991276|16705954|P1|Second Intervention Period|Other|0
4846049|NCT00991276|16705949|P6|Second Intervention Period|Protocol Violation|0
4846050|NCT00991276|16705950|P5|Second Intervention Period|Protocol Violation|0
4846051|NCT00991276|16705951|P4|Second Intervention Period|Protocol Violation|0
4846052|NCT00991276|16705952|P3|Second Intervention Period|Protocol Violation|0
4846053|NCT00991276|16705953|P2|Second Intervention Period|Protocol Violation|0
4846054|NCT00991276|16705954|P1|Second Intervention Period|Protocol Violation|1
4846055|NCT00991276|16705949|P6|Second Intervention Period|Adverse Event|0
4846056|NCT00991276|16705950|P5|Second Intervention Period|Adverse Event|1
4846057|NCT00991276|16705951|P4|Second Intervention Period|Adverse Event|1
4846058|NCT00991276|16705952|P3|Second Intervention Period|Adverse Event|0
4846059|NCT00991276|16705953|P2|Second Intervention Period|Adverse Event|2
4846060|NCT00991276|16705954|P1|Second Intervention Period|Adverse Event|0
4846061|NCT00991276|16705949|P6|First Intervention Period|Lost to Follow-up|0
4846062|NCT00991276|16705950|P5|First Intervention Period|Lost to Follow-up|0
4846063|NCT00991276|16705951|P4|First Intervention Period|Lost to Follow-up|1
4846064|NCT00991276|16705952|P3|First Intervention Period|Lost to Follow-up|0
4846065|NCT00991276|16705953|P2|First Intervention Period|Lost to Follow-up|1
4846066|NCT00991276|16705954|P1|First Intervention Period|Lost to Follow-up|0
4846067|NCT00991276|16705949|P6|First Intervention Period|Withdrawal by Subject|1
4846068|NCT00991276|16705950|P5|First Intervention Period|Withdrawal by Subject|0
4846069|NCT00991276|16705951|P4|First Intervention Period|Withdrawal by Subject|1
4846070|NCT00991276|16705952|P3|First Intervention Period|Withdrawal by Subject|0
4846071|NCT00991276|16705953|P2|First Intervention Period|Withdrawal by Subject|1
4846072|NCT00991276|16705954|P1|First Intervention Period|Withdrawal by Subject|0
4846073|NCT00991276|16705949|P6|First Intervention Period|Other|0
4846074|NCT00991276|16705950|P5|First Intervention Period|Other|1
4846075|NCT00991276|16705951|P4|First Intervention Period|Other|1
4846076|NCT00991276|16705952|P3|First Intervention Period|Other|0
4846077|NCT00991276|16705953|P2|First Intervention Period|Other|0
4846078|NCT00991276|16705954|P1|First Intervention Period|Other|0
4846079|NCT00991276|16705949|P6|First Intervention Period|Insufficient clinical response|0
4846080|NCT00991276|16705950|P5|First Intervention Period|Insufficient clinical response|1
4846081|NCT00991276|16705951|P4|First Intervention Period|Insufficient clinical response|0
4846082|NCT00991276|16705952|P3|First Intervention Period|Insufficient clinical response|0
4846083|NCT00991276|16705953|P2|First Intervention Period|Insufficient clinical response|0
4846084|NCT00991276|16705954|P1|First Intervention Period|Insufficient clinical response|0
4846085|NCT00991276|16705949|P6|First Intervention Period|Protocol Violation|0
4846086|NCT00991276|16705950|P5|First Intervention Period|Protocol Violation|2
4846087|NCT00991276|16705951|P4|First Intervention Period|Protocol Violation|0
4846088|NCT00991276|16705952|P3|First Intervention Period|Protocol Violation|0
4846089|NCT00991276|16705953|P2|First Intervention Period|Protocol Violation|0
4846090|NCT00991276|16705954|P1|First Intervention Period|Protocol Violation|0
4846091|NCT00991276|16705949|P6|First Intervention Period|Adverse Event|0
4846092|NCT00991276|16705950|P5|First Intervention Period|Adverse Event|0
4846093|NCT00991276|16705951|P4|First Intervention Period|Adverse Event|1
4846094|NCT00991276|16705952|P3|First Intervention Period|Adverse Event|0
4846095|NCT00991276|16705953|P2|First Intervention Period|Adverse Event|1
4846096|NCT00991276|16705954|P1|First Intervention Period|Adverse Event|0
4846097|NCT00990821|16706169|P14|Overall Study|Withdrawal by Subject|1
4846098|NCT00990821|16706170|P13|Overall Study|Withdrawal by Subject|2
4846099|NCT00990821|16706171|P12|Overall Study|Withdrawal by Subject|5
4846100|NCT00990821|16706172|P11|Overall Study|Withdrawal by Subject|3
4846101|NCT00990821|16706173|P10|Overall Study|Withdrawal by Subject|1
4846102|NCT00990821|16706174|P9|Overall Study|Withdrawal by Subject|0
4846103|NCT00990821|16706175|P8|Overall Study|Withdrawal by Subject|0
4846104|NCT00990821|16706176|P7|Overall Study|Withdrawal by Subject|1
4846105|NCT00990821|16706177|P6|Overall Study|Withdrawal by Subject|3
4846106|NCT00990821|16706178|P5|Overall Study|Withdrawal by Subject|3
4846107|NCT00990821|16706179|P4|Overall Study|Withdrawal by Subject|0
4846108|NCT00990821|16706180|P3|Overall Study|Withdrawal by Subject|0
4846109|NCT00990821|16706181|P2|Overall Study|Withdrawal by Subject|2
4846110|NCT00990821|16706182|P1|Overall Study|Withdrawal by Subject|0
4846111|NCT00990704|16706219|P2|Overall Study|Physician Decision|1
4846112|NCT00990704|16706220|P1|Overall Study|Physician Decision|0
4846113|NCT00990704|16706219|P2|Overall Study|Adverse Event|1
4846114|NCT00990704|16706220|P1|Overall Study|Adverse Event|1
4846115|NCT00990665|16706240|P1|Overall Study|System Explant|3
4846116|NCT00990665|16706240|P1|Overall Study|Lost to Follow-up|1
4846117|NCT00990665|16706240|P1|Overall Study|Withdrawal by Subject|6
4846118|NCT00990665|16706240|P1|Overall Study|Heart Transplant|1
4846119|NCT00990665|16706240|P1|Overall Study|Death|29
4846120|NCT00990665|16706240|P1|Overall Study|Unsuccessful Implant|8
4846121|NCT00990652|16706247|P1|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1
4846122|NCT00990652|16706247|P1|Pre-surgical Bortezomib|Adverse Event|1
4846123|NCT00990340|16706281|P2|First 14-day Treatment|Protocol Violation|2
4846124|NCT00990340|16706282|P1|First 14-day Treatment|Protocol Violation|2
4846125|NCT00990340|16706281|P2|First 14-day Treatment|Lost to Follow-up|1
4846126|NCT00990340|16706282|P1|First 14-day Treatment|Lost to Follow-up|2
4846127|NCT00990340|16706281|P2|First 14-day Treatment|Not Compliant|1
4846128|NCT00990340|16706282|P1|First 14-day Treatment|Not Compliant|2
4846129|NCT00990314|16706296|P1|Overall Study|Lack of Efficacy|1
4846130|NCT00990314|16706296|P1|Overall Study|Physician Decision|3
4846131|NCT00990314|16706296|P1|Overall Study|Non-Compliance|1
4846132|NCT00990314|16706296|P1|Overall Study|Withdrawal by Subject|3
4846133|NCT00990314|16706296|P1|Overall Study|Adverse Event|2
4846134|NCT00990314|16706296|P1|Overall Study|Death|2
4846135|NCT00990249|16706338|P1|Overall Study|Not treated|2
4846136|NCT00990249|16706338|P1|Overall Study|Death|2
4846137|NCT00990249|16706338|P1|Overall Study|Non-Compliance|1
4846138|NCT00990249|16706338|P1|Overall Study|Disease Progression|8
4846139|NCT00990184|16706353|P1|Overall Study|Physician Decision|1
4846140|NCT00990106|16706361|P2|Overall Study|scheduling conflicts|2
4846141|NCT00990106|16706362|P1|Overall Study|scheduling conflicts|0
4846142|NCT00990106|16706361|P2|Overall Study|planned major surgery|1
4846143|NCT00990106|16706362|P1|Overall Study|planned major surgery|0
4846144|NCT00990106|16706361|P2|Overall Study|started exclusionary medication|1
4846145|NCT00990106|16706362|P1|Overall Study|started exclusionary medication|0
4846146|NCT00990106|16706361|P2|Overall Study|relocation/deployment|1
4846147|NCT00990106|16706362|P1|Overall Study|relocation/deployment|4
4846148|NCT00990106|16706361|P2|Overall Study|opted for open label prazosin|1
4846149|NCT00990106|16706362|P1|Overall Study|opted for open label prazosin|1
4846150|NCT00990106|16706361|P2|Overall Study|Withdrawal by Subject|1
4846151|NCT00990106|16706362|P1|Overall Study|Withdrawal by Subject|2
4846152|NCT00990106|16706361|P2|Overall Study|Lost to Follow-up|3
4846153|NCT00990106|16706362|P1|Overall Study|Lost to Follow-up|1
4846154|NCT00990106|16706361|P2|Overall Study|"too busy to continue"|2
4846155|NCT00990106|16706362|P1|Overall Study|"too busy to continue"|1
4846156|NCT00990093|16706372|P2|Test Period 2 (15-28 Days)|Other|1
4846157|NCT00990093|16706373|P1|Test Period 2 (15-28 Days)|Other|0
4846158|NCT00990093|16706372|P2|Test Period 2 (15-28 Days)|Lack of Efficacy|0
4846159|NCT00990093|16706373|P1|Test Period 2 (15-28 Days)|Lack of Efficacy|1
4846160|NCT00990093|16706372|P2|Test Period 2 (15-28 Days)|Adverse Event|0
4846161|NCT00990093|16706373|P1|Test Period 2 (15-28 Days)|Adverse Event|1
4846162|NCT00990093|16706372|P2|Test Period 1 (1-14 Days)|Lack of Efficacy|2
4846163|NCT00990093|16706373|P1|Test Period 1 (1-14 Days)|Lack of Efficacy|0
4846164|NCT00990093|16706372|P2|Test Period 1 (1-14 Days)|Other|0
4846165|NCT00990093|16706373|P1|Test Period 1 (1-14 Days)|Other|1
4846166|NCT00990093|16706372|P2|Test Period 1 (1-14 Days)|Withdrawal by Subject|0
4846167|NCT00990093|16706373|P1|Test Period 1 (1-14 Days)|Withdrawal by Subject|2
4846168|NCT00990093|16706372|P2|Test Period 1 (1-14 Days)|Adverse Event|0
4846169|NCT00990093|16706373|P1|Test Period 1 (1-14 Days)|Adverse Event|1
4846170|NCT00989963|16706425|P3|Overall Study|Adverse Event|1
4846171|NCT00989963|16706426|P2|Overall Study|Adverse Event|1
4846172|NCT00989963|16706427|P1|Overall Study|Adverse Event|1
4846173|NCT00989950|16706463|P4|Randomized Phase|Adverse Event|0
4846174|NCT00989950|16706464|P3|Randomized Phase|Adverse Event|0
4846175|NCT00989950|16706465|P2|Randomized Phase|Adverse Event|1
4846176|NCT00989950|16706466|P1|Randomized Phase|Adverse Event|0
4846177|NCT00989950|16706463|P4|Randomized Phase|Protocol Violation|0
4846178|NCT00989950|16706464|P3|Randomized Phase|Protocol Violation|0
4846179|NCT00989950|16706465|P2|Randomized Phase|Protocol Violation|0
4846180|NCT00989950|16706466|P1|Randomized Phase|Protocol Violation|1
4846181|NCT00989833|16706498|P3|Overall Study|Incorrectly randomized|0
4846182|NCT00989833|16706499|P2|Overall Study|Incorrectly randomized|0
4846183|NCT00989833|16706500|P1|Overall Study|Incorrectly randomized|1
4846184|NCT00989833|16706498|P3|Overall Study|Withdrawal by Subject|1
4846185|NCT00989833|16706499|P2|Overall Study|Withdrawal by Subject|0
4846186|NCT00989833|16706500|P1|Overall Study|Withdrawal by Subject|0
4846187|NCT00989833|16706498|P3|Overall Study|Protocol Violation|1
4846188|NCT00989833|16706499|P2|Overall Study|Protocol Violation|2
4846189|NCT00989833|16706500|P1|Overall Study|Protocol Violation|1
4846190|NCT00989833|16706498|P3|Overall Study|Lost to Follow-up|0
4846191|NCT00989833|16706499|P2|Overall Study|Lost to Follow-up|1
4846192|NCT00989833|16706500|P1|Overall Study|Lost to Follow-up|0
4846193|NCT00989781|16706531|P2|Ovarian Response to hCG|Lost to Follow-up|2
4846194|NCT00989781|16706532|P1|Ovarian Response to hCG|Lost to Follow-up|3
4846195|NCT00989664|16706562|P1|Long-Term Follow-Up|Death|3
4846196|NCT00989664|16706562|P1|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1
4846197|NCT00989664|16706562|P1|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7
4846198|NCT00989664|16706562|P1|Dosimetric and Therapeutic Treatment|Death|1
4846199|NCT00989664|16706562|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|49
4846200|NCT00989664|16706562|P1|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2
4846201|NCT00989664|16706562|P1|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1
4846202|NCT00989287|16706647|P2|Overall Study|Lost to Follow-up|1
4846203|NCT00989287|16706648|P1|Overall Study|Lost to Follow-up|0
4846204|NCT00989287|16706647|P2|Overall Study|Adverse Event|0
4846205|NCT00989287|16706648|P1|Overall Study|Adverse Event|1
4846206|NCT00989261|16706750|P2|Overall Study|Lost to Follow-up|0
4846207|NCT00989261|16706751|P1|Overall Study|Lost to Follow-up|3
4846208|NCT00989261|16706750|P2|Overall Study|Withdrawal by Subject|1
4846209|NCT00989261|16706751|P1|Overall Study|Withdrawal by Subject|0
4846210|NCT00989261|16706750|P2|Overall Study|Still in follow up|21
4846211|NCT00989261|16706751|P1|Overall Study|Still in follow up|12
4846212|NCT00989235|16706781|P2|Overall Study|Lost to Follow-up|1
4846213|NCT00989235|16706782|P1|Overall Study|Lost to Follow-up|0
4846214|NCT00989235|16706781|P2|Overall Study|Randomized by Mistake|2
4846215|NCT00989235|16706782|P1|Overall Study|Randomized by Mistake|0
4846216|NCT00989235|16706781|P2|Overall Study|Desire to Become Pregnant|0
4846217|NCT00989235|16706782|P1|Overall Study|Desire to Become Pregnant|1
4846218|NCT00989235|16706781|P2|Overall Study|Withdrawal of Consent|1
4846219|NCT00989235|16706782|P1|Overall Study|Withdrawal of Consent|1
4846220|NCT00989235|16706781|P2|Overall Study|Lack of Efficacy|0
4846221|NCT00989235|16706782|P1|Overall Study|Lack of Efficacy|1
4846222|NCT00989235|16706781|P2|Overall Study|Adverse Event|1
4846223|NCT00989235|16706782|P1|Overall Study|Adverse Event|0
4846224|NCT00989235|16706781|P2|Overall Study|Death|1
4846225|NCT00989235|16706782|P1|Overall Study|Death|0
4846226|NCT00989196|16706827|P2|Treatment Period|Lost to Follow-up|0
4846227|NCT00989196|16706828|P1|Treatment Period|Lost to Follow-up|1
4846228|NCT00989092|16706866|P2|Overall Study|Did not receive study drug|0
4846229|NCT00989092|16706867|P1|Overall Study|Did not receive study drug|2
4846230|NCT00989092|16706866|P2|Overall Study|Erythropoietin therapy initiated|0
4846231|NCT00989092|16706867|P1|Overall Study|Erythropoietin therapy initiated|2
4846232|NCT00989092|16706866|P2|Overall Study|Protocol deviation|0
4846233|NCT00989092|16706867|P1|Overall Study|Protocol deviation|2
4846234|NCT00989092|16706866|P2|Overall Study|Other|1
4846235|NCT00989092|16706867|P1|Overall Study|Other|3
4846236|NCT00989092|16706866|P2|Overall Study|Lost to Follow-up|2
4846237|NCT00989092|16706867|P1|Overall Study|Lost to Follow-up|6
4846238|NCT00989092|16706866|P2|Overall Study|Ineligibility determined|3
4846239|NCT00989092|16706867|P1|Overall Study|Ineligibility determined|3
4846240|NCT00989092|16706866|P2|Overall Study|Death|2
4846241|NCT00989092|16706867|P1|Overall Study|Death|14
4846242|NCT00989092|16706866|P2|Overall Study|Withdrawal by Subject|9
4846243|NCT00989092|16706867|P1|Overall Study|Withdrawal by Subject|17
4846244|NCT00989092|16706866|P2|Overall Study|Chemotherapy initiated|4
4846245|NCT00989092|16706867|P1|Overall Study|Chemotherapy initiated|12
4846246|NCT00989092|16706866|P2|Overall Study|Adverse Event|1
4846247|NCT00989092|16706867|P1|Overall Study|Adverse Event|20
4846248|NCT00989092|16706866|P2|Overall Study|Physician Decision|6
4846249|NCT00989092|16706867|P1|Overall Study|Physician Decision|9
4846250|NCT00988884|16706919|P2|Overall Study|Withdrawal by Subject|18
4846251|NCT00988884|16706920|P1|Overall Study|Withdrawal by Subject|15
4846252|NCT00988884|16706919|P2|Overall Study|Protocol Violation|1
4846253|NCT00988884|16706920|P1|Overall Study|Protocol Violation|0
4846254|NCT00988884|16706919|P2|Overall Study|Lost to Follow-up|16
4846255|NCT00988884|16706920|P1|Overall Study|Lost to Follow-up|20
4846256|NCT00988884|16706919|P2|Overall Study|Adverse Event|1
4846257|NCT00988884|16706920|P1|Overall Study|Adverse Event|0
4846258|NCT00988858|16706942|P1|Overall Study|Sponsor Decision|1
4846259|NCT00988858|16706942|P1|Overall Study|Physician Decision|1
4846260|NCT00988858|16706942|P1|Overall Study|Death|1
4846261|NCT00988858|16706942|P1|Overall Study|Adverse Event|7
4846262|NCT00988637|16706991|P2|Overall Study|non-compliance with study drug|1
4846263|NCT00988637|16706992|P1|Overall Study|non-compliance with study drug|0
4846264|NCT00988637|16706991|P2|Overall Study|Withdrawal by Subject|1
4846265|NCT00988637|16706992|P1|Overall Study|Withdrawal by Subject|1
4846266|NCT00988637|16706991|P2|Overall Study|Lost to Follow-up|1
4846267|NCT00988637|16706992|P1|Overall Study|Lost to Follow-up|2
4846268|NCT00988559|16707026|P4|Overall Study|Lost to Follow-up|0
4846269|NCT00988559|16707027|P3|Overall Study|Lost to Follow-up|1
4846270|NCT00988559|16707028|P2|Overall Study|Lost to Follow-up|0
4846271|NCT00988559|16707029|P1|Overall Study|Lost to Follow-up|0
4846272|NCT00988559|16707026|P4|Overall Study|Pregnancy|0
4846273|NCT00988559|16707027|P3|Overall Study|Pregnancy|1
4846274|NCT00988559|16707028|P2|Overall Study|Pregnancy|1
4846275|NCT00988559|16707029|P1|Overall Study|Pregnancy|0
4846276|NCT00988559|16707026|P4|Overall Study|Withdrawal by Subject|1
4846277|NCT00988559|16707027|P3|Overall Study|Withdrawal by Subject|0
4846278|NCT00988559|16707028|P2|Overall Study|Withdrawal by Subject|1
4846279|NCT00988559|16707029|P1|Overall Study|Withdrawal by Subject|1
4846280|NCT00988533|16707043|P1|Overall Study|Lost to Follow-up|3
4846281|NCT00988442|16707057|P2|Overall Study|Early Study Closure|25
4846282|NCT00988442|16707058|P1|Overall Study|Early Study Closure|29
4846283|NCT00988442|16707057|P2|Overall Study|Lost to Follow-up|1
4846284|NCT00988442|16707058|P1|Overall Study|Lost to Follow-up|0
4846285|NCT00988442|16707057|P2|Overall Study|Death|2
4846286|NCT00988442|16707058|P1|Overall Study|Death|1
4846287|NCT00988429|16707121|P3|Overall Study|other reasons|1
4846288|NCT00988429|16707122|P2|Overall Study|other reasons|8
4846289|NCT00988429|16707123|P1|Overall Study|other reasons|8
4846290|NCT00988429|16707121|P3|Overall Study|Administrative Reasons|1
4846291|NCT00988429|16707122|P2|Overall Study|Administrative Reasons|2
4846292|NCT00988429|16707123|P1|Overall Study|Administrative Reasons|1
4846293|NCT00988429|16707121|P3|Overall Study|Withdrawal by Subject|12
4846294|NCT00988429|16707122|P2|Overall Study|Withdrawal by Subject|7
4846295|NCT00988429|16707123|P1|Overall Study|Withdrawal by Subject|7
4846296|NCT00988429|16707121|P3|Overall Study|Protocol Violation|3
4846297|NCT00988429|16707122|P2|Overall Study|Protocol Violation|3
4846298|NCT00988429|16707123|P1|Overall Study|Protocol Violation|4
4846299|NCT00988429|16707121|P3|Overall Study|Pregnancy|0
4846300|NCT00988429|16707122|P2|Overall Study|Pregnancy|1
4846301|NCT00988429|16707123|P1|Overall Study|Pregnancy|2
4846302|NCT00988429|16707121|P3|Overall Study|Physician Decision|3
4846303|NCT00988429|16707122|P2|Overall Study|Physician Decision|0
4846304|NCT00988429|16707123|P1|Overall Study|Physician Decision|1
4846305|NCT00988429|16707121|P3|Overall Study|Non-Compliance with Study Drug|3
4846306|NCT00988429|16707122|P2|Overall Study|Non-Compliance with Study Drug|1
4846307|NCT00988429|16707123|P1|Overall Study|Non-Compliance with Study Drug|5
4846308|NCT00988429|16707121|P3|Overall Study|Lack of Efficacy|1
4846309|NCT00988429|16707122|P2|Overall Study|Lack of Efficacy|0
4846310|NCT00988429|16707123|P1|Overall Study|Lack of Efficacy|0
4846311|NCT00988429|16707121|P3|Overall Study|Adverse Event|45
4846312|NCT00988429|16707122|P2|Overall Study|Adverse Event|21
4846313|NCT00988429|16707123|P1|Overall Study|Adverse Event|9
4846314|NCT00988351|16707136|P2|Overall Study|not using CPAP|3
4846315|NCT00988351|16707137|P1|Overall Study|not using CPAP|5
4846316|NCT00988351|16707136|P2|Overall Study|Lost to Follow-up|9
4846317|NCT00988351|16707137|P1|Overall Study|Lost to Follow-up|6
4846318|NCT00988351|16707136|P2|Overall Study|Withdrawal by Subject|0
4846319|NCT00988351|16707137|P1|Overall Study|Withdrawal by Subject|8
4846320|NCT00988247|16707214|P2|Overall Study|Other|0
4846321|NCT00988247|16707215|P1|Overall Study|Other|3
4846322|NCT00988247|16707214|P2|Overall Study|Sponsor requested withdrawal|1
4846323|NCT00988247|16707215|P1|Overall Study|Sponsor requested withdrawal|3
4846324|NCT00988247|16707214|P2|Overall Study|Protocol Violation|5
4846325|NCT00988247|16707215|P1|Overall Study|Protocol Violation|4
4846326|NCT00988247|16707214|P2|Overall Study|Lost to Follow-up|2
4846327|NCT00988247|16707215|P1|Overall Study|Lost to Follow-up|11
4846328|NCT00988247|16707214|P2|Overall Study|Pregnancy|2
4846329|NCT00988247|16707215|P1|Overall Study|Pregnancy|1
4846330|NCT00988247|16707214|P2|Overall Study|Withdrawal by Subject|13
4846331|NCT00988247|16707215|P1|Overall Study|Withdrawal by Subject|44
4846332|NCT00988247|16707214|P2|Overall Study|Adverse Event|3
4846333|NCT00988247|16707215|P1|Overall Study|Adverse Event|17
4846334|NCT00988221|16707234|P4|Part III|Refused Treatment|0
4846335|NCT00988221|16707235|P3|Part III|Refused Treatment|1
4846336|NCT00988221|16707236|P2|Part III|Refused Treatment|0
4846337|NCT00988221|16707237|P1|Part III|Refused Treatment|0
4846338|NCT00988221|16707234|P4|Part III|Insufficient Therapeutic Response|0
4846339|NCT00988221|16707235|P3|Part III|Insufficient Therapeutic Response|1
4846340|NCT00988221|16707236|P2|Part III|Insufficient Therapeutic Response|1
4846341|NCT00988221|16707237|P1|Part III|Insufficient Therapeutic Response|0
4846342|NCT00988221|16707234|P4|Part III|Adverse Event|0
4846343|NCT00988221|16707235|P3|Part III|Adverse Event|1
4846344|NCT00988221|16707236|P2|Part III|Adverse Event|0
4846345|NCT00988221|16707237|P1|Part III|Adverse Event|1
4846346|NCT00988221|16707234|P4|Part II|Reason not Specified|0
4846347|NCT00988221|16707235|P3|Part II|Reason not Specified|1
4846348|NCT00988221|16707236|P2|Part II|Reason not Specified|0
4846349|NCT00988221|16707237|P1|Part II|Reason not Specified|0
4846350|NCT00988221|16707234|P4|Part II|Withdrawal by Subject|2
4846351|NCT00988221|16707235|P3|Part II|Withdrawal by Subject|2
4846352|NCT00988221|16707236|P2|Part II|Withdrawal by Subject|0
4846353|NCT00988221|16707237|P1|Part II|Withdrawal by Subject|0
4846354|NCT00988221|16707234|P4|Part II|Adverse Event|1
4846355|NCT00988221|16707235|P3|Part II|Adverse Event|0
4846356|NCT00988221|16707236|P2|Part II|Adverse Event|0
4846357|NCT00988221|16707237|P1|Part II|Adverse Event|1
4846358|NCT00988221|16707234|P4|Part I|Lost to Follow-up|0
4846359|NCT00988221|16707235|P3|Part I|Lost to Follow-up|0
4846360|NCT00988221|16707236|P2|Part I|Lost to Follow-up|1
4846361|NCT00988221|16707237|P1|Part I|Lost to Follow-up|0
4846362|NCT00988221|16707234|P4|Part I|Refused Treatment|0
4846363|NCT00988221|16707235|P3|Part I|Refused Treatment|1
4846364|NCT00988221|16707236|P2|Part I|Refused Treatment|2
4846365|NCT00988221|16707237|P1|Part I|Refused Treatment|0
4846366|NCT00988221|16707234|P4|Part I|Insufficient Therapeutic Response|0
4846367|NCT00988221|16707235|P3|Part I|Insufficient Therapeutic Response|5
4846368|NCT00988221|16707236|P2|Part I|Insufficient Therapeutic Response|6
4846369|NCT00988221|16707237|P1|Part I|Insufficient Therapeutic Response|4
4846370|NCT00988221|16707234|P4|Part I|Adverse Event|0
4846371|NCT00988221|16707235|P3|Part I|Adverse Event|2
4846372|NCT00988221|16707236|P2|Part I|Adverse Event|1
4846373|NCT00988221|16707237|P1|Part I|Adverse Event|0
4846374|NCT00988208|16707410|P2|Overall Study|Other|3
4846375|NCT00988208|16707411|P1|Overall Study|Other|8
4846376|NCT00988208|16707410|P2|Overall Study|Subject Decision/Investigator Discretion|32
4846377|NCT00988208|16707411|P1|Overall Study|Subject Decision/Investigator Discretion|32
4846378|NCT00988208|16707410|P2|Overall Study|Clinical Deterioration|14
4846379|NCT00988208|16707411|P1|Overall Study|Clinical Deterioration|7
4846380|NCT00988208|16707410|P2|Overall Study|Biochemical Progression|7
4846381|NCT00988208|16707411|P1|Overall Study|Biochemical Progression|21
4846382|NCT00988208|16707410|P2|Overall Study|Clinical Progression|16
4846383|NCT00988208|16707411|P1|Overall Study|Clinical Progression|17
4846384|NCT00988208|16707410|P2|Overall Study|Sponsor Decision|78
4846385|NCT00988208|16707411|P1|Overall Study|Sponsor Decision|102
4846386|NCT00988208|16707410|P2|Overall Study|Protocol Violation|2
4846387|NCT00988208|16707411|P1|Overall Study|Protocol Violation|9
4846388|NCT00988208|16707410|P2|Overall Study|Lost to Follow-up|3
4846389|NCT00988208|16707411|P1|Overall Study|Lost to Follow-up|2
4846390|NCT00988208|16707410|P2|Overall Study|Death|15
4846391|NCT00988208|16707411|P1|Overall Study|Death|9
4846392|NCT00988208|16707410|P2|Overall Study|Withdrawal by Subject|57
4846393|NCT00988208|16707411|P1|Overall Study|Withdrawal by Subject|50
4846394|NCT00988208|16707410|P2|Overall Study|Disease Progression|89
4846395|NCT00988208|16707411|P1|Overall Study|Disease Progression|103
4846396|NCT00988208|16707410|P2|Overall Study|Adverse Event|122
4846397|NCT00988208|16707411|P1|Overall Study|Adverse Event|71
4846398|NCT00988169|16707429|P1|Overall Study|Withdrawal by Subject|1
4846399|NCT00988117|16707481|P1|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2
4846400|NCT00988117|16707481|P1|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1
4846401|NCT00988091|16707490|P2|Open-label Period|Other|3
4846402|NCT00988091|16707491|P1|Open-label Period|Other|2
4846403|NCT00988091|16707490|P2|Open-label Period|Lost to Follow-up|5
4846404|NCT00988091|16707491|P1|Open-label Period|Lost to Follow-up|3
4846405|NCT00988091|16707490|P2|Open-label Period|Withdrawal by Subject|16
4846406|NCT00988091|16707491|P1|Open-label Period|Withdrawal by Subject|10
4846407|NCT00988091|16707490|P2|Open-label Period|Protocol Violation|1
4846408|NCT00988091|16707491|P1|Open-label Period|Protocol Violation|1
4846409|NCT00988091|16707490|P2|Open-label Period|Use of exclusionary medication|1
4846410|NCT00988091|16707491|P1|Open-label Period|Use of exclusionary medication|1
4846411|NCT00988091|16707490|P2|Open-label Period|Adverse Event|7
4846412|NCT00988091|16707491|P1|Open-label Period|Adverse Event|4
4846413|NCT00988091|16707490|P2|Double-blind Period|Use of exclusionary medication|3
4846414|NCT00988091|16707491|P1|Double-blind Period|Use of exclusionary medication|2
4846415|NCT00988091|16707490|P2|Double-blind Period|Adverse Event|9
4846416|NCT00988091|16707491|P1|Double-blind Period|Adverse Event|6
4846417|NCT00988091|16707490|P2|Double-blind Period|Other|8
4846418|NCT00988091|16707491|P1|Double-blind Period|Other|8
4846419|NCT00988091|16707490|P2|Double-blind Period|Lost to Follow-up|14
4846420|NCT00988091|16707491|P1|Double-blind Period|Lost to Follow-up|12
4846421|NCT00988091|16707490|P2|Double-blind Period|Withdrawal by Subject|13
4846422|NCT00988091|16707491|P1|Double-blind Period|Withdrawal by Subject|15
4846423|NCT00988065|16707513|P3|Overall Study|Noncompliance with protocol|9
4846424|NCT00988065|16707514|P2|Overall Study|Noncompliance with protocol|6
4846425|NCT00988065|16707515|P1|Overall Study|Noncompliance with protocol|5
4846426|NCT00988065|16707513|P3|Overall Study|Subject withdrew consent|2
4846427|NCT00988065|16707514|P2|Overall Study|Subject withdrew consent|5
4846428|NCT00988065|16707515|P1|Overall Study|Subject withdrew consent|3
4846429|NCT00988065|16707513|P3|Overall Study|Lost to Follow-up|2
4846430|NCT00988065|16707514|P2|Overall Study|Lost to Follow-up|2
4846431|NCT00988065|16707515|P1|Overall Study|Lost to Follow-up|1
4846432|NCT00988065|16707513|P3|Overall Study|Adverse Event|2
4846433|NCT00988065|16707514|P2|Overall Study|Adverse Event|10
4846434|NCT00988065|16707515|P1|Overall Study|Adverse Event|4
4846435|NCT00988052|16707537|P2|Overall Study|Study terminated by sponsor|236
4846436|NCT00988052|16707538|P1|Overall Study|Study terminated by sponsor|240
4846437|NCT00988052|16707537|P2|Overall Study|Withdrawal by Subject|91
4846438|NCT00988052|16707538|P1|Overall Study|Withdrawal by Subject|90
4846439|NCT00988052|16707537|P2|Overall Study|Adverse Event|28
4846440|NCT00988052|16707538|P1|Overall Study|Adverse Event|35
4846441|NCT00988052|16707537|P2|Overall Study|Physician Decision|28
4846442|NCT00988052|16707538|P1|Overall Study|Physician Decision|27
4846443|NCT00988052|16707537|P2|Overall Study|Lost to Follow-up|11
4846444|NCT00988052|16707538|P1|Overall Study|Lost to Follow-up|6
4846445|NCT00988052|16707537|P2|Overall Study|Lack of Efficacy|7
4846446|NCT00988052|16707538|P1|Overall Study|Lack of Efficacy|8
4846447|NCT00988052|16707537|P2|Overall Study|Pregnancy|6
4846448|NCT00988052|16707538|P1|Overall Study|Pregnancy|6
4846449|NCT00988052|16707537|P2|Overall Study|Protocol Violation|5
4846450|NCT00988052|16707538|P1|Overall Study|Protocol Violation|6
4846451|NCT00988052|16707537|P2|Overall Study|Death|3
4846452|NCT00988052|16707538|P1|Overall Study|Death|1
4846453|NCT00988052|16707537|P2|Overall Study|Teva requested subject withdrawal|1
4846454|NCT00988052|16707538|P1|Overall Study|Teva requested subject withdrawal|3
4846455|NCT00988052|16707537|P2|Overall Study|Missing|0
4846456|NCT00988052|16707538|P1|Overall Study|Missing|1
4846457|NCT00987935|16707582|P9|Overall Study|Reason other than those specified above|1
4846458|NCT00987935|16707583|P8|Overall Study|Reason other than those specified above|0
4846459|NCT00987935|16707584|P7|Overall Study|Reason other than those specified above|0
4846460|NCT00987935|16707585|P6|Overall Study|Reason other than those specified above|0
4846461|NCT00987935|16707586|P5|Overall Study|Reason other than those specified above|0
4846462|NCT00987935|16707587|P4|Overall Study|Reason other than those specified above|0
4846463|NCT00987935|16707588|P3|Overall Study|Reason other than those specified above|0
4846464|NCT00987935|16707589|P2|Overall Study|Reason other than those specified above|0
4846465|NCT00987935|16707590|P1|Overall Study|Reason other than those specified above|0
4846466|NCT00987935|16707582|P9|Overall Study|Refused to continue taking trial med.|2
4846467|NCT00987935|16707583|P8|Overall Study|Refused to continue taking trial med.|4
4846468|NCT00987935|16707584|P7|Overall Study|Refused to continue taking trial med.|4
4846469|NCT00987935|16707585|P6|Overall Study|Refused to continue taking trial med.|0
4846470|NCT00987935|16707586|P5|Overall Study|Refused to continue taking trial med.|1
4846471|NCT00987935|16707587|P4|Overall Study|Refused to continue taking trial med.|0
4846472|NCT00987935|16707588|P3|Overall Study|Refused to continue taking trial med.|0
4846473|NCT00987935|16707589|P2|Overall Study|Refused to continue taking trial med.|0
4846474|NCT00987935|16707590|P1|Overall Study|Refused to continue taking trial med.|1
4846475|NCT00987935|16707582|P9|Overall Study|Adverse Event|6
4846476|NCT00987935|16707583|P8|Overall Study|Adverse Event|10
4846477|NCT00987935|16707584|P7|Overall Study|Adverse Event|2
4846478|NCT00987935|16707585|P6|Overall Study|Adverse Event|0
4846479|NCT00987935|16707586|P5|Overall Study|Adverse Event|1
4846480|NCT00987935|16707587|P4|Overall Study|Adverse Event|1
4846481|NCT00987935|16707588|P3|Overall Study|Adverse Event|0
4846482|NCT00987935|16707589|P2|Overall Study|Adverse Event|1
4846483|NCT00987935|16707590|P1|Overall Study|Adverse Event|0
4846484|NCT00987935|16707582|P9|Overall Study|Progressive disease|23
4846485|NCT00987935|16707583|P8|Overall Study|Progressive disease|48
4846486|NCT00987935|16707584|P7|Overall Study|Progressive disease|9
4846487|NCT00987935|16707585|P6|Overall Study|Progressive disease|3
4846488|NCT00987935|16707586|P5|Overall Study|Progressive disease|5
4846489|NCT00987935|16707587|P4|Overall Study|Progressive disease|2
4846490|NCT00987935|16707588|P3|Overall Study|Progressive disease|3
4846491|NCT00987935|16707589|P2|Overall Study|Progressive disease|2
4846492|NCT00987935|16707590|P1|Overall Study|Progressive disease|3
4846493|NCT00987831|16707646|P3|Overall Study|Lost to Follow-up|0
4846494|NCT00987831|16707647|P2|Overall Study|Lost to Follow-up|3
4846495|NCT00987831|16707648|P1|Overall Study|Lost to Follow-up|0
4846496|NCT00987831|16707646|P3|Overall Study|Never flared in 12 months|0
4846497|NCT00987831|16707647|P2|Overall Study|Never flared in 12 months|0
4846498|NCT00987831|16707648|P1|Overall Study|Never flared in 12 months|1
4846499|NCT00987623|16707670|P2|Overall Study|Influenza|1
4846500|NCT00987623|16707671|P1|Overall Study|Influenza|0
4846501|NCT00987623|16707670|P2|Overall Study|Biomicroscopy|1
4846502|NCT00987623|16707671|P1|Overall Study|Biomicroscopy|0
4846503|NCT00987623|16707670|P2|Overall Study|Discomfort|0
4846504|NCT00987623|16707671|P1|Overall Study|Discomfort|1
4846505|NCT00987623|16707670|P2|Overall Study|Time/job conflict|0
4846506|NCT00987623|16707671|P1|Overall Study|Time/job conflict|2
4846507|NCT00987623|16707670|P2|Overall Study|Lost to Follow-up|1
4846508|NCT00987623|16707671|P1|Overall Study|Lost to Follow-up|2
4846509|NCT00987467|16707700|P1|Overall Study|Lost to Follow-up|2
4846510|NCT00987402|16707724|P2|Overall Study|Insufficient data entry|98
4846511|NCT00987402|16707725|P1|Overall Study|Insufficient data entry|86
4846512|NCT00987389|16707733|P4|Overall Study|Multiple different reasons|1
4846513|NCT00987389|16707734|P3|Overall Study|Multiple different reasons|3
4846514|NCT00987389|16707735|P2|Overall Study|Multiple different reasons|0
4846515|NCT00987389|16707736|P1|Overall Study|Multiple different reasons|1
4846516|NCT00987389|16707733|P4|Overall Study|Withdrawn from Treatment|0
4846517|NCT00987389|16707734|P3|Overall Study|Withdrawn from Treatment|0
4846518|NCT00987389|16707735|P2|Overall Study|Withdrawn from Treatment|1
4846519|NCT00987389|16707736|P1|Overall Study|Withdrawn from Treatment|0
4846520|NCT00987389|16707733|P4|Overall Study|Withdrawal by Subject|1
4846521|NCT00987389|16707734|P3|Overall Study|Withdrawal by Subject|2
4846522|NCT00987389|16707735|P2|Overall Study|Withdrawal by Subject|3
4846523|NCT00987389|16707736|P1|Overall Study|Withdrawal by Subject|4
4846524|NCT00987389|16707733|P4|Overall Study|Lost to Follow-up|1
4846525|NCT00987389|16707734|P3|Overall Study|Lost to Follow-up|3
4846526|NCT00987389|16707735|P2|Overall Study|Lost to Follow-up|1
4846527|NCT00987389|16707736|P1|Overall Study|Lost to Follow-up|4
4846528|NCT00987389|16707733|P4|Overall Study|Ineligible|0
4846529|NCT00987389|16707734|P3|Overall Study|Ineligible|0
4846530|NCT00987389|16707735|P2|Overall Study|Ineligible|3
4846531|NCT00987389|16707736|P1|Overall Study|Ineligible|0
4846532|NCT00987337|16707755|P3|Overall Study|Participant Relapsed|5
4846533|NCT00987337|16707756|P2|Overall Study|Participant Relapsed|20
4846534|NCT00987337|16707757|P1|Overall Study|Participant Relapsed|18
4846535|NCT00987337|16707755|P3|Overall Study|Protocol Violation|2
4846536|NCT00987337|16707756|P2|Overall Study|Protocol Violation|0
4846537|NCT00987337|16707757|P1|Overall Study|Protocol Violation|1
4846538|NCT00987337|16707755|P3|Overall Study|Other|5
4846539|NCT00987337|16707756|P2|Overall Study|Other|2
4846540|NCT00987337|16707757|P1|Overall Study|Other|0
4846541|NCT00987337|16707755|P3|Overall Study|Withdrawal by Subject|9
4846542|NCT00987337|16707756|P2|Overall Study|Withdrawal by Subject|9
4846543|NCT00987337|16707757|P1|Overall Study|Withdrawal by Subject|6
4846544|NCT00987337|16707755|P3|Overall Study|Lost to Follow-up|2
4846545|NCT00987337|16707756|P2|Overall Study|Lost to Follow-up|6
4846546|NCT00987337|16707757|P1|Overall Study|Lost to Follow-up|10
4846547|NCT00987337|16707755|P3|Overall Study|Virologic Breakthrough|8
4846548|NCT00987337|16707756|P2|Overall Study|Virologic Breakthrough|2
4846549|NCT00987337|16707757|P1|Overall Study|Virologic Breakthrough|2
4846550|NCT00987337|16707755|P3|Overall Study|Insufficient Virologic Response|12
4846551|NCT00987337|16707756|P2|Overall Study|Insufficient Virologic Response|7
4846552|NCT00987337|16707757|P1|Overall Study|Insufficient Virologic Response|10
4846553|NCT00987337|16707755|P3|Overall Study|Adverse Event|8
4846554|NCT00987337|16707756|P2|Overall Study|Adverse Event|9
4846555|NCT00987337|16707757|P1|Overall Study|Adverse Event|10
4846556|NCT00986986|16707812|P2|Overall Study|Lost to Follow-up|1
4846557|NCT00986986|16707813|P1|Overall Study|Lost to Follow-up|0
4846558|NCT00986973|16707823|P1|Overall Study|Withdrawn by study team|1
4846559|NCT00986921|16707849|P2|Overall Study|Physician Decision|0
4846560|NCT00986921|16707850|P1|Overall Study|Physician Decision|1
4846561|NCT00986830|16707883|P1|Overall Study|Unable to access sinus with device|5
4846562|NCT00986830|16707883|P1|Overall Study|Lack of Efficacy|1
4846563|NCT00986830|16707883|P1|Overall Study|Lost to Follow-up|1
4846564|NCT00986830|16707883|P1|Overall Study|Death|1
4846565|NCT00986674|16707898|P3|Overall Study|unknown/not specify|9
4846566|NCT00986674|16707899|P2|Overall Study|unknown/not specify|7
4846567|NCT00986674|16707900|P1|Overall Study|unknown/not specify|0
4846568|NCT00986674|16707898|P3|Overall Study|not start protocol therapy|1
4846569|NCT00986674|16707899|P2|Overall Study|not start protocol therapy|3
4846570|NCT00986674|16707900|P1|Overall Study|not start protocol therapy|4
4846571|NCT00986674|16707898|P3|Overall Study|alternative therapy|1
4846572|NCT00986674|16707899|P2|Overall Study|alternative therapy|0
4846573|NCT00986674|16707900|P1|Overall Study|alternative therapy|0
4846574|NCT00986674|16707898|P3|Overall Study|Withdrawal by Subject|1
4846575|NCT00986674|16707899|P2|Overall Study|Withdrawal by Subject|2
4846576|NCT00986674|16707900|P1|Overall Study|Withdrawal by Subject|6
4846577|NCT00986674|16707898|P3|Overall Study|Death|4
4846578|NCT00986674|16707899|P2|Overall Study|Death|0
4846579|NCT00986674|16707900|P1|Overall Study|Death|5
4846580|NCT00986674|16707898|P3|Overall Study|Adverse Event|9
4846581|NCT00986674|16707899|P2|Overall Study|Adverse Event|8
4846582|NCT00986674|16707900|P1|Overall Study|Adverse Event|4
4846583|NCT00986674|16707898|P3|Overall Study|Lack of Efficacy|23
4846584|NCT00986674|16707899|P2|Overall Study|Lack of Efficacy|25
4846585|NCT00986674|16707900|P1|Overall Study|Lack of Efficacy|28
4846586|NCT00986570|16707933|P1|Overall Study|Potential bias for objective assessment|1
4846587|NCT00986570|16707933|P1|Overall Study|Lost to Follow-up|6
4846588|NCT00986479|16707950|P2|Period 1|Administrative reasons|0
4846589|NCT00986479|16707951|P1|Period 1|Administrative reasons|1
4846590|NCT00986479|16707950|P2|Period 1|Improved mood|0
4846591|NCT00986479|16707951|P1|Period 1|Improved mood|1
4846592|NCT00986427|16707997|P2|Overall Study|Withdrawal by Subject|0
4846593|NCT00986427|16707998|P1|Overall Study|Withdrawal by Subject|1
4846594|NCT00986427|16707997|P2|Overall Study|Lack of Efficacy|0
4846595|NCT00986427|16707998|P1|Overall Study|Lack of Efficacy|1
4846596|NCT00986427|16707997|P2|Overall Study|Lost to Follow-up|0
4846597|NCT00986427|16707998|P1|Overall Study|Lost to Follow-up|2
4846598|NCT00986362|16708026|P2|Overall Study|Lost to Follow-up|1
4846599|NCT00986362|16708027|P1|Overall Study|Lost to Follow-up|0
4846600|NCT00986362|16708026|P2|Overall Study|Death|0
4846601|NCT00986362|16708027|P1|Overall Study|Death|2
4846602|NCT00986349|16708033|P1|Overall Study|device migration|1
4846603|NCT00986349|16708033|P1|Overall Study|Physician Decision|1
4846604|NCT00986349|16708033|P1|Overall Study|Adverse Event|2
4846605|NCT00986349|16708033|P1|Overall Study|Unsuccessful implant procedure|3
4846606|NCT00986258|16708057|P1|Maintenance Period|Withdrawal by Subject|2
4846607|NCT00986258|16708057|P1|Maintenance Period|Lack of Efficacy|2
4846608|NCT00986258|16708057|P1|Maintenance Period|Adverse Event|5
4846609|NCT00986258|16708057|P1|Titration and Optimal Dose Period|Other|1
4846610|NCT00986258|16708057|P1|Titration and Optimal Dose Period|Non-Compliance|1
4846611|NCT00986258|16708057|P1|Titration and Optimal Dose Period|Withdrawal by Subject|3
4846612|NCT00986258|16708057|P1|Titration and Optimal Dose Period|Lack of Efficacy|3
4846613|NCT00986258|16708057|P1|Titration and Optimal Dose Period|Adverse Event|15
4846614|NCT00986258|16708057|P1|Observation Period|Not eligible to be dosed|11
4846615|NCT00986245|16708085|P2|Second Intervention|Protocol Violation|1
4846616|NCT00986245|16708086|P1|Second Intervention|Protocol Violation|0
4846617|NCT00986245|16708085|P2|Second Intervention|Lost to Follow-up|0
4846618|NCT00986245|16708086|P1|Second Intervention|Lost to Follow-up|1
4846619|NCT00986245|16708085|P2|Second Intervention|Poor compliance|0
4846620|NCT00986245|16708086|P1|Second Intervention|Poor compliance|1
4846621|NCT00986245|16708085|P2|First Intervention|Out of indication|0
4846622|NCT00986245|16708086|P1|First Intervention|Out of indication|1
4846623|NCT00986245|16708085|P2|First Intervention|Protocol Violation|1
4846624|NCT00986245|16708086|P1|First Intervention|Protocol Violation|0
4846625|NCT00986245|16708085|P2|First Intervention|Withdrawal by Subject|1
4846626|NCT00986245|16708086|P1|First Intervention|Withdrawal by Subject|0
4846627|NCT00986245|16708085|P2|First Intervention|Lack of Efficacy|2
4846628|NCT00986245|16708086|P1|First Intervention|Lack of Efficacy|1
4846629|NCT00986245|16708085|P2|First Intervention|Poor compliance|4
4846630|NCT00986245|16708086|P1|First Intervention|Poor compliance|8
4846631|NCT00986232|16708123|P4|Overall Study|Incomplete safety follow-up|2
4846632|NCT00986232|16708124|P3|Overall Study|Incomplete safety follow-up|2
4846633|NCT00986232|16708125|P2|Overall Study|Incomplete safety follow-up|7
4846634|NCT00986232|16708126|P1|Overall Study|Incomplete safety follow-up|3
4846635|NCT00986232|16708123|P4|Overall Study|Missed one or more bleeds|7
4846636|NCT00986232|16708124|P3|Overall Study|Missed one or more bleeds|6
4846637|NCT00986232|16708125|P2|Overall Study|Missed one or more bleeds|10
4846638|NCT00986232|16708126|P1|Overall Study|Missed one or more bleeds|13
4846639|NCT00986232|16708123|P4|Overall Study|Withdrawal by Subject|3
4846640|NCT00986232|16708124|P3|Overall Study|Withdrawal by Subject|12
4846641|NCT00986232|16708125|P2|Overall Study|Withdrawal by Subject|16
4846642|NCT00986232|16708126|P1|Overall Study|Withdrawal by Subject|13
4846643|NCT00986232|16708123|P4|Overall Study|Protocol Violation|1
4846644|NCT00986232|16708124|P3|Overall Study|Protocol Violation|0
4846645|NCT00986232|16708125|P2|Overall Study|Protocol Violation|3
4846646|NCT00986232|16708126|P1|Overall Study|Protocol Violation|2
4846647|NCT00986232|16708123|P4|Overall Study|Lost to Follow-up|7
4846648|NCT00986232|16708124|P3|Overall Study|Lost to Follow-up|12
4846649|NCT00986232|16708125|P2|Overall Study|Lost to Follow-up|12
4846650|NCT00986232|16708126|P1|Overall Study|Lost to Follow-up|19
4846651|NCT00986232|16708123|P4|Overall Study|Adverse Event|0
4846652|NCT00986232|16708124|P3|Overall Study|Adverse Event|3
4846653|NCT00986232|16708125|P2|Overall Study|Adverse Event|2
4846654|NCT00986232|16708126|P1|Overall Study|Adverse Event|1
4846655|NCT00986180|16708200|P2|Overall Study|Miscellanies|11
4846656|NCT00986180|16708201|P1|Overall Study|Miscellanies|10
4846657|NCT00986180|16708200|P2|Overall Study|Withdrawal by Subject|9
4846658|NCT00986180|16708201|P1|Overall Study|Withdrawal by Subject|1
4846659|NCT00986180|16708200|P2|Overall Study|Protocol Violation|0
4846660|NCT00986180|16708201|P1|Overall Study|Protocol Violation|2
4846661|NCT00986180|16708200|P2|Overall Study|Physician Decision|3
4846662|NCT00986180|16708201|P1|Overall Study|Physician Decision|1
4846663|NCT00986180|16708200|P2|Overall Study|Lost to Follow-up|7
4846664|NCT00986180|16708201|P1|Overall Study|Lost to Follow-up|5
4846665|NCT00986180|16708200|P2|Overall Study|Lack of Efficacy|3
4846666|NCT00986180|16708201|P1|Overall Study|Lack of Efficacy|4
4846667|NCT00986180|16708200|P2|Overall Study|Adverse Event|23
4846668|NCT00986180|16708201|P1|Overall Study|Adverse Event|21
4846669|NCT00986154|16708279|P2|Overall Study|never received study drug|27
4846670|NCT00986154|16708280|P1|Overall Study|never received study drug|25
4846671|NCT00986154|16708279|P2|Overall Study|investigator/subject decide not continue|3
4846672|NCT00986154|16708280|P1|Overall Study|investigator/subject decide not continue|6
4846673|NCT00986154|16708279|P2|Overall Study|Withdrawal by Subject|33
4846674|NCT00986154|16708280|P1|Overall Study|Withdrawal by Subject|32
4846675|NCT00986154|16708279|P2|Overall Study|Lost to Follow-up|4
4846676|NCT00986154|16708280|P1|Overall Study|Lost to Follow-up|7
4846677|NCT00986154|16708279|P2|Overall Study|Death|127
4846678|NCT00986154|16708280|P1|Overall Study|Death|136
4846679|NCT00986102|16708294|P4|Overall Study|Withdrawal by Subject|0
4846680|NCT00986102|16708295|P3|Overall Study|Withdrawal by Subject|0
4846681|NCT00986102|16708296|P2|Overall Study|Withdrawal by Subject|1
4846682|NCT00986102|16708297|P1|Overall Study|Withdrawal by Subject|1
4846683|NCT00986102|16708294|P4|Overall Study|Lost to Follow-up|1
4846684|NCT00986102|16708295|P3|Overall Study|Lost to Follow-up|0
4846685|NCT00986102|16708296|P2|Overall Study|Lost to Follow-up|1
4846686|NCT00986102|16708297|P1|Overall Study|Lost to Follow-up|0
4846687|NCT00985985|16708347|P4|Overall Study|Other Reason|2
4846688|NCT00985985|16708348|P3|Overall Study|Other Reason|4
4846689|NCT00985985|16708349|P2|Overall Study|Other Reason|1
4846690|NCT00985985|16708350|P1|Overall Study|Other Reason|6
4846691|NCT00985985|16708347|P4|Overall Study|Withdrawal by Subject|2
4846692|NCT00985985|16708348|P3|Overall Study|Withdrawal by Subject|2
4846693|NCT00985985|16708349|P2|Overall Study|Withdrawal by Subject|2
4846694|NCT00985985|16708350|P1|Overall Study|Withdrawal by Subject|4
4846695|NCT00985985|16708347|P4|Overall Study|Lack of Efficacy|3
4846696|NCT00985985|16708348|P3|Overall Study|Lack of Efficacy|1
4846697|NCT00985985|16708349|P2|Overall Study|Lack of Efficacy|6
4846698|NCT00985985|16708350|P1|Overall Study|Lack of Efficacy|5
4846699|NCT00985985|16708347|P4|Overall Study|Protocol Violation|1
4846700|NCT00985985|16708348|P3|Overall Study|Protocol Violation|0
4846701|NCT00985985|16708349|P2|Overall Study|Protocol Violation|2
4846702|NCT00985985|16708350|P1|Overall Study|Protocol Violation|1
4846703|NCT00985985|16708347|P4|Overall Study|Lost to Follow-up|3
4846704|NCT00985985|16708348|P3|Overall Study|Lost to Follow-up|2
4846705|NCT00985985|16708349|P2|Overall Study|Lost to Follow-up|11
4846706|NCT00985985|16708350|P1|Overall Study|Lost to Follow-up|4
4846707|NCT00985985|16708347|P4|Overall Study|Adverse Event|2
4846708|NCT00985985|16708348|P3|Overall Study|Adverse Event|2
4846709|NCT00985985|16708349|P2|Overall Study|Adverse Event|2
4846710|NCT00985985|16708350|P1|Overall Study|Adverse Event|4
4846711|NCT00985959|16708391|P3|Overall Study|Other|11
4846712|NCT00985959|16708392|P2|Overall Study|Other|0
4846713|NCT00985959|16708393|P1|Overall Study|Other|0
4846714|NCT00985959|16708391|P3|Overall Study|Complete response observed over 2 cycles|4
4846715|NCT00985959|16708392|P2|Overall Study|Complete response observed over 2 cycles|1
4846716|NCT00985959|16708393|P1|Overall Study|Complete response observed over 2 cycles|0
4846717|NCT00985959|16708391|P3|Overall Study|Pneumonitis or pulmonary fibrosis|2
4846718|NCT00985959|16708392|P2|Overall Study|Pneumonitis or pulmonary fibrosis|0
4846719|NCT00985959|16708393|P1|Overall Study|Pneumonitis or pulmonary fibrosis|2
4846720|NCT00985959|16708391|P3|Overall Study|Unrecovered toxicity|7
4846721|NCT00985959|16708392|P2|Overall Study|Unrecovered toxicity|0
4846722|NCT00985959|16708393|P1|Overall Study|Unrecovered toxicity|0
4846723|NCT00985959|16708391|P3|Overall Study|Progressive disease|8
4846724|NCT00985959|16708392|P2|Overall Study|Progressive disease|2
4846725|NCT00985959|16708393|P1|Overall Study|Progressive disease|1
4846726|NCT00985959|16708391|P3|Overall Study|Withdrawal by Subject|8
4846727|NCT00985959|16708392|P2|Overall Study|Withdrawal by Subject|0
4846728|NCT00985959|16708393|P1|Overall Study|Withdrawal by Subject|0
4846729|NCT00985959|16708391|P3|Overall Study|Adverse Event|19
4846730|NCT00985959|16708392|P2|Overall Study|Adverse Event|0
4846731|NCT00985959|16708393|P1|Overall Study|Adverse Event|0
4846732|NCT00985946|16708416|P1|Overall Study|Withdrawal by Subject|1
4846733|NCT00985946|16708416|P1|Overall Study|Lost to Follow-up|6
4846734|NCT00985790|16708445|P2|Overall Study|Lost to Follow-up|7
4846735|NCT00985790|16708446|P1|Overall Study|Lost to Follow-up|6
4846736|NCT00985790|16708445|P2|Overall Study|Withdrawal by Subject|1
4846737|NCT00985790|16708446|P1|Overall Study|Withdrawal by Subject|1
4846738|NCT00985751|16708487|P5|Overall Study|Adverse Event|1
4846739|NCT00985751|16708488|P4|Overall Study|Adverse Event|0
4846740|NCT00985751|16708489|P3|Overall Study|Adverse Event|0
4846741|NCT00985751|16708490|P2|Overall Study|Adverse Event|0
4846742|NCT00985751|16708491|P1|Overall Study|Adverse Event|0
4846743|NCT00985738|16708554|P2|Overall Study|Study closed prematurely|8
4846744|NCT00985738|16708555|P1|Overall Study|Study closed prematurely|8
4846745|NCT00985725|16708563|P2|Overall Study|Out-of-window visits|1
4846746|NCT00985725|16708564|P1|Overall Study|Out-of-window visits|0
4846747|NCT00985725|16708563|P2|Overall Study|Non-compliance|2
4846748|NCT00985725|16708564|P1|Overall Study|Non-compliance|1
4846749|NCT00985725|16708563|P2|Overall Study|Lack of Efficacy|1
4846750|NCT00985725|16708564|P1|Overall Study|Lack of Efficacy|0
4846751|NCT00985725|16708563|P2|Overall Study|Lost to Follow-up|1
4846752|NCT00985725|16708564|P1|Overall Study|Lost to Follow-up|1
4846753|NCT00985725|16708563|P2|Overall Study|Withdrawal by Subject|4
4846754|NCT00985725|16708564|P1|Overall Study|Withdrawal by Subject|4
4846755|NCT00985725|16708563|P2|Overall Study|Protocol Violation|3
4846756|NCT00985725|16708564|P1|Overall Study|Protocol Violation|1
4846757|NCT00985725|16708563|P2|Overall Study|Adverse Event|1
4846758|NCT00985725|16708564|P1|Overall Study|Adverse Event|4
4846759|NCT00985712|16708600|P2|Overall Study|Sponsor decision|2
4846760|NCT00985712|16708601|P1|Overall Study|Sponsor decision|0
4846761|NCT00985712|16708600|P2|Overall Study|Withdrawal by Subject|1
4846762|NCT00985712|16708601|P1|Overall Study|Withdrawal by Subject|4
4846763|NCT00985712|16708600|P2|Overall Study|Protocol Violation|1
4846764|NCT00985712|16708601|P1|Overall Study|Protocol Violation|0
4846765|NCT00985712|16708600|P2|Overall Study|Lost to Follow-up|2
4846766|NCT00985712|16708601|P1|Overall Study|Lost to Follow-up|2
4846767|NCT00985712|16708600|P2|Overall Study|Adverse Event|1
4846768|NCT00985712|16708601|P1|Overall Study|Adverse Event|0
4846769|NCT00985686|16708619|P4|Overall Study|Lost to Follow-up|2
4846770|NCT00985686|16708620|P3|Overall Study|Lost to Follow-up|0
4846771|NCT00985686|16708621|P2|Overall Study|Lost to Follow-up|1
4846772|NCT00985686|16708622|P1|Overall Study|Lost to Follow-up|1
4846773|NCT00985673|16708636|P6|Overall Study|Other|0
4846774|NCT00985673|16708637|P5|Overall Study|Other|1
4846775|NCT00985673|16708638|P4|Overall Study|Other|0
4846776|NCT00985673|16708639|P3|Overall Study|Other|1
4846777|NCT00985673|16708640|P2|Overall Study|Other|0
4846778|NCT00985673|16708641|P1|Overall Study|Other|1
4846779|NCT00985673|16708636|P6|Overall Study|Withdrawal by Subject|3
4846780|NCT00985673|16708637|P5|Overall Study|Withdrawal by Subject|2
4846781|NCT00985673|16708638|P4|Overall Study|Withdrawal by Subject|2
4846782|NCT00985673|16708639|P3|Overall Study|Withdrawal by Subject|5
4846783|NCT00985673|16708640|P2|Overall Study|Withdrawal by Subject|4
4846784|NCT00985673|16708641|P1|Overall Study|Withdrawal by Subject|0
4846785|NCT00985673|16708636|P6|Overall Study|Lost to Follow-up|3
4846786|NCT00985673|16708637|P5|Overall Study|Lost to Follow-up|5
4846787|NCT00985673|16708638|P4|Overall Study|Lost to Follow-up|10
4846788|NCT00985673|16708639|P3|Overall Study|Lost to Follow-up|6
4846789|NCT00985673|16708640|P2|Overall Study|Lost to Follow-up|7
4846790|NCT00985673|16708641|P1|Overall Study|Lost to Follow-up|6
4846791|NCT00985504|16708924|P2|Optimization Period|Withdrawal by Subject|8
4846792|NCT00985504|16708925|P1|Optimization Period|Withdrawal by Subject|10
4846793|NCT00985504|16708924|P2|Optimization Period|Protocol Violation|1
4846794|NCT00985504|16708925|P1|Optimization Period|Protocol Violation|3
4846795|NCT00985504|16708924|P2|Optimization Period|Physician Decision|0
4846796|NCT00985504|16708925|P1|Optimization Period|Physician Decision|1
4846797|NCT00985504|16708924|P2|Optimization Period|Lost to Follow-up|1
4846798|NCT00985504|16708925|P1|Optimization Period|Lost to Follow-up|0
4846799|NCT00985504|16708924|P2|Optimization Period|Lack of Efficacy|3
4846800|NCT00985504|16708925|P1|Optimization Period|Lack of Efficacy|5
4846801|NCT00985504|16708924|P2|Optimization Period|Death|1
4846802|NCT00985504|16708925|P1|Optimization Period|Death|0
4846803|NCT00985504|16708924|P2|Optimization Period|Adverse Event|9
4846804|NCT00985504|16708925|P1|Optimization Period|Adverse Event|7
4846805|NCT00985504|16708924|P2|Acute Treatment Period|Withdrawal by Subject|5
4846806|NCT00985504|16708925|P1|Acute Treatment Period|Withdrawal by Subject|9
4846807|NCT00985504|16708924|P2|Acute Treatment Period|Sponsor Decision|1
4846808|NCT00985504|16708925|P1|Acute Treatment Period|Sponsor Decision|0
4846809|NCT00985504|16708924|P2|Acute Treatment Period|Protocol Violation|0
4846810|NCT00985504|16708925|P1|Acute Treatment Period|Protocol Violation|2
4846811|NCT00985504|16708924|P2|Acute Treatment Period|Entry Criteria Not Met|2
4846812|NCT00985504|16708925|P1|Acute Treatment Period|Entry Criteria Not Met|1
4846813|NCT00985504|16708924|P2|Acute Treatment Period|Adverse Event|4
4846814|NCT00985504|16708925|P1|Acute Treatment Period|Adverse Event|3
4846815|NCT00985491|16708951|P1|Overall Study|implant failure|3
4846816|NCT00985491|16708951|P1|Overall Study|Withdrawal by Subject|1
4846817|NCT00985491|16708951|P1|Overall Study|device migration|7
4846818|NCT00985491|16708951|P1|Overall Study|Adverse Event|8
4846819|NCT00985465|16708958|P2|Overall Study|Considered to be part of the other group|1
4846820|NCT00985465|16708959|P1|Overall Study|Considered to be part of the other group|0
4846821|NCT00985465|16708958|P2|Overall Study|Withdrawal by Subject|2
4846822|NCT00985465|16708959|P1|Overall Study|Withdrawal by Subject|1
4846823|NCT00985439|16708986|P4|Overall Study|Adverse Event|0
4846824|NCT00985439|16708987|P3|Overall Study|Adverse Event|1
4846825|NCT00985439|16708988|P2|Overall Study|Adverse Event|0
4846826|NCT00985439|16708989|P1|Overall Study|Adverse Event|0
4846827|NCT00985231|16709005|P2|Overall Study|Study related symptoms & complaints|2
4846828|NCT00985231|16709006|P1|Overall Study|Study related symptoms & complaints|0
4846829|NCT00985231|16709005|P2|Overall Study|Lost to Follow-up|1
4846830|NCT00985231|16709006|P1|Overall Study|Lost to Follow-up|0
4846831|NCT00985231|16709005|P2|Overall Study|Withdrawal by Subject|0
4846832|NCT00985231|16709006|P1|Overall Study|Withdrawal by Subject|1
4846833|NCT00985231|16709005|P2|Overall Study|Protocol Violation|0
4846834|NCT00985231|16709006|P1|Overall Study|Protocol Violation|1
4846835|NCT00985231|16709005|P2|Overall Study|ineligible|0
4846836|NCT00985231|16709006|P1|Overall Study|ineligible|1
4846837|NCT00985192|16709014|P1|Overall Study|Determined to be Ineligible During Trial|2
4846838|NCT00985192|16709014|P1|Overall Study|Disease Progression|1
4846839|NCT00985192|16709014|P1|Overall Study|Withdrawal by Subject|1
4846840|NCT00985166|16709026|P3|Overall Study|Other|1
4846841|NCT00985166|16709027|P2|Overall Study|Other|0
4846842|NCT00985166|16709028|P1|Overall Study|Other|1
4846843|NCT00985166|16709026|P3|Overall Study|Test not done|4
4846844|NCT00985166|16709027|P2|Overall Study|Test not done|0
4846845|NCT00985166|16709028|P1|Overall Study|Test not done|2
4846846|NCT00985166|16709026|P3|Overall Study|Withdrawal by Subject|0
4846847|NCT00985166|16709027|P2|Overall Study|Withdrawal by Subject|2
4846848|NCT00985166|16709028|P1|Overall Study|Withdrawal by Subject|3
4846849|NCT00985166|16709026|P3|Overall Study|Lost to Follow-up|2
4846850|NCT00985166|16709027|P2|Overall Study|Lost to Follow-up|2
4846851|NCT00985166|16709028|P1|Overall Study|Lost to Follow-up|3
4846852|NCT00985153|16709048|P4|Overall Study|Incomplete Safety Follow-up|4
4846853|NCT00985153|16709049|P3|Overall Study|Incomplete Safety Follow-up|4
4846854|NCT00985153|16709050|P2|Overall Study|Incomplete Safety Follow-up|5
4846855|NCT00985153|16709051|P1|Overall Study|Incomplete Safety Follow-up|3
4846856|NCT00985153|16709048|P4|Overall Study|Missed One or More Bleeds|10
4846857|NCT00985153|16709049|P3|Overall Study|Missed One or More Bleeds|8
4846858|NCT00985153|16709050|P2|Overall Study|Missed One or More Bleeds|7
4846859|NCT00985153|16709051|P1|Overall Study|Missed One or More Bleeds|7
4846860|NCT00985153|16709048|P4|Overall Study|Withdrawal by Subject|10
4846861|NCT00985153|16709049|P3|Overall Study|Withdrawal by Subject|11
4846862|NCT00985153|16709050|P2|Overall Study|Withdrawal by Subject|11
4846863|NCT00985153|16709051|P1|Overall Study|Withdrawal by Subject|6
4846864|NCT00985153|16709048|P4|Overall Study|Protocol Violation|3
4846865|NCT00985153|16709049|P3|Overall Study|Protocol Violation|4
4846866|NCT00985153|16709050|P2|Overall Study|Protocol Violation|2
4846867|NCT00985153|16709051|P1|Overall Study|Protocol Violation|3
4846868|NCT00985153|16709048|P4|Overall Study|Lost to Follow-up|20
4846869|NCT00985153|16709049|P3|Overall Study|Lost to Follow-up|17
4846870|NCT00985153|16709050|P2|Overall Study|Lost to Follow-up|19
4846871|NCT00985153|16709051|P1|Overall Study|Lost to Follow-up|16
4846872|NCT00985114|16709099|P2|Overall Study|Withdrawal by Subject|2
4846873|NCT00985114|16709100|P1|Overall Study|Withdrawal by Subject|0
4846874|NCT00985114|16709099|P2|Overall Study|Adverse Event|0
4846875|NCT00985114|16709100|P1|Overall Study|Adverse Event|1
4846876|NCT00985088|16709114|P8|Overall Study|Lost to Follow-up|2
4846877|NCT00985088|16709115|P7|Overall Study|Lost to Follow-up|3
4846878|NCT00985088|16709116|P6|Overall Study|Lost to Follow-up|5
4846879|NCT00985088|16709117|P5|Overall Study|Lost to Follow-up|6
4846880|NCT00985088|16709118|P4|Overall Study|Lost to Follow-up|6
4846881|NCT00985088|16709119|P3|Overall Study|Lost to Follow-up|2
4846882|NCT00985088|16709120|P2|Overall Study|Lost to Follow-up|1
4846883|NCT00985088|16709121|P1|Overall Study|Lost to Follow-up|6
4846884|NCT00985088|16709114|P8|Overall Study|Migrated/moved from study area|1
4846885|NCT00985088|16709115|P7|Overall Study|Migrated/moved from study area|0
4846886|NCT00985088|16709116|P6|Overall Study|Migrated/moved from study area|0
4846887|NCT00985088|16709117|P5|Overall Study|Migrated/moved from study area|0
4846888|NCT00985088|16709118|P4|Overall Study|Migrated/moved from study area|0
4846889|NCT00985088|16709119|P3|Overall Study|Migrated/moved from study area|1
4846890|NCT00985088|16709120|P2|Overall Study|Migrated/moved from study area|0
4846891|NCT00985088|16709121|P1|Overall Study|Migrated/moved from study area|0
4846892|NCT00985088|16709114|P8|Overall Study|Withdrawal by Subject|2
4846893|NCT00985088|16709115|P7|Overall Study|Withdrawal by Subject|1
4846894|NCT00985088|16709116|P6|Overall Study|Withdrawal by Subject|2
4846895|NCT00985088|16709117|P5|Overall Study|Withdrawal by Subject|3
4846896|NCT00985088|16709118|P4|Overall Study|Withdrawal by Subject|1
4846897|NCT00985088|16709119|P3|Overall Study|Withdrawal by Subject|0
4846898|NCT00985088|16709120|P2|Overall Study|Withdrawal by Subject|0
4846899|NCT00985088|16709121|P1|Overall Study|Withdrawal by Subject|4
4846900|NCT00985088|16709114|P8|Overall Study|Adverse Event|0
4846901|NCT00985088|16709115|P7|Overall Study|Adverse Event|0
4846902|NCT00985088|16709116|P6|Overall Study|Adverse Event|0
4846903|NCT00985088|16709117|P5|Overall Study|Adverse Event|0
4846904|NCT00985088|16709118|P4|Overall Study|Adverse Event|0
4846905|NCT00985088|16709119|P3|Overall Study|Adverse Event|1
4846906|NCT00985088|16709120|P2|Overall Study|Adverse Event|0
4846907|NCT00985088|16709121|P1|Overall Study|Adverse Event|0
4846908|NCT00985088|16709114|P8|Overall Study|Serious Adverse Event|1
4846909|NCT00985088|16709115|P7|Overall Study|Serious Adverse Event|0
4846910|NCT00985088|16709116|P6|Overall Study|Serious Adverse Event|0
4846911|NCT00985088|16709117|P5|Overall Study|Serious Adverse Event|0
4846912|NCT00985088|16709118|P4|Overall Study|Serious Adverse Event|0
4846913|NCT00985088|16709119|P3|Overall Study|Serious Adverse Event|0
4846914|NCT00985088|16709120|P2|Overall Study|Serious Adverse Event|1
4846915|NCT00985088|16709121|P1|Overall Study|Serious Adverse Event|1
4846916|NCT00984867|16709390|P2|Overall Study|lack of efficacy and subject compliance|0
4846917|NCT00984867|16709391|P1|Overall Study|lack of efficacy and subject compliance|1
4846918|NCT00984867|16709390|P2|Overall Study|site closing|0
4846919|NCT00984867|16709391|P1|Overall Study|site closing|1
4846920|NCT00984867|16709390|P2|Overall Study|Subject no longer meets study criteria|1
4846921|NCT00984867|16709391|P1|Overall Study|Subject no longer meets study criteria|1
4846922|NCT00984867|16709390|P2|Overall Study|Poor/non-compliance|1
4846923|NCT00984867|16709391|P1|Overall Study|Poor/non-compliance|0
4846924|NCT00984867|16709390|P2|Overall Study|Lost to Follow-up|4
4846925|NCT00984867|16709391|P1|Overall Study|Lost to Follow-up|3
4846926|NCT00984867|16709390|P2|Overall Study|Withdrawal by Subject|4
4846927|NCT00984867|16709391|P1|Overall Study|Withdrawal by Subject|13
4846928|NCT00984867|16709390|P2|Overall Study|Death|0
4846929|NCT00984867|16709391|P1|Overall Study|Death|1
4846930|NCT00984867|16709390|P2|Overall Study|Adverse Event|7
4846931|NCT00984867|16709391|P1|Overall Study|Adverse Event|3
4846932|NCT00984659|16709431|P4|6-week Double-blind Treatment Period|Withdrawal by Subject|1
4846933|NCT00984659|16709432|P3|6-week Double-blind Treatment Period|Withdrawal by Subject|7
4846934|NCT00984659|16709433|P2|6-week Double-blind Treatment Period|Withdrawal by Subject|1
4846935|NCT00984659|16709434|P1|6-week Double-blind Treatment Period|Withdrawal by Subject|0
4846936|NCT00984659|16709431|P4|6-week Double-blind Treatment Period|Study Closed/Terminated|0
4846937|NCT00984659|16709432|P3|6-week Double-blind Treatment Period|Study Closed/Terminated|1
4846938|NCT00984659|16709433|P2|6-week Double-blind Treatment Period|Study Closed/Terminated|0
4846939|NCT00984659|16709434|P1|6-week Double-blind Treatment Period|Study Closed/Terminated|0
4846940|NCT00984659|16709431|P4|6-week Double-blind Treatment Period|Protocol Violation|4
4846941|NCT00984659|16709432|P3|6-week Double-blind Treatment Period|Protocol Violation|0
4846942|NCT00984659|16709433|P2|6-week Double-blind Treatment Period|Protocol Violation|0
4846943|NCT00984659|16709434|P1|6-week Double-blind Treatment Period|Protocol Violation|0
4846944|NCT00984659|16709431|P4|6-week Double-blind Treatment Period|Lack of Efficacy|1
4846945|NCT00984659|16709432|P3|6-week Double-blind Treatment Period|Lack of Efficacy|0
4846946|NCT00984659|16709433|P2|6-week Double-blind Treatment Period|Lack of Efficacy|2
4846947|NCT00984659|16709434|P1|6-week Double-blind Treatment Period|Lack of Efficacy|0
4846948|NCT00984659|16709431|P4|6-week Double-blind Treatment Period|Adverse Event|7
4846949|NCT00984659|16709432|P3|6-week Double-blind Treatment Period|Adverse Event|3
4846950|NCT00984659|16709433|P2|6-week Double-blind Treatment Period|Adverse Event|3
4846951|NCT00984659|16709434|P1|6-week Double-blind Treatment Period|Adverse Event|0
4846952|NCT00984659|16709431|P4|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4846953|NCT00984659|16709432|P3|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4846954|NCT00984659|16709433|P2|2-week Run-in Period|Did Not Meet Continuation Criteria|0
4846955|NCT00984659|16709434|P1|2-week Run-in Period|Did Not Meet Continuation Criteria|14
4846956|NCT00984659|16709431|P4|2-week Run-in Period|Withdrawal by Subject|0
4846957|NCT00984659|16709432|P3|2-week Run-in Period|Withdrawal by Subject|0
4846958|NCT00984659|16709433|P2|2-week Run-in Period|Withdrawal by Subject|0
4846959|NCT00984659|16709434|P1|2-week Run-in Period|Withdrawal by Subject|10
4846960|NCT00984659|16709431|P4|2-week Run-in Period|Physician Decision|0
4846961|NCT00984659|16709432|P3|2-week Run-in Period|Physician Decision|0
4846962|NCT00984659|16709433|P2|2-week Run-in Period|Physician Decision|0
4846963|NCT00984659|16709434|P1|2-week Run-in Period|Physician Decision|10
4846964|NCT00984659|16709431|P4|2-week Run-in Period|Lost to Follow-up|0
4846965|NCT00984659|16709432|P3|2-week Run-in Period|Lost to Follow-up|0
4846966|NCT00984659|16709433|P2|2-week Run-in Period|Lost to Follow-up|0
4846967|NCT00984659|16709434|P1|2-week Run-in Period|Lost to Follow-up|3
4846968|NCT00984659|16709431|P4|2-week Run-in Period|Study Closed/Terminated|0
4846969|NCT00984659|16709432|P3|2-week Run-in Period|Study Closed/Terminated|0
4846970|NCT00984659|16709433|P2|2-week Run-in Period|Study Closed/Terminated|0
4846971|NCT00984659|16709434|P1|2-week Run-in Period|Study Closed/Terminated|2
4846972|NCT00984659|16709431|P4|2-week Run-in Period|Protocol Violation|0
4846973|NCT00984659|16709432|P3|2-week Run-in Period|Protocol Violation|0
4846974|NCT00984659|16709433|P2|2-week Run-in Period|Protocol Violation|0
4846975|NCT00984659|16709434|P1|2-week Run-in Period|Protocol Violation|5
4846976|NCT00984659|16709431|P4|2-week Run-in Period|Adverse Event|0
4846977|NCT00984659|16709432|P3|2-week Run-in Period|Adverse Event|0
4846978|NCT00984659|16709433|P2|2-week Run-in Period|Adverse Event|0
4846979|NCT00984659|16709434|P1|2-week Run-in Period|Adverse Event|8
4846980|NCT00984620|16709461|P2|Overall Study|reason other than listed above|4
4846981|NCT00984620|16709462|P1|Overall Study|reason other than listed above|0
4846982|NCT00984620|16709461|P2|Overall Study|Withdrawal by Subject|2
4846983|NCT00984620|16709462|P1|Overall Study|Withdrawal by Subject|0
4846984|NCT00984620|16709461|P2|Overall Study|Lost to Follow-up|1
4846985|NCT00984620|16709462|P1|Overall Study|Lost to Follow-up|1
4846986|NCT00984620|16709461|P2|Overall Study|Adverse Event|5
4846987|NCT00984620|16709462|P1|Overall Study|Adverse Event|5
4846988|NCT00984594|16709500|P2|Overall Study|Withdrawal by Subject|1
4846989|NCT00984594|16709501|P1|Overall Study|Withdrawal by Subject|0
4846990|NCT00984594|16709500|P2|Overall Study|Lost to Follow-up|0
4846991|NCT00984594|16709501|P1|Overall Study|Lost to Follow-up|1
4846992|NCT00984568|16709517|P2|Overall Study|Unknown Reason|3
4846993|NCT00984568|16709518|P1|Overall Study|Unknown Reason|1
4846994|NCT00984568|16709517|P2|Overall Study|Opportunistic Infection|0
4846995|NCT00984568|16709518|P1|Overall Study|Opportunistic Infection|1
4846996|NCT00984568|16709517|P2|Overall Study|Lost to Follow-up|1
4846997|NCT00984568|16709518|P1|Overall Study|Lost to Follow-up|0
4846998|NCT00984568|16709517|P2|Overall Study|Did Not Meet Randomization Criteria|0
4846999|NCT00984568|16709518|P1|Overall Study|Did Not Meet Randomization Criteria|1
4847000|NCT00984568|16709517|P2|Overall Study|Adverse Event|0
4847001|NCT00984568|16709518|P1|Overall Study|Adverse Event|2
4847002|NCT00984568|16709517|P2|Overall Study|Lack of Efficacy|0
4847003|NCT00984568|16709518|P1|Overall Study|Lack of Efficacy|2
4847004|NCT00984568|16709517|P2|Overall Study|Withdrawal by Subject|2
4847005|NCT00984568|16709518|P1|Overall Study|Withdrawal by Subject|1
4847006|NCT00984542|16709526|P1|Overall Study|clinical deterioration|2
4847007|NCT00984542|16709526|P1|Overall Study|Withdrawal by Subject|3
4847008|NCT00984542|16709526|P1|Overall Study|complicating disease|3
4847009|NCT00984542|16709526|P1|Overall Study|Death|7
4847010|NCT00984542|16709526|P1|Overall Study|toxicity|7
4847011|NCT00984542|16709526|P1|Overall Study|disease progression|19
4847012|NCT00984295|16709576|P3|Overall Study|Incomplete safety follow-up|3
4847013|NCT00984295|16709577|P2|Overall Study|Incomplete safety follow-up|2
4847014|NCT00984295|16709578|P1|Overall Study|Incomplete safety follow-up|11
4847015|NCT00984295|16709576|P3|Overall Study|Missed one or more blood samplings|2
4847016|NCT00984295|16709577|P2|Overall Study|Missed one or more blood samplings|7
4847017|NCT00984295|16709578|P1|Overall Study|Missed one or more blood samplings|3
4847018|NCT00984295|16709576|P3|Overall Study|CAE - discontinued test vaccine|3
4847019|NCT00984295|16709577|P2|Overall Study|CAE - discontinued test vaccine|1
4847020|NCT00984295|16709578|P1|Overall Study|CAE - discontinued test vaccine|0
4847021|NCT00984295|16709576|P3|Overall Study|Withdrawal by Subject|12
4847022|NCT00984295|16709577|P2|Overall Study|Withdrawal by Subject|9
4847023|NCT00984295|16709578|P1|Overall Study|Withdrawal by Subject|18
4847024|NCT00984295|16709576|P3|Overall Study|Protocol Violation|4
4847025|NCT00984295|16709577|P2|Overall Study|Protocol Violation|1
4847026|NCT00984295|16709578|P1|Overall Study|Protocol Violation|2
4847027|NCT00984295|16709576|P3|Overall Study|Lost to Follow-up|13
4847028|NCT00984295|16709577|P2|Overall Study|Lost to Follow-up|12
4847029|NCT00984295|16709578|P1|Overall Study|Lost to Follow-up|31
4847030|NCT00984282|16709645|P2|Long Term Follow-up|Disease prog., recurrence or relapse|1
4847031|NCT00984282|16709646|P1|Long Term Follow-up|Disease prog., recurrence or relapse|0
4847032|NCT00984282|16709645|P2|Long Term Follow-up|Switched to commercial drug|2
4847033|NCT00984282|16709646|P1|Long Term Follow-up|Switched to commercial drug|4
4847034|NCT00984282|16709645|P2|Long Term Follow-up|Transferred to treat. continuation study|3
4847035|NCT00984282|16709646|P1|Long Term Follow-up|Transferred to treat. continuation study|2
4847036|NCT00984282|16709645|P2|Long Term Follow-up|Protocol driven decision point|26
4847037|NCT00984282|16709646|P1|Long Term Follow-up|Protocol driven decision point|25
4847038|NCT00984282|16709645|P2|Long Term Follow-up|Lost to Follow-up|6
4847039|NCT00984282|16709646|P1|Long Term Follow-up|Lost to Follow-up|3
4847040|NCT00984282|16709645|P2|Long Term Follow-up|Death|68
4847041|NCT00984282|16709646|P1|Long Term Follow-up|Death|27
4847042|NCT00984282|16709645|P2|Long Term Follow-up|Withdrawal by Subject|14
4847043|NCT00984282|16709646|P1|Long Term Follow-up|Withdrawal by Subject|8
4847044|NCT00984282|16709645|P2|Open-label Treatment|Physician Decision|0
4847045|NCT00984282|16709646|P1|Open-label Treatment|Physician Decision|1
4847046|NCT00984282|16709645|P2|Open-label Treatment|Switched to commercial drug|7
4847047|NCT00984282|16709646|P1|Open-label Treatment|Switched to commercial drug|6
4847048|NCT00984282|16709645|P2|Open-label Treatment|Transferred to treat. continuation study|3
4847049|NCT00984282|16709646|P1|Open-label Treatment|Transferred to treat. continuation study|2
4847050|NCT00984282|16709645|P2|Open-label Treatment|Protocol driven decision point|1
4847051|NCT00984282|16709646|P1|Open-label Treatment|Protocol driven decision point|1
4847052|NCT00984282|16709645|P2|Open-label Treatment|Target lesion removed|1
4847053|NCT00984282|16709646|P1|Open-label Treatment|Target lesion removed|0
4847054|NCT00984282|16709645|P2|Open-label Treatment|Non-compliant with study medication|0
4847055|NCT00984282|16709646|P1|Open-label Treatment|Non-compliant with study medication|1
4847056|NCT00984282|16709645|P2|Open-label Treatment|Patient convenience|0
4847057|NCT00984282|16709646|P1|Open-label Treatment|Patient convenience|1
4847058|NCT00984282|16709645|P2|Open-label Treatment|Lost to Follow-up|1
4847059|NCT00984282|16709646|P1|Open-label Treatment|Lost to Follow-up|1
4847060|NCT00984282|16709645|P2|Open-label Treatment|Progression, recurrence or relapse|82
4847061|NCT00984282|16709646|P1|Open-label Treatment|Progression, recurrence or relapse|40
4847062|NCT00984282|16709645|P2|Open-label Treatment|Death|15
4847063|NCT00984282|16709646|P1|Open-label Treatment|Death|7
4847064|NCT00984282|16709645|P2|Open-label Treatment|Withdrawal by Subject|21
4847065|NCT00984282|16709646|P1|Open-label Treatment|Withdrawal by Subject|6
4847066|NCT00984282|16709645|P2|Open-label Treatment|Adverse Event|30
4847067|NCT00984282|16709646|P1|Open-label Treatment|Adverse Event|20
4847068|NCT00984282|16709645|P2|Double Blind Treatment|Transferred to treat. continuation study|1
4847069|NCT00984282|16709646|P1|Double Blind Treatment|Transferred to treat. continuation study|2
4847070|NCT00984282|16709645|P2|Double Blind Treatment|Radiological and clinical progression|1
4847071|NCT00984282|16709646|P1|Double Blind Treatment|Radiological and clinical progression|0
4847072|NCT00984282|16709645|P2|Double Blind Treatment|protocol driven decision point|1
4847073|NCT00984282|16709646|P1|Double Blind Treatment|protocol driven decision point|1
4847074|NCT00984282|16709645|P2|Double Blind Treatment|Switched to commercial drug|1
4847075|NCT00984282|16709646|P1|Double Blind Treatment|Switched to commercial drug|6
4847076|NCT00984282|16709645|P2|Double Blind Treatment|Not treated|1
4847077|NCT00984282|16709646|P1|Double Blind Treatment|Not treated|0
4847078|NCT00984282|16709645|P2|Double Blind Treatment|Death|4
4847079|NCT00984282|16709646|P1|Double Blind Treatment|Death|8
4847080|NCT00984282|16709645|P2|Double Blind Treatment|Lost to Follow-up|0
4847081|NCT00984282|16709646|P1|Double Blind Treatment|Lost to Follow-up|3
4847082|NCT00984282|16709645|P2|Double Blind Treatment|Withdrawal by Subject|18
4847083|NCT00984282|16709646|P1|Double Blind Treatment|Withdrawal by Subject|13
4847084|NCT00984282|16709645|P2|Double Blind Treatment|Progression by clinical judgment|0
4847085|NCT00984282|16709646|P1|Double Blind Treatment|Progression by clinical judgment|2
4847086|NCT00984282|16709645|P2|Double Blind Treatment|Noncompliance with study medication|0
4847087|NCT00984282|16709646|P1|Double Blind Treatment|Noncompliance with study medication|3
4847088|NCT00984282|16709645|P2|Double Blind Treatment|Physician Decision|2
4847089|NCT00984282|16709646|P1|Double Blind Treatment|Physician Decision|1
4847090|NCT00984282|16709645|P2|Double Blind Treatment|Progression, recurrence or relapse|3
4847091|NCT00984282|16709646|P1|Double Blind Treatment|Progression, recurrence or relapse|25
4847092|NCT00984282|16709645|P2|Double Blind Treatment|Adverse Event|6
4847093|NCT00984282|16709646|P1|Double Blind Treatment|Adverse Event|40
4847094|NCT00984256|16709669|P2|Overall Study|Withdrawal by Subject|1
4847095|NCT00984256|16709670|P1|Overall Study|Withdrawal by Subject|0
4847096|NCT00984204|16709690|P1|Overall Study|Lack of Efficacy|10
4847097|NCT00984204|16709690|P1|Overall Study|Lost to Follow-up|4
4847098|NCT00984204|16709690|P1|Overall Study|Death|1
4847099|NCT00984165|16709700|P4|Overall Study|removed with a pair recipient|1
4847100|NCT00984165|16709701|P3|Overall Study|removed with a pair recipient|0
4847101|NCT00984165|16709702|P2|Overall Study|removed with a pair recipient|0
4847102|NCT00984165|16709703|P1|Overall Study|removed with a pair recipient|0
4847103|NCT00984165|16709700|P4|Overall Study|P+/donor pair removed from protocol|1
4847104|NCT00984165|16709701|P3|Overall Study|P+/donor pair removed from protocol|0
4847105|NCT00984165|16709702|P2|Overall Study|P+/donor pair removed from protocol|0
4847106|NCT00984165|16709703|P1|Overall Study|P+/donor pair removed from protocol|0
4847107|NCT00984165|16709700|P4|Overall Study|New protocol|1
4847108|NCT00984165|16709701|P3|Overall Study|New protocol|0
4847109|NCT00984165|16709702|P2|Overall Study|New protocol|0
4847110|NCT00984165|16709703|P1|Overall Study|New protocol|0
4847111|NCT00984165|16709700|P4|Overall Study|Death of recipient|1
4847112|NCT00984165|16709701|P3|Overall Study|Death of recipient|0
4847113|NCT00984165|16709702|P2|Overall Study|Death of recipient|0
4847114|NCT00984165|16709703|P1|Overall Study|Death of recipient|0
4847115|NCT00984165|16709700|P4|Overall Study|Disease progression on study|0
4847116|NCT00984165|16709701|P3|Overall Study|Disease progression on study|0
4847117|NCT00984165|16709702|P2|Overall Study|Disease progression on study|1
4847118|NCT00984165|16709703|P1|Overall Study|Disease progression on study|5
4847119|NCT00984165|16709700|P4|Overall Study|Death on study|0
4847120|NCT00984165|16709701|P3|Overall Study|Death on study|0
4847121|NCT00984165|16709702|P2|Overall Study|Death on study|0
4847122|NCT00984165|16709703|P1|Overall Study|Death on study|2
4847123|NCT00984126|16709732|P4|Overall Study|Withdrawal criteria|9
4847124|NCT00984126|16709733|P3|Overall Study|Withdrawal criteria|3
4847125|NCT00984126|16709734|P2|Overall Study|Withdrawal criteria|1
4847126|NCT00984126|16709735|P1|Overall Study|Withdrawal criteria|0
4847127|NCT00984126|16709732|P4|Overall Study|Choose to join Pathfinder trial™ + other|46
4847128|NCT00984126|16709733|P3|Overall Study|Choose to join Pathfinder trial™ + other|3
4847129|NCT00984126|16709734|P2|Overall Study|Choose to join Pathfinder trial™ + other|7
4847130|NCT00984126|16709735|P1|Overall Study|Choose to join Pathfinder trial™ + other|7
4847131|NCT00984126|16709732|P4|Overall Study|Adverse Event|2
4847132|NCT00984126|16709733|P3|Overall Study|Adverse Event|0
4847133|NCT00984126|16709734|P2|Overall Study|Adverse Event|0
4847134|NCT00984126|16709735|P1|Overall Study|Adverse Event|0
4847135|NCT00984126|16709732|P4|Overall Study|Protocol Violation|2
4847136|NCT00984126|16709733|P3|Overall Study|Protocol Violation|1
4847137|NCT00984126|16709734|P2|Overall Study|Protocol Violation|0
4847138|NCT00984126|16709735|P1|Overall Study|Protocol Violation|0
4847139|NCT00984061|16709760|P1|Clarithromycin Alone|Protocol Violation|1
4847140|NCT00984022|16709773|P2|Overall Study|Lost to Follow-up|14
4847141|NCT00984022|16709774|P1|Overall Study|Lost to Follow-up|10
4847142|NCT00984009|16709784|P1|Grapefruit Juice Alone|missed serving of grapefruit juice|1
4847143|NCT00983957|16709817|P1|Overall Study|Personal Reasons|1
4847144|NCT00983957|16709817|P1|Overall Study|Adverse Event|1
4847145|NCT00983931|16709851|P1|14 Day Washout Period|Physician Decision|1
4847146|NCT00983918|16709865|P4|Overall Study|conversion to open cholecystectomy|2
4847147|NCT00983918|16709866|P3|Overall Study|conversion to open cholecystectomy|2
4847148|NCT00983918|16709867|P2|Overall Study|conversion to open cholecystectomy|2
4847149|NCT00983918|16709868|P1|Overall Study|conversion to open cholecystectomy|0
4847150|NCT00983905|16709878|P1|Colchicine Alone|Adverse Event|2
4847151|NCT00983905|16709878|P1|Theophylline Alone|Adverse Event|1
4847152|NCT00983892|16709891|P2|Overall Study|Withdrawal by Subject|12
4847153|NCT00983892|16709892|P1|Overall Study|Withdrawal by Subject|10
4847154|NCT00983853|16709904|P6|Overall Study|Unable to come to study follow-up visits|0
4847155|NCT00983853|16709905|P5|Overall Study|Unable to come to study follow-up visits|0
4847156|NCT00983853|16709906|P4|Overall Study|Unable to come to study follow-up visits|0
4847157|NCT00983853|16709907|P3|Overall Study|Unable to come to study follow-up visits|0
4847158|NCT00983853|16709908|P2|Overall Study|Unable to come to study follow-up visits|1
4847159|NCT00983853|16709909|P1|Overall Study|Unable to come to study follow-up visits|0
4847160|NCT00983853|16709904|P6|Overall Study|Withdrawal by Subject|0
4847161|NCT00983853|16709905|P5|Overall Study|Withdrawal by Subject|1
4847162|NCT00983853|16709906|P4|Overall Study|Withdrawal by Subject|0
4847163|NCT00983853|16709907|P3|Overall Study|Withdrawal by Subject|1
4847164|NCT00983853|16709908|P2|Overall Study|Withdrawal by Subject|0
4847165|NCT00983853|16709909|P1|Overall Study|Withdrawal by Subject|0
4847166|NCT00983853|16709904|P6|Overall Study|Lost to Follow-up|1
4847167|NCT00983853|16709905|P5|Overall Study|Lost to Follow-up|2
4847168|NCT00983853|16709906|P4|Overall Study|Lost to Follow-up|2
4847169|NCT00983853|16709907|P3|Overall Study|Lost to Follow-up|2
4847170|NCT00983853|16709908|P2|Overall Study|Lost to Follow-up|1
4847171|NCT00983853|16709909|P1|Overall Study|Lost to Follow-up|1
4847172|NCT00983827|16709937|P1|Overall Study|Withdrawal by Subject|1
4847173|NCT00983749|16709943|P2|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3
4847174|NCT00983749|16709944|P1|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1
4847175|NCT00983619|16709979|P12|Overall Study|Other|0
4847176|NCT00983619|16709980|P11|Overall Study|Other|1
4847177|NCT00983619|16709981|P10|Overall Study|Other|1
4847178|NCT00983619|16709982|P9|Overall Study|Other|0
4847179|NCT00983619|16709983|P8|Overall Study|Other|2
4847180|NCT00983619|16709984|P7|Overall Study|Other|2
4847181|NCT00983619|16709985|P6|Overall Study|Other|12
4847182|NCT00983619|16709986|P5|Overall Study|Other|0
4847183|NCT00983619|16709987|P4|Overall Study|Other|1
4847184|NCT00983619|16709988|P3|Overall Study|Other|0
4847185|NCT00983619|16709989|P2|Overall Study|Other|0
4847186|NCT00983619|16709990|P1|Overall Study|Other|1
4847187|NCT00983619|16709979|P12|Overall Study|Death|8
4847188|NCT00983619|16709980|P11|Overall Study|Death|9
4847189|NCT00983619|16709981|P10|Overall Study|Death|2
4847190|NCT00983619|16709982|P9|Overall Study|Death|1
4847191|NCT00983619|16709983|P8|Overall Study|Death|0
4847192|NCT00983619|16709984|P7|Overall Study|Death|1
4847193|NCT00983619|16709985|P6|Overall Study|Death|30
4847194|NCT00983619|16709986|P5|Overall Study|Death|2
4847195|NCT00983619|16709987|P4|Overall Study|Death|1
4847196|NCT00983619|16709988|P3|Overall Study|Death|2
4847197|NCT00983619|16709989|P2|Overall Study|Death|2
4847198|NCT00983619|16709990|P1|Overall Study|Death|0
4847199|NCT00983619|16709979|P12|Overall Study|Withdrawal by Subject|1
4847200|NCT00983619|16709980|P11|Overall Study|Withdrawal by Subject|1
4847201|NCT00983619|16709981|P10|Overall Study|Withdrawal by Subject|0
4847202|NCT00983619|16709982|P9|Overall Study|Withdrawal by Subject|0
4847203|NCT00983619|16709983|P8|Overall Study|Withdrawal by Subject|0
4847204|NCT00983619|16709984|P7|Overall Study|Withdrawal by Subject|0
4847205|NCT00983619|16709985|P6|Overall Study|Withdrawal by Subject|23
4847206|NCT00983619|16709986|P5|Overall Study|Withdrawal by Subject|1
4847207|NCT00983619|16709987|P4|Overall Study|Withdrawal by Subject|3
4847208|NCT00983619|16709988|P3|Overall Study|Withdrawal by Subject|1
4847209|NCT00983619|16709989|P2|Overall Study|Withdrawal by Subject|1
4847210|NCT00983619|16709990|P1|Overall Study|Withdrawal by Subject|2
4847211|NCT00983619|16709979|P12|Overall Study|Lost to Follow-up|2
4847212|NCT00983619|16709980|P11|Overall Study|Lost to Follow-up|0
4847213|NCT00983619|16709981|P10|Overall Study|Lost to Follow-up|0
4847214|NCT00983619|16709982|P9|Overall Study|Lost to Follow-up|0
4847215|NCT00983619|16709983|P8|Overall Study|Lost to Follow-up|0
4847216|NCT00983619|16709984|P7|Overall Study|Lost to Follow-up|0
4847217|NCT00983619|16709985|P6|Overall Study|Lost to Follow-up|2
4847218|NCT00983619|16709986|P5|Overall Study|Lost to Follow-up|0
4847219|NCT00983619|16709987|P4|Overall Study|Lost to Follow-up|0
4847220|NCT00983619|16709988|P3|Overall Study|Lost to Follow-up|0
4847221|NCT00983619|16709989|P2|Overall Study|Lost to Follow-up|1
4847222|NCT00983619|16709990|P1|Overall Study|Lost to Follow-up|0
4847223|NCT00983580|16710295|P2|Overall Study|Ineligible|0
4847224|NCT00983580|16710296|P1|Overall Study|Ineligible|3
4847225|NCT00983580|16710295|P2|Overall Study|Protocol Violation|1
4847226|NCT00983580|16710296|P1|Overall Study|Protocol Violation|1
4847227|NCT00983580|16710295|P2|Overall Study|Cancel Prior to treatment|3
4847228|NCT00983580|16710296|P1|Overall Study|Cancel Prior to treatment|1
4847229|NCT00983528|16710322|P1|Overall Study|Study Terminated|1
4847230|NCT00983528|16710322|P1|Overall Study|Lost to Follow-up|1
4847231|NCT00983528|16710322|P1|Overall Study|Death|4
4847232|NCT00983515|16710327|P1|Colchicine With Ritonavir|Lost to Follow-up|1
4847233|NCT00983515|16710327|P1|Ritonavir Alone|liver panel out of range|6
4847234|NCT00983476|16710354|P3|Overall Study|Did not receive intervention|0
4847235|NCT00983476|16710355|P2|Overall Study|Did not receive intervention|22
4847236|NCT00983476|16710356|P1|Overall Study|Did not receive intervention|17
4847237|NCT00983437|16710388|P1|Overall Study|Other Reason|26
4847238|NCT00983437|16710388|P1|Overall Study|Lost to Follow-up|2
4847239|NCT00983437|16710388|P1|Overall Study|Noncompliance to Study Procedures|1
4847240|NCT00983437|16710388|P1|Overall Study|Withdrawal by Subject|8
4847241|NCT00983437|16710388|P1|Overall Study|Lack of Efficacy|1
4847242|NCT00983437|16710388|P1|Overall Study|Adverse Event|9
4847243|NCT00983385|16710407|P1|Observation Period|Not Evaluable due to Non Compliance|12
4847244|NCT00983385|16710407|P1|Observation Period|Not eligible to be dosed|20
4847245|NCT00983372|16710452|P1|Diltiazem ER Alone|Adverse Event|1
4847246|NCT00983372|16710452|P1|Diltiazem ER Alone|missed diltiazem dose|2
4847247|NCT00983372|16710452|P1|14 Day Washout Period|Withdrawal by Subject|1
4847248|NCT00983294|16710479|P1|Colchicine With Azithromycin|Adverse Event|1
4847249|NCT00983294|16710479|P1|14 Day Washout Period|Withdrawal by Subject|2
4847250|NCT00983073|16710521|P1|Maintenance Period|Other Reason|7
4847251|NCT00983073|16710521|P1|Maintenance Period|Lack of Efficacy|2
4847252|NCT00983073|16710521|P1|Maintenance Period|Withdrawal by Subject|2
4847253|NCT00983073|16710521|P1|Maintenance Period|Adverse Event|5
4847254|NCT00983073|16710521|P1|Titration and Optimal Dose Period|Other reason|4
4847255|NCT00983073|16710521|P1|Titration and Optimal Dose Period|Non-Compliance|1
4847256|NCT00983073|16710521|P1|Titration and Optimal Dose Period|Lack of Efficacy|5
4847257|NCT00983073|16710521|P1|Titration and Optimal Dose Period|Withdrawal by Subject|11
4847258|NCT00983073|16710521|P1|Titration and Optimal Dose Period|Adverse Event|19
4847259|NCT00982878|16710547|P1|Overall Study|Physician Decision|1
4847260|NCT00982735|16710845|P1|Overall Study|Patient ineligible for trial|224
4847261|NCT00982735|16710845|P1|Overall Study|Lost to Follow-up|6
4847262|NCT00982657|16710855|P4|Overall Study|On going at date of cut-off|1
4847263|NCT00982657|16710856|P3|Overall Study|On going at date of cut-off|0
4847264|NCT00982657|16710857|P2|Overall Study|On going at date of cut-off|0
4847265|NCT00982657|16710858|P1|Overall Study|On going at date of cut-off|0
4847266|NCT00982657|16710855|P4|Overall Study|Other|4
4847267|NCT00982657|16710856|P3|Overall Study|Other|0
4847268|NCT00982657|16710857|P2|Overall Study|Other|0
4847269|NCT00982657|16710858|P1|Overall Study|Other|0
4847270|NCT00982657|16710855|P4|Overall Study|Withdrawal by Subject|3
4847271|NCT00982657|16710856|P3|Overall Study|Withdrawal by Subject|1
4847272|NCT00982657|16710857|P2|Overall Study|Withdrawal by Subject|0
4847273|NCT00982657|16710858|P1|Overall Study|Withdrawal by Subject|0
4847274|NCT00982657|16710855|P4|Overall Study|Death|1
4847275|NCT00982657|16710856|P3|Overall Study|Death|1
4847276|NCT00982657|16710857|P2|Overall Study|Death|0
4847277|NCT00982657|16710858|P1|Overall Study|Death|1
4847278|NCT00982644|16710899|P2|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7
4847279|NCT00982644|16710900|P1|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23
4847280|NCT00982644|16710899|P2|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3
4847281|NCT00982644|16710900|P1|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6
4847282|NCT00982644|16710899|P2|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4
4847283|NCT00982644|16710900|P1|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2
4847284|NCT00982644|16710899|P2|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1
4847285|NCT00982644|16710900|P1|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3
4847286|NCT00982644|16710899|P2|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5
4847287|NCT00982644|16710900|P1|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12
4847288|NCT00982644|16710899|P2|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30
4847289|NCT00982644|16710900|P1|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84
4847290|NCT00982644|16710899|P2|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5
4847291|NCT00982644|16710900|P1|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9
4847292|NCT00982644|16710899|P2|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18
4847293|NCT00982644|16710900|P1|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46
4847294|NCT00982644|16710899|P2|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2
4847295|NCT00982644|16710900|P1|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7
4847296|NCT00982644|16710899|P2|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5
4847297|NCT00982644|16710900|P1|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20
4847298|NCT00982488|16710955|P5|Overall Study|Withdrawal by Subject|0
4847299|NCT00982488|16710956|P4|Overall Study|Withdrawal by Subject|0
4847300|NCT00982488|16710957|P3|Overall Study|Withdrawal by Subject|1
4847301|NCT00982488|16710958|P2|Overall Study|Withdrawal by Subject|1
4847302|NCT00982488|16710959|P1|Overall Study|Withdrawal by Subject|5
4847303|NCT00982488|16710955|P5|Overall Study|Study drug toxicity|0
4847304|NCT00982488|16710956|P4|Overall Study|Study drug toxicity|0
4847305|NCT00982488|16710957|P3|Overall Study|Study drug toxicity|6
4847306|NCT00982488|16710958|P2|Overall Study|Study drug toxicity|1
4847307|NCT00982488|16710959|P1|Overall Study|Study drug toxicity|34
4847308|NCT00982488|16710955|P5|Overall Study|Stem cell transplant|0
4847309|NCT00982488|16710956|P4|Overall Study|Stem cell transplant|1
4847310|NCT00982488|16710957|P3|Overall Study|Stem cell transplant|0
4847311|NCT00982488|16710958|P2|Overall Study|Stem cell transplant|0
4847312|NCT00982488|16710959|P1|Overall Study|Stem cell transplant|2
4847313|NCT00982488|16710955|P5|Overall Study|Poor compliance/noncompliance|0
4847314|NCT00982488|16710956|P4|Overall Study|Poor compliance/noncompliance|0
4847315|NCT00982488|16710957|P3|Overall Study|Poor compliance/noncompliance|0
4847316|NCT00982488|16710958|P2|Overall Study|Poor compliance/noncompliance|1
4847317|NCT00982488|16710959|P1|Overall Study|Poor compliance/noncompliance|0
4847318|NCT00982488|16710955|P5|Overall Study|Other|0
4847319|NCT00982488|16710956|P4|Overall Study|Other|1
4847320|NCT00982488|16710957|P3|Overall Study|Other|3
4847321|NCT00982488|16710958|P2|Overall Study|Other|1
4847322|NCT00982488|16710959|P1|Overall Study|Other|15
4847323|NCT00982488|16710955|P5|Overall Study|Maximum clinical benefit|0
4847324|NCT00982488|16710956|P4|Overall Study|Maximum clinical benefit|0
4847325|NCT00982488|16710957|P3|Overall Study|Maximum clinical benefit|1
4847326|NCT00982488|16710958|P2|Overall Study|Maximum clinical benefit|1
4847327|NCT00982488|16710959|P1|Overall Study|Maximum clinical benefit|1
4847328|NCT00982488|16710955|P5|Overall Study|Lost to Follow-up|0
4847329|NCT00982488|16710956|P4|Overall Study|Lost to Follow-up|0
4847330|NCT00982488|16710957|P3|Overall Study|Lost to Follow-up|0
4847331|NCT00982488|16710958|P2|Overall Study|Lost to Follow-up|0
4847332|NCT00982488|16710959|P1|Overall Study|Lost to Follow-up|1
4847333|NCT00982488|16710955|P5|Overall Study|Disease progression|1
4847334|NCT00982488|16710956|P4|Overall Study|Disease progression|1
4847335|NCT00982488|16710957|P3|Overall Study|Disease progression|10
4847336|NCT00982488|16710958|P2|Overall Study|Disease progression|5
4847337|NCT00982488|16710959|P1|Overall Study|Disease progression|30
4847338|NCT00982488|16710955|P5|Overall Study|Death|0
4847339|NCT00982488|16710956|P4|Overall Study|Death|0
4847340|NCT00982488|16710957|P3|Overall Study|Death|2
4847341|NCT00982488|16710958|P2|Overall Study|Death|0
4847342|NCT00982488|16710959|P1|Overall Study|Death|11
4847343|NCT00982488|16710955|P5|Overall Study|Adverse event unrelated to study drug|0
4847344|NCT00982488|16710956|P4|Overall Study|Adverse event unrelated to study drug|0
4847345|NCT00982488|16710957|P3|Overall Study|Adverse event unrelated to study drug|0
4847346|NCT00982488|16710958|P2|Overall Study|Adverse event unrelated to study drug|1
4847347|NCT00982488|16710959|P1|Overall Study|Adverse event unrelated to study drug|5
4847348|NCT00982488|16710955|P5|Overall Study|Administrative reason by sponsor|0
4847349|NCT00982488|16710956|P4|Overall Study|Administrative reason by sponsor|0
4847350|NCT00982488|16710957|P3|Overall Study|Administrative reason by sponsor|11
4847351|NCT00982488|16710958|P2|Overall Study|Administrative reason by sponsor|3
4847352|NCT00982488|16710959|P1|Overall Study|Administrative reason by sponsor|81
4847353|NCT00982410|16710992|P2|12-month Follow-up Assessment|scheduled, no-show|0
4847354|NCT00982410|16710993|P1|12-month Follow-up Assessment|scheduled, no-show|1
4847355|NCT00982410|16710992|P2|12-month Follow-up Assessment|incarceration|1
4847356|NCT00982410|16710993|P1|12-month Follow-up Assessment|incarceration|2
4847357|NCT00982410|16710992|P2|12-month Follow-up Assessment|Withdrawal by Subject|1
4847358|NCT00982410|16710993|P1|12-month Follow-up Assessment|Withdrawal by Subject|0
4847359|NCT00982410|16710992|P2|12-month Follow-up Assessment|could not reach to schedule|5
4847360|NCT00982410|16710993|P1|12-month Follow-up Assessment|could not reach to schedule|6
4847361|NCT00982410|16710992|P2|12-month Follow-up Assessment|Death|2
4847362|NCT00982410|16710993|P1|12-month Follow-up Assessment|Death|0
4847363|NCT00982410|16710992|P2|6-month Follow-up Assessment|scheduled, no-show|1
4847364|NCT00982410|16710993|P1|6-month Follow-up Assessment|scheduled, no-show|0
4847365|NCT00982410|16710992|P2|6-month Follow-up Assessment|patent surgery|1
4847366|NCT00982410|16710993|P1|6-month Follow-up Assessment|patent surgery|0
4847367|NCT00982410|16710992|P2|6-month Follow-up Assessment|incarceration|2
4847368|NCT00982410|16710993|P1|6-month Follow-up Assessment|incarceration|0
4847369|NCT00982410|16710992|P2|6-month Follow-up Assessment|participant no transportation|0
4847370|NCT00982410|16710993|P1|6-month Follow-up Assessment|participant no transportation|1
4847371|NCT00982410|16710992|P2|6-month Follow-up Assessment|Could not reach to schedule|7
4847372|NCT00982410|16710993|P1|6-month Follow-up Assessment|Could not reach to schedule|5
4847373|NCT00982410|16710992|P2|3-month Follow-up Assessment|Withdrawal by Subject|2
4847374|NCT00982410|16710993|P1|3-month Follow-up Assessment|Withdrawal by Subject|0
4847375|NCT00982410|16710992|P2|3-month Follow-up Assessment|Scheduled, no-show|2
4847376|NCT00982410|16710993|P1|3-month Follow-up Assessment|Scheduled, no-show|1
4847377|NCT00982410|16710992|P2|3-month Follow-up Assessment|Could not reach to schedule|9
4847378|NCT00982410|16710993|P1|3-month Follow-up Assessment|Could not reach to schedule|8
4847379|NCT00982319|16711034|P2|Overall Study|Pregnancy|1
4847380|NCT00982319|16711035|P1|Overall Study|Pregnancy|0
4847381|NCT00982319|16711034|P2|Overall Study|Preop values out of acceptable range|1
4847382|NCT00982319|16711035|P1|Overall Study|Preop values out of acceptable range|1
4847383|NCT00982319|16711034|P2|Overall Study|Surgery date change|0
4847384|NCT00982319|16711035|P1|Overall Study|Surgery date change|1
4847385|NCT00982280|16711043|P1|Maintenance Period|Adverse Event|1
4847386|NCT00982280|16711043|P1|Titration and Optimal Dose Period|Withdrawal by Subject|1
4847387|NCT00982280|16711043|P1|Titration and Optimal Dose Period|Lack of Efficacy|2
4847388|NCT00982280|16711043|P1|Titration and Optimal Dose Period|Adverse Event|5
4847389|NCT00982280|16711043|P1|Observation Period|Not eligible to be dosed|19
4847390|NCT00982228|16711068|P2|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1
4847391|NCT00982228|16711069|P1|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11
4847392|NCT00982228|16711068|P2|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0
4847393|NCT00982228|16711069|P1|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5
4847394|NCT00982228|16711068|P2|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2
4847395|NCT00982228|16711069|P1|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1
4847396|NCT00982228|16711068|P2|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0
4847397|NCT00982228|16711069|P1|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1
4847398|NCT00982228|16711068|P2|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2
4847399|NCT00982228|16711069|P1|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3
4847400|NCT00982228|16711068|P2|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13
4847401|NCT00982228|16711069|P1|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28
4847402|NCT00982228|16711068|P2|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3
4847403|NCT00982228|16711069|P1|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15
4847404|NCT00982228|16711068|P2|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2
4847405|NCT00982228|16711069|P1|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11
4847406|NCT00982228|16711068|P2|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0
4847407|NCT00982228|16711069|P1|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2
4847408|NCT00982228|16711068|P2|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2
4847409|NCT00982228|16711069|P1|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12
4847410|NCT00982137|16711128|P4|Overall Study|Withdrawal by Subject|0
4847411|NCT00982137|16711129|P3|Overall Study|Withdrawal by Subject|0
4847412|NCT00982137|16711130|P2|Overall Study|Withdrawal by Subject|1
4847413|NCT00982137|16711131|P1|Overall Study|Withdrawal by Subject|0
4847414|NCT00982137|16711128|P4|Overall Study|Lost to Follow-up|1
4847415|NCT00982137|16711129|P3|Overall Study|Lost to Follow-up|0
4847416|NCT00982137|16711130|P2|Overall Study|Lost to Follow-up|0
4847417|NCT00982137|16711131|P1|Overall Study|Lost to Follow-up|0
4847418|NCT00982111|16711163|P2|Overall Study|Withdrawal by Subject|17
4847419|NCT00982111|16711164|P1|Overall Study|Withdrawal by Subject|16
4847420|NCT00982111|16711163|P2|Overall Study|On Study Treatment at Conclusion|0
4847421|NCT00982111|16711164|P1|Overall Study|On Study Treatment at Conclusion|7
4847422|NCT00982111|16711163|P2|Overall Study|New Anti-Cancer Therapy|5
4847423|NCT00982111|16711164|P1|Overall Study|New Anti-Cancer Therapy|5
4847424|NCT00982111|16711163|P2|Overall Study|Lost to Follow-up|6
4847425|NCT00982111|16711164|P1|Overall Study|Lost to Follow-up|9
4847426|NCT00982111|16711163|P2|Overall Study|Progressive Disease|37
4847427|NCT00982111|16711164|P1|Overall Study|Progressive Disease|37
4847428|NCT00982111|16711163|P2|Overall Study|Adverse Event|1
4847429|NCT00982111|16711164|P1|Overall Study|Adverse Event|1
4847430|NCT00982020|16711197|P2|Overall Study|Clinical Relapse|1
4847431|NCT00982020|16711198|P1|Overall Study|Clinical Relapse|0
4847432|NCT00982020|16711197|P2|Overall Study|Protocol Violation|2
4847433|NCT00982020|16711198|P1|Overall Study|Protocol Violation|0
4847434|NCT00982020|16711197|P2|Overall Study|Entry Criteria Not Met|1
4847435|NCT00982020|16711198|P1|Overall Study|Entry Criteria Not Met|2
4847436|NCT00982020|16711197|P2|Overall Study|Physician Decision|5
4847437|NCT00982020|16711198|P1|Overall Study|Physician Decision|2
4847438|NCT00982020|16711197|P2|Overall Study|Treatment Non-compliance|6
4847439|NCT00982020|16711198|P1|Overall Study|Treatment Non-compliance|3
4847440|NCT00982020|16711197|P2|Overall Study|Parent/Caregiver Decision|5
4847441|NCT00982020|16711198|P1|Overall Study|Parent/Caregiver Decision|5
4847442|NCT00982020|16711197|P2|Overall Study|Lack of Efficacy|4
4847443|NCT00982020|16711198|P1|Overall Study|Lack of Efficacy|10
4847444|NCT00982020|16711197|P2|Overall Study|Lost to Follow-up|11
4847445|NCT00982020|16711198|P1|Overall Study|Lost to Follow-up|5
4847446|NCT00982020|16711197|P2|Overall Study|Withdrawal by Subject|14
4847447|NCT00982020|16711198|P1|Overall Study|Withdrawal by Subject|11
4847448|NCT00982020|16711197|P2|Overall Study|Adverse Event|15
4847449|NCT00982020|16711198|P1|Overall Study|Adverse Event|19
4847450|NCT00981799|16711252|P4|Overall Study|Adverse Event|0
4847451|NCT00981799|16711253|P3|Overall Study|Adverse Event|0
4847452|NCT00981799|16711254|P2|Overall Study|Adverse Event|1
4847453|NCT00981799|16711255|P1|Overall Study|Adverse Event|1
4847454|NCT00981747|16711269|P1|Placebo Oral Tablet|Withdrawal by Subject|1
4847455|NCT00981747|16711269|P1|Losartan|Death|1
4847456|NCT00981747|16711269|P1|Losartan|Withdrawal by Subject|1
4847457|NCT00981578|16711335|P1|Overall Study|Withdrawal by Subject|2
4847458|NCT00981578|16711335|P1|Overall Study|Death|1
4847459|NCT00981526|16711343|P2|Overall Study|Physician Decision|4
4847460|NCT00981526|16711344|P1|Overall Study|Physician Decision|4
4847461|NCT00981526|16711343|P2|Overall Study|Withdrawal by Subject|2
4847462|NCT00981526|16711344|P1|Overall Study|Withdrawal by Subject|0
4847463|NCT00981461|16711362|P2|Overall Study|Lost to Follow-up|2
4847464|NCT00981461|16711363|P1|Overall Study|Lost to Follow-up|5
4847465|NCT00981409|16711387|P2|Overall Study|Prostate Cancer Treatment before Trial|0
4847466|NCT00981409|16711388|P1|Overall Study|Prostate Cancer Treatment before Trial|2
4847467|NCT00981409|16711387|P2|Overall Study|Protocol Violation|1
4847468|NCT00981409|16711388|P1|Overall Study|Protocol Violation|0
4847469|NCT00981409|16711387|P2|Overall Study|Adverse Event|0
4847470|NCT00981409|16711388|P1|Overall Study|Adverse Event|4
4847471|NCT00981292|16711427|P6|Day 3|Protocol Violation|1
4847472|NCT00981292|16711428|P5|Day 3|Protocol Violation|0
4847473|NCT00981292|16711429|P4|Day 3|Protocol Violation|0
4847474|NCT00981292|16711430|P3|Day 3|Protocol Violation|0
4847475|NCT00981292|16711431|P2|Day 3|Protocol Violation|0
4847476|NCT00981292|16711432|P1|Day 3|Protocol Violation|0
4847477|NCT00981292|16711427|P6|Day 2|Protocol Violation|0
4847478|NCT00981292|16711428|P5|Day 2|Protocol Violation|0
4847479|NCT00981292|16711429|P4|Day 2|Protocol Violation|0
4847480|NCT00981292|16711430|P3|Day 2|Protocol Violation|0
4847481|NCT00981292|16711431|P2|Day 2|Protocol Violation|0
4847482|NCT00981292|16711432|P1|Day 2|Protocol Violation|2
4847483|NCT00981292|16711427|P6|Day 1|Protocol Violation|2
4847484|NCT00981292|16711428|P5|Day 1|Protocol Violation|0
4847485|NCT00981292|16711429|P4|Day 1|Protocol Violation|0
4847486|NCT00981292|16711430|P3|Day 1|Protocol Violation|0
4847487|NCT00981292|16711431|P2|Day 1|Protocol Violation|0
4847488|NCT00981292|16711432|P1|Day 1|Protocol Violation|1
4847489|NCT00981175|16711516|P2|Booster Dose Vaccination|Lost to Follow-up|3
4847490|NCT00981175|16711517|P1|Booster Dose Vaccination|Lost to Follow-up|2
4847491|NCT00981175|16711516|P2|Primary Dose Vaccination|Lost to Follow-up|1
4847492|NCT00981175|16711517|P1|Primary Dose Vaccination|Lost to Follow-up|2
4847493|NCT00981175|16711516|P2|Primary Dose Vaccination|Protocol Violation|1
4847494|NCT00981175|16711517|P1|Primary Dose Vaccination|Protocol Violation|0
4847495|NCT00981175|16711516|P2|Primary Dose Vaccination|Adverse Event|0
4847496|NCT00981175|16711517|P1|Primary Dose Vaccination|Adverse Event|1
4847497|NCT00981149|16711542|P2|Overall Study|Withdrawal by Subject|1
4847498|NCT00981149|16711543|P1|Overall Study|Withdrawal by Subject|1
4847499|NCT00981149|16711542|P2|Overall Study|Lost to Follow-up|2
4847500|NCT00981149|16711543|P1|Overall Study|Lost to Follow-up|1
4847501|NCT00981084|16711553|P2|Post Intervention (Data Analysis)|imbalance in disease subtype|0
4847502|NCT00981084|16711554|P1|Post Intervention (Data Analysis)|imbalance in disease subtype|1
4847503|NCT00981084|16711553|P2|Post Intervention (Data Analysis)|poor effort|1
4847504|NCT00981084|16711554|P1|Post Intervention (Data Analysis)|poor effort|1
4847505|NCT00981058|16711570|P2|Overall Study|On study treatment at conclusion|0
4847506|NCT00981058|16711571|P1|Overall Study|On study treatment at conclusion|9
4847507|NCT00981058|16711570|P2|Overall Study|Withdrawal by Subject|23
4847508|NCT00981058|16711571|P1|Overall Study|Withdrawal by Subject|25
4847509|NCT00981058|16711570|P2|Overall Study|Randomization Error|2
4847510|NCT00981058|16711571|P1|Overall Study|Randomization Error|1
4847511|NCT00981058|16711570|P2|Overall Study|Radiologist Error|1
4847512|NCT00981058|16711571|P1|Overall Study|Radiologist Error|0
4847513|NCT00981058|16711570|P2|Overall Study|Noncompliance|0
4847514|NCT00981058|16711571|P1|Overall Study|Noncompliance|1
4847515|NCT00981058|16711570|P2|Overall Study|New Anticancer Therapy|6
4847516|NCT00981058|16711571|P1|Overall Study|New Anticancer Therapy|6
4847517|NCT00981058|16711570|P2|Overall Study|Lost to Follow-up|15
4847518|NCT00981058|16711571|P1|Overall Study|Lost to Follow-up|16
4847519|NCT00981058|16711570|P2|Overall Study|Progressive Disease|49
4847520|NCT00981058|16711571|P1|Overall Study|Progressive Disease|61
4847521|NCT00981058|16711570|P2|Overall Study|Adverse Event|1
4847522|NCT00981058|16711571|P1|Overall Study|Adverse Event|1
4847523|NCT00981019|16711602|P1|Overall Study|Hit the survey after closure|79
4847524|NCT00981019|16711602|P1|Overall Study|Inadvertent exclusion|239
4847525|NCT00981019|16711602|P1|Overall Study|Did not match target population|94
4847526|NCT00981019|16711602|P1|Overall Study|Did not respond|65
4847527|NCT00980980|16711609|P3|Overall Study|Withdrawal by Hospital|0
4847528|NCT00980980|16711610|P2|Overall Study|Withdrawal by Hospital|1
4847529|NCT00980980|16711611|P1|Overall Study|Withdrawal by Hospital|0
4847530|NCT00980798|16711642|P2|Overall Study|Other|1
4847531|NCT00980798|16711643|P1|Overall Study|Other|0
4847532|NCT00980798|16711642|P2|Overall Study|Withdrawal by Subject|11
4847533|NCT00980798|16711643|P1|Overall Study|Withdrawal by Subject|8
4847534|NCT00980798|16711642|P2|Overall Study|Physician Decision|1
4847535|NCT00980798|16711643|P1|Overall Study|Physician Decision|2
4847536|NCT00980798|16711642|P2|Overall Study|Lost to Follow-up|1
4847537|NCT00980798|16711643|P1|Overall Study|Lost to Follow-up|0
4847538|NCT00980798|16711642|P2|Overall Study|Lack of Efficacy|5
4847539|NCT00980798|16711643|P1|Overall Study|Lack of Efficacy|16
4847540|NCT00980798|16711642|P2|Overall Study|Adverse Event|36
4847541|NCT00980798|16711643|P1|Overall Study|Adverse Event|7
4847542|NCT00980655|16711699|P2|Overall Study|Other|1
4847543|NCT00980655|16711700|P1|Overall Study|Other|0
4847544|NCT00980655|16711699|P2|Overall Study|Parent/legal guardian request|0
4847545|NCT00980655|16711700|P1|Overall Study|Parent/legal guardian request|1
4847546|NCT00980655|16711699|P2|Overall Study|Lost to Follow-up|1
4847547|NCT00980655|16711700|P1|Overall Study|Lost to Follow-up|0
4847548|NCT00980655|16711699|P2|Overall Study|Withdrawal by Subject|4
4847549|NCT00980655|16711700|P1|Overall Study|Withdrawal by Subject|0
4847550|NCT00980655|16711699|P2|Overall Study|Protocol Violation|7
4847551|NCT00980655|16711700|P1|Overall Study|Protocol Violation|2
4847552|NCT00980655|16711699|P2|Overall Study|Death|7
4847553|NCT00980655|16711700|P1|Overall Study|Death|0
4847554|NCT00980655|16711699|P2|Overall Study|Adverse Event|31
4847555|NCT00980655|16711700|P1|Overall Study|Adverse Event|13
4847556|NCT00980343|16711783|P2|Overall Study|no tumor at surgery - treatment effect|3
4847557|NCT00980343|16711784|P1|Overall Study|no tumor at surgery - treatment effect|1
4847558|NCT00980330|16711808|P7|Overall Study|(not specified)|0
4847559|NCT00980330|16711809|P6|Overall Study|(not specified)|1
4847560|NCT00980330|16711810|P5|Overall Study|(not specified)|1
4847561|NCT00980330|16711811|P4|Overall Study|(not specified)|1
4847562|NCT00980330|16711812|P3|Overall Study|(not specified)|0
4847563|NCT00980330|16711813|P2|Overall Study|(not specified)|0
4847564|NCT00980330|16711814|P1|Overall Study|(not specified)|2
4847565|NCT00980330|16711808|P7|Overall Study|Withdrawal by Subject|5
4847566|NCT00980330|16711809|P6|Overall Study|Withdrawal by Subject|2
4847567|NCT00980330|16711810|P5|Overall Study|Withdrawal by Subject|3
4847568|NCT00980330|16711811|P4|Overall Study|Withdrawal by Subject|1
4847569|NCT00980330|16711812|P3|Overall Study|Withdrawal by Subject|4
4847570|NCT00980330|16711813|P2|Overall Study|Withdrawal by Subject|4
4847571|NCT00980330|16711814|P1|Overall Study|Withdrawal by Subject|2
4847572|NCT00980330|16711808|P7|Overall Study|Lost to Follow-up|2
4847573|NCT00980330|16711809|P6|Overall Study|Lost to Follow-up|1
4847574|NCT00980330|16711810|P5|Overall Study|Lost to Follow-up|1
4847575|NCT00980330|16711811|P4|Overall Study|Lost to Follow-up|2
4847576|NCT00980330|16711812|P3|Overall Study|Lost to Follow-up|4
4847577|NCT00980330|16711813|P2|Overall Study|Lost to Follow-up|1
4847578|NCT00980330|16711814|P1|Overall Study|Lost to Follow-up|1
4847579|NCT00980330|16711808|P7|Overall Study|Adverse Event|0
4847580|NCT00980330|16711809|P6|Overall Study|Adverse Event|0
4847581|NCT00980330|16711810|P5|Overall Study|Adverse Event|0
4847582|NCT00980330|16711811|P4|Overall Study|Adverse Event|1
4847583|NCT00980330|16711812|P3|Overall Study|Adverse Event|0
4847584|NCT00980330|16711813|P2|Overall Study|Adverse Event|0
4847585|NCT00980330|16711814|P1|Overall Study|Adverse Event|0
4847586|NCT00980200|16711929|P5|7-day Treatment Period 3|Lack of Efficacy|1
4847587|NCT00980200|16711930|P4|7-day Treatment Period 3|Lack of Efficacy|0
4847588|NCT00980200|16711931|P3|7-day Treatment Period 3|Lack of Efficacy|0
4847589|NCT00980200|16711932|P2|7-day Treatment Period 3|Lack of Efficacy|1
4847590|NCT00980200|16711933|P1|7-day Treatment Period 3|Lack of Efficacy|0
4847591|NCT00980200|16711929|P5|7-day Treatment Period 1|Withdrawal by Subject|0
4847592|NCT00980200|16711930|P4|7-day Treatment Period 1|Withdrawal by Subject|0
4847593|NCT00980200|16711931|P3|7-day Treatment Period 1|Withdrawal by Subject|0
4847594|NCT00980200|16711932|P2|7-day Treatment Period 1|Withdrawal by Subject|1
4847595|NCT00980200|16711933|P1|7-day Treatment Period 1|Withdrawal by Subject|0
4847596|NCT00980174|16711952|P2|Overall Study|Other|1
4847597|NCT00980174|16711953|P1|Overall Study|Other|0
4847598|NCT00980174|16711952|P2|Overall Study|Death|1
4847599|NCT00980174|16711953|P1|Overall Study|Death|1
4847600|NCT00980174|16711952|P2|Overall Study|Ineligibility determined|1
4847601|NCT00980174|16711953|P1|Overall Study|Ineligibility determined|2
4847602|NCT00980174|16711952|P2|Overall Study|Adverse Event|3
4847603|NCT00980174|16711953|P1|Overall Study|Adverse Event|0
4847604|NCT00980174|16711952|P2|Overall Study|Withdrawal by Subject|4
4847605|NCT00980174|16711953|P1|Overall Study|Withdrawal by Subject|1
4847606|NCT00980148|16711971|P2|Overall Study|Various other reasons|9
4847607|NCT00980148|16711972|P1|Overall Study|Various other reasons|8
4847608|NCT00980148|16711971|P2|Overall Study|Negative for chlamydia at enrollment|9
4847609|NCT00980148|16711972|P1|Overall Study|Negative for chlamydia at enrollment|12
4847610|NCT00980148|16711971|P2|Overall Study|Received other antichlamydia treatment|14
4847611|NCT00980148|16711972|P1|Overall Study|Received other antichlamydia treatment|20
4847612|NCT00980148|16711971|P2|Overall Study|Discharged from facility|96
4847613|NCT00980148|16711972|P1|Overall Study|Discharged from facility|89
4847614|NCT00980057|16711980|P2|Overall Study|Withdrawal by Subject|1
4847615|NCT00980057|16711981|P1|Overall Study|Withdrawal by Subject|1
4847616|NCT00980057|16711980|P2|Overall Study|Lost to Follow-up|0
4847617|NCT00980057|16711981|P1|Overall Study|Lost to Follow-up|1
4847618|NCT00980057|16711980|P2|Overall Study|Physician Decision|0
4847619|NCT00980057|16711981|P1|Overall Study|Physician Decision|4
4847620|NCT00980057|16711980|P2|Overall Study|Adverse Event|1
4847621|NCT00980057|16711981|P1|Overall Study|Adverse Event|0
4847622|NCT00980057|16711980|P2|Overall Study|Death|3
4847623|NCT00980057|16711981|P1|Overall Study|Death|13
4847624|NCT00980044|16712004|P3|Overall Study|Protocol Violation|2
4847625|NCT00980044|16712005|P2|Overall Study|Protocol Violation|0
4847626|NCT00980044|16712006|P1|Overall Study|Protocol Violation|0
4847627|NCT00980044|16712004|P3|Overall Study|Withdrawal by Subject|3
4847628|NCT00980044|16712005|P2|Overall Study|Withdrawal by Subject|7
4847629|NCT00980044|16712006|P1|Overall Study|Withdrawal by Subject|5
4847630|NCT00980005|16712025|P2|Overall Study|Other|3
4847631|NCT00980005|16712026|P1|Overall Study|Other|4
4847632|NCT00980005|16712025|P2|Overall Study|Lost to Follow-up|43
4847633|NCT00980005|16712026|P1|Overall Study|Lost to Follow-up|37
4847634|NCT00980005|16712025|P2|Overall Study|Withdrawal by Subject|17
4847635|NCT00980005|16712026|P1|Overall Study|Withdrawal by Subject|6
4847636|NCT00979992|16712066|P1|Overall Study|Refused - Never Treated|2
4847637|NCT00979992|16712066|P1|Overall Study|Ineligible - wrong cell type|2
4847638|NCT00979992|16712066|P1|Overall Study|Ineligible - inadequate pathology|1
4847639|NCT00979953|16712078|P4|Overall Study|Protocol Violation|2
4847640|NCT00979953|16712079|P3|Overall Study|Protocol Violation|2
4847641|NCT00979953|16712080|P2|Overall Study|Protocol Violation|0
4847642|NCT00979953|16712081|P1|Overall Study|Protocol Violation|1
4847643|NCT00979953|16712078|P4|Overall Study|Withdrawal by Subject|1
4847644|NCT00979953|16712079|P3|Overall Study|Withdrawal by Subject|2
4847645|NCT00979953|16712080|P2|Overall Study|Withdrawal by Subject|0
4847646|NCT00979953|16712081|P1|Overall Study|Withdrawal by Subject|0
4847647|NCT00979953|16712078|P4|Overall Study|Lost to Follow-up|0
4847648|NCT00979953|16712079|P3|Overall Study|Lost to Follow-up|1
4847649|NCT00979953|16712080|P2|Overall Study|Lost to Follow-up|1
4847650|NCT00979953|16712081|P1|Overall Study|Lost to Follow-up|1
4847651|NCT00979953|16712078|P4|Overall Study|Lack of Efficacy|0
4847652|NCT00979953|16712079|P3|Overall Study|Lack of Efficacy|0
4847653|NCT00979953|16712080|P2|Overall Study|Lack of Efficacy|2
4847654|NCT00979953|16712081|P1|Overall Study|Lack of Efficacy|1
4847655|NCT00979953|16712078|P4|Overall Study|Adverse Event|4
4847656|NCT00979953|16712079|P3|Overall Study|Adverse Event|17
4847657|NCT00979953|16712080|P2|Overall Study|Adverse Event|2
4847658|NCT00979953|16712081|P1|Overall Study|Adverse Event|5
4847659|NCT00979901|16712104|P4|Overall Study|Treatment Group Terminated by Sponsor|112
4847660|NCT00979901|16712105|P3|Overall Study|Treatment Group Terminated by Sponsor|0
4847661|NCT00979901|16712106|P2|Overall Study|Treatment Group Terminated by Sponsor|0
4847662|NCT00979901|16712107|P1|Overall Study|Treatment Group Terminated by Sponsor|0
4847663|NCT00979901|16712104|P4|Overall Study|Left Country|0
4847664|NCT00979901|16712105|P3|Overall Study|Left Country|1
4847665|NCT00979901|16712106|P2|Overall Study|Left Country|0
4847666|NCT00979901|16712107|P1|Overall Study|Left Country|0
4847667|NCT00979901|16712104|P4|Overall Study|Discontinued in Error|0
4847668|NCT00979901|16712105|P3|Overall Study|Discontinued in Error|0
4847669|NCT00979901|16712106|P2|Overall Study|Discontinued in Error|1
4847670|NCT00979901|16712107|P1|Overall Study|Discontinued in Error|0
4847671|NCT00979901|16712104|P4|Overall Study|elevated lab values pre-randomization|0
4847672|NCT00979901|16712105|P3|Overall Study|elevated lab values pre-randomization|0
4847673|NCT00979901|16712106|P2|Overall Study|elevated lab values pre-randomization|0
4847674|NCT00979901|16712107|P1|Overall Study|elevated lab values pre-randomization|1
4847675|NCT00979901|16712104|P4|Overall Study|vacation|0
4847676|NCT00979901|16712105|P3|Overall Study|vacation|0
4847677|NCT00979901|16712106|P2|Overall Study|vacation|0
4847678|NCT00979901|16712107|P1|Overall Study|vacation|1
4847679|NCT00979901|16712104|P4|Overall Study|out-of-state|0
4847680|NCT00979901|16712105|P3|Overall Study|out-of-state|0
4847681|NCT00979901|16712106|P2|Overall Study|out-of-state|0
4847682|NCT00979901|16712107|P1|Overall Study|out-of-state|1
4847683|NCT00979901|16712104|P4|Overall Study|Noncompliance|0
4847684|NCT00979901|16712105|P3|Overall Study|Noncompliance|0
4847685|NCT00979901|16712106|P2|Overall Study|Noncompliance|0
4847686|NCT00979901|16712107|P1|Overall Study|Noncompliance|1
4847687|NCT00979901|16712104|P4|Overall Study|Withdrawal by Subject|1
4847688|NCT00979901|16712105|P3|Overall Study|Withdrawal by Subject|1
4847689|NCT00979901|16712106|P2|Overall Study|Withdrawal by Subject|1
4847690|NCT00979901|16712107|P1|Overall Study|Withdrawal by Subject|2
4847691|NCT00979901|16712104|P4|Overall Study|Protocol Violation|1
4847692|NCT00979901|16712105|P3|Overall Study|Protocol Violation|7
4847693|NCT00979901|16712106|P2|Overall Study|Protocol Violation|2
4847694|NCT00979901|16712107|P1|Overall Study|Protocol Violation|2
4847695|NCT00979901|16712104|P4|Overall Study|Lost to Follow-up|0
4847696|NCT00979901|16712105|P3|Overall Study|Lost to Follow-up|2
4847697|NCT00979901|16712106|P2|Overall Study|Lost to Follow-up|1
4847698|NCT00979901|16712107|P1|Overall Study|Lost to Follow-up|1
4847699|NCT00979901|16712104|P4|Overall Study|Lack of Efficacy|0
4847700|NCT00979901|16712105|P3|Overall Study|Lack of Efficacy|9
4847701|NCT00979901|16712106|P2|Overall Study|Lack of Efficacy|4
4847702|NCT00979901|16712107|P1|Overall Study|Lack of Efficacy|8
4847703|NCT00979901|16712104|P4|Overall Study|Adverse Event|2
4847704|NCT00979901|16712105|P3|Overall Study|Adverse Event|9
4847705|NCT00979901|16712106|P2|Overall Study|Adverse Event|3
4847706|NCT00979901|16712107|P1|Overall Study|Adverse Event|1
4847707|NCT00979654|16712180|P1|Overall Study|Unfavorable Risk-Benefit Analysis|1
4847708|NCT00979654|16712180|P1|Overall Study|Serious Adverse Event|1
4847709|NCT00979654|16712180|P1|Overall Study|Patient Wanted to Pursue Other Treatment|1
4847710|NCT00979654|16712180|P1|Overall Study|Per Principal Investigator's Discretion|1
4847711|NCT00979654|16712180|P1|Overall Study|Adverse Event of Diverticulitis|1
4847712|NCT00979654|16712180|P1|Overall Study|Adverse Event|1
4847713|NCT00979654|16712180|P1|Overall Study|Lack of Efficacy|6
4847714|NCT00979654|16712180|P1|Overall Study|Death|1
4847715|NCT00979654|16712180|P1|Overall Study|Withdrawal by Subject|22
4847716|NCT00979654|16712180|P1|Overall Study|Lost to Follow-up|1
4847717|NCT00979628|16712195|P3|Overall Study|transferred to ICU|1
4847718|NCT00979628|16712196|P2|Overall Study|transferred to ICU|2
4847719|NCT00979628|16712197|P1|Overall Study|transferred to ICU|1
4847720|NCT00979628|16712195|P3|Overall Study|received steroids|0
4847721|NCT00979628|16712196|P2|Overall Study|received steroids|1
4847722|NCT00979628|16712197|P1|Overall Study|received steroids|1
4847723|NCT00979628|16712195|P3|Overall Study|received regimen < 24 hours|5
4847724|NCT00979628|16712196|P2|Overall Study|received regimen < 24 hours|6
4847725|NCT00979628|16712197|P1|Overall Study|received regimen < 24 hours|7
4847726|NCT00979602|16712227|P2|Overall Study|Others|3
4847727|NCT00979602|16712228|P1|Overall Study|Others|3
4847728|NCT00979602|16712227|P2|Overall Study|Migrated/moved from study area|6
4847729|NCT00979602|16712228|P1|Overall Study|Migrated/moved from study area|3
4847730|NCT00979602|16712227|P2|Overall Study|Lost to Follow-up|96
4847731|NCT00979602|16712228|P1|Overall Study|Lost to Follow-up|100
4847732|NCT00979602|16712227|P2|Overall Study|Withdrawal by Subject|25
4847733|NCT00979602|16712228|P1|Overall Study|Withdrawal by Subject|31
4847734|NCT00979602|16712227|P2|Overall Study|Protocol Violation|0
4847735|NCT00979602|16712228|P1|Overall Study|Protocol Violation|3
4847736|NCT00979602|16712227|P2|Overall Study|Serious Adverse Event|3
4847737|NCT00979602|16712228|P1|Overall Study|Serious Adverse Event|5
4847738|NCT00979576|16712399|P3|Combination Followed by Monotherapy|Progressive Disease|1
4847739|NCT00979576|16712400|P2|Combination Followed by Monotherapy|Progressive Disease|2
4847740|NCT00979576|16712401|P1|Combination Followed by Monotherapy|Progressive Disease|0
4847741|NCT00979576|16712399|P3|Combination Treatment Phase|Adverse Event|2
4847742|NCT00979576|16712400|P2|Combination Treatment Phase|Adverse Event|2
4847743|NCT00979576|16712401|P1|Combination Treatment Phase|Adverse Event|0
4847744|NCT00979576|16712399|P3|Combination Treatment Phase|Dose limiting toxicity|2
4847745|NCT00979576|16712400|P2|Combination Treatment Phase|Dose limiting toxicity|3
4847746|NCT00979576|16712401|P1|Combination Treatment Phase|Dose limiting toxicity|0
4847747|NCT00979576|16712399|P3|Combination Treatment Phase|Progressive disease|5
4847748|NCT00979576|16712400|P2|Combination Treatment Phase|Progressive disease|1
4847749|NCT00979576|16712401|P1|Combination Treatment Phase|Progressive disease|3
4847750|NCT00979420|16712458|P4|Overall Study|Other reasons not related to Viramune|1
4847751|NCT00979420|16712459|P3|Overall Study|Other reasons not related to Viramune|0
4847752|NCT00979420|16712460|P2|Overall Study|Other reasons not related to Viramune|0
4847753|NCT00979420|16712461|P1|Overall Study|Other reasons not related to Viramune|3
4847754|NCT00979420|16712458|P4|Overall Study|Lack of Efficacy|1
4847755|NCT00979420|16712459|P3|Overall Study|Lack of Efficacy|1
4847756|NCT00979420|16712460|P2|Overall Study|Lack of Efficacy|0
4847757|NCT00979420|16712461|P1|Overall Study|Lack of Efficacy|3
4847758|NCT00979420|16712458|P4|Overall Study|Adverse Event|0
4847759|NCT00979420|16712459|P3|Overall Study|Adverse Event|0
4847760|NCT00979420|16712460|P2|Overall Study|Adverse Event|0
4847761|NCT00979420|16712461|P1|Overall Study|Adverse Event|1
4847762|NCT00979407|16712531|P2|Overall Study|Lost to Follow-up|3
4847763|NCT00979407|16712532|P1|Overall Study|Lost to Follow-up|3
4847764|NCT00979407|16712531|P2|Overall Study|Withdrawal by Subject|4
4847765|NCT00979407|16712532|P1|Overall Study|Withdrawal by Subject|3
4847766|NCT00979212|16712585|P2|Overall Study|No protocol therapy received|0
4847767|NCT00979212|16712586|P1|Overall Study|No protocol therapy received|1
4847768|NCT00979212|16712585|P2|Overall Study|Protocol Violation|8
4847769|NCT00979212|16712586|P1|Overall Study|Protocol Violation|1
4847770|NCT00979134|16712623|P3|Overall Study|Other|5
4847771|NCT00979134|16712624|P2|Overall Study|Other|1
4847772|NCT00979134|16712625|P1|Overall Study|Other|8
4847773|NCT00979134|16712623|P3|Overall Study|Death|26
4847774|NCT00979134|16712624|P2|Overall Study|Death|0
4847775|NCT00979134|16712625|P1|Overall Study|Death|4
4847776|NCT00979134|16712623|P3|Overall Study|Lost to Follow-up|0
4847777|NCT00979134|16712624|P2|Overall Study|Lost to Follow-up|2
4847778|NCT00979134|16712625|P1|Overall Study|Lost to Follow-up|2
4847779|NCT00979134|16712623|P3|Overall Study|Withdrawal by Subject|2
4847780|NCT00979134|16712624|P2|Overall Study|Withdrawal by Subject|1
4847781|NCT00979134|16712625|P1|Overall Study|Withdrawal by Subject|1
4847782|NCT00979134|16712623|P3|Overall Study|Adverse Event|2
4847783|NCT00979134|16712624|P2|Overall Study|Adverse Event|0
4847784|NCT00979134|16712625|P1|Overall Study|Adverse Event|0
4847785|NCT00979134|16712623|P3|Overall Study|Disease progression|5
4847786|NCT00979134|16712624|P2|Overall Study|Disease progression|2
4847787|NCT00979134|16712625|P1|Overall Study|Disease progression|18
4847788|NCT00978757|16712713|P2|Overall Study|Physician Decision|3
4847789|NCT00978757|16712714|P1|Overall Study|Physician Decision|1
4847790|NCT00978731|16712724|P4|Overall Study|No response|0
4847791|NCT00978731|16712725|P3|Overall Study|No response|0
4847792|NCT00978731|16712726|P2|Overall Study|No response|0
4847793|NCT00978731|16712727|P1|Overall Study|No response|1
4847794|NCT00978731|16712724|P4|Overall Study|Study closure|1
4847795|NCT00978731|16712725|P3|Overall Study|Study closure|1
4847796|NCT00978731|16712726|P2|Overall Study|Study closure|4
4847797|NCT00978731|16712727|P1|Overall Study|Study closure|3
4847798|NCT00978731|16712724|P4|Overall Study|Disease progression/relapse|2
4847799|NCT00978731|16712725|P3|Overall Study|Disease progression/relapse|2
4847800|NCT00978731|16712726|P2|Overall Study|Disease progression/relapse|4
4847801|NCT00978731|16712727|P1|Overall Study|Disease progression/relapse|5
4847802|NCT00978731|16712724|P4|Overall Study|Deterioration without progression|0
4847803|NCT00978731|16712725|P3|Overall Study|Deterioration without progression|0
4847804|NCT00978731|16712726|P2|Overall Study|Deterioration without progression|1
4847805|NCT00978731|16712727|P1|Overall Study|Deterioration without progression|0
4847806|NCT00978731|16712724|P4|Overall Study|Administrative reason|0
4847807|NCT00978731|16712725|P3|Overall Study|Administrative reason|1
4847808|NCT00978731|16712726|P2|Overall Study|Administrative reason|3
4847809|NCT00978731|16712727|P1|Overall Study|Administrative reason|3
4847810|NCT00978731|16712724|P4|Overall Study|Participant's request|0
4847811|NCT00978731|16712725|P3|Overall Study|Participant's request|0
4847812|NCT00978731|16712726|P2|Overall Study|Participant's request|0
4847813|NCT00978731|16712727|P1|Overall Study|Participant's request|1
4847814|NCT00978731|16712724|P4|Overall Study|Adverse Event|0
4847815|NCT00978731|16712725|P3|Overall Study|Adverse Event|0
4847816|NCT00978731|16712726|P2|Overall Study|Adverse Event|2
4847817|NCT00978731|16712727|P1|Overall Study|Adverse Event|5
4847818|NCT00978731|16712724|P4|Overall Study|Lost to Follow-up|1
4847819|NCT00978731|16712725|P3|Overall Study|Lost to Follow-up|0
4847820|NCT00978731|16712726|P2|Overall Study|Lost to Follow-up|0
4847821|NCT00978731|16712727|P1|Overall Study|Lost to Follow-up|0
4847822|NCT00978731|16712724|P4|Overall Study|Death|0
4847823|NCT00978731|16712725|P3|Overall Study|Death|1
4847824|NCT00978731|16712726|P2|Overall Study|Death|1
4847825|NCT00978731|16712727|P1|Overall Study|Death|4
4847826|NCT00978627|16712767|P2|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7
4847827|NCT00978627|16712768|P1|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12
4847828|NCT00978627|16712767|P2|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1
4847829|NCT00978627|16712768|P1|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2
4847830|NCT00978627|16712767|P2|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1
4847831|NCT00978627|16712768|P1|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4
4847832|NCT00978627|16712767|P2|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0
4847833|NCT00978627|16712768|P1|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3
4847834|NCT00978627|16712767|P2|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12
4847835|NCT00978627|16712768|P1|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25
4847836|NCT00978627|16712767|P2|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5
4847837|NCT00978627|16712768|P1|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7
4847838|NCT00978627|16712767|P2|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6
4847839|NCT00978627|16712768|P1|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8
4847840|NCT00978627|16712767|P2|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0
4847841|NCT00978627|16712768|P1|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2
4847842|NCT00978627|16712767|P2|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3
4847843|NCT00978627|16712768|P1|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4
4847844|NCT00978432|16712806|P3|Overall Study|Adverse Event|1
4847845|NCT00978432|16712807|P2|Overall Study|Adverse Event|0
4847846|NCT00978432|16712808|P1|Overall Study|Adverse Event|2
4847847|NCT00978432|16712806|P3|Overall Study|Lack of Efficacy|3
4847848|NCT00978432|16712807|P2|Overall Study|Lack of Efficacy|1
4847849|NCT00978432|16712808|P1|Overall Study|Lack of Efficacy|1
4847850|NCT00978432|16712806|P3|Overall Study|Withdrawal by Subject|1
4847851|NCT00978432|16712807|P2|Overall Study|Withdrawal by Subject|0
4847852|NCT00978432|16712808|P1|Overall Study|Withdrawal by Subject|0
4847853|NCT00978380|16712859|P1|Overall Study|Unclassified|8
4847854|NCT00978380|16712859|P1|Overall Study|Withdrawal criteria|9
4847855|NCT00978380|16712859|P1|Overall Study|Protocol Violation|2
4847856|NCT00978341|16712865|P2|Washout Period of 2 Weeks|Adverse Event|0
4847857|NCT00978341|16712866|P1|Washout Period of 2 Weeks|Adverse Event|1
4847858|NCT00978250|16712888|P4|Overall Study|Late determination of ineligibility|1
4847859|NCT00978250|16712889|P3|Overall Study|Late determination of ineligibility|0
4847860|NCT00978250|16712890|P2|Overall Study|Late determination of ineligibility|1
4847861|NCT00978250|16712891|P1|Overall Study|Late determination of ineligibility|0
4847862|NCT00978120|16712907|P4|Overall Study|Moved out of state|1
4847863|NCT00978120|16712908|P3|Overall Study|Moved out of state|0
4847864|NCT00978120|16712909|P2|Overall Study|Moved out of state|0
4847865|NCT00978120|16712910|P1|Overall Study|Moved out of state|0
4847866|NCT00978120|16712907|P4|Overall Study|Withdrawal by Subject|0
4847867|NCT00978120|16712908|P3|Overall Study|Withdrawal by Subject|0
4847868|NCT00978120|16712909|P2|Overall Study|Withdrawal by Subject|0
4847869|NCT00978120|16712910|P1|Overall Study|Withdrawal by Subject|2
4847870|NCT00978120|16712907|P4|Overall Study|Lost to Follow-up|0
4847871|NCT00978120|16712908|P3|Overall Study|Lost to Follow-up|3
4847872|NCT00978120|16712909|P2|Overall Study|Lost to Follow-up|0
4847873|NCT00978120|16712910|P1|Overall Study|Lost to Follow-up|0
4847874|NCT00978120|16712907|P4|Overall Study|Death|1
4847875|NCT00978120|16712908|P3|Overall Study|Death|0
4847876|NCT00978120|16712909|P2|Overall Study|Death|0
4847877|NCT00978120|16712910|P1|Overall Study|Death|0
4847878|NCT00978068|16712962|P2|Overall Study|Unable to Comply with Study|2
4847879|NCT00978068|16712963|P1|Overall Study|Unable to Comply with Study|0
4847880|NCT00978068|16712962|P2|Overall Study|Physician Decision|1
4847881|NCT00978068|16712963|P1|Overall Study|Physician Decision|0
4847882|NCT00978068|16712962|P2|Overall Study|Lost to Follow-up|2
4847883|NCT00978068|16712963|P1|Overall Study|Lost to Follow-up|1
4847884|NCT00978068|16712962|P2|Overall Study|Death|2
4847885|NCT00978068|16712963|P1|Overall Study|Death|1
4847886|NCT00978068|16712962|P2|Overall Study|Were Awaiting Initiation of ART|2
4847887|NCT00978068|16712963|P1|Overall Study|Were Awaiting Initiation of ART|2
4847888|NCT00978042|16712981|P2|Initial Treatment Period|Other Miscellaneous Reasons|0
4847889|NCT00978042|16712982|P1|Initial Treatment Period|Other Miscellaneous Reasons|13
4847890|NCT00978042|16712981|P2|Initial Treatment Period|Consent withdrawn|9
4847891|NCT00978042|16712982|P1|Initial Treatment Period|Consent withdrawn|22
4847892|NCT00978042|16712981|P2|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0
4847893|NCT00978042|16712982|P1|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2
4847894|NCT00978042|16712981|P2|Initial Treatment Period|Adverse Event|0
4847895|NCT00978042|16712982|P1|Initial Treatment Period|Adverse Event|2
4847896|NCT00978042|16712981|P2|Initial Treatment Period|Lost to Follow-up|3
4847897|NCT00978042|16712982|P1|Initial Treatment Period|Lost to Follow-up|21
4847898|NCT00978042|16712981|P2|Initial Treatment Period|Ineligibility|0
4847899|NCT00978042|16712982|P1|Initial Treatment Period|Ineligibility|1
4847900|NCT00978042|16712981|P2|Initial Treatment Period|Treated in Error|3
4847901|NCT00978042|16712982|P1|Initial Treatment Period|Treated in Error|0
4847902|NCT00978029|16712995|P3|Overall Study|Protocol Violation|0
4847903|NCT00978029|16712996|P2|Overall Study|Protocol Violation|1
4847904|NCT00978029|16712997|P1|Overall Study|Protocol Violation|0
4847905|NCT00978029|16712995|P3|Overall Study|Withdrawal by Subject|1
4847906|NCT00978029|16712996|P2|Overall Study|Withdrawal by Subject|0
4847907|NCT00978029|16712997|P1|Overall Study|Withdrawal by Subject|0
4847908|NCT00978029|16712995|P3|Overall Study|Adverse Event|5
4847909|NCT00978029|16712996|P2|Overall Study|Adverse Event|2
4847910|NCT00978029|16712997|P1|Overall Study|Adverse Event|1
4847911|NCT00977938|16713024|P4|Observation (30-33 mo. Post Procedure)|Other|0
4847912|NCT00977938|16713025|P3|Observation (30-33 mo. Post Procedure)|Other|0
4847913|NCT00977938|16713026|P2|Observation (30-33 mo. Post Procedure)|Other|4
4847914|NCT00977938|16713027|P1|Observation (30-33 mo. Post Procedure)|Other|8
4847915|NCT00977938|16713024|P4|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3
4847916|NCT00977938|16713025|P3|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10
4847917|NCT00977938|16713026|P2|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42
4847918|NCT00977938|16713027|P1|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34
4847919|NCT00977938|16713024|P4|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0
4847920|NCT00977938|16713025|P3|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2
4847921|NCT00977938|16713026|P2|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12
4847922|NCT00977938|16713027|P1|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9
4847923|NCT00977938|16713024|P4|Treatment (12-30 mo. Post Procedure)|Other|4
4847924|NCT00977938|16713025|P3|Treatment (12-30 mo. Post Procedure)|Other|3
4847925|NCT00977938|16713026|P2|Treatment (12-30 mo. Post Procedure)|Other|18
4847926|NCT00977938|16713027|P1|Treatment (12-30 mo. Post Procedure)|Other|17
4847927|NCT00977938|16713024|P4|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37
4847928|NCT00977938|16713025|P3|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30
4847929|NCT00977938|16713026|P2|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91
4847930|NCT00977938|16713027|P1|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88
4847931|NCT00977938|16713024|P4|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20
4847932|NCT00977938|16713025|P3|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13
4847933|NCT00977938|16713026|P2|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116
4847934|NCT00977938|16713027|P1|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132
4847935|NCT00977665|16713104|P2|Overall Study|Treatment failure|1
4847936|NCT00977665|16713105|P1|Overall Study|Treatment failure|0
4847937|NCT00977665|16713104|P2|Overall Study|Adverse Event|7
4847938|NCT00977665|16713105|P1|Overall Study|Adverse Event|14
4847939|NCT00977665|16713104|P2|Overall Study|Death|2
4847940|NCT00977665|16713105|P1|Overall Study|Death|3
4847941|NCT00977665|16713104|P2|Overall Study|Lost to Follow-up|0
4847942|NCT00977665|16713105|P1|Overall Study|Lost to Follow-up|1
4847943|NCT00977665|16713104|P2|Overall Study|Sponsor requested withdrawal|1
4847944|NCT00977665|16713105|P1|Overall Study|Sponsor requested withdrawal|0
4847945|NCT00977665|16713104|P2|Overall Study|Physician Decision|1
4847946|NCT00977665|16713105|P1|Overall Study|Physician Decision|2
4847947|NCT00977665|16713104|P2|Overall Study|Withdrawal by Subject|3
4847948|NCT00977665|16713105|P1|Overall Study|Withdrawal by Subject|1
4847949|NCT00977613|16713137|P1|Overall Study|Lost to Follow-up|16
4847950|NCT00977574|16713144|P3|Overall Study|Never Treated|4
4847951|NCT00977574|16713145|P2|Overall Study|Never Treated|2
4847952|NCT00977574|16713146|P1|Overall Study|Never Treated|4
4847953|NCT00977561|16713165|P2|Overall Study|Other|0
4847954|NCT00977561|16713166|P1|Overall Study|Other|2
4847955|NCT00977561|16713165|P2|Overall Study|Study terminated|2
4847956|NCT00977561|16713166|P1|Overall Study|Study terminated|0
4847957|NCT00977561|16713165|P2|Overall Study|Death|2
4847958|NCT00977561|16713166|P1|Overall Study|Death|3
4847959|NCT00977548|16713193|P1|Overall Study|Withdrawal by Subject|1
4847960|NCT00977548|16713193|P1|Overall Study|Adverse Event|8
4847961|NCT00977548|16713193|P1|Overall Study|Ineligible|4
4847962|NCT00977470|16713202|P2|Overall Study|Still on-study|0
4847963|NCT00977470|16713203|P1|Overall Study|Still on-study|2
4847964|NCT00977470|16713202|P2|Overall Study|prolonged recovery post-surgery|1
4847965|NCT00977470|16713203|P1|Overall Study|prolonged recovery post-surgery|0
4847966|NCT00977470|16713202|P2|Overall Study|clinical decline|1
4847967|NCT00977470|16713203|P1|Overall Study|clinical decline|0
4847968|NCT00977470|16713202|P2|Overall Study|Death|2
4847969|NCT00977470|16713203|P1|Overall Study|Death|0
4847970|NCT00977470|16713202|P2|Overall Study|Withdrawal by Subject|2
4847971|NCT00977470|16713203|P1|Overall Study|Withdrawal by Subject|0
4847972|NCT00977470|16713202|P2|Overall Study|Protocol Violation|0
4847973|NCT00977470|16713203|P1|Overall Study|Protocol Violation|1
4847974|NCT00977470|16713202|P2|Overall Study|Adverse Event|2
4847975|NCT00977470|16713203|P1|Overall Study|Adverse Event|1
4847976|NCT00977470|16713202|P2|Overall Study|Physician Decision|0
4847977|NCT00977470|16713203|P1|Overall Study|Physician Decision|2
4847978|NCT00977470|16713202|P2|Overall Study|Lack of Efficacy|30
4847979|NCT00977470|16713203|P1|Overall Study|Lack of Efficacy|32
4847980|NCT00977431|16713226|P5|Overall Study|Progressive disease|5
4847981|NCT00977431|16713227|P4|Overall Study|Progressive disease|3
4847982|NCT00977431|16713228|P3|Overall Study|Progressive disease|1
4847983|NCT00977431|16713229|P2|Overall Study|Progressive disease|6
4847984|NCT00977431|16713230|P1|Overall Study|Progressive disease|2
4847985|NCT00977431|16713226|P5|Overall Study|Dose-limiting toxicity (DLT)|0
4847986|NCT00977431|16713227|P4|Overall Study|Dose-limiting toxicity (DLT)|0
4847987|NCT00977431|16713228|P3|Overall Study|Dose-limiting toxicity (DLT)|1
4847988|NCT00977431|16713229|P2|Overall Study|Dose-limiting toxicity (DLT)|0
4847989|NCT00977431|16713230|P1|Overall Study|Dose-limiting toxicity (DLT)|1
4847990|NCT00977431|16713226|P5|Overall Study|Adverse Event|6
4847991|NCT00977431|16713227|P4|Overall Study|Adverse Event|0
4847992|NCT00977431|16713228|P3|Overall Study|Adverse Event|4
4847993|NCT00977431|16713229|P2|Overall Study|Adverse Event|0
4847994|NCT00977431|16713230|P1|Overall Study|Adverse Event|3
4847995|NCT00977431|16713226|P5|Overall Study|Protocol Violation|0
4847996|NCT00977431|16713227|P4|Overall Study|Protocol Violation|0
4847997|NCT00977431|16713228|P3|Overall Study|Protocol Violation|1
4847998|NCT00977431|16713229|P2|Overall Study|Protocol Violation|0
4847999|NCT00977431|16713230|P1|Overall Study|Protocol Violation|0
4848000|NCT00977431|16713226|P5|Overall Study|Other than listed|2
4848001|NCT00977431|16713227|P4|Overall Study|Other than listed|0
4848002|NCT00977431|16713228|P3|Overall Study|Other than listed|0
4848003|NCT00977431|16713229|P2|Overall Study|Other than listed|0
4848004|NCT00977431|16713230|P1|Overall Study|Other than listed|1
4848005|NCT00977379|16713263|P2|Overall Study|Randomization Error|1
4848006|NCT00977379|16713264|P1|Overall Study|Randomization Error|0
4848007|NCT00977379|16713263|P2|Overall Study|Participant Moving House|1
4848008|NCT00977379|16713264|P1|Overall Study|Participant Moving House|0
4848009|NCT00977379|16713263|P2|Overall Study|Premature Study Termination|0
4848010|NCT00977379|16713264|P1|Overall Study|Premature Study Termination|4
4848011|NCT00977379|16713263|P2|Overall Study|Death|9
4848012|NCT00977379|16713264|P1|Overall Study|Death|7
4848013|NCT00977379|16713263|P2|Overall Study|Withdrawal by Subject|1
4848014|NCT00977379|16713264|P1|Overall Study|Withdrawal by Subject|1
4848015|NCT00977314|16713300|P2|Overall Study|Physician Decision|0
4848016|NCT00977314|16713301|P1|Overall Study|Physician Decision|1
4848017|NCT00977314|16713300|P2|Overall Study|Withdrawal by Subject|0
4848018|NCT00977314|16713301|P1|Overall Study|Withdrawal by Subject|1
4848019|NCT00977197|16713309|P2|Overall Study|Nonadherence|1
4848020|NCT00977197|16713310|P1|Overall Study|Nonadherence|1
4848021|NCT00977197|16713309|P2|Overall Study|Lost to Follow-up|3
4848022|NCT00977197|16713310|P1|Overall Study|Lost to Follow-up|1
4848023|NCT00977197|16713309|P2|Overall Study|Lack of Efficacy|0
4848024|NCT00977197|16713310|P1|Overall Study|Lack of Efficacy|1
4848025|NCT00977197|16713309|P2|Overall Study|Adverse Event|1
4848026|NCT00977197|16713310|P1|Overall Study|Adverse Event|3
4848027|NCT00977197|16713309|P2|Overall Study|Withdrawal by Subject|4
4848028|NCT00977197|16713310|P1|Overall Study|Withdrawal by Subject|3
4848029|NCT00977106|16713373|P2|Overall Study|Other|0
4848030|NCT00977106|16713374|P1|Overall Study|Other|1
4848031|NCT00977106|16713373|P2|Overall Study|Protocol Violation|1
4848032|NCT00977106|16713374|P1|Overall Study|Protocol Violation|0
4848033|NCT00977106|16713373|P2|Overall Study|Lack of Efficacy|2
4848034|NCT00977106|16713374|P1|Overall Study|Lack of Efficacy|2
4848035|NCT00977106|16713373|P2|Overall Study|Withdrawal by Subject|2
4848036|NCT00977106|16713374|P1|Overall Study|Withdrawal by Subject|2
4848037|NCT00977106|16713373|P2|Overall Study|Adverse Event|6
4848038|NCT00977106|16713374|P1|Overall Study|Adverse Event|5
4848039|NCT00977080|16713466|P4|Overall Study|Travel for family reasons|0
4848040|NCT00977080|16713467|P3|Overall Study|Travel for family reasons|0
4848041|NCT00977080|16713468|P2|Overall Study|Travel for family reasons|0
4848042|NCT00977080|16713469|P1|Overall Study|Travel for family reasons|1
4848043|NCT00977080|16713466|P4|Overall Study|Required kidney transplantation|1
4848044|NCT00977080|16713467|P3|Overall Study|Required kidney transplantation|3
4848045|NCT00977080|16713468|P2|Overall Study|Required kidney transplantation|3
4848046|NCT00977080|16713469|P1|Overall Study|Required kidney transplantation|1
4848047|NCT00977080|16713466|P4|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1
4848048|NCT00977080|16713467|P3|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
4848049|NCT00977080|16713468|P2|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
4848050|NCT00977080|16713469|P1|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0
4848051|NCT00977080|16713466|P4|Overall Study|Noncompliance|0
4848052|NCT00977080|16713467|P3|Overall Study|Noncompliance|1
4848053|NCT00977080|16713468|P2|Overall Study|Noncompliance|2
4848054|NCT00977080|16713469|P1|Overall Study|Noncompliance|0
4848055|NCT00977080|16713466|P4|Overall Study|Protocol Violation|3
4848056|NCT00977080|16713467|P3|Overall Study|Protocol Violation|4
4848057|NCT00977080|16713468|P2|Overall Study|Protocol Violation|3
4848058|NCT00977080|16713469|P1|Overall Study|Protocol Violation|7
4848059|NCT00977080|16713466|P4|Overall Study|Withdrawal by Subject|5
4848060|NCT00977080|16713467|P3|Overall Study|Withdrawal by Subject|1
4848061|NCT00977080|16713468|P2|Overall Study|Withdrawal by Subject|5
4848062|NCT00977080|16713469|P1|Overall Study|Withdrawal by Subject|1
4848063|NCT00977080|16713466|P4|Overall Study|Adverse Event|7
4848064|NCT00977080|16713467|P3|Overall Study|Adverse Event|7
4848065|NCT00977080|16713468|P2|Overall Study|Adverse Event|7
4848066|NCT00977080|16713469|P1|Overall Study|Adverse Event|2
4848067|NCT00976989|16713502|P3|Overall Study|Other|1
4848068|NCT00976989|16713503|P2|Overall Study|Other|0
4848069|NCT00976989|16713504|P1|Overall Study|Other|1
4848070|NCT00976989|16713502|P3|Overall Study|Recurrence of Disease|0
4848071|NCT00976989|16713503|P2|Overall Study|Recurrence of Disease|1
4848072|NCT00976989|16713504|P1|Overall Study|Recurrence of Disease|0
4848073|NCT00976989|16713502|P3|Overall Study|Failure to Return|0
4848074|NCT00976989|16713503|P2|Overall Study|Failure to Return|1
4848075|NCT00976989|16713504|P1|Overall Study|Failure to Return|2
4848076|NCT00976989|16713502|P3|Overall Study|Refused Treatment|5
4848077|NCT00976989|16713503|P2|Overall Study|Refused Treatment|3
4848078|NCT00976989|16713504|P1|Overall Study|Refused Treatment|4
4848079|NCT00976989|16713502|P3|Overall Study|Death|10
4848080|NCT00976989|16713503|P2|Overall Study|Death|7
4848081|NCT00976989|16713504|P1|Overall Study|Death|5
4848082|NCT00976989|16713502|P3|Overall Study|Violation of Selection Criteria at Entry|1
4848083|NCT00976989|16713503|P2|Overall Study|Violation of Selection Criteria at Entry|0
4848084|NCT00976989|16713504|P1|Overall Study|Violation of Selection Criteria at Entry|1
4848085|NCT00976950|16713545|P1|Overall Study|Events with no relationship to Aptivus|3
4848086|NCT00976950|16713545|P1|Overall Study|Adverse Event|3
4848087|NCT00976937|16713553|P2|Overall Study|Personal and Familial Reason|2
4848088|NCT00976937|16713554|P1|Overall Study|Personal and Familial Reason|2
4848089|NCT00976937|16713553|P2|Overall Study|Poor compliance to protocol|0
4848090|NCT00976937|16713554|P1|Overall Study|Poor compliance to protocol|3
4848091|NCT00976937|16713553|P2|Overall Study|Withdrawal by Subject|3
4848092|NCT00976937|16713554|P1|Overall Study|Withdrawal by Subject|5
4848093|NCT00976937|16713553|P2|Overall Study|Lost to Follow-up|1
4848094|NCT00976937|16713554|P1|Overall Study|Lost to Follow-up|2
4848095|NCT00976937|16713553|P2|Overall Study|Adverse Event|5
4848096|NCT00976937|16713554|P1|Overall Study|Adverse Event|4
4848097|NCT00976911|16713596|P2|Overall Study|In Follow-Up as of 25 Jan 2013|37
4848098|NCT00976911|16713597|P1|Overall Study|In Follow-Up as of 25 Jan 2013|30
4848099|NCT00976911|16713596|P2|Overall Study|Other|9
4848100|NCT00976911|16713597|P1|Overall Study|Other|8
4848101|NCT00976911|16713596|P2|Overall Study|Protocol Violation|0
4848102|NCT00976911|16713597|P1|Overall Study|Protocol Violation|2
4848103|NCT00976911|16713596|P2|Overall Study|Adverse Event|1
4848104|NCT00976911|16713597|P1|Overall Study|Adverse Event|0
4848105|NCT00976911|16713596|P2|Overall Study|Death|126
4848106|NCT00976911|16713597|P1|Overall Study|Death|138
4848107|NCT00976911|16713596|P2|Overall Study|Withdrawal by Subject|6
4848108|NCT00976911|16713597|P1|Overall Study|Withdrawal by Subject|4
4848109|NCT00976898|16713615|P1|Overall Study|Progressive Disease|1
4848110|NCT00976898|16713615|P1|Overall Study|Liver Transplant|1
4848111|NCT00976898|16713615|P1|Overall Study|Physician Decision|1
4848112|NCT00976898|16713615|P1|Overall Study|Adverse Event|1
4848113|NCT00976898|16713615|P1|Overall Study|Protocol Violation|1
4848114|NCT00976820|16713626|P4|Overall Study|Withdrawal by Subject|4
4848115|NCT00976820|16713627|P3|Overall Study|Withdrawal by Subject|1
4848116|NCT00976820|16713628|P2|Overall Study|Withdrawal by Subject|4
4848117|NCT00976820|16713629|P1|Overall Study|Withdrawal by Subject|2
4848118|NCT00976820|16713626|P4|Overall Study|Poor Compliance. Numerous Visits Booked|0
4848119|NCT00976820|16713627|P3|Overall Study|Poor Compliance. Numerous Visits Booked|1
4848120|NCT00976820|16713628|P2|Overall Study|Poor Compliance. Numerous Visits Booked|0
4848121|NCT00976820|16713629|P1|Overall Study|Poor Compliance. Numerous Visits Booked|1
4848122|NCT00976820|16713626|P4|Overall Study|Lost to Follow-up|3
4848123|NCT00976820|16713627|P3|Overall Study|Lost to Follow-up|2
4848124|NCT00976820|16713628|P2|Overall Study|Lost to Follow-up|16
4848125|NCT00976820|16713629|P1|Overall Study|Lost to Follow-up|5
4848126|NCT00976716|16713965|P1|Overall Study|Adverse Event|1
4848127|NCT00976703|16713983|P2|Overall Study|ineligible for study|2
4848128|NCT00976703|16713984|P1|Overall Study|ineligible for study|2
4848129|NCT00976703|16713983|P2|Overall Study|Physician Decision|1
4848130|NCT00976703|16713984|P1|Overall Study|Physician Decision|1
4848131|NCT00976677|16713998|P2|Overall Study|Unknown/Missing|0
4848132|NCT00976677|16713999|P1|Overall Study|Unknown/Missing|1
4848133|NCT00976677|16713998|P2|Overall Study|Trial unblinded|2
4848134|NCT00976677|16713999|P1|Overall Study|Trial unblinded|2
4848135|NCT00976677|16713998|P2|Overall Study|Disease progression|1
4848136|NCT00976677|16713999|P1|Overall Study|Disease progression|1
4848137|NCT00976677|16713998|P2|Overall Study|Withdrawal by Subject|2
4848138|NCT00976677|16713999|P1|Overall Study|Withdrawal by Subject|0
4848139|NCT00976677|16713998|P2|Overall Study|Adverse Event|0
4848140|NCT00976677|16713999|P1|Overall Study|Adverse Event|1
4848141|NCT00976573|16714207|P2|Overall Study|Cancel prior to receiving treatment|2
4848142|NCT00976573|16714208|P1|Overall Study|Cancel prior to receiving treatment|4
4848143|NCT00976573|16714207|P2|Overall Study|Ineligible|1
4848144|NCT00976573|16714208|P1|Overall Study|Ineligible|0
4848145|NCT00976560|16714222|P2|Overall Study|Withdrawal by Subject|3
4848146|NCT00976560|16714223|P1|Overall Study|Withdrawal by Subject|2
4848147|NCT00976560|16714222|P2|Overall Study|Physician Decision|0
4848148|NCT00976560|16714223|P1|Overall Study|Physician Decision|2
4848149|NCT00976560|16714222|P2|Overall Study|Lost to Follow-up|0
4848150|NCT00976560|16714223|P1|Overall Study|Lost to Follow-up|1
4848151|NCT00976560|16714222|P2|Overall Study|Protocol Violation|0
4848152|NCT00976560|16714223|P1|Overall Study|Protocol Violation|1
4848153|NCT00976560|16714222|P2|Overall Study|Lack of Efficacy|5
4848154|NCT00976560|16714223|P1|Overall Study|Lack of Efficacy|3
4848155|NCT00976560|16714222|P2|Overall Study|Adverse Event|5
4848156|NCT00976560|16714223|P1|Overall Study|Adverse Event|5
4848157|NCT00976508|16714292|P2|Overall Study|Terminated by the Sponsor|1
4848158|NCT00976508|16714293|P1|Overall Study|Terminated by the Sponsor|0
4848159|NCT00976508|16714292|P2|Overall Study|Subject Enrolled in Hospice|0
4848160|NCT00976508|16714293|P1|Overall Study|Subject Enrolled in Hospice|1
4848161|NCT00976508|16714292|P2|Overall Study|Disease Progression|4
4848162|NCT00976508|16714293|P1|Overall Study|Disease Progression|4
4848163|NCT00976508|16714292|P2|Overall Study|Withdrawal by Subject|0
4848164|NCT00976508|16714293|P1|Overall Study|Withdrawal by Subject|1
4848165|NCT00976508|16714292|P2|Overall Study|Lost to Follow-up|0
4848166|NCT00976508|16714293|P1|Overall Study|Lost to Follow-up|1
4848167|NCT00976508|16714292|P2|Overall Study|Death|1
4848168|NCT00976508|16714293|P1|Overall Study|Death|7
4848169|NCT00976495|16714326|P3|Overall Study|Withdrawal by Subject|0
4848170|NCT00976495|16714327|P2|Overall Study|Withdrawal by Subject|1
4848171|NCT00976495|16714328|P1|Overall Study|Withdrawal by Subject|0
4848172|NCT00976482|16714345|P1|Overall Study|Protocol Violation|5
4848173|NCT00976482|16714345|P1|Overall Study|Center terminated|1
4848174|NCT00976482|16714345|P1|Overall Study|Withdrawal by Subject|45
4848175|NCT00976482|16714345|P1|Overall Study|Death|208
4848176|NCT00976456|16714351|P2|Overall Study|screening failure, unknown|4
4848177|NCT00976456|16714352|P1|Overall Study|screening failure, unknown|11
4848178|NCT00976456|16714351|P2|Overall Study|Withdrawal by Subject|1
4848179|NCT00976456|16714352|P1|Overall Study|Withdrawal by Subject|3
4848180|NCT00976456|16714351|P2|Overall Study|Lack of Efficacy|2
4848181|NCT00976456|16714352|P1|Overall Study|Lack of Efficacy|5
4848182|NCT00976456|16714351|P2|Overall Study|Death|9
4848183|NCT00976456|16714352|P1|Overall Study|Death|7
4848184|NCT00976456|16714351|P2|Overall Study|Adverse Event|22
4848185|NCT00976456|16714352|P1|Overall Study|Adverse Event|17
4848186|NCT00976391|16714379|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
4848187|NCT00976391|16714380|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
4848188|NCT00976391|16714379|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|7
4848189|NCT00976391|16714380|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
4848190|NCT00976391|16714379|P2|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8
4848191|NCT00976391|16714380|P1|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6
4848192|NCT00976391|16714379|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
4848193|NCT00976391|16714380|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|14
4848194|NCT00976391|16714379|P2|Follow-up Period (8 Weeks)|Noncompliance|2
4848195|NCT00976391|16714380|P1|Follow-up Period (8 Weeks)|Noncompliance|2
4848196|NCT00976391|16714379|P2|Follow-up Period (8 Weeks)|Adverse Event|1
4848197|NCT00976391|16714380|P1|Follow-up Period (8 Weeks)|Adverse Event|3
4848198|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Pregnancy|0
4848199|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Pregnancy|1
4848200|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4
4848201|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0
4848202|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Physician Decision|1
4848203|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Physician Decision|1
4848204|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Withdrawal by Subject|19
4848205|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Withdrawal by Subject|9
4848206|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Lost to Follow-up|8
4848207|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Lost to Follow-up|10
4848208|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Noncompliance|4
4848209|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Noncompliance|4
4848210|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Protocol Violation|1
4848211|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Protocol Violation|1
4848212|NCT00976391|16714379|P2|Treatment Period (52 Weeks)|Adverse Event|2
4848213|NCT00976391|16714380|P1|Treatment Period (52 Weeks)|Adverse Event|16
4848214|NCT00976274|16714428|P2|Overall Study|Physician Decision|2
4848215|NCT00976274|16714429|P1|Overall Study|Physician Decision|1
4848216|NCT00976274|16714428|P2|Overall Study|Withdrawal by Subject|1
4848217|NCT00976274|16714429|P1|Overall Study|Withdrawal by Subject|1
4848218|NCT00976274|16714428|P2|Overall Study|Lost to Follow-up|5
4848219|NCT00976274|16714429|P1|Overall Study|Lost to Follow-up|5
4848220|NCT00976209|16714445|P2|Treatment Period 2|Lost to Follow-up|1
4848221|NCT00976209|16714446|P1|Treatment Period 2|Lost to Follow-up|0
4848222|NCT00976209|16714445|P2|Treatment Period 2|Withdrawal by Subject|1
4848223|NCT00976209|16714446|P1|Treatment Period 2|Withdrawal by Subject|0
4848224|NCT00976209|16714445|P2|Wash-out Period|Other|0
4848225|NCT00976209|16714446|P1|Wash-out Period|Other|1
4848226|NCT00976209|16714445|P2|Wash-out Period|Protocol Violation|0
4848227|NCT00976209|16714446|P1|Wash-out Period|Protocol Violation|1
4848228|NCT00976209|16714445|P2|Wash-out Period|Lost to Follow-up|0
4848229|NCT00976209|16714446|P1|Wash-out Period|Lost to Follow-up|1
4848230|NCT00976209|16714445|P2|Wash-out Period|Adverse Event|2
4848231|NCT00976209|16714446|P1|Wash-out Period|Adverse Event|1
4848232|NCT00976209|16714445|P2|Treatment Period 1|Other|1
4848233|NCT00976209|16714446|P1|Treatment Period 1|Other|0
4848234|NCT00976209|16714445|P2|Treatment Period 1|Lost to Follow-up|0
4848235|NCT00976209|16714446|P1|Treatment Period 1|Lost to Follow-up|2
4848236|NCT00976209|16714445|P2|Treatment Period 1|Protocol Violation|0
4848237|NCT00976209|16714446|P1|Treatment Period 1|Protocol Violation|1
4848238|NCT00976027|16714459|P2|Overall Study|Withdrawal by Subject|66
4848239|NCT00976027|16714460|P1|Overall Study|Withdrawal by Subject|107
4848240|NCT00976027|16714459|P2|Overall Study|Lost to Follow-up|103
4848241|NCT00976027|16714460|P1|Overall Study|Lost to Follow-up|208
4848242|NCT00976027|16714459|P2|Overall Study|Protocol Violation|27
4848243|NCT00976027|16714460|P1|Overall Study|Protocol Violation|60
4848244|NCT00976027|16714459|P2|Overall Study|Adverse Event|2
4848245|NCT00976027|16714460|P1|Overall Study|Adverse Event|0
4848246|NCT00976027|16714459|P2|Overall Study|Serious Adverse Event|17
4848247|NCT00976027|16714460|P1|Overall Study|Serious Adverse Event|36
4848248|NCT00975975|16714472|P1|Overall Study|Death|6
4848249|NCT00975923|16714480|P2|Overall Study|Withdrawal by Subject|1
4848250|NCT00975923|16714481|P1|Overall Study|Withdrawal by Subject|0
4848251|NCT00975884|16714491|P2|Overall Study|Other|3
4848252|NCT00975884|16714492|P1|Overall Study|Other|1
4848253|NCT00975884|16714491|P2|Overall Study|Withdrawal by Subject|9
4848254|NCT00975884|16714492|P1|Overall Study|Withdrawal by Subject|9
4848255|NCT00975884|16714491|P2|Overall Study|Lost to Follow-up|3
4848256|NCT00975884|16714492|P1|Overall Study|Lost to Follow-up|5
4848257|NCT00975884|16714491|P2|Overall Study|Adverse Event|0
4848258|NCT00975884|16714492|P1|Overall Study|Adverse Event|1
4848259|NCT00975806|16714649|P3|Overall Study|Physician decision and disease related|1
4848260|NCT00975806|16714650|P2|Overall Study|Physician decision and disease related|0
4848261|NCT00975806|16714651|P1|Overall Study|Physician decision and disease related|1
4848262|NCT00975806|16714649|P3|Overall Study|Death|0
4848263|NCT00975806|16714650|P2|Overall Study|Death|1
4848264|NCT00975806|16714651|P1|Overall Study|Death|0
4848265|NCT00975806|16714649|P3|Overall Study|Withdrawal by Subject|0
4848266|NCT00975806|16714650|P2|Overall Study|Withdrawal by Subject|0
4848267|NCT00975806|16714651|P1|Overall Study|Withdrawal by Subject|1
4848268|NCT00975806|16714649|P3|Overall Study|Disease Progression|1
4848269|NCT00975806|16714650|P2|Overall Study|Disease Progression|5
4848270|NCT00975806|16714651|P1|Overall Study|Disease Progression|1
4848271|NCT00975806|16714649|P3|Overall Study|Adverse Event|2
4848272|NCT00975806|16714650|P2|Overall Study|Adverse Event|1
4848273|NCT00975806|16714651|P1|Overall Study|Adverse Event|2
4848274|NCT00975780|16714675|P2|Follow Up|Discharged from Facility|12
4848275|NCT00975780|16714676|P1|Follow Up|Discharged from Facility|7
4848276|NCT00975780|16714675|P2|Follow Up|Facility Withdrawal|23
4848277|NCT00975780|16714676|P1|Follow Up|Facility Withdrawal|7
4848278|NCT00975780|16714675|P2|Follow Up|Death|122
4848279|NCT00975780|16714676|P1|Follow Up|Death|88
4848280|NCT00975715|16714686|P2|Maintenance Period|Adverse Event|1
4848281|NCT00975715|16714687|P1|Maintenance Period|Adverse Event|2
4848282|NCT00975715|16714686|P2|Titration Period|Protocol Violation|0
4848283|NCT00975715|16714687|P1|Titration Period|Protocol Violation|1
4848284|NCT00975715|16714686|P2|Titration Period|Adverse Event|0
4848285|NCT00975715|16714687|P1|Titration Period|Adverse Event|6
4848286|NCT00975689|16714703|P2|Overall Study|Physician Decision|0
4848287|NCT00975689|16714704|P1|Overall Study|Physician Decision|1
4848288|NCT00975689|16714703|P2|Overall Study|Withdrawal by Subject|0
4848289|NCT00975689|16714704|P1|Overall Study|Withdrawal by Subject|1
4848290|NCT00975689|16714703|P2|Overall Study|Adverse Event|3
4848291|NCT00975689|16714704|P1|Overall Study|Adverse Event|0
4848292|NCT00975611|16714773|P1|Overall Study|Physician Decision|1
4848293|NCT00975611|16714773|P1|Overall Study|Screen Fail|16
4848294|NCT00975585|16714779|P2|Overall Study|Lens issue|2
4848295|NCT00975585|16714780|P1|Overall Study|Lens issue|2
4848296|NCT00975585|16714779|P2|Overall Study|Withdrawal by Subject|1
4848297|NCT00975585|16714780|P1|Overall Study|Withdrawal by Subject|2
4848298|NCT00975585|16714779|P2|Overall Study|Lost to Follow-up|5
4848299|NCT00975585|16714780|P1|Overall Study|Lost to Follow-up|3
4848300|NCT00975585|16714779|P2|Overall Study|Adverse Event|4
4848301|NCT00975585|16714780|P1|Overall Study|Adverse Event|0
4848302|NCT00975507|16714800|P2|Overall Study|Withdrawal by Subject|3
4848303|NCT00975507|16714801|P1|Overall Study|Withdrawal by Subject|10
4848304|NCT00975507|16714800|P2|Overall Study|Protocol Violation|0
4848305|NCT00975507|16714801|P1|Overall Study|Protocol Violation|2
4848306|NCT00975507|16714800|P2|Overall Study|Lost to Follow-up|1
4848307|NCT00975507|16714801|P1|Overall Study|Lost to Follow-up|7
4848308|NCT00975507|16714800|P2|Overall Study|Adverse Event|0
4848309|NCT00975507|16714801|P1|Overall Study|Adverse Event|1
4848310|NCT00975481|16714821|P6|Fifth Intervention Period|Withdrawal by Subject|0
4848311|NCT00975481|16714822|P5|Fifth Intervention Period|Withdrawal by Subject|1
4848312|NCT00975481|16714823|P4|Fifth Intervention Period|Withdrawal by Subject|0
4848313|NCT00975481|16714824|P3|Fifth Intervention Period|Withdrawal by Subject|0
4848314|NCT00975481|16714825|P2|Fifth Intervention Period|Withdrawal by Subject|0
4848315|NCT00975481|16714826|P1|Fifth Intervention Period|Withdrawal by Subject|0
4848316|NCT00975481|16714821|P6|Fourth Intervention Period|Withdrawal by Subject|0
4848317|NCT00975481|16714822|P5|Fourth Intervention Period|Withdrawal by Subject|0
4848318|NCT00975481|16714823|P4|Fourth Intervention Period|Withdrawal by Subject|1
4848319|NCT00975481|16714824|P3|Fourth Intervention Period|Withdrawal by Subject|1
4848320|NCT00975481|16714825|P2|Fourth Intervention Period|Withdrawal by Subject|0
4848321|NCT00975481|16714826|P1|Fourth Intervention Period|Withdrawal by Subject|0
4848322|NCT00975481|16714821|P6|Second Intervention Period|Withdrawal by Subject|0
4848323|NCT00975481|16714822|P5|Second Intervention Period|Withdrawal by Subject|0
4848324|NCT00975481|16714823|P4|Second Intervention Period|Withdrawal by Subject|0
4848325|NCT00975481|16714824|P3|Second Intervention Period|Withdrawal by Subject|1
4848326|NCT00975481|16714825|P2|Second Intervention Period|Withdrawal by Subject|0
4848327|NCT00975481|16714826|P1|Second Intervention Period|Withdrawal by Subject|0
4848328|NCT00975481|16714821|P6|Second Intervention Period|Adverse Event|0
4848329|NCT00975481|16714822|P5|Second Intervention Period|Adverse Event|0
4848330|NCT00975481|16714823|P4|Second Intervention Period|Adverse Event|0
4848331|NCT00975481|16714824|P3|Second Intervention Period|Adverse Event|0
4848332|NCT00975481|16714825|P2|Second Intervention Period|Adverse Event|1
4848333|NCT00975481|16714826|P1|Second Intervention Period|Adverse Event|2
4848334|NCT00975416|16714926|P2|Overall Study|early discharge from tx|5
4848335|NCT00975416|16714927|P1|Overall Study|early discharge from tx|3
4848336|NCT00975286|16714936|P2|Overall Study|Sponsor Decision|2
4848337|NCT00975286|16714937|P1|Overall Study|Sponsor Decision|0
4848338|NCT00975286|16714936|P2|Overall Study|Poor Compliance to Protocol|2
4848339|NCT00975286|16714937|P1|Overall Study|Poor Compliance to Protocol|0
4848340|NCT00975286|16714936|P2|Overall Study|Familial and Personal Reasons|2
4848341|NCT00975286|16714937|P1|Overall Study|Familial and Personal Reasons|2
4848342|NCT00975286|16714936|P2|Overall Study|Withdrawal by Subject|2
4848343|NCT00975286|16714937|P1|Overall Study|Withdrawal by Subject|0
4848344|NCT00975286|16714936|P2|Overall Study|Protocol Violation|2
4848345|NCT00975286|16714937|P1|Overall Study|Protocol Violation|1
4848346|NCT00975286|16714936|P2|Overall Study|Adverse Event|19
4848347|NCT00975286|16714937|P1|Overall Study|Adverse Event|9
4848348|NCT00975221|16714969|P2|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0
4848349|NCT00975221|16714970|P1|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1
4848350|NCT00975221|16714969|P2|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
4848351|NCT00975221|16714970|P1|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1
4848352|NCT00975221|16714969|P2|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1
4848353|NCT00975221|16714970|P1|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0
4848354|NCT00975221|16714969|P2|Titration Phase (Weeks 1-12)|Other|1
4848355|NCT00975221|16714970|P1|Titration Phase (Weeks 1-12)|Other|0
4848356|NCT00975221|16714969|P2|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0
4848357|NCT00975221|16714970|P1|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1
4848358|NCT00975221|16714969|P2|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3
4848359|NCT00975221|16714970|P1|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2
4848360|NCT00975195|16714986|P2|Overall Study|Not treated|2
4848361|NCT00975195|16714987|P1|Overall Study|Not treated|1
4848362|NCT00975195|16714986|P2|Overall Study|Other reason not defined above|33
4848363|NCT00975195|16714987|P1|Overall Study|Other reason not defined above|29
4848364|NCT00975195|16714986|P2|Overall Study|Withdrawal by Subject|61
4848365|NCT00975195|16714987|P1|Overall Study|Withdrawal by Subject|48
4848366|NCT00975195|16714986|P2|Overall Study|Lost to Follow-up|7
4848367|NCT00975195|16714987|P1|Overall Study|Lost to Follow-up|9
4848368|NCT00975195|16714986|P2|Overall Study|Protocol Violation|23
4848369|NCT00975195|16714987|P1|Overall Study|Protocol Violation|27
4848370|NCT00975195|16714986|P2|Overall Study|Lack of Efficacy|6
4848371|NCT00975195|16714987|P1|Overall Study|Lack of Efficacy|6
4848372|NCT00975195|16714986|P2|Overall Study|Adverse Event|101
4848373|NCT00975195|16714987|P1|Overall Study|Adverse Event|108
4848374|NCT00975156|16715047|P2|Overall Study|Protocol Violation|1
4848375|NCT00975156|16715048|P1|Overall Study|Protocol Violation|0
4848376|NCT00975143|16715060|P2|Overall Study|Details not available|4
4848377|NCT00975143|16715061|P1|Overall Study|Details not available|10
4848378|NCT00975143|16715060|P2|Overall Study|Physician Decision|2
4848379|NCT00975143|16715061|P1|Overall Study|Physician Decision|1
4848380|NCT00975143|16715060|P2|Overall Study|Non-compliance|8
4848381|NCT00975143|16715061|P1|Overall Study|Non-compliance|5
4848382|NCT00975143|16715060|P2|Overall Study|Lost to Follow-up|16
4848383|NCT00975143|16715061|P1|Overall Study|Lost to Follow-up|20
4848384|NCT00975143|16715060|P2|Overall Study|Withdrawal by Subject|15
4848385|NCT00975143|16715061|P1|Overall Study|Withdrawal by Subject|15
4848386|NCT00975143|16715060|P2|Overall Study|Adverse Event|15
4848387|NCT00975143|16715061|P1|Overall Study|Adverse Event|19
4848388|NCT00975130|16715071|P3|Study Part 2|Protocol Violation|1
4848389|NCT00975130|16715072|P2|Study Part 2|Protocol Violation|0
4848390|NCT00975130|16715073|P1|Study Part 2|Protocol Violation|0
4848391|NCT00975130|16715071|P3|Study Part 2|Administrative|0
4848392|NCT00975130|16715072|P2|Study Part 2|Administrative|1
4848393|NCT00975130|16715073|P1|Study Part 2|Administrative|0
4848394|NCT00975130|16715071|P3|Study Part 2|Did Not Meet Protocol Eligibility|1
4848395|NCT00975130|16715072|P2|Study Part 2|Did Not Meet Protocol Eligibility|4
4848396|NCT00975130|16715073|P1|Study Part 2|Did Not Meet Protocol Eligibility|0
4848397|NCT00975130|16715071|P3|Study Part 2|Withdrew Consent|2
4848398|NCT00975130|16715072|P2|Study Part 2|Withdrew Consent|6
4848399|NCT00975130|16715073|P1|Study Part 2|Withdrew Consent|0
4848400|NCT00975130|16715071|P3|Study Part 2|Withdrawal by Subject|5
4848401|NCT00975130|16715072|P2|Study Part 2|Withdrawal by Subject|13
4848402|NCT00975130|16715073|P1|Study Part 2|Withdrawal by Subject|0
4848403|NCT00975130|16715071|P3|Study Part 2|Lost to Follow-up|1
4848404|NCT00975130|16715072|P2|Study Part 2|Lost to Follow-up|0
4848405|NCT00975130|16715073|P1|Study Part 2|Lost to Follow-up|0
4848406|NCT00975130|16715071|P3|Study Part 2|Adverse Event|7
4848407|NCT00975130|16715072|P2|Study Part 2|Adverse Event|14
4848408|NCT00975130|16715073|P1|Study Part 2|Adverse Event|0
4848409|NCT00975130|16715071|P3|Study Part 1|Withdrew Consent|0
4848410|NCT00975130|16715072|P2|Study Part 1|Withdrew Consent|0
4848411|NCT00975130|16715073|P1|Study Part 1|Withdrew Consent|24
4848412|NCT00975130|16715071|P3|Study Part 1|Administrative|0
4848413|NCT00975130|16715072|P2|Study Part 1|Administrative|0
4848414|NCT00975130|16715073|P1|Study Part 1|Administrative|4
4848415|NCT00975130|16715071|P3|Study Part 1|Did Not Meet Protocol Eligibility|0
4848416|NCT00975130|16715072|P2|Study Part 1|Did Not Meet Protocol Eligibility|0
4848417|NCT00975130|16715073|P1|Study Part 1|Did Not Meet Protocol Eligibility|9
4848418|NCT00975130|16715071|P3|Study Part 1|Protocol Violation|0
4848419|NCT00975130|16715072|P2|Study Part 1|Protocol Violation|0
4848420|NCT00975130|16715073|P1|Study Part 1|Protocol Violation|13
4848421|NCT00975130|16715071|P3|Study Part 1|Withdrawal by Subject|0
4848422|NCT00975130|16715072|P2|Study Part 1|Withdrawal by Subject|0
4848423|NCT00975130|16715073|P1|Study Part 1|Withdrawal by Subject|61
4848424|NCT00975130|16715071|P3|Study Part 1|Lost to Follow-up|0
4848425|NCT00975130|16715072|P2|Study Part 1|Lost to Follow-up|0
4848426|NCT00975130|16715073|P1|Study Part 1|Lost to Follow-up|19
4848427|NCT00975130|16715071|P3|Study Part 1|Adverse Event|0
4848428|NCT00975130|16715072|P2|Study Part 1|Adverse Event|0
4848429|NCT00975130|16715073|P1|Study Part 1|Adverse Event|150
4848430|NCT00975000|16715257|P2|Overall Study|Non-compliance|1
4848431|NCT00975000|16715258|P1|Overall Study|Non-compliance|0
4848432|NCT00975000|16715257|P2|Overall Study|Protocol-specified Criteria|0
4848433|NCT00975000|16715258|P1|Overall Study|Protocol-specified Criteria|1
4848434|NCT00975000|16715257|P2|Overall Study|Lost to Follow-up|1
4848435|NCT00975000|16715258|P1|Overall Study|Lost to Follow-up|0
4848436|NCT00975000|16715257|P2|Overall Study|Withdrawal by Subject|2
4848437|NCT00975000|16715258|P1|Overall Study|Withdrawal by Subject|2
4848438|NCT00975000|16715257|P2|Overall Study|Adverse Event|1
4848439|NCT00975000|16715258|P1|Overall Study|Adverse Event|1
4848440|NCT00975000|16715257|P2|Overall Study|Other|0
4848441|NCT00975000|16715258|P1|Overall Study|Other|1
4848442|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Various|0
4848443|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Various|4
4848444|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Withdrawal by Subject|2
4848445|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Withdrawal by Subject|5
4848446|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Lost to Follow-up|1
4848447|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Lost to Follow-up|0
4848448|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Lack of Efficacy|2
4848449|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Lack of Efficacy|2
4848450|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Noncompliance with study drug|1
4848451|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Noncompliance with study drug|0
4848452|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Protocol Violation|1
4848453|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Protocol Violation|1
4848454|NCT00974974|16715282|P2|Maintenance - Double Blind Treatment|Adverse Event|3
4848455|NCT00974974|16715283|P1|Maintenance - Double Blind Treatment|Adverse Event|3
4848456|NCT00974974|16715282|P2|IPX066 Dose Conversion|Protocol Violation|0
4848457|NCT00974974|16715283|P1|IPX066 Dose Conversion|Protocol Violation|4
4848458|NCT00974974|16715282|P2|IPX066 Dose Conversion|Various|0
4848459|NCT00974974|16715283|P1|IPX066 Dose Conversion|Various|3
4848460|NCT00974974|16715282|P2|IPX066 Dose Conversion|Withdrawal by Subject|0
4848461|NCT00974974|16715283|P1|IPX066 Dose Conversion|Withdrawal by Subject|12
4848462|NCT00974974|16715282|P2|IPX066 Dose Conversion|Lack of Efficacy|0
4848463|NCT00974974|16715283|P1|IPX066 Dose Conversion|Lack of Efficacy|13
4848464|NCT00974974|16715282|P2|IPX066 Dose Conversion|Death|0
4848465|NCT00974974|16715283|P1|IPX066 Dose Conversion|Death|2
4848466|NCT00974974|16715282|P2|IPX066 Dose Conversion|Adverse Event|0
4848467|NCT00974974|16715283|P1|IPX066 Dose Conversion|Adverse Event|23
4848468|NCT00974974|16715282|P2|IR CD-LD Dose Adjustment|Various|9
4848469|NCT00974974|16715283|P1|IR CD-LD Dose Adjustment|Various|0
4848470|NCT00974974|16715282|P2|IR CD-LD Dose Adjustment|Withdrawal by Subject|7
4848471|NCT00974974|16715283|P1|IR CD-LD Dose Adjustment|Withdrawal by Subject|0
4848472|NCT00974974|16715282|P2|IR CD-LD Dose Adjustment|Noncompliance with study drug|1
4848473|NCT00974974|16715283|P1|IR CD-LD Dose Adjustment|Noncompliance with study drug|0
4848474|NCT00974974|16715282|P2|IR CD-LD Dose Adjustment|Protocol Violation|1
4848475|NCT00974974|16715283|P1|IR CD-LD Dose Adjustment|Protocol Violation|0
4848476|NCT00974974|16715282|P2|IR CD-LD Dose Adjustment|Adverse Event|3
4848477|NCT00974974|16715283|P1|IR CD-LD Dose Adjustment|Adverse Event|0
4848478|NCT00974922|16715293|P1|Overall Study|study terminated|24
4848479|NCT00974675|16715311|P4|Overall Study|Participant on holiday; unable to attend|1
4848480|NCT00974675|16715312|P3|Overall Study|Participant on holiday; unable to attend|0
4848481|NCT00974675|16715313|P2|Overall Study|Participant on holiday; unable to attend|0
4848482|NCT00974675|16715314|P1|Overall Study|Participant on holiday; unable to attend|0
4848483|NCT00974675|16715311|P4|Overall Study|Physician Decision|0
4848484|NCT00974675|16715312|P3|Overall Study|Physician Decision|1
4848485|NCT00974675|16715313|P2|Overall Study|Physician Decision|0
4848486|NCT00974675|16715314|P1|Overall Study|Physician Decision|0
4848487|NCT00974675|16715311|P4|Overall Study|Adverse Event|1
4848488|NCT00974675|16715312|P3|Overall Study|Adverse Event|1
4848489|NCT00974675|16715313|P2|Overall Study|Adverse Event|1
4848490|NCT00974675|16715314|P1|Overall Study|Adverse Event|2
4848491|NCT00974571|16715363|P3|Overall Study|Other|10
4848492|NCT00974571|16715364|P2|Overall Study|Other|0
4848493|NCT00974571|16715365|P1|Overall Study|Other|4
4848494|NCT00974571|16715363|P3|Overall Study|Patient Moved|1
4848495|NCT00974571|16715364|P2|Overall Study|Patient Moved|0
4848496|NCT00974571|16715365|P1|Overall Study|Patient Moved|1
4848497|NCT00974571|16715363|P3|Overall Study|Withdrawal by Subject|16
4848498|NCT00974571|16715364|P2|Overall Study|Withdrawal by Subject|5
4848499|NCT00974571|16715365|P1|Overall Study|Withdrawal by Subject|14
4848500|NCT00974571|16715363|P3|Overall Study|Protocol Violation|18
4848501|NCT00974571|16715364|P2|Overall Study|Protocol Violation|4
4848502|NCT00974571|16715365|P1|Overall Study|Protocol Violation|13
4848503|NCT00974571|16715363|P3|Overall Study|Lost to Follow-up|2
4848504|NCT00974571|16715364|P2|Overall Study|Lost to Follow-up|1
4848505|NCT00974571|16715365|P1|Overall Study|Lost to Follow-up|2
4848506|NCT00974571|16715363|P3|Overall Study|Lack of Efficacy|9
4848507|NCT00974571|16715364|P2|Overall Study|Lack of Efficacy|2
4848508|NCT00974571|16715365|P1|Overall Study|Lack of Efficacy|3
4848509|NCT00974571|16715363|P3|Overall Study|Adverse Event|27
4848510|NCT00974571|16715364|P2|Overall Study|Adverse Event|4
4848511|NCT00974571|16715365|P1|Overall Study|Adverse Event|31
4848512|NCT00974311|16715471|P2|OLE Phase (up to 77 Months)|Withdrawal by Subject|1
4848513|NCT00974311|16715472|P1|OLE Phase (up to 77 Months)|Withdrawal by Subject|2
4848514|NCT00974311|16715471|P2|OLE Phase (up to 77 Months)|Other|2
4848515|NCT00974311|16715472|P1|OLE Phase (up to 77 Months)|Other|15
4848516|NCT00974311|16715471|P2|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26
4848517|NCT00974311|16715472|P1|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78
4848518|NCT00974311|16715471|P2|OLE Phase (up to 77 Months)|Death|21
4848519|NCT00974311|16715472|P1|OLE Phase (up to 77 Months)|Death|14
4848520|NCT00974311|16715471|P2|DB Phase (up to 24 Months)|Other|0
4848521|NCT00974311|16715472|P1|DB Phase (up to 24 Months)|Other|1
4848522|NCT00974311|16715471|P2|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42
4848523|NCT00974311|16715472|P1|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108
4848524|NCT00974311|16715471|P2|DB Phase (up to 24 Months)|Withdrawal by Subject|7
4848525|NCT00974311|16715472|P1|DB Phase (up to 24 Months)|Withdrawal by Subject|16
4848526|NCT00974311|16715471|P2|DB Phase (up to 24 Months)|Death|298
4848527|NCT00974311|16715472|P1|DB Phase (up to 24 Months)|Death|561
4848528|NCT00974311|16715471|P2|DB Phase (up to 24 Months)|Lost to Follow-up|2
4848529|NCT00974311|16715472|P1|DB Phase (up to 24 Months)|Lost to Follow-up|5
4848530|NCT00974259|16715510|P2|Overall Study|Technically inadequate PbtO2 recordings|1
4848531|NCT00974259|16715511|P1|Overall Study|Technically inadequate PbtO2 recordings|2
4848532|NCT00974233|16715529|P1|Maintenance Lenalidomide|Adverse Event|8
4848533|NCT00974233|16715529|P1|Maintenance Lenalidomide|Lack of Efficacy|5
4848534|NCT00974233|16715529|P1|Induction Chemoimmunotherapy|Withdrawal by Subject|1
4848535|NCT00974233|16715529|P1|Induction Chemoimmunotherapy|Adverse Event|7
4848536|NCT00974233|16715529|P1|Induction Chemoimmunotherapy|Lack of Efficacy|5
4848537|NCT00974233|16715529|P1|Induction Chemoimmunotherapy|Death|2
4848538|NCT00974220|16715544|P2|Treatment Period 1|noncompliant subjects|1
4848539|NCT00974220|16715545|P1|Treatment Period 1|noncompliant subjects|0
4848540|NCT00974220|16715544|P2|Treatment Period 1|Adverse Event|1
4848541|NCT00974220|16715545|P1|Treatment Period 1|Adverse Event|2
4848542|NCT00974090|16715590|P2|Period 2: Open-label Period|Withdrawal by Subject|0
4848543|NCT00974090|16715591|P1|Period 2: Open-label Period|Withdrawal by Subject|1
4848544|NCT00974090|16715590|P2|Period 2: Open-label Period|Physician Decision|3
4848545|NCT00974090|16715591|P1|Period 2: Open-label Period|Physician Decision|0
4848546|NCT00974090|16715590|P2|Period 2: Open-label Period|Lack of Efficacy|1
4848547|NCT00974090|16715591|P1|Period 2: Open-label Period|Lack of Efficacy|3
4848548|NCT00974090|16715590|P2|Period 2: Open-label Period|Adverse Event|6
4848549|NCT00974090|16715591|P1|Period 2: Open-label Period|Adverse Event|4
4848550|NCT00974090|16715590|P2|Period 1: Double Blind Period|Physician Decision|0
4848551|NCT00974090|16715591|P1|Period 1: Double Blind Period|Physician Decision|1
4848552|NCT00974090|16715590|P2|Period 1: Double Blind Period|Adverse Event|1
4848553|NCT00974090|16715591|P1|Period 1: Double Blind Period|Adverse Event|2
4848554|NCT00973973|16715627|P2|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0
4848555|NCT00973973|16715628|P1|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1
4848556|NCT00973973|16715627|P2|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0
4848557|NCT00973973|16715628|P1|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1
4848558|NCT00973973|16715627|P2|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3
4848559|NCT00973973|16715628|P1|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1
4848560|NCT00973973|16715627|P2|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0
4848561|NCT00973973|16715628|P1|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1
4848562|NCT00973973|16715627|P2|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0
4848563|NCT00973973|16715628|P1|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1
4848564|NCT00973973|16715627|P2|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2
4848565|NCT00973973|16715628|P1|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1
4848566|NCT00973973|16715627|P2|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
4848567|NCT00973973|16715628|P1|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1
4848568|NCT00973973|16715627|P2|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
4848569|NCT00973973|16715628|P1|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1
4848570|NCT00973973|16715627|P2|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0
4848571|NCT00973973|16715628|P1|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1
4848572|NCT00973973|16715627|P2|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3
4848573|NCT00973973|16715628|P1|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1
4848574|NCT00973973|16715627|P2|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0
4848575|NCT00973973|16715628|P1|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1
4848576|NCT00973973|16715627|P2|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3
4848577|NCT00973973|16715628|P1|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1
4848578|NCT00973921|16715688|P1|Overall Study|IVUS results were not available|9
4848579|NCT00973765|16715705|P2|Overall Study|Lost to Follow-up|14
4848580|NCT00973765|16715706|P1|Overall Study|Lost to Follow-up|8
4848581|NCT00973700|16715728|P5|Overall Study|Unable to Classify|1
4848582|NCT00973700|16715729|P4|Overall Study|Unable to Classify|2
4848583|NCT00973700|16715730|P3|Overall Study|Unable to Classify|1
4848584|NCT00973700|16715731|P2|Overall Study|Unable to Classify|0
4848585|NCT00973700|16715732|P1|Overall Study|Unable to Classify|0
4848586|NCT00973700|16715728|P5|Overall Study|Inappropriate enrolment|0
4848587|NCT00973700|16715729|P4|Overall Study|Inappropriate enrolment|4
4848588|NCT00973700|16715730|P3|Overall Study|Inappropriate enrolment|0
4848589|NCT00973700|16715731|P2|Overall Study|Inappropriate enrolment|0
4848590|NCT00973700|16715732|P1|Overall Study|Inappropriate enrolment|0
4848591|NCT00973700|16715728|P5|Overall Study|Lost to Follow-up|5
4848592|NCT00973700|16715729|P4|Overall Study|Lost to Follow-up|8
4848593|NCT00973700|16715730|P3|Overall Study|Lost to Follow-up|1
4848594|NCT00973700|16715731|P2|Overall Study|Lost to Follow-up|0
4848595|NCT00973700|16715732|P1|Overall Study|Lost to Follow-up|5
4848596|NCT00973700|16715728|P5|Overall Study|Withdrawal by Subject|4
4848597|NCT00973700|16715729|P4|Overall Study|Withdrawal by Subject|4
4848598|NCT00973700|16715730|P3|Overall Study|Withdrawal by Subject|8
4848599|NCT00973700|16715731|P2|Overall Study|Withdrawal by Subject|2
4848600|NCT00973700|16715732|P1|Overall Study|Withdrawal by Subject|2
4848601|NCT00973674|16715781|P2|Overall Study|Protocol Violation|0
4848602|NCT00973674|16715782|P1|Overall Study|Protocol Violation|2
4848603|NCT00973622|16715796|P2|Overall Study|did not complete rTMS sessions|2
4848604|NCT00973622|16715797|P1|Overall Study|did not complete rTMS sessions|11
4848605|NCT00973622|16715796|P2|Overall Study|did not pass MRI screen|0
4848606|NCT00973622|16715797|P1|Overall Study|did not pass MRI screen|6
4848607|NCT00973622|16715796|P2|Overall Study|did not attend MRI|3
4848608|NCT00973622|16715797|P1|Overall Study|did not attend MRI|14
4848609|NCT00973479|16715805|P2|Overall Study|Other|7
4848610|NCT00973479|16715806|P1|Overall Study|Other|1
4848611|NCT00973479|16715805|P2|Overall Study|Protocol Violation|2
4848612|NCT00973479|16715806|P1|Overall Study|Protocol Violation|2
4848613|NCT00973479|16715805|P2|Overall Study|Adverse Event|32
4848614|NCT00973479|16715806|P1|Overall Study|Adverse Event|12
4848615|NCT00973479|16715805|P2|Overall Study|Lack of Efficacy|7
4848616|NCT00973479|16715806|P1|Overall Study|Lack of Efficacy|5
4848617|NCT00973479|16715805|P2|Overall Study|Withdrawal by Subject|16
4848618|NCT00973479|16715806|P1|Overall Study|Withdrawal by Subject|15
4848619|NCT00973479|16715805|P2|Overall Study|Death|2
4848620|NCT00973479|16715806|P1|Overall Study|Death|2
4848621|NCT00973479|16715805|P2|Overall Study|Lost to Follow-up|3
4848622|NCT00973479|16715806|P1|Overall Study|Lost to Follow-up|0
4848623|NCT00973362|16715824|P2|3-Year Follow-up|Lost to Follow-up|0
4848624|NCT00973362|16715825|P1|3-Year Follow-up|Lost to Follow-up|17
4848625|NCT00973362|16715824|P2|Baseline Evaluation|Inevaluable|223
4848626|NCT00973362|16715825|P1|Baseline Evaluation|Inevaluable|686
4848627|NCT00973362|16715824|P2|Baseline Evaluation|No colposcopy visit|0
4848628|NCT00973362|16715825|P1|Baseline Evaluation|No colposcopy visit|62
4848629|NCT00973362|16715824|P2|Baseline Evaluation|W/D, later determined to be ineligible|0
4848630|NCT00973362|16715825|P1|Baseline Evaluation|W/D, later determined to be ineligible|25
4848631|NCT00973349|16715850|P16|Overall Study|Unable to classify|0
4848632|NCT00973349|16715851|P15|Overall Study|Unable to classify|0
4848633|NCT00973349|16715852|P14|Overall Study|Unable to classify|0
4848634|NCT00973349|16715853|P13|Overall Study|Unable to classify|0
4848635|NCT00973349|16715854|P12|Overall Study|Unable to classify|0
4848636|NCT00973349|16715855|P11|Overall Study|Unable to classify|0
4848637|NCT00973349|16715856|P10|Overall Study|Unable to classify|1
4848638|NCT00973349|16715857|P9|Overall Study|Unable to classify|0
4848639|NCT00973349|16715858|P8|Overall Study|Unable to classify|0
4848640|NCT00973349|16715859|P7|Overall Study|Unable to classify|0
4848641|NCT00973349|16715860|P6|Overall Study|Unable to classify|1
4848642|NCT00973349|16715861|P5|Overall Study|Unable to classify|1
4848643|NCT00973349|16715862|P4|Overall Study|Unable to classify|0
4848644|NCT00973349|16715863|P3|Overall Study|Unable to classify|0
4848645|NCT00973349|16715864|P2|Overall Study|Unable to classify|0
4848646|NCT00973349|16715865|P1|Overall Study|Unable to classify|0
4848647|NCT00973349|16715850|P16|Overall Study|Protocol Violation|0
4848648|NCT00973349|16715851|P15|Overall Study|Protocol Violation|0
4848649|NCT00973349|16715852|P14|Overall Study|Protocol Violation|0
4848650|NCT00973349|16715853|P13|Overall Study|Protocol Violation|0
4848651|NCT00973349|16715854|P12|Overall Study|Protocol Violation|0
4848652|NCT00973349|16715855|P11|Overall Study|Protocol Violation|0
4848653|NCT00973349|16715856|P10|Overall Study|Protocol Violation|0
4848654|NCT00973349|16715857|P9|Overall Study|Protocol Violation|1
4848655|NCT00973349|16715858|P8|Overall Study|Protocol Violation|0
4848656|NCT00973349|16715859|P7|Overall Study|Protocol Violation|0
4848657|NCT00973349|16715860|P6|Overall Study|Protocol Violation|0
4848658|NCT00973349|16715861|P5|Overall Study|Protocol Violation|0
4848659|NCT00973349|16715862|P4|Overall Study|Protocol Violation|0
4848660|NCT00973349|16715863|P3|Overall Study|Protocol Violation|0
4848661|NCT00973349|16715864|P2|Overall Study|Protocol Violation|0
4848662|NCT00973349|16715865|P1|Overall Study|Protocol Violation|0
4848663|NCT00973349|16715850|P16|Overall Study|Inappropriate enrolment|1
4848664|NCT00973349|16715851|P15|Overall Study|Inappropriate enrolment|1
4848665|NCT00973349|16715852|P14|Overall Study|Inappropriate enrolment|0
4848666|NCT00973349|16715853|P13|Overall Study|Inappropriate enrolment|1
4848667|NCT00973349|16715854|P12|Overall Study|Inappropriate enrolment|0
4848668|NCT00973349|16715855|P11|Overall Study|Inappropriate enrolment|0
4848669|NCT00973349|16715856|P10|Overall Study|Inappropriate enrolment|2
4848670|NCT00973349|16715857|P9|Overall Study|Inappropriate enrolment|0
4848671|NCT00973349|16715858|P8|Overall Study|Inappropriate enrolment|0
4848672|NCT00973349|16715859|P7|Overall Study|Inappropriate enrolment|0
4848673|NCT00973349|16715860|P6|Overall Study|Inappropriate enrolment|0
4848674|NCT00973349|16715861|P5|Overall Study|Inappropriate enrolment|0
4848675|NCT00973349|16715862|P4|Overall Study|Inappropriate enrolment|0
4848676|NCT00973349|16715863|P3|Overall Study|Inappropriate enrolment|1
4848677|NCT00973349|16715864|P2|Overall Study|Inappropriate enrolment|0
4848678|NCT00973349|16715865|P1|Overall Study|Inappropriate enrolment|0
4848679|NCT00973349|16715850|P16|Overall Study|Lost to Follow-up|1
4848680|NCT00973349|16715851|P15|Overall Study|Lost to Follow-up|0
4848681|NCT00973349|16715852|P14|Overall Study|Lost to Follow-up|0
4848682|NCT00973349|16715853|P13|Overall Study|Lost to Follow-up|0
4848683|NCT00973349|16715854|P12|Overall Study|Lost to Follow-up|1
4848684|NCT00973349|16715855|P11|Overall Study|Lost to Follow-up|0
4848685|NCT00973349|16715856|P10|Overall Study|Lost to Follow-up|1
4848686|NCT00973349|16715857|P9|Overall Study|Lost to Follow-up|2
4848687|NCT00973349|16715858|P8|Overall Study|Lost to Follow-up|1
4848688|NCT00973349|16715859|P7|Overall Study|Lost to Follow-up|0
4848689|NCT00973349|16715860|P6|Overall Study|Lost to Follow-up|3
4848690|NCT00973349|16715861|P5|Overall Study|Lost to Follow-up|1
4848691|NCT00973349|16715862|P4|Overall Study|Lost to Follow-up|2
4848692|NCT00973349|16715863|P3|Overall Study|Lost to Follow-up|2
4848693|NCT00973349|16715864|P2|Overall Study|Lost to Follow-up|1
4848694|NCT00973349|16715865|P1|Overall Study|Lost to Follow-up|3
4848695|NCT00973349|16715850|P16|Overall Study|Withdrawal by Subject|0
4848696|NCT00973349|16715851|P15|Overall Study|Withdrawal by Subject|0
4848697|NCT00973349|16715852|P14|Overall Study|Withdrawal by Subject|0
4848698|NCT00973349|16715853|P13|Overall Study|Withdrawal by Subject|0
4848699|NCT00973349|16715854|P12|Overall Study|Withdrawal by Subject|1
4848700|NCT00973349|16715855|P11|Overall Study|Withdrawal by Subject|0
4848701|NCT00973349|16715856|P10|Overall Study|Withdrawal by Subject|2
4848702|NCT00973349|16715857|P9|Overall Study|Withdrawal by Subject|0
4848703|NCT00973349|16715858|P8|Overall Study|Withdrawal by Subject|2
4848704|NCT00973349|16715859|P7|Overall Study|Withdrawal by Subject|2
4848705|NCT00973349|16715860|P6|Overall Study|Withdrawal by Subject|0
4848706|NCT00973349|16715861|P5|Overall Study|Withdrawal by Subject|2
4848707|NCT00973349|16715862|P4|Overall Study|Withdrawal by Subject|3
4848708|NCT00973349|16715863|P3|Overall Study|Withdrawal by Subject|2
4848709|NCT00973349|16715864|P2|Overall Study|Withdrawal by Subject|2
4848710|NCT00973349|16715865|P1|Overall Study|Withdrawal by Subject|1
4848711|NCT00973349|16715850|P16|Overall Study|Adverse Event|0
4848712|NCT00973349|16715851|P15|Overall Study|Adverse Event|1
4848713|NCT00973349|16715852|P14|Overall Study|Adverse Event|0
4848714|NCT00973349|16715853|P13|Overall Study|Adverse Event|0
4848715|NCT00973349|16715854|P12|Overall Study|Adverse Event|0
4848716|NCT00973349|16715855|P11|Overall Study|Adverse Event|0
4848717|NCT00973349|16715856|P10|Overall Study|Adverse Event|0
4848718|NCT00973349|16715857|P9|Overall Study|Adverse Event|1
4848719|NCT00973349|16715858|P8|Overall Study|Adverse Event|0
4848720|NCT00973349|16715859|P7|Overall Study|Adverse Event|0
4848721|NCT00973349|16715860|P6|Overall Study|Adverse Event|0
4848722|NCT00973349|16715861|P5|Overall Study|Adverse Event|1
4848723|NCT00973349|16715862|P4|Overall Study|Adverse Event|0
4848724|NCT00973349|16715863|P3|Overall Study|Adverse Event|0
4848725|NCT00973349|16715864|P2|Overall Study|Adverse Event|0
4848726|NCT00973349|16715865|P1|Overall Study|Adverse Event|0
4848727|NCT00973102|16715965|P2|Overall Study|Prisoner|1
4848728|NCT00973102|16715966|P1|Overall Study|Prisoner|0
4848729|NCT00973102|16715965|P2|Overall Study|Protocol Violation|0
4848730|NCT00973102|16715966|P1|Overall Study|Protocol Violation|1
4848731|NCT00972816|16715997|P8|Overall Study|Unable to classify|0
4848732|NCT00972816|16715998|P7|Overall Study|Unable to classify|0
4848733|NCT00972816|16715999|P6|Overall Study|Unable to classify|0
4848734|NCT00972816|16716000|P5|Overall Study|Unable to classify|1
4848735|NCT00972816|16716001|P4|Overall Study|Unable to classify|0
4848736|NCT00972816|16716002|P3|Overall Study|Unable to classify|0
4848737|NCT00972816|16716003|P2|Overall Study|Unable to classify|0
4848738|NCT00972816|16716004|P1|Overall Study|Unable to classify|2
4848739|NCT00972816|16715997|P8|Overall Study|Inappropriate enrolment|0
4848740|NCT00972816|16715998|P7|Overall Study|Inappropriate enrolment|2
4848741|NCT00972816|16715999|P6|Overall Study|Inappropriate enrolment|0
4848742|NCT00972816|16716000|P5|Overall Study|Inappropriate enrolment|0
4848743|NCT00972816|16716001|P4|Overall Study|Inappropriate enrolment|0
4848744|NCT00972816|16716002|P3|Overall Study|Inappropriate enrolment|0
4848745|NCT00972816|16716003|P2|Overall Study|Inappropriate enrolment|0
4848746|NCT00972816|16716004|P1|Overall Study|Inappropriate enrolment|0
4848747|NCT00972816|16715997|P8|Overall Study|Lost to Follow-up|7
4848748|NCT00972816|16715998|P7|Overall Study|Lost to Follow-up|7
4848749|NCT00972816|16715999|P6|Overall Study|Lost to Follow-up|10
4848750|NCT00972816|16716000|P5|Overall Study|Lost to Follow-up|11
4848751|NCT00972816|16716001|P4|Overall Study|Lost to Follow-up|5
4848752|NCT00972816|16716002|P3|Overall Study|Lost to Follow-up|7
4848753|NCT00972816|16716003|P2|Overall Study|Lost to Follow-up|9
4848754|NCT00972816|16716004|P1|Overall Study|Lost to Follow-up|11
4848755|NCT00972816|16715997|P8|Overall Study|Withdrawal by Subject|2
4848756|NCT00972816|16715998|P7|Overall Study|Withdrawal by Subject|1
4848757|NCT00972816|16715999|P6|Overall Study|Withdrawal by Subject|1
4848758|NCT00972816|16716000|P5|Overall Study|Withdrawal by Subject|0
4848759|NCT00972816|16716001|P4|Overall Study|Withdrawal by Subject|3
4848760|NCT00972816|16716002|P3|Overall Study|Withdrawal by Subject|1
4848761|NCT00972816|16716003|P2|Overall Study|Withdrawal by Subject|2
4848762|NCT00972816|16716004|P1|Overall Study|Withdrawal by Subject|4
4848763|NCT00972816|16715997|P8|Overall Study|Adverse Event|0
4848764|NCT00972816|16715998|P7|Overall Study|Adverse Event|0
4848765|NCT00972816|16715999|P6|Overall Study|Adverse Event|0
4848766|NCT00972816|16716000|P5|Overall Study|Adverse Event|0
4848767|NCT00972816|16716001|P4|Overall Study|Adverse Event|0
4848768|NCT00972816|16716002|P3|Overall Study|Adverse Event|1
4848769|NCT00972816|16716003|P2|Overall Study|Adverse Event|0
4848770|NCT00972816|16716004|P1|Overall Study|Adverse Event|0
4848771|NCT00972777|16716088|P2|Overall Study|Missed visit|0
4848772|NCT00972777|16716089|P1|Overall Study|Missed visit|1
4848773|NCT00972777|16716088|P2|Overall Study|Screening Failure|1
4848774|NCT00972777|16716089|P1|Overall Study|Screening Failure|2
4848775|NCT00972777|16716088|P2|Overall Study|Protocol Violation|2
4848776|NCT00972777|16716089|P1|Overall Study|Protocol Violation|0
4848777|NCT00972777|16716088|P2|Overall Study|Physician Decision|0
4848778|NCT00972777|16716089|P1|Overall Study|Physician Decision|4
4848779|NCT00972777|16716088|P2|Overall Study|Withdrawal by Subject|5
4848780|NCT00972777|16716089|P1|Overall Study|Withdrawal by Subject|4
4848781|NCT00972777|16716088|P2|Overall Study|Lost to Follow-up|4
4848782|NCT00972777|16716089|P1|Overall Study|Lost to Follow-up|0
4848783|NCT00972777|16716088|P2|Overall Study|Adverse Event|2
4848784|NCT00972777|16716089|P1|Overall Study|Adverse Event|3
4848785|NCT00972738|16716104|P3|Overall Study|Other|1
4848786|NCT00972738|16716105|P2|Overall Study|Other|2
4848787|NCT00972738|16716106|P1|Overall Study|Other|1
4848788|NCT00972738|16716104|P3|Overall Study|Moved|1
4848789|NCT00972738|16716105|P2|Overall Study|Moved|0
4848790|NCT00972738|16716106|P1|Overall Study|Moved|0
4848791|NCT00972738|16716104|P3|Overall Study|Withdrawal by Subject|4
4848792|NCT00972738|16716105|P2|Overall Study|Withdrawal by Subject|1
4848793|NCT00972738|16716106|P1|Overall Study|Withdrawal by Subject|5
4848794|NCT00972738|16716104|P3|Overall Study|Lack of Efficacy|11
4848795|NCT00972738|16716105|P2|Overall Study|Lack of Efficacy|1
4848796|NCT00972738|16716106|P1|Overall Study|Lack of Efficacy|5
4848797|NCT00972738|16716104|P3|Overall Study|Lost to Follow-up|1
4848798|NCT00972738|16716105|P2|Overall Study|Lost to Follow-up|0
4848799|NCT00972738|16716106|P1|Overall Study|Lost to Follow-up|1
4848800|NCT00972738|16716104|P3|Overall Study|Protocol Violation|3
4848801|NCT00972738|16716105|P2|Overall Study|Protocol Violation|1
4848802|NCT00972738|16716106|P1|Overall Study|Protocol Violation|2
4848803|NCT00972738|16716104|P3|Overall Study|Adverse Event|8
4848804|NCT00972738|16716105|P2|Overall Study|Adverse Event|1
4848805|NCT00972738|16716106|P1|Overall Study|Adverse Event|7
4848806|NCT00972595|16716223|P2|Period 1|Adverse Event|0
4848807|NCT00972595|16716224|P1|Period 1|Adverse Event|1
4848808|NCT00972543|16716234|P2|Overall Study|Early study termination by sponsor|1
4848809|NCT00972543|16716235|P1|Overall Study|Early study termination by sponsor|4
4848810|NCT00972543|16716234|P2|Overall Study|Adverse Event|0
4848811|NCT00972543|16716235|P1|Overall Study|Adverse Event|1
4848812|NCT00972517|16716318|P6|Overall Study|Withdrawal by Subject|0
4848813|NCT00972517|16716319|P5|Overall Study|Withdrawal by Subject|1
4848814|NCT00972517|16716320|P4|Overall Study|Withdrawal by Subject|2
4848815|NCT00972517|16716321|P3|Overall Study|Withdrawal by Subject|0
4848816|NCT00972517|16716322|P2|Overall Study|Withdrawal by Subject|1
4848817|NCT00972517|16716323|P1|Overall Study|Withdrawal by Subject|0
4848818|NCT00972517|16716318|P6|Overall Study|Adverse Event|0
4848819|NCT00972517|16716319|P5|Overall Study|Adverse Event|0
4848820|NCT00972517|16716320|P4|Overall Study|Adverse Event|1
4848821|NCT00972517|16716321|P3|Overall Study|Adverse Event|0
4848822|NCT00972517|16716322|P2|Overall Study|Adverse Event|0
4848823|NCT00972517|16716323|P1|Overall Study|Adverse Event|0
4848824|NCT00972504|16716418|P1|Overall Study|Investigator discretion|1
4848825|NCT00972504|16716418|P1|Overall Study|Adverse Event|2
4848826|NCT00972478|16716450|P2|Overall Study|Not start protocol treatment|2
4848827|NCT00972478|16716451|P1|Overall Study|Not start protocol treatment|1
4848828|NCT00972478|16716450|P2|Overall Study|Ineligible|7
4848829|NCT00972478|16716451|P1|Overall Study|Ineligible|1
4848830|NCT00972478|16716450|P2|Overall Study|Not protocol specified|1
4848831|NCT00972478|16716451|P1|Overall Study|Not protocol specified|1
4848832|NCT00972478|16716450|P2|Overall Study|Death|2
4848833|NCT00972478|16716451|P1|Overall Study|Death|0
4848834|NCT00972478|16716450|P2|Overall Study|Progression/Relapse|2
4848835|NCT00972478|16716451|P1|Overall Study|Progression/Relapse|0
4848836|NCT00972478|16716450|P2|Overall Study|Withdrawal by Subject|8
4848837|NCT00972478|16716451|P1|Overall Study|Withdrawal by Subject|1
4848838|NCT00972478|16716450|P2|Overall Study|Adverse Event|16
4848839|NCT00972478|16716451|P1|Overall Study|Adverse Event|3
4848840|NCT00972322|16716496|P2|Overall Study|Consistently high glucose values|0
4848841|NCT00972322|16716497|P1|Overall Study|Consistently high glucose values|1
4848842|NCT00972322|16716496|P2|Overall Study|Lost to Follow-up|1
4848843|NCT00972322|16716497|P1|Overall Study|Lost to Follow-up|0
4848844|NCT00972322|16716496|P2|Overall Study|Positive drug screen|1
4848845|NCT00972322|16716497|P1|Overall Study|Positive drug screen|0
4848846|NCT00972322|16716496|P2|Overall Study|Adverse Event|1
4848847|NCT00972322|16716497|P1|Overall Study|Adverse Event|2
4848848|NCT00972283|16716509|P2|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5
4848849|NCT00972283|16716510|P1|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11
4848850|NCT00972283|16716509|P2|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2
4848851|NCT00972283|16716510|P1|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6
4848852|NCT00972283|16716509|P2|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0
4848853|NCT00972283|16716510|P1|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5
4848854|NCT00972283|16716509|P2|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
4848855|NCT00972283|16716510|P1|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1
4848856|NCT00972283|16716509|P2|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0
4848857|NCT00972283|16716510|P1|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4
4848858|NCT00972283|16716509|P2|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17
4848859|NCT00972283|16716510|P1|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72
4848860|NCT00972283|16716509|P2|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2
4848861|NCT00972283|16716510|P1|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8
4848862|NCT00972283|16716509|P2|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12
4848863|NCT00972283|16716510|P1|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23
4848864|NCT00972283|16716509|P2|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0
4848865|NCT00972283|16716510|P1|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3
4848866|NCT00972283|16716509|P2|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9
4848867|NCT00972283|16716510|P1|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31
4848868|NCT00972244|16716537|P5|Overall Study|Various|2
4848869|NCT00972244|16716538|P4|Overall Study|Various|0
4848870|NCT00972244|16716539|P3|Overall Study|Various|0
4848871|NCT00972244|16716540|P2|Overall Study|Various|0
4848872|NCT00972244|16716541|P1|Overall Study|Various|0
4848873|NCT00972244|16716537|P5|Overall Study|Death|0
4848874|NCT00972244|16716538|P4|Overall Study|Death|0
4848875|NCT00972244|16716539|P3|Overall Study|Death|0
4848876|NCT00972244|16716540|P2|Overall Study|Death|0
4848877|NCT00972244|16716541|P1|Overall Study|Death|1
4848878|NCT00972244|16716537|P5|Overall Study|Safety|1
4848879|NCT00972244|16716538|P4|Overall Study|Safety|0
4848880|NCT00972244|16716539|P3|Overall Study|Safety|0
4848881|NCT00972244|16716540|P2|Overall Study|Safety|0
4848882|NCT00972244|16716541|P1|Overall Study|Safety|0
4848883|NCT00972244|16716537|P5|Overall Study|Withdrawal by Subject|1
4848884|NCT00972244|16716538|P4|Overall Study|Withdrawal by Subject|0
4848885|NCT00972244|16716539|P3|Overall Study|Withdrawal by Subject|1
4848886|NCT00972244|16716540|P2|Overall Study|Withdrawal by Subject|2
4848887|NCT00972244|16716541|P1|Overall Study|Withdrawal by Subject|1
4848888|NCT00972244|16716537|P5|Overall Study|Subject No Longer Meets Study Criteria|5
4848889|NCT00972244|16716538|P4|Overall Study|Subject No Longer Meets Study Criteria|0
4848890|NCT00972244|16716539|P3|Overall Study|Subject No Longer Meets Study Criteria|0
4848891|NCT00972244|16716540|P2|Overall Study|Subject No Longer Meets Study Criteria|2
4848892|NCT00972244|16716541|P1|Overall Study|Subject No Longer Meets Study Criteria|2
4848893|NCT00972244|16716537|P5|Overall Study|Adverse Event|0
4848894|NCT00972244|16716538|P4|Overall Study|Adverse Event|0
4848895|NCT00972244|16716539|P3|Overall Study|Adverse Event|1
4848896|NCT00972244|16716540|P2|Overall Study|Adverse Event|1
4848897|NCT00972244|16716541|P1|Overall Study|Adverse Event|0
4848898|NCT00972244|16716537|P5|Overall Study|Incorrect Enrolment|0
4848899|NCT00972244|16716538|P4|Overall Study|Incorrect Enrolment|0
4848900|NCT00972244|16716539|P3|Overall Study|Incorrect Enrolment|0
4848901|NCT00972244|16716540|P2|Overall Study|Incorrect Enrolment|0
4848902|NCT00972244|16716541|P1|Overall Study|Incorrect Enrolment|1
4848903|NCT00972153|16716573|P3|Overall Study|Equipment malfunction during case|0
4848904|NCT00972153|16716574|P2|Overall Study|Equipment malfunction during case|1
4848905|NCT00972153|16716575|P1|Overall Study|Equipment malfunction during case|0
4848906|NCT00972023|16716590|P1|Overall Study|Withdrawal by Subject|1
4848907|NCT00971997|16716597|P1|Overall Study|Physician Decision|7
4848908|NCT00971997|16716597|P1|Overall Study|Withdrawal by Subject|5
4848909|NCT00971997|16716597|P1|Overall Study|Protocol Violation|4
4848910|NCT00971997|16716597|P1|Overall Study|Death|1
4848911|NCT00971997|16716597|P1|Overall Study|Adverse Event|2
4848912|NCT00971932|16716615|P1|Overall Study|Ongoing|4
4848913|NCT00971932|16716615|P1|Overall Study|Investigator's decision|2
4848914|NCT00971932|16716615|P1|Overall Study|Withdrawal by Subject|1
4848915|NCT00971425|16716716|P2|Overall Study|Withdrawal by Subject|1
4848916|NCT00971425|16716717|P1|Overall Study|Withdrawal by Subject|0
4848917|NCT00971425|16716716|P2|Overall Study|Adverse Event|1
4848918|NCT00971425|16716717|P1|Overall Study|Adverse Event|1
4848919|NCT00971321|16716753|P2|Up to Month 11-12|Lost to Follow-up|0
4848920|NCT00971321|16716754|P1|Up to Month 11-12|Lost to Follow-up|1
4848921|NCT00971321|16716753|P2|Up to Month 11-12|Migrated/moved from study area|2
4848922|NCT00971321|16716754|P1|Up to Month 11-12|Migrated/moved from study area|2
4848923|NCT00971321|16716753|P2|Up to Month 11-12|Withdrawal by Subject|1
4848924|NCT00971321|16716754|P1|Up to Month 11-12|Withdrawal by Subject|2
4848925|NCT00971321|16716753|P2|Up to Month 7|Migrated/moved from study area|2
4848926|NCT00971321|16716754|P1|Up to Month 7|Migrated/moved from study area|3
4848927|NCT00971321|16716753|P2|Up to Month 7|Withdrawal by Subject|0
4848928|NCT00971321|16716754|P1|Up to Month 7|Withdrawal by Subject|1
4848929|NCT00971243|16716834|P5|Open-label Period|Other reason|2
4848930|NCT00971243|16716835|P4|Open-label Period|Other reason|0
4848931|NCT00971243|16716836|P3|Open-label Period|Other reason|0
4848932|NCT00971243|16716837|P2|Open-label Period|Other reason|0
4848933|NCT00971243|16716838|P1|Open-label Period|Other reason|0
4848934|NCT00971243|16716834|P5|Open-label Period|Withdrawal by Subject|1
4848935|NCT00971243|16716835|P4|Open-label Period|Withdrawal by Subject|2
4848936|NCT00971243|16716836|P3|Open-label Period|Withdrawal by Subject|0
4848937|NCT00971243|16716837|P2|Open-label Period|Withdrawal by Subject|0
4848938|NCT00971243|16716838|P1|Open-label Period|Withdrawal by Subject|1
4848939|NCT00971243|16716834|P5|Open-label Period|Protocol Violation|1
4848940|NCT00971243|16716835|P4|Open-label Period|Protocol Violation|0
4848941|NCT00971243|16716836|P3|Open-label Period|Protocol Violation|1
4848942|NCT00971243|16716837|P2|Open-label Period|Protocol Violation|1
4848943|NCT00971243|16716838|P1|Open-label Period|Protocol Violation|1
4848944|NCT00971243|16716834|P5|Open-label Period|Physician Decision|2
4848945|NCT00971243|16716835|P4|Open-label Period|Physician Decision|7
4848946|NCT00971243|16716836|P3|Open-label Period|Physician Decision|3
4848947|NCT00971243|16716837|P2|Open-label Period|Physician Decision|9
4848948|NCT00971243|16716838|P1|Open-label Period|Physician Decision|5
4848949|NCT00971243|16716834|P5|Open-label Period|Adverse Event|0
4848950|NCT00971243|16716835|P4|Open-label Period|Adverse Event|1
4848951|NCT00971243|16716836|P3|Open-label Period|Adverse Event|1
4848952|NCT00971243|16716837|P2|Open-label Period|Adverse Event|0
4848953|NCT00971243|16716838|P1|Open-label Period|Adverse Event|1
4848954|NCT00971243|16716834|P5|Double Blind Period|Other reasons|1
4848955|NCT00971243|16716835|P4|Double Blind Period|Other reasons|0
4848956|NCT00971243|16716836|P3|Double Blind Period|Other reasons|2
4848957|NCT00971243|16716837|P2|Double Blind Period|Other reasons|0
4848958|NCT00971243|16716838|P1|Double Blind Period|Other reasons|1
4848959|NCT00971243|16716834|P5|Double Blind Period|Withdrawal by Subject|4
4848960|NCT00971243|16716835|P4|Double Blind Period|Withdrawal by Subject|4
4848961|NCT00971243|16716836|P3|Double Blind Period|Withdrawal by Subject|4
4848962|NCT00971243|16716837|P2|Double Blind Period|Withdrawal by Subject|1
4848963|NCT00971243|16716838|P1|Double Blind Period|Withdrawal by Subject|4
4848964|NCT00971243|16716834|P5|Double Blind Period|Protocol Violation|2
4848965|NCT00971243|16716835|P4|Double Blind Period|Protocol Violation|2
4848966|NCT00971243|16716836|P3|Double Blind Period|Protocol Violation|3
4848967|NCT00971243|16716837|P2|Double Blind Period|Protocol Violation|0
4848968|NCT00971243|16716838|P1|Double Blind Period|Protocol Violation|2
4848969|NCT00971243|16716834|P5|Double Blind Period|Physician Decision|7
4848970|NCT00971243|16716835|P4|Double Blind Period|Physician Decision|6
4848971|NCT00971243|16716836|P3|Double Blind Period|Physician Decision|7
4848972|NCT00971243|16716837|P2|Double Blind Period|Physician Decision|6
4848973|NCT00971243|16716838|P1|Double Blind Period|Physician Decision|10
4848974|NCT00971243|16716834|P5|Double Blind Period|Lost to Follow-up|1
4848975|NCT00971243|16716835|P4|Double Blind Period|Lost to Follow-up|0
4848976|NCT00971243|16716836|P3|Double Blind Period|Lost to Follow-up|1
4848977|NCT00971243|16716837|P2|Double Blind Period|Lost to Follow-up|1
4848978|NCT00971243|16716838|P1|Double Blind Period|Lost to Follow-up|0
4848979|NCT00971243|16716834|P5|Double Blind Period|Adverse Event|3
4848980|NCT00971243|16716835|P4|Double Blind Period|Adverse Event|2
4848981|NCT00971243|16716836|P3|Double Blind Period|Adverse Event|2
4848982|NCT00971243|16716837|P2|Double Blind Period|Adverse Event|3
4848983|NCT00971243|16716838|P1|Double Blind Period|Adverse Event|2
4848984|NCT00971204|16716855|P1|Overall Study|Lost to Follow-up|10
4848985|NCT00971204|16716855|P1|Overall Study|Did not meet all criteria-not treated|14
4848986|NCT00971048|16716863|P4|Overall Study|Physician Decision|1
4848987|NCT00971048|16716864|P3|Overall Study|Physician Decision|0
4848988|NCT00971048|16716865|P2|Overall Study|Physician Decision|0
4848989|NCT00971048|16716866|P1|Overall Study|Physician Decision|0
4848990|NCT00971048|16716863|P4|Overall Study|Adverse Event|0
4848991|NCT00971048|16716864|P3|Overall Study|Adverse Event|1
4848992|NCT00971048|16716865|P2|Overall Study|Adverse Event|0
4848993|NCT00971048|16716866|P1|Overall Study|Adverse Event|0
4848994|NCT00971048|16716863|P4|Overall Study|Protocol Violation|1
4848995|NCT00971048|16716864|P3|Overall Study|Protocol Violation|0
4848996|NCT00971048|16716865|P2|Overall Study|Protocol Violation|2
4848997|NCT00971048|16716866|P1|Overall Study|Protocol Violation|1
4848998|NCT00970944|16716890|P2|Overall Study|Physician Decision|2
4848999|NCT00970944|16716891|P1|Overall Study|Physician Decision|0
4849000|NCT00970944|16716890|P2|Overall Study|Death|0
4849001|NCT00970944|16716891|P1|Overall Study|Death|1
4849002|NCT00970684|16716943|P1|Overall Study|Withdrawal by Subject|1
4849003|NCT00970684|16716943|P1|Overall Study|Adverse Event|4
4849004|NCT00970684|16716943|P1|Overall Study|Lack of Efficacy|5
4849005|NCT00970632|16716952|P3|Overall Study|Sponsor decision|1
4849006|NCT00970632|16716953|P2|Overall Study|Sponsor decision|0
4849007|NCT00970632|16716954|P1|Overall Study|Sponsor decision|1
4849008|NCT00970632|16716952|P3|Overall Study|Entry criteria not met|2
4849009|NCT00970632|16716953|P2|Overall Study|Entry criteria not met|2
4849010|NCT00970632|16716954|P1|Overall Study|Entry criteria not met|0
4849011|NCT00970632|16716952|P3|Overall Study|Withdrawal by Subject|4
4849012|NCT00970632|16716953|P2|Overall Study|Withdrawal by Subject|6
4849013|NCT00970632|16716954|P1|Overall Study|Withdrawal by Subject|7
4849014|NCT00970632|16716952|P3|Overall Study|Protocol Violation|8
4849015|NCT00970632|16716953|P2|Overall Study|Protocol Violation|5
4849016|NCT00970632|16716954|P1|Overall Study|Protocol Violation|8
4849017|NCT00970632|16716952|P3|Overall Study|Lost to Follow-up|2
4849018|NCT00970632|16716953|P2|Overall Study|Lost to Follow-up|0
4849019|NCT00970632|16716954|P1|Overall Study|Lost to Follow-up|3
4849020|NCT00970632|16716952|P3|Overall Study|Lack of Efficacy|0
4849021|NCT00970632|16716953|P2|Overall Study|Lack of Efficacy|0
4849022|NCT00970632|16716954|P1|Overall Study|Lack of Efficacy|3
4849023|NCT00970632|16716952|P3|Overall Study|Adverse Event|1
4849024|NCT00970632|16716953|P2|Overall Study|Adverse Event|2
4849025|NCT00970632|16716954|P1|Overall Study|Adverse Event|2
4849026|NCT00970502|16717019|P1|Overall Study|Withdrawal by Subject|1
4849027|NCT00970489|16717030|P2|Overall Study|Death/Withdrew/Criteria Violation|41
4849028|NCT00970489|16717031|P1|Overall Study|Death/Withdrew/Criteria Violation|54
4849029|NCT00970359|16717043|P1|Overall Study|Not Treated|4
4849030|NCT00970307|16717073|P3|Overall Study|Withdrawal by Subject|2
4849031|NCT00970307|16717074|P2|Overall Study|Withdrawal by Subject|3
4849032|NCT00970307|16717075|P1|Overall Study|Withdrawal by Subject|2
4849033|NCT00970307|16717073|P3|Overall Study|Serious Adverse Event|0
4849034|NCT00970307|16717074|P2|Overall Study|Serious Adverse Event|0
4849035|NCT00970307|16717075|P1|Overall Study|Serious Adverse Event|1
4849036|NCT00970294|16717149|P1|Overall Study|Withdrawal by Subject|1
4849037|NCT00970294|16717149|P1|Overall Study|Physician Decision|4
4849038|NCT00970281|16717157|P2|Overall Study|Physician Decision|1
4849039|NCT00970281|16717158|P1|Overall Study|Physician Decision|1
4849040|NCT00970281|16717157|P2|Overall Study|Withdrawal by Subject|1
4849041|NCT00970281|16717158|P1|Overall Study|Withdrawal by Subject|0
4849042|NCT00970281|16717157|P2|Overall Study|Lack of Efficacy|14
4849043|NCT00970281|16717158|P1|Overall Study|Lack of Efficacy|1
4849044|NCT00970268|16717176|P2|Overall Study|Inclusion/Exclusion Criteria|0
4849045|NCT00970268|16717177|P1|Overall Study|Inclusion/Exclusion Criteria|1
4849046|NCT00970268|16717176|P2|Overall Study|Lost to Follow-up|2
4849047|NCT00970268|16717177|P1|Overall Study|Lost to Follow-up|1
4849048|NCT00970268|16717176|P2|Overall Study|COPD Exacerbation|2
4849049|NCT00970268|16717177|P1|Overall Study|COPD Exacerbation|4
4849050|NCT00970268|16717176|P2|Overall Study|Other Reason|1
4849051|NCT00970268|16717177|P1|Overall Study|Other Reason|3
4849052|NCT00970268|16717176|P2|Overall Study|Protocol Violation|7
4849053|NCT00970268|16717177|P1|Overall Study|Protocol Violation|4
4849054|NCT00970268|16717176|P2|Overall Study|Lack of Efficacy|6
4849055|NCT00970268|16717177|P1|Overall Study|Lack of Efficacy|3
4849056|NCT00970268|16717176|P2|Overall Study|Adverse Event|12
4849057|NCT00970268|16717177|P1|Overall Study|Adverse Event|15
4849058|NCT00970268|16717176|P2|Overall Study|Withdrawal by Subject|19
4849059|NCT00970268|16717177|P1|Overall Study|Withdrawal by Subject|12
4849060|NCT00969761|16717253|P12|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849061|NCT00969761|16717254|P11|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849062|NCT00969761|16717255|P10|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849063|NCT00969761|16717256|P9|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
4849064|NCT00969761|16717257|P8|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849065|NCT00969761|16717258|P7|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849066|NCT00969761|16717259|P6|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849067|NCT00969761|16717260|P5|Treated in and Beyond Treat. Cycle 2|Other adverse events|1
4849068|NCT00969761|16717261|P4|Treated in and Beyond Treat. Cycle 2|Other adverse events|2
4849069|NCT00969761|16717262|P3|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849070|NCT00969761|16717263|P2|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849071|NCT00969761|16717264|P1|Treated in and Beyond Treat. Cycle 2|Other adverse events|0
4849072|NCT00969761|16717253|P12|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4849073|NCT00969761|16717254|P11|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4849074|NCT00969761|16717255|P10|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
4849075|NCT00969761|16717256|P9|Treated in and Beyond Treat. Cycle 2|Progressive disease|9
4849076|NCT00969761|16717257|P8|Treated in and Beyond Treat. Cycle 2|Progressive disease|6
4849077|NCT00969761|16717258|P7|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4849078|NCT00969761|16717259|P6|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4849079|NCT00969761|16717260|P5|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
4849080|NCT00969761|16717261|P4|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4849081|NCT00969761|16717262|P3|Treated in and Beyond Treat. Cycle 2|Progressive disease|10
4849082|NCT00969761|16717263|P2|Treated in and Beyond Treat. Cycle 2|Progressive disease|3
4849083|NCT00969761|16717264|P1|Treated in and Beyond Treat. Cycle 2|Progressive disease|2
4849084|NCT00969761|16717253|P12|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849085|NCT00969761|16717254|P11|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849086|NCT00969761|16717255|P10|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849087|NCT00969761|16717256|P9|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1
4849088|NCT00969761|16717257|P8|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849089|NCT00969761|16717258|P7|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849090|NCT00969761|16717259|P6|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849091|NCT00969761|16717260|P5|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849092|NCT00969761|16717261|P4|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849093|NCT00969761|16717262|P3|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849094|NCT00969761|16717263|P2|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849095|NCT00969761|16717264|P1|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0
4849096|NCT00969761|16717253|P12|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849097|NCT00969761|16717254|P11|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849098|NCT00969761|16717255|P10|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849099|NCT00969761|16717256|P9|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849100|NCT00969761|16717257|P8|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849101|NCT00969761|16717258|P7|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849102|NCT00969761|16717259|P6|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849103|NCT00969761|16717260|P5|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849104|NCT00969761|16717261|P4|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849105|NCT00969761|16717262|P3|Discont. Before Start of Treat. Cycle 2|Other adverse events|1
4849106|NCT00969761|16717263|P2|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849107|NCT00969761|16717264|P1|Discont. Before Start of Treat. Cycle 2|Other adverse events|0
4849108|NCT00969761|16717253|P12|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849109|NCT00969761|16717254|P11|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849110|NCT00969761|16717255|P10|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849111|NCT00969761|16717256|P9|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849112|NCT00969761|16717257|P8|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849113|NCT00969761|16717258|P7|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849114|NCT00969761|16717259|P6|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849115|NCT00969761|16717260|P5|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849116|NCT00969761|16717261|P4|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849117|NCT00969761|16717262|P3|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1
4849118|NCT00969761|16717263|P2|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849119|NCT00969761|16717264|P1|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0
4849120|NCT00969761|16717253|P12|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849121|NCT00969761|16717254|P11|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849122|NCT00969761|16717255|P10|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4849123|NCT00969761|16717256|P9|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4849124|NCT00969761|16717257|P8|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849125|NCT00969761|16717258|P7|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849126|NCT00969761|16717259|P6|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849127|NCT00969761|16717260|P5|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849128|NCT00969761|16717261|P4|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4849129|NCT00969761|16717262|P3|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849130|NCT00969761|16717263|P2|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0
4849131|NCT00969761|16717264|P1|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1
4849132|NCT00969709|16717570|P4|Overall Study|Other reasons|0
4849133|NCT00969709|16717571|P3|Overall Study|Other reasons|3
4849134|NCT00969709|16717572|P2|Overall Study|Other reasons|0
4849135|NCT00969709|16717573|P1|Overall Study|Other reasons|0
4849136|NCT00969709|16717570|P4|Overall Study|Lost to Follow-up|15
4849137|NCT00969709|16717571|P3|Overall Study|Lost to Follow-up|8
4849138|NCT00969709|16717572|P2|Overall Study|Lost to Follow-up|14
4849139|NCT00969709|16717573|P1|Overall Study|Lost to Follow-up|10
4849140|NCT00969709|16717570|P4|Overall Study|Withdrawal by Subject|23
4849141|NCT00969709|16717571|P3|Overall Study|Withdrawal by Subject|11
4849142|NCT00969709|16717572|P2|Overall Study|Withdrawal by Subject|12
4849143|NCT00969709|16717573|P1|Overall Study|Withdrawal by Subject|9
4849144|NCT00969709|16717570|P4|Overall Study|Protocol Violation|10
4849145|NCT00969709|16717571|P3|Overall Study|Protocol Violation|9
4849146|NCT00969709|16717572|P2|Overall Study|Protocol Violation|5
4849147|NCT00969709|16717573|P1|Overall Study|Protocol Violation|9
4849148|NCT00969709|16717570|P4|Overall Study|Lack of Efficacy|3
4849149|NCT00969709|16717571|P3|Overall Study|Lack of Efficacy|1
4849150|NCT00969709|16717572|P2|Overall Study|Lack of Efficacy|4
4849151|NCT00969709|16717573|P1|Overall Study|Lack of Efficacy|7
4849152|NCT00969709|16717570|P4|Overall Study|Adverse Event|12
4849153|NCT00969709|16717571|P3|Overall Study|Adverse Event|26
4849154|NCT00969709|16717572|P2|Overall Study|Adverse Event|13
4849155|NCT00969709|16717573|P1|Overall Study|Adverse Event|3
4849156|NCT00969618|16717587|P1|Overall Study|Withdrawal by Subject|27
4849157|NCT00969618|16717587|P1|Overall Study|Protocol Violation|9
4849158|NCT00969618|16717587|P1|Overall Study|Physician Decision|1
4849159|NCT00969618|16717587|P1|Overall Study|Lost to Follow-up|7
4849160|NCT00969618|16717587|P1|Overall Study|Lack of Efficacy|2
4849161|NCT00969618|16717587|P1|Overall Study|Entry Criteria Not Met|3
4849162|NCT00969618|16717587|P1|Overall Study|Adverse Event|29
4849163|NCT00969553|16717607|P9|Overall Study|Not specified above|0
4849164|NCT00969553|16717608|P8|Overall Study|Not specified above|1
4849165|NCT00969553|16717609|P7|Overall Study|Not specified above|1
4849166|NCT00969553|16717610|P6|Overall Study|Not specified above|0
4849167|NCT00969553|16717611|P5|Overall Study|Not specified above|0
4849168|NCT00969553|16717612|P4|Overall Study|Not specified above|4
4849169|NCT00969553|16717613|P3|Overall Study|Not specified above|0
4849170|NCT00969553|16717614|P2|Overall Study|Not specified above|0
4849171|NCT00969553|16717615|P1|Overall Study|Not specified above|0
4849172|NCT00969553|16717607|P9|Overall Study|Refused cont. medication|0
4849173|NCT00969553|16717608|P8|Overall Study|Refused cont. medication|1
4849174|NCT00969553|16717609|P7|Overall Study|Refused cont. medication|0
4849175|NCT00969553|16717610|P6|Overall Study|Refused cont. medication|0
4849176|NCT00969553|16717611|P5|Overall Study|Refused cont. medication|0
4849177|NCT00969553|16717612|P4|Overall Study|Refused cont. medication|2
4849178|NCT00969553|16717613|P3|Overall Study|Refused cont. medication|0
4849179|NCT00969553|16717614|P2|Overall Study|Refused cont. medication|1
4849180|NCT00969553|16717615|P1|Overall Study|Refused cont. medication|1
4849181|NCT00969553|16717607|P9|Overall Study|Other Adverse Event|0
4849182|NCT00969553|16717608|P8|Overall Study|Other Adverse Event|0
4849183|NCT00969553|16717609|P7|Overall Study|Other Adverse Event|1
4849184|NCT00969553|16717610|P6|Overall Study|Other Adverse Event|0
4849185|NCT00969553|16717611|P5|Overall Study|Other Adverse Event|0
4849186|NCT00969553|16717612|P4|Overall Study|Other Adverse Event|1
4849187|NCT00969553|16717613|P3|Overall Study|Other Adverse Event|0
4849188|NCT00969553|16717614|P2|Overall Study|Other Adverse Event|0
4849189|NCT00969553|16717615|P1|Overall Study|Other Adverse Event|0
4849190|NCT00969553|16717607|P9|Overall Study|Dose limiting Toxicity (DLT)|0
4849191|NCT00969553|16717608|P8|Overall Study|Dose limiting Toxicity (DLT)|0
4849192|NCT00969553|16717609|P7|Overall Study|Dose limiting Toxicity (DLT)|0
4849193|NCT00969553|16717610|P6|Overall Study|Dose limiting Toxicity (DLT)|0
4849194|NCT00969553|16717611|P5|Overall Study|Dose limiting Toxicity (DLT)|1
4849195|NCT00969553|16717612|P4|Overall Study|Dose limiting Toxicity (DLT)|0
4849196|NCT00969553|16717613|P3|Overall Study|Dose limiting Toxicity (DLT)|0
4849197|NCT00969553|16717614|P2|Overall Study|Dose limiting Toxicity (DLT)|0
4849198|NCT00969553|16717615|P1|Overall Study|Dose limiting Toxicity (DLT)|0
4849199|NCT00969553|16717607|P9|Overall Study|Progressive disease (PD)|3
4849200|NCT00969553|16717608|P8|Overall Study|Progressive disease (PD)|12
4849201|NCT00969553|16717609|P7|Overall Study|Progressive disease (PD)|2
4849202|NCT00969553|16717610|P6|Overall Study|Progressive disease (PD)|4
4849203|NCT00969553|16717611|P5|Overall Study|Progressive disease (PD)|2
4849204|NCT00969553|16717612|P4|Overall Study|Progressive disease (PD)|9
4849205|NCT00969553|16717613|P3|Overall Study|Progressive disease (PD)|6
4849206|NCT00969553|16717614|P2|Overall Study|Progressive disease (PD)|2
4849207|NCT00969553|16717615|P1|Overall Study|Progressive disease (PD)|2
4849208|NCT00969540|16717758|P2|Overall Study|Lost to Follow-up|1
4849209|NCT00969540|16717759|P1|Overall Study|Lost to Follow-up|1
4849210|NCT00969436|16717784|P3|Overall Study|Lost to Follow-up|5
4849211|NCT00969436|16717785|P2|Overall Study|Lost to Follow-up|8
4849212|NCT00969436|16717786|P1|Overall Study|Lost to Follow-up|8
4849213|NCT00969436|16717784|P3|Overall Study|Withdrawal by Subject|2
4849214|NCT00969436|16717785|P2|Overall Study|Withdrawal by Subject|0
4849215|NCT00969436|16717786|P1|Overall Study|Withdrawal by Subject|3
4849216|NCT00969436|16717784|P3|Overall Study|Subject eliminated (other vaccine)|0
4849217|NCT00969436|16717785|P2|Overall Study|Subject eliminated (other vaccine)|0
4849218|NCT00969436|16717786|P1|Overall Study|Subject eliminated (other vaccine)|1
4849219|NCT00969436|16717784|P3|Overall Study|Parents personal problem|1
4849220|NCT00969436|16717785|P2|Overall Study|Parents personal problem|0
4849221|NCT00969436|16717786|P1|Overall Study|Parents personal problem|0
4849222|NCT00969436|16717784|P3|Overall Study|Father - serious health problem|1
4849223|NCT00969436|16717785|P2|Overall Study|Father - serious health problem|0
4849224|NCT00969436|16717786|P1|Overall Study|Father - serious health problem|0
4849225|NCT00969436|16717784|P3|Overall Study|Migrated/moved from study area|2
4849226|NCT00969436|16717785|P2|Overall Study|Migrated/moved from study area|10
4849227|NCT00969436|16717786|P1|Overall Study|Migrated/moved from study area|12
4849228|NCT00969436|16717784|P3|Overall Study|Protocol Violation|0
4849229|NCT00969436|16717785|P2|Overall Study|Protocol Violation|3
4849230|NCT00969436|16717786|P1|Overall Study|Protocol Violation|1
4849231|NCT00969332|16717818|P1|Overall Study|Withdrawal by Subject|3
4849232|NCT00969332|16717818|P1|Overall Study|Physician Decision|8
4849233|NCT00969280|16717834|P2|Overall Study|infection of influenza A(H1N1)|1
4849234|NCT00969280|16717835|P1|Overall Study|infection of influenza A(H1N1)|0
4849235|NCT00969280|16717834|P2|Overall Study|Withdrawal by Subject|1
4849236|NCT00969280|16717835|P1|Overall Study|Withdrawal by Subject|0
4849237|NCT00969280|16717834|P2|Overall Study|Protocol Violation|1
4849238|NCT00969280|16717835|P1|Overall Study|Protocol Violation|2
4849239|NCT00969228|16717843|P2|Overall Study|Porcine circovirus detection in vaccine|14
4849240|NCT00969228|16717844|P1|Overall Study|Porcine circovirus detection in vaccine|38
4849241|NCT00969228|16717843|P2|Overall Study|Withdrawal by Subject|0
4849242|NCT00969228|16717844|P1|Overall Study|Withdrawal by Subject|4
4849243|NCT00969228|16717843|P2|Overall Study|Adverse Event|0
4849244|NCT00969228|16717844|P1|Overall Study|Adverse Event|1
4849245|NCT00969150|16717862|P2|Overall Study|Other reasons|0
4849246|NCT00969150|16717863|P1|Overall Study|Other reasons|1
4849247|NCT00969150|16717862|P2|Overall Study|Lost to Follow-up|4
4849248|NCT00969150|16717863|P1|Overall Study|Lost to Follow-up|5
4849249|NCT00969150|16717862|P2|Overall Study|Withdrawal by Subject|9
4849250|NCT00969150|16717863|P1|Overall Study|Withdrawal by Subject|13
4849251|NCT00969150|16717862|P2|Overall Study|Protocol Violation|12
4849252|NCT00969150|16717863|P1|Overall Study|Protocol Violation|9
4849253|NCT00969150|16717862|P2|Overall Study|Lack of Efficacy|1
4849254|NCT00969150|16717863|P1|Overall Study|Lack of Efficacy|1
4849255|NCT00969150|16717862|P2|Overall Study|Adverse Event|14
4849256|NCT00969150|16717863|P1|Overall Study|Adverse Event|4
4849257|NCT00969124|16717871|P1|Overall Study|Technical error|1
4849258|NCT00969124|16717871|P1|Overall Study|Previously unrecognized disease|3
4849259|NCT00969124|16717871|P1|Overall Study|Inability to reach cecum|9
4849260|NCT00969124|16717871|P1|Overall Study|Inadequate bowel preparation|15
4849261|NCT00969124|16717871|P1|Overall Study|Protocol Violation|2
4849262|NCT00968981|16717880|P3|Overall Study|Withdrawal by Subject|3
4849263|NCT00968981|16717881|P2|Overall Study|Withdrawal by Subject|3
4849264|NCT00968981|16717882|P1|Overall Study|Withdrawal by Subject|1
4849265|NCT00968981|16717880|P3|Overall Study|Physician Decision|5
4849266|NCT00968981|16717881|P2|Overall Study|Physician Decision|3
4849267|NCT00968981|16717882|P1|Overall Study|Physician Decision|5
4849268|NCT00968981|16717880|P3|Overall Study|Lost to Follow-up|1
4849269|NCT00968981|16717881|P2|Overall Study|Lost to Follow-up|0
4849270|NCT00968981|16717882|P1|Overall Study|Lost to Follow-up|0
4849271|NCT00968981|16717880|P3|Overall Study|Disease Progression|13
4849272|NCT00968981|16717881|P2|Overall Study|Disease Progression|16
4849273|NCT00968981|16717882|P1|Overall Study|Disease Progression|14
4849274|NCT00968981|16717880|P3|Overall Study|Adverse Event|0
4849275|NCT00968981|16717881|P2|Overall Study|Adverse Event|0
4849276|NCT00968981|16717882|P1|Overall Study|Adverse Event|2
4849277|NCT00968968|16717920|P2|Overall Study|Lost to Follow-up|1
4849278|NCT00968968|16717921|P1|Overall Study|Lost to Follow-up|0
4849279|NCT00968968|16717920|P2|Overall Study|Physician Decision|2
4849280|NCT00968968|16717921|P1|Overall Study|Physician Decision|1
4849281|NCT00968968|16717920|P2|Overall Study|Withdrawal by Subject|0
4849282|NCT00968968|16717921|P1|Overall Study|Withdrawal by Subject|2
4849283|NCT00968968|16717920|P2|Overall Study|Protocol defined stopping criteria|1
4849284|NCT00968968|16717921|P1|Overall Study|Protocol defined stopping criteria|3
4849285|NCT00968968|16717920|P2|Overall Study|Study closed/terminated|10
4849286|NCT00968968|16717921|P1|Overall Study|Study closed/terminated|10
4849287|NCT00968864|16717967|P1|Overall Study|Protocol exception/ not evaluable|1
4849288|NCT00968812|16717995|P3|Overall Study|Other|40
4849289|NCT00968812|16717996|P2|Overall Study|Other|37
4849290|NCT00968812|16717997|P1|Overall Study|Other|25
4849291|NCT00968812|16717995|P3|Overall Study|Unable to take rescue therapy|17
4849292|NCT00968812|16717996|P2|Overall Study|Unable to take rescue therapy|12
4849293|NCT00968812|16717997|P1|Overall Study|Unable to take rescue therapy|12
4849294|NCT00968812|16717995|P3|Overall Study|Noncompliance with study drug|6
4849295|NCT00968812|16717996|P2|Overall Study|Noncompliance with study drug|1
4849296|NCT00968812|16717997|P1|Overall Study|Noncompliance with study drug|4
4849297|NCT00968812|16717995|P3|Overall Study|Creatinine or eGFR withdrawal criteria|7
4849298|NCT00968812|16717996|P2|Overall Study|Creatinine or eGFR withdrawal criteria|13
4849299|NCT00968812|16717997|P1|Overall Study|Creatinine or eGFR withdrawal criteria|9
4849300|NCT00968812|16717995|P3|Overall Study|Withdrawal by Subject|25
4849301|NCT00968812|16717996|P2|Overall Study|Withdrawal by Subject|23
4849302|NCT00968812|16717997|P1|Overall Study|Withdrawal by Subject|17
4849303|NCT00968812|16717995|P3|Overall Study|Protocol Violation|3
4849304|NCT00968812|16717996|P2|Overall Study|Protocol Violation|4
4849305|NCT00968812|16717997|P1|Overall Study|Protocol Violation|7
4849306|NCT00968812|16717995|P3|Overall Study|Physician Decision|9
4849307|NCT00968812|16717996|P2|Overall Study|Physician Decision|5
4849308|NCT00968812|16717997|P1|Overall Study|Physician Decision|8
4849309|NCT00968812|16717995|P3|Overall Study|Lost to Follow-up|11
4849310|NCT00968812|16717996|P2|Overall Study|Lost to Follow-up|12
4849311|NCT00968812|16717997|P1|Overall Study|Lost to Follow-up|17
4849312|NCT00968812|16717995|P3|Overall Study|Lack of Efficacy|16
4849313|NCT00968812|16717996|P2|Overall Study|Lack of Efficacy|7
4849314|NCT00968812|16717997|P1|Overall Study|Lack of Efficacy|9
4849315|NCT00968812|16717995|P3|Overall Study|Death|1
4849316|NCT00968812|16717996|P2|Overall Study|Death|2
4849317|NCT00968812|16717997|P1|Overall Study|Death|2
4849318|NCT00968812|16717995|P3|Overall Study|Adverse Event|33
4849319|NCT00968812|16717996|P2|Overall Study|Adverse Event|46
4849320|NCT00968812|16717997|P1|Overall Study|Adverse Event|30
4849321|NCT00968799|16718017|P1|Overall Study|Advanced disease, HIPEC not applicable|2
4849322|NCT00968708|16718027|P2|Overall Study|Other|34
4849323|NCT00968708|16718028|P1|Overall Study|Other|26
4849324|NCT00968708|16718027|P2|Overall Study|Investigator Discretion|1
4849325|NCT00968708|16718028|P1|Overall Study|Investigator Discretion|0
4849326|NCT00968708|16718027|P2|Overall Study|Voluntary Withdrawal|101
4849327|NCT00968708|16718028|P1|Overall Study|Voluntary Withdrawal|104
4849328|NCT00968708|16718027|P2|Overall Study|Lost to Follow-up|11
4849329|NCT00968708|16718028|P1|Overall Study|Lost to Follow-up|19
4849330|NCT00968708|16718027|P2|Overall Study|Major Protocol Deviation|1
4849331|NCT00968708|16718028|P1|Overall Study|Major Protocol Deviation|0
4849332|NCT00968708|16718027|P2|Overall Study|Adverse Event|150
4849333|NCT00968708|16718028|P1|Overall Study|Adverse Event|169
4849334|NCT00968669|16718040|P4|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1
4849335|NCT00968669|16718041|P3|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
4849336|NCT00968669|16718042|P2|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
4849337|NCT00968669|16718043|P1|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0
4849338|NCT00968669|16718040|P4|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
4849339|NCT00968669|16718041|P3|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
4849340|NCT00968669|16718042|P2|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1
4849341|NCT00968669|16718043|P1|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0
4849342|NCT00968669|16718040|P4|Overall Study|SUBJECT INCARCERATED|0
4849343|NCT00968669|16718041|P3|Overall Study|SUBJECT INCARCERATED|0
4849344|NCT00968669|16718042|P2|Overall Study|SUBJECT INCARCERATED|1
4849345|NCT00968669|16718043|P1|Overall Study|SUBJECT INCARCERATED|0
4849346|NCT00968669|16718040|P4|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
4849347|NCT00968669|16718041|P3|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
4849348|NCT00968669|16718042|P2|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1
4849349|NCT00968669|16718043|P1|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0
4849350|NCT00968669|16718040|P4|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
4849351|NCT00968669|16718041|P3|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1
4849352|NCT00968669|16718042|P2|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
4849353|NCT00968669|16718043|P1|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0
4849354|NCT00968669|16718040|P4|Overall Study|SPONSOR DECISION|0
4849355|NCT00968669|16718041|P3|Overall Study|SPONSOR DECISION|0
4849356|NCT00968669|16718042|P2|Overall Study|SPONSOR DECISION|1
4849357|NCT00968669|16718043|P1|Overall Study|SPONSOR DECISION|0
4849358|NCT00968669|16718040|P4|Overall Study|PATIENT WILL BE WORKING ABROAD|0
4849359|NCT00968669|16718041|P3|Overall Study|PATIENT WILL BE WORKING ABROAD|0
4849360|NCT00968669|16718042|P2|Overall Study|PATIENT WILL BE WORKING ABROAD|1
4849361|NCT00968669|16718043|P1|Overall Study|PATIENT WILL BE WORKING ABROAD|0
4849362|NCT00968669|16718040|P4|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
4849363|NCT00968669|16718041|P3|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
4849364|NCT00968669|16718042|P2|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1
4849365|NCT00968669|16718043|P1|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0
4849366|NCT00968669|16718040|P4|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
4849367|NCT00968669|16718041|P3|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
4849368|NCT00968669|16718042|P2|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1
4849369|NCT00968669|16718043|P1|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0
4849370|NCT00968669|16718040|P4|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
4849371|NCT00968669|16718041|P3|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
4849372|NCT00968669|16718042|P2|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1
4849373|NCT00968669|16718043|P1|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0
4849374|NCT00968669|16718040|P4|Overall Study|INEGIBILITY TO PERFORM VISIT|0
4849375|NCT00968669|16718041|P3|Overall Study|INEGIBILITY TO PERFORM VISIT|0
4849376|NCT00968669|16718042|P2|Overall Study|INEGIBILITY TO PERFORM VISIT|0
4849377|NCT00968669|16718043|P1|Overall Study|INEGIBILITY TO PERFORM VISIT|1
4849378|NCT00968669|16718040|P4|Overall Study|ERROR IN HADS ADMINISTRATION|0
4849379|NCT00968669|16718041|P3|Overall Study|ERROR IN HADS ADMINISTRATION|1
4849380|NCT00968669|16718042|P2|Overall Study|ERROR IN HADS ADMINISTRATION|0
4849381|NCT00968669|16718043|P1|Overall Study|ERROR IN HADS ADMINISTRATION|0
4849382|NCT00968669|16718040|P4|Overall Study|EARLY WITHDRAWAL|0
4849383|NCT00968669|16718041|P3|Overall Study|EARLY WITHDRAWAL|0
4849384|NCT00968669|16718042|P2|Overall Study|EARLY WITHDRAWAL|1
4849385|NCT00968669|16718043|P1|Overall Study|EARLY WITHDRAWAL|0
4849386|NCT00968669|16718040|P4|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
4849387|NCT00968669|16718041|P3|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1
4849388|NCT00968669|16718042|P2|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
4849389|NCT00968669|16718043|P1|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0
4849390|NCT00968669|16718040|P4|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
4849391|NCT00968669|16718041|P3|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
4849392|NCT00968669|16718042|P2|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0
4849393|NCT00968669|16718043|P1|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1
4849394|NCT00968669|16718040|P4|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
4849395|NCT00968669|16718041|P3|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
4849396|NCT00968669|16718042|P2|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0
4849397|NCT00968669|16718043|P1|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1
4849398|NCT00968669|16718040|P4|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1
4849399|NCT00968669|16718041|P3|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
4849400|NCT00968669|16718042|P2|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
4849401|NCT00968669|16718043|P1|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0
4849402|NCT00968669|16718040|P4|Overall Study|AE|0
4849403|NCT00968669|16718041|P3|Overall Study|AE|0
4849404|NCT00968669|16718042|P2|Overall Study|AE|0
4849405|NCT00968669|16718043|P1|Overall Study|AE|1
4849406|NCT00968669|16718040|P4|Overall Study|Pregnancy|0
4849407|NCT00968669|16718041|P3|Overall Study|Pregnancy|2
4849408|NCT00968669|16718042|P2|Overall Study|Pregnancy|0
4849409|NCT00968669|16718043|P1|Overall Study|Pregnancy|0
4849410|NCT00968669|16718040|P4|Overall Study|Withdrawal by Subject|3
4849411|NCT00968669|16718041|P3|Overall Study|Withdrawal by Subject|5
4849412|NCT00968669|16718042|P2|Overall Study|Withdrawal by Subject|7
4849413|NCT00968669|16718043|P1|Overall Study|Withdrawal by Subject|9
4849414|NCT00968669|16718040|P4|Overall Study|Lost to Follow-up|4
4849415|NCT00968669|16718041|P3|Overall Study|Lost to Follow-up|1
4849416|NCT00968669|16718042|P2|Overall Study|Lost to Follow-up|2
4849417|NCT00968669|16718043|P1|Overall Study|Lost to Follow-up|5
4849418|NCT00968617|16718133|P1|Overall Study|Study terminated by sponsor|6
4849419|NCT00968539|16718147|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
4849420|NCT00968539|16718148|P1|Overall Study|Lost to follow-up (incompl. vaccination)|1
4849421|NCT00968526|16718208|P2|Overall Study|Migrated/moved from study area|0
4849422|NCT00968526|16718209|P1|Overall Study|Migrated/moved from study area|1
4849423|NCT00968526|16718208|P2|Overall Study|Adverse Event|0
4849424|NCT00968526|16718209|P1|Overall Study|Adverse Event|2
4849425|NCT00968253|16718311|P3|Overall Study|Adverse Event|1
4849426|NCT00968253|16718312|P2|Overall Study|Adverse Event|0
4849427|NCT00968253|16718313|P1|Overall Study|Adverse Event|0
4849428|NCT00968253|16718311|P3|Overall Study|Disease Progression|3
4849429|NCT00968253|16718312|P2|Overall Study|Disease Progression|3
4849430|NCT00968253|16718313|P1|Overall Study|Disease Progression|0
4849431|NCT00968253|16718311|P3|Overall Study|Withdrawal by Subject|1
4849432|NCT00968253|16718312|P2|Overall Study|Withdrawal by Subject|0
4849433|NCT00968253|16718313|P1|Overall Study|Withdrawal by Subject|0
4849434|NCT00968253|16718311|P3|Overall Study|Death|2
4849435|NCT00968253|16718312|P2|Overall Study|Death|0
4849436|NCT00968253|16718313|P1|Overall Study|Death|0
4849437|NCT00968201|16718334|P3|Extension Study - (Period III)|Study Terminated for Admin Reasons|185
4849438|NCT00968201|16718335|P2|Extension Study - (Period III)|Study Terminated for Admin Reasons|74
4849439|NCT00968201|16718336|P1|Extension Study - (Period III)|Study Terminated for Admin Reasons|0
4849440|NCT00968201|16718334|P3|Extension Study - (Period III)|Other|2
4849441|NCT00968201|16718335|P2|Extension Study - (Period III)|Other|0
4849442|NCT00968201|16718336|P1|Extension Study - (Period III)|Other|0
4849443|NCT00968201|16718334|P3|Extension Study - (Period III)|Noncompliance|3
4849444|NCT00968201|16718335|P2|Extension Study - (Period III)|Noncompliance|0
4849445|NCT00968201|16718336|P1|Extension Study - (Period III)|Noncompliance|0
4849446|NCT00968201|16718334|P3|Extension Study - (Period III)|Patient Relocated|1
4849447|NCT00968201|16718335|P2|Extension Study - (Period III)|Patient Relocated|1
4849448|NCT00968201|16718336|P1|Extension Study - (Period III)|Patient Relocated|0
4849449|NCT00968201|16718334|P3|Extension Study - (Period III)|Withdrawal by Subject|40
4849450|NCT00968201|16718335|P2|Extension Study - (Period III)|Withdrawal by Subject|20
4849451|NCT00968201|16718336|P1|Extension Study - (Period III)|Withdrawal by Subject|0
4849452|NCT00968201|16718334|P3|Extension Study - (Period III)|Protocol Violation|14
4849453|NCT00968201|16718335|P2|Extension Study - (Period III)|Protocol Violation|17
4849454|NCT00968201|16718336|P1|Extension Study - (Period III)|Protocol Violation|0
4849455|NCT00968201|16718334|P3|Extension Study - (Period III)|Lost to Follow-up|13
4849456|NCT00968201|16718335|P2|Extension Study - (Period III)|Lost to Follow-up|7
4849457|NCT00968201|16718336|P1|Extension Study - (Period III)|Lost to Follow-up|0
4849458|NCT00968201|16718334|P3|Extension Study - (Period III)|Adverse Event|22
4849459|NCT00968201|16718335|P2|Extension Study - (Period III)|Adverse Event|5
4849460|NCT00968201|16718336|P1|Extension Study - (Period III)|Adverse Event|0
4849461|NCT00968201|16718334|P3|Base Study - (Period II)|Site Error|1
4849462|NCT00968201|16718335|P2|Base Study - (Period II)|Site Error|0
4849463|NCT00968201|16718336|P1|Base Study - (Period II)|Site Error|0
4849464|NCT00968201|16718334|P3|Base Study - (Period II)|Withdrawal by Subject|8
4849465|NCT00968201|16718335|P2|Base Study - (Period II)|Withdrawal by Subject|0
4849466|NCT00968201|16718336|P1|Base Study - (Period II)|Withdrawal by Subject|4
4849467|NCT00968201|16718334|P3|Base Study - (Period II)|Protocol Violation|12
4849468|NCT00968201|16718335|P2|Base Study - (Period II)|Protocol Violation|0
4849469|NCT00968201|16718336|P1|Base Study - (Period II)|Protocol Violation|12
4849470|NCT00968201|16718334|P3|Base Study - (Period II)|Lost to Follow-up|7
4849471|NCT00968201|16718335|P2|Base Study - (Period II)|Lost to Follow-up|0
4849472|NCT00968201|16718336|P1|Base Study - (Period II)|Lost to Follow-up|2
4849473|NCT00968201|16718334|P3|Base Study - (Period II)|Lack of Efficacy|1
4849474|NCT00968201|16718335|P2|Base Study - (Period II)|Lack of Efficacy|0
4849475|NCT00968201|16718336|P1|Base Study - (Period II)|Lack of Efficacy|0
4849476|NCT00968201|16718334|P3|Base Study - (Period II)|Adverse Event|16
4849477|NCT00968201|16718335|P2|Base Study - (Period II)|Adverse Event|0
4849478|NCT00968201|16718336|P1|Base Study - (Period II)|Adverse Event|8
4849479|NCT00968149|16718397|P2|Overall Study|Withdrawal by Subject|0
4849480|NCT00968149|16718398|P1|Overall Study|Withdrawal by Subject|2
4849481|NCT00968149|16718397|P2|Overall Study|Protocol Violation|0
4849482|NCT00968149|16718398|P1|Overall Study|Protocol Violation|4
4849483|NCT00968149|16718397|P2|Overall Study|Lost to Follow-up|1
4849484|NCT00968149|16718398|P1|Overall Study|Lost to Follow-up|0
4849485|NCT00968149|16718397|P2|Overall Study|Lack of Efficacy|4
4849486|NCT00968149|16718398|P1|Overall Study|Lack of Efficacy|0
4849487|NCT00968149|16718397|P2|Overall Study|Adverse Event|1
4849488|NCT00968149|16718398|P1|Overall Study|Adverse Event|5
4849489|NCT00967798|16718466|P2|Overall Study|Lost to Follow-up|1
4849490|NCT00967798|16718467|P1|Overall Study|Lost to Follow-up|4
4849491|NCT00967798|16718466|P2|Overall Study|Withdrawal by Subject|2
4849492|NCT00967798|16718467|P1|Overall Study|Withdrawal by Subject|5
4849493|NCT00967694|16718481|P1|Overall Study|Withdrawal by Subject|6
4849494|NCT00967668|16718488|P3|Overall Study|Pregnancy|0
4849495|NCT00967668|16718489|P2|Overall Study|Pregnancy|0
4849496|NCT00967668|16718490|P1|Overall Study|Pregnancy|1
4849497|NCT00967668|16718488|P3|Overall Study|Refused 12-mo assessment|9
4849498|NCT00967668|16718489|P2|Overall Study|Refused 12-mo assessment|1
4849499|NCT00967668|16718490|P1|Overall Study|Refused 12-mo assessment|3
4849500|NCT00967668|16718488|P3|Overall Study|Lost to Follow-up|16
4849501|NCT00967668|16718489|P2|Overall Study|Lost to Follow-up|9
4849502|NCT00967668|16718490|P1|Overall Study|Lost to Follow-up|15
4849503|NCT00967668|16718488|P3|Overall Study|Lost to follow-up at 12-mo|26
4849504|NCT00967668|16718489|P2|Overall Study|Lost to follow-up at 12-mo|29
4849505|NCT00967668|16718490|P1|Overall Study|Lost to follow-up at 12-mo|27
4849506|NCT00967668|16718488|P3|Overall Study|Refused Year 2|4
4849507|NCT00967668|16718489|P2|Overall Study|Refused Year 2|6
4849508|NCT00967668|16718490|P1|Overall Study|Refused Year 2|11
4849509|NCT00967668|16718488|P3|Overall Study|Removed due to behavior|2
4849510|NCT00967668|16718489|P2|Overall Study|Removed due to behavior|1
4849511|NCT00967668|16718490|P1|Overall Study|Removed due to behavior|1
4849512|NCT00967668|16718488|P3|Overall Study|Death|4
4849513|NCT00967668|16718489|P2|Overall Study|Death|2
4849514|NCT00967668|16718490|P1|Overall Study|Death|0
4849515|NCT00967668|16718488|P3|Overall Study|Withdrawal by Subject|8
4849516|NCT00967668|16718489|P2|Overall Study|Withdrawal by Subject|8
4849517|NCT00967668|16718490|P1|Overall Study|Withdrawal by Subject|13
4849518|NCT00967616|16718503|P2|Overall Study|Protocol Violation|0
4849519|NCT00967616|16718504|P1|Overall Study|Protocol Violation|1
4849520|NCT00967616|16718503|P2|Overall Study|Other|8
4849521|NCT00967616|16718504|P1|Overall Study|Other|8
4849522|NCT00967616|16718503|P2|Overall Study|Progressive Disease|18
4849523|NCT00967616|16718504|P1|Overall Study|Progressive Disease|31
4849524|NCT00967616|16718503|P2|Overall Study|Withdrawal by Subject|4
4849525|NCT00967616|16718504|P1|Overall Study|Withdrawal by Subject|8
4849526|NCT00967616|16718503|P2|Overall Study|Death|3
4849527|NCT00967616|16718504|P1|Overall Study|Death|0
4849528|NCT00967616|16718503|P2|Overall Study|Adverse Event or Serious Adverse Event|17
4849529|NCT00967616|16718504|P1|Overall Study|Adverse Event or Serious Adverse Event|2
4849530|NCT00967330|16718572|P2|Overall Study|Severe protocol deviation|1
4849531|NCT00967330|16718573|P1|Overall Study|Severe protocol deviation|0
4849532|NCT00967330|16718572|P2|Overall Study|Death|51
4849533|NCT00967330|16718573|P1|Overall Study|Death|102
4849534|NCT00967330|16718572|P2|Overall Study|Lost to Follow-up|1
4849535|NCT00967330|16718573|P1|Overall Study|Lost to Follow-up|1
4849536|NCT00967330|16718572|P2|Overall Study|Withdrawal by Subject|0
4849537|NCT00967330|16718573|P1|Overall Study|Withdrawal by Subject|6
4849538|NCT00967330|16718572|P2|Overall Study|Regular|3
4849539|NCT00967330|16718573|P1|Overall Study|Regular|10
4849540|NCT00967330|16718572|P2|Overall Study|Protocol Violation|4
4849541|NCT00967330|16718573|P1|Overall Study|Protocol Violation|3
4849542|NCT00967226|16718603|P2|Overall Study|Physician Decision|1
4849543|NCT00967226|16718604|P1|Overall Study|Physician Decision|0
4849544|NCT00967226|16718603|P2|Overall Study|Protocol Violation|0
4849545|NCT00967226|16718604|P1|Overall Study|Protocol Violation|2
4849546|NCT00967226|16718603|P2|Overall Study|Adverse Event|5
4849547|NCT00967226|16718604|P1|Overall Study|Adverse Event|0
4849548|NCT00967018|16718638|P1|Overall Study|Miscellaneous Reasons|9
4849549|NCT00967018|16718638|P1|Overall Study|Withdrawal by Subject|1
4849550|NCT00967018|16718638|P1|Overall Study|Lost to Follow-up|2
4849551|NCT00967018|16718638|P1|Overall Study|Physician Decision|7
4849552|NCT00967018|16718638|P1|Overall Study|Adverse Event|2
4849553|NCT00967005|16718647|P2|Overall Study|Lost to Follow-up|10
4849554|NCT00967005|16718648|P1|Overall Study|Lost to Follow-up|7
4849555|NCT00966940|16718734|P2|Period 1, First 6 Weeks|Protocol Violation|0
4849556|NCT00966940|16718735|P1|Period 1, First 6 Weeks|Protocol Violation|1
4849557|NCT00966940|16718734|P2|Period 1, First 6 Weeks|Withdrawal by Subject|0
4849558|NCT00966940|16718735|P1|Period 1, First 6 Weeks|Withdrawal by Subject|2
4849559|NCT00966875|16718762|P9|Part B|Entry Criteria|1
4849560|NCT00966875|16718763|P8|Part B|Entry Criteria|0
4849561|NCT00966875|16718764|P7|Part B|Entry Criteria|1
4849562|NCT00966875|16718765|P6|Part B|Entry Criteria|0
4849563|NCT00966875|16718766|P5|Part B|Entry Criteria|0
4849564|NCT00966875|16718767|P4|Part B|Entry Criteria|0
4849565|NCT00966875|16718768|P3|Part B|Entry Criteria|0
4849566|NCT00966875|16718769|P2|Part B|Entry Criteria|0
4849567|NCT00966875|16718770|P1|Part B|Entry Criteria|0
4849568|NCT00966875|16718762|P9|Part B|Withdrawal by Subject|5
4849569|NCT00966875|16718763|P8|Part B|Withdrawal by Subject|5
4849570|NCT00966875|16718764|P7|Part B|Withdrawal by Subject|4
4849571|NCT00966875|16718765|P6|Part B|Withdrawal by Subject|1
4849572|NCT00966875|16718766|P5|Part B|Withdrawal by Subject|2
4849573|NCT00966875|16718767|P4|Part B|Withdrawal by Subject|1
4849574|NCT00966875|16718768|P3|Part B|Withdrawal by Subject|2
4849575|NCT00966875|16718769|P2|Part B|Withdrawal by Subject|1
4849576|NCT00966875|16718770|P1|Part B|Withdrawal by Subject|2
4849577|NCT00966875|16718762|P9|Part B|Sponsor Decision|1
4849578|NCT00966875|16718763|P8|Part B|Sponsor Decision|2
4849579|NCT00966875|16718764|P7|Part B|Sponsor Decision|0
4849580|NCT00966875|16718765|P6|Part B|Sponsor Decision|1
4849581|NCT00966875|16718766|P5|Part B|Sponsor Decision|0
4849582|NCT00966875|16718767|P4|Part B|Sponsor Decision|0
4849583|NCT00966875|16718768|P3|Part B|Sponsor Decision|0
4849584|NCT00966875|16718769|P2|Part B|Sponsor Decision|0
4849585|NCT00966875|16718770|P1|Part B|Sponsor Decision|1
4849586|NCT00966875|16718762|P9|Part B|Physician Decision|2
4849587|NCT00966875|16718763|P8|Part B|Physician Decision|0
4849588|NCT00966875|16718764|P7|Part B|Physician Decision|0
4849589|NCT00966875|16718765|P6|Part B|Physician Decision|1
4849590|NCT00966875|16718766|P5|Part B|Physician Decision|2
4849591|NCT00966875|16718767|P4|Part B|Physician Decision|0
4849592|NCT00966875|16718768|P3|Part B|Physician Decision|1
4849593|NCT00966875|16718769|P2|Part B|Physician Decision|0
4849594|NCT00966875|16718770|P1|Part B|Physician Decision|0
4849595|NCT00966875|16718762|P9|Part B|Lost to Follow-up|1
4849596|NCT00966875|16718763|P8|Part B|Lost to Follow-up|0
4849597|NCT00966875|16718764|P7|Part B|Lost to Follow-up|0
4849598|NCT00966875|16718765|P6|Part B|Lost to Follow-up|0
4849599|NCT00966875|16718766|P5|Part B|Lost to Follow-up|0
4849600|NCT00966875|16718767|P4|Part B|Lost to Follow-up|1
4849601|NCT00966875|16718768|P3|Part B|Lost to Follow-up|0
4849602|NCT00966875|16718769|P2|Part B|Lost to Follow-up|0
4849603|NCT00966875|16718770|P1|Part B|Lost to Follow-up|0
4849604|NCT00966875|16718762|P9|Part B|Lack of Efficacy|6
4849605|NCT00966875|16718763|P8|Part B|Lack of Efficacy|9
4849606|NCT00966875|16718764|P7|Part B|Lack of Efficacy|12
4849607|NCT00966875|16718765|P6|Part B|Lack of Efficacy|3
4849608|NCT00966875|16718766|P5|Part B|Lack of Efficacy|2
4849609|NCT00966875|16718767|P4|Part B|Lack of Efficacy|1
4849610|NCT00966875|16718768|P3|Part B|Lack of Efficacy|1
4849611|NCT00966875|16718769|P2|Part B|Lack of Efficacy|1
4849612|NCT00966875|16718770|P1|Part B|Lack of Efficacy|2
4849613|NCT00966875|16718762|P9|Part B|Death|0
4849614|NCT00966875|16718763|P8|Part B|Death|1
4849615|NCT00966875|16718764|P7|Part B|Death|0
4849616|NCT00966875|16718765|P6|Part B|Death|0
4849617|NCT00966875|16718766|P5|Part B|Death|0
4849618|NCT00966875|16718767|P4|Part B|Death|0
4849619|NCT00966875|16718768|P3|Part B|Death|1
4849620|NCT00966875|16718769|P2|Part B|Death|0
4849621|NCT00966875|16718770|P1|Part B|Death|0
4849622|NCT00966875|16718762|P9|Part B|Adverse Event|2
4849623|NCT00966875|16718763|P8|Part B|Adverse Event|2
4849624|NCT00966875|16718764|P7|Part B|Adverse Event|5
4849625|NCT00966875|16718765|P6|Part B|Adverse Event|0
4849626|NCT00966875|16718766|P5|Part B|Adverse Event|1
4849627|NCT00966875|16718767|P4|Part B|Adverse Event|0
4849628|NCT00966875|16718768|P3|Part B|Adverse Event|1
4849629|NCT00966875|16718769|P2|Part B|Adverse Event|1
4849630|NCT00966875|16718770|P1|Part B|Adverse Event|0
4849631|NCT00966875|16718762|P9|Part A|Protocol Violation|1
4849632|NCT00966875|16718763|P8|Part A|Protocol Violation|1
4849633|NCT00966875|16718764|P7|Part A|Protocol Violation|2
4849634|NCT00966875|16718765|P6|Part A|Protocol Violation|0
4849635|NCT00966875|16718766|P5|Part A|Protocol Violation|0
4849636|NCT00966875|16718767|P4|Part A|Protocol Violation|0
4849637|NCT00966875|16718768|P3|Part A|Protocol Violation|0
4849638|NCT00966875|16718769|P2|Part A|Protocol Violation|0
4849639|NCT00966875|16718770|P1|Part A|Protocol Violation|0
4849640|NCT00966875|16718762|P9|Part A|Withdrawal by Subject|1
4849641|NCT00966875|16718763|P8|Part A|Withdrawal by Subject|1
4849642|NCT00966875|16718764|P7|Part A|Withdrawal by Subject|5
4849643|NCT00966875|16718765|P6|Part A|Withdrawal by Subject|0
4849644|NCT00966875|16718766|P5|Part A|Withdrawal by Subject|3
4849645|NCT00966875|16718767|P4|Part A|Withdrawal by Subject|1
4849646|NCT00966875|16718768|P3|Part A|Withdrawal by Subject|1
4849647|NCT00966875|16718769|P2|Part A|Withdrawal by Subject|2
4849648|NCT00966875|16718770|P1|Part A|Withdrawal by Subject|2
4849649|NCT00966875|16718762|P9|Part A|Sponsor Decision|1
4849650|NCT00966875|16718763|P8|Part A|Sponsor Decision|2
4849651|NCT00966875|16718764|P7|Part A|Sponsor Decision|0
4849652|NCT00966875|16718765|P6|Part A|Sponsor Decision|0
4849653|NCT00966875|16718766|P5|Part A|Sponsor Decision|1
4849654|NCT00966875|16718767|P4|Part A|Sponsor Decision|0
4849655|NCT00966875|16718768|P3|Part A|Sponsor Decision|1
4849656|NCT00966875|16718769|P2|Part A|Sponsor Decision|0
4849657|NCT00966875|16718770|P1|Part A|Sponsor Decision|0
4849658|NCT00966875|16718762|P9|Part A|Physician Decision|2
4849659|NCT00966875|16718763|P8|Part A|Physician Decision|0
4849660|NCT00966875|16718764|P7|Part A|Physician Decision|1
4849661|NCT00966875|16718765|P6|Part A|Physician Decision|0
4849662|NCT00966875|16718766|P5|Part A|Physician Decision|1
4849663|NCT00966875|16718767|P4|Part A|Physician Decision|0
4849664|NCT00966875|16718768|P3|Part A|Physician Decision|0
4849665|NCT00966875|16718769|P2|Part A|Physician Decision|0
4849666|NCT00966875|16718770|P1|Part A|Physician Decision|0
4849667|NCT00966875|16718762|P9|Part A|Parent/Caregiver Decision|0
4849668|NCT00966875|16718763|P8|Part A|Parent/Caregiver Decision|0
4849669|NCT00966875|16718764|P7|Part A|Parent/Caregiver Decision|0
4849670|NCT00966875|16718765|P6|Part A|Parent/Caregiver Decision|0
4849671|NCT00966875|16718766|P5|Part A|Parent/Caregiver Decision|0
4849672|NCT00966875|16718767|P4|Part A|Parent/Caregiver Decision|1
4849673|NCT00966875|16718768|P3|Part A|Parent/Caregiver Decision|0
4849674|NCT00966875|16718769|P2|Part A|Parent/Caregiver Decision|0
4849675|NCT00966875|16718770|P1|Part A|Parent/Caregiver Decision|0
4849676|NCT00966875|16718762|P9|Part A|Lost to Follow-up|0
4849677|NCT00966875|16718763|P8|Part A|Lost to Follow-up|0
4849678|NCT00966875|16718764|P7|Part A|Lost to Follow-up|0
4849679|NCT00966875|16718765|P6|Part A|Lost to Follow-up|1
4849680|NCT00966875|16718766|P5|Part A|Lost to Follow-up|0
4849681|NCT00966875|16718767|P4|Part A|Lost to Follow-up|0
4849682|NCT00966875|16718768|P3|Part A|Lost to Follow-up|0
4849683|NCT00966875|16718769|P2|Part A|Lost to Follow-up|0
4849684|NCT00966875|16718770|P1|Part A|Lost to Follow-up|2
4849685|NCT00966875|16718762|P9|Part A|Lack of Efficacy|0
4849686|NCT00966875|16718763|P8|Part A|Lack of Efficacy|0
4849687|NCT00966875|16718764|P7|Part A|Lack of Efficacy|4
4849688|NCT00966875|16718765|P6|Part A|Lack of Efficacy|0
4849689|NCT00966875|16718766|P5|Part A|Lack of Efficacy|0
4849690|NCT00966875|16718767|P4|Part A|Lack of Efficacy|0
4849691|NCT00966875|16718768|P3|Part A|Lack of Efficacy|0
4849692|NCT00966875|16718769|P2|Part A|Lack of Efficacy|1
4849693|NCT00966875|16718770|P1|Part A|Lack of Efficacy|0
4849694|NCT00966875|16718762|P9|Part A|Entry Criteria|0
4849695|NCT00966875|16718763|P8|Part A|Entry Criteria|0
4849696|NCT00966875|16718764|P7|Part A|Entry Criteria|0
4849697|NCT00966875|16718765|P6|Part A|Entry Criteria|2
4849698|NCT00966875|16718766|P5|Part A|Entry Criteria|0
4849699|NCT00966875|16718767|P4|Part A|Entry Criteria|0
4849700|NCT00966875|16718768|P3|Part A|Entry Criteria|0
4849701|NCT00966875|16718769|P2|Part A|Entry Criteria|0
4849702|NCT00966875|16718770|P1|Part A|Entry Criteria|0
4849703|NCT00966875|16718762|P9|Part A|Adverse Event|3
4849704|NCT00966875|16718763|P8|Part A|Adverse Event|3
4849705|NCT00966875|16718764|P7|Part A|Adverse Event|0
4849706|NCT00966875|16718765|P6|Part A|Adverse Event|1
4849707|NCT00966875|16718766|P5|Part A|Adverse Event|0
4849708|NCT00966875|16718767|P4|Part A|Adverse Event|1
4849709|NCT00966875|16718768|P3|Part A|Adverse Event|0
4849710|NCT00966875|16718769|P2|Part A|Adverse Event|1
4849711|NCT00966875|16718770|P1|Part A|Adverse Event|2
4849712|NCT00966719|16719121|P2|Overall Study|Lost to Follow-up|11
4849713|NCT00966719|16719122|P1|Overall Study|Lost to Follow-up|6
4849714|NCT00966654|16719142|P1|Overall Study|Study was terminated,PI left institution|12
4849715|NCT00966355|16719216|P3|Overall Study|Lost to Follow-up|3
4849716|NCT00966355|16719217|P2|Overall Study|Lost to Follow-up|4
4849717|NCT00966355|16719218|P1|Overall Study|Lost to Follow-up|5
4849718|NCT00966355|16719216|P3|Overall Study|newly diagnosed advanced HCC|10
4849719|NCT00966355|16719217|P2|Overall Study|newly diagnosed advanced HCC|12
4849720|NCT00966355|16719218|P1|Overall Study|newly diagnosed advanced HCC|11
4849721|NCT00966355|16719216|P3|Overall Study|non-variceal bleeding on endoscopy|71
4849722|NCT00966355|16719217|P2|Overall Study|non-variceal bleeding on endoscopy|70
4849723|NCT00966355|16719218|P1|Overall Study|non-variceal bleeding on endoscopy|68
4849724|NCT00966277|16719231|P2|Overall Study|Treatment Plan Changed|1
4849725|NCT00966277|16719232|P1|Overall Study|Treatment Plan Changed|0
4849726|NCT00966277|16719231|P2|Overall Study|Ineligible|3
4849727|NCT00966277|16719232|P1|Overall Study|Ineligible|1
4849728|NCT00966277|16719231|P2|Overall Study|Withdrawal by Subject|0
4849729|NCT00966277|16719232|P1|Overall Study|Withdrawal by Subject|3
4849730|NCT00966264|16719240|P2|Overall Study|Lost to Follow-up|3
4849731|NCT00966264|16719241|P1|Overall Study|Lost to Follow-up|4
4849732|NCT00965848|16719287|P3|Overall Study|Other|1
4849733|NCT00965848|16719288|P2|Overall Study|Other|0
4849734|NCT00965848|16719289|P1|Overall Study|Other|5
4849735|NCT00965848|16719287|P3|Overall Study|Not Clinically Evaluable|1
4849736|NCT00965848|16719288|P2|Overall Study|Not Clinically Evaluable|1
4849737|NCT00965848|16719289|P1|Overall Study|Not Clinically Evaluable|7
4849738|NCT00965848|16719287|P3|Overall Study|Indeterminate Clinical Outcome|1
4849739|NCT00965848|16719288|P2|Overall Study|Indeterminate Clinical Outcome|0
4849740|NCT00965848|16719289|P1|Overall Study|Indeterminate Clinical Outcome|2
4849741|NCT00965848|16719287|P3|Overall Study|Withdrawal by Subject|0
4849742|NCT00965848|16719288|P2|Overall Study|Withdrawal by Subject|0
4849743|NCT00965848|16719289|P1|Overall Study|Withdrawal by Subject|1
4849744|NCT00965848|16719287|P3|Overall Study|Lost to Follow-up|1
4849745|NCT00965848|16719288|P2|Overall Study|Lost to Follow-up|0
4849746|NCT00965848|16719289|P1|Overall Study|Lost to Follow-up|0
4849747|NCT00965848|16719287|P3|Overall Study|Death|5
4849748|NCT00965848|16719288|P2|Overall Study|Death|1
4849749|NCT00965848|16719289|P1|Overall Study|Death|11
4849750|NCT00965848|16719287|P3|Overall Study|Protocol Violation|1
4849751|NCT00965848|16719288|P2|Overall Study|Protocol Violation|0
4849752|NCT00965848|16719289|P1|Overall Study|Protocol Violation|3
4849753|NCT00965757|16719308|P4|Extension Phase|Other|1
4849754|NCT00965757|16719309|P3|Extension Phase|Other|2
4849755|NCT00965757|16719310|P2|Extension Phase|Other|0
4849756|NCT00965757|16719311|P1|Extension Phase|Other|0
4849757|NCT00965757|16719308|P4|Extension Phase|Protocol Violation|1
4849758|NCT00965757|16719309|P3|Extension Phase|Protocol Violation|0
4849759|NCT00965757|16719310|P2|Extension Phase|Protocol Violation|0
4849760|NCT00965757|16719311|P1|Extension Phase|Protocol Violation|0
4849761|NCT00965757|16719308|P4|Extension Phase|Ineligible after Taking Study Drug|3
4849762|NCT00965757|16719309|P3|Extension Phase|Ineligible after Taking Study Drug|3
4849763|NCT00965757|16719310|P2|Extension Phase|Ineligible after Taking Study Drug|0
4849764|NCT00965757|16719311|P1|Extension Phase|Ineligible after Taking Study Drug|0
4849765|NCT00965757|16719308|P4|Extension Phase|Lost to Follow-up|1
4849766|NCT00965757|16719309|P3|Extension Phase|Lost to Follow-up|0
4849767|NCT00965757|16719310|P2|Extension Phase|Lost to Follow-up|0
4849768|NCT00965757|16719311|P1|Extension Phase|Lost to Follow-up|0
4849769|NCT00965757|16719308|P4|Extension Phase|Drug Refusal Due to Adverse Event|0
4849770|NCT00965757|16719309|P3|Extension Phase|Drug Refusal Due to Adverse Event|4
4849771|NCT00965757|16719310|P2|Extension Phase|Drug Refusal Due to Adverse Event|0
4849772|NCT00965757|16719311|P1|Extension Phase|Drug Refusal Due to Adverse Event|0
4849773|NCT00965757|16719308|P4|Extension Phase|Lack of Efficacy|12
4849774|NCT00965757|16719309|P3|Extension Phase|Lack of Efficacy|8
4849775|NCT00965757|16719310|P2|Extension Phase|Lack of Efficacy|0
4849776|NCT00965757|16719311|P1|Extension Phase|Lack of Efficacy|0
4849777|NCT00965757|16719308|P4|Extension Phase|Abnormal Laboratory Value|1
4849778|NCT00965757|16719309|P3|Extension Phase|Abnormal Laboratory Value|6
4849779|NCT00965757|16719310|P2|Extension Phase|Abnormal Laboratory Value|0
4849780|NCT00965757|16719311|P1|Extension Phase|Abnormal Laboratory Value|0
4849781|NCT00965757|16719308|P4|Extension Phase|Adverse drug reaction|3
4849782|NCT00965757|16719309|P3|Extension Phase|Adverse drug reaction|6
4849783|NCT00965757|16719310|P2|Extension Phase|Adverse drug reaction|0
4849784|NCT00965757|16719311|P1|Extension Phase|Adverse drug reaction|0
4849785|NCT00965757|16719308|P4|Extension Phase|Progression of concomitant disease|2
4849786|NCT00965757|16719309|P3|Extension Phase|Progression of concomitant disease|4
4849787|NCT00965757|16719310|P2|Extension Phase|Progression of concomitant disease|0
4849788|NCT00965757|16719311|P1|Extension Phase|Progression of concomitant disease|0
4849789|NCT00965757|16719308|P4|Double-blind Phase|Other|0
4849790|NCT00965757|16719309|P3|Double-blind Phase|Other|0
4849791|NCT00965757|16719310|P2|Double-blind Phase|Other|0
4849792|NCT00965757|16719311|P1|Double-blind Phase|Other|1
4849793|NCT00965757|16719308|P4|Double-blind Phase|Ineligible after Taking Study Drug|0
4849794|NCT00965757|16719309|P3|Double-blind Phase|Ineligible after Taking Study Drug|0
4849795|NCT00965757|16719310|P2|Double-blind Phase|Ineligible after Taking Study Drug|3
4849796|NCT00965757|16719311|P1|Double-blind Phase|Ineligible after Taking Study Drug|2
4849797|NCT00965757|16719308|P4|Double-blind Phase|Lost to Follow-up|0
4849798|NCT00965757|16719309|P3|Double-blind Phase|Lost to Follow-up|0
4849799|NCT00965757|16719310|P2|Double-blind Phase|Lost to Follow-up|1
4849800|NCT00965757|16719311|P1|Double-blind Phase|Lost to Follow-up|0
4849801|NCT00965757|16719308|P4|Double-blind Phase|Drug Refusal Due to Adverse Event|0
4849802|NCT00965757|16719309|P3|Double-blind Phase|Drug Refusal Due to Adverse Event|0
4849803|NCT00965757|16719310|P2|Double-blind Phase|Drug Refusal Due to Adverse Event|0
4849804|NCT00965757|16719311|P1|Double-blind Phase|Drug Refusal Due to Adverse Event|2
4849805|NCT00965757|16719308|P4|Double-blind Phase|Lack of Efficacy|0
4849806|NCT00965757|16719309|P3|Double-blind Phase|Lack of Efficacy|0
4849807|NCT00965757|16719310|P2|Double-blind Phase|Lack of Efficacy|11
4849808|NCT00965757|16719311|P1|Double-blind Phase|Lack of Efficacy|7
4849809|NCT00965757|16719308|P4|Double-blind Phase|Abnormal Laboratory Value|0
4849810|NCT00965757|16719309|P3|Double-blind Phase|Abnormal Laboratory Value|0
4849811|NCT00965757|16719310|P2|Double-blind Phase|Abnormal Laboratory Value|0
4849812|NCT00965757|16719311|P1|Double-blind Phase|Abnormal Laboratory Value|2
4849813|NCT00965757|16719308|P4|Double-blind Phase|Adverse drug reaction|0
4849814|NCT00965757|16719309|P3|Double-blind Phase|Adverse drug reaction|0
4849815|NCT00965757|16719310|P2|Double-blind Phase|Adverse drug reaction|1
4849816|NCT00965757|16719311|P1|Double-blind Phase|Adverse drug reaction|2
4849817|NCT00965757|16719308|P4|Double-blind Phase|Progression of concomitant disease|0
4849818|NCT00965757|16719309|P3|Double-blind Phase|Progression of concomitant disease|0
4849819|NCT00965757|16719310|P2|Double-blind Phase|Progression of concomitant disease|2
4849820|NCT00965757|16719311|P1|Double-blind Phase|Progression of concomitant disease|1
4849821|NCT00965731|16719345|P2|Overall Study|Other|15
4849822|NCT00965731|16719346|P1|Overall Study|Other|7
4849823|NCT00965731|16719345|P2|Overall Study|Withdrawal by Subject|1
4849824|NCT00965731|16719346|P1|Overall Study|Withdrawal by Subject|0
4849825|NCT00965731|16719345|P2|Overall Study|Death|4
4849826|NCT00965731|16719346|P1|Overall Study|Death|0
4849827|NCT00965718|16719410|P1|Overall Study|Withdrawal by Subject|4
4849828|NCT00965575|16719422|P2|Overall Study|subject unwillingness to swallow study c|0
4849829|NCT00965575|16719423|P1|Overall Study|subject unwillingness to swallow study c|1
4849830|NCT00965562|16719434|P3|Overall Study|Withdrawal by Subject|0
4849831|NCT00965562|16719435|P2|Overall Study|Withdrawal by Subject|2
4849832|NCT00965562|16719436|P1|Overall Study|Withdrawal by Subject|2
4849833|NCT00965562|16719434|P3|Overall Study|Lost to Follow-up|3
4849834|NCT00965562|16719435|P2|Overall Study|Lost to Follow-up|2
4849835|NCT00965562|16719436|P1|Overall Study|Lost to Follow-up|1
4849836|NCT00965523|16719474|P1|Study 224|Physician Decision|1
4849837|NCT00965523|16719474|P1|Study 224|Progressive Disease|5
4849838|NCT00965523|16719474|P1|Study 221|Physician Decision|3
4849839|NCT00965523|16719474|P1|Study 221|Progressive Disease|4
4849840|NCT00965497|16719479|P1|Overall Study|Physician Decision|1
4849841|NCT00965484|16719484|P1|Overall Study|Withdrawal by Subject|1
4849842|NCT00965484|16719484|P1|Overall Study|Protocol Violation|1
4849843|NCT00965458|16719493|P2|Overall Study|Withdrawal by Subject|1
4849844|NCT00965458|16719494|P1|Overall Study|Withdrawal by Subject|0
4849845|NCT00965458|16719493|P2|Overall Study|Lost to Follow-up|3
4849846|NCT00965458|16719494|P1|Overall Study|Lost to Follow-up|1
4849847|NCT00965458|16719493|P2|Overall Study|Adverse Event|0
4849848|NCT00965458|16719494|P1|Overall Study|Adverse Event|1
4849849|NCT00965419|16719510|P1|Follow-up Phase|Lack of Efficacy|28
4849850|NCT00965419|16719510|P1|Follow-up Phase|Parent/Caregiver Decision|9
4849851|NCT00965419|16719510|P1|Follow-up Phase|Physician Decision|4
4849852|NCT00965419|16719510|P1|Follow-up Phase|Withdrawal by Subject|8
4849853|NCT00965419|16719510|P1|Follow-up Phase|Protocol Violation|4
4849854|NCT00965419|16719510|P1|Follow-up Phase|Adverse Event|9
4849855|NCT00965419|16719510|P1|Open Label Treatment for Responders|Lost to Follow-up|46
4849856|NCT00965419|16719510|P1|Open Label Treatment for Responders|Lack of Efficacy|67
4849857|NCT00965419|16719510|P1|Open Label Treatment for Responders|Parent/Caregiver Decision|41
4849858|NCT00965419|16719510|P1|Open Label Treatment for Responders|Sponsor Decision|5
4849859|NCT00965419|16719510|P1|Open Label Treatment for Responders|Physician Decision|6
4849860|NCT00965419|16719510|P1|Open Label Treatment for Responders|Withdrawal by Subject|27
4849861|NCT00965419|16719510|P1|Open Label Treatment for Responders|Protocol Violation|21
4849862|NCT00965419|16719510|P1|Open Label Treatment for Responders|Entry Criteria Not Met|1
4849863|NCT00965419|16719510|P1|Open Label Treatment for Responders|Adverse Event|33
4849864|NCT00965341|16719556|P2|Overall Study|Transportation issues|3
4849865|NCT00965341|16719557|P1|Overall Study|Transportation issues|4
4849866|NCT00965341|16719556|P2|Overall Study|Lost to Follow-up|0
4849867|NCT00965341|16719557|P1|Overall Study|Lost to Follow-up|1
4849868|NCT00965341|16719556|P2|Overall Study|Withdrew consent|5
4849869|NCT00965341|16719557|P1|Overall Study|Withdrew consent|1
4849870|NCT00965263|16719567|P2|Overall Study|Protocol Violation|2
4849871|NCT00965263|16719568|P1|Overall Study|Protocol Violation|0
4849872|NCT00965263|16719567|P2|Overall Study|Family emergency|1
4849873|NCT00965263|16719568|P1|Overall Study|Family emergency|0
4849874|NCT00965263|16719567|P2|Overall Study|Physician Decision|0
4849875|NCT00965263|16719568|P1|Overall Study|Physician Decision|2
4849876|NCT00965185|16719628|P2|Overall Study|Withdrawal by Subject|1
4849877|NCT00965185|16719629|P1|Overall Study|Withdrawal by Subject|0
4849878|NCT00965185|16719628|P2|Overall Study|Lost to Follow-up|0
4849879|NCT00965185|16719629|P1|Overall Study|Lost to Follow-up|2
4849880|NCT00965146|16719649|P1|Overall Study|Overall Study Termination|145
4849881|NCT00965146|16719649|P1|Overall Study|Revision / Removal of Study Implant|6
4849882|NCT00965146|16719649|P1|Overall Study|Intercurrent illness|1
4849883|NCT00965146|16719649|P1|Overall Study|Unwilling to return|11
4849884|NCT00965146|16719649|P1|Overall Study|Unable to return|1
4849885|NCT00965146|16719649|P1|Overall Study|Withdrawal by Subject|17
4849886|NCT00965146|16719649|P1|Overall Study|Lost to Follow-up|22
4849887|NCT00965146|16719649|P1|Overall Study|Death|7
4849888|NCT00965094|16719656|P2|Overall Study|Lost to Follow-up|1
4849889|NCT00965094|16719657|P1|Overall Study|Lost to Follow-up|0
4849890|NCT00965094|16719656|P2|Overall Study|Adverse Event|0
4849891|NCT00965094|16719657|P1|Overall Study|Adverse Event|5
4849892|NCT00965081|16719673|P2|Overall Study|Switched to Rescue Arm|12
4849893|NCT00965081|16719674|P1|Overall Study|Switched to Rescue Arm|5
4849894|NCT00965081|16719673|P2|Overall Study|Withdrawal by Subject|7
4849895|NCT00965081|16719674|P1|Overall Study|Withdrawal by Subject|4
4849896|NCT00965081|16719673|P2|Overall Study|Sponsor Decision|0
4849897|NCT00965081|16719674|P1|Overall Study|Sponsor Decision|1
4849898|NCT00965081|16719673|P2|Overall Study|Protocol Violation|5
4849899|NCT00965081|16719674|P1|Overall Study|Protocol Violation|2
4849900|NCT00965081|16719673|P2|Overall Study|Physician Decision|0
4849901|NCT00965081|16719674|P1|Overall Study|Physician Decision|2
4849902|NCT00965081|16719673|P2|Overall Study|Lost to Follow-up|5
4849903|NCT00965081|16719674|P1|Overall Study|Lost to Follow-up|4
4849904|NCT00965081|16719673|P2|Overall Study|Lack of Efficacy|5
4849905|NCT00965081|16719674|P1|Overall Study|Lack of Efficacy|2
4849906|NCT00965081|16719673|P2|Overall Study|Adverse Event|9
4849907|NCT00965081|16719674|P1|Overall Study|Adverse Event|14
4849908|NCT00964886|16719706|P4|Overall Study|Protocol Violation|0
4849909|NCT00964886|16719707|P3|Overall Study|Protocol Violation|0
4849910|NCT00964886|16719708|P2|Overall Study|Protocol Violation|2
4849911|NCT00964886|16719709|P1|Overall Study|Protocol Violation|0
4849912|NCT00964886|16719706|P4|Overall Study|Adverse Event|2
4849913|NCT00964886|16719707|P3|Overall Study|Adverse Event|5
4849914|NCT00964886|16719708|P2|Overall Study|Adverse Event|1
4849915|NCT00964886|16719709|P1|Overall Study|Adverse Event|3
4849916|NCT00964886|16719706|P4|Overall Study|Withdrawal by Subject|3
4849917|NCT00964886|16719707|P3|Overall Study|Withdrawal by Subject|5
4849918|NCT00964886|16719708|P2|Overall Study|Withdrawal by Subject|2
4849919|NCT00964886|16719709|P1|Overall Study|Withdrawal by Subject|6
4849920|NCT00964886|16719706|P4|Overall Study|Lost to Follow-up|4
4849921|NCT00964886|16719707|P3|Overall Study|Lost to Follow-up|6
4849922|NCT00964886|16719708|P2|Overall Study|Lost to Follow-up|2
4849923|NCT00964886|16719709|P1|Overall Study|Lost to Follow-up|2
4849924|NCT00964860|16719725|P2|Overall Study|Withdrawal by Subject|1
4849925|NCT00964860|16719726|P1|Overall Study|Withdrawal by Subject|0
4849926|NCT00964795|16719734|P1|Overall Study|Other|23
4849927|NCT00964795|16719734|P1|Overall Study|Unwilling to sign ICF for amendment 4|3
4849928|NCT00964795|16719734|P1|Overall Study|Termination of Study by Sponsor|169
4849929|NCT00964795|16719734|P1|Overall Study|Lost to Follow-up|7
4849930|NCT00964795|16719734|P1|Overall Study|Death|14
4849931|NCT00964795|16719734|P1|Overall Study|Adverse Event|12
4849932|NCT00964795|16719734|P1|Overall Study|Withdrawal by Subject|79
4849933|NCT00964782|16719743|P2|Overall Study|Lost to Follow-up|0
4849934|NCT00964782|16719744|P1|Overall Study|Lost to Follow-up|1
4849935|NCT00964743|16719758|P1|Overall Study|Neither patient completed 8 weeks of tre|2
4849936|NCT00964678|16719766|P1|Overall Study|Physician Decision|4
4849937|NCT00964392|16719830|P2|Overall Study|Not completed|168
4849938|NCT00964392|16719831|P1|Overall Study|Not completed|44
4849939|NCT00964392|16719830|P2|Overall Study|Early Termination, non-study arrhythmia|6
4849940|NCT00964392|16719831|P1|Overall Study|Early Termination, non-study arrhythmia|1
4849941|NCT00964392|16719830|P2|Overall Study|Lost to Follow-up|10
4849942|NCT00964392|16719831|P1|Overall Study|Lost to Follow-up|4
4849943|NCT00964392|16719830|P2|Overall Study|Withdrawal by Subject|6
4849944|NCT00964392|16719831|P1|Overall Study|Withdrawal by Subject|4
4849945|NCT00964366|16719841|P2|Overall Study|Withdrawal by Subject|1
4849946|NCT00964366|16719842|P1|Overall Study|Withdrawal by Subject|0
4849947|NCT00964366|16719841|P2|Overall Study|Did not qualify at Day 1|0
4849948|NCT00964366|16719842|P1|Overall Study|Did not qualify at Day 1|1
4849949|NCT00964223|16719867|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
4849950|NCT00964158|16719935|P3|Overall Study|Withdrawal by Subject|6
4849951|NCT00964158|16719936|P2|Overall Study|Withdrawal by Subject|0
4849952|NCT00964158|16719937|P1|Overall Study|Withdrawal by Subject|0
4849953|NCT00964158|16719935|P3|Overall Study|Lost to Follow-up|2
4849954|NCT00964158|16719936|P2|Overall Study|Lost to Follow-up|1
4849955|NCT00964158|16719937|P1|Overall Study|Lost to Follow-up|0
4849956|NCT00964028|16720012|P2|Overall Study|Withdrawal by Subject|1
4849957|NCT00964028|16720013|P1|Overall Study|Withdrawal by Subject|0
4849958|NCT00963937|16720028|P3|Overall Study|Physician Decision|4
4849959|NCT00963937|16720029|P2|Overall Study|Physician Decision|10
4849960|NCT00963937|16720030|P1|Overall Study|Physician Decision|18
4849961|NCT00963937|16720028|P3|Overall Study|Protocol Violation|0
4849962|NCT00963937|16720029|P2|Overall Study|Protocol Violation|1
4849963|NCT00963937|16720030|P1|Overall Study|Protocol Violation|1
4849964|NCT00963924|16720068|P2|Overall Study|Lost to Follow-up|1
4849965|NCT00963924|16720069|P1|Overall Study|Lost to Follow-up|0
4849966|NCT00963924|16720068|P2|Overall Study|Changed antipsychotic|1
4849967|NCT00963924|16720069|P1|Overall Study|Changed antipsychotic|0
4849968|NCT00963924|16720068|P2|Overall Study|Withdrawal by Subject|1
4849969|NCT00963924|16720069|P1|Overall Study|Withdrawal by Subject|0
4849970|NCT00963924|16720068|P2|Overall Study|Adverse Event|0
4849971|NCT00963924|16720069|P1|Overall Study|Adverse Event|1
4849972|NCT00963820|16720143|P12|Expansion Phase|Unsatisfactory Therapeutic Response|1
4849973|NCT00963820|16720144|P11|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849974|NCT00963820|16720145|P10|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849975|NCT00963820|16720146|P9|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849976|NCT00963820|16720147|P8|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849977|NCT00963820|16720148|P7|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849978|NCT00963820|16720149|P6|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849979|NCT00963820|16720150|P5|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849980|NCT00963820|16720151|P4|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849981|NCT00963820|16720152|P3|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849982|NCT00963820|16720153|P2|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849983|NCT00963820|16720154|P1|Expansion Phase|Unsatisfactory Therapeutic Response|0
4849984|NCT00963820|16720143|P12|Expansion Phase|Withdrawal by Subject|1
4849985|NCT00963820|16720144|P11|Expansion Phase|Withdrawal by Subject|1
4849986|NCT00963820|16720145|P10|Expansion Phase|Withdrawal by Subject|0
4849987|NCT00963820|16720146|P9|Expansion Phase|Withdrawal by Subject|1
4849988|NCT00963820|16720147|P8|Expansion Phase|Withdrawal by Subject|0
4849989|NCT00963820|16720148|P7|Expansion Phase|Withdrawal by Subject|0
4849990|NCT00963820|16720149|P6|Expansion Phase|Withdrawal by Subject|0
4849991|NCT00963820|16720150|P5|Expansion Phase|Withdrawal by Subject|0
4849992|NCT00963820|16720151|P4|Expansion Phase|Withdrawal by Subject|0
4849993|NCT00963820|16720152|P3|Expansion Phase|Withdrawal by Subject|0
4849994|NCT00963820|16720153|P2|Expansion Phase|Withdrawal by Subject|0
4849995|NCT00963820|16720154|P1|Expansion Phase|Withdrawal by Subject|0
4849996|NCT00963820|16720143|P12|Expansion Phase|Adverse Event|0
4849997|NCT00963820|16720144|P11|Expansion Phase|Adverse Event|0
4849998|NCT00963820|16720145|P10|Expansion Phase|Adverse Event|3
4849999|NCT00963820|16720146|P9|Expansion Phase|Adverse Event|1
4850000|NCT00963820|16720147|P8|Expansion Phase|Adverse Event|0
4850001|NCT00963820|16720148|P7|Expansion Phase|Adverse Event|0
4850002|NCT00963820|16720149|P6|Expansion Phase|Adverse Event|0
4850003|NCT00963820|16720150|P5|Expansion Phase|Adverse Event|0
4850004|NCT00963820|16720151|P4|Expansion Phase|Adverse Event|0
4850005|NCT00963820|16720152|P3|Expansion Phase|Adverse Event|0
4850006|NCT00963820|16720153|P2|Expansion Phase|Adverse Event|0
4850007|NCT00963820|16720154|P1|Expansion Phase|Adverse Event|0
4850008|NCT00963820|16720143|P12|Expansion Phase|Progressive Disease|2
4850009|NCT00963820|16720144|P11|Expansion Phase|Progressive Disease|4
4850010|NCT00963820|16720145|P10|Expansion Phase|Progressive Disease|6
4850011|NCT00963820|16720146|P9|Expansion Phase|Progressive Disease|8
4850012|NCT00963820|16720147|P8|Expansion Phase|Progressive Disease|0
4850013|NCT00963820|16720148|P7|Expansion Phase|Progressive Disease|0
4850014|NCT00963820|16720149|P6|Expansion Phase|Progressive Disease|0
4850015|NCT00963820|16720150|P5|Expansion Phase|Progressive Disease|0
4850016|NCT00963820|16720151|P4|Expansion Phase|Progressive Disease|0
4850017|NCT00963820|16720152|P3|Expansion Phase|Progressive Disease|0
4850018|NCT00963820|16720153|P2|Expansion Phase|Progressive Disease|0
4850019|NCT00963820|16720154|P1|Expansion Phase|Progressive Disease|0
4850020|NCT00963820|16720143|P12|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850021|NCT00963820|16720144|P11|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850022|NCT00963820|16720145|P10|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850023|NCT00963820|16720146|P9|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850024|NCT00963820|16720147|P8|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850025|NCT00963820|16720148|P7|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1
4850026|NCT00963820|16720149|P6|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850027|NCT00963820|16720150|P5|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850028|NCT00963820|16720151|P4|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850029|NCT00963820|16720152|P3|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850030|NCT00963820|16720153|P2|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850031|NCT00963820|16720154|P1|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0
4850032|NCT00963820|16720143|P12|Dose Escalation Phase|Withdrawal by Subject|0
4850033|NCT00963820|16720144|P11|Dose Escalation Phase|Withdrawal by Subject|0
4850034|NCT00963820|16720145|P10|Dose Escalation Phase|Withdrawal by Subject|0
4850035|NCT00963820|16720146|P9|Dose Escalation Phase|Withdrawal by Subject|0
4850036|NCT00963820|16720147|P8|Dose Escalation Phase|Withdrawal by Subject|2
4850037|NCT00963820|16720148|P7|Dose Escalation Phase|Withdrawal by Subject|1
4850038|NCT00963820|16720149|P6|Dose Escalation Phase|Withdrawal by Subject|0
4850039|NCT00963820|16720150|P5|Dose Escalation Phase|Withdrawal by Subject|0
4850040|NCT00963820|16720151|P4|Dose Escalation Phase|Withdrawal by Subject|0
4850041|NCT00963820|16720152|P3|Dose Escalation Phase|Withdrawal by Subject|0
4850042|NCT00963820|16720153|P2|Dose Escalation Phase|Withdrawal by Subject|0
4850043|NCT00963820|16720154|P1|Dose Escalation Phase|Withdrawal by Subject|0
4850044|NCT00963820|16720143|P12|Dose Escalation Phase|Adverse Event|0
4850045|NCT00963820|16720144|P11|Dose Escalation Phase|Adverse Event|0
4850046|NCT00963820|16720145|P10|Dose Escalation Phase|Adverse Event|0
4850047|NCT00963820|16720146|P9|Dose Escalation Phase|Adverse Event|0
4850048|NCT00963820|16720147|P8|Dose Escalation Phase|Adverse Event|1
4850049|NCT00963820|16720148|P7|Dose Escalation Phase|Adverse Event|3
4850050|NCT00963820|16720149|P6|Dose Escalation Phase|Adverse Event|0
4850051|NCT00963820|16720150|P5|Dose Escalation Phase|Adverse Event|0
4850052|NCT00963820|16720151|P4|Dose Escalation Phase|Adverse Event|0
4850053|NCT00963820|16720152|P3|Dose Escalation Phase|Adverse Event|0
4850054|NCT00963820|16720153|P2|Dose Escalation Phase|Adverse Event|0
4850055|NCT00963820|16720154|P1|Dose Escalation Phase|Adverse Event|0
4850056|NCT00963820|16720143|P12|Dose Escalation Phase|Progressive Disease|0
4850057|NCT00963820|16720144|P11|Dose Escalation Phase|Progressive Disease|0
4850058|NCT00963820|16720145|P10|Dose Escalation Phase|Progressive Disease|0
4850059|NCT00963820|16720146|P9|Dose Escalation Phase|Progressive Disease|0
4850060|NCT00963820|16720147|P8|Dose Escalation Phase|Progressive Disease|2
4850061|NCT00963820|16720148|P7|Dose Escalation Phase|Progressive Disease|3
4850062|NCT00963820|16720149|P6|Dose Escalation Phase|Progressive Disease|3
4850063|NCT00963820|16720150|P5|Dose Escalation Phase|Progressive Disease|4
4850064|NCT00963820|16720151|P4|Dose Escalation Phase|Progressive Disease|3
4850065|NCT00963820|16720152|P3|Dose Escalation Phase|Progressive Disease|3
4850066|NCT00963820|16720153|P2|Dose Escalation Phase|Progressive Disease|3
4850067|NCT00963820|16720154|P1|Dose Escalation Phase|Progressive Disease|3
4850068|NCT00963807|16720290|P1|Overall Study|Disease progression|15
4850069|NCT00963807|16720290|P1|Overall Study|Reaction to study chemotherapy regimen|1
4850070|NCT00963807|16720290|P1|Overall Study|Physician Decision|2
4850071|NCT00963599|16720323|P4|Overall Study|Withdrawal by Subject|3
4850072|NCT00963599|16720324|P3|Overall Study|Withdrawal by Subject|3
4850073|NCT00963599|16720325|P2|Overall Study|Withdrawal by Subject|1
4850074|NCT00963599|16720326|P1|Overall Study|Withdrawal by Subject|2
4850075|NCT00963599|16720323|P4|Overall Study|Protocol Violation|4
4850076|NCT00963599|16720324|P3|Overall Study|Protocol Violation|3
4850077|NCT00963599|16720325|P2|Overall Study|Protocol Violation|2
4850078|NCT00963599|16720326|P1|Overall Study|Protocol Violation|2
4850079|NCT00963599|16720323|P4|Overall Study|Lost to Follow-up|1
4850080|NCT00963599|16720324|P3|Overall Study|Lost to Follow-up|1
4850081|NCT00963599|16720325|P2|Overall Study|Lost to Follow-up|1
4850082|NCT00963599|16720326|P1|Overall Study|Lost to Follow-up|0
4850083|NCT00963599|16720323|P4|Overall Study|Lack of Efficacy|4
4850084|NCT00963599|16720324|P3|Overall Study|Lack of Efficacy|1
4850085|NCT00963599|16720325|P2|Overall Study|Lack of Efficacy|2
4850086|NCT00963599|16720326|P1|Overall Study|Lack of Efficacy|0
4850087|NCT00963599|16720323|P4|Overall Study|Adverse Event|2
4850088|NCT00963599|16720324|P3|Overall Study|Adverse Event|1
4850089|NCT00963599|16720325|P2|Overall Study|Adverse Event|0
4850090|NCT00963599|16720326|P1|Overall Study|Adverse Event|2
4850091|NCT00963547|16720397|P7|Overall Study|Reason Unknown|0
4850092|NCT00963547|16720398|P6|Overall Study|Reason Unknown|0
4850093|NCT00963547|16720399|P5|Overall Study|Reason Unknown|0
4850094|NCT00963547|16720400|P4|Overall Study|Reason Unknown|0
4850095|NCT00963547|16720401|P3|Overall Study|Reason Unknown|0
4850096|NCT00963547|16720402|P2|Overall Study|Reason Unknown|1
4850097|NCT00963547|16720403|P1|Overall Study|Reason Unknown|0
4850098|NCT00963547|16720397|P7|Overall Study|Withdrawal by Subject|0
4850099|NCT00963547|16720398|P6|Overall Study|Withdrawal by Subject|0
4850100|NCT00963547|16720399|P5|Overall Study|Withdrawal by Subject|0
4850101|NCT00963547|16720400|P4|Overall Study|Withdrawal by Subject|0
4850102|NCT00963547|16720401|P3|Overall Study|Withdrawal by Subject|3
4850103|NCT00963547|16720402|P2|Overall Study|Withdrawal by Subject|0
4850104|NCT00963547|16720403|P1|Overall Study|Withdrawal by Subject|0
4850105|NCT00963547|16720397|P7|Overall Study|Progressive Disease|0
4850106|NCT00963547|16720398|P6|Overall Study|Progressive Disease|0
4850107|NCT00963547|16720399|P5|Overall Study|Progressive Disease|0
4850108|NCT00963547|16720400|P4|Overall Study|Progressive Disease|5
4850109|NCT00963547|16720401|P3|Overall Study|Progressive Disease|9
4850110|NCT00963547|16720402|P2|Overall Study|Progressive Disease|8
4850111|NCT00963547|16720403|P1|Overall Study|Progressive Disease|3
4850112|NCT00963547|16720397|P7|Overall Study|Physician Decision|0
4850113|NCT00963547|16720398|P6|Overall Study|Physician Decision|0
4850114|NCT00963547|16720399|P5|Overall Study|Physician Decision|0
4850115|NCT00963547|16720400|P4|Overall Study|Physician Decision|0
4850116|NCT00963547|16720401|P3|Overall Study|Physician Decision|0
4850117|NCT00963547|16720402|P2|Overall Study|Physician Decision|1
4850118|NCT00963547|16720403|P1|Overall Study|Physician Decision|1
4850119|NCT00963547|16720397|P7|Overall Study|Adverse Event|0
4850120|NCT00963547|16720398|P6|Overall Study|Adverse Event|0
4850121|NCT00963547|16720399|P5|Overall Study|Adverse Event|0
4850122|NCT00963547|16720400|P4|Overall Study|Adverse Event|1
4850123|NCT00963547|16720401|P3|Overall Study|Adverse Event|0
4850124|NCT00963547|16720402|P2|Overall Study|Adverse Event|1
4850125|NCT00963547|16720403|P1|Overall Study|Adverse Event|0
4850126|NCT00963469|16720450|P3|Overall Study|Site closed (local pollen Season ended)|3
4850127|NCT00963469|16720451|P2|Overall Study|Site closed (local pollen Season ended)|1
4850128|NCT00963469|16720452|P1|Overall Study|Site closed (local pollen Season ended)|4
4850129|NCT00963469|16720450|P3|Overall Study|Moved|0
4850130|NCT00963469|16720451|P2|Overall Study|Moved|0
4850131|NCT00963469|16720452|P1|Overall Study|Moved|1
4850132|NCT00963469|16720450|P3|Overall Study|Pre-randomization Adverse Event|0
4850133|NCT00963469|16720451|P2|Overall Study|Pre-randomization Adverse Event|2
4850134|NCT00963469|16720452|P1|Overall Study|Pre-randomization Adverse Event|1
4850135|NCT00963469|16720450|P3|Overall Study|Withdrawal by Subject|1
4850136|NCT00963469|16720451|P2|Overall Study|Withdrawal by Subject|1
4850137|NCT00963469|16720452|P1|Overall Study|Withdrawal by Subject|4
4850138|NCT00963469|16720450|P3|Overall Study|Protocol Violation|3
4850139|NCT00963469|16720451|P2|Overall Study|Protocol Violation|5
4850140|NCT00963469|16720452|P1|Overall Study|Protocol Violation|5
4850141|NCT00963469|16720450|P3|Overall Study|Lost to Follow-up|0
4850142|NCT00963469|16720451|P2|Overall Study|Lost to Follow-up|1
4850143|NCT00963469|16720452|P1|Overall Study|Lost to Follow-up|1
4850144|NCT00963469|16720450|P3|Overall Study|Lack of Efficacy|2
4850145|NCT00963469|16720451|P2|Overall Study|Lack of Efficacy|7
4850146|NCT00963469|16720452|P1|Overall Study|Lack of Efficacy|10
4850147|NCT00963469|16720450|P3|Overall Study|Adverse Event|1
4850148|NCT00963469|16720451|P2|Overall Study|Adverse Event|11
4850149|NCT00963469|16720452|P1|Overall Study|Adverse Event|15
4850150|NCT00963235|16720519|P1|Overall Study|Other|1
4850151|NCT00963235|16720519|P1|Overall Study|Physician Decision|2
4850152|NCT00963235|16720519|P1|Overall Study|Adverse Event|5
4850153|NCT00963235|16720519|P1|Overall Study|Protocol Violation|7
4850154|NCT00963235|16720519|P1|Overall Study|Failed to return|9
4850155|NCT00963235|16720519|P1|Overall Study|Lost to Follow-up|14
4850156|NCT00963235|16720519|P1|Overall Study|Withdrawal by Subject|22
4850157|NCT00962780|16720811|P2|Overall Study|Other|1
4850158|NCT00962780|16720812|P1|Overall Study|Other|0
4850159|NCT00962780|16720811|P2|Overall Study|Withdrawal by Subject|8
4850160|NCT00962780|16720812|P1|Overall Study|Withdrawal by Subject|1
4850161|NCT00962780|16720811|P2|Overall Study|Protocol Violation|4
4850162|NCT00962780|16720812|P1|Overall Study|Protocol Violation|9
4850163|NCT00962780|16720811|P2|Overall Study|Death|1
4850164|NCT00962780|16720812|P1|Overall Study|Death|0
4850165|NCT00962741|16720887|P1|Overall Study|drug ineffective+prohibited drug taken|1
4850166|NCT00962741|16720887|P1|Overall Study|Lack of Efficacy|1
4850167|NCT00962741|16720887|P1|Overall Study|Withdrawal by Subject|1
4850168|NCT00962741|16720887|P1|Overall Study|Lost to Follow-up|2
4850169|NCT00962741|16720887|P1|Overall Study|Failed to return|3
4850170|NCT00962650|16720978|P1|Overall Study|Transgastric DP was not completed|2
4850171|NCT00962585|16720997|P4|Overall Study|Withdrew Consent|0
4850172|NCT00962585|16720998|P3|Overall Study|Withdrew Consent|0
4850173|NCT00962585|16720999|P2|Overall Study|Withdrew Consent|0
4850174|NCT00962585|16721000|P1|Overall Study|Withdrew Consent|2
4850175|NCT00962585|16720997|P4|Overall Study|Withdrawal by Subject|0
4850176|NCT00962585|16720998|P3|Overall Study|Withdrawal by Subject|0
4850177|NCT00962585|16720999|P2|Overall Study|Withdrawal by Subject|0
4850178|NCT00962585|16721000|P1|Overall Study|Withdrawal by Subject|1
4850179|NCT00962585|16720997|P4|Overall Study|Protocol Violation|0
4850180|NCT00962585|16720998|P3|Overall Study|Protocol Violation|1
4850181|NCT00962585|16720999|P2|Overall Study|Protocol Violation|0
4850182|NCT00962585|16721000|P1|Overall Study|Protocol Violation|0
4850183|NCT00962585|16720997|P4|Overall Study|Lost to Follow-up|0
4850184|NCT00962585|16720998|P3|Overall Study|Lost to Follow-up|1
4850185|NCT00962585|16720999|P2|Overall Study|Lost to Follow-up|0
4850186|NCT00962585|16721000|P1|Overall Study|Lost to Follow-up|3
4850187|NCT00962585|16720997|P4|Overall Study|Adverse Event|0
4850188|NCT00962585|16720998|P3|Overall Study|Adverse Event|1
4850189|NCT00962585|16720999|P2|Overall Study|Adverse Event|2
4850190|NCT00962585|16721000|P1|Overall Study|Adverse Event|0
4850191|NCT00962390|16721077|P4|Overall Study|Withdrawal by Subject|0
4850192|NCT00962390|16721078|P3|Overall Study|Withdrawal by Subject|1
4850193|NCT00962390|16721079|P2|Overall Study|Withdrawal by Subject|1
4850194|NCT00962390|16721080|P1|Overall Study|Withdrawal by Subject|1
4850195|NCT00962390|16721077|P4|Overall Study|Protocol Violation|0
4850196|NCT00962390|16721078|P3|Overall Study|Protocol Violation|0
4850197|NCT00962390|16721079|P2|Overall Study|Protocol Violation|0
4850198|NCT00962390|16721080|P1|Overall Study|Protocol Violation|1
4850199|NCT00962390|16721077|P4|Overall Study|Lost to Follow-up|0
4850200|NCT00962390|16721078|P3|Overall Study|Lost to Follow-up|0
4850201|NCT00962390|16721079|P2|Overall Study|Lost to Follow-up|2
4850202|NCT00962390|16721080|P1|Overall Study|Lost to Follow-up|2
4850203|NCT00962390|16721077|P4|Overall Study|Adverse Event|1
4850204|NCT00962390|16721078|P3|Overall Study|Adverse Event|3
4850205|NCT00962390|16721079|P2|Overall Study|Adverse Event|0
4850206|NCT00962390|16721080|P1|Overall Study|Adverse Event|0
4850207|NCT00962247|16721142|P1|25% Reduction of Sedentary Activity|Withdrawal by Subject|1
4850208|NCT00962247|16721142|P1|25% Reduction of Sedentary Activity|Protocol Violation|4
4850209|NCT00962208|16721153|P2|Overall Study|Lost to Follow-up|9
4850210|NCT00962208|16721154|P1|Overall Study|Lost to Follow-up|0
4850211|NCT00962208|16721153|P2|Overall Study|Contraindicated to continue study|1
4850212|NCT00962208|16721154|P1|Overall Study|Contraindicated to continue study|5
4850213|NCT00962208|16721153|P2|Overall Study|Could not achieve good vision|0
4850214|NCT00962208|16721154|P1|Overall Study|Could not achieve good vision|9
4850215|NCT00962104|16721162|P2|Overall Study|Other|0
4850216|NCT00962104|16721163|P1|Overall Study|Other|2
4850217|NCT00962104|16721162|P2|Overall Study|Withdrawal by Subject|6
4850218|NCT00962104|16721163|P1|Overall Study|Withdrawal by Subject|10
4850219|NCT00962104|16721162|P2|Overall Study|Sponsor Decision|1
4850220|NCT00962104|16721163|P1|Overall Study|Sponsor Decision|0
4850221|NCT00962104|16721162|P2|Overall Study|Protocol Violation|8
4850222|NCT00962104|16721163|P1|Overall Study|Protocol Violation|6
4850223|NCT00962104|16721162|P2|Overall Study|Physician Decision|0
4850224|NCT00962104|16721163|P1|Overall Study|Physician Decision|1
4850225|NCT00962104|16721162|P2|Overall Study|Lost to Follow-up|4
4850226|NCT00962104|16721163|P1|Overall Study|Lost to Follow-up|10
4850227|NCT00962104|16721162|P2|Overall Study|Lack of Efficacy|1
4850228|NCT00962104|16721163|P1|Overall Study|Lack of Efficacy|0
4850229|NCT00962104|16721162|P2|Overall Study|Entry Criteria Not Met|2
4850230|NCT00962104|16721163|P1|Overall Study|Entry Criteria Not Met|1
4850231|NCT00962104|16721162|P2|Overall Study|Adverse Event|3
4850232|NCT00962104|16721163|P1|Overall Study|Adverse Event|10
4850233|NCT00962091|16721196|P7|Overall Study|Adverse Event|1
4850234|NCT00962091|16721197|P6|Overall Study|Adverse Event|0
4850235|NCT00962091|16721198|P5|Overall Study|Adverse Event|0
4850236|NCT00962091|16721199|P4|Overall Study|Adverse Event|0
4850237|NCT00962091|16721200|P3|Overall Study|Adverse Event|0
4850238|NCT00962091|16721201|P2|Overall Study|Adverse Event|0
4850239|NCT00962091|16721202|P1|Overall Study|Adverse Event|0
4850240|NCT00962091|16721196|P7|Overall Study|Withdrawal by Subject|0
4850241|NCT00962091|16721197|P6|Overall Study|Withdrawal by Subject|1
4850242|NCT00962091|16721198|P5|Overall Study|Withdrawal by Subject|0
4850243|NCT00962091|16721199|P4|Overall Study|Withdrawal by Subject|1
4850244|NCT00962091|16721200|P3|Overall Study|Withdrawal by Subject|1
4850245|NCT00962091|16721201|P2|Overall Study|Withdrawal by Subject|2
4850246|NCT00962091|16721202|P1|Overall Study|Withdrawal by Subject|1
4850247|NCT00962013|16721305|P1|Overall Study|No 5 year evaluation|6
4850248|NCT00962013|16721305|P1|Overall Study|Site Termination|24
4850249|NCT00962013|16721305|P1|Overall Study|Removal of study device|3
4850250|NCT00962013|16721305|P1|Overall Study|Withdrawal by Subject|8
4850251|NCT00962013|16721305|P1|Overall Study|Unable/Unwilling to return|6
4850252|NCT00962013|16721305|P1|Overall Study|Lost to Follow-up|12
4850253|NCT00962013|16721305|P1|Overall Study|Death|8
4850254|NCT00962013|16721305|P1|Overall Study|Did not have surgery|1
4850255|NCT00961961|16721329|P4|Phase II|Withdrawal by Subject|0
4850256|NCT00961961|16721330|P3|Phase II|Withdrawal by Subject|1
4850257|NCT00961961|16721331|P2|Phase II|Withdrawal by Subject|0
4850258|NCT00961961|16721332|P1|Phase II|Withdrawal by Subject|0
4850259|NCT00961961|16721329|P4|Phase II|Physician Decision|0
4850260|NCT00961961|16721330|P3|Phase II|Physician Decision|1
4850261|NCT00961961|16721331|P2|Phase II|Physician Decision|0
4850262|NCT00961961|16721332|P1|Phase II|Physician Decision|0
4850263|NCT00961961|16721329|P4|Phase II|Adverse Event|1
4850264|NCT00961961|16721330|P3|Phase II|Adverse Event|0
4850265|NCT00961961|16721331|P2|Phase II|Adverse Event|0
4850266|NCT00961961|16721332|P1|Phase II|Adverse Event|0
4850267|NCT00961961|16721329|P4|Phase II|Lost to Follow-up|7
4850268|NCT00961961|16721330|P3|Phase II|Lost to Follow-up|10
4850269|NCT00961961|16721331|P2|Phase II|Lost to Follow-up|0
4850270|NCT00961961|16721332|P1|Phase II|Lost to Follow-up|0
4850271|NCT00961961|16721329|P4|Phase I|Physician Decision|0
4850272|NCT00961961|16721330|P3|Phase I|Physician Decision|0
4850273|NCT00961961|16721331|P2|Phase I|Physician Decision|0
4850274|NCT00961961|16721332|P1|Phase I|Physician Decision|8
4850275|NCT00961961|16721329|P4|Phase I|Adverse Event|0
4850276|NCT00961961|16721330|P3|Phase I|Adverse Event|0
4850277|NCT00961961|16721331|P2|Phase I|Adverse Event|0
4850278|NCT00961961|16721332|P1|Phase I|Adverse Event|7
4850279|NCT00961961|16721329|P4|Phase I|Lack of Efficacy|0
4850280|NCT00961961|16721330|P3|Phase I|Lack of Efficacy|0
4850281|NCT00961961|16721331|P2|Phase I|Lack of Efficacy|0
4850282|NCT00961961|16721332|P1|Phase I|Lack of Efficacy|94
4850283|NCT00961961|16721329|P4|Phase I|Lost to Follow-up|0
4850284|NCT00961961|16721330|P3|Phase I|Lost to Follow-up|0
4850285|NCT00961961|16721331|P2|Phase I|Lost to Follow-up|0
4850286|NCT00961961|16721332|P1|Phase I|Lost to Follow-up|10
4850287|NCT00961961|16721329|P4|Phase I|Withdrawal by Subject|0
4850288|NCT00961961|16721330|P3|Phase I|Withdrawal by Subject|0
4850289|NCT00961961|16721331|P2|Phase I|Withdrawal by Subject|0
4850290|NCT00961961|16721332|P1|Phase I|Withdrawal by Subject|7
4850291|NCT00961896|16721357|P3|Overall Study|Abnormal laboratory value|1
4850292|NCT00961896|16721358|P2|Overall Study|Abnormal laboratory value|0
4850293|NCT00961896|16721359|P1|Overall Study|Abnormal laboratory value|0
4850294|NCT00961649|16721426|P4|Overall Study|Study terminated by sponsor|1
4850295|NCT00961649|16721427|P3|Overall Study|Study terminated by sponsor|4
4850296|NCT00961649|16721428|P2|Overall Study|Study terminated by sponsor|4
4850297|NCT00961649|16721429|P1|Overall Study|Study terminated by sponsor|4
4850298|NCT00961649|16721426|P4|Overall Study|Patient left to Mexico-family emergency|0
4850299|NCT00961649|16721427|P3|Overall Study|Patient left to Mexico-family emergency|0
4850300|NCT00961649|16721428|P2|Overall Study|Patient left to Mexico-family emergency|0
4850301|NCT00961649|16721429|P1|Overall Study|Patient left to Mexico-family emergency|1
4850302|NCT00961649|16721426|P4|Overall Study|Patient has travel plans during holidays|0
4850303|NCT00961649|16721427|P3|Overall Study|Patient has travel plans during holidays|1
4850304|NCT00961649|16721428|P2|Overall Study|Patient has travel plans during holidays|0
4850305|NCT00961649|16721429|P1|Overall Study|Patient has travel plans during holidays|0
4850306|NCT00961649|16721426|P4|Overall Study|Inadequate control of IOP|1
4850307|NCT00961649|16721427|P3|Overall Study|Inadequate control of IOP|0
4850308|NCT00961649|16721428|P2|Overall Study|Inadequate control of IOP|0
4850309|NCT00961649|16721429|P1|Overall Study|Inadequate control of IOP|0
4850310|NCT00961649|16721426|P4|Overall Study|Adverse Event|2
4850311|NCT00961649|16721427|P3|Overall Study|Adverse Event|0
4850312|NCT00961649|16721428|P2|Overall Study|Adverse Event|0
4850313|NCT00961649|16721429|P1|Overall Study|Adverse Event|4
4850314|NCT00961636|16721443|P3|Overall Study|Withdrawal by Subject|13
4850315|NCT00961636|16721444|P2|Overall Study|Withdrawal by Subject|22
4850316|NCT00961636|16721445|P1|Overall Study|Withdrawal by Subject|29
4850317|NCT00961636|16721443|P3|Overall Study|Protocol Violation|1
4850318|NCT00961636|16721444|P2|Overall Study|Protocol Violation|5
4850319|NCT00961636|16721445|P1|Overall Study|Protocol Violation|9
4850320|NCT00961636|16721443|P3|Overall Study|Physician Decision|1
4850321|NCT00961636|16721444|P2|Overall Study|Physician Decision|1
4850322|NCT00961636|16721445|P1|Overall Study|Physician Decision|3
4850323|NCT00961636|16721443|P3|Overall Study|Lost to Follow-up|1
4850324|NCT00961636|16721444|P2|Overall Study|Lost to Follow-up|3
4850325|NCT00961636|16721445|P1|Overall Study|Lost to Follow-up|2
4850326|NCT00961636|16721443|P3|Overall Study|Flushing Symptoms|3
4850327|NCT00961636|16721444|P2|Overall Study|Flushing Symptoms|46
4850328|NCT00961636|16721445|P1|Overall Study|Flushing Symptoms|29
4850329|NCT00961636|16721443|P3|Overall Study|Adverse Event|13
4850330|NCT00961636|16721444|P2|Overall Study|Adverse Event|54
4850331|NCT00961636|16721445|P1|Overall Study|Adverse Event|35
4850332|NCT00961571|16721456|P1|Overall Study|Physician Decision|39
4850333|NCT00961415|16721484|P3|Maintenance Treatment Phase|Other reason|3
4850334|NCT00961415|16721485|P2|Maintenance Treatment Phase|Other reason|1
4850335|NCT00961415|16721486|P1|Maintenance Treatment Phase|Other reason|0
4850336|NCT00961415|16721484|P3|Maintenance Treatment Phase|Withdrawal by Subject|8
4850337|NCT00961415|16721485|P2|Maintenance Treatment Phase|Withdrawal by Subject|3
4850338|NCT00961415|16721486|P1|Maintenance Treatment Phase|Withdrawal by Subject|0
4850339|NCT00961415|16721484|P3|Maintenance Treatment Phase|Investigators decision|0
4850340|NCT00961415|16721485|P2|Maintenance Treatment Phase|Investigators decision|2
4850341|NCT00961415|16721486|P1|Maintenance Treatment Phase|Investigators decision|0
4850342|NCT00961415|16721484|P3|Maintenance Treatment Phase|Death|34
4850343|NCT00961415|16721485|P2|Maintenance Treatment Phase|Death|42
4850344|NCT00961415|16721486|P1|Maintenance Treatment Phase|Death|0
4850345|NCT00961415|16721484|P3|Induction Treatment Phase|Other Reason|0
4850346|NCT00961415|16721485|P2|Induction Treatment Phase|Other Reason|0
4850347|NCT00961415|16721486|P1|Induction Treatment Phase|Other Reason|5
4850348|NCT00961415|16721484|P3|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
4850349|NCT00961415|16721485|P2|Induction Treatment Phase|Didn't meet maintenance phase criteria|0
4850350|NCT00961415|16721486|P1|Induction Treatment Phase|Didn't meet maintenance phase criteria|27
4850351|NCT00961415|16721484|P3|Induction Treatment Phase|Physician Decision|0
4850352|NCT00961415|16721485|P2|Induction Treatment Phase|Physician Decision|0
4850353|NCT00961415|16721486|P1|Induction Treatment Phase|Physician Decision|2
4850354|NCT00961415|16721484|P3|Induction Treatment Phase|Protocol Violation|0
4850355|NCT00961415|16721485|P2|Induction Treatment Phase|Protocol Violation|0
4850356|NCT00961415|16721486|P1|Induction Treatment Phase|Protocol Violation|1
4850357|NCT00961415|16721484|P3|Induction Treatment Phase|Death|0
4850358|NCT00961415|16721485|P2|Induction Treatment Phase|Death|0
4850359|NCT00961415|16721486|P1|Induction Treatment Phase|Death|77
4850360|NCT00961415|16721484|P3|Induction Treatment Phase|Withdrawal by Subject|0
4850361|NCT00961415|16721485|P2|Induction Treatment Phase|Withdrawal by Subject|0
4850362|NCT00961415|16721486|P1|Induction Treatment Phase|Withdrawal by Subject|11
4850363|NCT00961350|16721526|P2|Overall Study|Misc|21
4850364|NCT00961350|16721527|P1|Overall Study|Misc|16
4850365|NCT00961350|16721526|P2|Overall Study|Lost to Follow-up|3
4850366|NCT00961350|16721527|P1|Overall Study|Lost to Follow-up|3
4850367|NCT00961350|16721526|P2|Overall Study|Withdrawal by Subject|10
4850368|NCT00961350|16721527|P1|Overall Study|Withdrawal by Subject|10
4850369|NCT00961350|16721526|P2|Overall Study|Adverse Event|33
4850370|NCT00961350|16721527|P1|Overall Study|Adverse Event|18
4850371|NCT00961298|16721548|P1|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1
4850372|NCT00961298|16721548|P1|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2
4850373|NCT00961298|16721548|P1|Two Week Placebo Run in|Withdrawal by Subject|1
4850374|NCT00961259|16721555|P3|Washout Period of 7 Days|due to concomitant medication used|0
4850375|NCT00961259|16721556|P2|Washout Period of 7 Days|due to concomitant medication used|1
4850376|NCT00961259|16721557|P1|Washout Period of 7 Days|due to concomitant medication used|0
4850377|NCT00961220|16721585|P1|Overall Study|Complete Response prior to 12 courses|1
4850378|NCT00961220|16721585|P1|Overall Study|O6BG no longer supplied|1
4850379|NCT00961220|16721585|P1|Overall Study|No IV access for O6BG|1
4850380|NCT00961220|16721585|P1|Overall Study|Lack of Efficacy|1
4850381|NCT00961220|16721585|P1|Overall Study|Adverse Event|3
4850382|NCT00961181|16721601|P1|Overall Study|Lost to Follow-up|1
4850383|NCT00961181|16721601|P1|Overall Study|Withdrawal by Subject|2
4850384|NCT00961181|16721601|P1|Overall Study|Death|2
4850385|NCT00961116|16721614|P2|Washout Period of 7 Days|Protocol Violation|1
4850386|NCT00961116|16721615|P1|Washout Period of 7 Days|Protocol Violation|0
4850387|NCT00961116|16721614|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4850388|NCT00961116|16721615|P1|Washout Period of 7 Days|Withdrawal by Subject|1
4850389|NCT00961116|16721614|P2|Washout Period of 7 Days|Adverse Event|1
4850390|NCT00961116|16721615|P1|Washout Period of 7 Days|Adverse Event|1
4850391|NCT00960999|16721642|P2|Overall Study|RT dose constraints not met|0
4850392|NCT00960999|16721643|P1|Overall Study|RT dose constraints not met|2
4850393|NCT00960999|16721642|P2|Overall Study|Protocol Violation|2
4850394|NCT00960999|16721643|P1|Overall Study|Protocol Violation|5
4850395|NCT00960999|16721642|P2|Overall Study|Withdrawal by Subject|0
4850396|NCT00960999|16721643|P1|Overall Study|Withdrawal by Subject|1
4850397|NCT00960986|16721675|P4|Period 3 (7-week Therapy Period)|Lack of Efficacy|0
4850398|NCT00960986|16721676|P3|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
4850399|NCT00960986|16721677|P2|Period 3 (7-week Therapy Period)|Lack of Efficacy|2
4850400|NCT00960986|16721678|P1|Period 3 (7-week Therapy Period)|Lack of Efficacy|1
4850401|NCT00960986|16721675|P4|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
4850402|NCT00960986|16721676|P3|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4
4850403|NCT00960986|16721677|P2|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
4850404|NCT00960986|16721678|P1|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2
4850405|NCT00960986|16721675|P4|Period 3 (7-week Therapy Period)|Protocol Violation|11
4850406|NCT00960986|16721676|P3|Period 3 (7-week Therapy Period)|Protocol Violation|3
4850407|NCT00960986|16721677|P2|Period 3 (7-week Therapy Period)|Protocol Violation|4
4850408|NCT00960986|16721678|P1|Period 3 (7-week Therapy Period)|Protocol Violation|10
4850409|NCT00960986|16721675|P4|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
4850410|NCT00960986|16721676|P3|Period 3 (7-week Therapy Period)|Lost to Follow-up|1
4850411|NCT00960986|16721677|P2|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
4850412|NCT00960986|16721678|P1|Period 3 (7-week Therapy Period)|Lost to Follow-up|0
4850413|NCT00960986|16721675|P4|Period 3 (7-week Therapy Period)|Death|0
4850414|NCT00960986|16721676|P3|Period 3 (7-week Therapy Period)|Death|1
4850415|NCT00960986|16721677|P2|Period 3 (7-week Therapy Period)|Death|0
4850416|NCT00960986|16721678|P1|Period 3 (7-week Therapy Period)|Death|0
4850417|NCT00960986|16721675|P4|Period 3 (7-week Therapy Period)|Adverse Event|12
4850418|NCT00960986|16721676|P3|Period 3 (7-week Therapy Period)|Adverse Event|10
4850419|NCT00960986|16721677|P2|Period 3 (7-week Therapy Period)|Adverse Event|15
4850420|NCT00960986|16721678|P1|Period 3 (7-week Therapy Period)|Adverse Event|17
4850421|NCT00960986|16721675|P4|Period 1 (Screening and Washout)|Withdrawal by Subject|1
4850422|NCT00960986|16721676|P3|Period 1 (Screening and Washout)|Withdrawal by Subject|1
4850423|NCT00960986|16721677|P2|Period 1 (Screening and Washout)|Withdrawal by Subject|2
4850424|NCT00960986|16721678|P1|Period 1 (Screening and Washout)|Withdrawal by Subject|1
4850425|NCT00960986|16721675|P4|Period 1 (Screening and Washout)|Protocol Violation|0
4850426|NCT00960986|16721676|P3|Period 1 (Screening and Washout)|Protocol Violation|0
4850427|NCT00960986|16721677|P2|Period 1 (Screening and Washout)|Protocol Violation|0
4850428|NCT00960986|16721678|P1|Period 1 (Screening and Washout)|Protocol Violation|1
4850429|NCT00960986|16721675|P4|Period 1 (Screening and Washout)|Lost to Follow-up|1
4850430|NCT00960986|16721676|P3|Period 1 (Screening and Washout)|Lost to Follow-up|2
4850431|NCT00960986|16721677|P2|Period 1 (Screening and Washout)|Lost to Follow-up|0
4850432|NCT00960986|16721678|P1|Period 1 (Screening and Washout)|Lost to Follow-up|0
4850433|NCT00960986|16721675|P4|Period 1 (Screening and Washout)|Adverse Event|1
4850434|NCT00960986|16721676|P3|Period 1 (Screening and Washout)|Adverse Event|1
4850435|NCT00960986|16721677|P2|Period 1 (Screening and Washout)|Adverse Event|2
4850436|NCT00960986|16721678|P1|Period 1 (Screening and Washout)|Adverse Event|1
4850437|NCT00960934|16721754|P6|Overall Study|Study Terminated by Sponsor|49
4850438|NCT00960934|16721755|P5|Overall Study|Study Terminated by Sponsor|49
4850439|NCT00960934|16721756|P4|Overall Study|Study Terminated by Sponsor|50
4850440|NCT00960934|16721757|P3|Overall Study|Study Terminated by Sponsor|52
4850441|NCT00960934|16721758|P2|Overall Study|Study Terminated by Sponsor|46
4850442|NCT00960934|16721759|P1|Overall Study|Study Terminated by Sponsor|50
4850443|NCT00960934|16721754|P6|Overall Study|Withdrawal by Subject|7
4850444|NCT00960934|16721755|P5|Overall Study|Withdrawal by Subject|5
4850445|NCT00960934|16721756|P4|Overall Study|Withdrawal by Subject|5
4850446|NCT00960934|16721757|P3|Overall Study|Withdrawal by Subject|4
4850447|NCT00960934|16721758|P2|Overall Study|Withdrawal by Subject|6
4850448|NCT00960934|16721759|P1|Overall Study|Withdrawal by Subject|5
4850449|NCT00960934|16721754|P6|Overall Study|Protocol Violation|2
4850450|NCT00960934|16721755|P5|Overall Study|Protocol Violation|3
4850451|NCT00960934|16721756|P4|Overall Study|Protocol Violation|3
4850452|NCT00960934|16721757|P3|Overall Study|Protocol Violation|0
4850453|NCT00960934|16721758|P2|Overall Study|Protocol Violation|4
4850454|NCT00960934|16721759|P1|Overall Study|Protocol Violation|3
4850455|NCT00960934|16721754|P6|Overall Study|Progressive Disease|1
4850456|NCT00960934|16721755|P5|Overall Study|Progressive Disease|1
4850457|NCT00960934|16721756|P4|Overall Study|Progressive Disease|0
4850458|NCT00960934|16721757|P3|Overall Study|Progressive Disease|0
4850459|NCT00960934|16721758|P2|Overall Study|Progressive Disease|1
4850460|NCT00960934|16721759|P1|Overall Study|Progressive Disease|1
4850461|NCT00960934|16721754|P6|Overall Study|Physician Decision|0
4850462|NCT00960934|16721755|P5|Overall Study|Physician Decision|0
4850463|NCT00960934|16721756|P4|Overall Study|Physician Decision|0
4850464|NCT00960934|16721757|P3|Overall Study|Physician Decision|0
4850465|NCT00960934|16721758|P2|Overall Study|Physician Decision|1
4850466|NCT00960934|16721759|P1|Overall Study|Physician Decision|0
4850467|NCT00960934|16721754|P6|Overall Study|Other|2
4850468|NCT00960934|16721755|P5|Overall Study|Other|2
4850469|NCT00960934|16721756|P4|Overall Study|Other|4
4850470|NCT00960934|16721757|P3|Overall Study|Other|5
4850471|NCT00960934|16721758|P2|Overall Study|Other|1
4850472|NCT00960934|16721759|P1|Overall Study|Other|2
4850473|NCT00960934|16721754|P6|Overall Study|Lost to Follow-up|0
4850474|NCT00960934|16721755|P5|Overall Study|Lost to Follow-up|0
4850475|NCT00960934|16721756|P4|Overall Study|Lost to Follow-up|0
4850476|NCT00960934|16721757|P3|Overall Study|Lost to Follow-up|0
4850477|NCT00960934|16721758|P2|Overall Study|Lost to Follow-up|1
4850478|NCT00960934|16721759|P1|Overall Study|Lost to Follow-up|0
4850479|NCT00960934|16721754|P6|Overall Study|Lack of Efficacy|0
4850480|NCT00960934|16721755|P5|Overall Study|Lack of Efficacy|0
4850481|NCT00960934|16721756|P4|Overall Study|Lack of Efficacy|0
4850482|NCT00960934|16721757|P3|Overall Study|Lack of Efficacy|0
4850483|NCT00960934|16721758|P2|Overall Study|Lack of Efficacy|0
4850484|NCT00960934|16721759|P1|Overall Study|Lack of Efficacy|1
4850485|NCT00960934|16721754|P6|Overall Study|Adverse Event|3
4850486|NCT00960934|16721755|P5|Overall Study|Adverse Event|4
4850487|NCT00960934|16721756|P4|Overall Study|Adverse Event|2
4850488|NCT00960934|16721757|P3|Overall Study|Adverse Event|3
4850489|NCT00960934|16721758|P2|Overall Study|Adverse Event|3
4850490|NCT00960934|16721759|P1|Overall Study|Adverse Event|2
4850491|NCT00960869|16721871|P2|Overall Study|Misc|18
4850492|NCT00960869|16721872|P1|Overall Study|Misc|19
4850493|NCT00960869|16721871|P2|Overall Study|Lost to Follow-up|4
4850494|NCT00960869|16721872|P1|Overall Study|Lost to Follow-up|1
4850495|NCT00960869|16721871|P2|Overall Study|Withdrawal by Subject|14
4850496|NCT00960869|16721872|P1|Overall Study|Withdrawal by Subject|16
4850497|NCT00960869|16721871|P2|Overall Study|Adverse Event|26
4850498|NCT00960869|16721872|P1|Overall Study|Adverse Event|17
4850499|NCT00960856|16721886|P4|Washout Period of 7 Days|Adverse Event|0
4850500|NCT00960856|16721887|P3|Washout Period of 7 Days|Adverse Event|1
4850501|NCT00960856|16721888|P2|Washout Period of 7 Days|Adverse Event|0
4850502|NCT00960856|16721889|P1|Washout Period of 7 Days|Adverse Event|0
4850503|NCT00960856|16721886|P4|Washout Period of 7 Days|Withdrawal by Subject|0
4850504|NCT00960856|16721887|P3|Washout Period of 7 Days|Withdrawal by Subject|0
4850505|NCT00960856|16721888|P2|Washout Period of 7 Days|Withdrawal by Subject|2
4850506|NCT00960856|16721889|P1|Washout Period of 7 Days|Withdrawal by Subject|0
4850507|NCT00960843|16721909|P2|Overall Study|Repeated needle dislodgment|1
4850508|NCT00960843|16721910|P1|Overall Study|Repeated needle dislodgment|0
4850509|NCT00960843|16721909|P2|Overall Study|Protocol Violation|4
4850510|NCT00960843|16721910|P1|Overall Study|Protocol Violation|0
4850511|NCT00960843|16721909|P2|Overall Study|Lost to Follow-up|0
4850512|NCT00960843|16721910|P1|Overall Study|Lost to Follow-up|2
4850513|NCT00960687|16721931|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4850514|NCT00960687|16721932|P1|Washout Period of 7 Days|Withdrawal by Subject|1
4850515|NCT00960687|16721931|P2|Washout Period of 7 Days|Adverse Event|2
4850516|NCT00960687|16721932|P1|Washout Period of 7 Days|Adverse Event|3
4850517|NCT00960661|16721944|P3|Interventional Phase|Lack of Efficacy|0
4850518|NCT00960661|16721945|P2|Interventional Phase|Lack of Efficacy|2
4850519|NCT00960661|16721946|P1|Interventional Phase|Lack of Efficacy|0
4850520|NCT00960661|16721944|P3|Interventional Phase|sponsor decision|0
4850521|NCT00960661|16721945|P2|Interventional Phase|sponsor decision|1
4850522|NCT00960661|16721946|P1|Interventional Phase|sponsor decision|0
4850523|NCT00960661|16721944|P3|Interventional Phase|Physician Decision|5
4850524|NCT00960661|16721945|P2|Interventional Phase|Physician Decision|3
4850525|NCT00960661|16721946|P1|Interventional Phase|Physician Decision|0
4850526|NCT00960661|16721944|P3|Interventional Phase|Withdrawal by Subject|29
4850527|NCT00960661|16721945|P2|Interventional Phase|Withdrawal by Subject|18
4850528|NCT00960661|16721946|P1|Interventional Phase|Withdrawal by Subject|0
4850529|NCT00960661|16721944|P3|Interventional Phase|Protocol Violation|2
4850530|NCT00960661|16721945|P2|Interventional Phase|Protocol Violation|7
4850531|NCT00960661|16721946|P1|Interventional Phase|Protocol Violation|0
4850532|NCT00960661|16721944|P3|Interventional Phase|entry criteria not met|0
4850533|NCT00960661|16721945|P2|Interventional Phase|entry criteria not met|3
4850534|NCT00960661|16721946|P1|Interventional Phase|entry criteria not met|0
4850535|NCT00960661|16721944|P3|Interventional Phase|Lost to Follow-up|2
4850536|NCT00960661|16721945|P2|Interventional Phase|Lost to Follow-up|0
4850537|NCT00960661|16721946|P1|Interventional Phase|Lost to Follow-up|0
4850538|NCT00960661|16721944|P3|Interventional Phase|Death|0
4850539|NCT00960661|16721945|P2|Interventional Phase|Death|1
4850540|NCT00960661|16721946|P1|Interventional Phase|Death|0
4850541|NCT00960661|16721944|P3|Interventional Phase|Adverse Event|8
4850542|NCT00960661|16721945|P2|Interventional Phase|Adverse Event|17
4850543|NCT00960661|16721946|P1|Interventional Phase|Adverse Event|0
4850544|NCT00960661|16721944|P3|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
4850545|NCT00960661|16721945|P2|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0
4850546|NCT00960661|16721946|P1|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3
4850547|NCT00960661|16721944|P3|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
4850548|NCT00960661|16721945|P2|Basal Insulin Optimization Phase (BIO)|Physician Decision|0
4850549|NCT00960661|16721946|P1|Basal Insulin Optimization Phase (BIO)|Physician Decision|8
4850550|NCT00960661|16721944|P3|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
4850551|NCT00960661|16721945|P2|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0
4850552|NCT00960661|16721946|P1|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47
4850553|NCT00960661|16721944|P3|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
4850554|NCT00960661|16721945|P2|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0
4850555|NCT00960661|16721946|P1|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331
4850556|NCT00960661|16721944|P3|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
4850557|NCT00960661|16721945|P2|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0
4850558|NCT00960661|16721946|P1|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4
4850559|NCT00960661|16721944|P3|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
4850560|NCT00960661|16721945|P2|Basal Insulin Optimization Phase (BIO)|Adverse Event|0
4850561|NCT00960661|16721946|P1|Basal Insulin Optimization Phase (BIO)|Adverse Event|6
4850562|NCT00960570|16721985|P1|1 Day Period Between Dosing|Withdrawal by Subject|1
4850563|NCT00960570|16721985|P1|1 Day Period Between Dosing|Adverse Event|2
4850564|NCT00960570|16721985|P1|21 Day Washout Period|Withdrawal by Subject|1
4850565|NCT00960570|16721985|P1|21 Day Washout Period|Adverse Event|1
4850566|NCT00960531|16722006|P10|Overall Study|Reason not Specified|1
4850567|NCT00960531|16722007|P9|Overall Study|Reason not Specified|8
4850568|NCT00960531|16722008|P8|Overall Study|Reason not Specified|0
4850569|NCT00960531|16722009|P7|Overall Study|Reason not Specified|16
4850570|NCT00960531|16722010|P6|Overall Study|Reason not Specified|0
4850571|NCT00960531|16722011|P5|Overall Study|Reason not Specified|2
4850572|NCT00960531|16722012|P4|Overall Study|Reason not Specified|1
4850573|NCT00960531|16722013|P3|Overall Study|Reason not Specified|13
4850574|NCT00960531|16722014|P2|Overall Study|Reason not Specified|1
4850575|NCT00960531|16722015|P1|Overall Study|Reason not Specified|2
4850576|NCT00960531|16722006|P10|Overall Study|Adverse Event (AE)|0
4850577|NCT00960531|16722007|P9|Overall Study|Adverse Event (AE)|2
4850578|NCT00960531|16722008|P8|Overall Study|Adverse Event (AE)|0
4850579|NCT00960531|16722009|P7|Overall Study|Adverse Event (AE)|2
4850580|NCT00960531|16722010|P6|Overall Study|Adverse Event (AE)|1
4850581|NCT00960531|16722011|P5|Overall Study|Adverse Event (AE)|0
4850582|NCT00960531|16722012|P4|Overall Study|Adverse Event (AE)|0
4850583|NCT00960531|16722013|P3|Overall Study|Adverse Event (AE)|0
4850584|NCT00960531|16722014|P2|Overall Study|Adverse Event (AE)|0
4850585|NCT00960531|16722015|P1|Overall Study|Adverse Event (AE)|2
4850586|NCT00960531|16722006|P10|Overall Study|Failed to Return|0
4850587|NCT00960531|16722007|P9|Overall Study|Failed to Return|0
4850588|NCT00960531|16722008|P8|Overall Study|Failed to Return|2
4850589|NCT00960531|16722009|P7|Overall Study|Failed to Return|0
4850590|NCT00960531|16722010|P6|Overall Study|Failed to Return|0
4850591|NCT00960531|16722011|P5|Overall Study|Failed to Return|0
4850592|NCT00960531|16722012|P4|Overall Study|Failed to Return|0
4850593|NCT00960531|16722013|P3|Overall Study|Failed to Return|0
4850594|NCT00960531|16722014|P2|Overall Study|Failed to Return|0
4850595|NCT00960531|16722015|P1|Overall Study|Failed to Return|2
4850596|NCT00960531|16722006|P10|Overall Study|Lost to Follow-up|0
4850597|NCT00960531|16722007|P9|Overall Study|Lost to Follow-up|0
4850598|NCT00960531|16722008|P8|Overall Study|Lost to Follow-up|0
4850599|NCT00960531|16722009|P7|Overall Study|Lost to Follow-up|1
4850600|NCT00960531|16722010|P6|Overall Study|Lost to Follow-up|0
4850601|NCT00960531|16722011|P5|Overall Study|Lost to Follow-up|0
4850602|NCT00960531|16722012|P4|Overall Study|Lost to Follow-up|0
4850603|NCT00960531|16722013|P3|Overall Study|Lost to Follow-up|1
4850604|NCT00960531|16722014|P2|Overall Study|Lost to Follow-up|0
4850605|NCT00960531|16722015|P1|Overall Study|Lost to Follow-up|0
4850606|NCT00960531|16722006|P10|Overall Study|Discontinuation of Study by Sponsor|0
4850607|NCT00960531|16722007|P9|Overall Study|Discontinuation of Study by Sponsor|0
4850608|NCT00960531|16722008|P8|Overall Study|Discontinuation of Study by Sponsor|1
4850609|NCT00960531|16722009|P7|Overall Study|Discontinuation of Study by Sponsor|0
4850610|NCT00960531|16722010|P6|Overall Study|Discontinuation of Study by Sponsor|0
4850611|NCT00960531|16722011|P5|Overall Study|Discontinuation of Study by Sponsor|0
4850612|NCT00960531|16722012|P4|Overall Study|Discontinuation of Study by Sponsor|0
4850613|NCT00960531|16722013|P3|Overall Study|Discontinuation of Study by Sponsor|0
4850614|NCT00960531|16722014|P2|Overall Study|Discontinuation of Study by Sponsor|0
4850615|NCT00960531|16722015|P1|Overall Study|Discontinuation of Study by Sponsor|0
4850616|NCT00960531|16722006|P10|Overall Study|Investigator Request|0
4850617|NCT00960531|16722007|P9|Overall Study|Investigator Request|0
4850618|NCT00960531|16722008|P8|Overall Study|Investigator Request|0
4850619|NCT00960531|16722009|P7|Overall Study|Investigator Request|0
4850620|NCT00960531|16722010|P6|Overall Study|Investigator Request|0
4850621|NCT00960531|16722011|P5|Overall Study|Investigator Request|0
4850622|NCT00960531|16722012|P4|Overall Study|Investigator Request|0
4850623|NCT00960531|16722013|P3|Overall Study|Investigator Request|1
4850624|NCT00960531|16722014|P2|Overall Study|Investigator Request|0
4850625|NCT00960531|16722015|P1|Overall Study|Investigator Request|0
4850626|NCT00960531|16722006|P10|Overall Study|Caregiver Request|0
4850627|NCT00960531|16722007|P9|Overall Study|Caregiver Request|3
4850628|NCT00960531|16722008|P8|Overall Study|Caregiver Request|1
4850629|NCT00960531|16722009|P7|Overall Study|Caregiver Request|3
4850630|NCT00960531|16722010|P6|Overall Study|Caregiver Request|2
4850631|NCT00960531|16722011|P5|Overall Study|Caregiver Request|0
4850632|NCT00960531|16722012|P4|Overall Study|Caregiver Request|5
4850633|NCT00960531|16722013|P3|Overall Study|Caregiver Request|6
4850634|NCT00960531|16722014|P2|Overall Study|Caregiver Request|0
4850635|NCT00960531|16722015|P1|Overall Study|Caregiver Request|2
4850636|NCT00960531|16722006|P10|Overall Study|Withdrawal by Subject|0
4850637|NCT00960531|16722007|P9|Overall Study|Withdrawal by Subject|1
4850638|NCT00960531|16722008|P8|Overall Study|Withdrawal by Subject|0
4850639|NCT00960531|16722009|P7|Overall Study|Withdrawal by Subject|2
4850640|NCT00960531|16722010|P6|Overall Study|Withdrawal by Subject|0
4850641|NCT00960531|16722011|P5|Overall Study|Withdrawal by Subject|0
4850642|NCT00960531|16722012|P4|Overall Study|Withdrawal by Subject|2
4850643|NCT00960531|16722013|P3|Overall Study|Withdrawal by Subject|5
4850644|NCT00960531|16722014|P2|Overall Study|Withdrawal by Subject|0
4850645|NCT00960531|16722015|P1|Overall Study|Withdrawal by Subject|1
4850646|NCT00960531|16722006|P10|Overall Study|Lack of Efficacy|0
4850647|NCT00960531|16722007|P9|Overall Study|Lack of Efficacy|0
4850648|NCT00960531|16722008|P8|Overall Study|Lack of Efficacy|0
4850649|NCT00960531|16722009|P7|Overall Study|Lack of Efficacy|0
4850650|NCT00960531|16722010|P6|Overall Study|Lack of Efficacy|0
4850651|NCT00960531|16722011|P5|Overall Study|Lack of Efficacy|0
4850652|NCT00960531|16722012|P4|Overall Study|Lack of Efficacy|0
4850653|NCT00960531|16722013|P3|Overall Study|Lack of Efficacy|0
4850654|NCT00960531|16722014|P2|Overall Study|Lack of Efficacy|0
4850655|NCT00960531|16722015|P1|Overall Study|Lack of Efficacy|1
4850656|NCT00960440|16722097|P4|Overall Study|Other|0
4850657|NCT00960440|16722098|P3|Overall Study|Other|1
4850658|NCT00960440|16722099|P2|Overall Study|Other|1
4850659|NCT00960440|16722100|P1|Overall Study|Other|1
4850660|NCT00960440|16722097|P4|Overall Study|Withdrawal by Subject|1
4850661|NCT00960440|16722098|P3|Overall Study|Withdrawal by Subject|2
4850662|NCT00960440|16722099|P2|Overall Study|Withdrawal by Subject|5
4850663|NCT00960440|16722100|P1|Overall Study|Withdrawal by Subject|9
4850664|NCT00960440|16722097|P4|Overall Study|Protocol Violation|4
4850665|NCT00960440|16722098|P3|Overall Study|Protocol Violation|3
4850666|NCT00960440|16722099|P2|Overall Study|Protocol Violation|8
4850667|NCT00960440|16722100|P1|Overall Study|Protocol Violation|2
4850668|NCT00960440|16722097|P4|Overall Study|Lack of Efficacy|8
4850669|NCT00960440|16722098|P3|Overall Study|Lack of Efficacy|3
4850670|NCT00960440|16722099|P2|Overall Study|Lack of Efficacy|5
4850671|NCT00960440|16722100|P1|Overall Study|Lack of Efficacy|2
4850672|NCT00960440|16722097|P4|Overall Study|Adverse Event|4
4850673|NCT00960440|16722098|P3|Overall Study|Adverse Event|4
4850674|NCT00960440|16722099|P2|Overall Study|Adverse Event|12
4850675|NCT00960440|16722100|P1|Overall Study|Adverse Event|12
4850676|NCT00960440|16722097|P4|Overall Study|Death|1
4850677|NCT00960440|16722098|P3|Overall Study|Death|0
4850678|NCT00960440|16722099|P2|Overall Study|Death|0
4850679|NCT00960440|16722100|P1|Overall Study|Death|0
4850680|NCT00960375|16722272|P2|Overall Study|Lost to Follow-up|22
4850681|NCT00960375|16722273|P1|Overall Study|Lost to Follow-up|20
4850682|NCT00960323|16722281|P1|Atorvastatin Alone|Withdrawal by Subject|1
4850683|NCT00960297|16722292|P1|Overall Study|Disease progression|1
4850684|NCT00960297|16722292|P1|Overall Study|Venous port infection|1
4850685|NCT00960297|16722292|P1|Overall Study|Physician Decision|1
4850686|NCT00960206|16722299|P3|Overall Study|Missing 10 year data|1
4850687|NCT00960206|16722300|P2|Overall Study|Missing 10 year data|1
4850688|NCT00960206|16722301|P1|Overall Study|Missing 10 year data|20
4850689|NCT00960206|16722299|P3|Overall Study|Revision of study component|2
4850690|NCT00960206|16722300|P2|Overall Study|Revision of study component|2
4850691|NCT00960206|16722301|P1|Overall Study|Revision of study component|2
4850692|NCT00960206|16722299|P3|Overall Study|Withdrawal by Subject|0
4850693|NCT00960206|16722300|P2|Overall Study|Withdrawal by Subject|4
4850694|NCT00960206|16722301|P1|Overall Study|Withdrawal by Subject|2
4850695|NCT00960206|16722299|P3|Overall Study|Lost to Follow-up|8
4850696|NCT00960206|16722300|P2|Overall Study|Lost to Follow-up|14
4850697|NCT00960206|16722301|P1|Overall Study|Lost to Follow-up|8
4850698|NCT00960206|16722299|P3|Overall Study|Unwilling/Unable to return|0
4850699|NCT00960206|16722300|P2|Overall Study|Unwilling/Unable to return|2
4850700|NCT00960206|16722301|P1|Overall Study|Unwilling/Unable to return|1
4850701|NCT00960206|16722299|P3|Overall Study|Death|1
4850702|NCT00960206|16722300|P2|Overall Study|Death|4
4850703|NCT00960206|16722301|P1|Overall Study|Death|7
4850704|NCT00960193|16722319|P1|14 Day Washout Period|Withdrawal by Subject|1
4850705|NCT00960154|16722332|P2|Overall Study|Study termination|25
4850706|NCT00960154|16722333|P1|Overall Study|Study termination|25
4850707|NCT00960141|16722344|P3|Overall Study|Withdrawal by Subject|1
4850708|NCT00960141|16722345|P2|Overall Study|Withdrawal by Subject|2
4850709|NCT00960141|16722346|P1|Overall Study|Withdrawal by Subject|1
4850710|NCT00960141|16722344|P3|Overall Study|Protocol Violation|2
4850711|NCT00960141|16722345|P2|Overall Study|Protocol Violation|3
4850712|NCT00960141|16722346|P1|Overall Study|Protocol Violation|1
4850713|NCT00960141|16722344|P3|Overall Study|Lost to Follow-up|0
4850714|NCT00960141|16722345|P2|Overall Study|Lost to Follow-up|0
4850715|NCT00960141|16722346|P1|Overall Study|Lost to Follow-up|1
4850716|NCT00960141|16722344|P3|Overall Study|Lack of Efficacy|2
4850717|NCT00960141|16722345|P2|Overall Study|Lack of Efficacy|4
4850718|NCT00960141|16722346|P1|Overall Study|Lack of Efficacy|3
4850719|NCT00960141|16722344|P3|Overall Study|Adverse Event|2
4850720|NCT00960141|16722345|P2|Overall Study|Adverse Event|8
4850721|NCT00960141|16722346|P1|Overall Study|Adverse Event|4
4850722|NCT00960115|16722371|P2|Overall Study|Ongoing treatment at data cut-off date|15
4850723|NCT00960115|16722372|P1|Overall Study|Ongoing treatment at data cut-off date|19
4850724|NCT00960076|16722386|P2|Overall Study|Did not attend the termination visit|1
4850725|NCT00960076|16722387|P1|Overall Study|Did not attend the termination visit|0
4850726|NCT00960076|16722386|P2|Overall Study|Hyperglycemia|5
4850727|NCT00960076|16722387|P1|Overall Study|Hyperglycemia|1
4850728|NCT00960076|16722386|P2|Overall Study|Severe non-compliance to protocol|2
4850729|NCT00960076|16722387|P1|Overall Study|Severe non-compliance to protocol|1
4850730|NCT00960076|16722386|P2|Overall Study|Lost to Follow-up|3
4850731|NCT00960076|16722387|P1|Overall Study|Lost to Follow-up|3
4850732|NCT00960076|16722386|P2|Overall Study|Withdrawal by Subject|2
4850733|NCT00960076|16722387|P1|Overall Study|Withdrawal by Subject|1
4850734|NCT00960076|16722386|P2|Overall Study|No longer met study criteria|5
4850735|NCT00960076|16722387|P1|Overall Study|No longer met study criteria|1
4850736|NCT00960076|16722386|P2|Overall Study|Adverse Event|7
4850737|NCT00960076|16722387|P1|Overall Study|Adverse Event|1
4850738|NCT00960063|16722402|P3|Overall Study|Progression of Disease|3
4850739|NCT00960063|16722403|P2|Overall Study|Progression of Disease|0
4850740|NCT00960063|16722404|P1|Overall Study|Progression of Disease|0
4850741|NCT00960063|16722402|P3|Overall Study|Adverse Event|0
4850742|NCT00960063|16722403|P2|Overall Study|Adverse Event|0
4850743|NCT00960063|16722404|P1|Overall Study|Adverse Event|1
4850744|NCT00960011|16722444|P2|Overall Study|Lost to Follow-up|2
4850745|NCT00960011|16722445|P1|Overall Study|Lost to Follow-up|6
4850746|NCT00960011|16722444|P2|Overall Study|Death|0
4850747|NCT00960011|16722445|P1|Overall Study|Death|5
4850748|NCT00959946|16722538|P8|Overall Study|Withdrawal by Subject|0
4850749|NCT00959946|16722539|P7|Overall Study|Withdrawal by Subject|0
4850750|NCT00959946|16722540|P6|Overall Study|Withdrawal by Subject|1
4850751|NCT00959946|16722541|P5|Overall Study|Withdrawal by Subject|0
4850752|NCT00959946|16722542|P4|Overall Study|Withdrawal by Subject|0
4850753|NCT00959946|16722543|P3|Overall Study|Withdrawal by Subject|0
4850754|NCT00959946|16722544|P2|Overall Study|Withdrawal by Subject|0
4850755|NCT00959946|16722545|P1|Overall Study|Withdrawal by Subject|0
4850756|NCT00959946|16722538|P8|Overall Study|Disease Progression|2
4850757|NCT00959946|16722539|P7|Overall Study|Disease Progression|2
4850758|NCT00959946|16722540|P6|Overall Study|Disease Progression|6
4850759|NCT00959946|16722541|P5|Overall Study|Disease Progression|4
4850760|NCT00959946|16722542|P4|Overall Study|Disease Progression|4
4850761|NCT00959946|16722543|P3|Overall Study|Disease Progression|2
4850762|NCT00959946|16722544|P2|Overall Study|Disease Progression|4
4850763|NCT00959946|16722545|P1|Overall Study|Disease Progression|2
4850764|NCT00959946|16722538|P8|Overall Study|Death|0
4850765|NCT00959946|16722539|P7|Overall Study|Death|0
4850766|NCT00959946|16722540|P6|Overall Study|Death|1
4850767|NCT00959946|16722541|P5|Overall Study|Death|0
4850768|NCT00959946|16722542|P4|Overall Study|Death|0
4850769|NCT00959946|16722543|P3|Overall Study|Death|0
4850770|NCT00959946|16722544|P2|Overall Study|Death|0
4850771|NCT00959946|16722545|P1|Overall Study|Death|0
4850772|NCT00959946|16722538|P8|Overall Study|Adverse Event|0
4850773|NCT00959946|16722539|P7|Overall Study|Adverse Event|0
4850774|NCT00959946|16722540|P6|Overall Study|Adverse Event|1
4850775|NCT00959946|16722541|P5|Overall Study|Adverse Event|0
4850776|NCT00959946|16722542|P4|Overall Study|Adverse Event|1
4850777|NCT00959946|16722543|P3|Overall Study|Adverse Event|2
4850778|NCT00959946|16722544|P2|Overall Study|Adverse Event|0
4850779|NCT00959946|16722545|P1|Overall Study|Adverse Event|0
4850780|NCT00959907|16722609|P2|Overall Study|Withdrawal by Subject|0
4850781|NCT00959907|16722610|P1|Overall Study|Withdrawal by Subject|2
4850782|NCT00959907|16722609|P2|Overall Study|Adverse Event|0
4850783|NCT00959907|16722610|P1|Overall Study|Adverse Event|1
4850784|NCT00959907|16722609|P2|Overall Study|Protocol Violation|1
4850785|NCT00959907|16722610|P1|Overall Study|Protocol Violation|0
4850786|NCT00959894|16722620|P1|Overall Study|Subject moved out of town|1
4850787|NCT00959894|16722620|P1|Overall Study|Need for contraindicated medication|1
4850788|NCT00959894|16722620|P1|Overall Study|Withdrawal by Subject|1
4850789|NCT00959894|16722620|P1|Overall Study|Adverse Event|3
4850790|NCT00959894|16722620|P1|Overall Study|Lost to Follow-up|10
4850791|NCT00959751|16722669|P2|Overall Study|No migraine headache without aura|7
4850792|NCT00959751|16722670|P1|Overall Study|No migraine headache without aura|7
4850793|NCT00959751|16722669|P2|Overall Study|Non-compliance to Study Procedures|1
4850794|NCT00959751|16722670|P1|Overall Study|Non-compliance to Study Procedures|0
4850795|NCT00959751|16722669|P2|Overall Study|Consent Withdrawn|1
4850796|NCT00959751|16722670|P1|Overall Study|Consent Withdrawn|0
4850797|NCT00959751|16722669|P2|Overall Study|Lost to Follow-up|3
4850798|NCT00959751|16722670|P1|Overall Study|Lost to Follow-up|2
4850799|NCT00959699|16722692|P2|Follow-up Period|Withdrawal by Subject|4
4850800|NCT00959699|16722693|P1|Follow-up Period|Withdrawal by Subject|3
4850801|NCT00959699|16722692|P2|Follow-up Period|Lost to Follow-up|2
4850802|NCT00959699|16722693|P1|Follow-up Period|Lost to Follow-up|3
4850803|NCT00959699|16722692|P2|Treatment Period|Futility/crossover to boceprevir|0
4850804|NCT00959699|16722693|P1|Treatment Period|Futility/crossover to boceprevir|4
4850805|NCT00959699|16722692|P2|Treatment Period|Did not receive treatment|1
4850806|NCT00959699|16722693|P1|Treatment Period|Did not receive treatment|0
4850807|NCT00959699|16722692|P2|Treatment Period|Non-Compliance with Protocol|1
4850808|NCT00959699|16722693|P1|Treatment Period|Non-Compliance with Protocol|0
4850809|NCT00959699|16722692|P2|Treatment Period|Withdrawal by Subject|3
4850810|NCT00959699|16722693|P1|Treatment Period|Withdrawal by Subject|1
4850811|NCT00959699|16722692|P2|Treatment Period|Lost to Follow-up|1
4850812|NCT00959699|16722693|P1|Treatment Period|Lost to Follow-up|0
4850813|NCT00959699|16722692|P2|Treatment Period|Lack of Efficacy|6
4850814|NCT00959699|16722693|P1|Treatment Period|Lack of Efficacy|15
4850815|NCT00959699|16722692|P2|Treatment Period|Adverse Event|13
4850816|NCT00959699|16722693|P1|Treatment Period|Adverse Event|3
4850817|NCT00959647|16722739|P1|Overall Study|Withdrawal by Subject|7
4850818|NCT00959647|16722739|P1|Overall Study|Study terminated by sponsor|4
4850819|NCT00959647|16722739|P1|Overall Study|Progressive disease|6
4850820|NCT00959647|16722739|P1|Overall Study|Adverse Event|2
4850821|NCT00959374|16722744|P1|Overall Study|Physician Decision|1
4850822|NCT00959374|16722744|P1|Overall Study|Implant Removed/Not Replaced|4
4850823|NCT00959374|16722744|P1|Overall Study|Protocol Violation|1
4850824|NCT00959374|16722744|P1|Overall Study|Death|1
4850825|NCT00959374|16722744|P1|Overall Study|Lost to Follow-up|14
4850826|NCT00959374|16722744|P1|Overall Study|Withdrawal by Subject|2
4850827|NCT00959192|16722758|P4|Overall Study|Caregiver Request|1
4850828|NCT00959192|16722759|P3|Overall Study|Caregiver Request|2
4850829|NCT00959192|16722760|P2|Overall Study|Caregiver Request|0
4850830|NCT00959192|16722761|P1|Overall Study|Caregiver Request|0
4850831|NCT00959192|16722758|P4|Overall Study|Investigator Request|0
4850832|NCT00959192|16722759|P3|Overall Study|Investigator Request|0
4850833|NCT00959192|16722760|P2|Overall Study|Investigator Request|0
4850834|NCT00959192|16722761|P1|Overall Study|Investigator Request|1
4850835|NCT00959192|16722758|P4|Overall Study|Adverse Event|0
4850836|NCT00959192|16722759|P3|Overall Study|Adverse Event|1
4850837|NCT00959192|16722760|P2|Overall Study|Adverse Event|1
4850838|NCT00959192|16722761|P1|Overall Study|Adverse Event|1
4850839|NCT00959049|16722820|P6|Overall Study|Withdrawal by Subject|0
4850840|NCT00959049|16722821|P5|Overall Study|Withdrawal by Subject|0
4850841|NCT00959049|16722822|P4|Overall Study|Withdrawal by Subject|0
4850842|NCT00959049|16722823|P3|Overall Study|Withdrawal by Subject|0
4850843|NCT00959049|16722824|P2|Overall Study|Withdrawal by Subject|2
4850844|NCT00959049|16722825|P1|Overall Study|Withdrawal by Subject|0
4850845|NCT00959049|16722820|P6|Overall Study|Contraindicated medication|0
4850846|NCT00959049|16722821|P5|Overall Study|Contraindicated medication|0
4850847|NCT00959049|16722822|P4|Overall Study|Contraindicated medication|1
4850848|NCT00959049|16722823|P3|Overall Study|Contraindicated medication|0
4850849|NCT00959049|16722824|P2|Overall Study|Contraindicated medication|0
4850850|NCT00959049|16722825|P1|Overall Study|Contraindicated medication|0
4850851|NCT00959049|16722820|P6|Overall Study|Lost to Follow-up|1
4850852|NCT00959049|16722821|P5|Overall Study|Lost to Follow-up|9
4850853|NCT00959049|16722822|P4|Overall Study|Lost to Follow-up|10
4850854|NCT00959049|16722823|P3|Overall Study|Lost to Follow-up|1
4850855|NCT00959049|16722824|P2|Overall Study|Lost to Follow-up|5
4850856|NCT00959049|16722825|P1|Overall Study|Lost to Follow-up|17
4850857|NCT00959049|16722820|P6|Overall Study|Adverse Event|0
4850858|NCT00959049|16722821|P5|Overall Study|Adverse Event|0
4850859|NCT00959049|16722822|P4|Overall Study|Adverse Event|0
4850860|NCT00959049|16722823|P3|Overall Study|Adverse Event|0
4850861|NCT00959049|16722824|P2|Overall Study|Adverse Event|0
4850862|NCT00959049|16722825|P1|Overall Study|Adverse Event|1
4850863|NCT00958893|16722890|P1|Overall Study|Study prematurely terminated|4
4850864|NCT00958880|16722896|P2|Overall Study|Lost to Follow-up|2
4850865|NCT00958880|16722897|P1|Overall Study|Lost to Follow-up|2
4850866|NCT00958841|16722905|P1|Overall Study|Discontinued prior to M*|28
4850867|NCT00958841|16722905|P1|Overall Study|Completed M6/did not enter extension|27
4850868|NCT00958841|16722905|P1|Overall Study|Unsatisfactory therapeutic effect|22
4850869|NCT00958841|16722905|P1|Overall Study|Withdrawal by Subject|1
4850870|NCT00958841|16722905|P1|Overall Study|New cancer therapy|5
4850871|NCT00958841|16722905|P1|Overall Study|Adverse Event|8
4850872|NCT00958841|16722905|P1|Overall Study|Administrative problems|1
4850873|NCT00958841|16722905|P1|Overall Study|Abnormal test procedure result(s)|3
4850874|NCT00958841|16722905|P1|Overall Study|Abnormal laboratory value(s)|1
4850875|NCT00958828|16722923|P2|Period 2, 1 Week of Wear|Unacceptable lens fit|1
4850876|NCT00958828|16722924|P1|Period 2, 1 Week of Wear|Unacceptable lens fit|0
4850877|NCT00958828|16722923|P2|Period 1, 1 Week of Wear|Randomization break|1
4850878|NCT00958828|16722924|P1|Period 1, 1 Week of Wear|Randomization break|0
4850879|NCT00958789|16722930|P1|Overall Study|Revision|7
4850880|NCT00958789|16722930|P1|Overall Study|Subject terminated|2
4850881|NCT00958789|16722930|P1|Overall Study|2 yr. Knee Society Score not calculable|1
4850882|NCT00958789|16722930|P1|Overall Study|No 2 yr. Knee Society Score data|4
4850883|NCT00958789|16722930|P1|Overall Study|Withdrawal by Subject|17
4850884|NCT00958789|16722930|P1|Overall Study|Lost to Follow-up|14
4850885|NCT00958789|16722930|P1|Overall Study|Death|5
4850886|NCT00958776|16722950|P2|Overall Study|Missing|1
4850887|NCT00958776|16722951|P1|Overall Study|Missing|1
4850888|NCT00958776|16722950|P2|Overall Study|Noncompliance; Protocol Deviations|3
4850889|NCT00958776|16722951|P1|Overall Study|Noncompliance; Protocol Deviations|2
4850890|NCT00958776|16722950|P2|Overall Study|Death|1
4850891|NCT00958776|16722951|P1|Overall Study|Death|2
4850892|NCT00958776|16722950|P2|Overall Study|Protocol Violation|1
4850893|NCT00958776|16722951|P1|Overall Study|Protocol Violation|1
4850894|NCT00958776|16722950|P2|Overall Study|Withdrawal by Subject|16
4850895|NCT00958776|16722951|P1|Overall Study|Withdrawal by Subject|7
4850896|NCT00958776|16722950|P2|Overall Study|Lost to Follow-up|6
4850897|NCT00958776|16722951|P1|Overall Study|Lost to Follow-up|2
4850898|NCT00958776|16722950|P2|Overall Study|Physician Decision|0
4850899|NCT00958776|16722951|P1|Overall Study|Physician Decision|1
4850900|NCT00958776|16722950|P2|Overall Study|Adverse Event|1
4850901|NCT00958776|16722951|P1|Overall Study|Adverse Event|0
4850902|NCT00958724|16722981|P1|Overall Study|Disease Progression|6
4850903|NCT00958711|16722993|P2|Overall Study|Adverse Event|2
4850904|NCT00958711|16722994|P1|Overall Study|Adverse Event|1
4850905|NCT00958711|16722993|P2|Overall Study|Death|2
4850906|NCT00958711|16722994|P1|Overall Study|Death|1
4850907|NCT00958711|16722993|P2|Overall Study|Other|5
4850908|NCT00958711|16722994|P1|Overall Study|Other|2
4850909|NCT00958711|16722993|P2|Overall Study|Lost to Follow-up|1
4850910|NCT00958711|16722994|P1|Overall Study|Lost to Follow-up|4
4850911|NCT00958711|16722993|P2|Overall Study|Physician Decision|7
4850912|NCT00958711|16722994|P1|Overall Study|Physician Decision|5
4850913|NCT00958711|16722993|P2|Overall Study|Withdrawal by Subject|4
4850914|NCT00958711|16722994|P1|Overall Study|Withdrawal by Subject|0
4850915|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
4850916|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1
4850917|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
4850918|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0
4850919|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
4850920|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1
4850921|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
4850922|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0
4850923|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1
4850924|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2
4850925|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
4850926|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0
4850927|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4
4850928|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5
4850929|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
4850930|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0
4850931|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8
4850932|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3
4850933|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
4850934|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0
4850935|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5
4850936|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11
4850937|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
4850938|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0
4850939|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15
4850940|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16
4850941|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
4850942|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0
4850943|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10
4850944|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19
4850945|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
4850946|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0
4850947|NCT00958568|16723039|P4|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63
4850948|NCT00958568|16723040|P3|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24
4850949|NCT00958568|16723041|P2|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
4850950|NCT00958568|16723042|P1|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0
4850951|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
4850952|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
4850953|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1
4850954|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0
4850955|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
4850956|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
4850957|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1
4850958|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0
4850959|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
4850960|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
4850961|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4
4850962|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0
4850963|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
4850964|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
4850965|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5
4850966|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0
4850967|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
4850968|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
4850969|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6
4850970|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0
4850971|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
4850972|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
4850973|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9
4850974|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0
4850975|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
4850976|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
4850977|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24
4850978|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0
4850979|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
4850980|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
4850981|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41
4850982|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0
4850983|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
4850984|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
4850985|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28
4850986|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0
4850987|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
4850988|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
4850989|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30
4850990|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0
4850991|NCT00958568|16723039|P4|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
4850992|NCT00958568|16723040|P3|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
4850993|NCT00958568|16723041|P2|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62
4850994|NCT00958568|16723042|P1|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0
4850995|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
4850996|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
4850997|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0
4850998|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1
4850999|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
4851000|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
4851001|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0
4851002|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8
4851003|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
4851004|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
4851005|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0
4851006|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4
4851007|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
4851008|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
4851009|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0
4851010|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13
4851011|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
4851012|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
4851013|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0
4851014|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14
4851015|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
4851016|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
4851017|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0
4851018|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39
4851019|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
4851020|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
4851021|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0
4851022|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34
4851023|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
4851024|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
4851025|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0
4851026|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44
4851027|NCT00958568|16723039|P4|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
4851028|NCT00958568|16723040|P3|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
4851029|NCT00958568|16723041|P2|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0
4851030|NCT00958568|16723042|P1|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80
4851031|NCT00958438|16723279|P3|Overall Study|Other than specified above|2
4851032|NCT00958438|16723280|P2|Overall Study|Other than specified above|3
4851033|NCT00958438|16723281|P1|Overall Study|Other than specified above|2
4851034|NCT00958438|16723279|P3|Overall Study|Physician Decision|1
4851035|NCT00958438|16723280|P2|Overall Study|Physician Decision|0
4851036|NCT00958438|16723281|P1|Overall Study|Physician Decision|1
4851037|NCT00958438|16723279|P3|Overall Study|Adverse Event|0
4851038|NCT00958438|16723280|P2|Overall Study|Adverse Event|3
4851039|NCT00958438|16723281|P1|Overall Study|Adverse Event|0
4851040|NCT00958438|16723279|P3|Overall Study|Withdrawal by Subject|1
4851041|NCT00958438|16723280|P2|Overall Study|Withdrawal by Subject|2
4851042|NCT00958438|16723281|P1|Overall Study|Withdrawal by Subject|4
4851043|NCT00958438|16723279|P3|Overall Study|Protocol Violation|2
4851044|NCT00958438|16723280|P2|Overall Study|Protocol Violation|2
4851045|NCT00958438|16723281|P1|Overall Study|Protocol Violation|3
4851046|NCT00958412|16723304|P1|Overall Study|Study prematurely terminated|18
4851047|NCT00958360|16723310|P2|Overall Study|Lost to Follow-up|1
4851048|NCT00958360|16723311|P1|Overall Study|Lost to Follow-up|0
4851049|NCT00958360|16723310|P2|Overall Study|Physician Decision|1
4851050|NCT00958360|16723311|P1|Overall Study|Physician Decision|2
4851051|NCT00958360|16723310|P2|Overall Study|Death|7
4851052|NCT00958360|16723311|P1|Overall Study|Death|6
4851053|NCT00958360|16723310|P2|Overall Study|Withdrawal by Subject|1
4851054|NCT00958360|16723311|P1|Overall Study|Withdrawal by Subject|3
4851055|NCT00958347|16723325|P1|Overall Study|study termination|135
4851056|NCT00958347|16723325|P1|Overall Study|revision/removal|10
4851057|NCT00958347|16723325|P1|Overall Study|Lost to Follow-up|15
4851058|NCT00958347|16723325|P1|Overall Study|Withdrawal by Subject|23
4851059|NCT00958347|16723325|P1|Overall Study|Death|43
4851060|NCT00958256|16723369|P1|Overall Study|Adverse Event|3
4851061|NCT00958243|16723379|P6|Overall Study|Lost to Follow-up|5
4851062|NCT00958243|16723380|P5|Overall Study|Lost to Follow-up|8
4851063|NCT00958243|16723381|P4|Overall Study|Lost to Follow-up|2
4851064|NCT00958243|16723382|P3|Overall Study|Lost to Follow-up|11
4851065|NCT00958243|16723383|P2|Overall Study|Lost to Follow-up|5
4851066|NCT00958243|16723384|P1|Overall Study|Lost to Follow-up|2
4851067|NCT00958243|16723379|P6|Overall Study|Withdrawal by Subject|5
4851068|NCT00958243|16723380|P5|Overall Study|Withdrawal by Subject|1
4851069|NCT00958243|16723381|P4|Overall Study|Withdrawal by Subject|1
4851070|NCT00958243|16723382|P3|Overall Study|Withdrawal by Subject|3
4851071|NCT00958243|16723383|P2|Overall Study|Withdrawal by Subject|1
4851072|NCT00958243|16723384|P1|Overall Study|Withdrawal by Subject|0
4851073|NCT00958217|16723442|P2|Overall Study|Inpatient hospitalization|1
4851074|NCT00958217|16723443|P1|Overall Study|Inpatient hospitalization|0
4851075|NCT00958217|16723442|P2|Overall Study|Moved out of area|1
4851076|NCT00958217|16723443|P1|Overall Study|Moved out of area|1
4851077|NCT00958217|16723442|P2|Overall Study|Lost to Follow-up|19
4851078|NCT00958217|16723443|P1|Overall Study|Lost to Follow-up|17
4851079|NCT00958217|16723442|P2|Overall Study|Withdrawal by Subject|3
4851080|NCT00958217|16723443|P1|Overall Study|Withdrawal by Subject|4
4851081|NCT00958217|16723442|P2|Overall Study|Death|1
4851082|NCT00958217|16723443|P1|Overall Study|Death|2
4851083|NCT00958191|16723454|P1|Overall Study|No 5 yr x-rays|56
4851084|NCT00958191|16723454|P1|Overall Study|Site termination|11
4851085|NCT00958191|16723454|P1|Overall Study|Revision of study device|4
4851086|NCT00958191|16723454|P1|Overall Study|Unable/Unwilling to Return/Withdrawal|21
4851087|NCT00958191|16723454|P1|Overall Study|Inadequate 5 yr x-ray quality|10
4851088|NCT00958191|16723454|P1|Overall Study|Lost to Follow-up|5
4851089|NCT00958191|16723454|P1|Overall Study|Death|4
4851090|NCT00958165|16723469|P1|Overall Study|Not eligible|9
4851091|NCT00958165|16723469|P1|Overall Study|Lost to Follow-up|5
4851092|NCT00958126|16723481|P8|Overall Study|Other Reason|0
4851093|NCT00958126|16723482|P7|Overall Study|Other Reason|0
4851094|NCT00958126|16723483|P6|Overall Study|Other Reason|1
4851095|NCT00958126|16723484|P5|Overall Study|Other Reason|0
4851096|NCT00958126|16723485|P4|Overall Study|Other Reason|1
4851097|NCT00958126|16723486|P3|Overall Study|Other Reason|0
4851098|NCT00958126|16723487|P2|Overall Study|Other Reason|0
4851099|NCT00958126|16723488|P1|Overall Study|Other Reason|0
4851100|NCT00958126|16723481|P8|Overall Study|Sponsor/Investigator decision|0
4851101|NCT00958126|16723482|P7|Overall Study|Sponsor/Investigator decision|0
4851102|NCT00958126|16723483|P6|Overall Study|Sponsor/Investigator decision|0
4851103|NCT00958126|16723484|P5|Overall Study|Sponsor/Investigator decision|0
4851104|NCT00958126|16723485|P4|Overall Study|Sponsor/Investigator decision|1
4851105|NCT00958126|16723486|P3|Overall Study|Sponsor/Investigator decision|0
4851106|NCT00958126|16723487|P2|Overall Study|Sponsor/Investigator decision|0
4851107|NCT00958126|16723488|P1|Overall Study|Sponsor/Investigator decision|0
4851108|NCT00958126|16723481|P8|Overall Study|Lost to Follow-up|0
4851109|NCT00958126|16723482|P7|Overall Study|Lost to Follow-up|0
4851110|NCT00958126|16723483|P6|Overall Study|Lost to Follow-up|0
4851111|NCT00958126|16723484|P5|Overall Study|Lost to Follow-up|0
4851112|NCT00958126|16723485|P4|Overall Study|Lost to Follow-up|8
4851113|NCT00958126|16723486|P3|Overall Study|Lost to Follow-up|9
4851114|NCT00958126|16723487|P2|Overall Study|Lost to Follow-up|5
4851115|NCT00958126|16723488|P1|Overall Study|Lost to Follow-up|1
4851116|NCT00958126|16723481|P8|Overall Study|Moved away from study area|0
4851117|NCT00958126|16723482|P7|Overall Study|Moved away from study area|0
4851118|NCT00958126|16723483|P6|Overall Study|Moved away from study area|0
4851119|NCT00958126|16723484|P5|Overall Study|Moved away from study area|0
4851120|NCT00958126|16723485|P4|Overall Study|Moved away from study area|1
4851121|NCT00958126|16723486|P3|Overall Study|Moved away from study area|1
4851122|NCT00958126|16723487|P2|Overall Study|Moved away from study area|0
4851123|NCT00958126|16723488|P1|Overall Study|Moved away from study area|0
4851124|NCT00958126|16723481|P8|Overall Study|Withdrawal by Subject|0
4851125|NCT00958126|16723482|P7|Overall Study|Withdrawal by Subject|0
4851126|NCT00958126|16723483|P6|Overall Study|Withdrawal by Subject|0
4851127|NCT00958126|16723484|P5|Overall Study|Withdrawal by Subject|0
4851128|NCT00958126|16723485|P4|Overall Study|Withdrawal by Subject|0
4851129|NCT00958126|16723486|P3|Overall Study|Withdrawal by Subject|0
4851130|NCT00958126|16723487|P2|Overall Study|Withdrawal by Subject|2
4851131|NCT00958126|16723488|P1|Overall Study|Withdrawal by Subject|0
4851132|NCT00958126|16723481|P8|Overall Study|Serious Adverse Event|0
4851133|NCT00958126|16723482|P7|Overall Study|Serious Adverse Event|1
4851134|NCT00958126|16723483|P6|Overall Study|Serious Adverse Event|0
4851135|NCT00958126|16723484|P5|Overall Study|Serious Adverse Event|0
4851136|NCT00958126|16723485|P4|Overall Study|Serious Adverse Event|0
4851137|NCT00958126|16723486|P3|Overall Study|Serious Adverse Event|0
4851138|NCT00958126|16723487|P2|Overall Study|Serious Adverse Event|2
4851139|NCT00958126|16723488|P1|Overall Study|Serious Adverse Event|0
4851140|NCT00958074|16723560|P2|Overall Study|Withdrawal by Subject|1
4851141|NCT00958074|16723561|P1|Overall Study|Withdrawal by Subject|0
4851142|NCT00958009|16723584|P1|Overall Study|Subject found device difficult to use|1
4851143|NCT00958009|16723584|P1|Overall Study|Adverse Event|1
4851144|NCT00957996|16723591|P2|Overall Study|Noncompliance; Protocol Deviations|6
4851145|NCT00957996|16723592|P1|Overall Study|Noncompliance; Protocol Deviations|5
4851146|NCT00957996|16723591|P2|Overall Study|Missing|0
4851147|NCT00957996|16723592|P1|Overall Study|Missing|1
4851148|NCT00957996|16723591|P2|Overall Study|Influenza-related complication|1
4851149|NCT00957996|16723592|P1|Overall Study|Influenza-related complication|0
4851150|NCT00957996|16723591|P2|Overall Study|Physician Decision|1
4851151|NCT00957996|16723592|P1|Overall Study|Physician Decision|1
4851152|NCT00957996|16723591|P2|Overall Study|Adverse Event|1
4851153|NCT00957996|16723592|P1|Overall Study|Adverse Event|2
4851154|NCT00957996|16723591|P2|Overall Study|Withdrawal by Subject|2
4851155|NCT00957996|16723592|P1|Overall Study|Withdrawal by Subject|9
4851156|NCT00957996|16723591|P2|Overall Study|Lost to Follow-up|7
4851157|NCT00957996|16723592|P1|Overall Study|Lost to Follow-up|4
4851158|NCT00957996|16723591|P2|Overall Study|Death|10
4851159|NCT00957996|16723592|P1|Overall Study|Death|4
4851160|NCT00957944|16723624|P2|First Intervention- 24 Hours|Withdrawal by Subject|1
4851161|NCT00957944|16723625|P1|First Intervention- 24 Hours|Withdrawal by Subject|0
4851162|NCT00957931|16723659|P1|Overall Study|Death|4
4851163|NCT00957905|16723669|P2|Part B|Protocol Violation|1
4851164|NCT00957905|16723670|P1|Part B|Protocol Violation|0
4851165|NCT00957905|16723669|P2|Part B|Death|1
4851166|NCT00957905|16723670|P1|Part B|Death|0
4851167|NCT00957905|16723669|P2|Part B|Physician Decision|1
4851168|NCT00957905|16723670|P1|Part B|Physician Decision|0
4851169|NCT00957905|16723669|P2|Part B|Not Treated|1
4851170|NCT00957905|16723670|P1|Part B|Not Treated|0
4851171|NCT00957853|16723679|P3|Overall Study|Withdrawal by Subject|0
4851172|NCT00957853|16723680|P2|Overall Study|Withdrawal by Subject|0
4851173|NCT00957853|16723681|P1|Overall Study|Withdrawal by Subject|1
4851174|NCT00957801|16723705|P4|Overall Study|Withdrawal by Subject|1
4851175|NCT00957801|16723706|P3|Overall Study|Withdrawal by Subject|0
4851176|NCT00957801|16723707|P2|Overall Study|Withdrawal by Subject|0
4851177|NCT00957801|16723708|P1|Overall Study|Withdrawal by Subject|0
4851178|NCT00957723|16723874|P1|Overall Study|2yr ROM Data Not Evaluable|12
4851179|NCT00957723|16723874|P1|Overall Study|Intercurrent Illness|2
4851180|NCT00957723|16723874|P1|Overall Study|Investigative Site Terminated|61
4851181|NCT00957723|16723874|P1|Overall Study|Withdrawal by Subject|24
4851182|NCT00957723|16723874|P1|Overall Study|Lost to Follow-up|8
4851183|NCT00957723|16723874|P1|Overall Study|Revision/ Removal of Study Implant|3
4851184|NCT00957723|16723874|P1|Overall Study|Death|3
4851185|NCT00957658|16723963|P1|Overall Study|Protocol Violation|5
4851186|NCT00957658|16723963|P1|Overall Study|surgery cancelled|2
4851187|NCT00957658|16723963|P1|Overall Study|unwilling/unable to return|2
4851188|NCT00957658|16723963|P1|Overall Study|Site termination|10
4851189|NCT00957658|16723963|P1|Overall Study|Incomplete 2 yr data|28
4851190|NCT00957658|16723963|P1|Overall Study|Revision|1
4851191|NCT00957658|16723963|P1|Overall Study|Withdrawal by Subject|12
4851192|NCT00957658|16723963|P1|Overall Study|Lost to Follow-up|4
4851193|NCT00957658|16723963|P1|Overall Study|Death|1
4851194|NCT00957580|16723990|P3|Overall Study|Enrolled but not treated|0
4851195|NCT00957580|16723991|P2|Overall Study|Enrolled but not treated|1
4851196|NCT00957580|16723992|P1|Overall Study|Enrolled but not treated|0
4851197|NCT00957580|16723990|P3|Overall Study|Ongoing at data cut-off|0
4851198|NCT00957580|16723991|P2|Overall Study|Ongoing at data cut-off|1
4851199|NCT00957580|16723992|P1|Overall Study|Ongoing at data cut-off|0
4851200|NCT00957528|16724139|P3|Overall Study|Withdrawal by Subject|1
4851201|NCT00957528|16724140|P2|Overall Study|Withdrawal by Subject|0
4851202|NCT00957528|16724141|P1|Overall Study|Withdrawal by Subject|0
4851203|NCT00957528|16724139|P3|Overall Study|Protocol Violation|0
4851204|NCT00957528|16724140|P2|Overall Study|Protocol Violation|1
4851205|NCT00957528|16724141|P1|Overall Study|Protocol Violation|0
4851206|NCT00957424|16724164|P1|Overall Study|Withdrawal by Subject|1
4851207|NCT00957424|16724164|P1|Overall Study|Protocol Violation|3
4851208|NCT00957424|16724164|P1|Overall Study|Lost to Follow-up|19
4851209|NCT00957372|16724174|P4|PART II|Patient non-compliance|4
4851210|NCT00957372|16724175|P3|PART II|Patient non-compliance|0
4851211|NCT00957372|16724176|P2|PART II|Patient non-compliance|0
4851212|NCT00957372|16724177|P1|PART II|Patient non-compliance|0
4851213|NCT00957372|16724174|P4|PART II|Adverse Event|10
4851214|NCT00957372|16724175|P3|PART II|Adverse Event|0
4851215|NCT00957372|16724176|P2|PART II|Adverse Event|0
4851216|NCT00957372|16724177|P1|PART II|Adverse Event|0
4851217|NCT00957372|16724174|P4|PART II|Not Know|20
4851218|NCT00957372|16724175|P3|PART II|Not Know|0
4851219|NCT00957372|16724176|P2|PART II|Not Know|0
4851220|NCT00957372|16724177|P1|PART II|Not Know|0
4851221|NCT00957372|16724174|P4|PART II|Pregnancy|1
4851222|NCT00957372|16724175|P3|PART II|Pregnancy|0
4851223|NCT00957372|16724176|P2|PART II|Pregnancy|0
4851224|NCT00957372|16724177|P1|PART II|Pregnancy|0
4851225|NCT00957372|16724174|P4|PART II|Physician Decision|1
4851226|NCT00957372|16724175|P3|PART II|Physician Decision|0
4851227|NCT00957372|16724176|P2|PART II|Physician Decision|0
4851228|NCT00957372|16724177|P1|PART II|Physician Decision|0
4851229|NCT00957372|16724174|P4|PART II|Withdrawal by Subject|8
4851230|NCT00957372|16724175|P3|PART II|Withdrawal by Subject|0
4851231|NCT00957372|16724176|P2|PART II|Withdrawal by Subject|0
4851232|NCT00957372|16724177|P1|PART II|Withdrawal by Subject|0
4851233|NCT00957372|16724174|P4|PART I|Lost to Follow-up|0
4851234|NCT00957372|16724175|P3|PART I|Lost to Follow-up|1
4851235|NCT00957372|16724176|P2|PART I|Lost to Follow-up|0
4851236|NCT00957372|16724177|P1|PART I|Lost to Follow-up|0
4851237|NCT00957268|16724317|P5|Overall Study|Voluntary Withdrawal|0
4851238|NCT00957268|16724318|P4|Overall Study|Voluntary Withdrawal|0
4851239|NCT00957268|16724319|P3|Overall Study|Voluntary Withdrawal|1
4851240|NCT00957268|16724320|P2|Overall Study|Voluntary Withdrawal|0
4851241|NCT00957268|16724321|P1|Overall Study|Voluntary Withdrawal|0
4851242|NCT00957034|16724443|P3|Overall Study|Withdrawal by Subject|0
4851243|NCT00957034|16724444|P2|Overall Study|Withdrawal by Subject|2
4851244|NCT00957034|16724445|P1|Overall Study|Withdrawal by Subject|0
4851245|NCT00957034|16724443|P3|Overall Study|Sponsor Terminated Study|5
4851246|NCT00957034|16724444|P2|Overall Study|Sponsor Terminated Study|1
4851247|NCT00957034|16724445|P1|Overall Study|Sponsor Terminated Study|6
4851248|NCT00957034|16724443|P3|Overall Study|Adverse Event|1
4851249|NCT00957034|16724444|P2|Overall Study|Adverse Event|1
4851250|NCT00957034|16724445|P1|Overall Study|Adverse Event|0
4851251|NCT00957021|16724468|P1|Overall Study|Termination due to language issue|2
4851252|NCT00957021|16724468|P1|Overall Study|Surgery Cancelled|9
4851253|NCT00957021|16724468|P1|Overall Study|Site Termination by the 2 yr visit|16
4851254|NCT00957021|16724468|P1|Overall Study|Revised study component by 2 yr visit|8
4851255|NCT00957021|16724468|P1|Overall Study|No 2 yr ROM data|35
4851256|NCT00957021|16724468|P1|Overall Study|Withdrawal by Subject|34
4851257|NCT00957021|16724468|P1|Overall Study|Lost to Follow-up|8
4851258|NCT00957021|16724468|P1|Overall Study|Death|5
4851259|NCT00957008|16724481|P4|Overall Study|Relocated; Family conflict|3
4851260|NCT00957008|16724482|P3|Overall Study|Relocated; Family conflict|1
4851261|NCT00957008|16724483|P2|Overall Study|Relocated; Family conflict|1
4851262|NCT00957008|16724484|P1|Overall Study|Relocated; Family conflict|4
4851263|NCT00957008|16724481|P4|Overall Study|Physician Decision|1
4851264|NCT00957008|16724482|P3|Overall Study|Physician Decision|1
4851265|NCT00957008|16724483|P2|Overall Study|Physician Decision|0
4851266|NCT00957008|16724484|P1|Overall Study|Physician Decision|1
4851267|NCT00957008|16724481|P4|Overall Study|Lost to Follow-up|4
4851268|NCT00957008|16724482|P3|Overall Study|Lost to Follow-up|3
4851269|NCT00957008|16724483|P2|Overall Study|Lost to Follow-up|1
4851270|NCT00957008|16724484|P1|Overall Study|Lost to Follow-up|3
4851271|NCT00957008|16724481|P4|Overall Study|Withdrawal by Subject|16
4851272|NCT00957008|16724482|P3|Overall Study|Withdrawal by Subject|12
4851273|NCT00957008|16724483|P2|Overall Study|Withdrawal by Subject|10
4851274|NCT00957008|16724484|P1|Overall Study|Withdrawal by Subject|13
4851275|NCT00956943|16724512|P2|Overall Study|Lost to Follow-up|10
4851276|NCT00956943|16724513|P1|Overall Study|Lost to Follow-up|9
4851277|NCT00956839|16724537|P3|Overall Study|Lost to Follow-up|3
4851278|NCT00956839|16724538|P2|Overall Study|Lost to Follow-up|0
4851279|NCT00956839|16724539|P1|Overall Study|Lost to Follow-up|3
4851280|NCT00956813|16724552|P2|Flaxseed and Placebo|Ineligible|1
4851281|NCT00956813|16724553|P1|Flaxseed and Placebo|Ineligible|3
4851282|NCT00956813|16724552|P2|Flaxseed and Placebo|Withdrawal by Subject|4
4851283|NCT00956813|16724553|P1|Flaxseed and Placebo|Withdrawal by Subject|5
4851284|NCT00956592|16724605|P2|Overall Study|Protocol Violation|3
4851285|NCT00956592|16724606|P1|Overall Study|Protocol Violation|1
4851286|NCT00956293|16724641|P3|Follow-up Period|Follow-up period was terminated.|0
4851287|NCT00956293|16724642|P2|Follow-up Period|Follow-up period was terminated.|32
4851288|NCT00956293|16724643|P1|Follow-up Period|Follow-up period was terminated.|20
4851289|NCT00956293|16724641|P3|Main Period (Randomization)|Adverse Event|0
4851290|NCT00956293|16724642|P2|Main Period (Randomization)|Adverse Event|15
4851291|NCT00956293|16724643|P1|Main Period (Randomization)|Adverse Event|0
4851292|NCT00956293|16724641|P3|Main Period (Randomization)|Lack of Efficacy|0
4851293|NCT00956293|16724642|P2|Main Period (Randomization)|Lack of Efficacy|10
4851294|NCT00956293|16724643|P1|Main Period (Randomization)|Lack of Efficacy|1
4851295|NCT00956293|16724641|P3|Main Period (Randomization)|Abnormal laboratory value|0
4851296|NCT00956293|16724642|P2|Main Period (Randomization)|Abnormal laboratory value|2
4851297|NCT00956293|16724643|P1|Main Period (Randomization)|Abnormal laboratory value|0
4851298|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Abnormal laboratory value|44
4851299|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Abnormal laboratory value|0
4851300|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Abnormal laboratory value|0
4851301|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Adverse Event|36
4851302|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Adverse Event|0
4851303|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Adverse Event|0
4851304|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Lack of Efficacy|20
4851305|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Lack of Efficacy|0
4851306|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Lack of Efficacy|0
4851307|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Withdrawal by Subject|12
4851308|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Withdrawal by Subject|0
4851309|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Withdrawal by Subject|0
4851310|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Graft loss|7
4851311|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Graft loss|0
4851312|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Graft loss|0
4851313|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Administrative problems|6
4851314|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Administrative problems|0
4851315|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Administrative problems|0
4851316|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Abnormal test procedure result|2
4851317|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Abnormal test procedure result|0
4851318|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Abnormal test procedure result|0
4851319|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Protocol Violation|1
4851320|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Protocol Violation|0
4851321|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Protocol Violation|0
4851322|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Death|1
4851323|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Death|0
4851324|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Death|0
4851325|NCT00956293|16724641|P3|Main Period (Pre-randomization)|Not specified (data missing)|1
4851326|NCT00956293|16724642|P2|Main Period (Pre-randomization)|Not specified (data missing)|0
4851327|NCT00956293|16724643|P1|Main Period (Pre-randomization)|Not specified (data missing)|0
4851328|NCT00955968|16724698|P2|Overall Study|Site closed|52
4851329|NCT00955968|16724699|P1|Overall Study|Site closed|55
4851330|NCT00955968|16724698|P2|Overall Study|Lost to Follow-up|39
4851331|NCT00955968|16724699|P1|Overall Study|Lost to Follow-up|45
4851332|NCT00955968|16724698|P2|Overall Study|Withdrawal by Subject|31
4851333|NCT00955968|16724699|P1|Overall Study|Withdrawal by Subject|35
4851334|NCT00955968|16724698|P2|Overall Study|Death|4
4851335|NCT00955968|16724699|P1|Overall Study|Death|2
4851336|NCT00955955|16724741|P3|Overall Study|Lost to Follow-up|0
4851337|NCT00955955|16724742|P2|Overall Study|Lost to Follow-up|0
4851338|NCT00955955|16724743|P1|Overall Study|Lost to Follow-up|2
4851339|NCT00955825|16724827|P2|Overall Study|Any other reason not above-mentioned|9
4851340|NCT00955825|16724828|P1|Overall Study|Any other reason not above-mentioned|7
4851341|NCT00955825|16724827|P2|Overall Study|Withdrawal by Subject|6
4851342|NCT00955825|16724828|P1|Overall Study|Withdrawal by Subject|4
4851343|NCT00955825|16724827|P2|Overall Study|Adverse Event|2
4851344|NCT00955825|16724828|P1|Overall Study|Adverse Event|15
4851345|NCT00955721|16724845|P2|Overall Study|Withdrawal by Subject|0
4851346|NCT00955721|16724846|P1|Overall Study|Withdrawal by Subject|1
4851347|NCT00955721|16724845|P2|Overall Study|Death|0
4851348|NCT00955721|16724846|P1|Overall Study|Death|1
4851349|NCT00955721|16724845|P2|Overall Study|Physician Decision|0
4851350|NCT00955721|16724846|P1|Overall Study|Physician Decision|1
4851351|NCT00955708|16724856|P1|Overall Study|Patient changed care provider/moved|91
4851352|NCT00955708|16724856|P1|Overall Study|Closure of study location|60
4851353|NCT00955708|16724856|P1|Overall Study|Patient Refused to participate further|116
4851354|NCT00955708|16724856|P1|Overall Study|Product removed from service|94
4851355|NCT00955708|16724856|P1|Overall Study|Registry Conclusion|186
4851356|NCT00955708|16724856|P1|Overall Study|Protocol Violation|134
4851357|NCT00955708|16724856|P1|Overall Study|Physician Decision|36
4851358|NCT00955708|16724856|P1|Overall Study|Lost to Follow-up|72
4851359|NCT00955708|16724856|P1|Overall Study|Death|269
4851360|NCT00955682|16724862|P2|Booster Period (Month 49)|Lost to Follow-up|1
4851361|NCT00955682|16724863|P1|Booster Period (Month 49)|Lost to Follow-up|1
4851362|NCT00955617|16724973|P2|Second MRA (Between Day 1 and Day 51)|conventional angiography|0
4851363|NCT00955617|16724974|P1|Second MRA (Between Day 1 and Day 51)|conventional angiography|1
4851364|NCT00955617|16724973|P2|Second MRA (Between Day 1 and Day 51)|technical incident|1
4851365|NCT00955617|16724974|P1|Second MRA (Between Day 1 and Day 51)|technical incident|0
4851366|NCT00955617|16724973|P2|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1
4851367|NCT00955617|16724974|P1|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0
4851368|NCT00955617|16724973|P2|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1
4851369|NCT00955617|16724974|P1|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2
4851370|NCT00955474|16725038|P2|Overall Study|Physician Decision|5
4851371|NCT00955474|16725039|P1|Overall Study|Physician Decision|7
4851372|NCT00955357|16725075|P2|Maintenance Phase|Non compliance to study procedures|0
4851373|NCT00955357|16725076|P1|Maintenance Phase|Non compliance to study procedures|1
4851374|NCT00955357|16725075|P2|Maintenance Phase|Patient moving out of area|1
4851375|NCT00955357|16725076|P1|Maintenance Phase|Patient moving out of area|0
4851376|NCT00955357|16725075|P2|Maintenance Phase|Withdrawal by Subject|4
4851377|NCT00955357|16725076|P1|Maintenance Phase|Withdrawal by Subject|4
4851378|NCT00955357|16725075|P2|Maintenance Phase|Lost to Follow-up|7
4851379|NCT00955357|16725076|P1|Maintenance Phase|Lost to Follow-up|2
4851380|NCT00955357|16725075|P2|Maintenance Phase|Protocol Violation|6
4851381|NCT00955357|16725076|P1|Maintenance Phase|Protocol Violation|2
4851382|NCT00955357|16725075|P2|Maintenance Phase|Lack of Efficacy|4
4851383|NCT00955357|16725076|P1|Maintenance Phase|Lack of Efficacy|0
4851384|NCT00955357|16725075|P2|Maintenance Phase|Adverse Event|23
4851385|NCT00955357|16725076|P1|Maintenance Phase|Adverse Event|3
4851386|NCT00955357|16725075|P2|Titration Phase|Non compliance to study procedures|1
4851387|NCT00955357|16725076|P1|Titration Phase|Non compliance to study procedures|0
4851388|NCT00955357|16725075|P2|Titration Phase|Study medication not tolerated|1
4851389|NCT00955357|16725076|P1|Titration Phase|Study medication not tolerated|0
4851390|NCT00955357|16725075|P2|Titration Phase|Prohibited Antiepileptic Drug change|1
4851391|NCT00955357|16725076|P1|Titration Phase|Prohibited Antiepileptic Drug change|0
4851392|NCT00955357|16725075|P2|Titration Phase|Withdrawal by Subject|5
4851393|NCT00955357|16725076|P1|Titration Phase|Withdrawal by Subject|3
4851394|NCT00955357|16725075|P2|Titration Phase|Lost to Follow-up|3
4851395|NCT00955357|16725076|P1|Titration Phase|Lost to Follow-up|1
4851396|NCT00955357|16725075|P2|Titration Phase|Protocol Violation|7
4851397|NCT00955357|16725076|P1|Titration Phase|Protocol Violation|3
4851398|NCT00955357|16725075|P2|Titration Phase|Lack of Efficacy|2
4851399|NCT00955357|16725076|P1|Titration Phase|Lack of Efficacy|0
4851400|NCT00955357|16725075|P2|Titration Phase|Adverse Event|46
4851401|NCT00955357|16725076|P1|Titration Phase|Adverse Event|9
4851402|NCT00955305|16725084|P2|Overall Study|Ineligible|7
4851403|NCT00955305|16725085|P1|Overall Study|Ineligible|5
4851404|NCT00955305|16725084|P2|Overall Study|Never started protocol treatment|5
4851405|NCT00955305|16725085|P1|Overall Study|Never started protocol treatment|5
4851406|NCT00955305|16725084|P2|Overall Study|No off-treatment reason submitted|0
4851407|NCT00955305|16725085|P1|Overall Study|No off-treatment reason submitted|1
4851408|NCT00955305|16725084|P2|Overall Study|Lost to Follow-up|1
4851409|NCT00955305|16725085|P1|Overall Study|Lost to Follow-up|0
4851410|NCT00955305|16725084|P2|Overall Study|Maximum response achieved|1
4851411|NCT00955305|16725085|P1|Overall Study|Maximum response achieved|0
4851412|NCT00955305|16725084|P2|Overall Study|Functional decline|0
4851413|NCT00955305|16725085|P1|Overall Study|Functional decline|2
4851414|NCT00955305|16725084|P2|Overall Study|Continued presence of residual disease|1
4851415|NCT00955305|16725085|P1|Overall Study|Continued presence of residual disease|0
4851416|NCT00955305|16725084|P2|Overall Study|Physician Decision|0
4851417|NCT00955305|16725085|P1|Overall Study|Physician Decision|1
4851418|NCT00955305|16725084|P2|Overall Study|Other complicating disease|4
4851419|NCT00955305|16725085|P1|Overall Study|Other complicating disease|2
4851420|NCT00955305|16725084|P2|Overall Study|Alternative therapy|0
4851421|NCT00955305|16725085|P1|Overall Study|Alternative therapy|4
4851422|NCT00955305|16725084|P2|Overall Study|Withdrawal by Subject|4
4851423|NCT00955305|16725085|P1|Overall Study|Withdrawal by Subject|5
4851424|NCT00955305|16725084|P2|Overall Study|Death|1
4851425|NCT00955305|16725085|P1|Overall Study|Death|2
4851426|NCT00955305|16725084|P2|Overall Study|Adverse Event|22
4851427|NCT00955305|16725085|P1|Overall Study|Adverse Event|22
4851428|NCT00955305|16725084|P2|Overall Study|Disease progression|41
4851429|NCT00955305|16725085|P1|Overall Study|Disease progression|39
4851430|NCT00955279|16725098|P3|Overall Study|Withdrawal by Subject|3
4851431|NCT00955279|16725099|P2|Overall Study|Withdrawal by Subject|0
4851432|NCT00955279|16725100|P1|Overall Study|Withdrawal by Subject|2
4851433|NCT00955279|16725098|P3|Overall Study|Lost to Follow-up|1
4851434|NCT00955279|16725099|P2|Overall Study|Lost to Follow-up|3
4851435|NCT00955279|16725100|P1|Overall Study|Lost to Follow-up|0
4851436|NCT00955279|16725098|P3|Overall Study|Death|1
4851437|NCT00955279|16725099|P2|Overall Study|Death|1
4851438|NCT00955279|16725100|P1|Overall Study|Death|1
4851439|NCT00955279|16725098|P3|Overall Study|Other|3
4851440|NCT00955279|16725099|P2|Overall Study|Other|0
4851441|NCT00955279|16725100|P1|Overall Study|Other|0
4851442|NCT00955110|16725308|P1|Treatment Phase|Withdrawn by physician pre-treatment|1
4851443|NCT00955110|16725308|P1|Treatment Phase|Non-compliance with study restrictions|1
4851444|NCT00955110|16725308|P1|Treatment Phase|Administrative reasons|2
4851445|NCT00955110|16725308|P1|Treatment Phase|Adverse Event|2
4851446|NCT00955110|16725308|P1|Qualification Phase|Did not meet eligibility criteria|24
4851447|NCT00954941|16725355|P2|Overall Study|Adverse Event|1
4851448|NCT00954941|16725356|P1|Overall Study|Adverse Event|0
4851449|NCT00954941|16725355|P2|Overall Study|Ineligible|2
4851450|NCT00954941|16725356|P1|Overall Study|Ineligible|2
4851451|NCT00954941|16725355|P2|Overall Study|Physician Decision|2
4851452|NCT00954941|16725356|P1|Overall Study|Physician Decision|2
4851453|NCT00954941|16725355|P2|Overall Study|Insurance Denial|2
4851454|NCT00954941|16725356|P1|Overall Study|Insurance Denial|2
4851455|NCT00954941|16725355|P2|Overall Study|Withdrawal by Subject|0
4851456|NCT00954941|16725356|P1|Overall Study|Withdrawal by Subject|1
4851457|NCT00954941|16725355|P2|Overall Study|Received treatment at home|0
4851458|NCT00954941|16725356|P1|Overall Study|Received treatment at home|1
4851459|NCT00954733|16725372|P1|Overall Study|blood gas machine did not work|1
4851460|NCT00954707|16725376|P1|Overall Study|Lost to Follow-up|33
4851461|NCT00954707|16725376|P1|Overall Study|Withdrawal by Subject|100
4851462|NCT00954707|16725376|P1|Overall Study|Death|34
4851463|NCT00954538|16725398|P6|Part III|Withdrawal by Subject|0
4851464|NCT00954538|16725399|P5|Part III|Withdrawal by Subject|1
4851465|NCT00954538|16725400|P4|Part III|Withdrawal by Subject|0
4851466|NCT00954538|16725401|P3|Part III|Withdrawal by Subject|0
4851467|NCT00954538|16725402|P2|Part III|Withdrawal by Subject|0
4851468|NCT00954538|16725403|P1|Part III|Withdrawal by Subject|0
4851469|NCT00954512|16725420|P6|Overall Study|Progression of Disease|1
4851470|NCT00954512|16725421|P5|Overall Study|Progression of Disease|1
4851471|NCT00954512|16725422|P4|Overall Study|Progression of Disease|1
4851472|NCT00954512|16725423|P3|Overall Study|Progression of Disease|0
4851473|NCT00954512|16725424|P2|Overall Study|Progression of Disease|1
4851474|NCT00954512|16725425|P1|Overall Study|Progression of Disease|2
4851475|NCT00954512|16725420|P6|Overall Study|Symptomatic Deterioration|0
4851476|NCT00954512|16725421|P5|Overall Study|Symptomatic Deterioration|2
4851477|NCT00954512|16725422|P4|Overall Study|Symptomatic Deterioration|0
4851478|NCT00954512|16725423|P3|Overall Study|Symptomatic Deterioration|0
4851479|NCT00954512|16725424|P2|Overall Study|Symptomatic Deterioration|1
4851480|NCT00954512|16725425|P1|Overall Study|Symptomatic Deterioration|0
4851481|NCT00954512|16725420|P6|Overall Study|Physician Decision|0
4851482|NCT00954512|16725421|P5|Overall Study|Physician Decision|0
4851483|NCT00954512|16725422|P4|Overall Study|Physician Decision|1
4851484|NCT00954512|16725423|P3|Overall Study|Physician Decision|0
4851485|NCT00954512|16725424|P2|Overall Study|Physician Decision|1
4851486|NCT00954512|16725425|P1|Overall Study|Physician Decision|0
4851487|NCT00954512|16725420|P6|Overall Study|Adverse Event|2
4851488|NCT00954512|16725421|P5|Overall Study|Adverse Event|1
4851489|NCT00954512|16725422|P4|Overall Study|Adverse Event|0
4851490|NCT00954512|16725423|P3|Overall Study|Adverse Event|0
4851491|NCT00954512|16725424|P2|Overall Study|Adverse Event|0
4851492|NCT00954512|16725425|P1|Overall Study|Adverse Event|0
4851493|NCT00954512|16725420|P6|Overall Study|Withdrawal by Subject|1
4851494|NCT00954512|16725421|P5|Overall Study|Withdrawal by Subject|0
4851495|NCT00954512|16725422|P4|Overall Study|Withdrawal by Subject|0
4851496|NCT00954512|16725423|P3|Overall Study|Withdrawal by Subject|0
4851497|NCT00954512|16725424|P2|Overall Study|Withdrawal by Subject|0
4851498|NCT00954512|16725425|P1|Overall Study|Withdrawal by Subject|0
4851499|NCT00954447|16725446|P2|Overall Study|Other|18
4851500|NCT00954447|16725447|P1|Overall Study|Other|21
4851501|NCT00954447|16725446|P2|Overall Study|Withdrawal by Subject|21
4851502|NCT00954447|16725447|P1|Overall Study|Withdrawal by Subject|26
4851503|NCT00954447|16725446|P2|Overall Study|Lost to Follow-up|14
4851504|NCT00954447|16725447|P1|Overall Study|Lost to Follow-up|8
4851505|NCT00954447|16725446|P2|Overall Study|Protocol Violation|7
4851506|NCT00954447|16725447|P1|Overall Study|Protocol Violation|5
4851507|NCT00954447|16725446|P2|Overall Study|Lack of Efficacy|3
4851508|NCT00954447|16725447|P1|Overall Study|Lack of Efficacy|17
4851509|NCT00954447|16725446|P2|Overall Study|Adverse Event|25
4851510|NCT00954447|16725447|P1|Overall Study|Adverse Event|33
4851511|NCT00954421|16725483|P1|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1
4851512|NCT00954421|16725483|P1|6 Months of DBS|Withdrawal by Subject|1
4851513|NCT00954421|16725483|P1|Screening|screen failures|3
4851514|NCT00954174|16725533|P4|Overall Study|Never Treated|3
4851515|NCT00954174|16725534|P3|Overall Study|Never Treated|0
4851516|NCT00954174|16725535|P2|Overall Study|Never Treated|17
4851517|NCT00954174|16725536|P1|Overall Study|Never Treated|4
4851518|NCT00954174|16725533|P4|Overall Study|Ineligible|4
4851519|NCT00954174|16725534|P3|Overall Study|Ineligible|7
4851520|NCT00954174|16725535|P2|Overall Study|Ineligible|47
4851521|NCT00954174|16725536|P1|Overall Study|Ineligible|40
4851522|NCT00954174|16725533|P4|Overall Study|Medical Reason|0
4851523|NCT00954174|16725534|P3|Overall Study|Medical Reason|1
4851524|NCT00954174|16725535|P2|Overall Study|Medical Reason|2
4851525|NCT00954174|16725536|P1|Overall Study|Medical Reason|4
4851526|NCT00954174|16725533|P4|Overall Study|Withdrawal by Subject|3
4851527|NCT00954174|16725534|P3|Overall Study|Withdrawal by Subject|4
4851528|NCT00954174|16725535|P2|Overall Study|Withdrawal by Subject|10
4851529|NCT00954174|16725536|P1|Overall Study|Withdrawal by Subject|14
4851530|NCT00954174|16725533|P4|Overall Study|Lack of Efficacy|6
4851531|NCT00954174|16725534|P3|Overall Study|Lack of Efficacy|8
4851532|NCT00954174|16725535|P2|Overall Study|Lack of Efficacy|22
4851533|NCT00954174|16725536|P1|Overall Study|Lack of Efficacy|32
4851534|NCT00954174|16725533|P4|Overall Study|Death|0
4851535|NCT00954174|16725534|P3|Overall Study|Death|0
4851536|NCT00954174|16725535|P2|Overall Study|Death|2
4851537|NCT00954174|16725536|P1|Overall Study|Death|4
4851538|NCT00954174|16725533|P4|Overall Study|Adverse Event|9
4851539|NCT00954174|16725534|P3|Overall Study|Adverse Event|4
4851540|NCT00954174|16725535|P2|Overall Study|Adverse Event|23
4851541|NCT00954174|16725536|P1|Overall Study|Adverse Event|28
4851542|NCT00954122|16725556|P1|Overall Study|Safety Reason|1
4851543|NCT00954122|16725556|P1|Overall Study|Adverse Event|1
4851544|NCT00954122|16725556|P1|Overall Study|Withdrawal by Subject|5
4851545|NCT00953927|16725573|P2|Overall Study|Other study discontinuation|1
4851546|NCT00953927|16725574|P1|Overall Study|Other study discontinuation|1
4851547|NCT00953927|16725573|P2|Overall Study|Death|4
4851548|NCT00953927|16725574|P1|Overall Study|Death|7
4851549|NCT00953927|16725573|P2|Overall Study|Withdrawal by Subject|25
4851550|NCT00953927|16725574|P1|Overall Study|Withdrawal by Subject|36
4851551|NCT00953927|16725573|P2|Overall Study|Lost to Follow-up|65
4851552|NCT00953927|16725574|P1|Overall Study|Lost to Follow-up|61
4851553|NCT00953745|16725629|P2|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0
4851554|NCT00953745|16725630|P1|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1
4851555|NCT00953745|16725629|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0
4851556|NCT00953745|16725630|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6
4851557|NCT00953745|16725629|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0
4851558|NCT00953745|16725630|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1
4851559|NCT00953745|16725629|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0
4851560|NCT00953745|16725630|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3
4851561|NCT00953745|16725629|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0
4851562|NCT00953745|16725630|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2
4851563|NCT00953745|16725629|P2|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0
4851564|NCT00953745|16725630|P1|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1
4851565|NCT00953706|16725663|P4|Part B (96-Week Open-Label Extension)|Other|2
4851566|NCT00953706|16725664|P3|Part B (96-Week Open-Label Extension)|Other|0
4851567|NCT00953706|16725665|P2|Part B (96-Week Open-Label Extension)|Other|0
4851568|NCT00953706|16725666|P1|Part B (96-Week Open-Label Extension)|Other|0
4851569|NCT00953706|16725663|P4|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2
4851570|NCT00953706|16725664|P3|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1
4851571|NCT00953706|16725665|P2|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
4851572|NCT00953706|16725666|P1|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0
4851573|NCT00953706|16725663|P4|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25
4851574|NCT00953706|16725664|P3|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4
4851575|NCT00953706|16725665|P2|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
4851576|NCT00953706|16725666|P1|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0
4851577|NCT00953706|16725663|P4|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1
4851578|NCT00953706|16725664|P3|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
4851579|NCT00953706|16725665|P2|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
4851580|NCT00953706|16725666|P1|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0
4851581|NCT00953706|16725663|P4|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1
4851582|NCT00953706|16725664|P3|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
4851583|NCT00953706|16725665|P2|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
4851584|NCT00953706|16725666|P1|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0
4851585|NCT00953706|16725663|P4|Part B (96-Week Open-Label Extension)|Adverse Event|2
4851586|NCT00953706|16725664|P3|Part B (96-Week Open-Label Extension)|Adverse Event|0
4851587|NCT00953706|16725665|P2|Part B (96-Week Open-Label Extension)|Adverse Event|0
4851588|NCT00953706|16725666|P1|Part B (96-Week Open-Label Extension)|Adverse Event|0
4851589|NCT00953706|16725663|P4|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
4851590|NCT00953706|16725664|P3|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
4851591|NCT00953706|16725665|P2|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1
4851592|NCT00953706|16725666|P1|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0
4851593|NCT00953706|16725663|P4|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
4851594|NCT00953706|16725664|P3|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
4851595|NCT00953706|16725665|P2|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1
4851596|NCT00953706|16725666|P1|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0
4851597|NCT00953706|16725663|P4|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
4851598|NCT00953706|16725664|P3|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
4851599|NCT00953706|16725665|P2|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2
4851600|NCT00953706|16725666|P1|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0
4851601|NCT00953706|16725663|P4|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
4851602|NCT00953706|16725664|P3|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
4851603|NCT00953706|16725665|P2|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1
4851604|NCT00953706|16725666|P1|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0
4851605|NCT00953706|16725663|P4|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
4851606|NCT00953706|16725664|P3|Part A (16-Week Double-Blind Treatment)|Adverse Event|0
4851607|NCT00953706|16725665|P2|Part A (16-Week Double-Blind Treatment)|Adverse Event|3
4851608|NCT00953706|16725666|P1|Part A (16-Week Double-Blind Treatment)|Adverse Event|2
4851609|NCT00953680|16725698|P2|Period 1|Withdrawal by Subject|1
4851610|NCT00953680|16725699|P1|Period 1|Withdrawal by Subject|0
4851611|NCT00953667|16725711|P1|Overall Study|poor venous access,unable to draw blood|4
4851612|NCT00953667|16725711|P1|Overall Study|Adverse Event|10
4851613|NCT00953667|16725711|P1|Overall Study|Withdrawal by Subject|63
4851614|NCT00953667|16725711|P1|Overall Study|Physician Decision|35
4851615|NCT00953667|16725711|P1|Overall Study|Lost to Follow-up|11
4851616|NCT00953615|16725732|P1|Overall Study|Adverse Event|1
4851617|NCT00953576|16725741|P2|Overall Study|Ineligible after Consent|0
4851618|NCT00953576|16725742|P1|Overall Study|Ineligible after Consent|2
4851619|NCT00953576|16725741|P2|Overall Study|Adverse Event|1
4851620|NCT00953576|16725742|P1|Overall Study|Adverse Event|0
4851621|NCT00953524|16725757|P4|Overall Study|Withdrawal by Subject|0
4851622|NCT00953524|16725758|P3|Overall Study|Withdrawal by Subject|1
4851623|NCT00953524|16725759|P2|Overall Study|Withdrawal by Subject|4
4851624|NCT00953524|16725760|P1|Overall Study|Withdrawal by Subject|2
4851625|NCT00953524|16725757|P4|Overall Study|Lost to Follow-up|0
4851626|NCT00953524|16725758|P3|Overall Study|Lost to Follow-up|1
4851627|NCT00953524|16725759|P2|Overall Study|Lost to Follow-up|1
4851628|NCT00953524|16725760|P1|Overall Study|Lost to Follow-up|0
4851629|NCT00953524|16725757|P4|Overall Study|Protocol Violation|6
4851630|NCT00953524|16725758|P3|Overall Study|Protocol Violation|11
4851631|NCT00953524|16725759|P2|Overall Study|Protocol Violation|10
4851632|NCT00953524|16725760|P1|Overall Study|Protocol Violation|18
4851633|NCT00953524|16725757|P4|Overall Study|Adverse Event|2
4851634|NCT00953524|16725758|P3|Overall Study|Adverse Event|1
4851635|NCT00953524|16725759|P2|Overall Study|Adverse Event|0
4851636|NCT00953524|16725760|P1|Overall Study|Adverse Event|2
4851637|NCT00953407|16725803|P5|Overall Study|Lost to Follow-up|0
4851638|NCT00953407|16725804|P4|Overall Study|Lost to Follow-up|1
4851639|NCT00953407|16725805|P3|Overall Study|Lost to Follow-up|0
4851640|NCT00953407|16725806|P2|Overall Study|Lost to Follow-up|0
4851641|NCT00953407|16725807|P1|Overall Study|Lost to Follow-up|0
4851642|NCT00953407|16725803|P5|Overall Study|Failed inclusion criteria|1
4851643|NCT00953407|16725804|P4|Overall Study|Failed inclusion criteria|1
4851644|NCT00953407|16725805|P3|Overall Study|Failed inclusion criteria|1
4851645|NCT00953407|16725806|P2|Overall Study|Failed inclusion criteria|1
4851646|NCT00953407|16725807|P1|Overall Study|Failed inclusion criteria|1
4851647|NCT00953329|16725819|P1|Overall Study|Lack of Efficacy|1
4851648|NCT00953225|16725832|P2|Overall Study|Withdrawal by Subject|0
4851649|NCT00953225|16725833|P1|Overall Study|Withdrawal by Subject|2
4851650|NCT00953160|16725917|P1|Overall Study|Withdrawal by Subject|4
4851651|NCT00953160|16725917|P1|Overall Study|Lost to Follow-up|23
4851652|NCT00953147|16725926|P3|Overall Study|Other|13
4851653|NCT00953147|16725927|P2|Overall Study|Other|11
4851654|NCT00953147|16725928|P1|Overall Study|Other|4
4851655|NCT00953147|16725926|P3|Overall Study|Physician Decision|3
4851656|NCT00953147|16725927|P2|Overall Study|Physician Decision|7
4851657|NCT00953147|16725928|P1|Overall Study|Physician Decision|2
4851658|NCT00953147|16725926|P3|Overall Study|Lost to Follow-up|4
4851659|NCT00953147|16725927|P2|Overall Study|Lost to Follow-up|9
4851660|NCT00953147|16725928|P1|Overall Study|Lost to Follow-up|8
4851661|NCT00953147|16725926|P3|Overall Study|Withdrawal by Subject|12
4851662|NCT00953147|16725927|P2|Overall Study|Withdrawal by Subject|15
4851663|NCT00953147|16725928|P1|Overall Study|Withdrawal by Subject|13
4851664|NCT00953147|16725926|P3|Overall Study|Protocol Violation|4
4851665|NCT00953147|16725927|P2|Overall Study|Protocol Violation|8
4851666|NCT00953147|16725928|P1|Overall Study|Protocol Violation|2
4851667|NCT00953147|16725926|P3|Overall Study|Adverse Event|6
4851668|NCT00953147|16725927|P2|Overall Study|Adverse Event|16
4851669|NCT00953147|16725928|P1|Overall Study|Adverse Event|8
4851670|NCT00953056|16726006|P6|Overall Study|Serious Adverse Event|1
4851671|NCT00953056|16726007|P5|Overall Study|Serious Adverse Event|0
4851672|NCT00953056|16726008|P4|Overall Study|Serious Adverse Event|0
4851673|NCT00953056|16726009|P3|Overall Study|Serious Adverse Event|0
4851674|NCT00953056|16726010|P2|Overall Study|Serious Adverse Event|0
4851675|NCT00953056|16726011|P1|Overall Study|Serious Adverse Event|0
4851676|NCT00953056|16726006|P6|Overall Study|Withdrew Consent|3
4851677|NCT00953056|16726007|P5|Overall Study|Withdrew Consent|2
4851678|NCT00953056|16726008|P4|Overall Study|Withdrew Consent|0
4851679|NCT00953056|16726009|P3|Overall Study|Withdrew Consent|0
4851680|NCT00953056|16726010|P2|Overall Study|Withdrew Consent|0
4851681|NCT00953056|16726011|P1|Overall Study|Withdrew Consent|0
4851682|NCT00953043|16726035|P2|Overall Study|Physician Decision|2
4851683|NCT00953043|16726036|P1|Overall Study|Physician Decision|0
4851684|NCT00953043|16726035|P2|Overall Study|Withdrawal by Subject|0
4851685|NCT00953043|16726036|P1|Overall Study|Withdrawal by Subject|4
4851686|NCT00953017|16726060|P4|Overall Study|Brown stool prior to procedure|0
4851687|NCT00953017|16726061|P3|Overall Study|Brown stool prior to procedure|1
4851688|NCT00953017|16726062|P2|Overall Study|Brown stool prior to procedure|0
4851689|NCT00953017|16726063|P1|Overall Study|Brown stool prior to procedure|0
4851690|NCT00953017|16726060|P4|Overall Study|Procedure incomplete due to pain/looping|1
4851691|NCT00953017|16726061|P3|Overall Study|Procedure incomplete due to pain/looping|0
4851692|NCT00953017|16726062|P2|Overall Study|Procedure incomplete due to pain/looping|1
4851693|NCT00953017|16726063|P1|Overall Study|Procedure incomplete due to pain/looping|0
4851694|NCT00953017|16726060|P4|Overall Study|Incomplete data|0
4851695|NCT00953017|16726061|P3|Overall Study|Incomplete data|0
4851696|NCT00953017|16726062|P2|Overall Study|Incomplete data|1
4851697|NCT00953017|16726063|P1|Overall Study|Incomplete data|1
4851698|NCT00953017|16726060|P4|Overall Study|DId not show up for colonoscopy|4
4851699|NCT00953017|16726061|P3|Overall Study|DId not show up for colonoscopy|5
4851700|NCT00953017|16726062|P2|Overall Study|DId not show up for colonoscopy|4
4851701|NCT00953017|16726063|P1|Overall Study|DId not show up for colonoscopy|4
4851702|NCT00952848|16726085|P1|Overall Study|Withdrawal by Subject|4
4851703|NCT00952822|16726092|P4|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
4851704|NCT00952822|16726093|P3|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1
4851705|NCT00952822|16726094|P2|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
4851706|NCT00952822|16726095|P1|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0
4851707|NCT00952822|16726092|P4|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
4851708|NCT00952822|16726093|P3|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
4851709|NCT00952822|16726094|P2|1st Pharmacokinetic Evaluation|Lost to Follow-up|1
4851710|NCT00952822|16726095|P1|1st Pharmacokinetic Evaluation|Lost to Follow-up|0
4851711|NCT00952731|16726127|P2|Overall Study|Drug supply expired|0
4851712|NCT00952731|16726128|P1|Overall Study|Drug supply expired|1
4851713|NCT00952705|16726160|P3|Overall Study|Exclusion criteria not met pre dose|0
4851714|NCT00952705|16726161|P2|Overall Study|Exclusion criteria not met pre dose|1
4851715|NCT00952705|16726162|P1|Overall Study|Exclusion criteria not met pre dose|0
4851716|NCT00952705|16726160|P3|Overall Study|Incarcerated post dose|0
4851717|NCT00952705|16726161|P2|Overall Study|Incarcerated post dose|0
4851718|NCT00952705|16726162|P1|Overall Study|Incarcerated post dose|5
4851719|NCT00952705|16726160|P3|Overall Study|Death|0
4851720|NCT00952705|16726161|P2|Overall Study|Death|0
4851721|NCT00952705|16726162|P1|Overall Study|Death|2
4851722|NCT00952705|16726160|P3|Overall Study|Withdrawal by Subject|1
4851723|NCT00952705|16726161|P2|Overall Study|Withdrawal by Subject|1
4851724|NCT00952705|16726162|P1|Overall Study|Withdrawal by Subject|2
4851725|NCT00952705|16726160|P3|Overall Study|Lost to Follow-up|9
4851726|NCT00952705|16726161|P2|Overall Study|Lost to Follow-up|8
4851727|NCT00952705|16726162|P1|Overall Study|Lost to Follow-up|24
4851728|NCT00952614|16726249|P1|Overall Study|other reason|1
4851729|NCT00952614|16726249|P1|Overall Study|Lost to Follow-up|3
4851730|NCT00952614|16726249|P1|Overall Study|Death|3
4851731|NCT00952588|16726256|P2|Overall Study|Lack of Efficacy|2
4851732|NCT00952588|16726257|P1|Overall Study|Lack of Efficacy|2
4851733|NCT00952588|16726256|P2|Overall Study|Physician Decision|1
4851734|NCT00952588|16726257|P1|Overall Study|Physician Decision|0
4851735|NCT00952588|16726256|P2|Overall Study|Lost to Follow-up|0
4851736|NCT00952588|16726257|P1|Overall Study|Lost to Follow-up|2
4851737|NCT00952588|16726256|P2|Overall Study|Adverse Event|3
4851738|NCT00952588|16726257|P1|Overall Study|Adverse Event|2
4851739|NCT00952588|16726256|P2|Overall Study|Withdrawal by Subject|5
4851740|NCT00952588|16726257|P1|Overall Study|Withdrawal by Subject|2
4851741|NCT00952588|16726256|P2|Overall Study|Death|13
4851742|NCT00952588|16726257|P1|Overall Study|Death|28
4851743|NCT00952523|16726275|P1|Overall Study|Withdrawal by Subject|7
4851744|NCT00952484|16726284|P3|Overall Study|Withdrawal by Subject|0
4851745|NCT00952484|16726285|P2|Overall Study|Withdrawal by Subject|1
4851746|NCT00952484|16726286|P1|Overall Study|Withdrawal by Subject|0
4851747|NCT00952419|16726313|P3|Overall Study|Withdrawal by Subject|0
4851748|NCT00952419|16726314|P2|Overall Study|Withdrawal by Subject|3
4851749|NCT00952419|16726315|P1|Overall Study|Withdrawal by Subject|1
4851750|NCT00952419|16726313|P3|Overall Study|Protocol Violation|0
4851751|NCT00952419|16726314|P2|Overall Study|Protocol Violation|7
4851752|NCT00952419|16726315|P1|Overall Study|Protocol Violation|3
4851753|NCT00952419|16726313|P3|Overall Study|Adverse Event|0
4851754|NCT00952419|16726314|P2|Overall Study|Adverse Event|0
4851755|NCT00952419|16726315|P1|Overall Study|Adverse Event|2
4851756|NCT00952380|16726356|P5|Overall Study|Non-compliant to protocol|0
4851757|NCT00952380|16726357|P4|Overall Study|Non-compliant to protocol|1
4851758|NCT00952380|16726358|P3|Overall Study|Non-compliant to protocol|0
4851759|NCT00952380|16726359|P2|Overall Study|Non-compliant to protocol|0
4851760|NCT00952380|16726360|P1|Overall Study|Non-compliant to protocol|0
4851761|NCT00952380|16726356|P5|Overall Study|Physician Decision|0
4851762|NCT00952380|16726357|P4|Overall Study|Physician Decision|2
4851763|NCT00952380|16726358|P3|Overall Study|Physician Decision|1
4851764|NCT00952380|16726359|P2|Overall Study|Physician Decision|0
4851765|NCT00952380|16726360|P1|Overall Study|Physician Decision|0
4851766|NCT00952380|16726356|P5|Overall Study|Adverse Event|3
4851767|NCT00952380|16726357|P4|Overall Study|Adverse Event|0
4851768|NCT00952380|16726358|P3|Overall Study|Adverse Event|0
4851769|NCT00952380|16726359|P2|Overall Study|Adverse Event|1
4851770|NCT00952380|16726360|P1|Overall Study|Adverse Event|0
4851771|NCT00952380|16726356|P5|Overall Study|Withdrawal by Subject|2
4851772|NCT00952380|16726357|P4|Overall Study|Withdrawal by Subject|0
4851773|NCT00952380|16726358|P3|Overall Study|Withdrawal by Subject|1
4851774|NCT00952380|16726359|P2|Overall Study|Withdrawal by Subject|0
4851775|NCT00952380|16726360|P1|Overall Study|Withdrawal by Subject|0
4851776|NCT00952380|16726356|P5|Overall Study|Other|1
4851777|NCT00952380|16726357|P4|Overall Study|Other|0
4851778|NCT00952380|16726358|P3|Overall Study|Other|0
4851779|NCT00952380|16726359|P2|Overall Study|Other|0
4851780|NCT00952380|16726360|P1|Overall Study|Other|0
4851781|NCT00952367|16726461|P1|Overall Study|Protocol Violation|3
4851782|NCT00952367|16726461|P1|Overall Study|Noncoordination|1
4851783|NCT00952367|16726461|P1|Overall Study|Withdrawal by Subject|2
4851784|NCT00952341|16726476|P2|Cycle 2|Progressive Disease|1
4851785|NCT00952341|16726477|P1|Cycle 2|Progressive Disease|0
4851786|NCT00952341|16726476|P2|Cycle 2|Physician Decision|1
4851787|NCT00952341|16726477|P1|Cycle 2|Physician Decision|1
4851788|NCT00952341|16726476|P2|Cycle 2|Lost to Follow-up|9
4851789|NCT00952341|16726477|P1|Cycle 2|Lost to Follow-up|6
4851790|NCT00952341|16726476|P2|Cycle 2|Protocol Violation|0
4851791|NCT00952341|16726477|P1|Cycle 2|Protocol Violation|1
4851792|NCT00952341|16726476|P2|Cycle 2|Withdrawal by Subject|1
4851793|NCT00952341|16726477|P1|Cycle 2|Withdrawal by Subject|1
4851794|NCT00952341|16726476|P2|Cycle 1|Physician Decision|1
4851795|NCT00952341|16726477|P1|Cycle 1|Physician Decision|0
4851796|NCT00952341|16726476|P2|Cycle 1|Lost to Follow-up|2
4851797|NCT00952341|16726477|P1|Cycle 1|Lost to Follow-up|11
4851798|NCT00952341|16726476|P2|Cycle 1|Protocol Violation|1
4851799|NCT00952341|16726477|P1|Cycle 1|Protocol Violation|2
4851800|NCT00952341|16726476|P2|Cycle 1|Withdrawal by Subject|8
4851801|NCT00952341|16726477|P1|Cycle 1|Withdrawal by Subject|3
4851802|NCT00952341|16726476|P2|Cycle 1|Adverse Event|1
4851803|NCT00952341|16726477|P1|Cycle 1|Adverse Event|4
4851804|NCT00952289|16726539|P2|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7
4851805|NCT00952289|16726540|P1|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0
4851806|NCT00952289|16726539|P2|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2
4851807|NCT00952289|16726540|P1|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0
4851808|NCT00952289|16726539|P2|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11
4851809|NCT00952289|16726540|P1|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0
4851810|NCT00952289|16726539|P2|Patients Who Crossed Over to Ruxolitinib|Disease progression|15
4851811|NCT00952289|16726540|P1|Patients Who Crossed Over to Ruxolitinib|Disease progression|0
4851812|NCT00952289|16726539|P2|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19
4851813|NCT00952289|16726540|P1|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0
4851814|NCT00952289|16726539|P2|All Participants|Data lost during site relocation|1
4851815|NCT00952289|16726540|P1|All Participants|Data lost during site relocation|0
4851816|NCT00952289|16726539|P2|All Participants|Withdrawal by Subject|10
4851817|NCT00952289|16726540|P1|All Participants|Withdrawal by Subject|1
4851818|NCT00952289|16726539|P2|All Participants|Disease progression|12
4851819|NCT00952289|16726540|P1|All Participants|Disease progression|3
4851820|NCT00952289|16726539|P2|All Participants|Adverse Event|8
4851821|NCT00952289|16726540|P1|All Participants|Adverse Event|8
4851822|NCT00952289|16726539|P2|All Participants|Death|9
4851823|NCT00952289|16726540|P1|All Participants|Death|9
4851824|NCT00952276|16726569|P5|Overall Study|Withdrawal by Subject|0
4851825|NCT00952276|16726570|P4|Overall Study|Withdrawal by Subject|1
4851826|NCT00952276|16726571|P3|Overall Study|Withdrawal by Subject|0
4851827|NCT00952276|16726572|P2|Overall Study|Withdrawal by Subject|0
4851828|NCT00952276|16726573|P1|Overall Study|Withdrawal by Subject|1
4851829|NCT00952068|16726659|P1|Overall Study|Withdrawal by Subject|4
4851830|NCT00952068|16726659|P1|Overall Study|Adverse Event|3
4851831|NCT00951912|16726670|P3|Overall Study|Other: Stroke|0
4851832|NCT00951912|16726671|P2|Overall Study|Other: Stroke|1
4851833|NCT00951912|16726672|P1|Overall Study|Other: Stroke|0
4851834|NCT00951912|16726670|P3|Overall Study|Other: Colon cancer|0
4851835|NCT00951912|16726671|P2|Overall Study|Other: Colon cancer|0
4851836|NCT00951912|16726672|P1|Overall Study|Other: Colon cancer|1
4851837|NCT00951912|16726670|P3|Overall Study|Other:Depression|0
4851838|NCT00951912|16726671|P2|Overall Study|Other:Depression|0
4851839|NCT00951912|16726672|P1|Overall Study|Other:Depression|1
4851840|NCT00951912|16726670|P3|Overall Study|Withdrawal by Subject|0
4851841|NCT00951912|16726671|P2|Overall Study|Withdrawal by Subject|1
4851842|NCT00951912|16726672|P1|Overall Study|Withdrawal by Subject|1
4851843|NCT00951912|16726670|P3|Overall Study|Physician Decision|1
4851844|NCT00951912|16726671|P2|Overall Study|Physician Decision|0
4851845|NCT00951912|16726672|P1|Overall Study|Physician Decision|1
4851846|NCT00951912|16726670|P3|Overall Study|Lost to Follow-up|0
4851847|NCT00951912|16726671|P2|Overall Study|Lost to Follow-up|2
4851848|NCT00951912|16726672|P1|Overall Study|Lost to Follow-up|2
4851849|NCT00951912|16726670|P3|Overall Study|Adverse Event|1
4851850|NCT00951912|16726671|P2|Overall Study|Adverse Event|1
4851851|NCT00951912|16726672|P1|Overall Study|Adverse Event|0
4851852|NCT00951912|16726670|P3|Overall Study|Lack of Efficacy|0
4851853|NCT00951912|16726671|P2|Overall Study|Lack of Efficacy|0
4851854|NCT00951912|16726672|P1|Overall Study|Lack of Efficacy|1
4851855|NCT00951665|16726772|P6|Phase 2a|Disease Progression|5
4851856|NCT00951665|16726773|P5|Phase 2a|Disease Progression|6
4851857|NCT00951665|16726774|P4|Phase 2a|Disease Progression|0
4851858|NCT00951665|16726775|P3|Phase 2a|Disease Progression|0
4851859|NCT00951665|16726776|P2|Phase 2a|Disease Progression|0
4851860|NCT00951665|16726777|P1|Phase 2a|Disease Progression|0
4851861|NCT00951665|16726772|P6|Phase 2a|Withdrawal by Subject|0
4851862|NCT00951665|16726773|P5|Phase 2a|Withdrawal by Subject|2
4851863|NCT00951665|16726774|P4|Phase 2a|Withdrawal by Subject|0
4851864|NCT00951665|16726775|P3|Phase 2a|Withdrawal by Subject|0
4851865|NCT00951665|16726776|P2|Phase 2a|Withdrawal by Subject|0
4851866|NCT00951665|16726777|P1|Phase 2a|Withdrawal by Subject|0
4851867|NCT00951665|16726772|P6|Phase 2a|Physician Decision|1
4851868|NCT00951665|16726773|P5|Phase 2a|Physician Decision|0
4851869|NCT00951665|16726774|P4|Phase 2a|Physician Decision|0
4851870|NCT00951665|16726775|P3|Phase 2a|Physician Decision|0
4851871|NCT00951665|16726776|P2|Phase 2a|Physician Decision|0
4851872|NCT00951665|16726777|P1|Phase 2a|Physician Decision|0
4851873|NCT00951665|16726772|P6|Phase 2a|Lost to Follow-up|0
4851874|NCT00951665|16726773|P5|Phase 2a|Lost to Follow-up|1
4851875|NCT00951665|16726774|P4|Phase 2a|Lost to Follow-up|0
4851876|NCT00951665|16726775|P3|Phase 2a|Lost to Follow-up|0
4851877|NCT00951665|16726776|P2|Phase 2a|Lost to Follow-up|0
4851878|NCT00951665|16726777|P1|Phase 2a|Lost to Follow-up|0
4851879|NCT00951665|16726772|P6|Phase 2a|Death|1
4851880|NCT00951665|16726773|P5|Phase 2a|Death|1
4851881|NCT00951665|16726774|P4|Phase 2a|Death|0
4851882|NCT00951665|16726775|P3|Phase 2a|Death|0
4851883|NCT00951665|16726776|P2|Phase 2a|Death|0
4851884|NCT00951665|16726777|P1|Phase 2a|Death|0
4851885|NCT00951665|16726772|P6|Phase 2a|Adverse Event|0
4851886|NCT00951665|16726773|P5|Phase 2a|Adverse Event|2
4851887|NCT00951665|16726774|P4|Phase 2a|Adverse Event|0
4851888|NCT00951665|16726775|P3|Phase 2a|Adverse Event|0
4851889|NCT00951665|16726776|P2|Phase 2a|Adverse Event|0
4851890|NCT00951665|16726777|P1|Phase 2a|Adverse Event|0
4851891|NCT00951665|16726772|P6|Phase 1b|Protocol Violation|0
4851892|NCT00951665|16726773|P5|Phase 1b|Protocol Violation|0
4851893|NCT00951665|16726774|P4|Phase 1b|Protocol Violation|0
4851894|NCT00951665|16726775|P3|Phase 1b|Protocol Violation|0
4851895|NCT00951665|16726776|P2|Phase 1b|Protocol Violation|0
4851896|NCT00951665|16726777|P1|Phase 1b|Protocol Violation|2
4851897|NCT00951665|16726772|P6|Phase 1b|Disease Progression|0
4851898|NCT00951665|16726773|P5|Phase 1b|Disease Progression|0
4851899|NCT00951665|16726774|P4|Phase 1b|Disease Progression|0
4851900|NCT00951665|16726775|P3|Phase 1b|Disease Progression|14
4851901|NCT00951665|16726776|P2|Phase 1b|Disease Progression|2
4851902|NCT00951665|16726777|P1|Phase 1b|Disease Progression|13
4851903|NCT00951665|16726772|P6|Phase 1b|Withdrawal by Subject|0
4851904|NCT00951665|16726773|P5|Phase 1b|Withdrawal by Subject|0
4851905|NCT00951665|16726774|P4|Phase 1b|Withdrawal by Subject|0
4851906|NCT00951665|16726775|P3|Phase 1b|Withdrawal by Subject|0
4851907|NCT00951665|16726776|P2|Phase 1b|Withdrawal by Subject|1
4851908|NCT00951665|16726777|P1|Phase 1b|Withdrawal by Subject|0
4851909|NCT00951665|16726772|P6|Phase 1b|Physician Decision|0
4851910|NCT00951665|16726773|P5|Phase 1b|Physician Decision|0
4851911|NCT00951665|16726774|P4|Phase 1b|Physician Decision|0
4851912|NCT00951665|16726775|P3|Phase 1b|Physician Decision|1
4851913|NCT00951665|16726776|P2|Phase 1b|Physician Decision|0
4851914|NCT00951665|16726777|P1|Phase 1b|Physician Decision|4
4851915|NCT00951665|16726772|P6|Phase 1b|Death|0
4851916|NCT00951665|16726773|P5|Phase 1b|Death|0
4851917|NCT00951665|16726774|P4|Phase 1b|Death|0
4851918|NCT00951665|16726775|P3|Phase 1b|Death|2
4851919|NCT00951665|16726776|P2|Phase 1b|Death|0
4851920|NCT00951665|16726777|P1|Phase 1b|Death|1
4851921|NCT00951665|16726772|P6|Phase 1b|Adverse Event|0
4851922|NCT00951665|16726773|P5|Phase 1b|Adverse Event|0
4851923|NCT00951665|16726774|P4|Phase 1b|Adverse Event|1
4851924|NCT00951665|16726775|P3|Phase 1b|Adverse Event|0
4851925|NCT00951665|16726776|P2|Phase 1b|Adverse Event|1
4851926|NCT00951665|16726777|P1|Phase 1b|Adverse Event|2
4851927|NCT00951509|16726886|P1|Overall Study|Withdrawal by Subject|2
4851928|NCT00951496|16726897|P3|Overall Study|Did not initiate study treatment|13
4851929|NCT00951496|16726898|P2|Overall Study|Did not initiate study treatment|8
4851930|NCT00951496|16726899|P1|Overall Study|Did not initiate study treatment|10
4851931|NCT00951483|16726927|P2|Overall Study|Withdrawal by Subject|0
4851932|NCT00951483|16726928|P1|Overall Study|Withdrawal by Subject|15
4851933|NCT00951483|16726927|P2|Overall Study|Physician Decision|0
4851934|NCT00951483|16726928|P1|Overall Study|Physician Decision|4
4851935|NCT00951379|16726948|P2|Overall Study|Disease Progression|1
4851936|NCT00951379|16726949|P1|Overall Study|Disease Progression|0
4851937|NCT00951379|16726948|P2|Overall Study|Noncompliance|0
4851938|NCT00951379|16726949|P1|Overall Study|Noncompliance|1
4851939|NCT00951379|16726948|P2|Overall Study|Withdrawal by Subject|0
4851940|NCT00951379|16726949|P1|Overall Study|Withdrawal by Subject|1
4851941|NCT00951379|16726948|P2|Overall Study|Adverse Event|1
4851942|NCT00951379|16726949|P1|Overall Study|Adverse Event|4
4851943|NCT00951275|16726991|P1|Overall Study|Protocol Violation|1
4851944|NCT00951275|16726991|P1|Overall Study|Withdrawal by Subject|4
4851945|NCT00951275|16726991|P1|Overall Study|Adverse Event|7
4851946|NCT00951275|16726991|P1|Overall Study|Administrative Reason|1
4851947|NCT00951171|16727023|P2|Overall Study|Adverse Event|0
4851948|NCT00951171|16727024|P1|Overall Study|Adverse Event|2
4851949|NCT00951080|16727056|P2|Overall Study|Other|22
4851950|NCT00951080|16727057|P1|Overall Study|Other|19
4851951|NCT00951080|16727056|P2|Overall Study|Physician Decision|1
4851952|NCT00951080|16727057|P1|Overall Study|Physician Decision|4
4851953|NCT00951080|16727056|P2|Overall Study|Lost to Follow-up|1
4851954|NCT00951080|16727057|P1|Overall Study|Lost to Follow-up|0
4851955|NCT00951080|16727056|P2|Overall Study|Adverse Event|3
4851956|NCT00951080|16727057|P1|Overall Study|Adverse Event|3
4851957|NCT00951041|16727065|P2|Overall Study|Other|0
4851958|NCT00951041|16727066|P1|Overall Study|Other|3
4851959|NCT00951041|16727065|P2|Overall Study|Lost to Follow-up|0
4851960|NCT00951041|16727066|P1|Overall Study|Lost to Follow-up|1
4851961|NCT00951041|16727065|P2|Overall Study|Withdrawal by Subject|1
4851962|NCT00951041|16727066|P1|Overall Study|Withdrawal by Subject|1
4851963|NCT00951015|16727121|P5|Open-label Phase|Physician Decision|8
4851964|NCT00951015|16727122|P4|Open-label Phase|Physician Decision|0
4851965|NCT00951015|16727123|P3|Open-label Phase|Physician Decision|0
4851966|NCT00951015|16727124|P2|Open-label Phase|Physician Decision|0
4851967|NCT00951015|16727125|P1|Open-label Phase|Physician Decision|0
4851968|NCT00951015|16727121|P5|Open-label Phase|Withdrawal by Subject|14
4851969|NCT00951015|16727122|P4|Open-label Phase|Withdrawal by Subject|0
4851970|NCT00951015|16727123|P3|Open-label Phase|Withdrawal by Subject|0
4851971|NCT00951015|16727124|P2|Open-label Phase|Withdrawal by Subject|0
4851972|NCT00951015|16727125|P1|Open-label Phase|Withdrawal by Subject|0
4851973|NCT00951015|16727121|P5|Open-label Phase|Lost to Follow-up|12
4851974|NCT00951015|16727122|P4|Open-label Phase|Lost to Follow-up|0
4851975|NCT00951015|16727123|P3|Open-label Phase|Lost to Follow-up|0
4851976|NCT00951015|16727124|P2|Open-label Phase|Lost to Follow-up|0
4851977|NCT00951015|16727125|P1|Open-label Phase|Lost to Follow-up|0
4851978|NCT00951015|16727121|P5|Open-label Phase|Protocol Violation|12
4851979|NCT00951015|16727122|P4|Open-label Phase|Protocol Violation|0
4851980|NCT00951015|16727123|P3|Open-label Phase|Protocol Violation|0
4851981|NCT00951015|16727124|P2|Open-label Phase|Protocol Violation|0
4851982|NCT00951015|16727125|P1|Open-label Phase|Protocol Violation|0
4851983|NCT00951015|16727121|P5|Open-label Phase|Lack of Efficacy|1
4851984|NCT00951015|16727122|P4|Open-label Phase|Lack of Efficacy|0
4851985|NCT00951015|16727123|P3|Open-label Phase|Lack of Efficacy|0
4851986|NCT00951015|16727124|P2|Open-label Phase|Lack of Efficacy|0
4851987|NCT00951015|16727125|P1|Open-label Phase|Lack of Efficacy|0
4851988|NCT00951015|16727121|P5|Open-label Phase|Adverse Event|3
4851989|NCT00951015|16727122|P4|Open-label Phase|Adverse Event|0
4851990|NCT00951015|16727123|P3|Open-label Phase|Adverse Event|0
4851991|NCT00951015|16727124|P2|Open-label Phase|Adverse Event|0
4851992|NCT00951015|16727125|P1|Open-label Phase|Adverse Event|0
4851993|NCT00951015|16727121|P5|Randomization Phase 96 Week|Withdrawal by Subject|0
4851994|NCT00951015|16727122|P4|Randomization Phase 96 Week|Withdrawal by Subject|2
4851995|NCT00951015|16727123|P3|Randomization Phase 96 Week|Withdrawal by Subject|1
4851996|NCT00951015|16727124|P2|Randomization Phase 96 Week|Withdrawal by Subject|1
4851997|NCT00951015|16727125|P1|Randomization Phase 96 Week|Withdrawal by Subject|2
4851998|NCT00951015|16727121|P5|Randomization Phase 96 Week|Lost to Follow-up|0
4851999|NCT00951015|16727122|P4|Randomization Phase 96 Week|Lost to Follow-up|2
4852000|NCT00951015|16727123|P3|Randomization Phase 96 Week|Lost to Follow-up|1
4852001|NCT00951015|16727124|P2|Randomization Phase 96 Week|Lost to Follow-up|3
4852002|NCT00951015|16727125|P1|Randomization Phase 96 Week|Lost to Follow-up|0
4852003|NCT00951015|16727121|P5|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4852004|NCT00951015|16727122|P4|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1
4852005|NCT00951015|16727123|P3|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4852006|NCT00951015|16727124|P2|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4852007|NCT00951015|16727125|P1|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0
4852008|NCT00951015|16727121|P5|Randomization Phase 96 Week|Protocol Violation|0
4852009|NCT00951015|16727122|P4|Randomization Phase 96 Week|Protocol Violation|0
4852010|NCT00951015|16727123|P3|Randomization Phase 96 Week|Protocol Violation|1
4852011|NCT00951015|16727124|P2|Randomization Phase 96 Week|Protocol Violation|1
4852012|NCT00951015|16727125|P1|Randomization Phase 96 Week|Protocol Violation|1
4852013|NCT00951015|16727121|P5|Randomization Phase 96 Week|Lack of Efficacy|0
4852014|NCT00951015|16727122|P4|Randomization Phase 96 Week|Lack of Efficacy|0
4852015|NCT00951015|16727123|P3|Randomization Phase 96 Week|Lack of Efficacy|0
4852016|NCT00951015|16727124|P2|Randomization Phase 96 Week|Lack of Efficacy|1
4852017|NCT00951015|16727125|P1|Randomization Phase 96 Week|Lack of Efficacy|1
4852018|NCT00951015|16727121|P5|Randomization Phase 96 Week|Adverse Event|0
4852019|NCT00951015|16727122|P4|Randomization Phase 96 Week|Adverse Event|5
4852020|NCT00951015|16727123|P3|Randomization Phase 96 Week|Adverse Event|2
4852021|NCT00951015|16727124|P2|Randomization Phase 96 Week|Adverse Event|1
4852022|NCT00951015|16727125|P1|Randomization Phase 96 Week|Adverse Event|1
4852023|NCT00950963|16727222|P2|Overall Study|Lost to Follow-up|24
4852024|NCT00950963|16727223|P1|Overall Study|Lost to Follow-up|29
4852025|NCT00950950|16727239|P2|Overall Study|Withdrawal by Subject|1
4852026|NCT00950950|16727240|P1|Overall Study|Withdrawal by Subject|0
4852027|NCT00950950|16727239|P2|Overall Study|Adverse Event|0
4852028|NCT00950950|16727240|P1|Overall Study|Adverse Event|1
4852029|NCT00950911|16727322|P2|Overall Study|Poor performance status|1
4852030|NCT00950911|16727323|P1|Overall Study|Poor performance status|0
4852031|NCT00950911|16727322|P2|Overall Study|Noncompliance|0
4852032|NCT00950911|16727323|P1|Overall Study|Noncompliance|1
4852033|NCT00950911|16727322|P2|Overall Study|Ineligibility determined|0
4852034|NCT00950911|16727323|P1|Overall Study|Ineligibility determined|1
4852035|NCT00950911|16727322|P2|Overall Study|Administrative decision|1
4852036|NCT00950911|16727323|P1|Overall Study|Administrative decision|3
4852037|NCT00950911|16727322|P2|Overall Study|Consent withdrawn|3
4852038|NCT00950911|16727323|P1|Overall Study|Consent withdrawn|1
4852039|NCT00950911|16727322|P2|Overall Study|Disease progression|2
4852040|NCT00950911|16727323|P1|Overall Study|Disease progression|2
4852041|NCT00950911|16727322|P2|Overall Study|Death|6
4852042|NCT00950911|16727323|P1|Overall Study|Death|4
4852043|NCT00950911|16727322|P2|Overall Study|Adverse Event|2
4852044|NCT00950911|16727323|P1|Overall Study|Adverse Event|0
4852045|NCT00950872|16727329|P1|Overall Study|Did not have surgery|2
4852046|NCT00950872|16727329|P1|Overall Study|Withdrawal by Subject|1
4852047|NCT00950859|16727338|P2|Overall Study|Lost to Follow-up|3
4852048|NCT00950859|16727339|P1|Overall Study|Lost to Follow-up|0
4852049|NCT00950859|16727338|P2|Overall Study|Protocol Violation|1
4852050|NCT00950859|16727339|P1|Overall Study|Protocol Violation|1
4852051|NCT00950859|16727338|P2|Overall Study|Insufficient Viral Load Response|3
4852052|NCT00950859|16727339|P1|Overall Study|Insufficient Viral Load Response|12
4852053|NCT00950859|16727338|P2|Overall Study|Adverse Event|3
4852054|NCT00950859|16727339|P1|Overall Study|Adverse Event|3
4852055|NCT00950807|16727438|P10|Treatment Period 3|Adverse Event|0
4852056|NCT00950807|16727439|P9|Treatment Period 3|Adverse Event|0
4852057|NCT00950807|16727440|P8|Treatment Period 3|Adverse Event|0
4852058|NCT00950807|16727441|P7|Treatment Period 3|Adverse Event|1
4852059|NCT00950807|16727442|P6|Treatment Period 3|Adverse Event|0
4852060|NCT00950807|16727443|P5|Treatment Period 3|Adverse Event|0
4852061|NCT00950807|16727444|P4|Treatment Period 3|Adverse Event|0
4852062|NCT00950807|16727445|P3|Treatment Period 3|Adverse Event|0
4852063|NCT00950807|16727446|P2|Treatment Period 3|Adverse Event|0
4852064|NCT00950807|16727447|P1|Treatment Period 3|Adverse Event|0
4852065|NCT00950807|16727438|P10|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852066|NCT00950807|16727439|P9|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852067|NCT00950807|16727440|P8|Treatment Period 3|Protocol-defined Stopping Criteria|1
4852068|NCT00950807|16727441|P7|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852069|NCT00950807|16727442|P6|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852070|NCT00950807|16727443|P5|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852071|NCT00950807|16727444|P4|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852072|NCT00950807|16727445|P3|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852073|NCT00950807|16727446|P2|Treatment Period 3|Protocol-defined Stopping Criteria|0
4852074|NCT00950807|16727447|P1|Treatment Period 3|Protocol-defined Stopping Criteria|1
4852075|NCT00950807|16727438|P10|Treatment Period 3|Withdrawal by Subject|1
4852076|NCT00950807|16727439|P9|Treatment Period 3|Withdrawal by Subject|0
4852077|NCT00950807|16727440|P8|Treatment Period 3|Withdrawal by Subject|0
4852078|NCT00950807|16727441|P7|Treatment Period 3|Withdrawal by Subject|0
4852079|NCT00950807|16727442|P6|Treatment Period 3|Withdrawal by Subject|0
4852080|NCT00950807|16727443|P5|Treatment Period 3|Withdrawal by Subject|0
4852081|NCT00950807|16727444|P4|Treatment Period 3|Withdrawal by Subject|0
4852082|NCT00950807|16727445|P3|Treatment Period 3|Withdrawal by Subject|0
4852083|NCT00950807|16727446|P2|Treatment Period 3|Withdrawal by Subject|0
4852084|NCT00950807|16727447|P1|Treatment Period 3|Withdrawal by Subject|0
4852085|NCT00950807|16727438|P10|Washout Period 2|Adverse Event|0
4852086|NCT00950807|16727439|P9|Washout Period 2|Adverse Event|0
4852087|NCT00950807|16727440|P8|Washout Period 2|Adverse Event|0
4852088|NCT00950807|16727441|P7|Washout Period 2|Adverse Event|0
4852089|NCT00950807|16727442|P6|Washout Period 2|Adverse Event|0
4852090|NCT00950807|16727443|P5|Washout Period 2|Adverse Event|0
4852091|NCT00950807|16727444|P4|Washout Period 2|Adverse Event|1
4852092|NCT00950807|16727445|P3|Washout Period 2|Adverse Event|0
4852093|NCT00950807|16727446|P2|Washout Period 2|Adverse Event|0
4852094|NCT00950807|16727447|P1|Washout Period 2|Adverse Event|3
4852095|NCT00950807|16727438|P10|Washout Period 2|Protocol-defined Stopping Criteria|0
4852096|NCT00950807|16727439|P9|Washout Period 2|Protocol-defined Stopping Criteria|0
4852097|NCT00950807|16727440|P8|Washout Period 2|Protocol-defined Stopping Criteria|1
4852098|NCT00950807|16727441|P7|Washout Period 2|Protocol-defined Stopping Criteria|1
4852099|NCT00950807|16727442|P6|Washout Period 2|Protocol-defined Stopping Criteria|0
4852100|NCT00950807|16727443|P5|Washout Period 2|Protocol-defined Stopping Criteria|1
4852101|NCT00950807|16727444|P4|Washout Period 2|Protocol-defined Stopping Criteria|0
4852102|NCT00950807|16727445|P3|Washout Period 2|Protocol-defined Stopping Criteria|0
4852103|NCT00950807|16727446|P2|Washout Period 2|Protocol-defined Stopping Criteria|1
4852104|NCT00950807|16727447|P1|Washout Period 2|Protocol-defined Stopping Criteria|0
4852105|NCT00950807|16727438|P10|Washout Period 2|Lack of Efficacy|0
4852106|NCT00950807|16727439|P9|Washout Period 2|Lack of Efficacy|0
4852107|NCT00950807|16727440|P8|Washout Period 2|Lack of Efficacy|0
4852108|NCT00950807|16727441|P7|Washout Period 2|Lack of Efficacy|0
4852109|NCT00950807|16727442|P6|Washout Period 2|Lack of Efficacy|0
4852110|NCT00950807|16727443|P5|Washout Period 2|Lack of Efficacy|0
4852111|NCT00950807|16727444|P4|Washout Period 2|Lack of Efficacy|0
4852112|NCT00950807|16727445|P3|Washout Period 2|Lack of Efficacy|0
4852113|NCT00950807|16727446|P2|Washout Period 2|Lack of Efficacy|0
4852114|NCT00950807|16727447|P1|Washout Period 2|Lack of Efficacy|1
4852115|NCT00950807|16727438|P10|Treatment Period 2|Adverse Event|0
4852116|NCT00950807|16727439|P9|Treatment Period 2|Adverse Event|0
4852117|NCT00950807|16727440|P8|Treatment Period 2|Adverse Event|1
4852118|NCT00950807|16727441|P7|Treatment Period 2|Adverse Event|0
4852119|NCT00950807|16727442|P6|Treatment Period 2|Adverse Event|1
4852120|NCT00950807|16727443|P5|Treatment Period 2|Adverse Event|0
4852121|NCT00950807|16727444|P4|Treatment Period 2|Adverse Event|1
4852122|NCT00950807|16727445|P3|Treatment Period 2|Adverse Event|0
4852123|NCT00950807|16727446|P2|Treatment Period 2|Adverse Event|1
4852124|NCT00950807|16727447|P1|Treatment Period 2|Adverse Event|0
4852125|NCT00950807|16727438|P10|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852126|NCT00950807|16727439|P9|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852127|NCT00950807|16727440|P8|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852128|NCT00950807|16727441|P7|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852129|NCT00950807|16727442|P6|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852213|NCT00950807|16727446|P2|Treatment Period 1|Withdrawal by Subject|0
4852130|NCT00950807|16727443|P5|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852131|NCT00950807|16727444|P4|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852132|NCT00950807|16727445|P3|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852133|NCT00950807|16727446|P2|Treatment Period 2|Protocol-defined Stopping Criteria|0
4852134|NCT00950807|16727447|P1|Treatment Period 2|Protocol-defined Stopping Criteria|1
4852135|NCT00950807|16727438|P10|Treatment Period 2|Withdrawal by Subject|0
4852136|NCT00950807|16727439|P9|Treatment Period 2|Withdrawal by Subject|0
4852137|NCT00950807|16727440|P8|Treatment Period 2|Withdrawal by Subject|2
4852138|NCT00950807|16727441|P7|Treatment Period 2|Withdrawal by Subject|1
4852139|NCT00950807|16727442|P6|Treatment Period 2|Withdrawal by Subject|0
4852140|NCT00950807|16727443|P5|Treatment Period 2|Withdrawal by Subject|0
4852141|NCT00950807|16727444|P4|Treatment Period 2|Withdrawal by Subject|0
4852142|NCT00950807|16727445|P3|Treatment Period 2|Withdrawal by Subject|0
4852143|NCT00950807|16727446|P2|Treatment Period 2|Withdrawal by Subject|0
4852144|NCT00950807|16727447|P1|Treatment Period 2|Withdrawal by Subject|0
4852145|NCT00950807|16727438|P10|Treatment Period 2|Lack of Efficacy|0
4852146|NCT00950807|16727439|P9|Treatment Period 2|Lack of Efficacy|0
4852147|NCT00950807|16727440|P8|Treatment Period 2|Lack of Efficacy|0
4852148|NCT00950807|16727441|P7|Treatment Period 2|Lack of Efficacy|0
4852149|NCT00950807|16727442|P6|Treatment Period 2|Lack of Efficacy|0
4852150|NCT00950807|16727443|P5|Treatment Period 2|Lack of Efficacy|0
4852151|NCT00950807|16727444|P4|Treatment Period 2|Lack of Efficacy|0
4852152|NCT00950807|16727445|P3|Treatment Period 2|Lack of Efficacy|0
4852153|NCT00950807|16727446|P2|Treatment Period 2|Lack of Efficacy|0
4852154|NCT00950807|16727447|P1|Treatment Period 2|Lack of Efficacy|1
4852155|NCT00950807|16727438|P10|Washout Period 1|Adverse Event|0
4852156|NCT00950807|16727439|P9|Washout Period 1|Adverse Event|0
4852157|NCT00950807|16727440|P8|Washout Period 1|Adverse Event|0
4852158|NCT00950807|16727441|P7|Washout Period 1|Adverse Event|0
4852159|NCT00950807|16727442|P6|Washout Period 1|Adverse Event|0
4852160|NCT00950807|16727443|P5|Washout Period 1|Adverse Event|1
4852161|NCT00950807|16727444|P4|Washout Period 1|Adverse Event|1
4852162|NCT00950807|16727445|P3|Washout Period 1|Adverse Event|0
4852163|NCT00950807|16727446|P2|Washout Period 1|Adverse Event|0
4852164|NCT00950807|16727447|P1|Washout Period 1|Adverse Event|2
4852165|NCT00950807|16727438|P10|Washout Period 1|Protocol-defined Stopping Criteria|0
4852166|NCT00950807|16727439|P9|Washout Period 1|Protocol-defined Stopping Criteria|0
4852167|NCT00950807|16727440|P8|Washout Period 1|Protocol-defined Stopping Criteria|1
4852168|NCT00950807|16727441|P7|Washout Period 1|Protocol-defined Stopping Criteria|1
4852169|NCT00950807|16727442|P6|Washout Period 1|Protocol-defined Stopping Criteria|0
4852170|NCT00950807|16727443|P5|Washout Period 1|Protocol-defined Stopping Criteria|0
4852171|NCT00950807|16727444|P4|Washout Period 1|Protocol-defined Stopping Criteria|0
4852172|NCT00950807|16727445|P3|Washout Period 1|Protocol-defined Stopping Criteria|0
4852173|NCT00950807|16727446|P2|Washout Period 1|Protocol-defined Stopping Criteria|0
4852174|NCT00950807|16727447|P1|Washout Period 1|Protocol-defined Stopping Criteria|3
4852175|NCT00950807|16727438|P10|Washout Period 1|Withdrawal by Subject|0
4852176|NCT00950807|16727439|P9|Washout Period 1|Withdrawal by Subject|1
4852177|NCT00950807|16727440|P8|Washout Period 1|Withdrawal by Subject|0
4852178|NCT00950807|16727441|P7|Washout Period 1|Withdrawal by Subject|0
4852179|NCT00950807|16727442|P6|Washout Period 1|Withdrawal by Subject|0
4852180|NCT00950807|16727443|P5|Washout Period 1|Withdrawal by Subject|0
4852181|NCT00950807|16727444|P4|Washout Period 1|Withdrawal by Subject|0
4852182|NCT00950807|16727445|P3|Washout Period 1|Withdrawal by Subject|0
4852183|NCT00950807|16727446|P2|Washout Period 1|Withdrawal by Subject|0
4852184|NCT00950807|16727447|P1|Washout Period 1|Withdrawal by Subject|0
4852185|NCT00950807|16727438|P10|Washout Period 1|Lack of Efficacy|0
4852186|NCT00950807|16727439|P9|Washout Period 1|Lack of Efficacy|0
4852187|NCT00950807|16727440|P8|Washout Period 1|Lack of Efficacy|0
4852188|NCT00950807|16727441|P7|Washout Period 1|Lack of Efficacy|1
4852189|NCT00950807|16727442|P6|Washout Period 1|Lack of Efficacy|0
4852190|NCT00950807|16727443|P5|Washout Period 1|Lack of Efficacy|0
4852191|NCT00950807|16727444|P4|Washout Period 1|Lack of Efficacy|0
4852192|NCT00950807|16727445|P3|Washout Period 1|Lack of Efficacy|0
4852193|NCT00950807|16727446|P2|Washout Period 1|Lack of Efficacy|0
4852194|NCT00950807|16727447|P1|Washout Period 1|Lack of Efficacy|0
4852195|NCT00950807|16727438|P10|Treatment Period 1|Adverse Event|0
4852196|NCT00950807|16727439|P9|Treatment Period 1|Adverse Event|0
4852197|NCT00950807|16727440|P8|Treatment Period 1|Adverse Event|0
4852198|NCT00950807|16727441|P7|Treatment Period 1|Adverse Event|0
4852199|NCT00950807|16727442|P6|Treatment Period 1|Adverse Event|1
4852200|NCT00950807|16727443|P5|Treatment Period 1|Adverse Event|0
4852201|NCT00950807|16727444|P4|Treatment Period 1|Adverse Event|0
4852202|NCT00950807|16727445|P3|Treatment Period 1|Adverse Event|0
4852203|NCT00950807|16727446|P2|Treatment Period 1|Adverse Event|0
4852204|NCT00950807|16727447|P1|Treatment Period 1|Adverse Event|0
4852205|NCT00950807|16727438|P10|Treatment Period 1|Withdrawal by Subject|0
4852206|NCT00950807|16727439|P9|Treatment Period 1|Withdrawal by Subject|1
4852207|NCT00950807|16727440|P8|Treatment Period 1|Withdrawal by Subject|0
4852208|NCT00950807|16727441|P7|Treatment Period 1|Withdrawal by Subject|0
4852209|NCT00950807|16727442|P6|Treatment Period 1|Withdrawal by Subject|0
4852210|NCT00950807|16727443|P5|Treatment Period 1|Withdrawal by Subject|1
4852211|NCT00950807|16727444|P4|Treatment Period 1|Withdrawal by Subject|0
4852212|NCT00950807|16727445|P3|Treatment Period 1|Withdrawal by Subject|0
4852214|NCT00950807|16727447|P1|Treatment Period 1|Withdrawal by Subject|1
4852215|NCT00950807|16727438|P10|Treatment Period 1|Lost to Follow-up|0
4852216|NCT00950807|16727439|P9|Treatment Period 1|Lost to Follow-up|0
4852217|NCT00950807|16727440|P8|Treatment Period 1|Lost to Follow-up|0
4852218|NCT00950807|16727441|P7|Treatment Period 1|Lost to Follow-up|0
4852219|NCT00950807|16727442|P6|Treatment Period 1|Lost to Follow-up|0
4852220|NCT00950807|16727443|P5|Treatment Period 1|Lost to Follow-up|0
4852221|NCT00950807|16727444|P4|Treatment Period 1|Lost to Follow-up|0
4852222|NCT00950807|16727445|P3|Treatment Period 1|Lost to Follow-up|1
4852223|NCT00950807|16727446|P2|Treatment Period 1|Lost to Follow-up|0
4852224|NCT00950807|16727447|P1|Treatment Period 1|Lost to Follow-up|0
4852225|NCT00950807|16727438|P10|Treatment Period 1|Protocol Violation|0
4852226|NCT00950807|16727439|P9|Treatment Period 1|Protocol Violation|0
4852227|NCT00950807|16727440|P8|Treatment Period 1|Protocol Violation|0
4852228|NCT00950807|16727441|P7|Treatment Period 1|Protocol Violation|0
4852229|NCT00950807|16727442|P6|Treatment Period 1|Protocol Violation|0
4852230|NCT00950807|16727443|P5|Treatment Period 1|Protocol Violation|0
4852231|NCT00950807|16727444|P4|Treatment Period 1|Protocol Violation|0
4852232|NCT00950807|16727445|P3|Treatment Period 1|Protocol Violation|0
4852233|NCT00950807|16727446|P2|Treatment Period 1|Protocol Violation|0
4852234|NCT00950807|16727447|P1|Treatment Period 1|Protocol Violation|1
4852235|NCT00950807|16727438|P10|Treatment Period 1|Lack of Efficacy|0
4852236|NCT00950807|16727439|P9|Treatment Period 1|Lack of Efficacy|0
4852237|NCT00950807|16727440|P8|Treatment Period 1|Lack of Efficacy|0
4852238|NCT00950807|16727441|P7|Treatment Period 1|Lack of Efficacy|0
4852239|NCT00950807|16727442|P6|Treatment Period 1|Lack of Efficacy|1
4852240|NCT00950807|16727443|P5|Treatment Period 1|Lack of Efficacy|0
4852241|NCT00950807|16727444|P4|Treatment Period 1|Lack of Efficacy|0
4852242|NCT00950807|16727445|P3|Treatment Period 1|Lack of Efficacy|0
4852243|NCT00950807|16727446|P2|Treatment Period 1|Lack of Efficacy|0
4852244|NCT00950807|16727447|P1|Treatment Period 1|Lack of Efficacy|1
4852245|NCT00950755|16727489|P1|Long-Term Follow-Up|Death|8
4852246|NCT00950755|16727489|P1|Long-Term Follow-Up|Lost to Follow-up|1
4852247|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Investigator Discretion|1
4852248|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6
4852249|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1
4852250|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1
4852251|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Death|1
4852252|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Progressive Disease|27
4852253|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1
4852254|NCT00950755|16727489|P1|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3
4852255|NCT00950742|16727515|P2|Overall Study|Dose limiting toxicity|0
4852256|NCT00950742|16727516|P1|Overall Study|Dose limiting toxicity|6
4852257|NCT00950742|16727515|P2|Overall Study|Progressive Disease|2
4852258|NCT00950742|16727516|P1|Overall Study|Progressive Disease|6
4852259|NCT00950742|16727515|P2|Overall Study|Withdrawal by Subject|0
4852260|NCT00950742|16727516|P1|Overall Study|Withdrawal by Subject|3
4852261|NCT00950742|16727515|P2|Overall Study|Other Adverse Event|0
4852262|NCT00950742|16727516|P1|Overall Study|Other Adverse Event|1
4852263|NCT00950690|16727537|P1|Overall Study|Other|163
4852264|NCT00950690|16727537|P1|Overall Study|Lost to Follow-up|40
4852265|NCT00950690|16727537|P1|Overall Study|Lack of Efficacy|22
4852266|NCT00950690|16727537|P1|Overall Study|Adverse Event|15
4852267|NCT00950690|16727537|P1|Overall Study|Death|4
4852268|NCT00950664|16727544|P2|First Intervention|Withdrawal by Subject|2
4852269|NCT00950664|16727545|P1|First Intervention|Withdrawal by Subject|2
4852270|NCT00950664|16727544|P2|First Intervention|Lost to Follow-up|3
4852271|NCT00950664|16727545|P1|First Intervention|Lost to Follow-up|1
4852272|NCT00950651|16727565|P2|Overall Study|Withdrawal by Subject|9
4852273|NCT00950651|16727566|P1|Overall Study|Withdrawal by Subject|8
4852274|NCT00950651|16727565|P2|Overall Study|Protocol Violation|4
4852275|NCT00950651|16727566|P1|Overall Study|Protocol Violation|3
4852276|NCT00950651|16727565|P2|Overall Study|Lack of Efficacy|2
4852277|NCT00950651|16727566|P1|Overall Study|Lack of Efficacy|2
4852278|NCT00950651|16727565|P2|Overall Study|Death|0
4852279|NCT00950651|16727566|P1|Overall Study|Death|1
4852280|NCT00950651|16727565|P2|Overall Study|Adverse Event|20
4852281|NCT00950651|16727566|P1|Overall Study|Adverse Event|17
4852282|NCT00950599|16727659|P10|Follow-Up Period|Subject withdrew Consent|1
4852283|NCT00950599|16727660|P9|Follow-Up Period|Subject withdrew Consent|2
4852284|NCT00950599|16727661|P8|Follow-Up Period|Subject withdrew Consent|0
4852285|NCT00950599|16727662|P7|Follow-Up Period|Subject withdrew Consent|0
4852286|NCT00950599|16727663|P6|Follow-Up Period|Subject withdrew Consent|0
4852287|NCT00950599|16727664|P5|Follow-Up Period|Subject withdrew Consent|0
4852288|NCT00950599|16727665|P4|Follow-Up Period|Subject withdrew Consent|0
4852289|NCT00950599|16727666|P3|Follow-Up Period|Subject withdrew Consent|0
4852290|NCT00950599|16727667|P2|Follow-Up Period|Subject withdrew Consent|0
4852291|NCT00950599|16727668|P1|Follow-Up Period|Subject withdrew Consent|0
4852292|NCT00950599|16727659|P10|Follow-Up Period|Poor/Noncompliance|0
4852293|NCT00950599|16727660|P9|Follow-Up Period|Poor/Noncompliance|1
4852294|NCT00950599|16727661|P8|Follow-Up Period|Poor/Noncompliance|0
4852295|NCT00950599|16727662|P7|Follow-Up Period|Poor/Noncompliance|0
4852296|NCT00950599|16727663|P6|Follow-Up Period|Poor/Noncompliance|0
4852297|NCT00950599|16727664|P5|Follow-Up Period|Poor/Noncompliance|0
4852298|NCT00950599|16727665|P4|Follow-Up Period|Poor/Noncompliance|0
4852299|NCT00950599|16727666|P3|Follow-Up Period|Poor/Noncompliance|0
4852300|NCT00950599|16727667|P2|Follow-Up Period|Poor/Noncompliance|0
4852301|NCT00950599|16727668|P1|Follow-Up Period|Poor/Noncompliance|0
4852302|NCT00950599|16727659|P10|Follow-Up Period|Physician Decision|0
4852303|NCT00950599|16727660|P9|Follow-Up Period|Physician Decision|1
4852304|NCT00950599|16727661|P8|Follow-Up Period|Physician Decision|0
4852305|NCT00950599|16727662|P7|Follow-Up Period|Physician Decision|0
4852306|NCT00950599|16727663|P6|Follow-Up Period|Physician Decision|0
4852307|NCT00950599|16727664|P5|Follow-Up Period|Physician Decision|0
4852308|NCT00950599|16727665|P4|Follow-Up Period|Physician Decision|0
4852309|NCT00950599|16727666|P3|Follow-Up Period|Physician Decision|0
4852310|NCT00950599|16727667|P2|Follow-Up Period|Physician Decision|0
4852311|NCT00950599|16727668|P1|Follow-Up Period|Physician Decision|0
4852312|NCT00950599|16727659|P10|Follow-Up Period|Lost to Follow-up|1
4852313|NCT00950599|16727660|P9|Follow-Up Period|Lost to Follow-up|5
4852314|NCT00950599|16727661|P8|Follow-Up Period|Lost to Follow-up|0
4852315|NCT00950599|16727662|P7|Follow-Up Period|Lost to Follow-up|0
4852316|NCT00950599|16727663|P6|Follow-Up Period|Lost to Follow-up|0
4852317|NCT00950599|16727664|P5|Follow-Up Period|Lost to Follow-up|0
4852318|NCT00950599|16727665|P4|Follow-Up Period|Lost to Follow-up|0
4852319|NCT00950599|16727666|P3|Follow-Up Period|Lost to Follow-up|0
4852320|NCT00950599|16727667|P2|Follow-Up Period|Lost to Follow-up|0
4852321|NCT00950599|16727668|P1|Follow-Up Period|Lost to Follow-up|0
4852322|NCT00950599|16727659|P10|Follow-Up Period|Lack of Efficacy|0
4852323|NCT00950599|16727660|P9|Follow-Up Period|Lack of Efficacy|3
4852324|NCT00950599|16727661|P8|Follow-Up Period|Lack of Efficacy|0
4852325|NCT00950599|16727662|P7|Follow-Up Period|Lack of Efficacy|0
4852326|NCT00950599|16727663|P6|Follow-Up Period|Lack of Efficacy|0
4852327|NCT00950599|16727664|P5|Follow-Up Period|Lack of Efficacy|0
4852328|NCT00950599|16727665|P4|Follow-Up Period|Lack of Efficacy|0
4852329|NCT00950599|16727666|P3|Follow-Up Period|Lack of Efficacy|0
4852330|NCT00950599|16727667|P2|Follow-Up Period|Lack of Efficacy|0
4852331|NCT00950599|16727668|P1|Follow-Up Period|Lack of Efficacy|0
4852332|NCT00950599|16727659|P10|Follow-Up Period|Adverse Event|0
4852333|NCT00950599|16727660|P9|Follow-Up Period|Adverse Event|1
4852334|NCT00950599|16727661|P8|Follow-Up Period|Adverse Event|0
4852335|NCT00950599|16727662|P7|Follow-Up Period|Adverse Event|0
4852336|NCT00950599|16727663|P6|Follow-Up Period|Adverse Event|0
4852337|NCT00950599|16727664|P5|Follow-Up Period|Adverse Event|0
4852338|NCT00950599|16727665|P4|Follow-Up Period|Adverse Event|0
4852339|NCT00950599|16727666|P3|Follow-Up Period|Adverse Event|0
4852340|NCT00950599|16727667|P2|Follow-Up Period|Adverse Event|0
4852341|NCT00950599|16727668|P1|Follow-Up Period|Adverse Event|0
4852342|NCT00950599|16727659|P10|Double-Blind Treatment Period|Subject Withdrew consent|0
4852343|NCT00950599|16727660|P9|Double-Blind Treatment Period|Subject Withdrew consent|0
4852344|NCT00950599|16727661|P8|Double-Blind Treatment Period|Subject Withdrew consent|3
4852345|NCT00950599|16727662|P7|Double-Blind Treatment Period|Subject Withdrew consent|0
4852346|NCT00950599|16727663|P6|Double-Blind Treatment Period|Subject Withdrew consent|2
4852347|NCT00950599|16727664|P5|Double-Blind Treatment Period|Subject Withdrew consent|1
4852348|NCT00950599|16727665|P4|Double-Blind Treatment Period|Subject Withdrew consent|1
4852349|NCT00950599|16727666|P3|Double-Blind Treatment Period|Subject Withdrew consent|3
4852350|NCT00950599|16727667|P2|Double-Blind Treatment Period|Subject Withdrew consent|3
4852351|NCT00950599|16727668|P1|Double-Blind Treatment Period|Subject Withdrew consent|4
4852352|NCT00950599|16727659|P10|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852353|NCT00950599|16727660|P9|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852354|NCT00950599|16727661|P8|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852355|NCT00950599|16727662|P7|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852356|NCT00950599|16727663|P6|Double-Blind Treatment Period|Subject no longer meets study criteria|1
4852357|NCT00950599|16727664|P5|Double-Blind Treatment Period|Subject no longer meets study criteria|1
4852358|NCT00950599|16727665|P4|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852359|NCT00950599|16727666|P3|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852360|NCT00950599|16727667|P2|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852361|NCT00950599|16727668|P1|Double-Blind Treatment Period|Subject no longer meets study criteria|0
4852362|NCT00950599|16727659|P10|Double-Blind Treatment Period|Poor/Noncompliance|0
4852363|NCT00950599|16727660|P9|Double-Blind Treatment Period|Poor/Noncompliance|0
4852364|NCT00950599|16727661|P8|Double-Blind Treatment Period|Poor/Noncompliance|1
4852365|NCT00950599|16727662|P7|Double-Blind Treatment Period|Poor/Noncompliance|0
4852366|NCT00950599|16727663|P6|Double-Blind Treatment Period|Poor/Noncompliance|0
4852367|NCT00950599|16727664|P5|Double-Blind Treatment Period|Poor/Noncompliance|0
4852368|NCT00950599|16727665|P4|Double-Blind Treatment Period|Poor/Noncompliance|0
4852369|NCT00950599|16727666|P3|Double-Blind Treatment Period|Poor/Noncompliance|0
4852370|NCT00950599|16727667|P2|Double-Blind Treatment Period|Poor/Noncompliance|1
4852371|NCT00950599|16727668|P1|Double-Blind Treatment Period|Poor/Noncompliance|1
4852372|NCT00950599|16727659|P10|Double-Blind Treatment Period|Lost to Follow-up|0
4852373|NCT00950599|16727660|P9|Double-Blind Treatment Period|Lost to Follow-up|0
4852374|NCT00950599|16727661|P8|Double-Blind Treatment Period|Lost to Follow-up|1
4852375|NCT00950599|16727662|P7|Double-Blind Treatment Period|Lost to Follow-up|0
4852376|NCT00950599|16727663|P6|Double-Blind Treatment Period|Lost to Follow-up|2
4852377|NCT00950599|16727664|P5|Double-Blind Treatment Period|Lost to Follow-up|1
4852378|NCT00950599|16727665|P4|Double-Blind Treatment Period|Lost to Follow-up|1
4852379|NCT00950599|16727666|P3|Double-Blind Treatment Period|Lost to Follow-up|0
4852380|NCT00950599|16727667|P2|Double-Blind Treatment Period|Lost to Follow-up|0
4852381|NCT00950599|16727668|P1|Double-Blind Treatment Period|Lost to Follow-up|0
4852382|NCT00950599|16727659|P10|Double-Blind Treatment Period|Lack of Efficacy|0
4852383|NCT00950599|16727660|P9|Double-Blind Treatment Period|Lack of Efficacy|0
4852384|NCT00950599|16727661|P8|Double-Blind Treatment Period|Lack of Efficacy|1
4852385|NCT00950599|16727662|P7|Double-Blind Treatment Period|Lack of Efficacy|0
4852386|NCT00950599|16727663|P6|Double-Blind Treatment Period|Lack of Efficacy|6
4852387|NCT00950599|16727664|P5|Double-Blind Treatment Period|Lack of Efficacy|3
4852388|NCT00950599|16727665|P4|Double-Blind Treatment Period|Lack of Efficacy|7
4852389|NCT00950599|16727666|P3|Double-Blind Treatment Period|Lack of Efficacy|5
4852390|NCT00950599|16727667|P2|Double-Blind Treatment Period|Lack of Efficacy|5
4852391|NCT00950599|16727668|P1|Double-Blind Treatment Period|Lack of Efficacy|2
4852392|NCT00950599|16727659|P10|Double-Blind Treatment Period|Adverse Event|0
4852393|NCT00950599|16727660|P9|Double-Blind Treatment Period|Adverse Event|0
4852394|NCT00950599|16727661|P8|Double-Blind Treatment Period|Adverse Event|0
4852395|NCT00950599|16727662|P7|Double-Blind Treatment Period|Adverse Event|0
4852396|NCT00950599|16727663|P6|Double-Blind Treatment Period|Adverse Event|1
4852397|NCT00950599|16727664|P5|Double-Blind Treatment Period|Adverse Event|1
4852398|NCT00950599|16727665|P4|Double-Blind Treatment Period|Adverse Event|1
4852399|NCT00950599|16727666|P3|Double-Blind Treatment Period|Adverse Event|1
4852400|NCT00950599|16727667|P2|Double-Blind Treatment Period|Adverse Event|1
4852401|NCT00950599|16727668|P1|Double-Blind Treatment Period|Adverse Event|0
4852402|NCT00950599|16727659|P10|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852403|NCT00950599|16727660|P9|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852404|NCT00950599|16727661|P8|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852405|NCT00950599|16727662|P7|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852406|NCT00950599|16727663|P6|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852407|NCT00950599|16727664|P5|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852408|NCT00950599|16727665|P4|Double-Blind Treatment Period|Administrative reason by sponsor|1
4852409|NCT00950599|16727666|P3|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852410|NCT00950599|16727667|P2|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852411|NCT00950599|16727668|P1|Double-Blind Treatment Period|Administrative reason by sponsor|0
4852412|NCT00950300|16728254|P2|SFU Period|Withdrawal by Subject|8
4852413|NCT00950300|16728255|P1|SFU Period|Withdrawal by Subject|4
4852414|NCT00950300|16728254|P2|SFU Period|Lost to Follow-up|28
4852415|NCT00950300|16728255|P1|SFU Period|Lost to Follow-up|30
4852416|NCT00950300|16728254|P2|SFU Period|Death|42
4852417|NCT00950300|16728255|P1|SFU Period|Death|44
4852418|NCT00950300|16728254|P2|TFFU Period|Other|3
4852419|NCT00950300|16728255|P1|TFFU Period|Other|4
4852420|NCT00950300|16728254|P2|TFFU Period|Recurrence of Disease|72
4852421|NCT00950300|16728255|P1|TFFU Period|Recurrence of Disease|63
4852422|NCT00950300|16728254|P2|TFFU Period|Failure to Return|16
4852423|NCT00950300|16728255|P1|TFFU Period|Failure to Return|16
4852424|NCT00950300|16728254|P2|TFFU Period|Refused Treatment|11
4852425|NCT00950300|16728255|P1|TFFU Period|Refused Treatment|10
4852426|NCT00950300|16728254|P2|TFFU Period|Death|1
4852427|NCT00950300|16728255|P1|TFFU Period|Death|4
4852428|NCT00950300|16728254|P2|TFFU Period|Adverse Event or Intercurrent Illness|4
4852429|NCT00950300|16728255|P1|TFFU Period|Adverse Event or Intercurrent Illness|3
4852430|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Other|1
4852431|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Other|1
4852432|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5
4852433|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10
4852434|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11
4852435|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12
4852436|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1
4852437|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2
4852438|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5
4852439|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4
4852440|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0
4852441|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1
4852442|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1
4852443|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2
4852444|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0
4852445|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3
4852446|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Death|3
4852447|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Death|1
4852448|NCT00950300|16728254|P2|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15
4852449|NCT00950300|16728255|P1|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6
4852450|NCT00950248|16728304|P3|Year 2&3 Treatment Randomization|MRI contraindication|0
4852451|NCT00950248|16728305|P2|Year 2&3 Treatment Randomization|MRI contraindication|1
4852452|NCT00950248|16728306|P1|Year 2&3 Treatment Randomization|MRI contraindication|0
4852453|NCT00950248|16728304|P3|Year 2&3 Treatment Randomization|Death|1
4852454|NCT00950248|16728305|P2|Year 2&3 Treatment Randomization|Death|0
4852455|NCT00950248|16728306|P1|Year 2&3 Treatment Randomization|Death|0
4852456|NCT00950248|16728304|P3|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
4852457|NCT00950248|16728305|P2|Year 2&3 Treatment Randomization|Withdrawal by Subject|3
4852458|NCT00950248|16728306|P1|Year 2&3 Treatment Randomization|Withdrawal by Subject|0
4852459|NCT00950248|16728304|P3|Year 2&3 Treatment Randomization|worsening of symptoms|4
4852460|NCT00950248|16728305|P2|Year 2&3 Treatment Randomization|worsening of symptoms|2
4852461|NCT00950248|16728306|P1|Year 2&3 Treatment Randomization|worsening of symptoms|0
4852462|NCT00950248|16728304|P3|Year 1: Baseline|worsening of symptoms|0
4852463|NCT00950248|16728305|P2|Year 1: Baseline|worsening of symptoms|0
4852464|NCT00950248|16728306|P1|Year 1: Baseline|worsening of symptoms|2
4852465|NCT00950248|16728304|P3|Year 1: Baseline|Withdrawal by Subject|0
4852466|NCT00950248|16728305|P2|Year 1: Baseline|Withdrawal by Subject|0
4852467|NCT00950248|16728306|P1|Year 1: Baseline|Withdrawal by Subject|6
4852468|NCT00950170|16728346|P1|Overall Study|Discontinuation of Study by Sponsor|1
4852469|NCT00950170|16728346|P1|Overall Study|Adverse Event|2
4852470|NCT00950170|16728346|P1|Overall Study|Parent/Legal Guardian Request|1
4852471|NCT00949988|16728397|P1|Overall Study|Withdrawal by Subject|3
4852472|NCT00949975|16728412|P4|Overall Study|Other|0
4852473|NCT00949975|16728413|P3|Overall Study|Other|0
4852474|NCT00949975|16728414|P2|Overall Study|Other|0
4852475|NCT00949975|16728415|P1|Overall Study|Other|1
4852476|NCT00949975|16728412|P4|Overall Study|Lost to Follow-up|3
4852477|NCT00949975|16728413|P3|Overall Study|Lost to Follow-up|1
4852478|NCT00949975|16728414|P2|Overall Study|Lost to Follow-up|0
4852479|NCT00949975|16728415|P1|Overall Study|Lost to Follow-up|1
4852480|NCT00949975|16728412|P4|Overall Study|Severe non-compliance|2
4852481|NCT00949975|16728413|P3|Overall Study|Severe non-compliance|0
4852482|NCT00949975|16728414|P2|Overall Study|Severe non-compliance|1
4852483|NCT00949975|16728415|P1|Overall Study|Severe non-compliance|3
4852484|NCT00949975|16728412|P4|Overall Study|Incorrect enrolment|7
4852485|NCT00949975|16728413|P3|Overall Study|Incorrect enrolment|4
4852486|NCT00949975|16728414|P2|Overall Study|Incorrect enrolment|10
4852487|NCT00949975|16728415|P1|Overall Study|Incorrect enrolment|5
4852488|NCT00949975|16728412|P4|Overall Study|Study-specific criteria|0
4852489|NCT00949975|16728413|P3|Overall Study|Study-specific criteria|1
4852490|NCT00949975|16728414|P2|Overall Study|Study-specific criteria|1
4852491|NCT00949975|16728415|P1|Overall Study|Study-specific criteria|0
4852492|NCT00949975|16728412|P4|Overall Study|Safety reason|0
4852493|NCT00949975|16728413|P3|Overall Study|Safety reason|0
4852494|NCT00949975|16728414|P2|Overall Study|Safety reason|1
4852495|NCT00949975|16728415|P1|Overall Study|Safety reason|0
4852496|NCT00949975|16728412|P4|Overall Study|Adverse Event|10
4852497|NCT00949975|16728413|P3|Overall Study|Adverse Event|10
4852498|NCT00949975|16728414|P2|Overall Study|Adverse Event|11
4852499|NCT00949975|16728415|P1|Overall Study|Adverse Event|11
4852500|NCT00949975|16728412|P4|Overall Study|Voluntary discontinuation|6
4852501|NCT00949975|16728413|P3|Overall Study|Voluntary discontinuation|3
4852502|NCT00949975|16728414|P2|Overall Study|Voluntary discontinuation|5
4852503|NCT00949975|16728415|P1|Overall Study|Voluntary discontinuation|6
4852504|NCT00949910|16728533|P1|Overall Study|No Data|9
4852505|NCT00949910|16728533|P1|Overall Study|Other|4
4852506|NCT00949910|16728533|P1|Overall Study|Physician/Participant Decision|7
4852507|NCT00949910|16728533|P1|Overall Study|Serious Adverse Event|6
4852508|NCT00949910|16728533|P1|Overall Study|Adverse Event|83
4852509|NCT00949910|16728533|P1|Overall Study|Prolonged Dosing Interruption|4
4852510|NCT00949910|16728533|P1|Overall Study|Non-Compliance|10
4852511|NCT00949910|16728533|P1|Overall Study|Logistical Reasons|13
4852512|NCT00949910|16728533|P1|Overall Study|Violation of Eligibility|23
4852513|NCT00949910|16728533|P1|Overall Study|Switched to Commercial Treatment|4
4852514|NCT00949910|16728533|P1|Overall Study|Switched to Compassionate/Other Use|174
4852515|NCT00949910|16728533|P1|Overall Study|Unspecified Progression/Deterioration|13
4852516|NCT00949910|16728533|P1|Overall Study|Death from Unknown Cause|5
4852517|NCT00949910|16728533|P1|Overall Study|Death Due to Toxicity|3
4852518|NCT00949910|16728533|P1|Overall Study|Death Due to Adverse Event|115
4852519|NCT00949910|16728533|P1|Overall Study|Death Due to Progression/Deterioration|4
4852520|NCT00949910|16728533|P1|Overall Study|Death Due to Malignant Disease|456
4852521|NCT00949910|16728533|P1|Overall Study|Participant Refusal|390
4852522|NCT00949910|16728533|P1|Overall Study|Study Drug-Related Adverse Event|315
4852523|NCT00949910|16728533|P1|Overall Study|Lost to Follow-up|100
4852524|NCT00949910|16728533|P1|Overall Study|Symptomatic Deterioration|1088
4852525|NCT00949910|16728533|P1|Overall Study|Progressive Disease|3750
4852526|NCT00949884|16728546|P3|Overall Study|Study terminated by sponsor|1
4852527|NCT00949884|16728547|P2|Overall Study|Study terminated by sponsor|0
4852528|NCT00949884|16728548|P1|Overall Study|Study terminated by sponsor|0
4852529|NCT00949884|16728546|P3|Overall Study|Lack of Efficacy|7
4852530|NCT00949884|16728547|P2|Overall Study|Lack of Efficacy|2
4852531|NCT00949884|16728548|P1|Overall Study|Lack of Efficacy|4
4852532|NCT00949884|16728546|P3|Overall Study|Withdrawal by Subject|16
4852533|NCT00949884|16728547|P2|Overall Study|Withdrawal by Subject|4
4852534|NCT00949884|16728548|P1|Overall Study|Withdrawal by Subject|13
4852535|NCT00949884|16728546|P3|Overall Study|Treatment non-compliance|8
4852536|NCT00949884|16728547|P2|Overall Study|Treatment non-compliance|0
4852537|NCT00949884|16728548|P1|Overall Study|Treatment non-compliance|5
4852538|NCT00949884|16728546|P3|Overall Study|Physician Decision|6
4852539|NCT00949884|16728547|P2|Overall Study|Physician Decision|0
4852540|NCT00949884|16728548|P1|Overall Study|Physician Decision|5
4852541|NCT00949884|16728546|P3|Overall Study|Lost to Follow-up|5
4852542|NCT00949884|16728547|P2|Overall Study|Lost to Follow-up|5
4852543|NCT00949884|16728548|P1|Overall Study|Lost to Follow-up|7
4852544|NCT00949884|16728546|P3|Overall Study|Did not meet inclusion/exclusion|3
4852545|NCT00949884|16728547|P2|Overall Study|Did not meet inclusion/exclusion|1
4852546|NCT00949884|16728548|P1|Overall Study|Did not meet inclusion/exclusion|2
4852547|NCT00949884|16728546|P3|Overall Study|Adverse Event|12
4852548|NCT00949884|16728547|P2|Overall Study|Adverse Event|3
4852549|NCT00949884|16728548|P1|Overall Study|Adverse Event|14
4852550|NCT00949715|16728603|P2|Overall Study|Missing 24 month LVEF measurement|0
4852551|NCT00949715|16728604|P1|Overall Study|Missing 24 month LVEF measurement|2
4852552|NCT00949715|16728603|P2|Overall Study|Lost to Follow-up|0
4852553|NCT00949715|16728604|P1|Overall Study|Lost to Follow-up|1
4852554|NCT00949715|16728603|P2|Overall Study|Physician Decision|0
4852555|NCT00949715|16728604|P1|Overall Study|Physician Decision|1
4852556|NCT00949702|16728615|P1|Overall Study|Withdrawal of consent|1
4852557|NCT00949702|16728615|P1|Overall Study|Disease progression|7
4852558|NCT00949702|16728615|P1|Overall Study|Death|40
4852559|NCT00949650|16728632|P2|Overall Study|Other not specified above|0
4852560|NCT00949650|16728633|P1|Overall Study|Other not specified above|5
4852561|NCT00949650|16728632|P2|Overall Study|Not treated|4
4852562|NCT00949650|16728633|P1|Overall Study|Not treated|1
4852563|NCT00949650|16728632|P2|Overall Study|Refusal to continue medication|11
4852564|NCT00949650|16728633|P1|Overall Study|Refusal to continue medication|7
4852565|NCT00949650|16728632|P2|Overall Study|Protocol Violation|4
4852566|NCT00949650|16728633|P1|Overall Study|Protocol Violation|1
4852567|NCT00949650|16728632|P2|Overall Study|Other Adverse Event (AE)|17
4852568|NCT00949650|16728633|P1|Overall Study|Other Adverse Event (AE)|28
4852569|NCT00949650|16728632|P2|Overall Study|Completed 6 courses of chemotherapy|60
4852570|NCT00949650|16728633|P1|Overall Study|Completed 6 courses of chemotherapy|0
4852571|NCT00949650|16728632|P2|Overall Study|Progressive disease|19
4852572|NCT00949650|16728633|P1|Overall Study|Progressive disease|188
4852573|NCT00949533|16728671|P2|Overall Study|Lost to Follow-up|1
4852574|NCT00949533|16728672|P1|Overall Study|Lost to Follow-up|0
4852575|NCT00949325|16728688|P3|Overall Study|Adverse Event|0
4852576|NCT00949325|16728689|P2|Overall Study|Adverse Event|2
4852577|NCT00949325|16728690|P1|Overall Study|Adverse Event|0
4852578|NCT00949117|16728714|P2|Overall Study|Adverse Event|1
4852579|NCT00949117|16728715|P1|Overall Study|Adverse Event|0
4852580|NCT00949117|16728714|P2|Overall Study|Protocol Violation|1
4852581|NCT00949117|16728715|P1|Overall Study|Protocol Violation|1
4852582|NCT00949117|16728714|P2|Overall Study|Lack of Efficacy|3
4852583|NCT00949117|16728715|P1|Overall Study|Lack of Efficacy|2
4852584|NCT00948974|16728756|P2|Overall Study|Lost to Follow-up|20
4852585|NCT00948974|16728757|P1|Overall Study|Lost to Follow-up|23
4852586|NCT00948922|16728775|P3|Overall Study|Not evaluable at time of analysis|0
4852587|NCT00948922|16728776|P2|Overall Study|Not evaluable at time of analysis|3
4852588|NCT00948922|16728777|P1|Overall Study|Not evaluable at time of analysis|0
4852589|NCT00948922|16728775|P3|Overall Study|Transplant eligibility issues|0
4852590|NCT00948922|16728776|P2|Overall Study|Transplant eligibility issues|3
4852591|NCT00948922|16728777|P1|Overall Study|Transplant eligibility issues|2
4852592|NCT00948922|16728775|P3|Overall Study|Insurance issues|0
4852593|NCT00948922|16728776|P2|Overall Study|Insurance issues|0
4852594|NCT00948922|16728777|P1|Overall Study|Insurance issues|1
4852595|NCT00948922|16728775|P3|Overall Study|Disease progression|0
4852596|NCT00948922|16728776|P2|Overall Study|Disease progression|1
4852597|NCT00948922|16728777|P1|Overall Study|Disease progression|0
4852598|NCT00948922|16728775|P3|Overall Study|Death|0
4852599|NCT00948922|16728776|P2|Overall Study|Death|0
4852600|NCT00948922|16728777|P1|Overall Study|Death|3
4852601|NCT00948922|16728775|P3|Overall Study|Withdrawal by Subject|1
4852602|NCT00948922|16728776|P2|Overall Study|Withdrawal by Subject|2
4852603|NCT00948922|16728777|P1|Overall Study|Withdrawal by Subject|0
4852604|NCT00948922|16728775|P3|Overall Study|Did not start study treatment|0
4852605|NCT00948922|16728776|P2|Overall Study|Did not start study treatment|5
4852606|NCT00948922|16728777|P1|Overall Study|Did not start study treatment|2
4852607|NCT00948896|16728800|P8|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852608|NCT00948896|16728801|P7|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852609|NCT00948896|16728802|P6|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852610|NCT00948896|16728803|P5|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852611|NCT00948896|16728804|P4|24 Months of Age to 36 Months of Age|Moved out of Study Area|1
4852612|NCT00948896|16728805|P3|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852613|NCT00948896|16728806|P2|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852614|NCT00948896|16728807|P1|24 Months of Age to 36 Months of Age|Moved out of Study Area|0
4852615|NCT00948896|16728800|P8|24 Months of Age to 36 Months of Age|Protocol Violation|0
4852616|NCT00948896|16728801|P7|24 Months of Age to 36 Months of Age|Protocol Violation|0
4852617|NCT00948896|16728802|P6|24 Months of Age to 36 Months of Age|Protocol Violation|1
4852618|NCT00948896|16728803|P5|24 Months of Age to 36 Months of Age|Protocol Violation|0
4852619|NCT00948896|16728804|P4|24 Months of Age to 36 Months of Age|Protocol Violation|0
4852620|NCT00948896|16728805|P3|24 Months of Age to 36 Months of Age|Protocol Violation|1
4852621|NCT00948896|16728806|P2|24 Months of Age to 36 Months of Age|Protocol Violation|0
4852622|NCT00948896|16728807|P1|24 Months of Age to 36 Months of Age|Protocol Violation|0
4852623|NCT00948896|16728800|P8|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4852624|NCT00948896|16728801|P7|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4852625|NCT00948896|16728802|P6|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4852626|NCT00948896|16728803|P5|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
4852627|NCT00948896|16728804|P4|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4852628|NCT00948896|16728805|P3|24 Months of Age to 36 Months of Age|Lost to Follow-up|1
4852629|NCT00948896|16728806|P2|24 Months of Age to 36 Months of Age|Lost to Follow-up|0
4852630|NCT00948896|16728807|P1|24 Months of Age to 36 Months of Age|Lost to Follow-up|2
4852631|NCT00948896|16728800|P8|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4852632|NCT00948896|16728801|P7|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4852633|NCT00948896|16728802|P6|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4852634|NCT00948896|16728803|P5|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4852635|NCT00948896|16728804|P4|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
4852636|NCT00948896|16728805|P3|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
4852637|NCT00948896|16728806|P2|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0
4852638|NCT00948896|16728807|P1|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1
4852639|NCT00948896|16728800|P8|24 Months of Age to 36 Months of Age|Death|0
4852640|NCT00948896|16728801|P7|24 Months of Age to 36 Months of Age|Death|0
4852641|NCT00948896|16728802|P6|24 Months of Age to 36 Months of Age|Death|1
4852642|NCT00948896|16728803|P5|24 Months of Age to 36 Months of Age|Death|0
4852643|NCT00948896|16728804|P4|24 Months of Age to 36 Months of Age|Death|0
4852644|NCT00948896|16728805|P3|24 Months of Age to 36 Months of Age|Death|2
4852645|NCT00948896|16728806|P2|24 Months of Age to 36 Months of Age|Death|2
4852646|NCT00948896|16728807|P1|24 Months of Age to 36 Months of Age|Death|0
4852647|NCT00948896|16728800|P8|Randomization to 24 Months of Age|Moved out of Study Area|0
4852648|NCT00948896|16728801|P7|Randomization to 24 Months of Age|Moved out of Study Area|0
4852649|NCT00948896|16728802|P6|Randomization to 24 Months of Age|Moved out of Study Area|2
4852650|NCT00948896|16728803|P5|Randomization to 24 Months of Age|Moved out of Study Area|0
4852651|NCT00948896|16728804|P4|Randomization to 24 Months of Age|Moved out of Study Area|1
4852652|NCT00948896|16728805|P3|Randomization to 24 Months of Age|Moved out of Study Area|3
4852653|NCT00948896|16728806|P2|Randomization to 24 Months of Age|Moved out of Study Area|3
4852654|NCT00948896|16728807|P1|Randomization to 24 Months of Age|Moved out of Study Area|0
4852655|NCT00948896|16728800|P8|Randomization to 24 Months of Age|Protocol Violation|1
4852656|NCT00948896|16728801|P7|Randomization to 24 Months of Age|Protocol Violation|1
4852657|NCT00948896|16728802|P6|Randomization to 24 Months of Age|Protocol Violation|0
4852658|NCT00948896|16728803|P5|Randomization to 24 Months of Age|Protocol Violation|0
4852659|NCT00948896|16728804|P4|Randomization to 24 Months of Age|Protocol Violation|1
4852660|NCT00948896|16728805|P3|Randomization to 24 Months of Age|Protocol Violation|0
4852661|NCT00948896|16728806|P2|Randomization to 24 Months of Age|Protocol Violation|1
4852662|NCT00948896|16728807|P1|Randomization to 24 Months of Age|Protocol Violation|0
4852663|NCT00948896|16728800|P8|Randomization to 24 Months of Age|Lost to Follow-up|0
4852664|NCT00948896|16728801|P7|Randomization to 24 Months of Age|Lost to Follow-up|1
4852665|NCT00948896|16728802|P6|Randomization to 24 Months of Age|Lost to Follow-up|0
4852666|NCT00948896|16728803|P5|Randomization to 24 Months of Age|Lost to Follow-up|0
4852667|NCT00948896|16728804|P4|Randomization to 24 Months of Age|Lost to Follow-up|5
4852668|NCT00948896|16728805|P3|Randomization to 24 Months of Age|Lost to Follow-up|2
4852669|NCT00948896|16728806|P2|Randomization to 24 Months of Age|Lost to Follow-up|4
4852670|NCT00948896|16728807|P1|Randomization to 24 Months of Age|Lost to Follow-up|4
4852671|NCT00948896|16728800|P8|Randomization to 24 Months of Age|Withdrawal by Subject|0
4852672|NCT00948896|16728801|P7|Randomization to 24 Months of Age|Withdrawal by Subject|0
4852673|NCT00948896|16728802|P6|Randomization to 24 Months of Age|Withdrawal by Subject|1
4852674|NCT00948896|16728803|P5|Randomization to 24 Months of Age|Withdrawal by Subject|0
4852675|NCT00948896|16728804|P4|Randomization to 24 Months of Age|Withdrawal by Subject|4
4852676|NCT00948896|16728805|P3|Randomization to 24 Months of Age|Withdrawal by Subject|4
4852677|NCT00948896|16728806|P2|Randomization to 24 Months of Age|Withdrawal by Subject|5
4852678|NCT00948896|16728807|P1|Randomization to 24 Months of Age|Withdrawal by Subject|3
4852679|NCT00948896|16728800|P8|Randomization to 24 Months of Age|Death|1
4852680|NCT00948896|16728801|P7|Randomization to 24 Months of Age|Death|2
4852681|NCT00948896|16728802|P6|Randomization to 24 Months of Age|Death|1
4852682|NCT00948896|16728803|P5|Randomization to 24 Months of Age|Death|2
4852683|NCT00948896|16728804|P4|Randomization to 24 Months of Age|Death|0
4852684|NCT00948896|16728805|P3|Randomization to 24 Months of Age|Death|0
4852685|NCT00948896|16728806|P2|Randomization to 24 Months of Age|Death|0
4852686|NCT00948896|16728807|P1|Randomization to 24 Months of Age|Death|1
4852687|NCT00948857|16728843|P2|Overall Study|Lost to Follow-up|0
4852688|NCT00948857|16728844|P1|Overall Study|Lost to Follow-up|1
4852689|NCT00948818|16728852|P2|Overall Study|Other Reason|5
4852690|NCT00948818|16728853|P1|Overall Study|Other Reason|4
4852691|NCT00948818|16728852|P2|Overall Study|Lack of Efficacy|5
4852692|NCT00948818|16728853|P1|Overall Study|Lack of Efficacy|4
4852693|NCT00948818|16728852|P2|Overall Study|Lost to Follow-up|17
4852694|NCT00948818|16728853|P1|Overall Study|Lost to Follow-up|10
4852695|NCT00948818|16728852|P2|Overall Study|Withdrawal by Subject|25
4852696|NCT00948818|16728853|P1|Overall Study|Withdrawal by Subject|25
4852697|NCT00948818|16728852|P2|Overall Study|Protocol Violation|10
4852698|NCT00948818|16728853|P1|Overall Study|Protocol Violation|9
4852699|NCT00948818|16728852|P2|Overall Study|Adverse Event|32
4852700|NCT00948818|16728853|P1|Overall Study|Adverse Event|10
4852701|NCT00948766|16728900|P2|Extension Study|Death|0
4852702|NCT00948766|16728901|P1|Extension Study|Death|4
4852703|NCT00948766|16728900|P2|Extension Study|Administrative Problems|0
4852704|NCT00948766|16728901|P1|Extension Study|Administrative Problems|1
4852705|NCT00948766|16728900|P2|Extension Study|Lost to Follow-up|0
4852706|NCT00948766|16728901|P1|Extension Study|Lost to Follow-up|8
4852707|NCT00948766|16728900|P2|Extension Study|Patient Withdrew Consent|0
4852708|NCT00948766|16728901|P1|Extension Study|Patient Withdrew Consent|32
4852709|NCT00948766|16728900|P2|Extension Study|Study Drug No Longer Required|0
4852710|NCT00948766|16728901|P1|Extension Study|Study Drug No Longer Required|1
4852711|NCT00948766|16728900|P2|Extension Study|Unsatisfactory Therapeutic Effect|0
4852712|NCT00948766|16728901|P1|Extension Study|Unsatisfactory Therapeutic Effect|2
4852713|NCT00948766|16728900|P2|Extension Study|Adverse Event|0
4852714|NCT00948766|16728901|P1|Extension Study|Adverse Event|43
4852715|NCT00948766|16728900|P2|Core Study|Protocol Deviation|10
4852716|NCT00948766|16728901|P1|Core Study|Protocol Deviation|8
4852717|NCT00948766|16728900|P2|Core Study|Death|1
4852718|NCT00948766|16728901|P1|Core Study|Death|1
4852719|NCT00948766|16728900|P2|Core Study|Administrative Problems|2
4852720|NCT00948766|16728901|P1|Core Study|Administrative Problems|2
4852721|NCT00948766|16728900|P2|Core Study|Lost to Follow-up|2
4852722|NCT00948766|16728901|P1|Core Study|Lost to Follow-up|3
4852723|NCT00948766|16728900|P2|Core Study|Patient Withdrew Consent|46
4852724|NCT00948766|16728901|P1|Core Study|Patient Withdrew Consent|27
4852725|NCT00948766|16728900|P2|Core Study|Unsatisfactory Therapeutic Effect|14
4852726|NCT00948766|16728901|P1|Core Study|Unsatisfactory Therapeutic Effect|13
4852727|NCT00948766|16728900|P2|Core Study|Adverse Event|51
4852728|NCT00948766|16728901|P1|Core Study|Adverse Event|73
4852729|NCT00948688|16728917|P2|Period 2: 100 mg Vorinostat|Adverse Event|1
4852730|NCT00948688|16728918|P1|Period 2: 100 mg Vorinostat|Adverse Event|0
4852731|NCT00948688|16728917|P2|Period 1: 200 mg Vorinostat|Protocol Violation|0
4852732|NCT00948688|16728918|P1|Period 1: 200 mg Vorinostat|Protocol Violation|1
4852733|NCT00948688|16728917|P2|Period 1: 200 mg Vorinostat|Adverse Event|0
4852734|NCT00948688|16728918|P1|Period 1: 200 mg Vorinostat|Adverse Event|1
4852735|NCT00948675|16728932|P2|Overall Study|Treatment ongoing|4
4852736|NCT00948675|16728933|P1|Overall Study|Treatment ongoing|5
4852737|NCT00948675|16728932|P2|Overall Study|Lost to Follow-up|0
4852738|NCT00948675|16728933|P1|Overall Study|Lost to Follow-up|2
4852739|NCT00948506|16728960|P2|Overall Study|Withdrawal by Subject|1
4852740|NCT00948506|16728961|P1|Overall Study|Withdrawal by Subject|3
4852741|NCT00948441|16728972|P2|Overall Study|no longer meet inclusion criteria|4
4852742|NCT00948441|16728973|P1|Overall Study|no longer meet inclusion criteria|1
4852743|NCT00948428|16728984|P3|Overall Study|Non-compliance|0
4852744|NCT00948428|16728985|P2|Overall Study|Non-compliance|2
4852745|NCT00948428|16728986|P1|Overall Study|Non-compliance|1
4852746|NCT00948428|16728984|P3|Overall Study|Intercurrent Illness|0
4852747|NCT00948428|16728985|P2|Overall Study|Intercurrent Illness|0
4852748|NCT00948428|16728986|P1|Overall Study|Intercurrent Illness|1
4852749|NCT00948428|16728984|P3|Overall Study|Death|0
4852750|NCT00948428|16728985|P2|Overall Study|Death|0
4852751|NCT00948428|16728986|P1|Overall Study|Death|2
4852752|NCT00948428|16728984|P3|Overall Study|Lost to Follow-up|1
4852753|NCT00948428|16728985|P2|Overall Study|Lost to Follow-up|1
4852754|NCT00948428|16728986|P1|Overall Study|Lost to Follow-up|2
4852755|NCT00948428|16728984|P3|Overall Study|Adverse Event|0
4852756|NCT00948428|16728985|P2|Overall Study|Adverse Event|3
4852757|NCT00948428|16728986|P1|Overall Study|Adverse Event|6
4852758|NCT00948428|16728984|P3|Overall Study|Withdrawal by Subject|7
4852759|NCT00948428|16728985|P2|Overall Study|Withdrawal by Subject|12
4852760|NCT00948428|16728986|P1|Overall Study|Withdrawal by Subject|6
4852761|NCT00948389|16729005|P5|Overall Study|Both Progression and Toxicity|0
4852762|NCT00948389|16729006|P4|Overall Study|Both Progression and Toxicity|0
4852763|NCT00948389|16729007|P3|Overall Study|Both Progression and Toxicity|0
4852764|NCT00948389|16729008|P2|Overall Study|Both Progression and Toxicity|0
4852765|NCT00948389|16729009|P1|Overall Study|Both Progression and Toxicity|1
4852766|NCT00948389|16729005|P5|Overall Study|Thrombocytopenia, Grade 4|0
4852767|NCT00948389|16729006|P4|Overall Study|Thrombocytopenia, Grade 4|1
4852768|NCT00948389|16729007|P3|Overall Study|Thrombocytopenia, Grade 4|0
4852769|NCT00948389|16729008|P2|Overall Study|Thrombocytopenia, Grade 4|0
4852770|NCT00948389|16729009|P1|Overall Study|Thrombocytopenia, Grade 4|2
4852771|NCT00948389|16729005|P5|Overall Study|Disease Progression/Relapse/Death|1
4852772|NCT00948389|16729006|P4|Overall Study|Disease Progression/Relapse/Death|8
4852773|NCT00948389|16729007|P3|Overall Study|Disease Progression/Relapse/Death|7
4852774|NCT00948389|16729008|P2|Overall Study|Disease Progression/Relapse/Death|3
4852775|NCT00948389|16729009|P1|Overall Study|Disease Progression/Relapse/Death|3
4852776|NCT00948246|16729057|P1|Overall Study|Withdrawal by Subject|1
4852777|NCT00948246|16729057|P1|Overall Study|Death|1
4852778|NCT00948246|16729057|P1|Overall Study|Adverse Event|11
4852779|NCT00948246|16729057|P1|Overall Study|Lost to Follow-up|11
4852780|NCT00948155|16729066|P2|Washout 14 Days|Lost to Follow-up|2
4852781|NCT00948155|16729067|P1|Washout 14 Days|Lost to Follow-up|1
4852782|NCT00948155|16729066|P2|First Intervention 21 Days|Lost to Follow-up|2
4852783|NCT00948155|16729067|P1|First Intervention 21 Days|Lost to Follow-up|2
4852784|NCT00948064|16729114|P3|Phase II|Withdrawal by Subject|0
4852785|NCT00948064|16729115|P2|Phase II|Withdrawal by Subject|1
4852786|NCT00948064|16729116|P1|Phase II|Withdrawal by Subject|0
4852787|NCT00948064|16729114|P3|Phase II|Physician Decision|1
4852788|NCT00948064|16729115|P2|Phase II|Physician Decision|0
4852789|NCT00948064|16729116|P1|Phase II|Physician Decision|0
4852790|NCT00948064|16729114|P3|Phase I|No treatment received|0
4852791|NCT00948064|16729115|P2|Phase I|No treatment received|0
4852792|NCT00948064|16729116|P1|Phase I|No treatment received|1
4852793|NCT00947882|16729131|P4|Overall Study|Trial Terminated by Sponsor|70
4852794|NCT00947882|16729132|P3|Overall Study|Trial Terminated by Sponsor|62
4852795|NCT00947882|16729133|P2|Overall Study|Trial Terminated by Sponsor|61
4852796|NCT00947882|16729134|P1|Overall Study|Trial Terminated by Sponsor|62
4852797|NCT00947882|16729131|P4|Overall Study|Other/Unknown|6
4852798|NCT00947882|16729132|P3|Overall Study|Other/Unknown|3
4852799|NCT00947882|16729133|P2|Overall Study|Other/Unknown|13
4852800|NCT00947882|16729134|P1|Overall Study|Other/Unknown|10
4852801|NCT00947882|16729131|P4|Overall Study|Lost to Follow-up|0
4852802|NCT00947882|16729132|P3|Overall Study|Lost to Follow-up|1
4852803|NCT00947882|16729133|P2|Overall Study|Lost to Follow-up|2
4852804|NCT00947882|16729134|P1|Overall Study|Lost to Follow-up|0
4852805|NCT00947882|16729131|P4|Overall Study|Protocol Violation|0
4852806|NCT00947882|16729132|P3|Overall Study|Protocol Violation|1
4852807|NCT00947882|16729133|P2|Overall Study|Protocol Violation|0
4852808|NCT00947882|16729134|P1|Overall Study|Protocol Violation|0
4852809|NCT00947882|16729131|P4|Overall Study|Withdrawal by Subject|2
4852810|NCT00947882|16729132|P3|Overall Study|Withdrawal by Subject|8
4852811|NCT00947882|16729133|P2|Overall Study|Withdrawal by Subject|0
4852812|NCT00947882|16729134|P1|Overall Study|Withdrawal by Subject|2
4852813|NCT00947882|16729131|P4|Overall Study|Adverse Event|4
4852814|NCT00947882|16729132|P3|Overall Study|Adverse Event|4
4852815|NCT00947882|16729133|P2|Overall Study|Adverse Event|1
4852816|NCT00947882|16729134|P1|Overall Study|Adverse Event|0
4852817|NCT00947856|16729162|P2|Follow-up Period|Withdrawal by Subject|0
4852818|NCT00947856|16729163|P1|Follow-up Period|Withdrawal by Subject|1
4852819|NCT00947856|16729162|P2|Follow-up Period|Patient unavailable for site visits|0
4852820|NCT00947856|16729163|P1|Follow-up Period|Patient unavailable for site visits|1
4852821|NCT00947856|16729162|P2|Follow-up Period|Lost to Follow-up|0
4852822|NCT00947856|16729163|P1|Follow-up Period|Lost to Follow-up|7
4852823|NCT00947856|16729162|P2|Follow-up Period|Re-enrolled for Retreatment|3
4852824|NCT00947856|16729163|P1|Follow-up Period|Re-enrolled for Retreatment|2
4852825|NCT00947856|16729162|P2|Follow-up Period|Study Stopped by Sponsor|20
4852826|NCT00947856|16729163|P1|Follow-up Period|Study Stopped by Sponsor|40
4852827|NCT00947856|16729162|P2|Treatment Period|Withdrawal by Subject|1
4852828|NCT00947856|16729163|P1|Treatment Period|Withdrawal by Subject|12
4852829|NCT00947856|16729162|P2|Treatment Period|Study Stopped by Sponsor|4
4852830|NCT00947856|16729163|P1|Treatment Period|Study Stopped by Sponsor|4
4852831|NCT00947856|16729162|P2|Treatment Period|Physician Decision|6
4852832|NCT00947856|16729163|P1|Treatment Period|Physician Decision|14
4852833|NCT00947856|16729162|P2|Treatment Period|Adverse Event|9
4852834|NCT00947856|16729163|P1|Treatment Period|Adverse Event|15
4852835|NCT00947856|16729162|P2|Treatment Period|Progressive Disease|12
4852836|NCT00947856|16729163|P1|Treatment Period|Progressive Disease|33
4852837|NCT00947544|16729252|P2|Safety-Extension Period (12 Months)|Withdrawal by Subject|0
4852838|NCT00947544|16729253|P1|Safety-Extension Period (12 Months)|Withdrawal by Subject|1
4852839|NCT00947531|16729279|P2|Overall Study|Other|1
4852840|NCT00947531|16729280|P1|Overall Study|Other|1
4852841|NCT00947531|16729279|P2|Overall Study|Lack of Efficacy|0
4852842|NCT00947531|16729280|P1|Overall Study|Lack of Efficacy|1
4852843|NCT00947531|16729279|P2|Overall Study|Adverse Event|2
4852844|NCT00947531|16729280|P1|Overall Study|Adverse Event|2
4852845|NCT00947531|16729279|P2|Overall Study|Administrative Reason|1
4852846|NCT00947531|16729280|P1|Overall Study|Administrative Reason|0
4852847|NCT00947531|16729279|P2|Overall Study|Withdrawal by Subject|7
4852848|NCT00947531|16729280|P1|Overall Study|Withdrawal by Subject|10
4852849|NCT00947427|16729318|P2|Overall Study|Protocol Violation|1
4852850|NCT00947427|16729319|P1|Overall Study|Protocol Violation|0
4852851|NCT00947427|16729318|P2|Overall Study|Withdrawal by Subject|3
4852852|NCT00947427|16729319|P1|Overall Study|Withdrawal by Subject|1
4852853|NCT00947349|16729329|P4|Overall Study Standard of Care|Other|1
4852854|NCT00947349|16729330|P3|Overall Study Standard of Care|Other|0
4852855|NCT00947349|16729331|P2|Overall Study Standard of Care|Other|0
4852856|NCT00947349|16729332|P1|Overall Study Standard of Care|Other|0
4852857|NCT00947349|16729329|P4|Overall Study Standard of Care|Withdrawal by Subject|0
4852858|NCT00947349|16729330|P3|Overall Study Standard of Care|Withdrawal by Subject|1
4852859|NCT00947349|16729331|P2|Overall Study Standard of Care|Withdrawal by Subject|0
4852860|NCT00947349|16729332|P1|Overall Study Standard of Care|Withdrawal by Subject|0
4852861|NCT00947349|16729329|P4|Overall Study Standard of Care|Lack of Efficacy|1
4852862|NCT00947349|16729330|P3|Overall Study Standard of Care|Lack of Efficacy|1
4852863|NCT00947349|16729331|P2|Overall Study Standard of Care|Lack of Efficacy|0
4852864|NCT00947349|16729332|P1|Overall Study Standard of Care|Lack of Efficacy|0
4852865|NCT00947349|16729329|P4|Triple Treatment Combination Period|Adverse Event|0
4852866|NCT00947349|16729330|P3|Triple Treatment Combination Period|Adverse Event|0
4852867|NCT00947349|16729331|P2|Triple Treatment Combination Period|Adverse Event|1
4852868|NCT00947349|16729332|P1|Triple Treatment Combination Period|Adverse Event|0
4852869|NCT00947193|16729541|P2|Overall Study|Factor VIII >1%|0
4852870|NCT00947193|16729542|P1|Overall Study|Factor VIII >1%|1
4852871|NCT00947193|16729541|P2|Overall Study|Withdrawal by Subject|0
4852872|NCT00947193|16729542|P1|Overall Study|Withdrawal by Subject|1
4852873|NCT00947193|16729541|P2|Overall Study|Lost to Follow-up|0
4852874|NCT00947193|16729542|P1|Overall Study|Lost to Follow-up|1
4852875|NCT00947154|16729557|P1|Overall Study|Lost to Follow-up|1
4852876|NCT00947011|16729564|P1|Overall Study|Study was terminated,PI left institution|12
4852877|NCT00946998|16729574|P2|Overall Study|Exited prior to first outcome assessment|3
4852878|NCT00946998|16729575|P1|Overall Study|Exited prior to first outcome assessment|5
4852879|NCT00946985|16729589|P1|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2
4852880|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Patient Moved Away|2
4852881|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1
4852882|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2
4852883|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139
4852884|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4
4852885|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Lost to Follow-up|5
4852886|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Lack of Efficacy|3
4852887|NCT00946985|16729589|P1|Stabilization Phase (25 Weeks)|Adverse Event|4
4852888|NCT00946920|16729595|P2|Overall Study|Miscellaneous reasons|3
4852889|NCT00946920|16729596|P1|Overall Study|Miscellaneous reasons|18
4852890|NCT00946920|16729595|P2|Overall Study|Protocol Violation|8
4852891|NCT00946920|16729596|P1|Overall Study|Protocol Violation|16
4852892|NCT00946920|16729595|P2|Overall Study|Adverse Event|14
4852893|NCT00946920|16729596|P1|Overall Study|Adverse Event|41
4852894|NCT00946920|16729595|P2|Overall Study|Physician Decision|2
4852895|NCT00946920|16729596|P1|Overall Study|Physician Decision|5
4852896|NCT00946920|16729595|P2|Overall Study|Lost to Follow-up|2
4852897|NCT00946920|16729596|P1|Overall Study|Lost to Follow-up|2
4852898|NCT00946920|16729595|P2|Overall Study|Withdrawal by Subject|15
4852899|NCT00946920|16729596|P1|Overall Study|Withdrawal by Subject|28
4852900|NCT00946881|16729611|P1|Retreatment|Withdrawal by Subject|1
4852901|NCT00946881|16729611|P1|First Treatment|Patient relocated to another state|1
4852902|NCT00946881|16729611|P1|First Treatment|Withdrawal by Subject|1
4852903|NCT00946712|16729642|P2|Overall Study|Ineligible|6
4852904|NCT00946712|16729643|P1|Overall Study|Ineligible|14
4852905|NCT00946712|16729642|P2|Overall Study|On Treatment|4
4852906|NCT00946712|16729643|P1|Overall Study|On Treatment|0
4852907|NCT00946712|16729642|P2|Overall Study|Other reasons|73
4852908|NCT00946712|16729643|P1|Overall Study|Other reasons|61
4852909|NCT00946712|16729642|P2|Overall Study|No treatment given|29
4852910|NCT00946712|16729643|P1|Overall Study|No treatment given|25
4852911|NCT00946712|16729642|P2|Overall Study|Death|22
4852912|NCT00946712|16729643|P1|Overall Study|Death|21
4852913|NCT00946712|16729642|P2|Overall Study|Disease progression|404
4852914|NCT00946712|16729643|P1|Overall Study|Disease progression|308
4852915|NCT00946712|16729642|P2|Overall Study|Adverse Event|124
4852916|NCT00946712|16729643|P1|Overall Study|Adverse Event|118
4852917|NCT00946647|16729662|P5|Phase ll Part|Subj cond no longer required study drug|0
4852918|NCT00946647|16729663|P4|Phase ll Part|Subj cond no longer required study drug|2
4852919|NCT00946647|16729664|P3|Phase ll Part|Subj cond no longer required study drug|0
4852920|NCT00946647|16729665|P2|Phase ll Part|Subj cond no longer required study drug|0
4852921|NCT00946647|16729666|P1|Phase ll Part|Subj cond no longer required study drug|0
4852922|NCT00946647|16729662|P5|Phase ll Part|Protocol Violation|2
4852923|NCT00946647|16729663|P4|Phase ll Part|Protocol Violation|4
4852924|NCT00946647|16729664|P3|Phase ll Part|Protocol Violation|0
4852925|NCT00946647|16729665|P2|Phase ll Part|Protocol Violation|0
4852926|NCT00946647|16729666|P1|Phase ll Part|Protocol Violation|0
4852927|NCT00946647|16729662|P5|Phase ll Part|Disease progression|14
4852928|NCT00946647|16729663|P4|Phase ll Part|Disease progression|6
4852929|NCT00946647|16729664|P3|Phase ll Part|Disease progression|0
4852930|NCT00946647|16729665|P2|Phase ll Part|Disease progression|0
4852931|NCT00946647|16729666|P1|Phase ll Part|Disease progression|0
4852932|NCT00946647|16729662|P5|Phase ll Part|Death|4
4852933|NCT00946647|16729663|P4|Phase ll Part|Death|7
4852934|NCT00946647|16729664|P3|Phase ll Part|Death|0
4852935|NCT00946647|16729665|P2|Phase ll Part|Death|0
4852936|NCT00946647|16729666|P1|Phase ll Part|Death|0
4852937|NCT00946647|16729662|P5|Phase ll Part|Administrative problems|8
4852938|NCT00946647|16729663|P4|Phase ll Part|Administrative problems|3
4852939|NCT00946647|16729664|P3|Phase ll Part|Administrative problems|0
4852940|NCT00946647|16729665|P2|Phase ll Part|Administrative problems|0
4852941|NCT00946647|16729666|P1|Phase ll Part|Administrative problems|0
4852942|NCT00946647|16729662|P5|Phase ll Part|Withdrawal by Subject|6
4852943|NCT00946647|16729663|P4|Phase ll Part|Withdrawal by Subject|8
4852944|NCT00946647|16729664|P3|Phase ll Part|Withdrawal by Subject|0
4852945|NCT00946647|16729665|P2|Phase ll Part|Withdrawal by Subject|0
4852946|NCT00946647|16729666|P1|Phase ll Part|Withdrawal by Subject|0
4852947|NCT00946647|16729662|P5|Phase ll Part|Adverse Event|6
4852948|NCT00946647|16729663|P4|Phase ll Part|Adverse Event|10
4852949|NCT00946647|16729664|P3|Phase ll Part|Adverse Event|0
4852950|NCT00946647|16729665|P2|Phase ll Part|Adverse Event|0
4852951|NCT00946647|16729666|P1|Phase ll Part|Adverse Event|0
4852952|NCT00946647|16729662|P5|Phase ll Part|Untreated|2
4852953|NCT00946647|16729663|P4|Phase ll Part|Untreated|0
4852954|NCT00946647|16729664|P3|Phase ll Part|Untreated|0
4852955|NCT00946647|16729665|P2|Phase ll Part|Untreated|0
4852956|NCT00946647|16729666|P1|Phase ll Part|Untreated|0
4852957|NCT00946647|16729662|P5|Phase 1 Part|Reason missing|0
4852958|NCT00946647|16729663|P4|Phase 1 Part|Reason missing|0
4852959|NCT00946647|16729664|P3|Phase 1 Part|Reason missing|0
4852960|NCT00946647|16729665|P2|Phase 1 Part|Reason missing|1
4852961|NCT00946647|16729666|P1|Phase 1 Part|Reason missing|0
4852962|NCT00946647|16729662|P5|Phase 1 Part|Abnormal values|0
4852963|NCT00946647|16729663|P4|Phase 1 Part|Abnormal values|0
4852964|NCT00946647|16729664|P3|Phase 1 Part|Abnormal values|0
4852965|NCT00946647|16729665|P2|Phase 1 Part|Abnormal values|2
4852966|NCT00946647|16729666|P1|Phase 1 Part|Abnormal values|0
4852967|NCT00946647|16729662|P5|Phase 1 Part|Withdrawal by Subject|0
4852968|NCT00946647|16729663|P4|Phase 1 Part|Withdrawal by Subject|0
4852969|NCT00946647|16729664|P3|Phase 1 Part|Withdrawal by Subject|3
4852970|NCT00946647|16729665|P2|Phase 1 Part|Withdrawal by Subject|4
4852971|NCT00946647|16729666|P1|Phase 1 Part|Withdrawal by Subject|1
4852972|NCT00946647|16729662|P5|Phase 1 Part|Disease progression|0
4852973|NCT00946647|16729663|P4|Phase 1 Part|Disease progression|0
4852974|NCT00946647|16729664|P3|Phase 1 Part|Disease progression|1
4852975|NCT00946647|16729665|P2|Phase 1 Part|Disease progression|6
4852976|NCT00946647|16729666|P1|Phase 1 Part|Disease progression|3
4852977|NCT00946647|16729662|P5|Phase 1 Part|Adverse Event|0
4852978|NCT00946647|16729663|P4|Phase 1 Part|Adverse Event|0
4852979|NCT00946647|16729664|P3|Phase 1 Part|Adverse Event|3
4852980|NCT00946647|16729665|P2|Phase 1 Part|Adverse Event|5
4852981|NCT00946647|16729666|P1|Phase 1 Part|Adverse Event|2
4852982|NCT00946530|16729700|P4|Overall Study|Physician Decision|1
4852983|NCT00946530|16729701|P3|Overall Study|Physician Decision|1
4852984|NCT00946530|16729702|P2|Overall Study|Physician Decision|1
4852985|NCT00946530|16729703|P1|Overall Study|Physician Decision|1
4852986|NCT00946530|16729700|P4|Overall Study|Withdrawal by Subject|3
4852987|NCT00946530|16729701|P3|Overall Study|Withdrawal by Subject|0
4852988|NCT00946530|16729702|P2|Overall Study|Withdrawal by Subject|3
4852989|NCT00946530|16729703|P1|Overall Study|Withdrawal by Subject|0
4852990|NCT00946322|16729735|P1|Post-treatment|participant failure to follow up|2
4852991|NCT00946322|16729735|P1|Pre-treatment|participant failure to follow up|1
4852992|NCT00946309|16729748|P2|Overall Study|Procedure cancelled/discontinued|3
4852993|NCT00946309|16729749|P1|Overall Study|Procedure cancelled/discontinued|0
4852994|NCT00946309|16729748|P2|Overall Study|Lost to Follow-up|1
4852995|NCT00946309|16729749|P1|Overall Study|Lost to Follow-up|0
4852996|NCT00946309|16729748|P2|Overall Study|Protocol Violation|0
4852997|NCT00946309|16729749|P1|Overall Study|Protocol Violation|1
4852998|NCT00946296|16729767|P2|Overall Study|Physician Decision|0
4852999|NCT00946296|16729768|P1|Overall Study|Physician Decision|3
4853000|NCT00946192|16729790|P3|Overall Study|Did not start medication|0
4853001|NCT00946192|16729791|P2|Overall Study|Did not start medication|0
4853002|NCT00946192|16729792|P1|Overall Study|Did not start medication|2
4853003|NCT00946192|16729790|P3|Overall Study|Withdrawal by Subject|3
4853004|NCT00946192|16729791|P2|Overall Study|Withdrawal by Subject|7
4853005|NCT00946192|16729792|P1|Overall Study|Withdrawal by Subject|10
4853006|NCT00946192|16729790|P3|Overall Study|Lost to Follow-up|9
4853007|NCT00946192|16729791|P2|Overall Study|Lost to Follow-up|11
4853008|NCT00946192|16729792|P1|Overall Study|Lost to Follow-up|6
4853009|NCT00946153|16729808|P5|Phase 2|14 days washout for recovery due to AE|4
4853010|NCT00946153|16729809|P4|Phase 2|14 days washout for recovery due to AE|0
4853011|NCT00946153|16729810|P3|Phase 2|14 days washout for recovery due to AE|0
4853012|NCT00946153|16729811|P2|Phase 2|14 days washout for recovery due to AE|0
4853013|NCT00946153|16729812|P1|Phase 2|14 days washout for recovery due to AE|0
4853014|NCT00946153|16729808|P5|Phase 2|Physician Decision|1
4853015|NCT00946153|16729809|P4|Phase 2|Physician Decision|0
4853016|NCT00946153|16729810|P3|Phase 2|Physician Decision|0
4853017|NCT00946153|16729811|P2|Phase 2|Physician Decision|0
4853018|NCT00946153|16729812|P1|Phase 2|Physician Decision|0
4853019|NCT00946153|16729808|P5|Phase 2|Need more reduction of dose|2
4853020|NCT00946153|16729809|P4|Phase 2|Need more reduction of dose|0
4853021|NCT00946153|16729810|P3|Phase 2|Need more reduction of dose|0
4853022|NCT00946153|16729811|P2|Phase 2|Need more reduction of dose|0
4853023|NCT00946153|16729812|P1|Phase 2|Need more reduction of dose|0
4853024|NCT00946153|16729808|P5|Phase 2|Adverse Event|6
4853025|NCT00946153|16729809|P4|Phase 2|Adverse Event|0
4853026|NCT00946153|16729810|P3|Phase 2|Adverse Event|0
4853027|NCT00946153|16729811|P2|Phase 2|Adverse Event|0
4853028|NCT00946153|16729812|P1|Phase 2|Adverse Event|0
4853029|NCT00946114|16729840|P2|Overall Study|Withdrawal by Subject|0
4853030|NCT00946114|16729841|P1|Overall Study|Withdrawal by Subject|2
4853031|NCT00946114|16729840|P2|Overall Study|Other|0
4853032|NCT00946114|16729841|P1|Overall Study|Other|1
4853033|NCT00946114|16729840|P2|Overall Study|Death|2
4853034|NCT00946114|16729841|P1|Overall Study|Death|5
4853035|NCT00946101|16729849|P2|Overall Study|Physician Decision|1
4853036|NCT00946101|16729850|P1|Overall Study|Physician Decision|0
4853037|NCT00946101|16729849|P2|Overall Study|Withdrawal of consent|0
4853038|NCT00946101|16729850|P1|Overall Study|Withdrawal of consent|2
4853039|NCT00946101|16729849|P2|Overall Study|Lost to Follow-up|1
4853040|NCT00946101|16729850|P1|Overall Study|Lost to Follow-up|2
4853041|NCT00946088|16729916|P2|Overall Study|Withdrawal by Subject|1
4853042|NCT00946088|16729917|P1|Overall Study|Withdrawal by Subject|0
4853043|NCT00945945|16729961|P2|Overall Study|Entry Criteria Not Met|1
4853044|NCT00945945|16729962|P1|Overall Study|Entry Criteria Not Met|0
4853045|NCT00945945|16729961|P2|Overall Study|Protocol Violation|2
4853046|NCT00945945|16729962|P1|Overall Study|Protocol Violation|4
4853047|NCT00945945|16729961|P2|Overall Study|Lack of Efficacy|2
4853048|NCT00945945|16729962|P1|Overall Study|Lack of Efficacy|6
4853049|NCT00945945|16729961|P2|Overall Study|Lost to Follow-up|5
4853050|NCT00945945|16729962|P1|Overall Study|Lost to Follow-up|4
4853051|NCT00945945|16729961|P2|Overall Study|Withdrawal by Subject|10
4853052|NCT00945945|16729962|P1|Overall Study|Withdrawal by Subject|7
4853053|NCT00945945|16729961|P2|Overall Study|Adverse Event|35
4853054|NCT00945945|16729962|P1|Overall Study|Adverse Event|15
4853055|NCT00945906|16729988|P1|Overall Study|Moved to another country|2
4853056|NCT00945906|16729988|P1|Overall Study|Unable to return for last visit|2
4853057|NCT00945906|16729988|P1|Overall Study|Did not want to return for last visit|2
4853058|NCT00945906|16729988|P1|Overall Study|Withdrawal by Subject|1
4853059|NCT00945893|16729999|P2|Overall Study|Withdrawal of consent|2
4853060|NCT00945893|16730000|P1|Overall Study|Withdrawal of consent|1
4853061|NCT00945893|16729999|P2|Overall Study|Lost to Follow-up|8
4853062|NCT00945893|16730000|P1|Overall Study|Lost to Follow-up|2
4853063|NCT00945815|16730077|P1|Overall Study|Did not begin protocol therapy|1
4853064|NCT00945815|16730077|P1|Overall Study|Ineligible|3
4853065|NCT00945815|16730077|P1|Overall Study|Not protocol specified|1
4853066|NCT00945815|16730077|P1|Overall Study|Death|3
4853067|NCT00945659|16730109|P3|Overall Study|Lost to Follow-up|17
4853068|NCT00945659|16730110|P2|Overall Study|Lost to Follow-up|20
4853069|NCT00945659|16730111|P1|Overall Study|Lost to Follow-up|7
4853070|NCT00945555|16730168|P1|Overall Study|Other|1
4853071|NCT00945555|16730168|P1|Overall Study|Death|18
4853072|NCT00945555|16730168|P1|Overall Study|Participant continued treatment at home|1
4853073|NCT00945555|16730168|P1|Overall Study|Withdrawal by Subject|2
4853074|NCT00945555|16730168|P1|Overall Study|Worsening condition, intensive care unit|1
4853075|NCT00945555|16730168|P1|Overall Study|Referred to another hospital|5
4853076|NCT00945477|16730179|P1|Overall Study|Withdrawal by Subject|1
4853077|NCT00945477|16730179|P1|Overall Study|Lack of Efficacy|2
4853078|NCT00945477|16730179|P1|Overall Study|Adverse Event|3
4853079|NCT00945321|16730195|P6|Period 4|Lost to Follow-up|1
4853080|NCT00945321|16730196|P5|Period 4|Lost to Follow-up|0
4853081|NCT00945321|16730197|P4|Period 4|Lost to Follow-up|0
4853082|NCT00945321|16730198|P3|Period 4|Lost to Follow-up|0
4853083|NCT00945321|16730199|P2|Period 4|Lost to Follow-up|0
4853084|NCT00945321|16730200|P1|Period 4|Lost to Follow-up|0
4853085|NCT00945321|16730195|P6|Period 1|Adverse Event|0
4853086|NCT00945321|16730196|P5|Period 1|Adverse Event|1
4853087|NCT00945321|16730197|P4|Period 1|Adverse Event|0
4853088|NCT00945321|16730198|P3|Period 1|Adverse Event|0
4853089|NCT00945321|16730199|P2|Period 1|Adverse Event|0
4853090|NCT00945321|16730200|P1|Period 1|Adverse Event|0
4853091|NCT00945243|16730333|P1|Overall Study|Study Terminated: Subjects Dispositioned|3
4853092|NCT00945009|16730529|P3|Overall Study|Refusal of further protocol|0
4853093|NCT00945009|16730530|P2|Overall Study|Refusal of further protocol|0
4853094|NCT00945009|16730531|P1|Overall Study|Refusal of further protocol|1
4853095|NCT00945009|16730529|P3|Overall Study|Inevaluable|0
4853096|NCT00945009|16730530|P2|Overall Study|Inevaluable|1
4853097|NCT00945009|16730531|P1|Overall Study|Inevaluable|0
4853098|NCT00945009|16730529|P3|Overall Study|Ineligible|0
4853099|NCT00945009|16730530|P2|Overall Study|Ineligible|1
4853100|NCT00945009|16730531|P1|Overall Study|Ineligible|6
4853101|NCT00945009|16730529|P3|Overall Study|Withdrawal by Subject|0
4853102|NCT00945009|16730530|P2|Overall Study|Withdrawal by Subject|0
4853103|NCT00945009|16730531|P1|Overall Study|Withdrawal by Subject|1
4853104|NCT00945009|16730529|P3|Overall Study|Protocol Violation|0
4853105|NCT00945009|16730530|P2|Overall Study|Protocol Violation|1
4853106|NCT00945009|16730531|P1|Overall Study|Protocol Violation|6
4853107|NCT00945009|16730529|P3|Overall Study|Physician Decision|3
4853108|NCT00945009|16730530|P2|Overall Study|Physician Decision|4
4853109|NCT00945009|16730531|P1|Overall Study|Physician Decision|21
4853110|NCT00945009|16730529|P3|Overall Study|Lack of Efficacy|0
4853111|NCT00945009|16730530|P2|Overall Study|Lack of Efficacy|0
4853112|NCT00945009|16730531|P1|Overall Study|Lack of Efficacy|10
4853113|NCT00944697|16730607|P2|Overall Study|Administrative|1
4853114|NCT00944697|16730608|P1|Overall Study|Administrative|1
4853115|NCT00944697|16730607|P2|Overall Study|Adverse Event|3
4853116|NCT00944697|16730608|P1|Overall Study|Adverse Event|0
4853117|NCT00944697|16730607|P2|Overall Study|Withdrawal by Subject|1
4853118|NCT00944697|16730608|P1|Overall Study|Withdrawal by Subject|1
4853119|NCT00944658|16730640|P2|Treatment 12 Weeks|Adverse Event|2
4853120|NCT00944658|16730641|P1|Treatment 12 Weeks|Adverse Event|0
4853121|NCT00944645|16730653|P2|Period 2|Withdrawal by Subject|6
4853122|NCT00944645|16730654|P1|Period 2|Withdrawal by Subject|7
4853123|NCT00944645|16730653|P2|Period 2|Lost to Follow-up|3
4853124|NCT00944645|16730654|P1|Period 2|Lost to Follow-up|0
4853125|NCT00944645|16730653|P2|Period 2|Adverse Event|0
4853126|NCT00944645|16730654|P1|Period 2|Adverse Event|1
4853127|NCT00944229|16730701|P1|Overall Study|Physician Decision|14
4853128|NCT00944229|16730701|P1|Overall Study|Withdrawal by Subject|11
4853129|NCT00944125|16730707|P2|6 Months to Study Completion|Withdrawal by Subject|2
4853130|NCT00944125|16730708|P1|6 Months to Study Completion|Withdrawal by Subject|0
4853131|NCT00944125|16730707|P2|3 to 6 Months|Withdrawal by Subject|2
4853132|NCT00944125|16730708|P1|3 to 6 Months|Withdrawal by Subject|0
4853133|NCT00944034|16730811|P12|Overall Study|Administrative reason|0
4853134|NCT00944034|16730812|P11|Overall Study|Administrative reason|0
4853135|NCT00944034|16730813|P10|Overall Study|Administrative reason|0
4853136|NCT00944034|16730814|P9|Overall Study|Administrative reason|0
4853137|NCT00944034|16730815|P8|Overall Study|Administrative reason|0
4853138|NCT00944034|16730816|P7|Overall Study|Administrative reason|1
4853139|NCT00944034|16730817|P6|Overall Study|Administrative reason|0
4853140|NCT00944034|16730818|P5|Overall Study|Administrative reason|0
4853141|NCT00944034|16730819|P4|Overall Study|Administrative reason|0
4853142|NCT00944034|16730820|P3|Overall Study|Administrative reason|0
4853143|NCT00944034|16730821|P2|Overall Study|Administrative reason|0
4853144|NCT00944034|16730822|P1|Overall Study|Administrative reason|0
4853145|NCT00944034|16730811|P12|Overall Study|Unable to classify|0
4853146|NCT00944034|16730812|P11|Overall Study|Unable to classify|0
4853147|NCT00944034|16730813|P10|Overall Study|Unable to classify|0
4853148|NCT00944034|16730814|P9|Overall Study|Unable to classify|0
4853149|NCT00944034|16730815|P8|Overall Study|Unable to classify|1
4853150|NCT00944034|16730816|P7|Overall Study|Unable to classify|1
4853151|NCT00944034|16730817|P6|Overall Study|Unable to classify|1
4853152|NCT00944034|16730818|P5|Overall Study|Unable to classify|0
4853153|NCT00944034|16730819|P4|Overall Study|Unable to classify|0
4853154|NCT00944034|16730820|P3|Overall Study|Unable to classify|0
4853155|NCT00944034|16730821|P2|Overall Study|Unable to classify|0
4853156|NCT00944034|16730822|P1|Overall Study|Unable to classify|0
4853157|NCT00944034|16730811|P12|Overall Study|Protocol Violation|0
4853158|NCT00944034|16730812|P11|Overall Study|Protocol Violation|0
4853159|NCT00944034|16730813|P10|Overall Study|Protocol Violation|4
4853160|NCT00944034|16730814|P9|Overall Study|Protocol Violation|1
4853161|NCT00944034|16730815|P8|Overall Study|Protocol Violation|1
4853162|NCT00944034|16730816|P7|Overall Study|Protocol Violation|0
4853163|NCT00944034|16730817|P6|Overall Study|Protocol Violation|3
4853164|NCT00944034|16730818|P5|Overall Study|Protocol Violation|2
4853165|NCT00944034|16730819|P4|Overall Study|Protocol Violation|1
4853166|NCT00944034|16730820|P3|Overall Study|Protocol Violation|0
4853167|NCT00944034|16730821|P2|Overall Study|Protocol Violation|0
4853168|NCT00944034|16730822|P1|Overall Study|Protocol Violation|2
4853169|NCT00944034|16730811|P12|Overall Study|Death|0
4853170|NCT00944034|16730812|P11|Overall Study|Death|0
4853171|NCT00944034|16730813|P10|Overall Study|Death|0
4853172|NCT00944034|16730814|P9|Overall Study|Death|0
4853173|NCT00944034|16730815|P8|Overall Study|Death|0
4853174|NCT00944034|16730816|P7|Overall Study|Death|0
4853175|NCT00944034|16730817|P6|Overall Study|Death|0
4853176|NCT00944034|16730818|P5|Overall Study|Death|0
4853177|NCT00944034|16730819|P4|Overall Study|Death|0
4853178|NCT00944034|16730820|P3|Overall Study|Death|1
4853179|NCT00944034|16730821|P2|Overall Study|Death|0
4853180|NCT00944034|16730822|P1|Overall Study|Death|0
4853181|NCT00944034|16730811|P12|Overall Study|Lost to Follow-up|0
4853182|NCT00944034|16730812|P11|Overall Study|Lost to Follow-up|1
4853183|NCT00944034|16730813|P10|Overall Study|Lost to Follow-up|1
4853184|NCT00944034|16730814|P9|Overall Study|Lost to Follow-up|5
4853185|NCT00944034|16730815|P8|Overall Study|Lost to Follow-up|1
4853186|NCT00944034|16730816|P7|Overall Study|Lost to Follow-up|0
4853187|NCT00944034|16730817|P6|Overall Study|Lost to Follow-up|7
4853188|NCT00944034|16730818|P5|Overall Study|Lost to Follow-up|5
4853189|NCT00944034|16730819|P4|Overall Study|Lost to Follow-up|0
4853190|NCT00944034|16730820|P3|Overall Study|Lost to Follow-up|2
4853191|NCT00944034|16730821|P2|Overall Study|Lost to Follow-up|4
4853192|NCT00944034|16730822|P1|Overall Study|Lost to Follow-up|0
4853193|NCT00944034|16730811|P12|Overall Study|Withdrawal by Subject|4
4853194|NCT00944034|16730812|P11|Overall Study|Withdrawal by Subject|0
4853195|NCT00944034|16730813|P10|Overall Study|Withdrawal by Subject|4
4853196|NCT00944034|16730814|P9|Overall Study|Withdrawal by Subject|3
4853197|NCT00944034|16730815|P8|Overall Study|Withdrawal by Subject|2
4853198|NCT00944034|16730816|P7|Overall Study|Withdrawal by Subject|2
4853199|NCT00944034|16730817|P6|Overall Study|Withdrawal by Subject|8
4853200|NCT00944034|16730818|P5|Overall Study|Withdrawal by Subject|5
4853201|NCT00944034|16730819|P4|Overall Study|Withdrawal by Subject|2
4853202|NCT00944034|16730820|P3|Overall Study|Withdrawal by Subject|6
4853203|NCT00944034|16730821|P2|Overall Study|Withdrawal by Subject|2
4853204|NCT00944034|16730822|P1|Overall Study|Withdrawal by Subject|3
4853205|NCT00944034|16730811|P12|Overall Study|Inappropriate enrollment|0
4853206|NCT00944034|16730812|P11|Overall Study|Inappropriate enrollment|0
4853207|NCT00944034|16730813|P10|Overall Study|Inappropriate enrollment|1
4853208|NCT00944034|16730814|P9|Overall Study|Inappropriate enrollment|1
4853209|NCT00944034|16730815|P8|Overall Study|Inappropriate enrollment|0
4853210|NCT00944034|16730816|P7|Overall Study|Inappropriate enrollment|0
4853211|NCT00944034|16730817|P6|Overall Study|Inappropriate enrollment|1
4853212|NCT00944034|16730818|P5|Overall Study|Inappropriate enrollment|2
4853213|NCT00944034|16730819|P4|Overall Study|Inappropriate enrollment|1
4853214|NCT00944034|16730820|P3|Overall Study|Inappropriate enrollment|0
4853215|NCT00944034|16730821|P2|Overall Study|Inappropriate enrollment|1
4853216|NCT00944034|16730822|P1|Overall Study|Inappropriate enrollment|0
4853217|NCT00943917|16730968|P15|Stage II Continuation|A1C elevation|0
4853218|NCT00943917|16730969|P14|Stage II Continuation|A1C elevation|1
4853219|NCT00943917|16730970|P13|Stage II Continuation|A1C elevation|0
4853220|NCT00943917|16730971|P12|Stage II Continuation|A1C elevation|0
4853221|NCT00943917|16730972|P11|Stage II Continuation|A1C elevation|0
4853222|NCT00943917|16730973|P10|Stage II Continuation|A1C elevation|0
4853223|NCT00943917|16730974|P9|Stage II Continuation|A1C elevation|0
4853224|NCT00943917|16730975|P8|Stage II Continuation|A1C elevation|0
4853225|NCT00943917|16730976|P7|Stage II Continuation|A1C elevation|0
4853226|NCT00943917|16730977|P6|Stage II Continuation|A1C elevation|0
4853227|NCT00943917|16730978|P5|Stage II Continuation|A1C elevation|0
4853228|NCT00943917|16730979|P4|Stage II Continuation|A1C elevation|0
4853229|NCT00943917|16730980|P3|Stage II Continuation|A1C elevation|0
4853230|NCT00943917|16730981|P2|Stage II Continuation|A1C elevation|0
4853231|NCT00943917|16730982|P1|Stage II Continuation|A1C elevation|0
4853232|NCT00943917|16730968|P15|Stage II Continuation|hypoglycemia|0
4853233|NCT00943917|16730969|P14|Stage II Continuation|hypoglycemia|0
4853234|NCT00943917|16730970|P13|Stage II Continuation|hypoglycemia|1
4853235|NCT00943917|16730971|P12|Stage II Continuation|hypoglycemia|0
4853236|NCT00943917|16730972|P11|Stage II Continuation|hypoglycemia|0
4853237|NCT00943917|16730973|P10|Stage II Continuation|hypoglycemia|0
4853238|NCT00943917|16730974|P9|Stage II Continuation|hypoglycemia|0
4853239|NCT00943917|16730975|P8|Stage II Continuation|hypoglycemia|0
4853240|NCT00943917|16730976|P7|Stage II Continuation|hypoglycemia|0
4853241|NCT00943917|16730977|P6|Stage II Continuation|hypoglycemia|0
4853242|NCT00943917|16730978|P5|Stage II Continuation|hypoglycemia|0
4853243|NCT00943917|16730979|P4|Stage II Continuation|hypoglycemia|0
4853244|NCT00943917|16730980|P3|Stage II Continuation|hypoglycemia|0
4853245|NCT00943917|16730981|P2|Stage II Continuation|hypoglycemia|0
4853246|NCT00943917|16730982|P1|Stage II Continuation|hypoglycemia|0
4853247|NCT00943917|16730968|P15|Stage II Continuation|Protocol Violation|0
4853248|NCT00943917|16730969|P14|Stage II Continuation|Protocol Violation|0
4853249|NCT00943917|16730970|P13|Stage II Continuation|Protocol Violation|0
4853250|NCT00943917|16730971|P12|Stage II Continuation|Protocol Violation|1
4853251|NCT00943917|16730972|P11|Stage II Continuation|Protocol Violation|0
4853252|NCT00943917|16730973|P10|Stage II Continuation|Protocol Violation|1
4853253|NCT00943917|16730974|P9|Stage II Continuation|Protocol Violation|0
4853254|NCT00943917|16730975|P8|Stage II Continuation|Protocol Violation|0
4853255|NCT00943917|16730976|P7|Stage II Continuation|Protocol Violation|0
4853256|NCT00943917|16730977|P6|Stage II Continuation|Protocol Violation|0
4853257|NCT00943917|16730978|P5|Stage II Continuation|Protocol Violation|0
4853258|NCT00943917|16730979|P4|Stage II Continuation|Protocol Violation|0
4853259|NCT00943917|16730980|P3|Stage II Continuation|Protocol Violation|0
4853260|NCT00943917|16730981|P2|Stage II Continuation|Protocol Violation|0
4853261|NCT00943917|16730982|P1|Stage II Continuation|Protocol Violation|0
4853262|NCT00943917|16730968|P15|Stage II Continuation|Withdrawal by Subject|3
4853263|NCT00943917|16730969|P14|Stage II Continuation|Withdrawal by Subject|1
4853264|NCT00943917|16730970|P13|Stage II Continuation|Withdrawal by Subject|0
4853265|NCT00943917|16730971|P12|Stage II Continuation|Withdrawal by Subject|0
4853266|NCT00943917|16730972|P11|Stage II Continuation|Withdrawal by Subject|0
4853267|NCT00943917|16730973|P10|Stage II Continuation|Withdrawal by Subject|0
4853268|NCT00943917|16730974|P9|Stage II Continuation|Withdrawal by Subject|0
4853269|NCT00943917|16730975|P8|Stage II Continuation|Withdrawal by Subject|0
4853270|NCT00943917|16730976|P7|Stage II Continuation|Withdrawal by Subject|0
4853271|NCT00943917|16730977|P6|Stage II Continuation|Withdrawal by Subject|0
4853272|NCT00943917|16730978|P5|Stage II Continuation|Withdrawal by Subject|0
4853273|NCT00943917|16730979|P4|Stage II Continuation|Withdrawal by Subject|0
4853274|NCT00943917|16730980|P3|Stage II Continuation|Withdrawal by Subject|0
4853275|NCT00943917|16730981|P2|Stage II Continuation|Withdrawal by Subject|0
4853276|NCT00943917|16730982|P1|Stage II Continuation|Withdrawal by Subject|0
4853277|NCT00943917|16730968|P15|Stage II Continuation|Adverse Event|1
4853278|NCT00943917|16730969|P14|Stage II Continuation|Adverse Event|1
4853279|NCT00943917|16730970|P13|Stage II Continuation|Adverse Event|2
4853280|NCT00943917|16730971|P12|Stage II Continuation|Adverse Event|1
4853281|NCT00943917|16730972|P11|Stage II Continuation|Adverse Event|0
4853282|NCT00943917|16730973|P10|Stage II Continuation|Adverse Event|0
4853283|NCT00943917|16730974|P9|Stage II Continuation|Adverse Event|0
4853284|NCT00943917|16730975|P8|Stage II Continuation|Adverse Event|0
4853285|NCT00943917|16730976|P7|Stage II Continuation|Adverse Event|0
4853286|NCT00943917|16730977|P6|Stage II Continuation|Adverse Event|0
4853287|NCT00943917|16730978|P5|Stage II Continuation|Adverse Event|0
4853288|NCT00943917|16730979|P4|Stage II Continuation|Adverse Event|0
4853289|NCT00943917|16730980|P3|Stage II Continuation|Adverse Event|0
4853290|NCT00943917|16730981|P2|Stage II Continuation|Adverse Event|0
4853291|NCT00943917|16730982|P1|Stage II Continuation|Adverse Event|0
4853292|NCT00943917|16730968|P15|Stage II|Pregnancy|0
4853293|NCT00943917|16730969|P14|Stage II|Pregnancy|0
4853294|NCT00943917|16730970|P13|Stage II|Pregnancy|0
4853295|NCT00943917|16730971|P12|Stage II|Pregnancy|0
4853296|NCT00943917|16730972|P11|Stage II|Pregnancy|0
4853297|NCT00943917|16730973|P10|Stage II|Pregnancy|0
4853298|NCT00943917|16730974|P9|Stage II|Pregnancy|0
4853299|NCT00943917|16730975|P8|Stage II|Pregnancy|0
4853300|NCT00943917|16730976|P7|Stage II|Pregnancy|0
4853301|NCT00943917|16730977|P6|Stage II|Pregnancy|1
4853302|NCT00943917|16730978|P5|Stage II|Pregnancy|0
4853303|NCT00943917|16730979|P4|Stage II|Pregnancy|0
4853304|NCT00943917|16730980|P3|Stage II|Pregnancy|0
4853305|NCT00943917|16730981|P2|Stage II|Pregnancy|0
4853306|NCT00943917|16730982|P1|Stage II|Pregnancy|0
4853307|NCT00943917|16730968|P15|Stage II|Withdrawal by Subject|0
4853308|NCT00943917|16730969|P14|Stage II|Withdrawal by Subject|0
4853309|NCT00943917|16730970|P13|Stage II|Withdrawal by Subject|0
4853310|NCT00943917|16730971|P12|Stage II|Withdrawal by Subject|0
4853311|NCT00943917|16730972|P11|Stage II|Withdrawal by Subject|0
4853312|NCT00943917|16730973|P10|Stage II|Withdrawal by Subject|0
4853313|NCT00943917|16730974|P9|Stage II|Withdrawal by Subject|0
4853314|NCT00943917|16730975|P8|Stage II|Withdrawal by Subject|0
4853315|NCT00943917|16730976|P7|Stage II|Withdrawal by Subject|0
4853316|NCT00943917|16730977|P6|Stage II|Withdrawal by Subject|1
4853317|NCT00943917|16730978|P5|Stage II|Withdrawal by Subject|0
4853318|NCT00943917|16730979|P4|Stage II|Withdrawal by Subject|0
4853319|NCT00943917|16730980|P3|Stage II|Withdrawal by Subject|0
4853320|NCT00943917|16730981|P2|Stage II|Withdrawal by Subject|0
4853321|NCT00943917|16730982|P1|Stage II|Withdrawal by Subject|0
4853322|NCT00943917|16730968|P15|Stage II|Adverse Event|0
4853323|NCT00943917|16730969|P14|Stage II|Adverse Event|0
4853324|NCT00943917|16730970|P13|Stage II|Adverse Event|0
4853325|NCT00943917|16730971|P12|Stage II|Adverse Event|0
4853326|NCT00943917|16730972|P11|Stage II|Adverse Event|0
4853327|NCT00943917|16730973|P10|Stage II|Adverse Event|0
4853328|NCT00943917|16730974|P9|Stage II|Adverse Event|1
4853329|NCT00943917|16730975|P8|Stage II|Adverse Event|0
4853330|NCT00943917|16730976|P7|Stage II|Adverse Event|3
4853331|NCT00943917|16730977|P6|Stage II|Adverse Event|1
4853332|NCT00943917|16730978|P5|Stage II|Adverse Event|0
4853333|NCT00943917|16730979|P4|Stage II|Adverse Event|0
4853334|NCT00943917|16730980|P3|Stage II|Adverse Event|0
4853335|NCT00943917|16730981|P2|Stage II|Adverse Event|0
4853336|NCT00943917|16730982|P1|Stage II|Adverse Event|0
4853337|NCT00943917|16730968|P15|Stage I|Withdrawal by Subject|0
4853338|NCT00943917|16730969|P14|Stage I|Withdrawal by Subject|0
4853339|NCT00943917|16730970|P13|Stage I|Withdrawal by Subject|0
4853340|NCT00943917|16730971|P12|Stage I|Withdrawal by Subject|0
4853341|NCT00943917|16730972|P11|Stage I|Withdrawal by Subject|0
4853342|NCT00943917|16730973|P10|Stage I|Withdrawal by Subject|0
4853343|NCT00943917|16730974|P9|Stage I|Withdrawal by Subject|0
4853344|NCT00943917|16730975|P8|Stage I|Withdrawal by Subject|0
4853345|NCT00943917|16730976|P7|Stage I|Withdrawal by Subject|0
4853346|NCT00943917|16730977|P6|Stage I|Withdrawal by Subject|0
4853347|NCT00943917|16730978|P5|Stage I|Withdrawal by Subject|0
4853348|NCT00943917|16730979|P4|Stage I|Withdrawal by Subject|0
4853349|NCT00943917|16730980|P3|Stage I|Withdrawal by Subject|2
4853350|NCT00943917|16730981|P2|Stage I|Withdrawal by Subject|1
4853351|NCT00943917|16730982|P1|Stage I|Withdrawal by Subject|2
4853352|NCT00943917|16730968|P15|Stage I|A1C elevation|0
4853353|NCT00943917|16730969|P14|Stage I|A1C elevation|0
4853354|NCT00943917|16730970|P13|Stage I|A1C elevation|0
4853355|NCT00943917|16730971|P12|Stage I|A1C elevation|0
4853356|NCT00943917|16730972|P11|Stage I|A1C elevation|0
4853357|NCT00943917|16730973|P10|Stage I|A1C elevation|0
4853358|NCT00943917|16730974|P9|Stage I|A1C elevation|0
4853359|NCT00943917|16730975|P8|Stage I|A1C elevation|0
4853360|NCT00943917|16730976|P7|Stage I|A1C elevation|0
4853361|NCT00943917|16730977|P6|Stage I|A1C elevation|0
4853362|NCT00943917|16730978|P5|Stage I|A1C elevation|0
4853363|NCT00943917|16730979|P4|Stage I|A1C elevation|0
4853364|NCT00943917|16730980|P3|Stage I|A1C elevation|0
4853365|NCT00943917|16730981|P2|Stage I|A1C elevation|0
4853366|NCT00943917|16730982|P1|Stage I|A1C elevation|1
4853367|NCT00943917|16730968|P15|Stage I|hyperglycemia|0
4853368|NCT00943917|16730969|P14|Stage I|hyperglycemia|0
4853369|NCT00943917|16730970|P13|Stage I|hyperglycemia|0
4853370|NCT00943917|16730971|P12|Stage I|hyperglycemia|0
4853371|NCT00943917|16730972|P11|Stage I|hyperglycemia|0
4853372|NCT00943917|16730973|P10|Stage I|hyperglycemia|0
4853373|NCT00943917|16730974|P9|Stage I|hyperglycemia|0
4853374|NCT00943917|16730975|P8|Stage I|hyperglycemia|0
4853375|NCT00943917|16730976|P7|Stage I|hyperglycemia|0
4853376|NCT00943917|16730977|P6|Stage I|hyperglycemia|0
4853377|NCT00943917|16730978|P5|Stage I|hyperglycemia|0
4853378|NCT00943917|16730979|P4|Stage I|hyperglycemia|0
4853379|NCT00943917|16730980|P3|Stage I|hyperglycemia|1
4853380|NCT00943917|16730981|P2|Stage I|hyperglycemia|0
4853381|NCT00943917|16730982|P1|Stage I|hyperglycemia|0
4853382|NCT00943917|16730968|P15|Stage I|Lost to Follow-up|0
4853383|NCT00943917|16730969|P14|Stage I|Lost to Follow-up|0
4853384|NCT00943917|16730970|P13|Stage I|Lost to Follow-up|0
4853385|NCT00943917|16730971|P12|Stage I|Lost to Follow-up|0
4853386|NCT00943917|16730972|P11|Stage I|Lost to Follow-up|0
4853387|NCT00943917|16730973|P10|Stage I|Lost to Follow-up|0
4853388|NCT00943917|16730974|P9|Stage I|Lost to Follow-up|0
4853389|NCT00943917|16730975|P8|Stage I|Lost to Follow-up|0
4853390|NCT00943917|16730976|P7|Stage I|Lost to Follow-up|0
4853391|NCT00943917|16730977|P6|Stage I|Lost to Follow-up|0
4853392|NCT00943917|16730978|P5|Stage I|Lost to Follow-up|0
4853393|NCT00943917|16730979|P4|Stage I|Lost to Follow-up|0
4853394|NCT00943917|16730980|P3|Stage I|Lost to Follow-up|1
4853395|NCT00943917|16730981|P2|Stage I|Lost to Follow-up|0
4853396|NCT00943917|16730982|P1|Stage I|Lost to Follow-up|0
4853397|NCT00943917|16730968|P15|Stage I|Adverse Event|0
4853398|NCT00943917|16730969|P14|Stage I|Adverse Event|0
4853399|NCT00943917|16730970|P13|Stage I|Adverse Event|0
4853400|NCT00943917|16730971|P12|Stage I|Adverse Event|0
4853401|NCT00943917|16730972|P11|Stage I|Adverse Event|0
4853402|NCT00943917|16730973|P10|Stage I|Adverse Event|0
4853403|NCT00943917|16730974|P9|Stage I|Adverse Event|0
4853404|NCT00943917|16730975|P8|Stage I|Adverse Event|0
4853405|NCT00943917|16730976|P7|Stage I|Adverse Event|0
4853406|NCT00943917|16730977|P6|Stage I|Adverse Event|0
4853407|NCT00943917|16730978|P5|Stage I|Adverse Event|0
4853408|NCT00943917|16730979|P4|Stage I|Adverse Event|0
4853409|NCT00943917|16730980|P3|Stage I|Adverse Event|2
4853410|NCT00943917|16730981|P2|Stage I|Adverse Event|2
4853411|NCT00943917|16730982|P1|Stage I|Adverse Event|1
4853412|NCT00943852|16731158|P10|Washout Period After Period 4 Treatment|Trial stopped early|0
4853413|NCT00943852|16731159|P9|Washout Period After Period 4 Treatment|Trial stopped early|0
4853414|NCT00943852|16731160|P8|Washout Period After Period 4 Treatment|Trial stopped early|0
4853415|NCT00943852|16731161|P7|Washout Period After Period 4 Treatment|Trial stopped early|1
4853416|NCT00943852|16731162|P6|Washout Period After Period 4 Treatment|Trial stopped early|0
4853417|NCT00943852|16731163|P5|Washout Period After Period 4 Treatment|Trial stopped early|0
4853418|NCT00943852|16731164|P4|Washout Period After Period 4 Treatment|Trial stopped early|1
4853419|NCT00943852|16731165|P3|Washout Period After Period 4 Treatment|Trial stopped early|1
4853420|NCT00943852|16731166|P2|Washout Period After Period 4 Treatment|Trial stopped early|0
4853421|NCT00943852|16731167|P1|Washout Period After Period 4 Treatment|Trial stopped early|1
4853422|NCT00943852|16731158|P10|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853423|NCT00943852|16731159|P9|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853424|NCT00943852|16731160|P8|Washout Period After Period 4 Treatment|Not taking medication per protocol|1
4853425|NCT00943852|16731161|P7|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853426|NCT00943852|16731162|P6|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853427|NCT00943852|16731163|P5|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853428|NCT00943852|16731164|P4|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853429|NCT00943852|16731165|P3|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853430|NCT00943852|16731166|P2|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853431|NCT00943852|16731167|P1|Washout Period After Period 4 Treatment|Not taking medication per protocol|0
4853432|NCT00943852|16731158|P10|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853433|NCT00943852|16731159|P9|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853434|NCT00943852|16731160|P8|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853435|NCT00943852|16731161|P7|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1
4853436|NCT00943852|16731162|P6|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853437|NCT00943852|16731163|P5|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853438|NCT00943852|16731164|P4|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853439|NCT00943852|16731165|P3|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853440|NCT00943852|16731166|P2|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853441|NCT00943852|16731167|P1|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0
4853442|NCT00943852|16731158|P10|Washout Period After Period 2 Treatment|Trial stopped early|0
4853443|NCT00943852|16731159|P9|Washout Period After Period 2 Treatment|Trial stopped early|0
4853444|NCT00943852|16731160|P8|Washout Period After Period 2 Treatment|Trial stopped early|0
4853445|NCT00943852|16731161|P7|Washout Period After Period 2 Treatment|Trial stopped early|0
4853446|NCT00943852|16731162|P6|Washout Period After Period 2 Treatment|Trial stopped early|1
4853447|NCT00943852|16731163|P5|Washout Period After Period 2 Treatment|Trial stopped early|0
4853448|NCT00943852|16731164|P4|Washout Period After Period 2 Treatment|Trial stopped early|0
4853449|NCT00943852|16731165|P3|Washout Period After Period 2 Treatment|Trial stopped early|0
4853450|NCT00943852|16731166|P2|Washout Period After Period 2 Treatment|Trial stopped early|0
4853451|NCT00943852|16731167|P1|Washout Period After Period 2 Treatment|Trial stopped early|0
4853452|NCT00943852|16731158|P10|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853453|NCT00943852|16731159|P9|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853454|NCT00943852|16731160|P8|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853455|NCT00943852|16731161|P7|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853456|NCT00943852|16731162|P6|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853457|NCT00943852|16731163|P5|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853458|NCT00943852|16731164|P4|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1
4853459|NCT00943852|16731165|P3|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853460|NCT00943852|16731166|P2|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853461|NCT00943852|16731167|P1|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0
4853462|NCT00943826|16731180|P2|After Primary Overall Survival Analysis|Withdrew Consent|0
4853463|NCT00943826|16731181|P1|After Primary Overall Survival Analysis|Withdrew Consent|4
4853464|NCT00943826|16731180|P2|After Primary Overall Survival Analysis|Progression of Disease|4
4853465|NCT00943826|16731181|P1|After Primary Overall Survival Analysis|Progression of Disease|2
4853466|NCT00943826|16731180|P2|After Primary Overall Survival Analysis|Administrative reasons|16
4853467|NCT00943826|16731181|P1|After Primary Overall Survival Analysis|Administrative reasons|10
4853468|NCT00943826|16731180|P2|After Primary Overall Survival Analysis|Adverse Event|0
4853469|NCT00943826|16731181|P1|After Primary Overall Survival Analysis|Adverse Event|11
4853470|NCT00943826|16731180|P2|Monotherapy Phase|Failure to return|1
4853471|NCT00943826|16731181|P1|Monotherapy Phase|Failure to return|2
4853472|NCT00943826|16731180|P2|Monotherapy Phase|Withdrew Consent|3
4853473|NCT00943826|16731181|P1|Monotherapy Phase|Withdrew Consent|2
4853474|NCT00943826|16731180|P2|Monotherapy Phase|Refused treatment/ Did not cooperate|2
4853475|NCT00943826|16731181|P1|Monotherapy Phase|Refused treatment/ Did not cooperate|8
4853476|NCT00943826|16731180|P2|Monotherapy Phase|Administrative reasons|5
4853477|NCT00943826|16731181|P1|Monotherapy Phase|Administrative reasons|11
4853478|NCT00943826|16731180|P2|Monotherapy Phase|Adverse Event|5
4853479|NCT00943826|16731181|P1|Monotherapy Phase|Adverse Event|42
4853480|NCT00943826|16731180|P2|Maintenance Phase|Failure to return|1
4853481|NCT00943826|16731181|P1|Maintenance Phase|Failure to return|0
4853482|NCT00943826|16731180|P2|Maintenance Phase|Administrative reasons|1
4853483|NCT00943826|16731181|P1|Maintenance Phase|Administrative reasons|4
4853484|NCT00943826|16731180|P2|Maintenance Phase|Refused treatment/Did not cooperate|3
4853485|NCT00943826|16731181|P1|Maintenance Phase|Refused treatment/Did not cooperate|6
4853486|NCT00943826|16731180|P2|Maintenance Phase|Withdrew consent|4
4853487|NCT00943826|16731181|P1|Maintenance Phase|Withdrew consent|2
4853488|NCT00943826|16731180|P2|Maintenance Phase|Adverse Event|30
4853489|NCT00943826|16731181|P1|Maintenance Phase|Adverse Event|31
4853490|NCT00943826|16731180|P2|Concurrent Phase|Protocol Violation|0
4853491|NCT00943826|16731181|P1|Concurrent Phase|Protocol Violation|1
4853492|NCT00943826|16731180|P2|Concurrent Phase|Administrative reasons|1
4853493|NCT00943826|16731181|P1|Concurrent Phase|Administrative reasons|2
4853494|NCT00943826|16731180|P2|Concurrent Phase|Refused treatment/Did not cooperate|7
4853495|NCT00943826|16731181|P1|Concurrent Phase|Refused treatment/Did not cooperate|5
4853496|NCT00943826|16731180|P2|Concurrent Phase|Withdrew consent|7
4853497|NCT00943826|16731181|P1|Concurrent Phase|Withdrew consent|3
4853498|NCT00943826|16731180|P2|Concurrent Phase|Adverse Event|27
4853499|NCT00943826|16731181|P1|Concurrent Phase|Adverse Event|50
4853500|NCT00943787|16731205|P1|Overall Study|Withdrawal by Subject|3
4853501|NCT00943787|16731205|P1|Overall Study|Physician Decision|4
4853502|NCT00943761|16731212|P2|Overall Study|Withdrawal by Subject|1
4853503|NCT00943761|16731213|P1|Overall Study|Withdrawal by Subject|2
4853504|NCT00943761|16731212|P2|Overall Study|Lost to Follow-up|0
4853505|NCT00943761|16731213|P1|Overall Study|Lost to Follow-up|2
4853506|NCT00943735|16731225|P1|Overall Study|Other|3
4853507|NCT00943735|16731225|P1|Overall Study|Other|8
4853508|NCT00943735|16731225|P1|Overall Study|Death|1
4853509|NCT00943735|16731225|P1|Overall Study|Withdrawal by Subject|8
4853510|NCT00943735|16731225|P1|Overall Study|Adverse Event|12
4853511|NCT00943722|16731263|P5|Overall Study|Withdrawal by Subject|8
4853512|NCT00943722|16731264|P4|Overall Study|Withdrawal by Subject|13
4853513|NCT00943722|16731265|P3|Overall Study|Withdrawal by Subject|2
4853514|NCT00943722|16731266|P2|Overall Study|Withdrawal by Subject|13
4853515|NCT00943722|16731267|P1|Overall Study|Withdrawal by Subject|12
4853516|NCT00943722|16731263|P5|Overall Study|Protocol Violation|2
4853517|NCT00943722|16731264|P4|Overall Study|Protocol Violation|0
4853518|NCT00943722|16731265|P3|Overall Study|Protocol Violation|0
4853519|NCT00943722|16731266|P2|Overall Study|Protocol Violation|1
4853520|NCT00943722|16731267|P1|Overall Study|Protocol Violation|0
4853521|NCT00943722|16731263|P5|Overall Study|Pregnancy|0
4853522|NCT00943722|16731264|P4|Overall Study|Pregnancy|0
4853523|NCT00943722|16731265|P3|Overall Study|Pregnancy|1
4853524|NCT00943722|16731266|P2|Overall Study|Pregnancy|0
4853525|NCT00943722|16731267|P1|Overall Study|Pregnancy|0
4853526|NCT00943722|16731263|P5|Overall Study|Physician Decision|1
4853527|NCT00943722|16731264|P4|Overall Study|Physician Decision|0
4853528|NCT00943722|16731265|P3|Overall Study|Physician Decision|0
4853529|NCT00943722|16731266|P2|Overall Study|Physician Decision|0
4853530|NCT00943722|16731267|P1|Overall Study|Physician Decision|1
4853531|NCT00943722|16731263|P5|Overall Study|Lost to Follow-up|11
4853532|NCT00943722|16731264|P4|Overall Study|Lost to Follow-up|8
4853533|NCT00943722|16731265|P3|Overall Study|Lost to Follow-up|10
4853534|NCT00943722|16731266|P2|Overall Study|Lost to Follow-up|8
4853535|NCT00943722|16731267|P1|Overall Study|Lost to Follow-up|12
4853536|NCT00943722|16731263|P5|Overall Study|Adverse Event|0
4853537|NCT00943722|16731264|P4|Overall Study|Adverse Event|1
4853538|NCT00943722|16731265|P3|Overall Study|Adverse Event|0
4853539|NCT00943722|16731266|P2|Overall Study|Adverse Event|0
4853540|NCT00943722|16731267|P1|Overall Study|Adverse Event|0
4853541|NCT00943683|16731297|P2|Overall Study|Patient Moved|0
4853542|NCT00943683|16731298|P1|Overall Study|Patient Moved|1
4853543|NCT00943683|16731297|P2|Overall Study|Withdrawal by Subject|0
4853544|NCT00943683|16731298|P1|Overall Study|Withdrawal by Subject|1
4853545|NCT00943683|16731297|P2|Overall Study|Protocol Violation|2
4853546|NCT00943683|16731298|P1|Overall Study|Protocol Violation|1
4853547|NCT00943683|16731297|P2|Overall Study|Lost to Follow-up|1
4853548|NCT00943683|16731298|P1|Overall Study|Lost to Follow-up|1
4853549|NCT00943683|16731297|P2|Overall Study|Adverse Event|3
4853550|NCT00943683|16731298|P1|Overall Study|Adverse Event|3
4853551|NCT00943670|16731304|P1|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5
4853552|NCT00943670|16731304|P1|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2
4853553|NCT00943670|16731304|P1|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6
4853554|NCT00943670|16731304|P1|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4
4853555|NCT00943670|16731304|P1|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1
4853556|NCT00943670|16731304|P1|Single-agent Trastuzumab Emtansine|Early progressive disease|20
4853639|NCT00942994|16731961|P1|Overall Study|Abnormal laboratory value(s)|1
4853557|NCT00943670|16731304|P1|Single-agent Trastuzumab Emtansine|Adverse Event|2
4853558|NCT00943670|16731304|P1|Single-agent Trastuzumab Emtansine|Systemic progression|15
4853559|NCT00943670|16731304|P1|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3
4853560|NCT00943670|16731304|P1|Single-agent Trastuzumab Emtansine|Physician Decision|2
4853561|NCT00943605|16731393|P2|Overall Study|Study termination|30
4853562|NCT00943605|16731394|P1|Overall Study|Study termination|30
4853563|NCT00943592|16731404|P1|Overall Study|Death|3
4853564|NCT00943579|16731417|P2|Overall Study|Lack of Efficacy|2
4853565|NCT00943579|16731418|P1|Overall Study|Lack of Efficacy|2
4853566|NCT00943579|16731417|P2|Overall Study|Adverse Event|3
4853567|NCT00943579|16731418|P1|Overall Study|Adverse Event|4
4853568|NCT00943397|16731519|P2|Overall Study|Site terminated and other|56
4853569|NCT00943397|16731520|P1|Overall Study|Site terminated and other|12
4853570|NCT00943397|16731519|P2|Overall Study|Withdrawal by Subject|1
4853571|NCT00943397|16731520|P1|Overall Study|Withdrawal by Subject|1
4853572|NCT00943397|16731519|P2|Overall Study|Protocol Violation|5
4853573|NCT00943397|16731520|P1|Overall Study|Protocol Violation|2
4853574|NCT00943397|16731519|P2|Overall Study|Lost to Follow-up|4
4853575|NCT00943397|16731520|P1|Overall Study|Lost to Follow-up|0
4853576|NCT00943397|16731519|P2|Overall Study|Adverse Event|6
4853577|NCT00943397|16731520|P1|Overall Study|Adverse Event|0
4853578|NCT00943384|16731526|P1|Overall Study|Withdrawal by Subject|5
4853579|NCT00943384|16731526|P1|Overall Study|Lost to Follow-up|16
4853580|NCT00943384|16731526|P1|Overall Study|Treated off protocol-protocol violation|5
4853581|NCT00943384|16731526|P1|Overall Study|Dispositioned prior to treatment|23
4853582|NCT00943319|16731540|P1|Overall Study|Death|1
4853583|NCT00943306|16731546|P1|Overall Study|Sponsor decision due to non-compliance|1
4853584|NCT00943306|16731546|P1|Overall Study|Death|1
4853585|NCT00943306|16731546|P1|Overall Study|Physician Decision|1
4853586|NCT00943124|16731848|P2|Period 1|Personal Reasons|1
4853587|NCT00943124|16731849|P1|Period 1|Personal Reasons|0
4853588|NCT00943124|16731848|P2|Period 1|Did Not Follow Study Procedures|0
4853589|NCT00943124|16731849|P1|Period 1|Did Not Follow Study Procedures|1
4853590|NCT00943124|16731848|P2|Period 1|Withdrawal by Subject|1
4853591|NCT00943124|16731849|P1|Period 1|Withdrawal by Subject|1
4853592|NCT00943111|16731871|P3|5 Years Long-term Treatment Period|Other than specified above|2
4853593|NCT00943111|16731872|P2|5 Years Long-term Treatment Period|Other than specified above|0
4853594|NCT00943111|16731873|P1|5 Years Long-term Treatment Period|Other than specified above|0
4853595|NCT00943111|16731871|P3|5 Years Long-term Treatment Period|Lost to Follow-up|1
4853596|NCT00943111|16731872|P2|5 Years Long-term Treatment Period|Lost to Follow-up|0
4853597|NCT00943111|16731873|P1|5 Years Long-term Treatment Period|Lost to Follow-up|0
4853598|NCT00943111|16731871|P3|5 Years Long-term Treatment Period|Pregnancy|4
4853599|NCT00943111|16731872|P2|5 Years Long-term Treatment Period|Pregnancy|0
4853600|NCT00943111|16731873|P1|5 Years Long-term Treatment Period|Pregnancy|0
4853601|NCT00943111|16731871|P3|5 Years Long-term Treatment Period|Withdrawal by Subject|8
4853602|NCT00943111|16731872|P2|5 Years Long-term Treatment Period|Withdrawal by Subject|0
4853603|NCT00943111|16731873|P1|5 Years Long-term Treatment Period|Withdrawal by Subject|0
4853604|NCT00943111|16731871|P3|5 Years Long-term Treatment Period|Adverse Event|9
4853605|NCT00943111|16731872|P2|5 Years Long-term Treatment Period|Adverse Event|0
4853606|NCT00943111|16731873|P1|5 Years Long-term Treatment Period|Adverse Event|0
4853607|NCT00943111|16731871|P3|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51
4853608|NCT00943111|16731872|P2|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
4853609|NCT00943111|16731873|P1|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0
4853610|NCT00943111|16731871|P3|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
4853611|NCT00943111|16731872|P2|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1
4853612|NCT00943111|16731873|P1|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0
4853613|NCT00943111|16731871|P3|52-Weeks Primary Analysis Period|Adverse Event|0
4853614|NCT00943111|16731872|P2|52-Weeks Primary Analysis Period|Adverse Event|1
4853615|NCT00943111|16731873|P1|52-Weeks Primary Analysis Period|Adverse Event|2
4853616|NCT00943072|16731941|P2|Overall Study|Other|1
4853617|NCT00943072|16731942|P1|Overall Study|Other|1
4853618|NCT00943072|16731941|P2|Overall Study|Lack of Efficacy|4
4853619|NCT00943072|16731942|P1|Overall Study|Lack of Efficacy|0
4853620|NCT00943072|16731941|P2|Overall Study|Lost to Follow-up|2
4853621|NCT00943072|16731942|P1|Overall Study|Lost to Follow-up|1
4853622|NCT00943072|16731941|P2|Overall Study|Protocol Violation|1
4853623|NCT00943072|16731942|P1|Overall Study|Protocol Violation|0
4853624|NCT00943072|16731941|P2|Overall Study|Withdrawal by Subject|1
4853625|NCT00943072|16731942|P1|Overall Study|Withdrawal by Subject|3
4853626|NCT00943072|16731941|P2|Overall Study|Death|2
4853627|NCT00943072|16731942|P1|Overall Study|Death|0
4853628|NCT00943072|16731941|P2|Overall Study|Adverse Event|3
4853629|NCT00943072|16731942|P1|Overall Study|Adverse Event|0
4853630|NCT00942994|16731960|P2|Overall Study|Protocol deviation|2
4853631|NCT00942994|16731961|P1|Overall Study|Protocol deviation|1
4853632|NCT00942994|16731960|P2|Overall Study|Lost to Follow-up|4
4853633|NCT00942994|16731961|P1|Overall Study|Lost to Follow-up|1
4853634|NCT00942994|16731960|P2|Overall Study|Patient withdrew consent|8
4853635|NCT00942994|16731961|P1|Overall Study|Patient withdrew consent|5
4853636|NCT00942994|16731960|P2|Overall Study|Unsatisfactory therapeutic effect|1
4853637|NCT00942994|16731961|P1|Overall Study|Unsatisfactory therapeutic effect|1
4853638|NCT00942994|16731960|P2|Overall Study|Abnormal laboratory value(s)|0
4853640|NCT00942994|16731960|P2|Overall Study|Adverse Event|4
4853641|NCT00942994|16731961|P1|Overall Study|Adverse Event|7
4853642|NCT00942968|16731977|P1|Overall Study|Deep vein thrombosis (DVT)|2
4853643|NCT00942968|16731977|P1|Overall Study|Participant required pancreatic biopsy|1
4853644|NCT00942968|16731977|P1|Overall Study|Pulmonary embolism (PE)|1
4853645|NCT00942968|16731977|P1|Overall Study|Inferior vena cava filter placement|4
4853646|NCT00942968|16731977|P1|Overall Study|Progression of disease|12
4853647|NCT00942968|16731977|P1|Overall Study|Physician Decision|11
4853648|NCT00942968|16731977|P1|Overall Study|Sponsor request|5
4853649|NCT00942968|16731977|P1|Overall Study|Withdrawal by Subject|44
4853650|NCT00942968|16731977|P1|Overall Study|Lost to Follow-up|4
4853651|NCT00942968|16731977|P1|Overall Study|Protocol Violation|9
4853652|NCT00942968|16731977|P1|Overall Study|Death|76
4853653|NCT00942968|16731977|P1|Overall Study|Adverse Event|60
4853654|NCT00942734|16732055|P1|Overall Study|Physician Decision|1
4853655|NCT00942734|16732055|P1|Overall Study|Disease Progression|2
4853656|NCT00942734|16732055|P1|Overall Study|Protocol Violation|3
4853657|NCT00942734|16732055|P1|Overall Study|Adverse Event|2
4853658|NCT00942708|16732059|P1|Overall Study|Withdrawal by Subject|1
4853659|NCT00942604|16732067|P2|Overall Study|Patient relocation|1
4853660|NCT00942604|16732068|P1|Overall Study|Patient relocation|1
4853661|NCT00942604|16732067|P2|Overall Study|Withdrawal by Subject|1
4853662|NCT00942604|16732068|P1|Overall Study|Withdrawal by Subject|0
4853663|NCT00942604|16732067|P2|Overall Study|Adverse Event|1
4853664|NCT00942604|16732068|P1|Overall Study|Adverse Event|0
4853665|NCT00942604|16732067|P2|Overall Study|Protocol Violation|1
4853666|NCT00942604|16732068|P1|Overall Study|Protocol Violation|1
4853667|NCT00942422|16732176|P1|Overall Study|Progressive diease|1
4853668|NCT00942422|16732176|P1|Overall Study|Death|1
4853669|NCT00942422|16732176|P1|Overall Study|Withdrawal by Subject|1
4853670|NCT00942409|16732180|P1|Overall Study|study drug unavailable|2
4853671|NCT00942409|16732180|P1|Overall Study|Lack of Efficacy|1
4853672|NCT00942357|16732186|P2|Overall Study|Ineligible|40
4853673|NCT00942357|16732187|P1|Overall Study|Ineligible|37
4853674|NCT00942331|16732203|P2|Overall Study|Did not start treatment|22
4853675|NCT00942331|16732204|P1|Overall Study|Did not start treatment|15
4853676|NCT00942266|16732216|P2|Overall Study|medical deterioration (pneumonia)|1
4853677|NCT00942266|16732217|P1|Overall Study|medical deterioration (pneumonia)|0
4853678|NCT00942266|16732216|P2|Overall Study|Physician Decision|0
4853679|NCT00942266|16732217|P1|Overall Study|Physician Decision|2
4853680|NCT00942266|16732216|P2|Overall Study|Intercurrent illness|1
4853681|NCT00942266|16732217|P1|Overall Study|Intercurrent illness|0
4853682|NCT00942266|16732216|P2|Overall Study|Failure to thrive and pt withdrawal|1
4853683|NCT00942266|16732217|P1|Overall Study|Failure to thrive and pt withdrawal|0
4853684|NCT00942266|16732216|P2|Overall Study|Disease Progression|11
4853685|NCT00942266|16732217|P1|Overall Study|Disease Progression|38
4853686|NCT00942266|16732216|P2|Overall Study|Adverse Event|1
4853687|NCT00942266|16732217|P1|Overall Study|Adverse Event|2
4853688|NCT00942266|16732216|P2|Overall Study|Withdrawal by Subject|0
4853689|NCT00942266|16732217|P1|Overall Study|Withdrawal by Subject|1
4853690|NCT00942188|16732239|P4|Overall Study|Sponsor Decision|1
4853691|NCT00942188|16732240|P3|Overall Study|Sponsor Decision|0
4853692|NCT00942188|16732241|P2|Overall Study|Sponsor Decision|2
4853693|NCT00942188|16732242|P1|Overall Study|Sponsor Decision|0
4853694|NCT00942188|16732239|P4|Overall Study|Physician Decision|0
4853695|NCT00942188|16732240|P3|Overall Study|Physician Decision|1
4853696|NCT00942188|16732241|P2|Overall Study|Physician Decision|0
4853697|NCT00942188|16732242|P1|Overall Study|Physician Decision|0
4853698|NCT00942188|16732239|P4|Overall Study|Withdrawal by Subject|2
4853699|NCT00942188|16732240|P3|Overall Study|Withdrawal by Subject|4
4853700|NCT00942188|16732241|P2|Overall Study|Withdrawal by Subject|3
4853701|NCT00942188|16732242|P1|Overall Study|Withdrawal by Subject|1
4853702|NCT00942188|16732239|P4|Overall Study|Lost to Follow-up|0
4853703|NCT00942188|16732240|P3|Overall Study|Lost to Follow-up|2
4853704|NCT00942188|16732241|P2|Overall Study|Lost to Follow-up|1
4853705|NCT00942188|16732242|P1|Overall Study|Lost to Follow-up|2
4853706|NCT00942188|16732239|P4|Overall Study|Protocol Violation|0
4853707|NCT00942188|16732240|P3|Overall Study|Protocol Violation|0
4853708|NCT00942188|16732241|P2|Overall Study|Protocol Violation|1
4853709|NCT00942188|16732242|P1|Overall Study|Protocol Violation|1
4853710|NCT00942188|16732239|P4|Overall Study|Lack of Efficacy|1
4853711|NCT00942188|16732240|P3|Overall Study|Lack of Efficacy|0
4853712|NCT00942188|16732241|P2|Overall Study|Lack of Efficacy|0
4853713|NCT00942188|16732242|P1|Overall Study|Lack of Efficacy|0
4853714|NCT00942188|16732239|P4|Overall Study|Adverse Event|0
4853715|NCT00942188|16732240|P3|Overall Study|Adverse Event|2
4853716|NCT00942188|16732241|P2|Overall Study|Adverse Event|3
4853717|NCT00942188|16732242|P1|Overall Study|Adverse Event|0
4853718|NCT00942175|16732281|P4|Overall Study|Low Platelet Count|0
4853719|NCT00942175|16732282|P3|Overall Study|Low Platelet Count|0
4853720|NCT00942175|16732283|P2|Overall Study|Low Platelet Count|2
4853721|NCT00942175|16732284|P1|Overall Study|Low Platelet Count|0
4853722|NCT00942175|16732281|P4|Overall Study|Elevated Alanine Amino Transferase|1
4853723|NCT00942175|16732282|P3|Overall Study|Elevated Alanine Amino Transferase|0
4853724|NCT00942175|16732283|P2|Overall Study|Elevated Alanine Amino Transferase|0
4853725|NCT00942175|16732284|P1|Overall Study|Elevated Alanine Amino Transferase|0
4853726|NCT00942175|16732281|P4|Overall Study|Pregnancy|1
4853727|NCT00942175|16732282|P3|Overall Study|Pregnancy|0
4853728|NCT00942175|16732283|P2|Overall Study|Pregnancy|0
4853729|NCT00942175|16732284|P1|Overall Study|Pregnancy|0
4853730|NCT00942175|16732281|P4|Overall Study|Protocol Violation|0
4853731|NCT00942175|16732282|P3|Overall Study|Protocol Violation|2
4853732|NCT00942175|16732283|P2|Overall Study|Protocol Violation|1
4853733|NCT00942175|16732284|P1|Overall Study|Protocol Violation|0
4853734|NCT00942175|16732281|P4|Overall Study|Adverse Event|0
4853735|NCT00942175|16732282|P3|Overall Study|Adverse Event|0
4853736|NCT00942175|16732283|P2|Overall Study|Adverse Event|1
4853737|NCT00942175|16732284|P1|Overall Study|Adverse Event|2
4853738|NCT00942162|16732337|P3|Overall Study|Other|0
4853739|NCT00942162|16732338|P2|Overall Study|Other|2
4853740|NCT00942162|16732339|P1|Overall Study|Other|8
4853741|NCT00942162|16732337|P3|Overall Study|Withdrawal by Subject|0
4853742|NCT00942162|16732338|P2|Overall Study|Withdrawal by Subject|2
4853743|NCT00942162|16732339|P1|Overall Study|Withdrawal by Subject|4
4853744|NCT00942162|16732337|P3|Overall Study|Protocol Violation|0
4853745|NCT00942162|16732338|P2|Overall Study|Protocol Violation|0
4853746|NCT00942162|16732339|P1|Overall Study|Protocol Violation|1
4853747|NCT00942162|16732337|P3|Overall Study|Adverse Event|0
4853748|NCT00942162|16732338|P2|Overall Study|Adverse Event|0
4853749|NCT00942162|16732339|P1|Overall Study|Adverse Event|2
4853750|NCT00942162|16732337|P3|Overall Study|Disease progression|1
4853751|NCT00942162|16732338|P2|Overall Study|Disease progression|43
4853752|NCT00942162|16732339|P1|Overall Study|Disease progression|53
4853753|NCT00942084|16732408|P1|Overall Study|Death|2
4853754|NCT00941928|16732425|P1|Overall Study|Disease Progression|1
4853755|NCT00941928|16732425|P1|Overall Study|Withdrawal by Subject|1
4853756|NCT00941863|16732443|P5|Continued After PCD|Disease progression, recurrence, relapse|18
4853757|NCT00941863|16732444|P4|Continued After PCD|Disease progression, recurrence, relapse|0
4853758|NCT00941863|16732445|P3|Continued After PCD|Disease progression, recurrence, relapse|0
4853759|NCT00941863|16732446|P2|Continued After PCD|Disease progression, recurrence, relapse|0
4853760|NCT00941863|16732447|P1|Continued After PCD|Disease progression, recurrence, relapse|0
4853761|NCT00941863|16732443|P5|Continued After PCD|Withdrawal by Subject|1
4853762|NCT00941863|16732444|P4|Continued After PCD|Withdrawal by Subject|0
4853763|NCT00941863|16732445|P3|Continued After PCD|Withdrawal by Subject|0
4853764|NCT00941863|16732446|P2|Continued After PCD|Withdrawal by Subject|0
4853765|NCT00941863|16732447|P1|Continued After PCD|Withdrawal by Subject|0
4853766|NCT00941863|16732443|P5|Until Primary Completion Date (PCD)|Disease progression|73
4853767|NCT00941863|16732444|P4|Until Primary Completion Date (PCD)|Disease progression|14
4853768|NCT00941863|16732445|P3|Until Primary Completion Date (PCD)|Disease progression|8
4853769|NCT00941863|16732446|P2|Until Primary Completion Date (PCD)|Disease progression|1
4853770|NCT00941863|16732447|P1|Until Primary Completion Date (PCD)|Disease progression|6
4853771|NCT00941863|16732443|P5|Until Primary Completion Date (PCD)|Death|7
4853772|NCT00941863|16732444|P4|Until Primary Completion Date (PCD)|Death|2
4853773|NCT00941863|16732445|P3|Until Primary Completion Date (PCD)|Death|1
4853774|NCT00941863|16732446|P2|Until Primary Completion Date (PCD)|Death|0
4853775|NCT00941863|16732447|P1|Until Primary Completion Date (PCD)|Death|0
4853776|NCT00941863|16732443|P5|Until Primary Completion Date (PCD)|Withdrawal by Subject|8
4853777|NCT00941863|16732444|P4|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
4853778|NCT00941863|16732445|P3|Until Primary Completion Date (PCD)|Withdrawal by Subject|1
4853779|NCT00941863|16732446|P2|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
4853780|NCT00941863|16732447|P1|Until Primary Completion Date (PCD)|Withdrawal by Subject|0
4853781|NCT00941863|16732443|P5|Until Primary Completion Date (PCD)|Physician Decision|1
4853782|NCT00941863|16732444|P4|Until Primary Completion Date (PCD)|Physician Decision|0
4853783|NCT00941863|16732445|P3|Until Primary Completion Date (PCD)|Physician Decision|0
4853784|NCT00941863|16732446|P2|Until Primary Completion Date (PCD)|Physician Decision|0
4853785|NCT00941863|16732447|P1|Until Primary Completion Date (PCD)|Physician Decision|0
4853786|NCT00941863|16732443|P5|Until Primary Completion Date (PCD)|Adverse Event|5
4853787|NCT00941863|16732444|P4|Until Primary Completion Date (PCD)|Adverse Event|1
4853788|NCT00941863|16732445|P3|Until Primary Completion Date (PCD)|Adverse Event|2
4853789|NCT00941863|16732446|P2|Until Primary Completion Date (PCD)|Adverse Event|2
4853790|NCT00941863|16732447|P1|Until Primary Completion Date (PCD)|Adverse Event|1
4853791|NCT00941798|16732474|P2|Overall Study|Death|1
4853792|NCT00941798|16732475|P1|Overall Study|Death|0
4853793|NCT00941798|16732474|P2|Overall Study|Abnormal laboratory values|2
4853794|NCT00941798|16732475|P1|Overall Study|Abnormal laboratory values|1
4853795|NCT00941798|16732474|P2|Overall Study|Abnormal test procedure results|1
4853796|NCT00941798|16732475|P1|Overall Study|Abnormal test procedure results|3
4853797|NCT00941798|16732474|P2|Overall Study|Patient's inability to use device|1
4853798|NCT00941798|16732475|P1|Overall Study|Patient's inability to use device|6
4853799|NCT00941798|16732474|P2|Overall Study|Lack of Efficacy|17
4853800|NCT00941798|16732475|P1|Overall Study|Lack of Efficacy|10
4853801|NCT00941798|16732474|P2|Overall Study|Administrative problems|23
4853802|NCT00941798|16732475|P1|Overall Study|Administrative problems|13
4853803|NCT00941798|16732474|P2|Overall Study|Protocol Violation|20
4853804|NCT00941798|16732475|P1|Overall Study|Protocol Violation|17
4853805|NCT00941798|16732474|P2|Overall Study|Lost to Follow-up|23
4853806|NCT00941798|16732475|P1|Overall Study|Lost to Follow-up|29
4853807|NCT00941798|16732474|P2|Overall Study|Adverse Event|23
4853808|NCT00941798|16732475|P1|Overall Study|Adverse Event|43
4853809|NCT00941798|16732474|P2|Overall Study|Withdrawal by Subject|74
4853810|NCT00941798|16732475|P1|Overall Study|Withdrawal by Subject|72
4853811|NCT00941733|16732505|P2|Overall Study|Protocol Violation|6
4853812|NCT00941733|16732506|P1|Overall Study|Protocol Violation|15
4853813|NCT00941733|16732505|P2|Overall Study|Lost to Follow-up|2
4853814|NCT00941733|16732506|P1|Overall Study|Lost to Follow-up|1
4853815|NCT00941733|16732505|P2|Overall Study|Adverse Event|4
4853816|NCT00941733|16732506|P1|Overall Study|Adverse Event|20
4853817|NCT00941733|16732505|P2|Overall Study|Withdrawal by Subject|6
4853818|NCT00941733|16732506|P1|Overall Study|Withdrawal by Subject|14
4853819|NCT00941733|16732505|P2|Overall Study|Death|10
4853820|NCT00941733|16732506|P1|Overall Study|Death|24
4853821|NCT00941720|16732546|P1|Overall Study|ineligible|2
4853822|NCT00941720|16732546|P1|Overall Study|Insurance denied participation|11
4853823|NCT00941720|16732546|P1|Overall Study|Withdrawal by Subject|1
4853824|NCT00941655|16732593|P2|Overall Study|non-compliant|1
4853825|NCT00941655|16732594|P1|Overall Study|non-compliant|0
4853826|NCT00941655|16732593|P2|Overall Study|withdrew consent|1
4853827|NCT00941655|16732594|P1|Overall Study|withdrew consent|0
4853828|NCT00941655|16732593|P2|Overall Study|refused further treatment|1
4853829|NCT00941655|16732594|P1|Overall Study|refused further treatment|0
4853830|NCT00941655|16732593|P2|Overall Study|progressed while on chemo|2
4853831|NCT00941655|16732594|P1|Overall Study|progressed while on chemo|0
4853832|NCT00941655|16732593|P2|Overall Study|not meet criteria for chemo foll surgery|0
4853833|NCT00941655|16732594|P1|Overall Study|not meet criteria for chemo foll surgery|4
4853834|NCT00941655|16732593|P2|Overall Study|received some chemo, 4 and 9 cycles|0
4853835|NCT00941655|16732594|P1|Overall Study|received some chemo, 4 and 9 cycles|1
4853836|NCT00941603|16732619|P6|Overall Study|Did not meet protocol eligibility|0
4853837|NCT00941603|16732620|P5|Overall Study|Did not meet protocol eligibility|0
4853838|NCT00941603|16732621|P4|Overall Study|Did not meet protocol eligibility|0
4853839|NCT00941603|16732622|P3|Overall Study|Did not meet protocol eligibility|0
4853840|NCT00941603|16732623|P2|Overall Study|Did not meet protocol eligibility|0
4853841|NCT00941603|16732624|P1|Overall Study|Did not meet protocol eligibility|1
4853842|NCT00941603|16732619|P6|Overall Study|Protocol Violation|0
4853843|NCT00941603|16732620|P5|Overall Study|Protocol Violation|0
4853844|NCT00941603|16732621|P4|Overall Study|Protocol Violation|0
4853845|NCT00941603|16732622|P3|Overall Study|Protocol Violation|0
4853846|NCT00941603|16732623|P2|Overall Study|Protocol Violation|1
4853847|NCT00941603|16732624|P1|Overall Study|Protocol Violation|0
4853848|NCT00941603|16732619|P6|Overall Study|Withdrawal by Subject|1
4853849|NCT00941603|16732620|P5|Overall Study|Withdrawal by Subject|0
4853850|NCT00941603|16732621|P4|Overall Study|Withdrawal by Subject|2
4853851|NCT00941603|16732622|P3|Overall Study|Withdrawal by Subject|0
4853852|NCT00941603|16732623|P2|Overall Study|Withdrawal by Subject|0
4853853|NCT00941603|16732624|P1|Overall Study|Withdrawal by Subject|0
4853854|NCT00941603|16732619|P6|Overall Study|Lost to Follow-up|2
4853855|NCT00941603|16732620|P5|Overall Study|Lost to Follow-up|0
4853856|NCT00941603|16732621|P4|Overall Study|Lost to Follow-up|1
4853857|NCT00941603|16732622|P3|Overall Study|Lost to Follow-up|0
4853858|NCT00941603|16732623|P2|Overall Study|Lost to Follow-up|0
4853859|NCT00941603|16732624|P1|Overall Study|Lost to Follow-up|0
4853860|NCT00941603|16732619|P6|Overall Study|Adverse Event|0
4853861|NCT00941603|16732620|P5|Overall Study|Adverse Event|4
4853862|NCT00941603|16732621|P4|Overall Study|Adverse Event|1
4853863|NCT00941603|16732622|P3|Overall Study|Adverse Event|5
4853864|NCT00941603|16732623|P2|Overall Study|Adverse Event|15
4853865|NCT00941603|16732624|P1|Overall Study|Adverse Event|10
4853866|NCT00941330|16732646|P2|Overall Study|Physician Decision|2
4853867|NCT00941330|16732647|P1|Overall Study|Physician Decision|0
4853868|NCT00941330|16732646|P2|Overall Study|Other|0
4853869|NCT00941330|16732647|P1|Overall Study|Other|1
4853870|NCT00941304|16732660|P5|Overall Study|Lost to Follow-up|0
4853871|NCT00941304|16732661|P4|Overall Study|Lost to Follow-up|0
4853872|NCT00941304|16732662|P3|Overall Study|Lost to Follow-up|0
4853873|NCT00941304|16732663|P2|Overall Study|Lost to Follow-up|0
4853874|NCT00941304|16732664|P1|Overall Study|Lost to Follow-up|1
4853875|NCT00941070|16732726|P1|Overall Study|Patient non-compliant|1
4853876|NCT00941031|16732746|P7|Maintenance Period|Lack of Efficacy|13
4853877|NCT00941031|16732747|P6|Maintenance Period|Lack of Efficacy|0
4853878|NCT00941031|16732748|P5|Maintenance Period|Lack of Efficacy|0
4853879|NCT00941031|16732749|P4|Maintenance Period|Lack of Efficacy|0
4853880|NCT00941031|16732750|P3|Maintenance Period|Lack of Efficacy|0
4853881|NCT00941031|16732751|P2|Maintenance Period|Lack of Efficacy|0
4853882|NCT00941031|16732752|P1|Maintenance Period|Lack of Efficacy|0
4853883|NCT00941031|16732746|P7|Maintenance Period|Lost to Follow-up|7
4853884|NCT00941031|16732747|P6|Maintenance Period|Lost to Follow-up|2
4853885|NCT00941031|16732748|P5|Maintenance Period|Lost to Follow-up|2
4853886|NCT00941031|16732749|P4|Maintenance Period|Lost to Follow-up|0
4853887|NCT00941031|16732750|P3|Maintenance Period|Lost to Follow-up|0
4853888|NCT00941031|16732751|P2|Maintenance Period|Lost to Follow-up|0
4853889|NCT00941031|16732752|P1|Maintenance Period|Lost to Follow-up|0
4853890|NCT00941031|16732746|P7|Maintenance Period|Adverse Event|8
4853891|NCT00941031|16732747|P6|Maintenance Period|Adverse Event|2
4853892|NCT00941031|16732748|P5|Maintenance Period|Adverse Event|0
4853893|NCT00941031|16732749|P4|Maintenance Period|Adverse Event|0
4853894|NCT00941031|16732750|P3|Maintenance Period|Adverse Event|0
4853895|NCT00941031|16732751|P2|Maintenance Period|Adverse Event|0
4853896|NCT00941031|16732752|P1|Maintenance Period|Adverse Event|0
4853897|NCT00941031|16732746|P7|Maintenance Period|Protocol Violation|1
4853898|NCT00941031|16732747|P6|Maintenance Period|Protocol Violation|0
4853899|NCT00941031|16732748|P5|Maintenance Period|Protocol Violation|0
4853900|NCT00941031|16732749|P4|Maintenance Period|Protocol Violation|0
4853901|NCT00941031|16732750|P3|Maintenance Period|Protocol Violation|0
4853902|NCT00941031|16732751|P2|Maintenance Period|Protocol Violation|0
4853903|NCT00941031|16732752|P1|Maintenance Period|Protocol Violation|0
4853904|NCT00941031|16732746|P7|Maintenance Period|Administrative Problems|1
4853905|NCT00941031|16732747|P6|Maintenance Period|Administrative Problems|0
4853906|NCT00941031|16732748|P5|Maintenance Period|Administrative Problems|1
4853907|NCT00941031|16732749|P4|Maintenance Period|Administrative Problems|0
4853908|NCT00941031|16732750|P3|Maintenance Period|Administrative Problems|0
4853909|NCT00941031|16732751|P2|Maintenance Period|Administrative Problems|0
4853910|NCT00941031|16732752|P1|Maintenance Period|Administrative Problems|0
4853911|NCT00941031|16732746|P7|Maintenance Period|Withdrawal by Subject|13
4853912|NCT00941031|16732747|P6|Maintenance Period|Withdrawal by Subject|2
4853913|NCT00941031|16732748|P5|Maintenance Period|Withdrawal by Subject|6
4853914|NCT00941031|16732749|P4|Maintenance Period|Withdrawal by Subject|0
4853915|NCT00941031|16732750|P3|Maintenance Period|Withdrawal by Subject|0
4853916|NCT00941031|16732751|P2|Maintenance Period|Withdrawal by Subject|0
4853917|NCT00941031|16732752|P1|Maintenance Period|Withdrawal by Subject|0
4853918|NCT00941031|16732746|P7|Induction Period|Adverse Event|0
4853919|NCT00941031|16732747|P6|Induction Period|Adverse Event|0
4853920|NCT00941031|16732748|P5|Induction Period|Adverse Event|0
4853921|NCT00941031|16732749|P4|Induction Period|Adverse Event|2
4853922|NCT00941031|16732750|P3|Induction Period|Adverse Event|3
4853923|NCT00941031|16732751|P2|Induction Period|Adverse Event|0
4853924|NCT00941031|16732752|P1|Induction Period|Adverse Event|1
4853925|NCT00941031|16732746|P7|Induction Period|Adminstative Problems|0
4853926|NCT00941031|16732747|P6|Induction Period|Adminstative Problems|0
4853927|NCT00941031|16732748|P5|Induction Period|Adminstative Problems|0
4853928|NCT00941031|16732749|P4|Induction Period|Adminstative Problems|0
4853929|NCT00941031|16732750|P3|Induction Period|Adminstative Problems|1
4853930|NCT00941031|16732751|P2|Induction Period|Adminstative Problems|1
4853931|NCT00941031|16732752|P1|Induction Period|Adminstative Problems|1
4853932|NCT00941031|16732746|P7|Induction Period|Withdrawal by Subject|0
4853933|NCT00941031|16732747|P6|Induction Period|Withdrawal by Subject|0
4853934|NCT00941031|16732748|P5|Induction Period|Withdrawal by Subject|0
4853935|NCT00941031|16732749|P4|Induction Period|Withdrawal by Subject|2
4853936|NCT00941031|16732750|P3|Induction Period|Withdrawal by Subject|2
4853937|NCT00941031|16732751|P2|Induction Period|Withdrawal by Subject|2
4853938|NCT00941031|16732752|P1|Induction Period|Withdrawal by Subject|1
4853939|NCT00941031|16732746|P7|Induction Period|Lack of Efficacy|0
4853940|NCT00941031|16732747|P6|Induction Period|Lack of Efficacy|0
4853941|NCT00941031|16732748|P5|Induction Period|Lack of Efficacy|0
4853942|NCT00941031|16732749|P4|Induction Period|Lack of Efficacy|5
4853943|NCT00941031|16732750|P3|Induction Period|Lack of Efficacy|0
4853944|NCT00941031|16732751|P2|Induction Period|Lack of Efficacy|1
4853945|NCT00941031|16732752|P1|Induction Period|Lack of Efficacy|2
4853946|NCT00940992|16732799|P3|Overall Study|Lost to Follow-up|1
4853947|NCT00940992|16732800|P2|Overall Study|Lost to Follow-up|1
4853948|NCT00940992|16732801|P1|Overall Study|Lost to Follow-up|0
4853949|NCT00940992|16732799|P3|Overall Study|subject request|0
4853950|NCT00940992|16732800|P2|Overall Study|subject request|1
4853951|NCT00940992|16732801|P1|Overall Study|subject request|2
4853952|NCT00940992|16732799|P3|Overall Study|Adverse Event|1
4853953|NCT00940992|16732800|P2|Overall Study|Adverse Event|0
4853954|NCT00940992|16732801|P1|Overall Study|Adverse Event|2
4853955|NCT00940888|16732830|P1|Overall Study|Lost to Follow-up|6
4853956|NCT00940888|16732830|P1|Overall Study|Withdrawn - Non-Death|364
4853957|NCT00940888|16732830|P1|Overall Study|Death|461
4853958|NCT00940888|16732830|P1|Overall Study|Unsuccessful Implant|4
4853959|NCT00940875|16732837|P2|Post-Study Treatment|Disease Progression|2
4853960|NCT00940875|16732838|P1|Post-Study Treatment|Disease Progression|0
4853961|NCT00940875|16732837|P2|Post-Study Treatment|Death|1
4853962|NCT00940875|16732838|P1|Post-Study Treatment|Death|0
4853963|NCT00940875|16732837|P2|Treatment Phase|Physician Decision|0
4853964|NCT00940875|16732838|P1|Treatment Phase|Physician Decision|1
4853965|NCT00940875|16732837|P2|Treatment Phase|Disease progression|11
4853966|NCT00940875|16732838|P1|Treatment Phase|Disease progression|9
4853967|NCT00940875|16732837|P2|Treatment Phase|Withdrawal by Subject|0
4853968|NCT00940875|16732838|P1|Treatment Phase|Withdrawal by Subject|3
4853969|NCT00940875|16732837|P2|Treatment Phase|Lack of Efficacy|0
4853970|NCT00940875|16732838|P1|Treatment Phase|Lack of Efficacy|1
4853971|NCT00940875|16732837|P2|Treatment Phase|Death|5
4853972|NCT00940875|16732838|P1|Treatment Phase|Death|3
4853973|NCT00940875|16732837|P2|Treatment Phase|Adverse Event|3
4853974|NCT00940875|16732838|P1|Treatment Phase|Adverse Event|9
4853975|NCT00940823|16732858|P2|Overall Study|Lost to Follow-up|20
4853976|NCT00940823|16732859|P1|Overall Study|Lost to Follow-up|27
4853977|NCT00940823|16732858|P2|Overall Study|Death|12
4853978|NCT00940823|16732859|P1|Overall Study|Death|8
4853979|NCT00940498|16732923|P8|Overall Study|Not treated due to disease related pain|0
4853980|NCT00940498|16732924|P7|Overall Study|Not treated due to disease related pain|0
4853981|NCT00940498|16732925|P6|Overall Study|Not treated due to disease related pain|0
4853982|NCT00940498|16732926|P5|Overall Study|Not treated due to disease related pain|1
4853983|NCT00940498|16732927|P4|Overall Study|Not treated due to disease related pain|0
4853984|NCT00940498|16732928|P3|Overall Study|Not treated due to disease related pain|0
4853985|NCT00940498|16732929|P2|Overall Study|Not treated due to disease related pain|0
4853986|NCT00940498|16732930|P1|Overall Study|Not treated due to disease related pain|0
4853987|NCT00940498|16732923|P8|Overall Study|Physician Decision|0
4853988|NCT00940498|16732924|P7|Overall Study|Physician Decision|0
4853989|NCT00940498|16732925|P6|Overall Study|Physician Decision|0
4853990|NCT00940498|16732926|P5|Overall Study|Physician Decision|2
4853991|NCT00940498|16732927|P4|Overall Study|Physician Decision|0
4853992|NCT00940498|16732928|P3|Overall Study|Physician Decision|0
4853993|NCT00940498|16732929|P2|Overall Study|Physician Decision|0
4853994|NCT00940498|16732930|P1|Overall Study|Physician Decision|0
4853995|NCT00940498|16732923|P8|Overall Study|Disease Progression|0
4853996|NCT00940498|16732924|P7|Overall Study|Disease Progression|0
4853997|NCT00940498|16732925|P6|Overall Study|Disease Progression|1
4853998|NCT00940498|16732926|P5|Overall Study|Disease Progression|0
4853999|NCT00940498|16732927|P4|Overall Study|Disease Progression|1
4854000|NCT00940498|16732928|P3|Overall Study|Disease Progression|1
4854001|NCT00940498|16732929|P2|Overall Study|Disease Progression|0
4854002|NCT00940498|16732930|P1|Overall Study|Disease Progression|0
4854003|NCT00940498|16732923|P8|Overall Study|Lost to Follow-up|1
4854004|NCT00940498|16732924|P7|Overall Study|Lost to Follow-up|0
4854005|NCT00940498|16732925|P6|Overall Study|Lost to Follow-up|0
4854006|NCT00940498|16732926|P5|Overall Study|Lost to Follow-up|1
4854007|NCT00940498|16732927|P4|Overall Study|Lost to Follow-up|0
4854008|NCT00940498|16732928|P3|Overall Study|Lost to Follow-up|2
4854009|NCT00940498|16732929|P2|Overall Study|Lost to Follow-up|1
4854010|NCT00940498|16732930|P1|Overall Study|Lost to Follow-up|1
4854011|NCT00940498|16732923|P8|Overall Study|Death|0
4854012|NCT00940498|16732924|P7|Overall Study|Death|1
4854013|NCT00940498|16732925|P6|Overall Study|Death|0
4854014|NCT00940498|16732926|P5|Overall Study|Death|5
4854015|NCT00940498|16732927|P4|Overall Study|Death|1
4854016|NCT00940498|16732928|P3|Overall Study|Death|0
4854017|NCT00940498|16732929|P2|Overall Study|Death|0
4854018|NCT00940498|16732930|P1|Overall Study|Death|2
4854019|NCT00940485|16733048|P2|Overall Study|Others|1
4854020|NCT00940485|16733049|P1|Overall Study|Others|1
4854021|NCT00940485|16733048|P2|Overall Study|Withdrawal by Subject|1
4854022|NCT00940485|16733049|P1|Overall Study|Withdrawal by Subject|1
4854023|NCT00940485|16733048|P2|Overall Study|Adverse Event|0
4854024|NCT00940485|16733049|P1|Overall Study|Adverse Event|8
4854025|NCT00940485|16733048|P2|Overall Study|Lost to Follow-up|3
4854026|NCT00940485|16733049|P1|Overall Study|Lost to Follow-up|2
4854027|NCT00940485|16733048|P2|Overall Study|HBeAb positive at Baseline|2
4854028|NCT00940485|16733049|P1|Overall Study|HBeAb positive at Baseline|3
4854029|NCT00940342|16733087|P3|Overall Study|Adverse Event|1
4854030|NCT00940342|16733088|P2|Overall Study|Adverse Event|2
4854031|NCT00940342|16733089|P1|Overall Study|Adverse Event|0
4854032|NCT00940316|16733100|P3|Treated After Cycle 5|Progressive disease|0
4854033|NCT00940316|16733101|P2|Treated After Cycle 5|Progressive disease|1
4854034|NCT00940316|16733102|P1|Treated After Cycle 5|Progressive disease|0
4854035|NCT00940316|16733100|P3|Treated After Cycle 5|Adverse Event|1
4854036|NCT00940316|16733101|P2|Treated After Cycle 5|Adverse Event|0
4854037|NCT00940316|16733102|P1|Treated After Cycle 5|Adverse Event|0
4854038|NCT00940316|16733100|P3|Moved on to be Treated Cycle 5|Adverse Event|0
4854039|NCT00940316|16733101|P2|Moved on to be Treated Cycle 5|Adverse Event|0
4854040|NCT00940316|16733102|P1|Moved on to be Treated Cycle 5|Adverse Event|2
4854041|NCT00940316|16733100|P3|Reached First Response at 8 Weeks|Progressive disease|0
4854042|NCT00940316|16733101|P2|Reached First Response at 8 Weeks|Progressive disease|3
4854043|NCT00940316|16733102|P1|Reached First Response at 8 Weeks|Progressive disease|1
4854044|NCT00940316|16733100|P3|Reached First Response at 8 Weeks|Adverse Event|0
4854045|NCT00940316|16733101|P2|Reached First Response at 8 Weeks|Adverse Event|1
4854046|NCT00940316|16733102|P1|Reached First Response at 8 Weeks|Adverse Event|2
4854047|NCT00940108|16733145|P4|Overall Study|Diagnosed with H1N1|1
4854048|NCT00940108|16733146|P3|Overall Study|Diagnosed with H1N1|0
4854049|NCT00940108|16733147|P2|Overall Study|Diagnosed with H1N1|0
4854050|NCT00940108|16733148|P1|Overall Study|Diagnosed with H1N1|0
4854051|NCT00940108|16733145|P4|Overall Study|Viral illness after Dose 1|0
4854052|NCT00940108|16733146|P3|Overall Study|Viral illness after Dose 1|0
4854053|NCT00940108|16733147|P2|Overall Study|Viral illness after Dose 1|1
4854054|NCT00940108|16733148|P1|Overall Study|Viral illness after Dose 1|0
4854055|NCT00940108|16733145|P4|Overall Study|Refused - pyrexia after Dose 1|0
4854056|NCT00940108|16733146|P3|Overall Study|Refused - pyrexia after Dose 1|0
4854057|NCT00940108|16733147|P2|Overall Study|Refused - pyrexia after Dose 1|1
4854058|NCT00940108|16733148|P1|Overall Study|Refused - pyrexia after Dose 1|0
4854059|NCT00940108|16733145|P4|Overall Study|Declined further vaccination|0
4854060|NCT00940108|16733146|P3|Overall Study|Declined further vaccination|3
4854061|NCT00940108|16733147|P2|Overall Study|Declined further vaccination|1
4854062|NCT00940108|16733148|P1|Overall Study|Declined further vaccination|0
4854063|NCT00940108|16733145|P4|Overall Study|Dose 2 contraindicated|1
4854064|NCT00940108|16733146|P3|Overall Study|Dose 2 contraindicated|0
4854065|NCT00940108|16733147|P2|Overall Study|Dose 2 contraindicated|1
4854066|NCT00940108|16733148|P1|Overall Study|Dose 2 contraindicated|1
4854067|NCT00940108|16733145|P4|Overall Study|Withdrew Consent|1
4854068|NCT00940108|16733146|P3|Overall Study|Withdrew Consent|0
4854069|NCT00940108|16733147|P2|Overall Study|Withdrew Consent|1
4854070|NCT00940108|16733148|P1|Overall Study|Withdrew Consent|2
4854071|NCT00940108|16733145|P4|Overall Study|Adverse Event|2
4854072|NCT00940108|16733146|P3|Overall Study|Adverse Event|0
4854073|NCT00940108|16733147|P2|Overall Study|Adverse Event|4
4854074|NCT00940108|16733148|P1|Overall Study|Adverse Event|2
4854075|NCT00940017|16733198|P1|Overall Study|Adverse Event|1
4854076|NCT00940017|16733198|P1|Overall Study|did not meet entrance criteria|3
4854077|NCT00939822|16733256|P2|Overall Study|Mental health issues|2
4854078|NCT00939822|16733257|P1|Overall Study|Mental health issues|0
4854079|NCT00939822|16733256|P2|Overall Study|withdrew from study due to busy schedule|1
4854080|NCT00939822|16733257|P1|Overall Study|withdrew from study due to busy schedule|1
4854081|NCT00939822|16733256|P2|Overall Study|Lost to Follow-up|0
4854082|NCT00939822|16733257|P1|Overall Study|Lost to Follow-up|1
4854083|NCT00939809|16733269|P1|Overall Study|Death|1
4854084|NCT00939809|16733269|P1|Overall Study|Adverse Event|2
4854085|NCT00939783|16733284|P1|Overall Study|Enrolled but not treated|1
4854086|NCT00939783|16733284|P1|Overall Study|Protocol Violation|3
4854087|NCT00939783|16733284|P1|Overall Study|Lost to Follow-up|8
4854088|NCT00939783|16733284|P1|Overall Study|Other|16
4854089|NCT00939783|16733284|P1|Overall Study|Withdrawal by Subject|78
4854090|NCT00939783|16733284|P1|Overall Study|Study Terminated by Sponsor|498
4854091|NCT00939783|16733284|P1|Overall Study|Adverse Event|39
4854092|NCT00939783|16733284|P1|Overall Study|Death|6
4854093|NCT00939770|16733299|P8|Overall Study|Withdrawal by Subject|2
4854094|NCT00939770|16733300|P7|Overall Study|Withdrawal by Subject|2
4854095|NCT00939770|16733301|P6|Overall Study|Withdrawal by Subject|0
4854096|NCT00939770|16733302|P5|Overall Study|Withdrawal by Subject|6
4854097|NCT00939770|16733303|P4|Overall Study|Withdrawal by Subject|2
4854098|NCT00939770|16733304|P3|Overall Study|Withdrawal by Subject|5
4854099|NCT00939770|16733305|P2|Overall Study|Withdrawal by Subject|1
4854100|NCT00939770|16733306|P1|Overall Study|Withdrawal by Subject|0
4854101|NCT00939770|16733299|P8|Overall Study|Protocol Violation|0
4854102|NCT00939770|16733300|P7|Overall Study|Protocol Violation|0
4854103|NCT00939770|16733301|P6|Overall Study|Protocol Violation|0
4854104|NCT00939770|16733302|P5|Overall Study|Protocol Violation|1
4854105|NCT00939770|16733303|P4|Overall Study|Protocol Violation|0
4854106|NCT00939770|16733304|P3|Overall Study|Protocol Violation|0
4854107|NCT00939770|16733305|P2|Overall Study|Protocol Violation|0
4854108|NCT00939770|16733306|P1|Overall Study|Protocol Violation|0
4854109|NCT00939770|16733299|P8|Overall Study|Physician Decision|6
4854110|NCT00939770|16733300|P7|Overall Study|Physician Decision|0
4854111|NCT00939770|16733301|P6|Overall Study|Physician Decision|1
4854112|NCT00939770|16733302|P5|Overall Study|Physician Decision|7
4854113|NCT00939770|16733303|P4|Overall Study|Physician Decision|0
4854114|NCT00939770|16733304|P3|Overall Study|Physician Decision|2
4854115|NCT00939770|16733305|P2|Overall Study|Physician Decision|0
4854116|NCT00939770|16733306|P1|Overall Study|Physician Decision|0
4854117|NCT00939770|16733299|P8|Overall Study|Lost to Follow-up|0
4854118|NCT00939770|16733300|P7|Overall Study|Lost to Follow-up|0
4854119|NCT00939770|16733301|P6|Overall Study|Lost to Follow-up|0
4854120|NCT00939770|16733302|P5|Overall Study|Lost to Follow-up|1
4854121|NCT00939770|16733303|P4|Overall Study|Lost to Follow-up|0
4854122|NCT00939770|16733304|P3|Overall Study|Lost to Follow-up|0
4854123|NCT00939770|16733305|P2|Overall Study|Lost to Follow-up|0
4854124|NCT00939770|16733306|P1|Overall Study|Lost to Follow-up|0
4854125|NCT00939770|16733299|P8|Overall Study|Lack of Efficacy|1
4854126|NCT00939770|16733300|P7|Overall Study|Lack of Efficacy|11
4854127|NCT00939770|16733301|P6|Overall Study|Lack of Efficacy|8
4854128|NCT00939770|16733302|P5|Overall Study|Lack of Efficacy|16
4854129|NCT00939770|16733303|P4|Overall Study|Lack of Efficacy|9
4854130|NCT00939770|16733304|P3|Overall Study|Lack of Efficacy|13
4854131|NCT00939770|16733305|P2|Overall Study|Lack of Efficacy|6
4854132|NCT00939770|16733306|P1|Overall Study|Lack of Efficacy|4
4854133|NCT00939770|16733299|P8|Overall Study|Adverse Event|1
4854134|NCT00939770|16733300|P7|Overall Study|Adverse Event|1
4854135|NCT00939770|16733301|P6|Overall Study|Adverse Event|2
4854136|NCT00939770|16733302|P5|Overall Study|Adverse Event|6
4854137|NCT00939770|16733303|P4|Overall Study|Adverse Event|0
4854138|NCT00939770|16733304|P3|Overall Study|Adverse Event|0
4854139|NCT00939770|16733305|P2|Overall Study|Adverse Event|1
4854140|NCT00939770|16733306|P1|Overall Study|Adverse Event|1
4854141|NCT00939692|16733391|P2|Period 2 - Second Intervent - 5 Days|Protocol Violation|1
4854142|NCT00939692|16733392|P1|Period 2 - Second Intervent - 5 Days|Protocol Violation|0
4854143|NCT00939692|16733391|P2|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0
4854144|NCT00939692|16733392|P1|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1
4854145|NCT00939640|16733407|P1|Overall Study|Physician Decision|1
4854146|NCT00939627|16733428|P3|Overall Study|No off-tx reason given|0
4854147|NCT00939627|16733429|P2|Overall Study|No off-tx reason given|2
4854148|NCT00939627|16733430|P1|Overall Study|No off-tx reason given|0
4854149|NCT00939627|16733428|P3|Overall Study|Not compliant|0
4854150|NCT00939627|16733429|P2|Overall Study|Not compliant|0
4854151|NCT00939627|16733430|P1|Overall Study|Not compliant|2
4854152|NCT00939627|16733428|P3|Overall Study|Other complicating disease|0
4854153|NCT00939627|16733429|P2|Overall Study|Other complicating disease|1
4854154|NCT00939627|16733430|P1|Overall Study|Other complicating disease|1
4854155|NCT00939627|16733428|P3|Overall Study|Withdrawal by Subject|0
4854156|NCT00939627|16733429|P2|Overall Study|Withdrawal by Subject|4
4854157|NCT00939627|16733430|P1|Overall Study|Withdrawal by Subject|2
4854158|NCT00939627|16733428|P3|Overall Study|Death|0
4854159|NCT00939627|16733429|P2|Overall Study|Death|2
4854160|NCT00939627|16733430|P1|Overall Study|Death|0
4854161|NCT00939627|16733428|P3|Overall Study|Adverse Event|0
4854162|NCT00939627|16733429|P2|Overall Study|Adverse Event|7
4854163|NCT00939627|16733430|P1|Overall Study|Adverse Event|6
4854164|NCT00939627|16733428|P3|Overall Study|Disease Progression|0
4854165|NCT00939627|16733429|P2|Overall Study|Disease Progression|12
4854166|NCT00939627|16733430|P1|Overall Study|Disease Progression|16
4854167|NCT00939523|16733470|P1|Overall Study|Physician Decision|2
4854168|NCT00939523|16733470|P1|Overall Study|Lack of Efficacy|1
4854169|NCT00939510|16733477|P1|Overall Study|Withdrawal by Subject|1
4854170|NCT00939484|16733486|P3|Overall Study|Progression/Relapse|3
4854171|NCT00939484|16733487|P2|Overall Study|Progression/Relapse|20
4854172|NCT00939484|16733488|P1|Overall Study|Progression/Relapse|8
4854173|NCT00939393|16733514|P2|Overall Study|Lost to Follow-up|0
4854174|NCT00939393|16733515|P1|Overall Study|Lost to Follow-up|3
4854175|NCT00939393|16733514|P2|Overall Study|Withdrawal by Subject|0
4854176|NCT00939393|16733515|P1|Overall Study|Withdrawal by Subject|1
4854177|NCT00939341|16733546|P1|Overall Study|Incorrect enrolment|8
4854178|NCT00939341|16733546|P1|Overall Study|Protocol Violation|6
4854179|NCT00939341|16733546|P1|Overall Study|Withdrawal by Subject|13
4854180|NCT00939341|16733546|P1|Overall Study|Lost to Follow-up|23
4854181|NCT00939341|16733546|P1|Overall Study|Pregnancy|1
4854182|NCT00939341|16733546|P1|Overall Study|Adverse Event|15
4854183|NCT00939185|16733633|P1|Overall Study|Randomized But Did Not Receive Treatment|10
4854184|NCT00939185|16733633|P1|Overall Study|Withdrawal by Subject|2
4854185|NCT00939185|16733633|P1|Overall Study|Other|3
4854186|NCT00939185|16733633|P1|Overall Study|Lost to Follow-up|6
4854187|NCT00939185|16733633|P1|Overall Study|Lack of Efficacy|1
4854188|NCT00939185|16733633|P1|Overall Study|Adverse Event|3
4854189|NCT00939107|16733671|P2|Overall Study|Lost to Follow-up|12
4854190|NCT00939107|16733672|P1|Overall Study|Lost to Follow-up|14
4854191|NCT00939094|16733686|P2|Overall Study|Abnormal ECG findings|0
4854192|NCT00939094|16733687|P1|Overall Study|Abnormal ECG findings|1
4854193|NCT00939094|16733686|P2|Overall Study|Study stopped by sponsor|2
4854194|NCT00939094|16733687|P1|Overall Study|Study stopped by sponsor|0
4854195|NCT00939094|16733686|P2|Overall Study|Severe non-compliance to protocol|1
4854196|NCT00939094|16733687|P1|Overall Study|Severe non-compliance to protocol|0
4854197|NCT00939094|16733686|P2|Overall Study|Eligibility criteria not fulfilled|0
4854198|NCT00939094|16733687|P1|Overall Study|Eligibility criteria not fulfilled|2
4854199|NCT00939094|16733686|P2|Overall Study|Lost to Follow-up|1
4854200|NCT00939094|16733687|P1|Overall Study|Lost to Follow-up|1
4854201|NCT00939094|16733686|P2|Overall Study|Withdrawal by Subject|6
4854202|NCT00939094|16733687|P1|Overall Study|Withdrawal by Subject|1
4854203|NCT00939094|16733686|P2|Overall Study|Adverse Event|0
4854204|NCT00939094|16733687|P1|Overall Study|Adverse Event|9
4854205|NCT00939055|16733709|P2|Overall Study|Discontinuation prior to procedure|0
4854206|NCT00939055|16733710|P1|Overall Study|Discontinuation prior to procedure|4
4854207|NCT00939029|16733720|P2|Overall Study|Adverse Event|1
4854208|NCT00939029|16733721|P1|Overall Study|Adverse Event|0
4854209|NCT00939029|16733720|P2|Overall Study|Lost to Follow-up|4
4854210|NCT00939029|16733721|P1|Overall Study|Lost to Follow-up|3
4854211|NCT00939029|16733720|P2|Overall Study|Withdrawal by Subject|7
4854212|NCT00939029|16733721|P1|Overall Study|Withdrawal by Subject|3
4854213|NCT00939003|16733733|P2|Open-label Treatment Period|Site Closure|4
4854214|NCT00939003|16733734|P1|Open-label Treatment Period|Site Closure|3
4854215|NCT00939003|16733733|P2|Open-label Treatment Period|Exclusion Criteria|0
4854216|NCT00939003|16733734|P1|Open-label Treatment Period|Exclusion Criteria|1
4854217|NCT00939003|16733733|P2|Open-label Treatment Period|Pregnancy|1
4854218|NCT00939003|16733734|P1|Open-label Treatment Period|Pregnancy|1
4854219|NCT00939003|16733733|P2|Open-label Treatment Period|Lack of Efficacy|9
4854220|NCT00939003|16733734|P1|Open-label Treatment Period|Lack of Efficacy|6
4854221|NCT00939003|16733733|P2|Open-label Treatment Period|Withdrawal by Subject|7
4854222|NCT00939003|16733734|P1|Open-label Treatment Period|Withdrawal by Subject|14
4854223|NCT00939003|16733733|P2|Open-label Treatment Period|Adverse Event|8
4854224|NCT00939003|16733734|P1|Open-label Treatment Period|Adverse Event|4
4854225|NCT00939003|16733733|P2|Double-blind Treatment Period|MRI Not Diagnostic|1
4854226|NCT00939003|16733734|P1|Double-blind Treatment Period|MRI Not Diagnostic|1
4854227|NCT00939003|16733733|P2|Double-blind Treatment Period|Pregnancy|1
4854228|NCT00939003|16733734|P1|Double-blind Treatment Period|Pregnancy|0
4854229|NCT00939003|16733733|P2|Double-blind Treatment Period|Lack of Efficacy|1
4854230|NCT00939003|16733734|P1|Double-blind Treatment Period|Lack of Efficacy|0
4854231|NCT00939003|16733733|P2|Double-blind Treatment Period|Adverse Event|1
4854232|NCT00939003|16733734|P1|Double-blind Treatment Period|Adverse Event|1
4854233|NCT00938964|16733771|P2|Overall Study|Found to Meet Exclusion Criteria|4
4854234|NCT00938964|16733772|P1|Overall Study|Found to Meet Exclusion Criteria|3
4854235|NCT00938964|16733771|P2|Overall Study|Withdrawal by Subject|18
4854236|NCT00938964|16733772|P1|Overall Study|Withdrawal by Subject|22
4854237|NCT00938964|16733771|P2|Overall Study|Lost to Follow-up|3
4854238|NCT00938964|16733772|P1|Overall Study|Lost to Follow-up|2
4854239|NCT00938964|16733771|P2|Overall Study|Death|3
4854240|NCT00938964|16733772|P1|Overall Study|Death|3
4854241|NCT00938886|16733836|P2|Overall Study|Lost to Follow-up|2
4854242|NCT00938886|16733837|P1|Overall Study|Lost to Follow-up|3
4854243|NCT00938886|16733836|P2|Overall Study|Withdrawal by Subject|7
4854244|NCT00938886|16733837|P1|Overall Study|Withdrawal by Subject|4
4854245|NCT00938886|16733836|P2|Overall Study|Death|1
4854246|NCT00938886|16733837|P1|Overall Study|Death|0
4854247|NCT00938860|16733847|P2|Overall Study|Protocol Violation|1
4854248|NCT00938860|16733848|P1|Overall Study|Protocol Violation|3
4854249|NCT00938860|16733847|P2|Overall Study|Death|1
4854250|NCT00938860|16733848|P1|Overall Study|Death|1
4854251|NCT00938860|16733847|P2|Overall Study|Administration problems|0
4854252|NCT00938860|16733848|P1|Overall Study|Administration problems|2
4854253|NCT00938860|16733847|P2|Overall Study|Lost to Follow-up|4
4854254|NCT00938860|16733848|P1|Overall Study|Lost to Follow-up|4
4854255|NCT00938860|16733847|P2|Overall Study|Withdrawal by Subject|8
4854256|NCT00938860|16733848|P1|Overall Study|Withdrawal by Subject|11
4854257|NCT00938860|16733847|P2|Overall Study|Abnormal laboratory values|2
4854258|NCT00938860|16733848|P1|Overall Study|Abnormal laboratory values|2
4854259|NCT00938860|16733847|P2|Overall Study|Adverse Event|1
4854260|NCT00938860|16733848|P1|Overall Study|Adverse Event|2
4854261|NCT00938717|16733881|P2|Overall Study|Other reason|2
4854262|NCT00938717|16733882|P1|Overall Study|Other reason|5
4854263|NCT00938717|16733881|P2|Overall Study|Lack of Efficacy|15
4854264|NCT00938717|16733882|P1|Overall Study|Lack of Efficacy|33
4854265|NCT00938717|16733881|P2|Overall Study|Lost to Follow-up|18
4854266|NCT00938717|16733882|P1|Overall Study|Lost to Follow-up|13
4854267|NCT00938717|16733881|P2|Overall Study|Withdrawal by Subject|24
4854268|NCT00938717|16733882|P1|Overall Study|Withdrawal by Subject|26
4854269|NCT00938717|16733881|P2|Overall Study|Protocol Violation|8
4854270|NCT00938717|16733882|P1|Overall Study|Protocol Violation|11
4854271|NCT00938717|16733881|P2|Overall Study|Adverse Event|41
4854272|NCT00938717|16733882|P1|Overall Study|Adverse Event|10
4854273|NCT00938639|16733933|P2|Overall Study|Participant noncompliance|0
4854274|NCT00938639|16733934|P1|Overall Study|Participant noncompliance|1
4854275|NCT00938639|16733933|P2|Overall Study|Family issues|1
4854276|NCT00938639|16733934|P1|Overall Study|Family issues|1
4854277|NCT00938639|16733933|P2|Overall Study|Lost to Follow-up|2
4854278|NCT00938639|16733934|P1|Overall Study|Lost to Follow-up|1
4854279|NCT00938639|16733933|P2|Overall Study|Moved away from study area|1
4854280|NCT00938639|16733934|P1|Overall Study|Moved away from study area|0
4854281|NCT00938470|16734017|P2|Overall Study|Other Reason|1
4854282|NCT00938470|16734018|P1|Overall Study|Other Reason|0
4854283|NCT00938470|16734017|P2|Overall Study|Death|2
4854284|NCT00938470|16734018|P1|Overall Study|Death|3
4854285|NCT00938470|16734017|P2|Overall Study|Alternate Treatment|0
4854286|NCT00938470|16734018|P1|Overall Study|Alternate Treatment|1
4854287|NCT00938470|16734017|P2|Overall Study|Disease Progression|0
4854288|NCT00938470|16734018|P1|Overall Study|Disease Progression|3
4854289|NCT00938431|16734048|P3|Overall Study|Reached maximum dose early|1
4854290|NCT00938431|16734049|P2|Overall Study|Reached maximum dose early|0
4854291|NCT00938431|16734050|P1|Overall Study|Reached maximum dose early|0
4854292|NCT00938431|16734048|P3|Overall Study|Dosing compliance issue|1
4854293|NCT00938431|16734049|P2|Overall Study|Dosing compliance issue|0
4854294|NCT00938431|16734050|P1|Overall Study|Dosing compliance issue|0
4854295|NCT00938431|16734048|P3|Overall Study|Did not up titrate to 12 mg kg/day|0
4854296|NCT00938431|16734049|P2|Overall Study|Did not up titrate to 12 mg kg/day|0
4854297|NCT00938431|16734050|P1|Overall Study|Did not up titrate to 12 mg kg/day|1
4854298|NCT00938431|16734048|P3|Overall Study|Lack of Efficacy|0
4854299|NCT00938431|16734049|P2|Overall Study|Lack of Efficacy|1
4854300|NCT00938431|16734050|P1|Overall Study|Lack of Efficacy|0
4854301|NCT00938431|16734048|P3|Overall Study|Adverse Event|6
4854302|NCT00938431|16734049|P2|Overall Study|Adverse Event|8
4854303|NCT00938431|16734050|P1|Overall Study|Adverse Event|5
4854304|NCT00938392|16734077|P2|Overall Study|Lost to Follow-up|2
4854305|NCT00938392|16734078|P1|Overall Study|Lost to Follow-up|2
4854306|NCT00938392|16734077|P2|Overall Study|Withdrawal by Subject|1
4854307|NCT00938392|16734078|P1|Overall Study|Withdrawal by Subject|0
4854308|NCT00938392|16734077|P2|Overall Study|Adverse Event|1
4854309|NCT00938392|16734078|P1|Overall Study|Adverse Event|0
4854310|NCT00938366|16734104|P2|Overall Study|Withdrawal by Subject|0
4854311|NCT00938366|16734105|P1|Overall Study|Withdrawal by Subject|1
4854312|NCT00938340|16734125|P1|Overall Study|Adverse Event|1
4854313|NCT00938340|16734125|P1|Overall Study|Protocol Violation|1
4854314|NCT00938340|16734125|P1|Overall Study|Withdrawal by Subject|3
4854315|NCT00938327|16734255|P1|Overall Study|Vaccine not received as out of stock|9
4854316|NCT00938327|16734255|P1|Overall Study|2nd dose received outside of the study|7
4854317|NCT00938327|16734255|P1|Overall Study|Lost to Follow-up|37
4854318|NCT00938327|16734255|P1|Overall Study|Withdrawal by Subject|4
4854319|NCT00938327|16734255|P1|Overall Study|Protocol Violation|1
4854320|NCT00938327|16734255|P1|Overall Study|Adverse Event|2
4854321|NCT00938041|16734323|P1|Overall Study|Adrenal Insufficiency|3
4854322|NCT00938041|16734323|P1|Overall Study|Death|12
4854323|NCT00938041|16734323|P1|Overall Study|Progressive Disease|5
4854324|NCT00938041|16734323|P1|Overall Study|Received Alternative Therapy|1
4854325|NCT00938041|16734323|P1|Overall Study|Lost to Follow-up|6
4854326|NCT00938015|16734332|P1|Overall Study|Reason not related to Etanercept|29
4854327|NCT00938015|16734332|P1|Overall Study|Non-responder|52
4854328|NCT00938015|16734332|P1|Overall Study|Adverse Event|32
4854329|NCT00938015|16734332|P1|Overall Study|Lost to Follow-up|32
4854330|NCT00938015|16734332|P1|Overall Study|Death|2
4854331|NCT00937950|16734348|P1|Overall Study|Other|18
4854332|NCT00937950|16734348|P1|Overall Study|Missing confirmed|4
4854333|NCT00937950|16734348|P1|Overall Study|Lost to Follow-up|144
4854334|NCT00937950|16734348|P1|Overall Study|Migrated/moved from study area|27
4854335|NCT00937950|16734348|P1|Overall Study|Withdrawal by Subject|23
4854336|NCT00937937|16734364|P1|Overall Study|Other|2
4854337|NCT00937937|16734364|P1|Overall Study|Death|1
4854338|NCT00937937|16734364|P1|Overall Study|Progression/relapse|61
4854339|NCT00937937|16734364|P1|Overall Study|Withdrawal by Subject|2
4854340|NCT00937937|16734364|P1|Overall Study|Adverse Event|6
4854341|NCT00937833|16734384|P2|Overall Study|Withdrawal by Subject|6
4854342|NCT00937833|16734385|P1|Overall Study|Withdrawal by Subject|4
4854343|NCT00937833|16734384|P2|Overall Study|Lost to Follow-up|8
4854344|NCT00937833|16734385|P1|Overall Study|Lost to Follow-up|10
4854345|NCT00937833|16734384|P2|Overall Study|Procedure delayed; enrollment closed|1
4854346|NCT00937833|16734385|P1|Overall Study|Procedure delayed; enrollment closed|0
4854347|NCT00937833|16734384|P2|Overall Study|Protocol Violation|2
4854348|NCT00937833|16734385|P1|Overall Study|Protocol Violation|1
4854349|NCT00937768|16734398|P2|Overall Study|No Further Funding|4
4854350|NCT00937768|16734399|P1|Overall Study|No Further Funding|4
4854351|NCT00937768|16734398|P2|Overall Study|Alternate Treatment|1
4854352|NCT00937768|16734399|P1|Overall Study|Alternate Treatment|0
4854353|NCT00937768|16734398|P2|Overall Study|Disease Progression|1
4854354|NCT00937768|16734399|P1|Overall Study|Disease Progression|1
4854355|NCT00937768|16734398|P2|Overall Study|Refused Further Treatment|2
4854356|NCT00937768|16734399|P1|Overall Study|Refused Further Treatment|3
4854357|NCT00937560|16734419|P1|Maintenance Treatment|According to protocol|1
4854358|NCT00937560|16734419|P1|Maintenance Treatment|Withdraw consent|5
4854359|NCT00937560|16734419|P1|Maintenance Treatment|Death|12
4854360|NCT00937560|16734419|P1|Initial Treatment|No end of study page|10
4854361|NCT00937560|16734419|P1|Initial Treatment|Lost to Follow-up|1
4854362|NCT00937560|16734419|P1|Initial Treatment|Adverse Event|1
4854363|NCT00937560|16734419|P1|Initial Treatment|Withdraw consent|3
4854364|NCT00937560|16734419|P1|Initial Treatment|Death|6
4854365|NCT00937547|16734430|P3|Overall Study|misdiagnosis|7
4854366|NCT00937547|16734431|P2|Overall Study|misdiagnosis|6
4854367|NCT00937547|16734432|P1|Overall Study|misdiagnosis|1
4854368|NCT00937521|16734469|P8|Booster Phase|Protocol Deviation|0
4854369|NCT00937521|16734470|P7|Booster Phase|Protocol Deviation|1
4854370|NCT00937521|16734471|P6|Booster Phase|Protocol Deviation|0
4854371|NCT00937521|16734472|P5|Booster Phase|Protocol Deviation|0
4854372|NCT00937521|16734473|P4|Booster Phase|Protocol Deviation|0
4854373|NCT00937521|16734474|P3|Booster Phase|Protocol Deviation|0
4854374|NCT00937521|16734475|P2|Booster Phase|Protocol Deviation|0
4854375|NCT00937521|16734476|P1|Booster Phase|Protocol Deviation|0
4854376|NCT00937521|16734469|P8|Booster Phase|Administrative Reason|0
4854377|NCT00937521|16734470|P7|Booster Phase|Administrative Reason|0
4854378|NCT00937521|16734471|P6|Booster Phase|Administrative Reason|1
4854379|NCT00937521|16734472|P5|Booster Phase|Administrative Reason|1
4854380|NCT00937521|16734473|P4|Booster Phase|Administrative Reason|0
4854381|NCT00937521|16734474|P3|Booster Phase|Administrative Reason|1
4854382|NCT00937521|16734475|P2|Booster Phase|Administrative Reason|0
4854383|NCT00937521|16734476|P1|Booster Phase|Administrative Reason|0
4854384|NCT00937521|16734469|P8|Booster Phase|Lost to Follow-up|0
4854385|NCT00937521|16734470|P7|Booster Phase|Lost to Follow-up|3
4854386|NCT00937521|16734471|P6|Booster Phase|Lost to Follow-up|4
4854387|NCT00937521|16734472|P5|Booster Phase|Lost to Follow-up|4
4854388|NCT00937521|16734473|P4|Booster Phase|Lost to Follow-up|2
4854389|NCT00937521|16734474|P3|Booster Phase|Lost to Follow-up|4
4854390|NCT00937521|16734475|P2|Booster Phase|Lost to Follow-up|2
4854391|NCT00937521|16734476|P1|Booster Phase|Lost to Follow-up|2
4854392|NCT00937521|16734469|P8|Booster Phase|Withdrawal by Subject|2
4854393|NCT00937521|16734470|P7|Booster Phase|Withdrawal by Subject|0
4854394|NCT00937521|16734471|P6|Booster Phase|Withdrawal by Subject|0
4854395|NCT00937521|16734472|P5|Booster Phase|Withdrawal by Subject|0
4854396|NCT00937521|16734473|P4|Booster Phase|Withdrawal by Subject|1
4854397|NCT00937521|16734474|P3|Booster Phase|Withdrawal by Subject|0
4854398|NCT00937521|16734475|P2|Booster Phase|Withdrawal by Subject|0
4854399|NCT00937521|16734476|P1|Booster Phase|Withdrawal by Subject|1
4854400|NCT00937521|16734469|P8|Booster Phase|Adverse Event|0
4854401|NCT00937521|16734470|P7|Booster Phase|Adverse Event|1
4854402|NCT00937521|16734471|P6|Booster Phase|Adverse Event|0
4854403|NCT00937521|16734472|P5|Booster Phase|Adverse Event|0
4854404|NCT00937521|16734473|P4|Booster Phase|Adverse Event|0
4854405|NCT00937521|16734474|P3|Booster Phase|Adverse Event|0
4854406|NCT00937521|16734475|P2|Booster Phase|Adverse Event|0
4854407|NCT00937521|16734476|P1|Booster Phase|Adverse Event|0
4854408|NCT00937521|16734469|P8|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4854409|NCT00937521|16734470|P7|Overall Study - Prior to Booster Dose|Protocol Deviation|1
4854410|NCT00937521|16734471|P6|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4854411|NCT00937521|16734472|P5|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4854412|NCT00937521|16734473|P4|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4854413|NCT00937521|16734474|P3|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4854414|NCT00937521|16734475|P2|Overall Study - Prior to Booster Dose|Protocol Deviation|0
4854415|NCT00937521|16734476|P1|Overall Study - Prior to Booster Dose|Protocol Deviation|1
4854416|NCT00937521|16734469|P8|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4854417|NCT00937521|16734470|P7|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
4854418|NCT00937521|16734471|P6|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1
4854419|NCT00937521|16734472|P5|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2
4854420|NCT00937521|16734473|P4|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4854421|NCT00937521|16734474|P3|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4854422|NCT00937521|16734475|P2|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4
4854423|NCT00937521|16734476|P1|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0
4854424|NCT00937521|16734469|P8|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4854425|NCT00937521|16734470|P7|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4854426|NCT00937521|16734471|P6|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4854427|NCT00937521|16734472|P5|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4854428|NCT00937521|16734473|P4|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
4854429|NCT00937521|16734474|P3|Overall Study - Prior to Booster Dose|Lost to Follow-up|1
4854430|NCT00937521|16734475|P2|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4854431|NCT00937521|16734476|P1|Overall Study - Prior to Booster Dose|Lost to Follow-up|0
4854432|NCT00937521|16734469|P8|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
4854433|NCT00937521|16734470|P7|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
4854434|NCT00937521|16734471|P6|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
4854435|NCT00937521|16734472|P5|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
4854436|NCT00937521|16734473|P4|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0
4854437|NCT00937521|16734474|P3|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3
4854438|NCT00937521|16734475|P2|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1
4854439|NCT00937521|16734476|P1|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2
4854440|NCT00937521|16734469|P8|Overall Study - Prior to Booster Dose|Adverse Event|0
4854441|NCT00937521|16734470|P7|Overall Study - Prior to Booster Dose|Adverse Event|1
4854442|NCT00937521|16734471|P6|Overall Study - Prior to Booster Dose|Adverse Event|0
4854443|NCT00937521|16734472|P5|Overall Study - Prior to Booster Dose|Adverse Event|0
4854444|NCT00937521|16734473|P4|Overall Study - Prior to Booster Dose|Adverse Event|0
4854445|NCT00937521|16734474|P3|Overall Study - Prior to Booster Dose|Adverse Event|2
4854446|NCT00937521|16734475|P2|Overall Study - Prior to Booster Dose|Adverse Event|0
4854447|NCT00937521|16734476|P1|Overall Study - Prior to Booster Dose|Adverse Event|0
4854448|NCT00937495|16734582|P1|Overall Study|Protocol Violation|2
4854449|NCT00937404|16734588|P1|Overall Study|Withdrawal by Subject|1
4854450|NCT00937404|16734588|P1|Overall Study|Protocol Violation|1
4854451|NCT00937391|16734597|P1|Stage 2|Withdrawal by Subject|1
4854452|NCT00937326|16734664|P5|Overall Study|Chest X-ray showed a suspicious shadow|0
4854453|NCT00937326|16734665|P4|Overall Study|Chest X-ray showed a suspicious shadow|0
4854454|NCT00937326|16734666|P3|Overall Study|Chest X-ray showed a suspicious shadow|1
4854455|NCT00937326|16734667|P2|Overall Study|Chest X-ray showed a suspicious shadow|0
4854456|NCT00937326|16734668|P1|Overall Study|Chest X-ray showed a suspicious shadow|0
4854457|NCT00937326|16734664|P5|Overall Study|Withdrawal by Subject|3
4854458|NCT00937326|16734665|P4|Overall Study|Withdrawal by Subject|4
4854459|NCT00937326|16734666|P3|Overall Study|Withdrawal by Subject|1
4854460|NCT00937326|16734667|P2|Overall Study|Withdrawal by Subject|4
4854461|NCT00937326|16734668|P1|Overall Study|Withdrawal by Subject|3
4854462|NCT00937326|16734664|P5|Overall Study|Death|0
4854463|NCT00937326|16734665|P4|Overall Study|Death|0
4854464|NCT00937326|16734666|P3|Overall Study|Death|1
4854465|NCT00937326|16734667|P2|Overall Study|Death|0
4854466|NCT00937326|16734668|P1|Overall Study|Death|0
4854467|NCT00937326|16734664|P5|Overall Study|Adverse Event|2
4854468|NCT00937326|16734665|P4|Overall Study|Adverse Event|1
4854469|NCT00937326|16734666|P3|Overall Study|Adverse Event|1
4854470|NCT00937326|16734667|P2|Overall Study|Adverse Event|3
4854471|NCT00937326|16734668|P1|Overall Study|Adverse Event|0
4854472|NCT00937157|16734917|P1|Overall Study|Lost to Follow-up|3
4854473|NCT00937157|16734917|P1|Overall Study|Pregnancy|1
4854474|NCT00937040|16734948|P2|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8
4854475|NCT00937040|16734949|P1|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5
4854476|NCT00937040|16734948|P2|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2
4854477|NCT00937040|16734949|P1|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3
4854478|NCT00937040|16734948|P2|Overall Study|Withdrawal by Subject|7
4854479|NCT00937040|16734949|P1|Overall Study|Withdrawal by Subject|13
4854480|NCT00937040|16734948|P2|Overall Study|Protocol Violation|0
4854481|NCT00937040|16734949|P1|Overall Study|Protocol Violation|3
4854482|NCT00937040|16734948|P2|Overall Study|Lost to Follow-up|12
4854483|NCT00937040|16734949|P1|Overall Study|Lost to Follow-up|12
4854484|NCT00937040|16734948|P2|Overall Study|Adverse Event|8
4854485|NCT00937040|16734949|P1|Overall Study|Adverse Event|5
4854486|NCT00936975|16734991|P1|Overall Study|Post-Tx scan uninterpretable|2
4854487|NCT00936975|16734991|P1|Overall Study|Disease progression|3
4854488|NCT00936975|16734991|P1|Overall Study|Withdrawal by Subject|1
4854489|NCT00936910|16735000|P1|Overall Study|Lack of Efficacy|3
4854490|NCT00936897|16735009|P2|Overall Study|Death|1
4854491|NCT00936897|16735010|P1|Overall Study|Death|0
4854492|NCT00936897|16735009|P2|Overall Study|Noncompliance|2
4854493|NCT00936897|16735010|P1|Overall Study|Noncompliance|0
4854494|NCT00936897|16735009|P2|Overall Study|Ineligibility Determined|3
4854495|NCT00936897|16735010|P1|Overall Study|Ineligibility Determined|0
4854496|NCT00936897|16735009|P2|Overall Study|Protocol Violation|1
4854497|NCT00936897|16735010|P1|Overall Study|Protocol Violation|1
4854498|NCT00936897|16735009|P2|Overall Study|Administrative Decision|2
4854499|NCT00936897|16735010|P1|Overall Study|Administrative Decision|1
4854500|NCT00936897|16735009|P2|Overall Study|Lost to Follow-up|10
4854501|NCT00936897|16735010|P1|Overall Study|Lost to Follow-up|1
4854502|NCT00936897|16735009|P2|Overall Study|Other|9
4854503|NCT00936897|16735010|P1|Overall Study|Other|3
4854504|NCT00936897|16735009|P2|Overall Study|Adverse Event|13
4854505|NCT00936897|16735010|P1|Overall Study|Adverse Event|4
4854506|NCT00936897|16735009|P2|Overall Study|Withdrawal by Subject|19
4854507|NCT00936897|16735010|P1|Overall Study|Withdrawal by Subject|9
4854508|NCT00936884|16735024|P3|Double-blind|Did not receive study drug|0
4854509|NCT00936884|16735025|P2|Double-blind|Did not receive study drug|1
4854510|NCT00936884|16735026|P1|Double-blind|Did not receive study drug|0
4854511|NCT00936884|16735024|P3|Double-blind|No post baseline diary entry|0
4854512|NCT00936884|16735025|P2|Double-blind|No post baseline diary entry|0
4854513|NCT00936884|16735026|P1|Double-blind|No post baseline diary entry|1
4854514|NCT00936884|16735024|P3|Double-blind|Physician Decision|0
4854515|NCT00936884|16735025|P2|Double-blind|Physician Decision|0
4854516|NCT00936884|16735026|P1|Double-blind|Physician Decision|1
4854517|NCT00936884|16735024|P3|Double-blind|Adverse Event|0
4854518|NCT00936884|16735025|P2|Double-blind|Adverse Event|0
4854519|NCT00936884|16735026|P1|Double-blind|Adverse Event|1
4854520|NCT00936884|16735024|P3|Double-blind|Lack of Efficacy|0
4854521|NCT00936884|16735025|P2|Double-blind|Lack of Efficacy|1
4854522|NCT00936884|16735026|P1|Double-blind|Lack of Efficacy|1
4854523|NCT00936884|16735024|P3|Double-blind|Death|0
4854524|NCT00936884|16735025|P2|Double-blind|Death|1
4854525|NCT00936884|16735026|P1|Double-blind|Death|2
4854526|NCT00936884|16735024|P3|Double-blind|Withdrawal by Subject|0
4854527|NCT00936884|16735025|P2|Double-blind|Withdrawal by Subject|4
4854528|NCT00936884|16735026|P1|Double-blind|Withdrawal by Subject|6
4854529|NCT00936715|16735042|P1|Overall Study|Safety or Tolerability Reasons|4
4854530|NCT00936715|16735042|P1|Overall Study|Protocol Violation|1
4854531|NCT00936715|16735042|P1|Overall Study|Investigators Discretion|1
4854532|NCT00936702|16735046|P1|Overall Study|Other|1
4854533|NCT00936702|16735046|P1|Overall Study|Alternative Treatment|1
4854534|NCT00936702|16735046|P1|Overall Study|Withdrawal by Subject|2
4854535|NCT00936702|16735046|P1|Overall Study|Adverse Event|8
4854536|NCT00936702|16735046|P1|Overall Study|Disease progression|34
4854537|NCT00936598|16735079|P2|Overall Study|Ineligible after consent|0
4854538|NCT00936598|16735080|P1|Overall Study|Ineligible after consent|1
4854539|NCT00936598|16735079|P2|Overall Study|Withdrawal by Subject|0
4854540|NCT00936598|16735080|P1|Overall Study|Withdrawal by Subject|1
4854541|NCT00936221|16735182|P2|Overall Study|Withdrawal by Subject|1
4854542|NCT00936221|16735183|P1|Overall Study|Withdrawal by Subject|1
4854543|NCT00936208|16735197|P2|Overall Study|Protocol Violation|22
4854544|NCT00936208|16735198|P1|Overall Study|Protocol Violation|37
4854545|NCT00936117|16735216|P1|Overall Study|Unable to continue oral medication|3
4854546|NCT00936117|16735216|P1|Overall Study|Adverse Event|7
4854547|NCT00936065|16735224|P3|Overall Study|Withdrawal by Subject|4
4854548|NCT00936065|16735225|P2|Overall Study|Withdrawal by Subject|2
4854549|NCT00936065|16735226|P1|Overall Study|Withdrawal by Subject|0
4854550|NCT00936065|16735224|P3|Overall Study|Protocol Violation|1
4854551|NCT00936065|16735225|P2|Overall Study|Protocol Violation|2
4854552|NCT00936065|16735226|P1|Overall Study|Protocol Violation|1
4854553|NCT00936065|16735224|P3|Overall Study|Lost to Follow-up|0
4854554|NCT00936065|16735225|P2|Overall Study|Lost to Follow-up|0
4854555|NCT00936065|16735226|P1|Overall Study|Lost to Follow-up|1
4854556|NCT00936065|16735224|P3|Overall Study|Lack of Efficacy|1
4854557|NCT00936065|16735225|P2|Overall Study|Lack of Efficacy|0
4854558|NCT00936065|16735226|P1|Overall Study|Lack of Efficacy|1
4854559|NCT00936065|16735224|P3|Overall Study|Adverse Event|1
4854560|NCT00936065|16735225|P2|Overall Study|Adverse Event|0
4854561|NCT00936065|16735226|P1|Overall Study|Adverse Event|1
4854562|NCT00935883|16735332|P2|Treatment Period|Withdrawal by Subject|2
4854563|NCT00935883|16735333|P1|Treatment Period|Withdrawal by Subject|0
4854564|NCT00935883|16735332|P2|Treatment Period|Physician Decision|0
4854565|NCT00935883|16735333|P1|Treatment Period|Physician Decision|1
4854566|NCT00935818|16735360|P2|Overall Study|Physician Decision|1
4854567|NCT00935818|16735361|P1|Overall Study|Physician Decision|0
4854568|NCT00935818|16735360|P2|Overall Study|Adverse Event|7
4854569|NCT00935818|16735361|P1|Overall Study|Adverse Event|6
4854570|NCT00935818|16735360|P2|Overall Study|Lost to Follow-up|42
4854571|NCT00935818|16735361|P1|Overall Study|Lost to Follow-up|40
4854572|NCT00935818|16735360|P2|Overall Study|Withdrawal by Subject|50
4854573|NCT00935818|16735361|P1|Overall Study|Withdrawal by Subject|45
4854574|NCT00935701|16735412|P1|Overall Study|Failure to Transition to Acupuncture|1
4854575|NCT00935584|16735429|P2|Overall Study|Provider dropped out of study|4
4854576|NCT00935584|16735430|P1|Overall Study|Provider dropped out of study|14
4854577|NCT00935584|16735429|P2|Overall Study|Patient changed provider|0
4854578|NCT00935584|16735430|P1|Overall Study|Patient changed provider|3
4854579|NCT00935584|16735429|P2|Overall Study|Relocated|0
4854580|NCT00935584|16735430|P1|Overall Study|Relocated|3
4854581|NCT00935584|16735429|P2|Overall Study|No show|0
4854582|NCT00935584|16735430|P1|Overall Study|No show|9
4854583|NCT00935584|16735429|P2|Overall Study|Lost to Follow-up|0
4854584|NCT00935584|16735430|P1|Overall Study|Lost to Follow-up|8
4854585|NCT00935584|16735429|P2|Overall Study|Death|0
4854586|NCT00935584|16735430|P1|Overall Study|Death|3
4854587|NCT00935584|16735429|P2|Overall Study|Withdrawal by Subject|0
4854588|NCT00935584|16735430|P1|Overall Study|Withdrawal by Subject|9
4854589|NCT00935532|16735442|P2|Overall Study|Loss Glucose Control|0
4854590|NCT00935532|16735443|P1|Overall Study|Loss Glucose Control|4
4854591|NCT00935532|16735442|P2|Overall Study|Sponsor Decision|1
4854592|NCT00935532|16735443|P1|Overall Study|Sponsor Decision|0
4854593|NCT00935532|16735442|P2|Overall Study|Subject Decision|1
4854594|NCT00935532|16735443|P1|Overall Study|Subject Decision|2
4854595|NCT00935532|16735442|P2|Overall Study|Protocol Violation|1
4854596|NCT00935532|16735443|P1|Overall Study|Protocol Violation|2
4854597|NCT00935532|16735442|P2|Overall Study|Physician Decision|2
4854598|NCT00935532|16735443|P1|Overall Study|Physician Decision|1
4854599|NCT00935532|16735442|P2|Overall Study|Lost to Follow-up|0
4854600|NCT00935532|16735443|P1|Overall Study|Lost to Follow-up|1
4854601|NCT00935532|16735442|P2|Overall Study|Death|0
4854602|NCT00935532|16735443|P1|Overall Study|Death|1
4854603|NCT00935532|16735442|P2|Overall Study|Adverse Event|6
4854604|NCT00935532|16735443|P1|Overall Study|Adverse Event|11
4854605|NCT00935493|16735472|P3|Overall Study|Treatment Discontinued|0
4854606|NCT00935493|16735473|P2|Overall Study|Treatment Discontinued|1
4854607|NCT00935493|16735474|P1|Overall Study|Treatment Discontinued|0
4854608|NCT00935493|16735472|P3|Overall Study|Lost to Follow-up|1
4854609|NCT00935493|16735473|P2|Overall Study|Lost to Follow-up|1
4854610|NCT00935493|16735474|P1|Overall Study|Lost to Follow-up|1
4854611|NCT00935272|16735523|P2|Overall Study|Protocol Violation|1
4854612|NCT00935272|16735524|P1|Overall Study|Protocol Violation|0
4854613|NCT00935272|16735523|P2|Overall Study|Physician Decision|0
4854614|NCT00935272|16735524|P1|Overall Study|Physician Decision|1
4854615|NCT00935272|16735523|P2|Overall Study|Withdrawal by Subject|2
4854616|NCT00935272|16735524|P1|Overall Study|Withdrawal by Subject|8
4854617|NCT00935272|16735523|P2|Overall Study|Lost to Follow-up|3
4854618|NCT00935272|16735524|P1|Overall Study|Lost to Follow-up|10
4854619|NCT00935259|16735533|P2|Period 1|Administrative (scheduling conflict)|1
4854620|NCT00935259|16735534|P1|Period 1|Administrative (scheduling conflict)|1
4854621|NCT00935220|16735548|P1|Overall Study|Other reason (not specified)|1
4854622|NCT00935220|16735548|P1|Overall Study|Adverse Event|1
4854623|NCT00934947|16735579|P2|Overall Study|Adverse Event|2
4854624|NCT00934947|16735580|P1|Overall Study|Adverse Event|0
4854625|NCT00934856|16735609|P6|Extension Part|Non-compliance with drug|1
4854626|NCT00934856|16735610|P5|Extension Part|Non-compliance with drug|0
4854627|NCT00934856|16735611|P4|Extension Part|Non-compliance with drug|0
4854628|NCT00934856|16735612|P3|Extension Part|Non-compliance with drug|0
4854629|NCT00934856|16735613|P2|Extension Part|Non-compliance with drug|0
4854630|NCT00934856|16735614|P1|Extension Part|Non-compliance with drug|0
4854631|NCT00934856|16735609|P6|Extension Part|Progressive disease|0
4854632|NCT00934856|16735610|P5|Extension Part|Progressive disease|0
4854633|NCT00934856|16735611|P4|Extension Part|Progressive disease|1
4854634|NCT00934856|16735612|P3|Extension Part|Progressive disease|0
4854635|NCT00934856|16735613|P2|Extension Part|Progressive disease|0
4854636|NCT00934856|16735614|P1|Extension Part|Progressive disease|0
4854637|NCT00934856|16735609|P6|Extension Part|Adverse Event|4
4854638|NCT00934856|16735610|P5|Extension Part|Adverse Event|4
4854639|NCT00934856|16735611|P4|Extension Part|Adverse Event|1
4854640|NCT00934856|16735612|P3|Extension Part|Adverse Event|0
4854641|NCT00934856|16735613|P2|Extension Part|Adverse Event|0
4854642|NCT00934856|16735614|P1|Extension Part|Adverse Event|0
4854643|NCT00934856|16735609|P6|Feasibility Part|Withdrawal by Subject|1
4854644|NCT00934856|16735610|P5|Feasibility Part|Withdrawal by Subject|0
4854645|NCT00934856|16735611|P4|Feasibility Part|Withdrawal by Subject|1
4854646|NCT00934856|16735612|P3|Feasibility Part|Withdrawal by Subject|0
4854647|NCT00934856|16735613|P2|Feasibility Part|Withdrawal by Subject|0
4854648|NCT00934856|16735614|P1|Feasibility Part|Withdrawal by Subject|0
4854649|NCT00934856|16735609|P6|Feasibility Part|Adverse Event|2
4854650|NCT00934856|16735610|P5|Feasibility Part|Adverse Event|0
4854651|NCT00934856|16735611|P4|Feasibility Part|Adverse Event|1
4854652|NCT00934856|16735612|P3|Feasibility Part|Adverse Event|0
4854653|NCT00934856|16735613|P2|Feasibility Part|Adverse Event|1
4854654|NCT00934856|16735614|P1|Feasibility Part|Adverse Event|1
4854655|NCT00934856|16735609|P6|Feasibility Part|Physician Decision|0
4854656|NCT00934856|16735610|P5|Feasibility Part|Physician Decision|0
4854657|NCT00934856|16735611|P4|Feasibility Part|Physician Decision|0
4854658|NCT00934856|16735612|P3|Feasibility Part|Physician Decision|1
4854659|NCT00934856|16735613|P2|Feasibility Part|Physician Decision|0
4854660|NCT00934856|16735614|P1|Feasibility Part|Physician Decision|0
4854661|NCT00934856|16735609|P6|Feasibility Part|Progressive disease|0
4854662|NCT00934856|16735610|P5|Feasibility Part|Progressive disease|0
4854663|NCT00934856|16735611|P4|Feasibility Part|Progressive disease|3
4854664|NCT00934856|16735612|P3|Feasibility Part|Progressive disease|2
4854665|NCT00934856|16735613|P2|Feasibility Part|Progressive disease|4
4854666|NCT00934856|16735614|P1|Feasibility Part|Progressive disease|4
4854667|NCT00934843|16735712|P2|Overall Study|Protocol Violation|1
4854668|NCT00934843|16735713|P1|Overall Study|Protocol Violation|0
4854669|NCT00934791|16735729|P2|Overall Study|Withdrawal by Subject|0
4854670|NCT00934791|16735730|P1|Overall Study|Withdrawal by Subject|1
4854671|NCT00934661|16735738|P2|Overall Study|Failure of Combined/Spinal Epidural|0
4854672|NCT00934661|16735739|P1|Overall Study|Failure of Combined/Spinal Epidural|1
4854673|NCT00934648|16735759|P1|Overall Study|Withdrawal by Subject|1
4854674|NCT00934648|16735759|P1|Overall Study|Failure to return|8
4854675|NCT00934622|16735803|P1|Overall Study|2nd Intraoperative exclusion criteria|1
4854676|NCT00934622|16735803|P1|Overall Study|Lost to Follow-up|7
4854677|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5
4854678|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0
4854679|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8
4854680|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
4854681|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1
4854682|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0
4854683|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1
4854684|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0
4854685|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4
4854686|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Disease progression|7
4854687|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Disease progression|4
4854688|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Disease progression|32
4854689|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Protocol Violation|5
4854690|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Protocol Violation|0
4854691|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Protocol Violation|2
4854692|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0
4854693|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9
4854694|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10
4854695|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Adverse Event|10
4854696|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Adverse Event|5
4854697|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Adverse Event|35
4854698|NCT00934544|16735841|P3|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6
4854699|NCT00934544|16735842|P2|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9
4854700|NCT00934544|16735843|P1|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16
4854701|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Entered extension phase|0
4854702|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Entered extension phase|18
4854703|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Entered extension phase|29
4854704|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Other reasons|0
4854705|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Other reasons|7
4854706|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Other reasons|7
4854707|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
4854708|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1
4854709|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0
4854710|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
4854711|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0
4854712|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2
4854713|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Disease Progression|0
4854714|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Disease Progression|3
4854715|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Disease Progression|1
4854716|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Protocol Violation|0
4854717|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Protocol Violation|0
4854718|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Protocol Violation|2
4854719|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0
4854720|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9
4854721|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2
4854722|NCT00934544|16735841|P3|Primary Endpoint Analysis (Interim)|Adverse Event|0
4854723|NCT00934544|16735842|P2|Primary Endpoint Analysis (Interim)|Adverse Event|4
4854724|NCT00934544|16735843|P1|Primary Endpoint Analysis (Interim)|Adverse Event|12
4854725|NCT00934440|16735879|P1|Overall Study|Lost to Follow-up|1
4854726|NCT00934362|16735895|P2|Overall Study|Adverse Event|0
4854727|NCT00934362|16735896|P1|Overall Study|Adverse Event|1
4854728|NCT00934128|16735946|P2|Second Intervention (2 Hours)|Claustrophobia/anxiety|3
4854729|NCT00934128|16735947|P1|Second Intervention (2 Hours)|Claustrophobia/anxiety|0
4854730|NCT00934128|16735946|P2|Washout Period (1 Hour)|Dyspnea too low to continue|2
4854731|NCT00934128|16735947|P1|Washout Period (1 Hour)|Dyspnea too low to continue|4
4854732|NCT00934128|16735946|P2|Washout Period (1 Hour)|Too tired|0
4854733|NCT00934128|16735947|P1|Washout Period (1 Hour)|Too tired|1
4854734|NCT00934128|16735946|P2|Washout Period (1 Hour)|Pain|0
4854735|NCT00934128|16735947|P1|Washout Period (1 Hour)|Pain|1
4854736|NCT00934128|16735946|P2|Washout Period (1 Hour)|Patient preference|3
4854737|NCT00934128|16735947|P1|Washout Period (1 Hour)|Patient preference|1
4854738|NCT00934128|16735946|P2|First Intervention (2 Hours)|Treatment Delivery Order Switched|0
4854739|NCT00934128|16735947|P1|First Intervention (2 Hours)|Treatment Delivery Order Switched|1
4854740|NCT00934128|16735946|P2|First Intervention (2 Hours)|Adverse Event|1
4854741|NCT00934128|16735947|P1|First Intervention (2 Hours)|Adverse Event|4
4854742|NCT00934128|16735946|P2|First Intervention (2 Hours)|Withdrawal by Subject|1
4854743|NCT00934128|16735947|P1|First Intervention (2 Hours)|Withdrawal by Subject|0
4854744|NCT00934102|16735955|P3|Period 1, One Night of Wear|Personal Reasons|0
4854745|NCT00934102|16735956|P2|Period 1, One Night of Wear|Personal Reasons|0
4854746|NCT00934102|16735957|P1|Period 1, One Night of Wear|Personal Reasons|1
4854747|NCT00934050|16735971|P6|Enrolled After 15 Dec 2009|Withdrawal by Subject|2
4854748|NCT00934050|16735972|P5|Enrolled After 15 Dec 2009|Withdrawal by Subject|4
4854749|NCT00934050|16735973|P4|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4854750|NCT00934050|16735974|P3|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4854751|NCT00934050|16735975|P2|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4854752|NCT00934050|16735976|P1|Enrolled After 15 Dec 2009|Withdrawal by Subject|0
4854753|NCT00934050|16735971|P6|Enrolled After 15 Dec 2009|Lost to Follow-up|1
4854754|NCT00934050|16735972|P5|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4854755|NCT00934050|16735973|P4|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4854756|NCT00934050|16735974|P3|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4854757|NCT00934050|16735975|P2|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4854758|NCT00934050|16735976|P1|Enrolled After 15 Dec 2009|Lost to Follow-up|0
4854759|NCT00934050|16735971|P6|Enrolled After 15 Dec 2009|Death|1
4854760|NCT00934050|16735972|P5|Enrolled After 15 Dec 2009|Death|0
4854761|NCT00934050|16735973|P4|Enrolled After 15 Dec 2009|Death|0
4854762|NCT00934050|16735974|P3|Enrolled After 15 Dec 2009|Death|0
4854763|NCT00934050|16735975|P2|Enrolled After 15 Dec 2009|Death|0
4854764|NCT00934050|16735976|P1|Enrolled After 15 Dec 2009|Death|0
4854765|NCT00934050|16735971|P6|Enrolled After 15 Dec 2009|Adverse Event|0
4854766|NCT00934050|16735972|P5|Enrolled After 15 Dec 2009|Adverse Event|3
4854767|NCT00934050|16735973|P4|Enrolled After 15 Dec 2009|Adverse Event|0
4854768|NCT00934050|16735974|P3|Enrolled After 15 Dec 2009|Adverse Event|0
4854769|NCT00934050|16735975|P2|Enrolled After 15 Dec 2009|Adverse Event|0
4854770|NCT00934050|16735976|P1|Enrolled After 15 Dec 2009|Adverse Event|0
4854771|NCT00934050|16735971|P6|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4854772|NCT00934050|16735972|P5|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4854773|NCT00934050|16735973|P4|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4854774|NCT00934050|16735974|P3|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1
4854775|NCT00934050|16735975|P2|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4854776|NCT00934050|16735976|P1|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0
4854777|NCT00934050|16735971|P6|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
4854778|NCT00934050|16735972|P5|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0
4854779|NCT00934050|16735973|P4|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13
4854780|NCT00934050|16735974|P3|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
4854781|NCT00934050|16735975|P2|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12
4854782|NCT00934050|16735976|P1|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11
4854783|NCT00934050|16735971|P6|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4854784|NCT00934050|16735972|P5|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4854785|NCT00934050|16735973|P4|Enrolled Prior to 15 Dec 2009|Adverse Event|1
4854786|NCT00934050|16735974|P3|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4854787|NCT00934050|16735975|P2|Enrolled Prior to 15 Dec 2009|Adverse Event|0
4854788|NCT00934050|16735976|P1|Enrolled Prior to 15 Dec 2009|Adverse Event|1
4854789|NCT00933933|16735999|P3|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
4854790|NCT00933933|16736000|P2|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2
4854791|NCT00933933|16736001|P1|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0
4854792|NCT00933933|16735999|P3|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
4854793|NCT00933933|16736000|P2|General Population From 16 to 89 Years|Did not meet criteria for analysis|20
4854794|NCT00933933|16736001|P1|General Population From 16 to 89 Years|Did not meet criteria for analysis|0
4854795|NCT00933686|16736019|P2|Overall Study|Failure to show up at endpoint visits|2
4854796|NCT00933686|16736020|P1|Overall Study|Failure to show up at endpoint visits|0
4854797|NCT00933686|16736019|P2|Overall Study|Physician Decision|0
4854798|NCT00933686|16736020|P1|Overall Study|Physician Decision|1
4854799|NCT00933686|16736019|P2|Overall Study|Adverse Event|1
4854800|NCT00933686|16736020|P1|Overall Study|Adverse Event|1
4854801|NCT00933686|16736019|P2|Overall Study|Withdrawal by Subject|5
4854802|NCT00933686|16736020|P1|Overall Study|Withdrawal by Subject|6
4854803|NCT00933686|16736019|P2|Overall Study|Lost to Follow-up|2
4854804|NCT00933686|16736020|P1|Overall Study|Lost to Follow-up|2
4854805|NCT00933686|16736019|P2|Overall Study|Protocol Violation|1
4854806|NCT00933686|16736020|P1|Overall Study|Protocol Violation|0
4854807|NCT00933608|16736040|P2|Overall Study|Physician Decision|0
4854808|NCT00933608|16736041|P1|Overall Study|Physician Decision|1
4854809|NCT00933608|16736040|P2|Overall Study|Adverse Event|2
4854810|NCT00933608|16736041|P1|Overall Study|Adverse Event|4
4854811|NCT00933543|16736049|P2|Overall Study|Other|1
4854812|NCT00933543|16736050|P1|Overall Study|Other|1
4854813|NCT00933543|16736049|P2|Overall Study|Lack of Efficacy|3
4854814|NCT00933543|16736050|P1|Overall Study|Lack of Efficacy|0
4854815|NCT00933543|16736049|P2|Overall Study|Withdrawal by Subject|1
4854816|NCT00933543|16736050|P1|Overall Study|Withdrawal by Subject|0
4854817|NCT00933543|16736049|P2|Overall Study|Lost to Follow-up|1
4854818|NCT00933543|16736050|P1|Overall Study|Lost to Follow-up|0
4854819|NCT00933543|16736049|P2|Overall Study|Adverse Event|1
4854820|NCT00933543|16736050|P1|Overall Study|Adverse Event|2
4854821|NCT00933335|16736119|P2|Overall Study|Co-morbid Illness|0
4854822|NCT00933335|16736120|P1|Overall Study|Co-morbid Illness|1
4854823|NCT00933335|16736119|P2|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1
4854824|NCT00933335|16736120|P1|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0
4854825|NCT00933335|16736119|P2|Overall Study|Progressive Disease|11
4854826|NCT00933335|16736120|P1|Overall Study|Progressive Disease|0
4854827|NCT00933335|16736119|P2|Overall Study|Withdrawal by Subject|1
4854828|NCT00933335|16736120|P1|Overall Study|Withdrawal by Subject|0
4854829|NCT00933335|16736119|P2|Overall Study|Lost to Follow-up|3
4854830|NCT00933335|16736120|P1|Overall Study|Lost to Follow-up|1
4854831|NCT00933270|16736190|P1|Overall Study|Moved or would not return|10
4854832|NCT00933270|16736190|P1|Overall Study|Death|24
4854833|NCT00933270|16736190|P1|Overall Study|Missed Visit|2
4854834|NCT00933270|16736190|P1|Overall Study|Adverse Event|1
4854835|NCT00933270|16736190|P1|Overall Study|Lost to Follow-up|14
4854836|NCT00933270|16736190|P1|Overall Study|Insufficient Follow-up|10
4854837|NCT00933270|16736190|P1|Overall Study|Withdrawal by Subject|26
4854838|NCT00933244|16736284|P3|Overall Study|Withdrawal by Subject|3
4854839|NCT00933244|16736285|P2|Overall Study|Withdrawal by Subject|1
4854840|NCT00933244|16736286|P1|Overall Study|Withdrawal by Subject|5
4854841|NCT00933166|16736303|P1|Overall Study|Withdrawal by Subject|1
4854842|NCT00933166|16736303|P1|Overall Study|Unavailable|4
4854843|NCT00933166|16736303|P1|Overall Study|Lack of Efficacy|9
4854844|NCT00933166|16736303|P1|Overall Study|Lost to Follow-up|4
4854845|NCT00932893|16736309|P2|Overall Study|Other|144
4854846|NCT00932893|16736310|P1|Overall Study|Other|5
4854847|NCT00932893|16736309|P2|Overall Study|Withdrawal by Subject|2
4854848|NCT00932893|16736310|P1|Overall Study|Withdrawal by Subject|5
4854849|NCT00932893|16736309|P2|Overall Study|Lost to Follow-up|0
4854850|NCT00932893|16736310|P1|Overall Study|Lost to Follow-up|8
4854851|NCT00932893|16736309|P2|Overall Study|Death|24
4854852|NCT00932893|16736310|P1|Overall Study|Death|115
4854853|NCT00932698|16736358|P11|Part 2 (Dose Expansion)|Adverse Event|0
4854854|NCT00932698|16736359|P10|Part 2 (Dose Expansion)|Adverse Event|1
4854855|NCT00932698|16736360|P9|Part 2 (Dose Expansion)|Adverse Event|1
4854856|NCT00932698|16736361|P8|Part 2 (Dose Expansion)|Adverse Event|5
4854857|NCT00932698|16736362|P7|Part 2 (Dose Expansion)|Adverse Event|0
4854858|NCT00932698|16736363|P6|Part 2 (Dose Expansion)|Adverse Event|0
4854859|NCT00932698|16736364|P5|Part 2 (Dose Expansion)|Adverse Event|0
4854860|NCT00932698|16736365|P4|Part 2 (Dose Expansion)|Adverse Event|0
4854861|NCT00932698|16736366|P3|Part 2 (Dose Expansion)|Adverse Event|0
4854862|NCT00932698|16736367|P2|Part 2 (Dose Expansion)|Adverse Event|0
4854863|NCT00932698|16736368|P1|Part 2 (Dose Expansion)|Adverse Event|0
4854864|NCT00932698|16736358|P11|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854865|NCT00932698|16736359|P10|Part 2 (Dose Expansion)|Withdrawal by Subject|2
4854866|NCT00932698|16736360|P9|Part 2 (Dose Expansion)|Withdrawal by Subject|3
4854867|NCT00932698|16736361|P8|Part 2 (Dose Expansion)|Withdrawal by Subject|1
4854868|NCT00932698|16736362|P7|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854869|NCT00932698|16736363|P6|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854870|NCT00932698|16736364|P5|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854871|NCT00932698|16736365|P4|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854872|NCT00932698|16736366|P3|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854873|NCT00932698|16736367|P2|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854874|NCT00932698|16736368|P1|Part 2 (Dose Expansion)|Withdrawal by Subject|0
4854875|NCT00932698|16736358|P11|Part 2 (Dose Expansion)|Progressive Disease|2
4854876|NCT00932698|16736359|P10|Part 2 (Dose Expansion)|Progressive Disease|3
4854877|NCT00932698|16736360|P9|Part 2 (Dose Expansion)|Progressive Disease|8
4854878|NCT00932698|16736361|P8|Part 2 (Dose Expansion)|Progressive Disease|14
4854879|NCT00932698|16736362|P7|Part 2 (Dose Expansion)|Progressive Disease|0
4854880|NCT00932698|16736363|P6|Part 2 (Dose Expansion)|Progressive Disease|0
4854881|NCT00932698|16736364|P5|Part 2 (Dose Expansion)|Progressive Disease|0
4854882|NCT00932698|16736365|P4|Part 2 (Dose Expansion)|Progressive Disease|0
4854883|NCT00932698|16736366|P3|Part 2 (Dose Expansion)|Progressive Disease|0
4854884|NCT00932698|16736367|P2|Part 2 (Dose Expansion)|Progressive Disease|0
4854885|NCT00932698|16736368|P1|Part 2 (Dose Expansion)|Progressive Disease|0
4854886|NCT00932698|16736358|P11|Part 1 (Dose Escalation)|Other|0
4854887|NCT00932698|16736359|P10|Part 1 (Dose Escalation)|Other|0
4854888|NCT00932698|16736360|P9|Part 1 (Dose Escalation)|Other|0
4854889|NCT00932698|16736361|P8|Part 1 (Dose Escalation)|Other|0
4854890|NCT00932698|16736362|P7|Part 1 (Dose Escalation)|Other|1
4854891|NCT00932698|16736363|P6|Part 1 (Dose Escalation)|Other|0
4854892|NCT00932698|16736364|P5|Part 1 (Dose Escalation)|Other|0
4854893|NCT00932698|16736365|P4|Part 1 (Dose Escalation)|Other|0
4854894|NCT00932698|16736366|P3|Part 1 (Dose Escalation)|Other|1
4854895|NCT00932698|16736367|P2|Part 1 (Dose Escalation)|Other|0
4854896|NCT00932698|16736368|P1|Part 1 (Dose Escalation)|Other|0
4854897|NCT00932698|16736358|P11|Part 1 (Dose Escalation)|Adverse Event|0
4854898|NCT00932698|16736359|P10|Part 1 (Dose Escalation)|Adverse Event|0
4854899|NCT00932698|16736360|P9|Part 1 (Dose Escalation)|Adverse Event|0
4854900|NCT00932698|16736361|P8|Part 1 (Dose Escalation)|Adverse Event|0
4854901|NCT00932698|16736362|P7|Part 1 (Dose Escalation)|Adverse Event|0
4854902|NCT00932698|16736363|P6|Part 1 (Dose Escalation)|Adverse Event|1
4854903|NCT00932698|16736364|P5|Part 1 (Dose Escalation)|Adverse Event|0
4854904|NCT00932698|16736365|P4|Part 1 (Dose Escalation)|Adverse Event|0
4854905|NCT00932698|16736366|P3|Part 1 (Dose Escalation)|Adverse Event|0
4854906|NCT00932698|16736367|P2|Part 1 (Dose Escalation)|Adverse Event|0
4854907|NCT00932698|16736368|P1|Part 1 (Dose Escalation)|Adverse Event|0
4854908|NCT00932698|16736358|P11|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854909|NCT00932698|16736359|P10|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854910|NCT00932698|16736360|P9|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854911|NCT00932698|16736361|P8|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854912|NCT00932698|16736362|P7|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4854913|NCT00932698|16736363|P6|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4854914|NCT00932698|16736364|P5|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854915|NCT00932698|16736365|P4|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4854916|NCT00932698|16736366|P3|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854917|NCT00932698|16736367|P2|Part 1 (Dose Escalation)|Withdrawal by Participant|1
4854918|NCT00932698|16736368|P1|Part 1 (Dose Escalation)|Withdrawal by Participant|0
4854919|NCT00932698|16736358|P11|Part 1 (Dose Escalation)|Progressive Disease|0
4854920|NCT00932698|16736359|P10|Part 1 (Dose Escalation)|Progressive Disease|0
4854921|NCT00932698|16736360|P9|Part 1 (Dose Escalation)|Progressive Disease|0
4854922|NCT00932698|16736361|P8|Part 1 (Dose Escalation)|Progressive Disease|0
4854923|NCT00932698|16736362|P7|Part 1 (Dose Escalation)|Progressive Disease|2
4854924|NCT00932698|16736363|P6|Part 1 (Dose Escalation)|Progressive Disease|5
4854925|NCT00932698|16736364|P5|Part 1 (Dose Escalation)|Progressive Disease|3
4854926|NCT00932698|16736365|P4|Part 1 (Dose Escalation)|Progressive Disease|2
4854927|NCT00932698|16736366|P3|Part 1 (Dose Escalation)|Progressive Disease|2
4854928|NCT00932698|16736367|P2|Part 1 (Dose Escalation)|Progressive Disease|2
4854929|NCT00932698|16736368|P1|Part 1 (Dose Escalation)|Progressive Disease|3
4854930|NCT00932646|16736542|P4|Overall Study|Withdrawal by Subject|0
4854931|NCT00932646|16736543|P3|Overall Study|Withdrawal by Subject|3
4854932|NCT00932646|16736544|P2|Overall Study|Withdrawal by Subject|1
4854933|NCT00932646|16736545|P1|Overall Study|Withdrawal by Subject|1
4854934|NCT00932646|16736542|P4|Overall Study|Lost to Follow-up|0
4854935|NCT00932646|16736543|P3|Overall Study|Lost to Follow-up|0
4854936|NCT00932646|16736544|P2|Overall Study|Lost to Follow-up|1
4854937|NCT00932646|16736545|P1|Overall Study|Lost to Follow-up|2
4854938|NCT00932646|16736542|P4|Overall Study|Adverse Event|1
4854939|NCT00932646|16736543|P3|Overall Study|Adverse Event|1
4854940|NCT00932646|16736544|P2|Overall Study|Adverse Event|1
4854941|NCT00932646|16736545|P1|Overall Study|Adverse Event|2
4854942|NCT00932451|16736632|P1|Overall Study|Other reasons|5
4854943|NCT00932451|16736632|P1|Overall Study|Death|726
4854944|NCT00932451|16736632|P1|Overall Study|Lost to Follow-up|22
4854945|NCT00932451|16736632|P1|Overall Study|Withdrawal by Subject|69
4854946|NCT00932425|16736656|P2|Overall Study|Withdrawal by Subject|1
4854947|NCT00932425|16736657|P1|Overall Study|Withdrawal by Subject|0
4854948|NCT00932425|16736656|P2|Overall Study|Lost to Follow-up|1
4854949|NCT00932425|16736657|P1|Overall Study|Lost to Follow-up|0
4854950|NCT00932373|16736690|P11|Overall Study|Lack of Efficacy|0
4854951|NCT00932373|16736691|P10|Overall Study|Lack of Efficacy|1
4854952|NCT00932373|16736692|P9|Overall Study|Lack of Efficacy|0
4854953|NCT00932373|16736693|P8|Overall Study|Lack of Efficacy|0
4854954|NCT00932373|16736694|P7|Overall Study|Lack of Efficacy|0
4854955|NCT00932373|16736695|P6|Overall Study|Lack of Efficacy|0
4854956|NCT00932373|16736696|P5|Overall Study|Lack of Efficacy|0
4854957|NCT00932373|16736697|P4|Overall Study|Lack of Efficacy|0
4854958|NCT00932373|16736698|P3|Overall Study|Lack of Efficacy|0
4854959|NCT00932373|16736699|P2|Overall Study|Lack of Efficacy|0
4854960|NCT00932373|16736700|P1|Overall Study|Lack of Efficacy|0
4854961|NCT00932373|16736690|P11|Overall Study|Clinical progression|0
4854962|NCT00932373|16736691|P10|Overall Study|Clinical progression|0
4854963|NCT00932373|16736692|P9|Overall Study|Clinical progression|0
4854964|NCT00932373|16736693|P8|Overall Study|Clinical progression|0
4854965|NCT00932373|16736694|P7|Overall Study|Clinical progression|1
4854966|NCT00932373|16736695|P6|Overall Study|Clinical progression|0
4854967|NCT00932373|16736696|P5|Overall Study|Clinical progression|0
4854968|NCT00932373|16736697|P4|Overall Study|Clinical progression|0
4854969|NCT00932373|16736698|P3|Overall Study|Clinical progression|0
4854970|NCT00932373|16736699|P2|Overall Study|Clinical progression|0
4854971|NCT00932373|16736700|P1|Overall Study|Clinical progression|0
4854972|NCT00932373|16736690|P11|Overall Study|Withdrawal by Subject|0
4854973|NCT00932373|16736691|P10|Overall Study|Withdrawal by Subject|0
4854974|NCT00932373|16736692|P9|Overall Study|Withdrawal by Subject|1
4854975|NCT00932373|16736693|P8|Overall Study|Withdrawal by Subject|0
4854976|NCT00932373|16736694|P7|Overall Study|Withdrawal by Subject|0
4854977|NCT00932373|16736695|P6|Overall Study|Withdrawal by Subject|0
4854978|NCT00932373|16736696|P5|Overall Study|Withdrawal by Subject|0
4854979|NCT00932373|16736697|P4|Overall Study|Withdrawal by Subject|0
4854980|NCT00932373|16736698|P3|Overall Study|Withdrawal by Subject|0
4854981|NCT00932373|16736699|P2|Overall Study|Withdrawal by Subject|0
4854982|NCT00932373|16736700|P1|Overall Study|Withdrawal by Subject|0
4854983|NCT00932373|16736690|P11|Overall Study|Dose limiting toxicity|0
4854984|NCT00932373|16736691|P10|Overall Study|Dose limiting toxicity|0
4854985|NCT00932373|16736692|P9|Overall Study|Dose limiting toxicity|0
4854986|NCT00932373|16736693|P8|Overall Study|Dose limiting toxicity|0
4854987|NCT00932373|16736694|P7|Overall Study|Dose limiting toxicity|0
4854988|NCT00932373|16736695|P6|Overall Study|Dose limiting toxicity|1
4854989|NCT00932373|16736696|P5|Overall Study|Dose limiting toxicity|0
4854990|NCT00932373|16736697|P4|Overall Study|Dose limiting toxicity|0
4854991|NCT00932373|16736698|P3|Overall Study|Dose limiting toxicity|0
4854992|NCT00932373|16736699|P2|Overall Study|Dose limiting toxicity|0
4854993|NCT00932373|16736700|P1|Overall Study|Dose limiting toxicity|0
4854994|NCT00932373|16736690|P11|Overall Study|Physician Decision|0
4854995|NCT00932373|16736691|P10|Overall Study|Physician Decision|1
4854996|NCT00932373|16736692|P9|Overall Study|Physician Decision|0
4854997|NCT00932373|16736693|P8|Overall Study|Physician Decision|0
4854998|NCT00932373|16736694|P7|Overall Study|Physician Decision|0
4854999|NCT00932373|16736695|P6|Overall Study|Physician Decision|0
4855000|NCT00932373|16736696|P5|Overall Study|Physician Decision|2
4855001|NCT00932373|16736697|P4|Overall Study|Physician Decision|0
4855002|NCT00932373|16736698|P3|Overall Study|Physician Decision|1
4855003|NCT00932373|16736699|P2|Overall Study|Physician Decision|0
4855004|NCT00932373|16736700|P1|Overall Study|Physician Decision|0
4855005|NCT00932373|16736690|P11|Overall Study|Adverse Event|1
4855006|NCT00932373|16736691|P10|Overall Study|Adverse Event|2
4855007|NCT00932373|16736692|P9|Overall Study|Adverse Event|0
4855008|NCT00932373|16736693|P8|Overall Study|Adverse Event|1
4855009|NCT00932373|16736694|P7|Overall Study|Adverse Event|0
4855010|NCT00932373|16736695|P6|Overall Study|Adverse Event|1
4855011|NCT00932373|16736696|P5|Overall Study|Adverse Event|2
4855012|NCT00932373|16736697|P4|Overall Study|Adverse Event|0
4855013|NCT00932373|16736698|P3|Overall Study|Adverse Event|0
4855014|NCT00932373|16736699|P2|Overall Study|Adverse Event|0
4855015|NCT00932373|16736700|P1|Overall Study|Adverse Event|0
4855016|NCT00932373|16736690|P11|Overall Study|Progressive disease|2
4855017|NCT00932373|16736691|P10|Overall Study|Progressive disease|9
4855018|NCT00932373|16736692|P9|Overall Study|Progressive disease|1
4855019|NCT00932373|16736693|P8|Overall Study|Progressive disease|2
4855020|NCT00932373|16736694|P7|Overall Study|Progressive disease|0
4855021|NCT00932373|16736695|P6|Overall Study|Progressive disease|1
4855022|NCT00932373|16736696|P5|Overall Study|Progressive disease|10
4855023|NCT00932373|16736697|P4|Overall Study|Progressive disease|0
4855024|NCT00932373|16736698|P3|Overall Study|Progressive disease|0
4855025|NCT00932373|16736699|P2|Overall Study|Progressive disease|1
4855026|NCT00932373|16736700|P1|Overall Study|Progressive disease|3
4855027|NCT00932360|16736800|P6|Washout (One Week)|Withdrawal by Subject|0
4855028|NCT00932360|16736801|P5|Washout (One Week)|Withdrawal by Subject|2
4855029|NCT00932360|16736802|P4|Washout (One Week)|Withdrawal by Subject|0
4855030|NCT00932360|16736803|P3|Washout (One Week)|Withdrawal by Subject|0
4855031|NCT00932360|16736804|P2|Washout (One Week)|Withdrawal by Subject|0
4855032|NCT00932360|16736805|P1|Washout (One Week)|Withdrawal by Subject|0
4855033|NCT00932165|16736862|P1|Overall Study|Lost to Follow-up|1
4855034|NCT00932126|16736886|P8|Overall Study|Other|2
4855035|NCT00932126|16736887|P7|Overall Study|Other|1
4855036|NCT00932126|16736888|P6|Overall Study|Other|0
4855037|NCT00932126|16736889|P5|Overall Study|Other|1
4855038|NCT00932126|16736890|P4|Overall Study|Other|0
4855039|NCT00932126|16736891|P3|Overall Study|Other|0
4855040|NCT00932126|16736892|P2|Overall Study|Other|0
4855041|NCT00932126|16736893|P1|Overall Study|Other|0
4855042|NCT00932126|16736886|P8|Overall Study|Objective progression or relapse|5
4855043|NCT00932126|16736887|P7|Overall Study|Objective progression or relapse|3
4855044|NCT00932126|16736888|P6|Overall Study|Objective progression or relapse|3
4855045|NCT00932126|16736889|P5|Overall Study|Objective progression or relapse|3
4855046|NCT00932126|16736890|P4|Overall Study|Objective progression or relapse|3
4855047|NCT00932126|16736891|P3|Overall Study|Objective progression or relapse|2
4855048|NCT00932126|16736892|P2|Overall Study|Objective progression or relapse|3
4855049|NCT00932126|16736893|P1|Overall Study|Objective progression or relapse|3
4855050|NCT00932126|16736886|P8|Overall Study|Withdrawal by Subject|1
4855051|NCT00932126|16736887|P7|Overall Study|Withdrawal by Subject|0
4855052|NCT00932126|16736888|P6|Overall Study|Withdrawal by Subject|0
4855053|NCT00932126|16736889|P5|Overall Study|Withdrawal by Subject|0
4855054|NCT00932126|16736890|P4|Overall Study|Withdrawal by Subject|0
4855055|NCT00932126|16736891|P3|Overall Study|Withdrawal by Subject|1
4855056|NCT00932126|16736892|P2|Overall Study|Withdrawal by Subject|0
4855057|NCT00932126|16736893|P1|Overall Study|Withdrawal by Subject|0
4855058|NCT00932126|16736886|P8|Overall Study|Protocol Violation|0
4855059|NCT00932126|16736887|P7|Overall Study|Protocol Violation|0
4855060|NCT00932126|16736888|P6|Overall Study|Protocol Violation|0
4855061|NCT00932126|16736889|P5|Overall Study|Protocol Violation|1
4855062|NCT00932126|16736890|P4|Overall Study|Protocol Violation|0
4855063|NCT00932126|16736891|P3|Overall Study|Protocol Violation|0
4855064|NCT00932126|16736892|P2|Overall Study|Protocol Violation|0
4855065|NCT00932126|16736893|P1|Overall Study|Protocol Violation|0
4855066|NCT00932126|16736886|P8|Overall Study|Adverse Event|2
4855067|NCT00932126|16736887|P7|Overall Study|Adverse Event|1
4855068|NCT00932126|16736888|P6|Overall Study|Adverse Event|0
4855069|NCT00932126|16736889|P5|Overall Study|Adverse Event|0
4855070|NCT00932126|16736890|P4|Overall Study|Adverse Event|0
4855071|NCT00932126|16736891|P3|Overall Study|Adverse Event|0
4855072|NCT00932126|16736892|P2|Overall Study|Adverse Event|0
4855073|NCT00932126|16736893|P1|Overall Study|Adverse Event|0
4855074|NCT00932113|16736931|P2|Overall Study|Lost to Follow-up|0
4855075|NCT00932113|16736932|P1|Overall Study|Lost to Follow-up|1
4855076|NCT00931918|16736984|P2|Overall Study|Did not receive study drug|2
4855077|NCT00931918|16736985|P1|Overall Study|Did not receive study drug|3
4855078|NCT00931918|16736984|P2|Overall Study|Other Reason not Specified|4
4855079|NCT00931918|16736985|P1|Overall Study|Other Reason not Specified|4
4855080|NCT00931918|16736984|P2|Overall Study|Withdrawal by Patient|4
4855081|NCT00931918|16736985|P1|Overall Study|Withdrawal by Patient|3
4855082|NCT00931918|16736984|P2|Overall Study|Symptomatic Deterioration|0
4855083|NCT00931918|16736985|P1|Overall Study|Symptomatic Deterioration|1
4855084|NCT00931918|16736984|P2|Overall Study|Progressive Disease|1
4855085|NCT00931918|16736985|P1|Overall Study|Progressive Disease|2
4855086|NCT00931918|16736984|P2|Overall Study|Adverse Event|6
4855087|NCT00931918|16736985|P1|Overall Study|Adverse Event|4
4855088|NCT00931801|16737037|P3|Overall Study|Confirmed Virologic Failure|3
4855089|NCT00931801|16737038|P2|Overall Study|Confirmed Virologic Failure|0
4855090|NCT00931801|16737039|P1|Overall Study|Confirmed Virologic Failure|0
4855091|NCT00931801|16737037|P3|Overall Study|Withdrawal by Subject|0
4855092|NCT00931801|16737038|P2|Overall Study|Withdrawal by Subject|0
4855093|NCT00931801|16737039|P1|Overall Study|Withdrawal by Subject|1
4855094|NCT00931801|16737037|P3|Overall Study|Lost to Follow-up|0
4855095|NCT00931801|16737038|P2|Overall Study|Lost to Follow-up|1
4855096|NCT00931801|16737039|P1|Overall Study|Lost to Follow-up|0
4855097|NCT00931801|16737037|P3|Overall Study|Adverse Event|1
4855098|NCT00931801|16737038|P2|Overall Study|Adverse Event|0
4855099|NCT00931801|16737039|P1|Overall Study|Adverse Event|0
4855100|NCT00931723|16737062|P2|Overall Study|Late hospital discharge|0
4855101|NCT00931723|16737063|P1|Overall Study|Late hospital discharge|1
4855102|NCT00931723|16737062|P2|Overall Study|Sponsor decision|0
4855103|NCT00931723|16737063|P1|Overall Study|Sponsor decision|1
4855104|NCT00931723|16737062|P2|Overall Study|Lack or insufficient theraputic response|5
4855105|NCT00931723|16737063|P1|Overall Study|Lack or insufficient theraputic response|2
4855106|NCT00931723|16737062|P2|Overall Study|Took prohibited concomitant medication|1
4855107|NCT00931723|16737063|P1|Overall Study|Took prohibited concomitant medication|0
4855108|NCT00931723|16737062|P2|Overall Study|Safety reasons|1
4855109|NCT00931723|16737063|P1|Overall Study|Safety reasons|0
4855110|NCT00931723|16737062|P2|Overall Study|Severe non-compliance to protocol|0
4855111|NCT00931723|16737063|P1|Overall Study|Severe non-compliance to protocol|2
4855112|NCT00931723|16737062|P2|Overall Study|Study-specific discontinuation criteria|1
4855113|NCT00931723|16737063|P1|Overall Study|Study-specific discontinuation criteria|1
4855114|NCT00931723|16737062|P2|Overall Study|Lost to Follow-up|2
4855115|NCT00931723|16737063|P1|Overall Study|Lost to Follow-up|1
4855116|NCT00931723|16737062|P2|Overall Study|Condition under investigation worsened|2
4855117|NCT00931723|16737063|P1|Overall Study|Condition under investigation worsened|1
4855118|NCT00931723|16737062|P2|Overall Study|Lithium found in blood|1
4855119|NCT00931723|16737063|P1|Overall Study|Lithium found in blood|0
4855120|NCT00931723|16737062|P2|Overall Study|Adverse Event|13
4855121|NCT00931723|16737063|P1|Overall Study|Adverse Event|6
4855122|NCT00931723|16737062|P2|Overall Study|Withdrawal by Subject|13
4855123|NCT00931723|16737063|P1|Overall Study|Withdrawal by Subject|11
4855124|NCT00931710|16737111|P2|Overall Study|Protocol deviation|2
4855125|NCT00931710|16737112|P1|Overall Study|Protocol deviation|1
4855126|NCT00931710|16737111|P2|Overall Study|Lost to Follow-up|5
4855127|NCT00931710|16737112|P1|Overall Study|Lost to Follow-up|6
4855128|NCT00931710|16737111|P2|Overall Study|Patient withdrew consent|9
4855129|NCT00931710|16737112|P1|Overall Study|Patient withdrew consent|4
4855130|NCT00931710|16737111|P2|Overall Study|Unsatisfactory therapeutic effects|12
4855131|NCT00931710|16737112|P1|Overall Study|Unsatisfactory therapeutic effects|5
4855132|NCT00931710|16737111|P2|Overall Study|Abnormal test procedure results|0
4855133|NCT00931710|16737112|P1|Overall Study|Abnormal test procedure results|2
4855134|NCT00931710|16737111|P2|Overall Study|Adverse Event|10
4855135|NCT00931710|16737112|P1|Overall Study|Adverse Event|16
4855136|NCT00931632|16737130|P2|Overall Study|Adverse Event|15
4855137|NCT00931632|16737131|P1|Overall Study|Adverse Event|19
4855138|NCT00931632|16737130|P2|Overall Study|Withdrawal by Subject|3
4855139|NCT00931632|16737131|P1|Overall Study|Withdrawal by Subject|2
4855140|NCT00931528|16737153|P2|Overall Study|Assessment outside of Time Frame|23
4855141|NCT00931528|16737154|P1|Overall Study|Assessment outside of Time Frame|22
4855142|NCT00931528|16737153|P2|Overall Study|Lost to Follow-up|13
4855143|NCT00931528|16737154|P1|Overall Study|Lost to Follow-up|6
4855144|NCT00931528|16737153|P2|Overall Study|Withdrawal by Subject|12
4855145|NCT00931528|16737154|P1|Overall Study|Withdrawal by Subject|4
4855146|NCT00931528|16737153|P2|Overall Study|Protocol Violation|12
4855147|NCT00931528|16737154|P1|Overall Study|Protocol Violation|9
4855148|NCT00931515|16737174|P2|Overall Study|Lost to Follow-up|5
4855149|NCT00931515|16737175|P1|Overall Study|Lost to Follow-up|2
4855150|NCT00931463|16737205|P2|Overall Study|Lost to Follow-up|1
4855151|NCT00931463|16737206|P1|Overall Study|Lost to Follow-up|4
4855152|NCT00931463|16737205|P2|Overall Study|Withdrawal by Subject|0
4855153|NCT00931463|16737206|P1|Overall Study|Withdrawal by Subject|5
4855154|NCT00931463|16737205|P2|Overall Study|Death|4
4855155|NCT00931463|16737206|P1|Overall Study|Death|8
4855156|NCT00931411|16737222|P2|After Crossover - 14 Days (up to Day 56)|Adverse Event|1
4855157|NCT00931411|16737223|P1|After Crossover - 14 Days (up to Day 56)|Adverse Event|0
4855158|NCT00931411|16737222|P2|First Intervention - 42 Days|Lost to Follow-up|0
4855159|NCT00931411|16737223|P1|First Intervention - 42 Days|Lost to Follow-up|2
4855160|NCT00931411|16737222|P2|First Intervention - 42 Days|Adverse Event|3
4855161|NCT00931411|16737223|P1|First Intervention - 42 Days|Adverse Event|2
4855162|NCT00931385|16737244|P4|Overall Study|Lost to Follow-up|1
4855163|NCT00931385|16737245|P3|Overall Study|Lost to Follow-up|0
4855164|NCT00931385|16737246|P2|Overall Study|Lost to Follow-up|0
4855165|NCT00931385|16737247|P1|Overall Study|Lost to Follow-up|0
4855166|NCT00931385|16737244|P4|Overall Study|Withdrawal by Subject|1
4855167|NCT00931385|16737245|P3|Overall Study|Withdrawal by Subject|0
4855168|NCT00931385|16737246|P2|Overall Study|Withdrawal by Subject|1
4855169|NCT00931385|16737247|P1|Overall Study|Withdrawal by Subject|0
4855170|NCT00931385|16737244|P4|Overall Study|Protocol Violation|0
4855171|NCT00931385|16737245|P3|Overall Study|Protocol Violation|1
4855172|NCT00931385|16737246|P2|Overall Study|Protocol Violation|0
4855173|NCT00931385|16737247|P1|Overall Study|Protocol Violation|0
4855174|NCT00931385|16737244|P4|Overall Study|Adverse Event|3
4855175|NCT00931385|16737245|P3|Overall Study|Adverse Event|0
4855176|NCT00931385|16737246|P2|Overall Study|Adverse Event|1
4855177|NCT00931385|16737247|P1|Overall Study|Adverse Event|2
4855178|NCT00931307|16737316|P1|Overall Study|Biomicroscopy|1
4855179|NCT00931307|16737316|P1|Overall Study|Lack of Efficacy|12
4855180|NCT00931268|16737320|P1|Overall Study|Lost to Follow-up|6
4855181|NCT00931255|16737332|P2|Overall Study|Follow up biopsy not done|3
4855182|NCT00931255|16737333|P1|Overall Study|Follow up biopsy not done|2
4855183|NCT00930982|16737370|P2|Overall Study|Withdrawal by Subject|1
4855184|NCT00930982|16737371|P1|Overall Study|Withdrawal by Subject|1
4855185|NCT00930982|16737370|P2|Overall Study|Protocol Violation|5
4855186|NCT00930982|16737371|P1|Overall Study|Protocol Violation|1
4855187|NCT00930982|16737370|P2|Overall Study|Adverse Event|23
4855188|NCT00930982|16737371|P1|Overall Study|Adverse Event|19
4855189|NCT00930969|16737405|P1|Overall Study|Withdrawal by Subject|19
4855190|NCT00930969|16737405|P1|Overall Study|Physician Decision|13
4855191|NCT00930969|16737405|P1|Overall Study|Lost to Follow-up|1
4855192|NCT00930969|16737405|P1|Overall Study|Death|5
4855193|NCT00930930|16737415|P2|Overall Study|patients not compliant|1
4855194|NCT00930930|16737416|P1|Overall Study|patients not compliant|1
4855195|NCT00930930|16737415|P2|Overall Study|excessive lapse btw txs, not eligible|1
4855196|NCT00930930|16737416|P1|Overall Study|excessive lapse btw txs, not eligible|0
4855197|NCT00930930|16737415|P2|Overall Study|Disease progression|3
4855198|NCT00930930|16737416|P1|Overall Study|Disease progression|2
4855199|NCT00930930|16737415|P2|Overall Study|Withdrawal by Subject|1
4855200|NCT00930930|16737416|P1|Overall Study|Withdrawal by Subject|3
4855201|NCT00930930|16737415|P2|Overall Study|Adverse Event|3
4855202|NCT00930930|16737416|P1|Overall Study|Adverse Event|13
4855203|NCT00930930|16737415|P2|Overall Study|Physician Decision|0
4855204|NCT00930930|16737416|P1|Overall Study|Physician Decision|1
4855205|NCT00930930|16737415|P2|Overall Study|Death|0
4855206|NCT00930930|16737416|P1|Overall Study|Death|1
4855207|NCT00930813|16737430|P2|Overall Study|Lost to Follow-up|4
4855208|NCT00930813|16737431|P1|Overall Study|Lost to Follow-up|2
4855209|NCT00930813|16737430|P2|Overall Study|Withdrawal by Subject|5
4855210|NCT00930813|16737431|P1|Overall Study|Withdrawal by Subject|2
4855211|NCT00930813|16737430|P2|Overall Study|Death|5
4855212|NCT00930813|16737431|P1|Overall Study|Death|4
4855213|NCT00930774|16737452|P4|Overall Study|Withdrawal by Subject|0
4855214|NCT00930774|16737453|P3|Overall Study|Withdrawal by Subject|2
4855215|NCT00930774|16737454|P2|Overall Study|Withdrawal by Subject|9
4855216|NCT00930774|16737455|P1|Overall Study|Withdrawal by Subject|1
4855217|NCT00930761|16737495|P2|Overall Study|less than 3 music therapy sessions|3
4855218|NCT00930761|16737496|P1|Overall Study|less than 3 music therapy sessions|0
4855219|NCT00930761|16737495|P2|Overall Study|3 newborns died; 1 mother quit the study|0
4855220|NCT00930761|16737496|P1|Overall Study|3 newborns died; 1 mother quit the study|4
4855221|NCT00930722|16737508|P1|Overall Study|Study terminated by sponsor|2
4855222|NCT00930722|16737508|P1|Overall Study|No longer willing to participate|9
4855223|NCT00930722|16737508|P1|Overall Study|Lost to Follow-up|16
4855224|NCT00930644|16737523|P1|Overall Study|Adverse Event|16
4855225|NCT00930644|16737523|P1|Overall Study|Death|1
4855226|NCT00930644|16737523|P1|Overall Study|Physician Decision|2
4855227|NCT00930644|16737523|P1|Overall Study|Withdrawal by Subject|4
4855228|NCT00930553|16737536|P1|Overall Study|Other than specified above|28
4855229|NCT00930553|16737536|P1|Overall Study|Study terminated by sponsor|24
4855230|NCT00930553|16737536|P1|Overall Study|Death|9
4855231|NCT00930553|16737536|P1|Overall Study|Lost to Follow-up|25
4855232|NCT00930553|16737536|P1|Overall Study|Withdrawal by Subject|88
4855233|NCT00930553|16737536|P1|Overall Study|Pregnancy|1
4855234|NCT00930553|16737536|P1|Overall Study|Protocol Violation|1
4855235|NCT00930553|16737536|P1|Overall Study|Physician Decision|39
4855236|NCT00930553|16737536|P1|Overall Study|Lack of Efficacy|7
4855237|NCT00930553|16737536|P1|Overall Study|Adverse Event|1
4855238|NCT00930176|16737613|P1|Overall Study|Death|1
4855239|NCT00930046|16737620|P2|Overall Study|Wound catheter malfunctioned|2
4855240|NCT00930046|16737621|P1|Overall Study|Wound catheter malfunctioned|1
4855241|NCT00929994|16737629|P1|Overall Study|employment|1
4855242|NCT00929994|16737629|P1|Overall Study|medical issue unrelated to intervention|4
4855243|NCT00929994|16737629|P1|Overall Study|Withdrawal by Subject|1
4855244|NCT00929864|16737648|P2|Overall Study|Non-specified|7
4855245|NCT00929864|16737649|P1|Overall Study|Non-specified|2
4855246|NCT00929864|16737648|P2|Overall Study|Administrative reason by Sponsor|1
4855247|NCT00929864|16737649|P1|Overall Study|Administrative reason by Sponsor|1
4855248|NCT00929864|16737648|P2|Overall Study|Pregnancy|3
4855249|NCT00929864|16737649|P1|Overall Study|Pregnancy|0
4855250|NCT00929864|16737648|P2|Overall Study|Poor or non-compliance|3
4855251|NCT00929864|16737649|P1|Overall Study|Poor or non-compliance|3
4855252|NCT00929864|16737648|P2|Overall Study|No longer met criteria|1
4855253|NCT00929864|16737649|P1|Overall Study|No longer met criteria|2
4855254|NCT00929864|16737648|P2|Overall Study|Withdrawal by Subject|9
4855255|NCT00929864|16737649|P1|Overall Study|Withdrawal by Subject|20
4855256|NCT00929864|16737648|P2|Overall Study|Lost to Follow-up|12
4855257|NCT00929864|16737649|P1|Overall Study|Lost to Follow-up|7
4855258|NCT00929864|16737648|P2|Overall Study|Lack of Efficacy|16
4855259|NCT00929864|16737649|P1|Overall Study|Lack of Efficacy|19
4855260|NCT00929864|16737648|P2|Overall Study|Adverse Event|30
4855261|NCT00929864|16737649|P1|Overall Study|Adverse Event|11
4855262|NCT00929864|16737648|P2|Overall Study|Death|1
4855263|NCT00929864|16737649|P1|Overall Study|Death|1
4855264|NCT00929734|16737705|P2|Overall Study|Withdrawal by Subject|2
4855265|NCT00929734|16737706|P1|Overall Study|Withdrawal by Subject|0
4855266|NCT00929734|16737705|P2|Overall Study|Lost to Follow-up|1
4855267|NCT00929734|16737706|P1|Overall Study|Lost to Follow-up|2
4855268|NCT00929708|16737723|P5|Overall Study|Lost to Follow-up|0
4855269|NCT00929708|16737724|P4|Overall Study|Lost to Follow-up|1
4855270|NCT00929708|16737725|P3|Overall Study|Lost to Follow-up|0
4855271|NCT00929708|16737726|P2|Overall Study|Lost to Follow-up|0
4855272|NCT00929708|16737727|P1|Overall Study|Lost to Follow-up|0
4855273|NCT00929708|16737723|P5|Overall Study|Physician Decision|1
4855274|NCT00929708|16737724|P4|Overall Study|Physician Decision|2
4855275|NCT00929708|16737725|P3|Overall Study|Physician Decision|2
4855276|NCT00929708|16737726|P2|Overall Study|Physician Decision|2
4855277|NCT00929708|16737727|P1|Overall Study|Physician Decision|0
4855278|NCT00929708|16737723|P5|Overall Study|Adverse Event|3
4855279|NCT00929708|16737724|P4|Overall Study|Adverse Event|0
4855280|NCT00929708|16737725|P3|Overall Study|Adverse Event|0
4855281|NCT00929708|16737726|P2|Overall Study|Adverse Event|0
4855282|NCT00929708|16737727|P1|Overall Study|Adverse Event|0
4855283|NCT00929708|16737723|P5|Overall Study|Withdrawal by Subject|1
4855284|NCT00929708|16737724|P4|Overall Study|Withdrawal by Subject|2
4855285|NCT00929708|16737725|P3|Overall Study|Withdrawal by Subject|0
4855286|NCT00929708|16737726|P2|Overall Study|Withdrawal by Subject|0
4855287|NCT00929708|16737727|P1|Overall Study|Withdrawal by Subject|2
4855288|NCT00929708|16737723|P5|Overall Study|Protocol Violation|1
4855289|NCT00929708|16737724|P4|Overall Study|Protocol Violation|1
4855290|NCT00929708|16737725|P3|Overall Study|Protocol Violation|1
4855291|NCT00929708|16737726|P2|Overall Study|Protocol Violation|1
4855292|NCT00929708|16737727|P1|Overall Study|Protocol Violation|2
4855293|NCT00929695|16737781|P2|Overall Study|incorrect stratification|0
4855294|NCT00929695|16737782|P1|Overall Study|incorrect stratification|2
4855295|NCT00929695|16737781|P2|Overall Study|discharge home|3
4855296|NCT00929695|16737782|P1|Overall Study|discharge home|4
4855297|NCT00929695|16737781|P2|Overall Study|Withdrawal by Subject|2
4855298|NCT00929695|16737782|P1|Overall Study|Withdrawal by Subject|0
4855299|NCT00929695|16737781|P2|Overall Study|Death|1
4855300|NCT00929695|16737782|P1|Overall Study|Death|2
4855301|NCT00929669|16737812|P1|Overall Study|elevated glucose levels|1
4855302|NCT00929656|16737819|P2|Overall Study|Lost to Follow-up|1
4855303|NCT00929656|16737820|P1|Overall Study|Lost to Follow-up|0
4855304|NCT00929643|16737834|P1|Overall Study|Protocol Violation|2
4855305|NCT00929526|16737856|P2|Overall Study|Other|6
4855306|NCT00929526|16737857|P1|Overall Study|Other|8
4855307|NCT00929526|16737856|P2|Overall Study|Lost to Follow-up|12
4855308|NCT00929526|16737857|P1|Overall Study|Lost to Follow-up|8
4855309|NCT00929526|16737856|P2|Overall Study|Withdrawal by Subject|11
4855310|NCT00929526|16737857|P1|Overall Study|Withdrawal by Subject|1
4855311|NCT00929240|16738011|P3|Maintenance Phase|Participant not treated|0
4855312|NCT00929240|16738012|P2|Maintenance Phase|Participant not treated|2
4855313|NCT00929240|16738013|P1|Maintenance Phase|Participant not treated|0
4855314|NCT00929240|16738011|P3|Maintenance Phase|Treatment ongoing at study closure|10
4855315|NCT00929240|16738012|P2|Maintenance Phase|Treatment ongoing at study closure|0
4855316|NCT00929240|16738013|P1|Maintenance Phase|Treatment ongoing at study closure|0
4855317|NCT00929240|16738011|P3|Maintenance Phase|Change of treatment|0
4855318|NCT00929240|16738012|P2|Maintenance Phase|Change of treatment|4
4855319|NCT00929240|16738013|P1|Maintenance Phase|Change of treatment|0
4855320|NCT00929240|16738011|P3|Maintenance Phase|Physician Decision|1
4855321|NCT00929240|16738012|P2|Maintenance Phase|Physician Decision|2
4855322|NCT00929240|16738013|P1|Maintenance Phase|Physician Decision|0
4855323|NCT00929240|16738011|P3|Maintenance Phase|Health authority/Study termination|2
4855324|NCT00929240|16738012|P2|Maintenance Phase|Health authority/Study termination|1
4855325|NCT00929240|16738013|P1|Maintenance Phase|Health authority/Study termination|0
4855326|NCT00929240|16738011|P3|Maintenance Phase|Protocol Violation|0
4855327|NCT00929240|16738012|P2|Maintenance Phase|Protocol Violation|1
4855328|NCT00929240|16738013|P1|Maintenance Phase|Protocol Violation|0
4855329|NCT00929240|16738011|P3|Maintenance Phase|Withdrawal by Subject|6
4855330|NCT00929240|16738012|P2|Maintenance Phase|Withdrawal by Subject|2
4855331|NCT00929240|16738013|P1|Maintenance Phase|Withdrawal by Subject|0
4855332|NCT00929240|16738011|P3|Maintenance Phase|Adverse Event|12
4855333|NCT00929240|16738012|P2|Maintenance Phase|Adverse Event|9
4855334|NCT00929240|16738013|P1|Maintenance Phase|Adverse Event|0
4855335|NCT00929240|16738011|P3|Maintenance Phase|Disease progression|60
4855336|NCT00929240|16738012|P2|Maintenance Phase|Disease progression|73
4855337|NCT00929240|16738013|P1|Maintenance Phase|Disease progression|0
4855338|NCT00929240|16738011|P3|Initial Treatment Phase|Physician Decision|0
4855339|NCT00929240|16738012|P2|Initial Treatment Phase|Physician Decision|0
4855340|NCT00929240|16738013|P1|Initial Treatment Phase|Physician Decision|4
4855341|NCT00929240|16738011|P3|Initial Treatment Phase|Health authority/Study termination|0
4855342|NCT00929240|16738012|P2|Initial Treatment Phase|Health authority/Study termination|0
4855343|NCT00929240|16738013|P1|Initial Treatment Phase|Health authority/Study termination|3
4855344|NCT00929240|16738011|P3|Initial Treatment Phase|Death|0
4855345|NCT00929240|16738012|P2|Initial Treatment Phase|Death|0
4855346|NCT00929240|16738013|P1|Initial Treatment Phase|Death|2
4855347|NCT00929240|16738011|P3|Initial Treatment Phase|Protocol Violation|0
4855348|NCT00929240|16738012|P2|Initial Treatment Phase|Protocol Violation|0
4855349|NCT00929240|16738013|P1|Initial Treatment Phase|Protocol Violation|5
4855350|NCT00929240|16738011|P3|Initial Treatment Phase|Withdrawal by Subject|0
4855351|NCT00929240|16738012|P2|Initial Treatment Phase|Withdrawal by Subject|0
4855352|NCT00929240|16738013|P1|Initial Treatment Phase|Withdrawal by Subject|13
4855353|NCT00929240|16738011|P3|Initial Treatment Phase|Disease progression|0
4855354|NCT00929240|16738012|P2|Initial Treatment Phase|Disease progression|0
4855355|NCT00929240|16738013|P1|Initial Treatment Phase|Disease progression|41
4855356|NCT00929240|16738011|P3|Initial Treatment Phase|Adverse Event|0
4855357|NCT00929240|16738012|P2|Initial Treatment Phase|Adverse Event|0
4855358|NCT00929240|16738013|P1|Initial Treatment Phase|Adverse Event|31
4855359|NCT00929201|16738040|P2|Period 1|Withdrawal by Subject|1
4855360|NCT00929201|16738041|P1|Period 1|Withdrawal by Subject|0
4855361|NCT00929162|16738051|P2|Overall Study|Other termination reason|6
4855362|NCT00929162|16738052|P1|Overall Study|Other termination reason|5
4855363|NCT00929162|16738051|P2|Overall Study|Protocol Violation|30
4855364|NCT00929162|16738052|P1|Overall Study|Protocol Violation|32
4855365|NCT00929162|16738051|P2|Overall Study|Withdrawal by Subject|1
4855366|NCT00929162|16738052|P1|Overall Study|Withdrawal by Subject|3
4855367|NCT00929162|16738051|P2|Overall Study|Adverse Event|5
4855368|NCT00929162|16738052|P1|Overall Study|Adverse Event|8
4855369|NCT00929110|16738065|P3|Overall Study|Patient inability to use the device|0
4855370|NCT00929110|16738066|P2|Overall Study|Patient inability to use the device|1
4855371|NCT00929110|16738067|P1|Overall Study|Patient inability to use the device|0
4855372|NCT00929110|16738065|P3|Overall Study|Abnormal test procedure result(s)|1
4855373|NCT00929110|16738066|P2|Overall Study|Abnormal test procedure result(s)|1
4855374|NCT00929110|16738067|P1|Overall Study|Abnormal test procedure result(s)|0
4855375|NCT00929110|16738065|P3|Overall Study|Abnormal laboratory value(s)|0
4855376|NCT00929110|16738066|P2|Overall Study|Abnormal laboratory value(s)|1
4855377|NCT00929110|16738067|P1|Overall Study|Abnormal laboratory value(s)|0
4855378|NCT00929110|16738065|P3|Overall Study|Death|2
4855379|NCT00929110|16738066|P2|Overall Study|Death|2
4855380|NCT00929110|16738067|P1|Overall Study|Death|2
4855381|NCT00929110|16738065|P3|Overall Study|Administrative problems|2
4855382|NCT00929110|16738066|P2|Overall Study|Administrative problems|1
4855383|NCT00929110|16738067|P1|Overall Study|Administrative problems|4
4855384|NCT00929110|16738065|P3|Overall Study|Protocol deviation|4
4855385|NCT00929110|16738066|P2|Overall Study|Protocol deviation|2
4855386|NCT00929110|16738067|P1|Overall Study|Protocol deviation|5
4855387|NCT00929110|16738065|P3|Overall Study|Lost to Follow-up|3
4855388|NCT00929110|16738066|P2|Overall Study|Lost to Follow-up|7
4855389|NCT00929110|16738067|P1|Overall Study|Lost to Follow-up|7
4855390|NCT00929110|16738065|P3|Overall Study|Unsatisfactory therapeutic effect|6
4855391|NCT00929110|16738066|P2|Overall Study|Unsatisfactory therapeutic effect|9
4855392|NCT00929110|16738067|P1|Overall Study|Unsatisfactory therapeutic effect|20
4855393|NCT00929110|16738065|P3|Overall Study|Subject withdrew consent|26
4855394|NCT00929110|16738066|P2|Overall Study|Subject withdrew consent|23
4855395|NCT00929110|16738067|P1|Overall Study|Subject withdrew consent|40
4855396|NCT00929110|16738065|P3|Overall Study|Adverse Event|18
4855397|NCT00929110|16738066|P2|Overall Study|Adverse Event|29
4855398|NCT00929110|16738067|P1|Overall Study|Adverse Event|40
4855399|NCT00928889|16738150|P2|Overall Study|Other|0
4855400|NCT00928889|16738151|P1|Overall Study|Other|1
4855401|NCT00928889|16738150|P2|Overall Study|Adverse Event|0
4855402|NCT00928889|16738151|P1|Overall Study|Adverse Event|1
4855403|NCT00928889|16738150|P2|Overall Study|Protocol Violation|1
4855404|NCT00928889|16738151|P1|Overall Study|Protocol Violation|0
4855405|NCT00928889|16738150|P2|Overall Study|Lost to Follow-up|1
4855406|NCT00928889|16738151|P1|Overall Study|Lost to Follow-up|3
4855407|NCT00928746|16738197|P1|Overall Study|Other|2
4855408|NCT00928746|16738197|P1|Overall Study|Withdrawal by Subject|1
4855409|NCT00928746|16738197|P1|Overall Study|Protocol Violation|1
4855410|NCT00928746|16738197|P1|Overall Study|Adverse Event|2
4855411|NCT00928707|16738247|P2|Overall Study|Protocol Violation|0
4855412|NCT00928707|16738248|P1|Overall Study|Protocol Violation|1
4855413|NCT00928668|16738269|P5|Overall Study|Other reasons not listed above|0
4855414|NCT00928668|16738270|P4|Overall Study|Other reasons not listed above|1
4855415|NCT00928668|16738271|P3|Overall Study|Other reasons not listed above|0
4855416|NCT00928668|16738272|P2|Overall Study|Other reasons not listed above|0
4855417|NCT00928668|16738273|P1|Overall Study|Other reasons not listed above|0
4855418|NCT00928668|16738269|P5|Overall Study|Withdrawal by Subject|0
4855419|NCT00928668|16738270|P4|Overall Study|Withdrawal by Subject|0
4855420|NCT00928668|16738271|P3|Overall Study|Withdrawal by Subject|1
4855421|NCT00928668|16738272|P2|Overall Study|Withdrawal by Subject|1
4855422|NCT00928668|16738273|P1|Overall Study|Withdrawal by Subject|0
4855423|NCT00928668|16738269|P5|Overall Study|Protocol Violation|1
4855424|NCT00928668|16738270|P4|Overall Study|Protocol Violation|0
4855425|NCT00928668|16738271|P3|Overall Study|Protocol Violation|0
4855426|NCT00928668|16738272|P2|Overall Study|Protocol Violation|0
4855427|NCT00928668|16738273|P1|Overall Study|Protocol Violation|0
4855428|NCT00928668|16738269|P5|Overall Study|Adverse Event|0
4855429|NCT00928668|16738270|P4|Overall Study|Adverse Event|0
4855430|NCT00928668|16738271|P3|Overall Study|Adverse Event|0
4855431|NCT00928668|16738272|P2|Overall Study|Adverse Event|0
4855432|NCT00928668|16738273|P1|Overall Study|Adverse Event|1
4855433|NCT00928512|16738329|P5|Overall Study|Administrative Problems|0
4855434|NCT00928512|16738330|P4|Overall Study|Administrative Problems|0
4855435|NCT00928512|16738331|P3|Overall Study|Administrative Problems|0
4855436|NCT00928512|16738332|P2|Overall Study|Administrative Problems|1
4855437|NCT00928512|16738333|P1|Overall Study|Administrative Problems|0
4855438|NCT00928512|16738329|P5|Overall Study|Lost to Follow-up|3
4855439|NCT00928512|16738330|P4|Overall Study|Lost to Follow-up|1
4855440|NCT00928512|16738331|P3|Overall Study|Lost to Follow-up|2
4855441|NCT00928512|16738332|P2|Overall Study|Lost to Follow-up|1
4855442|NCT00928512|16738333|P1|Overall Study|Lost to Follow-up|1
4855443|NCT00928512|16738329|P5|Overall Study|Withdrawal by Subject|0
4855444|NCT00928512|16738330|P4|Overall Study|Withdrawal by Subject|4
4855445|NCT00928512|16738331|P3|Overall Study|Withdrawal by Subject|3
4855446|NCT00928512|16738332|P2|Overall Study|Withdrawal by Subject|0
4855447|NCT00928512|16738333|P1|Overall Study|Withdrawal by Subject|3
4855448|NCT00928512|16738329|P5|Overall Study|Protocol Violation|3
4855449|NCT00928512|16738330|P4|Overall Study|Protocol Violation|1
4855450|NCT00928512|16738331|P3|Overall Study|Protocol Violation|0
4855451|NCT00928512|16738332|P2|Overall Study|Protocol Violation|1
4855452|NCT00928512|16738333|P1|Overall Study|Protocol Violation|0
4855453|NCT00928512|16738329|P5|Overall Study|Lack of Efficacy|3
4855454|NCT00928512|16738330|P4|Overall Study|Lack of Efficacy|7
4855455|NCT00928512|16738331|P3|Overall Study|Lack of Efficacy|4
4855456|NCT00928512|16738332|P2|Overall Study|Lack of Efficacy|0
4855457|NCT00928512|16738333|P1|Overall Study|Lack of Efficacy|2
4855458|NCT00928512|16738329|P5|Overall Study|Adverse Event|6
4855459|NCT00928512|16738330|P4|Overall Study|Adverse Event|8
4855460|NCT00928512|16738331|P3|Overall Study|Adverse Event|2
4855461|NCT00928512|16738332|P2|Overall Study|Adverse Event|3
4855462|NCT00928512|16738333|P1|Overall Study|Adverse Event|4
4855463|NCT00928486|16738434|P1|Overall Study|Withdrawal by Subject|1
4855464|NCT00928486|16738434|P1|Overall Study|Disease Progression|7
4855465|NCT00928486|16738434|P1|Overall Study|Adverse Event|2
4855466|NCT00928434|16738443|P3|Overall Study|Other (not meeting above criteria)|2
4855467|NCT00928434|16738444|P2|Overall Study|Other (not meeting above criteria)|1
4855468|NCT00928434|16738445|P1|Overall Study|Other (not meeting above criteria)|5
4855469|NCT00928434|16738443|P3|Overall Study|PSA failure (>2 ng/mL) on other visit|1
4855470|NCT00928434|16738444|P2|Overall Study|PSA failure (>2 ng/mL) on other visit|1
4855471|NCT00928434|16738445|P1|Overall Study|PSA failure (>2 ng/mL) on other visit|2
4855472|NCT00928434|16738443|P3|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7
4855473|NCT00928434|16738444|P2|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4
4855474|NCT00928434|16738445|P1|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10
4855475|NCT00928434|16738443|P3|Overall Study|Withdrawal by Subject|2
4855476|NCT00928434|16738444|P2|Overall Study|Withdrawal by Subject|3
4855477|NCT00928434|16738445|P1|Overall Study|Withdrawal by Subject|5
4855478|NCT00928434|16738443|P3|Overall Study|Lost to Follow-up|3
4855479|NCT00928434|16738444|P2|Overall Study|Lost to Follow-up|0
4855480|NCT00928434|16738445|P1|Overall Study|Lost to Follow-up|1
4855481|NCT00928434|16738443|P3|Overall Study|Physician Decision|3
4855482|NCT00928434|16738444|P2|Overall Study|Physician Decision|0
4855483|NCT00928434|16738445|P1|Overall Study|Physician Decision|2
4855484|NCT00928434|16738443|P3|Overall Study|Protocol Violation|8
4855485|NCT00928434|16738444|P2|Overall Study|Protocol Violation|0
4855486|NCT00928434|16738445|P1|Overall Study|Protocol Violation|5
4855487|NCT00928434|16738443|P3|Overall Study|Adverse Event|18
4855488|NCT00928434|16738444|P2|Overall Study|Adverse Event|5
4855489|NCT00928434|16738445|P1|Overall Study|Adverse Event|14
4855490|NCT00928408|16738521|P1|Overall Study|Lost to Follow-up|12
4855491|NCT00928408|16738521|P1|Overall Study|Death|5
4855492|NCT00928408|16738521|P1|Overall Study|Withdrawal by Subject|4
4855493|NCT00928408|16738521|P1|Overall Study|Other|2
4855494|NCT00928252|16738567|P1|Overall Study|Physician Decision|3
4855495|NCT00928187|16738627|P3|Overall Study|Protocol Violation|0
4855496|NCT00928187|16738628|P2|Overall Study|Protocol Violation|1
4855497|NCT00928187|16738629|P1|Overall Study|Protocol Violation|0
4855498|NCT00928187|16738627|P3|Overall Study|Withdrawal by Subject|1
4855499|NCT00928187|16738628|P2|Overall Study|Withdrawal by Subject|1
4855500|NCT00928187|16738629|P1|Overall Study|Withdrawal by Subject|0
4855501|NCT00928187|16738627|P3|Overall Study|Lost to Follow-up|1
4855502|NCT00928187|16738628|P2|Overall Study|Lost to Follow-up|2
4855503|NCT00928187|16738629|P1|Overall Study|Lost to Follow-up|1
4855504|NCT00928187|16738627|P3|Overall Study|Death|3
4855505|NCT00928187|16738628|P2|Overall Study|Death|2
4855506|NCT00928187|16738629|P1|Overall Study|Death|1
4855507|NCT00928070|16738799|P2|Overall Study|Other|5
4855508|NCT00928070|16738800|P1|Overall Study|Other|5
4855509|NCT00928070|16738799|P2|Overall Study|Randomized but not treated|2
4855510|NCT00928070|16738800|P1|Overall Study|Randomized but not treated|2
4855511|NCT00928070|16738799|P2|Overall Study|Protocol Violation|5
4855512|NCT00928070|16738800|P1|Overall Study|Protocol Violation|6
4855513|NCT00928070|16738799|P2|Overall Study|Did not meet entrance criteria|9
4855514|NCT00928070|16738800|P1|Overall Study|Did not meet entrance criteria|16
4855515|NCT00928070|16738799|P2|Overall Study|Lack of Efficacy|5
4855516|NCT00928070|16738800|P1|Overall Study|Lack of Efficacy|9
4855517|NCT00928070|16738799|P2|Overall Study|Adverse Event|26
4855518|NCT00928070|16738800|P1|Overall Study|Adverse Event|14
4855519|NCT00928070|16738799|P2|Overall Study|Withdrawal by Subject|3
4855520|NCT00928070|16738800|P1|Overall Study|Withdrawal by Subject|10
4855521|NCT00928070|16738799|P2|Overall Study|Lost to Follow-up|2
4855522|NCT00928070|16738800|P1|Overall Study|Lost to Follow-up|1
4855523|NCT00928057|16738858|P2|Overall Study|Protocol Violation|1
4855524|NCT00928057|16738859|P1|Overall Study|Protocol Violation|0
4855525|NCT00928057|16738858|P2|Overall Study|Lost to Follow-up|1
4855526|NCT00928057|16738859|P1|Overall Study|Lost to Follow-up|0
4855527|NCT00928057|16738858|P2|Overall Study|Withdrawal by Subject|0
4855528|NCT00928057|16738859|P1|Overall Study|Withdrawal by Subject|1
4855529|NCT00928057|16738858|P2|Overall Study|Adverse Event|2
4855530|NCT00928057|16738859|P1|Overall Study|Adverse Event|1
4855531|NCT00928018|16738884|P2|Overall Study|Withdrawal by Subject|0
4855532|NCT00928018|16738885|P1|Overall Study|Withdrawal by Subject|1
4855533|NCT00927953|16738915|P2|Overall Study|Death|1
4855534|NCT00927953|16738916|P1|Overall Study|Death|2
4855535|NCT00927940|16738930|P1|Overall Study|Death|1
4855536|NCT00927927|16738950|P15|Overall Study|Withdrawal by Subject|0
4855537|NCT00927927|16738951|P14|Overall Study|Withdrawal by Subject|0
4855538|NCT00927927|16738952|P13|Overall Study|Withdrawal by Subject|0
4855539|NCT00927927|16738953|P12|Overall Study|Withdrawal by Subject|2
4855540|NCT00927927|16738954|P11|Overall Study|Withdrawal by Subject|0
4855541|NCT00927927|16738955|P10|Overall Study|Withdrawal by Subject|0
4855542|NCT00927927|16738956|P9|Overall Study|Withdrawal by Subject|0
4855543|NCT00927927|16738957|P8|Overall Study|Withdrawal by Subject|2
4855544|NCT00927927|16738958|P7|Overall Study|Withdrawal by Subject|0
4855545|NCT00927927|16738959|P6|Overall Study|Withdrawal by Subject|0
4855546|NCT00927927|16738960|P5|Overall Study|Withdrawal by Subject|0
4855547|NCT00927927|16738961|P4|Overall Study|Withdrawal by Subject|0
4855548|NCT00927927|16738962|P3|Overall Study|Withdrawal by Subject|0
4855549|NCT00927927|16738963|P2|Overall Study|Withdrawal by Subject|0
4855550|NCT00927927|16738964|P1|Overall Study|Withdrawal by Subject|0
4855551|NCT00927901|16739011|P4|Treatment Period 4|Subject withdrew consent|0
4855552|NCT00927901|16739012|P3|Treatment Period 4|Subject withdrew consent|1
4855553|NCT00927901|16739013|P2|Treatment Period 4|Subject withdrew consent|0
4855554|NCT00927901|16739014|P1|Treatment Period 4|Subject withdrew consent|0
4855555|NCT00927901|16739011|P4|Treatment Period 4|Adverse Event|1
4855556|NCT00927901|16739012|P3|Treatment Period 4|Adverse Event|0
4855557|NCT00927901|16739013|P2|Treatment Period 4|Adverse Event|0
4855558|NCT00927901|16739014|P1|Treatment Period 4|Adverse Event|0
4855559|NCT00927901|16739011|P4|Treatment Period 1|Subject withdrew consent|0
4855560|NCT00927901|16739012|P3|Treatment Period 1|Subject withdrew consent|1
4855561|NCT00927901|16739013|P2|Treatment Period 1|Subject withdrew consent|0
4855562|NCT00927901|16739014|P1|Treatment Period 1|Subject withdrew consent|0
4855563|NCT00927862|16739055|P2|Overall Study|Missing data needed for endpt analyses|45
4855564|NCT00927862|16739056|P1|Overall Study|Missing data needed for endpt analyses|27
4855565|NCT00927823|16739091|P4|Continuous Dosing Period|Other|3
4855566|NCT00927823|16739092|P3|Continuous Dosing Period|Other|9
4855567|NCT00927823|16739093|P2|Continuous Dosing Period|Other|2
4855568|NCT00927823|16739094|P1|Continuous Dosing Period|Other|1
4855569|NCT00927823|16739091|P4|Continuous Dosing Period|Withdrawal by Subject|2
4855570|NCT00927823|16739092|P3|Continuous Dosing Period|Withdrawal by Subject|2
4855571|NCT00927823|16739093|P2|Continuous Dosing Period|Withdrawal by Subject|0
4855572|NCT00927823|16739094|P1|Continuous Dosing Period|Withdrawal by Subject|1
4855573|NCT00927823|16739091|P4|Continuous Dosing Period|Lost to Follow-up|0
4855574|NCT00927823|16739092|P3|Continuous Dosing Period|Lost to Follow-up|9
4855575|NCT00927823|16739093|P2|Continuous Dosing Period|Lost to Follow-up|1
4855576|NCT00927823|16739094|P1|Continuous Dosing Period|Lost to Follow-up|1
4855577|NCT00927823|16739091|P4|Continuous Dosing Period|Death|0
4855578|NCT00927823|16739092|P3|Continuous Dosing Period|Death|6
4855579|NCT00927823|16739093|P2|Continuous Dosing Period|Death|0
4855580|NCT00927823|16739094|P1|Continuous Dosing Period|Death|0
4855581|NCT00927784|16739160|P2|Overall Study|Withdrawal by Subject|0
4855582|NCT00927784|16739161|P1|Overall Study|Withdrawal by Subject|1
4855583|NCT00927784|16739160|P2|Overall Study|Death|0
4855584|NCT00927784|16739161|P1|Overall Study|Death|1
4855585|NCT00927758|16739191|P6|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
4855586|NCT00927758|16739192|P5|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
4855587|NCT00927758|16739193|P4|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
4855588|NCT00927758|16739194|P3|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1
4855589|NCT00927758|16739195|P2|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
4855590|NCT00927758|16739196|P1|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0
4855591|NCT00927758|16739191|P6|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
4855592|NCT00927758|16739192|P5|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4855593|NCT00927758|16739193|P4|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1
4855594|NCT00927758|16739194|P3|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4855595|NCT00927758|16739195|P2|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4855596|NCT00927758|16739196|P1|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0
4855597|NCT00927589|16739204|P1|Overall Study|Non-compliance|1
4855598|NCT00927589|16739204|P1|Overall Study|Disease Progression|8
4855599|NCT00927589|16739204|P1|Overall Study|Adverse Event|2
4855600|NCT00927589|16739204|P1|Overall Study|Withdrawal by Subject|3
4855601|NCT00927589|16739204|P1|Overall Study|Physician Decision|1
4855602|NCT00927589|16739204|P1|Overall Study|Death|1
4855603|NCT00927563|16739234|P1|Overall Study|Withdrawal by Subject|1
4855604|NCT00927563|16739234|P1|Overall Study|Lost to Follow-up|1
4855605|NCT00927472|16739242|P2|Overall Study|Post treatment Assessment out of window|4
4855606|NCT00927472|16739243|P1|Overall Study|Post treatment Assessment out of window|0
4855607|NCT00927472|16739242|P2|Overall Study|Protocol Violation|1
4855608|NCT00927472|16739243|P1|Overall Study|Protocol Violation|0
4855609|NCT00927472|16739242|P2|Overall Study|Lost to Follow-up|6
4855610|NCT00927472|16739243|P1|Overall Study|Lost to Follow-up|1
4855611|NCT00927472|16739242|P2|Overall Study|Withdrawal by Subject|11
4855612|NCT00927472|16739243|P1|Overall Study|Withdrawal by Subject|10
4855613|NCT00927394|16739269|P2|Overall Study|Randomized in error|1
4855614|NCT00927394|16739270|P1|Overall Study|Randomized in error|0
4855615|NCT00927394|16739269|P2|Overall Study|Protocol deviation|13
4855616|NCT00927394|16739270|P1|Overall Study|Protocol deviation|16
4855617|NCT00927394|16739269|P2|Overall Study|Death|1
4855618|NCT00927394|16739270|P1|Overall Study|Death|1
4855619|NCT00927394|16739269|P2|Overall Study|Administrative Problem|0
4855620|NCT00927394|16739270|P1|Overall Study|Administrative Problem|1
4855621|NCT00927394|16739269|P2|Overall Study|Lost to Follow-up|14
4855622|NCT00927394|16739270|P1|Overall Study|Lost to Follow-up|8
4855623|NCT00927394|16739269|P2|Overall Study|Withdrawal by Subject|24
4855624|NCT00927394|16739270|P1|Overall Study|Withdrawal by Subject|20
4855625|NCT00927394|16739269|P2|Overall Study|Unsatisfactory therapeutic effect|23
4855626|NCT00927394|16739270|P1|Overall Study|Unsatisfactory therapeutic effect|17
4855627|NCT00927394|16739269|P2|Overall Study|Adverse Event|9
4855628|NCT00927394|16739270|P1|Overall Study|Adverse Event|14
4855629|NCT00927368|16739301|P3|Overall Study|cancellation of surgery|2
4855630|NCT00927368|16739302|P2|Overall Study|cancellation of surgery|1
4855631|NCT00927368|16739303|P1|Overall Study|cancellation of surgery|0
4855632|NCT00927368|16739301|P3|Overall Study|ineligible post randomization|1
4855633|NCT00927368|16739302|P2|Overall Study|ineligible post randomization|3
4855634|NCT00927368|16739303|P1|Overall Study|ineligible post randomization|0
4855635|NCT00927368|16739301|P3|Overall Study|equipment failure|0
4855636|NCT00927368|16739302|P2|Overall Study|equipment failure|0
4855637|NCT00927368|16739303|P1|Overall Study|equipment failure|1
4855638|NCT00927368|16739301|P3|Overall Study|Lost to Follow-up|0
4855639|NCT00927368|16739302|P2|Overall Study|Lost to Follow-up|0
4855640|NCT00927368|16739303|P1|Overall Study|Lost to Follow-up|4
4855641|NCT00927368|16739301|P3|Overall Study|enrollment in another study|2
4855642|NCT00927368|16739302|P2|Overall Study|enrollment in another study|1
4855643|NCT00927368|16739303|P1|Overall Study|enrollment in another study|1
4855644|NCT00927355|16739322|P2|Overall Study|Adverse Event|1
4855645|NCT00927355|16739323|P1|Overall Study|Adverse Event|1
4855646|NCT00927251|16739358|P1|Overall Study|Patients not implanted with 4296 lead|8
4855647|NCT00927186|16739364|P2|12 Months Primary Study|Withdrawal by Subject|1
4855648|NCT00927186|16739365|P1|12 Months Primary Study|Withdrawal by Subject|1
4855649|NCT00927186|16739364|P2|12 Months Primary Study|Protocol Violation|1
4855650|NCT00927186|16739365|P1|12 Months Primary Study|Protocol Violation|0
4855651|NCT00927186|16739364|P2|12 Months Primary Study|Lost to Follow-up|0
4855652|NCT00927186|16739365|P1|12 Months Primary Study|Lost to Follow-up|1
4855653|NCT00927186|16739364|P2|12 Months Primary Study|Adverse Event|2
4855654|NCT00927186|16739365|P1|12 Months Primary Study|Adverse Event|5
4855655|NCT00927095|16739495|P3|Overall Study|Physician Decision|1
4855656|NCT00927095|16739496|P2|Overall Study|Physician Decision|2
4855657|NCT00927095|16739497|P1|Overall Study|Physician Decision|1
4855658|NCT00927095|16739495|P3|Overall Study|Withdrawal by Subject|1
4855659|NCT00927095|16739496|P2|Overall Study|Withdrawal by Subject|1
4855660|NCT00927095|16739497|P1|Overall Study|Withdrawal by Subject|2
4855661|NCT00927095|16739495|P3|Overall Study|Adverse Event|0
4855662|NCT00927095|16739496|P2|Overall Study|Adverse Event|1
4855663|NCT00927095|16739497|P1|Overall Study|Adverse Event|3
4855664|NCT00927082|16739509|P4|Overall Study|Screen fail,Participant migrated,Unknown|1
4855665|NCT00927082|16739510|P3|Overall Study|Screen fail,Participant migrated,Unknown|2
4855666|NCT00927082|16739511|P2|Overall Study|Screen fail,Participant migrated,Unknown|0
4855667|NCT00927082|16739512|P1|Overall Study|Screen fail,Participant migrated,Unknown|0
4855668|NCT00927082|16739509|P4|Overall Study|Death|0
4855669|NCT00927082|16739510|P3|Overall Study|Death|1
4855670|NCT00927082|16739511|P2|Overall Study|Death|0
4855671|NCT00927082|16739512|P1|Overall Study|Death|0
4855672|NCT00927082|16739509|P4|Overall Study|Withdrawal by Subject|2
4855673|NCT00927082|16739510|P3|Overall Study|Withdrawal by Subject|7
4855674|NCT00927082|16739511|P2|Overall Study|Withdrawal by Subject|2
4855675|NCT00927082|16739512|P1|Overall Study|Withdrawal by Subject|3
4855676|NCT00927082|16739509|P4|Overall Study|Lost to Follow-up|16
4855677|NCT00927082|16739510|P3|Overall Study|Lost to Follow-up|12
4855678|NCT00927082|16739511|P2|Overall Study|Lost to Follow-up|8
4855679|NCT00927082|16739512|P1|Overall Study|Lost to Follow-up|9
4855680|NCT00927069|16739576|P4|Week 12 to Week 24|Had a vaccination, removed from study|0
4855681|NCT00927069|16739577|P3|Week 12 to Week 24|Had a vaccination, removed from study|0
4855682|NCT00927069|16739578|P2|Week 12 to Week 24|Had a vaccination, removed from study|0
4855683|NCT00927069|16739579|P1|Week 12 to Week 24|Had a vaccination, removed from study|1
4855684|NCT00927069|16739576|P4|Week 12 to Week 24|Withdrawal by Subject|0
4855685|NCT00927069|16739577|P3|Week 12 to Week 24|Withdrawal by Subject|0
4855686|NCT00927069|16739578|P2|Week 12 to Week 24|Withdrawal by Subject|0
4855687|NCT00927069|16739579|P1|Week 12 to Week 24|Withdrawal by Subject|1
4855688|NCT00927069|16739576|P4|Week 12 to Week 24|Lost to Follow-up|0
4855689|NCT00927069|16739577|P3|Week 12 to Week 24|Lost to Follow-up|1
4855690|NCT00927069|16739578|P2|Week 12 to Week 24|Lost to Follow-up|0
4855691|NCT00927069|16739579|P1|Week 12 to Week 24|Lost to Follow-up|0
4855692|NCT00927069|16739576|P4|Week 12 to Week 24|Lack of Efficacy|3
4855693|NCT00927069|16739577|P3|Week 12 to Week 24|Lack of Efficacy|2
4855694|NCT00927069|16739578|P2|Week 12 to Week 24|Lack of Efficacy|0
4855695|NCT00927069|16739579|P1|Week 12 to Week 24|Lack of Efficacy|0
4855696|NCT00927069|16739576|P4|Week 0 to Week 12|Worsening of psoriasis|0
4855697|NCT00927069|16739577|P3|Week 0 to Week 12|Worsening of psoriasis|0
4855698|NCT00927069|16739578|P2|Week 0 to Week 12|Worsening of psoriasis|1
4855699|NCT00927069|16739579|P1|Week 0 to Week 12|Worsening of psoriasis|1
4855700|NCT00926796|16739635|P2|Overall Study|Withdrawal by Subject|0
4855701|NCT00926796|16739636|P1|Overall Study|Withdrawal by Subject|1
4855702|NCT00926796|16739635|P2|Overall Study|Protocol Violation|11
4855703|NCT00926796|16739636|P1|Overall Study|Protocol Violation|15
4855704|NCT00926796|16739635|P2|Overall Study|Lost to Follow-up|13
4855705|NCT00926796|16739636|P1|Overall Study|Lost to Follow-up|22
4855706|NCT00926796|16739635|P2|Overall Study|Adverse Event|14
4855707|NCT00926796|16739636|P1|Overall Study|Adverse Event|7
4855708|NCT00926796|16739635|P2|Overall Study|Ineligible, but positive for gonorrhea|1
4855709|NCT00926796|16739636|P1|Overall Study|Ineligible, but positive for gonorrhea|1
4855710|NCT00926796|16739635|P2|Overall Study|Ineligible, negative for gonorrhea|60
4855711|NCT00926796|16739636|P1|Overall Study|Ineligible, negative for gonorrhea|57
4855712|NCT00926796|16739635|P2|Overall Study|Did not receive randomized treatment|7
4855713|NCT00926796|16739636|P1|Overall Study|Did not receive randomized treatment|4
4855714|NCT00926783|16739657|P2|Overall Study|Incomplete CFAE Procedures|3
4855715|NCT00926783|16739658|P1|Overall Study|Incomplete CFAE Procedures|3
4855716|NCT00926575|16739685|P2|Overall Study|Withdrawal by Subject|9
4855717|NCT00926575|16739686|P1|Overall Study|Withdrawal by Subject|8
4855718|NCT00926575|16739685|P2|Overall Study|Protocol Violation|0
4855719|NCT00926575|16739686|P1|Overall Study|Protocol Violation|1
4855720|NCT00926575|16739685|P2|Overall Study|Physician Decision|2
4855721|NCT00926575|16739686|P1|Overall Study|Physician Decision|1
4855722|NCT00926575|16739685|P2|Overall Study|Lost to Follow-up|1
4855723|NCT00926575|16739686|P1|Overall Study|Lost to Follow-up|1
4855724|NCT00926575|16739685|P2|Overall Study|Death|4
4855725|NCT00926575|16739686|P1|Overall Study|Death|4
4855726|NCT00926575|16739685|P2|Overall Study|Adverse Event|1
4855727|NCT00926575|16739686|P1|Overall Study|Adverse Event|1
4855728|NCT00926536|16739698|P2|Overall Study|Physician Decision|2
4855729|NCT00926536|16739699|P1|Overall Study|Physician Decision|1
4855730|NCT00926393|16739720|P2|Overall Study|Adverse Event|1
4855731|NCT00926393|16739721|P1|Overall Study|Adverse Event|1
4855732|NCT00926393|16739720|P2|Overall Study|Withdrawal by Subject|2
4855733|NCT00926393|16739721|P1|Overall Study|Withdrawal by Subject|1
4855734|NCT00926367|16739766|P2|Overall Study|Skin Irritation|2
4855735|NCT00926367|16739767|P1|Overall Study|Skin Irritation|1
4855736|NCT00926367|16739766|P2|Overall Study|Lost to Follow-up|0
4855737|NCT00926367|16739767|P1|Overall Study|Lost to Follow-up|1
4855738|NCT00926367|16739766|P2|Overall Study|Withdrawal by Subject|1
4855739|NCT00926367|16739767|P1|Overall Study|Withdrawal by Subject|0
4855740|NCT00926328|16739809|P2|Overall Study|Lost to Follow-up|14
4855741|NCT00926328|16739810|P1|Overall Study|Lost to Follow-up|12
4855742|NCT00926289|16739820|P2|Overall Study|Other|3
4855743|NCT00926289|16739821|P1|Overall Study|Other|1
4855744|NCT00926289|16739820|P2|Overall Study|Withdrawal by Subject|4
4855745|NCT00926289|16739821|P1|Overall Study|Withdrawal by Subject|4
4855746|NCT00926289|16739820|P2|Overall Study|Lost to Follow-up|6
4855747|NCT00926289|16739821|P1|Overall Study|Lost to Follow-up|3
4855748|NCT00926289|16739820|P2|Overall Study|Protocol Violation|12
4855749|NCT00926289|16739821|P1|Overall Study|Protocol Violation|8
4855750|NCT00926289|16739820|P2|Overall Study|Adverse Event|11
4855751|NCT00926289|16739821|P1|Overall Study|Adverse Event|9
4855752|NCT00926211|16739889|P1|Overall Study|Lost to Follow-up|1
4855753|NCT00926029|16739920|P3|Overall Study|Lost to Follow-up|1
4855754|NCT00926029|16739921|P2|Overall Study|Lost to Follow-up|1
4855755|NCT00926029|16739922|P1|Overall Study|Lost to Follow-up|2
4855756|NCT00926003|16739936|P3|Post-Training 3-month Follow-up|Lost to Follow-up|0
4855757|NCT00926003|16739937|P2|Post-Training 3-month Follow-up|Lost to Follow-up|0
4855758|NCT00926003|16739938|P1|Post-Training 3-month Follow-up|Lost to Follow-up|1
4855759|NCT00926003|16739936|P3|Post-Training Evaluation|Withdrawal by Subject|0
4855760|NCT00926003|16739937|P2|Post-Training Evaluation|Withdrawal by Subject|0
4855761|NCT00926003|16739938|P1|Post-Training Evaluation|Withdrawal by Subject|1
4855762|NCT00925990|16739951|P2|Overall Study|moved out of state, missed medication|2
4855763|NCT00925990|16739952|P1|Overall Study|moved out of state, missed medication|0
4855764|NCT00925990|16739951|P2|Overall Study|Physician Decision|1
4855765|NCT00925990|16739952|P1|Overall Study|Physician Decision|1
4855766|NCT00925990|16739951|P2|Overall Study|Lost to Follow-up|3
4855767|NCT00925990|16739952|P1|Overall Study|Lost to Follow-up|1
4855768|NCT00925990|16739951|P2|Overall Study|Withdrawal by Subject|2
4855769|NCT00925990|16739952|P1|Overall Study|Withdrawal by Subject|2
4855770|NCT00925990|16739951|P2|Overall Study|Adverse Event|3
4855771|NCT00925990|16739952|P1|Overall Study|Adverse Event|1
4855772|NCT00925899|16739987|P2|Part 1|Withdrawal by Subject|9
4855773|NCT00925899|16739988|P1|Part 1|Withdrawal by Subject|10
4855774|NCT00925899|16739987|P2|Part 1|Death|2
4855775|NCT00925899|16739988|P1|Part 1|Death|1
4855776|NCT00925769|16740016|P6|Overall Study|Adverse Event|0
4855777|NCT00925769|16740017|P5|Overall Study|Adverse Event|1
4855778|NCT00925769|16740018|P4|Overall Study|Adverse Event|0
4855779|NCT00925769|16740019|P3|Overall Study|Adverse Event|0
4855780|NCT00925769|16740020|P2|Overall Study|Adverse Event|0
4855781|NCT00925769|16740021|P1|Overall Study|Adverse Event|0
4855782|NCT00925769|16740016|P6|Overall Study|Participant is unable to swallow drug|0
4855783|NCT00925769|16740017|P5|Overall Study|Participant is unable to swallow drug|0
4855784|NCT00925769|16740018|P4|Overall Study|Participant is unable to swallow drug|1
4855785|NCT00925769|16740019|P3|Overall Study|Participant is unable to swallow drug|0
4855786|NCT00925769|16740020|P2|Overall Study|Participant is unable to swallow drug|0
4855787|NCT00925769|16740021|P1|Overall Study|Participant is unable to swallow drug|0
4855788|NCT00925769|16740016|P6|Overall Study|End of study visit not done|0
4855789|NCT00925769|16740017|P5|Overall Study|End of study visit not done|0
4855790|NCT00925769|16740018|P4|Overall Study|End of study visit not done|0
4855791|NCT00925769|16740019|P3|Overall Study|End of study visit not done|1
4855792|NCT00925769|16740020|P2|Overall Study|End of study visit not done|0
4855793|NCT00925769|16740021|P1|Overall Study|End of study visit not done|0
4855794|NCT00925769|16740016|P6|Overall Study|Missing documentation|0
4855795|NCT00925769|16740017|P5|Overall Study|Missing documentation|0
4855796|NCT00925769|16740018|P4|Overall Study|Missing documentation|0
4855797|NCT00925769|16740019|P3|Overall Study|Missing documentation|0
4855798|NCT00925769|16740020|P2|Overall Study|Missing documentation|1
4855799|NCT00925769|16740021|P1|Overall Study|Missing documentation|0
4855800|NCT00925769|16740016|P6|Overall Study|Physician Decision|0
4855801|NCT00925769|16740017|P5|Overall Study|Physician Decision|0
4855802|NCT00925769|16740018|P4|Overall Study|Physician Decision|0
4855803|NCT00925769|16740019|P3|Overall Study|Physician Decision|0
4855804|NCT00925769|16740020|P2|Overall Study|Physician Decision|0
4855805|NCT00925769|16740021|P1|Overall Study|Physician Decision|1
4855806|NCT00925769|16740016|P6|Overall Study|Death|0
4855807|NCT00925769|16740017|P5|Overall Study|Death|0
4855808|NCT00925769|16740018|P4|Overall Study|Death|0
4855809|NCT00925769|16740019|P3|Overall Study|Death|1
4855810|NCT00925769|16740020|P2|Overall Study|Death|0
4855811|NCT00925769|16740021|P1|Overall Study|Death|0
4855812|NCT00925769|16740016|P6|Overall Study|Disease progression|3
4855813|NCT00925769|16740017|P5|Overall Study|Disease progression|2
4855814|NCT00925769|16740018|P4|Overall Study|Disease progression|4
4855815|NCT00925769|16740019|P3|Overall Study|Disease progression|3
4855816|NCT00925769|16740020|P2|Overall Study|Disease progression|5
4855817|NCT00925769|16740021|P1|Overall Study|Disease progression|4
4855818|NCT00925769|16740016|P6|Overall Study|Major toxicity|0
4855819|NCT00925769|16740017|P5|Overall Study|Major toxicity|0
4855820|NCT00925769|16740018|P4|Overall Study|Major toxicity|1
4855821|NCT00925769|16740019|P3|Overall Study|Major toxicity|1
4855822|NCT00925769|16740020|P2|Overall Study|Major toxicity|0
4855823|NCT00925769|16740021|P1|Overall Study|Major toxicity|1
4855824|NCT00925704|16740095|P6|Third Intervention|Withdrew consent|1
4855825|NCT00925704|16740096|P5|Third Intervention|Withdrew consent|0
4855826|NCT00925704|16740097|P4|Third Intervention|Withdrew consent|0
4855827|NCT00925704|16740098|P3|Third Intervention|Withdrew consent|0
4855828|NCT00925704|16740099|P2|Third Intervention|Withdrew consent|0
4855829|NCT00925704|16740100|P1|Third Intervention|Withdrew consent|0
4855830|NCT00925704|16740095|P6|Second Intervention|Withdrawal by Subject|0
4855831|NCT00925704|16740096|P5|Second Intervention|Withdrawal by Subject|1
4855832|NCT00925704|16740097|P4|Second Intervention|Withdrawal by Subject|0
4855833|NCT00925704|16740098|P3|Second Intervention|Withdrawal by Subject|0
4855834|NCT00925704|16740099|P2|Second Intervention|Withdrawal by Subject|0
4855835|NCT00925704|16740100|P1|Second Intervention|Withdrawal by Subject|1
4855836|NCT00925704|16740095|P6|First Intervention|Withdrew consent|0
4855837|NCT00925704|16740096|P5|First Intervention|Withdrew consent|1
4855838|NCT00925704|16740097|P4|First Intervention|Withdrew consent|1
4855839|NCT00925704|16740098|P3|First Intervention|Withdrew consent|0
4855840|NCT00925704|16740099|P2|First Intervention|Withdrew consent|0
4855841|NCT00925704|16740100|P1|First Intervention|Withdrew consent|0
4855842|NCT00925600|16740113|P2|Overall Study|Adverse Event|2
4855843|NCT00925600|16740114|P1|Overall Study|Adverse Event|1
4855844|NCT00925600|16740113|P2|Overall Study|Other|1
4855845|NCT00925600|16740114|P1|Overall Study|Other|3
4855846|NCT00925600|16740113|P2|Overall Study|Requirement for Alternative Therapy|1
4855847|NCT00925600|16740114|P1|Overall Study|Requirement for Alternative Therapy|0
4855848|NCT00925600|16740113|P2|Overall Study|Protocol Deviation|1
4855849|NCT00925600|16740114|P1|Overall Study|Protocol Deviation|0
4855850|NCT00925600|16740113|P2|Overall Study|Ineligibility Determined|0
4855851|NCT00925600|16740114|P1|Overall Study|Ineligibility Determined|2
4855852|NCT00925600|16740113|P2|Overall Study|Noncompliance|0
4855853|NCT00925600|16740114|P1|Overall Study|Noncompliance|2
4855854|NCT00925600|16740113|P2|Overall Study|Administrative Decision|1
4855855|NCT00925600|16740114|P1|Overall Study|Administrative Decision|1
4855856|NCT00925600|16740113|P2|Overall Study|Disease Progression|3
4855857|NCT00925600|16740114|P1|Overall Study|Disease Progression|1
4855858|NCT00925600|16740113|P2|Overall Study|Lost to Follow-up|2
4855859|NCT00925600|16740114|P1|Overall Study|Lost to Follow-up|2
4855860|NCT00925600|16740113|P2|Overall Study|Death|3
4855861|NCT00925600|16740114|P1|Overall Study|Death|4
4855862|NCT00925600|16740113|P2|Overall Study|Withdrawal by Subject|14
4855863|NCT00925600|16740114|P1|Overall Study|Withdrawal by Subject|16
4855864|NCT00925587|16740136|P2|Overall Study|Lost to Follow-up|1
4855865|NCT00925587|16740137|P1|Overall Study|Lost to Follow-up|0
4855866|NCT00925587|16740136|P2|Overall Study|Adverse Event|2
4855867|NCT00925587|16740137|P1|Overall Study|Adverse Event|6
4855868|NCT00925587|16740136|P2|Overall Study|Death|5
4855869|NCT00925587|16740137|P1|Overall Study|Death|5
4855870|NCT00925587|16740136|P2|Overall Study|Withdrawal by Subject|6
4855871|NCT00925587|16740137|P1|Overall Study|Withdrawal by Subject|9
4855872|NCT00925587|16740136|P2|Overall Study|Protocol Violation|4
4855873|NCT00925587|16740137|P1|Overall Study|Protocol Violation|6
4855874|NCT00925587|16740136|P2|Overall Study|Physician Decision|1
4855875|NCT00925587|16740137|P1|Overall Study|Physician Decision|4
4855876|NCT00925587|16740136|P2|Overall Study|Protocol Specified Criteria|6
4855877|NCT00925587|16740137|P1|Overall Study|Protocol Specified Criteria|6
4855878|NCT00925548|16740251|P2|Overall Study|Discontinuation of trial by sponsor|5
4855879|NCT00925548|16740252|P1|Overall Study|Discontinuation of trial by sponsor|10
4855880|NCT00925522|16740278|P1|Overall Study|study closed -- business decision|20
4855881|NCT00925353|16740282|P1|Overall Study|Failed preliminary EKG or lab criteria.|3
4855882|NCT00925301|16740288|P4|12-Month Open-label Extension (Optional)|Lost to Follow-up|1
4855883|NCT00925301|16740289|P3|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
4855884|NCT00925301|16740290|P2|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
4855885|NCT00925301|16740291|P1|12-Month Open-label Extension (Optional)|Lost to Follow-up|0
4855886|NCT00925301|16740288|P4|12-Month Open-label Extension (Optional)|Pregnancy|1
4855887|NCT00925301|16740289|P3|12-Month Open-label Extension (Optional)|Pregnancy|0
4855888|NCT00925301|16740290|P2|12-Month Open-label Extension (Optional)|Pregnancy|0
4855889|NCT00925301|16740291|P1|12-Month Open-label Extension (Optional)|Pregnancy|0
4855890|NCT00925301|16740288|P4|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1
4855891|NCT00925301|16740289|P3|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
4855892|NCT00925301|16740290|P2|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
4855893|NCT00925301|16740291|P1|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0
4855894|NCT00925301|16740288|P4|6-Month Open-label (Stage 2)|Adverse Event|0
4855895|NCT00925301|16740289|P3|6-Month Open-label (Stage 2)|Adverse Event|2
4855896|NCT00925301|16740290|P2|6-Month Open-label (Stage 2)|Adverse Event|0
4855897|NCT00925301|16740291|P1|6-Month Open-label (Stage 2)|Adverse Event|0
4855898|NCT00925301|16740288|P4|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
4855899|NCT00925301|16740289|P3|6-Month Open-label (Stage 2)|Withdrawal by Subject|1
4855900|NCT00925301|16740290|P2|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
4855901|NCT00925301|16740291|P1|6-Month Open-label (Stage 2)|Withdrawal by Subject|0
4855902|NCT00925301|16740288|P4|6-Month Double-blind (Stage 1)|Pregnancy|0
4855903|NCT00925301|16740289|P3|6-Month Double-blind (Stage 1)|Pregnancy|0
4855904|NCT00925301|16740290|P2|6-Month Double-blind (Stage 1)|Pregnancy|1
4855905|NCT00925301|16740291|P1|6-Month Double-blind (Stage 1)|Pregnancy|0
4855906|NCT00925301|16740288|P4|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
4855907|NCT00925301|16740289|P3|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
4855908|NCT00925301|16740290|P2|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2
4855909|NCT00925301|16740291|P1|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0
4855910|NCT00925288|16740307|P2|Overall Study|Lost to Follow-up|7
4855911|NCT00925288|16740308|P1|Overall Study|Lost to Follow-up|9
4855912|NCT00925132|16740320|P5|Overall Study|Removed due to disease progression|4
4855913|NCT00925132|16740321|P4|Overall Study|Removed due to disease progression|0
4855914|NCT00925132|16740322|P3|Overall Study|Removed due to disease progression|0
4855915|NCT00925132|16740323|P2|Overall Study|Removed due to disease progression|0
4855916|NCT00925132|16740324|P1|Overall Study|Removed due to disease progression|0
4855917|NCT00925132|16740320|P5|Overall Study|Withdrawal by Subject|1
4855918|NCT00925132|16740321|P4|Overall Study|Withdrawal by Subject|0
4855919|NCT00925132|16740322|P3|Overall Study|Withdrawal by Subject|0
4855920|NCT00925132|16740323|P2|Overall Study|Withdrawal by Subject|0
4855921|NCT00925132|16740324|P1|Overall Study|Withdrawal by Subject|2
4855922|NCT00925015|16740419|P3|Overall Study|Withdrawal by Subject|1
4855923|NCT00925015|16740420|P2|Overall Study|Withdrawal by Subject|0
4855924|NCT00925015|16740421|P1|Overall Study|Withdrawal by Subject|0
4855925|NCT00925015|16740419|P3|Overall Study|Progressive Disease|4
4855926|NCT00925015|16740420|P2|Overall Study|Progressive Disease|3
4855927|NCT00925015|16740421|P1|Overall Study|Progressive Disease|7
4855928|NCT00925015|16740419|P3|Overall Study|Physician Decision|0
4855929|NCT00925015|16740420|P2|Overall Study|Physician Decision|1
4855930|NCT00925015|16740421|P1|Overall Study|Physician Decision|0
4855931|NCT00925015|16740419|P3|Overall Study|Adverse Event|1
4855932|NCT00925015|16740420|P2|Overall Study|Adverse Event|2
4855933|NCT00925015|16740421|P1|Overall Study|Adverse Event|1
4855934|NCT00924950|16740477|P1|Overall Study|Lost to Follow-up|2
4855935|NCT00924898|16740484|P1|Overall Study|Withdrawal by Subject|2
4855936|NCT00924781|16740521|P2|Overall Study|Study terminated by sponsor|10
4855937|NCT00924781|16740522|P1|Overall Study|Study terminated by sponsor|12
4855938|NCT00924729|16740556|P2|Overall Study|Protocol Violation|0
4855939|NCT00924729|16740557|P1|Overall Study|Protocol Violation|1
4855940|NCT00924729|16740556|P2|Overall Study|insufficient volume for analysis|0
4855941|NCT00924729|16740557|P1|Overall Study|insufficient volume for analysis|1
4855942|NCT00924651|16740567|P2|Overall Study|Incomplete Form|1
4855943|NCT00924651|16740568|P1|Overall Study|Incomplete Form|2
4855944|NCT00924651|16740567|P2|Overall Study|Changed Mind|1
4855945|NCT00924651|16740568|P1|Overall Study|Changed Mind|10
4855946|NCT00924651|16740567|P2|Overall Study|Medical|3
4855947|NCT00924651|16740568|P1|Overall Study|Medical|1
4855948|NCT00924651|16740567|P2|Overall Study|Noncompliant|4
4855949|NCT00924651|16740568|P1|Overall Study|Noncompliant|1
4855950|NCT00924651|16740567|P2|Overall Study|Overwhelmed|6
4855951|NCT00924651|16740568|P1|Overall Study|Overwhelmed|6
4855952|NCT00924651|16740567|P2|Overall Study|No Reason|7
4855953|NCT00924651|16740568|P1|Overall Study|No Reason|3
4855954|NCT00924651|16740567|P2|Overall Study|Chemo started too soon|3
4855955|NCT00924651|16740568|P1|Overall Study|Chemo started too soon|2
4855956|NCT00924638|16740576|P2|Overall Study|Physician Decision|3
4855957|NCT00924638|16740577|P1|Overall Study|Physician Decision|3
4855958|NCT00924638|16740576|P2|Overall Study|Withdrawal by Subject|7
4855959|NCT00924638|16740577|P1|Overall Study|Withdrawal by Subject|5
4855960|NCT00924638|16740576|P2|Overall Study|Lost to Follow-up|1
4855961|NCT00924638|16740577|P1|Overall Study|Lost to Follow-up|1
4855962|NCT00924638|16740576|P2|Overall Study|Death|2
4855963|NCT00924638|16740577|P1|Overall Study|Death|3
4855964|NCT00924560|16740599|P3|Overall Study|Miscellaneous Reasons|10
4855965|NCT00924560|16740600|P2|Overall Study|Miscellaneous Reasons|10
4855966|NCT00924560|16740601|P1|Overall Study|Miscellaneous Reasons|13
4855967|NCT00924560|16740599|P3|Overall Study|Lost to Follow-up|45
4855968|NCT00924560|16740600|P2|Overall Study|Lost to Follow-up|94
4855969|NCT00924560|16740601|P1|Overall Study|Lost to Follow-up|78
4855970|NCT00924560|16740599|P3|Overall Study|Pregnancy|1
4855971|NCT00924560|16740600|P2|Overall Study|Pregnancy|7
4855972|NCT00924560|16740601|P1|Overall Study|Pregnancy|5
4855973|NCT00924560|16740599|P3|Overall Study|Adverse Event|0
4855974|NCT00924560|16740600|P2|Overall Study|Adverse Event|33
4855975|NCT00924560|16740601|P1|Overall Study|Adverse Event|39
4855976|NCT00924560|16740599|P3|Overall Study|Withdrawal by Subject|18
4855977|NCT00924560|16740600|P2|Overall Study|Withdrawal by Subject|44
4855978|NCT00924560|16740601|P1|Overall Study|Withdrawal by Subject|50
4855979|NCT00924560|16740599|P3|Overall Study|Physician Decision|4
4855980|NCT00924560|16740600|P2|Overall Study|Physician Decision|3
4855981|NCT00924560|16740601|P1|Overall Study|Physician Decision|2
4855982|NCT00924560|16740599|P3|Overall Study|Non Compliance with the Protocol|4
4855983|NCT00924560|16740600|P2|Overall Study|Non Compliance with the Protocol|15
4855984|NCT00924560|16740601|P1|Overall Study|Non Compliance with the Protocol|20
4855985|NCT00924560|16740599|P3|Overall Study|Did Not Meet Protocol Requirements|1
4855986|NCT00924560|16740600|P2|Overall Study|Did Not Meet Protocol Requirements|2
4855987|NCT00924560|16740601|P1|Overall Study|Did Not Meet Protocol Requirements|4
4855988|NCT00924508|16740645|P1|Overall Study|Withdrawal by Subject|3
4855989|NCT00924469|16740659|P2|Overall Study|Lost to Follow-up|1
4855990|NCT00924469|16740660|P1|Overall Study|Lost to Follow-up|0
4855991|NCT00924469|16740659|P2|Overall Study|Withdrawal by Subject|1
4855992|NCT00924469|16740660|P1|Overall Study|Withdrawal by Subject|0
4855993|NCT00924469|16740659|P2|Overall Study|Adverse Event|0
4855994|NCT00924469|16740660|P1|Overall Study|Adverse Event|2
4855995|NCT00924443|16740682|P1|Overall Study|Protocol Violation|1
4855996|NCT00924443|16740682|P1|Overall Study|Physician Decision|2
4855997|NCT00924404|16740692|P2|Overall Study|Lost to Follow-up|4
4855998|NCT00924404|16740693|P1|Overall Study|Lost to Follow-up|6
4855999|NCT00924313|16740764|P1|Overall Study|not imaged due to failed tracer imaging|1
4856000|NCT00924287|16740776|P1|Overall Study|Death|1
4856001|NCT00924170|16740792|P2|Overall Study|Death|0
4856002|NCT00924170|16740793|P1|Overall Study|Death|1
4856003|NCT00924170|16740792|P2|Overall Study|Stopped due to neutralizing antibodies|0
4856004|NCT00924170|16740793|P1|Overall Study|Stopped due to neutralizing antibodies|3
4856005|NCT00924170|16740792|P2|Overall Study|Progressive disease|6
4856006|NCT00924170|16740793|P1|Overall Study|Progressive disease|3
4856007|NCT00924170|16740792|P2|Overall Study|Physician Decision|1
4856008|NCT00924170|16740793|P1|Overall Study|Physician Decision|0
4856009|NCT00924170|16740792|P2|Overall Study|Refused further treatment|1
4856010|NCT00924170|16740793|P1|Overall Study|Refused further treatment|0
4856011|NCT00923975|16740918|P1|Overall Study|Did not meet inclusion criteria|1
4856012|NCT00923936|16740937|P2|Overall Study|Continuing in follow up period|1
4856013|NCT00923936|16740938|P1|Overall Study|Continuing in follow up period|2
4856014|NCT00923936|16740937|P2|Overall Study|Lost to follow up|0
4856015|NCT00923936|16740938|P1|Overall Study|Lost to follow up|2
4856016|NCT00923936|16740937|P2|Overall Study|Adverse Event|1
4856017|NCT00923936|16740938|P1|Overall Study|Adverse Event|2
4856018|NCT00923936|16740937|P2|Overall Study|progressive disease on study|1
4856019|NCT00923936|16740938|P1|Overall Study|progressive disease on study|2
4856020|NCT00923845|16740967|P2|Induction Therapy|Poor performance status|2
4856021|NCT00923845|16740968|P1|Induction Therapy|Poor performance status|0
4856022|NCT00923364|16741003|P2|Overall Study|Did not go to transplant|0
4856023|NCT00923364|16741004|P1|Overall Study|Did not go to transplant|1
4856024|NCT00923364|16741003|P2|Overall Study|Death|0
4856025|NCT00923364|16741004|P1|Overall Study|Death|3
4856026|NCT00923351|16741016|P3|Overall Study|no apheresis/adequate tumor sample|12
4856027|NCT00923351|16741017|P2|Overall Study|no apheresis/adequate tumor sample|0
4856028|NCT00923351|16741018|P1|Overall Study|no apheresis/adequate tumor sample|0
4856029|NCT00923273|16741033|P5|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4856030|NCT00923273|16741034|P4|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6
4856031|NCT00923273|16741035|P3|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4856032|NCT00923273|16741036|P2|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4856033|NCT00923273|16741037|P1|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0
4856034|NCT00923273|16741033|P5|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4856035|NCT00923273|16741034|P4|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1
4856036|NCT00923273|16741035|P3|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4856037|NCT00923273|16741036|P2|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4856038|NCT00923273|16741037|P1|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0
4856039|NCT00923260|16741062|P2|Overall Study|Lost to Follow-up|1
4856040|NCT00923260|16741063|P1|Overall Study|Lost to Follow-up|1
4856041|NCT00923195|16741226|P2|Overall Study|Death|1
4856042|NCT00923195|16741227|P1|Overall Study|Death|0
4856043|NCT00923156|16741238|P3|Overall Study|Lack of Efficacy|1
4856044|NCT00923156|16741239|P2|Overall Study|Lack of Efficacy|0
4856045|NCT00923156|16741240|P1|Overall Study|Lack of Efficacy|0
4856046|NCT00923156|16741238|P3|Overall Study|Death|0
4856047|NCT00923156|16741239|P2|Overall Study|Death|1
4856048|NCT00923156|16741240|P1|Overall Study|Death|0
4856049|NCT00923156|16741238|P3|Overall Study|Withdrawal by Subject|0
4856050|NCT00923156|16741239|P2|Overall Study|Withdrawal by Subject|1
4856051|NCT00923156|16741240|P1|Overall Study|Withdrawal by Subject|0
4856052|NCT00923156|16741238|P3|Overall Study|Abnormal laboratory values|1
4856053|NCT00923156|16741239|P2|Overall Study|Abnormal laboratory values|0
4856054|NCT00923156|16741240|P1|Overall Study|Abnormal laboratory values|0
4856055|NCT00923156|16741238|P3|Overall Study|Adverse Event|1
4856056|NCT00923156|16741239|P2|Overall Study|Adverse Event|2
4856057|NCT00923156|16741240|P1|Overall Study|Adverse Event|0
4856058|NCT00923130|16741266|P1|Overall Study|Refused further treatment|2
4856059|NCT00923130|16741266|P1|Overall Study|Switched to alternative treatment|2
4856060|NCT00923130|16741266|P1|Overall Study|Discontinued treatment due to toxicities|3
4856061|NCT00923130|16741266|P1|Overall Study|Death|1
4856062|NCT00923130|16741266|P1|Overall Study|Stopped treatment due to progression|17
4856063|NCT00923091|16741301|P13|Period VI (Open-Label)|Other Reason|0
4856064|NCT00923091|16741302|P12|Period VI (Open-Label)|Other Reason|0
4856065|NCT00923091|16741303|P11|Period VI (Open-Label)|Other Reason|0
4856066|NCT00923091|16741304|P10|Period VI (Open-Label)|Other Reason|0
4856067|NCT00923091|16741305|P9|Period VI (Open-Label)|Other Reason|0
4856068|NCT00923091|16741306|P8|Period VI (Open-Label)|Other Reason|0
4856069|NCT00923091|16741307|P7|Period VI (Open-Label)|Other Reason|0
4856070|NCT00923091|16741308|P6|Period VI (Open-Label)|Other Reason|0
4856071|NCT00923091|16741309|P5|Period VI (Open-Label)|Other Reason|1
4856072|NCT00923091|16741310|P4|Period VI (Open-Label)|Other Reason|1
4856073|NCT00923091|16741311|P3|Period VI (Open-Label)|Other Reason|0
4856074|NCT00923091|16741312|P2|Period VI (Open-Label)|Other Reason|0
4856075|NCT00923091|16741313|P1|Period VI (Open-Label)|Other Reason|0
4856076|NCT00923091|16741301|P13|Period VI (Open-Label)|Lost to Follow-up|0
4856077|NCT00923091|16741302|P12|Period VI (Open-Label)|Lost to Follow-up|0
4856078|NCT00923091|16741303|P11|Period VI (Open-Label)|Lost to Follow-up|0
4856079|NCT00923091|16741304|P10|Period VI (Open-Label)|Lost to Follow-up|0
4856080|NCT00923091|16741305|P9|Period VI (Open-Label)|Lost to Follow-up|0
4856081|NCT00923091|16741306|P8|Period VI (Open-Label)|Lost to Follow-up|0
4856082|NCT00923091|16741307|P7|Period VI (Open-Label)|Lost to Follow-up|0
4856083|NCT00923091|16741308|P6|Period VI (Open-Label)|Lost to Follow-up|0
4856084|NCT00923091|16741309|P5|Period VI (Open-Label)|Lost to Follow-up|0
4856085|NCT00923091|16741310|P4|Period VI (Open-Label)|Lost to Follow-up|0
4856086|NCT00923091|16741311|P3|Period VI (Open-Label)|Lost to Follow-up|1
4856087|NCT00923091|16741312|P2|Period VI (Open-Label)|Lost to Follow-up|0
4856088|NCT00923091|16741313|P1|Period VI (Open-Label)|Lost to Follow-up|1
4856089|NCT00923091|16741301|P13|Period VI (Open-Label)|Protocol Violation|0
4856090|NCT00923091|16741302|P12|Period VI (Open-Label)|Protocol Violation|0
4856091|NCT00923091|16741303|P11|Period VI (Open-Label)|Protocol Violation|0
4856092|NCT00923091|16741304|P10|Period VI (Open-Label)|Protocol Violation|0
4856093|NCT00923091|16741305|P9|Period VI (Open-Label)|Protocol Violation|0
4856094|NCT00923091|16741306|P8|Period VI (Open-Label)|Protocol Violation|0
4856095|NCT00923091|16741307|P7|Period VI (Open-Label)|Protocol Violation|0
4856096|NCT00923091|16741308|P6|Period VI (Open-Label)|Protocol Violation|0
4856097|NCT00923091|16741309|P5|Period VI (Open-Label)|Protocol Violation|4
4856098|NCT00923091|16741310|P4|Period VI (Open-Label)|Protocol Violation|1
4856099|NCT00923091|16741311|P3|Period VI (Open-Label)|Protocol Violation|3
4856100|NCT00923091|16741312|P2|Period VI (Open-Label)|Protocol Violation|1
4856101|NCT00923091|16741313|P1|Period VI (Open-Label)|Protocol Violation|6
4856102|NCT00923091|16741301|P13|Period VI (Open-Label)|Withdrawal by Subject|0
4856103|NCT00923091|16741302|P12|Period VI (Open-Label)|Withdrawal by Subject|0
4856104|NCT00923091|16741303|P11|Period VI (Open-Label)|Withdrawal by Subject|0
4856105|NCT00923091|16741304|P10|Period VI (Open-Label)|Withdrawal by Subject|0
4856106|NCT00923091|16741305|P9|Period VI (Open-Label)|Withdrawal by Subject|0
4856107|NCT00923091|16741306|P8|Period VI (Open-Label)|Withdrawal by Subject|0
4856108|NCT00923091|16741307|P7|Period VI (Open-Label)|Withdrawal by Subject|0
4856109|NCT00923091|16741308|P6|Period VI (Open-Label)|Withdrawal by Subject|0
4856110|NCT00923091|16741309|P5|Period VI (Open-Label)|Withdrawal by Subject|1
4856111|NCT00923091|16741310|P4|Period VI (Open-Label)|Withdrawal by Subject|0
4856112|NCT00923091|16741311|P3|Period VI (Open-Label)|Withdrawal by Subject|5
4856113|NCT00923091|16741312|P2|Period VI (Open-Label)|Withdrawal by Subject|7
4856114|NCT00923091|16741313|P1|Period VI (Open-Label)|Withdrawal by Subject|15
4856115|NCT00923091|16741301|P13|Period VI (Open-Label)|Adverse Event|0
4856116|NCT00923091|16741302|P12|Period VI (Open-Label)|Adverse Event|0
4856117|NCT00923091|16741303|P11|Period VI (Open-Label)|Adverse Event|0
4856118|NCT00923091|16741304|P10|Period VI (Open-Label)|Adverse Event|0
4856119|NCT00923091|16741305|P9|Period VI (Open-Label)|Adverse Event|0
4856120|NCT00923091|16741306|P8|Period VI (Open-Label)|Adverse Event|0
4856121|NCT00923091|16741307|P7|Period VI (Open-Label)|Adverse Event|0
4856122|NCT00923091|16741308|P6|Period VI (Open-Label)|Adverse Event|0
4856123|NCT00923091|16741309|P5|Period VI (Open-Label)|Adverse Event|1
4856124|NCT00923091|16741310|P4|Period VI (Open-Label)|Adverse Event|1
4856125|NCT00923091|16741311|P3|Period VI (Open-Label)|Adverse Event|4
4856126|NCT00923091|16741312|P2|Period VI (Open-Label)|Adverse Event|0
4856127|NCT00923091|16741313|P1|Period VI (Open-Label)|Adverse Event|17
4856128|NCT00923091|16741301|P13|Period V (Double -Blind)|Lost to Follow-up|0
4856129|NCT00923091|16741302|P12|Period V (Double -Blind)|Lost to Follow-up|0
4856130|NCT00923091|16741303|P11|Period V (Double -Blind)|Lost to Follow-up|1
4856131|NCT00923091|16741304|P10|Period V (Double -Blind)|Lost to Follow-up|0
4856132|NCT00923091|16741305|P9|Period V (Double -Blind)|Lost to Follow-up|0
4856133|NCT00923091|16741306|P8|Period V (Double -Blind)|Lost to Follow-up|0
4856134|NCT00923091|16741307|P7|Period V (Double -Blind)|Lost to Follow-up|0
4856135|NCT00923091|16741308|P6|Period V (Double -Blind)|Lost to Follow-up|0
4856136|NCT00923091|16741309|P5|Period V (Double -Blind)|Lost to Follow-up|0
4856137|NCT00923091|16741310|P4|Period V (Double -Blind)|Lost to Follow-up|0
4856138|NCT00923091|16741311|P3|Period V (Double -Blind)|Lost to Follow-up|0
4856139|NCT00923091|16741312|P2|Period V (Double -Blind)|Lost to Follow-up|0
4856140|NCT00923091|16741313|P1|Period V (Double -Blind)|Lost to Follow-up|0
4856141|NCT00923091|16741301|P13|Period V (Double -Blind)|Protocol Violation|1
4856142|NCT00923091|16741302|P12|Period V (Double -Blind)|Protocol Violation|0
4856143|NCT00923091|16741303|P11|Period V (Double -Blind)|Protocol Violation|0
4856144|NCT00923091|16741304|P10|Period V (Double -Blind)|Protocol Violation|0
4856145|NCT00923091|16741305|P9|Period V (Double -Blind)|Protocol Violation|0
4856146|NCT00923091|16741306|P8|Period V (Double -Blind)|Protocol Violation|0
4856147|NCT00923091|16741307|P7|Period V (Double -Blind)|Protocol Violation|0
4856148|NCT00923091|16741308|P6|Period V (Double -Blind)|Protocol Violation|0
4856149|NCT00923091|16741309|P5|Period V (Double -Blind)|Protocol Violation|0
4856150|NCT00923091|16741310|P4|Period V (Double -Blind)|Protocol Violation|0
4856151|NCT00923091|16741311|P3|Period V (Double -Blind)|Protocol Violation|0
4856152|NCT00923091|16741312|P2|Period V (Double -Blind)|Protocol Violation|0
4856153|NCT00923091|16741313|P1|Period V (Double -Blind)|Protocol Violation|0
4856154|NCT00923091|16741301|P13|Period V (Double -Blind)|Withdrawal by Subject|1
4856155|NCT00923091|16741302|P12|Period V (Double -Blind)|Withdrawal by Subject|0
4856156|NCT00923091|16741303|P11|Period V (Double -Blind)|Withdrawal by Subject|0
4856157|NCT00923091|16741304|P10|Period V (Double -Blind)|Withdrawal by Subject|0
4856158|NCT00923091|16741305|P9|Period V (Double -Blind)|Withdrawal by Subject|1
4856159|NCT00923091|16741306|P8|Period V (Double -Blind)|Withdrawal by Subject|0
4856160|NCT00923091|16741307|P7|Period V (Double -Blind)|Withdrawal by Subject|0
4856161|NCT00923091|16741308|P6|Period V (Double -Blind)|Withdrawal by Subject|0
4856162|NCT00923091|16741309|P5|Period V (Double -Blind)|Withdrawal by Subject|0
4856163|NCT00923091|16741310|P4|Period V (Double -Blind)|Withdrawal by Subject|0
4856164|NCT00923091|16741311|P3|Period V (Double -Blind)|Withdrawal by Subject|0
4856165|NCT00923091|16741312|P2|Period V (Double -Blind)|Withdrawal by Subject|0
4856166|NCT00923091|16741313|P1|Period V (Double -Blind)|Withdrawal by Subject|0
4856167|NCT00923091|16741301|P13|Period IV (Double-Blind)|Protocol Violation|0
4856168|NCT00923091|16741302|P12|Period IV (Double-Blind)|Protocol Violation|0
4856169|NCT00923091|16741303|P11|Period IV (Double-Blind)|Protocol Violation|0
4856170|NCT00923091|16741304|P10|Period IV (Double-Blind)|Protocol Violation|0
4856171|NCT00923091|16741305|P9|Period IV (Double-Blind)|Protocol Violation|0
4856172|NCT00923091|16741306|P8|Period IV (Double-Blind)|Protocol Violation|0
4856173|NCT00923091|16741307|P7|Period IV (Double-Blind)|Protocol Violation|0
4856174|NCT00923091|16741308|P6|Period IV (Double-Blind)|Protocol Violation|0
4856175|NCT00923091|16741309|P5|Period IV (Double-Blind)|Protocol Violation|0
4856176|NCT00923091|16741310|P4|Period IV (Double-Blind)|Protocol Violation|0
4856177|NCT00923091|16741311|P3|Period IV (Double-Blind)|Protocol Violation|0
4856178|NCT00923091|16741312|P2|Period IV (Double-Blind)|Protocol Violation|1
4856179|NCT00923091|16741313|P1|Period IV (Double-Blind)|Protocol Violation|0
4856180|NCT00923091|16741301|P13|Period IV (Double-Blind)|Withdrawal by Subject|0
4856181|NCT00923091|16741302|P12|Period IV (Double-Blind)|Withdrawal by Subject|0
4856182|NCT00923091|16741303|P11|Period IV (Double-Blind)|Withdrawal by Subject|0
4856183|NCT00923091|16741304|P10|Period IV (Double-Blind)|Withdrawal by Subject|0
4856184|NCT00923091|16741305|P9|Period IV (Double-Blind)|Withdrawal by Subject|0
4856185|NCT00923091|16741306|P8|Period IV (Double-Blind)|Withdrawal by Subject|0
4856186|NCT00923091|16741307|P7|Period IV (Double-Blind)|Withdrawal by Subject|0
4856187|NCT00923091|16741308|P6|Period IV (Double-Blind)|Withdrawal by Subject|0
4856188|NCT00923091|16741309|P5|Period IV (Double-Blind)|Withdrawal by Subject|0
4856189|NCT00923091|16741310|P4|Period IV (Double-Blind)|Withdrawal by Subject|0
4856190|NCT00923091|16741311|P3|Period IV (Double-Blind)|Withdrawal by Subject|0
4856191|NCT00923091|16741312|P2|Period IV (Double-Blind)|Withdrawal by Subject|1
4856192|NCT00923091|16741313|P1|Period IV (Double-Blind)|Withdrawal by Subject|0
4856193|NCT00923091|16741301|P13|Period IV (Double-Blind)|Adverse Event|0
4856194|NCT00923091|16741302|P12|Period IV (Double-Blind)|Adverse Event|0
4856195|NCT00923091|16741303|P11|Period IV (Double-Blind)|Adverse Event|0
4856196|NCT00923091|16741304|P10|Period IV (Double-Blind)|Adverse Event|0
4856197|NCT00923091|16741305|P9|Period IV (Double-Blind)|Adverse Event|0
4856198|NCT00923091|16741306|P8|Period IV (Double-Blind)|Adverse Event|0
4856199|NCT00923091|16741307|P7|Period IV (Double-Blind)|Adverse Event|0
4856200|NCT00923091|16741308|P6|Period IV (Double-Blind)|Adverse Event|0
4856201|NCT00923091|16741309|P5|Period IV (Double-Blind)|Adverse Event|0
4856202|NCT00923091|16741310|P4|Period IV (Double-Blind)|Adverse Event|0
4856203|NCT00923091|16741311|P3|Period IV (Double-Blind)|Adverse Event|0
4856204|NCT00923091|16741312|P2|Period IV (Double-Blind)|Adverse Event|0
4856205|NCT00923091|16741313|P1|Period IV (Double-Blind)|Adverse Event|2
4856206|NCT00923091|16741301|P13|Period III (Single-Blind)|Lost to Follow-up|0
4856207|NCT00923091|16741302|P12|Period III (Single-Blind)|Lost to Follow-up|0
4856208|NCT00923091|16741303|P11|Period III (Single-Blind)|Lost to Follow-up|0
4856209|NCT00923091|16741304|P10|Period III (Single-Blind)|Lost to Follow-up|0
4856210|NCT00923091|16741305|P9|Period III (Single-Blind)|Lost to Follow-up|0
4856211|NCT00923091|16741306|P8|Period III (Single-Blind)|Lost to Follow-up|0
4856212|NCT00923091|16741307|P7|Period III (Single-Blind)|Lost to Follow-up|0
4856213|NCT00923091|16741308|P6|Period III (Single-Blind)|Lost to Follow-up|0
4856214|NCT00923091|16741309|P5|Period III (Single-Blind)|Lost to Follow-up|0
4856215|NCT00923091|16741310|P4|Period III (Single-Blind)|Lost to Follow-up|0
4856216|NCT00923091|16741311|P3|Period III (Single-Blind)|Lost to Follow-up|0
4856217|NCT00923091|16741312|P2|Period III (Single-Blind)|Lost to Follow-up|0
4856218|NCT00923091|16741313|P1|Period III (Single-Blind)|Lost to Follow-up|2
4856219|NCT00923091|16741301|P13|Period III (Single-Blind)|Protocol Violation|0
4856220|NCT00923091|16741302|P12|Period III (Single-Blind)|Protocol Violation|0
4856221|NCT00923091|16741303|P11|Period III (Single-Blind)|Protocol Violation|0
4856222|NCT00923091|16741304|P10|Period III (Single-Blind)|Protocol Violation|0
4856223|NCT00923091|16741305|P9|Period III (Single-Blind)|Protocol Violation|0
4856224|NCT00923091|16741306|P8|Period III (Single-Blind)|Protocol Violation|0
4856225|NCT00923091|16741307|P7|Period III (Single-Blind)|Protocol Violation|0
4856226|NCT00923091|16741308|P6|Period III (Single-Blind)|Protocol Violation|0
4856227|NCT00923091|16741309|P5|Period III (Single-Blind)|Protocol Violation|0
4856228|NCT00923091|16741310|P4|Period III (Single-Blind)|Protocol Violation|0
4856229|NCT00923091|16741311|P3|Period III (Single-Blind)|Protocol Violation|0
4856230|NCT00923091|16741312|P2|Period III (Single-Blind)|Protocol Violation|0
4856231|NCT00923091|16741313|P1|Period III (Single-Blind)|Protocol Violation|3
4856232|NCT00923091|16741301|P13|Period III (Single-Blind)|Withdrawal by Subject|0
4856233|NCT00923091|16741302|P12|Period III (Single-Blind)|Withdrawal by Subject|0
4856234|NCT00923091|16741303|P11|Period III (Single-Blind)|Withdrawal by Subject|0
4856235|NCT00923091|16741304|P10|Period III (Single-Blind)|Withdrawal by Subject|0
4856236|NCT00923091|16741305|P9|Period III (Single-Blind)|Withdrawal by Subject|0
4856237|NCT00923091|16741306|P8|Period III (Single-Blind)|Withdrawal by Subject|0
4856238|NCT00923091|16741307|P7|Period III (Single-Blind)|Withdrawal by Subject|0
4856239|NCT00923091|16741308|P6|Period III (Single-Blind)|Withdrawal by Subject|0
4856240|NCT00923091|16741309|P5|Period III (Single-Blind)|Withdrawal by Subject|0
4856241|NCT00923091|16741310|P4|Period III (Single-Blind)|Withdrawal by Subject|0
4856242|NCT00923091|16741311|P3|Period III (Single-Blind)|Withdrawal by Subject|0
4856243|NCT00923091|16741312|P2|Period III (Single-Blind)|Withdrawal by Subject|0
4856244|NCT00923091|16741313|P1|Period III (Single-Blind)|Withdrawal by Subject|10
4856245|NCT00923091|16741301|P13|Period III (Single-Blind)|Adverse Event|0
4856246|NCT00923091|16741302|P12|Period III (Single-Blind)|Adverse Event|0
4856247|NCT00923091|16741303|P11|Period III (Single-Blind)|Adverse Event|0
4856248|NCT00923091|16741304|P10|Period III (Single-Blind)|Adverse Event|0
4856249|NCT00923091|16741305|P9|Period III (Single-Blind)|Adverse Event|0
4856250|NCT00923091|16741306|P8|Period III (Single-Blind)|Adverse Event|0
4856251|NCT00923091|16741307|P7|Period III (Single-Blind)|Adverse Event|0
4856252|NCT00923091|16741308|P6|Period III (Single-Blind)|Adverse Event|0
4856253|NCT00923091|16741309|P5|Period III (Single-Blind)|Adverse Event|0
4856254|NCT00923091|16741310|P4|Period III (Single-Blind)|Adverse Event|0
4856255|NCT00923091|16741311|P3|Period III (Single-Blind)|Adverse Event|0
4856256|NCT00923091|16741312|P2|Period III (Single-Blind)|Adverse Event|0
4856257|NCT00923091|16741313|P1|Period III (Single-Blind)|Adverse Event|5
4856258|NCT00923091|16741301|P13|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856259|NCT00923091|16741302|P12|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856260|NCT00923091|16741303|P11|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856261|NCT00923091|16741304|P10|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856262|NCT00923091|16741305|P9|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856263|NCT00923091|16741306|P8|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856264|NCT00923091|16741307|P7|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856265|NCT00923091|16741308|P6|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
4856266|NCT00923091|16741309|P5|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856267|NCT00923091|16741310|P4|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
4856268|NCT00923091|16741311|P3|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856269|NCT00923091|16741312|P2|PeriodI-II (Randomized, Double-Blind)|Other Reason|1
4856270|NCT00923091|16741313|P1|PeriodI-II (Randomized, Double-Blind)|Other Reason|0
4856271|NCT00923091|16741301|P13|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856272|NCT00923091|16741302|P12|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856273|NCT00923091|16741303|P11|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856274|NCT00923091|16741304|P10|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856275|NCT00923091|16741305|P9|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856276|NCT00923091|16741306|P8|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856277|NCT00923091|16741307|P7|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856278|NCT00923091|16741308|P6|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1
4856279|NCT00923091|16741309|P5|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856280|NCT00923091|16741310|P4|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856281|NCT00923091|16741311|P3|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856282|NCT00923091|16741312|P2|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856283|NCT00923091|16741313|P1|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0
4856284|NCT00923091|16741301|P13|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4856285|NCT00923091|16741302|P12|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4856286|NCT00923091|16741303|P11|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4856287|NCT00923091|16741304|P10|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4856288|NCT00923091|16741305|P9|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0
4856289|NCT00923091|16741306|P8|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3
4856290|NCT00923091|16741307|P7|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
4856291|NCT00923091|16741308|P6|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2
4856292|NCT00923091|16741309|P5|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4
4856293|NCT00923091|16741310|P4|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5
4856294|NCT00923091|16741311|P3|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
4856295|NCT00923091|16741312|P2|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
4856296|NCT00923091|16741313|P1|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1
4856297|NCT00923091|16741301|P13|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4856298|NCT00923091|16741302|P12|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4856299|NCT00923091|16741303|P11|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4856300|NCT00923091|16741304|P10|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4856301|NCT00923091|16741305|P9|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0
4856302|NCT00923091|16741306|P8|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
4856303|NCT00923091|16741307|P7|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
4856304|NCT00923091|16741308|P6|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
4856305|NCT00923091|16741309|P5|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7
4856306|NCT00923091|16741310|P4|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8
4856307|NCT00923091|16741311|P3|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5
4856308|NCT00923091|16741312|P2|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6
4856309|NCT00923091|16741313|P1|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4
4856310|NCT00923091|16741301|P13|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4856311|NCT00923091|16741302|P12|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4856312|NCT00923091|16741303|P11|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4856313|NCT00923091|16741304|P10|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4856314|NCT00923091|16741305|P9|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0
4856315|NCT00923091|16741306|P8|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17
4856316|NCT00923091|16741307|P7|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9
4856317|NCT00923091|16741308|P6|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5
4856318|NCT00923091|16741309|P5|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10
4856319|NCT00923091|16741310|P4|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13
4856320|NCT00923091|16741311|P3|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7
4856321|NCT00923091|16741312|P2|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3
4856322|NCT00923091|16741313|P1|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11
4856323|NCT00923078|16741363|P3|First Intervention (Weeks 1-4)|No intervention per protocol|20
4856324|NCT00923078|16741364|P2|First Intervention (Weeks 1-4)|No intervention per protocol|0
4856325|NCT00923078|16741365|P1|First Intervention (Weeks 1-4)|No intervention per protocol|0
4856326|NCT00923078|16741363|P3|First Intervention (Weeks 1-4)|Withdrawal by Subject|0
4856327|NCT00923078|16741364|P2|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
4856328|NCT00923078|16741365|P1|First Intervention (Weeks 1-4)|Withdrawal by Subject|1
4856329|NCT00922987|16741384|P1|Overall Study|Adverse Event|1
4856330|NCT00922987|16741384|P1|Overall Study|Protocol Violation|2
4856331|NCT00922987|16741384|P1|Overall Study|Insufficient clinical response|1
4856332|NCT00922974|16741399|P2|Phase III Component|Protocol Violation|6
4856333|NCT00922974|16741400|P1|Phase III Component|Protocol Violation|8
4856334|NCT00922974|16741399|P2|Phase II Component|Not evaluable for treatment review|0
4856335|NCT00922974|16741400|P1|Phase II Component|Not evaluable for treatment review|5
4856336|NCT00922974|16741399|P2|Phase II Component|Protocol Violation|0
4856337|NCT00922974|16741400|P1|Phase II Component|Protocol Violation|2
4856338|NCT00922935|16741415|P3|Overall Study|Lost to Follow-up|0
4856339|NCT00922935|16741416|P2|Overall Study|Lost to Follow-up|1
4856340|NCT00922935|16741417|P1|Overall Study|Lost to Follow-up|0
4856341|NCT00922935|16741415|P3|Overall Study|Physician Decision|0
4856342|NCT00922935|16741416|P2|Overall Study|Physician Decision|1
4856343|NCT00922935|16741417|P1|Overall Study|Physician Decision|1
4856344|NCT00922935|16741415|P3|Overall Study|Protocol Violation|0
4856345|NCT00922935|16741416|P2|Overall Study|Protocol Violation|3
4856346|NCT00922935|16741417|P1|Overall Study|Protocol Violation|0
4856347|NCT00922779|16741429|P1|Overall Study|Missing|1874
4856348|NCT00922779|16741429|P1|Overall Study|Other|27
4856349|NCT00922779|16741429|P1|Overall Study|Lost to Follow-up|44
4856350|NCT00922779|16741429|P1|Overall Study|Withdrawal by Subject|308
4856351|NCT00922779|16741429|P1|Overall Study|Pregnancy|7
4856352|NCT00922779|16741429|P1|Overall Study|Adverse Event|67
4856353|NCT00922766|16741436|P1|Overall Study|Adverse Event|1
4856354|NCT00922766|16741436|P1|Overall Study|Other|1
4856355|NCT00922766|16741436|P1|Overall Study|Withdrawal by Subject|2
4856356|NCT00922766|16741436|P1|Overall Study|Death|3
4856357|NCT00922636|16741454|P5|Overall Study|Lost to Follow-up|4
4856358|NCT00922636|16741455|P4|Overall Study|Lost to Follow-up|2
4856359|NCT00922636|16741456|P3|Overall Study|Lost to Follow-up|2
4856360|NCT00922636|16741457|P2|Overall Study|Lost to Follow-up|2
4856361|NCT00922636|16741458|P1|Overall Study|Lost to Follow-up|1
4856362|NCT00922636|16741454|P5|Overall Study|Parent/Caregiver Decision|2
4856363|NCT00922636|16741455|P4|Overall Study|Parent/Caregiver Decision|5
4856364|NCT00922636|16741456|P3|Overall Study|Parent/Caregiver Decision|3
4856365|NCT00922636|16741457|P2|Overall Study|Parent/Caregiver Decision|4
4856366|NCT00922636|16741458|P1|Overall Study|Parent/Caregiver Decision|2
4856367|NCT00922636|16741454|P5|Overall Study|Entry Criteria Not Met|0
4856368|NCT00922636|16741455|P4|Overall Study|Entry Criteria Not Met|1
4856369|NCT00922636|16741456|P3|Overall Study|Entry Criteria Not Met|1
4856370|NCT00922636|16741457|P2|Overall Study|Entry Criteria Not Met|0
4856371|NCT00922636|16741458|P1|Overall Study|Entry Criteria Not Met|0
4856372|NCT00922636|16741454|P5|Overall Study|Protocol Violation|0
4856373|NCT00922636|16741455|P4|Overall Study|Protocol Violation|2
4856374|NCT00922636|16741456|P3|Overall Study|Protocol Violation|2
4856375|NCT00922636|16741457|P2|Overall Study|Protocol Violation|0
4856376|NCT00922636|16741458|P1|Overall Study|Protocol Violation|0
4856377|NCT00922636|16741454|P5|Overall Study|Withdrawal by Subject|4
4856378|NCT00922636|16741455|P4|Overall Study|Withdrawal by Subject|2
4856379|NCT00922636|16741456|P3|Overall Study|Withdrawal by Subject|5
4856380|NCT00922636|16741457|P2|Overall Study|Withdrawal by Subject|0
4856381|NCT00922636|16741458|P1|Overall Study|Withdrawal by Subject|0
4856382|NCT00922636|16741454|P5|Overall Study|Sponsor Decision|0
4856383|NCT00922636|16741455|P4|Overall Study|Sponsor Decision|0
4856384|NCT00922636|16741456|P3|Overall Study|Sponsor Decision|2
4856385|NCT00922636|16741457|P2|Overall Study|Sponsor Decision|0
4856386|NCT00922636|16741458|P1|Overall Study|Sponsor Decision|0
4856387|NCT00922636|16741454|P5|Overall Study|Lack of Efficacy|4
4856388|NCT00922636|16741455|P4|Overall Study|Lack of Efficacy|2
4856389|NCT00922636|16741456|P3|Overall Study|Lack of Efficacy|3
4856390|NCT00922636|16741457|P2|Overall Study|Lack of Efficacy|7
4856391|NCT00922636|16741458|P1|Overall Study|Lack of Efficacy|1
4856392|NCT00922636|16741454|P5|Overall Study|Adverse Event|2
4856393|NCT00922636|16741455|P4|Overall Study|Adverse Event|3
4856394|NCT00922636|16741456|P3|Overall Study|Adverse Event|2
4856395|NCT00922636|16741457|P2|Overall Study|Adverse Event|3
4856396|NCT00922636|16741458|P1|Overall Study|Adverse Event|3
4856397|NCT00922623|16741605|P1|Overall Study|Lost to Follow-up|1
4856398|NCT00922623|16741605|P1|Overall Study|Other|4
4856399|NCT00922480|16741613|P2|Extension Study|Others|1
4856400|NCT00922480|16741614|P1|Extension Study|Others|0
4856401|NCT00922480|16741613|P2|Extension Study|Withdrawal by Subject|1
4856402|NCT00922480|16741614|P1|Extension Study|Withdrawal by Subject|1
4856403|NCT00922480|16741613|P2|Extension Study|Adverse Event|1
4856404|NCT00922480|16741614|P1|Extension Study|Adverse Event|1
4856405|NCT00922480|16741613|P2|Extension Study|Protocol Violation|0
4856406|NCT00922480|16741614|P1|Extension Study|Protocol Violation|3
4856407|NCT00922480|16741613|P2|Main Study|Physician Decision|1
4856408|NCT00922480|16741614|P1|Main Study|Physician Decision|0
4856409|NCT00922480|16741613|P2|Main Study|Lost to Follow-up|0
4856410|NCT00922480|16741614|P1|Main Study|Lost to Follow-up|5
4856411|NCT00922480|16741613|P2|Main Study|Withdrawal by Subject|15
4856412|NCT00922480|16741614|P1|Main Study|Withdrawal by Subject|20
4856413|NCT00922480|16741613|P2|Main Study|Lack of Efficacy|0
4856414|NCT00922480|16741614|P1|Main Study|Lack of Efficacy|3
4856415|NCT00922480|16741613|P2|Main Study|Adverse Event|7
4856416|NCT00922480|16741614|P1|Main Study|Adverse Event|6
4856417|NCT00922480|16741613|P2|Main Study|Protocol Violation|6
4856418|NCT00922480|16741614|P1|Main Study|Protocol Violation|3
4856419|NCT00922441|16741625|P3|Overall Study|Withdrawal by Subject|1
4856420|NCT00922441|16741626|P2|Overall Study|Withdrawal by Subject|0
4856421|NCT00922441|16741627|P1|Overall Study|Withdrawal by Subject|0
4856422|NCT00922441|16741625|P3|Overall Study|Protocol Violation|2
4856423|NCT00922441|16741626|P2|Overall Study|Protocol Violation|0
4856424|NCT00922441|16741627|P1|Overall Study|Protocol Violation|0
4856425|NCT00922428|16741635|P1|Overall Study|no medication use or questionable use|13
4856426|NCT00922428|16741635|P1|Overall Study|retrospective/extremely implausible data|2
4856427|NCT00922272|16741664|P2|Double-blind Phase|Positive urine drug screen|1
4856428|NCT00922272|16741665|P1|Double-blind Phase|Positive urine drug screen|1
4856429|NCT00922272|16741664|P2|Double-blind Phase|Noncompliance|1
4856430|NCT00922272|16741665|P1|Double-blind Phase|Noncompliance|1
4856431|NCT00922272|16741664|P2|Double-blind Phase|Withdrawal criteria met|1
4856432|NCT00922272|16741665|P1|Double-blind Phase|Withdrawal criteria met|1
4856433|NCT00922272|16741664|P2|Double-blind Phase|Lost to Follow-up|1
4856434|NCT00922272|16741665|P1|Double-blind Phase|Lost to Follow-up|2
4856435|NCT00922272|16741664|P2|Double-blind Phase|Withdrawal by Subject|1
4856436|NCT00922272|16741665|P1|Double-blind Phase|Withdrawal by Subject|1
4856437|NCT00922272|16741664|P2|Double-blind Phase|Adverse Event|1
4856438|NCT00922272|16741665|P1|Double-blind Phase|Adverse Event|1
4856439|NCT00922272|16741664|P2|Open-label Phase|Withdrawal criteria met|0
4856440|NCT00922272|16741665|P1|Open-label Phase|Withdrawal criteria met|5
4856441|NCT00922272|16741664|P2|Open-label Phase|Failure to meet randomization criteria|0
4856442|NCT00922272|16741665|P1|Open-label Phase|Failure to meet randomization criteria|1
4856443|NCT00922272|16741664|P2|Open-label Phase|Withdrawal by Subject|0
4856444|NCT00922272|16741665|P1|Open-label Phase|Withdrawal by Subject|11
4856445|NCT00922272|16741664|P2|Open-label Phase|Protocol Violation|0
4856446|NCT00922272|16741665|P1|Open-label Phase|Protocol Violation|1
4856447|NCT00922272|16741664|P2|Open-label Phase|Adverse Event|0
4856448|NCT00922272|16741665|P1|Open-label Phase|Adverse Event|5
4856449|NCT00922207|16741730|P3|Overall Study|Abnormality of Laboratory Test|1
4856450|NCT00922207|16741731|P2|Overall Study|Abnormality of Laboratory Test|1
4856451|NCT00922207|16741732|P1|Overall Study|Abnormality of Laboratory Test|0
4856452|NCT00922207|16741730|P3|Overall Study|Withdrew Consent|2
4856453|NCT00922207|16741731|P2|Overall Study|Withdrew Consent|5
4856454|NCT00922207|16741732|P1|Overall Study|Withdrew Consent|2
4856455|NCT00922207|16741730|P3|Overall Study|Refused Treatment/Did Not Cooperate|0
4856456|NCT00922207|16741731|P2|Overall Study|Refused Treatment/Did Not Cooperate|0
4856457|NCT00922207|16741732|P1|Overall Study|Refused Treatment/Did Not Cooperate|1
4856458|NCT00922207|16741730|P3|Overall Study|Violation of Selection Criteria at Entry|0
4856459|NCT00922207|16741731|P2|Overall Study|Violation of Selection Criteria at Entry|1
4856460|NCT00922207|16741732|P1|Overall Study|Violation of Selection Criteria at Entry|0
4856461|NCT00922207|16741730|P3|Overall Study|Insufficient Therapeutic Response|1
4856462|NCT00922207|16741731|P2|Overall Study|Insufficient Therapeutic Response|0
4856463|NCT00922207|16741732|P1|Overall Study|Insufficient Therapeutic Response|0
4856464|NCT00922207|16741730|P3|Overall Study|Adverse Event/Intercurrent Illness|0
4856465|NCT00922207|16741731|P2|Overall Study|Adverse Event/Intercurrent Illness|0
4856466|NCT00922207|16741732|P1|Overall Study|Adverse Event/Intercurrent Illness|3
4856467|NCT00922116|16741768|P1|Overall Study|Other|5
4856468|NCT00922116|16741768|P1|Overall Study|Withdrawal by Subject|4
4856469|NCT00922116|16741768|P1|Overall Study|Lost to Follow-up|1
4856470|NCT00922116|16741768|P1|Overall Study|Death|1
4856471|NCT00922116|16741768|P1|Overall Study|Adverse Event|4
4856472|NCT00921557|16741830|P3|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
4856473|NCT00921557|16741831|P2|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1
4856474|NCT00921557|16741832|P1|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2
4856475|NCT00921557|16741830|P3|Weeks 96-144 (Off Study Treatment)|Site closure|0
4856476|NCT00921557|16741831|P2|Weeks 96-144 (Off Study Treatment)|Site closure|0
4856477|NCT00921557|16741832|P1|Weeks 96-144 (Off Study Treatment)|Site closure|1
4856478|NCT00921557|16741830|P3|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1
4856479|NCT00921557|16741831|P2|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
4856480|NCT00921557|16741832|P1|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0
4856481|NCT00921557|16741830|P3|Weeks 48-96 (on Study Treatment)|Site Closure|0
4856482|NCT00921557|16741831|P2|Weeks 48-96 (on Study Treatment)|Site Closure|1
4856483|NCT00921557|16741832|P1|Weeks 48-96 (on Study Treatment)|Site Closure|0
4856484|NCT00921557|16741830|P3|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
4856485|NCT00921557|16741831|P2|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0
4856486|NCT00921557|16741832|P1|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2
4856487|NCT00921024|16741934|P2|Overall Study|Withdrawal by Subject|3
4856488|NCT00921024|16741935|P1|Overall Study|Withdrawal by Subject|0
4856489|NCT00921024|16741934|P2|Overall Study|Received concomittant therapy|0
4856490|NCT00921024|16741935|P1|Overall Study|Received concomittant therapy|2
4856491|NCT00921024|16741934|P2|Overall Study|Lost to Follow-up|0
4856492|NCT00921024|16741935|P1|Overall Study|Lost to Follow-up|2
4856493|NCT00920907|16741945|P2|Maintenance Period|Adverse Event|1
4856494|NCT00920907|16741946|P1|Maintenance Period|Adverse Event|0
4856495|NCT00920907|16741945|P2|Maintenance Period|Withdrawal by Subject|0
4856496|NCT00920907|16741946|P1|Maintenance Period|Withdrawal by Subject|1
4856497|NCT00920907|16741945|P2|Maintenance Period|Death|1
4856498|NCT00920907|16741946|P1|Maintenance Period|Death|1
4856499|NCT00920907|16741945|P2|Maintenance Period|Study Drug Toxicity|2
4856500|NCT00920907|16741946|P1|Maintenance Period|Study Drug Toxicity|0
4856501|NCT00920907|16741945|P2|Maintenance Period|Administrative (study closure)|2
4856502|NCT00920907|16741946|P1|Maintenance Period|Administrative (study closure)|7
4856503|NCT00920907|16741945|P2|Maintenance Period|Disease Progression|7
4856504|NCT00920907|16741946|P1|Maintenance Period|Disease Progression|3
4856505|NCT00920907|16741945|P2|Induction Period|Withdrawal by Subject|1
4856506|NCT00920907|16741946|P1|Induction Period|Withdrawal by Subject|1
4856507|NCT00920907|16741945|P2|Induction Period|No longer meets study criteria|1
4856508|NCT00920907|16741946|P1|Induction Period|No longer meets study criteria|0
4856509|NCT00920907|16741945|P2|Induction Period|Study Drug Toxicity|6
4856510|NCT00920907|16741946|P1|Induction Period|Study Drug Toxicity|8
4856511|NCT00920907|16741945|P2|Induction Period|Disease Progression|11
4856512|NCT00920907|16741946|P1|Induction Period|Disease Progression|12
4856513|NCT00920907|16741945|P2|Induction Period|Death|1
4856514|NCT00920907|16741946|P1|Induction Period|Death|1
4856515|NCT00920907|16741945|P2|Induction Period|Adverse Event|2
4856516|NCT00920907|16741946|P1|Induction Period|Adverse Event|0
4856517|NCT00920855|16741987|P3|Overall Study|Response plateau; started maintenance|1
4856518|NCT00920855|16741988|P2|Overall Study|Response plateau; started maintenance|0
4856519|NCT00920855|16741989|P1|Overall Study|Response plateau; started maintenance|0
4856520|NCT00920855|16741987|P3|Overall Study|Noncompliance to study medication|1
4856521|NCT00920855|16741988|P2|Overall Study|Noncompliance to study medication|0
4856522|NCT00920855|16741989|P1|Overall Study|Noncompliance to study medication|0
4856523|NCT00920855|16741987|P3|Overall Study|Disease progression|10
4856524|NCT00920855|16741988|P2|Overall Study|Disease progression|1
4856525|NCT00920855|16741989|P1|Overall Study|Disease progression|2
4856526|NCT00920855|16741987|P3|Overall Study|Withdrawal by Subject|6
4856527|NCT00920855|16741988|P2|Overall Study|Withdrawal by Subject|1
4856528|NCT00920855|16741989|P1|Overall Study|Withdrawal by Subject|2
4856529|NCT00920855|16741987|P3|Overall Study|Adverse Event|4
4856530|NCT00920855|16741988|P2|Overall Study|Adverse Event|1
4856531|NCT00920855|16741989|P1|Overall Study|Adverse Event|1
4856532|NCT00920829|16742015|P4|Available for Analysis|Required more treatment|1
4856533|NCT00920829|16742016|P3|Available for Analysis|Required more treatment|0
4856534|NCT00920829|16742017|P2|Available for Analysis|Required more treatment|2
4856535|NCT00920829|16742018|P1|Available for Analysis|Required more treatment|0
4856536|NCT00920829|16742015|P4|Available for Analysis|Protocol Violation|0
4856537|NCT00920829|16742016|P3|Available for Analysis|Protocol Violation|1
4856538|NCT00920829|16742017|P2|Available for Analysis|Protocol Violation|0
4856539|NCT00920829|16742018|P1|Available for Analysis|Protocol Violation|0
4856540|NCT00920829|16742015|P4|Available for Analysis|Death|0
4856541|NCT00920829|16742016|P3|Available for Analysis|Death|0
4856542|NCT00920829|16742017|P2|Available for Analysis|Death|0
4856543|NCT00920829|16742018|P1|Available for Analysis|Death|1
4856544|NCT00920829|16742015|P4|Available for Analysis|Adverse Event|0
4856545|NCT00920829|16742016|P3|Available for Analysis|Adverse Event|1
4856546|NCT00920829|16742017|P2|Available for Analysis|Adverse Event|2
4856547|NCT00920829|16742018|P1|Available for Analysis|Adverse Event|1
4856548|NCT00920829|16742015|P4|Available for Analysis|Required Medical Treatment|0
4856549|NCT00920829|16742016|P3|Available for Analysis|Required Medical Treatment|2
4856550|NCT00920829|16742017|P2|Available for Analysis|Required Medical Treatment|1
4856551|NCT00920829|16742018|P1|Available for Analysis|Required Medical Treatment|0
4856552|NCT00920829|16742015|P4|Available for Analysis|Withdrawal by Subject|10
4856553|NCT00920829|16742016|P3|Available for Analysis|Withdrawal by Subject|6
4856554|NCT00920829|16742017|P2|Available for Analysis|Withdrawal by Subject|6
4856555|NCT00920829|16742018|P1|Available for Analysis|Withdrawal by Subject|6
4856556|NCT00920829|16742015|P4|Allocation|No post randomization data|2
4856557|NCT00920829|16742016|P3|Allocation|No post randomization data|0
4856558|NCT00920829|16742017|P2|Allocation|No post randomization data|1
4856559|NCT00920829|16742018|P1|Allocation|No post randomization data|3
4856560|NCT00920816|16742032|P4|Overall Study|Ongoing|36
4856561|NCT00920816|16742033|P3|Overall Study|Ongoing|70
4856562|NCT00920816|16742034|P2|Overall Study|Ongoing|56
4856563|NCT00920816|16742035|P1|Overall Study|Ongoing|106
4856564|NCT00920816|16742032|P4|Overall Study|Withdrawal by Subject|1
4856565|NCT00920816|16742033|P3|Overall Study|Withdrawal by Subject|1
4856566|NCT00920816|16742034|P2|Overall Study|Withdrawal by Subject|2
4856567|NCT00920816|16742035|P1|Overall Study|Withdrawal by Subject|7
4856568|NCT00920816|16742032|P4|Overall Study|Objective progression or relapse|0
4856569|NCT00920816|16742033|P3|Overall Study|Objective progression or relapse|2
4856570|NCT00920816|16742034|P2|Overall Study|Objective progression or relapse|0
4856571|NCT00920816|16742035|P1|Overall Study|Objective progression or relapse|0
4856572|NCT00920816|16742032|P4|Overall Study|Lost to Follow-up|4
4856573|NCT00920816|16742033|P3|Overall Study|Lost to Follow-up|3
4856574|NCT00920816|16742034|P2|Overall Study|Lost to Follow-up|2
4856575|NCT00920816|16742035|P1|Overall Study|Lost to Follow-up|1
4856576|NCT00920816|16742032|P4|Overall Study|Adverse Event|0
4856577|NCT00920816|16742033|P3|Overall Study|Adverse Event|1
4856578|NCT00920816|16742034|P2|Overall Study|Adverse Event|0
4856579|NCT00920816|16742035|P1|Overall Study|Adverse Event|1
4856580|NCT00920816|16742032|P4|Overall Study|Death|28
4856581|NCT00920816|16742033|P3|Overall Study|Death|58
4856582|NCT00920816|16742034|P2|Overall Study|Death|36
4856583|NCT00920816|16742035|P1|Overall Study|Death|77
4856584|NCT00920790|16742073|P1|Overall Study|aggravation of general condition|14
4856585|NCT00920699|16742085|P3|Overall Study|Lost to Follow-up|2
4856586|NCT00920699|16742086|P2|Overall Study|Lost to Follow-up|0
4856587|NCT00920699|16742087|P1|Overall Study|Lost to Follow-up|0
4856588|NCT00920699|16742085|P3|Overall Study|no longer met eligibility|0
4856589|NCT00920699|16742086|P2|Overall Study|no longer met eligibility|1
4856590|NCT00920699|16742087|P1|Overall Study|no longer met eligibility|0
4856591|NCT00920699|16742085|P3|Overall Study|Withdrawal by Subject|2
4856592|NCT00920699|16742086|P2|Overall Study|Withdrawal by Subject|0
4856593|NCT00920699|16742087|P1|Overall Study|Withdrawal by Subject|2
4856594|NCT00920686|16742104|P3|Overall Study|Study drug dosing criteria not met|12
4856595|NCT00920686|16742105|P2|Overall Study|Study drug dosing criteria not met|19
4856596|NCT00920686|16742106|P1|Overall Study|Study drug dosing criteria not met|17
4856597|NCT00920686|16742104|P3|Overall Study|Lost to Follow-up|1
4856598|NCT00920686|16742105|P2|Overall Study|Lost to Follow-up|3
4856599|NCT00920686|16742106|P1|Overall Study|Lost to Follow-up|2
4856600|NCT00920621|16742185|P4|Overall Study|Blood sample not collected|0
4856601|NCT00920621|16742186|P3|Overall Study|Blood sample not collected|0
4856602|NCT00920621|16742187|P2|Overall Study|Blood sample not collected|14
4856603|NCT00920621|16742188|P1|Overall Study|Blood sample not collected|22
4856604|NCT00920621|16742185|P4|Overall Study|Fetal/neonatal deaths|14
4856605|NCT00920621|16742186|P3|Overall Study|Fetal/neonatal deaths|16
4856606|NCT00920621|16742187|P2|Overall Study|Fetal/neonatal deaths|14
4856607|NCT00920621|16742188|P1|Overall Study|Fetal/neonatal deaths|16
4856608|NCT00920621|16742185|P4|Overall Study|Lost to Follow-up|21
4856609|NCT00920621|16742186|P3|Overall Study|Lost to Follow-up|19
4856610|NCT00920621|16742187|P2|Overall Study|Lost to Follow-up|17
4856611|NCT00920621|16742188|P1|Overall Study|Lost to Follow-up|16
4856612|NCT00920556|16742218|P1|Overall Study|Withdrawal by Subject|1
4856613|NCT00920556|16742218|P1|Overall Study|Physician Decision|7
4856614|NCT00920556|16742218|P1|Overall Study|Adverse Event|16
4856615|NCT00920426|16742267|P4|ITZ111451|Adverse Event|0
4856616|NCT00920426|16742268|P3|ITZ111451|Adverse Event|0
4856617|NCT00920426|16742269|P2|ITZ111451|Adverse Event|0
4856618|NCT00920426|16742270|P1|ITZ111451|Adverse Event|1
4856619|NCT00920218|16742390|P4|Overall Study|Other|0
4856620|NCT00920218|16742391|P3|Overall Study|Other|1
4856621|NCT00920218|16742392|P2|Overall Study|Other|0
4856622|NCT00920218|16742393|P1|Overall Study|Other|0
4856623|NCT00920218|16742390|P4|Overall Study|Transplant failed/malignancy recurrence|3
4856624|NCT00920218|16742391|P3|Overall Study|Transplant failed/malignancy recurrence|2
4856625|NCT00920218|16742392|P2|Overall Study|Transplant failed/malignancy recurrence|1
4856626|NCT00920218|16742393|P1|Overall Study|Transplant failed/malignancy recurrence|0
4856627|NCT00920218|16742390|P4|Overall Study|Lost to Follow-up|3
4856628|NCT00920218|16742391|P3|Overall Study|Lost to Follow-up|0
4856629|NCT00920218|16742392|P2|Overall Study|Lost to Follow-up|1
4856630|NCT00920218|16742393|P1|Overall Study|Lost to Follow-up|0
4856631|NCT00920218|16742390|P4|Overall Study|Migrated/moved from study area|0
4856632|NCT00920218|16742391|P3|Overall Study|Migrated/moved from study area|1
4856633|NCT00920218|16742392|P2|Overall Study|Migrated/moved from study area|0
4856634|NCT00920218|16742393|P1|Overall Study|Migrated/moved from study area|0
4856635|NCT00920218|16742390|P4|Overall Study|Withdrawal by Subject|0
4856636|NCT00920218|16742391|P3|Overall Study|Withdrawal by Subject|2
4856637|NCT00920218|16742392|P2|Overall Study|Withdrawal by Subject|3
4856638|NCT00920218|16742393|P1|Overall Study|Withdrawal by Subject|0
4856639|NCT00920218|16742390|P4|Overall Study|Serious Adverse Event|1
4856640|NCT00920218|16742391|P3|Overall Study|Serious Adverse Event|2
4856641|NCT00920218|16742392|P2|Overall Study|Serious Adverse Event|0
4856642|NCT00920218|16742393|P1|Overall Study|Serious Adverse Event|2
4856643|NCT00920140|16742496|P5|Phase 2|Withdrawal by Subject|1
4856644|NCT00920140|16742497|P4|Phase 2|Withdrawal by Subject|2
4856645|NCT00920140|16742498|P3|Phase 2|Withdrawal by Subject|4
4856646|NCT00920140|16742499|P2|Phase 2|Withdrawal by Subject|0
4856647|NCT00920140|16742500|P1|Phase 2|Withdrawal by Subject|0
4856648|NCT00920140|16742496|P5|Phase 2|Physician Decision|2
4856649|NCT00920140|16742497|P4|Phase 2|Physician Decision|3
4856650|NCT00920140|16742498|P3|Phase 2|Physician Decision|3
4856651|NCT00920140|16742499|P2|Phase 2|Physician Decision|0
4856652|NCT00920140|16742500|P1|Phase 2|Physician Decision|0
4856653|NCT00920140|16742496|P5|Phase 2|Lost to Follow-up|0
4856654|NCT00920140|16742497|P4|Phase 2|Lost to Follow-up|1
4856655|NCT00920140|16742498|P3|Phase 2|Lost to Follow-up|0
4856656|NCT00920140|16742499|P2|Phase 2|Lost to Follow-up|0
4856657|NCT00920140|16742500|P1|Phase 2|Lost to Follow-up|0
4856658|NCT00920140|16742496|P5|Phase 2|Lack of Efficacy|5
4856659|NCT00920140|16742497|P4|Phase 2|Lack of Efficacy|14
4856660|NCT00920140|16742498|P3|Phase 2|Lack of Efficacy|29
4856661|NCT00920140|16742499|P2|Phase 2|Lack of Efficacy|0
4856662|NCT00920140|16742500|P1|Phase 2|Lack of Efficacy|0
4856663|NCT00920140|16742496|P5|Phase 2|Adverse Event|3
4856664|NCT00920140|16742497|P4|Phase 2|Adverse Event|2
4856665|NCT00920140|16742498|P3|Phase 2|Adverse Event|14
4856666|NCT00920140|16742499|P2|Phase 2|Adverse Event|0
4856667|NCT00920140|16742500|P1|Phase 2|Adverse Event|0
4856668|NCT00920140|16742496|P5|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4856669|NCT00920140|16742497|P4|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4856670|NCT00920140|16742498|P3|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4856671|NCT00920140|16742499|P2|Phase 1 (Dose Escalation)|Withdrawal by Subject|2
4856672|NCT00920140|16742500|P1|Phase 1 (Dose Escalation)|Withdrawal by Subject|0
4856673|NCT00920140|16742496|P5|Phase 1 (Dose Escalation)|Lack of Efficacy|0
4856674|NCT00920140|16742497|P4|Phase 1 (Dose Escalation)|Lack of Efficacy|0
4856675|NCT00920140|16742498|P3|Phase 1 (Dose Escalation)|Lack of Efficacy|0
4856676|NCT00920140|16742499|P2|Phase 1 (Dose Escalation)|Lack of Efficacy|4
4856677|NCT00920140|16742500|P1|Phase 1 (Dose Escalation)|Lack of Efficacy|2
4856678|NCT00920140|16742496|P5|Phase 1 (Dose Escalation)|Adverse Event|0
4856679|NCT00920140|16742497|P4|Phase 1 (Dose Escalation)|Adverse Event|0
4856680|NCT00920140|16742498|P3|Phase 1 (Dose Escalation)|Adverse Event|0
4856681|NCT00920140|16742499|P2|Phase 1 (Dose Escalation)|Adverse Event|3
4856682|NCT00920140|16742500|P1|Phase 1 (Dose Escalation)|Adverse Event|3
4856683|NCT00919893|16742562|P2|Overall Study|Protocol Violation|9
4856684|NCT00919893|16742563|P1|Overall Study|Protocol Violation|19
4856685|NCT00919867|16742575|P6|First Intervention|Physician Decision|1
4856686|NCT00919867|16742576|P5|First Intervention|Physician Decision|0
4856687|NCT00919867|16742577|P4|First Intervention|Physician Decision|0
4856688|NCT00919867|16742578|P3|First Intervention|Physician Decision|0
4856689|NCT00919867|16742579|P2|First Intervention|Physician Decision|0
4856690|NCT00919867|16742580|P1|First Intervention|Physician Decision|0
4856691|NCT00919867|16742575|P6|First Intervention|Withdrawal by Subject|0
4856692|NCT00919867|16742576|P5|First Intervention|Withdrawal by Subject|0
4856693|NCT00919867|16742577|P4|First Intervention|Withdrawal by Subject|0
4856694|NCT00919867|16742578|P3|First Intervention|Withdrawal by Subject|1
4856695|NCT00919867|16742579|P2|First Intervention|Withdrawal by Subject|0
4856696|NCT00919867|16742580|P1|First Intervention|Withdrawal by Subject|0
4856697|NCT00919854|16742601|P1|Overall Study|Adverse Event|1
4856698|NCT00919711|16742639|P2|Overall Study|Noncompliance|0
4856699|NCT00919711|16742640|P1|Overall Study|Noncompliance|1
4856700|NCT00919711|16742639|P2|Overall Study|Death|0
4856701|NCT00919711|16742640|P1|Overall Study|Death|1
4856702|NCT00919711|16742639|P2|Overall Study|Lost to Follow-up|0
4856703|NCT00919711|16742640|P1|Overall Study|Lost to Follow-up|2
4856704|NCT00919711|16742639|P2|Overall Study|Administrative Decision|1
4856705|NCT00919711|16742640|P1|Overall Study|Administrative Decision|0
4856706|NCT00919711|16742639|P2|Overall Study|Other|2
4856707|NCT00919711|16742640|P1|Overall Study|Other|1
4856708|NCT00919711|16742639|P2|Overall Study|Adverse Event|3
4856709|NCT00919711|16742640|P1|Overall Study|Adverse Event|13
4856710|NCT00919711|16742639|P2|Overall Study|Withdrawal by Subject|7
4856711|NCT00919711|16742640|P1|Overall Study|Withdrawal by Subject|15
4856712|NCT00919633|16742656|P4|Overall Study|Viral rebound outside protocol timepoint|0
4856713|NCT00919633|16742657|P3|Overall Study|Viral rebound outside protocol timepoint|1
4856714|NCT00919633|16742658|P2|Overall Study|Viral rebound outside protocol timepoint|0
4856715|NCT00919633|16742659|P1|Overall Study|Viral rebound outside protocol timepoint|0
4856716|NCT00919633|16742656|P4|Overall Study|Request of withdrawal w/o future contact|0
4856717|NCT00919633|16742657|P3|Overall Study|Request of withdrawal w/o future contact|1
4856718|NCT00919633|16742658|P2|Overall Study|Request of withdrawal w/o future contact|0
4856719|NCT00919633|16742659|P1|Overall Study|Request of withdrawal w/o future contact|0
4856720|NCT00919633|16742656|P4|Overall Study|Physician Decision|1
4856721|NCT00919633|16742657|P3|Overall Study|Physician Decision|0
4856722|NCT00919633|16742658|P2|Overall Study|Physician Decision|0
4856723|NCT00919633|16742659|P1|Overall Study|Physician Decision|0
4856724|NCT00919633|16742656|P4|Overall Study|Protocol Violation|1
4856725|NCT00919633|16742657|P3|Overall Study|Protocol Violation|0
4856726|NCT00919633|16742658|P2|Overall Study|Protocol Violation|0
4856727|NCT00919633|16742659|P1|Overall Study|Protocol Violation|0
4856728|NCT00919633|16742656|P4|Overall Study|Withdraw consent post transition to SOC|1
4856729|NCT00919633|16742657|P3|Overall Study|Withdraw consent post transition to SOC|1
4856730|NCT00919633|16742658|P2|Overall Study|Withdraw consent post transition to SOC|0
4856731|NCT00919633|16742659|P1|Overall Study|Withdraw consent post transition to SOC|0
4856732|NCT00919633|16742656|P4|Overall Study|Lost to Follow-up|2
4856733|NCT00919633|16742657|P3|Overall Study|Lost to Follow-up|0
4856734|NCT00919633|16742658|P2|Overall Study|Lost to Follow-up|1
4856735|NCT00919633|16742659|P1|Overall Study|Lost to Follow-up|3
4856736|NCT00919633|16742656|P4|Overall Study|Withdrawal by Subject|3
4856737|NCT00919633|16742657|P3|Overall Study|Withdrawal by Subject|4
4856738|NCT00919633|16742658|P2|Overall Study|Withdrawal by Subject|2
4856739|NCT00919633|16742659|P1|Overall Study|Withdrawal by Subject|1
4856740|NCT00919633|16742656|P4|Overall Study|Lack of Efficacy|3
4856741|NCT00919633|16742657|P3|Overall Study|Lack of Efficacy|2
4856742|NCT00919633|16742658|P2|Overall Study|Lack of Efficacy|3
4856743|NCT00919633|16742659|P1|Overall Study|Lack of Efficacy|17
4856744|NCT00919633|16742656|P4|Overall Study|Death|0
4856745|NCT00919633|16742657|P3|Overall Study|Death|2
4856746|NCT00919633|16742658|P2|Overall Study|Death|0
4856747|NCT00919633|16742659|P1|Overall Study|Death|0
4856748|NCT00919633|16742656|P4|Overall Study|Adverse Event|10
4856749|NCT00919633|16742657|P3|Overall Study|Adverse Event|12
4856750|NCT00919633|16742658|P2|Overall Study|Adverse Event|9
4856751|NCT00919633|16742659|P1|Overall Study|Adverse Event|1
4856752|NCT00919061|16742757|P1|Overall Study|Withdrawal by Subject|1
4856753|NCT00919061|16742757|P1|Overall Study|Adverse Event|1
4856754|NCT00918957|16742770|P2|Overall Study|Withdrawal by Subject|0
4856755|NCT00918957|16742771|P1|Overall Study|Withdrawal by Subject|1
4856756|NCT00918957|16742770|P2|Overall Study|Adverse Event|0
4856757|NCT00918957|16742771|P1|Overall Study|Adverse Event|2
4856758|NCT00918879|16742804|P2|Overall Study|Severe non-compliance to protocol|1
4856759|NCT00918879|16742805|P1|Overall Study|Severe non-compliance to protocol|1
4856760|NCT00918879|16742804|P2|Overall Study|Lost to Follow-up|1
4856761|NCT00918879|16742805|P1|Overall Study|Lost to Follow-up|1
4856762|NCT00918879|16742804|P2|Overall Study|Withdrawal by Subject|4
4856763|NCT00918879|16742805|P1|Overall Study|Withdrawal by Subject|4
4856764|NCT00918749|16742837|P3|Overall Study|No Study Medication Taken|0
4856765|NCT00918749|16742838|P2|Overall Study|No Study Medication Taken|0
4856766|NCT00918749|16742839|P1|Overall Study|No Study Medication Taken|1
4856767|NCT00918749|16742837|P3|Overall Study|Withdrawal by Subject|5
4856768|NCT00918749|16742838|P2|Overall Study|Withdrawal by Subject|3
4856769|NCT00918749|16742839|P1|Overall Study|Withdrawal by Subject|5
4856770|NCT00918749|16742837|P3|Overall Study|Lost to Follow-up|1
4856771|NCT00918749|16742838|P2|Overall Study|Lost to Follow-up|0
4856772|NCT00918749|16742839|P1|Overall Study|Lost to Follow-up|0
4856773|NCT00918749|16742837|P3|Overall Study|Adverse Event|1
4856774|NCT00918749|16742838|P2|Overall Study|Adverse Event|0
4856775|NCT00918749|16742839|P1|Overall Study|Adverse Event|1
4856776|NCT00918736|16742871|P1|Overall Study|Withdrawal by Subject|4
4856777|NCT00918684|16742884|P1|Treatment Phase|Withdrawal by Subject|8
4856778|NCT00918684|16742884|P1|Treatment Phase|Protocol Violation|1
4856779|NCT00918684|16742884|P1|Treatment Phase|Physician Decision|8
4856780|NCT00918684|16742884|P1|Treatment Phase|Lost to Follow-up|2
4856781|NCT00918684|16742884|P1|Treatment Phase|Lack of Efficacy|6
4856782|NCT00918684|16742884|P1|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16
4856783|NCT00918645|16742895|P1|Overall Study|Withdrawal by Subject|1
4856784|NCT00918580|16742901|P1|After 6-month FU to 1-year FU|Failed to Return|2
4856785|NCT00918580|16742901|P1|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58
4856786|NCT00918580|16742901|P1|Up to 6-month Follow-up(FU)|Failed to Return|1
4856787|NCT00918580|16742901|P1|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2
4856788|NCT00918580|16742901|P1|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2
4856789|NCT00918580|16742901|P1|Up to 6-month Follow-up(FU)|Lost to Follow-up|5
4856790|NCT00918580|16742901|P1|Up to 6-month Follow-up(FU)|Adverse Event|1
4856791|NCT00918567|16742921|P2|Overall Study|Adverse Event|0
4856792|NCT00918567|16742922|P1|Overall Study|Adverse Event|1
4856793|NCT00918567|16742921|P2|Overall Study|Withdrawal by Subject|1
4856794|NCT00918567|16742922|P1|Overall Study|Withdrawal by Subject|1
4856795|NCT00918567|16742921|P2|Overall Study|Lack of Efficacy|1
4856796|NCT00918567|16742922|P1|Overall Study|Lack of Efficacy|3
4856797|NCT00918463|16742948|P1|Overall Study|Lack of Efficacy|1
4856798|NCT00918463|16742948|P1|Overall Study|Death|1
4856799|NCT00918385|16742956|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7
4856800|NCT00918385|16742957|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
4856801|NCT00918385|16742956|P2|Combination Nilutamide and Dasatinib|Complicating illness|0
4856802|NCT00918385|16742957|P1|Combination Nilutamide and Dasatinib|Complicating illness|1
4856803|NCT00918385|16742956|P2|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0
4856804|NCT00918385|16742957|P1|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2
4856805|NCT00918385|16742956|P2|Combination Nilutamide and Dasatinib|Adverse Event|1
4856806|NCT00918385|16742957|P1|Combination Nilutamide and Dasatinib|Adverse Event|1
4856807|NCT00918385|16742956|P2|Monotherapy|Complicating illness|0
4856808|NCT00918385|16742957|P1|Monotherapy|Complicating illness|1
4856809|NCT00918385|16742956|P2|Monotherapy|Adverse Event|6
4856810|NCT00918385|16742957|P1|Monotherapy|Adverse Event|1
4856811|NCT00918346|16742966|P2|First Treatment Period (4 Weeks)|Lack of Efficacy|1
4856812|NCT00918346|16742967|P1|First Treatment Period (4 Weeks)|Lack of Efficacy|0
4856813|NCT00918333|16742983|P2|Overall Study|Withdrawal by Subject|1
4856814|NCT00918333|16742984|P1|Overall Study|Withdrawal by Subject|0
4856815|NCT00918333|16742983|P2|Overall Study|Ineligible|0
4856816|NCT00918333|16742984|P1|Overall Study|Ineligible|1
4856817|NCT00918333|16742983|P2|Overall Study|Inadequate amount of drugs provided|4
4856818|NCT00918333|16742984|P1|Overall Study|Inadequate amount of drugs provided|1
4856819|NCT00918333|16742983|P2|Overall Study|Drug not taken per protocol|0
4856820|NCT00918333|16742984|P1|Overall Study|Drug not taken per protocol|1
4856821|NCT00918281|16743004|P1|Overall Study|Physician Decision|29
4856822|NCT00918255|16743014|P3|Overall Study|Investigator discretion|0
4856823|NCT00918255|16743015|P2|Overall Study|Investigator discretion|0
4856824|NCT00918255|16743016|P1|Overall Study|Investigator discretion|1
4856825|NCT00918255|16743014|P3|Overall Study|Non-compliance|0
4856826|NCT00918255|16743015|P2|Overall Study|Non-compliance|0
4856827|NCT00918255|16743016|P1|Overall Study|Non-compliance|1
4856828|NCT00918255|16743014|P3|Overall Study|Exceeded allowed number of interventions|1
4856829|NCT00918255|16743015|P2|Overall Study|Exceeded allowed number of interventions|0
4856830|NCT00918255|16743016|P1|Overall Study|Exceeded allowed number of interventions|0
4856831|NCT00918255|16743014|P3|Overall Study|Lost to Follow-up|2
4856832|NCT00918255|16743015|P2|Overall Study|Lost to Follow-up|0
4856833|NCT00918255|16743016|P1|Overall Study|Lost to Follow-up|1
4856834|NCT00918255|16743014|P3|Overall Study|Lack of Efficacy|0
4856835|NCT00918255|16743015|P2|Overall Study|Lack of Efficacy|0
4856836|NCT00918255|16743016|P1|Overall Study|Lack of Efficacy|1
4856837|NCT00918255|16743014|P3|Overall Study|Withdrawal by Subject|2
4856838|NCT00918255|16743015|P2|Overall Study|Withdrawal by Subject|0
4856839|NCT00918255|16743016|P1|Overall Study|Withdrawal by Subject|1
4856840|NCT00918255|16743014|P3|Overall Study|Adverse Event|0
4856841|NCT00918255|16743015|P2|Overall Study|Adverse Event|0
4856842|NCT00918255|16743016|P1|Overall Study|Adverse Event|1
4856843|NCT00918203|16743049|P3|Treatment With or Without Olaratumab|Never Treated/Death|0
4856844|NCT00918203|16743050|P2|Treatment With or Without Olaratumab|Never Treated/Death|0
4856845|NCT00918203|16743051|P1|Treatment With or Without Olaratumab|Never Treated/Death|1
4856846|NCT00918203|16743049|P3|Treatment With or Without Olaratumab|Other Therapy Started|0
4856847|NCT00918203|16743050|P2|Treatment With or Without Olaratumab|Other Therapy Started|1
4856848|NCT00918203|16743051|P1|Treatment With or Without Olaratumab|Other Therapy Started|2
4856849|NCT00918203|16743049|P3|Treatment With or Without Olaratumab|Withdrawal by Subject|0
4856850|NCT00918203|16743050|P2|Treatment With or Without Olaratumab|Withdrawal by Subject|8
4856851|NCT00918203|16743051|P1|Treatment With or Without Olaratumab|Withdrawal by Subject|2
4856852|NCT00918203|16743049|P3|Treatment With or Without Olaratumab|Lost to Follow-up|0
4856853|NCT00918203|16743050|P2|Treatment With or Without Olaratumab|Lost to Follow-up|1
4856854|NCT00918203|16743051|P1|Treatment With or Without Olaratumab|Lost to Follow-up|1
4856855|NCT00918138|16743082|P2|Overall Study|Death|0
4856856|NCT00918138|16743083|P1|Overall Study|Death|1
4856857|NCT00918138|16743082|P2|Overall Study|Subject withdrew consent|1
4856858|NCT00918138|16743083|P1|Overall Study|Subject withdrew consent|1
4856859|NCT00917852|16743122|P1|Overall Study|Death|6
4856860|NCT00917644|16743140|P2|Period 2: Second Intervention|family emergency|0
4856861|NCT00917644|16743141|P1|Period 2: Second Intervention|family emergency|1
4856862|NCT00917644|16743140|P2|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0
4856863|NCT00917644|16743141|P1|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1
4856864|NCT00917644|16743140|P2|Period: Washout Period of > = 2 Weeks|Protocol Violation|0
4856865|NCT00917644|16743141|P1|Period: Washout Period of > = 2 Weeks|Protocol Violation|1
4856866|NCT00917579|16743155|P2|Washout >= 2 Weeks|Withdrawal by Subject|0
4856867|NCT00917579|16743156|P1|Washout >= 2 Weeks|Withdrawal by Subject|1
4856868|NCT00917579|16743155|P2|Washout >= 2 Weeks|Adverse Event|0
4856869|NCT00917579|16743156|P1|Washout >= 2 Weeks|Adverse Event|1
4856870|NCT00917553|16743172|P2|Overall Study|Lost to Follow-up|1
4856871|NCT00917553|16743173|P1|Overall Study|Lost to Follow-up|2
4856872|NCT00917501|16743189|P2|Overall Study|trouble swollowing capsules|1
4856873|NCT00917501|16743190|P1|Overall Study|trouble swollowing capsules|0
4856874|NCT00917501|16743189|P2|Overall Study|Lack of Efficacy|2
4856875|NCT00917501|16743190|P1|Overall Study|Lack of Efficacy|1
4856876|NCT00917501|16743189|P2|Overall Study|Withdrawal by Subject|1
4856877|NCT00917501|16743190|P1|Overall Study|Withdrawal by Subject|3
4856878|NCT00917501|16743189|P2|Overall Study|Lost to Follow-up|1
4856879|NCT00917501|16743190|P1|Overall Study|Lost to Follow-up|4
4856880|NCT00917462|16743196|P1|Overall Study|Clinical Deterioration|1
4856881|NCT00917384|16743206|P2|Overall Study|Withdrawal by Subject|2
4856882|NCT00917384|16743207|P1|Overall Study|Withdrawal by Subject|10
4856883|NCT00917384|16743206|P2|Overall Study|Lost to Follow-up|2
4856884|NCT00917384|16743207|P1|Overall Study|Lost to Follow-up|4
4856885|NCT00917267|16743231|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
4856886|NCT00917267|16743232|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|2
4856887|NCT00917267|16743231|P2|Overall Study|Sponsor Decision|5
4856888|NCT00917267|16743232|P1|Overall Study|Sponsor Decision|5
4856889|NCT00917267|16743231|P2|Overall Study|Entry Criteria Not Met|0
4856890|NCT00917267|16743232|P1|Overall Study|Entry Criteria Not Met|1
4856891|NCT00917267|16743231|P2|Overall Study|Lost to follow up|2
4856892|NCT00917267|16743232|P1|Overall Study|Lost to follow up|0
4856893|NCT00917267|16743231|P2|Overall Study|Withdrawal by Subject|12
4856894|NCT00917267|16743232|P1|Overall Study|Withdrawal by Subject|5
4856895|NCT00917267|16743231|P2|Overall Study|Protocol Violation|18
4856896|NCT00917267|16743232|P1|Overall Study|Protocol Violation|9
4856897|NCT00917267|16743231|P2|Overall Study|Physician Decision|4
4856898|NCT00917267|16743232|P1|Overall Study|Physician Decision|2
4856899|NCT00917267|16743231|P2|Overall Study|Adverse Event|36
4856900|NCT00917267|16743232|P1|Overall Study|Adverse Event|15
4856901|NCT00917124|16743260|P2|Overall Study|Protocol Violation|6
4856902|NCT00917124|16743261|P1|Overall Study|Protocol Violation|4
4856903|NCT00916929|16743271|P2|Overall Study|Device unable to process impedance data|7
4856904|NCT00916929|16743272|P1|Overall Study|Device unable to process impedance data|0
4856905|NCT00916929|16743271|P2|Overall Study|Moved to another state|1
4856906|NCT00916929|16743272|P1|Overall Study|Moved to another state|0
4856907|NCT00916929|16743271|P2|Overall Study|System explant|0
4856908|NCT00916929|16743272|P1|Overall Study|System explant|1
4856909|NCT00916929|16743271|P2|Overall Study|Transferred to hospice care|1
4856910|NCT00916929|16743272|P1|Overall Study|Transferred to hospice care|1
4856911|NCT00916929|16743271|P2|Overall Study|Left ventricular epicardial lead|2
4856912|NCT00916929|16743272|P1|Overall Study|Left ventricular epicardial lead|1
4856913|NCT00916929|16743271|P2|Overall Study|Withdrawal by Subject|5
4856914|NCT00916929|16743272|P1|Overall Study|Withdrawal by Subject|1
4856915|NCT00916929|16743271|P2|Overall Study|Death|10
4856916|NCT00916929|16743272|P1|Overall Study|Death|5
4856917|NCT00916929|16743271|P2|Overall Study|Lost to Follow-up|3
4856918|NCT00916929|16743272|P1|Overall Study|Lost to Follow-up|1
4856919|NCT00916721|16743282|P2|Overall Study|Protocol Violation|4
4856920|NCT00916721|16743283|P1|Overall Study|Protocol Violation|2
4856921|NCT00916721|16743282|P2|Overall Study|Withdrawal by Subject|2
4856922|NCT00916721|16743283|P1|Overall Study|Withdrawal by Subject|2
4856923|NCT00916721|16743282|P2|Overall Study|Adverse Event|3
4856924|NCT00916721|16743283|P1|Overall Study|Adverse Event|6
4856925|NCT00916721|16743282|P2|Overall Study|Lost to Follow-up|1
4856926|NCT00916721|16743283|P1|Overall Study|Lost to Follow-up|0
4856927|NCT00916617|16743306|P4|Overall Study|Other|2
4856928|NCT00916617|16743307|P3|Overall Study|Other|0
4856929|NCT00916617|16743308|P2|Overall Study|Other|0
4856930|NCT00916617|16743309|P1|Overall Study|Other|2
4856931|NCT00916617|16743306|P4|Overall Study|Lack of Efficacy|0
4856932|NCT00916617|16743307|P3|Overall Study|Lack of Efficacy|0
4856933|NCT00916617|16743308|P2|Overall Study|Lack of Efficacy|0
4856934|NCT00916617|16743309|P1|Overall Study|Lack of Efficacy|1
4856935|NCT00916617|16743306|P4|Overall Study|Lost to Follow-up|0
4856936|NCT00916617|16743307|P3|Overall Study|Lost to Follow-up|0
4856937|NCT00916617|16743308|P2|Overall Study|Lost to Follow-up|1
4856938|NCT00916617|16743309|P1|Overall Study|Lost to Follow-up|2
4856939|NCT00916617|16743306|P4|Overall Study|Discontinuation of Study by Sponsor|1
4856940|NCT00916617|16743307|P3|Overall Study|Discontinuation of Study by Sponsor|3
4856941|NCT00916617|16743308|P2|Overall Study|Discontinuation of Study by Sponsor|13
4856942|NCT00916617|16743309|P1|Overall Study|Discontinuation of Study by Sponsor|8
4856943|NCT00916617|16743306|P4|Overall Study|Physician Decision|0
4856944|NCT00916617|16743307|P3|Overall Study|Physician Decision|0
4856945|NCT00916617|16743308|P2|Overall Study|Physician Decision|1
4856946|NCT00916617|16743309|P1|Overall Study|Physician Decision|1
4856947|NCT00916617|16743306|P4|Overall Study|Caregiver Request|0
4856948|NCT00916617|16743307|P3|Overall Study|Caregiver Request|1
4856949|NCT00916617|16743308|P2|Overall Study|Caregiver Request|2
4856950|NCT00916617|16743309|P1|Overall Study|Caregiver Request|3
4856951|NCT00916617|16743306|P4|Overall Study|Withdrawal by Subject|1
4856952|NCT00916617|16743307|P3|Overall Study|Withdrawal by Subject|0
4856953|NCT00916617|16743308|P2|Overall Study|Withdrawal by Subject|2
4856954|NCT00916617|16743309|P1|Overall Study|Withdrawal by Subject|3
4856955|NCT00916617|16743306|P4|Overall Study|Adverse Event|3
4856956|NCT00916617|16743307|P3|Overall Study|Adverse Event|6
4856957|NCT00916617|16743308|P2|Overall Study|Adverse Event|2
4856958|NCT00916617|16743309|P1|Overall Study|Adverse Event|3
4856959|NCT00916578|16743323|P1|Overall Study|Insurance Denial|2
4856960|NCT00916578|16743323|P1|Overall Study|Withdrawal by Subject|3
4856961|NCT00916578|16743323|P1|Overall Study|Physician Decision|2
4856962|NCT00916383|16743352|P1|Overall Study|Protocol Violation|1
4856963|NCT00916383|16743352|P1|Overall Study|Death|1
4856964|NCT00916383|16743352|P1|Overall Study|Adverse Event|1
4856965|NCT00916370|16743380|P2|Overall Study|Physician Decision|1
4856966|NCT00916370|16743381|P1|Overall Study|Physician Decision|0
4856967|NCT00916370|16743380|P2|Overall Study|Withdrawal by Subject|0
4856968|NCT00916370|16743381|P1|Overall Study|Withdrawal by Subject|2
4856969|NCT00916370|16743380|P2|Overall Study|Death|1
4856970|NCT00916370|16743381|P1|Overall Study|Death|3
4856971|NCT00916357|16743555|P6|Period 2|Weight loss > 3 kilograms (kg)|0
4856972|NCT00916357|16743556|P5|Period 2|Weight loss > 3 kilograms (kg)|0
4856973|NCT00916357|16743557|P4|Period 2|Weight loss > 3 kilograms (kg)|1
4856974|NCT00916357|16743558|P3|Period 2|Weight loss > 3 kilograms (kg)|0
4856975|NCT00916357|16743559|P2|Period 2|Weight loss > 3 kilograms (kg)|0
4856976|NCT00916357|16743560|P1|Period 2|Weight loss > 3 kilograms (kg)|0
4856977|NCT00916357|16743555|P6|Period 1|Withdrawal by Subject|0
4856978|NCT00916357|16743556|P5|Period 1|Withdrawal by Subject|0
4856979|NCT00916357|16743557|P4|Period 1|Withdrawal by Subject|0
4856980|NCT00916357|16743558|P3|Period 1|Withdrawal by Subject|0
4856981|NCT00916357|16743559|P2|Period 1|Withdrawal by Subject|0
4856982|NCT00916357|16743560|P1|Period 1|Withdrawal by Subject|1
4856983|NCT00916344|16743598|P1|Overall Study|Drop-out|5
4856984|NCT00916344|16743598|P1|Overall Study|ICD upgrade|1
4856985|NCT00916344|16743598|P1|Overall Study|Death|2
4856986|NCT00916305|16743605|P2|Overall Study|Withdrawal by Subject|1
4856987|NCT00916305|16743606|P1|Overall Study|Withdrawal by Subject|0
4856988|NCT00916305|16743605|P2|Overall Study|Lost to Follow-up|27
4856989|NCT00916305|16743606|P1|Overall Study|Lost to Follow-up|21
4856990|NCT00916279|16743614|P1|Overall Study|Lost to Follow-up|2
4856991|NCT00916279|16743614|P1|Overall Study|Death|2
4856992|NCT00916149|16743625|P3|Overall Study|Unable to place scalp EEG leads|0
4856993|NCT00916149|16743626|P2|Overall Study|Unable to place scalp EEG leads|0
4856994|NCT00916149|16743627|P1|Overall Study|Unable to place scalp EEG leads|1
4856995|NCT00916149|16743625|P3|Overall Study|Lost to Follow-up|0
4856996|NCT00916149|16743626|P2|Overall Study|Lost to Follow-up|2
4856997|NCT00916149|16743627|P1|Overall Study|Lost to Follow-up|3
4856998|NCT00916058|16743714|P7|Phase 2|Screen Failure|3
4856999|NCT00916058|16743715|P6|Phase 2|Screen Failure|0
4857000|NCT00916058|16743716|P5|Phase 2|Screen Failure|0
4857001|NCT00916058|16743717|P4|Phase 2|Screen Failure|0
4857002|NCT00916058|16743718|P3|Phase 2|Screen Failure|0
4857003|NCT00916058|16743719|P2|Phase 2|Screen Failure|0
4857004|NCT00916058|16743720|P1|Phase 2|Screen Failure|0
4857005|NCT00916058|16743714|P7|Phase 1|Screen Failure|0
4857006|NCT00916058|16743715|P6|Phase 1|Screen Failure|1
4857007|NCT00916058|16743716|P5|Phase 1|Screen Failure|0
4857008|NCT00916058|16743717|P4|Phase 1|Screen Failure|0
4857009|NCT00916058|16743718|P3|Phase 1|Screen Failure|0
4857010|NCT00916058|16743719|P2|Phase 1|Screen Failure|0
4857011|NCT00916058|16743720|P1|Phase 1|Screen Failure|0
4857012|NCT00916006|16743783|P2|Overall Study|Protocol Violation|1
4857013|NCT00916006|16743784|P1|Overall Study|Protocol Violation|0
4857014|NCT00916006|16743783|P2|Overall Study|Withdrawal by Subject|5
4857015|NCT00916006|16743784|P1|Overall Study|Withdrawal by Subject|2
4857016|NCT00916006|16743783|P2|Overall Study|Adverse Event|1
4857017|NCT00916006|16743784|P1|Overall Study|Adverse Event|1
4857018|NCT00915876|16743846|P2|Overall Study|Adverse Event|1
4857019|NCT00915876|16743847|P1|Overall Study|Adverse Event|0
4857020|NCT00915772|16743883|P3|Overall Study|Any other reason|7
4857021|NCT00915772|16743884|P2|Overall Study|Any other reason|7
4857022|NCT00915772|16743885|P1|Overall Study|Any other reason|4
4857023|NCT00915772|16743883|P3|Overall Study|Refused to continue trial medication|4
4857024|NCT00915772|16743884|P2|Overall Study|Refused to continue trial medication|8
4857025|NCT00915772|16743885|P1|Overall Study|Refused to continue trial medication|6
4857026|NCT00915772|16743883|P3|Overall Study|Lack of Efficacy|3
4857027|NCT00915772|16743884|P2|Overall Study|Lack of Efficacy|15
4857028|NCT00915772|16743885|P1|Overall Study|Lack of Efficacy|9
4857029|NCT00915772|16743883|P3|Overall Study|Lost to Follow-up|2
4857030|NCT00915772|16743884|P2|Overall Study|Lost to Follow-up|2
4857031|NCT00915772|16743885|P1|Overall Study|Lost to Follow-up|1
4857032|NCT00915772|16743883|P3|Overall Study|Protocol Violation|2
4857033|NCT00915772|16743884|P2|Overall Study|Protocol Violation|1
4857034|NCT00915772|16743885|P1|Overall Study|Protocol Violation|4
4857035|NCT00915772|16743883|P3|Overall Study|Adverse Event|11
4857036|NCT00915772|16743884|P2|Overall Study|Adverse Event|13
4857037|NCT00915772|16743885|P1|Overall Study|Adverse Event|12
4857038|NCT00915551|16743984|P2|Overall Study|Withdrawal by Subject|1
4857039|NCT00915551|16743985|P1|Overall Study|Withdrawal by Subject|0
4857040|NCT00915525|16744006|P2|Overall Study|Patient Moved|9
4857041|NCT00915525|16744007|P1|Overall Study|Patient Moved|15
4857042|NCT00915525|16744006|P2|Overall Study|Non-Compliance|1
4857043|NCT00915525|16744007|P1|Overall Study|Non-Compliance|3
4857044|NCT00915525|16744006|P2|Overall Study|Study Burden|12
4857045|NCT00915525|16744007|P1|Overall Study|Study Burden|28
4857046|NCT00915525|16744006|P2|Overall Study|Retreat Request >Wk 144 (exclusionary)|5
4857047|NCT00915525|16744007|P1|Overall Study|Retreat Request >Wk 144 (exclusionary)|4
4857048|NCT00915525|16744006|P2|Overall Study|Site Closed|9
4857049|NCT00915525|16744007|P1|Overall Study|Site Closed|27
4857050|NCT00915525|16744006|P2|Overall Study|Other Reason|12
4857051|NCT00915525|16744007|P1|Overall Study|Other Reason|35
4857052|NCT00915525|16744006|P2|Overall Study|Missing|1
4857053|NCT00915525|16744007|P1|Overall Study|Missing|12
4857054|NCT00915525|16744006|P2|Overall Study|Adverse Event|13
4857055|NCT00915525|16744007|P1|Overall Study|Adverse Event|29
4857056|NCT00915525|16744006|P2|Overall Study|Lack of Efficacy|32
4857057|NCT00915525|16744007|P1|Overall Study|Lack of Efficacy|15
4857058|NCT00915525|16744006|P2|Overall Study|Pregnancy|0
4857059|NCT00915525|16744007|P1|Overall Study|Pregnancy|2
4857060|NCT00915525|16744006|P2|Overall Study|Lost to Follow-up|16
4857061|NCT00915525|16744007|P1|Overall Study|Lost to Follow-up|27
4857062|NCT00915525|16744006|P2|Overall Study|Withdrawal by Subject|21
4857063|NCT00915525|16744007|P1|Overall Study|Withdrawal by Subject|59
4857064|NCT00915525|16744006|P2|Overall Study|Protocol Violation|4
4857065|NCT00915525|16744007|P1|Overall Study|Protocol Violation|9
4857066|NCT00915473|16744121|P2|4-week Follow Up|Lost to Follow-up|5
4857067|NCT00915473|16744122|P1|4-week Follow Up|Lost to Follow-up|1
4857068|NCT00915473|16744121|P2|Screening|Withdrawal by Subject|0
4857069|NCT00915473|16744122|P1|Screening|Withdrawal by Subject|1
4857070|NCT00915356|16744139|P5|Overall Study|Withdrawal by Subject|0
4857071|NCT00915356|16744140|P4|Overall Study|Withdrawal by Subject|0
4857072|NCT00915356|16744141|P3|Overall Study|Withdrawal by Subject|0
4857073|NCT00915356|16744142|P2|Overall Study|Withdrawal by Subject|0
4857074|NCT00915356|16744143|P1|Overall Study|Withdrawal by Subject|1
4857075|NCT00915343|16744205|P3|Part B - Open Label Period|Did not attend the last visit|1
4857076|NCT00915343|16744206|P2|Part B - Open Label Period|Did not attend the last visit|0
4857077|NCT00915343|16744207|P1|Part B - Open Label Period|Did not attend the last visit|0
4857078|NCT00915343|16744205|P3|Part B - Open Label Period|Treatment switch|1
4857079|NCT00915343|16744206|P2|Part B - Open Label Period|Treatment switch|0
4857080|NCT00915343|16744207|P1|Part B - Open Label Period|Treatment switch|0
4857081|NCT00915278|16744292|P6|Overall Study|Admission to hospice|0
4857082|NCT00915278|16744293|P5|Overall Study|Admission to hospice|0
4857083|NCT00915278|16744294|P4|Overall Study|Admission to hospice|0
4857084|NCT00915278|16744295|P3|Overall Study|Admission to hospice|1
4857085|NCT00915278|16744296|P2|Overall Study|Admission to hospice|0
4857086|NCT00915278|16744297|P1|Overall Study|Admission to hospice|0
4857087|NCT00915278|16744292|P6|Overall Study|Infusion related AEs|2
4857088|NCT00915278|16744293|P5|Overall Study|Infusion related AEs|0
4857089|NCT00915278|16744294|P4|Overall Study|Infusion related AEs|0
4857090|NCT00915278|16744295|P3|Overall Study|Infusion related AEs|0
4857091|NCT00915278|16744296|P2|Overall Study|Infusion related AEs|0
4857092|NCT00915278|16744297|P1|Overall Study|Infusion related AEs|0
4857093|NCT00915278|16744292|P6|Overall Study|Progressive disease/clinical progression|2
4857094|NCT00915278|16744293|P5|Overall Study|Progressive disease/clinical progression|1
4857095|NCT00915278|16744294|P4|Overall Study|Progressive disease/clinical progression|3
4857096|NCT00915278|16744295|P3|Overall Study|Progressive disease/clinical progression|0
4857097|NCT00915278|16744296|P2|Overall Study|Progressive disease/clinical progression|0
4857098|NCT00915278|16744297|P1|Overall Study|Progressive disease/clinical progression|0
4857099|NCT00915278|16744292|P6|Overall Study|Adverse Event|0
4857100|NCT00915278|16744293|P5|Overall Study|Adverse Event|0
4857101|NCT00915278|16744294|P4|Overall Study|Adverse Event|0
4857102|NCT00915278|16744295|P3|Overall Study|Adverse Event|0
4857103|NCT00915278|16744296|P2|Overall Study|Adverse Event|1
4857104|NCT00915278|16744297|P1|Overall Study|Adverse Event|4
4857105|NCT00915278|16744292|P6|Overall Study|Withdrawal by Subject|4
4857106|NCT00915278|16744293|P5|Overall Study|Withdrawal by Subject|1
4857107|NCT00915278|16744294|P4|Overall Study|Withdrawal by Subject|0
4857108|NCT00915278|16744295|P3|Overall Study|Withdrawal by Subject|0
4857109|NCT00915278|16744296|P2|Overall Study|Withdrawal by Subject|1
4857110|NCT00915278|16744297|P1|Overall Study|Withdrawal by Subject|0
4857111|NCT00915278|16744292|P6|Overall Study|Lost to Follow-up|0
4857112|NCT00915278|16744293|P5|Overall Study|Lost to Follow-up|0
4857113|NCT00915278|16744294|P4|Overall Study|Lost to Follow-up|0
4857114|NCT00915278|16744295|P3|Overall Study|Lost to Follow-up|0
4857115|NCT00915278|16744296|P2|Overall Study|Lost to Follow-up|1
4857116|NCT00915278|16744297|P1|Overall Study|Lost to Follow-up|0
4857117|NCT00915278|16744292|P6|Overall Study|Death|0
4857118|NCT00915278|16744293|P5|Overall Study|Death|0
4857119|NCT00915278|16744294|P4|Overall Study|Death|0
4857120|NCT00915278|16744295|P3|Overall Study|Death|0
4857121|NCT00915278|16744296|P2|Overall Study|Death|0
4857122|NCT00915278|16744297|P1|Overall Study|Death|1
4857123|NCT00915018|16744458|P2|Overall Study|By Sponsor due to Protocol Amendment|105
4857124|NCT00915018|16744459|P1|Overall Study|By Sponsor due to Protocol Amendment|92
4857125|NCT00915018|16744458|P2|Overall Study|Withdrawal by Subject|27
4857126|NCT00915018|16744459|P1|Overall Study|Withdrawal by Subject|38
4857127|NCT00915018|16744458|P2|Overall Study|Lost to Follow-up|5
4857128|NCT00915018|16744459|P1|Overall Study|Lost to Follow-up|10
4857129|NCT00915018|16744458|P2|Overall Study|Death|70
4857130|NCT00915018|16744459|P1|Overall Study|Death|75
4857131|NCT00915005|16744475|P2|Overall Study|Insurance denial|15
4857132|NCT00915005|16744476|P1|Overall Study|Insurance denial|3
4857133|NCT00915005|16744475|P2|Overall Study|Patient preferred protons therapy|0
4857134|NCT00915005|16744476|P1|Overall Study|Patient preferred protons therapy|6
4857135|NCT00915005|16744475|P2|Overall Study|Withdrawal by Subject|4
4857136|NCT00915005|16744476|P1|Overall Study|Withdrawal by Subject|4
4857137|NCT00914966|16744484|P1|Step 2: 2000 Units|Withdrawal by Subject|1
4857138|NCT00914966|16744484|P1|Step 1: 1500 Units|Physician Decision|1
4857139|NCT00914966|16744484|P1|Step 1: 1500 Units|Withdrawal by Subject|1
4857140|NCT00914940|16744496|P1|2 Years to 5 Years Post-transplant|Death|3
4857141|NCT00914940|16744496|P1|D101 to 2 Years Post-transplant|Death|8
4857142|NCT00914940|16744496|P1|D0 to D100 Post-transplant|Death|2
4857143|NCT00914927|16744511|P7|Overall Study|Administrative/Other|0
4857144|NCT00914927|16744512|P6|Overall Study|Administrative/Other|0
4857145|NCT00914927|16744513|P5|Overall Study|Administrative/Other|1
4857146|NCT00914927|16744514|P4|Overall Study|Administrative/Other|0
4857147|NCT00914927|16744515|P3|Overall Study|Administrative/Other|0
4857148|NCT00914927|16744516|P2|Overall Study|Administrative/Other|1
4857149|NCT00914927|16744517|P1|Overall Study|Administrative/Other|2
4857150|NCT00914927|16744511|P7|Overall Study|Lost to Follow-up|0
4857151|NCT00914927|16744512|P6|Overall Study|Lost to Follow-up|0
4857152|NCT00914927|16744513|P5|Overall Study|Lost to Follow-up|0
4857153|NCT00914927|16744514|P4|Overall Study|Lost to Follow-up|1
4857154|NCT00914927|16744515|P3|Overall Study|Lost to Follow-up|0
4857155|NCT00914927|16744516|P2|Overall Study|Lost to Follow-up|0
4857156|NCT00914927|16744517|P1|Overall Study|Lost to Follow-up|0
4857157|NCT00914927|16744511|P7|Overall Study|Withdrawal by Subject|0
4857158|NCT00914927|16744512|P6|Overall Study|Withdrawal by Subject|0
4857159|NCT00914927|16744513|P5|Overall Study|Withdrawal by Subject|0
4857160|NCT00914927|16744514|P4|Overall Study|Withdrawal by Subject|1
4857161|NCT00914927|16744515|P3|Overall Study|Withdrawal by Subject|0
4857162|NCT00914927|16744516|P2|Overall Study|Withdrawal by Subject|1
4857163|NCT00914927|16744517|P1|Overall Study|Withdrawal by Subject|0
4857164|NCT00914927|16744511|P7|Overall Study|Adverse Event|0
4857165|NCT00914927|16744512|P6|Overall Study|Adverse Event|0
4857166|NCT00914927|16744513|P5|Overall Study|Adverse Event|1
4857167|NCT00914927|16744514|P4|Overall Study|Adverse Event|0
4857168|NCT00914927|16744515|P3|Overall Study|Adverse Event|0
4857169|NCT00914927|16744516|P2|Overall Study|Adverse Event|0
4857170|NCT00914927|16744517|P1|Overall Study|Adverse Event|0
4857171|NCT00914849|16744644|P2|Overall Study|Not eligible|1
4857172|NCT00914849|16744645|P1|Overall Study|Not eligible|0
4857173|NCT00914849|16744644|P2|Overall Study|Withdrawal by Subject|0
4857174|NCT00914849|16744645|P1|Overall Study|Withdrawal by Subject|1
4857175|NCT00914810|16744679|P2|Overall Study|Hospitalized and unable to follow up.|1
4857176|NCT00914810|16744680|P1|Overall Study|Hospitalized and unable to follow up.|0
4857177|NCT00914810|16744679|P2|Overall Study|Relocated out of state|0
4857178|NCT00914810|16744680|P1|Overall Study|Relocated out of state|1
4857179|NCT00914810|16744679|P2|Overall Study|Withdrawal by Subject|0
4857180|NCT00914810|16744680|P1|Overall Study|Withdrawal by Subject|1
4857181|NCT00914589|16744691|P3|Overall Study|Death|1
4857182|NCT00914589|16744692|P2|Overall Study|Death|1
4857183|NCT00914589|16744693|P1|Overall Study|Death|0
4857184|NCT00914589|16744691|P3|Overall Study|unclassified|7
4857185|NCT00914589|16744692|P2|Overall Study|unclassified|9
4857186|NCT00914589|16744693|P1|Overall Study|unclassified|16
4857187|NCT00914589|16744691|P3|Overall Study|Protocol Violation|3
4857188|NCT00914589|16744692|P2|Overall Study|Protocol Violation|6
4857189|NCT00914589|16744693|P1|Overall Study|Protocol Violation|8
4857190|NCT00914589|16744691|P3|Overall Study|Adverse Event|1
4857191|NCT00914589|16744692|P2|Overall Study|Adverse Event|0
4857192|NCT00914589|16744693|P1|Overall Study|Adverse Event|1
4857193|NCT00914459|16744719|P2|Overall Study|Parent/Legal guardian request|0
4857194|NCT00914459|16744720|P1|Overall Study|Parent/Legal guardian request|1
4857195|NCT00914459|16744719|P2|Overall Study|Protocol Violation|1
4857196|NCT00914459|16744720|P1|Overall Study|Protocol Violation|0
4857197|NCT00914316|16744750|P4|Phase 2|Withdrawal by Subject|0
4857198|NCT00914316|16744751|P3|Phase 2|Withdrawal by Subject|1
4857199|NCT00914316|16744752|P2|Phase 2|Withdrawal by Subject|0
4857200|NCT00914316|16744753|P1|Phase 2|Withdrawal by Subject|1
4857201|NCT00914316|16744750|P4|Phase 1|Adverse Event|0
4857202|NCT00914316|16744751|P3|Phase 1|Adverse Event|0
4857203|NCT00914316|16744752|P2|Phase 1|Adverse Event|0
4857204|NCT00914316|16744753|P1|Phase 1|Adverse Event|1
4857205|NCT00914316|16744750|P4|Phase 1|Withdrawal by Subject|0
4857206|NCT00914316|16744751|P3|Phase 1|Withdrawal by Subject|4
4857207|NCT00914316|16744752|P2|Phase 1|Withdrawal by Subject|2
4857208|NCT00914316|16744753|P1|Phase 1|Withdrawal by Subject|0
4857209|NCT00914316|16744750|P4|Phase 1|Physician Decision|2
4857210|NCT00914316|16744751|P3|Phase 1|Physician Decision|1
4857211|NCT00914316|16744752|P2|Phase 1|Physician Decision|0
4857212|NCT00914316|16744753|P1|Phase 1|Physician Decision|4
4857213|NCT00913978|16744825|P2|Overall Study|Surgeon choice|3
4857214|NCT00913978|16744826|P1|Overall Study|Surgeon choice|1
4857215|NCT00913835|16744843|P2|Lip Dox: Olaratumab Monotherapy|Other|3
4857216|NCT00913835|16744844|P1|Lip Dox: Olaratumab Monotherapy|Other|0
4857217|NCT00913835|16744843|P2|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
4857218|NCT00913835|16744844|P1|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1
4857219|NCT00913835|16744843|P2|Olara+Lip Dox and Lip Dox Monotherapy|Other|3
4857220|NCT00913835|16744844|P1|Olara+Lip Dox and Lip Dox Monotherapy|Other|4
4857221|NCT00913835|16744843|P2|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0
4857222|NCT00913835|16744844|P1|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1
4857223|NCT00913835|16744843|P2|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3
4857224|NCT00913835|16744844|P1|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2
4857225|NCT00913770|16744883|P3|Overall Study|Refused|8
4857226|NCT00913770|16744884|P2|Overall Study|Refused|10
4857227|NCT00913770|16744885|P1|Overall Study|Refused|11
4857228|NCT00913770|16744883|P3|Overall Study|Unable to contact|13
4857229|NCT00913770|16744884|P2|Overall Study|Unable to contact|19
4857230|NCT00913770|16744885|P1|Overall Study|Unable to contact|24
4857231|NCT00913744|16744898|P2|Overall Study|Death|0
4857232|NCT00913744|16744899|P1|Overall Study|Death|1
4857233|NCT00913744|16744898|P2|Overall Study|Withdrawal by Subject|1
4857234|NCT00913744|16744899|P1|Overall Study|Withdrawal by Subject|2
4857235|NCT00913744|16744898|P2|Overall Study|Adverse Event|0
4857236|NCT00913744|16744899|P1|Overall Study|Adverse Event|2
4857237|NCT00913692|16744905|P1|Treatment Phase 1 (5 Months)|Physician Decision|1
4857238|NCT00913692|16744905|P1|Screening (4 Months)|Not eligible after screening phase.|6
4857239|NCT00913692|16744905|P1|Screening (4 Months)|Physician Decision|3
4857240|NCT00913523|16744999|P3|Overall Study|Inadequate Number of Tampons Used|3
4857241|NCT00913523|16745000|P2|Overall Study|Inadequate Number of Tampons Used|2
4857242|NCT00913523|16745001|P1|Overall Study|Inadequate Number of Tampons Used|7
4857243|NCT00913523|16744999|P3|Overall Study|Pregnancy|0
4857244|NCT00913523|16745000|P2|Overall Study|Pregnancy|3
4857245|NCT00913523|16745001|P1|Overall Study|Pregnancy|1
4857246|NCT00913523|16744999|P3|Overall Study|Protocol Violation|8
4857247|NCT00913523|16745000|P2|Overall Study|Protocol Violation|8
4857248|NCT00913523|16745001|P1|Overall Study|Protocol Violation|5
4857249|NCT00913523|16744999|P3|Overall Study|Adverse Event|0
4857250|NCT00913523|16745000|P2|Overall Study|Adverse Event|0
4857251|NCT00913523|16745001|P1|Overall Study|Adverse Event|1
4857252|NCT00913523|16744999|P3|Overall Study|Lost to Follow-up|1
4857253|NCT00913523|16745000|P2|Overall Study|Lost to Follow-up|1
4857254|NCT00913523|16745001|P1|Overall Study|Lost to Follow-up|1
4857255|NCT00913523|16744999|P3|Overall Study|Withdrawal by Subject|2
4857256|NCT00913523|16745000|P2|Overall Study|Withdrawal by Subject|2
4857257|NCT00913523|16745001|P1|Overall Study|Withdrawal by Subject|3
4857258|NCT00913458|16745033|P7|Phase 3|Unsatisfactory Response per Investigator|4
4857259|NCT00913458|16745034|P6|Phase 3|Unsatisfactory Response per Investigator|11
4857260|NCT00913458|16745035|P5|Phase 3|Unsatisfactory Response per Investigator|14
4857261|NCT00913458|16745036|P4|Phase 3|Unsatisfactory Response per Investigator|0
4857262|NCT00913458|16745037|P3|Phase 3|Unsatisfactory Response per Investigator|0
4857263|NCT00913458|16745038|P2|Phase 3|Unsatisfactory Response per Investigator|0
4857264|NCT00913458|16745039|P1|Phase 3|Unsatisfactory Response per Investigator|0
4857265|NCT00913458|16745033|P7|Phase 3|Withdrawal by Subject|0
4857266|NCT00913458|16745034|P6|Phase 3|Withdrawal by Subject|2
4857267|NCT00913458|16745035|P5|Phase 3|Withdrawal by Subject|1
4857268|NCT00913458|16745036|P4|Phase 3|Withdrawal by Subject|0
4857269|NCT00913458|16745037|P3|Phase 3|Withdrawal by Subject|0
4857270|NCT00913458|16745038|P2|Phase 3|Withdrawal by Subject|0
4857271|NCT00913458|16745039|P1|Phase 3|Withdrawal by Subject|0
4857272|NCT00913458|16745033|P7|Phase 3|Non-Responder|3
4857273|NCT00913458|16745034|P6|Phase 3|Non-Responder|1
4857274|NCT00913458|16745035|P5|Phase 3|Non-Responder|0
4857275|NCT00913458|16745036|P4|Phase 3|Non-Responder|0
4857276|NCT00913458|16745037|P3|Phase 3|Non-Responder|0
4857277|NCT00913458|16745038|P2|Phase 3|Non-Responder|0
4857278|NCT00913458|16745039|P1|Phase 3|Non-Responder|0
4857279|NCT00913458|16745033|P7|Phase 3|Lost to Follow-up|0
4857280|NCT00913458|16745034|P6|Phase 3|Lost to Follow-up|0
4857281|NCT00913458|16745035|P5|Phase 3|Lost to Follow-up|2
4857282|NCT00913458|16745036|P4|Phase 3|Lost to Follow-up|0
4857283|NCT00913458|16745037|P3|Phase 3|Lost to Follow-up|0
4857284|NCT00913458|16745038|P2|Phase 3|Lost to Follow-up|0
4857285|NCT00913458|16745039|P1|Phase 3|Lost to Follow-up|0
4857286|NCT00913458|16745033|P7|Phase 3|Adverse Event|1
4857287|NCT00913458|16745034|P6|Phase 3|Adverse Event|4
4857288|NCT00913458|16745035|P5|Phase 3|Adverse Event|5
4857289|NCT00913458|16745036|P4|Phase 3|Adverse Event|0
4857290|NCT00913458|16745037|P3|Phase 3|Adverse Event|0
4857291|NCT00913458|16745038|P2|Phase 3|Adverse Event|0
4857292|NCT00913458|16745039|P1|Phase 3|Adverse Event|0
4857293|NCT00913458|16745033|P7|Phase 2|Unsatisfactory Response per Investigator|0
4857294|NCT00913458|16745034|P6|Phase 2|Unsatisfactory Response per Investigator|0
4857295|NCT00913458|16745035|P5|Phase 2|Unsatisfactory Response per Investigator|0
4857296|NCT00913458|16745036|P4|Phase 2|Unsatisfactory Response per Investigator|17
4857297|NCT00913458|16745037|P3|Phase 2|Unsatisfactory Response per Investigator|11
4857298|NCT00913458|16745038|P2|Phase 2|Unsatisfactory Response per Investigator|0
4857299|NCT00913458|16745039|P1|Phase 2|Unsatisfactory Response per Investigator|0
4857300|NCT00913458|16745033|P7|Phase 2|Protocol Violation|0
4857301|NCT00913458|16745034|P6|Phase 2|Protocol Violation|0
4857302|NCT00913458|16745035|P5|Phase 2|Protocol Violation|0
4857303|NCT00913458|16745036|P4|Phase 2|Protocol Violation|0
4857304|NCT00913458|16745037|P3|Phase 2|Protocol Violation|0
4857305|NCT00913458|16745038|P2|Phase 2|Protocol Violation|2
4857306|NCT00913458|16745039|P1|Phase 2|Protocol Violation|0
4857307|NCT00913458|16745033|P7|Phase 2|Lost to Follow-up|0
4857308|NCT00913458|16745034|P6|Phase 2|Lost to Follow-up|0
4857309|NCT00913458|16745035|P5|Phase 2|Lost to Follow-up|0
4857310|NCT00913458|16745036|P4|Phase 2|Lost to Follow-up|1
4857311|NCT00913458|16745037|P3|Phase 2|Lost to Follow-up|0
4857312|NCT00913458|16745038|P2|Phase 2|Lost to Follow-up|0
4857313|NCT00913458|16745039|P1|Phase 2|Lost to Follow-up|0
4857314|NCT00913458|16745033|P7|Phase 2|Adverse Event|0
4857315|NCT00913458|16745034|P6|Phase 2|Adverse Event|0
4857316|NCT00913458|16745035|P5|Phase 2|Adverse Event|0
4857317|NCT00913458|16745036|P4|Phase 2|Adverse Event|1
4857318|NCT00913458|16745037|P3|Phase 2|Adverse Event|0
4857319|NCT00913458|16745038|P2|Phase 2|Adverse Event|3
4857320|NCT00913458|16745039|P1|Phase 2|Adverse Event|0
4857321|NCT00913458|16745033|P7|Phase 2|Subject Request|0
4857322|NCT00913458|16745034|P6|Phase 2|Subject Request|0
4857323|NCT00913458|16745035|P5|Phase 2|Subject Request|0
4857324|NCT00913458|16745036|P4|Phase 2|Subject Request|2
4857325|NCT00913458|16745037|P3|Phase 2|Subject Request|1
4857326|NCT00913458|16745038|P2|Phase 2|Subject Request|0
4857327|NCT00913458|16745039|P1|Phase 2|Subject Request|0
4857328|NCT00913458|16745033|P7|Phase 2|Non-Responder|0
4857329|NCT00913458|16745034|P6|Phase 2|Non-Responder|0
4857330|NCT00913458|16745035|P5|Phase 2|Non-Responder|0
4857331|NCT00913458|16745036|P4|Phase 2|Non-Responder|12
4857332|NCT00913458|16745037|P3|Phase 2|Non-Responder|7
4857333|NCT00913458|16745038|P2|Phase 2|Non-Responder|5
4857334|NCT00913458|16745039|P1|Phase 2|Non-Responder|0
4857335|NCT00913458|16745033|P7|Phase 1|Unsatisfactory Response per Investigator|0
4857336|NCT00913458|16745034|P6|Phase 1|Unsatisfactory Response per Investigator|0
4857337|NCT00913458|16745035|P5|Phase 1|Unsatisfactory Response per Investigator|0
4857338|NCT00913458|16745036|P4|Phase 1|Unsatisfactory Response per Investigator|0
4857339|NCT00913458|16745037|P3|Phase 1|Unsatisfactory Response per Investigator|0
4857340|NCT00913458|16745038|P2|Phase 1|Unsatisfactory Response per Investigator|0
4857341|NCT00913458|16745039|P1|Phase 1|Unsatisfactory Response per Investigator|7
4857342|NCT00913458|16745033|P7|Phase 1|Sponsor|0
4857343|NCT00913458|16745034|P6|Phase 1|Sponsor|0
4857344|NCT00913458|16745035|P5|Phase 1|Sponsor|0
4857345|NCT00913458|16745036|P4|Phase 1|Sponsor|0
4857346|NCT00913458|16745037|P3|Phase 1|Sponsor|0
4857347|NCT00913458|16745038|P2|Phase 1|Sponsor|0
4857348|NCT00913458|16745039|P1|Phase 1|Sponsor|2
4857349|NCT00913458|16745033|P7|Phase 1|Protocol Violation|0
4857350|NCT00913458|16745034|P6|Phase 1|Protocol Violation|0
4857351|NCT00913458|16745035|P5|Phase 1|Protocol Violation|0
4857352|NCT00913458|16745036|P4|Phase 1|Protocol Violation|0
4857353|NCT00913458|16745037|P3|Phase 1|Protocol Violation|0
4857354|NCT00913458|16745038|P2|Phase 1|Protocol Violation|0
4857355|NCT00913458|16745039|P1|Phase 1|Protocol Violation|10
4857356|NCT00913458|16745033|P7|Phase 1|Lost to Follow-up|0
4857357|NCT00913458|16745034|P6|Phase 1|Lost to Follow-up|0
4857358|NCT00913458|16745035|P5|Phase 1|Lost to Follow-up|0
4857359|NCT00913458|16745036|P4|Phase 1|Lost to Follow-up|0
4857360|NCT00913458|16745037|P3|Phase 1|Lost to Follow-up|0
4857361|NCT00913458|16745038|P2|Phase 1|Lost to Follow-up|0
4857362|NCT00913458|16745039|P1|Phase 1|Lost to Follow-up|2
4857363|NCT00913458|16745033|P7|Phase 1|Adverse Event|0
4857364|NCT00913458|16745034|P6|Phase 1|Adverse Event|0
4857365|NCT00913458|16745035|P5|Phase 1|Adverse Event|0
4857366|NCT00913458|16745036|P4|Phase 1|Adverse Event|0
4857367|NCT00913458|16745037|P3|Phase 1|Adverse Event|0
4857368|NCT00913458|16745038|P2|Phase 1|Adverse Event|0
4857369|NCT00913458|16745039|P1|Phase 1|Adverse Event|20
4857370|NCT00913458|16745033|P7|Phase 1|Subject Request|0
4857371|NCT00913458|16745034|P6|Phase 1|Subject Request|0
4857372|NCT00913458|16745035|P5|Phase 1|Subject Request|0
4857373|NCT00913458|16745036|P4|Phase 1|Subject Request|0
4857374|NCT00913458|16745037|P3|Phase 1|Subject Request|0
4857375|NCT00913458|16745038|P2|Phase 1|Subject Request|0
4857376|NCT00913458|16745039|P1|Phase 1|Subject Request|17
4857377|NCT00913458|16745033|P7|Phase 1|Non-Responder|0
4857378|NCT00913458|16745034|P6|Phase 1|Non-Responder|0
4857379|NCT00913458|16745035|P5|Phase 1|Non-Responder|0
4857380|NCT00913458|16745036|P4|Phase 1|Non-Responder|0
4857381|NCT00913458|16745037|P3|Phase 1|Non-Responder|0
4857382|NCT00913458|16745038|P2|Phase 1|Non-Responder|0
4857383|NCT00913458|16745039|P1|Phase 1|Non-Responder|54
4857384|NCT00913380|16745132|P2|Clinical Outcomes|Lost to Follow-up|6
4857385|NCT00913380|16745133|P1|Clinical Outcomes|Lost to Follow-up|6
4857386|NCT00912964|16745212|P3|Overall Study|Randomized but never received study drug|0
4857387|NCT00912964|16745213|P2|Overall Study|Randomized but never received study drug|1
4857388|NCT00912964|16745214|P1|Overall Study|Randomized but never received study drug|0
4857389|NCT00912964|16745212|P3|Overall Study|Violation of exclusion criterion|2
4857390|NCT00912964|16745213|P2|Overall Study|Violation of exclusion criterion|0
4857391|NCT00912964|16745214|P1|Overall Study|Violation of exclusion criterion|0
4857392|NCT00912964|16745212|P3|Overall Study|Non-compliance with study procedures|0
4857393|NCT00912964|16745213|P2|Overall Study|Non-compliance with study procedures|0
4857394|NCT00912964|16745214|P1|Overall Study|Non-compliance with study procedures|2
4857395|NCT00912964|16745212|P3|Overall Study|Medical History|0
4857396|NCT00912964|16745213|P2|Overall Study|Medical History|0
4857397|NCT00912964|16745214|P1|Overall Study|Medical History|1
4857398|NCT00912964|16745212|P3|Overall Study|Taking exclusionary medications|8
4857399|NCT00912964|16745213|P2|Overall Study|Taking exclusionary medications|4
4857400|NCT00912964|16745214|P1|Overall Study|Taking exclusionary medications|7
4857401|NCT00912964|16745212|P3|Overall Study|Protocol Violation|8
4857402|NCT00912964|16745213|P2|Overall Study|Protocol Violation|3
4857403|NCT00912964|16745214|P1|Overall Study|Protocol Violation|5
4857404|NCT00912964|16745212|P3|Overall Study|Lost to Follow-up|3
4857405|NCT00912964|16745213|P2|Overall Study|Lost to Follow-up|3
4857406|NCT00912964|16745214|P1|Overall Study|Lost to Follow-up|4
4857407|NCT00912964|16745212|P3|Overall Study|Withdrawal by Subject|18
4857408|NCT00912964|16745213|P2|Overall Study|Withdrawal by Subject|12
4857409|NCT00912964|16745214|P1|Overall Study|Withdrawal by Subject|20
4857410|NCT00912964|16745212|P3|Overall Study|Lack of Efficacy|3
4857411|NCT00912964|16745213|P2|Overall Study|Lack of Efficacy|4
4857412|NCT00912964|16745214|P1|Overall Study|Lack of Efficacy|11
4857413|NCT00912964|16745212|P3|Overall Study|Adverse Event|12
4857414|NCT00912964|16745213|P2|Overall Study|Adverse Event|18
4857415|NCT00912964|16745214|P1|Overall Study|Adverse Event|15
4857416|NCT00912964|16745212|P3|Overall Study|Eligibility criterion not met|0
4857417|NCT00912964|16745213|P2|Overall Study|Eligibility criterion not met|1
4857418|NCT00912964|16745214|P1|Overall Study|Eligibility criterion not met|1
4857419|NCT00912912|16745357|P1|Overall Study|Disease Progression|3
4857420|NCT00912912|16745357|P1|Overall Study|Withdrawal by Subject|1
4857421|NCT00912808|16745363|P2|Second Intervention (6 Weeks)|Withdrawal by Subject|0
4857422|NCT00912808|16745364|P1|Second Intervention (6 Weeks)|Withdrawal by Subject|1
4857423|NCT00912808|16745363|P2|Second Intervention (6 Weeks)|Adverse Event|1
4857424|NCT00912808|16745364|P1|Second Intervention (6 Weeks)|Adverse Event|0
4857425|NCT00912808|16745363|P2|Washout|Withdrawal by Subject|1
4857426|NCT00912808|16745364|P1|Washout|Withdrawal by Subject|0
4857427|NCT00912808|16745363|P2|First Intervention (6 Weeks)|Adverse Event|1
4857428|NCT00912808|16745364|P1|First Intervention (6 Weeks)|Adverse Event|2
4857429|NCT00912782|16745389|P2|Overall Study|Relocated before study completion|1
4857430|NCT00912782|16745390|P1|Overall Study|Relocated before study completion|0
4857431|NCT00912782|16745389|P2|Overall Study|Did not receive vascular access type|2
4857432|NCT00912782|16745390|P1|Overall Study|Did not receive vascular access type|1
4857433|NCT00912782|16745389|P2|Overall Study|Lost to Follow-up|1
4857434|NCT00912782|16745390|P1|Overall Study|Lost to Follow-up|0
4857435|NCT00912782|16745389|P2|Overall Study|Death|1
4857436|NCT00912782|16745390|P1|Overall Study|Death|2
4857437|NCT00912743|16745400|P2|Overall Study|End of treatment form was not collected|0
4857438|NCT00912743|16745401|P1|Overall Study|End of treatment form was not collected|1
4857439|NCT00912743|16745400|P2|Overall Study|Toxicity|1
4857440|NCT00912743|16745401|P1|Overall Study|Toxicity|0
4857441|NCT00912743|16745400|P2|Overall Study|Lack of Efficacy|18
4857442|NCT00912743|16745401|P1|Overall Study|Lack of Efficacy|9
4857443|NCT00912743|16745400|P2|Overall Study|Adverse Event|1
4857444|NCT00912743|16745401|P1|Overall Study|Adverse Event|3
4857445|NCT00912509|16745413|P2|Overall Study|Lack of Efficacy|3
4857446|NCT00912509|16745414|P1|Overall Study|Lack of Efficacy|4
4857447|NCT00912509|16745413|P2|Overall Study|Lost to Follow-up|0
4857448|NCT00912509|16745414|P1|Overall Study|Lost to Follow-up|1
4857449|NCT00912405|16745422|P1|Overall Study|Lost to Follow-up|5
4857450|NCT00912340|16745432|P3|Overall Study|Protocol revised to remove arm|4
4857451|NCT00912340|16745433|P2|Overall Study|Protocol revised to remove arm|0
4857452|NCT00912340|16745434|P1|Overall Study|Protocol revised to remove arm|0
4857453|NCT00912340|16745432|P3|Overall Study|Adverse Event|0
4857454|NCT00912340|16745433|P2|Overall Study|Adverse Event|4
4857455|NCT00912340|16745434|P1|Overall Study|Adverse Event|2
4857456|NCT00912288|16745472|P2|Overall Study|Other|0
4857457|NCT00912288|16745473|P1|Overall Study|Other|1
4857458|NCT00912288|16745472|P2|Overall Study|Study terminated by sponsor|35
4857459|NCT00912288|16745473|P1|Overall Study|Study terminated by sponsor|34
4857460|NCT00912288|16745472|P2|Overall Study|Withdrawal by Subject|3
4857461|NCT00912288|16745473|P1|Overall Study|Withdrawal by Subject|3
4857462|NCT00912288|16745472|P2|Overall Study|Protocol Violation|0
4857463|NCT00912288|16745473|P1|Overall Study|Protocol Violation|1
4857464|NCT00912288|16745472|P2|Overall Study|Lost to Follow-up|0
4857465|NCT00912288|16745473|P1|Overall Study|Lost to Follow-up|1
4857466|NCT00912288|16745472|P2|Overall Study|Adverse Event|1
4857467|NCT00912288|16745473|P1|Overall Study|Adverse Event|1
4857468|NCT00912288|16745472|P2|Overall Study|Death|1
4857469|NCT00912288|16745473|P1|Overall Study|Death|0
4857470|NCT00912223|16745495|P1|Overall Study|Transformed disease|1
4857471|NCT00912223|16745495|P1|Overall Study|Not transplanted|1
4857472|NCT00912223|16745495|P1|Overall Study|Withdrawal by Subject|1
4857473|NCT00912093|16745526|P5|The Controlled Phase|Lost to Follow-up|1
4857474|NCT00912093|16745527|P4|The Controlled Phase|Lost to Follow-up|0
4857475|NCT00912093|16745528|P3|The Controlled Phase|Lost to Follow-up|0
4857476|NCT00912093|16745529|P2|The Controlled Phase|Lost to Follow-up|0
4857477|NCT00912093|16745530|P1|The Controlled Phase|Lost to Follow-up|0
4857478|NCT00912093|16745526|P5|The Controlled Phase|Medical Condition|0
4857479|NCT00912093|16745527|P4|The Controlled Phase|Medical Condition|0
4857480|NCT00912093|16745528|P3|The Controlled Phase|Medical Condition|0
4857481|NCT00912093|16745529|P2|The Controlled Phase|Medical Condition|1
4857482|NCT00912093|16745530|P1|The Controlled Phase|Medical Condition|0
4857483|NCT00912093|16745526|P5|The Controlled Phase|Death|0
4857484|NCT00912093|16745527|P4|The Controlled Phase|Death|0
4857485|NCT00912093|16745528|P3|The Controlled Phase|Death|0
4857486|NCT00912093|16745529|P2|The Controlled Phase|Death|1
4857487|NCT00912093|16745530|P1|The Controlled Phase|Death|0
4857488|NCT00912028|16745549|P5|Overall Study|Withdrawal by Subject|0
4857489|NCT00912028|16745550|P4|Overall Study|Withdrawal by Subject|0
4857490|NCT00912028|16745551|P3|Overall Study|Withdrawal by Subject|0
4857491|NCT00912028|16745552|P2|Overall Study|Withdrawal by Subject|0
4857492|NCT00912028|16745553|P1|Overall Study|Withdrawal by Subject|3
4857493|NCT00912028|16745549|P5|Overall Study|Lost to Follow-up|3
4857494|NCT00912028|16745550|P4|Overall Study|Lost to Follow-up|1
4857495|NCT00912028|16745551|P3|Overall Study|Lost to Follow-up|0
4857496|NCT00912028|16745552|P2|Overall Study|Lost to Follow-up|3
4857497|NCT00912028|16745553|P1|Overall Study|Lost to Follow-up|2
4857498|NCT00912015|16745582|P4|Overall Study|Adverse Event|1
4857499|NCT00912015|16745583|P3|Overall Study|Adverse Event|0
4857500|NCT00912015|16745584|P2|Overall Study|Adverse Event|0
4857501|NCT00912015|16745585|P1|Overall Study|Adverse Event|6
4857502|NCT00912015|16745582|P4|Overall Study|Protocol Violation|1
4857503|NCT00912015|16745583|P3|Overall Study|Protocol Violation|0
4857504|NCT00912015|16745584|P2|Overall Study|Protocol Violation|0
4857505|NCT00912015|16745585|P1|Overall Study|Protocol Violation|1
4857506|NCT00912015|16745582|P4|Overall Study|Withdrawal by Subject|0
4857507|NCT00912015|16745583|P3|Overall Study|Withdrawal by Subject|3
4857508|NCT00912015|16745584|P2|Overall Study|Withdrawal by Subject|8
4857509|NCT00912015|16745585|P1|Overall Study|Withdrawal by Subject|8
4857510|NCT00912015|16745582|P4|Overall Study|Lack of Efficacy|0
4857511|NCT00912015|16745583|P3|Overall Study|Lack of Efficacy|0
4857512|NCT00912015|16745584|P2|Overall Study|Lack of Efficacy|0
4857513|NCT00912015|16745585|P1|Overall Study|Lack of Efficacy|1
4857514|NCT00911989|16745601|P1|Overall Study|Adverse Event|1
4857515|NCT00911937|16745607|P2|Overall Study|Other|5
4857516|NCT00911937|16745608|P1|Overall Study|Other|9
4857517|NCT00911937|16745607|P2|Overall Study|Randomized but not treated|13
4857518|NCT00911937|16745608|P1|Overall Study|Randomized but not treated|13
4857519|NCT00911937|16745607|P2|Overall Study|Protocol Violation|23
4857520|NCT00911937|16745608|P1|Overall Study|Protocol Violation|14
4857521|NCT00911937|16745607|P2|Overall Study|Did not meet inclusion criteria|11
4857522|NCT00911937|16745608|P1|Overall Study|Did not meet inclusion criteria|9
4857523|NCT00911937|16745607|P2|Overall Study|Lack of Efficacy|6
4857524|NCT00911937|16745608|P1|Overall Study|Lack of Efficacy|11
4857525|NCT00911937|16745607|P2|Overall Study|Adverse Event|25
4857526|NCT00911937|16745608|P1|Overall Study|Adverse Event|11
4857527|NCT00911937|16745607|P2|Overall Study|Withdrawn due to pregnancy|0
4857528|NCT00911937|16745608|P1|Overall Study|Withdrawn due to pregnancy|1
4857529|NCT00911937|16745607|P2|Overall Study|Withdrawal by Subject|7
4857530|NCT00911937|16745608|P1|Overall Study|Withdrawal by Subject|10
4857531|NCT00911937|16745607|P2|Overall Study|Lost to Follow-up|5
4857532|NCT00911937|16745608|P1|Overall Study|Lost to Follow-up|8
4857533|NCT00911937|16745607|P2|Overall Study|Death|0
4857534|NCT00911937|16745608|P1|Overall Study|Death|1
4857535|NCT00911859|16745675|P3|Follow-up Period|Study terminated by sponsor|27
4857536|NCT00911859|16745676|P2|Follow-up Period|Study terminated by sponsor|33
4857537|NCT00911859|16745677|P1|Follow-up Period|Study terminated by sponsor|5
4857538|NCT00911859|16745675|P3|Follow-up Period|Withdrawal by Subject|4
4857539|NCT00911859|16745676|P2|Follow-up Period|Withdrawal by Subject|4
4857540|NCT00911859|16745677|P1|Follow-up Period|Withdrawal by Subject|0
4857541|NCT00911859|16745675|P3|Follow-up Period|Lost to Follow-up|0
4857542|NCT00911859|16745676|P2|Follow-up Period|Lost to Follow-up|1
4857543|NCT00911859|16745677|P1|Follow-up Period|Lost to Follow-up|1
4857544|NCT00911859|16745675|P3|Follow-up Period|Death|10
4857545|NCT00911859|16745676|P2|Follow-up Period|Death|8
4857546|NCT00911859|16745677|P1|Follow-up Period|Death|5
4857547|NCT00911859|16745675|P3|Maintainance Period|Withdrawal by Subject|3
4857548|NCT00911859|16745676|P2|Maintainance Period|Withdrawal by Subject|0
4857549|NCT00911859|16745677|P1|Maintainance Period|Withdrawal by Subject|0
4857550|NCT00911859|16745675|P3|Maintainance Period|Physician Decision|9
4857551|NCT00911859|16745676|P2|Maintainance Period|Physician Decision|0
4857552|NCT00911859|16745677|P1|Maintainance Period|Physician Decision|0
4857553|NCT00911859|16745675|P3|Maintainance Period|Lack of Efficacy|9
4857554|NCT00911859|16745676|P2|Maintainance Period|Lack of Efficacy|0
4857555|NCT00911859|16745677|P1|Maintainance Period|Lack of Efficacy|0
4857556|NCT00911859|16745675|P3|Treatment Period|Did not receive study treatment|0
4857557|NCT00911859|16745676|P2|Treatment Period|Did not receive study treatment|1
4857558|NCT00911859|16745677|P1|Treatment Period|Did not receive study treatment|0
4857559|NCT00911859|16745675|P3|Treatment Period|Withdrawal by Subject|5
4857560|NCT00911859|16745676|P2|Treatment Period|Withdrawal by Subject|4
4857561|NCT00911859|16745677|P1|Treatment Period|Withdrawal by Subject|0
4857562|NCT00911859|16745675|P3|Treatment Period|Physician Decision|3
4857563|NCT00911859|16745676|P2|Treatment Period|Physician Decision|3
4857564|NCT00911859|16745677|P1|Treatment Period|Physician Decision|3
4857565|NCT00911859|16745675|P3|Treatment Period|Lack of Efficacy|5
4857566|NCT00911859|16745676|P2|Treatment Period|Lack of Efficacy|7
4857567|NCT00911859|16745677|P1|Treatment Period|Lack of Efficacy|1
4857568|NCT00911859|16745675|P3|Treatment Period|Death|5
4857569|NCT00911859|16745676|P2|Treatment Period|Death|3
4857570|NCT00911859|16745677|P1|Treatment Period|Death|1
4857571|NCT00911859|16745675|P3|Treatment Period|Adverse Event|7
4857572|NCT00911859|16745676|P2|Treatment Period|Adverse Event|3
4857573|NCT00911859|16745677|P1|Treatment Period|Adverse Event|3
4857574|NCT00911820|16745703|P2|Overall Study|Withdraw before Receive Treatment|2
4857575|NCT00911820|16745704|P1|Overall Study|Withdraw before Receive Treatment|0
4857576|NCT00911820|16745703|P2|Overall Study|Pathology Not Confirmed|0
4857577|NCT00911820|16745704|P1|Overall Study|Pathology Not Confirmed|1
4857578|NCT00911820|16745703|P2|Overall Study|Still on Therapy|2
4857579|NCT00911820|16745704|P1|Overall Study|Still on Therapy|2
4857580|NCT00911820|16745703|P2|Overall Study|Pursue Radiation|0
4857581|NCT00911820|16745704|P1|Overall Study|Pursue Radiation|1
4857582|NCT00911820|16745703|P2|Overall Study|Pursue surgery|1
4857583|NCT00911820|16745704|P1|Overall Study|Pursue surgery|1
4857584|NCT00911820|16745703|P2|Overall Study|Death|2
4857585|NCT00911820|16745704|P1|Overall Study|Death|1
4857586|NCT00911820|16745703|P2|Overall Study|Withdrawal by Subject|4
4857587|NCT00911820|16745704|P1|Overall Study|Withdrawal by Subject|3
4857588|NCT00911820|16745703|P2|Overall Study|Decline in Performance Status|2
4857589|NCT00911820|16745704|P1|Overall Study|Decline in Performance Status|4
4857590|NCT00911820|16745703|P2|Overall Study|Physician Decision|9
4857591|NCT00911820|16745704|P1|Overall Study|Physician Decision|5
4857592|NCT00911820|16745703|P2|Overall Study|Clinical Progression|5
4857593|NCT00911820|16745704|P1|Overall Study|Clinical Progression|7
4857594|NCT00911820|16745703|P2|Overall Study|Adverse Event|8
4857595|NCT00911820|16745704|P1|Overall Study|Adverse Event|8
4857596|NCT00911820|16745703|P2|Overall Study|RECIST progression|8
4857597|NCT00911820|16745704|P1|Overall Study|RECIST progression|12
4857598|NCT00911807|16745721|P3|Overall Study|Organizational reasons|1
4857599|NCT00911807|16745722|P2|Overall Study|Organizational reasons|3
4857600|NCT00911807|16745723|P1|Overall Study|Organizational reasons|1
4857601|NCT00911807|16745721|P3|Overall Study|Withdrawal by Subject|7
4857602|NCT00911807|16745722|P2|Overall Study|Withdrawal by Subject|10
4857603|NCT00911807|16745723|P1|Overall Study|Withdrawal by Subject|8
4857604|NCT00911807|16745721|P3|Overall Study|Protocol Violation|9
4857605|NCT00911807|16745722|P2|Overall Study|Protocol Violation|4
4857606|NCT00911807|16745723|P1|Overall Study|Protocol Violation|6
4857607|NCT00911807|16745721|P3|Overall Study|Death|1
4857608|NCT00911807|16745722|P2|Overall Study|Death|0
4857609|NCT00911807|16745723|P1|Overall Study|Death|0
4857610|NCT00911807|16745721|P3|Overall Study|Adverse Event|5
4857611|NCT00911807|16745722|P2|Overall Study|Adverse Event|1
4857612|NCT00911807|16745723|P1|Overall Study|Adverse Event|2
4857613|NCT00911768|16745733|P2|Overall Study|Withdrawal by Subject|0
4857614|NCT00911768|16745734|P1|Overall Study|Withdrawal by Subject|1
4857615|NCT00911768|16745733|P2|Overall Study|Protocol Violation|4
4857616|NCT00911768|16745734|P1|Overall Study|Protocol Violation|5
4857617|NCT00911625|16745763|P2|Overall Study|Lost to Follow-up|0
4857618|NCT00911625|16745764|P1|Overall Study|Lost to Follow-up|7
4857619|NCT00911547|16745793|P4|Overall Study|Withdrawal by Subject|8
4857620|NCT00911547|16745794|P3|Overall Study|Withdrawal by Subject|4
4857621|NCT00911547|16745795|P2|Overall Study|Withdrawal by Subject|10
4857622|NCT00911547|16745796|P1|Overall Study|Withdrawal by Subject|3
4857623|NCT00911547|16745793|P4|Overall Study|Protocol Violation|1
4857624|NCT00911547|16745794|P3|Overall Study|Protocol Violation|5
4857625|NCT00911547|16745795|P2|Overall Study|Protocol Violation|5
4857626|NCT00911547|16745796|P1|Overall Study|Protocol Violation|0
4857627|NCT00911547|16745793|P4|Overall Study|Lost to Follow-up|1
4857628|NCT00911547|16745794|P3|Overall Study|Lost to Follow-up|2
4857629|NCT00911547|16745795|P2|Overall Study|Lost to Follow-up|0
4857630|NCT00911547|16745796|P1|Overall Study|Lost to Follow-up|0
4857631|NCT00911547|16745793|P4|Overall Study|Adverse Event|6
4857632|NCT00911547|16745794|P3|Overall Study|Adverse Event|11
4857633|NCT00911547|16745795|P2|Overall Study|Adverse Event|27
4857634|NCT00911547|16745796|P1|Overall Study|Adverse Event|8
4857635|NCT00911534|16745824|P2|Overall Study|Other|2
4857636|NCT00911534|16745825|P1|Overall Study|Other|2
4857637|NCT00911534|16745824|P2|Overall Study|Withdrawal of consent|4
4857638|NCT00911534|16745825|P1|Overall Study|Withdrawal of consent|1
4857639|NCT00911534|16745824|P2|Overall Study|Lack of Efficacy|1
4857640|NCT00911534|16745825|P1|Overall Study|Lack of Efficacy|4
4857641|NCT00911534|16745824|P2|Overall Study|Withdrawal by Subject|1
4857642|NCT00911534|16745825|P1|Overall Study|Withdrawal by Subject|2
4857643|NCT00911534|16745824|P2|Overall Study|Lost to Follow-up|4
4857644|NCT00911534|16745825|P1|Overall Study|Lost to Follow-up|2
4857645|NCT00911534|16745824|P2|Overall Study|Adverse Event|4
4857646|NCT00911534|16745825|P1|Overall Study|Adverse Event|4
4857647|NCT00911508|16745839|P2|Overall Study|Withdrawal by Subject|112
4857648|NCT00911508|16745840|P1|Overall Study|Withdrawal by Subject|79
4857649|NCT00911508|16745839|P2|Overall Study|Lost to Follow-up|18
4857650|NCT00911508|16745840|P1|Overall Study|Lost to Follow-up|27
4857651|NCT00911300|16745915|P2|Overall Study|Randomized; No Study Medication Received|2
4857652|NCT00911300|16745916|P1|Overall Study|Randomized; No Study Medication Received|0
4857653|NCT00911300|16745915|P2|Overall Study|Treatment Stopped by Mistake|1
4857654|NCT00911300|16745916|P1|Overall Study|Treatment Stopped by Mistake|0
4857655|NCT00911300|16745915|P2|Overall Study|Physician Decision|1
4857656|NCT00911300|16745916|P1|Overall Study|Physician Decision|0
4857657|NCT00911300|16745915|P2|Overall Study|Underlying Disease (Myocarditis)|1
4857658|NCT00911300|16745916|P1|Overall Study|Underlying Disease (Myocarditis)|0
4857659|NCT00911300|16745915|P2|Overall Study|Participant Refused Hospital Consulation|1
4857660|NCT00911300|16745916|P1|Overall Study|Participant Refused Hospital Consulation|0
4857661|NCT00911300|16745915|P2|Overall Study|International Normalized Ratio Too High|1
4857662|NCT00911300|16745916|P1|Overall Study|International Normalized Ratio Too High|0
4857663|NCT00911300|16745915|P2|Overall Study|Investigator's Decision; New AF Episode|1
4857664|NCT00911300|16745916|P1|Overall Study|Investigator's Decision; New AF Episode|0
4857665|NCT00911300|16745915|P2|Overall Study|Participant Could Not Stay in Hospital|1
4857666|NCT00911300|16745916|P1|Overall Study|Participant Could Not Stay in Hospital|0
4857667|NCT00911300|16745915|P2|Overall Study|CV Unsuccessful; Phenprocoumon Received|0
4857668|NCT00911300|16745916|P1|Overall Study|CV Unsuccessful; Phenprocoumon Received|1
4857669|NCT00911300|16745915|P2|Overall Study|Nurse Unavailable in Participant's City|0
4857670|NCT00911300|16745916|P1|Overall Study|Nurse Unavailable in Participant's City|1
4857671|NCT00911300|16745915|P2|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
4857672|NCT00911300|16745916|P1|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1
4857673|NCT00911300|16745915|P2|Overall Study|Recurrent Tachyarrhythmia|1
4857674|NCT00911300|16745916|P1|Overall Study|Recurrent Tachyarrhythmia|1
4857675|NCT00911300|16745915|P2|Overall Study|Received Commercial Treatment|0
4857676|NCT00911300|16745916|P1|Overall Study|Received Commercial Treatment|1
4857677|NCT00911300|16745915|P2|Overall Study|Atrial Fibrillation (AF) Recurrence|3
4857678|NCT00911300|16745916|P1|Overall Study|Atrial Fibrillation (AF) Recurrence|3
4857679|NCT00911300|16745915|P2|Overall Study|Coronary Angiography Performed|0
4857680|NCT00911300|16745916|P1|Overall Study|Coronary Angiography Performed|1
4857681|NCT00911300|16745915|P2|Overall Study|Consent Withdrawn|12
4857682|NCT00911300|16745916|P1|Overall Study|Consent Withdrawn|4
4857683|NCT00911300|16745915|P2|Overall Study|Protocol Violation|2
4857684|NCT00911300|16745916|P1|Overall Study|Protocol Violation|3
4857685|NCT00911300|16745915|P2|Overall Study|Adverse Event|6
4857686|NCT00911300|16745916|P1|Overall Study|Adverse Event|14
4857687|NCT00911300|16745915|P2|Overall Study|Thrombus Persistant in Second TEE|7
4857688|NCT00911300|16745916|P1|Overall Study|Thrombus Persistant in Second TEE|3
4857689|NCT00911300|16745915|P2|Overall Study|Death|0
4857690|NCT00911300|16745916|P1|Overall Study|Death|1
4857691|NCT00911300|16745915|P2|Overall Study|Primary Endpoint Component Occurred|2
4857692|NCT00911300|16745916|P1|Overall Study|Primary Endpoint Component Occurred|1
4857693|NCT00911170|16745953|P2|Long Term Follow-Up|Death|121
4857694|NCT00911170|16745954|P1|Long Term Follow-Up|Death|116
4857695|NCT00911170|16745953|P2|Long Term Follow-Up|Lost to Follow-up|7
4857696|NCT00911170|16745954|P1|Long Term Follow-Up|Lost to Follow-up|8
4857697|NCT00911170|16745953|P2|Long Term Follow-Up|Physician Decision|4
4857698|NCT00911170|16745954|P1|Long Term Follow-Up|Physician Decision|5
4857699|NCT00911170|16745953|P2|Long Term Follow-Up|Withdrawal by Subject|21
4857700|NCT00911170|16745954|P1|Long Term Follow-Up|Withdrawal by Subject|20
4857701|NCT00911170|16745953|P2|Long Term Follow-Up|Continuing in study|269
4857702|NCT00911170|16745954|P1|Long Term Follow-Up|Continuing in study|274
4857703|NCT00911170|16745953|P2|Treatment Period|Death|9
4857704|NCT00911170|16745954|P1|Treatment Period|Death|6
4857705|NCT00911170|16745953|P2|Treatment Period|Lost to Follow-up|1
4857706|NCT00911170|16745954|P1|Treatment Period|Lost to Follow-up|0
4857707|NCT00911170|16745953|P2|Treatment Period|Physician Decision|5
4857708|NCT00911170|16745954|P1|Treatment Period|Physician Decision|5
4857709|NCT00911170|16745953|P2|Treatment Period|Disease progression|2
4857710|NCT00911170|16745954|P1|Treatment Period|Disease progression|0
4857711|NCT00911170|16745953|P2|Treatment Period|Withdrawal by Subject|4
4857712|NCT00911170|16745954|P1|Treatment Period|Withdrawal by Subject|4
4857713|NCT00911170|16745953|P2|Treatment Period|Adverse Event|10
4857714|NCT00911170|16745954|P1|Treatment Period|Adverse Event|9
4857715|NCT00911170|16745953|P2|Treatment Period|Protocol deviation|2
4857716|NCT00911170|16745954|P1|Treatment Period|Protocol deviation|1
4857717|NCT00911170|16745953|P2|Treatment Period|Ineligibility determined|3
4857718|NCT00911170|16745954|P1|Treatment Period|Ineligibility determined|1
4857719|NCT00911170|16745953|P2|Treatment Period|Randomized in error|1
4857720|NCT00911170|16745954|P1|Treatment Period|Randomized in error|1
4857721|NCT00911157|16745978|P2|Overall Study|Need to treat for lung cancer|0
4857722|NCT00911157|16745979|P1|Overall Study|Need to treat for lung cancer|1
4857723|NCT00911157|16745978|P2|Overall Study|Need for prohibited drug (heparin)|0
4857724|NCT00911157|16745979|P1|Overall Study|Need for prohibited drug (heparin)|1
4857725|NCT00911157|16745978|P2|Overall Study|Withdrawal by Subject|1
4857726|NCT00911157|16745979|P1|Overall Study|Withdrawal by Subject|1
4857727|NCT00911157|16745978|P2|Overall Study|Adverse Event|1
4857728|NCT00911157|16745979|P1|Overall Study|Adverse Event|4
4857729|NCT00911144|16745995|P2|Overall Study|Withdrawal by Subject|5
4857730|NCT00911144|16745996|P1|Overall Study|Withdrawal by Subject|16
4857731|NCT00910988|16746050|P4|Overall Study|Lost to Follow-up|0
4857732|NCT00910988|16746051|P3|Overall Study|Lost to Follow-up|3
4857733|NCT00910988|16746052|P2|Overall Study|Lost to Follow-up|4
4857734|NCT00910988|16746053|P1|Overall Study|Lost to Follow-up|2
4857735|NCT00910962|16746098|P3|Overall Study|Reached defined stopping criteria|17
4857736|NCT00910962|16746099|P2|Overall Study|Reached defined stopping criteria|14
4857737|NCT00910962|16746100|P1|Overall Study|Reached defined stopping criteria|12
4857738|NCT00910962|16746098|P3|Overall Study|Withdrawal by Subject|32
4857739|NCT00910962|16746099|P2|Overall Study|Withdrawal by Subject|32
4857740|NCT00910962|16746100|P1|Overall Study|Withdrawal by Subject|25
4857741|NCT00910962|16746098|P3|Overall Study|Physician Decision|6
4857742|NCT00910962|16746099|P2|Overall Study|Physician Decision|6
4857743|NCT00910962|16746100|P1|Overall Study|Physician Decision|0
4857744|NCT00910962|16746098|P3|Overall Study|Lost to Follow-up|1
4857745|NCT00910962|16746099|P2|Overall Study|Lost to Follow-up|3
4857746|NCT00910962|16746100|P1|Overall Study|Lost to Follow-up|0
4857747|NCT00910962|16746098|P3|Overall Study|Protocol Violation|3
4857748|NCT00910962|16746099|P2|Overall Study|Protocol Violation|3
4857749|NCT00910962|16746100|P1|Overall Study|Protocol Violation|1
4857750|NCT00910962|16746098|P3|Overall Study|Adverse Event|17
4857751|NCT00910962|16746099|P2|Overall Study|Adverse Event|20
4857752|NCT00910962|16746100|P1|Overall Study|Adverse Event|5
4857753|NCT00910910|16746192|P2|Overall Study|Untreated before cycle 1|2
4857754|NCT00910910|16746193|P1|Overall Study|Untreated before cycle 1|1
4857755|NCT00910910|16746192|P2|Overall Study|Other|32
4857756|NCT00910910|16746193|P1|Overall Study|Other|114
4857757|NCT00910910|16746192|P2|Overall Study|Completed 13 cycles of treatment|118
4857758|NCT00910910|16746193|P1|Overall Study|Completed 13 cycles of treatment|0
4857759|NCT00910910|16746192|P2|Overall Study|Protocol Violation|2
4857760|NCT00910910|16746193|P1|Overall Study|Protocol Violation|2
4857761|NCT00910910|16746192|P2|Overall Study|Death|3
4857762|NCT00910910|16746193|P1|Overall Study|Death|9
4857763|NCT00910910|16746192|P2|Overall Study|Lost to Follow-up|2
4857764|NCT00910910|16746193|P1|Overall Study|Lost to Follow-up|2
4857765|NCT00910910|16746192|P2|Overall Study|Withdrawal by Subject|5
4857766|NCT00910910|16746193|P1|Overall Study|Withdrawal by Subject|7
4857767|NCT00910910|16746192|P2|Overall Study|PD with histologic change|2
4857768|NCT00910910|16746193|P1|Overall Study|PD with histologic change|0
4857769|NCT00910910|16746192|P2|Overall Study|PD without histologic change|23
4857770|NCT00910910|16746193|P1|Overall Study|PD without histologic change|27
4857771|NCT00910910|16746192|P2|Overall Study|Adverse Event|35
4857772|NCT00910910|16746193|P1|Overall Study|Adverse Event|63
4857773|NCT00910871|16746229|P1|Overall Study|Undefined|1
4857774|NCT00910871|16746229|P1|Overall Study|Subject didn't meet eligibility criteria|5
4857775|NCT00910871|16746229|P1|Overall Study|Withdrawal by Subject|12
4857776|NCT00910871|16746229|P1|Overall Study|Protocol Violation|11
4857777|NCT00910871|16746229|P1|Overall Study|Lost to Follow-up|8
4857778|NCT00910871|16746229|P1|Overall Study|Death|12
4857779|NCT00910871|16746229|P1|Overall Study|Adverse Event|5
4857780|NCT00910858|16746237|P3|Combined Treatment Phase|Other|1
4857781|NCT00910858|16746238|P2|Combined Treatment Phase|Other|2
4857782|NCT00910858|16746239|P1|Combined Treatment Phase|Other|0
4857783|NCT00910858|16746237|P3|Combined Treatment Phase|Protocol Violation|0
4857784|NCT00910858|16746238|P2|Combined Treatment Phase|Protocol Violation|0
4857785|NCT00910858|16746239|P1|Combined Treatment Phase|Protocol Violation|1
4857786|NCT00910858|16746237|P3|Combined Treatment Phase|Withdrawal by Subject|0
4857787|NCT00910858|16746238|P2|Combined Treatment Phase|Withdrawal by Subject|2
4857788|NCT00910858|16746239|P1|Combined Treatment Phase|Withdrawal by Subject|0
4857789|NCT00910858|16746237|P3|Combined Treatment Phase|Lack of therapeutic effect|3
4857790|NCT00910858|16746238|P2|Combined Treatment Phase|Lack of therapeutic effect|6
4857791|NCT00910858|16746239|P1|Combined Treatment Phase|Lack of therapeutic effect|8
4857792|NCT00910858|16746237|P3|Monotherapy Phase|Other|2
4857793|NCT00910858|16746238|P2|Monotherapy Phase|Other|4
4857794|NCT00910858|16746239|P1|Monotherapy Phase|Other|3
4857795|NCT00910858|16746237|P3|Monotherapy Phase|Protocol Violation|0
4857796|NCT00910858|16746238|P2|Monotherapy Phase|Protocol Violation|0
4857797|NCT00910858|16746239|P1|Monotherapy Phase|Protocol Violation|1
4857798|NCT00910858|16746237|P3|Monotherapy Phase|Withdrawal by Subject|1
4857799|NCT00910858|16746238|P2|Monotherapy Phase|Withdrawal by Subject|3
4857800|NCT00910858|16746239|P1|Monotherapy Phase|Withdrawal by Subject|1
4857801|NCT00910858|16746237|P3|Monotherapy Phase|Lack of therapeutic effect|4
4857802|NCT00910858|16746238|P2|Monotherapy Phase|Lack of therapeutic effect|6
4857803|NCT00910858|16746239|P1|Monotherapy Phase|Lack of therapeutic effect|9
4857804|NCT00910858|16746237|P3|Monotherapy Phase|Adverse Event|0
4857805|NCT00910858|16746238|P2|Monotherapy Phase|Adverse Event|2
4857806|NCT00910858|16746239|P1|Monotherapy Phase|Adverse Event|3
4857807|NCT00910858|16746237|P3|Pharmacokinetic Phase|Adverse Event|0
4857808|NCT00910858|16746238|P2|Pharmacokinetic Phase|Adverse Event|0
4857809|NCT00910858|16746239|P1|Pharmacokinetic Phase|Adverse Event|1
4857810|NCT00910728|16746284|P9|Overall Study|Adverse Event|1
4857811|NCT00910728|16746285|P8|Overall Study|Adverse Event|1
4857812|NCT00910728|16746286|P7|Overall Study|Adverse Event|2
4857813|NCT00910728|16746287|P6|Overall Study|Adverse Event|0
4857814|NCT00910728|16746288|P5|Overall Study|Adverse Event|0
4857815|NCT00910728|16746289|P4|Overall Study|Adverse Event|1
4857816|NCT00910728|16746290|P3|Overall Study|Adverse Event|1
4857817|NCT00910728|16746291|P2|Overall Study|Adverse Event|0
4857818|NCT00910728|16746292|P1|Overall Study|Adverse Event|2
4857819|NCT00910728|16746284|P9|Overall Study|(not specified)|0
4857820|NCT00910728|16746285|P8|Overall Study|(not specified)|0
4857821|NCT00910728|16746286|P7|Overall Study|(not specified)|0
4857822|NCT00910728|16746287|P6|Overall Study|(not specified)|0
4857823|NCT00910728|16746288|P5|Overall Study|(not specified)|1
4857824|NCT00910728|16746289|P4|Overall Study|(not specified)|0
4857825|NCT00910728|16746290|P3|Overall Study|(not specified)|1
4857826|NCT00910728|16746291|P2|Overall Study|(not specified)|0
4857827|NCT00910728|16746292|P1|Overall Study|(not specified)|2
4857828|NCT00910728|16746284|P9|Overall Study|Withdrawal by Subject|0
4857829|NCT00910728|16746285|P8|Overall Study|Withdrawal by Subject|0
4857830|NCT00910728|16746286|P7|Overall Study|Withdrawal by Subject|2
4857831|NCT00910728|16746287|P6|Overall Study|Withdrawal by Subject|1
4857832|NCT00910728|16746288|P5|Overall Study|Withdrawal by Subject|3
4857833|NCT00910728|16746289|P4|Overall Study|Withdrawal by Subject|0
4857834|NCT00910728|16746290|P3|Overall Study|Withdrawal by Subject|0
4857835|NCT00910728|16746291|P2|Overall Study|Withdrawal by Subject|0
4857836|NCT00910728|16746292|P1|Overall Study|Withdrawal by Subject|0
4857837|NCT00910728|16746284|P9|Overall Study|Lack of Efficacy|2
4857838|NCT00910728|16746285|P8|Overall Study|Lack of Efficacy|2
4857839|NCT00910728|16746286|P7|Overall Study|Lack of Efficacy|2
4857840|NCT00910728|16746287|P6|Overall Study|Lack of Efficacy|0
4857841|NCT00910728|16746288|P5|Overall Study|Lack of Efficacy|1
4857842|NCT00910728|16746289|P4|Overall Study|Lack of Efficacy|2
4857843|NCT00910728|16746290|P3|Overall Study|Lack of Efficacy|1
4857844|NCT00910728|16746291|P2|Overall Study|Lack of Efficacy|3
4857845|NCT00910728|16746292|P1|Overall Study|Lack of Efficacy|2
4857846|NCT00910715|16746414|P3|Overall Study|Lost to Follow-up|0
4857847|NCT00910715|16746415|P2|Overall Study|Lost to Follow-up|26
4857848|NCT00910715|16746416|P1|Overall Study|Lost to Follow-up|22
4857849|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Physician Decision|0
4857850|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Physician Decision|1
4857851|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Physician Decision|2
4857852|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Physician Decision|0
4857853|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Perceived Improvement|1
4857854|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Perceived Improvement|0
4857855|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Perceived Improvement|0
4857856|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Perceived Improvement|0
4857857|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Time Demands|0
4857858|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Time Demands|0
4857859|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Time Demands|1
4857860|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Time Demands|2
4857861|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Lack of Efficacy|1
4857862|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
4857863|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Lack of Efficacy|3
4857864|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Lack of Efficacy|2
4857865|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Pregnancy|0
4857866|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Pregnancy|0
4857867|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Pregnancy|0
4857868|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Pregnancy|1
4857869|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Adverse Event|2
4857870|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Adverse Event|2
4857871|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Adverse Event|4
4857872|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Adverse Event|2
4857873|NCT00910689|16746430|P4|Months 11- 16: Evaluation Period II|Lost to Follow-up|2
4857874|NCT00910689|16746431|P3|Months 11- 16: Evaluation Period II|Lost to Follow-up|1
4857875|NCT00910689|16746432|P2|Months 11- 16: Evaluation Period II|Lost to Follow-up|0
4857876|NCT00910689|16746433|P1|Months 11- 16: Evaluation Period II|Lost to Follow-up|3
4857877|NCT00910689|16746430|P4|Months 5 - 10: Evaluation Period I|Time Demands|1
4857878|NCT00910689|16746431|P3|Months 5 - 10: Evaluation Period I|Time Demands|1
4857879|NCT00910689|16746432|P2|Months 5 - 10: Evaluation Period I|Time Demands|0
4857880|NCT00910689|16746433|P1|Months 5 - 10: Evaluation Period I|Time Demands|0
4857881|NCT00910689|16746430|P4|Months 5 - 10: Evaluation Period I|Pregnancy|0
4857882|NCT00910689|16746431|P3|Months 5 - 10: Evaluation Period I|Pregnancy|2
4857883|NCT00910689|16746432|P2|Months 5 - 10: Evaluation Period I|Pregnancy|0
4857884|NCT00910689|16746433|P1|Months 5 - 10: Evaluation Period I|Pregnancy|0
4857885|NCT00910689|16746430|P4|Months 5 - 10: Evaluation Period I|Protocol Violation|0
4857886|NCT00910689|16746431|P3|Months 5 - 10: Evaluation Period I|Protocol Violation|0
4857887|NCT00910689|16746432|P2|Months 5 - 10: Evaluation Period I|Protocol Violation|1
4857888|NCT00910689|16746433|P1|Months 5 - 10: Evaluation Period I|Protocol Violation|1
4857889|NCT00910689|16746430|P4|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
4857890|NCT00910689|16746431|P3|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
4857891|NCT00910689|16746432|P2|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1
4857892|NCT00910689|16746433|P1|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0
4857893|NCT00910689|16746430|P4|Months 5 - 10: Evaluation Period I|Adverse Event|4
4857894|NCT00910689|16746431|P3|Months 5 - 10: Evaluation Period I|Adverse Event|2
4857895|NCT00910689|16746432|P2|Months 5 - 10: Evaluation Period I|Adverse Event|0
4857896|NCT00910689|16746433|P1|Months 5 - 10: Evaluation Period I|Adverse Event|1
4857897|NCT00910689|16746430|P4|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
4857898|NCT00910689|16746431|P3|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1
4857899|NCT00910689|16746432|P2|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5
4857900|NCT00910689|16746433|P1|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2
4857901|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Protocol Violation|0
4857902|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Protocol Violation|0
4857903|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Protocol Violation|0
4857904|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Protocol Violation|1
4857905|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Pregnancy|0
4857906|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Pregnancy|0
4857907|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Pregnancy|2
4857908|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Pregnancy|0
4857909|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Perceived Improvement|0
4857910|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Perceived Improvement|1
4857911|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Perceived Improvement|0
4857912|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Perceived Improvement|0
4857913|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Lack of Efficacy|0
4857914|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Lack of Efficacy|0
4857915|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Lack of Efficacy|1
4857916|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Lack of Efficacy|2
4857917|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Time Demands|8
4857918|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Time Demands|4
4857919|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Time Demands|0
4857920|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Time Demands|1
4857921|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Adverse Event|0
4857922|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Adverse Event|2
4857923|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Adverse Event|3
4857924|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Adverse Event|2
4857925|NCT00910689|16746430|P4|Month 2- 4: Treatment Period|Lost to Follow-up|3
4857926|NCT00910689|16746431|P3|Month 2- 4: Treatment Period|Lost to Follow-up|1
4857927|NCT00910689|16746432|P2|Month 2- 4: Treatment Period|Lost to Follow-up|4
4857928|NCT00910689|16746433|P1|Month 2- 4: Treatment Period|Lost to Follow-up|3
4857929|NCT00910689|16746430|P4|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10
4857930|NCT00910689|16746431|P3|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5
4857931|NCT00910689|16746432|P2|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1
4857932|NCT00910689|16746433|P1|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2
4857933|NCT00910663|16746465|P2|Period 1|Withdrawal by Subject|1
4857934|NCT00910663|16746466|P1|Period 1|Withdrawal by Subject|0
4857935|NCT00910624|16746480|P4|Follow-Up Phase|Administrative|0
4857936|NCT00910624|16746481|P3|Follow-Up Phase|Administrative|1
4857937|NCT00910624|16746482|P2|Follow-Up Phase|Administrative|1
4857938|NCT00910624|16746483|P1|Follow-Up Phase|Administrative|0
4857939|NCT00910624|16746480|P4|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
4857940|NCT00910624|16746481|P3|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
4857941|NCT00910624|16746482|P2|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0
4857942|NCT00910624|16746483|P1|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1
4857943|NCT00910624|16746480|P4|Follow-Up Phase|Withdrawal by Subject|0
4857944|NCT00910624|16746481|P3|Follow-Up Phase|Withdrawal by Subject|0
4857945|NCT00910624|16746482|P2|Follow-Up Phase|Withdrawal by Subject|0
4857946|NCT00910624|16746483|P1|Follow-Up Phase|Withdrawal by Subject|1
4857947|NCT00910624|16746480|P4|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
4857948|NCT00910624|16746481|P3|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0
4857949|NCT00910624|16746482|P2|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2
4857950|NCT00910624|16746483|P1|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1
4857951|NCT00910624|16746480|P4|Follow-Up Phase|Lost to Follow-up|0
4857952|NCT00910624|16746481|P3|Follow-Up Phase|Lost to Follow-up|2
4857953|NCT00910624|16746482|P2|Follow-Up Phase|Lost to Follow-up|1
4857954|NCT00910624|16746483|P1|Follow-Up Phase|Lost to Follow-up|3
4857955|NCT00910624|16746480|P4|Follow-Up Phase|Adverse Event|0
4857956|NCT00910624|16746481|P3|Follow-Up Phase|Adverse Event|1
4857957|NCT00910624|16746482|P2|Follow-Up Phase|Adverse Event|0
4857958|NCT00910624|16746483|P1|Follow-Up Phase|Adverse Event|0
4857959|NCT00910624|16746480|P4|Treatment Phase|Non-Compliance With Protocol|0
4857960|NCT00910624|16746481|P3|Treatment Phase|Non-Compliance With Protocol|1
4857961|NCT00910624|16746482|P2|Treatment Phase|Non-Compliance With Protocol|1
4857962|NCT00910624|16746483|P1|Treatment Phase|Non-Compliance With Protocol|0
4857963|NCT00910624|16746480|P4|Treatment Phase|Withdrawal by Subject|0
4857964|NCT00910624|16746481|P3|Treatment Phase|Withdrawal by Subject|0
4857965|NCT00910624|16746482|P2|Treatment Phase|Withdrawal by Subject|1
4857966|NCT00910624|16746483|P1|Treatment Phase|Withdrawal by Subject|2
4857967|NCT00910624|16746480|P4|Treatment Phase|Reasons Unrelated To Assigned Treatment|0
4857968|NCT00910624|16746481|P3|Treatment Phase|Reasons Unrelated To Assigned Treatment|1
4857969|NCT00910624|16746482|P2|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
4857970|NCT00910624|16746483|P1|Treatment Phase|Reasons Unrelated To Assigned Treatment|3
4857971|NCT00910624|16746480|P4|Treatment Phase|Lost to Follow-up|0
4857972|NCT00910624|16746481|P3|Treatment Phase|Lost to Follow-up|1
4857973|NCT00910624|16746482|P2|Treatment Phase|Lost to Follow-up|0
4857974|NCT00910624|16746483|P1|Treatment Phase|Lost to Follow-up|0
4857975|NCT00910624|16746480|P4|Treatment Phase|Treatment Failure|0
4857976|NCT00910624|16746481|P3|Treatment Phase|Treatment Failure|0
4857977|NCT00910624|16746482|P2|Treatment Phase|Treatment Failure|10
4857978|NCT00910624|16746483|P1|Treatment Phase|Treatment Failure|23
4857979|NCT00910624|16746480|P4|Treatment Phase|Adverse Event|0
4857980|NCT00910624|16746481|P3|Treatment Phase|Adverse Event|6
4857981|NCT00910624|16746482|P2|Treatment Phase|Adverse Event|6
4857982|NCT00910624|16746483|P1|Treatment Phase|Adverse Event|2
4857983|NCT00910429|16746510|P2|Overall Study|Lack of Efficacy|1
4857984|NCT00910429|16746511|P1|Overall Study|Lack of Efficacy|4
4857985|NCT00910429|16746510|P2|Overall Study|Drug non-compliance|0
4857986|NCT00910429|16746511|P1|Overall Study|Drug non-compliance|1
4857987|NCT00910429|16746510|P2|Overall Study|Adverse Event|5
4857988|NCT00910429|16746511|P1|Overall Study|Adverse Event|10
4857989|NCT00910429|16746510|P2|Overall Study|Lost to Follow-up|1
4857990|NCT00910429|16746511|P1|Overall Study|Lost to Follow-up|2
4857991|NCT00910429|16746510|P2|Overall Study|Protocol Violation|0
4857992|NCT00910429|16746511|P1|Overall Study|Protocol Violation|1
4857993|NCT00910429|16746510|P2|Overall Study|Withdrawal by Subject|2
4857994|NCT00910429|16746511|P1|Overall Study|Withdrawal by Subject|3
4857995|NCT00910429|16746510|P2|Overall Study|Death|12
4857996|NCT00910429|16746511|P1|Overall Study|Death|18
4857997|NCT00910299|16746573|P2|Overall Study|Didn't receive any study drug|1
4857998|NCT00910299|16746574|P1|Overall Study|Didn't receive any study drug|2
4857999|NCT00910299|16746573|P2|Overall Study|Sponsor Decision|60
4858000|NCT00910299|16746574|P1|Overall Study|Sponsor Decision|58
4858001|NCT00910299|16746573|P2|Overall Study|Withdrawal by Subject|13
4858002|NCT00910299|16746574|P1|Overall Study|Withdrawal by Subject|16
4858003|NCT00910273|16746586|P2|Overall Study|Lost to Follow-up|1
4858004|NCT00910273|16746587|P1|Overall Study|Lost to Follow-up|1
4858005|NCT00910273|16746586|P2|Overall Study|Protocol Violation|0
4858006|NCT00910273|16746587|P1|Overall Study|Protocol Violation|1
4858007|NCT00910273|16746586|P2|Overall Study|Discontinuation of study by sponsor|2
4858008|NCT00910273|16746587|P1|Overall Study|Discontinuation of study by sponsor|8
4858009|NCT00910273|16746586|P2|Overall Study|Withdrawal by Subject|0
4858010|NCT00910273|16746587|P1|Overall Study|Withdrawal by Subject|1
4858011|NCT00910273|16746586|P2|Overall Study|Adverse Event|1
4858012|NCT00910273|16746587|P1|Overall Study|Adverse Event|1
4858013|NCT00910273|16746586|P2|Overall Study|Lack of Efficacy|9
4858014|NCT00910273|16746587|P1|Overall Study|Lack of Efficacy|6
4858015|NCT00910247|16746637|P1|Overall Study|Not collected|4
4858016|NCT00910247|16746637|P1|Overall Study|Withdrawal by Subject|25
4858017|NCT00910247|16746637|P1|Overall Study|Protocol Violation|10
4858018|NCT00910247|16746637|P1|Overall Study|Physician Decision|3
4858019|NCT00910247|16746637|P1|Overall Study|Lost to Follow-up|10
4858020|NCT00910247|16746637|P1|Overall Study|Death|2
4858021|NCT00910247|16746637|P1|Overall Study|Adverse Event|15
4858022|NCT00910091|16746687|P2|Treatment and Survival|Adverse Event|0
4858023|NCT00910091|16746688|P1|Treatment and Survival|Adverse Event|1
4858024|NCT00910091|16746687|P2|Treatment and Survival|Withdrawal by Subject|4
4858025|NCT00910091|16746688|P1|Treatment and Survival|Withdrawal by Subject|3
4858026|NCT00910091|16746687|P2|Pre-assignment|Withdrawal by Subject|2
4858027|NCT00910091|16746688|P1|Pre-assignment|Withdrawal by Subject|0
4858028|NCT00910039|16746716|P1|Overall Study|Physician Decision|1
4858029|NCT00910000|16746733|P6|Overall Study|Withdrawal by Subject|0
4858030|NCT00910000|16746734|P5|Overall Study|Withdrawal by Subject|1
4858031|NCT00910000|16746735|P4|Overall Study|Withdrawal by Subject|0
4858032|NCT00910000|16746736|P3|Overall Study|Withdrawal by Subject|1
4858033|NCT00910000|16746737|P2|Overall Study|Withdrawal by Subject|0
4858034|NCT00910000|16746738|P1|Overall Study|Withdrawal by Subject|0
4858035|NCT00910000|16746733|P6|Overall Study|Adverse Event|1
4858036|NCT00910000|16746734|P5|Overall Study|Adverse Event|0
4858037|NCT00910000|16746735|P4|Overall Study|Adverse Event|2
4858038|NCT00910000|16746736|P3|Overall Study|Adverse Event|2
4858039|NCT00910000|16746737|P2|Overall Study|Adverse Event|3
4858040|NCT00910000|16746738|P1|Overall Study|Adverse Event|0
4858041|NCT00909870|16746756|P2|Overall Study|Other|5
4858042|NCT00909870|16746757|P1|Overall Study|Other|1
4858043|NCT00909870|16746756|P2|Overall Study|Physician Decision|2
4858044|NCT00909870|16746757|P1|Overall Study|Physician Decision|0
4858045|NCT00909870|16746756|P2|Overall Study|Lost to Follow-up|3
4858046|NCT00909870|16746757|P1|Overall Study|Lost to Follow-up|3
4858047|NCT00909870|16746756|P2|Overall Study|Withdrawal by Subject|8
4858048|NCT00909870|16746757|P1|Overall Study|Withdrawal by Subject|5
4858049|NCT00909870|16746756|P2|Overall Study|Protocol Violation|2
4858050|NCT00909870|16746757|P1|Overall Study|Protocol Violation|1
4858051|NCT00909870|16746756|P2|Overall Study|Adverse Event|7
4858052|NCT00909870|16746757|P1|Overall Study|Adverse Event|13
4858053|NCT00909857|16746769|P2|Overall Study|Did not receive study medication|24
4858054|NCT00909857|16746770|P1|Overall Study|Did not receive study medication|19
4858055|NCT00909857|16746769|P2|Overall Study|Other|0
4858056|NCT00909857|16746770|P1|Overall Study|Other|1
4858057|NCT00909857|16746769|P2|Overall Study|Pregnancy|0
4858058|NCT00909857|16746770|P1|Overall Study|Pregnancy|1
4858059|NCT00909857|16746769|P2|Overall Study|Protocol Violation|1
4858060|NCT00909857|16746770|P1|Overall Study|Protocol Violation|2
4858061|NCT00909857|16746769|P2|Overall Study|Lost to Follow-up|5
4858062|NCT00909857|16746770|P1|Overall Study|Lost to Follow-up|2
4858063|NCT00909857|16746769|P2|Overall Study|Adverse Event|5
4858064|NCT00909857|16746770|P1|Overall Study|Adverse Event|5
4858065|NCT00909857|16746769|P2|Overall Study|Withdrawal by Subject|10
4858066|NCT00909857|16746770|P1|Overall Study|Withdrawal by Subject|6
4858067|NCT00909844|16746910|P1|Overall Study|Lost to Follow-up|2
4858068|NCT00909844|16746910|P1|Overall Study|Withdrawal by Subject|1
4858069|NCT00909844|16746910|P1|Overall Study|Adverse Event|1
4858070|NCT00909792|16746928|P2|Period 2|Lost to Follow-up|1
4858071|NCT00909792|16746929|P1|Period 2|Lost to Follow-up|0
4858072|NCT00909792|16746928|P2|Period 2|Biomicroscopy|0
4858073|NCT00909792|16746929|P1|Period 2|Biomicroscopy|1
4858074|NCT00909792|16746928|P2|Period 1|Did not meet inclusion criteria|1
4858075|NCT00909792|16746929|P1|Period 1|Did not meet inclusion criteria|0
4858076|NCT00909779|16746937|P2|Overall Study|Randomized in error|1
4858077|NCT00909779|16746938|P1|Overall Study|Randomized in error|1
4858078|NCT00909779|16746937|P2|Overall Study|Noncompliance|1
4858079|NCT00909779|16746938|P1|Overall Study|Noncompliance|1
4858080|NCT00909779|16746937|P2|Overall Study|Medical Monitor Decision|0
4858081|NCT00909779|16746938|P1|Overall Study|Medical Monitor Decision|1
4858082|NCT00909779|16746937|P2|Overall Study|Site Ceasing Operation|2
4858083|NCT00909779|16746938|P1|Overall Study|Site Ceasing Operation|2
4858084|NCT00909779|16746937|P2|Overall Study|Withdrawal by Subject|80
4858085|NCT00909779|16746938|P1|Overall Study|Withdrawal by Subject|116
4858086|NCT00909779|16746937|P2|Overall Study|Protocol Violation|5
4858087|NCT00909779|16746938|P1|Overall Study|Protocol Violation|2
4858088|NCT00909779|16746937|P2|Overall Study|Physician Decision|2
4858089|NCT00909779|16746938|P1|Overall Study|Physician Decision|8
4858090|NCT00909779|16746937|P2|Overall Study|Lost to Follow-up|15
4858091|NCT00909779|16746938|P1|Overall Study|Lost to Follow-up|19
4858092|NCT00909779|16746937|P2|Overall Study|Lack of Efficacy|4
4858093|NCT00909779|16746938|P1|Overall Study|Lack of Efficacy|7
4858094|NCT00909779|16746937|P2|Overall Study|Adverse Event|55
4858095|NCT00909779|16746938|P1|Overall Study|Adverse Event|53
4858096|NCT00909753|16746962|P2|Period: Second Intervention|Protocol Violation|0
4858097|NCT00909753|16746963|P1|Period: Second Intervention|Protocol Violation|1
4858098|NCT00909753|16746962|P2|Period: Washout of 28 Days|Protocol Violation|3
4858099|NCT00909753|16746963|P1|Period: Washout of 28 Days|Protocol Violation|2
4858100|NCT00909727|16746983|P2|Overall Study|Prohibited Medication|0
4858101|NCT00909727|16746984|P1|Overall Study|Prohibited Medication|1
4858102|NCT00909727|16746983|P2|Overall Study|Withdrawal of Consent|0
4858103|NCT00909727|16746984|P1|Overall Study|Withdrawal of Consent|1
4858104|NCT00909727|16746983|P2|Overall Study|Wrong Genotype|0
4858105|NCT00909727|16746984|P1|Overall Study|Wrong Genotype|1
4858106|NCT00909727|16746983|P2|Overall Study|Adverse Event|0
4858107|NCT00909727|16746984|P1|Overall Study|Adverse Event|1
4858108|NCT00909610|16747007|P2|Period: Second Intervention|Adverse Event|0
4858109|NCT00909610|16747008|P1|Period: Second Intervention|Adverse Event|1
4858110|NCT00909610|16747007|P2|Period: Washout of 28 Days|Withdrawal by Subject|6
4858111|NCT00909610|16747008|P1|Period: Washout of 28 Days|Withdrawal by Subject|3
4858112|NCT00909610|16747007|P2|Period: First Intervention|Adverse Event|1
4858113|NCT00909610|16747008|P1|Period: First Intervention|Adverse Event|0
4858114|NCT00909532|16747169|P2|Overall Study|Increased Lab Draws, Difficult Lab Stick|0
4858115|NCT00909532|16747170|P1|Overall Study|Increased Lab Draws, Difficult Lab Stick|1
4858116|NCT00909532|16747169|P2|Overall Study|Wrong Genotype|0
4858117|NCT00909532|16747170|P1|Overall Study|Wrong Genotype|1
4858118|NCT00909532|16747169|P2|Overall Study|Physician Decision|0
4858119|NCT00909532|16747170|P1|Overall Study|Physician Decision|1
4858120|NCT00909532|16747169|P2|Overall Study|Noncompliance with Study Requirements|2
4858121|NCT00909532|16747170|P1|Overall Study|Noncompliance with Study Requirements|0
4858122|NCT00909532|16747169|P2|Overall Study|Withdrawal of Consent|1
4858123|NCT00909532|16747170|P1|Overall Study|Withdrawal of Consent|1
4858124|NCT00909532|16747169|P2|Overall Study|Prohibited Medication|1
4858125|NCT00909532|16747170|P1|Overall Study|Prohibited Medication|2
4858126|NCT00909532|16747169|P2|Overall Study|Pregnancy|1
4858127|NCT00909532|16747170|P1|Overall Study|Pregnancy|0
4858128|NCT00909532|16747169|P2|Overall Study|Adverse Event|1
4858129|NCT00909532|16747170|P1|Overall Study|Adverse Event|4
4858130|NCT00909480|16747188|P2|Overall Study|Unclassified|19
4858131|NCT00909480|16747189|P1|Overall Study|Unclassified|18
4858132|NCT00909480|16747188|P2|Overall Study|Withdrawal criteria|11
4858133|NCT00909480|16747189|P1|Overall Study|Withdrawal criteria|9
4858134|NCT00909480|16747188|P2|Overall Study|Protocol Violation|8
4858135|NCT00909480|16747189|P1|Overall Study|Protocol Violation|6
4858136|NCT00909480|16747188|P2|Overall Study|Adverse Event|3
4858137|NCT00909480|16747189|P1|Overall Study|Adverse Event|5
4858138|NCT00909428|16747224|P3|Overall Study|Lost to Follow-up|9
4858139|NCT00909428|16747225|P2|Overall Study|Lost to Follow-up|10
4858140|NCT00909428|16747226|P1|Overall Study|Lost to Follow-up|13
4858141|NCT00909389|16747233|P1|Overall Study|No Information|103
4858142|NCT00909389|16747233|P1|Overall Study|Lost to Follow-up|4
4858143|NCT00909389|16747233|P1|Overall Study|Poor Compliance|16
4858144|NCT00909389|16747233|P1|Overall Study|Death|4
4858145|NCT00909389|16747233|P1|Overall Study|Adverse Event|6
4858146|NCT00909363|16747240|P3|Overall Study|Lack of Efficacy|0
4858147|NCT00909363|16747241|P2|Overall Study|Lack of Efficacy|0
4858148|NCT00909363|16747242|P1|Overall Study|Lack of Efficacy|1
4858149|NCT00909363|16747240|P3|Overall Study|Withdrawal by Subject|0
4858150|NCT00909363|16747241|P2|Overall Study|Withdrawal by Subject|0
4858151|NCT00909363|16747242|P1|Overall Study|Withdrawal by Subject|1
4858152|NCT00909181|16747289|P3|Overall Study|Lost to Follow-up|33
4858153|NCT00909181|16747290|P2|Overall Study|Lost to Follow-up|18
4858154|NCT00909181|16747291|P1|Overall Study|Lost to Follow-up|39
4858155|NCT00909090|16747317|P2|Overall Study|Lost to Follow-up|17
4858156|NCT00909090|16747318|P1|Overall Study|Lost to Follow-up|17
4858157|NCT00909038|16747336|P1|Overall Study|Non-evaluable Subjects|230
4858158|NCT00909038|16747336|P1|Overall Study|Protocol Violation|187
4858159|NCT00908960|16747348|P3|Overall Study|Presence VTE dx or Absent VTE eval|2
4858160|NCT00908960|16747349|P2|Overall Study|Presence VTE dx or Absent VTE eval|1
4858161|NCT00908960|16747350|P1|Overall Study|Presence VTE dx or Absent VTE eval|1
4858162|NCT00908895|16747394|P2|Overall Study|Adverse Event|1
4858163|NCT00908895|16747395|P1|Overall Study|Adverse Event|1
4858164|NCT00908895|16747394|P2|Overall Study|algodystrophy|2
4858165|NCT00908895|16747395|P1|Overall Study|algodystrophy|2
4858166|NCT00908895|16747394|P2|Overall Study|Lost to Follow-up|3
4858167|NCT00908895|16747395|P1|Overall Study|Lost to Follow-up|1
4858168|NCT00908596|16747496|P4|Overall Study|Withdrawal by Subject|1
4858169|NCT00908596|16747497|P3|Overall Study|Withdrawal by Subject|3
4858170|NCT00908596|16747498|P2|Overall Study|Withdrawal by Subject|1
4858171|NCT00908596|16747499|P1|Overall Study|Withdrawal by Subject|0
4858172|NCT00908596|16747496|P4|Overall Study|Protocol Violation|0
4858173|NCT00908596|16747497|P3|Overall Study|Protocol Violation|0
4858174|NCT00908596|16747498|P2|Overall Study|Protocol Violation|0
4858175|NCT00908596|16747499|P1|Overall Study|Protocol Violation|1
4858176|NCT00908596|16747496|P4|Overall Study|Death|32
4858177|NCT00908596|16747497|P3|Overall Study|Death|57
4858178|NCT00908596|16747498|P2|Overall Study|Death|5
4858179|NCT00908596|16747499|P1|Overall Study|Death|0
4858180|NCT00908596|16747496|P4|Overall Study|Lost to Follow-up|4
4858181|NCT00908596|16747497|P3|Overall Study|Lost to Follow-up|12
4858182|NCT00908596|16747498|P2|Overall Study|Lost to Follow-up|1
4858183|NCT00908596|16747499|P1|Overall Study|Lost to Follow-up|0
4858184|NCT00908596|16747496|P4|Overall Study|Other reasons|0
4858185|NCT00908596|16747497|P3|Overall Study|Other reasons|2
4858186|NCT00908596|16747498|P2|Overall Study|Other reasons|6
4858187|NCT00908596|16747499|P1|Overall Study|Other reasons|46
4858188|NCT00908583|16747529|P1|Phase 5|Adverse Event|3
4858189|NCT00908583|16747529|P1|Phase 4|Physician Decision|1
4858190|NCT00908583|16747529|P1|Phase 4|Adverse Event|1
4858191|NCT00908583|16747529|P1|Phase 3|Adverse Event|2
4858192|NCT00908583|16747529|P1|Phase 2|Adverse Event|1
4858193|NCT00908583|16747529|P1|Phase 2|Physician Decision|1
4858194|NCT00908583|16747529|P1|Phase 1|Adverse Event|4
4858195|NCT00908583|16747529|P1|Phase 1|Withdrawal by Subject|1
4858196|NCT00908544|16747549|P2|Overall Study|Unable to visit sutdy center|0
4858197|NCT00908544|16747550|P1|Overall Study|Unable to visit sutdy center|1
4858198|NCT00908544|16747549|P2|Overall Study|Relocation abroad|1
4858199|NCT00908544|16747550|P1|Overall Study|Relocation abroad|1
4858200|NCT00908544|16747549|P2|Overall Study|Pregnancy|0
4858201|NCT00908544|16747550|P1|Overall Study|Pregnancy|1
4858202|NCT00908544|16747549|P2|Overall Study|Lack of Efficacy|1
4858203|NCT00908544|16747550|P1|Overall Study|Lack of Efficacy|0
4858204|NCT00908544|16747549|P2|Overall Study|Withdrawal by Subject|4
4858205|NCT00908544|16747550|P1|Overall Study|Withdrawal by Subject|2
4858206|NCT00908375|16747609|P2|Overall Study|Lost to Follow-up|6
4858207|NCT00908375|16747610|P1|Overall Study|Lost to Follow-up|8
4858208|NCT00908375|16747609|P2|Overall Study|Withdrawal by Subject|4
4858209|NCT00908375|16747610|P1|Overall Study|Withdrawal by Subject|2
4858210|NCT00908349|16747620|P1|Overall Study|Various|6
4858211|NCT00908349|16747620|P1|Overall Study|Lost to Follow-up|5
4858212|NCT00908349|16747620|P1|Overall Study|Physician Decision|5
4858213|NCT00908349|16747620|P1|Overall Study|Withdrawal by Subject|9
4858214|NCT00908349|16747620|P1|Overall Study|Adverse Event|10
4858215|NCT00908310|16747624|P1|Overall Study|Other reasons|4
4858216|NCT00908310|16747624|P1|Overall Study|Screening failure|5
4858217|NCT00908310|16747624|P1|Overall Study|Lost to Follow-up|7
4858218|NCT00908310|16747624|P1|Overall Study|Withdrawal by Subject|7
4858219|NCT00908310|16747624|P1|Overall Study|Death|37
4858220|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
4858221|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
4858222|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0
4858223|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1
4858224|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Other|0
4858225|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Other|0
4858226|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Other|1
4858227|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Other|3
4858228|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
4858229|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
4858230|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Physician Decision|0
4858231|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Physician Decision|2
4858232|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
4858233|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Adverse Event|0
4858234|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Adverse Event|2
4858235|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Adverse Event|17
4858236|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
4858237|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1
4858238|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0
4858239|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4
4858240|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Death|0
4858241|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Death|0
4858242|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Death|0
4858243|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Death|2
4858244|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
4858388|NCT00907881|16747867|P1|Overall Study|Protocol Violation|1
4858245|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
4858246|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0
4858247|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5
4858248|NCT00908232|16747628|P4|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
4858249|NCT00908232|16747629|P3|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
4858250|NCT00908232|16747630|P2|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0
4858251|NCT00908232|16747631|P1|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1
4858252|NCT00908232|16747628|P4|Cycle 1 to 4|Other|0
4858253|NCT00908232|16747629|P3|Cycle 1 to 4|Other|0
4858254|NCT00908232|16747630|P2|Cycle 1 to 4|Other|0
4858255|NCT00908232|16747631|P1|Cycle 1 to 4|Other|1
4858256|NCT00908232|16747628|P4|Cycle 1 to 4|Adverse Event|0
4858257|NCT00908232|16747629|P3|Cycle 1 to 4|Adverse Event|0
4858258|NCT00908232|16747630|P2|Cycle 1 to 4|Adverse Event|0
4858259|NCT00908232|16747631|P1|Cycle 1 to 4|Adverse Event|12
4858260|NCT00908232|16747628|P4|Cycle 1 to 4|Progressive Disease|0
4858261|NCT00908232|16747629|P3|Cycle 1 to 4|Progressive Disease|0
4858262|NCT00908232|16747630|P2|Cycle 1 to 4|Progressive Disease|0
4858263|NCT00908232|16747631|P1|Cycle 1 to 4|Progressive Disease|6
4858264|NCT00908232|16747628|P4|Cycle 1 to 4|Withdrawal by Subject|0
4858265|NCT00908232|16747629|P3|Cycle 1 to 4|Withdrawal by Subject|0
4858266|NCT00908232|16747630|P2|Cycle 1 to 4|Withdrawal by Subject|0
4858267|NCT00908232|16747631|P1|Cycle 1 to 4|Withdrawal by Subject|4
4858268|NCT00908232|16747628|P4|Cycle 1 to 4|Death|0
4858269|NCT00908232|16747629|P3|Cycle 1 to 4|Death|0
4858270|NCT00908232|16747630|P2|Cycle 1 to 4|Death|0
4858271|NCT00908232|16747631|P1|Cycle 1 to 4|Death|5
4858272|NCT00908141|16747649|P2|Overall Study|Withdrawal by Subject|1
4858273|NCT00908141|16747650|P1|Overall Study|Withdrawal by Subject|0
4858274|NCT00908115|16747667|P1|Overall Study|Other|14
4858275|NCT00908076|16747675|P2|Overall Study|Lack of Efficacy|1
4858276|NCT00908076|16747676|P1|Overall Study|Lack of Efficacy|1
4858277|NCT00908037|16747689|P12|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858278|NCT00908037|16747690|P11|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2
4858279|NCT00908037|16747691|P10|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858280|NCT00908037|16747692|P9|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858281|NCT00908037|16747693|P8|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858282|NCT00908037|16747694|P7|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858283|NCT00908037|16747695|P6|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858284|NCT00908037|16747696|P5|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858285|NCT00908037|16747697|P4|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858286|NCT00908037|16747698|P3|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858287|NCT00908037|16747699|P2|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858288|NCT00908037|16747700|P1|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0
4858289|NCT00908037|16747689|P12|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858290|NCT00908037|16747690|P11|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858291|NCT00908037|16747691|P10|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1
4858292|NCT00908037|16747692|P9|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858293|NCT00908037|16747693|P8|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858294|NCT00908037|16747694|P7|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858295|NCT00908037|16747695|P6|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858296|NCT00908037|16747696|P5|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858297|NCT00908037|16747697|P4|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858298|NCT00908037|16747698|P3|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858299|NCT00908037|16747699|P2|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858300|NCT00908037|16747700|P1|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0
4858301|NCT00908037|16747689|P12|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858302|NCT00908037|16747690|P11|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2
4858303|NCT00908037|16747691|P10|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858304|NCT00908037|16747692|P9|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858305|NCT00908037|16747693|P8|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858306|NCT00908037|16747694|P7|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858307|NCT00908037|16747695|P6|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858308|NCT00908037|16747696|P5|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858309|NCT00908037|16747697|P4|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858310|NCT00908037|16747698|P3|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858311|NCT00908037|16747699|P2|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858312|NCT00908037|16747700|P1|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0
4858313|NCT00908037|16747689|P12|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858314|NCT00908037|16747690|P11|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858315|NCT00908037|16747691|P10|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1
4858316|NCT00908037|16747692|P9|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858317|NCT00908037|16747693|P8|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858318|NCT00908037|16747694|P7|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858319|NCT00908037|16747695|P6|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858320|NCT00908037|16747696|P5|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858321|NCT00908037|16747697|P4|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858322|NCT00908037|16747698|P3|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858323|NCT00908037|16747699|P2|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858324|NCT00908037|16747700|P1|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0
4858325|NCT00908037|16747689|P12|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2
4858326|NCT00908037|16747690|P11|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858327|NCT00908037|16747691|P10|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1
4858328|NCT00908037|16747692|P9|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858329|NCT00908037|16747693|P8|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858330|NCT00908037|16747694|P7|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858331|NCT00908037|16747695|P6|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858332|NCT00908037|16747696|P5|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858333|NCT00908037|16747697|P4|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858334|NCT00908037|16747698|P3|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858335|NCT00908037|16747699|P2|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858336|NCT00908037|16747700|P1|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0
4858337|NCT00908037|16747689|P12|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1
4858338|NCT00908037|16747690|P11|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858339|NCT00908037|16747691|P10|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858340|NCT00908037|16747692|P9|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858341|NCT00908037|16747693|P8|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858342|NCT00908037|16747694|P7|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858343|NCT00908037|16747695|P6|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858344|NCT00908037|16747696|P5|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858345|NCT00908037|16747697|P4|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858346|NCT00908037|16747698|P3|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858347|NCT00908037|16747699|P2|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858348|NCT00908037|16747700|P1|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0
4858349|NCT00908037|16747689|P12|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858350|NCT00908037|16747690|P11|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858351|NCT00908037|16747691|P10|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858352|NCT00908037|16747692|P9|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858353|NCT00908037|16747693|P8|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858354|NCT00908037|16747694|P7|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
4858355|NCT00908037|16747695|P6|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858356|NCT00908037|16747696|P5|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858357|NCT00908037|16747697|P4|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1
4858358|NCT00908037|16747698|P3|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858359|NCT00908037|16747699|P2|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858360|NCT00908037|16747700|P1|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0
4858361|NCT00908037|16747689|P12|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858362|NCT00908037|16747690|P11|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858363|NCT00908037|16747691|P10|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858364|NCT00908037|16747692|P9|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4
4858365|NCT00908037|16747693|P8|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858366|NCT00908037|16747694|P7|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858367|NCT00908037|16747695|P6|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858368|NCT00908037|16747696|P5|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2
4858369|NCT00908037|16747697|P4|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858370|NCT00908037|16747698|P3|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858371|NCT00908037|16747699|P2|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858372|NCT00908037|16747700|P1|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0
4858373|NCT00908037|16747689|P12|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858374|NCT00908037|16747690|P11|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858375|NCT00908037|16747691|P10|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858376|NCT00908037|16747692|P9|Part 2 (7 Week Randomized Period)|Protocol Violation|1
4858377|NCT00908037|16747693|P8|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858378|NCT00908037|16747694|P7|Part 2 (7 Week Randomized Period)|Protocol Violation|3
4858379|NCT00908037|16747695|P6|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858380|NCT00908037|16747696|P5|Part 2 (7 Week Randomized Period)|Protocol Violation|1
4858381|NCT00908037|16747697|P4|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858382|NCT00908037|16747698|P3|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858383|NCT00908037|16747699|P2|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858384|NCT00908037|16747700|P1|Part 2 (7 Week Randomized Period)|Protocol Violation|0
4858385|NCT00908011|16747849|P2|Overall Study|Withdrawal by Subject|2
4858386|NCT00908011|16747850|P1|Overall Study|Withdrawal by Subject|2
4858387|NCT00907881|16747867|P1|Overall Study|Missing discontinuation information|15
4858389|NCT00907881|16747867|P1|Overall Study|Withdrawal by Subject|5
4858390|NCT00907881|16747867|P1|Overall Study|Noncompliance|5
4858391|NCT00907881|16747867|P1|Overall Study|Lost to Follow-up|59
4858392|NCT00907803|16747877|P3|Overall Study|Protocol Violation|0
4858393|NCT00907803|16747878|P2|Overall Study|Protocol Violation|1
4858394|NCT00907803|16747879|P1|Overall Study|Protocol Violation|0
4858395|NCT00907803|16747877|P3|Overall Study|Lost to Follow-up|0
4858396|NCT00907803|16747878|P2|Overall Study|Lost to Follow-up|1
4858397|NCT00907803|16747879|P1|Overall Study|Lost to Follow-up|0
4858398|NCT00907803|16747877|P3|Overall Study|Withdrawal by Subject|0
4858399|NCT00907803|16747878|P2|Overall Study|Withdrawal by Subject|1
4858400|NCT00907803|16747879|P1|Overall Study|Withdrawal by Subject|0
4858401|NCT00907803|16747877|P3|Overall Study|Adverse Event|0
4858402|NCT00907803|16747878|P2|Overall Study|Adverse Event|0
4858403|NCT00907803|16747879|P1|Overall Study|Adverse Event|2
4858404|NCT00907803|16747877|P3|Overall Study|Withdrawal of consent - long commute|0
4858405|NCT00907803|16747878|P2|Overall Study|Withdrawal of consent - long commute|0
4858406|NCT00907803|16747879|P1|Overall Study|Withdrawal of consent - long commute|1
4858407|NCT00907777|16747910|P2|Overall Study|Withdrawal by Subject|1
4858408|NCT00907777|16747911|P1|Overall Study|Withdrawal by Subject|0
4858409|NCT00907738|16747938|P5|Overall Study|Disease progression|2
4858410|NCT00907738|16747939|P4|Overall Study|Disease progression|4
4858411|NCT00907738|16747940|P3|Overall Study|Disease progression|6
4858412|NCT00907738|16747941|P2|Overall Study|Disease progression|1
4858413|NCT00907738|16747942|P1|Overall Study|Disease progression|8
4858414|NCT00907738|16747938|P5|Overall Study|not specified or withdrew consent|0
4858415|NCT00907738|16747939|P4|Overall Study|not specified or withdrew consent|0
4858416|NCT00907738|16747940|P3|Overall Study|not specified or withdrew consent|0
4858417|NCT00907738|16747941|P2|Overall Study|not specified or withdrew consent|0
4858418|NCT00907738|16747942|P1|Overall Study|not specified or withdrew consent|3
4858419|NCT00907738|16747938|P5|Overall Study|Adverse Event|0
4858420|NCT00907738|16747939|P4|Overall Study|Adverse Event|0
4858421|NCT00907738|16747940|P3|Overall Study|Adverse Event|1
4858422|NCT00907738|16747941|P2|Overall Study|Adverse Event|0
4858423|NCT00907738|16747942|P1|Overall Study|Adverse Event|2
4858424|NCT00907621|16747960|P2|Overall Study|intercurrent febrile illness|1
4858425|NCT00907621|16747961|P1|Overall Study|intercurrent febrile illness|1
4858426|NCT00907621|16747960|P2|Overall Study|Lost to Follow-up|3
4858427|NCT00907621|16747961|P1|Overall Study|Lost to Follow-up|6
4858428|NCT00907517|16747974|P5|Overall Study|Symptomatic Deterioration|1
4858429|NCT00907517|16747975|P4|Overall Study|Symptomatic Deterioration|0
4858430|NCT00907517|16747976|P3|Overall Study|Symptomatic Deterioration|0
4858431|NCT00907517|16747977|P2|Overall Study|Symptomatic Deterioration|0
4858432|NCT00907517|16747978|P1|Overall Study|Symptomatic Deterioration|0
4858433|NCT00907517|16747974|P5|Overall Study|Progressive Disease|4
4858434|NCT00907517|16747975|P4|Overall Study|Progressive Disease|4
4858435|NCT00907517|16747976|P3|Overall Study|Progressive Disease|4
4858436|NCT00907517|16747977|P2|Overall Study|Progressive Disease|3
4858437|NCT00907517|16747978|P1|Overall Study|Progressive Disease|3
4858438|NCT00907478|16748003|P3|Overall Study|Other|1
4858439|NCT00907478|16748004|P2|Overall Study|Other|0
4858440|NCT00907478|16748005|P1|Overall Study|Other|3
4858441|NCT00907478|16748003|P3|Overall Study|Lost to Follow-up|0
4858442|NCT00907478|16748004|P2|Overall Study|Lost to Follow-up|0
4858443|NCT00907478|16748005|P1|Overall Study|Lost to Follow-up|1
4858444|NCT00907478|16748003|P3|Overall Study|Pregnancy|1
4858445|NCT00907478|16748004|P2|Overall Study|Pregnancy|1
4858446|NCT00907478|16748005|P1|Overall Study|Pregnancy|0
4858447|NCT00907478|16748003|P3|Overall Study|Protocol-specified criteria|3
4858448|NCT00907478|16748004|P2|Overall Study|Protocol-specified criteria|2
4858449|NCT00907478|16748005|P1|Overall Study|Protocol-specified criteria|5
4858450|NCT00907478|16748003|P3|Overall Study|Death|1
4858451|NCT00907478|16748004|P2|Overall Study|Death|2
4858452|NCT00907478|16748005|P1|Overall Study|Death|4
4858453|NCT00907478|16748003|P3|Overall Study|Physician Decision|3
4858454|NCT00907478|16748004|P2|Overall Study|Physician Decision|0
4858455|NCT00907478|16748005|P1|Overall Study|Physician Decision|2
4858456|NCT00907478|16748003|P3|Overall Study|Requirement for alternative therapy|3
4858457|NCT00907478|16748004|P2|Overall Study|Requirement for alternative therapy|2
4858458|NCT00907478|16748005|P1|Overall Study|Requirement for alternative therapy|1
4858459|NCT00907478|16748003|P3|Overall Study|Withdrawal by Subject|6
4858460|NCT00907478|16748004|P2|Overall Study|Withdrawal by Subject|9
4858461|NCT00907478|16748005|P1|Overall Study|Withdrawal by Subject|8
4858462|NCT00907478|16748003|P3|Overall Study|Adverse Event|2
4858463|NCT00907478|16748004|P2|Overall Study|Adverse Event|1
4858464|NCT00907478|16748005|P1|Overall Study|Adverse Event|3
4858465|NCT00907478|16748003|P3|Overall Study|Noncompliance|1
4858466|NCT00907478|16748004|P2|Overall Study|Noncompliance|0
4858467|NCT00907478|16748005|P1|Overall Study|Noncompliance|0
4858468|NCT00907478|16748003|P3|Overall Study|Ineligibility determined|1
4858469|NCT00907478|16748004|P2|Overall Study|Ineligibility determined|0
4858470|NCT00907478|16748005|P1|Overall Study|Ineligibility determined|0
4858471|NCT00907374|16748055|P2|Overall Study|Noncompliant w/study protocol at <3 mos|2
4858472|NCT00907374|16748056|P1|Overall Study|Noncompliant w/study protocol at <3 mos|2
4858473|NCT00907335|16748070|P2|Overall Study|Lost to Follow-up|0
4858474|NCT00907335|16748071|P1|Overall Study|Lost to Follow-up|2
4858475|NCT00907335|16748070|P2|Overall Study|Adverse Event|1
4858476|NCT00907335|16748071|P1|Overall Study|Adverse Event|4
4858477|NCT00907335|16748070|P2|Overall Study|Withdrawal by Subject|0
4858478|NCT00907335|16748071|P1|Overall Study|Withdrawal by Subject|2
4858479|NCT00907296|16748097|P10|Overall Study|Lost to Follow-up|4
4858480|NCT00907296|16748098|P9|Overall Study|Lost to Follow-up|0
4858481|NCT00907296|16748099|P8|Overall Study|Lost to Follow-up|2
4858482|NCT00907296|16748100|P7|Overall Study|Lost to Follow-up|2
4858483|NCT00907296|16748101|P6|Overall Study|Lost to Follow-up|3
4858484|NCT00907296|16748102|P5|Overall Study|Lost to Follow-up|0
4858485|NCT00907296|16748103|P4|Overall Study|Lost to Follow-up|2
4858486|NCT00907296|16748104|P3|Overall Study|Lost to Follow-up|0
4858487|NCT00907296|16748105|P2|Overall Study|Lost to Follow-up|1
4858488|NCT00907296|16748106|P1|Overall Study|Lost to Follow-up|9
4858489|NCT00907296|16748097|P10|Overall Study|Withdrawal by Subject|2
4858490|NCT00907296|16748098|P9|Overall Study|Withdrawal by Subject|4
4858491|NCT00907296|16748099|P8|Overall Study|Withdrawal by Subject|2
4858492|NCT00907296|16748100|P7|Overall Study|Withdrawal by Subject|3
4858493|NCT00907296|16748101|P6|Overall Study|Withdrawal by Subject|5
4858494|NCT00907296|16748102|P5|Overall Study|Withdrawal by Subject|1
4858495|NCT00907296|16748103|P4|Overall Study|Withdrawal by Subject|1
4858496|NCT00907296|16748104|P3|Overall Study|Withdrawal by Subject|1
4858497|NCT00907296|16748105|P2|Overall Study|Withdrawal by Subject|2
4858498|NCT00907296|16748106|P1|Overall Study|Withdrawal by Subject|7
4858499|NCT00907296|16748097|P10|Overall Study|Adverse Event|1
4858500|NCT00907296|16748098|P9|Overall Study|Adverse Event|0
4858501|NCT00907296|16748099|P8|Overall Study|Adverse Event|0
4858502|NCT00907296|16748100|P7|Overall Study|Adverse Event|1
4858503|NCT00907296|16748101|P6|Overall Study|Adverse Event|0
4858504|NCT00907296|16748102|P5|Overall Study|Adverse Event|0
4858505|NCT00907296|16748103|P4|Overall Study|Adverse Event|0
4858506|NCT00907296|16748104|P3|Overall Study|Adverse Event|0
4858507|NCT00907296|16748105|P2|Overall Study|Adverse Event|0
4858508|NCT00907296|16748106|P1|Overall Study|Adverse Event|2
4858509|NCT00907296|16748097|P10|Overall Study|Noncompliance|0
4858510|NCT00907296|16748098|P9|Overall Study|Noncompliance|0
4858511|NCT00907296|16748099|P8|Overall Study|Noncompliance|2
4858512|NCT00907296|16748100|P7|Overall Study|Noncompliance|0
4858513|NCT00907296|16748101|P6|Overall Study|Noncompliance|1
4858514|NCT00907296|16748102|P5|Overall Study|Noncompliance|0
4858515|NCT00907296|16748103|P4|Overall Study|Noncompliance|0
4858516|NCT00907296|16748104|P3|Overall Study|Noncompliance|1
4858517|NCT00907296|16748105|P2|Overall Study|Noncompliance|1
4858518|NCT00907296|16748106|P1|Overall Study|Noncompliance|1
4858519|NCT00907296|16748097|P10|Overall Study|Protocol Deviation|0
4858520|NCT00907296|16748098|P9|Overall Study|Protocol Deviation|0
4858521|NCT00907296|16748099|P8|Overall Study|Protocol Deviation|0
4858522|NCT00907296|16748100|P7|Overall Study|Protocol Deviation|0
4858523|NCT00907296|16748101|P6|Overall Study|Protocol Deviation|0
4858524|NCT00907296|16748102|P5|Overall Study|Protocol Deviation|0
4858525|NCT00907296|16748103|P4|Overall Study|Protocol Deviation|0
4858526|NCT00907296|16748104|P3|Overall Study|Protocol Deviation|0
4858527|NCT00907296|16748105|P2|Overall Study|Protocol Deviation|1
4858528|NCT00907296|16748106|P1|Overall Study|Protocol Deviation|0
4858529|NCT00907296|16748097|P10|Overall Study|Ineligibility Determined|0
4858530|NCT00907296|16748098|P9|Overall Study|Ineligibility Determined|0
4858531|NCT00907296|16748099|P8|Overall Study|Ineligibility Determined|1
4858532|NCT00907296|16748100|P7|Overall Study|Ineligibility Determined|0
4858533|NCT00907296|16748101|P6|Overall Study|Ineligibility Determined|0
4858534|NCT00907296|16748102|P5|Overall Study|Ineligibility Determined|0
4858535|NCT00907296|16748103|P4|Overall Study|Ineligibility Determined|1
4858536|NCT00907296|16748104|P3|Overall Study|Ineligibility Determined|0
4858537|NCT00907296|16748105|P2|Overall Study|Ineligibility Determined|0
4858538|NCT00907296|16748106|P1|Overall Study|Ineligibility Determined|1
4858539|NCT00907257|16748160|P2|Overall Study|Personal Reasons|1
4858540|NCT00907257|16748161|P1|Overall Study|Personal Reasons|6
4858541|NCT00907257|16748160|P2|Overall Study|Moved|0
4858542|NCT00907257|16748161|P1|Overall Study|Moved|1
4858543|NCT00907257|16748160|P2|Overall Study|Per IRB-Subject became vulnerable|0
4858544|NCT00907257|16748161|P1|Overall Study|Per IRB-Subject became vulnerable|1
4858545|NCT00907257|16748160|P2|Overall Study|Withdrawal by Subject|2
4858546|NCT00907257|16748161|P1|Overall Study|Withdrawal by Subject|1
4858547|NCT00907257|16748160|P2|Overall Study|Lost to Follow-up|3
4858548|NCT00907257|16748161|P1|Overall Study|Lost to Follow-up|3
4858549|NCT00907257|16748160|P2|Overall Study|Protocol Violation|2
4858550|NCT00907257|16748161|P1|Overall Study|Protocol Violation|1
4858551|NCT00907257|16748160|P2|Overall Study|Adverse Event|4
4858552|NCT00907257|16748161|P1|Overall Study|Adverse Event|0
4858553|NCT00907153|16748183|P2|Overall Study|Withdrawal by Subject|3
4858554|NCT00907153|16748184|P1|Overall Study|Withdrawal by Subject|1
4858555|NCT00907153|16748183|P2|Overall Study|Lost to Follow-up|1
4858556|NCT00907153|16748184|P1|Overall Study|Lost to Follow-up|1
4858557|NCT00906971|16748245|P2|Overall Study|Lost to Follow-up|1
4858558|NCT00906971|16748246|P1|Overall Study|Lost to Follow-up|0
4858559|NCT00906971|16748245|P2|Overall Study|Withdrawal by Subject|2
4858560|NCT00906971|16748246|P1|Overall Study|Withdrawal by Subject|8
4858561|NCT00906945|16748259|P6|Overall Study|Physician Decision|1
4858562|NCT00906945|16748260|P5|Overall Study|Physician Decision|0
4858563|NCT00906945|16748261|P4|Overall Study|Physician Decision|0
4858564|NCT00906945|16748262|P3|Overall Study|Physician Decision|0
4858565|NCT00906945|16748263|P2|Overall Study|Physician Decision|0
4858566|NCT00906945|16748264|P1|Overall Study|Physician Decision|0
4858567|NCT00906945|16748259|P6|Overall Study|Found to be not eligible|1
4858568|NCT00906945|16748260|P5|Overall Study|Found to be not eligible|1
4858569|NCT00906945|16748261|P4|Overall Study|Found to be not eligible|1
4858570|NCT00906945|16748262|P3|Overall Study|Found to be not eligible|0
4858571|NCT00906945|16748263|P2|Overall Study|Found to be not eligible|0
4858572|NCT00906945|16748264|P1|Overall Study|Found to be not eligible|0
4858573|NCT00906698|16748324|P6|Overall Study|incl. non compliance, lost to follow-up|0
4858574|NCT00906698|16748325|P5|Overall Study|incl. non compliance, lost to follow-up|0
4858575|NCT00906698|16748326|P4|Overall Study|incl. non compliance, lost to follow-up|0
4858576|NCT00906698|16748327|P3|Overall Study|incl. non compliance, lost to follow-up|0
4858577|NCT00906698|16748328|P2|Overall Study|incl. non compliance, lost to follow-up|1
4858578|NCT00906698|16748329|P1|Overall Study|incl. non compliance, lost to follow-up|0
4858579|NCT00906698|16748324|P6|Overall Study|Withdrawal by Subject|0
4858580|NCT00906698|16748325|P5|Overall Study|Withdrawal by Subject|1
4858581|NCT00906698|16748326|P4|Overall Study|Withdrawal by Subject|0
4858582|NCT00906698|16748327|P3|Overall Study|Withdrawal by Subject|0
4858583|NCT00906698|16748328|P2|Overall Study|Withdrawal by Subject|0
4858584|NCT00906698|16748329|P1|Overall Study|Withdrawal by Subject|0
4858585|NCT00906698|16748324|P6|Overall Study|Disease progression|4
4858586|NCT00906698|16748325|P5|Overall Study|Disease progression|12
4858587|NCT00906698|16748326|P4|Overall Study|Disease progression|4
4858588|NCT00906698|16748327|P3|Overall Study|Disease progression|4
4858589|NCT00906698|16748328|P2|Overall Study|Disease progression|12
4858590|NCT00906698|16748329|P1|Overall Study|Disease progression|3
4858591|NCT00906698|16748324|P6|Overall Study|Adverse Event|1
4858592|NCT00906698|16748325|P5|Overall Study|Adverse Event|4
4858593|NCT00906698|16748326|P4|Overall Study|Adverse Event|0
4858594|NCT00906698|16748327|P3|Overall Study|Adverse Event|2
4858595|NCT00906698|16748328|P2|Overall Study|Adverse Event|0
4858596|NCT00906698|16748329|P1|Overall Study|Adverse Event|0
4858597|NCT00906698|16748324|P6|Overall Study|Dose-limiting toxicity (DLT)|0
4858598|NCT00906698|16748325|P5|Overall Study|Dose-limiting toxicity (DLT)|1
4858599|NCT00906698|16748326|P4|Overall Study|Dose-limiting toxicity (DLT)|0
4858600|NCT00906698|16748327|P3|Overall Study|Dose-limiting toxicity (DLT)|0
4858601|NCT00906698|16748328|P2|Overall Study|Dose-limiting toxicity (DLT)|6
4858602|NCT00906698|16748329|P1|Overall Study|Dose-limiting toxicity (DLT)|0
4858603|NCT00906399|16748431|P7|Year 2|Other|0
4858604|NCT00906399|16748432|P6|Year 2|Other|1
4858605|NCT00906399|16748433|P5|Year 2|Other|3
4858606|NCT00906399|16748434|P4|Year 2|Other|2
4858607|NCT00906399|16748435|P3|Year 2|Other|0
4858608|NCT00906399|16748436|P2|Year 2|Other|0
4858609|NCT00906399|16748437|P1|Year 2|Other|0
4858610|NCT00906399|16748431|P7|Year 2|Death|3
4858611|NCT00906399|16748432|P6|Year 2|Death|0
4858612|NCT00906399|16748433|P5|Year 2|Death|0
4858613|NCT00906399|16748434|P4|Year 2|Death|1
4858614|NCT00906399|16748435|P3|Year 2|Death|0
4858615|NCT00906399|16748436|P2|Year 2|Death|0
4858616|NCT00906399|16748437|P1|Year 2|Death|0
4858617|NCT00906399|16748431|P7|Year 2|Physician Decision|3
4858618|NCT00906399|16748432|P6|Year 2|Physician Decision|6
4858619|NCT00906399|16748433|P5|Year 2|Physician Decision|2
4858620|NCT00906399|16748434|P4|Year 2|Physician Decision|0
4858621|NCT00906399|16748435|P3|Year 2|Physician Decision|0
4858622|NCT00906399|16748436|P2|Year 2|Physician Decision|0
4858623|NCT00906399|16748437|P1|Year 2|Physician Decision|0
4858624|NCT00906399|16748431|P7|Year 2|Withdrawal by Subject|13
4858625|NCT00906399|16748432|P6|Year 2|Withdrawal by Subject|27
4858626|NCT00906399|16748433|P5|Year 2|Withdrawal by Subject|18
4858627|NCT00906399|16748434|P4|Year 2|Withdrawal by Subject|17
4858628|NCT00906399|16748435|P3|Year 2|Withdrawal by Subject|0
4858629|NCT00906399|16748436|P2|Year 2|Withdrawal by Subject|0
4858630|NCT00906399|16748437|P1|Year 2|Withdrawal by Subject|0
4858631|NCT00906399|16748431|P7|Year 2|Lost to Follow-up|4
4858632|NCT00906399|16748432|P6|Year 2|Lost to Follow-up|2
4858633|NCT00906399|16748433|P5|Year 2|Lost to Follow-up|4
4858634|NCT00906399|16748434|P4|Year 2|Lost to Follow-up|1
4858635|NCT00906399|16748435|P3|Year 2|Lost to Follow-up|0
4858636|NCT00906399|16748436|P2|Year 2|Lost to Follow-up|0
4858637|NCT00906399|16748437|P1|Year 2|Lost to Follow-up|0
4858638|NCT00906399|16748431|P7|Year 2|Adverse Event|6
4858639|NCT00906399|16748432|P6|Year 2|Adverse Event|11
4858640|NCT00906399|16748433|P5|Year 2|Adverse Event|8
4858641|NCT00906399|16748434|P4|Year 2|Adverse Event|9
4858642|NCT00906399|16748435|P3|Year 2|Adverse Event|0
4858643|NCT00906399|16748436|P2|Year 2|Adverse Event|0
4858644|NCT00906399|16748437|P1|Year 2|Adverse Event|0
4858645|NCT00906399|16748431|P7|Year 1|Other|0
4858646|NCT00906399|16748432|P6|Year 1|Other|0
4858647|NCT00906399|16748433|P5|Year 1|Other|0
4858648|NCT00906399|16748434|P4|Year 1|Other|0
4858649|NCT00906399|16748435|P3|Year 1|Other|7
4858650|NCT00906399|16748436|P2|Year 1|Other|2
4858651|NCT00906399|16748437|P1|Year 1|Other|4
4858652|NCT00906399|16748431|P7|Year 1|Death|0
4858653|NCT00906399|16748432|P6|Year 1|Death|0
4858654|NCT00906399|16748433|P5|Year 1|Death|0
4858655|NCT00906399|16748434|P4|Year 1|Death|0
4858656|NCT00906399|16748435|P3|Year 1|Death|1
4858657|NCT00906399|16748436|P2|Year 1|Death|1
4858658|NCT00906399|16748437|P1|Year 1|Death|2
4858659|NCT00906399|16748431|P7|Year 1|Physician Decision|0
4858660|NCT00906399|16748432|P6|Year 1|Physician Decision|0
4858661|NCT00906399|16748433|P5|Year 1|Physician Decision|0
4858662|NCT00906399|16748434|P4|Year 1|Physician Decision|0
4858663|NCT00906399|16748435|P3|Year 1|Physician Decision|3
4858664|NCT00906399|16748436|P2|Year 1|Physician Decision|1
4858665|NCT00906399|16748437|P1|Year 1|Physician Decision|0
4858666|NCT00906399|16748431|P7|Year 1|Withdrawal by Subject|0
4858667|NCT00906399|16748432|P6|Year 1|Withdrawal by Subject|0
4858668|NCT00906399|16748433|P5|Year 1|Withdrawal by Subject|0
4858669|NCT00906399|16748434|P4|Year 1|Withdrawal by Subject|0
4858670|NCT00906399|16748435|P3|Year 1|Withdrawal by Subject|36
4858671|NCT00906399|16748436|P2|Year 1|Withdrawal by Subject|32
4858672|NCT00906399|16748437|P1|Year 1|Withdrawal by Subject|30
4858673|NCT00906399|16748431|P7|Year 1|Lost to Follow-up|0
4858674|NCT00906399|16748432|P6|Year 1|Lost to Follow-up|0
4858675|NCT00906399|16748433|P5|Year 1|Lost to Follow-up|0
4858676|NCT00906399|16748434|P4|Year 1|Lost to Follow-up|0
4858677|NCT00906399|16748435|P3|Year 1|Lost to Follow-up|2
4858678|NCT00906399|16748436|P2|Year 1|Lost to Follow-up|4
4858679|NCT00906399|16748437|P1|Year 1|Lost to Follow-up|4
4858680|NCT00906399|16748431|P7|Year 1|Adverse Event|0
4858681|NCT00906399|16748432|P6|Year 1|Adverse Event|0
4858682|NCT00906399|16748433|P5|Year 1|Adverse Event|0
4858683|NCT00906399|16748434|P4|Year 1|Adverse Event|0
4858684|NCT00906399|16748435|P3|Year 1|Adverse Event|24
4858685|NCT00906399|16748436|P2|Year 1|Adverse Event|22
4858686|NCT00906399|16748437|P1|Year 1|Adverse Event|4
4858687|NCT00906399|16748431|P7|Year 1|Randomized But Not Treated|0
4858688|NCT00906399|16748432|P6|Year 1|Randomized But Not Treated|0
4858689|NCT00906399|16748433|P5|Year 1|Randomized But Not Treated|0
4858690|NCT00906399|16748434|P4|Year 1|Randomized But Not Treated|0
4858691|NCT00906399|16748435|P3|Year 1|Randomized But Not Treated|3
4858692|NCT00906399|16748436|P2|Year 1|Randomized But Not Treated|1
4858693|NCT00906399|16748437|P1|Year 1|Randomized But Not Treated|0
4858694|NCT00906373|16748460|P2|Overall Study|Still on treatment at cutoff date|2
4858695|NCT00906373|16748461|P1|Overall Study|Still on treatment at cutoff date|0
4858696|NCT00906373|16748460|P2|Overall Study|Other|1
4858697|NCT00906373|16748461|P1|Overall Study|Other|0
4858698|NCT00906373|16748460|P2|Overall Study|Withdrawal by Subject|5
4858699|NCT00906373|16748461|P1|Overall Study|Withdrawal by Subject|0
4858700|NCT00906347|16748500|P2|Received Study Drug|Uterine tachysystole or hypertonus|0
4858701|NCT00906347|16748501|P1|Received Study Drug|Uterine tachysystole or hypertonus|8
4858702|NCT00906347|16748500|P2|Received Study Drug|Refused study drug|0
4858703|NCT00906347|16748501|P1|Received Study Drug|Refused study drug|1
4858704|NCT00906347|16748500|P2|Received Study Drug|Nonreassuring fetal heart rate|1
4858705|NCT00906347|16748501|P1|Received Study Drug|Nonreassuring fetal heart rate|13
4858706|NCT00906347|16748500|P2|Received Study Drug|8 cm prior to initiation of study drug|30
4858707|NCT00906347|16748501|P1|Received Study Drug|8 cm prior to initiation of study drug|18
4858708|NCT00906282|16748521|P1|Preoperative Chemotherapy|Toxicity|1
4858709|NCT00906282|16748521|P1|Preoperative Chemotherapy|Progressive disease|6
4858710|NCT00906282|16748521|P1|Preoperative Chemotherapy|Not surgical candidates, off study|10
4858711|NCT00906282|16748521|P1|Preoperative Chemotherapy|Withdrawal by Subject|2
4858712|NCT00906204|16748535|P2|Secondary Endpoints (Long-term Safety)|Death|1
4858713|NCT00906204|16748536|P1|Secondary Endpoints (Long-term Safety)|Death|0
4858714|NCT00906204|16748535|P2|Secondary Endpoints (Long-term Safety)|Adverse Event|2
4858715|NCT00906204|16748536|P1|Secondary Endpoints (Long-term Safety)|Adverse Event|2
4858716|NCT00906204|16748535|P2|Primary Endpoint (Early Safety)|Withdrawal by Subject|0
4858717|NCT00906204|16748536|P1|Primary Endpoint (Early Safety)|Withdrawal by Subject|1
4858718|NCT00906204|16748535|P2|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1
4858719|NCT00906204|16748536|P1|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0
4858720|NCT00906204|16748535|P2|Primary Endpoint (Early Safety)|Physician Decision|0
4858721|NCT00906204|16748536|P1|Primary Endpoint (Early Safety)|Physician Decision|1
4858722|NCT00906087|16748590|P1|Initial Washout|Physician Decision|1
4858723|NCT00906087|16748590|P1|Initial Washout|Withdrawal by Subject|1
4858724|NCT00906035|16748627|P3|Overall Study|Withdrawal by Subject|0
4858725|NCT00906035|16748628|P2|Overall Study|Withdrawal by Subject|3
4858726|NCT00906035|16748629|P1|Overall Study|Withdrawal by Subject|2
4858727|NCT00905840|16748643|P1|Overall Study|Adverse Event|1
4858728|NCT00905840|16748643|P1|Overall Study|Withdrawal by Subject|1
4858729|NCT00905840|16748643|P1|Overall Study|Death|3
4858730|NCT00905840|16748643|P1|Overall Study|Lost to Follow-up|11
4858731|NCT00905632|16748674|P7|Overall Study|Adverse Event|4
4858732|NCT00905632|16748675|P6|Overall Study|Adverse Event|1
4858733|NCT00905632|16748676|P5|Overall Study|Adverse Event|0
4858734|NCT00905632|16748677|P4|Overall Study|Adverse Event|0
4858735|NCT00905632|16748678|P3|Overall Study|Adverse Event|0
4858736|NCT00905632|16748679|P2|Overall Study|Adverse Event|0
4858737|NCT00905632|16748680|P1|Overall Study|Adverse Event|0
4858738|NCT00905606|16748818|P2|Washout|Withdrawal by Subject|0
4858739|NCT00905606|16748819|P1|Washout|Withdrawal by Subject|1
4858740|NCT00905606|16748818|P2|Period 1|Adverse Event|1
4858741|NCT00905606|16748819|P1|Period 1|Adverse Event|0
4858742|NCT00905567|16748844|P2|Washout|Withdrawal by Subject|1
4858743|NCT00905567|16748845|P1|Washout|Withdrawal by Subject|0
4858744|NCT00905489|16748877|P1|Optional Extension Phase (OEP)|Adverse Event|1
4858745|NCT00905489|16748877|P1|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3
4858746|NCT00905489|16748877|P1|Pharmaco-kinetic (PK) Phase|Protocol Violation|2
4858747|NCT00905437|16748967|P2|Overall Study|Other|6
4858748|NCT00905437|16748968|P1|Overall Study|Other|5
4858749|NCT00905437|16748967|P2|Overall Study|Withdrawal by Subject|1
4858750|NCT00905437|16748968|P1|Overall Study|Withdrawal by Subject|0
4858751|NCT00905437|16748967|P2|Overall Study|Lost to Follow-up|1
4858752|NCT00905437|16748968|P1|Overall Study|Lost to Follow-up|0
4858753|NCT00905437|16748967|P2|Overall Study|Adverse Event|2
4858754|NCT00905437|16748968|P1|Overall Study|Adverse Event|3
4858755|NCT00905424|16748988|P2|Overall Study|Non-adherence to visit schedule|1
4858756|NCT00905424|16748989|P1|Overall Study|Non-adherence to visit schedule|0
4858757|NCT00905424|16748988|P2|Overall Study|Positive urine drug screen|1
4858758|NCT00905424|16748989|P1|Overall Study|Positive urine drug screen|0
4858759|NCT00905424|16748988|P2|Overall Study|Sponsor decision|0
4858760|NCT00905424|16748989|P1|Overall Study|Sponsor decision|1
4858761|NCT00905424|16748988|P2|Overall Study|Non-compliance with study medication|0
4858762|NCT00905424|16748989|P1|Overall Study|Non-compliance with study medication|2
4858763|NCT00905424|16748988|P2|Overall Study|Adverse Event|2
4858764|NCT00905424|16748989|P1|Overall Study|Adverse Event|4
4858765|NCT00905424|16748988|P2|Overall Study|Withdrawal by Subject|2
4858766|NCT00905424|16748989|P1|Overall Study|Withdrawal by Subject|1
4858767|NCT00905424|16748988|P2|Overall Study|Lost to Follow-up|3
4858768|NCT00905424|16748989|P1|Overall Study|Lost to Follow-up|3
4858769|NCT00905359|16749031|P2|Overall Study|Withdrawal consent|6
4858770|NCT00905359|16749032|P1|Overall Study|Withdrawal consent|5
4858771|NCT00905359|16749031|P2|Overall Study|Death|0
4858772|NCT00905359|16749032|P1|Overall Study|Death|2
4858773|NCT00905359|16749031|P2|Overall Study|Lost to Follow-up|10
4858774|NCT00905359|16749032|P1|Overall Study|Lost to Follow-up|17
4858775|NCT00905346|16749068|P2|Period 1|Withdrawal by Subject|0
4858776|NCT00905346|16749069|P1|Period 1|Withdrawal by Subject|1
4858777|NCT00905307|16749083|P6|Overall Study|Lack of Efficacy|8
4858778|NCT00905307|16749084|P5|Overall Study|Lack of Efficacy|4
4858779|NCT00905307|16749085|P4|Overall Study|Lack of Efficacy|4
4858780|NCT00905307|16749086|P3|Overall Study|Lack of Efficacy|5
4858781|NCT00905307|16749087|P2|Overall Study|Lack of Efficacy|3
4858782|NCT00905307|16749088|P1|Overall Study|Lack of Efficacy|6
4858783|NCT00905307|16749083|P6|Overall Study|Protocol Violation|0
4858784|NCT00905307|16749084|P5|Overall Study|Protocol Violation|0
4858785|NCT00905307|16749085|P4|Overall Study|Protocol Violation|0
4858786|NCT00905307|16749086|P3|Overall Study|Protocol Violation|1
4858787|NCT00905307|16749087|P2|Overall Study|Protocol Violation|0
4858788|NCT00905307|16749088|P1|Overall Study|Protocol Violation|1
4858789|NCT00905307|16749083|P6|Overall Study|Withdrawal by Subject|13
4858790|NCT00905307|16749084|P5|Overall Study|Withdrawal by Subject|4
4858791|NCT00905307|16749085|P4|Overall Study|Withdrawal by Subject|11
4858792|NCT00905307|16749086|P3|Overall Study|Withdrawal by Subject|15
4858793|NCT00905307|16749087|P2|Overall Study|Withdrawal by Subject|13
4858794|NCT00905307|16749088|P1|Overall Study|Withdrawal by Subject|5
4858795|NCT00905307|16749083|P6|Overall Study|Adverse Event|5
4858796|NCT00905307|16749084|P5|Overall Study|Adverse Event|3
4858797|NCT00905307|16749085|P4|Overall Study|Adverse Event|11
4858798|NCT00905307|16749086|P3|Overall Study|Adverse Event|5
4858799|NCT00905307|16749087|P2|Overall Study|Adverse Event|4
4858800|NCT00905307|16749088|P1|Overall Study|Adverse Event|3
4858801|NCT00905307|16749083|P6|Overall Study|Lost to Follow-up|1
4858802|NCT00905307|16749084|P5|Overall Study|Lost to Follow-up|1
4858803|NCT00905307|16749085|P4|Overall Study|Lost to Follow-up|0
4858804|NCT00905307|16749086|P3|Overall Study|Lost to Follow-up|0
4858805|NCT00905307|16749087|P2|Overall Study|Lost to Follow-up|0
4858806|NCT00905307|16749088|P1|Overall Study|Lost to Follow-up|0
4858807|NCT00905307|16749083|P6|Overall Study|Switched to Open Label Rescue|15
4858808|NCT00905307|16749084|P5|Overall Study|Switched to Open Label Rescue|4
4858809|NCT00905307|16749085|P4|Overall Study|Switched to Open Label Rescue|11
4858810|NCT00905307|16749086|P3|Overall Study|Switched to Open Label Rescue|11
4858811|NCT00905307|16749087|P2|Overall Study|Switched to Open Label Rescue|17
4858812|NCT00905307|16749088|P1|Overall Study|Switched to Open Label Rescue|7
4858813|NCT00905255|16749183|P2|Overall Study|Familial and Personal Reasons|0
4858814|NCT00905255|16749184|P1|Overall Study|Familial and Personal Reasons|1
4858815|NCT00905255|16749183|P2|Overall Study|Withdrawal by Subject|4
4858816|NCT00905255|16749184|P1|Overall Study|Withdrawal by Subject|5
4858817|NCT00905255|16749183|P2|Overall Study|Adverse Event|5
4858818|NCT00905255|16749184|P1|Overall Study|Adverse Event|7
4858819|NCT00905164|16749202|P2|Period 1|Protocol Violation|1
4858820|NCT00905164|16749203|P1|Period 1|Protocol Violation|0
4858821|NCT00905034|16749250|P1|Overall Study|Withdrawal by Subject|1
4858822|NCT00905021|16749254|P1|Overall Study|Adverse Event|2
4858823|NCT00904982|16749274|P4|Overall Study|Withdrawal by Subject|0
4858824|NCT00904982|16749275|P3|Overall Study|Withdrawal by Subject|0
4858825|NCT00904982|16749276|P2|Overall Study|Withdrawal by Subject|0
4858826|NCT00904982|16749277|P1|Overall Study|Withdrawal by Subject|2
4858827|NCT00904969|16749287|P1|Overall Study|Case Aborted; Subject Exited|1
4858828|NCT00904969|16749287|P1|Overall Study|Additional Treatments|11
4858829|NCT00904969|16749287|P1|Overall Study|Withdrawal by Subject|3
4858830|NCT00904969|16749287|P1|Overall Study|Lost to Follow-up|4
4858831|NCT00904917|16749352|P4|Overall Study|Lost to Follow-up|2
4858832|NCT00904917|16749353|P3|Overall Study|Lost to Follow-up|2
4858833|NCT00904917|16749354|P2|Overall Study|Lost to Follow-up|2
4858834|NCT00904917|16749355|P1|Overall Study|Lost to Follow-up|2
4858835|NCT00904839|16749373|P3|Overall Study|Other than above|7
4858836|NCT00904839|16749374|P2|Overall Study|Other than above|9
4858837|NCT00904839|16749375|P1|Overall Study|Other than above|0
4858838|NCT00904839|16749373|P3|Overall Study|Not treated|1
4858839|NCT00904839|16749374|P2|Overall Study|Not treated|0
4858840|NCT00904839|16749375|P1|Overall Study|Not treated|1
4858841|NCT00904839|16749373|P3|Overall Study|Withdrawal by Subject|0
4858842|NCT00904839|16749374|P2|Overall Study|Withdrawal by Subject|2
4858843|NCT00904839|16749375|P1|Overall Study|Withdrawal by Subject|0
4858844|NCT00904839|16749373|P3|Overall Study|Lost to Follow-up|2
4858845|NCT00904839|16749374|P2|Overall Study|Lost to Follow-up|1
4858846|NCT00904839|16749375|P1|Overall Study|Lost to Follow-up|0
4858847|NCT00904839|16749373|P3|Overall Study|Protocol Violation|1
4858848|NCT00904839|16749374|P2|Overall Study|Protocol Violation|1
4858849|NCT00904839|16749375|P1|Overall Study|Protocol Violation|0
4858850|NCT00904839|16749373|P3|Overall Study|Adverse Event|4
4858851|NCT00904839|16749374|P2|Overall Study|Adverse Event|5
4858852|NCT00904839|16749375|P1|Overall Study|Adverse Event|0
4858853|NCT00904748|16749421|P6|Overall Study|Adverse Event|0
4858854|NCT00904748|16749422|P5|Overall Study|Adverse Event|1
4858855|NCT00904748|16749423|P4|Overall Study|Adverse Event|0
4858856|NCT00904748|16749424|P3|Overall Study|Adverse Event|0
4858857|NCT00904748|16749425|P2|Overall Study|Adverse Event|0
4858858|NCT00904748|16749426|P1|Overall Study|Adverse Event|0
4858859|NCT00904748|16749421|P6|Overall Study|Withdrawal by Subject|0
4858860|NCT00904748|16749422|P5|Overall Study|Withdrawal by Subject|0
4858861|NCT00904748|16749423|P4|Overall Study|Withdrawal by Subject|2
4858862|NCT00904748|16749424|P3|Overall Study|Withdrawal by Subject|1
4858863|NCT00904748|16749425|P2|Overall Study|Withdrawal by Subject|1
4858864|NCT00904748|16749426|P1|Overall Study|Withdrawal by Subject|1
4858865|NCT00904722|16749450|P1|Overall Study|Physician Decision|1
4858866|NCT00904670|16749455|P2|Open Label Phase|Lost to Follow-up|0
4858867|NCT00904670|16749456|P1|Open Label Phase|Lost to Follow-up|1
4858868|NCT00904670|16749455|P2|Open Label Phase|Lack of Efficacy|0
4858869|NCT00904670|16749456|P1|Open Label Phase|Lack of Efficacy|1
4858870|NCT00904670|16749455|P2|Open Label Phase|Adverse Event|0
4858871|NCT00904670|16749456|P1|Open Label Phase|Adverse Event|2
4858872|NCT00904670|16749455|P2|Open Label Phase|Withdrawal by Subject|0
4858873|NCT00904670|16749456|P1|Open Label Phase|Withdrawal by Subject|2
4858874|NCT00904371|16749526|P1|Overall Study|Continued with Tritace|1
4858875|NCT00904371|16749526|P1|Overall Study|Discontinued at target blood pressure|2
4858876|NCT00904371|16749526|P1|Overall Study|Lost to Follow-up|4
4858877|NCT00904371|16749526|P1|Overall Study|Adverse Event|2
4858878|NCT00904215|16749540|P1|Overall Study|Other|28
4858879|NCT00904215|16749540|P1|Overall Study|Withdrawal by Subject|9
4858880|NCT00904215|16749540|P1|Overall Study|Lost to Follow-up|63
4858881|NCT00904215|16749540|P1|Overall Study|Protocol Violation|10
4858882|NCT00904215|16749540|P1|Overall Study|Adverse Event|25
4858883|NCT00904150|16749554|P2|Saliva Samples (DNA)|Australian samples of different genotype|145
4858884|NCT00904150|16749555|P1|Saliva Samples (DNA)|Australian samples of different genotype|0
4858885|NCT00904150|16749554|P2|Saliva Samples (DNA)|saliva samples not suitable for assay|0
4858886|NCT00904150|16749555|P1|Saliva Samples (DNA)|saliva samples not suitable for assay|3
4858887|NCT00904033|16749577|P4|Overall Study|Unable to obtain final blood draw|2
4858888|NCT00904033|16749578|P3|Overall Study|Unable to obtain final blood draw|0
4858889|NCT00904033|16749579|P2|Overall Study|Unable to obtain final blood draw|0
4858890|NCT00904033|16749580|P1|Overall Study|Unable to obtain final blood draw|0
4858891|NCT00904033|16749577|P4|Overall Study|Physician Decision|0
4858892|NCT00904033|16749578|P3|Overall Study|Physician Decision|1
4858893|NCT00904033|16749579|P2|Overall Study|Physician Decision|0
4858894|NCT00904033|16749580|P1|Overall Study|Physician Decision|0
4858895|NCT00904033|16749577|P4|Overall Study|Withdrawal by Subject|0
4858896|NCT00904033|16749578|P3|Overall Study|Withdrawal by Subject|0
4858897|NCT00904033|16749579|P2|Overall Study|Withdrawal by Subject|1
4858898|NCT00904033|16749580|P1|Overall Study|Withdrawal by Subject|1
4858899|NCT00903968|16749645|P8|Overall Study|Lack of Efficacy|3
4858900|NCT00903968|16749646|P7|Overall Study|Lack of Efficacy|0
4858901|NCT00903968|16749647|P6|Overall Study|Lack of Efficacy|0
4858902|NCT00903968|16749648|P5|Overall Study|Lack of Efficacy|0
4858903|NCT00903968|16749649|P4|Overall Study|Lack of Efficacy|0
4858904|NCT00903968|16749650|P3|Overall Study|Lack of Efficacy|0
4858905|NCT00903968|16749651|P2|Overall Study|Lack of Efficacy|0
4858906|NCT00903968|16749652|P1|Overall Study|Lack of Efficacy|0
4858907|NCT00903968|16749645|P8|Overall Study|Progressive Disease|18
4858908|NCT00903968|16749646|P7|Overall Study|Progressive Disease|0
4858909|NCT00903968|16749647|P6|Overall Study|Progressive Disease|3
4858910|NCT00903968|16749648|P5|Overall Study|Progressive Disease|3
4858911|NCT00903968|16749649|P4|Overall Study|Progressive Disease|3
4858912|NCT00903968|16749650|P3|Overall Study|Progressive Disease|2
4858913|NCT00903968|16749651|P2|Overall Study|Progressive Disease|3
4858914|NCT00903968|16749652|P1|Overall Study|Progressive Disease|2
4858915|NCT00903968|16749645|P8|Overall Study|Physician Decision|0
4858916|NCT00903968|16749646|P7|Overall Study|Physician Decision|0
4858917|NCT00903968|16749647|P6|Overall Study|Physician Decision|1
4858918|NCT00903968|16749648|P5|Overall Study|Physician Decision|0
4858919|NCT00903968|16749649|P4|Overall Study|Physician Decision|0
4858920|NCT00903968|16749650|P3|Overall Study|Physician Decision|0
4858921|NCT00903968|16749651|P2|Overall Study|Physician Decision|0
4858922|NCT00903968|16749652|P1|Overall Study|Physician Decision|0
4858923|NCT00903968|16749645|P8|Overall Study|Non-Compliance|0
4858924|NCT00903968|16749646|P7|Overall Study|Non-Compliance|0
4858925|NCT00903968|16749647|P6|Overall Study|Non-Compliance|1
4858926|NCT00903968|16749648|P5|Overall Study|Non-Compliance|0
4858927|NCT00903968|16749649|P4|Overall Study|Non-Compliance|0
4858928|NCT00903968|16749650|P3|Overall Study|Non-Compliance|0
4858929|NCT00903968|16749651|P2|Overall Study|Non-Compliance|0
4858930|NCT00903968|16749652|P1|Overall Study|Non-Compliance|0
4858931|NCT00903968|16749645|P8|Overall Study|Withdrawal by Subject|4
4858932|NCT00903968|16749646|P7|Overall Study|Withdrawal by Subject|0
4858933|NCT00903968|16749647|P6|Overall Study|Withdrawal by Subject|1
4858934|NCT00903968|16749648|P5|Overall Study|Withdrawal by Subject|1
4858935|NCT00903968|16749649|P4|Overall Study|Withdrawal by Subject|0
4858936|NCT00903968|16749650|P3|Overall Study|Withdrawal by Subject|1
4858937|NCT00903968|16749651|P2|Overall Study|Withdrawal by Subject|0
4858938|NCT00903968|16749652|P1|Overall Study|Withdrawal by Subject|1
4858939|NCT00903968|16749645|P8|Overall Study|DLT|0
4858940|NCT00903968|16749646|P7|Overall Study|DLT|2
4858941|NCT00903968|16749647|P6|Overall Study|DLT|0
4858942|NCT00903968|16749648|P5|Overall Study|DLT|0
4858943|NCT00903968|16749649|P4|Overall Study|DLT|0
4858944|NCT00903968|16749650|P3|Overall Study|DLT|0
4858945|NCT00903968|16749651|P2|Overall Study|DLT|0
4858946|NCT00903968|16749652|P1|Overall Study|DLT|0
4858947|NCT00903968|16749645|P8|Overall Study|Adverse Event|8
4858948|NCT00903968|16749646|P7|Overall Study|Adverse Event|1
4858949|NCT00903968|16749647|P6|Overall Study|Adverse Event|0
4858950|NCT00903968|16749648|P5|Overall Study|Adverse Event|0
4858951|NCT00903968|16749649|P4|Overall Study|Adverse Event|0
4858952|NCT00903968|16749650|P3|Overall Study|Adverse Event|0
4858953|NCT00903968|16749651|P2|Overall Study|Adverse Event|0
4858954|NCT00903968|16749652|P1|Overall Study|Adverse Event|0
4858955|NCT00903929|16749682|P4|Overall Study|Adverse Event|1
4858956|NCT00903929|16749683|P3|Overall Study|Adverse Event|0
4858957|NCT00903929|16749684|P2|Overall Study|Adverse Event|0
4858958|NCT00903929|16749685|P1|Overall Study|Adverse Event|0
4858959|NCT00903929|16749682|P4|Overall Study|Withdrawal by Subject|2
4858960|NCT00903929|16749683|P3|Overall Study|Withdrawal by Subject|1
4858961|NCT00903929|16749684|P2|Overall Study|Withdrawal by Subject|0
4858962|NCT00903929|16749685|P1|Overall Study|Withdrawal by Subject|0
4858963|NCT00903877|16749691|P1|Overall Study|Participation put on hold|4
4858964|NCT00903877|16749691|P1|Overall Study|Lost to Follow-up|1
4858965|NCT00903877|16749691|P1|Overall Study|Adverse Event|2
4858966|NCT00903877|16749691|P1|Overall Study|Withdrawal by Subject|3
4858967|NCT00903877|16749691|P1|Overall Study|Did not meet study criteria|33
4858968|NCT00903786|16749695|P1|Overall Study|Reason other than lack of efficacy|4
4858969|NCT00903786|16749695|P1|Overall Study|Lack of Efficacy|5
4858970|NCT00903786|16749695|P1|Overall Study|Physician Decision|6
4858971|NCT00903760|16749705|P2|Overall Study|Off treatment for long period|1
4858972|NCT00903760|16749706|P1|Overall Study|Off treatment for long period|0
4858973|NCT00903760|16749705|P2|Overall Study|Withdrawal by Subject|2
4858974|NCT00903760|16749706|P1|Overall Study|Withdrawal by Subject|1
4858975|NCT00903760|16749705|P2|Overall Study|Lost to Follow-up|0
4858976|NCT00903760|16749706|P1|Overall Study|Lost to Follow-up|1
4858977|NCT00903760|16749705|P2|Overall Study|Death|1
4858978|NCT00903760|16749706|P1|Overall Study|Death|0
4858979|NCT00903760|16749705|P2|Overall Study|Physician Decision|2
4858980|NCT00903760|16749706|P1|Overall Study|Physician Decision|1
4858981|NCT00903760|16749705|P2|Overall Study|Stem Cell Transplant|4
4858982|NCT00903760|16749706|P1|Overall Study|Stem Cell Transplant|8
4858983|NCT00903760|16749705|P2|Overall Study|Disease Progression/Death|6
4858984|NCT00903760|16749706|P1|Overall Study|Disease Progression/Death|8
4858985|NCT00903695|16749716|P2|Overall Study|lung cancer|0
4858986|NCT00903695|16749717|P1|Overall Study|lung cancer|1
4858987|NCT00903695|16749716|P2|Overall Study|medical exclusion after 1st testing|0
4858988|NCT00903695|16749717|P1|Overall Study|medical exclusion after 1st testing|1
4858989|NCT00903682|16749739|P2|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0
4858990|NCT00903682|16749740|P1|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1
4858991|NCT00903682|16749739|P2|Overall Study|Patient Couldn't Come For The Visit Due|0
4858992|NCT00903682|16749740|P1|Overall Study|Patient Couldn't Come For The Visit Due|1
4858993|NCT00903682|16749739|P2|Overall Study|Subject Non-Compliant|0
4858994|NCT00903682|16749740|P1|Overall Study|Subject Non-Compliant|1
4858995|NCT00903682|16749739|P2|Overall Study|Subject Reached A Virologic Endpoint|1
4858996|NCT00903682|16749740|P1|Overall Study|Subject Reached A Virologic Endpoint|1
4858997|NCT00903682|16749739|P2|Overall Study|Pregnancy|1
4858998|NCT00903682|16749740|P1|Overall Study|Pregnancy|0
4858999|NCT00903682|16749739|P2|Overall Study|Withdrawal by Subject|0
4859000|NCT00903682|16749740|P1|Overall Study|Withdrawal by Subject|5
4859001|NCT00903682|16749739|P2|Overall Study|Lost to Follow-up|0
4859002|NCT00903682|16749740|P1|Overall Study|Lost to Follow-up|1
4859003|NCT00903682|16749739|P2|Overall Study|Adverse Event|13
4859004|NCT00903682|16749740|P1|Overall Study|Adverse Event|6
4859005|NCT00903630|16749761|P3|Phase 2|Adverse Event|1
4859006|NCT00903630|16749762|P2|Phase 2|Adverse Event|0
4859007|NCT00903630|16749763|P1|Phase 2|Adverse Event|0
4859008|NCT00903617|16749781|P4|Overall Study|Withdrawal by Subject|0
4859009|NCT00903617|16749782|P3|Overall Study|Withdrawal by Subject|3
4859010|NCT00903617|16749783|P2|Overall Study|Withdrawal by Subject|2
4859011|NCT00903617|16749784|P1|Overall Study|Withdrawal by Subject|1
4859012|NCT00903617|16749781|P4|Overall Study|Lost to Follow-up|1
4859013|NCT00903617|16749782|P3|Overall Study|Lost to Follow-up|1
4859014|NCT00903617|16749783|P2|Overall Study|Lost to Follow-up|0
4859015|NCT00903617|16749784|P1|Overall Study|Lost to Follow-up|2
4859016|NCT00903617|16749781|P4|Overall Study|Protocol-defined stopping criteria|0
4859017|NCT00903617|16749782|P3|Overall Study|Protocol-defined stopping criteria|0
4859018|NCT00903617|16749783|P2|Overall Study|Protocol-defined stopping criteria|2
4859019|NCT00903617|16749784|P1|Overall Study|Protocol-defined stopping criteria|0
4859020|NCT00903617|16749781|P4|Overall Study|Adverse Event|0
4859021|NCT00903617|16749782|P3|Overall Study|Adverse Event|1
4859022|NCT00903617|16749783|P2|Overall Study|Adverse Event|1
4859023|NCT00903617|16749784|P1|Overall Study|Adverse Event|0
4859024|NCT00903409|16749887|P2|Overall Study|Lost to Follow-up|6
4859025|NCT00903409|16749888|P1|Overall Study|Lost to Follow-up|2
4859026|NCT00903409|16749887|P2|Overall Study|Other|3
4859027|NCT00903409|16749888|P1|Overall Study|Other|2
4859028|NCT00903409|16749887|P2|Overall Study|Withdrawal by Subject|8
4859029|NCT00903409|16749888|P1|Overall Study|Withdrawal by Subject|8
4859030|NCT00903409|16749887|P2|Overall Study|Laboratory Abnormality|0
4859031|NCT00903409|16749888|P1|Overall Study|Laboratory Abnormality|2
4859032|NCT00903409|16749887|P2|Overall Study|Non-compliance with Protocol|1
4859033|NCT00903409|16749888|P1|Overall Study|Non-compliance with Protocol|1
4859034|NCT00903409|16749887|P2|Overall Study|Adverse Event|9
4859035|NCT00903409|16749888|P1|Overall Study|Adverse Event|11
4859036|NCT00903383|16749939|P4|Overall Study|Patient Decision|1
4859037|NCT00903383|16749940|P3|Overall Study|Patient Decision|0
4859038|NCT00903383|16749941|P2|Overall Study|Patient Decision|0
4859039|NCT00903383|16749942|P1|Overall Study|Patient Decision|0
4859040|NCT00903383|16749939|P4|Overall Study|Patient Decision - Lack of Efficacy|0
4859041|NCT00903383|16749940|P3|Overall Study|Patient Decision - Lack of Efficacy|0
4859042|NCT00903383|16749941|P2|Overall Study|Patient Decision - Lack of Efficacy|1
4859043|NCT00903383|16749942|P1|Overall Study|Patient Decision - Lack of Efficacy|0
4859044|NCT00903383|16749939|P4|Overall Study|Withdrawal by Subject|2
4859045|NCT00903383|16749940|P3|Overall Study|Withdrawal by Subject|0
4859046|NCT00903383|16749941|P2|Overall Study|Withdrawal by Subject|1
4859047|NCT00903383|16749942|P1|Overall Study|Withdrawal by Subject|4
4859048|NCT00903383|16749939|P4|Overall Study|Decision of Sponsor|0
4859049|NCT00903383|16749940|P3|Overall Study|Decision of Sponsor|0
4859050|NCT00903383|16749941|P2|Overall Study|Decision of Sponsor|0
4859051|NCT00903383|16749942|P1|Overall Study|Decision of Sponsor|1
4859052|NCT00903383|16749939|P4|Overall Study|Lost to Follow-up|1
4859053|NCT00903383|16749940|P3|Overall Study|Lost to Follow-up|0
4859054|NCT00903383|16749941|P2|Overall Study|Lost to Follow-up|0
4859055|NCT00903383|16749942|P1|Overall Study|Lost to Follow-up|0
4859056|NCT00903383|16749939|P4|Overall Study|Physician Decision|0
4859057|NCT00903383|16749940|P3|Overall Study|Physician Decision|0
4859058|NCT00903383|16749941|P2|Overall Study|Physician Decision|2
4859059|NCT00903383|16749942|P1|Overall Study|Physician Decision|1
4859060|NCT00903383|16749939|P4|Overall Study|Adverse Event|1
4859061|NCT00903383|16749940|P3|Overall Study|Adverse Event|3
4859062|NCT00903383|16749941|P2|Overall Study|Adverse Event|2
4859063|NCT00903383|16749942|P1|Overall Study|Adverse Event|1
4859064|NCT00903370|16749974|P2|Overall Study|Lost to Follow-up|8
4859065|NCT00903370|16749975|P1|Overall Study|Lost to Follow-up|6
4859066|NCT00903370|16749974|P2|Overall Study|Withdrawal by Subject|6
4859067|NCT00903370|16749975|P1|Overall Study|Withdrawal by Subject|9
4859068|NCT00903370|16749974|P2|Overall Study|Death|10
4859069|NCT00903370|16749975|P1|Overall Study|Death|13
4859070|NCT00903357|16749983|P2|Second Intervention|Lost to Follow-up|0
4859071|NCT00903357|16749984|P1|Second Intervention|Lost to Follow-up|1
4859072|NCT00903357|16749983|P2|Wash Out Period of 2 Weeks|Flu|1
4859073|NCT00903357|16749984|P1|Wash Out Period of 2 Weeks|Flu|0
4859074|NCT00903357|16749983|P2|First Intervention|Flu|1
4859075|NCT00903357|16749984|P1|First Intervention|Flu|0
4859076|NCT00903357|16749983|P2|First Intervention|Withdrawal by Subject|3
4859077|NCT00903357|16749984|P1|First Intervention|Withdrawal by Subject|5
4859078|NCT00903344|16749996|P2|Overall Study|Lost to Follow-up|0
4859079|NCT00903344|16749997|P1|Overall Study|Lost to Follow-up|3
4859080|NCT00903344|16749996|P2|Overall Study|Pregnancy|3
4859081|NCT00903344|16749997|P1|Overall Study|Pregnancy|2
4859082|NCT00903331|16750015|P2|Overall Study|Lung transplant|2
4859083|NCT00903331|16750016|P1|Overall Study|Lung transplant|0
4859084|NCT00903331|16750015|P2|Overall Study|Withdrawal of consent|8
4859085|NCT00903331|16750016|P1|Overall Study|Withdrawal of consent|1
4859086|NCT00903331|16750015|P2|Overall Study|Death|8
4859087|NCT00903331|16750016|P1|Overall Study|Death|4
4859088|NCT00903201|16750027|P3|Overall Study|Withdrawal by Subject|1
4859089|NCT00903201|16750028|P2|Overall Study|Withdrawal by Subject|0
4859090|NCT00903201|16750029|P1|Overall Study|Withdrawal by Subject|1
4859091|NCT00903201|16750027|P3|Overall Study|Physician Decision|1
4859092|NCT00903201|16750028|P2|Overall Study|Physician Decision|0
4859093|NCT00903201|16750029|P1|Overall Study|Physician Decision|1
4859094|NCT00903201|16750027|P3|Overall Study|Lost to Follow-up|0
4859095|NCT00903201|16750028|P2|Overall Study|Lost to Follow-up|1
4859096|NCT00903201|16750029|P1|Overall Study|Lost to Follow-up|0
4859097|NCT00903201|16750027|P3|Overall Study|Protocol Violation|0
4859098|NCT00903201|16750028|P2|Overall Study|Protocol Violation|1
4859099|NCT00903201|16750029|P1|Overall Study|Protocol Violation|2
4859100|NCT00903201|16750027|P3|Overall Study|Adverse Event|0
4859101|NCT00903201|16750028|P2|Overall Study|Adverse Event|4
4859102|NCT00903201|16750029|P1|Overall Study|Adverse Event|1
4859103|NCT00903175|16750087|P2|Period 2 - Second Line|Death|2
4859104|NCT00903175|16750088|P1|Period 2 - Second Line|Death|5
4859105|NCT00903175|16750087|P2|Period 2 - Second Line|Administrative problems|9
4859106|NCT00903175|16750088|P1|Period 2 - Second Line|Administrative problems|19
4859107|NCT00903175|16750087|P2|Period 2 - Second Line|Lost to Follow-up|0
4859108|NCT00903175|16750088|P1|Period 2 - Second Line|Lost to Follow-up|1
4859109|NCT00903175|16750087|P2|Period 2 - Second Line|Withdrawal by Subject|5
4859110|NCT00903175|16750088|P1|Period 2 - Second Line|Withdrawal by Subject|7
4859111|NCT00903175|16750087|P2|Period 2 - Second Line|Adverse Event|20
4859112|NCT00903175|16750088|P1|Period 2 - Second Line|Adverse Event|16
4859113|NCT00903175|16750087|P2|Period 2 - Second Line|Missing|0
4859114|NCT00903175|16750088|P1|Period 2 - Second Line|Missing|1
4859115|NCT00903175|16750087|P2|Period 1 - First Line|Death|10
4859116|NCT00903175|16750088|P1|Period 1 - First Line|Death|17
4859117|NCT00903175|16750087|P2|Period 1 - First Line|Administrative problems|13
4859118|NCT00903175|16750088|P1|Period 1 - First Line|Administrative problems|12
4859119|NCT00903175|16750087|P2|Period 1 - First Line|Withdrawal by Subject|12
4859120|NCT00903175|16750088|P1|Period 1 - First Line|Withdrawal by Subject|8
4859121|NCT00903175|16750087|P2|Period 1 - First Line|Protocol Violation|3
4859122|NCT00903175|16750088|P1|Period 1 - First Line|Protocol Violation|3
4859123|NCT00903175|16750087|P2|Period 1 - First Line|Abnormal test procedure result(s)|0
4859124|NCT00903175|16750088|P1|Period 1 - First Line|Abnormal test procedure result(s)|1
4859125|NCT00903175|16750087|P2|Period 1 - First Line|Abnormal lab value(s)|1
4859126|NCT00903175|16750088|P1|Period 1 - First Line|Abnormal lab value(s)|0
4859127|NCT00903175|16750087|P2|Period 1 - First Line|Adverse Event|50
4859128|NCT00903175|16750088|P1|Period 1 - First Line|Adverse Event|36
4859129|NCT00903032|16750126|P2|Overall Study|Lost to Follow-up|2
4859130|NCT00903032|16750127|P1|Overall Study|Lost to Follow-up|2
4859131|NCT00903032|16750126|P2|Overall Study|Withdrawal by Subject|3
4859132|NCT00903032|16750127|P1|Overall Study|Withdrawal by Subject|5
4859133|NCT00903006|16750137|P4|Overall Study|Progressive Disease|0
4859134|NCT00903006|16750138|P3|Overall Study|Progressive Disease|1
4859135|NCT00903006|16750139|P2|Overall Study|Progressive Disease|3
4859136|NCT00903006|16750140|P1|Overall Study|Progressive Disease|0
4859137|NCT00903006|16750137|P4|Overall Study|Withdrawal by Subject|0
4859138|NCT00903006|16750138|P3|Overall Study|Withdrawal by Subject|0
4859139|NCT00903006|16750139|P2|Overall Study|Withdrawal by Subject|0
4859140|NCT00903006|16750140|P1|Overall Study|Withdrawal by Subject|2
4859141|NCT00902850|16750152|P2|Overall Study|Physician Decision|2
4859142|NCT00902850|16750153|P1|Overall Study|Physician Decision|2
4859143|NCT00902746|16750159|P1|Overall Study|Physician Decision|2
4859144|NCT00902746|16750159|P1|Overall Study|Lost to Follow-up|3
4859145|NCT00902746|16750159|P1|Overall Study|Adverse Event|8
4859146|NCT00902746|16750159|P1|Overall Study|Withdrawal by Subject|16
4859147|NCT00902746|16750159|P1|Overall Study|Protocol Violation|7
4859148|NCT00902668|16750164|P1|Overall Study|Protocol stopped due to slow accrual.|3
4859149|NCT00902577|16750168|P1|Overall Study|FMISO production failure|2
4859150|NCT00902577|16750168|P1|Overall Study|Withdrawal by Subject|6
4859151|NCT00902564|16750197|P1|Overall Study|Withdrawal by Subject|2
4859152|NCT00902538|16750212|P6|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4859153|NCT00902538|16750213|P5|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4859154|NCT00902538|16750214|P4|4-Randomized Double-blind 2 Treatments|Protocol Violation|3
4859155|NCT00902538|16750215|P3|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4859156|NCT00902538|16750216|P2|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4859157|NCT00902538|16750217|P1|4-Randomized Double-blind 2 Treatments|Protocol Violation|0
4859158|NCT00902538|16750212|P6|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4859159|NCT00902538|16750213|P5|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1
4859160|NCT00902538|16750214|P4|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3
4859161|NCT00902538|16750215|P3|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4859162|NCT00902538|16750216|P2|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4859163|NCT00902538|16750217|P1|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0
4859164|NCT00902538|16750212|P6|4-Randomized Double-blind 2 Treatments|Adverse Event|1
4859165|NCT00902538|16750213|P5|4-Randomized Double-blind 2 Treatments|Adverse Event|1
4859166|NCT00902538|16750214|P4|4-Randomized Double-blind 2 Treatments|Adverse Event|3
4859167|NCT00902538|16750215|P3|4-Randomized Double-blind 2 Treatments|Adverse Event|0
4859168|NCT00902538|16750216|P2|4-Randomized Double-blind 2 Treatments|Adverse Event|0
4859169|NCT00902538|16750217|P1|4-Randomized Double-blind 2 Treatments|Adverse Event|0
4859170|NCT00902538|16750212|P6|3-Single-blind, Single Treatment|Lost to Follow-up|0
4859171|NCT00902538|16750213|P5|3-Single-blind, Single Treatment|Lost to Follow-up|0
4859172|NCT00902538|16750214|P4|3-Single-blind, Single Treatment|Lost to Follow-up|0
4859173|NCT00902538|16750215|P3|3-Single-blind, Single Treatment|Lost to Follow-up|0
4859174|NCT00902538|16750216|P2|3-Single-blind, Single Treatment|Lost to Follow-up|1
4859175|NCT00902538|16750217|P1|3-Single-blind, Single Treatment|Lost to Follow-up|0
4859176|NCT00902538|16750212|P6|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4859177|NCT00902538|16750213|P5|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4859178|NCT00902538|16750214|P4|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4859179|NCT00902538|16750215|P3|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4859180|NCT00902538|16750216|P2|3-Single-blind, Single Treatment|Withdrawal by Subject|4
4859181|NCT00902538|16750217|P1|3-Single-blind, Single Treatment|Withdrawal by Subject|0
4859182|NCT00902538|16750212|P6|3-Single-blind, Single Treatment|Protocol Violation|0
4859183|NCT00902538|16750213|P5|3-Single-blind, Single Treatment|Protocol Violation|0
4859184|NCT00902538|16750214|P4|3-Single-blind, Single Treatment|Protocol Violation|0
4859185|NCT00902538|16750215|P3|3-Single-blind, Single Treatment|Protocol Violation|0
4859186|NCT00902538|16750216|P2|3-Single-blind, Single Treatment|Protocol Violation|5
4859187|NCT00902538|16750217|P1|3-Single-blind, Single Treatment|Protocol Violation|0
4859188|NCT00902538|16750212|P6|3-Single-blind, Single Treatment|Adverse Event|0
4859189|NCT00902538|16750213|P5|3-Single-blind, Single Treatment|Adverse Event|0
4859190|NCT00902538|16750214|P4|3-Single-blind, Single Treatment|Adverse Event|0
4859191|NCT00902538|16750215|P3|3-Single-blind, Single Treatment|Adverse Event|0
4859192|NCT00902538|16750216|P2|3-Single-blind, Single Treatment|Adverse Event|5
4859193|NCT00902538|16750217|P1|3-Single-blind, Single Treatment|Adverse Event|0
4859194|NCT00902538|16750212|P6|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
4859195|NCT00902538|16750213|P5|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
4859196|NCT00902538|16750214|P4|2-Randomized Double-blind 3 Treatments|Protocol Violation|0
4859197|NCT00902538|16750215|P3|2-Randomized Double-blind 3 Treatments|Protocol Violation|2
4859198|NCT00902538|16750216|P2|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
4859199|NCT00902538|16750217|P1|2-Randomized Double-blind 3 Treatments|Protocol Violation|1
4859200|NCT00902538|16750212|P6|2-Randomized Double-blind 3 Treatments|Other|0
4859201|NCT00902538|16750213|P5|2-Randomized Double-blind 3 Treatments|Other|0
4859202|NCT00902538|16750214|P4|2-Randomized Double-blind 3 Treatments|Other|0
4859203|NCT00902538|16750215|P3|2-Randomized Double-blind 3 Treatments|Other|0
4859204|NCT00902538|16750216|P2|2-Randomized Double-blind 3 Treatments|Other|1
4859205|NCT00902538|16750217|P1|2-Randomized Double-blind 3 Treatments|Other|2
4859206|NCT00902538|16750212|P6|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4859207|NCT00902538|16750213|P5|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4859208|NCT00902538|16750214|P4|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4859209|NCT00902538|16750215|P3|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2
4859210|NCT00902538|16750216|P2|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0
4859211|NCT00902538|16750217|P1|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1
4859212|NCT00902538|16750212|P6|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
4859213|NCT00902538|16750213|P5|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
4859214|NCT00902538|16750214|P4|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0
4859215|NCT00902538|16750215|P3|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
4859216|NCT00902538|16750216|P2|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2
4859217|NCT00902538|16750217|P1|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1
4859218|NCT00902538|16750212|P6|2-Randomized Double-blind 3 Treatments|Adverse Event|0
4859219|NCT00902538|16750213|P5|2-Randomized Double-blind 3 Treatments|Adverse Event|0
4859220|NCT00902538|16750214|P4|2-Randomized Double-blind 3 Treatments|Adverse Event|0
4859221|NCT00902538|16750215|P3|2-Randomized Double-blind 3 Treatments|Adverse Event|3
4859222|NCT00902538|16750216|P2|2-Randomized Double-blind 3 Treatments|Adverse Event|2
4859223|NCT00902538|16750217|P1|2-Randomized Double-blind 3 Treatments|Adverse Event|4
4859224|NCT00902538|16750212|P6|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4859225|NCT00902538|16750213|P5|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4859226|NCT00902538|16750214|P4|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4859227|NCT00902538|16750215|P3|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4859228|NCT00902538|16750216|P2|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0
4859229|NCT00902538|16750217|P1|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4
4859230|NCT00902538|16750212|P6|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4859231|NCT00902538|16750213|P5|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4859232|NCT00902538|16750214|P4|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4859233|NCT00902538|16750215|P3|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4859234|NCT00902538|16750216|P2|1-Single-blind, Run-in, Single-Treatment|Other Reason|0
4859235|NCT00902538|16750217|P1|1-Single-blind, Run-in, Single-Treatment|Other Reason|13
4859236|NCT00902538|16750212|P6|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4859237|NCT00902538|16750213|P5|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4859238|NCT00902538|16750214|P4|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4859239|NCT00902538|16750215|P3|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4859240|NCT00902538|16750216|P2|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0
4859241|NCT00902538|16750217|P1|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22
4859242|NCT00902538|16750212|P6|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4859243|NCT00902538|16750213|P5|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4859244|NCT00902538|16750214|P4|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4859245|NCT00902538|16750215|P3|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4859246|NCT00902538|16750216|P2|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0
4859247|NCT00902538|16750217|P1|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30
4859248|NCT00902538|16750212|P6|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4859249|NCT00902538|16750213|P5|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4859250|NCT00902538|16750214|P4|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4859251|NCT00902538|16750215|P3|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4859252|NCT00902538|16750216|P2|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0
4859253|NCT00902538|16750217|P1|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49
4859254|NCT00902486|16750251|P6|Follow-up (After Week 24)|Lost to Follow-up|0
4859255|NCT00902486|16750252|P5|Follow-up (After Week 24)|Lost to Follow-up|0
4859256|NCT00902486|16750253|P4|Follow-up (After Week 24)|Lost to Follow-up|1
4859257|NCT00902486|16750254|P3|Follow-up (After Week 24)|Lost to Follow-up|0
4859258|NCT00902486|16750255|P2|Follow-up (After Week 24)|Lost to Follow-up|0
4859259|NCT00902486|16750256|P1|Follow-up (After Week 24)|Lost to Follow-up|0
4859260|NCT00902486|16750251|P6|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4859261|NCT00902486|16750252|P5|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4859262|NCT00902486|16750253|P4|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4859263|NCT00902486|16750254|P3|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1
4859264|NCT00902486|16750255|P2|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4859265|NCT00902486|16750256|P1|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0
4859266|NCT00902486|16750251|P6|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4859267|NCT00902486|16750252|P5|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4859268|NCT00902486|16750253|P4|Extension Period (Weeks 12 Through 24)|Disease Progression|1
4859269|NCT00902486|16750254|P3|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4859270|NCT00902486|16750255|P2|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4859271|NCT00902486|16750256|P1|Extension Period (Weeks 12 Through 24)|Disease Progression|0
4859272|NCT00902486|16750251|P6|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1
4859273|NCT00902486|16750252|P5|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4859274|NCT00902486|16750253|P4|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4859275|NCT00902486|16750254|P3|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4859276|NCT00902486|16750255|P2|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4859277|NCT00902486|16750256|P1|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0
4859278|NCT00902486|16750251|P6|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4859279|NCT00902486|16750252|P5|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4859280|NCT00902486|16750253|P4|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
4859281|NCT00902486|16750254|P3|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1
4859282|NCT00902486|16750255|P2|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4859283|NCT00902486|16750256|P1|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0
4859284|NCT00902486|16750251|P6|Extension Period (Weeks 12 Through 24)|Adverse Event|2
4859285|NCT00902486|16750252|P5|Extension Period (Weeks 12 Through 24)|Adverse Event|1
4859286|NCT00902486|16750253|P4|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4859287|NCT00902486|16750254|P3|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4859288|NCT00902486|16750255|P2|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4859289|NCT00902486|16750256|P1|Extension Period (Weeks 12 Through 24)|Adverse Event|0
4859290|NCT00902486|16750251|P6|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4859291|NCT00902486|16750252|P5|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4859292|NCT00902486|16750253|P4|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1
4859293|NCT00902486|16750254|P3|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4859294|NCT00902486|16750255|P2|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4859295|NCT00902486|16750256|P1|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0
4859296|NCT00902486|16750251|P6|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4859297|NCT00902486|16750252|P5|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4859298|NCT00902486|16750253|P4|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1
4859299|NCT00902486|16750254|P3|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4859300|NCT00902486|16750255|P2|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4859301|NCT00902486|16750256|P1|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0
4859302|NCT00902486|16750251|P6|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
4859303|NCT00902486|16750252|P5|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1
4859304|NCT00902486|16750253|P4|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4859305|NCT00902486|16750254|P3|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4859306|NCT00902486|16750255|P2|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4859307|NCT00902486|16750256|P1|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0
4859308|NCT00902486|16750251|P6|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2
4859309|NCT00902486|16750252|P5|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4859310|NCT00902486|16750253|P4|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4859311|NCT00902486|16750254|P3|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4859312|NCT00902486|16750255|P2|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0
4859313|NCT00902486|16750256|P1|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1
4859314|NCT00902486|16750251|P6|Treatment Period (Weeks 0 Through 12)|Adverse Event|2
4859315|NCT00902486|16750252|P5|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
4859316|NCT00902486|16750253|P4|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
4859317|NCT00902486|16750254|P3|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
4859318|NCT00902486|16750255|P2|Treatment Period (Weeks 0 Through 12)|Adverse Event|0
4859319|NCT00902486|16750256|P1|Treatment Period (Weeks 0 Through 12)|Adverse Event|1
4859320|NCT00902330|16750394|P2|Overall Study|No post baseline data|0
4859321|NCT00902330|16750395|P1|Overall Study|No post baseline data|1
4859322|NCT00902330|16750394|P2|Overall Study|Adverse Event|0
4859323|NCT00902330|16750395|P1|Overall Study|Adverse Event|1
4859324|NCT00902330|16750394|P2|Overall Study|Too overwhelmed by treatment|5
4859325|NCT00902330|16750395|P1|Overall Study|Too overwhelmed by treatment|2
4859326|NCT00902304|16750432|P3|Overall Study|includes pregnancy|2
4859327|NCT00902304|16750433|P2|Overall Study|includes pregnancy|9
4859328|NCT00902304|16750434|P1|Overall Study|includes pregnancy|3
4859329|NCT00902304|16750432|P3|Overall Study|Withdrawal by Subject|43
4859330|NCT00902304|16750433|P2|Overall Study|Withdrawal by Subject|22
4859331|NCT00902304|16750434|P1|Overall Study|Withdrawal by Subject|32
4859332|NCT00902304|16750432|P3|Overall Study|Protocol Violation|20
4859333|NCT00902304|16750433|P2|Overall Study|Protocol Violation|18
4859334|NCT00902304|16750434|P1|Overall Study|Protocol Violation|9
4859335|NCT00902304|16750432|P3|Overall Study|Lost to Follow-up|7
4859336|NCT00902304|16750433|P2|Overall Study|Lost to Follow-up|7
4859337|NCT00902304|16750434|P1|Overall Study|Lost to Follow-up|7
4859338|NCT00902304|16750432|P3|Overall Study|Investigator discretion|13
4859339|NCT00902304|16750433|P2|Overall Study|Investigator discretion|5
4859340|NCT00902304|16750434|P1|Overall Study|Investigator discretion|3
4859341|NCT00902304|16750432|P3|Overall Study|Adverse Event|25
4859342|NCT00902304|16750433|P2|Overall Study|Adverse Event|10
4859343|NCT00902304|16750434|P1|Overall Study|Adverse Event|4
4859344|NCT00902278|16750484|P5|Overall Study|Lost to Follow-up|1
4859345|NCT00902278|16750485|P4|Overall Study|Lost to Follow-up|0
4859346|NCT00902278|16750486|P3|Overall Study|Lost to Follow-up|3
4859347|NCT00902278|16750487|P2|Overall Study|Lost to Follow-up|2
4859348|NCT00902278|16750488|P1|Overall Study|Lost to Follow-up|3
4859349|NCT00902278|16750484|P5|Overall Study|Physician Decision|1
4859350|NCT00902278|16750485|P4|Overall Study|Physician Decision|0
4859351|NCT00902278|16750486|P3|Overall Study|Physician Decision|2
4859352|NCT00902278|16750487|P2|Overall Study|Physician Decision|0
4859353|NCT00902278|16750488|P1|Overall Study|Physician Decision|1
4859354|NCT00902265|16750505|P1|Overall Study|Protocol Violation|1
4859355|NCT00902265|16750505|P1|Overall Study|Lack of Efficacy|2
4859356|NCT00902265|16750505|P1|Overall Study|Adverse Event|2
4859357|NCT00902265|16750505|P1|Overall Study|Lost to Follow-up Prior to First Visit|1
4859358|NCT00902174|16750529|P2|Overall Study|Administration problem|1
4859359|NCT00902174|16750530|P1|Overall Study|Administration problem|0
4859360|NCT00902174|16750529|P2|Overall Study|Protocol Violation|1
4859361|NCT00902174|16750530|P1|Overall Study|Protocol Violation|1
4859362|NCT00902174|16750529|P2|Overall Study|Abnormal labs|1
4859363|NCT00902174|16750530|P1|Overall Study|Abnormal labs|1
4859364|NCT00902174|16750529|P2|Overall Study|Withdrawal by Subject|1
4859365|NCT00902174|16750530|P1|Overall Study|Withdrawal by Subject|2
4859366|NCT00902174|16750529|P2|Overall Study|Death|2
4859367|NCT00902174|16750530|P1|Overall Study|Death|2
4859368|NCT00902174|16750529|P2|Overall Study|Lack of Efficacy|5
4859369|NCT00902174|16750530|P1|Overall Study|Lack of Efficacy|1
4859370|NCT00902174|16750529|P2|Overall Study|Adverse Event|7
4859371|NCT00902174|16750530|P1|Overall Study|Adverse Event|27
4859372|NCT00901927|16750605|P1|Overall Study|Withdrawal by Subject|2
4859373|NCT00901927|16750605|P1|Overall Study|Protocol Violation|3
4859374|NCT00901927|16750605|P1|Overall Study|Lack of Efficacy|1
4859375|NCT00901901|16750613|P2|Follow-up Period|Missing|80
4859376|NCT00901901|16750614|P1|Follow-up Period|Missing|94
4859377|NCT00901901|16750613|P2|Follow-up Period|Lost to Follow-up|8
4859378|NCT00901901|16750614|P1|Follow-up Period|Lost to Follow-up|12
4859379|NCT00901901|16750613|P2|Follow-up Period|Withdrawal by Subject|9
4859380|NCT00901901|16750614|P1|Follow-up Period|Withdrawal by Subject|6
4859381|NCT00901901|16750613|P2|Follow-up Period|Protocol driven decision point|36
4859382|NCT00901901|16750614|P1|Follow-up Period|Protocol driven decision point|47
4859383|NCT00901901|16750613|P2|Follow-up Period|Death|208
4859384|NCT00901901|16750614|P1|Follow-up Period|Death|181
4859385|NCT00901901|16750613|P2|Treatment Period|Transfer to treatment continuation study|2
4859386|NCT00901901|16750614|P1|Treatment Period|Transfer to treatment continuation study|5
4859387|NCT00901901|16750613|P2|Treatment Period|Switch to commercial drug|1
4859388|NCT00901901|16750614|P1|Treatment Period|Switch to commercial drug|1
4859389|NCT00901901|16750613|P2|Treatment Period|Protocol Violation|9
4859390|NCT00901901|16750614|P1|Treatment Period|Protocol Violation|5
4859391|NCT00901901|16750613|P2|Treatment Period|Study terminated by sponsor|0
4859392|NCT00901901|16750614|P1|Treatment Period|Study terminated by sponsor|2
4859393|NCT00901901|16750613|P2|Treatment Period|Protocol driven decision point|2
4859394|NCT00901901|16750614|P1|Treatment Period|Protocol driven decision point|0
4859395|NCT00901901|16750613|P2|Treatment Period|Never treated|3
4859396|NCT00901901|16750614|P1|Treatment Period|Never treated|0
4859397|NCT00901901|16750613|P2|Treatment Period|Missing|0
4859398|NCT00901901|16750614|P1|Treatment Period|Missing|1
4859399|NCT00901901|16750613|P2|Treatment Period|Noncompliance with study medication|1
4859400|NCT00901901|16750614|P1|Treatment Period|Noncompliance with study medication|4
4859401|NCT00901901|16750613|P2|Treatment Period|Lost to Follow-up|5
4859402|NCT00901901|16750614|P1|Treatment Period|Lost to Follow-up|3
4859403|NCT00901901|16750613|P2|Treatment Period|Physician Decision|2
4859404|NCT00901901|16750614|P1|Treatment Period|Physician Decision|2
4859405|NCT00901901|16750613|P2|Treatment Period|Withdrawal by Subject|24
4859406|NCT00901901|16750614|P1|Treatment Period|Withdrawal by Subject|26
4859407|NCT00901901|16750613|P2|Treatment Period|Adverse Event|128
4859408|NCT00901901|16750614|P1|Treatment Period|Adverse Event|120
4859409|NCT00901628|16750636|P2|Overall Study|peroneal nerve palsy|1
4859410|NCT00901628|16750637|P1|Overall Study|peroneal nerve palsy|0
4859411|NCT00901628|16750636|P2|Overall Study|disconnection of drain|1
4859412|NCT00901628|16750637|P1|Overall Study|disconnection of drain|0
4859413|NCT00901628|16750636|P2|Overall Study|disconnection of catheter|8
4859414|NCT00901628|16750637|P1|Overall Study|disconnection of catheter|4
4859415|NCT00901576|16750659|P6|Second Intervention|Physician Decision|0
4859416|NCT00901576|16750660|P5|Second Intervention|Physician Decision|0
4859417|NCT00901576|16750661|P4|Second Intervention|Physician Decision|0
4859418|NCT00901576|16750662|P3|Second Intervention|Physician Decision|0
4859419|NCT00901576|16750663|P2|Second Intervention|Physician Decision|0
4859420|NCT00901576|16750664|P1|Second Intervention|Physician Decision|1
4859421|NCT00901576|16750659|P6|Second Intervention|Withdrawal by Subject|1
4859422|NCT00901576|16750660|P5|Second Intervention|Withdrawal by Subject|0
4859423|NCT00901576|16750661|P4|Second Intervention|Withdrawal by Subject|1
4859424|NCT00901576|16750662|P3|Second Intervention|Withdrawal by Subject|0
4859425|NCT00901576|16750663|P2|Second Intervention|Withdrawal by Subject|0
4859426|NCT00901576|16750664|P1|Second Intervention|Withdrawal by Subject|0
4859427|NCT00901459|16750685|P1|Overall Study|Withdrawal by Subject|6
4859428|NCT00901394|16750699|P3|Overall Study|Physician Decision|2
4859429|NCT00901394|16750700|P2|Overall Study|Physician Decision|1
4859430|NCT00901394|16750701|P1|Overall Study|Physician Decision|1
4859431|NCT00901342|16750709|P1|Overall Study|Withdrawal by Subject|9
4859432|NCT00901342|16750709|P1|Overall Study|Disease progression|1
4859433|NCT00901342|16750709|P1|Overall Study|Death|4
4859434|NCT00901342|16750709|P1|Overall Study|Adverse Event|1
4859435|NCT00901186|16750742|P2|Overall Study|Protocol deviations|4
4859436|NCT00901186|16750743|P1|Overall Study|Protocol deviations|5
4859437|NCT00901186|16750742|P2|Overall Study|Administration problems|1
4859438|NCT00901186|16750743|P1|Overall Study|Administration problems|0
4859439|NCT00901186|16750742|P2|Overall Study|Adverse Event|4
4859440|NCT00901186|16750743|P1|Overall Study|Adverse Event|2
4859441|NCT00901186|16750742|P2|Overall Study|Lost to Follow-up|0
4859442|NCT00901186|16750743|P1|Overall Study|Lost to Follow-up|2
4859443|NCT00901186|16750742|P2|Overall Study|Abnormal laboratory values|1
4859444|NCT00901186|16750743|P1|Overall Study|Abnormal laboratory values|0
4859445|NCT00901186|16750742|P2|Overall Study|Lack of Efficacy|1
4859446|NCT00901186|16750743|P1|Overall Study|Lack of Efficacy|0
4859447|NCT00900796|16750783|P1|Phase 2|Lost to Follow-up|5
4859448|NCT00900796|16750783|P1|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110
4859449|NCT00900796|16750783|P1|Phase 1|Missing information at Week 16|7
4859450|NCT00900796|16750783|P1|Phase 1|Lacked sufficient information|4
4859451|NCT00900757|16750793|P1|Overall Study|screen failure|19
4859452|NCT00900731|16750803|P2|Overall Study|Death|2
4859453|NCT00900731|16750804|P1|Overall Study|Death|0
4859454|NCT00900731|16750803|P2|Overall Study|Lack of Efficacy|3
4859455|NCT00900731|16750804|P1|Overall Study|Lack of Efficacy|1
4859456|NCT00900731|16750803|P2|Overall Study|Lost to Follow-up|3
4859457|NCT00900731|16750804|P1|Overall Study|Lost to Follow-up|2
4859458|NCT00900731|16750803|P2|Overall Study|Abnormal Laboratory Value(s)|4
4859459|NCT00900731|16750804|P1|Overall Study|Abnormal Laboratory Value(s)|2
4859460|NCT00900731|16750803|P2|Overall Study|Abnormal Test Procedure Result(s)|0
4859461|NCT00900731|16750804|P1|Overall Study|Abnormal Test Procedure Result(s)|3
4859462|NCT00900731|16750803|P2|Overall Study|Administrative Problems|4
4859463|NCT00900731|16750804|P1|Overall Study|Administrative Problems|5
4859464|NCT00900731|16750803|P2|Overall Study|Protocol Deviation|11
4859465|NCT00900731|16750804|P1|Overall Study|Protocol Deviation|8
4859466|NCT00900731|16750803|P2|Overall Study|Withdrawal by Subject|7
4859467|NCT00900731|16750804|P1|Overall Study|Withdrawal by Subject|8
4859468|NCT00900731|16750803|P2|Overall Study|Adverse Event|27
4859469|NCT00900731|16750804|P1|Overall Study|Adverse Event|31
4859470|NCT00900627|16750841|P6|Overall Study|Death|24
4859471|NCT00900627|16750842|P5|Overall Study|Death|28
4859472|NCT00900627|16750843|P4|Overall Study|Death|0
4859473|NCT00900627|16750844|P3|Overall Study|Death|0
4859474|NCT00900627|16750845|P2|Overall Study|Death|0
4859475|NCT00900627|16750846|P1|Overall Study|Death|0
4859476|NCT00900627|16750841|P6|Overall Study|Adverse Event|0
4859477|NCT00900627|16750842|P5|Overall Study|Adverse Event|0
4859478|NCT00900627|16750843|P4|Overall Study|Adverse Event|3
4859479|NCT00900627|16750844|P3|Overall Study|Adverse Event|0
4859480|NCT00900627|16750845|P2|Overall Study|Adverse Event|2
4859481|NCT00900627|16750846|P1|Overall Study|Adverse Event|1
4859482|NCT00900627|16750841|P6|Overall Study|Withdrawal by Subject|2
4859483|NCT00900627|16750842|P5|Overall Study|Withdrawal by Subject|1
4859484|NCT00900627|16750843|P4|Overall Study|Withdrawal by Subject|0
4859485|NCT00900627|16750844|P3|Overall Study|Withdrawal by Subject|1
4859486|NCT00900627|16750845|P2|Overall Study|Withdrawal by Subject|0
4859487|NCT00900627|16750846|P1|Overall Study|Withdrawal by Subject|1
4859488|NCT00900627|16750841|P6|Overall Study|Condition under investigation worsened|0
4859489|NCT00900627|16750842|P5|Overall Study|Condition under investigation worsened|0
4859490|NCT00900627|16750843|P4|Overall Study|Condition under investigation worsened|3
4859491|NCT00900627|16750844|P3|Overall Study|Condition under investigation worsened|5
4859492|NCT00900627|16750845|P2|Overall Study|Condition under investigation worsened|0
4859493|NCT00900627|16750846|P1|Overall Study|Condition under investigation worsened|4
4859494|NCT00900601|16750864|P1|Overall Study|Physician Decision|1
4859495|NCT00900159|16750883|P2|Second Intervention|disempanelled for inappropriate behavior|0
4859496|NCT00900159|16750884|P1|Second Intervention|disempanelled for inappropriate behavior|1
4859497|NCT00900146|16750903|P5|Intermediate: Period III|Administrative problems|163
4859498|NCT00900146|16750904|P4|Intermediate: Period III|Administrative problems|90
4859499|NCT00900146|16750905|P3|Intermediate: Period III|Administrative problems|84
4859500|NCT00900146|16750906|P2|Intermediate: Period III|Administrative problems|92
4859501|NCT00900146|16750907|P1|Intermediate: Period III|Administrative problems|85
4859502|NCT00900146|16750903|P5|Intermediate: Period III|Lost to Follow-up|1
4859503|NCT00900146|16750904|P4|Intermediate: Period III|Lost to Follow-up|0
4859504|NCT00900146|16750905|P3|Intermediate: Period III|Lost to Follow-up|0
4859505|NCT00900146|16750906|P2|Intermediate: Period III|Lost to Follow-up|0
4859506|NCT00900146|16750907|P1|Intermediate: Period III|Lost to Follow-up|2
4859507|NCT00900146|16750903|P5|Intermediate: Period III|Withdrawal by Subject|3
4859508|NCT00900146|16750904|P4|Intermediate: Period III|Withdrawal by Subject|0
4859509|NCT00900146|16750905|P3|Intermediate: Period III|Withdrawal by Subject|0
4859510|NCT00900146|16750906|P2|Intermediate: Period III|Withdrawal by Subject|1
4859511|NCT00900146|16750907|P1|Intermediate: Period III|Withdrawal by Subject|0
4859512|NCT00900146|16750903|P5|Dose Finding: Period II (4 Months)|Administrative problems|0
4859513|NCT00900146|16750904|P4|Dose Finding: Period II (4 Months)|Administrative problems|0
4859514|NCT00900146|16750905|P3|Dose Finding: Period II (4 Months)|Administrative problems|0
4859515|NCT00900146|16750906|P2|Dose Finding: Period II (4 Months)|Administrative problems|0
4859516|NCT00900146|16750907|P1|Dose Finding: Period II (4 Months)|Administrative problems|1
4859517|NCT00900146|16750903|P5|Dose Finding: Period II (4 Months)|Lost to Follow-up|3
4859518|NCT00900146|16750904|P4|Dose Finding: Period II (4 Months)|Lost to Follow-up|1
4859519|NCT00900146|16750905|P3|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
4859520|NCT00900146|16750906|P2|Dose Finding: Period II (4 Months)|Lost to Follow-up|0
4859521|NCT00900146|16750907|P1|Dose Finding: Period II (4 Months)|Lost to Follow-up|2
4859522|NCT00900146|16750903|P5|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9
4859523|NCT00900146|16750904|P4|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1
4859524|NCT00900146|16750905|P3|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5
4859525|NCT00900146|16750906|P2|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
4859526|NCT00900146|16750907|P1|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2
4859527|NCT00900029|16751024|P5|Overall Study|Death|0
4859528|NCT00900029|16751025|P4|Overall Study|Death|1
4859529|NCT00900029|16751026|P3|Overall Study|Death|0
4859530|NCT00900029|16751027|P2|Overall Study|Death|0
4859531|NCT00900029|16751028|P1|Overall Study|Death|1
4859532|NCT00900029|16751024|P5|Overall Study|Adverse Event|1
4859533|NCT00900029|16751025|P4|Overall Study|Adverse Event|1
4859534|NCT00900029|16751026|P3|Overall Study|Adverse Event|1
4859535|NCT00900029|16751027|P2|Overall Study|Adverse Event|0
4859536|NCT00900029|16751028|P1|Overall Study|Adverse Event|0
4859537|NCT00900029|16751024|P5|Overall Study|Withdrawal by Subject|1
4859538|NCT00900029|16751025|P4|Overall Study|Withdrawal by Subject|1
4859539|NCT00900029|16751026|P3|Overall Study|Withdrawal by Subject|1
4859540|NCT00900029|16751027|P2|Overall Study|Withdrawal by Subject|2
4859541|NCT00900029|16751028|P1|Overall Study|Withdrawal by Subject|2
4859542|NCT00900029|16751024|P5|Overall Study|Lost to Follow-up|4
4859543|NCT00900029|16751025|P4|Overall Study|Lost to Follow-up|4
4859544|NCT00900029|16751026|P3|Overall Study|Lost to Follow-up|1
4859545|NCT00900029|16751027|P2|Overall Study|Lost to Follow-up|2
4859546|NCT00900029|16751028|P1|Overall Study|Lost to Follow-up|0
4859547|NCT00899847|16751045|P1|Overall Study|Lack of suitable allogeneic donor|2
4859548|NCT00899678|16751076|P3|Maintenance Period (Weeks 8 to 62)|Other reason|2
4859549|NCT00899678|16751077|P2|Maintenance Period (Weeks 8 to 62)|Other reason|2
4859550|NCT00899678|16751078|P1|Maintenance Period (Weeks 8 to 62)|Other reason|0
4859551|NCT00899678|16751076|P3|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2
4859552|NCT00899678|16751077|P2|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1
4859553|NCT00899678|16751078|P1|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0
4859554|NCT00899678|16751076|P3|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
4859555|NCT00899678|16751077|P2|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1
4859556|NCT00899678|16751078|P1|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0
4859557|NCT00899678|16751076|P3|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18
4859558|NCT00899678|16751077|P2|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11
4859559|NCT00899678|16751078|P1|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0
4859560|NCT00899678|16751076|P3|Maintenance Period (Weeks 8 to 62)|Adverse Event|5
4859561|NCT00899678|16751077|P2|Maintenance Period (Weeks 8 to 62)|Adverse Event|10
4859562|NCT00899678|16751078|P1|Maintenance Period (Weeks 8 to 62)|Adverse Event|0
4859563|NCT00899678|16751076|P3|Induction Period (Weeks 0 to 6)|Other reason|0
4859564|NCT00899678|16751077|P2|Induction Period (Weeks 0 to 6)|Other reason|0
4859565|NCT00899678|16751078|P1|Induction Period (Weeks 0 to 6)|Other reason|1
4859566|NCT00899678|16751076|P3|Induction Period (Weeks 0 to 6)|Protocol Violation|0
4859567|NCT00899678|16751077|P2|Induction Period (Weeks 0 to 6)|Protocol Violation|0
4859568|NCT00899678|16751078|P1|Induction Period (Weeks 0 to 6)|Protocol Violation|1
4859569|NCT00899678|16751076|P3|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
4859570|NCT00899678|16751077|P2|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0
4859571|NCT00899678|16751078|P1|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17
4859572|NCT00899678|16751076|P3|Induction Period (Weeks 0 to 6)|Adverse Event|0
4859573|NCT00899678|16751077|P2|Induction Period (Weeks 0 to 6)|Adverse Event|0
4859574|NCT00899678|16751078|P1|Induction Period (Weeks 0 to 6)|Adverse Event|6
4859575|NCT00899548|16751128|P1|Overall Study|Physician Decision|3
4859576|NCT00899431|16751222|P3|Overall Study|Physician Decision|0
4859577|NCT00899431|16751223|P2|Overall Study|Physician Decision|0
4859578|NCT00899431|16751224|P1|Overall Study|Physician Decision|1
4859579|NCT00899392|16751237|P2|Overall Study|Subject didn't finish/partial pilot data|24
4859580|NCT00899392|16751238|P1|Overall Study|Subject didn't finish/partial pilot data|21
4859581|NCT00899379|16751255|P5|Overall Study|Inc/Exc Criteria Not Met|0
4859582|NCT00899379|16751256|P4|Overall Study|Inc/Exc Criteria Not Met|0
4859583|NCT00899379|16751257|P3|Overall Study|Inc/Exc Criteria Not Met|1
4859584|NCT00899379|16751258|P2|Overall Study|Inc/Exc Criteria Not Met|0
4859585|NCT00899379|16751259|P1|Overall Study|Inc/Exc Criteria Not Met|0
4859586|NCT00899379|16751255|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
4859587|NCT00899379|16751256|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
4859588|NCT00899379|16751257|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
4859589|NCT00899379|16751258|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
4859590|NCT00899379|16751259|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
4859591|NCT00899379|16751255|P5|Overall Study|No Attack Pretreatment|4
4859592|NCT00899379|16751256|P4|Overall Study|No Attack Pretreatment|6
4859593|NCT00899379|16751257|P3|Overall Study|No Attack Pretreatment|5
4859594|NCT00899379|16751258|P2|Overall Study|No Attack Pretreatment|5
4859595|NCT00899379|16751259|P1|Overall Study|No Attack Pretreatment|3
4859596|NCT00899379|16751255|P5|Overall Study|Abnormal Baseline ECG|0
4859597|NCT00899379|16751256|P4|Overall Study|Abnormal Baseline ECG|1
4859598|NCT00899379|16751257|P3|Overall Study|Abnormal Baseline ECG|1
4859599|NCT00899379|16751258|P2|Overall Study|Abnormal Baseline ECG|0
4859600|NCT00899379|16751259|P1|Overall Study|Abnormal Baseline ECG|0
4859601|NCT00899379|16751255|P5|Overall Study|Abnormal Prestudy Labs|2
4859602|NCT00899379|16751256|P4|Overall Study|Abnormal Prestudy Labs|0
4859603|NCT00899379|16751257|P3|Overall Study|Abnormal Prestudy Labs|0
4859604|NCT00899379|16751258|P2|Overall Study|Abnormal Prestudy Labs|0
4859605|NCT00899379|16751259|P1|Overall Study|Abnormal Prestudy Labs|0
4859606|NCT00899379|16751255|P5|Overall Study|Patient Uncooperative|0
4859607|NCT00899379|16751256|P4|Overall Study|Patient Uncooperative|1
4859608|NCT00899379|16751257|P3|Overall Study|Patient Uncooperative|0
4859609|NCT00899379|16751258|P2|Overall Study|Patient Uncooperative|0
4859610|NCT00899379|16751259|P1|Overall Study|Patient Uncooperative|0
4859611|NCT00899379|16751255|P5|Overall Study|Pregnancy|0
4859612|NCT00899379|16751256|P4|Overall Study|Pregnancy|0
4859613|NCT00899379|16751257|P3|Overall Study|Pregnancy|0
4859614|NCT00899379|16751258|P2|Overall Study|Pregnancy|0
4859615|NCT00899379|16751259|P1|Overall Study|Pregnancy|1
4859616|NCT00899379|16751255|P5|Overall Study|Withdrawal by Subject|2
4859617|NCT00899379|16751256|P4|Overall Study|Withdrawal by Subject|7
4859618|NCT00899379|16751257|P3|Overall Study|Withdrawal by Subject|4
4859619|NCT00899379|16751258|P2|Overall Study|Withdrawal by Subject|7
4859620|NCT00899379|16751259|P1|Overall Study|Withdrawal by Subject|4
4859621|NCT00899379|16751255|P5|Overall Study|Lost to Follow-up|5
4859622|NCT00899379|16751256|P4|Overall Study|Lost to Follow-up|2
4859623|NCT00899379|16751257|P3|Overall Study|Lost to Follow-up|0
4859624|NCT00899379|16751258|P2|Overall Study|Lost to Follow-up|1
4859625|NCT00899379|16751259|P1|Overall Study|Lost to Follow-up|3
4859626|NCT00899379|16751255|P5|Overall Study|Study Terminated|1
4859627|NCT00899379|16751256|P4|Overall Study|Study Terminated|3
4859628|NCT00899379|16751257|P3|Overall Study|Study Terminated|3
4859629|NCT00899379|16751258|P2|Overall Study|Study Terminated|0
4859630|NCT00899379|16751259|P1|Overall Study|Study Terminated|3
4859631|NCT00899379|16751255|P5|Overall Study|Not Completed/Entered Extn|3
4859632|NCT00899379|16751256|P4|Overall Study|Not Completed/Entered Extn|4
4859633|NCT00899379|16751257|P3|Overall Study|Not Completed/Entered Extn|6
4859634|NCT00899379|16751258|P2|Overall Study|Not Completed/Entered Extn|1
4859635|NCT00899379|16751259|P1|Overall Study|Not Completed/Entered Extn|5
4859636|NCT00899379|16751255|P5|Overall Study|No Longer Met Inc/Exc Criteria|0
4859637|NCT00899379|16751256|P4|Overall Study|No Longer Met Inc/Exc Criteria|0
4859638|NCT00899379|16751257|P3|Overall Study|No Longer Met Inc/Exc Criteria|1
4859639|NCT00899379|16751258|P2|Overall Study|No Longer Met Inc/Exc Criteria|1
4859640|NCT00899379|16751259|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
4859641|NCT00899379|16751255|P5|Overall Study|Abnormal Baseline ECG|0
4859642|NCT00899379|16751256|P4|Overall Study|Abnormal Baseline ECG|1
4859643|NCT00899379|16751257|P3|Overall Study|Abnormal Baseline ECG|0
4859644|NCT00899379|16751258|P2|Overall Study|Abnormal Baseline ECG|0
4859645|NCT00899379|16751259|P1|Overall Study|Abnormal Baseline ECG|0
4859646|NCT00899379|16751255|P5|Overall Study|Patient Uncooperative|2
4859647|NCT00899379|16751256|P4|Overall Study|Patient Uncooperative|1
4859648|NCT00899379|16751257|P3|Overall Study|Patient Uncooperative|0
4859649|NCT00899379|16751258|P2|Overall Study|Patient Uncooperative|1
4859650|NCT00899379|16751259|P1|Overall Study|Patient Uncooperative|0
4859651|NCT00899379|16751255|P5|Overall Study|Pregnancy|1
4859652|NCT00899379|16751256|P4|Overall Study|Pregnancy|0
4859653|NCT00899379|16751257|P3|Overall Study|Pregnancy|1
4859654|NCT00899379|16751258|P2|Overall Study|Pregnancy|0
4859655|NCT00899379|16751259|P1|Overall Study|Pregnancy|0
4859656|NCT00899379|16751255|P5|Overall Study|Withdrawal by Subject|6
4859657|NCT00899379|16751256|P4|Overall Study|Withdrawal by Subject|3
4859658|NCT00899379|16751257|P3|Overall Study|Withdrawal by Subject|2
4859659|NCT00899379|16751258|P2|Overall Study|Withdrawal by Subject|4
4859660|NCT00899379|16751259|P1|Overall Study|Withdrawal by Subject|2
4859661|NCT00899379|16751255|P5|Overall Study|Protocol Violation|0
4859662|NCT00899379|16751256|P4|Overall Study|Protocol Violation|1
4859663|NCT00899379|16751257|P3|Overall Study|Protocol Violation|1
4859664|NCT00899379|16751258|P2|Overall Study|Protocol Violation|0
4859665|NCT00899379|16751259|P1|Overall Study|Protocol Violation|0
4859666|NCT00899379|16751255|P5|Overall Study|Lost to Follow-up|2
4859667|NCT00899379|16751256|P4|Overall Study|Lost to Follow-up|6
4859668|NCT00899379|16751257|P3|Overall Study|Lost to Follow-up|0
4859669|NCT00899379|16751258|P2|Overall Study|Lost to Follow-up|3
4859670|NCT00899379|16751259|P1|Overall Study|Lost to Follow-up|9
4859671|NCT00899379|16751255|P5|Overall Study|Lack of Efficacy|1
4859672|NCT00899379|16751256|P4|Overall Study|Lack of Efficacy|0
4859673|NCT00899379|16751257|P3|Overall Study|Lack of Efficacy|3
4859674|NCT00899379|16751258|P2|Overall Study|Lack of Efficacy|4
4859675|NCT00899379|16751259|P1|Overall Study|Lack of Efficacy|0
4859676|NCT00899379|16751255|P5|Overall Study|Adverse Event|2
4859677|NCT00899379|16751256|P4|Overall Study|Adverse Event|1
4859678|NCT00899379|16751257|P3|Overall Study|Adverse Event|1
4859679|NCT00899379|16751258|P2|Overall Study|Adverse Event|2
4859680|NCT00899379|16751259|P1|Overall Study|Adverse Event|2
4859681|NCT00899353|16751271|P1|Overall Study|Withdrawal by Subject|2
4859682|NCT00899353|16751271|P1|Overall Study|Lost to Follow-up|1
4859683|NCT00899353|16751271|P1|Overall Study|Adverse Event|2
4859684|NCT00898807|16751307|P2|Overall Study|Death|1
4859685|NCT00898807|16751308|P1|Overall Study|Death|0
4859686|NCT00898807|16751307|P2|Overall Study|Lost to Follow-up|3
4859687|NCT00898807|16751308|P1|Overall Study|Lost to Follow-up|1
4859688|NCT00898807|16751307|P2|Overall Study|Family pressure to discontinue|2
4859689|NCT00898807|16751308|P1|Overall Study|Family pressure to discontinue|2
4859690|NCT00898807|16751307|P2|Overall Study|Withdrawal by Subject|3
4859691|NCT00898807|16751308|P1|Overall Study|Withdrawal by Subject|5
4859692|NCT00898677|16751324|P4|Overall Study|Not Treated: Other (Not Specified)|0
4859693|NCT00898677|16751325|P3|Overall Study|Not Treated: Other (Not Specified)|2
4859694|NCT00898677|16751326|P2|Overall Study|Not Treated: Other (Not Specified)|0
4859695|NCT00898677|16751327|P1|Overall Study|Not Treated: Other (Not Specified)|0
4859696|NCT00898677|16751324|P4|Overall Study|Not Treated: Lack of Migraine Attack|12
4859697|NCT00898677|16751325|P3|Overall Study|Not Treated: Lack of Migraine Attack|43
4859698|NCT00898677|16751326|P2|Overall Study|Not Treated: Lack of Migraine Attack|39
4859699|NCT00898677|16751327|P1|Overall Study|Not Treated: Lack of Migraine Attack|9
4859700|NCT00898677|16751324|P4|Overall Study|Not Treated: No Longer Met Inc Criteria|0
4859701|NCT00898677|16751325|P3|Overall Study|Not Treated: No Longer Met Inc Criteria|1
4859702|NCT00898677|16751326|P2|Overall Study|Not Treated: No Longer Met Inc Criteria|3
4859703|NCT00898677|16751327|P1|Overall Study|Not Treated: No Longer Met Inc Criteria|0
4859704|NCT00898677|16751324|P4|Overall Study|Not Treated: Abnormal Baseline ECG|0
4859705|NCT00898677|16751325|P3|Overall Study|Not Treated: Abnormal Baseline ECG|0
4859706|NCT00898677|16751326|P2|Overall Study|Not Treated: Abnormal Baseline ECG|0
4859707|NCT00898677|16751327|P1|Overall Study|Not Treated: Abnormal Baseline ECG|1
4859708|NCT00898677|16751324|P4|Overall Study|Not Treated: Abnormal Prestudy Labs|1
4859709|NCT00898677|16751325|P3|Overall Study|Not Treated: Abnormal Prestudy Labs|0
4859710|NCT00898677|16751326|P2|Overall Study|Not Treated: Abnormal Prestudy Labs|0
4859711|NCT00898677|16751327|P1|Overall Study|Not Treated: Abnormal Prestudy Labs|0
4859712|NCT00898677|16751324|P4|Overall Study|Not Treated: Patient uncooperative|0
4859713|NCT00898677|16751325|P3|Overall Study|Not Treated: Patient uncooperative|1
4859714|NCT00898677|16751326|P2|Overall Study|Not Treated: Patient uncooperative|3
4859715|NCT00898677|16751327|P1|Overall Study|Not Treated: Patient uncooperative|2
4859716|NCT00898677|16751324|P4|Overall Study|Not Treated: Withdraw by Subject|3
4859717|NCT00898677|16751325|P3|Overall Study|Not Treated: Withdraw by Subject|11
4859718|NCT00898677|16751326|P2|Overall Study|Not Treated: Withdraw by Subject|16
4859719|NCT00898677|16751327|P1|Overall Study|Not Treated: Withdraw by Subject|2
4859720|NCT00898677|16751324|P4|Overall Study|Not Treated: Protocol Violation|0
4859721|NCT00898677|16751325|P3|Overall Study|Not Treated: Protocol Violation|2
4859722|NCT00898677|16751326|P2|Overall Study|Not Treated: Protocol Violation|0
4859723|NCT00898677|16751327|P1|Overall Study|Not Treated: Protocol Violation|2
4859724|NCT00898677|16751324|P4|Overall Study|Not Treated: Pregnancy|0
4859725|NCT00898677|16751325|P3|Overall Study|Not Treated: Pregnancy|1
4859726|NCT00898677|16751326|P2|Overall Study|Not Treated: Pregnancy|0
4859727|NCT00898677|16751327|P1|Overall Study|Not Treated: Pregnancy|0
4859728|NCT00898677|16751324|P4|Overall Study|Not Treated: Lost to Follow-Up|2
4859729|NCT00898677|16751325|P3|Overall Study|Not Treated: Lost to Follow-Up|5
4859730|NCT00898677|16751326|P2|Overall Study|Not Treated: Lost to Follow-Up|5
4859731|NCT00898677|16751327|P1|Overall Study|Not Treated: Lost to Follow-Up|0
4859732|NCT00898677|16751324|P4|Overall Study|Not Treated: Adverse Event|0
4859733|NCT00898677|16751325|P3|Overall Study|Not Treated: Adverse Event|1
4859734|NCT00898677|16751326|P2|Overall Study|Not Treated: Adverse Event|2
4859735|NCT00898677|16751327|P1|Overall Study|Not Treated: Adverse Event|0
4859736|NCT00898677|16751324|P4|Overall Study|Withdrawal by Subject|1
4859737|NCT00898677|16751325|P3|Overall Study|Withdrawal by Subject|0
4859738|NCT00898677|16751326|P2|Overall Study|Withdrawal by Subject|0
4859739|NCT00898677|16751327|P1|Overall Study|Withdrawal by Subject|0
4859740|NCT00898677|16751324|P4|Overall Study|Protocol Violation|0
4859741|NCT00898677|16751325|P3|Overall Study|Protocol Violation|2
4859742|NCT00898677|16751326|P2|Overall Study|Protocol Violation|1
4859743|NCT00898677|16751327|P1|Overall Study|Protocol Violation|1
4859744|NCT00898677|16751324|P4|Overall Study|Lost to Follow-up|0
4859745|NCT00898677|16751325|P3|Overall Study|Lost to Follow-up|2
4859746|NCT00898677|16751326|P2|Overall Study|Lost to Follow-up|0
4859747|NCT00898677|16751327|P1|Overall Study|Lost to Follow-up|0
4859748|NCT00898677|16751324|P4|Overall Study|Adverse Event|0
4859749|NCT00898677|16751325|P3|Overall Study|Adverse Event|1
4859750|NCT00898677|16751326|P2|Overall Study|Adverse Event|0
4859751|NCT00898677|16751327|P1|Overall Study|Adverse Event|0
4859752|NCT00898443|16751365|P2|Overall Study|Withdrawal by Subject|0
4859753|NCT00898443|16751366|P1|Overall Study|Withdrawal by Subject|1
4859754|NCT00897949|16751381|P3|Overall Study|Did not take study drug|4
4859755|NCT00897949|16751382|P2|Overall Study|Did not take study drug|3
4859756|NCT00897949|16751383|P1|Overall Study|Did not take study drug|9
4859757|NCT00897949|16751381|P3|Overall Study|Lack of Migraine Attack|19
4859758|NCT00897949|16751382|P2|Overall Study|Lack of Migraine Attack|30
4859759|NCT00897949|16751383|P1|Overall Study|Lack of Migraine Attack|29
4859760|NCT00897949|16751381|P3|Overall Study|Need for Concom. Med.|1
4859761|NCT00897949|16751382|P2|Overall Study|Need for Concom. Med.|1
4859762|NCT00897949|16751383|P1|Overall Study|Need for Concom. Med.|0
4859763|NCT00897949|16751381|P3|Overall Study|Abnormal Baseline ECG|4
4859764|NCT00897949|16751382|P2|Overall Study|Abnormal Baseline ECG|2
4859765|NCT00897949|16751383|P1|Overall Study|Abnormal Baseline ECG|2
4859766|NCT00897949|16751381|P3|Overall Study|Abnormal Prestudy Labs|4
4859767|NCT00897949|16751382|P2|Overall Study|Abnormal Prestudy Labs|3
4859768|NCT00897949|16751383|P1|Overall Study|Abnormal Prestudy Labs|2
4859769|NCT00897949|16751381|P3|Overall Study|Withdrawal by Subject|17
4859770|NCT00897949|16751382|P2|Overall Study|Withdrawal by Subject|31
4859771|NCT00897949|16751383|P1|Overall Study|Withdrawal by Subject|24
4859772|NCT00897949|16751381|P3|Overall Study|Lost to Follow-up|17
4859773|NCT00897949|16751382|P2|Overall Study|Lost to Follow-up|23
4859774|NCT00897949|16751383|P1|Overall Study|Lost to Follow-up|30
4859775|NCT00897949|16751381|P3|Overall Study|Patient Uncoorperative|1
4859776|NCT00897949|16751382|P2|Overall Study|Patient Uncoorperative|2
4859777|NCT00897949|16751383|P1|Overall Study|Patient Uncoorperative|0
4859778|NCT00897949|16751381|P3|Overall Study|Withdrawal by Subject|0
4859779|NCT00897949|16751382|P2|Overall Study|Withdrawal by Subject|2
4859780|NCT00897949|16751383|P1|Overall Study|Withdrawal by Subject|1
4859781|NCT00897949|16751381|P3|Overall Study|Protocol Violation|1
4859782|NCT00897949|16751382|P2|Overall Study|Protocol Violation|3
4859783|NCT00897949|16751383|P1|Overall Study|Protocol Violation|6
4859784|NCT00897949|16751381|P3|Overall Study|Lost to Follow-up|1
4859785|NCT00897949|16751382|P2|Overall Study|Lost to Follow-up|2
4859786|NCT00897949|16751383|P1|Overall Study|Lost to Follow-up|0
4859787|NCT00897949|16751381|P3|Overall Study|Adverse Event|0
4859788|NCT00897949|16751382|P2|Overall Study|Adverse Event|1
4859789|NCT00897949|16751383|P1|Overall Study|Adverse Event|1
4859790|NCT00897715|16751417|P2|Overall Study|increased risk of infection|0
4859791|NCT00897715|16751418|P1|Overall Study|increased risk of infection|1
4859792|NCT00897715|16751417|P2|Overall Study|Physician Decision|0
4859793|NCT00897715|16751418|P1|Overall Study|Physician Decision|1
4859794|NCT00897715|16751417|P2|Overall Study|Lost to Follow-up|1
4859795|NCT00897715|16751418|P1|Overall Study|Lost to Follow-up|0
4859796|NCT00897390|16751443|P1|Overall Study|Did not Return for the Clinic Visit|2
4859797|NCT00897390|16751443|P1|Overall Study|Personal Reasons|1
4859798|NCT00897390|16751443|P1|Overall Study|No Longer Met Study Criteria|1
4859799|NCT00897390|16751443|P1|Overall Study|Adverse Event|2
4859800|NCT00897104|16751533|P3|Overall Study|Withdrawal by Subject|1
4859801|NCT00897104|16751534|P2|Overall Study|Withdrawal by Subject|0
4859802|NCT00897104|16751535|P1|Overall Study|Withdrawal by Subject|0
4859803|NCT00897104|16751533|P3|Overall Study|Protocol Violation|0
4859804|NCT00897104|16751534|P2|Overall Study|Protocol Violation|0
4859805|NCT00897104|16751535|P1|Overall Study|Protocol Violation|1
4859806|NCT00897104|16751533|P3|Overall Study|Other|0
4859807|NCT00897104|16751534|P2|Overall Study|Other|0
4859808|NCT00897104|16751535|P1|Overall Study|Other|3
4859809|NCT00897104|16751533|P3|Overall Study|No Longer Met Inc/Exc Criteria|0
4859810|NCT00897104|16751534|P2|Overall Study|No Longer Met Inc/Exc Criteria|0
4859811|NCT00897104|16751535|P1|Overall Study|No Longer Met Inc/Exc Criteria|1
4859812|NCT00897104|16751533|P3|Overall Study|Lack of Migraine Attack|1
4859813|NCT00897104|16751534|P2|Overall Study|Lack of Migraine Attack|22
4859814|NCT00897104|16751535|P1|Overall Study|Lack of Migraine Attack|20
4859815|NCT00897104|16751533|P3|Overall Study|Need for Concom. Med.|1
4859816|NCT00897104|16751534|P2|Overall Study|Need for Concom. Med.|1
4859817|NCT00897104|16751535|P1|Overall Study|Need for Concom. Med.|0
4859818|NCT00897104|16751533|P3|Overall Study|Abnormal Baseline ECG|0
4859819|NCT00897104|16751534|P2|Overall Study|Abnormal Baseline ECG|2
4859820|NCT00897104|16751535|P1|Overall Study|Abnormal Baseline ECG|2
4859821|NCT00897104|16751533|P3|Overall Study|Abnormal Prestudy Labs|0
4859822|NCT00897104|16751534|P2|Overall Study|Abnormal Prestudy Labs|0
4859823|NCT00897104|16751535|P1|Overall Study|Abnormal Prestudy Labs|2
4859824|NCT00897104|16751533|P3|Overall Study|Withdrawal by Subject|3
4859825|NCT00897104|16751534|P2|Overall Study|Withdrawal by Subject|27
4859826|NCT00897104|16751535|P1|Overall Study|Withdrawal by Subject|23
4859827|NCT00897104|16751533|P3|Overall Study|Protocol Violation|0
4859828|NCT00897104|16751534|P2|Overall Study|Protocol Violation|1
4859829|NCT00897104|16751535|P1|Overall Study|Protocol Violation|0
4859830|NCT00897104|16751533|P3|Overall Study|Pregnancy|0
4859831|NCT00897104|16751534|P2|Overall Study|Pregnancy|1
4859832|NCT00897104|16751535|P1|Overall Study|Pregnancy|0
4859833|NCT00897104|16751533|P3|Overall Study|Lost to Follow-up|2
4859834|NCT00897104|16751534|P2|Overall Study|Lost to Follow-up|17
4859835|NCT00897104|16751535|P1|Overall Study|Lost to Follow-up|12
4859836|NCT00896649|16751570|P1|Overall Study|technical difficulties|2
4859837|NCT00896649|16751570|P1|Overall Study|missing documentation|1
4859838|NCT00896649|16751570|P1|Overall Study|Pregnancy|1
4859839|NCT00896649|16751570|P1|Overall Study|Physician Decision|1
4859840|NCT00896532|16751583|P23|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859841|NCT00896532|16751584|P22|Months 48-72: Follow-on Phase|Withdrawal by Subject|1
4859842|NCT00896532|16751585|P21|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859843|NCT00896532|16751586|P20|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859844|NCT00896532|16751587|P19|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859845|NCT00896532|16751588|P18|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859846|NCT00896532|16751589|P17|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859847|NCT00896532|16751590|P16|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859848|NCT00896532|16751591|P15|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859849|NCT00896532|16751592|P14|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859850|NCT00896532|16751593|P13|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859851|NCT00896532|16751594|P12|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859852|NCT00896532|16751595|P11|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859853|NCT00896532|16751596|P10|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859854|NCT00896532|16751597|P9|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859855|NCT00896532|16751598|P8|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859856|NCT00896532|16751599|P7|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859857|NCT00896532|16751600|P6|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859858|NCT00896532|16751601|P5|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859859|NCT00896532|16751602|P4|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859860|NCT00896532|16751603|P3|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859861|NCT00896532|16751604|P2|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859862|NCT00896532|16751605|P1|Months 48-72: Follow-on Phase|Withdrawal by Subject|0
4859863|NCT00896532|16751583|P23|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859864|NCT00896532|16751584|P22|Months 48-72: Follow-on Phase|Ineligibility Determined|1
4859865|NCT00896532|16751585|P21|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859866|NCT00896532|16751586|P20|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859867|NCT00896532|16751587|P19|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859868|NCT00896532|16751588|P18|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859869|NCT00896532|16751589|P17|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859870|NCT00896532|16751590|P16|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859871|NCT00896532|16751591|P15|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859872|NCT00896532|16751592|P14|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859873|NCT00896532|16751593|P13|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859874|NCT00896532|16751594|P12|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859875|NCT00896532|16751595|P11|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859876|NCT00896532|16751596|P10|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859877|NCT00896532|16751597|P9|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859878|NCT00896532|16751598|P8|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859879|NCT00896532|16751599|P7|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859880|NCT00896532|16751600|P6|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859881|NCT00896532|16751601|P5|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859882|NCT00896532|16751602|P4|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859883|NCT00896532|16751603|P3|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859884|NCT00896532|16751604|P2|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859885|NCT00896532|16751605|P1|Months 48-72: Follow-on Phase|Ineligibility Determined|0
4859886|NCT00896532|16751583|P23|Months 48-72: Follow-on Phase|Death|0
4859887|NCT00896532|16751584|P22|Months 48-72: Follow-on Phase|Death|0
4859888|NCT00896532|16751585|P21|Months 48-72: Follow-on Phase|Death|0
4859889|NCT00896532|16751586|P20|Months 48-72: Follow-on Phase|Death|0
4859890|NCT00896532|16751587|P19|Months 48-72: Follow-on Phase|Death|1
4859891|NCT00896532|16751588|P18|Months 48-72: Follow-on Phase|Death|0
4859892|NCT00896532|16751589|P17|Months 48-72: Follow-on Phase|Death|0
4859893|NCT00896532|16751590|P16|Months 48-72: Follow-on Phase|Death|0
4859894|NCT00896532|16751591|P15|Months 48-72: Follow-on Phase|Death|0
4859895|NCT00896532|16751592|P14|Months 48-72: Follow-on Phase|Death|0
4859896|NCT00896532|16751593|P13|Months 48-72: Follow-on Phase|Death|0
4859897|NCT00896532|16751594|P12|Months 48-72: Follow-on Phase|Death|0
4859898|NCT00896532|16751595|P11|Months 48-72: Follow-on Phase|Death|0
4859899|NCT00896532|16751596|P10|Months 48-72: Follow-on Phase|Death|0
4859900|NCT00896532|16751597|P9|Months 48-72: Follow-on Phase|Death|0
4859901|NCT00896532|16751598|P8|Months 48-72: Follow-on Phase|Death|0
4859902|NCT00896532|16751599|P7|Months 48-72: Follow-on Phase|Death|0
4859903|NCT00896532|16751600|P6|Months 48-72: Follow-on Phase|Death|0
4859904|NCT00896532|16751601|P5|Months 48-72: Follow-on Phase|Death|0
4859905|NCT00896532|16751602|P4|Months 48-72: Follow-on Phase|Death|0
4859906|NCT00896532|16751603|P3|Months 48-72: Follow-on Phase|Death|0
4859907|NCT00896532|16751604|P2|Months 48-72: Follow-on Phase|Death|0
4859908|NCT00896532|16751605|P1|Months 48-72: Follow-on Phase|Death|0
4859909|NCT00896532|16751583|P23|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859910|NCT00896532|16751584|P22|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859911|NCT00896532|16751585|P21|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859912|NCT00896532|16751586|P20|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859913|NCT00896532|16751587|P19|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859914|NCT00896532|16751588|P18|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859915|NCT00896532|16751589|P17|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1
4859916|NCT00896532|16751590|P16|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859917|NCT00896532|16751591|P15|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859918|NCT00896532|16751592|P14|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859919|NCT00896532|16751593|P13|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859920|NCT00896532|16751594|P12|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859921|NCT00896532|16751595|P11|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859922|NCT00896532|16751596|P10|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859923|NCT00896532|16751597|P9|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859924|NCT00896532|16751598|P8|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859925|NCT00896532|16751599|P7|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859926|NCT00896532|16751600|P6|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859927|NCT00896532|16751601|P5|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859928|NCT00896532|16751602|P4|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859929|NCT00896532|16751603|P3|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859930|NCT00896532|16751604|P2|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859931|NCT00896532|16751605|P1|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0
4859932|NCT00896532|16751583|P23|Months 36-48: Romosozumab Retreatment|Other|0
4859933|NCT00896532|16751584|P22|Months 36-48: Romosozumab Retreatment|Other|0
4859934|NCT00896532|16751585|P21|Months 36-48: Romosozumab Retreatment|Other|0
4859935|NCT00896532|16751586|P20|Months 36-48: Romosozumab Retreatment|Other|0
4859936|NCT00896532|16751587|P19|Months 36-48: Romosozumab Retreatment|Other|0
4859937|NCT00896532|16751588|P18|Months 36-48: Romosozumab Retreatment|Other|1
4859938|NCT00896532|16751589|P17|Months 36-48: Romosozumab Retreatment|Other|0
4859939|NCT00896532|16751590|P16|Months 36-48: Romosozumab Retreatment|Other|0
4859940|NCT00896532|16751591|P15|Months 36-48: Romosozumab Retreatment|Other|0
4859941|NCT00896532|16751592|P14|Months 36-48: Romosozumab Retreatment|Other|0
4859942|NCT00896532|16751593|P13|Months 36-48: Romosozumab Retreatment|Other|0
4859943|NCT00896532|16751594|P12|Months 36-48: Romosozumab Retreatment|Other|0
4859944|NCT00896532|16751595|P11|Months 36-48: Romosozumab Retreatment|Other|0
4859945|NCT00896532|16751596|P10|Months 36-48: Romosozumab Retreatment|Other|0
4859946|NCT00896532|16751597|P9|Months 36-48: Romosozumab Retreatment|Other|0
4859947|NCT00896532|16751598|P8|Months 36-48: Romosozumab Retreatment|Other|0
4859948|NCT00896532|16751599|P7|Months 36-48: Romosozumab Retreatment|Other|0
4859949|NCT00896532|16751600|P6|Months 36-48: Romosozumab Retreatment|Other|0
4859950|NCT00896532|16751601|P5|Months 36-48: Romosozumab Retreatment|Other|0
4859951|NCT00896532|16751602|P4|Months 36-48: Romosozumab Retreatment|Other|0
4859952|NCT00896532|16751603|P3|Months 36-48: Romosozumab Retreatment|Other|0
4859953|NCT00896532|16751604|P2|Months 36-48: Romosozumab Retreatment|Other|0
4859954|NCT00896532|16751605|P1|Months 36-48: Romosozumab Retreatment|Other|0
4859955|NCT00896532|16751583|P23|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859956|NCT00896532|16751584|P22|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859957|NCT00896532|16751585|P21|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859958|NCT00896532|16751586|P20|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859959|NCT00896532|16751587|P19|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859960|NCT00896532|16751588|P18|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859961|NCT00896532|16751589|P17|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1
4859962|NCT00896532|16751590|P16|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859963|NCT00896532|16751591|P15|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859964|NCT00896532|16751592|P14|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859965|NCT00896532|16751593|P13|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859966|NCT00896532|16751594|P12|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859967|NCT00896532|16751595|P11|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859968|NCT00896532|16751596|P10|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859969|NCT00896532|16751597|P9|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859970|NCT00896532|16751598|P8|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859971|NCT00896532|16751599|P7|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859972|NCT00896532|16751600|P6|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859973|NCT00896532|16751601|P5|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859974|NCT00896532|16751602|P4|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859975|NCT00896532|16751603|P3|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859976|NCT00896532|16751604|P2|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859977|NCT00896532|16751605|P1|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0
4859978|NCT00896532|16751583|P23|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859979|NCT00896532|16751584|P22|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859980|NCT00896532|16751585|P21|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859981|NCT00896532|16751586|P20|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859982|NCT00896532|16751587|P19|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859983|NCT00896532|16751588|P18|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
4859984|NCT00896532|16751589|P17|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2
4859985|NCT00896532|16751590|P16|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1
4859986|NCT00896532|16751591|P15|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859987|NCT00896532|16751592|P14|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859988|NCT00896532|16751593|P13|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859989|NCT00896532|16751594|P12|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859990|NCT00896532|16751595|P11|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859991|NCT00896532|16751596|P10|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859992|NCT00896532|16751597|P9|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859993|NCT00896532|16751598|P8|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859994|NCT00896532|16751599|P7|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859995|NCT00896532|16751600|P6|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859996|NCT00896532|16751601|P5|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859997|NCT00896532|16751602|P4|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859998|NCT00896532|16751603|P3|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4859999|NCT00896532|16751604|P2|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4860000|NCT00896532|16751605|P1|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0
4860001|NCT00896532|16751583|P23|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860002|NCT00896532|16751584|P22|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860003|NCT00896532|16751585|P21|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860004|NCT00896532|16751586|P20|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860005|NCT00896532|16751587|P19|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860006|NCT00896532|16751588|P18|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860007|NCT00896532|16751589|P17|Months 36-48: Romosozumab Retreatment|Adverse Event|3
4860008|NCT00896532|16751590|P16|Months 36-48: Romosozumab Retreatment|Adverse Event|1
4860009|NCT00896532|16751591|P15|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860010|NCT00896532|16751592|P14|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860011|NCT00896532|16751593|P13|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860012|NCT00896532|16751594|P12|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860013|NCT00896532|16751595|P11|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860014|NCT00896532|16751596|P10|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860015|NCT00896532|16751597|P9|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860016|NCT00896532|16751598|P8|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860017|NCT00896532|16751599|P7|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860018|NCT00896532|16751600|P6|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860019|NCT00896532|16751601|P5|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860020|NCT00896532|16751602|P4|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860021|NCT00896532|16751603|P3|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860022|NCT00896532|16751604|P2|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860023|NCT00896532|16751605|P1|Months 36-48: Romosozumab Retreatment|Adverse Event|0
4860024|NCT00896532|16751583|P23|Months 24-36: Denosumab Extension Phase|Other|0
4860025|NCT00896532|16751584|P22|Months 24-36: Denosumab Extension Phase|Other|0
4860026|NCT00896532|16751585|P21|Months 24-36: Denosumab Extension Phase|Other|0
4860027|NCT00896532|16751586|P20|Months 24-36: Denosumab Extension Phase|Other|0
4860028|NCT00896532|16751587|P19|Months 24-36: Denosumab Extension Phase|Other|0
4860029|NCT00896532|16751588|P18|Months 24-36: Denosumab Extension Phase|Other|0
4860030|NCT00896532|16751589|P17|Months 24-36: Denosumab Extension Phase|Other|0
4860031|NCT00896532|16751590|P16|Months 24-36: Denosumab Extension Phase|Other|0
4860032|NCT00896532|16751591|P15|Months 24-36: Denosumab Extension Phase|Other|0
4860033|NCT00896532|16751592|P14|Months 24-36: Denosumab Extension Phase|Other|1
4860034|NCT00896532|16751593|P13|Months 24-36: Denosumab Extension Phase|Other|2
4860035|NCT00896532|16751594|P12|Months 24-36: Denosumab Extension Phase|Other|2
4860036|NCT00896532|16751595|P11|Months 24-36: Denosumab Extension Phase|Other|1
4860037|NCT00896532|16751596|P10|Months 24-36: Denosumab Extension Phase|Other|0
4860038|NCT00896532|16751597|P9|Months 24-36: Denosumab Extension Phase|Other|0
4860039|NCT00896532|16751598|P8|Months 24-36: Denosumab Extension Phase|Other|0
4860040|NCT00896532|16751599|P7|Months 24-36: Denosumab Extension Phase|Other|0
4860041|NCT00896532|16751600|P6|Months 24-36: Denosumab Extension Phase|Other|0
4860042|NCT00896532|16751601|P5|Months 24-36: Denosumab Extension Phase|Other|0
4860043|NCT00896532|16751602|P4|Months 24-36: Denosumab Extension Phase|Other|0
4860044|NCT00896532|16751603|P3|Months 24-36: Denosumab Extension Phase|Other|0
4860045|NCT00896532|16751604|P2|Months 24-36: Denosumab Extension Phase|Other|0
4860046|NCT00896532|16751605|P1|Months 24-36: Denosumab Extension Phase|Other|0
4860047|NCT00896532|16751583|P23|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860048|NCT00896532|16751584|P22|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860049|NCT00896532|16751585|P21|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860050|NCT00896532|16751586|P20|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860051|NCT00896532|16751587|P19|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860052|NCT00896532|16751588|P18|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860053|NCT00896532|16751589|P17|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860054|NCT00896532|16751590|P16|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860055|NCT00896532|16751591|P15|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860056|NCT00896532|16751592|P14|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
4860057|NCT00896532|16751593|P13|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1
4860058|NCT00896532|16751594|P12|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860059|NCT00896532|16751595|P11|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860060|NCT00896532|16751596|P10|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860061|NCT00896532|16751597|P9|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860062|NCT00896532|16751598|P8|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860063|NCT00896532|16751599|P7|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860064|NCT00896532|16751600|P6|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860065|NCT00896532|16751601|P5|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860066|NCT00896532|16751602|P4|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860067|NCT00896532|16751603|P3|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860068|NCT00896532|16751604|P2|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860069|NCT00896532|16751605|P1|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0
4860070|NCT00896532|16751583|P23|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860071|NCT00896532|16751584|P22|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860072|NCT00896532|16751585|P21|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860073|NCT00896532|16751586|P20|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860074|NCT00896532|16751587|P19|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860075|NCT00896532|16751588|P18|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860076|NCT00896532|16751589|P17|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860077|NCT00896532|16751590|P16|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860078|NCT00896532|16751591|P15|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860079|NCT00896532|16751592|P14|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860080|NCT00896532|16751593|P13|Months 24-36: Denosumab Extension Phase|Adverse Event|1
4860081|NCT00896532|16751594|P12|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860082|NCT00896532|16751595|P11|Months 24-36: Denosumab Extension Phase|Adverse Event|1
4860083|NCT00896532|16751596|P10|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860084|NCT00896532|16751597|P9|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860085|NCT00896532|16751598|P8|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860086|NCT00896532|16751599|P7|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860087|NCT00896532|16751600|P6|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860088|NCT00896532|16751601|P5|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860089|NCT00896532|16751602|P4|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860090|NCT00896532|16751603|P3|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860091|NCT00896532|16751604|P2|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860092|NCT00896532|16751605|P1|Months 24-36: Denosumab Extension Phase|Adverse Event|0
4860093|NCT00896532|16751583|P23|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860094|NCT00896532|16751584|P22|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860095|NCT00896532|16751585|P21|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860096|NCT00896532|16751586|P20|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860097|NCT00896532|16751587|P19|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860098|NCT00896532|16751588|P18|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860099|NCT00896532|16751589|P17|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860100|NCT00896532|16751590|P16|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860101|NCT00896532|16751591|P15|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860102|NCT00896532|16751592|P14|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860103|NCT00896532|16751593|P13|Months 24-36: Denosumab Extension Phase|Noncompliance|1
4860104|NCT00896532|16751594|P12|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860105|NCT00896532|16751595|P11|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860106|NCT00896532|16751596|P10|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860107|NCT00896532|16751597|P9|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860108|NCT00896532|16751598|P8|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860109|NCT00896532|16751599|P7|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860110|NCT00896532|16751600|P6|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860111|NCT00896532|16751601|P5|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860112|NCT00896532|16751602|P4|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860113|NCT00896532|16751603|P3|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860114|NCT00896532|16751604|P2|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860115|NCT00896532|16751605|P1|Months 24-36: Denosumab Extension Phase|Noncompliance|0
4860116|NCT00896532|16751583|P23|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860117|NCT00896532|16751584|P22|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860118|NCT00896532|16751585|P21|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860119|NCT00896532|16751586|P20|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860120|NCT00896532|16751587|P19|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860121|NCT00896532|16751588|P18|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860122|NCT00896532|16751589|P17|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860123|NCT00896532|16751590|P16|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860124|NCT00896532|16751591|P15|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860125|NCT00896532|16751592|P14|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860126|NCT00896532|16751593|P13|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860127|NCT00896532|16751594|P12|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860128|NCT00896532|16751595|P11|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860129|NCT00896532|16751596|P10|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860130|NCT00896532|16751597|P9|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1
4860131|NCT00896532|16751598|P8|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860132|NCT00896532|16751599|P7|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860133|NCT00896532|16751600|P6|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860134|NCT00896532|16751601|P5|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860135|NCT00896532|16751602|P4|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860136|NCT00896532|16751603|P3|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860137|NCT00896532|16751604|P2|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860138|NCT00896532|16751605|P1|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0
4860139|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Other|0
4860140|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Other|0
4860141|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Other|0
4860142|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Other|0
4860143|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Other|0
4860144|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Other|0
4860145|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Other|0
4860146|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Other|0
4860147|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Other|0
4860148|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Other|0
4860149|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Other|0
4860150|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Other|0
4860151|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Other|0
4860152|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Other|0
4860153|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Other|0
4860154|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Other|0
4860155|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Other|0
4860156|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Other|0
4860157|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Other|1
4860158|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Other|1
4860159|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Other|0
4860160|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Other|1
4860161|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Other|0
4860162|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860163|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860164|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860165|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860166|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860167|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860168|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860169|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860170|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860171|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860172|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860173|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860174|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860175|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860176|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860177|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860178|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860179|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860180|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860181|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1
4860182|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860183|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860184|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0
4860185|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860186|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860187|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860188|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860189|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860190|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860191|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860192|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860193|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860194|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860195|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860196|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860197|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860198|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860199|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860200|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860201|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860202|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860203|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860204|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860205|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1
4860206|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860207|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0
4860208|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860209|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860210|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860211|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860212|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860213|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860214|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860215|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860216|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860217|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860218|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860219|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860220|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860221|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860222|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860223|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860224|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860225|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860226|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860227|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860228|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1
4860229|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860230|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0
4860231|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Death|0
4860232|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Death|0
4860233|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Death|0
4860234|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Death|0
4860235|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Death|0
4860236|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Death|0
4860237|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Death|0
4860238|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Death|0
4860239|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Death|0
4860240|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Death|0
4860241|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Death|0
4860242|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Death|0
4860243|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Death|0
4860244|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Death|0
4860245|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Death|0
4860246|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Death|0
4860247|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Death|0
4860248|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Death|0
4860249|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Death|0
4860250|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Death|1
4860251|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Death|0
4860252|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Death|0
4860253|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Death|1
4860254|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860255|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860256|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860257|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860258|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860259|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860260|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860261|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860262|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860263|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860264|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860265|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860266|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860267|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860268|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860269|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860270|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860271|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860272|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1
4860273|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860274|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2
4860275|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860276|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0
4860277|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860278|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860279|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860280|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860281|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860282|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860283|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860284|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860285|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860286|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860287|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860288|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860289|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860290|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860291|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0
4860292|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4860293|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4860294|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
4860295|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5
4860296|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6
4860297|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4860298|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3
4860299|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4
4860300|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860301|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860302|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860303|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860304|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860305|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860306|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860307|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860308|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860309|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860310|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860311|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860312|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860313|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860314|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860315|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0
4860316|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4860317|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4860318|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4860319|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
4860320|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4860321|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2
4860322|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1
4860323|NCT00896532|16751583|P23|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860324|NCT00896532|16751584|P22|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860325|NCT00896532|16751585|P21|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860326|NCT00896532|16751586|P20|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860327|NCT00896532|16751587|P19|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860328|NCT00896532|16751588|P18|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860329|NCT00896532|16751589|P17|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860330|NCT00896532|16751590|P16|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860331|NCT00896532|16751591|P15|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860332|NCT00896532|16751592|P14|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860333|NCT00896532|16751593|P13|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860334|NCT00896532|16751594|P12|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860335|NCT00896532|16751595|P11|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860336|NCT00896532|16751596|P10|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860337|NCT00896532|16751597|P9|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860338|NCT00896532|16751598|P8|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860339|NCT00896532|16751599|P7|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860340|NCT00896532|16751600|P6|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
4860341|NCT00896532|16751601|P5|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860342|NCT00896532|16751602|P4|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1
4860343|NCT00896532|16751603|P3|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860344|NCT00896532|16751604|P2|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860345|NCT00896532|16751605|P1|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0
4860346|NCT00896480|16751732|P1|Overall Study|Disease progression/recurrence|21
4860347|NCT00896454|16751780|P1|Overall Study|Withdrawal by Subject|1
4860348|NCT00896454|16751780|P1|Overall Study|Ongoing in study|2
4860349|NCT00896454|16751780|P1|Overall Study|Requirement for alternative therapy|3
4860350|NCT00896454|16751780|P1|Overall Study|Other|4
4860351|NCT00896454|16751780|P1|Overall Study|Disease Progression|5
4860352|NCT00896454|16751780|P1|Overall Study|Adverse Event|8
4860353|NCT00896454|16751780|P1|Overall Study|Death|10
4860354|NCT00896363|16751819|P3|Overall Study|Withdrawal by Subject|5
4860355|NCT00896363|16751820|P2|Overall Study|Withdrawal by Subject|5
4860356|NCT00896363|16751821|P1|Overall Study|Withdrawal by Subject|3
4860357|NCT00896363|16751819|P3|Overall Study|Lack of Efficacy|1
4860358|NCT00896363|16751820|P2|Overall Study|Lack of Efficacy|2
4860359|NCT00896363|16751821|P1|Overall Study|Lack of Efficacy|0
4860360|NCT00896363|16751819|P3|Overall Study|Adverse Event|2
4860361|NCT00896363|16751820|P2|Overall Study|Adverse Event|4
4860362|NCT00896363|16751821|P1|Overall Study|Adverse Event|3
4860363|NCT00896337|16751873|P1|Overall Study|Lost to Follow-up|11
4860364|NCT00896337|16751873|P1|Overall Study|Withdrawal by Subject|7
4860365|NCT00896337|16751873|P1|Overall Study|Death|7
4860366|NCT00896233|16751955|P1|Overall Study|Claustrophobia during MRI|1
4860367|NCT00896168|16751968|P2|Overall Study|Other|1
4860368|NCT00896168|16751969|P1|Overall Study|Other|1
4860369|NCT00896168|16751968|P2|Overall Study|Lost to Follow-up|1
4860370|NCT00896168|16751969|P1|Overall Study|Lost to Follow-up|1
4860371|NCT00896168|16751968|P2|Overall Study|Treatment failure|10
4860372|NCT00896168|16751969|P1|Overall Study|Treatment failure|8
4860373|NCT00896168|16751968|P2|Overall Study|Adverse Event|7
4860374|NCT00896168|16751969|P1|Overall Study|Adverse Event|4
4860375|NCT00896051|16752030|P2|Overall Study|Other|1
4860376|NCT00896051|16752031|P1|Overall Study|Other|1
4860377|NCT00896051|16752030|P2|Overall Study|Subject noncompliant|3
4860378|NCT00896051|16752031|P1|Overall Study|Subject noncompliant|1
4860379|NCT00896051|16752030|P2|Overall Study|Withdrawal by Subject|2
4860380|NCT00896051|16752031|P1|Overall Study|Withdrawal by Subject|3
4860381|NCT00896051|16752030|P2|Overall Study|Lost to Follow-up|2
4860382|NCT00896051|16752031|P1|Overall Study|Lost to Follow-up|3
4860383|NCT00896051|16752030|P2|Overall Study|Adverse Event|1
4860384|NCT00896051|16752031|P1|Overall Study|Adverse Event|2
4860385|NCT00895947|16752126|P2|Overall Study|Withdrawal by Subject|0
4860386|NCT00895947|16752127|P1|Overall Study|Withdrawal by Subject|2
4860387|NCT00895947|16752126|P2|Overall Study|Protocol Violation|2
4860388|NCT00895947|16752127|P1|Overall Study|Protocol Violation|4
4860389|NCT00895947|16752126|P2|Overall Study|Lost to Follow-up|4
4860390|NCT00895947|16752127|P1|Overall Study|Lost to Follow-up|3
4860391|NCT00895947|16752126|P2|Overall Study|Adverse Event|4
4860392|NCT00895947|16752127|P1|Overall Study|Adverse Event|3
4860393|NCT00895895|16752178|P5|Period 2|unsatisfactory response-efficacy|0
4860394|NCT00895895|16752179|P4|Period 2|unsatisfactory response-efficacy|0
4860395|NCT00895895|16752180|P3|Period 2|unsatisfactory response-efficacy|0
4860396|NCT00895895|16752181|P2|Period 2|unsatisfactory response-efficacy|1
4860397|NCT00895895|16752182|P1|Period 2|unsatisfactory response-efficacy|2
4860398|NCT00895895|16752178|P5|Period 2|Withdrawal by Subject|5
4860399|NCT00895895|16752179|P4|Period 2|Withdrawal by Subject|3
4860400|NCT00895895|16752180|P3|Period 2|Withdrawal by Subject|0
4860401|NCT00895895|16752181|P2|Period 2|Withdrawal by Subject|2
4860402|NCT00895895|16752182|P1|Period 2|Withdrawal by Subject|0
4860403|NCT00895895|16752178|P5|Period 2|Protocol Violation|1
4860404|NCT00895895|16752179|P4|Period 2|Protocol Violation|1
4860405|NCT00895895|16752180|P3|Period 2|Protocol Violation|1
4860406|NCT00895895|16752181|P2|Period 2|Protocol Violation|0
4860407|NCT00895895|16752182|P1|Period 2|Protocol Violation|1
4860408|NCT00895895|16752178|P5|Period 2|Other|1
4860409|NCT00895895|16752179|P4|Period 2|Other|1
4860410|NCT00895895|16752180|P3|Period 2|Other|3
4860411|NCT00895895|16752181|P2|Period 2|Other|1
4860412|NCT00895895|16752182|P1|Period 2|Other|1
4860413|NCT00895895|16752178|P5|Period 2|Lost to Follow-up|0
4860414|NCT00895895|16752179|P4|Period 2|Lost to Follow-up|1
4860415|NCT00895895|16752180|P3|Period 2|Lost to Follow-up|1
4860416|NCT00895895|16752181|P2|Period 2|Lost to Follow-up|2
4860417|NCT00895895|16752182|P1|Period 2|Lost to Follow-up|1
4860418|NCT00895895|16752178|P5|Period 2|investigator request|0
4860419|NCT00895895|16752179|P4|Period 2|investigator request|0
4860420|NCT00895895|16752180|P3|Period 2|investigator request|0
4860421|NCT00895895|16752181|P2|Period 2|investigator request|0
4860422|NCT00895895|16752182|P1|Period 2|investigator request|2
4860423|NCT00895895|16752178|P5|Period 2|failed to return|0
4860424|NCT00895895|16752179|P4|Period 2|failed to return|0
4860425|NCT00895895|16752180|P3|Period 2|failed to return|0
4860426|NCT00895895|16752181|P2|Period 2|failed to return|0
4860427|NCT00895895|16752182|P1|Period 2|failed to return|2
4860428|NCT00895895|16752178|P5|Period 2|discontinued by sponsor|37
4860429|NCT00895895|16752179|P4|Period 2|discontinued by sponsor|46
4860430|NCT00895895|16752180|P3|Period 2|discontinued by sponsor|38
4860431|NCT00895895|16752181|P2|Period 2|discontinued by sponsor|44
4860432|NCT00895895|16752182|P1|Period 2|discontinued by sponsor|44
4860433|NCT00895895|16752178|P5|Period 2|Death|0
4860434|NCT00895895|16752179|P4|Period 2|Death|0
4860435|NCT00895895|16752180|P3|Period 2|Death|1
4860436|NCT00895895|16752181|P2|Period 2|Death|0
4860437|NCT00895895|16752182|P1|Period 2|Death|0
4860438|NCT00895895|16752178|P5|Period 2|Adverse Event|5
4860439|NCT00895895|16752179|P4|Period 2|Adverse Event|2
4860440|NCT00895895|16752180|P3|Period 2|Adverse Event|5
4860441|NCT00895895|16752181|P2|Period 2|Adverse Event|3
4860442|NCT00895895|16752182|P1|Period 2|Adverse Event|3
4860443|NCT00895895|16752178|P5|After Period 1, Prior to Period 2|Withdrawal by Subject|1
4860444|NCT00895895|16752179|P4|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4860445|NCT00895895|16752180|P3|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4860446|NCT00895895|16752181|P2|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4860447|NCT00895895|16752182|P1|After Period 1, Prior to Period 2|Withdrawal by Subject|0
4860448|NCT00895895|16752178|P5|After Period 1, Prior to Period 2|Protocol Violation|1
4860449|NCT00895895|16752179|P4|After Period 1, Prior to Period 2|Protocol Violation|0
4860450|NCT00895895|16752180|P3|After Period 1, Prior to Period 2|Protocol Violation|0
4860451|NCT00895895|16752181|P2|After Period 1, Prior to Period 2|Protocol Violation|0
4860452|NCT00895895|16752182|P1|After Period 1, Prior to Period 2|Protocol Violation|0
4860453|NCT00895895|16752178|P5|After Period 1, Prior to Period 2|Other|0
4860454|NCT00895895|16752179|P4|After Period 1, Prior to Period 2|Other|0
4860455|NCT00895895|16752180|P3|After Period 1, Prior to Period 2|Other|1
4860456|NCT00895895|16752181|P2|After Period 1, Prior to Period 2|Other|0
4860457|NCT00895895|16752182|P1|After Period 1, Prior to Period 2|Other|0
4860458|NCT00895895|16752178|P5|After Period 1, Prior to Period 2|Adverse Event|0
4860459|NCT00895895|16752179|P4|After Period 1, Prior to Period 2|Adverse Event|0
4860460|NCT00895895|16752180|P3|After Period 1, Prior to Period 2|Adverse Event|1
4860461|NCT00895895|16752181|P2|After Period 1, Prior to Period 2|Adverse Event|0
4860462|NCT00895895|16752182|P1|After Period 1, Prior to Period 2|Adverse Event|0
4860463|NCT00895895|16752178|P5|Period 1|randomized and not treated|2
4860464|NCT00895895|16752179|P4|Period 1|randomized and not treated|1
4860465|NCT00895895|16752180|P3|Period 1|randomized and not treated|1
4860466|NCT00895895|16752181|P2|Period 1|randomized and not treated|3
4860467|NCT00895895|16752182|P1|Period 1|randomized and not treated|1
4860468|NCT00895895|16752178|P5|Period 1|unsatisfactory response-efficacy|0
4860469|NCT00895895|16752179|P4|Period 1|unsatisfactory response-efficacy|0
4860470|NCT00895895|16752180|P3|Period 1|unsatisfactory response-efficacy|0
4860471|NCT00895895|16752181|P2|Period 1|unsatisfactory response-efficacy|0
4860472|NCT00895895|16752182|P1|Period 1|unsatisfactory response-efficacy|2
4860473|NCT00895895|16752178|P5|Period 1|Withdrawal by Subject|4
4860474|NCT00895895|16752179|P4|Period 1|Withdrawal by Subject|2
4860475|NCT00895895|16752180|P3|Period 1|Withdrawal by Subject|8
4860476|NCT00895895|16752181|P2|Period 1|Withdrawal by Subject|6
4860477|NCT00895895|16752182|P1|Period 1|Withdrawal by Subject|6
4860478|NCT00895895|16752178|P5|Period 1|Protocol Violation|0
4860479|NCT00895895|16752179|P4|Period 1|Protocol Violation|0
4860480|NCT00895895|16752180|P3|Period 1|Protocol Violation|0
4860481|NCT00895895|16752181|P2|Period 1|Protocol Violation|1
4860482|NCT00895895|16752182|P1|Period 1|Protocol Violation|0
4860483|NCT00895895|16752178|P5|Period 1|Other|1
4860484|NCT00895895|16752179|P4|Period 1|Other|1
4860485|NCT00895895|16752180|P3|Period 1|Other|1
4860486|NCT00895895|16752181|P2|Period 1|Other|2
4860487|NCT00895895|16752182|P1|Period 1|Other|1
4860488|NCT00895895|16752178|P5|Period 1|Lost to Follow-up|3
4860489|NCT00895895|16752179|P4|Period 1|Lost to Follow-up|2
4860490|NCT00895895|16752180|P3|Period 1|Lost to Follow-up|3
4860491|NCT00895895|16752181|P2|Period 1|Lost to Follow-up|1
4860492|NCT00895895|16752182|P1|Period 1|Lost to Follow-up|2
4860493|NCT00895895|16752178|P5|Period 1|investigator request|0
4860494|NCT00895895|16752179|P4|Period 1|investigator request|0
4860495|NCT00895895|16752180|P3|Period 1|investigator request|0
4860496|NCT00895895|16752181|P2|Period 1|investigator request|1
4860497|NCT00895895|16752182|P1|Period 1|investigator request|0
4860498|NCT00895895|16752178|P5|Period 1|failed to return|1
4860499|NCT00895895|16752179|P4|Period 1|failed to return|0
4860500|NCT00895895|16752180|P3|Period 1|failed to return|1
4860501|NCT00895895|16752181|P2|Period 1|failed to return|0
4860502|NCT00895895|16752182|P1|Period 1|failed to return|0
4860503|NCT00895895|16752178|P5|Period 1|discontinued by sponsor|1
4860504|NCT00895895|16752179|P4|Period 1|discontinued by sponsor|1
4860505|NCT00895895|16752180|P3|Period 1|discontinued by sponsor|2
4860506|NCT00895895|16752181|P2|Period 1|discontinued by sponsor|1
4860507|NCT00895895|16752182|P1|Period 1|discontinued by sponsor|2
4860508|NCT00895895|16752178|P5|Period 1|Death|1
4860509|NCT00895895|16752179|P4|Period 1|Death|0
4860510|NCT00895895|16752180|P3|Period 1|Death|0
4860511|NCT00895895|16752181|P2|Period 1|Death|0
4860512|NCT00895895|16752182|P1|Period 1|Death|0
4860513|NCT00895895|16752178|P5|Period 1|Adverse Event|7
4860514|NCT00895895|16752179|P4|Period 1|Adverse Event|6
4860515|NCT00895895|16752180|P3|Period 1|Adverse Event|4
4860516|NCT00895895|16752181|P2|Period 1|Adverse Event|6
4860517|NCT00895895|16752182|P1|Period 1|Adverse Event|7
4860518|NCT00895843|16752296|P2|Overall Study|Protocol Violation|12
4860519|NCT00895843|16752297|P1|Overall Study|Protocol Violation|12
4860520|NCT00895661|16752344|P1|Overall Study|reason unknown|2
4860521|NCT00895661|16752344|P1|Overall Study|Death|1
4860522|NCT00895622|16752354|P3|Overall Study|Protocol Violation|4
4860523|NCT00895622|16752355|P2|Overall Study|Protocol Violation|4
4860524|NCT00895622|16752356|P1|Overall Study|Protocol Violation|5
4860525|NCT00895583|16752383|P2|Overall Study|Other|1
4860526|NCT00895583|16752384|P1|Overall Study|Other|0
4860527|NCT00895583|16752383|P2|Overall Study|Lack of Efficacy|0
4860528|NCT00895583|16752384|P1|Overall Study|Lack of Efficacy|5
4860529|NCT00895583|16752383|P2|Overall Study|Withdrawal by Subject|2
4860530|NCT00895583|16752384|P1|Overall Study|Withdrawal by Subject|4
4860531|NCT00895583|16752383|P2|Overall Study|Protocol Violation|0
4860532|NCT00895583|16752384|P1|Overall Study|Protocol Violation|1
4860533|NCT00895583|16752383|P2|Overall Study|Lost to Follow-up|3
4860534|NCT00895583|16752384|P1|Overall Study|Lost to Follow-up|1
4860535|NCT00895583|16752383|P2|Overall Study|Physician Decision|1
4860536|NCT00895583|16752384|P1|Overall Study|Physician Decision|3
4860537|NCT00895583|16752383|P2|Overall Study|Death|1
4860538|NCT00895583|16752384|P1|Overall Study|Death|2
4860539|NCT00895583|16752383|P2|Overall Study|Adverse Event|4
4860540|NCT00895583|16752384|P1|Overall Study|Adverse Event|28
4860541|NCT00895453|16752474|P3|Overall Study|Lost to Follow-up|23
4860542|NCT00895453|16752475|P2|Overall Study|Lost to Follow-up|25
4860543|NCT00895453|16752476|P1|Overall Study|Lost to Follow-up|25
4860544|NCT00895414|16752484|P2|First Intervention (14 Days)|Physician Decision|1
4860545|NCT00895414|16752485|P1|First Intervention (14 Days)|Physician Decision|0
4860546|NCT00895414|16752484|P2|First Intervention (14 Days)|Withdrawal by Subject|0
4860547|NCT00895414|16752485|P1|First Intervention (14 Days)|Withdrawal by Subject|1
4860548|NCT00895310|16752495|P1|Overall Study|Withdrawal by Subject|1
4860549|NCT00895245|16752511|P1|Overall Study|Lack of Efficacy|6
4860550|NCT00895154|16752589|P2|Overall Study|Withdrawal by Subject|1
4860551|NCT00895154|16752590|P1|Overall Study|Withdrawal by Subject|0
4860552|NCT00895154|16752589|P2|Overall Study|Lost to Follow-up|1
4860553|NCT00895154|16752590|P1|Overall Study|Lost to Follow-up|1
4860554|NCT00895037|16752625|P3|Overall Study|Death|1
4860555|NCT00895037|16752626|P2|Overall Study|Death|2
4860556|NCT00895037|16752627|P1|Overall Study|Death|0
4860557|NCT00895011|16752658|P3|Overall Study|schedule conflict|0
4860558|NCT00895011|16752659|P2|Overall Study|schedule conflict|0
4860559|NCT00895011|16752660|P1|Overall Study|schedule conflict|1
4860560|NCT00895011|16752658|P3|Overall Study|Adverse Event|2
4860561|NCT00895011|16752659|P2|Overall Study|Adverse Event|2
4860562|NCT00895011|16752660|P1|Overall Study|Adverse Event|1
4860563|NCT00895011|16752658|P3|Overall Study|Protocol Violation|3
4860564|NCT00895011|16752659|P2|Overall Study|Protocol Violation|1
4860565|NCT00895011|16752660|P1|Overall Study|Protocol Violation|3
4860566|NCT00895011|16752658|P3|Overall Study|Lost to Follow-up|1
4860567|NCT00895011|16752659|P2|Overall Study|Lost to Follow-up|4
4860568|NCT00895011|16752660|P1|Overall Study|Lost to Follow-up|5
4860569|NCT00895011|16752658|P3|Overall Study|Withdrawal by Subject|2
4860570|NCT00895011|16752659|P2|Overall Study|Withdrawal by Subject|7
4860571|NCT00895011|16752660|P1|Overall Study|Withdrawal by Subject|14
4860572|NCT00894933|16752674|P1|Overall Study|Did not meeting incl/excl criteria|1
4860573|NCT00894933|16752674|P1|Overall Study|Cancelled Procedure|1
4860574|NCT00894933|16752674|P1|Overall Study|Lost to Follow-up|2
4860575|NCT00894803|16752692|P2|Overall Study|Lost to Follow-up|1
4860576|NCT00894803|16752693|P1|Overall Study|Lost to Follow-up|0
4860577|NCT00894803|16752692|P2|Overall Study|Death|4
4860578|NCT00894803|16752693|P1|Overall Study|Death|20
4860579|NCT00894790|16752729|P2|Overall Study|Did not meet entrance criteria|0
4860580|NCT00894790|16752730|P1|Overall Study|Did not meet entrance criteria|1
4860581|NCT00894790|16752729|P2|Overall Study|Lost to Follow-up|1
4860582|NCT00894790|16752730|P1|Overall Study|Lost to Follow-up|0
4860583|NCT00894790|16752729|P2|Overall Study|Protocol Violation|1
4860584|NCT00894790|16752730|P1|Overall Study|Protocol Violation|0
4860585|NCT00894686|16752772|P1|Overall Study|Other|5
4860586|NCT00894686|16752772|P1|Overall Study|Physician Decision|1
4860587|NCT00894686|16752772|P1|Overall Study|Withdrawal by Subject|50
4860588|NCT00894647|16752796|P2|Overall Study|Other, not due to AE|2
4860589|NCT00894647|16752797|P1|Overall Study|Other, not due to AE|1
4860590|NCT00894647|16752796|P2|Overall Study|Non-compliance with study procedures|2
4860591|NCT00894647|16752797|P1|Overall Study|Non-compliance with study procedures|0
4860592|NCT00894647|16752796|P2|Overall Study|Lost to Follow-up|2
4860593|NCT00894647|16752797|P1|Overall Study|Lost to Follow-up|0
4860594|NCT00894647|16752796|P2|Overall Study|Withdrawal by Subject|4
4860595|NCT00894647|16752797|P1|Overall Study|Withdrawal by Subject|4
4860596|NCT00894647|16752796|P2|Overall Study|Adverse Event|4
4860597|NCT00894647|16752797|P1|Overall Study|Adverse Event|5
4860598|NCT00894556|16752810|P4|Treatment Phase|Lack of Qualifying Event|0
4860599|NCT00894556|16752811|P3|Treatment Phase|Lack of Qualifying Event|0
4860600|NCT00894556|16752812|P2|Treatment Phase|Lack of Qualifying Event|1
4860601|NCT00894556|16752813|P1|Treatment Phase|Lack of Qualifying Event|2
4860602|NCT00894556|16752810|P4|Treatment Phase|Lost to Follow-up|0
4860603|NCT00894556|16752811|P3|Treatment Phase|Lost to Follow-up|1
4860604|NCT00894556|16752812|P2|Treatment Phase|Lost to Follow-up|3
4860605|NCT00894556|16752813|P1|Treatment Phase|Lost to Follow-up|2
4860606|NCT00894556|16752810|P4|Baseline Phase|Did not meet Randomization Criteria|85
4860607|NCT00894556|16752811|P3|Baseline Phase|Did not meet Randomization Criteria|0
4860608|NCT00894556|16752812|P2|Baseline Phase|Did not meet Randomization Criteria|0
4860609|NCT00894556|16752813|P1|Baseline Phase|Did not meet Randomization Criteria|0
4860610|NCT00894543|16752824|P2|Week 4 to Week 8|No diary or lost or withdrew|2
4860611|NCT00894543|16752825|P1|Week 4 to Week 8|No diary or lost or withdrew|4
4860612|NCT00894543|16752824|P2|Baseline to Week 4|No diary or lost or withdrew|2
4860613|NCT00894543|16752825|P1|Baseline to Week 4|No diary or lost or withdrew|3
4860614|NCT00894413|16752891|P2|Overall Study|Withdrawal by Subject|4
4860615|NCT00894413|16752892|P1|Overall Study|Withdrawal by Subject|0
4860616|NCT00894413|16752891|P2|Overall Study|Adverse Event|2
4860617|NCT00894413|16752892|P1|Overall Study|Adverse Event|0
4860618|NCT00894413|16752891|P2|Overall Study|Physician Decision|2
4860619|NCT00894413|16752892|P1|Overall Study|Physician Decision|0
4860620|NCT00894387|16752900|P2|Overall Study|GCP non-compliance|2
4860621|NCT00894387|16752901|P1|Overall Study|GCP non-compliance|0
4860622|NCT00894387|16752900|P2|Overall Study|Mis-randomized|9
4860623|NCT00894387|16752901|P1|Overall Study|Mis-randomized|13
4860624|NCT00894387|16752900|P2|Overall Study|Other (Missing)|3
4860625|NCT00894387|16752901|P1|Overall Study|Other (Missing)|5
4860626|NCT00894387|16752900|P2|Overall Study|Patient's request|30
4860627|NCT00894387|16752901|P1|Overall Study|Patient's request|25
4860628|NCT00894387|16752900|P2|Overall Study|Protocol Deviation|0
4860629|NCT00894387|16752901|P1|Overall Study|Protocol Deviation|4
4860630|NCT00894387|16752900|P2|Overall Study|Death|76
4860631|NCT00894387|16752901|P1|Overall Study|Death|77
4860632|NCT00894387|16752900|P2|Overall Study|Administrative problems|2
4860633|NCT00894387|16752901|P1|Overall Study|Administrative problems|2
4860634|NCT00894387|16752900|P2|Overall Study|Lost to Follow-up|5
4860635|NCT00894387|16752901|P1|Overall Study|Lost to Follow-up|3
4860636|NCT00894387|16752900|P2|Overall Study|Unsatisfactory therapeutic effect|1
4860637|NCT00894387|16752901|P1|Overall Study|Unsatisfactory therapeutic effect|0
4860638|NCT00894387|16752900|P2|Overall Study|Abnormal Laboratory values|2
4860639|NCT00894387|16752901|P1|Overall Study|Abnormal Laboratory values|2
4860640|NCT00894387|16752900|P2|Overall Study|Adverse Event|45
4860641|NCT00894387|16752901|P1|Overall Study|Adverse Event|44
4860642|NCT00894361|16752921|P2|Overall Study|deaths and less than 2 years followup|64
4860643|NCT00894361|16752922|P1|Overall Study|deaths and less than 2 years followup|24
4860644|NCT00894322|16752933|P3|Overall Study|Withdrawal by Subject|0
4860645|NCT00894322|16752934|P2|Overall Study|Withdrawal by Subject|0
4860646|NCT00894322|16752935|P1|Overall Study|Withdrawal by Subject|1
4860647|NCT00894166|16752986|P8|Overall Study|Death|0
4860648|NCT00894166|16752987|P7|Overall Study|Death|0
4860649|NCT00894166|16752988|P6|Overall Study|Death|0
4860650|NCT00894166|16752989|P5|Overall Study|Death|0
4860651|NCT00894166|16752990|P4|Overall Study|Death|1
4860652|NCT00894166|16752991|P3|Overall Study|Death|0
4860653|NCT00894166|16752992|P2|Overall Study|Death|0
4860654|NCT00894166|16752993|P1|Overall Study|Death|0
4860655|NCT00894166|16752986|P8|Overall Study|Withdrew or Lost to Follow-Up|34
4860656|NCT00894166|16752987|P7|Overall Study|Withdrew or Lost to Follow-Up|16
4860657|NCT00894166|16752988|P6|Overall Study|Withdrew or Lost to Follow-Up|16
4860658|NCT00894166|16752989|P5|Overall Study|Withdrew or Lost to Follow-Up|24
4860659|NCT00894166|16752990|P4|Overall Study|Withdrew or Lost to Follow-Up|68
4860660|NCT00894166|16752991|P3|Overall Study|Withdrew or Lost to Follow-Up|62
4860661|NCT00894166|16752992|P2|Overall Study|Withdrew or Lost to Follow-Up|63
4860662|NCT00894166|16752993|P1|Overall Study|Withdrew or Lost to Follow-Up|61
4860663|NCT00893971|16753039|P1|Overall Study|Physician Decision|3
4860664|NCT00893789|16753157|P4|Overall Study|Lost to Follow-up|1
4860665|NCT00893789|16753158|P3|Overall Study|Lost to Follow-up|0
4860666|NCT00893789|16753159|P2|Overall Study|Lost to Follow-up|0
4860667|NCT00893789|16753160|P1|Overall Study|Lost to Follow-up|0
4860668|NCT00893789|16753157|P4|Overall Study|Protocol Violation|4
4860669|NCT00893789|16753158|P3|Overall Study|Protocol Violation|1
4860670|NCT00893789|16753159|P2|Overall Study|Protocol Violation|1
4860671|NCT00893789|16753160|P1|Overall Study|Protocol Violation|0
4860672|NCT00893789|16753157|P4|Overall Study|Adverse Event|5
4860673|NCT00893789|16753158|P3|Overall Study|Adverse Event|1
4860674|NCT00893789|16753159|P2|Overall Study|Adverse Event|2
4860675|NCT00893789|16753160|P1|Overall Study|Adverse Event|0
4860676|NCT00893789|16753157|P4|Overall Study|Taking Excluded Concomitant Medication|0
4860677|NCT00893789|16753158|P3|Overall Study|Taking Excluded Concomitant Medication|1
4860678|NCT00893789|16753159|P2|Overall Study|Taking Excluded Concomitant Medication|0
4860679|NCT00893789|16753160|P1|Overall Study|Taking Excluded Concomitant Medication|1
4860680|NCT00893789|16753157|P4|Overall Study|Noncompliance With Study Procedures|0
4860681|NCT00893789|16753158|P3|Overall Study|Noncompliance With Study Procedures|0
4860682|NCT00893789|16753159|P2|Overall Study|Noncompliance With Study Procedures|0
4860683|NCT00893789|16753160|P1|Overall Study|Noncompliance With Study Procedures|1
4860684|NCT00893789|16753157|P4|Overall Study|Noncompliance With Study Drug|2
4860685|NCT00893789|16753158|P3|Overall Study|Noncompliance With Study Drug|1
4860686|NCT00893789|16753159|P2|Overall Study|Noncompliance With Study Drug|0
4860687|NCT00893789|16753160|P1|Overall Study|Noncompliance With Study Drug|1
4860688|NCT00893789|16753157|P4|Overall Study|Withdrawal by Subject|1
4860689|NCT00893789|16753158|P3|Overall Study|Withdrawal by Subject|3
4860690|NCT00893789|16753159|P2|Overall Study|Withdrawal by Subject|1
4860691|NCT00893789|16753160|P1|Overall Study|Withdrawal by Subject|3
4860692|NCT00893763|16753244|P2|Overall Study|extubated|110
4860693|NCT00893763|16753245|P1|Overall Study|extubated|110
4860694|NCT00893737|16753253|P1|Overall Study|Lost to Follow-up|6
4860695|NCT00893737|16753253|P1|Overall Study|Withdrawal by Subject|2
4860696|NCT00893737|16753253|P1|Overall Study|Adverse Event|4
4860697|NCT00893464|16753267|P8|Overall Study|Did not complete therapy/experience PD|2
4860698|NCT00893464|16753268|P7|Overall Study|Did not complete therapy/experience PD|2
4860699|NCT00893464|16753269|P6|Overall Study|Did not complete therapy/experience PD|0
4860700|NCT00893464|16753270|P5|Overall Study|Did not complete therapy/experience PD|0
4860701|NCT00893464|16753271|P4|Overall Study|Did not complete therapy/experience PD|0
4860702|NCT00893464|16753272|P3|Overall Study|Did not complete therapy/experience PD|0
4860703|NCT00893464|16753273|P2|Overall Study|Did not complete therapy/experience PD|0
4860704|NCT00893464|16753274|P1|Overall Study|Did not complete therapy/experience PD|0
4860705|NCT00893113|16753401|P2|Overall Study|Withdrew Consent|7
4860706|NCT00893113|16753402|P1|Overall Study|Withdrew Consent|8
4860707|NCT00893113|16753401|P2|Overall Study|Early Termination|1
4860708|NCT00893113|16753402|P1|Overall Study|Early Termination|1
4860709|NCT00893113|16753401|P2|Overall Study|Lost to Follow-up|8
4860710|NCT00893113|16753402|P1|Overall Study|Lost to Follow-up|4
4860711|NCT00892957|16753432|P2|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2
4860712|NCT00892957|16753433|P1|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0
4860713|NCT00892957|16753432|P2|Between Postoperative Day 1 and Day 14|Death|2
4860714|NCT00892957|16753433|P1|Between Postoperative Day 1 and Day 14|Death|0
4860715|NCT00892775|16753521|P2|Overall Study|Lost to Follow-up|0
4860716|NCT00892775|16753522|P1|Overall Study|Lost to Follow-up|1
4860717|NCT00892775|16753521|P2|Overall Study|Withdrawal by Subject|1
4860718|NCT00892775|16753522|P1|Overall Study|Withdrawal by Subject|0
4860719|NCT00892775|16753521|P2|Overall Study|Migrated/ moved from study area|0
4860720|NCT00892775|16753522|P1|Overall Study|Migrated/ moved from study area|1
4860721|NCT00892775|16753521|P2|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0
4860722|NCT00892775|16753522|P1|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1
4860723|NCT00892775|16753521|P2|Overall Study|Subject difficulties with blood drawing|0
4860724|NCT00892775|16753522|P1|Overall Study|Subject difficulties with blood drawing|1
4860725|NCT00892775|16753521|P2|Overall Study|Protocol Violation|0
4860726|NCT00892775|16753522|P1|Overall Study|Protocol Violation|1
4860727|NCT00892723|16753549|P3|Overall Study|Withdrawal by Subject|1
4860728|NCT00892723|16753550|P2|Overall Study|Withdrawal by Subject|1
4860729|NCT00892723|16753551|P1|Overall Study|Withdrawal by Subject|1
4860730|NCT00892723|16753549|P3|Overall Study|Lost to Follow-up|1
4860731|NCT00892723|16753550|P2|Overall Study|Lost to Follow-up|3
4860732|NCT00892723|16753551|P1|Overall Study|Lost to Follow-up|1
4860733|NCT00892437|16753640|P2|Open-Label Extension Phase|Withdrew Consent|1
4860734|NCT00892437|16753641|P1|Open-Label Extension Phase|Withdrew Consent|3
4860735|NCT00892437|16753640|P2|Open-Label Extension Phase|Investigator's Discretion|0
4860736|NCT00892437|16753641|P1|Open-Label Extension Phase|Investigator's Discretion|1
4860737|NCT00892437|16753640|P2|Open-Label Extension Phase|Lost to Follow-up|1
4860738|NCT00892437|16753641|P1|Open-Label Extension Phase|Lost to Follow-up|3
4860739|NCT00892437|16753640|P2|Open-Label Extension Phase|Lack of Efficacy|0
4860740|NCT00892437|16753641|P1|Open-Label Extension Phase|Lack of Efficacy|1
4860741|NCT00892437|16753640|P2|Open-Label Extension Phase|Adverse Event|2
4860742|NCT00892437|16753641|P1|Open-Label Extension Phase|Adverse Event|4
4860743|NCT00892437|16753640|P2|Randomized Phase|Withdrew Consent|0
4860744|NCT00892437|16753641|P1|Randomized Phase|Withdrew Consent|1
4860745|NCT00892437|16753640|P2|Randomized Phase|Investigator's Discretion|0
4860746|NCT00892437|16753641|P1|Randomized Phase|Investigator's Discretion|1
4860747|NCT00892437|16753640|P2|Randomized Phase|Lost to Follow-up|3
4860748|NCT00892437|16753641|P1|Randomized Phase|Lost to Follow-up|1
4860749|NCT00892437|16753640|P2|Randomized Phase|Adverse Event|2
4860750|NCT00892437|16753641|P1|Randomized Phase|Adverse Event|2
4860751|NCT00892437|16753640|P2|Randomized Phase|Randomized but not treated|0
4860752|NCT00892437|16753641|P1|Randomized Phase|Randomized but not treated|6
4860753|NCT00892281|16753660|P2|Overall Study|Visit 4 date out of window|0
4860754|NCT00892281|16753661|P1|Overall Study|Visit 4 date out of window|1
4860755|NCT00892281|16753660|P2|Overall Study|Rash on hand|0
4860756|NCT00892281|16753661|P1|Overall Study|Rash on hand|1
4860757|NCT00892281|16753660|P2|Overall Study|Subject had history of drug abuse|0
4860758|NCT00892281|16753661|P1|Overall Study|Subject had history of drug abuse|1
4860759|NCT00892281|16753660|P2|Overall Study|Non-compliant with visits as scheduled|0
4860760|NCT00892281|16753661|P1|Overall Study|Non-compliant with visits as scheduled|1
4860761|NCT00892281|16753660|P2|Overall Study|Missed visits rescheduled out of window|0
4860762|NCT00892281|16753661|P1|Overall Study|Missed visits rescheduled out of window|1
4860763|NCT00892281|16753660|P2|Overall Study|Missed multiple visits|0
4860764|NCT00892281|16753661|P1|Overall Study|Missed multiple visits|1
4860765|NCT00892281|16753660|P2|Overall Study|No show Visit 2; prescription not filled|0
4860766|NCT00892281|16753661|P1|Overall Study|No show Visit 2; prescription not filled|1
4860767|NCT00892281|16753660|P2|Overall Study|Subject not seen by PI at final visit|0
4860768|NCT00892281|16753661|P1|Overall Study|Subject not seen by PI at final visit|1
4860769|NCT00892281|16753660|P2|Overall Study|Lack of efficacy of study product|0
4860770|NCT00892281|16753661|P1|Overall Study|Lack of efficacy of study product|2
4860771|NCT00892281|16753660|P2|Overall Study|Death in family|0
4860772|NCT00892281|16753661|P1|Overall Study|Death in family|1
4860773|NCT00892281|16753660|P2|Overall Study|Bad taste in mouth after taking Oracea®|1
4860774|NCT00892281|16753661|P1|Overall Study|Bad taste in mouth after taking Oracea®|0
4860775|NCT00892281|16753660|P2|Overall Study|Subject lost interest in program|1
4860776|NCT00892281|16753661|P1|Overall Study|Subject lost interest in program|0
4860777|NCT00892281|16753660|P2|Overall Study|PI complained of inadequate compensation|0
4860778|NCT00892281|16753661|P1|Overall Study|PI complained of inadequate compensation|3
4860779|NCT00892281|16753660|P2|Overall Study|Scheduled for knee replacement|1
4860780|NCT00892281|16753661|P1|Overall Study|Scheduled for knee replacement|0
4860781|NCT00892281|16753660|P2|Overall Study|Missed Visit 4 and off meds for 65 days|1
4860782|NCT00892281|16753661|P1|Overall Study|Missed Visit 4 and off meds for 65 days|1
4860783|NCT00892281|16753660|P2|Overall Study|Subject missed several visits/lost meds|0
4860784|NCT00892281|16753661|P1|Overall Study|Subject missed several visits/lost meds|1
4860785|NCT00892281|16753660|P2|Overall Study|Subject did not return for any visits|0
4860786|NCT00892281|16753661|P1|Overall Study|Subject did not return for any visits|1
4860787|NCT00892281|16753660|P2|Overall Study|Subject not good candidate for study|0
4860788|NCT00892281|16753661|P1|Overall Study|Subject not good candidate for study|1
4860789|NCT00892281|16753660|P2|Overall Study|Unable to redeem the drug voucher|0
4860790|NCT00892281|16753661|P1|Overall Study|Unable to redeem the drug voucher|1
4860791|NCT00892281|16753660|P2|Overall Study|Rosacea cleared; subject D/C'd self|0
4860792|NCT00892281|16753661|P1|Overall Study|Rosacea cleared; subject D/C'd self|1
4860793|NCT00892281|16753660|P2|Overall Study|Did not meet incl/excl criteria|0
4860794|NCT00892281|16753661|P1|Overall Study|Did not meet incl/excl criteria|1
4860795|NCT00892281|16753660|P2|Overall Study|Last visit not done - death in family|0
4860796|NCT00892281|16753661|P1|Overall Study|Last visit not done - death in family|1
4860797|NCT00892281|16753660|P2|Overall Study|Family emergency|0
4860798|NCT00892281|16753661|P1|Overall Study|Family emergency|1
4860799|NCT00892281|16753660|P2|Overall Study|Subject completed day after study closed|0
4860800|NCT00892281|16753661|P1|Overall Study|Subject completed day after study closed|1
4860801|NCT00892281|16753660|P2|Overall Study|Final visit completed 4 weeks late|1
4860802|NCT00892281|16753661|P1|Overall Study|Final visit completed 4 weeks late|0
4860803|NCT00892281|16753660|P2|Overall Study|Subject unable to keep follow-up visits|0
4860804|NCT00892281|16753661|P1|Overall Study|Subject unable to keep follow-up visits|1
4860805|NCT00892281|16753660|P2|Overall Study|Subject failed to return for final visit|0
4860806|NCT00892281|16753661|P1|Overall Study|Subject failed to return for final visit|2
4860807|NCT00892281|16753660|P2|Overall Study|Withdrawal by Subject|14
4860808|NCT00892281|16753661|P1|Overall Study|Withdrawal by Subject|86
4860809|NCT00892281|16753660|P2|Overall Study|Protocol Violation|2
4860810|NCT00892281|16753661|P1|Overall Study|Protocol Violation|7
4860811|NCT00892281|16753660|P2|Overall Study|Pregnancy|0
4860812|NCT00892281|16753661|P1|Overall Study|Pregnancy|1
4860813|NCT00892281|16753660|P2|Overall Study|Lost to Follow-up|8
4860814|NCT00892281|16753661|P1|Overall Study|Lost to Follow-up|81
4860815|NCT00892281|16753660|P2|Overall Study|Adverse Event|8
4860816|NCT00892281|16753661|P1|Overall Study|Adverse Event|65
4860817|NCT00892177|16753674|P6|Phase II|Withdrawal by Subject|1
4860818|NCT00892177|16753675|P5|Phase II|Withdrawal by Subject|4
4860819|NCT00892177|16753676|P4|Phase II|Withdrawal by Subject|0
4860820|NCT00892177|16753677|P3|Phase II|Withdrawal by Subject|0
4860821|NCT00892177|16753678|P2|Phase II|Withdrawal by Subject|0
4860822|NCT00892177|16753679|P1|Phase II|Withdrawal by Subject|0
4860823|NCT00892177|16753674|P6|Phase II|Ineligible|1
4860824|NCT00892177|16753675|P5|Phase II|Ineligible|1
4860825|NCT00892177|16753676|P4|Phase II|Ineligible|0
4860826|NCT00892177|16753677|P3|Phase II|Ineligible|0
4860827|NCT00892177|16753678|P2|Phase II|Ineligible|0
4860828|NCT00892177|16753679|P1|Phase II|Ineligible|0
4860829|NCT00892151|16753704|P1|Overall Study|Protocol Violation|1
4860830|NCT00892099|16753713|P3|Overall Study|Lost to Follow-up|1
4860831|NCT00892099|16753714|P2|Overall Study|Lost to Follow-up|0
4860832|NCT00892099|16753715|P1|Overall Study|Lost to Follow-up|0
4860833|NCT00892099|16753713|P3|Overall Study|investigator decision|1
4860834|NCT00892099|16753714|P2|Overall Study|investigator decision|0
4860835|NCT00892099|16753715|P1|Overall Study|investigator decision|0
4860836|NCT00892099|16753713|P3|Overall Study|kidney function recovered|0
4860837|NCT00892099|16753714|P2|Overall Study|kidney function recovered|1
4860838|NCT00892099|16753715|P1|Overall Study|kidney function recovered|0
4860839|NCT00892099|16753713|P3|Overall Study|no further details|1
4860840|NCT00892099|16753714|P2|Overall Study|no further details|0
4860841|NCT00892099|16753715|P1|Overall Study|no further details|1
4860842|NCT00892099|16753713|P3|Overall Study|Prolonged hospitalization|1
4860843|NCT00892099|16753714|P2|Overall Study|Prolonged hospitalization|0
4860844|NCT00892099|16753715|P1|Overall Study|Prolonged hospitalization|1
4860845|NCT00892099|16753713|P3|Overall Study|replocated|2
4860846|NCT00892099|16753714|P2|Overall Study|replocated|0
4860847|NCT00892099|16753715|P1|Overall Study|replocated|1
4860848|NCT00892099|16753713|P3|Overall Study|Adverse Event|0
4860849|NCT00892099|16753714|P2|Overall Study|Adverse Event|0
4860850|NCT00892099|16753715|P1|Overall Study|Adverse Event|1
4860851|NCT00892099|16753713|P3|Overall Study|Death|1
4860852|NCT00892099|16753714|P2|Overall Study|Death|0
4860853|NCT00892099|16753715|P1|Overall Study|Death|1
4860854|NCT00892047|16753740|P2|Overall Study|Lack of Efficacy|2
4860855|NCT00892047|16753741|P1|Overall Study|Lack of Efficacy|0
4860856|NCT00892047|16753740|P2|Overall Study|subject burden|3
4860857|NCT00892047|16753741|P1|Overall Study|subject burden|2
4860858|NCT00892047|16753740|P2|Overall Study|Adverse Event|2
4860859|NCT00892047|16753741|P1|Overall Study|Adverse Event|2
4860860|NCT00892008|16753757|P1|Overall Study|Adverse Event|37
4860861|NCT00892008|16753757|P1|Overall Study|Other|378
4860862|NCT00892008|16753757|P1|Overall Study|Lost to Follow-up|142
4860863|NCT00892008|16753757|P1|Overall Study|Lack of Efficacy|3
4860864|NCT00892008|16753757|P1|Overall Study|Death|5
4860865|NCT00891930|16753843|P1|Part 2: Panitumumab + Ganitumab|Withdrawal by Subject|1
4860866|NCT00891930|16753843|P1|Part 2: Panitumumab + Ganitumab|Death|30
4860867|NCT00891930|16753843|P1|Part 1: Panitumumab +Irinotecan|Lost to Follow-up|1
4860868|NCT00891930|16753843|P1|Part 1: Panitumumab +Irinotecan|Withdrawal by Subject|1
4860869|NCT00891930|16753843|P1|Part 1: Panitumumab +Irinotecan|Death|38
4860870|NCT00891904|16753864|P1|Overall Study|Adverse Event|1
4860871|NCT00891904|16753864|P1|Overall Study|Death|1
4860872|NCT00891839|16753890|P1|Overall Study|Disease progression|3
4860873|NCT00891839|16753890|P1|Overall Study|Withdrawal by Subject|2
4860874|NCT00891839|16753890|P1|Overall Study|Adverse Event|2
4860875|NCT00891813|16753899|P1|Overall Study|Protocol Violation|2
4860876|NCT00891813|16753899|P1|Overall Study|Patient Noncompliance|6
4860877|NCT00891813|16753899|P1|Overall Study|Withdrawal by Subject|1
4860878|NCT00891813|16753899|P1|Overall Study|Adverse Event|3
4860879|NCT00891774|16753905|P1|Overall Study|Protocol Violation|4
4860880|NCT00891774|16753905|P1|Overall Study|Withdrawal by Subject|2
4860881|NCT00891774|16753905|P1|Overall Study|Illness (Self/Mother)|3
4860882|NCT00891774|16753905|P1|Overall Study|Lost to Follow-up|5
4860883|NCT00891735|16753916|P4|Overall Study|Patient's decision to withdraw|8
4860884|NCT00891735|16753917|P3|Overall Study|Patient's decision to withdraw|4
4860885|NCT00891735|16753918|P2|Overall Study|Patient's decision to withdraw|9
4860886|NCT00891735|16753919|P1|Overall Study|Patient's decision to withdraw|4
4860887|NCT00891735|16753916|P4|Overall Study|Physician's decision to withdraw patient|0
4860888|NCT00891735|16753917|P3|Overall Study|Physician's decision to withdraw patient|0
4860889|NCT00891735|16753918|P2|Overall Study|Physician's decision to withdraw patient|0
4860890|NCT00891735|16753919|P1|Overall Study|Physician's decision to withdraw patient|1
4860891|NCT00891735|16753916|P4|Overall Study|Lost to Follow-up|2
4860892|NCT00891735|16753917|P3|Overall Study|Lost to Follow-up|2
4860893|NCT00891735|16753918|P2|Overall Study|Lost to Follow-up|2
4860894|NCT00891735|16753919|P1|Overall Study|Lost to Follow-up|2
4860895|NCT00891735|16753916|P4|Overall Study|Death|5
4860896|NCT00891735|16753917|P3|Overall Study|Death|4
4860897|NCT00891735|16753918|P2|Overall Study|Death|5
4860898|NCT00891735|16753919|P1|Overall Study|Death|8
4860899|NCT00891735|16753916|P4|Overall Study|Adverse Event|0
4860900|NCT00891735|16753917|P3|Overall Study|Adverse Event|2
4860901|NCT00891735|16753918|P2|Overall Study|Adverse Event|0
4860902|NCT00891735|16753919|P1|Overall Study|Adverse Event|2
4860903|NCT00891657|16753959|P2|Overall Study|Withdrawal by Subject|1
4860904|NCT00891657|16753960|P1|Overall Study|Withdrawal by Subject|1
4860905|NCT00891618|16753972|P1|Overall Study|Withdrawal by Subject|1
4860906|NCT00891527|16753976|P1|Overall Study|Withdrawal by Subject|2
4860907|NCT00891462|16753985|P3|Overall Study|Lost to Follow-up|0
4860908|NCT00891462|16753986|P2|Overall Study|Lost to Follow-up|2
4860909|NCT00891462|16753987|P1|Overall Study|Lost to Follow-up|0
4860910|NCT00891462|16753985|P3|Overall Study|Inclusion/exclusion criteria|2
4860911|NCT00891462|16753986|P2|Overall Study|Inclusion/exclusion criteria|2
4860912|NCT00891462|16753987|P1|Overall Study|Inclusion/exclusion criteria|0
4860913|NCT00891462|16753985|P3|Overall Study|Protocol Violation|3
4860914|NCT00891462|16753986|P2|Overall Study|Protocol Violation|1
4860915|NCT00891462|16753987|P1|Overall Study|Protocol Violation|2
4860916|NCT00891462|16753985|P3|Overall Study|Other Reason|3
4860917|NCT00891462|16753986|P2|Overall Study|Other Reason|5
4860918|NCT00891462|16753987|P1|Overall Study|Other Reason|2
4860919|NCT00891462|16753985|P3|Overall Study|COPD exacerbation|1
4860920|NCT00891462|16753986|P2|Overall Study|COPD exacerbation|4
4860921|NCT00891462|16753987|P1|Overall Study|COPD exacerbation|7
4860922|NCT00891462|16753985|P3|Overall Study|Lack of Efficacy|1
4860923|NCT00891462|16753986|P2|Overall Study|Lack of Efficacy|5
4860924|NCT00891462|16753987|P1|Overall Study|Lack of Efficacy|10
4860925|NCT00891462|16753985|P3|Overall Study|Adverse Event|7
4860926|NCT00891462|16753986|P2|Overall Study|Adverse Event|8
4860927|NCT00891462|16753987|P1|Overall Study|Adverse Event|7
4860928|NCT00891462|16753985|P3|Overall Study|Withdrawal by Subject|7
4860929|NCT00891462|16753986|P2|Overall Study|Withdrawal by Subject|6
4860930|NCT00891462|16753987|P1|Overall Study|Withdrawal by Subject|9
4860931|NCT00891371|16754009|P1|Treatment|Lost to Follow-up|1
4860932|NCT00891371|16754009|P1|Treatment|Death|1
4860933|NCT00891371|16754009|P1|Treatment|Adverse Event|2
4860934|NCT00891371|16754009|P1|Treatment|Lack of Efficacy|5
4860935|NCT00891371|16754009|P1|Pre-assignment|Consent withdrawal|1
4860936|NCT00891371|16754009|P1|Pre-assignment|Inclusion/exclusion|5
4860937|NCT00891293|16754031|P1|Overall Study|Sponsor termination|62
4860938|NCT00891293|16754031|P1|Overall Study|Subject withdrew consent|7
4860939|NCT00891293|16754031|P1|Overall Study|Lost to Follow-up|7
4860940|NCT00891293|16754031|P1|Overall Study|Laboratory abnormality|4
4860941|NCT00891293|16754031|P1|Overall Study|Protocol Violation|2
4860942|NCT00891293|16754031|P1|Overall Study|Adverse Event|2
4860943|NCT00891228|16754046|P3|Overall Study|Pregnancy|0
4860944|NCT00891228|16754047|P2|Overall Study|Pregnancy|1
4860945|NCT00891228|16754048|P1|Overall Study|Pregnancy|0
4860946|NCT00891228|16754046|P3|Overall Study|Lost to Follow-up|5
4860947|NCT00891228|16754047|P2|Overall Study|Lost to Follow-up|4
4860948|NCT00891228|16754048|P1|Overall Study|Lost to Follow-up|4
4860949|NCT00891228|16754046|P3|Overall Study|Physician Decision|0
4860950|NCT00891228|16754047|P2|Overall Study|Physician Decision|1
4860951|NCT00891228|16754048|P1|Overall Study|Physician Decision|2
4860952|NCT00891228|16754046|P3|Overall Study|Protocol Violation|2
4860953|NCT00891228|16754047|P2|Overall Study|Protocol Violation|1
4860954|NCT00891228|16754048|P1|Overall Study|Protocol Violation|3
4860955|NCT00891228|16754046|P3|Overall Study|Withdrawal by Subject|5
4860956|NCT00891228|16754047|P2|Overall Study|Withdrawal by Subject|4
4860957|NCT00891228|16754048|P1|Overall Study|Withdrawal by Subject|2
4860958|NCT00891228|16754046|P3|Overall Study|Adverse Event|3
4860959|NCT00891228|16754047|P2|Overall Study|Adverse Event|2
4860960|NCT00891228|16754048|P1|Overall Study|Adverse Event|0
4860961|NCT00891202|16754070|P4|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5
4860962|NCT00891202|16754071|P3|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2
4860963|NCT00891202|16754072|P2|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
4860964|NCT00891202|16754073|P1|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0
4860965|NCT00891202|16754070|P4|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
4860966|NCT00891202|16754071|P3|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1
4860967|NCT00891202|16754072|P2|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
4860968|NCT00891202|16754073|P1|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0
4860969|NCT00891202|16754070|P4|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
4860970|NCT00891202|16754071|P3|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4
4860971|NCT00891202|16754072|P2|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
4860972|NCT00891202|16754073|P1|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0
4860973|NCT00891202|16754070|P4|PAP (Up To Week 39)|Withdrawal by Subject|0
4860974|NCT00891202|16754071|P3|PAP (Up To Week 39)|Withdrawal by Subject|0
4860975|NCT00891202|16754072|P2|PAP (Up To Week 39)|Withdrawal by Subject|0
4860976|NCT00891202|16754073|P1|PAP (Up To Week 39)|Withdrawal by Subject|1
4860977|NCT00891046|16754249|P5|Overall Study|Lost to Follow-up|1
4860978|NCT00891046|16754250|P4|Overall Study|Lost to Follow-up|0
4860979|NCT00891046|16754251|P3|Overall Study|Lost to Follow-up|0
4860980|NCT00891046|16754252|P2|Overall Study|Lost to Follow-up|0
4860981|NCT00891046|16754253|P1|Overall Study|Lost to Follow-up|0
4860982|NCT00891046|16754249|P5|Overall Study|Withdrawal by Subject|1
4860983|NCT00891046|16754250|P4|Overall Study|Withdrawal by Subject|1
4860984|NCT00891046|16754251|P3|Overall Study|Withdrawal by Subject|2
4860985|NCT00891046|16754252|P2|Overall Study|Withdrawal by Subject|1
4860986|NCT00891046|16754253|P1|Overall Study|Withdrawal by Subject|2
4860987|NCT00891046|16754249|P5|Overall Study|Adverse Event|14
4860988|NCT00891046|16754250|P4|Overall Study|Adverse Event|0
4860989|NCT00891046|16754251|P3|Overall Study|Adverse Event|2
4860990|NCT00891046|16754252|P2|Overall Study|Adverse Event|3
4860991|NCT00891046|16754253|P1|Overall Study|Adverse Event|4
4860992|NCT00891046|16754249|P5|Overall Study|Participant no longer required drug|1
4860993|NCT00891046|16754250|P4|Overall Study|Participant no longer required drug|0
4860994|NCT00891046|16754251|P3|Overall Study|Participant no longer required drug|0
4860995|NCT00891046|16754252|P2|Overall Study|Participant no longer required drug|2
4860996|NCT00891046|16754253|P1|Overall Study|Participant no longer required drug|0
4860997|NCT00891046|16754249|P5|Overall Study|Administrative problems|1
4860998|NCT00891046|16754250|P4|Overall Study|Administrative problems|0
4860999|NCT00891046|16754251|P3|Overall Study|Administrative problems|0
4861000|NCT00891046|16754252|P2|Overall Study|Administrative problems|0
4861001|NCT00891046|16754253|P1|Overall Study|Administrative problems|0
4861002|NCT00891046|16754249|P5|Overall Study|Unsatisfactory therapeutic effect|20
4861003|NCT00891046|16754250|P4|Overall Study|Unsatisfactory therapeutic effect|2
4861004|NCT00891046|16754251|P3|Overall Study|Unsatisfactory therapeutic effect|19
4861005|NCT00891046|16754252|P2|Overall Study|Unsatisfactory therapeutic effect|2
4861006|NCT00891046|16754253|P1|Overall Study|Unsatisfactory therapeutic effect|5
4861007|NCT00891046|16754249|P5|Overall Study|Protocol Violation|1
4861008|NCT00891046|16754250|P4|Overall Study|Protocol Violation|0
4861009|NCT00891046|16754251|P3|Overall Study|Protocol Violation|0
4861010|NCT00891046|16754252|P2|Overall Study|Protocol Violation|1
4861011|NCT00891046|16754253|P1|Overall Study|Protocol Violation|1
4861012|NCT00891020|16754329|P3|Long-term Extension Period|Administrative|2
4861013|NCT00891020|16754330|P2|Long-term Extension Period|Administrative|2
4861014|NCT00891020|16754331|P1|Long-term Extension Period|Administrative|1
4861015|NCT00891020|16754329|P3|Long-term Extension Period|Failure to return|3
4861016|NCT00891020|16754330|P2|Long-term Extension Period|Failure to return|2
4861017|NCT00891020|16754331|P1|Long-term Extension Period|Failure to return|0
4861018|NCT00891020|16754329|P3|Long-term Extension Period|Refused treatment/did not cooperate|4
4861019|NCT00891020|16754330|P2|Long-term Extension Period|Refused treatment/did not cooperate|6
4861020|NCT00891020|16754331|P1|Long-term Extension Period|Refused treatment/did not cooperate|1
4861021|NCT00891020|16754329|P3|Long-term Extension Period|Protocol Violation|1
4861022|NCT00891020|16754330|P2|Long-term Extension Period|Protocol Violation|1
4861023|NCT00891020|16754331|P1|Long-term Extension Period|Protocol Violation|0
4861024|NCT00891020|16754329|P3|Long-term Extension Period|Insufficient therapeutic response|2
4861025|NCT00891020|16754330|P2|Long-term Extension Period|Insufficient therapeutic response|2
4861026|NCT00891020|16754331|P1|Long-term Extension Period|Insufficient therapeutic response|3
4861027|NCT00891020|16754329|P3|Long-term Extension Period|Death|1
4861028|NCT00891020|16754330|P2|Long-term Extension Period|Death|0
4861029|NCT00891020|16754331|P1|Long-term Extension Period|Death|0
4861030|NCT00891020|16754329|P3|Long-term Extension Period|Adverse Event|10
4861031|NCT00891020|16754330|P2|Long-term Extension Period|Adverse Event|11
4861032|NCT00891020|16754331|P1|Long-term Extension Period|Adverse Event|1
4861033|NCT00891020|16754329|P3|24 Week Treatment Period|Administrative/Other|1
4861034|NCT00891020|16754330|P2|24 Week Treatment Period|Administrative/Other|6
4861035|NCT00891020|16754331|P1|24 Week Treatment Period|Administrative/Other|5
4861036|NCT00891020|16754329|P3|24 Week Treatment Period|Withdrew consent|15
4861037|NCT00891020|16754330|P2|24 Week Treatment Period|Withdrew consent|3
4861038|NCT00891020|16754331|P1|24 Week Treatment Period|Withdrew consent|6
4861039|NCT00891020|16754329|P3|24 Week Treatment Period|Refused treatment/did not cooperate|1
4861040|NCT00891020|16754330|P2|24 Week Treatment Period|Refused treatment/did not cooperate|2
4861041|NCT00891020|16754331|P1|24 Week Treatment Period|Refused treatment/did not cooperate|3
4861042|NCT00891020|16754329|P3|24 Week Treatment Period|Other protocol violation|2
4861043|NCT00891020|16754330|P2|24 Week Treatment Period|Other protocol violation|1
4861044|NCT00891020|16754331|P1|24 Week Treatment Period|Other protocol violation|1
4861045|NCT00891020|16754329|P3|24 Week Treatment Period|Violation of selection criteria at entry|2
4861046|NCT00891020|16754330|P2|24 Week Treatment Period|Violation of selection criteria at entry|0
4861047|NCT00891020|16754331|P1|24 Week Treatment Period|Violation of selection criteria at entry|1
4861048|NCT00891020|16754329|P3|24 Week Treatment Period|Failure to return|5
4861049|NCT00891020|16754330|P2|24 Week Treatment Period|Failure to return|5
4861050|NCT00891020|16754331|P1|24 Week Treatment Period|Failure to return|4
4861051|NCT00891020|16754329|P3|24 Week Treatment Period|Insufficient therapeutic response|15
4861052|NCT00891020|16754330|P2|24 Week Treatment Period|Insufficient therapeutic response|9
4861053|NCT00891020|16754331|P1|24 Week Treatment Period|Insufficient therapeutic response|6
4861054|NCT00891020|16754329|P3|24 Week Treatment Period|Death|0
4861055|NCT00891020|16754330|P2|24 Week Treatment Period|Death|2
4861056|NCT00891020|16754331|P1|24 Week Treatment Period|Death|0
4861057|NCT00891020|16754329|P3|24 Week Treatment Period|Adverse event or intercurrent illness|17
4861058|NCT00891020|16754330|P2|24 Week Treatment Period|Adverse event or intercurrent illness|32
4861059|NCT00891020|16754331|P1|24 Week Treatment Period|Adverse event or intercurrent illness|11
4861060|NCT00890929|16754395|P1|Overall Study|Physician Decision|1
4861061|NCT00890929|16754395|P1|Overall Study|Withdrawal by Subject|3
4861062|NCT00890929|16754395|P1|Overall Study|Death before treatment|2
4861063|NCT00890825|16754413|P2|Overall Study|Alive at data cut off (DCO)|14
4861064|NCT00890825|16754414|P1|Overall Study|Alive at data cut off (DCO)|13
4861065|NCT00890825|16754413|P2|Overall Study|Withdrawal by Subject|0
4861066|NCT00890825|16754414|P1|Overall Study|Withdrawal by Subject|1
4861067|NCT00890695|16754443|P2|Overall Study|Protocol Violation|0
4861068|NCT00890695|16754444|P1|Overall Study|Protocol Violation|1
4861069|NCT00890591|16754478|P1|Overall Study|Lack of Efficacy|20
4861070|NCT00890552|16754484|P1|On-treatment|Early prog disease/ death|10
4861071|NCT00890552|16754484|P1|Enrollment and Pre-treatment|Death/ lost to follow up|1
4861072|NCT00890409|16754493|P2|Overall Study|Lost to Follow-up|21
4861073|NCT00890409|16754494|P1|Overall Study|Lost to Follow-up|20
4861074|NCT00890201|16754531|P2|Overall Study|Protocol Violation|56
4861075|NCT00890201|16754532|P1|Overall Study|Protocol Violation|5
4861076|NCT00890097|16754550|P3|Overall Study|Protocol Deviation|1
4861077|NCT00890097|16754551|P2|Overall Study|Protocol Deviation|1
4861078|NCT00890097|16754552|P1|Overall Study|Protocol Deviation|1
4861079|NCT00890097|16754550|P3|Overall Study|Subject Moved|0
4861080|NCT00890097|16754551|P2|Overall Study|Subject Moved|4
4861081|NCT00890097|16754552|P1|Overall Study|Subject Moved|0
4861082|NCT00890097|16754550|P3|Overall Study|Transportation|0
4861083|NCT00890097|16754551|P2|Overall Study|Transportation|2
4861084|NCT00890097|16754552|P1|Overall Study|Transportation|0
4861085|NCT00890097|16754550|P3|Overall Study|Failed inclusion criteria|0
4861086|NCT00890097|16754551|P2|Overall Study|Failed inclusion criteria|4
4861087|NCT00890097|16754552|P1|Overall Study|Failed inclusion criteria|3
4861088|NCT00890097|16754550|P3|Overall Study|Randomization Error|0
4861089|NCT00890097|16754551|P2|Overall Study|Randomization Error|0
4861090|NCT00890097|16754552|P1|Overall Study|Randomization Error|2
4861091|NCT00890097|16754550|P3|Overall Study|Subject Decision|6
4861092|NCT00890097|16754551|P2|Overall Study|Subject Decision|2
4861093|NCT00890097|16754552|P1|Overall Study|Subject Decision|3
4861094|NCT00890097|16754550|P3|Overall Study|Did not attend final visit|0
4861095|NCT00890097|16754551|P2|Overall Study|Did not attend final visit|3
4861096|NCT00890097|16754552|P1|Overall Study|Did not attend final visit|2
4861097|NCT00890097|16754550|P3|Overall Study|Sponsor Decision|7
4861098|NCT00890097|16754551|P2|Overall Study|Sponsor Decision|11
4861099|NCT00890097|16754552|P1|Overall Study|Sponsor Decision|7
4861100|NCT00890097|16754550|P3|Overall Study|Noncompliance|4
4861101|NCT00890097|16754551|P2|Overall Study|Noncompliance|4
4861102|NCT00890097|16754552|P1|Overall Study|Noncompliance|0
4861103|NCT00890097|16754550|P3|Overall Study|Lost to Follow-up|5
4861104|NCT00890097|16754551|P2|Overall Study|Lost to Follow-up|5
4861105|NCT00890097|16754552|P1|Overall Study|Lost to Follow-up|5
4861106|NCT00890097|16754550|P3|Overall Study|Withdrew Consent|9
4861107|NCT00890097|16754551|P2|Overall Study|Withdrew Consent|6
4861108|NCT00890097|16754552|P1|Overall Study|Withdrew Consent|9
4861109|NCT00890097|16754550|P3|Overall Study|Decision Unrelated to an Adverse Event|17
4861110|NCT00890097|16754551|P2|Overall Study|Decision Unrelated to an Adverse Event|12
4861111|NCT00890097|16754552|P1|Overall Study|Decision Unrelated to an Adverse Event|15
4861112|NCT00890097|16754550|P3|Overall Study|Adverse Event|28
4861113|NCT00890097|16754551|P2|Overall Study|Adverse Event|32
4861114|NCT00890097|16754552|P1|Overall Study|Adverse Event|21
4861115|NCT00890084|16754560|P1|Overall Study|Lost to Follow-up|126
4861116|NCT00890084|16754560|P1|Overall Study|Adverse Event|16
4861117|NCT00889863|16754600|P2|Part II: Randomized Double Blind|Protocol deviation|1
4861118|NCT00889863|16754601|P1|Part II: Randomized Double Blind|Protocol deviation|0
4861119|NCT00889863|16754600|P2|Part II: Randomized Double Blind|Withdrawal by Subject|1
4861120|NCT00889863|16754601|P1|Part II: Randomized Double Blind|Withdrawal by Subject|0
4861121|NCT00889863|16754600|P2|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20
4861122|NCT00889863|16754601|P1|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11
4861123|NCT00889863|16754600|P2|Part II: Randomized Double Blind|Adverse Event|4
4861124|NCT00889863|16754601|P1|Part II: Randomized Double Blind|Adverse Event|0
4861125|NCT00889863|16754600|P2|Part I: Open Label|Unsatisfactory therapeutic effect|0
4861126|NCT00889863|16754601|P1|Part I: Open Label|Unsatisfactory therapeutic effect|72
4861127|NCT00889863|16754600|P2|Part I: Open Label|Adverse Event|0
4861128|NCT00889863|16754601|P1|Part I: Open Label|Adverse Event|4
4861129|NCT00889863|16754600|P2|Part I: Open Label|Death|0
4861130|NCT00889863|16754601|P1|Part I: Open Label|Death|1
4861131|NCT00889720|16754627|P1|Overall Study|Other|4
4861132|NCT00889720|16754627|P1|Overall Study|Withdrawal by Subject|4
4861133|NCT00889707|16754654|P2|Overall Study|Lack of Efficacy|5
4861134|NCT00889707|16754655|P1|Overall Study|Lack of Efficacy|2
4861135|NCT00889707|16754654|P2|Overall Study|Lost to Follow-up|2
4861136|NCT00889707|16754655|P1|Overall Study|Lost to Follow-up|0
4861137|NCT00889707|16754654|P2|Overall Study|Withdrawal by Subject|3
4861138|NCT00889707|16754655|P1|Overall Study|Withdrawal by Subject|4
4861139|NCT00889707|16754654|P2|Overall Study|Adverse Event|0
4861140|NCT00889707|16754655|P1|Overall Study|Adverse Event|1
4861141|NCT00889681|16754663|P1|Overall Study|Insurance disapproval|1
4861142|NCT00889681|16754663|P1|Overall Study|Not meeting qualification Criteria|2
4861143|NCT00889603|16754670|P1|Overall Study|Other|4
4861144|NCT00889603|16754670|P1|Overall Study|No longer willing to participant in stud|4
4861145|NCT00889603|16754670|P1|Overall Study|Lost to Follow-up|19
4861146|NCT00889603|16754670|P1|Overall Study|Death|3
4861147|NCT00889603|16754670|P1|Overall Study|Adverse Event|7
4861148|NCT00889421|16754692|P1|Overall Study|Lack of Efficacy|3
4861149|NCT00889265|16754733|P1|Overall Study|Protocol Violation|1
4861150|NCT00889265|16754733|P1|Overall Study|Lost to Follow-up|5
4861151|NCT00889265|16754733|P1|Overall Study|Adverse Event|1
4861152|NCT00889252|16754740|P2|Overall Study|Protocol Violation|0
4861153|NCT00889252|16754741|P1|Overall Study|Protocol Violation|2
4861154|NCT00889252|16754740|P2|Overall Study|Withdrawal by Subject|0
4861155|NCT00889252|16754741|P1|Overall Study|Withdrawal by Subject|3
4861156|NCT00889252|16754740|P2|Overall Study|Adverse Event|4
4861157|NCT00889252|16754741|P1|Overall Study|Adverse Event|2
4861158|NCT00889005|16754818|P2|Overall Study|Withdrawal by Subject|0
4861159|NCT00889005|16754819|P1|Overall Study|Withdrawal by Subject|4
4861160|NCT00889005|16754818|P2|Overall Study|Lost to Follow-up|2
4861161|NCT00889005|16754819|P1|Overall Study|Lost to Follow-up|4
4861162|NCT00888940|16754833|P2|Overall Study|Randomized Not Treated|13
4861163|NCT00888940|16754834|P1|Overall Study|Randomized Not Treated|11
4861164|NCT00888940|16754833|P2|Overall Study|Lost to Follow-up|5
4861165|NCT00888940|16754834|P1|Overall Study|Lost to Follow-up|5
4861166|NCT00888940|16754833|P2|Overall Study|Adverse Event|3
4861167|NCT00888940|16754834|P1|Overall Study|Adverse Event|12
4861168|NCT00888849|16754844|P2|Overall Study|Lost to Follow-up|2
4861169|NCT00888849|16754845|P1|Overall Study|Lost to Follow-up|1
4861170|NCT00888849|16754844|P2|Overall Study|Death|7
4861171|NCT00888849|16754845|P1|Overall Study|Death|4
4861172|NCT00888654|16754855|P1|Overall Study|Stopped meds due to headaches|1
4861173|NCT00888654|16754855|P1|Overall Study|Change in surg date|1
4861174|NCT00888654|16754855|P1|Overall Study|Inelig. due to contraindication of med|1
4861175|NCT00888654|16754855|P1|Overall Study|Withdrawal by Subject|1
4861176|NCT00888654|16754855|P1|Overall Study|Surgery aborted|2
4861177|NCT00888654|16754855|P1|Overall Study|Not enough oral meds before surgery|3
4861178|NCT00888654|16754855|P1|Overall Study|Problems swallowing oral meds.|1
4861179|NCT00888615|16754873|P1|Overall Study|No treatment|2
4861180|NCT00888433|16754893|P2|Overall Study|Missed Visit|1
4861181|NCT00888433|16754894|P1|Overall Study|Missed Visit|2
4861182|NCT00888433|16754893|P2|Overall Study|Withdrawal by Subject|2
4861183|NCT00888433|16754894|P1|Overall Study|Withdrawal by Subject|1
4861184|NCT00888381|16754902|P2|Overall Study|Lost to Follow-up|1
4861185|NCT00888381|16754903|P1|Overall Study|Lost to Follow-up|0
4861186|NCT00888355|16754923|P4|Overall Study|Withdrawal by Subject|3
4861187|NCT00888355|16754924|P3|Overall Study|Withdrawal by Subject|1
4861188|NCT00888355|16754925|P2|Overall Study|Withdrawal by Subject|3
4861189|NCT00888355|16754926|P1|Overall Study|Withdrawal by Subject|0
4861190|NCT00888355|16754923|P4|Overall Study|Protocol Violation|2
4861191|NCT00888355|16754924|P3|Overall Study|Protocol Violation|1
4861192|NCT00888355|16754925|P2|Overall Study|Protocol Violation|2
4861193|NCT00888355|16754926|P1|Overall Study|Protocol Violation|3
4861194|NCT00888355|16754923|P4|Overall Study|Lost to Follow-up|0
4861195|NCT00888355|16754924|P3|Overall Study|Lost to Follow-up|2
4861196|NCT00888355|16754925|P2|Overall Study|Lost to Follow-up|2
4861197|NCT00888355|16754926|P1|Overall Study|Lost to Follow-up|0
4861198|NCT00888355|16754923|P4|Overall Study|Lack of Efficacy|2
4861199|NCT00888355|16754924|P3|Overall Study|Lack of Efficacy|5
4861200|NCT00888355|16754925|P2|Overall Study|Lack of Efficacy|2
4861201|NCT00888355|16754926|P1|Overall Study|Lack of Efficacy|9
4861202|NCT00888355|16754923|P4|Overall Study|Adverse Event|3
4861203|NCT00888355|16754924|P3|Overall Study|Adverse Event|3
4861204|NCT00888355|16754925|P2|Overall Study|Adverse Event|0
4861205|NCT00888355|16754926|P1|Overall Study|Adverse Event|10
4861206|NCT00888329|16754982|P2|Overall Study|Physician Decision|9
4861207|NCT00888329|16754983|P1|Overall Study|Physician Decision|6
4861208|NCT00888238|16754989|P3|Washout Period After Period 2|Adverse Event|1
4861209|NCT00888238|16754990|P2|Washout Period After Period 2|Adverse Event|0
4861210|NCT00888238|16754991|P1|Washout Period After Period 2|Adverse Event|0
4861211|NCT00888173|16754999|P1|Overall Study|Ineligible: required test not done|1
4861212|NCT00888173|16754999|P1|Overall Study|Wrong Primary|1
4861213|NCT00888134|16755007|P1|Follow-up|being followed for long-term survival|1
4861214|NCT00888134|16755007|P1|Treatment With Study Drug|Withdrawal by Subject|1
4861215|NCT00887978|16755017|P2|Overall Study|Lost to Follow-up|1
4861216|NCT00887978|16755018|P1|Overall Study|Lost to Follow-up|0
4861217|NCT00887978|16755017|P2|Overall Study|Withdrawal by Subject|2
4861218|NCT00887978|16755018|P1|Overall Study|Withdrawal by Subject|1
4861219|NCT00887978|16755017|P2|Overall Study|Death|3
4861220|NCT00887978|16755018|P1|Overall Study|Death|2
4861221|NCT00887978|16755017|P2|Overall Study|Clinical Worsening|4
4861222|NCT00887978|16755018|P1|Overall Study|Clinical Worsening|4
4861223|NCT00887978|16755017|P2|Overall Study|Adverse Event|5
4861224|NCT00887978|16755018|P1|Overall Study|Adverse Event|18
4861225|NCT00887926|16755088|P4|Overall Study|Withdrawal by Subject|0
4861226|NCT00887926|16755089|P3|Overall Study|Withdrawal by Subject|0
4861227|NCT00887926|16755090|P2|Overall Study|Withdrawal by Subject|1
4861228|NCT00887926|16755091|P1|Overall Study|Withdrawal by Subject|0
4861229|NCT00887913|16755126|P1|Overall Study|Withdrawal by Subject|6
4861230|NCT00887822|16755134|P2|Overall Study|Randomized but not treated|1
4861231|NCT00887822|16755135|P1|Overall Study|Randomized but not treated|0
4861232|NCT00887822|16755134|P2|Overall Study|Protocol Violation|1
4861233|NCT00887822|16755135|P1|Overall Study|Protocol Violation|0
4861234|NCT00887822|16755134|P2|Overall Study|Death|3
4861235|NCT00887822|16755135|P1|Overall Study|Death|2
4861236|NCT00887822|16755134|P2|Overall Study|Administrative/Other than specified|4
4861237|NCT00887822|16755135|P1|Overall Study|Administrative/Other than specified|5
4861238|NCT00887822|16755134|P2|Overall Study|Refused treatment/Did not cooperate|10
4861239|NCT00887822|16755135|P1|Overall Study|Refused treatment/Did not cooperate|12
4861240|NCT00887822|16755134|P2|Overall Study|Failure to return|11
4861241|NCT00887822|16755135|P1|Overall Study|Failure to return|11
4861242|NCT00887822|16755134|P2|Overall Study|Adverse Event|17
4861243|NCT00887822|16755135|P1|Overall Study|Adverse Event|14
4861244|NCT00887822|16755134|P2|Overall Study|Insufficient therapeutic response|55
4861245|NCT00887822|16755135|P1|Overall Study|Insufficient therapeutic response|53
4861246|NCT00887809|16755167|P2|Overall Study|Death|0
4861247|NCT00887809|16755168|P1|Overall Study|Death|1
4861248|NCT00887809|16755167|P2|Overall Study|Patient Not Treated|0
4861249|NCT00887809|16755168|P1|Overall Study|Patient Not Treated|3
4861250|NCT00887744|16755174|P1|Overall Study|Various reasons|9
4861251|NCT00887744|16755174|P1|Overall Study|Withdrawal by Subject|18
4861252|NCT00887744|16755174|P1|Overall Study|Lost to Follow-up|3
4861253|NCT00887744|16755174|P1|Overall Study|Death|1
4861254|NCT00887744|16755174|P1|Overall Study|Adverse Event|3
4861255|NCT00887679|16755183|P1|Overall Study|Physician Decision|5
4861256|NCT00887679|16755183|P1|Overall Study|Lost to Follow-up|4
4861257|NCT00887679|16755183|P1|Overall Study|Withdrawal by Subject|1
4861258|NCT00887588|16755213|P2|Extension Period|Lost to Follow-up|0
4861259|NCT00887588|16755214|P1|Extension Period|Lost to Follow-up|1
4861260|NCT00887588|16755213|P2|Extension Period|Protocol deviation|0
4861261|NCT00887588|16755214|P1|Extension Period|Protocol deviation|1
4861262|NCT00887588|16755213|P2|Extension Period|Death|1
4861263|NCT00887588|16755214|P1|Extension Period|Death|0
4861264|NCT00887588|16755213|P2|Extension Period|Adverse Event|4
4861265|NCT00887588|16755214|P1|Extension Period|Adverse Event|4
4861266|NCT00887588|16755213|P2|Core Period|Adverse Event|11
4861267|NCT00887588|16755214|P1|Core Period|Adverse Event|9
4861268|NCT00887588|16755213|P2|Core Period|Withdrawal by Subject|8
4861269|NCT00887588|16755214|P1|Core Period|Withdrawal by Subject|6
4861270|NCT00887588|16755213|P2|Core Period|Lost to Follow-up|1
4861271|NCT00887588|16755214|P1|Core Period|Lost to Follow-up|3
4861272|NCT00887588|16755213|P2|Core Period|Death|1
4861273|NCT00887588|16755214|P1|Core Period|Death|1
4861274|NCT00887549|16755295|P1|Maintenance Therapy|Death due to adverse event|1
4861275|NCT00887549|16755295|P1|Maintenance Therapy|Progressive Disease|25
4861276|NCT00887549|16755295|P1|Maintenance Therapy|Physician Decision|1
4861277|NCT00887549|16755295|P1|Maintenance Therapy|Adverse Event|16
4861278|NCT00887549|16755295|P1|Induction Therapy|Death due to Study Drug Toxicity|1
4861279|NCT00887549|16755295|P1|Induction Therapy|Death due to Study Disease|4
4861280|NCT00887549|16755295|P1|Induction Therapy|Progressive Disease|13
4861281|NCT00887549|16755295|P1|Induction Therapy|Physician Decision|1
4861282|NCT00887549|16755295|P1|Induction Therapy|Adverse Event|8
4861283|NCT00887484|16755313|P1|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1
4861284|NCT00887484|16755313|P1|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1
4861285|NCT00887484|16755313|P1|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1
4861286|NCT00887354|16755401|P2|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
4861287|NCT00887354|16755402|P1|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1
4861288|NCT00887354|16755401|P2|Open Label Phase (Week 26 to Week 78)|Adverse Event|0
4861289|NCT00887354|16755402|P1|Open Label Phase (Week 26 to Week 78)|Adverse Event|1
4861290|NCT00887354|16755401|P2|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2
4861291|NCT00887354|16755402|P1|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1
4861292|NCT00887354|16755401|P2|Open Label Phase (Week 26 to Week 78)|Physician Decision|1
4861293|NCT00887354|16755402|P1|Open Label Phase (Week 26 to Week 78)|Physician Decision|0
4861294|NCT00887354|16755401|P2|Open Label Phase (Week 26 to Week 78)|Death|2
4861295|NCT00887354|16755402|P1|Open Label Phase (Week 26 to Week 78)|Death|0
4861296|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Not Treated|3
4861297|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Not Treated|5
4861298|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|No efficacy data|25
4861299|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|No efficacy data|20
4861300|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2
4861301|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1
4861302|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
4861303|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3
4861304|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1
4861305|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2
4861306|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
4861307|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Adverse Event|3
4861308|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8
4861309|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14
4861310|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Physician Decision|1
4861311|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Physician Decision|2
4861312|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
4861313|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1
4861314|NCT00887354|16755401|P2|Treatment Phase (Week 0 to Week 26)|Death|1
4861315|NCT00887354|16755402|P1|Treatment Phase (Week 0 to Week 26)|Death|0
4861316|NCT00887341|16755422|P2|Overall Study|Lost to Follow-up|1
4861317|NCT00887341|16755423|P1|Overall Study|Lost to Follow-up|0
4861318|NCT00887341|16755422|P2|Overall Study|Adverse Event|1
4861319|NCT00887341|16755423|P1|Overall Study|Adverse Event|0
4861320|NCT00887341|16755422|P2|Overall Study|Withdrawal by Subject|1
4861321|NCT00887341|16755423|P1|Overall Study|Withdrawal by Subject|1
4861322|NCT00887341|16755422|P2|Overall Study|Refused treatment|0
4861323|NCT00887341|16755423|P1|Overall Study|Refused treatment|1
4861324|NCT00887315|16755459|P2|Overall Study|Study termination|4
4861325|NCT00887315|16755460|P1|Overall Study|Study termination|7
4861326|NCT00887289|16755468|P1|Overall Study|Other|20
4861327|NCT00887289|16755468|P1|Overall Study|Lost to Follow-up|8
4861328|NCT00887289|16755468|P1|Overall Study|Withdrawal by Subject|26
4861329|NCT00887289|16755468|P1|Overall Study|Adverse Event|27
4861330|NCT00887289|16755468|P1|Overall Study|Lack of Efficacy|14
4861331|NCT00887250|16755480|P3|Overall Study|Patient uncooperative|1
4861332|NCT00887250|16755481|P2|Overall Study|Patient uncooperative|0
4861333|NCT00887250|16755482|P1|Overall Study|Patient uncooperative|0
4861334|NCT00887250|16755480|P3|Overall Study|Withdrawal by Subject|2
4861335|NCT00887250|16755481|P2|Overall Study|Withdrawal by Subject|1
4861336|NCT00887250|16755482|P1|Overall Study|Withdrawal by Subject|2
4861337|NCT00887250|16755480|P3|Overall Study|Protocol Violation|1
4861338|NCT00887250|16755481|P2|Overall Study|Protocol Violation|2
4861339|NCT00887250|16755482|P1|Overall Study|Protocol Violation|2
4861340|NCT00887250|16755480|P3|Overall Study|Lost to Follow-up|1
4861341|NCT00887250|16755481|P2|Overall Study|Lost to Follow-up|3
4861342|NCT00887250|16755482|P1|Overall Study|Lost to Follow-up|2
4861343|NCT00887250|16755480|P3|Overall Study|Lack of Efficacy|1
4861344|NCT00887250|16755481|P2|Overall Study|Lack of Efficacy|6
4861345|NCT00887250|16755482|P1|Overall Study|Lack of Efficacy|9
4861346|NCT00887250|16755480|P3|Overall Study|Adverse Event|7
4861347|NCT00887250|16755481|P2|Overall Study|Adverse Event|0
4861348|NCT00887250|16755482|P1|Overall Study|Adverse Event|3
4861349|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11
4861350|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8
4861351|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0
4861352|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Protocol Violation|1
4861353|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Protocol Violation|4
4861354|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Protocol Violation|0
4861355|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Other|12
4861356|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Other|11
4861357|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Other|0
4861358|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
4861359|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2
4861360|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0
4861361|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Physician Decision|0
4861362|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Physician Decision|6
4861363|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Physician Decision|0
4861364|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Failed to return|4
4861365|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Failed to return|5
4861366|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Failed to return|0
4861367|NCT00887224|16755505|P3|DB Taper Phase / Post Study Follow Up|Adverse Event|0
4861368|NCT00887224|16755506|P2|DB Taper Phase / Post Study Follow Up|Adverse Event|5
4861369|NCT00887224|16755507|P1|DB Taper Phase / Post Study Follow Up|Adverse Event|0
4861370|NCT00887224|16755505|P3|Double-blind (DB) Phase|Withdrawal by Subject|12
4861371|NCT00887224|16755506|P2|Double-blind (DB) Phase|Withdrawal by Subject|6
4861372|NCT00887224|16755507|P1|Double-blind (DB) Phase|Withdrawal by Subject|0
4861373|NCT00887224|16755505|P3|Double-blind (DB) Phase|Protocol Violation|5
4861374|NCT00887224|16755506|P2|Double-blind (DB) Phase|Protocol Violation|8
4861375|NCT00887224|16755507|P1|Double-blind (DB) Phase|Protocol Violation|0
4861376|NCT00887224|16755505|P3|Double-blind (DB) Phase|Other|0
4861377|NCT00887224|16755506|P2|Double-blind (DB) Phase|Other|2
4861378|NCT00887224|16755507|P1|Double-blind (DB) Phase|Other|0
4861379|NCT00887224|16755505|P3|Double-blind (DB) Phase|Lost to Follow-up|8
4861380|NCT00887224|16755506|P2|Double-blind (DB) Phase|Lost to Follow-up|8
4861381|NCT00887224|16755507|P1|Double-blind (DB) Phase|Lost to Follow-up|0
4861382|NCT00887224|16755505|P3|Double-blind (DB) Phase|Lack of Efficacy|33
4861383|NCT00887224|16755506|P2|Double-blind (DB) Phase|Lack of Efficacy|67
4861384|NCT00887224|16755507|P1|Double-blind (DB) Phase|Lack of Efficacy|0
4861385|NCT00887224|16755505|P3|Double-blind (DB) Phase|Failed to return|2
4861386|NCT00887224|16755506|P2|Double-blind (DB) Phase|Failed to return|2
4861387|NCT00887224|16755507|P1|Double-blind (DB) Phase|Failed to return|0
4861388|NCT00887224|16755505|P3|Double-blind (DB) Phase|Adverse Event|2
4861389|NCT00887224|16755506|P2|Double-blind (DB) Phase|Adverse Event|7
4861390|NCT00887224|16755507|P1|Double-blind (DB) Phase|Adverse Event|0
4861391|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
4861392|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0
4861393|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48
4861394|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Protocol Violation|0
4861395|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Protocol Violation|0
4861396|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Protocol Violation|3
4861397|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Other|0
4861398|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Other|0
4861399|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Other|30
4861400|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
4861401|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Lost to Follow-up|0
4861402|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Lost to Follow-up|8
4861403|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Physician Decision|0
4861404|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Physician Decision|0
4861405|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Physician Decision|10
4861406|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Failed to return|0
4861407|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Failed to return|0
4861408|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Failed to return|17
4861409|NCT00887224|16755505|P3|OL Taper Phase / OL Follow Up|Adverse Event|0
4861410|NCT00887224|16755506|P2|OL Taper Phase / OL Follow Up|Adverse Event|0
4861411|NCT00887224|16755507|P1|OL Taper Phase / OL Follow Up|Adverse Event|28
4861412|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
4861413|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Withdrawal by Subject|0
4861414|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Withdrawal by Subject|19
4861415|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Protocol Violation|0
4861416|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Protocol Violation|0
4861417|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Protocol Violation|13
4861418|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Other|0
4861419|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Other|0
4861420|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Other|1
4861421|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Lost to Follow-up|0
4861422|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Lost to Follow-up|0
4861423|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Lost to Follow-up|9
4861424|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Lack of Efficacy|0
4861425|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Lack of Efficacy|0
4861426|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Lack of Efficacy|16
4861427|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Failed to return|0
4861428|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Failed to return|0
4861429|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Failed to return|3
4861430|NCT00887224|16755505|P3|Open-label Stability (OLS) Phase|Adverse Event|0
4861431|NCT00887224|16755506|P2|Open-label Stability (OLS) Phase|Adverse Event|0
4861432|NCT00887224|16755507|P1|Open-label Stability (OLS) Phase|Adverse Event|22
4861433|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Withdrawal by Subject|0
4861434|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Withdrawal by Subject|0
4861435|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Withdrawal by Subject|15
4861436|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Protocol Violation|0
4861437|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Protocol Violation|0
4861438|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Protocol Violation|12
4861439|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Other|0
4861440|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Other|0
4861441|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Other|1
4861442|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Lost to Follow-up|0
4861443|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Lost to Follow-up|0
4861444|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Lost to Follow-up|16
4861445|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Lack of Efficacy|0
4861446|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Lack of Efficacy|0
4861447|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Lack of Efficacy|26
4861448|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Failed to return|0
4861449|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Failed to return|0
4861450|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Failed to return|6
4861451|NCT00887224|16755505|P3|Open-label Response (OLR) Phase|Adverse Event|0
4861452|NCT00887224|16755506|P2|Open-label Response (OLR) Phase|Adverse Event|0
4861453|NCT00887224|16755507|P1|Open-label Response (OLR) Phase|Adverse Event|46
4861454|NCT00887198|16755534|P3|Cross Over (Placebo to AA)|Other|19
4861455|NCT00887198|16755535|P2|Cross Over (Placebo to AA)|Other|0
4861456|NCT00887198|16755536|P1|Cross Over (Placebo to AA)|Other|0
4861457|NCT00887198|16755534|P3|Cross Over (Placebo to AA)|Progressive disease|20
4861458|NCT00887198|16755535|P2|Cross Over (Placebo to AA)|Progressive disease|0
4861459|NCT00887198|16755536|P1|Cross Over (Placebo to AA)|Progressive disease|0
4861460|NCT00887198|16755534|P3|Cross Over (Placebo to AA)|Withdrawal by Subject|2
4861461|NCT00887198|16755535|P2|Cross Over (Placebo to AA)|Withdrawal by Subject|0
4861462|NCT00887198|16755536|P1|Cross Over (Placebo to AA)|Withdrawal by Subject|0
4861463|NCT00887198|16755534|P3|Cross Over (Placebo to AA)|Adverse Event|9
4861464|NCT00887198|16755535|P2|Cross Over (Placebo to AA)|Adverse Event|0
4861465|NCT00887198|16755536|P1|Cross Over (Placebo to AA)|Adverse Event|0
4861466|NCT00887198|16755534|P3|Cross Over (Placebo to AA)|Ongoing|35
4861467|NCT00887198|16755535|P2|Cross Over (Placebo to AA)|Ongoing|0
4861468|NCT00887198|16755536|P1|Cross Over (Placebo to AA)|Ongoing|0
4861469|NCT00887198|16755534|P3|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8
4861470|NCT00887198|16755535|P2|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
4861471|NCT00887198|16755536|P1|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0
4861472|NCT00887198|16755534|P3|Randomized Period|Randomized, Not treated|0
4861473|NCT00887198|16755535|P2|Randomized Period|Randomized, Not treated|2
4861474|NCT00887198|16755536|P1|Randomized Period|Randomized, Not treated|4
4861475|NCT00887198|16755534|P3|Randomized Period|Other|0
4861476|NCT00887198|16755535|P2|Randomized Period|Other|30
4861477|NCT00887198|16755536|P1|Randomized Period|Other|42
4861478|NCT00887198|16755534|P3|Randomized Period|Progressive disease|0
4861479|NCT00887198|16755535|P2|Randomized Period|Progressive disease|370
4861480|NCT00887198|16755536|P1|Randomized Period|Progressive disease|366
4861481|NCT00887198|16755534|P3|Randomized Period|Withdrawal by Subject|0
4861482|NCT00887198|16755535|P2|Randomized Period|Withdrawal by Subject|56
4861483|NCT00887198|16755536|P1|Randomized Period|Withdrawal by Subject|41
4861484|NCT00887198|16755534|P3|Randomized Period|Cross-over to AA (under amendment 3)|0
4861485|NCT00887198|16755535|P2|Randomized Period|Cross-over to AA (under amendment 3)|51
4861486|NCT00887198|16755536|P1|Randomized Period|Cross-over to AA (under amendment 3)|0
4861487|NCT00887198|16755534|P3|Randomized Period|Lost to Follow-up|0
4861488|NCT00887198|16755535|P2|Randomized Period|Lost to Follow-up|0
4861489|NCT00887198|16755536|P1|Randomized Period|Lost to Follow-up|1
4861490|NCT00887198|16755534|P3|Randomized Period|Adverse Event|0
4861491|NCT00887198|16755535|P2|Randomized Period|Adverse Event|33
4861492|NCT00887198|16755536|P1|Randomized Period|Adverse Event|50
4861493|NCT00887198|16755534|P3|Randomized Period|Ongoing|0
4861494|NCT00887198|16755535|P2|Randomized Period|Ongoing|0
4861495|NCT00887198|16755536|P1|Randomized Period|Ongoing|42
4861496|NCT00887159|16755567|P3|Overall Study|Never started assigned therapy|4
4861497|NCT00887159|16755568|P2|Overall Study|Never started assigned therapy|3
4861498|NCT00887159|16755569|P1|Overall Study|Never started assigned therapy|3
4861499|NCT00887159|16755567|P3|Overall Study|Ineligible|0
4861500|NCT00887159|16755568|P2|Overall Study|Ineligible|1
4861501|NCT00887159|16755569|P1|Overall Study|Ineligible|5
4861502|NCT00887159|16755567|P3|Overall Study|Received more tx instead of observation|0
4861503|NCT00887159|16755568|P2|Overall Study|Received more tx instead of observation|0
4861504|NCT00887159|16755569|P1|Overall Study|Received more tx instead of observation|1
4861505|NCT00887159|16755567|P3|Overall Study|Pt had PD but was SD when re-measured|0
4861506|NCT00887159|16755568|P2|Overall Study|Pt had PD but was SD when re-measured|1
4861507|NCT00887159|16755569|P1|Overall Study|Pt had PD but was SD when re-measured|0
4861508|NCT00887159|16755567|P3|Overall Study|Treatment delayed|0
4861509|NCT00887159|16755568|P2|Overall Study|Treatment delayed|1
4861510|NCT00887159|16755569|P1|Overall Study|Treatment delayed|1
4861511|NCT00887159|16755567|P3|Overall Study|Sympomatic deterioration|0
4861512|NCT00887159|16755568|P2|Overall Study|Sympomatic deterioration|0
4861513|NCT00887159|16755569|P1|Overall Study|Sympomatic deterioration|1
4861514|NCT00887159|16755567|P3|Overall Study|Physician Decision|0
4861515|NCT00887159|16755568|P2|Overall Study|Physician Decision|1
4861516|NCT00887159|16755569|P1|Overall Study|Physician Decision|1
4861517|NCT00887159|16755567|P3|Overall Study|Alternative therapy|0
4861518|NCT00887159|16755568|P2|Overall Study|Alternative therapy|0
4861519|NCT00887159|16755569|P1|Overall Study|Alternative therapy|2
4861520|NCT00887159|16755567|P3|Overall Study|Withdrawal by Subject|2
4861521|NCT00887159|16755568|P2|Overall Study|Withdrawal by Subject|4
4861522|NCT00887159|16755569|P1|Overall Study|Withdrawal by Subject|4
4861523|NCT00887159|16755567|P3|Overall Study|Death|0
4861524|NCT00887159|16755568|P2|Overall Study|Death|2
4861525|NCT00887159|16755569|P1|Overall Study|Death|2
4861526|NCT00887159|16755567|P3|Overall Study|Adverse Event|17
4861527|NCT00887159|16755568|P2|Overall Study|Adverse Event|4
4861528|NCT00887159|16755569|P1|Overall Study|Adverse Event|3
4861529|NCT00887159|16755567|P3|Overall Study|Disease progression|33
4861530|NCT00887159|16755568|P2|Overall Study|Disease progression|39
4861531|NCT00887159|16755569|P1|Overall Study|Disease progression|6
4861532|NCT00887068|16755587|P2|Overall Study|Didn't meet eligibility to start cycle 1|0
4861533|NCT00887068|16755588|P1|Overall Study|Didn't meet eligibility to start cycle 1|4
4861534|NCT00887068|16755587|P2|Overall Study|Withdrawal by Subject|0
4861535|NCT00887068|16755588|P1|Overall Study|Withdrawal by Subject|2
4861536|NCT00886938|16755596|P1|Overall Study|Withdrawal by Subject|1
4861537|NCT00886938|16755596|P1|Overall Study|Adverse Event|1
4861538|NCT00886834|16755609|P2|Overall Study|Protocol Violation|3
4861539|NCT00886834|16755610|P1|Overall Study|Protocol Violation|0
4861540|NCT00886821|16755632|P14|Stage 2|Lost to Follow-up|1
4861541|NCT00886821|16755633|P13|Stage 2|Lost to Follow-up|2
4861542|NCT00886821|16755634|P12|Stage 2|Lost to Follow-up|0
4861543|NCT00886821|16755635|P11|Stage 2|Lost to Follow-up|0
4861544|NCT00886821|16755636|P10|Stage 2|Lost to Follow-up|0
4861545|NCT00886821|16755637|P9|Stage 2|Lost to Follow-up|0
4861546|NCT00886821|16755638|P8|Stage 2|Lost to Follow-up|0
4861547|NCT00886821|16755639|P7|Stage 2|Lost to Follow-up|0
4861548|NCT00886821|16755640|P6|Stage 2|Lost to Follow-up|0
4861549|NCT00886821|16755641|P5|Stage 2|Lost to Follow-up|0
4861550|NCT00886821|16755642|P4|Stage 2|Lost to Follow-up|0
4861551|NCT00886821|16755643|P3|Stage 2|Lost to Follow-up|0
4861552|NCT00886821|16755644|P2|Stage 2|Lost to Follow-up|0
4861553|NCT00886821|16755645|P1|Stage 2|Lost to Follow-up|0
4861554|NCT00886821|16755632|P14|Stage 2|Adverse Event|0
4861555|NCT00886821|16755633|P13|Stage 2|Adverse Event|3
4861556|NCT00886821|16755634|P12|Stage 2|Adverse Event|1
4861557|NCT00886821|16755635|P11|Stage 2|Adverse Event|0
4861558|NCT00886821|16755636|P10|Stage 2|Adverse Event|0
4861559|NCT00886821|16755637|P9|Stage 2|Adverse Event|0
4861560|NCT00886821|16755638|P8|Stage 2|Adverse Event|0
4861561|NCT00886821|16755639|P7|Stage 2|Adverse Event|0
4861562|NCT00886821|16755640|P6|Stage 2|Adverse Event|0
4861563|NCT00886821|16755641|P5|Stage 2|Adverse Event|0
4861564|NCT00886821|16755642|P4|Stage 2|Adverse Event|0
4861565|NCT00886821|16755643|P3|Stage 2|Adverse Event|0
4861566|NCT00886821|16755644|P2|Stage 2|Adverse Event|0
4861567|NCT00886821|16755645|P1|Stage 2|Adverse Event|0
4861568|NCT00886795|16755870|P1|Overall Study|Lack of Efficacy|1
4861569|NCT00886769|16755877|P2|Overall Study|Unsatisfactory therapeutic effect|37
4861570|NCT00886769|16755878|P1|Overall Study|Unsatisfactory therapeutic effect|6
4861571|NCT00886743|16755902|P1|Overall Study|Other|1
4861572|NCT00886743|16755902|P1|Overall Study|Adverse Event|3
4861573|NCT00886639|16755940|P1|Overall Study|non-compliance|2
4861574|NCT00886639|16755940|P1|Overall Study|acute exacerbation|14
4861575|NCT00886613|16755954|P3|Overall Study|Subject withdrew consent (Part A)|2
4861576|NCT00886613|16755955|P2|Overall Study|Subject withdrew consent (Part A)|0
4861577|NCT00886613|16755956|P1|Overall Study|Subject withdrew consent (Part A)|0
4861578|NCT00886613|16755954|P3|Overall Study|Lost to follow-up (Part B)|1
4861579|NCT00886613|16755955|P2|Overall Study|Lost to follow-up (Part B)|0
4861580|NCT00886613|16755956|P1|Overall Study|Lost to follow-up (Part B)|1
4861581|NCT00886613|16755954|P3|Overall Study|Protocol deviation (Part B)|0
4861582|NCT00886613|16755955|P2|Overall Study|Protocol deviation (Part B)|0
4861583|NCT00886613|16755956|P1|Overall Study|Protocol deviation (Part B)|1
4861584|NCT00886600|16755978|P4|Combination Therapy Period|Protocol Violation|0
4861585|NCT00886600|16755979|P3|Combination Therapy Period|Protocol Violation|1
4861586|NCT00886600|16755980|P2|Combination Therapy Period|Protocol Violation|0
4861587|NCT00886600|16755981|P1|Combination Therapy Period|Protocol Violation|0
4861588|NCT00886600|16755978|P4|Combination Therapy Period|Adverse Event|0
4861589|NCT00886600|16755979|P3|Combination Therapy Period|Adverse Event|1
4861590|NCT00886600|16755980|P2|Combination Therapy Period|Adverse Event|0
4861591|NCT00886600|16755981|P1|Combination Therapy Period|Adverse Event|0
4861592|NCT00886600|16755978|P4|Double-blind Monotherapy|Withdrawal by Subject|0
4861593|NCT00886600|16755979|P3|Double-blind Monotherapy|Withdrawal by Subject|0
4861594|NCT00886600|16755980|P2|Double-blind Monotherapy|Withdrawal by Subject|0
4861595|NCT00886600|16755981|P1|Double-blind Monotherapy|Withdrawal by Subject|1
4861596|NCT00886600|16755978|P4|Double-blind Monotherapy|Protocol Violation|1
4861597|NCT00886600|16755979|P3|Double-blind Monotherapy|Protocol Violation|0
4861598|NCT00886600|16755980|P2|Double-blind Monotherapy|Protocol Violation|0
4861599|NCT00886600|16755981|P1|Double-blind Monotherapy|Protocol Violation|0
4861600|NCT00886600|16755978|P4|Double-blind Monotherapy|Adverse Event|1
4861601|NCT00886600|16755979|P3|Double-blind Monotherapy|Adverse Event|1
4861602|NCT00886600|16755980|P2|Double-blind Monotherapy|Adverse Event|1
4861603|NCT00886600|16755981|P1|Double-blind Monotherapy|Adverse Event|1
4861604|NCT00886587|16756005|P2|Overall Study|Withdrawal by Subject|1
4861605|NCT00886587|16756006|P1|Overall Study|Withdrawal by Subject|0
4861606|NCT00886587|16756005|P2|Overall Study|Protocol Violation|0
4861607|NCT00886587|16756006|P1|Overall Study|Protocol Violation|2
4861608|NCT00886587|16756005|P2|Overall Study|Adverse Event|1
4861609|NCT00886587|16756006|P1|Overall Study|Adverse Event|2
4861610|NCT00886483|16756020|P2|Overall Study|Distance to center, poor grades|0
4861611|NCT00886483|16756021|P1|Overall Study|Distance to center, poor grades|1
4861612|NCT00886483|16756020|P2|Overall Study|Pursue medications|2
4861613|NCT00886483|16756021|P1|Overall Study|Pursue medications|1
4861614|NCT00886483|16756020|P2|Overall Study|Lost to Follow-up|1
4861615|NCT00886483|16756021|P1|Overall Study|Lost to Follow-up|0
4861616|NCT00886340|16756039|P2|Overall Study|Withdrawal by Subject|7
4861617|NCT00886340|16756040|P1|Overall Study|Withdrawal by Subject|0
4861618|NCT00886288|16756048|P2|Overall Study|Lost to Follow-up|0
4861619|NCT00886288|16756049|P1|Overall Study|Lost to Follow-up|86
4861620|NCT00886288|16756048|P2|Overall Study|no respect of the 12 weeks period|227
4861621|NCT00886288|16756049|P1|Overall Study|no respect of the 12 weeks period|657
4861622|NCT00886119|16756105|P2|Period 1|Did not meet inclusion criteria|0
4861623|NCT00886119|16756106|P1|Period 1|Did not meet inclusion criteria|1
4861624|NCT00886015|16756114|P2|Overall Study|Death|2
4861625|NCT00886015|16756115|P1|Overall Study|Death|0
4861626|NCT00885846|16756134|P3|Overall Study|Withdrawal by Subject|2
4861627|NCT00885846|16756135|P2|Overall Study|Withdrawal by Subject|5
4861628|NCT00885846|16756136|P1|Overall Study|Withdrawal by Subject|2
4861629|NCT00885755|16756151|P3|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
4861630|NCT00885755|16756152|P2|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0
4861631|NCT00885755|16756153|P1|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5
4861632|NCT00885755|16756151|P3|Part I: Trastuzumab+Taxane|Death|1
4861633|NCT00885755|16756152|P2|Part I: Trastuzumab+Taxane|Death|0
4861634|NCT00885755|16756153|P1|Part I: Trastuzumab+Taxane|Death|0
4861635|NCT00885755|16756151|P3|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
4861636|NCT00885755|16756152|P2|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0
4861637|NCT00885755|16756153|P1|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1
4861638|NCT00885755|16756151|P3|Part I: Trastuzumab+Taxane|Unknown Reason|0
4861639|NCT00885755|16756152|P2|Part I: Trastuzumab+Taxane|Unknown Reason|0
4861640|NCT00885755|16756153|P1|Part I: Trastuzumab+Taxane|Unknown Reason|16
4861641|NCT00885755|16756151|P3|Part I: Trastuzumab+Taxane|Adverse Event|0
4861642|NCT00885755|16756152|P2|Part I: Trastuzumab+Taxane|Adverse Event|0
4861643|NCT00885755|16756153|P1|Part I: Trastuzumab+Taxane|Adverse Event|1
4861644|NCT00885703|16756196|P7|Overall Study|Ineligible (no CM)|1
4861645|NCT00885703|16756197|P6|Overall Study|Ineligible (no CM)|3
4861646|NCT00885703|16756198|P5|Overall Study|Ineligible (no CM)|2
4861647|NCT00885703|16756199|P4|Overall Study|Ineligible (no CM)|1
4861648|NCT00885703|16756200|P3|Overall Study|Ineligible (no CM)|2
4861649|NCT00885703|16756201|P2|Overall Study|Ineligible (no CM)|3
4861650|NCT00885703|16756202|P1|Overall Study|Ineligible (no CM)|1
4861651|NCT00885703|16756196|P7|Overall Study|Withdrawal by Subject|1
4861652|NCT00885703|16756197|P6|Overall Study|Withdrawal by Subject|1
4861653|NCT00885703|16756198|P5|Overall Study|Withdrawal by Subject|3
4861654|NCT00885703|16756199|P4|Overall Study|Withdrawal by Subject|1
4861655|NCT00885703|16756200|P3|Overall Study|Withdrawal by Subject|0
4861656|NCT00885703|16756201|P2|Overall Study|Withdrawal by Subject|0
4861657|NCT00885703|16756202|P1|Overall Study|Withdrawal by Subject|0
4861658|NCT00885703|16756196|P7|Overall Study|Lost to Follow-up|0
4861659|NCT00885703|16756197|P6|Overall Study|Lost to Follow-up|1
4861660|NCT00885703|16756198|P5|Overall Study|Lost to Follow-up|0
4861661|NCT00885703|16756199|P4|Overall Study|Lost to Follow-up|0
4861662|NCT00885703|16756200|P3|Overall Study|Lost to Follow-up|1
4861663|NCT00885703|16756201|P2|Overall Study|Lost to Follow-up|0
4861664|NCT00885703|16756202|P1|Overall Study|Lost to Follow-up|0
4861665|NCT00885703|16756196|P7|Overall Study|Death|4
4861666|NCT00885703|16756197|P6|Overall Study|Death|8
4861667|NCT00885703|16756198|P5|Overall Study|Death|7
4861668|NCT00885703|16756199|P4|Overall Study|Death|7
4861669|NCT00885703|16756200|P3|Overall Study|Death|8
4861670|NCT00885703|16756201|P2|Overall Study|Death|7
4861671|NCT00885703|16756202|P1|Overall Study|Death|9
4861672|NCT00885677|16756260|P2|Overall Study|Inclusion/exclusion not met|27
4861673|NCT00885677|16756261|P1|Overall Study|Inclusion/exclusion not met|25
4861674|NCT00885677|16756260|P2|Overall Study|Heart transplantation|0
4861675|NCT00885677|16756261|P1|Overall Study|Heart transplantation|1
4861676|NCT00885677|16756260|P2|Overall Study|device/lead revision or replacement|6
4861677|NCT00885677|16756261|P1|Overall Study|device/lead revision or replacement|7
4861678|NCT00885677|16756260|P2|Overall Study|premature study closure|44
4861679|NCT00885677|16756261|P1|Overall Study|premature study closure|41
4861680|NCT00885677|16756260|P2|Overall Study|Protocol Violation|54
4861681|NCT00885677|16756261|P1|Overall Study|Protocol Violation|54
4861682|NCT00885677|16756260|P2|Overall Study|Lost to Follow-up|13
4861683|NCT00885677|16756261|P1|Overall Study|Lost to Follow-up|15
4861684|NCT00885677|16756260|P2|Overall Study|Death|34
4861685|NCT00885677|16756261|P1|Overall Study|Death|40
4861686|NCT00885534|16756277|P1|Overall Study|Patient deemed ineligible|1
4861687|NCT00885482|16756281|P1|Overall Study|low Therapeutic drug monitoring (TDM)|1
4861688|NCT00885482|16756281|P1|Overall Study|Death|1
4861689|NCT00885482|16756281|P1|Overall Study|Lack of Efficacy|1
4861690|NCT00885482|16756281|P1|Overall Study|Pregnancy|1
4861691|NCT00885378|16756287|P2|Overall Study|Protocol Violation|0
4861692|NCT00885378|16756288|P1|Overall Study|Protocol Violation|2
4861693|NCT00885378|16756287|P2|Overall Study|Poor/Noncompliance|2
4861694|NCT00885378|16756288|P1|Overall Study|Poor/Noncompliance|2
4861695|NCT00885378|16756287|P2|Overall Study|Lost to Follow-up|2
4861696|NCT00885378|16756288|P1|Overall Study|Lost to Follow-up|1
4861697|NCT00885378|16756287|P2|Overall Study|Withdrawal by Subject|2
4861698|NCT00885378|16756288|P1|Overall Study|Withdrawal by Subject|1
4861699|NCT00885378|16756287|P2|Overall Study|Lack of Efficacy|2
4861700|NCT00885378|16756288|P1|Overall Study|Lack of Efficacy|2
4861701|NCT00885365|16756318|P2|4 Weeks ON Treatment|Withdrawal by Subject|0
4861702|NCT00885365|16756319|P1|4 Weeks ON Treatment|Withdrawal by Subject|1
4861703|NCT00885365|16756318|P2|4 Weeks ON Treatment|Protocol Violation|2
4861704|NCT00885365|16756319|P1|4 Weeks ON Treatment|Protocol Violation|1
4861705|NCT00885365|16756318|P2|4 Weeks ON Treatment|Adverse Event|4
4861706|NCT00885365|16756319|P1|4 Weeks ON Treatment|Adverse Event|2
4861707|NCT00885352|16756355|P2|Overall Study|Lab abnormalities|1
4861708|NCT00885352|16756356|P1|Overall Study|Lab abnormalities|1
4861709|NCT00885352|16756355|P2|Overall Study|Excluded medication|2
4861710|NCT00885352|16756356|P1|Overall Study|Excluded medication|2
4861711|NCT00885352|16756355|P2|Overall Study|Contradiction to study medication|2
4861712|NCT00885352|16756356|P1|Overall Study|Contradiction to study medication|0
4861713|NCT00885352|16756355|P2|Overall Study|Withdrawal by Subject|5
4861714|NCT00885352|16756356|P1|Overall Study|Withdrawal by Subject|1
4861715|NCT00885352|16756355|P2|Overall Study|Protocol Violation|2
4861716|NCT00885352|16756356|P1|Overall Study|Protocol Violation|0
4861717|NCT00885352|16756355|P2|Overall Study|Physician Decision|3
4861718|NCT00885352|16756356|P1|Overall Study|Physician Decision|0
4861719|NCT00885352|16756355|P2|Overall Study|Lost to Follow-up|2
4861720|NCT00885352|16756356|P1|Overall Study|Lost to Follow-up|2
4861721|NCT00885352|16756355|P2|Overall Study|Adverse Event|3
4861722|NCT00885352|16756356|P1|Overall Study|Adverse Event|2
4861723|NCT00885170|16756368|P2|Overall Study|Withdrawal by Subject|13
4861724|NCT00885170|16756369|P1|Overall Study|Withdrawal by Subject|13
4861725|NCT00885170|16756368|P2|Overall Study|Protocol Violation|1
4861726|NCT00885170|16756369|P1|Overall Study|Protocol Violation|3
4861727|NCT00885170|16756368|P2|Overall Study|Physician Decision|1
4861728|NCT00885170|16756369|P1|Overall Study|Physician Decision|2
4861729|NCT00885170|16756368|P2|Overall Study|Lost to Follow-up|1
4861730|NCT00885170|16756369|P1|Overall Study|Lost to Follow-up|2
4861731|NCT00885170|16756368|P2|Overall Study|Excessive bone loss|3
4861732|NCT00885170|16756369|P1|Overall Study|Excessive bone loss|6
4861733|NCT00885170|16756368|P2|Overall Study|Adverse Event|4
4861734|NCT00885170|16756369|P1|Overall Study|Adverse Event|12
4861735|NCT00885118|16756428|P5|Overall Study|Other reason not defined above|0
4861736|NCT00885118|16756429|P4|Overall Study|Other reason not defined above|0
4861737|NCT00885118|16756430|P3|Overall Study|Other reason not defined above|1
4861738|NCT00885118|16756431|P2|Overall Study|Other reason not defined above|0
4861739|NCT00885118|16756432|P1|Overall Study|Other reason not defined above|0
4861740|NCT00885118|16756428|P5|Overall Study|Withdrawal by Subject|1
4861741|NCT00885118|16756429|P4|Overall Study|Withdrawal by Subject|0
4861742|NCT00885118|16756430|P3|Overall Study|Withdrawal by Subject|0
4861743|NCT00885118|16756431|P2|Overall Study|Withdrawal by Subject|0
4861744|NCT00885118|16756432|P1|Overall Study|Withdrawal by Subject|0
4861745|NCT00885118|16756428|P5|Overall Study|Adverse Event|0
4861746|NCT00885118|16756429|P4|Overall Study|Adverse Event|0
4861747|NCT00885118|16756430|P3|Overall Study|Adverse Event|0
4861748|NCT00885118|16756431|P2|Overall Study|Adverse Event|0
4861749|NCT00885118|16756432|P1|Overall Study|Adverse Event|1
4861750|NCT00885105|16756571|P2|Overall Study|Protocol Violation|2
4861751|NCT00885105|16756572|P1|Overall Study|Protocol Violation|0
4861752|NCT00885105|16756571|P2|Overall Study|Adverse Event|0
4861753|NCT00885105|16756572|P1|Overall Study|Adverse Event|1
4861754|NCT00885105|16756571|P2|Overall Study|Withdrawal by Subject|8
4861755|NCT00885105|16756572|P1|Overall Study|Withdrawal by Subject|0
4861756|NCT00884949|16756612|P1|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1
4861757|NCT00884949|16756612|P1|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1
4861758|NCT00884832|16756647|P2|Overall Study|Withdrawal by Subject|1
4861759|NCT00884832|16756648|P1|Overall Study|Withdrawal by Subject|0
4861760|NCT00884793|16756683|P1|Overall Study|Withdrawal by Subject|1
4861761|NCT00884741|16756702|P4|Randomization|Protocol Violation|8
4861762|NCT00884741|16756703|P3|Randomization|Protocol Violation|8
4861763|NCT00884741|16756704|P2|Randomization|Protocol Violation|0
4861764|NCT00884741|16756705|P1|Randomization|Protocol Violation|0
4861765|NCT00884741|16756702|P4|Step 2 Registration: Tissue Analysis|Disease Progression|0
4861766|NCT00884741|16756703|P3|Step 2 Registration: Tissue Analysis|Disease Progression|0
4861767|NCT00884741|16756704|P2|Step 2 Registration: Tissue Analysis|Disease Progression|4
4861768|NCT00884741|16756705|P1|Step 2 Registration: Tissue Analysis|Disease Progression|0
4861769|NCT00884741|16756702|P4|Step 2 Registration: Tissue Analysis|Patient refusal|0
4861770|NCT00884741|16756703|P3|Step 2 Registration: Tissue Analysis|Patient refusal|0
4861771|NCT00884741|16756704|P2|Step 2 Registration: Tissue Analysis|Patient refusal|7
4861772|NCT00884741|16756705|P1|Step 2 Registration: Tissue Analysis|Patient refusal|0
4861773|NCT00884741|16756702|P4|Step 2 Registration: Tissue Analysis|Adverse Event|0
4861774|NCT00884741|16756703|P3|Step 2 Registration: Tissue Analysis|Adverse Event|0
4861775|NCT00884741|16756704|P2|Step 2 Registration: Tissue Analysis|Adverse Event|2
4861857|NCT00884286|16756825|P2|Overall Study|Thrombus in right auricle|0
4861776|NCT00884741|16756705|P1|Step 2 Registration: Tissue Analysis|Adverse Event|0
4861777|NCT00884741|16756702|P4|Step 2 Registration: Tissue Analysis|Death|0
4861778|NCT00884741|16756703|P3|Step 2 Registration: Tissue Analysis|Death|0
4861779|NCT00884741|16756704|P2|Step 2 Registration: Tissue Analysis|Death|1
4861780|NCT00884741|16756705|P1|Step 2 Registration: Tissue Analysis|Death|0
4861781|NCT00884741|16756702|P4|Step 2 Registration: Tissue Analysis|Protocol Violation|0
4861782|NCT00884741|16756703|P3|Step 2 Registration: Tissue Analysis|Protocol Violation|0
4861783|NCT00884741|16756704|P2|Step 2 Registration: Tissue Analysis|Protocol Violation|15
4861784|NCT00884741|16756705|P1|Step 2 Registration: Tissue Analysis|Protocol Violation|0
4861785|NCT00884741|16756702|P4|Step 1 Registration: Tissue Screening|Patient refusal|0
4861786|NCT00884741|16756703|P3|Step 1 Registration: Tissue Screening|Patient refusal|0
4861787|NCT00884741|16756704|P2|Step 1 Registration: Tissue Screening|Patient refusal|0
4861788|NCT00884741|16756705|P1|Step 1 Registration: Tissue Screening|Patient refusal|32
4861789|NCT00884741|16756702|P4|Step 1 Registration: Tissue Screening|Disease progression|0
4861790|NCT00884741|16756703|P3|Step 1 Registration: Tissue Screening|Disease progression|0
4861791|NCT00884741|16756704|P2|Step 1 Registration: Tissue Screening|Disease progression|0
4861792|NCT00884741|16756705|P1|Step 1 Registration: Tissue Screening|Disease progression|12
4861793|NCT00884741|16756702|P4|Step 1 Registration: Tissue Screening|Insufficient tissue|0
4861794|NCT00884741|16756703|P3|Step 1 Registration: Tissue Screening|Insufficient tissue|0
4861795|NCT00884741|16756704|P2|Step 1 Registration: Tissue Screening|Insufficient tissue|0
4861796|NCT00884741|16756705|P1|Step 1 Registration: Tissue Screening|Insufficient tissue|105
4861797|NCT00884741|16756702|P4|Step 1 Registration: Tissue Screening|Physician Decision|0
4861798|NCT00884741|16756703|P3|Step 1 Registration: Tissue Screening|Physician Decision|0
4861799|NCT00884741|16756704|P2|Step 1 Registration: Tissue Screening|Physician Decision|0
4861800|NCT00884741|16756705|P1|Step 1 Registration: Tissue Screening|Physician Decision|3
4861801|NCT00884741|16756702|P4|Step 1 Registration: Tissue Screening|Death|0
4861802|NCT00884741|16756703|P3|Step 1 Registration: Tissue Screening|Death|0
4861803|NCT00884741|16756704|P2|Step 1 Registration: Tissue Screening|Death|0
4861804|NCT00884741|16756705|P1|Step 1 Registration: Tissue Screening|Death|3
4861805|NCT00884741|16756702|P4|Step 1 Registration: Tissue Screening|Protocol Violation|0
4861806|NCT00884741|16756703|P3|Step 1 Registration: Tissue Screening|Protocol Violation|0
4861807|NCT00884741|16756704|P2|Step 1 Registration: Tissue Screening|Protocol Violation|0
4861808|NCT00884741|16756705|P1|Step 1 Registration: Tissue Screening|Protocol Violation|157
4861809|NCT00884390|16756755|P2|Overall Study|Other|1
4861810|NCT00884390|16756756|P1|Overall Study|Other|11
4861811|NCT00884390|16756755|P2|Overall Study|Discontinuation of Study by Sponsor|2
4861812|NCT00884390|16756756|P1|Overall Study|Discontinuation of Study by Sponsor|2
4861813|NCT00884390|16756755|P2|Overall Study|Withdrawal by Subject|1
4861814|NCT00884390|16756756|P1|Overall Study|Withdrawal by Subject|4
4861815|NCT00884390|16756755|P2|Overall Study|Protocol Violation|1
4861816|NCT00884390|16756756|P1|Overall Study|Protocol Violation|4
4861817|NCT00884390|16756755|P2|Overall Study|Physician Decision|1
4861818|NCT00884390|16756756|P1|Overall Study|Physician Decision|2
4861819|NCT00884390|16756755|P2|Overall Study|Lost to Follow-up|1
4861820|NCT00884390|16756756|P1|Overall Study|Lost to Follow-up|0
4861821|NCT00884390|16756755|P2|Overall Study|Adverse Event|1
4861822|NCT00884390|16756756|P1|Overall Study|Adverse Event|0
4861823|NCT00884377|16756774|P2|Overall Study|Physician Decision|1
4861824|NCT00884377|16756775|P1|Overall Study|Physician Decision|0
4861825|NCT00884377|16756774|P2|Overall Study|Could not confirm diagnosis|0
4861826|NCT00884377|16756775|P1|Overall Study|Could not confirm diagnosis|1
4861827|NCT00884377|16756774|P2|Overall Study|Withdrawal by Subject|0
4861828|NCT00884377|16756775|P1|Overall Study|Withdrawal by Subject|1
4861829|NCT00884325|16756797|P2|Overall Study|Not provided|0
4861830|NCT00884325|16756798|P1|Overall Study|Not provided|1
4861831|NCT00884325|16756797|P2|Overall Study|Withdrawal by Subject|1
4861832|NCT00884325|16756798|P1|Overall Study|Withdrawal by Subject|1
4861833|NCT00884325|16756797|P2|Overall Study|Lack of Efficacy|1
4861834|NCT00884325|16756798|P1|Overall Study|Lack of Efficacy|0
4861835|NCT00884325|16756797|P2|Overall Study|Lost to Follow-up|2
4861836|NCT00884325|16756798|P1|Overall Study|Lost to Follow-up|1
4861837|NCT00884312|16756808|P2|Overall Study|Did Not Receive Study Drug|1
4861838|NCT00884312|16756809|P1|Overall Study|Did Not Receive Study Drug|0
4861839|NCT00884312|16756808|P2|Overall Study|Other|4
4861840|NCT00884312|16756809|P1|Overall Study|Other|0
4861841|NCT00884312|16756808|P2|Overall Study|Physician Decision|1
4861842|NCT00884312|16756809|P1|Overall Study|Physician Decision|0
4861843|NCT00884312|16756808|P2|Overall Study|Withdrawal by Subject|6
4861844|NCT00884312|16756809|P1|Overall Study|Withdrawal by Subject|0
4861845|NCT00884312|16756808|P2|Overall Study|Fatal Adverse Event|4
4861846|NCT00884312|16756809|P1|Overall Study|Fatal Adverse Event|1
4861847|NCT00884312|16756808|P2|Overall Study|Non-fatal Adverse Event|0
4861848|NCT00884312|16756809|P1|Overall Study|Non-fatal Adverse Event|1
4861849|NCT00884312|16756808|P2|Overall Study|Fatal Progressive Disease|1
4861850|NCT00884312|16756809|P1|Overall Study|Fatal Progressive Disease|0
4861851|NCT00884312|16756808|P2|Overall Study|Non-fatal Progressive Disease|8
4861852|NCT00884312|16756809|P1|Overall Study|Non-fatal Progressive Disease|0
4861853|NCT00884286|16756825|P2|Overall Study|Comprised lung carcinoma|1
4861854|NCT00884286|16756826|P1|Overall Study|Comprised lung carcinoma|0
4861855|NCT00884286|16756825|P2|Overall Study|Not treated|1
4861856|NCT00884286|16756826|P1|Overall Study|Not treated|2
4861858|NCT00884286|16756826|P1|Overall Study|Thrombus in right auricle|1
4861859|NCT00884286|16756825|P2|Overall Study|Septic shock|0
4861860|NCT00884286|16756826|P1|Overall Study|Septic shock|1
4861861|NCT00884286|16756825|P2|Overall Study|Physician Decision|0
4861862|NCT00884286|16756826|P1|Overall Study|Physician Decision|1
4861863|NCT00884286|16756825|P2|Overall Study|Death|2
4861864|NCT00884286|16756826|P1|Overall Study|Death|2
4861865|NCT00884286|16756825|P2|Overall Study|Toxicity|1
4861866|NCT00884286|16756826|P1|Overall Study|Toxicity|4
4861867|NCT00884286|16756825|P2|Overall Study|Progressive disease|28
4861868|NCT00884286|16756826|P1|Overall Study|Progressive disease|21
4861869|NCT00884273|16756840|P2|Overall Study|Practical reasons|0
4861870|NCT00884273|16756841|P1|Overall Study|Practical reasons|1
4861871|NCT00884273|16756840|P2|Overall Study|Protocol Violation|3
4861872|NCT00884273|16756841|P1|Overall Study|Protocol Violation|1
4861873|NCT00884273|16756840|P2|Overall Study|Adverse Event|2
4861874|NCT00884273|16756841|P1|Overall Study|Adverse Event|0
4861875|NCT00884221|16756867|P2|Overall Study|Cancellation of Cycle and Other Reason|13
4861876|NCT00884221|16756868|P1|Overall Study|Cancellation of Cycle and Other Reason|12
4861877|NCT00884221|16756867|P2|Overall Study|Protocol Violation|13
4861878|NCT00884221|16756868|P1|Overall Study|Protocol Violation|16
4861879|NCT00884221|16756867|P2|Overall Study|Adverse Event|3
4861880|NCT00884221|16756868|P1|Overall Study|Adverse Event|6
4861881|NCT00884221|16756867|P2|Overall Study|Withdrawal by Subject|3
4861882|NCT00884221|16756868|P1|Overall Study|Withdrawal by Subject|0
4861883|NCT00884117|16756904|P1|Overall Study|Other|12
4861884|NCT00884117|16756904|P1|Overall Study|Lost to Follow-up|143
4861885|NCT00884117|16756904|P1|Overall Study|Death|3
4861886|NCT00884117|16756904|P1|Overall Study|Withdrawal by Subject|89
4861887|NCT00884117|16756904|P1|Overall Study|Adverse Event|2
4861888|NCT00884039|16756975|P2|Overall Study|Lack of Efficacy|0
4861889|NCT00884039|16756976|P1|Overall Study|Lack of Efficacy|2
4861890|NCT00884039|16756975|P2|Overall Study|Withdrawal by Subject|1
4861891|NCT00884039|16756976|P1|Overall Study|Withdrawal by Subject|0
4861892|NCT00883779|16756984|P2|Off-study Phase|Other|21
4861893|NCT00883779|16756985|P1|Off-study Phase|Other|18
4861894|NCT00883779|16756984|P2|Off-study Phase|Failure to return|6
4861895|NCT00883779|16756985|P1|Off-study Phase|Failure to return|5
4861896|NCT00883779|16756984|P2|Off-study Phase|Refused treatment|1
4861897|NCT00883779|16756985|P1|Off-study Phase|Refused treatment|1
4861898|NCT00883779|16756984|P2|Off-study Phase|Death|174
4861899|NCT00883779|16756985|P1|Off-study Phase|Death|185
4861900|NCT00883779|16756984|P2|Post-Study Treatment Phase|Ongoing in the study|6
4861901|NCT00883779|16756985|P1|Post-Study Treatment Phase|Ongoing in the study|0
4861902|NCT00883779|16756984|P2|Post-Study Treatment Phase|Other|0
4861903|NCT00883779|16756985|P1|Post-Study Treatment Phase|Other|3
4861904|NCT00883779|16756984|P2|Post-Study Treatment Phase|Disease progression|122
4861905|NCT00883779|16756985|P1|Post-Study Treatment Phase|Disease progression|103
4861906|NCT00883779|16756984|P2|Post-Study Treatment Phase|Refused Treatment|0
4861907|NCT00883779|16756985|P1|Post-Study Treatment Phase|Refused Treatment|3
4861908|NCT00883779|16756984|P2|Post-Study Treatment Phase|Protocol Violation|1
4861909|NCT00883779|16756985|P1|Post-Study Treatment Phase|Protocol Violation|0
4861910|NCT00883779|16756984|P2|Post-Study Treatment Phase|Death|3
4861911|NCT00883779|16756985|P1|Post-Study Treatment Phase|Death|1
4861912|NCT00883779|16756984|P2|Post-Study Treatment Phase|Adverse Event|3
4861913|NCT00883779|16756985|P1|Post-Study Treatment Phase|Adverse Event|2
4861914|NCT00883779|16756984|P2|Primary Study Treatment Phase|Other|0
4861915|NCT00883779|16756985|P1|Primary Study Treatment Phase|Other|3
4861916|NCT00883779|16756984|P2|Primary Study Treatment Phase|Refused Treatment|4
4861917|NCT00883779|16756985|P1|Primary Study Treatment Phase|Refused Treatment|5
4861918|NCT00883779|16756984|P2|Primary Study Treatment Phase|Death|3
4861919|NCT00883779|16756985|P1|Primary Study Treatment Phase|Death|2
4861920|NCT00883779|16756984|P2|Primary Study Treatment Phase|Adverse Event|16
4861921|NCT00883779|16756985|P1|Primary Study Treatment Phase|Adverse Event|16
4861922|NCT00883779|16756984|P2|Primary Study Treatment Phase|Disease progression|59
4861923|NCT00883779|16756985|P1|Primary Study Treatment Phase|Disease progression|75
4861924|NCT00883779|16756984|P2|Primary Study Treatment Phase|Did not receive allocated intervention|4
4861925|NCT00883779|16756985|P1|Primary Study Treatment Phase|Did not receive allocated intervention|4
4861926|NCT00883753|16757021|P1|Overall Study|Administrative/Other|8
4861927|NCT00883753|16757021|P1|Overall Study|Investigator's decision|17
4861928|NCT00883753|16757021|P1|Overall Study|Withdrew consent|10
4861929|NCT00883753|16757021|P1|Overall Study|Refused treatment|4
4861930|NCT00883753|16757021|P1|Overall Study|Protocol Violation|2
4861931|NCT00883753|16757021|P1|Overall Study|Violation of selection criteria at entry|7
4861932|NCT00883753|16757021|P1|Overall Study|Lost to Follow-up|4
4861933|NCT00883753|16757021|P1|Overall Study|Insufficient therapeutic response|16
4861934|NCT00883753|16757021|P1|Overall Study|Death|2
4861935|NCT00883753|16757021|P1|Overall Study|Adverse Event|37
4861936|NCT00883740|16757061|P2|Second Intervention|No longer willing to participate|1
4861937|NCT00883740|16757062|P1|Second Intervention|No longer willing to participate|0
4861938|NCT00883740|16757061|P2|Second Intervention|Protocol Violation|0
4861939|NCT00883740|16757062|P1|Second Intervention|Protocol Violation|1
4861940|NCT00883740|16757061|P2|First Intervention|Adverse Event|2
4861941|NCT00883740|16757062|P1|First Intervention|Adverse Event|1
4861942|NCT00883740|16757061|P2|First Intervention|Protocol Violation|6
4861943|NCT00883740|16757062|P1|First Intervention|Protocol Violation|3
4861944|NCT00883740|16757061|P2|First Intervention|No longer willing to participate|0
4861945|NCT00883740|16757062|P1|First Intervention|No longer willing to participate|2
4861946|NCT00883740|16757061|P2|First Intervention|Lost to Follow-up|0
4861947|NCT00883740|16757062|P1|First Intervention|Lost to Follow-up|1
4861948|NCT00883688|16757102|P1|Overall Study|Ineligible|2
4861949|NCT00883558|16757110|P3|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1
4861950|NCT00883558|16757111|P2|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
4861951|NCT00883558|16757112|P1|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0
4861952|NCT00883558|16757110|P3|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
4861953|NCT00883558|16757111|P2|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1
4861954|NCT00883558|16757112|P1|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0
4861955|NCT00883558|16757110|P3|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
4861956|NCT00883558|16757111|P2|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1
4861957|NCT00883558|16757112|P1|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0
4861958|NCT00883558|16757110|P3|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
4861959|NCT00883558|16757111|P2|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1
4861960|NCT00883558|16757112|P1|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0
4861961|NCT00883558|16757110|P3|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
4861962|NCT00883558|16757111|P2|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0
4861963|NCT00883558|16757112|P1|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2
4861964|NCT00883493|16757124|P2|Overall Study|Other|3
4861965|NCT00883493|16757125|P1|Overall Study|Other|5
4861966|NCT00883493|16757124|P2|Overall Study|Study specific disc. criteria|0
4861967|NCT00883493|16757125|P1|Overall Study|Study specific disc. criteria|2
4861968|NCT00883493|16757124|P2|Overall Study|Eligibility Criteria not fullfilled|6
4861969|NCT00883493|16757125|P1|Overall Study|Eligibility Criteria not fullfilled|6
4861970|NCT00883493|16757124|P2|Overall Study|Withdrawal by Subject|20
4861971|NCT00883493|16757125|P1|Overall Study|Withdrawal by Subject|11
4861972|NCT00883493|16757124|P2|Overall Study|Lost to Follow-up|6
4861973|NCT00883493|16757125|P1|Overall Study|Lost to Follow-up|7
4861974|NCT00883493|16757124|P2|Overall Study|Lack of Efficacy|3
4861975|NCT00883493|16757125|P1|Overall Study|Lack of Efficacy|4
4861976|NCT00883493|16757124|P2|Overall Study|Adverse Event|12
4861977|NCT00883493|16757125|P1|Overall Study|Adverse Event|11
4861978|NCT00883337|16757160|P3|Extension Treatment Period|Other than above|5
4861979|NCT00883337|16757161|P2|Extension Treatment Period|Other than above|9
4861980|NCT00883337|16757162|P1|Extension Treatment Period|Other than above|10
4861981|NCT00883337|16757160|P3|Extension Treatment Period|Lost to Follow-up|0
4861982|NCT00883337|16757161|P2|Extension Treatment Period|Lost to Follow-up|0
4861983|NCT00883337|16757162|P1|Extension Treatment Period|Lost to Follow-up|1
4861984|NCT00883337|16757160|P3|Extension Treatment Period|Poor compliance to protocol|1
4861985|NCT00883337|16757161|P2|Extension Treatment Period|Poor compliance to protocol|1
4861986|NCT00883337|16757162|P1|Extension Treatment Period|Poor compliance to protocol|1
4861987|NCT00883337|16757160|P3|Extension Treatment Period|Lack of Efficacy|8
4861988|NCT00883337|16757161|P2|Extension Treatment Period|Lack of Efficacy|8
4861989|NCT00883337|16757162|P1|Extension Treatment Period|Lack of Efficacy|8
4861990|NCT00883337|16757160|P3|Extension Treatment Period|Adverse Event|5
4861991|NCT00883337|16757161|P2|Extension Treatment Period|Adverse Event|5
4861992|NCT00883337|16757162|P1|Extension Treatment Period|Adverse Event|8
4861993|NCT00883337|16757160|P3|Core Treatment Period|Other than above|1
4861994|NCT00883337|16757161|P2|Core Treatment Period|Other than above|1
4861995|NCT00883337|16757162|P1|Core Treatment Period|Other than above|0
4861996|NCT00883337|16757160|P3|Core Treatment Period|Poor compliance to protocol|1
4861997|NCT00883337|16757161|P2|Core Treatment Period|Poor compliance to protocol|0
4861998|NCT00883337|16757162|P1|Core Treatment Period|Poor compliance to protocol|0
4861999|NCT00883337|16757160|P3|Core Treatment Period|Wish to be pregnant|1
4862000|NCT00883337|16757161|P2|Core Treatment Period|Wish to be pregnant|2
4862001|NCT00883337|16757162|P1|Core Treatment Period|Wish to be pregnant|1
4862002|NCT00883337|16757160|P3|Core Treatment Period|Withdrawal by Subject|6
4862003|NCT00883337|16757161|P2|Core Treatment Period|Withdrawal by Subject|2
4862004|NCT00883337|16757162|P1|Core Treatment Period|Withdrawal by Subject|2
4862005|NCT00883337|16757160|P3|Core Treatment Period|Lost to Follow-up|0
4862006|NCT00883337|16757161|P2|Core Treatment Period|Lost to Follow-up|1
4862007|NCT00883337|16757162|P1|Core Treatment Period|Lost to Follow-up|1
4862008|NCT00883337|16757160|P3|Core Treatment Period|Lack of Efficacy|2
4862009|NCT00883337|16757161|P2|Core Treatment Period|Lack of Efficacy|4
4862010|NCT00883337|16757162|P1|Core Treatment Period|Lack of Efficacy|7
4862011|NCT00883337|16757160|P3|Core Treatment Period|Adverse Event|22
4862012|NCT00883337|16757161|P2|Core Treatment Period|Adverse Event|12
4862013|NCT00883337|16757162|P1|Core Treatment Period|Adverse Event|9
4862014|NCT00883181|16757229|P1|Overall Study|Noncompliance|3
4862015|NCT00883181|16757229|P1|Overall Study|Protocol Deviation|3
4862016|NCT00883181|16757229|P1|Overall Study|Other|38
4862017|NCT00883181|16757229|P1|Overall Study|Death|31
4862018|NCT00883181|16757229|P1|Overall Study|Withdrawal by Subject|4
4862019|NCT00883181|16757229|P1|Overall Study|Administrative Reason|24
4862020|NCT00883181|16757229|P1|Overall Study|Disease Progression|94
4862021|NCT00883181|16757229|P1|Overall Study|Non-hematological Adverse Event|55
4862022|NCT00883181|16757229|P1|Overall Study|Hematological Adverse Event|26
4862023|NCT00883129|16757465|P2|Overall Study|Defined Treatment Failure|2
4862024|NCT00883129|16757466|P1|Overall Study|Defined Treatment Failure|0
4862025|NCT00883129|16757465|P2|Overall Study|Death|2
4862026|NCT00883129|16757466|P1|Overall Study|Death|1
4862027|NCT00883129|16757465|P2|Overall Study|Lost to Follow-up|2
4862028|NCT00883129|16757466|P1|Overall Study|Lost to Follow-up|1
4862029|NCT00883129|16757465|P2|Overall Study|Non-compliance|6
4862030|NCT00883129|16757466|P1|Overall Study|Non-compliance|3
4862031|NCT00883129|16757465|P2|Overall Study|Withdrawal by Subject|9
4862032|NCT00883129|16757466|P1|Overall Study|Withdrawal by Subject|8
4862033|NCT00883129|16757465|P2|Overall Study|Adverse Event|15
4862034|NCT00883129|16757466|P1|Overall Study|Adverse Event|7
4862035|NCT00883116|16757490|P2|Overall Study|No longer meets study criteria|2
4862036|NCT00883116|16757491|P1|Overall Study|No longer meets study criteria|2
4862037|NCT00883116|16757490|P2|Overall Study|Withdrawal by Subject|8
4862038|NCT00883116|16757491|P1|Overall Study|Withdrawal by Subject|14
4862039|NCT00883116|16757490|P2|Overall Study|Study drug toxicity|16
4862040|NCT00883116|16757491|P1|Overall Study|Study drug toxicity|36
4862041|NCT00883116|16757490|P2|Overall Study|Not identified|6
4862042|NCT00883116|16757491|P1|Overall Study|Not identified|3
4862043|NCT00883116|16757490|P2|Overall Study|Maximum clinical benefit|46
4862044|NCT00883116|16757491|P1|Overall Study|Maximum clinical benefit|13
4862045|NCT00883116|16757490|P2|Overall Study|Lost to Follow-up|1
4862046|NCT00883116|16757491|P1|Overall Study|Lost to Follow-up|0
4862047|NCT00883116|16757490|P2|Overall Study|Disease progression|128
4862048|NCT00883116|16757491|P1|Overall Study|Disease progression|130
4862049|NCT00883116|16757490|P2|Overall Study|Death|2
4862050|NCT00883116|16757491|P1|Overall Study|Death|6
4862051|NCT00883116|16757490|P2|Overall Study|Adverse event unrelated to study drug|10
4862052|NCT00883116|16757491|P1|Overall Study|Adverse event unrelated to study drug|5
4862053|NCT00883090|16757513|P1|Overall Study|Withdrawal by Subject|1
4862054|NCT00883090|16757513|P1|Overall Study|Sponsor's decision|1
4862055|NCT00883051|16757533|P5|Overall Study|Did not use study medication|17
4862056|NCT00883051|16757534|P4|Overall Study|Did not use study medication|29
4862057|NCT00883051|16757535|P3|Overall Study|Did not use study medication|29
4862058|NCT00883051|16757536|P2|Overall Study|Did not use study medication|22
4862059|NCT00883051|16757537|P1|Overall Study|Did not use study medication|24
4862060|NCT00883051|16757533|P5|Overall Study|Lost to Follow-up|1
4862061|NCT00883051|16757534|P4|Overall Study|Lost to Follow-up|0
4862062|NCT00883051|16757535|P3|Overall Study|Lost to Follow-up|0
4862063|NCT00883051|16757536|P2|Overall Study|Lost to Follow-up|0
4862064|NCT00883051|16757537|P1|Overall Study|Lost to Follow-up|0
4862065|NCT00882999|16757641|P7|Overall Study|Physician Decision|1
4862066|NCT00882999|16757642|P6|Overall Study|Physician Decision|1
4862067|NCT00882999|16757643|P5|Overall Study|Physician Decision|0
4862068|NCT00882999|16757644|P4|Overall Study|Physician Decision|0
4862069|NCT00882999|16757645|P3|Overall Study|Physician Decision|0
4862070|NCT00882999|16757646|P2|Overall Study|Physician Decision|0
4862071|NCT00882999|16757647|P1|Overall Study|Physician Decision|1
4862072|NCT00882999|16757641|P7|Overall Study|Lost to Follow-up|2
4862073|NCT00882999|16757642|P6|Overall Study|Lost to Follow-up|1
4862074|NCT00882999|16757643|P5|Overall Study|Lost to Follow-up|1
4862075|NCT00882999|16757644|P4|Overall Study|Lost to Follow-up|2
4862076|NCT00882999|16757645|P3|Overall Study|Lost to Follow-up|1
4862077|NCT00882999|16757646|P2|Overall Study|Lost to Follow-up|1
4862078|NCT00882999|16757647|P1|Overall Study|Lost to Follow-up|0
4862079|NCT00882999|16757641|P7|Overall Study|Withdrawal by Subject|5
4862080|NCT00882999|16757642|P6|Overall Study|Withdrawal by Subject|5
4862081|NCT00882999|16757643|P5|Overall Study|Withdrawal by Subject|6
4862082|NCT00882999|16757644|P4|Overall Study|Withdrawal by Subject|3
4862083|NCT00882999|16757645|P3|Overall Study|Withdrawal by Subject|3
4862084|NCT00882999|16757646|P2|Overall Study|Withdrawal by Subject|6
4862085|NCT00882999|16757647|P1|Overall Study|Withdrawal by Subject|7
4862086|NCT00882999|16757641|P7|Overall Study|Death|0
4862087|NCT00882999|16757642|P6|Overall Study|Death|0
4862088|NCT00882999|16757643|P5|Overall Study|Death|0
4862089|NCT00882999|16757644|P4|Overall Study|Death|0
4862090|NCT00882999|16757645|P3|Overall Study|Death|0
4862091|NCT00882999|16757646|P2|Overall Study|Death|1
4862092|NCT00882999|16757647|P1|Overall Study|Death|0
4862093|NCT00882999|16757641|P7|Overall Study|Adverse Event|0
4862094|NCT00882999|16757642|P6|Overall Study|Adverse Event|0
4862095|NCT00882999|16757643|P5|Overall Study|Adverse Event|1
4862096|NCT00882999|16757644|P4|Overall Study|Adverse Event|0
4862097|NCT00882999|16757645|P3|Overall Study|Adverse Event|0
4862098|NCT00882999|16757646|P2|Overall Study|Adverse Event|0
4862099|NCT00882999|16757647|P1|Overall Study|Adverse Event|0
4862100|NCT00882921|16757774|P1|Overall Study|Withdrawal Of Consent|1
4862101|NCT00882921|16757774|P1|Overall Study|Termination By Investigator|3
4862102|NCT00882921|16757774|P1|Overall Study|Lost to Follow-up|2
4862103|NCT00882921|16757774|P1|Overall Study|Other|3
4862104|NCT00882921|16757774|P1|Overall Study|Death|2
4862105|NCT00882908|16757784|P5|Overall Study|Study terminated in error|0
4862106|NCT00882908|16757785|P4|Overall Study|Study terminated in error|1
4862107|NCT00882908|16757786|P3|Overall Study|Study terminated in error|0
4862108|NCT00882908|16757787|P2|Overall Study|Study terminated in error|0
4862109|NCT00882908|16757788|P1|Overall Study|Study terminated in error|0
4862110|NCT00882908|16757784|P5|Overall Study|Subject reached a virologic endpoint|1
4862111|NCT00882908|16757785|P4|Overall Study|Subject reached a virologic endpoint|0
4862112|NCT00882908|16757786|P3|Overall Study|Subject reached a virologic endpoint|0
4862113|NCT00882908|16757787|P2|Overall Study|Subject reached a virologic endpoint|0
4862114|NCT00882908|16757788|P1|Overall Study|Subject reached a virologic endpoint|0
4862115|NCT00882908|16757784|P5|Overall Study|Withdrawal by Subject|2
4862116|NCT00882908|16757785|P4|Overall Study|Withdrawal by Subject|5
4862117|NCT00882908|16757786|P3|Overall Study|Withdrawal by Subject|3
4862118|NCT00882908|16757787|P2|Overall Study|Withdrawal by Subject|0
4862119|NCT00882908|16757788|P1|Overall Study|Withdrawal by Subject|0
4862120|NCT00882908|16757784|P5|Overall Study|Protocol Violation|0
4862121|NCT00882908|16757785|P4|Overall Study|Protocol Violation|0
4862122|NCT00882908|16757786|P3|Overall Study|Protocol Violation|0
4862123|NCT00882908|16757787|P2|Overall Study|Protocol Violation|1
4862124|NCT00882908|16757788|P1|Overall Study|Protocol Violation|0
4862125|NCT00882908|16757784|P5|Overall Study|Lost to Follow-up|2
4862126|NCT00882908|16757785|P4|Overall Study|Lost to Follow-up|1
4862127|NCT00882908|16757786|P3|Overall Study|Lost to Follow-up|3
4862128|NCT00882908|16757787|P2|Overall Study|Lost to Follow-up|5
4862129|NCT00882908|16757788|P1|Overall Study|Lost to Follow-up|3
4862130|NCT00882908|16757784|P5|Overall Study|Adverse Event|1
4862131|NCT00882908|16757785|P4|Overall Study|Adverse Event|0
4862132|NCT00882908|16757786|P3|Overall Study|Adverse Event|1
4862133|NCT00882908|16757787|P2|Overall Study|Adverse Event|0
4862134|NCT00882908|16757788|P1|Overall Study|Adverse Event|0
4862135|NCT00882713|16757894|P1|Overall Study|Other - Reasons|2
4862136|NCT00882713|16757894|P1|Overall Study|Failure to return|2
4862137|NCT00882713|16757894|P1|Overall Study|Insufficient therapeutic response|3
4862138|NCT00882713|16757894|P1|Overall Study|Blood transfusion|2
4862139|NCT00882713|16757894|P1|Overall Study|refused treatment/withdrew consent|4
4862140|NCT00882713|16757894|P1|Overall Study|Administrative reasons|4
4862141|NCT00882713|16757894|P1|Overall Study|Death|3
4862142|NCT00882713|16757894|P1|Overall Study|Adverse Event|2
4862143|NCT00882583|16757987|P2|Overall Study|Adverse Event|1
4862144|NCT00882583|16757988|P1|Overall Study|Adverse Event|0
4862145|NCT00882583|16757987|P2|Overall Study|Physician Decision|0
4862146|NCT00882583|16757988|P1|Overall Study|Physician Decision|1
4862147|NCT00882557|16757996|P2|Overall Study|Randomized Not Treated|1
4862148|NCT00882557|16757997|P1|Overall Study|Randomized Not Treated|0
4862149|NCT00882557|16757996|P2|Overall Study|Trouble with Vein Access|0
4862150|NCT00882557|16757997|P1|Overall Study|Trouble with Vein Access|1
4862151|NCT00882557|16757996|P2|Overall Study|Withdrawal by Subject|0
4862152|NCT00882557|16757997|P1|Overall Study|Withdrawal by Subject|1
4862153|NCT00882518|16758017|P2|Overall Study|Allocating random number by mistake|1
4862154|NCT00882518|16758018|P1|Overall Study|Allocating random number by mistake|0
4862155|NCT00882518|16758017|P2|Overall Study|Central lab closure for National day|0
4862156|NCT00882518|16758018|P1|Overall Study|Central lab closure for National day|1
4862157|NCT00882518|16758017|P2|Overall Study|Incorrect enrolment|2
4862158|NCT00882518|16758018|P1|Overall Study|Incorrect enrolment|4
4862159|NCT00882518|16758017|P2|Overall Study|Severe non-compliance to protocol|1
4862160|NCT00882518|16758018|P1|Overall Study|Severe non-compliance to protocol|3
4862161|NCT00882518|16758017|P2|Overall Study|Lack of Efficacy|9
4862162|NCT00882518|16758018|P1|Overall Study|Lack of Efficacy|12
4862163|NCT00882518|16758017|P2|Overall Study|Withdrawal by Subject|13
4862164|NCT00882518|16758018|P1|Overall Study|Withdrawal by Subject|9
4862165|NCT00882518|16758017|P2|Overall Study|Adverse Event|18
4862166|NCT00882518|16758018|P1|Overall Study|Adverse Event|9
4862167|NCT00882440|16758047|P7|Overall Study|Patient Uncooperative|0
4862168|NCT00882440|16758048|P6|Overall Study|Patient Uncooperative|0
4862169|NCT00882440|16758049|P5|Overall Study|Patient Uncooperative|1
4862170|NCT00882440|16758050|P4|Overall Study|Patient Uncooperative|0
4862171|NCT00882440|16758051|P3|Overall Study|Patient Uncooperative|0
4862172|NCT00882440|16758052|P2|Overall Study|Patient Uncooperative|0
4862173|NCT00882440|16758053|P1|Overall Study|Patient Uncooperative|2
4862174|NCT00882440|16758047|P7|Overall Study|Withdrawal by Subject|1
4862175|NCT00882440|16758048|P6|Overall Study|Withdrawal by Subject|0
4862176|NCT00882440|16758049|P5|Overall Study|Withdrawal by Subject|6
4862177|NCT00882440|16758050|P4|Overall Study|Withdrawal by Subject|0
4862178|NCT00882440|16758051|P3|Overall Study|Withdrawal by Subject|1
4862179|NCT00882440|16758052|P2|Overall Study|Withdrawal by Subject|1
4862180|NCT00882440|16758053|P1|Overall Study|Withdrawal by Subject|2
4862181|NCT00882440|16758047|P7|Overall Study|Protocol Violation|0
4862182|NCT00882440|16758048|P6|Overall Study|Protocol Violation|0
4862183|NCT00882440|16758049|P5|Overall Study|Protocol Violation|1
4862184|NCT00882440|16758050|P4|Overall Study|Protocol Violation|1
4862185|NCT00882440|16758051|P3|Overall Study|Protocol Violation|1
4862186|NCT00882440|16758052|P2|Overall Study|Protocol Violation|0
4862187|NCT00882440|16758053|P1|Overall Study|Protocol Violation|0
4862188|NCT00882440|16758047|P7|Overall Study|Lost to Follow-up|1
4862189|NCT00882440|16758048|P6|Overall Study|Lost to Follow-up|0
4862190|NCT00882440|16758049|P5|Overall Study|Lost to Follow-up|1
4862191|NCT00882440|16758050|P4|Overall Study|Lost to Follow-up|1
4862192|NCT00882440|16758051|P3|Overall Study|Lost to Follow-up|1
4862193|NCT00882440|16758052|P2|Overall Study|Lost to Follow-up|0
4862194|NCT00882440|16758053|P1|Overall Study|Lost to Follow-up|2
4862195|NCT00882440|16758047|P7|Overall Study|Lack of Efficacy|0
4862196|NCT00882440|16758048|P6|Overall Study|Lack of Efficacy|3
4862197|NCT00882440|16758049|P5|Overall Study|Lack of Efficacy|0
4862198|NCT00882440|16758050|P4|Overall Study|Lack of Efficacy|0
4862199|NCT00882440|16758051|P3|Overall Study|Lack of Efficacy|2
4862200|NCT00882440|16758052|P2|Overall Study|Lack of Efficacy|5
4862201|NCT00882440|16758053|P1|Overall Study|Lack of Efficacy|3
4862202|NCT00882440|16758047|P7|Overall Study|Adverse Event|2
4862203|NCT00882440|16758048|P6|Overall Study|Adverse Event|4
4862204|NCT00882440|16758049|P5|Overall Study|Adverse Event|1
4862205|NCT00882440|16758050|P4|Overall Study|Adverse Event|1
4862206|NCT00882440|16758051|P3|Overall Study|Adverse Event|2
4862207|NCT00882440|16758052|P2|Overall Study|Adverse Event|2
4862208|NCT00882440|16758053|P1|Overall Study|Adverse Event|2
4862209|NCT00882362|16758078|P2|Overall Study|change of residence or other commitments|0
4862210|NCT00882362|16758079|P1|Overall Study|change of residence or other commitments|5
4862211|NCT00882362|16758078|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
4862212|NCT00882362|16758079|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2
4862213|NCT00882362|16758078|P2|Overall Study|Physician Decision|1
4862214|NCT00882362|16758079|P1|Overall Study|Physician Decision|5
4862215|NCT00882362|16758078|P2|Overall Study|Pregnancy|0
4862216|NCT00882362|16758079|P1|Overall Study|Pregnancy|1
4862217|NCT00882362|16758078|P2|Overall Study|Protocol Violation|2
4862218|NCT00882362|16758079|P1|Overall Study|Protocol Violation|7
4862219|NCT00882362|16758078|P2|Overall Study|Lack of Efficacy|0
4862220|NCT00882362|16758079|P1|Overall Study|Lack of Efficacy|3
4862221|NCT00882362|16758078|P2|Overall Study|Withdrawal by Subject|10
4862222|NCT00882362|16758079|P1|Overall Study|Withdrawal by Subject|13
4862223|NCT00882362|16758078|P2|Overall Study|Adverse Event|10
4862224|NCT00882362|16758079|P1|Overall Study|Adverse Event|13
4862225|NCT00882310|16758085|P1|Overall Study|Adverse Event|1
4862226|NCT00882310|16758085|P1|Overall Study|Progression of disease|4
4862227|NCT00882310|16758085|P1|Overall Study|Death|6
4862228|NCT00882310|16758085|P1|Overall Study|Never received treatment|1
4862229|NCT00882310|16758085|P1|Overall Study|Screen Failure|10
4862230|NCT00882115|16758098|P1|Overall Study|did not respond to DEP challe|6
4862231|NCT00882115|16758098|P1|Overall Study|Withdrawal by Subject|3
4862232|NCT00881959|16758108|P2|Overall Study|Lost to Follow-up|4
4862233|NCT00881959|16758109|P1|Overall Study|Lost to Follow-up|2
4862234|NCT00881894|16758117|P2|Overall Study|Other reasons for premature termination|2
4862235|NCT00881894|16758118|P1|Overall Study|Other reasons for premature termination|1
4862236|NCT00881894|16758117|P2|Overall Study|Consent withdrawn|1
4862237|NCT00881894|16758118|P1|Overall Study|Consent withdrawn|0
4862238|NCT00881868|16758150|P2|Overall Study|Protocol Violation|0
4862239|NCT00881868|16758151|P1|Overall Study|Protocol Violation|2
4862240|NCT00881868|16758150|P2|Overall Study|Physician Decision|0
4862241|NCT00881868|16758151|P1|Overall Study|Physician Decision|4
4862242|NCT00881868|16758150|P2|Overall Study|Lost to Follow-up|1
4862243|NCT00881868|16758151|P1|Overall Study|Lost to Follow-up|2
4862244|NCT00881868|16758150|P2|Overall Study|Adverse Event|1
4862245|NCT00881868|16758151|P1|Overall Study|Adverse Event|0
4862246|NCT00881751|16758165|P2|Overall Study|Withdrawal by Subject|2
4862247|NCT00881751|16758166|P1|Overall Study|Withdrawal by Subject|0
4862248|NCT00881751|16758165|P2|Overall Study|Adverse Event|2
4862249|NCT00881751|16758166|P1|Overall Study|Adverse Event|0
4862250|NCT00881751|16758165|P2|Overall Study|Physician Decision|1
4862251|NCT00881751|16758166|P1|Overall Study|Physician Decision|0
4862252|NCT00881712|16758181|P3|Overall Study|Withdrawal by Subject|0
4862253|NCT00881712|16758182|P2|Overall Study|Withdrawal by Subject|0
4862254|NCT00881712|16758183|P1|Overall Study|Withdrawal by Subject|1
4862255|NCT00881712|16758181|P3|Overall Study|Death|0
4862256|NCT00881712|16758182|P2|Overall Study|Death|0
4862257|NCT00881712|16758183|P1|Overall Study|Death|1
4862258|NCT00881621|16758216|P1|Overall Study|Physician Decision|34
4862259|NCT00881608|16758228|P1|Overall Study|Study prematurely terminated|11
4862260|NCT00881569|16758247|P2|Overall Study|Disease progression|1
4862261|NCT00881569|16758248|P1|Overall Study|Disease progression|1
4862262|NCT00881530|16758264|P6|Overall Study|Other reason not defined above|2
4862263|NCT00881530|16758265|P5|Overall Study|Other reason not defined above|0
4862264|NCT00881530|16758266|P4|Overall Study|Other reason not defined above|0
4862265|NCT00881530|16758267|P3|Overall Study|Other reason not defined above|2
4862266|NCT00881530|16758268|P2|Overall Study|Other reason not defined above|1
4862267|NCT00881530|16758269|P1|Overall Study|Other reason not defined above|1
4862268|NCT00881530|16758264|P6|Overall Study|Refused to continue medication|0
4862269|NCT00881530|16758265|P5|Overall Study|Refused to continue medication|0
4862270|NCT00881530|16758266|P4|Overall Study|Refused to continue medication|2
4862271|NCT00881530|16758267|P3|Overall Study|Refused to continue medication|1
4862272|NCT00881530|16758268|P2|Overall Study|Refused to continue medication|2
4862273|NCT00881530|16758269|P1|Overall Study|Refused to continue medication|7
4862274|NCT00881530|16758264|P6|Overall Study|Lost to Follow-up|0
4862275|NCT00881530|16758265|P5|Overall Study|Lost to Follow-up|1
4862276|NCT00881530|16758266|P4|Overall Study|Lost to Follow-up|3
4862277|NCT00881530|16758267|P3|Overall Study|Lost to Follow-up|1
4862278|NCT00881530|16758268|P2|Overall Study|Lost to Follow-up|1
4862279|NCT00881530|16758269|P1|Overall Study|Lost to Follow-up|0
4862280|NCT00881530|16758264|P6|Overall Study|Not compliant with the protocol|0
4862281|NCT00881530|16758265|P5|Overall Study|Not compliant with the protocol|2
4862282|NCT00881530|16758266|P4|Overall Study|Not compliant with the protocol|0
4862283|NCT00881530|16758267|P3|Overall Study|Not compliant with the protocol|0
4862284|NCT00881530|16758268|P2|Overall Study|Not compliant with the protocol|0
4862285|NCT00881530|16758269|P1|Overall Study|Not compliant with the protocol|0
4862286|NCT00881530|16758264|P6|Overall Study|Lack of Efficacy|1
4862287|NCT00881530|16758265|P5|Overall Study|Lack of Efficacy|1
4862288|NCT00881530|16758266|P4|Overall Study|Lack of Efficacy|0
4862289|NCT00881530|16758267|P3|Overall Study|Lack of Efficacy|0
4862290|NCT00881530|16758268|P2|Overall Study|Lack of Efficacy|0
4862291|NCT00881530|16758269|P1|Overall Study|Lack of Efficacy|1
4862292|NCT00881530|16758264|P6|Overall Study|Adverse Event|2
4862293|NCT00881530|16758265|P5|Overall Study|Adverse Event|10
4862294|NCT00881530|16758266|P4|Overall Study|Adverse Event|4
4862295|NCT00881530|16758267|P3|Overall Study|Adverse Event|1
4862296|NCT00881530|16758268|P2|Overall Study|Adverse Event|1
4862297|NCT00881530|16758269|P1|Overall Study|Adverse Event|5
4862298|NCT00881504|16758325|P1|Overall Study|Withdrawal by Subject|1
4862299|NCT00881361|16758345|P3|Overall Study|Ineligible|2
4862300|NCT00881361|16758346|P2|Overall Study|Ineligible|2
4862301|NCT00881361|16758347|P1|Overall Study|Ineligible|17
4862302|NCT00881361|16758345|P3|Overall Study|Terminated prior to surgery|0
4862303|NCT00881361|16758346|P2|Overall Study|Terminated prior to surgery|7
4862304|NCT00881361|16758347|P1|Overall Study|Terminated prior to surgery|27
4862305|NCT00881335|16758362|P2|Overall Study|Lost to Follow-up|2
4862306|NCT00881335|16758363|P1|Overall Study|Lost to Follow-up|3
4862307|NCT00881205|16758383|P2|Overall Study|Condition no longer requires drug|0
4862308|NCT00881205|16758384|P1|Overall Study|Condition no longer requires drug|1
4862309|NCT00881205|16758383|P2|Overall Study|Administrative problems|1
4862310|NCT00881205|16758384|P1|Overall Study|Administrative problems|1
4862311|NCT00881205|16758383|P2|Overall Study|Lost to Follow-up|1
4862312|NCT00881205|16758384|P1|Overall Study|Lost to Follow-up|0
4862313|NCT00881205|16758383|P2|Overall Study|Withdrawal by Subject|2
4862314|NCT00881205|16758384|P1|Overall Study|Withdrawal by Subject|1
4862315|NCT00881205|16758383|P2|Overall Study|Adverse Event|3
4862316|NCT00881205|16758384|P1|Overall Study|Adverse Event|8
4862317|NCT00880906|16758452|P2|Overall Study|Did not meet criteria following patholog|6
4862318|NCT00880906|16758453|P1|Overall Study|Did not meet criteria following patholog|12
4862319|NCT00880906|16758452|P2|Overall Study|Lost to Follow-up|1
4862320|NCT00880906|16758453|P1|Overall Study|Lost to Follow-up|0
4862321|NCT00880893|16758463|P2|Overall Study|Serious adverse event|0
4862322|NCT00880893|16758464|P1|Overall Study|Serious adverse event|3
4862323|NCT00880893|16758463|P2|Overall Study|Lost to Follow-up|33
4862324|NCT00880893|16758464|P1|Overall Study|Lost to Follow-up|76
4862325|NCT00880893|16758463|P2|Overall Study|Withdrawal by Subject|11
4862326|NCT00880893|16758464|P1|Overall Study|Withdrawal by Subject|15
4862327|NCT00880893|16758463|P2|Overall Study|Protocol Violation|1
4862328|NCT00880893|16758464|P1|Overall Study|Protocol Violation|13
4862329|NCT00880763|16758516|P4|Extension Period (Part 2)|Lack of Efficacy|1
4862330|NCT00880763|16758517|P3|Extension Period (Part 2)|Lack of Efficacy|0
4862331|NCT00880763|16758518|P2|Extension Period (Part 2)|Lack of Efficacy|0
4862332|NCT00880763|16758519|P1|Extension Period (Part 2)|Lack of Efficacy|0
4862333|NCT00880763|16758516|P4|Extension Period (Part 2)|Physician Decision|0
4862334|NCT00880763|16758517|P3|Extension Period (Part 2)|Physician Decision|1
4862335|NCT00880763|16758518|P2|Extension Period (Part 2)|Physician Decision|1
4862336|NCT00880763|16758519|P1|Extension Period (Part 2)|Physician Decision|0
4862337|NCT00880763|16758516|P4|Extension Period (Part 2)|Withdrawal by Subject|1
4862338|NCT00880763|16758517|P3|Extension Period (Part 2)|Withdrawal by Subject|1
4862339|NCT00880763|16758518|P2|Extension Period (Part 2)|Withdrawal by Subject|2
4862340|NCT00880763|16758519|P1|Extension Period (Part 2)|Withdrawal by Subject|0
4862341|NCT00880763|16758516|P4|Extension Period (Part 2)|Adverse Event|1
4862342|NCT00880763|16758517|P3|Extension Period (Part 2)|Adverse Event|1
4862343|NCT00880763|16758518|P2|Extension Period (Part 2)|Adverse Event|0
4862344|NCT00880763|16758519|P1|Extension Period (Part 2)|Adverse Event|0
4862345|NCT00880750|16758551|P2|Second Intervention|Unable to collect urine|0
4862346|NCT00880750|16758552|P1|Second Intervention|Unable to collect urine|1
4862347|NCT00880750|16758551|P2|Second Intervention|Protocol Violation|0
4862348|NCT00880750|16758552|P1|Second Intervention|Protocol Violation|1
4862349|NCT00880750|16758551|P2|Second Intervention|Withdrawal by Subject|2
4862350|NCT00880750|16758552|P1|Second Intervention|Withdrawal by Subject|2
4862351|NCT00880750|16758551|P2|First Intervention|Lost to Follow-up|0
4862352|NCT00880750|16758552|P1|First Intervention|Lost to Follow-up|2
4862353|NCT00880750|16758551|P2|First Intervention|Withdrawal by Subject|0
4862354|NCT00880750|16758552|P1|First Intervention|Withdrawal by Subject|2
4862355|NCT00880750|16758551|P2|First Intervention|Non-compliance with meals|1
4862356|NCT00880750|16758552|P1|First Intervention|Non-compliance with meals|0
4862357|NCT00880750|16758551|P2|First Intervention|Unable to collect urine|0
4862358|NCT00880750|16758552|P1|First Intervention|Unable to collect urine|4
4862359|NCT00880750|16758551|P2|First Intervention|Adverse Event|0
4862360|NCT00880750|16758552|P1|First Intervention|Adverse Event|1
4862361|NCT00880698|16758570|P4|Overall Study|Lost to Follow-up|1
4862362|NCT00880698|16758571|P3|Overall Study|Lost to Follow-up|0
4862363|NCT00880698|16758572|P2|Overall Study|Lost to Follow-up|3
4862364|NCT00880698|16758573|P1|Overall Study|Lost to Follow-up|1
4862365|NCT00880698|16758570|P4|Overall Study|Death|2
4862366|NCT00880698|16758571|P3|Overall Study|Death|1
4862367|NCT00880698|16758572|P2|Overall Study|Death|0
4862368|NCT00880698|16758573|P1|Overall Study|Death|0
4862369|NCT00880685|16758599|P1|Memantine 20mg|Withdrawal by Subject|1
4862370|NCT00880685|16758599|P1|Memantine 10mg|Lost to Follow-up|2
4862371|NCT00880620|16758611|P4|Overall Study|Other|2
4862372|NCT00880620|16758612|P3|Overall Study|Other|2
4862373|NCT00880620|16758613|P2|Overall Study|Other|1
4862374|NCT00880620|16758614|P1|Overall Study|Other|1
4862375|NCT00880620|16758611|P4|Overall Study|Noncompliance|1
4862376|NCT00880620|16758612|P3|Overall Study|Noncompliance|1
4862377|NCT00880620|16758613|P2|Overall Study|Noncompliance|0
4862378|NCT00880620|16758614|P1|Overall Study|Noncompliance|0
4862379|NCT00880620|16758611|P4|Overall Study|Withdrawal by Subject|3
4862380|NCT00880620|16758612|P3|Overall Study|Withdrawal by Subject|1
4862381|NCT00880620|16758613|P2|Overall Study|Withdrawal by Subject|3
4862382|NCT00880620|16758614|P1|Overall Study|Withdrawal by Subject|4
4862383|NCT00880620|16758611|P4|Overall Study|Protocol Violation|2
4862384|NCT00880620|16758612|P3|Overall Study|Protocol Violation|0
4862385|NCT00880620|16758613|P2|Overall Study|Protocol Violation|1
4862386|NCT00880620|16758614|P1|Overall Study|Protocol Violation|0
4862387|NCT00880620|16758611|P4|Overall Study|Lost to Follow-up|0
4862388|NCT00880620|16758612|P3|Overall Study|Lost to Follow-up|1
4862389|NCT00880620|16758613|P2|Overall Study|Lost to Follow-up|1
4862390|NCT00880620|16758614|P1|Overall Study|Lost to Follow-up|0
4862391|NCT00880620|16758611|P4|Overall Study|Lack of Efficacy|1
4862392|NCT00880620|16758612|P3|Overall Study|Lack of Efficacy|0
4862393|NCT00880620|16758613|P2|Overall Study|Lack of Efficacy|4
4862394|NCT00880620|16758614|P1|Overall Study|Lack of Efficacy|12
4862395|NCT00880620|16758611|P4|Overall Study|Death|0
4862396|NCT00880620|16758612|P3|Overall Study|Death|1
4862397|NCT00880620|16758613|P2|Overall Study|Death|0
4862398|NCT00880620|16758614|P1|Overall Study|Death|0
4862399|NCT00880620|16758611|P4|Overall Study|Adverse Event|15
4862400|NCT00880620|16758612|P3|Overall Study|Adverse Event|15
4862401|NCT00880620|16758613|P2|Overall Study|Adverse Event|5
4862402|NCT00880620|16758614|P1|Overall Study|Adverse Event|4
4862403|NCT00880607|16758630|P2|Overall Study|surgery did not extend past L1 level|0
4862404|NCT00880607|16758631|P1|Overall Study|surgery did not extend past L1 level|3
4862405|NCT00880607|16758630|P2|Overall Study|Protocol Violation|1
4862406|NCT00880607|16758631|P1|Overall Study|Protocol Violation|2
4862407|NCT00880607|16758630|P2|Overall Study|Physician Decision|2
4862408|NCT00880607|16758631|P1|Overall Study|Physician Decision|2
4862409|NCT00880568|16758663|P9|Overall Study|Withdrawal by Subject|0
4862410|NCT00880568|16758664|P8|Overall Study|Withdrawal by Subject|1
4862411|NCT00880568|16758665|P7|Overall Study|Withdrawal by Subject|0
4862412|NCT00880568|16758666|P6|Overall Study|Withdrawal by Subject|0
4862413|NCT00880568|16758667|P5|Overall Study|Withdrawal by Subject|0
4862414|NCT00880568|16758668|P4|Overall Study|Withdrawal by Subject|0
4862415|NCT00880568|16758669|P3|Overall Study|Withdrawal by Subject|0
4862416|NCT00880568|16758670|P2|Overall Study|Withdrawal by Subject|0
4862417|NCT00880568|16758671|P1|Overall Study|Withdrawal by Subject|0
4862418|NCT00880568|16758663|P9|Overall Study|Adverse Event|0
4862419|NCT00880568|16758664|P8|Overall Study|Adverse Event|1
4862420|NCT00880568|16758665|P7|Overall Study|Adverse Event|1
4862421|NCT00880568|16758666|P6|Overall Study|Adverse Event|0
4862422|NCT00880568|16758667|P5|Overall Study|Adverse Event|0
4862423|NCT00880568|16758668|P4|Overall Study|Adverse Event|0
4862424|NCT00880568|16758669|P3|Overall Study|Adverse Event|0
4862425|NCT00880568|16758670|P2|Overall Study|Adverse Event|0
4862426|NCT00880568|16758671|P1|Overall Study|Adverse Event|0
4862427|NCT00880568|16758663|P9|Overall Study|Disease progression|3
4862428|NCT00880568|16758664|P8|Overall Study|Disease progression|0
4862429|NCT00880568|16758665|P7|Overall Study|Disease progression|5
4862430|NCT00880568|16758666|P6|Overall Study|Disease progression|3
4862431|NCT00880568|16758667|P5|Overall Study|Disease progression|3
4862432|NCT00880568|16758668|P4|Overall Study|Disease progression|1
4862433|NCT00880568|16758669|P3|Overall Study|Disease progression|3
4862434|NCT00880568|16758670|P2|Overall Study|Disease progression|3
4862435|NCT00880568|16758671|P1|Overall Study|Disease progression|3
4862436|NCT00880555|16758717|P6|Overall Study|Lost to Follow-up|0
4862437|NCT00880555|16758718|P5|Overall Study|Lost to Follow-up|0
4862438|NCT00880555|16758719|P4|Overall Study|Lost to Follow-up|0
4862439|NCT00880555|16758720|P3|Overall Study|Lost to Follow-up|0
4862440|NCT00880555|16758721|P2|Overall Study|Lost to Follow-up|1
4862441|NCT00880555|16758722|P1|Overall Study|Lost to Follow-up|0
4862442|NCT00880555|16758717|P6|Overall Study|Death|1
4862443|NCT00880555|16758718|P5|Overall Study|Death|0
4862444|NCT00880555|16758719|P4|Overall Study|Death|0
4862445|NCT00880555|16758720|P3|Overall Study|Death|0
4862446|NCT00880555|16758721|P2|Overall Study|Death|0
4862447|NCT00880555|16758722|P1|Overall Study|Death|0
4862448|NCT00880555|16758717|P6|Overall Study|Lack of resources (hired rater)|0
4862449|NCT00880555|16758718|P5|Overall Study|Lack of resources (hired rater)|0
4862450|NCT00880555|16758719|P4|Overall Study|Lack of resources (hired rater)|0
4862451|NCT00880555|16758720|P3|Overall Study|Lack of resources (hired rater)|5
4862452|NCT00880555|16758721|P2|Overall Study|Lack of resources (hired rater)|7
4862453|NCT00880555|16758722|P1|Overall Study|Lack of resources (hired rater)|9
4862454|NCT00880555|16758717|P6|Overall Study|Withdrawal by Subject|0
4862455|NCT00880555|16758718|P5|Overall Study|Withdrawal by Subject|0
4862456|NCT00880555|16758719|P4|Overall Study|Withdrawal by Subject|0
4862457|NCT00880555|16758720|P3|Overall Study|Withdrawal by Subject|0
4862458|NCT00880555|16758721|P2|Overall Study|Withdrawal by Subject|1
4862459|NCT00880555|16758722|P1|Overall Study|Withdrawal by Subject|1
4862460|NCT00880555|16758717|P6|Overall Study|Physician Decision|0
4862461|NCT00880555|16758718|P5|Overall Study|Physician Decision|1
4862462|NCT00880555|16758719|P4|Overall Study|Physician Decision|2
4862463|NCT00880555|16758720|P3|Overall Study|Physician Decision|0
4862464|NCT00880555|16758721|P2|Overall Study|Physician Decision|8
4862465|NCT00880555|16758722|P1|Overall Study|Physician Decision|0
4862466|NCT00880542|16758733|P1|REP: Surgical Resection|progressive disease|1
4862467|NCT00880542|16758733|P1|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2
4862468|NCT00880542|16758733|P1|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1
4862469|NCT00880399|16758750|P3|Overall Study|Withdrawal by Subject|3
4862470|NCT00880399|16758751|P2|Overall Study|Withdrawal by Subject|3
4862471|NCT00880399|16758752|P1|Overall Study|Withdrawal by Subject|6
4862472|NCT00880399|16758750|P3|Overall Study|Physician Decision|3
4862473|NCT00880399|16758751|P2|Overall Study|Physician Decision|0
4862474|NCT00880399|16758752|P1|Overall Study|Physician Decision|5
4862475|NCT00880399|16758750|P3|Overall Study|Lost to Follow-up|3
4862476|NCT00880399|16758751|P2|Overall Study|Lost to Follow-up|5
4862477|NCT00880399|16758752|P1|Overall Study|Lost to Follow-up|8
4862478|NCT00880399|16758750|P3|Overall Study|Study closed/terminated|4
4862479|NCT00880399|16758751|P2|Overall Study|Study closed/terminated|7
4862480|NCT00880399|16758752|P1|Overall Study|Study closed/terminated|3
4862481|NCT00880399|16758750|P3|Overall Study|Protocol Violation|6
4862482|NCT00880399|16758751|P2|Overall Study|Protocol Violation|4
4862483|NCT00880399|16758752|P1|Overall Study|Protocol Violation|4
4862484|NCT00880399|16758750|P3|Overall Study|Lack of Efficacy|2
4862485|NCT00880399|16758751|P2|Overall Study|Lack of Efficacy|4
4862486|NCT00880399|16758752|P1|Overall Study|Lack of Efficacy|1
4862487|NCT00880399|16758750|P3|Overall Study|Adverse Event|5
4862488|NCT00880399|16758751|P2|Overall Study|Adverse Event|6
4862489|NCT00880399|16758752|P1|Overall Study|Adverse Event|4
4862490|NCT00880334|16758815|P2|Randomized Phase|Crossover Participants|37
4862491|NCT00880334|16758816|P1|Randomized Phase|Crossover Participants|0
4862492|NCT00880334|16758815|P2|Randomized Phase|Brain Metastasis|1
4862493|NCT00880334|16758816|P1|Randomized Phase|Brain Metastasis|0
4862494|NCT00880334|16758815|P2|Randomized Phase|Inadequate Labs|1
4862495|NCT00880334|16758816|P1|Randomized Phase|Inadequate Labs|1
4862496|NCT00880334|16758815|P2|Randomized Phase|Withdrawal by Subject|1
4862497|NCT00880334|16758816|P1|Randomized Phase|Withdrawal by Subject|2
4862498|NCT00880334|16758815|P2|Randomized Phase|Physician Decision|0
4862499|NCT00880334|16758816|P1|Randomized Phase|Physician Decision|1
4862500|NCT00880269|16758833|P2|Overall Study|Adverse Event|9
4862501|NCT00880269|16758834|P1|Overall Study|Adverse Event|10
4862502|NCT00880269|16758833|P2|Overall Study|Withdrawal by Subject|4
4862503|NCT00880269|16758834|P1|Overall Study|Withdrawal by Subject|3
4862504|NCT00880269|16758833|P2|Overall Study|Lost to Follow-up|1
4862505|NCT00880269|16758834|P1|Overall Study|Lost to Follow-up|0
4862506|NCT00880269|16758833|P2|Overall Study|Death|2
4862507|NCT00880269|16758834|P1|Overall Study|Death|4
4862508|NCT00880269|16758833|P2|Overall Study|New Cancer Therapy|0
4862509|NCT00880269|16758834|P1|Overall Study|New Cancer Therapy|1
4862510|NCT00880269|16758833|P2|Overall Study|Disease Progression|11
4862511|NCT00880269|16758834|P1|Overall Study|Disease Progression|13
4862512|NCT00880269|16758833|P2|Overall Study|Protocol Violation|0
4862513|NCT00880269|16758834|P1|Overall Study|Protocol Violation|1
4862514|NCT00880256|16758850|P1|Overall Study|Lost to Follow-up|28
4862515|NCT00880191|16758877|P2|Overall Study|Hospitalization/efficacy|1
4862516|NCT00880191|16758878|P1|Overall Study|Hospitalization/efficacy|1
4862517|NCT00880191|16758877|P2|Overall Study|Adverse Event|6
4862518|NCT00880191|16758878|P1|Overall Study|Adverse Event|8
4862519|NCT00880191|16758877|P2|Overall Study|Refused further treatment|1
4862520|NCT00880191|16758878|P1|Overall Study|Refused further treatment|4
4862521|NCT00880165|16758898|P2|Overall Study|Lost to follow|15
4862522|NCT00880165|16758899|P1|Overall Study|Lost to follow|9
4862523|NCT00880165|16758898|P2|Overall Study|Required BIPAP or oxygen treatment|4
4862524|NCT00880165|16758899|P1|Overall Study|Required BIPAP or oxygen treatment|12
4862525|NCT00880165|16758898|P2|Overall Study|Not diagnosed with OSA|8
4862526|NCT00880165|16758899|P1|Overall Study|Not diagnosed with OSA|14
4862527|NCT00880165|16758898|P2|Overall Study|Withdrawal by Subject|23
4862528|NCT00880165|16758899|P1|Overall Study|Withdrawal by Subject|27
4862529|NCT00880100|16758909|P1|Treatment Phase With Ultrase® MT12|Protocol Violation|2
4862530|NCT00880100|16758909|P1|Treatment Phase With Ultrase® MT12|Adverse Event|1
4862531|NCT00880100|16758909|P1|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1
4862532|NCT00880087|16758922|P2|Overall Study|Lost to Follow-up|2
4862533|NCT00880087|16758923|P1|Overall Study|Lost to Follow-up|0
4862534|NCT00880048|16758938|P3|Overall Study|Study closed/terminated|6
4862535|NCT00880048|16758939|P2|Overall Study|Study closed/terminated|7
4862536|NCT00880048|16758940|P1|Overall Study|Study closed/terminated|9
4862537|NCT00880048|16758938|P3|Overall Study|Withdrawal by Subject|5
4862538|NCT00880048|16758939|P2|Overall Study|Withdrawal by Subject|8
4862539|NCT00880048|16758940|P1|Overall Study|Withdrawal by Subject|5
4862540|NCT00880048|16758938|P3|Overall Study|Physician Decision|7
4862541|NCT00880048|16758939|P2|Overall Study|Physician Decision|1
4862542|NCT00880048|16758940|P1|Overall Study|Physician Decision|1
4862543|NCT00880048|16758938|P3|Overall Study|Lost to Follow-up|5
4862544|NCT00880048|16758939|P2|Overall Study|Lost to Follow-up|6
4862545|NCT00880048|16758940|P1|Overall Study|Lost to Follow-up|6
4862546|NCT00880048|16758938|P3|Overall Study|Protocol Violation|5
4862547|NCT00880048|16758939|P2|Overall Study|Protocol Violation|6
4862548|NCT00880048|16758940|P1|Overall Study|Protocol Violation|4
4862549|NCT00880048|16758938|P3|Overall Study|Lack of Efficacy|2
4862550|NCT00880048|16758939|P2|Overall Study|Lack of Efficacy|2
4862551|NCT00880048|16758940|P1|Overall Study|Lack of Efficacy|1
4862552|NCT00880048|16758938|P3|Overall Study|Adverse Event|5
4862553|NCT00880048|16758939|P2|Overall Study|Adverse Event|3
4862554|NCT00880048|16758940|P1|Overall Study|Adverse Event|2
4862555|NCT00880009|16759007|P1|Overall Study|Protocol Violation|1
4862556|NCT00880009|16759007|P1|Overall Study|Withdrawal by Subject|1
4862557|NCT00880009|16759007|P1|Overall Study|Study terminated by sponsor|14
4862558|NCT00879996|16759031|P2|Overall Study|put on parole|0
4862559|NCT00879996|16759032|P1|Overall Study|put on parole|1
4862560|NCT00879996|16759031|P2|Overall Study|psychiatric problem|1
4862561|NCT00879996|16759032|P1|Overall Study|psychiatric problem|0
4862562|NCT00879996|16759031|P2|Overall Study|Physician Decision|2
4862563|NCT00879996|16759032|P1|Overall Study|Physician Decision|1
4862564|NCT00879996|16759031|P2|Overall Study|non-compliance|4
4862565|NCT00879996|16759032|P1|Overall Study|non-compliance|6
4862566|NCT00879996|16759031|P2|Overall Study|Lost to Follow-up|6
4862567|NCT00879996|16759032|P1|Overall Study|Lost to Follow-up|7
4862568|NCT00879970|16759047|P5|Period 2 Vitamin D Randomization|Death|0
4862569|NCT00879970|16759048|P4|Period 2 Vitamin D Randomization|Death|2
4862570|NCT00879970|16759049|P3|Period 2 Vitamin D Randomization|Death|0
4862571|NCT00879970|16759050|P2|Period 2 Vitamin D Randomization|Death|0
4862572|NCT00879970|16759051|P1|Period 2 Vitamin D Randomization|Death|0
4862573|NCT00879970|16759047|P5|Period 2 Vitamin D Randomization|Lost to Follow-up|1
4862574|NCT00879970|16759048|P4|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4862575|NCT00879970|16759049|P3|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4862576|NCT00879970|16759050|P2|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4862577|NCT00879970|16759051|P1|Period 2 Vitamin D Randomization|Lost to Follow-up|0
4862578|NCT00879970|16759047|P5|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6
4862579|NCT00879970|16759048|P4|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2
4862580|NCT00879970|16759049|P3|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
4862581|NCT00879970|16759050|P2|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
4862582|NCT00879970|16759051|P1|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0
4862583|NCT00879970|16759047|P5|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
4862584|NCT00879970|16759048|P4|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
4862585|NCT00879970|16759049|P3|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1
4862586|NCT00879970|16759050|P2|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0
4862587|NCT00879970|16759051|P1|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2
4862588|NCT00879970|16759047|P5|Period 1 TZD Randomization|Death|0
4862589|NCT00879970|16759048|P4|Period 1 TZD Randomization|Death|0
4862590|NCT00879970|16759049|P3|Period 1 TZD Randomization|Death|0
4862591|NCT00879970|16759050|P2|Period 1 TZD Randomization|Death|1
4862592|NCT00879970|16759051|P1|Period 1 TZD Randomization|Death|2
4862593|NCT00879970|16759047|P5|Period 1 TZD Randomization|Lost to Follow-up|0
4862594|NCT00879970|16759048|P4|Period 1 TZD Randomization|Lost to Follow-up|0
4862595|NCT00879970|16759049|P3|Period 1 TZD Randomization|Lost to Follow-up|1
4862596|NCT00879970|16759050|P2|Period 1 TZD Randomization|Lost to Follow-up|0
4862597|NCT00879970|16759051|P1|Period 1 TZD Randomization|Lost to Follow-up|1
4862598|NCT00879970|16759047|P5|Period 1 TZD Randomization|Refused to Attend Final Visit|0
4862599|NCT00879970|16759048|P4|Period 1 TZD Randomization|Refused to Attend Final Visit|0
4862600|NCT00879970|16759049|P3|Period 1 TZD Randomization|Refused to Attend Final Visit|4
4862601|NCT00879970|16759050|P2|Period 1 TZD Randomization|Refused to Attend Final Visit|3
4862602|NCT00879970|16759051|P1|Period 1 TZD Randomization|Refused to Attend Final Visit|3
4862603|NCT00879879|16759133|P1|Overall Study|Physician Decision|1
4862604|NCT00879879|16759133|P1|Overall Study|Withdrawal by Subject|1
4862605|NCT00879879|16759133|P1|Overall Study|Death|1
4862606|NCT00879814|16759141|P4|Overall Study|Other|0
4862607|NCT00879814|16759142|P3|Overall Study|Other|1
4862608|NCT00879814|16759143|P2|Overall Study|Other|0
4862609|NCT00879814|16759144|P1|Overall Study|Other|0
4862610|NCT00879814|16759141|P4|Overall Study|Physician Decision|0
4862611|NCT00879814|16759142|P3|Overall Study|Physician Decision|1
4862612|NCT00879814|16759143|P2|Overall Study|Physician Decision|0
4862613|NCT00879814|16759144|P1|Overall Study|Physician Decision|0
4862614|NCT00879814|16759141|P4|Overall Study|Withdrawal by Subject|2
4862615|NCT00879814|16759142|P3|Overall Study|Withdrawal by Subject|1
4862616|NCT00879814|16759143|P2|Overall Study|Withdrawal by Subject|1
4862617|NCT00879814|16759144|P1|Overall Study|Withdrawal by Subject|3
4862618|NCT00879814|16759141|P4|Overall Study|Participant Failed to Return|1
4862619|NCT00879814|16759142|P3|Overall Study|Participant Failed to Return|0
4862620|NCT00879814|16759143|P2|Overall Study|Participant Failed to Return|0
4862621|NCT00879814|16759144|P1|Overall Study|Participant Failed to Return|0
4862622|NCT00879814|16759141|P4|Overall Study|Lost to Follow-up|2
4862623|NCT00879814|16759142|P3|Overall Study|Lost to Follow-up|0
4862624|NCT00879814|16759143|P2|Overall Study|Lost to Follow-up|0
4862625|NCT00879814|16759144|P1|Overall Study|Lost to Follow-up|1
4862626|NCT00879814|16759141|P4|Overall Study|Adverse Event|0
4862627|NCT00879814|16759142|P3|Overall Study|Adverse Event|0
4862628|NCT00879814|16759143|P2|Overall Study|Adverse Event|1
4862629|NCT00879814|16759144|P1|Overall Study|Adverse Event|0
4862630|NCT00879775|16759252|P2|Overall Study|Lost to Follow-up|1
4862631|NCT00879775|16759253|P1|Overall Study|Lost to Follow-up|2
4862632|NCT00879710|16759269|P4|Phase 1 - 6 Weeks|Adverse Event|0
4862633|NCT00879710|16759270|P3|Phase 1 - 6 Weeks|Adverse Event|1
4862634|NCT00879710|16759271|P2|Phase 1 - 6 Weeks|Adverse Event|0
4862635|NCT00879710|16759272|P1|Phase 1 - 6 Weeks|Adverse Event|0
4862636|NCT00879710|16759269|P4|Phase 1 - 6 Weeks|Lost to Follow-up|4
4862637|NCT00879710|16759270|P3|Phase 1 - 6 Weeks|Lost to Follow-up|1
4862638|NCT00879710|16759271|P2|Phase 1 - 6 Weeks|Lost to Follow-up|3
4862639|NCT00879710|16759272|P1|Phase 1 - 6 Weeks|Lost to Follow-up|2
4862640|NCT00879697|16759282|P2|Overall Study|Physician Decision|2
4862641|NCT00879697|16759283|P1|Overall Study|Physician Decision|2
4862642|NCT00879684|16759289|P7|Stage 2: Expanded Cohort|Investigator declined participation|1
4862643|NCT00879684|16759290|P6|Stage 2: Expanded Cohort|Investigator declined participation|0
4862644|NCT00879684|16759291|P5|Stage 2: Expanded Cohort|Investigator declined participation|0
4862645|NCT00879684|16759292|P4|Stage 2: Expanded Cohort|Investigator declined participation|0
4862646|NCT00879684|16759293|P3|Stage 2: Expanded Cohort|Investigator declined participation|0
4862647|NCT00879684|16759294|P2|Stage 2: Expanded Cohort|Investigator declined participation|0
4862648|NCT00879684|16759295|P1|Stage 2: Expanded Cohort|Investigator declined participation|0
4862649|NCT00879684|16759289|P7|Stage 2: Expanded Cohort|Progressive Disease|11
4862650|NCT00879684|16759290|P6|Stage 2: Expanded Cohort|Progressive Disease|0
4862651|NCT00879684|16759291|P5|Stage 2: Expanded Cohort|Progressive Disease|0
4862652|NCT00879684|16759292|P4|Stage 2: Expanded Cohort|Progressive Disease|0
4862653|NCT00879684|16759293|P3|Stage 2: Expanded Cohort|Progressive Disease|0
4862654|NCT00879684|16759294|P2|Stage 2: Expanded Cohort|Progressive Disease|0
4862655|NCT00879684|16759295|P1|Stage 2: Expanded Cohort|Progressive Disease|0
4862656|NCT00879684|16759289|P7|Stage 2: Expanded Cohort|Lost to Follow-up|1
4862657|NCT00879684|16759290|P6|Stage 2: Expanded Cohort|Lost to Follow-up|0
4862658|NCT00879684|16759291|P5|Stage 2: Expanded Cohort|Lost to Follow-up|0
4862659|NCT00879684|16759292|P4|Stage 2: Expanded Cohort|Lost to Follow-up|0
4862660|NCT00879684|16759293|P3|Stage 2: Expanded Cohort|Lost to Follow-up|0
4862661|NCT00879684|16759294|P2|Stage 2: Expanded Cohort|Lost to Follow-up|0
4862662|NCT00879684|16759295|P1|Stage 2: Expanded Cohort|Lost to Follow-up|0
4862663|NCT00879684|16759289|P7|Stage 1: Dose Escalation|Death|0
4862664|NCT00879684|16759290|P6|Stage 1: Dose Escalation|Death|0
4862665|NCT00879684|16759291|P5|Stage 1: Dose Escalation|Death|0
4862666|NCT00879684|16759292|P4|Stage 1: Dose Escalation|Death|0
4862667|NCT00879684|16759293|P3|Stage 1: Dose Escalation|Death|1
4862668|NCT00879684|16759294|P2|Stage 1: Dose Escalation|Death|0
4862669|NCT00879684|16759295|P1|Stage 1: Dose Escalation|Death|0
4862670|NCT00879684|16759289|P7|Stage 1: Dose Escalation|Investigator declined participation|0
4862671|NCT00879684|16759290|P6|Stage 1: Dose Escalation|Investigator declined participation|0
4862672|NCT00879684|16759291|P5|Stage 1: Dose Escalation|Investigator declined participation|0
4862673|NCT00879684|16759292|P4|Stage 1: Dose Escalation|Investigator declined participation|2
4862674|NCT00879684|16759293|P3|Stage 1: Dose Escalation|Investigator declined participation|2
4862675|NCT00879684|16759294|P2|Stage 1: Dose Escalation|Investigator declined participation|0
4862676|NCT00879684|16759295|P1|Stage 1: Dose Escalation|Investigator declined participation|0
4862677|NCT00879684|16759289|P7|Stage 1: Dose Escalation|Progressive Disease|0
4862678|NCT00879684|16759290|P6|Stage 1: Dose Escalation|Progressive Disease|3
4862679|NCT00879684|16759291|P5|Stage 1: Dose Escalation|Progressive Disease|3
4862680|NCT00879684|16759292|P4|Stage 1: Dose Escalation|Progressive Disease|4
4862681|NCT00879684|16759293|P3|Stage 1: Dose Escalation|Progressive Disease|0
4862682|NCT00879684|16759294|P2|Stage 1: Dose Escalation|Progressive Disease|3
4862683|NCT00879684|16759295|P1|Stage 1: Dose Escalation|Progressive Disease|2
4862684|NCT00879684|16759289|P7|Stage 1: Dose Escalation|Adverse Event|0
4862685|NCT00879684|16759290|P6|Stage 1: Dose Escalation|Adverse Event|0
4862686|NCT00879684|16759291|P5|Stage 1: Dose Escalation|Adverse Event|0
4862687|NCT00879684|16759292|P4|Stage 1: Dose Escalation|Adverse Event|0
4862688|NCT00879684|16759293|P3|Stage 1: Dose Escalation|Adverse Event|0
4862689|NCT00879684|16759294|P2|Stage 1: Dose Escalation|Adverse Event|0
4862690|NCT00879684|16759295|P1|Stage 1: Dose Escalation|Adverse Event|1
4862691|NCT00879658|16759364|P7|Overall Study|misrandomized (never received study med)|0
4862692|NCT00879658|16759365|P6|Overall Study|misrandomized (never received study med)|0
4862693|NCT00879658|16759366|P5|Overall Study|misrandomized (never received study med)|0
4862694|NCT00879658|16759367|P4|Overall Study|misrandomized (never received study med)|1
4862695|NCT00879658|16759368|P3|Overall Study|misrandomized (never received study med)|0
4862696|NCT00879658|16759369|P2|Overall Study|misrandomized (never received study med)|0
4862697|NCT00879658|16759370|P1|Overall Study|misrandomized (never received study med)|0
4862698|NCT00879658|16759364|P7|Overall Study|Lack of Efficacy|0
4862699|NCT00879658|16759365|P6|Overall Study|Lack of Efficacy|0
4862700|NCT00879658|16759366|P5|Overall Study|Lack of Efficacy|0
4862701|NCT00879658|16759367|P4|Overall Study|Lack of Efficacy|0
4862702|NCT00879658|16759368|P3|Overall Study|Lack of Efficacy|2
4862703|NCT00879658|16759369|P2|Overall Study|Lack of Efficacy|0
4862704|NCT00879658|16759370|P1|Overall Study|Lack of Efficacy|0
4862705|NCT00879658|16759364|P7|Overall Study|Withdrawal by Subject|0
4862706|NCT00879658|16759365|P6|Overall Study|Withdrawal by Subject|1
4862707|NCT00879658|16759366|P5|Overall Study|Withdrawal by Subject|0
4862708|NCT00879658|16759367|P4|Overall Study|Withdrawal by Subject|0
4862709|NCT00879658|16759368|P3|Overall Study|Withdrawal by Subject|2
4862710|NCT00879658|16759369|P2|Overall Study|Withdrawal by Subject|0
4862711|NCT00879658|16759370|P1|Overall Study|Withdrawal by Subject|3
4862712|NCT00879658|16759364|P7|Overall Study|Protocol Violation|0
4862713|NCT00879658|16759365|P6|Overall Study|Protocol Violation|0
4862714|NCT00879658|16759366|P5|Overall Study|Protocol Violation|0
4862715|NCT00879658|16759367|P4|Overall Study|Protocol Violation|0
4862716|NCT00879658|16759368|P3|Overall Study|Protocol Violation|0
4862717|NCT00879658|16759369|P2|Overall Study|Protocol Violation|0
4862718|NCT00879658|16759370|P1|Overall Study|Protocol Violation|1
4862719|NCT00879658|16759364|P7|Overall Study|Adverse Event|0
4862720|NCT00879658|16759365|P6|Overall Study|Adverse Event|0
4862721|NCT00879658|16759366|P5|Overall Study|Adverse Event|2
4862722|NCT00879658|16759367|P4|Overall Study|Adverse Event|1
4862723|NCT00879658|16759368|P3|Overall Study|Adverse Event|3
4862724|NCT00879658|16759369|P2|Overall Study|Adverse Event|4
4862725|NCT00879658|16759370|P1|Overall Study|Adverse Event|6
4862726|NCT00879658|16759364|P7|Overall Study|Administrative problems|0
4862727|NCT00879658|16759365|P6|Overall Study|Administrative problems|0
4862728|NCT00879658|16759366|P5|Overall Study|Administrative problems|0
4862729|NCT00879658|16759367|P4|Overall Study|Administrative problems|1
4862730|NCT00879658|16759368|P3|Overall Study|Administrative problems|0
4862731|NCT00879658|16759369|P2|Overall Study|Administrative problems|1
4862732|NCT00879658|16759370|P1|Overall Study|Administrative problems|2
4862733|NCT00879658|16759364|P7|Overall Study|Abnormal laboratory value(s)|0
4862734|NCT00879658|16759365|P6|Overall Study|Abnormal laboratory value(s)|0
4862735|NCT00879658|16759366|P5|Overall Study|Abnormal laboratory value(s)|0
4862736|NCT00879658|16759367|P4|Overall Study|Abnormal laboratory value(s)|1
4862737|NCT00879658|16759368|P3|Overall Study|Abnormal laboratory value(s)|0
4862738|NCT00879658|16759369|P2|Overall Study|Abnormal laboratory value(s)|0
4862739|NCT00879658|16759370|P1|Overall Study|Abnormal laboratory value(s)|3
4862740|NCT00879645|16759456|P4|Overall Study|Adverse Event|0
4862741|NCT00879645|16759457|P3|Overall Study|Adverse Event|0
4862742|NCT00879645|16759458|P2|Overall Study|Adverse Event|0
4862743|NCT00879645|16759459|P1|Overall Study|Adverse Event|1
4862744|NCT00879411|16759486|P1|Overall Study|lost to follow-up (non-AE)|162
4862745|NCT00879398|16759492|P1|Overall Study|Other Reasons|171
4862746|NCT00879398|16759492|P1|Overall Study|Adverse Event|41
4862747|NCT00879398|16759492|P1|Overall Study|Lack of Efficacy|64
4862748|NCT00879398|16759492|P1|Overall Study|Visit Stop|399
4862749|NCT00879333|16759510|P2|Overall Study|Protocol Violation|1
4862750|NCT00879333|16759511|P1|Overall Study|Protocol Violation|1
4862751|NCT00879333|16759510|P2|Overall Study|Disease Progression|169
4862752|NCT00879333|16759511|P1|Overall Study|Disease Progression|292
4862753|NCT00879333|16759510|P2|Overall Study|Death|5
4862754|NCT00879333|16759511|P1|Overall Study|Death|16
4862755|NCT00879333|16759510|P2|Overall Study|Administrative Problems|0
4862756|NCT00879333|16759511|P1|Overall Study|Administrative Problems|2
4862757|NCT00879333|16759510|P2|Overall Study|Lost to Follow-up|1
4862758|NCT00879333|16759511|P1|Overall Study|Lost to Follow-up|2
4862759|NCT00879333|16759510|P2|Overall Study|Withdrawal by Subject|7
4862760|NCT00879333|16759511|P1|Overall Study|Withdrawal by Subject|20
4862761|NCT00879333|16759510|P2|Overall Study|Abnormal Laboratory Value|0
4862762|NCT00879333|16759511|P1|Overall Study|Abnormal Laboratory Value|1
4862763|NCT00879333|16759510|P2|Overall Study|Adverse Event|34
4862764|NCT00879333|16759511|P1|Overall Study|Adverse Event|94
4862765|NCT00879229|16759544|P2|Overall Study|Other|0
4862766|NCT00879229|16759545|P1|Overall Study|Other|1
4862767|NCT00879229|16759544|P2|Overall Study|Clinical status did not improve|0
4862768|NCT00879229|16759545|P1|Overall Study|Clinical status did not improve|1
4862769|NCT00879229|16759544|P2|Overall Study|Withdrawal by Subject|0
4862770|NCT00879229|16759545|P1|Overall Study|Withdrawal by Subject|1
4862771|NCT00879229|16759544|P2|Overall Study|Adverse Event|0
4862772|NCT00879229|16759545|P1|Overall Study|Adverse Event|2
4862773|NCT00879229|16759544|P2|Overall Study|Death|2
4862774|NCT00879229|16759545|P1|Overall Study|Death|4
4862775|NCT00879229|16759544|P2|Overall Study|Study terminated by Sponsor|12
4862776|NCT00879229|16759545|P1|Overall Study|Study terminated by Sponsor|13
4862777|NCT00878995|16759593|P2|Baseline Study - Midpoint Study|Withdrawal by Subject|2
4862778|NCT00878995|16759594|P1|Baseline Study - Midpoint Study|Withdrawal by Subject|0
4862779|NCT00878969|16759695|P3|Overall Study|Pregnancy|0
4862780|NCT00878969|16759696|P2|Overall Study|Pregnancy|1
4862781|NCT00878969|16759697|P1|Overall Study|Pregnancy|0
4862782|NCT00878969|16759695|P3|Overall Study|Death|2
4862783|NCT00878969|16759696|P2|Overall Study|Death|0
4862784|NCT00878969|16759697|P1|Overall Study|Death|0
4862785|NCT00878969|16759695|P3|Overall Study|Protocol Violation|0
4862786|NCT00878969|16759696|P2|Overall Study|Protocol Violation|0
4862787|NCT00878969|16759697|P1|Overall Study|Protocol Violation|2
4862788|NCT00878969|16759695|P3|Overall Study|Lost to Follow-up|0
4862789|NCT00878969|16759696|P2|Overall Study|Lost to Follow-up|1
4862790|NCT00878969|16759697|P1|Overall Study|Lost to Follow-up|2
4862791|NCT00878969|16759695|P3|Overall Study|Adverse Event|2
4862792|NCT00878969|16759696|P2|Overall Study|Adverse Event|1
4862793|NCT00878969|16759697|P1|Overall Study|Adverse Event|3
4862794|NCT00878969|16759695|P3|Overall Study|kidney transplant|2
4862795|NCT00878969|16759696|P2|Overall Study|kidney transplant|3
4862796|NCT00878969|16759697|P1|Overall Study|kidney transplant|2
4862797|NCT00878969|16759695|P3|Overall Study|Withdrawal by Subject|3
4862798|NCT00878969|16759696|P2|Overall Study|Withdrawal by Subject|6
4862799|NCT00878969|16759697|P1|Overall Study|Withdrawal by Subject|1
4862800|NCT00878969|16759695|P3|Overall Study|Physician Decision|2
4862801|NCT00878969|16759696|P2|Overall Study|Physician Decision|3
4862802|NCT00878969|16759697|P1|Overall Study|Physician Decision|5
4862803|NCT00878800|16759745|P5|Overall Study|Other|1
4862804|NCT00878800|16759746|P4|Overall Study|Other|0
4862805|NCT00878800|16759747|P3|Overall Study|Other|0
4862806|NCT00878800|16759748|P2|Overall Study|Other|1
4862807|NCT00878800|16759749|P1|Overall Study|Other|1
4862808|NCT00878800|16759745|P5|Overall Study|Death|0
4862809|NCT00878800|16759746|P4|Overall Study|Death|0
4862810|NCT00878800|16759747|P3|Overall Study|Death|1
4862811|NCT00878800|16759748|P2|Overall Study|Death|0
4862812|NCT00878800|16759749|P1|Overall Study|Death|0
4862813|NCT00878800|16759745|P5|Overall Study|Withdrew consent|1
4862814|NCT00878800|16759746|P4|Overall Study|Withdrew consent|1
4862815|NCT00878800|16759747|P3|Overall Study|Withdrew consent|0
4862816|NCT00878800|16759748|P2|Overall Study|Withdrew consent|1
4862817|NCT00878800|16759749|P1|Overall Study|Withdrew consent|1
4862818|NCT00878800|16759745|P5|Overall Study|Progressive disease|13
4862819|NCT00878800|16759746|P4|Overall Study|Progressive disease|5
4862820|NCT00878800|16759747|P3|Overall Study|Progressive disease|6
4862821|NCT00878800|16759748|P2|Overall Study|Progressive disease|5
4862822|NCT00878800|16759749|P1|Overall Study|Progressive disease|1
4862823|NCT00878800|16759745|P5|Overall Study|Adverse Event|1
4862824|NCT00878800|16759746|P4|Overall Study|Adverse Event|0
4862825|NCT00878800|16759747|P3|Overall Study|Adverse Event|2
4862826|NCT00878800|16759748|P2|Overall Study|Adverse Event|0
4862827|NCT00878800|16759749|P1|Overall Study|Adverse Event|0
4862828|NCT00878722|16759784|P8|Overall Study|Relapse|0
4862829|NCT00878722|16759785|P7|Overall Study|Relapse|0
4862830|NCT00878722|16759786|P6|Overall Study|Relapse|0
4862831|NCT00878722|16759787|P5|Overall Study|Relapse|0
4862832|NCT00878722|16759788|P4|Overall Study|Relapse|1
4862833|NCT00878722|16759789|P3|Overall Study|Relapse|0
4862834|NCT00878722|16759790|P2|Overall Study|Relapse|0
4862835|NCT00878722|16759791|P1|Overall Study|Relapse|0
4862836|NCT00878722|16759784|P8|Overall Study|Withdrawal by Subject|2
4862837|NCT00878722|16759785|P7|Overall Study|Withdrawal by Subject|0
4862838|NCT00878722|16759786|P6|Overall Study|Withdrawal by Subject|0
4862839|NCT00878722|16759787|P5|Overall Study|Withdrawal by Subject|0
4862840|NCT00878722|16759788|P4|Overall Study|Withdrawal by Subject|0
4862841|NCT00878722|16759789|P3|Overall Study|Withdrawal by Subject|0
4862842|NCT00878722|16759790|P2|Overall Study|Withdrawal by Subject|0
4862843|NCT00878722|16759791|P1|Overall Study|Withdrawal by Subject|0
4862844|NCT00878722|16759784|P8|Overall Study|Adverse Event|0
4862845|NCT00878722|16759785|P7|Overall Study|Adverse Event|2
4862846|NCT00878722|16759786|P6|Overall Study|Adverse Event|0
4862847|NCT00878722|16759787|P5|Overall Study|Adverse Event|0
4862848|NCT00878722|16759788|P4|Overall Study|Adverse Event|0
4862849|NCT00878722|16759789|P3|Overall Study|Adverse Event|0
4862850|NCT00878722|16759790|P2|Overall Study|Adverse Event|0
4862851|NCT00878722|16759791|P1|Overall Study|Adverse Event|0
4862852|NCT00878722|16759784|P8|Overall Study|Death|2
4862853|NCT00878722|16759785|P7|Overall Study|Death|0
4862854|NCT00878722|16759786|P6|Overall Study|Death|1
4862855|NCT00878722|16759787|P5|Overall Study|Death|0
4862856|NCT00878722|16759788|P4|Overall Study|Death|1
4862857|NCT00878722|16759789|P3|Overall Study|Death|0
4862858|NCT00878722|16759790|P2|Overall Study|Death|0
4862859|NCT00878722|16759791|P1|Overall Study|Death|0
4862860|NCT00878722|16759784|P8|Overall Study|Progressive disease|3
4862861|NCT00878722|16759785|P7|Overall Study|Progressive disease|4
4862862|NCT00878722|16759786|P6|Overall Study|Progressive disease|1
4862863|NCT00878722|16759787|P5|Overall Study|Progressive disease|7
4862864|NCT00878722|16759788|P4|Overall Study|Progressive disease|7
4862865|NCT00878722|16759789|P3|Overall Study|Progressive disease|3
4862866|NCT00878722|16759790|P2|Overall Study|Progressive disease|3
4862867|NCT00878722|16759791|P1|Overall Study|Progressive disease|3
4862868|NCT00878709|16759876|P2|Overall Study|Other Reasons|84
4862869|NCT00878709|16759877|P1|Overall Study|Other Reasons|93
4862870|NCT00878709|16759876|P2|Overall Study|Lost to Follow-up|33
4862871|NCT00878709|16759877|P1|Overall Study|Lost to Follow-up|35
4862872|NCT00878709|16759876|P2|Overall Study|Withdrawal by Subject|120
4862873|NCT00878709|16759877|P1|Overall Study|Withdrawal by Subject|197
4862874|NCT00878553|16759939|P5|PK Study|Withdrawal by Subject|0
4862875|NCT00878553|16759940|P4|PK Study|Withdrawal by Subject|1
4862876|NCT00878553|16759941|P3|PK Study|Withdrawal by Subject|0
4862877|NCT00878553|16759942|P2|PK Study|Withdrawal by Subject|0
4862878|NCT00878553|16759943|P1|PK Study|Withdrawal by Subject|0
4862879|NCT00878553|16759939|P5|Sleep Study|family emergency|0
4862880|NCT00878553|16759940|P4|Sleep Study|family emergency|0
4862881|NCT00878553|16759941|P3|Sleep Study|family emergency|0
4862882|NCT00878553|16759942|P2|Sleep Study|family emergency|0
4862883|NCT00878553|16759943|P1|Sleep Study|family emergency|1
4862884|NCT00878553|16759939|P5|Sleep Study|car accident|0
4862885|NCT00878553|16759940|P4|Sleep Study|car accident|0
4862886|NCT00878553|16759941|P3|Sleep Study|car accident|0
4862887|NCT00878553|16759942|P2|Sleep Study|car accident|0
4862888|NCT00878553|16759943|P1|Sleep Study|car accident|1
4862889|NCT00878553|16759939|P5|Sleep Study|Lost to Follow-up|0
4862890|NCT00878553|16759940|P4|Sleep Study|Lost to Follow-up|0
4862891|NCT00878553|16759941|P3|Sleep Study|Lost to Follow-up|0
4862892|NCT00878553|16759942|P2|Sleep Study|Lost to Follow-up|0
4862893|NCT00878553|16759943|P1|Sleep Study|Lost to Follow-up|1
4862894|NCT00878553|16759939|P5|Sleep Study|Withdrawal by Subject|0
4862895|NCT00878553|16759940|P4|Sleep Study|Withdrawal by Subject|0
4862896|NCT00878553|16759941|P3|Sleep Study|Withdrawal by Subject|0
4862897|NCT00878553|16759942|P2|Sleep Study|Withdrawal by Subject|0
4862898|NCT00878553|16759943|P1|Sleep Study|Withdrawal by Subject|2
4862899|NCT00878501|16760002|P3|Overall Study|Administrative|1
4862900|NCT00878501|16760003|P2|Overall Study|Administrative|0
4862901|NCT00878501|16760004|P1|Overall Study|Administrative|0
4862902|NCT00878501|16760002|P3|Overall Study|Mis-randomisation of patient|0
4862903|NCT00878501|16760003|P2|Overall Study|Mis-randomisation of patient|0
4862904|NCT00878501|16760004|P1|Overall Study|Mis-randomisation of patient|1
4862905|NCT00878501|16760002|P3|Overall Study|Intake of prohibited concom. medication|1
4862906|NCT00878501|16760003|P2|Overall Study|Intake of prohibited concom. medication|0
4862907|NCT00878501|16760004|P1|Overall Study|Intake of prohibited concom. medication|0
4862908|NCT00878501|16760002|P3|Overall Study|Incorrect enrolment|0
4862909|NCT00878501|16760003|P2|Overall Study|Incorrect enrolment|2
4862910|NCT00878501|16760004|P1|Overall Study|Incorrect enrolment|1
4862911|NCT00878501|16760002|P3|Overall Study|Protocol Violation|1
4862912|NCT00878501|16760003|P2|Overall Study|Protocol Violation|0
4862913|NCT00878501|16760004|P1|Overall Study|Protocol Violation|0
4862914|NCT00878501|16760002|P3|Overall Study|Withdrawal by Subject|2
4862915|NCT00878501|16760003|P2|Overall Study|Withdrawal by Subject|1
4862916|NCT00878501|16760004|P1|Overall Study|Withdrawal by Subject|2
4862917|NCT00878501|16760002|P3|Overall Study|Lack of Efficacy|0
4862918|NCT00878501|16760003|P2|Overall Study|Lack of Efficacy|1
4862919|NCT00878501|16760004|P1|Overall Study|Lack of Efficacy|2
4862920|NCT00878501|16760002|P3|Overall Study|Adverse Event|3
4862921|NCT00878501|16760003|P2|Overall Study|Adverse Event|3
4862922|NCT00878501|16760004|P1|Overall Study|Adverse Event|11
4862923|NCT00878215|16760053|P4|Overall Study|Determined to be ineligible|0
4862924|NCT00878215|16760054|P3|Overall Study|Determined to be ineligible|0
4862925|NCT00878215|16760055|P2|Overall Study|Determined to be ineligible|10
4862926|NCT00878215|16760056|P1|Overall Study|Determined to be ineligible|0
4862927|NCT00878189|16760068|P9|Overall Study|Objection Progression or Relapse|3
4862928|NCT00878189|16760069|P8|Overall Study|Objection Progression or Relapse|0
4862929|NCT00878189|16760070|P7|Overall Study|Objection Progression or Relapse|0
4862930|NCT00878189|16760071|P6|Overall Study|Objection Progression or Relapse|0
4862931|NCT00878189|16760072|P5|Overall Study|Objection Progression or Relapse|0
4862932|NCT00878189|16760073|P4|Overall Study|Objection Progression or Relapse|0
4862933|NCT00878189|16760074|P3|Overall Study|Objection Progression or Relapse|0
4862934|NCT00878189|16760075|P2|Overall Study|Objection Progression or Relapse|0
4862935|NCT00878189|16760076|P1|Overall Study|Objection Progression or Relapse|0
4862936|NCT00878189|16760068|P9|Overall Study|Lost to Follow-up|0
4862937|NCT00878189|16760069|P8|Overall Study|Lost to Follow-up|0
4862938|NCT00878189|16760070|P7|Overall Study|Lost to Follow-up|1
4862939|NCT00878189|16760071|P6|Overall Study|Lost to Follow-up|1
4862940|NCT00878189|16760072|P5|Overall Study|Lost to Follow-up|0
4862941|NCT00878189|16760073|P4|Overall Study|Lost to Follow-up|0
4862942|NCT00878189|16760074|P3|Overall Study|Lost to Follow-up|0
4862943|NCT00878189|16760075|P2|Overall Study|Lost to Follow-up|0
4862944|NCT00878189|16760076|P1|Overall Study|Lost to Follow-up|0
4862945|NCT00878189|16760068|P9|Overall Study|Other|4
4862946|NCT00878189|16760069|P8|Overall Study|Other|3
4862947|NCT00878189|16760070|P7|Overall Study|Other|15
4862948|NCT00878189|16760071|P6|Overall Study|Other|18
4862949|NCT00878189|16760072|P5|Overall Study|Other|4
4862950|NCT00878189|16760073|P4|Overall Study|Other|7
4862951|NCT00878189|16760074|P3|Overall Study|Other|4
4862952|NCT00878189|16760075|P2|Overall Study|Other|2
4862953|NCT00878189|16760076|P1|Overall Study|Other|3
4862954|NCT00878189|16760068|P9|Overall Study|Participant Refused to Follow-up|0
4862955|NCT00878189|16760069|P8|Overall Study|Participant Refused to Follow-up|0
4862956|NCT00878189|16760070|P7|Overall Study|Participant Refused to Follow-up|0
4862957|NCT00878189|16760071|P6|Overall Study|Participant Refused to Follow-up|4
4862958|NCT00878189|16760072|P5|Overall Study|Participant Refused to Follow-up|0
4862959|NCT00878189|16760073|P4|Overall Study|Participant Refused to Follow-up|0
4862960|NCT00878189|16760074|P3|Overall Study|Participant Refused to Follow-up|0
4862961|NCT00878189|16760075|P2|Overall Study|Participant Refused to Follow-up|0
4862962|NCT00878189|16760076|P1|Overall Study|Participant Refused to Follow-up|0
4862963|NCT00878189|16760068|P9|Overall Study|Death|1
4862964|NCT00878189|16760069|P8|Overall Study|Death|0
4862965|NCT00878189|16760070|P7|Overall Study|Death|0
4862966|NCT00878189|16760071|P6|Overall Study|Death|0
4862967|NCT00878189|16760072|P5|Overall Study|Death|0
4862968|NCT00878189|16760073|P4|Overall Study|Death|1
4862969|NCT00878189|16760074|P3|Overall Study|Death|0
4862970|NCT00878189|16760075|P2|Overall Study|Death|1
4862971|NCT00878189|16760076|P1|Overall Study|Death|0
4862972|NCT00877929|16760344|P2|Overall Study|Other reason (not specified)|6
4862973|NCT00877929|16760345|P1|Overall Study|Other reason (not specified)|2
4862974|NCT00877929|16760344|P2|Overall Study|Lack of Efficacy|1
4862975|NCT00877929|16760345|P1|Overall Study|Lack of Efficacy|0
4862976|NCT00877929|16760344|P2|Overall Study|Withdrawal by Subject|4
4862977|NCT00877929|16760345|P1|Overall Study|Withdrawal by Subject|4
4862978|NCT00877929|16760344|P2|Overall Study|Lost to Follow-up|1
4862979|NCT00877929|16760345|P1|Overall Study|Lost to Follow-up|0
4862980|NCT00877929|16760344|P2|Overall Study|Protocol Violation|3
4862981|NCT00877929|16760345|P1|Overall Study|Protocol Violation|3
4862982|NCT00877929|16760344|P2|Overall Study|Adverse Event|20
4862983|NCT00877929|16760345|P1|Overall Study|Adverse Event|11
4862984|NCT00877890|16760433|P2|Overall Study|Loss of Glucose Control|4
4862985|NCT00877890|16760434|P1|Overall Study|Loss of Glucose Control|3
4862986|NCT00877890|16760433|P2|Overall Study|Investigator Decision|2
4862987|NCT00877890|16760434|P1|Overall Study|Investigator Decision|0
4862988|NCT00877890|16760433|P2|Overall Study|Withdrawal of Consent|12
4862989|NCT00877890|16760434|P1|Overall Study|Withdrawal of Consent|6
4862990|NCT00877890|16760433|P2|Overall Study|Protocol Violation|1
4862991|NCT00877890|16760434|P1|Overall Study|Protocol Violation|0
4862992|NCT00877890|16760433|P2|Overall Study|Lost to Follow-up|5
4862993|NCT00877890|16760434|P1|Overall Study|Lost to Follow-up|5
4862994|NCT00877890|16760433|P2|Overall Study|Adverse Event|6
4862995|NCT00877890|16760434|P1|Overall Study|Adverse Event|6
4862996|NCT00877799|16760499|P5|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
4862997|NCT00877799|16760500|P4|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1
4862998|NCT00877799|16760501|P3|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
4862999|NCT00877799|16760502|P2|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
4863000|NCT00877799|16760503|P1|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0
4863001|NCT00877799|16760499|P5|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4863002|NCT00877799|16760500|P4|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1
4863003|NCT00877799|16760501|P3|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4863004|NCT00877799|16760502|P2|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4863005|NCT00877799|16760503|P1|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0
4863006|NCT00877799|16760499|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4863007|NCT00877799|16760500|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4863008|NCT00877799|16760501|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4863009|NCT00877799|16760502|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3
4863010|NCT00877799|16760503|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0
4863011|NCT00877799|16760499|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
4863012|NCT00877799|16760500|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0
4863013|NCT00877799|16760501|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2
4863014|NCT00877799|16760502|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
4863015|NCT00877799|16760503|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1
4863016|NCT00877799|16760499|P5|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
4863017|NCT00877799|16760500|P4|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0
4863018|NCT00877799|16760501|P3|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
4863019|NCT00877799|16760502|P2|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1
4863020|NCT00877799|16760503|P1|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2
4863021|NCT00877773|16760518|P1|Overall Study|Disease Progression|44
4863022|NCT00877487|16760531|P2|Double-blind Randomized Withdrawal Phase|Moved out of state|0
4863023|NCT00877487|16760532|P1|Double-blind Randomized Withdrawal Phase|Moved out of state|1
4863024|NCT00877487|16760531|P2|Double-blind Randomized Withdrawal Phase|Protocol Violation|1
4863025|NCT00877487|16760532|P1|Double-blind Randomized Withdrawal Phase|Protocol Violation|0
4863026|NCT00877487|16760531|P2|Double-blind Randomized Withdrawal Phase|Adverse Event|1
4863027|NCT00877487|16760532|P1|Double-blind Randomized Withdrawal Phase|Adverse Event|0
4863028|NCT00877487|16760531|P2|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45
4863029|NCT00877487|16760532|P1|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5
4863030|NCT00877487|16760531|P2|Open-label Treatment Phase|Out of country for business|0
4863031|NCT00877487|16760532|P1|Open-label Treatment Phase|Out of country for business|1
4863032|NCT00877487|16760531|P2|Open-label Treatment Phase|Lost to Follow-up|0
4863033|NCT00877487|16760532|P1|Open-label Treatment Phase|Lost to Follow-up|1
4863034|NCT00877487|16760531|P2|Open-label Treatment Phase|Withdrawal by Subject|0
4863035|NCT00877487|16760532|P1|Open-label Treatment Phase|Withdrawal by Subject|1
4863036|NCT00877487|16760531|P2|Open-label Treatment Phase|Protocol Violation|0
4863037|NCT00877487|16760532|P1|Open-label Treatment Phase|Protocol Violation|3
4863038|NCT00877487|16760531|P2|Open-label Treatment Phase|Adverse Event|0
4863039|NCT00877487|16760532|P1|Open-label Treatment Phase|Adverse Event|1
4863040|NCT00877383|16760580|P2|Overall Study|Death|2
4863041|NCT00877383|16760581|P1|Overall Study|Death|1
4863042|NCT00877383|16760580|P2|Overall Study|Unsatisfactory therapeutic effect|0
4863043|NCT00877383|16760581|P1|Overall Study|Unsatisfactory therapeutic effect|1
4863044|NCT00877383|16760580|P2|Overall Study|Protocol deviation|6
4863045|NCT00877383|16760581|P1|Overall Study|Protocol deviation|2
4863046|NCT00877383|16760580|P2|Overall Study|Administrative problems|0
4863047|NCT00877383|16760581|P1|Overall Study|Administrative problems|2
4863048|NCT00877383|16760580|P2|Overall Study|Subject no longer requires study drug|0
4863049|NCT00877383|16760581|P1|Overall Study|Subject no longer requires study drug|2
4863050|NCT00877383|16760580|P2|Overall Study|Subject withdrew consent|12
4863051|NCT00877383|16760581|P1|Overall Study|Subject withdrew consent|3
4863052|NCT00877383|16760580|P2|Overall Study|Lost to Follow-up|3
4863053|NCT00877383|16760581|P1|Overall Study|Lost to Follow-up|5
4863054|NCT00877383|16760580|P2|Overall Study|Adverse Event|14
4863055|NCT00877383|16760581|P1|Overall Study|Adverse Event|13
4863056|NCT00877071|16760601|P1|Overall Study|disease progression|2
4863057|NCT00877032|16760634|P7|Overall Study|Did not meet entrance criteria|2
4863058|NCT00877032|16760635|P6|Overall Study|Did not meet entrance criteria|0
4863059|NCT00877032|16760636|P5|Overall Study|Did not meet entrance criteria|0
4863060|NCT00877032|16760637|P4|Overall Study|Did not meet entrance criteria|1
4863061|NCT00877032|16760638|P3|Overall Study|Did not meet entrance criteria|0
4863062|NCT00877032|16760639|P2|Overall Study|Did not meet entrance criteria|0
4863063|NCT00877032|16760640|P1|Overall Study|Did not meet entrance criteria|0
4863064|NCT00877006|16760741|P2|Long-Term Follow-up Period|Other|9
4863065|NCT00877006|16760742|P1|Long-Term Follow-up Period|Other|7
4863066|NCT00877006|16760741|P2|Long-Term Follow-up Period|Death|18
4863067|NCT00877006|16760742|P1|Long-Term Follow-up Period|Death|26
4863068|NCT00877006|16760741|P2|Long-Term Follow-up Period|Lost to Follow-up|9
4863069|NCT00877006|16760742|P1|Long-Term Follow-up Period|Lost to Follow-up|8
4863070|NCT00877006|16760741|P2|Long-Term Follow-up Period|Withdrawal by Subject|19
4863071|NCT00877006|16760742|P1|Long-Term Follow-up Period|Withdrawal by Subject|12
4863072|NCT00877006|16760741|P2|Treatment Period|Randomized but Not Treated|8
4863073|NCT00877006|16760742|P1|Treatment Period|Randomized but Not Treated|3
4863074|NCT00877006|16760741|P2|Treatment Period|Other|4
4863075|NCT00877006|16760742|P1|Treatment Period|Other|4
4863076|NCT00877006|16760741|P2|Treatment Period|Started New Treatment Regimen|5
4863077|NCT00877006|16760742|P1|Treatment Period|Started New Treatment Regimen|2
4863078|NCT00877006|16760741|P2|Treatment Period|Disease Progression|2
4863079|NCT00877006|16760742|P1|Treatment Period|Disease Progression|1
4863080|NCT00877006|16760741|P2|Treatment Period|Lost to Follow-up|1
4863081|NCT00877006|16760742|P1|Treatment Period|Lost to Follow-up|0
4863082|NCT00877006|16760741|P2|Treatment Period|Protocol Violation|0
4863083|NCT00877006|16760742|P1|Treatment Period|Protocol Violation|1
4863084|NCT00877006|16760741|P2|Treatment Period|Withdrawal by Subject|3
4863085|NCT00877006|16760742|P1|Treatment Period|Withdrawal by Subject|2
4863086|NCT00877006|16760741|P2|Treatment Period|Adverse Event|3
4863087|NCT00877006|16760742|P1|Treatment Period|Adverse Event|10
4863088|NCT00877006|16760741|P2|Treatment Period|Death|1
4863089|NCT00877006|16760742|P1|Treatment Period|Death|2
4863090|NCT00876928|16760818|P2|Overall Study|Hypokalemia-affects insulin secretion|0
4863091|NCT00876928|16760819|P1|Overall Study|Hypokalemia-affects insulin secretion|1
4863092|NCT00876928|16760818|P2|Overall Study|Lost to Follow-up|5
4863093|NCT00876928|16760819|P1|Overall Study|Lost to Follow-up|2
4863094|NCT00876733|16760856|P4|Overall Study|Data not available|1
4863095|NCT00876733|16760857|P3|Overall Study|Data not available|7
4863096|NCT00876733|16760858|P2|Overall Study|Data not available|3
4863097|NCT00876733|16760859|P1|Overall Study|Data not available|14
4863098|NCT00876733|16760856|P4|Overall Study|Lost to Follow-up|2
4863099|NCT00876733|16760857|P3|Overall Study|Lost to Follow-up|3
4863100|NCT00876733|16760858|P2|Overall Study|Lost to Follow-up|10
4863101|NCT00876733|16760859|P1|Overall Study|Lost to Follow-up|26
4863102|NCT00876733|16760856|P4|Overall Study|Lack of Efficacy|1
4863103|NCT00876733|16760857|P3|Overall Study|Lack of Efficacy|10
4863104|NCT00876733|16760858|P2|Overall Study|Lack of Efficacy|9
4863105|NCT00876733|16760859|P1|Overall Study|Lack of Efficacy|17
4863106|NCT00876733|16760856|P4|Overall Study|Adverse Event|3
4863107|NCT00876733|16760857|P3|Overall Study|Adverse Event|10
4863108|NCT00876733|16760858|P2|Overall Study|Adverse Event|20
4863109|NCT00876733|16760859|P1|Overall Study|Adverse Event|34
4863110|NCT00876694|16760967|P2|Overall Study|Death|0
4863111|NCT00876694|16760968|P1|Overall Study|Death|1
4863112|NCT00876694|16760967|P2|Overall Study|Administrative problems|1
4863113|NCT00876694|16760968|P1|Overall Study|Administrative problems|1
4863114|NCT00876694|16760967|P2|Overall Study|Abnormal test procedure result(s)|0
4863115|NCT00876694|16760968|P1|Overall Study|Abnormal test procedure result(s)|1
4863116|NCT00876694|16760967|P2|Overall Study|Unsatisfactory therapeutic effect|0
4863117|NCT00876694|16760968|P1|Overall Study|Unsatisfactory therapeutic effect|2
4863118|NCT00876694|16760967|P2|Overall Study|Subject withdrew consent|4
4863119|NCT00876694|16760968|P1|Overall Study|Subject withdrew consent|6
4863120|NCT00876694|16760967|P2|Overall Study|Adverse Event|7
4863121|NCT00876694|16760968|P1|Overall Study|Adverse Event|10
4863122|NCT00876460|16760994|P8|Mono Therapy Phase|Adverse Event|0
4863123|NCT00876460|16760995|P7|Mono Therapy Phase|Adverse Event|0
4863124|NCT00876460|16760996|P6|Mono Therapy Phase|Adverse Event|0
4863125|NCT00876460|16760997|P5|Mono Therapy Phase|Adverse Event|0
4863126|NCT00876460|16760998|P4|Mono Therapy Phase|Adverse Event|1
4863127|NCT00876460|16760999|P3|Mono Therapy Phase|Adverse Event|0
4863128|NCT00876460|16761000|P2|Mono Therapy Phase|Adverse Event|0
4863129|NCT00876460|16761001|P1|Mono Therapy Phase|Adverse Event|0
4863130|NCT00876460|16760994|P8|Mono Therapy Phase|Withdrawal by Subject|0
4863131|NCT00876460|16760995|P7|Mono Therapy Phase|Withdrawal by Subject|0
4863132|NCT00876460|16760996|P6|Mono Therapy Phase|Withdrawal by Subject|0
4863133|NCT00876460|16760997|P5|Mono Therapy Phase|Withdrawal by Subject|0
4863134|NCT00876460|16760998|P4|Mono Therapy Phase|Withdrawal by Subject|0
4863135|NCT00876460|16760999|P3|Mono Therapy Phase|Withdrawal by Subject|0
4863136|NCT00876460|16761000|P2|Mono Therapy Phase|Withdrawal by Subject|1
4863137|NCT00876460|16761001|P1|Mono Therapy Phase|Withdrawal by Subject|0
4863138|NCT00876460|16760994|P8|Mono Therapy Phase|Progressive disease|3
4863139|NCT00876460|16760995|P7|Mono Therapy Phase|Progressive disease|1
4863140|NCT00876460|16760996|P6|Mono Therapy Phase|Progressive disease|0
4863141|NCT00876460|16760997|P5|Mono Therapy Phase|Progressive disease|2
4863142|NCT00876460|16760998|P4|Mono Therapy Phase|Progressive disease|0
4863143|NCT00876460|16760999|P3|Mono Therapy Phase|Progressive disease|0
4863144|NCT00876460|16761000|P2|Mono Therapy Phase|Progressive disease|0
4863145|NCT00876460|16761001|P1|Mono Therapy Phase|Progressive disease|0
4863146|NCT00876460|16760994|P8|Combination Therapy Phase|Not treated|0
4863147|NCT00876460|16760995|P7|Combination Therapy Phase|Not treated|1
4863148|NCT00876460|16760996|P6|Combination Therapy Phase|Not treated|0
4863149|NCT00876460|16760997|P5|Combination Therapy Phase|Not treated|0
4863150|NCT00876460|16760998|P4|Combination Therapy Phase|Not treated|0
4863151|NCT00876460|16760999|P3|Combination Therapy Phase|Not treated|0
4863152|NCT00876460|16761000|P2|Combination Therapy Phase|Not treated|0
4863153|NCT00876460|16761001|P1|Combination Therapy Phase|Not treated|0
4863154|NCT00876460|16760994|P8|Combination Therapy Phase|Other reason not defined above|2
4863155|NCT00876460|16760995|P7|Combination Therapy Phase|Other reason not defined above|1
4863156|NCT00876460|16760996|P6|Combination Therapy Phase|Other reason not defined above|0
4863157|NCT00876460|16760997|P5|Combination Therapy Phase|Other reason not defined above|0
4863158|NCT00876460|16760998|P4|Combination Therapy Phase|Other reason not defined above|0
4863159|NCT00876460|16760999|P3|Combination Therapy Phase|Other reason not defined above|0
4863160|NCT00876460|16761000|P2|Combination Therapy Phase|Other reason not defined above|0
4863161|NCT00876460|16761001|P1|Combination Therapy Phase|Other reason not defined above|0
4863162|NCT00876460|16760994|P8|Combination Therapy Phase|Withdrawal by Subject|0
4863163|NCT00876460|16760995|P7|Combination Therapy Phase|Withdrawal by Subject|0
4863164|NCT00876460|16760996|P6|Combination Therapy Phase|Withdrawal by Subject|0
4863165|NCT00876460|16760997|P5|Combination Therapy Phase|Withdrawal by Subject|1
4863166|NCT00876460|16760998|P4|Combination Therapy Phase|Withdrawal by Subject|0
4863167|NCT00876460|16760999|P3|Combination Therapy Phase|Withdrawal by Subject|0
4863168|NCT00876460|16761000|P2|Combination Therapy Phase|Withdrawal by Subject|1
4863169|NCT00876460|16761001|P1|Combination Therapy Phase|Withdrawal by Subject|1
4863170|NCT00876460|16760994|P8|Combination Therapy Phase|Adverse Event|2
4863171|NCT00876460|16760995|P7|Combination Therapy Phase|Adverse Event|3
4863172|NCT00876460|16760996|P6|Combination Therapy Phase|Adverse Event|0
4863173|NCT00876460|16760997|P5|Combination Therapy Phase|Adverse Event|2
4863174|NCT00876460|16760998|P4|Combination Therapy Phase|Adverse Event|2
4863175|NCT00876460|16760999|P3|Combination Therapy Phase|Adverse Event|0
4863176|NCT00876460|16761000|P2|Combination Therapy Phase|Adverse Event|2
4863177|NCT00876460|16761001|P1|Combination Therapy Phase|Adverse Event|0
4863178|NCT00876460|16760994|P8|Combination Therapy Phase|Dose limiting toxicity|1
4863179|NCT00876460|16760995|P7|Combination Therapy Phase|Dose limiting toxicity|2
4863180|NCT00876460|16760996|P6|Combination Therapy Phase|Dose limiting toxicity|2
4863181|NCT00876460|16760997|P5|Combination Therapy Phase|Dose limiting toxicity|1
4863182|NCT00876460|16760998|P4|Combination Therapy Phase|Dose limiting toxicity|1
4863183|NCT00876460|16760999|P3|Combination Therapy Phase|Dose limiting toxicity|0
4863184|NCT00876460|16761000|P2|Combination Therapy Phase|Dose limiting toxicity|1
4863185|NCT00876460|16761001|P1|Combination Therapy Phase|Dose limiting toxicity|0
4863186|NCT00876460|16760994|P8|Combination Therapy Phase|Progressive disease|1
4863187|NCT00876460|16760995|P7|Combination Therapy Phase|Progressive disease|1
4863188|NCT00876460|16760996|P6|Combination Therapy Phase|Progressive disease|1
4863189|NCT00876460|16760997|P5|Combination Therapy Phase|Progressive disease|3
4863190|NCT00876460|16760998|P4|Combination Therapy Phase|Progressive disease|3
4863191|NCT00876460|16760999|P3|Combination Therapy Phase|Progressive disease|3
4863192|NCT00876460|16761000|P2|Combination Therapy Phase|Progressive disease|3
4863193|NCT00876460|16761001|P1|Combination Therapy Phase|Progressive disease|2
4863194|NCT00876447|16761073|P2|Overall Study|Adverse Event|8
4863195|NCT00876447|16761074|P1|Overall Study|Adverse Event|4
4863196|NCT00876447|16761073|P2|Overall Study|Lack of Efficacy|3
4863197|NCT00876447|16761074|P1|Overall Study|Lack of Efficacy|5
4863198|NCT00876447|16761073|P2|Overall Study|Pregnancy|2
4863199|NCT00876447|16761074|P1|Overall Study|Pregnancy|4
4863200|NCT00876447|16761073|P2|Overall Study|Lost to Follow-up|15
4863201|NCT00876447|16761074|P1|Overall Study|Lost to Follow-up|6
4863202|NCT00876447|16761073|P2|Overall Study|Personal reasons|28
4863203|NCT00876447|16761074|P1|Overall Study|Personal reasons|30
4863204|NCT00876447|16761073|P2|Overall Study|Protocol Violation|3
4863205|NCT00876447|16761074|P1|Overall Study|Protocol Violation|9
4863206|NCT00876447|16761073|P2|Overall Study|Site closure|14
4863207|NCT00876447|16761074|P1|Overall Study|Site closure|19
4863208|NCT00876447|16761073|P2|Overall Study|Other miscellaneous reasons|8
4863209|NCT00876447|16761074|P1|Overall Study|Other miscellaneous reasons|3
4863210|NCT00876395|16761134|P2|Overall Study|Death|0
4863211|NCT00876395|16761135|P1|Overall Study|Death|12
4863212|NCT00876395|16761134|P2|Overall Study|Administrative problems|23
4863213|NCT00876395|16761135|P1|Overall Study|Administrative problems|39
4863214|NCT00876395|16761134|P2|Overall Study|Lost to Follow-up|0
4863215|NCT00876395|16761135|P1|Overall Study|Lost to Follow-up|2
4863216|NCT00876395|16761134|P2|Overall Study|Withdrawal by Subject|33
4863217|NCT00876395|16761135|P1|Overall Study|Withdrawal by Subject|66
4863218|NCT00876395|16761134|P2|Overall Study|Protocol Violation|2
4863219|NCT00876395|16761135|P1|Overall Study|Protocol Violation|5
4863220|NCT00876395|16761134|P2|Overall Study|New cancer therapy|7
4863221|NCT00876395|16761135|P1|Overall Study|New cancer therapy|25
4863222|NCT00876395|16761134|P2|Overall Study|Disease progression|162
4863223|NCT00876395|16761135|P1|Overall Study|Disease progression|259
4863224|NCT00876395|16761134|P2|Overall Study|Abnormal test procedure result(s)|0
4863225|NCT00876395|16761135|P1|Overall Study|Abnormal test procedure result(s)|1
4863226|NCT00876395|16761134|P2|Overall Study|Adverse Event|11
4863227|NCT00876395|16761135|P1|Overall Study|Adverse Event|63
4863228|NCT00876395|16761134|P2|Overall Study|Untreated|1
4863229|NCT00876395|16761135|P1|Overall Study|Untreated|8
4863230|NCT00876343|16761176|P3|Overall Study|Change of residence or other commitments|3
4863231|NCT00876343|16761177|P2|Overall Study|Change of residence or other commitments|2
4863232|NCT00876343|16761178|P1|Overall Study|Change of residence or other commitments|2
4863233|NCT00876343|16761176|P3|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
4863234|NCT00876343|16761177|P2|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1
4863235|NCT00876343|16761178|P1|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0
4863236|NCT00876343|16761176|P3|Overall Study|Physician Decision|1
4863237|NCT00876343|16761177|P2|Overall Study|Physician Decision|1
4863238|NCT00876343|16761178|P1|Overall Study|Physician Decision|0
4863239|NCT00876343|16761176|P3|Overall Study|Protocol Violation|1
4863240|NCT00876343|16761177|P2|Overall Study|Protocol Violation|1
4863241|NCT00876343|16761178|P1|Overall Study|Protocol Violation|4
4863242|NCT00876343|16761176|P3|Overall Study|Lack of Efficacy|1
4863243|NCT00876343|16761177|P2|Overall Study|Lack of Efficacy|0
4863244|NCT00876343|16761178|P1|Overall Study|Lack of Efficacy|0
4863245|NCT00876343|16761176|P3|Overall Study|Withdrawal by Subject|3
4863246|NCT00876343|16761177|P2|Overall Study|Withdrawal by Subject|4
4863247|NCT00876343|16761178|P1|Overall Study|Withdrawal by Subject|4
4863248|NCT00876343|16761176|P3|Overall Study|Adverse Event|2
4863249|NCT00876343|16761177|P2|Overall Study|Adverse Event|8
4863250|NCT00876343|16761178|P1|Overall Study|Adverse Event|7
4863251|NCT00876265|16761192|P1|Overall Study|Withdrawal by Subject|2
4863252|NCT00876265|16761192|P1|Overall Study|Lost to Follow-up|6
4863253|NCT00876265|16761192|P1|Overall Study|Miscellaneous reasons|4
4863254|NCT00876018|16761210|P3|Overall Study|Withdrew Consent due to Adverse Event|2
4863255|NCT00876018|16761211|P2|Overall Study|Withdrew Consent due to Adverse Event|4
4863256|NCT00876018|16761212|P1|Overall Study|Withdrew Consent due to Adverse Event|5
4863257|NCT00876018|16761210|P3|Overall Study|Lost to Follow-up|1
4863258|NCT00876018|16761211|P2|Overall Study|Lost to Follow-up|1
4863259|NCT00876018|16761212|P1|Overall Study|Lost to Follow-up|0
4863260|NCT00875979|16761267|P2|Dose Expansion Phase - 3.6 mg/kg|Death|1
4863261|NCT00875979|16761268|P1|Dose Expansion Phase - 3.6 mg/kg|Death|0
4863262|NCT00875979|16761267|P2|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3
4863263|NCT00875979|16761268|P1|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0
4863264|NCT00875979|16761267|P2|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3
4863265|NCT00875979|16761268|P1|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0
4863266|NCT00875979|16761267|P2|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3
4863267|NCT00875979|16761268|P1|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0
4863268|NCT00875979|16761267|P2|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37
4863269|NCT00875979|16761268|P1|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0
4863270|NCT00875979|16761267|P2|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6
4863271|NCT00875979|16761268|P1|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0
4863272|NCT00875979|16761267|P2|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0
4863273|NCT00875979|16761268|P1|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1
4863274|NCT00875979|16761267|P2|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0
4863275|NCT00875979|16761268|P1|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1
4863276|NCT00875979|16761267|P2|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0
4863277|NCT00875979|16761268|P1|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1
4863278|NCT00875810|16761291|P1|Overall Study|Device explanted|1
4863279|NCT00875810|16761291|P1|Overall Study|Patient enroled but not implanted|2
4863280|NCT00875810|16761291|P1|Overall Study|Lost to Follow-up|39
4863281|NCT00875810|16761291|P1|Overall Study|Physician Decision|3
4863282|NCT00875810|16761291|P1|Overall Study|Withdrawal by Subject|1
4863283|NCT00875797|16761300|P2|Overall Study|Protocol Violation|3
4863284|NCT00875797|16761301|P1|Overall Study|Protocol Violation|6
4863285|NCT00875706|16761314|P3|Overall Study|Withdrawal by Subject|0
4863286|NCT00875706|16761315|P2|Overall Study|Withdrawal by Subject|0
4863287|NCT00875706|16761316|P1|Overall Study|Withdrawal by Subject|1
4863288|NCT00875667|16761335|P2|Overall Study|Randomized but no Study Drug Given|1
4863289|NCT00875667|16761336|P1|Overall Study|Randomized but no Study Drug Given|3
4863290|NCT00875667|16761335|P2|Overall Study|Miscellaneous|6
4863291|NCT00875667|16761336|P1|Overall Study|Miscellaneous|12
4863292|NCT00875667|16761335|P2|Overall Study|Disease Progression|49
4863293|NCT00875667|16761336|P1|Overall Study|Disease Progression|100
4863294|NCT00875667|16761335|P2|Overall Study|Protocol Violation|0
4863295|NCT00875667|16761336|P1|Overall Study|Protocol Violation|2
4863296|NCT00875667|16761335|P2|Overall Study|Death|2
4863297|NCT00875667|16761336|P1|Overall Study|Death|7
4863298|NCT00875667|16761335|P2|Overall Study|Withdrawal by Subject|5
4863299|NCT00875667|16761336|P1|Overall Study|Withdrawal by Subject|17
4863300|NCT00875667|16761335|P2|Overall Study|Adverse Event|10
4863301|NCT00875667|16761336|P1|Overall Study|Adverse Event|29
4863302|NCT00875615|16761471|P1|Overall Study|Withdrawal by Subject|1
4863303|NCT00875563|16761485|P1|Overall Study|Still be eligible for follow-up|7
4863304|NCT00875563|16761485|P1|Overall Study|No long-term (3-5 year) consent|6
4863305|NCT00875563|16761485|P1|Overall Study|Withdrawal by Subject|7
4863306|NCT00875563|16761485|P1|Overall Study|Death|4
4863307|NCT00875524|16761510|P2|Overall Study|Withdrawal by Subject|5
4863308|NCT00875524|16761511|P1|Overall Study|Withdrawal by Subject|3
4863309|NCT00875524|16761510|P2|Overall Study|Lost to Follow-up|0
4863310|NCT00875524|16761511|P1|Overall Study|Lost to Follow-up|1
4863311|NCT00875524|16761510|P2|Overall Study|Protocol Violation|0
4863312|NCT00875524|16761511|P1|Overall Study|Protocol Violation|4
4863313|NCT00875524|16761510|P2|Overall Study|Serious adverse event|1
4863314|NCT00875524|16761511|P1|Overall Study|Serious adverse event|0
4863315|NCT00875485|16761529|P2|Challenge Dose Epoch|Pregnancy|0
4863316|NCT00875485|16761530|P1|Challenge Dose Epoch|Pregnancy|1
4863317|NCT00875433|16761570|P1|Overall Study|Other|3
4863318|NCT00875433|16761570|P1|Overall Study|Withdrawal by Subject|2
4863319|NCT00875433|16761570|P1|Overall Study|Other Adverse Event|14
4863320|NCT00875433|16761570|P1|Overall Study|Progressive disease|41
4863321|NCT00875420|16761600|P5|Overall Study|Withdrawal by Subject|0
4863322|NCT00875420|16761601|P4|Overall Study|Withdrawal by Subject|0
4863323|NCT00875420|16761602|P3|Overall Study|Withdrawal by Subject|1
4863324|NCT00875420|16761603|P2|Overall Study|Withdrawal by Subject|0
4863325|NCT00875420|16761604|P1|Overall Study|Withdrawal by Subject|0
4863326|NCT00875420|16761600|P5|Overall Study|Sponsor decision|0
4863327|NCT00875420|16761601|P4|Overall Study|Sponsor decision|0
4863328|NCT00875420|16761602|P3|Overall Study|Sponsor decision|0
4863329|NCT00875420|16761603|P2|Overall Study|Sponsor decision|1
4863330|NCT00875420|16761604|P1|Overall Study|Sponsor decision|0
4863331|NCT00875420|16761600|P5|Overall Study|Prohibited medication|0
4863332|NCT00875420|16761601|P4|Overall Study|Prohibited medication|1
4863333|NCT00875420|16761602|P3|Overall Study|Prohibited medication|0
4863334|NCT00875420|16761603|P2|Overall Study|Prohibited medication|0
4863335|NCT00875420|16761604|P1|Overall Study|Prohibited medication|0
4863336|NCT00875420|16761600|P5|Overall Study|Personal reason|1
4863337|NCT00875420|16761601|P4|Overall Study|Personal reason|0
4863338|NCT00875420|16761602|P3|Overall Study|Personal reason|0
4863339|NCT00875420|16761603|P2|Overall Study|Personal reason|0
4863340|NCT00875420|16761604|P1|Overall Study|Personal reason|0
4863341|NCT00875420|16761600|P5|Overall Study|Lost to Follow-up|0
4863342|NCT00875420|16761601|P4|Overall Study|Lost to Follow-up|0
4863343|NCT00875420|16761602|P3|Overall Study|Lost to Follow-up|0
4863344|NCT00875420|16761603|P2|Overall Study|Lost to Follow-up|0
4863345|NCT00875420|16761604|P1|Overall Study|Lost to Follow-up|1
4863346|NCT00875420|16761600|P5|Overall Study|Inability to complete study procedures|1
4863347|NCT00875420|16761601|P4|Overall Study|Inability to complete study procedures|1
4863348|NCT00875420|16761602|P3|Overall Study|Inability to complete study procedures|1
4863349|NCT00875420|16761603|P2|Overall Study|Inability to complete study procedures|0
4863350|NCT00875420|16761604|P1|Overall Study|Inability to complete study procedures|1
4863351|NCT00875420|16761600|P5|Overall Study|Adverse Event|0
4863352|NCT00875420|16761601|P4|Overall Study|Adverse Event|0
4863353|NCT00875420|16761602|P3|Overall Study|Adverse Event|1
4863354|NCT00875420|16761603|P2|Overall Study|Adverse Event|1
4863355|NCT00875420|16761604|P1|Overall Study|Adverse Event|0
4863356|NCT00875017|16761746|P6|Fourth Intervention|Inability to comply with fasting|1
4863357|NCT00875017|16761747|P5|Fourth Intervention|Inability to comply with fasting|0
4863358|NCT00875017|16761748|P4|Fourth Intervention|Inability to comply with fasting|0
4863359|NCT00875017|16761749|P3|Fourth Intervention|Inability to comply with fasting|0
4863360|NCT00875017|16761750|P2|Fourth Intervention|Inability to comply with fasting|0
4863361|NCT00875017|16761751|P1|Fourth Intervention|Inability to comply with fasting|0
4863362|NCT00875017|16761746|P6|Washout|Withdrawal by Subject|0
4863363|NCT00875017|16761747|P5|Washout|Withdrawal by Subject|1
4863364|NCT00875017|16761748|P4|Washout|Withdrawal by Subject|0
4863365|NCT00875017|16761749|P3|Washout|Withdrawal by Subject|0
4863366|NCT00875017|16761750|P2|Washout|Withdrawal by Subject|0
4863367|NCT00875017|16761751|P1|Washout|Withdrawal by Subject|0
4863368|NCT00875017|16761746|P6|Third Intervention|Adverse Event|0
4863369|NCT00875017|16761747|P5|Third Intervention|Adverse Event|0
4863370|NCT00875017|16761748|P4|Third Intervention|Adverse Event|0
4863371|NCT00875017|16761749|P3|Third Intervention|Adverse Event|1
4863372|NCT00875017|16761750|P2|Third Intervention|Adverse Event|1
4863373|NCT00875017|16761751|P1|Third Intervention|Adverse Event|0
4863374|NCT00875017|16761746|P6|Washout|Problems collecting rectal effluent|0
4863375|NCT00875017|16761747|P5|Washout|Problems collecting rectal effluent|0
4863376|NCT00875017|16761748|P4|Washout|Problems collecting rectal effluent|0
4863377|NCT00875017|16761749|P3|Washout|Problems collecting rectal effluent|0
4863378|NCT00875017|16761750|P2|Washout|Problems collecting rectal effluent|1
4863379|NCT00875017|16761751|P1|Washout|Problems collecting rectal effluent|0
4863380|NCT00875017|16761746|P6|Second Intervention|Adverse Event|0
4863381|NCT00875017|16761747|P5|Second Intervention|Adverse Event|0
4863382|NCT00875017|16761748|P4|Second Intervention|Adverse Event|1
4863383|NCT00875017|16761749|P3|Second Intervention|Adverse Event|0
4863384|NCT00875017|16761750|P2|Second Intervention|Adverse Event|0
4863385|NCT00875017|16761751|P1|Second Intervention|Adverse Event|0
4863386|NCT00875017|16761746|P6|Washout|Problem collecting rectal effluent|0
4863387|NCT00875017|16761747|P5|Washout|Problem collecting rectal effluent|0
4863388|NCT00875017|16761748|P4|Washout|Problem collecting rectal effluent|0
4863389|NCT00875017|16761749|P3|Washout|Problem collecting rectal effluent|1
4863390|NCT00875017|16761750|P2|Washout|Problem collecting rectal effluent|0
4863391|NCT00875017|16761751|P1|Washout|Problem collecting rectal effluent|0
4863392|NCT00875017|16761746|P6|First Intervention|Intolerance to nasogastric tube|0
4863393|NCT00875017|16761747|P5|First Intervention|Intolerance to nasogastric tube|1
4863478|NCT00874497|16761984|P1|Overall Study|Sponsor Discontinued Trial|7
4863394|NCT00875017|16761748|P4|First Intervention|Intolerance to nasogastric tube|0
4863395|NCT00875017|16761749|P3|First Intervention|Intolerance to nasogastric tube|0
4863396|NCT00875017|16761750|P2|First Intervention|Intolerance to nasogastric tube|0
4863397|NCT00875017|16761751|P1|First Intervention|Intolerance to nasogastric tube|0
4863398|NCT00875017|16761746|P6|First Intervention|Problems collecting rectal effluent|0
4863399|NCT00875017|16761747|P5|First Intervention|Problems collecting rectal effluent|0
4863400|NCT00875017|16761748|P4|First Intervention|Problems collecting rectal effluent|0
4863401|NCT00875017|16761749|P3|First Intervention|Problems collecting rectal effluent|0
4863402|NCT00875017|16761750|P2|First Intervention|Problems collecting rectal effluent|0
4863403|NCT00875017|16761751|P1|First Intervention|Problems collecting rectal effluent|1
4863404|NCT00875017|16761746|P6|First Intervention|Adverse Event|0
4863405|NCT00875017|16761747|P5|First Intervention|Adverse Event|0
4863406|NCT00875017|16761748|P4|First Intervention|Adverse Event|1
4863407|NCT00875017|16761749|P3|First Intervention|Adverse Event|0
4863408|NCT00875017|16761750|P2|First Intervention|Adverse Event|0
4863409|NCT00875017|16761751|P1|First Intervention|Adverse Event|0
4863410|NCT00875017|16761746|P6|First Intervention|Withdrawal by Subject|0
4863411|NCT00875017|16761747|P5|First Intervention|Withdrawal by Subject|0
4863412|NCT00875017|16761748|P4|First Intervention|Withdrawal by Subject|0
4863413|NCT00875017|16761749|P3|First Intervention|Withdrawal by Subject|1
4863414|NCT00875017|16761750|P2|First Intervention|Withdrawal by Subject|0
4863415|NCT00875017|16761751|P1|First Intervention|Withdrawal by Subject|1
4863416|NCT00874939|16761765|P1|Overall Study|Study terminated|4
4863417|NCT00874848|16761798|P2|Overall Study|Physician Decision|2
4863418|NCT00874848|16761799|P1|Overall Study|Physician Decision|0
4863419|NCT00874848|16761798|P2|Overall Study|Failure to comply with protocol|1
4863420|NCT00874848|16761799|P1|Overall Study|Failure to comply with protocol|0
4863421|NCT00874848|16761798|P2|Overall Study|Noncompliance|1
4863422|NCT00874848|16761799|P1|Overall Study|Noncompliance|1
4863423|NCT00874848|16761798|P2|Overall Study|Withdrawal by Subject|4
4863424|NCT00874848|16761799|P1|Overall Study|Withdrawal by Subject|7
4863425|NCT00874848|16761798|P2|Overall Study|Progressive neoplastic disease|18
4863426|NCT00874848|16761799|P1|Overall Study|Progressive neoplastic disease|38
4863427|NCT00874848|16761798|P2|Overall Study|Adverse Event|2
4863428|NCT00874848|16761799|P1|Overall Study|Adverse Event|13
4863429|NCT00874822|16761815|P1|Overall Study|excluded by criteria|8
4863430|NCT00874770|16761823|P4|Overall Study|Subject no Longer Meets Study Criteria|0
4863431|NCT00874770|16761824|P3|Overall Study|Subject no Longer Meets Study Criteria|0
4863432|NCT00874770|16761825|P2|Overall Study|Subject no Longer Meets Study Criteria|0
4863433|NCT00874770|16761826|P1|Overall Study|Subject no Longer Meets Study Criteria|1
4863434|NCT00874770|16761823|P4|Overall Study|Lost to Follow-up|1
4863435|NCT00874770|16761824|P3|Overall Study|Lost to Follow-up|0
4863436|NCT00874770|16761825|P2|Overall Study|Lost to Follow-up|0
4863437|NCT00874770|16761826|P1|Overall Study|Lost to Follow-up|1
4863438|NCT00874770|16761823|P4|Overall Study|Adverse Event|2
4863439|NCT00874770|16761824|P3|Overall Study|Adverse Event|4
4863440|NCT00874770|16761825|P2|Overall Study|Adverse Event|1
4863441|NCT00874770|16761826|P1|Overall Study|Adverse Event|1
4863442|NCT00874770|16761823|P4|Overall Study|Lack of Efficacy|2
4863443|NCT00874770|16761824|P3|Overall Study|Lack of Efficacy|0
4863444|NCT00874770|16761825|P2|Overall Study|Lack of Efficacy|0
4863445|NCT00874770|16761826|P1|Overall Study|Lack of Efficacy|2
4863446|NCT00874731|16761860|P3|Part 2: Ridaforolimus 40 mg|Disease Progression|19
4863447|NCT00874731|16761861|P2|Part 2: Ridaforolimus 40 mg|Disease Progression|0
4863448|NCT00874731|16761862|P1|Part 2: Ridaforolimus 40 mg|Disease Progression|0
4863449|NCT00874731|16761860|P3|Part 2: Ridaforolimus 40 mg|Adverse Event|3
4863450|NCT00874731|16761861|P2|Part 2: Ridaforolimus 40 mg|Adverse Event|0
4863451|NCT00874731|16761862|P1|Part 2: Ridaforolimus 40 mg|Adverse Event|0
4863452|NCT00874731|16761860|P3|Part 1, Day 1: Placebo|Disease Progression|0
4863453|NCT00874731|16761861|P2|Part 1, Day 1: Placebo|Disease Progression|0
4863454|NCT00874731|16761862|P1|Part 1, Day 1: Placebo|Disease Progression|1
4863455|NCT00874549|16761903|P4|Overall Study|Withdrawal by Subject|1
4863456|NCT00874549|16761904|P3|Overall Study|Withdrawal by Subject|0
4863457|NCT00874549|16761905|P2|Overall Study|Withdrawal by Subject|1
4863458|NCT00874549|16761906|P1|Overall Study|Withdrawal by Subject|0
4863459|NCT00874549|16761903|P4|Overall Study|Lost to Follow-up|0
4863460|NCT00874549|16761904|P3|Overall Study|Lost to Follow-up|1
4863461|NCT00874549|16761905|P2|Overall Study|Lost to Follow-up|0
4863462|NCT00874549|16761906|P1|Overall Study|Lost to Follow-up|0
4863463|NCT00874549|16761903|P4|Overall Study|Protocol Violation|1
4863464|NCT00874549|16761904|P3|Overall Study|Protocol Violation|2
4863465|NCT00874549|16761905|P2|Overall Study|Protocol Violation|0
4863466|NCT00874549|16761906|P1|Overall Study|Protocol Violation|1
4863467|NCT00874549|16761903|P4|Overall Study|Adverse Event|0
4863468|NCT00874549|16761904|P3|Overall Study|Adverse Event|1
4863469|NCT00874549|16761905|P2|Overall Study|Adverse Event|0
4863470|NCT00874549|16761906|P1|Overall Study|Adverse Event|0
4863471|NCT00874497|16761983|P2|Overall Study|Withdrawal by Subject|4
4863472|NCT00874497|16761984|P1|Overall Study|Withdrawal by Subject|5
4863473|NCT00874497|16761983|P2|Overall Study|Physician Decision|1
4863474|NCT00874497|16761984|P1|Overall Study|Physician Decision|1
4863475|NCT00874497|16761983|P2|Overall Study|Met Withdrawal Criteria|2
4863476|NCT00874497|16761984|P1|Overall Study|Met Withdrawal Criteria|4
4863477|NCT00874497|16761983|P2|Overall Study|Sponsor Discontinued Trial|3
4863479|NCT00874497|16761983|P2|Overall Study|Adverse Event|4
4863480|NCT00874497|16761984|P1|Overall Study|Adverse Event|9
4863481|NCT00874497|16761983|P2|Overall Study|Lost to Follow-up|4
4863482|NCT00874497|16761984|P1|Overall Study|Lost to Follow-up|2
4863483|NCT00874432|16762026|P4|Overall Study|Other|3
4863484|NCT00874432|16762027|P3|Overall Study|Other|8
4863485|NCT00874432|16762028|P2|Overall Study|Other|2
4863486|NCT00874432|16762029|P1|Overall Study|Other|1
4863487|NCT00874432|16762026|P4|Overall Study|Physician Decision|0
4863488|NCT00874432|16762027|P3|Overall Study|Physician Decision|0
4863489|NCT00874432|16762028|P2|Overall Study|Physician Decision|0
4863490|NCT00874432|16762029|P1|Overall Study|Physician Decision|1
4863491|NCT00874432|16762026|P4|Overall Study|Withdrawal by Subject|0
4863492|NCT00874432|16762027|P3|Overall Study|Withdrawal by Subject|0
4863493|NCT00874432|16762028|P2|Overall Study|Withdrawal by Subject|0
4863494|NCT00874432|16762029|P1|Overall Study|Withdrawal by Subject|1
4863495|NCT00874276|16762047|P2|Overall Study|Withdrawal by Subject|1
4863496|NCT00874276|16762048|P1|Overall Study|Withdrawal by Subject|1
4863497|NCT00874237|16762068|P6|Overall Study|Withdrawal by Subject|0
4863498|NCT00874237|16762069|P5|Overall Study|Withdrawal by Subject|0
4863499|NCT00874237|16762070|P4|Overall Study|Withdrawal by Subject|0
4863500|NCT00874237|16762071|P3|Overall Study|Withdrawal by Subject|1
4863501|NCT00874237|16762072|P2|Overall Study|Withdrawal by Subject|0
4863502|NCT00874237|16762073|P1|Overall Study|Withdrawal by Subject|0
4863503|NCT00874237|16762068|P6|Overall Study|Physician Decision|0
4863504|NCT00874237|16762069|P5|Overall Study|Physician Decision|0
4863505|NCT00874237|16762070|P4|Overall Study|Physician Decision|0
4863506|NCT00874237|16762071|P3|Overall Study|Physician Decision|0
4863507|NCT00874237|16762072|P2|Overall Study|Physician Decision|1
4863508|NCT00874237|16762073|P1|Overall Study|Physician Decision|0
4863509|NCT00874120|16762091|P2|Second Intervention|Protocol Violation|0
4863510|NCT00874120|16762092|P1|Second Intervention|Protocol Violation|1
4863511|NCT00874120|16762091|P2|Second Intervention|Withdrawal by Subject|0
4863512|NCT00874120|16762092|P1|Second Intervention|Withdrawal by Subject|1
4863513|NCT00874120|16762091|P2|First Intervention|positive drug test|0
4863514|NCT00874120|16762092|P1|First Intervention|positive drug test|1
4863515|NCT00874120|16762091|P2|First Intervention|Protocol Violation|0
4863516|NCT00874120|16762092|P1|First Intervention|Protocol Violation|3
4863517|NCT00874120|16762091|P2|First Intervention|Lost to Follow-up|1
4863518|NCT00874120|16762092|P1|First Intervention|Lost to Follow-up|0
4863519|NCT00874120|16762091|P2|First Intervention|Withdrawal by Subject|0
4863520|NCT00874120|16762092|P1|First Intervention|Withdrawal by Subject|2
4863521|NCT00874120|16762091|P2|First Intervention|Adverse Event|1
4863522|NCT00874120|16762092|P1|First Intervention|Adverse Event|0
4863523|NCT00874029|16762105|P1|Overall Study|Lost to Follow-up|5
4863524|NCT00874029|16762105|P1|Overall Study|Adverse Event|1
4863525|NCT00874029|16762105|P1|Overall Study|Physician Decision|1
4863526|NCT00874029|16762105|P1|Overall Study|Pregnancy|4
4863527|NCT00874029|16762105|P1|Overall Study|Withdrawal by Subject|10
4863528|NCT00873912|16762121|P2|Overall Study|Lost to Follow-up|0
4863529|NCT00873912|16762122|P1|Overall Study|Lost to Follow-up|2
4863530|NCT00873912|16762121|P2|Overall Study|Withdrawal by Subject|0
4863531|NCT00873912|16762122|P1|Overall Study|Withdrawal by Subject|1
4863532|NCT00873860|16762161|P4|Overall Study|Other|0
4863533|NCT00873860|16762162|P3|Overall Study|Other|1
4863534|NCT00873860|16762163|P2|Overall Study|Other|0
4863535|NCT00873860|16762164|P1|Overall Study|Other|1
4863536|NCT00873860|16762161|P4|Overall Study|Death|0
4863537|NCT00873860|16762162|P3|Overall Study|Death|0
4863538|NCT00873860|16762163|P2|Overall Study|Death|0
4863539|NCT00873860|16762164|P1|Overall Study|Death|1
4863540|NCT00873860|16762161|P4|Overall Study|Withdrawal by Subject|0
4863541|NCT00873860|16762162|P3|Overall Study|Withdrawal by Subject|2
4863542|NCT00873860|16762163|P2|Overall Study|Withdrawal by Subject|0
4863543|NCT00873860|16762164|P1|Overall Study|Withdrawal by Subject|1
4863544|NCT00873860|16762161|P4|Overall Study|Lost to Follow-up|1
4863545|NCT00873860|16762162|P3|Overall Study|Lost to Follow-up|0
4863546|NCT00873860|16762163|P2|Overall Study|Lost to Follow-up|0
4863547|NCT00873860|16762164|P1|Overall Study|Lost to Follow-up|1
4863548|NCT00873730|16762252|P2|Overall Study|Sponsor decision|0
4863549|NCT00873730|16762253|P1|Overall Study|Sponsor decision|1
4863550|NCT00873730|16762252|P2|Overall Study|Withdrawal by Subject|1
4863551|NCT00873730|16762253|P1|Overall Study|Withdrawal by Subject|0
4863552|NCT00873730|16762252|P2|Overall Study|Adverse Event|2
4863553|NCT00873730|16762253|P1|Overall Study|Adverse Event|0
4863554|NCT00873730|16762252|P2|Overall Study|Protocol Deviation|2
4863555|NCT00873730|16762253|P1|Overall Study|Protocol Deviation|5
4863556|NCT00873366|16762296|P1|Overall Study|Refused to continue DM-BT testing|3
4863557|NCT00873366|16762296|P1|Overall Study|Off tamoxifen due to side effects|2
4863558|NCT00873366|16762296|P1|Overall Study|Off tamoxifen for reconstructive surgery|1
4863559|NCT00873119|16762321|P2|Overall Study|Not treated|0
4863560|NCT00873119|16762322|P1|Overall Study|Not treated|2
4863561|NCT00873119|16762321|P2|Overall Study|Other|5
4863562|NCT00873119|16762322|P1|Overall Study|Other|2
4863563|NCT00873119|16762321|P2|Overall Study|Death|1
4863564|NCT00873119|16762322|P1|Overall Study|Death|2
4863565|NCT00873119|16762321|P2|Overall Study|Progressive disease|18
4863566|NCT00873119|16762322|P1|Overall Study|Progressive disease|26
4863567|NCT00873119|16762321|P2|Overall Study|Adverse Event|0
4863568|NCT00873119|16762322|P1|Overall Study|Adverse Event|8
4863569|NCT00873119|16762321|P2|Overall Study|Patient request|2
4863570|NCT00873119|16762322|P1|Overall Study|Patient request|4
4863571|NCT00873093|16762343|P5|Overall Study|Ineligible|0
4863572|NCT00873093|16762344|P4|Overall Study|Ineligible|1
4863573|NCT00873093|16762345|P3|Overall Study|Ineligible|0
4863574|NCT00873093|16762346|P2|Overall Study|Ineligible|1
4863575|NCT00873093|16762347|P1|Overall Study|Ineligible|0
4863576|NCT00873093|16762343|P5|Overall Study|Withdrawal by Subject|0
4863577|NCT00873093|16762344|P4|Overall Study|Withdrawal by Subject|0
4863578|NCT00873093|16762345|P3|Overall Study|Withdrawal by Subject|4
4863579|NCT00873093|16762346|P2|Overall Study|Withdrawal by Subject|4
4863580|NCT00873093|16762347|P1|Overall Study|Withdrawal by Subject|1
4863581|NCT00873093|16762343|P5|Overall Study|Physician Decision|2
4863582|NCT00873093|16762344|P4|Overall Study|Physician Decision|10
4863583|NCT00873093|16762345|P3|Overall Study|Physician Decision|10
4863584|NCT00873093|16762346|P2|Overall Study|Physician Decision|17
4863585|NCT00873093|16762347|P1|Overall Study|Physician Decision|0
4863586|NCT00873093|16762343|P5|Overall Study|Death|0
4863587|NCT00873093|16762344|P4|Overall Study|Death|0
4863588|NCT00873093|16762345|P3|Overall Study|Death|2
4863589|NCT00873093|16762346|P2|Overall Study|Death|3
4863590|NCT00873093|16762347|P1|Overall Study|Death|0
4863591|NCT00873093|16762343|P5|Overall Study|Adverse Event|0
4863592|NCT00873093|16762344|P4|Overall Study|Adverse Event|0
4863593|NCT00873093|16762345|P3|Overall Study|Adverse Event|0
4863594|NCT00873093|16762346|P2|Overall Study|Adverse Event|2
4863595|NCT00873093|16762347|P1|Overall Study|Adverse Event|0
4863596|NCT00873041|16762404|P3|Extension Study|Administrative reasons|1
4863597|NCT00873041|16762405|P2|Extension Study|Administrative reasons|0
4863598|NCT00873041|16762406|P1|Extension Study|Administrative reasons|0
4863599|NCT00873041|16762404|P3|Extension Study|Adverse Event|1
4863600|NCT00873041|16762405|P2|Extension Study|Adverse Event|0
4863601|NCT00873041|16762406|P1|Extension Study|Adverse Event|1
4863602|NCT00873041|16762404|P3|Core Study|Protocol deviation|1
4863603|NCT00873041|16762405|P2|Core Study|Protocol deviation|0
4863604|NCT00873041|16762406|P1|Core Study|Protocol deviation|1
4863605|NCT00873041|16762404|P3|Core Study|Abnormal laboratory value|1
4863606|NCT00873041|16762405|P2|Core Study|Abnormal laboratory value|0
4863607|NCT00873041|16762406|P1|Core Study|Abnormal laboratory value|0
4863608|NCT00873041|16762404|P3|Core Study|Lost to Follow-up|0
4863609|NCT00873041|16762405|P2|Core Study|Lost to Follow-up|1
4863610|NCT00873041|16762406|P1|Core Study|Lost to Follow-up|3
4863611|NCT00873041|16762404|P3|Core Study|Withdrawal by Subject|2
4863612|NCT00873041|16762405|P2|Core Study|Withdrawal by Subject|2
4863613|NCT00873041|16762406|P1|Core Study|Withdrawal by Subject|1
4863614|NCT00873041|16762404|P3|Core Study|Adverse Event|1
4863615|NCT00873041|16762405|P2|Core Study|Adverse Event|3
4863616|NCT00873041|16762406|P1|Core Study|Adverse Event|2
4863617|NCT00873015|16762464|P4|Overall Study|Withdrawal by Subject|0
4863618|NCT00873015|16762465|P3|Overall Study|Withdrawal by Subject|0
4863619|NCT00873015|16762466|P2|Overall Study|Withdrawal by Subject|1
4863620|NCT00873015|16762467|P1|Overall Study|Withdrawal by Subject|0
4863621|NCT00872989|16762484|P2|Overall Study|Not protocol specified|8
4863622|NCT00872989|16762485|P1|Overall Study|Not protocol specified|3
4863623|NCT00872989|16762484|P2|Overall Study|Progression/relapse|35
4863624|NCT00872989|16762485|P1|Overall Study|Progression/relapse|47
4863625|NCT00872989|16762484|P2|Overall Study|Withdrawal by Subject|5
4863626|NCT00872989|16762485|P1|Overall Study|Withdrawal by Subject|8
4863627|NCT00872989|16762484|P2|Overall Study|Adverse Event|15
4863628|NCT00872989|16762485|P1|Overall Study|Adverse Event|7
4863629|NCT00872898|16762504|P2|Part Two - Double Blind|Other reasons|0
4863630|NCT00872898|16762505|P1|Part Two - Double Blind|Other reasons|2
4863631|NCT00872898|16762504|P2|Part Two - Double Blind|Lost to Follow-up|2
4863632|NCT00872898|16762505|P1|Part Two - Double Blind|Lost to Follow-up|0
4863633|NCT00872898|16762504|P2|Part Two - Double Blind|Withdrawal by Subject|1
4863634|NCT00872898|16762505|P1|Part Two - Double Blind|Withdrawal by Subject|3
4863635|NCT00872898|16762504|P2|Part Two - Double Blind|Protocol Violation|0
4863636|NCT00872898|16762505|P1|Part Two - Double Blind|Protocol Violation|1
4863637|NCT00872898|16762504|P2|Part Two - Double Blind|Lack of Efficacy|0
4863638|NCT00872898|16762505|P1|Part Two - Double Blind|Lack of Efficacy|1
4863639|NCT00872898|16762504|P2|Part Two - Double Blind|Adverse Event|3
4863640|NCT00872898|16762505|P1|Part Two - Double Blind|Adverse Event|4
4863641|NCT00872599|16762579|P2|Second Washout Period|Adverse Event|1
4863642|NCT00872599|16762580|P1|Second Washout Period|Adverse Event|1
4863643|NCT00872521|16762600|P3|Secondary Endpoint Analysis|Efficacy data unavailable|1
4863644|NCT00872521|16762601|P2|Secondary Endpoint Analysis|Efficacy data unavailable|2
4863645|NCT00872521|16762602|P1|Secondary Endpoint Analysis|Efficacy data unavailable|0
4863646|NCT00872521|16762600|P3|Completed 3-month Follow up|Physician Decision|0
4863647|NCT00872521|16762601|P2|Completed 3-month Follow up|Physician Decision|1
4863648|NCT00872521|16762602|P1|Completed 3-month Follow up|Physician Decision|0
4863649|NCT00872521|16762600|P3|Completed 3-month Follow up|Other|0
4863650|NCT00872521|16762601|P2|Completed 3-month Follow up|Other|2
4863651|NCT00872521|16762602|P1|Completed 3-month Follow up|Other|0
4863652|NCT00872521|16762600|P3|Primary Endpoint Analysis|Patient response missing|1
4863653|NCT00872521|16762601|P2|Primary Endpoint Analysis|Patient response missing|0
4863654|NCT00872521|16762602|P1|Primary Endpoint Analysis|Patient response missing|0
4863655|NCT00872521|16762600|P3|Primary Endpoint Analysis|Efficacy data unavailable|0
4863656|NCT00872521|16762601|P2|Primary Endpoint Analysis|Efficacy data unavailable|2
4863657|NCT00872521|16762602|P1|Primary Endpoint Analysis|Efficacy data unavailable|0
4863658|NCT00872521|16762600|P3|Primary Endpoint Analysis|Patient choice|0
4863659|NCT00872521|16762601|P2|Primary Endpoint Analysis|Patient choice|1
4863660|NCT00872521|16762602|P1|Primary Endpoint Analysis|Patient choice|0
4863661|NCT00872521|16762600|P3|Primary Endpoint Analysis|Other|0
4863662|NCT00872521|16762601|P2|Primary Endpoint Analysis|Other|2
4863663|NCT00872521|16762602|P1|Primary Endpoint Analysis|Other|1
4863664|NCT00872521|16762600|P3|Completed PAD Induction|Death|0
4863665|NCT00872521|16762601|P2|Completed PAD Induction|Death|1
4863666|NCT00872521|16762602|P1|Completed PAD Induction|Death|1
4863667|NCT00872521|16762600|P3|Completed PAD Induction|Adverse Event|0
4863668|NCT00872521|16762601|P2|Completed PAD Induction|Adverse Event|0
4863669|NCT00872521|16762602|P1|Completed PAD Induction|Adverse Event|4
4863670|NCT00872521|16762600|P3|Completed PAD Induction|Disease progression|0
4863671|NCT00872521|16762601|P2|Completed PAD Induction|Disease progression|2
4863672|NCT00872521|16762602|P1|Completed PAD Induction|Disease progression|0
4863673|NCT00872521|16762600|P3|Completed PAD Induction|Patient choice|0
4863674|NCT00872521|16762601|P2|Completed PAD Induction|Patient choice|1
4863675|NCT00872521|16762602|P1|Completed PAD Induction|Patient choice|0
4863676|NCT00872170|16762673|P2|Overall Study|Adverse Event|0
4863677|NCT00872170|16762674|P1|Overall Study|Adverse Event|1
4863678|NCT00872001|16762704|P2|Overall Study|Administrative|15
4863679|NCT00872001|16762705|P1|Overall Study|Administrative|23
4863680|NCT00872001|16762704|P2|Overall Study|Did Not Meet Protocol Eligibility|36
4863681|NCT00872001|16762705|P1|Overall Study|Did Not Meet Protocol Eligibility|38
4863682|NCT00872001|16762704|P2|Overall Study|Protocol Violation|8
4863683|NCT00872001|16762705|P1|Overall Study|Protocol Violation|5
4863684|NCT00872001|16762704|P2|Overall Study|Withdrawal by Subject|30
4863685|NCT00872001|16762705|P1|Overall Study|Withdrawal by Subject|18
4863686|NCT00872001|16762704|P2|Overall Study|Lost to Follow-up|12
4863687|NCT00872001|16762705|P1|Overall Study|Lost to Follow-up|13
4863688|NCT00872001|16762704|P2|Overall Study|Protocol Defined Clinical Event|7
4863689|NCT00872001|16762705|P1|Overall Study|Protocol Defined Clinical Event|5
4863690|NCT00872001|16762704|P2|Overall Study|Adverse Event|23
4863691|NCT00872001|16762705|P1|Overall Study|Adverse Event|34
4863692|NCT00871975|16762713|P1|Overall Study|Motion artifact, tracing uninterpretable|5
4863693|NCT00871975|16762713|P1|Overall Study|Patient unable to void/insufficient vol|13
4863694|NCT00871975|16762713|P1|Overall Study|Catheters could not be inserted|1
4863695|NCT00871975|16762713|P1|Overall Study|Technical difficulty w155-1ith equipment|3
4863696|NCT00871871|16762719|P4|Part II|Protocol Violation|1
4863697|NCT00871871|16762720|P3|Part II|Protocol Violation|0
4863698|NCT00871871|16762721|P2|Part II|Protocol Violation|0
4863699|NCT00871871|16762722|P1|Part II|Protocol Violation|0
4863700|NCT00871871|16762719|P4|Part II|Adverse Event|2
4863701|NCT00871871|16762720|P3|Part II|Adverse Event|1
4863702|NCT00871871|16762721|P2|Part II|Adverse Event|0
4863703|NCT00871871|16762722|P1|Part II|Adverse Event|0
4863704|NCT00871871|16762719|P4|Part II|Withdrawal by Subject|1
4863705|NCT00871871|16762720|P3|Part II|Withdrawal by Subject|2
4863706|NCT00871871|16762721|P2|Part II|Withdrawal by Subject|0
4863707|NCT00871871|16762722|P1|Part II|Withdrawal by Subject|0
4863708|NCT00871871|16762719|P4|Part II|Lack of Efficacy|0
4863709|NCT00871871|16762720|P3|Part II|Lack of Efficacy|1
4863710|NCT00871871|16762721|P2|Part II|Lack of Efficacy|0
4863711|NCT00871871|16762722|P1|Part II|Lack of Efficacy|0
4863712|NCT00871871|16762719|P4|Part I|Laboratory abnormality|0
4863713|NCT00871871|16762720|P3|Part I|Laboratory abnormality|0
4863714|NCT00871871|16762721|P2|Part I|Laboratory abnormality|1
4863715|NCT00871871|16762722|P1|Part I|Laboratory abnormality|0
4863716|NCT00871871|16762719|P4|Part I|Withdrawal by Subject|0
4863717|NCT00871871|16762720|P3|Part I|Withdrawal by Subject|0
4863718|NCT00871871|16762721|P2|Part I|Withdrawal by Subject|0
4863719|NCT00871871|16762722|P1|Part I|Withdrawal by Subject|3
4863720|NCT00871871|16762719|P4|Part I|Adverse Event|0
4863721|NCT00871871|16762720|P3|Part I|Adverse Event|0
4863722|NCT00871871|16762721|P2|Part I|Adverse Event|2
4863723|NCT00871871|16762722|P1|Part I|Adverse Event|0
4863724|NCT00871780|16762759|P1|Overall Study|Physician Decision|1
4863725|NCT00871780|16762759|P1|Overall Study|Death|1
4863726|NCT00871780|16762759|P1|Overall Study|Voluntary Discontinuation|4
4863727|NCT00871780|16762759|P1|Overall Study|Adverse Event|6
4863728|NCT00871780|16762759|P1|Overall Study|Withdrawal by Subject|9
4863729|NCT00871780|16762759|P1|Overall Study|Enrolled But Not Treated|6
4863730|NCT00871741|16762779|P2|Overall Study|Premature study termination|7
4863731|NCT00871741|16762780|P1|Overall Study|Premature study termination|9
4863732|NCT00871728|16762794|P1|Overall Study|Withdrawal of Informed Consent|5
4863733|NCT00871728|16762794|P1|Overall Study|Participant Non-compliance|1
4863734|NCT00871728|16762794|P1|Overall Study|Failed to Visit Hospital|4
4863735|NCT00871728|16762794|P1|Overall Study|Lost to Follow-up|2
4863736|NCT00871728|16762794|P1|Overall Study|Protocol Violation|7
4863737|NCT00871728|16762794|P1|Overall Study|Adverse Event|1
4863738|NCT00871715|16762807|P3|Overall Study|Lost to Follow-up|9
4863739|NCT00871715|16762808|P2|Overall Study|Lost to Follow-up|6
4863740|NCT00871715|16762809|P1|Overall Study|Lost to Follow-up|3
4863741|NCT00871715|16762807|P3|Overall Study|Physician Decision|2
4863742|NCT00871715|16762808|P2|Overall Study|Physician Decision|0
4863743|NCT00871715|16762809|P1|Overall Study|Physician Decision|6
4863744|NCT00871715|16762807|P3|Overall Study|Withdrawal by Subject|15
4863745|NCT00871715|16762808|P2|Overall Study|Withdrawal by Subject|10
4863746|NCT00871715|16762809|P1|Overall Study|Withdrawal by Subject|6
4863747|NCT00871572|16762886|P4|Overall Study|Withdrawal by Subject|1
4863748|NCT00871572|16762887|P3|Overall Study|Withdrawal by Subject|3
4863749|NCT00871572|16762888|P2|Overall Study|Withdrawal by Subject|2
4863750|NCT00871572|16762889|P1|Overall Study|Withdrawal by Subject|1
4863751|NCT00871572|16762886|P4|Overall Study|Sponsor Decision|0
4863752|NCT00871572|16762887|P3|Overall Study|Sponsor Decision|0
4863753|NCT00871572|16762888|P2|Overall Study|Sponsor Decision|0
4863754|NCT00871572|16762889|P1|Overall Study|Sponsor Decision|1
4863755|NCT00871572|16762886|P4|Overall Study|Protocol Violation|1
4863756|NCT00871572|16762887|P3|Overall Study|Protocol Violation|1
4863757|NCT00871572|16762888|P2|Overall Study|Protocol Violation|0
4863758|NCT00871572|16762889|P1|Overall Study|Protocol Violation|0
4863759|NCT00871572|16762886|P4|Overall Study|Lost to Follow-up|1
4863760|NCT00871572|16762887|P3|Overall Study|Lost to Follow-up|0
4863761|NCT00871572|16762888|P2|Overall Study|Lost to Follow-up|1
4863762|NCT00871572|16762889|P1|Overall Study|Lost to Follow-up|0
4863763|NCT00871572|16762886|P4|Overall Study|Investigator Decision|1
4863764|NCT00871572|16762887|P3|Overall Study|Investigator Decision|0
4863765|NCT00871572|16762888|P2|Overall Study|Investigator Decision|1
4863766|NCT00871572|16762889|P1|Overall Study|Investigator Decision|0
4863767|NCT00871572|16762886|P4|Overall Study|Adverse Event|3
4863768|NCT00871572|16762887|P3|Overall Study|Adverse Event|0
4863769|NCT00871572|16762888|P2|Overall Study|Adverse Event|2
4863770|NCT00871572|16762889|P1|Overall Study|Adverse Event|0
4863771|NCT00871494|16762959|P1|Overall Study|Lost to Follow-up|1
4863772|NCT00871494|16762959|P1|Overall Study|Adverse Event|4
4863773|NCT00871494|16762959|P1|Overall Study|Lack of Efficacy|4
4863774|NCT00871494|16762959|P1|Overall Study|Protocol Violation|5
4863775|NCT00871429|16762966|P1|Overall Study|Questionnaire not completed|1
4863776|NCT00871429|16762966|P1|Overall Study|Withdrawal by Subject|17
4863777|NCT00871429|16762966|P1|Overall Study|Lost to Follow-up|6
4863778|NCT00871403|16762977|P3|Monotherapy Treatment Phase|Adverse Event|0
4863779|NCT00871403|16762978|P2|Monotherapy Treatment Phase|Adverse Event|4
4863780|NCT00871403|16762979|P1|Monotherapy Treatment Phase|Adverse Event|0
4863781|NCT00871403|16762977|P3|Monotherapy Treatment Phase|Disease Progression|1
4863782|NCT00871403|16762978|P2|Monotherapy Treatment Phase|Disease Progression|9
4863783|NCT00871403|16762979|P1|Monotherapy Treatment Phase|Disease Progression|0
4863784|NCT00871403|16762977|P3|Combination Treatment Phase|Physician Decision|3
4863785|NCT00871403|16762978|P2|Combination Treatment Phase|Physician Decision|1
4863786|NCT00871403|16762979|P1|Combination Treatment Phase|Physician Decision|0
4863787|NCT00871403|16762977|P3|Combination Treatment Phase|Withdrawal by Subject|1
4863788|NCT00871403|16762978|P2|Combination Treatment Phase|Withdrawal by Subject|3
4863789|NCT00871403|16762979|P1|Combination Treatment Phase|Withdrawal by Subject|0
4863790|NCT00871403|16762977|P3|Combination Treatment Phase|Disease Progression|5
4863791|NCT00871403|16762978|P2|Combination Treatment Phase|Disease Progression|8
4863792|NCT00871403|16762979|P1|Combination Treatment Phase|Disease Progression|0
4863793|NCT00871403|16762977|P3|Combination Treatment Phase|Adverse Event|2
4863794|NCT00871403|16762978|P2|Combination Treatment Phase|Adverse Event|17
4863795|NCT00871403|16762979|P1|Combination Treatment Phase|Adverse Event|0
4863796|NCT00871403|16762977|P3|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0
4863797|NCT00871403|16762978|P2|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19
4863798|NCT00871403|16762979|P1|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8
4863799|NCT00871403|16762977|P3|Combination Treatment Phase|Randomized but Not Treated|1
4863800|NCT00871403|16762978|P2|Combination Treatment Phase|Randomized but Not Treated|1
4863801|NCT00871403|16762979|P1|Combination Treatment Phase|Randomized but Not Treated|1
4863802|NCT00871377|16762992|P6|Third Intervention (10 Weeks)|Death|0
4863803|NCT00871377|16762993|P5|Third Intervention (10 Weeks)|Death|0
4863804|NCT00871377|16762994|P4|Third Intervention (10 Weeks)|Death|1
4863805|NCT00871377|16762995|P3|Third Intervention (10 Weeks)|Death|0
4863806|NCT00871377|16762996|P2|Third Intervention (10 Weeks)|Death|0
4863807|NCT00871377|16762997|P1|Third Intervention (10 Weeks)|Death|0
4863808|NCT00871377|16762992|P6|Washout (6 Weeks)|Withdrawal by Subject|1
4863809|NCT00871377|16762993|P5|Washout (6 Weeks)|Withdrawal by Subject|0
4863810|NCT00871377|16762994|P4|Washout (6 Weeks)|Withdrawal by Subject|0
4863811|NCT00871377|16762995|P3|Washout (6 Weeks)|Withdrawal by Subject|0
4863812|NCT00871377|16762996|P2|Washout (6 Weeks)|Withdrawal by Subject|0
4863813|NCT00871377|16762997|P1|Washout (6 Weeks)|Withdrawal by Subject|0
4863814|NCT00871377|16762992|P6|Washout (6 Weeks)|Withdrawal by Subject|0
4863815|NCT00871377|16762993|P5|Washout (6 Weeks)|Withdrawal by Subject|0
4863816|NCT00871377|16762994|P4|Washout (6 Weeks)|Withdrawal by Subject|0
4863817|NCT00871377|16762995|P3|Washout (6 Weeks)|Withdrawal by Subject|0
4863818|NCT00871377|16762996|P2|Washout (6 Weeks)|Withdrawal by Subject|0
4863819|NCT00871377|16762997|P1|Washout (6 Weeks)|Withdrawal by Subject|1
4863820|NCT00871377|16762992|P6|First Intervention (10 Weeks)|Lost to Follow-up|1
4863821|NCT00871377|16762993|P5|First Intervention (10 Weeks)|Lost to Follow-up|0
4863822|NCT00871377|16762994|P4|First Intervention (10 Weeks)|Lost to Follow-up|0
4863823|NCT00871377|16762995|P3|First Intervention (10 Weeks)|Lost to Follow-up|0
4863824|NCT00871377|16762996|P2|First Intervention (10 Weeks)|Lost to Follow-up|0
4863825|NCT00871377|16762997|P1|First Intervention (10 Weeks)|Lost to Follow-up|0
4863826|NCT00871377|16762992|P6|First Intervention (10 Weeks)|Withdrawal by Subject|0
4863827|NCT00871377|16762993|P5|First Intervention (10 Weeks)|Withdrawal by Subject|0
4863828|NCT00871377|16762994|P4|First Intervention (10 Weeks)|Withdrawal by Subject|0
4863829|NCT00871377|16762995|P3|First Intervention (10 Weeks)|Withdrawal by Subject|1
4863830|NCT00871377|16762996|P2|First Intervention (10 Weeks)|Withdrawal by Subject|0
4863831|NCT00871377|16762997|P1|First Intervention (10 Weeks)|Withdrawal by Subject|0
4863832|NCT00871351|16763008|P3|Overall Study|Adverse Event|0
4863833|NCT00871351|16763009|P2|Overall Study|Adverse Event|1
4863834|NCT00871351|16763010|P1|Overall Study|Adverse Event|3
4863835|NCT00871351|16763008|P3|Overall Study|Withdrawal by Subject|0
4863836|NCT00871351|16763009|P2|Overall Study|Withdrawal by Subject|0
4863837|NCT00871351|16763010|P1|Overall Study|Withdrawal by Subject|1
4863838|NCT00871338|16763032|P2|Prior to Booster|Lost to Follow-up|0
4863839|NCT00871338|16763033|P1|Prior to Booster|Lost to Follow-up|1
4863840|NCT00871338|16763032|P2|Prior to Booster|Withdrawal by Subject|3
4863841|NCT00871338|16763033|P1|Prior to Booster|Withdrawal by Subject|1
4863842|NCT00871234|16763122|P1|Overall Study|Lost to Follow-up|3
4863843|NCT00871234|16763122|P1|Overall Study|Adverse Event|2
4863844|NCT00871169|16763126|P1|Overall Study|Patient did not receive study treatment|2
4863845|NCT00871169|16763126|P1|Overall Study|Protocol Violation|1
4863846|NCT00871117|16763154|P2|Overall Study|Other|4
4863847|NCT00871117|16763155|P1|Overall Study|Other|0
4863848|NCT00871117|16763154|P2|Overall Study|Lost to Follow-up|6
4863849|NCT00871117|16763155|P1|Overall Study|Lost to Follow-up|5
4863850|NCT00871000|16763189|P2|Overall Study|Withdrawal by Subject|0
4863851|NCT00871000|16763190|P1|Overall Study|Withdrawal by Subject|1
4863852|NCT00870870|16763242|P4|Overall Study|Adverse Event|2
4863853|NCT00870870|16763243|P3|Overall Study|Adverse Event|2
4863854|NCT00870870|16763244|P2|Overall Study|Adverse Event|0
4863855|NCT00870870|16763245|P1|Overall Study|Adverse Event|0
4863856|NCT00870870|16763242|P4|Overall Study|Withdrawal by Subject|3
4863857|NCT00870870|16763243|P3|Overall Study|Withdrawal by Subject|1
4863858|NCT00870870|16763244|P2|Overall Study|Withdrawal by Subject|1
4863859|NCT00870870|16763245|P1|Overall Study|Withdrawal by Subject|0
4863860|NCT00870740|16763289|P6|Overall Study|Other|5
4863861|NCT00870740|16763290|P5|Overall Study|Other|3
4863862|NCT00870740|16763291|P4|Overall Study|Other|4
4863863|NCT00870740|16763292|P3|Overall Study|Other|2
4863864|NCT00870740|16763293|P2|Overall Study|Other|5
4863865|NCT00870740|16763294|P1|Overall Study|Other|2
4863866|NCT00870740|16763289|P6|Overall Study|Death|0
4863867|NCT00870740|16763290|P5|Overall Study|Death|1
4863868|NCT00870740|16763291|P4|Overall Study|Death|0
4863869|NCT00870740|16763292|P3|Overall Study|Death|0
4863870|NCT00870740|16763293|P2|Overall Study|Death|0
4863871|NCT00870740|16763294|P1|Overall Study|Death|0
4863872|NCT00870740|16763289|P6|Overall Study|Subject Non-compliance|1
4863873|NCT00870740|16763290|P5|Overall Study|Subject Non-compliance|0
4863874|NCT00870740|16763291|P4|Overall Study|Subject Non-compliance|0
4863875|NCT00870740|16763292|P3|Overall Study|Subject Non-compliance|0
4863876|NCT00870740|16763293|P2|Overall Study|Subject Non-compliance|0
4863877|NCT00870740|16763294|P1|Overall Study|Subject Non-compliance|0
4863878|NCT00870740|16763289|P6|Overall Study|Investigator Decision|0
4863879|NCT00870740|16763290|P5|Overall Study|Investigator Decision|0
4863880|NCT00870740|16763291|P4|Overall Study|Investigator Decision|0
4863881|NCT00870740|16763292|P3|Overall Study|Investigator Decision|1
4863882|NCT00870740|16763293|P2|Overall Study|Investigator Decision|0
4863883|NCT00870740|16763294|P1|Overall Study|Investigator Decision|2
4863884|NCT00870740|16763289|P6|Overall Study|Consent Withdrawn|5
4863885|NCT00870740|16763290|P5|Overall Study|Consent Withdrawn|6
4863886|NCT00870740|16763291|P4|Overall Study|Consent Withdrawn|6
4863887|NCT00870740|16763292|P3|Overall Study|Consent Withdrawn|4
4863888|NCT00870740|16763293|P2|Overall Study|Consent Withdrawn|3
4863889|NCT00870740|16763294|P1|Overall Study|Consent Withdrawn|6
4863890|NCT00870740|16763289|P6|Overall Study|Adverse Event|6
4863891|NCT00870740|16763290|P5|Overall Study|Adverse Event|1
4863892|NCT00870740|16763291|P4|Overall Study|Adverse Event|2
4863893|NCT00870740|16763292|P3|Overall Study|Adverse Event|3
4863894|NCT00870740|16763293|P2|Overall Study|Adverse Event|1
4863895|NCT00870740|16763294|P1|Overall Study|Adverse Event|2
4863896|NCT00870727|16763370|P2|Overall Study|Adverse Event|1
4863897|NCT00870727|16763371|P1|Overall Study|Adverse Event|0
4863898|NCT00870727|16763370|P2|Overall Study|Lack of Efficacy|3
4863899|NCT00870727|16763371|P1|Overall Study|Lack of Efficacy|1
4863900|NCT00870727|16763370|P2|Overall Study|Lost to Follow-up|1
4863901|NCT00870727|16763371|P1|Overall Study|Lost to Follow-up|0
4863902|NCT00870688|16763387|P1|Overall Study|Granules in the Stools|1
4863903|NCT00870688|16763387|P1|Overall Study|Death, Unrelated|1
4863904|NCT00870688|16763387|P1|Overall Study|Lost to Follow-up|2
4863905|NCT00870584|16763392|P2|Overall Study|Protocol Deviation|2
4863906|NCT00870584|16763393|P1|Overall Study|Protocol Deviation|2
4863907|NCT00870584|16763392|P2|Overall Study|Lost to Follow-up|1
4863908|NCT00870584|16763393|P1|Overall Study|Lost to Follow-up|5
4863909|NCT00870584|16763392|P2|Overall Study|Withdrawal by Subject|7
4863910|NCT00870584|16763393|P1|Overall Study|Withdrawal by Subject|6
4863911|NCT00870584|16763392|P2|Overall Study|Adverse Event|3
4863912|NCT00870584|16763393|P1|Overall Study|Adverse Event|3
4863913|NCT00870233|16763502|P1|Overall Study|Death|1
4863914|NCT00870233|16763502|P1|Overall Study|Incompatible internet browser|2
4863915|NCT00870233|16763502|P1|Overall Study|Did not undergo laparotomy|3
4863916|NCT00870233|16763502|P1|Overall Study|Withdrawal by Subject|18
4863917|NCT00870194|16763511|P2|Overall Study|Subject Decision|2
4863918|NCT00870194|16763512|P1|Overall Study|Subject Decision|7
4863919|NCT00870194|16763511|P2|Overall Study|Entry Criteria Not Met|2
4863920|NCT00870194|16763512|P1|Overall Study|Entry Criteria Not Met|1
4863921|NCT00870194|16763511|P2|Overall Study|Protocol Violation|3
4863922|NCT00870194|16763512|P1|Overall Study|Protocol Violation|3
4863923|NCT00870194|16763511|P2|Overall Study|Physician Decision|1
4863924|NCT00870194|16763512|P1|Overall Study|Physician Decision|3
4863925|NCT00870194|16763511|P2|Overall Study|Lost to Follow-up|0
4863926|NCT00870194|16763512|P1|Overall Study|Lost to Follow-up|2
4863927|NCT00870194|16763511|P2|Overall Study|Lack of Efficacy|1
4863928|NCT00870194|16763512|P1|Overall Study|Lack of Efficacy|0
4863929|NCT00870194|16763511|P2|Overall Study|Adverse Event|5
4863930|NCT00870194|16763512|P1|Overall Study|Adverse Event|10
4863931|NCT00870103|16763550|P1|Overall Study|Lost to Follow-up|2
4863932|NCT00870103|16763550|P1|Overall Study|Physician Decision|2
4863933|NCT00869999|16763555|P1|Overall Study|removed prior to starting therapy|1
4863934|NCT00869999|16763555|P1|Overall Study|Withdrawal by Subject|1
4863935|NCT00869960|16763561|P1|Overall Study|Lost to Follow-up|2
4863936|NCT00869778|16763610|P3|Overall Study|Unblinding|0
4863937|NCT00869778|16763611|P2|Overall Study|Unblinding|0
4863938|NCT00869778|16763612|P1|Overall Study|Unblinding|1
4863939|NCT00869778|16763610|P3|Overall Study|Protocol Violation|5
4863940|NCT00869778|16763611|P2|Overall Study|Protocol Violation|3
4863941|NCT00869778|16763612|P1|Overall Study|Protocol Violation|5
4863942|NCT00869778|16763610|P3|Overall Study|Pregnancy|0
4863943|NCT00869778|16763611|P2|Overall Study|Pregnancy|0
4863944|NCT00869778|16763612|P1|Overall Study|Pregnancy|1
4863945|NCT00869778|16763610|P3|Overall Study|Withdrawal by Subject|5
4863946|NCT00869778|16763611|P2|Overall Study|Withdrawal by Subject|4
4863947|NCT00869778|16763612|P1|Overall Study|Withdrawal by Subject|3
4863948|NCT00869778|16763610|P3|Overall Study|Adverse Event|0
4863949|NCT00869778|16763611|P2|Overall Study|Adverse Event|0
4863950|NCT00869778|16763612|P1|Overall Study|Adverse Event|2
4863951|NCT00869557|16763687|P2|Extension Phase|Withdrew Consent|0
4863952|NCT00869557|16763688|P1|Extension Phase|Withdrew Consent|2
4863953|NCT00869557|16763687|P2|Extension Phase|Investigator's Discretion|0
4863954|NCT00869557|16763688|P1|Extension Phase|Investigator's Discretion|2
4863955|NCT00869557|16763687|P2|Extension Phase|Lost to Follow-up|1
4863956|NCT00869557|16763688|P1|Extension Phase|Lost to Follow-up|3
4863957|NCT00869557|16763687|P2|Extension Phase|Lack of Efficacy|0
4863958|NCT00869557|16763688|P1|Extension Phase|Lack of Efficacy|1
4863959|NCT00869557|16763687|P2|Extension Phase|Adverse Event|2
4863960|NCT00869557|16763688|P1|Extension Phase|Adverse Event|2
4863961|NCT00869557|16763687|P2|Randomized Phase|Withdrew Consent|1
4863962|NCT00869557|16763688|P1|Randomized Phase|Withdrew Consent|0
4863963|NCT00869557|16763687|P2|Randomized Phase|Investigator's Discretion|0
4863964|NCT00869557|16763688|P1|Randomized Phase|Investigator's Discretion|1
4863965|NCT00869557|16763687|P2|Randomized Phase|Lost to Follow-up|1
4863966|NCT00869557|16763688|P1|Randomized Phase|Lost to Follow-up|2
4863967|NCT00869518|16763707|P2|Overall Study|Lost to Follow-up|1
4863968|NCT00869518|16763708|P1|Overall Study|Lost to Follow-up|1
4863969|NCT00869440|16763724|P4|Overall Study|Physician Decision|0
4863970|NCT00869440|16763725|P3|Overall Study|Physician Decision|0
4863971|NCT00869440|16763726|P2|Overall Study|Physician Decision|1
4863972|NCT00869440|16763727|P1|Overall Study|Physician Decision|1
4863973|NCT00869440|16763724|P4|Overall Study|Withdrawal by Subject|0
4863974|NCT00869440|16763725|P3|Overall Study|Withdrawal by Subject|0
4863975|NCT00869440|16763726|P2|Overall Study|Withdrawal by Subject|0
4863976|NCT00869440|16763727|P1|Overall Study|Withdrawal by Subject|1
4863977|NCT00869401|16763761|P5|Overall Study|Withdrawal by Subject|3
4863978|NCT00869401|16763762|P4|Overall Study|Withdrawal by Subject|5
4863979|NCT00869401|16763763|P3|Overall Study|Withdrawal by Subject|0
4863980|NCT00869401|16763764|P2|Overall Study|Withdrawal by Subject|0
4863981|NCT00869401|16763765|P1|Overall Study|Withdrawal by Subject|0
4863982|NCT00869362|16763794|P2|Overall Study|Lost to Follow-up|3
4863983|NCT00869362|16763795|P1|Overall Study|Lost to Follow-up|1
4863984|NCT00869362|16763794|P2|Overall Study|Death|2
4863985|NCT00869362|16763795|P1|Overall Study|Death|0
4863986|NCT00869323|16763816|P1|Maintenance Therapy|concurrent illness|1
4863987|NCT00869258|16763824|P1|Overall Study|Physician Decision|1
4863988|NCT00869128|16763889|P2|Overall Study|lack of Compliance|6
4863989|NCT00869128|16763890|P1|Overall Study|lack of Compliance|6
4863990|NCT00869089|16763894|P1|Overall Study|Screen Fail|1
4863991|NCT00869089|16763894|P1|Overall Study|Withdrawal by Subject|1
4863992|NCT00869089|16763894|P1|Overall Study|Lost to Follow-up|1
4863993|NCT00869050|16763898|P1|Overall Study|Screen Failure|3
4863994|NCT00869024|16763905|P2|Overall Study|Protocol Violation|1
4863995|NCT00869024|16763906|P1|Overall Study|Protocol Violation|0
4863996|NCT00869024|16763905|P2|Overall Study|Lost to Follow-up|1
4863997|NCT00869024|16763906|P1|Overall Study|Lost to Follow-up|0
4863998|NCT00869024|16763905|P2|Overall Study|Death|3
4863999|NCT00869024|16763906|P1|Overall Study|Death|2
4864000|NCT00868998|16763922|P1|Overall Study|Death|1
4864001|NCT00868998|16763922|P1|Overall Study|Progression of disease|2
4864002|NCT00868998|16763922|P1|Overall Study|Withdrawal by Subject|1
4864003|NCT00868998|16763922|P1|Overall Study|Screen Failure|1
4864004|NCT00868790|16763933|P14|Post-study|Excluded Medication|0
4864005|NCT00868790|16763934|P13|Post-study|Excluded Medication|0
4864006|NCT00868790|16763935|P12|Post-study|Excluded Medication|0
4864007|NCT00868790|16763936|P11|Post-study|Excluded Medication|0
4864008|NCT00868790|16763937|P10|Post-study|Excluded Medication|1
4864009|NCT00868790|16763938|P9|Post-study|Excluded Medication|0
4864010|NCT00868790|16763939|P8|Post-study|Excluded Medication|2
4864011|NCT00868790|16763940|P7|Post-study|Excluded Medication|0
4864012|NCT00868790|16763941|P6|Post-study|Excluded Medication|0
4864013|NCT00868790|16763942|P5|Post-study|Excluded Medication|0
4864014|NCT00868790|16763943|P4|Post-study|Excluded Medication|0
4864015|NCT00868790|16763944|P3|Post-study|Excluded Medication|0
4864016|NCT00868790|16763945|P2|Post-study|Excluded Medication|0
4864017|NCT00868790|16763946|P1|Post-study|Excluded Medication|0
4864018|NCT00868790|16763933|P14|Post-study|Withdrawal by Subject|0
4864019|NCT00868790|16763934|P13|Post-study|Withdrawal by Subject|0
4864020|NCT00868790|16763935|P12|Post-study|Withdrawal by Subject|0
4864021|NCT00868790|16763936|P11|Post-study|Withdrawal by Subject|0
4864022|NCT00868790|16763937|P10|Post-study|Withdrawal by Subject|0
4864023|NCT00868790|16763938|P9|Post-study|Withdrawal by Subject|0
4864024|NCT00868790|16763939|P8|Post-study|Withdrawal by Subject|0
4864025|NCT00868790|16763940|P7|Post-study|Withdrawal by Subject|0
4864026|NCT00868790|16763941|P6|Post-study|Withdrawal by Subject|0
4864027|NCT00868790|16763942|P5|Post-study|Withdrawal by Subject|1
4864028|NCT00868790|16763943|P4|Post-study|Withdrawal by Subject|0
4864029|NCT00868790|16763944|P3|Post-study|Withdrawal by Subject|0
4864030|NCT00868790|16763945|P2|Post-study|Withdrawal by Subject|0
4864031|NCT00868790|16763946|P1|Post-study|Withdrawal by Subject|0
4864032|NCT00868790|16763933|P14|Period 4|Abnormal ALT/AST|0
4864033|NCT00868790|16763934|P13|Period 4|Abnormal ALT/AST|0
4864034|NCT00868790|16763935|P12|Period 4|Abnormal ALT/AST|0
4864035|NCT00868790|16763936|P11|Period 4|Abnormal ALT/AST|0
4864036|NCT00868790|16763937|P10|Period 4|Abnormal ALT/AST|0
4864037|NCT00868790|16763938|P9|Period 4|Abnormal ALT/AST|0
4864038|NCT00868790|16763939|P8|Period 4|Abnormal ALT/AST|0
4864039|NCT00868790|16763940|P7|Period 4|Abnormal ALT/AST|0
4864040|NCT00868790|16763941|P6|Period 4|Abnormal ALT/AST|0
4864041|NCT00868790|16763942|P5|Period 4|Abnormal ALT/AST|0
4864042|NCT00868790|16763943|P4|Period 4|Abnormal ALT/AST|0
4864043|NCT00868790|16763944|P3|Period 4|Abnormal ALT/AST|1
4864044|NCT00868790|16763945|P2|Period 4|Abnormal ALT/AST|0
4864045|NCT00868790|16763946|P1|Period 4|Abnormal ALT/AST|0
4864046|NCT00868790|16763933|P14|Period 4|Study Terminated by Sponsor|1
4864047|NCT00868790|16763934|P13|Period 4|Study Terminated by Sponsor|0
4864048|NCT00868790|16763935|P12|Period 4|Study Terminated by Sponsor|1
4864049|NCT00868790|16763936|P11|Period 4|Study Terminated by Sponsor|2
4864050|NCT00868790|16763937|P10|Period 4|Study Terminated by Sponsor|0
4864051|NCT00868790|16763938|P9|Period 4|Study Terminated by Sponsor|2
4864052|NCT00868790|16763939|P8|Period 4|Study Terminated by Sponsor|1
4864053|NCT00868790|16763940|P7|Period 4|Study Terminated by Sponsor|0
4864054|NCT00868790|16763941|P6|Period 4|Study Terminated by Sponsor|0
4864055|NCT00868790|16763942|P5|Period 4|Study Terminated by Sponsor|0
4864056|NCT00868790|16763943|P4|Period 4|Study Terminated by Sponsor|0
4864057|NCT00868790|16763944|P3|Period 4|Study Terminated by Sponsor|0
4864058|NCT00868790|16763945|P2|Period 4|Study Terminated by Sponsor|0
4864059|NCT00868790|16763946|P1|Period 4|Study Terminated by Sponsor|2
4864060|NCT00868790|16763933|P14|Period 4|Lost to Follow-up|0
4864061|NCT00868790|16763934|P13|Period 4|Lost to Follow-up|0
4864062|NCT00868790|16763935|P12|Period 4|Lost to Follow-up|0
4864063|NCT00868790|16763936|P11|Period 4|Lost to Follow-up|0
4864064|NCT00868790|16763937|P10|Period 4|Lost to Follow-up|0
4864065|NCT00868790|16763938|P9|Period 4|Lost to Follow-up|0
4864066|NCT00868790|16763939|P8|Period 4|Lost to Follow-up|1
4864067|NCT00868790|16763940|P7|Period 4|Lost to Follow-up|0
4864068|NCT00868790|16763941|P6|Period 4|Lost to Follow-up|0
4864069|NCT00868790|16763942|P5|Period 4|Lost to Follow-up|0
4864070|NCT00868790|16763943|P4|Period 4|Lost to Follow-up|0
4864071|NCT00868790|16763944|P3|Period 4|Lost to Follow-up|0
4864072|NCT00868790|16763945|P2|Period 4|Lost to Follow-up|0
4864073|NCT00868790|16763946|P1|Period 4|Lost to Follow-up|0
4864074|NCT00868790|16763933|P14|Period 4|Adverse Event|0
4864075|NCT00868790|16763934|P13|Period 4|Adverse Event|1
4864076|NCT00868790|16763935|P12|Period 4|Adverse Event|0
4864077|NCT00868790|16763936|P11|Period 4|Adverse Event|1
4864078|NCT00868790|16763937|P10|Period 4|Adverse Event|0
4864079|NCT00868790|16763938|P9|Period 4|Adverse Event|0
4864080|NCT00868790|16763939|P8|Period 4|Adverse Event|1
4864081|NCT00868790|16763940|P7|Period 4|Adverse Event|0
4864082|NCT00868790|16763941|P6|Period 4|Adverse Event|0
4864083|NCT00868790|16763942|P5|Period 4|Adverse Event|0
4864084|NCT00868790|16763943|P4|Period 4|Adverse Event|0
4864085|NCT00868790|16763944|P3|Period 4|Adverse Event|0
4864086|NCT00868790|16763945|P2|Period 4|Adverse Event|0
4864087|NCT00868790|16763946|P1|Period 4|Adverse Event|0
4864088|NCT00868790|16763933|P14|Period 3|Study Terminated by Sponsor|0
4864089|NCT00868790|16763934|P13|Period 3|Study Terminated by Sponsor|0
4864090|NCT00868790|16763935|P12|Period 3|Study Terminated by Sponsor|0
4864091|NCT00868790|16763936|P11|Period 3|Study Terminated by Sponsor|0
4864092|NCT00868790|16763937|P10|Period 3|Study Terminated by Sponsor|0
4864093|NCT00868790|16763938|P9|Period 3|Study Terminated by Sponsor|0
4864094|NCT00868790|16763939|P8|Period 3|Study Terminated by Sponsor|0
4864095|NCT00868790|16763940|P7|Period 3|Study Terminated by Sponsor|0
4864096|NCT00868790|16763941|P6|Period 3|Study Terminated by Sponsor|0
4864097|NCT00868790|16763942|P5|Period 3|Study Terminated by Sponsor|0
4864098|NCT00868790|16763943|P4|Period 3|Study Terminated by Sponsor|1
4864099|NCT00868790|16763944|P3|Period 3|Study Terminated by Sponsor|0
4864100|NCT00868790|16763945|P2|Period 3|Study Terminated by Sponsor|0
4864101|NCT00868790|16763946|P1|Period 3|Study Terminated by Sponsor|0
4864102|NCT00868790|16763933|P14|Period 3|Protocol Violation|0
4864103|NCT00868790|16763934|P13|Period 3|Protocol Violation|0
4864104|NCT00868790|16763935|P12|Period 3|Protocol Violation|0
4864105|NCT00868790|16763936|P11|Period 3|Protocol Violation|1
4864106|NCT00868790|16763937|P10|Period 3|Protocol Violation|0
4864107|NCT00868790|16763938|P9|Period 3|Protocol Violation|0
4864108|NCT00868790|16763939|P8|Period 3|Protocol Violation|0
4864109|NCT00868790|16763940|P7|Period 3|Protocol Violation|0
4864110|NCT00868790|16763941|P6|Period 3|Protocol Violation|0
4864111|NCT00868790|16763942|P5|Period 3|Protocol Violation|0
4864112|NCT00868790|16763943|P4|Period 3|Protocol Violation|0
4864113|NCT00868790|16763944|P3|Period 3|Protocol Violation|0
4864114|NCT00868790|16763945|P2|Period 3|Protocol Violation|0
4864115|NCT00868790|16763946|P1|Period 3|Protocol Violation|0
4864116|NCT00868790|16763933|P14|Period 3|Adverse Event|0
4864117|NCT00868790|16763934|P13|Period 3|Adverse Event|0
4864118|NCT00868790|16763935|P12|Period 3|Adverse Event|0
4864119|NCT00868790|16763936|P11|Period 3|Adverse Event|0
4864120|NCT00868790|16763937|P10|Period 3|Adverse Event|1
4864121|NCT00868790|16763938|P9|Period 3|Adverse Event|0
4864122|NCT00868790|16763939|P8|Period 3|Adverse Event|0
4864123|NCT00868790|16763940|P7|Period 3|Adverse Event|0
4864124|NCT00868790|16763941|P6|Period 3|Adverse Event|0
4864125|NCT00868790|16763942|P5|Period 3|Adverse Event|0
4864126|NCT00868790|16763943|P4|Period 3|Adverse Event|0
4864127|NCT00868790|16763944|P3|Period 3|Adverse Event|0
4864128|NCT00868790|16763945|P2|Period 3|Adverse Event|0
4864129|NCT00868790|16763946|P1|Period 3|Adverse Event|0
4864130|NCT00868790|16763933|P14|Period 2|Withdrawal by Subject|1
4864131|NCT00868790|16763934|P13|Period 2|Withdrawal by Subject|0
4864132|NCT00868790|16763935|P12|Period 2|Withdrawal by Subject|0
4864133|NCT00868790|16763936|P11|Period 2|Withdrawal by Subject|0
4864134|NCT00868790|16763937|P10|Period 2|Withdrawal by Subject|0
4864135|NCT00868790|16763938|P9|Period 2|Withdrawal by Subject|1
4864136|NCT00868790|16763939|P8|Period 2|Withdrawal by Subject|0
4864137|NCT00868790|16763940|P7|Period 2|Withdrawal by Subject|0
4864138|NCT00868790|16763941|P6|Period 2|Withdrawal by Subject|0
4864139|NCT00868790|16763942|P5|Period 2|Withdrawal by Subject|0
4864140|NCT00868790|16763943|P4|Period 2|Withdrawal by Subject|0
4864141|NCT00868790|16763944|P3|Period 2|Withdrawal by Subject|0
4864142|NCT00868790|16763945|P2|Period 2|Withdrawal by Subject|0
4864143|NCT00868790|16763946|P1|Period 2|Withdrawal by Subject|0
4864144|NCT00868790|16763933|P14|Period 2|Lost to Follow-up|0
4864145|NCT00868790|16763934|P13|Period 2|Lost to Follow-up|0
4864146|NCT00868790|16763935|P12|Period 2|Lost to Follow-up|0
4864147|NCT00868790|16763936|P11|Period 2|Lost to Follow-up|0
4864148|NCT00868790|16763937|P10|Period 2|Lost to Follow-up|0
4864149|NCT00868790|16763938|P9|Period 2|Lost to Follow-up|0
4864150|NCT00868790|16763939|P8|Period 2|Lost to Follow-up|0
4864151|NCT00868790|16763940|P7|Period 2|Lost to Follow-up|0
4864152|NCT00868790|16763941|P6|Period 2|Lost to Follow-up|1
4864153|NCT00868790|16763942|P5|Period 2|Lost to Follow-up|0
4864154|NCT00868790|16763943|P4|Period 2|Lost to Follow-up|0
4864155|NCT00868790|16763944|P3|Period 2|Lost to Follow-up|0
4864156|NCT00868790|16763945|P2|Period 2|Lost to Follow-up|1
4864157|NCT00868790|16763946|P1|Period 2|Lost to Follow-up|0
4864158|NCT00868790|16763933|P14|Period 2|Adverse Event|0
4864159|NCT00868790|16763934|P13|Period 2|Adverse Event|0
4864160|NCT00868790|16763935|P12|Period 2|Adverse Event|0
4864161|NCT00868790|16763936|P11|Period 2|Adverse Event|0
4864162|NCT00868790|16763937|P10|Period 2|Adverse Event|0
4864163|NCT00868790|16763938|P9|Period 2|Adverse Event|1
4864164|NCT00868790|16763939|P8|Period 2|Adverse Event|0
4864165|NCT00868790|16763940|P7|Period 2|Adverse Event|0
4864166|NCT00868790|16763941|P6|Period 2|Adverse Event|0
4864167|NCT00868790|16763942|P5|Period 2|Adverse Event|0
4864168|NCT00868790|16763943|P4|Period 2|Adverse Event|0
4864169|NCT00868790|16763944|P3|Period 2|Adverse Event|0
4864170|NCT00868790|16763945|P2|Period 2|Adverse Event|0
4864171|NCT00868790|16763946|P1|Period 2|Adverse Event|0
4864172|NCT00868790|16763933|P14|Period 1|Lost to Follow-up|0
4864173|NCT00868790|16763934|P13|Period 1|Lost to Follow-up|0
4864174|NCT00868790|16763935|P12|Period 1|Lost to Follow-up|0
4864175|NCT00868790|16763936|P11|Period 1|Lost to Follow-up|0
4864176|NCT00868790|16763937|P10|Period 1|Lost to Follow-up|0
4864177|NCT00868790|16763938|P9|Period 1|Lost to Follow-up|0
4864178|NCT00868790|16763939|P8|Period 1|Lost to Follow-up|0
4864179|NCT00868790|16763940|P7|Period 1|Lost to Follow-up|0
4864180|NCT00868790|16763941|P6|Period 1|Lost to Follow-up|1
4864181|NCT00868790|16763942|P5|Period 1|Lost to Follow-up|0
4864182|NCT00868790|16763943|P4|Period 1|Lost to Follow-up|0
4864183|NCT00868790|16763944|P3|Period 1|Lost to Follow-up|0
4864184|NCT00868790|16763945|P2|Period 1|Lost to Follow-up|0
4864185|NCT00868790|16763946|P1|Period 1|Lost to Follow-up|0
4864186|NCT00868790|16763933|P14|Period 1|Abnormal Triglycerides|0
4864187|NCT00868790|16763934|P13|Period 1|Abnormal Triglycerides|0
4864188|NCT00868790|16763935|P12|Period 1|Abnormal Triglycerides|0
4864189|NCT00868790|16763936|P11|Period 1|Abnormal Triglycerides|0
4864190|NCT00868790|16763937|P10|Period 1|Abnormal Triglycerides|0
4864191|NCT00868790|16763938|P9|Period 1|Abnormal Triglycerides|0
4864192|NCT00868790|16763939|P8|Period 1|Abnormal Triglycerides|0
4864193|NCT00868790|16763940|P7|Period 1|Abnormal Triglycerides|0
4864194|NCT00868790|16763941|P6|Period 1|Abnormal Triglycerides|0
4864195|NCT00868790|16763942|P5|Period 1|Abnormal Triglycerides|1
4864196|NCT00868790|16763943|P4|Period 1|Abnormal Triglycerides|0
4864197|NCT00868790|16763944|P3|Period 1|Abnormal Triglycerides|0
4864198|NCT00868790|16763945|P2|Period 1|Abnormal Triglycerides|0
4864199|NCT00868790|16763946|P1|Period 1|Abnormal Triglycerides|0
4864200|NCT00868790|16763933|P14|Period 1|Withdrawal by Subject|1
4864201|NCT00868790|16763934|P13|Period 1|Withdrawal by Subject|0
4864202|NCT00868790|16763935|P12|Period 1|Withdrawal by Subject|0
4864203|NCT00868790|16763936|P11|Period 1|Withdrawal by Subject|0
4864204|NCT00868790|16763937|P10|Period 1|Withdrawal by Subject|0
4864205|NCT00868790|16763938|P9|Period 1|Withdrawal by Subject|0
4864206|NCT00868790|16763939|P8|Period 1|Withdrawal by Subject|0
4864207|NCT00868790|16763940|P7|Period 1|Withdrawal by Subject|0
4864208|NCT00868790|16763941|P6|Period 1|Withdrawal by Subject|0
4864209|NCT00868790|16763942|P5|Period 1|Withdrawal by Subject|0
4864210|NCT00868790|16763943|P4|Period 1|Withdrawal by Subject|0
4864211|NCT00868790|16763944|P3|Period 1|Withdrawal by Subject|0
4864212|NCT00868790|16763945|P2|Period 1|Withdrawal by Subject|1
4864213|NCT00868790|16763946|P1|Period 1|Withdrawal by Subject|0
4864214|NCT00868790|16763933|P14|Period 1|Protocol Violation|0
4864215|NCT00868790|16763934|P13|Period 1|Protocol Violation|0
4864216|NCT00868790|16763935|P12|Period 1|Protocol Violation|0
4864217|NCT00868790|16763936|P11|Period 1|Protocol Violation|0
4864218|NCT00868790|16763937|P10|Period 1|Protocol Violation|0
4864219|NCT00868790|16763938|P9|Period 1|Protocol Violation|0
4864220|NCT00868790|16763939|P8|Period 1|Protocol Violation|0
4864221|NCT00868790|16763940|P7|Period 1|Protocol Violation|0
4864222|NCT00868790|16763941|P6|Period 1|Protocol Violation|0
4864223|NCT00868790|16763942|P5|Period 1|Protocol Violation|0
4864224|NCT00868790|16763943|P4|Period 1|Protocol Violation|0
4864225|NCT00868790|16763944|P3|Period 1|Protocol Violation|0
4864226|NCT00868790|16763945|P2|Period 1|Protocol Violation|0
4864227|NCT00868790|16763946|P1|Period 1|Protocol Violation|1
4864228|NCT00868790|16763933|P14|Period 1|Adverse Event|1
4864229|NCT00868790|16763934|P13|Period 1|Adverse Event|0
4864230|NCT00868790|16763935|P12|Period 1|Adverse Event|0
4864231|NCT00868790|16763936|P11|Period 1|Adverse Event|0
4864232|NCT00868790|16763937|P10|Period 1|Adverse Event|0
4864233|NCT00868790|16763938|P9|Period 1|Adverse Event|1
4864234|NCT00868790|16763939|P8|Period 1|Adverse Event|3
4864235|NCT00868790|16763940|P7|Period 1|Adverse Event|0
4864236|NCT00868790|16763941|P6|Period 1|Adverse Event|0
4864237|NCT00868790|16763942|P5|Period 1|Adverse Event|0
4864238|NCT00868790|16763943|P4|Period 1|Adverse Event|0
4864239|NCT00868790|16763944|P3|Period 1|Adverse Event|0
4864240|NCT00868790|16763945|P2|Period 1|Adverse Event|0
4864241|NCT00868790|16763946|P1|Period 1|Adverse Event|1
4864242|NCT00868608|16764029|P3|Overall Study|Other - Unspecified|0
4864243|NCT00868608|16764030|P2|Overall Study|Other - Unspecified|0
4864244|NCT00868608|16764031|P1|Overall Study|Other - Unspecified|1
4864245|NCT00868608|16764029|P3|Overall Study|Death|4
4864246|NCT00868608|16764030|P2|Overall Study|Death|2
4864247|NCT00868608|16764031|P1|Overall Study|Death|16
4864248|NCT00868608|16764029|P3|Overall Study|Lost to Follow-up|1
4864249|NCT00868608|16764030|P2|Overall Study|Lost to Follow-up|0
4864250|NCT00868608|16764031|P1|Overall Study|Lost to Follow-up|3
4864251|NCT00868608|16764029|P3|Overall Study|Withdrawal by Subject|0
4864252|NCT00868608|16764030|P2|Overall Study|Withdrawal by Subject|1
4864253|NCT00868608|16764031|P1|Overall Study|Withdrawal by Subject|3
4864254|NCT00868530|16764055|P1|Overall Study|Lost to Follow-up|1
4864255|NCT00868530|16764055|P1|Overall Study|Adverse Event|3
4864256|NCT00868517|16764070|P3|Overall Study|Protocol Violation|0
4864257|NCT00868517|16764071|P2|Overall Study|Protocol Violation|1
4864258|NCT00868517|16764072|P1|Overall Study|Protocol Violation|1
4864259|NCT00868517|16764070|P3|Overall Study|Withdrawal by Subject|2
4864260|NCT00868517|16764071|P2|Overall Study|Withdrawal by Subject|3
4864261|NCT00868517|16764072|P1|Overall Study|Withdrawal by Subject|3
4864262|NCT00868439|16764110|P2|Overall Study|Withdrawal by Subject|1
4864263|NCT00868439|16764111|P1|Overall Study|Withdrawal by Subject|0
4864264|NCT00868439|16764110|P2|Overall Study|Physician Decision|0
4864265|NCT00868439|16764111|P1|Overall Study|Physician Decision|1
4864266|NCT00868439|16764110|P2|Overall Study|Protocol Violation|1
4864267|NCT00868439|16764111|P1|Overall Study|Protocol Violation|1
4864268|NCT00868439|16764110|P2|Overall Study|Death|1
4864269|NCT00868439|16764111|P1|Overall Study|Death|0
4864270|NCT00868439|16764110|P2|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3
4864271|NCT00868439|16764111|P1|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2
4864272|NCT00868439|16764110|P2|Overall Study|Adverse Event|3
4864273|NCT00868439|16764111|P1|Overall Study|Adverse Event|4
4864274|NCT00868296|16764168|P2|Overall Study|Withdrawal by Subject|1
4864275|NCT00868296|16764169|P1|Overall Study|Withdrawal by Subject|0
4864276|NCT00868296|16764168|P2|Overall Study|Adverse Event|2
4864277|NCT00868296|16764169|P1|Overall Study|Adverse Event|0
4864278|NCT00868231|16764177|P6|Treatment Period 3|Adverse Event|0
4864279|NCT00868231|16764178|P5|Treatment Period 3|Adverse Event|0
4864280|NCT00868231|16764179|P4|Treatment Period 3|Adverse Event|0
4864281|NCT00868231|16764180|P3|Treatment Period 3|Adverse Event|1
4864282|NCT00868231|16764181|P2|Treatment Period 3|Adverse Event|0
4864283|NCT00868231|16764182|P1|Treatment Period 3|Adverse Event|0
4864284|NCT00868231|16764177|P6|Treatment Period 2|Adverse Event|0
4864285|NCT00868231|16764178|P5|Treatment Period 2|Adverse Event|0
4864286|NCT00868231|16764179|P4|Treatment Period 2|Adverse Event|0
4864287|NCT00868231|16764180|P3|Treatment Period 2|Adverse Event|0
4864288|NCT00868231|16764181|P2|Treatment Period 2|Adverse Event|0
4864289|NCT00868231|16764182|P1|Treatment Period 2|Adverse Event|1
4864290|NCT00868231|16764177|P6|Treatment Period 1|Adverse Event|0
4864291|NCT00868231|16764178|P5|Treatment Period 1|Adverse Event|1
4864292|NCT00868231|16764179|P4|Treatment Period 1|Adverse Event|0
4864293|NCT00868231|16764180|P3|Treatment Period 1|Adverse Event|0
4864294|NCT00868231|16764181|P2|Treatment Period 1|Adverse Event|0
4864295|NCT00868231|16764182|P1|Treatment Period 1|Adverse Event|0
4864296|NCT00868192|16764248|P1|Overall Study|Ineligible|4
4864297|NCT00868166|16764265|P2|Overall Study|Non-compliance with IMP|1
4864298|NCT00868166|16764266|P1|Overall Study|Non-compliance with IMP|1
4864299|NCT00868166|16764265|P2|Overall Study|Lack of efficacy, logistics, unwell|10
4864300|NCT00868166|16764266|P1|Overall Study|Lack of efficacy, logistics, unwell|9
4864301|NCT00868166|16764265|P2|Overall Study|Adverse Event|10
4864302|NCT00868166|16764266|P1|Overall Study|Adverse Event|9
4864303|NCT00868166|16764265|P2|Overall Study|Lost to Follow-up|3
4864304|NCT00868166|16764266|P1|Overall Study|Lost to Follow-up|1
4864305|NCT00868166|16764265|P2|Overall Study|Protocol Violation|0
4864306|NCT00868166|16764266|P1|Overall Study|Protocol Violation|1
4864307|NCT00868166|16764265|P2|Overall Study|Withdrawal by Subject|25
4864308|NCT00868166|16764266|P1|Overall Study|Withdrawal by Subject|33
4864309|NCT00868166|16764265|P2|Overall Study|Death|65
4864310|NCT00868166|16764266|P1|Overall Study|Death|58
4864311|NCT00867815|16764328|P1|Overall Study|Lost to Follow-up|1
4864312|NCT00867568|16764339|P1|Overall Study|Withdrawal by Subject|1
4864313|NCT00867568|16764339|P1|Overall Study|Adverse Event|4
4864314|NCT00867568|16764339|P1|Overall Study|Lack of Efficacy|10
4864315|NCT00867503|16764356|P1|Overall Study|Withdrawal by Subject|1
4864316|NCT00867490|16764362|P1|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1
4864317|NCT00867490|16764362|P1|Phase 2 - Aliskiren+HCTZ|Adverse Event|2
4864318|NCT00867490|16764362|P1|Phase 1 - Candesartan+HCTZ|Administrative Problems|1
4864319|NCT00867490|16764362|P1|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4
4864320|NCT00867490|16764362|P1|Phase 1 - Candesartan+HCTZ|Adverse Event|5
4864321|NCT00867360|16764404|P2|Overall Study|Physician Decision|1
4864322|NCT00867360|16764405|P1|Overall Study|Physician Decision|0
4864323|NCT00867360|16764404|P2|Overall Study|Withdrawal by Subject|0
4864324|NCT00867360|16764405|P1|Overall Study|Withdrawal by Subject|1
4864325|NCT00867334|16764417|P2|Overall Study|Withdrawal by Subject|0
4864326|NCT00867334|16764418|P1|Overall Study|Withdrawal by Subject|1
4864327|NCT00867334|16764417|P2|Overall Study|Withdrawal by Subject|0
4864328|NCT00867334|16764418|P1|Overall Study|Withdrawal by Subject|1
4864329|NCT00867334|16764417|P2|Overall Study|Withdrawal by Subject|1
4864330|NCT00867334|16764418|P1|Overall Study|Withdrawal by Subject|0
4864331|NCT00867308|16764454|P2|Overall Study|Withdrawal by Subject|2
4864332|NCT00867308|16764455|P1|Overall Study|Withdrawal by Subject|1
4864333|NCT00867308|16764454|P2|Overall Study|Lack of Efficacy|12
4864334|NCT00867308|16764455|P1|Overall Study|Lack of Efficacy|6
4864335|NCT00867308|16764454|P2|Overall Study|Adverse Event|4
4864336|NCT00867308|16764455|P1|Overall Study|Adverse Event|1
4864337|NCT00867308|16764454|P2|Overall Study|Death|0
4864338|NCT00867308|16764455|P1|Overall Study|Death|1
4864339|NCT00867165|16764474|P2|Overall Study|Withdrawal by Subject|0
4864340|NCT00867165|16764475|P1|Overall Study|Withdrawal by Subject|1
4864341|NCT00867165|16764474|P2|Overall Study|Adverse Event|0
4864342|NCT00867165|16764475|P1|Overall Study|Adverse Event|3
4864343|NCT00867113|16764623|P1|Post Treatment After Survival Follow-up|Administrative problems|4
4864344|NCT00867113|16764623|P1|Post Treatment After Survival Follow-up|Lost to Follow-up|5
4864345|NCT00867113|16764623|P1|Post Treatment After Survival Follow-up|Withdrawal by Subject|1
4864346|NCT00867113|16764623|P1|Post Treatment After Survival Follow-up|Death|1
4864347|NCT00867113|16764623|P1|Treatment Period|Protocol Violation|4
4864348|NCT00867113|16764623|P1|Treatment Period|Disease progression/relapse|1
4864349|NCT00867113|16764623|P1|Treatment Period|Administrative problems|1
4864350|NCT00867113|16764623|P1|Treatment Period|Lost to Follow-up|3
4864351|NCT00867113|16764623|P1|Treatment Period|Withdrawal by Subject|19
4864352|NCT00867113|16764623|P1|Treatment Period|Death|2
4864353|NCT00867113|16764623|P1|Treatment Period|Adverse Event|15
4864354|NCT00867087|16764687|P1|Overall Study|Death|37
4864355|NCT00867087|16764687|P1|Overall Study|Withdrawal by Subject|4
4864356|NCT00867087|16764687|P1|Overall Study|Other|1
4864357|NCT00867035|16764703|P2|Baseline to 1 Week|Withdrawal by Subject|0
4864358|NCT00867035|16764704|P1|Baseline to 1 Week|Withdrawal by Subject|1
4864359|NCT00867035|16764703|P2|Baseline to 1 Hour|Withdrawal by Subject|1
4864360|NCT00867035|16764704|P1|Baseline to 1 Hour|Withdrawal by Subject|1
4864361|NCT00867009|16764730|P1|Maintenance Period|On-going in the Study at Data Cut-off|4
4864362|NCT00867009|16764730|P1|Induction Period|Progressive Disease (PD)|25
4864363|NCT00867009|16764730|P1|Induction Period|Physician Decision|3
4864364|NCT00867009|16764730|P1|Induction Period|Withdrawal by Subject|8
4864365|NCT00867009|16764730|P1|Induction Period|Protocol Violation|1
4864366|NCT00867009|16764730|P1|Induction Period|Death due to Study Disease|4
4864367|NCT00867009|16764730|P1|Induction Period|Death due to serious adverse event|6
4864368|NCT00867009|16764730|P1|Induction Period|Serious Adverse Event|10
4864369|NCT00867009|16764730|P1|Induction Period|Nonserious Adverse Event|5
4864370|NCT00866918|16764739|P2|Overall Study|Secondary malignancy|0
4864371|NCT00866918|16764740|P1|Overall Study|Secondary malignancy|1
4864372|NCT00866918|16764739|P2|Overall Study|Inevaluable- RQPCR negative at diagnosi|0
4864373|NCT00866918|16764740|P1|Overall Study|Inevaluable- RQPCR negative at diagnosi|1
4864374|NCT00866918|16764739|P2|Overall Study|Ineligible|4
4864375|NCT00866918|16764740|P1|Overall Study|Ineligible|2
4864376|NCT00866918|16764739|P2|Overall Study|Physician Decision|2
4864377|NCT00866918|16764740|P1|Overall Study|Physician Decision|10
4864378|NCT00866918|16764739|P2|Overall Study|Lack of Efficacy|1
4864379|NCT00866918|16764740|P1|Overall Study|Lack of Efficacy|1
4864380|NCT00866918|16764739|P2|Overall Study|Death|5
4864381|NCT00866918|16764740|P1|Overall Study|Death|1
4864382|NCT00866814|16764774|P1|Overall Study|Moved to area without study site|1
4864383|NCT00866814|16764774|P1|Overall Study|Unable to meet follow-up requirements|2
4864384|NCT00866814|16764774|P1|Overall Study|No longer wished to participate|1
4864385|NCT00866814|16764774|P1|Overall Study|Death|1
4864386|NCT00866814|16764774|P1|Overall Study|Physician Decision|1
4864387|NCT00866814|16764774|P1|Overall Study|Adverse Event|2
4864388|NCT00866814|16764774|P1|Overall Study|Lost to Follow-up|12
4864389|NCT00866788|16764787|P4|Overall Study|Physician Decision|1
4864390|NCT00866788|16764788|P3|Overall Study|Physician Decision|1
4864391|NCT00866788|16764789|P2|Overall Study|Physician Decision|0
4864392|NCT00866788|16764790|P1|Overall Study|Physician Decision|0
4864393|NCT00866788|16764787|P4|Overall Study|Disease progression|0
4864394|NCT00866788|16764788|P3|Overall Study|Disease progression|1
4864395|NCT00866788|16764789|P2|Overall Study|Disease progression|1
4864396|NCT00866788|16764790|P1|Overall Study|Disease progression|3
4864397|NCT00866788|16764787|P4|Overall Study|Pregnancy|0
4864398|NCT00866788|16764788|P3|Overall Study|Pregnancy|0
4864399|NCT00866788|16764789|P2|Overall Study|Pregnancy|1
4864400|NCT00866788|16764790|P1|Overall Study|Pregnancy|0
4864401|NCT00866788|16764787|P4|Overall Study|Withdrawal by Subject|1
4864402|NCT00866788|16764788|P3|Overall Study|Withdrawal by Subject|0
4864403|NCT00866788|16764789|P2|Overall Study|Withdrawal by Subject|1
4864404|NCT00866788|16764790|P1|Overall Study|Withdrawal by Subject|2
4864405|NCT00866788|16764787|P4|Overall Study|Lost to Follow-up|2
4864406|NCT00866788|16764788|P3|Overall Study|Lost to Follow-up|0
4864407|NCT00866788|16764789|P2|Overall Study|Lost to Follow-up|1
4864408|NCT00866788|16764790|P1|Overall Study|Lost to Follow-up|1
4864409|NCT00866788|16764787|P4|Overall Study|Adverse Event|1
4864410|NCT00866788|16764788|P3|Overall Study|Adverse Event|0
4864411|NCT00866788|16764789|P2|Overall Study|Adverse Event|2
4864412|NCT00866788|16764790|P1|Overall Study|Adverse Event|0
4864413|NCT00866775|16764838|P2|Overall Study|discontinued due to communication error|1
4864414|NCT00866775|16764839|P1|Overall Study|discontinued due to communication error|0
4864415|NCT00866775|16764838|P2|Overall Study|met exit criteria|17
4864416|NCT00866775|16764839|P1|Overall Study|met exit criteria|23
4864417|NCT00866775|16764838|P2|Overall Study|Withdrawal by Subject|4
4864418|NCT00866775|16764839|P1|Overall Study|Withdrawal by Subject|4
4864419|NCT00866775|16764838|P2|Overall Study|Protocol Violation|4
4864420|NCT00866775|16764839|P1|Overall Study|Protocol Violation|3
4864421|NCT00866775|16764838|P2|Overall Study|Physician Decision|3
4864422|NCT00866775|16764839|P1|Overall Study|Physician Decision|0
4864423|NCT00866775|16764838|P2|Overall Study|Lost to Follow-up|4
4864424|NCT00866775|16764839|P1|Overall Study|Lost to Follow-up|0
4864425|NCT00866775|16764838|P2|Overall Study|Death|0
4864426|NCT00866775|16764839|P1|Overall Study|Death|1
4864427|NCT00866775|16764838|P2|Overall Study|Adverse Event|19
4864428|NCT00866775|16764839|P1|Overall Study|Adverse Event|5
4864429|NCT00866723|16764882|P1|Overall Study|Disease Progression|4
4864430|NCT00866723|16764882|P1|Overall Study|Withdrawal by Subject|1
4864431|NCT00866697|16764889|P2|Overall Study|Withdrawal by Subject|57
4864432|NCT00866697|16764890|P1|Overall Study|Withdrawal by Subject|33
4864433|NCT00866697|16764889|P2|Overall Study|Physician Decision|5
4864434|NCT00866697|16764890|P1|Overall Study|Physician Decision|3
4864435|NCT00866697|16764889|P2|Overall Study|Lost to Follow-up|28
4864436|NCT00866697|16764890|P1|Overall Study|Lost to Follow-up|22
4864437|NCT00866697|16764889|P2|Overall Study|Study closed/terminated|138
4864438|NCT00866697|16764890|P1|Overall Study|Study closed/terminated|156
4864439|NCT00866658|16764932|P2|Overall Study|Familial and Personal Reasons|5
4864440|NCT00866658|16764933|P1|Overall Study|Familial and Personal Reasons|4
4864441|NCT00866658|16764932|P2|Overall Study|Protocol Violation|1
4864442|NCT00866658|16764933|P1|Overall Study|Protocol Violation|1
4864443|NCT00866658|16764932|P2|Overall Study|Withdrawal by Subject|0
4864444|NCT00866658|16764933|P1|Overall Study|Withdrawal by Subject|1
4864445|NCT00866658|16764932|P2|Overall Study|Lack of Efficacy|1
4864446|NCT00866658|16764933|P1|Overall Study|Lack of Efficacy|2
4864447|NCT00866658|16764932|P2|Overall Study|Adverse Event|14
4864448|NCT00866658|16764933|P1|Overall Study|Adverse Event|5
4864449|NCT00866619|16764965|P4|Overall Study|Lost to Follow-up|425
4864450|NCT00866619|16764966|P3|Overall Study|Lost to Follow-up|568
4864451|NCT00866619|16764967|P2|Overall Study|Lost to Follow-up|830
4864452|NCT00866619|16764968|P1|Overall Study|Lost to Follow-up|1145
4864453|NCT00866619|16764965|P4|Overall Study|Withdrawal by Subject|144
4864454|NCT00866619|16764966|P3|Overall Study|Withdrawal by Subject|272
4864455|NCT00866619|16764967|P2|Overall Study|Withdrawal by Subject|295
4864456|NCT00866619|16764968|P1|Overall Study|Withdrawal by Subject|587
4864457|NCT00866619|16764965|P4|Overall Study|Protocol Violation|17
4864458|NCT00866619|16764966|P3|Overall Study|Protocol Violation|2
4864459|NCT00866619|16764967|P2|Overall Study|Protocol Violation|39
4864460|NCT00866619|16764968|P1|Overall Study|Protocol Violation|2
4864461|NCT00866619|16764965|P4|Overall Study|Adverse Event|44
4864462|NCT00866619|16764966|P3|Overall Study|Adverse Event|47
4864463|NCT00866619|16764967|P2|Overall Study|Adverse Event|106
4864464|NCT00866619|16764968|P1|Overall Study|Adverse Event|112
4864465|NCT00866606|16765288|P1|Overall Study|Adverse Event|1
4864466|NCT00866606|16765288|P1|Overall Study|Lost to Follow-up|3
4864467|NCT00866359|16765302|P4|Extension Phase (Day 86 to 169)|Adverse Event|3
4864468|NCT00866359|16765303|P3|Extension Phase (Day 86 to 169)|Adverse Event|1
4864469|NCT00866359|16765304|P2|Extension Phase (Day 86 to 169)|Adverse Event|0
4864470|NCT00866359|16765305|P1|Extension Phase (Day 86 to 169)|Adverse Event|0
4864471|NCT00866359|16765302|P4|Treatment Phase (Days 1 to 85)|Other|0
4864472|NCT00866359|16765303|P3|Treatment Phase (Days 1 to 85)|Other|0
4864473|NCT00866359|16765304|P2|Treatment Phase (Days 1 to 85)|Other|0
4864474|NCT00866359|16765305|P1|Treatment Phase (Days 1 to 85)|Other|1
4864475|NCT00866359|16765302|P4|Treatment Phase (Days 1 to 85)|Protocol Violation|0
4864476|NCT00866359|16765303|P3|Treatment Phase (Days 1 to 85)|Protocol Violation|0
4864477|NCT00866359|16765304|P2|Treatment Phase (Days 1 to 85)|Protocol Violation|1
4864478|NCT00866359|16765305|P1|Treatment Phase (Days 1 to 85)|Protocol Violation|1
4864479|NCT00866359|16765302|P4|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
4864480|NCT00866359|16765303|P3|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
4864481|NCT00866359|16765304|P2|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0
4864482|NCT00866359|16765305|P1|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1
4864483|NCT00866359|16765302|P4|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
4864484|NCT00866359|16765303|P3|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
4864485|NCT00866359|16765304|P2|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0
4864486|NCT00866359|16765305|P1|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3
4864487|NCT00866359|16765302|P4|Treatment Phase (Days 1 to 85)|Adverse Event|0
4864488|NCT00866359|16765303|P3|Treatment Phase (Days 1 to 85)|Adverse Event|0
4864489|NCT00866359|16765304|P2|Treatment Phase (Days 1 to 85)|Adverse Event|4
4864490|NCT00866359|16765305|P1|Treatment Phase (Days 1 to 85)|Adverse Event|5
4864491|NCT00866333|16765361|P3|Overall Study|Study Terminated by Sponsor|9
4864492|NCT00866333|16765362|P2|Overall Study|Study Terminated by Sponsor|5
4864493|NCT00866333|16765363|P1|Overall Study|Study Terminated by Sponsor|2
4864494|NCT00866333|16765361|P3|Overall Study|Reason not Specified|1
4864495|NCT00866333|16765362|P2|Overall Study|Reason not Specified|1
4864496|NCT00866333|16765363|P1|Overall Study|Reason not Specified|3
4864497|NCT00866333|16765361|P3|Overall Study|Withdrawal of consent|2
4864498|NCT00866333|16765362|P2|Overall Study|Withdrawal of consent|1
4864499|NCT00866333|16765363|P1|Overall Study|Withdrawal of consent|0
4864500|NCT00866320|16765380|P1|Overall Study|Death|2
4864501|NCT00866320|16765380|P1|Overall Study|Withdrawal by Subject|4
4864502|NCT00866307|16765387|P3|Consolidation/Maintenance|Patient moved to non-participating inst|0
4864503|NCT00866307|16765388|P2|Consolidation/Maintenance|Patient moved to non-participating inst|1
4864504|NCT00866307|16765389|P1|Consolidation/Maintenance|Patient moved to non-participating inst|0
4864505|NCT00866307|16765387|P3|Consolidation/Maintenance|Non-compliance|1
4864506|NCT00866307|16765388|P2|Consolidation/Maintenance|Non-compliance|0
4864507|NCT00866307|16765389|P1|Consolidation/Maintenance|Non-compliance|0
4864508|NCT00866307|16765387|P3|Consolidation/Maintenance|Therapy error|0
4864509|NCT00866307|16765388|P2|Consolidation/Maintenance|Therapy error|1
4864510|NCT00866307|16765389|P1|Consolidation/Maintenance|Therapy error|0
4864511|NCT00866307|16765387|P3|Consolidation/Maintenance|Recurrent leukemia following remission|1
4864512|NCT00866307|16765388|P2|Consolidation/Maintenance|Recurrent leukemia following remission|3
4864513|NCT00866307|16765389|P1|Consolidation/Maintenance|Recurrent leukemia following remission|0
4864514|NCT00866307|16765387|P3|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2
4864515|NCT00866307|16765388|P2|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
4864516|NCT00866307|16765389|P1|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0
4864517|NCT00866307|16765387|P3|Consolidation/Maintenance|Withdrawal by Subject|1
4864518|NCT00866307|16765388|P2|Consolidation/Maintenance|Withdrawal by Subject|1
4864519|NCT00866307|16765389|P1|Consolidation/Maintenance|Withdrawal by Subject|0
4864520|NCT00866307|16765387|P3|Consolidation/Maintenance|Physician Decision|2
4864521|NCT00866307|16765388|P2|Consolidation/Maintenance|Physician Decision|3
4864522|NCT00866307|16765389|P1|Consolidation/Maintenance|Physician Decision|0
4864523|NCT00866307|16765387|P3|Consolidation/Maintenance|Death|1
4864524|NCT00866307|16765388|P2|Consolidation/Maintenance|Death|0
4864525|NCT00866307|16765389|P1|Consolidation/Maintenance|Death|0
4864526|NCT00866307|16765387|P3|Consolidation/Maintenance|Adverse Event|8
4864527|NCT00866307|16765388|P2|Consolidation/Maintenance|Adverse Event|0
4864528|NCT00866307|16765389|P1|Consolidation/Maintenance|Adverse Event|0
4864529|NCT00866307|16765387|P3|Induction|Study was closed at the time|0
4864530|NCT00866307|16765388|P2|Induction|Study was closed at the time|0
4864531|NCT00866307|16765389|P1|Induction|Study was closed at the time|1
4864532|NCT00866307|16765387|P3|Induction|Improper post-induction consent|0
4864533|NCT00866307|16765388|P2|Induction|Improper post-induction consent|0
4864534|NCT00866307|16765389|P1|Induction|Improper post-induction consent|2
4864535|NCT00866307|16765387|P3|Induction|Inadequate cytognetic samples th|0
4864536|NCT00866307|16765388|P2|Induction|Inadequate cytognetic samples th|0
4864537|NCT00866307|16765389|P1|Induction|Inadequate cytognetic samples th|1
4864538|NCT00866307|16765387|P3|Induction|Identification of Patients with Day 29 M|0
4864539|NCT00866307|16765388|P2|Induction|Identification of Patients with Day 29 M|0
4864540|NCT00866307|16765389|P1|Induction|Identification of Patients with Day 29 M|3
4864541|NCT00866307|16765387|P3|Induction|Progressive Disease|0
4864542|NCT00866307|16765388|P2|Induction|Progressive Disease|0
4864543|NCT00866307|16765389|P1|Induction|Progressive Disease|1
4864544|NCT00866307|16765387|P3|Induction|Physician Decision|0
4864545|NCT00866307|16765388|P2|Induction|Physician Decision|0
4864546|NCT00866307|16765389|P1|Induction|Physician Decision|5
4864547|NCT00866307|16765387|P3|Induction|Death|0
4864548|NCT00866307|16765388|P2|Induction|Death|0
4864549|NCT00866307|16765389|P1|Induction|Death|2
4864550|NCT00866307|16765387|P3|Induction|Adverse Event|0
4864551|NCT00866307|16765388|P2|Induction|Adverse Event|0
4864552|NCT00866307|16765389|P1|Induction|Adverse Event|5
4864553|NCT00866294|16765399|P3|Overall Study|Physician Decision|1
4864554|NCT00866294|16765400|P2|Overall Study|Physician Decision|2
4864555|NCT00866294|16765401|P1|Overall Study|Physician Decision|6
4864556|NCT00866294|16765399|P3|Overall Study|Lost to Follow-up|0
4864557|NCT00866294|16765400|P2|Overall Study|Lost to Follow-up|3
4864558|NCT00866294|16765401|P1|Overall Study|Lost to Follow-up|1
4864559|NCT00866294|16765399|P3|Overall Study|Met Protocol-defined Stopping Criteria|1
4864560|NCT00866294|16765400|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
4864561|NCT00866294|16765401|P1|Overall Study|Met Protocol-defined Stopping Criteria|5
4864562|NCT00866294|16765399|P3|Overall Study|Protocol Violation|0
4864563|NCT00866294|16765400|P2|Overall Study|Protocol Violation|0
4864564|NCT00866294|16765401|P1|Overall Study|Protocol Violation|2
4864565|NCT00866294|16765399|P3|Overall Study|Lack of Efficacy|0
4864566|NCT00866294|16765400|P2|Overall Study|Lack of Efficacy|1
4864567|NCT00866294|16765401|P1|Overall Study|Lack of Efficacy|7
4864568|NCT00866294|16765399|P3|Overall Study|Adverse Event|9
4864569|NCT00866294|16765400|P2|Overall Study|Adverse Event|13
4864570|NCT00866294|16765401|P1|Overall Study|Adverse Event|12
4864571|NCT00866281|16765430|P2|Overall Study|New cancer therapy|4
4864572|NCT00866281|16765431|P1|Overall Study|New cancer therapy|0
4864573|NCT00866281|16765430|P2|Overall Study|Disease progression|11
4864574|NCT00866281|16765431|P1|Overall Study|Disease progression|3
4864575|NCT00866281|16765430|P2|Overall Study|Withdrawal by participants|0
4864576|NCT00866281|16765431|P1|Overall Study|Withdrawal by participants|3
4864577|NCT00866281|16765430|P2|Overall Study|Adverse Event|0
4864578|NCT00866281|16765431|P1|Overall Study|Adverse Event|1
4864579|NCT00866177|16765447|P1|Overall Study|Not Treated|151
4864580|NCT00866177|16765447|P1|Overall Study|Withdrawal by Subject|1
4864581|NCT00866047|16765451|P1|Follow-up Period|Lost to Follow-up|5
4864582|NCT00866047|16765451|P1|Treatment Period|Withdrawal by Subject|5
4864583|NCT00866047|16765451|P1|Treatment Period|Physician Decision|14
4864584|NCT00866047|16765451|P1|Treatment Period|Adverse Event|16
4864585|NCT00866047|16765451|P1|Treatment Period|Progressive disease|13
4864586|NCT00865904|16765483|P5|Overall Study|Randomized but not Treated|1
4864587|NCT00865904|16765484|P4|Overall Study|Randomized but not Treated|1
4864588|NCT00865904|16765485|P3|Overall Study|Randomized but not Treated|0
4864589|NCT00865904|16765486|P2|Overall Study|Randomized but not Treated|0
4864590|NCT00865904|16765487|P1|Overall Study|Randomized but not Treated|2
4864591|NCT00865709|16765544|P2|Treatment|Surgery|3
4864592|NCT00865709|16765545|P1|Treatment|Surgery|8
4864593|NCT00865709|16765544|P2|Treatment|Physician Decision|2
4864594|NCT00865709|16765545|P1|Treatment|Physician Decision|3
4864595|NCT00865709|16765544|P2|Treatment|Withdrawal by Subject|7
4864596|NCT00865709|16765545|P1|Treatment|Withdrawal by Subject|10
4864597|NCT00865709|16765544|P2|Treatment|Adverse Event|6
4864598|NCT00865709|16765545|P1|Treatment|Adverse Event|9
4864599|NCT00865566|16765563|P2|Overall Study|HIV infection|7
4864600|NCT00865566|16765564|P1|Overall Study|HIV infection|5
4864601|NCT00865566|16765563|P2|Overall Study|Other; N=245 due to early study closure|139
4864602|NCT00865566|16765564|P1|Overall Study|Other; N=245 due to early study closure|154
4864603|NCT00865566|16765563|P2|Overall Study|Participant unable to adhere|42
4864604|NCT00865566|16765564|P1|Overall Study|Participant unable to adhere|27
4864605|NCT00865566|16765563|P2|Overall Study|Participant relocated|107
4864606|NCT00865566|16765564|P1|Overall Study|Participant relocated|78
4864607|NCT00865566|16765563|P2|Overall Study|Physician Decision|1
4864608|NCT00865566|16765564|P1|Overall Study|Physician Decision|0
4864609|NCT00865566|16765563|P2|Overall Study|Withdrawal by Subject|65
4864610|NCT00865566|16765564|P1|Overall Study|Withdrawal by Subject|45
4864611|NCT00865566|16765563|P2|Overall Study|Lost to Follow-up|315
4864612|NCT00865566|16765564|P1|Overall Study|Lost to Follow-up|314
4864613|NCT00865566|16765563|P2|Overall Study|Death|11
4864614|NCT00865566|16765564|P1|Overall Study|Death|1
4864615|NCT00865514|16765584|P1|Overall Study|Infusion cost exceeded funding|2
4864616|NCT00865345|16765589|P1|Overall Study|Withdrawal by Subject|2
4864617|NCT00865306|16765596|P2|Controlled Trial|Withdrawal by Subject|1
4864618|NCT00865306|16765597|P1|Controlled Trial|Withdrawal by Subject|0
4864619|NCT00865306|16765596|P2|Controlled Trial|Sought treatment for conduct disorder|0
4864620|NCT00865306|16765597|P1|Controlled Trial|Sought treatment for conduct disorder|1
4864621|NCT00865306|16765596|P2|Controlled Trial|Improved btw baseline and first session|0
4864622|NCT00865306|16765597|P1|Controlled Trial|Improved btw baseline and first session|1
4864623|NCT00865306|16765596|P2|Controlled Trial|Difficulty commuting|0
4864624|NCT00865306|16765597|P1|Controlled Trial|Difficulty commuting|2
4864625|NCT00865306|16765596|P2|Controlled Trial|Lost to Follow-up|1
4864626|NCT00865306|16765597|P1|Controlled Trial|Lost to Follow-up|1
4864627|NCT00865189|16765626|P2|Overall Study|Withdrawal by Subject|0
4864628|NCT00865189|16765627|P1|Overall Study|Withdrawal by Subject|1
4864629|NCT00865189|16765626|P2|Overall Study|Lost to Follow-up|6
4864630|NCT00865189|16765627|P1|Overall Study|Lost to Follow-up|6
4864631|NCT00865189|16765626|P2|Overall Study|Death|11
4864632|NCT00865189|16765627|P1|Overall Study|Death|4
4864633|NCT00865189|16765626|P2|Overall Study|Other|2
4864634|NCT00865189|16765627|P1|Overall Study|Other|1
4864635|NCT00865124|16765655|P3|Overall Study|Withdrawn consent|0
4864636|NCT00865124|16765656|P2|Overall Study|Withdrawn consent|0
4864637|NCT00865124|16765657|P1|Overall Study|Withdrawn consent|2
4864638|NCT00865124|16765655|P3|Overall Study|Physician Decision|0
4864639|NCT00865124|16765656|P2|Overall Study|Physician Decision|1
4864640|NCT00865124|16765657|P1|Overall Study|Physician Decision|2
4864641|NCT00865098|16765674|P1|Overall Study|Progressive disease|1
4864642|NCT00865046|16765686|P3|Overall Study|Withdrawal by Subject|0
4864643|NCT00865046|16765687|P2|Overall Study|Withdrawal by Subject|0
4864644|NCT00865046|16765688|P1|Overall Study|Withdrawal by Subject|5
4864645|NCT00865046|16765686|P3|Overall Study|Death|1
4864646|NCT00865046|16765687|P2|Overall Study|Death|1
4864647|NCT00865046|16765688|P1|Overall Study|Death|0
4864648|NCT00865046|16765686|P3|Overall Study|Lost to Follow-up|0
4864649|NCT00865046|16765687|P2|Overall Study|Lost to Follow-up|4
4864650|NCT00865046|16765688|P1|Overall Study|Lost to Follow-up|1
4864651|NCT00865020|16765698|P2|Overall Study|Randomized but discontinued|4
4864652|NCT00865020|16765699|P1|Overall Study|Randomized but discontinued|2
4864653|NCT00865020|16765698|P2|Overall Study|Death|1
4864654|NCT00865020|16765699|P1|Overall Study|Death|0
4864655|NCT00865020|16765698|P2|Overall Study|Abnormal laboratory value(s)|1
4864656|NCT00865020|16765699|P1|Overall Study|Abnormal laboratory value(s)|0
4864657|NCT00865020|16765698|P2|Overall Study|Administrative problems|2
4864658|NCT00865020|16765699|P1|Overall Study|Administrative problems|0
4864659|NCT00865020|16765698|P2|Overall Study|Protocol deviation|1
4864660|NCT00865020|16765699|P1|Overall Study|Protocol deviation|4
4864661|NCT00865020|16765698|P2|Overall Study|Lost to Follow-up|4
4864662|NCT00865020|16765699|P1|Overall Study|Lost to Follow-up|6
4864663|NCT00865020|16765698|P2|Overall Study|Abnormal test procedure result(s)|8
4864664|NCT00865020|16765699|P1|Overall Study|Abnormal test procedure result(s)|6
4864665|NCT00865020|16765698|P2|Overall Study|Adverse Event|14
4864666|NCT00865020|16765699|P1|Overall Study|Adverse Event|9
4864667|NCT00865020|16765698|P2|Overall Study|Withdrawal by Subject|16
4864668|NCT00865020|16765699|P1|Overall Study|Withdrawal by Subject|22
4864669|NCT00864916|16765715|P2|Overall Study|Withdrawal by Subject|0
4864670|NCT00864916|16765716|P1|Overall Study|Withdrawal by Subject|1
4864671|NCT00864916|16765715|P2|Overall Study|Protocol Violation|0
4864672|NCT00864916|16765716|P1|Overall Study|Protocol Violation|1
4864673|NCT00864916|16765715|P2|Overall Study|Lost to Follow-up|4
4864674|NCT00864916|16765716|P1|Overall Study|Lost to Follow-up|4
4864675|NCT00864851|16765725|P3|Overall Study|Patient uncooperative|0
4864676|NCT00864851|16765726|P2|Overall Study|Patient uncooperative|0
4864677|NCT00864851|16765727|P1|Overall Study|Patient uncooperative|1
4864678|NCT00864851|16765725|P3|Overall Study|Death|0
4864679|NCT00864851|16765726|P2|Overall Study|Death|0
4864680|NCT00864851|16765727|P1|Overall Study|Death|1
4864681|NCT00864851|16765725|P3|Overall Study|Physician Decision|0
4864682|NCT00864851|16765726|P2|Overall Study|Physician Decision|0
4864683|NCT00864851|16765727|P1|Overall Study|Physician Decision|1
4864684|NCT00864851|16765725|P3|Overall Study|Withdrawal by Subject|0
4864685|NCT00864851|16765726|P2|Overall Study|Withdrawal by Subject|1
4864686|NCT00864851|16765727|P1|Overall Study|Withdrawal by Subject|0
4864687|NCT00864721|16765761|P1|Overall Study|Adverse Event|21
4864688|NCT00864721|16765761|P1|Overall Study|Drug hold/delay more than 4 weeks|1
4864689|NCT00864721|16765761|P1|Overall Study|Hospitalized|1
4864690|NCT00864721|16765761|P1|Overall Study|Patient request|11
4864691|NCT00864682|16765781|P3|Overall Study|Protocol Violation|2
4864692|NCT00864682|16765782|P2|Overall Study|Protocol Violation|1
4864693|NCT00864682|16765783|P1|Overall Study|Protocol Violation|2
4864694|NCT00864513|16765822|P1|Overall Study|Withdrawal by Subject|3
4864695|NCT00864253|16765906|P2|Overall Study|Untreated|7
4864696|NCT00864253|16765907|P1|Overall Study|Untreated|7
4864697|NCT00864253|16765906|P2|Overall Study|Ongoing|3
4864698|NCT00864253|16765907|P1|Overall Study|Ongoing|2
4864699|NCT00864253|16765906|P2|Overall Study|Death|0
4864700|NCT00864253|16765907|P1|Overall Study|Death|1
4864701|NCT00864253|16765906|P2|Overall Study|Withdrawal by Subject|18
4864702|NCT00864253|16765907|P1|Overall Study|Withdrawal by Subject|18
4864703|NCT00864253|16765906|P2|Overall Study|Lost to Follow-up|1
4864704|NCT00864253|16765907|P1|Overall Study|Lost to Follow-up|1
4864705|NCT00864253|16765906|P2|Overall Study|Protocol Violation|2
4864706|NCT00864253|16765907|P1|Overall Study|Protocol Violation|0
4864707|NCT00864253|16765906|P2|Overall Study|Physician Decision|15
4864708|NCT00864253|16765907|P1|Overall Study|Physician Decision|11
4864709|NCT00864253|16765906|P2|Overall Study|Unrelated Adverse Event|1
4864710|NCT00864253|16765907|P1|Overall Study|Unrelated Adverse Event|3
4864711|NCT00864253|16765906|P2|Overall Study|Adverse Event|11
4864712|NCT00864253|16765907|P1|Overall Study|Adverse Event|56
4864713|NCT00864227|16765937|P1|Overall Study|Disease Relapse/Progression|3
4864714|NCT00864227|16765937|P1|Overall Study|Withdrawal by Subject|1
4864715|NCT00863928|16765998|P2|Overall Study|medication allergy|0
4864716|NCT00863928|16765999|P1|Overall Study|medication allergy|3
4864717|NCT00863928|16765998|P2|Overall Study|surgery cancellation|0
4864718|NCT00863928|16765999|P1|Overall Study|surgery cancellation|4
4864719|NCT00863928|16765998|P2|Overall Study|Withdrawal by Subject|0
4864720|NCT00863928|16765999|P1|Overall Study|Withdrawal by Subject|3
4864721|NCT00863928|16765998|P2|Overall Study|Protocol Violation|0
4864722|NCT00863928|16765999|P1|Overall Study|Protocol Violation|26
4864723|NCT00863798|16766008|P3|Overall Study|Randomized not treated|3
4864724|NCT00863798|16766009|P2|Overall Study|Randomized not treated|2
4864725|NCT00863798|16766010|P1|Overall Study|Randomized not treated|4
4864726|NCT00863798|16766008|P3|Overall Study|Withdrawal by Subject|4
4864727|NCT00863798|16766009|P2|Overall Study|Withdrawal by Subject|7
4864728|NCT00863798|16766010|P1|Overall Study|Withdrawal by Subject|8
4864729|NCT00863798|16766008|P3|Overall Study|Protocol Violation|1
4864730|NCT00863798|16766009|P2|Overall Study|Protocol Violation|1
4864731|NCT00863798|16766010|P1|Overall Study|Protocol Violation|0
4864732|NCT00863798|16766008|P3|Overall Study|Other|1
4864733|NCT00863798|16766009|P2|Overall Study|Other|3
4864734|NCT00863798|16766010|P1|Overall Study|Other|2
4864735|NCT00863798|16766008|P3|Overall Study|Lost to Follow-up|5
4864736|NCT00863798|16766009|P2|Overall Study|Lost to Follow-up|9
4864737|NCT00863798|16766010|P1|Overall Study|Lost to Follow-up|6
4864738|NCT00863798|16766008|P3|Overall Study|Lack of Efficacy|6
4864739|NCT00863798|16766009|P2|Overall Study|Lack of Efficacy|3
4864740|NCT00863798|16766010|P1|Overall Study|Lack of Efficacy|4
4864741|NCT00863798|16766008|P3|Overall Study|Investigator request|1
4864742|NCT00863798|16766009|P2|Overall Study|Investigator request|2
4864743|NCT00863798|16766010|P1|Overall Study|Investigator request|1
4864744|NCT00863798|16766008|P3|Overall Study|Participant failed to return|0
4864745|NCT00863798|16766009|P2|Overall Study|Participant failed to return|1
4864746|NCT00863798|16766010|P1|Overall Study|Participant failed to return|2
4864747|NCT00863798|16766008|P3|Overall Study|Adverse Event|4
4864748|NCT00863798|16766009|P2|Overall Study|Adverse Event|2
4864749|NCT00863798|16766010|P1|Overall Study|Adverse Event|5
4864750|NCT00863746|16766062|P2|Survival Follow up|Consent Withdrawn|8
4864751|NCT00863746|16766063|P1|Survival Follow up|Consent Withdrawn|7
4864752|NCT00863746|16766062|P2|Survival Follow up|Lost to Follow-up|1
4864753|NCT00863746|16766063|P1|Survival Follow up|Lost to Follow-up|2
4864754|NCT00863746|16766062|P2|Survival Follow up|Death|271
4864755|NCT00863746|16766063|P1|Survival Follow up|Death|244
4864756|NCT00863746|16766062|P2|Treatment|Other|0
4864757|NCT00863746|16766063|P1|Treatment|Other|1
4864758|NCT00863746|16766062|P2|Treatment|Protocol Violation|3
4864759|NCT00863746|16766063|P1|Treatment|Protocol Violation|5
4864760|NCT00863746|16766062|P2|Treatment|Lost to Follow-up|0
4864761|NCT00863746|16766063|P1|Treatment|Lost to Follow-up|1
4864762|NCT00863746|16766062|P2|Treatment|Consent withdrawn|14
4864763|NCT00863746|16766063|P1|Treatment|Consent withdrawn|15
4864764|NCT00863746|16766062|P2|Treatment|non-compliant with study medication|0
4864765|NCT00863746|16766063|P1|Treatment|non-compliant with study medication|4
4864766|NCT00863746|16766062|P2|Treatment|Adverse Event|16
4864767|NCT00863746|16766063|P1|Treatment|Adverse Event|41
4864768|NCT00863746|16766062|P2|Treatment|Not treated|2
4864769|NCT00863746|16766063|P1|Treatment|Not treated|4
4864770|NCT00863707|16766089|P2|Overall Study|Randomized, but drug not received|3
4864771|NCT00863707|16766090|P1|Overall Study|Randomized, but drug not received|4
4864772|NCT00863681|16766099|P3|Overall Study|Non-compliance with study drug|0
4864773|NCT00863681|16766100|P2|Overall Study|Non-compliance with study drug|3
4864774|NCT00863681|16766101|P1|Overall Study|Non-compliance with study drug|1
4864775|NCT00863681|16766099|P3|Overall Study|Lack of Efficacy|1
4864776|NCT00863681|16766100|P2|Overall Study|Lack of Efficacy|2
4864777|NCT00863681|16766101|P1|Overall Study|Lack of Efficacy|2
4864778|NCT00863681|16766099|P3|Overall Study|Adverse Event|6
4864779|NCT00863681|16766100|P2|Overall Study|Adverse Event|10
4864780|NCT00863681|16766101|P1|Overall Study|Adverse Event|28
4864781|NCT00863681|16766099|P3|Overall Study|Lost to Follow-up|3
4864782|NCT00863681|16766100|P2|Overall Study|Lost to Follow-up|0
4864783|NCT00863681|16766101|P1|Overall Study|Lost to Follow-up|3
4864784|NCT00863681|16766099|P3|Overall Study|Protocol Violation|0
4864785|NCT00863681|16766100|P2|Overall Study|Protocol Violation|0
4864786|NCT00863681|16766101|P1|Overall Study|Protocol Violation|2
4864787|NCT00863681|16766099|P3|Overall Study|Withdrawal by Subject|2
4864788|NCT00863681|16766100|P2|Overall Study|Withdrawal by Subject|5
4864789|NCT00863681|16766101|P1|Overall Study|Withdrawal by Subject|12
4864790|NCT00863681|16766099|P3|Overall Study|Death|6
4864791|NCT00863681|16766100|P2|Overall Study|Death|23
4864792|NCT00863681|16766101|P1|Overall Study|Death|40
4864793|NCT00863681|16766099|P3|Overall Study|Missing|0
4864794|NCT00863681|16766100|P2|Overall Study|Missing|0
4864795|NCT00863681|16766101|P1|Overall Study|Missing|1
4864796|NCT00863681|16766099|P3|Overall Study|Other|0
4864797|NCT00863681|16766100|P2|Overall Study|Other|0
4864798|NCT00863681|16766101|P1|Overall Study|Other|2
4864799|NCT00863655|16766186|P2|Overall Study|Treatment completed as per protocol|1
4864800|NCT00863655|16766187|P1|Overall Study|Treatment completed as per protocol|5
4864801|NCT00863655|16766186|P2|Overall Study|Disease progression|221
4864802|NCT00863655|16766187|P1|Overall Study|Disease progression|364
4864803|NCT00863655|16766186|P2|Overall Study|New cancer therapy|1
4864804|NCT00863655|16766187|P1|Overall Study|New cancer therapy|5
4864805|NCT00863655|16766186|P2|Overall Study|Death|1
4864806|NCT00863655|16766187|P1|Overall Study|Death|7
4864807|NCT00863655|16766186|P2|Overall Study|Administrative problems|0
4864808|NCT00863655|16766187|P1|Overall Study|Administrative problems|1
4864809|NCT00863655|16766186|P2|Overall Study|Withdrawal by Subject|7
4864810|NCT00863655|16766187|P1|Overall Study|Withdrawal by Subject|47
4864811|NCT00863655|16766186|P2|Overall Study|Adverse Event|8
4864812|NCT00863655|16766187|P1|Overall Study|Adverse Event|52
4864813|NCT00863655|16766186|P2|Overall Study|Protocol Violation|0
4864814|NCT00863655|16766187|P1|Overall Study|Protocol Violation|4
4864815|NCT00863512|16766224|P2|Overall Study|Physician Decision|0
4864816|NCT00863512|16766225|P1|Overall Study|Physician Decision|1
4864817|NCT00863512|16766224|P2|Overall Study|Withdrawal by Subject|0
4864818|NCT00863512|16766225|P1|Overall Study|Withdrawal by Subject|11
4864819|NCT00863512|16766224|P2|Overall Study|Adverse Event|0
4864820|NCT00863512|16766225|P1|Overall Study|Adverse Event|2
4864821|NCT00863330|16766256|P1|Overall Study|study terminated early due to administra|6
4864822|NCT00863317|16766262|P2|Overall Study|Lost to Follow-up|9
4864823|NCT00863317|16766263|P1|Overall Study|Lost to Follow-up|8
4864824|NCT00863057|16766319|P4|Period 2 (Weeks 6-10)|Physician Decision|1
4864825|NCT00863057|16766320|P3|Period 2 (Weeks 6-10)|Physician Decision|0
4864826|NCT00863057|16766321|P2|Period 2 (Weeks 6-10)|Physician Decision|0
4864827|NCT00863057|16766322|P1|Period 2 (Weeks 6-10)|Physician Decision|0
4864828|NCT00863057|16766319|P4|Period 2 (Weeks 6-10)|Adverse Event|0
4864829|NCT00863057|16766320|P3|Period 2 (Weeks 6-10)|Adverse Event|1
4864830|NCT00863057|16766321|P2|Period 2 (Weeks 6-10)|Adverse Event|1
4864831|NCT00863057|16766322|P1|Period 2 (Weeks 6-10)|Adverse Event|0
4864832|NCT00863057|16766319|P4|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
4864833|NCT00863057|16766320|P3|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
4864834|NCT00863057|16766321|P2|Milestones Period 1 (Weeks 0-5)|Physician Decision|1
4864835|NCT00863057|16766322|P1|Milestones Period 1 (Weeks 0-5)|Physician Decision|0
4864836|NCT00863057|16766319|P4|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
4864837|NCT00863057|16766320|P3|Milestones Period 1 (Weeks 0-5)|Adverse Event|0
4864838|NCT00863057|16766321|P2|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
4864839|NCT00863057|16766322|P1|Milestones Period 1 (Weeks 0-5)|Adverse Event|1
4864840|NCT00862979|16766380|P2|Overall Study|Death|1
4864841|NCT00862979|16766381|P1|Overall Study|Death|0
4864842|NCT00862979|16766380|P2|Overall Study|Administrative problems|1
4864843|NCT00862979|16766381|P1|Overall Study|Administrative problems|0
4864844|NCT00862979|16766380|P2|Overall Study|Patient withdrew consent|1
4864845|NCT00862979|16766381|P1|Overall Study|Patient withdrew consent|2
4864846|NCT00862979|16766380|P2|Overall Study|Protocol Violation|1
4864847|NCT00862979|16766381|P1|Overall Study|Protocol Violation|0
4864848|NCT00862979|16766380|P2|Overall Study|Adverse Event|3
4864849|NCT00862979|16766381|P1|Overall Study|Adverse Event|6
4864850|NCT00862940|16766399|P2|Overall Study|Administrative or other reason(s)|3
4864851|NCT00862940|16766400|P1|Overall Study|Administrative or other reason(s)|4
4864852|NCT00862940|16766399|P2|Overall Study|Lost to Follow-up|1
4864853|NCT00862940|16766400|P1|Overall Study|Lost to Follow-up|0
4864854|NCT00862940|16766399|P2|Overall Study|Non-compliance|0
4864855|NCT00862940|16766400|P1|Overall Study|Non-compliance|4
4864856|NCT00862940|16766399|P2|Overall Study|Withdrawal by Subject|6
4864857|NCT00862940|16766400|P1|Overall Study|Withdrawal by Subject|4
4864858|NCT00862940|16766399|P2|Overall Study|Protocol Violation|5
4864859|NCT00862940|16766400|P1|Overall Study|Protocol Violation|2
4864860|NCT00862940|16766399|P2|Overall Study|Lack of Efficacy|3
4864861|NCT00862940|16766400|P1|Overall Study|Lack of Efficacy|1
4864862|NCT00862940|16766399|P2|Overall Study|Adverse Event|12
4864863|NCT00862940|16766400|P1|Overall Study|Adverse Event|15
4864864|NCT00862849|16766412|P6|Washout 2 (3 to 14 Days)|Protocol Violation|0
4864865|NCT00862849|16766413|P5|Washout 2 (3 to 14 Days)|Protocol Violation|0
4864866|NCT00862849|16766414|P4|Washout 2 (3 to 14 Days)|Protocol Violation|0
4864867|NCT00862849|16766415|P3|Washout 2 (3 to 14 Days)|Protocol Violation|0
4864868|NCT00862849|16766416|P2|Washout 2 (3 to 14 Days)|Protocol Violation|1
4864869|NCT00862849|16766417|P1|Washout 2 (3 to 14 Days)|Protocol Violation|0
4864870|NCT00862849|16766412|P6|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4864871|NCT00862849|16766413|P5|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4864872|NCT00862849|16766414|P4|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4864873|NCT00862849|16766415|P3|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4864874|NCT00862849|16766416|P2|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1
4864875|NCT00862849|16766417|P1|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0
4864876|NCT00862836|16766440|P1|Overall Study|Withdrawal by Subject|1
4864877|NCT00862823|16766451|P2|First Intervention|Withdrawal by Subject|1
4864878|NCT00862823|16766452|P1|First Intervention|Withdrawal by Subject|1
4864879|NCT00862719|16766501|P4|Overall Study|Veno-Occlusive Disease|0
4864880|NCT00862719|16766502|P3|Overall Study|Veno-Occlusive Disease|1
4864881|NCT00862719|16766503|P2|Overall Study|Veno-Occlusive Disease|0
4864882|NCT00862719|16766504|P1|Overall Study|Veno-Occlusive Disease|0
4864883|NCT00862719|16766501|P4|Overall Study|Engraftment failure|0
4864884|NCT00862719|16766502|P3|Overall Study|Engraftment failure|1
4864885|NCT00862719|16766503|P2|Overall Study|Engraftment failure|0
4864886|NCT00862719|16766504|P1|Overall Study|Engraftment failure|0
4864887|NCT00862719|16766501|P4|Overall Study|Death|1
4864888|NCT00862719|16766502|P3|Overall Study|Death|1
4864889|NCT00862719|16766503|P2|Overall Study|Death|6
4864890|NCT00862719|16766504|P1|Overall Study|Death|5
4864891|NCT00862719|16766501|P4|Overall Study|Disease Progression|0
4864892|NCT00862719|16766502|P3|Overall Study|Disease Progression|1
4864893|NCT00862719|16766503|P2|Overall Study|Disease Progression|0
4864894|NCT00862719|16766504|P1|Overall Study|Disease Progression|5
4864895|NCT00862654|16766527|P4|Overall Study|Included after end of inclusions|0
4864896|NCT00862654|16766528|P3|Overall Study|Included after end of inclusions|1
4864897|NCT00862654|16766529|P2|Overall Study|Included after end of inclusions|0
4864898|NCT00862654|16766530|P1|Overall Study|Included after end of inclusions|0
4864899|NCT00862654|16766527|P4|Overall Study|Never used study drugs|0
4864900|NCT00862654|16766528|P3|Overall Study|Never used study drugs|0
4864901|NCT00862654|16766529|P2|Overall Study|Never used study drugs|0
4864902|NCT00862654|16766530|P1|Overall Study|Never used study drugs|1
4864903|NCT00862654|16766527|P4|Overall Study|Familly constraint|0
4864904|NCT00862654|16766528|P3|Overall Study|Familly constraint|0
4864905|NCT00862654|16766529|P2|Overall Study|Familly constraint|1
4864906|NCT00862654|16766530|P1|Overall Study|Familly constraint|0
4864907|NCT00862654|16766527|P4|Overall Study|Subject mistake|0
4864908|NCT00862654|16766528|P3|Overall Study|Subject mistake|0
4864909|NCT00862654|16766529|P2|Overall Study|Subject mistake|1
4864910|NCT00862654|16766530|P1|Overall Study|Subject mistake|0
4864911|NCT00862654|16766527|P4|Overall Study|Withdrawal by Subject|3
4864912|NCT00862654|16766528|P3|Overall Study|Withdrawal by Subject|2
4864913|NCT00862654|16766529|P2|Overall Study|Withdrawal by Subject|2
4864914|NCT00862654|16766530|P1|Overall Study|Withdrawal by Subject|2
4864915|NCT00862654|16766527|P4|Overall Study|Pregnancy|0
4864916|NCT00862654|16766528|P3|Overall Study|Pregnancy|0
4864917|NCT00862654|16766529|P2|Overall Study|Pregnancy|1
4864918|NCT00862654|16766530|P1|Overall Study|Pregnancy|1
4864919|NCT00862654|16766527|P4|Overall Study|Adverse Event|0
4864920|NCT00862654|16766528|P3|Overall Study|Adverse Event|1
4864921|NCT00862654|16766529|P2|Overall Study|Adverse Event|1
4864922|NCT00862654|16766530|P1|Overall Study|Adverse Event|0
4864923|NCT00862654|16766527|P4|Overall Study|Lost to Follow-up|3
4864924|NCT00862654|16766528|P3|Overall Study|Lost to Follow-up|1
4864925|NCT00862654|16766529|P2|Overall Study|Lost to Follow-up|2
4864926|NCT00862654|16766530|P1|Overall Study|Lost to Follow-up|1
4864927|NCT00862654|16766527|P4|Overall Study|Lack of Efficacy|0
4864928|NCT00862654|16766528|P3|Overall Study|Lack of Efficacy|1
4864929|NCT00862654|16766529|P2|Overall Study|Lack of Efficacy|0
4864930|NCT00862654|16766530|P1|Overall Study|Lack of Efficacy|1
4864931|NCT00862641|16766544|P4|Overall Study|Randomized, but drug not received|4
4864932|NCT00862641|16766545|P3|Overall Study|Randomized, but drug not received|1
4864933|NCT00862641|16766546|P2|Overall Study|Randomized, but drug not received|4
4864934|NCT00862641|16766547|P1|Overall Study|Randomized, but drug not received|1
4864935|NCT00862459|16766641|P3|Overall Study|Administrative problems|0
4864936|NCT00862459|16766642|P2|Overall Study|Administrative problems|1
4864937|NCT00862459|16766643|P1|Overall Study|Administrative problems|0
4864938|NCT00862459|16766641|P3|Overall Study|Inclusion/exclusion criteria not met|0
4864939|NCT00862459|16766642|P2|Overall Study|Inclusion/exclusion criteria not met|1
4864940|NCT00862459|16766643|P1|Overall Study|Inclusion/exclusion criteria not met|0
4864941|NCT00862459|16766641|P3|Overall Study|Unable to hold still for imaging|0
4864942|NCT00862459|16766642|P2|Overall Study|Unable to hold still for imaging|1
4864943|NCT00862459|16766643|P1|Overall Study|Unable to hold still for imaging|0
4864944|NCT00862459|16766641|P3|Overall Study|Intravenous (IV) site problems|1
4864945|NCT00862459|16766642|P2|Overall Study|Intravenous (IV) site problems|0
4864946|NCT00862459|16766643|P1|Overall Study|Intravenous (IV) site problems|1
4864947|NCT00862459|16766641|P3|Overall Study|Operation|0
4864948|NCT00862459|16766642|P2|Overall Study|Operation|1
4864949|NCT00862459|16766643|P1|Overall Study|Operation|1
4864950|NCT00862459|16766641|P3|Overall Study|Personal reasons|0
4864951|NCT00862459|16766642|P2|Overall Study|Personal reasons|0
4864952|NCT00862459|16766643|P1|Overall Study|Personal reasons|1
4864953|NCT00862459|16766641|P3|Overall Study|Adverse Event|0
4864954|NCT00862459|16766642|P2|Overall Study|Adverse Event|1
4864955|NCT00862459|16766643|P1|Overall Study|Adverse Event|0
4864956|NCT00862459|16766641|P3|Overall Study|Withdrawal by Subject|3
4864957|NCT00862459|16766642|P2|Overall Study|Withdrawal by Subject|1
4864958|NCT00862459|16766643|P1|Overall Study|Withdrawal by Subject|1
4864959|NCT00862459|16766641|P3|Overall Study|Protocol Violation|0
4864960|NCT00862459|16766642|P2|Overall Study|Protocol Violation|0
4864961|NCT00862459|16766643|P1|Overall Study|Protocol Violation|1
4864962|NCT00862459|16766641|P3|Overall Study|Lost to Follow-up|2
4864963|NCT00862459|16766642|P2|Overall Study|Lost to Follow-up|2
4864964|NCT00862459|16766643|P1|Overall Study|Lost to Follow-up|1
4864965|NCT00862277|16766790|P3|Overall Study|Protocol Violation|5
4864966|NCT00862277|16766791|P2|Overall Study|Protocol Violation|2
4864967|NCT00862277|16766792|P1|Overall Study|Protocol Violation|1
4864968|NCT00862251|16766806|P3|Overall Study|Withdrawal by Subject|6
4864969|NCT00862251|16766807|P2|Overall Study|Withdrawal by Subject|2
4864970|NCT00862251|16766808|P1|Overall Study|Withdrawal by Subject|9
4864971|NCT00862251|16766806|P3|Overall Study|Protocol Violation|1
4864972|NCT00862251|16766807|P2|Overall Study|Protocol Violation|0
4864973|NCT00862251|16766808|P1|Overall Study|Protocol Violation|2
4864974|NCT00862251|16766806|P3|Overall Study|Lost to Follow-up|1
4864975|NCT00862251|16766807|P2|Overall Study|Lost to Follow-up|0
4864976|NCT00862251|16766808|P1|Overall Study|Lost to Follow-up|0
4864977|NCT00862251|16766806|P3|Overall Study|Adverse Event|1
4864978|NCT00862251|16766807|P2|Overall Study|Adverse Event|3
4864979|NCT00862251|16766808|P1|Overall Study|Adverse Event|8
4864980|NCT00862134|16766868|P2|Overall Study|Withdrew prior to dosing|0
4864981|NCT00862134|16766869|P1|Overall Study|Withdrew prior to dosing|2
4864982|NCT00862134|16766868|P2|Overall Study|Adverse Event|2
4864983|NCT00862134|16766869|P1|Overall Study|Adverse Event|2
4864984|NCT00862134|16766868|P2|Overall Study|Sponsor terminated study|7
4864985|NCT00862134|16766869|P1|Overall Study|Sponsor terminated study|5
4864986|NCT00862134|16766868|P2|Overall Study|Withdrawal by Subject|2
4864987|NCT00862134|16766869|P1|Overall Study|Withdrawal by Subject|1
4864988|NCT00862134|16766868|P2|Overall Study|Physician Decision|1
4864989|NCT00862134|16766869|P1|Overall Study|Physician Decision|0
4864990|NCT00862134|16766868|P2|Overall Study|Death|0
4864991|NCT00862134|16766869|P1|Overall Study|Death|1
4864992|NCT00862121|16766881|P2|Overall Study|Incorrect randomisation|1
4864993|NCT00862121|16766882|P1|Overall Study|Incorrect randomisation|0
4864994|NCT00862121|16766881|P2|Overall Study|Exclusion criterion violation|1
4864995|NCT00862121|16766882|P1|Overall Study|Exclusion criterion violation|0
4864996|NCT00862121|16766881|P2|Overall Study|Protocol Violation|1
4864997|NCT00862121|16766882|P1|Overall Study|Protocol Violation|0
4864998|NCT00862121|16766881|P2|Overall Study|Lack of Efficacy|3
4864999|NCT00862121|16766882|P1|Overall Study|Lack of Efficacy|0
4865000|NCT00862121|16766881|P2|Overall Study|Adverse Event|2
4865001|NCT00862121|16766882|P1|Overall Study|Adverse Event|1
4865002|NCT00862082|16766900|P2|Overall Study|Withdrawal by Subject|1
4865003|NCT00862082|16766901|P1|Overall Study|Withdrawal by Subject|0
4865004|NCT00862082|16766900|P2|Overall Study|Sponsor decision to terminate the study|0
4865005|NCT00862082|16766901|P1|Overall Study|Sponsor decision to terminate the study|5
4865006|NCT00861757|16766956|P4|Overall Study|Withdrawal by Subject|2
4865007|NCT00861757|16766957|P3|Overall Study|Withdrawal by Subject|5
4865008|NCT00861757|16766958|P2|Overall Study|Withdrawal by Subject|5
4865009|NCT00861757|16766959|P1|Overall Study|Withdrawal by Subject|1
4865010|NCT00861757|16766956|P4|Overall Study|Protocol Violation|1
4865011|NCT00861757|16766957|P3|Overall Study|Protocol Violation|4
4865012|NCT00861757|16766958|P2|Overall Study|Protocol Violation|2
4865013|NCT00861757|16766959|P1|Overall Study|Protocol Violation|2
4865014|NCT00861757|16766956|P4|Overall Study|Physician Decision|1
4865015|NCT00861757|16766957|P3|Overall Study|Physician Decision|0
4865016|NCT00861757|16766958|P2|Overall Study|Physician Decision|0
4865017|NCT00861757|16766959|P1|Overall Study|Physician Decision|0
4865018|NCT00861757|16766956|P4|Overall Study|Lost to Follow-up|1
4865019|NCT00861757|16766957|P3|Overall Study|Lost to Follow-up|1
4865020|NCT00861757|16766958|P2|Overall Study|Lost to Follow-up|0
4865021|NCT00861757|16766959|P1|Overall Study|Lost to Follow-up|1
4865022|NCT00861757|16766956|P4|Overall Study|Lack of Efficacy|1
4865023|NCT00861757|16766957|P3|Overall Study|Lack of Efficacy|0
4865024|NCT00861757|16766958|P2|Overall Study|Lack of Efficacy|1
4865025|NCT00861757|16766959|P1|Overall Study|Lack of Efficacy|3
4865026|NCT00861757|16766956|P4|Overall Study|Entry Criteria Not Met|1
4865027|NCT00861757|16766957|P3|Overall Study|Entry Criteria Not Met|1
4865028|NCT00861757|16766958|P2|Overall Study|Entry Criteria Not Met|2
4865029|NCT00861757|16766959|P1|Overall Study|Entry Criteria Not Met|1
4865030|NCT00861757|16766956|P4|Overall Study|Adverse Event|2
4865031|NCT00861757|16766957|P3|Overall Study|Adverse Event|7
4865032|NCT00861757|16766958|P2|Overall Study|Adverse Event|5
4865033|NCT00861757|16766959|P1|Overall Study|Adverse Event|1
4865034|NCT00861744|16767017|P4|Overall Study|Blood draws|1
4865035|NCT00861744|16767018|P3|Overall Study|Blood draws|0
4865036|NCT00861744|16767019|P2|Overall Study|Blood draws|0
4865037|NCT00861744|16767020|P1|Overall Study|Blood draws|0
4865038|NCT00861744|16767017|P4|Overall Study|Migration from study area|0
4865039|NCT00861744|16767018|P3|Overall Study|Migration from study area|1
4865040|NCT00861744|16767019|P2|Overall Study|Migration from study area|3
4865041|NCT00861744|16767020|P1|Overall Study|Migration from study area|0
4865042|NCT00861744|16767017|P4|Overall Study|Protocol Violation|0
4865043|NCT00861744|16767018|P3|Overall Study|Protocol Violation|0
4865044|NCT00861744|16767019|P2|Overall Study|Protocol Violation|1
4865045|NCT00861744|16767020|P1|Overall Study|Protocol Violation|0
4865046|NCT00861744|16767017|P4|Overall Study|Withdrawal by Subject|19
4865047|NCT00861744|16767018|P3|Overall Study|Withdrawal by Subject|6
4865048|NCT00861744|16767019|P2|Overall Study|Withdrawal by Subject|6
4865049|NCT00861744|16767020|P1|Overall Study|Withdrawal by Subject|10
4865050|NCT00861744|16767017|P4|Overall Study|Lost to Follow-up|12
4865051|NCT00861744|16767018|P3|Overall Study|Lost to Follow-up|17
4865052|NCT00861744|16767019|P2|Overall Study|Lost to Follow-up|19
4865053|NCT00861744|16767020|P1|Overall Study|Lost to Follow-up|7
4865054|NCT00861744|16767017|P4|Overall Study|Adverse Event|1
4865055|NCT00861744|16767018|P3|Overall Study|Adverse Event|0
4865056|NCT00861744|16767019|P2|Overall Study|Adverse Event|0
4865057|NCT00861744|16767020|P1|Overall Study|Adverse Event|0
4865058|NCT00861705|16767202|P4|Overall Study|Never Began Treatment|1
4865059|NCT00861705|16767203|P3|Overall Study|Never Began Treatment|0
4865060|NCT00861705|16767204|P2|Overall Study|Never Began Treatment|3
4865061|NCT00861705|16767205|P1|Overall Study|Never Began Treatment|7
4865062|NCT00861692|16767245|P1|Overall Study|Death|6
4865063|NCT00861614|16767257|P2|Overall Study|Other|22
4865064|NCT00861614|16767258|P1|Overall Study|Other|17
4865065|NCT00861614|16767257|P2|Overall Study|Withdrawal by Subject|35
4865066|NCT00861614|16767258|P1|Overall Study|Withdrawal by Subject|34
4865067|NCT00861614|16767257|P2|Overall Study|Adverse Event|23
4865068|NCT00861614|16767258|P1|Overall Study|Adverse Event|27
4865069|NCT00861614|16767257|P2|Overall Study|Death|19
4865070|NCT00861614|16767258|P1|Overall Study|Death|32
4865071|NCT00861614|16767257|P2|Overall Study|Study Drug Toxicity|6
4865072|NCT00861614|16767258|P1|Overall Study|Study Drug Toxicity|79
4865073|NCT00861614|16767257|P2|Overall Study|Disease Progression|263
4865074|NCT00861614|16767258|P1|Overall Study|Disease Progression|182
4865075|NCT00861471|16767343|P1|Overall Study|Physician Decision|2
4865076|NCT00861471|16767343|P1|Overall Study|treatment for lumbar laminectomy|1
4865077|NCT00861471|16767343|P1|Overall Study|Lack of Efficacy|3
4865078|NCT00861471|16767343|P1|Overall Study|Adverse Event|2
4865079|NCT00861471|16767343|P1|Overall Study|Withdrawal by Subject|1
4865080|NCT00861380|16767358|P7|Overall Study|Withdrawal Information not recorded|3020
4865081|NCT00861380|16767359|P6|Overall Study|Withdrawal Information not recorded|6249
4865082|NCT00861380|16767360|P5|Overall Study|Withdrawal Information not recorded|1812
4865083|NCT00861380|16767361|P4|Overall Study|Withdrawal Information not recorded|3689
4865084|NCT00861380|16767362|P3|Overall Study|Withdrawal Information not recorded|8872
4865085|NCT00861380|16767363|P2|Overall Study|Withdrawal Information not recorded|9112
4865086|NCT00861380|16767364|P1|Overall Study|Withdrawal Information not recorded|8427
4865087|NCT00861341|16767448|P1|Overall Study|Withdrawal by Subject|2
4865088|NCT00861198|16767457|P1|Overall Study|SpyGlass Failed|5
4865089|NCT00860951|16767474|P1|Overall Study|Lost to Follow-up|5
4865090|NCT00860951|16767474|P1|Overall Study|Withdrawal by Subject|2
4865091|NCT00860743|16767531|P2|Overall Study|Withdrawal by Subject|0
4865092|NCT00860743|16767532|P1|Overall Study|Withdrawal by Subject|3
4865093|NCT00860470|16767545|P2|Overall Study|Lost to Follow-up|39
4865094|NCT00860470|16767546|P1|Overall Study|Lost to Follow-up|34
4865095|NCT00860470|16767545|P2|Overall Study|Moved away|10
4865096|NCT00860470|16767546|P1|Overall Study|Moved away|8
4865097|NCT00860470|16767545|P2|Overall Study|Death|10
4865098|NCT00860470|16767546|P1|Overall Study|Death|6
4865099|NCT00860405|16767576|P2|Overall Study|Main reason: Follow-up data not complete|4
4865100|NCT00860405|16767577|P1|Overall Study|Main reason: Follow-up data not complete|5
4865101|NCT00860262|16767617|P3|Overall Study|Other|1
4865102|NCT00860262|16767618|P2|Overall Study|Other|3
4865103|NCT00860262|16767619|P1|Overall Study|Other|5
4865104|NCT00860262|16767617|P3|Overall Study|Lack of Efficacy|3
4865105|NCT00860262|16767618|P2|Overall Study|Lack of Efficacy|4
4865106|NCT00860262|16767619|P1|Overall Study|Lack of Efficacy|0
4865107|NCT00860262|16767617|P3|Overall Study|Withdrawal by Subject|6
4865108|NCT00860262|16767618|P2|Overall Study|Withdrawal by Subject|8
4865109|NCT00860262|16767619|P1|Overall Study|Withdrawal by Subject|4
4865110|NCT00860262|16767617|P3|Overall Study|Lost to Follow-up|1
4865111|NCT00860262|16767618|P2|Overall Study|Lost to Follow-up|0
4865112|NCT00860262|16767619|P1|Overall Study|Lost to Follow-up|2
4865113|NCT00860262|16767617|P3|Overall Study|Protocol Violation|0
4865114|NCT00860262|16767618|P2|Overall Study|Protocol Violation|1
4865115|NCT00860262|16767619|P1|Overall Study|Protocol Violation|0
4865116|NCT00860262|16767617|P3|Overall Study|Adverse Event|7
4865117|NCT00860262|16767618|P2|Overall Study|Adverse Event|6
4865118|NCT00860262|16767619|P1|Overall Study|Adverse Event|9
4865119|NCT00860249|16767732|P3|Overall Study|trial was terminated prior to completion|21
4865120|NCT00860249|16767733|P2|Overall Study|trial was terminated prior to completion|18
4865121|NCT00860249|16767734|P1|Overall Study|trial was terminated prior to completion|21
4865122|NCT00860158|16767754|P1|Overall Study|Study Terminated|1
4865123|NCT00860067|16767766|P3|Overall Study|Pregnancy|0
4865124|NCT00860067|16767767|P2|Overall Study|Pregnancy|0
4865125|NCT00860067|16767768|P1|Overall Study|Pregnancy|1
4865126|NCT00860067|16767766|P3|Overall Study|Withdrawal by Subject|0
4865127|NCT00860067|16767767|P2|Overall Study|Withdrawal by Subject|0
4865128|NCT00860067|16767768|P1|Overall Study|Withdrawal by Subject|4
4865129|NCT00860067|16767766|P3|Overall Study|Lost to Follow-up|9
4865130|NCT00860067|16767767|P2|Overall Study|Lost to Follow-up|9
4865131|NCT00860067|16767768|P1|Overall Study|Lost to Follow-up|46
4865132|NCT00860028|16767828|P2|Placebo Controlled Pretreatment Period|No longer interested in treatment|1
4865133|NCT00860028|16767829|P1|Placebo Controlled Pretreatment Period|No longer interested in treatment|2
4865134|NCT00859937|16767871|P2|Overall Study|Protocol Violation|0
4865135|NCT00859937|16767872|P1|Overall Study|Protocol Violation|1
4865136|NCT00859898|16767887|P3|Overall Study|non-specified|1
4865137|NCT00859898|16767888|P2|Overall Study|non-specified|1
4865138|NCT00859898|16767889|P1|Overall Study|non-specified|1
4865139|NCT00859898|16767887|P3|Overall Study|No longer meets criteria|0
4865140|NCT00859898|16767888|P2|Overall Study|No longer meets criteria|1
4865141|NCT00859898|16767889|P1|Overall Study|No longer meets criteria|0
4865142|NCT00859898|16767887|P3|Overall Study|poor/non-compliance|0
4865143|NCT00859898|16767888|P2|Overall Study|poor/non-compliance|0
4865144|NCT00859898|16767889|P1|Overall Study|poor/non-compliance|2
4865145|NCT00859898|16767887|P3|Overall Study|Lost to Follow-up|5
4865146|NCT00859898|16767888|P2|Overall Study|Lost to Follow-up|11
4865147|NCT00859898|16767889|P1|Overall Study|Lost to Follow-up|10
4865148|NCT00859898|16767887|P3|Overall Study|Death|1
4865149|NCT00859898|16767888|P2|Overall Study|Death|0
4865150|NCT00859898|16767889|P1|Overall Study|Death|0
4865151|NCT00859898|16767887|P3|Overall Study|Withdrawal by Subject|11
4865152|NCT00859898|16767888|P2|Overall Study|Withdrawal by Subject|8
4865153|NCT00859898|16767889|P1|Overall Study|Withdrawal by Subject|11
4865154|NCT00859898|16767887|P3|Overall Study|Adverse Event|8
4865155|NCT00859898|16767888|P2|Overall Study|Adverse Event|9
4865156|NCT00859898|16767889|P1|Overall Study|Adverse Event|4
4865157|NCT00859898|16767887|P3|Overall Study|Lack of Efficacy|1
4865158|NCT00859898|16767888|P2|Overall Study|Lack of Efficacy|1
4865159|NCT00859898|16767889|P1|Overall Study|Lack of Efficacy|0
4865160|NCT00859638|16767948|P2|Overall Study|Ill health|1
4865161|NCT00859638|16767949|P1|Overall Study|Ill health|1
4865162|NCT00859638|16767948|P2|Overall Study|Withdrawal by Subject|2
4865163|NCT00859638|16767949|P1|Overall Study|Withdrawal by Subject|3
4865164|NCT00859638|16767948|P2|Overall Study|Lost to Follow-up|1
4865165|NCT00859638|16767949|P1|Overall Study|Lost to Follow-up|6
4865166|NCT00859586|16767955|P1|Overall Study|Donors|4
4865167|NCT00859573|16767971|P2|Overall Study|Physician Decision|1
4865168|NCT00859573|16767972|P1|Overall Study|Physician Decision|1
4865169|NCT00859573|16767971|P2|Overall Study|Withdrawal by Subject|1
4865170|NCT00859573|16767972|P1|Overall Study|Withdrawal by Subject|4
4865171|NCT00859547|16767978|P1|Overall Study|Parent withdrew consent|1
4865172|NCT00859547|16767978|P1|Overall Study|Lost to Follow-up|1
4865173|NCT00859521|16767991|P2|Washout|Withdrawal by Subject|1
4865174|NCT00859521|16767992|P1|Washout|Withdrawal by Subject|0
4865175|NCT00859469|16768013|P1|Overall Study|Death|16
4865176|NCT00859469|16768013|P1|Overall Study|Withdrawal by Subject|1
4865177|NCT00859469|16768013|P1|Overall Study|Lack of Efficacy|9
4865178|NCT00859469|16768013|P1|Overall Study|Adverse Event|2
4865179|NCT00859456|16768019|P1|Overall Study|Non-compliance|3
4865180|NCT00859456|16768019|P1|Overall Study|Progressive disease|2
4865181|NCT00859456|16768019|P1|Overall Study|Adverse Event|3
4865182|NCT00859430|16768025|P2|First Intervention|Withdrawal by Subject|1
4865183|NCT00859430|16768026|P1|First Intervention|Withdrawal by Subject|0
4865184|NCT00859313|16768042|P1|Overall Study|staff error|1
4865185|NCT00859313|16768042|P1|Overall Study|Adverse Event|1
4865186|NCT00859313|16768042|P1|Overall Study|Lack of Efficacy|2
4865187|NCT00859222|16768049|P5|Overall Study|DLT|0
4865188|NCT00859222|16768050|P4|Overall Study|DLT|0
4865189|NCT00859222|16768051|P3|Overall Study|DLT|0
4865190|NCT00859222|16768052|P2|Overall Study|DLT|0
4865191|NCT00859222|16768053|P1|Overall Study|DLT|1
4865192|NCT00859222|16768049|P5|Overall Study|Adverse Event|15
4865193|NCT00859222|16768050|P4|Overall Study|Adverse Event|24
4865194|NCT00859222|16768051|P3|Overall Study|Adverse Event|6
4865195|NCT00859222|16768052|P2|Overall Study|Adverse Event|3
4865196|NCT00859222|16768053|P1|Overall Study|Adverse Event|2
4865197|NCT00859014|16768175|P1|Overall Study|Lost to Follow-up|1
4865198|NCT00859014|16768175|P1|Overall Study|Death|4
4865199|NCT00858988|16768182|P2|Analysis|Lactulose unable to be detected in urine|1
4865200|NCT00858988|16768183|P1|Analysis|Lactulose unable to be detected in urine|2
4865201|NCT00858845|16768199|P2|Overall Study|Patient underwent heart transplant.|1
4865202|NCT00858845|16768200|P1|Overall Study|Patient underwent heart transplant.|0
4865203|NCT00858832|16768212|P2|Overall Study|Adverse Event|1
4865204|NCT00858832|16768213|P1|Overall Study|Adverse Event|0
4865205|NCT00858832|16768212|P2|Overall Study|became ineligible: delivered vaginally|0
4865206|NCT00858832|16768213|P1|Overall Study|became ineligible: delivered vaginally|1
4865207|NCT00858780|16768219|P5|OL Re-Treatment (Failure to Week 48)|Other|1
4865208|NCT00858780|16768220|P4|OL Re-Treatment (Failure to Week 48)|Other|0
4865209|NCT00858780|16768221|P3|OL Re-Treatment (Failure to Week 48)|Other|0
4865210|NCT00858780|16768222|P2|OL Re-Treatment (Failure to Week 48)|Other|0
4865211|NCT00858780|16768223|P1|OL Re-Treatment (Failure to Week 48)|Other|0
4865212|NCT00858780|16768219|P5|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1
4865213|NCT00858780|16768220|P4|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4865214|NCT00858780|16768221|P3|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4865215|NCT00858780|16768222|P2|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4865216|NCT00858780|16768223|P1|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0
4865217|NCT00858780|16768219|P5|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4865218|NCT00858780|16768220|P4|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4865219|NCT00858780|16768221|P3|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4865220|NCT00858780|16768222|P2|Double-Blind (Week 0 to Failure/Week 48)|Other|1
4865221|NCT00858780|16768223|P1|Double-Blind (Week 0 to Failure/Week 48)|Other|0
4865222|NCT00858780|16768219|P5|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
4865223|NCT00858780|16768220|P4|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
4865224|NCT00858780|16768221|P3|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
4865225|NCT00858780|16768222|P2|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1
4865226|NCT00858780|16768223|P1|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0
4865227|NCT00858780|16768219|P5|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4865228|NCT00858780|16768220|P4|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4865229|NCT00858780|16768221|P3|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1
4865230|NCT00858780|16768222|P2|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4865231|NCT00858780|16768223|P1|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0
4865232|NCT00858780|16768219|P5|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4865233|NCT00858780|16768220|P4|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4865234|NCT00858780|16768221|P3|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4865235|NCT00858780|16768222|P2|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0
4865236|NCT00858780|16768223|P1|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18
4865237|NCT00858702|16768298|P2|Overall Study|Withdrawal by Subject|0
4865238|NCT00858702|16768299|P1|Overall Study|Withdrawal by Subject|1
4865239|NCT00858702|16768298|P2|Overall Study|Other|1
4865240|NCT00858702|16768299|P1|Overall Study|Other|2
4865241|NCT00858702|16768298|P2|Overall Study|Protocol Violation|1
4865242|NCT00858702|16768299|P1|Overall Study|Protocol Violation|1
4865243|NCT00858702|16768298|P2|Overall Study|Lack of Efficacy|0
4865244|NCT00858702|16768299|P1|Overall Study|Lack of Efficacy|1
4865245|NCT00858637|16768314|P6|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1
4865246|NCT00858637|16768315|P5|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4865247|NCT00858637|16768316|P4|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4865248|NCT00858637|16768317|P3|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4865249|NCT00858637|16768318|P2|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4865250|NCT00858637|16768319|P1|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0
4865251|NCT00858637|16768314|P6|Placebo-controlled Withdrawal Phase|Death|0
4865252|NCT00858637|16768315|P5|Placebo-controlled Withdrawal Phase|Death|1
4865253|NCT00858637|16768316|P4|Placebo-controlled Withdrawal Phase|Death|0
4865254|NCT00858637|16768317|P3|Placebo-controlled Withdrawal Phase|Death|1
4865255|NCT00858637|16768318|P2|Placebo-controlled Withdrawal Phase|Death|0
4865256|NCT00858637|16768319|P1|Placebo-controlled Withdrawal Phase|Death|0
4865257|NCT00858637|16768314|P6|Active Comparison Phase|Other Reasons|0
4865258|NCT00858637|16768315|P5|Active Comparison Phase|Other Reasons|0
4865259|NCT00858637|16768316|P4|Active Comparison Phase|Other Reasons|1
4865260|NCT00858637|16768317|P3|Active Comparison Phase|Other Reasons|0
4865261|NCT00858637|16768318|P2|Active Comparison Phase|Other Reasons|0
4865262|NCT00858637|16768319|P1|Active Comparison Phase|Other Reasons|1
4865263|NCT00858637|16768314|P6|Active Comparison Phase|Withdrawal by Subject|0
4865264|NCT00858637|16768315|P5|Active Comparison Phase|Withdrawal by Subject|0
4865265|NCT00858637|16768316|P4|Active Comparison Phase|Withdrawal by Subject|6
4865266|NCT00858637|16768317|P3|Active Comparison Phase|Withdrawal by Subject|0
4865267|NCT00858637|16768318|P2|Active Comparison Phase|Withdrawal by Subject|0
4865268|NCT00858637|16768319|P1|Active Comparison Phase|Withdrawal by Subject|7
4865269|NCT00858637|16768314|P6|Active Comparison Phase|Physician Decision|0
4865270|NCT00858637|16768315|P5|Active Comparison Phase|Physician Decision|0
4865271|NCT00858637|16768316|P4|Active Comparison Phase|Physician Decision|1
4865272|NCT00858637|16768317|P3|Active Comparison Phase|Physician Decision|0
4865273|NCT00858637|16768318|P2|Active Comparison Phase|Physician Decision|0
4865274|NCT00858637|16768319|P1|Active Comparison Phase|Physician Decision|1
4865275|NCT00858637|16768314|P6|Active Comparison Phase|Death|0
4865276|NCT00858637|16768315|P5|Active Comparison Phase|Death|0
4865277|NCT00858637|16768316|P4|Active Comparison Phase|Death|1
4865278|NCT00858637|16768317|P3|Active Comparison Phase|Death|0
4865279|NCT00858637|16768318|P2|Active Comparison Phase|Death|0
4865280|NCT00858637|16768319|P1|Active Comparison Phase|Death|1
4865281|NCT00858637|16768314|P6|Active Comparison Phase|Adverse Event|0
4865282|NCT00858637|16768315|P5|Active Comparison Phase|Adverse Event|0
4865283|NCT00858637|16768316|P4|Active Comparison Phase|Adverse Event|9
4865284|NCT00858637|16768317|P3|Active Comparison Phase|Adverse Event|0
4865285|NCT00858637|16768318|P2|Active Comparison Phase|Adverse Event|0
4865286|NCT00858637|16768319|P1|Active Comparison Phase|Adverse Event|14
4865287|NCT00858442|16768360|P2|Compression:Start to Finish|Lost to Follow-up|3
4865288|NCT00858442|16768361|P1|Compression:Start to Finish|Lost to Follow-up|1
4865289|NCT00858403|16768371|P1|Overall Study|Disease Progression|1
4865290|NCT00858403|16768371|P1|Overall Study|Death|3
4865291|NCT00858403|16768371|P1|Overall Study|Withdrawal by Subject|1
4865292|NCT00858364|16768392|P2|Overall Study|Still on-study|247
4865293|NCT00858364|16768393|P1|Overall Study|Still on-study|114
4865294|NCT00858364|16768392|P2|Overall Study|Missing|1
4865295|NCT00858364|16768393|P1|Overall Study|Missing|1
4865296|NCT00858364|16768392|P2|Overall Study|Other|17
4865297|NCT00858364|16768393|P1|Overall Study|Other|9
4865298|NCT00858364|16768392|P2|Overall Study|Protocol Deviation|2
4865299|NCT00858364|16768393|P1|Overall Study|Protocol Deviation|0
4865300|NCT00858364|16768392|P2|Overall Study|Noncompliance|4
4865301|NCT00858364|16768393|P1|Overall Study|Noncompliance|3
4865302|NCT00858364|16768392|P2|Overall Study|Lost to Follow-up|54
4865303|NCT00858364|16768393|P1|Overall Study|Lost to Follow-up|24
4865304|NCT00858364|16768392|P2|Overall Study|Ineligibility Determined|10
4865305|NCT00858364|16768393|P1|Overall Study|Ineligibility Determined|1
4865306|NCT00858364|16768392|P2|Overall Study|Withdrawal by Subject|118
4865307|NCT00858364|16768393|P1|Overall Study|Withdrawal by Subject|44
4865308|NCT00858364|16768392|P2|Overall Study|Adverse Event|2
4865309|NCT00858364|16768393|P1|Overall Study|Adverse Event|5
4865310|NCT00858364|16768392|P2|Overall Study|Administrative Decision|2
4865311|NCT00858364|16768393|P1|Overall Study|Administrative Decision|3
4865312|NCT00858247|16768415|P2|Week 12 Follow-up|Withdrawal by Subject|1
4865313|NCT00858247|16768416|P1|Week 12 Follow-up|Withdrawal by Subject|0
4865314|NCT00858247|16768415|P2|Baseline Assessment|Protocol Violation|1
4865315|NCT00858247|16768416|P1|Baseline Assessment|Protocol Violation|0
4865316|NCT00858247|16768415|P2|Baseline Assessment|Poor IV access|0
4865317|NCT00858247|16768416|P1|Baseline Assessment|Poor IV access|1
4865318|NCT00858247|16768415|P2|Baseline Assessment|Withdrawal by Subject|1
4865319|NCT00858247|16768416|P1|Baseline Assessment|Withdrawal by Subject|1
4865320|NCT00858208|16768432|P1|Overall Study|Other|10
4865321|NCT00858208|16768432|P1|Overall Study|Participant refused|40
4865322|NCT00858208|16768432|P1|Overall Study|Lost to Follow-up|26
4865323|NCT00858208|16768432|P1|Overall Study|Adverse Event|3
4865324|NCT00858143|16768449|P1|Overall Study|Other|23
4865325|NCT00858143|16768449|P1|Overall Study|Death|7
4865326|NCT00858143|16768449|P1|Overall Study|Lack of Efficacy|4
4865327|NCT00858143|16768449|P1|Overall Study|Adverse Event|16
4865328|NCT00858117|16768506|P1|Follow up for 5 Years|No further data collected for study|9
4865329|NCT00858117|16768506|P1|Follow up for 5 Years|Death|4
4865330|NCT00858117|16768506|P1|Treatment on Study|Adverse Event|2
4865331|NCT00857948|16768569|P4|Overall Study|Protocol Violation|0
4865332|NCT00857948|16768570|P3|Overall Study|Protocol Violation|1
4865333|NCT00857948|16768571|P2|Overall Study|Protocol Violation|0
4865334|NCT00857948|16768572|P1|Overall Study|Protocol Violation|1
4865335|NCT00857948|16768569|P4|Overall Study|Withdrawal by Subject|0
4865336|NCT00857948|16768570|P3|Overall Study|Withdrawal by Subject|0
4865337|NCT00857948|16768571|P2|Overall Study|Withdrawal by Subject|0
4865338|NCT00857948|16768572|P1|Overall Study|Withdrawal by Subject|2
4865339|NCT00857896|16768594|P1|Baseline to Week 4|Withdrawal by Subject|1
4865340|NCT00857818|16768750|P2|Overall Study|Investigator decision|0
4865341|NCT00857818|16768751|P1|Overall Study|Investigator decision|1
4865342|NCT00857818|16768750|P2|Overall Study|Sponsor terminated study|4
4865343|NCT00857818|16768751|P1|Overall Study|Sponsor terminated study|6
4865344|NCT00857818|16768750|P2|Overall Study|Withdrawal by Subject|4
4865345|NCT00857818|16768751|P1|Overall Study|Withdrawal by Subject|0
4865346|NCT00857818|16768750|P2|Overall Study|Adverse Event|0
4865347|NCT00857818|16768751|P1|Overall Study|Adverse Event|3
4865348|NCT00857818|16768750|P2|Overall Study|Lack of Efficacy|0
4865349|NCT00857818|16768751|P1|Overall Study|Lack of Efficacy|1
4865350|NCT00857792|16768779|P1|Overall Study|inadequate image quality for analysis|12
4865351|NCT00857766|16768785|P2|Overall Study|Participant Withdrew Consent|4
4865352|NCT00857766|16768786|P1|Overall Study|Participant Withdrew Consent|4
4865353|NCT00857766|16768785|P2|Overall Study|Investigator Discretion|3
4865354|NCT00857766|16768786|P1|Overall Study|Investigator Discretion|2
4865355|NCT00857766|16768785|P2|Overall Study|Lost to Follow-up|0
4865356|NCT00857766|16768786|P1|Overall Study|Lost to Follow-up|1
4865357|NCT00857766|16768785|P2|Overall Study|Protocol Violation|11
4865358|NCT00857766|16768786|P1|Overall Study|Protocol Violation|11
4865359|NCT00857766|16768785|P2|Overall Study|Adverse Event|12
4865360|NCT00857766|16768786|P1|Overall Study|Adverse Event|13
4865361|NCT00857649|16768828|P2|Overall Study|Other Reasons|3
4865362|NCT00857649|16768829|P1|Overall Study|Other Reasons|1
4865363|NCT00857649|16768828|P2|Overall Study|Nursing Home Placement|9
4865364|NCT00857649|16768829|P1|Overall Study|Nursing Home Placement|2
4865365|NCT00857649|16768828|P2|Overall Study|Withdrawal of Consent|7
4865366|NCT00857649|16768829|P1|Overall Study|Withdrawal of Consent|10
4865367|NCT00857649|16768828|P2|Overall Study|Protocol Violation|2
4865368|NCT00857649|16768829|P1|Overall Study|Protocol Violation|2
4865369|NCT00857649|16768828|P2|Overall Study|Non-compliance|1
4865370|NCT00857649|16768829|P1|Overall Study|Non-compliance|1
4865371|NCT00857649|16768828|P2|Overall Study|Adverse Event|10
4865372|NCT00857649|16768829|P1|Overall Study|Adverse Event|15
4865373|NCT00857623|16768845|P2|Overall Study|Positive for HEP C|1
4865374|NCT00857623|16768846|P1|Overall Study|Positive for HEP C|0
4865375|NCT00857623|16768845|P2|Overall Study|Intake of prohibited medication|1
4865376|NCT00857623|16768846|P1|Overall Study|Intake of prohibited medication|0
4865377|NCT00857623|16768845|P2|Overall Study|Severe non-compliance to protocol|1
4865378|NCT00857623|16768846|P1|Overall Study|Severe non-compliance to protocol|1
4865379|NCT00857623|16768845|P2|Overall Study|Lack of Efficacy|1
4865380|NCT00857623|16768846|P1|Overall Study|Lack of Efficacy|1
4865381|NCT00857623|16768845|P2|Overall Study|Withdrawal by Subject|1
4865382|NCT00857623|16768846|P1|Overall Study|Withdrawal by Subject|2
4865383|NCT00857623|16768845|P2|Overall Study|Study-specific discontinuation criteria|3
4865384|NCT00857623|16768846|P1|Overall Study|Study-specific discontinuation criteria|5
4865385|NCT00857623|16768845|P2|Overall Study|Adverse Event|2
4865386|NCT00857623|16768846|P1|Overall Study|Adverse Event|5
4865387|NCT00857584|16768870|P2|Overall Study|Physician Decision|1
4865388|NCT00857584|16768871|P1|Overall Study|Physician Decision|1
4865389|NCT00857584|16768870|P2|Overall Study|Adverse Event|2
4865390|NCT00857584|16768871|P1|Overall Study|Adverse Event|2
4865391|NCT00857584|16768870|P2|Overall Study|Lack of Efficacy|2
4865392|NCT00857584|16768871|P1|Overall Study|Lack of Efficacy|1
4865393|NCT00857454|16768998|P1|Overall Study|MTE09 enrollment criteria not met|6
4865394|NCT00857454|16768998|P1|Overall Study|Total Testosterone <300 ng/dL|8
4865395|NCT00857454|16768998|P1|Overall Study|Total Testosterone >1050 ng/dL|1
4865396|NCT00857454|16768998|P1|Overall Study|Adverse Event|2
4865397|NCT00857454|16768998|P1|Overall Study|Lost to Follow-up|1
4865398|NCT00857454|16768998|P1|Overall Study|Withdrawal by Subject|2
4865399|NCT00857415|16769011|P2|Overall Study|Deceased with no autopsy|0
4865400|NCT00857415|16769012|P1|Overall Study|Deceased with no autopsy|2
4865401|NCT00857415|16769011|P2|Overall Study|Subject still living at end of study|0
4865402|NCT00857415|16769012|P1|Overall Study|Subject still living at end of study|110
4865403|NCT00857415|16769011|P2|Overall Study|Invalid image or not imaged|0
4865404|NCT00857415|16769012|P1|Overall Study|Invalid image or not imaged|3
4865405|NCT00857415|16769011|P2|Overall Study|Image acquisition failure|0
4865406|NCT00857415|16769012|P1|Overall Study|Image acquisition failure|2
4865407|NCT00857389|16769019|P1|Overall Study|Did not proceed to transplant|2
4865408|NCT00857311|16769033|P4|Overall Study|Lost to Follow-up|0
4865409|NCT00857311|16769034|P3|Overall Study|Lost to Follow-up|0
4865410|NCT00857311|16769035|P2|Overall Study|Lost to Follow-up|0
4865411|NCT00857311|16769036|P1|Overall Study|Lost to Follow-up|1
4865412|NCT00857285|16769048|P2|Overall Study|Randomization criteria not met|1
4865413|NCT00857285|16769049|P1|Overall Study|Randomization criteria not met|1
4865414|NCT00857285|16769048|P2|Overall Study|Withdrawal by Subject|0
4865415|NCT00857285|16769049|P1|Overall Study|Withdrawal by Subject|4
4865416|NCT00857285|16769048|P2|Overall Study|Protocol Violation|1
4865417|NCT00857285|16769049|P1|Overall Study|Protocol Violation|3
4865418|NCT00857285|16769048|P2|Overall Study|Lack of Efficacy|2
4865419|NCT00857285|16769049|P1|Overall Study|Lack of Efficacy|0
4865420|NCT00857285|16769048|P2|Overall Study|Adverse Event|2
4865421|NCT00857285|16769049|P1|Overall Study|Adverse Event|4
4865422|NCT00857259|16769065|P3|Overall Study|Protocol Violation|1
4865423|NCT00857259|16769066|P2|Overall Study|Protocol Violation|0
4865424|NCT00857259|16769067|P1|Overall Study|Protocol Violation|1
4865425|NCT00857246|16769077|P1|ChemoRT|Adverse Event|2
4865426|NCT00857246|16769077|P1|ChemoRT|Withdrawal by Subject|1
4865427|NCT00857246|16769077|P1|Surgery (Curative)|disease progression|6
4865428|NCT00857246|16769077|P1|Induction Regimen|Withdrawal by Subject|1
4865429|NCT00857246|16769077|P1|Induction Regimen|disease-related complications|1
4865430|NCT00857246|16769077|P1|Induction Regimen|Adverse Event|1
4865431|NCT00857233|16769087|P1|Overall Study|Other Reasons|2
4865432|NCT00857233|16769087|P1|Overall Study|Nursing Home Placement|14
4865433|NCT00857233|16769087|P1|Overall Study|Lost to Follow-up|4
4865434|NCT00857233|16769087|P1|Overall Study|Withdrawal of Consent|9
4865435|NCT00857233|16769087|P1|Overall Study|Non-compliance|1
4865436|NCT00857233|16769087|P1|Overall Study|Lack of Efficacy|1
4865437|NCT00857233|16769087|P1|Overall Study|Adverse Event|24
4865438|NCT00857220|16769096|P1|Overall Study|Miscellaneous|8
4865439|NCT00857220|16769096|P1|Overall Study|Site Closed|5
4865440|NCT00857220|16769096|P1|Overall Study|Clinical Hold|6
4865441|NCT00857220|16769096|P1|Overall Study|Withdrawal by Subject|67
4865442|NCT00857220|16769096|P1|Overall Study|Protocol Violation|16
4865443|NCT00857220|16769096|P1|Overall Study|Physician Decision|4
4865444|NCT00857220|16769096|P1|Overall Study|Lost to Follow-up|30
4865445|NCT00857220|16769096|P1|Overall Study|Lack of Efficacy|11
4865446|NCT00857220|16769096|P1|Overall Study|Death|1
4865447|NCT00857220|16769096|P1|Overall Study|Adverse Event|35
4865448|NCT00856999|16769113|P1|Overall Study|Withdrawal by Subject|5
4865449|NCT00856986|16769123|P5|Extension Period, Weeks 26-52|Unclassified|0
4865450|NCT00856986|16769124|P4|Extension Period, Weeks 26-52|Unclassified|0
4865451|NCT00856986|16769125|P3|Extension Period, Weeks 26-52|Unclassified|11
4865452|NCT00856986|16769126|P2|Extension Period, Weeks 26-52|Unclassified|2
4865453|NCT00856986|16769127|P1|Extension Period, Weeks 26-52|Unclassified|4
4865454|NCT00856986|16769123|P5|Extension Period, Weeks 26-52|Lack of Efficacy|0
4865455|NCT00856986|16769124|P4|Extension Period, Weeks 26-52|Lack of Efficacy|0
4865456|NCT00856986|16769125|P3|Extension Period, Weeks 26-52|Lack of Efficacy|2
4865457|NCT00856986|16769126|P2|Extension Period, Weeks 26-52|Lack of Efficacy|2
4865458|NCT00856986|16769127|P1|Extension Period, Weeks 26-52|Lack of Efficacy|4
4865459|NCT00856986|16769123|P5|Extension Period, Weeks 26-52|Lost to Follow-up|0
4865460|NCT00856986|16769124|P4|Extension Period, Weeks 26-52|Lost to Follow-up|0
4865461|NCT00856986|16769125|P3|Extension Period, Weeks 26-52|Lost to Follow-up|2
4865462|NCT00856986|16769126|P2|Extension Period, Weeks 26-52|Lost to Follow-up|5
4865463|NCT00856986|16769127|P1|Extension Period, Weeks 26-52|Lost to Follow-up|0
4865464|NCT00856986|16769123|P5|Extension Period, Weeks 26-52|Withdrawal Criteria|0
4865465|NCT00856986|16769124|P4|Extension Period, Weeks 26-52|Withdrawal Criteria|0
4865466|NCT00856986|16769125|P3|Extension Period, Weeks 26-52|Withdrawal Criteria|8
4865467|NCT00856986|16769126|P2|Extension Period, Weeks 26-52|Withdrawal Criteria|0
4865468|NCT00856986|16769127|P1|Extension Period, Weeks 26-52|Withdrawal Criteria|2
4865469|NCT00856986|16769123|P5|Extension Period, Weeks 26-52|Protocol Violation|0
4865470|NCT00856986|16769124|P4|Extension Period, Weeks 26-52|Protocol Violation|0
4865471|NCT00856986|16769125|P3|Extension Period, Weeks 26-52|Protocol Violation|5
4865472|NCT00856986|16769126|P2|Extension Period, Weeks 26-52|Protocol Violation|2
4865473|NCT00856986|16769127|P1|Extension Period, Weeks 26-52|Protocol Violation|6
4865474|NCT00856986|16769123|P5|Extension Period, Weeks 26-52|Adverse Event|0
4865475|NCT00856986|16769124|P4|Extension Period, Weeks 26-52|Adverse Event|0
4865476|NCT00856986|16769125|P3|Extension Period, Weeks 26-52|Adverse Event|10
4865477|NCT00856986|16769126|P2|Extension Period, Weeks 26-52|Adverse Event|3
4865478|NCT00856986|16769127|P1|Extension Period, Weeks 26-52|Adverse Event|3
4865479|NCT00856986|16769123|P5|Main Period, Weeks 0-26|Unclassified|0
4865480|NCT00856986|16769124|P4|Main Period, Weeks 0-26|Unclassified|0
4865481|NCT00856986|16769125|P3|Main Period, Weeks 0-26|Unclassified|7
4865482|NCT00856986|16769126|P2|Main Period, Weeks 0-26|Unclassified|6
4865483|NCT00856986|16769127|P1|Main Period, Weeks 0-26|Unclassified|7
4865484|NCT00856986|16769123|P5|Main Period, Weeks 0-26|Lack of Efficacy|0
4865485|NCT00856986|16769124|P4|Main Period, Weeks 0-26|Lack of Efficacy|0
4865486|NCT00856986|16769125|P3|Main Period, Weeks 0-26|Lack of Efficacy|0
4865487|NCT00856986|16769126|P2|Main Period, Weeks 0-26|Lack of Efficacy|2
4865488|NCT00856986|16769127|P1|Main Period, Weeks 0-26|Lack of Efficacy|5
4865489|NCT00856986|16769123|P5|Main Period, Weeks 0-26|Lost to Follow-up|0
4865490|NCT00856986|16769124|P4|Main Period, Weeks 0-26|Lost to Follow-up|0
4865491|NCT00856986|16769125|P3|Main Period, Weeks 0-26|Lost to Follow-up|2
4865492|NCT00856986|16769126|P2|Main Period, Weeks 0-26|Lost to Follow-up|1
4865493|NCT00856986|16769127|P1|Main Period, Weeks 0-26|Lost to Follow-up|1
4865494|NCT00856986|16769123|P5|Main Period, Weeks 0-26|Withdrawal Criteria|0
4865495|NCT00856986|16769124|P4|Main Period, Weeks 0-26|Withdrawal Criteria|0
4865496|NCT00856986|16769125|P3|Main Period, Weeks 0-26|Withdrawal Criteria|3
4865497|NCT00856986|16769126|P2|Main Period, Weeks 0-26|Withdrawal Criteria|0
4865498|NCT00856986|16769127|P1|Main Period, Weeks 0-26|Withdrawal Criteria|11
4865499|NCT00856986|16769123|P5|Main Period, Weeks 0-26|Protocol Violation|0
4865500|NCT00856986|16769124|P4|Main Period, Weeks 0-26|Protocol Violation|0
4865501|NCT00856986|16769125|P3|Main Period, Weeks 0-26|Protocol Violation|7
4865502|NCT00856986|16769126|P2|Main Period, Weeks 0-26|Protocol Violation|5
4865503|NCT00856986|16769127|P1|Main Period, Weeks 0-26|Protocol Violation|4
4865504|NCT00856986|16769123|P5|Main Period, Weeks 0-26|Adverse Event|0
4865505|NCT00856986|16769124|P4|Main Period, Weeks 0-26|Adverse Event|0
4865506|NCT00856986|16769125|P3|Main Period, Weeks 0-26|Adverse Event|9
4865507|NCT00856986|16769126|P2|Main Period, Weeks 0-26|Adverse Event|4
4865508|NCT00856986|16769127|P1|Main Period, Weeks 0-26|Adverse Event|6
4865509|NCT00856986|16769123|P5|Run-in Period, Weeks -12-0|Unclassified|0
4865510|NCT00856986|16769124|P4|Run-in Period, Weeks -12-0|Unclassified|24
4865511|NCT00856986|16769125|P3|Run-in Period, Weeks -12-0|Unclassified|0
4865512|NCT00856986|16769126|P2|Run-in Period, Weeks -12-0|Unclassified|0
4865513|NCT00856986|16769127|P1|Run-in Period, Weeks -12-0|Unclassified|0
4865514|NCT00856986|16769123|P5|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4865515|NCT00856986|16769124|P4|Run-in Period, Weeks -12-0|Lack of Efficacy|6
4865516|NCT00856986|16769125|P3|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4865517|NCT00856986|16769126|P2|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4865518|NCT00856986|16769127|P1|Run-in Period, Weeks -12-0|Lack of Efficacy|0
4865519|NCT00856986|16769123|P5|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4865520|NCT00856986|16769124|P4|Run-in Period, Weeks -12-0|Lost to Follow-up|11
4865521|NCT00856986|16769125|P3|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4865522|NCT00856986|16769126|P2|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4865523|NCT00856986|16769127|P1|Run-in Period, Weeks -12-0|Lost to Follow-up|0
4865524|NCT00856986|16769123|P5|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4865525|NCT00856986|16769124|P4|Run-in Period, Weeks -12-0|Withdrawal Criteria|10
4865526|NCT00856986|16769125|P3|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4865527|NCT00856986|16769126|P2|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4865528|NCT00856986|16769127|P1|Run-in Period, Weeks -12-0|Withdrawal Criteria|0
4865529|NCT00856986|16769123|P5|Run-in Period, Weeks -12-0|Protocol Violation|0
4865530|NCT00856986|16769124|P4|Run-in Period, Weeks -12-0|Protocol Violation|24
4865531|NCT00856986|16769125|P3|Run-in Period, Weeks -12-0|Protocol Violation|0
4865532|NCT00856986|16769126|P2|Run-in Period, Weeks -12-0|Protocol Violation|0
4865533|NCT00856986|16769127|P1|Run-in Period, Weeks -12-0|Protocol Violation|0
4865534|NCT00856986|16769123|P5|Run-in Period, Weeks -12-0|Adverse Event|0
4865535|NCT00856986|16769124|P4|Run-in Period, Weeks -12-0|Adverse Event|92
4865536|NCT00856986|16769125|P3|Run-in Period, Weeks -12-0|Adverse Event|0
4865537|NCT00856986|16769126|P2|Run-in Period, Weeks -12-0|Adverse Event|0
4865538|NCT00856986|16769127|P1|Run-in Period, Weeks -12-0|Adverse Event|0
4865539|NCT00856973|16769297|P3|Overall Study|Other|13
4865540|NCT00856973|16769298|P2|Overall Study|Other|12
4865541|NCT00856973|16769299|P1|Overall Study|Other|11
4865542|NCT00856973|16769297|P3|Overall Study|Withdrawal by Subject|15
4865543|NCT00856973|16769298|P2|Overall Study|Withdrawal by Subject|16
4865544|NCT00856973|16769299|P1|Overall Study|Withdrawal by Subject|13
4865545|NCT00856973|16769297|P3|Overall Study|Protocol Violation|1
4865546|NCT00856973|16769298|P2|Overall Study|Protocol Violation|2
4865547|NCT00856973|16769299|P1|Overall Study|Protocol Violation|1
4865548|NCT00856973|16769297|P3|Overall Study|Physician Decision|1
4865549|NCT00856973|16769298|P2|Overall Study|Physician Decision|3
4865550|NCT00856973|16769299|P1|Overall Study|Physician Decision|0
4865551|NCT00856973|16769297|P3|Overall Study|Lost to Follow-up|5
4865552|NCT00856973|16769298|P2|Overall Study|Lost to Follow-up|3
4865553|NCT00856973|16769299|P1|Overall Study|Lost to Follow-up|6
4865554|NCT00856973|16769297|P3|Overall Study|Adverse Event|3
4865555|NCT00856973|16769298|P2|Overall Study|Adverse Event|5
4865556|NCT00856973|16769299|P1|Overall Study|Adverse Event|5
4865557|NCT00856908|16769379|P2|Overall Study|Lost to Follow-up|0
4865558|NCT00856908|16769380|P1|Overall Study|Lost to Follow-up|1
4865559|NCT00856856|16769405|P1|4-year Clinical Follow-up|Missed visit|1
4865560|NCT00856856|16769405|P1|2-year Clinical Follow-up|Lost to Follow-up|1
4865561|NCT00856843|16769604|P2|Overall Study|Lack of Efficacy|0
4865562|NCT00856843|16769605|P1|Overall Study|Lack of Efficacy|1
4865563|NCT00856843|16769604|P2|Overall Study|Withdrawal by Subject|5
4865564|NCT00856843|16769605|P1|Overall Study|Withdrawal by Subject|1
4865565|NCT00856830|16769641|P4|Irinotecan & Bendamustine|Physician Decision|1
4865566|NCT00856830|16769642|P3|Irinotecan & Bendamustine|Physician Decision|0
4865567|NCT00856830|16769643|P2|Irinotecan & Bendamustine|Physician Decision|0
4865568|NCT00856830|16769644|P1|Irinotecan & Bendamustine|Physician Decision|0
4865569|NCT00856830|16769641|P4|Irinotecan & Bendamustine|Death|2
4865570|NCT00856830|16769642|P3|Irinotecan & Bendamustine|Death|0
4865571|NCT00856830|16769643|P2|Irinotecan & Bendamustine|Death|0
4865572|NCT00856830|16769644|P1|Irinotecan & Bendamustine|Death|0
4865573|NCT00856778|16769655|P1|Overall Study|Lost to Follow-up|5
4865574|NCT00856778|16769655|P1|Overall Study|Study deviation|2
4865575|NCT00856778|16769655|P1|Overall Study|Withdrawal by Subject|10
4865576|NCT00856778|16769655|P1|Overall Study|Adverse Event|7
4865577|NCT00856661|16769698|P2|Overall Study|Physician Judgement|5
4865578|NCT00856661|16769699|P1|Overall Study|Physician Judgement|8
4865579|NCT00856661|16769698|P2|Overall Study|Lost to Follow-up|3
4865580|NCT00856661|16769699|P1|Overall Study|Lost to Follow-up|1
4865581|NCT00856661|16769698|P2|Overall Study|Withdrawal by Subject|2
4865582|NCT00856661|16769699|P1|Overall Study|Withdrawal by Subject|1
4865583|NCT00856661|16769698|P2|Overall Study|Protocol Violation|1
4865584|NCT00856661|16769699|P1|Overall Study|Protocol Violation|2
4865585|NCT00856661|16769698|P2|Overall Study|Death|18
4865586|NCT00856661|16769699|P1|Overall Study|Death|15
4865587|NCT00856635|16769713|P2|Overall Study|Discontinued at Randomization|2
4865588|NCT00856635|16769714|P1|Overall Study|Discontinued at Randomization|2
4865589|NCT00856635|16769713|P2|Overall Study|Other|0
4865590|NCT00856635|16769714|P1|Overall Study|Other|1
4865591|NCT00856635|16769713|P2|Overall Study|Serious Adverse Event|0
4865592|NCT00856635|16769714|P1|Overall Study|Serious Adverse Event|1
4865593|NCT00856635|16769713|P2|Overall Study|Withdrawal by Subject|1
4865594|NCT00856635|16769714|P1|Overall Study|Withdrawal by Subject|3
4865595|NCT00856635|16769713|P2|Overall Study|Pregnancy|0
4865596|NCT00856635|16769714|P1|Overall Study|Pregnancy|1
4865597|NCT00856635|16769713|P2|Overall Study|Lost to Follow-up|5
4865598|NCT00856635|16769714|P1|Overall Study|Lost to Follow-up|2
4865599|NCT00856609|16769724|P2|Overall Study|Adverse Event|0
4865600|NCT00856609|16769725|P1|Overall Study|Adverse Event|1
4865601|NCT00856583|16769737|P2|Overall Study|Non-evaluable: Patient on Polytherapy|604
4865602|NCT00856583|16769738|P1|Overall Study|Non-evaluable: Patient on Polytherapy|694
4865603|NCT00856583|16769737|P2|Overall Study|Other|104
4865604|NCT00856583|16769738|P1|Overall Study|Other|92
4865605|NCT00856583|16769737|P2|Overall Study|Pregnancy|5
4865606|NCT00856583|16769738|P1|Overall Study|Pregnancy|14
4865607|NCT00856583|16769737|P2|Overall Study|Physician Decision|82
4865608|NCT00856583|16769738|P1|Overall Study|Physician Decision|59
4865609|NCT00856583|16769737|P2|Overall Study|Withdrawal by Subject|919
4865610|NCT00856583|16769738|P1|Overall Study|Withdrawal by Subject|1092
4865611|NCT00856583|16769737|P2|Overall Study|Non-compliance|262
4865612|NCT00856583|16769738|P1|Overall Study|Non-compliance|305
4865613|NCT00856583|16769737|P2|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179
4865614|NCT00856583|16769738|P1|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393
4865615|NCT00856583|16769737|P2|Overall Study|Serious Adverse Event (SAE)|65
4865616|NCT00856583|16769738|P1|Overall Study|Serious Adverse Event (SAE)|99
4865617|NCT00856583|16769737|P2|Overall Study|Lack of Efficacy|377
4865618|NCT00856583|16769738|P1|Overall Study|Lack of Efficacy|389
4865619|NCT00856557|16769768|P2|Overall Study|No patients with contextual flags|16
4865620|NCT00856557|16769769|P1|Overall Study|No patients with contextual flags|12
4865621|NCT00856544|16769783|P4|Overall Study|Withdrawal by Subject|1
4865622|NCT00856544|16769784|P3|Overall Study|Withdrawal by Subject|0
4865623|NCT00856544|16769785|P2|Overall Study|Withdrawal by Subject|5
4865624|NCT00856544|16769786|P1|Overall Study|Withdrawal by Subject|8
4865625|NCT00856544|16769783|P4|Overall Study|Lost to Follow-up|0
4865626|NCT00856544|16769784|P3|Overall Study|Lost to Follow-up|2
4865627|NCT00856544|16769785|P2|Overall Study|Lost to Follow-up|2
4865628|NCT00856544|16769786|P1|Overall Study|Lost to Follow-up|1
4865629|NCT00856544|16769783|P4|Overall Study|Other|6
4865630|NCT00856544|16769784|P3|Overall Study|Other|1
4865631|NCT00856544|16769785|P2|Overall Study|Other|16
4865632|NCT00856544|16769786|P1|Overall Study|Other|9
4865633|NCT00856544|16769783|P4|Overall Study|Lack of Efficacy|3
4865634|NCT00856544|16769784|P3|Overall Study|Lack of Efficacy|3
4865635|NCT00856544|16769785|P2|Overall Study|Lack of Efficacy|12
4865636|NCT00856544|16769786|P1|Overall Study|Lack of Efficacy|16
4865637|NCT00856544|16769783|P4|Overall Study|Adverse Event|3
4865638|NCT00856544|16769784|P3|Overall Study|Adverse Event|2
4865639|NCT00856544|16769785|P2|Overall Study|Adverse Event|29
4865640|NCT00856544|16769786|P1|Overall Study|Adverse Event|20
4865641|NCT00856544|16769783|P4|Overall Study|Death|0
4865642|NCT00856544|16769784|P3|Overall Study|Death|0
4865643|NCT00856544|16769785|P2|Overall Study|Death|2
4865644|NCT00856544|16769786|P1|Overall Study|Death|0
4865645|NCT00856544|16769783|P4|Overall Study|Randomized but not treated|0
4865646|NCT00856544|16769784|P3|Overall Study|Randomized but not treated|0
4865647|NCT00856544|16769785|P2|Overall Study|Randomized but not treated|0
4865648|NCT00856544|16769786|P1|Overall Study|Randomized but not treated|3
4865649|NCT00856518|16769965|P2|Overall Study|Lost to Follow-up|2
4865650|NCT00856518|16769966|P1|Overall Study|Lost to Follow-up|4
4865651|NCT00856492|16769979|P3|Overall Study|Ineligible or withdrew consent|2
4865652|NCT00856492|16769980|P2|Overall Study|Ineligible or withdrew consent|1
4865653|NCT00856492|16769981|P1|Overall Study|Ineligible or withdrew consent|1
4865654|NCT00856388|16770003|P1|Overall Study|Other|1
4865655|NCT00856349|16770014|P1|Overall Study|Subject changed Dr, insurance issue, etc|130
4865656|NCT00856349|16770014|P1|Overall Study|Site closure|78
4865657|NCT00856349|16770014|P1|Overall Study|Device explant|33
4865658|NCT00856349|16770014|P1|Overall Study|Subject relocation|104
4865659|NCT00856349|16770014|P1|Overall Study|Physician Decision|13
4865660|NCT00856349|16770014|P1|Overall Study|Protocol Violation|38
4865661|NCT00856349|16770014|P1|Overall Study|Lost to Follow-up|91
4865662|NCT00856349|16770014|P1|Overall Study|Withdrawal by Subject|116
4865663|NCT00856349|16770014|P1|Overall Study|Death|418
4865664|NCT00856323|16770023|P1|Overall Study|Withdrawal by Subject|2
4865665|NCT00856297|16770035|P5|Overall Study|Unable to classify|0
4865666|NCT00856297|16770036|P4|Overall Study|Unable to classify|0
4865667|NCT00856297|16770037|P3|Overall Study|Unable to classify|0
4865668|NCT00856297|16770038|P2|Overall Study|Unable to classify|0
4865669|NCT00856297|16770039|P1|Overall Study|Unable to classify|2
4865670|NCT00856284|16770072|P3|Overall Study|Randomized in error|1
4865671|NCT00856284|16770073|P2|Overall Study|Randomized in error|0
4865672|NCT00856284|16770074|P1|Overall Study|Randomized in error|0
4865673|NCT00856284|16770072|P3|Overall Study|Other|14
4865674|NCT00856284|16770073|P2|Overall Study|Other|17
4865675|NCT00856284|16770074|P1|Overall Study|Other|15
4865676|NCT00856284|16770072|P3|Overall Study|Investigator discretion|10
4865677|NCT00856284|16770073|P2|Overall Study|Investigator discretion|8
4865678|NCT00856284|16770074|P1|Overall Study|Investigator discretion|9
4865679|NCT00856284|16770072|P3|Overall Study|Pregnancy|0
4865680|NCT00856284|16770073|P2|Overall Study|Pregnancy|2
4865681|NCT00856284|16770074|P1|Overall Study|Pregnancy|1
4865682|NCT00856284|16770072|P3|Overall Study|Voluntary withdrawal|62
4865683|NCT00856284|16770073|P2|Overall Study|Voluntary withdrawal|52
4865684|NCT00856284|16770074|P1|Overall Study|Voluntary withdrawal|48
4865685|NCT00856284|16770072|P3|Overall Study|Lost to Follow-up|28
4865686|NCT00856284|16770073|P2|Overall Study|Lost to Follow-up|22
4865687|NCT00856284|16770074|P1|Overall Study|Lost to Follow-up|20
4865688|NCT00856284|16770072|P3|Overall Study|Major protocol deviation|15
4865689|NCT00856284|16770073|P2|Overall Study|Major protocol deviation|16
4865690|NCT00856284|16770074|P1|Overall Study|Major protocol deviation|24
4865691|NCT00856284|16770072|P3|Overall Study|Adverse Event|82
4865692|NCT00856284|16770073|P2|Overall Study|Adverse Event|74
4865693|NCT00856284|16770074|P1|Overall Study|Adverse Event|60
4865694|NCT00856284|16770072|P3|Overall Study|Hyperglycemic rescue|235
4865695|NCT00856284|16770073|P2|Overall Study|Hyperglycemic rescue|201
4865696|NCT00856284|16770074|P1|Overall Study|Hyperglycemic rescue|231
4865697|NCT00856245|16770100|P1|Overall Study|Was not transplanted|5
4865698|NCT00856206|16770123|P2|Overall Study|Other than specified above|10
4865699|NCT00856206|16770124|P1|Overall Study|Other than specified above|3
4865700|NCT00856206|16770123|P2|Overall Study|Decision by the Sponsor|8
4865701|NCT00856206|16770124|P1|Overall Study|Decision by the Sponsor|4
4865702|NCT00856206|16770123|P2|Overall Study|Death|2
4865703|NCT00856206|16770124|P1|Overall Study|Death|2
4865704|NCT00856206|16770123|P2|Overall Study|Lost to Follow-up|39
4865705|NCT00856206|16770124|P1|Overall Study|Lost to Follow-up|13
4865706|NCT00856206|16770123|P2|Overall Study|Withdrawal by Subject|36
4865707|NCT00856206|16770124|P1|Overall Study|Withdrawal by Subject|15
4865708|NCT00856206|16770123|P2|Overall Study|Lack of Efficacy|2
4865709|NCT00856206|16770124|P1|Overall Study|Lack of Efficacy|1
4865710|NCT00856206|16770123|P2|Overall Study|Adverse Event|46
4865711|NCT00856206|16770124|P1|Overall Study|Adverse Event|10
4865712|NCT00856206|16770123|P2|Overall Study|Protocol Violation|18
4865713|NCT00856206|16770124|P1|Overall Study|Protocol Violation|6
4865714|NCT00856193|16770138|P2|Period 2|Lost to Follow-up|1
4865715|NCT00856193|16770139|P1|Period 2|Lost to Follow-up|0
4865716|NCT00856193|16770138|P2|Period 2|Abnormal test procedure results|1
4865717|NCT00856193|16770139|P1|Period 2|Abnormal test procedure results|0
4865718|NCT00856180|16770151|P1|Overall Study|Progressive Disease|16
4865719|NCT00856180|16770151|P1|Overall Study|Adverse Event|4
4865720|NCT00855959|16770176|P1|Overall Study|Incorrect enrolment|1
4865721|NCT00855959|16770176|P1|Overall Study|Pregnancy|1
4865722|NCT00855959|16770176|P1|Overall Study|Withdrawal by Subject|3
4865723|NCT00855959|16770176|P1|Overall Study|Lost to Follow-up|2
4865724|NCT00855959|16770176|P1|Overall Study|Adverse Event|2
4865725|NCT00855933|16770193|P2|Overall Study|Withdrawal by Subject|1
4865726|NCT00855933|16770194|P1|Overall Study|Withdrawal by Subject|0
4865727|NCT00855920|16770203|P3|Overall Study|Other than specified above|1
4865728|NCT00855920|16770204|P2|Overall Study|Other than specified above|1
4865729|NCT00855920|16770205|P1|Overall Study|Other than specified above|1
4865730|NCT00855920|16770203|P3|Overall Study|Decision by the sponsor|1
4865731|NCT00855920|16770204|P2|Overall Study|Decision by the sponsor|1
4865732|NCT00855920|16770205|P1|Overall Study|Decision by the sponsor|0
4865733|NCT00855920|16770203|P3|Overall Study|Death|0
4865734|NCT00855920|16770204|P2|Overall Study|Death|1
4865735|NCT00855920|16770205|P1|Overall Study|Death|0
4865736|NCT00855920|16770203|P3|Overall Study|Lost to Follow-up|2
4865737|NCT00855920|16770204|P2|Overall Study|Lost to Follow-up|0
4865738|NCT00855920|16770205|P1|Overall Study|Lost to Follow-up|1
4865739|NCT00855920|16770203|P3|Overall Study|Withdrawal by Subject|2
4865740|NCT00855920|16770204|P2|Overall Study|Withdrawal by Subject|3
4865741|NCT00855920|16770205|P1|Overall Study|Withdrawal by Subject|2
4865742|NCT00855920|16770203|P3|Overall Study|Lack of Efficacy|2
4865743|NCT00855920|16770204|P2|Overall Study|Lack of Efficacy|2
4865744|NCT00855920|16770205|P1|Overall Study|Lack of Efficacy|2
4865745|NCT00855920|16770203|P3|Overall Study|Adverse Event|1
4865746|NCT00855920|16770204|P2|Overall Study|Adverse Event|1
4865747|NCT00855920|16770205|P1|Overall Study|Adverse Event|2
4865748|NCT00855920|16770203|P3|Overall Study|Protocol Violation|2
4865749|NCT00855920|16770204|P2|Overall Study|Protocol Violation|0
4865750|NCT00855920|16770205|P1|Overall Study|Protocol Violation|0
4865751|NCT00855894|16770222|P1|Overall Study|Disease progression|1
4865752|NCT00855894|16770222|P1|Overall Study|Patient's decision|1
4865753|NCT00855894|16770222|P1|Overall Study|Death|31
4865754|NCT00855816|16770245|P2|Overall Study|Became ineligible|1
4865755|NCT00855816|16770246|P1|Overall Study|Became ineligible|0
4865756|NCT00855816|16770245|P2|Overall Study|Death|0
4865757|NCT00855816|16770246|P1|Overall Study|Death|1
4865758|NCT00855816|16770245|P2|Overall Study|Lost to Follow-up|5
4865759|NCT00855816|16770246|P1|Overall Study|Lost to Follow-up|3
4865760|NCT00855816|16770245|P2|Overall Study|Withdrawal by Subject|15
4865761|NCT00855816|16770246|P1|Overall Study|Withdrawal by Subject|22
4865762|NCT00855738|16770252|P1|Overall Study|Death|1
4865763|NCT00855738|16770252|P1|Overall Study|Subject Defaulted|1
4865764|NCT00855738|16770252|P1|Overall Study|Adverse Event|1
4865765|NCT00855738|16770252|P1|Overall Study|Lost to Follow-up|2
4865766|NCT00855595|16770280|P2|Overall Study|patient left country|1
4865767|NCT00855595|16770281|P1|Overall Study|patient left country|0
4865768|NCT00855595|16770280|P2|Overall Study|patient moved out of state|0
4865769|NCT00855595|16770281|P1|Overall Study|patient moved out of state|1
4865770|NCT00855595|16770280|P2|Overall Study|Adverse Event|1
4865771|NCT00855595|16770281|P1|Overall Study|Adverse Event|1
4865772|NCT00855595|16770280|P2|Overall Study|Lost to Follow-up|3
4865773|NCT00855595|16770281|P1|Overall Study|Lost to Follow-up|3
4865774|NCT00855595|16770280|P2|Overall Study|Withdrawal by Subject|2
4865775|NCT00855595|16770281|P1|Overall Study|Withdrawal by Subject|1
4865776|NCT00855582|16770320|P3|Overall Study|Withdrawal by Subject|8
4865777|NCT00855582|16770321|P2|Overall Study|Withdrawal by Subject|4
4865778|NCT00855582|16770322|P1|Overall Study|Withdrawal by Subject|7
4865779|NCT00855582|16770320|P3|Overall Study|Entry Criteria Not Met|3
4865780|NCT00855582|16770321|P2|Overall Study|Entry Criteria Not Met|6
4865781|NCT00855582|16770322|P1|Overall Study|Entry Criteria Not Met|8
4865782|NCT00855582|16770320|P3|Overall Study|Protocol Violation|6
4865783|NCT00855582|16770321|P2|Overall Study|Protocol Violation|2
4865784|NCT00855582|16770322|P1|Overall Study|Protocol Violation|6
4865785|NCT00855582|16770320|P3|Overall Study|Physician Decision|1
4865786|NCT00855582|16770321|P2|Overall Study|Physician Decision|0
4865787|NCT00855582|16770322|P1|Overall Study|Physician Decision|0
4865788|NCT00855582|16770320|P3|Overall Study|Lost to Follow-up|1
4865789|NCT00855582|16770321|P2|Overall Study|Lost to Follow-up|3
4865790|NCT00855582|16770322|P1|Overall Study|Lost to Follow-up|1
4865791|NCT00855582|16770320|P3|Overall Study|Lack of Efficacy|8
4865792|NCT00855582|16770321|P2|Overall Study|Lack of Efficacy|3
4865793|NCT00855582|16770322|P1|Overall Study|Lack of Efficacy|1
4865794|NCT00855582|16770320|P3|Overall Study|Death|0
4865795|NCT00855582|16770321|P2|Overall Study|Death|0
4865796|NCT00855582|16770322|P1|Overall Study|Death|1
4865797|NCT00855582|16770320|P3|Overall Study|Adverse Event|3
4865798|NCT00855582|16770321|P2|Overall Study|Adverse Event|6
4865799|NCT00855582|16770322|P1|Overall Study|Adverse Event|2
4865800|NCT00855465|16770411|P2|Follow-up Period (FUP)|Missing|0
4865801|NCT00855465|16770412|P1|Follow-up Period (FUP)|Missing|1
4865802|NCT00855465|16770411|P2|Follow-up Period (FUP)|Withdrawal by Subject|0
4865803|NCT00855465|16770412|P1|Follow-up Period (FUP)|Withdrawal by Subject|4
4865804|NCT00855465|16770411|P2|Follow-up Period (FUP)|Lost to Follow-up|0
4865805|NCT00855465|16770412|P1|Follow-up Period (FUP)|Lost to Follow-up|3
4865806|NCT00855465|16770411|P2|Follow-up Period (FUP)|Death|1
4865807|NCT00855465|16770412|P1|Follow-up Period (FUP)|Death|0
4865808|NCT00855465|16770411|P2|Follow-up Period (FUP)|Adverse Event|1
4865809|NCT00855465|16770412|P1|Follow-up Period (FUP)|Adverse Event|0
4865810|NCT00855465|16770411|P2|Treatment Period|Not treated|0
4865811|NCT00855465|16770412|P1|Treatment Period|Not treated|1
4865812|NCT00855465|16770411|P2|Treatment Period|Withdrawal by Subject|0
4865813|NCT00855465|16770412|P1|Treatment Period|Withdrawal by Subject|2
4865814|NCT00855465|16770411|P2|Treatment Period|Protocol Violation|0
4865815|NCT00855465|16770412|P1|Treatment Period|Protocol Violation|2
4865816|NCT00855465|16770411|P2|Treatment Period|Non-compliance|0
4865817|NCT00855465|16770412|P1|Treatment Period|Non-compliance|1
4865818|NCT00855465|16770411|P2|Treatment Period|Lack of Efficacy|1
4865819|NCT00855465|16770412|P1|Treatment Period|Lack of Efficacy|2
4865820|NCT00855465|16770411|P2|Treatment Period|Death|2
4865821|NCT00855465|16770412|P1|Treatment Period|Death|2
4865822|NCT00855465|16770411|P2|Treatment Period|Adverse Event|2
4865823|NCT00855465|16770412|P1|Treatment Period|Adverse Event|4
4865824|NCT00855439|16770502|P2|Overall Study|Pregnancy|0
4865825|NCT00855439|16770503|P1|Overall Study|Pregnancy|1
4865826|NCT00855439|16770502|P2|Overall Study|Withdrawal by Subject|0
4865827|NCT00855439|16770503|P1|Overall Study|Withdrawal by Subject|2
4865828|NCT00855335|16770561|P5|Overall Study|Other|1
4865829|NCT00855335|16770562|P4|Overall Study|Other|5
4865830|NCT00855335|16770563|P3|Overall Study|Other|2
4865831|NCT00855335|16770564|P2|Overall Study|Other|1
4865832|NCT00855335|16770565|P1|Overall Study|Other|2
4865833|NCT00855335|16770561|P5|Overall Study|Physician Decision|0
4865834|NCT00855335|16770562|P4|Overall Study|Physician Decision|0
4865835|NCT00855335|16770563|P3|Overall Study|Physician Decision|0
4865836|NCT00855335|16770564|P2|Overall Study|Physician Decision|1
4865837|NCT00855335|16770565|P1|Overall Study|Physician Decision|1
4865838|NCT00855335|16770561|P5|Overall Study|Adverse Event|0
4865839|NCT00855335|16770562|P4|Overall Study|Adverse Event|0
4865840|NCT00855335|16770563|P3|Overall Study|Adverse Event|0
4865841|NCT00855335|16770564|P2|Overall Study|Adverse Event|0
4865842|NCT00855335|16770565|P1|Overall Study|Adverse Event|2
4865843|NCT00855335|16770561|P5|Overall Study|Withdrawal by Subject|0
4865844|NCT00855335|16770562|P4|Overall Study|Withdrawal by Subject|1
4865845|NCT00855335|16770563|P3|Overall Study|Withdrawal by Subject|0
4865846|NCT00855335|16770564|P2|Overall Study|Withdrawal by Subject|0
4865847|NCT00855335|16770565|P1|Overall Study|Withdrawal by Subject|0
4865848|NCT00855335|16770561|P5|Overall Study|Lost to Follow-up|0
4865849|NCT00855335|16770562|P4|Overall Study|Lost to Follow-up|1
4865850|NCT00855335|16770563|P3|Overall Study|Lost to Follow-up|3
4865851|NCT00855335|16770564|P2|Overall Study|Lost to Follow-up|0
4865852|NCT00855335|16770565|P1|Overall Study|Lost to Follow-up|0
4865853|NCT00855309|16770652|P2|Overall Study|patient never recieved drug|0
4865854|NCT00855309|16770653|P1|Overall Study|patient never recieved drug|1
4865855|NCT00855218|16770661|P2|Overall Study|Clinical endpoint reached|13
4865856|NCT00855218|16770662|P1|Overall Study|Clinical endpoint reached|10
4865857|NCT00855218|16770661|P2|Overall Study|Progression measurement proven|15
4865858|NCT00855218|16770662|P1|Overall Study|Progression measurement proven|7
4865859|NCT00855218|16770661|P2|Overall Study|Second malignancy|1
4865860|NCT00855218|16770662|P1|Overall Study|Second malignancy|0
4865861|NCT00855218|16770661|P2|Overall Study|Untreatable disease progression|67
4865862|NCT00855218|16770662|P1|Overall Study|Untreatable disease progression|54
4865863|NCT00855218|16770661|P2|Overall Study|Still treated with study medication|1
4865864|NCT00855218|16770662|P1|Overall Study|Still treated with study medication|0
4865865|NCT00855218|16770661|P2|Overall Study|technical problems|1
4865866|NCT00855218|16770662|P1|Overall Study|technical problems|2
4865867|NCT00855218|16770661|P2|Overall Study|patient convenience|0
4865868|NCT00855218|16770662|P1|Overall Study|patient convenience|2
4865869|NCT00855218|16770661|P2|Overall Study|non-compliant with study drug|1
4865870|NCT00855218|16770662|P1|Overall Study|non-compliant with study drug|3
4865871|NCT00855218|16770661|P2|Overall Study|Protocol Violation|9
4865872|NCT00855218|16770662|P1|Overall Study|Protocol Violation|5
4865873|NCT00855218|16770661|P2|Overall Study|Lost to Follow-up|1
4865874|NCT00855218|16770662|P1|Overall Study|Lost to Follow-up|0
4865875|NCT00855218|16770661|P2|Overall Study|Physician Decision|11
4865876|NCT00855218|16770662|P1|Overall Study|Physician Decision|18
4865877|NCT00855218|16770661|P2|Overall Study|Withdrawal by Subject|6
4865878|NCT00855218|16770662|P1|Overall Study|Withdrawal by Subject|10
4865879|NCT00855218|16770661|P2|Overall Study|Adverse Event|27
4865880|NCT00855218|16770662|P1|Overall Study|Adverse Event|43
4865881|NCT00855166|16770680|P2|Overall Study|Subject no longer meets study criteria|1
4865882|NCT00855166|16770681|P1|Overall Study|Subject no longer meets study criteria|1
4865883|NCT00855166|16770680|P2|Overall Study|Administrative reasons by sponsor|0
4865884|NCT00855166|16770681|P1|Overall Study|Administrative reasons by sponsor|1
4865885|NCT00855166|16770680|P2|Overall Study|Poor/non-compliance|0
4865886|NCT00855166|16770681|P1|Overall Study|Poor/non-compliance|2
4865887|NCT00855166|16770680|P2|Overall Study|Withdrawal by Subject|4
4865888|NCT00855166|16770681|P1|Overall Study|Withdrawal by Subject|1
4865889|NCT00855166|16770680|P2|Overall Study|Death|1
4865890|NCT00855166|16770681|P1|Overall Study|Death|0
4865891|NCT00855166|16770680|P2|Overall Study|Adverse Event|2
4865892|NCT00855166|16770681|P1|Overall Study|Adverse Event|0
4865893|NCT00855062|16770701|P2|Step2|Initiation of antiretroviral therapy/ART|1
4865894|NCT00855062|16770702|P1|Step2|Initiation of antiretroviral therapy/ART|0
4865895|NCT00855062|16770701|P2|Step2|Adverse Event|3
4865896|NCT00855062|16770702|P1|Step2|Adverse Event|0
4865897|NCT00855062|16770701|P2|Step2|Early Study Closure|2
4865898|NCT00855062|16770702|P1|Step2|Early Study Closure|6
4865899|NCT00855062|16770701|P2|Step1|Withdrawal by Subject|3
4865900|NCT00855062|16770702|P1|Step1|Withdrawal by Subject|2
4865901|NCT00855062|16770701|P2|Step1|Pregnancy|0
4865902|NCT00855062|16770702|P1|Step1|Pregnancy|1
4865903|NCT00855062|16770701|P2|Step1|Protocol Violation|0
4865904|NCT00855062|16770702|P1|Step1|Protocol Violation|1
4865905|NCT00855062|16770701|P2|Step1|Adverse Event|1
4865906|NCT00855062|16770702|P1|Step1|Adverse Event|1
4865907|NCT00855062|16770701|P2|Step1|Early Study Closure|7
4865908|NCT00855062|16770702|P1|Step1|Early Study Closure|5
4865909|NCT00854906|16770751|P1|Overall Study|One person had no ocular history|1
4865910|NCT00854724|16770760|P2|Second Intervention|Physician Decision|1
4865911|NCT00854724|16770761|P1|Second Intervention|Physician Decision|0
4865912|NCT00854724|16770760|P2|Second Intervention|Protocol Violation|0
4865913|NCT00854724|16770761|P1|Second Intervention|Protocol Violation|1
4865914|NCT00854724|16770760|P2|Washout|Withdrawal by Subject|1
4865915|NCT00854724|16770761|P1|Washout|Withdrawal by Subject|0
4865916|NCT00854724|16770760|P2|Washout|Protocol Violation|0
4865917|NCT00854724|16770761|P1|Washout|Protocol Violation|1
4865918|NCT00854724|16770760|P2|First Intervention|Withdrawal by Subject|1
4865919|NCT00854724|16770761|P1|First Intervention|Withdrawal by Subject|1
4865920|NCT00854620|16770767|P1|Overall Study|Adverse Event|1
4865921|NCT00854607|16770771|P1|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65
4865922|NCT00854581|16770819|P1|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3
4865923|NCT00854581|16770819|P1|Induction (Up to Day 21)|Physician Decision|1
4865924|NCT00854581|16770819|P1|Induction (Up to Day 21)|Death|1
4865925|NCT00854581|16770819|P1|Induction (Up to Day 21)|Lack of Efficacy|4
4865926|NCT00854373|16770834|P2|Overall Study|Forgot to take study drug|1
4865927|NCT00854373|16770835|P1|Overall Study|Forgot to take study drug|1
4865928|NCT00854373|16770834|P2|Overall Study|Withdrawal by Subject|3
4865929|NCT00854373|16770835|P1|Overall Study|Withdrawal by Subject|1
4865930|NCT00854360|16770849|P4|Overall Study|Other|3
4865931|NCT00854360|16770850|P3|Overall Study|Other|0
4865932|NCT00854360|16770851|P2|Overall Study|Other|0
4865933|NCT00854360|16770852|P1|Overall Study|Other|0
4865934|NCT00854360|16770849|P4|Overall Study|Lack of Efficacy|0
4865935|NCT00854360|16770850|P3|Overall Study|Lack of Efficacy|0
4865936|NCT00854360|16770851|P2|Overall Study|Lack of Efficacy|1
4865937|NCT00854360|16770852|P1|Overall Study|Lack of Efficacy|2
4865938|NCT00854360|16770849|P4|Overall Study|Pregnancy|0
4865939|NCT00854360|16770850|P3|Overall Study|Pregnancy|0
4865940|NCT00854360|16770851|P2|Overall Study|Pregnancy|1
4865941|NCT00854360|16770852|P1|Overall Study|Pregnancy|0
4865942|NCT00854360|16770849|P4|Overall Study|Withdrawal by Subject|1
4865943|NCT00854360|16770850|P3|Overall Study|Withdrawal by Subject|0
4865944|NCT00854360|16770851|P2|Overall Study|Withdrawal by Subject|0
4865945|NCT00854360|16770852|P1|Overall Study|Withdrawal by Subject|0
4865946|NCT00854360|16770849|P4|Overall Study|Adverse Event|6
4865947|NCT00854360|16770850|P3|Overall Study|Adverse Event|2
4865948|NCT00854360|16770851|P2|Overall Study|Adverse Event|1
4865949|NCT00854360|16770852|P1|Overall Study|Adverse Event|0
4865950|NCT00854308|16770884|P2|Overall Study|Sponsor's decision to terminate study|1
4865951|NCT00854308|16770885|P1|Overall Study|Sponsor's decision to terminate study|0
4865952|NCT00854308|16770884|P2|Overall Study|Withdrawal by Subject|2
4865953|NCT00854308|16770885|P1|Overall Study|Withdrawal by Subject|4
4865954|NCT00854308|16770884|P2|Overall Study|Physician Decision|6
4865955|NCT00854308|16770885|P1|Overall Study|Physician Decision|6
4865956|NCT00854308|16770884|P2|Overall Study|Death|5
4865957|NCT00854308|16770885|P1|Overall Study|Death|2
4865958|NCT00854308|16770884|P2|Overall Study|Adverse Event|3
4865959|NCT00854308|16770885|P1|Overall Study|Adverse Event|8
4865960|NCT00854308|16770884|P2|Overall Study|Disease progression|50
4865961|NCT00854308|16770885|P1|Overall Study|Disease progression|42
4865962|NCT00854113|16770910|P11|Overall Study|Withdrawal by Subject|0
4865963|NCT00854113|16770911|P10|Overall Study|Withdrawal by Subject|0
4865964|NCT00854113|16770912|P9|Overall Study|Withdrawal by Subject|1
4865965|NCT00854113|16770913|P8|Overall Study|Withdrawal by Subject|1
4865966|NCT00854113|16770914|P7|Overall Study|Withdrawal by Subject|0
4865967|NCT00854113|16770915|P6|Overall Study|Withdrawal by Subject|0
4865968|NCT00854113|16770916|P5|Overall Study|Withdrawal by Subject|0
4865969|NCT00854113|16770917|P4|Overall Study|Withdrawal by Subject|0
4865970|NCT00854113|16770918|P3|Overall Study|Withdrawal by Subject|0
4865971|NCT00854113|16770919|P2|Overall Study|Withdrawal by Subject|0
4865972|NCT00854113|16770920|P1|Overall Study|Withdrawal by Subject|0
4865973|NCT00854113|16770910|P11|Overall Study|Adverse Event|0
4865974|NCT00854113|16770911|P10|Overall Study|Adverse Event|0
4865975|NCT00854113|16770912|P9|Overall Study|Adverse Event|0
4865976|NCT00854113|16770913|P8|Overall Study|Adverse Event|2
4865977|NCT00854113|16770914|P7|Overall Study|Adverse Event|0
4865978|NCT00854113|16770915|P6|Overall Study|Adverse Event|0
4865979|NCT00854113|16770916|P5|Overall Study|Adverse Event|0
4865980|NCT00854113|16770917|P4|Overall Study|Adverse Event|0
4865981|NCT00854113|16770918|P3|Overall Study|Adverse Event|0
4865982|NCT00854113|16770919|P2|Overall Study|Adverse Event|0
4865983|NCT00854113|16770920|P1|Overall Study|Adverse Event|0
4865984|NCT00854100|16771024|P3|Overall Study|Adverse Event|2
4865985|NCT00854100|16771025|P2|Overall Study|Adverse Event|1
4865986|NCT00854100|16771026|P1|Overall Study|Adverse Event|2
4865987|NCT00854100|16771024|P3|Overall Study|Protocol Violation|3
4865988|NCT00854100|16771025|P2|Overall Study|Protocol Violation|4
4865989|NCT00854100|16771026|P1|Overall Study|Protocol Violation|2
4865990|NCT00854100|16771024|P3|Overall Study|Withdrawal by Subject|2
4865991|NCT00854100|16771025|P2|Overall Study|Withdrawal by Subject|1
4865992|NCT00854100|16771026|P1|Overall Study|Withdrawal by Subject|3
4865993|NCT00854100|16771024|P3|Overall Study|Lost to Follow-up|3
4865994|NCT00854100|16771025|P2|Overall Study|Lost to Follow-up|0
4865995|NCT00854100|16771026|P1|Overall Study|Lost to Follow-up|2
4865996|NCT00854100|16771024|P3|Overall Study|Inability to complete the study visits|1
4865997|NCT00854100|16771025|P2|Overall Study|Inability to complete the study visits|0
4865998|NCT00854100|16771026|P1|Overall Study|Inability to complete the study visits|0
4865999|NCT00853970|16771065|P2|Overall Study|Cancelled surgery|2
4866000|NCT00853970|16771066|P1|Overall Study|Cancelled surgery|4
4866001|NCT00853970|16771065|P2|Overall Study|Withdrawal by Subject|1
4866002|NCT00853970|16771066|P1|Overall Study|Withdrawal by Subject|2
4866003|NCT00853957|16771076|P2|Overall Study|Protocol deviation|3
4866004|NCT00853957|16771077|P1|Overall Study|Protocol deviation|0
4866005|NCT00853957|16771076|P2|Overall Study|Lost to Follow-up|6
4866006|NCT00853957|16771077|P1|Overall Study|Lost to Follow-up|1
4866007|NCT00853957|16771076|P2|Overall Study|Subject withdrew consent|5
4866008|NCT00853957|16771077|P1|Overall Study|Subject withdrew consent|4
4866009|NCT00853957|16771076|P2|Overall Study|Unsatisfactory therapeutic effect|2
4866010|NCT00853957|16771077|P1|Overall Study|Unsatisfactory therapeutic effect|0
4866011|NCT00853957|16771076|P2|Overall Study|Adverse Event|3
4866012|NCT00853957|16771077|P1|Overall Study|Adverse Event|9
4866013|NCT00853905|16771095|P2|Overall Study|never had surgery|0
4866014|NCT00853905|16771096|P1|Overall Study|never had surgery|1
4866015|NCT00853905|16771095|P2|Overall Study|Withdrawal by Subject|1
4866016|NCT00853905|16771096|P1|Overall Study|Withdrawal by Subject|0
4866017|NCT00853905|16771095|P2|Overall Study|Lost to Follow-up|3
4866018|NCT00853905|16771096|P1|Overall Study|Lost to Follow-up|1
4866019|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Death|6
4866020|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Death|1
4866021|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Administrative problems|56
4866022|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Administrative problems|45
4866023|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Lost to Follow-up|10
4866024|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Lost to Follow-up|8
4866025|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Withdrawal by Subject|18
4866026|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Withdrawal by Subject|19
4866027|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Protocol Violation|1
4866028|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Protocol Violation|2
4866029|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1
4866030|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3
4866031|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Lack of Efficacy|0
4866032|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Lack of Efficacy|1
4866033|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Abnormal laboratory values|3
4866034|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Abnormal laboratory values|0
4866035|NCT00853827|16771128|P2|Double Blind Period (103 Weeks)|Adverse Event|14
4866036|NCT00853827|16771129|P1|Double Blind Period (103 Weeks)|Adverse Event|25
4866037|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Protocol Violation|0
4866038|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Protocol Violation|12
4866039|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Lost to Follow-up|0
4866040|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Lost to Follow-up|1
4866041|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Withdrawal by Subject|0
4866042|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Withdrawal by Subject|9
4866043|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Abnormal test procedure result|0
4866044|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Abnormal test procedure result|1
4866045|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Abnormal laboratory value|0
4866046|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Abnormal laboratory value|3
4866047|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Adverse Event|0
4866048|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Adverse Event|9
4866049|NCT00853827|16771128|P2|Single Blind Period (1 Week)|Other|0
4866050|NCT00853827|16771129|P1|Single Blind Period (1 Week)|Other|4
4866051|NCT00853762|16771145|P4|Overall Study|Randomised but not Treated|0
4866052|NCT00853762|16771146|P3|Overall Study|Randomised but not Treated|2
4866053|NCT00853762|16771147|P2|Overall Study|Randomised but not Treated|2
4866054|NCT00853762|16771148|P1|Overall Study|Randomised but not Treated|0
4866055|NCT00853762|16771145|P4|Overall Study|Other|0
4866056|NCT00853762|16771146|P3|Overall Study|Other|0
4866057|NCT00853762|16771147|P2|Overall Study|Other|2
4866058|NCT00853762|16771148|P1|Overall Study|Other|0
4866059|NCT00853762|16771145|P4|Overall Study|Withdrawal by Subject|0
4866060|NCT00853762|16771146|P3|Overall Study|Withdrawal by Subject|1
4866061|NCT00853762|16771147|P2|Overall Study|Withdrawal by Subject|0
4866062|NCT00853762|16771148|P1|Overall Study|Withdrawal by Subject|0
4866063|NCT00853762|16771145|P4|Overall Study|Protocol Violation|1
4866064|NCT00853762|16771146|P3|Overall Study|Protocol Violation|0
4866065|NCT00853762|16771147|P2|Overall Study|Protocol Violation|0
4866066|NCT00853762|16771148|P1|Overall Study|Protocol Violation|0
4866067|NCT00853762|16771145|P4|Overall Study|Premature Termination|21
4866068|NCT00853762|16771146|P3|Overall Study|Premature Termination|14
4866069|NCT00853762|16771147|P2|Overall Study|Premature Termination|15
4866070|NCT00853762|16771148|P1|Overall Study|Premature Termination|16
4866071|NCT00853749|16771216|P2|Overall Study|Lost to Follow-up|1
4866072|NCT00853749|16771217|P1|Overall Study|Lost to Follow-up|0
4866073|NCT00853723|16771238|P3|Overall Study|Protocol Violation|1
4866074|NCT00853723|16771239|P2|Overall Study|Protocol Violation|2
4866075|NCT00853723|16771240|P1|Overall Study|Protocol Violation|1
4866076|NCT00853723|16771238|P3|Overall Study|Withdrawal by Subject|0
4866077|NCT00853723|16771239|P2|Overall Study|Withdrawal by Subject|1
4866078|NCT00853723|16771240|P1|Overall Study|Withdrawal by Subject|2
4866079|NCT00853723|16771238|P3|Overall Study|Adverse Event|1
4866080|NCT00853723|16771239|P2|Overall Study|Adverse Event|4
4866081|NCT00853723|16771240|P1|Overall Study|Adverse Event|3
4866082|NCT00853658|16771294|P3|Overall Study|Missing study completion information|6
4866083|NCT00853658|16771295|P2|Overall Study|Missing study completion information|4
4866084|NCT00853658|16771296|P1|Overall Study|Missing study completion information|5
4866085|NCT00853658|16771294|P3|Overall Study|Patient's request|11
4866086|NCT00853658|16771295|P2|Overall Study|Patient's request|17
4866087|NCT00853658|16771296|P1|Overall Study|Patient's request|21
4866088|NCT00853658|16771294|P3|Overall Study|Vital Status at study end N/A|10
4866089|NCT00853658|16771295|P2|Overall Study|Vital Status at study end N/A|10
4866090|NCT00853658|16771296|P1|Overall Study|Vital Status at study end N/A|8
4866091|NCT00853658|16771294|P3|Overall Study|Vital Status unknown at study end|0
4866092|NCT00853658|16771295|P2|Overall Study|Vital Status unknown at study end|1
4866093|NCT00853658|16771296|P1|Overall Study|Vital Status unknown at study end|1
4866094|NCT00853658|16771294|P3|Overall Study|Vital Status known (alive) at study end|3
4866095|NCT00853658|16771295|P2|Overall Study|Vital Status known (alive) at study end|3
4866096|NCT00853658|16771296|P1|Overall Study|Vital Status known (alive) at study end|2
4866097|NCT00853658|16771294|P3|Overall Study|IRB request|2
4866098|NCT00853658|16771295|P2|Overall Study|IRB request|0
4866099|NCT00853658|16771296|P1|Overall Study|IRB request|0
4866100|NCT00853658|16771294|P3|Overall Study|H.A. Request|19
4866101|NCT00853658|16771295|P2|Overall Study|H.A. Request|23
4866102|NCT00853658|16771296|P1|Overall Study|H.A. Request|26
4866103|NCT00853658|16771294|P3|Overall Study|Lost to Follow-up|11
4866104|NCT00853658|16771295|P2|Overall Study|Lost to Follow-up|6
4866105|NCT00853658|16771296|P1|Overall Study|Lost to Follow-up|11
4866106|NCT00853658|16771294|P3|Overall Study|Death|753
4866107|NCT00853658|16771295|P2|Overall Study|Death|768
4866108|NCT00853658|16771296|P1|Overall Study|Death|713
4866109|NCT00853593|16771316|P1|Overall Study|Implant not attempted|4
4866110|NCT00853593|16771316|P1|Overall Study|Model 4396 lead not attempted|29
4866111|NCT00853593|16771316|P1|Overall Study|Subjects did not receive a 4396 lead|12
4866112|NCT00853580|16771343|P2|Overall Study|Commenced contraindicated therapy|2
4866113|NCT00853580|16771344|P1|Overall Study|Commenced contraindicated therapy|0
4866114|NCT00853580|16771343|P2|Overall Study|Withdrawal by Subject|8
4866115|NCT00853580|16771344|P1|Overall Study|Withdrawal by Subject|2
4866116|NCT00853580|16771343|P2|Overall Study|Protocol Violation|1
4866117|NCT00853580|16771344|P1|Overall Study|Protocol Violation|2
4866118|NCT00853580|16771343|P2|Overall Study|Lost to Follow-up|5
4866119|NCT00853580|16771344|P1|Overall Study|Lost to Follow-up|3
4866120|NCT00853567|16771391|P1|Overall Study|Study prematurely terminated|71
4866121|NCT00853489|16771401|P2|Overall Study|Lost to Follow-up|2
4866122|NCT00853489|16771402|P1|Overall Study|Lost to Follow-up|5
4866123|NCT00853385|16771417|P5|Overall Study|Other|12
4866124|NCT00853385|16771418|P4|Overall Study|Other|4
4866125|NCT00853385|16771419|P3|Overall Study|Other|4
4866126|NCT00853385|16771420|P2|Overall Study|Other|9
4866127|NCT00853385|16771421|P1|Overall Study|Other|18
4866128|NCT00853385|16771417|P5|Overall Study|Withdrawal by Subject|1
4866129|NCT00853385|16771418|P4|Overall Study|Withdrawal by Subject|1
4866130|NCT00853385|16771419|P3|Overall Study|Withdrawal by Subject|0
4866131|NCT00853385|16771420|P2|Overall Study|Withdrawal by Subject|2
4866132|NCT00853385|16771421|P1|Overall Study|Withdrawal by Subject|4
4866133|NCT00853385|16771417|P5|Overall Study|Lost to Follow-up|0
4866134|NCT00853385|16771418|P4|Overall Study|Lost to Follow-up|0
4866135|NCT00853385|16771419|P3|Overall Study|Lost to Follow-up|0
4866136|NCT00853385|16771420|P2|Overall Study|Lost to Follow-up|1
4866137|NCT00853385|16771421|P1|Overall Study|Lost to Follow-up|2
4866138|NCT00853385|16771417|P5|Overall Study|Lack of Efficacy|6
4866139|NCT00853385|16771418|P4|Overall Study|Lack of Efficacy|3
4866140|NCT00853385|16771419|P3|Overall Study|Lack of Efficacy|3
4866141|NCT00853385|16771420|P2|Overall Study|Lack of Efficacy|7
4866142|NCT00853385|16771421|P1|Overall Study|Lack of Efficacy|6
4866143|NCT00853385|16771417|P5|Overall Study|Adverse Event|22
4866144|NCT00853385|16771418|P4|Overall Study|Adverse Event|5
4866145|NCT00853385|16771419|P3|Overall Study|Adverse Event|2
4866146|NCT00853385|16771420|P2|Overall Study|Adverse Event|24
4866147|NCT00853385|16771421|P1|Overall Study|Adverse Event|24
4866148|NCT00853385|16771417|P5|Overall Study|Death|1
4866149|NCT00853385|16771418|P4|Overall Study|Death|0
4866150|NCT00853385|16771419|P3|Overall Study|Death|0
4866151|NCT00853385|16771420|P2|Overall Study|Death|0
4866152|NCT00853385|16771421|P1|Overall Study|Death|0
4866153|NCT00853372|16771636|P2|Overall Study|Full Consent Withdrawn|1
4866154|NCT00853372|16771637|P1|Overall Study|Full Consent Withdrawn|1
4866155|NCT00853372|16771636|P2|Overall Study|Lost to Follow-up|2
4866156|NCT00853372|16771637|P1|Overall Study|Lost to Follow-up|1
4866157|NCT00853372|16771636|P2|Overall Study|Death|26
4866158|NCT00853372|16771637|P1|Overall Study|Death|30
4866159|NCT00853307|16771686|P2|Overall Study|Reason Not Specified|1
4866160|NCT00853307|16771687|P1|Overall Study|Reason Not Specified|0
4866161|NCT00853307|16771686|P2|Overall Study|Withdrawal by Subject|2
4866162|NCT00853307|16771687|P1|Overall Study|Withdrawal by Subject|1
4866163|NCT00853307|16771686|P2|Overall Study|Adverse Event|2
4866164|NCT00853307|16771687|P1|Overall Study|Adverse Event|1
4866165|NCT00853242|16771714|P7|Overall Study|Other|2
4866166|NCT00853242|16771715|P6|Overall Study|Other|1
4866167|NCT00853242|16771716|P5|Overall Study|Other|0
4866168|NCT00853242|16771717|P4|Overall Study|Other|0
4866169|NCT00853242|16771718|P3|Overall Study|Other|2
4866170|NCT00853242|16771719|P2|Overall Study|Other|0
4866171|NCT00853242|16771720|P1|Overall Study|Other|2
4866172|NCT00853242|16771714|P7|Overall Study|Withdrawal by Subject|2
4866173|NCT00853242|16771715|P6|Overall Study|Withdrawal by Subject|0
4866174|NCT00853242|16771716|P5|Overall Study|Withdrawal by Subject|0
4866175|NCT00853242|16771717|P4|Overall Study|Withdrawal by Subject|4
4866176|NCT00853242|16771718|P3|Overall Study|Withdrawal by Subject|0
4866177|NCT00853242|16771719|P2|Overall Study|Withdrawal by Subject|2
4866178|NCT00853242|16771720|P1|Overall Study|Withdrawal by Subject|1
4866179|NCT00853242|16771714|P7|Overall Study|Noncompliant|0
4866180|NCT00853242|16771715|P6|Overall Study|Noncompliant|0
4866181|NCT00853242|16771716|P5|Overall Study|Noncompliant|1
4866182|NCT00853242|16771717|P4|Overall Study|Noncompliant|0
4866183|NCT00853242|16771718|P3|Overall Study|Noncompliant|0
4866184|NCT00853242|16771719|P2|Overall Study|Noncompliant|0
4866185|NCT00853242|16771720|P1|Overall Study|Noncompliant|0
4866186|NCT00853242|16771714|P7|Overall Study|Adverse Event|1
4866187|NCT00853242|16771715|P6|Overall Study|Adverse Event|1
4866188|NCT00853242|16771716|P5|Overall Study|Adverse Event|3
4866189|NCT00853242|16771717|P4|Overall Study|Adverse Event|0
4866190|NCT00853242|16771718|P3|Overall Study|Adverse Event|1
4866191|NCT00853242|16771719|P2|Overall Study|Adverse Event|1
4866192|NCT00853242|16771720|P1|Overall Study|Adverse Event|0
4866193|NCT00853229|16771762|P2|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
4866194|NCT00853229|16771763|P1|Phase 1: Initial Intervention|Early study termination, poor enrollment|8
4866195|NCT00853151|16771773|P4|Overall Study|Sponsor Decision|0
4866196|NCT00853151|16771774|P3|Overall Study|Sponsor Decision|0
4866197|NCT00853151|16771775|P2|Overall Study|Sponsor Decision|3
4866198|NCT00853151|16771776|P1|Overall Study|Sponsor Decision|0
4866199|NCT00853151|16771773|P4|Overall Study|Physician Decision|0
4866200|NCT00853151|16771774|P3|Overall Study|Physician Decision|1
4866201|NCT00853151|16771775|P2|Overall Study|Physician Decision|2
4866202|NCT00853151|16771776|P1|Overall Study|Physician Decision|0
4866203|NCT00853151|16771773|P4|Overall Study|Withdrawal by Subject|1
4866204|NCT00853151|16771774|P3|Overall Study|Withdrawal by Subject|2
4866205|NCT00853151|16771775|P2|Overall Study|Withdrawal by Subject|4
4866206|NCT00853151|16771776|P1|Overall Study|Withdrawal by Subject|5
4866207|NCT00853151|16771773|P4|Overall Study|Protocol Violation|1
4866208|NCT00853151|16771774|P3|Overall Study|Protocol Violation|0
4866209|NCT00853151|16771775|P2|Overall Study|Protocol Violation|0
4866210|NCT00853151|16771776|P1|Overall Study|Protocol Violation|0
4866211|NCT00853151|16771773|P4|Overall Study|Death|1
4866212|NCT00853151|16771774|P3|Overall Study|Death|0
4866213|NCT00853151|16771775|P2|Overall Study|Death|0
4866214|NCT00853151|16771776|P1|Overall Study|Death|1
4866215|NCT00853151|16771773|P4|Overall Study|Lost to Follow-up|0
4866216|NCT00853151|16771774|P3|Overall Study|Lost to Follow-up|3
4866217|NCT00853151|16771775|P2|Overall Study|Lost to Follow-up|0
4866218|NCT00853151|16771776|P1|Overall Study|Lost to Follow-up|2
4866219|NCT00853151|16771773|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4866220|NCT00853151|16771774|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4866221|NCT00853151|16771775|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4866222|NCT00853151|16771776|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4866223|NCT00853151|16771773|P4|Overall Study|Adverse Event|0
4866224|NCT00853151|16771774|P3|Overall Study|Adverse Event|2
4866225|NCT00853151|16771775|P2|Overall Study|Adverse Event|4
4866226|NCT00853151|16771776|P1|Overall Study|Adverse Event|1
4866227|NCT00853125|16771918|P1|Overall Study|Study participant's donor was CMV +|1
4866228|NCT00853112|16771930|P7|Overall Study|Randomized but not treated|1
4866229|NCT00853112|16771931|P6|Overall Study|Randomized but not treated|0
4866230|NCT00853112|16771932|P5|Overall Study|Randomized but not treated|0
4866231|NCT00853112|16771933|P4|Overall Study|Randomized but not treated|2
4866232|NCT00853112|16771934|P3|Overall Study|Randomized but not treated|0
4866233|NCT00853112|16771935|P2|Overall Study|Randomized but not treated|1
4866234|NCT00853112|16771936|P1|Overall Study|Randomized but not treated|0
4866235|NCT00853099|16772046|P4|Double-blind + Open-label Periods|Other|6
4866236|NCT00853099|16772047|P3|Double-blind + Open-label Periods|Other|0
4866237|NCT00853099|16772048|P2|Double-blind + Open-label Periods|Other|0
4866238|NCT00853099|16772049|P1|Double-blind + Open-label Periods|Other|0
4866239|NCT00853099|16772046|P4|Double-blind + Open-label Periods|Withdrawal by Subject|20
4866240|NCT00853099|16772047|P3|Double-blind + Open-label Periods|Withdrawal by Subject|0
4866241|NCT00853099|16772048|P2|Double-blind + Open-label Periods|Withdrawal by Subject|0
4866242|NCT00853099|16772049|P1|Double-blind + Open-label Periods|Withdrawal by Subject|0
4866243|NCT00853099|16772046|P4|Double-blind + Open-label Periods|Adverse Event|47
4866244|NCT00853099|16772047|P3|Double-blind + Open-label Periods|Adverse Event|0
4866245|NCT00853099|16772048|P2|Double-blind + Open-label Periods|Adverse Event|0
4866246|NCT00853099|16772049|P1|Double-blind + Open-label Periods|Adverse Event|0
4866247|NCT00853099|16772046|P4|Double-blind + Open-label Periods|Lack of Efficacy|74
4866248|NCT00853099|16772047|P3|Double-blind + Open-label Periods|Lack of Efficacy|0
4866249|NCT00853099|16772048|P2|Double-blind + Open-label Periods|Lack of Efficacy|0
4866250|NCT00853099|16772049|P1|Double-blind + Open-label Periods|Lack of Efficacy|0
4866251|NCT00853099|16772046|P4|Double-blind Period|Mistreated with rescue study drug|0
4866252|NCT00853099|16772047|P3|Double-blind Period|Mistreated with rescue study drug|1
4866253|NCT00853099|16772048|P2|Double-blind Period|Mistreated with rescue study drug|0
4866254|NCT00853099|16772049|P1|Double-blind Period|Mistreated with rescue study drug|0
4866255|NCT00853099|16772046|P4|Double-blind Period|Other|0
4866256|NCT00853099|16772047|P3|Double-blind Period|Other|1
4866257|NCT00853099|16772048|P2|Double-blind Period|Other|0
4866258|NCT00853099|16772049|P1|Double-blind Period|Other|0
4866259|NCT00853099|16772046|P4|Double-blind Period|Lack of Efficacy|0
4866260|NCT00853099|16772047|P3|Double-blind Period|Lack of Efficacy|16
4866261|NCT00853099|16772048|P2|Double-blind Period|Lack of Efficacy|17
4866262|NCT00853099|16772049|P1|Double-blind Period|Lack of Efficacy|14
4866263|NCT00853099|16772046|P4|Double-blind Period|Withdrawal by Subject|0
4866264|NCT00853099|16772047|P3|Double-blind Period|Withdrawal by Subject|0
4866265|NCT00853099|16772048|P2|Double-blind Period|Withdrawal by Subject|3
4866266|NCT00853099|16772049|P1|Double-blind Period|Withdrawal by Subject|2
4866267|NCT00853099|16772046|P4|Double-blind Period|Adverse Event|0
4866268|NCT00853099|16772047|P3|Double-blind Period|Adverse Event|13
4866269|NCT00853099|16772048|P2|Double-blind Period|Adverse Event|9
4866270|NCT00853099|16772049|P1|Double-blind Period|Adverse Event|7
4866271|NCT00853073|16772091|P2|Overall Study|Withdrawal by Subject|2
4866272|NCT00853073|16772092|P1|Overall Study|Withdrawal by Subject|3
4866273|NCT00853047|16772105|P6|Open-Label Extension Phase|Reason Not Specified|6
4866274|NCT00853047|16772106|P5|Open-Label Extension Phase|Reason Not Specified|0
4866275|NCT00853047|16772107|P4|Open-Label Extension Phase|Reason Not Specified|0
4866276|NCT00853047|16772108|P3|Open-Label Extension Phase|Reason Not Specified|0
4866277|NCT00853047|16772109|P2|Open-Label Extension Phase|Reason Not Specified|0
4866278|NCT00853047|16772110|P1|Open-Label Extension Phase|Reason Not Specified|0
4866279|NCT00853047|16772105|P6|Open-Label Extension Phase|Investigator Decision|1
4866280|NCT00853047|16772106|P5|Open-Label Extension Phase|Investigator Decision|0
4866368|NCT00852917|16772273|P2|Overall Study|Physician Decision|7
4866281|NCT00853047|16772107|P4|Open-Label Extension Phase|Investigator Decision|0
4866282|NCT00853047|16772108|P3|Open-Label Extension Phase|Investigator Decision|0
4866283|NCT00853047|16772109|P2|Open-Label Extension Phase|Investigator Decision|0
4866284|NCT00853047|16772110|P1|Open-Label Extension Phase|Investigator Decision|0
4866285|NCT00853047|16772105|P6|Open-Label Extension Phase|Transfer to LX1606-302|2
4866286|NCT00853047|16772106|P5|Open-Label Extension Phase|Transfer to LX1606-302|0
4866287|NCT00853047|16772107|P4|Open-Label Extension Phase|Transfer to LX1606-302|0
4866288|NCT00853047|16772108|P3|Open-Label Extension Phase|Transfer to LX1606-302|0
4866289|NCT00853047|16772109|P2|Open-Label Extension Phase|Transfer to LX1606-302|0
4866290|NCT00853047|16772110|P1|Open-Label Extension Phase|Transfer to LX1606-302|0
4866291|NCT00853047|16772105|P6|Open-Label Extension Phase|Lost to Follow-up|1
4866292|NCT00853047|16772106|P5|Open-Label Extension Phase|Lost to Follow-up|0
4866293|NCT00853047|16772107|P4|Open-Label Extension Phase|Lost to Follow-up|0
4866294|NCT00853047|16772108|P3|Open-Label Extension Phase|Lost to Follow-up|0
4866295|NCT00853047|16772109|P2|Open-Label Extension Phase|Lost to Follow-up|0
4866296|NCT00853047|16772110|P1|Open-Label Extension Phase|Lost to Follow-up|0
4866297|NCT00853047|16772105|P6|Open-Label Extension Phase|Participant Request|7
4866298|NCT00853047|16772106|P5|Open-Label Extension Phase|Participant Request|0
4866299|NCT00853047|16772107|P4|Open-Label Extension Phase|Participant Request|0
4866300|NCT00853047|16772108|P3|Open-Label Extension Phase|Participant Request|0
4866301|NCT00853047|16772109|P2|Open-Label Extension Phase|Participant Request|0
4866302|NCT00853047|16772110|P1|Open-Label Extension Phase|Participant Request|0
4866303|NCT00853047|16772105|P6|Core Phase|Participant Request|0
4866304|NCT00853047|16772106|P5|Core Phase|Participant Request|0
4866305|NCT00853047|16772107|P4|Core Phase|Participant Request|1
4866306|NCT00853047|16772108|P3|Core Phase|Participant Request|0
4866307|NCT00853047|16772109|P2|Core Phase|Participant Request|0
4866308|NCT00853047|16772110|P1|Core Phase|Participant Request|0
4866309|NCT00853021|16772176|P1|Overall Study|Death|1
4866310|NCT00853021|16772176|P1|Overall Study|Withdrawal by Subject|2
4866311|NCT00853021|16772176|P1|Overall Study|Adverse Event|2
4866312|NCT00852995|16772188|P5|Overall Study|Moved Out of Area|0
4866313|NCT00852995|16772189|P4|Overall Study|Moved Out of Area|0
4866314|NCT00852995|16772190|P3|Overall Study|Moved Out of Area|0
4866315|NCT00852995|16772191|P2|Overall Study|Moved Out of Area|0
4866316|NCT00852995|16772192|P1|Overall Study|Moved Out of Area|1
4866317|NCT00852995|16772188|P5|Overall Study|Protocol Violation|1
4866318|NCT00852995|16772189|P4|Overall Study|Protocol Violation|0
4866319|NCT00852995|16772190|P3|Overall Study|Protocol Violation|0
4866320|NCT00852995|16772191|P2|Overall Study|Protocol Violation|0
4866321|NCT00852995|16772192|P1|Overall Study|Protocol Violation|0
4866322|NCT00852995|16772188|P5|Overall Study|Physician Decision|0
4866323|NCT00852995|16772189|P4|Overall Study|Physician Decision|0
4866324|NCT00852995|16772190|P3|Overall Study|Physician Decision|0
4866325|NCT00852995|16772191|P2|Overall Study|Physician Decision|0
4866326|NCT00852995|16772192|P1|Overall Study|Physician Decision|1
4866327|NCT00852995|16772188|P5|Overall Study|Progressive Disease|1
4866328|NCT00852995|16772189|P4|Overall Study|Progressive Disease|2
4866329|NCT00852995|16772190|P3|Overall Study|Progressive Disease|0
4866330|NCT00852995|16772191|P2|Overall Study|Progressive Disease|0
4866331|NCT00852995|16772192|P1|Overall Study|Progressive Disease|1
4866332|NCT00852995|16772188|P5|Overall Study|Non-Compliance|0
4866333|NCT00852995|16772189|P4|Overall Study|Non-Compliance|2
4866334|NCT00852995|16772190|P3|Overall Study|Non-Compliance|0
4866335|NCT00852995|16772191|P2|Overall Study|Non-Compliance|0
4866336|NCT00852995|16772192|P1|Overall Study|Non-Compliance|0
4866337|NCT00852995|16772188|P5|Overall Study|Withdrawal by Subject|2
4866338|NCT00852995|16772189|P4|Overall Study|Withdrawal by Subject|1
4866339|NCT00852995|16772190|P3|Overall Study|Withdrawal by Subject|0
4866340|NCT00852995|16772191|P2|Overall Study|Withdrawal by Subject|0
4866341|NCT00852995|16772192|P1|Overall Study|Withdrawal by Subject|4
4866342|NCT00852995|16772188|P5|Overall Study|Lost to Follow-up|0
4866343|NCT00852995|16772189|P4|Overall Study|Lost to Follow-up|0
4866344|NCT00852995|16772190|P3|Overall Study|Lost to Follow-up|1
4866345|NCT00852995|16772191|P2|Overall Study|Lost to Follow-up|1
4866346|NCT00852995|16772192|P1|Overall Study|Lost to Follow-up|0
4866347|NCT00852995|16772188|P5|Overall Study|Adverse Event|0
4866348|NCT00852995|16772189|P4|Overall Study|Adverse Event|0
4866349|NCT00852995|16772190|P3|Overall Study|Adverse Event|4
4866350|NCT00852995|16772191|P2|Overall Study|Adverse Event|0
4866351|NCT00852995|16772192|P1|Overall Study|Adverse Event|1
4866352|NCT00852969|16772236|P2|Overall Study|Lost to Follow-up|1
4866353|NCT00852969|16772237|P1|Overall Study|Lost to Follow-up|0
4866354|NCT00852969|16772236|P2|Overall Study|Adverse Event|1
4866355|NCT00852969|16772237|P1|Overall Study|Adverse Event|0
4866356|NCT00852930|16772248|P3|Overall Study|Physician Decision|1
4866357|NCT00852930|16772249|P2|Overall Study|Physician Decision|0
4866358|NCT00852930|16772250|P1|Overall Study|Physician Decision|0
4866359|NCT00852930|16772248|P3|Overall Study|Withdrawal by Subject|1
4866360|NCT00852930|16772249|P2|Overall Study|Withdrawal by Subject|1
4866361|NCT00852930|16772250|P1|Overall Study|Withdrawal by Subject|1
4866362|NCT00852917|16772271|P4|Overall Study|Death|1
4866363|NCT00852917|16772272|P3|Overall Study|Death|0
4866364|NCT00852917|16772273|P2|Overall Study|Death|0
4866365|NCT00852917|16772274|P1|Overall Study|Death|0
4866366|NCT00852917|16772271|P4|Overall Study|Physician Decision|19
4866367|NCT00852917|16772272|P3|Overall Study|Physician Decision|2
4866369|NCT00852917|16772274|P1|Overall Study|Physician Decision|6
4866370|NCT00852917|16772271|P4|Overall Study|Withdrawal by Subject|9
4866371|NCT00852917|16772272|P3|Overall Study|Withdrawal by Subject|10
4866372|NCT00852917|16772273|P2|Overall Study|Withdrawal by Subject|8
4866373|NCT00852917|16772274|P1|Overall Study|Withdrawal by Subject|4
4866374|NCT00852917|16772271|P4|Overall Study|Lack of Efficacy|47
4866375|NCT00852917|16772272|P3|Overall Study|Lack of Efficacy|11
4866376|NCT00852917|16772273|P2|Overall Study|Lack of Efficacy|11
4866377|NCT00852917|16772274|P1|Overall Study|Lack of Efficacy|21
4866378|NCT00852917|16772271|P4|Overall Study|Adverse Event|17
4866379|NCT00852917|16772272|P3|Overall Study|Adverse Event|35
4866380|NCT00852917|16772273|P2|Overall Study|Adverse Event|20
4866381|NCT00852917|16772274|P1|Overall Study|Adverse Event|13
4866382|NCT00852540|16772402|P2|Overall Study|Did Not Receive Study Drug|3
4866383|NCT00852540|16772403|P1|Overall Study|Did Not Receive Study Drug|3
4866384|NCT00852540|16772402|P2|Overall Study|Withdrawal by Subject|1
4866385|NCT00852540|16772403|P1|Overall Study|Withdrawal by Subject|3
4866386|NCT00852540|16772402|P2|Overall Study|Investigator Discretion|3
4866387|NCT00852540|16772403|P1|Overall Study|Investigator Discretion|2
4866388|NCT00852540|16772402|P2|Overall Study|Lost to Follow-up|3
4866389|NCT00852540|16772403|P1|Overall Study|Lost to Follow-up|2
4866390|NCT00852540|16772402|P2|Overall Study|Protocol Violation|2
4866391|NCT00852540|16772403|P1|Overall Study|Protocol Violation|1
4866392|NCT00852540|16772402|P2|Overall Study|Lack of Efficacy|3
4866393|NCT00852540|16772403|P1|Overall Study|Lack of Efficacy|15
4866394|NCT00852540|16772402|P2|Overall Study|Adverse Event|3
4866395|NCT00852540|16772403|P1|Overall Study|Adverse Event|10
4866396|NCT00852475|16772437|P2|Overall Study|Lost to Follow-up|4
4866397|NCT00852475|16772438|P1|Overall Study|Lost to Follow-up|3
4866398|NCT00852397|16772449|P3|Overall Study|Protocol Violation|1
4866399|NCT00852397|16772450|P2|Overall Study|Protocol Violation|0
4866400|NCT00852397|16772451|P1|Overall Study|Protocol Violation|0
4866401|NCT00852397|16772449|P3|Overall Study|Difficulty in study site visit|0
4866402|NCT00852397|16772450|P2|Overall Study|Difficulty in study site visit|0
4866403|NCT00852397|16772451|P1|Overall Study|Difficulty in study site visit|1
4866404|NCT00852397|16772449|P3|Overall Study|Study terminated by sponsor|6
4866405|NCT00852397|16772450|P2|Overall Study|Study terminated by sponsor|1
4866406|NCT00852397|16772451|P1|Overall Study|Study terminated by sponsor|2
4866407|NCT00852397|16772449|P3|Overall Study|Withdrawal by Subject|2
4866408|NCT00852397|16772450|P2|Overall Study|Withdrawal by Subject|1
4866409|NCT00852397|16772451|P1|Overall Study|Withdrawal by Subject|4
4866410|NCT00852397|16772449|P3|Overall Study|Death|1
4866411|NCT00852397|16772450|P2|Overall Study|Death|0
4866412|NCT00852397|16772451|P1|Overall Study|Death|0
4866413|NCT00852397|16772449|P3|Overall Study|Adverse Event|4
4866414|NCT00852397|16772450|P2|Overall Study|Adverse Event|6
4866415|NCT00852397|16772451|P1|Overall Study|Adverse Event|4
4866416|NCT00852241|16772480|P1|Overall Study|Physician Decision|18
4866417|NCT00852202|16772487|P3|Overall Study|pregnancy,moving away and surgery|2
4866418|NCT00852202|16772488|P2|Overall Study|pregnancy,moving away and surgery|0
4866419|NCT00852202|16772489|P1|Overall Study|pregnancy,moving away and surgery|1
4866420|NCT00852202|16772487|P3|Overall Study|Lost to Follow-up|6
4866421|NCT00852202|16772488|P2|Overall Study|Lost to Follow-up|5
4866422|NCT00852202|16772489|P1|Overall Study|Lost to Follow-up|5
4866423|NCT00852202|16772487|P3|Overall Study|Withdrawal by Subject|2
4866424|NCT00852202|16772488|P2|Overall Study|Withdrawal by Subject|1
4866425|NCT00852202|16772489|P1|Overall Study|Withdrawal by Subject|3
4866426|NCT00852202|16772487|P3|Overall Study|Protocol Violation|7
4866427|NCT00852202|16772488|P2|Overall Study|Protocol Violation|2
4866428|NCT00852202|16772489|P1|Overall Study|Protocol Violation|2
4866429|NCT00852202|16772487|P3|Overall Study|Lack of Efficacy|2
4866430|NCT00852202|16772488|P2|Overall Study|Lack of Efficacy|1
4866431|NCT00852202|16772489|P1|Overall Study|Lack of Efficacy|4
4866432|NCT00852202|16772487|P3|Overall Study|Adverse Event|7
4866433|NCT00852202|16772488|P2|Overall Study|Adverse Event|3
4866434|NCT00852202|16772489|P1|Overall Study|Adverse Event|2
4866435|NCT00851903|16772531|P1|Overall Study|Withdrawal by Subject|2
4866436|NCT00851890|16772545|P4|Overall Study|Lost to Follow-up|1
4866437|NCT00851890|16772546|P3|Overall Study|Lost to Follow-up|0
4866438|NCT00851890|16772547|P2|Overall Study|Lost to Follow-up|1
4866439|NCT00851890|16772548|P1|Overall Study|Lost to Follow-up|0
4866440|NCT00851877|16772605|P3|Phase II|Withdrawal by Subject|3
4866441|NCT00851877|16772606|P2|Phase II|Withdrawal by Subject|0
4866442|NCT00851877|16772607|P1|Phase II|Withdrawal by Subject|0
4866443|NCT00851877|16772605|P3|Phase I-1|Death|0
4866444|NCT00851877|16772606|P2|Phase I-1|Death|0
4866445|NCT00851877|16772607|P1|Phase I-1|Death|1
4866446|NCT00851799|16772617|P3|Overall Study|Completed protocol due to pregnancy|1
4866447|NCT00851799|16772618|P2|Overall Study|Completed protocol due to pregnancy|0
4866448|NCT00851799|16772619|P1|Overall Study|Completed protocol due to pregnancy|0
4866449|NCT00851799|16772617|P3|Overall Study|Severe Debilitation|0
4866450|NCT00851799|16772618|P2|Overall Study|Severe Debilitation|1
4866451|NCT00851799|16772619|P1|Overall Study|Severe Debilitation|0
4866452|NCT00851799|16772617|P3|Overall Study|Withdrew consent prior study completion|1
4866453|NCT00851799|16772618|P2|Overall Study|Withdrew consent prior study completion|2
4866454|NCT00851799|16772619|P1|Overall Study|Withdrew consent prior study completion|1
4866455|NCT00851799|16772617|P3|Overall Study|Not willing to adhere to requirements|2
4866456|NCT00851799|16772618|P2|Overall Study|Not willing to adhere to requirements|2
4866457|NCT00851799|16772619|P1|Overall Study|Not willing to adhere to requirements|1
4866458|NCT00851799|16772617|P3|Overall Study|Not able to get to clinic|9
4866459|NCT00851799|16772618|P2|Overall Study|Not able to get to clinic|5
4866460|NCT00851799|16772619|P1|Overall Study|Not able to get to clinic|8
4866461|NCT00851799|16772617|P3|Overall Study|Lost to Follow-up|10
4866462|NCT00851799|16772618|P2|Overall Study|Lost to Follow-up|3
4866463|NCT00851799|16772619|P1|Overall Study|Lost to Follow-up|5
4866464|NCT00851799|16772617|P3|Overall Study|Death|1
4866465|NCT00851799|16772618|P2|Overall Study|Death|0
4866466|NCT00851799|16772619|P1|Overall Study|Death|1
4866467|NCT00851786|16772707|P2|Overall Study|Cannot Adhere to Protocol Requirement|0
4866468|NCT00851786|16772708|P1|Overall Study|Cannot Adhere to Protocol Requirement|2
4866469|NCT00851786|16772707|P2|Overall Study|Site Closure|0
4866470|NCT00851786|16772708|P1|Overall Study|Site Closure|1
4866471|NCT00851786|16772707|P2|Overall Study|Incarceration|0
4866472|NCT00851786|16772708|P1|Overall Study|Incarceration|1
4866473|NCT00851786|16772707|P2|Overall Study|Lost to Follow-up|0
4866474|NCT00851786|16772708|P1|Overall Study|Lost to Follow-up|1
4866475|NCT00851786|16772707|P2|Overall Study|Protocol Violation|1
4866476|NCT00851786|16772708|P1|Overall Study|Protocol Violation|0
4866477|NCT00851786|16772707|P2|Overall Study|Withdrawal by Subject|1
4866478|NCT00851786|16772708|P1|Overall Study|Withdrawal by Subject|0
4866479|NCT00851747|16772721|P3|Overall Study|Physician Decision|6
4866480|NCT00851747|16772722|P2|Overall Study|Physician Decision|6
4866481|NCT00851747|16772723|P1|Overall Study|Physician Decision|6
4866482|NCT00851721|16772732|P2|Overall Study|Adverse Event|1
4866483|NCT00851721|16772733|P1|Overall Study|Adverse Event|0
4866484|NCT00851721|16772732|P2|Overall Study|Death|0
4866485|NCT00851721|16772733|P1|Overall Study|Death|1
4866486|NCT00851721|16772732|P2|Overall Study|planned surgery|0
4866487|NCT00851721|16772733|P1|Overall Study|planned surgery|1
4866488|NCT00851682|16772823|P2|Overall Study|screen failure|0
4866489|NCT00851682|16772824|P1|Overall Study|screen failure|5
4866490|NCT00851643|16772838|P6|Extension Study (Up to 36 Months)|Moved|1
4866491|NCT00851643|16772839|P5|Extension Study (Up to 36 Months)|Moved|0
4866492|NCT00851643|16772840|P4|Extension Study (Up to 36 Months)|Moved|1
4866493|NCT00851643|16772841|P3|Extension Study (Up to 36 Months)|Moved|1
4866494|NCT00851643|16772842|P2|Extension Study (Up to 36 Months)|Moved|2
4866495|NCT00851643|16772843|P1|Extension Study (Up to 36 Months)|Moved|0
4866496|NCT00851643|16772838|P6|Extension Study (Up to 36 Months)|Lost to Follow-up|0
4866497|NCT00851643|16772839|P5|Extension Study (Up to 36 Months)|Lost to Follow-up|2
4866498|NCT00851643|16772840|P4|Extension Study (Up to 36 Months)|Lost to Follow-up|1
4866499|NCT00851643|16772841|P3|Extension Study (Up to 36 Months)|Lost to Follow-up|4
4866500|NCT00851643|16772842|P2|Extension Study (Up to 36 Months)|Lost to Follow-up|2
4866501|NCT00851643|16772843|P1|Extension Study (Up to 36 Months)|Lost to Follow-up|4
4866502|NCT00851643|16772838|P6|Base Study (Up to 12 Months)|Other|1
4866503|NCT00851643|16772839|P5|Base Study (Up to 12 Months)|Other|0
4866504|NCT00851643|16772840|P4|Base Study (Up to 12 Months)|Other|0
4866505|NCT00851643|16772841|P3|Base Study (Up to 12 Months)|Other|0
4866506|NCT00851643|16772842|P2|Base Study (Up to 12 Months)|Other|0
4866507|NCT00851643|16772843|P1|Base Study (Up to 12 Months)|Other|0
4866508|NCT00851643|16772838|P6|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4866509|NCT00851643|16772839|P5|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4866510|NCT00851643|16772840|P4|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4866511|NCT00851643|16772841|P3|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4866512|NCT00851643|16772842|P2|Base Study (Up to 12 Months)|Withdrawal by Subject|0
4866513|NCT00851643|16772843|P1|Base Study (Up to 12 Months)|Withdrawal by Subject|1
4866514|NCT00851630|16772864|P2|Overall Study|Clinical failure|1
4866515|NCT00851630|16772865|P1|Overall Study|Clinical failure|0
4866516|NCT00851630|16772864|P2|Overall Study|Death|1
4866517|NCT00851630|16772865|P1|Overall Study|Death|2
4866518|NCT00851591|16772879|P2|Overall Study|Withdrawal by Subject|0
4866519|NCT00851591|16772880|P1|Overall Study|Withdrawal by Subject|2
4866520|NCT00851552|16772886|P1|Overall Study|Disease Progression|4
4866521|NCT00851552|16772886|P1|Overall Study|Adverse Event|1
4866522|NCT00851552|16772886|P1|Overall Study|Death|2
4866523|NCT00851318|16772916|P4|Overall Study|Physician Decision|1
4866524|NCT00851318|16772917|P3|Overall Study|Physician Decision|1
4866525|NCT00851318|16772918|P2|Overall Study|Physician Decision|0
4866526|NCT00851318|16772919|P1|Overall Study|Physician Decision|0
4866527|NCT00851318|16772916|P4|Overall Study|Non-compliance with Study Procedures|0
4866528|NCT00851318|16772917|P3|Overall Study|Non-compliance with Study Procedures|1
4866529|NCT00851318|16772918|P2|Overall Study|Non-compliance with Study Procedures|0
4866530|NCT00851318|16772919|P1|Overall Study|Non-compliance with Study Procedures|2
4866531|NCT00851318|16772916|P4|Overall Study|Lack of Efficacy|2
4866532|NCT00851318|16772917|P3|Overall Study|Lack of Efficacy|4
4866533|NCT00851318|16772918|P2|Overall Study|Lack of Efficacy|2
4866534|NCT00851318|16772919|P1|Overall Study|Lack of Efficacy|8
4866535|NCT00851318|16772916|P4|Overall Study|Pregnancy|1
4866536|NCT00851318|16772917|P3|Overall Study|Pregnancy|1
4866537|NCT00851318|16772918|P2|Overall Study|Pregnancy|0
4866538|NCT00851318|16772919|P1|Overall Study|Pregnancy|0
4866539|NCT00851318|16772916|P4|Overall Study|Adverse Event|12
4866540|NCT00851318|16772917|P3|Overall Study|Adverse Event|9
4866541|NCT00851318|16772918|P2|Overall Study|Adverse Event|2
4866542|NCT00851318|16772919|P1|Overall Study|Adverse Event|13
4866543|NCT00851318|16772916|P4|Overall Study|Withdrawal by Subject|3
4866544|NCT00851318|16772917|P3|Overall Study|Withdrawal by Subject|5
4866545|NCT00851318|16772918|P2|Overall Study|Withdrawal by Subject|1
4866546|NCT00851318|16772919|P1|Overall Study|Withdrawal by Subject|7
4866547|NCT00851253|16772955|P2|Overall Study|Disease Progression|0
4866548|NCT00851253|16772956|P1|Overall Study|Disease Progression|1
4866549|NCT00851084|16772966|P2|Overall Study|Other|1
4866550|NCT00851084|16772967|P1|Overall Study|Other|7
4866551|NCT00851084|16772966|P2|Overall Study|Metastatic surgery|6
4866552|NCT00851084|16772967|P1|Overall Study|Metastatic surgery|6
4866553|NCT00851084|16772966|P2|Overall Study|Withdrawal by Subject|12
4866554|NCT00851084|16772967|P1|Overall Study|Withdrawal by Subject|11
4866555|NCT00851084|16772966|P2|Overall Study|Consent withdrawn|2
4866556|NCT00851084|16772967|P1|Overall Study|Consent withdrawn|0
4866557|NCT00851084|16772966|P2|Overall Study|Physician Decision|14
4866558|NCT00851084|16772967|P1|Overall Study|Physician Decision|13
4866559|NCT00851084|16772966|P2|Overall Study|Poor compliance to protocol|1
4866560|NCT00851084|16772967|P1|Overall Study|Poor compliance to protocol|1
4866561|NCT00851084|16772966|P2|Overall Study|Disease progression|47
4866562|NCT00851084|16772967|P1|Overall Study|Disease progression|52
4866563|NCT00851084|16772966|P2|Overall Study|Adverse Event|36
4866564|NCT00851084|16772967|P1|Overall Study|Adverse Event|26
4866565|NCT00851084|16772966|P2|Overall Study|Randomized but not treated|0
4866566|NCT00851084|16772967|P1|Overall Study|Randomized but not treated|1
4866567|NCT00850993|16772995|P4|Overall Study|Parent/Guardian Voluntarily Withdrew|1
4866568|NCT00850993|16772996|P3|Overall Study|Parent/Guardian Voluntarily Withdrew|0
4866569|NCT00850993|16772997|P2|Overall Study|Parent/Guardian Voluntarily Withdrew|0
4866570|NCT00850993|16772998|P1|Overall Study|Parent/Guardian Voluntarily Withdrew|1
4866571|NCT00850759|16773027|P4|Overall Study|Lost to Follow-up|3
4866572|NCT00850759|16773028|P3|Overall Study|Lost to Follow-up|5
4866573|NCT00850759|16773029|P2|Overall Study|Lost to Follow-up|5
4866574|NCT00850759|16773030|P1|Overall Study|Lost to Follow-up|7
4866575|NCT00850564|16773111|P1|Overall Study|Withdrawal by Subject|2
4866576|NCT00850538|16773116|P1|Overall Study|Protocol Violation|2
4866577|NCT00850538|16773116|P1|Overall Study|radiology error|2
4866578|NCT00850538|16773116|P1|Overall Study|Withdrawal by Subject|3
4866579|NCT00850538|16773116|P1|Overall Study|specimen unusable|7
4866580|NCT00850538|16773116|P1|Overall Study|specimen missed due to scheduling error|14
4866581|NCT00850538|16773116|P1|Overall Study|unable/unwilling to complete MRI|13
4866582|NCT00850499|16773122|P2|Overall Study|Lack of Efficacy|1
4866583|NCT00850499|16773123|P1|Overall Study|Lack of Efficacy|0
4866584|NCT00850499|16773122|P2|Overall Study|Adverse Event|1
4866585|NCT00850499|16773123|P1|Overall Study|Adverse Event|3
4866586|NCT00850460|16773137|P2|Overall Study|Lost to Follow-up|4
4866587|NCT00850460|16773138|P1|Overall Study|Lost to Follow-up|4
4866588|NCT00850395|16773152|P1|Overall Study|Other|5
4866589|NCT00850395|16773152|P1|Overall Study|Insufficient clinical response|3
4866590|NCT00850395|16773152|P1|Overall Study|Adverse Event|1
4866591|NCT00850395|16773152|P1|Overall Study|Death|1
4866592|NCT00850343|16773172|P4|Overall Study|Physician Decision|1
4866593|NCT00850343|16773173|P3|Overall Study|Physician Decision|1
4866594|NCT00850343|16773174|P2|Overall Study|Physician Decision|1
4866595|NCT00850343|16773175|P1|Overall Study|Physician Decision|2
4866596|NCT00850343|16773172|P4|Overall Study|Non-compliance with Study Procedures|1
4866597|NCT00850343|16773173|P3|Overall Study|Non-compliance with Study Procedures|1
4866598|NCT00850343|16773174|P2|Overall Study|Non-compliance with Study Procedures|0
4866599|NCT00850343|16773175|P1|Overall Study|Non-compliance with Study Procedures|1
4866600|NCT00850343|16773172|P4|Overall Study|Lack of Efficacy|2
4866601|NCT00850343|16773173|P3|Overall Study|Lack of Efficacy|3
4866602|NCT00850343|16773174|P2|Overall Study|Lack of Efficacy|0
4866603|NCT00850343|16773175|P1|Overall Study|Lack of Efficacy|17
4866604|NCT00850343|16773172|P4|Overall Study|Pregnancy|1
4866605|NCT00850343|16773173|P3|Overall Study|Pregnancy|0
4866606|NCT00850343|16773174|P2|Overall Study|Pregnancy|0
4866607|NCT00850343|16773175|P1|Overall Study|Pregnancy|0
4866608|NCT00850343|16773172|P4|Overall Study|Adverse Event|6
4866609|NCT00850343|16773173|P3|Overall Study|Adverse Event|6
4866610|NCT00850343|16773174|P2|Overall Study|Adverse Event|2
4866611|NCT00850343|16773175|P1|Overall Study|Adverse Event|15
4866612|NCT00850343|16773172|P4|Overall Study|Withdrawal by Subject|2
4866613|NCT00850343|16773173|P3|Overall Study|Withdrawal by Subject|3
4866614|NCT00850343|16773174|P2|Overall Study|Withdrawal by Subject|0
4866615|NCT00850343|16773175|P1|Overall Study|Withdrawal by Subject|11
4866616|NCT00850200|16773205|P1|Overall Study|Withdrawal by Subject|1
4866617|NCT00850200|16773205|P1|Overall Study|Did not recieve treatment|2
4866618|NCT00850200|16773205|P1|Overall Study|Physician Decision|2
4866619|NCT00850174|16773215|P2|Second Intervention|Withdrawal by Subject|0
4866620|NCT00850174|16773216|P1|Second Intervention|Withdrawal by Subject|1
4866621|NCT00850174|16773215|P2|Washout: One Week|Withdrawal by Subject|2
4866622|NCT00850174|16773216|P1|Washout: One Week|Withdrawal by Subject|0
4866623|NCT00850135|16773230|P1|Overall Study|Physician Decision|1
4866624|NCT00850070|16773249|P2|Overall Study|Adverse Event|0
4866625|NCT00850070|16773250|P1|Overall Study|Adverse Event|2
4866626|NCT00850070|16773249|P2|Overall Study|Lack of Efficacy|1
4866627|NCT00850070|16773250|P1|Overall Study|Lack of Efficacy|1
4866628|NCT00849940|16773279|P1|Overall Study|Physician Decision|4
4866629|NCT00849901|16773290|P3|Extension Phase|Lack of Efficacy|1
4866630|NCT00849901|16773291|P2|Extension Phase|Lack of Efficacy|4
4866631|NCT00849901|16773292|P1|Extension Phase|Lack of Efficacy|2
4866632|NCT00849901|16773290|P3|Extension Phase|Physician Decision|0
4866633|NCT00849901|16773291|P2|Extension Phase|Physician Decision|2
4866634|NCT00849901|16773292|P1|Extension Phase|Physician Decision|1
4866635|NCT00849901|16773290|P3|Extension Phase|Parent or Caregiver Decision|4
4866636|NCT00849901|16773291|P2|Extension Phase|Parent or Caregiver Decision|4
4866637|NCT00849901|16773292|P1|Extension Phase|Parent or Caregiver Decision|10
4866638|NCT00849901|16773290|P3|Extension Phase|Withdrawal by Subject|3
4866639|NCT00849901|16773291|P2|Extension Phase|Withdrawal by Subject|6
4866640|NCT00849901|16773292|P1|Extension Phase|Withdrawal by Subject|7
4866641|NCT00849901|16773290|P3|Extension Phase|Protocol Violation|4
4866642|NCT00849901|16773291|P2|Extension Phase|Protocol Violation|2
4866643|NCT00849901|16773292|P1|Extension Phase|Protocol Violation|2
4866644|NCT00849901|16773290|P3|Extension Phase|Lost to Follow-up|1
4866645|NCT00849901|16773291|P2|Extension Phase|Lost to Follow-up|0
4866646|NCT00849901|16773292|P1|Extension Phase|Lost to Follow-up|3
4866647|NCT00849901|16773290|P3|Extension Phase|Adverse Event|4
4866648|NCT00849901|16773291|P2|Extension Phase|Adverse Event|8
4866649|NCT00849901|16773292|P1|Extension Phase|Adverse Event|2
4866650|NCT00849901|16773290|P3|Acute Treatment Phase|Lack of Efficacy|2
4866651|NCT00849901|16773291|P2|Acute Treatment Phase|Lack of Efficacy|3
4866652|NCT00849901|16773292|P1|Acute Treatment Phase|Lack of Efficacy|2
4866653|NCT00849901|16773290|P3|Acute Treatment Phase|Sponsor Decision|0
4866654|NCT00849901|16773291|P2|Acute Treatment Phase|Sponsor Decision|0
4866655|NCT00849901|16773292|P1|Acute Treatment Phase|Sponsor Decision|1
4866656|NCT00849901|16773290|P3|Acute Treatment Phase|Physician Decision|1
4866657|NCT00849901|16773291|P2|Acute Treatment Phase|Physician Decision|1
4866658|NCT00849901|16773292|P1|Acute Treatment Phase|Physician Decision|1
4866659|NCT00849901|16773290|P3|Acute Treatment Phase|Parent or Caregiver Decision|4
4866660|NCT00849901|16773291|P2|Acute Treatment Phase|Parent or Caregiver Decision|5
4866661|NCT00849901|16773292|P1|Acute Treatment Phase|Parent or Caregiver Decision|11
4866662|NCT00849901|16773290|P3|Acute Treatment Phase|Withdrawal by Subject|4
4866663|NCT00849901|16773291|P2|Acute Treatment Phase|Withdrawal by Subject|10
4866664|NCT00849901|16773292|P1|Acute Treatment Phase|Withdrawal by Subject|4
4866665|NCT00849901|16773290|P3|Acute Treatment Phase|Protocol Violation|1
4866666|NCT00849901|16773291|P2|Acute Treatment Phase|Protocol Violation|2
4866667|NCT00849901|16773292|P1|Acute Treatment Phase|Protocol Violation|0
4866668|NCT00849901|16773290|P3|Acute Treatment Phase|Lost to Follow-up|1
4866669|NCT00849901|16773291|P2|Acute Treatment Phase|Lost to Follow-up|4
4866670|NCT00849901|16773292|P1|Acute Treatment Phase|Lost to Follow-up|2
4866671|NCT00849901|16773290|P3|Acute Treatment Phase|Adverse Event|3
4866672|NCT00849901|16773291|P2|Acute Treatment Phase|Adverse Event|1
4866673|NCT00849901|16773292|P1|Acute Treatment Phase|Adverse Event|9
4866674|NCT00849875|16773339|P1|Overall Study|Lost to Follow-up|2
4866675|NCT00849875|16773339|P1|Overall Study|Others|6
4866676|NCT00849875|16773339|P1|Overall Study|Ongoing (unknown completion status)|11
4866677|NCT00849875|16773339|P1|Overall Study|Death|28
4866678|NCT00849797|16773436|P2|Washout: One Week|Withdrawal by Subject|2
4866679|NCT00849797|16773437|P1|Washout: One Week|Withdrawal by Subject|0
4866680|NCT00849797|16773436|P2|First Intervention|Adverse Event|1
4866681|NCT00849797|16773437|P1|First Intervention|Adverse Event|0
4866682|NCT00849797|16773436|P2|First Intervention|bad veins|0
4866683|NCT00849797|16773437|P1|First Intervention|bad veins|1
4866684|NCT00849693|16773455|P4|Extension Phase|Lack of Efficacy|1
4866685|NCT00849693|16773456|P3|Extension Phase|Lack of Efficacy|2
4866686|NCT00849693|16773457|P2|Extension Phase|Lack of Efficacy|2
4866687|NCT00849693|16773458|P1|Extension Phase|Lack of Efficacy|2
4866688|NCT00849693|16773455|P4|Extension Phase|Sponsor decision|1
4866689|NCT00849693|16773456|P3|Extension Phase|Sponsor decision|0
4866690|NCT00849693|16773457|P2|Extension Phase|Sponsor decision|0
4866691|NCT00849693|16773458|P1|Extension Phase|Sponsor decision|1
4866692|NCT00849693|16773455|P4|Extension Phase|Physician Decision|0
4866693|NCT00849693|16773456|P3|Extension Phase|Physician Decision|2
4866694|NCT00849693|16773457|P2|Extension Phase|Physician Decision|1
4866695|NCT00849693|16773458|P1|Extension Phase|Physician Decision|1
4866696|NCT00849693|16773455|P4|Extension Phase|Parent or caregiver decision|5
4866697|NCT00849693|16773456|P3|Extension Phase|Parent or caregiver decision|10
4866698|NCT00849693|16773457|P2|Extension Phase|Parent or caregiver decision|4
4866699|NCT00849693|16773458|P1|Extension Phase|Parent or caregiver decision|9
4866700|NCT00849693|16773455|P4|Extension Phase|Withdrawal by Subject|15
4866701|NCT00849693|16773456|P3|Extension Phase|Withdrawal by Subject|10
4866702|NCT00849693|16773457|P2|Extension Phase|Withdrawal by Subject|9
4866703|NCT00849693|16773458|P1|Extension Phase|Withdrawal by Subject|6
4866704|NCT00849693|16773455|P4|Extension Phase|Protocol Violation|3
4866705|NCT00849693|16773456|P3|Extension Phase|Protocol Violation|2
4866706|NCT00849693|16773457|P2|Extension Phase|Protocol Violation|3
4866707|NCT00849693|16773458|P1|Extension Phase|Protocol Violation|0
4866708|NCT00849693|16773455|P4|Extension Phase|Lost to Follow-up|6
4866709|NCT00849693|16773456|P3|Extension Phase|Lost to Follow-up|6
4866710|NCT00849693|16773457|P2|Extension Phase|Lost to Follow-up|5
4866711|NCT00849693|16773458|P1|Extension Phase|Lost to Follow-up|7
4866712|NCT00849693|16773455|P4|Extension Phase|Adverse Event|7
4866713|NCT00849693|16773456|P3|Extension Phase|Adverse Event|3
4866714|NCT00849693|16773457|P2|Extension Phase|Adverse Event|6
4866715|NCT00849693|16773458|P1|Extension Phase|Adverse Event|4
4866716|NCT00849693|16773455|P4|Acute Treatment Phase|Lack of Efficacy|2
4866717|NCT00849693|16773456|P3|Acute Treatment Phase|Lack of Efficacy|1
4866718|NCT00849693|16773457|P2|Acute Treatment Phase|Lack of Efficacy|3
4866719|NCT00849693|16773458|P1|Acute Treatment Phase|Lack of Efficacy|1
4866720|NCT00849693|16773455|P4|Acute Treatment Phase|Sponsor decision|0
4866721|NCT00849693|16773456|P3|Acute Treatment Phase|Sponsor decision|1
4866722|NCT00849693|16773457|P2|Acute Treatment Phase|Sponsor decision|0
4866723|NCT00849693|16773458|P1|Acute Treatment Phase|Sponsor decision|0
4866724|NCT00849693|16773455|P4|Acute Treatment Phase|Physician Decision|1
4866725|NCT00849693|16773456|P3|Acute Treatment Phase|Physician Decision|2
4866726|NCT00849693|16773457|P2|Acute Treatment Phase|Physician Decision|1
4866727|NCT00849693|16773458|P1|Acute Treatment Phase|Physician Decision|2
4866728|NCT00849693|16773455|P4|Acute Treatment Phase|Parent or caregiver decision|7
4866729|NCT00849693|16773456|P3|Acute Treatment Phase|Parent or caregiver decision|7
4866730|NCT00849693|16773457|P2|Acute Treatment Phase|Parent or caregiver decision|6
4866731|NCT00849693|16773458|P1|Acute Treatment Phase|Parent or caregiver decision|7
4866732|NCT00849693|16773455|P4|Acute Treatment Phase|Withdrawal by Subject|8
4866733|NCT00849693|16773456|P3|Acute Treatment Phase|Withdrawal by Subject|3
4866734|NCT00849693|16773457|P2|Acute Treatment Phase|Withdrawal by Subject|5
4866735|NCT00849693|16773458|P1|Acute Treatment Phase|Withdrawal by Subject|5
4866736|NCT00849693|16773455|P4|Acute Treatment Phase|Protocol Violation|6
4866737|NCT00849693|16773456|P3|Acute Treatment Phase|Protocol Violation|2
4866738|NCT00849693|16773457|P2|Acute Treatment Phase|Protocol Violation|5
4866739|NCT00849693|16773458|P1|Acute Treatment Phase|Protocol Violation|1
4866740|NCT00849693|16773455|P4|Acute Treatment Phase|Lost to Follow-up|9
4866741|NCT00849693|16773456|P3|Acute Treatment Phase|Lost to Follow-up|11
4866742|NCT00849693|16773457|P2|Acute Treatment Phase|Lost to Follow-up|8
4866743|NCT00849693|16773458|P1|Acute Treatment Phase|Lost to Follow-up|5
4866744|NCT00849693|16773455|P4|Acute Treatment Phase|Adverse Event|4
4866745|NCT00849693|16773456|P3|Acute Treatment Phase|Adverse Event|6
4866746|NCT00849693|16773457|P2|Acute Treatment Phase|Adverse Event|7
4866747|NCT00849693|16773458|P1|Acute Treatment Phase|Adverse Event|12
4866748|NCT00849680|16773525|P8|Overall Study|Subject unable to comply with protocol|0
4866749|NCT00849680|16773526|P7|Overall Study|Subject unable to comply with protocol|0
4866750|NCT00849680|16773527|P6|Overall Study|Subject unable to comply with protocol|0
4866751|NCT00849680|16773528|P5|Overall Study|Subject unable to comply with protocol|0
4866752|NCT00849680|16773529|P4|Overall Study|Subject unable to comply with protocol|0
4866753|NCT00849680|16773530|P3|Overall Study|Subject unable to comply with protocol|0
4866754|NCT00849680|16773531|P2|Overall Study|Subject unable to comply with protocol|0
4866755|NCT00849680|16773532|P1|Overall Study|Subject unable to comply with protocol|1
4866756|NCT00849680|16773525|P8|Overall Study|Withdrawal by Subject|1
4866757|NCT00849680|16773526|P7|Overall Study|Withdrawal by Subject|1
4866758|NCT00849680|16773527|P6|Overall Study|Withdrawal by Subject|2
4866759|NCT00849680|16773528|P5|Overall Study|Withdrawal by Subject|2
4866760|NCT00849680|16773529|P4|Overall Study|Withdrawal by Subject|2
4866761|NCT00849680|16773530|P3|Overall Study|Withdrawal by Subject|0
4866762|NCT00849680|16773531|P2|Overall Study|Withdrawal by Subject|0
4866763|NCT00849680|16773532|P1|Overall Study|Withdrawal by Subject|2
4866764|NCT00849680|16773525|P8|Overall Study|Subject moved|2
4866765|NCT00849680|16773526|P7|Overall Study|Subject moved|2
4866766|NCT00849680|16773527|P6|Overall Study|Subject moved|2
4866767|NCT00849680|16773528|P5|Overall Study|Subject moved|0
4866768|NCT00849680|16773529|P4|Overall Study|Subject moved|1
4866769|NCT00849680|16773530|P3|Overall Study|Subject moved|3
4866770|NCT00849680|16773531|P2|Overall Study|Subject moved|0
4866771|NCT00849680|16773532|P1|Overall Study|Subject moved|1
4866772|NCT00849680|16773525|P8|Overall Study|Lost to Follow-up|5
4866773|NCT00849680|16773526|P7|Overall Study|Lost to Follow-up|12
4866774|NCT00849680|16773527|P6|Overall Study|Lost to Follow-up|11
4866775|NCT00849680|16773528|P5|Overall Study|Lost to Follow-up|8
4866776|NCT00849680|16773529|P4|Overall Study|Lost to Follow-up|11
4866777|NCT00849680|16773530|P3|Overall Study|Lost to Follow-up|12
4866778|NCT00849680|16773531|P2|Overall Study|Lost to Follow-up|3
4866779|NCT00849680|16773532|P1|Overall Study|Lost to Follow-up|7
4866780|NCT00849680|16773525|P8|Overall Study|Adverse Event|0
4866781|NCT00849680|16773526|P7|Overall Study|Adverse Event|2
4866782|NCT00849680|16773527|P6|Overall Study|Adverse Event|0
4866783|NCT00849680|16773528|P5|Overall Study|Adverse Event|0
4866784|NCT00849680|16773529|P4|Overall Study|Adverse Event|0
4866785|NCT00849680|16773530|P3|Overall Study|Adverse Event|0
4866786|NCT00849680|16773531|P2|Overall Study|Adverse Event|0
4866787|NCT00849680|16773532|P1|Overall Study|Adverse Event|0
4866788|NCT00849524|16773574|P1|Overall Study|Lack of Efficacy|3
4866789|NCT00849472|16773591|P1|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1
4866790|NCT00849472|16773591|P1|Pazopanib Postsurgery Treatment|Moved|1
4866791|NCT00849472|16773591|P1|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5
4866792|NCT00849472|16773591|P1|Pazopanib Postsurgery Treatment|Adverse Event|19
4866793|NCT00849472|16773591|P1|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1
4866794|NCT00849472|16773591|P1|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1
4866795|NCT00849472|16773591|P1|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4
4866796|NCT00849472|16773591|P1|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52
4866797|NCT00849472|16773591|P1|Weekly Paclitaxel|Physician Decision|3
4866798|NCT00849472|16773591|P1|Weekly Paclitaxel|Withdrawal by Subject|1
4866799|NCT00849472|16773591|P1|Weekly Paclitaxel|Adverse Event|11
4866800|NCT00849472|16773591|P1|Weekly Paclitaxel|Disease Progression|1
4866801|NCT00849472|16773591|P1|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1
4866802|NCT00849472|16773591|P1|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1
4866803|NCT00849472|16773591|P1|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1
4866804|NCT00849472|16773591|P1|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1
4866805|NCT00849472|16773591|P1|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2
4866806|NCT00849381|16773605|P1|Overall Study|Other|4
4866807|NCT00849381|16773605|P1|Overall Study|Withdrawal by Subject|6
4866808|NCT00849381|16773605|P1|Overall Study|Protocol Violation|5
4866809|NCT00849381|16773605|P1|Overall Study|Lost to Follow-up|129
4866810|NCT00849381|16773605|P1|Overall Study|Adverse Event|1
4866811|NCT00849290|16773611|P1|Overall Study|Disease Progression|20
4866812|NCT00849290|16773611|P1|Overall Study|Protocol Violation|5
4866813|NCT00849290|16773611|P1|Overall Study|Lost to Follow-up|2
4866814|NCT00849290|16773611|P1|Overall Study|Withdrawal by Subject|11
4866815|NCT00849290|16773611|P1|Overall Study|Death|14
4866816|NCT00849290|16773611|P1|Overall Study|Adverse Event|3
4866817|NCT00849212|16773622|P1|Overall Study|Miscellaneous|1
4866818|NCT00849212|16773622|P1|Overall Study|Adverse Event|2
4866819|NCT00849212|16773622|P1|Overall Study|Withdrawal by Subject|3
4866820|NCT00849212|16773622|P1|Overall Study|Lack of Efficacy|1
4866821|NCT00849186|16773627|P1|Overall Study|Other|1
4866822|NCT00849186|16773627|P1|Overall Study|not treated|6
4866823|NCT00849186|16773627|P1|Overall Study|Withdrawal by Subject|1
4866824|NCT00849186|16773627|P1|Overall Study|Adverse Event|2
4866825|NCT00849147|16773633|P1|Overall Study|Disease Relapse/Progression|2
4866826|NCT00849147|16773633|P1|Overall Study|Protocol Violation|2
4866827|NCT00849147|16773633|P1|Overall Study|Withdrawal by Subject|1
4866828|NCT00849108|16773666|P2|Cohort 2 Efficacy|Other|9
4866829|NCT00849108|16773667|P1|Cohort 2 Efficacy|Other|0
4866830|NCT00849108|16773666|P2|Cohort 2 Efficacy|Adverse Event|1
4866831|NCT00849108|16773667|P1|Cohort 2 Efficacy|Adverse Event|0
4866832|NCT00849108|16773666|P2|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0
4866833|NCT00849108|16773667|P1|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1
4866834|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Early Termination|0
4866835|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Early Termination|1
4866836|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4
4866837|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1
4866838|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
4866839|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
4866840|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7
4866841|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9
4866842|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9
4866843|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14
4866844|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
4866845|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
4866846|NCT00849056|16773677|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3
4866847|NCT00849056|16773678|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
4866848|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|0
4866849|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|1
4866850|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0
4866851|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1
4866852|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4
4866853|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1
4866854|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|3
4866855|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|3
4866856|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18
4866857|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31
4866858|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5
4866859|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
4866860|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|3
4866861|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|3
4866862|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|6
4866863|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|3
4866864|NCT00849056|16773677|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|11
4866865|NCT00849056|16773678|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|13
4866866|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
4866867|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0
4866868|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1
4866869|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
4866870|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1
4866871|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3
4866872|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Physician Decision|1
4866873|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Physician Decision|1
4866874|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Physician Decision|0
4866875|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Withdrawal by Subject|3
4866876|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
4866877|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|4
4866878|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4
4866879|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
4866880|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1
4866881|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|16
4866882|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|12
4866883|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|13
4866884|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Noncompliance|0
4866885|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Noncompliance|1
4866886|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Noncompliance|2
4866887|NCT00849017|16773703|P3|Follow-up Period (8 Weeks)|Adverse Event|0
4866888|NCT00849017|16773704|P2|Follow-up Period (8 Weeks)|Adverse Event|0
4866889|NCT00849017|16773705|P1|Follow-up Period (8 Weeks)|Adverse Event|1
4866890|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1
4866891|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
4866892|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0
4866893|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Pregnancy|1
4866894|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Pregnancy|0
4866895|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Pregnancy|1
4866896|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Participant Moved to Africa|0
4866897|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Participant Moved to Africa|0
4866898|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Participant Moved to Africa|1
4866899|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
4866900|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0
4866901|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1
4866902|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Increased Calcitonin|0
4866903|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Increased Calcitonin|0
4866904|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Increased Calcitonin|1
4866905|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
4866906|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1
4866907|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3
4866908|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Physician Decision|1
4866909|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Physician Decision|2
4866910|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Physician Decision|0
4866911|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|11
4866912|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|14
4866913|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|18
4866914|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Lost to Follow-up|8
4866915|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Lost to Follow-up|7
4866916|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Lost to Follow-up|10
4866917|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Noncompliance|4
4866918|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Noncompliance|3
4866919|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Noncompliance|3
4866920|NCT00849017|16773703|P3|Treatment Period (156 Weeks)|Adverse Event|15
4866921|NCT00849017|16773704|P2|Treatment Period (156 Weeks)|Adverse Event|6
4866922|NCT00849017|16773705|P1|Treatment Period (156 Weeks)|Adverse Event|5
4866923|NCT00848965|16773748|P1|Overall Study|Withdrawal by Subject|1
4866924|NCT00848965|16773748|P1|Overall Study|Adverse Event|1
4866925|NCT00848926|16773790|P1|Follow-up Period|Other|2
4866926|NCT00848926|16773790|P1|Follow-up Period|Withdrawal by Subject|3
4866927|NCT00848926|16773790|P1|Follow-up Period|Lost to Follow-up|7
4866928|NCT00848926|16773790|P1|Treatment Period|Withdrawal by Subject|7
4866929|NCT00848926|16773790|P1|Treatment Period|Physician Decision|12
4866930|NCT00848926|16773790|P1|Treatment Period|Adverse Event|20
4866931|NCT00848926|16773790|P1|Treatment Period|Progressive disease|45
4866932|NCT00848718|16773840|P13|Overall Study|Progressive disease during treatment|2
4866933|NCT00848718|16773841|P12|Overall Study|Progressive disease during treatment|0
4866934|NCT00848718|16773842|P11|Overall Study|Progressive disease during treatment|0
4866935|NCT00848718|16773843|P10|Overall Study|Progressive disease during treatment|0
4866936|NCT00848718|16773844|P9|Overall Study|Progressive disease during treatment|0
4866937|NCT00848718|16773845|P8|Overall Study|Progressive disease during treatment|2
4866938|NCT00848718|16773846|P7|Overall Study|Progressive disease during treatment|0
4866939|NCT00848718|16773847|P6|Overall Study|Progressive disease during treatment|0
4866940|NCT00848718|16773848|P5|Overall Study|Progressive disease during treatment|0
4866941|NCT00848718|16773849|P4|Overall Study|Progressive disease during treatment|0
4866942|NCT00848718|16773850|P3|Overall Study|Progressive disease during treatment|3
4866943|NCT00848718|16773851|P2|Overall Study|Progressive disease during treatment|0
4866944|NCT00848718|16773852|P1|Overall Study|Progressive disease during treatment|3
4866945|NCT00848718|16773840|P13|Overall Study|Withdrawal by Subject|0
4866946|NCT00848718|16773841|P12|Overall Study|Withdrawal by Subject|0
4866947|NCT00848718|16773842|P11|Overall Study|Withdrawal by Subject|1
4866948|NCT00848718|16773843|P10|Overall Study|Withdrawal by Subject|0
4866949|NCT00848718|16773844|P9|Overall Study|Withdrawal by Subject|0
4866950|NCT00848718|16773845|P8|Overall Study|Withdrawal by Subject|0
4866951|NCT00848718|16773846|P7|Overall Study|Withdrawal by Subject|0
4866952|NCT00848718|16773847|P6|Overall Study|Withdrawal by Subject|0
4866953|NCT00848718|16773848|P5|Overall Study|Withdrawal by Subject|0
4866954|NCT00848718|16773849|P4|Overall Study|Withdrawal by Subject|1
4866955|NCT00848718|16773850|P3|Overall Study|Withdrawal by Subject|0
4866956|NCT00848718|16773851|P2|Overall Study|Withdrawal by Subject|0
4866957|NCT00848718|16773852|P1|Overall Study|Withdrawal by Subject|1
4866958|NCT00848718|16773840|P13|Overall Study|Protocol Violation|1
4866959|NCT00848718|16773841|P12|Overall Study|Protocol Violation|0
4866960|NCT00848718|16773842|P11|Overall Study|Protocol Violation|0
4866961|NCT00848718|16773843|P10|Overall Study|Protocol Violation|0
4866962|NCT00848718|16773844|P9|Overall Study|Protocol Violation|0
4866963|NCT00848718|16773845|P8|Overall Study|Protocol Violation|1
4866964|NCT00848718|16773846|P7|Overall Study|Protocol Violation|0
4866965|NCT00848718|16773847|P6|Overall Study|Protocol Violation|0
4866966|NCT00848718|16773848|P5|Overall Study|Protocol Violation|0
4866967|NCT00848718|16773849|P4|Overall Study|Protocol Violation|0
4866968|NCT00848718|16773850|P3|Overall Study|Protocol Violation|0
4866969|NCT00848718|16773851|P2|Overall Study|Protocol Violation|1
4866970|NCT00848718|16773852|P1|Overall Study|Protocol Violation|0
4866971|NCT00848718|16773840|P13|Overall Study|Progressive disease before treatment|2
4866972|NCT00848718|16773841|P12|Overall Study|Progressive disease before treatment|6
4866973|NCT00848718|16773842|P11|Overall Study|Progressive disease before treatment|3
4866974|NCT00848718|16773843|P10|Overall Study|Progressive disease before treatment|7
4866975|NCT00848718|16773844|P9|Overall Study|Progressive disease before treatment|2
4866976|NCT00848718|16773845|P8|Overall Study|Progressive disease before treatment|1
4866977|NCT00848718|16773846|P7|Overall Study|Progressive disease before treatment|2
4866978|NCT00848718|16773847|P6|Overall Study|Progressive disease before treatment|4
4866979|NCT00848718|16773848|P5|Overall Study|Progressive disease before treatment|4
4866980|NCT00848718|16773849|P4|Overall Study|Progressive disease before treatment|3
4866981|NCT00848718|16773850|P3|Overall Study|Progressive disease before treatment|1
4866982|NCT00848718|16773851|P2|Overall Study|Progressive disease before treatment|5
4866983|NCT00848718|16773852|P1|Overall Study|Progressive disease before treatment|1
4866984|NCT00848718|16773840|P13|Overall Study|Physician Decision|1
4866985|NCT00848718|16773841|P12|Overall Study|Physician Decision|0
4866986|NCT00848718|16773842|P11|Overall Study|Physician Decision|0
4866987|NCT00848718|16773843|P10|Overall Study|Physician Decision|2
4866988|NCT00848718|16773844|P9|Overall Study|Physician Decision|1
4866989|NCT00848718|16773845|P8|Overall Study|Physician Decision|0
4866990|NCT00848718|16773846|P7|Overall Study|Physician Decision|0
4866991|NCT00848718|16773847|P6|Overall Study|Physician Decision|1
4866992|NCT00848718|16773848|P5|Overall Study|Physician Decision|1
4866993|NCT00848718|16773849|P4|Overall Study|Physician Decision|0
4866994|NCT00848718|16773850|P3|Overall Study|Physician Decision|0
4866995|NCT00848718|16773851|P2|Overall Study|Physician Decision|1
4866996|NCT00848718|16773852|P1|Overall Study|Physician Decision|0
4866997|NCT00848718|16773840|P13|Overall Study|Lack of Efficacy|0
4866998|NCT00848718|16773841|P12|Overall Study|Lack of Efficacy|0
4866999|NCT00848718|16773842|P11|Overall Study|Lack of Efficacy|0
4867000|NCT00848718|16773843|P10|Overall Study|Lack of Efficacy|0
4867001|NCT00848718|16773844|P9|Overall Study|Lack of Efficacy|0
4867002|NCT00848718|16773845|P8|Overall Study|Lack of Efficacy|0
4867003|NCT00848718|16773846|P7|Overall Study|Lack of Efficacy|1
4867004|NCT00848718|16773847|P6|Overall Study|Lack of Efficacy|0
4867005|NCT00848718|16773848|P5|Overall Study|Lack of Efficacy|0
4867006|NCT00848718|16773849|P4|Overall Study|Lack of Efficacy|0
4867007|NCT00848718|16773850|P3|Overall Study|Lack of Efficacy|1
4867008|NCT00848718|16773851|P2|Overall Study|Lack of Efficacy|0
4867009|NCT00848718|16773852|P1|Overall Study|Lack of Efficacy|0
4867010|NCT00848718|16773840|P13|Overall Study|Adverse Event|2
4867011|NCT00848718|16773841|P12|Overall Study|Adverse Event|0
4867012|NCT00848718|16773842|P11|Overall Study|Adverse Event|0
4867013|NCT00848718|16773843|P10|Overall Study|Adverse Event|0
4867014|NCT00848718|16773844|P9|Overall Study|Adverse Event|1
4867015|NCT00848718|16773845|P8|Overall Study|Adverse Event|1
4867016|NCT00848718|16773846|P7|Overall Study|Adverse Event|0
4867017|NCT00848718|16773847|P6|Overall Study|Adverse Event|0
4867018|NCT00848718|16773848|P5|Overall Study|Adverse Event|1
4867019|NCT00848718|16773849|P4|Overall Study|Adverse Event|1
4867020|NCT00848718|16773850|P3|Overall Study|Adverse Event|1
4867021|NCT00848718|16773851|P2|Overall Study|Adverse Event|2
4867022|NCT00848718|16773852|P1|Overall Study|Adverse Event|2
4867023|NCT00848549|16773953|P2|E2090-E044-314 (Extension Study)|Other|6
4867024|NCT00848549|16773954|P1|E2090-E044-314 (Extension Study)|Other|5
4867025|NCT00848549|16773953|P2|E2090-E044-314 (Extension Study)|Physician Decision|2
4867026|NCT00848549|16773954|P1|E2090-E044-314 (Extension Study)|Physician Decision|0
4867027|NCT00848549|16773953|P2|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
4867028|NCT00848549|16773954|P1|E2090-E044-314 (Extension Study)|Lack of Efficacy|1
4867029|NCT00848549|16773953|P2|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12
4867030|NCT00848549|16773954|P1|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8
4867031|NCT00848549|16773953|P2|E2090-E044-314 (Extension Study)|Protocol Violation|2
4867032|NCT00848549|16773954|P1|E2090-E044-314 (Extension Study)|Protocol Violation|1
4867033|NCT00848549|16773953|P2|E2090-E044-314 (Extension Study)|Adverse Event|1
4867034|NCT00848549|16773954|P1|E2090-E044-314 (Extension Study)|Adverse Event|2
4867035|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34
4867036|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24
4867037|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Other|3
4867038|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Other|4
4867039|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11
4867040|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21
4867041|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Physician Decision|5
4867042|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Physician Decision|4
4867043|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8
4867044|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3
4867045|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
4867046|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23
4867047|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24
4867048|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35
4867049|NCT00848549|16773953|P2|E2090-E044-310 (Base Study) Disposition|Adverse Event|35
4867050|NCT00848549|16773954|P1|E2090-E044-310 (Base Study) Disposition|Adverse Event|31
4867051|NCT00848536|16773972|P2|Overall Study|Patient Moved|2
4867052|NCT00848536|16773973|P1|Overall Study|Patient Moved|0
4867053|NCT00848536|16773972|P2|Overall Study|Inadequate Control of IOP|1
4867054|NCT00848536|16773973|P1|Overall Study|Inadequate Control of IOP|1
4867055|NCT00848536|16773972|P2|Overall Study|Noncompliance|0
4867056|NCT00848536|16773973|P1|Overall Study|Noncompliance|1
4867057|NCT00848536|16773972|P2|Overall Study|Protocol Violation|1
4867058|NCT00848536|16773973|P1|Overall Study|Protocol Violation|0
4867059|NCT00848536|16773972|P2|Overall Study|Withdrawal by Subject|1
4867060|NCT00848536|16773973|P1|Overall Study|Withdrawal by Subject|0
4867061|NCT00848536|16773972|P2|Overall Study|Adverse Event|2
4867062|NCT00848536|16773973|P1|Overall Study|Adverse Event|2
4867063|NCT00848497|16774038|P2|Overall Study|Withdrawal by Subject|1
4867064|NCT00848497|16774039|P1|Overall Study|Withdrawal by Subject|0
4867065|NCT00848497|16774038|P2|Overall Study|Screen failure|0
4867066|NCT00848497|16774039|P1|Overall Study|Screen failure|2
4867067|NCT00848484|16774053|P2|Second Intervention (Treatment Period 2)|Lost to Follow-up|1
4867068|NCT00848484|16774054|P1|Second Intervention (Treatment Period 2)|Lost to Follow-up|0
4867069|NCT00848484|16774053|P2|Washout Period of Two Weeks|Withdrawal by Subject|3
4867070|NCT00848484|16774054|P1|Washout Period of Two Weeks|Withdrawal by Subject|0
4867071|NCT00848484|16774053|P2|First Intervention (Treatment Period 1)|Withdrawal by Subject|1
4867072|NCT00848484|16774054|P1|First Intervention (Treatment Period 1)|Withdrawal by Subject|0
4867073|NCT00848484|16774053|P2|First Intervention (Treatment Period 1)|Physician Decision|1
4867074|NCT00848484|16774054|P1|First Intervention (Treatment Period 1)|Physician Decision|0
4867075|NCT00848484|16774053|P2|First Intervention (Treatment Period 1)|Adverse Event|1
4867076|NCT00848484|16774054|P1|First Intervention (Treatment Period 1)|Adverse Event|2
4867077|NCT00848393|16774073|P3|Overall Study|surgical complications unrelated to stud|2
4867078|NCT00848393|16774074|P2|Overall Study|surgical complications unrelated to stud|0
4867079|NCT00848393|16774075|P1|Overall Study|surgical complications unrelated to stud|0
4867080|NCT00848393|16774073|P3|Overall Study|Protocol Violation|1
4867081|NCT00848393|16774074|P2|Overall Study|Protocol Violation|0
4867082|NCT00848393|16774075|P1|Overall Study|Protocol Violation|0
4867083|NCT00848354|16774114|P2|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0
4867084|NCT00848354|16774115|P1|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2
4867085|NCT00848354|16774114|P2|Phase 2 Year 2|Subject Request|1
4867086|NCT00848354|16774115|P1|Phase 2 Year 2|Subject Request|1
4867087|NCT00848354|16774114|P2|Phase 2 Year 2|Protocol Violation|1
4867088|NCT00848354|16774115|P1|Phase 2 Year 2|Protocol Violation|1
4867089|NCT00848354|16774114|P2|Phase 2 Year 2|Unspecified Reason|0
4867090|NCT00848354|16774115|P1|Phase 2 Year 2|Unspecified Reason|1
4867091|NCT00848354|16774114|P2|Phase 2 Year 2|Lost to Follow-up|3
4867092|NCT00848354|16774115|P1|Phase 2 Year 2|Lost to Follow-up|1
4867093|NCT00848354|16774114|P2|Phase 2 Year 2|Failed to return|0
4867094|NCT00848354|16774115|P1|Phase 2 Year 2|Failed to return|3
4867095|NCT00848354|16774114|P2|Phase 2 Year 2|Death|0
4867096|NCT00848354|16774115|P1|Phase 2 Year 2|Death|2
4867097|NCT00848354|16774114|P2|Phase 2 Year 2|Adverse Event|2
4867098|NCT00848354|16774115|P1|Phase 2 Year 2|Adverse Event|12
4867099|NCT00848354|16774114|P2|Phase 2 Year 1|Subject Request|2
4867100|NCT00848354|16774115|P1|Phase 2 Year 1|Subject Request|1
4867101|NCT00848354|16774114|P2|Phase 2 Year 1|Protocol Violation|1
4867102|NCT00848354|16774115|P1|Phase 2 Year 1|Protocol Violation|4
4867103|NCT00848354|16774114|P2|Phase 2 Year 1|Unspecified Reason|0
4867104|NCT00848354|16774115|P1|Phase 2 Year 1|Unspecified Reason|3
4867105|NCT00848354|16774114|P2|Phase 2 Year 1|Lost to Follow-up|0
4867106|NCT00848354|16774115|P1|Phase 2 Year 1|Lost to Follow-up|1
4867107|NCT00848354|16774114|P2|Phase 2 Year 1|Failed to Return|1
4867108|NCT00848354|16774115|P1|Phase 2 Year 1|Failed to Return|1
4867109|NCT00848354|16774114|P2|Phase 2 Year 1|Death|0
4867110|NCT00848354|16774115|P1|Phase 2 Year 1|Death|1
4867111|NCT00848354|16774114|P2|Phase 2 Year 1|Adverse Event|2
4867112|NCT00848354|16774115|P1|Phase 2 Year 1|Adverse Event|7
4867113|NCT00848354|16774114|P2|Phase 1|Lack of Efficacy|1
4867114|NCT00848354|16774115|P1|Phase 1|Lack of Efficacy|0
4867115|NCT00848354|16774114|P2|Phase 1|Withdrawal by Subject|4
4867116|NCT00848354|16774115|P1|Phase 1|Withdrawal by Subject|2
4867117|NCT00848354|16774114|P2|Phase 1|Protocol Violation|1
4867118|NCT00848354|16774115|P1|Phase 1|Protocol Violation|1
4867119|NCT00848354|16774114|P2|Phase 1|Unspecified Reason|1
4867120|NCT00848354|16774115|P1|Phase 1|Unspecified Reason|1
4867121|NCT00848354|16774114|P2|Phase 1|Lost to Follow-up|1
4867122|NCT00848354|16774115|P1|Phase 1|Lost to Follow-up|1
4867123|NCT00848354|16774114|P2|Phase 1|Failed to return|1
4867124|NCT00848354|16774115|P1|Phase 1|Failed to return|0
4867125|NCT00848354|16774114|P2|Phase 1|Discontinuation of study by sponsor|1
4867126|NCT00848354|16774115|P1|Phase 1|Discontinuation of study by sponsor|2
4867127|NCT00848354|16774114|P2|Phase 1|Adverse Event|4
4867128|NCT00848354|16774115|P1|Phase 1|Adverse Event|5
4867129|NCT00848250|16774267|P2|Overall Study|surgery was completed without cardiopulm|1
4867130|NCT00848250|16774268|P1|Overall Study|surgery was completed without cardiopulm|0
4867131|NCT00848211|16774299|P4|Overall Study|Adverse Event|0
4867132|NCT00848211|16774300|P3|Overall Study|Adverse Event|0
4867133|NCT00848211|16774301|P2|Overall Study|Adverse Event|0
4867134|NCT00848211|16774302|P1|Overall Study|Adverse Event|0
4867135|NCT00848211|16774299|P4|Overall Study|Protocol Violation|0
4867136|NCT00848211|16774300|P3|Overall Study|Protocol Violation|1
4867137|NCT00848211|16774301|P2|Overall Study|Protocol Violation|1
4867138|NCT00848211|16774302|P1|Overall Study|Protocol Violation|0
4867139|NCT00848198|16774320|P1|Overall Study|Incomplete Case Report Forms|15
4867140|NCT00848120|16774385|P1|Overall Study|Adverse Event|1
4867141|NCT00848107|16774397|P1|Overall Study|Pregnancy|1
4867142|NCT00848107|16774397|P1|Overall Study|Death|1
4867143|NCT00848107|16774397|P1|Overall Study|Adverse Event|9
4867144|NCT00848107|16774397|P1|Overall Study|Withdrawal by Subject|8
4867145|NCT00848107|16774397|P1|Overall Study|Lost to Follow-up|2
4867146|NCT00848081|16774407|P2|Overall Study|Withdrawal by Subject|3
4867147|NCT00848081|16774408|P1|Overall Study|Withdrawal by Subject|5
4867148|NCT00848081|16774407|P2|Overall Study|Physician Decision|3
4867149|NCT00848081|16774408|P1|Overall Study|Physician Decision|0
4867150|NCT00848081|16774407|P2|Overall Study|Lost to Follow-up|0
4867151|NCT00848081|16774408|P1|Overall Study|Lost to Follow-up|1
4867152|NCT00848081|16774407|P2|Overall Study|Protocol Violation|5
4867153|NCT00848081|16774408|P1|Overall Study|Protocol Violation|8
4867154|NCT00848081|16774407|P2|Overall Study|Adverse Event|7
4867155|NCT00848081|16774408|P1|Overall Study|Adverse Event|6
4867156|NCT00848042|16774425|P3|Overall Study|Other Therapy|0
4867157|NCT00848042|16774426|P2|Overall Study|Other Therapy|0
4867158|NCT00848042|16774427|P1|Overall Study|Other Therapy|3
4867159|NCT00848042|16774425|P3|Overall Study|Death|0
4867160|NCT00848042|16774426|P2|Overall Study|Death|2
4867161|NCT00848042|16774427|P1|Overall Study|Death|1
4867162|NCT00847912|16774463|P2|Overall Study|Withdrawal by Subject|6
4867163|NCT00847912|16774464|P1|Overall Study|Withdrawal by Subject|3
4867164|NCT00847912|16774463|P2|Overall Study|Protocol Violation|7
4867165|NCT00847912|16774464|P1|Overall Study|Protocol Violation|6
4867166|NCT00847886|16774474|P2|Overall Study|Adverse Event|1
4867167|NCT00847886|16774475|P1|Overall Study|Adverse Event|0
4867168|NCT00847808|16774501|P1|Overall Study|Participant Took Excluded Medication|1
4867169|NCT00847808|16774501|P1|Overall Study|Participant Reported Lack of Efficacy|1
4867170|NCT00847808|16774501|P1|Overall Study|Withdrawal by Subject|4
4867171|NCT00847808|16774501|P1|Overall Study|Lost to Follow-up|1
4867172|NCT00847808|16774501|P1|Overall Study|Protocol Violation|1
4867173|NCT00847808|16774501|P1|Overall Study|Adverse Event|7
4867174|NCT00847730|16774518|P1|Overall Study|Multiple interruptions in therapy|8
4867175|NCT00847704|16774522|P1|Overall Study|Withdrawal by Subject|1
4867176|NCT00847665|16774533|P2|Overall Study|Withdrawal by Subject|0
4867177|NCT00847665|16774534|P1|Overall Study|Withdrawal by Subject|1
4867178|NCT00847626|16774557|P11|Overall Study|Other|3
4867179|NCT00847626|16774558|P10|Overall Study|Other|1
4867180|NCT00847626|16774559|P9|Overall Study|Other|1
4867181|NCT00847626|16774560|P8|Overall Study|Other|3
4867182|NCT00847626|16774561|P7|Overall Study|Other|2
4867183|NCT00847626|16774562|P6|Overall Study|Other|2
4867184|NCT00847626|16774563|P5|Overall Study|Other|2
4867185|NCT00847626|16774564|P4|Overall Study|Other|1
4867186|NCT00847626|16774565|P3|Overall Study|Other|4
4867187|NCT00847626|16774566|P2|Overall Study|Other|5
4867188|NCT00847626|16774567|P1|Overall Study|Other|1
4867189|NCT00847626|16774557|P11|Overall Study|Lack of Efficacy|7
4867190|NCT00847626|16774558|P10|Overall Study|Lack of Efficacy|1
4867191|NCT00847626|16774559|P9|Overall Study|Lack of Efficacy|5
4867192|NCT00847626|16774560|P8|Overall Study|Lack of Efficacy|2
4867193|NCT00847626|16774561|P7|Overall Study|Lack of Efficacy|6
4867194|NCT00847626|16774562|P6|Overall Study|Lack of Efficacy|0
4867195|NCT00847626|16774563|P5|Overall Study|Lack of Efficacy|2
4867196|NCT00847626|16774564|P4|Overall Study|Lack of Efficacy|1
4867197|NCT00847626|16774565|P3|Overall Study|Lack of Efficacy|0
4867198|NCT00847626|16774566|P2|Overall Study|Lack of Efficacy|1
4867199|NCT00847626|16774567|P1|Overall Study|Lack of Efficacy|3
4867200|NCT00847626|16774557|P11|Overall Study|Withdrawal by Subject|2
4867201|NCT00847626|16774558|P10|Overall Study|Withdrawal by Subject|5
4867202|NCT00847626|16774559|P9|Overall Study|Withdrawal by Subject|4
4867203|NCT00847626|16774560|P8|Overall Study|Withdrawal by Subject|4
4867204|NCT00847626|16774561|P7|Overall Study|Withdrawal by Subject|8
4867205|NCT00847626|16774562|P6|Overall Study|Withdrawal by Subject|9
4867206|NCT00847626|16774563|P5|Overall Study|Withdrawal by Subject|12
4867207|NCT00847626|16774564|P4|Overall Study|Withdrawal by Subject|8
4867208|NCT00847626|16774565|P3|Overall Study|Withdrawal by Subject|3
4867209|NCT00847626|16774566|P2|Overall Study|Withdrawal by Subject|5
4867210|NCT00847626|16774567|P1|Overall Study|Withdrawal by Subject|5
4867211|NCT00847626|16774557|P11|Overall Study|Lost to Follow-up|1
4867212|NCT00847626|16774558|P10|Overall Study|Lost to Follow-up|0
4867213|NCT00847626|16774559|P9|Overall Study|Lost to Follow-up|1
4867214|NCT00847626|16774560|P8|Overall Study|Lost to Follow-up|3
4867215|NCT00847626|16774561|P7|Overall Study|Lost to Follow-up|1
4867216|NCT00847626|16774562|P6|Overall Study|Lost to Follow-up|3
4867217|NCT00847626|16774563|P5|Overall Study|Lost to Follow-up|0
4867218|NCT00847626|16774564|P4|Overall Study|Lost to Follow-up|1
4867219|NCT00847626|16774565|P3|Overall Study|Lost to Follow-up|1
4867220|NCT00847626|16774566|P2|Overall Study|Lost to Follow-up|1
4867221|NCT00847626|16774567|P1|Overall Study|Lost to Follow-up|0
4867222|NCT00847626|16774557|P11|Overall Study|Protocol Violation|1
4867223|NCT00847626|16774558|P10|Overall Study|Protocol Violation|1
4867224|NCT00847626|16774559|P9|Overall Study|Protocol Violation|0
4867225|NCT00847626|16774560|P8|Overall Study|Protocol Violation|1
4867226|NCT00847626|16774561|P7|Overall Study|Protocol Violation|1
4867227|NCT00847626|16774562|P6|Overall Study|Protocol Violation|1
4867228|NCT00847626|16774563|P5|Overall Study|Protocol Violation|1
4867229|NCT00847626|16774564|P4|Overall Study|Protocol Violation|1
4867230|NCT00847626|16774565|P3|Overall Study|Protocol Violation|2
4867231|NCT00847626|16774566|P2|Overall Study|Protocol Violation|1
4867232|NCT00847626|16774567|P1|Overall Study|Protocol Violation|2
4867233|NCT00847626|16774557|P11|Overall Study|Adverse Event|6
4867234|NCT00847626|16774558|P10|Overall Study|Adverse Event|6
4867235|NCT00847626|16774559|P9|Overall Study|Adverse Event|3
4867236|NCT00847626|16774560|P8|Overall Study|Adverse Event|6
4867237|NCT00847626|16774561|P7|Overall Study|Adverse Event|4
4867238|NCT00847626|16774562|P6|Overall Study|Adverse Event|22
4867239|NCT00847626|16774563|P5|Overall Study|Adverse Event|11
4867240|NCT00847626|16774564|P4|Overall Study|Adverse Event|19
4867241|NCT00847626|16774565|P3|Overall Study|Adverse Event|6
4867242|NCT00847626|16774566|P2|Overall Study|Adverse Event|10
4867243|NCT00847626|16774567|P1|Overall Study|Adverse Event|10
4867244|NCT00847613|16774766|P4|Overall Study|Other|0
4867245|NCT00847613|16774767|P3|Overall Study|Other|2
4867246|NCT00847613|16774768|P2|Overall Study|Other|1
4867247|NCT00847613|16774769|P1|Overall Study|Other|1
4867248|NCT00847613|16774766|P4|Overall Study|Randomized, but not treated|0
4867249|NCT00847613|16774767|P3|Overall Study|Randomized, but not treated|0
4867250|NCT00847613|16774768|P2|Overall Study|Randomized, but not treated|3
4867251|NCT00847613|16774769|P1|Overall Study|Randomized, but not treated|0
4867252|NCT00847613|16774766|P4|Overall Study|Sponsor request|0
4867253|NCT00847613|16774767|P3|Overall Study|Sponsor request|0
4867254|NCT00847613|16774768|P2|Overall Study|Sponsor request|1
4867255|NCT00847613|16774769|P1|Overall Study|Sponsor request|0
4867256|NCT00847613|16774766|P4|Overall Study|Participant moved|0
4867257|NCT00847613|16774767|P3|Overall Study|Participant moved|0
4867258|NCT00847613|16774768|P2|Overall Study|Participant moved|1
4867259|NCT00847613|16774769|P1|Overall Study|Participant moved|4
4867260|NCT00847613|16774766|P4|Overall Study|Withdrawal by Subject|2
4867261|NCT00847613|16774767|P3|Overall Study|Withdrawal by Subject|2
4867262|NCT00847613|16774768|P2|Overall Study|Withdrawal by Subject|11
4867263|NCT00847613|16774769|P1|Overall Study|Withdrawal by Subject|8
4867264|NCT00847613|16774766|P4|Overall Study|Site closure|1
4867265|NCT00847613|16774767|P3|Overall Study|Site closure|0
4867266|NCT00847613|16774768|P2|Overall Study|Site closure|0
4867267|NCT00847613|16774769|P1|Overall Study|Site closure|1
4867268|NCT00847613|16774766|P4|Overall Study|Pregnancy|0
4867269|NCT00847613|16774767|P3|Overall Study|Pregnancy|0
4867270|NCT00847613|16774768|P2|Overall Study|Pregnancy|1
4867271|NCT00847613|16774769|P1|Overall Study|Pregnancy|1
4867272|NCT00847613|16774766|P4|Overall Study|Protocol Violation|1
4867273|NCT00847613|16774767|P3|Overall Study|Protocol Violation|3
4867274|NCT00847613|16774768|P2|Overall Study|Protocol Violation|6
4867275|NCT00847613|16774769|P1|Overall Study|Protocol Violation|6
4867276|NCT00847613|16774766|P4|Overall Study|Lost to Follow-up|3
4867277|NCT00847613|16774767|P3|Overall Study|Lost to Follow-up|0
4867278|NCT00847613|16774768|P2|Overall Study|Lost to Follow-up|0
4867279|NCT00847613|16774769|P1|Overall Study|Lost to Follow-up|5
4867280|NCT00847613|16774766|P4|Overall Study|Study terminated by Sponsor|1
4867281|NCT00847613|16774767|P3|Overall Study|Study terminated by Sponsor|2
4867282|NCT00847613|16774768|P2|Overall Study|Study terminated by Sponsor|0
4867283|NCT00847613|16774769|P1|Overall Study|Study terminated by Sponsor|1
4867284|NCT00847613|16774766|P4|Overall Study|Lack of Efficacy|1
4867285|NCT00847613|16774767|P3|Overall Study|Lack of Efficacy|3
4867286|NCT00847613|16774768|P2|Overall Study|Lack of Efficacy|3
4867287|NCT00847613|16774769|P1|Overall Study|Lack of Efficacy|7
4867288|NCT00847613|16774766|P4|Overall Study|Adverse Event|6
4867289|NCT00847613|16774767|P3|Overall Study|Adverse Event|5
4867290|NCT00847613|16774768|P2|Overall Study|Adverse Event|26
4867291|NCT00847613|16774769|P1|Overall Study|Adverse Event|36
4867292|NCT00847613|16774766|P4|Overall Study|Death|0
4867293|NCT00847613|16774767|P3|Overall Study|Death|0
4867294|NCT00847613|16774768|P2|Overall Study|Death|1
4867295|NCT00847613|16774769|P1|Overall Study|Death|1
4867296|NCT00847613|16774766|P4|Overall Study|Ongoing at cut-off date|64
4867297|NCT00847613|16774767|P3|Overall Study|Ongoing at cut-off date|64
4867298|NCT00847613|16774768|P2|Overall Study|Ongoing at cut-off date|265
4867299|NCT00847613|16774769|P1|Overall Study|Ongoing at cut-off date|250
4867300|NCT00847561|16775020|P2|Overall Study|Unable to schedule|1
4867301|NCT00847561|16775021|P1|Overall Study|Unable to schedule|9
4867302|NCT00847561|16775020|P2|Overall Study|Withdrawal by Subject|3
4867303|NCT00847561|16775021|P1|Overall Study|Withdrawal by Subject|4
4867304|NCT00847535|16775027|P3|Overall Study|Lost to Follow-up|0
4867305|NCT00847535|16775028|P2|Overall Study|Lost to Follow-up|1
4867306|NCT00847535|16775029|P1|Overall Study|Lost to Follow-up|0
4867307|NCT00847535|16775027|P3|Overall Study|Withdrawal by Subject|1
4867308|NCT00847535|16775028|P2|Overall Study|Withdrawal by Subject|1
4867309|NCT00847535|16775029|P1|Overall Study|Withdrawal by Subject|2
4867310|NCT00847405|16775048|P2|Washout of 7 Days|Withdrawal by Subject|0
4867311|NCT00847405|16775049|P1|Washout of 7 Days|Withdrawal by Subject|1
4867312|NCT00847405|16775048|P2|First Intervention|Adverse Event|1
4867313|NCT00847405|16775049|P1|First Intervention|Adverse Event|0
4867314|NCT00847379|16775060|P3|Overall Study|Study terminated by Sponsor|57
4867315|NCT00847379|16775061|P2|Overall Study|Study terminated by Sponsor|57
4867316|NCT00847379|16775062|P1|Overall Study|Study terminated by Sponsor|59
4867317|NCT00847301|16775160|P1|Overall Study|Other reason not defined above|1
4867318|NCT00847301|16775160|P1|Overall Study|No prescription after hospital discharge|1
4867319|NCT00847301|16775160|P1|Overall Study|Lost to Follow-up|1
4867320|NCT00847301|16775160|P1|Overall Study|Switch to other anticoagulants|16
4867321|NCT00847301|16775160|P1|Overall Study|Adverse Event|35
4867322|NCT00847197|16775208|P2|Overall Study|Withdrawal by Subject|1
4867323|NCT00847197|16775209|P1|Overall Study|Withdrawal by Subject|3
4867324|NCT00847197|16775208|P2|Overall Study|Protocol Violation|1
4867325|NCT00847197|16775209|P1|Overall Study|Protocol Violation|0
4867326|NCT00847197|16775208|P2|Overall Study|Adverse Event|3
4867327|NCT00847197|16775209|P1|Overall Study|Adverse Event|21
4867328|NCT00847145|16775233|P8|Overall Study|Protocol Violation|1
4867329|NCT00847145|16775234|P7|Overall Study|Protocol Violation|0
4867330|NCT00847145|16775235|P6|Overall Study|Protocol Violation|0
4867331|NCT00847145|16775236|P5|Overall Study|Protocol Violation|1
4867332|NCT00847145|16775237|P4|Overall Study|Protocol Violation|0
4867333|NCT00847145|16775238|P3|Overall Study|Protocol Violation|3
4867334|NCT00847145|16775239|P2|Overall Study|Protocol Violation|0
4867335|NCT00847145|16775240|P1|Overall Study|Protocol Violation|0
4867336|NCT00847145|16775233|P8|Overall Study|Inappropriate enrollment|0
4867337|NCT00847145|16775234|P7|Overall Study|Inappropriate enrollment|0
4867338|NCT00847145|16775235|P6|Overall Study|Inappropriate enrollment|0
4867339|NCT00847145|16775236|P5|Overall Study|Inappropriate enrollment|1
4867340|NCT00847145|16775237|P4|Overall Study|Inappropriate enrollment|0
4867341|NCT00847145|16775238|P3|Overall Study|Inappropriate enrollment|0
4867342|NCT00847145|16775239|P2|Overall Study|Inappropriate enrollment|0
4867343|NCT00847145|16775240|P1|Overall Study|Inappropriate enrollment|0
4867344|NCT00847145|16775233|P8|Overall Study|Lost to Follow-up|2
4867345|NCT00847145|16775234|P7|Overall Study|Lost to Follow-up|8
4867346|NCT00847145|16775235|P6|Overall Study|Lost to Follow-up|4
4867347|NCT00847145|16775236|P5|Overall Study|Lost to Follow-up|4
4867348|NCT00847145|16775237|P4|Overall Study|Lost to Follow-up|0
4867349|NCT00847145|16775238|P3|Overall Study|Lost to Follow-up|1
4867350|NCT00847145|16775239|P2|Overall Study|Lost to Follow-up|1
4867351|NCT00847145|16775240|P1|Overall Study|Lost to Follow-up|3
4867352|NCT00847145|16775233|P8|Overall Study|Withdrawal by Subject|1
4867353|NCT00847145|16775234|P7|Overall Study|Withdrawal by Subject|1
4867354|NCT00847145|16775235|P6|Overall Study|Withdrawal by Subject|0
4867355|NCT00847145|16775236|P5|Overall Study|Withdrawal by Subject|0
4867356|NCT00847145|16775237|P4|Overall Study|Withdrawal by Subject|1
4867357|NCT00847145|16775238|P3|Overall Study|Withdrawal by Subject|6
4867358|NCT00847145|16775239|P2|Overall Study|Withdrawal by Subject|4
4867359|NCT00847145|16775240|P1|Overall Study|Withdrawal by Subject|3
4867360|NCT00847145|16775233|P8|Overall Study|AE or Death|0
4867361|NCT00847145|16775234|P7|Overall Study|AE or Death|0
4867362|NCT00847145|16775235|P6|Overall Study|AE or Death|0
4867363|NCT00847145|16775236|P5|Overall Study|AE or Death|0
4867364|NCT00847145|16775237|P4|Overall Study|AE or Death|0
4867365|NCT00847145|16775238|P3|Overall Study|AE or Death|1
4867366|NCT00847145|16775239|P2|Overall Study|AE or Death|1
4867367|NCT00847145|16775240|P1|Overall Study|AE or Death|0
4867368|NCT00847132|16775290|P2|Overall Study|Death|1
4867369|NCT00847132|16775291|P1|Overall Study|Death|1
4867370|NCT00847015|16775299|P1|Overall Study|partial cystectomy vs radical cystectomy|1
4867371|NCT00847015|16775299|P1|Overall Study|declined any surgery|1
4867372|NCT00847015|16775299|P1|Overall Study|Withdrawal by Subject|1
4867373|NCT00846846|16775327|P1|Overall Study|Withdrawal by Subject|19
4867374|NCT00846846|16775327|P1|Overall Study|Death|56
4867375|NCT00846807|16775332|P1|Overall Study|Other|60
4867376|NCT00846807|16775332|P1|Overall Study|No prescription after hospital discharge|56
4867377|NCT00846807|16775332|P1|Overall Study|Switch to other anticoagulants|89
4867378|NCT00846807|16775332|P1|Overall Study|Non compliant with European label|7
4867379|NCT00846807|16775332|P1|Overall Study|Withdrawal by Subject|56
4867380|NCT00846807|16775332|P1|Overall Study|Lost to Follow-up|94
4867381|NCT00846807|16775332|P1|Overall Study|Adverse Event|270
4867382|NCT00846768|16775340|P4|Overall Study|Adverse Event|0
4867383|NCT00846768|16775341|P3|Overall Study|Adverse Event|0
4867384|NCT00846768|16775342|P2|Overall Study|Adverse Event|1
4867385|NCT00846768|16775343|P1|Overall Study|Adverse Event|0
4867386|NCT00846742|16775413|P1|Overall Study|Withdrawal by Subject|1
4867387|NCT00846586|16775440|P2|Overall Study|Unsatisfactory therapeutic effect|1
4867388|NCT00846586|16775441|P1|Overall Study|Unsatisfactory therapeutic effect|0
4867389|NCT00846586|16775440|P2|Overall Study|Lost to Follow-up|4
4867390|NCT00846586|16775441|P1|Overall Study|Lost to Follow-up|1
4867391|NCT00846586|16775440|P2|Overall Study|Abnormal test procedure result(s)|0
4867392|NCT00846586|16775441|P1|Overall Study|Abnormal test procedure result(s)|1
4867393|NCT00846586|16775440|P2|Overall Study|Protocol deviation|6
4867394|NCT00846586|16775441|P1|Overall Study|Protocol deviation|2
4867395|NCT00846586|16775440|P2|Overall Study|Death|0
4867396|NCT00846586|16775441|P1|Overall Study|Death|2
4867397|NCT00846586|16775440|P2|Overall Study|Administrative problems|4
4867398|NCT00846586|16775441|P1|Overall Study|Administrative problems|5
4867399|NCT00846586|16775440|P2|Overall Study|Subject withdrew consent|10
4867400|NCT00846586|16775441|P1|Overall Study|Subject withdrew consent|8
4867401|NCT00846586|16775440|P2|Overall Study|Adverse Event|10
4867402|NCT00846586|16775441|P1|Overall Study|Adverse Event|20
4867403|NCT00846521|16775475|P1|Overall Study|Protocol Violation|1
4867404|NCT00846521|16775475|P1|Overall Study|Did not meet OGTT/ CGMS criteria|5
4867405|NCT00846521|16775475|P1|Overall Study|Withdrawal by Subject|5
4867406|NCT00846495|16775482|P2|Overall Study|Physician Decision|0
4867407|NCT00846495|16775483|P1|Overall Study|Physician Decision|1
4867408|NCT00846495|16775482|P2|Overall Study|Lack of Efficacy|2
4867409|NCT00846495|16775483|P1|Overall Study|Lack of Efficacy|1
4867410|NCT00846495|16775482|P2|Overall Study|Adverse Event|1
4867411|NCT00846495|16775483|P1|Overall Study|Adverse Event|5
4867412|NCT00846495|16775482|P2|Overall Study|Lost to Follow-up|0
4867413|NCT00846495|16775483|P1|Overall Study|Lost to Follow-up|1
4867414|NCT00846391|16775511|P3|Overall Study|Study Terminated by Sponsor|2
4867415|NCT00846391|16775512|P2|Overall Study|Study Terminated by Sponsor|2
4867416|NCT00846391|16775513|P1|Overall Study|Study Terminated by Sponsor|1
4867417|NCT00846391|16775511|P3|Overall Study|Physician Decision|1
4867418|NCT00846391|16775512|P2|Overall Study|Physician Decision|0
4867419|NCT00846391|16775513|P1|Overall Study|Physician Decision|0
4867420|NCT00846365|16775524|P3|Overall Study|Other|6
4867421|NCT00846365|16775525|P2|Overall Study|Other|1
4867422|NCT00846365|16775526|P1|Overall Study|Other|9
4867423|NCT00846365|16775524|P3|Overall Study|Lack of Efficacy|2
4867424|NCT00846365|16775525|P2|Overall Study|Lack of Efficacy|1
4867425|NCT00846365|16775526|P1|Overall Study|Lack of Efficacy|1
4867426|NCT00846365|16775524|P3|Overall Study|Pregnancy|0
4867427|NCT00846365|16775525|P2|Overall Study|Pregnancy|0
4867428|NCT00846365|16775526|P1|Overall Study|Pregnancy|1
4867429|NCT00846365|16775524|P3|Overall Study|Withdrawal by Subject|9
4867430|NCT00846365|16775525|P2|Overall Study|Withdrawal by Subject|11
4867431|NCT00846365|16775526|P1|Overall Study|Withdrawal by Subject|11
4867432|NCT00846365|16775524|P3|Overall Study|Lost to Follow-up|5
4867433|NCT00846365|16775525|P2|Overall Study|Lost to Follow-up|2
4867434|NCT00846365|16775526|P1|Overall Study|Lost to Follow-up|8
4867435|NCT00846365|16775524|P3|Overall Study|Protocol Violation|0
4867436|NCT00846365|16775525|P2|Overall Study|Protocol Violation|4
4867437|NCT00846365|16775526|P1|Overall Study|Protocol Violation|5
4867438|NCT00846365|16775524|P3|Overall Study|Adverse Event|11
4867439|NCT00846365|16775525|P2|Overall Study|Adverse Event|30
4867440|NCT00846365|16775526|P1|Overall Study|Adverse Event|20
4867441|NCT00846053|16775607|P2|Overall Study|Physician Decision|0
4867442|NCT00846053|16775608|P1|Overall Study|Physician Decision|3
4867443|NCT00846027|16775616|P1|Overall Study|Subject Not Treated|7
4867444|NCT00846027|16775616|P1|Overall Study|Protocol Violation|2
4867445|NCT00846027|16775616|P1|Overall Study|Investigator Discretion|29
4867446|NCT00846027|16775616|P1|Overall Study|Patient Decision|7
4867447|NCT00846027|16775616|P1|Overall Study|Toxicity|12
4867448|NCT00846027|16775616|P1|Overall Study|Disease Progression|30
4867449|NCT00846027|16775616|P1|Overall Study|Death|3
4867450|NCT00845897|16775639|P3|Overall Study|Too ill to participate|0
4867451|NCT00845897|16775640|P2|Overall Study|Too ill to participate|1
4867452|NCT00845897|16775641|P1|Overall Study|Too ill to participate|0
4867453|NCT00845897|16775639|P3|Overall Study|Ulcer did not heal|1
4867454|NCT00845897|16775640|P2|Overall Study|Ulcer did not heal|0
4867455|NCT00845897|16775641|P1|Overall Study|Ulcer did not heal|1
4867456|NCT00845897|16775639|P3|Overall Study|Withdrawal by Subject|2
4867457|NCT00845897|16775640|P2|Overall Study|Withdrawal by Subject|3
4867458|NCT00845897|16775641|P1|Overall Study|Withdrawal by Subject|0
4867459|NCT00845897|16775639|P3|Overall Study|Lost to Follow-up|0
4867460|NCT00845897|16775640|P2|Overall Study|Lost to Follow-up|1
4867461|NCT00845897|16775641|P1|Overall Study|Lost to Follow-up|1
4867462|NCT00845858|16775655|P3|Overall Study|not eligible|2
4867463|NCT00845858|16775656|P2|Overall Study|not eligible|3
4867464|NCT00845858|16775657|P1|Overall Study|not eligible|0
4867465|NCT00845858|16775655|P3|Overall Study|Protocol Violation|1
4867466|NCT00845858|16775656|P2|Overall Study|Protocol Violation|0
4867467|NCT00845858|16775657|P1|Overall Study|Protocol Violation|0
4867468|NCT00845858|16775655|P3|Overall Study|Adverse Event|4
4867469|NCT00845858|16775656|P2|Overall Study|Adverse Event|8
4867470|NCT00845858|16775657|P1|Overall Study|Adverse Event|3
4867471|NCT00845858|16775655|P3|Overall Study|Withdrawal by Subject|1
4867472|NCT00845858|16775656|P2|Overall Study|Withdrawal by Subject|1
4867473|NCT00845858|16775657|P1|Overall Study|Withdrawal by Subject|5
4867474|NCT00845845|16775670|P2|Overall Study|Lost to Follow-up|4
4867475|NCT00845845|16775671|P1|Overall Study|Lost to Follow-up|0
4867476|NCT00845832|16775682|P3|Extended Safety Follow-Up|Withdrawal by Subject|7
4867477|NCT00845832|16775683|P2|Extended Safety Follow-Up|Withdrawal by Subject|0
4867478|NCT00845832|16775684|P1|Extended Safety Follow-Up|Withdrawal by Subject|0
4867479|NCT00845832|16775682|P3|Safety Follow-Up|Withdrawal by Subject|0
4867480|NCT00845832|16775683|P2|Safety Follow-Up|Withdrawal by Subject|0
4867481|NCT00845832|16775684|P1|Safety Follow-Up|Withdrawal by Subject|1
4867482|NCT00845832|16775682|P3|Treatment Period|Protocol Violation|0
4867483|NCT00845832|16775683|P2|Treatment Period|Protocol Violation|1
4867484|NCT00845832|16775684|P1|Treatment Period|Protocol Violation|1
4867485|NCT00845832|16775682|P3|Treatment Period|Adverse Event|0
4867486|NCT00845832|16775683|P2|Treatment Period|Adverse Event|2
4867487|NCT00845832|16775684|P1|Treatment Period|Adverse Event|0
4867488|NCT00845728|16775730|P2|Overall Study|Withdrawal by Subject|108
4867489|NCT00845728|16775731|P1|Overall Study|Withdrawal by Subject|105
4867490|NCT00845728|16775730|P2|Overall Study|Adverse Event|96
4867491|NCT00845728|16775731|P1|Overall Study|Adverse Event|101
4867492|NCT00845728|16775730|P2|Overall Study|Lack of Efficacy|39
4867493|NCT00845728|16775731|P1|Overall Study|Lack of Efficacy|51
4867494|NCT00845728|16775730|P2|Overall Study|Protocol Violation|24
4867495|NCT00845728|16775731|P1|Overall Study|Protocol Violation|36
4867496|NCT00845728|16775730|P2|Overall Study|Administrative Problems|26
4867497|NCT00845728|16775731|P1|Overall Study|Administrative Problems|34
4867498|NCT00845728|16775730|P2|Overall Study|Death|26
4867499|NCT00845728|16775731|P1|Overall Study|Death|24
4867500|NCT00845728|16775730|P2|Overall Study|Lost to Follow-up|13
4867501|NCT00845728|16775731|P1|Overall Study|Lost to Follow-up|22
4867502|NCT00845728|16775730|P2|Overall Study|Abnormal test procedure result (s)|2
4867503|NCT00845728|16775731|P1|Overall Study|Abnormal test procedure result (s)|7
4867504|NCT00845728|16775730|P2|Overall Study|Patient's inability to use the device|6
4867505|NCT00845728|16775731|P1|Overall Study|Patient's inability to use the device|4
4867506|NCT00845728|16775730|P2|Overall Study|Abnormal laboratory value (s)|2
4867507|NCT00845728|16775731|P1|Overall Study|Abnormal laboratory value (s)|2
4867508|NCT00845676|16775745|P1|Overall Study|Adverse Event|1
4867509|NCT00845676|16775745|P1|Overall Study|Virologic breakthrough at week 20|1
4867510|NCT00845650|16775808|P6|Overall Study|Unable to access IV line|0
4867511|NCT00845650|16775809|P5|Overall Study|Unable to access IV line|0
4867512|NCT00845650|16775810|P4|Overall Study|Unable to access IV line|0
4867513|NCT00845650|16775811|P3|Overall Study|Unable to access IV line|0
4867514|NCT00845650|16775812|P2|Overall Study|Unable to access IV line|0
4867515|NCT00845650|16775813|P1|Overall Study|Unable to access IV line|1
4867516|NCT00845650|16775808|P6|Overall Study|Sponsor hold on dosing|1
4867517|NCT00845650|16775809|P5|Overall Study|Sponsor hold on dosing|1
4867518|NCT00845650|16775810|P4|Overall Study|Sponsor hold on dosing|0
4867519|NCT00845650|16775811|P3|Overall Study|Sponsor hold on dosing|0
4867520|NCT00845650|16775812|P2|Overall Study|Sponsor hold on dosing|0
4867521|NCT00845650|16775813|P1|Overall Study|Sponsor hold on dosing|0
4867522|NCT00845650|16775808|P6|Overall Study|Lost to Follow-up|1
4867523|NCT00845650|16775809|P5|Overall Study|Lost to Follow-up|0
4867524|NCT00845650|16775810|P4|Overall Study|Lost to Follow-up|1
4867525|NCT00845650|16775811|P3|Overall Study|Lost to Follow-up|3
4867526|NCT00845650|16775812|P2|Overall Study|Lost to Follow-up|0
4867527|NCT00845650|16775813|P1|Overall Study|Lost to Follow-up|0
4867528|NCT00845650|16775808|P6|Overall Study|Withdrawal by Subject|0
4867529|NCT00845650|16775809|P5|Overall Study|Withdrawal by Subject|2
4867530|NCT00845650|16775810|P4|Overall Study|Withdrawal by Subject|0
4867531|NCT00845650|16775811|P3|Overall Study|Withdrawal by Subject|0
4867532|NCT00845650|16775812|P2|Overall Study|Withdrawal by Subject|0
4867533|NCT00845650|16775813|P1|Overall Study|Withdrawal by Subject|0
4867534|NCT00845520|16775851|P3|Overall Study|Adverse Event|1
4867535|NCT00845520|16775852|P2|Overall Study|Adverse Event|0
4867536|NCT00845520|16775853|P1|Overall Study|Adverse Event|0
4867537|NCT00845520|16775851|P3|Overall Study|Lost to Follow-up|0
4867538|NCT00845520|16775852|P2|Overall Study|Lost to Follow-up|0
4867539|NCT00845520|16775853|P1|Overall Study|Lost to Follow-up|1
4867540|NCT00845520|16775851|P3|Overall Study|Death|0
4867541|NCT00845520|16775852|P2|Overall Study|Death|2
4867542|NCT00845520|16775853|P1|Overall Study|Death|1
4867543|NCT00845429|16775890|P3|Overall Study|Serious adverse event|1
4867544|NCT00845429|16775891|P2|Overall Study|Serious adverse event|0
4867545|NCT00845429|16775892|P1|Overall Study|Serious adverse event|0
4867546|NCT00845429|16775890|P3|Overall Study|Withdrawal by Subject|2
4867547|NCT00845429|16775891|P2|Overall Study|Withdrawal by Subject|2
4867548|NCT00845429|16775892|P1|Overall Study|Withdrawal by Subject|2
4867549|NCT00845429|16775890|P3|Overall Study|Lost to Follow-up|10
4867550|NCT00845429|16775891|P2|Overall Study|Lost to Follow-up|9
4867551|NCT00845429|16775892|P1|Overall Study|Lost to Follow-up|7
4867552|NCT00845429|16775890|P3|Overall Study|Protocol Violation|7
4867553|NCT00845429|16775891|P2|Overall Study|Protocol Violation|4
4867554|NCT00845429|16775892|P1|Overall Study|Protocol Violation|5
4867555|NCT00845182|16775927|P3|Overall Study|Physician Decision|1
4867556|NCT00845182|16775928|P2|Overall Study|Physician Decision|0
4867557|NCT00845182|16775929|P1|Overall Study|Physician Decision|0
4867558|NCT00845182|16775927|P3|Overall Study|Adverse Event|1
4867559|NCT00845182|16775928|P2|Overall Study|Adverse Event|1
4867560|NCT00845182|16775929|P1|Overall Study|Adverse Event|0
4867561|NCT00845182|16775927|P3|Overall Study|Lost to Follow-up|4
4867562|NCT00845182|16775928|P2|Overall Study|Lost to Follow-up|3
4867563|NCT00845182|16775929|P1|Overall Study|Lost to Follow-up|3
4867564|NCT00845065|16775954|P2|Overall Study|Non-Medical Reasons|11
4867565|NCT00845065|16775955|P1|Overall Study|Non-Medical Reasons|1
4867566|NCT00845065|16775954|P2|Overall Study|Lack of Efficacy|21
4867567|NCT00845065|16775955|P1|Overall Study|Lack of Efficacy|43
4867568|NCT00845065|16775954|P2|Overall Study|Adverse Event|23
4867569|NCT00845065|16775955|P1|Overall Study|Adverse Event|3
4867570|NCT00844896|16776023|P2|Overall Study|Parents did not have time to complete|1
4867571|NCT00844896|16776024|P1|Overall Study|Parents did not have time to complete|0
4867572|NCT00844896|16776023|P2|Overall Study|Lost to Follow-up|16
4867573|NCT00844896|16776024|P1|Overall Study|Lost to Follow-up|12
4867574|NCT00844883|16776046|P1|Overall Study|Bridged to resection|1
4867575|NCT00844883|16776046|P1|Overall Study|Bridged to liver transplant|3
4867576|NCT00844857|16776058|P2|Overall Study|Good Clinical Practice Violations|11
4867577|NCT00844857|16776059|P1|Overall Study|Good Clinical Practice Violations|21
4867578|NCT00844857|16776058|P2|Overall Study|Did Not Take Study Drug|1
4867579|NCT00844857|16776059|P1|Overall Study|Did Not Take Study Drug|3
4867580|NCT00844857|16776058|P2|Overall Study|Lost to Follow-up|3
4867581|NCT00844857|16776059|P1|Overall Study|Lost to Follow-up|2
4867582|NCT00844857|16776058|P2|Overall Study|Entry Criteria Not Met|1
4867583|NCT00844857|16776059|P1|Overall Study|Entry Criteria Not Met|0
4867584|NCT00844857|16776058|P2|Overall Study|Clinical Relapse|1
4867585|NCT00844857|16776059|P1|Overall Study|Clinical Relapse|0
4867586|NCT00844857|16776058|P2|Overall Study|Lack of Efficacy|5
4867587|NCT00844857|16776059|P1|Overall Study|Lack of Efficacy|5
4867588|NCT00844857|16776058|P2|Overall Study|Protocol Violation|0
4867589|NCT00844857|16776059|P1|Overall Study|Protocol Violation|6
4867590|NCT00844857|16776058|P2|Overall Study|Withdrawal by Subject|7
4867591|NCT00844857|16776059|P1|Overall Study|Withdrawal by Subject|8
4867592|NCT00844857|16776058|P2|Overall Study|Parent/Caregiver Decision|2
4867593|NCT00844857|16776059|P1|Overall Study|Parent/Caregiver Decision|6
4867594|NCT00844857|16776058|P2|Overall Study|Physician Decision|0
4867595|NCT00844857|16776059|P1|Overall Study|Physician Decision|2
4867596|NCT00844857|16776058|P2|Overall Study|Sponsor Decision|1
4867597|NCT00844857|16776059|P1|Overall Study|Sponsor Decision|1
4867598|NCT00844857|16776058|P2|Overall Study|Adverse Event|5
4867599|NCT00844857|16776059|P1|Overall Study|Adverse Event|24
4867600|NCT00844844|16776103|P1|Post Treatment Period|Withdrawal by Subject|1
4867601|NCT00844844|16776103|P1|Extension Treatment Period|Adverse Event|2
4867602|NCT00844844|16776103|P1|Treatment Period (26 Weeks)|Protocol Violation|1
4867603|NCT00844844|16776103|P1|Treatment Period (26 Weeks)|Adverse Event|1
4867604|NCT00844831|16776117|P1|Overall Study|Physician Decision|1
4867605|NCT00844831|16776117|P1|Overall Study|Adverse Event|1
4867606|NCT00844831|16776117|P1|Overall Study|Withdrawal by Subject|4
4867607|NCT00844805|16776127|P4|Follow-Up Phase|Did Not Meet Protocol Eligibility|1
4867608|NCT00844805|16776128|P3|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
4867609|NCT00844805|16776129|P2|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
4867610|NCT00844805|16776130|P1|Follow-Up Phase|Did Not Meet Protocol Eligibility|0
4867611|NCT00844805|16776127|P4|Follow-Up Phase|Relapse/Recurrence|4
4867612|NCT00844805|16776128|P3|Follow-Up Phase|Relapse/Recurrence|2
4867613|NCT00844805|16776129|P2|Follow-Up Phase|Relapse/Recurrence|0
4867614|NCT00844805|16776130|P1|Follow-Up Phase|Relapse/Recurrence|0
4867615|NCT00844805|16776127|P4|Follow-Up Phase|Noncompliance With Protocol|1
4867616|NCT00844805|16776128|P3|Follow-Up Phase|Noncompliance With Protocol|0
4867617|NCT00844805|16776129|P2|Follow-Up Phase|Noncompliance With Protocol|0
4867618|NCT00844805|16776130|P1|Follow-Up Phase|Noncompliance With Protocol|0
4867619|NCT00844805|16776127|P4|Follow-Up Phase|Withdrawal by Subject|3
4867620|NCT00844805|16776128|P3|Follow-Up Phase|Withdrawal by Subject|6
4867621|NCT00844805|16776129|P2|Follow-Up Phase|Withdrawal by Subject|0
4867622|NCT00844805|16776130|P1|Follow-Up Phase|Withdrawal by Subject|0
4867623|NCT00844805|16776127|P4|Follow-Up Phase|Adverse Event|0
4867624|NCT00844805|16776128|P3|Follow-Up Phase|Adverse Event|1
4867625|NCT00844805|16776129|P2|Follow-Up Phase|Adverse Event|0
4867626|NCT00844805|16776130|P1|Follow-Up Phase|Adverse Event|0
4867627|NCT00844805|16776127|P4|Treatment Phase|Did Not Meet Protocol Eligibility|0
4867628|NCT00844805|16776128|P3|Treatment Phase|Did Not Meet Protocol Eligibility|0
4867629|NCT00844805|16776129|P2|Treatment Phase|Did Not Meet Protocol Eligibility|2
4867630|NCT00844805|16776130|P1|Treatment Phase|Did Not Meet Protocol Eligibility|1
4867631|NCT00844805|16776127|P4|Treatment Phase|Noncompliance With Protocol|0
4867632|NCT00844805|16776128|P3|Treatment Phase|Noncompliance With Protocol|0
4867633|NCT00844805|16776129|P2|Treatment Phase|Noncompliance With Protocol|0
4867634|NCT00844805|16776130|P1|Treatment Phase|Noncompliance With Protocol|1
4867635|NCT00844805|16776127|P4|Treatment Phase|Withdrawal by Subject|0
4867636|NCT00844805|16776128|P3|Treatment Phase|Withdrawal by Subject|0
4867637|NCT00844805|16776129|P2|Treatment Phase|Withdrawal by Subject|4
4867638|NCT00844805|16776130|P1|Treatment Phase|Withdrawal by Subject|3
4867639|NCT00844805|16776127|P4|Treatment Phase|Adverse Event|0
4867640|NCT00844805|16776128|P3|Treatment Phase|Adverse Event|0
4867641|NCT00844805|16776129|P2|Treatment Phase|Adverse Event|1
4867642|NCT00844805|16776130|P1|Treatment Phase|Adverse Event|5
4867643|NCT00844753|16776174|P4|Overall Study|Withdrawal by Subject|3
4867644|NCT00844753|16776175|P3|Overall Study|Withdrawal by Subject|0
4867645|NCT00844753|16776176|P2|Overall Study|Withdrawal by Subject|0
4867646|NCT00844753|16776177|P1|Overall Study|Withdrawal by Subject|1
4867647|NCT00844753|16776174|P4|Overall Study|could not swallow medication|0
4867648|NCT00844753|16776175|P3|Overall Study|could not swallow medication|0
4867649|NCT00844753|16776176|P2|Overall Study|could not swallow medication|0
4867650|NCT00844753|16776177|P1|Overall Study|could not swallow medication|2
4867651|NCT00844753|16776174|P4|Overall Study|Lost to Follow-up|1
4867652|NCT00844753|16776175|P3|Overall Study|Lost to Follow-up|0
4867653|NCT00844753|16776176|P2|Overall Study|Lost to Follow-up|1
4867654|NCT00844753|16776177|P1|Overall Study|Lost to Follow-up|1
4867655|NCT00844753|16776174|P4|Overall Study|Adverse Event|5
4867656|NCT00844753|16776175|P3|Overall Study|Adverse Event|5
4867657|NCT00844753|16776176|P2|Overall Study|Adverse Event|2
4867658|NCT00844753|16776177|P1|Overall Study|Adverse Event|3
4867659|NCT00844753|16776174|P4|Overall Study|Lack of Efficacy|2
4867660|NCT00844753|16776175|P3|Overall Study|Lack of Efficacy|2
4867661|NCT00844753|16776176|P2|Overall Study|Lack of Efficacy|0
4867662|NCT00844753|16776177|P1|Overall Study|Lack of Efficacy|1
4867663|NCT00844649|16776195|P2|Overall Study|Withdrew prior to starting treatment|27
4867664|NCT00844649|16776196|P1|Overall Study|Withdrew prior to starting treatment|11
4867665|NCT00844649|16776195|P2|Overall Study|Other|10
4867666|NCT00844649|16776196|P1|Overall Study|Other|7
4867667|NCT00844649|16776195|P2|Overall Study|Withdrawal by Subject|39
4867668|NCT00844649|16776196|P1|Overall Study|Withdrawal by Subject|28
4867669|NCT00844649|16776195|P2|Overall Study|Protocol Violation|6
4867670|NCT00844649|16776196|P1|Overall Study|Protocol Violation|10
4867671|NCT00844649|16776195|P2|Overall Study|Physician Decision|18
4867672|NCT00844649|16776196|P1|Overall Study|Physician Decision|25
4867673|NCT00844649|16776195|P2|Overall Study|Adverse Event|73
4867674|NCT00844649|16776196|P1|Overall Study|Adverse Event|128
4867675|NCT00844649|16776195|P2|Overall Study|Progressive Disease|245
4867676|NCT00844649|16776196|P1|Overall Study|Progressive Disease|196
4867677|NCT00844597|16776220|P6|Overall Study|Adverse Event|0
4867678|NCT00844597|16776221|P5|Overall Study|Adverse Event|0
4867679|NCT00844597|16776222|P4|Overall Study|Adverse Event|1
4867680|NCT00844597|16776223|P3|Overall Study|Adverse Event|0
4867681|NCT00844597|16776224|P2|Overall Study|Adverse Event|0
4867682|NCT00844597|16776225|P1|Overall Study|Adverse Event|0
4867683|NCT00844558|16776245|P2|Overall Study|Physician Decision|0
4867684|NCT00844558|16776246|P1|Overall Study|Physician Decision|1
4867685|NCT00844558|16776245|P2|Overall Study|Lost to Follow-up|1
4867686|NCT00844558|16776246|P1|Overall Study|Lost to Follow-up|0
4867687|NCT00844558|16776245|P2|Overall Study|Protocol Violation|1
4867688|NCT00844558|16776246|P1|Overall Study|Protocol Violation|1
4867689|NCT00844558|16776245|P2|Overall Study|Death|0
4867690|NCT00844558|16776246|P1|Overall Study|Death|1
4867691|NCT00844558|16776245|P2|Overall Study|Withdrawal by Subject|2
4867692|NCT00844558|16776246|P1|Overall Study|Withdrawal by Subject|9
4867693|NCT00844545|16776262|P1|Post Treatment Period|Withdrawal by Subject|1
4867694|NCT00844545|16776262|P1|Extension Treatment Period|Adverse Event|2
4867695|NCT00844545|16776262|P1|Treatment Period (26 Weeks)|Protocol Violation|1
4867696|NCT00844545|16776262|P1|Treatment Period (26 Weeks)|Adverse Event|1
4867697|NCT00844532|16776276|P1|Overall Study|Lost to Follow-up|7
4867698|NCT00844532|16776276|P1|Overall Study|Withdrawal by Subject|16
4867699|NCT00844532|16776276|P1|Overall Study|Death|16
4867700|NCT00844519|16776362|P2|Overall Study|Adverse Event|0
4867701|NCT00844519|16776363|P1|Overall Study|Adverse Event|1
4867702|NCT00844519|16776362|P2|Overall Study|Withdrawal by Subject|1
4867703|NCT00844519|16776363|P1|Overall Study|Withdrawal by Subject|1
4867704|NCT00844480|16776371|P2|Overall Study|Withdrawal by Subject|3
4867705|NCT00844480|16776372|P1|Overall Study|Withdrawal by Subject|2
4867706|NCT00844428|16776380|P1|Post Treatment Period (Patients Who Disc|Death|1
4867707|NCT00844428|16776380|P1|Extension Treatment Period|Death|1
4867708|NCT00844428|16776380|P1|Screening Period|Screen Failure|3
4867709|NCT00844415|16776396|P1|Overall Study|Withdrawal by Subject|1
4867710|NCT00844376|16776410|P2|Period 1: First Intervention|Withdrawal by Subject|0
4867711|NCT00844376|16776411|P1|Period 1: First Intervention|Withdrawal by Subject|1
4867712|NCT00844194|16776435|P2|Overall Study|Other reason (not specified)|0
4867713|NCT00844194|16776436|P1|Overall Study|Other reason (not specified)|1
4867714|NCT00844194|16776435|P2|Overall Study|Lack of Efficacy|0
4867715|NCT00844194|16776436|P1|Overall Study|Lack of Efficacy|3
4867716|NCT00844194|16776435|P2|Overall Study|Withdrawal by Subject|1
4867717|NCT00844194|16776436|P1|Overall Study|Withdrawal by Subject|2
4867718|NCT00844194|16776435|P2|Overall Study|Lost to Follow-up|1
4867719|NCT00844194|16776436|P1|Overall Study|Lost to Follow-up|1
4867720|NCT00844194|16776435|P2|Overall Study|Protocol Violation|1
4867721|NCT00844194|16776436|P1|Overall Study|Protocol Violation|1
4867722|NCT00844194|16776435|P2|Overall Study|Adverse Event|5
4867723|NCT00844194|16776436|P1|Overall Study|Adverse Event|17
4867724|NCT00843856|16776691|P2|Overall Study|Lost to Follow-up|2
4867725|NCT00843856|16776692|P1|Overall Study|Lost to Follow-up|1
4867726|NCT00843843|16776702|P2|Overall Study|Protocol Violation|1
4867727|NCT00843843|16776703|P1|Overall Study|Protocol Violation|1
4867728|NCT00843843|16776702|P2|Overall Study|Physician Decision|1
4867729|NCT00843843|16776703|P1|Overall Study|Physician Decision|1
4867730|NCT00843778|16776716|P1|Overall Study|Withdrawal by Subject|4
4867731|NCT00843778|16776716|P1|Overall Study|Loss of efficacy|2
4867732|NCT00843778|16776716|P1|Overall Study|Lack of Efficacy|14
4867733|NCT00843778|16776716|P1|Overall Study|Adverse Event|15
4867734|NCT00843635|16776761|P3|Overall Study|Adverse Event|0
4867735|NCT00843635|16776762|P2|Overall Study|Adverse Event|2
4867736|NCT00843635|16776763|P1|Overall Study|Adverse Event|2
4867737|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Caregiver decision|7
4867738|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Caregiver decision|7
4867739|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0
4867740|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2
4867741|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Protocol Violation|5
4867742|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Protocol Violation|2
4867743|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Physician Decision|1
4867744|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Physician Decision|2
4867745|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Lost to Follow-up|3
4867746|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Lost to Follow-up|2
4867747|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Death|1
4867748|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Death|0
4867749|NCT00843518|16776802|P2|Period 2 (Double-blind Treatment)|Adverse Event|3
4867750|NCT00843518|16776803|P1|Period 2 (Double-blind Treatment)|Adverse Event|5
4867751|NCT00843492|16776833|P2|Overall Study|Deep-vein Thrombosis|0
4867752|NCT00843492|16776834|P1|Overall Study|Deep-vein Thrombosis|1
4867753|NCT00843492|16776833|P2|Overall Study|Visit Not Performed|0
4867754|NCT00843492|16776834|P1|Overall Study|Visit Not Performed|1
4867755|NCT00843492|16776833|P2|Overall Study|Orthopedic Surgery|2
4867756|NCT00843492|16776834|P1|Overall Study|Orthopedic Surgery|0
4867757|NCT00843492|16776833|P2|Overall Study|Investigator/Orthopedic Surgeon Decision|1
4867758|NCT00843492|16776834|P1|Overall Study|Investigator/Orthopedic Surgeon Decision|1
4867759|NCT00843492|16776833|P2|Overall Study|Immobilization Stopped|0
4867760|NCT00843492|16776834|P1|Overall Study|Immobilization Stopped|1
4867761|NCT00843492|16776833|P2|Overall Study|Withdrawal by Subject|4
4867762|NCT00843492|16776834|P1|Overall Study|Withdrawal by Subject|0
4867763|NCT00843492|16776833|P2|Overall Study|Lost to Follow-up|4
4867764|NCT00843492|16776834|P1|Overall Study|Lost to Follow-up|4
4867765|NCT00843492|16776833|P2|Overall Study|Adverse Event|3
4867766|NCT00843492|16776834|P1|Overall Study|Adverse Event|0
4867767|NCT00843284|16776905|P1|Overall Study|Death|3
4867768|NCT00843284|16776905|P1|Overall Study|Withdrawal by Subject|4
4867769|NCT00843284|16776905|P1|Overall Study|Other|10
4867770|NCT00843284|16776905|P1|Overall Study|Lost to Follow-up|11
4867771|NCT00843284|16776905|P1|Overall Study|Lack of Efficacy|5
4867772|NCT00843284|16776905|P1|Overall Study|Adverse Event|39
4867773|NCT00843193|16776915|P2|Overall Study|Withdrawal by Subject|3
4867774|NCT00843193|16776916|P1|Overall Study|Withdrawal by Subject|3
4867775|NCT00843193|16776915|P2|Overall Study|Physician Decision|1
4867776|NCT00843193|16776916|P1|Overall Study|Physician Decision|0
4867777|NCT00843193|16776915|P2|Overall Study|Lost to Follow-up|0
4867778|NCT00843193|16776916|P1|Overall Study|Lost to Follow-up|1
4867779|NCT00843193|16776915|P2|Overall Study|Protocol Violation|2
4867780|NCT00843193|16776916|P1|Overall Study|Protocol Violation|1
4867781|NCT00843193|16776915|P2|Overall Study|Lack of Efficacy|1
4867782|NCT00843193|16776916|P1|Overall Study|Lack of Efficacy|1
4867783|NCT00843193|16776915|P2|Overall Study|Adverse Event|4
4867784|NCT00843193|16776916|P1|Overall Study|Adverse Event|2
4867785|NCT00843167|16776967|P2|Treatment Period|Withdrawal by Subject|3
4867786|NCT00843167|16776968|P1|Treatment Period|Withdrawal by Subject|2
4867787|NCT00843167|16776967|P2|Treatment Period|Adverse Event|5
4867788|NCT00843167|16776968|P1|Treatment Period|Adverse Event|1
4867789|NCT00843115|16776981|P1|Overall Study|Syndrome De Glissement|1
4867790|NCT00843115|16776981|P1|Overall Study|week 12 not done|1
4867791|NCT00843115|16776981|P1|Overall Study|hospitalized due to deterioration|1
4867792|NCT00843115|16776981|P1|Overall Study|patient never took the medication|1
4867793|NCT00843115|16776981|P1|Overall Study|patient took for 2 days then stopped|1
4867794|NCT00843115|16776981|P1|Overall Study|Family discontinued meds|1
4867795|NCT00843115|16776981|P1|Overall Study|Physician Decision|1
4867796|NCT00843115|16776981|P1|Overall Study|Does not meet entrance criteria|1
4867797|NCT00843115|16776981|P1|Overall Study|Patient forgot to take meds|1
4867798|NCT00843115|16776981|P1|Overall Study|Family does not want continuation|1
4867799|NCT00843115|16776981|P1|Overall Study|Family wanted meds stopped|1
4867800|NCT00843115|16776981|P1|Overall Study|Withdrawal by Subject|17
4867801|NCT00843115|16776981|P1|Overall Study|Lost to Follow-up|4
4867802|NCT00843115|16776981|P1|Overall Study|Adverse Event|30
4867803|NCT00843115|16776981|P1|Overall Study|Death|4
4867804|NCT00843024|16777037|P6|Double-blind Treatment Phase|Lack of Efficacy|0
4867805|NCT00843024|16777038|P5|Double-blind Treatment Phase|Lack of Efficacy|1
4867806|NCT00843024|16777039|P4|Double-blind Treatment Phase|Lack of Efficacy|0
4867807|NCT00843024|16777040|P3|Double-blind Treatment Phase|Lack of Efficacy|0
4867808|NCT00843024|16777041|P2|Double-blind Treatment Phase|Lack of Efficacy|0
4867809|NCT00843024|16777042|P1|Double-blind Treatment Phase|Lack of Efficacy|0
4867810|NCT00843024|16777037|P6|Double-blind Treatment Phase|Adverse Event|1
4867811|NCT00843024|16777038|P5|Double-blind Treatment Phase|Adverse Event|1
4867812|NCT00843024|16777039|P4|Double-blind Treatment Phase|Adverse Event|0
4867813|NCT00843024|16777040|P3|Double-blind Treatment Phase|Adverse Event|0
4867814|NCT00843024|16777041|P2|Double-blind Treatment Phase|Adverse Event|0
4867815|NCT00843024|16777042|P1|Double-blind Treatment Phase|Adverse Event|0
4867816|NCT00843024|16777037|P6|Double-blind Treatment Phase|Physician Decision|1
4867817|NCT00843024|16777038|P5|Double-blind Treatment Phase|Physician Decision|1
4867818|NCT00843024|16777039|P4|Double-blind Treatment Phase|Physician Decision|3
4867819|NCT00843024|16777040|P3|Double-blind Treatment Phase|Physician Decision|0
4867820|NCT00843024|16777041|P2|Double-blind Treatment Phase|Physician Decision|0
4867821|NCT00843024|16777042|P1|Double-blind Treatment Phase|Physician Decision|0
4867822|NCT00843024|16777037|P6|Double-blind Treatment Phase|Protocol Violation|3
4867823|NCT00843024|16777038|P5|Double-blind Treatment Phase|Protocol Violation|0
4867824|NCT00843024|16777039|P4|Double-blind Treatment Phase|Protocol Violation|0
4867825|NCT00843024|16777040|P3|Double-blind Treatment Phase|Protocol Violation|3
4867826|NCT00843024|16777041|P2|Double-blind Treatment Phase|Protocol Violation|0
4867827|NCT00843024|16777042|P1|Double-blind Treatment Phase|Protocol Violation|0
4867828|NCT00843024|16777037|P6|Double-blind Treatment Phase|Withdrawal by Subject|2
4867829|NCT00843024|16777038|P5|Double-blind Treatment Phase|Withdrawal by Subject|0
4867830|NCT00843024|16777039|P4|Double-blind Treatment Phase|Withdrawal by Subject|6
4867831|NCT00843024|16777040|P3|Double-blind Treatment Phase|Withdrawal by Subject|0
4867832|NCT00843024|16777041|P2|Double-blind Treatment Phase|Withdrawal by Subject|0
4867833|NCT00843024|16777042|P1|Double-blind Treatment Phase|Withdrawal by Subject|0
4867834|NCT00843024|16777037|P6|Double-blind Treatment Phase|Lost to Follow-up|4
4867835|NCT00843024|16777038|P5|Double-blind Treatment Phase|Lost to Follow-up|4
4867836|NCT00843024|16777039|P4|Double-blind Treatment Phase|Lost to Follow-up|4
4867837|NCT00843024|16777040|P3|Double-blind Treatment Phase|Lost to Follow-up|8
4867838|NCT00843024|16777041|P2|Double-blind Treatment Phase|Lost to Follow-up|0
4867839|NCT00843024|16777042|P1|Double-blind Treatment Phase|Lost to Follow-up|0
4867840|NCT00843024|16777037|P6|Double-blind Treatment Phase|No opportunity to treat migraine|14
4867841|NCT00843024|16777038|P5|Double-blind Treatment Phase|No opportunity to treat migraine|13
4867842|NCT00843024|16777039|P4|Double-blind Treatment Phase|No opportunity to treat migraine|10
4867843|NCT00843024|16777040|P3|Double-blind Treatment Phase|No opportunity to treat migraine|20
4867844|NCT00843024|16777041|P2|Double-blind Treatment Phase|No opportunity to treat migraine|0
4867845|NCT00843024|16777042|P1|Double-blind Treatment Phase|No opportunity to treat migraine|0
4867846|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Other|0
4867847|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Other|0
4867848|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Other|0
4867849|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Other|0
4867850|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Other|1
4867851|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Other|0
4867852|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Adverse Event|0
4867853|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Adverse Event|0
4867854|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Adverse Event|0
4867855|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Adverse Event|0
4867856|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Adverse Event|1
4867857|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Adverse Event|0
4867858|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Physician Decision|0
4867859|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Physician Decision|0
4867860|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Physician Decision|0
4867861|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Physician Decision|0
4867862|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Physician Decision|6
4867863|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Physician Decision|2
4867864|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Protocol Violation|0
4867865|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Protocol Violation|0
4867866|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Protocol Violation|0
4867867|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Protocol Violation|0
4867868|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Protocol Violation|5
4867869|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Protocol Violation|4
4867870|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4867871|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4867872|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4867873|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0
4867874|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18
4867875|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19
4867876|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4867877|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4867878|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4867879|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Lost to Follow-up|0
4867880|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Lost to Follow-up|31
4867881|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Lost to Follow-up|36
4867882|NCT00843024|16777037|P6|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4867883|NCT00843024|16777038|P5|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4867884|NCT00843024|16777039|P4|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4867885|NCT00843024|16777040|P3|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0
4867886|NCT00843024|16777041|P2|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74
4867887|NCT00843024|16777042|P1|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79
4867888|NCT00842985|16777107|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
4867889|NCT00842985|16777107|P1|Washout Period of GE 4 Days|Withdrawal by Subject|2
4867890|NCT00842985|16777107|P1|First Intervention|Protocol Violation|3
4867891|NCT00842985|16777107|P1|First Intervention|Withdrawal by Subject|3
4867892|NCT00842985|16777107|P1|Screening|Did not meet entrance requirements|27
4867893|NCT00842829|16777125|P3|Continuation Period|Non-compliance to study drug|1
4867894|NCT00842829|16777126|P2|Continuation Period|Non-compliance to study drug|0
4867895|NCT00842829|16777127|P1|Continuation Period|Non-compliance to study drug|0
4867896|NCT00842829|16777125|P3|Continuation Period|Non-compliance to study procedures|2
4867979|NCT00842712|16777189|P4|Safety Run-in Part|Progressive disease|1
4867897|NCT00842829|16777126|P2|Continuation Period|Non-compliance to study procedures|0
4867898|NCT00842829|16777127|P1|Continuation Period|Non-compliance to study procedures|0
4867899|NCT00842829|16777125|P3|Continuation Period|Other|7
4867900|NCT00842829|16777126|P2|Continuation Period|Other|0
4867901|NCT00842829|16777127|P1|Continuation Period|Other|0
4867902|NCT00842829|16777125|P3|Continuation Period|Withdrawal by Subject|10
4867903|NCT00842829|16777126|P2|Continuation Period|Withdrawal by Subject|0
4867904|NCT00842829|16777127|P1|Continuation Period|Withdrawal by Subject|0
4867905|NCT00842829|16777125|P3|Continuation Period|Unstable persistent cancer pain|3
4867906|NCT00842829|16777126|P2|Continuation Period|Unstable persistent cancer pain|0
4867907|NCT00842829|16777127|P1|Continuation Period|Unstable persistent cancer pain|0
4867908|NCT00842829|16777125|P3|Continuation Period|Lack of Efficacy|6
4867909|NCT00842829|16777126|P2|Continuation Period|Lack of Efficacy|0
4867910|NCT00842829|16777127|P1|Continuation Period|Lack of Efficacy|0
4867911|NCT00842829|16777125|P3|Continuation Period|Adverse Event|32
4867912|NCT00842829|16777126|P2|Continuation Period|Adverse Event|0
4867913|NCT00842829|16777127|P1|Continuation Period|Adverse Event|0
4867914|NCT00842829|16777125|P3|Treatment Period|Unclear completion status|1
4867915|NCT00842829|16777126|P2|Treatment Period|Unclear completion status|0
4867916|NCT00842829|16777127|P1|Treatment Period|Unclear completion status|0
4867917|NCT00842829|16777125|P3|Treatment Period|Non-compliance to study procedures|4
4867918|NCT00842829|16777126|P2|Treatment Period|Non-compliance to study procedures|0
4867919|NCT00842829|16777127|P1|Treatment Period|Non-compliance to study procedures|0
4867920|NCT00842829|16777125|P3|Treatment Period|Other|18
4867921|NCT00842829|16777126|P2|Treatment Period|Other|0
4867922|NCT00842829|16777127|P1|Treatment Period|Other|0
4867923|NCT00842829|16777125|P3|Treatment Period|Protocol Violation|2
4867924|NCT00842829|16777126|P2|Treatment Period|Protocol Violation|0
4867925|NCT00842829|16777127|P1|Treatment Period|Protocol Violation|0
4867926|NCT00842829|16777125|P3|Treatment Period|Consistently >4 BTP episodes daily|1
4867927|NCT00842829|16777126|P2|Treatment Period|Consistently >4 BTP episodes daily|0
4867928|NCT00842829|16777127|P1|Treatment Period|Consistently >4 BTP episodes daily|0
4867929|NCT00842829|16777125|P3|Treatment Period|Withdrawal by Subject|11
4867930|NCT00842829|16777126|P2|Treatment Period|Withdrawal by Subject|0
4867931|NCT00842829|16777127|P1|Treatment Period|Withdrawal by Subject|0
4867932|NCT00842829|16777125|P3|Treatment Period|Unstable persistent cancer pain|5
4867933|NCT00842829|16777126|P2|Treatment Period|Unstable persistent cancer pain|0
4867934|NCT00842829|16777127|P1|Treatment Period|Unstable persistent cancer pain|0
4867935|NCT00842829|16777125|P3|Treatment Period|Lack of Efficacy|6
4867936|NCT00842829|16777126|P2|Treatment Period|Lack of Efficacy|0
4867937|NCT00842829|16777127|P1|Treatment Period|Lack of Efficacy|0
4867938|NCT00842829|16777125|P3|Treatment Period|Adverse Event|15
4867939|NCT00842829|16777126|P2|Treatment Period|Adverse Event|0
4867940|NCT00842829|16777127|P1|Treatment Period|Adverse Event|0
4867941|NCT00842829|16777125|P3|Dose Titration Period|Non-compliance to study drug|0
4867942|NCT00842829|16777126|P2|Dose Titration Period|Non-compliance to study drug|1
4867943|NCT00842829|16777127|P1|Dose Titration Period|Non-compliance to study drug|2
4867944|NCT00842829|16777125|P3|Dose Titration Period|Non-compliance to study procedures|0
4867945|NCT00842829|16777126|P2|Dose Titration Period|Non-compliance to study procedures|1
4867946|NCT00842829|16777127|P1|Dose Titration Period|Non-compliance to study procedures|1
4867947|NCT00842829|16777125|P3|Dose Titration Period|Other|0
4867948|NCT00842829|16777126|P2|Dose Titration Period|Other|4
4867949|NCT00842829|16777127|P1|Dose Titration Period|Other|5
4867950|NCT00842829|16777125|P3|Dose Titration Period|Withdrawal by Subject|0
4867951|NCT00842829|16777126|P2|Dose Titration Period|Withdrawal by Subject|6
4867952|NCT00842829|16777127|P1|Dose Titration Period|Withdrawal by Subject|2
4867953|NCT00842829|16777125|P3|Dose Titration Period|Unstable persistent cancer pain|0
4867954|NCT00842829|16777126|P2|Dose Titration Period|Unstable persistent cancer pain|0
4867955|NCT00842829|16777127|P1|Dose Titration Period|Unstable persistent cancer pain|1
4867956|NCT00842829|16777125|P3|Dose Titration Period|Lack of Efficacy|0
4867957|NCT00842829|16777126|P2|Dose Titration Period|Lack of Efficacy|1
4867958|NCT00842829|16777127|P1|Dose Titration Period|Lack of Efficacy|4
4867959|NCT00842829|16777125|P3|Dose Titration Period|Adverse Event|0
4867960|NCT00842829|16777126|P2|Dose Titration Period|Adverse Event|10
4867961|NCT00842829|16777127|P1|Dose Titration Period|Adverse Event|11
4867962|NCT00842712|16777186|P7|Randomized Part|Ongoing at cut-off date|2
4867963|NCT00842712|16777187|P6|Randomized Part|Ongoing at cut-off date|0
4867964|NCT00842712|16777188|P5|Randomized Part|Ongoing at cut-off date|0
4867965|NCT00842712|16777189|P4|Randomized Part|Ongoing at cut-off date|0
4867966|NCT00842712|16777190|P3|Randomized Part|Ongoing at cut-off date|0
4867967|NCT00842712|16777191|P2|Randomized Part|Ongoing at cut-off date|0
4867968|NCT00842712|16777192|P1|Randomized Part|Ongoing at cut-off date|0
4867969|NCT00842712|16777186|P7|Randomized Part|Randomized but not treated|4
4867970|NCT00842712|16777187|P6|Randomized Part|Randomized but not treated|1
4867971|NCT00842712|16777188|P5|Randomized Part|Randomized but not treated|0
4867972|NCT00842712|16777189|P4|Randomized Part|Randomized but not treated|0
4867973|NCT00842712|16777190|P3|Randomized Part|Randomized but not treated|0
4867974|NCT00842712|16777191|P2|Randomized Part|Randomized but not treated|0
4867975|NCT00842712|16777192|P1|Randomized Part|Randomized but not treated|0
4867976|NCT00842712|16777186|P7|Safety Run-in Part|Progressive disease|0
4867977|NCT00842712|16777187|P6|Safety Run-in Part|Progressive disease|0
4867978|NCT00842712|16777188|P5|Safety Run-in Part|Progressive disease|0
4867980|NCT00842712|16777190|P3|Safety Run-in Part|Progressive disease|0
4867981|NCT00842712|16777191|P2|Safety Run-in Part|Progressive disease|1
4867982|NCT00842712|16777192|P1|Safety Run-in Part|Progressive disease|3
4867983|NCT00842712|16777186|P7|Safety Run-in Part|Adverse Event|0
4867984|NCT00842712|16777187|P6|Safety Run-in Part|Adverse Event|0
4867985|NCT00842712|16777188|P5|Safety Run-in Part|Adverse Event|0
4867986|NCT00842712|16777189|P4|Safety Run-in Part|Adverse Event|0
4867987|NCT00842712|16777190|P3|Safety Run-in Part|Adverse Event|0
4867988|NCT00842712|16777191|P2|Safety Run-in Part|Adverse Event|1
4867989|NCT00842712|16777192|P1|Safety Run-in Part|Adverse Event|0
4867990|NCT00842543|16777249|P4|Overall Study|Withdrawal by Subject|4
4867991|NCT00842543|16777250|P3|Overall Study|Withdrawal by Subject|3
4867992|NCT00842543|16777251|P2|Overall Study|Withdrawal by Subject|0
4867993|NCT00842543|16777252|P1|Overall Study|Withdrawal by Subject|2
4867994|NCT00842530|16777266|P2|Overall Study|Withdrawal by Subject|28
4867995|NCT00842530|16777267|P1|Overall Study|Withdrawal by Subject|73
4867996|NCT00842530|16777266|P2|Overall Study|Lost to Follow-up|8
4867997|NCT00842530|16777267|P1|Overall Study|Lost to Follow-up|6
4867998|NCT00842530|16777266|P2|Overall Study|Protocol Violation|14
4867999|NCT00842530|16777267|P1|Overall Study|Protocol Violation|32
4868000|NCT00842530|16777266|P2|Overall Study|Other adverse event|1
4868001|NCT00842530|16777267|P1|Overall Study|Other adverse event|6
4868002|NCT00842530|16777266|P2|Overall Study|Serious adverse event|6
4868003|NCT00842530|16777267|P1|Overall Study|Serious adverse event|0
4868004|NCT00842361|16777297|P2|Overall Study|Unclassified|2
4868005|NCT00842361|16777298|P1|Overall Study|Unclassified|0
4868006|NCT00842361|16777297|P2|Overall Study|Protocol Violation|0
4868007|NCT00842361|16777298|P1|Overall Study|Protocol Violation|1
4868008|NCT00842348|16777318|P2|Study 729|Surgical resection|0
4868009|NCT00842348|16777319|P1|Study 729|Surgical resection|1
4868010|NCT00842348|16777318|P2|Study 729|Sponsor's decision|0
4868011|NCT00842348|16777319|P1|Study 729|Sponsor's decision|1
4868012|NCT00842348|16777318|P2|Study 729|Due to non-availability of IP|1
4868013|NCT00842348|16777319|P1|Study 729|Due to non-availability of IP|0
4868014|NCT00842348|16777318|P2|Study 729|Due to Sponsor stopping the study|1
4868015|NCT00842348|16777319|P1|Study 729|Due to Sponsor stopping the study|1
4868016|NCT00842348|16777318|P2|Study 729|Withdrawal by Subject|4
4868017|NCT00842348|16777319|P1|Study 729|Withdrawal by Subject|2
4868018|NCT00842348|16777318|P2|Study 729|Protocol Violation|1
4868019|NCT00842348|16777319|P1|Study 729|Protocol Violation|1
4868020|NCT00842348|16777318|P2|Study 729|Adverse Event|1
4868021|NCT00842348|16777319|P1|Study 729|Adverse Event|1
4868022|NCT00842348|16777318|P2|Study 729|Disease progression/death|30
4868023|NCT00842348|16777319|P1|Study 729|Disease progression/death|19
4868024|NCT00842348|16777318|P2|Patients Randomised in Study 726|Did not enter Study 729|56
4868025|NCT00842348|16777319|P1|Patients Randomised in Study 726|Did not enter Study 729|59
4868026|NCT00842309|16777338|P2|Overall Study|Withdrawal by Subject|1
4868027|NCT00842309|16777339|P1|Overall Study|Withdrawal by Subject|3
4868028|NCT00842257|16777373|P1|Overall Study|Adverse Event|1
4868029|NCT00842244|16777380|P1|Overall Study|Other|17
4868030|NCT00842244|16777380|P1|Overall Study|Withdrawal by Subject|1
4868031|NCT00842244|16777380|P1|Overall Study|Death|3
4868032|NCT00842153|16777407|P2|Overall Study|Lost to Follow-up|2
4868033|NCT00842153|16777408|P1|Overall Study|Lost to Follow-up|1
4868034|NCT00842153|16777407|P2|Overall Study|Adverse Event|1
4868035|NCT00842153|16777408|P1|Overall Study|Adverse Event|0
4868036|NCT00841906|16777483|P2|Overall Study|Withdrawal by Subject|0
4868037|NCT00841906|16777484|P1|Overall Study|Withdrawal by Subject|2
4868038|NCT00841815|16777509|P2|Washout|Withdrawal by Subject|1
4868039|NCT00841815|16777510|P1|Washout|Withdrawal by Subject|0
4868040|NCT00841776|16777520|P2|Overall Study|Withdrawal by Subject|1
4868041|NCT00841776|16777521|P1|Overall Study|Withdrawal by Subject|0
4868042|NCT00841776|16777520|P2|Overall Study|Lost to Follow-up|1
4868043|NCT00841776|16777521|P1|Overall Study|Lost to Follow-up|2
4868044|NCT00841776|16777520|P2|Overall Study|Lack of Efficacy|1
4868045|NCT00841776|16777521|P1|Overall Study|Lack of Efficacy|0
4868046|NCT00841763|16777539|P4|Overall Study|Unable to Classify|0
4868047|NCT00841763|16777540|P3|Overall Study|Unable to Classify|0
4868048|NCT00841763|16777541|P2|Overall Study|Unable to Classify|1
4868049|NCT00841763|16777542|P1|Overall Study|Unable to Classify|7
4868050|NCT00841763|16777539|P4|Overall Study|Administrative Reasons|0
4868051|NCT00841763|16777540|P3|Overall Study|Administrative Reasons|0
4868052|NCT00841763|16777541|P2|Overall Study|Administrative Reasons|1
4868053|NCT00841763|16777542|P1|Overall Study|Administrative Reasons|3
4868054|NCT00841763|16777539|P4|Overall Study|Protocol Violation|0
4868055|NCT00841763|16777540|P3|Overall Study|Protocol Violation|1
4868056|NCT00841763|16777541|P2|Overall Study|Protocol Violation|3
4868057|NCT00841763|16777542|P1|Overall Study|Protocol Violation|20
4868058|NCT00841763|16777539|P4|Overall Study|Lost to Follow-up|0
4868059|NCT00841763|16777540|P3|Overall Study|Lost to Follow-up|0
4868060|NCT00841763|16777541|P2|Overall Study|Lost to Follow-up|25
4868061|NCT00841763|16777542|P1|Overall Study|Lost to Follow-up|63
4868062|NCT00841763|16777539|P4|Overall Study|Adverse Event|2
4868063|NCT00841763|16777540|P3|Overall Study|Adverse Event|3
4868064|NCT00841763|16777541|P2|Overall Study|Adverse Event|10
4868065|NCT00841763|16777542|P1|Overall Study|Adverse Event|9
4868066|NCT00841763|16777539|P4|Overall Study|Withdrawal by Subject|1
4868067|NCT00841763|16777540|P3|Overall Study|Withdrawal by Subject|4
4868068|NCT00841763|16777541|P2|Overall Study|Withdrawal by Subject|17
4868069|NCT00841763|16777542|P1|Overall Study|Withdrawal by Subject|60
4868070|NCT00841698|16777604|P2|First Intervention|Withdrawal by Subject|0
4868071|NCT00841698|16777605|P1|First Intervention|Withdrawal by Subject|1
4868072|NCT00841672|16777615|P2|Overall Study|Protocol Deviation|1
4868073|NCT00841672|16777616|P1|Overall Study|Protocol Deviation|0
4868074|NCT00841672|16777615|P2|Overall Study|Misrandomized|0
4868075|NCT00841672|16777616|P1|Overall Study|Misrandomized|1
4868076|NCT00841672|16777615|P2|Overall Study|Administrative problems|9
4868077|NCT00841672|16777616|P1|Overall Study|Administrative problems|9
4868078|NCT00841672|16777615|P2|Overall Study|Lost to Follow-up|1
4868079|NCT00841672|16777616|P1|Overall Study|Lost to Follow-up|1
4868080|NCT00841672|16777615|P2|Overall Study|Subject withdrew consent|4
4868081|NCT00841672|16777616|P1|Overall Study|Subject withdrew consent|2
4868082|NCT00841672|16777615|P2|Overall Study|Abnormal test procedure result(s)|1
4868083|NCT00841672|16777616|P1|Overall Study|Abnormal test procedure result(s)|0
4868084|NCT00841672|16777615|P2|Overall Study|Adverse Event|16
4868085|NCT00841672|16777616|P1|Overall Study|Adverse Event|7
4868086|NCT00841659|16777632|P2|Washout: 2 Weeks|Protocol Violation|0
4868087|NCT00841659|16777633|P1|Washout: 2 Weeks|Protocol Violation|1
4868088|NCT00841568|16777641|P1|Overall Study|Creatinine over the withdrawal criteria|1
4868089|NCT00841568|16777641|P1|Overall Study|Withdrawal by Subject|2
4868090|NCT00841568|16777641|P1|Overall Study|Death|1
4868091|NCT00841568|16777641|P1|Overall Study|Adverse Event|1
4868092|NCT00841542|16777669|P2|Period 1|Adverse Event|0
4868093|NCT00841542|16777670|P1|Period 1|Adverse Event|1
4868094|NCT00841321|16777685|P2|Overall Study|Adverse Event|2
4868095|NCT00841321|16777686|P1|Overall Study|Adverse Event|0
4868096|NCT00841321|16777685|P2|Overall Study|Lost to Follow-up|1
4868097|NCT00841321|16777686|P1|Overall Study|Lost to Follow-up|1
4868098|NCT00841100|16777733|P1|Phase 1 (28 Days)|Participant non-compliance|2
4868099|NCT00841100|16777733|P1|Phase 1 (28 Days)|Adverse Event|1
4868100|NCT00841035|16777758|P1|Phase 1 Overall Study|Physician Decision|13
4868101|NCT00840996|16777765|P2|Overall Study|Withdrawal by Subject|0
4868102|NCT00840996|16777766|P1|Overall Study|Withdrawal by Subject|1
4868103|NCT00840970|16777784|P3|Overall Study|Adverse Event|1
4868104|NCT00840970|16777785|P2|Overall Study|Adverse Event|0
4868105|NCT00840970|16777786|P1|Overall Study|Adverse Event|0
4868106|NCT00840879|16777806|P2|Second Intervention|Withdrawal by Subject|0
4868107|NCT00840879|16777807|P1|Second Intervention|Withdrawal by Subject|1
4868108|NCT00840827|16777843|P1|Overall Study|Physician Decision|1
4868109|NCT00840827|16777843|P1|Overall Study|Lack of Efficacy|4
4868110|NCT00840827|16777843|P1|Overall Study|Adverse Event|1
4868111|NCT00840749|16777858|P2|Overall Study|study closed|14
4868112|NCT00840749|16777859|P1|Overall Study|study closed|19
4868113|NCT00840749|16777858|P2|Overall Study|not treated on study arm|11
4868114|NCT00840749|16777859|P1|Overall Study|not treated on study arm|11
4868115|NCT00840749|16777858|P2|Overall Study|Death|2
4868116|NCT00840749|16777859|P1|Overall Study|Death|1
4868117|NCT00840658|16777871|P4|Overall Study|Lost to Follow-up|1
4868118|NCT00840658|16777872|P3|Overall Study|Lost to Follow-up|2
4868119|NCT00840658|16777873|P2|Overall Study|Lost to Follow-up|1
4868120|NCT00840658|16777874|P1|Overall Study|Lost to Follow-up|3
4868121|NCT00840658|16777871|P4|Overall Study|Death|3
4868122|NCT00840658|16777872|P3|Overall Study|Death|3
4868123|NCT00840658|16777873|P2|Overall Study|Death|2
4868124|NCT00840658|16777874|P1|Overall Study|Death|2
4868125|NCT00840632|16777892|P2|Washout|Withdrawal by Subject|1
4868126|NCT00840632|16777893|P1|Washout|Withdrawal by Subject|1
4868127|NCT00840632|16777892|P2|First Intervention|Withdrawal by Subject|1
4868128|NCT00840632|16777893|P1|First Intervention|Withdrawal by Subject|0
4868129|NCT00840463|16777920|P2|Overall Study|Adverse Event|0
4868130|NCT00840463|16777921|P1|Overall Study|Adverse Event|1
4868131|NCT00840450|16777935|P1|Overall Study|Lack of Efficacy|2
4868132|NCT00840450|16777935|P1|Overall Study|Adverse Event|1
4868133|NCT00840411|16777943|P2|Washout|Withdrawal by Subject|0
4868134|NCT00840411|16777944|P1|Washout|Withdrawal by Subject|1
4868135|NCT00840411|16777943|P2|First Intervention|Adverse Event|0
4868136|NCT00840411|16777944|P1|First Intervention|Adverse Event|1
4868137|NCT00840294|16777958|P2|Overall Study|Illness|1
4868138|NCT00840294|16777959|P1|Overall Study|Illness|0
4868139|NCT00840294|16777958|P2|Overall Study|Protocol Violation|3
4868140|NCT00840294|16777959|P1|Overall Study|Protocol Violation|1
4868141|NCT00840294|16777958|P2|Overall Study|Withdrawal by Subject|1
4868142|NCT00840294|16777959|P1|Overall Study|Withdrawal by Subject|2
4868143|NCT00840216|16777980|P2|Washout: 7 Days|Withdrawal by Subject|0
4868144|NCT00840216|16777981|P1|Washout: 7 Days|Withdrawal by Subject|1
4868145|NCT00840203|16777991|P2|Washout|Protocol Violation|0
4868146|NCT00840203|16777992|P1|Washout|Protocol Violation|1
4868147|NCT00840203|16777991|P2|First Intervention|Protocol Violation|1
4868148|NCT00840203|16777992|P1|First Intervention|Protocol Violation|1
4868149|NCT00840177|16778009|P3|Overall Study|Did not start treatment|1
4868150|NCT00840177|16778010|P2|Overall Study|Did not start treatment|0
4868151|NCT00840177|16778011|P1|Overall Study|Did not start treatment|0
4868152|NCT00840177|16778009|P3|Overall Study|Ineligible|3
4868153|NCT00840177|16778010|P2|Overall Study|Ineligible|0
4868154|NCT00840177|16778011|P1|Overall Study|Ineligible|0
4868155|NCT00840177|16778009|P3|Overall Study|not protocol specified|0
4868156|NCT00840177|16778010|P2|Overall Study|not protocol specified|3
4868157|NCT00840177|16778011|P1|Overall Study|not protocol specified|6
4868158|NCT00840177|16778009|P3|Overall Study|Death|5
4868159|NCT00840177|16778010|P2|Overall Study|Death|5
4868160|NCT00840177|16778011|P1|Overall Study|Death|4
4868161|NCT00840177|16778009|P3|Overall Study|Progression/relapse|0
4868162|NCT00840177|16778010|P2|Overall Study|Progression/relapse|0
4868163|NCT00840177|16778011|P1|Overall Study|Progression/relapse|2
4868164|NCT00840177|16778009|P3|Overall Study|Refusal unrelated to adverse events|1
4868165|NCT00840177|16778010|P2|Overall Study|Refusal unrelated to adverse events|0
4868166|NCT00840177|16778011|P1|Overall Study|Refusal unrelated to adverse events|1
4868167|NCT00840177|16778009|P3|Overall Study|Adverse Event|1
4868168|NCT00840177|16778010|P2|Overall Study|Adverse Event|1
4868169|NCT00840177|16778011|P1|Overall Study|Adverse Event|5
4868170|NCT00840086|16778045|P1|Overall Study|Lost to Follow-up|1
4868171|NCT00840086|16778045|P1|Overall Study|Protocol Violation|2
4868172|NCT00840086|16778045|P1|Overall Study|Adverse Event|1
4868173|NCT00840073|16778054|P2|Second Intervention|Missed 72 hour blood draw|1
4868174|NCT00840073|16778055|P1|Second Intervention|Missed 72 hour blood draw|1
4868175|NCT00840060|16778069|P2|Overall Study|Change in emotional/behavioral status|1
4868176|NCT00840060|16778070|P1|Overall Study|Change in emotional/behavioral status|0
4868177|NCT00840060|16778069|P2|Overall Study|Withdrawal by Subject|0
4868178|NCT00840060|16778070|P1|Overall Study|Withdrawal by Subject|1
4868179|NCT00840034|16778080|P2|Taper Phase|Withdrawal by Subject|1
4868180|NCT00840034|16778081|P1|Taper Phase|Withdrawal by Subject|1
4868181|NCT00840034|16778080|P2|Taper Phase|Lost to Follow-up|1
4868182|NCT00840034|16778081|P1|Taper Phase|Lost to Follow-up|1
4868183|NCT00840034|16778080|P2|Taper Phase|Adverse Event|0
4868184|NCT00840034|16778081|P1|Taper Phase|Adverse Event|1
4868185|NCT00840034|16778080|P2|Acute Treatment Phase|Withdrawal by Subject|11
4868186|NCT00840034|16778081|P1|Acute Treatment Phase|Withdrawal by Subject|6
4868187|NCT00840034|16778080|P2|Acute Treatment Phase|Protocol Violation|4
4868188|NCT00840034|16778081|P1|Acute Treatment Phase|Protocol Violation|2
4868189|NCT00840034|16778080|P2|Acute Treatment Phase|Physician Decision|1
4868190|NCT00840034|16778081|P1|Acute Treatment Phase|Physician Decision|0
4868191|NCT00840034|16778080|P2|Acute Treatment Phase|Lost to Follow-up|12
4868192|NCT00840034|16778081|P1|Acute Treatment Phase|Lost to Follow-up|5
4868193|NCT00840034|16778080|P2|Acute Treatment Phase|Lack of Efficacy|0
4868194|NCT00840034|16778081|P1|Acute Treatment Phase|Lack of Efficacy|2
4868195|NCT00840034|16778080|P2|Acute Treatment Phase|Adverse Event|8
4868196|NCT00840034|16778081|P1|Acute Treatment Phase|Adverse Event|6
4868197|NCT00839956|16778134|P1|Overall Study|Withdrawal by Subject|3
4868198|NCT00839956|16778134|P1|Overall Study|Physician Decision|1
4868199|NCT00839956|16778134|P1|Overall Study|Lack of Efficacy|6
4868200|NCT00839956|16778134|P1|Overall Study|Adverse Event|2
4868201|NCT00839917|16778154|P2|Overall Study|Did not receive vaccine|1
4868202|NCT00839917|16778155|P1|Overall Study|Did not receive vaccine|0
4868203|NCT00839917|16778154|P2|Overall Study|Lost to Follow-up|0
4868204|NCT00839917|16778155|P1|Overall Study|Lost to Follow-up|1
4868205|NCT00839852|16778191|P1|Overall Study|Pregnancy|1
4868206|NCT00839852|16778191|P1|Overall Study|Lack of Compliance While in Jail|1
4868207|NCT00839852|16778191|P1|Overall Study|Lost to Follow-up|7
4868208|NCT00839852|16778191|P1|Overall Study|Withdrawal of Consent|16
4868209|NCT00839852|16778191|P1|Overall Study|Protocol Violation|9
4868210|NCT00839852|16778191|P1|Overall Study|Insufficient Therapeutic Response|3
4868211|NCT00839852|16778191|P1|Overall Study|Adverse Event|10
4868212|NCT00839800|16778198|P2|Overall Study|Severe Non-Compliance to Protocol|7
4868213|NCT00839800|16778199|P1|Overall Study|Severe Non-Compliance to Protocol|7
4868214|NCT00839800|16778198|P2|Overall Study|Other|14
4868215|NCT00839800|16778199|P1|Overall Study|Other|8
4868216|NCT00839800|16778198|P2|Overall Study|Safety Reasons|1
4868217|NCT00839800|16778199|P1|Overall Study|Safety Reasons|2
4868218|NCT00839800|16778198|P2|Overall Study|Study-Specific Discontinuation Criteria|13
4868219|NCT00839800|16778199|P1|Overall Study|Study-Specific Discontinuation Criteria|6
4868220|NCT00839800|16778198|P2|Overall Study|Incorrect Enrolment|3
4868221|NCT00839800|16778199|P1|Overall Study|Incorrect Enrolment|3
4868222|NCT00839800|16778198|P2|Overall Study|Withdrawal by Subject|34
4868223|NCT00839800|16778199|P1|Overall Study|Withdrawal by Subject|28
4868224|NCT00839800|16778198|P2|Overall Study|Lost to Follow-up|26
4868225|NCT00839800|16778199|P1|Overall Study|Lost to Follow-up|31
4868226|NCT00839800|16778198|P2|Overall Study|Adverse Event|12
4868227|NCT00839800|16778199|P1|Overall Study|Adverse Event|8
4868228|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
4868229|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1
4868230|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0
4868231|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
4868232|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1
4868233|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0
4868234|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
4868235|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0
4868236|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1
4868237|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
4868238|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Site Closed|1
4868239|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Site Closed|0
4868240|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
4868241|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0
4868242|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1
4868243|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
4868244|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0
4868245|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1
4868246|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5
4868247|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10
4868248|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3
4868249|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1
4868250|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
4868251|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0
4868252|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19
4868253|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21
4868254|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12
4868255|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29
4868256|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20
4868257|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8
4868258|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5
4868259|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0
4868260|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1
4868261|NCT00839527|16778245|P3|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
4868262|NCT00839527|16778246|P2|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2
4868263|NCT00839527|16778247|P1|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1
4868264|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1
4868265|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
4868266|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0
4868267|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Site Closed|0
4868268|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Site Closed|2
4868269|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Site Closed|1
4868270|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Pregnancy|1
4868271|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Pregnancy|1
4868272|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Pregnancy|0
4868273|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1
4868274|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
4868275|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0
4868276|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Missing|0
4868277|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Missing|1
4868278|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Missing|0
4868279|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5
4868280|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8
4868281|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3
4868282|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Physician Decision|1
4868283|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Physician Decision|6
4868284|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Physician Decision|1
4868285|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64
4868286|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46
4868287|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32
4868288|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7
4868289|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12
4868290|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3
4868291|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Noncompliance|16
4868292|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Noncompliance|6
4868293|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Noncompliance|5
4868294|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Protocol Violation|1
4868295|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Protocol Violation|7
4868296|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Protocol Violation|4
4868297|NCT00839527|16778245|P3|Treatment Period (TP) (156 Weeks)|Adverse Event|22
4868298|NCT00839527|16778246|P2|Treatment Period (TP) (156 Weeks)|Adverse Event|29
4868299|NCT00839527|16778247|P1|Treatment Period (TP) (156 Weeks)|Adverse Event|11
4868300|NCT00839436|16778282|P3|Overall Study|Study drug no longer available|1
4868301|NCT00839436|16778283|P2|Overall Study|Study drug no longer available|0
4868302|NCT00839436|16778284|P1|Overall Study|Study drug no longer available|0
4868303|NCT00839436|16778282|P3|Overall Study|Withdrawal by Subject|0
4868304|NCT00839436|16778283|P2|Overall Study|Withdrawal by Subject|1
4868305|NCT00839436|16778284|P1|Overall Study|Withdrawal by Subject|0
4868306|NCT00839436|16778282|P3|Overall Study|Developed exclusionary condition|0
4868307|NCT00839436|16778283|P2|Overall Study|Developed exclusionary condition|0
4868308|NCT00839436|16778284|P1|Overall Study|Developed exclusionary condition|1
4868309|NCT00839423|16778296|P4|Overall Study|Administrative or other reasons|0
4868310|NCT00839423|16778297|P3|Overall Study|Administrative or other reasons|1
4868311|NCT00839423|16778298|P2|Overall Study|Administrative or other reasons|0
4868312|NCT00839423|16778299|P1|Overall Study|Administrative or other reasons|3
4868313|NCT00839423|16778296|P4|Overall Study|Lost to Follow-up|0
4868314|NCT00839423|16778297|P3|Overall Study|Lost to Follow-up|1
4868315|NCT00839423|16778298|P2|Overall Study|Lost to Follow-up|0
4868316|NCT00839423|16778299|P1|Overall Study|Lost to Follow-up|1
4868317|NCT00839423|16778296|P4|Overall Study|Withdrawal of consent|1
4868318|NCT00839423|16778297|P3|Overall Study|Withdrawal of consent|4
4868319|NCT00839423|16778298|P2|Overall Study|Withdrawal of consent|0
4868320|NCT00839423|16778299|P1|Overall Study|Withdrawal of consent|4
4868321|NCT00839423|16778296|P4|Overall Study|Protocol Violation|0
4868322|NCT00839423|16778297|P3|Overall Study|Protocol Violation|2
4868323|NCT00839423|16778298|P2|Overall Study|Protocol Violation|1
4868324|NCT00839423|16778299|P1|Overall Study|Protocol Violation|0
4868325|NCT00839423|16778296|P4|Overall Study|Non-compliance|1
4868326|NCT00839423|16778297|P3|Overall Study|Non-compliance|0
4868327|NCT00839423|16778298|P2|Overall Study|Non-compliance|0
4868328|NCT00839423|16778299|P1|Overall Study|Non-compliance|0
4868329|NCT00839423|16778296|P4|Overall Study|Lack of Efficacy|2
4868330|NCT00839423|16778297|P3|Overall Study|Lack of Efficacy|3
4868331|NCT00839423|16778298|P2|Overall Study|Lack of Efficacy|6
4868332|NCT00839423|16778299|P1|Overall Study|Lack of Efficacy|6
4868333|NCT00839423|16778296|P4|Overall Study|Adverse Event|16
4868334|NCT00839423|16778297|P3|Overall Study|Adverse Event|7
4868335|NCT00839423|16778298|P2|Overall Study|Adverse Event|3
4868336|NCT00839423|16778299|P1|Overall Study|Adverse Event|4
4868337|NCT00839332|16778340|P3|Phase 2|Lost to Follow-up|1
4868338|NCT00839332|16778341|P2|Phase 2|Lost to Follow-up|0
4868339|NCT00839332|16778342|P1|Phase 2|Lost to Follow-up|0
4868340|NCT00839332|16778340|P3|Phase 2|Physician Decision|1
4868341|NCT00839332|16778341|P2|Phase 2|Physician Decision|4
4868342|NCT00839332|16778342|P1|Phase 2|Physician Decision|0
4868343|NCT00839332|16778340|P3|Phase 2|Withdrawal by Subject|8
4868344|NCT00839332|16778341|P2|Phase 2|Withdrawal by Subject|5
4868345|NCT00839332|16778342|P1|Phase 2|Withdrawal by Subject|0
4868346|NCT00839332|16778340|P3|Phase 2|Death|2
4868347|NCT00839332|16778341|P2|Phase 2|Death|4
4868348|NCT00839332|16778342|P1|Phase 2|Death|0
4868349|NCT00839332|16778340|P3|Phase 2|Adverse Event|6
4868350|NCT00839332|16778341|P2|Phase 2|Adverse Event|8
4868351|NCT00839332|16778342|P1|Phase 2|Adverse Event|0
4868352|NCT00839332|16778340|P3|Phase 2|Disease Progression|21
4868353|NCT00839332|16778341|P2|Phase 2|Disease Progression|46
4868354|NCT00839332|16778342|P1|Phase 2|Disease Progression|0
4868355|NCT00839332|16778340|P3|Phase 2|Protocol Violation|0
4868356|NCT00839332|16778341|P2|Phase 2|Protocol Violation|1
4868357|NCT00839332|16778342|P1|Phase 2|Protocol Violation|0
4868358|NCT00839332|16778340|P3|Phase 1|Physician Decision|0
4868359|NCT00839332|16778341|P2|Phase 1|Physician Decision|0
4868360|NCT00839332|16778342|P1|Phase 1|Physician Decision|2
4868361|NCT00839332|16778340|P3|Phase 1|Withdrawal by Subject|0
4868362|NCT00839332|16778341|P2|Phase 1|Withdrawal by Subject|0
4868363|NCT00839332|16778342|P1|Phase 1|Withdrawal by Subject|4
4868364|NCT00839332|16778340|P3|Phase 1|Adverse Event|0
4868365|NCT00839332|16778341|P2|Phase 1|Adverse Event|0
4868366|NCT00839332|16778342|P1|Phase 1|Adverse Event|6
4868367|NCT00839332|16778340|P3|Phase 1|Disease Progression|0
4868368|NCT00839332|16778341|P2|Phase 1|Disease Progression|0
4868369|NCT00839332|16778342|P1|Phase 1|Disease Progression|38
4868370|NCT00839306|16778403|P2|Overall Study|Other|18
4868371|NCT00839306|16778404|P1|Overall Study|Other|6
4868372|NCT00839306|16778403|P2|Overall Study|Lack of Efficacy|4
4868373|NCT00839306|16778404|P1|Overall Study|Lack of Efficacy|5
4868374|NCT00839306|16778403|P2|Overall Study|Withdrawal by Subject|7
4868375|NCT00839306|16778404|P1|Overall Study|Withdrawal by Subject|5
4868376|NCT00839306|16778403|P2|Overall Study|Lost to Follow-up|9
4868377|NCT00839306|16778404|P1|Overall Study|Lost to Follow-up|6
4868378|NCT00839306|16778403|P2|Overall Study|Adverse Event|5
4868379|NCT00839306|16778404|P1|Overall Study|Adverse Event|3
4868380|NCT00839254|16778420|P8|Overall Study|Lost to Follow-up|2
4868381|NCT00839254|16778421|P7|Overall Study|Lost to Follow-up|4
4868382|NCT00839254|16778422|P6|Overall Study|Lost to Follow-up|8
4868383|NCT00839254|16778423|P5|Overall Study|Lost to Follow-up|8
4868384|NCT00839254|16778424|P4|Overall Study|Lost to Follow-up|24
4868385|NCT00839254|16778425|P3|Overall Study|Lost to Follow-up|32
4868386|NCT00839254|16778426|P2|Overall Study|Lost to Follow-up|30
4868387|NCT00839254|16778427|P1|Overall Study|Lost to Follow-up|51
4868388|NCT00839254|16778420|P8|Overall Study|Withdrawn due to non-compliance|0
4868389|NCT00839254|16778421|P7|Overall Study|Withdrawn due to non-compliance|0
4868390|NCT00839254|16778422|P6|Overall Study|Withdrawn due to non-compliance|0
4868391|NCT00839254|16778423|P5|Overall Study|Withdrawn due to non-compliance|0
4868392|NCT00839254|16778424|P4|Overall Study|Withdrawn due to non-compliance|0
4868393|NCT00839254|16778425|P3|Overall Study|Withdrawn due to non-compliance|0
4868394|NCT00839254|16778426|P2|Overall Study|Withdrawn due to non-compliance|0
4868395|NCT00839254|16778427|P1|Overall Study|Withdrawn due to non-compliance|2
4868396|NCT00839254|16778420|P8|Overall Study|Parents wanted pneumococcal vaccine|0
4868397|NCT00839254|16778421|P7|Overall Study|Parents wanted pneumococcal vaccine|0
4868398|NCT00839254|16778422|P6|Overall Study|Parents wanted pneumococcal vaccine|1
4868399|NCT00839254|16778423|P5|Overall Study|Parents wanted pneumococcal vaccine|0
4868400|NCT00839254|16778424|P4|Overall Study|Parents wanted pneumococcal vaccine|0
4868401|NCT00839254|16778425|P3|Overall Study|Parents wanted pneumococcal vaccine|0
4868402|NCT00839254|16778426|P2|Overall Study|Parents wanted pneumococcal vaccine|0
4868403|NCT00839254|16778427|P1|Overall Study|Parents wanted pneumococcal vaccine|1
4868404|NCT00839254|16778420|P8|Overall Study|Wrong group allocation|0
4868405|NCT00839254|16778421|P7|Overall Study|Wrong group allocation|1
4868406|NCT00839254|16778422|P6|Overall Study|Wrong group allocation|0
4868407|NCT00839254|16778423|P5|Overall Study|Wrong group allocation|0
4868408|NCT00839254|16778424|P4|Overall Study|Wrong group allocation|0
4868409|NCT00839254|16778425|P3|Overall Study|Wrong group allocation|0
4868410|NCT00839254|16778426|P2|Overall Study|Wrong group allocation|0
4868411|NCT00839254|16778427|P1|Overall Study|Wrong group allocation|0
4868412|NCT00839254|16778420|P8|Overall Study|Withdrawal by Subject|9
4868413|NCT00839254|16778421|P7|Overall Study|Withdrawal by Subject|22
4868414|NCT00839254|16778422|P6|Overall Study|Withdrawal by Subject|15
4868415|NCT00839254|16778423|P5|Overall Study|Withdrawal by Subject|27
4868416|NCT00839254|16778424|P4|Overall Study|Withdrawal by Subject|32
4868417|NCT00839254|16778425|P3|Overall Study|Withdrawal by Subject|54
4868418|NCT00839254|16778426|P2|Overall Study|Withdrawal by Subject|53
4868419|NCT00839254|16778427|P1|Overall Study|Withdrawal by Subject|87
4868420|NCT00839254|16778420|P8|Overall Study|Adverse Event|1
4868421|NCT00839254|16778421|P7|Overall Study|Adverse Event|0
4868422|NCT00839254|16778422|P6|Overall Study|Adverse Event|1
4868423|NCT00839254|16778423|P5|Overall Study|Adverse Event|2
4868424|NCT00839254|16778424|P4|Overall Study|Adverse Event|5
4868425|NCT00839254|16778425|P3|Overall Study|Adverse Event|3
4868426|NCT00839254|16778426|P2|Overall Study|Adverse Event|6
4868427|NCT00839254|16778427|P1|Overall Study|Adverse Event|12
4868428|NCT00839254|16778420|P8|Overall Study|Wrong treatment number allocation|0
4868429|NCT00839254|16778421|P7|Overall Study|Wrong treatment number allocation|0
4868430|NCT00839254|16778422|P6|Overall Study|Wrong treatment number allocation|1
4868431|NCT00839254|16778423|P5|Overall Study|Wrong treatment number allocation|0
4868432|NCT00839254|16778424|P4|Overall Study|Wrong treatment number allocation|0
4868433|NCT00839254|16778425|P3|Overall Study|Wrong treatment number allocation|0
4868434|NCT00839254|16778426|P2|Overall Study|Wrong treatment number allocation|1
4868435|NCT00839254|16778427|P1|Overall Study|Wrong treatment number allocation|0
4868436|NCT00839254|16778420|P8|Overall Study|Physician Decision|1
4868437|NCT00839254|16778421|P7|Overall Study|Physician Decision|0
4868438|NCT00839254|16778422|P6|Overall Study|Physician Decision|0
4868439|NCT00839254|16778423|P5|Overall Study|Physician Decision|0
4868440|NCT00839254|16778424|P4|Overall Study|Physician Decision|0
4868441|NCT00839254|16778425|P3|Overall Study|Physician Decision|0
4868442|NCT00839254|16778426|P2|Overall Study|Physician Decision|1
4868443|NCT00839254|16778427|P1|Overall Study|Physician Decision|0
4868444|NCT00839254|16778420|P8|Overall Study|Protocol Violation|2
4868445|NCT00839254|16778421|P7|Overall Study|Protocol Violation|1
4868446|NCT00839254|16778422|P6|Overall Study|Protocol Violation|0
4868447|NCT00839254|16778423|P5|Overall Study|Protocol Violation|0
4868448|NCT00839254|16778424|P4|Overall Study|Protocol Violation|1
4868449|NCT00839254|16778425|P3|Overall Study|Protocol Violation|1
4868450|NCT00839254|16778426|P2|Overall Study|Protocol Violation|1
4868451|NCT00839254|16778427|P1|Overall Study|Protocol Violation|0
4868452|NCT00839098|16778739|P3|Overall Study|Withdrawal by Subject|7
4868453|NCT00839098|16778740|P2|Overall Study|Withdrawal by Subject|1
4868454|NCT00839098|16778741|P1|Overall Study|Withdrawal by Subject|2
4868455|NCT00839072|16778767|P2|Second Intervention Period|Withdrawal by Subject|0
4868456|NCT00839072|16778768|P1|Second Intervention Period|Withdrawal by Subject|1
4868457|NCT00839072|16778767|P2|First Intervention Period|Adverse Event|1
4868458|NCT00839072|16778768|P1|First Intervention Period|Adverse Event|1
4868459|NCT00839072|16778767|P2|First Intervention Period|Withdrawal by Subject|0
4868460|NCT00839072|16778768|P1|First Intervention Period|Withdrawal by Subject|1
4868461|NCT00838929|16778812|P3|Overall Study|Disease progression|1
4868462|NCT00838929|16778813|P2|Overall Study|Disease progression|2
4868463|NCT00838929|16778814|P1|Overall Study|Disease progression|0
4868464|NCT00838929|16778812|P3|Overall Study|Protocol Violation|0
4868465|NCT00838929|16778813|P2|Overall Study|Protocol Violation|1
4868466|NCT00838929|16778814|P1|Overall Study|Protocol Violation|0
4868467|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Missing|0
4868468|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Missing|3
4868469|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Withdrawal by Subject|0
4868470|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Withdrawal by Subject|2
4868471|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0
4868472|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2
4868473|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Physician Decision|0
4868474|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Physician Decision|2
4868475|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12
4868476|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26
4868477|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
4868478|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7
4868479|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|22
4868480|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|38
4868481|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Noncompliance|5
4868482|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Noncompliance|6
4868483|NCT00838916|16778822|P2|Follow-up Period (8 Weeks)|Adverse Event|5
4868484|NCT00838916|16778823|P1|Follow-up Period (8 Weeks)|Adverse Event|10
4868485|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Pregnancy|0
4868486|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Pregnancy|2
4868487|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Missing|1
4868488|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Missing|3
4868489|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0
4868490|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1
4868491|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Physician Decision|1
4868492|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Physician Decision|6
4868493|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|29
4868494|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|81
4868495|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Lost to Follow-up|18
4868496|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Lost to Follow-up|19
4868497|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4868498|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
4868499|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Noncompliance|14
4868500|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Noncompliance|21
4868501|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Protocol Violation|3
4868502|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Protocol Violation|12
4868503|NCT00838916|16778822|P2|Treatment Period (156 Weeks)|Adverse Event|11
4868504|NCT00838916|16778823|P1|Treatment Period (156 Weeks)|Adverse Event|50
4868505|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Missing|1
4868506|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Missing|1
4868507|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Missing|2
4868508|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Missing|1
4868509|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Subject Moved out of Town|1
4868510|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
4868511|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
4868512|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Subject Moved out of Town|0
4868513|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
4868514|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
4868515|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1
4868516|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0
4868517|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|ICF Withdrawn|0
4868518|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|ICF Withdrawn|0
4868519|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|ICF Withdrawn|1
4868520|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|ICF Withdrawn|0
4868521|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
4868522|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6
4868523|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4
4868524|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3
4868525|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Physician Decision|1
4868526|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Physician Decision|1
4868527|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Physician Decision|1
4868528|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Physician Decision|1
4868529|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
4868530|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14
4868531|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13
4868532|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8
4868533|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
4868534|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12
4868535|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7
4868536|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5
4868537|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Lost to Follow-up|24
4868538|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Lost to Follow-up|22
4868539|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Lost to Follow-up|28
4868540|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Lost to Follow-up|6
4868541|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Noncompliance|5
4868542|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Noncompliance|5
4868543|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Noncompliance|8
4868544|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Noncompliance|2
4868545|NCT00838903|16778852|P4|Follow-up Period (8 Weeks)|Adverse Event|1
4868546|NCT00838903|16778853|P3|Follow-up Period (8 Weeks)|Adverse Event|3
4868547|NCT00838903|16778854|P2|Follow-up Period (8 Weeks)|Adverse Event|0
4868548|NCT00838903|16778855|P1|Follow-up Period (8 Weeks)|Adverse Event|0
4868549|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
4868550|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
4868551|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Missing Active Treatment Status|0
4868552|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Missing Active Treatment Status|1
4868553|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
4868554|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
4868555|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1
4868556|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0
4868557|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
4868558|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
4868559|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0
4868560|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1
4868561|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Site closed|0
4868562|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Site closed|1
4868563|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Site closed|0
4868564|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Site closed|0
4868565|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
4868566|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1
4868567|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
4868568|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0
4868569|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Pregnancy|0
4868570|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Pregnancy|1
4868571|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Pregnancy|0
4868572|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Pregnancy|0
4868573|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
4868574|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
4868575|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Poor Therapeutic Response|0
4868576|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Poor Therapeutic Response|1
4868577|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Poor Glycemic Control|1
4868578|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Poor Glycemic Control|0
4868579|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Poor Glycemic Control|0
4868580|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Poor Glycemic Control|0
4868581|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
4868582|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
4868583|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1
4868584|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0
4868585|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4
4868586|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
4868587|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5
4868588|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3
4868589|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Physician Decision|2
4868590|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Physician Decision|1
4868591|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Physician Decision|2
4868592|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Physician Decision|1
4868593|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Withdrawal by Subject|53
4868594|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Withdrawal by Subject|56
4868595|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Withdrawal by Subject|55
4868596|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Withdrawal by Subject|20
4868597|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Lost to Follow-up|13
4868598|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Lost to Follow-up|15
4868599|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Lost to Follow-up|16
4868600|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Lost to Follow-up|4
4868601|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4868602|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1
4868603|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4868604|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0
4868605|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Noncompliance|6
4868606|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Noncompliance|12
4868607|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Noncompliance|13
4868608|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Noncompliance|9
4868609|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Protocol Violation|5
4868610|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Protocol Violation|6
4868611|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Protocol Violation|6
4868612|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Protocol Violation|1
4868613|NCT00838903|16778852|P4|Treatment Period (156 Weeks)|Adverse Event|25
4868614|NCT00838903|16778853|P3|Treatment Period (156 Weeks)|Adverse Event|17
4868615|NCT00838903|16778854|P2|Treatment Period (156 Weeks)|Adverse Event|13
4868616|NCT00838903|16778855|P1|Treatment Period (156 Weeks)|Adverse Event|5
4868617|NCT00838682|16778910|P2|Overall Study|Withdrawal by Subject|1
4868618|NCT00838682|16778911|P1|Overall Study|Withdrawal by Subject|0
4868619|NCT00838682|16778910|P2|Overall Study|Protocol Violation|1
4868620|NCT00838682|16778911|P1|Overall Study|Protocol Violation|0
4868621|NCT00838682|16778910|P2|Overall Study|detection of exclusion criteria|3
4868622|NCT00838682|16778911|P1|Overall Study|detection of exclusion criteria|4
4868623|NCT00838682|16778910|P2|Overall Study|Lost to Follow-up|14
4868624|NCT00838682|16778911|P1|Overall Study|Lost to Follow-up|21
4868625|NCT00838630|16778929|P2|Washout: 7 Days|Protocol Violation|0
4868626|NCT00838630|16778930|P1|Washout: 7 Days|Protocol Violation|1
4868627|NCT00838630|16778929|P2|First Intervention|Adverse Event|0
4868628|NCT00838630|16778930|P1|First Intervention|Adverse Event|1
4868629|NCT00838578|16778938|P1|Overall Study|Protocol Violation|2
4868630|NCT00838565|16778952|P6|Overall Study|Randomized but not Treated|0
4868631|NCT00838565|16778953|P5|Overall Study|Randomized but not Treated|0
4868632|NCT00838565|16778954|P4|Overall Study|Randomized but not Treated|0
4868633|NCT00838565|16778955|P3|Overall Study|Randomized but not Treated|0
4868634|NCT00838565|16778956|P2|Overall Study|Randomized but not Treated|1
4868635|NCT00838565|16778957|P1|Overall Study|Randomized but not Treated|0
4868636|NCT00838565|16778952|P6|Overall Study|Other|0
4868637|NCT00838565|16778953|P5|Overall Study|Other|0
4868638|NCT00838565|16778954|P4|Overall Study|Other|0
4868639|NCT00838565|16778955|P3|Overall Study|Other|0
4868640|NCT00838565|16778956|P2|Overall Study|Other|2
4868641|NCT00838565|16778957|P1|Overall Study|Other|0
4868642|NCT00838565|16778952|P6|Overall Study|Withdrawal by Subject|2
4868643|NCT00838565|16778953|P5|Overall Study|Withdrawal by Subject|0
4868644|NCT00838565|16778954|P4|Overall Study|Withdrawal by Subject|0
4868645|NCT00838565|16778955|P3|Overall Study|Withdrawal by Subject|1
4868646|NCT00838565|16778956|P2|Overall Study|Withdrawal by Subject|0
4868647|NCT00838565|16778957|P1|Overall Study|Withdrawal by Subject|0
4868648|NCT00838539|16779062|P12|Overall Study|Symptomatic Deterioration|0
4868649|NCT00838539|16779063|P11|Overall Study|Symptomatic Deterioration|0
4868650|NCT00838539|16779064|P10|Overall Study|Symptomatic Deterioration|1
4868651|NCT00838539|16779065|P9|Overall Study|Symptomatic Deterioration|0
4868652|NCT00838539|16779066|P8|Overall Study|Symptomatic Deterioration|0
4868653|NCT00838539|16779067|P7|Overall Study|Symptomatic Deterioration|0
4868654|NCT00838539|16779068|P6|Overall Study|Symptomatic Deterioration|1
4868655|NCT00838539|16779069|P5|Overall Study|Symptomatic Deterioration|0
4868656|NCT00838539|16779070|P4|Overall Study|Symptomatic Deterioration|1
4868657|NCT00838539|16779071|P3|Overall Study|Symptomatic Deterioration|1
4868658|NCT00838539|16779072|P2|Overall Study|Symptomatic Deterioration|0
4868659|NCT00838539|16779073|P1|Overall Study|Symptomatic Deterioration|0
4868660|NCT00838539|16779062|P12|Overall Study|Clinical Progression|0
4868661|NCT00838539|16779063|P11|Overall Study|Clinical Progression|0
4868662|NCT00838539|16779064|P10|Overall Study|Clinical Progression|0
4868663|NCT00838539|16779065|P9|Overall Study|Clinical Progression|0
4868664|NCT00838539|16779066|P8|Overall Study|Clinical Progression|0
4868665|NCT00838539|16779067|P7|Overall Study|Clinical Progression|1
4868666|NCT00838539|16779068|P6|Overall Study|Clinical Progression|0
4868667|NCT00838539|16779069|P5|Overall Study|Clinical Progression|0
4868668|NCT00838539|16779070|P4|Overall Study|Clinical Progression|0
4868669|NCT00838539|16779071|P3|Overall Study|Clinical Progression|0
4868670|NCT00838539|16779072|P2|Overall Study|Clinical Progression|0
4868671|NCT00838539|16779073|P1|Overall Study|Clinical Progression|0
4868672|NCT00838539|16779062|P12|Overall Study|Physician Decision|0
4868673|NCT00838539|16779063|P11|Overall Study|Physician Decision|0
4868674|NCT00838539|16779064|P10|Overall Study|Physician Decision|0
4868675|NCT00838539|16779065|P9|Overall Study|Physician Decision|1
4868676|NCT00838539|16779066|P8|Overall Study|Physician Decision|0
4868677|NCT00838539|16779067|P7|Overall Study|Physician Decision|0
4868678|NCT00838539|16779068|P6|Overall Study|Physician Decision|0
4868679|NCT00838539|16779069|P5|Overall Study|Physician Decision|0
4868680|NCT00838539|16779070|P4|Overall Study|Physician Decision|0
4868681|NCT00838539|16779071|P3|Overall Study|Physician Decision|0
4868682|NCT00838539|16779072|P2|Overall Study|Physician Decision|0
4868683|NCT00838539|16779073|P1|Overall Study|Physician Decision|0
4868684|NCT00838539|16779062|P12|Overall Study|Death|0
4868685|NCT00838539|16779063|P11|Overall Study|Death|0
4868686|NCT00838539|16779064|P10|Overall Study|Death|0
4868687|NCT00838539|16779065|P9|Overall Study|Death|0
4868688|NCT00838539|16779066|P8|Overall Study|Death|0
4868689|NCT00838539|16779067|P7|Overall Study|Death|1
4868690|NCT00838539|16779068|P6|Overall Study|Death|0
4868691|NCT00838539|16779069|P5|Overall Study|Death|0
4868692|NCT00838539|16779070|P4|Overall Study|Death|0
4868693|NCT00838539|16779071|P3|Overall Study|Death|0
4868694|NCT00838539|16779072|P2|Overall Study|Death|0
4868695|NCT00838539|16779073|P1|Overall Study|Death|0
4868696|NCT00838539|16779062|P12|Overall Study|Withdrawal by Subject|0
4868697|NCT00838539|16779063|P11|Overall Study|Withdrawal by Subject|2
4868698|NCT00838539|16779064|P10|Overall Study|Withdrawal by Subject|1
4868699|NCT00838539|16779065|P9|Overall Study|Withdrawal by Subject|0
4868700|NCT00838539|16779066|P8|Overall Study|Withdrawal by Subject|0
4868701|NCT00838539|16779067|P7|Overall Study|Withdrawal by Subject|0
4868702|NCT00838539|16779068|P6|Overall Study|Withdrawal by Subject|0
4868703|NCT00838539|16779069|P5|Overall Study|Withdrawal by Subject|0
4868704|NCT00838539|16779070|P4|Overall Study|Withdrawal by Subject|0
4868705|NCT00838539|16779071|P3|Overall Study|Withdrawal by Subject|0
4868706|NCT00838539|16779072|P2|Overall Study|Withdrawal by Subject|1
4868707|NCT00838539|16779073|P1|Overall Study|Withdrawal by Subject|0
4868708|NCT00838539|16779062|P12|Overall Study|Adverse Event|0
4868709|NCT00838539|16779063|P11|Overall Study|Adverse Event|2
4868710|NCT00838539|16779064|P10|Overall Study|Adverse Event|1
4868711|NCT00838539|16779065|P9|Overall Study|Adverse Event|0
4868712|NCT00838539|16779066|P8|Overall Study|Adverse Event|2
4868713|NCT00838539|16779067|P7|Overall Study|Adverse Event|0
4868714|NCT00838539|16779068|P6|Overall Study|Adverse Event|1
4868715|NCT00838539|16779069|P5|Overall Study|Adverse Event|2
4868716|NCT00838539|16779070|P4|Overall Study|Adverse Event|1
4868717|NCT00838539|16779071|P3|Overall Study|Adverse Event|1
4868718|NCT00838539|16779072|P2|Overall Study|Adverse Event|1
4868719|NCT00838539|16779073|P1|Overall Study|Adverse Event|1
4868720|NCT00838539|16779062|P12|Overall Study|Disease Progression|4
4868721|NCT00838539|16779063|P11|Overall Study|Disease Progression|1
4868722|NCT00838539|16779064|P10|Overall Study|Disease Progression|5
4868723|NCT00838539|16779065|P9|Overall Study|Disease Progression|4
4868724|NCT00838539|16779066|P8|Overall Study|Disease Progression|4
4868725|NCT00838539|16779067|P7|Overall Study|Disease Progression|3
4868726|NCT00838539|16779068|P6|Overall Study|Disease Progression|2
4868727|NCT00838539|16779069|P5|Overall Study|Disease Progression|4
4868728|NCT00838539|16779070|P4|Overall Study|Disease Progression|2
4868729|NCT00838539|16779071|P3|Overall Study|Disease Progression|3
4868730|NCT00838539|16779072|P2|Overall Study|Disease Progression|4
4868731|NCT00838539|16779073|P1|Overall Study|Disease Progression|2
4868732|NCT00838526|16779123|P2|Overall Study|Other|7
4868733|NCT00838526|16779124|P1|Overall Study|Other|11
4868734|NCT00838526|16779123|P2|Overall Study|Lack of Efficacy|3
4868735|NCT00838526|16779124|P1|Overall Study|Lack of Efficacy|2
4868736|NCT00838526|16779123|P2|Overall Study|Withdrawal by Subject|5
4868737|NCT00838526|16779124|P1|Overall Study|Withdrawal by Subject|4
4868738|NCT00838526|16779123|P2|Overall Study|Lost to Follow-up|12
4868739|NCT00838526|16779124|P1|Overall Study|Lost to Follow-up|4
4868740|NCT00838526|16779123|P2|Overall Study|Adverse Event|12
4868741|NCT00838526|16779124|P1|Overall Study|Adverse Event|3
4868742|NCT00838513|16779132|P1|Post Treatment Period (Patients Who Disc|Death|1
4868743|NCT00838513|16779132|P1|Extension Treatment Period|Death|1
4868744|NCT00838513|16779132|P1|Screening Period|Screen Failure|3
4868745|NCT00838331|16779148|P1|Aged Blood Transfusion|Withdrawal by Subject|9
4868746|NCT00838279|16779154|P2|Washout|Withdrawal by Subject|1
4868747|NCT00838279|16779155|P1|Washout|Withdrawal by Subject|0
4868748|NCT00838279|16779154|P2|Washout|Protocol Violation|0
4868749|NCT00838279|16779155|P1|Washout|Protocol Violation|1
4868750|NCT00838201|16779165|P2|Overall Study|Death|13
4868751|NCT00838201|16779166|P1|Overall Study|Death|11
4868752|NCT00838201|16779165|P2|Overall Study|Adverse Event|9
4868753|NCT00838201|16779166|P1|Overall Study|Adverse Event|5
4868754|NCT00838201|16779165|P2|Overall Study|Lost to Follow-up|3
4868755|NCT00838201|16779166|P1|Overall Study|Lost to Follow-up|4
4868756|NCT00838201|16779165|P2|Overall Study|Consent withdrawn|19
4868757|NCT00838201|16779166|P1|Overall Study|Consent withdrawn|16
4868758|NCT00838201|16779165|P2|Overall Study|Disease progression|3
4868759|NCT00838201|16779166|P1|Overall Study|Disease progression|3
4868760|NCT00838201|16779165|P2|Overall Study|Administrative decision|2
4868761|NCT00838201|16779166|P1|Overall Study|Administrative decision|1
4868762|NCT00838201|16779165|P2|Overall Study|Noncompliance|1
4868763|NCT00838201|16779166|P1|Overall Study|Noncompliance|0
4868764|NCT00838201|16779165|P2|Overall Study|Investigator decision, or other reasons|3
4868765|NCT00838201|16779166|P1|Overall Study|Investigator decision, or other reasons|2
4868766|NCT00838110|16779234|P4|Overall Study|Randomized but not treated|0
4868767|NCT00838110|16779235|P3|Overall Study|Randomized but not treated|0
4868768|NCT00838110|16779236|P2|Overall Study|Randomized but not treated|1
4868769|NCT00838110|16779237|P1|Overall Study|Randomized but not treated|0
4868770|NCT00838110|16779234|P4|Overall Study|Did not meet eligibility criteria|2
4868771|NCT00838110|16779235|P3|Overall Study|Did not meet eligibility criteria|1
4868772|NCT00838110|16779236|P2|Overall Study|Did not meet eligibility criteria|0
4868773|NCT00838110|16779237|P1|Overall Study|Did not meet eligibility criteria|0
4868774|NCT00838110|16779234|P4|Overall Study|Lost to Follow-up|0
4868775|NCT00838110|16779235|P3|Overall Study|Lost to Follow-up|0
4868776|NCT00838110|16779236|P2|Overall Study|Lost to Follow-up|0
4868777|NCT00838110|16779237|P1|Overall Study|Lost to Follow-up|3
4868778|NCT00838110|16779234|P4|Overall Study|Protocol Violation|1
4868779|NCT00838110|16779235|P3|Overall Study|Protocol Violation|1
4868780|NCT00838110|16779236|P2|Overall Study|Protocol Violation|2
4868781|NCT00838110|16779237|P1|Overall Study|Protocol Violation|0
4868782|NCT00838110|16779234|P4|Overall Study|Other|2
4868783|NCT00838110|16779235|P3|Overall Study|Other|3
4868784|NCT00838110|16779236|P2|Overall Study|Other|3
4868785|NCT00838110|16779237|P1|Overall Study|Other|3
4868786|NCT00838110|16779234|P4|Overall Study|Withdrawal by Subject|4
4868787|NCT00838110|16779235|P3|Overall Study|Withdrawal by Subject|3
4868788|NCT00838110|16779236|P2|Overall Study|Withdrawal by Subject|6
4868789|NCT00838110|16779237|P1|Overall Study|Withdrawal by Subject|5
4868790|NCT00838110|16779234|P4|Overall Study|Adverse Event|7
4868791|NCT00838110|16779235|P3|Overall Study|Adverse Event|8
4868792|NCT00838110|16779236|P2|Overall Study|Adverse Event|10
4868793|NCT00838110|16779237|P1|Overall Study|Adverse Event|11
4868794|NCT00838110|16779234|P4|Overall Study|Death|2
4868795|NCT00838110|16779235|P3|Overall Study|Death|1
4868796|NCT00838110|16779236|P2|Overall Study|Death|0
4868797|NCT00838110|16779237|P1|Overall Study|Death|0
4868798|NCT00838097|16779257|P1|Overall Study|Protocol-specified criteria|142
4868799|NCT00838097|16779257|P1|Overall Study|Death|6
4868800|NCT00838097|16779257|P1|Overall Study|Lost to Follow-up|11
4868801|NCT00838097|16779257|P1|Overall Study|Physician Decision|4
4868802|NCT00838097|16779257|P1|Overall Study|Requirement for alternative therapy|2
4868803|NCT00838097|16779257|P1|Overall Study|Withdrawal by Subject|3
4868804|NCT00838097|16779257|P1|Overall Study|Adverse Event|2
4868805|NCT00838097|16779257|P1|Overall Study|Ineligibility determined|6
4868806|NCT00837967|16779281|P2|Washout Period of 7 - 14 Days|Adverse Event|0
4868807|NCT00837967|16779282|P1|Washout Period of 7 - 14 Days|Adverse Event|2
4868808|NCT00837876|16779308|P1|Overall Study|disease progression|24
4868809|NCT00837876|16779308|P1|Overall Study|Withdrawal by Subject|3
4868810|NCT00837876|16779308|P1|Overall Study|Physician Decision|1
4868811|NCT00837876|16779308|P1|Overall Study|Adverse Event|7
4868812|NCT00837876|16779308|P1|Overall Study|Death|2
4868813|NCT00837811|16779330|P3|Overall Study|Sponsor Decision|0
4868814|NCT00837811|16779331|P2|Overall Study|Sponsor Decision|2
4868815|NCT00837811|16779332|P1|Overall Study|Sponsor Decision|0
4868816|NCT00837811|16779330|P3|Overall Study|Withdrawal by Subject|0
4868817|NCT00837811|16779331|P2|Overall Study|Withdrawal by Subject|9
4868818|NCT00837811|16779332|P1|Overall Study|Withdrawal by Subject|1
4868819|NCT00837811|16779330|P3|Overall Study|Physician Decision|1
4868820|NCT00837811|16779331|P2|Overall Study|Physician Decision|2
4868821|NCT00837811|16779332|P1|Overall Study|Physician Decision|0
4868822|NCT00837811|16779330|P3|Overall Study|Lost to Follow-up|0
4868823|NCT00837811|16779331|P2|Overall Study|Lost to Follow-up|3
4868824|NCT00837811|16779332|P1|Overall Study|Lost to Follow-up|1
4868825|NCT00837811|16779330|P3|Overall Study|Lack of Efficacy|0
4868826|NCT00837811|16779331|P2|Overall Study|Lack of Efficacy|11
4868827|NCT00837811|16779332|P1|Overall Study|Lack of Efficacy|0
4868828|NCT00837811|16779330|P3|Overall Study|Death|0
4868829|NCT00837811|16779331|P2|Overall Study|Death|1
4868830|NCT00837811|16779332|P1|Overall Study|Death|1
4868831|NCT00837811|16779330|P3|Overall Study|Adverse Event|0
4868832|NCT00837811|16779331|P2|Overall Study|Adverse Event|6
4868833|NCT00837811|16779332|P1|Overall Study|Adverse Event|4
4868834|NCT00837759|16779417|P1|Overall Study|Lost to Follow-up|1
4868835|NCT00837759|16779417|P1|Overall Study|Protocol Violation|3
4868836|NCT00837694|16779432|P6|Overall Study|Lost to Follow-up|1
4868837|NCT00837694|16779433|P5|Overall Study|Lost to Follow-up|1
4868838|NCT00837694|16779434|P4|Overall Study|Lost to Follow-up|1
4868839|NCT00837694|16779435|P3|Overall Study|Lost to Follow-up|2
4868840|NCT00837694|16779436|P2|Overall Study|Lost to Follow-up|0
4868841|NCT00837694|16779437|P1|Overall Study|Lost to Follow-up|2
4868842|NCT00837616|16779453|P2|Overall Study|Withdrawal by Subject|1
4868843|NCT00837616|16779454|P1|Overall Study|Withdrawal by Subject|0
4868844|NCT00837577|16779493|P2|Open-label Period|Other Reason|1
4868845|NCT00837577|16779494|P1|Open-label Period|Other Reason|1
4868846|NCT00837577|16779493|P2|Open-label Period|Withdrawal by Subject|2
4868847|NCT00837577|16779494|P1|Open-label Period|Withdrawal by Subject|1
4868848|NCT00837577|16779493|P2|Open-label Period|Lack of Efficacy|3
4868849|NCT00837577|16779494|P1|Open-label Period|Lack of Efficacy|4
4868850|NCT00837577|16779493|P2|Open-label Period|Laboratory Adverse Event|1
4868851|NCT00837577|16779494|P1|Open-label Period|Laboratory Adverse Event|0
4868852|NCT00837577|16779493|P2|Open-label Period|Clinical Adverse Event|2
4868853|NCT00837577|16779494|P1|Open-label Period|Clinical Adverse Event|2
4868854|NCT00837577|16779493|P2|Double-blind Period|Withdrawal by Subject|0
4868855|NCT00837577|16779494|P1|Double-blind Period|Withdrawal by Subject|1
4868856|NCT00837577|16779493|P2|Double-blind Period|Clinical Adverse Event|0
4868857|NCT00837577|16779494|P1|Double-blind Period|Clinical Adverse Event|1
4868858|NCT00837486|16779514|P2|Long-term Follow-up Phase - Open Label|Death|0
4868859|NCT00837486|16779515|P1|Long-term Follow-up Phase - Open Label|Death|1
4868860|NCT00837486|16779514|P2|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0
4868861|NCT00837486|16779515|P1|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2
4868862|NCT00837486|16779514|P2|Long-term Follow-up Phase - Open Label|Physician Decision|0
4868863|NCT00837486|16779515|P1|Long-term Follow-up Phase - Open Label|Physician Decision|2
4868864|NCT00837486|16779514|P2|Blinded-treatment Phase|Physician Decision|0
4868865|NCT00837486|16779515|P1|Blinded-treatment Phase|Physician Decision|1
4868866|NCT00837473|16779527|P1|Overall Study|Withdrawal by Subject|2
4868867|NCT00837473|16779527|P1|Overall Study|Lost to Follow-up|1
4868868|NCT00837434|16779547|P2|Overall Study|Unable to obtain study drug|0
4868869|NCT00837434|16779548|P1|Overall Study|Unable to obtain study drug|1
4868870|NCT00837434|16779547|P2|Overall Study|Baseline assessments not done in time|0
4868871|NCT00837434|16779548|P1|Overall Study|Baseline assessments not done in time|1
4868872|NCT00837434|16779547|P2|Overall Study|Noncompliant|0
4868873|NCT00837434|16779548|P1|Overall Study|Noncompliant|2
4868874|NCT00837434|16779547|P2|Overall Study|Withdrawn by sponsor/regulatory agency|0
4868875|NCT00837434|16779548|P1|Overall Study|Withdrawn by sponsor/regulatory agency|1
4868876|NCT00837434|16779547|P2|Overall Study|Lost to Follow-up|1
4868877|NCT00837434|16779548|P1|Overall Study|Lost to Follow-up|1
4868878|NCT00837434|16779547|P2|Overall Study|Physician Decision|0
4868879|NCT00837434|16779548|P1|Overall Study|Physician Decision|3
4868880|NCT00837330|16779568|P2|Overall Study|Lost to Follow-up|3
4868881|NCT00837330|16779569|P1|Overall Study|Lost to Follow-up|1
4868882|NCT00837213|16779592|P2|Overall Study|not stated|1
4868883|NCT00837213|16779593|P1|Overall Study|not stated|1
4868884|NCT00837213|16779592|P2|Overall Study|Withdrawal by Subject|2
4868885|NCT00837213|16779593|P1|Overall Study|Withdrawal by Subject|2
4868886|NCT00837213|16779592|P2|Overall Study|Lost to Follow-up|2
4868887|NCT00837213|16779593|P1|Overall Study|Lost to Follow-up|3
4868888|NCT00837161|16779619|P1|Overall Study|refused hysterectomy|2
4868889|NCT00837148|16779627|P1|Overall Study|Death|1
4868890|NCT00837148|16779627|P1|Overall Study|Adverse Event|1
4868891|NCT00837096|16779633|P2|Overall Study|Not reported|8
4868892|NCT00837096|16779634|P1|Overall Study|Not reported|9
4868893|NCT00837096|16779633|P2|Overall Study|Physician Decision|1
4868894|NCT00837096|16779634|P1|Overall Study|Physician Decision|1
4868895|NCT00836953|16779646|P1|Overall Study|Lost to Follow-up|1
4868896|NCT00836953|16779646|P1|Overall Study|Withdrawal by Subject|1
4868897|NCT00836927|16779657|P5|Overall Study|Withdrawal by Subject|0
4868898|NCT00836927|16779658|P4|Overall Study|Withdrawal by Subject|0
4868899|NCT00836927|16779659|P3|Overall Study|Withdrawal by Subject|0
4868900|NCT00836927|16779660|P2|Overall Study|Withdrawal by Subject|0
4868901|NCT00836927|16779661|P1|Overall Study|Withdrawal by Subject|1
4868902|NCT00836927|16779657|P5|Overall Study|Progressive disease|1
4868903|NCT00836927|16779658|P4|Overall Study|Progressive disease|1
4868904|NCT00836927|16779659|P3|Overall Study|Progressive disease|0
4868905|NCT00836927|16779660|P2|Overall Study|Progressive disease|0
4868906|NCT00836927|16779661|P1|Overall Study|Progressive disease|2
4868907|NCT00836901|16779697|P2|First Intervention|Withdrawal by Subject|0
4868908|NCT00836901|16779698|P1|First Intervention|Withdrawal by Subject|1
4868909|NCT00836875|16779747|P2|Overall Study|Withdrawal by Subject|1
4868910|NCT00836875|16779748|P1|Overall Study|Withdrawal by Subject|0
4868911|NCT00836875|16779747|P2|Overall Study|Death|2
4868912|NCT00836875|16779748|P1|Overall Study|Death|3
4868913|NCT00836810|16779764|P2|Overall Study|New diagnosis|0
4868914|NCT00836810|16779765|P1|Overall Study|New diagnosis|1
4868915|NCT00836745|16779787|P1|Overall Study|Other|2
4868916|NCT00836745|16779787|P1|Overall Study|Objective progression or relapse|4
4868917|NCT00836745|16779787|P1|Overall Study|Adverse Event|3
4868918|NCT00836745|16779787|P1|Overall Study|Lost to Follow-up|10
4868919|NCT00836745|16779787|P1|Overall Study|Death|2
4868920|NCT00836706|16779801|P2|Washout: 7 Days|Withdrawal by Subject|1
4868921|NCT00836706|16779802|P1|Washout: 7 Days|Withdrawal by Subject|0
4868922|NCT00836693|16779812|P2|Overall Study|Lost to Follow-up|0
4868923|NCT00836693|16779813|P1|Overall Study|Lost to Follow-up|1
4868924|NCT00836693|16779812|P2|Overall Study|Protocol Violation|0
4868925|NCT00836693|16779813|P1|Overall Study|Protocol Violation|1
4868926|NCT00836693|16779812|P2|Overall Study|Withdrawal by Subject|4
4868927|NCT00836693|16779813|P1|Overall Study|Withdrawal by Subject|9
4868928|NCT00836693|16779812|P2|Overall Study|Physician Decision|0
4868929|NCT00836693|16779813|P1|Overall Study|Physician Decision|2
4868930|NCT00836693|16779812|P2|Overall Study|Sponsor Decision|1
4868931|NCT00836693|16779813|P1|Overall Study|Sponsor Decision|0
4868932|NCT00836693|16779812|P2|Overall Study|Adverse Event|1
4868933|NCT00836693|16779813|P1|Overall Study|Adverse Event|4
4868934|NCT00836589|16779863|P1|Overall Study|Withdrawal by Subject or Physician|591
4868935|NCT00836589|16779863|P1|Overall Study|Death|429
4868936|NCT00836589|16779863|P1|Overall Study|Lost to Follow-up|246
4868937|NCT00836498|16779896|P2|Overall Study|Withdrawal by Subject|1
4868938|NCT00836498|16779897|P1|Overall Study|Withdrawal by Subject|2
4868939|NCT00836498|16779896|P2|Overall Study|Lost to Follow-up|0
4868940|NCT00836498|16779897|P1|Overall Study|Lost to Follow-up|1
4868941|NCT00836498|16779896|P2|Overall Study|Adverse Event|0
4868942|NCT00836498|16779897|P1|Overall Study|Adverse Event|1
4868943|NCT00836472|16779929|P2|Washout|Withdrawal by Subject|1
4868944|NCT00836472|16779930|P1|Washout|Withdrawal by Subject|1
4868945|NCT00836472|16779929|P2|Washout|Adverse Event|2
4868946|NCT00836472|16779930|P1|Washout|Adverse Event|1
4868947|NCT00836277|16780007|P1|Overall Study|Not evaluable for response|6
4868948|NCT00836186|16780015|P1|Overall Study|Blood could not be drawn|1
4868949|NCT00836095|16780023|P2|Overall Study|Physician Decision|3
4868950|NCT00836095|16780024|P1|Overall Study|Physician Decision|0
4868951|NCT00836056|16780034|P2|First Intervention|Adverse Event|0
4868952|NCT00836056|16780035|P1|First Intervention|Adverse Event|1
4868953|NCT00835991|16780064|P2|Washout|Withdrawal by Subject|1
4868954|NCT00835991|16780065|P1|Washout|Withdrawal by Subject|3
4868955|NCT00835991|16780064|P2|Washout|Protocol Violation|2
4868956|NCT00835991|16780065|P1|Washout|Protocol Violation|0
4868957|NCT00835991|16780064|P2|First Intervention|Adverse Event|1
4868958|NCT00835991|16780065|P1|First Intervention|Adverse Event|0
4868959|NCT00835978|16780083|P4|Overall Study|Study terminated by sponsor|0
4868960|NCT00835978|16780084|P3|Overall Study|Study terminated by sponsor|30
4868961|NCT00835978|16780085|P2|Overall Study|Study terminated by sponsor|8
4868962|NCT00835978|16780086|P1|Overall Study|Study terminated by sponsor|12
4868963|NCT00835978|16780083|P4|Overall Study|Withdrawal by Subject|5
4868964|NCT00835978|16780084|P3|Overall Study|Withdrawal by Subject|0
4868965|NCT00835978|16780085|P2|Overall Study|Withdrawal by Subject|3
4868966|NCT00835978|16780086|P1|Overall Study|Withdrawal by Subject|0
4868967|NCT00835978|16780083|P4|Overall Study|Adverse Event|0
4868968|NCT00835978|16780084|P3|Overall Study|Adverse Event|1
4868969|NCT00835978|16780085|P2|Overall Study|Adverse Event|0
4868970|NCT00835978|16780086|P1|Overall Study|Adverse Event|1
4868971|NCT00835978|16780083|P4|Overall Study|Objective progression or relapse|0
4868972|NCT00835978|16780084|P3|Overall Study|Objective progression or relapse|1
4868973|NCT00835978|16780085|P2|Overall Study|Objective progression or relapse|0
4868974|NCT00835978|16780086|P1|Overall Study|Objective progression or relapse|2
4868975|NCT00835978|16780083|P4|Overall Study|Other|0
4868976|NCT00835978|16780084|P3|Overall Study|Other|8
4868977|NCT00835978|16780085|P2|Overall Study|Other|1
4868978|NCT00835978|16780086|P1|Overall Study|Other|5
4868979|NCT00835978|16780083|P4|Overall Study|Lost to Follow-up|1
4868980|NCT00835978|16780084|P3|Overall Study|Lost to Follow-up|2
4868981|NCT00835978|16780085|P2|Overall Study|Lost to Follow-up|4
4868982|NCT00835978|16780086|P1|Overall Study|Lost to Follow-up|3
4868983|NCT00835978|16780083|P4|Overall Study|Death|4
4868984|NCT00835978|16780084|P3|Overall Study|Death|49
4868985|NCT00835978|16780085|P2|Overall Study|Death|40
4868986|NCT00835978|16780086|P1|Overall Study|Death|33
4868987|NCT00835796|16780197|P2|First Intervention|Withdrawal by Subject|1
4868988|NCT00835796|16780198|P1|First Intervention|Withdrawal by Subject|0
4868989|NCT00835731|16780208|P2|Overall Study|Physician Decision|1
4868990|NCT00835731|16780209|P1|Overall Study|Physician Decision|1
4868991|NCT00835731|16780208|P2|Overall Study|Withdrawal by Subject|0
4868992|NCT00835731|16780209|P1|Overall Study|Withdrawal by Subject|1
4868993|NCT00835705|16780229|P2|Second Intervention|Difficulty with vein|0
4868994|NCT00835705|16780230|P1|Second Intervention|Difficulty with vein|1
4868995|NCT00835705|16780229|P2|First Intervention|Difficulty with vein|0
4868996|NCT00835705|16780230|P1|First Intervention|Difficulty with vein|1
4868997|NCT00835692|16780246|P2|First Intervention|Withdrawal by Subject|0
4868998|NCT00835692|16780247|P1|First Intervention|Withdrawal by Subject|1
4868999|NCT00835679|16780259|P4|Overall Study|Withdrawal by Subject|0
4869000|NCT00835679|16780260|P3|Overall Study|Withdrawal by Subject|0
4869001|NCT00835679|16780261|P2|Overall Study|Withdrawal by Subject|0
4869002|NCT00835679|16780262|P1|Overall Study|Withdrawal by Subject|1
4869003|NCT00835666|16780286|P2|Washout|Withdrawal by Subject|0
4869004|NCT00835666|16780287|P1|Washout|Withdrawal by Subject|1
4869005|NCT00835666|16780286|P2|Washout|Protocol Violation|0
4869006|NCT00835666|16780287|P1|Washout|Protocol Violation|1
4869007|NCT00835640|16780297|P2|Second Intervention|Protocol Violation|0
4869008|NCT00835640|16780298|P1|Second Intervention|Protocol Violation|1
4869009|NCT00835575|16780330|P2|Washout of 14 Days|Withdrawal by Subject|0
4869010|NCT00835575|16780331|P1|Washout of 14 Days|Withdrawal by Subject|1
4869011|NCT00835549|16780341|P2|Washout of 7 Days|Withdrawal by Subject|0
4869012|NCT00835549|16780342|P1|Washout of 7 Days|Withdrawal by Subject|2
4869013|NCT00835536|16780352|P2|Washout of 5 Weeks|Withdrawal by Subject|0
4869014|NCT00835536|16780353|P1|Washout of 5 Weeks|Withdrawal by Subject|1
4869015|NCT00835406|16780414|P2|Period: Washout of 7 Days|Withdrawal by Subject|2
4869016|NCT00835406|16780415|P1|Period: Washout of 7 Days|Withdrawal by Subject|0
4869017|NCT00835406|16780414|P2|Period: First Intervention|Withdrawal by Subject|0
4869018|NCT00835406|16780415|P1|Period: First Intervention|Withdrawal by Subject|2
4869019|NCT00835406|16780414|P2|Period: First Intervention|Adverse Event|1
4869020|NCT00835406|16780415|P1|Period: First Intervention|Adverse Event|0
4869021|NCT00835380|16780421|P1|Overall Study|Withdrawal by Subject|2
4869022|NCT00835367|16780428|P2|Second Intervention|Adverse Event|1
4869023|NCT00835367|16780429|P1|Second Intervention|Adverse Event|1
4869024|NCT00835367|16780428|P2|Washout|Withdrawal by Subject|0
4869025|NCT00835367|16780429|P1|Washout|Withdrawal by Subject|1
4869026|NCT00835367|16780428|P2|Washout|Adverse Event|0
4869027|NCT00835367|16780429|P1|Washout|Adverse Event|2
4869028|NCT00835354|16780451|P2|First Intervention|Adverse Event|1
4869029|NCT00835354|16780452|P1|First Intervention|Adverse Event|0
4869030|NCT00835341|16780462|P2|Overall Study|Lost to Follow-up|12
4869031|NCT00835341|16780463|P1|Overall Study|Lost to Follow-up|3
4869032|NCT00835263|16780526|P2|Second Intervention|Adverse Event|0
4869033|NCT00835263|16780527|P1|Second Intervention|Adverse Event|1
4869034|NCT00835237|16780537|P2|Overall Study|Withdrawal by Subject|0
4869035|NCT00835237|16780538|P1|Overall Study|Withdrawal by Subject|2
4869036|NCT00835237|16780537|P2|Overall Study|Lost to Follow-up|0
4869037|NCT00835237|16780538|P1|Overall Study|Lost to Follow-up|4
4869038|NCT00835211|16780578|P2|Washout: 7 Days|Withdrawal by Subject|0
4869039|NCT00835211|16780579|P1|Washout: 7 Days|Withdrawal by Subject|1
4869040|NCT00835211|16780578|P2|Washout: 7 Days|Adverse Event|1
4869041|NCT00835211|16780579|P1|Washout: 7 Days|Adverse Event|2
4869042|NCT00835211|16780578|P2|First Intervention|Withdrawal by Subject|1
4869043|NCT00835211|16780579|P1|First Intervention|Withdrawal by Subject|0
4869044|NCT00835172|16780625|P2|Washout|Protocol Violation|1
4869045|NCT00835172|16780626|P1|Washout|Protocol Violation|0
4869046|NCT00835120|16780652|P1|Overall Study|Withdrawal by Subject|2
4869047|NCT00835120|16780652|P1|Overall Study|Adverse Event|2
4869048|NCT00835120|16780652|P1|Overall Study|Lost to Follow-up|3
4869049|NCT00835120|16780652|P1|Overall Study|Lack of Efficacy|1
4869050|NCT00835081|16780662|P2|Washout of 7 Days|Withdrawal by Subject|0
4869051|NCT00835081|16780663|P1|Washout of 7 Days|Withdrawal by Subject|1
4869052|NCT00835068|16780673|P2|Overall Study|Withdrawal by Subject|0
4869053|NCT00835068|16780674|P1|Overall Study|Withdrawal by Subject|1
4869054|NCT00835068|16780673|P2|Overall Study|Other|0
4869055|NCT00835068|16780674|P1|Overall Study|Other|8
4869056|NCT00835068|16780673|P2|Overall Study|Adverse Event|1
4869057|NCT00835068|16780674|P1|Overall Study|Adverse Event|0
4869058|NCT00835068|16780673|P2|Overall Study|Death|0
4869059|NCT00835068|16780674|P1|Overall Study|Death|1
4869060|NCT00835042|16780694|P2|Washout of 21 Days|Withdrawal by Subject|2
4869061|NCT00835042|16780695|P1|Washout of 21 Days|Withdrawal by Subject|0
4869062|NCT00835042|16780694|P2|First Intervention|Adverse Event|2
4869063|NCT00835042|16780695|P1|First Intervention|Adverse Event|1
4869064|NCT00835042|16780694|P2|First Intervention|Withdrawal by Subject|0
4869065|NCT00835042|16780695|P1|First Intervention|Withdrawal by Subject|3
4869066|NCT00834912|16780781|P6|Treatment Period 2|Withdrawal by Subject|0
4869067|NCT00834912|16780782|P5|Treatment Period 2|Withdrawal by Subject|1
4869068|NCT00834912|16780783|P4|Treatment Period 2|Withdrawal by Subject|0
4869069|NCT00834912|16780784|P3|Treatment Period 2|Withdrawal by Subject|1
4869070|NCT00834912|16780785|P2|Treatment Period 2|Withdrawal by Subject|0
4869071|NCT00834912|16780786|P1|Treatment Period 2|Withdrawal by Subject|0
4869072|NCT00834912|16780781|P6|Treatment Period 1|Adverse Event|0
4869073|NCT00834912|16780782|P5|Treatment Period 1|Adverse Event|0
4869074|NCT00834912|16780783|P4|Treatment Period 1|Adverse Event|1
4869075|NCT00834912|16780784|P3|Treatment Period 1|Adverse Event|0
4869076|NCT00834912|16780785|P2|Treatment Period 1|Adverse Event|1
4869077|NCT00834912|16780786|P1|Treatment Period 1|Adverse Event|0
4869078|NCT00834899|16780808|P2|Overall Study|Withdrawal by Subject|1
4869079|NCT00834899|16780809|P1|Overall Study|Withdrawal by Subject|1
4869080|NCT00834873|16780848|P2|First Intervention|Adverse Event|1
4869081|NCT00834873|16780849|P1|First Intervention|Adverse Event|0
4869082|NCT00834834|16780859|P2|Overall Study|Withdrawal by Subject|3
4869083|NCT00834834|16780860|P1|Overall Study|Withdrawal by Subject|4
4869084|NCT00834795|16780895|P2|Second Intervention|Adverse Event|0
4869085|NCT00834795|16780896|P1|Second Intervention|Adverse Event|1
4869086|NCT00834795|16780895|P2|Washout: 7 Days|Withdrawal by Subject|1
4869087|NCT00834795|16780896|P1|Washout: 7 Days|Withdrawal by Subject|0
4869088|NCT00834756|16780906|P2|Washout: 21 Days|Withdrawal by Subject|0
4869089|NCT00834756|16780907|P1|Washout: 21 Days|Withdrawal by Subject|1
4869090|NCT00834756|16780906|P2|First Intervention|Adverse Event|0
4869091|NCT00834756|16780907|P1|First Intervention|Adverse Event|1
4869092|NCT00834743|16780917|P2|Second Intervention|Withdrawal by Subject|0
4869093|NCT00834743|16780918|P1|Second Intervention|Withdrawal by Subject|1
4869094|NCT00834717|16780928|P2|First Intervention|Withdrawal by Subject|1
4869095|NCT00834717|16780929|P1|First Intervention|Withdrawal by Subject|0
4869096|NCT00834717|16780928|P2|First Intervention|Adverse Event|0
4869097|NCT00834717|16780929|P1|First Intervention|Adverse Event|1
4869098|NCT00834639|16780960|P2|Second Intervention|Physician Decision|2
4869099|NCT00834639|16780961|P1|Second Intervention|Physician Decision|0
4869100|NCT00834613|16780978|P2|First Intervention|Protocol Violation|0
4869101|NCT00834613|16780979|P1|First Intervention|Protocol Violation|1
4869102|NCT00834587|16780989|P2|Washout: 7 Days|Withdrawal by Subject|0
4869103|NCT00834587|16780990|P1|Washout: 7 Days|Withdrawal by Subject|1
4869104|NCT00834522|16781039|P2|Washout|Withdrawal by Subject|1
4869105|NCT00834522|16781040|P1|Washout|Withdrawal by Subject|2
4869106|NCT00834522|16781039|P2|Washout|Adverse Event|0
4869107|NCT00834522|16781040|P1|Washout|Adverse Event|1
4869108|NCT00834444|16781063|P2|Second Intervention|Adverse Event|0
4869109|NCT00834444|16781064|P1|Second Intervention|Adverse Event|1
4869110|NCT00834444|16781063|P2|Washout of 7 Days|Withdrawal by Subject|1
4869111|NCT00834444|16781064|P1|Washout of 7 Days|Withdrawal by Subject|0
4869112|NCT00834444|16781063|P2|First Intervention|Intolerance to Venopuncture|1
4869113|NCT00834444|16781064|P1|First Intervention|Intolerance to Venopuncture|0
4869114|NCT00834444|16781063|P2|First Intervention|Adverse Event|0
4869115|NCT00834444|16781064|P1|First Intervention|Adverse Event|1
4869116|NCT00834431|16781074|P2|Washout of 7 Days|Withdrawal by Subject|1
4869117|NCT00834431|16781075|P1|Washout of 7 Days|Withdrawal by Subject|0
4869118|NCT00834431|16781074|P2|First Intervention|Adverse Event|1
4869119|NCT00834431|16781075|P1|First Intervention|Adverse Event|0
4869120|NCT00834418|16781085|P2|Overall Study|Adverse Event|2
4869121|NCT00834418|16781086|P1|Overall Study|Adverse Event|0
4869122|NCT00834366|16781103|P2|Treatment Period 1|Adverse Event|1
4869123|NCT00834366|16781104|P1|Treatment Period 1|Adverse Event|1
4869124|NCT00834340|16781120|P2|Washout|Withdrawal by Subject|0
4869125|NCT00834340|16781121|P1|Washout|Withdrawal by Subject|1
4869126|NCT00834340|16781120|P2|Washout|Adverse Event|0
4869127|NCT00834340|16781121|P1|Washout|Adverse Event|1
4869128|NCT00834249|16781165|P2|Second Intervention|Adverse Event|0
4869129|NCT00834249|16781166|P1|Second Intervention|Adverse Event|1
4869130|NCT00834249|16781165|P2|Washout: 7 Days|Withdrawal by Subject|1
4869131|NCT00834249|16781166|P1|Washout: 7 Days|Withdrawal by Subject|1
4869132|NCT00834080|16781262|P1|Overall Study|Subject Relocated|1
4869133|NCT00834080|16781262|P1|Overall Study|Physician Decision|1
4869134|NCT00834080|16781262|P1|Overall Study|Other - False positive tests of the UDS|1
4869135|NCT00834080|16781262|P1|Overall Study|Other - Pregnancy|1
4869136|NCT00834080|16781262|P1|Overall Study|Withdrawal by Subject|5
4869137|NCT00834080|16781262|P1|Overall Study|Lost to Follow-up|7
4869138|NCT00834080|16781262|P1|Overall Study|Adverse Event|7
4869139|NCT00834067|16781268|P2|Washout of 21 Days|Protocol Violation|1
4869140|NCT00834067|16781269|P1|Washout of 21 Days|Protocol Violation|0
4869141|NCT00834041|16781291|P2|Overall Study|Lost to Follow-up|1
4869142|NCT00834041|16781292|P1|Overall Study|Lost to Follow-up|0
4869143|NCT00834041|16781291|P2|Overall Study|Withdrawal by Subject|0
4869144|NCT00834041|16781292|P1|Overall Study|Withdrawal by Subject|1
4869145|NCT00833989|16781310|P4|Overall Study|Withdrawal by Subject|1
4869146|NCT00833989|16781311|P3|Overall Study|Withdrawal by Subject|1
4869147|NCT00833989|16781312|P2|Overall Study|Withdrawal by Subject|0
4869148|NCT00833989|16781313|P1|Overall Study|Withdrawal by Subject|3
4869149|NCT00833989|16781310|P4|Overall Study|Physician Decision|1
4869150|NCT00833989|16781311|P3|Overall Study|Physician Decision|0
4869151|NCT00833989|16781312|P2|Overall Study|Physician Decision|0
4869152|NCT00833989|16781313|P1|Overall Study|Physician Decision|0
4869153|NCT00833976|16781417|P1|Overall Study|Physician Decision|1
4869154|NCT00833976|16781417|P1|Overall Study|Did not meet eligibility criteria|41
4869155|NCT00833976|16781417|P1|Overall Study|Lost to Follow-up|4
4869156|NCT00833976|16781417|P1|Overall Study|Withdrawal by Subject|5
4869157|NCT00833937|16781425|P2|Washout|Withdrawal by Subject|0
4869158|NCT00833937|16781426|P1|Washout|Withdrawal by Subject|1
4869159|NCT00833924|16781434|P1|Overall Study|In study follow-up|71
4869160|NCT00833924|16781434|P1|Overall Study|Withdrawal by Subject|13
4869161|NCT00833924|16781434|P1|Overall Study|Lost to Follow-up|2
4869162|NCT00833924|16781434|P1|Overall Study|Conversion|2
4869163|NCT00833924|16781434|P1|Overall Study|Death|21
4869164|NCT00833911|16781439|P1|Maintenance Phase II|Lack of Efficacy|1
4869165|NCT00833911|16781439|P1|Maintenance Phase II|Withdrawal by Subject|1
4869166|NCT00833911|16781439|P1|Maintenance Phase II|Physician Decision|2
4869167|NCT00833911|16781439|P1|Maintenance Phase II|Adverse Event|6
4869168|NCT00833911|16781439|P1|Maintenance Phase I|Lack of Efficacy|4
4869169|NCT00833911|16781439|P1|Maintenance Phase I|Physician Decision|10
4869170|NCT00833911|16781439|P1|Maintenance Phase I|Withdrawal by Subject|11
4869171|NCT00833911|16781439|P1|Maintenance Phase I|Adverse Event|73
4869172|NCT00833911|16781439|P1|Titration|Withdrawal by Subject|3
4869173|NCT00833911|16781439|P1|Titration|Adverse Event|18
4869174|NCT00833898|16781449|P2|Overall Study|Patient did not receive transplant|2
4869175|NCT00833898|16781450|P1|Overall Study|Patient did not receive transplant|0
4869176|NCT00833898|16781449|P2|Overall Study|Lost to Follow-up|7
4869177|NCT00833898|16781450|P1|Overall Study|Lost to Follow-up|7
4869178|NCT00833898|16781449|P2|Overall Study|Withdrawal by Subject|27
4869179|NCT00833898|16781450|P1|Overall Study|Withdrawal by Subject|33
4869180|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1
4869181|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4869182|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4869183|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4869184|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4869185|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0
4869186|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Other|3
4869187|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Other|4
4869188|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Other|0
4869189|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Other|0
4869190|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Other|0
4869191|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Other|0
4869192|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7
4869193|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5
4869194|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4869195|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4869196|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4869197|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0
4869198|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6
4869199|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7
4869200|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869201|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869202|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869203|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869204|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Death|9
4869205|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Death|8
4869206|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Death|0
4869207|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Death|0
4869208|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Death|0
4869209|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Death|0
4869210|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Adverse Event|13
4869211|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Adverse Event|8
4869212|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Adverse Event|0
4869213|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Adverse Event|0
4869214|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Adverse Event|0
4869215|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Adverse Event|0
4869216|NCT00833833|16781509|P6|Phase 2 (as of 01 April 2011)|Still active in study|22
4869217|NCT00833833|16781510|P5|Phase 2 (as of 01 April 2011)|Still active in study|23
4869218|NCT00833833|16781511|P4|Phase 2 (as of 01 April 2011)|Still active in study|0
4869219|NCT00833833|16781512|P3|Phase 2 (as of 01 April 2011)|Still active in study|0
4869220|NCT00833833|16781513|P2|Phase 2 (as of 01 April 2011)|Still active in study|0
4869221|NCT00833833|16781514|P1|Phase 2 (as of 01 April 2011)|Still active in study|0
4869222|NCT00833833|16781509|P6|Phase 1 (as of 01 April 2011)|Other|0
4869223|NCT00833833|16781510|P5|Phase 1 (as of 01 April 2011)|Other|0
4869224|NCT00833833|16781511|P4|Phase 1 (as of 01 April 2011)|Other|1
4869225|NCT00833833|16781512|P3|Phase 1 (as of 01 April 2011)|Other|0
4869226|NCT00833833|16781513|P2|Phase 1 (as of 01 April 2011)|Other|3
4869227|NCT00833833|16781514|P1|Phase 1 (as of 01 April 2011)|Other|1
4869228|NCT00833833|16781509|P6|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869229|NCT00833833|16781510|P5|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869230|NCT00833833|16781511|P4|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869231|NCT00833833|16781512|P3|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
4869232|NCT00833833|16781513|P2|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0
4869233|NCT00833833|16781514|P1|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1
4869234|NCT00833833|16781509|P6|Phase 1 (as of 01 April 2011)|Death|0
4869235|NCT00833833|16781510|P5|Phase 1 (as of 01 April 2011)|Death|0
4869236|NCT00833833|16781511|P4|Phase 1 (as of 01 April 2011)|Death|0
4869237|NCT00833833|16781512|P3|Phase 1 (as of 01 April 2011)|Death|2
4869238|NCT00833833|16781513|P2|Phase 1 (as of 01 April 2011)|Death|1
4869239|NCT00833833|16781514|P1|Phase 1 (as of 01 April 2011)|Death|0
4869240|NCT00833833|16781509|P6|Phase 1 (as of 01 April 2011)|Adverse Event|0
4869241|NCT00833833|16781510|P5|Phase 1 (as of 01 April 2011)|Adverse Event|0
4869242|NCT00833833|16781511|P4|Phase 1 (as of 01 April 2011)|Adverse Event|1
4869243|NCT00833833|16781512|P3|Phase 1 (as of 01 April 2011)|Adverse Event|2
4869244|NCT00833833|16781513|P2|Phase 1 (as of 01 April 2011)|Adverse Event|0
4869245|NCT00833833|16781514|P1|Phase 1 (as of 01 April 2011)|Adverse Event|1
4869246|NCT00833833|16781509|P6|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
4869247|NCT00833833|16781510|P5|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0
4869248|NCT00833833|16781511|P4|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
4869249|NCT00833833|16781512|P3|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2
4869250|NCT00833833|16781513|P2|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
4869251|NCT00833833|16781514|P1|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1
4869252|NCT00833833|16781509|P6|Phase 1 (as of 01 April 2011)|Still active in study|0
4869253|NCT00833833|16781510|P5|Phase 1 (as of 01 April 2011)|Still active in study|0
4869254|NCT00833833|16781511|P4|Phase 1 (as of 01 April 2011)|Still active in study|2
4869255|NCT00833833|16781512|P3|Phase 1 (as of 01 April 2011)|Still active in study|2
4869256|NCT00833833|16781513|P2|Phase 1 (as of 01 April 2011)|Still active in study|0
4869257|NCT00833833|16781514|P1|Phase 1 (as of 01 April 2011)|Still active in study|0
4869258|NCT00833794|16781554|P2|Double-blind Phase|Administrative reason|3
4869259|NCT00833794|16781555|P1|Double-blind Phase|Administrative reason|1
4869260|NCT00833794|16781554|P2|Double-blind Phase|Physician Decision|7
4869261|NCT00833794|16781555|P1|Double-blind Phase|Physician Decision|4
4869262|NCT00833794|16781554|P2|Double-blind Phase|Withdrawal by Subject|6
4869263|NCT00833794|16781555|P1|Double-blind Phase|Withdrawal by Subject|23
4869264|NCT00833794|16781554|P2|Double-blind Phase|Lack of Efficacy|22
4869265|NCT00833794|16781555|P1|Double-blind Phase|Lack of Efficacy|34
4869266|NCT00833794|16781554|P2|Double-blind Phase|Adverse Event|11
4869267|NCT00833794|16781555|P1|Double-blind Phase|Adverse Event|44
4869268|NCT00833794|16781554|P2|Open-label Phase|enrolled in error (immediately D/C)|0
4869269|NCT00833794|16781555|P1|Open-label Phase|enrolled in error (immediately D/C)|1
4869270|NCT00833794|16781554|P2|Open-label Phase|Did not complete wash-out period|0
4869271|NCT00833794|16781555|P1|Open-label Phase|Did not complete wash-out period|12
4869272|NCT00833794|16781554|P2|Open-label Phase|Protocol Violation|0
4869273|NCT00833794|16781555|P1|Open-label Phase|Protocol Violation|47
4869274|NCT00833794|16781554|P2|Open-label Phase|Administrative reason|0
4869275|NCT00833794|16781555|P1|Open-label Phase|Administrative reason|1
4869276|NCT00833794|16781554|P2|Open-label Phase|Physician Decision|0
4869277|NCT00833794|16781555|P1|Open-label Phase|Physician Decision|20
4869278|NCT00833794|16781554|P2|Open-label Phase|Withdrawal by Subject|0
4869279|NCT00833794|16781555|P1|Open-label Phase|Withdrawal by Subject|48
4869280|NCT00833794|16781554|P2|Open-label Phase|Lack of Efficacy|0
4869281|NCT00833794|16781555|P1|Open-label Phase|Lack of Efficacy|28
4869282|NCT00833794|16781554|P2|Open-label Phase|Adverse Event|0
4869283|NCT00833794|16781555|P1|Open-label Phase|Adverse Event|225
4869284|NCT00833755|16781599|P4|Overall Study|Subject had scheduling issues|0
4869285|NCT00833755|16781600|P3|Overall Study|Subject had scheduling issues|0
4869286|NCT00833755|16781601|P2|Overall Study|Subject had scheduling issues|1
4869287|NCT00833755|16781602|P1|Overall Study|Subject had scheduling issues|0
4869288|NCT00833755|16781599|P4|Overall Study|Physician Decision|6
4869289|NCT00833755|16781600|P3|Overall Study|Physician Decision|2
4869290|NCT00833755|16781601|P2|Overall Study|Physician Decision|4
4869291|NCT00833755|16781602|P1|Overall Study|Physician Decision|4
4869292|NCT00833703|16781622|P2|Overall Study|Parent(s)/guardian(s)'s request|1
4869293|NCT00833703|16781623|P1|Overall Study|Parent(s)/guardian(s)'s request|0
4869294|NCT00833690|16781636|P3|Overall Study|Discontinued study drug|0
4869295|NCT00833690|16781637|P2|Overall Study|Discontinued study drug|2
4869296|NCT00833690|16781638|P1|Overall Study|Discontinued study drug|3
4869297|NCT00833690|16781636|P3|Overall Study|Withdrawal by Subject|0
4869298|NCT00833690|16781637|P2|Overall Study|Withdrawal by Subject|0
4869299|NCT00833690|16781638|P1|Overall Study|Withdrawal by Subject|1
4869300|NCT00833638|16781774|P3|Phase 3: Open-label Extension Phase|Protocol Violation|2
4869301|NCT00833638|16781775|P2|Phase 3: Open-label Extension Phase|Protocol Violation|1
4869302|NCT00833638|16781776|P1|Phase 3: Open-label Extension Phase|Protocol Violation|0
4869303|NCT00833638|16781774|P3|Phase 3: Open-label Extension Phase|Lost to Follow-up|0
4869304|NCT00833638|16781775|P2|Phase 3: Open-label Extension Phase|Lost to Follow-up|2
4869305|NCT00833638|16781776|P1|Phase 3: Open-label Extension Phase|Lost to Follow-up|1
4869306|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2
4869307|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
4869308|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1
4869309|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2
4869310|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
4869311|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0
4869312|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
4869313|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
4869314|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Protocol Violation|3
4869315|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Physician Decision|0
4869316|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Physician Decision|0
4869317|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Physician Decision|1
4869318|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
4869319|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2
4869320|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1
4869321|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1
4869322|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2
4869323|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3
4869324|NCT00833638|16781774|P3|Phase 2: Double-blind Treatment Phase|Adverse Event|0
4869325|NCT00833638|16781775|P2|Phase 2: Double-blind Treatment Phase|Adverse Event|2
4869326|NCT00833638|16781776|P1|Phase 2: Double-blind Treatment Phase|Adverse Event|1
4869327|NCT00833560|16781827|P1|Overall Study|Other|5
4869328|NCT00833560|16781827|P1|Overall Study|Pregression of other disease|1
4869329|NCT00833560|16781827|P1|Overall Study|Death|2
4869330|NCT00833560|16781827|P1|Overall Study|Lack of Efficacy|4
4869331|NCT00833560|16781827|P1|Overall Study|Protocol Violation|6
4869332|NCT00833560|16781827|P1|Overall Study|Adverse Event|11
4869333|NCT00833560|16781827|P1|Overall Study|Toxicity|13
4869334|NCT00833547|16781836|P2|Overall Study|Withdrawal by Subject|2
4869335|NCT00833547|16781837|P1|Overall Study|Withdrawal by Subject|2
4869336|NCT00833482|16781858|P6|Days 21-30|Withdrawal by Subject|0
4869337|NCT00833482|16781859|P5|Days 21-30|Withdrawal by Subject|1
4869338|NCT00833482|16781860|P4|Days 21-30|Withdrawal by Subject|0
4869339|NCT00833482|16781861|P3|Days 21-30|Withdrawal by Subject|0
4869340|NCT00833482|16781862|P2|Days 21-30|Withdrawal by Subject|0
4869341|NCT00833482|16781863|P1|Days 21-30|Withdrawal by Subject|0
4869342|NCT00833482|16781858|P6|Days 21-30|Adverse Event|0
4869343|NCT00833482|16781859|P5|Days 21-30|Adverse Event|0
4869344|NCT00833482|16781860|P4|Days 21-30|Adverse Event|0
4869345|NCT00833482|16781861|P3|Days 21-30|Adverse Event|1
4869346|NCT00833482|16781862|P2|Days 21-30|Adverse Event|0
4869347|NCT00833482|16781863|P1|Days 21-30|Adverse Event|0
4869348|NCT00833482|16781858|P6|Days 11-20|Withdrawal by Subject|0
4869349|NCT00833482|16781859|P5|Days 11-20|Withdrawal by Subject|0
4869350|NCT00833482|16781860|P4|Days 11-20|Withdrawal by Subject|0
4869351|NCT00833482|16781861|P3|Days 11-20|Withdrawal by Subject|0
4869352|NCT00833482|16781862|P2|Days 11-20|Withdrawal by Subject|1
4869353|NCT00833482|16781863|P1|Days 11-20|Withdrawal by Subject|0
4869354|NCT00833482|16781858|P6|Days 11-20|Adverse Event|0
4869355|NCT00833482|16781859|P5|Days 11-20|Adverse Event|0
4869356|NCT00833482|16781860|P4|Days 11-20|Adverse Event|0
4869357|NCT00833482|16781861|P3|Days 11-20|Adverse Event|0
4869358|NCT00833482|16781862|P2|Days 11-20|Adverse Event|2
4869359|NCT00833482|16781863|P1|Days 11-20|Adverse Event|0
4869360|NCT00833469|16781919|P1|Overall Study|Lost to Follow-up|1
4869361|NCT00833469|16781919|P1|Overall Study|Withdrawal by Subject|1
4869362|NCT00833417|16781942|P2|Overall Study|Reason Not Specified|1
4869363|NCT00833417|16781943|P1|Overall Study|Reason Not Specified|0
4869364|NCT00833417|16781942|P2|Overall Study|Disease Progression|17
4869365|NCT00833417|16781943|P1|Overall Study|Disease Progression|18
4869366|NCT00833417|16781942|P2|Overall Study|Sponsor Decision to Terminate Study|2
4869367|NCT00833417|16781943|P1|Overall Study|Sponsor Decision to Terminate Study|1
4869368|NCT00833417|16781942|P2|Overall Study|Patient Decision to Withdraw|23
4869369|NCT00833417|16781943|P1|Overall Study|Patient Decision to Withdraw|4
4869370|NCT00833417|16781942|P2|Overall Study|Physician Decision to Withdraw Patient|7
4869371|NCT00833417|16781943|P1|Overall Study|Physician Decision to Withdraw Patient|3
4869372|NCT00833417|16781942|P2|Overall Study|Lost to Follow-up|2
4869373|NCT00833417|16781943|P1|Overall Study|Lost to Follow-up|1
4869374|NCT00833417|16781942|P2|Overall Study|Death|3
4869375|NCT00833417|16781943|P1|Overall Study|Death|1
4869376|NCT00833417|16781942|P2|Overall Study|Adverse Event|16
4869377|NCT00833417|16781943|P1|Overall Study|Adverse Event|5
4869378|NCT00833261|16781967|P1|Overall Study|Withdrawal by Subject|4
4869379|NCT00833248|16781974|P2|Overall Study|Withdrawal by Subject|1
4869380|NCT00833248|16781975|P1|Overall Study|Withdrawal by Subject|0
4869381|NCT00833248|16781974|P2|Overall Study|Protocol Violation|2
4869382|NCT00833248|16781975|P1|Overall Study|Protocol Violation|1
4869383|NCT00833248|16781974|P2|Overall Study|Adverse Event|0
4869384|NCT00833248|16781975|P1|Overall Study|Adverse Event|3
4869385|NCT00833105|16781997|P1|Overall Study|Adverse Event|2
4869386|NCT00833105|16781997|P1|Overall Study|Withdrawal by Subject|1
4869387|NCT00833092|16782015|P2|Overall Study|constipation|1
4869388|NCT00833092|16782016|P1|Overall Study|constipation|0
4869389|NCT00833092|16782015|P2|Overall Study|Diarrhea|2
4869390|NCT00833092|16782016|P1|Overall Study|Diarrhea|0
4869391|NCT00833092|16782015|P2|Overall Study|Protocol Violation|1
4869392|NCT00833092|16782016|P1|Overall Study|Protocol Violation|2
4869393|NCT00833092|16782015|P2|Overall Study|Withdrawal by Subject|3
4869394|NCT00833092|16782016|P1|Overall Study|Withdrawal by Subject|2
4869395|NCT00833053|16782024|P2|Overall Study|Protocol Violation|1
4869396|NCT00833053|16782025|P1|Overall Study|Protocol Violation|2
4869397|NCT00833053|16782024|P2|Overall Study|Withdrawal by Subject|1
4869398|NCT00833053|16782025|P1|Overall Study|Withdrawal by Subject|0
4869399|NCT00833053|16782024|P2|Overall Study|Treatment Failure|1
4869400|NCT00833053|16782025|P1|Overall Study|Treatment Failure|3
4869401|NCT00833053|16782024|P2|Overall Study|Adverse Event|0
4869402|NCT00833053|16782025|P1|Overall Study|Adverse Event|4
4869403|NCT00833040|16782043|P6|Overall Study|Adverse Event|1
4869404|NCT00833040|16782044|P5|Overall Study|Adverse Event|0
4869405|NCT00833040|16782045|P4|Overall Study|Adverse Event|0
4869406|NCT00833040|16782046|P3|Overall Study|Adverse Event|0
4869407|NCT00833040|16782047|P2|Overall Study|Adverse Event|0
4869408|NCT00833040|16782048|P1|Overall Study|Adverse Event|0
4869409|NCT00833027|16782053|P1|Overall Study|Missing|10
4869410|NCT00833027|16782053|P1|Overall Study|Withdrawal by Subject|16
4869411|NCT00833027|16782053|P1|Overall Study|Protocol Violation|115
4869412|NCT00833027|16782053|P1|Overall Study|Lost to Follow-up|24
4869413|NCT00833027|16782053|P1|Overall Study|Lack of Efficacy|12
4869414|NCT00833027|16782053|P1|Overall Study|Death|1
4869415|NCT00833027|16782053|P1|Overall Study|Adverse Event|33
4869416|NCT00832975|16782058|P1|Overall Study|Other reasons|14
4869417|NCT00832975|16782058|P1|Overall Study|Withdrawal by Subject|3
4869418|NCT00832975|16782058|P1|Overall Study|Physician Decision|4
4869419|NCT00832975|16782058|P1|Overall Study|Death|5
4869420|NCT00832975|16782058|P1|Overall Study|Protocol Violation|6
4869421|NCT00832975|16782058|P1|Overall Study|Lost to Follow-up|7
4869422|NCT00832819|16782072|P3|Overall Study|Protocol Violation|1
4869423|NCT00832819|16782073|P2|Overall Study|Protocol Violation|0
4869424|NCT00832819|16782074|P1|Overall Study|Protocol Violation|0
4869425|NCT00832819|16782072|P3|Overall Study|Adverse Event|0
4869426|NCT00832819|16782073|P2|Overall Study|Adverse Event|1
4869427|NCT00832819|16782074|P1|Overall Study|Adverse Event|0
4869428|NCT00832780|16782080|P1|Overall Study|Physician Decision|1
4869429|NCT00832780|16782080|P1|Overall Study|other complicating condition|2
4869430|NCT00832780|16782080|P1|Overall Study|no reason given|2
4869431|NCT00832780|16782080|P1|Overall Study|Lost to Follow-up|4
4869432|NCT00832780|16782080|P1|Overall Study|Death|16
4869433|NCT00832650|16782122|P3|Overall Study|Randomized but not treated|1
4869434|NCT00832650|16782123|P2|Overall Study|Randomized but not treated|0
4869435|NCT00832650|16782124|P1|Overall Study|Randomized but not treated|0
4869436|NCT00832624|16782164|P1|Overall Study|Study Terminated|10
4869437|NCT00832585|16782174|P1|Overall Study|Lost to Follow-up|1
4869438|NCT00832585|16782174|P1|Overall Study|Withdrawal by Subject|1
4869439|NCT00832455|16782199|P1|Overall Study|Patient moved|1
4869440|NCT00832455|16782199|P1|Overall Study|No improvement|3
4869441|NCT00832455|16782199|P1|Overall Study|Parent dissatisfied|1
4869442|NCT00832455|16782199|P1|Overall Study|Parent misunderstood study|1
4869443|NCT00832455|16782199|P1|Overall Study|Stopped Medication|4
4869444|NCT00832455|16782199|P1|Overall Study|Screening Failure|2
4869445|NCT00832455|16782199|P1|Overall Study|Withdrawal by Subject|17
4869446|NCT00832455|16782199|P1|Overall Study|Protocol Violation|4
4869447|NCT00832455|16782199|P1|Overall Study|Lost to Follow-up|26
4869448|NCT00832455|16782199|P1|Overall Study|Adverse Event|13
4869449|NCT00832416|16782223|P4|Overall Study|Death|0
4869450|NCT00832416|16782224|P3|Overall Study|Death|0
4869451|NCT00832416|16782225|P2|Overall Study|Death|0
4869452|NCT00832416|16782226|P1|Overall Study|Death|1
4869453|NCT00832416|16782223|P4|Overall Study|Adverse Event|10
4869454|NCT00832416|16782224|P3|Overall Study|Adverse Event|41
4869455|NCT00832416|16782225|P2|Overall Study|Adverse Event|19
4869456|NCT00832416|16782226|P1|Overall Study|Adverse Event|21
4869457|NCT00832416|16782223|P4|Overall Study|Administrative|1
4869458|NCT00832416|16782224|P3|Overall Study|Administrative|0
4869459|NCT00832416|16782225|P2|Overall Study|Administrative|0
4869460|NCT00832416|16782226|P1|Overall Study|Administrative|0
4869461|NCT00832416|16782223|P4|Overall Study|Physician Decision|10
4869462|NCT00832416|16782224|P3|Overall Study|Physician Decision|5
4869463|NCT00832416|16782225|P2|Overall Study|Physician Decision|12
4869464|NCT00832416|16782226|P1|Overall Study|Physician Decision|2
4869465|NCT00832416|16782223|P4|Overall Study|Withdrawal by Subject|10
4869466|NCT00832416|16782224|P3|Overall Study|Withdrawal by Subject|2
4869467|NCT00832416|16782225|P2|Overall Study|Withdrawal by Subject|7
4869468|NCT00832416|16782226|P1|Overall Study|Withdrawal by Subject|5
4869469|NCT00832416|16782223|P4|Overall Study|Lack of Efficacy|52
4869470|NCT00832416|16782224|P3|Overall Study|Lack of Efficacy|13
4869471|NCT00832416|16782225|P2|Overall Study|Lack of Efficacy|15
4869472|NCT00832416|16782226|P1|Overall Study|Lack of Efficacy|17
4869473|NCT00832377|16782277|P1|Overall Study|Protocol Violation|1
4869474|NCT00832091|16782323|P2|Overall Study|Prohibited Medication|0
4869475|NCT00832091|16782324|P1|Overall Study|Prohibited Medication|1
4869476|NCT00832091|16782323|P2|Overall Study|Withdrawal by Subject|1
4869477|NCT00832091|16782324|P1|Overall Study|Withdrawal by Subject|2
4869478|NCT00832091|16782323|P2|Overall Study|Protocol Violation|0
4869479|NCT00832091|16782324|P1|Overall Study|Protocol Violation|1
4869480|NCT00832091|16782323|P2|Overall Study|Adverse Event|1
4869481|NCT00832091|16782324|P1|Overall Study|Adverse Event|1
4869482|NCT00832078|16782332|P2|Test Day 2 - 2 Period|Lack of Efficacy|0
4869483|NCT00832078|16782333|P1|Test Day 2 - 2 Period|Lack of Efficacy|1
4869484|NCT00832078|16782332|P2|Test Day 1-2 Period|Lack of Efficacy|2
4869485|NCT00832078|16782333|P1|Test Day 1-2 Period|Lack of Efficacy|0
4869486|NCT00832000|16782339|P2|Overall Study|No calls to IVR in period 2|0
4869487|NCT00832000|16782340|P1|Overall Study|No calls to IVR in period 2|2
4869488|NCT00832000|16782339|P2|Overall Study|No calls to IVR in either period|1
4869489|NCT00832000|16782340|P1|Overall Study|No calls to IVR in either period|1
4869490|NCT00832000|16782339|P2|Overall Study|Withdrawal by Subject|0
4869491|NCT00832000|16782340|P1|Overall Study|Withdrawal by Subject|1
4869492|NCT00832000|16782339|P2|Overall Study|Adverse Event|0
4869493|NCT00832000|16782340|P1|Overall Study|Adverse Event|2
4869494|NCT00831844|16782401|P10|Overall Study|Ineligible|0
4869495|NCT00831844|16782402|P9|Overall Study|Ineligible|0
4869496|NCT00831844|16782403|P8|Overall Study|Ineligible|0
4869497|NCT00831844|16782404|P7|Overall Study|Ineligible|0
4869498|NCT00831844|16782405|P6|Overall Study|Ineligible|0
4869499|NCT00831844|16782406|P5|Overall Study|Ineligible|1
4869500|NCT00831844|16782407|P4|Overall Study|Ineligible|0
4869501|NCT00831844|16782408|P3|Overall Study|Ineligible|1
4869502|NCT00831844|16782409|P2|Overall Study|Ineligible|1
4869503|NCT00831844|16782410|P1|Overall Study|Ineligible|0
4869504|NCT00831844|16782401|P10|Overall Study|Withdrawal by Subject|0
4869505|NCT00831844|16782402|P9|Overall Study|Withdrawal by Subject|1
4869506|NCT00831844|16782403|P8|Overall Study|Withdrawal by Subject|1
4869507|NCT00831844|16782404|P7|Overall Study|Withdrawal by Subject|0
4869508|NCT00831844|16782405|P6|Overall Study|Withdrawal by Subject|0
4869509|NCT00831844|16782406|P5|Overall Study|Withdrawal by Subject|0
4869510|NCT00831844|16782407|P4|Overall Study|Withdrawal by Subject|0
4869511|NCT00831844|16782408|P3|Overall Study|Withdrawal by Subject|1
4869512|NCT00831844|16782409|P2|Overall Study|Withdrawal by Subject|0
4869513|NCT00831844|16782410|P1|Overall Study|Withdrawal by Subject|0
4869514|NCT00831844|16782401|P10|Overall Study|Physician Decision|0
4869515|NCT00831844|16782402|P9|Overall Study|Physician Decision|1
4869516|NCT00831844|16782403|P8|Overall Study|Physician Decision|0
4869517|NCT00831844|16782404|P7|Overall Study|Physician Decision|0
4869518|NCT00831844|16782405|P6|Overall Study|Physician Decision|1
4869519|NCT00831844|16782406|P5|Overall Study|Physician Decision|1
4869520|NCT00831844|16782407|P4|Overall Study|Physician Decision|1
4869521|NCT00831844|16782408|P3|Overall Study|Physician Decision|3
4869522|NCT00831844|16782409|P2|Overall Study|Physician Decision|1
4869523|NCT00831844|16782410|P1|Overall Study|Physician Decision|0
4869524|NCT00831844|16782401|P10|Overall Study|Lack of Efficacy|0
4869525|NCT00831844|16782402|P9|Overall Study|Lack of Efficacy|7
4869526|NCT00831844|16782403|P8|Overall Study|Lack of Efficacy|9
4869527|NCT00831844|16782404|P7|Overall Study|Lack of Efficacy|8
4869528|NCT00831844|16782405|P6|Overall Study|Lack of Efficacy|17
4869529|NCT00831844|16782406|P5|Overall Study|Lack of Efficacy|11
4869530|NCT00831844|16782407|P4|Overall Study|Lack of Efficacy|8
4869531|NCT00831844|16782408|P3|Overall Study|Lack of Efficacy|15
4869532|NCT00831844|16782409|P2|Overall Study|Lack of Efficacy|10
4869533|NCT00831844|16782410|P1|Overall Study|Lack of Efficacy|8
4869534|NCT00831844|16782401|P10|Overall Study|Death|0
4869535|NCT00831844|16782402|P9|Overall Study|Death|0
4869536|NCT00831844|16782403|P8|Overall Study|Death|0
4869537|NCT00831844|16782404|P7|Overall Study|Death|0
4869538|NCT00831844|16782405|P6|Overall Study|Death|0
4869539|NCT00831844|16782406|P5|Overall Study|Death|0
4869540|NCT00831844|16782407|P4|Overall Study|Death|1
4869541|NCT00831844|16782408|P3|Overall Study|Death|0
4869542|NCT00831844|16782409|P2|Overall Study|Death|0
4869543|NCT00831844|16782410|P1|Overall Study|Death|0
4869544|NCT00831844|16782401|P10|Overall Study|Adverse Event|0
4869545|NCT00831844|16782402|P9|Overall Study|Adverse Event|0
4869546|NCT00831844|16782403|P8|Overall Study|Adverse Event|0
4869547|NCT00831844|16782404|P7|Overall Study|Adverse Event|2
4869548|NCT00831844|16782405|P6|Overall Study|Adverse Event|1
4869549|NCT00831844|16782406|P5|Overall Study|Adverse Event|1
4869550|NCT00831844|16782407|P4|Overall Study|Adverse Event|0
4869551|NCT00831844|16782408|P3|Overall Study|Adverse Event|0
4869552|NCT00831844|16782409|P2|Overall Study|Adverse Event|0
4869553|NCT00831844|16782410|P1|Overall Study|Adverse Event|2
4869554|NCT00831792|16782432|P1|Overall Study|Lack of Efficacy|1
4869555|NCT00831792|16782432|P1|Overall Study|Death|1
4869556|NCT00831792|16782432|P1|Overall Study|Adverse Event|1
4869557|NCT00831792|16782432|P1|Overall Study|Not Eligible|3
4869558|NCT00831779|16782438|P2|Overall Study|No longer met criteria|1
4869559|NCT00831779|16782439|P1|Overall Study|No longer met criteria|0
4869560|NCT00831779|16782438|P2|Overall Study|Lost to Follow-up|0
4869561|NCT00831779|16782439|P1|Overall Study|Lost to Follow-up|1
4869562|NCT00831701|16782476|P2|Overall Study|Lost to Follow-up|3
4869563|NCT00831701|16782477|P1|Overall Study|Lost to Follow-up|1
4869564|NCT00831701|16782476|P2|Overall Study|Stone expulsion before first medication|2
4869565|NCT00831701|16782477|P1|Overall Study|Stone expulsion before first medication|2
4869566|NCT00831701|16782476|P2|Overall Study|Withdrawal by Subject|0
4869567|NCT00831701|16782477|P1|Overall Study|Withdrawal by Subject|2
4869568|NCT00831493|16782506|P1|Overall Study|Intractable nausea and vomiting|1
4869569|NCT00831441|16782516|P2|Follow Up (30 Days)|missing end of study status|1
4869570|NCT00831441|16782517|P1|Follow Up (30 Days)|missing end of study status|0
4869571|NCT00831441|16782516|P2|Follow Up (30 Days)|non-specified|26
4869572|NCT00831441|16782517|P1|Follow Up (30 Days)|non-specified|16
4869573|NCT00831441|16782516|P2|Follow Up (30 Days)|Death|86
4869574|NCT00831441|16782517|P1|Follow Up (30 Days)|Death|63
4869575|NCT00831441|16782516|P2|Follow Up (30 Days)|Lost to Follow-up|27
4869576|NCT00831441|16782517|P1|Follow Up (30 Days)|Lost to Follow-up|13
4869577|NCT00831441|16782516|P2|Follow Up (30 Days)|Withdrawal by Subject|34
4869578|NCT00831441|16782517|P1|Follow Up (30 Days)|Withdrawal by Subject|41
4869579|NCT00831441|16782516|P2|Randomized|non-specified|266
4869580|NCT00831441|16782517|P1|Randomized|non-specified|276
4869581|NCT00831441|16782516|P2|Randomized|poor/non-compliance|38
4869582|NCT00831441|16782517|P1|Randomized|poor/non-compliance|30
4869583|NCT00831441|16782516|P2|Randomized|Administrative reason by sponsor|2671
4869584|NCT00831441|16782517|P1|Randomized|Administrative reason by sponsor|2780
4869585|NCT00831441|16782516|P2|Randomized|Lost to Follow-up|35
4869586|NCT00831441|16782517|P1|Randomized|Lost to Follow-up|26
4869587|NCT00831441|16782516|P2|Randomized|Withdrawal by Subject|212
4869588|NCT00831441|16782517|P1|Randomized|Withdrawal by Subject|178
4869589|NCT00831441|16782516|P2|Randomized|No longer met criteria|19
4869590|NCT00831441|16782517|P1|Randomized|No longer met criteria|13
4869591|NCT00831441|16782516|P2|Randomized|Physician Decision|35
4869592|NCT00831441|16782517|P1|Randomized|Physician Decision|26
4869593|NCT00831441|16782516|P2|Randomized|Elective procedure|25
4869594|NCT00831441|16782517|P1|Randomized|Elective procedure|26
4869595|NCT00831441|16782516|P2|Randomized|Emergency procedure|2
4869596|NCT00831441|16782517|P1|Randomized|Emergency procedure|2
4869597|NCT00831441|16782516|P2|Randomized|Adverse Event|321
4869598|NCT00831441|16782517|P1|Randomized|Adverse Event|248
4869599|NCT00831441|16782516|P2|Randomized|Death|81
4869600|NCT00831441|16782517|P1|Randomized|Death|82
4869601|NCT00831415|16782549|P1|Overall Study|Death|1
4869602|NCT00831415|16782549|P1|Overall Study|Unsatisfactory response - Efficacy|4
4869603|NCT00831415|16782549|P1|Overall Study|Withdrawal by Subject|35
4869604|NCT00831415|16782549|P1|Overall Study|Protocol Violation|3
4869605|NCT00831415|16782549|P1|Overall Study|Lost to Follow-up|9
4869606|NCT00831415|16782549|P1|Overall Study|Physician Decision|6
4869607|NCT00831415|16782549|P1|Overall Study|Failed to return|3
4869608|NCT00831415|16782549|P1|Overall Study|Adverse Event|14
4869609|NCT00831389|16782558|P2|Overall Study|Withdrawal by Subject|1
4869610|NCT00831389|16782559|P1|Overall Study|Withdrawal by Subject|0
4869611|NCT00831311|16782585|P2|Overall Study|Withdrawal by Subject|4
4869612|NCT00831311|16782586|P1|Overall Study|Withdrawal by Subject|6
4869613|NCT00831311|16782585|P2|Overall Study|Physician Decision|1
4869614|NCT00831311|16782586|P1|Overall Study|Physician Decision|0
4869615|NCT00831311|16782585|P2|Overall Study|Lost to Follow-up|0
4869616|NCT00831311|16782586|P1|Overall Study|Lost to Follow-up|3
4869617|NCT00831311|16782585|P2|Overall Study|Definitive Contraindication|3
4869618|NCT00831311|16782586|P1|Overall Study|Definitive Contraindication|3
4869619|NCT00831233|16782623|P2|Overall Study|Selection Criteria Not Met|0
4869620|NCT00831233|16782624|P1|Overall Study|Selection Criteria Not Met|2
4869621|NCT00831233|16782623|P2|Overall Study|Protocol Violation|0
4869622|NCT00831233|16782624|P1|Overall Study|Protocol Violation|1
4869623|NCT00831233|16782623|P2|Overall Study|Adverse Event|1
4869624|NCT00831233|16782624|P1|Overall Study|Adverse Event|0
4869625|NCT00831181|16782648|P1|Overall Study|Adverse Event|12
4869626|NCT00831129|16782661|P2|Overall Study|9 lost to follow-up reasons uknown|9
4869627|NCT00831129|16782662|P1|Overall Study|9 lost to follow-up reasons uknown|0
4869628|NCT00831129|16782661|P2|Overall Study|Adverse Event|1
4869629|NCT00831129|16782662|P1|Overall Study|Adverse Event|0
4869630|NCT00830960|16782704|P6|Overall Study|No study drug received|7
4869631|NCT00830960|16782705|P5|Overall Study|No study drug received|5
4869632|NCT00830960|16782706|P4|Overall Study|No study drug received|3
4869633|NCT00830960|16782707|P3|Overall Study|No study drug received|4
4869634|NCT00830960|16782708|P2|Overall Study|No study drug received|2
4869635|NCT00830960|16782709|P1|Overall Study|No study drug received|7
4869636|NCT00830960|16782704|P6|Overall Study|Sponsor Decision|7
4869637|NCT00830960|16782705|P5|Overall Study|Sponsor Decision|5
4869638|NCT00830960|16782706|P4|Overall Study|Sponsor Decision|4
4869639|NCT00830960|16782707|P3|Overall Study|Sponsor Decision|3
4869640|NCT00830960|16782708|P2|Overall Study|Sponsor Decision|2
4869641|NCT00830960|16782709|P1|Overall Study|Sponsor Decision|1
4869642|NCT00830960|16782704|P6|Overall Study|Withdrawal by Subject|21
4869643|NCT00830960|16782705|P5|Overall Study|Withdrawal by Subject|16
4869644|NCT00830960|16782706|P4|Overall Study|Withdrawal by Subject|23
4869645|NCT00830960|16782707|P3|Overall Study|Withdrawal by Subject|18
4869646|NCT00830960|16782708|P2|Overall Study|Withdrawal by Subject|19
4869647|NCT00830960|16782709|P1|Overall Study|Withdrawal by Subject|19
4869648|NCT00830960|16782704|P6|Overall Study|Lost to Follow-up|1
4869649|NCT00830960|16782705|P5|Overall Study|Lost to Follow-up|0
4869650|NCT00830960|16782706|P4|Overall Study|Lost to Follow-up|0
4869651|NCT00830960|16782707|P3|Overall Study|Lost to Follow-up|1
4869652|NCT00830960|16782708|P2|Overall Study|Lost to Follow-up|1
4869653|NCT00830960|16782709|P1|Overall Study|Lost to Follow-up|1
4869654|NCT00830960|16782704|P6|Overall Study|Death|1
4869655|NCT00830960|16782705|P5|Overall Study|Death|6
4869656|NCT00830960|16782706|P4|Overall Study|Death|2
4869657|NCT00830960|16782707|P3|Overall Study|Death|3
4869658|NCT00830960|16782708|P2|Overall Study|Death|4
4869659|NCT00830960|16782709|P1|Overall Study|Death|5
4869660|NCT00830947|16782825|P2|Overall Study|Lost to Follow-up|4
4869661|NCT00830947|16782826|P1|Overall Study|Lost to Follow-up|4
4869662|NCT00830869|16782844|P12|Period 2: Part 2|Other|0
4869663|NCT00830869|16782845|P11|Period 2: Part 2|Other|0
4869664|NCT00830869|16782846|P10|Period 2: Part 2|Other|1
4869665|NCT00830869|16782847|P9|Period 2: Part 2|Other|0
4869666|NCT00830869|16782848|P8|Period 2: Part 2|Other|0
4869667|NCT00830869|16782849|P7|Period 2: Part 2|Other|0
4869668|NCT00830869|16782850|P6|Period 2: Part 2|Other|0
4869669|NCT00830869|16782851|P5|Period 2: Part 2|Other|0
4869670|NCT00830869|16782852|P4|Period 2: Part 2|Other|0
4869671|NCT00830869|16782853|P3|Period 2: Part 2|Other|0
4869672|NCT00830869|16782854|P2|Period 2: Part 2|Other|0
4869673|NCT00830869|16782855|P1|Period 2: Part 2|Other|0
4869674|NCT00830869|16782844|P12|Period 2: Part 2|Progressive disease|15
4869675|NCT00830869|16782845|P11|Period 2: Part 2|Progressive disease|8
4869676|NCT00830869|16782846|P10|Period 2: Part 2|Progressive disease|12
4869677|NCT00830869|16782847|P9|Period 2: Part 2|Progressive disease|11
4869678|NCT00830869|16782848|P8|Period 2: Part 2|Progressive disease|14
4869679|NCT00830869|16782849|P7|Period 2: Part 2|Progressive disease|0
4869680|NCT00830869|16782850|P6|Period 2: Part 2|Progressive disease|0
4869681|NCT00830869|16782851|P5|Period 2: Part 2|Progressive disease|0
4869682|NCT00830869|16782852|P4|Period 2: Part 2|Progressive disease|0
4869683|NCT00830869|16782853|P3|Period 2: Part 2|Progressive disease|0
4869684|NCT00830869|16782854|P2|Period 2: Part 2|Progressive disease|0
4869685|NCT00830869|16782855|P1|Period 2: Part 2|Progressive disease|0
4869686|NCT00830869|16782844|P12|Period 2: Part 2|Symptomatic Deterioration|4
4869687|NCT00830869|16782845|P11|Period 2: Part 2|Symptomatic Deterioration|1
4869688|NCT00830869|16782846|P10|Period 2: Part 2|Symptomatic Deterioration|3
4869689|NCT00830869|16782847|P9|Period 2: Part 2|Symptomatic Deterioration|6
4869690|NCT00830869|16782848|P8|Period 2: Part 2|Symptomatic Deterioration|0
4869691|NCT00830869|16782849|P7|Period 2: Part 2|Symptomatic Deterioration|0
4869692|NCT00830869|16782850|P6|Period 2: Part 2|Symptomatic Deterioration|0
4869693|NCT00830869|16782851|P5|Period 2: Part 2|Symptomatic Deterioration|0
4869694|NCT00830869|16782852|P4|Period 2: Part 2|Symptomatic Deterioration|0
4869695|NCT00830869|16782853|P3|Period 2: Part 2|Symptomatic Deterioration|0
4869696|NCT00830869|16782854|P2|Period 2: Part 2|Symptomatic Deterioration|0
4869697|NCT00830869|16782855|P1|Period 2: Part 2|Symptomatic Deterioration|0
4869698|NCT00830869|16782844|P12|Period 2: Part 2|Adverse Event|0
4869699|NCT00830869|16782845|P11|Period 2: Part 2|Adverse Event|2
4869700|NCT00830869|16782846|P10|Period 2: Part 2|Adverse Event|2
4869701|NCT00830869|16782847|P9|Period 2: Part 2|Adverse Event|3
4869702|NCT00830869|16782848|P8|Period 2: Part 2|Adverse Event|4
4869703|NCT00830869|16782849|P7|Period 2: Part 2|Adverse Event|0
4869704|NCT00830869|16782850|P6|Period 2: Part 2|Adverse Event|0
4869705|NCT00830869|16782851|P5|Period 2: Part 2|Adverse Event|0
4869706|NCT00830869|16782852|P4|Period 2: Part 2|Adverse Event|0
4869707|NCT00830869|16782853|P3|Period 2: Part 2|Adverse Event|0
4869708|NCT00830869|16782854|P2|Period 2: Part 2|Adverse Event|0
4869709|NCT00830869|16782855|P1|Period 2: Part 2|Adverse Event|0
4869710|NCT00830869|16782844|P12|Period 2: Part 2|Withdrawal by Subject|1
4869711|NCT00830869|16782845|P11|Period 2: Part 2|Withdrawal by Subject|0
4869712|NCT00830869|16782846|P10|Period 2: Part 2|Withdrawal by Subject|1
4869713|NCT00830869|16782847|P9|Period 2: Part 2|Withdrawal by Subject|2
4869714|NCT00830869|16782848|P8|Period 2: Part 2|Withdrawal by Subject|1
4869715|NCT00830869|16782849|P7|Period 2: Part 2|Withdrawal by Subject|0
4869716|NCT00830869|16782850|P6|Period 2: Part 2|Withdrawal by Subject|0
4869717|NCT00830869|16782851|P5|Period 2: Part 2|Withdrawal by Subject|0
4869718|NCT00830869|16782852|P4|Period 2: Part 2|Withdrawal by Subject|0
4869719|NCT00830869|16782853|P3|Period 2: Part 2|Withdrawal by Subject|0
4869720|NCT00830869|16782854|P2|Period 2: Part 2|Withdrawal by Subject|0
4869721|NCT00830869|16782855|P1|Period 2: Part 2|Withdrawal by Subject|0
4869722|NCT00830869|16782844|P12|Period 2: Part 2|Protocol Violation|0
4869723|NCT00830869|16782845|P11|Period 2: Part 2|Protocol Violation|0
4869724|NCT00830869|16782846|P10|Period 2: Part 2|Protocol Violation|1
4869725|NCT00830869|16782847|P9|Period 2: Part 2|Protocol Violation|0
4869726|NCT00830869|16782848|P8|Period 2: Part 2|Protocol Violation|1
4869727|NCT00830869|16782849|P7|Period 2: Part 2|Protocol Violation|0
4869728|NCT00830869|16782850|P6|Period 2: Part 2|Protocol Violation|0
4869729|NCT00830869|16782851|P5|Period 2: Part 2|Protocol Violation|0
4869730|NCT00830869|16782852|P4|Period 2: Part 2|Protocol Violation|0
4869731|NCT00830869|16782853|P3|Period 2: Part 2|Protocol Violation|0
4869732|NCT00830869|16782854|P2|Period 2: Part 2|Protocol Violation|0
4869733|NCT00830869|16782855|P1|Period 2: Part 2|Protocol Violation|0
4869734|NCT00830869|16782844|P12|Period 1: Part 1|Progressive disease|0
4869735|NCT00830869|16782845|P11|Period 1: Part 1|Progressive disease|0
4869736|NCT00830869|16782846|P10|Period 1: Part 1|Progressive disease|0
4869737|NCT00830869|16782847|P9|Period 1: Part 1|Progressive disease|0
4869738|NCT00830869|16782848|P8|Period 1: Part 1|Progressive disease|0
4869739|NCT00830869|16782849|P7|Period 1: Part 1|Progressive disease|1
4869740|NCT00830869|16782850|P6|Period 1: Part 1|Progressive disease|4
4869741|NCT00830869|16782851|P5|Period 1: Part 1|Progressive disease|4
4869742|NCT00830869|16782852|P4|Period 1: Part 1|Progressive disease|6
4869743|NCT00830869|16782853|P3|Period 1: Part 1|Progressive disease|1
4869744|NCT00830869|16782854|P2|Period 1: Part 1|Progressive disease|0
4869745|NCT00830869|16782855|P1|Period 1: Part 1|Progressive disease|1
4869746|NCT00830869|16782844|P12|Period 1: Part 1|Adverse Event|0
4869747|NCT00830869|16782845|P11|Period 1: Part 1|Adverse Event|0
4869748|NCT00830869|16782846|P10|Period 1: Part 1|Adverse Event|0
4869749|NCT00830869|16782847|P9|Period 1: Part 1|Adverse Event|0
4869750|NCT00830869|16782848|P8|Period 1: Part 1|Adverse Event|0
4869751|NCT00830869|16782849|P7|Period 1: Part 1|Adverse Event|1
4869752|NCT00830869|16782850|P6|Period 1: Part 1|Adverse Event|1
4869753|NCT00830869|16782851|P5|Period 1: Part 1|Adverse Event|0
4869754|NCT00830869|16782852|P4|Period 1: Part 1|Adverse Event|0
4869755|NCT00830869|16782853|P3|Period 1: Part 1|Adverse Event|0
4869756|NCT00830869|16782854|P2|Period 1: Part 1|Adverse Event|0
4869757|NCT00830869|16782855|P1|Period 1: Part 1|Adverse Event|0
4869758|NCT00830869|16782844|P12|Period 1: Part 1|Withdrawal by Subject|0
4869759|NCT00830869|16782845|P11|Period 1: Part 1|Withdrawal by Subject|0
4869760|NCT00830869|16782846|P10|Period 1: Part 1|Withdrawal by Subject|0
4869761|NCT00830869|16782847|P9|Period 1: Part 1|Withdrawal by Subject|0
4869762|NCT00830869|16782848|P8|Period 1: Part 1|Withdrawal by Subject|0
4869763|NCT00830869|16782849|P7|Period 1: Part 1|Withdrawal by Subject|0
4869764|NCT00830869|16782850|P6|Period 1: Part 1|Withdrawal by Subject|0
4869765|NCT00830869|16782851|P5|Period 1: Part 1|Withdrawal by Subject|0
4869766|NCT00830869|16782852|P4|Period 1: Part 1|Withdrawal by Subject|0
4869767|NCT00830869|16782853|P3|Period 1: Part 1|Withdrawal by Subject|0
4869768|NCT00830869|16782854|P2|Period 1: Part 1|Withdrawal by Subject|1
4869769|NCT00830869|16782855|P1|Period 1: Part 1|Withdrawal by Subject|0
4869770|NCT00830869|16782844|P12|Period 1: Part 1|Symptomatic deterioration|0
4869771|NCT00830869|16782845|P11|Period 1: Part 1|Symptomatic deterioration|0
4869772|NCT00830869|16782846|P10|Period 1: Part 1|Symptomatic deterioration|0
4869773|NCT00830869|16782847|P9|Period 1: Part 1|Symptomatic deterioration|0
4869774|NCT00830869|16782848|P8|Period 1: Part 1|Symptomatic deterioration|0
4869775|NCT00830869|16782849|P7|Period 1: Part 1|Symptomatic deterioration|1
4869776|NCT00830869|16782850|P6|Period 1: Part 1|Symptomatic deterioration|1
4869777|NCT00830869|16782851|P5|Period 1: Part 1|Symptomatic deterioration|0
4869778|NCT00830869|16782852|P4|Period 1: Part 1|Symptomatic deterioration|1
4869779|NCT00830869|16782853|P3|Period 1: Part 1|Symptomatic deterioration|0
4869780|NCT00830869|16782854|P2|Period 1: Part 1|Symptomatic deterioration|0
4869781|NCT00830869|16782855|P1|Period 1: Part 1|Symptomatic deterioration|0
4869782|NCT00830804|16782991|P1|Overall Study|Unwilling to adhere to study requirement|1
4869783|NCT00830804|16782991|P1|Overall Study|Consent withdrawn|2
4869784|NCT00830804|16782991|P1|Overall Study|Unable to get to clinic|7
4869785|NCT00830804|16782991|P1|Overall Study|Death|1
4869786|NCT00830804|16782991|P1|Overall Study|Lost to Follow-up|4
4869787|NCT00830765|16783071|P2|Overall Study|Protocol Violation|2
4869788|NCT00830765|16783072|P1|Overall Study|Protocol Violation|3
4869789|NCT00830518|16783105|P2|Overall Study|Reason not Specified|1
4869790|NCT00830518|16783106|P1|Overall Study|Reason not Specified|8
4869791|NCT00830518|16783105|P2|Overall Study|Withdrawal by Patient|0
4869792|NCT00830518|16783106|P1|Overall Study|Withdrawal by Patient|2
4869793|NCT00830518|16783105|P2|Overall Study|Adverse Event|1
4869794|NCT00830518|16783106|P1|Overall Study|Adverse Event|14
4869795|NCT00830518|16783105|P2|Overall Study|Symptomatic Deterioration|1
4869796|NCT00830518|16783106|P1|Overall Study|Symptomatic Deterioration|4
4869797|NCT00830518|16783105|P2|Overall Study|Progressive Disease|8
4869798|NCT00830518|16783106|P1|Overall Study|Progressive Disease|18
4869799|NCT00830440|16783125|P2|Overall Study|Adverse Event|0
4869800|NCT00830440|16783126|P1|Overall Study|Adverse Event|2
4869801|NCT00830440|16783125|P2|Overall Study|unsuccessful procedure|0
4869802|NCT00830440|16783126|P1|Overall Study|unsuccessful procedure|4
4869803|NCT00830440|16783125|P2|Overall Study|Withdrawal by Subject|0
4869804|NCT00830440|16783126|P1|Overall Study|Withdrawal by Subject|1
4869805|NCT00830440|16783125|P2|Overall Study|Protocol Violation|0
4869806|NCT00830440|16783126|P1|Overall Study|Protocol Violation|1
4869807|NCT00830375|16783141|P1|Overall Study|Lost to Follow-up|1
4869808|NCT00830336|16783156|P2|Washout: 21 Days|Withdrawal by Subject|0
4869809|NCT00830336|16783157|P1|Washout: 21 Days|Withdrawal by Subject|1
4869810|NCT00830258|16783184|P2|Washout: 7 Days|Protocol Violation|0
4869811|NCT00830258|16783185|P1|Washout: 7 Days|Protocol Violation|1
4869812|NCT00830258|16783184|P2|First Intervention|Adverse Event|0
4869813|NCT00830258|16783185|P1|First Intervention|Adverse Event|1
4869814|NCT00830219|16783204|P2|Washout of 7 Days|Withdrawal by Subject|1
4869815|NCT00830219|16783205|P1|Washout of 7 Days|Withdrawal by Subject|1
4869816|NCT00830206|16783215|P2|Washout: 21 Days|Withdrawal by Subject|1
4869817|NCT00830206|16783216|P1|Washout: 21 Days|Withdrawal by Subject|1
4869818|NCT00830167|16783226|P2|Overall Study|Other|2
4869819|NCT00830167|16783227|P1|Overall Study|Other|2
4869820|NCT00830167|16783226|P2|Overall Study|Protocol Violation|1
4869821|NCT00830167|16783227|P1|Overall Study|Protocol Violation|0
4869822|NCT00830167|16783226|P2|Overall Study|Lost to Follow-up|1
4869823|NCT00830167|16783227|P1|Overall Study|Lost to Follow-up|0
4869824|NCT00830167|16783226|P2|Overall Study|Withdrawal by Subject|0
4869825|NCT00830167|16783227|P1|Overall Study|Withdrawal by Subject|2
4869826|NCT00830167|16783226|P2|Overall Study|Not meeting entrance criteria|5
4869827|NCT00830167|16783227|P1|Overall Study|Not meeting entrance criteria|2
4869828|NCT00830167|16783226|P2|Overall Study|Adverse Event|24
4869829|NCT00830167|16783227|P1|Overall Study|Adverse Event|8
4869830|NCT00830167|16783226|P2|Overall Study|Lack of Efficacy|10
4869831|NCT00830167|16783227|P1|Overall Study|Lack of Efficacy|26
4869832|NCT00830128|16783297|P1|Overall Study|Operating a vehicle|1
4869833|NCT00830128|16783297|P1|Overall Study|Work obligation|1
4869834|NCT00830128|16783297|P1|Overall Study|Relocation|1
4869835|NCT00830128|16783297|P1|Overall Study|Family obligation|1
4869836|NCT00830128|16783297|P1|Overall Study|Withdrawal by Subject|2
4869837|NCT00830128|16783297|P1|Overall Study|Protocol Violation|1
4869838|NCT00830128|16783297|P1|Overall Study|Lack of Efficacy|7
4869839|NCT00830128|16783297|P1|Overall Study|Adverse Event|5
4869840|NCT00830115|16783312|P1|Overall Study|Improvement/recovery|1
4869841|NCT00830115|16783312|P1|Overall Study|Adverse Event|2
4869842|NCT00830037|16783339|P2|Overall Study|Active when terminated by DSMB|14
4869843|NCT00830037|16783340|P1|Overall Study|Active when terminated by DSMB|15
4869844|NCT00830037|16783339|P2|Overall Study|Lost to Follow-up|2
4869845|NCT00830037|16783340|P1|Overall Study|Lost to Follow-up|1
4869846|NCT00830037|16783339|P2|Overall Study|Withdrawal by Subject|3
4869847|NCT00830037|16783340|P1|Overall Study|Withdrawal by Subject|2
4869848|NCT00830024|16783350|P2|Washout: 7 Days|Withdrawal by Subject|0
4869849|NCT00830024|16783351|P1|Washout: 7 Days|Withdrawal by Subject|1
4869850|NCT00829998|16783361|P2|Washout|Adverse Event|1
4869851|NCT00829998|16783362|P1|Washout|Adverse Event|0
4869852|NCT00829933|16783391|P4|Overall Study|withdrew before treatment started|9
4869853|NCT00829933|16783392|P3|Overall Study|withdrew before treatment started|2
4869941|NCT00829413|16783580|P1|Overall Study|Training Patients|67
4869854|NCT00829933|16783393|P2|Overall Study|withdrew before treatment started|1
4869855|NCT00829933|16783394|P1|Overall Study|withdrew before treatment started|5
4869856|NCT00829933|16783391|P4|Overall Study|Protocol Violation|0
4869857|NCT00829933|16783392|P3|Overall Study|Protocol Violation|0
4869858|NCT00829933|16783393|P2|Overall Study|Protocol Violation|1
4869859|NCT00829933|16783394|P1|Overall Study|Protocol Violation|2
4869860|NCT00829933|16783391|P4|Overall Study|Pregnancy|2
4869861|NCT00829933|16783392|P3|Overall Study|Pregnancy|0
4869862|NCT00829933|16783393|P2|Overall Study|Pregnancy|0
4869863|NCT00829933|16783394|P1|Overall Study|Pregnancy|0
4869864|NCT00829933|16783391|P4|Overall Study|Physician Decision|1
4869865|NCT00829933|16783392|P3|Overall Study|Physician Decision|8
4869866|NCT00829933|16783393|P2|Overall Study|Physician Decision|7
4869867|NCT00829933|16783394|P1|Overall Study|Physician Decision|5
4869868|NCT00829933|16783391|P4|Overall Study|Lack of Efficacy|0
4869869|NCT00829933|16783392|P3|Overall Study|Lack of Efficacy|0
4869870|NCT00829933|16783393|P2|Overall Study|Lack of Efficacy|1
4869871|NCT00829933|16783394|P1|Overall Study|Lack of Efficacy|0
4869872|NCT00829933|16783391|P4|Overall Study|Death|1
4869873|NCT00829933|16783392|P3|Overall Study|Death|1
4869874|NCT00829933|16783393|P2|Overall Study|Death|0
4869875|NCT00829933|16783394|P1|Overall Study|Death|0
4869876|NCT00829933|16783391|P4|Overall Study|Adverse Event|1
4869877|NCT00829933|16783392|P3|Overall Study|Adverse Event|2
4869878|NCT00829933|16783393|P2|Overall Study|Adverse Event|3
4869879|NCT00829933|16783394|P1|Overall Study|Adverse Event|2
4869880|NCT00829868|16783406|P2|Washout|Physician Decision|0
4869881|NCT00829868|16783407|P1|Washout|Physician Decision|1
4869882|NCT00829829|16783418|P3|Overall Study|Other than specified above|1
4869883|NCT00829829|16783419|P2|Overall Study|Other than specified above|2
4869884|NCT00829829|16783420|P1|Overall Study|Other than specified above|2
4869885|NCT00829829|16783418|P3|Overall Study|Lost to Follow-up|3
4869886|NCT00829829|16783419|P2|Overall Study|Lost to Follow-up|3
4869887|NCT00829829|16783420|P1|Overall Study|Lost to Follow-up|7
4869888|NCT00829829|16783418|P3|Overall Study|Decision by the Sponsor|2
4869889|NCT00829829|16783419|P2|Overall Study|Decision by the Sponsor|0
4869890|NCT00829829|16783420|P1|Overall Study|Decision by the Sponsor|1
4869891|NCT00829829|16783418|P3|Overall Study|Withdrawal by Subject|2
4869892|NCT00829829|16783419|P2|Overall Study|Withdrawal by Subject|4
4869893|NCT00829829|16783420|P1|Overall Study|Withdrawal by Subject|8
4869894|NCT00829829|16783418|P3|Overall Study|Adverse Event|3
4869895|NCT00829829|16783419|P2|Overall Study|Adverse Event|4
4869896|NCT00829829|16783420|P1|Overall Study|Adverse Event|4
4869897|NCT00829829|16783418|P3|Overall Study|Protocol Violation|0
4869898|NCT00829829|16783419|P2|Overall Study|Protocol Violation|3
4869899|NCT00829829|16783420|P1|Overall Study|Protocol Violation|0
4869900|NCT00829790|16783445|P2|Washout of 14 Days|Withdrawal by Subject|1
4869901|NCT00829790|16783446|P1|Washout of 14 Days|Withdrawal by Subject|0
4869902|NCT00829764|16783456|P2|First Intervention|Withdrawal by Subject|1
4869903|NCT00829764|16783457|P1|First Intervention|Withdrawal by Subject|1
4869904|NCT00829764|16783456|P2|First Intervention|Adverse Event|0
4869905|NCT00829764|16783457|P1|First Intervention|Adverse Event|1
4869906|NCT00829712|16783483|P2|Washout of 7 Days|Withdrawal by Subject|1
4869907|NCT00829712|16783484|P1|Washout of 7 Days|Withdrawal by Subject|0
4869908|NCT00829673|16783503|P2|Washout of 7 Days|Withdrawal by Subject|0
4869909|NCT00829673|16783504|P1|Washout of 7 Days|Withdrawal by Subject|1
4869910|NCT00829621|16783514|P2|Overall Study|Lost to Follow-up|4
4869911|NCT00829621|16783515|P1|Overall Study|Lost to Follow-up|3
4869912|NCT00829621|16783514|P2|Overall Study|Death|0
4869913|NCT00829621|16783515|P1|Overall Study|Death|1
4869914|NCT00829530|16783523|P2|Second Intervention|Intolerance to Venopuncture|0
4869915|NCT00829530|16783524|P1|Second Intervention|Intolerance to Venopuncture|1
4869916|NCT00829530|16783523|P2|First Intervention|Intolerance to Venopuncture|1
4869917|NCT00829530|16783524|P1|First Intervention|Intolerance to Venopuncture|0
4869918|NCT00829530|16783523|P2|First Intervention|Adverse Event|1
4869919|NCT00829530|16783524|P1|First Intervention|Adverse Event|0
4869920|NCT00829504|16783538|P2|Second Intervention|Physician Decision|0
4869921|NCT00829504|16783539|P1|Second Intervention|Physician Decision|1
4869922|NCT00829504|16783538|P2|Washout of 7 Days|Withdrawal by Subject|0
4869923|NCT00829504|16783539|P1|Washout of 7 Days|Withdrawal by Subject|1
4869924|NCT00829504|16783538|P2|First Intervention|Adverse Event|0
4869925|NCT00829504|16783539|P1|First Intervention|Adverse Event|1
4869926|NCT00829452|16783549|P2|Second Intervention|Physician Decision|1
4869927|NCT00829452|16783550|P1|Second Intervention|Physician Decision|0
4869928|NCT00829452|16783549|P2|Washout of 42 Days|Withdrawal by Subject|1
4869929|NCT00829452|16783550|P1|Washout of 42 Days|Withdrawal by Subject|0
4869930|NCT00829452|16783549|P2|First Intervention|Withdrawal by Subject|1
4869931|NCT00829452|16783550|P1|First Intervention|Withdrawal by Subject|0
4869932|NCT00829439|16783562|P4|Overall Study|Adverse Event|0
4869933|NCT00829439|16783563|P3|Overall Study|Adverse Event|1
4869934|NCT00829439|16783564|P2|Overall Study|Adverse Event|0
4869935|NCT00829439|16783565|P1|Overall Study|Adverse Event|0
4869936|NCT00829426|16783571|P2|Washout: 7 Days|Withdrawal by Subject|0
4869937|NCT00829426|16783572|P1|Washout: 7 Days|Withdrawal by Subject|1
4869938|NCT00829413|16783580|P1|Overall Study|Indeterminate diagnosis from truth stand|3
4869939|NCT00829413|16783580|P1|Overall Study|Technically inadequate truth standard|2
4869940|NCT00829413|16783580|P1|Overall Study|No truth standard procedure available|9
4869942|NCT00829413|16783580|P1|Overall Study|No study drug admimnistered|13
4869943|NCT00829387|16783629|P2|Overall Study|Disqualified by PI|0
4869944|NCT00829387|16783630|P1|Overall Study|Disqualified by PI|1
4869945|NCT00829387|16783629|P2|Overall Study|Withdrawal by Subject|3
4869946|NCT00829387|16783630|P1|Overall Study|Withdrawal by Subject|2
4869947|NCT00829309|16783648|P2|Washout: 7 Days|Protocol Violation|0
4869948|NCT00829309|16783649|P1|Washout: 7 Days|Protocol Violation|1
4869949|NCT00829296|16783659|P2|Overall Study|Adverse Event|4
4869950|NCT00829296|16783660|P1|Overall Study|Adverse Event|5
4869951|NCT00829283|16783674|P2|Overall Study|Lost to Follow-up|25
4869952|NCT00829283|16783675|P1|Overall Study|Lost to Follow-up|7
4869953|NCT00829244|16783685|P2|Overall Study|No embryo cleavage|2
4869954|NCT00829244|16783686|P1|Overall Study|No embryo cleavage|0
4869955|NCT00829244|16783685|P2|Overall Study|All embryos discarded|3
4869956|NCT00829244|16783686|P1|Overall Study|All embryos discarded|0
4869957|NCT00829244|16783685|P2|Overall Study|No fertilization|2
4869958|NCT00829244|16783686|P1|Overall Study|No fertilization|2
4869959|NCT00829244|16783685|P2|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6
4869960|NCT00829244|16783686|P1|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1
4869961|NCT00829244|16783685|P2|Overall Study|Lack of ovarian response to stimulation|5
4869962|NCT00829244|16783686|P1|Overall Study|Lack of ovarian response to stimulation|9
4869963|NCT00829244|16783685|P2|Overall Study|Protocol Violation|0
4869964|NCT00829244|16783686|P1|Overall Study|Protocol Violation|1
4869965|NCT00829244|16783685|P2|Overall Study|Adverse Event|3
4869966|NCT00829244|16783686|P1|Overall Study|Adverse Event|1
4869967|NCT00829179|16783716|P1|Overall Study|Withdrawal by Subject|1
4869968|NCT00829166|16783722|P2|Overall Study|Reason Not Specified|3
4869969|NCT00829166|16783723|P1|Overall Study|Reason Not Specified|3
4869970|NCT00829166|16783722|P2|Overall Study|Sponsor's Decision|98
4869971|NCT00829166|16783723|P1|Overall Study|Sponsor's Decision|137
4869972|NCT00829166|16783722|P2|Overall Study|Subject's Decision|55
4869973|NCT00829166|16783723|P1|Overall Study|Subject's Decision|41
4869974|NCT00829166|16783722|P2|Overall Study|Physician's Decision|3
4869975|NCT00829166|16783723|P1|Overall Study|Physician's Decision|4
4869976|NCT00829166|16783722|P2|Overall Study|Lost to Follow-up|4
4869977|NCT00829166|16783723|P1|Overall Study|Lost to Follow-up|5
4869978|NCT00829166|16783722|P2|Overall Study|Death|333
4869979|NCT00829166|16783723|P1|Overall Study|Death|305
4869980|NCT00829010|16783786|P5|Overall Study|Migrated/Moved from study area|0
4869981|NCT00829010|16783787|P4|Overall Study|Migrated/Moved from study area|5
4869982|NCT00829010|16783788|P3|Overall Study|Migrated/Moved from study area|0
4869983|NCT00829010|16783789|P2|Overall Study|Migrated/Moved from study area|4
4869984|NCT00829010|16783790|P1|Overall Study|Migrated/Moved from study area|3
4869985|NCT00829010|16783786|P5|Overall Study|Fatality|0
4869986|NCT00829010|16783787|P4|Overall Study|Fatality|3
4869987|NCT00829010|16783788|P3|Overall Study|Fatality|0
4869988|NCT00829010|16783789|P2|Overall Study|Fatality|4
4869989|NCT00829010|16783790|P1|Overall Study|Fatality|5
4869990|NCT00829010|16783786|P5|Overall Study|Lost to Follow-up|0
4869991|NCT00829010|16783787|P4|Overall Study|Lost to Follow-up|0
4869992|NCT00829010|16783788|P3|Overall Study|Lost to Follow-up|2
4869993|NCT00829010|16783789|P2|Overall Study|Lost to Follow-up|0
4869994|NCT00829010|16783790|P1|Overall Study|Lost to Follow-up|1
4869995|NCT00829010|16783786|P5|Overall Study|Withdrawal by Subject|2
4869996|NCT00829010|16783787|P4|Overall Study|Withdrawal by Subject|0
4869997|NCT00829010|16783788|P3|Overall Study|Withdrawal by Subject|1
4869998|NCT00829010|16783789|P2|Overall Study|Withdrawal by Subject|1
4869999|NCT00829010|16783790|P1|Overall Study|Withdrawal by Subject|0
4870000|NCT00829010|16783786|P5|Overall Study|Adverse Event|0
4870001|NCT00829010|16783787|P4|Overall Study|Adverse Event|0
4870002|NCT00829010|16783788|P3|Overall Study|Adverse Event|0
4870003|NCT00829010|16783789|P2|Overall Study|Adverse Event|0
4870004|NCT00829010|16783790|P1|Overall Study|Adverse Event|1
4870005|NCT00828984|16783955|P3|Overall Study|ConMed|1
4870006|NCT00828984|16783956|P2|Overall Study|ConMed|1
4870007|NCT00828984|16783957|P1|Overall Study|ConMed|1
4870008|NCT00828984|16783955|P3|Overall Study|Noncompliant|3
4870009|NCT00828984|16783956|P2|Overall Study|Noncompliant|2
4870010|NCT00828984|16783957|P1|Overall Study|Noncompliant|1
4870011|NCT00828984|16783955|P3|Overall Study|Medical Contraindication|0
4870012|NCT00828984|16783956|P2|Overall Study|Medical Contraindication|1
4870013|NCT00828984|16783957|P1|Overall Study|Medical Contraindication|0
4870014|NCT00828984|16783955|P3|Overall Study|Ineligable|0
4870015|NCT00828984|16783956|P2|Overall Study|Ineligable|2
4870016|NCT00828984|16783957|P1|Overall Study|Ineligable|1
4870017|NCT00828984|16783955|P3|Overall Study|Withdrawal by Subject|4
4870018|NCT00828984|16783956|P2|Overall Study|Withdrawal by Subject|4
4870019|NCT00828984|16783957|P1|Overall Study|Withdrawal by Subject|4
4870020|NCT00828984|16783955|P3|Overall Study|Lost to Follow-up|1
4870021|NCT00828984|16783956|P2|Overall Study|Lost to Follow-up|3
4870022|NCT00828984|16783957|P1|Overall Study|Lost to Follow-up|5
4870023|NCT00828984|16783955|P3|Overall Study|Adverse Event|0
4870024|NCT00828984|16783956|P2|Overall Study|Adverse Event|3
4870025|NCT00828984|16783957|P1|Overall Study|Adverse Event|2
4870026|NCT00828945|16783980|P1|Overall Study|Other|36
4870027|NCT00828945|16783980|P1|Overall Study|Participant was missing|1
4870028|NCT00828945|16783980|P1|Overall Study|Death|4
4870029|NCT00828750|16784012|P1|Overall Study|Normal PC Remained While No Treatment|1
4870030|NCT00828750|16784012|P1|Overall Study|Lack of Efficacy|3
4870031|NCT00828711|16784026|P3|Overall Study|Lost to Follow-up|0
4870032|NCT00828711|16784027|P2|Overall Study|Lost to Follow-up|0
4870033|NCT00828711|16784028|P1|Overall Study|Lost to Follow-up|1
4870034|NCT00828672|16784059|P2|Post-surgery (<30 Days)|No central review materials|1
4870035|NCT00828672|16784060|P1|Post-surgery (<30 Days)|No central review materials|0
4870036|NCT00828672|16784059|P2|Study Treatment|Complete response, no surgery|1
4870037|NCT00828672|16784060|P1|Study Treatment|Complete response, no surgery|1
4870038|NCT00828672|16784059|P2|Study Treatment|Adverse Event|1
4870039|NCT00828672|16784060|P1|Study Treatment|Adverse Event|0
4870040|NCT00828672|16784059|P2|Study Treatment|Lost to Follow-up|0
4870041|NCT00828672|16784060|P1|Study Treatment|Lost to Follow-up|1
4870042|NCT00828568|16784081|P3|Treated - Received at Least One Dose|Protocol Violation|3
4870043|NCT00828568|16784082|P2|Treated - Received at Least One Dose|Protocol Violation|5
4870044|NCT00828568|16784083|P1|Treated - Received at Least One Dose|Protocol Violation|9
4870045|NCT00828568|16784081|P3|Treated - Received at Least One Dose|Lost to Follow-up|1
4870046|NCT00828568|16784082|P2|Treated - Received at Least One Dose|Lost to Follow-up|5
4870047|NCT00828568|16784083|P1|Treated - Received at Least One Dose|Lost to Follow-up|1
4870048|NCT00828568|16784081|P3|Treated - Received at Least One Dose|Withdrawal by Subject|0
4870049|NCT00828568|16784082|P2|Treated - Received at Least One Dose|Withdrawal by Subject|11
4870050|NCT00828568|16784083|P1|Treated - Received at Least One Dose|Withdrawal by Subject|9
4870051|NCT00828568|16784081|P3|Treated - Received at Least One Dose|Adverse Event|1
4870052|NCT00828568|16784082|P2|Treated - Received at Least One Dose|Adverse Event|8
4870053|NCT00828568|16784083|P1|Treated - Received at Least One Dose|Adverse Event|11
4870054|NCT00828568|16784081|P3|Randomized|Withdrawal by Subject|2
4870055|NCT00828568|16784082|P2|Randomized|Withdrawal by Subject|0
4870056|NCT00828568|16784083|P1|Randomized|Withdrawal by Subject|1
4870057|NCT00828516|16784105|P1|Clinical Phase: Series 1|Withdrawal by Subject|2
4870058|NCT00828464|16784110|P1|Overall Study|Withdrawal by Subject|1
4870059|NCT00828451|16784127|P1|Overall Study|Deterioration in clinical status|1
4870060|NCT00828451|16784127|P1|Overall Study|Withdrawal by Subject|1
4870061|NCT00828451|16784127|P1|Overall Study|Lack of intravenous line|7
4870062|NCT00828451|16784127|P1|Overall Study|Death|2
4870063|NCT00828321|16784153|P2|Second Intervention|Protocol Violation|1
4870064|NCT00828321|16784154|P1|Second Intervention|Protocol Violation|0
4870065|NCT00828321|16784153|P2|Washout of 42 Days|Withdrawal by Subject|0
4870066|NCT00828321|16784154|P1|Washout of 42 Days|Withdrawal by Subject|2
4870067|NCT00828204|16784183|P2|Extension Study|Physician Decision|2
4870068|NCT00828204|16784184|P1|Extension Study|Physician Decision|0
4870069|NCT00828204|16784183|P2|Extension Study|Lost to Follow-up|1
4870070|NCT00828204|16784184|P1|Extension Study|Lost to Follow-up|0
4870071|NCT00828204|16784183|P2|Main Study: After Study Restart|Noncompliance|1
4870072|NCT00828204|16784184|P1|Main Study: After Study Restart|Noncompliance|0
4870073|NCT00828204|16784183|P2|Main Study: After Study Restart|Adverse Event|2
4870074|NCT00828204|16784184|P1|Main Study: After Study Restart|Adverse Event|0
4870075|NCT00828204|16784183|P2|Main Study: Prior to Study Suspension|Study Suspension|0
4870076|NCT00828204|16784184|P1|Main Study: Prior to Study Suspension|Study Suspension|11
4870077|NCT00828204|16784183|P2|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0
4870078|NCT00828204|16784184|P1|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2
4870079|NCT00828204|16784183|P2|Main Study: Prior to Study Suspension|Adverse Event|0
4870080|NCT00828204|16784184|P1|Main Study: Prior to Study Suspension|Adverse Event|1
4870081|NCT00828139|16784231|P4|Overall Study|Other|2
4870082|NCT00828139|16784232|P3|Overall Study|Other|5
4870083|NCT00828139|16784233|P2|Overall Study|Other|2
4870084|NCT00828139|16784234|P1|Overall Study|Other|4
4870085|NCT00828139|16784231|P4|Overall Study|Disease Progression|39
4870086|NCT00828139|16784232|P3|Overall Study|Disease Progression|35
4870087|NCT00828139|16784233|P2|Overall Study|Disease Progression|33
4870088|NCT00828139|16784234|P1|Overall Study|Disease Progression|24
4870089|NCT00828139|16784231|P4|Overall Study|Refusal unrelated to toxicity|3
4870090|NCT00828139|16784232|P3|Overall Study|Refusal unrelated to toxicity|5
4870091|NCT00828139|16784233|P2|Overall Study|Refusal unrelated to toxicity|4
4870092|NCT00828139|16784234|P1|Overall Study|Refusal unrelated to toxicity|3
4870093|NCT00828139|16784231|P4|Overall Study|Death|2
4870094|NCT00828139|16784232|P3|Overall Study|Death|0
4870095|NCT00828139|16784233|P2|Overall Study|Death|1
4870096|NCT00828139|16784234|P1|Overall Study|Death|2
4870097|NCT00828139|16784231|P4|Overall Study|Adverse Event|5
4870098|NCT00828139|16784232|P3|Overall Study|Adverse Event|10
4870099|NCT00828139|16784233|P2|Overall Study|Adverse Event|1
4870100|NCT00828139|16784234|P1|Overall Study|Adverse Event|8
4870101|NCT00828113|16784254|P2|Overall Study|Lost to Follow-up|5
4870102|NCT00828113|16784255|P1|Overall Study|Lost to Follow-up|3
4870103|NCT00828113|16784254|P2|Overall Study|Withdrawal by Subject|26
4870104|NCT00828113|16784255|P1|Overall Study|Withdrawal by Subject|27
4870105|NCT00828009|16784293|P1|Step 2 - Maintenance Therapy|Other|1
4870106|NCT00828009|16784293|P1|Step 2 - Maintenance Therapy|Complicating disease|2
4870107|NCT00828009|16784293|P1|Step 2 - Maintenance Therapy|Withdrawal by Subject|4
4870108|NCT00828009|16784293|P1|Step 2 - Maintenance Therapy|Death|1
4870109|NCT00828009|16784293|P1|Step 2 - Maintenance Therapy|Adverse Event|13
4870110|NCT00828009|16784293|P1|Step 2 - Maintenance Therapy|Progressive disease|12
4870111|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2
4870112|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2
4870113|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1
4870114|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11
4870115|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3
4870116|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|Death|2
4870117|NCT00828009|16784293|P1|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10
4870118|NCT00827931|16784336|P2|Overall Study|Other|0
4870119|NCT00827931|16784337|P1|Overall Study|Other|1
4870120|NCT00827931|16784336|P2|Overall Study|Withdrawal by Subject|1
4870121|NCT00827931|16784337|P1|Overall Study|Withdrawal by Subject|0
4870122|NCT00827931|16784336|P2|Overall Study|Lost to Follow-up|0
4870123|NCT00827931|16784337|P1|Overall Study|Lost to Follow-up|1
4870124|NCT00827931|16784336|P2|Overall Study|Adverse Event|0
4870125|NCT00827931|16784337|P1|Overall Study|Adverse Event|1
4870126|NCT00827931|16784336|P2|Overall Study|Death|5
4870127|NCT00827931|16784337|P1|Overall Study|Death|3
4870128|NCT00827918|16784358|P3|Overall Study|Withdrawal by Subject|6
4870129|NCT00827918|16784359|P2|Overall Study|Withdrawal by Subject|2
4870130|NCT00827918|16784360|P1|Overall Study|Withdrawal by Subject|6
4870131|NCT00827918|16784358|P3|Overall Study|Protocol Violation|0
4870132|NCT00827918|16784359|P2|Overall Study|Protocol Violation|1
4870133|NCT00827918|16784360|P1|Overall Study|Protocol Violation|0
4870134|NCT00827918|16784358|P3|Overall Study|Progressive Disease|0
4870135|NCT00827918|16784359|P2|Overall Study|Progressive Disease|1
4870136|NCT00827918|16784360|P1|Overall Study|Progressive Disease|1
4870137|NCT00827918|16784358|P3|Overall Study|Pregnancy|0
4870138|NCT00827918|16784359|P2|Overall Study|Pregnancy|1
4870139|NCT00827918|16784360|P1|Overall Study|Pregnancy|0
4870140|NCT00827918|16784358|P3|Overall Study|Physician Decision|0
4870141|NCT00827918|16784359|P2|Overall Study|Physician Decision|0
4870142|NCT00827918|16784360|P1|Overall Study|Physician Decision|1
4870143|NCT00827918|16784358|P3|Overall Study|Lack of Efficacy|15
4870144|NCT00827918|16784359|P2|Overall Study|Lack of Efficacy|4
4870145|NCT00827918|16784360|P1|Overall Study|Lack of Efficacy|16
4870146|NCT00827918|16784358|P3|Overall Study|Adverse Event|0
4870147|NCT00827918|16784359|P2|Overall Study|Adverse Event|0
4870148|NCT00827918|16784360|P1|Overall Study|Adverse Event|4
4870149|NCT00827827|16784388|P2|Overall Study|Burned with water at home|0
4870150|NCT00827827|16784389|P1|Overall Study|Burned with water at home|1
4870151|NCT00827827|16784388|P2|Overall Study|Transportation issues|0
4870152|NCT00827827|16784389|P1|Overall Study|Transportation issues|1
4870153|NCT00827827|16784388|P2|Overall Study|Gout|0
4870154|NCT00827827|16784389|P1|Overall Study|Gout|1
4870155|NCT00827827|16784388|P2|Overall Study|Another cerebrovascular accident (CVA)|0
4870156|NCT00827827|16784389|P1|Overall Study|Another cerebrovascular accident (CVA)|1
4870157|NCT00827827|16784388|P2|Overall Study|Fall at home- hospitalization|0
4870158|NCT00827827|16784389|P1|Overall Study|Fall at home- hospitalization|1
4870159|NCT00827827|16784388|P2|Overall Study|Lost to Follow-up|0
4870160|NCT00827827|16784389|P1|Overall Study|Lost to Follow-up|3
4870161|NCT00827632|16784433|P2|Overall Study|Early withdrawal|11
4870162|NCT00827632|16784434|P1|Overall Study|Early withdrawal|14
4870163|NCT00827632|16784433|P2|Overall Study|Lost to Follow-up|12
4870164|NCT00827632|16784434|P1|Overall Study|Lost to Follow-up|8
4870165|NCT00827606|16784446|P2|Overall Study|Adverse Event|2
4870166|NCT00827606|16784447|P1|Overall Study|Adverse Event|4
4870167|NCT00827606|16784446|P2|Overall Study|LDL below 2.59 mmol/L|12
4870168|NCT00827606|16784447|P1|Overall Study|LDL below 2.59 mmol/L|4
4870169|NCT00827606|16784446|P2|Overall Study|Other|13
4870170|NCT00827606|16784447|P1|Overall Study|Other|5
4870171|NCT00827606|16784446|P2|Overall Study|Pregnancy|1
4870172|NCT00827606|16784447|P1|Overall Study|Pregnancy|0
4870173|NCT00827606|16784446|P2|Overall Study|Withdrawal by Subject|6
4870174|NCT00827606|16784447|P1|Overall Study|Withdrawal by Subject|7
4870175|NCT00827606|16784446|P2|Overall Study|Lost to Follow-up|1
4870176|NCT00827606|16784447|P1|Overall Study|Lost to Follow-up|3
4870177|NCT00827606|16784446|P2|Overall Study|Protocol Violation|3
4870178|NCT00827606|16784447|P1|Overall Study|Protocol Violation|4
4870179|NCT00827567|16784508|P1|Overall Study|Progression of Disease/Screen Failure|4
4870180|NCT00827541|16784514|P2|Overall Study|Lack of effectiveness|0
4870181|NCT00827541|16784515|P1|Overall Study|Lack of effectiveness|1
4870182|NCT00827541|16784514|P2|Overall Study|Pathogen not susceptible|0
4870183|NCT00827541|16784515|P1|Overall Study|Pathogen not susceptible|1
4870184|NCT00827541|16784514|P2|Overall Study|Other|3
4870185|NCT00827541|16784515|P1|Overall Study|Other|1
4870186|NCT00827541|16784514|P2|Overall Study|Exitus|8
4870187|NCT00827541|16784515|P1|Overall Study|Exitus|1
4870188|NCT00827502|16784527|P1|Overall Study|Withdrawal by Subject|5
4870189|NCT00827502|16784527|P1|Overall Study|Lost to Follow-up|4
4870190|NCT00827502|16784527|P1|Overall Study|Adverse Event|1
4870191|NCT00827502|16784527|P1|Overall Study|randomized but not treated|11
4870192|NCT00827372|16784533|P1|Overall Study|Lack of Efficacy|3
4870193|NCT00827372|16784533|P1|Overall Study|Adverse Event|5
4870194|NCT00827242|16784548|P2|Overall Study|Lack of Efficacy|0
4870195|NCT00827242|16784549|P1|Overall Study|Lack of Efficacy|1
4870196|NCT00827242|16784548|P2|Overall Study|Death|0
4870197|NCT00827242|16784549|P1|Overall Study|Death|1
4870198|NCT00827242|16784548|P2|Overall Study|Physician Decision|0
4870199|NCT00827242|16784549|P1|Overall Study|Physician Decision|2
4870200|NCT00827242|16784548|P2|Overall Study|Entry Criteria Not Met|1
4870201|NCT00827242|16784549|P1|Overall Study|Entry Criteria Not Met|4
4870202|NCT00827242|16784548|P2|Overall Study|Adverse Event Excluding Death|1
4870203|NCT00827242|16784549|P1|Overall Study|Adverse Event Excluding Death|2
4870204|NCT00827242|16784548|P2|Overall Study|Lost to Follow-up|3
4870205|NCT00827242|16784549|P1|Overall Study|Lost to Follow-up|0
4870206|NCT00827242|16784548|P2|Overall Study|Protocol Violation|3
4870207|NCT00827242|16784549|P1|Overall Study|Protocol Violation|1
4870208|NCT00827242|16784548|P2|Overall Study|Withdrawal by Subject|4
4870209|NCT00827242|16784549|P1|Overall Study|Withdrawal by Subject|2
4870210|NCT00827112|16784587|P2|Overall Study|Other|3
4870211|NCT00827112|16784588|P1|Overall Study|Other|1
4870212|NCT00827112|16784587|P2|Overall Study|Randomized but not treated|3
4870213|NCT00827112|16784588|P1|Overall Study|Randomized but not treated|5
4870214|NCT00827112|16784587|P2|Overall Study|Withdrawal by Subject|1
4870215|NCT00827112|16784588|P1|Overall Study|Withdrawal by Subject|2
4870216|NCT00827112|16784587|P2|Overall Study|Protocol Violation|2
4870217|NCT00827112|16784588|P1|Overall Study|Protocol Violation|0
4870218|NCT00827112|16784587|P2|Overall Study|Pregnancy|1
4870219|NCT00827112|16784588|P1|Overall Study|Pregnancy|0
4870220|NCT00827112|16784587|P2|Overall Study|Lost to Follow-up|2
4870221|NCT00827112|16784588|P1|Overall Study|Lost to Follow-up|3
4870222|NCT00827112|16784587|P2|Overall Study|Lack of Efficacy|0
4870223|NCT00827112|16784588|P1|Overall Study|Lack of Efficacy|2
4870224|NCT00827112|16784587|P2|Overall Study|Adverse Event|0
4870225|NCT00827112|16784588|P1|Overall Study|Adverse Event|2
4870226|NCT00826943|16784641|P6|Overall Study|Withdrawal by Subject|0
4870227|NCT00826943|16784642|P5|Overall Study|Withdrawal by Subject|1
4870228|NCT00826943|16784643|P4|Overall Study|Withdrawal by Subject|0
4870229|NCT00826943|16784644|P3|Overall Study|Withdrawal by Subject|0
4870230|NCT00826943|16784645|P2|Overall Study|Withdrawal by Subject|0
4870231|NCT00826943|16784646|P1|Overall Study|Withdrawal by Subject|0
4870232|NCT00826748|16784667|P3|Overall Study|Samples Did Not pass QC|1
4870233|NCT00826748|16784668|P2|Overall Study|Samples Did Not pass QC|0
4870234|NCT00826748|16784669|P1|Overall Study|Samples Did Not pass QC|0
4870235|NCT00826748|16784667|P3|Overall Study|Physician Decision|1
4870236|NCT00826748|16784668|P2|Overall Study|Physician Decision|0
4870237|NCT00826748|16784669|P1|Overall Study|Physician Decision|0
4870238|NCT00826748|16784667|P3|Overall Study|Withdrawal by Subject|2
4870239|NCT00826748|16784668|P2|Overall Study|Withdrawal by Subject|0
4870240|NCT00826748|16784669|P1|Overall Study|Withdrawal by Subject|0
4870241|NCT00826618|16784677|P1|Overall Study|Withdrawal by Subject|1
4870242|NCT00826540|16784681|P1|Overall Study|Withdrawal by Subject|1
4870243|NCT00826540|16784681|P1|Overall Study|ineligible|3
4870244|NCT00826449|16784687|P1|Overall Study|Withdrawal by Subject|1
4870245|NCT00826449|16784687|P1|Overall Study|Disease Progression|4
4870246|NCT00826280|16784696|P3|Overall Study|One or more non-interpretable scan|1
4870247|NCT00826280|16784697|P2|Overall Study|One or more non-interpretable scan|1
4870248|NCT00826280|16784698|P1|Overall Study|One or more non-interpretable scan|0
4870249|NCT00826280|16784696|P3|Overall Study|Machine Failure|0
4870250|NCT00826280|16784697|P2|Overall Study|Machine Failure|1
4870251|NCT00826280|16784698|P1|Overall Study|Machine Failure|1
4870252|NCT00826280|16784696|P3|Overall Study|Interpretation Failure|0
4870253|NCT00826280|16784697|P2|Overall Study|Interpretation Failure|0
4870254|NCT00826280|16784698|P1|Overall Study|Interpretation Failure|1
4870255|NCT00826280|16784696|P3|Overall Study|Reversible ischemic defect not present|44
4870256|NCT00826280|16784697|P2|Overall Study|Reversible ischemic defect not present|40
4870257|NCT00826280|16784698|P1|Overall Study|Reversible ischemic defect not present|43
4870258|NCT00826280|16784696|P3|Overall Study|Sponsor discontinued subject or study|0
4870259|NCT00826280|16784697|P2|Overall Study|Sponsor discontinued subject or study|0
4870260|NCT00826280|16784698|P1|Overall Study|Sponsor discontinued subject or study|1
4870261|NCT00826280|16784696|P3|Overall Study|Lost to Follow-up|0
4870262|NCT00826280|16784697|P2|Overall Study|Lost to Follow-up|1
4870263|NCT00826280|16784698|P1|Overall Study|Lost to Follow-up|0
4870264|NCT00826280|16784696|P3|Overall Study|Adverse Event|0
4870265|NCT00826280|16784697|P2|Overall Study|Adverse Event|3
4870266|NCT00826280|16784698|P1|Overall Study|Adverse Event|1
4870267|NCT00826280|16784696|P3|Overall Study|Randomized but drug not received|1
4870268|NCT00826280|16784697|P2|Overall Study|Randomized but drug not received|0
4870269|NCT00826280|16784698|P1|Overall Study|Randomized but drug not received|1
4870270|NCT00826267|16784727|P3|Overall Study|Other Adverse Event|0
4870271|NCT00826267|16784728|P2|Overall Study|Other Adverse Event|0
4870272|NCT00826267|16784729|P1|Overall Study|Other Adverse Event|1
4870273|NCT00826241|16784747|P1|Overall Study|Pt opt not to proceed w/trmt|1
4870274|NCT00826241|16784747|P1|Overall Study|Pt unable to proceed to registration|1
4870275|NCT00826241|16784747|P1|Overall Study|Screen failure|2
4870276|NCT00826241|16784747|P1|Overall Study|Could not obtain records|1
4870277|NCT00826241|16784747|P1|Overall Study|Lost to Follow-up|9
4870278|NCT00826241|16784747|P1|Overall Study|Patient refused follow-up|3
4870279|NCT00826241|16784747|P1|Overall Study|Progression of disease|1
4870280|NCT00826241|16784747|P1|Overall Study|Non-compliance|1
4870281|NCT00826241|16784747|P1|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1
4870282|NCT00826241|16784747|P1|Overall Study|Death|4
4870283|NCT00826241|16784747|P1|Overall Study|Withdrew consent|2
4870284|NCT00826241|16784747|P1|Overall Study|Withdrawal from Follow-up|1
4870285|NCT00826228|16784753|P1|Overall Study|Withdrawal by Subject|1
4870286|NCT00826176|16784775|P2|Overall Study|Administrative|0
4870287|NCT00826176|16784776|P1|Overall Study|Administrative|9
4870288|NCT00826176|16784775|P2|Overall Study|Subject Withdrew Consent|0
4870289|NCT00826176|16784776|P1|Overall Study|Subject Withdrew Consent|3
4870290|NCT00826176|16784775|P2|Overall Study|Lost to Follow-up|0
4870291|NCT00826176|16784776|P1|Overall Study|Lost to Follow-up|1
4870292|NCT00826111|16784825|P2|Overall Study|Physician Decision|1
4870293|NCT00826111|16784826|P1|Overall Study|Physician Decision|1
4870294|NCT00826111|16784825|P2|Overall Study|Withdrawal by Subject|0
4870295|NCT00826111|16784826|P1|Overall Study|Withdrawal by Subject|5
4870296|NCT00826111|16784825|P2|Overall Study|Protocol Violation|0
4870297|NCT00826111|16784826|P1|Overall Study|Protocol Violation|1
4870298|NCT00826111|16784825|P2|Overall Study|Lost to Follow-up|1
4870299|NCT00826111|16784826|P1|Overall Study|Lost to Follow-up|0
4870300|NCT00825994|16784861|P1|Overall Study|Placebo Responder at V2|1
4870301|NCT00825994|16784861|P1|Overall Study|Protocol Violation|1
4870302|NCT00825994|16784861|P1|Overall Study|Lost to Follow-up|1
4870303|NCT00825994|16784861|P1|Overall Study|Withdrawal by Subject|2
4870304|NCT00825916|16784869|P3|Overall Study|Lost to Follow-up|1
4870305|NCT00825916|16784870|P2|Overall Study|Lost to Follow-up|2
4870306|NCT00825916|16784871|P1|Overall Study|Lost to Follow-up|4
4870307|NCT00825825|16784912|P6|Third Medication Period (14 Days)|poor data quality|0
4870308|NCT00825825|16784913|P5|Third Medication Period (14 Days)|poor data quality|0
4870309|NCT00825825|16784914|P4|Third Medication Period (14 Days)|poor data quality|0
4870310|NCT00825825|16784915|P3|Third Medication Period (14 Days)|poor data quality|0
4870311|NCT00825825|16784916|P2|Third Medication Period (14 Days)|poor data quality|1
4870312|NCT00825825|16784917|P1|Third Medication Period (14 Days)|poor data quality|0
4870313|NCT00825825|16784912|P6|Third Medication Period (14 Days)|Protocol Violation|2
4870314|NCT00825825|16784913|P5|Third Medication Period (14 Days)|Protocol Violation|0
4870315|NCT00825825|16784914|P4|Third Medication Period (14 Days)|Protocol Violation|0
4870316|NCT00825825|16784915|P3|Third Medication Period (14 Days)|Protocol Violation|0
4870317|NCT00825825|16784916|P2|Third Medication Period (14 Days)|Protocol Violation|0
4870318|NCT00825825|16784917|P1|Third Medication Period (14 Days)|Protocol Violation|0
4870319|NCT00825825|16784912|P6|Third Medication Period (14 Days)|Adverse Event|0
4870320|NCT00825825|16784913|P5|Third Medication Period (14 Days)|Adverse Event|0
4870321|NCT00825825|16784914|P4|Third Medication Period (14 Days)|Adverse Event|0
4870322|NCT00825825|16784915|P3|Third Medication Period (14 Days)|Adverse Event|0
4870323|NCT00825825|16784916|P2|Third Medication Period (14 Days)|Adverse Event|1
4870324|NCT00825825|16784917|P1|Third Medication Period (14 Days)|Adverse Event|0
4870325|NCT00825825|16784912|P6|Second Medication Period (14 Days)|Protocol Violation|0
4870326|NCT00825825|16784913|P5|Second Medication Period (14 Days)|Protocol Violation|1
4870327|NCT00825825|16784914|P4|Second Medication Period (14 Days)|Protocol Violation|0
4870328|NCT00825825|16784915|P3|Second Medication Period (14 Days)|Protocol Violation|0
4870329|NCT00825825|16784916|P2|Second Medication Period (14 Days)|Protocol Violation|0
4870330|NCT00825825|16784917|P1|Second Medication Period (14 Days)|Protocol Violation|1
4870331|NCT00825825|16784912|P6|Second Medication Period (14 Days)|Physician Decision|0
4870332|NCT00825825|16784913|P5|Second Medication Period (14 Days)|Physician Decision|0
4870333|NCT00825825|16784914|P4|Second Medication Period (14 Days)|Physician Decision|2
4870334|NCT00825825|16784915|P3|Second Medication Period (14 Days)|Physician Decision|0
4870335|NCT00825825|16784916|P2|Second Medication Period (14 Days)|Physician Decision|0
4870336|NCT00825825|16784917|P1|Second Medication Period (14 Days)|Physician Decision|1
4870337|NCT00825825|16784912|P6|First Medication Period (14 Days)|Physician Decision|1
4870338|NCT00825825|16784913|P5|First Medication Period (14 Days)|Physician Decision|0
4870339|NCT00825825|16784914|P4|First Medication Period (14 Days)|Physician Decision|0
4870340|NCT00825825|16784915|P3|First Medication Period (14 Days)|Physician Decision|1
4870341|NCT00825825|16784916|P2|First Medication Period (14 Days)|Physician Decision|0
4870342|NCT00825825|16784917|P1|First Medication Period (14 Days)|Physician Decision|2
4870343|NCT00825825|16784912|P6|First Medication Period (14 Days)|Adverse Event|1
4870344|NCT00825825|16784913|P5|First Medication Period (14 Days)|Adverse Event|0
4870345|NCT00825825|16784914|P4|First Medication Period (14 Days)|Adverse Event|0
4870346|NCT00825825|16784915|P3|First Medication Period (14 Days)|Adverse Event|0
4870347|NCT00825825|16784916|P2|First Medication Period (14 Days)|Adverse Event|0
4870348|NCT00825825|16784917|P1|First Medication Period (14 Days)|Adverse Event|1
4870349|NCT00825812|16784933|P4|Overall Study|Administrative|5
4870350|NCT00825812|16784934|P3|Overall Study|Administrative|3
4870351|NCT00825812|16784935|P2|Overall Study|Administrative|1
4870352|NCT00825812|16784936|P1|Overall Study|Administrative|0
4870353|NCT00825812|16784933|P4|Overall Study|Non-compliance with protocol|1
4870354|NCT00825812|16784934|P3|Overall Study|Non-compliance with protocol|0
4870355|NCT00825812|16784935|P2|Overall Study|Non-compliance with protocol|0
4870356|NCT00825812|16784936|P1|Overall Study|Non-compliance with protocol|0
4870357|NCT00825812|16784933|P4|Overall Study|Subject withdrew consent|2
4870358|NCT00825812|16784934|P3|Overall Study|Subject withdrew consent|3
4870359|NCT00825812|16784935|P2|Overall Study|Subject withdrew consent|0
4870360|NCT00825812|16784936|P1|Overall Study|Subject withdrew consent|0
4870361|NCT00825812|16784933|P4|Overall Study|Adverse Event|1
4870362|NCT00825812|16784934|P3|Overall Study|Adverse Event|0
4870363|NCT00825812|16784935|P2|Overall Study|Adverse Event|0
4870364|NCT00825812|16784936|P1|Overall Study|Adverse Event|0
4870365|NCT00825812|16784933|P4|Overall Study|Never entered follow up|1
4870366|NCT00825812|16784934|P3|Overall Study|Never entered follow up|0
4870367|NCT00825812|16784935|P2|Overall Study|Never entered follow up|0
4870368|NCT00825812|16784936|P1|Overall Study|Never entered follow up|0
4870369|NCT00825682|16784983|P2|Overall Study|personal reasons/ inconvenience|5
4870370|NCT00825682|16784984|P1|Overall Study|personal reasons/ inconvenience|13
4870371|NCT00825305|16785075|P2|Overall Study|Can not be classified|1
4870372|NCT00825305|16785076|P1|Overall Study|Can not be classified|0
4870373|NCT00825305|16785075|P2|Overall Study|Protocol Violation|9
4870374|NCT00825305|16785076|P1|Overall Study|Protocol Violation|9
4870375|NCT00825305|16785075|P2|Overall Study|Inappropriate inclusion|0
4870376|NCT00825305|16785076|P1|Overall Study|Inappropriate inclusion|1
4870377|NCT00825305|16785075|P2|Overall Study|Withdrawal by Subject|12
4870378|NCT00825305|16785076|P1|Overall Study|Withdrawal by Subject|6
4870379|NCT00825305|16785075|P2|Overall Study|Adverse Event|1
4870380|NCT00825305|16785076|P1|Overall Study|Adverse Event|1
4870381|NCT00825175|16785116|P2|Overall Study|Withdrawal by Subject|5
4870382|NCT00825175|16785117|P1|Overall Study|Withdrawal by Subject|0
4870383|NCT00825162|16785126|P3|Overall Study|Unable to attend the study visit|0
4870384|NCT00825162|16785127|P2|Overall Study|Unable to attend the study visit|2
4870385|NCT00825162|16785128|P1|Overall Study|Unable to attend the study visit|5
4870386|NCT00825162|16785126|P3|Overall Study|Move away from the study area|0
4870387|NCT00825162|16785127|P2|Overall Study|Move away from the study area|0
4870388|NCT00825162|16785128|P1|Overall Study|Move away from the study area|1
4870389|NCT00825162|16785126|P3|Overall Study|Physician Decision|0
4870390|NCT00825162|16785127|P2|Overall Study|Physician Decision|0
4870391|NCT00825162|16785128|P1|Overall Study|Physician Decision|2
4870392|NCT00825162|16785126|P3|Overall Study|Lost to Follow-up|3
4870393|NCT00825162|16785127|P2|Overall Study|Lost to Follow-up|6
4870394|NCT00825162|16785128|P1|Overall Study|Lost to Follow-up|9
4870395|NCT00825162|16785126|P3|Overall Study|Withdrawal by Subject|3
4870396|NCT00825162|16785127|P2|Overall Study|Withdrawal by Subject|13
4870397|NCT00825162|16785128|P1|Overall Study|Withdrawal by Subject|11
4870398|NCT00824993|16785154|P2|Overall Study|Death|3
4870399|NCT00824993|16785155|P1|Overall Study|Death|0
4870400|NCT00824993|16785154|P2|Overall Study|Insurance Issue|1
4870401|NCT00824993|16785155|P1|Overall Study|Insurance Issue|2
4870402|NCT00824993|16785154|P2|Overall Study|Non-Compliant|1
4870403|NCT00824993|16785155|P1|Overall Study|Non-Compliant|2
4870404|NCT00824993|16785154|P2|Overall Study|Rapid Bone Loss|1
4870405|NCT00824993|16785155|P1|Overall Study|Rapid Bone Loss|0
4870406|NCT00824993|16785154|P2|Overall Study|Malignancy Relapse|10
4870407|NCT00824993|16785155|P1|Overall Study|Malignancy Relapse|9
4870408|NCT00824993|16785154|P2|Overall Study|Withdrawal by Subject|1
4870409|NCT00824993|16785155|P1|Overall Study|Withdrawal by Subject|1
4870410|NCT00824850|16785163|P2|Overall Study|Withdrawal by Subject|1
4870411|NCT00824850|16785164|P1|Overall Study|Withdrawal by Subject|0
4870412|NCT00824772|16785217|P1|Overall Study|Withdrawal by Subject|8
4870413|NCT00824720|16785237|P3|Overall Study|Protocol Violation|1
4870414|NCT00824720|16785238|P2|Overall Study|Protocol Violation|0
4870415|NCT00824720|16785239|P1|Overall Study|Protocol Violation|0
4870416|NCT00824720|16785237|P3|Overall Study|failed plug insertion|0
4870417|NCT00824720|16785238|P2|Overall Study|failed plug insertion|1
4870418|NCT00824720|16785239|P1|Overall Study|failed plug insertion|3
4870419|NCT00824655|16785255|P2|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0
4870420|NCT00824655|16785256|P1|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1
4870421|NCT00824655|16785255|P2|Toddler Dose (12 Months of Age)|Adverse Event|0
4870422|NCT00824655|16785256|P1|Toddler Dose (12 Months of Age)|Adverse Event|1
4870423|NCT00824616|16785276|P2|Overall Study|Withdrawal by Subject|1
4870424|NCT00824616|16785277|P1|Overall Study|Withdrawal by Subject|1
4870425|NCT00824616|16785276|P2|Overall Study|Lost to Follow-up|1
4870426|NCT00824616|16785277|P1|Overall Study|Lost to Follow-up|0
4870427|NCT00824616|16785276|P2|Overall Study|Lack of Efficacy|1
4870428|NCT00824616|16785277|P1|Overall Study|Lack of Efficacy|2
4870429|NCT00824616|16785276|P2|Overall Study|Hyperglycemia|1
4870430|NCT00824616|16785277|P1|Overall Study|Hyperglycemia|1
4870431|NCT00824616|16785276|P2|Overall Study|Creatinine/Creatinine Clearance|2
4870432|NCT00824616|16785277|P1|Overall Study|Creatinine/Creatinine Clearance|0
4870433|NCT00824616|16785276|P2|Overall Study|Adverse Event|1
4870434|NCT00824616|16785277|P1|Overall Study|Adverse Event|2
4870435|NCT00824564|16785287|P2|Overall Study|Randomized, but not treated|0
4870436|NCT00824564|16785288|P1|Overall Study|Randomized, but not treated|1
4870437|NCT00824564|16785287|P2|Overall Study|Other|2
4870438|NCT00824564|16785288|P1|Overall Study|Other|1
4870439|NCT00824564|16785287|P2|Overall Study|Withdrawal by Subject|1
4870440|NCT00824564|16785288|P1|Overall Study|Withdrawal by Subject|1
4870441|NCT00824564|16785287|P2|Overall Study|Lost to Follow-up|7
4870442|NCT00824564|16785288|P1|Overall Study|Lost to Follow-up|5
4870443|NCT00824473|16785367|P2|Overall Study|Other|1
4870444|NCT00824473|16785368|P1|Overall Study|Other|1
4870445|NCT00824473|16785367|P2|Overall Study|Withdrawal by Subject|3
4870446|NCT00824473|16785368|P1|Overall Study|Withdrawal by Subject|2
4870447|NCT00824473|16785367|P2|Overall Study|Non-Compliance|2
4870448|NCT00824473|16785368|P1|Overall Study|Non-Compliance|4
4870449|NCT00824473|16785367|P2|Overall Study|Protocol Violation|0
4870450|NCT00824473|16785368|P1|Overall Study|Protocol Violation|2
4870451|NCT00824473|16785367|P2|Overall Study|Lack of Efficacy|2
4870452|NCT00824473|16785368|P1|Overall Study|Lack of Efficacy|2
4870453|NCT00824473|16785367|P2|Overall Study|Adverse Event|5
4870454|NCT00824473|16785368|P1|Overall Study|Adverse Event|4
4870455|NCT00824421|16785449|P3|Overall Study|Other|0
4870456|NCT00824421|16785450|P2|Overall Study|Other|1
4870457|NCT00824421|16785451|P1|Overall Study|Other|0
4870458|NCT00824421|16785449|P3|Overall Study|Randomized but not Treated|0
4870459|NCT00824421|16785450|P2|Overall Study|Randomized but not Treated|1
4870460|NCT00824421|16785451|P1|Overall Study|Randomized but not Treated|1
4870461|NCT00824421|16785449|P3|Overall Study|Withdrawal by Subject|3
4870462|NCT00824421|16785450|P2|Overall Study|Withdrawal by Subject|3
4870463|NCT00824421|16785451|P1|Overall Study|Withdrawal by Subject|2
4870464|NCT00824421|16785449|P3|Overall Study|Pregnancy|1
4870465|NCT00824421|16785450|P2|Overall Study|Pregnancy|0
4870466|NCT00824421|16785451|P1|Overall Study|Pregnancy|1
4870467|NCT00824421|16785449|P3|Overall Study|Lost to Follow-up|0
4870468|NCT00824421|16785450|P2|Overall Study|Lost to Follow-up|3
4870469|NCT00824421|16785451|P1|Overall Study|Lost to Follow-up|2
4870470|NCT00824421|16785449|P3|Overall Study|Lack of Efficacy|4
4870471|NCT00824421|16785450|P2|Overall Study|Lack of Efficacy|7
4870472|NCT00824421|16785451|P1|Overall Study|Lack of Efficacy|5
4870473|NCT00824421|16785449|P3|Overall Study|Death|0
4870474|NCT00824421|16785450|P2|Overall Study|Death|1
4870475|NCT00824421|16785451|P1|Overall Study|Death|0
4870476|NCT00824421|16785449|P3|Overall Study|Adverse Event|6
4870477|NCT00824421|16785450|P2|Overall Study|Adverse Event|6
4870478|NCT00824421|16785451|P1|Overall Study|Adverse Event|6
4870479|NCT00824408|16785502|P5|Randomized Phase|Other reason not defined above|4
4870480|NCT00824408|16785503|P4|Randomized Phase|Other reason not defined above|2
4870481|NCT00824408|16785504|P3|Randomized Phase|Other reason not defined above|4
4870482|NCT00824408|16785505|P2|Randomized Phase|Other reason not defined above|0
4870483|NCT00824408|16785506|P1|Randomized Phase|Other reason not defined above|0
4870484|NCT00824408|16785502|P5|Randomized Phase|Refused to continue medication|2
4870485|NCT00824408|16785503|P4|Randomized Phase|Refused to continue medication|2
4870486|NCT00824408|16785504|P3|Randomized Phase|Refused to continue medication|2
4870487|NCT00824408|16785505|P2|Randomized Phase|Refused to continue medication|0
4870488|NCT00824408|16785506|P1|Randomized Phase|Refused to continue medication|0
4870489|NCT00824408|16785502|P5|Randomized Phase|Adverse Event|5
4870490|NCT00824408|16785503|P4|Randomized Phase|Adverse Event|5
4870491|NCT00824408|16785504|P3|Randomized Phase|Adverse Event|4
4870492|NCT00824408|16785505|P2|Randomized Phase|Adverse Event|0
4870493|NCT00824408|16785506|P1|Randomized Phase|Adverse Event|0
4870494|NCT00824408|16785502|P5|Randomized Phase|Progressive disease|34
4870495|NCT00824408|16785503|P4|Randomized Phase|Progressive disease|36
4870496|NCT00824408|16785504|P3|Randomized Phase|Progressive disease|25
4870497|NCT00824408|16785505|P2|Randomized Phase|Progressive disease|0
4870498|NCT00824408|16785506|P1|Randomized Phase|Progressive disease|0
4870499|NCT00824408|16785502|P5|Randomized Phase|Not treated|1
4870500|NCT00824408|16785503|P4|Randomized Phase|Not treated|1
4870501|NCT00824408|16785504|P3|Randomized Phase|Not treated|1
4870502|NCT00824408|16785505|P2|Randomized Phase|Not treated|0
4870503|NCT00824408|16785506|P1|Randomized Phase|Not treated|0
4870504|NCT00824408|16785502|P5|Run-in Phase|Other reason not defined above|0
4870505|NCT00824408|16785503|P4|Run-in Phase|Other reason not defined above|0
4870506|NCT00824408|16785504|P3|Run-in Phase|Other reason not defined above|0
4870507|NCT00824408|16785505|P2|Run-in Phase|Other reason not defined above|1
4870508|NCT00824408|16785506|P1|Run-in Phase|Other reason not defined above|0
4870509|NCT00824408|16785502|P5|Run-in Phase|Refused to continue medication|0
4870510|NCT00824408|16785503|P4|Run-in Phase|Refused to continue medication|0
4870511|NCT00824408|16785504|P3|Run-in Phase|Refused to continue medication|0
4870512|NCT00824408|16785505|P2|Run-in Phase|Refused to continue medication|0
4870513|NCT00824408|16785506|P1|Run-in Phase|Refused to continue medication|1
4870514|NCT00824408|16785502|P5|Run-in Phase|Adverse Event|0
4870515|NCT00824408|16785503|P4|Run-in Phase|Adverse Event|0
4870516|NCT00824408|16785504|P3|Run-in Phase|Adverse Event|0
4870517|NCT00824408|16785505|P2|Run-in Phase|Adverse Event|1
4870518|NCT00824408|16785506|P1|Run-in Phase|Adverse Event|1
4870519|NCT00824408|16785502|P5|Run-in Phase|Progressive disease|0
4870520|NCT00824408|16785503|P4|Run-in Phase|Progressive disease|0
4870521|NCT00824408|16785504|P3|Run-in Phase|Progressive disease|0
4870522|NCT00824408|16785505|P2|Run-in Phase|Progressive disease|4
4870523|NCT00824408|16785506|P1|Run-in Phase|Progressive disease|4
4870524|NCT00824382|16785558|P4|Overall Study|Investigator's decision|0
4870525|NCT00824382|16785559|P3|Overall Study|Investigator's decision|2
4870526|NCT00824382|16785560|P2|Overall Study|Investigator's decision|1
4870527|NCT00824382|16785561|P1|Overall Study|Investigator's decision|0
4870528|NCT00824382|16785558|P4|Overall Study|Protocol Violation|1
4870529|NCT00824382|16785559|P3|Overall Study|Protocol Violation|0
4870530|NCT00824382|16785560|P2|Overall Study|Protocol Violation|0
4870531|NCT00824382|16785561|P1|Overall Study|Protocol Violation|1
4870532|NCT00824382|16785558|P4|Overall Study|Adverse Event|4
4870533|NCT00824382|16785559|P3|Overall Study|Adverse Event|1
4870534|NCT00824382|16785560|P2|Overall Study|Adverse Event|1
4870535|NCT00824382|16785561|P1|Overall Study|Adverse Event|4
4870536|NCT00824369|16785637|P6|Overall Study|Lost to Follow-up|0
4870537|NCT00824369|16785638|P5|Overall Study|Lost to Follow-up|1
4870538|NCT00824369|16785639|P4|Overall Study|Lost to Follow-up|0
4870539|NCT00824369|16785640|P3|Overall Study|Lost to Follow-up|0
4870540|NCT00824369|16785641|P2|Overall Study|Lost to Follow-up|0
4870541|NCT00824369|16785642|P1|Overall Study|Lost to Follow-up|0
4870542|NCT00824369|16785637|P6|Overall Study|Nolonger willing to participate in study|1
4870543|NCT00824369|16785638|P5|Overall Study|Nolonger willing to participate in study|0
4870544|NCT00824369|16785639|P4|Overall Study|Nolonger willing to participate in study|2
4870545|NCT00824369|16785640|P3|Overall Study|Nolonger willing to participate in study|1
4870546|NCT00824369|16785641|P2|Overall Study|Nolonger willing to participate in study|0
4870547|NCT00824369|16785642|P1|Overall Study|Nolonger willing to participate in study|1
4870548|NCT00824291|16785682|P2|Overall Study|Participant on prohibited medication|0
4870549|NCT00824291|16785683|P1|Overall Study|Participant on prohibited medication|1
4870550|NCT00824291|16785682|P2|Overall Study|Lack of Efficacy|8
4870551|NCT00824291|16785683|P1|Overall Study|Lack of Efficacy|7
4870552|NCT00824291|16785682|P2|Overall Study|Withdrawal by Subject|8
4870553|NCT00824291|16785683|P1|Overall Study|Withdrawal by Subject|14
4870554|NCT00824291|16785682|P2|Overall Study|Protocol Violation|1
4870555|NCT00824291|16785683|P1|Overall Study|Protocol Violation|4
4870556|NCT00824291|16785682|P2|Overall Study|Non-compliance|1
4870557|NCT00824291|16785683|P1|Overall Study|Non-compliance|1
4870558|NCT00824291|16785682|P2|Overall Study|Lost to Follow-up|9
4870559|NCT00824291|16785683|P1|Overall Study|Lost to Follow-up|11
4870560|NCT00824291|16785682|P2|Overall Study|Discontinuation of Study by Sponsor|2
4870561|NCT00824291|16785683|P1|Overall Study|Discontinuation of Study by Sponsor|1
4870562|NCT00824291|16785682|P2|Overall Study|Adverse Event|6
4870563|NCT00824291|16785683|P1|Overall Study|Adverse Event|15
4870564|NCT00824265|16785705|P2|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16
4870565|NCT00824265|16785706|P1|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9
4870566|NCT00824265|16785705|P2|Follow-up Phase|w/drew consent, no f/u, or MD choice|31
4870567|NCT00824265|16785706|P1|Follow-up Phase|w/drew consent, no f/u, or MD choice|18
4870568|NCT00824265|16785705|P2|Treatment Phase|Withdrawal by Subject|15
4870569|NCT00824265|16785706|P1|Treatment Phase|Withdrawal by Subject|6
4870570|NCT00824265|16785705|P2|Treatment Phase|Physician Decision|12
4870571|NCT00824265|16785706|P1|Treatment Phase|Physician Decision|6
4870572|NCT00824265|16785705|P2|Treatment Phase|Lost to Follow-up|1
4870573|NCT00824265|16785706|P1|Treatment Phase|Lost to Follow-up|1
4870574|NCT00824265|16785705|P2|Treatment Phase|Protocol Violation|0
4870575|NCT00824265|16785706|P1|Treatment Phase|Protocol Violation|1
4870576|NCT00824265|16785705|P2|Treatment Phase|Adverse Event,non-fatal|52
4870577|NCT00824265|16785706|P1|Treatment Phase|Adverse Event,non-fatal|50
4870578|NCT00824161|16785767|P1|Overall Study|Screen Failure|1
4870579|NCT00824161|16785767|P1|Overall Study|Withdrawal by Subject|1
4870580|NCT00824005|16785833|P2|Overall Study|Lost to Follow-up|1
4870581|NCT00824005|16785834|P1|Overall Study|Lost to Follow-up|0
4870582|NCT00824005|16785833|P2|Overall Study|Death|1
4870583|NCT00824005|16785834|P1|Overall Study|Death|0
4870584|NCT00823979|16785869|P3|Overall Study|Study Terminated by Sponsor|7
4870585|NCT00823979|16785870|P2|Overall Study|Study Terminated by Sponsor|5
4870586|NCT00823979|16785871|P1|Overall Study|Study Terminated by Sponsor|5
4870587|NCT00823979|16785869|P3|Overall Study|Randomized but not Treated|1
4870588|NCT00823979|16785870|P2|Overall Study|Randomized but not Treated|3
4870589|NCT00823979|16785871|P1|Overall Study|Randomized but not Treated|4
4870590|NCT00823979|16785869|P3|Overall Study|Other|1
4870591|NCT00823979|16785870|P2|Overall Study|Other|0
4870592|NCT00823979|16785871|P1|Overall Study|Other|2
4870593|NCT00823979|16785869|P3|Overall Study|Adverse Event|4
4870594|NCT00823979|16785870|P2|Overall Study|Adverse Event|2
4870595|NCT00823979|16785871|P1|Overall Study|Adverse Event|0
4870596|NCT00823979|16785869|P3|Overall Study|Pregnancy|0
4870597|NCT00823979|16785870|P2|Overall Study|Pregnancy|1
4870598|NCT00823979|16785871|P1|Overall Study|Pregnancy|0
4870599|NCT00823979|16785869|P3|Overall Study|Protocol Violation|0
4870600|NCT00823979|16785870|P2|Overall Study|Protocol Violation|1
4870601|NCT00823979|16785871|P1|Overall Study|Protocol Violation|1
4870602|NCT00823979|16785869|P3|Overall Study|Withdrawal by Subject|2
4870603|NCT00823979|16785870|P2|Overall Study|Withdrawal by Subject|3
4870604|NCT00823979|16785871|P1|Overall Study|Withdrawal by Subject|2
4870605|NCT00823979|16785869|P3|Overall Study|Lost to Follow-up|0
4870606|NCT00823979|16785870|P2|Overall Study|Lost to Follow-up|1
4870607|NCT00823979|16785871|P1|Overall Study|Lost to Follow-up|2
4870608|NCT00823979|16785869|P3|Overall Study|Lack of Efficacy|9
4870609|NCT00823979|16785870|P2|Overall Study|Lack of Efficacy|16
4870610|NCT00823979|16785871|P1|Overall Study|Lack of Efficacy|13
4870611|NCT00823901|16785916|P2|Overall Study|Lost to Follow-up|1
4870612|NCT00823901|16785917|P1|Overall Study|Lost to Follow-up|2
4870613|NCT00823901|16785916|P2|Overall Study|Lack of Efficacy|0
4870614|NCT00823901|16785917|P1|Overall Study|Lack of Efficacy|1
4870615|NCT00823901|16785916|P2|Overall Study|Adverse Event|1
4870616|NCT00823901|16785917|P1|Overall Study|Adverse Event|1
4870617|NCT00823836|16785925|P2|Long-term Phase|Withdrawal by Subject|1
4870618|NCT00823836|16785926|P1|Long-term Phase|Withdrawal by Subject|1
4870619|NCT00823836|16785925|P2|Long-term Phase|Physician Decision|2
4870620|NCT00823836|16785926|P1|Long-term Phase|Physician Decision|1
4870621|NCT00823836|16785925|P2|Long-term Phase|Adverse Event|2
4870622|NCT00823836|16785926|P1|Long-term Phase|Adverse Event|3
4870623|NCT00823836|16785925|P2|NV and PR/XR Switching Phases|Withdrawal by Subject|5
4870624|NCT00823836|16785926|P1|NV and PR/XR Switching Phases|Withdrawal by Subject|4
4870625|NCT00823836|16785925|P2|NV and PR/XR Switching Phases|Physician Decision|2
4870626|NCT00823836|16785926|P1|NV and PR/XR Switching Phases|Physician Decision|5
4870627|NCT00823836|16785925|P2|NV and PR/XR Switching Phases|Protocol Violation|1
4870628|NCT00823836|16785926|P1|NV and PR/XR Switching Phases|Protocol Violation|1
4870629|NCT00823836|16785925|P2|NV and PR/XR Switching Phases|Adverse Event|21
4870630|NCT00823836|16785926|P1|NV and PR/XR Switching Phases|Adverse Event|22
4870631|NCT00823823|16786032|P2|Overall Study|Protocol Violation|5
4870632|NCT00823823|16786033|P1|Overall Study|Protocol Violation|5
4870633|NCT00823823|16786032|P2|Overall Study|Lost to Follow-up|1
4870634|NCT00823823|16786033|P1|Overall Study|Lost to Follow-up|3
4870635|NCT00823719|16786057|P2|Overall Study|Disease Progression|4
4870636|NCT00823719|16786058|P1|Overall Study|Disease Progression|4
4870637|NCT00823719|16786057|P2|Overall Study|Withdrawal by Subject|1
4870638|NCT00823719|16786058|P1|Overall Study|Withdrawal by Subject|0
4870639|NCT00823719|16786057|P2|Overall Study|Physician Decision|4
4870640|NCT00823719|16786058|P1|Overall Study|Physician Decision|1
4870641|NCT00823719|16786057|P2|Overall Study|Adverse Event|2
4870642|NCT00823719|16786058|P1|Overall Study|Adverse Event|1
4870643|NCT00823615|16786111|P2|Period 2|Time/Job Conflict|2
4870644|NCT00823615|16786112|P1|Period 2|Time/Job Conflict|1
4870645|NCT00823615|16786111|P2|Period 2|Lost to Follow-up|0
4870646|NCT00823615|16786112|P1|Period 2|Lost to Follow-up|2
4870647|NCT00823472|16786122|P2|Overall Study|Physician Decision|28
4870648|NCT00823472|16786123|P1|Overall Study|Physician Decision|24
4870649|NCT00823264|16786150|P2|Overall Study|Protocol Violation|0
4870650|NCT00823264|16786151|P1|Overall Study|Protocol Violation|2
4870651|NCT00823212|16786159|P2|Overall Study|Missed 12-month visit|21
4870652|NCT00823212|16786160|P1|Overall Study|Missed 12-month visit|21
4870653|NCT00823212|16786159|P2|Overall Study|Incarcerated|1
4870654|NCT00823212|16786160|P1|Overall Study|Incarcerated|0
4870655|NCT00823212|16786159|P2|Overall Study|Withdrawal by Subject|1
4870656|NCT00823212|16786160|P1|Overall Study|Withdrawal by Subject|6
4870657|NCT00823212|16786159|P2|Overall Study|Death|10
4870658|NCT00823212|16786160|P1|Overall Study|Death|8
4870659|NCT00823199|16786242|P1|Overall Study|Withdrawal by Subject|2
4870660|NCT00823134|16786248|P1|Overall Study|Invalid measurement|1
4870661|NCT00822926|16786321|P2|Second Injection Visit|Withdrawal by Subject|1
4870662|NCT00822926|16786322|P1|Second Injection Visit|Withdrawal by Subject|0
4870663|NCT00822926|16786321|P2|Second Injection Visit|Lost to Follow-up|0
4870664|NCT00822926|16786322|P1|Second Injection Visit|Lost to Follow-up|1
4870665|NCT00822900|16786336|P2|Overall Study|Became a ward of the state|1
4870666|NCT00822900|16786337|P1|Overall Study|Became a ward of the state|2
4870667|NCT00822900|16786336|P2|Overall Study|Death|69
4870668|NCT00822900|16786337|P1|Overall Study|Death|83
4870669|NCT00822900|16786336|P2|Overall Study|Lost to Follow-up|9
4870670|NCT00822900|16786337|P1|Overall Study|Lost to Follow-up|9
4870671|NCT00822900|16786336|P2|Overall Study|Withdrawal by Subject|14
4870672|NCT00822900|16786337|P1|Overall Study|Withdrawal by Subject|14
4870673|NCT00822770|16786367|P2|Overall Study|Death|1
4870674|NCT00822770|16786368|P1|Overall Study|Death|1
4870675|NCT00822770|16786367|P2|Overall Study|Complication/Incomplete treatment|0
4870676|NCT00822770|16786368|P1|Overall Study|Complication/Incomplete treatment|1
4870677|NCT00822770|16786367|P2|Overall Study|Not treated|0
4870678|NCT00822770|16786368|P1|Overall Study|Not treated|1
4870679|NCT00822692|16786390|P2|Overall Study|Lost to Follow-up|25
4870680|NCT00822692|16786391|P1|Overall Study|Lost to Follow-up|17
4870681|NCT00822237|16786529|P2|Dose 2 Vaccination|Lost to Follow-up|9
4870682|NCT00822237|16786530|P1|Dose 2 Vaccination|Lost to Follow-up|2
4870683|NCT00822237|16786529|P2|Dose 2 Vaccination|Withdrawal by Subject|2
4870684|NCT00822237|16786530|P1|Dose 2 Vaccination|Withdrawal by Subject|2
4870685|NCT00822237|16786529|P2|Dose 1 Vaccination|Lost to Follow-up|12
4870686|NCT00822237|16786530|P1|Dose 1 Vaccination|Lost to Follow-up|9
4870687|NCT00822237|16786529|P2|Dose 1 Vaccination|Withdrawal by Subject|14
4870688|NCT00822237|16786530|P1|Dose 1 Vaccination|Withdrawal by Subject|13
4870689|NCT00822237|16786529|P2|Dose 1 Vaccination|Not vaccinated|0
4870690|NCT00822237|16786530|P1|Dose 1 Vaccination|Not vaccinated|3
4870691|NCT00822172|16786611|P2|Overall Study|Other|1
4870692|NCT00822172|16786612|P1|Overall Study|Other|0
4870693|NCT00822172|16786611|P2|Overall Study|site closed|1
4870694|NCT00822172|16786612|P1|Overall Study|site closed|0
4870695|NCT00822172|16786611|P2|Overall Study|Withdrawal by Subject|4
4870696|NCT00822172|16786612|P1|Overall Study|Withdrawal by Subject|1
4870697|NCT00822172|16786611|P2|Overall Study|Lost to Follow-up|1
4870698|NCT00822172|16786612|P1|Overall Study|Lost to Follow-up|3
4870699|NCT00822172|16786611|P2|Overall Study|Death|0
4870700|NCT00822172|16786612|P1|Overall Study|Death|1
4870701|NCT00822172|16786611|P2|Overall Study|Adverse Event|12
4870702|NCT00822172|16786612|P1|Overall Study|Adverse Event|10
4870703|NCT00822120|16786632|P6|PET-directed Therapy|Protocol Violation|0
4870704|NCT00822120|16786633|P5|PET-directed Therapy|Protocol Violation|0
4870705|NCT00822120|16786634|P4|PET-directed Therapy|Protocol Violation|6
4870706|NCT00822120|16786635|P3|PET-directed Therapy|Protocol Violation|0
4870707|NCT00822120|16786636|P2|PET-directed Therapy|Protocol Violation|0
4870708|NCT00822120|16786637|P1|PET-directed Therapy|Protocol Violation|0
4870709|NCT00822120|16786632|P6|PET-directed Therapy|Death|0
4870710|NCT00822120|16786633|P5|PET-directed Therapy|Death|0
4870711|NCT00822120|16786634|P4|PET-directed Therapy|Death|2
4870712|NCT00822120|16786635|P3|PET-directed Therapy|Death|0
4870713|NCT00822120|16786636|P2|PET-directed Therapy|Death|0
4870714|NCT00822120|16786637|P1|PET-directed Therapy|Death|0
4870715|NCT00822120|16786632|P6|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4870716|NCT00822120|16786633|P5|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4870717|NCT00822120|16786634|P4|PET-directed Therapy|Refusal Unrelated to Adverse Event|1
4870718|NCT00822120|16786635|P3|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4870719|NCT00822120|16786636|P2|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4870720|NCT00822120|16786637|P1|PET-directed Therapy|Refusal Unrelated to Adverse Event|0
4870721|NCT00822120|16786632|P6|PET-directed Therapy|Adverse Event|0
4870722|NCT00822120|16786633|P5|PET-directed Therapy|Adverse Event|0
4870723|NCT00822120|16786634|P4|PET-directed Therapy|Adverse Event|1
4870724|NCT00822120|16786635|P3|PET-directed Therapy|Adverse Event|0
4870725|NCT00822120|16786636|P2|PET-directed Therapy|Adverse Event|0
4870726|NCT00822120|16786637|P1|PET-directed Therapy|Adverse Event|0
4870727|NCT00822120|16786632|P6|Initial Registration|Ineligible|0
4870728|NCT00822120|16786633|P5|Initial Registration|Ineligible|0
4870729|NCT00822120|16786634|P4|Initial Registration|Ineligible|0
4870730|NCT00822120|16786635|P3|Initial Registration|Ineligible|0
4870731|NCT00822120|16786636|P2|Initial Registration|Ineligible|1
4870732|NCT00822120|16786637|P1|Initial Registration|Ineligible|22
4870733|NCT00822120|16786632|P6|Initial Registration|Reasons not Protocol Specified|0
4870734|NCT00822120|16786633|P5|Initial Registration|Reasons not Protocol Specified|0
4870735|NCT00822120|16786634|P4|Initial Registration|Reasons not Protocol Specified|0
4870736|NCT00822120|16786635|P3|Initial Registration|Reasons not Protocol Specified|0
4870737|NCT00822120|16786636|P2|Initial Registration|Reasons not Protocol Specified|0
4870738|NCT00822120|16786637|P1|Initial Registration|Reasons not Protocol Specified|2
4870739|NCT00822120|16786632|P6|Initial Registration|Refusal Unrelated to Adverse Event|0
4870740|NCT00822120|16786633|P5|Initial Registration|Refusal Unrelated to Adverse Event|0
4870741|NCT00822120|16786634|P4|Initial Registration|Refusal Unrelated to Adverse Event|0
4870742|NCT00822120|16786635|P3|Initial Registration|Refusal Unrelated to Adverse Event|0
4870743|NCT00822120|16786636|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
4870744|NCT00822120|16786637|P1|Initial Registration|Refusal Unrelated to Adverse Event|1
4870745|NCT00822120|16786632|P6|Initial Registration|Adverse Event|0
4870746|NCT00822120|16786633|P5|Initial Registration|Adverse Event|0
4870747|NCT00822120|16786634|P4|Initial Registration|Adverse Event|0
4870748|NCT00822120|16786635|P3|Initial Registration|Adverse Event|0
4870749|NCT00822120|16786636|P2|Initial Registration|Adverse Event|0
4870750|NCT00822120|16786637|P1|Initial Registration|Adverse Event|1
4870751|NCT00821873|16786703|P1|Overall Study|Lost to Follow-up|4
4870752|NCT00821678|16786733|P2|Overall Study|Death|2
4870753|NCT00821678|16786734|P1|Overall Study|Death|0
4870754|NCT00821678|16786733|P2|Overall Study|Lost to Follow-up|12
4870755|NCT00821678|16786734|P1|Overall Study|Lost to Follow-up|13
4870756|NCT00821678|16786733|P2|Overall Study|Withdrawal by Subject|0
4870757|NCT00821678|16786734|P1|Overall Study|Withdrawal by Subject|8
4870758|NCT00821587|16786769|P2|Overall Study|Physician Decision|1
4870759|NCT00821587|16786770|P1|Overall Study|Physician Decision|0
4870760|NCT00821509|16786779|P3|Overall Study|Withdrawal by Subject|34
4870761|NCT00821509|16786780|P2|Overall Study|Withdrawal by Subject|11
4870762|NCT00821509|16786781|P1|Overall Study|Withdrawal by Subject|12
4870763|NCT00821431|16786794|P2|Overall Study|Physician Decision|1
4870764|NCT00821431|16786795|P1|Overall Study|Physician Decision|0
4870765|NCT00821431|16786794|P2|Overall Study|Protocol Violation|1
4870766|NCT00821431|16786795|P1|Overall Study|Protocol Violation|3
4870767|NCT00821431|16786794|P2|Overall Study|Lost to Follow-up|0
4870768|NCT00821431|16786795|P1|Overall Study|Lost to Follow-up|1
4870769|NCT00821431|16786794|P2|Overall Study|Withdrawal by Subject|0
4870770|NCT00821431|16786795|P1|Overall Study|Withdrawal by Subject|5
4870771|NCT00821431|16786794|P2|Overall Study|Adverse Event|3
4870772|NCT00821431|16786795|P1|Overall Study|Adverse Event|6
4870773|NCT00821327|16786803|P1|Overall Study|Other/Unknown|5
4870774|NCT00821327|16786803|P1|Overall Study|Disease Progression|13
4870775|NCT00821327|16786803|P1|Overall Study|Sponsor Request|1
4870776|NCT00821327|16786803|P1|Overall Study|Investigator Request|2
4870777|NCT00821327|16786803|P1|Overall Study|Patient Request|1
4870778|NCT00821327|16786803|P1|Overall Study|Adverse Event|13
4870779|NCT00821236|16786812|P1|Overall Study|Lost to Follow-up|3
4870780|NCT00821093|16786852|P2|Overall Study|Administrative problems|2
4870781|NCT00821093|16786853|P1|Overall Study|Administrative problems|1
4870782|NCT00821093|16786852|P2|Overall Study|Abnormal test procedure result(s)|1
4870783|NCT00821093|16786853|P1|Overall Study|Abnormal test procedure result(s)|1
4870784|NCT00821093|16786852|P2|Overall Study|Death|1
4870785|NCT00821093|16786853|P1|Overall Study|Death|2
4870786|NCT00821093|16786852|P2|Overall Study|Lack of Efficacy|2
4870787|NCT00821093|16786853|P1|Overall Study|Lack of Efficacy|2
4870788|NCT00821093|16786852|P2|Overall Study|Abnormal laboratory value(s)|0
4870789|NCT00821093|16786853|P1|Overall Study|Abnormal laboratory value(s)|2
4870790|NCT00821093|16786852|P2|Overall Study|Protocol deviation|6
4870791|NCT00821093|16786853|P1|Overall Study|Protocol deviation|3
4870792|NCT00821093|16786852|P2|Overall Study|Lost to Follow-up|3
4870793|NCT00821093|16786853|P1|Overall Study|Lost to Follow-up|9
4870794|NCT00821093|16786852|P2|Overall Study|Withdrawal by Subject|13
4870795|NCT00821093|16786853|P1|Overall Study|Withdrawal by Subject|9
4870796|NCT00821093|16786852|P2|Overall Study|Adverse Event|12
4870797|NCT00821093|16786853|P1|Overall Study|Adverse Event|20
4870798|NCT00821015|16786872|P1|Overall Study|Lost to Follow-up|12
4870799|NCT00820898|16786883|P1|Overall Study|Inelgible - wrong primary site|1
4870800|NCT00820755|16786897|P3|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
4870884|NCT00819832|16787196|P3|Overall Study|Sponsor Termination of Study|0
4870801|NCT00820755|16786898|P2|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45
4870802|NCT00820755|16786899|P1|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0
4870803|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Other|0
4870804|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Other|0
4870805|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Other|11
4870806|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
4870807|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0
4870808|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14
4870809|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Progressive disease|0
4870810|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Progressive disease|0
4870811|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Progressive disease|114
4870812|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
4870813|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Withdrawal by Subject|0
4870814|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Withdrawal by Subject|21
4870815|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Lost to Follow-up|0
4870816|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Lost to Follow-up|0
4870817|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Lost to Follow-up|1
4870818|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Protocol Violation|0
4870819|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Protocol Violation|0
4870820|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Protocol Violation|4
4870821|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Death|0
4870822|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Death|0
4870823|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Death|28
4870824|NCT00820755|16786897|P3|Period 1: Combination Therapy Phase|Adverse Event|0
4870825|NCT00820755|16786898|P2|Period 1: Combination Therapy Phase|Adverse Event|0
4870826|NCT00820755|16786899|P1|Period 1: Combination Therapy Phase|Adverse Event|77
4870827|NCT00820248|16786992|P2|Overall Study|No treated|1
4870828|NCT00820248|16786993|P1|Overall Study|No treated|4
4870829|NCT00820222|16787025|P2|Overall Study|Unkown|7
4870830|NCT00820222|16787026|P1|Overall Study|Unkown|11
4870831|NCT00820222|16787025|P2|Overall Study|Sponsor Terminated Study|65
4870832|NCT00820222|16787026|P1|Overall Study|Sponsor Terminated Study|43
4870833|NCT00820222|16787025|P2|Overall Study|Physician Decision|88
4870834|NCT00820222|16787026|P1|Overall Study|Physician Decision|93
4870835|NCT00820222|16787025|P2|Overall Study|Withdrawal by Subject|21
4870836|NCT00820222|16787026|P1|Overall Study|Withdrawal by Subject|19
4870837|NCT00820222|16787025|P2|Overall Study|Lost to Follow-up|9
4870838|NCT00820222|16787026|P1|Overall Study|Lost to Follow-up|10
4870839|NCT00820170|16787057|P5|Overall Study|Progressive Disease|2
4870840|NCT00820170|16787058|P4|Overall Study|Progressive Disease|0
4870841|NCT00820170|16787059|P3|Overall Study|Progressive Disease|0
4870842|NCT00820170|16787060|P2|Overall Study|Progressive Disease|0
4870843|NCT00820170|16787061|P1|Overall Study|Progressive Disease|0
4870844|NCT00820170|16787057|P5|Overall Study|Adverse Event|2
4870845|NCT00820170|16787058|P4|Overall Study|Adverse Event|0
4870846|NCT00820170|16787059|P3|Overall Study|Adverse Event|0
4870847|NCT00820170|16787060|P2|Overall Study|Adverse Event|0
4870848|NCT00820170|16787061|P1|Overall Study|Adverse Event|0
4870849|NCT00820027|16787113|P4|Overall Study|Withdrawal by Subject|6
4870850|NCT00820027|16787114|P3|Overall Study|Withdrawal by Subject|4
4870851|NCT00820027|16787115|P2|Overall Study|Withdrawal by Subject|4
4870852|NCT00820027|16787116|P1|Overall Study|Withdrawal by Subject|6
4870853|NCT00820027|16787113|P4|Overall Study|Protocol Violation|0
4870854|NCT00820027|16787114|P3|Overall Study|Protocol Violation|4
4870855|NCT00820027|16787115|P2|Overall Study|Protocol Violation|0
4870856|NCT00820027|16787116|P1|Overall Study|Protocol Violation|3
4870857|NCT00820027|16787113|P4|Overall Study|Physician Decision|0
4870858|NCT00820027|16787114|P3|Overall Study|Physician Decision|1
4870859|NCT00820027|16787115|P2|Overall Study|Physician Decision|1
4870860|NCT00820027|16787116|P1|Overall Study|Physician Decision|0
4870861|NCT00820027|16787113|P4|Overall Study|Lack of Efficacy|2
4870862|NCT00820027|16787114|P3|Overall Study|Lack of Efficacy|2
4870863|NCT00820027|16787115|P2|Overall Study|Lack of Efficacy|1
4870864|NCT00820027|16787116|P1|Overall Study|Lack of Efficacy|2
4870865|NCT00820027|16787113|P4|Overall Study|Adverse Event|5
4870866|NCT00820027|16787114|P3|Overall Study|Adverse Event|10
4870867|NCT00820027|16787115|P2|Overall Study|Adverse Event|8
4870868|NCT00820027|16787116|P1|Overall Study|Adverse Event|15
4870869|NCT00819910|16787158|P4|Overall Study|Lost to Follow-up|0
4870870|NCT00819910|16787159|P3|Overall Study|Lost to Follow-up|0
4870871|NCT00819910|16787160|P2|Overall Study|Lost to Follow-up|0
4870872|NCT00819910|16787161|P1|Overall Study|Lost to Follow-up|1
4870873|NCT00819910|16787158|P4|Overall Study|Withdrawal by Subject|0
4870874|NCT00819910|16787159|P3|Overall Study|Withdrawal by Subject|1
4870875|NCT00819910|16787160|P2|Overall Study|Withdrawal by Subject|1
4870876|NCT00819910|16787161|P1|Overall Study|Withdrawal by Subject|1
4870877|NCT00819910|16787158|P4|Overall Study|Adverse Event|1
4870878|NCT00819910|16787159|P3|Overall Study|Adverse Event|2
4870879|NCT00819910|16787160|P2|Overall Study|Adverse Event|0
4870880|NCT00819910|16787161|P1|Overall Study|Adverse Event|0
4870881|NCT00819832|16787193|P6|Overall Study|Sponsor Termination of Study|0
4870882|NCT00819832|16787194|P5|Overall Study|Sponsor Termination of Study|0
4870883|NCT00819832|16787195|P4|Overall Study|Sponsor Termination of Study|0
4870885|NCT00819832|16787197|P2|Overall Study|Sponsor Termination of Study|0
4870886|NCT00819832|16787198|P1|Overall Study|Sponsor Termination of Study|3
4870887|NCT00819780|16787219|P2|Overall Study|Still in treatment|17
4870888|NCT00819780|16787220|P1|Overall Study|Still in treatment|25
4870889|NCT00819780|16787219|P2|Overall Study|Did not receive study drug|4
4870890|NCT00819780|16787220|P1|Overall Study|Did not receive study drug|3
4870891|NCT00819767|16787254|P2|Overall Study|Unsatisfactory therapeutic effect|2
4870892|NCT00819767|16787255|P1|Overall Study|Unsatisfactory therapeutic effect|1
4870893|NCT00819741|16787267|P2|Overall Study|Reasons unknown|3
4870894|NCT00819741|16787268|P1|Overall Study|Reasons unknown|3
4870895|NCT00819741|16787267|P2|Overall Study|Unclassified|0
4870896|NCT00819741|16787268|P1|Overall Study|Unclassified|6
4870897|NCT00819741|16787267|P2|Overall Study|Withdrawal by Subject|2
4870898|NCT00819741|16787268|P1|Overall Study|Withdrawal by Subject|2
4870899|NCT00819741|16787267|P2|Overall Study|Protocol Violation|4
4870900|NCT00819741|16787268|P1|Overall Study|Protocol Violation|3
4870901|NCT00819741|16787267|P2|Overall Study|Lost to Follow-up|1
4870902|NCT00819741|16787268|P1|Overall Study|Lost to Follow-up|3
4870903|NCT00819741|16787267|P2|Overall Study|Lack of Efficacy|2
4870904|NCT00819741|16787268|P1|Overall Study|Lack of Efficacy|0
4870905|NCT00819741|16787267|P2|Overall Study|Adverse Event|2
4870906|NCT00819741|16787268|P1|Overall Study|Adverse Event|5
4870907|NCT00819585|16787322|P11|Extension Study|Death|0
4870908|NCT00819585|16787323|P10|Extension Study|Death|0
4870909|NCT00819585|16787324|P9|Extension Study|Death|2
4870910|NCT00819585|16787325|P8|Extension Study|Death|0
4870911|NCT00819585|16787326|P7|Extension Study|Death|0
4870912|NCT00819585|16787327|P6|Extension Study|Death|0
4870913|NCT00819585|16787328|P5|Extension Study|Death|0
4870914|NCT00819585|16787329|P4|Extension Study|Death|0
4870915|NCT00819585|16787330|P3|Extension Study|Death|0
4870916|NCT00819585|16787331|P2|Extension Study|Death|0
4870917|NCT00819585|16787332|P1|Extension Study|Death|0
4870918|NCT00819585|16787322|P11|Extension Study|Lost to Follow-up|1
4870919|NCT00819585|16787323|P10|Extension Study|Lost to Follow-up|1
4870920|NCT00819585|16787324|P9|Extension Study|Lost to Follow-up|2
4870921|NCT00819585|16787325|P8|Extension Study|Lost to Follow-up|0
4870922|NCT00819585|16787326|P7|Extension Study|Lost to Follow-up|0
4870923|NCT00819585|16787327|P6|Extension Study|Lost to Follow-up|0
4870924|NCT00819585|16787328|P5|Extension Study|Lost to Follow-up|0
4870925|NCT00819585|16787329|P4|Extension Study|Lost to Follow-up|0
4870926|NCT00819585|16787330|P3|Extension Study|Lost to Follow-up|0
4870927|NCT00819585|16787331|P2|Extension Study|Lost to Follow-up|0
4870928|NCT00819585|16787332|P1|Extension Study|Lost to Follow-up|0
4870929|NCT00819585|16787322|P11|Extension Study|Subject Withdrew Consent|1
4870930|NCT00819585|16787323|P10|Extension Study|Subject Withdrew Consent|0
4870931|NCT00819585|16787324|P9|Extension Study|Subject Withdrew Consent|3
4870932|NCT00819585|16787325|P8|Extension Study|Subject Withdrew Consent|0
4870933|NCT00819585|16787326|P7|Extension Study|Subject Withdrew Consent|0
4870934|NCT00819585|16787327|P6|Extension Study|Subject Withdrew Consent|0
4870935|NCT00819585|16787328|P5|Extension Study|Subject Withdrew Consent|0
4870936|NCT00819585|16787329|P4|Extension Study|Subject Withdrew Consent|0
4870937|NCT00819585|16787330|P3|Extension Study|Subject Withdrew Consent|0
4870938|NCT00819585|16787331|P2|Extension Study|Subject Withdrew Consent|0
4870939|NCT00819585|16787332|P1|Extension Study|Subject Withdrew Consent|0
4870940|NCT00819585|16787322|P11|Extension Study|Abnormal Laboratory Value(s)|0
4870941|NCT00819585|16787323|P10|Extension Study|Abnormal Laboratory Value(s)|0
4870942|NCT00819585|16787324|P9|Extension Study|Abnormal Laboratory Value(s)|1
4870943|NCT00819585|16787325|P8|Extension Study|Abnormal Laboratory Value(s)|0
4870944|NCT00819585|16787326|P7|Extension Study|Abnormal Laboratory Value(s)|0
4870945|NCT00819585|16787327|P6|Extension Study|Abnormal Laboratory Value(s)|0
4870946|NCT00819585|16787328|P5|Extension Study|Abnormal Laboratory Value(s)|0
4870947|NCT00819585|16787329|P4|Extension Study|Abnormal Laboratory Value(s)|0
4870948|NCT00819585|16787330|P3|Extension Study|Abnormal Laboratory Value(s)|0
4870949|NCT00819585|16787331|P2|Extension Study|Abnormal Laboratory Value(s)|0
4870950|NCT00819585|16787332|P1|Extension Study|Abnormal Laboratory Value(s)|0
4870951|NCT00819585|16787322|P11|Core Study|Protocol Violation|0
4870952|NCT00819585|16787323|P10|Core Study|Protocol Violation|0
4870953|NCT00819585|16787324|P9|Core Study|Protocol Violation|0
4870954|NCT00819585|16787325|P8|Core Study|Protocol Violation|0
4870955|NCT00819585|16787326|P7|Core Study|Protocol Violation|3
4870956|NCT00819585|16787327|P6|Core Study|Protocol Violation|1
4870957|NCT00819585|16787328|P5|Core Study|Protocol Violation|0
4870958|NCT00819585|16787329|P4|Core Study|Protocol Violation|0
4870959|NCT00819585|16787330|P3|Core Study|Protocol Violation|1
4870960|NCT00819585|16787331|P2|Core Study|Protocol Violation|0
4870961|NCT00819585|16787332|P1|Core Study|Protocol Violation|0
4870962|NCT00819585|16787322|P11|Core Study|Death|0
4870963|NCT00819585|16787323|P10|Core Study|Death|0
4870964|NCT00819585|16787324|P9|Core Study|Death|0
4870965|NCT00819585|16787325|P8|Core Study|Death|0
4870966|NCT00819585|16787326|P7|Core Study|Death|1
4870967|NCT00819585|16787327|P6|Core Study|Death|0
4870968|NCT00819585|16787328|P5|Core Study|Death|0
4870969|NCT00819585|16787329|P4|Core Study|Death|0
4870970|NCT00819585|16787330|P3|Core Study|Death|0
4870971|NCT00819585|16787331|P2|Core Study|Death|0
4870972|NCT00819585|16787332|P1|Core Study|Death|0
4870973|NCT00819585|16787322|P11|Core Study|Administrative Problems|0
4870974|NCT00819585|16787323|P10|Core Study|Administrative Problems|0
4870975|NCT00819585|16787324|P9|Core Study|Administrative Problems|0
4870976|NCT00819585|16787325|P8|Core Study|Administrative Problems|0
4870977|NCT00819585|16787326|P7|Core Study|Administrative Problems|2
4870978|NCT00819585|16787327|P6|Core Study|Administrative Problems|0
4870979|NCT00819585|16787328|P5|Core Study|Administrative Problems|0
4870980|NCT00819585|16787329|P4|Core Study|Administrative Problems|0
4870981|NCT00819585|16787330|P3|Core Study|Administrative Problems|0
4870982|NCT00819585|16787331|P2|Core Study|Administrative Problems|0
4870983|NCT00819585|16787332|P1|Core Study|Administrative Problems|0
4870984|NCT00819585|16787322|P11|Core Study|Lost to Follow-up|0
4870985|NCT00819585|16787323|P10|Core Study|Lost to Follow-up|0
4870986|NCT00819585|16787324|P9|Core Study|Lost to Follow-up|0
4870987|NCT00819585|16787325|P8|Core Study|Lost to Follow-up|0
4870988|NCT00819585|16787326|P7|Core Study|Lost to Follow-up|1
4870989|NCT00819585|16787327|P6|Core Study|Lost to Follow-up|1
4870990|NCT00819585|16787328|P5|Core Study|Lost to Follow-up|1
4870991|NCT00819585|16787329|P4|Core Study|Lost to Follow-up|0
4870992|NCT00819585|16787330|P3|Core Study|Lost to Follow-up|2
4870993|NCT00819585|16787331|P2|Core Study|Lost to Follow-up|1
4870994|NCT00819585|16787332|P1|Core Study|Lost to Follow-up|2
4870995|NCT00819585|16787322|P11|Core Study|Subject Withdrew Consent|0
4870996|NCT00819585|16787323|P10|Core Study|Subject Withdrew Consent|0
4870997|NCT00819585|16787324|P9|Core Study|Subject Withdrew Consent|0
4870998|NCT00819585|16787325|P8|Core Study|Subject Withdrew Consent|0
4870999|NCT00819585|16787326|P7|Core Study|Subject Withdrew Consent|3
4871000|NCT00819585|16787327|P6|Core Study|Subject Withdrew Consent|0
4871001|NCT00819585|16787328|P5|Core Study|Subject Withdrew Consent|0
4871002|NCT00819585|16787329|P4|Core Study|Subject Withdrew Consent|1
4871003|NCT00819585|16787330|P3|Core Study|Subject Withdrew Consent|2
4871004|NCT00819585|16787331|P2|Core Study|Subject Withdrew Consent|3
4871005|NCT00819585|16787332|P1|Core Study|Subject Withdrew Consent|0
4871006|NCT00819585|16787322|P11|Core Study|Subject No Longer Requires Study Drug|0
4871007|NCT00819585|16787323|P10|Core Study|Subject No Longer Requires Study Drug|0
4871008|NCT00819585|16787324|P9|Core Study|Subject No Longer Requires Study Drug|0
4871009|NCT00819585|16787325|P8|Core Study|Subject No Longer Requires Study Drug|0
4871010|NCT00819585|16787326|P7|Core Study|Subject No Longer Requires Study Drug|0
4871011|NCT00819585|16787327|P6|Core Study|Subject No Longer Requires Study Drug|0
4871012|NCT00819585|16787328|P5|Core Study|Subject No Longer Requires Study Drug|1
4871013|NCT00819585|16787329|P4|Core Study|Subject No Longer Requires Study Drug|0
4871014|NCT00819585|16787330|P3|Core Study|Subject No Longer Requires Study Drug|0
4871015|NCT00819585|16787331|P2|Core Study|Subject No Longer Requires Study Drug|0
4871016|NCT00819585|16787332|P1|Core Study|Subject No Longer Requires Study Drug|0
4871017|NCT00819585|16787322|P11|Core Study|Unsatisfactory Therapeutic Effect|0
4871018|NCT00819585|16787323|P10|Core Study|Unsatisfactory Therapeutic Effect|0
4871019|NCT00819585|16787324|P9|Core Study|Unsatisfactory Therapeutic Effect|0
4871020|NCT00819585|16787325|P8|Core Study|Unsatisfactory Therapeutic Effect|0
4871021|NCT00819585|16787326|P7|Core Study|Unsatisfactory Therapeutic Effect|1
4871022|NCT00819585|16787327|P6|Core Study|Unsatisfactory Therapeutic Effect|0
4871023|NCT00819585|16787328|P5|Core Study|Unsatisfactory Therapeutic Effect|0
4871024|NCT00819585|16787329|P4|Core Study|Unsatisfactory Therapeutic Effect|0
4871025|NCT00819585|16787330|P3|Core Study|Unsatisfactory Therapeutic Effect|0
4871026|NCT00819585|16787331|P2|Core Study|Unsatisfactory Therapeutic Effect|1
4871027|NCT00819585|16787332|P1|Core Study|Unsatisfactory Therapeutic Effect|0
4871028|NCT00819585|16787322|P11|Core Study|Abnormal Laboratory Value(s)|0
4871029|NCT00819585|16787323|P10|Core Study|Abnormal Laboratory Value(s)|0
4871030|NCT00819585|16787324|P9|Core Study|Abnormal Laboratory Value(s)|0
4871031|NCT00819585|16787325|P8|Core Study|Abnormal Laboratory Value(s)|0
4871032|NCT00819585|16787326|P7|Core Study|Abnormal Laboratory Value(s)|0
4871033|NCT00819585|16787327|P6|Core Study|Abnormal Laboratory Value(s)|0
4871034|NCT00819585|16787328|P5|Core Study|Abnormal Laboratory Value(s)|0
4871035|NCT00819585|16787329|P4|Core Study|Abnormal Laboratory Value(s)|0
4871036|NCT00819585|16787330|P3|Core Study|Abnormal Laboratory Value(s)|0
4871037|NCT00819585|16787331|P2|Core Study|Abnormal Laboratory Value(s)|0
4871038|NCT00819585|16787332|P1|Core Study|Abnormal Laboratory Value(s)|2
4871039|NCT00819585|16787322|P11|Core Study|Adverse Event|0
4871040|NCT00819585|16787323|P10|Core Study|Adverse Event|0
4871041|NCT00819585|16787324|P9|Core Study|Adverse Event|0
4871042|NCT00819585|16787325|P8|Core Study|Adverse Event|0
4871043|NCT00819585|16787326|P7|Core Study|Adverse Event|2
4871044|NCT00819585|16787327|P6|Core Study|Adverse Event|0
4871045|NCT00819585|16787328|P5|Core Study|Adverse Event|1
4871046|NCT00819585|16787329|P4|Core Study|Adverse Event|4
4871047|NCT00819585|16787330|P3|Core Study|Adverse Event|1
4871048|NCT00819585|16787331|P2|Core Study|Adverse Event|1
4871049|NCT00819585|16787332|P1|Core Study|Adverse Event|2
4871050|NCT00819390|16787423|P4|Overall Study|Adverse Event|0
4871051|NCT00819390|16787424|P3|Overall Study|Adverse Event|1
4871052|NCT00819390|16787425|P2|Overall Study|Adverse Event|0
4871053|NCT00819390|16787426|P1|Overall Study|Adverse Event|0
4871054|NCT00819390|16787423|P4|Overall Study|Withdrawal by Subject|0
4871055|NCT00819390|16787424|P3|Overall Study|Withdrawal by Subject|0
4871056|NCT00819390|16787425|P2|Overall Study|Withdrawal by Subject|0
4871057|NCT00819390|16787426|P1|Overall Study|Withdrawal by Subject|2
4871058|NCT00819390|16787423|P4|Overall Study|Lost to Follow-up|0
4871059|NCT00819390|16787424|P3|Overall Study|Lost to Follow-up|0
4871060|NCT00819390|16787425|P2|Overall Study|Lost to Follow-up|1
4871061|NCT00819390|16787426|P1|Overall Study|Lost to Follow-up|1
4871062|NCT00819247|16787562|P3|Overall Study|Other|0
4871063|NCT00819247|16787563|P2|Overall Study|Other|0
4871064|NCT00819247|16787564|P1|Overall Study|Other|1
4871065|NCT00819247|16787562|P3|Overall Study|Bad prostate-specific antigen response|0
4871066|NCT00819247|16787563|P2|Overall Study|Bad prostate-specific antigen response|2
4871067|NCT00819247|16787564|P1|Overall Study|Bad prostate-specific antigen response|3
4871068|NCT00819247|16787562|P3|Overall Study|Mistakenly withdrawn|0
4871069|NCT00819247|16787563|P2|Overall Study|Mistakenly withdrawn|1
4871070|NCT00819247|16787564|P1|Overall Study|Mistakenly withdrawn|0
4871071|NCT00819247|16787562|P3|Overall Study|Protocol Violation|1
4871072|NCT00819247|16787563|P2|Overall Study|Protocol Violation|0
4871073|NCT00819247|16787564|P1|Overall Study|Protocol Violation|1
4871074|NCT00819247|16787562|P3|Overall Study|Withdrawal by Subject|0
4871075|NCT00819247|16787563|P2|Overall Study|Withdrawal by Subject|0
4871076|NCT00819247|16787564|P1|Overall Study|Withdrawal by Subject|1
4871077|NCT00819247|16787562|P3|Overall Study|Insufficient testosterone response|10
4871078|NCT00819247|16787563|P2|Overall Study|Insufficient testosterone response|8
4871079|NCT00819247|16787564|P1|Overall Study|Insufficient testosterone response|5
4871080|NCT00819247|16787562|P3|Overall Study|Adverse Event|3
4871081|NCT00819247|16787563|P2|Overall Study|Adverse Event|5
4871082|NCT00819247|16787564|P1|Overall Study|Adverse Event|0
4871083|NCT00819234|16787590|P10|Overall Study|Lost to Follow-up|2
4871084|NCT00819234|16787591|P9|Overall Study|Lost to Follow-up|1
4871085|NCT00819234|16787592|P8|Overall Study|Lost to Follow-up|1
4871086|NCT00819234|16787593|P7|Overall Study|Lost to Follow-up|1
4871087|NCT00819234|16787594|P6|Overall Study|Lost to Follow-up|1
4871088|NCT00819234|16787595|P5|Overall Study|Lost to Follow-up|1
4871089|NCT00819234|16787596|P4|Overall Study|Lost to Follow-up|2
4871090|NCT00819234|16787597|P3|Overall Study|Lost to Follow-up|0
4871091|NCT00819234|16787598|P2|Overall Study|Lost to Follow-up|2
4871092|NCT00819234|16787599|P1|Overall Study|Lost to Follow-up|2
4871093|NCT00819234|16787590|P10|Overall Study|Protocol Violation|0
4871094|NCT00819234|16787591|P9|Overall Study|Protocol Violation|0
4871095|NCT00819234|16787592|P8|Overall Study|Protocol Violation|0
4871096|NCT00819234|16787593|P7|Overall Study|Protocol Violation|0
4871097|NCT00819234|16787594|P6|Overall Study|Protocol Violation|0
4871098|NCT00819234|16787595|P5|Overall Study|Protocol Violation|0
4871099|NCT00819234|16787596|P4|Overall Study|Protocol Violation|0
4871100|NCT00819234|16787597|P3|Overall Study|Protocol Violation|1
4871101|NCT00819234|16787598|P2|Overall Study|Protocol Violation|0
4871102|NCT00819234|16787599|P1|Overall Study|Protocol Violation|0
4871103|NCT00819234|16787590|P10|Overall Study|Physician Decision|2
4871104|NCT00819234|16787591|P9|Overall Study|Physician Decision|0
4871105|NCT00819234|16787592|P8|Overall Study|Physician Decision|0
4871106|NCT00819234|16787593|P7|Overall Study|Physician Decision|0
4871107|NCT00819234|16787594|P6|Overall Study|Physician Decision|0
4871108|NCT00819234|16787595|P5|Overall Study|Physician Decision|0
4871109|NCT00819234|16787596|P4|Overall Study|Physician Decision|1
4871110|NCT00819234|16787597|P3|Overall Study|Physician Decision|0
4871111|NCT00819234|16787598|P2|Overall Study|Physician Decision|0
4871112|NCT00819234|16787599|P1|Overall Study|Physician Decision|0
4871113|NCT00819234|16787590|P10|Overall Study|Adverse Event|0
4871114|NCT00819234|16787591|P9|Overall Study|Adverse Event|0
4871115|NCT00819234|16787592|P8|Overall Study|Adverse Event|0
4871116|NCT00819234|16787593|P7|Overall Study|Adverse Event|0
4871117|NCT00819234|16787594|P6|Overall Study|Adverse Event|2
4871118|NCT00819234|16787595|P5|Overall Study|Adverse Event|0
4871119|NCT00819234|16787596|P4|Overall Study|Adverse Event|0
4871120|NCT00819234|16787597|P3|Overall Study|Adverse Event|1
4871121|NCT00819234|16787598|P2|Overall Study|Adverse Event|0
4871122|NCT00819234|16787599|P1|Overall Study|Adverse Event|0
4871123|NCT00819234|16787590|P10|Overall Study|Withdrawal by Subject|3
4871124|NCT00819234|16787591|P9|Overall Study|Withdrawal by Subject|5
4871125|NCT00819234|16787592|P8|Overall Study|Withdrawal by Subject|8
4871126|NCT00819234|16787593|P7|Overall Study|Withdrawal by Subject|4
4871127|NCT00819234|16787594|P6|Overall Study|Withdrawal by Subject|4
4871128|NCT00819234|16787595|P5|Overall Study|Withdrawal by Subject|0
4871129|NCT00819234|16787596|P4|Overall Study|Withdrawal by Subject|3
4871130|NCT00819234|16787597|P3|Overall Study|Withdrawal by Subject|6
4871131|NCT00819234|16787598|P2|Overall Study|Withdrawal by Subject|13
4871132|NCT00819234|16787599|P1|Overall Study|Withdrawal by Subject|8
4871133|NCT00819156|16787798|P6|Overall Study|Prostate-specific antigen progression|0
4871134|NCT00819156|16787799|P5|Overall Study|Prostate-specific antigen progression|1
4871135|NCT00819156|16787800|P4|Overall Study|Prostate-specific antigen progression|0
4871136|NCT00819156|16787801|P3|Overall Study|Prostate-specific antigen progression|0
4871137|NCT00819156|16787802|P2|Overall Study|Prostate-specific antigen progression|0
4871138|NCT00819156|16787803|P1|Overall Study|Prostate-specific antigen progression|0
4871139|NCT00819156|16787798|P6|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4871140|NCT00819156|16787799|P5|Overall Study|Testosterone >=.5ng/ml 2 visits|1
4871141|NCT00819156|16787800|P4|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4871142|NCT00819156|16787801|P3|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4871143|NCT00819156|16787802|P2|Overall Study|Testosterone >=.5ng/ml 2 visits|0
4871144|NCT00819156|16787803|P1|Overall Study|Testosterone >=.5ng/ml 2 visits|3
4871145|NCT00819156|16787798|P6|Overall Study|Testosterone >1ng/ml from Day 28+|2
4871235|NCT00818883|16788137|P2|Overall Study|Adverse Event|19
4871146|NCT00819156|16787799|P5|Overall Study|Testosterone >1ng/ml from Day 28+|1
4871147|NCT00819156|16787800|P4|Overall Study|Testosterone >1ng/ml from Day 28+|1
4871148|NCT00819156|16787801|P3|Overall Study|Testosterone >1ng/ml from Day 28+|1
4871149|NCT00819156|16787802|P2|Overall Study|Testosterone >1ng/ml from Day 28+|2
4871150|NCT00819156|16787803|P1|Overall Study|Testosterone >1ng/ml from Day 28+|5
4871151|NCT00819156|16787798|P6|Overall Study|Lost to Follow-up|2
4871152|NCT00819156|16787799|P5|Overall Study|Lost to Follow-up|0
4871153|NCT00819156|16787800|P4|Overall Study|Lost to Follow-up|0
4871154|NCT00819156|16787801|P3|Overall Study|Lost to Follow-up|0
4871155|NCT00819156|16787802|P2|Overall Study|Lost to Follow-up|1
4871156|NCT00819156|16787803|P1|Overall Study|Lost to Follow-up|0
4871157|NCT00819156|16787798|P6|Overall Study|Protocol Violation|1
4871158|NCT00819156|16787799|P5|Overall Study|Protocol Violation|0
4871159|NCT00819156|16787800|P4|Overall Study|Protocol Violation|0
4871160|NCT00819156|16787801|P3|Overall Study|Protocol Violation|1
4871161|NCT00819156|16787802|P2|Overall Study|Protocol Violation|0
4871162|NCT00819156|16787803|P1|Overall Study|Protocol Violation|1
4871163|NCT00819156|16787798|P6|Overall Study|Withdrawal by Subject|0
4871164|NCT00819156|16787799|P5|Overall Study|Withdrawal by Subject|1
4871165|NCT00819156|16787800|P4|Overall Study|Withdrawal by Subject|0
4871166|NCT00819156|16787801|P3|Overall Study|Withdrawal by Subject|2
4871167|NCT00819156|16787802|P2|Overall Study|Withdrawal by Subject|3
4871168|NCT00819156|16787803|P1|Overall Study|Withdrawal by Subject|0
4871169|NCT00819156|16787798|P6|Overall Study|Adverse Event|3
4871170|NCT00819156|16787799|P5|Overall Study|Adverse Event|2
4871171|NCT00819156|16787800|P4|Overall Study|Adverse Event|1
4871172|NCT00819156|16787801|P3|Overall Study|Adverse Event|2
4871173|NCT00819156|16787802|P2|Overall Study|Adverse Event|4
4871174|NCT00819156|16787803|P1|Overall Study|Adverse Event|1
4871175|NCT00819091|16787893|P2|Overall Study|Other|2
4871176|NCT00819091|16787894|P1|Overall Study|Other|1
4871177|NCT00819091|16787893|P2|Overall Study|Withdrawal by Subject|2
4871178|NCT00819091|16787894|P1|Overall Study|Withdrawal by Subject|1
4871179|NCT00819091|16787893|P2|Overall Study|Lost to Follow-up|0
4871180|NCT00819091|16787894|P1|Overall Study|Lost to Follow-up|2
4871181|NCT00819091|16787893|P2|Overall Study|Protocol Violation|1
4871182|NCT00819091|16787894|P1|Overall Study|Protocol Violation|0
4871183|NCT00819091|16787893|P2|Overall Study|Adverse Event|5
4871184|NCT00819091|16787894|P1|Overall Study|Adverse Event|3
4871185|NCT00819052|16787920|P2|Overall Study|Death or events leading to death|0
4871186|NCT00819052|16787921|P1|Overall Study|Death or events leading to death|1
4871187|NCT00819052|16787920|P2|Overall Study|Pregnancy|2
4871188|NCT00819052|16787921|P1|Overall Study|Pregnancy|1
4871189|NCT00819052|16787920|P2|Overall Study|Lack of Efficacy|1
4871190|NCT00819052|16787921|P1|Overall Study|Lack of Efficacy|1
4871191|NCT00819052|16787920|P2|Overall Study|Withdrawal by Subject|2
4871192|NCT00819052|16787921|P1|Overall Study|Withdrawal by Subject|1
4871193|NCT00819052|16787920|P2|Overall Study|Lost to Follow-up|2
4871194|NCT00819052|16787921|P1|Overall Study|Lost to Follow-up|1
4871195|NCT00819052|16787920|P2|Overall Study|Protocol Violation|2
4871196|NCT00819052|16787921|P1|Overall Study|Protocol Violation|1
4871197|NCT00819052|16787920|P2|Overall Study|Adverse Event|5
4871198|NCT00819052|16787921|P1|Overall Study|Adverse Event|0
4871199|NCT00819039|16788036|P3|Overall Study|Protocol Violation|0
4871200|NCT00819039|16788037|P2|Overall Study|Protocol Violation|0
4871201|NCT00819039|16788038|P1|Overall Study|Protocol Violation|1
4871202|NCT00819039|16788036|P3|Overall Study|Physician Decision|1
4871203|NCT00819039|16788037|P2|Overall Study|Physician Decision|0
4871204|NCT00819039|16788038|P1|Overall Study|Physician Decision|1
4871205|NCT00819013|16788068|P4|Overall Study|Death|1
4871206|NCT00819013|16788069|P3|Overall Study|Death|0
4871207|NCT00819013|16788070|P2|Overall Study|Death|0
4871208|NCT00819013|16788071|P1|Overall Study|Death|0
4871209|NCT00819013|16788068|P4|Overall Study|Lost to Follow-up|2
4871210|NCT00819013|16788069|P3|Overall Study|Lost to Follow-up|1
4871211|NCT00819013|16788070|P2|Overall Study|Lost to Follow-up|0
4871212|NCT00819013|16788071|P1|Overall Study|Lost to Follow-up|0
4871213|NCT00819013|16788068|P4|Overall Study|Withdrawal by Subject|0
4871214|NCT00819013|16788069|P3|Overall Study|Withdrawal by Subject|1
4871215|NCT00819013|16788070|P2|Overall Study|Withdrawal by Subject|0
4871216|NCT00819013|16788071|P1|Overall Study|Withdrawal by Subject|1
4871217|NCT00819013|16788068|P4|Overall Study|Adverse Event|0
4871218|NCT00819013|16788069|P3|Overall Study|Adverse Event|1
4871219|NCT00819013|16788070|P2|Overall Study|Adverse Event|0
4871220|NCT00819013|16788071|P1|Overall Study|Adverse Event|0
4871221|NCT00819013|16788068|P4|Overall Study|Not meeting continuing study eligibility|1
4871222|NCT00819013|16788069|P3|Overall Study|Not meeting continuing study eligibility|2
4871223|NCT00819013|16788070|P2|Overall Study|Not meeting continuing study eligibility|1
4871224|NCT00819013|16788071|P1|Overall Study|Not meeting continuing study eligibility|2
4871225|NCT00818883|16788137|P2|Overall Study|Other|7
4871226|NCT00818883|16788138|P1|Overall Study|Other|2
4871227|NCT00818883|16788137|P2|Overall Study|Lack of Efficacy|2
4871228|NCT00818883|16788138|P1|Overall Study|Lack of Efficacy|0
4871229|NCT00818883|16788137|P2|Overall Study|Withdrawal by Subject|14
4871230|NCT00818883|16788138|P1|Overall Study|Withdrawal by Subject|16
4871231|NCT00818883|16788137|P2|Overall Study|Lost to Follow-up|2
4871232|NCT00818883|16788138|P1|Overall Study|Lost to Follow-up|3
4871233|NCT00818883|16788137|P2|Overall Study|Protocol Violation|2
4871234|NCT00818883|16788138|P1|Overall Study|Protocol Violation|2
4871236|NCT00818883|16788138|P1|Overall Study|Adverse Event|28
4871237|NCT00818779|16788185|P2|Overall Study|Adverse Event|1
4871238|NCT00818779|16788186|P1|Overall Study|Adverse Event|4
4871239|NCT00818779|16788185|P2|Overall Study|Lost to Follow-up|0
4871240|NCT00818779|16788186|P1|Overall Study|Lost to Follow-up|1
4871241|NCT00818779|16788185|P2|Overall Study|Protocol Violation|0
4871242|NCT00818779|16788186|P1|Overall Study|Protocol Violation|1
4871243|NCT00818766|16788202|P2|Overall Study|Did not Receive Allocated Intervention|0
4871244|NCT00818766|16788203|P1|Overall Study|Did not Receive Allocated Intervention|3
4871245|NCT00818766|16788202|P2|Overall Study|Death|0
4871246|NCT00818766|16788203|P1|Overall Study|Death|1
4871247|NCT00818766|16788202|P2|Overall Study|Could not be Contacted on Day 28|10
4871248|NCT00818766|16788203|P1|Overall Study|Could not be Contacted on Day 28|11
4871249|NCT00818753|16788232|P3|Overall Study|Randomised and not treated|0
4871250|NCT00818753|16788233|P2|Overall Study|Randomised and not treated|0
4871251|NCT00818753|16788234|P1|Overall Study|Randomised and not treated|2
4871252|NCT00818753|16788232|P3|Overall Study|Other reason (not specified)|1
4871253|NCT00818753|16788233|P2|Overall Study|Other reason (not specified)|0
4871254|NCT00818753|16788234|P1|Overall Study|Other reason (not specified)|0
4871255|NCT00818753|16788232|P3|Overall Study|Protocol Violation|0
4871256|NCT00818753|16788233|P2|Overall Study|Protocol Violation|0
4871257|NCT00818753|16788234|P1|Overall Study|Protocol Violation|1
4871258|NCT00818662|16788258|P4|Overall Study|Admitted to long term nursing care|0
4871259|NCT00818662|16788259|P3|Overall Study|Admitted to long term nursing care|0
4871260|NCT00818662|16788260|P2|Overall Study|Admitted to long term nursing care|1
4871261|NCT00818662|16788261|P1|Overall Study|Admitted to long term nursing care|0
4871262|NCT00818662|16788258|P4|Overall Study|Study partner decision|1
4871263|NCT00818662|16788259|P3|Overall Study|Study partner decision|0
4871264|NCT00818662|16788260|P2|Overall Study|Study partner decision|0
4871265|NCT00818662|16788261|P1|Overall Study|Study partner decision|0
4871266|NCT00818662|16788258|P4|Overall Study|Change in living situation|1
4871267|NCT00818662|16788259|P3|Overall Study|Change in living situation|0
4871268|NCT00818662|16788260|P2|Overall Study|Change in living situation|0
4871269|NCT00818662|16788261|P1|Overall Study|Change in living situation|0
4871270|NCT00818662|16788258|P4|Overall Study|Declined move to another study site|0
4871271|NCT00818662|16788259|P3|Overall Study|Declined move to another study site|0
4871272|NCT00818662|16788260|P2|Overall Study|Declined move to another study site|0
4871273|NCT00818662|16788261|P1|Overall Study|Declined move to another study site|1
4871274|NCT00818662|16788258|P4|Overall Study|Moving out of state|1
4871275|NCT00818662|16788259|P3|Overall Study|Moving out of state|0
4871276|NCT00818662|16788260|P2|Overall Study|Moving out of state|0
4871277|NCT00818662|16788261|P1|Overall Study|Moving out of state|0
4871278|NCT00818662|16788258|P4|Overall Study|Caregiver to pursue other treatment|0
4871279|NCT00818662|16788259|P3|Overall Study|Caregiver to pursue other treatment|0
4871280|NCT00818662|16788260|P2|Overall Study|Caregiver to pursue other treatment|1
4871281|NCT00818662|16788261|P1|Overall Study|Caregiver to pursue other treatment|0
4871282|NCT00818662|16788258|P4|Overall Study|Participant's health declined|1
4871283|NCT00818662|16788259|P3|Overall Study|Participant's health declined|0
4871284|NCT00818662|16788260|P2|Overall Study|Participant's health declined|0
4871285|NCT00818662|16788261|P1|Overall Study|Participant's health declined|0
4871286|NCT00818662|16788258|P4|Overall Study|Study Partner Unwilling or Unable|1
4871287|NCT00818662|16788259|P3|Overall Study|Study Partner Unwilling or Unable|1
4871288|NCT00818662|16788260|P2|Overall Study|Study Partner Unwilling or Unable|2
4871289|NCT00818662|16788261|P1|Overall Study|Study Partner Unwilling or Unable|3
4871290|NCT00818662|16788258|P4|Overall Study|Safety Risk|1
4871291|NCT00818662|16788259|P3|Overall Study|Safety Risk|0
4871292|NCT00818662|16788260|P2|Overall Study|Safety Risk|1
4871293|NCT00818662|16788261|P1|Overall Study|Safety Risk|1
4871294|NCT00818662|16788258|P4|Overall Study|Requires a Prohibited Medication|0
4871295|NCT00818662|16788259|P3|Overall Study|Requires a Prohibited Medication|0
4871296|NCT00818662|16788260|P2|Overall Study|Requires a Prohibited Medication|0
4871297|NCT00818662|16788261|P1|Overall Study|Requires a Prohibited Medication|1
4871298|NCT00818662|16788258|P4|Overall Study|Protocol Violation|0
4871299|NCT00818662|16788259|P3|Overall Study|Protocol Violation|0
4871300|NCT00818662|16788260|P2|Overall Study|Protocol Violation|1
4871301|NCT00818662|16788261|P1|Overall Study|Protocol Violation|1
4871302|NCT00818662|16788258|P4|Overall Study|Unwilling or Unable to Participate|4
4871303|NCT00818662|16788259|P3|Overall Study|Unwilling or Unable to Participate|2
4871304|NCT00818662|16788260|P2|Overall Study|Unwilling or Unable to Participate|6
4871305|NCT00818662|16788261|P1|Overall Study|Unwilling or Unable to Participate|4
4871306|NCT00818662|16788258|P4|Overall Study|Lost to Follow-up|1
4871307|NCT00818662|16788259|P3|Overall Study|Lost to Follow-up|0
4871308|NCT00818662|16788260|P2|Overall Study|Lost to Follow-up|0
4871309|NCT00818662|16788261|P1|Overall Study|Lost to Follow-up|0
4871310|NCT00818662|16788258|P4|Overall Study|Physician Decision|0
4871311|NCT00818662|16788259|P3|Overall Study|Physician Decision|0
4871312|NCT00818662|16788260|P2|Overall Study|Physician Decision|0
4871313|NCT00818662|16788261|P1|Overall Study|Physician Decision|1
4871314|NCT00818662|16788258|P4|Overall Study|Death|0
4871315|NCT00818662|16788259|P3|Overall Study|Death|0
4871316|NCT00818662|16788260|P2|Overall Study|Death|3
4871317|NCT00818662|16788261|P1|Overall Study|Death|1
4871318|NCT00818662|16788258|P4|Overall Study|Withdrawal by Subject|2
4871319|NCT00818662|16788259|P3|Overall Study|Withdrawal by Subject|2
4871320|NCT00818662|16788260|P2|Overall Study|Withdrawal by Subject|4
4871321|NCT00818662|16788261|P1|Overall Study|Withdrawal by Subject|5
4871322|NCT00818662|16788258|P4|Overall Study|Adverse Event|3
4871323|NCT00818662|16788259|P3|Overall Study|Adverse Event|4
4871324|NCT00818662|16788260|P2|Overall Study|Adverse Event|14
4871325|NCT00818662|16788261|P1|Overall Study|Adverse Event|5
4871326|NCT00818649|16788347|P1|Overall Study|Adverse Event|1
4871327|NCT00818649|16788347|P1|Overall Study|Unrelated hip fracture-unable to proceed|1
4871328|NCT00818649|16788347|P1|Overall Study|Declining performance status|2
4871329|NCT00818623|16788361|P8|Overall Study|Disease progression|0
4871330|NCT00818623|16788362|P7|Overall Study|Disease progression|1
4871331|NCT00818623|16788363|P6|Overall Study|Disease progression|0
4871332|NCT00818623|16788364|P5|Overall Study|Disease progression|0
4871333|NCT00818623|16788365|P4|Overall Study|Disease progression|0
4871334|NCT00818623|16788366|P3|Overall Study|Disease progression|0
4871335|NCT00818623|16788367|P2|Overall Study|Disease progression|0
4871336|NCT00818623|16788368|P1|Overall Study|Disease progression|0
4871337|NCT00818623|16788361|P8|Overall Study|Lack of trial drug at site|0
4871338|NCT00818623|16788362|P7|Overall Study|Lack of trial drug at site|1
4871339|NCT00818623|16788363|P6|Overall Study|Lack of trial drug at site|0
4871340|NCT00818623|16788364|P5|Overall Study|Lack of trial drug at site|2
4871341|NCT00818623|16788365|P4|Overall Study|Lack of trial drug at site|0
4871342|NCT00818623|16788366|P3|Overall Study|Lack of trial drug at site|0
4871343|NCT00818623|16788367|P2|Overall Study|Lack of trial drug at site|0
4871344|NCT00818623|16788368|P1|Overall Study|Lack of trial drug at site|0
4871345|NCT00818623|16788361|P8|Overall Study|Need of additional treatment|0
4871346|NCT00818623|16788362|P7|Overall Study|Need of additional treatment|0
4871347|NCT00818623|16788363|P6|Overall Study|Need of additional treatment|0
4871348|NCT00818623|16788364|P5|Overall Study|Need of additional treatment|1
4871349|NCT00818623|16788365|P4|Overall Study|Need of additional treatment|0
4871350|NCT00818623|16788366|P3|Overall Study|Need of additional treatment|0
4871351|NCT00818623|16788367|P2|Overall Study|Need of additional treatment|0
4871352|NCT00818623|16788368|P1|Overall Study|Need of additional treatment|0
4871353|NCT00818623|16788361|P8|Overall Study|Protocol Violation|0
4871354|NCT00818623|16788362|P7|Overall Study|Protocol Violation|1
4871355|NCT00818623|16788363|P6|Overall Study|Protocol Violation|0
4871356|NCT00818623|16788364|P5|Overall Study|Protocol Violation|1
4871357|NCT00818623|16788365|P4|Overall Study|Protocol Violation|0
4871358|NCT00818623|16788366|P3|Overall Study|Protocol Violation|0
4871359|NCT00818623|16788367|P2|Overall Study|Protocol Violation|0
4871360|NCT00818623|16788368|P1|Overall Study|Protocol Violation|1
4871361|NCT00818623|16788361|P8|Overall Study|Withdrawal by Subject|1
4871362|NCT00818623|16788362|P7|Overall Study|Withdrawal by Subject|1
4871363|NCT00818623|16788363|P6|Overall Study|Withdrawal by Subject|1
4871364|NCT00818623|16788364|P5|Overall Study|Withdrawal by Subject|0
4871365|NCT00818623|16788365|P4|Overall Study|Withdrawal by Subject|0
4871366|NCT00818623|16788366|P3|Overall Study|Withdrawal by Subject|1
4871367|NCT00818623|16788367|P2|Overall Study|Withdrawal by Subject|1
4871368|NCT00818623|16788368|P1|Overall Study|Withdrawal by Subject|0
4871369|NCT00818623|16788361|P8|Overall Study|Bad prostate specific antigen response|0
4871370|NCT00818623|16788362|P7|Overall Study|Bad prostate specific antigen response|0
4871371|NCT00818623|16788363|P6|Overall Study|Bad prostate specific antigen response|1
4871372|NCT00818623|16788364|P5|Overall Study|Bad prostate specific antigen response|0
4871373|NCT00818623|16788365|P4|Overall Study|Bad prostate specific antigen response|5
4871374|NCT00818623|16788366|P3|Overall Study|Bad prostate specific antigen response|2
4871375|NCT00818623|16788367|P2|Overall Study|Bad prostate specific antigen response|3
4871376|NCT00818623|16788368|P1|Overall Study|Bad prostate specific antigen response|0
4871377|NCT00818623|16788361|P8|Overall Study|Adverse Event|0
4871378|NCT00818623|16788362|P7|Overall Study|Adverse Event|0
4871379|NCT00818623|16788363|P6|Overall Study|Adverse Event|1
4871380|NCT00818623|16788364|P5|Overall Study|Adverse Event|0
4871381|NCT00818623|16788365|P4|Overall Study|Adverse Event|0
4871382|NCT00818623|16788366|P3|Overall Study|Adverse Event|1
4871383|NCT00818623|16788367|P2|Overall Study|Adverse Event|0
4871384|NCT00818623|16788368|P1|Overall Study|Adverse Event|1
4871385|NCT00818519|16788444|P2|Overall Study|participant will leave for long tme|0
4871386|NCT00818519|16788445|P1|Overall Study|participant will leave for long tme|1
4871387|NCT00818519|16788444|P2|Overall Study|participant recovered completely|0
4871388|NCT00818519|16788445|P1|Overall Study|participant recovered completely|1
4871389|NCT00818519|16788444|P2|Overall Study|Withdrawal by Subject|9
4871390|NCT00818519|16788445|P1|Overall Study|Withdrawal by Subject|4
4871391|NCT00818519|16788444|P2|Overall Study|Pregnancy|1
4871392|NCT00818519|16788445|P1|Overall Study|Pregnancy|0
4871393|NCT00818519|16788444|P2|Overall Study|Protocol Violation|1
4871394|NCT00818519|16788445|P1|Overall Study|Protocol Violation|2
4871395|NCT00818519|16788444|P2|Overall Study|Lost to Follow-up|6
4871396|NCT00818519|16788445|P1|Overall Study|Lost to Follow-up|4
4871397|NCT00818519|16788444|P2|Overall Study|Adverse Event|2
4871398|NCT00818519|16788445|P1|Overall Study|Adverse Event|2
4871399|NCT00818454|16788475|P4|Treatment Period 3|Adverse Event|1
4871400|NCT00818454|16788476|P3|Treatment Period 3|Adverse Event|0
4871401|NCT00818454|16788477|P2|Treatment Period 3|Adverse Event|0
4871402|NCT00818454|16788478|P1|Treatment Period 3|Adverse Event|0
4871403|NCT00818454|16788475|P4|Treatment Period 2|Other|0
4871404|NCT00818454|16788476|P3|Treatment Period 2|Other|0
4871405|NCT00818454|16788477|P2|Treatment Period 2|Other|1
4871406|NCT00818454|16788478|P1|Treatment Period 2|Other|2
4871407|NCT00818454|16788475|P4|Washout Period of 1 Week|Other|0
4871408|NCT00818454|16788476|P3|Washout Period of 1 Week|Other|0
4871409|NCT00818454|16788477|P2|Washout Period of 1 Week|Other|2
4871410|NCT00818454|16788478|P1|Washout Period of 1 Week|Other|1
4871411|NCT00818454|16788475|P4|Washout Period of 1 Week|Protocol Violation|0
4871412|NCT00818454|16788476|P3|Washout Period of 1 Week|Protocol Violation|0
4871413|NCT00818454|16788477|P2|Washout Period of 1 Week|Protocol Violation|0
4871414|NCT00818454|16788478|P1|Washout Period of 1 Week|Protocol Violation|2
4871415|NCT00818454|16788475|P4|Washout Period of 1 Week|Adverse Event|0
4871416|NCT00818454|16788476|P3|Washout Period of 1 Week|Adverse Event|0
4871417|NCT00818454|16788477|P2|Washout Period of 1 Week|Adverse Event|1
4871418|NCT00818454|16788478|P1|Washout Period of 1 Week|Adverse Event|1
4871419|NCT00818454|16788475|P4|Treatment Period 1|Other|0
4871420|NCT00818454|16788476|P3|Treatment Period 1|Other|0
4871421|NCT00818454|16788477|P2|Treatment Period 1|Other|0
4871422|NCT00818454|16788478|P1|Treatment Period 1|Other|3
4871423|NCT00818454|16788475|P4|Treatment Period 1|Adverse Event|0
4871424|NCT00818454|16788476|P3|Treatment Period 1|Adverse Event|0
4871425|NCT00818454|16788477|P2|Treatment Period 1|Adverse Event|1
4871426|NCT00818454|16788478|P1|Treatment Period 1|Adverse Event|0
4871427|NCT00818441|16788506|P2|Overall Study|Study terminated by sponsor|2
4871428|NCT00818441|16788507|P1|Overall Study|Study terminated by sponsor|11
4871429|NCT00818441|16788506|P2|Overall Study|Adverse Event|1
4871430|NCT00818441|16788507|P1|Overall Study|Adverse Event|0
4871431|NCT00818441|16788506|P2|Overall Study|Withdrawal by Subject|0
4871432|NCT00818441|16788507|P1|Overall Study|Withdrawal by Subject|2
4871433|NCT00818441|16788506|P2|Overall Study|Lost to Follow-up|1
4871434|NCT00818441|16788507|P1|Overall Study|Lost to Follow-up|2
4871435|NCT00818441|16788506|P2|Overall Study|Other|0
4871436|NCT00818441|16788507|P1|Overall Study|Other|5
4871437|NCT00818441|16788506|P2|Overall Study|Death|26
4871438|NCT00818441|16788507|P1|Overall Study|Death|69
4871439|NCT00818389|16788529|P2|Overall Study|Adverse Event|1
4871440|NCT00818389|16788530|P1|Overall Study|Adverse Event|0
4871441|NCT00818389|16788529|P2|Overall Study|Withdrawal by Subject|2
4871442|NCT00818389|16788530|P1|Overall Study|Withdrawal by Subject|2
4871443|NCT00818389|16788529|P2|Overall Study|ALS Disease Progression|0
4871444|NCT00818389|16788530|P1|Overall Study|ALS Disease Progression|1
4871445|NCT00818389|16788529|P2|Overall Study|Death|3
4871446|NCT00818389|16788530|P1|Overall Study|Death|1
4871447|NCT00818259|16788565|P9|Part V|Adverse Event|0
4871448|NCT00818259|16788566|P8|Part V|Adverse Event|1
4871449|NCT00818259|16788567|P7|Part V|Adverse Event|0
4871450|NCT00818259|16788568|P6|Part V|Adverse Event|0
4871451|NCT00818259|16788569|P5|Part V|Adverse Event|0
4871452|NCT00818259|16788570|P4|Part V|Adverse Event|0
4871453|NCT00818259|16788571|P3|Part V|Adverse Event|0
4871454|NCT00818259|16788572|P2|Part V|Adverse Event|0
4871455|NCT00818259|16788573|P1|Part V|Adverse Event|0
4871456|NCT00818259|16788565|P9|Part IV|Physician Decision|0
4871457|NCT00818259|16788566|P8|Part IV|Physician Decision|0
4871458|NCT00818259|16788567|P7|Part IV|Physician Decision|0
4871459|NCT00818259|16788568|P6|Part IV|Physician Decision|1
4871460|NCT00818259|16788569|P5|Part IV|Physician Decision|0
4871461|NCT00818259|16788570|P4|Part IV|Physician Decision|0
4871462|NCT00818259|16788571|P3|Part IV|Physician Decision|0
4871463|NCT00818259|16788572|P2|Part IV|Physician Decision|0
4871464|NCT00818259|16788573|P1|Part IV|Physician Decision|0
4871465|NCT00818259|16788565|P9|Part II|Not Treated|0
4871466|NCT00818259|16788566|P8|Part II|Not Treated|0
4871467|NCT00818259|16788567|P7|Part II|Not Treated|0
4871468|NCT00818259|16788568|P6|Part II|Not Treated|0
4871469|NCT00818259|16788569|P5|Part II|Not Treated|0
4871470|NCT00818259|16788570|P4|Part II|Not Treated|1
4871471|NCT00818259|16788571|P3|Part II|Not Treated|0
4871472|NCT00818259|16788572|P2|Part II|Not Treated|0
4871473|NCT00818259|16788573|P1|Part II|Not Treated|0
4871474|NCT00818259|16788565|P9|Part II|Lack of Efficacy|0
4871475|NCT00818259|16788566|P8|Part II|Lack of Efficacy|0
4871476|NCT00818259|16788567|P7|Part II|Lack of Efficacy|0
4871477|NCT00818259|16788568|P6|Part II|Lack of Efficacy|0
4871478|NCT00818259|16788569|P5|Part II|Lack of Efficacy|0
4871479|NCT00818259|16788570|P4|Part II|Lack of Efficacy|1
4871480|NCT00818259|16788571|P3|Part II|Lack of Efficacy|0
4871481|NCT00818259|16788572|P2|Part II|Lack of Efficacy|0
4871482|NCT00818259|16788573|P1|Part II|Lack of Efficacy|0
4871483|NCT00818259|16788565|P9|Part II|Physician Decision|0
4871484|NCT00818259|16788566|P8|Part II|Physician Decision|0
4871485|NCT00818259|16788567|P7|Part II|Physician Decision|0
4871486|NCT00818259|16788568|P6|Part II|Physician Decision|0
4871487|NCT00818259|16788569|P5|Part II|Physician Decision|0
4871488|NCT00818259|16788570|P4|Part II|Physician Decision|0
4871489|NCT00818259|16788571|P3|Part II|Physician Decision|1
4871490|NCT00818259|16788572|P2|Part II|Physician Decision|0
4871491|NCT00818259|16788573|P1|Part II|Physician Decision|0
4871492|NCT00818259|16788565|P9|Part I|Withdrawal by Subject|0
4871493|NCT00818259|16788566|P8|Part I|Withdrawal by Subject|0
4871494|NCT00818259|16788567|P7|Part I|Withdrawal by Subject|0
4871495|NCT00818259|16788568|P6|Part I|Withdrawal by Subject|0
4871496|NCT00818259|16788569|P5|Part I|Withdrawal by Subject|0
4871497|NCT00818259|16788570|P4|Part I|Withdrawal by Subject|0
4871498|NCT00818259|16788571|P3|Part I|Withdrawal by Subject|0
4871499|NCT00818259|16788572|P2|Part I|Withdrawal by Subject|0
4871500|NCT00818259|16788573|P1|Part I|Withdrawal by Subject|1
4871501|NCT00818246|16788645|P1|Overall Study|Impossible to match pictures|5
4871502|NCT00818207|16788654|P2|Overall Study|Death|5
4871503|NCT00818207|16788655|P1|Overall Study|Death|3
4871504|NCT00818207|16788654|P2|Overall Study|Withdrawal by Subject|104
4871505|NCT00818207|16788655|P1|Overall Study|Withdrawal by Subject|42
4871506|NCT00818207|16788654|P2|Overall Study|Multiple reasons|12
4871507|NCT00818207|16788655|P1|Overall Study|Multiple reasons|11
4871508|NCT00818207|16788654|P2|Overall Study|Lost to Follow-up|146
4871509|NCT00818207|16788655|P1|Overall Study|Lost to Follow-up|160
4871510|NCT00818207|16788654|P2|Overall Study|Adverse Event|0
4871511|NCT00818207|16788655|P1|Overall Study|Adverse Event|6
4871512|NCT00818168|16788669|P1|Overall Study|Participant Moved|2
4871513|NCT00818168|16788669|P1|Overall Study|Reason for Non-completion Not reported|6
4871514|NCT00818168|16788669|P1|Overall Study|Adverse Event|19
4871515|NCT00818168|16788669|P1|Overall Study|Lost to Follow-up|7
4871516|NCT00818168|16788669|P1|Overall Study|Withdrawal by Subject|16
4871517|NCT00818168|16788669|P1|Overall Study|Pregnancy|2
4871518|NCT00818168|16788669|P1|Overall Study|Lack of Efficacy|18
4871519|NCT00817778|16788709|P2|Overall Study|Poor venous access|0
4871520|NCT00817778|16788710|P1|Overall Study|Poor venous access|1
4871521|NCT00817778|16788709|P2|Overall Study|Study-specific discontinuation criteria|1
4871522|NCT00817778|16788710|P1|Overall Study|Study-specific discontinuation criteria|0
4871523|NCT00817778|16788709|P2|Overall Study|Protocol Violation|1
4871524|NCT00817778|16788710|P1|Overall Study|Protocol Violation|0
4871525|NCT00817778|16788709|P2|Overall Study|Withdrawal by Subject|1
4871526|NCT00817778|16788710|P1|Overall Study|Withdrawal by Subject|1
4871527|NCT00817778|16788709|P2|Overall Study|Adverse Event|0
4871528|NCT00817778|16788710|P1|Overall Study|Adverse Event|1
4871529|NCT00817531|16788739|P1|Overall Study|Lack of Efficacy|1
4871530|NCT00817531|16788739|P1|Overall Study|Adverse Event|1
4871531|NCT00817479|16788745|P2|Overall Study|Physician Decision|1
4871532|NCT00817479|16788746|P1|Overall Study|Physician Decision|1
4871533|NCT00817336|16788756|P2|Overall Study|Withdrawal by Subject|1
4871534|NCT00817336|16788757|P1|Overall Study|Withdrawal by Subject|1
4871535|NCT00817206|16788783|P2|Overall Study|Physician Decision|0
4871536|NCT00817206|16788784|P1|Overall Study|Physician Decision|2
4871537|NCT00817206|16788783|P2|Overall Study|Withdrawal by Subject|3
4871538|NCT00817206|16788784|P1|Overall Study|Withdrawal by Subject|7
4871539|NCT00817206|16788783|P2|Overall Study|Death|0
4871540|NCT00817206|16788784|P1|Overall Study|Death|2
4871541|NCT00817206|16788783|P2|Overall Study|Lost to Follow-up|1
4871542|NCT00817206|16788784|P1|Overall Study|Lost to Follow-up|0
4871543|NCT00817206|16788783|P2|Overall Study|Protocol Violation|2
4871544|NCT00817206|16788784|P1|Overall Study|Protocol Violation|0
4871545|NCT00817206|16788783|P2|Overall Study|Adverse Event|3
4871546|NCT00817206|16788784|P1|Overall Study|Adverse Event|10
4871547|NCT00817089|16788794|P4|Second Alcohol Challenge|Lost to Follow-up|0
4871548|NCT00817089|16788795|P3|Second Alcohol Challenge|Lost to Follow-up|0
4871549|NCT00817089|16788796|P2|Second Alcohol Challenge|Lost to Follow-up|1
4871550|NCT00817089|16788797|P1|Second Alcohol Challenge|Lost to Follow-up|0
4871551|NCT00817089|16788794|P4|First Alcohol Challenge|Lost to Follow-up|1
4871552|NCT00817089|16788795|P3|First Alcohol Challenge|Lost to Follow-up|0
4871553|NCT00817089|16788796|P2|First Alcohol Challenge|Lost to Follow-up|0
4871554|NCT00817089|16788797|P1|First Alcohol Challenge|Lost to Follow-up|0
4871555|NCT00817063|16788813|P2|Overall Study|Abnormality of Laboratory Test|1
4871556|NCT00817063|16788814|P1|Overall Study|Abnormality of Laboratory Test|2
4871557|NCT00817063|16788813|P2|Overall Study|Administrative|4
4871558|NCT00817063|16788814|P1|Overall Study|Administrative|10
4871559|NCT00817063|16788813|P2|Overall Study|Early Improvement|4
4871560|NCT00817063|16788814|P1|Overall Study|Early Improvement|19
4871561|NCT00817063|16788813|P2|Overall Study|Withdrawal by Subject|37
4871562|NCT00817063|16788814|P1|Overall Study|Withdrawal by Subject|17
4871563|NCT00817063|16788813|P2|Overall Study|Protocol Violation|8
4871564|NCT00817063|16788814|P1|Overall Study|Protocol Violation|3
4871565|NCT00817063|16788813|P2|Overall Study|Violation of Selection at Entry|4
4871566|NCT00817063|16788814|P1|Overall Study|Violation of Selection at Entry|7
4871567|NCT00817063|16788813|P2|Overall Study|Failure to Return|12
4871568|NCT00817063|16788814|P1|Overall Study|Failure to Return|13
4871569|NCT00817063|16788813|P2|Overall Study|Lack of Efficacy|86
4871570|NCT00817063|16788814|P1|Overall Study|Lack of Efficacy|33
4871571|NCT00817063|16788813|P2|Overall Study|Death|1
4871572|NCT00817063|16788814|P1|Overall Study|Death|1
4871573|NCT00817063|16788813|P2|Overall Study|Adverse Event|13
4871574|NCT00817063|16788814|P1|Overall Study|Adverse Event|32
4871575|NCT00816595|16788942|P2|Overall Study|Withdrawal by Subject|0
4871576|NCT00816595|16788943|P1|Overall Study|Withdrawal by Subject|2
4871577|NCT00816556|16788956|P3|Overall Study|Lost to Follow-up|1
4871578|NCT00816556|16788957|P2|Overall Study|Lost to Follow-up|0
4871579|NCT00816556|16788958|P1|Overall Study|Lost to Follow-up|0
4871580|NCT00816556|16788956|P3|Overall Study|Withdrawal by Subject|1
4871581|NCT00816556|16788957|P2|Overall Study|Withdrawal by Subject|1
4871582|NCT00816556|16788958|P1|Overall Study|Withdrawal by Subject|1
4871583|NCT00816556|16788956|P3|Overall Study|Adverse Event|1
4871584|NCT00816556|16788957|P2|Overall Study|Adverse Event|1
4871585|NCT00816556|16788958|P1|Overall Study|Adverse Event|1
4871586|NCT00816400|16788981|P9|Overall Study|In hospice care at the end of the study|0
4871587|NCT00816400|16788982|P8|Overall Study|In hospice care at the end of the study|0
4871588|NCT00816400|16788983|P7|Overall Study|In hospice care at the end of the study|0
4871589|NCT00816400|16788984|P6|Overall Study|In hospice care at the end of the study|0
4871590|NCT00816400|16788985|P5|Overall Study|In hospice care at the end of the study|0
4871591|NCT00816400|16788986|P4|Overall Study|In hospice care at the end of the study|0
4871592|NCT00816400|16788987|P3|Overall Study|In hospice care at the end of the study|2
4871593|NCT00816400|16788988|P2|Overall Study|In hospice care at the end of the study|0
4871594|NCT00816400|16788989|P1|Overall Study|In hospice care at the end of the study|0
4871595|NCT00816400|16788981|P9|Overall Study|Death|6
4871596|NCT00816400|16788982|P8|Overall Study|Death|5
4871597|NCT00816400|16788983|P7|Overall Study|Death|2
4871598|NCT00816400|16788984|P6|Overall Study|Death|3
4871599|NCT00816400|16788985|P5|Overall Study|Death|2
4871600|NCT00816400|16788986|P4|Overall Study|Death|3
4871601|NCT00816400|16788987|P3|Overall Study|Death|3
4871602|NCT00816400|16788988|P2|Overall Study|Death|3
4871603|NCT00816400|16788989|P1|Overall Study|Death|2
4871604|NCT00816361|16789180|P9|Overall Study|Other|1
4871605|NCT00816361|16789181|P8|Overall Study|Other|0
4871606|NCT00816361|16789182|P7|Overall Study|Other|0
4871607|NCT00816361|16789183|P6|Overall Study|Other|0
4871608|NCT00816361|16789184|P5|Overall Study|Other|0
4871609|NCT00816361|16789185|P4|Overall Study|Other|0
4871610|NCT00816361|16789186|P3|Overall Study|Other|0
4871611|NCT00816361|16789187|P2|Overall Study|Other|0
4871612|NCT00816361|16789188|P1|Overall Study|Other|0
4871613|NCT00816361|16789180|P9|Overall Study|Death|8
4871614|NCT00816361|16789181|P8|Overall Study|Death|7
4871615|NCT00816361|16789182|P7|Overall Study|Death|3
4871616|NCT00816361|16789183|P6|Overall Study|Death|1
4871617|NCT00816361|16789184|P5|Overall Study|Death|1
4871618|NCT00816361|16789185|P4|Overall Study|Death|3
4871619|NCT00816361|16789186|P3|Overall Study|Death|3
4871620|NCT00816361|16789187|P2|Overall Study|Death|3
4871621|NCT00816361|16789188|P1|Overall Study|Death|4
4871622|NCT00816361|16789180|P9|Overall Study|Withdrawal by Subject|1
4871623|NCT00816361|16789181|P8|Overall Study|Withdrawal by Subject|2
4871624|NCT00816361|16789182|P7|Overall Study|Withdrawal by Subject|0
4871625|NCT00816361|16789183|P6|Overall Study|Withdrawal by Subject|2
4871626|NCT00816361|16789184|P5|Overall Study|Withdrawal by Subject|1
4871627|NCT00816361|16789185|P4|Overall Study|Withdrawal by Subject|0
4871628|NCT00816361|16789186|P3|Overall Study|Withdrawal by Subject|0
4871629|NCT00816361|16789187|P2|Overall Study|Withdrawal by Subject|0
4871630|NCT00816361|16789188|P1|Overall Study|Withdrawal by Subject|0
4871631|NCT00816166|16789347|P2|Overall Study|Death|2
4871632|NCT00816166|16789348|P1|Overall Study|Death|4
4871633|NCT00816166|16789347|P2|Overall Study|Lost to Follow-up|10
4871634|NCT00816166|16789348|P1|Overall Study|Lost to Follow-up|6
4871635|NCT00816036|16789380|P2|Overall Study|Withdrawal by Subject|23
4871636|NCT00816036|16789381|P1|Overall Study|Withdrawal by Subject|54
4871637|NCT00816036|16789380|P2|Overall Study|Lost to Follow-up|57
4871638|NCT00816036|16789381|P1|Overall Study|Lost to Follow-up|75
4871639|NCT00816036|16789380|P2|Overall Study|Death|28
4871640|NCT00816036|16789381|P1|Overall Study|Death|47
4871641|NCT00816023|16789395|P4|Overall Study|Randomized Not Treated|11
4871642|NCT00816023|16789396|P3|Overall Study|Randomized Not Treated|6
4871643|NCT00816023|16789397|P2|Overall Study|Randomized Not Treated|4
4871644|NCT00816023|16789398|P1|Overall Study|Randomized Not Treated|6
4871645|NCT00816023|16789395|P4|Overall Study|assessments complete prior to window|1
4871646|NCT00816023|16789396|P3|Overall Study|assessments complete prior to window|2
4871647|NCT00816023|16789397|P2|Overall Study|assessments complete prior to window|1
4871648|NCT00816023|16789398|P1|Overall Study|assessments complete prior to window|1
4871649|NCT00816023|16789395|P4|Overall Study|Physician Decision|0
4871650|NCT00816023|16789396|P3|Overall Study|Physician Decision|1
4871651|NCT00816023|16789397|P2|Overall Study|Physician Decision|0
4871652|NCT00816023|16789398|P1|Overall Study|Physician Decision|0
4871653|NCT00816023|16789395|P4|Overall Study|Withdrawal by Subject|0
4871654|NCT00816023|16789396|P3|Overall Study|Withdrawal by Subject|0
4871655|NCT00816023|16789397|P2|Overall Study|Withdrawal by Subject|0
4871656|NCT00816023|16789398|P1|Overall Study|Withdrawal by Subject|1
4871657|NCT00816023|16789395|P4|Overall Study|Lost to Follow-up|0
4871658|NCT00816023|16789396|P3|Overall Study|Lost to Follow-up|0
4871659|NCT00816023|16789397|P2|Overall Study|Lost to Follow-up|1
4871660|NCT00816023|16789398|P1|Overall Study|Lost to Follow-up|1
4871661|NCT00815919|16789435|P1|Overall Study|Lack of Efficacy|2
4871662|NCT00815919|16789435|P1|Overall Study|AML Relapse|1
4871663|NCT00815919|16789435|P1|Overall Study|Unrelated Fungal Infection|1
4871664|NCT00815659|16789478|P1|Overall Study|Protocol Violation|1
4871665|NCT00815659|16789478|P1|Overall Study|Lost to Follow-up|4
4871666|NCT00815659|16789478|P1|Overall Study|Withdrawal by Subject|9
4871667|NCT00815659|16789478|P1|Overall Study|Adverse Event|9
4871668|NCT00815633|16789521|P1|Overall Study|study terminated|1
4871669|NCT00815516|16789528|P2|Overall Study|Physician Decision|0
4871670|NCT00815516|16789529|P1|Overall Study|Physician Decision|1
4871671|NCT00815516|16789528|P2|Overall Study|Death|1
4871672|NCT00815516|16789529|P1|Overall Study|Death|3
4871673|NCT00815308|16789594|P1|Overall Study|Protocol Violation|6
4871674|NCT00815308|16789594|P1|Overall Study|Withdrawal by Subject|0
4871675|NCT00815308|16789594|P1|Overall Study|Adverse Event|4
4871676|NCT00815295|16789603|P3|Overall Study|Cetuximab hypersensitivity reaction|3
4871677|NCT00815295|16789604|P2|Overall Study|Cetuximab hypersensitivity reaction|1
4871678|NCT00815295|16789605|P1|Overall Study|Cetuximab hypersensitivity reaction|0
4871679|NCT00815191|16789617|P2|Overall Study|Protocol Violation|1
4871680|NCT00815191|16789618|P1|Overall Study|Protocol Violation|1
4871681|NCT00814983|16789655|P2|Overall Study|Graft failure|0
4871682|NCT00814983|16789656|P1|Overall Study|Graft failure|1
4871683|NCT00814983|16789655|P2|Overall Study|Withdrawal by Subject|0
4871684|NCT00814983|16789656|P1|Overall Study|Withdrawal by Subject|1
4871685|NCT00814983|16789655|P2|Overall Study|Screen failure|0
4871686|NCT00814983|16789656|P1|Overall Study|Screen failure|1
4871687|NCT00814892|16789687|P1|Overall Study|Study Termination|1
4871688|NCT00814892|16789687|P1|Overall Study|Disease Progression|1
4871689|NCT00814879|16789699|P2|By Week 48|Death|1
4871690|NCT00814879|16789700|P1|By Week 48|Death|0
4871691|NCT00814879|16789699|P2|By Week 48|Lost to Follow-up|2
4871692|NCT00814879|16789700|P1|By Week 48|Lost to Follow-up|2
4871693|NCT00814879|16789699|P2|By Week 24|Incarceration|1
4871694|NCT00814879|16789700|P1|By Week 24|Incarceration|0
4871695|NCT00814879|16789699|P2|By Week 24|Cancer Diagnosis|0
4871696|NCT00814879|16789700|P1|By Week 24|Cancer Diagnosis|1
4871697|NCT00814801|16789719|P3|Overall Study|Other|4
4871698|NCT00814801|16789720|P2|Overall Study|Other|6
4871699|NCT00814801|16789721|P1|Overall Study|Other|2
4871700|NCT00814801|16789719|P3|Overall Study|Non-compliance|1
4871701|NCT00814801|16789720|P2|Overall Study|Non-compliance|1
4871702|NCT00814801|16789721|P1|Overall Study|Non-compliance|0
4871703|NCT00814801|16789719|P3|Overall Study|Missing or change of caregiver|4
4871704|NCT00814801|16789720|P2|Overall Study|Missing or change of caregiver|2
4871705|NCT00814801|16789721|P1|Overall Study|Missing or change of caregiver|6
4871706|NCT00814801|16789719|P3|Overall Study|Change of patients for CIBIC plus-J|0
4871707|NCT00814801|16789720|P2|Overall Study|Change of patients for CIBIC plus-J|1
4871708|NCT00814801|16789721|P1|Overall Study|Change of patients for CIBIC plus-J|1
4871709|NCT00814801|16789719|P3|Overall Study|Inappropriate as a subject|1
4871710|NCT00814801|16789720|P2|Overall Study|Inappropriate as a subject|1
4871711|NCT00814801|16789721|P1|Overall Study|Inappropriate as a subject|1
4871712|NCT00814801|16789719|P3|Overall Study|Withdrawal by Subject|14
4871713|NCT00814801|16789720|P2|Overall Study|Withdrawal by Subject|11
4871714|NCT00814801|16789721|P1|Overall Study|Withdrawal by Subject|9
4871715|NCT00814801|16789719|P3|Overall Study|Adverse Event|19
4871716|NCT00814801|16789720|P2|Overall Study|Adverse Event|16
4871717|NCT00814801|16789721|P1|Overall Study|Adverse Event|15
4871718|NCT00814710|16789760|P2|Overall Study|Lost to Follow-up|3
4871719|NCT00814710|16789761|P1|Overall Study|Lost to Follow-up|7
4871720|NCT00814710|16789760|P2|Overall Study|Adverse Event|0
4871721|NCT00814710|16789761|P1|Overall Study|Adverse Event|1
4871722|NCT00814658|16789829|P2|Overall Study|Adverse Event|3
4871723|NCT00814658|16789830|P1|Overall Study|Adverse Event|3
4871724|NCT00814658|16789829|P2|Overall Study|Physician Decision|0
4871725|NCT00814658|16789830|P1|Overall Study|Physician Decision|1
4871726|NCT00814658|16789829|P2|Overall Study|Lost to Follow-up|1
4871727|NCT00814658|16789830|P1|Overall Study|Lost to Follow-up|0
4871728|NCT00814632|16789896|P1|Overall Study|Lack of Efficacy|2
4871729|NCT00814580|16789902|P2|Overall Study|Did Not Take Drug|2
4871730|NCT00814580|16789903|P1|Overall Study|Did Not Take Drug|2
4871731|NCT00814580|16789902|P2|Overall Study|Other|3
4871732|NCT00814580|16789903|P1|Overall Study|Other|1
4871733|NCT00814580|16789902|P2|Overall Study|Withdrawal by Subject|2
4871734|NCT00814580|16789903|P1|Overall Study|Withdrawal by Subject|2
4871735|NCT00814580|16789902|P2|Overall Study|Protocol Violation|0
4871736|NCT00814580|16789903|P1|Overall Study|Protocol Violation|2
4871737|NCT00814580|16789902|P2|Overall Study|Lack of Efficacy|25
4871738|NCT00814580|16789903|P1|Overall Study|Lack of Efficacy|18
4871739|NCT00814580|16789902|P2|Overall Study|Adverse Event|15
4871740|NCT00814580|16789903|P1|Overall Study|Adverse Event|6
4871741|NCT00814502|16790033|P2|Overall Study|Withdrawal by Subject|2
4871742|NCT00814502|16790034|P1|Overall Study|Withdrawal by Subject|0
4871743|NCT00814502|16790033|P2|Overall Study|Adverse Event|0
4871744|NCT00814502|16790034|P1|Overall Study|Adverse Event|1
4871745|NCT00814489|16790047|P3|Overall Study|Other|1
4871746|NCT00814489|16790048|P2|Overall Study|Other|0
4871747|NCT00814489|16790049|P1|Overall Study|Other|2
4871748|NCT00814463|16790081|P1|Overall Study|Lost to Follow-up|1
4871749|NCT00814346|16790094|P2|Open Phase (17 Months)|Not otherwise specified|0
4871750|NCT00814346|16790095|P1|Open Phase (17 Months)|Not otherwise specified|1
4871751|NCT00814346|16790094|P2|Open Phase (17 Months)|Lost to Follow-up|0
4871752|NCT00814346|16790095|P1|Open Phase (17 Months)|Lost to Follow-up|2
4871753|NCT00814346|16790094|P2|Open Phase (17 Months)|Consent|0
4871754|NCT00814346|16790095|P1|Open Phase (17 Months)|Consent|2
4871755|NCT00814346|16790094|P2|Open Phase (17 Months)|Adverse Event|0
4871756|NCT00814346|16790095|P1|Open Phase (17 Months)|Adverse Event|5
4871757|NCT00814346|16790094|P2|Double-blind Phase (4 Weeks)|Not otherwise specified|2
4871758|NCT00814346|16790095|P1|Double-blind Phase (4 Weeks)|Not otherwise specified|0
4871759|NCT00814346|16790094|P2|Double-blind Phase (4 Weeks)|Adverse Event|1
4871760|NCT00814346|16790095|P1|Double-blind Phase (4 Weeks)|Adverse Event|0
4871761|NCT00814333|16790161|P2|Enrollment|Lost to Follow-up|0
4871762|NCT00814333|16790162|P1|Enrollment|Lost to Follow-up|1
4871763|NCT00814320|16790170|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3
4871764|NCT00814320|16790171|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0
4871765|NCT00814320|16790170|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1
4871766|NCT00814320|16790171|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0
4871767|NCT00814320|16790170|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1
4871768|NCT00814320|16790171|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0
4871769|NCT00814320|16790170|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1
4871770|NCT00814320|16790171|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2
4871771|NCT00814320|16790170|P2|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4
4871772|NCT00814320|16790171|P1|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1
4871773|NCT00814320|16790170|P2|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0
4871774|NCT00814320|16790171|P1|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1
4871775|NCT00814320|16790170|P2|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0
4871776|NCT00814320|16790171|P1|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1
4871777|NCT00814320|16790170|P2|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1
4871778|NCT00814320|16790171|P1|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0
4871779|NCT00814320|16790170|P2|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2
4871780|NCT00814320|16790171|P1|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0
4871781|NCT00814320|16790170|P2|Epoch 1 (IV Treatment)|Withdrawal by Subject|0
4871782|NCT00814320|16790171|P1|Epoch 1 (IV Treatment)|Withdrawal by Subject|1
4871783|NCT00814307|16790303|P4|Overall Study|Death|0
4871784|NCT00814307|16790304|P3|Overall Study|Death|0
4871785|NCT00814307|16790305|P2|Overall Study|Death|1
4871786|NCT00814307|16790306|P1|Overall Study|Death|0
4871787|NCT00814307|16790303|P4|Overall Study|Withdrawal by Subject|2
4871788|NCT00814307|16790304|P3|Overall Study|Withdrawal by Subject|0
4871789|NCT00814307|16790305|P2|Overall Study|Withdrawal by Subject|6
4871790|NCT00814307|16790306|P1|Overall Study|Withdrawal by Subject|4
4871791|NCT00814307|16790303|P4|Overall Study|Protocol Violation|1
4871792|NCT00814307|16790304|P3|Overall Study|Protocol Violation|1
4871793|NCT00814307|16790305|P2|Overall Study|Protocol Violation|8
4871794|NCT00814307|16790306|P1|Overall Study|Protocol Violation|2
4871795|NCT00814307|16790303|P4|Overall Study|Other|1
4871796|NCT00814307|16790304|P3|Overall Study|Other|0
4871797|NCT00814307|16790305|P2|Overall Study|Other|2
4871798|NCT00814307|16790306|P1|Overall Study|Other|1
4871799|NCT00814307|16790303|P4|Overall Study|Lack of Efficacy|4
4871800|NCT00814307|16790304|P3|Overall Study|Lack of Efficacy|3
4871801|NCT00814307|16790305|P2|Overall Study|Lack of Efficacy|1
4871802|NCT00814307|16790306|P1|Overall Study|Lack of Efficacy|1
4871803|NCT00814307|16790303|P4|Overall Study|Adverse Event|2
4871804|NCT00814307|16790304|P3|Overall Study|Adverse Event|3
4871805|NCT00814307|16790305|P2|Overall Study|Adverse Event|9
4871806|NCT00814307|16790306|P1|Overall Study|Adverse Event|3
4871807|NCT00814307|16790303|P4|Overall Study|Randomized but not treated|0
4871808|NCT00814307|16790304|P3|Overall Study|Randomized but not treated|0
4871809|NCT00814307|16790305|P2|Overall Study|Randomized but not treated|0
4871810|NCT00814307|16790306|P1|Overall Study|Randomized but not treated|1
4871811|NCT00814164|16790502|P1|Overall Study|Death|5
4871812|NCT00814164|16790502|P1|Overall Study|not stated|7
4871813|NCT00814164|16790502|P1|Overall Study|Progression|7
4871814|NCT00813995|16790536|P2|Overall Study|Withdrawal by Subject|5
4871815|NCT00813995|16790537|P1|Overall Study|Withdrawal by Subject|0
4871816|NCT00813995|16790536|P2|Overall Study|Subject moved|0
4871817|NCT00813995|16790537|P1|Overall Study|Subject moved|4
4871818|NCT00813995|16790536|P2|Overall Study|Protocol Violation|2
4871819|NCT00813995|16790537|P1|Overall Study|Protocol Violation|3
4871820|NCT00813995|16790536|P2|Overall Study|Other reason|2
4871821|NCT00813995|16790537|P1|Overall Study|Other reason|2
4871822|NCT00813995|16790536|P2|Overall Study|Lost to Follow-up|2
4871823|NCT00813995|16790537|P1|Overall Study|Lost to Follow-up|4
4871824|NCT00813995|16790536|P2|Overall Study|Lack of Efficacy|0
4871825|NCT00813995|16790537|P1|Overall Study|Lack of Efficacy|1
4871826|NCT00813995|16790536|P2|Overall Study|Laboratory adverse event|2
4871827|NCT00813995|16790537|P1|Overall Study|Laboratory adverse event|0
4871828|NCT00813995|16790536|P2|Overall Study|Clinical adverse event|3
4871829|NCT00813995|16790537|P1|Overall Study|Clinical adverse event|9
4871830|NCT00813943|16790560|P3|Overall Study|Ongoing at cut-off date|3
4871831|NCT00813943|16790561|P2|Overall Study|Ongoing at cut-off date|5
4871832|NCT00813943|16790562|P1|Overall Study|Ongoing at cut-off date|5
4871833|NCT00813917|16790592|P2|Overall Study|Lost to Follow-up|1
4871834|NCT00813917|16790593|P1|Overall Study|Lost to Follow-up|3
4871835|NCT00813917|16790592|P2|Overall Study|Withdrawal by Subject|4
4871836|NCT00813917|16790593|P1|Overall Study|Withdrawal by Subject|3
4871837|NCT00813917|16790592|P2|Overall Study|Adverse Event|1
4871838|NCT00813917|16790593|P1|Overall Study|Adverse Event|0
4871839|NCT00813904|16790599|P1|Overall Study|Death|1
4871840|NCT00813865|16790605|P1|Overall Study|Withdrawal by Subject|1
4871841|NCT00813865|16790605|P1|Overall Study|Lost to Follow-up|3
4871842|NCT00813865|16790605|P1|Overall Study|Failure to Respond|3
4871843|NCT00813813|16790613|P2|Overall Study|Other|1
4871844|NCT00813813|16790614|P1|Overall Study|Other|0
4871845|NCT00813813|16790613|P2|Overall Study|Lost to Follow-up|7
4871846|NCT00813813|16790614|P1|Overall Study|Lost to Follow-up|2
4871847|NCT00813813|16790613|P2|Overall Study|Withdrawal by Subject|1
4871848|NCT00813813|16790614|P1|Overall Study|Withdrawal by Subject|1
4871849|NCT00813800|16790630|P1|Overall Study|Physician Decision|1
4871850|NCT00813800|16790630|P1|Overall Study|Worsening of depression|2
4871851|NCT00813800|16790630|P1|Overall Study|Adverse Event|1
4871852|NCT00813800|16790630|P1|Overall Study|Screen Failure after Consent|2
4871853|NCT00813761|16790638|P4|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
4871854|NCT00813761|16790639|P3|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6
4871855|NCT00813761|16790640|P2|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0
4871856|NCT00813761|16790641|P1|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9
4871857|NCT00813761|16790638|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3
4871858|NCT00813761|16790639|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0
4871859|NCT00813761|16790640|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4
4871860|NCT00813761|16790641|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1
4871861|NCT00813761|16790638|P4|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0
4871862|NCT00813761|16790639|P3|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
4871863|NCT00813761|16790640|P2|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
4871864|NCT00813761|16790641|P1|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1
4871865|NCT00813761|16790638|P4|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
4871866|NCT00813761|16790639|P3|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
4871867|NCT00813761|16790640|P2|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1
4871868|NCT00813761|16790641|P1|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0
4871869|NCT00813761|16790638|P4|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1
4871870|NCT00813761|16790639|P3|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2
4871871|NCT00813761|16790640|P2|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0
4871872|NCT00813761|16790641|P1|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3
4871873|NCT00813761|16790638|P4|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
4871874|NCT00813761|16790639|P3|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0
4871875|NCT00813761|16790640|P2|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3
4871876|NCT00813761|16790641|P1|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2
4871877|NCT00813761|16790638|P4|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
4871878|NCT00813761|16790639|P3|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
4871879|NCT00813761|16790640|P2|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1
4871880|NCT00813761|16790641|P1|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0
4871881|NCT00813761|16790638|P4|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
4871882|NCT00813761|16790639|P3|Phase 1 (Baseline to 4 Weeks)|poor comfort|5
4871883|NCT00813761|16790640|P2|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
4871884|NCT00813761|16790641|P1|Phase 1 (Baseline to 4 Weeks)|poor comfort|1
4871885|NCT00813761|16790638|P4|Phase 1 (Baseline to 4 Weeks)|poor vision|0
4871886|NCT00813761|16790639|P3|Phase 1 (Baseline to 4 Weeks)|poor vision|3
4871887|NCT00813761|16790640|P2|Phase 1 (Baseline to 4 Weeks)|poor vision|0
4871888|NCT00813761|16790641|P1|Phase 1 (Baseline to 4 Weeks)|poor vision|0
4871889|NCT00813761|16790638|P4|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0
4871890|NCT00813761|16790639|P3|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
4871891|NCT00813761|16790640|P2|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
4871892|NCT00813761|16790641|P1|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1
4871893|NCT00813761|16790638|P4|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1
4871894|NCT00813761|16790639|P3|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3
4871895|NCT00813761|16790640|P2|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
4871896|NCT00813761|16790641|P1|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0
4871897|NCT00813761|16790638|P4|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
4871898|NCT00813761|16790639|P3|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
4871899|NCT00813761|16790640|P2|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0
4871900|NCT00813761|16790641|P1|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2
4871901|NCT00813748|16790691|P2|Skin Test Substudy|Physician Decision|1
4871902|NCT00813748|16790692|P1|Skin Test Substudy|Physician Decision|0
4871903|NCT00813709|16790721|P6|Open Label Period|Other|6
4871904|NCT00813709|16790722|P5|Open Label Period|Other|5
4871905|NCT00813709|16790723|P4|Open Label Period|Other|11
4871906|NCT00813709|16790724|P3|Open Label Period|Other|0
4871907|NCT00813709|16790725|P2|Open Label Period|Other|0
4871908|NCT00813709|16790726|P1|Open Label Period|Other|0
4871909|NCT00813709|16790721|P6|Open Label Period|Randomized but not treated|1
4871910|NCT00813709|16790722|P5|Open Label Period|Randomized but not treated|0
4871911|NCT00813709|16790723|P4|Open Label Period|Randomized but not treated|1
4871912|NCT00813709|16790724|P3|Open Label Period|Randomized but not treated|0
4871913|NCT00813709|16790725|P2|Open Label Period|Randomized but not treated|0
4871914|NCT00813709|16790726|P1|Open Label Period|Randomized but not treated|0
4871915|NCT00813709|16790721|P6|Open Label Period|Lack of Efficacy|1
4871916|NCT00813709|16790722|P5|Open Label Period|Lack of Efficacy|1
4871917|NCT00813709|16790723|P4|Open Label Period|Lack of Efficacy|3
4871918|NCT00813709|16790724|P3|Open Label Period|Lack of Efficacy|0
4871919|NCT00813709|16790725|P2|Open Label Period|Lack of Efficacy|0
4871920|NCT00813709|16790726|P1|Open Label Period|Lack of Efficacy|0
4871921|NCT00813709|16790721|P6|Open Label Period|Adverse Event|3
4871922|NCT00813709|16790722|P5|Open Label Period|Adverse Event|4
4871923|NCT00813709|16790723|P4|Open Label Period|Adverse Event|5
4871924|NCT00813709|16790724|P3|Open Label Period|Adverse Event|0
4871925|NCT00813709|16790725|P2|Open Label Period|Adverse Event|0
4871926|NCT00813709|16790726|P1|Open Label Period|Adverse Event|0
4871927|NCT00813709|16790721|P6|Double Blind Period|Other|0
4871928|NCT00813709|16790722|P5|Double Blind Period|Other|0
4871929|NCT00813709|16790723|P4|Double Blind Period|Other|0
4871930|NCT00813709|16790724|P3|Double Blind Period|Other|6
4871931|NCT00813709|16790725|P2|Double Blind Period|Other|9
4871932|NCT00813709|16790726|P1|Double Blind Period|Other|14
4871933|NCT00813709|16790721|P6|Double Blind Period|Randomized but not treated|0
4871934|NCT00813709|16790722|P5|Double Blind Period|Randomized but not treated|0
4871935|NCT00813709|16790723|P4|Double Blind Period|Randomized but not treated|0
4871936|NCT00813709|16790724|P3|Double Blind Period|Randomized but not treated|1
4871937|NCT00813709|16790725|P2|Double Blind Period|Randomized but not treated|3
4871938|NCT00813709|16790726|P1|Double Blind Period|Randomized but not treated|1
4871939|NCT00813709|16790721|P6|Double Blind Period|Switched to open label phase|0
4871940|NCT00813709|16790722|P5|Double Blind Period|Switched to open label phase|0
4871941|NCT00813709|16790723|P4|Double Blind Period|Switched to open label phase|0
4871942|NCT00813709|16790724|P3|Double Blind Period|Switched to open label phase|18
4871943|NCT00813709|16790725|P2|Double Blind Period|Switched to open label phase|26
4871944|NCT00813709|16790726|P1|Double Blind Period|Switched to open label phase|9
4871945|NCT00813709|16790721|P6|Double Blind Period|Lost to Follow-up|0
4871946|NCT00813709|16790722|P5|Double Blind Period|Lost to Follow-up|0
4871947|NCT00813709|16790723|P4|Double Blind Period|Lost to Follow-up|0
4871948|NCT00813709|16790724|P3|Double Blind Period|Lost to Follow-up|2
4871949|NCT00813709|16790725|P2|Double Blind Period|Lost to Follow-up|2
4871950|NCT00813709|16790726|P1|Double Blind Period|Lost to Follow-up|3
4871951|NCT00813709|16790721|P6|Double Blind Period|Adverse Event|0
4871952|NCT00813709|16790722|P5|Double Blind Period|Adverse Event|0
4871953|NCT00813709|16790723|P4|Double Blind Period|Adverse Event|0
4871954|NCT00813709|16790724|P3|Double Blind Period|Adverse Event|4
4871955|NCT00813709|16790725|P2|Double Blind Period|Adverse Event|1
4871956|NCT00813709|16790726|P1|Double Blind Period|Adverse Event|4
4871957|NCT00813592|16790806|P1|Overall Study|Disease assessment was not completed per|2
4871958|NCT00813488|16790815|P2|Open-label Extension|Other|0
4871959|NCT00813488|16790816|P1|Open-label Extension|Other|1
4871960|NCT00813488|16790815|P2|Open-label Extension|Non-compliance study procedures|1
4871961|NCT00813488|16790816|P1|Open-label Extension|Non-compliance study procedures|2
4871962|NCT00813488|16790815|P2|Open-label Extension|Non-compliance study medication|0
4871963|NCT00813488|16790816|P1|Open-label Extension|Non-compliance study medication|4
4871964|NCT00813488|16790815|P2|Open-label Extension|Protocol Violation|2
4871965|NCT00813488|16790816|P1|Open-label Extension|Protocol Violation|1
4871966|NCT00813488|16790815|P2|Open-label Extension|Withdrawal by Subject|2
4871967|NCT00813488|16790816|P1|Open-label Extension|Withdrawal by Subject|0
4871968|NCT00813488|16790815|P2|Open-label Extension|Lack of Efficacy|0
4871969|NCT00813488|16790816|P1|Open-label Extension|Lack of Efficacy|3
4871970|NCT00813488|16790815|P2|Open-label Extension|Adverse Event|2
4871971|NCT00813488|16790816|P1|Open-label Extension|Adverse Event|1
4871972|NCT00813488|16790815|P2|Double-blind Treatment Period 2|Other|0
4871973|NCT00813488|16790816|P1|Double-blind Treatment Period 2|Other|1
4871974|NCT00813488|16790815|P2|Double-blind Treatment Period 2|Protocol Violation|0
4871975|NCT00813488|16790816|P1|Double-blind Treatment Period 2|Protocol Violation|2
4871976|NCT00813488|16790815|P2|Double-blind Treatment Period 2|Withdrawal by Subject|1
4871977|NCT00813488|16790816|P1|Double-blind Treatment Period 2|Withdrawal by Subject|1
4871978|NCT00813488|16790815|P2|Double-blind Treatment Period 2|Adverse Event|0
4871979|NCT00813488|16790816|P1|Double-blind Treatment Period 2|Adverse Event|1
4871980|NCT00813488|16790815|P2|Double-blind Treatment Period 1|Lost to Follow-up|1
4871981|NCT00813488|16790816|P1|Double-blind Treatment Period 1|Lost to Follow-up|0
4871982|NCT00813488|16790815|P2|Double-blind Treatment Period 1|Protocol Violation|2
4871983|NCT00813488|16790816|P1|Double-blind Treatment Period 1|Protocol Violation|0
4871984|NCT00813488|16790815|P2|Double-blind Treatment Period 1|Withdrawal by Subject|1
4871985|NCT00813488|16790816|P1|Double-blind Treatment Period 1|Withdrawal by Subject|0
4871986|NCT00813488|16790815|P2|Double-blind Treatment Period 1|Adverse Event|1
4871987|NCT00813488|16790816|P1|Double-blind Treatment Period 1|Adverse Event|1
4871988|NCT00813488|16790815|P2|Titration Period 2|Non-compliance with study procedures|1
4871989|NCT00813488|16790816|P1|Titration Period 2|Non-compliance with study procedures|2
4871990|NCT00813488|16790815|P2|Titration Period 2|Lost to Follow-up|0
4871991|NCT00813488|16790816|P1|Titration Period 2|Lost to Follow-up|1
4871992|NCT00813488|16790815|P2|Titration Period 2|Protocol Violation|2
4871993|NCT00813488|16790816|P1|Titration Period 2|Protocol Violation|3
4871994|NCT00813488|16790815|P2|Titration Period 2|Lack of Efficacy|4
4871995|NCT00813488|16790816|P1|Titration Period 2|Lack of Efficacy|8
4871996|NCT00813488|16790815|P2|Titration Period 2|Adverse Event|3
4871997|NCT00813488|16790816|P1|Titration Period 2|Adverse Event|2
4871998|NCT00813488|16790815|P2|Titration Period 1|Technical Difficulties|1
4871999|NCT00813488|16790816|P1|Titration Period 1|Technical Difficulties|0
4872000|NCT00813488|16790815|P2|Titration Period 1|Non-compliance to study procedures|2
4872001|NCT00813488|16790816|P1|Titration Period 1|Non-compliance to study procedures|2
4872002|NCT00813488|16790815|P2|Titration Period 1|Non-compliance to study medication|1
4872003|NCT00813488|16790816|P1|Titration Period 1|Non-compliance to study medication|4
4872004|NCT00813488|16790815|P2|Titration Period 1|Protocol Violation|3
4872005|NCT00813488|16790816|P1|Titration Period 1|Protocol Violation|4
4872006|NCT00813488|16790815|P2|Titration Period 1|Withdrawal by Subject|2
4872007|NCT00813488|16790816|P1|Titration Period 1|Withdrawal by Subject|2
4872008|NCT00813488|16790815|P2|Titration Period 1|Lack of Efficacy|7
4872009|NCT00813488|16790816|P1|Titration Period 1|Lack of Efficacy|9
4872010|NCT00813488|16790815|P2|Titration Period 1|Adverse Event|1
4872011|NCT00813488|16790816|P1|Titration Period 1|Adverse Event|6
4872012|NCT00813293|16790927|P2|Overall Study|Adverse Event|1
4872013|NCT00813293|16790928|P1|Overall Study|Adverse Event|0
4872014|NCT00813293|16790927|P2|Overall Study|Intercurrent illness|0
4872015|NCT00813293|16790928|P1|Overall Study|Intercurrent illness|1
4872016|NCT00813150|16790967|P2|Long Term Follow-up|Progression/Relapse|24
4872017|NCT00813150|16790968|P1|Long Term Follow-up|Progression/Relapse|22
4872018|NCT00813150|16790967|P2|Long Term Follow-up|Lost to Follow-up|0
4872019|NCT00813150|16790968|P1|Long Term Follow-up|Lost to Follow-up|2
4872020|NCT00813150|16790967|P2|Long Term Follow-up|Other|3
4872021|NCT00813150|16790968|P1|Long Term Follow-up|Other|0
4872022|NCT00813150|16790967|P2|Long Term Follow-up|Death|4
4872023|NCT00813150|16790968|P1|Long Term Follow-up|Death|0
4872024|NCT00813150|16790967|P2|Treatment Period|Data not available|2
4872025|NCT00813150|16790968|P1|Treatment Period|Data not available|1
4872026|NCT00813150|16790967|P2|Treatment Period|Reason not specified|4
4872027|NCT00813150|16790968|P1|Treatment Period|Reason not specified|3
4872028|NCT00813150|16790967|P2|Treatment Period|Non compliance|1
4872029|NCT00813150|16790968|P1|Treatment Period|Non compliance|0
4872030|NCT00813150|16790967|P2|Treatment Period|Withdrawal by Subject|3
4872031|NCT00813150|16790968|P1|Treatment Period|Withdrawal by Subject|5
4872032|NCT00813150|16790967|P2|Treatment Period|Protocol Violation|4
4872033|NCT00813150|16790968|P1|Treatment Period|Protocol Violation|3
4872034|NCT00813150|16790967|P2|Treatment Period|Stable disease|2
4872035|NCT00813150|16790968|P1|Treatment Period|Stable disease|1
4872036|NCT00813150|16790967|P2|Treatment Period|Complete response|1
4872037|NCT00813150|16790968|P1|Treatment Period|Complete response|0
4872038|NCT00813150|16790967|P2|Treatment Period|Progressive disease|0
4872039|NCT00813150|16790968|P1|Treatment Period|Progressive disease|1
4872040|NCT00813150|16790967|P2|Treatment Period|Death|0
4872041|NCT00813150|16790968|P1|Treatment Period|Death|2
4872042|NCT00813150|16790967|P2|Treatment Period|Adverse Event|15
4872043|NCT00813150|16790968|P1|Treatment Period|Adverse Event|16
4872044|NCT00813098|16790992|P3|Overall Study|Withdrew Consent|0
4872045|NCT00813098|16790993|P2|Overall Study|Withdrew Consent|1
4872046|NCT00813098|16790994|P1|Overall Study|Withdrew Consent|0
4872047|NCT00813098|16790992|P3|Overall Study|Principal Investigator decision|0
4872048|NCT00813098|16790993|P2|Overall Study|Principal Investigator decision|1
4872049|NCT00813098|16790994|P1|Overall Study|Principal Investigator decision|0
4872050|NCT00813098|16790992|P3|Overall Study|Protocol Violation|1
4872051|NCT00813098|16790993|P2|Overall Study|Protocol Violation|0
4872052|NCT00813098|16790994|P1|Overall Study|Protocol Violation|0
4872053|NCT00813098|16790992|P3|Overall Study|Lost to Follow-up|0
4872054|NCT00813098|16790993|P2|Overall Study|Lost to Follow-up|1
4872055|NCT00813098|16790994|P1|Overall Study|Lost to Follow-up|0
4872056|NCT00813098|16790992|P3|Overall Study|Inability to complete study procedures|0
4872057|NCT00813098|16790993|P2|Overall Study|Inability to complete study procedures|0
4872058|NCT00813098|16790994|P1|Overall Study|Inability to complete study procedures|1
4872059|NCT00813098|16790992|P3|Overall Study|Withdrawal by Subject|0
4872060|NCT00813098|16790993|P2|Overall Study|Withdrawal by Subject|1
4872061|NCT00813098|16790994|P1|Overall Study|Withdrawal by Subject|0
4872062|NCT00813098|16790992|P3|Overall Study|Adverse Event|1
4872063|NCT00813098|16790993|P2|Overall Study|Adverse Event|4
4872064|NCT00813098|16790994|P1|Overall Study|Adverse Event|2
4872065|NCT00812981|16791019|P2|Overall Study|Other|1
4872066|NCT00812981|16791020|P1|Overall Study|Other|0
4872067|NCT00812968|16791058|P1|Overall Study|Study closed due to marketing approval|3
4872068|NCT00812968|16791058|P1|Overall Study|No further treatment required|1
4872069|NCT00812968|16791058|P1|Overall Study|Disease progression|1
4872070|NCT00812968|16791058|P1|Overall Study|Relapse after erythroid response|6
4872071|NCT00812955|16791093|P4|Overall Study|randomized in error|0
4872072|NCT00812955|16791094|P3|Overall Study|randomized in error|1
4872073|NCT00812955|16791095|P2|Overall Study|randomized in error|0
4872074|NCT00812955|16791096|P1|Overall Study|randomized in error|0
4872075|NCT00812955|16791093|P4|Overall Study|Withdrawal by Subject|2
4872076|NCT00812955|16791094|P3|Overall Study|Withdrawal by Subject|1
4872077|NCT00812955|16791095|P2|Overall Study|Withdrawal by Subject|0
4872078|NCT00812955|16791096|P1|Overall Study|Withdrawal by Subject|1
4872079|NCT00812955|16791093|P4|Overall Study|Lost to Follow-up|2
4872080|NCT00812955|16791094|P3|Overall Study|Lost to Follow-up|1
4872081|NCT00812955|16791095|P2|Overall Study|Lost to Follow-up|1
4872082|NCT00812955|16791096|P1|Overall Study|Lost to Follow-up|2
4872083|NCT00812955|16791093|P4|Overall Study|Adverse Event|4
4872084|NCT00812955|16791094|P3|Overall Study|Adverse Event|3
4872085|NCT00812955|16791095|P2|Overall Study|Adverse Event|6
4872086|NCT00812955|16791096|P1|Overall Study|Adverse Event|7
4872087|NCT00812929|16791116|P10|Washout Period 3 (7 Days)|Adverse Event|0
4872088|NCT00812929|16791117|P9|Washout Period 3 (7 Days)|Adverse Event|0
4872089|NCT00812929|16791118|P8|Washout Period 3 (7 Days)|Adverse Event|0
4872090|NCT00812929|16791119|P7|Washout Period 3 (7 Days)|Adverse Event|0
4872091|NCT00812929|16791120|P6|Washout Period 3 (7 Days)|Adverse Event|1
4872092|NCT00812929|16791121|P5|Washout Period 3 (7 Days)|Adverse Event|0
4872093|NCT00812929|16791122|P4|Washout Period 3 (7 Days)|Adverse Event|0
4872094|NCT00812929|16791123|P3|Washout Period 3 (7 Days)|Adverse Event|0
4872095|NCT00812929|16791124|P2|Washout Period 3 (7 Days)|Adverse Event|0
4872096|NCT00812929|16791125|P1|Washout Period 3 (7 Days)|Adverse Event|0
4872097|NCT00812929|16791116|P10|Washout Period 2 (7 Days)|Physician Decision|1
4872098|NCT00812929|16791117|P9|Washout Period 2 (7 Days)|Physician Decision|0
4872099|NCT00812929|16791118|P8|Washout Period 2 (7 Days)|Physician Decision|0
4872100|NCT00812929|16791119|P7|Washout Period 2 (7 Days)|Physician Decision|0
4872101|NCT00812929|16791120|P6|Washout Period 2 (7 Days)|Physician Decision|0
4872102|NCT00812929|16791121|P5|Washout Period 2 (7 Days)|Physician Decision|0
4872103|NCT00812929|16791122|P4|Washout Period 2 (7 Days)|Physician Decision|0
4872104|NCT00812929|16791123|P3|Washout Period 2 (7 Days)|Physician Decision|0
4872105|NCT00812929|16791124|P2|Washout Period 2 (7 Days)|Physician Decision|0
4872106|NCT00812929|16791125|P1|Washout Period 2 (7 Days)|Physician Decision|0
4872107|NCT00812929|16791116|P10|Washout Period 1 (7 Days)|Physician Decision|0
4872108|NCT00812929|16791117|P9|Washout Period 1 (7 Days)|Physician Decision|0
4872109|NCT00812929|16791118|P8|Washout Period 1 (7 Days)|Physician Decision|0
4872110|NCT00812929|16791119|P7|Washout Period 1 (7 Days)|Physician Decision|0
4872111|NCT00812929|16791120|P6|Washout Period 1 (7 Days)|Physician Decision|0
4872112|NCT00812929|16791121|P5|Washout Period 1 (7 Days)|Physician Decision|0
4872113|NCT00812929|16791122|P4|Washout Period 1 (7 Days)|Physician Decision|0
4872114|NCT00812929|16791123|P3|Washout Period 1 (7 Days)|Physician Decision|1
4872115|NCT00812929|16791124|P2|Washout Period 1 (7 Days)|Physician Decision|0
4872116|NCT00812929|16791125|P1|Washout Period 1 (7 Days)|Physician Decision|0
4872117|NCT00812812|16791280|P2|Overall Study|Withdrawal by Subject|2
4872118|NCT00812812|16791281|P1|Overall Study|Withdrawal by Subject|0
4872119|NCT00812812|16791280|P2|Overall Study|Lost to Follow-up|1
4872120|NCT00812812|16791281|P1|Overall Study|Lost to Follow-up|0
4872121|NCT00812812|16791280|P2|Overall Study|Lack of Efficacy|0
4872122|NCT00812812|16791281|P1|Overall Study|Lack of Efficacy|1
4872123|NCT00812812|16791280|P2|Overall Study|Adverse Event|1
4872124|NCT00812812|16791281|P1|Overall Study|Adverse Event|2
4872125|NCT00812708|16791294|P1|Overall Study|Signed consent but later withdrew|3
4872126|NCT00812708|16791294|P1|Overall Study|Surgery cancelled due to uveitis|1
4872127|NCT00812708|16791294|P1|Overall Study|Switched to another study|1
4872128|NCT00812708|16791294|P1|Overall Study|Lack of medical insurance|1
4872129|NCT00812708|16791294|P1|Overall Study|Device could not be implanted|2
4872130|NCT00812565|16791322|P8|Overall Study|Reason Not Specified|0
4872131|NCT00812565|16791323|P7|Overall Study|Reason Not Specified|0
4872132|NCT00812565|16791324|P6|Overall Study|Reason Not Specified|1
4872133|NCT00812565|16791325|P5|Overall Study|Reason Not Specified|0
4872134|NCT00812565|16791326|P4|Overall Study|Reason Not Specified|0
4872135|NCT00812565|16791327|P3|Overall Study|Reason Not Specified|0
4872136|NCT00812565|16791328|P2|Overall Study|Reason Not Specified|0
4872137|NCT00812565|16791329|P1|Overall Study|Reason Not Specified|0
4872138|NCT00812565|16791322|P8|Overall Study|Withdrawal of Consent|0
4872139|NCT00812565|16791323|P7|Overall Study|Withdrawal of Consent|0
4872140|NCT00812565|16791324|P6|Overall Study|Withdrawal of Consent|0
4872141|NCT00812565|16791325|P5|Overall Study|Withdrawal of Consent|1
4872142|NCT00812565|16791326|P4|Overall Study|Withdrawal of Consent|0
4872143|NCT00812565|16791327|P3|Overall Study|Withdrawal of Consent|0
4872144|NCT00812565|16791328|P2|Overall Study|Withdrawal of Consent|0
4872145|NCT00812565|16791329|P1|Overall Study|Withdrawal of Consent|1
4872146|NCT00812565|16791322|P8|Overall Study|Did Not Come to Study Visit|0
4872147|NCT00812565|16791323|P7|Overall Study|Did Not Come to Study Visit|0
4872148|NCT00812565|16791324|P6|Overall Study|Did Not Come to Study Visit|0
4872149|NCT00812565|16791325|P5|Overall Study|Did Not Come to Study Visit|0
4872150|NCT00812565|16791326|P4|Overall Study|Did Not Come to Study Visit|0
4872151|NCT00812565|16791327|P3|Overall Study|Did Not Come to Study Visit|0
4872152|NCT00812565|16791328|P2|Overall Study|Did Not Come to Study Visit|0
4872153|NCT00812565|16791329|P1|Overall Study|Did Not Come to Study Visit|1
4872154|NCT00812565|16791322|P8|Overall Study|Adverse Event|1
4872155|NCT00812565|16791323|P7|Overall Study|Adverse Event|0
4872156|NCT00812565|16791324|P6|Overall Study|Adverse Event|0
4872157|NCT00812565|16791325|P5|Overall Study|Adverse Event|0
4872158|NCT00812565|16791326|P4|Overall Study|Adverse Event|2
4872159|NCT00812565|16791327|P3|Overall Study|Adverse Event|0
4872160|NCT00812565|16791328|P2|Overall Study|Adverse Event|0
4872161|NCT00812565|16791329|P1|Overall Study|Adverse Event|0
4872162|NCT00812565|16791322|P8|Overall Study|Did Not Receive Study Medication|0
4872163|NCT00812565|16791323|P7|Overall Study|Did Not Receive Study Medication|0
4872164|NCT00812565|16791324|P6|Overall Study|Did Not Receive Study Medication|0
4872165|NCT00812565|16791325|P5|Overall Study|Did Not Receive Study Medication|0
4872166|NCT00812565|16791326|P4|Overall Study|Did Not Receive Study Medication|0
4872167|NCT00812565|16791327|P3|Overall Study|Did Not Receive Study Medication|0
4872168|NCT00812565|16791328|P2|Overall Study|Did Not Receive Study Medication|1
4872169|NCT00812565|16791329|P1|Overall Study|Did Not Receive Study Medication|1
4872170|NCT00812487|16791453|P2|Overall Study|Protocol Violation|1
4872171|NCT00812487|16791454|P1|Overall Study|Protocol Violation|0
4872172|NCT00812487|16791453|P2|Overall Study|Transfer to ICU prior to intervention|0
4872173|NCT00812487|16791454|P1|Overall Study|Transfer to ICU prior to intervention|1
4872174|NCT00812487|16791453|P2|Overall Study|Withdrawal by Subject|2
4872175|NCT00812487|16791454|P1|Overall Study|Withdrawal by Subject|3
4872176|NCT00812487|16791453|P2|Overall Study|Lost to Follow-up|0
4872177|NCT00812487|16791454|P1|Overall Study|Lost to Follow-up|2
4872178|NCT00812461|16791480|P2|All Treated Patients|Other Reason|21
4872179|NCT00812461|16791481|P1|All Treated Patients|Other Reason|13
4872180|NCT00812461|16791480|P2|All Treated Patients|Lost to Follow-up|14
4872181|NCT00812461|16791481|P1|All Treated Patients|Lost to Follow-up|11
4872182|NCT00812461|16791480|P2|All Treated Patients|Withdrawal by Subject|54
4872183|NCT00812461|16791481|P1|All Treated Patients|Withdrawal by Subject|45
4872184|NCT00812461|16791480|P2|All Treated Patients|Protocol Violation|27
4872185|NCT00812461|16791481|P1|All Treated Patients|Protocol Violation|36
4872186|NCT00812461|16791480|P2|All Treated Patients|Non-compliance|9
4872187|NCT00812461|16791481|P1|All Treated Patients|Non-compliance|6
4872188|NCT00812461|16791480|P2|All Treated Patients|Lack of Efficacy|7
4872189|NCT00812461|16791481|P1|All Treated Patients|Lack of Efficacy|13
4872190|NCT00812461|16791480|P2|All Treated Patients|Adverse Event|15
4872191|NCT00812461|16791481|P1|All Treated Patients|Adverse Event|8
4872192|NCT00812461|16791480|P2|All Randomised Patients|Did not receive placebo/nalmefene|17
4872193|NCT00812461|16791481|P1|All Randomised Patients|Did not receive placebo/nalmefene|23
4872194|NCT00812331|16791504|P5|Overall Study|Adverse Event|0
4872195|NCT00812331|16791505|P4|Overall Study|Adverse Event|0
4872196|NCT00812331|16791506|P3|Overall Study|Adverse Event|0
4872197|NCT00812331|16791507|P2|Overall Study|Adverse Event|0
4872198|NCT00812331|16791508|P1|Overall Study|Adverse Event|1
4872199|NCT00812253|16791583|P2|Overall Study|Lost to Follow-up|0
4872200|NCT00812253|16791584|P1|Overall Study|Lost to Follow-up|2
4872201|NCT00812253|16791583|P2|Overall Study|Protocol Violation|1
4872202|NCT00812253|16791584|P1|Overall Study|Protocol Violation|1
4872203|NCT00812253|16791583|P2|Overall Study|Withdrawal by Subject|2
4872204|NCT00812253|16791584|P1|Overall Study|Withdrawal by Subject|3
4872205|NCT00812097|16791609|P4|Overall Study|Unknown reasons and patient/doctor moves|5
4872206|NCT00812097|16791610|P3|Overall Study|Unknown reasons and patient/doctor moves|15
4872207|NCT00812097|16791611|P2|Overall Study|Unknown reasons and patient/doctor moves|24
4872208|NCT00812097|16791612|P1|Overall Study|Unknown reasons and patient/doctor moves|111
4872209|NCT00812097|16791609|P4|Overall Study|Explantation of study device(s)|20
4872210|NCT00812097|16791610|P3|Overall Study|Explantation of study device(s)|14
4872211|NCT00812097|16791611|P2|Overall Study|Explantation of study device(s)|29
4872212|NCT00812097|16791612|P1|Overall Study|Explantation of study device(s)|27
4872213|NCT00812097|16791609|P4|Overall Study|Lost to Follow-up|5
4872214|NCT00812097|16791610|P3|Overall Study|Lost to Follow-up|17
4872215|NCT00812097|16791611|P2|Overall Study|Lost to Follow-up|14
4872216|NCT00812097|16791612|P1|Overall Study|Lost to Follow-up|90
4872217|NCT00812097|16791609|P4|Overall Study|Withdrawal by Subject|2
4872218|NCT00812097|16791610|P3|Overall Study|Withdrawal by Subject|8
4872219|NCT00812097|16791611|P2|Overall Study|Withdrawal by Subject|12
4872220|NCT00812097|16791612|P1|Overall Study|Withdrawal by Subject|14
4872221|NCT00812097|16791609|P4|Overall Study|Death|3
4872222|NCT00812097|16791610|P3|Overall Study|Death|3
4872223|NCT00812097|16791611|P2|Overall Study|Death|10
4872224|NCT00812097|16791612|P1|Overall Study|Death|3
4872225|NCT00812006|16791641|P3|Overall Study|Lack of Qualifying Event|2
4872226|NCT00812006|16791642|P2|Overall Study|Lack of Qualifying Event|2
4872227|NCT00812006|16791643|P1|Overall Study|Lack of Qualifying Event|4
4872228|NCT00812006|16791641|P3|Overall Study|Withdrawal by Subject|1
4872229|NCT00812006|16791642|P2|Overall Study|Withdrawal by Subject|1
4872230|NCT00812006|16791643|P1|Overall Study|Withdrawal by Subject|2
4872231|NCT00812006|16791641|P3|Overall Study|Physician Decision|1
4872232|NCT00812006|16791642|P2|Overall Study|Physician Decision|0
4872233|NCT00812006|16791643|P1|Overall Study|Physician Decision|0
4872234|NCT00812006|16791641|P3|Overall Study|Lost to Follow-up|2
4872235|NCT00812006|16791642|P2|Overall Study|Lost to Follow-up|0
4872236|NCT00812006|16791643|P1|Overall Study|Lost to Follow-up|0
4872237|NCT00811954|16791660|P3|Overall Study|Complete Protocol: No follow-up|1
4872238|NCT00811954|16791661|P2|Overall Study|Complete Protocol: No follow-up|0
4872239|NCT00811954|16791662|P1|Overall Study|Complete Protocol: No follow-up|0
4872240|NCT00811954|16791660|P3|Overall Study|Severe Debilitation|1
4872241|NCT00811954|16791661|P2|Overall Study|Severe Debilitation|0
4872242|NCT00811954|16791662|P1|Overall Study|Severe Debilitation|2
4872243|NCT00811954|16791660|P3|Overall Study|Site Closure|1
4872244|NCT00811954|16791661|P2|Overall Study|Site Closure|0
4872245|NCT00811954|16791662|P1|Overall Study|Site Closure|4
4872246|NCT00811954|16791660|P3|Overall Study|Withdraw consent prior study completion|5
4872247|NCT00811954|16791661|P2|Overall Study|Withdraw consent prior study completion|6
4872248|NCT00811954|16791662|P1|Overall Study|Withdraw consent prior study completion|4
4872249|NCT00811954|16791660|P3|Overall Study|Not willing to adhere to requirements|16
4872250|NCT00811954|16791661|P2|Overall Study|Not willing to adhere to requirements|2
4872251|NCT00811954|16791662|P1|Overall Study|Not willing to adhere to requirements|12
4872252|NCT00811954|16791660|P3|Overall Study|Not able to get to clinic|30
4872253|NCT00811954|16791661|P2|Overall Study|Not able to get to clinic|35
4872254|NCT00811954|16791662|P1|Overall Study|Not able to get to clinic|28
4872255|NCT00811954|16791660|P3|Overall Study|Lost to Follow-up|34
4872256|NCT00811954|16791661|P2|Overall Study|Lost to Follow-up|23
4872257|NCT00811954|16791662|P1|Overall Study|Lost to Follow-up|29
4872258|NCT00811954|16791660|P3|Overall Study|Death|13
4872259|NCT00811954|16791661|P2|Overall Study|Death|6
4872260|NCT00811954|16791662|P1|Overall Study|Death|10
4872261|NCT00811941|16791726|P2|All Treated Patients|Other Reason|14
4872262|NCT00811941|16791727|P1|All Treated Patients|Other Reason|4
4872263|NCT00811941|16791726|P2|All Treated Patients|Lost to Follow-up|12
4872264|NCT00811941|16791727|P1|All Treated Patients|Lost to Follow-up|3
4872265|NCT00811941|16791726|P2|All Treated Patients|Withdrawal by Subject|94
4872266|NCT00811941|16791727|P1|All Treated Patients|Withdrawal by Subject|35
4872267|NCT00811941|16791726|P2|All Treated Patients|Protocol Violation|17
4872268|NCT00811941|16791727|P1|All Treated Patients|Protocol Violation|5
4872269|NCT00811941|16791726|P2|All Treated Patients|Non-compliance|8
4872270|NCT00811941|16791727|P1|All Treated Patients|Non-compliance|1
4872271|NCT00811941|16791726|P2|All Treated Patients|Lack of Efficacy|3
4872272|NCT00811941|16791727|P1|All Treated Patients|Lack of Efficacy|2
4872273|NCT00811941|16791726|P2|All Treated Patients|Adverse Event|43
4872274|NCT00811941|16791727|P1|All Treated Patients|Adverse Event|2
4872275|NCT00811941|16791726|P2|All Randomised Patients|Did not receive placebo/nalmefene|8
4872276|NCT00811941|16791727|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
4872277|NCT00811928|16791765|P2|Overall Study|Poor Compliance|5
4872278|NCT00811928|16791766|P1|Overall Study|Poor Compliance|2
4872279|NCT00811928|16791765|P2|Overall Study|Investigator Decision|1
4872280|NCT00811928|16791766|P1|Overall Study|Investigator Decision|2
4872281|NCT00811928|16791765|P2|Overall Study|Without Primary Efficacy Endpoint Data|4
4872282|NCT00811928|16791766|P1|Overall Study|Without Primary Efficacy Endpoint Data|7
4872283|NCT00811928|16791765|P2|Overall Study|Did Not Take Study Drug|0
4872284|NCT00811928|16791766|P1|Overall Study|Did Not Take Study Drug|3
4872285|NCT00811928|16791765|P2|Overall Study|Withdrawal by Subject|12
4872286|NCT00811928|16791766|P1|Overall Study|Withdrawal by Subject|18
4872287|NCT00811928|16791765|P2|Overall Study|AEs and SAEs Including Death|11
4872288|NCT00811928|16791766|P1|Overall Study|AEs and SAEs Including Death|7
4872289|NCT00811733|16791810|P2|Overall Study|Withdrawal by Subject|2
4872290|NCT00811733|16791811|P1|Overall Study|Withdrawal by Subject|1
4872291|NCT00811733|16791810|P2|Overall Study|Investigator Discretion|8
4872292|NCT00811733|16791811|P1|Overall Study|Investigator Discretion|10
4872293|NCT00811720|16791859|P2|All Treated Patients|Other Reason|4
4872294|NCT00811720|16791860|P1|All Treated Patients|Other Reason|7
4872295|NCT00811720|16791859|P2|All Treated Patients|Lost to Follow-up|16
4872296|NCT00811720|16791860|P1|All Treated Patients|Lost to Follow-up|10
4872297|NCT00811720|16791859|P2|All Treated Patients|Withdrawal by Subject|34
4872298|NCT00811720|16791860|P1|All Treated Patients|Withdrawal by Subject|28
4872299|NCT00811720|16791859|P2|All Treated Patients|Protocol Violation|16
4872300|NCT00811720|16791860|P1|All Treated Patients|Protocol Violation|9
4872301|NCT00811720|16791859|P2|All Treated Patients|Non-compliance|14
4872302|NCT00811720|16791860|P1|All Treated Patients|Non-compliance|0
4872303|NCT00811720|16791859|P2|All Treated Patients|Lack of Efficacy|18
4872304|NCT00811720|16791860|P1|All Treated Patients|Lack of Efficacy|22
4872305|NCT00811720|16791859|P2|All Treated Patients|Adverse Event|62
4872306|NCT00811720|16791860|P1|All Treated Patients|Adverse Event|20
4872307|NCT00811720|16791859|P2|All Randomised Patients|Did not receive placebo/nalmefene|4
4872308|NCT00811720|16791860|P1|All Randomised Patients|Did not receive placebo/nalmefene|2
4872309|NCT00811655|16791878|P1|Overall Study|Physician Decision|1
4872310|NCT00811642|16791890|P1|Overall Study|Cumulative use of antifungal agent|2
4872311|NCT00811642|16791890|P1|Overall Study|Withdrawal by Subject|7
4872312|NCT00811642|16791890|P1|Overall Study|Death|2
4872313|NCT00811642|16791890|P1|Overall Study|Protocol Violation|1
4872314|NCT00811642|16791890|P1|Overall Study|Adverse Event|3
4872315|NCT00811577|16791906|P2|Overall Study|Withdrawal by Subject|0
4872316|NCT00811577|16791907|P1|Overall Study|Withdrawal by Subject|3
4872317|NCT00811577|16791906|P2|Overall Study|Lost to Follow-up|1
4872318|NCT00811577|16791907|P1|Overall Study|Lost to Follow-up|7
4872319|NCT00811473|16791967|P2|Overall Study|Safety Reasons|0
4872320|NCT00811473|16791968|P1|Overall Study|Safety Reasons|1
4872321|NCT00811473|16791967|P2|Overall Study|Incorrect Enrollment|0
4872322|NCT00811473|16791968|P1|Overall Study|Incorrect Enrollment|1
4872323|NCT00811473|16791967|P2|Overall Study|Other 2|1
4872324|NCT00811473|16791968|P1|Overall Study|Other 2|4
4872325|NCT00811473|16791967|P2|Overall Study|Condition under investigation worsened|3
4872326|NCT00811473|16791968|P1|Overall Study|Condition under investigation worsened|1
4872327|NCT00811473|16791967|P2|Overall Study|Lack of therapeutic response|1
4872328|NCT00811473|16791968|P1|Overall Study|Lack of therapeutic response|4
4872329|NCT00811473|16791967|P2|Overall Study|Severe non-compliance to protocol|4
4872330|NCT00811473|16791968|P1|Overall Study|Severe non-compliance to protocol|2
4872331|NCT00811473|16791967|P2|Overall Study|Withdrawal by Subject|4
4872332|NCT00811473|16791968|P1|Overall Study|Withdrawal by Subject|2
4872333|NCT00811473|16791967|P2|Overall Study|Lost to Follow-up|1
4872334|NCT00811473|16791968|P1|Overall Study|Lost to Follow-up|5
4872335|NCT00811473|16791967|P2|Overall Study|Adverse Event|12
4872336|NCT00811473|16791968|P1|Overall Study|Adverse Event|3
4872337|NCT00811395|16791999|P6|Extension Treatment|Other than above|0
4872338|NCT00811395|16792000|P5|Extension Treatment|Other than above|0
4872339|NCT00811395|16792001|P4|Extension Treatment|Other than above|0
4872340|NCT00811395|16792002|P3|Extension Treatment|Other than above|1
4872341|NCT00811395|16792003|P2|Extension Treatment|Other than above|0
4872342|NCT00811395|16792004|P1|Extension Treatment|Other than above|0
4872343|NCT00811395|16791999|P6|Extension Treatment|Participant did not wish to continue|1
4872344|NCT00811395|16792000|P5|Extension Treatment|Participant did not wish to continue|0
4872345|NCT00811395|16792001|P4|Extension Treatment|Participant did not wish to continue|1
4872346|NCT00811395|16792002|P3|Extension Treatment|Participant did not wish to continue|0
4872347|NCT00811395|16792003|P2|Extension Treatment|Participant did not wish to continue|3
4872348|NCT00811395|16792004|P1|Extension Treatment|Participant did not wish to continue|0
4872349|NCT00811395|16791999|P6|Extension Treatment|Progressive disease|0
4872350|NCT00811395|16792000|P5|Extension Treatment|Progressive disease|0
4872351|NCT00811395|16792001|P4|Extension Treatment|Progressive disease|0
4872352|NCT00811395|16792002|P3|Extension Treatment|Progressive disease|0
4872353|NCT00811395|16792003|P2|Extension Treatment|Progressive disease|1
4872354|NCT00811395|16792004|P1|Extension Treatment|Progressive disease|1
4872355|NCT00811395|16791999|P6|Extension Treatment|Adverse Event|1
4872356|NCT00811395|16792000|P5|Extension Treatment|Adverse Event|0
4872357|NCT00811395|16792001|P4|Extension Treatment|Adverse Event|2
4872358|NCT00811395|16792002|P3|Extension Treatment|Adverse Event|2
4872359|NCT00811395|16792003|P2|Extension Treatment|Adverse Event|2
4872360|NCT00811395|16792004|P1|Extension Treatment|Adverse Event|1
4872361|NCT00811252|16792110|P3|Overall Study|Administrative or Other Reasons|2
4872362|NCT00811252|16792111|P2|Overall Study|Administrative or Other Reasons|3
4872363|NCT00811252|16792112|P1|Overall Study|Administrative or Other Reasons|0
4872364|NCT00811252|16792110|P3|Overall Study|Lost to Follow-up|2
4872365|NCT00811252|16792111|P2|Overall Study|Lost to Follow-up|0
4872366|NCT00811252|16792112|P1|Overall Study|Lost to Follow-up|0
4872367|NCT00811252|16792110|P3|Overall Study|Withdrawal of Consent|2
4872368|NCT00811252|16792111|P2|Overall Study|Withdrawal of Consent|2
4872369|NCT00811252|16792112|P1|Overall Study|Withdrawal of Consent|1
4872370|NCT00811252|16792110|P3|Overall Study|Protocol Violation|2
4872371|NCT00811252|16792111|P2|Overall Study|Protocol Violation|3
4872372|NCT00811252|16792112|P1|Overall Study|Protocol Violation|3
4872373|NCT00811252|16792110|P3|Overall Study|Lack of Efficacy|0
4872374|NCT00811252|16792111|P2|Overall Study|Lack of Efficacy|2
4872375|NCT00811252|16792112|P1|Overall Study|Lack of Efficacy|7
4872376|NCT00811252|16792110|P3|Overall Study|Adverse Event|15
4872377|NCT00811252|16792111|P2|Overall Study|Adverse Event|10
4872378|NCT00811252|16792112|P1|Overall Study|Adverse Event|6
4872379|NCT00811187|16792158|P2|Overall Study|Unable to place device / procedure abort|3
4872380|NCT00811187|16792159|P1|Overall Study|Unable to place device / procedure abort|3
4872381|NCT00811174|16792165|P1|Overall Study|Sponsors Decision|1
4872382|NCT00811174|16792165|P1|Overall Study|Protocol Violation|2
4872383|NCT00811135|16792176|P1|Overall Study|Ongoing|59
4872384|NCT00811135|16792176|P1|Overall Study|Administrative/Other Unspecified|11
4872385|NCT00811135|16792176|P1|Overall Study|Withdrawal by Subject|3
4872386|NCT00811135|16792176|P1|Overall Study|Refused Treatment|1
4872387|NCT00811135|16792176|P1|Overall Study|Violation of Selection Criteria|1
4872388|NCT00811135|16792176|P1|Overall Study|Protocol Violation|2
4872389|NCT00811135|16792176|P1|Overall Study|Death|3
4872390|NCT00811135|16792176|P1|Overall Study|Adverse Event/Intercurrent Illness|8
4872391|NCT00811070|16792194|P6|Overall Study|Physician Decision|1
4872392|NCT00811070|16792195|P5|Overall Study|Physician Decision|0
4872393|NCT00811070|16792196|P4|Overall Study|Physician Decision|0
4872394|NCT00811070|16792197|P3|Overall Study|Physician Decision|0
4872395|NCT00811070|16792198|P2|Overall Study|Physician Decision|0
4872396|NCT00811070|16792199|P1|Overall Study|Physician Decision|0
4872397|NCT00811070|16792194|P6|Overall Study|Withdrawal by Subject|0
4872398|NCT00811070|16792195|P5|Overall Study|Withdrawal by Subject|0
4872399|NCT00811070|16792196|P4|Overall Study|Withdrawal by Subject|0
4872400|NCT00811070|16792197|P3|Overall Study|Withdrawal by Subject|0
4872401|NCT00811070|16792198|P2|Overall Study|Withdrawal by Subject|1
4872402|NCT00811070|16792199|P1|Overall Study|Withdrawal by Subject|0
4872403|NCT00811070|16792194|P6|Overall Study|Other|0
4872404|NCT00811070|16792195|P5|Overall Study|Other|0
4872405|NCT00811070|16792196|P4|Overall Study|Other|0
4872406|NCT00811070|16792197|P3|Overall Study|Other|0
4872407|NCT00811070|16792198|P2|Overall Study|Other|0
4872408|NCT00811070|16792199|P1|Overall Study|Other|1
4872409|NCT00811070|16792194|P6|Overall Study|Death|0
4872410|NCT00811070|16792195|P5|Overall Study|Death|5
4872411|NCT00811070|16792196|P4|Overall Study|Death|2
4872412|NCT00811070|16792197|P3|Overall Study|Death|0
4872413|NCT00811070|16792198|P2|Overall Study|Death|0
4872414|NCT00811070|16792199|P1|Overall Study|Death|0
4872415|NCT00811057|16792259|P3|Overall Study|Protocol Violation|10
4872416|NCT00811057|16792260|P2|Overall Study|Protocol Violation|10
4872417|NCT00811057|16792261|P1|Overall Study|Protocol Violation|5
4872418|NCT00811018|16792272|P1|Overall Study|Other|26
4872419|NCT00811018|16792272|P1|Overall Study|WHO FC deterioration and 6MWD decrease|9
4872420|NCT00811018|16792272|P1|Overall Study|Withdrawal by Subject|70
4872421|NCT00811018|16792272|P1|Overall Study|Sponsor Decision|450
4872422|NCT00811018|16792272|P1|Overall Study|Pregnancy|6
4872423|NCT00811018|16792272|P1|Overall Study|Lost to Follow-up|19
4872424|NCT00811018|16792272|P1|Overall Study|Investigator Decision|57
4872425|NCT00811018|16792272|P1|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70
4872426|NCT00811018|16792272|P1|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4
4872427|NCT00811018|16792272|P1|Overall Study|Death|147
4872428|NCT00811018|16792272|P1|Overall Study|Adverse Event|79
4872429|NCT00811018|16792272|P1|Overall Study|Additional Chronic Treatment|31
4872430|NCT00810901|16792290|P2|Overall Study|Lost to Follow-up|58
4872431|NCT00810901|16792291|P1|Overall Study|Lost to Follow-up|88
4872432|NCT00810810|16792337|P4|Overall Study|Physician Decision|5
4872433|NCT00810810|16792338|P3|Overall Study|Physician Decision|1
4872434|NCT00810810|16792339|P2|Overall Study|Physician Decision|3
4872435|NCT00810810|16792340|P1|Overall Study|Physician Decision|0
4872436|NCT00810810|16792337|P4|Overall Study|Withdrawal by Subject|8
4872437|NCT00810810|16792338|P3|Overall Study|Withdrawal by Subject|10
4872438|NCT00810810|16792339|P2|Overall Study|Withdrawal by Subject|8
4872439|NCT00810810|16792340|P1|Overall Study|Withdrawal by Subject|0
4872440|NCT00810693|16792393|P3|Follow-up Period (FUP)|Withdrawal by Subject|0
4872441|NCT00810693|16792394|P2|Follow-up Period (FUP)|Withdrawal by Subject|1
4872442|NCT00810693|16792395|P1|Follow-up Period (FUP)|Withdrawal by Subject|2
4872443|NCT00810693|16792393|P3|Follow-up Period (FUP)|Protocol Violation|0
4872444|NCT00810693|16792394|P2|Follow-up Period (FUP)|Protocol Violation|1
4872445|NCT00810693|16792395|P1|Follow-up Period (FUP)|Protocol Violation|0
4872446|NCT00810693|16792393|P3|Follow-up Period (FUP)|Lost to Follow-up|2
4872447|NCT00810693|16792394|P2|Follow-up Period (FUP)|Lost to Follow-up|0
4872448|NCT00810693|16792395|P1|Follow-up Period (FUP)|Lost to Follow-up|1
4872449|NCT00810693|16792393|P3|Follow-up Period (FUP)|Death|1
4872450|NCT00810693|16792394|P2|Follow-up Period (FUP)|Death|0
4872451|NCT00810693|16792395|P1|Follow-up Period (FUP)|Death|2
4872452|NCT00810693|16792393|P3|Follow-up Period (FUP)|Adverse Event|1
4872453|NCT00810693|16792394|P2|Follow-up Period (FUP)|Adverse Event|1
4872454|NCT00810693|16792395|P1|Follow-up Period (FUP)|Adverse Event|3
4872455|NCT00810693|16792393|P3|Treatment Period|Not treated|1
4872456|NCT00810693|16792394|P2|Treatment Period|Not treated|1
4872457|NCT00810693|16792395|P1|Treatment Period|Not treated|0
4872458|NCT00810693|16792393|P3|Treatment Period|Withdrawal by Subject|3
4872459|NCT00810693|16792394|P2|Treatment Period|Withdrawal by Subject|2
4872460|NCT00810693|16792395|P1|Treatment Period|Withdrawal by Subject|6
4872461|NCT00810693|16792393|P3|Treatment Period|Protocol Violation|2
4872462|NCT00810693|16792394|P2|Treatment Period|Protocol Violation|2
4872463|NCT00810693|16792395|P1|Treatment Period|Protocol Violation|1
4872464|NCT00810693|16792393|P3|Treatment Period|Non-compliance|0
4872465|NCT00810693|16792394|P2|Treatment Period|Non-compliance|0
4872466|NCT00810693|16792395|P1|Treatment Period|Non-compliance|1
4872467|NCT00810693|16792393|P3|Treatment Period|Lost to Follow-up|0
4872468|NCT00810693|16792394|P2|Treatment Period|Lost to Follow-up|0
4872469|NCT00810693|16792395|P1|Treatment Period|Lost to Follow-up|1
4872470|NCT00810693|16792393|P3|Treatment Period|Lack of Efficacy|1
4872471|NCT00810693|16792394|P2|Treatment Period|Lack of Efficacy|0
4872472|NCT00810693|16792395|P1|Treatment Period|Lack of Efficacy|0
4872473|NCT00810693|16792393|P3|Treatment Period|Death|2
4872474|NCT00810693|16792394|P2|Treatment Period|Death|1
4872475|NCT00810693|16792395|P1|Treatment Period|Death|0
4872476|NCT00810693|16792393|P3|Treatment Period|Adverse Event|7
4872477|NCT00810693|16792394|P2|Treatment Period|Adverse Event|1
4872478|NCT00810693|16792395|P1|Treatment Period|Adverse Event|8
4872479|NCT00810641|16792427|P3|Overall Study|Withdrawal by Subject|2
4872480|NCT00810641|16792428|P2|Overall Study|Withdrawal by Subject|1
4872481|NCT00810641|16792429|P1|Overall Study|Withdrawal by Subject|0
4872482|NCT00810615|16792439|P2|Overall Study|Withdrawal by Subject|1
4872483|NCT00810615|16792440|P1|Overall Study|Withdrawal by Subject|1
4872484|NCT00810602|16792490|P2|Overall Study|Withdrawal by Subject|3
4872485|NCT00810602|16792491|P1|Overall Study|Withdrawal by Subject|8
4872486|NCT00810511|16792504|P2|Overall Study|deposits on contact lens|1
4872487|NCT00810511|16792505|P1|Overall Study|deposits on contact lens|0
4872488|NCT00810511|16792504|P2|Overall Study|Lost to Follow-up|0
4872489|NCT00810511|16792505|P1|Overall Study|Lost to Follow-up|1
4872490|NCT00810511|16792504|P2|Overall Study|death in the family|1
4872491|NCT00810511|16792505|P1|Overall Study|death in the family|0
4872492|NCT00810511|16792504|P2|Overall Study|Lack of Efficacy|1
4872493|NCT00810511|16792505|P1|Overall Study|Lack of Efficacy|9
4872494|NCT00810511|16792504|P2|Overall Study|Protocol Violation|1
4872495|NCT00810511|16792505|P1|Overall Study|Protocol Violation|0
4872496|NCT00810407|16792523|P1|Overall Study|No Visit After First Day of Treatment|3
4872497|NCT00810407|16792523|P1|Overall Study|Protocol Violation|3
4872498|NCT00810394|16792535|P1|Overall Study|Withdrawal by Subject|3
4872499|NCT00810368|16792543|P2|Overall Study|Lack of Efficacy|0
4872500|NCT00810368|16792544|P1|Overall Study|Lack of Efficacy|2
4872501|NCT00810368|16792543|P2|Overall Study|Lost to Follow-up|2
4872502|NCT00810368|16792544|P1|Overall Study|Lost to Follow-up|4
4872503|NCT00810355|16792565|P3|Overall Study|Withdrawal by Subject|0
4872504|NCT00810355|16792566|P2|Overall Study|Withdrawal by Subject|0
4872505|NCT00810355|16792567|P1|Overall Study|Withdrawal by Subject|1
4872506|NCT00810355|16792565|P3|Overall Study|Lost to Follow-up|11
4872507|NCT00810355|16792566|P2|Overall Study|Lost to Follow-up|17
4872508|NCT00810355|16792567|P1|Overall Study|Lost to Follow-up|13
4872509|NCT00810342|16792583|P2|12-month Followup|Lost to Follow-up|1
4872510|NCT00810342|16792584|P1|12-month Followup|Lost to Follow-up|3
4872511|NCT00810342|16792583|P2|12-month Followup|Pregnancy|10
4872512|NCT00810342|16792584|P1|12-month Followup|Pregnancy|9
4872513|NCT00810342|16792583|P2|6-month Follow-up|Pregnancy|2
4872514|NCT00810342|16792584|P1|6-month Follow-up|Pregnancy|6
4872515|NCT00810342|16792583|P2|6-month Follow-up|Lost to Follow-up|6
4872516|NCT00810342|16792584|P1|6-month Follow-up|Lost to Follow-up|18
4872517|NCT00810342|16792583|P2|Month 1 Follow-up|Pregnancy|0
4872518|NCT00810342|16792584|P1|Month 1 Follow-up|Pregnancy|1
4872519|NCT00810342|16792583|P2|Month 1 Follow-up|Lost to Follow-up|2
4872520|NCT00810342|16792584|P1|Month 1 Follow-up|Lost to Follow-up|4
4872521|NCT00810277|16792617|P1|Overall Study|Adverse Event|1
4872522|NCT00810264|16792630|P1|Overall Study|Death|641
4872523|NCT00810264|16792630|P1|Overall Study|Withdrawal by subject or physician|721
4872524|NCT00810264|16792630|P1|Overall Study|Lost to Follow-up|191
4872525|NCT00810199|16792657|P2|Overall Study|Did not receive study drug|1
4872526|NCT00810199|16792658|P1|Overall Study|Did not receive study drug|2
4872527|NCT00810199|16792657|P2|Overall Study|Failure to return|4
4872528|NCT00810199|16792658|P1|Overall Study|Failure to return|1
4872529|NCT00810199|16792657|P2|Overall Study|Protocol Violation|6
4872530|NCT00810199|16792658|P1|Overall Study|Protocol Violation|2
4872531|NCT00810199|16792657|P2|Overall Study|Administrative/Other|6
4872532|NCT00810199|16792658|P1|Overall Study|Administrative/Other|5
4872533|NCT00810199|16792657|P2|Overall Study|Refused treatment/Did not cooperate|7
4872534|NCT00810199|16792658|P1|Overall Study|Refused treatment/Did not cooperate|7
4872535|NCT00810199|16792657|P2|Overall Study|Insufficient therapeutic response|14
4872536|NCT00810199|16792658|P1|Overall Study|Insufficient therapeutic response|5
4872537|NCT00810199|16792657|P2|Overall Study|Withdrew consent|12
4872538|NCT00810199|16792658|P1|Overall Study|Withdrew consent|9
4872539|NCT00810199|16792657|P2|Overall Study|Death|6
4872540|NCT00810199|16792658|P1|Overall Study|Death|4
4872541|NCT00810199|16792657|P2|Overall Study|Adverse Event|26
4872542|NCT00810199|16792658|P1|Overall Study|Adverse Event|24
4872543|NCT00810108|16792736|P2|Overall Study|Withdrawal by Subject|0
4872544|NCT00810108|16792737|P1|Overall Study|Withdrawal by Subject|1
4872545|NCT00810082|16792751|P2|Overall Study|Lost to Follow-up|4
4872546|NCT00810082|16792752|P1|Overall Study|Lost to Follow-up|0
4872547|NCT00810069|16792760|P3|Double-Blind Period II|Protocol Violation|6
4872548|NCT00810069|16792761|P2|Double-Blind Period II|Protocol Violation|7
4872549|NCT00810069|16792762|P1|Double-Blind Period II|Protocol Violation|0
4872550|NCT00810069|16792760|P3|Double-Blind Period II|Clinical relapse|0
4872551|NCT00810069|16792761|P2|Double-Blind Period II|Clinical relapse|3
4872552|NCT00810069|16792762|P1|Double-Blind Period II|Clinical relapse|0
4872553|NCT00810069|16792760|P3|Double-Blind Period II|Protocol entry criterion not met|1
4872554|NCT00810069|16792761|P2|Double-Blind Period II|Protocol entry criterion not met|0
4872555|NCT00810069|16792762|P1|Double-Blind Period II|Protocol entry criterion not met|0
4872556|NCT00810069|16792760|P3|Double-Blind Period II|Withdrawal by Subject|35
4872557|NCT00810069|16792761|P2|Double-Blind Period II|Withdrawal by Subject|21
4872558|NCT00810069|16792762|P1|Double-Blind Period II|Withdrawal by Subject|0
4872559|NCT00810069|16792760|P3|Double-Blind Period II|Physician Decision|1
4872560|NCT00810069|16792761|P2|Double-Blind Period II|Physician Decision|0
4872561|NCT00810069|16792762|P1|Double-Blind Period II|Physician Decision|0
4872562|NCT00810069|16792760|P3|Double-Blind Period II|Lost to Follow-up|9
4872563|NCT00810069|16792761|P2|Double-Blind Period II|Lost to Follow-up|9
4872564|NCT00810069|16792762|P1|Double-Blind Period II|Lost to Follow-up|0
4872565|NCT00810069|16792760|P3|Double-Blind Period II|Lack of Efficacy|12
4872566|NCT00810069|16792761|P2|Double-Blind Period II|Lack of Efficacy|7
4872567|NCT00810069|16792762|P1|Double-Blind Period II|Lack of Efficacy|0
4872568|NCT00810069|16792760|P3|Double-Blind Period II|Adverse Event|8
4872569|NCT00810069|16792761|P2|Double-Blind Period II|Adverse Event|9
4872570|NCT00810069|16792762|P1|Double-Blind Period II|Adverse Event|0
4872571|NCT00810069|16792760|P3|Lead-in Period I|Randomization criteria not met|0
4872572|NCT00810069|16792761|P2|Lead-in Period I|Randomization criteria not met|0
4872573|NCT00810069|16792762|P1|Lead-in Period I|Randomization criteria not met|158
4872574|NCT00810069|16792760|P3|Lead-in Period I|Protocol entry criterion not met|0
4872575|NCT00810069|16792761|P2|Lead-in Period I|Protocol entry criterion not met|0
4872576|NCT00810069|16792762|P1|Lead-in Period I|Protocol entry criterion not met|5
4872577|NCT00810069|16792760|P3|Lead-in Period I|Withdrawal by Subject|0
4872578|NCT00810069|16792761|P2|Lead-in Period I|Withdrawal by Subject|0
4872579|NCT00810069|16792762|P1|Lead-in Period I|Withdrawal by Subject|46
4872580|NCT00810069|16792760|P3|Lead-in Period I|Protocol Violation|0
4872581|NCT00810069|16792761|P2|Lead-in Period I|Protocol Violation|0
4872582|NCT00810069|16792762|P1|Lead-in Period I|Protocol Violation|1
4872583|NCT00810069|16792760|P3|Lead-in Period I|Physician Decision|0
4872584|NCT00810069|16792761|P2|Lead-in Period I|Physician Decision|0
4872585|NCT00810069|16792762|P1|Lead-in Period I|Physician Decision|1
4872586|NCT00810069|16792760|P3|Lead-in Period I|Lost to Follow-up|0
4872587|NCT00810069|16792761|P2|Lead-in Period I|Lost to Follow-up|0
4872588|NCT00810069|16792762|P1|Lead-in Period I|Lost to Follow-up|19
4872589|NCT00810069|16792760|P3|Lead-in Period I|Lack of Efficacy|0
4872590|NCT00810069|16792761|P2|Lead-in Period I|Lack of Efficacy|0
4872591|NCT00810069|16792762|P1|Lead-in Period I|Lack of Efficacy|1
4872592|NCT00810069|16792760|P3|Lead-in Period I|Adverse Event|0
4872593|NCT00810069|16792761|P2|Lead-in Period I|Adverse Event|0
4872594|NCT00810069|16792762|P1|Lead-in Period I|Adverse Event|43
4872595|NCT00810043|16792807|P3|Overall Study|No longer met enrollment criteria|3
4872596|NCT00810043|16792808|P2|Overall Study|No longer met enrollment criteria|0
4872597|NCT00810043|16792809|P1|Overall Study|No longer met enrollment criteria|0
4872598|NCT00810043|16792807|P3|Overall Study|Non-medical problem|1
4872599|NCT00810043|16792808|P2|Overall Study|Non-medical problem|0
4872600|NCT00810043|16792809|P1|Overall Study|Non-medical problem|0
4872601|NCT00810043|16792807|P3|Overall Study|Unrelated medical problem|0
4872602|NCT00810043|16792808|P2|Overall Study|Unrelated medical problem|1
4872603|NCT00810043|16792809|P1|Overall Study|Unrelated medical problem|0
4872604|NCT00810043|16792807|P3|Overall Study|Death|0
4872605|NCT00810043|16792808|P2|Overall Study|Death|0
4872606|NCT00810043|16792809|P1|Overall Study|Death|2
4872607|NCT00810043|16792807|P3|Overall Study|Physician Decision|2
4872608|NCT00810043|16792808|P2|Overall Study|Physician Decision|0
4872609|NCT00810043|16792809|P1|Overall Study|Physician Decision|0
4872610|NCT00810043|16792807|P3|Overall Study|Lost to Follow-up|0
4872611|NCT00810043|16792808|P2|Overall Study|Lost to Follow-up|0
4872612|NCT00810043|16792809|P1|Overall Study|Lost to Follow-up|1
4872613|NCT00810043|16792807|P3|Overall Study|Withdrawal by Subject|2
4872614|NCT00810043|16792808|P2|Overall Study|Withdrawal by Subject|0
4872615|NCT00810043|16792809|P1|Overall Study|Withdrawal by Subject|1
4872616|NCT00809965|16792831|P3|Overall Study|Other Reason|189
4872617|NCT00809965|16792832|P2|Overall Study|Other Reason|170
4872618|NCT00809965|16792833|P1|Overall Study|Other Reason|167
4872619|NCT00809965|16792831|P3|Overall Study|Withdrawal by Subject|441
4872620|NCT00809965|16792832|P2|Overall Study|Withdrawal by Subject|448
4872621|NCT00809965|16792833|P1|Overall Study|Withdrawal by Subject|405
4872622|NCT00809965|16792831|P3|Overall Study|Lost to Follow-up|18
4872623|NCT00809965|16792832|P2|Overall Study|Lost to Follow-up|10
4872624|NCT00809965|16792833|P1|Overall Study|Lost to Follow-up|17
4872625|NCT00809965|16792831|P3|Overall Study|Death|196
4872626|NCT00809965|16792832|P2|Overall Study|Death|147
4872627|NCT00809965|16792833|P1|Overall Study|Death|194
4872628|NCT00809926|16792855|P2|Overall Study|Protocol deviation|2
4872629|NCT00809926|16792856|P1|Overall Study|Protocol deviation|0
4872630|NCT00809926|16792855|P2|Overall Study|Administrative Problems|1
4872631|NCT00809926|16792856|P1|Overall Study|Administrative Problems|0
4872632|NCT00809926|16792855|P2|Overall Study|Lost to Follow-up|1
4872633|NCT00809926|16792856|P1|Overall Study|Lost to Follow-up|2
4872634|NCT00809926|16792855|P2|Overall Study|Patient withdrew consent|6
4872635|NCT00809926|16792856|P1|Overall Study|Patient withdrew consent|8
4872636|NCT00809926|16792855|P2|Overall Study|Unsatisfactory therapeutic effect|3
4872637|NCT00809926|16792856|P1|Overall Study|Unsatisfactory therapeutic effect|3
4872638|NCT00809926|16792855|P2|Overall Study|Adverse Event|10
4872639|NCT00809926|16792856|P1|Overall Study|Adverse Event|18
4872640|NCT00809835|16792910|P4|Overall Study|Withdrawal by Subject|0
4872641|NCT00809835|16792911|P3|Overall Study|Withdrawal by Subject|1
4872642|NCT00809835|16792912|P2|Overall Study|Withdrawal by Subject|1
4872643|NCT00809835|16792913|P1|Overall Study|Withdrawal by Subject|1
4872644|NCT00809835|16792910|P4|Overall Study|Lost to Follow-up|2
4872645|NCT00809835|16792911|P3|Overall Study|Lost to Follow-up|10
4872646|NCT00809835|16792912|P2|Overall Study|Lost to Follow-up|6
4872647|NCT00809835|16792913|P1|Overall Study|Lost to Follow-up|7
4872648|NCT00809757|16792943|P3|Overall Study|Noncompliance with Medication|1
4872649|NCT00809757|16792944|P2|Overall Study|Noncompliance with Medication|0
4872650|NCT00809757|16792945|P1|Overall Study|Noncompliance with Medication|0
4872651|NCT00809757|16792943|P3|Overall Study|Subject Uncooperative|2
4872652|NCT00809757|16792944|P2|Overall Study|Subject Uncooperative|0
4872653|NCT00809757|16792945|P1|Overall Study|Subject Uncooperative|1
4872654|NCT00809757|16792943|P3|Overall Study|Withdrawal by Subject|3
4872655|NCT00809757|16792944|P2|Overall Study|Withdrawal by Subject|1
4872656|NCT00809757|16792945|P1|Overall Study|Withdrawal by Subject|2
4872657|NCT00809757|16792943|P3|Overall Study|Protocol Violation|1
4872658|NCT00809757|16792944|P2|Overall Study|Protocol Violation|1
4872659|NCT00809757|16792945|P1|Overall Study|Protocol Violation|1
4872660|NCT00809757|16792943|P3|Overall Study|Lost to Follow-up|1
4872661|NCT00809757|16792944|P2|Overall Study|Lost to Follow-up|0
4872662|NCT00809757|16792945|P1|Overall Study|Lost to Follow-up|0
4872663|NCT00809757|16792943|P3|Overall Study|Adverse Event|3
4872664|NCT00809757|16792944|P2|Overall Study|Adverse Event|3
4872665|NCT00809757|16792945|P1|Overall Study|Adverse Event|2
4872666|NCT00809614|16793030|P2|Overall Study|Withdrawal by Subject|1
4872667|NCT00809614|16793031|P1|Overall Study|Withdrawal by Subject|1
4872668|NCT00809614|16793030|P2|Overall Study|Lack of Efficacy|3
4872669|NCT00809614|16793031|P1|Overall Study|Lack of Efficacy|2
4872670|NCT00809471|16793075|P3|Overall Study|Requirement for restricted medication|0
4872671|NCT00809471|16793076|P2|Overall Study|Requirement for restricted medication|1
4872672|NCT00809471|16793077|P1|Overall Study|Requirement for restricted medication|1
4872673|NCT00809471|16793075|P3|Overall Study|Adverse Event|2
4872674|NCT00809471|16793076|P2|Overall Study|Adverse Event|2
4872675|NCT00809471|16793077|P1|Overall Study|Adverse Event|0
4872676|NCT00809471|16793075|P3|Overall Study|Lost to Follow-up|9
4872677|NCT00809471|16793076|P2|Overall Study|Lost to Follow-up|2
4872678|NCT00809471|16793077|P1|Overall Study|Lost to Follow-up|4
4872679|NCT00809471|16793075|P3|Overall Study|Protocol non-compliance|6
4872680|NCT00809471|16793076|P2|Overall Study|Protocol non-compliance|15
4872681|NCT00809471|16793077|P1|Overall Study|Protocol non-compliance|15
4872682|NCT00809445|16793107|P3|6 Month Follow-up|Withdrew consent|1
4872683|NCT00809445|16793108|P2|6 Month Follow-up|Withdrew consent|0
4872684|NCT00809445|16793109|P1|6 Month Follow-up|Withdrew consent|0
4872685|NCT00809445|16793107|P3|6 Month Follow-up|Incarcerated|8
4872686|NCT00809445|16793108|P2|6 Month Follow-up|Incarcerated|8
4872687|NCT00809445|16793109|P1|6 Month Follow-up|Incarcerated|6
4872688|NCT00809445|16793107|P3|6 Month Follow-up|Death|1
4872689|NCT00809445|16793108|P2|6 Month Follow-up|Death|1
4872690|NCT00809445|16793109|P1|6 Month Follow-up|Death|2
4872691|NCT00809445|16793107|P3|6 Month Follow-up|Lost contact|14
4872692|NCT00809445|16793108|P2|6 Month Follow-up|Lost contact|14
4872693|NCT00809445|16793109|P1|6 Month Follow-up|Lost contact|16
4872694|NCT00809445|16793107|P3|1 Month Follow-up|Incarcerated|1
4872695|NCT00809445|16793108|P2|1 Month Follow-up|Incarcerated|0
4872696|NCT00809445|16793109|P1|1 Month Follow-up|Incarcerated|0
4872697|NCT00809445|16793107|P3|1 Month Follow-up|Death|1
4872698|NCT00809445|16793108|P2|1 Month Follow-up|Death|1
4872699|NCT00809445|16793109|P1|1 Month Follow-up|Death|0
4872700|NCT00809445|16793107|P3|1 Month Follow-up|Withdrew consent|1
4872701|NCT00809445|16793108|P2|1 Month Follow-up|Withdrew consent|1
4872702|NCT00809445|16793109|P1|1 Month Follow-up|Withdrew consent|1
4872703|NCT00809445|16793107|P3|1 Month Follow-up|Lost contact|1
4872704|NCT00809445|16793108|P2|1 Month Follow-up|Lost contact|2
4872705|NCT00809445|16793109|P1|1 Month Follow-up|Lost contact|1
4872706|NCT00809341|16793128|P2|Overall Study|Physician Decision|1
4872707|NCT00809341|16793129|P1|Overall Study|Physician Decision|0
4872708|NCT00809328|16793137|P1|Overall Study|Withdrawal by Subject|2
4872709|NCT00809328|16793137|P1|Overall Study|Protocol Violation|3
4872710|NCT00809328|16793137|P1|Overall Study|Adverse Event|6
4872711|NCT00809328|16793137|P1|Overall Study|Lack of Efficacy|18
4872712|NCT00809159|16793159|P6|Part 1 and 2|Withdrawal by Subject|1
4872713|NCT00809159|16793160|P5|Part 1 and 2|Withdrawal by Subject|0
4872714|NCT00809159|16793161|P4|Part 1 and 2|Withdrawal by Subject|0
4872715|NCT00809159|16793162|P3|Part 1 and 2|Withdrawal by Subject|4
4872716|NCT00809159|16793163|P2|Part 1 and 2|Withdrawal by Subject|0
4872717|NCT00809159|16793164|P1|Part 1 and 2|Withdrawal by Subject|0
4872718|NCT00809159|16793159|P6|Part 1 and 2|Lost to Follow-up|0
4872719|NCT00809159|16793160|P5|Part 1 and 2|Lost to Follow-up|0
4872720|NCT00809159|16793161|P4|Part 1 and 2|Lost to Follow-up|1
4872721|NCT00809159|16793162|P3|Part 1 and 2|Lost to Follow-up|1
4872722|NCT00809159|16793163|P2|Part 1 and 2|Lost to Follow-up|0
4872723|NCT00809159|16793164|P1|Part 1 and 2|Lost to Follow-up|0
4872724|NCT00809159|16793159|P6|Part 1 and 2|Adverse Event|1
4872725|NCT00809159|16793160|P5|Part 1 and 2|Adverse Event|1
4872726|NCT00809159|16793161|P4|Part 1 and 2|Adverse Event|0
4872727|NCT00809159|16793162|P3|Part 1 and 2|Adverse Event|1
4872728|NCT00809159|16793163|P2|Part 1 and 2|Adverse Event|0
4872729|NCT00809159|16793164|P1|Part 1 and 2|Adverse Event|0
4872730|NCT00809159|16793159|P6|Part 1 and 2|Administrative problems|0
4872731|NCT00809159|16793160|P5|Part 1 and 2|Administrative problems|0
4872732|NCT00809159|16793161|P4|Part 1 and 2|Administrative problems|1
4872733|NCT00809159|16793162|P3|Part 1 and 2|Administrative problems|0
4872734|NCT00809159|16793163|P2|Part 1 and 2|Administrative problems|0
4872735|NCT00809159|16793164|P1|Part 1 and 2|Administrative problems|0
4872736|NCT00809159|16793159|P6|Part 1 and 2|Unsatisfactory therapeutic effect|1
4872737|NCT00809159|16793160|P5|Part 1 and 2|Unsatisfactory therapeutic effect|5
4872738|NCT00809159|16793161|P4|Part 1 and 2|Unsatisfactory therapeutic effect|3
4872739|NCT00809159|16793162|P3|Part 1 and 2|Unsatisfactory therapeutic effect|4
4872740|NCT00809159|16793163|P2|Part 1 and 2|Unsatisfactory therapeutic effect|0
4872741|NCT00809159|16793164|P1|Part 1 and 2|Unsatisfactory therapeutic effect|0
4872742|NCT00809159|16793159|P6|Part 1|Unsatisfactory therapeutic effect|0
4872743|NCT00809159|16793160|P5|Part 1|Unsatisfactory therapeutic effect|0
4872744|NCT00809159|16793161|P4|Part 1|Unsatisfactory therapeutic effect|0
4872745|NCT00809159|16793162|P3|Part 1|Unsatisfactory therapeutic effect|0
4872746|NCT00809159|16793163|P2|Part 1|Unsatisfactory therapeutic effect|1
4872747|NCT00809159|16793164|P1|Part 1|Unsatisfactory therapeutic effect|3
4872748|NCT00809159|16793159|P6|Part 1|Withdrawal by Subject|0
4872749|NCT00809159|16793160|P5|Part 1|Withdrawal by Subject|0
4872750|NCT00809159|16793161|P4|Part 1|Withdrawal by Subject|0
4872751|NCT00809159|16793162|P3|Part 1|Withdrawal by Subject|0
4872752|NCT00809159|16793163|P2|Part 1|Withdrawal by Subject|1
4872753|NCT00809159|16793164|P1|Part 1|Withdrawal by Subject|3
4872754|NCT00809159|16793159|P6|Part 1|Lost to Follow-up|0
4872755|NCT00809159|16793160|P5|Part 1|Lost to Follow-up|0
4872756|NCT00809159|16793161|P4|Part 1|Lost to Follow-up|0
4872757|NCT00809159|16793162|P3|Part 1|Lost to Follow-up|0
4872758|NCT00809159|16793163|P2|Part 1|Lost to Follow-up|0
4872759|NCT00809159|16793164|P1|Part 1|Lost to Follow-up|1
4872760|NCT00809159|16793159|P6|Part 1|Adverse Event|0
4872761|NCT00809159|16793160|P5|Part 1|Adverse Event|0
4872762|NCT00809159|16793161|P4|Part 1|Adverse Event|0
4872763|NCT00809159|16793162|P3|Part 1|Adverse Event|0
4872764|NCT00809159|16793163|P2|Part 1|Adverse Event|1
4872765|NCT00809159|16793164|P1|Part 1|Adverse Event|1
4872766|NCT00809133|16793269|P14|Overall Study|Other not mentioned above|0
4872767|NCT00809133|16793270|P13|Overall Study|Other not mentioned above|0
4872768|NCT00809133|16793271|P12|Overall Study|Other not mentioned above|0
4872769|NCT00809133|16793272|P11|Overall Study|Other not mentioned above|0
4872770|NCT00809133|16793273|P10|Overall Study|Other not mentioned above|0
4872771|NCT00809133|16793274|P9|Overall Study|Other not mentioned above|0
4872772|NCT00809133|16793275|P8|Overall Study|Other not mentioned above|0
4872773|NCT00809133|16793276|P7|Overall Study|Other not mentioned above|0
4872774|NCT00809133|16793277|P6|Overall Study|Other not mentioned above|1
4872775|NCT00809133|16793278|P5|Overall Study|Other not mentioned above|0
4872776|NCT00809133|16793279|P4|Overall Study|Other not mentioned above|0
4872777|NCT00809133|16793280|P3|Overall Study|Other not mentioned above|0
4872778|NCT00809133|16793281|P2|Overall Study|Other not mentioned above|1
4872779|NCT00809133|16793282|P1|Overall Study|Other not mentioned above|0
4872780|NCT00809133|16793269|P14|Overall Study|Consent withdrawn|0
4872781|NCT00809133|16793270|P13|Overall Study|Consent withdrawn|0
4872782|NCT00809133|16793271|P12|Overall Study|Consent withdrawn|0
4872783|NCT00809133|16793272|P11|Overall Study|Consent withdrawn|0
4872784|NCT00809133|16793273|P10|Overall Study|Consent withdrawn|0
4872785|NCT00809133|16793274|P9|Overall Study|Consent withdrawn|0
4872786|NCT00809133|16793275|P8|Overall Study|Consent withdrawn|0
4872787|NCT00809133|16793276|P7|Overall Study|Consent withdrawn|0
4872788|NCT00809133|16793277|P6|Overall Study|Consent withdrawn|0
4872789|NCT00809133|16793278|P5|Overall Study|Consent withdrawn|1
4872790|NCT00809133|16793279|P4|Overall Study|Consent withdrawn|0
4872791|NCT00809133|16793280|P3|Overall Study|Consent withdrawn|0
4872792|NCT00809133|16793281|P2|Overall Study|Consent withdrawn|0
4872793|NCT00809133|16793282|P1|Overall Study|Consent withdrawn|0
4872794|NCT00809133|16793269|P14|Overall Study|Lost to Follow-up|0
4872795|NCT00809133|16793270|P13|Overall Study|Lost to Follow-up|0
4872796|NCT00809133|16793271|P12|Overall Study|Lost to Follow-up|0
4872797|NCT00809133|16793272|P11|Overall Study|Lost to Follow-up|0
4872798|NCT00809133|16793273|P10|Overall Study|Lost to Follow-up|0
4872799|NCT00809133|16793274|P9|Overall Study|Lost to Follow-up|0
4872800|NCT00809133|16793275|P8|Overall Study|Lost to Follow-up|0
4872801|NCT00809133|16793276|P7|Overall Study|Lost to Follow-up|0
4872802|NCT00809133|16793277|P6|Overall Study|Lost to Follow-up|1
4872803|NCT00809133|16793278|P5|Overall Study|Lost to Follow-up|0
4872804|NCT00809133|16793279|P4|Overall Study|Lost to Follow-up|0
4872805|NCT00809133|16793280|P3|Overall Study|Lost to Follow-up|0
4872806|NCT00809133|16793281|P2|Overall Study|Lost to Follow-up|0
4872807|NCT00809133|16793282|P1|Overall Study|Lost to Follow-up|0
4872808|NCT00809133|16793269|P14|Overall Study|Other adverse event|1
4872809|NCT00809133|16793270|P13|Overall Study|Other adverse event|0
4872810|NCT00809133|16793271|P12|Overall Study|Other adverse event|1
4872811|NCT00809133|16793272|P11|Overall Study|Other adverse event|1
4872812|NCT00809133|16793273|P10|Overall Study|Other adverse event|0
4872813|NCT00809133|16793274|P9|Overall Study|Other adverse event|0
4872814|NCT00809133|16793275|P8|Overall Study|Other adverse event|4
4872815|NCT00809133|16793276|P7|Overall Study|Other adverse event|2
4872816|NCT00809133|16793277|P6|Overall Study|Other adverse event|3
4872817|NCT00809133|16793278|P5|Overall Study|Other adverse event|0
4872818|NCT00809133|16793279|P4|Overall Study|Other adverse event|0
4872819|NCT00809133|16793280|P3|Overall Study|Other adverse event|1
4872820|NCT00809133|16793281|P2|Overall Study|Other adverse event|1
4872821|NCT00809133|16793282|P1|Overall Study|Other adverse event|1
4872822|NCT00809133|16793269|P14|Overall Study|Dose Limiting Toxicity (DLT)|2
4872823|NCT00809133|16793270|P13|Overall Study|Dose Limiting Toxicity (DLT)|0
4872824|NCT00809133|16793271|P12|Overall Study|Dose Limiting Toxicity (DLT)|0
4872825|NCT00809133|16793272|P11|Overall Study|Dose Limiting Toxicity (DLT)|0
4872826|NCT00809133|16793273|P10|Overall Study|Dose Limiting Toxicity (DLT)|0
4872827|NCT00809133|16793274|P9|Overall Study|Dose Limiting Toxicity (DLT)|0
4872828|NCT00809133|16793275|P8|Overall Study|Dose Limiting Toxicity (DLT)|1
4872829|NCT00809133|16793276|P7|Overall Study|Dose Limiting Toxicity (DLT)|1
4872830|NCT00809133|16793277|P6|Overall Study|Dose Limiting Toxicity (DLT)|1
4872831|NCT00809133|16793278|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
4872832|NCT00809133|16793279|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
4872833|NCT00809133|16793280|P3|Overall Study|Dose Limiting Toxicity (DLT)|0
4872834|NCT00809133|16793281|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
4872835|NCT00809133|16793282|P1|Overall Study|Dose Limiting Toxicity (DLT)|0
4872836|NCT00809133|16793269|P14|Overall Study|Progressive disease|4
4872837|NCT00809133|16793270|P13|Overall Study|Progressive disease|5
4872838|NCT00809133|16793271|P12|Overall Study|Progressive disease|7
4872839|NCT00809133|16793272|P11|Overall Study|Progressive disease|5
4872840|NCT00809133|16793273|P10|Overall Study|Progressive disease|9
4872841|NCT00809133|16793274|P9|Overall Study|Progressive disease|3
4872842|NCT00809133|16793275|P8|Overall Study|Progressive disease|3
4872843|NCT00809133|16793276|P7|Overall Study|Progressive disease|3
4872844|NCT00809133|16793277|P6|Overall Study|Progressive disease|1
4872845|NCT00809133|16793278|P5|Overall Study|Progressive disease|4
4872846|NCT00809133|16793279|P4|Overall Study|Progressive disease|3
4872847|NCT00809133|16793280|P3|Overall Study|Progressive disease|5
4872848|NCT00809133|16793281|P2|Overall Study|Progressive disease|5
4872849|NCT00809133|16793282|P1|Overall Study|Progressive disease|2
4872850|NCT00809094|16793436|P2|Overall Study|Lost to Follow-up|1
4872851|NCT00809094|16793437|P1|Overall Study|Lost to Follow-up|0
4872852|NCT00808899|16793482|P1|Overall Study|Physician Decision|3
4872853|NCT00808899|16793482|P1|Overall Study|Death|1
4872854|NCT00808808|16793496|P3|Overall Study|Employee was not vaccinated.|2255
4872855|NCT00808808|16793497|P2|Overall Study|Employee was not vaccinated.|2268
4872856|NCT00808808|16793498|P1|Overall Study|Employee was not vaccinated.|2686
4872857|NCT00808808|16793496|P3|Overall Study|Vaccinated; survey not completed|302
4872858|NCT00808808|16793497|P2|Overall Study|Vaccinated; survey not completed|169
4872859|NCT00808808|16793498|P1|Overall Study|Vaccinated; survey not completed|131
4872860|NCT00808665|16793533|P2|Overall Study|Medication stopped by resident|1
4872861|NCT00808665|16793534|P1|Overall Study|Medication stopped by resident|0
4872862|NCT00808665|16793533|P2|Overall Study|Physician Decision|1
4872863|NCT00808665|16793534|P1|Overall Study|Physician Decision|3
4872864|NCT00808665|16793533|P2|Overall Study|required an additional procedure|1
4872865|NCT00808665|16793534|P1|Overall Study|required an additional procedure|0
4872866|NCT00808665|16793533|P2|Overall Study|surgery cancelled|0
4872867|NCT00808665|16793534|P1|Overall Study|surgery cancelled|1
4872868|NCT00808665|16793533|P2|Overall Study|only required minimally invasive surgery|0
4872869|NCT00808665|16793534|P1|Overall Study|only required minimally invasive surgery|1
4872870|NCT00808665|16793533|P2|Overall Study|Withdrawal by Subject|0
4872871|NCT00808665|16793534|P1|Overall Study|Withdrawal by Subject|1
4872872|NCT00808639|16793540|P1|Overall Study|Disease progression before surgery.|1
4872873|NCT00808509|16793548|P2|Randomized Phase|Patient refused rescue therapy|3
4872874|NCT00808509|16793549|P1|Randomized Phase|Patient refused rescue therapy|0
4872875|NCT00808509|16793548|P2|Randomized Phase|Reduced methotrexate dose|2
4872876|NCT00808509|16793549|P1|Randomized Phase|Reduced methotrexate dose|1
4872877|NCT00808509|16793548|P2|Randomized Phase|Did not meet eligibility criteria|0
4872878|NCT00808509|16793549|P1|Randomized Phase|Did not meet eligibility criteria|1
4872879|NCT00808483|16793647|P2|From 5 Months to 12 Months|Lack of Efficacy|0
4872880|NCT00808483|16793648|P1|From 5 Months to 12 Months|Lack of Efficacy|1
4872881|NCT00808483|16793647|P2|From 3 to 5 Months After Surgery|Lack of Efficacy|0
4872882|NCT00808483|16793648|P1|From 3 to 5 Months After Surgery|Lack of Efficacy|1
4872883|NCT00808483|16793647|P2|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
4872884|NCT00808483|16793648|P1|From 3 to 5 Months After Surgery|Withdrawal by Subject|1
4872885|NCT00808444|16793685|P2|Overall Study|Lost to Follow-up|1
4872886|NCT00808444|16793686|P1|Overall Study|Lost to Follow-up|0
4872887|NCT00808444|16793685|P2|Overall Study|Withdrawal by Subject|0
4872888|NCT00808444|16793686|P1|Overall Study|Withdrawal by Subject|1
4872889|NCT00808249|16793761|P4|Overall Study|All other reasons|1
4872890|NCT00808249|16793762|P3|Overall Study|All other reasons|3
4872891|NCT00808249|16793763|P2|Overall Study|All other reasons|1
4872892|NCT00808249|16793764|P1|Overall Study|All other reasons|2
4872893|NCT00808249|16793761|P4|Overall Study|study specific discontinuation criteria|0
4872894|NCT00808249|16793762|P3|Overall Study|study specific discontinuation criteria|1
4872895|NCT00808249|16793763|P2|Overall Study|study specific discontinuation criteria|0
4872896|NCT00808249|16793764|P1|Overall Study|study specific discontinuation criteria|1
4872897|NCT00808249|16793761|P4|Overall Study|Lack of Efficacy|0
4872898|NCT00808249|16793762|P3|Overall Study|Lack of Efficacy|0
4872899|NCT00808249|16793763|P2|Overall Study|Lack of Efficacy|1
4872900|NCT00808249|16793764|P1|Overall Study|Lack of Efficacy|1
4872901|NCT00808249|16793761|P4|Overall Study|Protocol Violation|0
4872902|NCT00808249|16793762|P3|Overall Study|Protocol Violation|3
4872903|NCT00808249|16793763|P2|Overall Study|Protocol Violation|3
4872904|NCT00808249|16793764|P1|Overall Study|Protocol Violation|3
4872905|NCT00808249|16793761|P4|Overall Study|Withdrawal by Subject|4
4872906|NCT00808249|16793762|P3|Overall Study|Withdrawal by Subject|2
4872907|NCT00808249|16793763|P2|Overall Study|Withdrawal by Subject|0
4872908|NCT00808249|16793764|P1|Overall Study|Withdrawal by Subject|4
4872909|NCT00808249|16793761|P4|Overall Study|Lost to Follow-up|5
4872910|NCT00808249|16793762|P3|Overall Study|Lost to Follow-up|3
4872911|NCT00808249|16793763|P2|Overall Study|Lost to Follow-up|3
4872912|NCT00808249|16793764|P1|Overall Study|Lost to Follow-up|2
4872913|NCT00808249|16793761|P4|Overall Study|Adverse Event|6
4872914|NCT00808249|16793762|P3|Overall Study|Adverse Event|10
4872915|NCT00808249|16793763|P2|Overall Study|Adverse Event|7
4872916|NCT00808249|16793764|P1|Overall Study|Adverse Event|4
4872917|NCT00808236|16793792|P2|Overall Study|Death|30
4872918|NCT00808236|16793793|P1|Overall Study|Death|18
4872919|NCT00808236|16793792|P2|Overall Study|Physician Decision|1
4872920|NCT00808236|16793793|P1|Overall Study|Physician Decision|0
4872921|NCT00808236|16793792|P2|Overall Study|Lost to Follow-up|1
4872922|NCT00808236|16793793|P1|Overall Study|Lost to Follow-up|1
4872923|NCT00808236|16793792|P2|Overall Study|Pre-defined exclusion|3
4872924|NCT00808236|16793793|P1|Overall Study|Pre-defined exclusion|13
4872925|NCT00808236|16793792|P2|Overall Study|Was not resuscitated|56
4872926|NCT00808236|16793793|P1|Overall Study|Was not resuscitated|50
4872927|NCT00808132|16793826|P5|Overall Study|Unsatisfactory response|12
4872928|NCT00808132|16793827|P4|Overall Study|Unsatisfactory response|4
4872929|NCT00808132|16793828|P3|Overall Study|Unsatisfactory response|6
4872930|NCT00808132|16793829|P2|Overall Study|Unsatisfactory response|6
4872931|NCT00808132|16793830|P1|Overall Study|Unsatisfactory response|5
4872932|NCT00808132|16793826|P5|Overall Study|Randomized, but not treated|9
4872933|NCT00808132|16793827|P4|Overall Study|Randomized, but not treated|8
4872934|NCT00808132|16793828|P3|Overall Study|Randomized, but not treated|9
4872935|NCT00808132|16793829|P2|Overall Study|Randomized, but not treated|7
4872936|NCT00808132|16793830|P1|Overall Study|Randomized, but not treated|10
4872937|NCT00808132|16793826|P5|Overall Study|Other|15
4872938|NCT00808132|16793827|P4|Overall Study|Other|2
4872939|NCT00808132|16793828|P3|Overall Study|Other|6
4872940|NCT00808132|16793829|P2|Overall Study|Other|4
4872941|NCT00808132|16793830|P1|Overall Study|Other|6
4872942|NCT00808132|16793826|P5|Overall Study|Withdrawal by Subject|16
4872943|NCT00808132|16793827|P4|Overall Study|Withdrawal by Subject|7
4872944|NCT00808132|16793828|P3|Overall Study|Withdrawal by Subject|2
4872945|NCT00808132|16793829|P2|Overall Study|Withdrawal by Subject|18
4872946|NCT00808132|16793830|P1|Overall Study|Withdrawal by Subject|27
4872947|NCT00808132|16793826|P5|Overall Study|Protocol Violation|5
4872948|NCT00808132|16793827|P4|Overall Study|Protocol Violation|9
4872949|NCT00808132|16793828|P3|Overall Study|Protocol Violation|4
4872950|NCT00808132|16793829|P2|Overall Study|Protocol Violation|9
4872951|NCT00808132|16793830|P1|Overall Study|Protocol Violation|8
4872952|NCT00808132|16793826|P5|Overall Study|Lost to Follow-up|9
4872953|NCT00808132|16793827|P4|Overall Study|Lost to Follow-up|8
4872954|NCT00808132|16793828|P3|Overall Study|Lost to Follow-up|11
4872955|NCT00808132|16793829|P2|Overall Study|Lost to Follow-up|10
4872956|NCT00808132|16793830|P1|Overall Study|Lost to Follow-up|8
4872957|NCT00808132|16793826|P5|Overall Study|Physician Decision|0
4872958|NCT00808132|16793827|P4|Overall Study|Physician Decision|0
4872959|NCT00808132|16793828|P3|Overall Study|Physician Decision|0
4872960|NCT00808132|16793829|P2|Overall Study|Physician Decision|1
4872961|NCT00808132|16793830|P1|Overall Study|Physician Decision|0
4872962|NCT00808132|16793826|P5|Overall Study|Death|1
4872963|NCT00808132|16793827|P4|Overall Study|Death|0
4872964|NCT00808132|16793828|P3|Overall Study|Death|0
4872965|NCT00808132|16793829|P2|Overall Study|Death|0
4872966|NCT00808132|16793830|P1|Overall Study|Death|0
4872967|NCT00808132|16793826|P5|Overall Study|Adverse Event|33
4872968|NCT00808132|16793827|P4|Overall Study|Adverse Event|31
4872969|NCT00808132|16793828|P3|Overall Study|Adverse Event|16
4872970|NCT00808132|16793829|P2|Overall Study|Adverse Event|33
4872971|NCT00808132|16793830|P1|Overall Study|Adverse Event|34
4872972|NCT00808080|16793902|P1|Overall Study|Patients Became Ineligible for infusion|6
4872973|NCT00808067|16793909|P2|Overall Study|Excluded from analysis|19
4872974|NCT00808067|16793910|P1|Overall Study|Excluded from analysis|13
4872975|NCT00808067|16793909|P2|Overall Study|Other reason not defined above|5
4872976|NCT00808067|16793910|P1|Overall Study|Other reason not defined above|5
4872977|NCT00808067|16793909|P2|Overall Study|Site closed for cause|19
4872978|NCT00808067|16793910|P1|Overall Study|Site closed for cause|19
4872979|NCT00808067|16793909|P2|Overall Study|Patient elected|9
4872980|NCT00808067|16793910|P1|Overall Study|Patient elected|7
4872981|NCT00808067|16793909|P2|Overall Study|Protocol Violation|11
4872982|NCT00808067|16793910|P1|Overall Study|Protocol Violation|3
4872983|NCT00808067|16793909|P2|Overall Study|Physician Decision|38
4872984|NCT00808067|16793910|P1|Overall Study|Physician Decision|47
4872985|NCT00808067|16793909|P2|Overall Study|Site closed|3
4872986|NCT00808067|16793910|P1|Overall Study|Site closed|4
4872987|NCT00808067|16793909|P2|Overall Study|Withdrawal by Subject|25
4872988|NCT00808067|16793910|P1|Overall Study|Withdrawal by Subject|21
4872989|NCT00808067|16793909|P2|Overall Study|Procedure|7
4872990|NCT00808067|16793910|P1|Overall Study|Procedure|6
4872991|NCT00808067|16793909|P2|Overall Study|Death|1
4872992|NCT00808067|16793910|P1|Overall Study|Death|1
4872993|NCT00808067|16793909|P2|Overall Study|Missing|0
4872994|NCT00808067|16793910|P1|Overall Study|Missing|1
4872995|NCT00808067|16793909|P2|Overall Study|Patient refused to take study medication|76
4872996|NCT00808067|16793910|P1|Overall Study|Patient refused to take study medication|65
4872997|NCT00808067|16793909|P2|Overall Study|Elevated LFT results|3
4872998|NCT00808067|16793910|P1|Overall Study|Elevated LFT results|7
4872999|NCT00808067|16793909|P2|Overall Study|Reduced creatinine clearance|55
4873000|NCT00808067|16793910|P1|Overall Study|Reduced creatinine clearance|53
4873001|NCT00808067|16793909|P2|Overall Study|Hospitalization due to surgery|40
4873002|NCT00808067|16793910|P1|Overall Study|Hospitalization due to surgery|37
4873003|NCT00808067|16793909|P2|Overall Study|Hospitalization (not including surgery)|17
4873004|NCT00808067|16793910|P1|Overall Study|Hospitalization (not including surgery)|18
4873005|NCT00808067|16793909|P2|Overall Study|Adverse Event|121
4873006|NCT00808067|16793910|P1|Overall Study|Adverse Event|111
4873007|NCT00808067|16793909|P2|Overall Study|Outcome event - other|25
4873008|NCT00808067|16793910|P1|Overall Study|Outcome event - other|33
4873009|NCT00808067|16793909|P2|Overall Study|Major/minor bleed|44
4873010|NCT00808067|16793910|P1|Overall Study|Major/minor bleed|30
4873011|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Non-compliance|0
4873012|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Non-compliance|1
4873013|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Non-compliance|0
4873014|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Non-compliance|0
4873015|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Death|0
4873016|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Death|1
4873017|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Death|0
4873018|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Death|0
4873019|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
4873020|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2
4873021|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
4873022|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0
4873023|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Other|1
4873024|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Other|1
4873025|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Other|0
4873026|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Other|0
4873027|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Adverse Event|0
4873028|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Adverse Event|1
4873029|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Adverse Event|0
4873030|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Adverse Event|1
4873031|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Failed to return|4
4873032|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Failed to return|5
4873033|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Failed to return|0
4873034|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Failed to return|2
4873035|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7
4873036|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8
4873037|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0
4873038|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2
4873039|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
4873040|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Protocol Violation|1
4873041|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
4873042|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Protocol Violation|0
4873043|NCT00808028|16793946|P4|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11
4873044|NCT00808028|16793947|P3|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9
4873045|NCT00808028|16793948|P2|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0
4873046|NCT00808028|16793949|P1|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6
4873047|NCT00808028|16793946|P4|Stage 1 (6 Months)|Protocol Violation|1
4873048|NCT00808028|16793947|P3|Stage 1 (6 Months)|Protocol Violation|0
4873049|NCT00808028|16793948|P2|Stage 1 (6 Months)|Protocol Violation|0
4873050|NCT00808028|16793949|P1|Stage 1 (6 Months)|Protocol Violation|0
4873051|NCT00808028|16793946|P4|Stage 1 (6 Months)|Lost to Follow-up|0
4873052|NCT00808028|16793947|P3|Stage 1 (6 Months)|Lost to Follow-up|1
4873053|NCT00808028|16793948|P2|Stage 1 (6 Months)|Lost to Follow-up|0
4873054|NCT00808028|16793949|P1|Stage 1 (6 Months)|Lost to Follow-up|1
4873055|NCT00808028|16793946|P4|Stage 1 (6 Months)|Adverse Event|2
4873056|NCT00808028|16793947|P3|Stage 1 (6 Months)|Adverse Event|1
4873057|NCT00808028|16793948|P2|Stage 1 (6 Months)|Adverse Event|0
4873058|NCT00808028|16793949|P1|Stage 1 (6 Months)|Adverse Event|0
4873059|NCT00808028|16793946|P4|Stage 1 (6 Months)|Parent/legal guardian request|3
4873060|NCT00808028|16793947|P3|Stage 1 (6 Months)|Parent/legal guardian request|1
4873061|NCT00808028|16793948|P2|Stage 1 (6 Months)|Parent/legal guardian request|1
4873062|NCT00808028|16793949|P1|Stage 1 (6 Months)|Parent/legal guardian request|0
4873063|NCT00808028|16793946|P4|Stage 1 (6 Months)|Other|4
4873064|NCT00808028|16793947|P3|Stage 1 (6 Months)|Other|2
4873065|NCT00808028|16793948|P2|Stage 1 (6 Months)|Other|0
4873066|NCT00808028|16793949|P1|Stage 1 (6 Months)|Other|1
4873067|NCT00808028|16793946|P4|Stage 1 (6 Months)|Withdrawal by Subject|5
4873068|NCT00808028|16793947|P3|Stage 1 (6 Months)|Withdrawal by Subject|2
4873069|NCT00808028|16793948|P2|Stage 1 (6 Months)|Withdrawal by Subject|0
4873070|NCT00808028|16793949|P1|Stage 1 (6 Months)|Withdrawal by Subject|3
4873071|NCT00808015|16793985|P1|Overall Study|Enrolled but not treated|4
4873072|NCT00808015|16793985|P1|Overall Study|Other|25
4873073|NCT00808015|16793985|P1|Overall Study|Adverse Event|22
4873074|NCT00808015|16793985|P1|Overall Study|Participants not willing to participate|158
4873075|NCT00808015|16793985|P1|Overall Study|Lost to Follow-up|76
4873076|NCT00808015|16793985|P1|Overall Study|Lack of Efficacy|58
4873077|NCT00808015|16793985|P1|Overall Study|Death|1
4873078|NCT00807937|16794014|P4|Overall Study|All other reasons (not provided)|1
4873079|NCT00807937|16794015|P3|Overall Study|All other reasons (not provided)|0
4873080|NCT00807937|16794016|P2|Overall Study|All other reasons (not provided)|4
4873081|NCT00807937|16794017|P1|Overall Study|All other reasons (not provided)|2
4873082|NCT00807937|16794014|P4|Overall Study|Intake of prohibited medicine|0
4873083|NCT00807937|16794015|P3|Overall Study|Intake of prohibited medicine|2
4873084|NCT00807937|16794016|P2|Overall Study|Intake of prohibited medicine|0
4873085|NCT00807937|16794017|P1|Overall Study|Intake of prohibited medicine|0
4873086|NCT00807937|16794014|P4|Overall Study|Lack of Efficacy|2
4873087|NCT00807937|16794015|P3|Overall Study|Lack of Efficacy|1
4873088|NCT00807937|16794016|P2|Overall Study|Lack of Efficacy|0
4873089|NCT00807937|16794017|P1|Overall Study|Lack of Efficacy|0
4873090|NCT00807937|16794014|P4|Overall Study|Lost to Follow-up|1
4873091|NCT00807937|16794015|P3|Overall Study|Lost to Follow-up|2
4873092|NCT00807937|16794016|P2|Overall Study|Lost to Follow-up|0
4873093|NCT00807937|16794017|P1|Overall Study|Lost to Follow-up|4
4873094|NCT00807937|16794014|P4|Overall Study|Withdrawal by Subject|4
4873095|NCT00807937|16794015|P3|Overall Study|Withdrawal by Subject|1
4873096|NCT00807937|16794016|P2|Overall Study|Withdrawal by Subject|4
4873097|NCT00807937|16794017|P1|Overall Study|Withdrawal by Subject|5
4873098|NCT00807937|16794014|P4|Overall Study|Protocol Violation|3
4873099|NCT00807937|16794015|P3|Overall Study|Protocol Violation|3
4873100|NCT00807937|16794016|P2|Overall Study|Protocol Violation|5
4873101|NCT00807937|16794017|P1|Overall Study|Protocol Violation|4
4873102|NCT00807937|16794014|P4|Overall Study|Adverse Event|4
4873103|NCT00807937|16794015|P3|Overall Study|Adverse Event|5
4873104|NCT00807937|16794016|P2|Overall Study|Adverse Event|12
4873105|NCT00807937|16794017|P1|Overall Study|Adverse Event|12
4873106|NCT00807885|16794052|P9|Overall Study|Lost to Follow-up|0
4873107|NCT00807885|16794053|P8|Overall Study|Lost to Follow-up|0
4873108|NCT00807885|16794054|P7|Overall Study|Lost to Follow-up|0
4873109|NCT00807885|16794055|P6|Overall Study|Lost to Follow-up|1
4873110|NCT00807885|16794056|P5|Overall Study|Lost to Follow-up|0
4873111|NCT00807885|16794057|P4|Overall Study|Lost to Follow-up|0
4873112|NCT00807885|16794058|P3|Overall Study|Lost to Follow-up|0
4873113|NCT00807885|16794059|P2|Overall Study|Lost to Follow-up|0
4873114|NCT00807885|16794060|P1|Overall Study|Lost to Follow-up|0
4873115|NCT00807846|16794109|P2|Overall Study|Other|2
4873116|NCT00807846|16794110|P1|Overall Study|Other|1
4873117|NCT00807846|16794109|P2|Overall Study|Withdrawal by Subject|1
4873118|NCT00807846|16794110|P1|Overall Study|Withdrawal by Subject|2
4873119|NCT00807846|16794109|P2|Overall Study|Protocol Violation|1
4873120|NCT00807846|16794110|P1|Overall Study|Protocol Violation|2
4873121|NCT00807846|16794109|P2|Overall Study|Lack of Efficacy|0
4873122|NCT00807846|16794110|P1|Overall Study|Lack of Efficacy|2
4873123|NCT00807846|16794109|P2|Overall Study|Adverse Event|0
4873124|NCT00807846|16794110|P1|Overall Study|Adverse Event|5
4873125|NCT00807742|16794163|P2|Overall Study|Lost to Follow-up|51
4873126|NCT00807742|16794164|P1|Overall Study|Lost to Follow-up|35
4873127|NCT00807742|16794163|P2|Overall Study|Withdrawal by Subject|1
4873128|NCT00807742|16794164|P1|Overall Study|Withdrawal by Subject|2
4873129|NCT00807742|16794163|P2|Overall Study|Death|2
4873130|NCT00807742|16794164|P1|Overall Study|Death|9
4873131|NCT00807599|16794223|P3|Overall Study|Withdrawal by Subject|1
4873132|NCT00807599|16794224|P2|Overall Study|Withdrawal by Subject|0
4873133|NCT00807599|16794225|P1|Overall Study|Withdrawal by Subject|0
4873134|NCT00807599|16794223|P3|Overall Study|Inadequate response to induction|9
4873135|NCT00807599|16794224|P2|Overall Study|Inadequate response to induction|0
4873136|NCT00807599|16794225|P1|Overall Study|Inadequate response to induction|0
4873137|NCT00807599|16794223|P3|Overall Study|Adverse Event|5
4873138|NCT00807599|16794224|P2|Overall Study|Adverse Event|0
4873139|NCT00807599|16794225|P1|Overall Study|Adverse Event|0
4873140|NCT00807599|16794223|P3|Overall Study|Not treated on protocol study|2
4873141|NCT00807599|16794224|P2|Overall Study|Not treated on protocol study|0
4873142|NCT00807599|16794225|P1|Overall Study|Not treated on protocol study|0
4873143|NCT00807573|16794252|P1|Overall Study|Adverse Event|1
4873144|NCT00807573|16794252|P1|Overall Study|Withdrawal by Subject|1
4873145|NCT00807495|16794298|P5|Overall Study|Reason Not Specified|3
4873146|NCT00807495|16794299|P4|Overall Study|Reason Not Specified|0
4873147|NCT00807495|16794300|P3|Overall Study|Reason Not Specified|2
4873148|NCT00807495|16794301|P2|Overall Study|Reason Not Specified|3
4873149|NCT00807495|16794302|P1|Overall Study|Reason Not Specified|0
4873150|NCT00807495|16794298|P5|Overall Study|Withdrawal by Patient|0
4873151|NCT00807495|16794299|P4|Overall Study|Withdrawal by Patient|0
4873152|NCT00807495|16794300|P3|Overall Study|Withdrawal by Patient|1
4873153|NCT00807495|16794301|P2|Overall Study|Withdrawal by Patient|0
4873154|NCT00807495|16794302|P1|Overall Study|Withdrawal by Patient|2
4873155|NCT00807495|16794298|P5|Overall Study|Adverse Event|2
4873156|NCT00807495|16794299|P4|Overall Study|Adverse Event|1
4873157|NCT00807495|16794300|P3|Overall Study|Adverse Event|1
4873158|NCT00807495|16794301|P2|Overall Study|Adverse Event|3
4873159|NCT00807495|16794302|P1|Overall Study|Adverse Event|6
4873160|NCT00807365|16794348|P1|Overall Study|Study Terminated|5
4873161|NCT00807248|16794356|P4|Overall Study|Other Reason|0
4873162|NCT00807248|16794357|P3|Overall Study|Other Reason|2
4873163|NCT00807248|16794358|P2|Overall Study|Other Reason|0
4873164|NCT00807248|16794359|P1|Overall Study|Other Reason|0
4873165|NCT00807248|16794356|P4|Overall Study|Lost to Follow-up|0
4873166|NCT00807248|16794357|P3|Overall Study|Lost to Follow-up|0
4873167|NCT00807248|16794358|P2|Overall Study|Lost to Follow-up|0
4873168|NCT00807248|16794359|P1|Overall Study|Lost to Follow-up|1
4873169|NCT00807248|16794356|P4|Overall Study|Withdrawal of Consent|5
4873170|NCT00807248|16794357|P3|Overall Study|Withdrawal of Consent|5
4873171|NCT00807248|16794358|P2|Overall Study|Withdrawal of Consent|5
4873172|NCT00807248|16794359|P1|Overall Study|Withdrawal of Consent|5
4873173|NCT00807248|16794356|P4|Overall Study|Protocol Violation|0
4873174|NCT00807248|16794357|P3|Overall Study|Protocol Violation|1
4873175|NCT00807248|16794358|P2|Overall Study|Protocol Violation|1
4873176|NCT00807248|16794359|P1|Overall Study|Protocol Violation|0
4873177|NCT00807248|16794356|P4|Overall Study|Lack of Efficacy|3
4873178|NCT00807248|16794357|P3|Overall Study|Lack of Efficacy|8
4873179|NCT00807248|16794358|P2|Overall Study|Lack of Efficacy|4
4873180|NCT00807248|16794359|P1|Overall Study|Lack of Efficacy|14
4873181|NCT00807248|16794356|P4|Overall Study|Adverse Event|6
4873182|NCT00807248|16794357|P3|Overall Study|Adverse Event|2
4873183|NCT00807248|16794358|P2|Overall Study|Adverse Event|2
4873184|NCT00807248|16794359|P1|Overall Study|Adverse Event|1
4873185|NCT00807235|16794403|P2|Overall Study|Adverse Event|0
4873186|NCT00807235|16794404|P1|Overall Study|Adverse Event|1
4873187|NCT00807092|16794449|P2|Overall Study|CGMS data collection failed|1
4873188|NCT00807092|16794450|P1|Overall Study|CGMS data collection failed|0
4873189|NCT00807092|16794449|P2|Overall Study|Withdrawal by Subject|0
4873190|NCT00807092|16794450|P1|Overall Study|Withdrawal by Subject|1
4873191|NCT00807092|16794449|P2|Overall Study|Protocol Violation|2
4873192|NCT00807092|16794450|P1|Overall Study|Protocol Violation|0
4873193|NCT00807092|16794449|P2|Overall Study|Adverse Event|1
4873194|NCT00807092|16794450|P1|Overall Study|Adverse Event|0
4873195|NCT00807040|16794480|P2|Overall Study|Lost to Follow-up|6
4873196|NCT00807040|16794481|P1|Overall Study|Lost to Follow-up|4
4873197|NCT00807040|16794480|P2|Overall Study|Withdrawal by Subject|6
4873198|NCT00807040|16794481|P1|Overall Study|Withdrawal by Subject|8
4873199|NCT00807040|16794480|P2|Overall Study|Death|29
4873200|NCT00807040|16794481|P1|Overall Study|Death|24
4873201|NCT00807014|16794491|P2|Overall Study|Missed Visit 2 Due to Personal Reasons|1
4873202|NCT00807014|16794492|P1|Overall Study|Missed Visit 2 Due to Personal Reasons|0
4873203|NCT00807014|16794491|P2|Overall Study|Recovery|0
4873204|NCT00807014|16794492|P1|Overall Study|Recovery|1
4873205|NCT00807014|16794491|P2|Overall Study|Lost to Follow-up|7
4873206|NCT00807014|16794492|P1|Overall Study|Lost to Follow-up|9
4873207|NCT00807014|16794491|P2|Overall Study|Adverse Event|2
4873208|NCT00807014|16794492|P1|Overall Study|Adverse Event|0
4873209|NCT00807014|16794491|P2|Overall Study|Protocol Violation|8
4873210|NCT00807014|16794492|P1|Overall Study|Protocol Violation|2
4873211|NCT00807014|16794491|P2|Overall Study|Participant Considered Disease Not Cured|7
4873212|NCT00807014|16794492|P1|Overall Study|Participant Considered Disease Not Cured|2
4873213|NCT00807014|16794491|P2|Overall Study|Participant Considered Disease Cured|2
4873214|NCT00807014|16794492|P1|Overall Study|Participant Considered Disease Cured|13
4873215|NCT00807001|16794523|P5|Overall Study|Non-compliance|0
4873216|NCT00807001|16794524|P4|Overall Study|Non-compliance|0
4873217|NCT00807001|16794525|P3|Overall Study|Non-compliance|0
4873218|NCT00807001|16794526|P2|Overall Study|Non-compliance|1
4873219|NCT00807001|16794527|P1|Overall Study|Non-compliance|0
4873220|NCT00806988|16794546|P2|Overall Study|Lost to Follow-up|19
4873221|NCT00806988|16794547|P1|Overall Study|Lost to Follow-up|4
4873222|NCT00806988|16794546|P2|Overall Study|Withdrawal by Subject|8
4873223|NCT00806988|16794547|P1|Overall Study|Withdrawal by Subject|8
4873224|NCT00806988|16794546|P2|Overall Study|Death|16
4873225|NCT00806988|16794547|P1|Overall Study|Death|15
4873226|NCT00806819|16794557|P2|Overall Study|Reasons other than stated above|41
4873227|NCT00806819|16794558|P1|Overall Study|Reasons other than stated above|25
4873228|NCT00806819|16794557|P2|Overall Study|Not treated|3
4873229|NCT00806819|16794558|P1|Overall Study|Not treated|6
4873230|NCT00806819|16794557|P2|Overall Study|Withdrawal by Subject|29
4873231|NCT00806819|16794558|P1|Overall Study|Withdrawal by Subject|32
4873232|NCT00806819|16794557|P2|Overall Study|Lost to Follow-up|0
4873233|NCT00806819|16794558|P1|Overall Study|Lost to Follow-up|1
4873234|NCT00806819|16794557|P2|Overall Study|Protocol Violation|4
4873235|NCT00806819|16794558|P1|Overall Study|Protocol Violation|9
4873236|NCT00806819|16794557|P2|Overall Study|Other AE|40
4873237|NCT00806819|16794558|P1|Overall Study|Other AE|38
4873238|NCT00806819|16794557|P2|Overall Study|Worsening or AE of underlying disease|25
4873239|NCT00806819|16794558|P1|Overall Study|Worsening or AE of underlying disease|18
4873240|NCT00806819|16794557|P2|Overall Study|progressive disease (modified RECIST )|216
4873241|NCT00806819|16794558|P1|Overall Study|progressive disease (modified RECIST )|217
4873242|NCT00806624|16794627|P3|Overall Study|discontinued before start of treatment|1
4873243|NCT00806624|16794628|P2|Overall Study|discontinued before start of treatment|0
4873244|NCT00806624|16794629|P1|Overall Study|discontinued before start of treatment|0
4873245|NCT00806624|16794627|P3|Overall Study|Withdrawal by Subject|3
4873246|NCT00806624|16794628|P2|Overall Study|Withdrawal by Subject|3
4873247|NCT00806624|16794629|P1|Overall Study|Withdrawal by Subject|6
4873248|NCT00806624|16794627|P3|Overall Study|Lost to Follow-up|1
4873249|NCT00806624|16794628|P2|Overall Study|Lost to Follow-up|0
4873250|NCT00806624|16794629|P1|Overall Study|Lost to Follow-up|1
4873251|NCT00806624|16794627|P3|Overall Study|Death|1
4873252|NCT00806624|16794628|P2|Overall Study|Death|1
4873253|NCT00806624|16794629|P1|Overall Study|Death|0
4873254|NCT00806624|16794627|P3|Overall Study|Adverse Event|0
4873255|NCT00806624|16794628|P2|Overall Study|Adverse Event|8
4873256|NCT00806624|16794629|P1|Overall Study|Adverse Event|2
4873257|NCT00806585|16794646|P5|Overall Study|Completion status unknown|12
4873258|NCT00806585|16794647|P4|Overall Study|Completion status unknown|4
4873259|NCT00806585|16794648|P3|Overall Study|Completion status unknown|12
4873260|NCT00806585|16794649|P2|Overall Study|Completion status unknown|14
4873261|NCT00806585|16794650|P1|Overall Study|Completion status unknown|15
4873262|NCT00806585|16794646|P5|Overall Study|Withdrawal by Subject|11
4873263|NCT00806585|16794647|P4|Overall Study|Withdrawal by Subject|3
4873264|NCT00806585|16794648|P3|Overall Study|Withdrawal by Subject|9
4873265|NCT00806585|16794649|P2|Overall Study|Withdrawal by Subject|8
4873266|NCT00806585|16794650|P1|Overall Study|Withdrawal by Subject|10
4873267|NCT00806585|16794646|P5|Overall Study|Adverse Event|2
4873268|NCT00806585|16794647|P4|Overall Study|Adverse Event|4
4873269|NCT00806585|16794648|P3|Overall Study|Adverse Event|3
4873270|NCT00806585|16794649|P2|Overall Study|Adverse Event|5
4873271|NCT00806585|16794650|P1|Overall Study|Adverse Event|1
4873272|NCT00806585|16794646|P5|Overall Study|Lack of Efficacy|0
4873273|NCT00806585|16794647|P4|Overall Study|Lack of Efficacy|0
4873274|NCT00806585|16794648|P3|Overall Study|Lack of Efficacy|0
4873275|NCT00806585|16794649|P2|Overall Study|Lack of Efficacy|0
4873276|NCT00806585|16794650|P1|Overall Study|Lack of Efficacy|1
4873277|NCT00806585|16794646|P5|Overall Study|Lost to Follow-up|5
4873278|NCT00806585|16794647|P4|Overall Study|Lost to Follow-up|2
4873279|NCT00806585|16794648|P3|Overall Study|Lost to Follow-up|2
4873280|NCT00806585|16794649|P2|Overall Study|Lost to Follow-up|1
4873281|NCT00806585|16794650|P1|Overall Study|Lost to Follow-up|2
4873282|NCT00806585|16794646|P5|Overall Study|Physician Decision|1
4873283|NCT00806585|16794647|P4|Overall Study|Physician Decision|0
4873284|NCT00806585|16794648|P3|Overall Study|Physician Decision|3
4873285|NCT00806585|16794649|P2|Overall Study|Physician Decision|2
4873286|NCT00806585|16794650|P1|Overall Study|Physician Decision|0
4873287|NCT00806585|16794646|P5|Overall Study|Protocol Violation|0
4873288|NCT00806585|16794647|P4|Overall Study|Protocol Violation|0
4873289|NCT00806585|16794648|P3|Overall Study|Protocol Violation|2
4873290|NCT00806585|16794649|P2|Overall Study|Protocol Violation|1
4873291|NCT00806585|16794650|P1|Overall Study|Protocol Violation|3
4873292|NCT00806585|16794646|P5|Overall Study|Study terminated by Sponsor|0
4873293|NCT00806585|16794647|P4|Overall Study|Study terminated by Sponsor|2
4873294|NCT00806585|16794648|P3|Overall Study|Study terminated by Sponsor|1
4873295|NCT00806585|16794649|P2|Overall Study|Study terminated by Sponsor|0
4873296|NCT00806585|16794650|P1|Overall Study|Study terminated by Sponsor|0
4873297|NCT00806546|16794682|P1|Overall Study|Various|42
4873298|NCT00806546|16794682|P1|Overall Study|Protocol Violation|49
4873299|NCT00806546|16794682|P1|Overall Study|Withdrawal by Subject|75
4873300|NCT00806546|16794682|P1|Overall Study|Adverse Event|74
4873301|NCT00806546|16794682|P1|Overall Study|Lost to Follow-up|32
4873302|NCT00806546|16794682|P1|Overall Study|Enrolled, not treated|35
4873303|NCT00806494|16794686|P1|Overall Study|Withdrawal by Subject|5
4873304|NCT00806494|16794686|P1|Overall Study|Other|30
4873305|NCT00806494|16794686|P1|Overall Study|Lost to Follow-up|10
4873306|NCT00806494|16794686|P1|Overall Study|Lack of Efficacy|6
4873307|NCT00806494|16794686|P1|Overall Study|Adverse Event|29
4873308|NCT00806442|16794710|P2|Overall Study|Withdrawal by Subject|5
4873309|NCT00806442|16794711|P1|Overall Study|Withdrawal by Subject|1
4873310|NCT00806442|16794710|P2|Overall Study|Lost to Follow-up|2
4873311|NCT00806442|16794711|P1|Overall Study|Lost to Follow-up|3
4873312|NCT00806416|16794733|P4|Period 1 - Part II|Withdrawal by Subject|2
4873313|NCT00806416|16794734|P3|Period 1 - Part II|Withdrawal by Subject|0
4873314|NCT00806416|16794735|P2|Period 1 - Part II|Withdrawal by Subject|0
4873315|NCT00806416|16794736|P1|Period 1 - Part II|Withdrawal by Subject|0
4873316|NCT00806416|16794733|P4|Period 1 - Part I|Withdrawal by Subject|0
4873317|NCT00806416|16794734|P3|Period 1 - Part I|Withdrawal by Subject|0
4873318|NCT00806416|16794735|P2|Period 1 - Part I|Withdrawal by Subject|1
4873319|NCT00806416|16794736|P1|Period 1 - Part I|Withdrawal by Subject|3
4873320|NCT00806416|16794733|P4|Period 1 - Part I|Lost to Follow-up|0
4873321|NCT00806416|16794734|P3|Period 1 - Part I|Lost to Follow-up|0
4873322|NCT00806416|16794735|P2|Period 1 - Part I|Lost to Follow-up|2
4873323|NCT00806416|16794736|P1|Period 1 - Part I|Lost to Follow-up|0
4873324|NCT00806416|16794733|P4|Period 1 - Part I|Adverse Event|0
4873325|NCT00806416|16794734|P3|Period 1 - Part I|Adverse Event|0
4873326|NCT00806416|16794735|P2|Period 1 - Part I|Adverse Event|1
4873327|NCT00806416|16794736|P1|Period 1 - Part I|Adverse Event|0
4873328|NCT00806403|16794749|P2|Overall Study|Death|3
4873329|NCT00806403|16794750|P1|Overall Study|Death|4
4873330|NCT00806351|16794773|P2|Overall Study|Death|4
4873331|NCT00806351|16794774|P1|Overall Study|Death|5
4873332|NCT00806286|16794808|P3|Overall Study|Due to a variety of reasons|1
4873333|NCT00806286|16794809|P2|Overall Study|Due to a variety of reasons|2
4873334|NCT00806286|16794810|P1|Overall Study|Due to a variety of reasons|7
4873335|NCT00806286|16794808|P3|Overall Study|Physician Decision|0
4873336|NCT00806286|16794809|P2|Overall Study|Physician Decision|2
4873337|NCT00806286|16794810|P1|Overall Study|Physician Decision|2
4873338|NCT00806286|16794808|P3|Overall Study|Withdrawal by Subject|1
4873339|NCT00806286|16794809|P2|Overall Study|Withdrawal by Subject|3
4873340|NCT00806286|16794810|P1|Overall Study|Withdrawal by Subject|8
4873341|NCT00806286|16794808|P3|Overall Study|Lost to Follow-up|0
4873342|NCT00806286|16794809|P2|Overall Study|Lost to Follow-up|1
4873343|NCT00806286|16794810|P1|Overall Study|Lost to Follow-up|0
4873344|NCT00806286|16794808|P3|Overall Study|Death|0
4873345|NCT00806286|16794809|P2|Overall Study|Death|6
4873346|NCT00806286|16794810|P1|Overall Study|Death|1
4873347|NCT00806286|16794808|P3|Overall Study|Disease progression|1
4873348|NCT00806286|16794809|P2|Overall Study|Disease progression|38
4873349|NCT00806286|16794810|P1|Overall Study|Disease progression|31
4873350|NCT00806286|16794808|P3|Overall Study|Adverse Event|0
4873351|NCT00806286|16794809|P2|Overall Study|Adverse Event|2
4873352|NCT00806286|16794810|P1|Overall Study|Adverse Event|5
4873353|NCT00806260|16794832|P6|Period 3|Pregnancy|0
4873354|NCT00806260|16794833|P5|Period 3|Pregnancy|0
4873355|NCT00806260|16794834|P4|Period 3|Pregnancy|0
4873356|NCT00806260|16794835|P3|Period 3|Pregnancy|0
4873357|NCT00806260|16794836|P2|Period 3|Pregnancy|0
4873358|NCT00806260|16794837|P1|Period 3|Pregnancy|1
4873359|NCT00806260|16794832|P6|Period 3|Protocol Violation|0
4873360|NCT00806260|16794833|P5|Period 3|Protocol Violation|0
4873361|NCT00806260|16794834|P4|Period 3|Protocol Violation|0
4873362|NCT00806260|16794835|P3|Period 3|Protocol Violation|1
4873363|NCT00806260|16794836|P2|Period 3|Protocol Violation|1
4873364|NCT00806260|16794837|P1|Period 3|Protocol Violation|0
4873365|NCT00806260|16794832|P6|Period 2|sponsor request|0
4873366|NCT00806260|16794833|P5|Period 2|sponsor request|0
4873367|NCT00806260|16794834|P4|Period 2|sponsor request|1
4873368|NCT00806260|16794835|P3|Period 2|sponsor request|1
4873369|NCT00806260|16794836|P2|Period 2|sponsor request|0
4873370|NCT00806260|16794837|P1|Period 2|sponsor request|0
4873371|NCT00806260|16794832|P6|Period 2|Need to take concomitant medication|0
4873372|NCT00806260|16794833|P5|Period 2|Need to take concomitant medication|0
4873373|NCT00806260|16794834|P4|Period 2|Need to take concomitant medication|0
4873374|NCT00806260|16794835|P3|Period 2|Need to take concomitant medication|0
4873375|NCT00806260|16794836|P2|Period 2|Need to take concomitant medication|0
4873376|NCT00806260|16794837|P1|Period 2|Need to take concomitant medication|1
4873377|NCT00806260|16794832|P6|Period 2|Protocol Violation|0
4873378|NCT00806260|16794833|P5|Period 2|Protocol Violation|0
4873379|NCT00806260|16794834|P4|Period 2|Protocol Violation|0
4873380|NCT00806260|16794835|P3|Period 2|Protocol Violation|1
4873381|NCT00806260|16794836|P2|Period 2|Protocol Violation|0
4873382|NCT00806260|16794837|P1|Period 2|Protocol Violation|1
4873383|NCT00806260|16794832|P6|Period 2|Adverse Event|0
4873384|NCT00806260|16794833|P5|Period 2|Adverse Event|0
4873385|NCT00806260|16794834|P4|Period 2|Adverse Event|1
4873386|NCT00806260|16794835|P3|Period 2|Adverse Event|0
4873387|NCT00806260|16794836|P2|Period 2|Adverse Event|0
4873388|NCT00806260|16794837|P1|Period 2|Adverse Event|0
4873389|NCT00806260|16794832|P6|Period 1 (1 Day)|Adverse Event|0
4873390|NCT00806260|16794833|P5|Period 1 (1 Day)|Adverse Event|3
4873391|NCT00806260|16794834|P4|Period 1 (1 Day)|Adverse Event|0
4873392|NCT00806260|16794835|P3|Period 1 (1 Day)|Adverse Event|0
4873393|NCT00806260|16794836|P2|Period 1 (1 Day)|Adverse Event|0
4873394|NCT00806260|16794837|P1|Period 1 (1 Day)|Adverse Event|0
4873395|NCT00806195|16794882|P4|Overall Study|Protocol Violation|9
4873396|NCT00806195|16794883|P3|Overall Study|Protocol Violation|26
4873397|NCT00806195|16794884|P2|Overall Study|Protocol Violation|24
4873398|NCT00806195|16794885|P1|Overall Study|Protocol Violation|34
4873399|NCT00806195|16794882|P4|Overall Study|Administrative Reason|26
4873400|NCT00806195|16794883|P3|Overall Study|Administrative Reason|66
4873401|NCT00806195|16794884|P2|Overall Study|Administrative Reason|35
4873402|NCT00806195|16794885|P1|Overall Study|Administrative Reason|113
4873403|NCT00806195|16794882|P4|Overall Study|Inappropriate Enrollment|0
4873404|NCT00806195|16794883|P3|Overall Study|Inappropriate Enrollment|0
4873405|NCT00806195|16794884|P2|Overall Study|Inappropriate Enrollment|1
4873406|NCT00806195|16794885|P1|Overall Study|Inappropriate Enrollment|0
4873407|NCT00806195|16794882|P4|Overall Study|Lost to Follow-up|34
4873408|NCT00806195|16794883|P3|Overall Study|Lost to Follow-up|90
4873409|NCT00806195|16794884|P2|Overall Study|Lost to Follow-up|66
4873410|NCT00806195|16794885|P1|Overall Study|Lost to Follow-up|217
4873411|NCT00806195|16794882|P4|Overall Study|Withdrawal by Subject|35
4873412|NCT00806195|16794883|P3|Overall Study|Withdrawal by Subject|76
4873413|NCT00806195|16794884|P2|Overall Study|Withdrawal by Subject|31
4873414|NCT00806195|16794885|P1|Overall Study|Withdrawal by Subject|119
4873415|NCT00806195|16794882|P4|Overall Study|Adverse Event|2
4873416|NCT00806195|16794883|P3|Overall Study|Adverse Event|11
4873417|NCT00806195|16794884|P2|Overall Study|Adverse Event|5
4873418|NCT00806195|16794885|P1|Overall Study|Adverse Event|25
4873419|NCT00806195|16794882|P4|Overall Study|Death|0
4873420|NCT00806195|16794883|P3|Overall Study|Death|1
4873421|NCT00806195|16794884|P2|Overall Study|Death|0
4873422|NCT00806195|16794885|P1|Overall Study|Death|6
4873423|NCT00806026|16794916|P6|Overall Study|Adverse Event|9
4873424|NCT00806026|16794917|P5|Overall Study|Adverse Event|9
4873425|NCT00806026|16794918|P4|Overall Study|Adverse Event|17
4873426|NCT00806026|16794919|P3|Overall Study|Adverse Event|44
4873427|NCT00806026|16794920|P2|Overall Study|Adverse Event|35
4873428|NCT00806026|16794921|P1|Overall Study|Adverse Event|52
4873429|NCT00806026|16794916|P6|Overall Study|Protocol Violation|3
4873430|NCT00806026|16794917|P5|Overall Study|Protocol Violation|2
4873431|NCT00806026|16794918|P4|Overall Study|Protocol Violation|0
4873432|NCT00806026|16794919|P3|Overall Study|Protocol Violation|9
4873433|NCT00806026|16794920|P2|Overall Study|Protocol Violation|9
4873434|NCT00806026|16794921|P1|Overall Study|Protocol Violation|6
4873435|NCT00806026|16794916|P6|Overall Study|Other|4
4873436|NCT00806026|16794917|P5|Overall Study|Other|0
4873437|NCT00806026|16794918|P4|Overall Study|Other|2
4873438|NCT00806026|16794919|P3|Overall Study|Other|8
4873439|NCT00806026|16794920|P2|Overall Study|Other|6
4873440|NCT00806026|16794921|P1|Overall Study|Other|3
4873441|NCT00806026|16794916|P6|Overall Study|Withdrawal by Subject|3
4873442|NCT00806026|16794917|P5|Overall Study|Withdrawal by Subject|5
4873443|NCT00806026|16794918|P4|Overall Study|Withdrawal by Subject|2
4873444|NCT00806026|16794919|P3|Overall Study|Withdrawal by Subject|9
4873445|NCT00806026|16794920|P2|Overall Study|Withdrawal by Subject|17
4873446|NCT00806026|16794921|P1|Overall Study|Withdrawal by Subject|14
4873447|NCT00806026|16794916|P6|Overall Study|Lost to Follow-up|6
4873448|NCT00806026|16794917|P5|Overall Study|Lost to Follow-up|6
4873449|NCT00806026|16794918|P4|Overall Study|Lost to Follow-up|2
4873450|NCT00806026|16794919|P3|Overall Study|Lost to Follow-up|8
4873451|NCT00806026|16794920|P2|Overall Study|Lost to Follow-up|15
4873452|NCT00806026|16794921|P1|Overall Study|Lost to Follow-up|8
4873453|NCT00806026|16794916|P6|Overall Study|Lack of Efficacy|7
4873454|NCT00806026|16794917|P5|Overall Study|Lack of Efficacy|8
4873455|NCT00806026|16794918|P4|Overall Study|Lack of Efficacy|4
4873456|NCT00806026|16794919|P3|Overall Study|Lack of Efficacy|13
4873457|NCT00806026|16794920|P2|Overall Study|Lack of Efficacy|18
4873458|NCT00806026|16794921|P1|Overall Study|Lack of Efficacy|5
4873459|NCT00806026|16794916|P6|Overall Study|Did not meet entrance criteria|0
4873460|NCT00806026|16794917|P5|Overall Study|Did not meet entrance criteria|0
4873461|NCT00806026|16794918|P4|Overall Study|Did not meet entrance criteria|1
4873462|NCT00806026|16794919|P3|Overall Study|Did not meet entrance criteria|2
4873463|NCT00806026|16794920|P2|Overall Study|Did not meet entrance criteria|1
4873464|NCT00806026|16794921|P1|Overall Study|Did not meet entrance criteria|4
4873465|NCT00806026|16794916|P6|Overall Study|Death|0
4873466|NCT00806026|16794917|P5|Overall Study|Death|0
4873467|NCT00806026|16794918|P4|Overall Study|Death|1
4873468|NCT00806026|16794919|P3|Overall Study|Death|0
4873469|NCT00806026|16794920|P2|Overall Study|Death|0
4873470|NCT00806026|16794921|P1|Overall Study|Death|0
4873471|NCT00805961|16795016|P1|Maintenance Treatment|Withdrawn Consent|1
4873472|NCT00805961|16795016|P1|Maintenance Treatment|Symptomatic Deterioration|2
4873473|NCT00805961|16795016|P1|Maintenance Treatment|Withdrawal by Subject|5
4873474|NCT00805961|16795016|P1|Maintenance Treatment|Adverse Event|6
4873475|NCT00805961|16795016|P1|Maintenance Treatment|Intercurrent Illness|7
4873476|NCT00805961|16795016|P1|Maintenance Treatment|Lack of Efficacy|13
4873477|NCT00805961|16795016|P1|Treatment-Free Interval|Lack of Efficacy|1
4873478|NCT00805961|16795016|P1|Treatment-Free Interval|Physician Decision|1
4873479|NCT00805961|16795016|P1|Treatment-Free Interval|Intercurrent Illness|2
4873480|NCT00805961|16795016|P1|Treatment-Free Interval|Adverse Event|3
4873481|NCT00805961|16795016|P1|Modality Therapy|Disease Progression|2
4873482|NCT00805961|16795016|P1|Modality Therapy|Adverse Event|1
4873483|NCT00805961|16795016|P1|Modality Therapy|Withdrawal by Subject|1
4873484|NCT00805935|16795040|P4|Overall Study|Serious Adverse Event-congenital anomaly|0
4873485|NCT00805935|16795041|P3|Overall Study|Serious Adverse Event-congenital anomaly|0
4873486|NCT00805935|16795042|P2|Overall Study|Serious Adverse Event-congenital anomaly|1
4873487|NCT00805935|16795043|P1|Overall Study|Serious Adverse Event-congenital anomaly|0
4873488|NCT00805935|16795040|P4|Overall Study|Ectopic pregnancy|0
4873489|NCT00805935|16795041|P3|Overall Study|Ectopic pregnancy|1
4873490|NCT00805935|16795042|P2|Overall Study|Ectopic pregnancy|0
4873491|NCT00805935|16795043|P1|Overall Study|Ectopic pregnancy|0
4873492|NCT00805935|16795040|P4|Overall Study|Chemical pregnancy|2
4873493|NCT00805935|16795041|P3|Overall Study|Chemical pregnancy|3
4873494|NCT00805935|16795042|P2|Overall Study|Chemical pregnancy|5
4873495|NCT00805935|16795043|P1|Overall Study|Chemical pregnancy|0
4873496|NCT00805935|16795040|P4|Overall Study|Biochemical pregnancy|0
4873497|NCT00805935|16795041|P3|Overall Study|Biochemical pregnancy|0
4873498|NCT00805935|16795042|P2|Overall Study|Biochemical pregnancy|1
4873499|NCT00805935|16795043|P1|Overall Study|Biochemical pregnancy|0
4873500|NCT00805935|16795040|P4|Overall Study|Pregnancy loss/miscarriage|0
4873501|NCT00805935|16795041|P3|Overall Study|Pregnancy loss/miscarriage|0
4873502|NCT00805935|16795042|P2|Overall Study|Pregnancy loss/miscarriage|0
4873503|NCT00805935|16795043|P1|Overall Study|Pregnancy loss/miscarriage|2
4873504|NCT00805935|16795040|P4|Overall Study|Pregnancy not confirmed by ultrasound|1
4873505|NCT00805935|16795041|P3|Overall Study|Pregnancy not confirmed by ultrasound|0
4873506|NCT00805935|16795042|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
4873507|NCT00805935|16795043|P1|Overall Study|Pregnancy not confirmed by ultrasound|0
4873508|NCT00805935|16795040|P4|Overall Study|No positive serum pregnancy|5
4873509|NCT00805935|16795041|P3|Overall Study|No positive serum pregnancy|6
4873510|NCT00805935|16795042|P2|Overall Study|No positive serum pregnancy|7
4873511|NCT00805935|16795043|P1|Overall Study|No positive serum pregnancy|8
4873512|NCT00805935|16795040|P4|Overall Study|Lost to Follow-up|0
4873513|NCT00805935|16795041|P3|Overall Study|Lost to Follow-up|0
4873514|NCT00805935|16795042|P2|Overall Study|Lost to Follow-up|0
4873515|NCT00805935|16795043|P1|Overall Study|Lost to Follow-up|1
4873516|NCT00805935|16795040|P4|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1
4873517|NCT00805935|16795041|P3|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
4873518|NCT00805935|16795042|P2|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
4873519|NCT00805935|16795043|P1|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0
4873520|NCT00805935|16795040|P4|Overall Study|Cycle cancellation for risk of OHSS|0
4873521|NCT00805935|16795041|P3|Overall Study|Cycle cancellation for risk of OHSS|1
4873522|NCT00805935|16795042|P2|Overall Study|Cycle cancellation for risk of OHSS|0
4873523|NCT00805935|16795043|P1|Overall Study|Cycle cancellation for risk of OHSS|1
4873524|NCT00805935|16795040|P4|Overall Study|Cycle cancelled|0
4873525|NCT00805935|16795041|P3|Overall Study|Cycle cancelled|2
4873526|NCT00805935|16795042|P2|Overall Study|Cycle cancelled|0
4873527|NCT00805935|16795043|P1|Overall Study|Cycle cancelled|0
4873528|NCT00805935|16795040|P4|Overall Study|Stimulation Failure|2
4873529|NCT00805935|16795041|P3|Overall Study|Stimulation Failure|2
4873530|NCT00805935|16795042|P2|Overall Study|Stimulation Failure|5
4873531|NCT00805935|16795043|P1|Overall Study|Stimulation Failure|1
4873532|NCT00805792|16795110|P1|Overall Study|Lost to Follow-up|2
4873533|NCT00805792|16795110|P1|Overall Study|Death|3
4873534|NCT00805766|16795118|P1|Increased Dose Period|Withdrawal by Subject|1
4873535|NCT00805766|16795118|P1|Increased Dose Period|Pregnancy|1
4873536|NCT00805766|16795118|P1|Increased Dose Period|Lack of Efficacy|7
4873537|NCT00805766|16795118|P1|Increased Dose Period|Adverse Event|4
4873538|NCT00805766|16795118|P1|Screening Period|Responder|2
4873539|NCT00805766|16795118|P1|Screening Period|Pregnancy|1
4873540|NCT00805766|16795118|P1|Screening Period|Lack of Efficacy|2
4873541|NCT00805766|16795118|P1|Screening Period|Adverse Event|1
4873542|NCT00805740|16795132|P2|Overall Study|Randomized, but not treated|0
4873543|NCT00805740|16795133|P1|Overall Study|Randomized, but not treated|2
4873544|NCT00805740|16795132|P2|Overall Study|Lost to Follow-up|0
4873545|NCT00805740|16795133|P1|Overall Study|Lost to Follow-up|1
4873546|NCT00805740|16795132|P2|Overall Study|Withdrawal by Subject|0
4873547|NCT00805740|16795133|P1|Overall Study|Withdrawal by Subject|1
4873548|NCT00805740|16795132|P2|Overall Study|Death|4
4873549|NCT00805740|16795133|P1|Overall Study|Death|7
4873550|NCT00805675|16795158|P3|Overall Study|Adverse Event|1
4873551|NCT00805675|16795159|P2|Overall Study|Adverse Event|0
4873552|NCT00805675|16795160|P1|Overall Study|Adverse Event|0
4873553|NCT00805545|16795194|P2|Overall Study|Protocol Violation|1
4873554|NCT00805545|16795195|P1|Overall Study|Protocol Violation|3
4873555|NCT00805545|16795194|P2|Overall Study|Protocol Violation|2
4873556|NCT00805545|16795195|P1|Overall Study|Protocol Violation|3
4873557|NCT00805532|16795203|P2|Overall Study|invalid data|1
4873558|NCT00805532|16795204|P1|Overall Study|invalid data|0
4873559|NCT00805480|16795238|P4|Overall Study|Adverse Event|0
4873560|NCT00805480|16795239|P3|Overall Study|Adverse Event|1
4873561|NCT00805480|16795240|P2|Overall Study|Adverse Event|0
4873562|NCT00805480|16795241|P1|Overall Study|Adverse Event|0
4873563|NCT00805480|16795238|P4|Overall Study|Lost to Follow-up|0
4873564|NCT00805480|16795239|P3|Overall Study|Lost to Follow-up|0
4873565|NCT00805480|16795240|P2|Overall Study|Lost to Follow-up|2
4873566|NCT00805480|16795241|P1|Overall Study|Lost to Follow-up|1
4873567|NCT00805480|16795238|P4|Overall Study|Withdrawal by Subject|5
4873568|NCT00805480|16795239|P3|Overall Study|Withdrawal by Subject|11
4873569|NCT00805480|16795240|P2|Overall Study|Withdrawal by Subject|5
4873570|NCT00805480|16795241|P1|Overall Study|Withdrawal by Subject|13
4873571|NCT00805467|16795270|P4|Overall Study|Not reported|7
4873572|NCT00805467|16795271|P3|Overall Study|Not reported|3
4873573|NCT00805467|16795272|P2|Overall Study|Not reported|0
4873574|NCT00805467|16795273|P1|Overall Study|Not reported|0
4873575|NCT00805467|16795270|P4|Overall Study|Physician Decision|6
4873576|NCT00805467|16795271|P3|Overall Study|Physician Decision|2
4873577|NCT00805467|16795272|P2|Overall Study|Physician Decision|1
4873578|NCT00805467|16795273|P1|Overall Study|Physician Decision|0
4873579|NCT00805467|16795270|P4|Overall Study|Death|5
4873580|NCT00805467|16795271|P3|Overall Study|Death|7
4873581|NCT00805467|16795272|P2|Overall Study|Death|2
4873582|NCT00805467|16795273|P1|Overall Study|Death|0
4873583|NCT00805467|16795270|P4|Overall Study|Adverse Event|57
4873584|NCT00805467|16795271|P3|Overall Study|Adverse Event|26
4873585|NCT00805467|16795272|P2|Overall Study|Adverse Event|13
4873586|NCT00805467|16795273|P1|Overall Study|Adverse Event|0
4873587|NCT00805467|16795270|P4|Overall Study|Protocol Violation|5
4873588|NCT00805467|16795271|P3|Overall Study|Protocol Violation|0
4873589|NCT00805467|16795272|P2|Overall Study|Protocol Violation|3
4873590|NCT00805467|16795273|P1|Overall Study|Protocol Violation|0
4873591|NCT00805467|16795270|P4|Overall Study|Withdrawal by Subject|50
4873592|NCT00805467|16795271|P3|Overall Study|Withdrawal by Subject|45
4873593|NCT00805467|16795272|P2|Overall Study|Withdrawal by Subject|6
4873594|NCT00805467|16795273|P1|Overall Study|Withdrawal by Subject|0
4873595|NCT00805467|16795270|P4|Overall Study|Lost to Follow-up|21
4873596|NCT00805467|16795271|P3|Overall Study|Lost to Follow-up|7
4873597|NCT00805467|16795272|P2|Overall Study|Lost to Follow-up|1
4873598|NCT00805467|16795273|P1|Overall Study|Lost to Follow-up|0
4873599|NCT00805467|16795270|P4|Overall Study|Lack of Efficacy|86
4873600|NCT00805467|16795271|P3|Overall Study|Lack of Efficacy|13
4873601|NCT00805467|16795272|P2|Overall Study|Lack of Efficacy|8
4873602|NCT00805467|16795273|P1|Overall Study|Lack of Efficacy|0
4873603|NCT00805441|16795293|P2|Overall Study|Acute Alcohol Withdrawal|1
4873604|NCT00805441|16795294|P1|Overall Study|Acute Alcohol Withdrawal|0
4873605|NCT00805441|16795293|P2|Overall Study|Physician Decision|1
4873606|NCT00805441|16795294|P1|Overall Study|Physician Decision|0
4873607|NCT00805441|16795293|P2|Overall Study|Withdrawal by Subject|9
4873608|NCT00805441|16795294|P1|Overall Study|Withdrawal by Subject|15
4873609|NCT00805441|16795293|P2|Overall Study|Lost to Follow-up|13
4873610|NCT00805441|16795294|P1|Overall Study|Lost to Follow-up|10
4873611|NCT00805441|16795293|P2|Overall Study|Protocol Violation|8
4873612|NCT00805441|16795294|P1|Overall Study|Protocol Violation|4
4873613|NCT00805441|16795293|P2|Overall Study|Lack of Efficacy|2
4873614|NCT00805441|16795294|P1|Overall Study|Lack of Efficacy|0
4873615|NCT00805441|16795293|P2|Overall Study|Adverse Event|2
4873616|NCT00805441|16795294|P1|Overall Study|Adverse Event|5
4873617|NCT00805389|16795329|P5|Overall Study|Withdrawal by Subject|4
4873618|NCT00805389|16795330|P4|Overall Study|Withdrawal by Subject|5
4873619|NCT00805389|16795331|P3|Overall Study|Withdrawal by Subject|4
4873620|NCT00805389|16795332|P2|Overall Study|Withdrawal by Subject|2
4873621|NCT00805389|16795333|P1|Overall Study|Withdrawal by Subject|3
4873622|NCT00805389|16795329|P5|Overall Study|Protocol Violation|0
4873623|NCT00805389|16795330|P4|Overall Study|Protocol Violation|0
4873624|NCT00805389|16795331|P3|Overall Study|Protocol Violation|1
4873625|NCT00805389|16795332|P2|Overall Study|Protocol Violation|0
4873626|NCT00805389|16795333|P1|Overall Study|Protocol Violation|0
4873627|NCT00805389|16795329|P5|Overall Study|Lost to Follow-up|9
4873628|NCT00805389|16795330|P4|Overall Study|Lost to Follow-up|10
4873629|NCT00805389|16795331|P3|Overall Study|Lost to Follow-up|6
4873630|NCT00805389|16795332|P2|Overall Study|Lost to Follow-up|3
4873631|NCT00805389|16795333|P1|Overall Study|Lost to Follow-up|4
4873632|NCT00805389|16795329|P5|Overall Study|Adverse Event|0
4873633|NCT00805389|16795330|P4|Overall Study|Adverse Event|2
4873634|NCT00805389|16795331|P3|Overall Study|Adverse Event|1
4873635|NCT00805389|16795332|P2|Overall Study|Adverse Event|0
4873636|NCT00805389|16795333|P1|Overall Study|Adverse Event|0
4873637|NCT00805285|16795580|P1|Overall Study|Lack of Efficacy|1
4873638|NCT00805207|16795597|P9|Overall Study|Withdrawal by Subject|0
4873639|NCT00805207|16795598|P8|Overall Study|Withdrawal by Subject|0
4873640|NCT00805207|16795599|P7|Overall Study|Withdrawal by Subject|0
4873641|NCT00805207|16795600|P6|Overall Study|Withdrawal by Subject|2
4873642|NCT00805207|16795601|P5|Overall Study|Withdrawal by Subject|1
4873643|NCT00805207|16795602|P4|Overall Study|Withdrawal by Subject|0
4873644|NCT00805207|16795603|P3|Overall Study|Withdrawal by Subject|0
4873645|NCT00805207|16795604|P2|Overall Study|Withdrawal by Subject|1
4873646|NCT00805207|16795605|P1|Overall Study|Withdrawal by Subject|0
4873647|NCT00805207|16795597|P9|Overall Study|Physician Decision|0
4873648|NCT00805207|16795598|P8|Overall Study|Physician Decision|0
4873649|NCT00805207|16795599|P7|Overall Study|Physician Decision|0
4873650|NCT00805207|16795600|P6|Overall Study|Physician Decision|1
4873651|NCT00805207|16795601|P5|Overall Study|Physician Decision|0
4873652|NCT00805207|16795602|P4|Overall Study|Physician Decision|0
4873653|NCT00805207|16795603|P3|Overall Study|Physician Decision|0
4873654|NCT00805207|16795604|P2|Overall Study|Physician Decision|1
4873655|NCT00805207|16795605|P1|Overall Study|Physician Decision|0
4873656|NCT00805207|16795597|P9|Overall Study|Protocol Violation|0
4873657|NCT00805207|16795598|P8|Overall Study|Protocol Violation|0
4873658|NCT00805207|16795599|P7|Overall Study|Protocol Violation|0
4873659|NCT00805207|16795600|P6|Overall Study|Protocol Violation|0
4873660|NCT00805207|16795601|P5|Overall Study|Protocol Violation|0
4873661|NCT00805207|16795602|P4|Overall Study|Protocol Violation|0
4873662|NCT00805207|16795603|P3|Overall Study|Protocol Violation|1
4873663|NCT00805207|16795604|P2|Overall Study|Protocol Violation|0
4873664|NCT00805207|16795605|P1|Overall Study|Protocol Violation|0
4873665|NCT00805194|16795663|P2|Overall Study|Reasons other than stated above|16
4873754|NCT00804843|16795934|P2|Overall Study|Adverse Event|5
4873666|NCT00805194|16795664|P1|Overall Study|Reasons other than stated above|20
4873667|NCT00805194|16795663|P2|Overall Study|Not treated|4
4873668|NCT00805194|16795664|P1|Overall Study|Not treated|3
4873669|NCT00805194|16795663|P2|Overall Study|Withdrawal by Subject|42
4873670|NCT00805194|16795664|P1|Overall Study|Withdrawal by Subject|60
4873671|NCT00805194|16795663|P2|Overall Study|Lost to Follow-up|5
4873672|NCT00805194|16795664|P1|Overall Study|Lost to Follow-up|5
4873673|NCT00805194|16795663|P2|Overall Study|Protocol Violation|9
4873674|NCT00805194|16795664|P1|Overall Study|Protocol Violation|9
4873675|NCT00805194|16795663|P2|Overall Study|Other AE|73
4873676|NCT00805194|16795664|P1|Overall Study|Other AE|84
4873677|NCT00805194|16795663|P2|Overall Study|Worsening or AE of underlying disease|70
4873678|NCT00805194|16795664|P1|Overall Study|Worsening or AE of underlying disease|64
4873679|NCT00805194|16795663|P2|Overall Study|Progressive disease (modified RECIST)|435
4873680|NCT00805194|16795664|P1|Overall Study|Progressive disease (modified RECIST)|404
4873681|NCT00805142|16795698|P2|Maintenance Period|Other|1
4873682|NCT00805142|16795699|P1|Maintenance Period|Other|0
4873683|NCT00805142|16795698|P2|Maintenance Period|Adverse Event|1
4873684|NCT00805142|16795699|P1|Maintenance Period|Adverse Event|0
4873685|NCT00805142|16795698|P2|Titration Period|Other|3
4873686|NCT00805142|16795699|P1|Titration Period|Other|0
4873687|NCT00805142|16795698|P2|Titration Period|Withdrawal of consent|1
4873688|NCT00805142|16795699|P1|Titration Period|Withdrawal of consent|0
4873689|NCT00805142|16795698|P2|Titration Period|Disease Progression|1
4873690|NCT00805142|16795699|P1|Titration Period|Disease Progression|2
4873691|NCT00805142|16795698|P2|Titration Period|Lost to Follow-up|1
4873692|NCT00805142|16795699|P1|Titration Period|Lost to Follow-up|0
4873693|NCT00805142|16795698|P2|Titration Period|Lack of Efficacy|1
4873694|NCT00805142|16795699|P1|Titration Period|Lack of Efficacy|1
4873695|NCT00805142|16795698|P2|Titration Period|Adverse Event|3
4873696|NCT00805142|16795699|P1|Titration Period|Adverse Event|3
4873697|NCT00805025|16795732|P1|Overall Study|Physician Decision|1
4873698|NCT00805025|16795732|P1|Overall Study|Withdrawal by Subject|2
4873699|NCT00805025|16795732|P1|Overall Study|Adverse Event|4
4873700|NCT00805025|16795732|P1|Overall Study|Screened but not enrolled/treated|42
4873701|NCT00804986|16795761|P6|Overall Study|Physician Decision|0
4873702|NCT00804986|16795762|P5|Overall Study|Physician Decision|0
4873703|NCT00804986|16795763|P4|Overall Study|Physician Decision|0
4873704|NCT00804986|16795764|P3|Overall Study|Physician Decision|0
4873705|NCT00804986|16795765|P2|Overall Study|Physician Decision|0
4873706|NCT00804986|16795766|P1|Overall Study|Physician Decision|1
4873707|NCT00804986|16795761|P6|Overall Study|Sponsor Decision|0
4873708|NCT00804986|16795762|P5|Overall Study|Sponsor Decision|0
4873709|NCT00804986|16795763|P4|Overall Study|Sponsor Decision|0
4873710|NCT00804986|16795764|P3|Overall Study|Sponsor Decision|0
4873711|NCT00804986|16795765|P2|Overall Study|Sponsor Decision|1
4873712|NCT00804986|16795766|P1|Overall Study|Sponsor Decision|0
4873713|NCT00804986|16795761|P6|Overall Study|Inclusion/Exclusion criteria not met|1
4873714|NCT00804986|16795762|P5|Overall Study|Inclusion/Exclusion criteria not met|0
4873715|NCT00804986|16795763|P4|Overall Study|Inclusion/Exclusion criteria not met|1
4873716|NCT00804986|16795764|P3|Overall Study|Inclusion/Exclusion criteria not met|0
4873717|NCT00804986|16795765|P2|Overall Study|Inclusion/Exclusion criteria not met|2
4873718|NCT00804986|16795766|P1|Overall Study|Inclusion/Exclusion criteria not met|0
4873719|NCT00804986|16795761|P6|Overall Study|Withdrawal by Subject|3
4873720|NCT00804986|16795762|P5|Overall Study|Withdrawal by Subject|5
4873721|NCT00804986|16795763|P4|Overall Study|Withdrawal by Subject|3
4873722|NCT00804986|16795764|P3|Overall Study|Withdrawal by Subject|0
4873723|NCT00804986|16795765|P2|Overall Study|Withdrawal by Subject|3
4873724|NCT00804986|16795766|P1|Overall Study|Withdrawal by Subject|0
4873725|NCT00804986|16795761|P6|Overall Study|Protocol Violation|0
4873726|NCT00804986|16795762|P5|Overall Study|Protocol Violation|0
4873727|NCT00804986|16795763|P4|Overall Study|Protocol Violation|1
4873728|NCT00804986|16795764|P3|Overall Study|Protocol Violation|0
4873729|NCT00804986|16795765|P2|Overall Study|Protocol Violation|1
4873730|NCT00804986|16795766|P1|Overall Study|Protocol Violation|0
4873731|NCT00804986|16795761|P6|Overall Study|Lost to Follow-up|3
4873732|NCT00804986|16795762|P5|Overall Study|Lost to Follow-up|1
4873733|NCT00804986|16795763|P4|Overall Study|Lost to Follow-up|1
4873734|NCT00804986|16795764|P3|Overall Study|Lost to Follow-up|0
4873735|NCT00804986|16795765|P2|Overall Study|Lost to Follow-up|0
4873736|NCT00804986|16795766|P1|Overall Study|Lost to Follow-up|0
4873737|NCT00804986|16795761|P6|Overall Study|Lack of Efficacy|3
4873738|NCT00804986|16795762|P5|Overall Study|Lack of Efficacy|0
4873739|NCT00804986|16795763|P4|Overall Study|Lack of Efficacy|1
4873740|NCT00804986|16795764|P3|Overall Study|Lack of Efficacy|0
4873741|NCT00804986|16795765|P2|Overall Study|Lack of Efficacy|0
4873742|NCT00804986|16795766|P1|Overall Study|Lack of Efficacy|0
4873743|NCT00804986|16795761|P6|Overall Study|Adverse Event|0
4873744|NCT00804986|16795762|P5|Overall Study|Adverse Event|3
4873745|NCT00804986|16795763|P4|Overall Study|Adverse Event|1
4873746|NCT00804986|16795764|P3|Overall Study|Adverse Event|2
4873747|NCT00804986|16795765|P2|Overall Study|Adverse Event|1
4873748|NCT00804986|16795766|P1|Overall Study|Adverse Event|0
4873749|NCT00804908|16795901|P3|Overall Study|Other|114
4873750|NCT00804908|16795902|P2|Overall Study|Other|116
4873751|NCT00804908|16795903|P1|Overall Study|Other|115
4873752|NCT00804843|16795934|P2|Overall Study|Withdrawal by Subject|2
4873753|NCT00804843|16795935|P1|Overall Study|Withdrawal by Subject|1
4873755|NCT00804843|16795935|P1|Overall Study|Adverse Event|8
4873756|NCT00804843|16795934|P2|Overall Study|Protocol Violation|0
4873757|NCT00804843|16795935|P1|Overall Study|Protocol Violation|1
4873758|NCT00804687|16795953|P6|Period 5: Treatment Period|Positive drug test|0
4873759|NCT00804687|16795954|P5|Period 5: Treatment Period|Positive drug test|0
4873760|NCT00804687|16795955|P4|Period 5: Treatment Period|Positive drug test|0
4873761|NCT00804687|16795956|P3|Period 5: Treatment Period|Positive drug test|0
4873762|NCT00804687|16795957|P2|Period 5: Treatment Period|Positive drug test|0
4873763|NCT00804687|16795958|P1|Period 5: Treatment Period|Positive drug test|1
4873764|NCT00804687|16795953|P6|Period 5: Treatment Period|Positive drugs of abuse|0
4873765|NCT00804687|16795954|P5|Period 5: Treatment Period|Positive drugs of abuse|0
4873766|NCT00804687|16795955|P4|Period 5: Treatment Period|Positive drugs of abuse|0
4873767|NCT00804687|16795956|P3|Period 5: Treatment Period|Positive drugs of abuse|1
4873768|NCT00804687|16795957|P2|Period 5: Treatment Period|Positive drugs of abuse|0
4873769|NCT00804687|16795958|P1|Period 5: Treatment Period|Positive drugs of abuse|0
4873770|NCT00804687|16795953|P6|Period 5: Treatment Period|Withdrawal by Subject|0
4873771|NCT00804687|16795954|P5|Period 5: Treatment Period|Withdrawal by Subject|1
4873772|NCT00804687|16795955|P4|Period 5: Treatment Period|Withdrawal by Subject|0
4873773|NCT00804687|16795956|P3|Period 5: Treatment Period|Withdrawal by Subject|0
4873774|NCT00804687|16795957|P2|Period 5: Treatment Period|Withdrawal by Subject|0
4873775|NCT00804687|16795958|P1|Period 5: Treatment Period|Withdrawal by Subject|0
4873776|NCT00804687|16795953|P6|Period 3: Treatment Period|Positive Drug screen|0
4873777|NCT00804687|16795954|P5|Period 3: Treatment Period|Positive Drug screen|0
4873778|NCT00804687|16795955|P4|Period 3: Treatment Period|Positive Drug screen|1
4873779|NCT00804687|16795956|P3|Period 3: Treatment Period|Positive Drug screen|0
4873780|NCT00804687|16795957|P2|Period 3: Treatment Period|Positive Drug screen|0
4873781|NCT00804687|16795958|P1|Period 3: Treatment Period|Positive Drug screen|0
4873782|NCT00804570|16796037|P2|Overall Study|Withdrawal by Subject|38
4873783|NCT00804570|16796038|P1|Overall Study|Withdrawal by Subject|21
4873784|NCT00804570|16796037|P2|Overall Study|Sponsor decision|4
4873785|NCT00804570|16796038|P1|Overall Study|Sponsor decision|1
4873786|NCT00804570|16796037|P2|Overall Study|Physician Decision|2
4873787|NCT00804570|16796038|P1|Overall Study|Physician Decision|1
4873788|NCT00804570|16796037|P2|Overall Study|Protocol Violation|16
4873789|NCT00804570|16796038|P1|Overall Study|Protocol Violation|12
4873790|NCT00804570|16796037|P2|Overall Study|Entry criteria not met|5
4873791|NCT00804570|16796038|P1|Overall Study|Entry criteria not met|5
4873792|NCT00804570|16796037|P2|Overall Study|Lost to Follow-up|21
4873793|NCT00804570|16796038|P1|Overall Study|Lost to Follow-up|18
4873794|NCT00804570|16796037|P2|Overall Study|Lack of Efficacy|1
4873795|NCT00804570|16796038|P1|Overall Study|Lack of Efficacy|0
4873796|NCT00804570|16796037|P2|Overall Study|Adverse Event|7
4873797|NCT00804570|16796038|P1|Overall Study|Adverse Event|14
4873798|NCT00804193|16796112|P3|Overall Study|Withdrawal by Subject|2
4873799|NCT00804193|16796113|P2|Overall Study|Withdrawal by Subject|1
4873800|NCT00804193|16796114|P1|Overall Study|Withdrawal by Subject|3
4873801|NCT00804193|16796112|P3|Overall Study|Lost to Follow-up|4
4873802|NCT00804193|16796113|P2|Overall Study|Lost to Follow-up|3
4873803|NCT00804193|16796114|P1|Overall Study|Lost to Follow-up|3
4873804|NCT00804193|16796112|P3|Overall Study|Protocol Violation|2
4873805|NCT00804193|16796113|P2|Overall Study|Protocol Violation|8
4873806|NCT00804193|16796114|P1|Overall Study|Protocol Violation|0
4873807|NCT00804193|16796112|P3|Overall Study|Lack of Efficacy|3
4873808|NCT00804193|16796113|P2|Overall Study|Lack of Efficacy|1
4873809|NCT00804193|16796114|P1|Overall Study|Lack of Efficacy|1
4873810|NCT00804193|16796112|P3|Overall Study|Adverse Event|2
4873811|NCT00804193|16796113|P2|Overall Study|Adverse Event|0
4873812|NCT00804193|16796114|P1|Overall Study|Adverse Event|0
4873813|NCT00804193|16796112|P3|Overall Study|Lack of baseline fungus|19
4873814|NCT00804193|16796113|P2|Overall Study|Lack of baseline fungus|31
4873815|NCT00804193|16796114|P1|Overall Study|Lack of baseline fungus|32
4873816|NCT00804141|16796128|P1|Overall Study|Enrolled but not treated|6
4873817|NCT00804141|16796128|P1|Overall Study|Other than specified|30
4873818|NCT00804141|16796128|P1|Overall Study|Lack of Efficacy|46
4873819|NCT00804141|16796128|P1|Overall Study|Withdrawal by Subject|131
4873820|NCT00804141|16796128|P1|Overall Study|Protocol Violation|85
4873821|NCT00804141|16796128|P1|Overall Study|Investigator request|8
4873822|NCT00804141|16796128|P1|Overall Study|Failed to return|96
4873823|NCT00804141|16796128|P1|Overall Study|Death|4
4873824|NCT00804141|16796128|P1|Overall Study|Adverse Event|157
4873825|NCT00803790|16796168|P4|Period 2|Positive Drug Screen or Personal Reasons|0
4873826|NCT00803790|16796169|P3|Period 2|Positive Drug Screen or Personal Reasons|0
4873827|NCT00803790|16796170|P2|Period 2|Positive Drug Screen or Personal Reasons|0
4873828|NCT00803790|16796171|P1|Period 2|Positive Drug Screen or Personal Reasons|1
4873829|NCT00803790|16796168|P4|Period 2|Withdrawal by Subject|0
4873830|NCT00803790|16796169|P3|Period 2|Withdrawal by Subject|0
4873831|NCT00803790|16796170|P2|Period 2|Withdrawal by Subject|0
4873832|NCT00803790|16796171|P1|Period 2|Withdrawal by Subject|1
4873833|NCT00803790|16796168|P4|Period 2|Adverse Event|1
4873834|NCT00803790|16796169|P3|Period 2|Adverse Event|1
4873835|NCT00803790|16796170|P2|Period 2|Adverse Event|0
4873836|NCT00803790|16796171|P1|Period 2|Adverse Event|0
4873837|NCT00803790|16796168|P4|Period 1|Protocol Violation|0
4873838|NCT00803790|16796169|P3|Period 1|Protocol Violation|1
4873839|NCT00803790|16796170|P2|Period 1|Protocol Violation|0
4873840|NCT00803790|16796171|P1|Period 1|Protocol Violation|0
4873841|NCT00803790|16796168|P4|Period 1|positive drug screen or personal reasons|4
4873842|NCT00803790|16796169|P3|Period 1|positive drug screen or personal reasons|0
4873843|NCT00803790|16796170|P2|Period 1|positive drug screen or personal reasons|3
4873844|NCT00803790|16796171|P1|Period 1|positive drug screen or personal reasons|0
4873845|NCT00803790|16796168|P4|Period 1|Withdrawal by Subject|0
4873846|NCT00803790|16796169|P3|Period 1|Withdrawal by Subject|0
4873847|NCT00803790|16796170|P2|Period 1|Withdrawal by Subject|6
4873848|NCT00803790|16796171|P1|Period 1|Withdrawal by Subject|8
4873849|NCT00803790|16796168|P4|Period 1|Lost to Follow-up|0
4873850|NCT00803790|16796169|P3|Period 1|Lost to Follow-up|0
4873851|NCT00803790|16796170|P2|Period 1|Lost to Follow-up|2
4873852|NCT00803790|16796171|P1|Period 1|Lost to Follow-up|1
4873853|NCT00803790|16796168|P4|Period 1|Adverse Event|0
4873854|NCT00803790|16796169|P3|Period 1|Adverse Event|0
4873855|NCT00803790|16796170|P2|Period 1|Adverse Event|1
4873856|NCT00803790|16796171|P1|Period 1|Adverse Event|0
4873857|NCT00803738|16796211|P2|Overall Study|Positive Results for STD or abnormal PAP|8
4873858|NCT00803738|16796212|P1|Overall Study|Positive Results for STD or abnormal PAP|2
4873859|NCT00803738|16796211|P2|Overall Study|Negative Baseline Culture of Candida|63
4873860|NCT00803738|16796212|P1|Overall Study|Negative Baseline Culture of Candida|56
4873861|NCT00803738|16796211|P2|Overall Study|Lack of Efficacy|16
4873862|NCT00803738|16796212|P1|Overall Study|Lack of Efficacy|10
4873863|NCT00803738|16796211|P2|Overall Study|Withdrawal by Subject|4
4873864|NCT00803738|16796212|P1|Overall Study|Withdrawal by Subject|1
4873865|NCT00803738|16796211|P2|Overall Study|Protocol Violation|10
4873866|NCT00803738|16796212|P1|Overall Study|Protocol Violation|18
4873867|NCT00803738|16796211|P2|Overall Study|Lost to Follow-up|4
4873868|NCT00803738|16796212|P1|Overall Study|Lost to Follow-up|4
4873869|NCT00803738|16796211|P2|Overall Study|Adverse Event|5
4873870|NCT00803738|16796212|P1|Overall Study|Adverse Event|3
4873871|NCT00803712|16796224|P2|Overall Study|Protocol criteria (parathyroidectomy)|1
4873872|NCT00803712|16796225|P1|Overall Study|Protocol criteria (parathyroidectomy)|1
4873873|NCT00803712|16796224|P2|Overall Study|Administrative decision|3
4873874|NCT00803712|16796225|P1|Overall Study|Administrative decision|2
4873875|NCT00803712|16796224|P2|Overall Study|Protocol criteria (renal transplant)|8
4873876|NCT00803712|16796225|P1|Overall Study|Protocol criteria (renal transplant)|12
4873877|NCT00803712|16796224|P2|Overall Study|Protocol criteria (other)|2
4873878|NCT00803712|16796225|P1|Overall Study|Protocol criteria (other)|0
4873879|NCT00803712|16796224|P2|Overall Study|"Other in electronic Case Report Form"|1
4873880|NCT00803712|16796225|P1|Overall Study|"Other in electronic Case Report Form"|0
4873881|NCT00803712|16796224|P2|Overall Study|Withdrawal by Subject|4
4873882|NCT00803712|16796225|P1|Overall Study|Withdrawal by Subject|2
4873883|NCT00803712|16796224|P2|Overall Study|Lost to Follow-up|1
4873884|NCT00803712|16796225|P1|Overall Study|Lost to Follow-up|3
4873885|NCT00803712|16796224|P2|Overall Study|Death|7
4873886|NCT00803712|16796225|P1|Overall Study|Death|8
4873887|NCT00803712|16796224|P2|Overall Study|Adverse Event|0
4873888|NCT00803712|16796225|P1|Overall Study|Adverse Event|5
4873889|NCT00803712|16796224|P2|Overall Study|Noncompliance|0
4873890|NCT00803712|16796225|P1|Overall Study|Noncompliance|3
4873891|NCT00803634|16796324|P2|Overall Study|Death|2
4873892|NCT00803634|16796325|P1|Overall Study|Death|3
4873893|NCT00803634|16796324|P2|Overall Study|Lost to Follow-up|3
4873894|NCT00803634|16796325|P1|Overall Study|Lost to Follow-up|2
4873895|NCT00803634|16796324|P2|Overall Study|Withdrew Consent|0
4873896|NCT00803634|16796325|P1|Overall Study|Withdrew Consent|1
4873897|NCT00803595|16796354|P3|Overall Study|Withdrawal by Subject|3
4873898|NCT00803595|16796355|P2|Overall Study|Withdrawal by Subject|2
4873899|NCT00803595|16796356|P1|Overall Study|Withdrawal by Subject|5
4873900|NCT00803595|16796354|P3|Overall Study|Protocol Violation|12
4873901|NCT00803595|16796355|P2|Overall Study|Protocol Violation|2
4873902|NCT00803595|16796356|P1|Overall Study|Protocol Violation|7
4873903|NCT00803595|16796354|P3|Overall Study|Adverse Event|1
4873904|NCT00803595|16796355|P2|Overall Study|Adverse Event|4
4873905|NCT00803595|16796356|P1|Overall Study|Adverse Event|3
4873906|NCT00803569|16796367|P1|Overall Study|Noncompliance|1
4873907|NCT00803569|16796367|P1|Overall Study|Progressive Disease|3
4873908|NCT00803452|16796401|P2|Overall Study|Lost to Follow-up|3
4873909|NCT00803452|16796402|P1|Overall Study|Lost to Follow-up|0
4873910|NCT00803452|16796401|P2|Overall Study|Adverse Event|2
4873911|NCT00803452|16796402|P1|Overall Study|Adverse Event|0
4873912|NCT00803361|16796440|P2|Overall Study|Withdrawal by Subject|6
4873913|NCT00803361|16796441|P1|Overall Study|Withdrawal by Subject|5
4873914|NCT00803361|16796440|P2|Overall Study|Protocol Violation|4
4873915|NCT00803361|16796441|P1|Overall Study|Protocol Violation|2
4873916|NCT00803361|16796440|P2|Overall Study|Physician Decision|0
4873917|NCT00803361|16796441|P1|Overall Study|Physician Decision|1
4873918|NCT00803361|16796440|P2|Overall Study|Lost to Follow-up|2
4873919|NCT00803361|16796441|P1|Overall Study|Lost to Follow-up|1
4873920|NCT00803361|16796440|P2|Overall Study|Lack of Efficacy|13
4873921|NCT00803361|16796441|P1|Overall Study|Lack of Efficacy|4
4873922|NCT00803361|16796440|P2|Overall Study|Adverse Event|3
4873923|NCT00803361|16796441|P1|Overall Study|Adverse Event|13
4873924|NCT00803270|16796488|P2|Overall Study|Lost to Follow-up|2
4873925|NCT00803270|16796489|P1|Overall Study|Lost to Follow-up|1
4873926|NCT00803244|16796499|P2|Overall Study|Any other reason not above-mentioned|10
4873927|NCT00803244|16796500|P1|Overall Study|Any other reason not above-mentioned|4
4873928|NCT00803244|16796499|P2|Overall Study|Withdrawal by Subject|3
4873929|NCT00803244|16796500|P1|Overall Study|Withdrawal by Subject|2
4873930|NCT00803244|16796499|P2|Overall Study|Adverse Event|2
4873931|NCT00803244|16796500|P1|Overall Study|Adverse Event|1
4873932|NCT00803205|16796510|P2|Overall Study|Sponsor Decision|1
4873933|NCT00803205|16796511|P1|Overall Study|Sponsor Decision|0
4873934|NCT00803205|16796510|P2|Overall Study|Acquired a Lung Infection|1
4873935|NCT00803205|16796511|P1|Overall Study|Acquired a Lung Infection|0
4873936|NCT00803205|16796510|P2|Overall Study|Medical Monitor Decision|0
4873937|NCT00803205|16796511|P1|Overall Study|Medical Monitor Decision|1
4873938|NCT00803205|16796510|P2|Overall Study|Protocol Violation|1
4873939|NCT00803205|16796511|P1|Overall Study|Protocol Violation|1
4873940|NCT00803205|16796510|P2|Overall Study|Physician Decision|0
4873941|NCT00803205|16796511|P1|Overall Study|Physician Decision|1
4873942|NCT00803205|16796510|P2|Overall Study|Withdrawal by Subject|9
4873943|NCT00803205|16796511|P1|Overall Study|Withdrawal by Subject|9
4873944|NCT00803205|16796510|P2|Overall Study|Lost to Follow-up|0
4873945|NCT00803205|16796511|P1|Overall Study|Lost to Follow-up|1
4873946|NCT00803205|16796510|P2|Overall Study|Adverse Event|2
4873947|NCT00803205|16796511|P1|Overall Study|Adverse Event|7
4873948|NCT00803179|16796554|P1|Overall Study|Lost to Follow-up|3
4873949|NCT00803101|16796573|P2|Overall Study|Patient did not have surgery|1
4873950|NCT00803101|16796574|P1|Overall Study|Patient did not have surgery|1
4873951|NCT00803101|16796573|P2|Overall Study|Patient did not attend scheduled visit|1
4873952|NCT00803101|16796574|P1|Overall Study|Patient did not attend scheduled visit|2
4873953|NCT00803101|16796573|P2|Overall Study|Patient died outside SAE report period|0
4873954|NCT00803101|16796574|P1|Overall Study|Patient died outside SAE report period|1
4873955|NCT00803101|16796573|P2|Overall Study|Surgery finished outside protocol window|1
4873956|NCT00803101|16796574|P1|Overall Study|Surgery finished outside protocol window|1
4873957|NCT00803101|16796573|P2|Overall Study|Protocol Violation|7
4873958|NCT00803101|16796574|P1|Overall Study|Protocol Violation|1
4873959|NCT00803101|16796573|P2|Overall Study|Lost to Follow-up|2
4873960|NCT00803101|16796574|P1|Overall Study|Lost to Follow-up|2
4873961|NCT00803101|16796573|P2|Overall Study|Withdrawal by Subject|4
4873962|NCT00803101|16796574|P1|Overall Study|Withdrawal by Subject|6
4873963|NCT00803101|16796573|P2|Overall Study|Death / Serious Adverse Event|6
4873964|NCT00803101|16796574|P1|Overall Study|Death / Serious Adverse Event|4
4873965|NCT00803049|16796625|P4|Overall Study|Other than Specified Above|5
4873966|NCT00803049|16796626|P3|Overall Study|Other than Specified Above|2
4873967|NCT00803049|16796627|P2|Overall Study|Other than Specified Above|9
4873968|NCT00803049|16796628|P1|Overall Study|Other than Specified Above|3
4873969|NCT00803049|16796625|P4|Overall Study|Randomized and Not Treated|2
4873970|NCT00803049|16796626|P3|Overall Study|Randomized and Not Treated|0
4873971|NCT00803049|16796627|P2|Overall Study|Randomized and Not Treated|0
4873972|NCT00803049|16796628|P1|Overall Study|Randomized and Not Treated|0
4873973|NCT00803049|16796625|P4|Overall Study|Protocol Violation|0
4873974|NCT00803049|16796626|P3|Overall Study|Protocol Violation|1
4873975|NCT00803049|16796627|P2|Overall Study|Protocol Violation|1
4873976|NCT00803049|16796628|P1|Overall Study|Protocol Violation|0
4873977|NCT00803049|16796625|P4|Overall Study|Withdrawal by Subject|44
4873978|NCT00803049|16796626|P3|Overall Study|Withdrawal by Subject|16
4873979|NCT00803049|16796627|P2|Overall Study|Withdrawal by Subject|43
4873980|NCT00803049|16796628|P1|Overall Study|Withdrawal by Subject|19
4873981|NCT00803049|16796625|P4|Overall Study|Progressive Disease|6
4873982|NCT00803049|16796626|P3|Overall Study|Progressive Disease|6
4873983|NCT00803049|16796627|P2|Overall Study|Progressive Disease|10
4873984|NCT00803049|16796628|P1|Overall Study|Progressive Disease|6
4873985|NCT00803049|16796625|P4|Overall Study|Death|2
4873986|NCT00803049|16796626|P3|Overall Study|Death|0
4873987|NCT00803049|16796627|P2|Overall Study|Death|1
4873988|NCT00803049|16796628|P1|Overall Study|Death|2
4873989|NCT00803049|16796625|P4|Overall Study|Lost to Follow-up|3
4873990|NCT00803049|16796626|P3|Overall Study|Lost to Follow-up|0
4873991|NCT00803049|16796627|P2|Overall Study|Lost to Follow-up|2
4873992|NCT00803049|16796628|P1|Overall Study|Lost to Follow-up|0
4873993|NCT00803049|16796625|P4|Overall Study|Lack of Efficacy|13
4873994|NCT00803049|16796626|P3|Overall Study|Lack of Efficacy|6
4873995|NCT00803049|16796627|P2|Overall Study|Lack of Efficacy|19
4873996|NCT00803049|16796628|P1|Overall Study|Lack of Efficacy|10
4873997|NCT00803049|16796625|P4|Overall Study|Adverse Event|27
4873998|NCT00803049|16796626|P3|Overall Study|Adverse Event|13
4873999|NCT00803049|16796627|P2|Overall Study|Adverse Event|33
4874000|NCT00803049|16796628|P1|Overall Study|Adverse Event|21
4874001|NCT00803023|16796662|P4|Overall Study|Lack of Efficacy|1
4874002|NCT00803023|16796663|P3|Overall Study|Lack of Efficacy|1
4874003|NCT00803023|16796664|P2|Overall Study|Lack of Efficacy|1
4874004|NCT00803023|16796665|P1|Overall Study|Lack of Efficacy|0
4874005|NCT00803023|16796662|P4|Overall Study|Lost to Follow-up|1
4874006|NCT00803023|16796663|P3|Overall Study|Lost to Follow-up|2
4874007|NCT00803023|16796664|P2|Overall Study|Lost to Follow-up|1
4874008|NCT00803023|16796665|P1|Overall Study|Lost to Follow-up|0
4874009|NCT00803023|16796662|P4|Overall Study|Withdrawal by Subject|0
4874010|NCT00803023|16796663|P3|Overall Study|Withdrawal by Subject|0
4874011|NCT00803023|16796664|P2|Overall Study|Withdrawal by Subject|2
4874012|NCT00803023|16796665|P1|Overall Study|Withdrawal by Subject|0
4874013|NCT00803023|16796662|P4|Overall Study|Adverse Event|6
4874014|NCT00803023|16796663|P3|Overall Study|Adverse Event|8
4874015|NCT00803023|16796664|P2|Overall Study|Adverse Event|4
4874016|NCT00803023|16796665|P1|Overall Study|Adverse Event|5
4874017|NCT00802945|16796703|P2|Overall Study|Terminated by sponsor|12
4874018|NCT00802945|16796704|P1|Overall Study|Terminated by sponsor|8
4874019|NCT00802945|16796703|P2|Overall Study|Death|23
4874020|NCT00802945|16796704|P1|Overall Study|Death|27
4874021|NCT00802893|16796735|P1|Overall Study|study terminated|3
4874022|NCT00802867|16796759|P1|Overall Study|Withdrawal by Subject|1
4874023|NCT00802867|16796759|P1|Overall Study|Protocol Violation|6
4874024|NCT00802867|16796759|P1|Overall Study|Lost to Follow-up|6
4874025|NCT00802841|16796782|P2|Overall Study|Treatment duration completed|76
4874026|NCT00802841|16796783|P1|Overall Study|Treatment duration completed|66
4874027|NCT00802841|16796782|P2|Overall Study|Protocol deviation|6
4874028|NCT00802841|16796783|P1|Overall Study|Protocol deviation|2
4874029|NCT00802841|16796782|P2|Overall Study|Withdrawal by Subject|5
4874030|NCT00802841|16796783|P1|Overall Study|Withdrawal by Subject|9
4874031|NCT00802841|16796782|P2|Overall Study|Disease progression|3
4874032|NCT00802841|16796783|P1|Overall Study|Disease progression|7
4874033|NCT00802841|16796782|P2|Overall Study|Adverse Event|2
4874034|NCT00802841|16796783|P1|Overall Study|Adverse Event|8
4874035|NCT00802841|16796782|P2|Overall Study|Death|2
4874036|NCT00802841|16796783|P1|Overall Study|Death|1
4874037|NCT00802841|16796782|P2|Overall Study|Lost to Follow-up|1
4874038|NCT00802841|16796783|P1|Overall Study|Lost to Follow-up|2
4874039|NCT00802841|16796782|P2|Overall Study|Administrative problems|0
4874040|NCT00802841|16796783|P1|Overall Study|Administrative problems|1
4874041|NCT00802737|16796808|P3|Overall Study|Participant too Unwell|0
4874042|NCT00802737|16796809|P2|Overall Study|Participant too Unwell|2
4874043|NCT00802737|16796810|P1|Overall Study|Participant too Unwell|0
4874044|NCT00802737|16796808|P3|Overall Study|Ongoing CLL-Treatment|0
4874045|NCT00802737|16796809|P2|Overall Study|Ongoing CLL-Treatment|1
4874046|NCT00802737|16796810|P1|Overall Study|Ongoing CLL-Treatment|0
4874047|NCT00802737|16796808|P3|Overall Study|Received Prohibited Therapy|0
4874048|NCT00802737|16796809|P2|Overall Study|Received Prohibited Therapy|0
4874049|NCT00802737|16796810|P1|Overall Study|Received Prohibited Therapy|1
4874050|NCT00802737|16796808|P3|Overall Study|Adverse Event|0
4874051|NCT00802737|16796809|P2|Overall Study|Adverse Event|0
4874052|NCT00802737|16796810|P1|Overall Study|Adverse Event|1
4874053|NCT00802737|16796808|P3|Overall Study|Death|1
4874054|NCT00802737|16796809|P2|Overall Study|Death|5
4874055|NCT00802737|16796810|P1|Overall Study|Death|6
4874056|NCT00802737|16796808|P3|Overall Study|Withdrawn due to Disease Progression|0
4874057|NCT00802737|16796809|P2|Overall Study|Withdrawn due to Disease Progression|3
4874058|NCT00802737|16796810|P1|Overall Study|Withdrawn due to Disease Progression|9
4874059|NCT00802672|16796870|P3|Overall Study|other|2
4874060|NCT00802672|16796871|P2|Overall Study|other|1
4874061|NCT00802672|16796872|P1|Overall Study|other|3
4874062|NCT00802672|16796870|P3|Overall Study|Withdrawal by Subject|2
4874063|NCT00802672|16796871|P2|Overall Study|Withdrawal by Subject|1
4874064|NCT00802672|16796872|P1|Overall Study|Withdrawal by Subject|1
4874065|NCT00802672|16796870|P3|Overall Study|Lost to Follow-up|3
4874066|NCT00802672|16796871|P2|Overall Study|Lost to Follow-up|5
4874067|NCT00802672|16796872|P1|Overall Study|Lost to Follow-up|5
4874068|NCT00802672|16796870|P3|Overall Study|Protocol Violation|1
4874069|NCT00802672|16796871|P2|Overall Study|Protocol Violation|1
4874070|NCT00802672|16796872|P1|Overall Study|Protocol Violation|2
4874071|NCT00802672|16796870|P3|Overall Study|Adverse Event|1
4874072|NCT00802672|16796871|P2|Overall Study|Adverse Event|1
4874073|NCT00802672|16796872|P1|Overall Study|Adverse Event|1
4874074|NCT00802672|16796870|P3|Overall Study|Lack of fungal pathogen at baseline|25
4874075|NCT00802672|16796871|P2|Overall Study|Lack of fungal pathogen at baseline|43
4874076|NCT00802672|16796872|P1|Overall Study|Lack of fungal pathogen at baseline|56
4874077|NCT00802659|16796890|P4|Overall Study|Physician Decision|0
4874078|NCT00802659|16796891|P3|Overall Study|Physician Decision|0
4874079|NCT00802659|16796892|P2|Overall Study|Physician Decision|1
4874080|NCT00802659|16796893|P1|Overall Study|Physician Decision|0
4874081|NCT00802529|16796932|P2|Overall Study|Lost to Follow-up|1
4874082|NCT00802529|16796933|P1|Overall Study|Lost to Follow-up|0
4874083|NCT00802464|16796972|P4|Month 8 - Month 14|Lost to Follow-up|0
4874084|NCT00802464|16796973|P3|Month 8 - Month 14|Lost to Follow-up|1
4874085|NCT00802464|16796974|P2|Month 8 - Month 14|Lost to Follow-up|0
4874086|NCT00802464|16796975|P1|Month 8 - Month 14|Lost to Follow-up|0
4874087|NCT00802464|16796972|P4|Month 8 - Month 14|Withdrawal by Subject|0
4874088|NCT00802464|16796973|P3|Month 8 - Month 14|Withdrawal by Subject|0
4874089|NCT00802464|16796974|P2|Month 8 - Month 14|Withdrawal by Subject|1
4874090|NCT00802464|16796975|P1|Month 8 - Month 14|Withdrawal by Subject|1
4874091|NCT00802464|16796972|P4|Month 8 - Month 14|Adverse Event|0
4874092|NCT00802464|16796973|P3|Month 8 - Month 14|Adverse Event|0
4874093|NCT00802464|16796974|P2|Month 8 - Month 14|Adverse Event|1
4874094|NCT00802464|16796975|P1|Month 8 - Month 14|Adverse Event|0
4874095|NCT00802464|16796972|P4|Month 0 - Month 8|Other|0
4874096|NCT00802464|16796973|P3|Month 0 - Month 8|Other|1
4874097|NCT00802464|16796974|P2|Month 0 - Month 8|Other|0
4874098|NCT00802464|16796975|P1|Month 0 - Month 8|Other|0
4874099|NCT00802464|16796972|P4|Month 0 - Month 8|Lost to Follow-up|2
4874100|NCT00802464|16796973|P3|Month 0 - Month 8|Lost to Follow-up|2
4874101|NCT00802464|16796974|P2|Month 0 - Month 8|Lost to Follow-up|1
4874102|NCT00802464|16796975|P1|Month 0 - Month 8|Lost to Follow-up|0
4874103|NCT00802464|16796972|P4|Month 0 - Month 8|Withdrawal by Subject|5
4874104|NCT00802464|16796973|P3|Month 0 - Month 8|Withdrawal by Subject|2
4874105|NCT00802464|16796974|P2|Month 0 - Month 8|Withdrawal by Subject|1
4874106|NCT00802464|16796975|P1|Month 0 - Month 8|Withdrawal by Subject|0
4874107|NCT00802464|16796972|P4|Month 0 - Month 8|Protocol Violation|0
4874108|NCT00802464|16796973|P3|Month 0 - Month 8|Protocol Violation|1
4874109|NCT00802464|16796974|P2|Month 0 - Month 8|Protocol Violation|0
4874110|NCT00802464|16796975|P1|Month 0 - Month 8|Protocol Violation|0
4874111|NCT00802464|16796972|P4|Month 0 - Month 8|Adverse Event|2
4874112|NCT00802464|16796973|P3|Month 0 - Month 8|Adverse Event|1
4874113|NCT00802464|16796974|P2|Month 0 - Month 8|Adverse Event|1
4874114|NCT00802464|16796975|P1|Month 0 - Month 8|Adverse Event|0
4874115|NCT00802438|16797061|P1|Overall Study|Physician Decision|1
4874116|NCT00802438|16797061|P1|Overall Study|Withdrawal by Subject|7
4874117|NCT00802438|16797061|P1|Overall Study|Screen Failure|20
4874118|NCT00802360|16797081|P4|Overall Study|Other|3
4874119|NCT00802360|16797082|P3|Overall Study|Other|6
4874120|NCT00802360|16797083|P2|Overall Study|Other|3
4874121|NCT00802360|16797084|P1|Overall Study|Other|2
4874122|NCT00802360|16797081|P4|Overall Study|Pregnancy loss/miscarriage|3
4874123|NCT00802360|16797082|P3|Overall Study|Pregnancy loss/miscarriage|0
4874124|NCT00802360|16797083|P2|Overall Study|Pregnancy loss/miscarriage|2
4874125|NCT00802360|16797084|P1|Overall Study|Pregnancy loss/miscarriage|0
4874126|NCT00802360|16797081|P4|Overall Study|Pregnancy not confirmed by ultrasound|0
4874127|NCT00802360|16797082|P3|Overall Study|Pregnancy not confirmed by ultrasound|1
4874128|NCT00802360|16797083|P2|Overall Study|Pregnancy not confirmed by ultrasound|0
4874129|NCT00802360|16797084|P1|Overall Study|Pregnancy not confirmed by ultrasound|1
4874130|NCT00802360|16797081|P4|Overall Study|No positive serum pregnancy|10
4874131|NCT00802360|16797082|P3|Overall Study|No positive serum pregnancy|14
4874132|NCT00802360|16797083|P2|Overall Study|No positive serum pregnancy|20
4874133|NCT00802360|16797084|P1|Overall Study|No positive serum pregnancy|17
4874134|NCT00802360|16797081|P4|Overall Study|Risk of ovarian hyperstimulation syndrom|1
4874135|NCT00802360|16797082|P3|Overall Study|Risk of ovarian hyperstimulation syndrom|0
4874136|NCT00802360|16797083|P2|Overall Study|Risk of ovarian hyperstimulation syndrom|0
4874137|NCT00802360|16797084|P1|Overall Study|Risk of ovarian hyperstimulation syndrom|0
4874138|NCT00802360|16797081|P4|Overall Study|Cycle cancelled|1
4874139|NCT00802360|16797082|P3|Overall Study|Cycle cancelled|1
4874140|NCT00802360|16797083|P2|Overall Study|Cycle cancelled|1
4874141|NCT00802360|16797084|P1|Overall Study|Cycle cancelled|0
4874142|NCT00802360|16797081|P4|Overall Study|Inadequate number of oocytes retrieved|1
4874143|NCT00802360|16797082|P3|Overall Study|Inadequate number of oocytes retrieved|0
4874144|NCT00802360|16797083|P2|Overall Study|Inadequate number of oocytes retrieved|0
4874145|NCT00802360|16797084|P1|Overall Study|Inadequate number of oocytes retrieved|0
4874146|NCT00802360|16797081|P4|Overall Study|Stimulation failure|3
4874147|NCT00802360|16797082|P3|Overall Study|Stimulation failure|3
4874148|NCT00802360|16797083|P2|Overall Study|Stimulation failure|0
4874149|NCT00802360|16797084|P1|Overall Study|Stimulation failure|4
4874150|NCT00802178|16797151|P1|Overall Study|Patients wish and other reason|1
4874151|NCT00802178|16797151|P1|Overall Study|IT and patient wish|8
4874152|NCT00802178|16797151|P1|Overall Study|Lack of efficacy and patient wish|1
4874153|NCT00802178|16797151|P1|Overall Study|Other|32
4874154|NCT00802178|16797151|P1|Overall Study|Withdrawal by Subject|18
4874155|NCT00802178|16797151|P1|Overall Study|Insufficient tolerability (IT)|17
4874156|NCT00802178|16797151|P1|Overall Study|Lack of Efficacy|36
4874157|NCT00802074|16797199|P6|Overall Study|Withdrawal by Subject|0
4874158|NCT00802074|16797200|P5|Overall Study|Withdrawal by Subject|0
4874159|NCT00802074|16797201|P4|Overall Study|Withdrawal by Subject|0
4874160|NCT00802074|16797202|P3|Overall Study|Withdrawal by Subject|0
4874161|NCT00802074|16797203|P2|Overall Study|Withdrawal by Subject|0
4874162|NCT00802074|16797204|P1|Overall Study|Withdrawal by Subject|1
4874163|NCT00802074|16797199|P6|Overall Study|Adverse Event|0
4874164|NCT00802074|16797200|P5|Overall Study|Adverse Event|0
4874165|NCT00802074|16797201|P4|Overall Study|Adverse Event|0
4874166|NCT00802074|16797202|P3|Overall Study|Adverse Event|1
4874167|NCT00802074|16797203|P2|Overall Study|Adverse Event|1
4874168|NCT00802074|16797204|P1|Overall Study|Adverse Event|1
4874169|NCT00801983|16797238|P2|Period 2|Withdrawal by Subject|1
4874170|NCT00801983|16797239|P1|Period 2|Withdrawal by Subject|2
4874171|NCT00801983|16797238|P2|Period 1|Withdrawal by Subject|8
4874172|NCT00801983|16797239|P1|Period 1|Withdrawal by Subject|2
4874173|NCT00801983|16797238|P2|Period 1|Lost to Follow-up|0
4874174|NCT00801983|16797239|P1|Period 1|Lost to Follow-up|2
4874175|NCT00801892|16797254|P2|Sham Crossover Period|Lost to Follow-up|2
4874176|NCT00801892|16797255|P1|Sham Crossover Period|Lost to Follow-up|0
4874177|NCT00801892|16797254|P2|Main Study Period|Withdrawal by Subject|1
4874178|NCT00801892|16797255|P1|Main Study Period|Withdrawal by Subject|0
4874179|NCT00801632|16797315|P1|Overall Study|Re-transplant|1
4874180|NCT00801242|16797393|P1|Overall Study|Miscellaneous reasons|20
4874181|NCT00801242|16797393|P1|Overall Study|Lost to Follow-up|1
4874182|NCT00801242|16797393|P1|Overall Study|Physician Decision|3
4874183|NCT00801242|16797393|P1|Overall Study|Protocol Violation|5
4874184|NCT00801242|16797393|P1|Overall Study|Withdrawal by Subject|13
4874185|NCT00801242|16797393|P1|Overall Study|Adverse Event|10
4874186|NCT00801229|16797406|P2|Received Study Drug/Placebo|Adverse Event|1
4874187|NCT00801229|16797407|P1|Received Study Drug/Placebo|Adverse Event|1
4874188|NCT00801229|16797406|P2|Received Study Drug/Placebo|Lost to Follow-up|1
4874189|NCT00801229|16797407|P1|Received Study Drug/Placebo|Lost to Follow-up|0
4874190|NCT00801229|16797406|P2|Received Study Drug/Placebo|Withdrawal by Subject|0
4874191|NCT00801229|16797407|P1|Received Study Drug/Placebo|Withdrawal by Subject|1
4874192|NCT00801229|16797406|P2|Received Study Drug/Placebo|Simulator sickness|1
4874193|NCT00801229|16797407|P1|Received Study Drug/Placebo|Simulator sickness|1
4874194|NCT00801229|16797406|P2|Received Study Drug/Placebo|Sub-threshold ADHD|1
4874195|NCT00801229|16797407|P1|Received Study Drug/Placebo|Sub-threshold ADHD|0
4874196|NCT00801229|16797406|P2|Received Study Drug/Placebo|Elevated SGOT level|0
4874197|NCT00801229|16797407|P1|Received Study Drug/Placebo|Elevated SGOT level|1
4874198|NCT00801229|16797406|P2|Signed Consent|Found Ineligible|1
4874199|NCT00801229|16797407|P1|Signed Consent|Found Ineligible|1
4874200|NCT00801229|16797406|P2|Signed Consent|Withdrawal by Subject|2
4874201|NCT00801229|16797407|P1|Signed Consent|Withdrawal by Subject|2
4874202|NCT00801099|16797442|P1|Overall Study|Lost to Follow-up|101
4874203|NCT00800982|16797448|P2|Overall Study|Patient moved out of state|0
4874204|NCT00800982|16797449|P1|Overall Study|Patient moved out of state|1
4874205|NCT00800982|16797448|P2|Overall Study|Withdrawal by Subject|1
4874206|NCT00800982|16797449|P1|Overall Study|Withdrawal by Subject|0
4874207|NCT00800982|16797448|P2|Overall Study|Lost to Follow-up|2
4874208|NCT00800982|16797449|P1|Overall Study|Lost to Follow-up|1
4874209|NCT00800735|16797475|P1|Overall Study|Withdrew Consent|3
4874210|NCT00800735|16797475|P1|Overall Study|Violation of Selection Criteria at Entry|7
4874211|NCT00800735|16797475|P1|Overall Study|Insufficient Therapeutic Response|2
4874212|NCT00800735|16797475|P1|Overall Study|Administrative/Other|2
4874213|NCT00800683|16797481|P2|Overall Study|Other|2
4874214|NCT00800683|16797482|P1|Overall Study|Other|1
4874215|NCT00800683|16797481|P2|Overall Study|Lack of Efficacy|1
4874216|NCT00800683|16797482|P1|Overall Study|Lack of Efficacy|1
4874217|NCT00800683|16797481|P2|Overall Study|Withdrawal by Subject|7
4874218|NCT00800683|16797482|P1|Overall Study|Withdrawal by Subject|1
4874219|NCT00800683|16797481|P2|Overall Study|Lost to Follow-up|1
4874220|NCT00800683|16797482|P1|Overall Study|Lost to Follow-up|3
4874221|NCT00800683|16797481|P2|Overall Study|Adverse Event|8
4874222|NCT00800683|16797482|P1|Overall Study|Adverse Event|11
4874223|NCT00800540|16797528|P2|Period 2: 6 Weeks|Adverse Event|1
4874224|NCT00800540|16797529|P1|Period 2: 6 Weeks|Adverse Event|0
4874225|NCT00800540|16797528|P2|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1
4874226|NCT00800540|16797529|P1|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0
4874227|NCT00800540|16797528|P2|Period One: 6 Weeks|Noncompliance|0
4874228|NCT00800540|16797529|P1|Period One: 6 Weeks|Noncompliance|1
4874229|NCT00800436|16797564|P7|Overall Study|Withdrawal by Subject|0
4874230|NCT00800436|16797565|P6|Overall Study|Withdrawal by Subject|0
4874231|NCT00800436|16797566|P5|Overall Study|Withdrawal by Subject|0
4874232|NCT00800436|16797567|P4|Overall Study|Withdrawal by Subject|1
4874233|NCT00800436|16797568|P3|Overall Study|Withdrawal by Subject|1
4874234|NCT00800436|16797569|P2|Overall Study|Withdrawal by Subject|0
4874235|NCT00800436|16797570|P1|Overall Study|Withdrawal by Subject|0
4874236|NCT00800384|16797616|P2|Overall Study|Lost to Follow-up|26
4874237|NCT00800384|16797617|P1|Overall Study|Lost to Follow-up|17
4874238|NCT00800384|16797616|P2|Overall Study|Withdrawal by Subject|17
4874239|NCT00800384|16797617|P1|Overall Study|Withdrawal by Subject|24
4874240|NCT00800202|16797655|P2|Overall Study|Disease Progression|18
4874241|NCT00800202|16797656|P1|Overall Study|Disease Progression|54
4874242|NCT00800202|16797655|P2|Overall Study|Other|0
4874243|NCT00800202|16797656|P1|Overall Study|Other|5
4874244|NCT00800202|16797655|P2|Overall Study|Death|0
4874245|NCT00800202|16797656|P1|Overall Study|Death|1
4874246|NCT00800202|16797655|P2|Overall Study|Adverse Event|6
4874247|NCT00800202|16797656|P1|Overall Study|Adverse Event|7
4874248|NCT00799903|16797676|P2|Overall Study|Lost to Follow-up|80
4874249|NCT00799903|16797677|P1|Overall Study|Lost to Follow-up|69
4874250|NCT00799903|16797676|P2|Overall Study|Withdrawal by Subject|175
4874251|NCT00799903|16797677|P1|Overall Study|Withdrawal by Subject|179
4874252|NCT00799903|16797676|P2|Overall Study|Investigator Site Closed|23
4874253|NCT00799903|16797677|P1|Overall Study|Investigator Site Closed|25
4874254|NCT00799825|16797697|P1|Overall Study|Pregnancy|3
4874255|NCT00799825|16797697|P1|Overall Study|Lost to Follow-up|38
4874256|NCT00799825|16797697|P1|Overall Study|Withdrawal by Subject|6
4874257|NCT00799825|16797697|P1|Overall Study|Adverse Event|1
4874258|NCT00799708|16797737|P3|Overall Study|non-compliance|0
4874259|NCT00799708|16797738|P2|Overall Study|non-compliance|0
4874260|NCT00799708|16797739|P1|Overall Study|non-compliance|1
4874261|NCT00799617|16797762|P2|Anemia Trial|Withdrawal by Subject|3
4874262|NCT00799617|16797763|P1|Anemia Trial|Withdrawal by Subject|3
4874263|NCT00799617|16797762|P2|Cognitive Function Trial|Lost to Follow-up|1
4874264|NCT00799617|16797763|P1|Cognitive Function Trial|Lost to Follow-up|0
4874265|NCT00799617|16797762|P2|Bone Trial|Month 12 scan not available|16
4874266|NCT00799617|16797763|P1|Bone Trial|Month 12 scan not available|6
4874267|NCT00799617|16797762|P2|Cardiovascular Trial|Baseline scan not analyzable|2
4874268|NCT00799617|16797763|P1|Cardiovascular Trial|Baseline scan not analyzable|0
4874269|NCT00799617|16797762|P2|Cardiovascular Trial|Month 12 scan not available|15
4874270|NCT00799617|16797763|P1|Cardiovascular Trial|Month 12 scan not available|15
4874271|NCT00799617|16797762|P2|Vitality Trial|Lost to Follow-up|22
4874272|NCT00799617|16797763|P1|Vitality Trial|Lost to Follow-up|7
4874273|NCT00799617|16797762|P2|Physical Function Trial|Lost to Follow-up|11
4874274|NCT00799617|16797763|P1|Physical Function Trial|Lost to Follow-up|6
4874275|NCT00799617|16797762|P2|Sexual Funtion Trial|No Baseline Data|7
4874276|NCT00799617|16797763|P1|Sexual Funtion Trial|No Baseline Data|4
4874277|NCT00799617|16797762|P2|Sexual Funtion Trial|Lost to Follow-up|14
4874278|NCT00799617|16797763|P1|Sexual Funtion Trial|Lost to Follow-up|12
4874279|NCT00799617|16797762|P2|Main Testosterone Trial|Lost to Follow-up|20
4874280|NCT00799617|16797763|P1|Main Testosterone Trial|Lost to Follow-up|18
4874281|NCT00799617|16797762|P2|Main Testosterone Trial|Randomized in error|1
4874282|NCT00799617|16797763|P1|Main Testosterone Trial|Randomized in error|1
4874283|NCT00799591|16797870|P1|Overall Study|Infectious origin not probable|1
4874284|NCT00799591|16797870|P1|Overall Study|Antibiotic changed, no apparent reason|1
4874285|NCT00799591|16797870|P1|Overall Study|Persistance of fever undetermined origin|1
4874286|NCT00799591|16797870|P1|Overall Study|Resistance germ and technical failure|2
4874287|NCT00799591|16797870|P1|Overall Study|New infection|4
4874288|NCT00799591|16797870|P1|Overall Study|Resistant germ|11
4874289|NCT00799591|16797870|P1|Overall Study|Technical failure|12
4874290|NCT00799591|16797870|P1|Overall Study|Death|14
4874291|NCT00799591|16797870|P1|Overall Study|De-escalation of doses|20
4874292|NCT00799487|16797888|P3|Double-Blind Assessment Period|Overslept and missed lab day 2|0
4874293|NCT00799487|16797889|P2|Double-Blind Assessment Period|Overslept and missed lab day 2|1
4874294|NCT00799487|16797890|P1|Double-Blind Assessment Period|Overslept and missed lab day 2|0
4874295|NCT00799487|16797888|P3|Double-Blind Assessment Period|Subject was out of the state|1
4874296|NCT00799487|16797889|P2|Double-Blind Assessment Period|Subject was out of the state|0
4874297|NCT00799487|16797890|P1|Double-Blind Assessment Period|Subject was out of the state|0
4874298|NCT00799487|16797888|P3|Double-Blind Assessment Period|Lost to Follow-up|1
4874299|NCT00799487|16797889|P2|Double-Blind Assessment Period|Lost to Follow-up|0
4874300|NCT00799487|16797890|P1|Double-Blind Assessment Period|Lost to Follow-up|0
4874301|NCT00799487|16797888|P3|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
4874302|NCT00799487|16797889|P2|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0
4874303|NCT00799487|16797890|P1|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2
4874304|NCT00799487|16797888|P3|Dose Adjustment Period|Missed laboratory day 1|0
4874305|NCT00799487|16797889|P2|Dose Adjustment Period|Missed laboratory day 1|0
4874306|NCT00799487|16797890|P1|Dose Adjustment Period|Missed laboratory day 1|1
4874307|NCT00799487|16797888|P3|Dose Adjustment Period|Child too young (exclusion)|0
4874308|NCT00799487|16797889|P2|Dose Adjustment Period|Child too young (exclusion)|0
4874309|NCT00799487|16797890|P1|Dose Adjustment Period|Child too young (exclusion)|1
4874310|NCT00799487|16797888|P3|Dose Adjustment Period|Parent to home school child (exclusion)|0
4874311|NCT00799487|16797889|P2|Dose Adjustment Period|Parent to home school child (exclusion)|0
4874312|NCT00799487|16797890|P1|Dose Adjustment Period|Parent to home school child (exclusion)|1
4874313|NCT00799487|16797888|P3|Dose Adjustment Period|Withdrawal by Subject|0
4874314|NCT00799487|16797889|P2|Dose Adjustment Period|Withdrawal by Subject|0
4874315|NCT00799487|16797890|P1|Dose Adjustment Period|Withdrawal by Subject|3
4874316|NCT00799487|16797888|P3|Dose Adjustment Period|Investigator Discretion|0
4874317|NCT00799487|16797889|P2|Dose Adjustment Period|Investigator Discretion|0
4874318|NCT00799487|16797890|P1|Dose Adjustment Period|Investigator Discretion|2
4874319|NCT00799487|16797888|P3|Dose Adjustment Period|Optimal Dose Not Achieved|0
4874320|NCT00799487|16797889|P2|Dose Adjustment Period|Optimal Dose Not Achieved|0
4874321|NCT00799487|16797890|P1|Dose Adjustment Period|Optimal Dose Not Achieved|8
4874322|NCT00799487|16797888|P3|Dose Adjustment Period|Adverse Event|0
4874323|NCT00799487|16797889|P2|Dose Adjustment Period|Adverse Event|0
4874324|NCT00799487|16797890|P1|Dose Adjustment Period|Adverse Event|2
4874325|NCT00799487|16797888|P3|Dose Adjustment Period|Lost to Follow-up|0
4874326|NCT00799487|16797889|P2|Dose Adjustment Period|Lost to Follow-up|0
4874327|NCT00799487|16797890|P1|Dose Adjustment Period|Lost to Follow-up|1
4874328|NCT00799422|16797987|P6|First Week of Wear|Adverse Event|0
4874329|NCT00799422|16797988|P5|First Week of Wear|Adverse Event|0
4874330|NCT00799422|16797989|P4|First Week of Wear|Adverse Event|1
4874331|NCT00799422|16797990|P3|First Week of Wear|Adverse Event|0
4874332|NCT00799422|16797991|P2|First Week of Wear|Adverse Event|0
4874333|NCT00799422|16797992|P1|First Week of Wear|Adverse Event|0
4874334|NCT00799422|16797987|P6|First Week of Wear|Lost to Follow-up|0
4874335|NCT00799422|16797988|P5|First Week of Wear|Lost to Follow-up|0
4874336|NCT00799422|16797989|P4|First Week of Wear|Lost to Follow-up|0
4874337|NCT00799422|16797990|P3|First Week of Wear|Lost to Follow-up|1
4874338|NCT00799422|16797991|P2|First Week of Wear|Lost to Follow-up|0
4874339|NCT00799422|16797992|P1|First Week of Wear|Lost to Follow-up|0
4874340|NCT00799409|16798009|P3|Overall Study|medication compliance|0
4874341|NCT00799409|16798010|P2|Overall Study|medication compliance|0
4874342|NCT00799409|16798011|P1|Overall Study|medication compliance|1
4874343|NCT00799409|16798009|P3|Overall Study|Did not attend lab school day 1|0
4874344|NCT00799409|16798010|P2|Overall Study|Did not attend lab school day 1|0
4874345|NCT00799409|16798011|P1|Overall Study|Did not attend lab school day 1|1
4874346|NCT00799409|16798009|P3|Overall Study|Failure to follow study protocol)|0
4874347|NCT00799409|16798010|P2|Overall Study|Failure to follow study protocol)|0
4874348|NCT00799409|16798011|P1|Overall Study|Failure to follow study protocol)|1
4874349|NCT00799409|16798009|P3|Overall Study|Optimal Dose Not Achieved|0
4874350|NCT00799409|16798010|P2|Overall Study|Optimal Dose Not Achieved|0
4874351|NCT00799409|16798011|P1|Overall Study|Optimal Dose Not Achieved|2
4874352|NCT00799409|16798009|P3|Overall Study|Lost to Follow-up|0
4874353|NCT00799409|16798010|P2|Overall Study|Lost to Follow-up|0
4874354|NCT00799409|16798011|P1|Overall Study|Lost to Follow-up|1
4874355|NCT00799409|16798009|P3|Overall Study|Withdrawal by Subject|0
4874356|NCT00799409|16798010|P2|Overall Study|Withdrawal by Subject|0
4874357|NCT00799409|16798011|P1|Overall Study|Withdrawal by Subject|1
4874358|NCT00799396|16798091|P1|Clopidogrel Plus Aspirin|Physician Decision|4
4874359|NCT00799396|16798091|P1|Clopidogrel Plus Aspirin|Adverse Event|2
4874360|NCT00799396|16798091|P1|Clopidogrel Treatment|Withdrawal by Subject|2
4874361|NCT00799396|16798091|P1|Clopidogrel Treatment|Physician Decision|5
4874362|NCT00799396|16798091|P1|Clopidogrel Treatment|Adverse Event|6
4874363|NCT00799383|16798098|P2|Overall Study|Withdrawal by Subject|1
4874364|NCT00799383|16798099|P1|Overall Study|Withdrawal by Subject|0
4874365|NCT00799383|16798098|P2|Overall Study|Urinary Calcium/Creatinine > 0.2|1
4874366|NCT00799383|16798099|P1|Overall Study|Urinary Calcium/Creatinine > 0.2|1
4874367|NCT00799383|16798098|P2|Overall Study|Lost to Follow-up|2
4874368|NCT00799383|16798099|P1|Overall Study|Lost to Follow-up|1
4874369|NCT00799383|16798098|P2|Overall Study|Adverse Event|1
4874370|NCT00799383|16798099|P1|Overall Study|Adverse Event|0
4874371|NCT00799383|16798098|P2|Overall Study|Protocol Violation|1
4874372|NCT00799383|16798099|P1|Overall Study|Protocol Violation|1
4874373|NCT00799266|16798128|P2|Overall Study|Subject withdrew consent|0
4874374|NCT00799266|16798129|P1|Overall Study|Subject withdrew consent|3
4874375|NCT00799266|16798128|P2|Overall Study|Adverse Event|1
4874376|NCT00799266|16798129|P1|Overall Study|Adverse Event|0
4874377|NCT00798967|16798169|P2|Overall Study|Randomized in error by site|0
4874378|NCT00798967|16798170|P1|Overall Study|Randomized in error by site|1
4874379|NCT00798967|16798169|P2|Overall Study|Physician Decision|0
4874380|NCT00798967|16798170|P1|Overall Study|Physician Decision|1
4874381|NCT00798967|16798169|P2|Overall Study|Withdrawal by Subject|1
4874382|NCT00798967|16798170|P1|Overall Study|Withdrawal by Subject|0
4874383|NCT00798967|16798169|P2|Overall Study|Adverse Event|3
4874384|NCT00798967|16798170|P1|Overall Study|Adverse Event|2
4874385|NCT00798889|16798178|P1|Overall Study|Enrolled, Not treated|3
4874386|NCT00798889|16798178|P1|Overall Study|Decision of Sponsor|11
4874387|NCT00798889|16798178|P1|Overall Study|Lack of Efficacy|213
4874388|NCT00798889|16798178|P1|Overall Study|Lost to Follow-up|1
4874389|NCT00798889|16798178|P1|Overall Study|Withdrawal by Subject|31
4874390|NCT00798889|16798178|P1|Overall Study|Protocol Violation|2
4874391|NCT00798889|16798178|P1|Overall Study|Adverse Event|53
4874392|NCT00798759|16798184|P2|Overall Study|Other|1
4874393|NCT00798759|16798185|P1|Overall Study|Other|0
4874394|NCT00798759|16798184|P2|Overall Study|Protocol Violation|8
4874395|NCT00798759|16798185|P1|Overall Study|Protocol Violation|4
4874396|NCT00798759|16798184|P2|Overall Study|Lost to Follow-up|1
4874397|NCT00798759|16798185|P1|Overall Study|Lost to Follow-up|1
4874398|NCT00798759|16798184|P2|Overall Study|Adverse Event|3
4874399|NCT00798759|16798185|P1|Overall Study|Adverse Event|3
4874400|NCT00798707|16798203|P3|Overall Study|Randomized not treated|1
4874401|NCT00798707|16798204|P2|Overall Study|Randomized not treated|5
4874402|NCT00798707|16798205|P1|Overall Study|Randomized not treated|4
4874403|NCT00798707|16798203|P3|Overall Study|Withdrawal by Subject|2
4874404|NCT00798707|16798204|P2|Overall Study|Withdrawal by Subject|8
4874405|NCT00798707|16798205|P1|Overall Study|Withdrawal by Subject|3
4874406|NCT00798707|16798203|P3|Overall Study|Protocol Violation|2
4874407|NCT00798707|16798204|P2|Overall Study|Protocol Violation|0
4874408|NCT00798707|16798205|P1|Overall Study|Protocol Violation|4
4874409|NCT00798707|16798203|P3|Overall Study|Other|0
4874410|NCT00798707|16798204|P2|Overall Study|Other|1
4874411|NCT00798707|16798205|P1|Overall Study|Other|0
4874412|NCT00798707|16798203|P3|Overall Study|Lost to Follow-up|6
4874413|NCT00798707|16798204|P2|Overall Study|Lost to Follow-up|6
4874414|NCT00798707|16798205|P1|Overall Study|Lost to Follow-up|5
4874415|NCT00798707|16798203|P3|Overall Study|Lack of Efficacy|1
4874416|NCT00798707|16798204|P2|Overall Study|Lack of Efficacy|2
4874417|NCT00798707|16798205|P1|Overall Study|Lack of Efficacy|2
4874418|NCT00798707|16798203|P3|Overall Study|Investigator|2
4874419|NCT00798707|16798204|P2|Overall Study|Investigator|1
4874420|NCT00798707|16798205|P1|Overall Study|Investigator|0
4874421|NCT00798707|16798203|P3|Overall Study|Failed to return|0
4874422|NCT00798707|16798204|P2|Overall Study|Failed to return|2
4874423|NCT00798707|16798205|P1|Overall Study|Failed to return|2
4874424|NCT00798707|16798203|P3|Overall Study|Adverse Event|8
4874425|NCT00798707|16798204|P2|Overall Study|Adverse Event|8
4874426|NCT00798707|16798205|P1|Overall Study|Adverse Event|6
4874427|NCT00798694|16798257|P2|Overall Study|Physician Decision|0
4874428|NCT00798694|16798258|P1|Overall Study|Physician Decision|1
4874429|NCT00798694|16798257|P2|Overall Study|Lost to Follow-up|1
4874430|NCT00798694|16798258|P1|Overall Study|Lost to Follow-up|1
4874431|NCT00798655|16798282|P1|Overall Study|Did not receive at least one dose of pan|2
4874432|NCT00798603|16798287|P1|Overall Study|Lack of insurance coverage|1
4874433|NCT00798603|16798287|P1|Overall Study|Physician Decision|1
4874434|NCT00798603|16798287|P1|Overall Study|Adverse Event|22
4874435|NCT00798603|16798287|P1|Overall Study|Withdrawal by Subject|10
4874436|NCT00798603|16798287|P1|Overall Study|Still on treatment as of 11/6/2012|1
4874437|NCT00798590|16798309|P2|Overall Study|P.I, Left institution. Study terminated|8
4874438|NCT00798590|16798310|P1|Overall Study|P.I, Left institution. Study terminated|11
4874439|NCT00798434|16798344|P2|Open-Label|Not Treated|1
4874440|NCT00798434|16798345|P1|Open-Label|Not Treated|0
4874441|NCT00798434|16798344|P2|Open-Label|Other|2
4874442|NCT00798434|16798345|P1|Open-Label|Other|1
4874443|NCT00798434|16798344|P2|Open-Label|Protocol Violation|0
4874444|NCT00798434|16798345|P1|Open-Label|Protocol Violation|1
4874445|NCT00798434|16798344|P2|Open-Label|Withdrawal by Subject|7
4874446|NCT00798434|16798345|P1|Open-Label|Withdrawal by Subject|2
4874447|NCT00798434|16798344|P2|Open-Label|Lack of Efficacy|11
4874448|NCT00798434|16798345|P1|Open-Label|Lack of Efficacy|5
4874449|NCT00798434|16798344|P2|Open-Label|Adverse Event|11
4874450|NCT00798434|16798345|P1|Open-Label|Adverse Event|33
4874451|NCT00798434|16798344|P2|Double-Blind|Not Treated|6
4874452|NCT00798434|16798345|P1|Double-Blind|Not Treated|3
4874453|NCT00798434|16798344|P2|Double-Blind|Other|0
4874454|NCT00798434|16798345|P1|Double-Blind|Other|1
4874455|NCT00798434|16798344|P2|Double-Blind|Did Not Meet Entrance Criteria|1
4874456|NCT00798434|16798345|P1|Double-Blind|Did Not Meet Entrance Criteria|2
4874457|NCT00798434|16798344|P2|Double-Blind|Protocol Violation|4
4874458|NCT00798434|16798345|P1|Double-Blind|Protocol Violation|1
4874459|NCT00798434|16798344|P2|Double-Blind|Withdrawal by Subject|14
4874460|NCT00798434|16798345|P1|Double-Blind|Withdrawal by Subject|17
4874461|NCT00798434|16798344|P2|Double-Blind|Lack of Efficacy|12
4874462|NCT00798434|16798345|P1|Double-Blind|Lack of Efficacy|8
4874463|NCT00798434|16798344|P2|Double-Blind|Lost to Follow-up|0
4874464|NCT00798434|16798345|P1|Double-Blind|Lost to Follow-up|1
4874465|NCT00798434|16798344|P2|Double-Blind|Death|1
4874466|NCT00798434|16798345|P1|Double-Blind|Death|0
4874467|NCT00798434|16798344|P2|Double-Blind|Adverse Event|46
4874468|NCT00798434|16798345|P1|Double-Blind|Adverse Event|22
4874469|NCT00798369|16798431|P6|Overall Study|Adminstrative problems|1
4874470|NCT00798369|16798432|P5|Overall Study|Adminstrative problems|0
4874471|NCT00798369|16798433|P4|Overall Study|Adminstrative problems|0
4874472|NCT00798369|16798434|P3|Overall Study|Adminstrative problems|0
4874473|NCT00798369|16798435|P2|Overall Study|Adminstrative problems|0
4874474|NCT00798369|16798436|P1|Overall Study|Adminstrative problems|0
4874475|NCT00798369|16798431|P6|Overall Study|Lost to Follow-up|0
4874476|NCT00798369|16798432|P5|Overall Study|Lost to Follow-up|1
4874477|NCT00798369|16798433|P4|Overall Study|Lost to Follow-up|0
4874478|NCT00798369|16798434|P3|Overall Study|Lost to Follow-up|1
4874479|NCT00798369|16798435|P2|Overall Study|Lost to Follow-up|1
4874480|NCT00798369|16798436|P1|Overall Study|Lost to Follow-up|1
4874481|NCT00798369|16798431|P6|Overall Study|Subject withdrew consent|2
4874482|NCT00798369|16798432|P5|Overall Study|Subject withdrew consent|0
4874483|NCT00798369|16798433|P4|Overall Study|Subject withdrew consent|1
4874484|NCT00798369|16798434|P3|Overall Study|Subject withdrew consent|1
4874485|NCT00798369|16798435|P2|Overall Study|Subject withdrew consent|0
4874486|NCT00798369|16798436|P1|Overall Study|Subject withdrew consent|0
4874487|NCT00798317|16798483|P2|Overall Study|Death|0
4874488|NCT00798317|16798484|P1|Overall Study|Death|1
4874489|NCT00798317|16798483|P2|Overall Study|Adverse Event|0
4874490|NCT00798317|16798484|P1|Overall Study|Adverse Event|2
4874491|NCT00798317|16798483|P2|Overall Study|Lost to Follow-up|2
4874492|NCT00798317|16798484|P1|Overall Study|Lost to Follow-up|2
4874493|NCT00798317|16798483|P2|Overall Study|Withdrawal by Subject|4
4874494|NCT00798317|16798484|P1|Overall Study|Withdrawal by Subject|5
4874495|NCT00798317|16798483|P2|Overall Study|Physician Decision|1
4874496|NCT00798317|16798484|P1|Overall Study|Physician Decision|0
4874497|NCT00798304|16798495|P3|Overall Study|Discontinuation by Sponsor|9
4874498|NCT00798304|16798496|P2|Overall Study|Discontinuation by Sponsor|21
4874499|NCT00798304|16798497|P1|Overall Study|Discontinuation by Sponsor|14
4874500|NCT00798304|16798495|P3|Overall Study|Adverse Event|1
4874501|NCT00798304|16798496|P2|Overall Study|Adverse Event|1
4874502|NCT00798304|16798497|P1|Overall Study|Adverse Event|0
4874503|NCT00798174|16798523|P2|Overall Study|Inability to sedate for DFT testing|0
4874504|NCT00798174|16798524|P1|Overall Study|Inability to sedate for DFT testing|1
4874505|NCT00798174|16798523|P2|Overall Study|inability to implant azygos coil|3
4874506|NCT00798174|16798524|P1|Overall Study|inability to implant azygos coil|3
4874507|NCT00798161|16798535|P7|Overall Study|Other reason (incl. lack of efficacy)|5
4874508|NCT00798161|16798536|P6|Overall Study|Other reason (incl. lack of efficacy)|4
4874509|NCT00798161|16798537|P5|Overall Study|Other reason (incl. lack of efficacy)|2
4874510|NCT00798161|16798538|P4|Overall Study|Other reason (incl. lack of efficacy)|5
4874511|NCT00798161|16798539|P3|Overall Study|Other reason (incl. lack of efficacy)|3
4874512|NCT00798161|16798540|P2|Overall Study|Other reason (incl. lack of efficacy)|5
4874513|NCT00798161|16798541|P1|Overall Study|Other reason (incl. lack of efficacy)|7
4874514|NCT00798161|16798535|P7|Overall Study|Withdrawal by Subject|1
4874515|NCT00798161|16798536|P6|Overall Study|Withdrawal by Subject|3
4874516|NCT00798161|16798537|P5|Overall Study|Withdrawal by Subject|2
4874517|NCT00798161|16798538|P4|Overall Study|Withdrawal by Subject|4
4874518|NCT00798161|16798539|P3|Overall Study|Withdrawal by Subject|5
4874519|NCT00798161|16798540|P2|Overall Study|Withdrawal by Subject|4
4874520|NCT00798161|16798541|P1|Overall Study|Withdrawal by Subject|5
4874521|NCT00798161|16798535|P7|Overall Study|Lost to Follow-up|0
4874522|NCT00798161|16798536|P6|Overall Study|Lost to Follow-up|0
4874523|NCT00798161|16798537|P5|Overall Study|Lost to Follow-up|4
4874524|NCT00798161|16798538|P4|Overall Study|Lost to Follow-up|3
4874525|NCT00798161|16798539|P3|Overall Study|Lost to Follow-up|4
4874526|NCT00798161|16798540|P2|Overall Study|Lost to Follow-up|3
4874527|NCT00798161|16798541|P1|Overall Study|Lost to Follow-up|1
4874528|NCT00798161|16798535|P7|Overall Study|Protocol Violation|0
4874529|NCT00798161|16798536|P6|Overall Study|Protocol Violation|2
4874530|NCT00798161|16798537|P5|Overall Study|Protocol Violation|3
4874531|NCT00798161|16798538|P4|Overall Study|Protocol Violation|3
4874532|NCT00798161|16798539|P3|Overall Study|Protocol Violation|3
4874533|NCT00798161|16798540|P2|Overall Study|Protocol Violation|1
4874534|NCT00798161|16798541|P1|Overall Study|Protocol Violation|2
4874535|NCT00798161|16798535|P7|Overall Study|Adverse Event|4
4874536|NCT00798161|16798536|P6|Overall Study|Adverse Event|2
4874537|NCT00798161|16798537|P5|Overall Study|Adverse Event|5
4874538|NCT00798161|16798538|P4|Overall Study|Adverse Event|6
4874539|NCT00798161|16798539|P3|Overall Study|Adverse Event|6
4874540|NCT00798161|16798540|P2|Overall Study|Adverse Event|4
4874541|NCT00798161|16798541|P1|Overall Study|Adverse Event|3
4874542|NCT00798135|16798648|P1|Overall Study|Physician Decision|1
4874543|NCT00798135|16798648|P1|Overall Study|Disease progression, refractory|1
4874544|NCT00798135|16798648|P1|Overall Study|Disease progression, relapse|11
4874545|NCT00798096|16798654|P1|Overall Study|Ongoing|2
4874546|NCT00797966|16798682|P6|Phase A+|Protocol deviation|4
4874547|NCT00797966|16798683|P5|Phase A+|Protocol deviation|0
4874548|NCT00797966|16798684|P4|Phase A+|Protocol deviation|0
4874549|NCT00797966|16798685|P3|Phase A+|Protocol deviation|0
4874550|NCT00797966|16798686|P2|Phase A+|Protocol deviation|0
4874551|NCT00797966|16798687|P1|Phase A+|Protocol deviation|0
4874552|NCT00797966|16798682|P6|Phase A+|Adverse Event|4
4874553|NCT00797966|16798683|P5|Phase A+|Adverse Event|0
4874554|NCT00797966|16798684|P4|Phase A+|Adverse Event|0
4874555|NCT00797966|16798685|P3|Phase A+|Adverse Event|0
4874556|NCT00797966|16798686|P2|Phase A+|Adverse Event|0
4874557|NCT00797966|16798687|P1|Phase A+|Adverse Event|0
4874558|NCT00797966|16798682|P6|Phase A+|Withdrawal by Subject|6
4874559|NCT00797966|16798683|P5|Phase A+|Withdrawal by Subject|0
4874560|NCT00797966|16798684|P4|Phase A+|Withdrawal by Subject|0
4874561|NCT00797966|16798685|P3|Phase A+|Withdrawal by Subject|0
4874562|NCT00797966|16798686|P2|Phase A+|Withdrawal by Subject|0
4874563|NCT00797966|16798687|P1|Phase A+|Withdrawal by Subject|0
4874564|NCT00797966|16798682|P6|Phase A+|Met withdrawal criteria|5
4874565|NCT00797966|16798683|P5|Phase A+|Met withdrawal criteria|0
4874566|NCT00797966|16798684|P4|Phase A+|Met withdrawal criteria|0
4874567|NCT00797966|16798685|P3|Phase A+|Met withdrawal criteria|0
4874568|NCT00797966|16798686|P2|Phase A+|Met withdrawal criteria|0
4874569|NCT00797966|16798687|P1|Phase A+|Met withdrawal criteria|0
4874570|NCT00797966|16798682|P6|Phase A+|Lost to Follow-up|9
4874571|NCT00797966|16798683|P5|Phase A+|Lost to Follow-up|0
4874572|NCT00797966|16798684|P4|Phase A+|Lost to Follow-up|0
4874573|NCT00797966|16798685|P3|Phase A+|Lost to Follow-up|0
4874574|NCT00797966|16798686|P2|Phase A+|Lost to Follow-up|0
4874575|NCT00797966|16798687|P1|Phase A+|Lost to Follow-up|0
4874576|NCT00797966|16798682|P6|Phase B|Lack of Efficacy|0
4874577|NCT00797966|16798683|P5|Phase B|Lack of Efficacy|0
4874578|NCT00797966|16798684|P4|Phase B|Lack of Efficacy|4
4874579|NCT00797966|16798685|P3|Phase B|Lack of Efficacy|1
4874580|NCT00797966|16798686|P2|Phase B|Lack of Efficacy|1
4874581|NCT00797966|16798687|P1|Phase B|Lack of Efficacy|0
4874582|NCT00797966|16798682|P6|Phase B|Protocol Deviation|0
4874583|NCT00797966|16798683|P5|Phase B|Protocol Deviation|0
4874584|NCT00797966|16798684|P4|Phase B|Protocol Deviation|6
4874585|NCT00797966|16798685|P3|Phase B|Protocol Deviation|2
4874586|NCT00797966|16798686|P2|Phase B|Protocol Deviation|8
4874587|NCT00797966|16798687|P1|Phase B|Protocol Deviation|4
4874588|NCT00797966|16798682|P6|Phase B|Withdrawal by Subject|0
4874589|NCT00797966|16798683|P5|Phase B|Withdrawal by Subject|0
4874590|NCT00797966|16798684|P4|Phase B|Withdrawal by Subject|3
4874591|NCT00797966|16798685|P3|Phase B|Withdrawal by Subject|3
4874592|NCT00797966|16798686|P2|Phase B|Withdrawal by Subject|4
4874593|NCT00797966|16798687|P1|Phase B|Withdrawal by Subject|1
4874594|NCT00797966|16798682|P6|Phase B|Physician Decision|0
4874595|NCT00797966|16798683|P5|Phase B|Physician Decision|0
4874596|NCT00797966|16798684|P4|Phase B|Physician Decision|1
4874597|NCT00797966|16798685|P3|Phase B|Physician Decision|3
4874598|NCT00797966|16798686|P2|Phase B|Physician Decision|0
4874599|NCT00797966|16798687|P1|Phase B|Physician Decision|1
4874600|NCT00797966|16798682|P6|Phase B|Met Withdrawal Criteria|0
4874601|NCT00797966|16798683|P5|Phase B|Met Withdrawal Criteria|0
4874602|NCT00797966|16798684|P4|Phase B|Met Withdrawal Criteria|1
4874603|NCT00797966|16798685|P3|Phase B|Met Withdrawal Criteria|6
4874604|NCT00797966|16798686|P2|Phase B|Met Withdrawal Criteria|3
4874605|NCT00797966|16798687|P1|Phase B|Met Withdrawal Criteria|3
4874606|NCT00797966|16798682|P6|Phase B|Adverse Event|0
4874607|NCT00797966|16798683|P5|Phase B|Adverse Event|0
4874608|NCT00797966|16798684|P4|Phase B|Adverse Event|1
4874609|NCT00797966|16798685|P3|Phase B|Adverse Event|3
4874610|NCT00797966|16798686|P2|Phase B|Adverse Event|1
4874611|NCT00797966|16798687|P1|Phase B|Adverse Event|2
4874612|NCT00797966|16798682|P6|Phase B|Lost to Follow-up|0
4874613|NCT00797966|16798683|P5|Phase B|Lost to Follow-up|0
4874614|NCT00797966|16798684|P4|Phase B|Lost to Follow-up|0
4874615|NCT00797966|16798685|P3|Phase B|Lost to Follow-up|3
4874616|NCT00797966|16798686|P2|Phase B|Lost to Follow-up|1
4874617|NCT00797966|16798687|P1|Phase B|Lost to Follow-up|0
4874618|NCT00797966|16798682|P6|Phase A|Protocol deviation|0
4874619|NCT00797966|16798683|P5|Phase A|Protocol deviation|56
4874620|NCT00797966|16798684|P4|Phase A|Protocol deviation|0
4874621|NCT00797966|16798685|P3|Phase A|Protocol deviation|0
4874622|NCT00797966|16798686|P2|Phase A|Protocol deviation|0
4874623|NCT00797966|16798687|P1|Phase A|Protocol deviation|0
4874624|NCT00797966|16798682|P6|Phase A|Withdrawal by Subject|0
4874625|NCT00797966|16798683|P5|Phase A|Withdrawal by Subject|33
4874626|NCT00797966|16798684|P4|Phase A|Withdrawal by Subject|0
4874627|NCT00797966|16798685|P3|Phase A|Withdrawal by Subject|0
4874628|NCT00797966|16798686|P2|Phase A|Withdrawal by Subject|0
4874629|NCT00797966|16798687|P1|Phase A|Withdrawal by Subject|0
4874630|NCT00797966|16798682|P6|Phase A|Physician Decision|0
4874631|NCT00797966|16798683|P5|Phase A|Physician Decision|13
4874632|NCT00797966|16798684|P4|Phase A|Physician Decision|0
4874633|NCT00797966|16798685|P3|Phase A|Physician Decision|0
4874634|NCT00797966|16798686|P2|Phase A|Physician Decision|0
4874635|NCT00797966|16798687|P1|Phase A|Physician Decision|0
4874636|NCT00797966|16798682|P6|Phase A|Met withdrawal criteria|0
4874637|NCT00797966|16798683|P5|Phase A|Met withdrawal criteria|4
4874638|NCT00797966|16798684|P4|Phase A|Met withdrawal criteria|0
4874639|NCT00797966|16798685|P3|Phase A|Met withdrawal criteria|0
4874640|NCT00797966|16798686|P2|Phase A|Met withdrawal criteria|0
4874641|NCT00797966|16798687|P1|Phase A|Met withdrawal criteria|0
4874642|NCT00797966|16798682|P6|Phase A|Adverse Event|0
4874643|NCT00797966|16798683|P5|Phase A|Adverse Event|46
4874644|NCT00797966|16798684|P4|Phase A|Adverse Event|0
4874645|NCT00797966|16798685|P3|Phase A|Adverse Event|0
4874646|NCT00797966|16798686|P2|Phase A|Adverse Event|0
4874647|NCT00797966|16798687|P1|Phase A|Adverse Event|0
4874648|NCT00797966|16798682|P6|Phase A|Lost to Follow-up|0
4874649|NCT00797966|16798683|P5|Phase A|Lost to Follow-up|33
4874650|NCT00797966|16798684|P4|Phase A|Lost to Follow-up|0
4874651|NCT00797966|16798685|P3|Phase A|Lost to Follow-up|0
4874652|NCT00797966|16798686|P2|Phase A|Lost to Follow-up|0
4874653|NCT00797966|16798687|P1|Phase A|Lost to Follow-up|0
4874654|NCT00797862|16798752|P3|Overall Study|Mis-randomized|1
4874655|NCT00797862|16798753|P2|Overall Study|Mis-randomized|3
4874656|NCT00797862|16798754|P1|Overall Study|Mis-randomized|3
4874657|NCT00797862|16798752|P3|Overall Study|Protocol Violation|8
4874658|NCT00797862|16798753|P2|Overall Study|Protocol Violation|6
4874659|NCT00797862|16798754|P1|Overall Study|Protocol Violation|4
4874660|NCT00797862|16798752|P3|Overall Study|Administrative Problem|0
4874661|NCT00797862|16798753|P2|Overall Study|Administrative Problem|0
4874662|NCT00797862|16798754|P1|Overall Study|Administrative Problem|4
4874663|NCT00797862|16798752|P3|Overall Study|Lost to Follow-up|5
4874664|NCT00797862|16798753|P2|Overall Study|Lost to Follow-up|0
4874665|NCT00797862|16798754|P1|Overall Study|Lost to Follow-up|11
4874666|NCT00797862|16798752|P3|Overall Study|Withdrawal by Subject|7
4874667|NCT00797862|16798753|P2|Overall Study|Withdrawal by Subject|7
4874668|NCT00797862|16798754|P1|Overall Study|Withdrawal by Subject|14
4874669|NCT00797862|16798752|P3|Overall Study|No longer required study medication|0
4874670|NCT00797862|16798753|P2|Overall Study|No longer required study medication|0
4874671|NCT00797862|16798754|P1|Overall Study|No longer required study medication|1
4874672|NCT00797862|16798752|P3|Overall Study|Lack of Efficacy|6
4874673|NCT00797862|16798753|P2|Overall Study|Lack of Efficacy|7
4874674|NCT00797862|16798754|P1|Overall Study|Lack of Efficacy|1
4874675|NCT00797862|16798752|P3|Overall Study|Abnormal Test Procedure Result|1
4874676|NCT00797862|16798753|P2|Overall Study|Abnormal Test Procedure Result|1
4874677|NCT00797862|16798754|P1|Overall Study|Abnormal Test Procedure Result|0
4874678|NCT00797862|16798752|P3|Overall Study|Adverse Event|58
4874679|NCT00797862|16798753|P2|Overall Study|Adverse Event|44
4874680|NCT00797862|16798754|P1|Overall Study|Adverse Event|86
4874681|NCT00797823|16798783|P3|First Period (Initial Randomization)|Physician Decision|0
4874682|NCT00797823|16798784|P2|First Period (Initial Randomization)|Physician Decision|0
4874683|NCT00797823|16798785|P1|First Period (Initial Randomization)|Physician Decision|1
4874684|NCT00797732|16798807|P3|Overall Study|Refused to Participate|123
4874685|NCT00797732|16798808|P2|Overall Study|Refused to Participate|0
4874686|NCT00797732|16798809|P1|Overall Study|Refused to Participate|0
4874687|NCT00797732|16798807|P3|Overall Study|Excluded due to time constraints|24
4874688|NCT00797732|16798808|P2|Overall Study|Excluded due to time constraints|0
4874689|NCT00797732|16798809|P1|Overall Study|Excluded due to time constraints|0
4874690|NCT00797732|16798807|P3|Overall Study|Not meet inclusion criteria|7
4874691|NCT00797732|16798808|P2|Overall Study|Not meet inclusion criteria|0
4874692|NCT00797732|16798809|P1|Overall Study|Not meet inclusion criteria|0
4874693|NCT00797732|16798807|P3|Overall Study|Death|0
4874694|NCT00797732|16798808|P2|Overall Study|Death|0
4874695|NCT00797732|16798809|P1|Overall Study|Death|1
4874696|NCT00797732|16798807|P3|Overall Study|Lost to Follow-up|0
4874697|NCT00797732|16798808|P2|Overall Study|Lost to Follow-up|0
4874698|NCT00797732|16798809|P1|Overall Study|Lost to Follow-up|1
4874699|NCT00797732|16798807|P3|Overall Study|Withdrawal by Subject|0
4874700|NCT00797732|16798808|P2|Overall Study|Withdrawal by Subject|3
4874701|NCT00797732|16798809|P1|Overall Study|Withdrawal by Subject|3
4874702|NCT00797667|16798824|P3|Overall Study|Adverse Event|8
4874703|NCT00797667|16798825|P2|Overall Study|Adverse Event|8
4874704|NCT00797667|16798826|P1|Overall Study|Adverse Event|19
4874705|NCT00797667|16798824|P3|Overall Study|Withdrawal by Subject|2
4874706|NCT00797667|16798825|P2|Overall Study|Withdrawal by Subject|14
4874707|NCT00797667|16798826|P1|Overall Study|Withdrawal by Subject|9
4874708|NCT00797667|16798824|P3|Overall Study|Study Terminated by Sponsor|115
4874709|NCT00797667|16798825|P2|Overall Study|Study Terminated by Sponsor|216
4874710|NCT00797667|16798826|P1|Overall Study|Study Terminated by Sponsor|217
4874711|NCT00797667|16798824|P3|Overall Study|Protocol Violation|0
4874712|NCT00797667|16798825|P2|Overall Study|Protocol Violation|7
4874713|NCT00797667|16798826|P1|Overall Study|Protocol Violation|2
4874714|NCT00797667|16798824|P3|Overall Study|Pregnancy|0
4874715|NCT00797667|16798825|P2|Overall Study|Pregnancy|0
4874716|NCT00797667|16798826|P1|Overall Study|Pregnancy|2
4874717|NCT00797667|16798824|P3|Overall Study|Physician Decision|0
4874718|NCT00797667|16798825|P2|Overall Study|Physician Decision|1
4874719|NCT00797667|16798826|P1|Overall Study|Physician Decision|3
4874720|NCT00797667|16798824|P3|Overall Study|Lost to Follow-up|2
4874721|NCT00797667|16798825|P2|Overall Study|Lost to Follow-up|12
4874722|NCT00797667|16798826|P1|Overall Study|Lost to Follow-up|8
4874723|NCT00797667|16798824|P3|Overall Study|Lack of Efficacy|0
4874724|NCT00797667|16798825|P2|Overall Study|Lack of Efficacy|1
4874725|NCT00797667|16798826|P1|Overall Study|Lack of Efficacy|0
4874726|NCT00797563|16798852|P1|Overall Study|Adverse Event|1
4874727|NCT00797511|16798858|P1|Overall Study|Withdrawal by Subject|1
4874728|NCT00797316|16798876|P2|Overall Study|Unsatisfactory therapeutic effect|13
4874729|NCT00797316|16798877|P1|Overall Study|Unsatisfactory therapeutic effect|0
4874730|NCT00797316|16798876|P2|Overall Study|Patient withdrew consent|6
4874731|NCT00797316|16798877|P1|Overall Study|Patient withdrew consent|12
4874732|NCT00797316|16798876|P2|Overall Study|Protocol Deviation|2
4874733|NCT00797316|16798877|P1|Overall Study|Protocol Deviation|1
4874734|NCT00797316|16798876|P2|Overall Study|Lost to Follow-up|8
4874735|NCT00797316|16798877|P1|Overall Study|Lost to Follow-up|4
4874736|NCT00797316|16798876|P2|Overall Study|Adverse Event|3
4874737|NCT00797316|16798877|P1|Overall Study|Adverse Event|5
4874738|NCT00797316|16798876|P2|Overall Study|Administrative problems|0
4874739|NCT00797316|16798877|P1|Overall Study|Administrative problems|1
4874740|NCT00797225|16798906|P8|Weeks 13 to 24|Sponsor Decision|0
4874741|NCT00797225|16798907|P7|Weeks 13 to 24|Sponsor Decision|1
4874742|NCT00797225|16798908|P6|Weeks 13 to 24|Sponsor Decision|0
4874743|NCT00797225|16798909|P5|Weeks 13 to 24|Sponsor Decision|0
4874744|NCT00797225|16798910|P4|Weeks 13 to 24|Sponsor Decision|0
4874745|NCT00797225|16798911|P3|Weeks 13 to 24|Sponsor Decision|0
4874746|NCT00797225|16798912|P2|Weeks 13 to 24|Sponsor Decision|0
4874747|NCT00797225|16798913|P1|Weeks 13 to 24|Sponsor Decision|0
4874748|NCT00797225|16798906|P8|Weeks 13 to 24|Adverse Event|0
4874749|NCT00797225|16798907|P7|Weeks 13 to 24|Adverse Event|1
4874750|NCT00797225|16798908|P6|Weeks 13 to 24|Adverse Event|0
4874751|NCT00797225|16798909|P5|Weeks 13 to 24|Adverse Event|0
4874752|NCT00797225|16798910|P4|Weeks 13 to 24|Adverse Event|0
4874753|NCT00797225|16798911|P3|Weeks 13 to 24|Adverse Event|0
4874754|NCT00797225|16798912|P2|Weeks 13 to 24|Adverse Event|1
4874755|NCT00797225|16798913|P1|Weeks 13 to 24|Adverse Event|0
4874756|NCT00797225|16798906|P8|Weeks 13 to 24|Lost to Follow-up|0
4874757|NCT00797225|16798907|P7|Weeks 13 to 24|Lost to Follow-up|0
4874758|NCT00797225|16798908|P6|Weeks 13 to 24|Lost to Follow-up|0
4874759|NCT00797225|16798909|P5|Weeks 13 to 24|Lost to Follow-up|1
4874760|NCT00797225|16798910|P4|Weeks 13 to 24|Lost to Follow-up|0
4874761|NCT00797225|16798911|P3|Weeks 13 to 24|Lost to Follow-up|1
4874762|NCT00797225|16798912|P2|Weeks 13 to 24|Lost to Follow-up|0
4874763|NCT00797225|16798913|P1|Weeks 13 to 24|Lost to Follow-up|0
4874764|NCT00797225|16798906|P8|Weeks 13 to 24|Withdrawal by Subject|0
4874765|NCT00797225|16798907|P7|Weeks 13 to 24|Withdrawal by Subject|0
4874766|NCT00797225|16798908|P6|Weeks 13 to 24|Withdrawal by Subject|0
4874767|NCT00797225|16798909|P5|Weeks 13 to 24|Withdrawal by Subject|0
4874768|NCT00797225|16798910|P4|Weeks 13 to 24|Withdrawal by Subject|0
4874769|NCT00797225|16798911|P3|Weeks 13 to 24|Withdrawal by Subject|1
4874770|NCT00797225|16798912|P2|Weeks 13 to 24|Withdrawal by Subject|1
4874771|NCT00797225|16798913|P1|Weeks 13 to 24|Withdrawal by Subject|0
4874772|NCT00797225|16798906|P8|Weeks 13 to 24|Non-compliance|0
4874773|NCT00797225|16798907|P7|Weeks 13 to 24|Non-compliance|0
4874774|NCT00797225|16798908|P6|Weeks 13 to 24|Non-compliance|0
4874775|NCT00797225|16798909|P5|Weeks 13 to 24|Non-compliance|0
4874776|NCT00797225|16798910|P4|Weeks 13 to 24|Non-compliance|0
4874777|NCT00797225|16798911|P3|Weeks 13 to 24|Non-compliance|0
4874778|NCT00797225|16798912|P2|Weeks 13 to 24|Non-compliance|2
4874779|NCT00797225|16798913|P1|Weeks 13 to 24|Non-compliance|0
4874780|NCT00797225|16798906|P8|Weeks 1 to 12|Sponsor Decision|0
4874781|NCT00797225|16798907|P7|Weeks 1 to 12|Sponsor Decision|0
4874782|NCT00797225|16798908|P6|Weeks 1 to 12|Sponsor Decision|0
4874783|NCT00797225|16798909|P5|Weeks 1 to 12|Sponsor Decision|0
4874784|NCT00797225|16798910|P4|Weeks 1 to 12|Sponsor Decision|0
4874785|NCT00797225|16798911|P3|Weeks 1 to 12|Sponsor Decision|0
4874786|NCT00797225|16798912|P2|Weeks 1 to 12|Sponsor Decision|0
4874787|NCT00797225|16798913|P1|Weeks 1 to 12|Sponsor Decision|1
4874788|NCT00797225|16798906|P8|Weeks 1 to 12|Lack of Efficacy|0
4874789|NCT00797225|16798907|P7|Weeks 1 to 12|Lack of Efficacy|0
4874790|NCT00797225|16798908|P6|Weeks 1 to 12|Lack of Efficacy|0
4874791|NCT00797225|16798909|P5|Weeks 1 to 12|Lack of Efficacy|0
4874792|NCT00797225|16798910|P4|Weeks 1 to 12|Lack of Efficacy|0
4874793|NCT00797225|16798911|P3|Weeks 1 to 12|Lack of Efficacy|0
4874794|NCT00797225|16798912|P2|Weeks 1 to 12|Lack of Efficacy|0
4874795|NCT00797225|16798913|P1|Weeks 1 to 12|Lack of Efficacy|1
4874796|NCT00797225|16798906|P8|Weeks 1 to 12|Non-compliance|0
4874797|NCT00797225|16798907|P7|Weeks 1 to 12|Non-compliance|0
4874798|NCT00797225|16798908|P6|Weeks 1 to 12|Non-compliance|0
4874799|NCT00797225|16798909|P5|Weeks 1 to 12|Non-compliance|0
4874800|NCT00797225|16798910|P4|Weeks 1 to 12|Non-compliance|0
4874801|NCT00797225|16798911|P3|Weeks 1 to 12|Non-compliance|0
4874802|NCT00797225|16798912|P2|Weeks 1 to 12|Non-compliance|1
4874803|NCT00797225|16798913|P1|Weeks 1 to 12|Non-compliance|0
4874804|NCT00797225|16798906|P8|Weeks 1 to 12|Adverse Event|0
4874805|NCT00797225|16798907|P7|Weeks 1 to 12|Adverse Event|0
4874806|NCT00797225|16798908|P6|Weeks 1 to 12|Adverse Event|0
4874807|NCT00797225|16798909|P5|Weeks 1 to 12|Adverse Event|0
4874808|NCT00797225|16798910|P4|Weeks 1 to 12|Adverse Event|0
4874809|NCT00797225|16798911|P3|Weeks 1 to 12|Adverse Event|1
4874810|NCT00797225|16798912|P2|Weeks 1 to 12|Adverse Event|0
4874811|NCT00797225|16798913|P1|Weeks 1 to 12|Adverse Event|0
4874812|NCT00797108|16799030|P3|Overall Study|Randomized but not Treated|0
4874813|NCT00797108|16799031|P2|Overall Study|Randomized but not Treated|0
4874814|NCT00797108|16799032|P1|Overall Study|Randomized but not Treated|2
4874815|NCT00797108|16799030|P3|Overall Study|Other|2
4874816|NCT00797108|16799031|P2|Overall Study|Other|0
4874817|NCT00797108|16799032|P1|Overall Study|Other|0
4874818|NCT00797108|16799030|P3|Overall Study|Lack of Efficacy|1
4874819|NCT00797108|16799031|P2|Overall Study|Lack of Efficacy|0
4874820|NCT00797108|16799032|P1|Overall Study|Lack of Efficacy|1
4874821|NCT00797108|16799030|P3|Overall Study|Global Deterioration of Health Status|0
4874822|NCT00797108|16799031|P2|Overall Study|Global Deterioration of Health Status|1
4874823|NCT00797108|16799032|P1|Overall Study|Global Deterioration of Health Status|0
4874824|NCT00797108|16799030|P3|Overall Study|Did Not Meet Entrance Criteria|0
4874825|NCT00797108|16799031|P2|Overall Study|Did Not Meet Entrance Criteria|1
4874826|NCT00797108|16799032|P1|Overall Study|Did Not Meet Entrance Criteria|0
4874827|NCT00797108|16799030|P3|Overall Study|Adverse Event|3
4874828|NCT00797108|16799031|P2|Overall Study|Adverse Event|0
4874829|NCT00797108|16799032|P1|Overall Study|Adverse Event|1
4874830|NCT00796991|16799067|P3|Overall Study|Withdrawal by Subject|1
4874831|NCT00796991|16799068|P2|Overall Study|Withdrawal by Subject|0
4874832|NCT00796991|16799069|P1|Overall Study|Withdrawal by Subject|0
4874833|NCT00796991|16799067|P3|Overall Study|Study Drug Toxicity|5
4874834|NCT00796991|16799068|P2|Overall Study|Study Drug Toxicity|3
4874835|NCT00796991|16799069|P1|Overall Study|Study Drug Toxicity|3
4874836|NCT00796991|16799067|P3|Overall Study|Disease Progression|7
4874837|NCT00796991|16799068|P2|Overall Study|Disease Progression|9
4874838|NCT00796991|16799069|P1|Overall Study|Disease Progression|10
4874839|NCT00796991|16799067|P3|Overall Study|Death|0
4874840|NCT00796991|16799068|P2|Overall Study|Death|0
4874841|NCT00796991|16799069|P1|Overall Study|Death|2
4874842|NCT00796991|16799067|P3|Overall Study|Adverse Event|1
4874843|NCT00796991|16799068|P2|Overall Study|Adverse Event|0
4874844|NCT00796991|16799069|P1|Overall Study|Adverse Event|0
4874845|NCT00796978|16799167|P1|Overall Study|Withdrawal by Subject|3
4874846|NCT00796978|16799167|P1|Overall Study|Adverse Event|4
4874847|NCT00796978|16799167|P1|Overall Study|Cardiac adverse event|5
4874848|NCT00796861|16799193|P1|Overall Study|Death|2
4874849|NCT00796861|16799193|P1|Overall Study|Withdrawal by Subject|2
4874850|NCT00796822|16799199|P2|Overall Study|Adverse Event|0
4874851|NCT00796822|16799200|P1|Overall Study|Adverse Event|1
4874852|NCT00796822|16799199|P2|Overall Study|Lost to Follow-up|0
4874853|NCT00796822|16799200|P1|Overall Study|Lost to Follow-up|2
4874854|NCT00796757|16799208|P1|Overall Study|Other|7
4874855|NCT00796757|16799208|P1|Overall Study|Investigator's decision|2
4874856|NCT00796757|16799208|P1|Overall Study|Participant noncompliance|1
4874857|NCT00796757|16799208|P1|Overall Study|Protocol Violation|1
4874858|NCT00796757|16799208|P1|Overall Study|Death|61
4874859|NCT00796757|16799208|P1|Overall Study|Withdrawal by Subject|14
4874860|NCT00796718|16799242|P1|Overall Study|Withdrawal by Informed Consent|1
4874861|NCT00796718|16799242|P1|Overall Study|Lost to Follow-up|5
4874862|NCT00796718|16799242|P1|Overall Study|Exclusion Criteria|1
4874863|NCT00796718|16799242|P1|Overall Study|Adverse Event|2
4874864|NCT00796666|16799294|P2|Overall Study|Randomized and not treated|0
4874865|NCT00796666|16799295|P1|Overall Study|Randomized and not treated|1
4874866|NCT00796666|16799294|P2|Overall Study|Terminated by sponsor|55
4874867|NCT00796666|16799295|P1|Overall Study|Terminated by sponsor|53
4874868|NCT00796666|16799294|P2|Overall Study|Other|0
4874869|NCT00796666|16799295|P1|Overall Study|Other|1
4874870|NCT00796666|16799294|P2|Overall Study|Protocol Violation|0
4874871|NCT00796666|16799295|P1|Overall Study|Protocol Violation|1
4874872|NCT00796666|16799294|P2|Overall Study|Adverse Event|5
4874873|NCT00796666|16799295|P1|Overall Study|Adverse Event|7
4874874|NCT00796666|16799294|P2|Overall Study|Withdrawal by Subject|0
4874875|NCT00796666|16799295|P1|Overall Study|Withdrawal by Subject|2
4874876|NCT00796666|16799294|P2|Overall Study|Death|4
4874877|NCT00796666|16799295|P1|Overall Study|Death|2
4874878|NCT00796653|16799329|P4|Overall Study|Other reason not described above|4
4874879|NCT00796653|16799330|P3|Overall Study|Other reason not described above|7
4874880|NCT00796653|16799331|P2|Overall Study|Other reason not described above|9
4874881|NCT00796653|16799332|P1|Overall Study|Other reason not described above|4
4874882|NCT00796653|16799329|P4|Overall Study|Non compliance with protocol|2
4874883|NCT00796653|16799330|P3|Overall Study|Non compliance with protocol|0
4874884|NCT00796653|16799331|P2|Overall Study|Non compliance with protocol|2
4874885|NCT00796653|16799332|P1|Overall Study|Non compliance with protocol|2
4874886|NCT00796653|16799329|P4|Overall Study|Lack of Efficacy|2
4874887|NCT00796653|16799330|P3|Overall Study|Lack of Efficacy|3
4874888|NCT00796653|16799331|P2|Overall Study|Lack of Efficacy|1
4874889|NCT00796653|16799332|P1|Overall Study|Lack of Efficacy|8
4874890|NCT00796653|16799329|P4|Overall Study|Withdrawal by Subject|13
4874891|NCT00796653|16799330|P3|Overall Study|Withdrawal by Subject|8
4874892|NCT00796653|16799331|P2|Overall Study|Withdrawal by Subject|8
4874893|NCT00796653|16799332|P1|Overall Study|Withdrawal by Subject|16
4874894|NCT00796653|16799329|P4|Overall Study|Lost to Follow-up|3
4874895|NCT00796653|16799330|P3|Overall Study|Lost to Follow-up|2
4874896|NCT00796653|16799331|P2|Overall Study|Lost to Follow-up|1
4874897|NCT00796653|16799332|P1|Overall Study|Lost to Follow-up|2
4874898|NCT00796653|16799329|P4|Overall Study|Adverse Event|16
4874899|NCT00796653|16799330|P3|Overall Study|Adverse Event|16
4874900|NCT00796653|16799331|P2|Overall Study|Adverse Event|16
4874901|NCT00796653|16799332|P1|Overall Study|Adverse Event|19
4874902|NCT00796614|16799617|P4|Overall Study|Other than stated|0
4874903|NCT00796614|16799618|P3|Overall Study|Other than stated|0
4874904|NCT00796614|16799619|P2|Overall Study|Other than stated|0
4874905|NCT00796614|16799620|P1|Overall Study|Other than stated|1
4874906|NCT00796614|16799617|P4|Overall Study|Withdrawal by Subject|1
4874907|NCT00796614|16799618|P3|Overall Study|Withdrawal by Subject|0
4874908|NCT00796614|16799619|P2|Overall Study|Withdrawal by Subject|0
4874909|NCT00796614|16799620|P1|Overall Study|Withdrawal by Subject|1
4874910|NCT00796614|16799617|P4|Overall Study|Lost to Follow-up|0
4874911|NCT00796614|16799618|P3|Overall Study|Lost to Follow-up|1
4874912|NCT00796614|16799619|P2|Overall Study|Lost to Follow-up|2
4874913|NCT00796614|16799620|P1|Overall Study|Lost to Follow-up|2
4874914|NCT00796614|16799617|P4|Overall Study|Protocol Violation|0
4874915|NCT00796614|16799618|P3|Overall Study|Protocol Violation|2
4874916|NCT00796614|16799619|P2|Overall Study|Protocol Violation|0
4874917|NCT00796614|16799620|P1|Overall Study|Protocol Violation|0
4874918|NCT00796614|16799617|P4|Overall Study|Adverse Event|0
4874919|NCT00796614|16799618|P3|Overall Study|Adverse Event|0
4874920|NCT00796614|16799619|P2|Overall Study|Adverse Event|2
4874921|NCT00796614|16799620|P1|Overall Study|Adverse Event|1
4874922|NCT00796562|16799662|P1|Overall Study|Death|49
4874923|NCT00796549|16799671|P1|Overall Study|Progressive disease|56
4874924|NCT00796549|16799671|P1|Overall Study|Other|2
4874925|NCT00796549|16799671|P1|Overall Study|not entered|149
4874926|NCT00796549|16799671|P1|Overall Study|Adverse Event|11
4874927|NCT00796523|16799688|P2|Overall Study|Lost to Follow-up|7
4874928|NCT00796523|16799689|P1|Overall Study|Lost to Follow-up|9
4874929|NCT00796510|16799699|P2|Overall Study|Study Terminated|0
4874930|NCT00796510|16799700|P1|Overall Study|Study Terminated|2
4874931|NCT00796510|16799699|P2|Overall Study|Death|0
4874932|NCT00796510|16799700|P1|Overall Study|Death|1
4874933|NCT00796445|16799712|P2|Overall Study|Withdrawal by Subject|9
4874934|NCT00796445|16799713|P1|Overall Study|Withdrawal by Subject|18
4874935|NCT00796445|16799712|P2|Overall Study|Other|7
4874936|NCT00796445|16799713|P1|Overall Study|Other|10
4874937|NCT00796445|16799712|P2|Overall Study|Disease progression/recurrence|268
4874938|NCT00796445|16799713|P1|Overall Study|Disease progression/recurrence|537
4874939|NCT00796445|16799712|P2|Overall Study|Adverse event, non-fatal|0
4874940|NCT00796445|16799713|P1|Overall Study|Adverse event, non-fatal|4
4874941|NCT00796445|16799712|P2|Overall Study|Adverse event, serious fatal|5
4874942|NCT00796445|16799713|P1|Overall Study|Adverse event, serious fatal|10
4874943|NCT00796445|16799712|P2|Overall Study|Protocol Violation|3
4874944|NCT00796445|16799713|P1|Overall Study|Protocol Violation|5
4874945|NCT00796419|16799765|P2|Overall Study|Death|1
4874946|NCT00796419|16799766|P1|Overall Study|Death|0
4874947|NCT00796367|16799779|P3|Overall Study|other|3
4874948|NCT00796367|16799780|P2|Overall Study|other|4
4874949|NCT00796367|16799781|P1|Overall Study|other|2
4874950|NCT00796367|16799779|P3|Overall Study|Requirement for restricted medication|2
4874951|NCT00796367|16799780|P2|Overall Study|Requirement for restricted medication|0
4874952|NCT00796367|16799781|P1|Overall Study|Requirement for restricted medication|2
4874953|NCT00796367|16799779|P3|Overall Study|Pregnancy|1
4874954|NCT00796367|16799780|P2|Overall Study|Pregnancy|0
4874955|NCT00796367|16799781|P1|Overall Study|Pregnancy|1
4874956|NCT00796367|16799779|P3|Overall Study|non compliance|1
4874957|NCT00796367|16799780|P2|Overall Study|non compliance|1
4874958|NCT00796367|16799781|P1|Overall Study|non compliance|3
4874959|NCT00796367|16799779|P3|Overall Study|Lack of Efficacy|0
4874960|NCT00796367|16799780|P2|Overall Study|Lack of Efficacy|1
4874961|NCT00796367|16799781|P1|Overall Study|Lack of Efficacy|2
4874962|NCT00796367|16799779|P3|Overall Study|Withdrawal by Subject|12
4874963|NCT00796367|16799780|P2|Overall Study|Withdrawal by Subject|11
4874964|NCT00796367|16799781|P1|Overall Study|Withdrawal by Subject|9
4874965|NCT00796367|16799779|P3|Overall Study|Lost to Follow-up|21
4874966|NCT00796367|16799780|P2|Overall Study|Lost to Follow-up|4
4874967|NCT00796367|16799781|P1|Overall Study|Lost to Follow-up|5
4874968|NCT00796367|16799779|P3|Overall Study|Adverse Event|7
4874969|NCT00796367|16799780|P2|Overall Study|Adverse Event|4
4874970|NCT00796367|16799781|P1|Overall Study|Adverse Event|6
4874971|NCT00796328|16799792|P1|Overall Study|experienced hypotension requiring tx|6
4874972|NCT00796315|16799796|P3|Overall Study|Protocol Violation|0
4874973|NCT00796315|16799797|P2|Overall Study|Protocol Violation|1
4874974|NCT00796315|16799798|P1|Overall Study|Protocol Violation|0
4874975|NCT00796224|16799826|P2|Overall Study|Protocol Violation|1
4874976|NCT00796224|16799827|P1|Overall Study|Protocol Violation|0
4874977|NCT00796224|16799826|P2|Overall Study|Adverse Event|0
4874978|NCT00796224|16799827|P1|Overall Study|Adverse Event|1
4874979|NCT00796120|16799847|P2|Overall Study|Randomized but not treated|3
4874980|NCT00796120|16799848|P1|Overall Study|Randomized but not treated|0
4874981|NCT00796120|16799847|P2|Overall Study|Physician Decision|17
4874982|NCT00796120|16799848|P1|Overall Study|Physician Decision|16
4874983|NCT00796120|16799847|P2|Overall Study|Other|17
4874984|NCT00796120|16799848|P1|Overall Study|Other|6
4874985|NCT00796120|16799847|P2|Overall Study|Participant refusal|4
4874986|NCT00796120|16799848|P1|Overall Study|Participant refusal|3
4874987|NCT00796120|16799847|P2|Overall Study|Progressive disease|13
4874988|NCT00796120|16799848|P1|Overall Study|Progressive disease|22
4874989|NCT00796120|16799847|P2|Overall Study|Adverse Event|6
4874990|NCT00796120|16799848|P1|Overall Study|Adverse Event|11
4874991|NCT00796120|16799847|P2|Overall Study|Death|0
4874992|NCT00796120|16799848|P1|Overall Study|Death|3
4874993|NCT00796003|16799864|P2|Overall Study|Participants Not treated|2
4874994|NCT00796003|16799865|P1|Overall Study|Participants Not treated|0
4874995|NCT00796003|16799864|P2|Overall Study|Other|1
4874996|NCT00796003|16799865|P1|Overall Study|Other|0
4874997|NCT00796003|16799864|P2|Overall Study|Withdrawal by Subject|1
4874998|NCT00796003|16799865|P1|Overall Study|Withdrawal by Subject|0
4874999|NCT00796003|16799864|P2|Overall Study|Physician Decision|4
4875000|NCT00796003|16799865|P1|Overall Study|Physician Decision|0
4875001|NCT00796003|16799864|P2|Overall Study|Specified organ function not met|1
4875002|NCT00796003|16799865|P1|Overall Study|Specified organ function not met|0
4875003|NCT00796003|16799864|P2|Overall Study|Adverse Event|7
4875004|NCT00796003|16799865|P1|Overall Study|Adverse Event|1
4875005|NCT00796003|16799864|P2|Overall Study|Disease Progression|13
4875006|NCT00796003|16799865|P1|Overall Study|Disease Progression|2
4875007|NCT00795951|16799886|P1|Overall Study|Withdrawal by Subject|1
4875008|NCT00795951|16799886|P1|Overall Study|Lost to Follow-up|1
4875009|NCT00795886|16799979|P1|Overall Study|Death|10
4875010|NCT00795821|16799987|P2|Taper Phase|Withdrawal by Subject|0
4875011|NCT00795821|16799988|P1|Taper Phase|Withdrawal by Subject|4
4875012|NCT00795821|16799987|P2|Taper Phase|Physician Decision|0
4875013|NCT00795821|16799988|P1|Taper Phase|Physician Decision|2
4875014|NCT00795821|16799987|P2|Taper Phase|Lost to Follow-up|0
4875015|NCT00795821|16799988|P1|Taper Phase|Lost to Follow-up|1
4875016|NCT00795821|16799987|P2|Taper Phase|Adverse Event|0
4875017|NCT00795821|16799988|P1|Taper Phase|Adverse Event|2
4875018|NCT00795821|16799987|P2|Long-term Extension Phase|Withdrawal by Subject|25
4875019|NCT00795821|16799988|P1|Long-term Extension Phase|Withdrawal by Subject|25
4875020|NCT00795821|16799987|P2|Long-term Extension Phase|Protocol Violation|5
4875021|NCT00795821|16799988|P1|Long-term Extension Phase|Protocol Violation|3
4875022|NCT00795821|16799987|P2|Long-term Extension Phase|Physician Decision|2
4875023|NCT00795821|16799988|P1|Long-term Extension Phase|Physician Decision|1
4875024|NCT00795821|16799987|P2|Long-term Extension Phase|Lost to Follow-up|16
4875025|NCT00795821|16799988|P1|Long-term Extension Phase|Lost to Follow-up|20
4875026|NCT00795821|16799987|P2|Long-term Extension Phase|Lack of Efficacy|12
4875027|NCT00795821|16799988|P1|Long-term Extension Phase|Lack of Efficacy|16
4875028|NCT00795821|16799987|P2|Long-term Extension Phase|Adverse Event|32
4875029|NCT00795821|16799988|P1|Long-term Extension Phase|Adverse Event|25
4875030|NCT00795821|16799987|P2|Acute Treatment Phase|Withdrawal by Subject|10
4875031|NCT00795821|16799988|P1|Acute Treatment Phase|Withdrawal by Subject|16
4875032|NCT00795821|16799987|P2|Acute Treatment Phase|Protocol Violation|2
4875033|NCT00795821|16799988|P1|Acute Treatment Phase|Protocol Violation|1
4875034|NCT00795821|16799987|P2|Acute Treatment Phase|Physician Decision|1
4875035|NCT00795821|16799988|P1|Acute Treatment Phase|Physician Decision|1
4875036|NCT00795821|16799987|P2|Acute Treatment Phase|Lost to Follow-up|12
4875037|NCT00795821|16799988|P1|Acute Treatment Phase|Lost to Follow-up|9
4875038|NCT00795821|16799987|P2|Acute Treatment Phase|Lack of Efficacy|2
4875039|NCT00795821|16799988|P1|Acute Treatment Phase|Lack of Efficacy|5
4875040|NCT00795821|16799987|P2|Acute Treatment Phase|Death|0
4875041|NCT00795821|16799988|P1|Acute Treatment Phase|Death|1
4875042|NCT00795821|16799987|P2|Acute Treatment Phase|Adverse Event|4
4875043|NCT00795821|16799988|P1|Acute Treatment Phase|Adverse Event|23
4875044|NCT00795717|16800063|P2|Phase II|too busy|1
4875045|NCT00795717|16800064|P1|Phase II|too busy|0
4875046|NCT00795717|16800063|P2|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1
4875047|NCT00795717|16800064|P1|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0
4875048|NCT00795717|16800063|P2|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
4875049|NCT00795717|16800064|P1|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1
4875050|NCT00795717|16800063|P2|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0
4875051|NCT00795717|16800064|P1|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1
4875052|NCT00795704|16800076|P2|Overall Study|Adverse Event|1
4875053|NCT00795704|16800077|P1|Overall Study|Adverse Event|1
4875054|NCT00795704|16800076|P2|Overall Study|Withdrawal by Subject|2
4875055|NCT00795704|16800077|P1|Overall Study|Withdrawal by Subject|3
4875056|NCT00795639|16800097|P2|Overall Study|Randomized and not treated|1
4875057|NCT00795639|16800098|P1|Overall Study|Randomized and not treated|0
4875058|NCT00795639|16800097|P2|Overall Study|Terminated by sponsor|12
4875059|NCT00795639|16800098|P1|Overall Study|Terminated by sponsor|13
4875060|NCT00795639|16800097|P2|Overall Study|Other|2
4875061|NCT00795639|16800098|P1|Overall Study|Other|0
4875062|NCT00795639|16800097|P2|Overall Study|Adverse Event|2
4875063|NCT00795639|16800098|P1|Overall Study|Adverse Event|5
4875064|NCT00795639|16800097|P2|Overall Study|Pregnancy|0
4875065|NCT00795639|16800098|P1|Overall Study|Pregnancy|1
4875066|NCT00795639|16800097|P2|Overall Study|Withdrawal by Subject|3
4875067|NCT00795639|16800098|P1|Overall Study|Withdrawal by Subject|1
4875068|NCT00795639|16800097|P2|Overall Study|Death|6
4875069|NCT00795639|16800098|P1|Overall Study|Death|1
4875070|NCT00795600|16800110|P2|Overall Study|Unclassified|1
4875071|NCT00795600|16800111|P1|Overall Study|Unclassified|1
4875072|NCT00795600|16800110|P2|Overall Study|Withdrawal by Subject|0
4875073|NCT00795600|16800111|P1|Overall Study|Withdrawal by Subject|1
4875074|NCT00795600|16800110|P2|Overall Study|Protocol Violation|2
4875075|NCT00795600|16800111|P1|Overall Study|Protocol Violation|1
4875076|NCT00795600|16800110|P2|Overall Study|Adverse Event|1
4875077|NCT00795600|16800111|P1|Overall Study|Adverse Event|1
4875078|NCT00795535|16800231|P1|Overall Study|incomplete data and technical problems|20
4875079|NCT00795509|16800238|P1|Overall Study|Protocol Violation|31
4875080|NCT00795184|16800307|P2|Overall Study|Tissue sampling incomplete/conclusive|13
4875081|NCT00795184|16800308|P1|Overall Study|Tissue sampling incomplete/conclusive|8
4875082|NCT00795132|16800369|P1|Overall Study|Relapse|2
4875083|NCT00795132|16800369|P1|Overall Study|Death|1
4875084|NCT00794963|16800396|P2|Overall Study|Withdrawal by Subject|4
4875085|NCT00794963|16800397|P1|Overall Study|Withdrawal by Subject|1
4875086|NCT00794950|16800403|P1|Beginning Sunitinib Treatment|Lost to Follow-up|1
4875087|NCT00794950|16800403|P1|Beginning Sunitinib Treatment|Withdrawal by Subject|1
4875088|NCT00794950|16800403|P1|Beginning Sunitinib Treatment|Physician Decision|5
4875089|NCT00794950|16800403|P1|Beginning Sunitinib Treatment|cystectomy|5
4875090|NCT00794950|16800403|P1|BCG Induction|Adverse Event|1
4875091|NCT00794950|16800403|P1|BCG Induction|noncompliant w. BCG|1
4875092|NCT00794950|16800403|P1|BCG Induction|ineligible|3
4875093|NCT00794950|16800403|P1|BCG Induction|Withdrawal by Subject|2
4875094|NCT00794924|16800412|P2|Overall Study|Adverse Event|2
4875095|NCT00794924|16800413|P1|Overall Study|Adverse Event|6
4875096|NCT00794924|16800412|P2|Overall Study|Withdrawal by Subject|60
4875097|NCT00794924|16800413|P1|Overall Study|Withdrawal by Subject|48
4875098|NCT00794924|16800412|P2|Overall Study|Lost to Follow-up|8
4875099|NCT00794924|16800413|P1|Overall Study|Lost to Follow-up|6
4875100|NCT00794820|16800417|P1|Overall Study|Ineligible/Screen Failure|1
4875101|NCT00794820|16800417|P1|Overall Study|Resistant Disease|2
4875102|NCT00794820|16800417|P1|Overall Study|Secondary Malignancies|2
4875103|NCT00794820|16800417|P1|Overall Study|Adverse Event|11
4875104|NCT00794677|16800425|P2|First Intervention|Withdrawal by Subject|0
4875105|NCT00794677|16800426|P1|First Intervention|Withdrawal by Subject|2
4875106|NCT00794664|16800448|P2|Follow-up Period|Protocol non-compliance|1
4875107|NCT00794664|16800449|P1|Follow-up Period|Protocol non-compliance|0
4875108|NCT00794664|16800448|P2|Follow-up Period|Withdrawal by Subject|2
4875109|NCT00794664|16800449|P1|Follow-up Period|Withdrawal by Subject|0
4875110|NCT00794664|16800448|P2|Follow-up Period|Other|2
4875111|NCT00794664|16800449|P1|Follow-up Period|Other|1
4875112|NCT00794664|16800448|P2|Treatment Period|Adverse Event|8
4875113|NCT00794664|16800449|P1|Treatment Period|Adverse Event|1
4875114|NCT00794664|16800448|P2|Treatment Period|Other|1
4875115|NCT00794664|16800449|P1|Treatment Period|Other|0
4875116|NCT00794664|16800448|P2|Treatment Period|Protocol non-compliance|1
4875117|NCT00794664|16800449|P1|Treatment Period|Protocol non-compliance|0
4875118|NCT00794664|16800448|P2|Treatment Period|Withdrawal by Subject|2
4875119|NCT00794664|16800449|P1|Treatment Period|Withdrawal by Subject|0
4875120|NCT00794573|16800495|P2|Overall Study|Lost to Follow-up|33
4875121|NCT00794573|16800496|P1|Overall Study|Lost to Follow-up|26
4875122|NCT00794573|16800495|P2|Overall Study|Withdrawal by Subject|12
4875123|NCT00794573|16800496|P1|Overall Study|Withdrawal by Subject|9
4875124|NCT00794573|16800495|P2|Overall Study|Death|0
4875125|NCT00794573|16800496|P1|Overall Study|Death|3
4875126|NCT00794365|16800565|P1|Overall Study|Lack of Efficacy|3
4875127|NCT00794365|16800565|P1|Overall Study|Adverse Event|10
4875128|NCT00794365|16800565|P1|Overall Study|Poor Compliance|11
4875129|NCT00794365|16800565|P1|Overall Study|Other|17
4875130|NCT00794365|16800565|P1|Overall Study|Lost to Follow-up|38
4875131|NCT00794196|16800586|P2|Overall Study|Lost to Follow-up|23
4875132|NCT00794196|16800587|P1|Overall Study|Lost to Follow-up|5
4875133|NCT00794157|16800607|P3|Overall Study|Protocol deviation|1
4875134|NCT00794157|16800608|P2|Overall Study|Protocol deviation|1
4875135|NCT00794157|16800609|P1|Overall Study|Protocol deviation|0
4875136|NCT00794157|16800607|P3|Overall Study|Abnormal test procedure result(s)|0
4875137|NCT00794157|16800608|P2|Overall Study|Abnormal test procedure result(s)|1
4875138|NCT00794157|16800609|P1|Overall Study|Abnormal test procedure result(s)|0
4875139|NCT00794157|16800607|P3|Overall Study|Administrative problems|4
4875140|NCT00794157|16800608|P2|Overall Study|Administrative problems|7
4875141|NCT00794157|16800609|P1|Overall Study|Administrative problems|1
4875142|NCT00794157|16800607|P3|Overall Study|Unsatisfactory therapeutic effect|2
4875143|NCT00794157|16800608|P2|Overall Study|Unsatisfactory therapeutic effect|0
4875144|NCT00794157|16800609|P1|Overall Study|Unsatisfactory therapeutic effect|1
4875145|NCT00794157|16800607|P3|Overall Study|Lost to Follow-up|1
4875146|NCT00794157|16800608|P2|Overall Study|Lost to Follow-up|0
4875147|NCT00794157|16800609|P1|Overall Study|Lost to Follow-up|2
4875148|NCT00794157|16800607|P3|Overall Study|Subject withdrew consent|3
4875149|NCT00794157|16800608|P2|Overall Study|Subject withdrew consent|0
4875150|NCT00794157|16800609|P1|Overall Study|Subject withdrew consent|2
4875151|NCT00794157|16800607|P3|Overall Study|Adverse Event|8
4875152|NCT00794157|16800608|P2|Overall Study|Adverse Event|1
4875153|NCT00794157|16800609|P1|Overall Study|Adverse Event|4
4875154|NCT00794118|16800638|P1|Overall Study|Changed hospital center|2
4875155|NCT00794118|16800638|P1|Overall Study|Withdrawal by Subject|9
4875156|NCT00794118|16800638|P1|Overall Study|Lost to Follow-up|16
4875157|NCT00794040|16800698|P2|Overall Study|Physician Decision|1
4875158|NCT00794040|16800699|P1|Overall Study|Physician Decision|0
4875159|NCT00794040|16800698|P2|Overall Study|Withdrawal by Subject|4
4875160|NCT00794040|16800699|P1|Overall Study|Withdrawal by Subject|3
4875161|NCT00793910|16800715|P2|Overall Study|Withdrawal by Subject|1
4875162|NCT00793910|16800716|P1|Overall Study|Withdrawal by Subject|0
4875163|NCT00793910|16800715|P2|Overall Study|decided to undergo LASIK instead of PRK|1
4875164|NCT00793910|16800716|P1|Overall Study|decided to undergo LASIK instead of PRK|2
4875165|NCT00793910|16800715|P2|Overall Study|ineligible based on entry criteria|3
4875166|NCT00793910|16800716|P1|Overall Study|ineligible based on entry criteria|2
4875167|NCT00793910|16800715|P2|Overall Study|did not pick up medications|1
4875168|NCT00793910|16800716|P1|Overall Study|did not pick up medications|1
4875169|NCT00793910|16800715|P2|Overall Study|discarded study pills|1
4875170|NCT00793910|16800716|P1|Overall Study|discarded study pills|0
4875171|NCT00793871|16800730|P1|Overall Study|Study terminated by the Sponsor|7
4875172|NCT00793871|16800730|P1|Overall Study|Lost to Follow-up|3
4875173|NCT00793871|16800730|P1|Overall Study|Death|50
4875174|NCT00793819|16800744|P2|Overall Study|Lost to Follow-up|1
4875175|NCT00793819|16800745|P1|Overall Study|Lost to Follow-up|1
4875176|NCT00793819|16800744|P2|Overall Study|Withdrawal by Subject|3
4875177|NCT00793819|16800745|P1|Overall Study|Withdrawal by Subject|4
4875178|NCT00793819|16800744|P2|Overall Study|Lack of Efficacy|1
4875179|NCT00793819|16800745|P1|Overall Study|Lack of Efficacy|1
4875180|NCT00793819|16800744|P2|Overall Study|Adverse Event|4
4875181|NCT00793819|16800745|P1|Overall Study|Adverse Event|8
4875182|NCT00793793|16800763|P12|Overall Study|reason not specified|4
4875183|NCT00793793|16800764|P11|Overall Study|reason not specified|2
4875184|NCT00793793|16800765|P10|Overall Study|reason not specified|6
4875185|NCT00793793|16800766|P9|Overall Study|reason not specified|7
4875186|NCT00793793|16800767|P8|Overall Study|reason not specified|0
4875187|NCT00793793|16800768|P7|Overall Study|reason not specified|2
4875188|NCT00793793|16800769|P6|Overall Study|reason not specified|1
4875189|NCT00793793|16800770|P5|Overall Study|reason not specified|1
4875190|NCT00793793|16800771|P4|Overall Study|reason not specified|1
4875191|NCT00793793|16800772|P3|Overall Study|reason not specified|0
4875192|NCT00793793|16800773|P2|Overall Study|reason not specified|1
4875193|NCT00793793|16800774|P1|Overall Study|reason not specified|0
4875194|NCT00793793|16800763|P12|Overall Study|Withdrawal by Subject|0
4875195|NCT00793793|16800764|P11|Overall Study|Withdrawal by Subject|0
4875196|NCT00793793|16800765|P10|Overall Study|Withdrawal by Subject|0
4875197|NCT00793793|16800766|P9|Overall Study|Withdrawal by Subject|1
4875198|NCT00793793|16800767|P8|Overall Study|Withdrawal by Subject|0
4875199|NCT00793793|16800768|P7|Overall Study|Withdrawal by Subject|0
4875200|NCT00793793|16800769|P6|Overall Study|Withdrawal by Subject|0
4875201|NCT00793793|16800770|P5|Overall Study|Withdrawal by Subject|1
4875202|NCT00793793|16800771|P4|Overall Study|Withdrawal by Subject|0
4875203|NCT00793793|16800772|P3|Overall Study|Withdrawal by Subject|0
4875204|NCT00793793|16800773|P2|Overall Study|Withdrawal by Subject|0
4875205|NCT00793793|16800774|P1|Overall Study|Withdrawal by Subject|0
4875206|NCT00793793|16800763|P12|Overall Study|Lost to Follow-up|0
4875207|NCT00793793|16800764|P11|Overall Study|Lost to Follow-up|1
4875208|NCT00793793|16800765|P10|Overall Study|Lost to Follow-up|3
4875209|NCT00793793|16800766|P9|Overall Study|Lost to Follow-up|1
4875210|NCT00793793|16800767|P8|Overall Study|Lost to Follow-up|0
4875211|NCT00793793|16800768|P7|Overall Study|Lost to Follow-up|0
4875212|NCT00793793|16800769|P6|Overall Study|Lost to Follow-up|0
4875213|NCT00793793|16800770|P5|Overall Study|Lost to Follow-up|0
4875214|NCT00793793|16800771|P4|Overall Study|Lost to Follow-up|0
4875215|NCT00793793|16800772|P3|Overall Study|Lost to Follow-up|1
4875216|NCT00793793|16800773|P2|Overall Study|Lost to Follow-up|0
4875217|NCT00793793|16800774|P1|Overall Study|Lost to Follow-up|0
4875218|NCT00793793|16800763|P12|Overall Study|Protocol Violation|0
4875219|NCT00793793|16800764|P11|Overall Study|Protocol Violation|0
4875220|NCT00793793|16800765|P10|Overall Study|Protocol Violation|0
4875221|NCT00793793|16800766|P9|Overall Study|Protocol Violation|0
4875222|NCT00793793|16800767|P8|Overall Study|Protocol Violation|0
4875223|NCT00793793|16800768|P7|Overall Study|Protocol Violation|0
4875224|NCT00793793|16800769|P6|Overall Study|Protocol Violation|0
4875225|NCT00793793|16800770|P5|Overall Study|Protocol Violation|0
4875226|NCT00793793|16800771|P4|Overall Study|Protocol Violation|1
4875227|NCT00793793|16800772|P3|Overall Study|Protocol Violation|0
4875228|NCT00793793|16800773|P2|Overall Study|Protocol Violation|0
4875229|NCT00793793|16800774|P1|Overall Study|Protocol Violation|0
4875230|NCT00793793|16800763|P12|Overall Study|Adverse Event|2
4875231|NCT00793793|16800764|P11|Overall Study|Adverse Event|0
4875232|NCT00793793|16800765|P10|Overall Study|Adverse Event|0
4875233|NCT00793793|16800766|P9|Overall Study|Adverse Event|0
4875234|NCT00793793|16800767|P8|Overall Study|Adverse Event|0
4875235|NCT00793793|16800768|P7|Overall Study|Adverse Event|2
4875236|NCT00793793|16800769|P6|Overall Study|Adverse Event|1
4875237|NCT00793793|16800770|P5|Overall Study|Adverse Event|0
4875238|NCT00793793|16800771|P4|Overall Study|Adverse Event|1
4875239|NCT00793793|16800772|P3|Overall Study|Adverse Event|1
4875240|NCT00793793|16800773|P2|Overall Study|Adverse Event|0
4875241|NCT00793793|16800774|P1|Overall Study|Adverse Event|0
4875242|NCT00793780|16801149|P2|Overall Study|Withdrawal by Subject|1
4875243|NCT00793780|16801150|P1|Overall Study|Withdrawal by Subject|2
4875244|NCT00793624|16801181|P4|Overall Study|Other reason not described above|3
4875245|NCT00793624|16801182|P3|Overall Study|Other reason not described above|6
4875246|NCT00793624|16801183|P2|Overall Study|Other reason not described above|4
4875247|NCT00793624|16801184|P1|Overall Study|Other reason not described above|6
4875248|NCT00793624|16801181|P4|Overall Study|Non compliance with protocol|3
4875249|NCT00793624|16801182|P3|Overall Study|Non compliance with protocol|2
4875250|NCT00793624|16801183|P2|Overall Study|Non compliance with protocol|3
4875251|NCT00793624|16801184|P1|Overall Study|Non compliance with protocol|2
4875252|NCT00793624|16801181|P4|Overall Study|Lack of Efficacy|3
4875253|NCT00793624|16801182|P3|Overall Study|Lack of Efficacy|1
4875254|NCT00793624|16801183|P2|Overall Study|Lack of Efficacy|2
4875255|NCT00793624|16801184|P1|Overall Study|Lack of Efficacy|9
4875256|NCT00793624|16801181|P4|Overall Study|Withdrawal by Subject|14
4875257|NCT00793624|16801182|P3|Overall Study|Withdrawal by Subject|11
4875258|NCT00793624|16801183|P2|Overall Study|Withdrawal by Subject|9
4875259|NCT00793624|16801184|P1|Overall Study|Withdrawal by Subject|20
4875260|NCT00793624|16801181|P4|Overall Study|Lost to Follow-up|0
4875261|NCT00793624|16801182|P3|Overall Study|Lost to Follow-up|4
4875262|NCT00793624|16801183|P2|Overall Study|Lost to Follow-up|2
4875263|NCT00793624|16801184|P1|Overall Study|Lost to Follow-up|2
4875264|NCT00793624|16801181|P4|Overall Study|Adverse Event|20
4875265|NCT00793624|16801182|P3|Overall Study|Adverse Event|15
4875266|NCT00793624|16801183|P2|Overall Study|Adverse Event|16
4875267|NCT00793624|16801184|P1|Overall Study|Adverse Event|18
4875268|NCT00793585|16801465|P2|Overall Study|Protocol Violation|2
4875269|NCT00793585|16801466|P1|Overall Study|Protocol Violation|1
4875270|NCT00793585|16801465|P2|Overall Study|Adverse Event|1
4875271|NCT00793585|16801466|P1|Overall Study|Adverse Event|1
4875272|NCT00793546|16801485|P2|Overall Study|Other|0
4875273|NCT00793546|16801486|P1|Overall Study|Other|1
4875274|NCT00793546|16801485|P2|Overall Study|Study Terminated by Sponsor|27
4875275|NCT00793546|16801486|P1|Overall Study|Study Terminated by Sponsor|8
4875276|NCT00793546|16801485|P2|Overall Study|Withdrawal by Subject|1
4875277|NCT00793546|16801486|P1|Overall Study|Withdrawal by Subject|1
4875278|NCT00793546|16801485|P2|Overall Study|Lost to Follow-up|0
4875279|NCT00793546|16801486|P1|Overall Study|Lost to Follow-up|1
4875280|NCT00793546|16801485|P2|Overall Study|Death|0
4875281|NCT00793546|16801486|P1|Overall Study|Death|3
4875282|NCT00793403|16801536|P1|Overall Study|Other|73
4875283|NCT00793325|16801583|P1|Overall Study|Lost to Follow-up|1
4875284|NCT00793325|16801583|P1|Overall Study|Protocol Violation|18
4875285|NCT00793182|16801609|P2|Overall Study|Adverse Event|1
4875286|NCT00793182|16801610|P1|Overall Study|Adverse Event|0
4875287|NCT00793104|16801620|P1|Overall Study|Lost to Follow-up|1
4875288|NCT00792948|16801628|P1|Overall Study|Protocol Violation|1
4875289|NCT00792948|16801628|P1|Overall Study|Physician Decision|11
4875290|NCT00792948|16801628|P1|Overall Study|Insurance denial - not treated|1
4875291|NCT00792948|16801628|P1|Overall Study|Ineligible|2
4875292|NCT00792948|16801628|P1|Overall Study|Withdrawal by Subject|3
4875293|NCT00792948|16801628|P1|Overall Study|Death|4
4875294|NCT00792948|16801628|P1|Overall Study|Adverse Event|6
4875295|NCT00792935|16801639|P2|Overall Study|Withdrawal by Subject|1
4875296|NCT00792935|16801640|P1|Overall Study|Withdrawal by Subject|0
4875297|NCT00792935|16801639|P2|Overall Study|Protocol Violation|0
4875298|NCT00792935|16801640|P1|Overall Study|Protocol Violation|2
4875299|NCT00792935|16801639|P2|Overall Study|Lost to Follow-up|1
4875300|NCT00792935|16801640|P1|Overall Study|Lost to Follow-up|0
4875301|NCT00792935|16801639|P2|Overall Study|Adverse Event|1
4875302|NCT00792935|16801640|P1|Overall Study|Adverse Event|2
4875303|NCT00792909|16801672|P3|Overall Study|Withdrawal by Subject|0
4875304|NCT00792909|16801673|P2|Overall Study|Withdrawal by Subject|1
4875305|NCT00792909|16801674|P1|Overall Study|Withdrawal by Subject|0
4875306|NCT00792805|16801730|P3|Overall Study|Protocol deviation|1
4875307|NCT00792805|16801731|P2|Overall Study|Protocol deviation|1
4875308|NCT00792805|16801732|P1|Overall Study|Protocol deviation|0
4875309|NCT00792805|16801730|P3|Overall Study|Abnormal laboratory value(s)|1
4875310|NCT00792805|16801731|P2|Overall Study|Abnormal laboratory value(s)|0
4875311|NCT00792805|16801732|P1|Overall Study|Abnormal laboratory value(s)|0
4875312|NCT00792805|16801730|P3|Overall Study|Lost to Follow-up|6
4875313|NCT00792805|16801731|P2|Overall Study|Lost to Follow-up|1
4875314|NCT00792805|16801732|P1|Overall Study|Lost to Follow-up|1
4875315|NCT00792805|16801730|P3|Overall Study|Unsatisfactory therapeutic effect|6
4875316|NCT00792805|16801731|P2|Overall Study|Unsatisfactory therapeutic effect|6
4875317|NCT00792805|16801732|P1|Overall Study|Unsatisfactory therapeutic effect|1
4875318|NCT00792805|16801730|P3|Overall Study|Abnormal test procedure result(s)|0
4875319|NCT00792805|16801731|P2|Overall Study|Abnormal test procedure result(s)|2
4875320|NCT00792805|16801732|P1|Overall Study|Abnormal test procedure result(s)|1
4875321|NCT00792805|16801730|P3|Overall Study|Administrative problems|4
4875322|NCT00792805|16801731|P2|Overall Study|Administrative problems|0
4875323|NCT00792805|16801732|P1|Overall Study|Administrative problems|2
4875324|NCT00792805|16801730|P3|Overall Study|Subject withdrew consent|5
4875325|NCT00792805|16801731|P2|Overall Study|Subject withdrew consent|6
4875326|NCT00792805|16801732|P1|Overall Study|Subject withdrew consent|5
4875327|NCT00792805|16801730|P3|Overall Study|Adverse Event|10
4875328|NCT00792805|16801731|P2|Overall Study|Adverse Event|10
4875329|NCT00792805|16801732|P1|Overall Study|Adverse Event|12
4875330|NCT00792701|16801742|P2|Overall Study|Not protocol specified|0
4875331|NCT00792701|16801743|P1|Overall Study|Not protocol specified|17
4875332|NCT00792701|16801742|P2|Overall Study|Withdrawal by Subject|19
4875333|NCT00792701|16801743|P1|Overall Study|Withdrawal by Subject|1
4875334|NCT00792701|16801742|P2|Overall Study|Ineligible|3
4875335|NCT00792701|16801743|P1|Overall Study|Ineligible|1
4875336|NCT00792701|16801742|P2|Overall Study|Adverse Event|22
4875337|NCT00792701|16801743|P1|Overall Study|Adverse Event|0
4875338|NCT00792636|16801773|P3|Overall Study|Investigator Discretion|2
4875339|NCT00792636|16801774|P2|Overall Study|Investigator Discretion|0
4875340|NCT00792636|16801775|P1|Overall Study|Investigator Discretion|2
4875341|NCT00792636|16801773|P3|Overall Study|Adverse Event|3
4875342|NCT00792636|16801774|P2|Overall Study|Adverse Event|2
4875343|NCT00792636|16801775|P1|Overall Study|Adverse Event|4
4875344|NCT00792636|16801773|P3|Overall Study|Lack of Efficacy|13
4875345|NCT00792636|16801774|P2|Overall Study|Lack of Efficacy|4
4875346|NCT00792636|16801775|P1|Overall Study|Lack of Efficacy|3
4875347|NCT00792636|16801773|P3|Overall Study|Withdrew Consent|9
4875348|NCT00792636|16801774|P2|Overall Study|Withdrew Consent|13
4875349|NCT00792636|16801775|P1|Overall Study|Withdrew Consent|10
4875350|NCT00792636|16801773|P3|Overall Study|Lost to Follow-up|14
4875351|NCT00792636|16801774|P2|Overall Study|Lost to Follow-up|19
4875352|NCT00792636|16801775|P1|Overall Study|Lost to Follow-up|13
4875353|NCT00792636|16801773|P3|Overall Study|Met Protocol-defined Stopping Criteria|20
4875354|NCT00792636|16801774|P2|Overall Study|Met Protocol-defined Stopping Criteria|20
4875355|NCT00792636|16801775|P1|Overall Study|Met Protocol-defined Stopping Criteria|19
4875356|NCT00792636|16801773|P3|Overall Study|Protocol Violation|20
4875357|NCT00792636|16801774|P2|Overall Study|Protocol Violation|23
4875358|NCT00792636|16801775|P1|Overall Study|Protocol Violation|17
4875359|NCT00792623|16801812|P1|Overall Study|Withdrawal by Subject|5
4875360|NCT00792623|16801812|P1|Overall Study|Adverse Event|2
4875361|NCT00792571|16801829|P1|Overall Study|Other|4
4875362|NCT00792571|16801829|P1|Overall Study|Withdrawal by Subject|1
4875363|NCT00792571|16801829|P1|Overall Study|Adverse Event|4
4875364|NCT00792571|16801829|P1|Overall Study|Death|1
4875365|NCT00792298|16801849|P8|Treatment Period 2|Withdrawal by Subject|2
4875366|NCT00792298|16801850|P7|Treatment Period 2|Withdrawal by Subject|0
4875367|NCT00792298|16801851|P6|Treatment Period 2|Withdrawal by Subject|0
4875368|NCT00792298|16801852|P5|Treatment Period 2|Withdrawal by Subject|1
4875369|NCT00792298|16801853|P4|Treatment Period 2|Withdrawal by Subject|2
4875370|NCT00792298|16801854|P3|Treatment Period 2|Withdrawal by Subject|0
4875371|NCT00792298|16801855|P2|Treatment Period 2|Withdrawal by Subject|1
4875372|NCT00792298|16801856|P1|Treatment Period 2|Withdrawal by Subject|1
4875373|NCT00792298|16801849|P8|Treatment Period 2|Pregnancy|0
4875374|NCT00792298|16801850|P7|Treatment Period 2|Pregnancy|0
4875375|NCT00792298|16801851|P6|Treatment Period 2|Pregnancy|0
4875376|NCT00792298|16801852|P5|Treatment Period 2|Pregnancy|0
4875377|NCT00792298|16801853|P4|Treatment Period 2|Pregnancy|0
4875378|NCT00792298|16801854|P3|Treatment Period 2|Pregnancy|1
4875379|NCT00792298|16801855|P2|Treatment Period 2|Pregnancy|0
4875380|NCT00792298|16801856|P1|Treatment Period 2|Pregnancy|0
4875381|NCT00792298|16801849|P8|Treatment Period 2|Physician Decision|0
4875382|NCT00792298|16801850|P7|Treatment Period 2|Physician Decision|1
4875383|NCT00792298|16801851|P6|Treatment Period 2|Physician Decision|0
4875384|NCT00792298|16801852|P5|Treatment Period 2|Physician Decision|0
4875385|NCT00792298|16801853|P4|Treatment Period 2|Physician Decision|0
4875386|NCT00792298|16801854|P3|Treatment Period 2|Physician Decision|0
4875387|NCT00792298|16801855|P2|Treatment Period 2|Physician Decision|0
4875388|NCT00792298|16801856|P1|Treatment Period 2|Physician Decision|0
4875389|NCT00792298|16801849|P8|Treatment Period 2|Lack of Efficacy|0
4875390|NCT00792298|16801850|P7|Treatment Period 2|Lack of Efficacy|0
4875391|NCT00792298|16801851|P6|Treatment Period 2|Lack of Efficacy|0
4875392|NCT00792298|16801852|P5|Treatment Period 2|Lack of Efficacy|1
4875393|NCT00792298|16801853|P4|Treatment Period 2|Lack of Efficacy|0
4875394|NCT00792298|16801854|P3|Treatment Period 2|Lack of Efficacy|0
4875395|NCT00792298|16801855|P2|Treatment Period 2|Lack of Efficacy|0
4875396|NCT00792298|16801856|P1|Treatment Period 2|Lack of Efficacy|0
4875397|NCT00792298|16801849|P8|Washout|Withdrawal by Subject|0
4875398|NCT00792298|16801850|P7|Washout|Withdrawal by Subject|0
4875399|NCT00792298|16801851|P6|Washout|Withdrawal by Subject|1
4875400|NCT00792298|16801852|P5|Washout|Withdrawal by Subject|0
4875401|NCT00792298|16801853|P4|Washout|Withdrawal by Subject|0
4875402|NCT00792298|16801854|P3|Washout|Withdrawal by Subject|1
4875403|NCT00792298|16801855|P2|Washout|Withdrawal by Subject|0
4875404|NCT00792298|16801856|P1|Washout|Withdrawal by Subject|0
4875405|NCT00792298|16801849|P8|Washout|Adverse Event|0
4875406|NCT00792298|16801850|P7|Washout|Adverse Event|0
4875407|NCT00792298|16801851|P6|Washout|Adverse Event|1
4875408|NCT00792298|16801852|P5|Washout|Adverse Event|0
4875409|NCT00792298|16801853|P4|Washout|Adverse Event|0
4875410|NCT00792298|16801854|P3|Washout|Adverse Event|0
4875411|NCT00792298|16801855|P2|Washout|Adverse Event|0
4875412|NCT00792298|16801856|P1|Washout|Adverse Event|0
4875413|NCT00792298|16801849|P8|Treatment Period 1|Protocol Violation|1
4875414|NCT00792298|16801850|P7|Treatment Period 1|Protocol Violation|0
4875415|NCT00792298|16801851|P6|Treatment Period 1|Protocol Violation|0
4875416|NCT00792298|16801852|P5|Treatment Period 1|Protocol Violation|0
4875417|NCT00792298|16801853|P4|Treatment Period 1|Protocol Violation|0
4875418|NCT00792298|16801854|P3|Treatment Period 1|Protocol Violation|0
4875419|NCT00792298|16801855|P2|Treatment Period 1|Protocol Violation|0
4875420|NCT00792298|16801856|P1|Treatment Period 1|Protocol Violation|0
4875421|NCT00792298|16801849|P8|Treatment Period 1|Physician Decision|0
4875422|NCT00792298|16801850|P7|Treatment Period 1|Physician Decision|1
4875423|NCT00792298|16801851|P6|Treatment Period 1|Physician Decision|0
4875424|NCT00792298|16801852|P5|Treatment Period 1|Physician Decision|0
4875425|NCT00792298|16801853|P4|Treatment Period 1|Physician Decision|1
4875426|NCT00792298|16801854|P3|Treatment Period 1|Physician Decision|0
4875427|NCT00792298|16801855|P2|Treatment Period 1|Physician Decision|0
4875428|NCT00792298|16801856|P1|Treatment Period 1|Physician Decision|0
4875429|NCT00792298|16801849|P8|Treatment Period 1|Lost to Follow-up|0
4875430|NCT00792298|16801850|P7|Treatment Period 1|Lost to Follow-up|1
4875431|NCT00792298|16801851|P6|Treatment Period 1|Lost to Follow-up|0
4875432|NCT00792298|16801852|P5|Treatment Period 1|Lost to Follow-up|0
4875433|NCT00792298|16801853|P4|Treatment Period 1|Lost to Follow-up|0
4875434|NCT00792298|16801854|P3|Treatment Period 1|Lost to Follow-up|0
4875435|NCT00792298|16801855|P2|Treatment Period 1|Lost to Follow-up|0
4875436|NCT00792298|16801856|P1|Treatment Period 1|Lost to Follow-up|0
4875437|NCT00792298|16801849|P8|Treatment Period 1|Withdrawal by Subject|0
4875438|NCT00792298|16801850|P7|Treatment Period 1|Withdrawal by Subject|1
4875439|NCT00792298|16801851|P6|Treatment Period 1|Withdrawal by Subject|2
4875440|NCT00792298|16801852|P5|Treatment Period 1|Withdrawal by Subject|0
4875441|NCT00792298|16801853|P4|Treatment Period 1|Withdrawal by Subject|2
4875442|NCT00792298|16801854|P3|Treatment Period 1|Withdrawal by Subject|1
4875443|NCT00792298|16801855|P2|Treatment Period 1|Withdrawal by Subject|0
4875444|NCT00792298|16801856|P1|Treatment Period 1|Withdrawal by Subject|1
4875445|NCT00792298|16801849|P8|Treatment Period 1|Lack of Efficacy|0
4875446|NCT00792298|16801850|P7|Treatment Period 1|Lack of Efficacy|0
4875447|NCT00792298|16801851|P6|Treatment Period 1|Lack of Efficacy|0
4875448|NCT00792298|16801852|P5|Treatment Period 1|Lack of Efficacy|0
4875449|NCT00792298|16801853|P4|Treatment Period 1|Lack of Efficacy|0
4875450|NCT00792298|16801854|P3|Treatment Period 1|Lack of Efficacy|1
4875451|NCT00792298|16801855|P2|Treatment Period 1|Lack of Efficacy|0
4875452|NCT00792298|16801856|P1|Treatment Period 1|Lack of Efficacy|0
4875453|NCT00792298|16801849|P8|Treatment Period 1|Adverse Event|0
4875454|NCT00792298|16801850|P7|Treatment Period 1|Adverse Event|1
4875455|NCT00792298|16801851|P6|Treatment Period 1|Adverse Event|1
4875456|NCT00792298|16801852|P5|Treatment Period 1|Adverse Event|0
4875457|NCT00792298|16801853|P4|Treatment Period 1|Adverse Event|1
4875458|NCT00792298|16801854|P3|Treatment Period 1|Adverse Event|0
4875459|NCT00792298|16801855|P2|Treatment Period 1|Adverse Event|1
4875460|NCT00792298|16801856|P1|Treatment Period 1|Adverse Event|0
4875461|NCT00792259|16801886|P3|Overall Study|Poor Quality Scans|0
4875462|NCT00792259|16801887|P2|Overall Study|Poor Quality Scans|0
4875463|NCT00792259|16801888|P1|Overall Study|Poor Quality Scans|1
4875464|NCT00792116|16801905|P2|Overall Study|Discontnued intervention|0
4875465|NCT00792116|16801906|P1|Overall Study|Discontnued intervention|1
4875466|NCT00792116|16801905|P2|Overall Study|Lost to Follow-up|1
4875467|NCT00792116|16801906|P1|Overall Study|Lost to Follow-up|0
4875468|NCT00792103|16801916|P1|Overall Study|Did not apply 6 patches in 1st 3 mths|14
4875469|NCT00792103|16801916|P1|Overall Study|Protocol Violation|10
4875470|NCT00792103|16801916|P1|Overall Study|Withdrawal by Subject|52
4875471|NCT00792103|16801916|P1|Overall Study|Adverse Event|25
4875472|NCT00792103|16801916|P1|Overall Study|Lost to Follow-up|17
4875473|NCT00792103|16801916|P1|Overall Study|Enrolled, not treated|15
4875474|NCT00791999|16801928|P4|Overall Study|Reason other than those above|0
4875475|NCT00791999|16801929|P3|Overall Study|Reason other than those above|1
4875476|NCT00791999|16801930|P2|Overall Study|Reason other than those above|0
4875477|NCT00791999|16801931|P1|Overall Study|Reason other than those above|1
4875478|NCT00791999|16801928|P4|Overall Study|Lack of Efficacy|2
4875479|NCT00791999|16801929|P3|Overall Study|Lack of Efficacy|0
4875480|NCT00791999|16801930|P2|Overall Study|Lack of Efficacy|1
4875481|NCT00791999|16801931|P1|Overall Study|Lack of Efficacy|0
4875482|NCT00791999|16801928|P4|Overall Study|Adverse Event|3
4875483|NCT00791999|16801929|P3|Overall Study|Adverse Event|7
4875484|NCT00791999|16801930|P2|Overall Study|Adverse Event|3
4875485|NCT00791999|16801931|P1|Overall Study|Adverse Event|3
4875486|NCT00791999|16801928|P4|Overall Study|Protocol Violation|0
4875487|NCT00791999|16801929|P3|Overall Study|Protocol Violation|1
4875488|NCT00791999|16801930|P2|Overall Study|Protocol Violation|0
4875489|NCT00791999|16801931|P1|Overall Study|Protocol Violation|3
4875490|NCT00791999|16801928|P4|Overall Study|Withdrawal by Subject|2
4875491|NCT00791999|16801929|P3|Overall Study|Withdrawal by Subject|0
4875492|NCT00791999|16801930|P2|Overall Study|Withdrawal by Subject|1
4875493|NCT00791999|16801931|P1|Overall Study|Withdrawal by Subject|0
4875494|NCT00791999|16801928|P4|Overall Study|Protocol planed withdrawal|45
4875495|NCT00791999|16801929|P3|Overall Study|Protocol planed withdrawal|11
4875496|NCT00791999|16801930|P2|Overall Study|Protocol planed withdrawal|11
4875497|NCT00791999|16801931|P1|Overall Study|Protocol planed withdrawal|14
4875498|NCT00791934|16801956|P1|Overall Study|Did not consent for extended follow-up|13
4875499|NCT00791934|16801956|P1|Overall Study|Withdrawal by Subject|2
4875500|NCT00791921|16801966|P2|Overall Study|Reason other than those above|1
4875501|NCT00791921|16801967|P1|Overall Study|Reason other than those above|0
4875502|NCT00791921|16801966|P2|Overall Study|Lack of study drug administration|1
4875503|NCT00791921|16801967|P1|Overall Study|Lack of study drug administration|1
4875504|NCT00791921|16801966|P2|Overall Study|Lack of Efficacy|2
4875505|NCT00791921|16801967|P1|Overall Study|Lack of Efficacy|0
4875506|NCT00791921|16801966|P2|Overall Study|Adverse Event|2
4875507|NCT00791921|16801967|P1|Overall Study|Adverse Event|8
4875508|NCT00791921|16801966|P2|Overall Study|Withdrawal by Subject|2
4875509|NCT00791921|16801967|P1|Overall Study|Withdrawal by Subject|1
4875510|NCT00791921|16801966|P2|Overall Study|Protocol planed|88
4875511|NCT00791921|16801967|P1|Overall Study|Protocol planed|24
4875512|NCT00791778|16801998|P2|Follow-up|Lost to Follow-up|1
4875513|NCT00791778|16801999|P1|Follow-up|Lost to Follow-up|2
4875514|NCT00791778|16801998|P2|Follow-up|Withdrawal by Subject|0
4875515|NCT00791778|16801999|P1|Follow-up|Withdrawal by Subject|3
4875516|NCT00791778|16801998|P2|Double-blind Treatment|Non-compliant with study medication|0
4875517|NCT00791778|16801999|P1|Double-blind Treatment|Non-compliant with study medication|2
4875518|NCT00791778|16801998|P2|Double-blind Treatment|Withdrawal by Subject|9
4875519|NCT00791778|16801999|P1|Double-blind Treatment|Withdrawal by Subject|20
4875520|NCT00791778|16801998|P2|Double-blind Treatment|Protocol Violation|4
4875521|NCT00791778|16801999|P1|Double-blind Treatment|Protocol Violation|0
4875522|NCT00791778|16801998|P2|Double-blind Treatment|Physician Decision|26
4875523|NCT00791778|16801999|P1|Double-blind Treatment|Physician Decision|6
4875524|NCT00791778|16801998|P2|Double-blind Treatment|Adverse Event|9
4875525|NCT00791778|16801999|P1|Double-blind Treatment|Adverse Event|49
4875526|NCT00791765|16802053|P2|Weeks 13 to 24|Other|1
4875527|NCT00791765|16802054|P1|Weeks 13 to 24|Other|0
4875528|NCT00791765|16802053|P2|Weeks 13 to 24|Lost to Follow-up|2
4875529|NCT00791765|16802054|P1|Weeks 13 to 24|Lost to Follow-up|1
4875530|NCT00791765|16802053|P2|Weeks 13 to 24|Disease progression|1
4875531|NCT00791765|16802054|P1|Weeks 13 to 24|Disease progression|0
4875532|NCT00791765|16802053|P2|Weeks 13 to 24|Withdrawal by Subject|1
4875533|NCT00791765|16802054|P1|Weeks 13 to 24|Withdrawal by Subject|2
4875534|NCT00791765|16802053|P2|Weeks 13 to 24|Adverse Event|3
4875535|NCT00791765|16802054|P1|Weeks 13 to 24|Adverse Event|0
4875536|NCT00791765|16802053|P2|Weeks 13 to 24|Protocol deviation|0
4875537|NCT00791765|16802054|P1|Weeks 13 to 24|Protocol deviation|2
4875538|NCT00791765|16802053|P2|Weeks 1 to 12|Ineligibility determined|3
4875539|NCT00791765|16802054|P1|Weeks 1 to 12|Ineligibility determined|0
4875540|NCT00791765|16802053|P2|Weeks 1 to 12|Disease progression|0
4875541|NCT00791765|16802054|P1|Weeks 1 to 12|Disease progression|3
4875542|NCT00791765|16802053|P2|Weeks 1 to 12|Physician Decision|0
4875543|NCT00791765|16802054|P1|Weeks 1 to 12|Physician Decision|1
4875544|NCT00791765|16802053|P2|Weeks 1 to 12|Withdrawal by Subject|0
4875545|NCT00791765|16802054|P1|Weeks 1 to 12|Withdrawal by Subject|3
4875546|NCT00791765|16802053|P2|Weeks 1 to 12|Lost to Follow-up|0
4875547|NCT00791765|16802054|P1|Weeks 1 to 12|Lost to Follow-up|1
4875548|NCT00791765|16802053|P2|Weeks 1 to 12|Adverse Event|1
4875549|NCT00791765|16802054|P1|Weeks 1 to 12|Adverse Event|0
4875550|NCT00791700|16802069|P4|Overall Study|Adverse Event|1
4875551|NCT00791700|16802070|P3|Overall Study|Adverse Event|1
4875552|NCT00791700|16802071|P2|Overall Study|Adverse Event|0
4875553|NCT00791700|16802072|P1|Overall Study|Adverse Event|0
4875554|NCT00791700|16802069|P4|Overall Study|Lost to Follow-up|6
4875555|NCT00791700|16802070|P3|Overall Study|Lost to Follow-up|4
4875556|NCT00791700|16802071|P2|Overall Study|Lost to Follow-up|3
4875557|NCT00791700|16802072|P1|Overall Study|Lost to Follow-up|4
4875558|NCT00791700|16802069|P4|Overall Study|Death|1
4875559|NCT00791700|16802070|P3|Overall Study|Death|0
4875560|NCT00791700|16802071|P2|Overall Study|Death|0
4875561|NCT00791700|16802072|P1|Overall Study|Death|0
4875562|NCT00791700|16802069|P4|Overall Study|Other|1
4875563|NCT00791700|16802070|P3|Overall Study|Other|0
4875564|NCT00791700|16802071|P2|Overall Study|Other|1
4875565|NCT00791700|16802072|P1|Overall Study|Other|0
4875566|NCT00791700|16802069|P4|Overall Study|Withdrawn due to pregnancy|1
4875567|NCT00791700|16802070|P3|Overall Study|Withdrawn due to pregnancy|0
4875568|NCT00791700|16802071|P2|Overall Study|Withdrawn due to pregnancy|0
4875569|NCT00791700|16802072|P1|Overall Study|Withdrawn due to pregnancy|0
4875570|NCT00791700|16802069|P4|Overall Study|Non-compliance with study treatment|4
4875571|NCT00791700|16802070|P3|Overall Study|Non-compliance with study treatment|0
4875572|NCT00791700|16802071|P2|Overall Study|Non-compliance with study treatment|2
4875573|NCT00791700|16802072|P1|Overall Study|Non-compliance with study treatment|0
4875574|NCT00791700|16802069|P4|Overall Study|No longer willing to participate|8
4875575|NCT00791700|16802070|P3|Overall Study|No longer willing to participate|0
4875576|NCT00791700|16802071|P2|Overall Study|No longer willing to participate|1
4875577|NCT00791700|16802072|P1|Overall Study|No longer willing to participate|1
4875578|NCT00791700|16802069|P4|Overall Study|Insufficient clinical response|8
4875579|NCT00791700|16802070|P3|Overall Study|Insufficient clinical response|1
4875580|NCT00791700|16802071|P2|Overall Study|Insufficient clinical response|4
4875581|NCT00791700|16802072|P1|Overall Study|Insufficient clinical response|1
4875582|NCT00791661|16802160|P3|7 Day Wash-out|Abnormal Clinical Laboratory Test|1
4875583|NCT00791661|16802161|P2|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
4875584|NCT00791661|16802162|P1|7 Day Wash-out|Abnormal Clinical Laboratory Test|0
4875585|NCT00791661|16802160|P3|7 Day Wash-out|Adverse Event|1
4875586|NCT00791661|16802161|P2|7 Day Wash-out|Adverse Event|0
4875587|NCT00791661|16802162|P1|7 Day Wash-out|Adverse Event|0
4875588|NCT00791648|16802255|P2|Overall Study|Withdrawal by Subject|1
4875589|NCT00791648|16802256|P1|Overall Study|Withdrawal by Subject|0
4875590|NCT00791648|16802255|P2|Overall Study|Physician Decision|1
4875591|NCT00791648|16802256|P1|Overall Study|Physician Decision|0
4875592|NCT00791557|16802292|P1|Overall Study|Adverse Event|1
4875593|NCT00791518|16802296|P1|Overall Study|Protocol Violation|93
4875594|NCT00791492|16802324|P2|Overall Study|Liver transplantation|1
4875595|NCT00791492|16802325|P1|Overall Study|Liver transplantation|5
4875596|NCT00791492|16802324|P2|Overall Study|Withdrawal by Subject|2
4875597|NCT00791492|16802325|P1|Overall Study|Withdrawal by Subject|1
4875598|NCT00791479|16802373|P6|Overall Study|Withdrawal by Subject|1
4875599|NCT00791479|16802374|P5|Overall Study|Withdrawal by Subject|0
4875600|NCT00791479|16802375|P4|Overall Study|Withdrawal by Subject|1
4875601|NCT00791479|16802376|P3|Overall Study|Withdrawal by Subject|0
4875602|NCT00791479|16802377|P2|Overall Study|Withdrawal by Subject|0
4875603|NCT00791479|16802378|P1|Overall Study|Withdrawal by Subject|0
4875604|NCT00791479|16802373|P6|Overall Study|Protocol Violation|0
4875605|NCT00791479|16802374|P5|Overall Study|Protocol Violation|0
4875606|NCT00791479|16802375|P4|Overall Study|Protocol Violation|1
4875607|NCT00791479|16802376|P3|Overall Study|Protocol Violation|0
4875608|NCT00791479|16802377|P2|Overall Study|Protocol Violation|1
4875609|NCT00791479|16802378|P1|Overall Study|Protocol Violation|2
4875610|NCT00791479|16802373|P6|Overall Study|Lost to Follow-up|1
4875611|NCT00791479|16802374|P5|Overall Study|Lost to Follow-up|0
4875612|NCT00791479|16802375|P4|Overall Study|Lost to Follow-up|0
4875613|NCT00791479|16802376|P3|Overall Study|Lost to Follow-up|0
4875614|NCT00791479|16802377|P2|Overall Study|Lost to Follow-up|1
4875615|NCT00791479|16802378|P1|Overall Study|Lost to Follow-up|0
4875616|NCT00791479|16802373|P6|Overall Study|Adverse Event|1
4875617|NCT00791479|16802374|P5|Overall Study|Adverse Event|0
4875618|NCT00791479|16802375|P4|Overall Study|Adverse Event|2
4875619|NCT00791479|16802376|P3|Overall Study|Adverse Event|0
4875620|NCT00791479|16802377|P2|Overall Study|Adverse Event|1
4875621|NCT00791479|16802378|P1|Overall Study|Adverse Event|0
4875622|NCT00791479|16802373|P6|Overall Study|Dose Discontinued per Sponsor Decision|0
4875623|NCT00791479|16802374|P5|Overall Study|Dose Discontinued per Sponsor Decision|3
4875624|NCT00791479|16802375|P4|Overall Study|Dose Discontinued per Sponsor Decision|0
4875625|NCT00791479|16802376|P3|Overall Study|Dose Discontinued per Sponsor Decision|0
4875626|NCT00791479|16802377|P2|Overall Study|Dose Discontinued per Sponsor Decision|0
4875627|NCT00791479|16802378|P1|Overall Study|Dose Discontinued per Sponsor Decision|0
4875628|NCT00791388|16802477|P5|Period 4 - 400 mg Dose Group|Adverse Event|4
4875629|NCT00791388|16802478|P4|Period 4 - 400 mg Dose Group|Adverse Event|0
4875630|NCT00791388|16802479|P3|Period 4 - 400 mg Dose Group|Adverse Event|0
4875631|NCT00791388|16802480|P2|Period 4 - 400 mg Dose Group|Adverse Event|0
4875632|NCT00791388|16802481|P1|Period 4 - 400 mg Dose Group|Adverse Event|0
4875633|NCT00791388|16802477|P5|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4875634|NCT00791388|16802478|P4|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4875635|NCT00791388|16802479|P3|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4875636|NCT00791388|16802480|P2|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0
4875637|NCT00791388|16802481|P1|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1
4875638|NCT00791388|16802477|P5|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4875639|NCT00791388|16802478|P4|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4875640|NCT00791388|16802479|P3|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4875641|NCT00791388|16802480|P2|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1
4875642|NCT00791388|16802481|P1|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0
4875643|NCT00791258|16802523|P1|Overall Study|Lack of Efficacy|1
4875644|NCT00791258|16802523|P1|Overall Study|Subject required restricted medication|1
4875645|NCT00791258|16802523|P1|Overall Study|Subject incarcerated|1
4875646|NCT00791258|16802523|P1|Overall Study|non-compliance|3
4875647|NCT00791258|16802523|P1|Overall Study|subject left area|2
4875648|NCT00791258|16802523|P1|Overall Study|Did not take medication for >3 days|1
4875649|NCT00791258|16802523|P1|Overall Study|Withdrawal by Subject|40
4875650|NCT00791258|16802523|P1|Overall Study|Protocol Violation|109
4875651|NCT00791258|16802523|P1|Overall Study|Lost to Follow-up|18
4875652|NCT00791258|16802523|P1|Overall Study|Adverse Event|87
4875653|NCT00791128|16802616|P1|Overall Study|abdominal tumor, unrelated to device|1
4875654|NCT00791128|16802616|P1|Overall Study|non-compliance by subject|2
4875655|NCT00791128|16802616|P1|Overall Study|Device migration|2
4875656|NCT00791128|16802616|P1|Overall Study|Adverse Event|4
4875657|NCT00791076|16802647|P1|Overall Study|Study was terminated,PI left institution|8
4875658|NCT00790933|16802667|P5|Overall Study|Reason Not Specified|9
4875659|NCT00790933|16802668|P4|Overall Study|Reason Not Specified|1
4875660|NCT00790933|16802669|P3|Overall Study|Reason Not Specified|4
4875661|NCT00790933|16802670|P2|Overall Study|Reason Not Specified|16
4875662|NCT00790933|16802671|P1|Overall Study|Reason Not Specified|8
4875663|NCT00790933|16802667|P5|Overall Study|Lost to Follow-up|15
4875664|NCT00790933|16802668|P4|Overall Study|Lost to Follow-up|1
4875665|NCT00790933|16802669|P3|Overall Study|Lost to Follow-up|10
4875666|NCT00790933|16802670|P2|Overall Study|Lost to Follow-up|31
4875667|NCT00790933|16802671|P1|Overall Study|Lost to Follow-up|13
4875668|NCT00790933|16802667|P5|Overall Study|Withdrawal by Subject|50
4875669|NCT00790933|16802668|P4|Overall Study|Withdrawal by Subject|6
4875670|NCT00790933|16802669|P3|Overall Study|Withdrawal by Subject|52
4875671|NCT00790933|16802670|P2|Overall Study|Withdrawal by Subject|120
4875672|NCT00790933|16802671|P1|Overall Study|Withdrawal by Subject|123
4875673|NCT00790933|16802667|P5|Overall Study|Study Terminated by Sponsor|0
4875674|NCT00790933|16802668|P4|Overall Study|Study Terminated by Sponsor|0
4875675|NCT00790933|16802669|P3|Overall Study|Study Terminated by Sponsor|1
4875676|NCT00790933|16802670|P2|Overall Study|Study Terminated by Sponsor|0
4875677|NCT00790933|16802671|P1|Overall Study|Study Terminated by Sponsor|0
4875678|NCT00790933|16802667|P5|Overall Study|Lack of Efficacy|121
4875679|NCT00790933|16802668|P4|Overall Study|Lack of Efficacy|1
4875680|NCT00790933|16802669|P3|Overall Study|Lack of Efficacy|130
4875681|NCT00790933|16802670|P2|Overall Study|Lack of Efficacy|176
4875682|NCT00790933|16802671|P1|Overall Study|Lack of Efficacy|192
4875683|NCT00790933|16802667|P5|Overall Study|Protocol Violation(s)|12
4875684|NCT00790933|16802668|P4|Overall Study|Protocol Violation(s)|0
4875685|NCT00790933|16802669|P3|Overall Study|Protocol Violation(s)|7
4875686|NCT00790933|16802670|P2|Overall Study|Protocol Violation(s)|18
4875687|NCT00790933|16802671|P1|Overall Study|Protocol Violation(s)|8
4875688|NCT00790933|16802667|P5|Overall Study|Adverse Event|69
4875689|NCT00790933|16802668|P4|Overall Study|Adverse Event|5
4875690|NCT00790933|16802669|P3|Overall Study|Adverse Event|65
4875691|NCT00790933|16802670|P2|Overall Study|Adverse Event|119
4875692|NCT00790933|16802671|P1|Overall Study|Adverse Event|94
4875693|NCT00790907|16803202|P3|Overall Study|Did Not Receive Study Drug|0
4875694|NCT00790907|16803203|P2|Overall Study|Did Not Receive Study Drug|0
4875695|NCT00790907|16803204|P1|Overall Study|Did Not Receive Study Drug|10
4875696|NCT00790907|16803202|P3|Overall Study|Verbatim Reason on the Case Report Form|29
4875697|NCT00790907|16803203|P2|Overall Study|Verbatim Reason on the Case Report Form|20
4875698|NCT00790907|16803204|P1|Overall Study|Verbatim Reason on the Case Report Form|74
4875699|NCT00790907|16803202|P3|Overall Study|Qualifying Condition Not Present|16
4875700|NCT00790907|16803203|P2|Overall Study|Qualifying Condition Not Present|14
4875701|NCT00790907|16803204|P1|Overall Study|Qualifying Condition Not Present|29
4875702|NCT00790907|16803202|P3|Overall Study|Required Protocol-prohibited Therapy|7
4875703|NCT00790907|16803203|P2|Overall Study|Required Protocol-prohibited Therapy|5
4875704|NCT00790907|16803204|P1|Overall Study|Required Protocol-prohibited Therapy|17
4875705|NCT00790907|16803202|P3|Overall Study|Bleeding Event|21
4875706|NCT00790907|16803203|P2|Overall Study|Bleeding Event|16
4875707|NCT00790907|16803204|P1|Overall Study|Bleeding Event|11
4875708|NCT00790907|16803202|P3|Overall Study|Withdrawal by Subject|5
4875709|NCT00790907|16803203|P2|Overall Study|Withdrawal by Subject|7
4875710|NCT00790907|16803204|P1|Overall Study|Withdrawal by Subject|1
4875711|NCT00790907|16803202|P3|Overall Study|Physician Decision|255
4875712|NCT00790907|16803203|P2|Overall Study|Physician Decision|271
4875713|NCT00790907|16803204|P1|Overall Study|Physician Decision|304
4875714|NCT00790907|16803202|P3|Overall Study|Adverse Event|6
4875715|NCT00790907|16803203|P2|Overall Study|Adverse Event|7
4875716|NCT00790907|16803204|P1|Overall Study|Adverse Event|9
4875717|NCT00790868|16803227|P2|Overall Study|Lost to Follow-up|12
4875718|NCT00790868|16803228|P1|Overall Study|Lost to Follow-up|2
4875719|NCT00790868|16803227|P2|Overall Study|Withdrawal by Subject|5
4875720|NCT00790868|16803228|P1|Overall Study|Withdrawal by Subject|4
4875721|NCT00790842|16803250|P11|Expansion Cohort|Study Closure|0
4875722|NCT00790842|16803251|P10|Expansion Cohort|Study Closure|0
4875723|NCT00790842|16803252|P9|Expansion Cohort|Study Closure|0
4875724|NCT00790842|16803253|P8|Expansion Cohort|Study Closure|0
4875725|NCT00790842|16803254|P7|Expansion Cohort|Study Closure|0
4875726|NCT00790842|16803255|P6|Expansion Cohort|Study Closure|0
4875727|NCT00790842|16803256|P5|Expansion Cohort|Study Closure|0
4875728|NCT00790842|16803257|P4|Expansion Cohort|Study Closure|0
4875729|NCT00790842|16803258|P3|Expansion Cohort|Study Closure|1
4875730|NCT00790842|16803259|P2|Expansion Cohort|Study Closure|0
4875731|NCT00790842|16803260|P1|Expansion Cohort|Study Closure|0
4875732|NCT00790842|16803250|P11|Expansion Cohort|Withdrawal by Subject|0
4875733|NCT00790842|16803251|P10|Expansion Cohort|Withdrawal by Subject|0
4875734|NCT00790842|16803252|P9|Expansion Cohort|Withdrawal by Subject|0
4875735|NCT00790842|16803253|P8|Expansion Cohort|Withdrawal by Subject|0
4875736|NCT00790842|16803254|P7|Expansion Cohort|Withdrawal by Subject|0
4875737|NCT00790842|16803255|P6|Expansion Cohort|Withdrawal by Subject|0
4875738|NCT00790842|16803256|P5|Expansion Cohort|Withdrawal by Subject|0
4875739|NCT00790842|16803257|P4|Expansion Cohort|Withdrawal by Subject|0
4875740|NCT00790842|16803258|P3|Expansion Cohort|Withdrawal by Subject|3
4875741|NCT00790842|16803259|P2|Expansion Cohort|Withdrawal by Subject|0
4875742|NCT00790842|16803260|P1|Expansion Cohort|Withdrawal by Subject|0
4875743|NCT00790842|16803250|P11|Expansion Cohort|Physician Decision|0
4875744|NCT00790842|16803251|P10|Expansion Cohort|Physician Decision|0
4875745|NCT00790842|16803252|P9|Expansion Cohort|Physician Decision|0
4875746|NCT00790842|16803253|P8|Expansion Cohort|Physician Decision|0
4875747|NCT00790842|16803254|P7|Expansion Cohort|Physician Decision|0
4875748|NCT00790842|16803255|P6|Expansion Cohort|Physician Decision|0
4875749|NCT00790842|16803256|P5|Expansion Cohort|Physician Decision|0
4875750|NCT00790842|16803257|P4|Expansion Cohort|Physician Decision|0
4875751|NCT00790842|16803258|P3|Expansion Cohort|Physician Decision|1
4875752|NCT00790842|16803259|P2|Expansion Cohort|Physician Decision|0
4875753|NCT00790842|16803260|P1|Expansion Cohort|Physician Decision|0
4875754|NCT00790842|16803250|P11|Expansion Cohort|Death|0
4875755|NCT00790842|16803251|P10|Expansion Cohort|Death|0
4875756|NCT00790842|16803252|P9|Expansion Cohort|Death|0
4875757|NCT00790842|16803253|P8|Expansion Cohort|Death|0
4875758|NCT00790842|16803254|P7|Expansion Cohort|Death|0
4875759|NCT00790842|16803255|P6|Expansion Cohort|Death|0
4875760|NCT00790842|16803256|P5|Expansion Cohort|Death|0
4875761|NCT00790842|16803257|P4|Expansion Cohort|Death|0
4875762|NCT00790842|16803258|P3|Expansion Cohort|Death|2
4875763|NCT00790842|16803259|P2|Expansion Cohort|Death|0
4875764|NCT00790842|16803260|P1|Expansion Cohort|Death|0
4875765|NCT00790842|16803250|P11|Expansion Cohort|Adverse Event|0
4875766|NCT00790842|16803251|P10|Expansion Cohort|Adverse Event|0
4875767|NCT00790842|16803252|P9|Expansion Cohort|Adverse Event|0
4875768|NCT00790842|16803253|P8|Expansion Cohort|Adverse Event|0
4875769|NCT00790842|16803254|P7|Expansion Cohort|Adverse Event|1
4875770|NCT00790842|16803255|P6|Expansion Cohort|Adverse Event|0
4875771|NCT00790842|16803256|P5|Expansion Cohort|Adverse Event|0
4875772|NCT00790842|16803257|P4|Expansion Cohort|Adverse Event|0
4875773|NCT00790842|16803258|P3|Expansion Cohort|Adverse Event|0
4875774|NCT00790842|16803259|P2|Expansion Cohort|Adverse Event|0
4875775|NCT00790842|16803260|P1|Expansion Cohort|Adverse Event|0
4875776|NCT00790842|16803250|P11|Dose Level 4|Withdrawal by Subject|1
4875777|NCT00790842|16803251|P10|Dose Level 4|Withdrawal by Subject|0
4875778|NCT00790842|16803252|P9|Dose Level 4|Withdrawal by Subject|0
4875779|NCT00790842|16803253|P8|Dose Level 4|Withdrawal by Subject|0
4875780|NCT00790842|16803254|P7|Dose Level 4|Withdrawal by Subject|0
4875781|NCT00790842|16803255|P6|Dose Level 4|Withdrawal by Subject|0
4875782|NCT00790842|16803256|P5|Dose Level 4|Withdrawal by Subject|0
4875783|NCT00790842|16803257|P4|Dose Level 4|Withdrawal by Subject|0
4875784|NCT00790842|16803258|P3|Dose Level 4|Withdrawal by Subject|0
4875785|NCT00790842|16803259|P2|Dose Level 4|Withdrawal by Subject|0
4875786|NCT00790842|16803260|P1|Dose Level 4|Withdrawal by Subject|0
4875787|NCT00790842|16803250|P11|Dose Level 4|Physician Decision|1
4875788|NCT00790842|16803251|P10|Dose Level 4|Physician Decision|0
4875789|NCT00790842|16803252|P9|Dose Level 4|Physician Decision|0
4875790|NCT00790842|16803253|P8|Dose Level 4|Physician Decision|0
4875791|NCT00790842|16803254|P7|Dose Level 4|Physician Decision|1
4875792|NCT00790842|16803255|P6|Dose Level 4|Physician Decision|0
4875793|NCT00790842|16803256|P5|Dose Level 4|Physician Decision|0
4875794|NCT00790842|16803257|P4|Dose Level 4|Physician Decision|0
4875795|NCT00790842|16803258|P3|Dose Level 4|Physician Decision|0
4875796|NCT00790842|16803259|P2|Dose Level 4|Physician Decision|0
4875797|NCT00790842|16803260|P1|Dose Level 4|Physician Decision|0
4875798|NCT00790842|16803250|P11|Dose Level 4|Adverse Event|0
4875799|NCT00790842|16803251|P10|Dose Level 4|Adverse Event|0
4875800|NCT00790842|16803252|P9|Dose Level 4|Adverse Event|0
4875801|NCT00790842|16803253|P8|Dose Level 4|Adverse Event|0
4875802|NCT00790842|16803254|P7|Dose Level 4|Adverse Event|1
4875803|NCT00790842|16803255|P6|Dose Level 4|Adverse Event|0
4875804|NCT00790842|16803256|P5|Dose Level 4|Adverse Event|0
4875805|NCT00790842|16803257|P4|Dose Level 4|Adverse Event|0
4875806|NCT00790842|16803258|P3|Dose Level 4|Adverse Event|0
4875807|NCT00790842|16803259|P2|Dose Level 4|Adverse Event|0
4875808|NCT00790842|16803260|P1|Dose Level 4|Adverse Event|0
4875809|NCT00790842|16803250|P11|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875810|NCT00790842|16803251|P10|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875811|NCT00790842|16803252|P9|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875812|NCT00790842|16803253|P8|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875813|NCT00790842|16803254|P7|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875814|NCT00790842|16803255|P6|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875815|NCT00790842|16803256|P5|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875816|NCT00790842|16803257|P4|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875817|NCT00790842|16803258|P3|Dose Level 3|Ineligible/Withdrew before Treatment|1
4875818|NCT00790842|16803259|P2|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875819|NCT00790842|16803260|P1|Dose Level 3|Ineligible/Withdrew before Treatment|0
4875820|NCT00790842|16803250|P11|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875821|NCT00790842|16803251|P10|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875822|NCT00790842|16803252|P9|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875823|NCT00790842|16803253|P8|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875824|NCT00790842|16803254|P7|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875825|NCT00790842|16803255|P6|Dose Level 3|Intercurrent Illness/Alternative Therapy|1
4875826|NCT00790842|16803256|P5|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875827|NCT00790842|16803257|P4|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875828|NCT00790842|16803258|P3|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875829|NCT00790842|16803259|P2|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875830|NCT00790842|16803260|P1|Dose Level 3|Intercurrent Illness/Alternative Therapy|0
4875831|NCT00790842|16803250|P11|Dose Level 3|Withdrawal by Subject|0
4875832|NCT00790842|16803251|P10|Dose Level 3|Withdrawal by Subject|2
4875833|NCT00790842|16803252|P9|Dose Level 3|Withdrawal by Subject|0
4875834|NCT00790842|16803253|P8|Dose Level 3|Withdrawal by Subject|0
4875835|NCT00790842|16803254|P7|Dose Level 3|Withdrawal by Subject|0
4875836|NCT00790842|16803255|P6|Dose Level 3|Withdrawal by Subject|0
4875837|NCT00790842|16803256|P5|Dose Level 3|Withdrawal by Subject|0
4875838|NCT00790842|16803257|P4|Dose Level 3|Withdrawal by Subject|0
4875839|NCT00790842|16803258|P3|Dose Level 3|Withdrawal by Subject|3
4875840|NCT00790842|16803259|P2|Dose Level 3|Withdrawal by Subject|0
4875841|NCT00790842|16803260|P1|Dose Level 3|Withdrawal by Subject|0
4875842|NCT00790842|16803250|P11|Dose Level 3|Adverse Event|0
4875843|NCT00790842|16803251|P10|Dose Level 3|Adverse Event|0
4875844|NCT00790842|16803252|P9|Dose Level 3|Adverse Event|0
4875845|NCT00790842|16803253|P8|Dose Level 3|Adverse Event|0
4875846|NCT00790842|16803254|P7|Dose Level 3|Adverse Event|0
4875847|NCT00790842|16803255|P6|Dose Level 3|Adverse Event|0
4875848|NCT00790842|16803256|P5|Dose Level 3|Adverse Event|0
4875849|NCT00790842|16803257|P4|Dose Level 3|Adverse Event|0
4875850|NCT00790842|16803258|P3|Dose Level 3|Adverse Event|1
4875851|NCT00790842|16803259|P2|Dose Level 3|Adverse Event|0
4875852|NCT00790842|16803260|P1|Dose Level 3|Adverse Event|0
4875853|NCT00790842|16803250|P11|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875854|NCT00790842|16803251|P10|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875855|NCT00790842|16803252|P9|Dose Level 2|Intercurrent Illness/Other Treatment|2
4875856|NCT00790842|16803253|P8|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875857|NCT00790842|16803254|P7|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875858|NCT00790842|16803255|P6|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875859|NCT00790842|16803256|P5|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875860|NCT00790842|16803257|P4|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875861|NCT00790842|16803258|P3|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875862|NCT00790842|16803259|P2|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875863|NCT00790842|16803260|P1|Dose Level 2|Intercurrent Illness/Other Treatment|0
4875864|NCT00790842|16803250|P11|Dose Level 2|Withdrawal by Subject|0
4875865|NCT00790842|16803251|P10|Dose Level 2|Withdrawal by Subject|0
4875866|NCT00790842|16803252|P9|Dose Level 2|Withdrawal by Subject|0
4875867|NCT00790842|16803253|P8|Dose Level 2|Withdrawal by Subject|0
4875868|NCT00790842|16803254|P7|Dose Level 2|Withdrawal by Subject|0
4875869|NCT00790842|16803255|P6|Dose Level 2|Withdrawal by Subject|0
4875870|NCT00790842|16803256|P5|Dose Level 2|Withdrawal by Subject|0
4875871|NCT00790842|16803257|P4|Dose Level 2|Withdrawal by Subject|0
4875872|NCT00790842|16803258|P3|Dose Level 2|Withdrawal by Subject|0
4875873|NCT00790842|16803259|P2|Dose Level 2|Withdrawal by Subject|1
4875874|NCT00790842|16803260|P1|Dose Level 2|Withdrawal by Subject|0
4875875|NCT00790842|16803250|P11|Dose Level 2|Physician Decision|0
4875876|NCT00790842|16803251|P10|Dose Level 2|Physician Decision|0
4875877|NCT00790842|16803252|P9|Dose Level 2|Physician Decision|0
4875878|NCT00790842|16803253|P8|Dose Level 2|Physician Decision|0
4875879|NCT00790842|16803254|P7|Dose Level 2|Physician Decision|0
4875880|NCT00790842|16803255|P6|Dose Level 2|Physician Decision|0
4875881|NCT00790842|16803256|P5|Dose Level 2|Physician Decision|0
4875882|NCT00790842|16803257|P4|Dose Level 2|Physician Decision|0
4875883|NCT00790842|16803258|P3|Dose Level 2|Physician Decision|0
4875884|NCT00790842|16803259|P2|Dose Level 2|Physician Decision|1
4875885|NCT00790842|16803260|P1|Dose Level 2|Physician Decision|0
4875886|NCT00790842|16803250|P11|Dose Level 2|Death|0
4875887|NCT00790842|16803251|P10|Dose Level 2|Death|0
4875888|NCT00790842|16803252|P9|Dose Level 2|Death|0
4875889|NCT00790842|16803253|P8|Dose Level 2|Death|0
4875890|NCT00790842|16803254|P7|Dose Level 2|Death|0
4875891|NCT00790842|16803255|P6|Dose Level 2|Death|0
4875892|NCT00790842|16803256|P5|Dose Level 2|Death|1
4875893|NCT00790842|16803257|P4|Dose Level 2|Death|0
4875894|NCT00790842|16803258|P3|Dose Level 2|Death|0
4875895|NCT00790842|16803259|P2|Dose Level 2|Death|1
4875896|NCT00790842|16803260|P1|Dose Level 2|Death|0
4875897|NCT00790842|16803250|P11|Dose Level 1|Withdrawal by Subject|0
4875898|NCT00790842|16803251|P10|Dose Level 1|Withdrawal by Subject|0
4875899|NCT00790842|16803252|P9|Dose Level 1|Withdrawal by Subject|0
4875900|NCT00790842|16803253|P8|Dose Level 1|Withdrawal by Subject|0
4875901|NCT00790842|16803254|P7|Dose Level 1|Withdrawal by Subject|0
4875902|NCT00790842|16803255|P6|Dose Level 1|Withdrawal by Subject|0
4875903|NCT00790842|16803256|P5|Dose Level 1|Withdrawal by Subject|0
4875904|NCT00790842|16803257|P4|Dose Level 1|Withdrawal by Subject|0
4875905|NCT00790842|16803258|P3|Dose Level 1|Withdrawal by Subject|0
4875906|NCT00790842|16803259|P2|Dose Level 1|Withdrawal by Subject|0
4875907|NCT00790842|16803260|P1|Dose Level 1|Withdrawal by Subject|1
4875908|NCT00790842|16803250|P11|Dose Level 1|Physician Decision|0
4875909|NCT00790842|16803251|P10|Dose Level 1|Physician Decision|0
4875910|NCT00790842|16803252|P9|Dose Level 1|Physician Decision|0
4875911|NCT00790842|16803253|P8|Dose Level 1|Physician Decision|1
4875912|NCT00790842|16803254|P7|Dose Level 1|Physician Decision|0
4875913|NCT00790842|16803255|P6|Dose Level 1|Physician Decision|0
4875914|NCT00790842|16803256|P5|Dose Level 1|Physician Decision|0
4875915|NCT00790842|16803257|P4|Dose Level 1|Physician Decision|0
4875916|NCT00790842|16803258|P3|Dose Level 1|Physician Decision|0
4875917|NCT00790842|16803259|P2|Dose Level 1|Physician Decision|0
4875918|NCT00790842|16803260|P1|Dose Level 1|Physician Decision|1
4875919|NCT00790842|16803250|P11|Dose Level 1|Adverse Event|0
4875920|NCT00790842|16803251|P10|Dose Level 1|Adverse Event|0
4875921|NCT00790842|16803252|P9|Dose Level 1|Adverse Event|0
4875922|NCT00790842|16803253|P8|Dose Level 1|Adverse Event|1
4875923|NCT00790842|16803254|P7|Dose Level 1|Adverse Event|0
4875924|NCT00790842|16803255|P6|Dose Level 1|Adverse Event|0
4875925|NCT00790842|16803256|P5|Dose Level 1|Adverse Event|0
4875926|NCT00790842|16803257|P4|Dose Level 1|Adverse Event|2
4875927|NCT00790842|16803258|P3|Dose Level 1|Adverse Event|0
4875928|NCT00790842|16803259|P2|Dose Level 1|Adverse Event|0
4875929|NCT00790842|16803260|P1|Dose Level 1|Adverse Event|1
4875930|NCT00790790|16803328|P3|Study Period 2: Therapy Phase|Physician Decision|0
4875931|NCT00790790|16803329|P2|Study Period 2: Therapy Phase|Physician Decision|1
4875932|NCT00790790|16803330|P1|Study Period 2: Therapy Phase|Physician Decision|0
4875933|NCT00790790|16803328|P3|Study Period 2: Therapy Phase|Lack of Efficacy|3
4875934|NCT00790790|16803329|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
4875935|NCT00790790|16803330|P1|Study Period 2: Therapy Phase|Lack of Efficacy|1
4875936|NCT00790790|16803328|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|2
4875937|NCT00790790|16803329|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|0
4875938|NCT00790790|16803330|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|7
4875939|NCT00790790|16803328|P3|Study Period 2: Therapy Phase|Protocol Violation|0
4875940|NCT00790790|16803329|P2|Study Period 2: Therapy Phase|Protocol Violation|1
4875941|NCT00790790|16803330|P1|Study Period 2: Therapy Phase|Protocol Violation|1
4875942|NCT00790790|16803328|P3|Study Period 2: Therapy Phase|Adverse Event|16
4875943|NCT00790790|16803329|P2|Study Period 2: Therapy Phase|Adverse Event|16
4875944|NCT00790790|16803330|P1|Study Period 2: Therapy Phase|Adverse Event|3
4875945|NCT00790751|16803407|P4|Overall Study|Physician Decision|1
4875946|NCT00790751|16803408|P3|Overall Study|Physician Decision|0
4875947|NCT00790751|16803409|P2|Overall Study|Physician Decision|0
4875948|NCT00790751|16803410|P1|Overall Study|Physician Decision|0
4875949|NCT00790751|16803407|P4|Overall Study|Death|0
4875950|NCT00790751|16803408|P3|Overall Study|Death|1
4875951|NCT00790751|16803409|P2|Overall Study|Death|0
4875952|NCT00790751|16803410|P1|Overall Study|Death|0
4875953|NCT00790751|16803407|P4|Overall Study|Requirement for restricted medication|0
4875954|NCT00790751|16803408|P3|Overall Study|Requirement for restricted medication|0
4875955|NCT00790751|16803409|P2|Overall Study|Requirement for restricted medication|2
4875956|NCT00790751|16803410|P1|Overall Study|Requirement for restricted medication|0
4875957|NCT00790751|16803407|P4|Overall Study|Adverse Event|4
4875958|NCT00790751|16803408|P3|Overall Study|Adverse Event|5
4875959|NCT00790751|16803409|P2|Overall Study|Adverse Event|3
4875960|NCT00790751|16803410|P1|Overall Study|Adverse Event|5
4875961|NCT00790751|16803407|P4|Overall Study|Lost to Follow-up|5
4875962|NCT00790751|16803408|P3|Overall Study|Lost to Follow-up|4
4875963|NCT00790751|16803409|P2|Overall Study|Lost to Follow-up|9
4875964|NCT00790751|16803410|P1|Overall Study|Lost to Follow-up|4
4875965|NCT00790751|16803407|P4|Overall Study|Protocol non-compliance|11
4875966|NCT00790751|16803408|P3|Overall Study|Protocol non-compliance|10
4875967|NCT00790751|16803409|P2|Overall Study|Protocol non-compliance|16
4875968|NCT00790751|16803410|P1|Overall Study|Protocol non-compliance|16
4875969|NCT00790647|16803469|P1|Overall Study|Adverse Event|1
4875970|NCT00790569|16803479|P3|End of Study (12 Month Interview)|Lost to Follow-up|50
4875971|NCT00790569|16803480|P2|End of Study (12 Month Interview)|Lost to Follow-up|19
4875972|NCT00790569|16803481|P1|End of Study (12 Month Interview)|Lost to Follow-up|66
4875973|NCT00790569|16803479|P3|End of Treatment (6 Month Interview)|Incarcerated|3
4875974|NCT00790569|16803480|P2|End of Treatment (6 Month Interview)|Incarcerated|0
4875975|NCT00790569|16803481|P1|End of Treatment (6 Month Interview)|Incarcerated|0
4875976|NCT00790569|16803479|P3|End of Treatment (6 Month Interview)|Residential Treatment|2
4875977|NCT00790569|16803480|P2|End of Treatment (6 Month Interview)|Residential Treatment|0
4875978|NCT00790569|16803481|P1|End of Treatment (6 Month Interview)|Residential Treatment|0
4875979|NCT00790569|16803479|P3|End of Treatment (6 Month Interview)|Hospitalized|0
4875980|NCT00790569|16803480|P2|End of Treatment (6 Month Interview)|Hospitalized|0
4875981|NCT00790569|16803481|P1|End of Treatment (6 Month Interview)|Hospitalized|2
4875982|NCT00790569|16803479|P3|End of Treatment (6 Month Interview)|Death|1
4875983|NCT00790569|16803480|P2|End of Treatment (6 Month Interview)|Death|2
4875984|NCT00790569|16803481|P1|End of Treatment (6 Month Interview)|Death|0
4875985|NCT00790569|16803479|P3|End of Treatment (6 Month Interview)|Lost to Follow-up|20
4875986|NCT00790569|16803480|P2|End of Treatment (6 Month Interview)|Lost to Follow-up|8
4875987|NCT00790569|16803481|P1|End of Treatment (6 Month Interview)|Lost to Follow-up|20
4875988|NCT00790556|16803522|P2|Treatment Period 1|Withdrawal by Subject|0
4875989|NCT00790556|16803523|P1|Treatment Period 1|Withdrawal by Subject|1
4875990|NCT00790556|16803522|P2|Treatment Period 1|Physician Decision|0
4875991|NCT00790556|16803523|P1|Treatment Period 1|Physician Decision|1
4875992|NCT00790452|16803535|P2|Overall Study|Drug supply issue|0
4875993|NCT00790452|16803536|P1|Overall Study|Drug supply issue|1
4875994|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|New treatment|0
4875995|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|New treatment|2
4875996|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Protocol Violation|0
4875997|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Protocol Violation|1
4875998|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Disease progression|0
4875999|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Disease progression|5
4876000|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Death|0
4876001|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Death|1
4876002|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Administrative problems|0
4876003|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Administrative problems|2
4876004|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Lost to Follow-up|0
4876005|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Lost to Follow-up|1
4876006|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Withdrawal by Subject|0
4876007|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Withdrawal by Subject|7
4876008|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0
4876009|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1
4876010|NCT00790400|16803544|P2|Everolimus Period (Core or Extension)|Adverse Event|0
4876011|NCT00790400|16803545|P1|Everolimus Period (Core or Extension)|Adverse Event|9
4876012|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Death|0
4876013|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Death|1
4876014|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Administrative problems|0
4876015|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Administrative problems|1
4876016|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Withdrawal by Subject|0
4876017|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Withdrawal by Subject|1
4876191|NCT00789581|16804323|P1|Adjuvant Therapy|Adverse Event|20
4876018|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Abnormal lab value (s)|0
4876019|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Abnormal lab value (s)|1
4876020|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Adverse Event|4
4876021|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Adverse Event|2
4876022|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Progressive disease|9
4876023|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Progressive disease|0
4876024|NCT00790400|16803544|P2|Double-blind Period (Core Phase)|Protocol Violation|0
4876025|NCT00790400|16803545|P1|Double-blind Period (Core Phase)|Protocol Violation|1
4876026|NCT00790296|16803635|P2|Overall Study|Adverse Event|1
4876027|NCT00790296|16803636|P1|Overall Study|Adverse Event|0
4876028|NCT00790296|16803635|P2|Overall Study|Did not meet study eligibility criteria|1
4876029|NCT00790296|16803636|P1|Overall Study|Did not meet study eligibility criteria|1
4876030|NCT00790218|16803658|P3|Overall Study|Death|0
4876031|NCT00790218|16803659|P2|Overall Study|Death|0
4876032|NCT00790218|16803660|P1|Overall Study|Death|1
4876033|NCT00790205|16803670|P2|Overall Study|Withdrawal by Subject|363
4876034|NCT00790205|16803671|P1|Overall Study|Withdrawal by Subject|299
4876035|NCT00790205|16803670|P2|Overall Study|Lost to Follow-up|71
4876036|NCT00790205|16803671|P1|Overall Study|Lost to Follow-up|61
4876037|NCT00790088|16803732|P1|Overall Study|Physician Decision|4
4876038|NCT00790088|16803732|P1|Overall Study|Lost to Follow-up|7
4876039|NCT00790088|16803732|P1|Overall Study|Withdrawal by Subject|17
4876040|NCT00790088|16803732|P1|Overall Study|Protocol Violation|11
4876041|NCT00790036|16803778|P2|Overall Study|Subject/guardian decision|7
4876042|NCT00790036|16803779|P1|Overall Study|Subject/guardian decision|20
4876043|NCT00790036|16803778|P2|Overall Study|Withdrawal by Subject|7
4876044|NCT00790036|16803779|P1|Overall Study|Withdrawal by Subject|18
4876045|NCT00790036|16803778|P2|Overall Study|Protocol Violation|2
4876046|NCT00790036|16803779|P1|Overall Study|Protocol Violation|10
4876047|NCT00790036|16803778|P2|Overall Study|Lost to Follow-up|2
4876048|NCT00790036|16803779|P1|Overall Study|Lost to Follow-up|1
4876049|NCT00790036|16803778|P2|Overall Study|Disease progression|48
4876050|NCT00790036|16803779|P1|Overall Study|Disease progression|24
4876051|NCT00790036|16803778|P2|Overall Study|Death|0
4876052|NCT00790036|16803779|P1|Overall Study|Death|1
4876053|NCT00790036|16803778|P2|Overall Study|Adverse Event|44
4876054|NCT00790036|16803779|P1|Overall Study|Adverse Event|113
4876055|NCT00790036|16803778|P2|Overall Study|Administrative problems|9
4876056|NCT00790036|16803779|P1|Overall Study|Administrative problems|5
4876057|NCT00790036|16803778|P2|Overall Study|Abnormal lab values|2
4876058|NCT00790036|16803779|P1|Overall Study|Abnormal lab values|3
4876059|NCT00790023|16803793|P3|Overall Study|Other|8
4876060|NCT00790023|16803794|P2|Overall Study|Other|5
4876061|NCT00790023|16803795|P1|Overall Study|Other|5
4876062|NCT00790023|16803793|P3|Overall Study|Lost to Follow-up|1
4876063|NCT00790023|16803794|P2|Overall Study|Lost to Follow-up|0
4876064|NCT00790023|16803795|P1|Overall Study|Lost to Follow-up|0
4876065|NCT00790023|16803793|P3|Overall Study|Withdrawal by Subject|6
4876066|NCT00790023|16803794|P2|Overall Study|Withdrawal by Subject|0
4876067|NCT00790023|16803795|P1|Overall Study|Withdrawal by Subject|2
4876068|NCT00790023|16803793|P3|Overall Study|Protocol Violation|2
4876069|NCT00790023|16803794|P2|Overall Study|Protocol Violation|4
4876070|NCT00790023|16803795|P1|Overall Study|Protocol Violation|2
4876071|NCT00790023|16803793|P3|Overall Study|Adverse Event|4
4876072|NCT00790023|16803794|P2|Overall Study|Adverse Event|1
4876073|NCT00790023|16803795|P1|Overall Study|Adverse Event|2
4876074|NCT00789958|16803894|P1|Overall Study|Not eligible/not analyzable|26
4876075|NCT00789958|16803894|P1|Overall Study|not protocol specified|1
4876076|NCT00789958|16803894|P1|Overall Study|Progression|3
4876077|NCT00789958|16803894|P1|Overall Study|Withdrawal by Subject|4
4876078|NCT00789958|16803894|P1|Overall Study|Adverse Event|3
4876079|NCT00789880|16803913|P6|Overall Study|Withdrawal by Subject|0
4876080|NCT00789880|16803914|P5|Overall Study|Withdrawal by Subject|2
4876081|NCT00789880|16803915|P4|Overall Study|Withdrawal by Subject|0
4876082|NCT00789880|16803916|P3|Overall Study|Withdrawal by Subject|0
4876083|NCT00789880|16803917|P2|Overall Study|Withdrawal by Subject|0
4876084|NCT00789880|16803918|P1|Overall Study|Withdrawal by Subject|1
4876085|NCT00789880|16803913|P6|Overall Study|Protocol Violation|0
4876086|NCT00789880|16803914|P5|Overall Study|Protocol Violation|0
4876087|NCT00789880|16803915|P4|Overall Study|Protocol Violation|1
4876088|NCT00789880|16803916|P3|Overall Study|Protocol Violation|0
4876089|NCT00789880|16803917|P2|Overall Study|Protocol Violation|1
4876090|NCT00789880|16803918|P1|Overall Study|Protocol Violation|0
4876091|NCT00789880|16803913|P6|Overall Study|Adverse Event|0
4876092|NCT00789880|16803914|P5|Overall Study|Adverse Event|1
4876093|NCT00789880|16803915|P4|Overall Study|Adverse Event|0
4876094|NCT00789880|16803916|P3|Overall Study|Adverse Event|0
4876095|NCT00789880|16803917|P2|Overall Study|Adverse Event|0
4876096|NCT00789880|16803918|P1|Overall Study|Adverse Event|0
4876097|NCT00789854|16803975|P3|Overall Study|Other|5
4876098|NCT00789854|16803976|P2|Overall Study|Other|0
4876099|NCT00789854|16803977|P1|Overall Study|Other|6
4876100|NCT00789854|16803975|P3|Overall Study|Safety reasons|2
4876101|NCT00789854|16803976|P2|Overall Study|Safety reasons|0
4876102|NCT00789854|16803977|P1|Overall Study|Safety reasons|0
4876103|NCT00789854|16803975|P3|Overall Study|Severe non-compliance to the protocol|0
4876104|NCT00789854|16803976|P2|Overall Study|Severe non-compliance to the protocol|0
4876105|NCT00789854|16803977|P1|Overall Study|Severe non-compliance to the protocol|3
4876106|NCT00789854|16803975|P3|Overall Study|Eligibility criteria not fulfilled|1
4876107|NCT00789854|16803976|P2|Overall Study|Eligibility criteria not fulfilled|5
4876108|NCT00789854|16803977|P1|Overall Study|Eligibility criteria not fulfilled|2
4876109|NCT00789854|16803975|P3|Overall Study|Withdrawal by Subject|17
4876110|NCT00789854|16803976|P2|Overall Study|Withdrawal by Subject|6
4876111|NCT00789854|16803977|P1|Overall Study|Withdrawal by Subject|9
4876112|NCT00789854|16803975|P3|Overall Study|Lost to Follow-up|4
4876113|NCT00789854|16803976|P2|Overall Study|Lost to Follow-up|1
4876114|NCT00789854|16803977|P1|Overall Study|Lost to Follow-up|1
4876115|NCT00789854|16803975|P3|Overall Study|Adverse Event|18
4876116|NCT00789854|16803976|P2|Overall Study|Adverse Event|23
4876117|NCT00789854|16803977|P1|Overall Study|Adverse Event|28
4876118|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|New treatment for indication under study|0
4876119|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|New treatment for indication under study|1
4876120|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|Disease progression|0
4876121|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|Disease progression|1
4876122|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|Death|0
4876123|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|Death|1
4876124|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|Administrative problems|0
4876125|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|Administrative problems|7
4876126|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|Lost to Follow-up|0
4876127|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|Lost to Follow-up|3
4876128|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|Withdrawal by Subject|0
4876129|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|Withdrawal by Subject|6
4876130|NCT00789828|16804074|P2|Open-label Extension Period (4 Years)|Adverse Event|0
4876131|NCT00789828|16804075|P1|Open-label Extension Period (4 Years)|Adverse Event|10
4876132|NCT00789828|16804074|P2|Core Period (48 Weeks)|Lost to Follow-up|1
4876133|NCT00789828|16804075|P1|Core Period (48 Weeks)|Lost to Follow-up|0
4876134|NCT00789828|16804074|P2|Core Period (48 Weeks)|Withdrawal by Subject|4
4876135|NCT00789828|16804075|P1|Core Period (48 Weeks)|Withdrawal by Subject|0
4876136|NCT00789828|16804074|P2|Core Period (48 Weeks)|Administrative problems|1
4876137|NCT00789828|16804075|P1|Core Period (48 Weeks)|Administrative problems|0
4876138|NCT00789815|16804109|P2|Overall Study|Intubation due to massive bleeding|0
4876139|NCT00789815|16804110|P1|Overall Study|Intubation due to massive bleeding|1
4876140|NCT00789815|16804109|P2|Overall Study|Protocol Violation|1
4876141|NCT00789815|16804110|P1|Overall Study|Protocol Violation|6
4876142|NCT00789737|16804220|P2|Overall Study|Other|7
4876143|NCT00789737|16804221|P1|Overall Study|Other|11
4876144|NCT00789737|16804220|P2|Overall Study|hyperglycemia that met protocol-specifie|4
4876145|NCT00789737|16804221|P1|Overall Study|hyperglycemia that met protocol-specifie|0
4876146|NCT00789737|16804220|P2|Overall Study|Lack of Efficacy|0
4876147|NCT00789737|16804221|P1|Overall Study|Lack of Efficacy|3
4876148|NCT00789737|16804220|P2|Overall Study|Protocol Violation|0
4876149|NCT00789737|16804221|P1|Overall Study|Protocol Violation|3
4876150|NCT00789737|16804220|P2|Overall Study|Adverse Event|8
4876151|NCT00789737|16804221|P1|Overall Study|Adverse Event|8
4876152|NCT00789737|16804220|P2|Overall Study|Lost to Follow-up|14
4876153|NCT00789737|16804221|P1|Overall Study|Lost to Follow-up|10
4876154|NCT00789737|16804220|P2|Overall Study|Withdrawal by Subject|22
4876155|NCT00789737|16804221|P1|Overall Study|Withdrawal by Subject|13
4876156|NCT00789698|16804264|P4|Overall Study|Administrative|1
4876157|NCT00789698|16804265|P3|Overall Study|Administrative|3
4876158|NCT00789698|16804266|P2|Overall Study|Administrative|3
4876159|NCT00789698|16804267|P1|Overall Study|Administrative|0
4876160|NCT00789698|16804264|P4|Overall Study|Withdrawal by Subject|19
4876161|NCT00789698|16804265|P3|Overall Study|Withdrawal by Subject|12
4876162|NCT00789698|16804266|P2|Overall Study|Withdrawal by Subject|15
4876163|NCT00789698|16804267|P1|Overall Study|Withdrawal by Subject|14
4876164|NCT00789698|16804264|P4|Overall Study|Protocol Violation|1
4876165|NCT00789698|16804265|P3|Overall Study|Protocol Violation|2
4876166|NCT00789698|16804266|P2|Overall Study|Protocol Violation|1
4876167|NCT00789698|16804267|P1|Overall Study|Protocol Violation|6
4876168|NCT00789698|16804264|P4|Overall Study|Lost to Follow-up|9
4876169|NCT00789698|16804265|P3|Overall Study|Lost to Follow-up|2
4876170|NCT00789698|16804266|P2|Overall Study|Lost to Follow-up|5
4876171|NCT00789698|16804267|P1|Overall Study|Lost to Follow-up|5
4876172|NCT00789698|16804264|P4|Overall Study|Adverse Event|4
4876173|NCT00789698|16804265|P3|Overall Study|Adverse Event|3
4876174|NCT00789698|16804266|P2|Overall Study|Adverse Event|5
4876175|NCT00789698|16804267|P1|Overall Study|Adverse Event|5
4876176|NCT00789698|16804264|P4|Overall Study|Lack of Efficacy|18
4876177|NCT00789698|16804265|P3|Overall Study|Lack of Efficacy|5
4876178|NCT00789698|16804266|P2|Overall Study|Lack of Efficacy|4
4876179|NCT00789698|16804267|P1|Overall Study|Lack of Efficacy|10
4876180|NCT00789581|16804322|P2|Adjuvant Therapy|Other|1
4876181|NCT00789581|16804323|P1|Adjuvant Therapy|Other|0
4876182|NCT00789581|16804322|P2|Adjuvant Therapy|Protocol Violation|1
4876183|NCT00789581|16804323|P1|Adjuvant Therapy|Protocol Violation|1
4876184|NCT00789581|16804322|P2|Adjuvant Therapy|Intercurrent Illness|3
4876185|NCT00789581|16804323|P1|Adjuvant Therapy|Intercurrent Illness|1
4876186|NCT00789581|16804322|P2|Adjuvant Therapy|Disease recurrence|1
4876187|NCT00789581|16804323|P1|Adjuvant Therapy|Disease recurrence|2
4876188|NCT00789581|16804322|P2|Adjuvant Therapy|Withdrawal by Subject|5
4876189|NCT00789581|16804323|P1|Adjuvant Therapy|Withdrawal by Subject|14
4876190|NCT00789581|16804322|P2|Adjuvant Therapy|Adverse Event|44
4876192|NCT00789581|16804322|P2|Adjuvant Therapy|Never treated|2
4876193|NCT00789581|16804323|P1|Adjuvant Therapy|Never treated|2
4876194|NCT00789581|16804322|P2|AC Therapy|Other|2
4876195|NCT00789581|16804323|P1|AC Therapy|Other|0
4876196|NCT00789581|16804322|P2|AC Therapy|Never Treated|4
4876197|NCT00789581|16804323|P1|AC Therapy|Never Treated|1
4876198|NCT00789581|16804322|P2|AC Therapy|Intercurrent Illness|0
4876199|NCT00789581|16804323|P1|AC Therapy|Intercurrent Illness|1
4876200|NCT00789581|16804322|P2|AC Therapy|Disease recurrence|1
4876201|NCT00789581|16804323|P1|AC Therapy|Disease recurrence|3
4876202|NCT00789581|16804322|P2|AC Therapy|Withdrawal by Subject|7
4876203|NCT00789581|16804323|P1|AC Therapy|Withdrawal by Subject|4
4876204|NCT00789581|16804322|P2|AC Therapy|Adverse Event|3
4876205|NCT00789581|16804323|P1|AC Therapy|Adverse Event|2
4876206|NCT00789555|16804334|P3|Overall Study|Protocol Violation|13
4876207|NCT00789555|16804335|P2|Overall Study|Protocol Violation|9
4876208|NCT00789555|16804336|P1|Overall Study|Protocol Violation|6
4876209|NCT00789555|16804334|P3|Overall Study|Treatment failure|12
4876210|NCT00789555|16804335|P2|Overall Study|Treatment failure|8
4876211|NCT00789555|16804336|P1|Overall Study|Treatment failure|11
4876212|NCT00789555|16804334|P3|Overall Study|Patient decision unnrelated to adv event|26
4876213|NCT00789555|16804335|P2|Overall Study|Patient decision unnrelated to adv event|29
4876214|NCT00789555|16804336|P1|Overall Study|Patient decision unnrelated to adv event|38
4876215|NCT00789555|16804334|P3|Overall Study|Lost to Follow-up|18
4876216|NCT00789555|16804335|P2|Overall Study|Lost to Follow-up|10
4876217|NCT00789555|16804336|P1|Overall Study|Lost to Follow-up|9
4876218|NCT00789555|16804334|P3|Overall Study|Adverse Event|10
4876219|NCT00789555|16804335|P2|Overall Study|Adverse Event|7
4876220|NCT00789555|16804336|P1|Overall Study|Adverse Event|17
4876221|NCT00789555|16804334|P3|Overall Study|Protocol Amendment|80
4876222|NCT00789555|16804335|P2|Overall Study|Protocol Amendment|76
4876223|NCT00789555|16804336|P1|Overall Study|Protocol Amendment|78
4876224|NCT00789529|16804361|P2|Overall Study|Other Reason|0
4876225|NCT00789529|16804362|P1|Overall Study|Other Reason|1
4876226|NCT00789529|16804361|P2|Overall Study|Withdrawal by Subject|1
4876227|NCT00789529|16804362|P1|Overall Study|Withdrawal by Subject|0
4876228|NCT00789477|16804375|P5|Overall Study|Other|0
4876229|NCT00789477|16804376|P4|Overall Study|Other|3
4876230|NCT00789477|16804377|P3|Overall Study|Other|1
4876231|NCT00789477|16804378|P2|Overall Study|Other|0
4876232|NCT00789477|16804379|P1|Overall Study|Other|2
4876233|NCT00789477|16804375|P5|Overall Study|Lack of Efficacy|0
4876234|NCT00789477|16804376|P4|Overall Study|Lack of Efficacy|0
4876235|NCT00789477|16804377|P3|Overall Study|Lack of Efficacy|0
4876236|NCT00789477|16804378|P2|Overall Study|Lack of Efficacy|0
4876237|NCT00789477|16804379|P1|Overall Study|Lack of Efficacy|2
4876238|NCT00789477|16804375|P5|Overall Study|Lost to Follow-up|4
4876239|NCT00789477|16804376|P4|Overall Study|Lost to Follow-up|2
4876240|NCT00789477|16804377|P3|Overall Study|Lost to Follow-up|4
4876241|NCT00789477|16804378|P2|Overall Study|Lost to Follow-up|1
4876242|NCT00789477|16804379|P1|Overall Study|Lost to Follow-up|0
4876243|NCT00789477|16804375|P5|Overall Study|Death|0
4876244|NCT00789477|16804376|P4|Overall Study|Death|2
4876245|NCT00789477|16804377|P3|Overall Study|Death|2
4876246|NCT00789477|16804378|P2|Overall Study|Death|1
4876247|NCT00789477|16804379|P1|Overall Study|Death|1
4876248|NCT00789477|16804375|P5|Overall Study|Adverse Event|0
4876249|NCT00789477|16804376|P4|Overall Study|Adverse Event|0
4876250|NCT00789477|16804377|P3|Overall Study|Adverse Event|1
4876251|NCT00789477|16804378|P2|Overall Study|Adverse Event|3
4876252|NCT00789477|16804379|P1|Overall Study|Adverse Event|3
4876253|NCT00789477|16804375|P5|Overall Study|Protocol Violation|0
4876254|NCT00789477|16804376|P4|Overall Study|Protocol Violation|1
4876255|NCT00789477|16804377|P3|Overall Study|Protocol Violation|0
4876256|NCT00789477|16804378|P2|Overall Study|Protocol Violation|0
4876257|NCT00789477|16804379|P1|Overall Study|Protocol Violation|1
4876258|NCT00789477|16804375|P5|Overall Study|Withdrawal by Subject|3
4876259|NCT00789477|16804376|P4|Overall Study|Withdrawal by Subject|2
4876260|NCT00789477|16804377|P3|Overall Study|Withdrawal by Subject|3
4876261|NCT00789477|16804378|P2|Overall Study|Withdrawal by Subject|1
4876262|NCT00789477|16804379|P1|Overall Study|Withdrawal by Subject|2
4876263|NCT00789373|16804424|P3|Maintenance|Participants On-Going at Data Cut-Off|0
4876264|NCT00789373|16804425|P2|Maintenance|Participants On-Going at Data Cut-Off|4
4876265|NCT00789373|16804426|P1|Maintenance|Participants On-Going at Data Cut-Off|0
4876266|NCT00789373|16804424|P3|Maintenance|Sponsor Decision|2
4876267|NCT00789373|16804425|P2|Maintenance|Sponsor Decision|0
4876268|NCT00789373|16804426|P1|Maintenance|Sponsor Decision|0
4876269|NCT00789373|16804424|P3|Maintenance|Withdrawal by Subject|8
4876270|NCT00789373|16804425|P2|Maintenance|Withdrawal by Subject|21
4876271|NCT00789373|16804426|P1|Maintenance|Withdrawal by Subject|0
4876272|NCT00789373|16804424|P3|Maintenance|Progressive Disease|152
4876273|NCT00789373|16804425|P2|Maintenance|Progressive Disease|253
4876274|NCT00789373|16804426|P1|Maintenance|Progressive Disease|0
4876275|NCT00789373|16804424|P3|Maintenance|Lost to Follow-up|0
4876276|NCT00789373|16804425|P2|Maintenance|Lost to Follow-up|2
4876277|NCT00789373|16804426|P1|Maintenance|Lost to Follow-up|0
4876278|NCT00789373|16804424|P3|Maintenance|Protocol entry criteria not met|0
4876279|NCT00789373|16804425|P2|Maintenance|Protocol entry criteria not met|2
4876280|NCT00789373|16804426|P1|Maintenance|Protocol entry criteria not met|0
4876281|NCT00789373|16804424|P3|Maintenance|Investigator Decision|2
4876282|NCT00789373|16804425|P2|Maintenance|Investigator Decision|4
4876283|NCT00789373|16804426|P1|Maintenance|Investigator Decision|0
4876284|NCT00789373|16804424|P3|Maintenance|Death due to toxicity|2
4876285|NCT00789373|16804425|P2|Maintenance|Death due to toxicity|1
4876286|NCT00789373|16804426|P1|Maintenance|Death due to toxicity|0
4876287|NCT00789373|16804424|P3|Maintenance|Death due to adverse event|1
4876288|NCT00789373|16804425|P2|Maintenance|Death due to adverse event|4
4876289|NCT00789373|16804426|P1|Maintenance|Death due to adverse event|0
4876290|NCT00789373|16804424|P3|Maintenance|Death due to study disease|1
4876291|NCT00789373|16804425|P2|Maintenance|Death due to study disease|3
4876292|NCT00789373|16804426|P1|Maintenance|Death due to study disease|0
4876293|NCT00789373|16804424|P3|Maintenance|Adverse Event|12
4876294|NCT00789373|16804425|P2|Maintenance|Adverse Event|65
4876295|NCT00789373|16804426|P1|Maintenance|Adverse Event|0
4876296|NCT00789373|16804424|P3|Induction|Withdrawal by Subject|0
4876297|NCT00789373|16804425|P2|Induction|Withdrawal by Subject|0
4876298|NCT00789373|16804426|P1|Induction|Withdrawal by Subject|37
4876299|NCT00789373|16804424|P3|Induction|Progressive Disease|0
4876300|NCT00789373|16804425|P2|Induction|Progressive Disease|0
4876301|NCT00789373|16804426|P1|Induction|Progressive Disease|220
4876302|NCT00789373|16804424|P3|Induction|Protocol Violation|0
4876303|NCT00789373|16804425|P2|Induction|Protocol Violation|0
4876304|NCT00789373|16804426|P1|Induction|Protocol Violation|1
4876305|NCT00789373|16804424|P3|Induction|Lost to Follow-up|0
4876306|NCT00789373|16804425|P2|Induction|Lost to Follow-up|0
4876307|NCT00789373|16804426|P1|Induction|Lost to Follow-up|6
4876308|NCT00789373|16804424|P3|Induction|Protocol entry criteria not met|0
4876309|NCT00789373|16804425|P2|Induction|Protocol entry criteria not met|0
4876310|NCT00789373|16804426|P1|Induction|Protocol entry criteria not met|9
4876311|NCT00789373|16804424|P3|Induction|Investigator decision|0
4876312|NCT00789373|16804425|P2|Induction|Investigator decision|0
4876313|NCT00789373|16804426|P1|Induction|Investigator decision|7
4876314|NCT00789373|16804424|P3|Induction|Death due to procedure|0
4876315|NCT00789373|16804425|P2|Induction|Death due to procedure|0
4876316|NCT00789373|16804426|P1|Induction|Death due to procedure|1
4876317|NCT00789373|16804424|P3|Induction|Death due to toxicity|0
4876318|NCT00789373|16804425|P2|Induction|Death due to toxicity|0
4876319|NCT00789373|16804426|P1|Induction|Death due to toxicity|11
4876320|NCT00789373|16804424|P3|Induction|Death due to adverse event|0
4876321|NCT00789373|16804425|P2|Induction|Death due to adverse event|0
4876322|NCT00789373|16804426|P1|Induction|Death due to adverse event|19
4876323|NCT00789373|16804424|P3|Induction|Death Due to study disease|0
4876324|NCT00789373|16804425|P2|Induction|Death Due to study disease|0
4876325|NCT00789373|16804426|P1|Induction|Death Due to study disease|24
4876326|NCT00789373|16804424|P3|Induction|Adverse Event|0
4876327|NCT00789373|16804425|P2|Induction|Adverse Event|0
4876328|NCT00789373|16804426|P1|Induction|Adverse Event|64
4876329|NCT00789360|16804453|P2|Overall Study|Protocol Violation|1
4876330|NCT00789360|16804454|P1|Overall Study|Protocol Violation|3
4876331|NCT00789321|16804464|P2|Overall Study|Adverse Event|1
4876332|NCT00789321|16804465|P1|Overall Study|Adverse Event|0
4876333|NCT00789191|16804487|P2|Overall Study|Unclassified|3
4876334|NCT00789191|16804488|P1|Overall Study|Unclassified|5
4876335|NCT00789191|16804487|P2|Overall Study|Withdrawal Criteria|4
4876336|NCT00789191|16804488|P1|Overall Study|Withdrawal Criteria|2
4876337|NCT00789191|16804487|P2|Overall Study|Protocol Violation|3
4876338|NCT00789191|16804488|P1|Overall Study|Protocol Violation|5
4876339|NCT00789191|16804487|P2|Overall Study|Lack of Efficacy|5
4876340|NCT00789191|16804488|P1|Overall Study|Lack of Efficacy|0
4876341|NCT00789191|16804487|P2|Overall Study|Adverse Event|4
4876342|NCT00789191|16804488|P1|Overall Study|Adverse Event|2
4876343|NCT00789035|16804545|P5|Overall Study|Other reason not defined above|1
4876344|NCT00789035|16804546|P4|Overall Study|Other reason not defined above|0
4876345|NCT00789035|16804547|P3|Overall Study|Other reason not defined above|1
4876346|NCT00789035|16804548|P2|Overall Study|Other reason not defined above|3
4876347|NCT00789035|16804549|P1|Overall Study|Other reason not defined above|2
4876348|NCT00789035|16804545|P5|Overall Study|Withdrawal by Subject|0
4876349|NCT00789035|16804546|P4|Overall Study|Withdrawal by Subject|0
4876350|NCT00789035|16804547|P3|Overall Study|Withdrawal by Subject|0
4876351|NCT00789035|16804548|P2|Overall Study|Withdrawal by Subject|2
4876352|NCT00789035|16804549|P1|Overall Study|Withdrawal by Subject|0
4876353|NCT00789035|16804545|P5|Overall Study|Protocol Violation|0
4876354|NCT00789035|16804546|P4|Overall Study|Protocol Violation|0
4876355|NCT00789035|16804547|P3|Overall Study|Protocol Violation|0
4876356|NCT00789035|16804548|P2|Overall Study|Protocol Violation|0
4876357|NCT00789035|16804549|P1|Overall Study|Protocol Violation|1
4876358|NCT00789035|16804545|P5|Overall Study|Lack of Efficacy|2
4876359|NCT00789035|16804546|P4|Overall Study|Lack of Efficacy|0
4876360|NCT00789035|16804547|P3|Overall Study|Lack of Efficacy|0
4876361|NCT00789035|16804548|P2|Overall Study|Lack of Efficacy|0
4876362|NCT00789035|16804549|P1|Overall Study|Lack of Efficacy|3
4876363|NCT00789035|16804545|P5|Overall Study|Adverse Event|3
4876364|NCT00789035|16804546|P4|Overall Study|Adverse Event|1
4876365|NCT00789035|16804547|P3|Overall Study|Adverse Event|0
4876366|NCT00789035|16804548|P2|Overall Study|Adverse Event|2
4876367|NCT00789035|16804549|P1|Overall Study|Adverse Event|0
4876368|NCT00788957|16804608|P6|Part 3|On-study at time of data cut-off|0
4876369|NCT00788957|16804609|P5|Part 3|On-study at time of data cut-off|1
4876370|NCT00788957|16804610|P4|Part 3|On-study at time of data cut-off|0
4876371|NCT00788957|16804611|P3|Part 3|On-study at time of data cut-off|0
4876372|NCT00788957|16804612|P2|Part 3|On-study at time of data cut-off|0
4876373|NCT00788957|16804613|P1|Part 3|On-study at time of data cut-off|0
4876374|NCT00788957|16804608|P6|Part 3|Death|9
4876375|NCT00788957|16804609|P5|Part 3|Death|8
4876376|NCT00788957|16804610|P4|Part 3|Death|0
4876377|NCT00788957|16804611|P3|Part 3|Death|0
4876378|NCT00788957|16804612|P2|Part 3|Death|0
4876379|NCT00788957|16804613|P1|Part 3|Death|0
4876380|NCT00788957|16804608|P6|Part 3|Withdrawal by Subject|2
4876381|NCT00788957|16804609|P5|Part 3|Withdrawal by Subject|0
4876382|NCT00788957|16804610|P4|Part 3|Withdrawal by Subject|0
4876383|NCT00788957|16804611|P3|Part 3|Withdrawal by Subject|0
4876384|NCT00788957|16804612|P2|Part 3|Withdrawal by Subject|0
4876385|NCT00788957|16804613|P1|Part 3|Withdrawal by Subject|0
4876386|NCT00788957|16804608|P6|Part 2|On-study at time of data cut-off|0
4876387|NCT00788957|16804609|P5|Part 2|On-study at time of data cut-off|0
4876388|NCT00788957|16804610|P4|Part 2|On-study at time of data cut-off|1
4876389|NCT00788957|16804611|P3|Part 2|On-study at time of data cut-off|1
4876390|NCT00788957|16804612|P2|Part 2|On-study at time of data cut-off|1
4876391|NCT00788957|16804613|P1|Part 2|On-study at time of data cut-off|0
4876392|NCT00788957|16804608|P6|Part 2|Lost to Follow-up|0
4876393|NCT00788957|16804609|P5|Part 2|Lost to Follow-up|0
4876394|NCT00788957|16804610|P4|Part 2|Lost to Follow-up|0
4876395|NCT00788957|16804611|P3|Part 2|Lost to Follow-up|3
4876396|NCT00788957|16804612|P2|Part 2|Lost to Follow-up|0
4876397|NCT00788957|16804613|P1|Part 2|Lost to Follow-up|0
4876398|NCT00788957|16804608|P6|Part 2|Death|0
4876399|NCT00788957|16804609|P5|Part 2|Death|0
4876400|NCT00788957|16804610|P4|Part 2|Death|37
4876401|NCT00788957|16804611|P3|Part 2|Death|35
4876402|NCT00788957|16804612|P2|Part 2|Death|32
4876403|NCT00788957|16804613|P1|Part 2|Death|0
4876404|NCT00788957|16804608|P6|Part 2|Withdrawal by Subject|0
4876405|NCT00788957|16804609|P5|Part 2|Withdrawal by Subject|0
4876406|NCT00788957|16804610|P4|Part 2|Withdrawal by Subject|3
4876407|NCT00788957|16804611|P3|Part 2|Withdrawal by Subject|5
4876408|NCT00788957|16804612|P2|Part 2|Withdrawal by Subject|9
4876409|NCT00788957|16804613|P1|Part 2|Withdrawal by Subject|0
4876410|NCT00788957|16804608|P6|Part 1|Lost to Follow-up|0
4876411|NCT00788957|16804609|P5|Part 1|Lost to Follow-up|0
4876412|NCT00788957|16804610|P4|Part 1|Lost to Follow-up|0
4876413|NCT00788957|16804611|P3|Part 1|Lost to Follow-up|0
4876414|NCT00788957|16804612|P2|Part 1|Lost to Follow-up|0
4876415|NCT00788957|16804613|P1|Part 1|Lost to Follow-up|1
4876416|NCT00788957|16804608|P6|Part 1|Death|0
4876417|NCT00788957|16804609|P5|Part 1|Death|0
4876418|NCT00788957|16804610|P4|Part 1|Death|0
4876419|NCT00788957|16804611|P3|Part 1|Death|0
4876420|NCT00788957|16804612|P2|Part 1|Death|0
4876421|NCT00788957|16804613|P1|Part 1|Death|8
4876422|NCT00788827|16804686|P1|Overall Study|Lack of Efficacy|2
4876423|NCT00788775|16804700|P2|Overall Study|Patient's measurable disease resected.|0
4876424|NCT00788775|16804701|P1|Overall Study|Patient's measurable disease resected.|1
4876425|NCT00788775|16804700|P2|Overall Study|Patient Non-Compliance|0
4876426|NCT00788775|16804701|P1|Overall Study|Patient Non-Compliance|1
4876427|NCT00788775|16804700|P2|Overall Study|Withdrawal by Subject|2
4876428|NCT00788775|16804701|P1|Overall Study|Withdrawal by Subject|0
4876429|NCT00788775|16804700|P2|Overall Study|Progressive Disease|6
4876430|NCT00788775|16804701|P1|Overall Study|Progressive Disease|8
4876431|NCT00788710|16804716|P3|Overall Study|Withdrawal by Subject|0
4876432|NCT00788710|16804717|P2|Overall Study|Withdrawal by Subject|2
4876433|NCT00788710|16804718|P1|Overall Study|Withdrawal by Subject|2
4876434|NCT00788710|16804716|P3|Overall Study|Protocol Violation|1
4876435|NCT00788710|16804717|P2|Overall Study|Protocol Violation|1
4876436|NCT00788710|16804718|P1|Overall Study|Protocol Violation|0
4876437|NCT00788710|16804716|P3|Overall Study|Physician Decision|0
4876438|NCT00788710|16804717|P2|Overall Study|Physician Decision|1
4876439|NCT00788710|16804718|P1|Overall Study|Physician Decision|2
4876440|NCT00788710|16804716|P3|Overall Study|Lost to Follow-up|0
4876441|NCT00788710|16804717|P2|Overall Study|Lost to Follow-up|1
4876442|NCT00788710|16804718|P1|Overall Study|Lost to Follow-up|0
4876443|NCT00788710|16804716|P3|Overall Study|Lack of Efficacy|1
4876444|NCT00788710|16804717|P2|Overall Study|Lack of Efficacy|0
4876445|NCT00788710|16804718|P1|Overall Study|Lack of Efficacy|0
4876446|NCT00788710|16804716|P3|Overall Study|Adverse Event|4
4876447|NCT00788710|16804717|P2|Overall Study|Adverse Event|3
4876448|NCT00788710|16804718|P1|Overall Study|Adverse Event|1
4876449|NCT00788697|16804732|P1|Overall Study|Indeterminate diagnosis from truth stand|17
4876450|NCT00788697|16804732|P1|Overall Study|Technically inadequate truth standard|1
4876451|NCT00788697|16804732|P1|Overall Study|no truth standard procedure available|5
4876452|NCT00788697|16804732|P1|Overall Study|Training Patients|74
4876453|NCT00788697|16804732|P1|Overall Study|No study drug administered|12
4876454|NCT00788593|16804779|P3|Second Intervention Period|Other|1
4876455|NCT00788593|16804780|P2|Second Intervention Period|Other|0
4876456|NCT00788593|16804781|P1|Second Intervention Period|Other|0
4876457|NCT00788593|16804779|P3|Second Intervention Period|Lost to Follow-up|0
4876458|NCT00788593|16804780|P2|Second Intervention Period|Lost to Follow-up|1
4876459|NCT00788593|16804781|P1|Second Intervention Period|Lost to Follow-up|0
4876460|NCT00788593|16804779|P3|First Intervention Period|Adverse Event|0
4876461|NCT00788593|16804780|P2|First Intervention Period|Adverse Event|1
4876462|NCT00788593|16804781|P1|First Intervention Period|Adverse Event|0
4876463|NCT00788593|16804779|P3|Placebo Run-in Phase|Protocol Violation|0
4876464|NCT00788593|16804780|P2|Placebo Run-in Phase|Protocol Violation|0
4876465|NCT00788593|16804781|P1|Placebo Run-in Phase|Protocol Violation|2
4876466|NCT00788593|16804779|P3|Placebo Run-in Phase|Withdrawal by Subject|0
4876467|NCT00788593|16804780|P2|Placebo Run-in Phase|Withdrawal by Subject|0
4876468|NCT00788593|16804781|P1|Placebo Run-in Phase|Withdrawal by Subject|2
4876469|NCT00788593|16804779|P3|Placebo Run-in Phase|Adverse Event|0
4876470|NCT00788593|16804780|P2|Placebo Run-in Phase|Adverse Event|0
4876471|NCT00788593|16804781|P1|Placebo Run-in Phase|Adverse Event|2
4876472|NCT00788372|16804798|P1|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1
4876473|NCT00788372|16804798|P1|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9
4876474|NCT00788372|16804798|P1|Period 2 (Week 4 to Week 52)|Physician Decision|9
4876475|NCT00788372|16804798|P1|Period 2 (Week 4 to Week 52)|Adverse Event|13
4876476|NCT00788372|16804798|P1|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4
4876477|NCT00788372|16804798|P1|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9
4876478|NCT00788372|16804798|P1|Period 1 (up to 4 Weeks)|Adverse Event|18
4876479|NCT00788151|16804827|P2|Overall Study|Enrolled but not treated|1
4876480|NCT00788151|16804828|P1|Overall Study|Enrolled but not treated|1
4876481|NCT00788151|16804827|P2|Overall Study|Withdrawal by Subject|6
4876482|NCT00788151|16804828|P1|Overall Study|Withdrawal by Subject|13
4876483|NCT00788151|16804827|P2|Overall Study|Protocol Violation|1
4876484|NCT00788151|16804828|P1|Overall Study|Protocol Violation|0
4876485|NCT00788151|16804827|P2|Overall Study|Other adverse event|2
4876486|NCT00788151|16804828|P1|Overall Study|Other adverse event|0
4876487|NCT00788073|16804872|P2|Placebo Then STX209|Protocol Violation|1
4876488|NCT00788073|16804873|P1|Placebo Then STX209|Protocol Violation|0
4876489|NCT00788073|16804872|P2|Placebo Then STX209|Adverse Event|0
4876490|NCT00788073|16804873|P1|Placebo Then STX209|Adverse Event|2
4876491|NCT00788073|16804872|P2|STX209 Then Placebo|unable to return due to travel|1
4876492|NCT00788073|16804873|P1|STX209 Then Placebo|unable to return due to travel|0
4876493|NCT00788073|16804872|P2|STX209 Then Placebo|Withdrawal by Subject|1
4876494|NCT00788073|16804873|P1|STX209 Then Placebo|Withdrawal by Subject|0
4876495|NCT00788073|16804872|P2|STX209 Then Placebo|Lost to Follow-up|1
4876496|NCT00788073|16804873|P1|STX209 Then Placebo|Lost to Follow-up|0
4876497|NCT00788073|16804872|P2|STX209 Then Placebo|Adverse Event|0
4876498|NCT00788073|16804873|P1|STX209 Then Placebo|Adverse Event|1
4876499|NCT00787930|16804898|P1|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3
4876500|NCT00787917|16804913|P2|Open Label|Administrative problems|0
4876501|NCT00787917|16804914|P1|Open Label|Administrative problems|3
4876502|NCT00787917|16804913|P2|Open Label|Unsatisfactory therapeutic effect|0
4876503|NCT00787917|16804914|P1|Open Label|Unsatisfactory therapeutic effect|1
4876504|NCT00787917|16804913|P2|Blinded Treatment|Administrative problems|2
4876505|NCT00787917|16804914|P1|Blinded Treatment|Administrative problems|3
4876506|NCT00787917|16804913|P2|Blinded Treatment|Lack of Efficacy|0
4876507|NCT00787917|16804914|P1|Blinded Treatment|Lack of Efficacy|1
4876508|NCT00787917|16804913|P2|Blinded Treatment|Adverse Event|0
4876509|NCT00787917|16804914|P1|Blinded Treatment|Adverse Event|1
4876510|NCT00787891|16804944|P2|Maintenance Double-blind Phase (Part 2)|Other|2
4876511|NCT00787891|16804945|P1|Maintenance Double-blind Phase (Part 2)|Other|5
4876512|NCT00787891|16804944|P2|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3
4876513|NCT00787891|16804945|P1|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1
4876514|NCT00787891|16804944|P2|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
4876515|NCT00787891|16804945|P1|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1
4876516|NCT00787891|16804944|P2|Maintenance Double-blind Phase (Part 2)|Adverse Event|1
4876517|NCT00787891|16804945|P1|Maintenance Double-blind Phase (Part 2)|Adverse Event|0
4876518|NCT00787891|16804944|P2|Short-term Double-blind Phase (Part 1)|Other|2
4876519|NCT00787891|16804945|P1|Short-term Double-blind Phase (Part 1)|Other|0
4876520|NCT00787891|16804944|P2|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2
4876521|NCT00787891|16804945|P1|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6
4876522|NCT00787891|16804944|P2|Short-term Double-blind Phase (Part 1)|Physician Decision|0
4876523|NCT00787891|16804945|P1|Short-term Double-blind Phase (Part 1)|Physician Decision|1
4876524|NCT00787891|16804944|P2|Short-term Double-blind Phase (Part 1)|Protocol Violation|1
4876525|NCT00787891|16804945|P1|Short-term Double-blind Phase (Part 1)|Protocol Violation|0
4876526|NCT00787891|16804944|P2|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
4876527|NCT00787891|16804945|P1|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2
4876528|NCT00787891|16804944|P2|Short-term Double-blind Phase (Part 1)|Adverse Event|2
4876529|NCT00787891|16804945|P1|Short-term Double-blind Phase (Part 1)|Adverse Event|1
4876530|NCT00787839|16804972|P1|Overall Study|Failure to have the OGTT was most common|404
4876531|NCT00787800|16804995|P2|Overall Study|Death|2
4876532|NCT00787800|16804996|P1|Overall Study|Death|0
4876533|NCT00787800|16804995|P2|Overall Study|Withdrawal by Subject|5
4876534|NCT00787800|16804996|P1|Overall Study|Withdrawal by Subject|3
4876535|NCT00787787|16805012|P1|Overall Study|Adverse Event|3
4876536|NCT00787787|16805012|P1|Overall Study|Lack of Efficacy|4
4876537|NCT00787644|16805040|P2|Overall Study|Withdrawal by Subject|1
4876538|NCT00787644|16805041|P1|Overall Study|Withdrawal by Subject|1
4876539|NCT00787644|16805040|P2|Overall Study|Lost to Follow-up|1
4876540|NCT00787644|16805041|P1|Overall Study|Lost to Follow-up|1
4876541|NCT00787605|16805062|P2|Overall Study|Lack of Efficacy|9
4876542|NCT00787605|16805063|P1|Overall Study|Lack of Efficacy|13
4876543|NCT00787605|16805062|P2|Overall Study|Withdrawal by Subject|13
4876544|NCT00787605|16805063|P1|Overall Study|Withdrawal by Subject|6
4876545|NCT00787605|16805062|P2|Overall Study|Protocol Violation|3
4876546|NCT00787605|16805063|P1|Overall Study|Protocol Violation|7
4876547|NCT00787605|16805062|P2|Overall Study|Lost to Follow-up|6
4876548|NCT00787605|16805063|P1|Overall Study|Lost to Follow-up|3
4876549|NCT00787605|16805062|P2|Overall Study|Adverse Event|25
4876550|NCT00787605|16805063|P1|Overall Study|Adverse Event|14
4876551|NCT00787605|16805062|P2|Overall Study|Administrative Problems|0
4876552|NCT00787605|16805063|P1|Overall Study|Administrative Problems|3
4876553|NCT00787566|16805082|P3|Overall Study|AE related to chemotherapy|0
4876554|NCT00787566|16805083|P2|Overall Study|AE related to chemotherapy|1
4876555|NCT00787566|16805084|P1|Overall Study|AE related to chemotherapy|0
4876556|NCT00787527|16805092|P1|Overall Study|Toxicity|3
4876557|NCT00787319|16805109|P1|Overall Study|Inactive disease|5
4876558|NCT00787319|16805109|P1|Overall Study|Stabilized disease findings|3
4876559|NCT00787319|16805109|P1|Overall Study|No health insurance reimbursement|2
4876560|NCT00787319|16805109|P1|Overall Study|Unresponsiveness to visit invitation|1
4876561|NCT00787319|16805109|P1|Overall Study|Budget exhausted/exceeded|1
4876562|NCT00787319|16805109|P1|Overall Study|Lack of Efficacy|1
4876563|NCT00787319|16805109|P1|Overall Study|Objective progression or relapse|30
4876564|NCT00787319|16805109|P1|Overall Study|Adverse Event|3
4876565|NCT00787319|16805109|P1|Overall Study|Withdrawal by Subject|15
4876566|NCT00787319|16805109|P1|Overall Study|Lost to Follow-up|2
4876567|NCT00787267|16805121|P1|Overall Study|Withdrawal by Subject|1
4876568|NCT00787267|16805121|P1|Overall Study|No Reason Provided|1
4876569|NCT00787267|16805121|P1|Overall Study|Screen failure/Ineligible|10
4876570|NCT00787254|16805131|P2|Overall Study|Physician Decision|8
4876571|NCT00787254|16805132|P1|Overall Study|Physician Decision|4
4876572|NCT00787254|16805131|P2|Overall Study|Institution closed|0
4876573|NCT00787254|16805132|P1|Overall Study|Institution closed|1
4876574|NCT00787254|16805131|P2|Overall Study|NSAIDs discontinuation|2
4876575|NCT00787254|16805132|P1|Overall Study|NSAIDs discontinuation|1
4876576|NCT00787254|16805131|P2|Overall Study|Lack of Efficacy|15
4876577|NCT00787254|16805132|P1|Overall Study|Lack of Efficacy|4
4876578|NCT00787254|16805131|P2|Overall Study|Withdrawal by Subject|11
4876579|NCT00787254|16805132|P1|Overall Study|Withdrawal by Subject|16
4876580|NCT00787254|16805131|P2|Overall Study|Protocol Violation|23
4876581|NCT00787254|16805132|P1|Overall Study|Protocol Violation|26
4876582|NCT00787254|16805131|P2|Overall Study|Adverse Event|23
4876583|NCT00787254|16805132|P1|Overall Study|Adverse Event|24
4876584|NCT00787202|16805256|P5|Overall Study|Randomized, not treated|0
4876585|NCT00787202|16805257|P4|Overall Study|Randomized, not treated|0
4876586|NCT00787202|16805258|P3|Overall Study|Randomized, not treated|0
4876587|NCT00787202|16805259|P2|Overall Study|Randomized, not treated|0
4876588|NCT00787202|16805260|P1|Overall Study|Randomized, not treated|1
4876589|NCT00787202|16805256|P5|Overall Study|Protocol Violation|1
4876590|NCT00787202|16805257|P4|Overall Study|Protocol Violation|0
4876591|NCT00787202|16805258|P3|Overall Study|Protocol Violation|0
4876592|NCT00787202|16805259|P2|Overall Study|Protocol Violation|1
4876593|NCT00787202|16805260|P1|Overall Study|Protocol Violation|2
4876594|NCT00787202|16805256|P5|Overall Study|Withdrawal by Subject|0
4876595|NCT00787202|16805257|P4|Overall Study|Withdrawal by Subject|0
4876596|NCT00787202|16805258|P3|Overall Study|Withdrawal by Subject|2
4876597|NCT00787202|16805259|P2|Overall Study|Withdrawal by Subject|2
4876598|NCT00787202|16805260|P1|Overall Study|Withdrawal by Subject|2
4876599|NCT00787202|16805256|P5|Overall Study|Lost to Follow-up|0
4876600|NCT00787202|16805257|P4|Overall Study|Lost to Follow-up|0
4876601|NCT00787202|16805258|P3|Overall Study|Lost to Follow-up|0
4876602|NCT00787202|16805259|P2|Overall Study|Lost to Follow-up|0
4876603|NCT00787202|16805260|P1|Overall Study|Lost to Follow-up|1
4876604|NCT00787202|16805256|P5|Overall Study|Lack of Efficacy|1
4876605|NCT00787202|16805257|P4|Overall Study|Lack of Efficacy|2
4876606|NCT00787202|16805258|P3|Overall Study|Lack of Efficacy|5
4876607|NCT00787202|16805259|P2|Overall Study|Lack of Efficacy|6
4876608|NCT00787202|16805260|P1|Overall Study|Lack of Efficacy|5
4876609|NCT00787202|16805256|P5|Overall Study|Adverse Event|2
4876610|NCT00787202|16805257|P4|Overall Study|Adverse Event|0
4876611|NCT00787202|16805258|P3|Overall Study|Adverse Event|0
4876612|NCT00787202|16805259|P2|Overall Study|Adverse Event|2
4876613|NCT00787202|16805260|P1|Overall Study|Adverse Event|3
4876614|NCT00787189|16805313|P2|Overall Study|Lost to Follow-up|2
4876615|NCT00787189|16805314|P1|Overall Study|Lost to Follow-up|2
4876616|NCT00787150|16805323|P3|Overall Study|Dosing incorrect study durg|0
4876617|NCT00787150|16805324|P2|Overall Study|Dosing incorrect study durg|0
4876618|NCT00787150|16805325|P1|Overall Study|Dosing incorrect study durg|2
4876619|NCT00787150|16805323|P3|Overall Study|Withdrawal by Subject|0
4876620|NCT00787150|16805324|P2|Overall Study|Withdrawal by Subject|1
4876621|NCT00787150|16805325|P1|Overall Study|Withdrawal by Subject|2
4876622|NCT00787150|16805323|P3|Overall Study|Physician Decision|1
4876623|NCT00787150|16805324|P2|Overall Study|Physician Decision|2
4876624|NCT00787150|16805325|P1|Overall Study|Physician Decision|1
4876625|NCT00787150|16805323|P3|Overall Study|Adverse Event|4
4876626|NCT00787150|16805324|P2|Overall Study|Adverse Event|4
4876627|NCT00787150|16805325|P1|Overall Study|Adverse Event|4
4876628|NCT00787137|16805370|P3|Overall Study|Study Termination|1
4876629|NCT00787137|16805371|P2|Overall Study|Study Termination|0
4876630|NCT00787137|16805372|P1|Overall Study|Study Termination|0
4876631|NCT00786864|16805447|P2|Overall Study|Sustained serious back injury|0
4876632|NCT00786864|16805448|P1|Overall Study|Sustained serious back injury|1
4876633|NCT00786864|16805447|P2|Overall Study|Lost to Follow-up|1
4876634|NCT00786864|16805448|P1|Overall Study|Lost to Follow-up|0
4876635|NCT00786838|16805460|P1|Overall Study|Withdrawal by Subject|4
4876636|NCT00786838|16805460|P1|Overall Study|Progressive disease|31
4876637|NCT00786838|16805460|P1|Overall Study|Adverse Event|6
4876638|NCT00786838|16805460|P1|Overall Study|Death|4
4876639|NCT00786838|16805460|P1|Overall Study|Physician Decision|4
4876640|NCT00786799|16805496|P2|Overall Study|Lost to Follow-up|1
4876641|NCT00786799|16805497|P1|Overall Study|Lost to Follow-up|1
4876642|NCT00786565|16805527|P1|Post Surgery|Adapt AO implanted posterior side up|1
4876643|NCT00786565|16805527|P1|Post Surgery|Abnormal macular pucker|1
4876644|NCT00786565|16805527|P1|Enrollment Prior to Surgery|Protocol Violation|3
4876645|NCT00786565|16805527|P1|Enrollment Prior to Surgery|Site Closed|3
4876646|NCT00786474|16805584|P2|Overall Study|Other|4
4876647|NCT00786474|16805585|P1|Overall Study|Other|4
4876648|NCT00786474|16805584|P2|Overall Study|Physician Decision|1
4876649|NCT00786474|16805585|P1|Overall Study|Physician Decision|2
4876650|NCT00786474|16805584|P2|Overall Study|Lost to Follow-up|3
4876651|NCT00786474|16805585|P1|Overall Study|Lost to Follow-up|3
4876652|NCT00786474|16805584|P2|Overall Study|Withdrawal by Subject|31
4876653|NCT00786474|16805585|P1|Overall Study|Withdrawal by Subject|23
4876654|NCT00786474|16805584|P2|Overall Study|Death|4
4876655|NCT00786474|16805585|P1|Overall Study|Death|5
4876656|NCT00786422|16805597|P1|Follow-up Period|End-of-study done up to 4 days early|2
4876657|NCT00786422|16805597|P1|Follow-up Period|Death|1
4876658|NCT00786422|16805597|P1|Rivaroxaban Treatment|Adverse Event|2
4876659|NCT00786422|16805597|P1|Rivaroxaban Treatment|Non-compliance with study drug treatment|1
4876660|NCT00786422|16805597|P1|Rivaroxaban Treatment|Withdrawal by Subject|1
4876661|NCT00786422|16805597|P1|Rivaroxaban Treatment|Physician Decision|1
4876662|NCT00786422|16805597|P1|Rivaroxaban Treatment|Lack of Efficacy|1
4876663|NCT00786422|16805597|P1|Rivaroxaban Treatment|Final visit earlier than planned|3
4876664|NCT00786422|16805597|P1|Rivaroxaban Treatment|Death|2
4876665|NCT00786409|16805613|P1|Overall Study|Lost to Follow-up|1
4876666|NCT00786409|16805613|P1|Overall Study|Pregnancy|2
4876667|NCT00786409|16805613|P1|Overall Study|Adverse Event|2
4876668|NCT00786409|16805613|P1|Overall Study|Withdrawal by Subject|2
4876669|NCT00786188|16805630|P2|Overall Study|Withdrawal by Subject|0
4876670|NCT00786188|16805631|P1|Overall Study|Withdrawal by Subject|2
4876671|NCT00786188|16805630|P2|Overall Study|Adverse Event|1
4876672|NCT00786188|16805631|P1|Overall Study|Adverse Event|3
4876673|NCT00786032|16805657|P1|Overall Study|Did not complete in the timeframe|6
4876674|NCT00786032|16805657|P1|Overall Study|Withdrawal by Subject|14
4876675|NCT00786032|16805657|P1|Overall Study|Death|4
4876676|NCT00785980|16805678|P1|7 Day Washout Period|Protocol Violation|3
4876677|NCT00785928|16805696|P7|Treatment Phase|Withdrawal by Subject|0
4876678|NCT00785928|16805697|P6|Treatment Phase|Withdrawal by Subject|0
4876679|NCT00785928|16805698|P5|Treatment Phase|Withdrawal by Subject|1
4876680|NCT00785928|16805699|P4|Treatment Phase|Withdrawal by Subject|0
4876681|NCT00785928|16805700|P3|Treatment Phase|Withdrawal by Subject|0
4876682|NCT00785928|16805701|P2|Treatment Phase|Withdrawal by Subject|2
4876683|NCT00785928|16805702|P1|Treatment Phase|Withdrawal by Subject|1
4876684|NCT00785928|16805696|P7|Treatment Phase|Sponsor Decision|1
4876685|NCT00785928|16805697|P6|Treatment Phase|Sponsor Decision|0
4876686|NCT00785928|16805698|P5|Treatment Phase|Sponsor Decision|0
4876687|NCT00785928|16805699|P4|Treatment Phase|Sponsor Decision|0
4876688|NCT00785928|16805700|P3|Treatment Phase|Sponsor Decision|0
4876689|NCT00785928|16805701|P2|Treatment Phase|Sponsor Decision|0
4876690|NCT00785928|16805702|P1|Treatment Phase|Sponsor Decision|1
4876691|NCT00785928|16805696|P7|Treatment Phase|Physician Decision|0
4876692|NCT00785928|16805697|P6|Treatment Phase|Physician Decision|0
4876693|NCT00785928|16805698|P5|Treatment Phase|Physician Decision|1
4876694|NCT00785928|16805699|P4|Treatment Phase|Physician Decision|0
4876695|NCT00785928|16805700|P3|Treatment Phase|Physician Decision|0
4876696|NCT00785928|16805701|P2|Treatment Phase|Physician Decision|0
4876697|NCT00785928|16805702|P1|Treatment Phase|Physician Decision|0
4876698|NCT00785928|16805696|P7|Treatment Phase|Lack of Efficacy|0
4876699|NCT00785928|16805697|P6|Treatment Phase|Lack of Efficacy|0
4876700|NCT00785928|16805698|P5|Treatment Phase|Lack of Efficacy|0
4876701|NCT00785928|16805699|P4|Treatment Phase|Lack of Efficacy|0
4876702|NCT00785928|16805700|P3|Treatment Phase|Lack of Efficacy|1
4876703|NCT00785928|16805701|P2|Treatment Phase|Lack of Efficacy|1
4876704|NCT00785928|16805702|P1|Treatment Phase|Lack of Efficacy|0
4876705|NCT00785928|16805696|P7|Treatment Phase|Inadequate Response|0
4876706|NCT00785928|16805697|P6|Treatment Phase|Inadequate Response|0
4876707|NCT00785928|16805698|P5|Treatment Phase|Inadequate Response|0
4876708|NCT00785928|16805699|P4|Treatment Phase|Inadequate Response|0
4876709|NCT00785928|16805700|P3|Treatment Phase|Inadequate Response|0
4876710|NCT00785928|16805701|P2|Treatment Phase|Inadequate Response|1
4876711|NCT00785928|16805702|P1|Treatment Phase|Inadequate Response|0
4876712|NCT00785928|16805696|P7|Treatment Phase|Adverse Event|2
4876713|NCT00785928|16805697|P6|Treatment Phase|Adverse Event|0
4876714|NCT00785928|16805698|P5|Treatment Phase|Adverse Event|0
4876715|NCT00785928|16805699|P4|Treatment Phase|Adverse Event|0
4876716|NCT00785928|16805700|P3|Treatment Phase|Adverse Event|2
4876717|NCT00785928|16805701|P2|Treatment Phase|Adverse Event|1
4876718|NCT00785928|16805702|P1|Treatment Phase|Adverse Event|1
4876719|NCT00785785|16805849|P2|Optional Extension Phase|Study terminated by sponsor|37
4876720|NCT00785785|16805850|P1|Optional Extension Phase|Study terminated by sponsor|3
4876721|NCT00785785|16805849|P2|Optional Extension Phase|Protocol deviation|2
4876722|NCT00785785|16805850|P1|Optional Extension Phase|Protocol deviation|0
4876723|NCT00785785|16805849|P2|Optional Extension Phase|Disease progression|70
4876724|NCT00785785|16805850|P1|Optional Extension Phase|Disease progression|22
4876725|NCT00785785|16805849|P2|Optional Extension Phase|Death|5
4876726|NCT00785785|16805850|P1|Optional Extension Phase|Death|1
4876727|NCT00785785|16805849|P2|Optional Extension Phase|Administrative problems|0
4876728|NCT00785785|16805850|P1|Optional Extension Phase|Administrative problems|2
4876729|NCT00785785|16805849|P2|Optional Extension Phase|Lost to Follow-up|0
4876730|NCT00785785|16805850|P1|Optional Extension Phase|Lost to Follow-up|1
4876731|NCT00785785|16805849|P2|Optional Extension Phase|Withdrawal by Subject|6
4876732|NCT00785785|16805850|P1|Optional Extension Phase|Withdrawal by Subject|6
4876733|NCT00785785|16805849|P2|Optional Extension Phase|Adverse Event|5
4876734|NCT00785785|16805850|P1|Optional Extension Phase|Adverse Event|4
4876735|NCT00785785|16805849|P2|Core Phase up to 36 Months|Study terminated by sponsor|133
4876736|NCT00785785|16805850|P1|Core Phase up to 36 Months|Study terminated by sponsor|116
4876737|NCT00785785|16805849|P2|Core Phase up to 36 Months|Protocol deviation|6
4876738|NCT00785785|16805850|P1|Core Phase up to 36 Months|Protocol deviation|5
4876739|NCT00785785|16805849|P2|Core Phase up to 36 Months|Disease progression|119
4876740|NCT00785785|16805850|P1|Core Phase up to 36 Months|Disease progression|139
4876741|NCT00785785|16805849|P2|Core Phase up to 36 Months|Death|8
4876742|NCT00785785|16805850|P1|Core Phase up to 36 Months|Death|5
4876743|NCT00785785|16805849|P2|Core Phase up to 36 Months|Administrative problems|3
4876744|NCT00785785|16805850|P1|Core Phase up to 36 Months|Administrative problems|3
4876745|NCT00785785|16805849|P2|Core Phase up to 36 Months|Lost to Follow-up|7
4876746|NCT00785785|16805850|P1|Core Phase up to 36 Months|Lost to Follow-up|3
4876747|NCT00785785|16805849|P2|Core Phase up to 36 Months|Withdrawal by Subject|17
4876748|NCT00785785|16805850|P1|Core Phase up to 36 Months|Withdrawal by Subject|16
4876749|NCT00785785|16805849|P2|Core Phase up to 36 Months|Abnormal test procedure result|2
4876750|NCT00785785|16805850|P1|Core Phase up to 36 Months|Abnormal test procedure result|2
4876751|NCT00785785|16805849|P2|Core Phase up to 36 Months|Abnormal laboratory value|0
4876752|NCT00785785|16805850|P1|Core Phase up to 36 Months|Abnormal laboratory value|1
4876753|NCT00785785|16805849|P2|Core Phase up to 36 Months|Adverse Event|21
4876754|NCT00785785|16805850|P1|Core Phase up to 36 Months|Adverse Event|31
4876755|NCT00785785|16805849|P2|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4
4876756|NCT00785785|16805850|P1|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3
4876757|NCT00785707|16805864|P1|Overall Study|Lost to Follow-up|7
4876758|NCT00785629|16805873|P4|Overall Study|Withdrawal by Subject|2
4876759|NCT00785629|16805874|P3|Overall Study|Withdrawal by Subject|2
4876760|NCT00785629|16805875|P2|Overall Study|Withdrawal by Subject|1
4876761|NCT00785629|16805876|P1|Overall Study|Withdrawal by Subject|0
4876762|NCT00785629|16805873|P4|Overall Study|administrative decision|4
4876763|NCT00785629|16805874|P3|Overall Study|administrative decision|3
4876764|NCT00785629|16805875|P2|Overall Study|administrative decision|1
4876765|NCT00785629|16805876|P1|Overall Study|administrative decision|5
4876766|NCT00785629|16805873|P4|Overall Study|Protocol Violation|5
4876767|NCT00785629|16805874|P3|Overall Study|Protocol Violation|4
4876768|NCT00785629|16805875|P2|Overall Study|Protocol Violation|2
4876769|NCT00785629|16805876|P1|Overall Study|Protocol Violation|1
4876770|NCT00785629|16805873|P4|Overall Study|Adverse Event|5
4876771|NCT00785629|16805874|P3|Overall Study|Adverse Event|1
4876772|NCT00785629|16805875|P2|Overall Study|Adverse Event|1
4876773|NCT00785629|16805876|P1|Overall Study|Adverse Event|2
4876774|NCT00785577|16805889|P5|Study Period 3: 1-Week Washout Phase|Death|1
4876775|NCT00785577|16805890|P4|Study Period 3: 1-Week Washout Phase|Death|0
4876776|NCT00785577|16805891|P3|Study Period 3: 1-Week Washout Phase|Death|0
4876777|NCT00785577|16805892|P2|Study Period 3: 1-Week Washout Phase|Death|0
4876778|NCT00785577|16805893|P1|Study Period 3: 1-Week Washout Phase|Death|0
4876779|NCT00785577|16805889|P5|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4876780|NCT00785577|16805890|P4|Study Period 3: 1-Week Washout Phase|Adverse Event|1
4876781|NCT00785577|16805891|P3|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4876782|NCT00785577|16805892|P2|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4876783|NCT00785577|16805893|P1|Study Period 3: 1-Week Washout Phase|Adverse Event|0
4876784|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Sponsor Decision|0
4876785|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Sponsor Decision|1
4876786|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Sponsor Decision|1
4876787|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Sponsor Decision|0
4876788|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Sponsor Decision|1
4876789|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
4876790|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
4876791|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
4876792|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0
4876793|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1
4876794|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Withdrawal by Subject|1
4876795|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Withdrawal by Subject|0
4876796|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Withdrawal by Subject|1
4876797|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Withdrawal by Subject|1
4876798|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Withdrawal by Subject|2
4876799|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Protocol Violation|1
4876800|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Protocol Violation|0
4876801|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Protocol Violation|1
4876802|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Protocol Violation|1
4876803|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Protocol Violation|1
4876804|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Physician Decision|0
4876805|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Physician Decision|0
4876806|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Physician Decision|0
4876807|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Physician Decision|0
4876808|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Physician Decision|1
4876809|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Lost to Follow-up|0
4876810|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Lost to Follow-up|1
4876811|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Lost to Follow-up|0
4876812|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Lost to Follow-up|0
4876813|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Lost to Follow-up|0
4876814|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Lack of Efficacy|1
4876815|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Lack of Efficacy|0
4876816|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Lack of Efficacy|0
4876817|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Lack of Efficacy|0
4876818|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Lack of Efficacy|0
4876819|NCT00785577|16805889|P5|Study Period 2: Therapy Phase|Adverse Event|17
4876820|NCT00785577|16805890|P4|Study Period 2: Therapy Phase|Adverse Event|10
4876821|NCT00785577|16805891|P3|Study Period 2: Therapy Phase|Adverse Event|14
4876822|NCT00785577|16805892|P2|Study Period 2: Therapy Phase|Adverse Event|7
4876823|NCT00785577|16805893|P1|Study Period 2: Therapy Phase|Adverse Event|5
4876824|NCT00785538|16806033|P4|Treatment Period|Withdrawal by Subject|1
4876825|NCT00785538|16806034|P3|Treatment Period|Withdrawal by Subject|0
4876826|NCT00785538|16806035|P2|Treatment Period|Withdrawal by Subject|0
4876827|NCT00785538|16806036|P1|Treatment Period|Withdrawal by Subject|0
4876828|NCT00785538|16806033|P4|Treatment Period|Adverse Event|0
4876829|NCT00785538|16806034|P3|Treatment Period|Adverse Event|2
4876830|NCT00785538|16806035|P2|Treatment Period|Adverse Event|2
4876831|NCT00785538|16806036|P1|Treatment Period|Adverse Event|1
4876832|NCT00785512|16806084|P2|Overall Study|Lack of compliance|1
4876833|NCT00785512|16806085|P1|Overall Study|Lack of compliance|0
4876834|NCT00785512|16806084|P2|Overall Study|Physician Decision|0
4876835|NCT00785512|16806085|P1|Overall Study|Physician Decision|0
4876836|NCT00785512|16806084|P2|Overall Study|IVRS Programing Error|0
4876837|NCT00785512|16806085|P1|Overall Study|IVRS Programing Error|0
4876838|NCT00785512|16806084|P2|Overall Study|Precedure Refused|0
4876839|NCT00785512|16806085|P1|Overall Study|Precedure Refused|0
4876840|NCT00785512|16806084|P2|Overall Study|Lost to Follow-up|0
4876841|NCT00785512|16806085|P1|Overall Study|Lost to Follow-up|3
4876842|NCT00785512|16806084|P2|Overall Study|Withdrawal by Subject|1
4876843|NCT00785512|16806085|P1|Overall Study|Withdrawal by Subject|0
4876844|NCT00785512|16806084|P2|Overall Study|Lack of Efficacy|2
4876845|NCT00785512|16806085|P1|Overall Study|Lack of Efficacy|0
4876846|NCT00785512|16806084|P2|Overall Study|Adverse Event|0
4876847|NCT00785512|16806085|P1|Overall Study|Adverse Event|0
4876848|NCT00785512|16806084|P2|Overall Study|Inclusion/Exclusion not meet|0
4876849|NCT00785512|16806085|P1|Overall Study|Inclusion/Exclusion not meet|0
4876850|NCT00785486|16806094|P1|Midazolam Alone|Withdrawal by Subject|1
4876851|NCT00785356|16806118|P1|Overall Study|Study prematurely terminated|8
4876852|NCT00785291|16806129|P3|Overall Study|Other Medical Reasons|15
4876853|NCT00785291|16806130|P2|Overall Study|Other Medical Reasons|25
4876854|NCT00785291|16806131|P1|Overall Study|Other Medical Reasons|29
4876855|NCT00785291|16806129|P3|Overall Study|Complicating illness|4
4876856|NCT00785291|16806130|P2|Overall Study|Complicating illness|4
4876857|NCT00785291|16806131|P1|Overall Study|Complicating illness|6
4876858|NCT00785291|16806129|P3|Overall Study|Alternative Therapy|7
4876859|NCT00785291|16806130|P2|Overall Study|Alternative Therapy|6
4876860|NCT00785291|16806131|P1|Overall Study|Alternative Therapy|12
4876861|NCT00785291|16806129|P3|Overall Study|Withdrawal by Subject|17
4876862|NCT00785291|16806130|P2|Overall Study|Withdrawal by Subject|36
4876863|NCT00785291|16806131|P1|Overall Study|Withdrawal by Subject|35
4876864|NCT00785291|16806129|P3|Overall Study|Death|3
4876865|NCT00785291|16806130|P2|Overall Study|Death|4
4876866|NCT00785291|16806131|P1|Overall Study|Death|7
4876867|NCT00785291|16806129|P3|Overall Study|Adverse Event|56
4876868|NCT00785291|16806130|P2|Overall Study|Adverse Event|70
4876869|NCT00785291|16806131|P1|Overall Study|Adverse Event|39
4876870|NCT00785291|16806129|P3|Overall Study|Never began treatment|4
4876871|NCT00785291|16806130|P2|Overall Study|Never began treatment|4
4876872|NCT00785291|16806131|P1|Overall Study|Never began treatment|8
4876873|NCT00785213|16806151|P1|Rosiglitazone With Quinine Sulfate|Adverse Event|1
4876874|NCT00785213|16806151|P1|Quinine Sulfate Alone|Adverse Event|4
4876875|NCT00785044|16806162|P1|Overall Study|Withdrawal by Subject|1
4876876|NCT00785044|16806162|P1|Overall Study|Lost to Follow-up|266
4876877|NCT00785044|16806162|P1|Overall Study|Death|77
4876878|NCT00785044|16806162|P1|Overall Study|Dosed at non-participating sites|152
4876879|NCT00784979|16806167|P1|Overall Study|incomplete data|6
4876880|NCT00784927|16806171|P1|Overall Study|Ineligible|1
4876881|NCT00784927|16806171|P1|Overall Study|Protocol Violation|1
4876882|NCT00784927|16806171|P1|Overall Study|Cancel Prior to Initiating Treatment|1
4876883|NCT00784875|16806183|P4|Period D|Lost to Follow-up|1
4876884|NCT00784875|16806184|P3|Period D|Lost to Follow-up|1
4876885|NCT00784875|16806185|P2|Period D|Lost to Follow-up|0
4876886|NCT00784875|16806186|P1|Period D|Lost to Follow-up|1
4876887|NCT00784875|16806183|P4|Period D|Sponsor Decision|0
4876888|NCT00784875|16806184|P3|Period D|Sponsor Decision|1
4876889|NCT00784875|16806185|P2|Period D|Sponsor Decision|1
4876890|NCT00784875|16806186|P1|Period D|Sponsor Decision|1
4876891|NCT00784875|16806183|P4|Period D|Physician Decision|0
4876892|NCT00784875|16806184|P3|Period D|Physician Decision|0
4876893|NCT00784875|16806185|P2|Period D|Physician Decision|1
4876894|NCT00784875|16806186|P1|Period D|Physician Decision|0
4876895|NCT00784875|16806183|P4|Period D|Withdrawal by Subject|0
4876896|NCT00784875|16806184|P3|Period D|Withdrawal by Subject|2
4876897|NCT00784875|16806185|P2|Period D|Withdrawal by Subject|0
4876898|NCT00784875|16806186|P1|Period D|Withdrawal by Subject|2
4876899|NCT00784875|16806183|P4|Period D|Protocol Violation|0
4876900|NCT00784875|16806184|P3|Period D|Protocol Violation|0
4876901|NCT00784875|16806185|P2|Period D|Protocol Violation|0
4876902|NCT00784875|16806186|P1|Period D|Protocol Violation|1
4876903|NCT00784875|16806183|P4|Period D|Adverse Event|0
4876904|NCT00784875|16806184|P3|Period D|Adverse Event|2
4876905|NCT00784875|16806185|P2|Period D|Adverse Event|2
4876906|NCT00784875|16806186|P1|Period D|Adverse Event|0
4876907|NCT00784875|16806183|P4|Period C|Sponsor Decision|2
4876908|NCT00784875|16806184|P3|Period C|Sponsor Decision|4
4876909|NCT00784875|16806185|P2|Period C|Sponsor Decision|5
4876910|NCT00784875|16806186|P1|Period C|Sponsor Decision|5
4876911|NCT00784875|16806183|P4|Period C|Physician Decision|1
4876912|NCT00784875|16806184|P3|Period C|Physician Decision|1
4876913|NCT00784875|16806185|P2|Period C|Physician Decision|0
4876914|NCT00784875|16806186|P1|Period C|Physician Decision|0
4876915|NCT00784875|16806183|P4|Period C|Withdrawal by Subject|0
4876916|NCT00784875|16806184|P3|Period C|Withdrawal by Subject|2
4876917|NCT00784875|16806185|P2|Period C|Withdrawal by Subject|1
4876918|NCT00784875|16806186|P1|Period C|Withdrawal by Subject|1
4876919|NCT00784875|16806183|P4|Period C|Lack of Efficacy|0
4876920|NCT00784875|16806184|P3|Period C|Lack of Efficacy|1
4876921|NCT00784875|16806185|P2|Period C|Lack of Efficacy|0
4876922|NCT00784875|16806186|P1|Period C|Lack of Efficacy|0
4876923|NCT00784875|16806183|P4|Period C|Protocol Violation|2
4876924|NCT00784875|16806184|P3|Period C|Protocol Violation|1
4876925|NCT00784875|16806185|P2|Period C|Protocol Violation|0
4876926|NCT00784875|16806186|P1|Period C|Protocol Violation|0
4876927|NCT00784875|16806183|P4|Period C|Adverse Event|2
4876928|NCT00784875|16806184|P3|Period C|Adverse Event|4
4876929|NCT00784875|16806185|P2|Period C|Adverse Event|0
4876930|NCT00784875|16806186|P1|Period C|Adverse Event|1
4876931|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Lost to Follow-up|0
4876932|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Lost to Follow-up|1
4876933|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Lost to Follow-up|0
4876934|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Lost to Follow-up|0
4876935|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Sponsor Decision|12
4876936|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Sponsor Decision|12
4876937|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Sponsor Decision|6
4876938|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Sponsor Decision|9
4876939|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Physician Decision|0
4876940|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Physician Decision|1
4876941|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Physician Decision|0
4876942|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Physician Decision|0
4876943|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Withdrawal by Subject|2
4876944|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Withdrawal by Subject|1
4876945|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Withdrawal by Subject|1
4876946|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Withdrawal by Subject|4
4876947|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Lack of Efficacy|0
4876948|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Lack of Efficacy|0
4876949|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Lack of Efficacy|1
4876950|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Lack of Efficacy|0
4876951|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Protocol Violation|3
4876952|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Protocol Violation|2
4876953|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Protocol Violation|1
4876954|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Protocol Violation|1
4876955|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Adverse Event|1
4876956|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Adverse Event|2
4876957|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Adverse Event|3
4876958|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Adverse Event|0
4876959|NCT00784875|16806183|P4|Period B - Efficacy Endpoint|Entry Criteria Not Met|1
4876960|NCT00784875|16806184|P3|Period B - Efficacy Endpoint|Entry Criteria Not Met|2
4876961|NCT00784875|16806185|P2|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
4876962|NCT00784875|16806186|P1|Period B - Efficacy Endpoint|Entry Criteria Not Met|0
4876963|NCT00784875|16806183|P4|Period A - Baseline|Lost to Follow-up|2
4876964|NCT00784875|16806184|P3|Period A - Baseline|Lost to Follow-up|0
4876965|NCT00784875|16806185|P2|Period A - Baseline|Lost to Follow-up|0
4876966|NCT00784875|16806186|P1|Period A - Baseline|Lost to Follow-up|0
4876967|NCT00784875|16806183|P4|Period A - Baseline|Sponsor Decision|113
4876968|NCT00784875|16806184|P3|Period A - Baseline|Sponsor Decision|0
4876969|NCT00784875|16806185|P2|Period A - Baseline|Sponsor Decision|0
4876970|NCT00784875|16806186|P1|Period A - Baseline|Sponsor Decision|0
4876971|NCT00784875|16806183|P4|Period A - Baseline|Physician Decision|2
4876972|NCT00784875|16806184|P3|Period A - Baseline|Physician Decision|0
4876973|NCT00784875|16806185|P2|Period A - Baseline|Physician Decision|0
4876974|NCT00784875|16806186|P1|Period A - Baseline|Physician Decision|0
4876975|NCT00784875|16806183|P4|Period A - Baseline|Withdrawal by Subject|27
4876976|NCT00784875|16806184|P3|Period A - Baseline|Withdrawal by Subject|0
4876977|NCT00784875|16806185|P2|Period A - Baseline|Withdrawal by Subject|0
4876978|NCT00784875|16806186|P1|Period A - Baseline|Withdrawal by Subject|0
4876979|NCT00784875|16806183|P4|Period A - Baseline|Protocol Violation|25
4876980|NCT00784875|16806184|P3|Period A - Baseline|Protocol Violation|0
4876981|NCT00784875|16806185|P2|Period A - Baseline|Protocol Violation|0
4876982|NCT00784875|16806186|P1|Period A - Baseline|Protocol Violation|0
4876983|NCT00784875|16806183|P4|Period A - Baseline|Adverse Event|8
4876984|NCT00784875|16806184|P3|Period A - Baseline|Adverse Event|0
4876985|NCT00784875|16806185|P2|Period A - Baseline|Adverse Event|0
4876986|NCT00784875|16806186|P1|Period A - Baseline|Adverse Event|0
4876987|NCT00784875|16806183|P4|Period A - Baseline|Entry Criteria Not Met|5
4876988|NCT00784875|16806184|P3|Period A - Baseline|Entry Criteria Not Met|0
4876989|NCT00784875|16806185|P2|Period A - Baseline|Entry Criteria Not Met|0
4876990|NCT00784875|16806186|P1|Period A - Baseline|Entry Criteria Not Met|0
4876991|NCT00784836|16806306|P1|Overall Study|Early Study Termination|3
4876992|NCT00784810|16806313|P2|Overall Study|Lost to Follow-up|1
4876993|NCT00784810|16806314|P1|Overall Study|Lost to Follow-up|1
4876994|NCT00784810|16806313|P2|Overall Study|Administrative|8
4876995|NCT00784810|16806314|P1|Overall Study|Administrative|5
4876996|NCT00784810|16806313|P2|Overall Study|Withdrawal by Subject|9
4876997|NCT00784810|16806314|P1|Overall Study|Withdrawal by Subject|11
4876998|NCT00784810|16806313|P2|Overall Study|Lack of Efficacy|11
4876999|NCT00784810|16806314|P1|Overall Study|Lack of Efficacy|14
4877000|NCT00784810|16806313|P2|Overall Study|Adverse Event|20
4877001|NCT00784810|16806314|P1|Overall Study|Adverse Event|32
4877002|NCT00784784|16806324|P2|Overall Study|Withdrawal by Subject|2
4877003|NCT00784784|16806325|P1|Overall Study|Withdrawal by Subject|2
4877004|NCT00784758|16806335|P2|Overall Study|Adverse Event|0
4877005|NCT00784758|16806336|P1|Overall Study|Adverse Event|1
4877006|NCT00784758|16806335|P2|Overall Study|Withdrawal by Subject|0
4877007|NCT00784758|16806336|P1|Overall Study|Withdrawal by Subject|3
4877008|NCT00784719|16806385|P7|Overall Study|Withdrawal by Subject|1
4877009|NCT00784719|16806386|P6|Overall Study|Withdrawal by Subject|0
4877010|NCT00784719|16806387|P5|Overall Study|Withdrawal by Subject|2
4877011|NCT00784719|16806388|P4|Overall Study|Withdrawal by Subject|0
4877012|NCT00784719|16806389|P3|Overall Study|Withdrawal by Subject|0
4877013|NCT00784719|16806390|P2|Overall Study|Withdrawal by Subject|0
4877014|NCT00784719|16806391|P1|Overall Study|Withdrawal by Subject|1
4877015|NCT00784719|16806385|P7|Overall Study|Other|3
4877016|NCT00784719|16806386|P6|Overall Study|Other|1
4877017|NCT00784719|16806387|P5|Overall Study|Other|2
4877018|NCT00784719|16806388|P4|Overall Study|Other|0
4877019|NCT00784719|16806389|P3|Overall Study|Other|1
4877020|NCT00784719|16806390|P2|Overall Study|Other|1
4877021|NCT00784719|16806391|P1|Overall Study|Other|2
4877022|NCT00784719|16806385|P7|Overall Study|Lost to Follow-up|0
4877023|NCT00784719|16806386|P6|Overall Study|Lost to Follow-up|1
4877024|NCT00784719|16806387|P5|Overall Study|Lost to Follow-up|1
4877025|NCT00784719|16806388|P4|Overall Study|Lost to Follow-up|0
4877026|NCT00784719|16806389|P3|Overall Study|Lost to Follow-up|0
4877027|NCT00784719|16806390|P2|Overall Study|Lost to Follow-up|0
4877028|NCT00784719|16806391|P1|Overall Study|Lost to Follow-up|0
4877029|NCT00784719|16806385|P7|Overall Study|Adverse Event|1
4877030|NCT00784719|16806386|P6|Overall Study|Adverse Event|1
4877031|NCT00784719|16806387|P5|Overall Study|Adverse Event|1
4877032|NCT00784719|16806388|P4|Overall Study|Adverse Event|0
4877033|NCT00784719|16806389|P3|Overall Study|Adverse Event|0
4877034|NCT00784719|16806390|P2|Overall Study|Adverse Event|2
4877035|NCT00784719|16806391|P1|Overall Study|Adverse Event|0
4877036|NCT00784654|16806561|P3|Randomized Withdrawal Period|Family reasons|1
4877037|NCT00784654|16806562|P2|Randomized Withdrawal Period|Family reasons|0
4877038|NCT00784654|16806563|P1|Randomized Withdrawal Period|Family reasons|0
4877039|NCT00784654|16806561|P3|Randomized Withdrawal Period|Did not complete a visit|0
4877040|NCT00784654|16806562|P2|Randomized Withdrawal Period|Did not complete a visit|1
4877041|NCT00784654|16806563|P1|Randomized Withdrawal Period|Did not complete a visit|0
4877042|NCT00784654|16806561|P3|Randomized Withdrawal Period|Adverse Event|1
4877043|NCT00784654|16806562|P2|Randomized Withdrawal Period|Adverse Event|1
4877044|NCT00784654|16806563|P1|Randomized Withdrawal Period|Adverse Event|0
4877045|NCT00784654|16806561|P3|Randomized Withdrawal Period|Protocol Violation|1
4877046|NCT00784654|16806562|P2|Randomized Withdrawal Period|Protocol Violation|2
4877047|NCT00784654|16806563|P1|Randomized Withdrawal Period|Protocol Violation|0
4877048|NCT00784654|16806561|P3|Randomized Withdrawal Period|Withdrawal by Subject|7
4877049|NCT00784654|16806562|P2|Randomized Withdrawal Period|Withdrawal by Subject|1
4877050|NCT00784654|16806563|P1|Randomized Withdrawal Period|Withdrawal by Subject|0
4877051|NCT00784654|16806561|P3|Randomized Withdrawal Period|Lack of Efficacy|18
4877052|NCT00784654|16806562|P2|Randomized Withdrawal Period|Lack of Efficacy|5
4877053|NCT00784654|16806563|P1|Randomized Withdrawal Period|Lack of Efficacy|0
4877054|NCT00784654|16806561|P3|Randomized Withdrawal Period|Met relapse criteria per investigator|35
4877055|NCT00784654|16806562|P2|Randomized Withdrawal Period|Met relapse criteria per investigator|8
4877056|NCT00784654|16806563|P1|Randomized Withdrawal Period|Met relapse criteria per investigator|0
4877057|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
4877058|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Did not provide end of study page|0
4877059|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Did not provide end of study page|1
4877060|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
4877061|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0
4877062|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1
4877063|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
4877064|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0
4877065|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1
4877066|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Home situation intolerable|0
4877067|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Home situation intolerable|0
4877068|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Home situation intolerable|1
4877069|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
4877070|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Decision of medical monitor|0
4877071|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Decision of medical monitor|1
4877072|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
4877073|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Mother is a drug addict|0
4877074|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Mother is a drug addict|1
4877075|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Protocol Violation|0
4877076|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Protocol Violation|0
4877077|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Protocol Violation|7
4877078|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
4877079|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Lost to Follow-up|0
4877080|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Lost to Follow-up|11
4877081|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
4877082|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Lack of Efficacy|0
4877083|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Lack of Efficacy|21
4877084|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
4877085|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0
4877086|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22
4877087|NCT00784654|16806561|P3|Open-Label Period (Non-Randomized)|Adverse Event|0
4877088|NCT00784654|16806562|P2|Open-Label Period (Non-Randomized)|Adverse Event|0
4877089|NCT00784654|16806563|P1|Open-Label Period (Non-Randomized)|Adverse Event|44
4877090|NCT00784563|16806611|P3|Year 3|Adverse Event|1
4877091|NCT00784563|16806612|P2|Year 3|Adverse Event|0
4877092|NCT00784563|16806613|P1|Year 3|Adverse Event|0
4877093|NCT00784563|16806611|P3|Year 3|Withdrawal by Subject|2
4877094|NCT00784563|16806612|P2|Year 3|Withdrawal by Subject|0
4877095|NCT00784563|16806613|P1|Year 3|Withdrawal by Subject|0
4877096|NCT00784563|16806611|P3|Years 1 & 2|Adverse Event|0
4877097|NCT00784563|16806612|P2|Years 1 & 2|Adverse Event|3
4877098|NCT00784563|16806613|P1|Years 1 & 2|Adverse Event|0
4877099|NCT00784563|16806611|P3|Years 1 & 2|Withdrawal by Subject|0
4877100|NCT00784563|16806612|P2|Years 1 & 2|Withdrawal by Subject|2
4877101|NCT00784563|16806613|P1|Years 1 & 2|Withdrawal by Subject|3
4877102|NCT00784550|16806631|P2|Overall Study|Withdrawal by Subject|13
4877103|NCT00784550|16806632|P1|Overall Study|Withdrawal by Subject|4
4877104|NCT00784550|16806631|P2|Overall Study|Physician Decision|3
4877105|NCT00784550|16806632|P1|Overall Study|Physician Decision|2
4877106|NCT00784550|16806631|P2|Overall Study|Lost to Follow-up|5
4877107|NCT00784550|16806632|P1|Overall Study|Lost to Follow-up|8
4877108|NCT00784550|16806631|P2|Overall Study|Protocol Violation|10
4877109|NCT00784550|16806632|P1|Overall Study|Protocol Violation|10
4877110|NCT00784550|16806631|P2|Overall Study|Lack of Efficacy|1
4877111|NCT00784550|16806632|P1|Overall Study|Lack of Efficacy|0
4877112|NCT00784550|16806631|P2|Overall Study|Adverse Event|10
4877113|NCT00784550|16806632|P1|Overall Study|Adverse Event|12
4877114|NCT00784459|16806658|P2|Overall Study|Adverse Event|2
4877115|NCT00784459|16806659|P1|Overall Study|Adverse Event|0
4877116|NCT00784368|16806670|P3|Overall Study|Withdrawal of informed consent|0
4877117|NCT00784368|16806671|P2|Overall Study|Withdrawal of informed consent|1
4877118|NCT00784368|16806672|P1|Overall Study|Withdrawal of informed consent|0
4877119|NCT00784368|16806670|P3|Overall Study|Worsening of symptoms|0
4877120|NCT00784368|16806671|P2|Overall Study|Worsening of symptoms|1
4877121|NCT00784368|16806672|P1|Overall Study|Worsening of symptoms|0
4877122|NCT00784368|16806670|P3|Overall Study|Worsening of complications|1
4877123|NCT00784368|16806671|P2|Overall Study|Worsening of complications|0
4877124|NCT00784368|16806672|P1|Overall Study|Worsening of complications|0
4877125|NCT00784368|16806670|P3|Overall Study|Diagnosis of fever|1
4877126|NCT00784368|16806671|P2|Overall Study|Diagnosis of fever|0
4877127|NCT00784368|16806672|P1|Overall Study|Diagnosis of fever|0
4877128|NCT00784368|16806670|P3|Overall Study|Adverse Event|2
4877129|NCT00784368|16806671|P2|Overall Study|Adverse Event|9
4877130|NCT00784368|16806672|P1|Overall Study|Adverse Event|6
4877131|NCT00784368|16806670|P3|Overall Study|Lack of Efficacy|1
4877132|NCT00784368|16806671|P2|Overall Study|Lack of Efficacy|0
4877133|NCT00784368|16806672|P1|Overall Study|Lack of Efficacy|2
4877134|NCT00784368|16806670|P3|Overall Study|Physician Decision|6
4877135|NCT00784368|16806671|P2|Overall Study|Physician Decision|0
4877136|NCT00784368|16806672|P1|Overall Study|Physician Decision|0
4877137|NCT00784277|16806748|P7|ER Treatment|Other|2
4877138|NCT00784277|16806749|P6|ER Treatment|Other|3
4877139|NCT00784277|16806750|P5|ER Treatment|Other|1
4877140|NCT00784277|16806751|P4|ER Treatment|Other|0
4877141|NCT00784277|16806752|P3|ER Treatment|Other|0
4877142|NCT00784277|16806753|P2|ER Treatment|Other|0
4877143|NCT00784277|16806754|P1|ER Treatment|Other|0
4877144|NCT00784277|16806748|P7|ER Treatment|Study Medication Non-Compliant|3
4877145|NCT00784277|16806749|P6|ER Treatment|Study Medication Non-Compliant|3
4877146|NCT00784277|16806750|P5|ER Treatment|Study Medication Non-Compliant|2
4877147|NCT00784277|16806751|P4|ER Treatment|Study Medication Non-Compliant|0
4877148|NCT00784277|16806752|P3|ER Treatment|Study Medication Non-Compliant|0
4877149|NCT00784277|16806753|P2|ER Treatment|Study Medication Non-Compliant|0
4877150|NCT00784277|16806754|P1|ER Treatment|Study Medication Non-Compliant|0
4877151|NCT00784277|16806748|P7|ER Treatment|Withdrawal by Subject|3
4877152|NCT00784277|16806749|P6|ER Treatment|Withdrawal by Subject|5
4877153|NCT00784277|16806750|P5|ER Treatment|Withdrawal by Subject|2
4877154|NCT00784277|16806751|P4|ER Treatment|Withdrawal by Subject|0
4877155|NCT00784277|16806752|P3|ER Treatment|Withdrawal by Subject|0
4877156|NCT00784277|16806753|P2|ER Treatment|Withdrawal by Subject|0
4877157|NCT00784277|16806754|P1|ER Treatment|Withdrawal by Subject|0
4877158|NCT00784277|16806748|P7|ER Treatment|Lost to Follow-up|0
4877159|NCT00784277|16806749|P6|ER Treatment|Lost to Follow-up|2
4877160|NCT00784277|16806750|P5|ER Treatment|Lost to Follow-up|0
4877161|NCT00784277|16806751|P4|ER Treatment|Lost to Follow-up|0
4877162|NCT00784277|16806752|P3|ER Treatment|Lost to Follow-up|0
4877163|NCT00784277|16806753|P2|ER Treatment|Lost to Follow-up|0
4877164|NCT00784277|16806754|P1|ER Treatment|Lost to Follow-up|0
4877165|NCT00784277|16806748|P7|ER Treatment|Lack of Efficacy|0
4877166|NCT00784277|16806749|P6|ER Treatment|Lack of Efficacy|4
4877167|NCT00784277|16806750|P5|ER Treatment|Lack of Efficacy|3
4877168|NCT00784277|16806751|P4|ER Treatment|Lack of Efficacy|0
4877169|NCT00784277|16806752|P3|ER Treatment|Lack of Efficacy|0
4877170|NCT00784277|16806753|P2|ER Treatment|Lack of Efficacy|0
4877171|NCT00784277|16806754|P1|ER Treatment|Lack of Efficacy|0
4877172|NCT00784277|16806748|P7|ER Treatment|Adverse Event|7
4877173|NCT00784277|16806749|P6|ER Treatment|Adverse Event|7
4877174|NCT00784277|16806750|P5|ER Treatment|Adverse Event|1
4877175|NCT00784277|16806751|P4|ER Treatment|Adverse Event|0
4877176|NCT00784277|16806752|P3|ER Treatment|Adverse Event|0
4877177|NCT00784277|16806753|P2|ER Treatment|Adverse Event|0
4877178|NCT00784277|16806754|P1|ER Treatment|Adverse Event|0
4877179|NCT00784277|16806748|P7|IR Treatment|Other|0
4877180|NCT00784277|16806749|P6|IR Treatment|Other|0
4877181|NCT00784277|16806750|P5|IR Treatment|Other|0
4877182|NCT00784277|16806751|P4|IR Treatment|Other|2
4877183|NCT00784277|16806752|P3|IR Treatment|Other|3
4877184|NCT00784277|16806753|P2|IR Treatment|Other|3
4877185|NCT00784277|16806754|P1|IR Treatment|Other|2
4877186|NCT00784277|16806748|P7|IR Treatment|Resolution Of Pain|0
4877187|NCT00784277|16806749|P6|IR Treatment|Resolution Of Pain|0
4877188|NCT00784277|16806750|P5|IR Treatment|Resolution Of Pain|0
4877189|NCT00784277|16806751|P4|IR Treatment|Resolution Of Pain|0
4877190|NCT00784277|16806752|P3|IR Treatment|Resolution Of Pain|0
4877191|NCT00784277|16806753|P2|IR Treatment|Resolution Of Pain|1
4877192|NCT00784277|16806754|P1|IR Treatment|Resolution Of Pain|0
4877193|NCT00784277|16806748|P7|IR Treatment|Withdrawal by Subject|0
4877194|NCT00784277|16806749|P6|IR Treatment|Withdrawal by Subject|0
4877195|NCT00784277|16806750|P5|IR Treatment|Withdrawal by Subject|0
4877196|NCT00784277|16806751|P4|IR Treatment|Withdrawal by Subject|6
4877197|NCT00784277|16806752|P3|IR Treatment|Withdrawal by Subject|4
4877198|NCT00784277|16806753|P2|IR Treatment|Withdrawal by Subject|1
4877199|NCT00784277|16806754|P1|IR Treatment|Withdrawal by Subject|5
4877200|NCT00784277|16806748|P7|IR Treatment|Lost to Follow-up|0
4877201|NCT00784277|16806749|P6|IR Treatment|Lost to Follow-up|0
4877202|NCT00784277|16806750|P5|IR Treatment|Lost to Follow-up|0
4877203|NCT00784277|16806751|P4|IR Treatment|Lost to Follow-up|0
4877204|NCT00784277|16806752|P3|IR Treatment|Lost to Follow-up|1
4877205|NCT00784277|16806753|P2|IR Treatment|Lost to Follow-up|0
4877206|NCT00784277|16806754|P1|IR Treatment|Lost to Follow-up|1
4877207|NCT00784277|16806748|P7|IR Treatment|Lack of Efficacy|0
4877208|NCT00784277|16806749|P6|IR Treatment|Lack of Efficacy|0
4877209|NCT00784277|16806750|P5|IR Treatment|Lack of Efficacy|0
4877210|NCT00784277|16806751|P4|IR Treatment|Lack of Efficacy|0
4877211|NCT00784277|16806752|P3|IR Treatment|Lack of Efficacy|1
4877212|NCT00784277|16806753|P2|IR Treatment|Lack of Efficacy|4
4877213|NCT00784277|16806754|P1|IR Treatment|Lack of Efficacy|4
4877214|NCT00784277|16806748|P7|IR Treatment|Adverse Event|0
4877215|NCT00784277|16806749|P6|IR Treatment|Adverse Event|0
4877216|NCT00784277|16806750|P5|IR Treatment|Adverse Event|0
4877217|NCT00784277|16806751|P4|IR Treatment|Adverse Event|35
4877218|NCT00784277|16806752|P3|IR Treatment|Adverse Event|19
4877219|NCT00784277|16806753|P2|IR Treatment|Adverse Event|8
4877220|NCT00784277|16806754|P1|IR Treatment|Adverse Event|4
4877221|NCT00784238|16806771|P1|Overall Study|Other|14
4877222|NCT00784238|16806771|P1|Overall Study|Withdrawal by Subject|26
4877223|NCT00784238|16806771|P1|Overall Study|Pregnancy|1
4877224|NCT00784238|16806771|P1|Overall Study|Lost to Follow-up|29
4877225|NCT00784238|16806771|P1|Overall Study|Lack of Efficacy|33
4877226|NCT00784238|16806771|P1|Overall Study|Death|2
4877227|NCT00784238|16806771|P1|Overall Study|Adverse Event|14
4877228|NCT00784147|16806843|P2|Overall Study|Death|0
4877229|NCT00784147|16806844|P1|Overall Study|Death|2
4877230|NCT00784147|16806843|P2|Overall Study|Protocol Violation|1
4877231|NCT00784147|16806844|P1|Overall Study|Protocol Violation|1
4877232|NCT00784147|16806843|P2|Overall Study|Physician Decision|1
4877233|NCT00784147|16806844|P1|Overall Study|Physician Decision|2
4877234|NCT00784147|16806843|P2|Overall Study|Withdrawal by Subject|3
4877235|NCT00784147|16806844|P1|Overall Study|Withdrawal by Subject|1
4877236|NCT00784147|16806843|P2|Overall Study|Lost to Follow-up|4
4877237|NCT00784147|16806844|P1|Overall Study|Lost to Follow-up|2
4877238|NCT00784134|16806864|P2|Overall Study|Lost to Follow-up|6
4877239|NCT00784134|16806865|P1|Overall Study|Lost to Follow-up|3
4877240|NCT00784043|16806988|P2|Overall Study|Protocol Terminated|1
4877241|NCT00784043|16806989|P1|Overall Study|Protocol Terminated|23
4877242|NCT00784043|16806988|P2|Overall Study|Withdrawal by Subject|5
4877243|NCT00784043|16806989|P1|Overall Study|Withdrawal by Subject|8
4877244|NCT00783835|16807024|P1|Overall Study|Participant not Adherent|3
4877245|NCT00783835|16807024|P1|Overall Study|Lost to Follow-up|1
4877246|NCT00783835|16807024|P1|Overall Study|Withdrawal by Subject|2
4877247|NCT00783835|16807024|P1|Overall Study|Medical Criteria|1
4877248|NCT00783835|16807024|P1|Overall Study|Adverse Event|3
4877249|NCT00783796|16807036|P1|Overall Study|Received commercial XIENCE V stent|1
4877250|NCT00783796|16807036|P1|Overall Study|Received non-XIENCE V stent|1
4877251|NCT00783796|16807036|P1|Overall Study|Did not receive any stent|4
4877252|NCT00783718|16807141|P7|Maintenance Phase|Lost to Follow-up|2
4877253|NCT00783718|16807142|P6|Maintenance Phase|Lost to Follow-up|0
4877254|NCT00783718|16807143|P5|Maintenance Phase|Lost to Follow-up|2
4877255|NCT00783718|16807144|P4|Maintenance Phase|Lost to Follow-up|0
4877256|NCT00783718|16807145|P3|Maintenance Phase|Lost to Follow-up|0
4877257|NCT00783718|16807146|P2|Maintenance Phase|Lost to Follow-up|0
4877258|NCT00783718|16807147|P1|Maintenance Phase|Lost to Follow-up|3
4877259|NCT00783718|16807141|P7|Maintenance Phase|Withdrawal by Subject|20
4877260|NCT00783718|16807142|P6|Maintenance Phase|Withdrawal by Subject|2
4877261|NCT00783718|16807143|P5|Maintenance Phase|Withdrawal by Subject|5
4877262|NCT00783718|16807144|P4|Maintenance Phase|Withdrawal by Subject|2
4877263|NCT00783718|16807145|P3|Maintenance Phase|Withdrawal by Subject|0
4877264|NCT00783718|16807146|P2|Maintenance Phase|Withdrawal by Subject|0
4877265|NCT00783718|16807147|P1|Maintenance Phase|Withdrawal by Subject|6
4877266|NCT00783718|16807141|P7|Maintenance Phase|Lack of Efficacy|155
4877267|NCT00783718|16807142|P6|Maintenance Phase|Lack of Efficacy|33
4877268|NCT00783718|16807143|P5|Maintenance Phase|Lack of Efficacy|31
4877269|NCT00783718|16807144|P4|Maintenance Phase|Lack of Efficacy|61
4877270|NCT00783718|16807145|P3|Maintenance Phase|Lack of Efficacy|0
4877271|NCT00783718|16807146|P2|Maintenance Phase|Lack of Efficacy|0
4877272|NCT00783718|16807147|P1|Maintenance Phase|Lack of Efficacy|83
4877273|NCT00783718|16807141|P7|Maintenance Phase|Protocol Violation|2
4877274|NCT00783718|16807142|P6|Maintenance Phase|Protocol Violation|0
4877275|NCT00783718|16807143|P5|Maintenance Phase|Protocol Violation|0
4877276|NCT00783718|16807144|P4|Maintenance Phase|Protocol Violation|0
4877277|NCT00783718|16807145|P3|Maintenance Phase|Protocol Violation|0
4877278|NCT00783718|16807146|P2|Maintenance Phase|Protocol Violation|0
4877279|NCT00783718|16807147|P1|Maintenance Phase|Protocol Violation|1
4877280|NCT00783718|16807141|P7|Maintenance Phase|Adverse Event|16
4877281|NCT00783718|16807142|P6|Maintenance Phase|Adverse Event|6
4877282|NCT00783718|16807143|P5|Maintenance Phase|Adverse Event|7
4877283|NCT00783718|16807144|P4|Maintenance Phase|Adverse Event|15
4877284|NCT00783718|16807145|P3|Maintenance Phase|Adverse Event|0
4877285|NCT00783718|16807146|P2|Maintenance Phase|Adverse Event|0
4877286|NCT00783718|16807147|P1|Maintenance Phase|Adverse Event|12
4877287|NCT00783718|16807141|P7|Induction Phase|Lost to Follow-up|0
4877288|NCT00783718|16807142|P6|Induction Phase|Lost to Follow-up|0
4877289|NCT00783718|16807143|P5|Induction Phase|Lost to Follow-up|0
4877290|NCT00783718|16807144|P4|Induction Phase|Lost to Follow-up|0
4877291|NCT00783718|16807145|P3|Induction Phase|Lost to Follow-up|1
4877292|NCT00783718|16807146|P2|Induction Phase|Lost to Follow-up|0
4877293|NCT00783718|16807147|P1|Induction Phase|Lost to Follow-up|1
4877294|NCT00783718|16807141|P7|Induction Phase|Withdrawal by Subject|0
4877295|NCT00783718|16807142|P6|Induction Phase|Withdrawal by Subject|0
4877296|NCT00783718|16807143|P5|Induction Phase|Withdrawal by Subject|0
4877297|NCT00783718|16807144|P4|Induction Phase|Withdrawal by Subject|0
4877298|NCT00783718|16807145|P3|Induction Phase|Withdrawal by Subject|8
4877299|NCT00783718|16807146|P2|Induction Phase|Withdrawal by Subject|4
4877300|NCT00783718|16807147|P1|Induction Phase|Withdrawal by Subject|3
4877301|NCT00783718|16807141|P7|Induction Phase|Lack of Efficacy|0
4877302|NCT00783718|16807142|P6|Induction Phase|Lack of Efficacy|0
4877303|NCT00783718|16807143|P5|Induction Phase|Lack of Efficacy|0
4877304|NCT00783718|16807144|P4|Induction Phase|Lack of Efficacy|0
4877305|NCT00783718|16807145|P3|Induction Phase|Lack of Efficacy|14
4877306|NCT00783718|16807146|P2|Induction Phase|Lack of Efficacy|2
4877307|NCT00783718|16807147|P1|Induction Phase|Lack of Efficacy|5
4877308|NCT00783718|16807141|P7|Induction Phase|Protocol Violation|0
4877309|NCT00783718|16807142|P6|Induction Phase|Protocol Violation|0
4877310|NCT00783718|16807143|P5|Induction Phase|Protocol Violation|0
4877311|NCT00783718|16807144|P4|Induction Phase|Protocol Violation|0
4877312|NCT00783718|16807145|P3|Induction Phase|Protocol Violation|6
4877313|NCT00783718|16807146|P2|Induction Phase|Protocol Violation|1
4877314|NCT00783718|16807147|P1|Induction Phase|Protocol Violation|1
4877315|NCT00783718|16807141|P7|Induction Phase|Adverse Event|0
4877316|NCT00783718|16807142|P6|Induction Phase|Adverse Event|0
4877317|NCT00783718|16807143|P5|Induction Phase|Adverse Event|0
4877318|NCT00783718|16807144|P4|Induction Phase|Adverse Event|0
4877319|NCT00783718|16807145|P3|Induction Phase|Adverse Event|7
4877320|NCT00783718|16807146|P2|Induction Phase|Adverse Event|0
4877321|NCT00783718|16807147|P1|Induction Phase|Adverse Event|4
4877322|NCT00783705|16807175|P2|Overall Study|Lost to Follow-up|3
4877323|NCT00783705|16807176|P1|Overall Study|Lost to Follow-up|1
4877324|NCT00783705|16807175|P2|Overall Study|Withdrawal by Subject|2
4877325|NCT00783705|16807176|P1|Overall Study|Withdrawal by Subject|3
4877326|NCT00783705|16807175|P2|Overall Study|Adverse Event|0
4877327|NCT00783705|16807176|P1|Overall Study|Adverse Event|2
4877328|NCT00783692|16807223|P7|Maintenance Phase|Other|1
4877329|NCT00783692|16807224|P6|Maintenance Phase|Other|1
4877330|NCT00783692|16807225|P5|Maintenance Phase|Other|0
4877331|NCT00783692|16807226|P4|Maintenance Phase|Other|1
4877332|NCT00783692|16807227|P3|Maintenance Phase|Other|0
4877333|NCT00783692|16807228|P2|Maintenance Phase|Other|0
4877334|NCT00783692|16807229|P1|Maintenance Phase|Other|0
4877335|NCT00783692|16807223|P7|Maintenance Phase|Lost to Follow-up|5
4877336|NCT00783692|16807224|P6|Maintenance Phase|Lost to Follow-up|2
4877337|NCT00783692|16807225|P5|Maintenance Phase|Lost to Follow-up|3
4877338|NCT00783692|16807226|P4|Maintenance Phase|Lost to Follow-up|1
4877339|NCT00783692|16807227|P3|Maintenance Phase|Lost to Follow-up|0
4877340|NCT00783692|16807228|P2|Maintenance Phase|Lost to Follow-up|0
4877341|NCT00783692|16807229|P1|Maintenance Phase|Lost to Follow-up|2
4877342|NCT00783692|16807223|P7|Maintenance Phase|Withdrawal by Subject|24
4877343|NCT00783692|16807224|P6|Maintenance Phase|Withdrawal by Subject|9
4877344|NCT00783692|16807225|P5|Maintenance Phase|Withdrawal by Subject|6
4877345|NCT00783692|16807226|P4|Maintenance Phase|Withdrawal by Subject|7
4877346|NCT00783692|16807227|P3|Maintenance Phase|Withdrawal by Subject|0
4877347|NCT00783692|16807228|P2|Maintenance Phase|Withdrawal by Subject|0
4877348|NCT00783692|16807229|P1|Maintenance Phase|Withdrawal by Subject|7
4877349|NCT00783692|16807223|P7|Maintenance Phase|Lack of Efficacy|177
4877350|NCT00783692|16807224|P6|Maintenance Phase|Lack of Efficacy|48
4877351|NCT00783692|16807225|P5|Maintenance Phase|Lack of Efficacy|58
4877352|NCT00783692|16807226|P4|Maintenance Phase|Lack of Efficacy|64
4877353|NCT00783692|16807227|P3|Maintenance Phase|Lack of Efficacy|0
4877354|NCT00783692|16807228|P2|Maintenance Phase|Lack of Efficacy|0
4877355|NCT00783692|16807229|P1|Maintenance Phase|Lack of Efficacy|79
4877356|NCT00783692|16807223|P7|Maintenance Phase|Protocol Violation|4
4877357|NCT00783692|16807224|P6|Maintenance Phase|Protocol Violation|3
4877358|NCT00783692|16807225|P5|Maintenance Phase|Protocol Violation|2
4877359|NCT00783692|16807226|P4|Maintenance Phase|Protocol Violation|1
4877360|NCT00783692|16807227|P3|Maintenance Phase|Protocol Violation|0
4877361|NCT00783692|16807228|P2|Maintenance Phase|Protocol Violation|0
4877362|NCT00783692|16807229|P1|Maintenance Phase|Protocol Violation|0
4877363|NCT00783692|16807223|P7|Maintenance Phase|Adverse Event|38
4877364|NCT00783692|16807224|P6|Maintenance Phase|Adverse Event|9
4877365|NCT00783692|16807225|P5|Maintenance Phase|Adverse Event|12
4877366|NCT00783692|16807226|P4|Maintenance Phase|Adverse Event|15
4877367|NCT00783692|16807227|P3|Maintenance Phase|Adverse Event|0
4877368|NCT00783692|16807228|P2|Maintenance Phase|Adverse Event|0
4877369|NCT00783692|16807229|P1|Maintenance Phase|Adverse Event|7
4877370|NCT00783692|16807223|P7|Induction Phase|Other|0
4877371|NCT00783692|16807224|P6|Induction Phase|Other|0
4877372|NCT00783692|16807225|P5|Induction Phase|Other|0
4877373|NCT00783692|16807226|P4|Induction Phase|Other|0
4877374|NCT00783692|16807227|P3|Induction Phase|Other|2
4877375|NCT00783692|16807228|P2|Induction Phase|Other|0
4877376|NCT00783692|16807229|P1|Induction Phase|Other|0
4877377|NCT00783692|16807223|P7|Induction Phase|Lost to Follow-up|0
4877378|NCT00783692|16807224|P6|Induction Phase|Lost to Follow-up|0
4877379|NCT00783692|16807225|P5|Induction Phase|Lost to Follow-up|0
4877380|NCT00783692|16807226|P4|Induction Phase|Lost to Follow-up|0
4877381|NCT00783692|16807227|P3|Induction Phase|Lost to Follow-up|3
4877382|NCT00783692|16807228|P2|Induction Phase|Lost to Follow-up|0
4877383|NCT00783692|16807229|P1|Induction Phase|Lost to Follow-up|0
4877384|NCT00783692|16807223|P7|Induction Phase|Withdrawal by Subject|0
4877385|NCT00783692|16807224|P6|Induction Phase|Withdrawal by Subject|0
4877386|NCT00783692|16807225|P5|Induction Phase|Withdrawal by Subject|0
4877387|NCT00783692|16807226|P4|Induction Phase|Withdrawal by Subject|0
4877388|NCT00783692|16807227|P3|Induction Phase|Withdrawal by Subject|16
4877389|NCT00783692|16807228|P2|Induction Phase|Withdrawal by Subject|9
4877390|NCT00783692|16807229|P1|Induction Phase|Withdrawal by Subject|3
4877391|NCT00783692|16807223|P7|Induction Phase|Lack of Efficacy|0
4877392|NCT00783692|16807224|P6|Induction Phase|Lack of Efficacy|0
4877393|NCT00783692|16807225|P5|Induction Phase|Lack of Efficacy|0
4877394|NCT00783692|16807226|P4|Induction Phase|Lack of Efficacy|0
4877395|NCT00783692|16807227|P3|Induction Phase|Lack of Efficacy|28
4877396|NCT00783692|16807228|P2|Induction Phase|Lack of Efficacy|3
4877397|NCT00783692|16807229|P1|Induction Phase|Lack of Efficacy|1
4877398|NCT00783692|16807223|P7|Induction Phase|Protocol Violation|0
4877399|NCT00783692|16807224|P6|Induction Phase|Protocol Violation|0
4877400|NCT00783692|16807225|P5|Induction Phase|Protocol Violation|0
4877401|NCT00783692|16807226|P4|Induction Phase|Protocol Violation|0
4877402|NCT00783692|16807227|P3|Induction Phase|Protocol Violation|1
4877403|NCT00783692|16807228|P2|Induction Phase|Protocol Violation|0
4877404|NCT00783692|16807229|P1|Induction Phase|Protocol Violation|0
4877405|NCT00783692|16807223|P7|Induction Phase|Adverse Event|0
4877406|NCT00783692|16807224|P6|Induction Phase|Adverse Event|0
4877407|NCT00783692|16807225|P5|Induction Phase|Adverse Event|0
4877408|NCT00783692|16807226|P4|Induction Phase|Adverse Event|0
4877409|NCT00783692|16807227|P3|Induction Phase|Adverse Event|24
4877410|NCT00783692|16807228|P2|Induction Phase|Adverse Event|9
4877411|NCT00783692|16807229|P1|Induction Phase|Adverse Event|7
4877412|NCT00783432|16807275|P2|Overall Study|Protocol Violation|9
4877413|NCT00783432|16807276|P1|Overall Study|Protocol Violation|6
4877414|NCT00783432|16807275|P2|Overall Study|subject moved|5
4877415|NCT00783432|16807276|P1|Overall Study|subject moved|3
4877416|NCT00783432|16807275|P2|Overall Study|Withdrawal by Subject|20
4877417|NCT00783432|16807276|P1|Overall Study|Withdrawal by Subject|23
4877418|NCT00783432|16807275|P2|Overall Study|Lost to Follow-up|6
4877419|NCT00783432|16807276|P1|Overall Study|Lost to Follow-up|11
4877420|NCT00783432|16807275|P2|Overall Study|Lack of Efficacy|21
4877421|NCT00783432|16807276|P1|Overall Study|Lack of Efficacy|20
4877422|NCT00783432|16807275|P2|Overall Study|Adverse Event|17
4877423|NCT00783432|16807276|P1|Overall Study|Adverse Event|22
4877424|NCT00783302|16807286|P1|Overall Study|Withdrawal by Subject|3
4877425|NCT00783302|16807286|P1|Overall Study|Physician Decision|1
4877426|NCT00783302|16807286|P1|Overall Study|Protocol Violation|3
4877427|NCT00783302|16807286|P1|Overall Study|Technical Problems|11
4877428|NCT00783302|16807286|P1|Overall Study|Lost to Follow-up|17
4877429|NCT00783289|16807308|P4|Overall Study|Protocol Violation|0
4877430|NCT00783289|16807309|P3|Overall Study|Protocol Violation|0
4877431|NCT00783289|16807310|P2|Overall Study|Protocol Violation|1
4877432|NCT00783289|16807311|P1|Overall Study|Protocol Violation|0
4877433|NCT00783263|16807341|P4|Overall Study|Withdrawal by Subject|2
4877434|NCT00783263|16807342|P3|Overall Study|Withdrawal by Subject|1
4877435|NCT00783263|16807343|P2|Overall Study|Withdrawal by Subject|1
4877436|NCT00783263|16807344|P1|Overall Study|Withdrawal by Subject|0
4877437|NCT00783263|16807341|P4|Overall Study|Lost to Follow-up|0
4877438|NCT00783263|16807342|P3|Overall Study|Lost to Follow-up|0
4877439|NCT00783263|16807343|P2|Overall Study|Lost to Follow-up|1
4877440|NCT00783263|16807344|P1|Overall Study|Lost to Follow-up|1
4877441|NCT00783263|16807341|P4|Overall Study|Adverse Event|1
4877442|NCT00783263|16807342|P3|Overall Study|Adverse Event|2
4877443|NCT00783263|16807343|P2|Overall Study|Adverse Event|0
4877444|NCT00783263|16807344|P1|Overall Study|Adverse Event|3
4877445|NCT00783224|16807374|P4|Overall Study|Inappropriate as a study subject|1
4877446|NCT00783224|16807375|P3|Overall Study|Inappropriate as a study subject|0
4877447|NCT00783224|16807376|P2|Overall Study|Inappropriate as a study subject|0
4877448|NCT00783224|16807377|P1|Overall Study|Inappropriate as a study subject|0
4877449|NCT00783224|16807374|P4|Overall Study|Discarded the Investigational Drug Used|1
4877450|NCT00783224|16807375|P3|Overall Study|Discarded the Investigational Drug Used|0
4877451|NCT00783224|16807376|P2|Overall Study|Discarded the Investigational Drug Used|0
4877452|NCT00783224|16807377|P1|Overall Study|Discarded the Investigational Drug Used|0
4877453|NCT00783224|16807374|P4|Overall Study|Adverse Event|0
4877454|NCT00783224|16807375|P3|Overall Study|Adverse Event|1
4877455|NCT00783224|16807376|P2|Overall Study|Adverse Event|0
4877456|NCT00783224|16807377|P1|Overall Study|Adverse Event|0
4877457|NCT00783198|16807389|P3|Overall Study|Administrative|2
4877458|NCT00783198|16807390|P2|Overall Study|Administrative|1
4877459|NCT00783198|16807391|P1|Overall Study|Administrative|2
4877460|NCT00783198|16807389|P3|Overall Study|Did not meet protocol eligibility|0
4877461|NCT00783198|16807390|P2|Overall Study|Did not meet protocol eligibility|1
4877462|NCT00783198|16807391|P1|Overall Study|Did not meet protocol eligibility|0
4877463|NCT00783198|16807389|P3|Overall Study|Noncompliance with protocol|10
4877464|NCT00783198|16807390|P2|Overall Study|Noncompliance with protocol|7
4877465|NCT00783198|16807391|P1|Overall Study|Noncompliance with protocol|7
4877466|NCT00783198|16807389|P3|Overall Study|Withdrawal by Subject|20
4877467|NCT00783198|16807390|P2|Overall Study|Withdrawal by Subject|14
4877468|NCT00783198|16807391|P1|Overall Study|Withdrawal by Subject|22
4877469|NCT00783198|16807389|P3|Overall Study|Lost to Follow-up|7
4877470|NCT00783198|16807390|P2|Overall Study|Lost to Follow-up|1
4877471|NCT00783198|16807391|P1|Overall Study|Lost to Follow-up|11
4877472|NCT00783198|16807389|P3|Overall Study|Adverse Event|3
4877473|NCT00783198|16807390|P2|Overall Study|Adverse Event|19
4877474|NCT00783198|16807391|P1|Overall Study|Adverse Event|15
4877475|NCT00783094|16807414|P3|Open-Label Extension Period|Lack of Efficacy|0
4877476|NCT00783094|16807415|P2|Open-Label Extension Period|Lack of Efficacy|4
4877477|NCT00783094|16807416|P1|Open-Label Extension Period|Lack of Efficacy|1
4877478|NCT00783094|16807414|P3|Open-Label Extension Period|Physician Decision|3
4877479|NCT00783094|16807415|P2|Open-Label Extension Period|Physician Decision|2
4877480|NCT00783094|16807416|P1|Open-Label Extension Period|Physician Decision|4
4877481|NCT00783094|16807414|P3|Open-Label Extension Period|Withdrawal by Subject|3
4877482|NCT00783094|16807415|P2|Open-Label Extension Period|Withdrawal by Subject|1
4877483|NCT00783094|16807416|P1|Open-Label Extension Period|Withdrawal by Subject|1
4877484|NCT00783094|16807414|P3|Open-Label Extension Period|Protocol Violation|7
4877485|NCT00783094|16807415|P2|Open-Label Extension Period|Protocol Violation|5
4877486|NCT00783094|16807416|P1|Open-Label Extension Period|Protocol Violation|4
4877487|NCT00783094|16807414|P3|Open-Label Extension Period|Death|1
4877488|NCT00783094|16807415|P2|Open-Label Extension Period|Death|0
4877489|NCT00783094|16807416|P1|Open-Label Extension Period|Death|0
4877490|NCT00783094|16807414|P3|Open-Label Extension Period|Adverse Event|16
4877491|NCT00783094|16807415|P2|Open-Label Extension Period|Adverse Event|7
4877492|NCT00783094|16807416|P1|Open-Label Extension Period|Adverse Event|12
4877493|NCT00783094|16807414|P3|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
4877494|NCT00783094|16807415|P2|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1
4877495|NCT00783094|16807416|P1|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2
4877496|NCT00783094|16807414|P3|Randomized Double-Blind Treatment Period|Protocol Violation|1
4877497|NCT00783094|16807415|P2|Randomized Double-Blind Treatment Period|Protocol Violation|2
4877498|NCT00783094|16807416|P1|Randomized Double-Blind Treatment Period|Protocol Violation|1
4877499|NCT00783094|16807414|P3|Randomized Double-Blind Treatment Period|Physician Decision|0
4877500|NCT00783094|16807415|P2|Randomized Double-Blind Treatment Period|Physician Decision|2
4877501|NCT00783094|16807416|P1|Randomized Double-Blind Treatment Period|Physician Decision|0
4877502|NCT00783094|16807414|P3|Randomized Double-Blind Treatment Period|Lack of Efficacy|1
4877503|NCT00783094|16807415|P2|Randomized Double-Blind Treatment Period|Lack of Efficacy|2
4877504|NCT00783094|16807416|P1|Randomized Double-Blind Treatment Period|Lack of Efficacy|0
4877505|NCT00783094|16807414|P3|Randomized Double-Blind Treatment Period|Adverse Event|5
4877506|NCT00783094|16807415|P2|Randomized Double-Blind Treatment Period|Adverse Event|5
4877507|NCT00783094|16807416|P1|Randomized Double-Blind Treatment Period|Adverse Event|4
4877508|NCT00782834|16807492|P1|Treatment Phase|fibrous tumor not GIST|1
4877509|NCT00782795|16807532|P2|Overall Study|Withdrawal by Subject|2
4877510|NCT00782795|16807533|P1|Overall Study|Withdrawal by Subject|1
4877511|NCT00782717|16807573|P2|Overall Study|Exited in error|2
4877512|NCT00782717|16807574|P1|Overall Study|Exited in error|0
4877513|NCT00782717|16807573|P2|Overall Study|Did not meet entrance criteria|3
4877514|NCT00782717|16807574|P1|Overall Study|Did not meet entrance criteria|1
4877515|NCT00782717|16807573|P2|Overall Study|Enrollment close prior to surgery|0
4877516|NCT00782717|16807574|P1|Overall Study|Enrollment close prior to surgery|1
4877517|NCT00782717|16807573|P2|Overall Study|Treatment failure|14
4877518|NCT00782717|16807574|P1|Overall Study|Treatment failure|3
4877519|NCT00782717|16807573|P2|Overall Study|Noncompliance|1
4877520|NCT00782717|16807574|P1|Overall Study|Noncompliance|2
4877521|NCT00782717|16807573|P2|Overall Study|Patient decision unrelated to AE|3
4877522|NCT00782717|16807574|P1|Overall Study|Patient decision unrelated to AE|6
4877523|NCT00782717|16807573|P2|Overall Study|Adverse Event|5
4877524|NCT00782717|16807574|P1|Overall Study|Adverse Event|2
4877525|NCT00782626|16807601|P1|Overall Study|Other Complicating Disease|1
4877526|NCT00782626|16807601|P1|Overall Study|Progressive Disease|5
4877527|NCT00782626|16807601|P1|Overall Study|Adverse Event|1
4877528|NCT00782509|16807608|P3|Overall Study|Lack of Efficacy|2
4877529|NCT00782509|16807609|P2|Overall Study|Lack of Efficacy|5
4877530|NCT00782509|16807610|P1|Overall Study|Lack of Efficacy|10
4877531|NCT00782509|16807608|P3|Overall Study|Other reasons not stated above|3
4877532|NCT00782509|16807609|P2|Overall Study|Other reasons not stated above|2
4877533|NCT00782509|16807610|P1|Overall Study|Other reasons not stated above|5
4877534|NCT00782509|16807608|P3|Overall Study|Non compliance with protocol|0
4877535|NCT00782509|16807609|P2|Overall Study|Non compliance with protocol|0
4877536|NCT00782509|16807610|P1|Overall Study|Non compliance with protocol|2
4877537|NCT00782509|16807608|P3|Overall Study|Withdrawal by Subject|8
4877538|NCT00782509|16807609|P2|Overall Study|Withdrawal by Subject|5
4877539|NCT00782509|16807610|P1|Overall Study|Withdrawal by Subject|3
4877540|NCT00782509|16807608|P3|Overall Study|Lost to Follow-up|3
4877541|NCT00782509|16807609|P2|Overall Study|Lost to Follow-up|2
4877542|NCT00782509|16807610|P1|Overall Study|Lost to Follow-up|1
4877543|NCT00782509|16807608|P3|Overall Study|Adverse Event|20
4877544|NCT00782509|16807609|P2|Overall Study|Adverse Event|10
4877545|NCT00782509|16807610|P1|Overall Study|Adverse Event|20
4877546|NCT00782496|16807803|P2|Overall Study|Lost to Follow-up|15
4877547|NCT00782496|16807804|P1|Overall Study|Lost to Follow-up|14
4877548|NCT00782483|16807811|P1|Overall Study|Early Termination of Protocol - PI Reloc|6
4877549|NCT00782418|16807815|P7|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4877550|NCT00782418|16807816|P6|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
4877551|NCT00782418|16807817|P5|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
4877552|NCT00782418|16807818|P4|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4877553|NCT00782418|16807819|P3|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4877554|NCT00782418|16807820|P2|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0
4877555|NCT00782418|16807821|P1|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1
4877556|NCT00782418|16807815|P7|Period 1 Procedure/Treatment Groups|Adverse Event|0
4877557|NCT00782418|16807816|P6|Period 1 Procedure/Treatment Groups|Adverse Event|0
4877558|NCT00782418|16807817|P5|Period 1 Procedure/Treatment Groups|Adverse Event|0
4877559|NCT00782418|16807818|P4|Period 1 Procedure/Treatment Groups|Adverse Event|0
4877560|NCT00782418|16807819|P3|Period 1 Procedure/Treatment Groups|Adverse Event|0
4877561|NCT00782418|16807820|P2|Period 1 Procedure/Treatment Groups|Adverse Event|0
4877562|NCT00782418|16807821|P1|Period 1 Procedure/Treatment Groups|Adverse Event|1
4877563|NCT00782340|16807858|P3|Open Label Titration|Randomized in error|0
4877564|NCT00782340|16807859|P2|Open Label Titration|Randomized in error|0
4877565|NCT00782340|16807860|P1|Open Label Titration|Randomized in error|6
4877566|NCT00782340|16807858|P3|Open Label Titration|Lost to Follow-up|0
4877567|NCT00782340|16807859|P2|Open Label Titration|Lost to Follow-up|0
4877568|NCT00782340|16807860|P1|Open Label Titration|Lost to Follow-up|5
4877569|NCT00782340|16807858|P3|Open Label Titration|Did not meet responder criteria|0
4877570|NCT00782340|16807859|P2|Open Label Titration|Did not meet responder criteria|0
4877571|NCT00782340|16807860|P1|Open Label Titration|Did not meet responder criteria|2
4877572|NCT00782340|16807858|P3|Open Label Titration|Enrollment capped|0
4877573|NCT00782340|16807859|P2|Open Label Titration|Enrollment capped|0
4877574|NCT00782340|16807860|P1|Open Label Titration|Enrollment capped|16
4877575|NCT00782340|16807858|P3|Open Label Titration|Withdrawal by Subject|0
4877576|NCT00782340|16807859|P2|Open Label Titration|Withdrawal by Subject|0
4877577|NCT00782340|16807860|P1|Open Label Titration|Withdrawal by Subject|5
4877578|NCT00782340|16807858|P3|Open Label Titration|Protocol Violation|0
4877579|NCT00782340|16807859|P2|Open Label Titration|Protocol Violation|0
4877580|NCT00782340|16807860|P1|Open Label Titration|Protocol Violation|5
4877581|NCT00782340|16807858|P3|Open Label Titration|Treatment failure|0
4877582|NCT00782340|16807859|P2|Open Label Titration|Treatment failure|0
4877583|NCT00782340|16807860|P1|Open Label Titration|Treatment failure|50
4877584|NCT00782340|16807858|P3|Open Label Titration|Adverse Event|0
4877585|NCT00782340|16807859|P2|Open Label Titration|Adverse Event|0
4877586|NCT00782340|16807860|P1|Open Label Titration|Adverse Event|12
4877587|NCT00782275|16807930|P1|Overall Study|Other|3
4877588|NCT00782275|16807930|P1|Overall Study|Not started treatment|1
4877589|NCT00782275|16807930|P1|Overall Study|Physician Decision|4
4877590|NCT00782275|16807930|P1|Overall Study|Progressive Disease|21
4877591|NCT00782275|16807930|P1|Overall Study|Withdrawal by Subject|1
4877592|NCT00782275|16807930|P1|Overall Study|Adverse Event|11
4877593|NCT00782210|16807939|P3|Overall Study|Other reason not described above|3
4877594|NCT00782210|16807940|P2|Overall Study|Other reason not described above|2
4877595|NCT00782210|16807941|P1|Overall Study|Other reason not described above|3
4877596|NCT00782210|16807939|P3|Overall Study|Lack of Efficacy|1
4877597|NCT00782210|16807940|P2|Overall Study|Lack of Efficacy|4
4877598|NCT00782210|16807941|P1|Overall Study|Lack of Efficacy|13
4877599|NCT00782210|16807939|P3|Overall Study|Non compliance with protocol|2
4877600|NCT00782210|16807940|P2|Overall Study|Non compliance with protocol|3
4877601|NCT00782210|16807941|P1|Overall Study|Non compliance with protocol|0
4877602|NCT00782210|16807939|P3|Overall Study|Withdrawal by Subject|11
4877603|NCT00782210|16807940|P2|Overall Study|Withdrawal by Subject|8
4877604|NCT00782210|16807941|P1|Overall Study|Withdrawal by Subject|11
4877605|NCT00782210|16807939|P3|Overall Study|Lost to Follow-up|2
4877606|NCT00782210|16807940|P2|Overall Study|Lost to Follow-up|1
4877607|NCT00782210|16807941|P1|Overall Study|Lost to Follow-up|2
4877608|NCT00782210|16807939|P3|Overall Study|Adverse Event|16
4877609|NCT00782210|16807940|P2|Overall Study|Adverse Event|17
4877610|NCT00782210|16807941|P1|Overall Study|Adverse Event|21
4877611|NCT00782184|16808134|P2|Overall Study|Withdrawal by Subject|2
4877612|NCT00782184|16808135|P1|Overall Study|Withdrawal by Subject|3
4877613|NCT00782184|16808134|P2|Overall Study|Protocol Violation|1
4877614|NCT00782184|16808135|P1|Overall Study|Protocol Violation|0
4877615|NCT00782184|16808134|P2|Overall Study|Adverse Event|2
4877616|NCT00782184|16808135|P1|Overall Study|Adverse Event|1
4877617|NCT00782171|16808172|P2|Overall Study|not eligible|6
4877618|NCT00782171|16808173|P1|Overall Study|not eligible|8
4877619|NCT00782171|16808172|P2|Overall Study|others|9
4877620|NCT00782171|16808173|P1|Overall Study|others|7
4877621|NCT00782171|16808172|P2|Overall Study|complications|1
4877622|NCT00782171|16808173|P1|Overall Study|complications|3
4877623|NCT00782171|16808172|P2|Overall Study|Withdrawal by Subject|1
4877624|NCT00782171|16808173|P1|Overall Study|Withdrawal by Subject|2
4877625|NCT00782171|16808172|P2|Overall Study|Lost to Follow-up|2
4877626|NCT00782171|16808173|P1|Overall Study|Lost to Follow-up|2
4877627|NCT00782067|16808205|P1|Overall Study|Protocol deviation|2
4877628|NCT00782067|16808205|P1|Overall Study|Disease progression|43
4877629|NCT00782067|16808205|P1|Overall Study|Death|9
4877630|NCT00782067|16808205|P1|Overall Study|Administrative problems|14
4877631|NCT00782067|16808205|P1|Overall Study|Lost to Follow-up|2
4877632|NCT00782067|16808205|P1|Overall Study|Subject withdrew consent|11
4877633|NCT00782067|16808205|P1|Overall Study|Adverse Event|35
4877634|NCT00781963|16808217|P2|Overall Study|Refused follow-up|0
4877635|NCT00781963|16808218|P1|Overall Study|Refused follow-up|9
4877636|NCT00781963|16808217|P2|Overall Study|Withdrawal by Subject|1
4877637|NCT00781963|16808218|P1|Overall Study|Withdrawal by Subject|3
4877638|NCT00781963|16808217|P2|Overall Study|Lost to Follow-up|1
4877639|NCT00781963|16808218|P1|Overall Study|Lost to Follow-up|2
4877640|NCT00781963|16808217|P2|Overall Study|Death|0
4877641|NCT00781963|16808218|P1|Overall Study|Death|3
4877642|NCT00781937|16808247|P2|Follow up Period (Week 56-68)|Unclassified|4
4877643|NCT00781937|16808248|P1|Follow up Period (Week 56-68)|Unclassified|5
4877644|NCT00781937|16808247|P2|Follow up Period (Week 56-68)|Protocol Violation|1
4877645|NCT00781937|16808248|P1|Follow up Period (Week 56-68)|Protocol Violation|1
4877646|NCT00781937|16808247|P2|Main Trial Period Through Week 56|Unclassified|15
4877647|NCT00781937|16808248|P1|Main Trial Period Through Week 56|Unclassified|10
4877648|NCT00781937|16808247|P2|Main Trial Period Through Week 56|Withdrawal by Subject|24
4877649|NCT00781937|16808248|P1|Main Trial Period Through Week 56|Withdrawal by Subject|17
4877650|NCT00781937|16808247|P2|Main Trial Period Through Week 56|Protocol Violation|5
4877651|NCT00781937|16808248|P1|Main Trial Period Through Week 56|Protocol Violation|8
4877652|NCT00781937|16808247|P2|Main Trial Period Through Week 56|Lack of Efficacy|2
4877653|NCT00781937|16808248|P1|Main Trial Period Through Week 56|Lack of Efficacy|0
4877654|NCT00781937|16808247|P2|Main Trial Period Through Week 56|Adverse Event|18
4877655|NCT00781937|16808248|P1|Main Trial Period Through Week 56|Adverse Event|18
4877656|NCT00781911|16808306|P2|Overall Study|Sponsor Decision|0
4877657|NCT00781911|16808307|P1|Overall Study|Sponsor Decision|1
4877658|NCT00781911|16808306|P2|Overall Study|Physician Decision|2
4877659|NCT00781911|16808307|P1|Overall Study|Physician Decision|0
4877660|NCT00781911|16808306|P2|Overall Study|Withdrawal by Subject|2
4877661|NCT00781911|16808307|P1|Overall Study|Withdrawal by Subject|1
4877662|NCT00781911|16808306|P2|Overall Study|Adverse Event|4
4877663|NCT00781911|16808307|P1|Overall Study|Adverse Event|4
4877664|NCT00781885|16808342|P1|Overall Study|Physician Decision|1
4877665|NCT00781859|16808359|P2|Overall Study|Death|0
4877666|NCT00781859|16808360|P1|Overall Study|Death|3
4877667|NCT00781859|16808359|P2|Overall Study|Lost to Follow-up|3
4877668|NCT00781859|16808360|P1|Overall Study|Lost to Follow-up|6
4877669|NCT00781859|16808359|P2|Overall Study|Withdrawal by Subject|4
4877670|NCT00781859|16808360|P1|Overall Study|Withdrawal by Subject|8
4877671|NCT00781859|16808359|P2|Overall Study|Adverse Event|2
4877672|NCT00781859|16808360|P1|Overall Study|Adverse Event|2
4877673|NCT00781768|16808370|P2|Overall Study|Not transplanted.|2
4877674|NCT00781768|16808371|P1|Overall Study|Not transplanted.|0
4877675|NCT00781599|16808379|P2|Overall Study|Lost to Follow-up|4
4877676|NCT00781599|16808380|P1|Overall Study|Lost to Follow-up|7
4877677|NCT00781456|16808405|P2|Overall Study|Other Reason, Unknown|1
4877678|NCT00781456|16808406|P1|Overall Study|Other Reason, Unknown|0
4877679|NCT00781456|16808405|P2|Overall Study|Lost to Follow-up|5
4877680|NCT00781456|16808406|P1|Overall Study|Lost to Follow-up|10
4877681|NCT00781456|16808405|P2|Overall Study|Noncompliance With Protocol|1
4877682|NCT00781456|16808406|P1|Overall Study|Noncompliance With Protocol|1
4877683|NCT00781456|16808405|P2|Overall Study|Protocol Violation|1
4877684|NCT00781456|16808406|P1|Overall Study|Protocol Violation|4
4877685|NCT00781456|16808405|P2|Overall Study|Withdrawal by Subject|5
4877686|NCT00781456|16808406|P1|Overall Study|Withdrawal by Subject|3
4877687|NCT00781456|16808405|P2|Overall Study|Adverse Event|3
4877688|NCT00781456|16808406|P1|Overall Study|Adverse Event|3
4877689|NCT00781391|16808429|P3|Overall Study|Lost to Follow-up|1
4877690|NCT00781391|16808430|P2|Overall Study|Lost to Follow-up|0
4877691|NCT00781391|16808431|P1|Overall Study|Lost to Follow-up|0
4877692|NCT00781391|16808429|P3|Overall Study|Withdrawal by Subject|25
4877693|NCT00781391|16808430|P2|Overall Study|Withdrawal by Subject|37
4877694|NCT00781391|16808431|P1|Overall Study|Withdrawal by Subject|47
4877695|NCT00781391|16808429|P3|Overall Study|Death|706
4877696|NCT00781391|16808430|P2|Overall Study|Death|730
4877697|NCT00781391|16808431|P1|Overall Study|Death|789
4877698|NCT00781391|16808429|P3|Overall Study|Protocol Violation|20
4877699|NCT00781391|16808430|P2|Overall Study|Protocol Violation|17
4877700|NCT00781391|16808431|P1|Overall Study|Protocol Violation|19
4877701|NCT00781391|16808429|P3|Overall Study|never received study drug|32
4877702|NCT00781391|16808430|P2|Overall Study|never received study drug|23
4877703|NCT00781391|16808431|P1|Overall Study|never received study drug|24
4877704|NCT00781365|16808465|P2|Overall Study|Language barrier|0
4877705|NCT00781365|16808466|P1|Overall Study|Language barrier|1
4877706|NCT00781365|16808465|P2|Overall Study|Did Not Attend Visit|28
4877707|NCT00781365|16808466|P1|Overall Study|Did Not Attend Visit|20
4877708|NCT00781365|16808465|P2|Overall Study|Withdrawal by Subject|8
4877709|NCT00781365|16808466|P1|Overall Study|Withdrawal by Subject|13
4877710|NCT00781326|16808476|P1|Phase I|Physician Decision|2
4877711|NCT00781326|16808476|P1|Phase I|Withdrawal by Subject|1
4877712|NCT00781326|16808476|P1|Phase I|Adverse Event|1
4877713|NCT00781274|16808480|P1|Overall Study|Withdrawal by Subject|2
4877714|NCT00780910|16808512|P1|Overall Study|Adverse Event|2
4877715|NCT00780559|16808574|P2|Overall Study|Death|0
4877716|NCT00780559|16808575|P1|Overall Study|Death|1
4877717|NCT00780559|16808574|P2|Overall Study|Lost to Follow-up|7
4877718|NCT00780559|16808575|P1|Overall Study|Lost to Follow-up|2
4877719|NCT00780416|16808643|P2|Overall Study|Withdrawal by Subject|6
4877720|NCT00780416|16808644|P1|Overall Study|Withdrawal by Subject|8
4877721|NCT00780416|16808643|P2|Overall Study|Protocol Violation|0
4877722|NCT00780416|16808644|P1|Overall Study|Protocol Violation|1
4877723|NCT00780416|16808643|P2|Overall Study|Physician Decision|3
4877724|NCT00780416|16808644|P1|Overall Study|Physician Decision|3
4877725|NCT00780273|16808689|P1|Overall Study|Lost to Follow-up|1
4877726|NCT00780273|16808689|P1|Overall Study|Death|1
4877727|NCT00780143|16808712|P1|Overall Study|Adverse Event|1
4877728|NCT00780143|16808712|P1|Overall Study|Toxicity|1
4877729|NCT00780143|16808712|P1|Overall Study|Progressive disease|1
4877730|NCT00779909|16808743|P4|Overall Study|Withdrawal by Subject|0
4877731|NCT00779909|16808744|P3|Overall Study|Withdrawal by Subject|0
4877732|NCT00779909|16808745|P2|Overall Study|Withdrawal by Subject|1
4877733|NCT00779909|16808746|P1|Overall Study|Withdrawal by Subject|0
4877734|NCT00779909|16808743|P4|Overall Study|Lost to Follow-up|1
4877735|NCT00779909|16808744|P3|Overall Study|Lost to Follow-up|0
4877736|NCT00779909|16808745|P2|Overall Study|Lost to Follow-up|0
4877737|NCT00779909|16808746|P1|Overall Study|Lost to Follow-up|1
4877738|NCT00779857|16808810|P1|Overall Study|Missed Visit|2
4877739|NCT00779857|16808810|P1|Overall Study|Withdrawal by Subject|3
4877740|NCT00779857|16808810|P1|Overall Study|Death|1
4877741|NCT00779779|16808815|P1|Overall Study|Lost to Follow-up|5
4877742|NCT00779779|16808815|P1|Overall Study|Withdrawal by Subject|4
4877743|NCT00779779|16808815|P1|Overall Study|Protocol Violation|14
4877744|NCT00779779|16808815|P1|Overall Study|Adverse Event|1
4877745|NCT00779766|16808824|P2|Month 72|Other|1
4877746|NCT00779766|16808825|P1|Month 72|Other|0
4877747|NCT00779766|16808824|P2|Month 72|Lost to Follow-up|8
4877748|NCT00779766|16808825|P1|Month 72|Lost to Follow-up|6
4877749|NCT00779766|16808824|P2|Month 72|Migrated/moved from study area|109
4877750|NCT00779766|16808825|P1|Month 72|Migrated/moved from study area|124
4877751|NCT00779766|16808824|P2|Month 72|Withdrawal by Subject|71
4877752|NCT00779766|16808825|P1|Month 72|Withdrawal by Subject|55
4877753|NCT00779766|16808824|P2|Month 48|Other|0
4877754|NCT00779766|16808825|P1|Month 48|Other|1
4877755|NCT00779766|16808824|P2|Month 48|Lost to Follow-up|30
4877756|NCT00779766|16808825|P1|Month 48|Lost to Follow-up|29
4877757|NCT00779766|16808824|P2|Month 48|Migrated/moved from study area|75
4877758|NCT00779766|16808825|P1|Month 48|Migrated/moved from study area|76
4877759|NCT00779766|16808824|P2|Month 48|Withdrawal by Subject|63
4877760|NCT00779766|16808825|P1|Month 48|Withdrawal by Subject|68
4877761|NCT00779766|16808824|P2|Month 24|Other|27
4877762|NCT00779766|16808825|P1|Month 24|Other|18
4877763|NCT00779766|16808824|P2|Month 24|Lost to Follow-up|9
4877764|NCT00779766|16808825|P1|Month 24|Lost to Follow-up|9
4877765|NCT00779766|16808824|P2|Month 24|Migrated/moved from study area|162
4877766|NCT00779766|16808825|P1|Month 24|Migrated/moved from study area|138
4877767|NCT00779766|16808824|P2|Month 24|Withdrawal by Subject|127
4877768|NCT00779766|16808825|P1|Month 24|Withdrawal by Subject|159
4877769|NCT00779766|16808824|P2|Month 24|Protocol Violation|1
4877770|NCT00779766|16808825|P1|Month 24|Protocol Violation|3
4877771|NCT00779766|16808824|P2|Month 24|Adverse Event|3
4877772|NCT00779766|16808825|P1|Month 24|Adverse Event|3
4877773|NCT00779766|16808824|P2|Month 24|Serious Adverse Event|3
4877774|NCT00779766|16808825|P1|Month 24|Serious Adverse Event|2
4877775|NCT00779675|16808913|P1|Extended Treatment Period|Lost to Follow-up|6
4877776|NCT00779675|16808913|P1|Extended Treatment Period|Protocol defined clinical event|1
4877777|NCT00779675|16808913|P1|Extended Treatment Period|Treatment Failure|11
4877778|NCT00779675|16808913|P1|Extended Treatment Period|Adverse Event|6
4877779|NCT00779675|16808913|P1|Extended Treatment Period|Protocol Violation|13
4877780|NCT00779675|16808913|P1|Extended Treatment Period|Reasons unrelated to study treatment|9
4877781|NCT00779675|16808913|P1|Treatment Period|Administrative|3
4877782|NCT00779675|16808913|P1|Treatment Period|Did Not Meet Protocol Eligibility|1
4877783|NCT00779675|16808913|P1|Treatment Period|Protocol Violation|54
4877784|NCT00779675|16808913|P1|Treatment Period|Withdrawal by Subject|46
4877785|NCT00779675|16808913|P1|Treatment Period|Lost to Follow-up|23
4877786|NCT00779675|16808913|P1|Treatment Period|Transferred to Another Study|38
4877787|NCT00779675|16808913|P1|Treatment Period|Treatment Failure|80
4877788|NCT00779675|16808913|P1|Treatment Period|Adverse Event|87
4877789|NCT00779584|16808941|P9|Overall Study|Ongoing in Study|0
4877790|NCT00779584|16808942|P8|Overall Study|Ongoing in Study|0
4877791|NCT00779584|16808943|P7|Overall Study|Ongoing in Study|0
4877792|NCT00779584|16808944|P6|Overall Study|Ongoing in Study|1
4877793|NCT00779584|16808945|P5|Overall Study|Ongoing in Study|1
4877794|NCT00779584|16808946|P4|Overall Study|Ongoing in Study|0
4877795|NCT00779584|16808947|P3|Overall Study|Ongoing in Study|0
4877796|NCT00779584|16808948|P2|Overall Study|Ongoing in Study|0
4877797|NCT00779584|16808949|P1|Overall Study|Ongoing in Study|0
4877798|NCT00779584|16808941|P9|Overall Study|Symptomatic Deterioration|0
4877799|NCT00779584|16808942|P8|Overall Study|Symptomatic Deterioration|0
4877800|NCT00779584|16808943|P7|Overall Study|Symptomatic Deterioration|1
4877801|NCT00779584|16808944|P6|Overall Study|Symptomatic Deterioration|1
4877802|NCT00779584|16808945|P5|Overall Study|Symptomatic Deterioration|0
4877803|NCT00779584|16808946|P4|Overall Study|Symptomatic Deterioration|0
4877804|NCT00779584|16808947|P3|Overall Study|Symptomatic Deterioration|1
4877805|NCT00779584|16808948|P2|Overall Study|Symptomatic Deterioration|1
4877806|NCT00779584|16808949|P1|Overall Study|Symptomatic Deterioration|1
4877807|NCT00779584|16808941|P9|Overall Study|Adverse Event|1
4877808|NCT00779584|16808942|P8|Overall Study|Adverse Event|1
4877809|NCT00779584|16808943|P7|Overall Study|Adverse Event|2
4877810|NCT00779584|16808944|P6|Overall Study|Adverse Event|0
4877811|NCT00779584|16808945|P5|Overall Study|Adverse Event|0
4877812|NCT00779584|16808946|P4|Overall Study|Adverse Event|0
4877813|NCT00779584|16808947|P3|Overall Study|Adverse Event|2
4877814|NCT00779584|16808948|P2|Overall Study|Adverse Event|0
4877815|NCT00779584|16808949|P1|Overall Study|Adverse Event|1
4877816|NCT00779584|16808941|P9|Overall Study|Progression of Disease|1
4877817|NCT00779584|16808942|P8|Overall Study|Progression of Disease|2
4877818|NCT00779584|16808943|P7|Overall Study|Progression of Disease|4
4877819|NCT00779584|16808944|P6|Overall Study|Progression of Disease|1
4877820|NCT00779584|16808945|P5|Overall Study|Progression of Disease|5
4877821|NCT00779584|16808946|P4|Overall Study|Progression of Disease|6
4877822|NCT00779584|16808947|P3|Overall Study|Progression of Disease|2
4877823|NCT00779584|16808948|P2|Overall Study|Progression of Disease|1
4877824|NCT00779584|16808949|P1|Overall Study|Progression of Disease|0
4877825|NCT00779584|16808941|P9|Overall Study|Lost to Follow-up|0
4877826|NCT00779584|16808942|P8|Overall Study|Lost to Follow-up|0
4877827|NCT00779584|16808943|P7|Overall Study|Lost to Follow-up|0
4877828|NCT00779584|16808944|P6|Overall Study|Lost to Follow-up|0
4877829|NCT00779584|16808945|P5|Overall Study|Lost to Follow-up|1
4877830|NCT00779584|16808946|P4|Overall Study|Lost to Follow-up|0
4877831|NCT00779584|16808947|P3|Overall Study|Lost to Follow-up|0
4877832|NCT00779584|16808948|P2|Overall Study|Lost to Follow-up|0
4877833|NCT00779584|16808949|P1|Overall Study|Lost to Follow-up|0
4877834|NCT00779584|16808941|P9|Overall Study|Withdrawal by Subject|0
4877835|NCT00779584|16808942|P8|Overall Study|Withdrawal by Subject|0
4877836|NCT00779584|16808943|P7|Overall Study|Withdrawal by Subject|1
4877837|NCT00779584|16808944|P6|Overall Study|Withdrawal by Subject|2
4877838|NCT00779584|16808945|P5|Overall Study|Withdrawal by Subject|0
4877839|NCT00779584|16808946|P4|Overall Study|Withdrawal by Subject|0
4877840|NCT00779584|16808947|P3|Overall Study|Withdrawal by Subject|2
4877841|NCT00779584|16808948|P2|Overall Study|Withdrawal by Subject|1
4877842|NCT00779584|16808949|P1|Overall Study|Withdrawal by Subject|1
4877843|NCT00779584|16808941|P9|Overall Study|Protocol Violation|0
4877844|NCT00779584|16808942|P8|Overall Study|Protocol Violation|0
4877845|NCT00779584|16808943|P7|Overall Study|Protocol Violation|0
4877846|NCT00779584|16808944|P6|Overall Study|Protocol Violation|1
4877847|NCT00779584|16808945|P5|Overall Study|Protocol Violation|0
4877848|NCT00779584|16808946|P4|Overall Study|Protocol Violation|0
4877849|NCT00779584|16808947|P3|Overall Study|Protocol Violation|0
4877850|NCT00779584|16808948|P2|Overall Study|Protocol Violation|0
4877851|NCT00779584|16808949|P1|Overall Study|Protocol Violation|0
4877852|NCT00779506|16809040|P1|Overall Study|Lost to Follow-up|1
4877853|NCT00779506|16809040|P1|Overall Study|Withdrawal by Subject|6
4877854|NCT00779506|16809040|P1|Overall Study|Protocol Violation|5
4877855|NCT00779506|16809040|P1|Overall Study|Lack of Efficacy|11
4877856|NCT00779506|16809040|P1|Overall Study|Adverse Event|4
4877857|NCT00779506|16809040|P1|Overall Study|Screening Failed|2
4877858|NCT00779467|16809054|P4|Overall Study|unavailable research staff|1
4877859|NCT00779467|16809055|P3|Overall Study|unavailable research staff|0
4877860|NCT00779467|16809056|P2|Overall Study|unavailable research staff|0
4877861|NCT00779467|16809057|P1|Overall Study|unavailable research staff|0
4877862|NCT00779467|16809054|P4|Overall Study|technical issue|1
4877863|NCT00779467|16809055|P3|Overall Study|technical issue|2
4877864|NCT00779467|16809056|P2|Overall Study|technical issue|0
4877865|NCT00779467|16809057|P1|Overall Study|technical issue|0
4877866|NCT00779467|16809054|P4|Overall Study|missing data|4
4877867|NCT00779467|16809055|P3|Overall Study|missing data|1
4877868|NCT00779467|16809056|P2|Overall Study|missing data|0
4877869|NCT00779467|16809057|P1|Overall Study|missing data|1
4877870|NCT00779467|16809054|P4|Overall Study|failed inclusion criteria|2
4877871|NCT00779467|16809055|P3|Overall Study|failed inclusion criteria|1
4877872|NCT00779467|16809056|P2|Overall Study|failed inclusion criteria|3
4877873|NCT00779467|16809057|P1|Overall Study|failed inclusion criteria|3
4877874|NCT00779467|16809054|P4|Overall Study|Lack of Efficacy|11
4877875|NCT00779467|16809055|P3|Overall Study|Lack of Efficacy|6
4877876|NCT00779467|16809056|P2|Overall Study|Lack of Efficacy|2
4877877|NCT00779467|16809057|P1|Overall Study|Lack of Efficacy|11
4877878|NCT00779402|16809097|P2|Long-term Follow-up|Completed Protocol Visits|2
4877879|NCT00779402|16809098|P1|Long-term Follow-up|Completed Protocol Visits|6
4877880|NCT00779402|16809097|P2|Long-term Follow-up|Closure of Study|4
4877881|NCT00779402|16809098|P1|Long-term Follow-up|Closure of Study|8
4877882|NCT00779402|16809097|P2|Long-term Follow-up|Other|0
4877883|NCT00779402|16809098|P1|Long-term Follow-up|Other|5
4877884|NCT00779402|16809097|P2|Long-term Follow-up|Patient refused to continue|0
4877885|NCT00779402|16809098|P1|Long-term Follow-up|Patient refused to continue|2
4877886|NCT00779402|16809097|P2|Surveillance Phase|Completed Protocol Visits|2
4877887|NCT00779402|16809098|P1|Surveillance Phase|Completed Protocol Visits|3
4877888|NCT00779402|16809097|P2|Surveillance Phase|Closure of study|6
4877889|NCT00779402|16809098|P1|Surveillance Phase|Closure of study|5
4877890|NCT00779402|16809097|P2|Surveillance Phase|Withdrawal by Subject|1
4877891|NCT00779402|16809098|P1|Surveillance Phase|Withdrawal by Subject|4
4877892|NCT00779402|16809097|P2|Surveillance Phase|Other|5
4877893|NCT00779402|16809098|P1|Surveillance Phase|Other|5
4877894|NCT00779402|16809097|P2|Surveillance Phase|Intercurrent Illness|0
4877895|NCT00779402|16809098|P1|Surveillance Phase|Intercurrent Illness|2
4877896|NCT00779402|16809097|P2|Surveillance Phase|Death|1
4877897|NCT00779402|16809098|P1|Surveillance Phase|Death|0
4877898|NCT00779402|16809097|P2|Surveillance Phase|Lost to Follow-up|1
4877899|NCT00779402|16809098|P1|Surveillance Phase|Lost to Follow-up|2
4877900|NCT00779402|16809097|P2|Surveillance Phase|Patient refused to continue|14
4877901|NCT00779402|16809098|P1|Surveillance Phase|Patient refused to continue|22
4877902|NCT00779402|16809097|P2|Surveillance Phase|Protocol Violation|1
4877903|NCT00779402|16809098|P1|Surveillance Phase|Protocol Violation|0
4877904|NCT00779402|16809097|P2|Treatment Phase 1|Completed Protocol Visits|6
4877905|NCT00779402|16809098|P1|Treatment Phase 1|Completed Protocol Visits|3
4877906|NCT00779402|16809097|P2|Treatment Phase 1|Closure of Study|2
4877907|NCT00779402|16809098|P1|Treatment Phase 1|Closure of Study|3
4877908|NCT00779402|16809097|P2|Treatment Phase 1|Other|2
4877909|NCT00779402|16809098|P1|Treatment Phase 1|Other|4
4877910|NCT00779402|16809097|P2|Treatment Phase 1|Withdrawal by Subject|0
4877911|NCT00779402|16809098|P1|Treatment Phase 1|Withdrawal by Subject|1
4877912|NCT00779402|16809097|P2|Treatment Phase 1|Intercurrent Illness|1
4877913|NCT00779402|16809098|P1|Treatment Phase 1|Intercurrent Illness|1
4877914|NCT00779402|16809097|P2|Treatment Phase 1|Death|1
4877915|NCT00779402|16809098|P1|Treatment Phase 1|Death|0
4877916|NCT00779402|16809097|P2|Treatment Phase 1|Lost to Follow-up|1
4877917|NCT00779402|16809098|P1|Treatment Phase 1|Lost to Follow-up|0
4877918|NCT00779402|16809097|P2|Treatment Phase 1|Patient Refused to Continue|2
4877919|NCT00779402|16809098|P1|Treatment Phase 1|Patient Refused to Continue|17
4877920|NCT00779402|16809097|P2|Treatment Phase 1|Protocol Violation|0
4877921|NCT00779402|16809098|P1|Treatment Phase 1|Protocol Violation|1
4877922|NCT00779402|16809097|P2|Treatment Phase 1|Adverse Event|0
4877923|NCT00779402|16809098|P1|Treatment Phase 1|Adverse Event|2
4877924|NCT00779402|16809097|P2|Treatment Phase 1|Disease Progression|0
4877925|NCT00779402|16809098|P1|Treatment Phase 1|Disease Progression|1
4877926|NCT00779259|16809141|P1|Quinine Alone|Adverse Event|2
4877927|NCT00779246|16809162|P2|Overall Study|Missing sufficient data for analysis|53
4877928|NCT00779246|16809163|P1|Overall Study|Missing sufficient data for analysis|33
4877929|NCT00779142|16809182|P1|Overall Study|Screen Failures|3
4877930|NCT00779038|16809196|P1|Overall Study|Study Prematurely Terminated|13
4877931|NCT00779025|16809205|P1|Overall Study|Withdrawal by Subject|1
4877932|NCT00778999|16809216|P2|Overall Study|Did not receive recFSH|20
4877933|NCT00778999|16809217|P1|Overall Study|Did not receive recFSH|14
4877934|NCT00778999|16809216|P2|Overall Study|Discontinuation: no embryo transfer|14
4877935|NCT00778999|16809217|P1|Overall Study|Discontinuation: no embryo transfer|14
4877936|NCT00778921|16809226|P3|Overall Study|Not treated|2
4877937|NCT00778921|16809227|P2|Overall Study|Not treated|2
4877938|NCT00778921|16809228|P1|Overall Study|Not treated|0
4877939|NCT00778921|16809226|P3|Overall Study|Protocol Violation|2
4877940|NCT00778921|16809227|P2|Overall Study|Protocol Violation|0
4877941|NCT00778921|16809228|P1|Overall Study|Protocol Violation|3
4877942|NCT00778921|16809226|P3|Overall Study|Administrative Problems|0
4877943|NCT00778921|16809227|P2|Overall Study|Administrative Problems|2
4877944|NCT00778921|16809228|P1|Overall Study|Administrative Problems|1
4877945|NCT00778921|16809226|P3|Overall Study|Lost to Follow-up|1
4877946|NCT00778921|16809227|P2|Overall Study|Lost to Follow-up|2
4877947|NCT00778921|16809228|P1|Overall Study|Lost to Follow-up|0
4877948|NCT00778921|16809226|P3|Overall Study|Patient withdrew request|6
4877949|NCT00778921|16809227|P2|Overall Study|Patient withdrew request|1
4877950|NCT00778921|16809228|P1|Overall Study|Patient withdrew request|3
4877951|NCT00778921|16809226|P3|Overall Study|Patient No Longer Requires Study Drug|0
4877952|NCT00778921|16809227|P2|Overall Study|Patient No Longer Requires Study Drug|1
4877953|NCT00778921|16809228|P1|Overall Study|Patient No Longer Requires Study Drug|0
4877954|NCT00778921|16809226|P3|Overall Study|Unsatisfactory therapeutic response|1
4877955|NCT00778921|16809227|P2|Overall Study|Unsatisfactory therapeutic response|1
4877956|NCT00778921|16809228|P1|Overall Study|Unsatisfactory therapeutic response|1
4877957|NCT00778921|16809226|P3|Overall Study|Abnormal Test Procedure Result(s)|2
4877958|NCT00778921|16809227|P2|Overall Study|Abnormal Test Procedure Result(s)|0
4877959|NCT00778921|16809228|P1|Overall Study|Abnormal Test Procedure Result(s)|0
4877960|NCT00778921|16809226|P3|Overall Study|Abnormal Laboratory Value(s)|0
4877961|NCT00778921|16809227|P2|Overall Study|Abnormal Laboratory Value(s)|0
4877962|NCT00778921|16809228|P1|Overall Study|Abnormal Laboratory Value(s)|1
4877963|NCT00778921|16809226|P3|Overall Study|Adverse Event|14
4877964|NCT00778921|16809227|P2|Overall Study|Adverse Event|10
4877965|NCT00778921|16809228|P1|Overall Study|Adverse Event|9
4877966|NCT00778895|16809245|P3|ESFU Phase|Other|0
4877967|NCT00778895|16809246|P2|ESFU Phase|Other|0
4877968|NCT00778895|16809247|P1|ESFU Phase|Other|2
4877969|NCT00778895|16809245|P3|ESFU Phase|Lost to Follow-up|2
4877970|NCT00778895|16809246|P2|ESFU Phase|Lost to Follow-up|7
4877971|NCT00778895|16809247|P1|ESFU Phase|Lost to Follow-up|6
4877972|NCT00778895|16809245|P3|ESFU Phase|Withdrawal by Subject|0
4877973|NCT00778895|16809246|P2|ESFU Phase|Withdrawal by Subject|4
4877974|NCT00778895|16809247|P1|ESFU Phase|Withdrawal by Subject|1
4877975|NCT00778895|16809245|P3|ESFU Phase|Adverse Event|0
4877976|NCT00778895|16809246|P2|ESFU Phase|Adverse Event|1
4877977|NCT00778895|16809247|P1|ESFU Phase|Adverse Event|2
4877978|NCT00778895|16809245|P3|Active Phase|Other|0
4877979|NCT00778895|16809246|P2|Active Phase|Other|0
4877980|NCT00778895|16809247|P1|Active Phase|Other|2
4877981|NCT00778895|16809245|P3|Active Phase|Lost to Follow-up|0
4877982|NCT00778895|16809246|P2|Active Phase|Lost to Follow-up|1
4877983|NCT00778895|16809247|P1|Active Phase|Lost to Follow-up|1
4877984|NCT00778895|16809245|P3|Active Phase|Withdrawal by Subject|0
4877985|NCT00778895|16809246|P2|Active Phase|Withdrawal by Subject|4
4877986|NCT00778895|16809247|P1|Active Phase|Withdrawal by Subject|1
4877987|NCT00778895|16809245|P3|Active Phase|Adverse Event|0
4877988|NCT00778895|16809246|P2|Active Phase|Adverse Event|1
4877989|NCT00778895|16809247|P1|Active Phase|Adverse Event|3
4877990|NCT00778830|16809291|P2|Overall Study|Ongoing at data cut-off|1
4877991|NCT00778830|16809292|P1|Overall Study|Ongoing at data cut-off|0
4877992|NCT00778817|16809304|P1|Overall Study|Withdrawal by Subject|2
4877993|NCT00778817|16809304|P1|Overall Study|Adverse Event|2
4877994|NCT00778622|16809331|P3|Overall Study|Other|1
4877995|NCT00778622|16809332|P2|Overall Study|Other|0
4877996|NCT00778622|16809333|P1|Overall Study|Other|1
4877997|NCT00778622|16809331|P3|Overall Study|immigration|0
4877998|NCT00778622|16809332|P2|Overall Study|immigration|0
4877999|NCT00778622|16809333|P1|Overall Study|immigration|1
4878000|NCT00778622|16809331|P3|Overall Study|Lack of Efficacy|0
4878001|NCT00778622|16809332|P2|Overall Study|Lack of Efficacy|0
4878002|NCT00778622|16809333|P1|Overall Study|Lack of Efficacy|2
4878003|NCT00778622|16809331|P3|Overall Study|Protocol Violation|0
4878004|NCT00778622|16809332|P2|Overall Study|Protocol Violation|3
4878005|NCT00778622|16809333|P1|Overall Study|Protocol Violation|0
4878006|NCT00778622|16809331|P3|Overall Study|Lost to Follow-up|2
4878007|NCT00778622|16809332|P2|Overall Study|Lost to Follow-up|3
4878008|NCT00778622|16809333|P1|Overall Study|Lost to Follow-up|3
4878009|NCT00778622|16809331|P3|Overall Study|Withdrawal by Subject|5
4878010|NCT00778622|16809332|P2|Overall Study|Withdrawal by Subject|5
4878011|NCT00778622|16809333|P1|Overall Study|Withdrawal by Subject|4
4878012|NCT00778622|16809331|P3|Overall Study|Adverse Event|7
4878013|NCT00778622|16809332|P2|Overall Study|Adverse Event|4
4878014|NCT00778622|16809333|P1|Overall Study|Adverse Event|5
4878015|NCT00778375|16809386|P1|Overall Study|Ineligible|3
4878016|NCT00778336|16809400|P4|3 Month Follow Up|Death|0
4878017|NCT00778336|16809401|P3|3 Month Follow Up|Death|2
4878018|NCT00778336|16809402|P2|3 Month Follow Up|Death|3
4878019|NCT00778336|16809403|P1|3 Month Follow Up|Death|8
4878020|NCT00778336|16809400|P4|3 Month Follow Up|Lost to Follow-up|0
4878021|NCT00778336|16809401|P3|3 Month Follow Up|Lost to Follow-up|3
4878022|NCT00778336|16809402|P2|3 Month Follow Up|Lost to Follow-up|20
4878023|NCT00778336|16809403|P1|3 Month Follow Up|Lost to Follow-up|15
4878024|NCT00778336|16809400|P4|Index Procedure-Discharge|Death|0
4878025|NCT00778336|16809401|P3|Index Procedure-Discharge|Death|2
4878026|NCT00778336|16809402|P2|Index Procedure-Discharge|Death|3
4878027|NCT00778336|16809403|P1|Index Procedure-Discharge|Death|6
4878028|NCT00778258|16809441|P9|Overall Study|Other|0
4878029|NCT00778258|16809442|P8|Overall Study|Other|0
4878030|NCT00778258|16809443|P7|Overall Study|Other|1
4878031|NCT00778258|16809444|P6|Overall Study|Other|0
4878032|NCT00778258|16809445|P5|Overall Study|Other|0
4878033|NCT00778258|16809446|P4|Overall Study|Other|0
4878034|NCT00778258|16809447|P3|Overall Study|Other|0
4878035|NCT00778258|16809448|P2|Overall Study|Other|0
4878036|NCT00778258|16809449|P1|Overall Study|Other|0
4878037|NCT00778258|16809441|P9|Overall Study|Non-compliance|0
4878038|NCT00778258|16809442|P8|Overall Study|Non-compliance|0
4878039|NCT00778258|16809443|P7|Overall Study|Non-compliance|0
4878040|NCT00778258|16809444|P6|Overall Study|Non-compliance|0
4878041|NCT00778258|16809445|P5|Overall Study|Non-compliance|0
4878042|NCT00778258|16809446|P4|Overall Study|Non-compliance|1
4878043|NCT00778258|16809447|P3|Overall Study|Non-compliance|0
4878044|NCT00778258|16809448|P2|Overall Study|Non-compliance|0
4878045|NCT00778258|16809449|P1|Overall Study|Non-compliance|0
4878046|NCT00778258|16809441|P9|Overall Study|New Contraindication|0
4878047|NCT00778258|16809442|P8|Overall Study|New Contraindication|1
4878048|NCT00778258|16809443|P7|Overall Study|New Contraindication|0
4878049|NCT00778258|16809444|P6|Overall Study|New Contraindication|0
4878050|NCT00778258|16809445|P5|Overall Study|New Contraindication|0
4878051|NCT00778258|16809446|P4|Overall Study|New Contraindication|0
4878052|NCT00778258|16809447|P3|Overall Study|New Contraindication|0
4878053|NCT00778258|16809448|P2|Overall Study|New Contraindication|0
4878054|NCT00778258|16809449|P1|Overall Study|New Contraindication|0
4878055|NCT00778258|16809441|P9|Overall Study|Withdrawal by Subject|4
4878056|NCT00778258|16809442|P8|Overall Study|Withdrawal by Subject|12
4878057|NCT00778258|16809443|P7|Overall Study|Withdrawal by Subject|12
4878058|NCT00778258|16809444|P6|Overall Study|Withdrawal by Subject|6
4878059|NCT00778258|16809445|P5|Overall Study|Withdrawal by Subject|0
4878060|NCT00778258|16809446|P4|Overall Study|Withdrawal by Subject|2
4878061|NCT00778258|16809447|P3|Overall Study|Withdrawal by Subject|8
4878062|NCT00778258|16809448|P2|Overall Study|Withdrawal by Subject|2
4878063|NCT00778258|16809449|P1|Overall Study|Withdrawal by Subject|6
4878064|NCT00778258|16809441|P9|Overall Study|Lost to Follow-up|0
4878065|NCT00778258|16809442|P8|Overall Study|Lost to Follow-up|2
4878066|NCT00778258|16809443|P7|Overall Study|Lost to Follow-up|2
4878067|NCT00778258|16809444|P6|Overall Study|Lost to Follow-up|3
4878068|NCT00778258|16809445|P5|Overall Study|Lost to Follow-up|0
4878069|NCT00778258|16809446|P4|Overall Study|Lost to Follow-up|0
4878070|NCT00778258|16809447|P3|Overall Study|Lost to Follow-up|2
4878071|NCT00778258|16809448|P2|Overall Study|Lost to Follow-up|0
4878072|NCT00778258|16809449|P1|Overall Study|Lost to Follow-up|0
4878073|NCT00778258|16809441|P9|Overall Study|Adverse Event|0
4878074|NCT00778258|16809442|P8|Overall Study|Adverse Event|0
4878075|NCT00778258|16809443|P7|Overall Study|Adverse Event|0
4878076|NCT00778258|16809444|P6|Overall Study|Adverse Event|1
4878077|NCT00778258|16809445|P5|Overall Study|Adverse Event|0
4878078|NCT00778258|16809446|P4|Overall Study|Adverse Event|0
4878079|NCT00778258|16809447|P3|Overall Study|Adverse Event|0
4878080|NCT00778258|16809448|P2|Overall Study|Adverse Event|0
4878081|NCT00778258|16809449|P1|Overall Study|Adverse Event|1
4878082|NCT00778102|16809516|P2|Overall Study|Administrative Reason|10
4878083|NCT00778102|16809517|P1|Overall Study|Administrative Reason|7
4878084|NCT00778102|16809516|P2|Overall Study|Withdrawal by Subject|1
4878085|NCT00778102|16809517|P1|Overall Study|Withdrawal by Subject|1
4878086|NCT00778102|16809516|P2|Overall Study|Refused Treatment|3
4878087|NCT00778102|16809517|P1|Overall Study|Refused Treatment|2
4878088|NCT00778102|16809516|P2|Overall Study|Protocol Violation|1
4878089|NCT00778102|16809517|P1|Overall Study|Protocol Violation|0
4878090|NCT00778102|16809516|P2|Overall Study|Violation of Selection Criteria|1
4878091|NCT00778102|16809517|P1|Overall Study|Violation of Selection Criteria|1
4878092|NCT00778102|16809516|P2|Overall Study|Lost to Follow-up|0
4878093|NCT00778102|16809517|P1|Overall Study|Lost to Follow-up|1
4878094|NCT00778102|16809516|P2|Overall Study|Death|1
4878095|NCT00778102|16809517|P1|Overall Study|Death|1
4878096|NCT00778102|16809516|P2|Overall Study|Adverse Event|5
4878097|NCT00778102|16809517|P1|Overall Study|Adverse Event|8
4878098|NCT00777946|16809552|P3|Overall Study|Randomized in error|0
4878099|NCT00777946|16809553|P2|Overall Study|Randomized in error|1
4878100|NCT00777946|16809554|P1|Overall Study|Randomized in error|1
4878101|NCT00777946|16809552|P3|Overall Study|Protocol deviation|1
4878102|NCT00777946|16809553|P2|Overall Study|Protocol deviation|1
4878103|NCT00777946|16809554|P1|Overall Study|Protocol deviation|2
4878104|NCT00777946|16809552|P3|Overall Study|Lost to Follow-up|0
4878105|NCT00777946|16809553|P2|Overall Study|Lost to Follow-up|1
4878106|NCT00777946|16809554|P1|Overall Study|Lost to Follow-up|3
4878107|NCT00777946|16809552|P3|Overall Study|Patient withdrew consent|3
4878108|NCT00777946|16809553|P2|Overall Study|Patient withdrew consent|2
4878109|NCT00777946|16809554|P1|Overall Study|Patient withdrew consent|3
4878110|NCT00777946|16809552|P3|Overall Study|Condition no longer required study drug|0
4878111|NCT00777946|16809553|P2|Overall Study|Condition no longer required study drug|0
4878112|NCT00777946|16809554|P1|Overall Study|Condition no longer required study drug|1
4878113|NCT00777946|16809552|P3|Overall Study|Lack of Efficacy|9
4878114|NCT00777946|16809553|P2|Overall Study|Lack of Efficacy|0
4878115|NCT00777946|16809554|P1|Overall Study|Lack of Efficacy|0
4878116|NCT00777946|16809552|P3|Overall Study|Adverse Event|3
4878117|NCT00777946|16809553|P2|Overall Study|Adverse Event|1
4878118|NCT00777946|16809554|P1|Overall Study|Adverse Event|11
4878119|NCT00777920|16809577|P1|Overall Study|Other, not specified|4
4878120|NCT00777920|16809577|P1|Overall Study|Clinical status did not improve|1
4878121|NCT00777920|16809577|P1|Overall Study|Investigator's discretion|1
4878122|NCT00777920|16809577|P1|Overall Study|Lost to Follow-up|1
4878123|NCT00777920|16809577|P1|Overall Study|Withdrawal of Consent|4
4878124|NCT00777920|16809577|P1|Overall Study|Adverse Event|39
4878125|NCT00777803|16809593|P2|Overall Study|Non-compliance|2
4878126|NCT00777803|16809594|P1|Overall Study|Non-compliance|2
4878127|NCT00777803|16809593|P2|Overall Study|Adverse Event|0
4878128|NCT00777803|16809594|P1|Overall Study|Adverse Event|1
4878129|NCT00777803|16809593|P2|Overall Study|Lost to Follow-up|5
4878130|NCT00777803|16809594|P1|Overall Study|Lost to Follow-up|12
4878131|NCT00777608|16809673|P2|Overall Study|Investigator Decision|2
4878132|NCT00777608|16809674|P1|Overall Study|Investigator Decision|1
4878133|NCT00777608|16809673|P2|Overall Study|Protocol Violation|0
4878134|NCT00777608|16809674|P1|Overall Study|Protocol Violation|1
4878135|NCT00777608|16809673|P2|Overall Study|Withdrawal by Subject|3
4878136|NCT00777608|16809674|P1|Overall Study|Withdrawal by Subject|1
4878137|NCT00777608|16809673|P2|Overall Study|Lost to Follow-up|1
4878138|NCT00777608|16809674|P1|Overall Study|Lost to Follow-up|1
4878139|NCT00777556|16809684|P1|Overall Study|Did not complete all 3 follow-up visits|20
4878140|NCT00777556|16809684|P1|Overall Study|Dispensed but did not use product|12
4878141|NCT00777556|16809684|P1|Overall Study|Inappropriate self-selection|34
4878142|NCT00777491|16809693|P2|Overall Study|Did not receive any protocol treatment|0
4878143|NCT00777491|16809694|P1|Overall Study|Did not receive any protocol treatment|2
4878144|NCT00777491|16809693|P2|Overall Study|Protocol Violation|2
4878145|NCT00777491|16809694|P1|Overall Study|Protocol Violation|0
4878146|NCT00777296|16809727|P4|Overall Study|CRF form not completed|0
4878147|NCT00777296|16809728|P3|Overall Study|CRF form not completed|2
4878148|NCT00777296|16809729|P2|Overall Study|CRF form not completed|0
4878149|NCT00777296|16809730|P1|Overall Study|CRF form not completed|0
4878150|NCT00777296|16809727|P4|Overall Study|Withdrawal by Subject|0
4878151|NCT00777296|16809728|P3|Overall Study|Withdrawal by Subject|0
4878152|NCT00777296|16809729|P2|Overall Study|Withdrawal by Subject|0
4878153|NCT00777296|16809730|P1|Overall Study|Withdrawal by Subject|1
4878154|NCT00777296|16809727|P4|Overall Study|Adverse Event|1
4878155|NCT00777296|16809728|P3|Overall Study|Adverse Event|0
4878156|NCT00777296|16809729|P2|Overall Study|Adverse Event|1
4878157|NCT00777296|16809730|P1|Overall Study|Adverse Event|0
4878158|NCT00777257|16809772|P3|Overall Study|Withdrawal by Subject|5
4878159|NCT00777257|16809773|P2|Overall Study|Withdrawal by Subject|6
4878160|NCT00777257|16809774|P1|Overall Study|Withdrawal by Subject|3
4878161|NCT00777257|16809772|P3|Overall Study|Protocol Violation|2
4878162|NCT00777257|16809773|P2|Overall Study|Protocol Violation|2
4878163|NCT00777257|16809774|P1|Overall Study|Protocol Violation|2
4878164|NCT00777257|16809772|P3|Overall Study|Lost to Follow-up|2
4878165|NCT00777257|16809773|P2|Overall Study|Lost to Follow-up|3
4878166|NCT00777257|16809774|P1|Overall Study|Lost to Follow-up|3
4878167|NCT00777257|16809772|P3|Overall Study|Adverse Event|0
4878168|NCT00777257|16809773|P2|Overall Study|Adverse Event|1
4878169|NCT00777257|16809774|P1|Overall Study|Adverse Event|3
4878170|NCT00777205|16809793|P2|Overall Study|Protocol Violation|56
4878171|NCT00777205|16809794|P1|Overall Study|Protocol Violation|0
4878172|NCT00777205|16809793|P2|Overall Study|Death|2
4878173|NCT00777205|16809794|P1|Overall Study|Death|0
4878174|NCT00777205|16809793|P2|Overall Study|Withdrawal by Subject|4
4878175|NCT00777205|16809794|P1|Overall Study|Withdrawal by Subject|6
4878176|NCT00777205|16809793|P2|Overall Study|Lost to Follow-up|9
4878177|NCT00777205|16809794|P1|Overall Study|Lost to Follow-up|25
4878178|NCT00777153|16809828|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|1
4878179|NCT00777153|16809829|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|5
4878180|NCT00777153|16809830|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|1
4878181|NCT00777153|16809828|P3|Overall Study|Withdrawal by Subject|3
4878182|NCT00777153|16809829|P2|Overall Study|Withdrawal by Subject|4
4878183|NCT00777153|16809830|P1|Overall Study|Withdrawal by Subject|3
4878184|NCT00777153|16809828|P3|Overall Study|Death|33
4878185|NCT00777153|16809829|P2|Overall Study|Death|73
4878186|NCT00777153|16809830|P1|Overall Study|Death|85
4878187|NCT00777153|16809828|P3|Overall Study|Lost to Follow-up|0
4878188|NCT00777153|16809829|P2|Overall Study|Lost to Follow-up|1
4878189|NCT00777153|16809830|P1|Overall Study|Lost to Follow-up|1
4878190|NCT00777101|16809855|P2|Overall Study|Failed to Return|1
4878191|NCT00777101|16809856|P1|Overall Study|Failed to Return|0
4878192|NCT00777101|16809855|P2|Overall Study|Discontinuation of Study by Sponsor|0
4878193|NCT00777101|16809856|P1|Overall Study|Discontinuation of Study by Sponsor|1
4878194|NCT00777101|16809855|P2|Overall Study|Lost to Follow-up|1
4878195|NCT00777101|16809856|P1|Overall Study|Lost to Follow-up|2
4878196|NCT00777101|16809855|P2|Overall Study|Withdrawal by Subject|6
4878197|NCT00777101|16809856|P1|Overall Study|Withdrawal by Subject|11
4878198|NCT00777101|16809855|P2|Overall Study|Death|43
4878199|NCT00777101|16809856|P1|Overall Study|Death|48
4878200|NCT00777088|16809874|P1|Overall Study|PED Treatment not attempted|1
4878201|NCT00777049|16809899|P2|Overall Study|No treatment (elevated liver enzymes)|1
4878202|NCT00777049|16809900|P1|Overall Study|No treatment (elevated liver enzymes)|0
4878203|NCT00777049|16809899|P2|Overall Study|Withdrawal by Subject|0
4878204|NCT00777049|16809900|P1|Overall Study|Withdrawal by Subject|1
4878205|NCT00777036|16809909|P3|Follow-Up|Death|0
4878206|NCT00777036|16809910|P2|Follow-Up|Death|8
4878207|NCT00777036|16809911|P1|Follow-Up|Death|1
4878208|NCT00777036|16809909|P3|Follow-Up|Withdrawal by Subject|4
4878209|NCT00777036|16809910|P2|Follow-Up|Withdrawal by Subject|0
4878210|NCT00777036|16809911|P1|Follow-Up|Withdrawal by Subject|1
4878211|NCT00777036|16809909|P3|Follow-Up|Reason Not Specified|0
4878212|NCT00777036|16809910|P2|Follow-Up|Reason Not Specified|0
4878213|NCT00777036|16809911|P1|Follow-Up|Reason Not Specified|2
4878214|NCT00777036|16809909|P3|Follow-Up|Lost to Follow-up|0
4878215|NCT00777036|16809910|P2|Follow-Up|Lost to Follow-up|0
4878216|NCT00777036|16809911|P1|Follow-Up|Lost to Follow-up|1
4878217|NCT00777036|16809909|P3|On Treatment|Progressive Disease|6
4878218|NCT00777036|16809910|P2|On Treatment|Progressive Disease|4
4878219|NCT00777036|16809911|P1|On Treatment|Progressive Disease|5
4878220|NCT00777036|16809909|P3|On Treatment|Study Drug Toxicity|1
4878221|NCT00777036|16809910|P2|On Treatment|Study Drug Toxicity|0
4878222|NCT00777036|16809911|P1|On Treatment|Study Drug Toxicity|0
4878223|NCT00777036|16809909|P3|On Treatment|Death|0
4878224|NCT00777036|16809910|P2|On Treatment|Death|2
4878225|NCT00777036|16809911|P1|On Treatment|Death|0
4878226|NCT00777036|16809909|P3|On Treatment|Withdrawal by Subject|3
4878227|NCT00777036|16809910|P2|On Treatment|Withdrawal by Subject|2
4878228|NCT00777036|16809911|P1|On Treatment|Withdrawal by Subject|3
4878229|NCT00777036|16809909|P3|On Treatment|Maximum Clinical Benefit|1
4878230|NCT00777036|16809910|P2|On Treatment|Maximum Clinical Benefit|0
4878231|NCT00777036|16809911|P1|On Treatment|Maximum Clinical Benefit|2
4878232|NCT00777036|16809909|P3|On Treatment|Non-compliance with Study Drug|0
4878233|NCT00777036|16809910|P2|On Treatment|Non-compliance with Study Drug|0
4878234|NCT00777036|16809911|P1|On Treatment|Non-compliance with Study Drug|1
4878235|NCT00777036|16809909|P3|On Treatment|Failure to Meet Study Criteria|0
4878236|NCT00777036|16809910|P2|On Treatment|Failure to Meet Study Criteria|1
4878237|NCT00777036|16809911|P1|On Treatment|Failure to Meet Study Criteria|0
4878238|NCT00777036|16809909|P3|On Treatment|Reason Not Specified|12
4878239|NCT00777036|16809910|P2|On Treatment|Reason Not Specified|7
4878240|NCT00777036|16809911|P1|On Treatment|Reason Not Specified|4
4878241|NCT00777023|16810007|P3|Overall Study|Last dose date unknown|1
4878242|NCT00777023|16810008|P2|Overall Study|Last dose date unknown|3
4878243|NCT00777023|16810009|P1|Overall Study|Last dose date unknown|3
4878244|NCT00777023|16810007|P3|Overall Study|Reasons not specified|2
4878245|NCT00777023|16810008|P2|Overall Study|Reasons not specified|4
4878246|NCT00777023|16810009|P1|Overall Study|Reasons not specified|4
4878247|NCT00777023|16810007|P3|Overall Study|Missing data|0
4878248|NCT00777023|16810008|P2|Overall Study|Missing data|1
4878249|NCT00777023|16810009|P1|Overall Study|Missing data|1
4878250|NCT00777023|16810007|P3|Overall Study|Withdrawal by Subject|8
4878251|NCT00777023|16810008|P2|Overall Study|Withdrawal by Subject|7
4878252|NCT00777023|16810009|P1|Overall Study|Withdrawal by Subject|7
4878253|NCT00777023|16810007|P3|Overall Study|Death|0
4878254|NCT00777023|16810008|P2|Overall Study|Death|1
4878255|NCT00777023|16810009|P1|Overall Study|Death|0
4878256|NCT00777023|16810007|P3|Overall Study|Lost to Follow-up|3
4878257|NCT00777023|16810008|P2|Overall Study|Lost to Follow-up|3
4878258|NCT00777023|16810009|P1|Overall Study|Lost to Follow-up|2
4878259|NCT00777023|16810007|P3|Overall Study|Protocol Violation|1
4878260|NCT00777023|16810008|P2|Overall Study|Protocol Violation|1
4878261|NCT00777023|16810009|P1|Overall Study|Protocol Violation|2
4878262|NCT00777023|16810007|P3|Overall Study|Lack of Efficacy|14
4878263|NCT00777023|16810008|P2|Overall Study|Lack of Efficacy|0
4878264|NCT00777023|16810009|P1|Overall Study|Lack of Efficacy|1
4878265|NCT00777023|16810007|P3|Overall Study|Adverse Event|8
4878266|NCT00777023|16810008|P2|Overall Study|Adverse Event|21
4878267|NCT00777023|16810009|P1|Overall Study|Adverse Event|15
4878268|NCT00776997|16810026|P1|Overall Study|Adverse Event|2
4878269|NCT00776984|16810035|P2|Overall Study|Other|9
4878270|NCT00776984|16810036|P1|Overall Study|Other|5
4878271|NCT00776984|16810035|P2|Overall Study|Lack of Efficacy|1
4878272|NCT00776984|16810036|P1|Overall Study|Lack of Efficacy|0
4878273|NCT00776984|16810035|P2|Overall Study|Withdrawal by Subject|7
4878274|NCT00776984|16810036|P1|Overall Study|Withdrawal by Subject|12
4878275|NCT00776984|16810035|P2|Overall Study|Lost to Follow-up|0
4878276|NCT00776984|16810036|P1|Overall Study|Lost to Follow-up|2
4878277|NCT00776984|16810035|P2|Overall Study|Protocol Violation|2
4878278|NCT00776984|16810036|P1|Overall Study|Protocol Violation|4
4878279|NCT00776984|16810035|P2|Overall Study|Adverse Event|2
4878280|NCT00776984|16810036|P1|Overall Study|Adverse Event|8
4878281|NCT00776919|16810110|P4|Overall Study|Other: Lack of Efficacy/Lost Medication|2
4878282|NCT00776919|16810111|P3|Overall Study|Other: Lack of Efficacy/Lost Medication|4
4878283|NCT00776919|16810112|P2|Overall Study|Other: Lack of Efficacy/Lost Medication|5
4878284|NCT00776919|16810113|P1|Overall Study|Other: Lack of Efficacy/Lost Medication|1
4878285|NCT00776919|16810110|P4|Overall Study|Protocol Violation|1
4878286|NCT00776919|16810111|P3|Overall Study|Protocol Violation|0
4878287|NCT00776919|16810112|P2|Overall Study|Protocol Violation|2
4878288|NCT00776919|16810113|P1|Overall Study|Protocol Violation|1
4878289|NCT00776919|16810110|P4|Overall Study|Adverse Event|2
4878290|NCT00776919|16810111|P3|Overall Study|Adverse Event|2
4878291|NCT00776919|16810112|P2|Overall Study|Adverse Event|0
4878292|NCT00776919|16810113|P1|Overall Study|Adverse Event|1
4878293|NCT00776919|16810110|P4|Overall Study|Lost to Follow-up|8
4878294|NCT00776919|16810111|P3|Overall Study|Lost to Follow-up|11
4878295|NCT00776919|16810112|P2|Overall Study|Lost to Follow-up|12
4878296|NCT00776919|16810113|P1|Overall Study|Lost to Follow-up|8
4878297|NCT00776919|16810110|P4|Overall Study|Withdrawal by Subject|26
4878298|NCT00776919|16810111|P3|Overall Study|Withdrawal by Subject|15
4878299|NCT00776919|16810112|P2|Overall Study|Withdrawal by Subject|14
4878300|NCT00776919|16810113|P1|Overall Study|Withdrawal by Subject|16
4878301|NCT00776789|16810177|P2|Overall Study|Poor quality video|1
4878302|NCT00776789|16810178|P1|Overall Study|Poor quality video|1
4878303|NCT00776789|16810177|P2|Overall Study|Consent refusal|2
4878304|NCT00776789|16810178|P1|Overall Study|Consent refusal|2
4878305|NCT00776659|16810190|P1|Overall Study|Study Terminated by Sponsor|1
4878306|NCT00776659|16810190|P1|Overall Study|Withdrawal by Subject|10
4878307|NCT00776659|16810190|P1|Overall Study|Lost to Follow-up|15
4878308|NCT00776555|16810217|P2|Overall Study|Study terminated|0
4878309|NCT00776555|16810218|P1|Overall Study|Study terminated|3
4878310|NCT00776230|16810236|P3|Overall Study|Subject missed Visit 4|0
4878311|NCT00776230|16810237|P2|Overall Study|Subject missed Visit 4|1
4878312|NCT00776230|16810238|P1|Overall Study|Subject missed Visit 4|0
4878313|NCT00776230|16810236|P3|Overall Study|Withdrawal by Subject|0
4878314|NCT00776230|16810237|P2|Overall Study|Withdrawal by Subject|1
4878315|NCT00776230|16810238|P1|Overall Study|Withdrawal by Subject|0
4878316|NCT00776230|16810236|P3|Overall Study|Not vaccinated at Day 0|0
4878317|NCT00776230|16810237|P2|Overall Study|Not vaccinated at Day 0|0
4878318|NCT00776230|16810238|P1|Overall Study|Not vaccinated at Day 0|1
4878319|NCT00776230|16810236|P3|Overall Study|Lost to Follow-up|5
4878320|NCT00776230|16810237|P2|Overall Study|Lost to Follow-up|1
4878321|NCT00776230|16810238|P1|Overall Study|Lost to Follow-up|2
4878322|NCT00776100|16810248|P2|Overall Study|Disease Progression|0
4878323|NCT00776100|16810249|P1|Overall Study|Disease Progression|1
4878324|NCT00776009|16810271|P6|Period 3: Third Intervention|Withdrawal by Subject|0
4878325|NCT00776009|16810272|P5|Period 3: Third Intervention|Withdrawal by Subject|0
4878326|NCT00776009|16810273|P4|Period 3: Third Intervention|Withdrawal by Subject|0
4878327|NCT00776009|16810274|P3|Period 3: Third Intervention|Withdrawal by Subject|0
4878328|NCT00776009|16810275|P2|Period 3: Third Intervention|Withdrawal by Subject|0
4878329|NCT00776009|16810276|P1|Period 3: Third Intervention|Withdrawal by Subject|1
4878330|NCT00776009|16810271|P6|Period 2: Second Intervention|Protocol Violation|0
4878331|NCT00776009|16810272|P5|Period 2: Second Intervention|Protocol Violation|0
4878332|NCT00776009|16810273|P4|Period 2: Second Intervention|Protocol Violation|0
4878333|NCT00776009|16810274|P3|Period 2: Second Intervention|Protocol Violation|1
4878334|NCT00776009|16810275|P2|Period 2: Second Intervention|Protocol Violation|0
4878335|NCT00776009|16810276|P1|Period 2: Second Intervention|Protocol Violation|1
4878336|NCT00776009|16810271|P6|Period 2: Second Intervention|Withdrawal by Subject|1
4878337|NCT00776009|16810272|P5|Period 2: Second Intervention|Withdrawal by Subject|0
4878338|NCT00776009|16810273|P4|Period 2: Second Intervention|Withdrawal by Subject|0
4878339|NCT00776009|16810274|P3|Period 2: Second Intervention|Withdrawal by Subject|0
4878340|NCT00776009|16810275|P2|Period 2: Second Intervention|Withdrawal by Subject|0
4878341|NCT00776009|16810276|P1|Period 2: Second Intervention|Withdrawal by Subject|0
4878342|NCT00776009|16810271|P6|Period 1: First Intervention|Protocol Violation|0
4878343|NCT00776009|16810272|P5|Period 1: First Intervention|Protocol Violation|1
4878344|NCT00776009|16810273|P4|Period 1: First Intervention|Protocol Violation|0
4878345|NCT00776009|16810274|P3|Period 1: First Intervention|Protocol Violation|0
4878346|NCT00776009|16810275|P2|Period 1: First Intervention|Protocol Violation|1
4878347|NCT00776009|16810276|P1|Period 1: First Intervention|Protocol Violation|0
4878348|NCT00776009|16810271|P6|Period 1: First Intervention|Withdrawal by Subject|0
4878349|NCT00776009|16810272|P5|Period 1: First Intervention|Withdrawal by Subject|1
4878350|NCT00776009|16810273|P4|Period 1: First Intervention|Withdrawal by Subject|0
4878351|NCT00776009|16810274|P3|Period 1: First Intervention|Withdrawal by Subject|1
4878352|NCT00776009|16810275|P2|Period 1: First Intervention|Withdrawal by Subject|0
4878353|NCT00776009|16810276|P1|Period 1: First Intervention|Withdrawal by Subject|0
4878354|NCT00775983|16810298|P2|Overall Study|Protocol Violation|2
4878355|NCT00775983|16810299|P1|Overall Study|Protocol Violation|1
4878356|NCT00775606|16810425|P2|Overall Study|Study sponsor terminated funding|0
4878357|NCT00775606|16810426|P1|Overall Study|Study sponsor terminated funding|3
4878358|NCT00775593|16810436|P1|Overall Study|Death|1
4878359|NCT00775593|16810436|P1|Overall Study|Unmet eligibility criteria|6
4878360|NCT00775528|16810443|P1|Overall Study|Protocol Violation|1
4878361|NCT00775463|16810452|P2|Overall Study|Lack of Efficacy|1
4878362|NCT00775463|16810453|P1|Overall Study|Lack of Efficacy|1
4878363|NCT00775463|16810452|P2|Overall Study|Lost to Follow-up|0
4878364|NCT00775463|16810453|P1|Overall Study|Lost to Follow-up|1
4878365|NCT00775463|16810452|P2|Overall Study|Protocol Violation|2
4878366|NCT00775463|16810453|P1|Overall Study|Protocol Violation|2
4878367|NCT00775463|16810452|P2|Overall Study|Adverse Event|9
4878368|NCT00775463|16810453|P1|Overall Study|Adverse Event|7
4878369|NCT00775463|16810452|P2|Overall Study|Withdrawal by Subject|1
4878370|NCT00775463|16810453|P1|Overall Study|Withdrawal by Subject|0
4878371|NCT00775450|16810490|P5|Overall Study|Withdrawal by Subject|1
4878372|NCT00775450|16810491|P4|Overall Study|Withdrawal by Subject|0
4878373|NCT00775450|16810492|P3|Overall Study|Withdrawal by Subject|0
4878374|NCT00775450|16810493|P2|Overall Study|Withdrawal by Subject|0
4878375|NCT00775450|16810494|P1|Overall Study|Withdrawal by Subject|1
4878376|NCT00775450|16810490|P5|Overall Study|Protocol Violation|1
4878377|NCT00775450|16810491|P4|Overall Study|Protocol Violation|0
4878378|NCT00775450|16810492|P3|Overall Study|Protocol Violation|0
4878379|NCT00775450|16810493|P2|Overall Study|Protocol Violation|0
4878380|NCT00775450|16810494|P1|Overall Study|Protocol Violation|0
4878381|NCT00775450|16810490|P5|Overall Study|Serious Adverse Event|0
4878382|NCT00775450|16810491|P4|Overall Study|Serious Adverse Event|0
4878383|NCT00775450|16810492|P3|Overall Study|Serious Adverse Event|0
4878384|NCT00775450|16810493|P2|Overall Study|Serious Adverse Event|0
4878385|NCT00775450|16810494|P1|Overall Study|Serious Adverse Event|2
4878386|NCT00775437|16810521|P1|Overall Study|Lost to Follow-up|1
4878387|NCT00775437|16810521|P1|Overall Study|Withdrawal by Subject|3
4878388|NCT00775437|16810521|P1|Overall Study|Loss of efficacy|2
4878389|NCT00775203|16810596|P2|Overall Study|Physician Decision|1
4878390|NCT00775203|16810597|P1|Overall Study|Physician Decision|0
4878391|NCT00775203|16810596|P2|Overall Study|Entered other study|0
4878392|NCT00775203|16810597|P1|Overall Study|Entered other study|1
4878393|NCT00775203|16810596|P2|Overall Study|Protocol Violation|1
4878394|NCT00775203|16810597|P1|Overall Study|Protocol Violation|0
4878395|NCT00775203|16810596|P2|Overall Study|Noncompliance|2
4878396|NCT00775203|16810597|P1|Overall Study|Noncompliance|4
4878397|NCT00775203|16810596|P2|Overall Study|Administrative reason|0
4878398|NCT00775203|16810597|P1|Overall Study|Administrative reason|2
4878399|NCT00775203|16810596|P2|Overall Study|Lost to Follow-up|15
4878400|NCT00775203|16810597|P1|Overall Study|Lost to Follow-up|11
4878401|NCT00775203|16810596|P2|Overall Study|Withdrawal by Subject|9
4878402|NCT00775203|16810597|P1|Overall Study|Withdrawal by Subject|11
4878403|NCT00775203|16810596|P2|Overall Study|Lack of Efficacy|9
4878404|NCT00775203|16810597|P1|Overall Study|Lack of Efficacy|8
4878405|NCT00775203|16810596|P2|Overall Study|Adverse Event|6
4878406|NCT00775203|16810597|P1|Overall Study|Adverse Event|25
4878407|NCT00775190|16810631|P2|Overall Study|Protocol Violation|0
4878408|NCT00775190|16810632|P1|Overall Study|Protocol Violation|1
4878409|NCT00775190|16810631|P2|Overall Study|Withdrawal by Subject|2
4878410|NCT00775190|16810632|P1|Overall Study|Withdrawal by Subject|1
4878411|NCT00775190|16810631|P2|Overall Study|Lost to Follow-up|3
4878412|NCT00775190|16810632|P1|Overall Study|Lost to Follow-up|2
4878413|NCT00775138|16810658|P4|Overall Study|Adverse Event|0
4878414|NCT00775138|16810659|P3|Overall Study|Adverse Event|1
4878415|NCT00775138|16810660|P2|Overall Study|Adverse Event|0
4878416|NCT00775138|16810661|P1|Overall Study|Adverse Event|0
4878417|NCT00775138|16810658|P4|Overall Study|Withdrawal by Subject|2
4878418|NCT00775138|16810659|P3|Overall Study|Withdrawal by Subject|2
4878419|NCT00775138|16810660|P2|Overall Study|Withdrawal by Subject|0
4878420|NCT00775138|16810661|P1|Overall Study|Withdrawal by Subject|0
4878421|NCT00775021|16810707|P2|Second Intervention|Adverse Event|1
4878422|NCT00775021|16810708|P1|Second Intervention|Adverse Event|0
4878423|NCT00775021|16810707|P2|First Intervention|Lost to Follow-up|0
4878424|NCT00775021|16810708|P1|First Intervention|Lost to Follow-up|1
4878425|NCT00774995|16810726|P4|Overall Study|Protocol Violation|0
4878426|NCT00774995|16810727|P3|Overall Study|Protocol Violation|1
4878427|NCT00774995|16810728|P2|Overall Study|Protocol Violation|0
4878428|NCT00774995|16810729|P1|Overall Study|Protocol Violation|0
4878429|NCT00774930|16810769|P2|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1
4878430|NCT00774930|16810770|P1|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0
4878431|NCT00774930|16810769|P2|LTOLE Phase|Tumour Progression of Hepatic Metastases|1
4878432|NCT00774930|16810770|P1|LTOLE Phase|Tumour Progression of Hepatic Metastases|0
4878433|NCT00774930|16810769|P2|LTOLE Phase|Disease Progression|5
4878434|NCT00774930|16810770|P1|LTOLE Phase|Disease Progression|2
4878435|NCT00774930|16810769|P2|LTOLE Phase|Sponsor decision|1
4878436|NCT00774930|16810770|P1|LTOLE Phase|Sponsor decision|2
4878437|NCT00774930|16810769|P2|LTOLE Phase|Physician Decision|1
4878438|NCT00774930|16810770|P1|LTOLE Phase|Physician Decision|4
4878439|NCT00774930|16810769|P2|LTOLE Phase|Subject decision|5
4878440|NCT00774930|16810770|P1|LTOLE Phase|Subject decision|0
4878441|NCT00774930|16810769|P2|LTOLE Phase|Adverse Event|3
4878442|NCT00774930|16810770|P1|LTOLE Phase|Adverse Event|7
4878443|NCT00774930|16810769|P2|IOL Phase|Brain radiation|1
4878444|NCT00774930|16810770|P1|IOL Phase|Brain radiation|0
4878445|NCT00774930|16810769|P2|IOL Phase|Other|0
4878446|NCT00774930|16810770|P1|IOL Phase|Other|1
4878447|NCT00774930|16810769|P2|IOL Phase|Peptide Receptor Radionuclide Therapy|1
4878448|NCT00774930|16810770|P1|IOL Phase|Peptide Receptor Radionuclide Therapy|0
4878449|NCT00774930|16810769|P2|IOL Phase|Subject Consumed Prohibited Medication|0
4878450|NCT00774930|16810770|P1|IOL Phase|Subject Consumed Prohibited Medication|1
4878451|NCT00774930|16810769|P2|IOL Phase|Disease Progression|1
4878452|NCT00774930|16810770|P1|IOL Phase|Disease Progression|2
4878453|NCT00774930|16810769|P2|IOL Phase|Sponsor Decision|0
4878454|NCT00774930|16810770|P1|IOL Phase|Sponsor Decision|1
4878455|NCT00774930|16810769|P2|IOL Phase|Physician Decision|2
4878456|NCT00774930|16810770|P1|IOL Phase|Physician Decision|3
4878457|NCT00774930|16810769|P2|IOL Phase|Subject Decision|3
4878458|NCT00774930|16810770|P1|IOL Phase|Subject Decision|4
4878459|NCT00774930|16810769|P2|IOL Phase|Adverse Event|1
4878460|NCT00774930|16810770|P1|IOL Phase|Adverse Event|1
4878461|NCT00774930|16810769|P2|DB Phase|Started Nonprotocol Radiation therapy|1
4878462|NCT00774930|16810770|P1|DB Phase|Started Nonprotocol Radiation therapy|0
4878463|NCT00774930|16810769|P2|DB Phase|Disease Progression|1
4878464|NCT00774930|16810770|P1|DB Phase|Disease Progression|1
4878465|NCT00774930|16810769|P2|DB Phase|Sponsor Decision|1
4878466|NCT00774930|16810770|P1|DB Phase|Sponsor Decision|0
4878467|NCT00774930|16810769|P2|DB Phase|Subject Decision|5
4878468|NCT00774930|16810770|P1|DB Phase|Subject Decision|1
4878469|NCT00774930|16810769|P2|DB Phase|Adverse Event|2
4878470|NCT00774930|16810770|P1|DB Phase|Adverse Event|1
4878471|NCT00774930|16810769|P2|DB Phase|Early Roll Over (ERO) to IOL phase|12
4878472|NCT00774930|16810770|P1|DB Phase|Early Roll Over (ERO) to IOL phase|11
4878473|NCT00774852|16810798|P2|Overall Study|Subject received prohibited medication|0
4878474|NCT00774852|16810799|P1|Overall Study|Subject received prohibited medication|1
4878475|NCT00774852|16810798|P2|Overall Study|Protocol Violation|0
4878476|NCT00774852|16810799|P1|Overall Study|Protocol Violation|1
4878477|NCT00774852|16810798|P2|Overall Study|Subject non-compliance|1
4878478|NCT00774852|16810799|P1|Overall Study|Subject non-compliance|0
4878479|NCT00774852|16810798|P2|Overall Study|Non-responder|11
4878480|NCT00774852|16810799|P1|Overall Study|Non-responder|15
4878481|NCT00774852|16810798|P2|Overall Study|Withdrawal by Subject|2
4878482|NCT00774852|16810799|P1|Overall Study|Withdrawal by Subject|2
4878483|NCT00774852|16810798|P2|Overall Study|Pregnancy|2
4878484|NCT00774852|16810799|P1|Overall Study|Pregnancy|1
4878485|NCT00774852|16810798|P2|Overall Study|Physician Decision|6
4878486|NCT00774852|16810799|P1|Overall Study|Physician Decision|2
4878487|NCT00774852|16810798|P2|Overall Study|Lost to Follow-up|5
4878488|NCT00774852|16810799|P1|Overall Study|Lost to Follow-up|9
4878489|NCT00774852|16810798|P2|Overall Study|Lack of Efficacy|7
4878490|NCT00774852|16810799|P1|Overall Study|Lack of Efficacy|3
4878491|NCT00774852|16810798|P2|Overall Study|Death|1
4878492|NCT00774852|16810799|P1|Overall Study|Death|2
4878493|NCT00774852|16810798|P2|Overall Study|Adverse Event|6
4878494|NCT00774852|16810799|P1|Overall Study|Adverse Event|9
4878495|NCT00774800|16810847|P1|Intervention 4|Withdrawal by Subject|1
4878496|NCT00774787|16810869|P1|Overall Study|Lost to Follow-up|1
4878497|NCT00774748|16810876|P1|Overall Study|Lost to Follow-up|3
4878498|NCT00774397|16810902|P7|Overall Study|Other than those stated above|1
4878499|NCT00774397|16810903|P6|Overall Study|Other than those stated above|0
4878500|NCT00774397|16810904|P5|Overall Study|Other than those stated above|2
4878501|NCT00774397|16810905|P4|Overall Study|Other than those stated above|2
4878502|NCT00774397|16810906|P3|Overall Study|Other than those stated above|3
4878503|NCT00774397|16810907|P2|Overall Study|Other than those stated above|1
4878504|NCT00774397|16810908|P1|Overall Study|Other than those stated above|1
4878505|NCT00774397|16810902|P7|Overall Study|Not treated|1
4878506|NCT00774397|16810903|P6|Overall Study|Not treated|0
4878507|NCT00774397|16810904|P5|Overall Study|Not treated|1
4878508|NCT00774397|16810905|P4|Overall Study|Not treated|0
4878509|NCT00774397|16810906|P3|Overall Study|Not treated|0
4878510|NCT00774397|16810907|P2|Overall Study|Not treated|0
4878511|NCT00774397|16810908|P1|Overall Study|Not treated|0
4878512|NCT00774397|16810902|P7|Overall Study|Refused to continue trial medication|3
4878513|NCT00774397|16810903|P6|Overall Study|Refused to continue trial medication|2
4878514|NCT00774397|16810904|P5|Overall Study|Refused to continue trial medication|6
4878515|NCT00774397|16810905|P4|Overall Study|Refused to continue trial medication|2
4878516|NCT00774397|16810906|P3|Overall Study|Refused to continue trial medication|2
4878517|NCT00774397|16810907|P2|Overall Study|Refused to continue trial medication|3
4878518|NCT00774397|16810908|P1|Overall Study|Refused to continue trial medication|1
4878519|NCT00774397|16810902|P7|Overall Study|Lost to Follow-up|0
4878520|NCT00774397|16810903|P6|Overall Study|Lost to Follow-up|1
4878521|NCT00774397|16810904|P5|Overall Study|Lost to Follow-up|0
4878522|NCT00774397|16810905|P4|Overall Study|Lost to Follow-up|1
4878523|NCT00774397|16810906|P3|Overall Study|Lost to Follow-up|1
4878524|NCT00774397|16810907|P2|Overall Study|Lost to Follow-up|1
4878525|NCT00774397|16810908|P1|Overall Study|Lost to Follow-up|0
4878526|NCT00774397|16810902|P7|Overall Study|Protocol Violation|0
4878527|NCT00774397|16810903|P6|Overall Study|Protocol Violation|1
4878528|NCT00774397|16810904|P5|Overall Study|Protocol Violation|2
4878529|NCT00774397|16810905|P4|Overall Study|Protocol Violation|1
4878530|NCT00774397|16810906|P3|Overall Study|Protocol Violation|3
4878531|NCT00774397|16810907|P2|Overall Study|Protocol Violation|1
4878532|NCT00774397|16810908|P1|Overall Study|Protocol Violation|0
4878533|NCT00774397|16810902|P7|Overall Study|Lack of Efficacy|9
4878534|NCT00774397|16810903|P6|Overall Study|Lack of Efficacy|15
4878535|NCT00774397|16810904|P5|Overall Study|Lack of Efficacy|27
4878536|NCT00774397|16810905|P4|Overall Study|Lack of Efficacy|3
4878537|NCT00774397|16810906|P3|Overall Study|Lack of Efficacy|5
4878538|NCT00774397|16810907|P2|Overall Study|Lack of Efficacy|4
4878539|NCT00774397|16810908|P1|Overall Study|Lack of Efficacy|11
4878540|NCT00774397|16810902|P7|Overall Study|Adverse Event|16
4878541|NCT00774397|16810903|P6|Overall Study|Adverse Event|3
4878542|NCT00774397|16810904|P5|Overall Study|Adverse Event|8
4878543|NCT00774397|16810905|P4|Overall Study|Adverse Event|8
4878544|NCT00774397|16810906|P3|Overall Study|Adverse Event|16
4878545|NCT00774397|16810907|P2|Overall Study|Adverse Event|3
4878546|NCT00774397|16810908|P1|Overall Study|Adverse Event|1
4878547|NCT00774306|16811144|P4|Overall Study|Death|0
4878548|NCT00774306|16811145|P3|Overall Study|Death|0
4878549|NCT00774306|16811146|P2|Overall Study|Death|1
4878550|NCT00774306|16811147|P1|Overall Study|Death|1
4878551|NCT00774306|16811144|P4|Overall Study|Lost to Follow-up|5
4878552|NCT00774306|16811145|P3|Overall Study|Lost to Follow-up|4
4878553|NCT00774306|16811146|P2|Overall Study|Lost to Follow-up|0
4878554|NCT00774306|16811147|P1|Overall Study|Lost to Follow-up|6
4878555|NCT00774306|16811144|P4|Overall Study|Withdrawal by Subject|0
4878556|NCT00774306|16811145|P3|Overall Study|Withdrawal by Subject|1
4878557|NCT00774306|16811146|P2|Overall Study|Withdrawal by Subject|1
4878558|NCT00774306|16811147|P1|Overall Study|Withdrawal by Subject|6
4878559|NCT00774306|16811144|P4|Overall Study|Protocol Violation|0
4878560|NCT00774306|16811145|P3|Overall Study|Protocol Violation|3
4878561|NCT00774306|16811146|P2|Overall Study|Protocol Violation|0
4878562|NCT00774306|16811147|P1|Overall Study|Protocol Violation|2
4878563|NCT00774306|16811144|P4|Overall Study|Adverse Event|0
4878564|NCT00774306|16811145|P3|Overall Study|Adverse Event|0
4878565|NCT00774306|16811146|P2|Overall Study|Adverse Event|0
4878566|NCT00774306|16811147|P1|Overall Study|Adverse Event|3
4878567|NCT00774046|16811228|P1|Stem Cell Mobilization|Count too low (2), sudden death (1)|3
4878568|NCT00774046|16811228|P1|Enrollment|Desired other therapy/refused|28
4878569|NCT00774046|16811228|P1|Screening|Not eligible|56
4878570|NCT00773968|16811238|P1|Overall Study|Other|8
4878571|NCT00773968|16811238|P1|Overall Study|Screen Failure|17
4878572|NCT00773968|16811238|P1|Overall Study|Withdrawal by Subject|11
4878573|NCT00773968|16811238|P1|Overall Study|Protocol Violation|1
4878574|NCT00773968|16811238|P1|Overall Study|Lack of Efficacy|3
4878575|NCT00773968|16811238|P1|Overall Study|Failure to Return|2
4878576|NCT00773968|16811238|P1|Overall Study|Death|1
4878577|NCT00773968|16811238|P1|Overall Study|Adverse Event|2
4878578|NCT00773734|16811269|P6|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4878579|NCT00773734|16811270|P5|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4878580|NCT00773734|16811271|P4|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
4878581|NCT00773734|16811272|P3|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4
4878582|NCT00773734|16811273|P2|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4878583|NCT00773734|16811274|P1|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0
4878584|NCT00773734|16811269|P6|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4878585|NCT00773734|16811270|P5|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4878586|NCT00773734|16811271|P4|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3
4878587|NCT00773734|16811272|P3|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6
4878588|NCT00773734|16811273|P2|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4878589|NCT00773734|16811274|P1|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0
4878590|NCT00773734|16811269|P6|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4878591|NCT00773734|16811270|P5|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4878592|NCT00773734|16811271|P4|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4
4878593|NCT00773734|16811272|P3|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2
4878594|NCT00773734|16811273|P2|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4878595|NCT00773734|16811274|P1|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0
4878596|NCT00773734|16811269|P6|LTE Period: Week 52 to 6 Years|Adverse Event|0
4878597|NCT00773734|16811270|P5|LTE Period: Week 52 to 6 Years|Adverse Event|0
4878598|NCT00773734|16811271|P4|LTE Period: Week 52 to 6 Years|Adverse Event|1
4878599|NCT00773734|16811272|P3|LTE Period: Week 52 to 6 Years|Adverse Event|0
4878600|NCT00773734|16811273|P2|LTE Period: Week 52 to 6 Years|Adverse Event|0
4878601|NCT00773734|16811274|P1|LTE Period: Week 52 to 6 Years|Adverse Event|0
4878602|NCT00773734|16811269|P6|Extension: Active Treatment Week 24-52|Other|1
4878603|NCT00773734|16811270|P5|Extension: Active Treatment Week 24-52|Other|0
4878604|NCT00773734|16811271|P4|Extension: Active Treatment Week 24-52|Other|2
4878605|NCT00773734|16811272|P3|Extension: Active Treatment Week 24-52|Other|1
4878606|NCT00773734|16811273|P2|Extension: Active Treatment Week 24-52|Other|0
4878607|NCT00773734|16811274|P1|Extension: Active Treatment Week 24-52|Other|0
4878608|NCT00773734|16811269|P6|Extension: Active Treatment Week 24-52|Lost to Follow-up|1
4878609|NCT00773734|16811270|P5|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
4878610|NCT00773734|16811271|P4|Extension: Active Treatment Week 24-52|Lost to Follow-up|3
4878611|NCT00773734|16811272|P3|Extension: Active Treatment Week 24-52|Lost to Follow-up|5
4878612|NCT00773734|16811273|P2|Extension: Active Treatment Week 24-52|Lost to Follow-up|2
4878613|NCT00773734|16811274|P1|Extension: Active Treatment Week 24-52|Lost to Follow-up|0
4878614|NCT00773734|16811269|P6|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
4878615|NCT00773734|16811270|P5|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
4878616|NCT00773734|16811271|P4|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2
4878617|NCT00773734|16811272|P3|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1
4878618|NCT00773734|16811273|P2|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3
4878619|NCT00773734|16811274|P1|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0
4878620|NCT00773734|16811269|P6|Extension: Active Treatment Week 24-52|Lack of Efficacy|2
4878621|NCT00773734|16811270|P5|Extension: Active Treatment Week 24-52|Lack of Efficacy|1
4878622|NCT00773734|16811271|P4|Extension: Active Treatment Week 24-52|Lack of Efficacy|3
4878623|NCT00773734|16811272|P3|Extension: Active Treatment Week 24-52|Lack of Efficacy|10
4878624|NCT00773734|16811273|P2|Extension: Active Treatment Week 24-52|Lack of Efficacy|8
4878625|NCT00773734|16811274|P1|Extension: Active Treatment Week 24-52|Lack of Efficacy|0
4878626|NCT00773734|16811269|P6|Extension: Active Treatment Week 24-52|Adverse Event|1
4878627|NCT00773734|16811270|P5|Extension: Active Treatment Week 24-52|Adverse Event|2
4878628|NCT00773734|16811271|P4|Extension: Active Treatment Week 24-52|Adverse Event|0
4878629|NCT00773734|16811272|P3|Extension: Active Treatment Week 24-52|Adverse Event|0
4878630|NCT00773734|16811273|P2|Extension: Active Treatment Week 24-52|Adverse Event|0
4878631|NCT00773734|16811274|P1|Extension: Active Treatment Week 24-52|Adverse Event|0
4878632|NCT00773734|16811269|P6|Core: Active Treatment Phase Week 16-24|Other|0
4878633|NCT00773734|16811270|P5|Core: Active Treatment Phase Week 16-24|Other|0
4878634|NCT00773734|16811271|P4|Core: Active Treatment Phase Week 16-24|Other|0
4878635|NCT00773734|16811272|P3|Core: Active Treatment Phase Week 16-24|Other|0
4878636|NCT00773734|16811273|P2|Core: Active Treatment Phase Week 16-24|Other|1
4878637|NCT00773734|16811274|P1|Core: Active Treatment Phase Week 16-24|Other|0
4878638|NCT00773734|16811269|P6|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4878639|NCT00773734|16811270|P5|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
4878640|NCT00773734|16811271|P4|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4878641|NCT00773734|16811272|P3|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4878642|NCT00773734|16811273|P2|Core: Active Treatment Phase Week 16-24|Protocol Violation|1
4878643|NCT00773734|16811274|P1|Core: Active Treatment Phase Week 16-24|Protocol Violation|0
4878644|NCT00773734|16811269|P6|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4878645|NCT00773734|16811270|P5|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4878646|NCT00773734|16811271|P4|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4878647|NCT00773734|16811272|P3|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
4878648|NCT00773734|16811273|P2|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1
4878649|NCT00773734|16811274|P1|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0
4878650|NCT00773734|16811269|P6|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2
4878651|NCT00773734|16811270|P5|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
4878652|NCT00773734|16811271|P4|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
4878653|NCT00773734|16811272|P3|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
4878654|NCT00773734|16811273|P2|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1
4878655|NCT00773734|16811274|P1|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0
4878656|NCT00773734|16811269|P6|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
4878657|NCT00773734|16811270|P5|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
4878658|NCT00773734|16811271|P4|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1
4878659|NCT00773734|16811272|P3|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
4878660|NCT00773734|16811273|P2|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4
4878661|NCT00773734|16811274|P1|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0
4878662|NCT00773734|16811269|P6|Core: Active Treatment Phase Week 16-24|Adverse Event|2
4878663|NCT00773734|16811270|P5|Core: Active Treatment Phase Week 16-24|Adverse Event|1
4878664|NCT00773734|16811271|P4|Core: Active Treatment Phase Week 16-24|Adverse Event|0
4878665|NCT00773734|16811272|P3|Core: Active Treatment Phase Week 16-24|Adverse Event|0
4878666|NCT00773734|16811273|P2|Core: Active Treatment Phase Week 16-24|Adverse Event|4
4878667|NCT00773734|16811274|P1|Core: Active Treatment Phase Week 16-24|Adverse Event|0
4878668|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Other|0
4878669|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Other|0
4878670|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Other|1
4878671|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Other|1
4878672|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Other|1
4878673|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Other|1
4878674|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
4878675|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
4878676|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0
4878677|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4
4878678|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3
4878679|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1
4878680|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4878681|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4878682|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1
4878683|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4878684|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0
4878685|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2
4878686|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Death|0
4878687|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Death|0
4878688|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Death|0
4878689|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Death|0
4878690|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Death|0
4878691|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Death|1
4878692|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
4878693|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0
4878694|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4
4878695|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6
4878696|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
4878697|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2
4878698|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
4878699|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0
4878700|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
4878701|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2
4878702|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3
4878703|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4
4878704|NCT00773734|16811269|P6|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
4878705|NCT00773734|16811270|P5|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0
4878706|NCT00773734|16811271|P4|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10
4878707|NCT00773734|16811272|P3|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8
4878708|NCT00773734|16811273|P2|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1
4878709|NCT00773734|16811274|P1|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5
4878710|NCT00773513|16811842|P2|Overall Study|Death|545
4878711|NCT00773513|16811843|P1|Overall Study|Death|531
4878712|NCT00773513|16811842|P2|Overall Study|Reason Not Specified|126
4878713|NCT00773513|16811843|P1|Overall Study|Reason Not Specified|159
4878714|NCT00773513|16811842|P2|Overall Study|Insufficient Therapeutic Response|18
4878715|NCT00773513|16811843|P1|Overall Study|Insufficient Therapeutic Response|1
4878716|NCT00773513|16811842|P2|Overall Study|Failure to Return|8
4878717|NCT00773513|16811843|P1|Overall Study|Failure to Return|22
4878718|NCT00773513|16811842|P2|Overall Study|Refused Treatment / Did not Cooperate|32
4878719|NCT00773513|16811843|P1|Overall Study|Refused Treatment / Did not Cooperate|26
4878720|NCT00773513|16811842|P2|Overall Study|Withdrew Consent|69
4878721|NCT00773513|16811843|P1|Overall Study|Withdrew Consent|68
4878722|NCT00773513|16811842|P2|Overall Study|Adverse Event / Intercurrent Illness|48
4878723|NCT00773513|16811843|P1|Overall Study|Adverse Event / Intercurrent Illness|40
4878724|NCT00773513|16811842|P2|Overall Study|Renal Transplant|263
4878725|NCT00773513|16811843|P1|Overall Study|Renal Transplant|254
4878726|NCT00773461|16811872|P2|Overall Study|Withdrawal by Subject|1
4878727|NCT00773461|16811873|P1|Overall Study|Withdrawal by Subject|4
4878728|NCT00773461|16811872|P2|Overall Study|Adverse Event|3
4878729|NCT00773461|16811873|P1|Overall Study|Adverse Event|1
4878730|NCT00773383|16811927|P1|Overall Study|No study dose received|1
4878731|NCT00773383|16811927|P1|Overall Study|Other|2
4878732|NCT00773383|16811927|P1|Overall Study|Progression of Disease|23
4878733|NCT00773383|16811927|P1|Overall Study|Death|1
4878734|NCT00773383|16811927|P1|Overall Study|Adverse Event|4
4878735|NCT00773279|16811962|P2|Period 2|Unclassified|2
4878736|NCT00773279|16811963|P1|Period 2|Unclassified|2
4878737|NCT00773279|16811962|P2|Period 2|Protocol Violation|3
4878738|NCT00773279|16811963|P1|Period 2|Protocol Violation|0
4878739|NCT00773279|16811962|P2|Period 2|Lack of Efficacy|0
4878740|NCT00773279|16811963|P1|Period 2|Lack of Efficacy|1
4878741|NCT00773279|16811962|P2|Period 2|Adverse Event|1
4878742|NCT00773279|16811963|P1|Period 2|Adverse Event|0
4878743|NCT00773279|16811962|P2|Period 1|Unclassified|1
4878744|NCT00773279|16811963|P1|Period 1|Unclassified|5
4878745|NCT00773279|16811962|P2|Period 1|Lack of Efficacy|2
4878746|NCT00773279|16811963|P1|Period 1|Lack of Efficacy|0
4878747|NCT00773279|16811962|P2|Period 1|Adverse Event|1
4878748|NCT00773279|16811963|P1|Period 1|Adverse Event|2
4878749|NCT00773253|16811984|P2|First Intervention (Week 0-24)|Frontalis Test Negative|1
4878750|NCT00773253|16811985|P1|First Intervention (Week 0-24)|Frontalis Test Negative|0
4878751|NCT00773175|16811995|P2|Overall Study|Consent Withdrawn|2
4878752|NCT00773175|16811996|P1|Overall Study|Consent Withdrawn|0
4878753|NCT00773175|16811995|P2|Overall Study|Adverse Event|0
4878754|NCT00773175|16811996|P1|Overall Study|Adverse Event|2
4878755|NCT00773136|16812088|P1|Overall Study|Physician Decision|2
4878756|NCT00773097|16812093|P1|Overall Study|Physician Decision|6
4878757|NCT00773097|16812093|P1|Overall Study|Withdrawal by Subject|1
4878758|NCT00772967|16812099|P6|Crossover Treatment 3|Adverse Event|0
4878759|NCT00772967|16812100|P5|Crossover Treatment 3|Adverse Event|1
4878760|NCT00772967|16812101|P4|Crossover Treatment 3|Adverse Event|0
4878761|NCT00772967|16812102|P3|Crossover Treatment 3|Adverse Event|0
4878762|NCT00772967|16812103|P2|Crossover Treatment 3|Adverse Event|0
4878763|NCT00772967|16812104|P1|Crossover Treatment 3|Adverse Event|0
4878764|NCT00772967|16812099|P6|Break 1 (4-7 Days)|Withdrawal by Subject|0
4878765|NCT00772967|16812100|P5|Break 1 (4-7 Days)|Withdrawal by Subject|0
4878766|NCT00772967|16812101|P4|Break 1 (4-7 Days)|Withdrawal by Subject|0
4878767|NCT00772967|16812102|P3|Break 1 (4-7 Days)|Withdrawal by Subject|0
4878768|NCT00772967|16812103|P2|Break 1 (4-7 Days)|Withdrawal by Subject|1
4878769|NCT00772967|16812104|P1|Break 1 (4-7 Days)|Withdrawal by Subject|0
4878770|NCT00772967|16812099|P6|Crossover Treatment 1|Adverse Event (Pain)|0
4878771|NCT00772967|16812100|P5|Crossover Treatment 1|Adverse Event (Pain)|0
4878772|NCT00772967|16812101|P4|Crossover Treatment 1|Adverse Event (Pain)|1
4878773|NCT00772967|16812102|P3|Crossover Treatment 1|Adverse Event (Pain)|0
4878774|NCT00772967|16812103|P2|Crossover Treatment 1|Adverse Event (Pain)|0
4878775|NCT00772967|16812104|P1|Crossover Treatment 1|Adverse Event (Pain)|0
4878776|NCT00772954|16812124|P3|Overall Study|Adverse Event|1
4878777|NCT00772954|16812125|P2|Overall Study|Adverse Event|0
4878778|NCT00772954|16812126|P1|Overall Study|Adverse Event|0
4878779|NCT00772941|16812134|P1|Overall Study|GPSP Violation|90
4878780|NCT00772941|16812134|P1|Overall Study|Poor Compliance|7
4878781|NCT00772941|16812134|P1|Overall Study|Missed Visits|374
4878782|NCT00772941|16812134|P1|Overall Study|Study not completed|16
4878783|NCT00772941|16812134|P1|Overall Study|CRFs not available|195
4878784|NCT00772928|16812165|P2|Overall Study|Did not receive vaccine|1
4878785|NCT00772928|16812166|P1|Overall Study|Did not receive vaccine|0
4878786|NCT00772928|16812165|P2|Overall Study|Withdrawal by Subject|22
4878787|NCT00772928|16812166|P1|Overall Study|Withdrawal by Subject|25
4878788|NCT00772928|16812165|P2|Overall Study|Protocol Violation|12
4878789|NCT00772928|16812166|P1|Overall Study|Protocol Violation|10
4878790|NCT00772928|16812165|P2|Overall Study|Lost to Follow-up|6
4878791|NCT00772928|16812166|P1|Overall Study|Lost to Follow-up|9
4878792|NCT00772889|16812187|P3|Overall Study|Lost to Follow-up|7
4878793|NCT00772889|16812188|P2|Overall Study|Lost to Follow-up|6
4878794|NCT00772889|16812189|P1|Overall Study|Lost to Follow-up|6
4878795|NCT00772889|16812187|P3|Overall Study|Withdrawal by Subject|9
4878796|NCT00772889|16812188|P2|Overall Study|Withdrawal by Subject|8
4878797|NCT00772889|16812189|P1|Overall Study|Withdrawal by Subject|9
4878798|NCT00772889|16812187|P3|Overall Study|Adverse Event|0
4878799|NCT00772889|16812188|P2|Overall Study|Adverse Event|4
4878800|NCT00772889|16812189|P1|Overall Study|Adverse Event|7
4878801|NCT00772707|16812247|P1|Overall Study|Withdrawn|3
4878802|NCT00772668|16812252|P1|Overall Study|Physician Decision|3
4878803|NCT00772629|16812261|P2|Overall Study|Subject was not vaccinated|0
4878804|NCT00772629|16812262|P1|Overall Study|Subject was not vaccinated|1
4878805|NCT00772603|16812271|P3|Overall Study|Other|2
4878806|NCT00772603|16812272|P2|Overall Study|Other|0
4878807|NCT00772603|16812273|P1|Overall Study|Other|2
4878808|NCT00772603|16812271|P3|Overall Study|Physician Decision|1
4878809|NCT00772603|16812272|P2|Overall Study|Physician Decision|0
4878810|NCT00772603|16812273|P1|Overall Study|Physician Decision|0
4878811|NCT00772603|16812271|P3|Overall Study|Lost to Follow-up|2
4878812|NCT00772603|16812272|P2|Overall Study|Lost to Follow-up|5
4878813|NCT00772603|16812273|P1|Overall Study|Lost to Follow-up|1
4878814|NCT00772603|16812271|P3|Overall Study|Protocol Violation|1
4878815|NCT00772603|16812272|P2|Overall Study|Protocol Violation|1
4878816|NCT00772603|16812273|P1|Overall Study|Protocol Violation|0
4878817|NCT00772603|16812271|P3|Overall Study|Subject Non-compliance|4
4878818|NCT00772603|16812272|P2|Overall Study|Subject Non-compliance|6
4878819|NCT00772603|16812273|P1|Overall Study|Subject Non-compliance|1
4878820|NCT00772603|16812271|P3|Overall Study|Adverse Event|10
4878821|NCT00772603|16812272|P2|Overall Study|Adverse Event|18
4878822|NCT00772603|16812273|P1|Overall Study|Adverse Event|37
4878823|NCT00772603|16812271|P3|Overall Study|Withdrawal by Subject|6
4878824|NCT00772603|16812272|P2|Overall Study|Withdrawal by Subject|10
4878825|NCT00772603|16812273|P1|Overall Study|Withdrawal by Subject|11
4878826|NCT00772577|16812312|P2|Overall Study|Protocol Deviation|2
4878827|NCT00772577|16812313|P1|Overall Study|Protocol Deviation|3
4878828|NCT00772577|16812312|P2|Overall Study|Administrative problems|1
4878829|NCT00772577|16812313|P1|Overall Study|Administrative problems|2
4878830|NCT00772577|16812312|P2|Overall Study|Lost to Follow-up|3
4878831|NCT00772577|16812313|P1|Overall Study|Lost to Follow-up|4
4878832|NCT00772577|16812312|P2|Overall Study|Patient withdrew consent|5
4878833|NCT00772577|16812313|P1|Overall Study|Patient withdrew consent|8
4878834|NCT00772577|16812312|P2|Overall Study|Unsatisfactory therapeutic effect|8
4878835|NCT00772577|16812313|P1|Overall Study|Unsatisfactory therapeutic effect|0
4878836|NCT00772577|16812312|P2|Overall Study|Abnormal laboratory values|1
4878837|NCT00772577|16812313|P1|Overall Study|Abnormal laboratory values|0
4878838|NCT00772577|16812312|P2|Overall Study|Adverse Event|3
4878839|NCT00772577|16812313|P1|Overall Study|Adverse Event|6
4878840|NCT00772538|16812329|P2|Overall Study|Other|7
4878841|NCT00772538|16812330|P1|Overall Study|Other|7
4878842|NCT00772538|16812329|P2|Overall Study|Lack of Efficacy|1
4878843|NCT00772538|16812330|P1|Overall Study|Lack of Efficacy|0
4878844|NCT00772538|16812329|P2|Overall Study|Withdrawal by Subject|8
4878845|NCT00772538|16812330|P1|Overall Study|Withdrawal by Subject|3
4878846|NCT00772538|16812329|P2|Overall Study|Lost to Follow-up|1
4878847|NCT00772538|16812330|P1|Overall Study|Lost to Follow-up|1
4878848|NCT00772538|16812329|P2|Overall Study|Protocol Violation|3
4878849|NCT00772538|16812330|P1|Overall Study|Protocol Violation|3
4878850|NCT00772538|16812329|P2|Overall Study|Adverse Event|6
4878851|NCT00772538|16812330|P1|Overall Study|Adverse Event|6
4878852|NCT00772447|16812402|P2|Overall Study|all others|2
4878853|NCT00772447|16812403|P1|Overall Study|all others|2
4878854|NCT00772447|16812402|P2|Overall Study|Protocol Violation|1
4878855|NCT00772447|16812403|P1|Overall Study|Protocol Violation|0
4878856|NCT00772447|16812402|P2|Overall Study|incorrect enrolment|4
4878857|NCT00772447|16812403|P1|Overall Study|incorrect enrolment|3
4878858|NCT00772447|16812402|P2|Overall Study|Lost to Follow-up|4
4878859|NCT00772447|16812403|P1|Overall Study|Lost to Follow-up|2
4878860|NCT00772447|16812402|P2|Overall Study|Physician Decision|8
4878861|NCT00772447|16812403|P1|Overall Study|Physician Decision|4
4878862|NCT00772447|16812402|P2|Overall Study|Withdrawal by Subject|5
4878863|NCT00772447|16812403|P1|Overall Study|Withdrawal by Subject|9
4878864|NCT00772382|16812431|P1|Overall Study|Other Reasons|10
4878865|NCT00772382|16812431|P1|Overall Study|Withdrawal by Subject|10
4878866|NCT00772382|16812431|P1|Overall Study|Protocol Violation|1
4878867|NCT00772382|16812431|P1|Overall Study|Physician Decision|5
4878868|NCT00772382|16812431|P1|Overall Study|Lack of Efficacy|4
4878869|NCT00772382|16812431|P1|Overall Study|Death|6
4878870|NCT00772382|16812431|P1|Overall Study|Adverse Event|19
4878871|NCT00772369|16812436|P1|Overall Study|Did not return record release form|1
4878872|NCT00772148|16812447|P2|Maintenance Phase (Week 52)|Administrative/other|2
4878873|NCT00772148|16812448|P1|Maintenance Phase (Week 52)|Administrative/other|1
4878874|NCT00772148|16812447|P2|Maintenance Phase (Week 52)|Withdrawal by Subject|1
4878875|NCT00772148|16812448|P1|Maintenance Phase (Week 52)|Withdrawal by Subject|0
4878876|NCT00772148|16812447|P2|Maintenance Phase (Week 52)|Adverse Event|0
4878877|NCT00772148|16812448|P1|Maintenance Phase (Week 52)|Adverse Event|1
4878878|NCT00772148|16812447|P2|Maintenance Phase (Week 52)|Death|2
4878879|NCT00772148|16812448|P1|Maintenance Phase (Week 52)|Death|2
4878880|NCT00772148|16812447|P2|Pharmacokinetic Phase (14 Days)|Administrative/other|0
4878881|NCT00772148|16812448|P1|Pharmacokinetic Phase (14 Days)|Administrative/other|2
4878882|NCT00772148|16812447|P2|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5
4878883|NCT00772148|16812448|P1|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3
4878884|NCT00772148|16812447|P2|Pharmacokinetic Phase (14 Days)|Adverse Event|1
4878885|NCT00772148|16812448|P1|Pharmacokinetic Phase (14 Days)|Adverse Event|3
4878886|NCT00772109|16812468|P4|Overall Study|Withdrawal by Subject|16
4878887|NCT00772109|16812469|P3|Overall Study|Withdrawal by Subject|6
4878888|NCT00772109|16812470|P2|Overall Study|Withdrawal by Subject|8
4878889|NCT00772109|16812471|P1|Overall Study|Withdrawal by Subject|8
4878890|NCT00772109|16812468|P4|Overall Study|Lost to Follow-up|9
4878891|NCT00772109|16812469|P3|Overall Study|Lost to Follow-up|5
4878892|NCT00772109|16812470|P2|Overall Study|Lost to Follow-up|3
4878893|NCT00772109|16812471|P1|Overall Study|Lost to Follow-up|7
4878894|NCT00772109|16812468|P4|Overall Study|Protocol Violation|6
4878895|NCT00772109|16812469|P3|Overall Study|Protocol Violation|7
4878896|NCT00772109|16812470|P2|Overall Study|Protocol Violation|8
4878897|NCT00772109|16812471|P1|Overall Study|Protocol Violation|5
4878898|NCT00772109|16812468|P4|Overall Study|Serious adverse event|0
4878899|NCT00772109|16812469|P3|Overall Study|Serious adverse event|1
4878900|NCT00772109|16812470|P2|Overall Study|Serious adverse event|0
4878901|NCT00772109|16812471|P1|Overall Study|Serious adverse event|1
4878902|NCT00772070|16812495|P2|Overall Study|Vaccination error-wrong dose/expired lot|0
4878903|NCT00772070|16812496|P1|Overall Study|Vaccination error-wrong dose/expired lot|2
4878904|NCT00772070|16812495|P2|Overall Study|Withdrawal by Subject|2
4878905|NCT00772070|16812496|P1|Overall Study|Withdrawal by Subject|0
4878906|NCT00772070|16812495|P2|Overall Study|Lost to Follow-up|8
4878907|NCT00772070|16812496|P1|Overall Study|Lost to Follow-up|0
4878908|NCT00772031|16812508|P2|Overall Study|Lost to Follow-up|33
4878909|NCT00772031|16812509|P1|Overall Study|Lost to Follow-up|20
4878910|NCT00772031|16812508|P2|Overall Study|Early termination of trial|10
4878911|NCT00772031|16812509|P1|Overall Study|Early termination of trial|12
4878912|NCT00772005|16812535|P4|Overall Study|Non-compliance with drug administration|1
4878913|NCT00772005|16812536|P3|Overall Study|Non-compliance with drug administration|1
4878914|NCT00772005|16812537|P2|Overall Study|Non-compliance with drug administration|0
4878915|NCT00772005|16812538|P1|Overall Study|Non-compliance with drug administration|3
4878916|NCT00772005|16812535|P4|Overall Study|Non-compliance with study procedures|1
4878917|NCT00772005|16812536|P3|Overall Study|Non-compliance with study procedures|0
4878918|NCT00772005|16812537|P2|Overall Study|Non-compliance with study procedures|1
4878919|NCT00772005|16812538|P1|Overall Study|Non-compliance with study procedures|1
4878920|NCT00772005|16812535|P4|Overall Study|Lost to Follow-up|3
4878921|NCT00772005|16812536|P3|Overall Study|Lost to Follow-up|6
4878922|NCT00772005|16812537|P2|Overall Study|Lost to Follow-up|3
4878923|NCT00772005|16812538|P1|Overall Study|Lost to Follow-up|7
4878924|NCT00772005|16812535|P4|Overall Study|Protocol Violation|6
4878925|NCT00772005|16812536|P3|Overall Study|Protocol Violation|1
4878926|NCT00772005|16812537|P2|Overall Study|Protocol Violation|4
4878927|NCT00772005|16812538|P1|Overall Study|Protocol Violation|2
4878928|NCT00772005|16812535|P4|Overall Study|Withdrawal by Subject|2
4878929|NCT00772005|16812536|P3|Overall Study|Withdrawal by Subject|10
4878930|NCT00772005|16812537|P2|Overall Study|Withdrawal by Subject|7
4878931|NCT00772005|16812538|P1|Overall Study|Withdrawal by Subject|3
4878932|NCT00772005|16812535|P4|Overall Study|Lack of Efficacy|0
4878933|NCT00772005|16812536|P3|Overall Study|Lack of Efficacy|0
4878934|NCT00772005|16812537|P2|Overall Study|Lack of Efficacy|1
4878935|NCT00772005|16812538|P1|Overall Study|Lack of Efficacy|0
4878936|NCT00772005|16812535|P4|Overall Study|Adverse Event|13
4878937|NCT00772005|16812536|P3|Overall Study|Adverse Event|10
4878938|NCT00772005|16812537|P2|Overall Study|Adverse Event|14
4878939|NCT00772005|16812538|P1|Overall Study|Adverse Event|9
4878940|NCT00771953|16813226|P2|Overall Study|Withdrawal by Subject|3
4878941|NCT00771953|16813227|P1|Overall Study|Withdrawal by Subject|0
4878942|NCT00771953|16813226|P2|Overall Study|Other complicating disease|0
4878943|NCT00771953|16813227|P1|Overall Study|Other complicating disease|1
4878944|NCT00771953|16813226|P2|Overall Study|Sponsor decision|0
4878945|NCT00771953|16813227|P1|Overall Study|Sponsor decision|1
4878946|NCT00771953|16813226|P2|Overall Study|Progression before active Tx|2
4878947|NCT00771953|16813227|P1|Overall Study|Progression before active Tx|1
4878948|NCT00771953|16813226|P2|Overall Study|Death|2
4878949|NCT00771953|16813227|P1|Overall Study|Death|2
4878950|NCT00771953|16813226|P2|Overall Study|Adverse Event|3
4878951|NCT00771953|16813227|P1|Overall Study|Adverse Event|5
4878952|NCT00771927|16813237|P2|Overall Study|Other reason|27
4878953|NCT00771927|16813238|P1|Overall Study|Other reason|23
4878954|NCT00771927|16813237|P2|Overall Study|Withdrawal by Subject|17
4878955|NCT00771927|16813238|P1|Overall Study|Withdrawal by Subject|16
4878956|NCT00771927|16813237|P2|Overall Study|Lost to Follow-up|46
4878957|NCT00771927|16813238|P1|Overall Study|Lost to Follow-up|46
4878958|NCT00771927|16813237|P2|Overall Study|Lack of Efficacy|42
4878959|NCT00771927|16813238|P1|Overall Study|Lack of Efficacy|70
4878960|NCT00771927|16813237|P2|Overall Study|Adverse Event|105
4878961|NCT00771927|16813238|P1|Overall Study|Adverse Event|100
4878962|NCT00771914|16813250|P4|Overall Study|Lost to Follow-up|1
4878963|NCT00771914|16813251|P3|Overall Study|Lost to Follow-up|0
4878964|NCT00771914|16813252|P2|Overall Study|Lost to Follow-up|0
4878965|NCT00771914|16813253|P1|Overall Study|Lost to Follow-up|0
4878966|NCT00771914|16813250|P4|Overall Study|Physician Decision|1
4878967|NCT00771914|16813251|P3|Overall Study|Physician Decision|0
4878968|NCT00771914|16813252|P2|Overall Study|Physician Decision|0
4878969|NCT00771914|16813253|P1|Overall Study|Physician Decision|0
4878970|NCT00771901|16813266|P3|Overall Study|Dissat w/# of study medication (40/day)|4
4878971|NCT00771901|16813267|P2|Overall Study|Dissat w/# of study medication (40/day)|0
4878972|NCT00771901|16813268|P1|Overall Study|Dissat w/# of study medication (40/day)|0
4878973|NCT00771849|16813315|P2|Overall Study|Not vaccinated|1
4878974|NCT00771849|16813316|P1|Overall Study|Not vaccinated|0
4878975|NCT00771849|16813315|P2|Overall Study|Withdrawal by Subject|1
4878976|NCT00771849|16813316|P1|Overall Study|Withdrawal by Subject|1
4878977|NCT00771849|16813315|P2|Overall Study|Lost to Follow-up|2
4878978|NCT00771849|16813316|P1|Overall Study|Lost to Follow-up|1
4878979|NCT00771810|16813327|P3|Overall Study|Other|1
4878980|NCT00771810|16813328|P2|Overall Study|Other|0
4878981|NCT00771810|16813329|P1|Overall Study|Other|0
4878982|NCT00771810|16813327|P3|Overall Study|Withdrawal by Subject|0
4878983|NCT00771810|16813328|P2|Overall Study|Withdrawal by Subject|2
4878984|NCT00771810|16813329|P1|Overall Study|Withdrawal by Subject|1
4878985|NCT00771810|16813327|P3|Overall Study|Protocol Violation|1
4878986|NCT00771810|16813328|P2|Overall Study|Protocol Violation|1
4878987|NCT00771810|16813329|P1|Overall Study|Protocol Violation|0
4878988|NCT00771810|16813327|P3|Overall Study|Physician Decision|2
4878989|NCT00771810|16813328|P2|Overall Study|Physician Decision|2
4878990|NCT00771810|16813329|P1|Overall Study|Physician Decision|1
4878991|NCT00771810|16813327|P3|Overall Study|Lost to Follow-up|1
4878992|NCT00771810|16813328|P2|Overall Study|Lost to Follow-up|0
4878993|NCT00771810|16813329|P1|Overall Study|Lost to Follow-up|0
4878994|NCT00771810|16813327|P3|Overall Study|Adverse Event|2
4878995|NCT00771810|16813328|P2|Overall Study|Adverse Event|0
4878996|NCT00771810|16813329|P1|Overall Study|Adverse Event|3
4878997|NCT00771758|16813367|P3|Overall Study|Other|0
4878998|NCT00771758|16813368|P2|Overall Study|Other|2
4878999|NCT00771758|16813369|P1|Overall Study|Other|3
4879000|NCT00771758|16813367|P3|Overall Study|Withdrawal by Subject|0
4879001|NCT00771758|16813368|P2|Overall Study|Withdrawal by Subject|0
4879002|NCT00771758|16813369|P1|Overall Study|Withdrawal by Subject|1
4879003|NCT00771758|16813367|P3|Overall Study|Protocol Violation|0
4879004|NCT00771758|16813368|P2|Overall Study|Protocol Violation|0
4879005|NCT00771758|16813369|P1|Overall Study|Protocol Violation|1
4879006|NCT00771758|16813367|P3|Overall Study|Lost to Follow-up|0
4879007|NCT00771758|16813368|P2|Overall Study|Lost to Follow-up|0
4879008|NCT00771758|16813369|P1|Overall Study|Lost to Follow-up|1
4879009|NCT00771758|16813367|P3|Overall Study|Lack of Efficacy|1
4879010|NCT00771758|16813368|P2|Overall Study|Lack of Efficacy|2
4879011|NCT00771758|16813369|P1|Overall Study|Lack of Efficacy|0
4879012|NCT00771758|16813367|P3|Overall Study|Adverse Event|1
4879013|NCT00771758|16813368|P2|Overall Study|Adverse Event|8
4879014|NCT00771758|16813369|P1|Overall Study|Adverse Event|2
4879015|NCT00771667|16813530|P10|Maintenance Phase|Other|3
4879016|NCT00771667|16813531|P9|Maintenance Phase|Other|3
4879017|NCT00771667|16813532|P8|Maintenance Phase|Other|2
4879018|NCT00771667|16813533|P7|Maintenance Phase|Other|2
4879019|NCT00771667|16813534|P6|Maintenance Phase|Other|1
4879020|NCT00771667|16813535|P5|Maintenance Phase|Other|0
4879021|NCT00771667|16813536|P4|Maintenance Phase|Other|0
4879022|NCT00771667|16813537|P3|Maintenance Phase|Other|0
4879023|NCT00771667|16813538|P2|Maintenance Phase|Other|0
4879024|NCT00771667|16813539|P1|Maintenance Phase|Other|0
4879025|NCT00771667|16813530|P10|Maintenance Phase|Lack of Efficacy|7
4879026|NCT00771667|16813531|P9|Maintenance Phase|Lack of Efficacy|11
4879027|NCT00771667|16813532|P8|Maintenance Phase|Lack of Efficacy|2
4879028|NCT00771667|16813533|P7|Maintenance Phase|Lack of Efficacy|3
4879029|NCT00771667|16813534|P6|Maintenance Phase|Lack of Efficacy|3
4879030|NCT00771667|16813535|P5|Maintenance Phase|Lack of Efficacy|1
4879031|NCT00771667|16813536|P4|Maintenance Phase|Lack of Efficacy|0
4879032|NCT00771667|16813537|P3|Maintenance Phase|Lack of Efficacy|0
4879033|NCT00771667|16813538|P2|Maintenance Phase|Lack of Efficacy|0
4879034|NCT00771667|16813539|P1|Maintenance Phase|Lack of Efficacy|0
4879035|NCT00771667|16813530|P10|Maintenance Phase|Adverse Event|7
4879036|NCT00771667|16813531|P9|Maintenance Phase|Adverse Event|8
4879037|NCT00771667|16813532|P8|Maintenance Phase|Adverse Event|1
4879038|NCT00771667|16813533|P7|Maintenance Phase|Adverse Event|5
4879039|NCT00771667|16813534|P6|Maintenance Phase|Adverse Event|3
4879040|NCT00771667|16813535|P5|Maintenance Phase|Adverse Event|1
4879041|NCT00771667|16813536|P4|Maintenance Phase|Adverse Event|0
4879042|NCT00771667|16813537|P3|Maintenance Phase|Adverse Event|0
4879043|NCT00771667|16813538|P2|Maintenance Phase|Adverse Event|0
4879044|NCT00771667|16813539|P1|Maintenance Phase|Adverse Event|0
4879045|NCT00771667|16813530|P10|Induction Phase|Other|0
4879046|NCT00771667|16813531|P9|Induction Phase|Other|0
4879047|NCT00771667|16813532|P8|Induction Phase|Other|0
4879048|NCT00771667|16813533|P7|Induction Phase|Other|0
4879049|NCT00771667|16813534|P6|Induction Phase|Other|0
4879050|NCT00771667|16813535|P5|Induction Phase|Other|0
4879051|NCT00771667|16813536|P4|Induction Phase|Other|4
4879052|NCT00771667|16813537|P3|Induction Phase|Other|3
4879053|NCT00771667|16813538|P2|Induction Phase|Other|6
4879054|NCT00771667|16813539|P1|Induction Phase|Other|4
4879055|NCT00771667|16813530|P10|Induction Phase|Lost to Follow-up|0
4879056|NCT00771667|16813531|P9|Induction Phase|Lost to Follow-up|0
4879057|NCT00771667|16813532|P8|Induction Phase|Lost to Follow-up|0
4879058|NCT00771667|16813533|P7|Induction Phase|Lost to Follow-up|0
4879059|NCT00771667|16813534|P6|Induction Phase|Lost to Follow-up|0
4879060|NCT00771667|16813535|P5|Induction Phase|Lost to Follow-up|0
4879061|NCT00771667|16813536|P4|Induction Phase|Lost to Follow-up|0
4879062|NCT00771667|16813537|P3|Induction Phase|Lost to Follow-up|1
4879063|NCT00771667|16813538|P2|Induction Phase|Lost to Follow-up|0
4879064|NCT00771667|16813539|P1|Induction Phase|Lost to Follow-up|1
4879065|NCT00771667|16813530|P10|Induction Phase|Lack of Efficacy|0
4879066|NCT00771667|16813531|P9|Induction Phase|Lack of Efficacy|0
4879067|NCT00771667|16813532|P8|Induction Phase|Lack of Efficacy|0
4879068|NCT00771667|16813533|P7|Induction Phase|Lack of Efficacy|0
4879069|NCT00771667|16813534|P6|Induction Phase|Lack of Efficacy|0
4879070|NCT00771667|16813535|P5|Induction Phase|Lack of Efficacy|0
4879071|NCT00771667|16813536|P4|Induction Phase|Lack of Efficacy|3
4879072|NCT00771667|16813537|P3|Induction Phase|Lack of Efficacy|4
4879073|NCT00771667|16813538|P2|Induction Phase|Lack of Efficacy|2
4879074|NCT00771667|16813539|P1|Induction Phase|Lack of Efficacy|9
4879075|NCT00771667|16813530|P10|Induction Phase|Adverse Event|0
4879076|NCT00771667|16813531|P9|Induction Phase|Adverse Event|0
4879077|NCT00771667|16813532|P8|Induction Phase|Adverse Event|0
4879078|NCT00771667|16813533|P7|Induction Phase|Adverse Event|0
4879079|NCT00771667|16813534|P6|Induction Phase|Adverse Event|0
4879080|NCT00771667|16813535|P5|Induction Phase|Adverse Event|0
4879081|NCT00771667|16813536|P4|Induction Phase|Adverse Event|1
4879082|NCT00771667|16813537|P3|Induction Phase|Adverse Event|4
4879083|NCT00771667|16813538|P2|Induction Phase|Adverse Event|2
4879084|NCT00771667|16813539|P1|Induction Phase|Adverse Event|5
4879085|NCT00771615|16813584|P9|Overall Study|Lost to Follow-up|0
4879086|NCT00771615|16813585|P8|Overall Study|Lost to Follow-up|0
4879087|NCT00771615|16813586|P7|Overall Study|Lost to Follow-up|1
4879088|NCT00771615|16813587|P6|Overall Study|Lost to Follow-up|1
4879089|NCT00771615|16813588|P5|Overall Study|Lost to Follow-up|0
4879090|NCT00771615|16813589|P4|Overall Study|Lost to Follow-up|1
4879091|NCT00771615|16813590|P3|Overall Study|Lost to Follow-up|1
4879092|NCT00771615|16813591|P2|Overall Study|Lost to Follow-up|1
4879093|NCT00771615|16813592|P1|Overall Study|Lost to Follow-up|1
4879094|NCT00771615|16813584|P9|Overall Study|Withdrawal by Subject|0
4879095|NCT00771615|16813585|P8|Overall Study|Withdrawal by Subject|1
4879096|NCT00771615|16813586|P7|Overall Study|Withdrawal by Subject|0
4879097|NCT00771615|16813587|P6|Overall Study|Withdrawal by Subject|0
4879098|NCT00771615|16813588|P5|Overall Study|Withdrawal by Subject|0
4879099|NCT00771615|16813589|P4|Overall Study|Withdrawal by Subject|0
4879100|NCT00771615|16813590|P3|Overall Study|Withdrawal by Subject|0
4879101|NCT00771615|16813591|P2|Overall Study|Withdrawal by Subject|1
4879102|NCT00771615|16813592|P1|Overall Study|Withdrawal by Subject|0
4879103|NCT00771472|16813853|P2|Overall Study|Protocol Violation|0
4879104|NCT00771472|16813854|P1|Overall Study|Protocol Violation|1
4879105|NCT00771472|16813853|P2|Overall Study|Progressive Disease|1
4879106|NCT00771472|16813854|P1|Overall Study|Progressive Disease|3
4879107|NCT00771472|16813853|P2|Overall Study|Physician Decision|3
4879108|NCT00771472|16813854|P1|Overall Study|Physician Decision|2
4879109|NCT00771316|16813874|P2|Overall Study|Discontinued due to early termination|0
4879110|NCT00771316|16813875|P1|Overall Study|Discontinued due to early termination|1
4879111|NCT00771316|16813874|P2|Overall Study|Patient withdrew consent|0
4879112|NCT00771316|16813875|P1|Overall Study|Patient withdrew consent|1
4879113|NCT00771316|16813874|P2|Overall Study|Adverse Event|1
4879114|NCT00771316|16813875|P1|Overall Study|Adverse Event|0
4879115|NCT00770991|16813927|P2|Overall Study|Pregnancy|0
4879116|NCT00770991|16813928|P1|Overall Study|Pregnancy|1
4879117|NCT00770991|16813927|P2|Overall Study|Adverse Event|5
4879118|NCT00770991|16813928|P1|Overall Study|Adverse Event|1
4879119|NCT00770991|16813927|P2|Overall Study|Withdrawal by Subject|0
4879120|NCT00770991|16813928|P1|Overall Study|Withdrawal by Subject|1
4879121|NCT00770991|16813927|P2|Overall Study|Physician Decision|0
4879122|NCT00770991|16813928|P1|Overall Study|Physician Decision|2
4879123|NCT00770965|16813944|P4|Excluded Set|Withdrawal by Subject|3
4879124|NCT00770965|16813945|P3|Excluded Set|Withdrawal by Subject|2
4879125|NCT00770965|16813946|P2|Excluded Set|Withdrawal by Subject|1
4879126|NCT00770965|16813947|P1|Excluded Set|Withdrawal by Subject|1
4879127|NCT00770965|16813944|P4|Excluded Set|Administrative problems|10
4879128|NCT00770965|16813945|P3|Excluded Set|Administrative problems|12
4879129|NCT00770965|16813946|P2|Excluded Set|Administrative problems|12
4879130|NCT00770965|16813947|P1|Excluded Set|Administrative problems|14
4879131|NCT00770965|16813944|P4|Safety Set|Protocol deviation|0
4879132|NCT00770965|16813945|P3|Safety Set|Protocol deviation|1
4879133|NCT00770965|16813946|P2|Safety Set|Protocol deviation|0
4879134|NCT00770965|16813947|P1|Safety Set|Protocol deviation|0
4879135|NCT00770965|16813944|P4|Safety Set|Withdrawal by Subject|1
4879136|NCT00770965|16813945|P3|Safety Set|Withdrawal by Subject|0
4879137|NCT00770965|16813946|P2|Safety Set|Withdrawal by Subject|0
4879138|NCT00770965|16813947|P1|Safety Set|Withdrawal by Subject|0
4879139|NCT00770913|16813968|P3|Overall Study|Incorrect drug was allocated|0
4879140|NCT00770913|16813969|P2|Overall Study|Incorrect drug was allocated|0
4879141|NCT00770913|16813970|P1|Overall Study|Incorrect drug was allocated|1
4879142|NCT00770913|16813968|P3|Overall Study|Protocol Violation|1
4879143|NCT00770913|16813969|P2|Overall Study|Protocol Violation|0
4879144|NCT00770913|16813970|P1|Overall Study|Protocol Violation|3
4879145|NCT00770913|16813968|P3|Overall Study|Physician Decision|1
4879146|NCT00770913|16813969|P2|Overall Study|Physician Decision|1
4879147|NCT00770913|16813970|P1|Overall Study|Physician Decision|0
4879148|NCT00770913|16813968|P3|Overall Study|Refusal to continue participation|5
4879149|NCT00770913|16813969|P2|Overall Study|Refusal to continue participation|4
4879150|NCT00770913|16813970|P1|Overall Study|Refusal to continue participation|6
4879151|NCT00770913|16813968|P3|Overall Study|Adverse Event|6
4879152|NCT00770913|16813969|P2|Overall Study|Adverse Event|3
4879153|NCT00770913|16813970|P1|Overall Study|Adverse Event|1
4879154|NCT00770809|16814003|P3|Overall Study|Other Medical Reasons|3
4879155|NCT00770809|16814004|P2|Overall Study|Other Medical Reasons|4
4879156|NCT00770809|16814005|P1|Overall Study|Other Medical Reasons|2
4879157|NCT00770809|16814003|P3|Overall Study|Complicating illness|1
4879158|NCT00770809|16814004|P2|Overall Study|Complicating illness|0
4879159|NCT00770809|16814005|P1|Overall Study|Complicating illness|0
4879160|NCT00770809|16814003|P3|Overall Study|Progression|0
4879161|NCT00770809|16814004|P2|Overall Study|Progression|2
4879162|NCT00770809|16814005|P1|Overall Study|Progression|2
4879163|NCT00770809|16814003|P3|Overall Study|Withdrawal by Subject|7
4879164|NCT00770809|16814004|P2|Overall Study|Withdrawal by Subject|3
4879165|NCT00770809|16814005|P1|Overall Study|Withdrawal by Subject|3
4879166|NCT00770809|16814003|P3|Overall Study|Death|0
4879167|NCT00770809|16814004|P2|Overall Study|Death|0
4879168|NCT00770809|16814005|P1|Overall Study|Death|1
4879169|NCT00770809|16814003|P3|Overall Study|Adverse Event|12
4879170|NCT00770809|16814004|P2|Overall Study|Adverse Event|1
4879171|NCT00770809|16814005|P1|Overall Study|Adverse Event|9
4879172|NCT00770770|16814015|P2|Overall Study|Study Terminated|0
4879173|NCT00770770|16814016|P1|Overall Study|Study Terminated|8
4879174|NCT00770770|16814015|P2|Overall Study|Death|1
4879175|NCT00770770|16814016|P1|Overall Study|Death|0
4879176|NCT00770770|16814015|P2|Overall Study|Withdrawal by Subject|0
4879177|NCT00770770|16814016|P1|Overall Study|Withdrawal by Subject|1
4879178|NCT00770770|16814015|P2|Overall Study|Lost to Follow-up|0
4879179|NCT00770770|16814016|P1|Overall Study|Lost to Follow-up|1
4879180|NCT00770692|16814034|P4|Overall Study|Investigator judgment|1
4879181|NCT00770692|16814035|P3|Overall Study|Investigator judgment|1
4879182|NCT00770692|16814036|P2|Overall Study|Investigator judgment|0
4879183|NCT00770692|16814037|P1|Overall Study|Investigator judgment|2
4879184|NCT00770692|16814034|P4|Overall Study|Adverse Event|4
4879185|NCT00770692|16814035|P3|Overall Study|Adverse Event|4
4879186|NCT00770692|16814036|P2|Overall Study|Adverse Event|0
4879187|NCT00770692|16814037|P1|Overall Study|Adverse Event|3
4879188|NCT00770692|16814034|P4|Overall Study|Withdrawal by Subject|6
4879189|NCT00770692|16814035|P3|Overall Study|Withdrawal by Subject|9
4879190|NCT00770692|16814036|P2|Overall Study|Withdrawal by Subject|9
4879191|NCT00770692|16814037|P1|Overall Study|Withdrawal by Subject|7
4879192|NCT00770679|16814063|P1|Overall Study|Follow-up LDL measurement not collected|3
4879193|NCT00770679|16814063|P1|Overall Study|Lost to Follow-up|3
4879194|NCT00770653|16814071|P2|Overall Study|Physician Decision|0
4879195|NCT00770653|16814072|P1|Overall Study|Physician Decision|1
4879196|NCT00770653|16814071|P2|Overall Study|Lost to Follow-up|2
4879197|NCT00770653|16814072|P1|Overall Study|Lost to Follow-up|1
4879198|NCT00770653|16814071|P2|Overall Study|> Three Moderate Hypoglycemic Episodes|2
4879199|NCT00770653|16814072|P1|Overall Study|> Three Moderate Hypoglycemic Episodes|0
4879200|NCT00770653|16814071|P2|Overall Study|Fasting Glucose > 240 mg/dL|1
4879201|NCT00770653|16814072|P1|Overall Study|Fasting Glucose > 240 mg/dL|2
4879202|NCT00770653|16814071|P2|Overall Study|Worsening of Glycosolated Hemoglobin|2
4879203|NCT00770653|16814072|P1|Overall Study|Worsening of Glycosolated Hemoglobin|2
4879204|NCT00770653|16814071|P2|Overall Study|Lack of Compliance|4
4879205|NCT00770653|16814072|P1|Overall Study|Lack of Compliance|1
4879206|NCT00770653|16814071|P2|Overall Study|Withdrawal by Subject|7
4879207|NCT00770653|16814072|P1|Overall Study|Withdrawal by Subject|4
4879208|NCT00770653|16814071|P2|Overall Study|Protocol Violation|6
4879209|NCT00770653|16814072|P1|Overall Study|Protocol Violation|8
4879210|NCT00770653|16814071|P2|Overall Study|Adverse Event|5
4879211|NCT00770653|16814072|P1|Overall Study|Adverse Event|13
4879212|NCT00770588|16814142|P2|Overall Study|Withdrawal by Subject|1
4879213|NCT00770588|16814143|P1|Overall Study|Withdrawal by Subject|1
4879214|NCT00770588|16814142|P2|Overall Study|Lost to Follow-up|1
4879215|NCT00770588|16814143|P1|Overall Study|Lost to Follow-up|1
4879216|NCT00770588|16814142|P2|Overall Study|Death caused by progression of disease|91
4879217|NCT00770588|16814143|P1|Overall Study|Death caused by progression of disease|70
4879218|NCT00770588|16814142|P2|Overall Study|Adverse Event|2
4879219|NCT00770588|16814143|P1|Overall Study|Adverse Event|9
4879220|NCT00770562|16814159|P2|Overall Study|Did not take treatment|1
4879221|NCT00770562|16814160|P1|Overall Study|Did not take treatment|1
4879222|NCT00770510|16814171|P1|Overall Study|Withdrawal by Subject|2
4879223|NCT00770510|16814171|P1|Overall Study|Pregnancy|1
4879224|NCT00770510|16814171|P1|Overall Study|Lost to Follow-up|2
4879225|NCT00770484|16814210|P2|Overall Study|Withdrawal by Subject|0
4879226|NCT00770484|16814211|P1|Overall Study|Withdrawal by Subject|1
4879227|NCT00770432|16814219|P2|Overall Study|Non-compliance|1
4879228|NCT00770432|16814220|P1|Overall Study|Non-compliance|0
4879229|NCT00770432|16814219|P2|Overall Study|Other|6
4879230|NCT00770432|16814220|P1|Overall Study|Other|4
4879231|NCT00770367|16814228|P2|Second Intervention|Lost to Follow-up|0
4879232|NCT00770367|16814229|P1|Second Intervention|Lost to Follow-up|2
4879233|NCT00770367|16814228|P2|Washout Period of 4 Weeks|Withdrawal by Subject|1
4879234|NCT00770367|16814229|P1|Washout Period of 4 Weeks|Withdrawal by Subject|0
4879235|NCT00770367|16814228|P2|First Intervention|Withdrawal by Subject|2
4879236|NCT00770367|16814229|P1|First Intervention|Withdrawal by Subject|0
4879237|NCT00770341|16814240|P3|Overall Study|Not treated|0
4879238|NCT00770341|16814241|P2|Overall Study|Not treated|0
4879239|NCT00770341|16814242|P1|Overall Study|Not treated|1
4879240|NCT00770341|16814240|P3|Overall Study|Other|0
4879241|NCT00770341|16814241|P2|Overall Study|Other|0
4879242|NCT00770341|16814242|P1|Overall Study|Other|1
4879243|NCT00770341|16814240|P3|Overall Study|Lack of Efficacy|1
4879244|NCT00770341|16814241|P2|Overall Study|Lack of Efficacy|0
4879245|NCT00770341|16814242|P1|Overall Study|Lack of Efficacy|3
4879246|NCT00770341|16814240|P3|Overall Study|Laboratory adverse event|0
4879247|NCT00770341|16814241|P2|Overall Study|Laboratory adverse event|3
4879248|NCT00770341|16814242|P1|Overall Study|Laboratory adverse event|3
4879249|NCT00770341|16814240|P3|Overall Study|Clinical Adverse Event|2
4879250|NCT00770341|16814241|P2|Overall Study|Clinical Adverse Event|1
4879251|NCT00770341|16814242|P1|Overall Study|Clinical Adverse Event|3
4879252|NCT00770341|16814240|P3|Overall Study|Withdrawal by Subject|0
4879253|NCT00770341|16814241|P2|Overall Study|Withdrawal by Subject|1
4879254|NCT00770341|16814242|P1|Overall Study|Withdrawal by Subject|0
4879255|NCT00770341|16814240|P3|Overall Study|Did not meet eligibility criteria|0
4879256|NCT00770341|16814241|P2|Overall Study|Did not meet eligibility criteria|0
4879257|NCT00770341|16814242|P1|Overall Study|Did not meet eligibility criteria|1
4879258|NCT00770328|16814268|P2|Overall Study|Lost to Follow-up|2
4879259|NCT00770328|16814269|P1|Overall Study|Lost to Follow-up|2
4879260|NCT00770328|16814268|P2|Overall Study|Adverse Event|2
4879261|NCT00770328|16814269|P1|Overall Study|Adverse Event|11
4879262|NCT00770315|16814285|P4|Overall Study|Noncompliance with Protocol|9
4879263|NCT00770315|16814286|P3|Overall Study|Noncompliance with Protocol|7
4879264|NCT00770315|16814287|P2|Overall Study|Noncompliance with Protocol|4
4879265|NCT00770315|16814288|P1|Overall Study|Noncompliance with Protocol|7
4879266|NCT00770315|16814285|P4|Overall Study|Withdrawal by Subject|20
4879267|NCT00770315|16814286|P3|Overall Study|Withdrawal by Subject|24
4879268|NCT00770315|16814287|P2|Overall Study|Withdrawal by Subject|17
4879269|NCT00770315|16814288|P1|Overall Study|Withdrawal by Subject|13
4879270|NCT00770315|16814285|P4|Overall Study|Lost to Follow-up|3
4879271|NCT00770315|16814286|P3|Overall Study|Lost to Follow-up|10
4879272|NCT00770315|16814287|P2|Overall Study|Lost to Follow-up|5
4879273|NCT00770315|16814288|P1|Overall Study|Lost to Follow-up|9
4879274|NCT00770315|16814285|P4|Overall Study|Adverse Event|6
4879275|NCT00770315|16814286|P3|Overall Study|Adverse Event|16
4879276|NCT00770315|16814287|P2|Overall Study|Adverse Event|17
4879277|NCT00770315|16814288|P1|Overall Study|Adverse Event|11
4879278|NCT00770289|16814314|P1|Overall Study|Other|6
4879279|NCT00770224|16814323|P2|Step 2: Maintenance|Ineligible|2
4879280|NCT00770224|16814324|P1|Step 2: Maintenance|Ineligible|0
4879281|NCT00770224|16814323|P2|Step 2: Maintenance|Other reason not protocol specified|7
4879282|NCT00770224|16814324|P1|Step 2: Maintenance|Other reason not protocol specified|0
4879283|NCT00770224|16814323|P2|Step 2: Maintenance|Death|2
4879284|NCT00770224|16814324|P1|Step 2: Maintenance|Death|0
4879285|NCT00770224|16814323|P2|Step 2: Maintenance|Progression/relapse|1
4879286|NCT00770224|16814324|P1|Step 2: Maintenance|Progression/relapse|0
4879287|NCT00770224|16814323|P2|Step 2: Maintenance|Refusal unrelated to adverse event|8
4879288|NCT00770224|16814324|P1|Step 2: Maintenance|Refusal unrelated to adverse event|0
4879289|NCT00770224|16814323|P2|Step 2: Maintenance|Adverse Event|10
4879290|NCT00770224|16814324|P1|Step 2: Maintenance|Adverse Event|0
4879291|NCT00770224|16814323|P2|Step 1: Induction|No protocol treatment given|0
4879292|NCT00770224|16814324|P1|Step 1: Induction|No protocol treatment given|1
4879293|NCT00770224|16814323|P2|Step 1: Induction|Ineligible|0
4879294|NCT00770224|16814324|P1|Step 1: Induction|Ineligible|2
4879295|NCT00770224|16814323|P2|Step 1: Induction|Other reason not protocol specified|0
4879296|NCT00770224|16814324|P1|Step 1: Induction|Other reason not protocol specified|2
4879297|NCT00770224|16814323|P2|Step 1: Induction|Refusal unrelated to adverse event|0
4879298|NCT00770224|16814324|P1|Step 1: Induction|Refusal unrelated to adverse event|6
4879299|NCT00770224|16814323|P2|Step 1: Induction|Adverse Event|0
4879300|NCT00770224|16814324|P1|Step 1: Induction|Adverse Event|3
4879301|NCT00770211|16814336|P2|Overall Study|Withdrawal by Subject|2
4879302|NCT00770211|16814337|P1|Overall Study|Withdrawal by Subject|0
4879303|NCT00770211|16814336|P2|Overall Study|Lost to Follow-up|0
4879304|NCT00770211|16814337|P1|Overall Study|Lost to Follow-up|1
4879305|NCT00770146|16814353|P2|Follow-up Period|Other|5
4879306|NCT00770146|16814354|P1|Follow-up Period|Other|4
4879307|NCT00770146|16814353|P2|Follow-up Period|Adverse Event|2
4879308|NCT00770146|16814354|P1|Follow-up Period|Adverse Event|0
4879309|NCT00770146|16814353|P2|Follow-up Period|Withdrawal by Subject|13
4879310|NCT00770146|16814354|P1|Follow-up Period|Withdrawal by Subject|7
4879311|NCT00770146|16814353|P2|Treatment Period|Protocol non-compliance|1
4879312|NCT00770146|16814354|P1|Treatment Period|Protocol non-compliance|0
4879313|NCT00770146|16814353|P2|Treatment Period|Other|5
4879314|NCT00770146|16814354|P1|Treatment Period|Other|1
4879315|NCT00770146|16814353|P2|Treatment Period|Adverse Event|26
4879316|NCT00770146|16814354|P1|Treatment Period|Adverse Event|2
4879317|NCT00770146|16814353|P2|Treatment Period|Withdrawal by Subject|13
4879318|NCT00770146|16814354|P1|Treatment Period|Withdrawal by Subject|6
4879319|NCT00770120|16814443|P1|Overall Study|Reason under Review|1
4879320|NCT00770120|16814443|P1|Overall Study|Never Received Treatment/Not Analyzable|1
4879321|NCT00770120|16814443|P1|Overall Study|Ineligible|1
4879322|NCT00770120|16814443|P1|Overall Study|Withdrawal by Subject|2
4879323|NCT00770120|16814443|P1|Overall Study|Death|3
4879324|NCT00770120|16814443|P1|Overall Study|Not Protocol Specified|11
4879325|NCT00770120|16814443|P1|Overall Study|Adverse Event|11
4879326|NCT00770120|16814443|P1|Overall Study|Progression|31
4879327|NCT00770029|16814452|P2|Overall Study|Adverse Event|0
4879328|NCT00770029|16814453|P1|Overall Study|Adverse Event|1
4879329|NCT00770029|16814452|P2|Overall Study|Withdrawal by Subject|3
4879330|NCT00770029|16814453|P1|Overall Study|Withdrawal by Subject|3
4879331|NCT00770029|16814452|P2|Overall Study|Lost to Follow-up|0
4879332|NCT00770029|16814453|P1|Overall Study|Lost to Follow-up|2
4879333|NCT00769860|16814514|P2|Overall Study|Withdrawal by Subject|0
4879334|NCT00769860|16814515|P1|Overall Study|Withdrawal by Subject|2
4879335|NCT00769704|16814553|P2|Overall Study|Other|2
4879336|NCT00769704|16814554|P1|Overall Study|Other|1
4879337|NCT00769704|16814553|P2|Overall Study|Withdrawal by Subject|5
4879338|NCT00769704|16814554|P1|Overall Study|Withdrawal by Subject|12
4879339|NCT00769704|16814553|P2|Overall Study|Death|190
4879340|NCT00769704|16814554|P1|Overall Study|Death|95
4879341|NCT00769704|16814553|P2|Overall Study|Lost to Follow-up|2
4879342|NCT00769704|16814554|P1|Overall Study|Lost to Follow-up|3
4879343|NCT00769561|16814604|P2|Overall Study|Lost to Follow-up|3
4879344|NCT00769561|16814605|P1|Overall Study|Lost to Follow-up|1
4879345|NCT00769561|16814604|P2|Overall Study|Withdrawal by Subject|2
4879346|NCT00769561|16814605|P1|Overall Study|Withdrawal by Subject|2
4879347|NCT00769483|16814631|P6|Overall Study|Withdrawal by Subject|0
4879348|NCT00769483|16814632|P5|Overall Study|Withdrawal by Subject|1
4879349|NCT00769483|16814633|P4|Overall Study|Withdrawal by Subject|0
4879350|NCT00769483|16814634|P3|Overall Study|Withdrawal by Subject|0
4879351|NCT00769483|16814635|P2|Overall Study|Withdrawal by Subject|1
4879352|NCT00769483|16814636|P1|Overall Study|Withdrawal by Subject|0
4879353|NCT00769184|16814708|P2|No Treatment (6 Weeks)|Adverse Event|1
4879354|NCT00769184|16814709|P1|No Treatment (6 Weeks)|Adverse Event|1
4879355|NCT00769184|16814708|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1
4879356|NCT00769184|16814709|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0
4879357|NCT00769184|16814708|P2|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0
4879358|NCT00769184|16814709|P1|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1
4879359|NCT00769132|16814717|P4|Period 4|Withdrawal by Subject|0
4879360|NCT00769132|16814718|P3|Period 4|Withdrawal by Subject|0
4879361|NCT00769132|16814719|P2|Period 4|Withdrawal by Subject|1
4879362|NCT00769132|16814720|P1|Period 4|Withdrawal by Subject|0
4879363|NCT00769132|16814717|P4|Period 3|Withdrawal by Subject|0
4879364|NCT00769132|16814718|P3|Period 3|Withdrawal by Subject|0
4879365|NCT00769132|16814719|P2|Period 3|Withdrawal by Subject|0
4879366|NCT00769132|16814720|P1|Period 3|Withdrawal by Subject|1
4879367|NCT00769132|16814717|P4|Period 2|Withdrawal by Subject|1
4879368|NCT00769132|16814718|P3|Period 2|Withdrawal by Subject|0
4879369|NCT00769132|16814719|P2|Period 2|Withdrawal by Subject|0
4879370|NCT00769132|16814720|P1|Period 2|Withdrawal by Subject|0
4879371|NCT00769132|16814717|P4|Period 1|Adverse Event|1
4879372|NCT00769132|16814718|P3|Period 1|Adverse Event|0
4879373|NCT00769132|16814719|P2|Period 1|Adverse Event|0
4879374|NCT00769132|16814720|P1|Period 1|Adverse Event|1
4879375|NCT00769119|16814736|P2|Overall Study|Disallowed medication|0
4879376|NCT00769119|16814737|P1|Overall Study|Disallowed medication|1
4879377|NCT00769119|16814736|P2|Overall Study|Adverse Event|1
4879378|NCT00769119|16814737|P1|Overall Study|Adverse Event|1
4879379|NCT00769119|16814736|P2|Overall Study|Voluntary discontinuation|2
4879380|NCT00769119|16814737|P1|Overall Study|Voluntary discontinuation|0
4879381|NCT00769067|16814783|P2|Overall Study|Withdrawal by Subject|1
4879382|NCT00769067|16814784|P1|Overall Study|Withdrawal by Subject|0
4879383|NCT00769067|16814783|P2|Overall Study|Other|3
4879384|NCT00769067|16814784|P1|Overall Study|Other|1
4879385|NCT00769067|16814783|P2|Overall Study|Study terminated by sponsor|3
4879386|NCT00769067|16814784|P1|Overall Study|Study terminated by sponsor|1
4879387|NCT00769067|16814783|P2|Overall Study|Lost to Follow-up|1
4879388|NCT00769067|16814784|P1|Overall Study|Lost to Follow-up|3
4879389|NCT00769067|16814783|P2|Overall Study|Death|86
4879390|NCT00769067|16814784|P1|Overall Study|Death|89
4879391|NCT00769002|16814834|P2|Overall Study|Study was not completed, no data|9
4879392|NCT00769002|16814835|P1|Overall Study|Study was not completed, no data|9
4879393|NCT00768989|16814842|P2|On or After Week 36|Sponsor Termination|26
4879394|NCT00768989|16814843|P1|On or After Week 36|Sponsor Termination|45
4879395|NCT00768989|16814842|P2|On or After Week 36|Did not attend termination visit|0
4879396|NCT00768989|16814843|P1|On or After Week 36|Did not attend termination visit|2
4879397|NCT00768989|16814842|P2|On or After Week 36|Protocol Violation|0
4879398|NCT00768989|16814843|P1|On or After Week 36|Protocol Violation|1
4879399|NCT00768989|16814842|P2|On or After Week 36|Poor Compliance|0
4879400|NCT00768989|16814843|P1|On or After Week 36|Poor Compliance|1
4879401|NCT00768989|16814842|P2|On or After Week 36|Lost to Follow-up|0
4879402|NCT00768989|16814843|P1|On or After Week 36|Lost to Follow-up|1
4879403|NCT00768989|16814842|P2|On or After Week 36|Adverse Event|1
4879404|NCT00768989|16814843|P1|On or After Week 36|Adverse Event|0
4879405|NCT00768989|16814842|P2|On or After Week 36|Lack of Efficacy|0
4879406|NCT00768989|16814843|P1|On or After Week 36|Lack of Efficacy|1
4879407|NCT00768989|16814842|P2|Week 24 to Prior to Week 36|Withdrawal by Subject|0
4879408|NCT00768989|16814843|P1|Week 24 to Prior to Week 36|Withdrawal by Subject|1
4879409|NCT00768989|16814842|P2|Week 24 to Prior to Week 36|Lack of Efficacy|0
4879410|NCT00768989|16814843|P1|Week 24 to Prior to Week 36|Lack of Efficacy|6
4879411|NCT00768989|16814842|P2|Week 24 to Prior to Week 36|Adverse Event|0
4879412|NCT00768989|16814843|P1|Week 24 to Prior to Week 36|Adverse Event|1
4879413|NCT00768989|16814842|P2|Prior to Week 24|Protocol Violation|2
4879414|NCT00768989|16814843|P1|Prior to Week 24|Protocol Violation|0
4879415|NCT00768989|16814842|P2|Prior to Week 24|Lost to Follow-up|1
4879416|NCT00768989|16814843|P1|Prior to Week 24|Lost to Follow-up|0
4879417|NCT00768989|16814842|P2|Prior to Week 24|Adverse Event|0
4879418|NCT00768989|16814843|P1|Prior to Week 24|Adverse Event|3
4879419|NCT00768989|16814842|P2|Prior to Week 24|Withdrawal by Subject|0
4879420|NCT00768989|16814843|P1|Prior to Week 24|Withdrawal by Subject|1
4879421|NCT00768898|16814891|P1|Overall Study|Headache|1
4879422|NCT00768898|16814891|P1|Overall Study|Unrelated injury|1
4879423|NCT00768755|16814915|P4|Phase 2|Randomized but not treated|2
4879424|NCT00768755|16814916|P3|Phase 2|Randomized but not treated|0
4879425|NCT00768755|16814917|P2|Phase 2|Randomized but not treated|0
4879426|NCT00768755|16814918|P1|Phase 2|Randomized but not treated|0
4879427|NCT00768755|16814915|P4|Phase 2|Study Terminated by Sponsor|14
4879428|NCT00768755|16814916|P3|Phase 2|Study Terminated by Sponsor|7
4879429|NCT00768755|16814917|P2|Phase 2|Study Terminated by Sponsor|13
4879430|NCT00768755|16814918|P1|Phase 2|Study Terminated by Sponsor|0
4879431|NCT00768755|16814915|P4|Phase 2|Other|4
4879432|NCT00768755|16814916|P3|Phase 2|Other|2
4879433|NCT00768755|16814917|P2|Phase 2|Other|1
4879434|NCT00768755|16814918|P1|Phase 2|Other|0
4879435|NCT00768755|16814915|P4|Phase 2|Withdrawal by Subject|1
4879436|NCT00768755|16814916|P3|Phase 2|Withdrawal by Subject|0
4879437|NCT00768755|16814917|P2|Phase 2|Withdrawal by Subject|1
4879438|NCT00768755|16814918|P1|Phase 2|Withdrawal by Subject|0
4879439|NCT00768755|16814915|P4|Phase 2|Lost to Follow-up|4
4879440|NCT00768755|16814916|P3|Phase 2|Lost to Follow-up|1
4879441|NCT00768755|16814917|P2|Phase 2|Lost to Follow-up|1
4879442|NCT00768755|16814918|P1|Phase 2|Lost to Follow-up|0
4879443|NCT00768755|16814915|P4|Phase 2|Protocol Violation|1
4879444|NCT00768755|16814916|P3|Phase 2|Protocol Violation|0
4879445|NCT00768755|16814917|P2|Phase 2|Protocol Violation|2
4879446|NCT00768755|16814918|P1|Phase 2|Protocol Violation|0
4879447|NCT00768755|16814915|P4|Phase 2|Death|31
4879448|NCT00768755|16814916|P3|Phase 2|Death|48
4879449|NCT00768755|16814917|P2|Phase 2|Death|37
4879450|NCT00768755|16814918|P1|Phase 2|Death|0
4879451|NCT00768755|16814915|P4|Phase 1|Other|0
4879452|NCT00768755|16814916|P3|Phase 1|Other|0
4879453|NCT00768755|16814917|P2|Phase 1|Other|0
4879454|NCT00768755|16814918|P1|Phase 1|Other|4
4879455|NCT00768755|16814915|P4|Phase 1|Death|0
4879456|NCT00768755|16814916|P3|Phase 1|Death|0
4879457|NCT00768755|16814917|P2|Phase 1|Death|0
4879458|NCT00768755|16814918|P1|Phase 1|Death|6
4879459|NCT00768651|16814966|P1|Overall Study|Withdrawal by Subject|1
4879460|NCT00768560|16815005|P6|Intervention Set 1|Adverse Event|0
4879461|NCT00768560|16815006|P5|Intervention Set 1|Adverse Event|0
4879462|NCT00768560|16815007|P4|Intervention Set 1|Adverse Event|0
4879463|NCT00768560|16815008|P3|Intervention Set 1|Adverse Event|0
4879464|NCT00768560|16815009|P2|Intervention Set 1|Adverse Event|1
4879465|NCT00768560|16815010|P1|Intervention Set 1|Adverse Event|0
4879466|NCT00768469|16815047|P2|Overall Study|Withdrawal by Subject|1
4879467|NCT00768469|16815048|P1|Overall Study|Withdrawal by Subject|0
4879468|NCT00768469|16815047|P2|Overall Study|Disease Progression|4
4879469|NCT00768469|16815048|P1|Overall Study|Disease Progression|3
4879470|NCT00768469|16815047|P2|Overall Study|Adverse Event|2
4879471|NCT00768469|16815048|P1|Overall Study|Adverse Event|0
4879472|NCT00768430|16815063|P2|7 Day Endpoint|Withdrawal by Subject|3
4879473|NCT00768430|16815064|P1|7 Day Endpoint|Withdrawal by Subject|2
4879474|NCT00768300|16815072|P2|Overall Study|Missing data|0
4879475|NCT00768300|16815073|P1|Overall Study|Missing data|1
4879476|NCT00768300|16815072|P2|Overall Study|Treated but never dosed with Study drug|0
4879477|NCT00768300|16815073|P1|Overall Study|Treated but never dosed with Study drug|1
4879478|NCT00768300|16815072|P2|Overall Study|Began prohibited concomitant medication|1
4879479|NCT00768300|16815073|P1|Overall Study|Began prohibited concomitant medication|0
4879480|NCT00768300|16815072|P2|Overall Study|Lost to Follow-up|1
4879481|NCT00768300|16815073|P1|Overall Study|Lost to Follow-up|0
4879482|NCT00768300|16815072|P2|Overall Study|Received lung transplant|1
4879483|NCT00768300|16815073|P1|Overall Study|Received lung transplant|1
4879484|NCT00768300|16815072|P2|Overall Study|Screen failure following randomization|0
4879485|NCT00768300|16815073|P1|Overall Study|Screen failure following randomization|1
4879486|NCT00768300|16815072|P2|Overall Study|Subject moved to pursue lung transplant|1
4879487|NCT00768300|16815073|P1|Overall Study|Subject moved to pursue lung transplant|1
4879488|NCT00768300|16815072|P2|Overall Study|Death|5
4879489|NCT00768300|16815073|P1|Overall Study|Death|21
4879490|NCT00768300|16815072|P2|Overall Study|Study discontinued by Sponsor|140
4879491|NCT00768300|16815073|P1|Overall Study|Study discontinued by Sponsor|271
4879492|NCT00768300|16815072|P2|Overall Study|Physician Decision|3
4879493|NCT00768300|16815073|P1|Overall Study|Physician Decision|2
4879494|NCT00768300|16815072|P2|Overall Study|Withdrawal by Subject|7
4879495|NCT00768300|16815073|P1|Overall Study|Withdrawal by Subject|13
4879496|NCT00768300|16815072|P2|Overall Study|Protocol Violation|1
4879497|NCT00768300|16815073|P1|Overall Study|Protocol Violation|6
4879498|NCT00768300|16815072|P2|Overall Study|Adverse Event|2
4879499|NCT00768300|16815073|P1|Overall Study|Adverse Event|10
4879500|NCT00768300|16815072|P2|Overall Study|Randomized but not treated|1
4879501|NCT00768300|16815073|P1|Overall Study|Randomized but not treated|1
4879502|NCT00768248|16815157|P2|Overall Study|Research coordinator didn't collect data|1
4879503|NCT00768248|16815158|P1|Overall Study|Research coordinator didn't collect data|1
4879504|NCT00768222|16815174|P2|Overall Study|Protocol Violation|2
4879505|NCT00768222|16815175|P1|Overall Study|Protocol Violation|0
4879506|NCT00768222|16815174|P2|Overall Study|Withdrawal by Subject|1
4879507|NCT00768222|16815175|P1|Overall Study|Withdrawal by Subject|3
4879508|NCT00768222|16815174|P2|Overall Study|Lost to Follow-up|1
4879509|NCT00768222|16815175|P1|Overall Study|Lost to Follow-up|1
4879510|NCT00768144|16815197|P1|Overall Study|Pt Withdrew Consent|1
4879511|NCT00768144|16815197|P1|Overall Study|Patient or MD Decision to End Treatment|1
4879512|NCT00768144|16815197|P1|Overall Study|Progressive Disease|21
4879513|NCT00768144|16815197|P1|Overall Study|Adverse Event|13
4879514|NCT00768079|16815210|P3|Overall Study|Participant incarcerated|0
4879515|NCT00768079|16815211|P2|Overall Study|Participant incarcerated|1
4879516|NCT00768079|16815212|P1|Overall Study|Participant incarcerated|0
4879517|NCT00768079|16815210|P3|Overall Study|Lost to Follow-up|4
4879518|NCT00768079|16815211|P2|Overall Study|Lost to Follow-up|0
4879519|NCT00768079|16815212|P1|Overall Study|Lost to Follow-up|2
4879520|NCT00768066|16815269|P3|Overall Study|Did not receive study product injection.|0
4879521|NCT00768066|16815270|P2|Overall Study|Did not receive study product injection.|3
4879522|NCT00768066|16815271|P1|Overall Study|Did not receive study product injection.|3
4879523|NCT00768053|16815303|P1|Overall Study|Lost to Follow-up|1
4879524|NCT00768053|16815303|P1|Overall Study|Adverse Event|10
4879525|NCT00768040|16815334|P2|Overall Study|Abnormal laboratory value|1
4879526|NCT00768040|16815335|P1|Overall Study|Abnormal laboratory value|1
4879527|NCT00768040|16815334|P2|Overall Study|Adverse Event|2
4879528|NCT00768040|16815335|P1|Overall Study|Adverse Event|3
4879529|NCT00767819|16815344|P3|Overall Study|Lost to Follow-up|0
4879530|NCT00767819|16815345|P2|Overall Study|Lost to Follow-up|0
4879531|NCT00767819|16815346|P1|Overall Study|Lost to Follow-up|1
4879532|NCT00767819|16815344|P3|Overall Study|Abnormal lab values|0
4879533|NCT00767819|16815345|P2|Overall Study|Abnormal lab values|0
4879534|NCT00767819|16815346|P1|Overall Study|Abnormal lab values|1
4879535|NCT00767819|16815344|P3|Overall Study|Adverse Event|0
4879536|NCT00767819|16815345|P2|Overall Study|Adverse Event|0
4879537|NCT00767819|16815346|P1|Overall Study|Adverse Event|2
4879538|NCT00767819|16815344|P3|Overall Study|Death|0
4879539|NCT00767819|16815345|P2|Overall Study|Death|3
4879540|NCT00767819|16815346|P1|Overall Study|Death|2
4879541|NCT00767819|16815344|P3|Overall Study|Administrative problems|0
4879542|NCT00767819|16815345|P2|Overall Study|Administrative problems|1
4879543|NCT00767819|16815346|P1|Overall Study|Administrative problems|0
4879544|NCT00767819|16815344|P3|Overall Study|Withdrawal by Subject|0
4879545|NCT00767819|16815345|P2|Overall Study|Withdrawal by Subject|1
4879546|NCT00767819|16815346|P1|Overall Study|Withdrawal by Subject|1
4879547|NCT00767819|16815344|P3|Overall Study|Unsatisfactory therapeutic effect|0
4879548|NCT00767819|16815345|P2|Overall Study|Unsatisfactory therapeutic effect|14
4879549|NCT00767819|16815346|P1|Overall Study|Unsatisfactory therapeutic effect|18
4879550|NCT00767806|16815371|P2|Overall Study|Sponsor Decision|1
4879551|NCT00767806|16815372|P1|Overall Study|Sponsor Decision|0
4879552|NCT00767806|16815371|P2|Overall Study|Entry Criteria Not Met|1
4879553|NCT00767806|16815372|P1|Overall Study|Entry Criteria Not Met|1
4879554|NCT00767806|16815371|P2|Overall Study|Lost to Follow-up|4
4879555|NCT00767806|16815372|P1|Overall Study|Lost to Follow-up|1
4879556|NCT00767806|16815371|P2|Overall Study|Physician Decision|3
4879557|NCT00767806|16815372|P1|Overall Study|Physician Decision|4
4879558|NCT00767806|16815371|P2|Overall Study|Lack of Efficacy|9
4879559|NCT00767806|16815372|P1|Overall Study|Lack of Efficacy|1
4879560|NCT00767806|16815371|P2|Overall Study|Protocol Violation|5
4879561|NCT00767806|16815372|P1|Overall Study|Protocol Violation|6
4879562|NCT00767806|16815371|P2|Overall Study|Withdrawal by Subject|13
4879563|NCT00767806|16815372|P1|Overall Study|Withdrawal by Subject|8
4879564|NCT00767806|16815371|P2|Overall Study|Adverse Event|11
4879565|NCT00767806|16815372|P1|Overall Study|Adverse Event|30
4879566|NCT00767676|16815449|P1|Overall Study|Investigator error|54
4879567|NCT00767520|16815472|P2|Overall Study|Randomized in error and Never treated|2
4879568|NCT00767520|16815473|P1|Overall Study|Randomized in error and Never treated|0
4879569|NCT00767520|16815472|P2|Overall Study|Participants still on treatment|15
4879570|NCT00767520|16815473|P1|Overall Study|Participants still on treatment|11
4879571|NCT00767455|16815526|P1|Overall Study|Investigator error|19
4879572|NCT00767325|16815560|P1|Overall Study|Missed visit due to family reasons|1
4879573|NCT00767325|16815560|P1|Overall Study|No longer met study criteria|2
4879574|NCT00767325|16815560|P1|Overall Study|Lost to Follow-up|3
4879575|NCT00767325|16815560|P1|Overall Study|Adverse Event|7
4879576|NCT00767325|16815560|P1|Overall Study|Lack of Efficacy|2
4879577|NCT00767104|16815571|P2|Overall Study|Lost to Follow-up|2
4879578|NCT00767104|16815572|P1|Overall Study|Lost to Follow-up|1
4879579|NCT00767039|16815582|P2|Overall Study|Death|2
4879580|NCT00767039|16815583|P1|Overall Study|Death|5
4879581|NCT00767000|16815614|P5|Optional 104-week Extension|Study terminated by sponsor|4
4879582|NCT00767000|16815615|P4|Optional 104-week Extension|Study terminated by sponsor|2
4879583|NCT00767000|16815616|P3|Optional 104-week Extension|Study terminated by sponsor|7
4879584|NCT00767000|16815617|P2|Optional 104-week Extension|Study terminated by sponsor|3
4879585|NCT00767000|16815618|P1|Optional 104-week Extension|Study terminated by sponsor|7
4879586|NCT00767000|16815614|P5|54-week Study|Reason not reported|0
4879587|NCT00767000|16815615|P4|54-week Study|Reason not reported|1
4879588|NCT00767000|16815616|P3|54-week Study|Reason not reported|0
4879589|NCT00767000|16815617|P2|54-week Study|Reason not reported|0
4879590|NCT00767000|16815618|P1|54-week Study|Reason not reported|0
4879591|NCT00767000|16815614|P5|54-week Study|Study terminated by sponsor|194
4879592|NCT00767000|16815615|P4|54-week Study|Study terminated by sponsor|196
4879593|NCT00767000|16815616|P3|54-week Study|Study terminated by sponsor|89
4879594|NCT00767000|16815617|P2|54-week Study|Study terminated by sponsor|102
4879595|NCT00767000|16815618|P1|54-week Study|Study terminated by sponsor|90
4879596|NCT00767000|16815614|P5|54-week Study|Withdrawal by Subject|13
4879597|NCT00767000|16815615|P4|54-week Study|Withdrawal by Subject|11
4879598|NCT00767000|16815616|P3|54-week Study|Withdrawal by Subject|5
4879599|NCT00767000|16815617|P2|54-week Study|Withdrawal by Subject|3
4879600|NCT00767000|16815618|P1|54-week Study|Withdrawal by Subject|2
4879601|NCT00767000|16815614|P5|54-week Study|Protocol Violation|0
4879602|NCT00767000|16815615|P4|54-week Study|Protocol Violation|2
4879603|NCT00767000|16815616|P3|54-week Study|Protocol Violation|1
4879604|NCT00767000|16815617|P2|54-week Study|Protocol Violation|0
4879605|NCT00767000|16815618|P1|54-week Study|Protocol Violation|0
4879606|NCT00767000|16815614|P5|54-week Study|Progressive disease|0
4879607|NCT00767000|16815615|P4|54-week Study|Progressive disease|0
4879608|NCT00767000|16815616|P3|54-week Study|Progressive disease|1
4879609|NCT00767000|16815617|P2|54-week Study|Progressive disease|0
4879610|NCT00767000|16815618|P1|54-week Study|Progressive disease|0
4879611|NCT00767000|16815614|P5|54-week Study|Physician Decision|1
4879612|NCT00767000|16815615|P4|54-week Study|Physician Decision|1
4879613|NCT00767000|16815616|P3|54-week Study|Physician Decision|1
4879614|NCT00767000|16815617|P2|54-week Study|Physician Decision|0
4879615|NCT00767000|16815618|P1|54-week Study|Physician Decision|4
4879616|NCT00767000|16815614|P5|54-week Study|Lost to Follow-up|2
4879617|NCT00767000|16815615|P4|54-week Study|Lost to Follow-up|4
4879618|NCT00767000|16815616|P3|54-week Study|Lost to Follow-up|1
4879619|NCT00767000|16815617|P2|54-week Study|Lost to Follow-up|0
4879620|NCT00767000|16815618|P1|54-week Study|Lost to Follow-up|4
4879621|NCT00767000|16815614|P5|54-week Study|Lack of Efficacy|5
4879622|NCT00767000|16815615|P4|54-week Study|Lack of Efficacy|0
4879623|NCT00767000|16815616|P3|54-week Study|Lack of Efficacy|1
4879624|NCT00767000|16815617|P2|54-week Study|Lack of Efficacy|0
4879625|NCT00767000|16815618|P1|54-week Study|Lack of Efficacy|2
4879626|NCT00767000|16815614|P5|54-week Study|Interruption of study medication|0
4879627|NCT00767000|16815615|P4|54-week Study|Interruption of study medication|0
4879628|NCT00767000|16815616|P3|54-week Study|Interruption of study medication|1
4879629|NCT00767000|16815617|P2|54-week Study|Interruption of study medication|0
4879630|NCT00767000|16815618|P1|54-week Study|Interruption of study medication|0
4879631|NCT00767000|16815614|P5|54-week Study|Hypoglycemia|0
4879632|NCT00767000|16815615|P4|54-week Study|Hypoglycemia|0
4879633|NCT00767000|16815616|P3|54-week Study|Hypoglycemia|0
4879634|NCT00767000|16815617|P2|54-week Study|Hypoglycemia|1
4879635|NCT00767000|16815618|P1|54-week Study|Hypoglycemia|0
4879636|NCT00767000|16815614|P5|54-week Study|Hyperglycemia|1
4879637|NCT00767000|16815615|P4|54-week Study|Hyperglycemia|0
4879638|NCT00767000|16815616|P3|54-week Study|Hyperglycemia|1
4879639|NCT00767000|16815617|P2|54-week Study|Hyperglycemia|0
4879640|NCT00767000|16815618|P1|54-week Study|Hyperglycemia|0
4879641|NCT00767000|16815614|P5|54-week Study|Creaninine/creatinine clearance|4
4879642|NCT00767000|16815615|P4|54-week Study|Creaninine/creatinine clearance|2
4879643|NCT00767000|16815616|P3|54-week Study|Creaninine/creatinine clearance|2
4879644|NCT00767000|16815617|P2|54-week Study|Creaninine/creatinine clearance|1
4879645|NCT00767000|16815618|P1|54-week Study|Creaninine/creatinine clearance|2
4879646|NCT00767000|16815614|P5|54-week Study|Adverse Event|4
4879647|NCT00767000|16815615|P4|54-week Study|Adverse Event|8
4879648|NCT00767000|16815616|P3|54-week Study|Adverse Event|6
4879649|NCT00767000|16815617|P2|54-week Study|Adverse Event|6
4879650|NCT00767000|16815618|P1|54-week Study|Adverse Event|4
4879651|NCT00766831|16815660|P1|Overall Study|Other|28
4879652|NCT00766831|16815660|P1|Overall Study|Non cooperation by participants|14
4879653|NCT00766831|16815660|P1|Overall Study|Withdrawal of consent|26
4879654|NCT00766831|16815660|P1|Overall Study|Physician Decision|5
4879655|NCT00766831|16815660|P1|Overall Study|Protocol Violation|15
4879656|NCT00766831|16815660|P1|Overall Study|Adverse Event|20
4879657|NCT00766831|16815660|P1|Overall Study|Lost to Follow-up|3
4879658|NCT00766831|16815660|P1|Overall Study|Withdrawal by Subject|4
4879659|NCT00766675|16815690|P1|Overall Study|Insufficient therapy|1
4879660|NCT00766675|16815690|P1|Overall Study|Receive other anti-neoplastic treatment|1
4879661|NCT00766675|16815690|P1|Overall Study|Participant took prohibited medication|1
4879662|NCT00766675|16815690|P1|Overall Study|Protocol Violation|8
4879663|NCT00766675|16815690|P1|Overall Study|Withdrawal by Subject|11
4879664|NCT00766675|16815690|P1|Overall Study|Lost to Follow-up|2
4879665|NCT00766675|16815690|P1|Overall Study|Adverse Event|16
4879666|NCT00766636|16815719|P2|Overall Study|Disease Progression|0
4879667|NCT00766636|16815720|P1|Overall Study|Disease Progression|1
4879668|NCT00766636|16815719|P2|Overall Study|Adverse Event|0
4879669|NCT00766636|16815720|P1|Overall Study|Adverse Event|1
4879670|NCT00766636|16815719|P2|Overall Study|Incomplete Treatment|1
4879671|NCT00766636|16815720|P1|Overall Study|Incomplete Treatment|0
4879672|NCT00766636|16815719|P2|Overall Study|Withdrawal by Subject|1
4879673|NCT00766636|16815720|P1|Overall Study|Withdrawal by Subject|1
4879674|NCT00766597|16815726|P1|Overall Study|Without CCR5-tropic virus|5
4879675|NCT00766597|16815726|P1|Overall Study|Unexpected closure of study|4
4879676|NCT00766532|16815738|P1|Overall Study|Protocol Violation|2
4879677|NCT00766506|16815744|P2|Overall Study|Other|2
4879678|NCT00766506|16815745|P1|Overall Study|Other|2
4879679|NCT00766506|16815744|P2|Overall Study|Use rescue medication after 3 hours|0
4879680|NCT00766506|16815745|P1|Overall Study|Use rescue medication after 3 hours|3
4879681|NCT00766493|16815769|P1|30 Days Post-Procedure|Missed Visit - No Phone Contact|1
4879682|NCT00766493|16815769|P1|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4
4879683|NCT00766493|16815769|P1|30 Days Post-Procedure|Discontinued|7
4879684|NCT00766467|16815779|P2|Overall Study|Physician Decision|0
4879685|NCT00766467|16815780|P1|Overall Study|Physician Decision|1
4879686|NCT00766467|16815779|P2|Overall Study|Tumor Progression on Study|1
4879687|NCT00766467|16815780|P1|Overall Study|Tumor Progression on Study|0
4879688|NCT00766467|16815779|P2|Overall Study|Protocol Violation|4
4879689|NCT00766467|16815780|P1|Overall Study|Protocol Violation|2
4879690|NCT00766467|16815779|P2|Overall Study|Adverse Event|1
4879691|NCT00766467|16815780|P1|Overall Study|Adverse Event|1
4879692|NCT00766467|16815779|P2|Overall Study|Withdrawal by Subject|2
4879693|NCT00766467|16815780|P1|Overall Study|Withdrawal by Subject|7
4879694|NCT00766415|16815792|P2|Overall Study|Withdrawal by Subject|1
4879695|NCT00766415|16815793|P1|Overall Study|Withdrawal by Subject|0
4879696|NCT00766376|16815841|P1|Overall Study|Withdrawal by Subject|27
4879697|NCT00766363|16815850|P4|Overall Study|Adverse Event Prior to Randomization|0
4879698|NCT00766363|16815851|P3|Overall Study|Adverse Event Prior to Randomization|0
4879699|NCT00766363|16815852|P2|Overall Study|Adverse Event Prior to Randomization|1
4879700|NCT00766363|16815853|P1|Overall Study|Adverse Event Prior to Randomization|0
4879701|NCT00766363|16815850|P4|Overall Study|Withdrawal by Subject|0
4879702|NCT00766363|16815851|P3|Overall Study|Withdrawal by Subject|0
4879703|NCT00766363|16815852|P2|Overall Study|Withdrawal by Subject|0
4879704|NCT00766363|16815853|P1|Overall Study|Withdrawal by Subject|1
4879705|NCT00766090|16815899|P12|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879706|NCT00766090|16815900|P11|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879707|NCT00766090|16815901|P10|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879708|NCT00766090|16815902|P9|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879709|NCT00766090|16815903|P8|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879710|NCT00766090|16815904|P7|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879711|NCT00766090|16815905|P6|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879712|NCT00766090|16815906|P5|Treatment Period 3 (28 Days)|Lost to Follow-up|1
4879713|NCT00766090|16815907|P4|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879714|NCT00766090|16815908|P3|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879715|NCT00766090|16815909|P2|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879716|NCT00766090|16815910|P1|Treatment Period 3 (28 Days)|Lost to Follow-up|0
4879717|NCT00766090|16815899|P12|Treatment Period 3 (28 Days)|Lack of Efficacy|1
4879718|NCT00766090|16815900|P11|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879719|NCT00766090|16815901|P10|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879720|NCT00766090|16815902|P9|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879721|NCT00766090|16815903|P8|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879722|NCT00766090|16815904|P7|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879723|NCT00766090|16815905|P6|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879724|NCT00766090|16815906|P5|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879725|NCT00766090|16815907|P4|Treatment Period 3 (28 Days)|Lack of Efficacy|1
4879726|NCT00766090|16815908|P3|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879727|NCT00766090|16815909|P2|Treatment Period 3 (28 Days)|Lack of Efficacy|1
4879728|NCT00766090|16815910|P1|Treatment Period 3 (28 Days)|Lack of Efficacy|0
4879729|NCT00766090|16815899|P12|Treatment Period 3 (28 Days)|Protocol Violation|0
4879730|NCT00766090|16815900|P11|Treatment Period 3 (28 Days)|Protocol Violation|0
4879731|NCT00766090|16815901|P10|Treatment Period 3 (28 Days)|Protocol Violation|0
4879732|NCT00766090|16815902|P9|Treatment Period 3 (28 Days)|Protocol Violation|0
4879733|NCT00766090|16815903|P8|Treatment Period 3 (28 Days)|Protocol Violation|0
4879734|NCT00766090|16815904|P7|Treatment Period 3 (28 Days)|Protocol Violation|0
4879735|NCT00766090|16815905|P6|Treatment Period 3 (28 Days)|Protocol Violation|1
4879736|NCT00766090|16815906|P5|Treatment Period 3 (28 Days)|Protocol Violation|0
4879737|NCT00766090|16815907|P4|Treatment Period 3 (28 Days)|Protocol Violation|0
4879738|NCT00766090|16815908|P3|Treatment Period 3 (28 Days)|Protocol Violation|0
4879739|NCT00766090|16815909|P2|Treatment Period 3 (28 Days)|Protocol Violation|0
4879740|NCT00766090|16815910|P1|Treatment Period 3 (28 Days)|Protocol Violation|0
4879741|NCT00766090|16815899|P12|Washout Period 2 (14 Days)|Physician Decision|0
4879742|NCT00766090|16815900|P11|Washout Period 2 (14 Days)|Physician Decision|0
4879743|NCT00766090|16815901|P10|Washout Period 2 (14 Days)|Physician Decision|0
4879744|NCT00766090|16815902|P9|Washout Period 2 (14 Days)|Physician Decision|0
4879745|NCT00766090|16815903|P8|Washout Period 2 (14 Days)|Physician Decision|0
4879746|NCT00766090|16815904|P7|Washout Period 2 (14 Days)|Physician Decision|0
4879747|NCT00766090|16815905|P6|Washout Period 2 (14 Days)|Physician Decision|0
4879748|NCT00766090|16815906|P5|Washout Period 2 (14 Days)|Physician Decision|0
4879749|NCT00766090|16815907|P4|Washout Period 2 (14 Days)|Physician Decision|0
4879750|NCT00766090|16815908|P3|Washout Period 2 (14 Days)|Physician Decision|1
4879751|NCT00766090|16815909|P2|Washout Period 2 (14 Days)|Physician Decision|0
4879752|NCT00766090|16815910|P1|Washout Period 2 (14 Days)|Physician Decision|0
4879753|NCT00766090|16815899|P12|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879754|NCT00766090|16815900|P11|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879755|NCT00766090|16815901|P10|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879756|NCT00766090|16815902|P9|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879757|NCT00766090|16815903|P8|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879758|NCT00766090|16815904|P7|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879759|NCT00766090|16815905|P6|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879760|NCT00766090|16815906|P5|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879761|NCT00766090|16815907|P4|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879762|NCT00766090|16815908|P3|Treatment Period 2 (28 Days)|Lack of Efficacy|1
4879763|NCT00766090|16815909|P2|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879764|NCT00766090|16815910|P1|Treatment Period 2 (28 Days)|Lack of Efficacy|0
4879765|NCT00766090|16815899|P12|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879766|NCT00766090|16815900|P11|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879767|NCT00766090|16815901|P10|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879768|NCT00766090|16815902|P9|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879769|NCT00766090|16815903|P8|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879770|NCT00766090|16815904|P7|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879771|NCT00766090|16815905|P6|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879772|NCT00766090|16815906|P5|Treatment Period 2 (28 Days)|Lost to Follow-up|2
4879773|NCT00766090|16815907|P4|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879774|NCT00766090|16815908|P3|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879775|NCT00766090|16815909|P2|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879776|NCT00766090|16815910|P1|Treatment Period 2 (28 Days)|Lost to Follow-up|0
4879777|NCT00766090|16815899|P12|Washout Period 1 (14 Days)|Protocol Violation|0
4879778|NCT00766090|16815900|P11|Washout Period 1 (14 Days)|Protocol Violation|0
4879779|NCT00766090|16815901|P10|Washout Period 1 (14 Days)|Protocol Violation|0
4879780|NCT00766090|16815902|P9|Washout Period 1 (14 Days)|Protocol Violation|0
4879781|NCT00766090|16815903|P8|Washout Period 1 (14 Days)|Protocol Violation|0
4879782|NCT00766090|16815904|P7|Washout Period 1 (14 Days)|Protocol Violation|0
4879783|NCT00766090|16815905|P6|Washout Period 1 (14 Days)|Protocol Violation|0
4879784|NCT00766090|16815906|P5|Washout Period 1 (14 Days)|Protocol Violation|0
4879785|NCT00766090|16815907|P4|Washout Period 1 (14 Days)|Protocol Violation|0
4879786|NCT00766090|16815908|P3|Washout Period 1 (14 Days)|Protocol Violation|1
4879787|NCT00766090|16815909|P2|Washout Period 1 (14 Days)|Protocol Violation|0
4879788|NCT00766090|16815910|P1|Washout Period 1 (14 Days)|Protocol Violation|0
4879789|NCT00766090|16815899|P12|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879790|NCT00766090|16815900|P11|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879791|NCT00766090|16815901|P10|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879792|NCT00766090|16815902|P9|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879793|NCT00766090|16815903|P8|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879794|NCT00766090|16815904|P7|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879795|NCT00766090|16815905|P6|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879796|NCT00766090|16815906|P5|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879797|NCT00766090|16815907|P4|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4879798|NCT00766090|16815908|P3|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879799|NCT00766090|16815909|P2|Treatment Period 1 (28 Days)|Withdrawal by Subject|0
4879800|NCT00766090|16815910|P1|Treatment Period 1 (28 Days)|Withdrawal by Subject|1
4879801|NCT00766090|16815899|P12|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879802|NCT00766090|16815900|P11|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879803|NCT00766090|16815901|P10|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879804|NCT00766090|16815902|P9|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879805|NCT00766090|16815903|P8|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879806|NCT00766090|16815904|P7|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879807|NCT00766090|16815905|P6|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879808|NCT00766090|16815906|P5|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879809|NCT00766090|16815907|P4|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879810|NCT00766090|16815908|P3|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879811|NCT00766090|16815909|P2|Treatment Period 1 (28 Days)|Lack of Efficacy|0
4879812|NCT00766090|16815910|P1|Treatment Period 1 (28 Days)|Lack of Efficacy|2
4879813|NCT00766090|16815899|P12|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879814|NCT00766090|16815900|P11|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879815|NCT00766090|16815901|P10|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879816|NCT00766090|16815902|P9|Treatment Period 1 (28 Days)|Lost to Follow-up|1
4879817|NCT00766090|16815903|P8|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879818|NCT00766090|16815904|P7|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879819|NCT00766090|16815905|P6|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879820|NCT00766090|16815906|P5|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879821|NCT00766090|16815907|P4|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879822|NCT00766090|16815908|P3|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879823|NCT00766090|16815909|P2|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879824|NCT00766090|16815910|P1|Treatment Period 1 (28 Days)|Lost to Follow-up|0
4879825|NCT00766051|16815951|P2|Overall Study|Withdrawal by Subject|0
4879826|NCT00766051|16815952|P1|Overall Study|Withdrawal by Subject|2
4879827|NCT00766038|16815964|P2|Overall Study|Lost to Follow-up|14
4879828|NCT00766038|16815965|P1|Overall Study|Lost to Follow-up|15
4879829|NCT00765999|16815981|P1|Overall Study|Other Miscellaneous Reasons|51
4879830|NCT00765999|16815981|P1|Overall Study|Study Terminated by Sponsor|2
4879831|NCT00765999|16815981|P1|Overall Study|Lost to Follow-up|131
4879832|NCT00765999|16815981|P1|Overall Study|Consent Withdrawn|202
4879833|NCT00765999|16815981|P1|Overall Study|Protocol Violation|95
4879834|NCT00765999|16815981|P1|Overall Study|Insufficient Therapeutic Response|100
4879835|NCT00765999|16815981|P1|Overall Study|Adverse Event|203
4879836|NCT00765882|16816008|P3|Overall Study|Other Reason|2
4879837|NCT00765882|16816009|P2|Overall Study|Other Reason|1
4879838|NCT00765882|16816010|P1|Overall Study|Other Reason|3
4879839|NCT00765882|16816008|P3|Overall Study|Lost to Follow-up|6
4879840|NCT00765882|16816009|P2|Overall Study|Lost to Follow-up|9
4879841|NCT00765882|16816010|P1|Overall Study|Lost to Follow-up|1
4879842|NCT00765882|16816008|P3|Overall Study|Withdrawal by Subject|6
4879843|NCT00765882|16816009|P2|Overall Study|Withdrawal by Subject|6
4879844|NCT00765882|16816010|P1|Overall Study|Withdrawal by Subject|2
4879845|NCT00765882|16816008|P3|Overall Study|Protocol Violation|1
4879846|NCT00765882|16816009|P2|Overall Study|Protocol Violation|3
4879847|NCT00765882|16816010|P1|Overall Study|Protocol Violation|4
4879848|NCT00765882|16816008|P3|Overall Study|Lack of Efficacy|1
4879849|NCT00765882|16816009|P2|Overall Study|Lack of Efficacy|0
4879850|NCT00765882|16816010|P1|Overall Study|Lack of Efficacy|4
4879851|NCT00765882|16816008|P3|Overall Study|Adverse Event|20
4879852|NCT00765882|16816009|P2|Overall Study|Adverse Event|21
4879853|NCT00765882|16816010|P1|Overall Study|Adverse Event|10
4879854|NCT00765843|16816042|P3|Overall Study|Adverse Event|1
4879855|NCT00765843|16816043|P2|Overall Study|Adverse Event|0
4879856|NCT00765843|16816044|P1|Overall Study|Adverse Event|0
4879857|NCT00765843|16816042|P3|Overall Study|did not return to receive intervention|0
4879858|NCT00765843|16816043|P2|Overall Study|did not return to receive intervention|1
4879859|NCT00765843|16816044|P1|Overall Study|did not return to receive intervention|0
4879860|NCT00765843|16816042|P3|Overall Study|Lost to Follow-up|2
4879861|NCT00765843|16816043|P2|Overall Study|Lost to Follow-up|3
4879862|NCT00765843|16816044|P1|Overall Study|Lost to Follow-up|1
4879863|NCT00765817|16816054|P2|Overall Study|Subject decision|11
4879864|NCT00765817|16816055|P1|Overall Study|Subject decision|7
4879865|NCT00765817|16816054|P2|Overall Study|Protocol Violation|1
4879866|NCT00765817|16816055|P1|Overall Study|Protocol Violation|1
4879867|NCT00765817|16816054|P2|Overall Study|Physician Decision|1
4879868|NCT00765817|16816055|P1|Overall Study|Physician Decision|2
4879869|NCT00765817|16816054|P2|Overall Study|Lost to Follow-up|3
4879870|NCT00765817|16816055|P1|Overall Study|Lost to Follow-up|1
4879871|NCT00765817|16816054|P2|Overall Study|Loss of glucose control|2
4879872|NCT00765817|16816055|P1|Overall Study|Loss of glucose control|0
4879873|NCT00765817|16816054|P2|Overall Study|Entry criteria not met|2
4879874|NCT00765817|16816055|P1|Overall Study|Entry criteria not met|2
4879875|NCT00765817|16816054|P2|Overall Study|Death|1
4879876|NCT00765817|16816055|P1|Overall Study|Death|0
4879877|NCT00765817|16816054|P2|Overall Study|Adverse Event|1
4879878|NCT00765817|16816055|P1|Overall Study|Adverse Event|13
4879879|NCT00765726|16816103|P1|Overall Study|Discontinuation of study by sponsor|8
4879880|NCT00765726|16816103|P1|Overall Study|Withdrawal by Subject|1
4879881|NCT00765674|16816111|P4|Overall Study|Randomized in Error - No Study Drug|1
4879882|NCT00765674|16816112|P3|Overall Study|Randomized in Error - No Study Drug|0
4879883|NCT00765674|16816113|P2|Overall Study|Randomized in Error - No Study Drug|1
4879884|NCT00765674|16816114|P1|Overall Study|Randomized in Error - No Study Drug|0
4879885|NCT00765674|16816111|P4|Overall Study|Lost to Follow-up|1
4879886|NCT00765674|16816112|P3|Overall Study|Lost to Follow-up|2
4879887|NCT00765674|16816113|P2|Overall Study|Lost to Follow-up|6
4879888|NCT00765674|16816114|P1|Overall Study|Lost to Follow-up|4
4879889|NCT00765674|16816111|P4|Overall Study|Withdrawal by Subject|8
4879890|NCT00765674|16816112|P3|Overall Study|Withdrawal by Subject|3
4879891|NCT00765674|16816113|P2|Overall Study|Withdrawal by Subject|7
4879892|NCT00765674|16816114|P1|Overall Study|Withdrawal by Subject|5
4879893|NCT00765674|16816111|P4|Overall Study|Protocol Violation|0
4879894|NCT00765674|16816112|P3|Overall Study|Protocol Violation|1
4879895|NCT00765674|16816113|P2|Overall Study|Protocol Violation|0
4879896|NCT00765674|16816114|P1|Overall Study|Protocol Violation|2
4879897|NCT00765674|16816111|P4|Overall Study|Lack of Efficacy|2
4879898|NCT00765674|16816112|P3|Overall Study|Lack of Efficacy|1
4879899|NCT00765674|16816113|P2|Overall Study|Lack of Efficacy|3
4879900|NCT00765674|16816114|P1|Overall Study|Lack of Efficacy|2
4879901|NCT00765674|16816111|P4|Overall Study|Abnormal Test Procedure Result(s)|2
4879902|NCT00765674|16816112|P3|Overall Study|Abnormal Test Procedure Result(s)|1
4879903|NCT00765674|16816113|P2|Overall Study|Abnormal Test Procedure Result(s)|3
4879904|NCT00765674|16816114|P1|Overall Study|Abnormal Test Procedure Result(s)|1
4879905|NCT00765674|16816111|P4|Overall Study|Abnormal Laboratory Value(s)|0
4879906|NCT00765674|16816112|P3|Overall Study|Abnormal Laboratory Value(s)|1
4879907|NCT00765674|16816113|P2|Overall Study|Abnormal Laboratory Value(s)|0
4879908|NCT00765674|16816114|P1|Overall Study|Abnormal Laboratory Value(s)|0
4879909|NCT00765674|16816111|P4|Overall Study|Adverse Event|11
4879910|NCT00765674|16816112|P3|Overall Study|Adverse Event|8
4879911|NCT00765674|16816113|P2|Overall Study|Adverse Event|2
4879912|NCT00765674|16816114|P1|Overall Study|Adverse Event|7
4879913|NCT00765388|16816181|P2|Period 1|Hip operation|1
4879914|NCT00765388|16816182|P1|Period 1|Hip operation|0
4879915|NCT00765388|16816181|P2|Period 1|Herpes Zoster|1
4879916|NCT00765388|16816182|P1|Period 1|Herpes Zoster|0
4879917|NCT00765388|16816181|P2|Period 1|Lost to Follow-up|1
4879918|NCT00765388|16816182|P1|Period 1|Lost to Follow-up|0
4879919|NCT00765388|16816181|P2|Period 1|Lack of Efficacy|2
4879920|NCT00765388|16816182|P1|Period 1|Lack of Efficacy|1
4879921|NCT00765362|16816216|P1|Overall Study|Lost to Follow-up|95
4879922|NCT00765362|16816216|P1|Overall Study|Withdrawal by Subject|13
4879923|NCT00765362|16816216|P1|Overall Study|Protocol Violation|18
4879924|NCT00765362|16816216|P1|Overall Study|Adverse Event|2
4879925|NCT00765362|16816216|P1|Overall Study|Death|9
4879926|NCT00765336|16816224|P2|Overall Study|Adverse Event|1
4879927|NCT00765336|16816225|P1|Overall Study|Adverse Event|2
4879928|NCT00765336|16816224|P2|Overall Study|Lost to Follow-up|9
4879929|NCT00765336|16816225|P1|Overall Study|Lost to Follow-up|7
4879930|NCT00765336|16816224|P2|Overall Study|Withdrawal by Subject|4
4879931|NCT00765336|16816225|P1|Overall Study|Withdrawal by Subject|6
4879932|NCT00765336|16816224|P2|Overall Study|Protocol Violation|2
4879933|NCT00765336|16816225|P1|Overall Study|Protocol Violation|4
4879934|NCT00765245|16816233|P2|Overall Study|Death|0
4879935|NCT00765245|16816234|P1|Overall Study|Death|1
4879936|NCT00765245|16816233|P2|Overall Study|Physician Decision|0
4879937|NCT00765245|16816234|P1|Overall Study|Physician Decision|1
4879938|NCT00765245|16816233|P2|Overall Study|Adverse Event|0
4879939|NCT00765245|16816234|P1|Overall Study|Adverse Event|5
4879940|NCT00765245|16816233|P2|Overall Study|Withdrawal by Subject|0
4879941|NCT00765245|16816234|P1|Overall Study|Withdrawal by Subject|3
4879942|NCT00765245|16816233|P2|Overall Study|disease progression|2
4879943|NCT00765245|16816234|P1|Overall Study|disease progression|3
4879944|NCT00765102|16816280|P1|Overall Study|Protocol Violation|1
4879945|NCT00765102|16816280|P1|Overall Study|Withdrawal by Subject|2
4879946|NCT00765102|16816280|P1|Overall Study|Physician Decision|4
4879947|NCT00765102|16816280|P1|Overall Study|Adverse Event|6
4879948|NCT00765102|16816280|P1|Overall Study|Progressive disease|18
4879949|NCT00765076|16816305|P3|Overall Study|Withdrawal by Subject|1
4879950|NCT00765076|16816306|P2|Overall Study|Withdrawal by Subject|0
4879951|NCT00765076|16816307|P1|Overall Study|Withdrawal by Subject|0
4879952|NCT00765076|16816305|P3|Overall Study|Adverse Event|0
4879953|NCT00765076|16816306|P2|Overall Study|Adverse Event|0
4879954|NCT00765076|16816307|P1|Overall Study|Adverse Event|1
4879955|NCT00765063|16816360|P1|Overall Study|Adverse Event|4
4879956|NCT00765063|16816360|P1|Overall Study|Protocol Violation|6
4879957|NCT00765063|16816360|P1|Overall Study|Other|16
4879958|NCT00765063|16816360|P1|Overall Study|Withdrawal by Subject|1
4879959|NCT00765063|16816360|P1|Overall Study|Lack of Efficacy|5
4879960|NCT00765037|16816376|P1|Overall Study|Adverse Event|1
4879961|NCT00765037|16816376|P1|Overall Study|Lost to Follow-up|5
4879962|NCT00764946|16816383|P3|Overall Study|Never Treated|1
4879963|NCT00764946|16816384|P2|Overall Study|Never Treated|1
4879964|NCT00764946|16816385|P1|Overall Study|Never Treated|1
4879965|NCT00764946|16816383|P3|Overall Study|Withdrawal by Subject|2
4879966|NCT00764946|16816384|P2|Overall Study|Withdrawal by Subject|6
4879967|NCT00764946|16816385|P1|Overall Study|Withdrawal by Subject|3
4879968|NCT00764946|16816383|P3|Overall Study|Adverse Event|1
4879969|NCT00764946|16816384|P2|Overall Study|Adverse Event|2
4879970|NCT00764946|16816385|P1|Overall Study|Adverse Event|3
4879971|NCT00764946|16816383|P3|Overall Study|Physician Decision|0
4879972|NCT00764946|16816384|P2|Overall Study|Physician Decision|4
4879973|NCT00764946|16816385|P1|Overall Study|Physician Decision|2
4879974|NCT00764946|16816383|P3|Overall Study|Lost to Follow-up|0
4879975|NCT00764946|16816384|P2|Overall Study|Lost to Follow-up|4
4879976|NCT00764946|16816385|P1|Overall Study|Lost to Follow-up|3
4879977|NCT00764946|16816383|P3|Overall Study|Lack of Efficacy|0
4879978|NCT00764946|16816384|P2|Overall Study|Lack of Efficacy|0
4879979|NCT00764946|16816385|P1|Overall Study|Lack of Efficacy|1
4879980|NCT00764881|16816413|P2|Overall Study|no treatment or no observation|2
4879981|NCT00764881|16816414|P1|Overall Study|no treatment or no observation|2
4879982|NCT00764881|16816413|P2|Overall Study|Possibly noncompliant (study drug)|2
4879983|NCT00764881|16816414|P1|Overall Study|Possibly noncompliant (study drug)|0
4879984|NCT00764881|16816413|P2|Overall Study|Carcinoma detected|0
4879985|NCT00764881|16816414|P1|Overall Study|Carcinoma detected|1
4879986|NCT00764881|16816413|P2|Overall Study|Wished to become pregnant|0
4879987|NCT00764881|16816414|P1|Overall Study|Wished to become pregnant|1
4879988|NCT00764881|16816413|P2|Overall Study|Accidentally discontinued study drug|0
4879989|NCT00764881|16816414|P1|Overall Study|Accidentally discontinued study drug|1
4879990|NCT00764881|16816413|P2|Overall Study|Noncompliant|0
4879991|NCT00764881|16816414|P1|Overall Study|Noncompliant|1
4879992|NCT00764881|16816413|P2|Overall Study|Lost to Follow-up|0
4879993|NCT00764881|16816414|P1|Overall Study|Lost to Follow-up|2
4879994|NCT00764881|16816413|P2|Overall Study|Protocol Violation|2
4879995|NCT00764881|16816414|P1|Overall Study|Protocol Violation|2
4879996|NCT00764881|16816413|P2|Overall Study|Withdrawal by Subject|3
4879997|NCT00764881|16816414|P1|Overall Study|Withdrawal by Subject|1
4879998|NCT00764881|16816413|P2|Overall Study|Adverse Event|1
4879999|NCT00764881|16816414|P1|Overall Study|Adverse Event|5
4880000|NCT00764868|16816638|P1|Overall Study|Sponsor requested withdrawal|1
4880001|NCT00764868|16816638|P1|Overall Study|Positive drug screen|2
4880002|NCT00764868|16816638|P1|Overall Study|Met an exclusion criteria|1
4880003|NCT00764868|16816638|P1|Overall Study|Subject sent to boarding school|1
4880004|NCT00764868|16816638|P1|Overall Study|Misuse and compliance of study drug|1
4880005|NCT00764868|16816638|P1|Overall Study|Out of town|1
4880006|NCT00764868|16816638|P1|Overall Study|Prohibited medication|1
4880007|NCT00764868|16816638|P1|Overall Study|Pregnancy|3
4880008|NCT00764868|16816638|P1|Overall Study|Subject moved|7
4880009|NCT00764868|16816638|P1|Overall Study|Lack of Efficacy|5
4880010|NCT00764868|16816638|P1|Overall Study|Lost to Follow-up|25
4880011|NCT00764868|16816638|P1|Overall Study|Non-compliance|16
4880012|NCT00764868|16816638|P1|Overall Study|Withdrawal by Subject|31
4880013|NCT00764868|16816638|P1|Overall Study|Adverse Event|18
4880014|NCT00764790|16816647|P3|Overall Study|Lost to Follow-up|23
4880015|NCT00764790|16816648|P2|Overall Study|Lost to Follow-up|29
4880016|NCT00764790|16816649|P1|Overall Study|Lost to Follow-up|28
4880017|NCT00764790|16816647|P3|Overall Study|Withdrawal by Subject|6
4880018|NCT00764790|16816648|P2|Overall Study|Withdrawal by Subject|12
4880019|NCT00764790|16816649|P1|Overall Study|Withdrawal by Subject|10
4880020|NCT00764790|16816647|P3|Overall Study|Protocol Violation|1
4880021|NCT00764790|16816648|P2|Overall Study|Protocol Violation|0
4880022|NCT00764790|16816649|P1|Overall Study|Protocol Violation|0
4880023|NCT00764751|16816683|P2|Overall Study|Psoriasis flare up on the scalp|0
4880024|NCT00764751|16816684|P1|Overall Study|Psoriasis flare up on the scalp|1
4880025|NCT00764751|16816683|P2|Overall Study|Adverse Event|1
4880026|NCT00764751|16816684|P1|Overall Study|Adverse Event|1
4880027|NCT00764699|16816747|P1|Overall Study|PI left and study terminated|3
4880028|NCT00764673|16816751|P1|Overall Study|Revision of Device|2
4880029|NCT00764673|16816751|P1|Overall Study|Withdrawal by Subject|6
4880030|NCT00764673|16816751|P1|Overall Study|Lost to Follow-up|3
4880031|NCT00764673|16816751|P1|Overall Study|Death|1
4880032|NCT00764660|16816761|P2|Overall Study|Did Not Meet Protocol Eligibility|0
4880033|NCT00764660|16816762|P1|Overall Study|Did Not Meet Protocol Eligibility|1
4880034|NCT00764660|16816761|P2|Overall Study|Noncompliance With Protocol|1
4880035|NCT00764660|16816762|P1|Overall Study|Noncompliance With Protocol|5
4880036|NCT00764660|16816761|P2|Overall Study|Withdrawal by Subject|3
4880037|NCT00764660|16816762|P1|Overall Study|Withdrawal by Subject|7
4880038|NCT00764660|16816761|P2|Overall Study|Lost to Follow-up|4
4880039|NCT00764660|16816762|P1|Overall Study|Lost to Follow-up|3
4880040|NCT00764660|16816761|P2|Overall Study|Adverse Event|3
4880041|NCT00764660|16816762|P1|Overall Study|Adverse Event|6
4880042|NCT00764517|16816796|P2|Overall Study|Physician Decision|0
4880043|NCT00764517|16816797|P1|Overall Study|Physician Decision|3
4880044|NCT00764517|16816796|P2|Overall Study|Death|11
4880045|NCT00764517|16816797|P1|Overall Study|Death|3
4880046|NCT00764517|16816796|P2|Overall Study|Adverse Event|3
4880047|NCT00764517|16816797|P1|Overall Study|Adverse Event|9
4880048|NCT00764504|16816818|P3|Overall Study|Lost to Follow-up|72
4880049|NCT00764504|16816819|P2|Overall Study|Lost to Follow-up|34
4880050|NCT00764504|16816820|P1|Overall Study|Lost to Follow-up|40
4880051|NCT00764504|16816818|P3|Overall Study|Withdrawal by Subject|4
4880052|NCT00764504|16816819|P2|Overall Study|Withdrawal by Subject|7
4880053|NCT00764504|16816820|P1|Overall Study|Withdrawal by Subject|1
4880054|NCT00764504|16816818|P3|Overall Study|Physician Decision|0
4880055|NCT00764504|16816819|P2|Overall Study|Physician Decision|0
4880056|NCT00764504|16816820|P1|Overall Study|Physician Decision|1
4880057|NCT00764504|16816818|P3|Overall Study|Revision of Device|14
4880058|NCT00764504|16816819|P2|Overall Study|Revision of Device|23
4880059|NCT00764504|16816820|P1|Overall Study|Revision of Device|12
4880060|NCT00764504|16816818|P3|Overall Study|Death|13
4880061|NCT00764504|16816819|P2|Overall Study|Death|6
4880062|NCT00764504|16816820|P1|Overall Study|Death|12
4880063|NCT00764478|16816849|P3|Overall Study|Protocol Violation|1
4880064|NCT00764478|16816850|P2|Overall Study|Protocol Violation|1
4880065|NCT00764478|16816851|P1|Overall Study|Protocol Violation|0
4880066|NCT00764478|16816849|P3|Overall Study|Lost to Follow-up|5
4880067|NCT00764478|16816850|P2|Overall Study|Lost to Follow-up|8
4880068|NCT00764478|16816851|P1|Overall Study|Lost to Follow-up|7
4880069|NCT00764478|16816849|P3|Overall Study|Withdrawal by Subject|1
4880070|NCT00764478|16816850|P2|Overall Study|Withdrawal by Subject|12
4880071|NCT00764478|16816851|P1|Overall Study|Withdrawal by Subject|7
4880072|NCT00764478|16816849|P3|Overall Study|Adverse Event|1
4880073|NCT00764478|16816850|P2|Overall Study|Adverse Event|1
4880074|NCT00764478|16816851|P1|Overall Study|Adverse Event|1
4880075|NCT00764465|16816931|P6|Overall Study|Withdrawal by Subject|0
4880076|NCT00764465|16816932|P5|Overall Study|Withdrawal by Subject|0
4880077|NCT00764465|16816933|P4|Overall Study|Withdrawal by Subject|0
4880078|NCT00764465|16816934|P3|Overall Study|Withdrawal by Subject|1
4880079|NCT00764465|16816935|P2|Overall Study|Withdrawal by Subject|1
4880080|NCT00764465|16816936|P1|Overall Study|Withdrawal by Subject|0
4880081|NCT00764465|16816931|P6|Overall Study|Adverse Event|1
4880082|NCT00764465|16816932|P5|Overall Study|Adverse Event|1
4880083|NCT00764465|16816933|P4|Overall Study|Adverse Event|1
4880084|NCT00764465|16816934|P3|Overall Study|Adverse Event|0
4880085|NCT00764465|16816935|P2|Overall Study|Adverse Event|0
4880086|NCT00764465|16816936|P1|Overall Study|Adverse Event|2
4880087|NCT00764361|16816964|P2|Overall Study|Adverse Event|1
4880088|NCT00764361|16816965|P1|Overall Study|Adverse Event|0
4880089|NCT00764361|16816964|P2|Overall Study|Withdrawal by Subject|3
4880090|NCT00764361|16816965|P1|Overall Study|Withdrawal by Subject|2
4880091|NCT00764322|16816973|P1|Overall Study|No CYP2D6 genotyping|9
4880092|NCT00764322|16816973|P1|Overall Study|Withdrawal by Subject|11
4880093|NCT00763971|16817000|P3|Overall Study|Participation in 489-326 required|0
4880094|NCT00763971|16817001|P2|Overall Study|Participation in 489-326 required|0
4880095|NCT00763971|16817002|P1|Overall Study|Participation in 489-326 required|1
4880096|NCT00763971|16817000|P3|Overall Study|Performed final visit on phone|0
4880097|NCT00763971|16817001|P2|Overall Study|Performed final visit on phone|1
4880098|NCT00763971|16817002|P1|Overall Study|Performed final visit on phone|0
4880099|NCT00763971|16817000|P3|Overall Study|Lack of availability|0
4880100|NCT00763971|16817001|P2|Overall Study|Lack of availability|1
4880101|NCT00763971|16817002|P1|Overall Study|Lack of availability|0
4880102|NCT00763971|16817000|P3|Overall Study|Subject wanted dose reduction|0
4880103|NCT00763971|16817001|P2|Overall Study|Subject wanted dose reduction|1
4880104|NCT00763971|16817002|P1|Overall Study|Subject wanted dose reduction|0
4880105|NCT00763971|16817000|P3|Overall Study|Moved to another country|0
4880106|NCT00763971|16817001|P2|Overall Study|Moved to another country|1
4880107|NCT00763971|16817002|P1|Overall Study|Moved to another country|0
4880108|NCT00763971|16817000|P3|Overall Study|Medical monitor decision|1
4880109|NCT00763971|16817001|P2|Overall Study|Medical monitor decision|0
4880110|NCT00763971|16817002|P1|Overall Study|Medical monitor decision|0
4880111|NCT00763971|16817000|P3|Overall Study|Randomization error|1
4880112|NCT00763971|16817001|P2|Overall Study|Randomization error|0
4880113|NCT00763971|16817002|P1|Overall Study|Randomization error|0
4880114|NCT00763971|16817000|P3|Overall Study|Due to holiday season|1
4880115|NCT00763971|16817001|P2|Overall Study|Due to holiday season|0
4880116|NCT00763971|16817002|P1|Overall Study|Due to holiday season|2
4880117|NCT00763971|16817000|P3|Overall Study|Sponsor decision|0
4880118|NCT00763971|16817001|P2|Overall Study|Sponsor decision|0
4880119|NCT00763971|16817002|P1|Overall Study|Sponsor decision|1
4880120|NCT00763971|16817000|P3|Overall Study|Exclusion criteria met|0
4880121|NCT00763971|16817001|P2|Overall Study|Exclusion criteria met|0
4880122|NCT00763971|16817002|P1|Overall Study|Exclusion criteria met|1
4880123|NCT00763971|16817000|P3|Overall Study|Personal reason|0
4880124|NCT00763971|16817001|P2|Overall Study|Personal reason|0
4880125|NCT00763971|16817002|P1|Overall Study|Personal reason|3
4880126|NCT00763971|16817000|P3|Overall Study|Unable to swallow capsule|1
4880127|NCT00763971|16817001|P2|Overall Study|Unable to swallow capsule|1
4880128|NCT00763971|16817002|P1|Overall Study|Unable to swallow capsule|2
4880129|NCT00763971|16817000|P3|Overall Study|Lack of Efficacy|54
4880130|NCT00763971|16817001|P2|Overall Study|Lack of Efficacy|22
4880131|NCT00763971|16817002|P1|Overall Study|Lack of Efficacy|11
4880132|NCT00763971|16817000|P3|Overall Study|Lost to Follow-up|0
4880133|NCT00763971|16817001|P2|Overall Study|Lost to Follow-up|1
4880134|NCT00763971|16817002|P1|Overall Study|Lost to Follow-up|0
4880135|NCT00763971|16817000|P3|Overall Study|Withdrawal by Subject|5
4880136|NCT00763971|16817001|P2|Overall Study|Withdrawal by Subject|5
4880137|NCT00763971|16817002|P1|Overall Study|Withdrawal by Subject|4
4880138|NCT00763971|16817000|P3|Overall Study|Protocol Violation|2
4880139|NCT00763971|16817001|P2|Overall Study|Protocol Violation|3
4880140|NCT00763971|16817002|P1|Overall Study|Protocol Violation|3
4880141|NCT00763971|16817000|P3|Overall Study|Adverse Event|4
4880142|NCT00763971|16817001|P2|Overall Study|Adverse Event|2
4880143|NCT00763971|16817002|P1|Overall Study|Adverse Event|5
4880144|NCT00763958|16817033|P2|Overall Study|Believed they were receiving placebo|5
4880145|NCT00763958|16817034|P1|Overall Study|Believed they were receiving placebo|0
4880146|NCT00763958|16817033|P2|Overall Study|Lost to Follow-up|2
4880147|NCT00763958|16817034|P1|Overall Study|Lost to Follow-up|10
4880148|NCT00763958|16817033|P2|Overall Study|did not meet final criteria|4
4880149|NCT00763958|16817034|P1|Overall Study|did not meet final criteria|4
4880150|NCT00763815|16817169|P2|Overall Study|Sponsor's Decision|1
4880151|NCT00763815|16817170|P1|Overall Study|Sponsor's Decision|0
4880152|NCT00763815|16817169|P2|Overall Study|Protocol Violation|5
4880153|NCT00763815|16817170|P1|Overall Study|Protocol Violation|2
4880154|NCT00763815|16817169|P2|Overall Study|Withdrawal by Subject|12
4880155|NCT00763815|16817170|P1|Overall Study|Withdrawal by Subject|7
4880156|NCT00763815|16817169|P2|Overall Study|Physician Decision|0
4880157|NCT00763815|16817170|P1|Overall Study|Physician Decision|1
4880158|NCT00763815|16817169|P2|Overall Study|Familial and Personal Reasons|16
4880159|NCT00763815|16817170|P1|Overall Study|Familial and Personal Reasons|9
4880160|NCT00763815|16817169|P2|Overall Study|Early Termination|0
4880161|NCT00763815|16817170|P1|Overall Study|Early Termination|1
4880162|NCT00763815|16817169|P2|Overall Study|Lost to Follow-up|4
4880163|NCT00763815|16817170|P1|Overall Study|Lost to Follow-up|2
4880164|NCT00763815|16817169|P2|Overall Study|Poor Compliance to Protocol|6
4880165|NCT00763815|16817170|P1|Overall Study|Poor Compliance to Protocol|6
4880166|NCT00763815|16817169|P2|Overall Study|Lack of Efficacy|11
4880167|NCT00763815|16817170|P1|Overall Study|Lack of Efficacy|10
4880168|NCT00763815|16817169|P2|Overall Study|Adverse Event|29
4880169|NCT00763815|16817170|P1|Overall Study|Adverse Event|14
4880170|NCT00763698|16817198|P1|Overall Study|Withdrawal by Subject|1
4880171|NCT00763698|16817198|P1|Overall Study|Death|4
4880172|NCT00763698|16817198|P1|Overall Study|Unsuccessful Implant|5
4880173|NCT00763451|16817215|P4|Overall Study|Study Site Reason|1
4880174|NCT00763451|16817216|P3|Overall Study|Study Site Reason|1
4880175|NCT00763451|16817217|P2|Overall Study|Study Site Reason|1
4880176|NCT00763451|16817218|P1|Overall Study|Study Site Reason|0
4880177|NCT00763451|16817215|P4|Overall Study|Randomized but not Treated|0
4880178|NCT00763451|16817216|P3|Overall Study|Randomized but not Treated|0
4880179|NCT00763451|16817217|P2|Overall Study|Randomized but not Treated|1
4880180|NCT00763451|16817218|P1|Overall Study|Randomized but not Treated|1
4880181|NCT00763451|16817215|P4|Overall Study|Familial and Personal Reasons|4
4880182|NCT00763451|16817216|P3|Overall Study|Familial and Personal Reasons|5
4880183|NCT00763451|16817217|P2|Overall Study|Familial and Personal Reasons|3
4880184|NCT00763451|16817218|P1|Overall Study|Familial and Personal Reasons|5
4880185|NCT00763451|16817215|P4|Overall Study|Poor Compliance to Protocol|2
4880186|NCT00763451|16817216|P3|Overall Study|Poor Compliance to Protocol|2
4880187|NCT00763451|16817217|P2|Overall Study|Poor Compliance to Protocol|1
4880188|NCT00763451|16817218|P1|Overall Study|Poor Compliance to Protocol|1
4880189|NCT00763451|16817215|P4|Overall Study|Protocol Violation|0
4880190|NCT00763451|16817216|P3|Overall Study|Protocol Violation|1
4880191|NCT00763451|16817217|P2|Overall Study|Protocol Violation|0
4880192|NCT00763451|16817218|P1|Overall Study|Protocol Violation|0
4880193|NCT00763451|16817215|P4|Overall Study|Withdrawal by Subject|7
4880194|NCT00763451|16817216|P3|Overall Study|Withdrawal by Subject|9
4880195|NCT00763451|16817217|P2|Overall Study|Withdrawal by Subject|6
4880196|NCT00763451|16817218|P1|Overall Study|Withdrawal by Subject|1
4880197|NCT00763451|16817215|P4|Overall Study|Lack of Efficacy|2
4880198|NCT00763451|16817216|P3|Overall Study|Lack of Efficacy|3
4880199|NCT00763451|16817217|P2|Overall Study|Lack of Efficacy|4
4880200|NCT00763451|16817218|P1|Overall Study|Lack of Efficacy|1
4880201|NCT00763451|16817215|P4|Overall Study|Adverse Event|14
4880202|NCT00763451|16817216|P3|Overall Study|Adverse Event|19
4880203|NCT00763451|16817217|P2|Overall Study|Adverse Event|6
4880204|NCT00763451|16817218|P1|Overall Study|Adverse Event|4
4880205|NCT00763386|16817277|P2|Overall Study|Study Prosthesis Removed|0
4880206|NCT00763386|16817278|P1|Overall Study|Study Prosthesis Removed|1
4880207|NCT00763386|16817277|P2|Overall Study|CRF missing|1
4880208|NCT00763386|16817278|P1|Overall Study|CRF missing|0
4880209|NCT00763386|16817277|P2|Overall Study|Withdrawal by Subject|1
4880210|NCT00763386|16817278|P1|Overall Study|Withdrawal by Subject|0
4880211|NCT00763386|16817277|P2|Overall Study|Lost to Follow-up|3
4880212|NCT00763386|16817278|P1|Overall Study|Lost to Follow-up|3
4880213|NCT00763386|16817277|P2|Overall Study|Death|2
4880214|NCT00763386|16817278|P1|Overall Study|Death|1
4880215|NCT00763386|16817277|P2|Overall Study|Adverse Event|33
4880216|NCT00763386|16817278|P1|Overall Study|Adverse Event|43
4880217|NCT00763321|16817311|P3|Double-blind Period|Other|3
4880218|NCT00763321|16817312|P2|Double-blind Period|Other|2
4880219|NCT00763321|16817313|P1|Double-blind Period|Other|0
4880220|NCT00763321|16817311|P3|Double-blind Period|Withdrawal by Subject|3
4880221|NCT00763321|16817312|P2|Double-blind Period|Withdrawal by Subject|2
4880222|NCT00763321|16817313|P1|Double-blind Period|Withdrawal by Subject|0
4880223|NCT00763321|16817311|P3|Double-blind Period|Lost to Follow-up|2
4880224|NCT00763321|16817312|P2|Double-blind Period|Lost to Follow-up|4
4880225|NCT00763321|16817313|P1|Double-blind Period|Lost to Follow-up|0
4880226|NCT00763321|16817311|P3|Double-blind Period|Adverse Event|4
4880227|NCT00763321|16817312|P2|Double-blind Period|Adverse Event|4
4880228|NCT00763321|16817313|P1|Double-blind Period|Adverse Event|0
4880229|NCT00763321|16817311|P3|Double-blind Period|Lack of Efficacy|17
4880230|NCT00763321|16817312|P2|Double-blind Period|Lack of Efficacy|9
4880231|NCT00763321|16817313|P1|Double-blind Period|Lack of Efficacy|0
4880232|NCT00763321|16817311|P3|Open-label Period|Other|0
4880233|NCT00763321|16817312|P2|Open-label Period|Other|0
4880234|NCT00763321|16817313|P1|Open-label Period|Other|4
4880235|NCT00763321|16817311|P3|Open-label Period|Lack of Efficacy|0
4880236|NCT00763321|16817312|P2|Open-label Period|Lack of Efficacy|0
4880237|NCT00763321|16817313|P1|Open-label Period|Lack of Efficacy|2
4880238|NCT00763321|16817311|P3|Open-label Period|Did not meet DB randomization criteria|0
4880239|NCT00763321|16817312|P2|Open-label Period|Did not meet DB randomization criteria|0
4880240|NCT00763321|16817313|P1|Open-label Period|Did not meet DB randomization criteria|5
4880241|NCT00763321|16817311|P3|Open-label Period|Subject noncompliant|0
4880242|NCT00763321|16817312|P2|Open-label Period|Subject noncompliant|0
4880243|NCT00763321|16817313|P1|Open-label Period|Subject noncompliant|7
4880244|NCT00763321|16817311|P3|Open-label Period|Withdrawal by Subject|0
4880245|NCT00763321|16817312|P2|Open-label Period|Withdrawal by Subject|0
4880246|NCT00763321|16817313|P1|Open-label Period|Withdrawal by Subject|7
4880247|NCT00763321|16817311|P3|Open-label Period|Lost to Follow-up|0
4880248|NCT00763321|16817312|P2|Open-label Period|Lost to Follow-up|0
4880249|NCT00763321|16817313|P1|Open-label Period|Lost to Follow-up|14
4880250|NCT00763321|16817311|P3|Open-label Period|Adverse Event|0
4880251|NCT00763321|16817312|P2|Open-label Period|Adverse Event|0
4880252|NCT00763321|16817313|P1|Open-label Period|Adverse Event|24
4880253|NCT00763282|16817324|P2|Overall Study|Lost to Follow-up|26
4880254|NCT00763282|16817325|P1|Overall Study|Lost to Follow-up|22
4880255|NCT00763282|16817324|P2|Overall Study|Death|3
4880256|NCT00763282|16817325|P1|Overall Study|Death|4
4880257|NCT00763282|16817324|P2|Overall Study|Withdrawal by Subject|5
4880258|NCT00763282|16817325|P1|Overall Study|Withdrawal by Subject|6
4880259|NCT00763269|16817341|P2|Overall Study|Lost to Follow-up|13
4880260|NCT00763269|16817342|P1|Overall Study|Lost to Follow-up|12
4880261|NCT00763256|16817356|P2|Overall Study|Didn't return for appointments|10
4880262|NCT00763256|16817357|P1|Overall Study|Didn't return for appointments|7
4880263|NCT00763139|16817393|P2|Overall Study|med change not allowed by protocol|0
4880264|NCT00763139|16817394|P1|Overall Study|med change not allowed by protocol|1
4880265|NCT00763139|16817393|P2|Overall Study|Withdrawal by Subject|1
4880266|NCT00763139|16817394|P1|Overall Study|Withdrawal by Subject|0
4880267|NCT00763139|16817393|P2|Overall Study|Adverse Event|2
4880268|NCT00763139|16817394|P1|Overall Study|Adverse Event|4
4880269|NCT00763035|16817456|P2|Second Intervention|Physician Decision|0
4880270|NCT00763035|16817457|P1|Second Intervention|Physician Decision|2
4880271|NCT00763035|16817456|P2|Second Intervention|Adverse Event|0
4880272|NCT00763035|16817457|P1|Second Intervention|Adverse Event|1
4880273|NCT00763035|16817456|P2|First Intervention|Adverse Event|1
4880274|NCT00763035|16817457|P1|First Intervention|Adverse Event|0
4880275|NCT00763035|16817456|P2|First Intervention|Did not meeting inclusion/exclusion|0
4880276|NCT00763035|16817457|P1|First Intervention|Did not meeting inclusion/exclusion|1
4880277|NCT00763009|16817475|P1|Overall Study|Coronary Anatomy unsuitable|1
4880278|NCT00762996|16817480|P4|Period One|Withdrawal by Subject|0
4880279|NCT00762996|16817481|P3|Period One|Withdrawal by Subject|1
4880280|NCT00762996|16817482|P2|Period One|Withdrawal by Subject|0
4880281|NCT00762996|16817483|P1|Period One|Withdrawal by Subject|0
4880282|NCT00762996|16817480|P4|Period One|Adverse Event|0
4880283|NCT00762996|16817481|P3|Period One|Adverse Event|1
4880284|NCT00762996|16817482|P2|Period One|Adverse Event|0
4880285|NCT00762996|16817483|P1|Period One|Adverse Event|0
4880286|NCT00762996|16817480|P4|Period One|ineligible|1
4880287|NCT00762996|16817481|P3|Period One|ineligible|1
4880288|NCT00762996|16817482|P2|Period One|ineligible|0
4880289|NCT00762996|16817483|P1|Period One|ineligible|0
4880290|NCT00762996|16817480|P4|Period One|Protocol Violation|0
4880291|NCT00762996|16817481|P3|Period One|Protocol Violation|1
4880292|NCT00762996|16817482|P2|Period One|Protocol Violation|0
4880293|NCT00762996|16817483|P1|Period One|Protocol Violation|0
4880294|NCT00762970|16817496|P3|Overall Study|Difficulty of handling lens|0
4880295|NCT00762970|16817497|P2|Overall Study|Difficulty of handling lens|2
4880296|NCT00762970|16817498|P1|Overall Study|Difficulty of handling lens|1
4880297|NCT00762970|16817496|P3|Overall Study|Lost to Follow-up|0
4880298|NCT00762970|16817497|P2|Overall Study|Lost to Follow-up|2
4880299|NCT00762970|16817498|P1|Overall Study|Lost to Follow-up|1
4880300|NCT00762970|16817496|P3|Overall Study|Protocol Violation|1
4880301|NCT00762970|16817497|P2|Overall Study|Protocol Violation|1
4880302|NCT00762970|16817498|P1|Overall Study|Protocol Violation|3
4880303|NCT00762970|16817496|P3|Overall Study|Withdrawal by Subject|0
4880304|NCT00762970|16817497|P2|Overall Study|Withdrawal by Subject|4
4880305|NCT00762970|16817498|P1|Overall Study|Withdrawal by Subject|7
4880306|NCT00762892|16817516|P2|Overall Study|Incarceration|0
4880307|NCT00762892|16817517|P1|Overall Study|Incarceration|1
4880308|NCT00762892|16817516|P2|Overall Study|Pregnancy|0
4880309|NCT00762892|16817517|P1|Overall Study|Pregnancy|1
4880310|NCT00762892|16817516|P2|Overall Study|Death|0
4880311|NCT00762892|16817517|P1|Overall Study|Death|1
4880312|NCT00762892|16817516|P2|Overall Study|Withdrawal by Subject|1
4880313|NCT00762892|16817517|P1|Overall Study|Withdrawal by Subject|0
4880314|NCT00762892|16817516|P2|Overall Study|Lost to Follow-up|5
4880315|NCT00762892|16817517|P1|Overall Study|Lost to Follow-up|2
4880316|NCT00762788|16817546|P6|Overall Study|Lost to Follow-up|21
4880317|NCT00762788|16817547|P5|Overall Study|Lost to Follow-up|13
4880318|NCT00762788|16817548|P4|Overall Study|Lost to Follow-up|26
4880319|NCT00762788|16817549|P3|Overall Study|Lost to Follow-up|21
4880320|NCT00762788|16817550|P2|Overall Study|Lost to Follow-up|37
4880321|NCT00762788|16817551|P1|Overall Study|Lost to Follow-up|26
4880322|NCT00762762|16817573|P2|Overall Study|Did not report for appointments|10
4880323|NCT00762762|16817574|P1|Overall Study|Did not report for appointments|8
4880324|NCT00762723|16817591|P3|Overall Study|Study Terminated slow enrollement|3
4880325|NCT00762723|16817592|P2|Overall Study|Study Terminated slow enrollement|5
4880326|NCT00762723|16817593|P1|Overall Study|Study Terminated slow enrollement|5
4880327|NCT00762606|16817766|P2|Overall Study|Lost to Follow-up|13
4880328|NCT00762606|16817767|P1|Overall Study|Lost to Follow-up|18
4880329|NCT00762502|16817812|P3|Month 3 to Month 6 (Period 2)|Pregnancy|0
4880330|NCT00762502|16817813|P2|Month 3 to Month 6 (Period 2)|Pregnancy|1
4880331|NCT00762502|16817814|P1|Month 3 to Month 6 (Period 2)|Pregnancy|0
4880332|NCT00762502|16817812|P3|Baseline to Month 3 (Period 1)|Lost to Follow-up|13
4880333|NCT00762502|16817813|P2|Baseline to Month 3 (Period 1)|Lost to Follow-up|3
4880334|NCT00762502|16817814|P1|Baseline to Month 3 (Period 1)|Lost to Follow-up|6
4880335|NCT00762502|16817812|P3|Baseline to Month 3 (Period 1)|Adverse Event|6
4880336|NCT00762502|16817813|P2|Baseline to Month 3 (Period 1)|Adverse Event|3
4880337|NCT00762502|16817814|P1|Baseline to Month 3 (Period 1)|Adverse Event|4
4880338|NCT00762476|16817828|P2|Overall Study|Seasonal allergies|0
4880339|NCT00762476|16817829|P1|Overall Study|Seasonal allergies|1
4880340|NCT00762476|16817828|P2|Overall Study|non-compliance with study visits|2
4880341|NCT00762476|16817829|P1|Overall Study|non-compliance with study visits|0
4880342|NCT00762476|16817828|P2|Overall Study|antibiotic use|1
4880343|NCT00762476|16817829|P1|Overall Study|antibiotic use|0
4880344|NCT00762476|16817828|P2|Overall Study|Withdrawal by Subject|12
4880345|NCT00762476|16817829|P1|Overall Study|Withdrawal by Subject|6
4880346|NCT00762476|16817828|P2|Overall Study|Physician Decision|14
4880347|NCT00762476|16817829|P1|Overall Study|Physician Decision|2
4880348|NCT00762476|16817828|P2|Overall Study|Protocol Violation|6
4880349|NCT00762476|16817829|P1|Overall Study|Protocol Violation|5
4880350|NCT00762476|16817828|P2|Overall Study|Lost to Follow-up|0
4880351|NCT00762476|16817829|P1|Overall Study|Lost to Follow-up|2
4880352|NCT00762476|16817828|P2|Overall Study|Adverse Event|1
4880353|NCT00762476|16817829|P1|Overall Study|Adverse Event|7
4880354|NCT00762463|16817841|P4|Extension Phase (Week 6 to Week 12)|Other|1
4880355|NCT00762463|16817842|P3|Extension Phase (Week 6 to Week 12)|Other|0
4880356|NCT00762463|16817843|P2|Extension Phase (Week 6 to Week 12)|Other|0
4880357|NCT00762463|16817844|P1|Extension Phase (Week 6 to Week 12)|Other|0
4880358|NCT00762463|16817841|P4|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
4880359|NCT00762463|16817842|P3|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3
4880360|NCT00762463|16817843|P2|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0
4880361|NCT00762463|16817844|P1|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1
4880362|NCT00762463|16817841|P4|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
4880363|NCT00762463|16817842|P3|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0
4880364|NCT00762463|16817843|P2|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
4880365|NCT00762463|16817844|P1|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1
4880366|NCT00762463|16817841|P4|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
4880367|NCT00762463|16817842|P3|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
4880368|NCT00762463|16817843|P2|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0
4880369|NCT00762463|16817844|P1|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1
4880370|NCT00762463|16817841|P4|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
4880371|NCT00762463|16817842|P3|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0
4880372|NCT00762463|16817843|P2|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1
4880373|NCT00762463|16817844|P1|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4
4880374|NCT00762463|16817841|P4|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
4880375|NCT00762463|16817842|P3|Double-blind Phase (Baseline to Week 6)|Adverse Event|0
4880376|NCT00762463|16817843|P2|Double-blind Phase (Baseline to Week 6)|Adverse Event|4
4880377|NCT00762463|16817844|P1|Double-blind Phase (Baseline to Week 6)|Adverse Event|2
4880378|NCT00762463|16817841|P4|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
4880379|NCT00762463|16817842|P3|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0
4880380|NCT00762463|16817843|P2|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4
4880381|NCT00762463|16817844|P1|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3
4880382|NCT00762463|16817841|P4|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
4880383|NCT00762463|16817842|P3|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0
4880384|NCT00762463|16817843|P2|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
4880385|NCT00762463|16817844|P1|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2
4880386|NCT00762411|16817950|P2|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54
4880387|NCT00762411|16817951|P1|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48
4880388|NCT00762411|16817950|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
4880389|NCT00762411|16817951|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|8
4880390|NCT00762411|16817950|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
4880391|NCT00762411|16817951|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6
4880392|NCT00762411|16817950|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46
4880393|NCT00762411|16817951|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21
4880394|NCT00762411|16817950|P2|Safety Follow Up (SFU)-Optional|Adverse Event|1
4880395|NCT00762411|16817951|P1|Safety Follow Up (SFU)-Optional|Adverse Event|0
4880396|NCT00762411|16817950|P2|Safety Follow Up (SFU)-Optional|Death|8
4880397|NCT00762411|16817951|P1|Safety Follow Up (SFU)-Optional|Death|1
4880398|NCT00762411|16817950|P2|Delayed Start|Caregiver Decision|1
4880399|NCT00762411|16817951|P1|Delayed Start|Caregiver Decision|1
4880400|NCT00762411|16817950|P2|Delayed Start|Sponsor Decision|20
4880401|NCT00762411|16817951|P1|Delayed Start|Sponsor Decision|16
4880402|NCT00762411|16817950|P2|Delayed Start|Protocol Violation|1
4880403|NCT00762411|16817951|P1|Delayed Start|Protocol Violation|0
4880404|NCT00762411|16817950|P2|Delayed Start|Adverse Event|4
4880405|NCT00762411|16817951|P1|Delayed Start|Adverse Event|0
4880406|NCT00762411|16817950|P2|Initial Treatment|Entry Criteria Exclusion|1
4880407|NCT00762411|16817951|P1|Initial Treatment|Entry Criteria Exclusion|0
4880408|NCT00762411|16817950|P2|Initial Treatment|Abnormal Lab/ECG Result|4
4880409|NCT00762411|16817951|P1|Initial Treatment|Abnormal Lab/ECG Result|6
4880410|NCT00762411|16817950|P2|Initial Treatment|Caregiver Decision|16
4880411|NCT00762411|16817951|P1|Initial Treatment|Caregiver Decision|21
4880412|NCT00762411|16817950|P2|Initial Treatment|Lost to Follow-up|0
4880413|NCT00762411|16817951|P1|Initial Treatment|Lost to Follow-up|5
4880414|NCT00762411|16817950|P2|Initial Treatment|Sponsor Decision|401
4880415|NCT00762411|16817951|P1|Initial Treatment|Sponsor Decision|293
4880416|NCT00762411|16817950|P2|Initial Treatment|Physician Decision|0
4880417|NCT00762411|16817951|P1|Initial Treatment|Physician Decision|1
4880418|NCT00762411|16817950|P2|Initial Treatment|Withdrawal by Subject|52
4880419|NCT00762411|16817951|P1|Initial Treatment|Withdrawal by Subject|65
4880420|NCT00762411|16817950|P2|Initial Treatment|Protocol Violation|1
4880421|NCT00762411|16817951|P1|Initial Treatment|Protocol Violation|4
4880422|NCT00762411|16817950|P2|Initial Treatment|Adverse Event|40
4880423|NCT00762411|16817951|P1|Initial Treatment|Adverse Event|132
4880424|NCT00762411|16817950|P2|Initial Treatment|Death|6
4880425|NCT00762411|16817951|P1|Initial Treatment|Death|7
4880426|NCT00762385|16818015|P2|Second Intervention|Protocol Violation|3
4880427|NCT00762385|16818016|P1|Second Intervention|Protocol Violation|3
4880428|NCT00762385|16818015|P2|First Intervention|Protocol Violation|1
4880429|NCT00762385|16818016|P1|First Intervention|Protocol Violation|0
4880430|NCT00762385|16818015|P2|First Intervention|Ineligible|0
4880431|NCT00762385|16818016|P1|First Intervention|Ineligible|1
4880432|NCT00762385|16818015|P2|First Intervention|Lost to Follow-up|2
4880433|NCT00762385|16818016|P1|First Intervention|Lost to Follow-up|0
4880434|NCT00762385|16818015|P2|First Intervention|Lens Issue|1
4880435|NCT00762385|16818016|P1|First Intervention|Lens Issue|1
4880436|NCT00762372|16818029|P3|Overall Study|Adverse Event|0
4880437|NCT00762372|16818030|P2|Overall Study|Adverse Event|0
4880438|NCT00762372|16818031|P1|Overall Study|Adverse Event|1
4880439|NCT00762359|16818107|P2|Overall Study|Withdrew consent|0
4880440|NCT00762359|16818108|P1|Overall Study|Withdrew consent|1
4880441|NCT00762359|16818107|P2|Overall Study|Removal|1
4880442|NCT00762359|16818108|P1|Overall Study|Removal|0
4880443|NCT00762359|16818107|P2|Overall Study|Physician Decision|3
4880444|NCT00762359|16818108|P1|Overall Study|Physician Decision|2
4880445|NCT00762359|16818107|P2|Overall Study|Institution closed|3
4880446|NCT00762359|16818108|P1|Overall Study|Institution closed|2
4880447|NCT00762359|16818107|P2|Overall Study|Lack of Efficacy|4
4880448|NCT00762359|16818108|P1|Overall Study|Lack of Efficacy|0
4880449|NCT00762359|16818107|P2|Overall Study|Withdrawal by Subject|10
4880450|NCT00762359|16818108|P1|Overall Study|Withdrawal by Subject|13
4880451|NCT00762359|16818107|P2|Overall Study|Protocol Violation|13
4880452|NCT00762359|16818108|P1|Overall Study|Protocol Violation|21
4880453|NCT00762359|16818107|P2|Overall Study|Adverse Event|23
4880454|NCT00762359|16818108|P1|Overall Study|Adverse Event|20
4880455|NCT00762268|16818225|P2|Overall Study|Withdrawal by Subject|3
4880456|NCT00762268|16818226|P1|Overall Study|Withdrawal by Subject|3
4880457|NCT00762229|16818238|P2|Overall Study|did not recveive intervention|1
4880458|NCT00762229|16818239|P1|Overall Study|did not recveive intervention|0
4880459|NCT00762229|16818238|P2|Overall Study|Lost to Follow-up|1
4880460|NCT00762229|16818239|P1|Overall Study|Lost to Follow-up|1
4880461|NCT00762164|16818336|P2|Overall Study|Withdrawal by Subject|1
4880462|NCT00762164|16818337|P1|Overall Study|Withdrawal by Subject|0
4880463|NCT00762164|16818336|P2|Overall Study|Discontinued medication|0
4880464|NCT00762164|16818337|P1|Overall Study|Discontinued medication|2
4880465|NCT00762164|16818336|P2|Overall Study|Lost to Follow-up|1
4880466|NCT00762164|16818337|P1|Overall Study|Lost to Follow-up|1
4880467|NCT00762086|16818347|P2|Overall Study|Ineligible to participate in the study|0
4880468|NCT00762086|16818348|P1|Overall Study|Ineligible to participate in the study|1
4880469|NCT00762086|16818347|P2|Overall Study|Withdrawal by Subject|2
4880470|NCT00762086|16818348|P1|Overall Study|Withdrawal by Subject|2
4880471|NCT00762086|16818347|P2|Overall Study|Non compliance|0
4880472|NCT00762086|16818348|P1|Overall Study|Non compliance|1
4880473|NCT00762086|16818347|P2|Overall Study|Lost to Follow-up|2
4880474|NCT00762086|16818348|P1|Overall Study|Lost to Follow-up|0
4880475|NCT00762086|16818347|P2|Overall Study|Adverse Event|0
4880476|NCT00762086|16818348|P1|Overall Study|Adverse Event|2
4880477|NCT00762073|16818358|P4|Overall Study|Not on treatment for >/= 77 days|0
4880478|NCT00762073|16818359|P3|Overall Study|Not on treatment for >/= 77 days|0
4880479|NCT00762073|16818360|P2|Overall Study|Not on treatment for >/= 77 days|0
4880480|NCT00762073|16818361|P1|Overall Study|Not on treatment for >/= 77 days|1
4880481|NCT00762073|16818358|P4|Overall Study|Withdrawal by Subject|1
4880482|NCT00762073|16818359|P3|Overall Study|Withdrawal by Subject|1
4880483|NCT00762073|16818360|P2|Overall Study|Withdrawal by Subject|2
4880484|NCT00762073|16818361|P1|Overall Study|Withdrawal by Subject|1
4880485|NCT00762073|16818358|P4|Overall Study|Significant Subject Noncompliance|1
4880486|NCT00762073|16818359|P3|Overall Study|Significant Subject Noncompliance|0
4880487|NCT00762073|16818360|P2|Overall Study|Significant Subject Noncompliance|1
4880488|NCT00762073|16818361|P1|Overall Study|Significant Subject Noncompliance|0
4880489|NCT00762073|16818358|P4|Overall Study|Adverse Event|1
4880490|NCT00762073|16818359|P3|Overall Study|Adverse Event|1
4880491|NCT00762073|16818360|P2|Overall Study|Adverse Event|0
4880492|NCT00762073|16818361|P1|Overall Study|Adverse Event|1
4880493|NCT00762073|16818358|P4|Overall Study|Lack of Efficacy|0
4880494|NCT00762073|16818359|P3|Overall Study|Lack of Efficacy|0
4880495|NCT00762073|16818360|P2|Overall Study|Lack of Efficacy|1
4880496|NCT00762073|16818361|P1|Overall Study|Lack of Efficacy|1
4880497|NCT00762034|16818425|P2|Maintenance Period|Other|1
4880498|NCT00762034|16818426|P1|Maintenance Period|Other|1
4880499|NCT00762034|16818425|P2|Maintenance Period|Death due to study disease|3
4880500|NCT00762034|16818426|P1|Maintenance Period|Death due to study disease|3
4880501|NCT00762034|16818425|P2|Maintenance Period|Death not due to study disease|5
4880502|NCT00762034|16818426|P1|Maintenance Period|Death not due to study disease|2
4880503|NCT00762034|16818425|P2|Maintenance Period|Withdrawal by Subject|14
4880504|NCT00762034|16818426|P1|Maintenance Period|Withdrawal by Subject|34
4880505|NCT00762034|16818425|P2|Maintenance Period|Physician Decision|20
4880506|NCT00762034|16818426|P1|Maintenance Period|Physician Decision|25
4880507|NCT00762034|16818425|P2|Maintenance Period|Progressive Disease|224
4880508|NCT00762034|16818426|P1|Maintenance Period|Progressive Disease|186
4880509|NCT00762034|16818425|P2|Maintenance Period|Adverse Event|26
4880510|NCT00762034|16818426|P1|Maintenance Period|Adverse Event|42
4880511|NCT00762034|16818425|P2|Maintenance Period|Entry Criterion Not Met|2
4880512|NCT00762034|16818426|P1|Maintenance Period|Entry Criterion Not Met|0
4880513|NCT00762034|16818425|P2|Maintenance Period|Protocol Violation|3
4880514|NCT00762034|16818426|P1|Maintenance Period|Protocol Violation|1
4880515|NCT00762034|16818425|P2|Induction Period|Deaths Due to Study Disease|9
4880516|NCT00762034|16818426|P1|Induction Period|Deaths Due to Study Disease|9
4880517|NCT00762034|16818425|P2|Induction Period|Deaths Not Due to Study Disease|14
4880518|NCT00762034|16818426|P1|Induction Period|Deaths Not Due to Study Disease|19
4880519|NCT00762034|16818425|P2|Induction Period|Withdrawal by Subject|19
4880520|NCT00762034|16818426|P1|Induction Period|Withdrawal by Subject|15
4880521|NCT00762034|16818425|P2|Induction Period|Physician Decision|20
4880522|NCT00762034|16818426|P1|Induction Period|Physician Decision|21
4880523|NCT00762034|16818425|P2|Induction Period|Progressive Disease|55
4880524|NCT00762034|16818426|P1|Induction Period|Progressive Disease|73
4880525|NCT00762034|16818425|P2|Induction Period|Lost to Follow-up|1
4880526|NCT00762034|16818426|P1|Induction Period|Lost to Follow-up|1
4880527|NCT00762034|16818425|P2|Induction Period|Adverse Event|38
4880528|NCT00762034|16818426|P1|Induction Period|Adverse Event|27
4880529|NCT00762034|16818425|P2|Induction Period|Entry Criterion Not Met|11
4880530|NCT00762034|16818426|P1|Induction Period|Entry Criterion Not Met|12
4880531|NCT00762034|16818425|P2|Induction Period|Protocol Violation|2
4880532|NCT00762034|16818426|P1|Induction Period|Protocol Violation|1
4880533|NCT00761969|16818498|P2|Overall Study|Lost to Follow-up|93
4880534|NCT00761969|16818499|P1|Overall Study|Lost to Follow-up|88
4880535|NCT00761969|16818498|P2|Overall Study|Death|47
4880536|NCT00761969|16818499|P1|Overall Study|Death|112
4880537|NCT00761956|16818509|P2|Overall Study|Adverse Event|34
4880538|NCT00761956|16818510|P1|Overall Study|Adverse Event|26
4880539|NCT00761956|16818509|P2|Overall Study|Death|1
4880540|NCT00761956|16818510|P1|Overall Study|Death|0
4880541|NCT00761956|16818509|P2|Overall Study|Withdrawal by Subject|8
4880542|NCT00761956|16818510|P1|Overall Study|Withdrawal by Subject|3
4880543|NCT00761956|16818509|P2|Overall Study|Lost to Follow-up|11
4880544|NCT00761956|16818510|P1|Overall Study|Lost to Follow-up|6
4880545|NCT00761891|16818537|P1|Overall Study|Withdrawal by Subject|10
4880546|NCT00761865|16818544|P2|Overall Study|Lost to Follow-up|7
4880547|NCT00761865|16818545|P1|Overall Study|Lost to Follow-up|8
4880548|NCT00761774|16818566|P1|Overall Study|IP stopped by hospital physician|1
4880549|NCT00761774|16818566|P1|Overall Study|Subject IP non-compliance|1
4880550|NCT00761774|16818566|P1|Overall Study|Coordinator leaving site|1
4880551|NCT00761774|16818566|P1|Overall Study|Patient moved out of study area|1
4880552|NCT00761774|16818566|P1|Overall Study|Investigator clinical judgement|1
4880553|NCT00761774|16818566|P1|Overall Study|Sponsor decision|1
4880554|NCT00761774|16818566|P1|Overall Study|Medical decision to read SUSAR reports|1
4880555|NCT00761774|16818566|P1|Overall Study|Reclassification of seizures|1
4880556|NCT00761774|16818566|P1|Overall Study|End of study|2
4880557|NCT00761774|16818566|P1|Overall Study|Non-compliance|4
4880558|NCT00761774|16818566|P1|Overall Study|Withdrawal by Subject|9
4880559|NCT00761774|16818566|P1|Overall Study|Lost to Follow-up|2
4880560|NCT00761774|16818566|P1|Overall Study|Lack of Efficacy|37
4880561|NCT00761774|16818566|P1|Overall Study|Adverse Event|17
4880562|NCT00761761|16818577|P2|Overall Study|Withdrawal by Subject|0
4880563|NCT00761761|16818578|P1|Overall Study|Withdrawal by Subject|3
4880564|NCT00761761|16818577|P2|Overall Study|Lost to Follow-up|1
4880565|NCT00761761|16818578|P1|Overall Study|Lost to Follow-up|3
4880566|NCT00761748|16818590|P2|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3
4880567|NCT00761748|16818591|P1|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0
4880568|NCT00761748|16818590|P2|First Intervention (21 +/- 3 Days)|Adverse Event|0
4880569|NCT00761748|16818591|P1|First Intervention (21 +/- 3 Days)|Adverse Event|3
4880570|NCT00761735|16818597|P1|Overall Study|Administrative|1
4880571|NCT00761735|16818597|P1|Overall Study|Non-compliance with protocol|1
4880572|NCT00761735|16818597|P1|Overall Study|Withdrawal by Subject|6
4880573|NCT00761735|16818597|P1|Overall Study|Lost to Follow-up|6
4880574|NCT00761631|16818613|P6|Overall Study|Other|1
4880575|NCT00761631|16818614|P5|Overall Study|Other|1
4880576|NCT00761631|16818615|P4|Overall Study|Other|0
4880577|NCT00761631|16818616|P3|Overall Study|Other|0
4880578|NCT00761631|16818617|P2|Overall Study|Other|0
4880579|NCT00761631|16818618|P1|Overall Study|Other|0
4880580|NCT00761631|16818613|P6|Overall Study|Physician Decision|0
4880581|NCT00761631|16818614|P5|Overall Study|Physician Decision|0
4880582|NCT00761631|16818615|P4|Overall Study|Physician Decision|0
4880583|NCT00761631|16818616|P3|Overall Study|Physician Decision|0
4880584|NCT00761631|16818617|P2|Overall Study|Physician Decision|0
4880585|NCT00761631|16818618|P1|Overall Study|Physician Decision|1
4880586|NCT00761631|16818613|P6|Overall Study|Failed to return|2
4880587|NCT00761631|16818614|P5|Overall Study|Failed to return|5
4880588|NCT00761631|16818615|P4|Overall Study|Failed to return|1
4880589|NCT00761631|16818616|P3|Overall Study|Failed to return|1
4880590|NCT00761631|16818617|P2|Overall Study|Failed to return|0
4880591|NCT00761631|16818618|P1|Overall Study|Failed to return|1
4880592|NCT00761631|16818613|P6|Overall Study|Randomized, not treated|0
4880593|NCT00761631|16818614|P5|Overall Study|Randomized, not treated|0
4880594|NCT00761631|16818615|P4|Overall Study|Randomized, not treated|0
4880595|NCT00761631|16818616|P3|Overall Study|Randomized, not treated|0
4880596|NCT00761631|16818617|P2|Overall Study|Randomized, not treated|0
4880597|NCT00761631|16818618|P1|Overall Study|Randomized, not treated|1
4880598|NCT00761631|16818613|P6|Overall Study|Protocol Violation|1
4880599|NCT00761631|16818614|P5|Overall Study|Protocol Violation|5
4880600|NCT00761631|16818615|P4|Overall Study|Protocol Violation|1
4880601|NCT00761631|16818616|P3|Overall Study|Protocol Violation|0
4880602|NCT00761631|16818617|P2|Overall Study|Protocol Violation|0
4880603|NCT00761631|16818618|P1|Overall Study|Protocol Violation|2
4880604|NCT00761631|16818613|P6|Overall Study|Lost to Follow-up|1
4880605|NCT00761631|16818614|P5|Overall Study|Lost to Follow-up|6
4880606|NCT00761631|16818615|P4|Overall Study|Lost to Follow-up|1
4880607|NCT00761631|16818616|P3|Overall Study|Lost to Follow-up|7
4880608|NCT00761631|16818617|P2|Overall Study|Lost to Follow-up|4
4880609|NCT00761631|16818618|P1|Overall Study|Lost to Follow-up|2
4880610|NCT00761631|16818613|P6|Overall Study|Parent/legal guardian request|0
4880611|NCT00761631|16818614|P5|Overall Study|Parent/legal guardian request|5
4880612|NCT00761631|16818615|P4|Overall Study|Parent/legal guardian request|0
4880613|NCT00761631|16818616|P3|Overall Study|Parent/legal guardian request|8
4880614|NCT00761631|16818617|P2|Overall Study|Parent/legal guardian request|3
4880615|NCT00761631|16818618|P1|Overall Study|Parent/legal guardian request|8
4880616|NCT00761605|16818653|P1|Overall Study|Other|21
4880617|NCT00761605|16818653|P1|Overall Study|Withdrawal by Subject|37
4880618|NCT00761605|16818653|P1|Overall Study|Lost to Follow-up|29
4880619|NCT00761605|16818653|P1|Overall Study|Lack of Efficacy|26
4880620|NCT00761605|16818653|P1|Overall Study|Death|2
4880621|NCT00761605|16818653|P1|Overall Study|Adverse Event|26
4880622|NCT00761579|16818697|P1|Overall Study|Intake of prohibited concomitant drug|1
4880623|NCT00761579|16818697|P1|Overall Study|Lost survey form|1
4880624|NCT00761579|16818697|P1|Overall Study|Aggravation of symptoms by changing drug|1
4880625|NCT00761579|16818697|P1|Overall Study|Aggravation of depression|1
4880626|NCT00761579|16818697|P1|Overall Study|Drug overdose|1
4880627|NCT00761579|16818697|P1|Overall Study|Protocol deviation|1
4880628|NCT00761579|16818697|P1|Overall Study|Lack of compliance|2
4880629|NCT00761579|16818697|P1|Overall Study|Withdrawal by Subject|34
4880630|NCT00761579|16818697|P1|Overall Study|Pregnancy|1
4880631|NCT00761579|16818697|P1|Overall Study|Lost to Follow-up|16
4880632|NCT00761579|16818697|P1|Overall Study|Lack of Efficacy|21
4880633|NCT00761579|16818697|P1|Overall Study|Death|2
4880634|NCT00761579|16818697|P1|Overall Study|Adverse Event|10
4880635|NCT00761527|16818730|P1|Overall Study|Unknown reason|2
4880636|NCT00761527|16818730|P1|Overall Study|Lost to Follow-up|9
4880637|NCT00761527|16818730|P1|Overall Study|Poor Compliance|8
4880638|NCT00761527|16818730|P1|Overall Study|Adverse Event|3
4880639|NCT00761514|16818737|P1|Overall Study|Unable to pay for medications|1
4880640|NCT00761514|16818737|P1|Overall Study|Problem complying with study visit|1
4880641|NCT00761514|16818737|P1|Overall Study|Health insurance didn't cover study drug|1
4880642|NCT00761514|16818737|P1|Overall Study|Lost to Follow-up|1
4880643|NCT00761514|16818737|P1|Overall Study|Withdrawal by Subject|2
4880644|NCT00761514|16818737|P1|Overall Study|Adverse Event|1
4880645|NCT00761462|16818744|P2|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21
4880646|NCT00761462|16818745|P1|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75
4880647|NCT00761462|16818744|P2|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30
4880648|NCT00761462|16818745|P1|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75
4880649|NCT00761462|16818744|P2|2 or 5 Years Long-term Safety Follow-up|Death|0
4880650|NCT00761462|16818745|P1|2 or 5 Years Long-term Safety Follow-up|Death|4
4880651|NCT00761462|16818744|P2|Treatment|Subjects never received study medication|12
4880652|NCT00761462|16818745|P1|Treatment|Subjects never received study medication|23
4880653|NCT00761319|16818759|P2|Overall Study|Missing|0
4880654|NCT00761319|16818760|P1|Overall Study|Missing|1
4880655|NCT00761319|16818759|P2|Overall Study|Nonspecified|2
4880656|NCT00761319|16818760|P1|Overall Study|Nonspecified|2
4880657|NCT00761319|16818759|P2|Overall Study|Lost to Follow-up|1
4880658|NCT00761319|16818760|P1|Overall Study|Lost to Follow-up|1
4880659|NCT00761319|16818759|P2|Overall Study|Noncompliance|3
4880660|NCT00761319|16818760|P1|Overall Study|Noncompliance|4
4880661|NCT00761319|16818759|P2|Overall Study|Withdrawal by Subject|7
4880662|NCT00761319|16818760|P1|Overall Study|Withdrawal by Subject|8
4880663|NCT00761319|16818759|P2|Overall Study|Adverse Event|7
4880664|NCT00761319|16818760|P1|Overall Study|Adverse Event|11
4880665|NCT00761319|16818759|P2|Overall Study|Protocol Violation|14
4880666|NCT00761319|16818760|P1|Overall Study|Protocol Violation|21
4880667|NCT00761306|16818768|P1|Overall Study|Administrative or Other Reasons|5
4880668|NCT00761306|16818768|P1|Overall Study|Lost to Follow-up|1
4880669|NCT00761306|16818768|P1|Overall Study|Withdrawal of Consent|3
4880670|NCT00761306|16818768|P1|Overall Study|Protocol Violation|2
4880671|NCT00761306|16818768|P1|Overall Study|Lack of Efficacy|4
4880672|NCT00761306|16818768|P1|Overall Study|Adverse Event|5
4880673|NCT00761280|16818779|P2|First Dose to End of Study|Lost to Follow-up|1
4880674|NCT00761280|16818780|P1|First Dose to End of Study|Lost to Follow-up|0
4880675|NCT00761280|16818779|P2|First Dose to End of Study|Death|0
4880676|NCT00761280|16818780|P1|First Dose to End of Study|Death|1
4880677|NCT00761280|16818779|P2|First Dose to End of Study|Sponsor decision|2
4880678|NCT00761280|16818780|P1|First Dose to End of Study|Sponsor decision|1
4880679|NCT00761280|16818779|P2|First Dose to End of Study|Progressive disease|3
4880680|NCT00761280|16818780|P1|First Dose to End of Study|Progressive disease|5
4880681|NCT00761280|16818779|P2|First Dose to End of Study|End of trial|5
4880682|NCT00761280|16818780|P1|First Dose to End of Study|End of trial|5
4880683|NCT00761280|16818779|P2|Randomization to First Dose|Other|0
4880684|NCT00761280|16818780|P1|Randomization to First Dose|Other|1
4880685|NCT00761280|16818779|P2|Randomization to First Dose|Sponsor decision|0
4880686|NCT00761280|16818780|P1|Randomization to First Dose|Sponsor decision|1
4880687|NCT00761280|16818779|P2|Randomization to First Dose|Withdrawal by Subject|2
4880688|NCT00761280|16818780|P1|Randomization to First Dose|Withdrawal by Subject|0
4880689|NCT00761267|16818811|P3|Overall Study|Withdrawal by Subject|0
4880690|NCT00761267|16818812|P2|Overall Study|Withdrawal by Subject|1
4880691|NCT00761267|16818813|P1|Overall Study|Withdrawal by Subject|0
4880692|NCT00761267|16818811|P3|Overall Study|Randomized but not treated|0
4880693|NCT00761267|16818812|P2|Overall Study|Randomized but not treated|1
4880694|NCT00761267|16818813|P1|Overall Study|Randomized but not treated|1
4880695|NCT00761267|16818811|P3|Overall Study|Lost to Follow-up|1
4880696|NCT00761267|16818812|P2|Overall Study|Lost to Follow-up|0
4880697|NCT00761267|16818813|P1|Overall Study|Lost to Follow-up|0
4880698|NCT00761267|16818811|P3|Overall Study|Death|5
4880699|NCT00761267|16818812|P2|Overall Study|Death|2
4880700|NCT00761267|16818813|P1|Overall Study|Death|1
4880701|NCT00761215|16818864|P3|Overall Study|Bacteremia|0
4880702|NCT00761215|16818865|P2|Overall Study|Bacteremia|0
4880703|NCT00761215|16818866|P1|Overall Study|Bacteremia|1
4880704|NCT00761215|16818864|P3|Overall Study|Withdrawal by Subject|0
4880705|NCT00761215|16818865|P2|Overall Study|Withdrawal by Subject|0
4880706|NCT00761215|16818866|P1|Overall Study|Withdrawal by Subject|1
4880707|NCT00761215|16818864|P3|Overall Study|Lost to Follow-up|6
4880708|NCT00761215|16818865|P2|Overall Study|Lost to Follow-up|3
4880709|NCT00761215|16818866|P1|Overall Study|Lost to Follow-up|6
4880710|NCT00761215|16818864|P3|Overall Study|Randomized but didn't receive drug|2
4880711|NCT00761215|16818865|P2|Overall Study|Randomized but didn't receive drug|1
4880712|NCT00761215|16818866|P1|Overall Study|Randomized but didn't receive drug|1
4880713|NCT00761189|16818908|P1|Overall Study|Other|13
4880714|NCT00761189|16818908|P1|Overall Study|Withdrawal by Subject|49
4880715|NCT00761189|16818908|P1|Overall Study|Lost to Follow-up|36
4880716|NCT00761189|16818908|P1|Overall Study|Lack of Efficacy|45
4880717|NCT00761189|16818908|P1|Overall Study|Adverse Event|42
4880718|NCT00761176|16818925|P2|Overall Study|Withdrawal by Subject|1
4880719|NCT00761176|16818926|P1|Overall Study|Withdrawal by Subject|1
4880720|NCT00761176|16818925|P2|Overall Study|Death|0
4880721|NCT00761176|16818926|P1|Overall Study|Death|1
4880722|NCT00761150|16818935|P3|Double-blind Period|Other|3
4880723|NCT00761150|16818936|P2|Double-blind Period|Other|3
4880724|NCT00761150|16818937|P1|Double-blind Period|Other|0
4880725|NCT00761150|16818935|P3|Double-blind Period|Noncompliance|0
4880726|NCT00761150|16818936|P2|Double-blind Period|Noncompliance|1
4880727|NCT00761150|16818937|P1|Double-blind Period|Noncompliance|0
4880728|NCT00761150|16818935|P3|Double-blind Period|Did not meet DB randomization criteria|1
4880729|NCT00761150|16818936|P2|Double-blind Period|Did not meet DB randomization criteria|0
4880730|NCT00761150|16818937|P1|Double-blind Period|Did not meet DB randomization criteria|0
4880731|NCT00761150|16818935|P3|Double-blind Period|Lost to Follow-up|1
4880732|NCT00761150|16818936|P2|Double-blind Period|Lost to Follow-up|2
4880733|NCT00761150|16818937|P1|Double-blind Period|Lost to Follow-up|0
4880734|NCT00761150|16818935|P3|Double-blind Period|Withdrawal by Subject|2
4880735|NCT00761150|16818936|P2|Double-blind Period|Withdrawal by Subject|3
4880736|NCT00761150|16818937|P1|Double-blind Period|Withdrawal by Subject|0
4880737|NCT00761150|16818935|P3|Double-blind Period|Adverse Event|3
4880738|NCT00761150|16818936|P2|Double-blind Period|Adverse Event|3
4880739|NCT00761150|16818937|P1|Double-blind Period|Adverse Event|0
4880740|NCT00761150|16818935|P3|Double-blind Period|Lack of Efficacy|19
4880741|NCT00761150|16818936|P2|Double-blind Period|Lack of Efficacy|2
4880742|NCT00761150|16818937|P1|Double-blind Period|Lack of Efficacy|0
4880743|NCT00761150|16818935|P3|Open-label Period|Other|0
4880744|NCT00761150|16818936|P2|Open-label Period|Other|0
4880745|NCT00761150|16818937|P1|Open-label Period|Other|5
4880746|NCT00761150|16818935|P3|Open-label Period|Noncompliance|0
4880747|NCT00761150|16818936|P2|Open-label Period|Noncompliance|0
4880748|NCT00761150|16818937|P1|Open-label Period|Noncompliance|2
4880749|NCT00761150|16818935|P3|Open-label Period|Withdrawal by Subject|0
4880750|NCT00761150|16818936|P2|Open-label Period|Withdrawal by Subject|0
4880751|NCT00761150|16818937|P1|Open-label Period|Withdrawal by Subject|5
4880752|NCT00761150|16818935|P3|Open-label Period|Lack of Efficacy|0
4880753|NCT00761150|16818936|P2|Open-label Period|Lack of Efficacy|0
4880754|NCT00761150|16818937|P1|Open-label Period|Lack of Efficacy|4
4880755|NCT00761150|16818935|P3|Open-label Period|Lost to Follow-up|0
4880756|NCT00761150|16818936|P2|Open-label Period|Lost to Follow-up|0
4880757|NCT00761150|16818937|P1|Open-label Period|Lost to Follow-up|7
4880758|NCT00761150|16818935|P3|Open-label Period|Did not meet DB randomization criteria|0
4880759|NCT00761150|16818936|P2|Open-label Period|Did not meet DB randomization criteria|0
4880760|NCT00761150|16818937|P1|Open-label Period|Did not meet DB randomization criteria|11
4880761|NCT00761150|16818935|P3|Open-label Period|Adverse Event|0
4880762|NCT00761150|16818936|P2|Open-label Period|Adverse Event|0
4880763|NCT00761150|16818937|P1|Open-label Period|Adverse Event|36
4880764|NCT00760994|16819010|P3|Overall Study|Lost to Follow-up|3
4880765|NCT00760994|16819011|P2|Overall Study|Lost to Follow-up|4
4880766|NCT00760994|16819012|P1|Overall Study|Lost to Follow-up|4
4880767|NCT00760877|16819025|P2|Overall Study|Treatment failure|0
4880768|NCT00760877|16819026|P1|Overall Study|Treatment failure|1
4880769|NCT00760877|16819025|P2|Overall Study|Participants transferred to AMN107A2408|1
4880770|NCT00760877|16819026|P1|Overall Study|Participants transferred to AMN107A2408|11
4880771|NCT00760877|16819025|P2|Overall Study|Physician Decision|2
4880772|NCT00760877|16819026|P1|Overall Study|Physician Decision|1
4880773|NCT00760877|16819025|P2|Overall Study|Participant not eligible to cross-over|1
4880774|NCT00760877|16819026|P1|Overall Study|Participant not eligible to cross-over|0
4880775|NCT00760877|16819025|P2|Overall Study|Participant diagnosed with AML|1
4880776|NCT00760877|16819026|P1|Overall Study|Participant diagnosed with AML|0
4880777|NCT00760877|16819025|P2|Overall Study|Adverse Event|12
4880778|NCT00760877|16819026|P1|Overall Study|Adverse Event|19
4880779|NCT00760877|16819025|P2|Overall Study|Withdrawal by Subject|3
4880780|NCT00760877|16819026|P1|Overall Study|Withdrawal by Subject|7
4880781|NCT00760877|16819025|P2|Overall Study|Death|1
4880782|NCT00760877|16819026|P1|Overall Study|Death|2
4880783|NCT00760877|16819025|P2|Overall Study|Pregnancy|4
4880784|NCT00760877|16819026|P1|Overall Study|Pregnancy|1
4880785|NCT00760877|16819025|P2|Overall Study|Non-compliance with protocol treatment|1
4880786|NCT00760877|16819026|P1|Overall Study|Non-compliance with protocol treatment|2
4880787|NCT00760877|16819025|P2|Overall Study|Protocol Violation|0
4880788|NCT00760877|16819026|P1|Overall Study|Protocol Violation|1
4880789|NCT00760838|16819044|P2|Overall Study|Withdrawal by Subject|1
4880790|NCT00760838|16819045|P1|Overall Study|Withdrawal by Subject|1
4880791|NCT00760838|16819044|P2|Overall Study|Lost to Follow-up|0
4880792|NCT00760838|16819045|P1|Overall Study|Lost to Follow-up|2
4880793|NCT00760838|16819044|P2|Overall Study|Lack of Efficacy|0
4880794|NCT00760838|16819045|P1|Overall Study|Lack of Efficacy|1
4880795|NCT00760838|16819044|P2|Overall Study|Adverse Event|1
4880796|NCT00760838|16819045|P1|Overall Study|Adverse Event|1
4880797|NCT00760747|16819063|P2|Study Period III|Physician Decision|1
4880798|NCT00760747|16819064|P1|Study Period III|Physician Decision|0
4880799|NCT00760747|16819063|P2|Study Period III|Protocol Violation|1
4880800|NCT00760747|16819064|P1|Study Period III|Protocol Violation|1
4880801|NCT00760747|16819063|P2|Study Period III|Parent/Caregiver Decision|1
4880802|NCT00760747|16819064|P1|Study Period III|Parent/Caregiver Decision|0
4880803|NCT00760747|16819063|P2|Study Period III|Lack of Efficacy|0
4880804|NCT00760747|16819064|P1|Study Period III|Lack of Efficacy|1
4880805|NCT00760747|16819063|P2|Study Period III|Adverse Event|0
4880806|NCT00760747|16819064|P1|Study Period III|Adverse Event|1
4880807|NCT00760747|16819063|P2|Study Period II|No drug administered|1
4880808|NCT00760747|16819064|P1|Study Period II|No drug administered|0
4880809|NCT00760747|16819063|P2|Study Period II|Withdrawal by Subject|0
4880810|NCT00760747|16819064|P1|Study Period II|Withdrawal by Subject|1
4880811|NCT00760747|16819063|P2|Study Period II|Protocol Violation|3
4880812|NCT00760747|16819064|P1|Study Period II|Protocol Violation|6
4880813|NCT00760747|16819063|P2|Study Period II|Parent/Caregiver Decision|0
4880814|NCT00760747|16819064|P1|Study Period II|Parent/Caregiver Decision|3
4880815|NCT00760747|16819063|P2|Study Period II|Lack of Efficacy|6
4880816|NCT00760747|16819064|P1|Study Period II|Lack of Efficacy|0
4880817|NCT00760747|16819063|P2|Study Period II|Adverse Event|4
4880818|NCT00760747|16819064|P1|Study Period II|Adverse Event|3
4880819|NCT00760669|16819092|P1|Overall Study|Took drug before entering in contract|5
4880820|NCT00760669|16819092|P1|Overall Study|Participants with overlapping cases|1
4880821|NCT00760669|16819092|P1|Overall Study|Participants missing efficacy assessment|6
4880822|NCT00760669|16819092|P1|Overall Study|Not assessed for overall improvement|18
4880823|NCT00760617|16819109|P3|Overall Study|Lost to Follow-up|5
4880824|NCT00760617|16819110|P2|Overall Study|Lost to Follow-up|0
4880825|NCT00760617|16819111|P1|Overall Study|Lost to Follow-up|0
4880826|NCT00760617|16819109|P3|Overall Study|Adverse Event|0
4880827|NCT00760617|16819110|P2|Overall Study|Adverse Event|2
4880828|NCT00760617|16819111|P1|Overall Study|Adverse Event|5
4880829|NCT00760552|16819225|P2|Overall Study|Lost to Follow-up|10
4880830|NCT00760552|16819226|P1|Overall Study|Lost to Follow-up|11
4880831|NCT00760552|16819225|P2|Overall Study|Death|0
4880832|NCT00760552|16819226|P1|Overall Study|Death|2
4880833|NCT00760513|16819262|P2|Overall Study|Withdrawal by Subject|7
4880834|NCT00760513|16819263|P1|Overall Study|Withdrawal by Subject|5
4880835|NCT00760487|16819273|P1|Overall Study|Unilateral implantation|3
4880836|NCT00760474|16819279|P2|Period 2 (P2)|Adverse Event|1
4880837|NCT00760474|16819280|P1|Period 2 (P2)|Adverse Event|0
4880838|NCT00760474|16819279|P2|Period 2 (P2)|Lost to Follow-up|0
4880839|NCT00760474|16819280|P1|Period 2 (P2)|Lost to Follow-up|1
4880840|NCT00760474|16819279|P2|Placebo Washout Period|Other|1
4880841|NCT00760474|16819280|P1|Placebo Washout Period|Other|0
4880842|NCT00760474|16819279|P2|Period 1 (P1)|Discontinued then re-entered|1
4880843|NCT00760474|16819280|P1|Period 1 (P1)|Discontinued then re-entered|1
4880844|NCT00760383|16819337|P2|Overall Study|moved away; withdrew; medical reasons|7
4880845|NCT00760383|16819338|P1|Overall Study|moved away; withdrew; medical reasons|5
4880846|NCT00760266|16819350|P2|Overall Study|Administrative Problems|1
4880847|NCT00760266|16819351|P1|Overall Study|Administrative Problems|0
4880848|NCT00760266|16819350|P2|Overall Study|Lost to Follow-up|1
4880849|NCT00760266|16819351|P1|Overall Study|Lost to Follow-up|2
4880850|NCT00760266|16819350|P2|Overall Study|Patient withdrew consent|3
4880851|NCT00760266|16819351|P1|Overall Study|Patient withdrew consent|3
4880852|NCT00760266|16819350|P2|Overall Study|Protocol deviation|4
4880853|NCT00760266|16819351|P1|Overall Study|Protocol deviation|2
4880854|NCT00760266|16819350|P2|Overall Study|Lack of Efficacy|2
4880855|NCT00760266|16819351|P1|Overall Study|Lack of Efficacy|2
4880856|NCT00760266|16819350|P2|Overall Study|Abnormal test procedure result(s)|0
4880857|NCT00760266|16819351|P1|Overall Study|Abnormal test procedure result(s)|1
4880858|NCT00760266|16819350|P2|Overall Study|Abnormal laboratory value(s)|0
4880859|NCT00760266|16819351|P1|Overall Study|Abnormal laboratory value(s)|1
4880860|NCT00760266|16819350|P2|Overall Study|Adverse Event|7
4880861|NCT00760266|16819351|P1|Overall Study|Adverse Event|13
4880862|NCT00760214|16819368|P3|Overall Study|Other|6
4880863|NCT00760214|16819369|P2|Overall Study|Other|4
4880864|NCT00760214|16819370|P1|Overall Study|Other|3
4880865|NCT00760214|16819368|P3|Overall Study|Physician Decision|1
4880866|NCT00760214|16819369|P2|Overall Study|Physician Decision|1
4880867|NCT00760214|16819370|P1|Overall Study|Physician Decision|1
4880868|NCT00760214|16819368|P3|Overall Study|Pregnancy|1
4880869|NCT00760214|16819369|P2|Overall Study|Pregnancy|0
4880870|NCT00760214|16819370|P1|Overall Study|Pregnancy|0
4880871|NCT00760214|16819368|P3|Overall Study|Lack of Efficacy|4
4880872|NCT00760214|16819369|P2|Overall Study|Lack of Efficacy|2
4880873|NCT00760214|16819370|P1|Overall Study|Lack of Efficacy|3
4880874|NCT00760214|16819368|P3|Overall Study|Withdrawal by Subject|13
4880875|NCT00760214|16819369|P2|Overall Study|Withdrawal by Subject|14
4880876|NCT00760214|16819370|P1|Overall Study|Withdrawal by Subject|12
4880877|NCT00760214|16819368|P3|Overall Study|Lost to Follow-up|1
4880878|NCT00760214|16819369|P2|Overall Study|Lost to Follow-up|0
4880879|NCT00760214|16819370|P1|Overall Study|Lost to Follow-up|0
4880880|NCT00760214|16819368|P3|Overall Study|Protocol Violation|3
4880881|NCT00760214|16819369|P2|Overall Study|Protocol Violation|0
4880882|NCT00760214|16819370|P1|Overall Study|Protocol Violation|3
4880883|NCT00760214|16819368|P3|Overall Study|Adverse Event|12
4880884|NCT00760214|16819369|P2|Overall Study|Adverse Event|9
4880885|NCT00760214|16819370|P1|Overall Study|Adverse Event|8
4880886|NCT00760084|16819411|P1|Overall Study|Progressive Disease|3
4880887|NCT00760084|16819411|P1|Overall Study|Withdrawal by Subject|2
4880888|NCT00760084|16819411|P1|Overall Study|Physician Decision|5
4880889|NCT00759954|16819454|P2|Overall Study|Adverse Event|2
4880890|NCT00759954|16819455|P1|Overall Study|Adverse Event|1
4880891|NCT00759954|16819454|P2|Overall Study|Personal reason|0
4880892|NCT00759954|16819455|P1|Overall Study|Personal reason|1
4880893|NCT00759941|16819469|P2|Overall Study|Exited in error by site|1
4880894|NCT00759941|16819470|P1|Overall Study|Exited in error by site|1
4880895|NCT00759941|16819469|P2|Overall Study|Adverse Event|0
4880896|NCT00759941|16819470|P1|Overall Study|Adverse Event|1
4880897|NCT00759941|16819469|P2|Overall Study|Use of medication|0
4880898|NCT00759941|16819470|P1|Overall Study|Use of medication|1
4880899|NCT00759915|16819484|P2|Overall Study|Adverse Event|1
4880900|NCT00759915|16819485|P1|Overall Study|Adverse Event|0
4880901|NCT00759915|16819484|P2|Overall Study|Withdrawal by Subject|0
4880902|NCT00759915|16819485|P1|Overall Study|Withdrawal by Subject|1
4880903|NCT00759902|16819499|P2|Overall Study|Adverse Event|1
4880904|NCT00759902|16819500|P1|Overall Study|Adverse Event|0
4880905|NCT00759863|16819514|P2|Overall Study|Death, moved, or lost contact|18
4880906|NCT00759863|16819515|P1|Overall Study|Death, moved, or lost contact|20
4880907|NCT00759785|16819536|P2|Overall Study|Withdrawal by Subject|1
4880908|NCT00759785|16819537|P1|Overall Study|Withdrawal by Subject|0
4880909|NCT00759785|16819536|P2|Overall Study|Physician Decision|1
4880910|NCT00759785|16819537|P1|Overall Study|Physician Decision|0
4880911|NCT00759785|16819536|P2|Overall Study|Protocol Violation|0
4880912|NCT00759785|16819537|P1|Overall Study|Protocol Violation|1
4880913|NCT00759785|16819536|P2|Overall Study|Participant sample lost|1
4880914|NCT00759785|16819537|P1|Overall Study|Participant sample lost|0
4880915|NCT00759785|16819536|P2|Overall Study|Participant sample not evaluable|2
4880916|NCT00759785|16819537|P1|Overall Study|Participant sample not evaluable|11
4880917|NCT00759759|16819560|P2|Overall Study|Withdrawal by Subject|1
4880918|NCT00759759|16819561|P1|Overall Study|Withdrawal by Subject|2
4880919|NCT00759759|16819560|P2|Overall Study|Didn't receive drug in period 2|0
4880920|NCT00759759|16819561|P1|Overall Study|Didn't receive drug in period 2|1
4880921|NCT00759759|16819560|P2|Overall Study|didn't return for period 2|0
4880922|NCT00759759|16819561|P1|Overall Study|didn't return for period 2|1
4880923|NCT00759681|16819579|P2|Overall Study|Lost to Follow-up|5
4880924|NCT00759681|16819580|P1|Overall Study|Lost to Follow-up|8
4880925|NCT00759681|16819579|P2|Overall Study|Death|5
4880926|NCT00759681|16819580|P1|Overall Study|Death|2
4880927|NCT00759655|16819607|P1|Overall Study|Termination of the study by sponsor|1
4880928|NCT00759564|16819635|P5|Washout Period (at Least 14 Days)|Adverse Event|1
4880929|NCT00759564|16819636|P4|Washout Period (at Least 14 Days)|Adverse Event|0
4880930|NCT00759564|16819637|P3|Washout Period (at Least 14 Days)|Adverse Event|0
4880931|NCT00759564|16819638|P2|Washout Period (at Least 14 Days)|Adverse Event|0
4880932|NCT00759564|16819639|P1|Washout Period (at Least 14 Days)|Adverse Event|0
4880933|NCT00759395|16819816|P2|Overall Study|Lack of Efficacy|2
4880934|NCT00759395|16819817|P1|Overall Study|Lack of Efficacy|0
4880935|NCT00759395|16819816|P2|Overall Study|Withdrawal by Subject|0
4880936|NCT00759395|16819817|P1|Overall Study|Withdrawal by Subject|1
4880937|NCT00759395|16819816|P2|Overall Study|Adverse Event|0
4880938|NCT00759395|16819817|P1|Overall Study|Adverse Event|1
4880939|NCT00759356|16819833|P2|Overall Study|Subject was unable to return|0
4880940|NCT00759356|16819834|P1|Overall Study|Subject was unable to return|1
4880941|NCT00759356|16819833|P2|Overall Study|Withdrawal by Subject|2
4880942|NCT00759356|16819834|P1|Overall Study|Withdrawal by Subject|0
4880943|NCT00759356|16819833|P2|Overall Study|Adverse Event|1
4880944|NCT00759356|16819834|P1|Overall Study|Adverse Event|0
4880945|NCT00759174|16819914|P2|Overall Study|Other|2
4880946|NCT00759174|16819915|P1|Overall Study|Other|0
4880947|NCT00759148|16819939|P2|Overall Study|Reason not given|0
4880948|NCT00759148|16819940|P1|Overall Study|Reason not given|1
4880949|NCT00759148|16819939|P2|Overall Study|Treatment Failure|10
4880950|NCT00759148|16819940|P1|Overall Study|Treatment Failure|6
4880951|NCT00759148|16819939|P2|Overall Study|Lost to Follow-up|9
4880952|NCT00759148|16819940|P1|Overall Study|Lost to Follow-up|3
4880953|NCT00759148|16819939|P2|Overall Study|Withdrawal by Subject|7
4880954|NCT00759148|16819940|P1|Overall Study|Withdrawal by Subject|3
4880955|NCT00759148|16819939|P2|Overall Study|Adverse Event|6
4880956|NCT00759148|16819940|P1|Overall Study|Adverse Event|1
4880957|NCT00759109|16819950|P2|Overall Study|Lost during study|0
4880958|NCT00759109|16819951|P1|Overall Study|Lost during study|1
4880959|NCT00759109|16819950|P2|Overall Study|Participant had a liver transplant|1
4880960|NCT00759109|16819951|P1|Overall Study|Participant had a liver transplant|0
4880961|NCT00759109|16819950|P2|Overall Study|Participant moved to a different city|1
4880962|NCT00759109|16819951|P1|Overall Study|Participant moved to a different city|0
4880963|NCT00759109|16819950|P2|Overall Study|HCV RNA negative|0
4880964|NCT00759109|16819951|P1|Overall Study|HCV RNA negative|1
4880965|NCT00759109|16819950|P2|Overall Study|Started new therapy|6
4880966|NCT00759109|16819951|P1|Overall Study|Started new therapy|2
4880967|NCT00759109|16819950|P2|Overall Study|Lost to Follow-up|6
4880968|NCT00759109|16819951|P1|Overall Study|Lost to Follow-up|4
4880969|NCT00759109|16819950|P2|Overall Study|Death|3
4880970|NCT00759109|16819951|P1|Overall Study|Death|4
4880971|NCT00759109|16819950|P2|Overall Study|Withdrawal by Subject|5
4880972|NCT00759109|16819951|P1|Overall Study|Withdrawal by Subject|9
4880973|NCT00759109|16819950|P2|Overall Study|Inability to comply|1
4880974|NCT00759109|16819951|P1|Overall Study|Inability to comply|1
4880975|NCT00759109|16819950|P2|Overall Study|Adverse Event|12
4880976|NCT00759109|16819951|P1|Overall Study|Adverse Event|17
4880977|NCT00759031|16819973|P2|First Intervention (1 Day)|Screening failure|0
4880978|NCT00759031|16819974|P1|First Intervention (1 Day)|Screening failure|1
4880979|NCT00759031|16819973|P2|First Intervention (1 Day)|Withdrawal by Subject|1
4880980|NCT00759031|16819974|P1|First Intervention (1 Day)|Withdrawal by Subject|0
4880981|NCT00759031|16819973|P2|First Intervention (1 Day)|Physician Decision|0
4880982|NCT00759031|16819974|P1|First Intervention (1 Day)|Physician Decision|1
4880983|NCT00758771|16820033|P2|Overall Study|Did not meet eligibility criteria|4
4880984|NCT00758771|16820034|P1|Overall Study|Did not meet eligibility criteria|2
4880985|NCT00758771|16820033|P2|Overall Study|Withdrawal by Subject|1
4880986|NCT00758771|16820034|P1|Overall Study|Withdrawal by Subject|1
4880987|NCT00758706|16820092|P2|Overall Study|Adverse Event|4
4880988|NCT00758706|16820093|P1|Overall Study|Adverse Event|4
4880989|NCT00758680|16820129|P10|Overall Study|Withdrawal by Subject|0
4880990|NCT00758680|16820130|P9|Overall Study|Withdrawal by Subject|1
4880991|NCT00758680|16820131|P8|Overall Study|Withdrawal by Subject|0
4880992|NCT00758680|16820132|P7|Overall Study|Withdrawal by Subject|1
4880993|NCT00758680|16820133|P6|Overall Study|Withdrawal by Subject|0
4880994|NCT00758680|16820134|P5|Overall Study|Withdrawal by Subject|0
4880995|NCT00758680|16820135|P4|Overall Study|Withdrawal by Subject|0
4880996|NCT00758680|16820136|P3|Overall Study|Withdrawal by Subject|0
4880997|NCT00758680|16820137|P2|Overall Study|Withdrawal by Subject|0
4880998|NCT00758680|16820138|P1|Overall Study|Withdrawal by Subject|0
4880999|NCT00758680|16820129|P10|Overall Study|Laboratory Adverse Event|0
4881000|NCT00758680|16820130|P9|Overall Study|Laboratory Adverse Event|1
4881001|NCT00758680|16820131|P8|Overall Study|Laboratory Adverse Event|0
4881002|NCT00758680|16820132|P7|Overall Study|Laboratory Adverse Event|0
4881003|NCT00758680|16820133|P6|Overall Study|Laboratory Adverse Event|0
4881004|NCT00758680|16820134|P5|Overall Study|Laboratory Adverse Event|0
4881005|NCT00758680|16820135|P4|Overall Study|Laboratory Adverse Event|0
4881006|NCT00758680|16820136|P3|Overall Study|Laboratory Adverse Event|0
4881007|NCT00758680|16820137|P2|Overall Study|Laboratory Adverse Event|0
4881008|NCT00758680|16820138|P1|Overall Study|Laboratory Adverse Event|0
4881009|NCT00758680|16820129|P10|Overall Study|Adverse Event|1
4881010|NCT00758680|16820130|P9|Overall Study|Adverse Event|0
4881011|NCT00758680|16820131|P8|Overall Study|Adverse Event|1
4881012|NCT00758680|16820132|P7|Overall Study|Adverse Event|0
4881013|NCT00758680|16820133|P6|Overall Study|Adverse Event|0
4881014|NCT00758680|16820134|P5|Overall Study|Adverse Event|0
4881015|NCT00758680|16820135|P4|Overall Study|Adverse Event|0
4881016|NCT00758680|16820136|P3|Overall Study|Adverse Event|0
4881017|NCT00758680|16820137|P2|Overall Study|Adverse Event|0
4881018|NCT00758680|16820138|P1|Overall Study|Adverse Event|0
4881019|NCT00758602|16820191|P2|Overall Study|Reason not specified|3
4881020|NCT00758602|16820192|P1|Overall Study|Reason not specified|3
4881021|NCT00758602|16820191|P2|Overall Study|Death|1
4881022|NCT00758602|16820192|P1|Overall Study|Death|0
4881023|NCT00758602|16820191|P2|Overall Study|Protocol Violation|2
4881024|NCT00758602|16820192|P1|Overall Study|Protocol Violation|0
4881025|NCT00758602|16820191|P2|Overall Study|Withdrawal by Subject|3
4881026|NCT00758602|16820192|P1|Overall Study|Withdrawal by Subject|1
4881027|NCT00758602|16820191|P2|Overall Study|Lost to Follow-up|3
4881028|NCT00758602|16820192|P1|Overall Study|Lost to Follow-up|4
4881029|NCT00758602|16820191|P2|Overall Study|Adverse Event|10
4881030|NCT00758602|16820192|P1|Overall Study|Adverse Event|11
4881031|NCT00758589|16820218|P4|Overall Study|Palm stopped to work|1
4881032|NCT00758589|16820219|P3|Overall Study|Palm stopped to work|0
4881033|NCT00758589|16820220|P2|Overall Study|Palm stopped to work|0
4881034|NCT00758589|16820221|P1|Overall Study|Palm stopped to work|0
4881035|NCT00758589|16820218|P4|Overall Study|Withdrawal by Subject|1
4881036|NCT00758589|16820219|P3|Overall Study|Withdrawal by Subject|1
4881037|NCT00758589|16820220|P2|Overall Study|Withdrawal by Subject|1
4881038|NCT00758589|16820221|P1|Overall Study|Withdrawal by Subject|0
4881039|NCT00758589|16820218|P4|Overall Study|Adverse Event|4
4881040|NCT00758589|16820219|P3|Overall Study|Adverse Event|5
4881041|NCT00758589|16820220|P2|Overall Study|Adverse Event|2
4881042|NCT00758589|16820221|P1|Overall Study|Adverse Event|3
4881043|NCT00758498|16820314|P3|Overall Study|Noncompliance to study procedures|1
4881044|NCT00758498|16820315|P2|Overall Study|Noncompliance to study procedures|0
4881045|NCT00758498|16820316|P1|Overall Study|Noncompliance to study procedures|0
4881046|NCT00758498|16820314|P3|Overall Study|Withdrawal by Subject|1
4881047|NCT00758498|16820315|P2|Overall Study|Withdrawal by Subject|0
4881048|NCT00758498|16820316|P1|Overall Study|Withdrawal by Subject|0
4881049|NCT00758498|16820314|P3|Overall Study|Subject legally detained out of state|0
4881050|NCT00758498|16820315|P2|Overall Study|Subject legally detained out of state|0
4881051|NCT00758498|16820316|P1|Overall Study|Subject legally detained out of state|1
4881052|NCT00758498|16820314|P3|Overall Study|Adverse Event|3
4881053|NCT00758498|16820315|P2|Overall Study|Adverse Event|2
4881054|NCT00758498|16820316|P1|Overall Study|Adverse Event|2
4881055|NCT00758485|16820401|P2|Overall Study|Not Treated|2
4881056|NCT00758485|16820402|P1|Overall Study|Not Treated|1
4881057|NCT00758485|16820401|P2|Overall Study|Lost to Follow-up|1
4881058|NCT00758485|16820402|P1|Overall Study|Lost to Follow-up|0
4881059|NCT00758459|16820414|P2|Overall Study|Withdrawal by Subject|1
4881060|NCT00758459|16820415|P1|Overall Study|Withdrawal by Subject|0
4881061|NCT00758459|16820414|P2|Overall Study|Protocol Violation|1
4881062|NCT00758459|16820415|P1|Overall Study|Protocol Violation|0
4881063|NCT00758459|16820414|P2|Overall Study|Adverse Event|2
4881064|NCT00758459|16820415|P1|Overall Study|Adverse Event|3
4881065|NCT00758394|16820460|P4|3rd Intervention|Lost to Follow-up|1
4881066|NCT00758394|16820461|P3|3rd Intervention|Lost to Follow-up|0
4881067|NCT00758394|16820462|P2|3rd Intervention|Lost to Follow-up|0
4881068|NCT00758394|16820463|P1|3rd Intervention|Lost to Follow-up|1
4881069|NCT00758394|16820460|P4|2nd Intervention Order|Lost to Follow-up|0
4881070|NCT00758394|16820461|P3|2nd Intervention Order|Lost to Follow-up|0
4881071|NCT00758394|16820462|P2|2nd Intervention Order|Lost to Follow-up|1
4881072|NCT00758394|16820463|P1|2nd Intervention Order|Lost to Follow-up|0
4881073|NCT00758264|16820492|P3|Active Phase|Other|4
4881074|NCT00758264|16820493|P2|Active Phase|Other|0
4881075|NCT00758264|16820494|P1|Active Phase|Other|0
4881076|NCT00758264|16820492|P3|Active Phase|Lost to Follow-up|0
4881077|NCT00758264|16820493|P2|Active Phase|Lost to Follow-up|0
4881078|NCT00758264|16820494|P1|Active Phase|Lost to Follow-up|1
4881079|NCT00758264|16820492|P3|Active Phase|Withdrawal by Subject|1
4881080|NCT00758264|16820493|P2|Active Phase|Withdrawal by Subject|0
4881081|NCT00758264|16820494|P1|Active Phase|Withdrawal by Subject|0
4881082|NCT00758160|16820553|P1|Overall Study|Withdrawal by Subject|8
4881083|NCT00758160|16820553|P1|Overall Study|Protocol Violation|12
4881084|NCT00758160|16820553|P1|Overall Study|Lost to Follow-up|14
4881085|NCT00758160|16820553|P1|Overall Study|Lack of Efficacy|10
4881086|NCT00758160|16820553|P1|Overall Study|Adverse Event|15
4881087|NCT00758160|16820553|P1|Overall Study|Administration Problems|3
4881088|NCT00758160|16820553|P1|Overall Study|No Longer Requires Study Medication|4
4881089|NCT00758069|16820574|P3|Overall Study|Incorrect Study Drug|0
4881090|NCT00758069|16820575|P2|Overall Study|Incorrect Study Drug|0
4881091|NCT00758069|16820576|P1|Overall Study|Incorrect Study Drug|1
4881092|NCT00758069|16820574|P3|Overall Study|Lack of Efficacy|1
4881093|NCT00758069|16820575|P2|Overall Study|Lack of Efficacy|0
4881094|NCT00758069|16820576|P1|Overall Study|Lack of Efficacy|0
4881095|NCT00758043|16820591|P4|Overall Study|Other Reasons|5
4881096|NCT00758043|16820592|P3|Overall Study|Other Reasons|0
4881097|NCT00758043|16820593|P2|Overall Study|Other Reasons|1
4881098|NCT00758043|16820594|P1|Overall Study|Other Reasons|0
4881099|NCT00758043|16820591|P4|Overall Study|Non-Compliant With study Drug|1
4881100|NCT00758043|16820592|P3|Overall Study|Non-Compliant With study Drug|0
4881101|NCT00758043|16820593|P2|Overall Study|Non-Compliant With study Drug|0
4881102|NCT00758043|16820594|P1|Overall Study|Non-Compliant With study Drug|0
4881103|NCT00758043|16820591|P4|Overall Study|Required Prohibited Medication|3
4881104|NCT00758043|16820592|P3|Overall Study|Required Prohibited Medication|1
4881105|NCT00758043|16820593|P2|Overall Study|Required Prohibited Medication|0
4881106|NCT00758043|16820594|P1|Overall Study|Required Prohibited Medication|0
4881107|NCT00758043|16820591|P4|Overall Study|Withdrawal by Subject|4
4881108|NCT00758043|16820592|P3|Overall Study|Withdrawal by Subject|1
4881109|NCT00758043|16820593|P2|Overall Study|Withdrawal by Subject|1
4881110|NCT00758043|16820594|P1|Overall Study|Withdrawal by Subject|0
4881111|NCT00758043|16820591|P4|Overall Study|Lost to Follow-up|5
4881112|NCT00758043|16820592|P3|Overall Study|Lost to Follow-up|2
4881113|NCT00758043|16820593|P2|Overall Study|Lost to Follow-up|2
4881114|NCT00758043|16820594|P1|Overall Study|Lost to Follow-up|0
4881115|NCT00758043|16820591|P4|Overall Study|Refused Further Treatment|8
4881116|NCT00758043|16820592|P3|Overall Study|Refused Further Treatment|5
4881117|NCT00758043|16820593|P2|Overall Study|Refused Further Treatment|11
4881118|NCT00758043|16820594|P1|Overall Study|Refused Further Treatment|0
4881119|NCT00758043|16820591|P4|Overall Study|Lack of Efficacy|12
4881120|NCT00758043|16820592|P3|Overall Study|Lack of Efficacy|18
4881121|NCT00758043|16820593|P2|Overall Study|Lack of Efficacy|6
4881122|NCT00758043|16820594|P1|Overall Study|Lack of Efficacy|0
4881123|NCT00758043|16820591|P4|Overall Study|Adverse Event|62
4881124|NCT00758043|16820592|P3|Overall Study|Adverse Event|12
4881125|NCT00758043|16820593|P2|Overall Study|Adverse Event|20
4881126|NCT00758043|16820594|P1|Overall Study|Adverse Event|1
4881127|NCT00757848|16820622|P2|Overall Study|Incorrect enrolment|0
4881128|NCT00757848|16820623|P1|Overall Study|Incorrect enrolment|1
4881129|NCT00757848|16820622|P2|Overall Study|Adverse Event|2
4881130|NCT00757848|16820623|P1|Overall Study|Adverse Event|1
4881131|NCT00757848|16820622|P2|Overall Study|Voluntary discontinuation|0
4881132|NCT00757848|16820623|P1|Overall Study|Voluntary discontinuation|1
4881133|NCT00757783|16820692|P2|Overall Study|Other|2
4881134|NCT00757783|16820693|P1|Overall Study|Other|1
4881135|NCT00757783|16820692|P2|Overall Study|Withdrawal by Subject|1
4881136|NCT00757783|16820693|P1|Overall Study|Withdrawal by Subject|2
4881137|NCT00757783|16820692|P2|Overall Study|Protocol Violation|0
4881138|NCT00757783|16820693|P1|Overall Study|Protocol Violation|1
4881139|NCT00757783|16820692|P2|Overall Study|Lost to Follow-up|1
4881140|NCT00757783|16820693|P1|Overall Study|Lost to Follow-up|1
4881141|NCT00757783|16820692|P2|Overall Study|Adverse Event|2
4881142|NCT00757783|16820693|P1|Overall Study|Adverse Event|0
4881143|NCT00757705|16820729|P1|Overall Study|Other|18
4881144|NCT00757705|16820729|P1|Overall Study|Non-compliant|9
4881145|NCT00757705|16820729|P1|Overall Study|Ineligible to continue|8
4881146|NCT00757705|16820729|P1|Overall Study|Insufficient Response|26
4881147|NCT00757705|16820729|P1|Overall Study|Withdrawal by Subject|25
4881148|NCT00757705|16820729|P1|Overall Study|Lost to Follow-up|16
4881149|NCT00757705|16820729|P1|Overall Study|Adverse Event|19
4881150|NCT00757627|16820758|P1|Overall Study|Other|1
4881151|NCT00757627|16820758|P1|Overall Study|Withdrawal by Subject|27
4881152|NCT00757627|16820758|P1|Overall Study|Lost to Follow-up|28
4881153|NCT00757627|16820758|P1|Overall Study|Lack of Efficacy|10
4881154|NCT00757627|16820758|P1|Overall Study|Adverse Event|15
4881155|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Other|0
4881156|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Other|1
4881157|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4
4881158|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5
4881159|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Pregnancy|0
4881160|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Pregnancy|1
4881161|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2
4881162|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5
4881163|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
4881164|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1
4881165|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2
4881166|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4
4881167|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Adverse Event|0
4881168|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Adverse Event|4
4881169|NCT00757588|16820893|P2|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0
4881170|NCT00757588|16820894|P1|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1
4881171|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Other|1
4881172|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Other|0
4881173|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0
4881174|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5
4881175|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1
4881176|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5
4881177|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5
4881178|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3
4881179|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Death|0
4881180|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Death|1
4881181|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5
4881182|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13
4881183|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Adverse Event|3
4881184|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Adverse Event|6
4881185|NCT00757588|16820893|P2|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2
4881186|NCT00757588|16820894|P1|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3
4881187|NCT00757237|16820935|P2|Overall Study|Other|2
4881188|NCT00757237|16820936|P1|Overall Study|Other|0
4881189|NCT00757237|16820935|P2|Overall Study|Safety or Tolerability|5
4881190|NCT00757237|16820936|P1|Overall Study|Safety or Tolerability|3
4881191|NCT00757237|16820935|P2|Overall Study|Withdrawal by Subject|12
4881192|NCT00757237|16820936|P1|Overall Study|Withdrawal by Subject|8
4881193|NCT00757237|16820935|P2|Overall Study|Physician Decision|3
4881194|NCT00757237|16820936|P1|Overall Study|Physician Decision|2
4881195|NCT00757237|16820935|P2|Overall Study|Protocol Violation|2
4881196|NCT00757237|16820936|P1|Overall Study|Protocol Violation|0
4881197|NCT00757237|16820935|P2|Overall Study|Lost to Follow-up|1
4881198|NCT00757237|16820936|P1|Overall Study|Lost to Follow-up|0
4881199|NCT00757172|16820964|P1|Overall Study|Progression|4
4881200|NCT00757172|16820964|P1|Overall Study|Physician Decision|3
4881201|NCT00757172|16820964|P1|Overall Study|Withdrawal by Subject|4
4881202|NCT00757003|16820972|P1|Overall Study|Not implanted|1
4881203|NCT00757003|16820972|P1|Overall Study|Surgically explanted|2
4881204|NCT00757003|16820972|P1|Overall Study|Withdrawal by Subject|4
4881205|NCT00757003|16820972|P1|Overall Study|Lost to Follow-up|9
4881206|NCT00757003|16820972|P1|Overall Study|Death|33
4881207|NCT00756938|16821019|P4|Optional Extension|Adverse Event|1
4881208|NCT00756938|16821020|P3|Optional Extension|Adverse Event|0
4881209|NCT00756938|16821021|P2|Optional Extension|Adverse Event|0
4881210|NCT00756938|16821022|P1|Optional Extension|Adverse Event|0
4881211|NCT00756938|16821019|P4|Optional Extension|Withdrawal by Subject|10
4881212|NCT00756938|16821020|P3|Optional Extension|Withdrawal by Subject|0
4881213|NCT00756938|16821021|P2|Optional Extension|Withdrawal by Subject|0
4881214|NCT00756938|16821022|P1|Optional Extension|Withdrawal by Subject|0
4881215|NCT00756938|16821019|P4|Optional Extension|Protocol Violation|1
4881216|NCT00756938|16821020|P3|Optional Extension|Protocol Violation|0
4881217|NCT00756938|16821021|P2|Optional Extension|Protocol Violation|0
4881218|NCT00756938|16821022|P1|Optional Extension|Protocol Violation|0
4881219|NCT00756938|16821019|P4|Optional Extension|Lost to Follow-up|1
4881220|NCT00756938|16821020|P3|Optional Extension|Lost to Follow-up|0
4881221|NCT00756938|16821021|P2|Optional Extension|Lost to Follow-up|0
4881222|NCT00756938|16821022|P1|Optional Extension|Lost to Follow-up|0
4881223|NCT00756938|16821019|P4|Optional Extension|Physician Decision|3
4881224|NCT00756938|16821020|P3|Optional Extension|Physician Decision|0
4881225|NCT00756938|16821021|P2|Optional Extension|Physician Decision|0
4881226|NCT00756938|16821022|P1|Optional Extension|Physician Decision|0
4881227|NCT00756938|16821019|P4|Optional Extension|Protocol-specific criteria met|9
4881228|NCT00756938|16821020|P3|Optional Extension|Protocol-specific criteria met|0
4881229|NCT00756938|16821021|P2|Optional Extension|Protocol-specific criteria met|0
4881230|NCT00756938|16821022|P1|Optional Extension|Protocol-specific criteria met|0
4881231|NCT00756938|16821019|P4|Optional Extension|End of Study|11
4881232|NCT00756938|16821020|P3|Optional Extension|End of Study|0
4881233|NCT00756938|16821021|P2|Optional Extension|End of Study|0
4881234|NCT00756938|16821022|P1|Optional Extension|End of Study|0
4881235|NCT00756938|16821019|P4|Optional Extension|Lack of Efficacy|1
4881236|NCT00756938|16821020|P3|Optional Extension|Lack of Efficacy|0
4881237|NCT00756938|16821021|P2|Optional Extension|Lack of Efficacy|0
4881238|NCT00756938|16821022|P1|Optional Extension|Lack of Efficacy|0
4881239|NCT00756938|16821019|P4|12-week Base Study|Lost to Follow-up|0
4881240|NCT00756938|16821020|P3|12-week Base Study|Lost to Follow-up|0
4881241|NCT00756938|16821021|P2|12-week Base Study|Lost to Follow-up|0
4881242|NCT00756938|16821022|P1|12-week Base Study|Lost to Follow-up|1
4881243|NCT00756938|16821019|P4|12-week Base Study|Protocol Violation|0
4881244|NCT00756938|16821020|P3|12-week Base Study|Protocol Violation|1
4881245|NCT00756938|16821021|P2|12-week Base Study|Protocol Violation|0
4881246|NCT00756938|16821022|P1|12-week Base Study|Protocol Violation|0
4881247|NCT00756938|16821019|P4|12-week Base Study|Protocol-specific Criteria Met|0
4881248|NCT00756938|16821020|P3|12-week Base Study|Protocol-specific Criteria Met|1
4881249|NCT00756938|16821021|P2|12-week Base Study|Protocol-specific Criteria Met|0
4881250|NCT00756938|16821022|P1|12-week Base Study|Protocol-specific Criteria Met|1
4881251|NCT00756886|16821050|P2|Overall Study|Ineligible|4
4881252|NCT00756886|16821051|P1|Overall Study|Ineligible|9
4881253|NCT00756886|16821050|P2|Overall Study|Lack of Efficacy|0
4881254|NCT00756886|16821051|P1|Overall Study|Lack of Efficacy|1
4881255|NCT00756886|16821050|P2|Overall Study|Adverse Event|3
4881256|NCT00756886|16821051|P1|Overall Study|Adverse Event|0
4881257|NCT00756886|16821050|P2|Overall Study|Lost to Follow-up|0
4881258|NCT00756886|16821051|P1|Overall Study|Lost to Follow-up|1
4881259|NCT00756730|16821059|P2|Overall Study|persistent low-level viremmia|1
4881260|NCT00756730|16821060|P1|Overall Study|persistent low-level viremmia|0
4881261|NCT00756730|16821059|P2|Overall Study|discontinued due to rash prior to week 4|1
4881262|NCT00756730|16821060|P1|Overall Study|discontinued due to rash prior to week 4|0
4881263|NCT00756717|16821080|P1|Overall Study|Withdrawal by Subject|2
4881264|NCT00756652|16821097|P2|Re-Op Phase|Withdrawn after explant|0
4881265|NCT00756652|16821098|P1|Re-Op Phase|Withdrawn after explant|14
4881266|NCT00756652|16821097|P2|Re-Op Phase|Site Closed|0
4881267|NCT00756652|16821098|P1|Re-Op Phase|Site Closed|2454
4881268|NCT00756652|16821097|P2|Re-Op Phase|Lost to Follow-up|0
4881269|NCT00756652|16821098|P1|Re-Op Phase|Lost to Follow-up|340
4881270|NCT00756652|16821097|P2|Re-Op Phase|Death|0
4881271|NCT00756652|16821098|P1|Re-Op Phase|Death|6
4881272|NCT00756652|16821097|P2|Re-Op Phase|Withdrawal by Subject|0
4881273|NCT00756652|16821098|P1|Re-Op Phase|Withdrawal by Subject|62
4881274|NCT00756652|16821097|P2|Original Phase|Not due for F/U at Phase One closure|2
4881275|NCT00756652|16821098|P1|Original Phase|Not due for F/U at Phase One closure|11076
4881276|NCT00756652|16821097|P2|Original Phase|Death|1
4881277|NCT00756652|16821098|P1|Original Phase|Death|168
4881278|NCT00756652|16821097|P2|Original Phase|Participants without data|466
4881279|NCT00756652|16821098|P1|Original Phase|Participants without data|3259
4881280|NCT00756652|16821097|P2|Original Phase|Unknown Discontinuation Reason|0
4881281|NCT00756652|16821098|P1|Original Phase|Unknown Discontinuation Reason|2
4881282|NCT00756652|16821097|P2|Original Phase|Participant Noncompliance|424
4881283|NCT00756652|16821098|P1|Original Phase|Participant Noncompliance|18622
4881284|NCT00756652|16821097|P2|Original Phase|Other Discontinuation|5
4881285|NCT00756652|16821098|P1|Original Phase|Other Discontinuation|797
4881286|NCT00756652|16821097|P2|Original Phase|Lost to Follow-up|0
4881287|NCT00756652|16821098|P1|Original Phase|Lost to Follow-up|601
4881288|NCT00756652|16821097|P2|Original Phase|Withdrawal by Subject|23
4881289|NCT00756652|16821098|P1|Original Phase|Withdrawal by Subject|864
4881290|NCT00756574|16821209|P2|Overall Study|Lost to Follow-up|4
4881291|NCT00756574|16821210|P1|Overall Study|Lost to Follow-up|4
4881292|NCT00756574|16821209|P2|Overall Study|Withdrawal by Subject|7
4881293|NCT00756574|16821210|P1|Overall Study|Withdrawal by Subject|9
4881294|NCT00756470|16821254|P1|Overall Study|Adverse Event|4
4881295|NCT00756470|16821254|P1|Overall Study|Withdrawal by Subject|1
4881296|NCT00756457|16821261|P2|Overall Study|Lost to Follow-up|2
4881297|NCT00756457|16821262|P1|Overall Study|Lost to Follow-up|1
4881298|NCT00756444|16821292|P2|Overall Study|Ineligibility Determined|0
4881299|NCT00756444|16821293|P1|Overall Study|Ineligibility Determined|1
4881300|NCT00756444|16821292|P2|Overall Study|Disease Progression|7
4881301|NCT00756444|16821293|P1|Overall Study|Disease Progression|2
4881302|NCT00756444|16821292|P2|Overall Study|Death|4
4881303|NCT00756444|16821293|P1|Overall Study|Death|5
4881304|NCT00756444|16821292|P2|Overall Study|Lost to Follow-up|1
4881305|NCT00756444|16821293|P1|Overall Study|Lost to Follow-up|0
4881306|NCT00756444|16821292|P2|Overall Study|Withdrawal by Subject|8
4881307|NCT00756444|16821293|P1|Overall Study|Withdrawal by Subject|6
4881308|NCT00756444|16821292|P2|Overall Study|Adverse Event|1
4881309|NCT00756444|16821293|P1|Overall Study|Adverse Event|1
4881310|NCT00756314|16821304|P2|Overall Study|Lost to Follow-up|59
4881311|NCT00756314|16821305|P1|Overall Study|Lost to Follow-up|2
4881312|NCT00756275|16821321|P2|Overall Study|Withdrawal by Subject|7
4881313|NCT00756275|16821322|P1|Overall Study|Withdrawal by Subject|4
4881314|NCT00756275|16821321|P2|Overall Study|Lost to Follow-up|21
4881315|NCT00756275|16821322|P1|Overall Study|Lost to Follow-up|25
4881316|NCT00756002|16821386|P2|Double-Blind Treatment Period|Other|2
4881317|NCT00756002|16821387|P1|Double-Blind Treatment Period|Other|2
4881318|NCT00756002|16821386|P2|Double-Blind Treatment Period|Protocol Violation|5
4881319|NCT00756002|16821387|P1|Double-Blind Treatment Period|Protocol Violation|6
4881320|NCT00756002|16821386|P2|Double-Blind Treatment Period|Withdrawal by Subject|6
4881321|NCT00756002|16821387|P1|Double-Blind Treatment Period|Withdrawal by Subject|6
4881322|NCT00756002|16821386|P2|Double-Blind Treatment Period|Lost to Follow-up|1
4881323|NCT00756002|16821387|P1|Double-Blind Treatment Period|Lost to Follow-up|0
4881324|NCT00756002|16821386|P2|Double-Blind Treatment Period|Lack of Efficacy|1
4881325|NCT00756002|16821387|P1|Double-Blind Treatment Period|Lack of Efficacy|1
4881326|NCT00755937|16821481|P1|Observational Follow-up|Lost to Follow-up|148
4881327|NCT00755937|16821481|P1|Recruitment|Unknown if infliximab received|164
4881328|NCT00755846|16821508|P6|Overall Study|Participant Non-compliance|0
4881329|NCT00755846|16821509|P5|Overall Study|Participant Non-compliance|1
4881330|NCT00755846|16821510|P4|Overall Study|Participant Non-compliance|0
4881331|NCT00755846|16821511|P3|Overall Study|Participant Non-compliance|0
4881332|NCT00755846|16821512|P2|Overall Study|Participant Non-compliance|0
4881333|NCT00755846|16821513|P1|Overall Study|Participant Non-compliance|0
4881334|NCT00755846|16821508|P6|Overall Study|Administrative Error|0
4881335|NCT00755846|16821509|P5|Overall Study|Administrative Error|0
4881336|NCT00755846|16821510|P4|Overall Study|Administrative Error|0
4881337|NCT00755846|16821511|P3|Overall Study|Administrative Error|0
4881338|NCT00755846|16821512|P2|Overall Study|Administrative Error|1
4881339|NCT00755846|16821513|P1|Overall Study|Administrative Error|0
4881340|NCT00755846|16821508|P6|Overall Study|Physician Decision|1
4881341|NCT00755846|16821509|P5|Overall Study|Physician Decision|0
4881342|NCT00755846|16821510|P4|Overall Study|Physician Decision|1
4881343|NCT00755846|16821511|P3|Overall Study|Physician Decision|0
4881344|NCT00755846|16821512|P2|Overall Study|Physician Decision|3
4881345|NCT00755846|16821513|P1|Overall Study|Physician Decision|1
4881346|NCT00755846|16821508|P6|Overall Study|Hyperglycemic Rescue|7
4881347|NCT00755846|16821509|P5|Overall Study|Hyperglycemic Rescue|8
4881348|NCT00755846|16821510|P4|Overall Study|Hyperglycemic Rescue|8
4881349|NCT00755846|16821511|P3|Overall Study|Hyperglycemic Rescue|5
4881350|NCT00755846|16821512|P2|Overall Study|Hyperglycemic Rescue|7
4881351|NCT00755846|16821513|P1|Overall Study|Hyperglycemic Rescue|21
4881352|NCT00755846|16821508|P6|Overall Study|Withdrawal by Subject|1
4881353|NCT00755846|16821509|P5|Overall Study|Withdrawal by Subject|0
4881354|NCT00755846|16821510|P4|Overall Study|Withdrawal by Subject|2
4881355|NCT00755846|16821511|P3|Overall Study|Withdrawal by Subject|5
4881356|NCT00755846|16821512|P2|Overall Study|Withdrawal by Subject|3
4881357|NCT00755846|16821513|P1|Overall Study|Withdrawal by Subject|2
4881358|NCT00755846|16821508|P6|Overall Study|Lost to Follow-up|2
4881359|NCT00755846|16821509|P5|Overall Study|Lost to Follow-up|4
4881360|NCT00755846|16821510|P4|Overall Study|Lost to Follow-up|0
4881361|NCT00755846|16821511|P3|Overall Study|Lost to Follow-up|1
4881362|NCT00755846|16821512|P2|Overall Study|Lost to Follow-up|2
4881363|NCT00755846|16821513|P1|Overall Study|Lost to Follow-up|0
4881364|NCT00755846|16821508|P6|Overall Study|Protocol Violation|1
4881365|NCT00755846|16821509|P5|Overall Study|Protocol Violation|1
4881366|NCT00755846|16821510|P4|Overall Study|Protocol Violation|1
4881367|NCT00755846|16821511|P3|Overall Study|Protocol Violation|1
4881368|NCT00755846|16821512|P2|Overall Study|Protocol Violation|1
4881369|NCT00755846|16821513|P1|Overall Study|Protocol Violation|1
4881370|NCT00755846|16821508|P6|Overall Study|Adverse Event|2
4881371|NCT00755846|16821509|P5|Overall Study|Adverse Event|3
4881372|NCT00755846|16821510|P4|Overall Study|Adverse Event|1
4881373|NCT00755846|16821511|P3|Overall Study|Adverse Event|0
4881374|NCT00755846|16821512|P2|Overall Study|Adverse Event|0
4881375|NCT00755846|16821513|P1|Overall Study|Adverse Event|0
4881376|NCT00755807|16821613|P2|Open-label Extension Phase|Sponsor Decision|1
4881377|NCT00755807|16821614|P1|Open-label Extension Phase|Sponsor Decision|0
4881378|NCT00755807|16821613|P2|Open-label Extension Phase|Lost to Follow-up|0
4881379|NCT00755807|16821614|P1|Open-label Extension Phase|Lost to Follow-up|2
4881380|NCT00755807|16821613|P2|Open-label Extension Phase|Withdrawal by Subject|3
4881381|NCT00755807|16821614|P1|Open-label Extension Phase|Withdrawal by Subject|1
4881382|NCT00755807|16821613|P2|Open-label Extension Phase|Lack of Efficacy|3
4881383|NCT00755807|16821614|P1|Open-label Extension Phase|Lack of Efficacy|3
4881384|NCT00755807|16821613|P2|Open-label Extension Phase|Protocol Violation|2
4881385|NCT00755807|16821614|P1|Open-label Extension Phase|Protocol Violation|5
4881386|NCT00755807|16821613|P2|Open-label Extension Phase|Adverse Event|7
4881387|NCT00755807|16821614|P1|Open-label Extension Phase|Adverse Event|7
4881388|NCT00755807|16821613|P2|Acute Phase|Physician Decision|1
4881389|NCT00755807|16821614|P1|Acute Phase|Physician Decision|0
4881390|NCT00755807|16821613|P2|Acute Phase|Lack of Efficacy|1
4881391|NCT00755807|16821614|P1|Acute Phase|Lack of Efficacy|0
4881392|NCT00755807|16821613|P2|Acute Phase|Withdrawal by Subject|2
4881393|NCT00755807|16821614|P1|Acute Phase|Withdrawal by Subject|1
4881394|NCT00755807|16821613|P2|Acute Phase|Protocol Violation|3
4881395|NCT00755807|16821614|P1|Acute Phase|Protocol Violation|1
4881396|NCT00755807|16821613|P2|Acute Phase|Adverse Event|5
4881397|NCT00755807|16821614|P1|Acute Phase|Adverse Event|16
4881398|NCT00755716|16821694|P3|Overall Study|work schedule issues|1
4881399|NCT00755716|16821695|P2|Overall Study|work schedule issues|1
4881400|NCT00755716|16821696|P1|Overall Study|work schedule issues|0
4881401|NCT00755716|16821694|P3|Overall Study|Lost to Follow-up|1
4881402|NCT00755716|16821695|P2|Overall Study|Lost to Follow-up|3
4881403|NCT00755716|16821696|P1|Overall Study|Lost to Follow-up|5
4881404|NCT00755716|16821694|P3|Overall Study|Lack of Efficacy|0
4881405|NCT00755716|16821695|P2|Overall Study|Lack of Efficacy|0
4881406|NCT00755716|16821696|P1|Overall Study|Lack of Efficacy|2
4881407|NCT00755716|16821694|P3|Overall Study|Adverse Event|1
4881408|NCT00755716|16821695|P2|Overall Study|Adverse Event|4
4881409|NCT00755716|16821696|P1|Overall Study|Adverse Event|1
4881410|NCT00755417|16821710|P3|Overall Study|Not specified or missing data|12
4881411|NCT00755417|16821711|P2|Overall Study|Not specified or missing data|18
4881412|NCT00755417|16821712|P1|Overall Study|Not specified or missing data|9
4881413|NCT00755417|16821710|P3|Overall Study|Withdrawal by Subject|12
4881414|NCT00755417|16821711|P2|Overall Study|Withdrawal by Subject|12
4881415|NCT00755417|16821712|P1|Overall Study|Withdrawal by Subject|12
4881416|NCT00755417|16821710|P3|Overall Study|Lost to Follow-up|1
4881417|NCT00755417|16821711|P2|Overall Study|Lost to Follow-up|0
4881418|NCT00755417|16821712|P1|Overall Study|Lost to Follow-up|3
4881419|NCT00755417|16821710|P3|Overall Study|Protocol Violation|1
4881420|NCT00755417|16821711|P2|Overall Study|Protocol Violation|1
4881421|NCT00755417|16821712|P1|Overall Study|Protocol Violation|2
4881422|NCT00755417|16821710|P3|Overall Study|Lack of Efficacy|9
4881423|NCT00755417|16821711|P2|Overall Study|Lack of Efficacy|4
4881424|NCT00755417|16821712|P1|Overall Study|Lack of Efficacy|8
4881425|NCT00755417|16821710|P3|Overall Study|Adverse Event|7
4881426|NCT00755417|16821711|P2|Overall Study|Adverse Event|20
4881427|NCT00755417|16821712|P1|Overall Study|Adverse Event|28
4881428|NCT00755326|16821731|P2|Overall Study|Lost to Follow-up|3
4881429|NCT00755326|16821732|P1|Overall Study|Lost to Follow-up|2
4881430|NCT00755222|16821782|P2|Overall Study|Protocol Violation|0
4881431|NCT00755222|16821783|P1|Overall Study|Protocol Violation|2
4881432|NCT00755222|16821782|P2|Overall Study|Adverse Event|0
4881433|NCT00755222|16821783|P1|Overall Study|Adverse Event|2
4881434|NCT00755222|16821782|P2|Overall Study|Withdrawal by Subject|2
4881435|NCT00755222|16821783|P1|Overall Study|Withdrawal by Subject|4
4881436|NCT00755196|16821797|P1|Overall Study|Lack of Efficiency|1
4881437|NCT00755196|16821797|P1|Overall Study|Lost to Follow-up|1
4881438|NCT00755183|16821804|P2|Overall Study|Administrative|1
4881439|NCT00755183|16821805|P1|Overall Study|Administrative|2
4881440|NCT00755183|16821804|P2|Overall Study|Withdrawal by Subject|2
4881441|NCT00755183|16821805|P1|Overall Study|Withdrawal by Subject|0
4881442|NCT00755183|16821804|P2|Overall Study|Protocol Violation|1
4881443|NCT00755183|16821805|P1|Overall Study|Protocol Violation|0
4881444|NCT00755183|16821804|P2|Overall Study|Adverse Event|2
4881445|NCT00755183|16821805|P1|Overall Study|Adverse Event|5
4881446|NCT00755105|16821829|P3|Overall Study|Withdrawal by Subject|4
4881447|NCT00755105|16821830|P2|Overall Study|Withdrawal by Subject|11
4881448|NCT00755105|16821831|P1|Overall Study|Withdrawal by Subject|9
4881449|NCT00755079|16821841|P2|Overall Study|Withdrawal by Subject|2
4881450|NCT00755079|16821842|P1|Overall Study|Withdrawal by Subject|0
4881451|NCT00755079|16821841|P2|Overall Study|Adverse Event|1
4881452|NCT00755079|16821842|P1|Overall Study|Adverse Event|0
4881453|NCT00755079|16821841|P2|Overall Study|Lost to Follow-up|3
4881454|NCT00755079|16821842|P1|Overall Study|Lost to Follow-up|1
4881455|NCT00754936|16821861|P1|Overall Study|Inter-current medical events|3
4881456|NCT00754936|16821861|P1|Overall Study|Side Effects|3
4881457|NCT00754936|16821861|P1|Overall Study|Withdrawal by Subject|2
4881458|NCT00754936|16821861|P1|Overall Study|Physician Decision|1
4881459|NCT00754936|16821861|P1|Overall Study|Lost to Follow-up|3
4881460|NCT00754793|16821901|P2|Overall Study|voluntary withdrawn from study|1
4881461|NCT00754793|16821902|P1|Overall Study|voluntary withdrawn from study|0
4881462|NCT00754741|16821920|P3|Overall Study|Died or disenrolled|54
4881463|NCT00754741|16821921|P2|Overall Study|Died or disenrolled|69
4881464|NCT00754741|16821922|P1|Overall Study|Died or disenrolled|57
4881465|NCT00754650|16821969|P1|Overall Study|Disease Progression|2
4881466|NCT00754624|16821974|P1|Overall Study|Lost to Follow-up|3
4881467|NCT00754624|16821974|P1|Overall Study|Various|12
4881468|NCT00754624|16821974|P1|Overall Study|Withdrawal by Subject|28
4881469|NCT00754624|16821974|P1|Overall Study|Protocol Violation|1
4881470|NCT00754624|16821974|P1|Overall Study|Physician Decision|8
4881471|NCT00754624|16821974|P1|Overall Study|Death|1
4881472|NCT00754624|16821974|P1|Overall Study|Adverse Event|16
4881473|NCT00754572|16821984|P1|Overall Study|Lost to Follow-up|1
4881474|NCT00754572|16821984|P1|Overall Study|Administrative Reason|3
4881475|NCT00754572|16821984|P1|Overall Study|Death|1
4881476|NCT00754572|16821984|P1|Overall Study|Lack of Efficacy|2
4881477|NCT00754572|16821984|P1|Overall Study|Withdrawal by Subject|3
4881478|NCT00754572|16821984|P1|Overall Study|Protocol Violation|3
4881479|NCT00754572|16821984|P1|Overall Study|Other|39
4881480|NCT00754572|16821984|P1|Overall Study|Adverse Event|19
4881481|NCT00754559|16822011|P1|Overall Study|Withdrawal by Subject|3
4881482|NCT00754559|16822011|P1|Overall Study|Other|5
4881483|NCT00754559|16822011|P1|Overall Study|Administrative reason|1
4881484|NCT00754559|16822011|P1|Overall Study|Lost to Follow-up|2
4881485|NCT00754559|16822011|P1|Overall Study|Lack of Efficacy|10
4881486|NCT00754559|16822011|P1|Overall Study|Protocol Violation|11
4881487|NCT00754559|16822011|P1|Overall Study|Adverse Event|15
4881488|NCT00754442|16822111|P2|Overall Study|Withdrawal by Subject|3
4881489|NCT00754442|16822112|P1|Overall Study|Withdrawal by Subject|5
4881490|NCT00754390|16822119|P1|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1
4881491|NCT00754390|16822119|P1|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1
4881492|NCT00754390|16822119|P1|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2
4881493|NCT00754390|16822119|P1|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3
4881494|NCT00754338|16822141|P4|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
4881495|NCT00754338|16822142|P3|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
4881496|NCT00754338|16822143|P2|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1
4881497|NCT00754338|16822144|P1|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0
4881498|NCT00754338|16822141|P4|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
4881499|NCT00754338|16822142|P3|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
4881500|NCT00754338|16822143|P2|First Intervention for Phase1&Phase2|Withdrawal by Subject|3
4881501|NCT00754338|16822144|P1|First Intervention for Phase1&Phase2|Withdrawal by Subject|0
4881502|NCT00754325|16822176|P2|Initial Treatment|Disease Progression|35
4881503|NCT00754325|16822177|P1|Initial Treatment|Disease Progression|35
4881504|NCT00754325|16822176|P2|Initial Treatment|Sponsor Request|1
4881505|NCT00754325|16822177|P1|Initial Treatment|Sponsor Request|0
4881506|NCT00754325|16822176|P2|Initial Treatment|Physician Decision|0
4881507|NCT00754325|16822177|P1|Initial Treatment|Physician Decision|2
4881508|NCT00754325|16822176|P2|Initial Treatment|Withdrawal by Subject|2
4881509|NCT00754325|16822177|P1|Initial Treatment|Withdrawal by Subject|2
4881510|NCT00754325|16822176|P2|Initial Treatment|Adverse Event|6
4881511|NCT00754325|16822177|P1|Initial Treatment|Adverse Event|7
4881512|NCT00754325|16822176|P2|Initial Treatment|Continuing Active Treatment|5
4881513|NCT00754325|16822177|P1|Initial Treatment|Continuing Active Treatment|4
4881514|NCT00754234|16822230|P1|Overall Study|Withdrawal by Subject|3
4881515|NCT00754065|16822316|P2|Overall Study|Reason not specified or unknown, etc.|27
4881516|NCT00754065|16822317|P1|Overall Study|Reason not specified or unknown, etc.|21
4881517|NCT00754065|16822316|P2|Overall Study|Pregnancy|0
4881518|NCT00754065|16822317|P1|Overall Study|Pregnancy|6
4881519|NCT00754065|16822316|P2|Overall Study|Withdrawal by Subject|5
4881520|NCT00754065|16822317|P1|Overall Study|Withdrawal by Subject|4
4881521|NCT00754065|16822316|P2|Overall Study|Protocol Violation|10
4881522|NCT00754065|16822317|P1|Overall Study|Protocol Violation|12
4881523|NCT00754065|16822316|P2|Overall Study|Lost to Follow-up|11
4881524|NCT00754065|16822317|P1|Overall Study|Lost to Follow-up|7
4881525|NCT00754065|16822316|P2|Overall Study|Adverse Event|25
4881526|NCT00754065|16822317|P1|Overall Study|Adverse Event|19
4881527|NCT00754065|16822316|P2|Overall Study|Never received treatment|2
4881528|NCT00754065|16822317|P1|Overall Study|Never received treatment|12
4881529|NCT00754052|16822557|P2|Overall Study|Study terminated by Sponsor|3
4881530|NCT00754052|16822558|P1|Overall Study|Study terminated by Sponsor|5
4881531|NCT00754013|16822572|P2|Overall Study|didn't return after study termed|4
4881532|NCT00754013|16822573|P1|Overall Study|didn't return after study termed|3
4881533|NCT00754013|16822572|P2|Overall Study|Lost to Follow-up|1
4881534|NCT00754013|16822573|P1|Overall Study|Lost to Follow-up|1
4881535|NCT00753922|16822610|P4|Overall Study|Discontinuation Due to Explantation|4
4881536|NCT00753922|16822611|P3|Overall Study|Discontinuation Due to Explantation|14
4881537|NCT00753922|16822612|P2|Overall Study|Discontinuation Due to Explantation|14
4881538|NCT00753922|16822613|P1|Overall Study|Discontinuation Due to Explantation|14
4881539|NCT00753922|16822610|P4|Overall Study|Death|1
4881540|NCT00753922|16822611|P3|Overall Study|Death|2
4881541|NCT00753922|16822612|P2|Overall Study|Death|23
4881542|NCT00753922|16822613|P1|Overall Study|Death|2
4881543|NCT00753922|16822610|P4|Overall Study|Patients Not Completing Visit|0
4881544|NCT00753922|16822611|P3|Overall Study|Patients Not Completing Visit|1
4881545|NCT00753922|16822612|P2|Overall Study|Patients Not Completing Visit|0
4881546|NCT00753922|16822613|P1|Overall Study|Patients Not Completing Visit|11
4881547|NCT00753922|16822610|P4|Overall Study|Patient Non-compliance|11
4881548|NCT00753922|16822611|P3|Overall Study|Patient Non-compliance|14
4881549|NCT00753922|16822612|P2|Overall Study|Patient Non-compliance|22
4881550|NCT00753922|16822613|P1|Overall Study|Patient Non-compliance|55
4881551|NCT00753922|16822610|P4|Overall Study|Withdrawal by Subject|2
4881552|NCT00753922|16822611|P3|Overall Study|Withdrawal by Subject|4
4881553|NCT00753922|16822612|P2|Overall Study|Withdrawal by Subject|11
4881554|NCT00753922|16822613|P1|Overall Study|Withdrawal by Subject|9
4881555|NCT00753922|16822610|P4|Overall Study|Lost to Follow-up|5
4881556|NCT00753922|16822611|P3|Overall Study|Lost to Follow-up|28
4881557|NCT00753922|16822612|P2|Overall Study|Lost to Follow-up|24
4881558|NCT00753922|16822613|P1|Overall Study|Lost to Follow-up|155
4881559|NCT00753896|16822643|P1|Overall Study|Entry Criteria Not Met|4
4881560|NCT00753896|16822643|P1|Overall Study|Withdrawal by Subject|4
4881561|NCT00753896|16822643|P1|Overall Study|Protocol Violation|1
4881562|NCT00753896|16822643|P1|Overall Study|Lost to Follow-up|2
4881563|NCT00753896|16822643|P1|Overall Study|Death|1
4881564|NCT00753896|16822643|P1|Overall Study|Adverse Event|4
4881565|NCT00753766|16822659|P2|Overall Study|Physician Decision|0
4881566|NCT00753766|16822660|P1|Overall Study|Physician Decision|1
4881567|NCT00753714|16822682|P2|Overall Study|Other|5
4881568|NCT00753714|16822683|P1|Overall Study|Other|7
4881569|NCT00753714|16822682|P2|Overall Study|Death|3
4881570|NCT00753714|16822683|P1|Overall Study|Death|3
4881571|NCT00753714|16822682|P2|Overall Study|Withdrawal by Subject|1
4881572|NCT00753714|16822683|P1|Overall Study|Withdrawal by Subject|2
4881573|NCT00753714|16822682|P2|Overall Study|Lost to Follow-up|1
4881574|NCT00753714|16822683|P1|Overall Study|Lost to Follow-up|0
4881575|NCT00753714|16822682|P2|Overall Study|Protocol Violation|0
4881576|NCT00753714|16822683|P1|Overall Study|Protocol Violation|1
4881577|NCT00753714|16822682|P2|Overall Study|Adverse Event|18
4881578|NCT00753714|16822683|P1|Overall Study|Adverse Event|26
4881579|NCT00753714|16822682|P2|Overall Study|Lack of Efficacy|34
4881580|NCT00753714|16822683|P1|Overall Study|Lack of Efficacy|21
4881581|NCT00753688|16822699|P2|Overall Study|Adverse Event|1
4881582|NCT00753688|16822700|P1|Overall Study|Adverse Event|0
4881583|NCT00753688|16822699|P2|Overall Study|Ongoing - in Follow-up|31
4881584|NCT00753688|16822700|P1|Overall Study|Ongoing - in Follow-up|15
4881585|NCT00753688|16822699|P2|Overall Study|Participant Withdrew Consent|2
4881586|NCT00753688|16822700|P1|Overall Study|Participant Withdrew Consent|2
4881587|NCT00753688|16822699|P2|Overall Study|Missing|9
4881588|NCT00753688|16822700|P1|Overall Study|Missing|4
4881589|NCT00753688|16822699|P2|Overall Study|Death|203
4881590|NCT00753688|16822700|P1|Overall Study|Death|102
4881591|NCT00753675|16822729|P3|Overall Study|Lost to Follow-up|0
4881592|NCT00753675|16822730|P2|Overall Study|Lost to Follow-up|0
4881593|NCT00753675|16822731|P1|Overall Study|Lost to Follow-up|1
4881594|NCT00753675|16822729|P3|Overall Study|Withdrawal by Subject|0
4881595|NCT00753675|16822730|P2|Overall Study|Withdrawal by Subject|1
4881596|NCT00753675|16822731|P1|Overall Study|Withdrawal by Subject|0
4881597|NCT00753675|16822729|P3|Overall Study|Objective progression of disease|35
4881598|NCT00753675|16822730|P2|Overall Study|Objective progression of disease|35
4881599|NCT00753675|16822731|P1|Overall Study|Objective progression of disease|35
4881600|NCT00753675|16822729|P3|Overall Study|Adverse Event|4
4881601|NCT00753675|16822730|P2|Overall Study|Adverse Event|9
4881602|NCT00753675|16822731|P1|Overall Study|Adverse Event|11
4881603|NCT00753675|16822729|P3|Overall Study|Death|4
4881604|NCT00753675|16822730|P2|Overall Study|Death|2
4881605|NCT00753675|16822731|P1|Overall Study|Death|1
4881606|NCT00753675|16822729|P3|Overall Study|other reason|13
4881607|NCT00753675|16822730|P2|Overall Study|other reason|12
4881608|NCT00753675|16822731|P1|Overall Study|other reason|11
4881609|NCT00753649|16822753|P2|Overall Study|Protocol Violation|0
4881610|NCT00753649|16822754|P1|Overall Study|Protocol Violation|2
4881611|NCT00753649|16822753|P2|Overall Study|Lost to follow-up-complete vaccination|0
4881612|NCT00753649|16822754|P1|Overall Study|Lost to follow-up-complete vaccination|1
4881613|NCT00753649|16822753|P2|Overall Study|Lost to follow-up-incomplete vaccination|0
4881614|NCT00753649|16822754|P1|Overall Study|Lost to follow-up-incomplete vaccination|3
4881615|NCT00753649|16822753|P2|Overall Study|Migrated/moved from study area|0
4881616|NCT00753649|16822754|P1|Overall Study|Migrated/moved from study area|1
4881617|NCT00753623|16822786|P2|Phase II (14 Days)|Physician Decision|1
4881618|NCT00753623|16822787|P1|Phase II (14 Days)|Physician Decision|0
4881619|NCT00753623|16822786|P2|Washout (7 Days)|Physician Decision|0
4881620|NCT00753623|16822787|P1|Washout (7 Days)|Physician Decision|1
4881621|NCT00753623|16822786|P2|Phase I (14 Days)|Adverse Event|1
4881622|NCT00753623|16822787|P1|Phase I (14 Days)|Adverse Event|0
4881623|NCT00753623|16822786|P2|Phase I (14 Days)|Physician Decision|2
4881624|NCT00753623|16822787|P1|Phase I (14 Days)|Physician Decision|1
4881625|NCT00753623|16822786|P2|Phase I (14 Days)|Withdrawal by Subject|1
4881626|NCT00753623|16822787|P1|Phase I (14 Days)|Withdrawal by Subject|1
4881627|NCT00753545|16822795|P2|Overall Study|Voluntary Discontinuation of Patient|3
4881628|NCT00753545|16822796|P1|Overall Study|Voluntary Discontinuation of Patient|7
4881629|NCT00753545|16822795|P2|Overall Study|Protocol Violation|0
4881630|NCT00753545|16822796|P1|Overall Study|Protocol Violation|1
4881631|NCT00753545|16822795|P2|Overall Study|Lost to Follow-up|3
4881632|NCT00753545|16822796|P1|Overall Study|Lost to Follow-up|2
4881633|NCT00753545|16822795|P2|Overall Study|Death|112
4881634|NCT00753545|16822796|P1|Overall Study|Death|98
4881635|NCT00753519|16822834|P2|Overall Study|Withdrawal by Subject|2
4881636|NCT00753519|16822835|P1|Overall Study|Withdrawal by Subject|0
4881637|NCT00753506|16822857|P2|Overall Study|Other reason|1
4881638|NCT00753506|16822858|P1|Overall Study|Other reason|1
4881639|NCT00753506|16822857|P2|Overall Study|Lost to Follow-up|0
4881640|NCT00753506|16822858|P1|Overall Study|Lost to Follow-up|2
4881641|NCT00753506|16822857|P2|Overall Study|Withdrawal by Subject|1
4881642|NCT00753506|16822858|P1|Overall Study|Withdrawal by Subject|4
4881643|NCT00753454|16822864|P1|Overall Study|Investigator Decision|1
4881644|NCT00753454|16822864|P1|Overall Study|Withdrawal by Subject|5
4881645|NCT00753454|16822864|P1|Overall Study|Lost to Follow-up|3
4881646|NCT00753454|16822864|P1|Overall Study|Lack of Efficacy|1
4881647|NCT00753454|16822864|P1|Overall Study|Adverse Event|4
4881648|NCT00753415|16822898|P10|Part B|Disease progression|1
4881649|NCT00753415|16822899|P9|Part B|Disease progression|2
4881650|NCT00753415|16822900|P8|Part B|Disease progression|0
4881651|NCT00753415|16822901|P7|Part B|Disease progression|0
4881652|NCT00753415|16822902|P6|Part B|Disease progression|0
4881653|NCT00753415|16822903|P5|Part B|Disease progression|0
4881654|NCT00753415|16822904|P4|Part B|Disease progression|0
4881655|NCT00753415|16822905|P3|Part B|Disease progression|0
4881656|NCT00753415|16822906|P2|Part B|Disease progression|0
4881657|NCT00753415|16822907|P1|Part B|Disease progression|0
4881658|NCT00753415|16822898|P10|Part B|Lost to Follow-up|0
4881659|NCT00753415|16822899|P9|Part B|Lost to Follow-up|1
4881660|NCT00753415|16822900|P8|Part B|Lost to Follow-up|1
4881661|NCT00753415|16822901|P7|Part B|Lost to Follow-up|0
4881662|NCT00753415|16822902|P6|Part B|Lost to Follow-up|0
4881663|NCT00753415|16822903|P5|Part B|Lost to Follow-up|0
4881664|NCT00753415|16822904|P4|Part B|Lost to Follow-up|0
4881665|NCT00753415|16822905|P3|Part B|Lost to Follow-up|0
4881666|NCT00753415|16822906|P2|Part B|Lost to Follow-up|0
4881667|NCT00753415|16822907|P1|Part B|Lost to Follow-up|0
4881668|NCT00753415|16822898|P10|Part A|Withdrawal by Subject|0
4881669|NCT00753415|16822899|P9|Part A|Withdrawal by Subject|0
4881670|NCT00753415|16822900|P8|Part A|Withdrawal by Subject|0
4881671|NCT00753415|16822901|P7|Part A|Withdrawal by Subject|0
4881672|NCT00753415|16822902|P6|Part A|Withdrawal by Subject|0
4881673|NCT00753415|16822903|P5|Part A|Withdrawal by Subject|0
4881674|NCT00753415|16822904|P4|Part A|Withdrawal by Subject|0
4881675|NCT00753415|16822905|P3|Part A|Withdrawal by Subject|1
4881676|NCT00753415|16822906|P2|Part A|Withdrawal by Subject|0
4881677|NCT00753415|16822907|P1|Part A|Withdrawal by Subject|0
4881678|NCT00753415|16822898|P10|Part A|Disease progression|0
4881679|NCT00753415|16822899|P9|Part A|Disease progression|0
4881680|NCT00753415|16822900|P8|Part A|Disease progression|0
4881681|NCT00753415|16822901|P7|Part A|Disease progression|0
4881682|NCT00753415|16822902|P6|Part A|Disease progression|0
4881683|NCT00753415|16822903|P5|Part A|Disease progression|0
4881684|NCT00753415|16822904|P4|Part A|Disease progression|2
4881685|NCT00753415|16822905|P3|Part A|Disease progression|1
4881686|NCT00753415|16822906|P2|Part A|Disease progression|0
4881687|NCT00753415|16822907|P1|Part A|Disease progression|1
4881688|NCT00753272|16822997|P2|Overall Study|Other|1088
4881689|NCT00753272|16822998|P1|Overall Study|Other|1104
4881690|NCT00753272|16822997|P2|Overall Study|Lost to Follow-up|497
4881691|NCT00753272|16822998|P1|Overall Study|Lost to Follow-up|491
4881692|NCT00753272|16822997|P2|Overall Study|Withdrawal by Subject|2407
4881693|NCT00753272|16822998|P1|Overall Study|Withdrawal by Subject|2481
4881694|NCT00753272|16822997|P2|Overall Study|Protocol Violation|46
4881695|NCT00753272|16822998|P1|Overall Study|Protocol Violation|28
4881696|NCT00753272|16822997|P2|Overall Study|Adverse Event|869
4881697|NCT00753272|16822998|P1|Overall Study|Adverse Event|878
4881698|NCT00753012|16823082|P2|Overall Study|Confounded endpoint data|0
4881699|NCT00753012|16823083|P1|Overall Study|Confounded endpoint data|1
4881700|NCT00753012|16823082|P2|Overall Study|Lost to Follow-up|0
4881701|NCT00753012|16823083|P1|Overall Study|Lost to Follow-up|4
4881702|NCT00753012|16823082|P2|Overall Study|Withdrawal by Subject|1
4881703|NCT00753012|16823083|P1|Overall Study|Withdrawal by Subject|0
4881704|NCT00753012|16823082|P2|Overall Study|Adverse Event|0
4881705|NCT00753012|16823083|P1|Overall Study|Adverse Event|2
4881706|NCT00753012|16823082|P2|Overall Study|Ineligible, abnormal cardiac histo|0
4881707|NCT00753012|16823083|P1|Overall Study|Ineligible, abnormal cardiac histo|1
4881708|NCT00752986|16823096|P3|Overall Study|Protocol Violation|0
4881709|NCT00752986|16823097|P2|Overall Study|Protocol Violation|0
4881710|NCT00752986|16823098|P1|Overall Study|Protocol Violation|3
4881711|NCT00752986|16823096|P3|Overall Study|Withdrawal by Subject|2
4881712|NCT00752986|16823097|P2|Overall Study|Withdrawal by Subject|1
4881713|NCT00752986|16823098|P1|Overall Study|Withdrawal by Subject|2
4881714|NCT00752895|16823138|P2|Overall Study|Withdrawal by Subject|3
4881715|NCT00752895|16823139|P1|Overall Study|Withdrawal by Subject|8
4881716|NCT00752856|16823149|P2|Overall Study|randomized but did not do viral kinetics|1
4881717|NCT00752856|16823150|P1|Overall Study|randomized but did not do viral kinetics|0
4881718|NCT00752791|16823162|P1|Overall Study|Protocol deviation|1
4881719|NCT00752791|16823162|P1|Overall Study|Switched to hemodialysis|2
4881720|NCT00752791|16823162|P1|Overall Study|Renal transplant|3
4881721|NCT00752791|16823162|P1|Overall Study|Death|1
4881722|NCT00752791|16823162|P1|Overall Study|Physician Decision|1
4881723|NCT00752791|16823162|P1|Overall Study|Withdrawal by Subject|1
4881724|NCT00752791|16823162|P1|Overall Study|Adverse Event|7
4881725|NCT00752726|16823174|P2|Overall Study|Other Reason|2
4881726|NCT00752726|16823175|P1|Overall Study|Other Reason|1
4881727|NCT00752726|16823174|P2|Overall Study|Withdrawal by Subject|10
4881728|NCT00752726|16823175|P1|Overall Study|Withdrawal by Subject|5
4881729|NCT00752726|16823174|P2|Overall Study|Adverse Event|0
4881730|NCT00752726|16823175|P1|Overall Study|Adverse Event|3
4881731|NCT00752726|16823174|P2|Overall Study|Lost to Follow-up|1
4881732|NCT00752726|16823175|P1|Overall Study|Lost to Follow-up|2
4881733|NCT00752622|16823200|P1|Interventional Phase|Premature Study Termination|5
4881734|NCT00752622|16823200|P1|Interventional Phase|Physician Decision|1
4881735|NCT00752622|16823200|P1|Interventional Phase|Non-responder|2
4881736|NCT00752622|16823200|P1|Observational Phase|Other|2
4881737|NCT00752622|16823200|P1|Observational Phase|Adverse Event|1
4881738|NCT00752622|16823200|P1|Observational Phase|Withdrawal by Subject|2
4881739|NCT00752622|16823200|P1|Observational Phase|Non-responder|2
4881740|NCT00752622|16823200|P1|Observational Phase|Premature Study Termination|36
4881741|NCT00752622|16823200|P1|Induction Phase|Premature study termination|14
4881742|NCT00752622|16823200|P1|Induction Phase|Withdrawal by Subject|1
4881743|NCT00752622|16823200|P1|Induction Phase|Non-responder|14
4881744|NCT00752622|16823200|P1|Induction Phase|Other|3
4881745|NCT00752622|16823200|P1|Induction Phase|Adverse Event|3
4881746|NCT00752609|16823213|P2|Overall Study|Received Aranesp in error|0
4881747|NCT00752609|16823214|P1|Overall Study|Received Aranesp in error|1
4881748|NCT00752609|16823213|P2|Overall Study|Met exclusion criteria|0
4881749|NCT00752609|16823214|P1|Overall Study|Met exclusion criteria|1
4881750|NCT00752609|16823213|P2|Overall Study|Death|0
4881751|NCT00752609|16823214|P1|Overall Study|Death|1
4881752|NCT00752609|16823213|P2|Overall Study|Physician Decision|0
4881753|NCT00752609|16823214|P1|Overall Study|Physician Decision|1
4881754|NCT00752609|16823213|P2|Overall Study|Withdrawal by Subject|0
4881755|NCT00752609|16823214|P1|Overall Study|Withdrawal by Subject|3
4881756|NCT00752609|16823213|P2|Overall Study|Adverse Event|2
4881757|NCT00752609|16823214|P1|Overall Study|Adverse Event|2
4881758|NCT00752557|16823236|P3|Overall Study|Lost to Follow-up|1
4881759|NCT00752557|16823237|P2|Overall Study|Lost to Follow-up|0
4881760|NCT00752557|16823238|P1|Overall Study|Lost to Follow-up|1
4881761|NCT00752557|16823236|P3|Overall Study|Unspecified resaons|2
4881762|NCT00752557|16823237|P2|Overall Study|Unspecified resaons|2
4881763|NCT00752557|16823238|P1|Overall Study|Unspecified resaons|0
4881764|NCT00752557|16823236|P3|Overall Study|Withdrawal by Subject|3
4881765|NCT00752557|16823237|P2|Overall Study|Withdrawal by Subject|3
4881766|NCT00752557|16823238|P1|Overall Study|Withdrawal by Subject|4
4881767|NCT00752232|16823270|P7|Overall Study|Caregiver could not attend the subject|0
4881768|NCT00752232|16823271|P6|Overall Study|Caregiver could not attend the subject|0
4881769|NCT00752232|16823272|P5|Overall Study|Caregiver could not attend the subject|1
4881770|NCT00752232|16823273|P4|Overall Study|Caregiver could not attend the subject|0
4881771|NCT00752232|16823274|P3|Overall Study|Caregiver could not attend the subject|0
4881772|NCT00752232|16823275|P2|Overall Study|Caregiver could not attend the subject|0
4881773|NCT00752232|16823276|P1|Overall Study|Caregiver could not attend the subject|0
4881774|NCT00752232|16823270|P7|Overall Study|Group home admission|0
4881775|NCT00752232|16823271|P6|Overall Study|Group home admission|0
4881776|NCT00752232|16823272|P5|Overall Study|Group home admission|0
4881777|NCT00752232|16823273|P4|Overall Study|Group home admission|1
4881778|NCT00752232|16823274|P3|Overall Study|Group home admission|0
4881779|NCT00752232|16823275|P2|Overall Study|Group home admission|0
4881780|NCT00752232|16823276|P1|Overall Study|Group home admission|0
4881781|NCT00752232|16823270|P7|Overall Study|Subject request|0
4881782|NCT00752232|16823271|P6|Overall Study|Subject request|0
4881783|NCT00752232|16823272|P5|Overall Study|Subject request|0
4881784|NCT00752232|16823273|P4|Overall Study|Subject request|0
4881785|NCT00752232|16823274|P3|Overall Study|Subject request|1
4881786|NCT00752232|16823275|P2|Overall Study|Subject request|0
4881787|NCT00752232|16823276|P1|Overall Study|Subject request|0
4881788|NCT00752232|16823270|P7|Overall Study|Investigator request|0
4881789|NCT00752232|16823271|P6|Overall Study|Investigator request|0
4881790|NCT00752232|16823272|P5|Overall Study|Investigator request|1
4881791|NCT00752232|16823273|P4|Overall Study|Investigator request|0
4881792|NCT00752232|16823274|P3|Overall Study|Investigator request|0
4881793|NCT00752232|16823275|P2|Overall Study|Investigator request|0
4881794|NCT00752232|16823276|P1|Overall Study|Investigator request|0
4881795|NCT00752232|16823270|P7|Overall Study|Caregiver request|0
4881796|NCT00752232|16823271|P6|Overall Study|Caregiver request|0
4881797|NCT00752232|16823272|P5|Overall Study|Caregiver request|1
4881798|NCT00752232|16823273|P4|Overall Study|Caregiver request|0
4881799|NCT00752232|16823274|P3|Overall Study|Caregiver request|0
4881800|NCT00752232|16823275|P2|Overall Study|Caregiver request|0
4881801|NCT00752232|16823276|P1|Overall Study|Caregiver request|2
4881802|NCT00752232|16823270|P7|Overall Study|Protocol Violation|0
4881803|NCT00752232|16823271|P6|Overall Study|Protocol Violation|1
4881804|NCT00752232|16823272|P5|Overall Study|Protocol Violation|0
4881805|NCT00752232|16823273|P4|Overall Study|Protocol Violation|0
4881806|NCT00752232|16823274|P3|Overall Study|Protocol Violation|0
4881807|NCT00752232|16823275|P2|Overall Study|Protocol Violation|0
4881808|NCT00752232|16823276|P1|Overall Study|Protocol Violation|0
4881809|NCT00752219|16823350|P2|Overall Study|Other|0
4881810|NCT00752219|16823351|P1|Overall Study|Other|3
4881811|NCT00752219|16823350|P2|Overall Study|Randomized but not treated|0
4881812|NCT00752219|16823351|P1|Overall Study|Randomized but not treated|1
4881813|NCT00752219|16823350|P2|Overall Study|Lost to Follow-up|2
4881814|NCT00752219|16823351|P1|Overall Study|Lost to Follow-up|1
4881815|NCT00752219|16823350|P2|Overall Study|Protocol deviation|0
4881816|NCT00752219|16823351|P1|Overall Study|Protocol deviation|1
4881817|NCT00752219|16823350|P2|Overall Study|Adverse Event|3
4881818|NCT00752219|16823351|P1|Overall Study|Adverse Event|5
4881819|NCT00752219|16823350|P2|Overall Study|Clinical failure|1
4881820|NCT00752219|16823351|P1|Overall Study|Clinical failure|0
4881821|NCT00752206|16823377|P2|Overall Study|Pregnancy|0
4881822|NCT00752206|16823378|P1|Overall Study|Pregnancy|1
4881823|NCT00752206|16823377|P2|Overall Study|Disease progression|11
4881824|NCT00752206|16823378|P1|Overall Study|Disease progression|8
4881825|NCT00752128|16823396|P1|Overall Study|Withdrawal by Subject|4
4881826|NCT00752089|16823410|P1|Overall Study|Cannot continue the study|1
4881827|NCT00752089|16823410|P1|Overall Study|Not capable of wearing partial denture|1
4881828|NCT00752089|16823410|P1|Overall Study|Could not attend visit 9|1
4881829|NCT00752089|16823410|P1|Overall Study|Protocol Deviation|2
4881830|NCT00752089|16823410|P1|Overall Study|Adverse Event|1
4881831|NCT00751998|16823424|P1|Overall Study|Withdrawal by Subject|2
4881832|NCT00751998|16823424|P1|Overall Study|Death|11
4881833|NCT00751998|16823424|P1|Overall Study|Lost to Follow-up|7
4881834|NCT00751933|16823443|P4|Overall Study|Physician Decision|1
4881835|NCT00751933|16823444|P3|Overall Study|Physician Decision|1
4881836|NCT00751933|16823445|P2|Overall Study|Physician Decision|0
4881837|NCT00751933|16823446|P1|Overall Study|Physician Decision|0
4881838|NCT00751933|16823443|P4|Overall Study|Withdrawal by Subject|0
4881839|NCT00751933|16823444|P3|Overall Study|Withdrawal by Subject|0
4881840|NCT00751933|16823445|P2|Overall Study|Withdrawal by Subject|1
4881841|NCT00751933|16823446|P1|Overall Study|Withdrawal by Subject|0
4881842|NCT00751881|16823454|P3|Extension Study Period|Other than specified above|18
4881843|NCT00751881|16823455|P2|Extension Study Period|Other than specified above|30
4881844|NCT00751881|16823456|P1|Extension Study Period|Other than specified above|26
4881845|NCT00751881|16823454|P3|Extension Study Period|Poor Compliance to Protocol|1
4881846|NCT00751881|16823455|P2|Extension Study Period|Poor Compliance to Protocol|2
4881847|NCT00751881|16823456|P1|Extension Study Period|Poor Compliance to Protocol|3
4881848|NCT00751881|16823454|P3|Extension Study Period|Lost to Follow-up|6
4881849|NCT00751881|16823455|P2|Extension Study Period|Lost to Follow-up|9
4881850|NCT00751881|16823456|P1|Extension Study Period|Lost to Follow-up|4
4881851|NCT00751881|16823454|P3|Extension Study Period|Lack of Efficacy|20
4881852|NCT00751881|16823455|P2|Extension Study Period|Lack of Efficacy|10
4881853|NCT00751881|16823456|P1|Extension Study Period|Lack of Efficacy|14
4881854|NCT00751881|16823454|P3|Extension Study Period|Adverse Event|21
4881855|NCT00751881|16823455|P2|Extension Study Period|Adverse Event|20
4881856|NCT00751881|16823456|P1|Extension Study Period|Adverse Event|18
4881857|NCT00751881|16823454|P3|Core Treatment Period|Other:participant's decision/unspecified|16
4881858|NCT00751881|16823455|P2|Core Treatment Period|Other:participant's decision/unspecified|22
4881859|NCT00751881|16823456|P1|Core Treatment Period|Other:participant's decision/unspecified|19
4881860|NCT00751881|16823454|P3|Core Treatment Period|Other: tolerability complaints|0
4881861|NCT00751881|16823455|P2|Core Treatment Period|Other: tolerability complaints|0
4881862|NCT00751881|16823456|P1|Core Treatment Period|Other: tolerability complaints|2
4881863|NCT00751881|16823454|P3|Core Treatment Period|Other: MS treatment change|4
4881864|NCT00751881|16823455|P2|Core Treatment Period|Other: MS treatment change|4
4881865|NCT00751881|16823456|P1|Core Treatment Period|Other: MS treatment change|6
4881866|NCT00751881|16823454|P3|Core Treatment Period|Other: personal/family constraints|10
4881867|NCT00751881|16823455|P2|Core Treatment Period|Other: personal/family constraints|7
4881868|NCT00751881|16823456|P1|Core Treatment Period|Other: personal/family constraints|6
4881869|NCT00751881|16823454|P3|Core Treatment Period|Other: wish to parent|4
4881870|NCT00751881|16823455|P2|Core Treatment Period|Other: wish to parent|7
4881871|NCT00751881|16823456|P1|Core Treatment Period|Other: wish to parent|5
4881872|NCT00751881|16823454|P3|Core Treatment Period|Other: protocol deviation|7
4881873|NCT00751881|16823455|P2|Core Treatment Period|Other: protocol deviation|3
4881874|NCT00751881|16823456|P1|Core Treatment Period|Other: protocol deviation|3
4881875|NCT00751881|16823454|P3|Core Treatment Period|Lost to Follow-up|3
4881876|NCT00751881|16823455|P2|Core Treatment Period|Lost to Follow-up|4
4881877|NCT00751881|16823456|P1|Core Treatment Period|Lost to Follow-up|6
4881878|NCT00751881|16823454|P3|Core Treatment Period|Poor compliance to protocol|4
4881879|NCT00751881|16823455|P2|Core Treatment Period|Poor compliance to protocol|3
4881880|NCT00751881|16823456|P1|Core Treatment Period|Poor compliance to protocol|15
4881881|NCT00751881|16823454|P3|Core Treatment Period|Lack of Efficacy|20
4881882|NCT00751881|16823455|P2|Core Treatment Period|Lack of Efficacy|30
4881883|NCT00751881|16823456|P1|Core Treatment Period|Lack of Efficacy|37
4881884|NCT00751881|16823454|P3|Core Treatment Period|Adverse Event|58
4881885|NCT00751881|16823455|P2|Core Treatment Period|Adverse Event|54
4881886|NCT00751881|16823456|P1|Core Treatment Period|Adverse Event|26
4881887|NCT00751881|16823454|P3|Core Treatment Period|Not treated|2
4881888|NCT00751881|16823455|P2|Core Treatment Period|Not treated|1
4881889|NCT00751881|16823456|P1|Core Treatment Period|Not treated|1
4881890|NCT00751790|16823503|P1|Overall Study|Withdrawal by Subject|1
4881891|NCT00751790|16823503|P1|Overall Study|Death|3
4881892|NCT00751790|16823503|P1|Overall Study|Lost to Follow-up|1
4881893|NCT00751621|16823534|P1|Overall Study|Poor adherence to asthma treatment|1
4881894|NCT00751621|16823534|P1|Overall Study|Subject moved to another country|1
4881895|NCT00751621|16823534|P1|Overall Study|Withdrawal by Subject|1
4881896|NCT00751621|16823534|P1|Overall Study|Adverse Event|1
4881897|NCT00751400|16823568|P1|Overall Study|Lost to Follow-up|10
4881898|NCT00751348|16823583|P2|Overall Study|Migration from study area|0
4881899|NCT00751348|16823584|P1|Overall Study|Migration from study area|1
4881900|NCT00751348|16823583|P2|Overall Study|Withdrawal by Subject|2
4881901|NCT00751348|16823584|P1|Overall Study|Withdrawal by Subject|5
4881902|NCT00751296|16823617|P1|Overall Study|Adverse Event|2
4881903|NCT00751140|16823645|P1|Overall Study|benign angioma excluded from analysis|1
4881904|NCT00751114|16823655|P2|Overall Study|Move to another city|0
4881905|NCT00751114|16823656|P1|Overall Study|Move to another city|1
4881906|NCT00751114|16823655|P2|Overall Study|Out of country for 2 months|0
4881907|NCT00751114|16823656|P1|Overall Study|Out of country for 2 months|1
4881908|NCT00751114|16823655|P2|Overall Study|Not Treated|1
4881909|NCT00751114|16823656|P1|Overall Study|Not Treated|13
4881910|NCT00751114|16823655|P2|Overall Study|Lack of Efficacy|7
4881911|NCT00751114|16823656|P1|Overall Study|Lack of Efficacy|0
4881912|NCT00751114|16823655|P2|Overall Study|Lost to Follow-up|7
4881913|NCT00751114|16823656|P1|Overall Study|Lost to Follow-up|4
4881914|NCT00751114|16823655|P2|Overall Study|Withdrawal by Subject|4
4881915|NCT00751114|16823656|P1|Overall Study|Withdrawal by Subject|9
4881916|NCT00751114|16823655|P2|Overall Study|Protocol Violation|9
4881917|NCT00751114|16823656|P1|Overall Study|Protocol Violation|8
4881918|NCT00751114|16823655|P2|Overall Study|Adverse Event|4
4881919|NCT00751114|16823656|P1|Overall Study|Adverse Event|2
4881920|NCT00751101|16823681|P2|Overall Study|Physician Decision|1
4881921|NCT00751101|16823682|P1|Overall Study|Physician Decision|0
4881922|NCT00751101|16823681|P2|Overall Study|Never began capecitabine|0
4881923|NCT00751101|16823682|P1|Overall Study|Never began capecitabine|1
4881924|NCT00751101|16823681|P2|Overall Study|No HFS / Never Started Patch/|4
4881925|NCT00751101|16823682|P1|Overall Study|No HFS / Never Started Patch/|0
4881926|NCT00751101|16823681|P2|Overall Study|Withdrawal by Subject|0
4881927|NCT00751101|16823682|P1|Overall Study|Withdrawal by Subject|1
4881928|NCT00751036|16823702|P2|Overall Study|Missing end of Treatment Page|3
4881929|NCT00751036|16823703|P1|Overall Study|Missing end of Treatment Page|2
4881930|NCT00751036|16823702|P2|Overall Study|Protocol Violation|0
4881931|NCT00751036|16823703|P1|Overall Study|Protocol Violation|1
4881932|NCT00751036|16823702|P2|Overall Study|Lost to Follow-up|1
4881933|NCT00751036|16823703|P1|Overall Study|Lost to Follow-up|0
4881934|NCT00751036|16823702|P2|Overall Study|Death|3
4881935|NCT00751036|16823703|P1|Overall Study|Death|3
4881936|NCT00751036|16823702|P2|Overall Study|Withdrawal by Subject|2
4881937|NCT00751036|16823703|P1|Overall Study|Withdrawal by Subject|5
4881938|NCT00751036|16823702|P2|Overall Study|Administrative Problems|4
4881939|NCT00751036|16823703|P1|Overall Study|Administrative Problems|3
4881940|NCT00751036|16823702|P2|Overall Study|Adverse Event|4
4881941|NCT00751036|16823703|P1|Overall Study|Adverse Event|6
4881942|NCT00751036|16823702|P2|Overall Study|Disease Progression|29
4881943|NCT00751036|16823703|P1|Overall Study|Disease Progression|28
4881944|NCT00751023|16823717|P2|Overall Study|Lost to Follow-up|7
4881945|NCT00751023|16823718|P1|Overall Study|Lost to Follow-up|11
4881946|NCT00750919|16823738|P1|Overall Study|Other|36
4881947|NCT00750919|16823738|P1|Overall Study|Could not cooperate, unrelated to trial|4
4881948|NCT00750919|16823738|P1|Overall Study|Lack of Efficacy|8
4881949|NCT00750919|16823738|P1|Overall Study|Withdrawal by Subject|1
4881950|NCT00750919|16823738|P1|Overall Study|Adverse Event|9
4881951|NCT00750893|16823746|P1|Overall Study|Other|17
4881952|NCT00750893|16823746|P1|Overall Study|Lost to Follow-up|510
4881953|NCT00750893|16823746|P1|Overall Study|Withdrawal by Subject|10
4881954|NCT00750893|16823746|P1|Overall Study|Adverse Event|5
4881955|NCT00750880|16823758|P1|Overall Study|Administrative|11
4881956|NCT00750880|16823758|P1|Overall Study|Physician Decision|20
4881957|NCT00750880|16823758|P1|Overall Study|Withdrawal by Subject|33
4881958|NCT00750880|16823758|P1|Overall Study|Protocol Violation|15
4881959|NCT00750880|16823758|P1|Overall Study|Lost to Follow-up|10
4881960|NCT00750880|16823758|P1|Overall Study|Lack of Efficacy|46
4881961|NCT00750880|16823758|P1|Overall Study|Death|4
4881962|NCT00750880|16823758|P1|Overall Study|Adverse Event|76
4881963|NCT00750867|16823781|P1|Overall Study|Adverse Event|2
4881964|NCT00750737|16823802|P2|Overall Study|Withdrawal by Subject|3
4881965|NCT00750737|16823803|P1|Overall Study|Withdrawal by Subject|3
4881966|NCT00750438|16823818|P2|Overall Study|Withdrawal by Subject|1
4881967|NCT00750438|16823819|P1|Overall Study|Withdrawal by Subject|1
4881968|NCT00750438|16823818|P2|Overall Study|Physician Decision|2
4881969|NCT00750438|16823819|P1|Overall Study|Physician Decision|2
4881970|NCT00750438|16823818|P2|Overall Study|Protocol Violation|1
4881971|NCT00750438|16823819|P1|Overall Study|Protocol Violation|4
4881972|NCT00750308|16823885|P12|Third Treatment|Withdrawal by Subject|0
4881973|NCT00750308|16823886|P11|Third Treatment|Withdrawal by Subject|0
4881974|NCT00750308|16823887|P10|Third Treatment|Withdrawal by Subject|0
4881975|NCT00750308|16823888|P9|Third Treatment|Withdrawal by Subject|0
4881976|NCT00750308|16823889|P8|Third Treatment|Withdrawal by Subject|0
4881977|NCT00750308|16823890|P7|Third Treatment|Withdrawal by Subject|0
4881978|NCT00750308|16823891|P6|Third Treatment|Withdrawal by Subject|0
4881979|NCT00750308|16823892|P5|Third Treatment|Withdrawal by Subject|0
4881980|NCT00750308|16823893|P4|Third Treatment|Withdrawal by Subject|0
4881981|NCT00750308|16823894|P3|Third Treatment|Withdrawal by Subject|0
4881982|NCT00750308|16823895|P2|Third Treatment|Withdrawal by Subject|1
4881983|NCT00750308|16823896|P1|Third Treatment|Withdrawal by Subject|0
4881984|NCT00750308|16823885|P12|Second Treatment|Withdrawal by Subject|0
4881985|NCT00750308|16823886|P11|Second Treatment|Withdrawal by Subject|0
4881986|NCT00750308|16823887|P10|Second Treatment|Withdrawal by Subject|0
4881987|NCT00750308|16823888|P9|Second Treatment|Withdrawal by Subject|0
4881988|NCT00750308|16823889|P8|Second Treatment|Withdrawal by Subject|0
4881989|NCT00750308|16823890|P7|Second Treatment|Withdrawal by Subject|0
4881990|NCT00750308|16823891|P6|Second Treatment|Withdrawal by Subject|0
4881991|NCT00750308|16823892|P5|Second Treatment|Withdrawal by Subject|1
4881992|NCT00750308|16823893|P4|Second Treatment|Withdrawal by Subject|0
4881993|NCT00750308|16823894|P3|Second Treatment|Withdrawal by Subject|0
4881994|NCT00750308|16823895|P2|Second Treatment|Withdrawal by Subject|0
4881995|NCT00750308|16823896|P1|Second Treatment|Withdrawal by Subject|0
4881996|NCT00750308|16823885|P12|Second Treatment|Adverse Event|0
4881997|NCT00750308|16823886|P11|Second Treatment|Adverse Event|0
4881998|NCT00750308|16823887|P10|Second Treatment|Adverse Event|0
4881999|NCT00750308|16823888|P9|Second Treatment|Adverse Event|1
4882000|NCT00750308|16823889|P8|Second Treatment|Adverse Event|0
4882001|NCT00750308|16823890|P7|Second Treatment|Adverse Event|0
4882002|NCT00750308|16823891|P6|Second Treatment|Adverse Event|1
4882003|NCT00750308|16823892|P5|Second Treatment|Adverse Event|0
4882004|NCT00750308|16823893|P4|Second Treatment|Adverse Event|0
4882005|NCT00750308|16823894|P3|Second Treatment|Adverse Event|0
4882006|NCT00750308|16823895|P2|Second Treatment|Adverse Event|0
4882007|NCT00750308|16823896|P1|Second Treatment|Adverse Event|0
4882008|NCT00750308|16823885|P12|First Treatment|Withdrawal by Subject|0
4882009|NCT00750308|16823886|P11|First Treatment|Withdrawal by Subject|0
4882010|NCT00750308|16823887|P10|First Treatment|Withdrawal by Subject|0
4882011|NCT00750308|16823888|P9|First Treatment|Withdrawal by Subject|0
4882012|NCT00750308|16823889|P8|First Treatment|Withdrawal by Subject|1
4882013|NCT00750308|16823890|P7|First Treatment|Withdrawal by Subject|0
4882014|NCT00750308|16823891|P6|First Treatment|Withdrawal by Subject|0
4882015|NCT00750308|16823892|P5|First Treatment|Withdrawal by Subject|0
4882016|NCT00750308|16823893|P4|First Treatment|Withdrawal by Subject|1
4882017|NCT00750308|16823894|P3|First Treatment|Withdrawal by Subject|0
4882018|NCT00750308|16823895|P2|First Treatment|Withdrawal by Subject|0
4882019|NCT00750308|16823896|P1|First Treatment|Withdrawal by Subject|0
4882020|NCT00750308|16823885|P12|First Treatment|Adverse Event|1
4882021|NCT00750308|16823886|P11|First Treatment|Adverse Event|1
4882022|NCT00750308|16823887|P10|First Treatment|Adverse Event|0
4882023|NCT00750308|16823888|P9|First Treatment|Adverse Event|0
4882024|NCT00750308|16823889|P8|First Treatment|Adverse Event|0
4882025|NCT00750308|16823890|P7|First Treatment|Adverse Event|0
4882026|NCT00750308|16823891|P6|First Treatment|Adverse Event|0
4882027|NCT00750308|16823892|P5|First Treatment|Adverse Event|0
4882028|NCT00750308|16823893|P4|First Treatment|Adverse Event|0
4882029|NCT00750308|16823894|P3|First Treatment|Adverse Event|0
4882030|NCT00750308|16823895|P2|First Treatment|Adverse Event|1
4882031|NCT00750308|16823896|P1|First Treatment|Adverse Event|0
4882032|NCT00750269|16823946|P5|Overall Study|Fiducials could not be placed|1
4882033|NCT00750269|16823947|P4|Overall Study|Fiducials could not be placed|0
4882034|NCT00750269|16823948|P3|Overall Study|Fiducials could not be placed|0
4882035|NCT00750269|16823949|P2|Overall Study|Fiducials could not be placed|0
4882036|NCT00750269|16823950|P1|Overall Study|Fiducials could not be placed|0
4882037|NCT00750269|16823946|P5|Overall Study|SBRT plan could not be drawn|1
4882038|NCT00750269|16823947|P4|Overall Study|SBRT plan could not be drawn|0
4882039|NCT00750269|16823948|P3|Overall Study|SBRT plan could not be drawn|0
4882040|NCT00750269|16823949|P2|Overall Study|SBRT plan could not be drawn|0
4882041|NCT00750269|16823950|P1|Overall Study|SBRT plan could not be drawn|0
4882042|NCT00750269|16823946|P5|Overall Study|Site error|0
4882043|NCT00750269|16823947|P4|Overall Study|Site error|1
4882044|NCT00750269|16823948|P3|Overall Study|Site error|0
4882045|NCT00750269|16823949|P2|Overall Study|Site error|0
4882046|NCT00750269|16823950|P1|Overall Study|Site error|0
4882047|NCT00750269|16823946|P5|Overall Study|Patient too large for positioning|0
4882048|NCT00750269|16823947|P4|Overall Study|Patient too large for positioning|0
4882049|NCT00750269|16823948|P3|Overall Study|Patient too large for positioning|1
4882050|NCT00750269|16823949|P2|Overall Study|Patient too large for positioning|0
4882051|NCT00750269|16823950|P1|Overall Study|Patient too large for positioning|0
4882052|NCT00750269|16823946|P5|Overall Study|Physician Decision|2
4882053|NCT00750269|16823947|P4|Overall Study|Physician Decision|0
4882054|NCT00750269|16823948|P3|Overall Study|Physician Decision|0
4882055|NCT00750269|16823949|P2|Overall Study|Physician Decision|0
4882056|NCT00750269|16823950|P1|Overall Study|Physician Decision|0
4882057|NCT00750269|16823946|P5|Overall Study|Withdrawal by Subject|2
4882058|NCT00750269|16823947|P4|Overall Study|Withdrawal by Subject|2
4882059|NCT00750269|16823948|P3|Overall Study|Withdrawal by Subject|2
4882060|NCT00750269|16823949|P2|Overall Study|Withdrawal by Subject|0
4882061|NCT00750269|16823950|P1|Overall Study|Withdrawal by Subject|0
4882062|NCT00750269|16823946|P5|Overall Study|Protocol Violation|4
4882063|NCT00750269|16823947|P4|Overall Study|Protocol Violation|2
4882064|NCT00750269|16823948|P3|Overall Study|Protocol Violation|1
4882065|NCT00750269|16823949|P2|Overall Study|Protocol Violation|1
4882066|NCT00750269|16823950|P1|Overall Study|Protocol Violation|0
4882067|NCT00750204|16823997|P2|Overall Study|study halted prematurely|1
4882068|NCT00750204|16823998|P1|Overall Study|study halted prematurely|1
4882069|NCT00750152|16824028|P2|Overall Study|Other|8
4882070|NCT00750152|16824029|P1|Overall Study|Other|7
4882071|NCT00750152|16824028|P2|Overall Study|Termination by sponsor|0
4882072|NCT00750152|16824029|P1|Overall Study|Termination by sponsor|1
4882073|NCT00750152|16824028|P2|Overall Study|Non-compliance|1
4882074|NCT00750152|16824029|P1|Overall Study|Non-compliance|0
4882075|NCT00750152|16824028|P2|Overall Study|Physician Decision|1
4882076|NCT00750152|16824029|P1|Overall Study|Physician Decision|1
4882077|NCT00750152|16824028|P2|Overall Study|Withdrawal by Subject|3
4882078|NCT00750152|16824029|P1|Overall Study|Withdrawal by Subject|3
4882079|NCT00750152|16824028|P2|Overall Study|Lost to Follow-up|13
4882080|NCT00750152|16824029|P1|Overall Study|Lost to Follow-up|8
4882081|NCT00750152|16824028|P2|Overall Study|Adverse Event|1
4882082|NCT00750152|16824029|P1|Overall Study|Adverse Event|2
4882083|NCT00750139|16824041|P4|Overall Study|Non-specific|33
4882084|NCT00750139|16824042|P3|Overall Study|Non-specific|79
4882085|NCT00750139|16824043|P2|Overall Study|Non-specific|42
4882086|NCT00750139|16824044|P1|Overall Study|Non-specific|62
4882087|NCT00750139|16824041|P4|Overall Study|Termination by sponsor|1
4882088|NCT00750139|16824042|P3|Overall Study|Termination by sponsor|0
4882089|NCT00750139|16824043|P2|Overall Study|Termination by sponsor|0
4882090|NCT00750139|16824044|P1|Overall Study|Termination by sponsor|4
4882091|NCT00750139|16824041|P4|Overall Study|Non-compliance|3
4882092|NCT00750139|16824042|P3|Overall Study|Non-compliance|1
4882093|NCT00750139|16824043|P2|Overall Study|Non-compliance|0
4882094|NCT00750139|16824044|P1|Overall Study|Non-compliance|1
4882095|NCT00750139|16824041|P4|Overall Study|Physician Decision|0
4882096|NCT00750139|16824042|P3|Overall Study|Physician Decision|0
4882097|NCT00750139|16824043|P2|Overall Study|Physician Decision|1
4882098|NCT00750139|16824044|P1|Overall Study|Physician Decision|1
4882099|NCT00750139|16824041|P4|Overall Study|Withdrawal by Subject|2
4882100|NCT00750139|16824042|P3|Overall Study|Withdrawal by Subject|6
4882101|NCT00750139|16824043|P2|Overall Study|Withdrawal by Subject|2
4882102|NCT00750139|16824044|P1|Overall Study|Withdrawal by Subject|3
4882103|NCT00750139|16824041|P4|Overall Study|Lost to Follow-up|6
4882104|NCT00750139|16824042|P3|Overall Study|Lost to Follow-up|15
4882105|NCT00750139|16824043|P2|Overall Study|Lost to Follow-up|12
4882106|NCT00750139|16824044|P1|Overall Study|Lost to Follow-up|17
4882107|NCT00750139|16824041|P4|Overall Study|Adverse Event|1
4882108|NCT00750139|16824042|P3|Overall Study|Adverse Event|0
4882109|NCT00750139|16824043|P2|Overall Study|Adverse Event|2
4882110|NCT00750139|16824044|P1|Overall Study|Adverse Event|1
4882111|NCT00750061|16824060|P2|Overall Study|Physician Decision|1
4882112|NCT00750061|16824061|P1|Overall Study|Physician Decision|0
4882113|NCT00750061|16824060|P2|Overall Study|Withdrawal by Subject|1
4882114|NCT00750061|16824061|P1|Overall Study|Withdrawal by Subject|0
4882115|NCT00750061|16824060|P2|Overall Study|Adverse Event|0
4882116|NCT00750061|16824061|P1|Overall Study|Adverse Event|2
4882117|NCT00749996|16824071|P2|Overall Study|Death|0
4882118|NCT00749996|16824072|P1|Overall Study|Death|1
4882119|NCT00749996|16824071|P2|Overall Study|Adverse Event|0
4882120|NCT00749996|16824072|P1|Overall Study|Adverse Event|1
4882121|NCT00749996|16824071|P2|Overall Study|Pregnancy|2
4882122|NCT00749996|16824072|P1|Overall Study|Pregnancy|0
4882123|NCT00749996|16824071|P2|Overall Study|Physician Decision|0
4882124|NCT00749996|16824072|P1|Overall Study|Physician Decision|2
4882125|NCT00749996|16824071|P2|Overall Study|Protocol Violation|3
4882126|NCT00749996|16824072|P1|Overall Study|Protocol Violation|2
4882127|NCT00749996|16824071|P2|Overall Study|Withdrawal by Subject|4
4882128|NCT00749996|16824072|P1|Overall Study|Withdrawal by Subject|5
4882129|NCT00749996|16824071|P2|Overall Study|Lost to Follow-up|4
4882130|NCT00749996|16824072|P1|Overall Study|Lost to Follow-up|7
4882131|NCT00749944|16824095|P2|Overall Study|Withdrawal by Subject|0
4882132|NCT00749944|16824096|P1|Overall Study|Withdrawal by Subject|2
4882133|NCT00749944|16824095|P2|Overall Study|Other|0
4882134|NCT00749944|16824096|P1|Overall Study|Other|1
4882135|NCT00749944|16824095|P2|Overall Study|Lost to Follow-up|1
4882136|NCT00749944|16824096|P1|Overall Study|Lost to Follow-up|2
4882137|NCT00749892|16824175|P1|Overall Study|Withdrawal by Subject|3
4882138|NCT00749775|16824211|P1|Overall Study|No drug administration|3
4882139|NCT00749775|16824211|P1|Overall Study|No visit after first day of treatment|44
4882140|NCT00749775|16824211|P1|Overall Study|Lost to Follow-up|36
4882141|NCT00749775|16824211|P1|Overall Study|Protocol Violation|24
4882142|NCT00749684|16824227|P1|Overall Study|Missing|9
4882143|NCT00749684|16824227|P1|Overall Study|AE+discontinuation on participants wish|1
4882144|NCT00749684|16824227|P1|Overall Study|Therapy according to protocol + AE|2
4882145|NCT00749684|16824227|P1|Overall Study|Progressive Desease|31
4882146|NCT00749684|16824227|P1|Overall Study|Not Documented|1
4882147|NCT00749684|16824227|P1|Overall Study|Participant's Wish|10
4882148|NCT00749684|16824227|P1|Overall Study|Adverse Event|27
4882149|NCT00749684|16824227|P1|Overall Study|Death|1
4882150|NCT00749580|16824266|P2|Overall Study|Adverse Event|1
4882151|NCT00749580|16824267|P1|Overall Study|Adverse Event|0
4882152|NCT00749580|16824266|P2|Overall Study|Lost to Follow-up|8
4882153|NCT00749580|16824267|P1|Overall Study|Lost to Follow-up|4
4882154|NCT00749463|16824301|P3|Overall Study|Withdrawal by Subject|0
4882155|NCT00749463|16824302|P2|Overall Study|Withdrawal by Subject|0
4882156|NCT00749463|16824303|P1|Overall Study|Withdrawal by Subject|1
4882157|NCT00749463|16824301|P3|Overall Study|Adverse Event|1
4882158|NCT00749463|16824302|P2|Overall Study|Adverse Event|4
4882159|NCT00749463|16824303|P1|Overall Study|Adverse Event|0
4882160|NCT00749411|16824331|P2|Overall Study|Protocol-defined stopping criteria|1
4882161|NCT00749411|16824332|P1|Overall Study|Protocol-defined stopping criteria|0
4882162|NCT00749411|16824331|P2|Overall Study|Protocol Violation|1
4882163|NCT00749411|16824332|P1|Overall Study|Protocol Violation|1
4882164|NCT00749411|16824331|P2|Overall Study|Lack of Efficacy|1
4882165|NCT00749411|16824332|P1|Overall Study|Lack of Efficacy|0
4882166|NCT00749411|16824331|P2|Overall Study|Adverse Event|2
4882167|NCT00749411|16824332|P1|Overall Study|Adverse Event|0
4882168|NCT00749398|16824340|P1|Overall Study|Unknown reason|1
4882169|NCT00749398|16824340|P1|Overall Study|Reason not specified|2
4882170|NCT00749398|16824340|P1|Overall Study|Lost to Follow-up|11
4882171|NCT00749398|16824340|P1|Overall Study|Withdrawal by Subject|17
4882172|NCT00749398|16824340|P1|Overall Study|Serious adverse event|11
4882173|NCT00749398|16824340|P1|Overall Study|Adverse Event|4
4882174|NCT00749398|16824340|P1|Overall Study|Lack of Efficacy|7
4882175|NCT00749203|16824383|P2|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1
4882176|NCT00749203|16824384|P1|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0
4882177|NCT00749203|16824383|P2|Second Infusion at 2 Weeks|Protocol Violation|1
4882178|NCT00749203|16824384|P1|Second Infusion at 2 Weeks|Protocol Violation|0
4882179|NCT00749203|16824383|P2|no Infusion at Week 1|low baseline PTSD symptoms level|1
4882180|NCT00749203|16824384|P1|no Infusion at Week 1|low baseline PTSD symptoms level|0
4882181|NCT00749203|16824383|P2|no Infusion at Week 1|delayed-onset sedation|1
4882182|NCT00749203|16824384|P1|no Infusion at Week 1|delayed-onset sedation|0
4882183|NCT00749203|16824383|P2|no Infusion at Week 1|Withdrawal by Subject|1
4882184|NCT00749203|16824384|P1|no Infusion at Week 1|Withdrawal by Subject|0
4882185|NCT00749203|16824383|P2|no Infusion at Week 1|Lost to Follow-up|1
4882186|NCT00749203|16824384|P1|no Infusion at Week 1|Lost to Follow-up|0
4882187|NCT00749190|16824405|P7|Overall Study|Other reason not defined above|0
4882188|NCT00749190|16824406|P6|Overall Study|Other reason not defined above|0
4882189|NCT00749190|16824407|P5|Overall Study|Other reason not defined above|0
4882190|NCT00749190|16824408|P4|Overall Study|Other reason not defined above|1
4882191|NCT00749190|16824409|P3|Overall Study|Other reason not defined above|0
4882192|NCT00749190|16824410|P2|Overall Study|Other reason not defined above|0
4882193|NCT00749190|16824411|P1|Overall Study|Other reason not defined above|0
4882194|NCT00749190|16824405|P7|Overall Study|Protocol Violation|1
4882195|NCT00749190|16824406|P6|Overall Study|Protocol Violation|0
4882196|NCT00749190|16824407|P5|Overall Study|Protocol Violation|0
4882197|NCT00749190|16824408|P4|Overall Study|Protocol Violation|0
4882198|NCT00749190|16824409|P3|Overall Study|Protocol Violation|0
4882199|NCT00749190|16824410|P2|Overall Study|Protocol Violation|1
4882200|NCT00749190|16824411|P1|Overall Study|Protocol Violation|0
4882201|NCT00749190|16824405|P7|Overall Study|Withdrawal by Subject|0
4882202|NCT00749190|16824406|P6|Overall Study|Withdrawal by Subject|1
4882203|NCT00749190|16824407|P5|Overall Study|Withdrawal by Subject|0
4882204|NCT00749190|16824408|P4|Overall Study|Withdrawal by Subject|0
4882205|NCT00749190|16824409|P3|Overall Study|Withdrawal by Subject|0
4882206|NCT00749190|16824410|P2|Overall Study|Withdrawal by Subject|1
4882207|NCT00749190|16824411|P1|Overall Study|Withdrawal by Subject|2
4882208|NCT00749190|16824405|P7|Overall Study|Lack of Efficacy|0
4882209|NCT00749190|16824406|P6|Overall Study|Lack of Efficacy|1
4882210|NCT00749190|16824407|P5|Overall Study|Lack of Efficacy|0
4882211|NCT00749190|16824408|P4|Overall Study|Lack of Efficacy|0
4882212|NCT00749190|16824409|P3|Overall Study|Lack of Efficacy|1
4882213|NCT00749190|16824410|P2|Overall Study|Lack of Efficacy|1
4882214|NCT00749190|16824411|P1|Overall Study|Lack of Efficacy|3
4882215|NCT00749190|16824405|P7|Overall Study|Adverse Event|0
4882216|NCT00749190|16824406|P6|Overall Study|Adverse Event|3
4882217|NCT00749190|16824407|P5|Overall Study|Adverse Event|0
4882218|NCT00749190|16824408|P4|Overall Study|Adverse Event|4
4882219|NCT00749190|16824409|P3|Overall Study|Adverse Event|0
4882220|NCT00749190|16824410|P2|Overall Study|Adverse Event|2
4882221|NCT00749190|16824411|P1|Overall Study|Adverse Event|0
4882222|NCT00748969|16824520|P2|Overall Study|Withdrawal by Subject|1
4882223|NCT00748969|16824521|P1|Overall Study|Withdrawal by Subject|0
4882224|NCT00748969|16824520|P2|Overall Study|Withdrawal by Subject|0
4882225|NCT00748969|16824521|P1|Overall Study|Withdrawal by Subject|1
4882226|NCT00748709|16824571|P1|Overall Study|Other Reasons|1
4882227|NCT00748709|16824571|P1|Overall Study|Withdrawal by Subject|1
4882228|NCT00748709|16824571|P1|Overall Study|Other Adverse Event|1
4882229|NCT00748709|16824571|P1|Overall Study|Drug reducing Toxity|2
4882230|NCT00748709|16824571|P1|Overall Study|Progressive disease|15
4882231|NCT00748566|16824614|P1|Overall Study|Other|9
4882232|NCT00748566|16824614|P1|Overall Study|Study terminated by sponsor|5
4882233|NCT00748566|16824614|P1|Overall Study|Withdrawal by Subject|22
4882234|NCT00748566|16824614|P1|Overall Study|Protocol Violation|13
4882235|NCT00748566|16824614|P1|Overall Study|Lost to Follow-up|1
4882236|NCT00748566|16824614|P1|Overall Study|Lack of Efficacy|12
4882237|NCT00748566|16824614|P1|Overall Study|Death|1
4882238|NCT00748566|16824614|P1|Overall Study|Adverse Event|49
4882239|NCT00748553|16824644|P2|Overall Study|noncompliance|0
4882240|NCT00748553|16824645|P1|Overall Study|noncompliance|1
4882241|NCT00748553|16824644|P2|Overall Study|disease progression|0
4882242|NCT00748553|16824645|P1|Overall Study|disease progression|2
4882243|NCT00748553|16824644|P2|Overall Study|Adverse Event|1
4882244|NCT00748553|16824645|P1|Overall Study|Adverse Event|0
4882245|NCT00748540|16824652|P1|Overall Study|Physician Decision|1
4882246|NCT00748241|16824659|P1|Overall Study|Death|2
4882247|NCT00748241|16824659|P1|Overall Study|Lost to Follow-up|5
4882248|NCT00748241|16824659|P1|Overall Study|Implant failure|1
4882249|NCT00748189|16824669|P2|Overall Study|Study terminated by Sponsor|79
4882250|NCT00748189|16824670|P1|Overall Study|Study terminated by Sponsor|70
4882251|NCT00748189|16824669|P2|Overall Study|Lost to Follow-up|15
4882252|NCT00748189|16824670|P1|Overall Study|Lost to Follow-up|8
4882253|NCT00748189|16824669|P2|Overall Study|Physician Decision|5
4882254|NCT00748189|16824670|P1|Overall Study|Physician Decision|16
4882255|NCT00748189|16824669|P2|Overall Study|Withdrawal by Subject|29
4882256|NCT00748189|16824670|P1|Overall Study|Withdrawal by Subject|23
4882257|NCT00748189|16824669|P2|Overall Study|Death|84
4882258|NCT00748189|16824670|P1|Overall Study|Death|99
4882259|NCT00748098|16824725|P2|Second Treatment Intervention Period|Withdrawal by Subject|1
4882260|NCT00748098|16824726|P1|Second Treatment Intervention Period|Withdrawal by Subject|1
4882261|NCT00748098|16824725|P2|Second Treatment Intervention Period|Lost to Follow-up|1
4882262|NCT00748098|16824726|P1|Second Treatment Intervention Period|Lost to Follow-up|1
4882263|NCT00748098|16824725|P2|Second Treatment Intervention Period|Adverse Event|1
4882264|NCT00748098|16824726|P1|Second Treatment Intervention Period|Adverse Event|4
4882265|NCT00748098|16824725|P2|1-Week Washout Period|Withdrawal by Subject|0
4882266|NCT00748098|16824726|P1|1-Week Washout Period|Withdrawal by Subject|2
4882267|NCT00748098|16824725|P2|1-Week Washout Period|Adverse Event|1
4882268|NCT00748098|16824726|P1|1-Week Washout Period|Adverse Event|0
4882269|NCT00748098|16824725|P2|First Taper Period|Protocol Stopping Criteria Met|1
4882270|NCT00748098|16824726|P1|First Taper Period|Protocol Stopping Criteria Met|0
4882271|NCT00748098|16824725|P2|First Taper Period|Withdrawal by Subject|0
4882272|NCT00748098|16824726|P1|First Taper Period|Withdrawal by Subject|2
4882273|NCT00748098|16824725|P2|First Taper Period|Protocol Violation|0
4882274|NCT00748098|16824726|P1|First Taper Period|Protocol Violation|1
4882275|NCT00748098|16824725|P2|First Treatment Intervention Period|Withdrawal by Subject|0
4882276|NCT00748098|16824726|P1|First Treatment Intervention Period|Withdrawal by Subject|2
4882277|NCT00748098|16824725|P2|First Treatment Intervention Period|Lost to Follow-up|0
4882278|NCT00748098|16824726|P1|First Treatment Intervention Period|Lost to Follow-up|1
4882279|NCT00748098|16824725|P2|First Treatment Intervention Period|Protocol Violation|0
4882280|NCT00748098|16824726|P1|First Treatment Intervention Period|Protocol Violation|1
4882281|NCT00748098|16824725|P2|First Treatment Intervention Period|Adverse Event|1
4882282|NCT00748098|16824726|P1|First Treatment Intervention Period|Adverse Event|1
4882283|NCT00747812|16824807|P2|Overall Study|Research Site Staff Relocation|3
4882284|NCT00747812|16824808|P1|Overall Study|Research Site Staff Relocation|5
4882285|NCT00747643|16824846|P2|Overall Study|Withdrawal by Subject|27
4882286|NCT00747643|16824847|P1|Overall Study|Withdrawal by Subject|36
4882287|NCT00747617|16824861|P2|Overall Study|Lost to Follow-up|1
4882288|NCT00747617|16824862|P1|Overall Study|Lost to Follow-up|3
4882289|NCT00747565|16824872|P2|Overall Study|Lost to Follow-up|1
4882290|NCT00747565|16824873|P1|Overall Study|Lost to Follow-up|4
4882291|NCT00747565|16824872|P2|Overall Study|Withdrawal by Subject|6
4882292|NCT00747565|16824873|P1|Overall Study|Withdrawal by Subject|10
4882293|NCT00747474|16824886|P12|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882294|NCT00747474|16824887|P11|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882295|NCT00747474|16824888|P10|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882296|NCT00747474|16824889|P9|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882297|NCT00747474|16824890|P8|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1
4882298|NCT00747474|16824891|P7|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882299|NCT00747474|16824892|P6|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882300|NCT00747474|16824893|P5|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882301|NCT00747474|16824894|P4|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882302|NCT00747474|16824895|P3|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882303|NCT00747474|16824896|P2|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882304|NCT00747474|16824897|P1|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0
4882305|NCT00747461|16824923|P1|Overall Study|study terminated by sponsor|5
4882306|NCT00747435|16824928|P1|Overall Study|Still undergoing follow up|1
4882307|NCT00747435|16824928|P1|Overall Study|Withdrawal by Subject|3
4882308|NCT00747435|16824928|P1|Overall Study|Lost to Follow-up|2
4882309|NCT00747344|16824938|P4|After Controlled Period|Adverse Event|1
4882310|NCT00747344|16824939|P3|After Controlled Period|Adverse Event|0
4882311|NCT00747344|16824940|P2|After Controlled Period|Adverse Event|0
4882312|NCT00747344|16824941|P1|After Controlled Period|Adverse Event|0
4882313|NCT00747344|16824938|P4|Controlled Period|Other|0
4882314|NCT00747344|16824939|P3|Controlled Period|Other|0
4882315|NCT00747344|16824940|P2|Controlled Period|Other|3
4882316|NCT00747344|16824941|P1|Controlled Period|Other|0
4882317|NCT00747344|16824938|P4|Controlled Period|Lack of Efficacy|0
4882318|NCT00747344|16824939|P3|Controlled Period|Lack of Efficacy|0
4882319|NCT00747344|16824940|P2|Controlled Period|Lack of Efficacy|1
4882320|NCT00747344|16824941|P1|Controlled Period|Lack of Efficacy|2
4882321|NCT00747344|16824938|P4|Controlled Period|Adverse Event|0
4882322|NCT00747344|16824939|P3|Controlled Period|Adverse Event|0
4882323|NCT00747344|16824940|P2|Controlled Period|Adverse Event|0
4882324|NCT00747344|16824941|P1|Controlled Period|Adverse Event|3
4882325|NCT00747227|16824955|P2|Overall Study|Illness|1
4882326|NCT00747227|16824956|P1|Overall Study|Illness|1
4882327|NCT00747227|16824955|P2|Overall Study|Lost to Follow-up|2
4882328|NCT00747227|16824956|P1|Overall Study|Lost to Follow-up|1
4882329|NCT00747227|16824955|P2|Overall Study|Withdrawal by Subject|0
4882330|NCT00747227|16824956|P1|Overall Study|Withdrawal by Subject|1
4882331|NCT00747227|16824955|P2|Overall Study|Death|1
4882332|NCT00747227|16824956|P1|Overall Study|Death|3
4882333|NCT00747149|16824985|P2|Overall Study|Not reported|4
4882334|NCT00747149|16824986|P1|Overall Study|Not reported|1
4882335|NCT00747149|16824985|P2|Overall Study|Severe non-compliance to protocol|1
4882336|NCT00747149|16824986|P1|Overall Study|Severe non-compliance to protocol|0
4882337|NCT00747149|16824985|P2|Overall Study|Incorrect enrollment|6
4882338|NCT00747149|16824986|P1|Overall Study|Incorrect enrollment|0
4882339|NCT00747149|16824985|P2|Overall Study|Did not receive treatment|1
4882340|NCT00747149|16824986|P1|Overall Study|Did not receive treatment|0
4882341|NCT00747149|16824985|P2|Overall Study|Withdrawal by Subject|6
4882342|NCT00747149|16824986|P1|Overall Study|Withdrawal by Subject|0
4882343|NCT00747149|16824985|P2|Overall Study|Lost to Follow-up|10
4882344|NCT00747149|16824986|P1|Overall Study|Lost to Follow-up|0
4882345|NCT00747149|16824985|P2|Overall Study|Adverse Event|15
4882346|NCT00747149|16824986|P1|Overall Study|Adverse Event|0
4882347|NCT00747006|16825001|P3|Overall Study|Physician Decision|1
4882348|NCT00747006|16825002|P2|Overall Study|Physician Decision|0
4882349|NCT00747006|16825003|P1|Overall Study|Physician Decision|2
4882350|NCT00747006|16825001|P3|Overall Study|Lost to Follow-up|0
4882351|NCT00747006|16825002|P2|Overall Study|Lost to Follow-up|1
4882352|NCT00747006|16825003|P1|Overall Study|Lost to Follow-up|0
4882353|NCT00747006|16825001|P3|Overall Study|Adverse Event|0
4882354|NCT00747006|16825002|P2|Overall Study|Adverse Event|0
4882355|NCT00747006|16825003|P1|Overall Study|Adverse Event|1
4882356|NCT00746941|16825081|P4|Overall Study|Adverse Event|1
4882357|NCT00746941|16825082|P3|Overall Study|Adverse Event|0
4882358|NCT00746941|16825083|P2|Overall Study|Adverse Event|0
4882359|NCT00746941|16825084|P1|Overall Study|Adverse Event|0
4882360|NCT00746941|16825081|P4|Overall Study|Other, reason not provided|4
4882361|NCT00746941|16825082|P3|Overall Study|Other, reason not provided|0
4882362|NCT00746941|16825083|P2|Overall Study|Other, reason not provided|4
4882363|NCT00746941|16825084|P1|Overall Study|Other, reason not provided|2
4882364|NCT00746941|16825081|P4|Overall Study|Withdrawal by Subject|2
4882365|NCT00746941|16825082|P3|Overall Study|Withdrawal by Subject|0
4882366|NCT00746941|16825083|P2|Overall Study|Withdrawal by Subject|0
4882367|NCT00746941|16825084|P1|Overall Study|Withdrawal by Subject|3
4882368|NCT00746941|16825081|P4|Overall Study|Physician Decision|0
4882369|NCT00746941|16825082|P3|Overall Study|Physician Decision|2
4882370|NCT00746941|16825083|P2|Overall Study|Physician Decision|0
4882371|NCT00746941|16825084|P1|Overall Study|Physician Decision|0
4882372|NCT00746941|16825081|P4|Overall Study|Death|6
4882373|NCT00746941|16825082|P3|Overall Study|Death|0
4882374|NCT00746941|16825083|P2|Overall Study|Death|0
4882375|NCT00746941|16825084|P1|Overall Study|Death|2
4882376|NCT00746798|16825142|P4|Overall Study|Participant unable to return for visit|0
4882377|NCT00746798|16825143|P3|Overall Study|Participant unable to return for visit|0
4882378|NCT00746798|16825144|P2|Overall Study|Participant unable to return for visit|0
4882379|NCT00746798|16825145|P1|Overall Study|Participant unable to return for visit|1
4882380|NCT00746798|16825142|P4|Overall Study|Death|0
4882381|NCT00746798|16825143|P3|Overall Study|Death|2
4882382|NCT00746798|16825144|P2|Overall Study|Death|0
4882383|NCT00746798|16825145|P1|Overall Study|Death|0
4882384|NCT00746798|16825142|P4|Overall Study|Withdrawal by Subject|0
4882385|NCT00746798|16825143|P3|Overall Study|Withdrawal by Subject|1
4882386|NCT00746798|16825144|P2|Overall Study|Withdrawal by Subject|1
4882387|NCT00746798|16825145|P1|Overall Study|Withdrawal by Subject|0
4882388|NCT00746798|16825142|P4|Overall Study|Protocol Violation|0
4882389|NCT00746798|16825143|P3|Overall Study|Protocol Violation|0
4882390|NCT00746798|16825144|P2|Overall Study|Protocol Violation|1
4882391|NCT00746798|16825145|P1|Overall Study|Protocol Violation|0
4882392|NCT00746785|16825170|P3|Overall Study|Lost to Follow-up|27
4882393|NCT00746785|16825171|P2|Overall Study|Lost to Follow-up|25
4882394|NCT00746785|16825172|P1|Overall Study|Lost to Follow-up|29
4882395|NCT00746733|16825180|P2|Third Intervention|Withdrawal by Subject|1
4882396|NCT00746733|16825181|P1|Third Intervention|Withdrawal by Subject|1
4882397|NCT00746733|16825180|P2|Second Intervention|Adverse Event|0
4882398|NCT00746733|16825181|P1|Second Intervention|Adverse Event|1
4882399|NCT00746590|16825265|P1|Overall Study|Death|1
4882400|NCT00746564|16825269|P1|Overall Study|Required Pacemaker/ICD Implant|2
4882401|NCT00746551|16825284|P2|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8
4882402|NCT00746551|16825285|P1|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6
4882403|NCT00746551|16825284|P2|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7
4882404|NCT00746551|16825285|P1|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9
4882405|NCT00746551|16825284|P2|At Gestational Age of 36 Weeks|Lost to Follow-up|4
4882406|NCT00746551|16825285|P1|At Gestational Age of 36 Weeks|Lost to Follow-up|2
4882407|NCT00746356|16825336|P2|Overall Study|Patient relocated|0
4882408|NCT00746356|16825337|P1|Overall Study|Patient relocated|1
4882409|NCT00746356|16825336|P2|Overall Study|Removal of Device|1
4882410|NCT00746356|16825337|P1|Overall Study|Removal of Device|0
4882411|NCT00746356|16825336|P2|Overall Study|Lost to Follow-up|0
4882412|NCT00746356|16825337|P1|Overall Study|Lost to Follow-up|1
4882413|NCT00746356|16825336|P2|Overall Study|Death|3
4882414|NCT00746356|16825337|P1|Overall Study|Death|7
4882415|NCT00746356|16825336|P2|Overall Study|Withdrawal by Subject|3
4882416|NCT00746356|16825337|P1|Overall Study|Withdrawal by Subject|2
4882417|NCT00746330|16825349|P4|Period 1|Abnormal test procedure result|0
4882418|NCT00746330|16825350|P3|Period 1|Abnormal test procedure result|1
4882419|NCT00746330|16825351|P2|Period 1|Abnormal test procedure result|0
4882420|NCT00746330|16825352|P1|Period 1|Abnormal test procedure result|0
4882421|NCT00746252|16825382|P2|Overall Study|weight gain >7.5 %|2
4882422|NCT00746252|16825383|P1|Overall Study|weight gain >7.5 %|1
4882423|NCT00746096|16825418|P2|Overall Study|No study drug treatment|1
4882424|NCT00746096|16825419|P1|Overall Study|No study drug treatment|1
4882425|NCT00746096|16825418|P2|Overall Study|Protocol Violation|0
4882426|NCT00746096|16825419|P1|Overall Study|Protocol Violation|1
4882427|NCT00746096|16825418|P2|Overall Study|Lost to Follow-up|1
4882428|NCT00746096|16825419|P1|Overall Study|Lost to Follow-up|2
4882429|NCT00746096|16825418|P2|Overall Study|Withdrawal by Subject|1
4882430|NCT00746096|16825419|P1|Overall Study|Withdrawal by Subject|5
4882431|NCT00746096|16825418|P2|Overall Study|Adverse Event|0
4882432|NCT00746096|16825419|P1|Overall Study|Adverse Event|1
4882433|NCT00745901|16825450|P2|Overall Study|Patient didn't take any study medication|3
4882434|NCT00745901|16825451|P1|Overall Study|Patient didn't take any study medication|7
4882435|NCT00745901|16825450|P2|Overall Study|Chlamydia test at Visit 1 was positive|1
4882436|NCT00745901|16825451|P1|Overall Study|Chlamydia test at Visit 1 was positive|1
4882437|NCT00745901|16825450|P2|Overall Study|Results of Pap smear at Vis 1 malignant|2
4882438|NCT00745901|16825451|P1|Overall Study|Results of Pap smear at Vis 1 malignant|0
4882439|NCT00745901|16825450|P2|Overall Study|Patient's next menses did not start with|0
4882440|NCT00745901|16825451|P1|Overall Study|Patient's next menses did not start with|1
4882441|NCT00745901|16825450|P2|Overall Study|Lack of compliance|2
4882442|NCT00745901|16825451|P1|Overall Study|Lack of compliance|2
4882443|NCT00745901|16825450|P2|Overall Study|Pregnancy|4
4882444|NCT00745901|16825451|P1|Overall Study|Pregnancy|2
4882445|NCT00745901|16825450|P2|Overall Study|Lost to Follow-up|4
4882446|NCT00745901|16825451|P1|Overall Study|Lost to Follow-up|7
4882447|NCT00745901|16825450|P2|Overall Study|Withdrawal by Subject|0
4882448|NCT00745901|16825451|P1|Overall Study|Withdrawal by Subject|1
4882449|NCT00745901|16825450|P2|Overall Study|Protocol Violation|1
4882450|NCT00745901|16825451|P1|Overall Study|Protocol Violation|0
4882451|NCT00745901|16825450|P2|Overall Study|Adverse Event|4
4882452|NCT00745901|16825451|P1|Overall Study|Adverse Event|3
4882453|NCT00745875|16825497|P2|Overall Study|Continuing study treatment|4
4882454|NCT00745875|16825498|P1|Overall Study|Continuing study treatment|4
4882455|NCT00745849|16825506|P2|Second Intervention|Lost to Follow-up|1
4882456|NCT00745849|16825507|P1|Second Intervention|Lost to Follow-up|2
4882457|NCT00745849|16825506|P2|First Intervention|Lost to Follow-up|1
4882458|NCT00745849|16825507|P1|First Intervention|Lost to Follow-up|1
4882459|NCT00745849|16825506|P2|First Intervention|Withdrawal by Subject|1
4882460|NCT00745849|16825507|P1|First Intervention|Withdrawal by Subject|0
4882461|NCT00745823|16825515|P2|Overall Study|Study Terminated by Sponsor|349
4882462|NCT00745823|16825516|P1|Overall Study|Study Terminated by Sponsor|326
4882463|NCT00745823|16825515|P2|Overall Study|Withdrawal by Subject|8
4882464|NCT00745823|16825516|P1|Overall Study|Withdrawal by Subject|14
4882465|NCT00745823|16825515|P2|Overall Study|Pregnancy|4
4882466|NCT00745823|16825516|P1|Overall Study|Pregnancy|0
4882467|NCT00745823|16825515|P2|Overall Study|Physician Decision|5
4882468|NCT00745823|16825516|P1|Overall Study|Physician Decision|10
4882469|NCT00745823|16825515|P2|Overall Study|Lost to Follow-up|11
4882470|NCT00745823|16825516|P1|Overall Study|Lost to Follow-up|10
4882471|NCT00745823|16825515|P2|Overall Study|Lack of Efficacy|6
4882472|NCT00745823|16825516|P1|Overall Study|Lack of Efficacy|20
4882473|NCT00745823|16825515|P2|Overall Study|Adverse Event|3
4882474|NCT00745823|16825516|P1|Overall Study|Adverse Event|5
4882475|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10
4882476|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8
4882477|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4882478|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4882479|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4882480|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0
4882481|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Death|1
4882482|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Death|0
4882483|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Death|0
4882484|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Death|0
4882485|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Death|0
4882486|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Death|0
4882487|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1
4882488|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4882489|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4882490|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4882491|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4882492|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0
4882493|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3
4882494|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1
4882495|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4882496|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4882497|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4882498|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0
4882499|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Pregnancy|5
4882500|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Pregnancy|2
4882501|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4882502|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4882503|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4882504|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Pregnancy|0
4882505|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Adverse Event|8
4882506|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Adverse Event|2
4882507|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4882508|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4882509|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4882510|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Adverse Event|0
4882511|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Physician Decision|11
4882512|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Physician Decision|9
4882513|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4882514|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4882515|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4882516|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Physician Decision|0
4882517|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
4882518|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19
4882519|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4882520|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4882521|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4882522|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0
4882523|NCT00745615|16825544|P6|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
4882524|NCT00745615|16825545|P5|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50
4882525|NCT00745615|16825546|P4|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4882526|NCT00745615|16825547|P3|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4882527|NCT00745615|16825548|P2|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4882528|NCT00745615|16825549|P1|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0
4882529|NCT00745615|16825544|P6|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4882530|NCT00745615|16825545|P5|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4882531|NCT00745615|16825546|P4|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4882532|NCT00745615|16825547|P3|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4882533|NCT00745615|16825548|P2|Double-Blind Extension (36 Weeks)|Other Than Specified|1
4882534|NCT00745615|16825549|P1|Double-Blind Extension (36 Weeks)|Other Than Specified|0
4882535|NCT00745615|16825544|P6|Double-Blind Extension (36 Weeks)|Pregnancy|0
4882536|NCT00745615|16825545|P5|Double-Blind Extension (36 Weeks)|Pregnancy|0
4882537|NCT00745615|16825546|P4|Double-Blind Extension (36 Weeks)|Pregnancy|0
4882538|NCT00745615|16825547|P3|Double-Blind Extension (36 Weeks)|Pregnancy|0
4882539|NCT00745615|16825548|P2|Double-Blind Extension (36 Weeks)|Pregnancy|1
4882540|NCT00745615|16825549|P1|Double-Blind Extension (36 Weeks)|Pregnancy|0
4882541|NCT00745615|16825544|P6|Double-Blind Extension (36 Weeks)|Adverse Event|0
4882542|NCT00745615|16825545|P5|Double-Blind Extension (36 Weeks)|Adverse Event|0
4882543|NCT00745615|16825546|P4|Double-Blind Extension (36 Weeks)|Adverse Event|1
4882544|NCT00745615|16825547|P3|Double-Blind Extension (36 Weeks)|Adverse Event|1
4882545|NCT00745615|16825548|P2|Double-Blind Extension (36 Weeks)|Adverse Event|3
4882546|NCT00745615|16825549|P1|Double-Blind Extension (36 Weeks)|Adverse Event|2
4882547|NCT00745615|16825544|P6|Double-Blind Extension (36 Weeks)|Physician Decision|0
4882548|NCT00745615|16825545|P5|Double-Blind Extension (36 Weeks)|Physician Decision|0
4882549|NCT00745615|16825546|P4|Double-Blind Extension (36 Weeks)|Physician Decision|0
4882550|NCT00745615|16825547|P3|Double-Blind Extension (36 Weeks)|Physician Decision|0
4882551|NCT00745615|16825548|P2|Double-Blind Extension (36 Weeks)|Physician Decision|1
4882552|NCT00745615|16825549|P1|Double-Blind Extension (36 Weeks)|Physician Decision|0
4882553|NCT00745615|16825544|P6|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
4882554|NCT00745615|16825545|P5|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
4882555|NCT00745615|16825546|P4|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4
4882556|NCT00745615|16825547|P3|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0
4882557|NCT00745615|16825548|P2|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1
4882558|NCT00745615|16825549|P1|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3
4882559|NCT00745498|16825598|P3|Overall Study|Edophthalmitis after preoperative IVB|0
4882560|NCT00745498|16825599|P2|Overall Study|Edophthalmitis after preoperative IVB|0
4882561|NCT00745498|16825600|P1|Overall Study|Edophthalmitis after preoperative IVB|1
4882562|NCT00745498|16825598|P3|Overall Study|Non-PDR related VH|1
4882563|NCT00745498|16825599|P2|Overall Study|Non-PDR related VH|1
4882564|NCT00745498|16825600|P1|Overall Study|Non-PDR related VH|0
4882565|NCT00745498|16825598|P3|Overall Study|Injection of intravitreal silicone oil o|4
4882566|NCT00745498|16825599|P2|Overall Study|Injection of intravitreal silicone oil o|4
4882567|NCT00745498|16825600|P1|Overall Study|Injection of intravitreal silicone oil o|3
4882568|NCT00745498|16825598|P3|Overall Study|Lost to Follow-up|3
4882569|NCT00745498|16825599|P2|Overall Study|Lost to Follow-up|1
4882570|NCT00745498|16825600|P1|Overall Study|Lost to Follow-up|1
4882571|NCT00745420|16825614|P1|Overall Study|Ineligible|1
4882572|NCT00745368|16825631|P1|Overall Study|Unable to provide sample|3
4882573|NCT00745251|16825653|P2|Overall Study|Withdrawal by Subject|1
4882574|NCT00745251|16825654|P1|Overall Study|Withdrawal by Subject|1
4882575|NCT00745251|16825653|P2|Overall Study|Adverse Event|2
4882576|NCT00745251|16825654|P1|Overall Study|Adverse Event|1
4882577|NCT00745121|16825664|P2|Overall Study|Withdrawal by Subject|2
4882578|NCT00745121|16825665|P1|Overall Study|Withdrawal by Subject|4
4882579|NCT00745121|16825664|P2|Overall Study|Lost to Follow-up|0
4882580|NCT00745121|16825665|P1|Overall Study|Lost to Follow-up|1
4882581|NCT00745121|16825664|P2|Overall Study|Adverse Event|0
4882582|NCT00745121|16825665|P1|Overall Study|Adverse Event|1
4882583|NCT00745121|16825664|P2|Overall Study|Death|0
4882584|NCT00745121|16825665|P1|Overall Study|Death|3
4882585|NCT00745095|16825677|P6|Overall Study|Ineligible due to GFR criteria|28
4882586|NCT00745095|16825678|P5|Overall Study|Ineligible due to GFR criteria|30
4882587|NCT00745095|16825679|P4|Overall Study|Ineligible due to GFR criteria|3
4882588|NCT00745095|16825680|P3|Overall Study|Ineligible due to GFR criteria|3
4882589|NCT00745095|16825681|P2|Overall Study|Ineligible due to GFR criteria|2
4882590|NCT00745095|16825682|P1|Overall Study|Ineligible due to GFR criteria|0
4882591|NCT00745095|16825677|P6|Overall Study|Declined to participate|95
4882592|NCT00745095|16825678|P5|Overall Study|Declined to participate|92
4882593|NCT00745095|16825679|P4|Overall Study|Declined to participate|0
4882594|NCT00745095|16825680|P3|Overall Study|Declined to participate|0
4882595|NCT00745095|16825681|P2|Overall Study|Declined to participate|0
4882596|NCT00745095|16825682|P1|Overall Study|Declined to participate|1
4882597|NCT00744991|16825711|P1|Overall Study|Protocol Entry Criteria Unmet|1
4882598|NCT00744991|16825711|P1|Overall Study|Adverse Event|2
4882599|NCT00744991|16825711|P1|Overall Study|Physician Decision|3
4882600|NCT00744991|16825711|P1|Overall Study|Withdrawal by Subject|8
4882601|NCT00744991|16825711|P1|Overall Study|Progressive Disease|11
4882602|NCT00744978|16825728|P2|Period 2|Adverse Event|1
4882603|NCT00744978|16825729|P1|Period 2|Adverse Event|0
4882604|NCT00744978|16825728|P2|Period 1|Randomized but not Treated|1
4882605|NCT00744978|16825729|P1|Period 1|Randomized but not Treated|1
4882606|NCT00744978|16825728|P2|Period 1|Adverse Event|0
4882607|NCT00744978|16825729|P1|Period 1|Adverse Event|4
4882608|NCT00744978|16825728|P2|Period 1|Other|2
4882609|NCT00744978|16825729|P1|Period 1|Other|0
4882610|NCT00744978|16825728|P2|Period 1|Withdrawal by Subject|2
4882611|NCT00744978|16825729|P1|Period 1|Withdrawal by Subject|0
4882612|NCT00744978|16825728|P2|Period 1|Lost to Follow-up|0
4882613|NCT00744978|16825729|P1|Period 1|Lost to Follow-up|1
4882614|NCT00744939|16825810|P1|Overall Study|incorrect race|1
4882615|NCT00744939|16825810|P1|Overall Study|coma|1
4882616|NCT00744939|16825810|P1|Overall Study|Failed inclusion/exclusion criteria|19
4882617|NCT00744939|16825810|P1|Overall Study|Did not receive Magnevist|7
4882618|NCT00744939|16825810|P1|Overall Study|Medical history exclusionary|1
4882619|NCT00744939|16825810|P1|Overall Study|Lost to Follow-up|12
4882620|NCT00744939|16825810|P1|Overall Study|distance|4
4882621|NCT00744939|16825810|P1|Overall Study|Death|24
4882622|NCT00744939|16825810|P1|Overall Study|Protocol Violation|13
4882623|NCT00744939|16825810|P1|Overall Study|Withdrawal by Subject|9
4882624|NCT00744874|16825846|P1|Overall Study|Unable to accomodate schedule|1
4882625|NCT00744874|16825846|P1|Overall Study|Study Device not available at procedure|1
4882626|NCT00744874|16825846|P1|Overall Study|Withdrawal by Subject|1
4882627|NCT00744874|16825846|P1|Overall Study|Lost to Follow-up|1
4882628|NCT00744757|16825871|P1|Overall Study|Adverse Event|2
4882629|NCT00744757|16825871|P1|Overall Study|Death|6
4882630|NCT00744757|16825871|P1|Overall Study|Withdrawal by Subject|1
4882631|NCT00744757|16825871|P1|Overall Study|Physician Decision|5
4882632|NCT00744757|16825871|P1|Overall Study|Objective disease progression|7
4882633|NCT00744653|16825896|P1|Overall Study|Physician Decision|3
4882634|NCT00744653|16825896|P1|Overall Study|Lost to Follow-up|1
4882635|NCT00744653|16825896|P1|Overall Study|Death|1
4882636|NCT00744653|16825896|P1|Overall Study|antineoplastic treatment|11
4882637|NCT00744627|16825904|P2|Overall Study|Other|0
4882638|NCT00744627|16825905|P1|Overall Study|Other|1
4882639|NCT00744627|16825904|P2|Overall Study|Lost to Follow-up|1
4882640|NCT00744627|16825905|P1|Overall Study|Lost to Follow-up|2
4882641|NCT00744627|16825904|P2|Overall Study|Voluntary Withdrawal|6
4882642|NCT00744627|16825905|P1|Overall Study|Voluntary Withdrawal|9
4882643|NCT00744627|16825904|P2|Overall Study|Protocol Deviations|2
4882644|NCT00744627|16825905|P1|Overall Study|Protocol Deviations|0
4882645|NCT00744627|16825904|P2|Overall Study|Noncompliance|1
4882646|NCT00744627|16825905|P1|Overall Study|Noncompliance|0
4882647|NCT00744627|16825904|P2|Overall Study|Lack of Efficacy|3
4882648|NCT00744627|16825905|P1|Overall Study|Lack of Efficacy|7
4882649|NCT00744627|16825904|P2|Overall Study|Adverse Event|9
4882650|NCT00744627|16825905|P1|Overall Study|Adverse Event|6
4882651|NCT00744523|16825961|P2|30 Days After the Procedure|Insufficient follow-up|5
4882652|NCT00744523|16825962|P1|30 Days After the Procedure|Insufficient follow-up|0
4882653|NCT00744497|16825982|P2|Overall Study|Not defined|13
4882654|NCT00744497|16825983|P1|Overall Study|Not defined|19
4882655|NCT00744497|16825982|P2|Overall Study|Maximum clinical benefit|142
4882656|NCT00744497|16825983|P1|Overall Study|Maximum clinical benefit|141
4882657|NCT00744497|16825982|P2|Overall Study|Patient requested to stop study drug|80
4882658|NCT00744497|16825983|P1|Overall Study|Patient requested to stop study drug|65
4882659|NCT00744497|16825982|P2|Overall Study|Adverse event unrelated to study drug|122
4882660|NCT00744497|16825983|P1|Overall Study|Adverse event unrelated to study drug|78
4882661|NCT00744497|16825982|P2|Overall Study|Study drug toxicity|141
4882662|NCT00744497|16825983|P1|Overall Study|Study drug toxicity|68
4882663|NCT00744497|16825982|P2|Overall Study|Disease progression|219
4882664|NCT00744497|16825983|P1|Overall Study|Disease progression|312
4882665|NCT00744497|16825982|P2|Overall Study|Administrative Reason By Sponsor|8
4882666|NCT00744497|16825983|P1|Overall Study|Administrative Reason By Sponsor|25
4882667|NCT00744497|16825982|P2|Overall Study|No longer meets study criteria|3
4882668|NCT00744497|16825983|P1|Overall Study|No longer meets study criteria|7
4882669|NCT00744497|16825982|P2|Overall Study|Poor compliance/noncompliance|5
4882670|NCT00744497|16825983|P1|Overall Study|Poor compliance/noncompliance|9
4882671|NCT00744497|16825982|P2|Overall Study|Lost to Follow-up|2
4882672|NCT00744497|16825983|P1|Overall Study|Lost to Follow-up|4
4882673|NCT00744497|16825982|P2|Overall Study|Death|9
4882674|NCT00744497|16825983|P1|Overall Study|Death|11
4882675|NCT00744497|16825982|P2|Overall Study|Withdrawal by Subject|18
4882676|NCT00744497|16825983|P1|Overall Study|Withdrawal by Subject|21
4882677|NCT00744328|16826043|P3|Overall Study|Found ineligible after randomization|1
4882678|NCT00744328|16826044|P2|Overall Study|Found ineligible after randomization|0
4882679|NCT00744328|16826045|P1|Overall Study|Found ineligible after randomization|0
4882680|NCT00744328|16826043|P3|Overall Study|Withdrawal by Subject|4
4882681|NCT00744328|16826044|P2|Overall Study|Withdrawal by Subject|3
4882682|NCT00744328|16826045|P1|Overall Study|Withdrawal by Subject|5
4882683|NCT00744328|16826043|P3|Overall Study|Lost to Follow-up|3
4882684|NCT00744328|16826044|P2|Overall Study|Lost to Follow-up|5
4882685|NCT00744328|16826045|P1|Overall Study|Lost to Follow-up|2
4882686|NCT00744263|16826058|P2|Overall Study|Other|2
4882687|NCT00744263|16826059|P1|Overall Study|Other|2
4882688|NCT00744263|16826058|P2|Overall Study|Adverse Event|0
4882689|NCT00744263|16826059|P1|Overall Study|Adverse Event|1
4882690|NCT00744263|16826058|P2|Overall Study|Protocol Violation|5
4882691|NCT00744263|16826059|P1|Overall Study|Protocol Violation|3
4882692|NCT00744263|16826058|P2|Overall Study|Physician Decision|23
4882693|NCT00744263|16826059|P1|Overall Study|Physician Decision|20
4882694|NCT00744263|16826058|P2|Overall Study|Withdrawal by Subject|150
4882695|NCT00744263|16826059|P1|Overall Study|Withdrawal by Subject|166
4882696|NCT00744263|16826058|P2|Overall Study|Lost to Follow-up|2135
4882697|NCT00744263|16826059|P1|Overall Study|Lost to Follow-up|2038
4882698|NCT00744263|16826058|P2|Overall Study|Death|3005
4882699|NCT00744263|16826059|P1|Overall Study|Death|3006
4882700|NCT00744237|16826082|P3|Overall Study|Adverse Event|5
4882701|NCT00744237|16826083|P2|Overall Study|Adverse Event|13
4882702|NCT00744237|16826084|P1|Overall Study|Adverse Event|9
4882703|NCT00744237|16826082|P3|Overall Study|Administrative. Site Closed|1
4882704|NCT00744237|16826083|P2|Overall Study|Administrative. Site Closed|1
4882705|NCT00744237|16826084|P1|Overall Study|Administrative. Site Closed|1
4882706|NCT00744237|16826082|P3|Overall Study|Poor Compliance|0
4882707|NCT00744237|16826083|P2|Overall Study|Poor Compliance|2
4882708|NCT00744237|16826084|P1|Overall Study|Poor Compliance|0
4882709|NCT00744237|16826082|P3|Overall Study|Prohibited Concomitant Medication|1
4882710|NCT00744237|16826083|P2|Overall Study|Prohibited Concomitant Medication|0
4882711|NCT00744237|16826084|P1|Overall Study|Prohibited Concomitant Medication|0
4882712|NCT00744237|16826082|P3|Overall Study|Study Drug Error|0
4882713|NCT00744237|16826083|P2|Overall Study|Study Drug Error|0
4882714|NCT00744237|16826084|P1|Overall Study|Study Drug Error|1
4882715|NCT00744237|16826082|P3|Overall Study|Dosing Error|1
4882716|NCT00744237|16826083|P2|Overall Study|Dosing Error|0
4882717|NCT00744237|16826084|P1|Overall Study|Dosing Error|1
4882718|NCT00744237|16826082|P3|Overall Study|Inclusion/Exclusion criteria not met|0
4882719|NCT00744237|16826083|P2|Overall Study|Inclusion/Exclusion criteria not met|0
4882720|NCT00744237|16826084|P1|Overall Study|Inclusion/Exclusion criteria not met|1
4882721|NCT00744237|16826082|P3|Overall Study|Protocol Violation|3
4882722|NCT00744237|16826083|P2|Overall Study|Protocol Violation|4
4882723|NCT00744237|16826084|P1|Overall Study|Protocol Violation|3
4882724|NCT00744237|16826082|P3|Overall Study|Lost to Follow-up|1
4882725|NCT00744237|16826083|P2|Overall Study|Lost to Follow-up|1
4882726|NCT00744237|16826084|P1|Overall Study|Lost to Follow-up|1
4882727|NCT00744237|16826082|P3|Overall Study|Withdrawal by Subject|3
4882728|NCT00744237|16826083|P2|Overall Study|Withdrawal by Subject|5
4882729|NCT00744237|16826084|P1|Overall Study|Withdrawal by Subject|9
4882730|NCT00744237|16826082|P3|Overall Study|Lack of Efficacy|0
4882731|NCT00744237|16826083|P2|Overall Study|Lack of Efficacy|1
4882732|NCT00744237|16826084|P1|Overall Study|Lack of Efficacy|1
4882733|NCT00744055|16826118|P2|Overall Study|Lost to Follow-up|1
4882734|NCT00744055|16826119|P1|Overall Study|Lost to Follow-up|0
4882735|NCT00744055|16826118|P2|Overall Study|Protocol Violation|1
4882736|NCT00744055|16826119|P1|Overall Study|Protocol Violation|1
4882737|NCT00744055|16826118|P2|Overall Study|Physician Decision|2
4882738|NCT00744055|16826119|P1|Overall Study|Physician Decision|0
4882739|NCT00744055|16826118|P2|Overall Study|Lack of Efficacy|1
4882740|NCT00744055|16826119|P1|Overall Study|Lack of Efficacy|0
4882741|NCT00744055|16826118|P2|Overall Study|Withdrawal by Subject|9
4882742|NCT00744055|16826119|P1|Overall Study|Withdrawal by Subject|6
4882743|NCT00744042|16826127|P1|Overall Study|Withdrawal by Subject|1
4882744|NCT00743652|16826173|P5|Overall Study|Lost to Follow-up|0
4882745|NCT00743652|16826174|P4|Overall Study|Lost to Follow-up|0
4882746|NCT00743652|16826175|P3|Overall Study|Lost to Follow-up|0
4882747|NCT00743652|16826176|P2|Overall Study|Lost to Follow-up|0
4882748|NCT00743652|16826177|P1|Overall Study|Lost to Follow-up|1
4882749|NCT00743652|16826173|P5|Overall Study|Other|0
4882750|NCT00743652|16826174|P4|Overall Study|Other|0
4882751|NCT00743652|16826175|P3|Overall Study|Other|0
4882752|NCT00743652|16826176|P2|Overall Study|Other|1
4882753|NCT00743652|16826177|P1|Overall Study|Other|1
4882754|NCT00743652|16826173|P5|Overall Study|Investigator Request|0
4882755|NCT00743652|16826174|P4|Overall Study|Investigator Request|2
4882756|NCT00743652|16826175|P3|Overall Study|Investigator Request|0
4882757|NCT00743652|16826176|P2|Overall Study|Investigator Request|0
4882758|NCT00743652|16826177|P1|Overall Study|Investigator Request|0
4882759|NCT00743652|16826173|P5|Overall Study|Death|0
4882760|NCT00743652|16826174|P4|Overall Study|Death|0
4882761|NCT00743652|16826175|P3|Overall Study|Death|0
4882762|NCT00743652|16826176|P2|Overall Study|Death|0
4882763|NCT00743652|16826177|P1|Overall Study|Death|2
4882764|NCT00743652|16826173|P5|Overall Study|Adverse Event|0
4882765|NCT00743652|16826174|P4|Overall Study|Adverse Event|0
4882766|NCT00743652|16826175|P3|Overall Study|Adverse Event|0
4882767|NCT00743652|16826176|P2|Overall Study|Adverse Event|0
4882768|NCT00743652|16826177|P1|Overall Study|Adverse Event|3
4882769|NCT00743652|16826173|P5|Overall Study|Parent/Legal Guardian Request|0
4882770|NCT00743652|16826174|P4|Overall Study|Parent/Legal Guardian Request|2
4882771|NCT00743652|16826175|P3|Overall Study|Parent/Legal Guardian Request|2
4882772|NCT00743652|16826176|P2|Overall Study|Parent/Legal Guardian Request|2
4882773|NCT00743652|16826177|P1|Overall Study|Parent/Legal Guardian Request|3
4882774|NCT00743509|16826261|P1|Overall Study|Withdrawal by Subject|2
4882775|NCT00743483|16826266|P1|Treatment Period|Adverse Event|1
4882776|NCT00743483|16826266|P1|Baseline Period|Physician Decision|1
4882777|NCT00743444|16826270|P2|Washout Period|Adverse Event|1
4882778|NCT00743444|16826271|P1|Washout Period|Adverse Event|0
4882779|NCT00743444|16826270|P2|First Intervention|Catheter placement problems|1
4882780|NCT00743444|16826271|P1|First Intervention|Catheter placement problems|0
4882781|NCT00743431|16826280|P1|Overall Study|No documentation available|13
4882782|NCT00743431|16826280|P1|Overall Study|Reason for discontinuation not specified|29
4882783|NCT00743431|16826280|P1|Overall Study|Death|9
4882784|NCT00743431|16826280|P1|Overall Study|Withdrawal by Subject|13
4882785|NCT00743431|16826280|P1|Overall Study|Tumor progression|56
4882786|NCT00743431|16826280|P1|Overall Study|Toxicity|6
4882787|NCT00743366|16826284|P2|Intervention 1 (8 Days)|Withdrawal by Subject|3
4882788|NCT00743366|16826285|P1|Intervention 1 (8 Days)|Withdrawal by Subject|3
4882789|NCT00743340|16826291|P1|Overall Study|Participant Relocated|1
4882790|NCT00743340|16826291|P1|Overall Study|Rolled over to other Gilead Study|23
4882791|NCT00743340|16826291|P1|Overall Study|Pregnancy|1
4882792|NCT00743340|16826291|P1|Overall Study|Virologic failure|8
4882793|NCT00743340|16826291|P1|Overall Study|Protocol Violation|1
4882794|NCT00743340|16826291|P1|Overall Study|Withdrawal from the Study|5
4882795|NCT00743340|16826291|P1|Overall Study|Lost to Follow-up|1
4882796|NCT00743340|16826291|P1|Overall Study|Study medication non-compliance|1
4882797|NCT00743288|16826295|P7|Overall Study|Worsening of condition (Not PD)|0
4882798|NCT00743288|16826296|P6|Overall Study|Worsening of condition (Not PD)|0
4882799|NCT00743288|16826297|P5|Overall Study|Worsening of condition (Not PD)|0
4882800|NCT00743288|16826298|P4|Overall Study|Worsening of condition (Not PD)|1
4882801|NCT00743288|16826299|P3|Overall Study|Worsening of condition (Not PD)|1
4882802|NCT00743288|16826300|P2|Overall Study|Worsening of condition (Not PD)|2
4882803|NCT00743288|16826301|P1|Overall Study|Worsening of condition (Not PD)|0
4882804|NCT00743288|16826295|P7|Overall Study|Progressive disease (PD)|6
4882805|NCT00743288|16826296|P6|Overall Study|Progressive disease (PD)|3
4882806|NCT00743288|16826297|P5|Overall Study|Progressive disease (PD)|5
4882807|NCT00743288|16826298|P4|Overall Study|Progressive disease (PD)|4
4882808|NCT00743288|16826299|P3|Overall Study|Progressive disease (PD)|1
4882809|NCT00743288|16826300|P2|Overall Study|Progressive disease (PD)|0
4882810|NCT00743288|16826301|P1|Overall Study|Progressive disease (PD)|2
4882811|NCT00743288|16826295|P7|Overall Study|Withdrawal by Subject|1
4882812|NCT00743288|16826296|P6|Overall Study|Withdrawal by Subject|1
4882813|NCT00743288|16826297|P5|Overall Study|Withdrawal by Subject|0
4882814|NCT00743288|16826298|P4|Overall Study|Withdrawal by Subject|0
4882815|NCT00743288|16826299|P3|Overall Study|Withdrawal by Subject|1
4882816|NCT00743288|16826300|P2|Overall Study|Withdrawal by Subject|0
4882817|NCT00743288|16826301|P1|Overall Study|Withdrawal by Subject|0
4882818|NCT00743288|16826295|P7|Overall Study|Adverse Event|2
4882819|NCT00743288|16826296|P6|Overall Study|Adverse Event|1
4882820|NCT00743288|16826297|P5|Overall Study|Adverse Event|1
4882821|NCT00743288|16826298|P4|Overall Study|Adverse Event|2
4882822|NCT00743288|16826299|P3|Overall Study|Adverse Event|2
4882823|NCT00743288|16826300|P2|Overall Study|Adverse Event|1
4882824|NCT00743288|16826301|P1|Overall Study|Adverse Event|1
4882825|NCT00743275|16826315|P2|Overall Study|Protocol Violation|1
4882826|NCT00743275|16826316|P1|Overall Study|Protocol Violation|0
4882827|NCT00743249|16826336|P2|Overall Study|Unsuccessful insertion of stent|1
4882828|NCT00743249|16826337|P1|Overall Study|Unsuccessful insertion of stent|2
4882829|NCT00743249|16826336|P2|Overall Study|Patient Decision Unrelated to Ad Event|1
4882830|NCT00743249|16826337|P1|Overall Study|Patient Decision Unrelated to Ad Event|0
4882831|NCT00743249|16826336|P2|Overall Study|Adverse Event|4
4882832|NCT00743249|16826337|P1|Overall Study|Adverse Event|0
4882833|NCT00743197|16826347|P2|Overall Study|Study terminated due to departure of PI.|2
4882834|NCT00743197|16826348|P1|Overall Study|Study terminated due to departure of PI.|1
4882835|NCT00743145|16826354|P1|Overall Study|Pregnancy|1
4882836|NCT00743145|16826354|P1|Overall Study|Adverse Event|2
4882837|NCT00743145|16826354|P1|Overall Study|Withdrawal by Subject|1
4882838|NCT00743119|16826368|P1|Overall Study|Withdrawal by Subject|1
4882839|NCT00743119|16826368|P1|Overall Study|unreliable|3
4882840|NCT00743106|16826382|P2|Overall Study|Met intraoperative exclusion criterion|5
4882841|NCT00743106|16826383|P1|Overall Study|Met intraoperative exclusion criterion|8
4882842|NCT00742924|16826410|P4|Overall Study|Withdrawal by Subject|0
4882843|NCT00742924|16826411|P3|Overall Study|Withdrawal by Subject|1
4882844|NCT00742924|16826412|P2|Overall Study|Withdrawal by Subject|1
4882845|NCT00742924|16826413|P1|Overall Study|Withdrawal by Subject|0
4882846|NCT00742924|16826410|P4|Overall Study|Physician Decision|1
4882847|NCT00742924|16826411|P3|Overall Study|Physician Decision|0
4882848|NCT00742924|16826412|P2|Overall Study|Physician Decision|0
4882849|NCT00742924|16826413|P1|Overall Study|Physician Decision|0
4882850|NCT00742924|16826410|P4|Overall Study|Lack of Efficacy|4
4882851|NCT00742924|16826411|P3|Overall Study|Lack of Efficacy|2
4882852|NCT00742924|16826412|P2|Overall Study|Lack of Efficacy|1
4882853|NCT00742924|16826413|P1|Overall Study|Lack of Efficacy|5
4882854|NCT00742924|16826410|P4|Overall Study|Adverse Event|1
4882855|NCT00742924|16826411|P3|Overall Study|Adverse Event|1
4882856|NCT00742924|16826412|P2|Overall Study|Adverse Event|0
4882857|NCT00742924|16826413|P1|Overall Study|Adverse Event|0
4882858|NCT00742885|16826425|P2|Overall Study|Lost to Follow-up|0
4882859|NCT00742885|16826426|P1|Overall Study|Lost to Follow-up|1
4882860|NCT00742859|16826485|P4|Overall Study|Site error|1
4882861|NCT00742859|16826486|P3|Overall Study|Site error|1
4882862|NCT00742859|16826487|P2|Overall Study|Site error|0
4882863|NCT00742859|16826488|P1|Overall Study|Site error|0
4882864|NCT00742859|16826485|P4|Overall Study|Sponsor request patient out of town|1
4882865|NCT00742859|16826486|P3|Overall Study|Sponsor request patient out of town|1
4882866|NCT00742859|16826487|P2|Overall Study|Sponsor request patient out of town|0
4882867|NCT00742859|16826488|P1|Overall Study|Sponsor request patient out of town|0
4882868|NCT00742859|16826485|P4|Overall Study|Sponsor req visit schedule noncompliance|1
4882869|NCT00742859|16826486|P3|Overall Study|Sponsor req visit schedule noncompliance|0
4882870|NCT00742859|16826487|P2|Overall Study|Sponsor req visit schedule noncompliance|0
4882871|NCT00742859|16826488|P1|Overall Study|Sponsor req visit schedule noncompliance|0
4882872|NCT00742859|16826485|P4|Overall Study|Amendment 2 patient off study drug >4wks|0
4882873|NCT00742859|16826486|P3|Overall Study|Amendment 2 patient off study drug >4wks|1
4882874|NCT00742859|16826487|P2|Overall Study|Amendment 2 patient off study drug >4wks|1
4882875|NCT00742859|16826488|P1|Overall Study|Amendment 2 patient off study drug >4wks|0
4882876|NCT00742859|16826485|P4|Overall Study|Endpoint|2
4882877|NCT00742859|16826486|P3|Overall Study|Endpoint|1
4882878|NCT00742859|16826487|P2|Overall Study|Endpoint|1
4882879|NCT00742859|16826488|P1|Overall Study|Endpoint|0
4882880|NCT00742859|16826485|P4|Overall Study|Withdrawal by Subject|1
4882881|NCT00742859|16826486|P3|Overall Study|Withdrawal by Subject|4
4882882|NCT00742859|16826487|P2|Overall Study|Withdrawal by Subject|2
4882883|NCT00742859|16826488|P1|Overall Study|Withdrawal by Subject|4
4882884|NCT00742859|16826485|P4|Overall Study|Physician Decision|0
4882885|NCT00742859|16826486|P3|Overall Study|Physician Decision|0
4882886|NCT00742859|16826487|P2|Overall Study|Physician Decision|2
4882887|NCT00742859|16826488|P1|Overall Study|Physician Decision|1
4882888|NCT00742859|16826485|P4|Overall Study|Death|1
4882889|NCT00742859|16826486|P3|Overall Study|Death|0
4882890|NCT00742859|16826487|P2|Overall Study|Death|0
4882891|NCT00742859|16826488|P1|Overall Study|Death|1
4882892|NCT00742859|16826485|P4|Overall Study|Adverse Event|1
4882893|NCT00742859|16826486|P3|Overall Study|Adverse Event|3
4882894|NCT00742859|16826487|P2|Overall Study|Adverse Event|6
4882895|NCT00742859|16826488|P1|Overall Study|Adverse Event|5
4882896|NCT00742781|16826502|P1|Overall Study|Withdrawal by Subject|3
4882897|NCT00742625|16826511|P1|Consolidation|Non protocol therapy|13
4882898|NCT00742625|16826511|P1|Consolidation|Refused|1
4882899|NCT00742625|16826511|P1|Consolidation|Death|1
4882900|NCT00742625|16826511|P1|Consolidation|Adverse Event|1
4882901|NCT00742625|16826511|P1|Consolidation|Progression|5
4882902|NCT00742625|16826511|P1|Remission Induction|Other, not specified|5
4882903|NCT00742625|16826511|P1|Remission Induction|Non protocol treatment|17
4882904|NCT00742625|16826511|P1|Remission Induction|Refusal|5
4882905|NCT00742625|16826511|P1|Remission Induction|Death|10
4882906|NCT00742625|16826511|P1|Remission Induction|Adverse Event|3
4882907|NCT00742625|16826511|P1|Remission Induction|Failed induction|8
4882908|NCT00742625|16826511|P1|Remission Induction|Progression|6
4882909|NCT00742560|16826536|P5|Overall Study|MIssing|1
4882910|NCT00742560|16826537|P4|Overall Study|MIssing|0
4882911|NCT00742560|16826538|P3|Overall Study|MIssing|0
4882912|NCT00742560|16826539|P2|Overall Study|MIssing|0
4882913|NCT00742560|16826540|P1|Overall Study|MIssing|0
4882914|NCT00742560|16826536|P5|Overall Study|Other|9
4882915|NCT00742560|16826537|P4|Overall Study|Other|9
4882916|NCT00742560|16826538|P3|Overall Study|Other|8
4882917|NCT00742560|16826539|P2|Overall Study|Other|1
4882918|NCT00742560|16826540|P1|Overall Study|Other|0
4882919|NCT00742560|16826536|P5|Overall Study|New Multiple Myeloma Therapy|4
4882920|NCT00742560|16826537|P4|Overall Study|New Multiple Myeloma Therapy|3
4882921|NCT00742560|16826538|P3|Overall Study|New Multiple Myeloma Therapy|2
4882922|NCT00742560|16826539|P2|Overall Study|New Multiple Myeloma Therapy|0
4882923|NCT00742560|16826540|P1|Overall Study|New Multiple Myeloma Therapy|1
4882924|NCT00742560|16826536|P5|Overall Study|Disease Progression|16
4882925|NCT00742560|16826537|P4|Overall Study|Disease Progression|17
4882926|NCT00742560|16826538|P3|Overall Study|Disease Progression|5
4882927|NCT00742560|16826539|P2|Overall Study|Disease Progression|0
4882928|NCT00742560|16826540|P1|Overall Study|Disease Progression|1
4882929|NCT00742560|16826536|P5|Overall Study|Investigator's Decision|0
4882930|NCT00742560|16826537|P4|Overall Study|Investigator's Decision|1
4882931|NCT00742560|16826538|P3|Overall Study|Investigator's Decision|4
4882932|NCT00742560|16826539|P2|Overall Study|Investigator's Decision|0
4882933|NCT00742560|16826540|P1|Overall Study|Investigator's Decision|0
4882934|NCT00742560|16826536|P5|Overall Study|Subject's Decision|3
4882935|NCT00742560|16826537|P4|Overall Study|Subject's Decision|3
4882936|NCT00742560|16826538|P3|Overall Study|Subject's Decision|2
4882937|NCT00742560|16826539|P2|Overall Study|Subject's Decision|0
4882938|NCT00742560|16826540|P1|Overall Study|Subject's Decision|1
4882939|NCT00742560|16826536|P5|Overall Study|Death|3
4882940|NCT00742560|16826537|P4|Overall Study|Death|2
4882941|NCT00742560|16826538|P3|Overall Study|Death|0
4882942|NCT00742560|16826539|P2|Overall Study|Death|2
4882943|NCT00742560|16826540|P1|Overall Study|Death|0
4882944|NCT00742560|16826536|P5|Overall Study|Adverse Event|1
4882945|NCT00742560|16826537|P4|Overall Study|Adverse Event|1
4882946|NCT00742560|16826538|P3|Overall Study|Adverse Event|1
4882947|NCT00742560|16826539|P2|Overall Study|Adverse Event|0
4882948|NCT00742560|16826540|P1|Overall Study|Adverse Event|0
4882949|NCT00742508|16826614|P2|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1
4882950|NCT00742508|16826615|P1|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0
4882951|NCT00742508|16826614|P2|8-Week Primary Evaluation Period|Withdrawal by Subject|2
4882952|NCT00742508|16826615|P1|8-Week Primary Evaluation Period|Withdrawal by Subject|0
4882953|NCT00742508|16826614|P2|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5
4882954|NCT00742508|16826615|P1|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8
4882955|NCT00742508|16826614|P2|8-Week Primary Evaluation Period|Protocol Violation|0
4882956|NCT00742508|16826615|P1|8-Week Primary Evaluation Period|Protocol Violation|1
4882957|NCT00742508|16826614|P2|8-Week Primary Evaluation Period|Adverse Event|4
4882958|NCT00742508|16826615|P1|8-Week Primary Evaluation Period|Adverse Event|2
4882959|NCT00742417|16826688|P2|Intensive Period|Adverse Event|0
4882960|NCT00742417|16826689|P1|Intensive Period|Adverse Event|2
4882961|NCT00742417|16826688|P2|Intensive Period|Withdrawal by Subject|1
4882962|NCT00742417|16826689|P1|Intensive Period|Withdrawal by Subject|1
4882963|NCT00742417|16826688|P2|Randomized|Physician Decision|0
4882964|NCT00742417|16826689|P1|Randomized|Physician Decision|1
4882965|NCT00742417|16826688|P2|Randomized|Withdrawal by Subject|0
4882966|NCT00742417|16826689|P1|Randomized|Withdrawal by Subject|1
4882967|NCT00742417|16826688|P2|Randomized|Withdrawal by legal representative|1
4882968|NCT00742417|16826689|P1|Randomized|Withdrawal by legal representative|0
4882969|NCT00742391|16826713|P2|Overall Study|Protocol Violation|0
4882970|NCT00742391|16826714|P1|Overall Study|Protocol Violation|1
4882971|NCT00742391|16826713|P2|Overall Study|Lost to Follow-up|0
4882972|NCT00742391|16826714|P1|Overall Study|Lost to Follow-up|1
4882973|NCT00742391|16826713|P2|Overall Study|Adverse Event|1
4882974|NCT00742391|16826714|P1|Overall Study|Adverse Event|2
4882975|NCT00742326|16826724|P2|Overall Study|Physician Decision|1
4882976|NCT00742326|16826725|P1|Overall Study|Physician Decision|0
4882977|NCT00742274|16826744|P2|Overall Study|Removed for medical reasons|1
4882978|NCT00742274|16826745|P1|Overall Study|Removed for medical reasons|1
4882979|NCT00742274|16826744|P2|Overall Study|Withdrawal by Subject|2
4882980|NCT00742274|16826745|P1|Overall Study|Withdrawal by Subject|1
4882981|NCT00742274|16826744|P2|Overall Study|Death|0
4882982|NCT00742274|16826745|P1|Overall Study|Death|1
4882983|NCT00742235|16826753|P2|Overall Study|Lost to Follow-up|31
4882984|NCT00742235|16826754|P1|Overall Study|Lost to Follow-up|0
4882985|NCT00742209|16826767|P5|Overall Study|Investigator Discretion|1
4882986|NCT00742209|16826768|P4|Overall Study|Investigator Discretion|1
4882987|NCT00742209|16826769|P3|Overall Study|Investigator Discretion|5
4882988|NCT00742209|16826770|P2|Overall Study|Investigator Discretion|0
4882989|NCT00742209|16826771|P1|Overall Study|Investigator Discretion|0
4882990|NCT00742209|16826767|P5|Overall Study|Lack of Efficacy|1
4882991|NCT00742209|16826768|P4|Overall Study|Lack of Efficacy|3
4882992|NCT00742209|16826769|P3|Overall Study|Lack of Efficacy|1
4882993|NCT00742209|16826770|P2|Overall Study|Lack of Efficacy|1
4882994|NCT00742209|16826771|P1|Overall Study|Lack of Efficacy|6
4882995|NCT00742209|16826767|P5|Overall Study|Lost to Follow-up|3
4882996|NCT00742209|16826768|P4|Overall Study|Lost to Follow-up|5
4882997|NCT00742209|16826769|P3|Overall Study|Lost to Follow-up|5
4882998|NCT00742209|16826770|P2|Overall Study|Lost to Follow-up|4
4882999|NCT00742209|16826771|P1|Overall Study|Lost to Follow-up|3
4883000|NCT00742209|16826767|P5|Overall Study|Protocol Violation|3
4883001|NCT00742209|16826768|P4|Overall Study|Protocol Violation|5
4883002|NCT00742209|16826769|P3|Overall Study|Protocol Violation|4
4883003|NCT00742209|16826770|P2|Overall Study|Protocol Violation|5
4883004|NCT00742209|16826771|P1|Overall Study|Protocol Violation|6
4883005|NCT00742209|16826767|P5|Overall Study|Participant Withdrew Consent|4
4883006|NCT00742209|16826768|P4|Overall Study|Participant Withdrew Consent|7
4883007|NCT00742209|16826769|P3|Overall Study|Participant Withdrew Consent|14
4883008|NCT00742209|16826770|P2|Overall Study|Participant Withdrew Consent|4
4883009|NCT00742209|16826771|P1|Overall Study|Participant Withdrew Consent|8
4883010|NCT00742209|16826767|P5|Overall Study|Adverse Event|13
4883011|NCT00742209|16826768|P4|Overall Study|Adverse Event|16
4883012|NCT00742209|16826769|P3|Overall Study|Adverse Event|17
4883013|NCT00742209|16826770|P2|Overall Study|Adverse Event|4
4883014|NCT00742209|16826771|P1|Overall Study|Adverse Event|11
4883015|NCT00742183|16826874|P2|Overall Study|Lack of Efficacy|3
4883016|NCT00742183|16826875|P1|Overall Study|Lack of Efficacy|0
4883017|NCT00742183|16826874|P2|Overall Study|Withdrawal by Subject|0
4883018|NCT00742183|16826875|P1|Overall Study|Withdrawal by Subject|1
4883019|NCT00742183|16826874|P2|Overall Study|Required skin-graft|1
4883020|NCT00742183|16826875|P1|Overall Study|Required skin-graft|1
4883021|NCT00742183|16826874|P2|Overall Study|Lost to Follow-up|4
4883022|NCT00742183|16826875|P1|Overall Study|Lost to Follow-up|4
4883023|NCT00742183|16826874|P2|Overall Study|Physician Decision|2
4883024|NCT00742183|16826875|P1|Overall Study|Physician Decision|0
4883025|NCT00742183|16826874|P2|Overall Study|Death|0
4883026|NCT00742183|16826875|P1|Overall Study|Death|1
4883027|NCT00742183|16826874|P2|Overall Study|Adverse Event|2
4883028|NCT00742183|16826875|P1|Overall Study|Adverse Event|2
4883029|NCT00742079|16826894|P2|Overall Study|Lost to Follow-up|1
4883030|NCT00742079|16826895|P1|Overall Study|Lost to Follow-up|0
4883031|NCT00742001|16826916|P3|Overall Study|Withdrawn; health exclusion (flu)|1
4883032|NCT00742001|16826917|P2|Overall Study|Withdrawn; health exclusion (flu)|0
4883033|NCT00742001|16826918|P1|Overall Study|Withdrawn; health exclusion (flu)|0
4883034|NCT00741988|16826934|P2|Overall Study|Lack of Efficacy|0
4883035|NCT00741988|16826935|P1|Overall Study|Lack of Efficacy|2
4883036|NCT00741988|16826934|P2|Overall Study|Adverse Event|4
4883037|NCT00741988|16826935|P1|Overall Study|Adverse Event|2
4883038|NCT00741936|16826947|P2|Overall Study|Low compliance|0
4883039|NCT00741936|16826948|P1|Overall Study|Low compliance|3
4883040|NCT00741936|16826947|P2|Overall Study|Lack of Efficacy|2
4883041|NCT00741936|16826948|P1|Overall Study|Lack of Efficacy|0
4883042|NCT00741936|16826947|P2|Overall Study|Protocol Violation|0
4883043|NCT00741936|16826948|P1|Overall Study|Protocol Violation|2
4883044|NCT00741936|16826947|P2|Overall Study|Pregnancy|1
4883045|NCT00741936|16826948|P1|Overall Study|Pregnancy|0
4883046|NCT00741936|16826947|P2|Overall Study|Adverse Event|4
4883047|NCT00741936|16826948|P1|Overall Study|Adverse Event|3
4883048|NCT00741936|16826947|P2|Overall Study|Lost to Follow-up|1
4883049|NCT00741936|16826948|P1|Overall Study|Lost to Follow-up|1
4883050|NCT00741819|16826983|P1|Overall Study|Disease progression|1
4883051|NCT00741819|16826983|P1|Overall Study|Death|1
4883052|NCT00741819|16826983|P1|Overall Study|Withdrawal by Subject|3
4883053|NCT00741819|16826983|P1|Overall Study|Adverse Event|3
4883054|NCT00741611|16826997|P3|Overall Study|Withdrawal by Subject|2
4883055|NCT00741611|16826998|P2|Overall Study|Withdrawal by Subject|2
4883056|NCT00741611|16826999|P1|Overall Study|Withdrawal by Subject|0
4883057|NCT00741611|16826997|P3|Overall Study|Death|1
4883058|NCT00741611|16826998|P2|Overall Study|Death|0
4883059|NCT00741611|16826999|P1|Overall Study|Death|0
4883060|NCT00741598|16827018|P2|Overall Study|Withdrawal by Subject|2
4883061|NCT00741598|16827019|P1|Overall Study|Withdrawal by Subject|3
4883062|NCT00741598|16827018|P2|Overall Study|Pregnancy|0
4883063|NCT00741598|16827019|P1|Overall Study|Pregnancy|1
4883064|NCT00741598|16827018|P2|Overall Study|Physician Decision|1
4883065|NCT00741598|16827019|P1|Overall Study|Physician Decision|1
4883066|NCT00741598|16827018|P2|Overall Study|Lack of Efficacy|2
4883067|NCT00741598|16827019|P1|Overall Study|Lack of Efficacy|1
4883068|NCT00741598|16827018|P2|Overall Study|Lost to Follow-up|4
4883069|NCT00741598|16827019|P1|Overall Study|Lost to Follow-up|3
4883070|NCT00741338|16827065|P2|Overall Study|Adverse Event|1
4883071|NCT00741338|16827066|P1|Overall Study|Adverse Event|0
4883072|NCT00741286|16827076|P2|Overall Study|Primary Outcome|1
4883073|NCT00741286|16827077|P1|Overall Study|Primary Outcome|1
4883074|NCT00741286|16827076|P2|Overall Study|Protocol Violation|2
4883075|NCT00741286|16827077|P1|Overall Study|Protocol Violation|3
4883076|NCT00741286|16827076|P2|Overall Study|Adverse Event|6
4883077|NCT00741286|16827077|P1|Overall Study|Adverse Event|1
4883078|NCT00741286|16827076|P2|Overall Study|Lost to Follow-up|10
4883079|NCT00741286|16827077|P1|Overall Study|Lost to Follow-up|15
4883080|NCT00741260|16827111|P7|Overall Study|Other|1
4883081|NCT00741260|16827112|P6|Overall Study|Other|3
4883082|NCT00741260|16827113|P5|Overall Study|Other|1
4883083|NCT00741260|16827114|P4|Overall Study|Other|2
4883084|NCT00741260|16827115|P3|Overall Study|Other|1
4883085|NCT00741260|16827116|P2|Overall Study|Other|1
4883086|NCT00741260|16827117|P1|Overall Study|Other|2
4883087|NCT00741260|16827111|P7|Overall Study|Physician Decision|0
4883088|NCT00741260|16827112|P6|Overall Study|Physician Decision|0
4883089|NCT00741260|16827113|P5|Overall Study|Physician Decision|0
4883090|NCT00741260|16827114|P4|Overall Study|Physician Decision|0
4883091|NCT00741260|16827115|P3|Overall Study|Physician Decision|0
4883092|NCT00741260|16827116|P2|Overall Study|Physician Decision|1
4883093|NCT00741260|16827117|P1|Overall Study|Physician Decision|1
4883094|NCT00741260|16827111|P7|Overall Study|Withdrawal by Subject|1
4883095|NCT00741260|16827112|P6|Overall Study|Withdrawal by Subject|3
4883096|NCT00741260|16827113|P5|Overall Study|Withdrawal by Subject|1
4883097|NCT00741260|16827114|P4|Overall Study|Withdrawal by Subject|0
4883098|NCT00741260|16827115|P3|Overall Study|Withdrawal by Subject|0
4883099|NCT00741260|16827116|P2|Overall Study|Withdrawal by Subject|0
4883100|NCT00741260|16827117|P1|Overall Study|Withdrawal by Subject|0
4883101|NCT00741260|16827111|P7|Overall Study|Death|1
4883102|NCT00741260|16827112|P6|Overall Study|Death|2
4883103|NCT00741260|16827113|P5|Overall Study|Death|2
4883104|NCT00741260|16827114|P4|Overall Study|Death|1
4883105|NCT00741260|16827115|P3|Overall Study|Death|0
4883106|NCT00741260|16827116|P2|Overall Study|Death|1
4883107|NCT00741260|16827117|P1|Overall Study|Death|0
4883108|NCT00741260|16827111|P7|Overall Study|Disease Progression|4
4883109|NCT00741260|16827112|P6|Overall Study|Disease Progression|37
4883110|NCT00741260|16827113|P5|Overall Study|Disease Progression|5
4883111|NCT00741260|16827114|P4|Overall Study|Disease Progression|3
4883112|NCT00741260|16827115|P3|Overall Study|Disease Progression|3
4883113|NCT00741260|16827116|P2|Overall Study|Disease Progression|5
4883114|NCT00741260|16827117|P1|Overall Study|Disease Progression|3
4883115|NCT00741091|16827166|P1|Overall Study|Missed Visit|22
4883116|NCT00741091|16827166|P1|Overall Study|Withdrawal by Subject|6
4883117|NCT00741091|16827166|P1|Overall Study|Lost to Follow-up|16
4883118|NCT00741091|16827166|P1|Overall Study|Death|13
4883119|NCT00741039|16827176|P2|Overall Study|Patient non-compliance|0
4883120|NCT00741039|16827177|P1|Overall Study|Patient non-compliance|2
4883121|NCT00741013|16827214|P3|Overall Study|Discovered failed screen after enrolled|0
4883122|NCT00741013|16827215|P2|Overall Study|Discovered failed screen after enrolled|2
4883123|NCT00741013|16827216|P1|Overall Study|Discovered failed screen after enrolled|0
4883124|NCT00741013|16827214|P3|Overall Study|Withdrawal by Subject|1
4883125|NCT00741013|16827215|P2|Overall Study|Withdrawal by Subject|0
4883126|NCT00741013|16827216|P1|Overall Study|Withdrawal by Subject|0
4883127|NCT00741013|16827214|P3|Overall Study|Adverse Event|0
4883128|NCT00741013|16827215|P2|Overall Study|Adverse Event|0
4883129|NCT00741013|16827216|P1|Overall Study|Adverse Event|1
4883130|NCT00740870|16827227|P1|Overall Study|Further testing contraindicated implant|17
4883131|NCT00740870|16827227|P1|Overall Study|Not Catheterized|4
4883132|NCT00740857|16827242|P3|Overall Study|Withdrawal by Subject|0
4883133|NCT00740857|16827243|P2|Overall Study|Withdrawal by Subject|0
4883134|NCT00740857|16827244|P1|Overall Study|Withdrawal by Subject|1
4883135|NCT00740792|16827299|P4|Overall Study|administrative|2
4883136|NCT00740792|16827300|P3|Overall Study|administrative|8
4883137|NCT00740792|16827301|P2|Overall Study|administrative|3
4883138|NCT00740792|16827302|P1|Overall Study|administrative|3
4883139|NCT00740792|16827299|P4|Overall Study|Withdrawal by Subject|0
4883140|NCT00740792|16827300|P3|Overall Study|Withdrawal by Subject|0
4883141|NCT00740792|16827301|P2|Overall Study|Withdrawal by Subject|1
4883142|NCT00740792|16827302|P1|Overall Study|Withdrawal by Subject|1
4883143|NCT00740792|16827299|P4|Overall Study|Protocol Violation|2
4883144|NCT00740792|16827300|P3|Overall Study|Protocol Violation|0
4883145|NCT00740792|16827301|P2|Overall Study|Protocol Violation|1
4883146|NCT00740792|16827302|P1|Overall Study|Protocol Violation|0
4883147|NCT00740792|16827299|P4|Overall Study|Lost to Follow-up|0
4883148|NCT00740792|16827300|P3|Overall Study|Lost to Follow-up|0
4883149|NCT00740792|16827301|P2|Overall Study|Lost to Follow-up|1
4883150|NCT00740792|16827302|P1|Overall Study|Lost to Follow-up|2
4883151|NCT00740792|16827299|P4|Overall Study|Lack of Efficacy|3
4883152|NCT00740792|16827300|P3|Overall Study|Lack of Efficacy|0
4883153|NCT00740792|16827301|P2|Overall Study|Lack of Efficacy|1
4883154|NCT00740792|16827302|P1|Overall Study|Lack of Efficacy|1
4883155|NCT00740792|16827299|P4|Overall Study|Adverse Event|3
4883156|NCT00740792|16827300|P3|Overall Study|Adverse Event|1
4883157|NCT00740792|16827301|P2|Overall Study|Adverse Event|1
4883158|NCT00740792|16827302|P1|Overall Study|Adverse Event|3
4883159|NCT00740779|16827323|P3|Overall Study|Lost to Follow-up|5
4883160|NCT00740779|16827324|P2|Overall Study|Lost to Follow-up|3
4883161|NCT00740779|16827325|P1|Overall Study|Lost to Follow-up|2
4883162|NCT00740779|16827323|P3|Overall Study|Withdrawal by Subject|2
4883163|NCT00740779|16827324|P2|Overall Study|Withdrawal by Subject|4
4883164|NCT00740779|16827325|P1|Overall Study|Withdrawal by Subject|2
4883165|NCT00740779|16827323|P3|Overall Study|Lack of Efficacy|2
4883166|NCT00740779|16827324|P2|Overall Study|Lack of Efficacy|0
4883167|NCT00740779|16827325|P1|Overall Study|Lack of Efficacy|0
4883168|NCT00740779|16827323|P3|Overall Study|Protocol Violation|1
4883169|NCT00740779|16827324|P2|Overall Study|Protocol Violation|1
4883170|NCT00740779|16827325|P1|Overall Study|Protocol Violation|1
4883171|NCT00740779|16827323|P3|Overall Study|Adverse Event|3
4883172|NCT00740779|16827324|P2|Overall Study|Adverse Event|6
4883173|NCT00740779|16827325|P1|Overall Study|Adverse Event|4
4883174|NCT00740714|16827342|P3|Overall Study|Withdrawal by Subject|29
4883175|NCT00740714|16827343|P2|Overall Study|Withdrawal by Subject|19
4883176|NCT00740714|16827344|P1|Overall Study|Withdrawal by Subject|17
4883177|NCT00740636|16827420|P2|Overall Study|Death|0
4883178|NCT00740636|16827421|P1|Overall Study|Death|1
4883179|NCT00740636|16827420|P2|Overall Study|Progressive Disease|0
4883180|NCT00740636|16827421|P1|Overall Study|Progressive Disease|1
4883181|NCT00740636|16827420|P2|Overall Study|Patient Not Treated|1
4883182|NCT00740636|16827421|P1|Overall Study|Patient Not Treated|0
4883183|NCT00740636|16827420|P2|Overall Study|Patient Ineligible|1
4883184|NCT00740636|16827421|P1|Overall Study|Patient Ineligible|0
4883185|NCT00740636|16827420|P2|Overall Study|Adverse Event|2
4883186|NCT00740636|16827421|P1|Overall Study|Adverse Event|0
4883187|NCT00740597|16827427|P1|Overall Study|insurance would not cover treatment|1
4883188|NCT00740584|16827431|P1|Overall Study|Withdrawal by Subject|1
4883189|NCT00740480|16827436|P1|Overall Study|Physician Decision|1
4883190|NCT00740480|16827436|P1|Overall Study|Adverse Event|1
4883191|NCT00740220|16827461|P1|Overall Study|screen failures (non-COPD patients)|9
4883192|NCT00740051|16827486|P2|Overall Study|Other reason (not specified)|1
4883193|NCT00740051|16827487|P1|Overall Study|Other reason (not specified)|4
4883194|NCT00740051|16827486|P2|Overall Study|Withdrawal by Subject|8
4883195|NCT00740051|16827487|P1|Overall Study|Withdrawal by Subject|6
4883196|NCT00740051|16827486|P2|Overall Study|Lost to Follow-up|8
4883197|NCT00740051|16827487|P1|Overall Study|Lost to Follow-up|3
4883198|NCT00740051|16827486|P2|Overall Study|Protocol Violation|6
4883199|NCT00740051|16827487|P1|Overall Study|Protocol Violation|2
4883200|NCT00740051|16827486|P2|Overall Study|Adverse Event|4
4883201|NCT00740051|16827487|P1|Overall Study|Adverse Event|1
4883202|NCT00740051|16827486|P2|Overall Study|Lack of Efficacy|5
4883203|NCT00740051|16827487|P1|Overall Study|Lack of Efficacy|2
4883204|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883205|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883206|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2
4883207|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883208|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883209|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883210|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883211|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1
4883212|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0
4883213|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
4883214|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
4883215|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
4883216|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
4883217|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
4883218|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2
4883219|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1
4883220|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3
4883221|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5
4883222|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883223|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883224|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1
4883225|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883226|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883227|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883228|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883229|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883230|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0
4883231|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
4883232|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3
4883233|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
4883234|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
4883235|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
4883236|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1
4883237|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4
4883238|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2
4883239|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0
4883240|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4883241|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
4883242|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
4883243|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4883244|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4883245|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3
4883246|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4883247|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2
4883248|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4
4883249|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883250|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883251|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883252|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883253|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883254|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883255|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1
4883256|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883257|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0
4883258|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
4883259|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
4883260|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1
4883261|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
4883262|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2
4883263|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4
4883264|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
4883265|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8
4883266|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17
4883267|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883268|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883269|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883270|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883271|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883272|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883273|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0
4883274|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
4883275|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1
4883276|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883277|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
4883278|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883279|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883280|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1
4883281|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883282|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883283|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883284|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0
4883285|NCT00739973|16827590|P9|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
4883286|NCT00739973|16827591|P8|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
4883287|NCT00739973|16827592|P7|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4
4883288|NCT00739973|16827593|P6|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
4883289|NCT00739973|16827594|P5|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7
4883290|NCT00739973|16827595|P4|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2
4883291|NCT00739973|16827596|P3|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1
4883292|NCT00739973|16827597|P2|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
4883293|NCT00739973|16827598|P1|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3
4883294|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883295|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883296|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883297|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883298|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883299|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883300|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883301|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0
4883302|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11
4883303|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883304|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883305|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883306|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883307|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883308|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883309|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883310|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Administrative problems|0
4883311|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Administrative problems|12
4883312|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883313|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883314|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883315|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883316|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883317|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883318|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883319|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0
4883320|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17
4883321|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883322|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883323|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883324|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883325|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883326|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883327|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883328|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0
4883329|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86
4883330|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883331|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883332|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883333|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883334|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883335|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883336|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883337|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0
4883338|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810
4883339|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883340|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883341|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883342|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883343|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883344|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883345|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883346|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0
4883347|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38
4883348|NCT00739973|16827590|P9|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883349|NCT00739973|16827591|P8|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883350|NCT00739973|16827592|P7|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883351|NCT00739973|16827593|P6|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883352|NCT00739973|16827594|P5|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883353|NCT00739973|16827595|P4|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883354|NCT00739973|16827596|P3|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883355|NCT00739973|16827597|P2|Single-blind Period (2 to 4 Weeks)|Adverse Event|0
4883356|NCT00739973|16827598|P1|Single-blind Period (2 to 4 Weeks)|Adverse Event|35
4883357|NCT00739934|16827689|P1|Voriconazole Oral|Other|3
4883358|NCT00739934|16827689|P1|Voriconazole IV|Adverse Event|6
4883359|NCT00739908|16827711|P2|Overall Study|Relocation|1
4883360|NCT00739908|16827712|P1|Overall Study|Relocation|0
4883361|NCT00739908|16827711|P2|Overall Study|Lack of Efficacy|1
4883362|NCT00739908|16827712|P1|Overall Study|Lack of Efficacy|0
4883363|NCT00739908|16827711|P2|Overall Study|Non-Compliance With Study Medication|3
4883364|NCT00739908|16827712|P1|Overall Study|Non-Compliance With Study Medication|0
4883365|NCT00739908|16827711|P2|Overall Study|Non-Compliance With Study Procedures|3
4883366|NCT00739908|16827712|P1|Overall Study|Non-Compliance With Study Procedures|2
4883367|NCT00739908|16827711|P2|Overall Study|Lost to Follow-up|9
4883368|NCT00739908|16827712|P1|Overall Study|Lost to Follow-up|14
4883369|NCT00739908|16827711|P2|Overall Study|Withdrawal by Subject|2
4883370|NCT00739908|16827712|P1|Overall Study|Withdrawal by Subject|4
4883371|NCT00739908|16827711|P2|Overall Study|Adverse Event|6
4883372|NCT00739908|16827712|P1|Overall Study|Adverse Event|5
4883373|NCT00739882|16827732|P2|Open-label Period|Other|5
4883374|NCT00739882|16827733|P1|Open-label Period|Other|9
4883375|NCT00739882|16827732|P2|Open-label Period|Adverse Event|0
4883376|NCT00739882|16827733|P1|Open-label Period|Adverse Event|1
4883377|NCT00739882|16827732|P2|Double-blind Period|Other|8
4883378|NCT00739882|16827733|P1|Double-blind Period|Other|16
4883379|NCT00739882|16827732|P2|Double-blind Period|Lack of Efficacy|1
4883380|NCT00739882|16827733|P1|Double-blind Period|Lack of Efficacy|1
4883381|NCT00739882|16827732|P2|Double-blind Period|Protocol Violation|0
4883382|NCT00739882|16827733|P1|Double-blind Period|Protocol Violation|1
4883383|NCT00739882|16827732|P2|Double-blind Period|Adverse Event|2
4883384|NCT00739882|16827733|P1|Double-blind Period|Adverse Event|1
4883385|NCT00739674|16827794|P2|Overall Study|Erectile dysfunction|1
4883386|NCT00739674|16827795|P1|Overall Study|Erectile dysfunction|0
4883387|NCT00739674|16827794|P2|Overall Study|Home monitoring off meds|0
4883388|NCT00739674|16827795|P1|Overall Study|Home monitoring off meds|1
4883389|NCT00739674|16827794|P2|Overall Study|Unable to attend visit|1
4883390|NCT00739674|16827795|P1|Overall Study|Unable to attend visit|3
4883391|NCT00739674|16827794|P2|Overall Study|Non compliant|0
4883392|NCT00739674|16827795|P1|Overall Study|Non compliant|4
4883393|NCT00739674|16827794|P2|Overall Study|Patient moved|2
4883394|NCT00739674|16827795|P1|Overall Study|Patient moved|3
4883395|NCT00739674|16827794|P2|Overall Study|Clinic closed|4
4883396|NCT00739674|16827795|P1|Overall Study|Clinic closed|6
4883397|NCT00739674|16827794|P2|Overall Study|Reason missing|0
4883398|NCT00739674|16827795|P1|Overall Study|Reason missing|2
4883399|NCT00739674|16827794|P2|Overall Study|Withdrawal by Subject|9
4883400|NCT00739674|16827795|P1|Overall Study|Withdrawal by Subject|9
4883401|NCT00739674|16827794|P2|Overall Study|Protocol Violation|5
4883402|NCT00739674|16827795|P1|Overall Study|Protocol Violation|5
4883403|NCT00739674|16827794|P2|Overall Study|Lost to Follow-up|30
4883404|NCT00739674|16827795|P1|Overall Study|Lost to Follow-up|52
4883405|NCT00739674|16827794|P2|Overall Study|Lack of Efficacy|0
4883406|NCT00739674|16827795|P1|Overall Study|Lack of Efficacy|1
4883407|NCT00739674|16827794|P2|Overall Study|Death|0
4883408|NCT00739674|16827795|P1|Overall Study|Death|1
4883409|NCT00739674|16827794|P2|Overall Study|Adverse Event|13
4883410|NCT00739674|16827795|P1|Overall Study|Adverse Event|22
4883411|NCT00739674|16827794|P2|Overall Study|Dietician consultation >30 days|9
4883412|NCT00739674|16827795|P1|Overall Study|Dietician consultation >30 days|1
4883413|NCT00739674|16827794|P2|Overall Study|No follow-up data|18
4883414|NCT00739674|16827795|P1|Overall Study|No follow-up data|33
4883415|NCT00739674|16827794|P2|Overall Study|Site 212 removal|13
4883416|NCT00739674|16827795|P1|Overall Study|Site 212 removal|19
4883417|NCT00739674|16827794|P2|Overall Study|Screening failures|17
4883418|NCT00739674|16827795|P1|Overall Study|Screening failures|19
4883419|NCT00739661|16827823|P2|Overall Study|Reason for discontinuation not available|1
4883420|NCT00739661|16827824|P1|Overall Study|Reason for discontinuation not available|1
4883421|NCT00739661|16827823|P2|Overall Study|Disease progression, radiographic|37
4883422|NCT00739661|16827824|P1|Overall Study|Disease progression, radiographic|33
4883423|NCT00739661|16827823|P2|Overall Study|Patient decision to withdraw|4
4883424|NCT00739661|16827824|P1|Overall Study|Patient decision to withdraw|9
4883425|NCT00739661|16827823|P2|Overall Study|Physician decision to withdraw patient|0
4883426|NCT00739661|16827824|P1|Overall Study|Physician decision to withdraw patient|1
4883427|NCT00739661|16827823|P2|Overall Study|Adverse Event|0
4883428|NCT00739661|16827824|P1|Overall Study|Adverse Event|2
4883429|NCT00739648|16827836|P2|Overall Study|Do not know|6
4883430|NCT00739648|16827837|P1|Overall Study|Do not know|4
4883431|NCT00739648|16827836|P2|Overall Study|Death|0
4883432|NCT00739648|16827837|P1|Overall Study|Death|2
4883433|NCT00739648|16827836|P2|Overall Study|Lost to Follow-up|7
4883434|NCT00739648|16827837|P1|Overall Study|Lost to Follow-up|4
4883435|NCT00739648|16827836|P2|Overall Study|Withdrawal by Subject|25
4883436|NCT00739648|16827837|P1|Overall Study|Withdrawal by Subject|13
4883437|NCT00739648|16827836|P2|Overall Study|Adverse Event|15
4883438|NCT00739648|16827837|P1|Overall Study|Adverse Event|3
4883439|NCT00739596|16827851|P2|Overall Study|Protocol Deviation|1
4883440|NCT00739596|16827852|P1|Overall Study|Protocol Deviation|1
4883441|NCT00739596|16827851|P2|Overall Study|Lost to Follow-up|2
4883442|NCT00739596|16827852|P1|Overall Study|Lost to Follow-up|0
4883443|NCT00739596|16827851|P2|Overall Study|Patient Withdrew Consent|8
4883444|NCT00739596|16827852|P1|Overall Study|Patient Withdrew Consent|8
4883445|NCT00739596|16827851|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
4883446|NCT00739596|16827852|P1|Overall Study|Unsatisfactory Therapeutic Effect|4
4883447|NCT00739596|16827851|P2|Overall Study|Adverse Event|6
4883448|NCT00739596|16827852|P1|Overall Study|Adverse Event|12
4883449|NCT00739310|16827894|P1|Overall Study|Lost to Follow-up|2
4883450|NCT00739310|16827894|P1|Overall Study|Withdrawal by Subject|1
4883451|NCT00739310|16827894|P1|Overall Study|Poor adherance to prescribed therapy|4
4883452|NCT00739297|16827899|P7|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
4883453|NCT00739297|16827900|P6|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1
4883454|NCT00739297|16827901|P5|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4883455|NCT00739297|16827902|P4|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4883456|NCT00739297|16827903|P3|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4883457|NCT00739297|16827904|P2|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4883458|NCT00739297|16827905|P1|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0
4883459|NCT00739297|16827899|P7|First Washout Period of 4-7 Days|Adverse Event|2
4883460|NCT00739297|16827900|P6|First Washout Period of 4-7 Days|Adverse Event|0
4883461|NCT00739297|16827901|P5|First Washout Period of 4-7 Days|Adverse Event|0
4883462|NCT00739297|16827902|P4|First Washout Period of 4-7 Days|Adverse Event|2
4883463|NCT00739297|16827903|P3|First Washout Period of 4-7 Days|Adverse Event|0
4883464|NCT00739297|16827904|P2|First Washout Period of 4-7 Days|Adverse Event|0
4883465|NCT00739297|16827905|P1|First Washout Period of 4-7 Days|Adverse Event|0
4883466|NCT00739102|16827933|P1|Overall Study|Withdrawal by Subject|10
4883467|NCT00739102|16827933|P1|Overall Study|Death|5
4883468|NCT00739063|16827949|P1|Overall Study|Screen failures|8
4883469|NCT00738894|16827994|P2|Overall Study|Death|0
4883470|NCT00738894|16827995|P1|Overall Study|Death|2
4883471|NCT00738894|16827994|P2|Overall Study|Physician Decision|5
4883472|NCT00738894|16827995|P1|Overall Study|Physician Decision|4
4883473|NCT00738894|16827994|P2|Overall Study|Withdrawal by Subject|15
4883474|NCT00738894|16827995|P1|Overall Study|Withdrawal by Subject|10
4883475|NCT00738894|16827994|P2|Overall Study|Lost to Follow-up|13
4883476|NCT00738894|16827995|P1|Overall Study|Lost to Follow-up|23
4883477|NCT00738881|16828008|P2|Overall Study|Withdrawal by Subject|2
4883478|NCT00738881|16828009|P1|Overall Study|Withdrawal by Subject|0
4883479|NCT00738699|16828023|P2|Overall Study|Other|0
4883480|NCT00738699|16828024|P1|Overall Study|Other|2
4883481|NCT00738699|16828023|P2|Overall Study|Discontinuation of study by Sponsor|72
4883482|NCT00738699|16828024|P1|Overall Study|Discontinuation of study by Sponsor|123
4883483|NCT00738699|16828023|P2|Overall Study|Death|68
4883484|NCT00738699|16828024|P1|Overall Study|Death|144
4883485|NCT00738699|16828023|P2|Overall Study|Lost to Follow-up|0
4883486|NCT00738699|16828024|P1|Overall Study|Lost to Follow-up|1
4883487|NCT00738699|16828023|P2|Overall Study|Withdrawal by Subject|0
4883488|NCT00738699|16828024|P1|Overall Study|Withdrawal by Subject|5
4883489|NCT00738673|16828042|P2|Overall Study|Withdrawal by Subject|1
4883490|NCT00738673|16828043|P1|Overall Study|Withdrawal by Subject|3
4883491|NCT00738673|16828042|P2|Overall Study|Protocol Violation|2
4883492|NCT00738673|16828043|P1|Overall Study|Protocol Violation|1
4883493|NCT00738673|16828042|P2|Overall Study|Lack of Efficacy|8
4883494|NCT00738673|16828043|P1|Overall Study|Lack of Efficacy|19
4883495|NCT00738673|16828042|P2|Overall Study|Adverse Event|0
4883496|NCT00738673|16828043|P1|Overall Study|Adverse Event|1
4883497|NCT00738530|16828081|P2|Overall Study|Withdrawal by Subject|8
4883498|NCT00738530|16828082|P1|Overall Study|Withdrawal by Subject|6
4883499|NCT00738530|16828081|P2|Overall Study|Lost to Follow-up|6
4883500|NCT00738530|16828082|P1|Overall Study|Lost to Follow-up|8
4883501|NCT00738530|16828081|P2|Overall Study|Death|224
4883502|NCT00738530|16828082|P1|Overall Study|Death|220
4883503|NCT00738400|16828117|P2|Overall Study|Non-compliant with study medication|1
4883504|NCT00738400|16828118|P1|Overall Study|Non-compliant with study medication|0
4883505|NCT00738400|16828117|P2|Overall Study|Protocol Violation|0
4883506|NCT00738400|16828118|P1|Overall Study|Protocol Violation|1
4883507|NCT00738400|16828117|P2|Overall Study|Lost to Follow-up|3
4883508|NCT00738400|16828118|P1|Overall Study|Lost to Follow-up|0
4883509|NCT00738400|16828117|P2|Overall Study|Lack of Efficacy|1
4883510|NCT00738400|16828118|P1|Overall Study|Lack of Efficacy|0
4883511|NCT00738400|16828117|P2|Overall Study|Withdrawal by Subject|1
4883512|NCT00738400|16828118|P1|Overall Study|Withdrawal by Subject|0
4883513|NCT00738400|16828117|P2|Overall Study|Adverse Event|1
4883514|NCT00738400|16828118|P1|Overall Study|Adverse Event|3
4883515|NCT00738374|16828139|P4|Maintenance Treatment/Observation Phase|Other|0
4883516|NCT00738374|16828140|P3|Maintenance Treatment/Observation Phase|Other|0
4883517|NCT00738374|16828141|P2|Maintenance Treatment/Observation Phase|Other|1
4883518|NCT00738374|16828142|P1|Maintenance Treatment/Observation Phase|Other|0
4883519|NCT00738374|16828139|P4|Maintenance Treatment/Observation Phase|Protocol Violation|0
4883520|NCT00738374|16828140|P3|Maintenance Treatment/Observation Phase|Protocol Violation|0
4883521|NCT00738374|16828141|P2|Maintenance Treatment/Observation Phase|Protocol Violation|1
4883522|NCT00738374|16828142|P1|Maintenance Treatment/Observation Phase|Protocol Violation|0
4883523|NCT00738374|16828139|P4|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1
4883524|NCT00738374|16828140|P3|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
4883525|NCT00738374|16828141|P2|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
4883526|NCT00738374|16828142|P1|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0
4883527|NCT00738374|16828139|P4|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11
4883528|NCT00738374|16828140|P3|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5
4883529|NCT00738374|16828141|P2|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4
4883530|NCT00738374|16828142|P1|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0
4883531|NCT00738374|16828139|P4|Maintenance Treatment/Observation Phase|Adverse Event|0
4883532|NCT00738374|16828140|P3|Maintenance Treatment/Observation Phase|Adverse Event|2
4883533|NCT00738374|16828141|P2|Maintenance Treatment/Observation Phase|Adverse Event|1
4883534|NCT00738374|16828142|P1|Maintenance Treatment/Observation Phase|Adverse Event|0
4883535|NCT00738374|16828139|P4|Induction Treatment Phase|Withdrawal by Subject|0
4883536|NCT00738374|16828140|P3|Induction Treatment Phase|Withdrawal by Subject|0
4883537|NCT00738374|16828141|P2|Induction Treatment Phase|Withdrawal by Subject|0
4883538|NCT00738374|16828142|P1|Induction Treatment Phase|Withdrawal by Subject|1
4883539|NCT00738374|16828139|P4|Induction Treatment Phase|Non-compliance|0
4883540|NCT00738374|16828140|P3|Induction Treatment Phase|Non-compliance|0
4883541|NCT00738374|16828141|P2|Induction Treatment Phase|Non-compliance|0
4883542|NCT00738374|16828142|P1|Induction Treatment Phase|Non-compliance|1
4883543|NCT00738374|16828139|P4|Induction Treatment Phase|Protocol Violation|0
4883544|NCT00738374|16828140|P3|Induction Treatment Phase|Protocol Violation|0
4883545|NCT00738374|16828141|P2|Induction Treatment Phase|Protocol Violation|0
4883546|NCT00738374|16828142|P1|Induction Treatment Phase|Protocol Violation|2
4883547|NCT00738374|16828139|P4|Induction Treatment Phase|Physician Decision|0
4883548|NCT00738374|16828140|P3|Induction Treatment Phase|Physician Decision|0
4883549|NCT00738374|16828141|P2|Induction Treatment Phase|Physician Decision|0
4883550|NCT00738374|16828142|P1|Induction Treatment Phase|Physician Decision|2
4883551|NCT00738374|16828139|P4|Induction Treatment Phase|Disease progression/relapse/stable|0
4883552|NCT00738374|16828140|P3|Induction Treatment Phase|Disease progression/relapse/stable|0
4883553|NCT00738374|16828141|P2|Induction Treatment Phase|Disease progression/relapse/stable|0
4883554|NCT00738374|16828142|P1|Induction Treatment Phase|Disease progression/relapse/stable|4
4883555|NCT00738374|16828139|P4|Induction Treatment Phase|Adverse Event|0
4883556|NCT00738374|16828140|P3|Induction Treatment Phase|Adverse Event|0
4883557|NCT00738374|16828141|P2|Induction Treatment Phase|Adverse Event|0
4883558|NCT00738374|16828142|P1|Induction Treatment Phase|Adverse Event|14
4883559|NCT00738283|16828180|P1|Overall Study|Discharge home prior to end of study|1
4883560|NCT00738283|16828180|P1|Overall Study|Transfer to another facility|2
4883561|NCT00738283|16828180|P1|Overall Study|Death|1
4883562|NCT00738101|16828184|P1|Overall Study|Repeat enrollment|1
4883563|NCT00738101|16828184|P1|Overall Study|Death|1
4883564|NCT00738101|16828184|P1|Overall Study|Physician Decision|5
4883565|NCT00738062|16828199|P3|Open-Label Extension|Study Terminated|0
4883566|NCT00738062|16828200|P2|Open-Label Extension|Study Terminated|0
4883567|NCT00738062|16828201|P1|Open-Label Extension|Study Terminated|2
4883568|NCT00738062|16828199|P3|Open-Label Extension|Protocol Violation|0
4883569|NCT00738062|16828200|P2|Open-Label Extension|Protocol Violation|0
4883570|NCT00738062|16828201|P1|Open-Label Extension|Protocol Violation|1
4883571|NCT00738062|16828199|P3|Open-Label Extension|Withdrawal by Subject|0
4883572|NCT00738062|16828200|P2|Open-Label Extension|Withdrawal by Subject|0
4883573|NCT00738062|16828201|P1|Open-Label Extension|Withdrawal by Subject|6
4883574|NCT00738062|16828199|P3|Open-Label Extension|Lack of Efficacy|0
4883575|NCT00738062|16828200|P2|Open-Label Extension|Lack of Efficacy|0
4883576|NCT00738062|16828201|P1|Open-Label Extension|Lack of Efficacy|2
4883577|NCT00738062|16828199|P3|Open-Label Extension|Physician Decision|0
4883578|NCT00738062|16828200|P2|Open-Label Extension|Physician Decision|0
4883579|NCT00738062|16828201|P1|Open-Label Extension|Physician Decision|1
4883580|NCT00738062|16828199|P3|Open-Label Extension|Adverse Event|0
4883581|NCT00738062|16828200|P2|Open-Label Extension|Adverse Event|0
4883582|NCT00738062|16828201|P1|Open-Label Extension|Adverse Event|5
4883583|NCT00738062|16828199|P3|Open Label Treatment|Investigator Decision|0
4883584|NCT00738062|16828200|P2|Open Label Treatment|Investigator Decision|0
4883585|NCT00738062|16828201|P1|Open Label Treatment|Investigator Decision|1
4883586|NCT00738062|16828199|P3|Open Label Treatment|Withdrawal by Subject|0
4883587|NCT00738062|16828200|P2|Open Label Treatment|Withdrawal by Subject|0
4883588|NCT00738062|16828201|P1|Open Label Treatment|Withdrawal by Subject|9
4883589|NCT00738062|16828199|P3|Open Label Treatment|Protocol Violation|0
4883590|NCT00738062|16828200|P2|Open Label Treatment|Protocol Violation|0
4883591|NCT00738062|16828201|P1|Open Label Treatment|Protocol Violation|2
4883592|NCT00738062|16828199|P3|Open Label Treatment|Adverse Event|0
4883593|NCT00738062|16828200|P2|Open Label Treatment|Adverse Event|0
4883594|NCT00738062|16828201|P1|Open Label Treatment|Adverse Event|11
4883595|NCT00738062|16828199|P3|Open Label Treatment|Lack of Efficacy|0
4883596|NCT00738062|16828200|P2|Open Label Treatment|Lack of Efficacy|0
4883597|NCT00738062|16828201|P1|Open Label Treatment|Lack of Efficacy|5
4883598|NCT00737711|16828314|P1|Overall Study|Other|5
4883599|NCT00737711|16828314|P1|Overall Study|Blood transfusion|6
4883600|NCT00737711|16828314|P1|Overall Study|Withdrawal by Subject|5
4883601|NCT00737711|16828314|P1|Overall Study|Protocol Violation|1
4883602|NCT00737711|16828314|P1|Overall Study|Failure to return|4
4883603|NCT00737711|16828314|P1|Overall Study|Death|8
4883604|NCT00737711|16828314|P1|Overall Study|Adverse Event|2
4883605|NCT00737698|16828348|P3|Overall Study|Death|1
4883606|NCT00737698|16828349|P2|Overall Study|Death|0
4883607|NCT00737698|16828350|P1|Overall Study|Death|0
4883608|NCT00737698|16828348|P3|Overall Study|Withdrawal by Subject|3
4883609|NCT00737698|16828349|P2|Overall Study|Withdrawal by Subject|5
4883610|NCT00737698|16828350|P1|Overall Study|Withdrawal by Subject|6
4883611|NCT00737672|16828360|P2|Overall Study|Physician Decision|2
4883612|NCT00737672|16828361|P1|Overall Study|Physician Decision|0
4883613|NCT00737672|16828360|P2|Overall Study|Miscellaneous|1
4883614|NCT00737672|16828361|P1|Overall Study|Miscellaneous|7
4883615|NCT00737672|16828360|P2|Overall Study|Lost to Follow-up|0
4883616|NCT00737672|16828361|P1|Overall Study|Lost to Follow-up|1
4883617|NCT00737672|16828360|P2|Overall Study|Withdrawal by Subject|2
4883618|NCT00737672|16828361|P1|Overall Study|Withdrawal by Subject|1
4883619|NCT00737672|16828360|P2|Overall Study|Death|22
4883620|NCT00737672|16828361|P1|Overall Study|Death|23
4883621|NCT00737672|16828360|P2|Overall Study|Graft Abandonment|56
4883622|NCT00737672|16828361|P1|Overall Study|Graft Abandonment|48
4883623|NCT00737633|16828399|P2|Overall Study|protocol non-compliance|1
4883624|NCT00737633|16828400|P1|Overall Study|protocol non-compliance|0
4883625|NCT00737633|16828399|P2|Overall Study|Lost to Follow-up|1
4883626|NCT00737633|16828400|P1|Overall Study|Lost to Follow-up|0
4883627|NCT00737633|16828399|P2|Overall Study|Study terminated by sponsor|55
4883628|NCT00737633|16828400|P1|Overall Study|Study terminated by sponsor|44
4883629|NCT00737568|16828423|P2|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0
4883630|NCT00737568|16828424|P1|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1
4883631|NCT00737568|16828423|P2|Treatment-Free Follow-up (TFFU) Period|Death|1
4883632|NCT00737568|16828424|P1|Treatment-Free Follow-up (TFFU) Period|Death|0
4883633|NCT00737568|16828423|P2|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17
4883634|NCT00737568|16828424|P1|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25
4883635|NCT00737568|16828423|P2|Treatment Period Through Week 240|Study Discontinued by Sponsor|0
4883636|NCT00737568|16828424|P1|Treatment Period Through Week 240|Study Discontinued by Sponsor|1
4883637|NCT00737568|16828423|P2|Treatment Period Through Week 240|Protocol Violation|3
4883638|NCT00737568|16828424|P1|Treatment Period Through Week 240|Protocol Violation|2
4883639|NCT00737568|16828423|P2|Treatment Period Through Week 240|Lost to Follow-up|3
4883640|NCT00737568|16828424|P1|Treatment Period Through Week 240|Lost to Follow-up|3
4883641|NCT00737568|16828423|P2|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4
4883642|NCT00737568|16828424|P1|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3
4883643|NCT00737568|16828423|P2|Treatment Period Through Week 240|Withdrew Consent|6
4883644|NCT00737568|16828424|P1|Treatment Period Through Week 240|Withdrew Consent|5
4883645|NCT00737568|16828423|P2|Treatment Period Through Week 240|Investigator's Discretion|5
4883646|NCT00737568|16828424|P1|Treatment Period Through Week 240|Investigator's Discretion|6
4883647|NCT00737529|16828454|P1|Overall Study|Other|4
4883648|NCT00737529|16828454|P1|Overall Study|Protocol Violation|1
4883649|NCT00737529|16828454|P1|Overall Study|Death|4
4883650|NCT00737529|16828454|P1|Overall Study|Withdrawal by Subject|5
4883651|NCT00737529|16828454|P1|Overall Study|Adverse Event|24
4883652|NCT00737529|16828454|P1|Overall Study|Disease Progression|95
4883653|NCT00737477|16828468|P1|Overall Study|Other|4
4883654|NCT00737477|16828468|P1|Overall Study|Renal Transplantation|10
4883655|NCT00737477|16828468|P1|Overall Study|Withdrawal by Subject|1
4883656|NCT00737477|16828468|P1|Overall Study|Treatment Refusal|1
4883657|NCT00737477|16828468|P1|Overall Study|Death|9
4883658|NCT00737477|16828468|P1|Overall Study|Adverse Event|9
4883659|NCT00737464|16828484|P1|Overall Study|Other reasons|4
4883660|NCT00737464|16828484|P1|Overall Study|Refused Treatment / Withdrew Consent|6
4883661|NCT00737464|16828484|P1|Overall Study|Other - Failure to Return|1
4883662|NCT00737464|16828484|P1|Overall Study|Death|6
4883663|NCT00737464|16828484|P1|Overall Study|Adverse Event|1
4883664|NCT00737438|16828505|P1|Overall Study|Patient ineligible|1
4883665|NCT00737438|16828505|P1|Overall Study|Withdrawal by Subject|2
4883666|NCT00737282|16828518|P1|Overall Study|Study prematurely terminated|175
4883667|NCT00737100|16828561|P3|Overall Study|Reason discontinued not explained above|1
4883668|NCT00737100|16828562|P2|Overall Study|Reason discontinued not explained above|1
4883669|NCT00737100|16828563|P1|Overall Study|Reason discontinued not explained above|1
4883670|NCT00737100|16828561|P3|Overall Study|Withdrawal by Subject|3
4883671|NCT00737100|16828562|P2|Overall Study|Withdrawal by Subject|0
4883672|NCT00737100|16828563|P1|Overall Study|Withdrawal by Subject|0
4883673|NCT00737100|16828561|P3|Overall Study|Lost to Follow-up|0
4883674|NCT00737100|16828562|P2|Overall Study|Lost to Follow-up|1
4883675|NCT00737100|16828563|P1|Overall Study|Lost to Follow-up|0
4883676|NCT00737100|16828561|P3|Overall Study|Adverse Event|3
4883677|NCT00737100|16828562|P2|Overall Study|Adverse Event|5
4883678|NCT00737100|16828563|P1|Overall Study|Adverse Event|6
4883679|NCT00737061|16828607|P1|1 Year Wearing Period|Terminated for protocol non-compliance|1
4883680|NCT00737061|16828607|P1|1 Year Wearing Period|Discontinued reilance|3
4883681|NCT00737061|16828607|P1|1 Year Wearing Period|Withdrawal by Subject|2
4883682|NCT00737061|16828607|P1|1 Year Wearing Period|Lost to Follow-up|11
4883683|NCT00737061|16828607|P1|Waiting Period|Elected surgical tubal ligation|5
4883684|NCT00737061|16828607|P1|Waiting Period|Alternative contraception failure|3
4883685|NCT00737061|16828607|P1|Waiting Period|Deemed patent following HSG|26
4883686|NCT00737061|16828607|P1|Waiting Period|Bilateral placement failure|34
4883687|NCT00737061|16828607|P1|Waiting Period|Withdrawal by Subject|1
4883688|NCT00737061|16828607|P1|Waiting Period|Lost to Follow-up|6
4883689|NCT00737048|16828624|P3|Overall Study|Worsening of the symptoms|3
4883690|NCT00737048|16828625|P2|Overall Study|Worsening of the symptoms|5
4883691|NCT00737048|16828626|P1|Overall Study|Worsening of the symptoms|3
4883692|NCT00737048|16828624|P3|Overall Study|Adverse Event|0
4883693|NCT00737048|16828625|P2|Overall Study|Adverse Event|1
4883694|NCT00737048|16828626|P1|Overall Study|Adverse Event|0
4883695|NCT00737048|16828624|P3|Overall Study|Physician Decision|1
4883696|NCT00737048|16828625|P2|Overall Study|Physician Decision|0
4883697|NCT00737048|16828626|P1|Overall Study|Physician Decision|0
4883698|NCT00736996|16828670|P3|Overall Study|Lost to Follow-up|2
4883699|NCT00736996|16828671|P2|Overall Study|Lost to Follow-up|9
4883700|NCT00736996|16828672|P1|Overall Study|Lost to Follow-up|1
4883701|NCT00736957|16828686|P1|Overall Study|Physician Decision|5
4883702|NCT00736957|16828686|P1|Overall Study|not eligible for Treatment Period I|22
4883703|NCT00736957|16828686|P1|Overall Study|did not attend hospital appointments|1
4883704|NCT00736957|16828686|P1|Overall Study|violation of eligibility criteria|2
4883705|NCT00736957|16828686|P1|Overall Study|Withdrawal by Subject|49
4883706|NCT00736957|16828686|P1|Overall Study|Adverse Event|43
4883707|NCT00736944|16828696|P1|Definitive Treatment|Physician Decision|1
4883708|NCT00736944|16828696|P1|Induction|Death|1
4883709|NCT00736879|16828730|P4|Follow up Period - No Drug Treatment|non-specified|0
4883710|NCT00736879|16828731|P3|Follow up Period - No Drug Treatment|non-specified|0
4883711|NCT00736879|16828732|P2|Follow up Period - No Drug Treatment|non-specified|2
4883712|NCT00736879|16828733|P1|Follow up Period - No Drug Treatment|non-specified|1
4883713|NCT00736879|16828730|P4|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
4883714|NCT00736879|16828731|P3|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
4883715|NCT00736879|16828732|P2|Follow up Period - No Drug Treatment|Withdrawal by Subject|1
4883716|NCT00736879|16828733|P1|Follow up Period - No Drug Treatment|Withdrawal by Subject|0
4883717|NCT00736879|16828730|P4|Double Blind Treatment Period|non-specified|0
4883718|NCT00736879|16828731|P3|Double Blind Treatment Period|non-specified|0
4883719|NCT00736879|16828732|P2|Double Blind Treatment Period|non-specified|1
4883720|NCT00736879|16828733|P1|Double Blind Treatment Period|non-specified|0
4883721|NCT00736879|16828730|P4|Double Blind Treatment Period|No longer met criteria|0
4883722|NCT00736879|16828731|P3|Double Blind Treatment Period|No longer met criteria|0
4883723|NCT00736879|16828732|P2|Double Blind Treatment Period|No longer met criteria|1
4883724|NCT00736879|16828733|P1|Double Blind Treatment Period|No longer met criteria|0
4883725|NCT00736879|16828730|P4|Double Blind Treatment Period|Poor non-compliance|1
4883726|NCT00736879|16828731|P3|Double Blind Treatment Period|Poor non-compliance|1
4883727|NCT00736879|16828732|P2|Double Blind Treatment Period|Poor non-compliance|0
4883728|NCT00736879|16828733|P1|Double Blind Treatment Period|Poor non-compliance|0
4883729|NCT00736879|16828730|P4|Double Blind Treatment Period|Lost to Follow-up|1
4883730|NCT00736879|16828731|P3|Double Blind Treatment Period|Lost to Follow-up|2
4883731|NCT00736879|16828732|P2|Double Blind Treatment Period|Lost to Follow-up|0
4883732|NCT00736879|16828733|P1|Double Blind Treatment Period|Lost to Follow-up|0
4883733|NCT00736879|16828730|P4|Double Blind Treatment Period|Withdrawal by Subject|3
4883734|NCT00736879|16828731|P3|Double Blind Treatment Period|Withdrawal by Subject|3
4883735|NCT00736879|16828732|P2|Double Blind Treatment Period|Withdrawal by Subject|1
4883736|NCT00736879|16828733|P1|Double Blind Treatment Period|Withdrawal by Subject|2
4883737|NCT00736879|16828730|P4|Double Blind Treatment Period|Adverse Event|0
4883738|NCT00736879|16828731|P3|Double Blind Treatment Period|Adverse Event|1
4883739|NCT00736879|16828732|P2|Double Blind Treatment Period|Adverse Event|1
4883740|NCT00736879|16828733|P1|Double Blind Treatment Period|Adverse Event|0
4883741|NCT00736879|16828730|P4|Double Blind Treatment Period|Lack of Efficacy|0
4883742|NCT00736879|16828731|P3|Double Blind Treatment Period|Lack of Efficacy|0
4883743|NCT00736879|16828732|P2|Double Blind Treatment Period|Lack of Efficacy|0
4883744|NCT00736879|16828733|P1|Double Blind Treatment Period|Lack of Efficacy|1
4883745|NCT00736853|16828787|P3|Double-Blind Period|Ineligible to participate the study|0
4883746|NCT00736853|16828788|P2|Double-Blind Period|Ineligible to participate the study|1
4883747|NCT00736853|16828789|P1|Double-Blind Period|Ineligible to participate the study|0
4883748|NCT00736853|16828787|P3|Double-Blind Period|Withdrawal by Subject|4
4883749|NCT00736853|16828788|P2|Double-Blind Period|Withdrawal by Subject|1
4883750|NCT00736853|16828789|P1|Double-Blind Period|Withdrawal by Subject|0
4883751|NCT00736853|16828787|P3|Double-Blind Period|Adverse Event|2
4883752|NCT00736853|16828788|P2|Double-Blind Period|Adverse Event|3
4883753|NCT00736853|16828789|P1|Double-Blind Period|Adverse Event|0
4883754|NCT00736853|16828787|P3|Double-Blind Period|Lack of Efficacy|42
4883755|NCT00736853|16828788|P2|Double-Blind Period|Lack of Efficacy|19
4883756|NCT00736853|16828789|P1|Double-Blind Period|Lack of Efficacy|0
4883757|NCT00736853|16828787|P3|Open-Label Period|Unable to attend hospital appointments|0
4883758|NCT00736853|16828788|P2|Open-Label Period|Unable to attend hospital appointments|0
4883759|NCT00736853|16828789|P1|Open-Label Period|Unable to attend hospital appointments|1
4883760|NCT00736853|16828787|P3|Open-Label Period|Failed to meet the transfer criteria|0
4883761|NCT00736853|16828788|P2|Open-Label Period|Failed to meet the transfer criteria|0
4883762|NCT00736853|16828789|P1|Open-Label Period|Failed to meet the transfer criteria|40
4883763|NCT00736853|16828787|P3|Open-Label Period|Started but not treated|0
4883764|NCT00736853|16828788|P2|Open-Label Period|Started but not treated|0
4883765|NCT00736853|16828789|P1|Open-Label Period|Started but not treated|42
4883766|NCT00736853|16828787|P3|Open-Label Period|Withdrawal by Subject|0
4883767|NCT00736853|16828788|P2|Open-Label Period|Withdrawal by Subject|0
4883768|NCT00736853|16828789|P1|Open-Label Period|Withdrawal by Subject|16
4883769|NCT00736853|16828787|P3|Open-Label Period|Adverse Event|0
4883770|NCT00736853|16828788|P2|Open-Label Period|Adverse Event|0
4883771|NCT00736853|16828789|P1|Open-Label Period|Adverse Event|31
4883772|NCT00736853|16828787|P3|Open-Label Period|Physician Decision|0
4883773|NCT00736853|16828788|P2|Open-Label Period|Physician Decision|0
4883774|NCT00736853|16828789|P1|Open-Label Period|Physician Decision|2
4883775|NCT00736840|16828829|P1|Overall Study|Lost to Follow-up|13
4883776|NCT00736723|16828836|P2|Overall Study|Withdrawal by Subject|3
4883777|NCT00736723|16828837|P1|Overall Study|Withdrawal by Subject|4
4883778|NCT00736645|16828847|P4|Overall Study|Adverse Event|0
4883779|NCT00736645|16828848|P3|Overall Study|Adverse Event|0
4883780|NCT00736645|16828849|P2|Overall Study|Adverse Event|2
4883781|NCT00736645|16828850|P1|Overall Study|Adverse Event|0
4883782|NCT00736502|16828900|P1|Overall Study|Lost to Follow-up|27
4883783|NCT00736502|16828900|P1|Overall Study|Lack of Efficacy|16
4883784|NCT00736502|16828900|P1|Overall Study|Adverse Event|22
4883785|NCT00736489|16828906|P6|Period 1|Withdrawal by Subject|1
4883786|NCT00736489|16828907|P5|Period 1|Withdrawal by Subject|0
4883787|NCT00736489|16828908|P4|Period 1|Withdrawal by Subject|0
4883788|NCT00736489|16828909|P3|Period 1|Withdrawal by Subject|0
4883789|NCT00736489|16828910|P2|Period 1|Withdrawal by Subject|0
4883790|NCT00736489|16828911|P1|Period 1|Withdrawal by Subject|0
4883791|NCT00736489|16828906|P6|Period 1|Lost to Follow-up|0
4883792|NCT00736489|16828907|P5|Period 1|Lost to Follow-up|0
4883793|NCT00736489|16828908|P4|Period 1|Lost to Follow-up|0
4883794|NCT00736489|16828909|P3|Period 1|Lost to Follow-up|0
4883795|NCT00736489|16828910|P2|Period 1|Lost to Follow-up|0
4883796|NCT00736489|16828911|P1|Period 1|Lost to Follow-up|1
4883797|NCT00736476|16829065|P2|Overall Study|Adverse Event|0
4883798|NCT00736476|16829066|P1|Overall Study|Adverse Event|1
4883799|NCT00736450|16829086|P1|Overall Study|Physician Decision|1
4883800|NCT00736450|16829086|P1|Overall Study|Withdrawal by Subject|5
4883801|NCT00736450|16829086|P1|Overall Study|Not ABC gene eligible|19
4883802|NCT00736385|16829094|P2|Overall Study|Adverse Event|1
4883803|NCT00736385|16829095|P1|Overall Study|Adverse Event|0
4883804|NCT00736385|16829094|P2|Overall Study|Withdrawal by Subject|2
4883805|NCT00736385|16829095|P1|Overall Study|Withdrawal by Subject|2
4883806|NCT00736333|16829107|P1|Overall Study|Other|4
4883807|NCT00736333|16829107|P1|Overall Study|Death|7
4883808|NCT00736333|16829107|P1|Overall Study|Withdrawal by Subject|10
4883809|NCT00736333|16829107|P1|Overall Study|Toxicity|6
4883810|NCT00736333|16829107|P1|Overall Study|Tumor Progression|75
4883811|NCT00736333|16829107|P1|Overall Study|Data Missing|2
4883812|NCT00736333|16829107|P1|Overall Study|Did Not Receive Drug or Not Documented|7
4883813|NCT00736255|16829118|P2|Overall Study|Non-compliance|1
4883814|NCT00736255|16829119|P1|Overall Study|Non-compliance|1
4883815|NCT00736255|16829118|P2|Overall Study|Physician Decision|0
4883816|NCT00736255|16829119|P1|Overall Study|Physician Decision|1
4883817|NCT00736255|16829118|P2|Overall Study|Adverse Event|0
4883818|NCT00736255|16829119|P1|Overall Study|Adverse Event|1
4883819|NCT00736190|16829166|P1|Overall Study|Adverse Event|1
4883820|NCT00736190|16829166|P1|Overall Study|Withdrawal by Subject|1
4883821|NCT00736190|16829166|P1|Overall Study|Pregnancy|1
4883822|NCT00736099|16829196|P2|Overall Study|Other reason|10
4883823|NCT00736099|16829197|P1|Overall Study|Other reason|43
4883824|NCT00736099|16829196|P2|Overall Study|Lack of Efficacy|8
4883825|NCT00736099|16829197|P1|Overall Study|Lack of Efficacy|15
4883826|NCT00736099|16829196|P2|Overall Study|Withdrawal by Subject|13
4883827|NCT00736099|16829197|P1|Overall Study|Withdrawal by Subject|42
4883828|NCT00736099|16829196|P2|Overall Study|Lost to Follow-up|5
4883829|NCT00736099|16829197|P1|Overall Study|Lost to Follow-up|12
4883830|NCT00736099|16829196|P2|Overall Study|Protocol Violation|4
4883831|NCT00736099|16829197|P1|Overall Study|Protocol Violation|10
4883832|NCT00736099|16829196|P2|Overall Study|Adverse Event|18
4883833|NCT00736099|16829197|P1|Overall Study|Adverse Event|61
4883834|NCT00736034|16829306|P1|Overall Study|Adverse Event|2
4883835|NCT00735943|16829314|P1|Overall Study|Adverse Event|1
4883836|NCT00735943|16829314|P1|Overall Study|Lost to Follow-up|1
4883837|NCT00735904|16829339|P1|Overall Study|Other|8
4883838|NCT00735904|16829339|P1|Overall Study|Study Terminated by Sponsor|5
4883839|NCT00735904|16829339|P1|Overall Study|Withdrawal by Subject|1
4883840|NCT00735904|16829339|P1|Overall Study|Protocol Violation|1
4883841|NCT00735904|16829339|P1|Overall Study|Death|20
4883842|NCT00735904|16829339|P1|Overall Study|Adverse Event|3
4883843|NCT00735878|16829349|P3|Phase I- Dose Determination|Withdrawal by Subject|1
4883844|NCT00735878|16829350|P2|Phase I- Dose Determination|Withdrawal by Subject|0
4883845|NCT00735878|16829351|P1|Phase I- Dose Determination|Withdrawal by Subject|0
4883846|NCT00735709|16829430|P4|Overall Study|Excluded medication|1
4883847|NCT00735709|16829431|P3|Overall Study|Excluded medication|0
4883848|NCT00735709|16829432|P2|Overall Study|Excluded medication|0
4883849|NCT00735709|16829433|P1|Overall Study|Excluded medication|1
4883850|NCT00735709|16829430|P4|Overall Study|Lost to Follow-up|1
4883851|NCT00735709|16829431|P3|Overall Study|Lost to Follow-up|1
4883852|NCT00735709|16829432|P2|Overall Study|Lost to Follow-up|1
4883853|NCT00735709|16829433|P1|Overall Study|Lost to Follow-up|0
4883854|NCT00735709|16829430|P4|Overall Study|Voluntary Withdrawal|7
4883855|NCT00735709|16829431|P3|Overall Study|Voluntary Withdrawal|5
4883856|NCT00735709|16829432|P2|Overall Study|Voluntary Withdrawal|3
4883857|NCT00735709|16829433|P1|Overall Study|Voluntary Withdrawal|1
4883858|NCT00735709|16829430|P4|Overall Study|Protocol deviations|1
4883859|NCT00735709|16829431|P3|Overall Study|Protocol deviations|1
4883860|NCT00735709|16829432|P2|Overall Study|Protocol deviations|2
4883861|NCT00735709|16829433|P1|Overall Study|Protocol deviations|1
4883862|NCT00735709|16829430|P4|Overall Study|Noncompliance|0
4883863|NCT00735709|16829431|P3|Overall Study|Noncompliance|1
4883864|NCT00735709|16829432|P2|Overall Study|Noncompliance|0
4883865|NCT00735709|16829433|P1|Overall Study|Noncompliance|0
4883866|NCT00735709|16829430|P4|Overall Study|Lack of Efficacy|3
4883867|NCT00735709|16829431|P3|Overall Study|Lack of Efficacy|2
4883868|NCT00735709|16829432|P2|Overall Study|Lack of Efficacy|4
4883869|NCT00735709|16829433|P1|Overall Study|Lack of Efficacy|8
4883870|NCT00735709|16829430|P4|Overall Study|Adverse Event|5
4883871|NCT00735709|16829431|P3|Overall Study|Adverse Event|1
4883872|NCT00735709|16829432|P2|Overall Study|Adverse Event|3
4883873|NCT00735709|16829433|P1|Overall Study|Adverse Event|2
4883874|NCT00735696|16829543|P1|Overall Study|Enrolled but never Treated|1
4883875|NCT00735696|16829543|P1|Overall Study|Withdrawal by Subject|1
4883876|NCT00735644|16829571|P5|Overall Study|Withdrawal by Subject|0
4883877|NCT00735644|16829572|P4|Overall Study|Withdrawal by Subject|1
4883878|NCT00735644|16829573|P3|Overall Study|Withdrawal by Subject|1
4883879|NCT00735644|16829574|P2|Overall Study|Withdrawal by Subject|1
4883880|NCT00735644|16829575|P1|Overall Study|Withdrawal by Subject|0
4883881|NCT00735644|16829571|P5|Overall Study|Did not receive study vaccine|0
4883882|NCT00735644|16829572|P4|Overall Study|Did not receive study vaccine|0
4883883|NCT00735644|16829573|P3|Overall Study|Did not receive study vaccine|0
4883884|NCT00735644|16829574|P2|Overall Study|Did not receive study vaccine|1
4883885|NCT00735644|16829575|P1|Overall Study|Did not receive study vaccine|0
4883886|NCT00735553|16829619|P1|Overall Study|Study prematurely terminated|77
4883887|NCT00735475|16829629|P2|Overall Study|Withdrawal by Subject|5
4883888|NCT00735475|16829630|P1|Overall Study|Withdrawal by Subject|4
4883889|NCT00735475|16829629|P2|Overall Study|Physician Decision|1
4883890|NCT00735475|16829630|P1|Overall Study|Physician Decision|0
4883891|NCT00735475|16829629|P2|Overall Study|Lost to Follow-up|3
4883892|NCT00735475|16829630|P1|Overall Study|Lost to Follow-up|3
4883893|NCT00735475|16829629|P2|Overall Study|Death|1
4883894|NCT00735475|16829630|P1|Overall Study|Death|1
4883895|NCT00735475|16829629|P2|Overall Study|Adverse Event|1
4883896|NCT00735475|16829630|P1|Overall Study|Adverse Event|0
4883897|NCT00735397|16829690|P1|Overall Study|Administrative/Other|502
4883898|NCT00735397|16829690|P1|Overall Study|Inadequate therapeutic effect|202
4883899|NCT00735397|16829690|P1|Overall Study|Participant choice|252
4883900|NCT00735397|16829690|P1|Overall Study|Lost to Follow-up|33
4883901|NCT00735397|16829690|P1|Overall Study|Adverse Event|194
4883902|NCT00735371|16829704|P4|Overall Study|Exclusion criteria|0
4883903|NCT00735371|16829705|P3|Overall Study|Exclusion criteria|0
4883904|NCT00735371|16829706|P2|Overall Study|Exclusion criteria|0
4883905|NCT00735371|16829707|P1|Overall Study|Exclusion criteria|1
4883906|NCT00735371|16829704|P4|Overall Study|Prior Vyvanse Exposure|0
4883907|NCT00735371|16829705|P3|Overall Study|Prior Vyvanse Exposure|0
4883908|NCT00735371|16829706|P2|Overall Study|Prior Vyvanse Exposure|1
4883909|NCT00735371|16829707|P1|Overall Study|Prior Vyvanse Exposure|1
4883910|NCT00735371|16829704|P4|Overall Study|Protocol Violation|0
4883911|NCT00735371|16829705|P3|Overall Study|Protocol Violation|2
4883912|NCT00735371|16829706|P2|Overall Study|Protocol Violation|1
4883913|NCT00735371|16829707|P1|Overall Study|Protocol Violation|0
4883914|NCT00735371|16829704|P4|Overall Study|Sponsor Decision|1
4883915|NCT00735371|16829705|P3|Overall Study|Sponsor Decision|0
4883916|NCT00735371|16829706|P2|Overall Study|Sponsor Decision|1
4883917|NCT00735371|16829707|P1|Overall Study|Sponsor Decision|3
4883918|NCT00735371|16829704|P4|Overall Study|Lack of Efficacy|4
4883919|NCT00735371|16829705|P3|Overall Study|Lack of Efficacy|0
4883920|NCT00735371|16829706|P2|Overall Study|Lack of Efficacy|2
4883921|NCT00735371|16829707|P1|Overall Study|Lack of Efficacy|4
4883922|NCT00735371|16829704|P4|Overall Study|Lost to Follow-up|1
4883923|NCT00735371|16829705|P3|Overall Study|Lost to Follow-up|3
4883924|NCT00735371|16829706|P2|Overall Study|Lost to Follow-up|1
4883925|NCT00735371|16829707|P1|Overall Study|Lost to Follow-up|1
4883926|NCT00735371|16829704|P4|Overall Study|Withdrawal by Subject|0
4883927|NCT00735371|16829705|P3|Overall Study|Withdrawal by Subject|2
4883928|NCT00735371|16829706|P2|Overall Study|Withdrawal by Subject|2
4883929|NCT00735371|16829707|P1|Overall Study|Withdrawal by Subject|0
4883930|NCT00735371|16829704|P4|Overall Study|Protocol Violation|3
4883931|NCT00735371|16829705|P3|Overall Study|Protocol Violation|0
4883932|NCT00735371|16829706|P2|Overall Study|Protocol Violation|2
4883933|NCT00735371|16829707|P1|Overall Study|Protocol Violation|2
4883934|NCT00735371|16829704|P4|Overall Study|Adverse Event|1
4883935|NCT00735371|16829705|P3|Overall Study|Adverse Event|4
4883936|NCT00735371|16829706|P2|Overall Study|Adverse Event|3
4883937|NCT00735371|16829707|P1|Overall Study|Adverse Event|3
4883938|NCT00735254|16829735|P4|Overall Study|Protocol Violation|0
4883939|NCT00735254|16829736|P3|Overall Study|Protocol Violation|1
4883940|NCT00735254|16829737|P2|Overall Study|Protocol Violation|1
4883941|NCT00735254|16829738|P1|Overall Study|Protocol Violation|1
4883942|NCT00735072|16829750|P2|Overall Study|Subject interrupted ARVs (non-adherence)|1
4883943|NCT00735072|16829751|P1|Overall Study|Subject interrupted ARVs (non-adherence)|0
4883944|NCT00735072|16829750|P2|Overall Study|interrupted study med during ARV change|0
4883945|NCT00735072|16829751|P1|Overall Study|interrupted study med during ARV change|1
4883946|NCT00735007|16829765|P1|Overall Study|Protocol Violation|1
4883947|NCT00735007|16829765|P1|Overall Study|Adverse Event|4
4883948|NCT00734994|16829790|P1|Overall Study|Withdrawal by Subject|1
4883949|NCT00734929|16829810|P2|Overall Study|No intervention/ screen fail|3
4883950|NCT00734929|16829811|P1|Overall Study|No intervention/ screen fail|5
4883951|NCT00734929|16829810|P2|Overall Study|Lost to Follow-up|2
4883952|NCT00734929|16829811|P1|Overall Study|Lost to Follow-up|1
4883953|NCT00734851|16829868|P1|Overall Study|Physician Decision|18
4883954|NCT00734851|16829868|P1|Overall Study|Lost to Follow-up|1
4883955|NCT00734851|16829868|P1|Overall Study|Withdrawal by Subject|2
4883956|NCT00734747|16829889|P1|6 Month Follow-up|Did not meet inclusion criteria|3
4883957|NCT00734747|16829889|P1|SRS Procedure|No staples placed|3
4883958|NCT00734656|16829903|P4|Lab Session 4|Withdrawal by Subject|1
4883959|NCT00734656|16829904|P3|Lab Session 4|Withdrawal by Subject|0
4883960|NCT00734656|16829905|P2|Lab Session 4|Withdrawal by Subject|0
4883961|NCT00734656|16829906|P1|Lab Session 4|Withdrawal by Subject|0
4883962|NCT00734656|16829903|P4|Washout 3|Withdrawal by Subject|1
4883963|NCT00734656|16829904|P3|Washout 3|Withdrawal by Subject|0
4883964|NCT00734656|16829905|P2|Washout 3|Withdrawal by Subject|0
4883965|NCT00734656|16829906|P1|Washout 3|Withdrawal by Subject|1
4883966|NCT00734656|16829903|P4|Washout 2|Withdrawal by Subject|0
4883967|NCT00734656|16829904|P3|Washout 2|Withdrawal by Subject|1
4883968|NCT00734656|16829905|P2|Washout 2|Withdrawal by Subject|1
4883969|NCT00734656|16829906|P1|Washout 2|Withdrawal by Subject|1
4883970|NCT00734656|16829903|P4|Lab Session 2|Withdrawal by Subject|1
4883971|NCT00734656|16829904|P3|Lab Session 2|Withdrawal by Subject|0
4883972|NCT00734656|16829905|P2|Lab Session 2|Withdrawal by Subject|0
4883973|NCT00734656|16829906|P1|Lab Session 2|Withdrawal by Subject|1
4883974|NCT00734656|16829903|P4|Washout 1|Withdrawal by Subject|3
4883975|NCT00734656|16829904|P3|Washout 1|Withdrawal by Subject|2
4883976|NCT00734656|16829905|P2|Washout 1|Withdrawal by Subject|5
4883977|NCT00734656|16829906|P1|Washout 1|Withdrawal by Subject|1
4883978|NCT00734656|16829903|P4|Lab Session 1|Withdrawal by Subject|0
4883979|NCT00734656|16829904|P3|Lab Session 1|Withdrawal by Subject|0
4883980|NCT00734656|16829905|P2|Lab Session 1|Withdrawal by Subject|0
4883981|NCT00734656|16829906|P1|Lab Session 1|Withdrawal by Subject|2
4883982|NCT00734630|16829930|P2|Overall Study|Poor Compliance|1
4883983|NCT00734630|16829931|P1|Overall Study|Poor Compliance|1
4883984|NCT00734630|16829930|P2|Overall Study|Tested Positive for Illegal Drug Use|1
4883985|NCT00734630|16829931|P1|Overall Study|Tested Positive for Illegal Drug Use|1
4883986|NCT00734630|16829930|P2|Overall Study|Randomized in Error|1
4883987|NCT00734630|16829931|P1|Overall Study|Randomized in Error|0
4883988|NCT00734630|16829930|P2|Overall Study|Adverse Event|6
4883989|NCT00734630|16829931|P1|Overall Study|Adverse Event|3
4883990|NCT00734630|16829930|P2|Overall Study|Inclusion/Exclusion criteria not met|1
4883991|NCT00734630|16829931|P1|Overall Study|Inclusion/Exclusion criteria not met|0
4883992|NCT00734630|16829930|P2|Overall Study|Protocol Violation|3
4883993|NCT00734630|16829931|P1|Overall Study|Protocol Violation|0
4883994|NCT00734630|16829930|P2|Overall Study|Lost to Follow-up|7
4883995|NCT00734630|16829931|P1|Overall Study|Lost to Follow-up|13
4883996|NCT00734630|16829930|P2|Overall Study|Withdrawal by Subject|9
4883997|NCT00734630|16829931|P1|Overall Study|Withdrawal by Subject|7
4883998|NCT00734630|16829930|P2|Overall Study|Lack of Efficacy|4
4883999|NCT00734630|16829931|P1|Overall Study|Lack of Efficacy|4
4884000|NCT00734617|16829941|P2|Overall Study|Withdrawal by Subject|95
4884001|NCT00734617|16829942|P1|Overall Study|Withdrawal by Subject|103
4884002|NCT00734617|16829941|P2|Overall Study|Adverse Event|7
4884003|NCT00734617|16829942|P1|Overall Study|Adverse Event|4
4884004|NCT00734604|16829954|P6|Overall Study|Lack of Efficacy|0
4884005|NCT00734604|16829955|P5|Overall Study|Lack of Efficacy|0
4884006|NCT00734604|16829956|P4|Overall Study|Lack of Efficacy|0
4884007|NCT00734604|16829957|P3|Overall Study|Lack of Efficacy|1
4884008|NCT00734604|16829958|P2|Overall Study|Lack of Efficacy|1
4884009|NCT00734604|16829959|P1|Overall Study|Lack of Efficacy|0
4884010|NCT00734604|16829954|P6|Overall Study|Withdrawal by Subject|1
4884011|NCT00734604|16829955|P5|Overall Study|Withdrawal by Subject|2
4884012|NCT00734604|16829956|P4|Overall Study|Withdrawal by Subject|1
4884013|NCT00734604|16829957|P3|Overall Study|Withdrawal by Subject|0
4884014|NCT00734604|16829958|P2|Overall Study|Withdrawal by Subject|2
4884015|NCT00734604|16829959|P1|Overall Study|Withdrawal by Subject|0
4884016|NCT00734604|16829954|P6|Overall Study|Sponsor Decision|0
4884017|NCT00734604|16829955|P5|Overall Study|Sponsor Decision|2
4884018|NCT00734604|16829956|P4|Overall Study|Sponsor Decision|0
4884019|NCT00734604|16829957|P3|Overall Study|Sponsor Decision|1
4884020|NCT00734604|16829958|P2|Overall Study|Sponsor Decision|2
4884021|NCT00734604|16829959|P1|Overall Study|Sponsor Decision|1
4884022|NCT00734604|16829954|P6|Overall Study|Protocol Violation|0
4884023|NCT00734604|16829955|P5|Overall Study|Protocol Violation|1
4884024|NCT00734604|16829956|P4|Overall Study|Protocol Violation|0
4884025|NCT00734604|16829957|P3|Overall Study|Protocol Violation|0
4884026|NCT00734604|16829958|P2|Overall Study|Protocol Violation|2
4884027|NCT00734604|16829959|P1|Overall Study|Protocol Violation|0
4884028|NCT00734604|16829954|P6|Overall Study|Physician Decision|0
4884029|NCT00734604|16829955|P5|Overall Study|Physician Decision|0
4884030|NCT00734604|16829956|P4|Overall Study|Physician Decision|0
4884031|NCT00734604|16829957|P3|Overall Study|Physician Decision|1
4884032|NCT00734604|16829958|P2|Overall Study|Physician Decision|1
4884033|NCT00734604|16829959|P1|Overall Study|Physician Decision|0
4884034|NCT00734604|16829954|P6|Overall Study|Lost to Follow-up|3
4884035|NCT00734604|16829955|P5|Overall Study|Lost to Follow-up|2
4884036|NCT00734604|16829956|P4|Overall Study|Lost to Follow-up|4
4884037|NCT00734604|16829957|P3|Overall Study|Lost to Follow-up|2
4884038|NCT00734604|16829958|P2|Overall Study|Lost to Follow-up|2
4884039|NCT00734604|16829959|P1|Overall Study|Lost to Follow-up|1
4884040|NCT00734604|16829954|P6|Overall Study|Serious Adverse Event|1
4884041|NCT00734604|16829955|P5|Overall Study|Serious Adverse Event|0
4884042|NCT00734604|16829956|P4|Overall Study|Serious Adverse Event|2
4884043|NCT00734604|16829957|P3|Overall Study|Serious Adverse Event|1
4884044|NCT00734604|16829958|P2|Overall Study|Serious Adverse Event|0
4884045|NCT00734604|16829959|P1|Overall Study|Serious Adverse Event|1
4884046|NCT00734604|16829954|P6|Overall Study|Adverse Event|1
4884047|NCT00734604|16829955|P5|Overall Study|Adverse Event|1
4884048|NCT00734604|16829956|P4|Overall Study|Adverse Event|2
4884049|NCT00734604|16829957|P3|Overall Study|Adverse Event|0
4884050|NCT00734604|16829958|P2|Overall Study|Adverse Event|2
4884051|NCT00734604|16829959|P1|Overall Study|Adverse Event|0
4884052|NCT00734591|16830009|P2|Prospective Period|Other|2
4884053|NCT00734591|16830010|P1|Prospective Period|Other|2
4884054|NCT00734591|16830009|P2|Prospective Period|Study Terminated|0
4884055|NCT00734591|16830010|P1|Prospective Period|Study Terminated|1
4884056|NCT00734591|16830009|P2|Prospective Period|Lost to Follow-up|33
4884057|NCT00734591|16830010|P1|Prospective Period|Lost to Follow-up|37
4884058|NCT00734591|16830009|P2|Prospective Period|Withdrawal by Subject|9
4884059|NCT00734591|16830010|P1|Prospective Period|Withdrawal by Subject|11
4884060|NCT00734591|16830009|P2|Screening for Prospective Period|Patient at partic. site not enrolled|803
4884061|NCT00734591|16830010|P1|Screening for Prospective Period|Patient at partic. site not enrolled|913
4884062|NCT00734591|16830009|P2|Screening for Prospective Period|Site did not participate|1488
4884063|NCT00734591|16830010|P1|Screening for Prospective Period|Site did not participate|1604
4884064|NCT00734578|16830025|P3|Overall Study|Exclusion criteria|0
4884065|NCT00734578|16830026|P2|Overall Study|Exclusion criteria|0
4884066|NCT00734578|16830027|P1|Overall Study|Exclusion criteria|1
4884067|NCT00734578|16830025|P3|Overall Study|Randomized in error|0
4884068|NCT00734578|16830026|P2|Overall Study|Randomized in error|0
4884069|NCT00734578|16830027|P1|Overall Study|Randomized in error|1
4884070|NCT00734578|16830025|P3|Overall Study|Lack of Efficacy|5
4884071|NCT00734578|16830026|P2|Overall Study|Lack of Efficacy|2
4884072|NCT00734578|16830027|P1|Overall Study|Lack of Efficacy|3
4884073|NCT00734578|16830025|P3|Overall Study|Lost to Follow-up|5
4884074|NCT00734578|16830026|P2|Overall Study|Lost to Follow-up|3
4884075|NCT00734578|16830027|P1|Overall Study|Lost to Follow-up|9
4884076|NCT00734578|16830025|P3|Overall Study|Withdrawal by Subject|11
4884077|NCT00734578|16830026|P2|Overall Study|Withdrawal by Subject|8
4884078|NCT00734578|16830027|P1|Overall Study|Withdrawal by Subject|7
4884079|NCT00734578|16830025|P3|Overall Study|Protocol Violation|3
4884080|NCT00734578|16830026|P2|Overall Study|Protocol Violation|6
4884081|NCT00734578|16830027|P1|Overall Study|Protocol Violation|8
4884082|NCT00734578|16830025|P3|Overall Study|Adverse Event|1
4884083|NCT00734578|16830026|P2|Overall Study|Adverse Event|6
4884084|NCT00734578|16830027|P1|Overall Study|Adverse Event|4
4884085|NCT00734539|16830061|P2|Main Study|Enrolled in error; ineligible|0
4884086|NCT00734539|16830062|P1|Main Study|Enrolled in error; ineligible|1
4884087|NCT00734539|16830061|P2|Main Study|Withdrawal by Subject|3
4884088|NCT00734539|16830062|P1|Main Study|Withdrawal by Subject|1
4884089|NCT00734539|16830061|P2|Main Study|Physician Decision|0
4884090|NCT00734539|16830062|P1|Main Study|Physician Decision|2
4884091|NCT00734539|16830061|P2|Main Study|Death|32
4884092|NCT00734539|16830062|P1|Main Study|Death|33
4884093|NCT00734474|16830104|P9|Overall Study|Lack of Efficacy|6
4884094|NCT00734474|16830105|P8|Overall Study|Lack of Efficacy|4
4884095|NCT00734474|16830106|P7|Overall Study|Lack of Efficacy|0
4884096|NCT00734474|16830107|P6|Overall Study|Lack of Efficacy|0
4884097|NCT00734474|16830108|P5|Overall Study|Lack of Efficacy|0
4884098|NCT00734474|16830109|P4|Overall Study|Lack of Efficacy|0
4884099|NCT00734474|16830110|P3|Overall Study|Lack of Efficacy|4
4884100|NCT00734474|16830111|P2|Overall Study|Lack of Efficacy|0
4884101|NCT00734474|16830112|P1|Overall Study|Lack of Efficacy|0
4884102|NCT00734474|16830104|P9|Overall Study|Death|1
4884103|NCT00734474|16830105|P8|Overall Study|Death|2
4884104|NCT00734474|16830106|P7|Overall Study|Death|0
4884105|NCT00734474|16830107|P6|Overall Study|Death|0
4884106|NCT00734474|16830108|P5|Overall Study|Death|0
4884107|NCT00734474|16830109|P4|Overall Study|Death|0
4884108|NCT00734474|16830110|P3|Overall Study|Death|1
4884109|NCT00734474|16830111|P2|Overall Study|Death|0
4884110|NCT00734474|16830112|P1|Overall Study|Death|0
4884111|NCT00734474|16830104|P9|Overall Study|Sponsor Decision|0
4884112|NCT00734474|16830105|P8|Overall Study|Sponsor Decision|0
4884113|NCT00734474|16830106|P7|Overall Study|Sponsor Decision|0
4884114|NCT00734474|16830107|P6|Overall Study|Sponsor Decision|0
4884115|NCT00734474|16830108|P5|Overall Study|Sponsor Decision|2
4884116|NCT00734474|16830109|P4|Overall Study|Sponsor Decision|0
4884117|NCT00734474|16830110|P3|Overall Study|Sponsor Decision|0
4884118|NCT00734474|16830111|P2|Overall Study|Sponsor Decision|0
4884119|NCT00734474|16830112|P1|Overall Study|Sponsor Decision|0
4884120|NCT00734474|16830104|P9|Overall Study|Sponsor Decision, Arm Discontinued|0
4884121|NCT00734474|16830105|P8|Overall Study|Sponsor Decision, Arm Discontinued|0
4884122|NCT00734474|16830106|P7|Overall Study|Sponsor Decision, Arm Discontinued|23
4884123|NCT00734474|16830107|P6|Overall Study|Sponsor Decision, Arm Discontinued|21
4884124|NCT00734474|16830108|P5|Overall Study|Sponsor Decision, Arm Discontinued|0
4884125|NCT00734474|16830109|P4|Overall Study|Sponsor Decision, Arm Discontinued|8
4884126|NCT00734474|16830110|P3|Overall Study|Sponsor Decision, Arm Discontinued|0
4884127|NCT00734474|16830111|P2|Overall Study|Sponsor Decision, Arm Discontinued|25
4884128|NCT00734474|16830112|P1|Overall Study|Sponsor Decision, Arm Discontinued|8
4884129|NCT00734474|16830104|P9|Overall Study|Protocol Violation|1
4884130|NCT00734474|16830105|P8|Overall Study|Protocol Violation|3
4884131|NCT00734474|16830106|P7|Overall Study|Protocol Violation|0
4884132|NCT00734474|16830107|P6|Overall Study|Protocol Violation|0
4884133|NCT00734474|16830108|P5|Overall Study|Protocol Violation|3
4884134|NCT00734474|16830109|P4|Overall Study|Protocol Violation|0
4884135|NCT00734474|16830110|P3|Overall Study|Protocol Violation|4
4884136|NCT00734474|16830111|P2|Overall Study|Protocol Violation|0
4884137|NCT00734474|16830112|P1|Overall Study|Protocol Violation|0
4884138|NCT00734474|16830104|P9|Overall Study|Adverse Event|39
4884139|NCT00734474|16830105|P8|Overall Study|Adverse Event|65
4884140|NCT00734474|16830106|P7|Overall Study|Adverse Event|1
4884141|NCT00734474|16830107|P6|Overall Study|Adverse Event|0
4884142|NCT00734474|16830108|P5|Overall Study|Adverse Event|64
4884143|NCT00734474|16830109|P4|Overall Study|Adverse Event|1
4884144|NCT00734474|16830110|P3|Overall Study|Adverse Event|63
4884145|NCT00734474|16830111|P2|Overall Study|Adverse Event|4
4884146|NCT00734474|16830112|P1|Overall Study|Adverse Event|4
4884147|NCT00734474|16830104|P9|Overall Study|Physician Decision|9
4884148|NCT00734474|16830105|P8|Overall Study|Physician Decision|9
4884149|NCT00734474|16830106|P7|Overall Study|Physician Decision|0
4884150|NCT00734474|16830107|P6|Overall Study|Physician Decision|0
4884151|NCT00734474|16830108|P5|Overall Study|Physician Decision|11
4884152|NCT00734474|16830109|P4|Overall Study|Physician Decision|1
4884153|NCT00734474|16830110|P3|Overall Study|Physician Decision|4
4884154|NCT00734474|16830111|P2|Overall Study|Physician Decision|0
4884155|NCT00734474|16830112|P1|Overall Study|Physician Decision|0
4884156|NCT00734474|16830104|P9|Overall Study|Withdrawal by Subject|21
4884157|NCT00734474|16830105|P8|Overall Study|Withdrawal by Subject|36
4884158|NCT00734474|16830106|P7|Overall Study|Withdrawal by Subject|0
4884159|NCT00734474|16830107|P6|Overall Study|Withdrawal by Subject|2
4884160|NCT00734474|16830108|P5|Overall Study|Withdrawal by Subject|24
4884161|NCT00734474|16830109|P4|Overall Study|Withdrawal by Subject|0
4884162|NCT00734474|16830110|P3|Overall Study|Withdrawal by Subject|18
4884163|NCT00734474|16830111|P2|Overall Study|Withdrawal by Subject|1
4884164|NCT00734474|16830112|P1|Overall Study|Withdrawal by Subject|2
4884165|NCT00734474|16830104|P9|Overall Study|Lost to Follow-up|4
4884166|NCT00734474|16830105|P8|Overall Study|Lost to Follow-up|9
4884167|NCT00734474|16830106|P7|Overall Study|Lost to Follow-up|0
4884168|NCT00734474|16830107|P6|Overall Study|Lost to Follow-up|1
4884169|NCT00734474|16830108|P5|Overall Study|Lost to Follow-up|11
4884170|NCT00734474|16830109|P4|Overall Study|Lost to Follow-up|0
4884171|NCT00734474|16830110|P3|Overall Study|Lost to Follow-up|13
4884172|NCT00734474|16830111|P2|Overall Study|Lost to Follow-up|0
4884173|NCT00734474|16830112|P1|Overall Study|Lost to Follow-up|1
4884174|NCT00734474|16830104|P9|Overall Study|Entry Criteria Not Met|1
4884175|NCT00734474|16830105|P8|Overall Study|Entry Criteria Not Met|1
4884176|NCT00734474|16830106|P7|Overall Study|Entry Criteria Not Met|0
4884177|NCT00734474|16830107|P6|Overall Study|Entry Criteria Not Met|1
4884178|NCT00734474|16830108|P5|Overall Study|Entry Criteria Not Met|3
4884179|NCT00734474|16830109|P4|Overall Study|Entry Criteria Not Met|0
4884180|NCT00734474|16830110|P3|Overall Study|Entry Criteria Not Met|5
4884181|NCT00734474|16830111|P2|Overall Study|Entry Criteria Not Met|0
4884182|NCT00734474|16830112|P1|Overall Study|Entry Criteria Not Met|0
4884183|NCT00734214|16830402|P2|Overall Study|MD withdrawal|0
4884184|NCT00734214|16830403|P1|Overall Study|MD withdrawal|1
4884185|NCT00734214|16830402|P2|Overall Study|Withdrawal by Subject|4
4884186|NCT00734214|16830403|P1|Overall Study|Withdrawal by Subject|3
4884187|NCT00734162|16830413|P4|Open-Label Phase|Did Not Meet Entrance Criteria|1
4884188|NCT00734162|16830414|P3|Open-Label Phase|Did Not Meet Entrance Criteria|0
4884189|NCT00734162|16830415|P2|Open-Label Phase|Did Not Meet Entrance Criteria|0
4884190|NCT00734162|16830416|P1|Open-Label Phase|Did Not Meet Entrance Criteria|0
4884191|NCT00734162|16830413|P4|Open-Label Phase|Lost to Follow-up|1
4884192|NCT00734162|16830414|P3|Open-Label Phase|Lost to Follow-up|0
4884193|NCT00734162|16830415|P2|Open-Label Phase|Lost to Follow-up|2
4884194|NCT00734162|16830416|P1|Open-Label Phase|Lost to Follow-up|1
4884195|NCT00734162|16830413|P4|Open-Label Phase|Withdrew Consent|1
4884196|NCT00734162|16830414|P3|Open-Label Phase|Withdrew Consent|1
4884197|NCT00734162|16830415|P2|Open-Label Phase|Withdrew Consent|0
4884198|NCT00734162|16830416|P1|Open-Label Phase|Withdrew Consent|1
4884199|NCT00734162|16830413|P4|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
4884200|NCT00734162|16830414|P3|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
4884201|NCT00734162|16830415|P2|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0
4884202|NCT00734162|16830416|P1|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1
4884203|NCT00734162|16830413|P4|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2
4884204|NCT00734162|16830414|P3|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
4884205|NCT00734162|16830415|P2|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
4884206|NCT00734162|16830416|P1|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0
4884207|NCT00734162|16830413|P4|Randomized Phase (Through Week 72)|Investigator's Discretion|2
4884208|NCT00734162|16830414|P3|Randomized Phase (Through Week 72)|Investigator's Discretion|0
4884209|NCT00734162|16830415|P2|Randomized Phase (Through Week 72)|Investigator's Discretion|1
4884210|NCT00734162|16830416|P1|Randomized Phase (Through Week 72)|Investigator's Discretion|0
4884211|NCT00734149|16830640|P1|Overall Study|Withdrawal by Subject|1
4884212|NCT00734097|16830647|P1|Open Label|Protocol Violation|4
4884213|NCT00734097|16830647|P1|Open Label|Withdrawal by Subject|5
4884214|NCT00734097|16830647|P1|Open Label|Lost to Follow-up|7
4884215|NCT00734097|16830647|P1|Screening|Unconfirmed pregnancy|1
4884216|NCT00734097|16830647|P1|Screening|Lost to Follow-up|2
4884217|NCT00734097|16830647|P1|Screening|Withdrawal by Subject|5
4884218|NCT00734097|16830647|P1|Screening|Protocol Violation|12
4884219|NCT00734071|16830664|P2|Overall Study|Other|2
4884220|NCT00734071|16830665|P1|Overall Study|Other|1
4884221|NCT00734071|16830664|P2|Overall Study|Lost to Follow-up|8
4884222|NCT00734071|16830665|P1|Overall Study|Lost to Follow-up|16
4884223|NCT00734071|16830664|P2|Overall Study|Voluntary Withdrawal|7
4884224|NCT00734071|16830665|P1|Overall Study|Voluntary Withdrawal|9
4884225|NCT00734071|16830664|P2|Overall Study|Protocol Deviations|4
4884226|NCT00734071|16830665|P1|Overall Study|Protocol Deviations|3
4884227|NCT00734071|16830664|P2|Overall Study|Noncompliance|2
4884228|NCT00734071|16830665|P1|Overall Study|Noncompliance|2
4884229|NCT00734071|16830664|P2|Overall Study|Lack of Efficacy|1
4884230|NCT00734071|16830665|P1|Overall Study|Lack of Efficacy|3
4884231|NCT00734071|16830664|P2|Overall Study|Adverse Event|3
4884232|NCT00734071|16830665|P1|Overall Study|Adverse Event|4
4884233|NCT00734032|16830723|P4|Overall Study|Adverse Event|0
4884234|NCT00734032|16830724|P3|Overall Study|Adverse Event|0
4884235|NCT00734032|16830725|P2|Overall Study|Adverse Event|1
4884236|NCT00734032|16830726|P1|Overall Study|Adverse Event|0
4884237|NCT00733980|16830782|P2|Overall Study|Withdrawal by Subject|2
4884238|NCT00733980|16830783|P1|Overall Study|Withdrawal by Subject|6
4884239|NCT00733980|16830782|P2|Overall Study|Physician Decision|3
4884240|NCT00733980|16830783|P1|Overall Study|Physician Decision|2
4884241|NCT00733980|16830782|P2|Overall Study|Lost to Follow-up|11
4884242|NCT00733980|16830783|P1|Overall Study|Lost to Follow-up|6
4884243|NCT00733980|16830782|P2|Overall Study|Protocol defined stopping criteria reach|1
4884244|NCT00733980|16830783|P1|Overall Study|Protocol defined stopping criteria reach|1
4884245|NCT00733980|16830782|P2|Overall Study|Protocol Violation|1
4884246|NCT00733980|16830783|P1|Overall Study|Protocol Violation|2
4884247|NCT00733980|16830782|P2|Overall Study|Lack of Efficacy|1
4884248|NCT00733980|16830783|P1|Overall Study|Lack of Efficacy|0
4884249|NCT00733980|16830782|P2|Overall Study|Adverse Event|2
4884250|NCT00733980|16830783|P1|Overall Study|Adverse Event|5
4884251|NCT00733954|16830827|P2|Overall Study|Withdrawal by Subject|0
4884252|NCT00733954|16830828|P1|Overall Study|Withdrawal by Subject|2
4884253|NCT00733954|16830827|P2|Overall Study|Protocol Violation|0
4884254|NCT00733954|16830828|P1|Overall Study|Protocol Violation|1
4884255|NCT00733954|16830827|P2|Overall Study|Lost to Follow-up|2
4884256|NCT00733954|16830828|P1|Overall Study|Lost to Follow-up|5
4884257|NCT00733824|16830875|P5|Phase I|Withdrawal by Subject|0
4884258|NCT00733824|16830876|P4|Phase I|Withdrawal by Subject|0
4884259|NCT00733824|16830877|P3|Phase I|Withdrawal by Subject|0
4884260|NCT00733824|16830878|P2|Phase I|Withdrawal by Subject|0
4884261|NCT00733824|16830879|P1|Phase I|Withdrawal by Subject|1
4884262|NCT00733746|16830898|P1|Overall Study|Ineligible|5
4884263|NCT00733499|16830913|P2|10 Year Followup|missing, unable to locate|2
4884264|NCT00733499|16830914|P1|10 Year Followup|missing, unable to locate|0
4884265|NCT00733499|16830913|P2|10 Year Followup|Withdrawal by Subject|5
4884266|NCT00733499|16830914|P1|10 Year Followup|Withdrawal by Subject|5
4884267|NCT00733499|16830913|P2|10 Year Followup|Lost to Follow-up|2
4884268|NCT00733499|16830914|P1|10 Year Followup|Lost to Follow-up|3
4884269|NCT00733499|16830913|P2|10 Year Followup|Adverse Event|3
4884270|NCT00733499|16830914|P1|10 Year Followup|Adverse Event|3
4884271|NCT00733499|16830913|P2|10 Year Followup|Death|7
4884272|NCT00733499|16830914|P1|10 Year Followup|Death|9
4884273|NCT00733499|16830913|P2|5 Year Followup|Withdrawal by Subject|1
4884274|NCT00733499|16830914|P1|5 Year Followup|Withdrawal by Subject|4
4884275|NCT00733499|16830913|P2|5 Year Followup|missing, unable to locate|1
4884276|NCT00733499|16830914|P1|5 Year Followup|missing, unable to locate|0
4884277|NCT00733499|16830913|P2|5 Year Followup|Death|19
4884278|NCT00733499|16830914|P1|5 Year Followup|Death|13
4884279|NCT00733499|16830913|P2|5 Year Followup|Lost to Follow-up|0
4884280|NCT00733499|16830914|P1|5 Year Followup|Lost to Follow-up|2
4884281|NCT00733499|16830913|P2|5 Year Followup|Revision of Study Implant|1
4884282|NCT00733499|16830914|P1|5 Year Followup|Revision of Study Implant|0
4884283|NCT00733499|16830913|P2|5 Year Followup|Non device related AE|1
4884284|NCT00733499|16830914|P1|5 Year Followup|Non device related AE|0
4884285|NCT00733499|16830913|P2|5 Year Followup|Adverse Event|2
4884286|NCT00733499|16830914|P1|5 Year Followup|Adverse Event|2
4884287|NCT00733499|16830913|P2|24 Months Follow-up|Death|1
4884288|NCT00733499|16830914|P1|24 Months Follow-up|Death|0
4884289|NCT00733499|16830913|P2|12 Months Follow-up|Death|1
4884290|NCT00733499|16830914|P1|12 Months Follow-up|Death|2
4884291|NCT00733499|16830913|P2|6 Months Follow-up|Adverse Event|1
4884292|NCT00733499|16830914|P1|6 Months Follow-up|Adverse Event|0
4884293|NCT00733499|16830913|P2|6 Months Follow-up|Death|2
4884294|NCT00733499|16830914|P1|6 Months Follow-up|Death|0
4884295|NCT00733499|16830913|P2|3 Months Follow-up|Death|2
4884296|NCT00733499|16830914|P1|3 Months Follow-up|Death|1
4884297|NCT00733499|16830913|P2|Pre-operative|Protocol Violation|1
4884298|NCT00733499|16830914|P1|Pre-operative|Protocol Violation|0
4884299|NCT00733421|16830974|P2|Overall Study|Withdrawal by Subject|1
4884300|NCT00733421|16830975|P1|Overall Study|Withdrawal by Subject|1
4884301|NCT00733408|16830997|P1|Overall Study|Adverse Event|4
4884302|NCT00733369|16831009|P2|Overall Study|Protocol Violation|4
4884303|NCT00733369|16831010|P1|Overall Study|Protocol Violation|4
4884304|NCT00733369|16831009|P2|Overall Study|Adverse Event|4
4884305|NCT00733369|16831010|P1|Overall Study|Adverse Event|4
4884306|NCT00733369|16831009|P2|Overall Study|Lost to Follow-up|1
4884307|NCT00733369|16831010|P1|Overall Study|Lost to Follow-up|2
4884308|NCT00733304|16831309|P3|Overall Study|Withdrawal by Subject|0
4884309|NCT00733304|16831310|P2|Overall Study|Withdrawal by Subject|1
4884310|NCT00733304|16831311|P1|Overall Study|Withdrawal by Subject|1
4884311|NCT00733304|16831309|P3|Overall Study|Physician Decision|3
4884312|NCT00733304|16831310|P2|Overall Study|Physician Decision|1
4884313|NCT00733304|16831311|P1|Overall Study|Physician Decision|3
4884314|NCT00733304|16831309|P3|Overall Study|Lost to Follow-up|0
4884315|NCT00733304|16831310|P2|Overall Study|Lost to Follow-up|1
4884316|NCT00733304|16831311|P1|Overall Study|Lost to Follow-up|0
4884317|NCT00733304|16831309|P3|Overall Study|Lack of Efficacy|2
4884318|NCT00733304|16831310|P2|Overall Study|Lack of Efficacy|0
4884319|NCT00733304|16831311|P1|Overall Study|Lack of Efficacy|0
4884320|NCT00733304|16831309|P3|Overall Study|Adverse Event|0
4884321|NCT00733304|16831310|P2|Overall Study|Adverse Event|0
4884322|NCT00733304|16831311|P1|Overall Study|Adverse Event|3
4884323|NCT00733291|16831393|P4|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
4884324|NCT00733291|16831394|P3|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
4884325|NCT00733291|16831395|P2|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0
4884326|NCT00733291|16831396|P1|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1
4884327|NCT00733226|16831425|P2|Overall Study|moved to another place|0
4884328|NCT00733226|16831426|P1|Overall Study|moved to another place|2
4884329|NCT00733226|16831425|P2|Overall Study|Lost to Follow-up|0
4884330|NCT00733226|16831426|P1|Overall Study|Lost to Follow-up|2
4884331|NCT00733226|16831425|P2|Overall Study|Withdrawal by Subject|0
4884332|NCT00733226|16831426|P1|Overall Study|Withdrawal by Subject|1
4884333|NCT00733005|16831475|P2|Overall Study|Protocol Violation|0
4884334|NCT00733005|16831476|P1|Overall Study|Protocol Violation|2
4884335|NCT00733005|16831475|P2|Overall Study|Withdrawal by Subject|1
4884336|NCT00733005|16831476|P1|Overall Study|Withdrawal by Subject|0
4884337|NCT00733005|16831475|P2|Overall Study|Treatment Failure|1
4884338|NCT00733005|16831476|P1|Overall Study|Treatment Failure|0
4884339|NCT00733005|16831475|P2|Overall Study|Adverse Event|1
4884340|NCT00733005|16831476|P1|Overall Study|Adverse Event|0
4884341|NCT00732992|16831486|P2|Overall Study|Withdrawal by Subject|0
4884342|NCT00732992|16831487|P1|Overall Study|Withdrawal by Subject|1
4884343|NCT00732992|16831486|P2|Overall Study|Global Deterioration of Health Status|0
4884344|NCT00732992|16831487|P1|Overall Study|Global Deterioration of Health Status|1
4884345|NCT00732992|16831486|P2|Overall Study|Objective Progression or Relapse|5
4884346|NCT00732992|16831487|P1|Overall Study|Objective Progression or Relapse|3
4884347|NCT00732992|16831486|P2|Overall Study|Adverse Event|1
4884348|NCT00732992|16831487|P1|Overall Study|Adverse Event|1
4884349|NCT00732940|16831506|P2|Overall Study|Lost to Follow-up|0
4884350|NCT00732940|16831507|P1|Overall Study|Lost to Follow-up|1
4884351|NCT00732940|16831506|P2|Overall Study|Adverse Event|1
4884352|NCT00732940|16831507|P1|Overall Study|Adverse Event|0
4884353|NCT00732940|16831506|P2|Overall Study|Withdrawal by Subject|2
4884354|NCT00732940|16831507|P1|Overall Study|Withdrawal by Subject|1
4884355|NCT00732875|16831588|P1|Overall Study|Lack of Efficacy|13
4884356|NCT00732875|16831588|P1|Overall Study|Withdrawal by Subject|6
4884357|NCT00732875|16831588|P1|Overall Study|Adverse Event|16
4884358|NCT00732758|16831596|P2|Overall Study|Lost to Follow-up|16
4884359|NCT00732758|16831597|P1|Overall Study|Lost to Follow-up|8
4884360|NCT00732641|16831637|P2|Overall Study|Other|5
4884361|NCT00732641|16831638|P1|Overall Study|Other|18
4884362|NCT00732641|16831637|P2|Overall Study|Unable to Complete|1
4884363|NCT00732641|16831638|P1|Overall Study|Unable to Complete|1
4884364|NCT00732641|16831637|P2|Overall Study|Withdrawal by Subject|2
4884365|NCT00732641|16831638|P1|Overall Study|Withdrawal by Subject|4
4884366|NCT00732641|16831637|P2|Overall Study|Physician Decision|0
4884367|NCT00732641|16831638|P1|Overall Study|Physician Decision|6
4884368|NCT00732641|16831637|P2|Overall Study|Serious Adverse Events|3
4884369|NCT00732641|16831638|P1|Overall Study|Serious Adverse Events|12
4884370|NCT00732641|16831637|P2|Overall Study|Relapse or Progressive Disease|101
4884371|NCT00732641|16831638|P1|Overall Study|Relapse or Progressive Disease|65
4884372|NCT00732615|16831658|P2|Overall Study|Non-Compliance, Subject/Physician Dec.|1
4884373|NCT00732615|16831659|P1|Overall Study|Non-Compliance, Subject/Physician Dec.|1
4884374|NCT00732615|16831658|P2|Overall Study|Physician Decision|0
4884375|NCT00732615|16831659|P1|Overall Study|Physician Decision|3
4884376|NCT00732615|16831658|P2|Overall Study|Adverse Event|2
4884377|NCT00732615|16831659|P1|Overall Study|Adverse Event|0
4884378|NCT00732615|16831658|P2|Overall Study|Lost to Follow-up|1
4884379|NCT00732615|16831659|P1|Overall Study|Lost to Follow-up|0
4884380|NCT00732615|16831658|P2|Overall Study|Withdrawal by Subject|1
4884381|NCT00732615|16831659|P1|Overall Study|Withdrawal by Subject|3
4884382|NCT00732498|16831671|P1|Overall Study|Physician Decision|3
4884383|NCT00732498|16831671|P1|Overall Study|Adverse Event|2
4884384|NCT00732498|16831671|P1|Overall Study|Ineligible|1
4884385|NCT00732472|16831682|P4|Overall Study|Withdrawal by Subject|1
4884386|NCT00732472|16831683|P3|Overall Study|Withdrawal by Subject|0
4884387|NCT00732472|16831684|P2|Overall Study|Withdrawal by Subject|2
4884388|NCT00732472|16831685|P1|Overall Study|Withdrawal by Subject|0
4884389|NCT00732472|16831682|P4|Overall Study|Protocol Violation|1
4884390|NCT00732472|16831683|P3|Overall Study|Protocol Violation|0
4884391|NCT00732472|16831684|P2|Overall Study|Protocol Violation|0
4884392|NCT00732472|16831685|P1|Overall Study|Protocol Violation|0
4884393|NCT00732472|16831682|P4|Overall Study|Adverse Event|1
4884394|NCT00732472|16831683|P3|Overall Study|Adverse Event|1
4884395|NCT00732472|16831684|P2|Overall Study|Adverse Event|1
4884396|NCT00732472|16831685|P1|Overall Study|Adverse Event|0
4884397|NCT00732381|16831785|P2|Overall Study|Treatment Failure|1
4884398|NCT00732381|16831786|P1|Overall Study|Treatment Failure|1
4884399|NCT00732381|16831785|P2|Overall Study|Adverse Event|0
4884400|NCT00732381|16831786|P1|Overall Study|Adverse Event|1
4884401|NCT00732303|16831794|P1|Overall Study|Study Terminated|2
4884402|NCT00732251|16831800|P1|Overall Study|Early Term due to Site Closure|1
4884403|NCT00732251|16831800|P1|Overall Study|Withdrawal by Subject|3
4884404|NCT00732251|16831800|P1|Overall Study|Lost to Follow-up|3
4884405|NCT00732238|16831808|P2|Overall Study|Asymptomatic bacteriuria|0
4884406|NCT00732238|16831809|P1|Overall Study|Asymptomatic bacteriuria|1
4884407|NCT00732238|16831808|P2|Overall Study|Bacteremia|1
4884408|NCT00732238|16831809|P1|Overall Study|Bacteremia|4
4884409|NCT00732199|16831910|P2|Overall Study|sleep apnea, inadequate signals/sleep|8
4884410|NCT00732199|16831911|P1|Overall Study|sleep apnea, inadequate signals/sleep|9
4884411|NCT00732199|16831910|P2|Overall Study|Withdrawal by Subject|18
4884412|NCT00732199|16831911|P1|Overall Study|Withdrawal by Subject|25
4884413|NCT00732160|16831926|P4|Overall Study|scheduling|1
4884414|NCT00732160|16831927|P3|Overall Study|scheduling|2
4884415|NCT00732160|16831928|P2|Overall Study|scheduling|4
4884416|NCT00732160|16831929|P1|Overall Study|scheduling|4
4884417|NCT00732160|16831926|P4|Overall Study|Adverse Event|1
4884418|NCT00732160|16831927|P3|Overall Study|Adverse Event|1
4884419|NCT00732160|16831928|P2|Overall Study|Adverse Event|0
4884420|NCT00732160|16831929|P1|Overall Study|Adverse Event|1
4884421|NCT00732069|16831943|P6|Washout After First Study Drug|Adverse Event|0
4884422|NCT00732069|16831944|P5|Washout After First Study Drug|Adverse Event|0
4884423|NCT00732069|16831945|P4|Washout After First Study Drug|Adverse Event|0
4884424|NCT00732069|16831946|P3|Washout After First Study Drug|Adverse Event|0
4884425|NCT00732069|16831947|P2|Washout After First Study Drug|Adverse Event|0
4884426|NCT00732069|16831948|P1|Washout After First Study Drug|Adverse Event|1
4884427|NCT00731939|16831966|P1|Overall Study|Did not meet enrollment criteria|2
4884428|NCT00731939|16831966|P1|Overall Study|Withdrawal by Subject|2
4884429|NCT00731939|16831966|P1|Overall Study|Not implanted with study device|9
4884430|NCT00731939|16831966|P1|Overall Study|Lost to Follow-up|15
4884431|NCT00731939|16831966|P1|Overall Study|Adverse Event|6
4884432|NCT00731822|16832043|P2|Overall Study|Lost to Follow-up|0
4884433|NCT00731822|16832044|P1|Overall Study|Lost to Follow-up|1
4884434|NCT00731822|16832043|P2|Overall Study|Protocol Violation|0
4884435|NCT00731822|16832044|P1|Overall Study|Protocol Violation|1
4884436|NCT00731822|16832043|P2|Overall Study|Adverse Event|1
4884437|NCT00731822|16832044|P1|Overall Study|Adverse Event|2
4884438|NCT00731783|16832058|P2|12 Month Follow-Up Visit|Lost to Follow-up|7
4884439|NCT00731783|16832059|P1|12 Month Follow-Up Visit|Lost to Follow-up|6
4884440|NCT00731783|16832058|P2|Six Month Follow-Up Visit|Lost to Follow-up|3
4884441|NCT00731783|16832059|P1|Six Month Follow-Up Visit|Lost to Follow-up|6
4884442|NCT00731783|16832058|P2|Three Month Follow-Up Visit|Lost to Follow-up|16
4884443|NCT00731783|16832059|P1|Three Month Follow-Up Visit|Lost to Follow-up|7
4884444|NCT00731783|16832058|P2|One Month Follow-Up Visit|Lost to Follow-up|22
4884445|NCT00731783|16832059|P1|One Month Follow-Up Visit|Lost to Follow-up|14
4884446|NCT00731731|16832093|P3|Overall Study|Cancel prior to treatment|2
4884447|NCT00731731|16832094|P2|Overall Study|Cancel prior to treatment|0
4884448|NCT00731731|16832095|P1|Overall Study|Cancel prior to treatment|0
4884449|NCT00731731|16832093|P3|Overall Study|Protocol Violation|1
4884450|NCT00731731|16832094|P2|Overall Study|Protocol Violation|0
4884451|NCT00731731|16832095|P1|Overall Study|Protocol Violation|0
4884452|NCT00731692|16832113|P3|Extension Phase|Adverse Event|15
4884453|NCT00731692|16832114|P2|Extension Phase|Adverse Event|1
4884454|NCT00731692|16832115|P1|Extension Phase|Adverse Event|1
4884455|NCT00731692|16832113|P3|Extension Phase|Withdrawal by Subject|3
4884456|NCT00731692|16832114|P2|Extension Phase|Withdrawal by Subject|5
4884457|NCT00731692|16832115|P1|Extension Phase|Withdrawal by Subject|4
4884458|NCT00731692|16832113|P3|Extension Phase|Lost to Follow-up|4
4884459|NCT00731692|16832114|P2|Extension Phase|Lost to Follow-up|1
4884460|NCT00731692|16832115|P1|Extension Phase|Lost to Follow-up|0
4884461|NCT00731692|16832113|P3|Extension Phase|Abnormal lab values|1
4884462|NCT00731692|16832114|P2|Extension Phase|Abnormal lab values|0
4884463|NCT00731692|16832115|P1|Extension Phase|Abnormal lab values|0
4884464|NCT00731692|16832113|P3|Extension Phase|Abnormal test procedure|1
4884465|NCT00731692|16832114|P2|Extension Phase|Abnormal test procedure|0
4884466|NCT00731692|16832115|P1|Extension Phase|Abnormal test procedure|0
4884467|NCT00731692|16832113|P3|Extension Phase|Admin Problems: Terminated # patients|277
4884468|NCT00731692|16832114|P2|Extension Phase|Admin Problems: Terminated # patients|189
4884469|NCT00731692|16832115|P1|Extension Phase|Admin Problems: Terminated # patients|69
4884470|NCT00731692|16832113|P3|Core Study (36 Months)|Withdrawal by Subject|46
4884471|NCT00731692|16832114|P2|Core Study (36 Months)|Withdrawal by Subject|32
4884472|NCT00731692|16832115|P1|Core Study (36 Months)|Withdrawal by Subject|12
4884473|NCT00731692|16832113|P3|Core Study (36 Months)|Adverse Event|29
4884474|NCT00731692|16832114|P2|Core Study (36 Months)|Adverse Event|28
4884475|NCT00731692|16832115|P1|Core Study (36 Months)|Adverse Event|25
4884476|NCT00731692|16832113|P3|Core Study (36 Months)|Abnormal Lab values|5
4884477|NCT00731692|16832114|P2|Core Study (36 Months)|Abnormal Lab values|19
4884478|NCT00731692|16832115|P1|Core Study (36 Months)|Abnormal Lab values|6
4884479|NCT00731692|16832113|P3|Core Study (36 Months)|Protocol Violation|8
4884480|NCT00731692|16832114|P2|Core Study (36 Months)|Protocol Violation|5
4884481|NCT00731692|16832115|P1|Core Study (36 Months)|Protocol Violation|4
4884482|NCT00731692|16832113|P3|Core Study (36 Months)|Abnormal Test Procedure Result|5
4884483|NCT00731692|16832114|P2|Core Study (36 Months)|Abnormal Test Procedure Result|3
4884484|NCT00731692|16832115|P1|Core Study (36 Months)|Abnormal Test Procedure Result|4
4884485|NCT00731692|16832113|P3|Core Study (36 Months)|Administrative|6
4884486|NCT00731692|16832114|P2|Core Study (36 Months)|Administrative|2
4884487|NCT00731692|16832115|P1|Core Study (36 Months)|Administrative|2
4884488|NCT00731692|16832113|P3|Core Study (36 Months)|Lost to Follow-up|3
4884489|NCT00731692|16832114|P2|Core Study (36 Months)|Lost to Follow-up|3
4884490|NCT00731692|16832115|P1|Core Study (36 Months)|Lost to Follow-up|1
4884491|NCT00731692|16832113|P3|Core Study (36 Months)|Death|2
4884492|NCT00731692|16832114|P2|Core Study (36 Months)|Death|1
4884493|NCT00731692|16832115|P1|Core Study (36 Months)|Death|2
4884494|NCT00731692|16832113|P3|Core Study (36 Months)|Physician Decision|2
4884495|NCT00731692|16832114|P2|Core Study (36 Months)|Physician Decision|0
4884496|NCT00731692|16832115|P1|Core Study (36 Months)|Physician Decision|1
4884497|NCT00731692|16832113|P3|Core Study (36 Months)|Lack of Efficacy|64
4884498|NCT00731692|16832114|P2|Core Study (36 Months)|Lack of Efficacy|23
4884499|NCT00731692|16832115|P1|Core Study (36 Months)|Lack of Efficacy|11
4884500|NCT00731679|16832161|P2|Overall Study|Pregnancy|1
4884501|NCT00731679|16832162|P1|Overall Study|Pregnancy|0
4884502|NCT00731679|16832161|P2|Overall Study|Noncompliance|1
4884503|NCT00731679|16832162|P1|Overall Study|Noncompliance|0
4884504|NCT00731679|16832161|P2|Overall Study|Lost to Follow-up|8
4884505|NCT00731679|16832162|P1|Overall Study|Lost to Follow-up|7
4884506|NCT00731679|16832161|P2|Overall Study|Withdrawal by Subject|8
4884507|NCT00731679|16832162|P1|Overall Study|Withdrawal by Subject|8
4884508|NCT00731679|16832161|P2|Overall Study|Adverse Event|8
4884509|NCT00731679|16832162|P1|Overall Study|Adverse Event|7
4884510|NCT00731666|16832170|P1|Overall Study|Withdrawal by Subject|2
4884511|NCT00731666|16832170|P1|Overall Study|Lost to Follow-up|8
4884512|NCT00731666|16832170|P1|Overall Study|Adverse Event|2
4884513|NCT00731549|16832206|P1|Overall Study|Lack of efficacy without AE|6
4884514|NCT00731549|16832206|P1|Overall Study|Lack of efficacy with AE|37
4884515|NCT00731549|16832206|P1|Overall Study|Adverse Event|31
4884516|NCT00731549|16832206|P1|Overall Study|Protocol deviation|1
4884517|NCT00731549|16832206|P1|Overall Study|Withdrawal by Subject|89
4884518|NCT00731549|16832206|P1|Overall Study|Physician Decision|16
4884519|NCT00731549|16832206|P1|Overall Study|Met withdrawal criteria|24
4884520|NCT00731549|16832206|P1|Overall Study|Lost to Follow-up|19
4884521|NCT00731133|16832246|P1|Overall Study|Withdrawal by Subject|10
4884522|NCT00731120|16832254|P3|Overall Study|Other|1
4884523|NCT00731120|16832255|P2|Overall Study|Other|0
4884524|NCT00731120|16832256|P1|Overall Study|Other|4
4884525|NCT00731120|16832254|P3|Overall Study|Lost to Follow-up|17
4884526|NCT00731120|16832255|P2|Overall Study|Lost to Follow-up|15
4884527|NCT00731120|16832256|P1|Overall Study|Lost to Follow-up|10
4884528|NCT00731120|16832254|P3|Overall Study|Withdrawal of Consent|4
4884529|NCT00731120|16832255|P2|Overall Study|Withdrawal of Consent|8
4884530|NCT00731120|16832256|P1|Overall Study|Withdrawal of Consent|13
4884531|NCT00731120|16832254|P3|Overall Study|Protocol Deviations|1
4884532|NCT00731120|16832255|P2|Overall Study|Protocol Deviations|6
4884533|NCT00731120|16832256|P1|Overall Study|Protocol Deviations|1
4884534|NCT00731120|16832254|P3|Overall Study|Noncompliance with Study Drug|1
4884535|NCT00731120|16832255|P2|Overall Study|Noncompliance with Study Drug|3
4884536|NCT00731120|16832256|P1|Overall Study|Noncompliance with Study Drug|3
4884537|NCT00731120|16832254|P3|Overall Study|Lack of Efficacy|4
4884538|NCT00731120|16832255|P2|Overall Study|Lack of Efficacy|5
4884539|NCT00731120|16832256|P1|Overall Study|Lack of Efficacy|4
4884540|NCT00731120|16832254|P3|Overall Study|Adverse Event|8
4884541|NCT00731120|16832255|P2|Overall Study|Adverse Event|6
4884542|NCT00731120|16832256|P1|Overall Study|Adverse Event|7
4884543|NCT00731042|16832373|P2|Second Intervention|Did not meet inclusion criteria|2
4884544|NCT00731042|16832374|P1|Second Intervention|Did not meet inclusion criteria|0
4884545|NCT00730925|16832385|P1|Overall Study|Other|1
4884546|NCT00730925|16832385|P1|Overall Study|Switch to combination therapy|8
4884547|NCT00730925|16832385|P1|Overall Study|Withdrawal by Subject|1
4884548|NCT00730925|16832385|P1|Overall Study|Protocol Violation|1
4884549|NCT00730925|16832385|P1|Overall Study|Other Averse Event|7
4884550|NCT00730925|16832385|P1|Overall Study|Dose reducing Event|2
4884551|NCT00730925|16832385|P1|Overall Study|Progressive Disease|21
4884552|NCT00730912|16832395|P3|Overall Study|Discontinued|1
4884553|NCT00730912|16832396|P2|Overall Study|Discontinued|0
4884554|NCT00730912|16832397|P1|Overall Study|Discontinued|0
4884555|NCT00730886|16832410|P2|Overall Study|Physician Decision|0
4884556|NCT00730886|16832411|P1|Overall Study|Physician Decision|1
4884557|NCT00730886|16832410|P2|Overall Study|Lost to Follow-up|0
4884558|NCT00730886|16832411|P1|Overall Study|Lost to Follow-up|1
4884559|NCT00730847|16832435|P1|Overall Study|Other|24
4884560|NCT00730847|16832435|P1|Overall Study|Unknown completion status|21
4884561|NCT00730847|16832435|P1|Overall Study|Lost to Follow-up|67
4884562|NCT00730847|16832435|P1|Overall Study|Withdrawal by Subject|16
4884563|NCT00730847|16832435|P1|Overall Study|Protocol Violation|2
4884564|NCT00730847|16832435|P1|Overall Study|Adverse Event|1
4884565|NCT00730756|16832444|P2|Overall Study|Withdrew Consent|1
4884566|NCT00730756|16832445|P1|Overall Study|Withdrew Consent|0
4884567|NCT00730756|16832444|P2|Overall Study|Lost to Follow-up|1
4884568|NCT00730756|16832445|P1|Overall Study|Lost to Follow-up|0
4884569|NCT00730756|16832444|P2|Overall Study|Protocol Deviation|2
4884570|NCT00730756|16832445|P1|Overall Study|Protocol Deviation|1
4884571|NCT00730756|16832444|P2|Overall Study|Lack of Efficacy|1
4884572|NCT00730756|16832445|P1|Overall Study|Lack of Efficacy|1
4884573|NCT00730756|16832444|P2|Overall Study|Adverse Event|0
4884574|NCT00730756|16832445|P1|Overall Study|Adverse Event|2
4884575|NCT00730691|16832479|P5|Overall Study|Other|2
4884576|NCT00730691|16832480|P4|Overall Study|Other|2
4884577|NCT00730691|16832481|P3|Overall Study|Other|1
4884578|NCT00730691|16832482|P2|Overall Study|Other|1
4884579|NCT00730691|16832483|P1|Overall Study|Other|1
4884580|NCT00730691|16832479|P5|Overall Study|Lost to Follow-up|13
4884581|NCT00730691|16832480|P4|Overall Study|Lost to Follow-up|15
4884582|NCT00730691|16832481|P3|Overall Study|Lost to Follow-up|13
4884583|NCT00730691|16832482|P2|Overall Study|Lost to Follow-up|8
4884584|NCT00730691|16832483|P1|Overall Study|Lost to Follow-up|11
4884585|NCT00730691|16832479|P5|Overall Study|Withdrawal of Consent|3
4884586|NCT00730691|16832480|P4|Overall Study|Withdrawal of Consent|6
4884587|NCT00730691|16832481|P3|Overall Study|Withdrawal of Consent|3
4884588|NCT00730691|16832482|P2|Overall Study|Withdrawal of Consent|9
4884589|NCT00730691|16832483|P1|Overall Study|Withdrawal of Consent|7
4884590|NCT00730691|16832479|P5|Overall Study|Protocol Deviations|5
4884591|NCT00730691|16832480|P4|Overall Study|Protocol Deviations|7
4884592|NCT00730691|16832481|P3|Overall Study|Protocol Deviations|3
4884593|NCT00730691|16832482|P2|Overall Study|Protocol Deviations|5
4884594|NCT00730691|16832483|P1|Overall Study|Protocol Deviations|3
4884595|NCT00730691|16832479|P5|Overall Study|Non-compliance with Study Drug|3
4884596|NCT00730691|16832480|P4|Overall Study|Non-compliance with Study Drug|3
4884597|NCT00730691|16832481|P3|Overall Study|Non-compliance with Study Drug|6
4884598|NCT00730691|16832482|P2|Overall Study|Non-compliance with Study Drug|1
4884599|NCT00730691|16832483|P1|Overall Study|Non-compliance with Study Drug|6
4884600|NCT00730691|16832479|P5|Overall Study|Lack of Efficacy|1
4884601|NCT00730691|16832480|P4|Overall Study|Lack of Efficacy|1
4884602|NCT00730691|16832481|P3|Overall Study|Lack of Efficacy|2
4884603|NCT00730691|16832482|P2|Overall Study|Lack of Efficacy|4
4884604|NCT00730691|16832483|P1|Overall Study|Lack of Efficacy|4
4884605|NCT00730691|16832479|P5|Overall Study|Adverse Event|23
4884606|NCT00730691|16832480|P4|Overall Study|Adverse Event|11
4884607|NCT00730691|16832481|P3|Overall Study|Adverse Event|11
4884608|NCT00730691|16832482|P2|Overall Study|Adverse Event|8
4884609|NCT00730691|16832483|P1|Overall Study|Adverse Event|4
4884610|NCT00730639|16832575|P5|Overall Study|Treatment on-going|4
4884611|NCT00730639|16832576|P4|Overall Study|Treatment on-going|4
4884612|NCT00730639|16832577|P3|Overall Study|Treatment on-going|5
4884613|NCT00730639|16832578|P2|Overall Study|Treatment on-going|5
4884614|NCT00730639|16832579|P1|Overall Study|Treatment on-going|2
4884615|NCT00730639|16832575|P5|Overall Study|Withdrawal by Subject|4
4884616|NCT00730639|16832576|P4|Overall Study|Withdrawal by Subject|3
4884617|NCT00730639|16832577|P3|Overall Study|Withdrawal by Subject|6
4884618|NCT00730639|16832578|P2|Overall Study|Withdrawal by Subject|0
4884619|NCT00730639|16832579|P1|Overall Study|Withdrawal by Subject|0
4884620|NCT00730639|16832575|P5|Overall Study|Protocol Violation|0
4884621|NCT00730639|16832576|P4|Overall Study|Protocol Violation|0
4884622|NCT00730639|16832577|P3|Overall Study|Protocol Violation|1
4884623|NCT00730639|16832578|P2|Overall Study|Protocol Violation|0
4884624|NCT00730639|16832579|P1|Overall Study|Protocol Violation|0
4884625|NCT00730639|16832575|P5|Overall Study|non-specified|3
4884626|NCT00730639|16832576|P4|Overall Study|non-specified|2
4884627|NCT00730639|16832577|P3|Overall Study|non-specified|4
4884628|NCT00730639|16832578|P2|Overall Study|non-specified|0
4884629|NCT00730639|16832579|P1|Overall Study|non-specified|0
4884630|NCT00730639|16832575|P5|Overall Study|Disease Progression|88
4884631|NCT00730639|16832576|P4|Overall Study|Disease Progression|32
4884632|NCT00730639|16832577|P3|Overall Study|Disease Progression|48
4884633|NCT00730639|16832578|P2|Overall Study|Disease Progression|13
4884634|NCT00730639|16832579|P1|Overall Study|Disease Progression|12
4884635|NCT00730639|16832575|P5|Overall Study|Death|2
4884636|NCT00730639|16832576|P4|Overall Study|Death|0
4884637|NCT00730639|16832577|P3|Overall Study|Death|0
4884638|NCT00730639|16832578|P2|Overall Study|Death|0
4884639|NCT00730639|16832579|P1|Overall Study|Death|0
4884640|NCT00730639|16832575|P5|Overall Study|Completed Maximum Cycles|6
4884641|NCT00730639|16832576|P4|Overall Study|Completed Maximum Cycles|3
4884642|NCT00730639|16832577|P3|Overall Study|Completed Maximum Cycles|11
4884643|NCT00730639|16832578|P2|Overall Study|Completed Maximum Cycles|0
4884644|NCT00730639|16832579|P1|Overall Study|Completed Maximum Cycles|0
4884645|NCT00730639|16832575|P5|Overall Study|Complete Response|1
4884646|NCT00730639|16832576|P4|Overall Study|Complete Response|2
4884647|NCT00730639|16832577|P3|Overall Study|Complete Response|2
4884648|NCT00730639|16832578|P2|Overall Study|Complete Response|0
4884649|NCT00730639|16832579|P1|Overall Study|Complete Response|0
4884650|NCT00730639|16832575|P5|Overall Study|Adverse Event|23
4884651|NCT00730639|16832576|P4|Overall Study|Adverse Event|8
4884652|NCT00730639|16832577|P3|Overall Study|Adverse Event|9
4884653|NCT00730639|16832578|P2|Overall Study|Adverse Event|0
4884654|NCT00730639|16832579|P1|Overall Study|Adverse Event|3
4884655|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Atrial fibrillation history|0
4884656|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Atrial fibrillation history|0
4884657|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Atrial fibrillation history|0
4884658|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Atrial fibrillation history|0
4884659|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Atrial fibrillation history|1
4884660|NCT00730405|16832656|P5|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4884661|NCT00730405|16832657|P4|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1
4884662|NCT00730405|16832658|P3|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4884663|NCT00730405|16832659|P2|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4884664|NCT00730405|16832660|P1|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0
4884665|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Other Protocol violation|0
4884666|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Other Protocol violation|0
4884667|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Other Protocol violation|1
4884668|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Other Protocol violation|0
4884669|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Other Protocol violation|0
4884670|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Mis-randomized|0
4884671|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Mis-randomized|0
4884672|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Mis-randomized|0
4884673|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Mis-randomized|1
4884674|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Mis-randomized|0
4884675|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4884676|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4884677|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1
4884678|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4884679|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0
4884680|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Use an exclusionary medication|1
4884681|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Use an exclusionary medication|0
4884682|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Use an exclusionary medication|0
4884683|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Use an exclusionary medication|0
4884684|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Use an exclusionary medication|0
4884685|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Missing|0
4884686|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Missing|0
4884687|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Missing|2
4884688|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Missing|0
4884689|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Missing|0
4884690|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Non-compliance|0
4884691|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Non-compliance|0
4884692|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Non-compliance|2
4884693|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Non-compliance|0
4884694|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Non-compliance|1
4884695|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Use of restricted medication|0
4884696|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Use of restricted medication|0
4884697|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Use of restricted medication|0
4884698|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Use of restricted medication|1
4884699|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Use of restricted medication|0
4884700|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Declined to continue with follow-up|0
4884701|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Declined to continue with follow-up|0
4884702|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Declined to continue with follow-up|0
4884703|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Declined to continue with follow-up|1
4884704|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Declined to continue with follow-up|1
4884705|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
4884706|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
4884707|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
4884708|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1
4884709|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0
4884710|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4884711|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Refused follow-up due to AE|1
4884712|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4884713|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4884714|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Refused follow-up due to AE|0
4884715|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4884716|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4884717|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4884718|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Prohibited concomitant medication|0
4884719|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Prohibited concomitant medication|1
4884720|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1
4884721|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4884722|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4884723|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4884724|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0
4884725|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4884726|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4884727|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Participant meets exclusion criteria|1
4884728|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4884729|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Participant meets exclusion criteria|0
4884730|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4884731|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4884732|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Non-compliance with study treatment|1
4884733|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4884734|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Non-compliance with study treatment|0
4884735|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Did not met eligibility|0
4884736|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Did not met eligibility|0
4884737|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Did not met eligibility|1
4884738|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Did not met eligibility|0
4884739|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Did not met eligibility|0
4884740|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Change of location|0
4884892|NCT00730028|16832872|P1|Overall Study|Treatment Failure|5
4884741|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Change of location|1
4884742|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Change of location|0
4884743|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Change of location|1
4884744|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Change of location|1
4884745|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Death|0
4884746|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Death|1
4884747|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Death|0
4884748|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Death|1
4884749|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Death|0
4884750|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Withdrawal by Subject|10
4884751|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Withdrawal by Subject|6
4884752|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Withdrawal by Subject|3
4884753|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Withdrawal by Subject|3
4884754|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Withdrawal by Subject|7
4884755|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Lost to Follow-up|6
4884756|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Lost to Follow-up|4
4884757|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Lost to Follow-up|8
4884758|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Lost to Follow-up|6
4884759|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Lost to Follow-up|7
4884760|NCT00730405|16832656|P5|Overall Study-follow-up Phase|Adverse Event|4
4884761|NCT00730405|16832657|P4|Overall Study-follow-up Phase|Adverse Event|3
4884762|NCT00730405|16832658|P3|Overall Study-follow-up Phase|Adverse Event|2
4884763|NCT00730405|16832659|P2|Overall Study-follow-up Phase|Adverse Event|6
4884764|NCT00730405|16832660|P1|Overall Study-follow-up Phase|Adverse Event|2
4884765|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Atrial fibrillation history|0
4884766|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Atrial fibrillation history|0
4884767|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Atrial fibrillation history|0
4884768|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Atrial fibrillation history|0
4884769|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Atrial fibrillation history|1
4884770|NCT00730405|16832656|P5|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1
4884771|NCT00730405|16832657|P4|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4884772|NCT00730405|16832658|P3|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4884773|NCT00730405|16832659|P2|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4884774|NCT00730405|16832660|P1|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0
4884775|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Pregnancy|0
4884776|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Pregnancy|0
4884777|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Pregnancy|0
4884778|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Pregnancy|1
4884779|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Pregnancy|0
4884780|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Change of location|0
4884781|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Change of location|1
4884782|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Change of location|0
4884783|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Change of location|0
4884784|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Change of location|0
4884785|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4884786|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4884787|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Protocol violation due to eligibility|1
4884788|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4884789|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Protocol violation due to eligibility|0
4884790|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4884791|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Due to in-vitro fertilization|1
4884792|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4884793|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4884794|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Due to in-vitro fertilization|0
4884795|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Study drug interrupted|0
4884796|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Study drug interrupted|0
4884797|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Study drug interrupted|0
4884798|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Study drug interrupted|1
4884799|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Study drug interrupted|0
4884800|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Misrandomized|0
4884801|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Misrandomized|0
4884802|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Misrandomized|0
4884803|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Misrandomized|1
4884804|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Misrandomized|0
4884805|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4884806|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4884807|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1
4884808|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4884809|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0
4884810|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Use of prohibited medication|2
4884811|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Use of prohibited medication|0
4884812|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Use of prohibited medication|0
4884813|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Use of prohibited medication|1
4884814|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Use of prohibited medication|0
4884815|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Withdrew from study treatment|0
4884816|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Withdrew from study treatment|0
4884817|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Withdrew from study treatment|0
4884818|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Withdrew from study treatment|1
4884819|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Withdrew from study treatment|0
4884820|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4884821|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4884822|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4884823|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Prohibited concomitant medication|0
4884824|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Prohibited concomitant medication|1
4884825|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Participant meets exclusion|0
4884826|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Participant meets exclusion|0
4884827|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Participant meets exclusion|1
4884828|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Participant meets exclusion|0
4884829|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Participant meets exclusion|0
4884830|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Did not met eligibility|0
4884831|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Did not met eligibility|0
4884832|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Did not met eligibility|1
4884833|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Did not met eligibility|0
4884834|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Did not met eligibility|0
4884835|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Withdrawal by Subject|8
4884836|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Withdrawal by Subject|5
4884837|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Withdrawal by Subject|2
4884838|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Withdrawal by Subject|1
4884839|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Withdrawal by Subject|7
4884840|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
4884841|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
4884842|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5
4884843|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0
4884844|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1
4884845|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Lost to Follow-up|4
4884846|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Lost to Follow-up|4
4884847|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Lost to Follow-up|6
4884848|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Lost to Follow-up|5
4884849|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Lost to Follow-up|4
4884850|NCT00730405|16832656|P5|Overall Study-Treatment Phase|Adverse Event|4
4884851|NCT00730405|16832657|P4|Overall Study-Treatment Phase|Adverse Event|8
4884852|NCT00730405|16832658|P3|Overall Study-Treatment Phase|Adverse Event|4
4884853|NCT00730405|16832659|P2|Overall Study-Treatment Phase|Adverse Event|10
4884854|NCT00730405|16832660|P1|Overall Study-Treatment Phase|Adverse Event|5
4884855|NCT00730327|16832707|P2|Overall Study|Subject withdrew (reason not specified)|7
4884856|NCT00730327|16832708|P1|Overall Study|Subject withdrew (reason not specified)|2
4884857|NCT00730327|16832707|P2|Overall Study|Withdrawal by Subject|13
4884858|NCT00730327|16832708|P1|Overall Study|Withdrawal by Subject|3
4884859|NCT00730327|16832707|P2|Overall Study|Adverse Event|1
4884860|NCT00730327|16832708|P1|Overall Study|Adverse Event|8
4884861|NCT00730327|16832707|P2|Overall Study|Lost to Follow-up|16
4884862|NCT00730327|16832708|P1|Overall Study|Lost to Follow-up|14
4884863|NCT00730275|16832733|P4|Overall Study|Withdrawal by Subject|1
4884864|NCT00730275|16832734|P3|Overall Study|Withdrawal by Subject|0
4884865|NCT00730275|16832735|P2|Overall Study|Withdrawal by Subject|0
4884866|NCT00730275|16832736|P1|Overall Study|Withdrawal by Subject|0
4884867|NCT00730236|16832762|P1|Overall Study|Non-compliance|1
4884868|NCT00730236|16832762|P1|Overall Study|Withdrawal by Subject|1
4884869|NCT00730236|16832762|P1|Overall Study|Adverse Event|4
4884870|NCT00730171|16832777|P1|Overall Study|Other|61
4884871|NCT00730171|16832777|P1|Overall Study|Insufficient Therapeutic Response|141
4884872|NCT00730171|16832777|P1|Overall Study|Lost to Follow-up|121
4884873|NCT00730171|16832777|P1|Overall Study|Withdrawal by Subject|202
4884874|NCT00730171|16832777|P1|Overall Study|Protocol Violation|48
4884875|NCT00730171|16832777|P1|Overall Study|Adverse Event|193
4884876|NCT00730171|16832777|P1|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5
4884877|NCT00730158|16832787|P2|Overall Study|Withdrawal by Subject|1
4884878|NCT00730158|16832788|P1|Overall Study|Withdrawal by Subject|1
4884879|NCT00730132|16832826|P1|Overall Study|Death|1
4884880|NCT00730132|16832826|P1|Overall Study|Protocol Violation|154
4884881|NCT00730041|16832844|P2|Overall Study|Lost to Follow-up|2
4884882|NCT00730041|16832845|P1|Overall Study|Lost to Follow-up|0
4884883|NCT00730028|16832868|P5|Overall Study|Randomization Error|2
4884884|NCT00730028|16832869|P4|Overall Study|Randomization Error|0
4884885|NCT00730028|16832870|P3|Overall Study|Randomization Error|0
4884886|NCT00730028|16832871|P2|Overall Study|Randomization Error|0
4884887|NCT00730028|16832872|P1|Overall Study|Randomization Error|1
4884888|NCT00730028|16832868|P5|Overall Study|Treatment Failure|1
4884889|NCT00730028|16832869|P4|Overall Study|Treatment Failure|0
4884890|NCT00730028|16832870|P3|Overall Study|Treatment Failure|0
4884891|NCT00730028|16832871|P2|Overall Study|Treatment Failure|5
4884893|NCT00730028|16832868|P5|Overall Study|Physician Decision|2
4884894|NCT00730028|16832869|P4|Overall Study|Physician Decision|3
4884895|NCT00730028|16832870|P3|Overall Study|Physician Decision|2
4884896|NCT00730028|16832871|P2|Overall Study|Physician Decision|3
4884897|NCT00730028|16832872|P1|Overall Study|Physician Decision|3
4884898|NCT00730028|16832868|P5|Overall Study|Withdrawal by Subject|9
4884899|NCT00730028|16832869|P4|Overall Study|Withdrawal by Subject|5
4884900|NCT00730028|16832870|P3|Overall Study|Withdrawal by Subject|4
4884901|NCT00730028|16832871|P2|Overall Study|Withdrawal by Subject|5
4884902|NCT00730028|16832872|P1|Overall Study|Withdrawal by Subject|9
4884903|NCT00730028|16832868|P5|Overall Study|Protocol Violation|0
4884904|NCT00730028|16832869|P4|Overall Study|Protocol Violation|2
4884905|NCT00730028|16832870|P3|Overall Study|Protocol Violation|1
4884906|NCT00730028|16832871|P2|Overall Study|Protocol Violation|1
4884907|NCT00730028|16832872|P1|Overall Study|Protocol Violation|6
4884908|NCT00730028|16832868|P5|Overall Study|Lost to Follow-up|25
4884909|NCT00730028|16832869|P4|Overall Study|Lost to Follow-up|26
4884910|NCT00730028|16832870|P3|Overall Study|Lost to Follow-up|22
4884911|NCT00730028|16832871|P2|Overall Study|Lost to Follow-up|26
4884912|NCT00730028|16832872|P1|Overall Study|Lost to Follow-up|13
4884913|NCT00730028|16832868|P5|Overall Study|Adverse Event|43
4884914|NCT00730028|16832869|P4|Overall Study|Adverse Event|20
4884915|NCT00730028|16832870|P3|Overall Study|Adverse Event|16
4884916|NCT00730028|16832871|P2|Overall Study|Adverse Event|26
4884917|NCT00730028|16832872|P1|Overall Study|Adverse Event|23
4884918|NCT00730015|16832922|P3|Overall Study|Other Reason|1
4884919|NCT00730015|16832923|P2|Overall Study|Other Reason|0
4884920|NCT00730015|16832924|P1|Overall Study|Other Reason|1
4884921|NCT00730015|16832922|P3|Overall Study|Lack of Efficacy|8
4884922|NCT00730015|16832923|P2|Overall Study|Lack of Efficacy|2
4884923|NCT00730015|16832924|P1|Overall Study|Lack of Efficacy|1
4884924|NCT00730015|16832922|P3|Overall Study|Lost to Follow-up|3
4884925|NCT00730015|16832923|P2|Overall Study|Lost to Follow-up|10
4884926|NCT00730015|16832924|P1|Overall Study|Lost to Follow-up|4
4884927|NCT00730015|16832922|P3|Overall Study|Withdrawal by Subject|8
4884928|NCT00730015|16832923|P2|Overall Study|Withdrawal by Subject|12
4884929|NCT00730015|16832924|P1|Overall Study|Withdrawal by Subject|12
4884930|NCT00730015|16832922|P3|Overall Study|Protocol Violation|4
4884931|NCT00730015|16832923|P2|Overall Study|Protocol Violation|6
4884932|NCT00730015|16832924|P1|Overall Study|Protocol Violation|2
4884933|NCT00730015|16832922|P3|Overall Study|Adverse Event|8
4884934|NCT00730015|16832923|P2|Overall Study|Adverse Event|10
4884935|NCT00730015|16832924|P1|Overall Study|Adverse Event|11
4884936|NCT00729937|16832964|P6|Overall Study|Incarcerated|0
4884937|NCT00729937|16832965|P5|Overall Study|Incarcerated|0
4884938|NCT00729937|16832966|P4|Overall Study|Incarcerated|1
4884939|NCT00729937|16832967|P3|Overall Study|Incarcerated|1
4884940|NCT00729937|16832968|P2|Overall Study|Incarcerated|2
4884941|NCT00729937|16832969|P1|Overall Study|Incarcerated|0
4884942|NCT00729937|16832964|P6|Overall Study|Did not meet eligibility criteria|0
4884943|NCT00729937|16832965|P5|Overall Study|Did not meet eligibility criteria|0
4884944|NCT00729937|16832966|P4|Overall Study|Did not meet eligibility criteria|0
4884945|NCT00729937|16832967|P3|Overall Study|Did not meet eligibility criteria|0
4884946|NCT00729937|16832968|P2|Overall Study|Did not meet eligibility criteria|1
4884947|NCT00729937|16832969|P1|Overall Study|Did not meet eligibility criteria|2
4884948|NCT00729937|16832964|P6|Overall Study|Randomized but not treated|3
4884949|NCT00729937|16832965|P5|Overall Study|Randomized but not treated|1
4884950|NCT00729937|16832966|P4|Overall Study|Randomized but not treated|0
4884951|NCT00729937|16832967|P3|Overall Study|Randomized but not treated|1
4884952|NCT00729937|16832968|P2|Overall Study|Randomized but not treated|6
4884953|NCT00729937|16832969|P1|Overall Study|Randomized but not treated|12
4884954|NCT00729937|16832964|P6|Overall Study|Withdrawal by Subject|2
4884955|NCT00729937|16832965|P5|Overall Study|Withdrawal by Subject|4
4884956|NCT00729937|16832966|P4|Overall Study|Withdrawal by Subject|0
4884957|NCT00729937|16832967|P3|Overall Study|Withdrawal by Subject|6
4884958|NCT00729937|16832968|P2|Overall Study|Withdrawal by Subject|5
4884959|NCT00729937|16832969|P1|Overall Study|Withdrawal by Subject|3
4884960|NCT00729937|16832964|P6|Overall Study|Death|1
4884961|NCT00729937|16832965|P5|Overall Study|Death|0
4884962|NCT00729937|16832966|P4|Overall Study|Death|0
4884963|NCT00729937|16832967|P3|Overall Study|Death|1
4884964|NCT00729937|16832968|P2|Overall Study|Death|0
4884965|NCT00729937|16832969|P1|Overall Study|Death|1
4884966|NCT00729937|16832964|P6|Overall Study|Physician Decision|8
4884967|NCT00729937|16832965|P5|Overall Study|Physician Decision|5
4884968|NCT00729937|16832966|P4|Overall Study|Physician Decision|0
4884969|NCT00729937|16832967|P3|Overall Study|Physician Decision|2
4884970|NCT00729937|16832968|P2|Overall Study|Physician Decision|16
4884971|NCT00729937|16832969|P1|Overall Study|Physician Decision|7
4884972|NCT00729937|16832964|P6|Overall Study|Lost to Follow-up|23
4884973|NCT00729937|16832965|P5|Overall Study|Lost to Follow-up|18
4884974|NCT00729937|16832966|P4|Overall Study|Lost to Follow-up|33
4884975|NCT00729937|16832967|P3|Overall Study|Lost to Follow-up|18
4884976|NCT00729937|16832968|P2|Overall Study|Lost to Follow-up|58
4884977|NCT00729937|16832969|P1|Overall Study|Lost to Follow-up|49
4884978|NCT00729859|16833173|P3|Overall Study|Withdrawal by Subject|0
4884979|NCT00729859|16833174|P2|Overall Study|Withdrawal by Subject|1
4884980|NCT00729859|16833175|P1|Overall Study|Withdrawal by Subject|0
4884981|NCT00729859|16833173|P3|Overall Study|Adverse Event|0
4884982|NCT00729859|16833174|P2|Overall Study|Adverse Event|1
4884983|NCT00729859|16833175|P1|Overall Study|Adverse Event|0
4884984|NCT00729833|16833219|P4|Overall Study|Unspecified Reasons|1
4884985|NCT00729833|16833220|P3|Overall Study|Unspecified Reasons|5
4884986|NCT00729833|16833221|P2|Overall Study|Unspecified Reasons|5
4884987|NCT00729833|16833222|P1|Overall Study|Unspecified Reasons|11
4884988|NCT00729833|16833219|P4|Overall Study|Withdrawal by Subject|0
4884989|NCT00729833|16833220|P3|Overall Study|Withdrawal by Subject|3
4884990|NCT00729833|16833221|P2|Overall Study|Withdrawal by Subject|1
4884991|NCT00729833|16833222|P1|Overall Study|Withdrawal by Subject|3
4884992|NCT00729833|16833219|P4|Overall Study|Lost to Follow-up|0
4884993|NCT00729833|16833220|P3|Overall Study|Lost to Follow-up|0
4884994|NCT00729833|16833221|P2|Overall Study|Lost to Follow-up|0
4884995|NCT00729833|16833222|P1|Overall Study|Lost to Follow-up|1
4884996|NCT00729833|16833219|P4|Overall Study|Study Terminated by Sponsor|0
4884997|NCT00729833|16833220|P3|Overall Study|Study Terminated by Sponsor|1
4884998|NCT00729833|16833221|P2|Overall Study|Study Terminated by Sponsor|0
4884999|NCT00729833|16833222|P1|Overall Study|Study Terminated by Sponsor|0
4885000|NCT00729833|16833219|P4|Overall Study|Death|5
4885001|NCT00729833|16833220|P3|Overall Study|Death|3
4885002|NCT00729833|16833221|P2|Overall Study|Death|1
4885003|NCT00729833|16833222|P1|Overall Study|Death|5
4885004|NCT00729690|16833280|P3|Overall Study|IT Catheter Malfunction|2
4885005|NCT00729690|16833281|P2|Overall Study|IT Catheter Malfunction|2
4885006|NCT00729690|16833282|P1|Overall Study|IT Catheter Malfunction|0
4885007|NCT00729651|16833312|P2|Overall Study|Subject's private reason|0
4885008|NCT00729651|16833313|P1|Overall Study|Subject's private reason|2
4885009|NCT00729651|16833312|P2|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4
4885010|NCT00729651|16833313|P1|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0
4885011|NCT00729651|16833312|P2|Overall Study|Adverse Event|3
4885012|NCT00729651|16833313|P1|Overall Study|Adverse Event|7
4885013|NCT00729651|16833312|P2|Overall Study|Protocol Violation|1
4885014|NCT00729651|16833313|P1|Overall Study|Protocol Violation|0
4885015|NCT00729651|16833312|P2|Overall Study|Lost to Follow-up|4
4885016|NCT00729651|16833313|P1|Overall Study|Lost to Follow-up|5
4885017|NCT00729651|16833312|P2|Overall Study|Withdrawal by Subject|6
4885018|NCT00729651|16833313|P1|Overall Study|Withdrawal by Subject|5
4885019|NCT00729612|16833325|P1|Overall Study|Non evaluable for response|10
4885020|NCT00729586|16833334|P2|Overall Study|never treated|0
4885021|NCT00729586|16833335|P1|Overall Study|never treated|1
4885022|NCT00729586|16833334|P2|Overall Study|Ineligible|1
4885023|NCT00729586|16833335|P1|Overall Study|Ineligible|0
4885024|NCT00729560|16833348|P1|Overall Study|Withdrawal by Subject|3
4885025|NCT00729469|16833374|P2|Overall Study|Other-Not mentioned|4
4885026|NCT00729469|16833375|P1|Overall Study|Other-Not mentioned|9
4885027|NCT00729469|16833374|P2|Overall Study|Withdrawal by Subject|8
4885028|NCT00729469|16833375|P1|Overall Study|Withdrawal by Subject|19
4885029|NCT00729469|16833374|P2|Overall Study|Protocol Violation|1
4885030|NCT00729469|16833375|P1|Overall Study|Protocol Violation|2
4885031|NCT00729469|16833374|P2|Overall Study|Lost to Follow-up|9
4885032|NCT00729469|16833375|P1|Overall Study|Lost to Follow-up|9
4885033|NCT00729469|16833374|P2|Overall Study|Adverse Event|25
4885034|NCT00729469|16833375|P1|Overall Study|Adverse Event|14
4885035|NCT00729378|16833428|P2|36-months|Lost to Follow-up|6
4885036|NCT00729378|16833429|P1|36-months|Lost to Follow-up|15
4885037|NCT00729378|16833428|P2|24-months|Lost to Follow-up|51
4885038|NCT00729378|16833429|P1|24-months|Lost to Follow-up|72
4885039|NCT00729378|16833428|P2|12-months|Lost to Follow-up|65
4885040|NCT00729378|16833429|P1|12-months|Lost to Follow-up|100
4885041|NCT00729378|16833428|P2|Baseline|Withdrawal by Subject|59
4885042|NCT00729378|16833429|P1|Baseline|Withdrawal by Subject|66
4885043|NCT00729378|16833428|P2|Baseline|Did not complete study measurements|33
4885044|NCT00729378|16833429|P1|Baseline|Did not complete study measurements|72
4885045|NCT00729365|16833628|P3|Overall Study|Physician Decision|7
4885046|NCT00729365|16833629|P2|Overall Study|Physician Decision|6
4885047|NCT00729365|16833630|P1|Overall Study|Physician Decision|33
4885048|NCT00729326|16833643|P2|Overall Study|Sponsor Decision|2
4885049|NCT00729326|16833644|P1|Overall Study|Sponsor Decision|1
4885050|NCT00729326|16833643|P2|Overall Study|Subject Decision|4
4885051|NCT00729326|16833644|P1|Overall Study|Subject Decision|4
4885052|NCT00729326|16833643|P2|Overall Study|Protocol Violation|2
4885053|NCT00729326|16833644|P1|Overall Study|Protocol Violation|3
4885054|NCT00729326|16833643|P2|Overall Study|Physician Decision|1
4885055|NCT00729326|16833644|P1|Overall Study|Physician Decision|0
4885056|NCT00729326|16833643|P2|Overall Study|Lost to Follow-up|0
4885057|NCT00729326|16833644|P1|Overall Study|Lost to Follow-up|2
4885058|NCT00729248|16833686|P1|Overall Study|Physician Decision|2
4885059|NCT00729183|16833693|P2|Overall Study|Withdrawal by Subject|7
4885060|NCT00729183|16833694|P1|Overall Study|Withdrawal by Subject|9
4885061|NCT00729183|16833693|P2|Overall Study|Protocol Violation|0
4885062|NCT00729183|16833694|P1|Overall Study|Protocol Violation|1
4885063|NCT00729183|16833693|P2|Overall Study|Physician Decision|1
4885064|NCT00729183|16833694|P1|Overall Study|Physician Decision|1
4885065|NCT00729183|16833693|P2|Overall Study|Lost to Follow-up|1
4885066|NCT00729183|16833694|P1|Overall Study|Lost to Follow-up|3
4885067|NCT00729183|16833693|P2|Overall Study|Lack of Efficacy|1
4885068|NCT00729183|16833694|P1|Overall Study|Lack of Efficacy|0
4885069|NCT00729183|16833693|P2|Overall Study|Adverse Event|5
4885070|NCT00729183|16833694|P1|Overall Study|Adverse Event|11
4885071|NCT00729157|16833726|P1|Overall Study|Withdrawal by Subject|1
4885072|NCT00728988|16833769|P2|Overall Study|Withdrawal by Subject|6
4885073|NCT00728988|16833770|P1|Overall Study|Withdrawal by Subject|2
4885074|NCT00728988|16833769|P2|Overall Study|Other|77
4885075|NCT00728988|16833770|P1|Overall Study|Other|85
4885076|NCT00728988|16833769|P2|Overall Study|Adverse Event|2
4885077|NCT00728988|16833770|P1|Overall Study|Adverse Event|3
4885078|NCT00728988|16833769|P2|Overall Study|Death|1
4885079|NCT00728988|16833770|P1|Overall Study|Death|1
4885080|NCT00728988|16833769|P2|Overall Study|Not Treated|2
4885081|NCT00728988|16833770|P1|Overall Study|Not Treated|2
4885082|NCT00728962|16833788|P1|Two Year Post Placement Follow-up|Lost to Follow-up|3
4885083|NCT00728962|16833788|P1|Permanent Prosthesis Placement|Adverse Event|3
4885084|NCT00728962|16833788|P1|Implant Placement Surgery|Protocol Violation|1
4885085|NCT00728962|16833788|P1|Implant Placement Surgery|Lost to Follow-up|1
4885086|NCT00728962|16833788|P1|Implant Placement Surgery|Adverse Event|8
4885087|NCT00728949|16833794|P2|Overall Study|On treatment at cutoff date|0
4885088|NCT00728949|16833795|P1|Overall Study|On treatment at cutoff date|1
4885089|NCT00728949|16833794|P2|Overall Study|Abnormal Lab Results|2
4885090|NCT00728949|16833795|P1|Overall Study|Abnormal Lab Results|0
4885091|NCT00728949|16833794|P2|Overall Study|Withdrawal by Subject|2
4885092|NCT00728949|16833795|P1|Overall Study|Withdrawal by Subject|2
4885093|NCT00728949|16833794|P2|Overall Study|Adverse Event|0
4885094|NCT00728949|16833795|P1|Overall Study|Adverse Event|8
4885095|NCT00728936|16833820|P7|Overall Study|Withdrawal by Subject|0
4885096|NCT00728936|16833821|P6|Overall Study|Withdrawal by Subject|1
4885097|NCT00728936|16833822|P5|Overall Study|Withdrawal by Subject|0
4885098|NCT00728936|16833823|P4|Overall Study|Withdrawal by Subject|0
4885099|NCT00728936|16833824|P3|Overall Study|Withdrawal by Subject|0
4885100|NCT00728936|16833825|P2|Overall Study|Withdrawal by Subject|0
4885101|NCT00728936|16833826|P1|Overall Study|Withdrawal by Subject|0
4885102|NCT00728884|16833859|P1|One Year Post Placement Follow-up|Lost to Follow-up|4
4885103|NCT00728884|16833859|P1|Permanent Prosthesis Placement|Lost to Follow-up|13
4885104|NCT00728754|16833895|P2|One Year Post Placement Follow-up|Adverse Event|0
4885105|NCT00728754|16833896|P1|One Year Post Placement Follow-up|Adverse Event|1
4885106|NCT00728754|16833895|P2|Permanent Prosthesis Placement|Lost to Follow-up|3
4885107|NCT00728754|16833896|P1|Permanent Prosthesis Placement|Lost to Follow-up|3
4885108|NCT00728754|16833895|P2|Permanent Prosthesis Placement|Adverse Event|1
4885109|NCT00728754|16833896|P1|Permanent Prosthesis Placement|Adverse Event|1
4885110|NCT00728689|16833925|P2|Washout Period (Days 4 - 10)|Death in family|0
4885111|NCT00728689|16833926|P1|Washout Period (Days 4 - 10)|Death in family|1
4885112|NCT00728494|16833955|P2|Overall Study|No data available|1
4885113|NCT00728494|16833956|P1|Overall Study|No data available|0
4885114|NCT00728494|16833955|P2|Overall Study|Lack of Efficacy|4
4885115|NCT00728494|16833956|P1|Overall Study|Lack of Efficacy|2
4885116|NCT00728494|16833955|P2|Overall Study|Withdrawal by Subject|2
4885117|NCT00728494|16833956|P1|Overall Study|Withdrawal by Subject|0
4885118|NCT00728494|16833955|P2|Overall Study|Adverse Event|0
4885119|NCT00728494|16833956|P1|Overall Study|Adverse Event|7
4885120|NCT00728481|16833974|P2|Overall Study|Incorrectly assigned to opposite arm|0
4885121|NCT00728481|16833975|P1|Overall Study|Incorrectly assigned to opposite arm|1
4885122|NCT00728481|16833974|P2|Overall Study|Study medication non-compliance|2
4885123|NCT00728481|16833975|P1|Overall Study|Study medication non-compliance|0
4885124|NCT00728481|16833974|P2|Overall Study|Adverse Event|1
4885125|NCT00728481|16833975|P1|Overall Study|Adverse Event|0
4885126|NCT00728481|16833974|P2|Overall Study|Withdrawal by Subject|1
4885127|NCT00728481|16833975|P1|Overall Study|Withdrawal by Subject|0
4885128|NCT00728468|16833991|P1|Overall Study|Study terminated by sponsor|1
4885129|NCT00728468|16833991|P1|Overall Study|Objective progression or relapse|9
4885130|NCT00728468|16833991|P1|Overall Study|Protocol Violation|4
4885131|NCT00728468|16833991|P1|Overall Study|Death|1
4885132|NCT00728468|16833991|P1|Overall Study|Enrolled but not treated|1
4885133|NCT00728416|16834015|P2|Overall Study|Withdrawal by Subject|0
4885134|NCT00728416|16834016|P1|Overall Study|Withdrawal by Subject|1
4885135|NCT00728416|16834015|P2|Overall Study|Treatment Failure|1
4885136|NCT00728416|16834016|P1|Overall Study|Treatment Failure|0
4885137|NCT00728416|16834015|P2|Overall Study|Adverse Event|1
4885138|NCT00728416|16834016|P1|Overall Study|Adverse Event|1
4885139|NCT00728182|16834032|P2|Overall Study|Protocol Noncompliance|1
4885140|NCT00728182|16834033|P1|Overall Study|Protocol Noncompliance|0
4885141|NCT00728182|16834032|P2|Overall Study|Death|2
4885142|NCT00728182|16834033|P1|Overall Study|Death|0
4885143|NCT00728182|16834032|P2|Overall Study|Lost to Follow-up|0
4885144|NCT00728182|16834033|P1|Overall Study|Lost to Follow-up|2
4885145|NCT00728182|16834032|P2|Overall Study|Adverse Event|0
4885146|NCT00728182|16834033|P1|Overall Study|Adverse Event|1
4885147|NCT00728130|16834061|P1|Overall Study|Physician Decision|1
4885148|NCT00728130|16834061|P1|Overall Study|Paperwork not completed in time|1
4885149|NCT00728130|16834061|P1|Overall Study|Withdrawal by Subject|1
4885150|NCT00727961|16834066|P1|Overall Study|Progression|30
4885151|NCT00727961|16834066|P1|Overall Study|Patient's refusal|2
4885152|NCT00727961|16834066|P1|Overall Study|Adverse Event|4
4885153|NCT00727961|16834066|P1|Overall Study|Lost to Follow-up|1
4885154|NCT00727909|16834076|P4|Overall Study|Death|0
4885155|NCT00727909|16834077|P3|Overall Study|Death|1
4885156|NCT00727909|16834078|P2|Overall Study|Death|0
4885157|NCT00727909|16834079|P1|Overall Study|Death|0
4885158|NCT00727909|16834076|P4|Overall Study|Withdrawal by Subject|5
4885159|NCT00727909|16834077|P3|Overall Study|Withdrawal by Subject|8
4885160|NCT00727909|16834078|P2|Overall Study|Withdrawal by Subject|11
4885161|NCT00727909|16834079|P1|Overall Study|Withdrawal by Subject|5
4885162|NCT00727844|16834176|P4|Initial Randomization|Physician Decision|0
4885163|NCT00727844|16834177|P3|Initial Randomization|Physician Decision|0
4885164|NCT00727844|16834178|P2|Initial Randomization|Physician Decision|0
4885165|NCT00727844|16834179|P1|Initial Randomization|Physician Decision|2
4885166|NCT00727714|16834193|P1|Overall Study|Lost to Follow-up|2
4885167|NCT00727649|16834203|P2|Second Intervention (4-weeks)|Withdrawal by Subject|2
4885168|NCT00727649|16834204|P1|Second Intervention (4-weeks)|Withdrawal by Subject|0
4885169|NCT00727649|16834203|P2|Second Intervention (4-weeks)|Lost to Follow-up|1
4885170|NCT00727649|16834204|P1|Second Intervention (4-weeks)|Lost to Follow-up|0
4885171|NCT00727649|16834203|P2|Second Intervention (4-weeks)|Death|0
4885172|NCT00727649|16834204|P1|Second Intervention (4-weeks)|Death|1
4885173|NCT00727649|16834203|P2|Wash-out (2-weeks)|Withdrawal by Subject|2
4885174|NCT00727649|16834204|P1|Wash-out (2-weeks)|Withdrawal by Subject|1
4885175|NCT00727649|16834203|P2|Wash-out (2-weeks)|Lost to Follow-up|1
4885176|NCT00727649|16834204|P1|Wash-out (2-weeks)|Lost to Follow-up|3
4885177|NCT00727649|16834203|P2|First Intervention (4-weeks)|Withdrawal by Subject|1
4885178|NCT00727649|16834204|P1|First Intervention (4-weeks)|Withdrawal by Subject|2
4885179|NCT00727649|16834203|P2|First Intervention (4-weeks)|Lost to Follow-up|2
4885180|NCT00727649|16834204|P1|First Intervention (4-weeks)|Lost to Follow-up|1
4885181|NCT00727571|16834246|P4|Overall Study|Other|0
4885182|NCT00727571|16834247|P3|Overall Study|Other|6
4885183|NCT00727571|16834248|P2|Overall Study|Other|4
4885184|NCT00727571|16834249|P1|Overall Study|Other|0
4885185|NCT00727571|16834246|P4|Overall Study|AE not leading to hospitalization|0
4885186|NCT00727571|16834247|P3|Overall Study|AE not leading to hospitalization|2
4885187|NCT00727571|16834248|P2|Overall Study|AE not leading to hospitalization|0
4885188|NCT00727571|16834249|P1|Overall Study|AE not leading to hospitalization|0
4885189|NCT00727571|16834246|P4|Overall Study|Hospitalization|1
4885190|NCT00727571|16834247|P3|Overall Study|Hospitalization|0
4885191|NCT00727571|16834248|P2|Overall Study|Hospitalization|1
4885192|NCT00727571|16834249|P1|Overall Study|Hospitalization|0
4885193|NCT00727571|16834246|P4|Overall Study|Dismissed from nursing home|0
4885194|NCT00727571|16834247|P3|Overall Study|Dismissed from nursing home|5
4885195|NCT00727571|16834248|P2|Overall Study|Dismissed from nursing home|9
4885196|NCT00727571|16834249|P1|Overall Study|Dismissed from nursing home|0
4885197|NCT00727571|16834246|P4|Overall Study|Subject Non Compliance|4
4885198|NCT00727571|16834247|P3|Overall Study|Subject Non Compliance|0
4885199|NCT00727571|16834248|P2|Overall Study|Subject Non Compliance|6
4885200|NCT00727571|16834249|P1|Overall Study|Subject Non Compliance|0
4885201|NCT00727571|16834246|P4|Overall Study|Withdrawal by Subject|0
4885202|NCT00727571|16834247|P3|Overall Study|Withdrawal by Subject|11
4885203|NCT00727571|16834248|P2|Overall Study|Withdrawal by Subject|10
4885204|NCT00727571|16834249|P1|Overall Study|Withdrawal by Subject|0
4885205|NCT00727571|16834246|P4|Overall Study|Physician Decision|0
4885206|NCT00727571|16834247|P3|Overall Study|Physician Decision|0
4885207|NCT00727571|16834248|P2|Overall Study|Physician Decision|5
4885208|NCT00727571|16834249|P1|Overall Study|Physician Decision|0
4885209|NCT00727571|16834246|P4|Overall Study|Death|1
4885210|NCT00727571|16834247|P3|Overall Study|Death|5
4885211|NCT00727571|16834248|P2|Overall Study|Death|19
4885212|NCT00727571|16834249|P1|Overall Study|Death|0
4885213|NCT00727571|16834246|P4|Overall Study|Ineligibility determined|0
4885214|NCT00727571|16834247|P3|Overall Study|Ineligibility determined|1
4885215|NCT00727571|16834248|P2|Overall Study|Ineligibility determined|1
4885216|NCT00727571|16834249|P1|Overall Study|Ineligibility determined|1
4885217|NCT00727558|16834276|P2|Overall Study|Lost to Follow-up|0
4885218|NCT00727558|16834277|P1|Overall Study|Lost to Follow-up|1
4885219|NCT00727558|16834276|P2|Overall Study|Subject unable to return for follow-up|1
4885220|NCT00727558|16834277|P1|Overall Study|Subject unable to return for follow-up|1
4885221|NCT00727558|16834276|P2|Overall Study|Adverse Event|1
4885222|NCT00727558|16834277|P1|Overall Study|Adverse Event|0
4885223|NCT00727558|16834276|P2|Overall Study|Lens issue|1
4885224|NCT00727558|16834277|P1|Overall Study|Lens issue|0
4885225|NCT00727532|16834295|P1|Overall Study|Withdrawal by Subject|1
4885226|NCT00727532|16834295|P1|Overall Study|Adverse Event|1
4885227|NCT00727506|16834307|P6|Overall Study|Other reason not described above|1
4885228|NCT00727506|16834308|P5|Overall Study|Other reason not described above|1
4885229|NCT00727506|16834309|P4|Overall Study|Other reason not described above|4
4885230|NCT00727506|16834310|P3|Overall Study|Other reason not described above|1
4885231|NCT00727506|16834311|P2|Overall Study|Other reason not described above|0
4885232|NCT00727506|16834312|P1|Overall Study|Other reason not described above|0
4885233|NCT00727506|16834307|P6|Overall Study|Refused to continue medication|2
4885234|NCT00727506|16834308|P5|Overall Study|Refused to continue medication|1
4885235|NCT00727506|16834309|P4|Overall Study|Refused to continue medication|3
4885236|NCT00727506|16834310|P3|Overall Study|Refused to continue medication|2
4885237|NCT00727506|16834311|P2|Overall Study|Refused to continue medication|1
4885238|NCT00727506|16834312|P1|Overall Study|Refused to continue medication|0
4885239|NCT00727506|16834307|P6|Overall Study|Progressive disease|28
4885240|NCT00727506|16834308|P5|Overall Study|Progressive disease|38
4885241|NCT00727506|16834309|P4|Overall Study|Progressive disease|28
4885242|NCT00727506|16834310|P3|Overall Study|Progressive disease|9
4885243|NCT00727506|16834311|P2|Overall Study|Progressive disease|7
4885244|NCT00727506|16834312|P1|Overall Study|Progressive disease|4
4885245|NCT00727506|16834307|P6|Overall Study|Dose Limiting Toxicity (DLT)|0
4885246|NCT00727506|16834308|P5|Overall Study|Dose Limiting Toxicity (DLT)|0
4885247|NCT00727506|16834309|P4|Overall Study|Dose Limiting Toxicity (DLT)|0
4885248|NCT00727506|16834310|P3|Overall Study|Dose Limiting Toxicity (DLT)|2
4885249|NCT00727506|16834311|P2|Overall Study|Dose Limiting Toxicity (DLT)|0
4885250|NCT00727506|16834312|P1|Overall Study|Dose Limiting Toxicity (DLT)|2
4885251|NCT00727506|16834307|P6|Overall Study|Adverse Event|8
4885252|NCT00727506|16834308|P5|Overall Study|Adverse Event|1
4885253|NCT00727506|16834309|P4|Overall Study|Adverse Event|4
4885254|NCT00727506|16834310|P3|Overall Study|Adverse Event|4
4885255|NCT00727506|16834311|P2|Overall Study|Adverse Event|0
4885256|NCT00727506|16834312|P1|Overall Study|Adverse Event|0
4885257|NCT00727441|16834408|P3|Overall Study|Withdrawal by Subject|0
4885258|NCT00727441|16834409|P2|Overall Study|Withdrawal by Subject|1
4885259|NCT00727441|16834410|P1|Overall Study|Withdrawal by Subject|0
4885260|NCT00727441|16834408|P3|Overall Study|Physician Decision|0
4885261|NCT00727441|16834409|P2|Overall Study|Physician Decision|1
4885262|NCT00727441|16834410|P1|Overall Study|Physician Decision|0
4885263|NCT00727441|16834408|P3|Overall Study|Death|1
4885264|NCT00727441|16834409|P2|Overall Study|Death|1
4885265|NCT00727441|16834410|P1|Overall Study|Death|0
4885266|NCT00727441|16834408|P3|Overall Study|Eligibility|7
4885267|NCT00727441|16834409|P2|Overall Study|Eligibility|5
4885268|NCT00727441|16834410|P1|Overall Study|Eligibility|7
4885269|NCT00727441|16834408|P3|Overall Study|Disease Progression|17
4885270|NCT00727441|16834409|P2|Overall Study|Disease Progression|14
4885271|NCT00727441|16834410|P1|Overall Study|Disease Progression|11
4885272|NCT00727415|16834430|P1|Phase I|Dose Limiting Toxicity|2
4885273|NCT00727402|16834439|P1|Overall Study|Physician Decision|116
4885274|NCT00727311|16834468|P1|Overall Study|Multiple reasons|39
4885275|NCT00727311|16834468|P1|Overall Study|Other|97
4885276|NCT00727311|16834468|P1|Overall Study|Withdrawal by Subject|77
4885277|NCT00727311|16834468|P1|Overall Study|Lost to Follow-up|73
4885278|NCT00727311|16834468|P1|Overall Study|Lack of Efficacy|242
4885279|NCT00727311|16834468|P1|Overall Study|Adverse Event|58
4885280|NCT00727311|16834468|P1|Overall Study|Missing end of therapy data|205
4885281|NCT00727311|16834468|P1|Overall Study|Did not receive drug|316
4885282|NCT00727272|16834481|P3|Washout Period B|Withdrawal by Subject|1
4885283|NCT00727272|16834482|P2|Washout Period B|Withdrawal by Subject|0
4885284|NCT00727272|16834483|P1|Washout Period B|Withdrawal by Subject|0
4885285|NCT00727272|16834481|P3|Washout Period A|Adverse Event|1
4885286|NCT00727272|16834482|P2|Washout Period A|Adverse Event|0
4885287|NCT00727272|16834483|P1|Washout Period A|Adverse Event|0
4885288|NCT00727259|16834500|P1|Overall Study|Not all questionnaires completed|1055
4885289|NCT00727246|16834509|P4|Overall Study|withdrawn|0
4885290|NCT00727246|16834510|P3|Overall Study|withdrawn|1
4885291|NCT00727246|16834511|P2|Overall Study|withdrawn|0
4885292|NCT00727246|16834512|P1|Overall Study|withdrawn|0
4885293|NCT00727246|16834509|P4|Overall Study|incidental finding|1
4885294|NCT00727246|16834510|P3|Overall Study|incidental finding|0
4885295|NCT00727246|16834511|P2|Overall Study|incidental finding|0
4885296|NCT00727246|16834512|P1|Overall Study|incidental finding|0
4885297|NCT00727246|16834509|P4|Overall Study|could not complete MRI|1
4885298|NCT00727246|16834510|P3|Overall Study|could not complete MRI|0
4885299|NCT00727246|16834511|P2|Overall Study|could not complete MRI|1
4885300|NCT00727246|16834512|P1|Overall Study|could not complete MRI|0
4885301|NCT00727194|16834535|P3|Treatment Period 2|Lack of Efficacy|0
4885302|NCT00727194|16834536|P2|Treatment Period 2|Lack of Efficacy|1
4885303|NCT00727194|16834537|P1|Treatment Period 2|Lack of Efficacy|0
4885304|NCT00727194|16834535|P3|Screening Period|History of thymoma|1
4885305|NCT00727194|16834536|P2|Screening Period|History of thymoma|0
4885306|NCT00727194|16834537|P1|Screening Period|History of thymoma|0
4885307|NCT00727194|16834535|P3|Screening Period|Severe infections|2
4885308|NCT00727194|16834536|P2|Screening Period|Severe infections|0
4885309|NCT00727194|16834537|P1|Screening Period|Severe infections|0
4885310|NCT00727194|16834535|P3|Screening Period|Not stable on concomitant MG therapy|2
4885311|NCT00727194|16834536|P2|Screening Period|Not stable on concomitant MG therapy|0
4885312|NCT00727194|16834537|P1|Screening Period|Not stable on concomitant MG therapy|0
4885313|NCT00727194|16834535|P3|Screening Period|Lacked AChR antibodies|5
4885314|NCT00727194|16834536|P2|Screening Period|Lacked AChR antibodies|0
4885315|NCT00727194|16834537|P1|Screening Period|Lacked AChR antibodies|0
4885316|NCT00727194|16834535|P3|Screening Period|Low QMG scores|6
4885317|NCT00727194|16834536|P2|Screening Period|Low QMG scores|0
4885318|NCT00727194|16834537|P1|Screening Period|Low QMG scores|0
4885319|NCT00727025|16834609|P1|Overall Study|Physician Decision|23
4885320|NCT00726999|16834621|P2|Overall Study|Protocol Violation|0
4885321|NCT00726999|16834622|P1|Overall Study|Protocol Violation|1
4885322|NCT00726999|16834621|P2|Overall Study|Withdrawal by Subject|0
4885323|NCT00726999|16834622|P1|Overall Study|Withdrawal by Subject|2
4885324|NCT00726999|16834621|P2|Overall Study|Physician Decision|1
4885325|NCT00726999|16834622|P1|Overall Study|Physician Decision|0
4885326|NCT00726986|16834634|P1|Maintenance Phase|Lack of Efficacy|2
4885327|NCT00726986|16834634|P1|Maintenance Phase|Adverse Event|1
4885328|NCT00726986|16834634|P1|Induction Phase|Secondary Disease|2
4885329|NCT00726986|16834634|P1|Induction Phase|Lack of Efficacy|5
4885330|NCT00726986|16834634|P1|Induction Phase|Death|2
4885331|NCT00726986|16834634|P1|Induction Phase|Withdrawal by Subject|2
4885332|NCT00726986|16834634|P1|Induction Phase|Adverse Event|4
4885333|NCT00726895|16834641|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4885334|NCT00726895|16834642|P1|Washout Period of 7 Days|Withdrawal by Subject|0
4885335|NCT00726882|16834655|P1|Overall Study|Other|10
4885336|NCT00726882|16834655|P1|Overall Study|Lost to Follow-up|7
4885337|NCT00726882|16834655|P1|Overall Study|Withdrawal by Subject|5
4885338|NCT00726752|16834670|P1|Overall Study|Lack of Efficacy|6
4885339|NCT00726661|16834732|P2|Overall Study|Other|35
4885340|NCT00726661|16834733|P1|Overall Study|Other|47
4885341|NCT00726661|16834732|P2|Overall Study|Physician Decision|13
4885342|NCT00726661|16834733|P1|Overall Study|Physician Decision|25
4885343|NCT00726661|16834732|P2|Overall Study|Death|159
4885344|NCT00726661|16834733|P1|Overall Study|Death|475
4885345|NCT00726661|16834732|P2|Overall Study|Trial terminated by sponsor|187
4885346|NCT00726661|16834733|P1|Overall Study|Trial terminated by sponsor|214
4885347|NCT00726661|16834732|P2|Overall Study|Withdrawal by Subject|13
4885348|NCT00726661|16834733|P1|Overall Study|Withdrawal by Subject|17
4885349|NCT00726661|16834732|P2|Overall Study|Lost to Follow-up|11
4885350|NCT00726661|16834733|P1|Overall Study|Lost to Follow-up|36
4885351|NCT00726622|16834750|P2|Overall Study|Metastasis|0
4885352|NCT00726622|16834751|P1|Overall Study|Metastasis|2
4885353|NCT00726622|16834750|P2|Overall Study|Physician Decision|1
4885354|NCT00726622|16834751|P1|Overall Study|Physician Decision|0
4885355|NCT00726622|16834750|P2|Overall Study|Withdrawal by Subject|2
4885356|NCT00726622|16834751|P1|Overall Study|Withdrawal by Subject|16
4885357|NCT00726609|16834769|P1|Overall Study|Other|3
4885358|NCT00726609|16834769|P1|Overall Study|Missing|42
4885359|NCT00726609|16834769|P1|Overall Study|Other|16
4885360|NCT00726609|16834769|P1|Overall Study|Lack of Efficacy|25
4885361|NCT00726609|16834769|P1|Overall Study|Withdrawal by Subject|2
4885362|NCT00726609|16834769|P1|Overall Study|Adverse Event|10
4885363|NCT00726557|16834773|P1|Overall Study|Inclusion criteria not met|15
4885364|NCT00726557|16834773|P1|Overall Study|Treatment less than 3 months|17
4885365|NCT00726557|16834773|P1|Overall Study|No follow-up documentation available|55
4885366|NCT00726557|16834773|P1|Overall Study|No end of treatment documentation|37
4885367|NCT00726557|16834773|P1|Overall Study|Screening failure|4
4885368|NCT00726453|16834780|P2|38 mm Length Group|Death|3
4885369|NCT00726453|16834781|P1|38 mm Length Group|Death|0
4885370|NCT00726453|16834780|P2|Primary Enrollment Group|Withdrawal by Subject|0
4885371|NCT00726453|16834781|P1|Primary Enrollment Group|Withdrawal by Subject|13
4885372|NCT00726453|16834780|P2|Primary Enrollment Group|Death|0
4885373|NCT00726453|16834781|P1|Primary Enrollment Group|Death|18
4885374|NCT00726323|16834809|P2|Overall Study|Metastatic lesions inferred cyst|1
4885375|NCT00726323|16834810|P1|Overall Study|Metastatic lesions inferred cyst|0
4885376|NCT00726323|16834809|P2|Overall Study|Participant wished to discontinue|1
4885377|NCT00726323|16834810|P1|Overall Study|Participant wished to discontinue|0
4885378|NCT00726323|16834809|P2|Overall Study|Death|0
4885379|NCT00726323|16834810|P1|Overall Study|Death|1
4885380|NCT00726323|16834809|P2|Overall Study|Adverse Event|9
4885381|NCT00726323|16834810|P1|Overall Study|Adverse Event|9
4885382|NCT00726323|16834809|P2|Overall Study|Clinical progression|3
4885383|NCT00726323|16834810|P1|Overall Study|Clinical progression|0
4885384|NCT00726323|16834809|P2|Overall Study|Progressive disease|16
4885385|NCT00726323|16834810|P1|Overall Study|Progressive disease|23
4885386|NCT00726323|16834809|P2|Overall Study|Physician Decision|0
4885387|NCT00726323|16834810|P1|Overall Study|Physician Decision|1
4885388|NCT00726323|16834809|P2|Overall Study|Withdrawal by Subject|1
4885389|NCT00726323|16834810|P1|Overall Study|Withdrawal by Subject|3
4885390|NCT00726232|16834840|P8|Expansion Phase|Unspecified reason|0
4885391|NCT00726232|16834841|P7|Expansion Phase|Unspecified reason|1
4885392|NCT00726232|16834842|P6|Expansion Phase|Unspecified reason|0
4885393|NCT00726232|16834843|P5|Expansion Phase|Unspecified reason|0
4885394|NCT00726232|16834844|P4|Expansion Phase|Unspecified reason|0
4885395|NCT00726232|16834845|P3|Expansion Phase|Unspecified reason|0
4885396|NCT00726232|16834846|P2|Expansion Phase|Unspecified reason|0
4885397|NCT00726232|16834847|P1|Expansion Phase|Unspecified reason|0
4885398|NCT00726232|16834840|P8|Expansion Phase|Per Investigator: lack of response|7
4885399|NCT00726232|16834841|P7|Expansion Phase|Per Investigator: lack of response|1
4885400|NCT00726232|16834842|P6|Expansion Phase|Per Investigator: lack of response|0
4885401|NCT00726232|16834843|P5|Expansion Phase|Per Investigator: lack of response|0
4885402|NCT00726232|16834844|P4|Expansion Phase|Per Investigator: lack of response|0
4885403|NCT00726232|16834845|P3|Expansion Phase|Per Investigator: lack of response|0
4885404|NCT00726232|16834846|P2|Expansion Phase|Per Investigator: lack of response|0
4885405|NCT00726232|16834847|P1|Expansion Phase|Per Investigator: lack of response|0
4885406|NCT00726232|16834840|P8|Expansion Phase|Termination of the trial by sponsor|16
4885407|NCT00726232|16834841|P7|Expansion Phase|Termination of the trial by sponsor|10
4885408|NCT00726232|16834842|P6|Expansion Phase|Termination of the trial by sponsor|0
4885409|NCT00726232|16834843|P5|Expansion Phase|Termination of the trial by sponsor|0
4885410|NCT00726232|16834844|P4|Expansion Phase|Termination of the trial by sponsor|0
4885411|NCT00726232|16834845|P3|Expansion Phase|Termination of the trial by sponsor|0
4885412|NCT00726232|16834846|P2|Expansion Phase|Termination of the trial by sponsor|0
4885413|NCT00726232|16834847|P1|Expansion Phase|Termination of the trial by sponsor|0
4885414|NCT00726232|16834840|P8|Expansion Phase|Disease progression|0
4885415|NCT00726232|16834841|P7|Expansion Phase|Disease progression|4
4885416|NCT00726232|16834842|P6|Expansion Phase|Disease progression|0
4885417|NCT00726232|16834843|P5|Expansion Phase|Disease progression|0
4885418|NCT00726232|16834844|P4|Expansion Phase|Disease progression|0
4885419|NCT00726232|16834845|P3|Expansion Phase|Disease progression|0
4885420|NCT00726232|16834846|P2|Expansion Phase|Disease progression|0
4885421|NCT00726232|16834847|P1|Expansion Phase|Disease progression|0
4885422|NCT00726232|16834840|P8|Expansion Phase|Withdrawal by Subject|3
4885423|NCT00726232|16834841|P7|Expansion Phase|Withdrawal by Subject|2
4885424|NCT00726232|16834842|P6|Expansion Phase|Withdrawal by Subject|0
4885425|NCT00726232|16834843|P5|Expansion Phase|Withdrawal by Subject|0
4885426|NCT00726232|16834844|P4|Expansion Phase|Withdrawal by Subject|0
4885427|NCT00726232|16834845|P3|Expansion Phase|Withdrawal by Subject|0
4885428|NCT00726232|16834846|P2|Expansion Phase|Withdrawal by Subject|0
4885429|NCT00726232|16834847|P1|Expansion Phase|Withdrawal by Subject|0
4885430|NCT00726232|16834840|P8|Expansion Phase|Adverse Event|11
4885431|NCT00726232|16834841|P7|Expansion Phase|Adverse Event|6
4885432|NCT00726232|16834842|P6|Expansion Phase|Adverse Event|0
4885433|NCT00726232|16834843|P5|Expansion Phase|Adverse Event|0
4885434|NCT00726232|16834844|P4|Expansion Phase|Adverse Event|0
4885435|NCT00726232|16834845|P3|Expansion Phase|Adverse Event|0
4885436|NCT00726232|16834846|P2|Expansion Phase|Adverse Event|0
4885437|NCT00726232|16834847|P1|Expansion Phase|Adverse Event|0
4885438|NCT00726232|16834840|P8|Expansion Phase|Death|1
4885439|NCT00726232|16834841|P7|Expansion Phase|Death|0
4885440|NCT00726232|16834842|P6|Expansion Phase|Death|0
4885441|NCT00726232|16834843|P5|Expansion Phase|Death|0
4885442|NCT00726232|16834844|P4|Expansion Phase|Death|0
4885443|NCT00726232|16834845|P3|Expansion Phase|Death|0
4885444|NCT00726232|16834846|P2|Expansion Phase|Death|0
4885445|NCT00726232|16834847|P1|Expansion Phase|Death|0
4885446|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Unspecified reason|0
4885447|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Unspecified reason|0
4885448|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Unspecified reason|0
4885449|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Unspecified reason|0
4885450|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Unspecified reason|0
4885451|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Unspecified reason|0
4885452|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Unspecified reason|0
4885453|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Unspecified reason|1
4885454|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4885455|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4885456|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
4885457|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Per Investigator: lack of response|4
4885458|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Per Investigator: lack of response|2
4885459|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4885460|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Per Investigator: lack of response|0
4885461|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Per Investigator: lack of response|1
4885462|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
4885463|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0
4885464|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
4885465|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9
4885466|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
4885467|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
4885468|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3
4885469|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4
4885470|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Disease progression|0
4885471|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Disease progression|0
4885472|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Disease progression|0
4885473|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Disease progression|0
4885474|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Disease progression|0
4885475|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Disease progression|0
4885476|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Disease progression|1
4885477|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Disease progression|3
4885478|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4885479|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4885480|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Withdrawal by Subject|2
4885481|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4885482|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Withdrawal by Subject|1
4885483|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4885484|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Withdrawal by Subject|0
4885485|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Withdrawal by Subject|2
4885486|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Adverse Event|0
4885487|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Adverse Event|0
4885488|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Adverse Event|3
4885489|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Adverse Event|7
4885490|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Adverse Event|1
4885491|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Adverse Event|2
4885492|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Adverse Event|2
4885493|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Adverse Event|2
4885494|NCT00726232|16834840|P8|Initial Phase (Dose-finding)|Death|0
4885495|NCT00726232|16834841|P7|Initial Phase (Dose-finding)|Death|0
4885496|NCT00726232|16834842|P6|Initial Phase (Dose-finding)|Death|0
4885497|NCT00726232|16834843|P5|Initial Phase (Dose-finding)|Death|1
4885498|NCT00726232|16834844|P4|Initial Phase (Dose-finding)|Death|0
4885499|NCT00726232|16834845|P3|Initial Phase (Dose-finding)|Death|0
4885500|NCT00726232|16834846|P2|Initial Phase (Dose-finding)|Death|0
4885501|NCT00726232|16834847|P1|Initial Phase (Dose-finding)|Death|0
4885502|NCT00726063|16834899|P2|Overall Study|Adverse Event|7
4885503|NCT00726063|16834900|P1|Overall Study|Adverse Event|9
4885504|NCT00725985|16834914|P12|LTFU (No Cladribine Treatment)|Other|14
4885505|NCT00725985|16834915|P11|LTFU (No Cladribine Treatment)|Other|36
4885506|NCT00725985|16834916|P10|LTFU (No Cladribine Treatment)|Other|34
4885507|NCT00725985|16834917|P9|LTFU (No Cladribine Treatment)|Other|0
4885508|NCT00725985|16834918|P8|LTFU (No Cladribine Treatment)|Other|0
4885509|NCT00725985|16834919|P7|LTFU (No Cladribine Treatment)|Other|0
4885510|NCT00725985|16834920|P6|LTFU (No Cladribine Treatment)|Other|0
4885511|NCT00725985|16834921|P5|LTFU (No Cladribine Treatment)|Other|0
4885512|NCT00725985|16834922|P4|LTFU (No Cladribine Treatment)|Other|0
4885513|NCT00725985|16834923|P3|LTFU (No Cladribine Treatment)|Other|0
4885514|NCT00725985|16834924|P2|LTFU (No Cladribine Treatment)|Other|0
4885515|NCT00725985|16834925|P1|LTFU (No Cladribine Treatment)|Other|0
4885516|NCT00725985|16834914|P12|LTFU (With Cladribine Treatment)|Other|0
4885517|NCT00725985|16834915|P11|LTFU (With Cladribine Treatment)|Other|0
4885518|NCT00725985|16834916|P10|LTFU (With Cladribine Treatment)|Other|0
4885519|NCT00725985|16834917|P9|LTFU (With Cladribine Treatment)|Other|16
4885520|NCT00725985|16834918|P8|LTFU (With Cladribine Treatment)|Other|8
4885521|NCT00725985|16834919|P7|LTFU (With Cladribine Treatment)|Other|9
4885522|NCT00725985|16834920|P6|LTFU (With Cladribine Treatment)|Other|0
4885523|NCT00725985|16834921|P5|LTFU (With Cladribine Treatment)|Other|0
4885524|NCT00725985|16834922|P4|LTFU (With Cladribine Treatment)|Other|0
4885525|NCT00725985|16834923|P3|LTFU (With Cladribine Treatment)|Other|0
4885526|NCT00725985|16834924|P2|LTFU (With Cladribine Treatment)|Other|0
4885527|NCT00725985|16834925|P1|LTFU (With Cladribine Treatment)|Other|0
4885528|NCT00725985|16834914|P12|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885529|NCT00725985|16834915|P11|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885530|NCT00725985|16834916|P10|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885531|NCT00725985|16834917|P9|LTFU (With Cladribine Treatment)|Lost to Follow-up|1
4885532|NCT00725985|16834918|P8|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885533|NCT00725985|16834919|P7|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885534|NCT00725985|16834920|P6|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885535|NCT00725985|16834921|P5|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885536|NCT00725985|16834922|P4|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885537|NCT00725985|16834923|P3|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885538|NCT00725985|16834924|P2|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885539|NCT00725985|16834925|P1|LTFU (With Cladribine Treatment)|Lost to Follow-up|0
4885540|NCT00725985|16834914|P12|LTFU (With Cladribine Treatment)|Adverse Event|0
4885541|NCT00725985|16834915|P11|LTFU (With Cladribine Treatment)|Adverse Event|0
4885542|NCT00725985|16834916|P10|LTFU (With Cladribine Treatment)|Adverse Event|0
4885543|NCT00725985|16834917|P9|LTFU (With Cladribine Treatment)|Adverse Event|0
4885544|NCT00725985|16834918|P8|LTFU (With Cladribine Treatment)|Adverse Event|1
4885545|NCT00725985|16834919|P7|LTFU (With Cladribine Treatment)|Adverse Event|0
4885546|NCT00725985|16834920|P6|LTFU (With Cladribine Treatment)|Adverse Event|0
4885547|NCT00725985|16834921|P5|LTFU (With Cladribine Treatment)|Adverse Event|0
4885548|NCT00725985|16834922|P4|LTFU (With Cladribine Treatment)|Adverse Event|0
4885549|NCT00725985|16834923|P3|LTFU (With Cladribine Treatment)|Adverse Event|0
4885550|NCT00725985|16834924|P2|LTFU (With Cladribine Treatment)|Adverse Event|0
4885551|NCT00725985|16834925|P1|LTFU (With Cladribine Treatment)|Adverse Event|0
4885552|NCT00725985|16834914|P12|OLMP|Other|0
4885553|NCT00725985|16834915|P11|OLMP|Other|0
4885554|NCT00725985|16834916|P10|OLMP|Other|0
4885555|NCT00725985|16834917|P9|OLMP|Other|0
4885556|NCT00725985|16834918|P8|OLMP|Other|0
4885557|NCT00725985|16834919|P7|OLMP|Other|0
4885558|NCT00725985|16834920|P6|OLMP|Other|44
4885559|NCT00725985|16834921|P5|OLMP|Other|20
4885560|NCT00725985|16834922|P4|OLMP|Other|15
4885561|NCT00725985|16834923|P3|OLMP|Other|0
4885562|NCT00725985|16834924|P2|OLMP|Other|0
4885563|NCT00725985|16834925|P1|OLMP|Other|0
4885564|NCT00725985|16834914|P12|OLMP|Disease progression|0
4885565|NCT00725985|16834915|P11|OLMP|Disease progression|0
4885566|NCT00725985|16834916|P10|OLMP|Disease progression|0
4885567|NCT00725985|16834917|P9|OLMP|Disease progression|0
4885568|NCT00725985|16834918|P8|OLMP|Disease progression|0
4885569|NCT00725985|16834919|P7|OLMP|Disease progression|0
4885570|NCT00725985|16834920|P6|OLMP|Disease progression|4
4885571|NCT00725985|16834921|P5|OLMP|Disease progression|0
4885572|NCT00725985|16834922|P4|OLMP|Disease progression|0
4885573|NCT00725985|16834923|P3|OLMP|Disease progression|0
4885574|NCT00725985|16834924|P2|OLMP|Disease progression|0
4885575|NCT00725985|16834925|P1|OLMP|Disease progression|0
4885576|NCT00725985|16834914|P12|OLMP|Lost to Follow-up|0
4885577|NCT00725985|16834915|P11|OLMP|Lost to Follow-up|0
4885578|NCT00725985|16834916|P10|OLMP|Lost to Follow-up|0
4885579|NCT00725985|16834917|P9|OLMP|Lost to Follow-up|0
4885580|NCT00725985|16834918|P8|OLMP|Lost to Follow-up|0
4885581|NCT00725985|16834919|P7|OLMP|Lost to Follow-up|0
4885582|NCT00725985|16834920|P6|OLMP|Lost to Follow-up|0
4885583|NCT00725985|16834921|P5|OLMP|Lost to Follow-up|0
4885584|NCT00725985|16834922|P4|OLMP|Lost to Follow-up|1
4885585|NCT00725985|16834923|P3|OLMP|Lost to Follow-up|0
4885586|NCT00725985|16834924|P2|OLMP|Lost to Follow-up|0
4885587|NCT00725985|16834925|P1|OLMP|Lost to Follow-up|0
4885588|NCT00725985|16834914|P12|OLMP|Death|0
4885589|NCT00725985|16834915|P11|OLMP|Death|0
4885590|NCT00725985|16834916|P10|OLMP|Death|0
4885591|NCT00725985|16834917|P9|OLMP|Death|0
4885592|NCT00725985|16834918|P8|OLMP|Death|0
4885593|NCT00725985|16834919|P7|OLMP|Death|0
4885594|NCT00725985|16834920|P6|OLMP|Death|0
4885595|NCT00725985|16834921|P5|OLMP|Death|1
4885596|NCT00725985|16834922|P4|OLMP|Death|0
4885597|NCT00725985|16834923|P3|OLMP|Death|0
4885598|NCT00725985|16834924|P2|OLMP|Death|0
4885599|NCT00725985|16834925|P1|OLMP|Death|0
4885600|NCT00725985|16834914|P12|OLMP|Adverse Event|0
4885601|NCT00725985|16834915|P11|OLMP|Adverse Event|0
4885602|NCT00725985|16834916|P10|OLMP|Adverse Event|0
4885603|NCT00725985|16834917|P9|OLMP|Adverse Event|0
4885604|NCT00725985|16834918|P8|OLMP|Adverse Event|0
4885605|NCT00725985|16834919|P7|OLMP|Adverse Event|0
4885606|NCT00725985|16834920|P6|OLMP|Adverse Event|5
4885607|NCT00725985|16834921|P5|OLMP|Adverse Event|2
4885608|NCT00725985|16834922|P4|OLMP|Adverse Event|2
4885609|NCT00725985|16834923|P3|OLMP|Adverse Event|0
4885610|NCT00725985|16834924|P2|OLMP|Adverse Event|0
4885611|NCT00725985|16834925|P1|OLMP|Adverse Event|0
4885612|NCT00725985|16834914|P12|ITP (Up to 96 Weeks)|Other|0
4885613|NCT00725985|16834915|P11|ITP (Up to 96 Weeks)|Other|0
4885614|NCT00725985|16834916|P10|ITP (Up to 96 Weeks)|Other|0
4885615|NCT00725985|16834917|P9|ITP (Up to 96 Weeks)|Other|0
4885616|NCT00725985|16834918|P8|ITP (Up to 96 Weeks)|Other|0
4885617|NCT00725985|16834919|P7|ITP (Up to 96 Weeks)|Other|0
4885618|NCT00725985|16834920|P6|ITP (Up to 96 Weeks)|Other|0
4885619|NCT00725985|16834921|P5|ITP (Up to 96 Weeks)|Other|0
4885620|NCT00725985|16834922|P4|ITP (Up to 96 Weeks)|Other|0
4885621|NCT00725985|16834923|P3|ITP (Up to 96 Weeks)|Other|24
4885622|NCT00725985|16834924|P2|ITP (Up to 96 Weeks)|Other|38
4885623|NCT00725985|16834925|P1|ITP (Up to 96 Weeks)|Other|50
4885624|NCT00725985|16834914|P12|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885625|NCT00725985|16834915|P11|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885626|NCT00725985|16834916|P10|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885627|NCT00725985|16834917|P9|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885628|NCT00725985|16834918|P8|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885629|NCT00725985|16834919|P7|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885630|NCT00725985|16834920|P6|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885631|NCT00725985|16834921|P5|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885632|NCT00725985|16834922|P4|ITP (Up to 96 Weeks)|Converted to CDMS|0
4885633|NCT00725985|16834923|P3|ITP (Up to 96 Weeks)|Converted to CDMS|71
4885634|NCT00725985|16834924|P2|ITP (Up to 96 Weeks)|Converted to CDMS|27
4885635|NCT00725985|16834925|P1|ITP (Up to 96 Weeks)|Converted to CDMS|30
4885636|NCT00725985|16834914|P12|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885637|NCT00725985|16834915|P11|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885638|NCT00725985|16834916|P10|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885639|NCT00725985|16834917|P9|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885640|NCT00725985|16834918|P8|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885641|NCT00725985|16834919|P7|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885642|NCT00725985|16834920|P6|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885643|NCT00725985|16834921|P5|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885644|NCT00725985|16834922|P4|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885645|NCT00725985|16834923|P3|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885646|NCT00725985|16834924|P2|ITP (Up to 96 Weeks)|Randomized but not treated|0
4885647|NCT00725985|16834925|P1|ITP (Up to 96 Weeks)|Randomized but not treated|1
4885648|NCT00725985|16834914|P12|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885649|NCT00725985|16834915|P11|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885650|NCT00725985|16834916|P10|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885651|NCT00725985|16834917|P9|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885652|NCT00725985|16834918|P8|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885653|NCT00725985|16834919|P7|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885654|NCT00725985|16834920|P6|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885655|NCT00725985|16834921|P5|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885656|NCT00725985|16834922|P4|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885657|NCT00725985|16834923|P3|ITP (Up to 96 Weeks)|Lost to Follow-up|2
4885658|NCT00725985|16834924|P2|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885659|NCT00725985|16834925|P1|ITP (Up to 96 Weeks)|Lost to Follow-up|0
4885660|NCT00725985|16834914|P12|ITP (Up to 96 Weeks)|Adverse Event|0
4885661|NCT00725985|16834915|P11|ITP (Up to 96 Weeks)|Adverse Event|0
4885662|NCT00725985|16834916|P10|ITP (Up to 96 Weeks)|Adverse Event|0
4885663|NCT00725985|16834917|P9|ITP (Up to 96 Weeks)|Adverse Event|0
4885664|NCT00725985|16834918|P8|ITP (Up to 96 Weeks)|Adverse Event|0
4885665|NCT00725985|16834919|P7|ITP (Up to 96 Weeks)|Adverse Event|0
4885666|NCT00725985|16834920|P6|ITP (Up to 96 Weeks)|Adverse Event|0
4885667|NCT00725985|16834921|P5|ITP (Up to 96 Weeks)|Adverse Event|0
4885668|NCT00725985|16834922|P4|ITP (Up to 96 Weeks)|Adverse Event|0
4885669|NCT00725985|16834923|P3|ITP (Up to 96 Weeks)|Adverse Event|5
4885670|NCT00725985|16834924|P2|ITP (Up to 96 Weeks)|Adverse Event|10
4885671|NCT00725985|16834925|P1|ITP (Up to 96 Weeks)|Adverse Event|20
4885672|NCT00725920|16834962|P2|Overall Study|Lack of Efficacy|6
4885673|NCT00725920|16834963|P1|Overall Study|Lack of Efficacy|3
4885674|NCT00725842|16834969|P1|Overall Study|No Visit 1 data|1
4885675|NCT00725842|16834969|P1|Overall Study|Inclusion criterion not met|1
4885676|NCT00725842|16834969|P1|Overall Study|Consent date prior to study start date|5
4885677|NCT00725842|16834969|P1|Overall Study|Positive HCV-RNA at Visit 2|13
4885678|NCT00725842|16834969|P1|Overall Study|Death|1
4885679|NCT00725842|16834969|P1|Overall Study|Lost to Follow-up|19
4885680|NCT00725764|16834976|P1|Overall Study|Decline in performance status|1
4885681|NCT00725764|16834976|P1|Overall Study|Participant non compliant with protocol|1
4885682|NCT00725764|16834976|P1|Overall Study|Death|1
4885683|NCT00725764|16834976|P1|Overall Study|Lost to Follow-up|1
4885684|NCT00725764|16834976|P1|Overall Study|Progressive Disease|7
4885685|NCT00725764|16834976|P1|Overall Study|Physician Decision|1
4885686|NCT00725764|16834976|P1|Overall Study|Withdrawal by Subject|2
4885687|NCT00725725|16835009|P3|Overall Study|Protocol Violation|0
4885688|NCT00725725|16835010|P2|Overall Study|Protocol Violation|1
4885689|NCT00725725|16835011|P1|Overall Study|Protocol Violation|0
4885690|NCT00725725|16835009|P3|Overall Study|Withdrawal by Subject|1
4885691|NCT00725725|16835010|P2|Overall Study|Withdrawal by Subject|0
4885692|NCT00725725|16835011|P1|Overall Study|Withdrawal by Subject|1
4885693|NCT00725725|16835009|P3|Overall Study|Lost to Follow-up|2
4885694|NCT00725725|16835010|P2|Overall Study|Lost to Follow-up|0
4885695|NCT00725725|16835011|P1|Overall Study|Lost to Follow-up|2
4885696|NCT00725725|16835009|P3|Overall Study|Adverse Event|2
4885697|NCT00725725|16835010|P2|Overall Study|Adverse Event|3
4885698|NCT00725725|16835011|P1|Overall Study|Adverse Event|1
4885699|NCT00725712|16835054|P2|Overall Study|Hospitalized, unable to continue|1
4885700|NCT00725712|16835055|P1|Overall Study|Hospitalized, unable to continue|0
4885701|NCT00725712|16835054|P2|Overall Study|Other: Death|0
4885702|NCT00725712|16835055|P1|Overall Study|Other: Death|1
4885703|NCT00725712|16835054|P2|Overall Study|Death|0
4885704|NCT00725712|16835055|P1|Overall Study|Death|2
4885705|NCT00725712|16835054|P2|Overall Study|Adverse Event|5
4885706|NCT00725712|16835055|P1|Overall Study|Adverse Event|5
4885707|NCT00725712|16835054|P2|Overall Study|Clinical progression not based on RECIST|3
4885708|NCT00725712|16835055|P1|Overall Study|Clinical progression not based on RECIST|0
4885709|NCT00725712|16835054|P2|Overall Study|Progressive disease|16
4885710|NCT00725712|16835055|P1|Overall Study|Progressive disease|37
4885711|NCT00725712|16835054|P2|Overall Study|Protocol Violation|0
4885712|NCT00725712|16835055|P1|Overall Study|Protocol Violation|1
4885713|NCT00725712|16835054|P2|Overall Study|Withdrawal by Subject|1
4885714|NCT00725712|16835055|P1|Overall Study|Withdrawal by Subject|2
4885715|NCT00725621|16835091|P1|Overall Study|Reason not specified|55
4885716|NCT00725621|16835091|P1|Overall Study|Prepared for elective surgery|1
4885717|NCT00725621|16835091|P1|Overall Study|Switched to other drug|1
4885718|NCT00725621|16835091|P1|Overall Study|Switched to other study|1
4885719|NCT00725621|16835091|P1|Overall Study|Continued treatment by other physician|6
4885720|NCT00725621|16835091|P1|Overall Study|Non-compliance|8
4885721|NCT00725621|16835091|P1|Overall Study|Lost to Follow-up|52
4885722|NCT00725621|16835091|P1|Overall Study|Physician Decision|19
4885723|NCT00725621|16835091|P1|Overall Study|Withdrawal by Subject|57
4885724|NCT00725621|16835091|P1|Overall Study|Lack of Efficacy|46
4885725|NCT00725621|16835091|P1|Overall Study|Adverse Event|25
4885726|NCT00725608|16835114|P1|Overall Study|Other|7
4885727|NCT00725608|16835114|P1|Overall Study|Individual reasons|86
4885728|NCT00725608|16835114|P1|Overall Study|Adverse Event|14
4885729|NCT00725608|16835114|P1|Overall Study|Lost to Follow-up|60
4885730|NCT00725543|16835120|P1|Overall Study|Other|119
4885731|NCT00725543|16835120|P1|Overall Study|Non-compliance|2
4885732|NCT00725543|16835120|P1|Overall Study|Lost to Follow-up|4
4885733|NCT00725543|16835120|P1|Overall Study|Physician Decision|5
4885734|NCT00725543|16835120|P1|Overall Study|Withdrawal by Subject|10
4885735|NCT00725543|16835120|P1|Overall Study|Lack of Efficacy|3
4885736|NCT00725543|16835120|P1|Overall Study|Adverse Event|10
4885737|NCT00725491|16835145|P2|Overall Study|No/too few embryos/ bad quality embryos|2
4885738|NCT00725491|16835146|P1|Overall Study|No/too few embryos/ bad quality embryos|3
4885739|NCT00725491|16835145|P2|Overall Study|Fertilization failure|1
4885740|NCT00725491|16835146|P1|Overall Study|Fertilization failure|0
4885741|NCT00725491|16835145|P2|Overall Study|No/too few oocytes/bad quality oocytes|1
4885742|NCT00725491|16835146|P1|Overall Study|No/too few oocytes/bad quality oocytes|1
4885743|NCT00725491|16835145|P2|Overall Study|Risk for hyperstimulation|9
4885744|NCT00725491|16835146|P1|Overall Study|Risk for hyperstimulation|2
4885745|NCT00725491|16835145|P2|Overall Study|Pregnancy|3
4885746|NCT00725491|16835146|P1|Overall Study|Pregnancy|0
4885747|NCT00725491|16835145|P2|Overall Study|Adverse Event|2
4885748|NCT00725491|16835146|P1|Overall Study|Adverse Event|3
4885749|NCT00725452|16835152|P1|Overall Study|Lost to Follow-up|1
4885750|NCT00725452|16835152|P1|Overall Study|Withdrawal by Subject|3
4885751|NCT00725452|16835152|P1|Overall Study|Physician Decision|1
4885752|NCT00725452|16835152|P1|Overall Study|Reason not specified|1
4885753|NCT00725452|16835152|P1|Overall Study|Lack of Efficacy|2
4885754|NCT00725452|16835152|P1|Overall Study|Adverse Event|3
4885755|NCT00725322|16835171|P2|Washout (28 Days)|Protocol Violation|1
4885756|NCT00725322|16835172|P1|Washout (28 Days)|Protocol Violation|0
4885757|NCT00725322|16835171|P2|Washout (28 Days)|Withdrawal by Subject|0
4885758|NCT00725322|16835172|P1|Washout (28 Days)|Withdrawal by Subject|2
4885759|NCT00725296|16835180|P1|Overall Study|Other|38
4885760|NCT00725296|16835180|P1|Overall Study|Lost to Follow-up|1
4885761|NCT00725296|16835180|P1|Overall Study|Non-Compliance|2
4885762|NCT00725296|16835180|P1|Overall Study|Withdrawal by Subject|3
4885763|NCT00725296|16835180|P1|Overall Study|Lack of Efficacy|7
4885764|NCT00725296|16835180|P1|Overall Study|Adverse Event|11
4885765|NCT00725283|16835189|P1|Overall Study|Withdrawal by Subject|10
4885766|NCT00725283|16835189|P1|Overall Study|Other|6
4885767|NCT00725283|16835189|P1|Overall Study|Death|5
4885768|NCT00725283|16835189|P1|Overall Study|Missing Code|3
4885769|NCT00725205|16835210|P1|Overall Study|Treatment Failure|41
4885770|NCT00725205|16835210|P1|Overall Study|Protocol Defined Clinical Event|1
4885771|NCT00725205|16835210|P1|Overall Study|Other|8
4885772|NCT00725205|16835210|P1|Overall Study|Non-compliance With Protocol|14
4885773|NCT00725205|16835210|P1|Overall Study|Investigator Discontinued|1
4885774|NCT00725205|16835210|P1|Overall Study|Adverse Event|22
4885775|NCT00725101|16835223|P1|Overall Study|not specified/no reason given|11
4885776|NCT00725101|16835223|P1|Overall Study|Withdrawal by Subject|127
4885777|NCT00725101|16835223|P1|Overall Study|Protocol Violation|1
4885778|NCT00725101|16835223|P1|Overall Study|Lost to Follow-up|353
4885779|NCT00725101|16835223|P1|Overall Study|Death|3
4885780|NCT00725075|16835246|P3|Overall Study|Other|0
4885781|NCT00725075|16835247|P2|Overall Study|Other|0
4885782|NCT00725075|16835248|P1|Overall Study|Other|1
4885783|NCT00725075|16835246|P3|Overall Study|Inclusion/Exclusion Criteria|1
4885784|NCT00725075|16835247|P2|Overall Study|Inclusion/Exclusion Criteria|0
4885785|NCT00725075|16835248|P1|Overall Study|Inclusion/Exclusion Criteria|1
4885786|NCT00725075|16835246|P3|Overall Study|Worsening of Disease|2
4885787|NCT00725075|16835247|P2|Overall Study|Worsening of Disease|1
4885788|NCT00725075|16835248|P1|Overall Study|Worsening of Disease|2
4885789|NCT00725075|16835246|P3|Overall Study|Adverse Event|1
4885790|NCT00725075|16835247|P2|Overall Study|Adverse Event|1
4885791|NCT00725075|16835248|P1|Overall Study|Adverse Event|2
4885792|NCT00725075|16835246|P3|Overall Study|Withdrawal by Subject|4
4885793|NCT00725075|16835247|P2|Overall Study|Withdrawal by Subject|5
4885794|NCT00725075|16835248|P1|Overall Study|Withdrawal by Subject|4
4885795|NCT00725075|16835246|P3|Overall Study|Lost to Follow-up|0
4885796|NCT00725075|16835247|P2|Overall Study|Lost to Follow-up|0
4885797|NCT00725075|16835248|P1|Overall Study|Lost to Follow-up|1
4885798|NCT00725075|16835246|P3|Overall Study|Protocol Violation|1
4885799|NCT00725075|16835247|P2|Overall Study|Protocol Violation|0
4885800|NCT00725075|16835248|P1|Overall Study|Protocol Violation|0
4885801|NCT00725075|16835246|P3|Overall Study|Use of Excluded Medication|0
4885802|NCT00725075|16835247|P2|Overall Study|Use of Excluded Medication|1
4885803|NCT00725075|16835248|P1|Overall Study|Use of Excluded Medication|0
4885804|NCT00725010|16835301|P1|Overall Study|Intensified treatment scheme: 3 on 1 off|2
4885805|NCT00725010|16835301|P1|Overall Study|No further documentation|1
4885806|NCT00725010|16835301|P1|Overall Study|Suspect lymph nodes neck thorax abdomen|1
4885807|NCT00725010|16835301|P1|Overall Study|Hepatopathy probably not Temodal-related|1
4885808|NCT00725010|16835301|P1|Overall Study|Lost to Follow-up|1
4885809|NCT00725010|16835301|P1|Overall Study|Death|1
4885810|NCT00725010|16835301|P1|Overall Study|Withdrawal by Subject|2
4885811|NCT00725010|16835301|P1|Overall Study|Tumor Progression|7
4885812|NCT00725010|16835301|P1|Overall Study|Toxicity|9
4885813|NCT00724971|16835334|P1|Overall Study|Withdrawal by Subject|1
4885814|NCT00724971|16835334|P1|Overall Study|Adverse Event|5
4885815|NCT00724958|16835349|P1|Overall Study|No documentation for end of therapy|13
4885816|NCT00724958|16835349|P1|Overall Study|Other Reason|76
4885817|NCT00724958|16835349|P1|Overall Study|Remission|7
4885818|NCT00724958|16835349|P1|Overall Study|No Response|18
4885819|NCT00724958|16835349|P1|Overall Study|Loss of Response|40
4885820|NCT00724958|16835349|P1|Overall Study|Adverse Event|28
4885821|NCT00724945|16835358|P2|Period 2|lens physiology issue|0
4885822|NCT00724945|16835359|P1|Period 2|lens physiology issue|1
4885823|NCT00724945|16835358|P2|Period 2|lens comfort issue|0
4885824|NCT00724945|16835359|P1|Period 2|lens comfort issue|3
4885825|NCT00724945|16835358|P2|Period 1|Lost to Follow-up|0
4885826|NCT00724945|16835359|P1|Period 1|Lost to Follow-up|1
4885827|NCT00724945|16835358|P2|Period 1|Adverse Event|1
4885828|NCT00724945|16835359|P1|Period 1|Adverse Event|1
4885829|NCT00724945|16835358|P2|Period 1|non-compliance|0
4885830|NCT00724945|16835359|P1|Period 1|non-compliance|1
4885831|NCT00724932|16835371|P2|Overall Study|Not treated|3
4885832|NCT00724932|16835372|P1|Overall Study|Not treated|4
4885833|NCT00724932|16835371|P2|Overall Study|Lost to Follow-up|0
4885834|NCT00724932|16835372|P1|Overall Study|Lost to Follow-up|1
4885835|NCT00724893|16835443|P2|Overall Study|Unknown, missing data|1
4885836|NCT00724893|16835444|P1|Overall Study|Unknown, missing data|1
4885837|NCT00724893|16835443|P2|Overall Study|Lost to Follow-up|52
4885838|NCT00724893|16835444|P1|Overall Study|Lost to Follow-up|0
4885839|NCT00724893|16835443|P2|Overall Study|Assigned shorter treatment|2
4885840|NCT00724893|16835444|P1|Overall Study|Assigned shorter treatment|0
4885841|NCT00724893|16835443|P2|Overall Study|Financial reasons|2
4885842|NCT00724893|16835444|P1|Overall Study|Financial reasons|0
4885843|NCT00724893|16835443|P2|Overall Study|Substance abuse|3
4885844|NCT00724893|16835444|P1|Overall Study|Substance abuse|0
4885845|NCT00724893|16835443|P2|Overall Study|Incarceration|9
4885846|NCT00724893|16835444|P1|Overall Study|Incarceration|0
4885847|NCT00724893|16835443|P2|Overall Study|Geographic reasons|11
4885848|NCT00724893|16835444|P1|Overall Study|Geographic reasons|0
4885849|NCT00724893|16835443|P2|Overall Study|Patient choice|26
4885850|NCT00724893|16835444|P1|Overall Study|Patient choice|0
4885851|NCT00724893|16835443|P2|Overall Study|Reason not specified|7
4885852|NCT00724893|16835444|P1|Overall Study|Reason not specified|193
4885853|NCT00724893|16835443|P2|Overall Study|Lack of virologic response|202
4885854|NCT00724893|16835444|P1|Overall Study|Lack of virologic response|94
4885855|NCT00724893|16835443|P2|Overall Study|Withdrawal by Subject|1
4885856|NCT00724893|16835444|P1|Overall Study|Withdrawal by Subject|0
4885857|NCT00724893|16835443|P2|Overall Study|Adverse Event|142
4885858|NCT00724893|16835444|P1|Overall Study|Adverse Event|76
4885859|NCT00724867|16835512|P1|Overall Study|Elected to exit due to site closure|2
4885860|NCT00724867|16835512|P1|Overall Study|Subject moved out of state|1
4885861|NCT00724867|16835512|P1|Overall Study|Developed withdrawal criteria- pregnancy|4
4885862|NCT00724867|16835512|P1|Overall Study|Subject incarcerated|1
4885863|NCT00724867|16835512|P1|Overall Study|Sponsor decision to end study|14
4885864|NCT00724867|16835512|P1|Overall Study|Withdrawal by Subject|31
4885865|NCT00724867|16835512|P1|Overall Study|Protocol Violation|1
4885866|NCT00724867|16835512|P1|Overall Study|Physician Decision|17
4885867|NCT00724867|16835512|P1|Overall Study|Non-compliance with study drug|6
4885868|NCT00724867|16835512|P1|Overall Study|Lost to Follow-up|12
4885869|NCT00724867|16835512|P1|Overall Study|Lack of Efficacy|14
4885870|NCT00724867|16835512|P1|Overall Study|Adverse Event|25
4885871|NCT00724854|16835552|P2|Overall Study|Adverse event + lack of efficacy|1
4885872|NCT00724854|16835553|P1|Overall Study|Adverse event + lack of efficacy|2
4885873|NCT00724854|16835552|P2|Overall Study|Withdrawal by Subject|0
4885874|NCT00724854|16835553|P1|Overall Study|Withdrawal by Subject|5
4885875|NCT00724854|16835552|P2|Overall Study|Change of treatment|0
4885876|NCT00724854|16835553|P1|Overall Study|Change of treatment|7
4885877|NCT00724854|16835552|P2|Overall Study|Death|0
4885878|NCT00724854|16835553|P1|Overall Study|Death|11
4885879|NCT00724854|16835552|P2|Overall Study|Other|3
4885880|NCT00724854|16835553|P1|Overall Study|Other|42
4885881|NCT00724854|16835552|P2|Overall Study|Adverse Event|4
4885882|NCT00724854|16835553|P1|Overall Study|Adverse Event|62
4885883|NCT00724854|16835552|P2|Overall Study|Lost to Follow-up|10
4885884|NCT00724854|16835553|P1|Overall Study|Lost to Follow-up|87
4885885|NCT00724854|16835552|P2|Overall Study|Lack of Efficacy|13
4885886|NCT00724854|16835553|P1|Overall Study|Lack of Efficacy|187
4885887|NCT00724815|16835570|P2|Overall Study|Other Various|5
4885888|NCT00724815|16835571|P1|Overall Study|Other Various|3
4885889|NCT00724815|16835570|P2|Overall Study|Lost to Follow-up|1
4885890|NCT00724815|16835571|P1|Overall Study|Lost to Follow-up|4
4885891|NCT00724815|16835570|P2|Overall Study|Adverse Event|3
4885892|NCT00724815|16835571|P1|Overall Study|Adverse Event|5
4885893|NCT00724815|16835570|P2|Overall Study|Randomized, not treated|30
4885894|NCT00724815|16835571|P1|Overall Study|Randomized, not treated|31
4885895|NCT00724711|16835604|P2|Overall Study|Protocol Violation|0
4885896|NCT00724711|16835605|P1|Overall Study|Protocol Violation|1
4885897|NCT00724711|16835604|P2|Overall Study|Lost to Follow-up|5
4885898|NCT00724711|16835605|P1|Overall Study|Lost to Follow-up|4
4885899|NCT00724711|16835604|P2|Overall Study|Withdrawal by Subject|4
4885900|NCT00724711|16835605|P1|Overall Study|Withdrawal by Subject|5
4885901|NCT00724711|16835604|P2|Overall Study|Physician Decision|3
4885902|NCT00724711|16835605|P1|Overall Study|Physician Decision|0
4885903|NCT00724711|16835604|P2|Overall Study|Lack of Efficacy|1
4885904|NCT00724711|16835605|P1|Overall Study|Lack of Efficacy|0
4885905|NCT00724711|16835604|P2|Overall Study|Pregnancy|1
4885906|NCT00724711|16835605|P1|Overall Study|Pregnancy|0
4885907|NCT00724711|16835604|P2|Overall Study|Adverse Event|3
4885908|NCT00724711|16835605|P1|Overall Study|Adverse Event|7
4885909|NCT00724698|16835637|P1|Overall Study|No Info|25
4885910|NCT00724698|16835637|P1|Overall Study|Lost to Follow-up|36
4885911|NCT00724698|16835637|P1|Overall Study|Poor Compliance|16
4885912|NCT00724698|16835637|P1|Overall Study|Failure of Therapy|4
4885913|NCT00724698|16835637|P1|Overall Study|Adverse Event|9
4885914|NCT00724503|16835690|P2|Overall Study|Not otherwise specified|7
4885915|NCT00724503|16835691|P1|Overall Study|Not otherwise specified|4
4885916|NCT00724503|16835690|P2|Overall Study|Adverse Event|0
4885917|NCT00724503|16835691|P1|Overall Study|Adverse Event|1
4885918|NCT00724503|16835690|P2|Overall Study|Death|182
4885919|NCT00724503|16835691|P1|Overall Study|Death|190
4885920|NCT00724503|16835690|P2|Overall Study|Withdrawal by Subject|23
4885921|NCT00724503|16835691|P1|Overall Study|Withdrawal by Subject|11
4885922|NCT00724503|16835690|P2|Overall Study|Lost to Follow-up|8
4885923|NCT00724503|16835691|P1|Overall Study|Lost to Follow-up|4
4885924|NCT00724451|16835715|P1|Overall Study|Investigator + Participant Decision|13
4885925|NCT00724451|16835715|P1|Overall Study|Withdrawal by Subject|45
4885926|NCT00724451|16835715|P1|Overall Study|Physician Decision|116
4885927|NCT00724451|16835715|P1|Overall Study|Unknown; No Data Sources Available|9
4885928|NCT00724451|16835715|P1|Overall Study|Never Started Treatment|89
4885929|NCT00724451|16835715|P1|Overall Study|Participant Refused Treatment|89
4885930|NCT00724451|16835715|P1|Overall Study|Not Eligible for Treatment|431
4885931|NCT00724451|16835715|P1|Overall Study|Excluded - Hepatitis C Virus Negative|3
4885932|NCT00724451|16835715|P1|Overall Study|Excluded - Prior Use of Peginterferon|7
4885933|NCT00724373|16835721|P1|Overall Study|Tolerability|23
4885934|NCT00724373|16835721|P1|Overall Study|Drug Relapse|1
4885935|NCT00724373|16835721|P1|Overall Study|Acute HCV infection|1
4885936|NCT00724373|16835721|P1|Overall Study|Viral Relapse|1
4885937|NCT00724373|16835721|P1|Overall Study|Only to have 24 week regimen|1
4885938|NCT00724373|16835721|P1|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2
4885939|NCT00724373|16835721|P1|Overall Study|Participant moved away|1
4885940|NCT00724373|16835721|P1|Overall Study|HCV RNA negative after 4 weeks|9
4885941|NCT00724373|16835721|P1|Overall Study|Non-compliance|2
4885942|NCT00724373|16835721|P1|Overall Study|Lost to Follow-up|7
4885943|NCT00724373|16835721|P1|Overall Study|Lack of Efficacy|82
4885944|NCT00724373|16835721|P1|Overall Study|Adverse Event|41
4885945|NCT00724282|16835738|P1|Overall Study|Physician Decision|1
4885946|NCT00724282|16835738|P1|Overall Study|Withdrawal by Subject|3
4885947|NCT00724243|16835742|P1|Overall Study|Adverse Event|5
4885948|NCT00724243|16835742|P1|Overall Study|Lack of Efficacy|10
4885949|NCT00724152|16835752|P3|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
4885950|NCT00724152|16835753|P2|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2
4885951|NCT00724152|16835754|P1|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1
4885952|NCT00724152|16835752|P3|Two-arm Study Period|Withdrawal by Subject|0
4885953|NCT00724152|16835753|P2|Two-arm Study Period|Withdrawal by Subject|2
4885954|NCT00724152|16835754|P1|Two-arm Study Period|Withdrawal by Subject|3
4885955|NCT00724126|16835771|P2|Overall Study|Subject had to leave vicinity of site|1
4885956|NCT00724126|16835772|P1|Overall Study|Subject had to leave vicinity of site|0
4885957|NCT00724126|16835771|P2|Overall Study|Subject randomized although ineligible|1
4885958|NCT00724126|16835772|P1|Overall Study|Subject randomized although ineligible|1
4885959|NCT00724126|16835771|P2|Overall Study|Noncompliance|1
4885960|NCT00724126|16835772|P1|Overall Study|Noncompliance|2
4885961|NCT00724126|16835771|P2|Overall Study|Lost to Follow-up|6
4885962|NCT00724126|16835772|P1|Overall Study|Lost to Follow-up|6
4885963|NCT00724126|16835771|P2|Overall Study|Withdrawal by Subject|6
4885964|NCT00724126|16835772|P1|Overall Study|Withdrawal by Subject|8
4885965|NCT00724126|16835771|P2|Overall Study|Adverse Event|0
4885966|NCT00724126|16835772|P1|Overall Study|Adverse Event|2
4885967|NCT00724061|16835780|P1|Dose Escalation Phase|Disease Progression|3
4885968|NCT00724061|16835780|P1|Dose Escalation Phase|Adverse Event|2
4885969|NCT00723944|16835800|P2|One Year Post Placement Follow-up|Lost to Follow-up|4
4885970|NCT00723944|16835801|P1|One Year Post Placement Follow-up|Lost to Follow-up|1
4885971|NCT00723944|16835800|P2|Permanent Prosthesis Placement|Lost to Follow-up|2
4885972|NCT00723944|16835801|P1|Permanent Prosthesis Placement|Lost to Follow-up|2
4885973|NCT00723944|16835800|P2|Permanent Prosthesis Placement|Adverse Event|7
4885974|NCT00723944|16835801|P1|Permanent Prosthesis Placement|Adverse Event|1
4885975|NCT00723892|16835814|P2|Overall Study|Drug addiction|0
4885976|NCT00723892|16835815|P1|Overall Study|Drug addiction|1
4885977|NCT00723892|16835814|P2|Overall Study|Intercurrent infection|0
4885978|NCT00723892|16835815|P1|Overall Study|Intercurrent infection|2
4885979|NCT00723892|16835814|P2|Overall Study|Alcohol abuse|1
4885980|NCT00723892|16835815|P1|Overall Study|Alcohol abuse|0
4885981|NCT00723892|16835814|P2|Overall Study|Weight loss|3
4885982|NCT00723892|16835815|P1|Overall Study|Weight loss|1
4885983|NCT00723892|16835814|P2|Overall Study|Study end|3
4885984|NCT00723892|16835815|P1|Overall Study|Study end|1
4885985|NCT00723892|16835814|P2|Overall Study|Other|3
4885986|NCT00723892|16835815|P1|Overall Study|Other|6
4885987|NCT00723892|16835814|P2|Overall Study|Multiple reasons|12
4885988|NCT00723892|16835815|P1|Overall Study|Multiple reasons|17
4885989|NCT00723892|16835814|P2|Overall Study|Bad tolerance|5
4885990|NCT00723892|16835815|P1|Overall Study|Bad tolerance|5
4885991|NCT00723892|16835814|P2|Overall Study|End planned|7
4885992|NCT00723892|16835815|P1|Overall Study|End planned|11
4885993|NCT00723892|16835814|P2|Overall Study|Withdrawal by Subject|9
4885994|NCT00723892|16835815|P1|Overall Study|Withdrawal by Subject|6
4885995|NCT00723892|16835814|P2|Overall Study|Virological criterion|9
4885996|NCT00723892|16835815|P1|Overall Study|Virological criterion|24
4885997|NCT00723892|16835814|P2|Overall Study|Participant not tracked|35
4885998|NCT00723892|16835815|P1|Overall Study|Participant not tracked|33
4885999|NCT00723840|16835822|P1|Overall Study|Unspecified reason|2
4886000|NCT00723840|16835822|P1|Overall Study|Other Medical Event|2
4886001|NCT00723840|16835822|P1|Overall Study|Serious Adverse Events|3
4886002|NCT00723840|16835822|P1|Overall Study|Withdrawal by Subject|55
4886003|NCT00723840|16835822|P1|Overall Study|Failure to return|18
4886004|NCT00723840|16835822|P1|Overall Study|Lost to Follow-up|2
4886005|NCT00723801|16835843|P2|Overall Study|Protocol Violation|1
4886006|NCT00723801|16835844|P1|Overall Study|Protocol Violation|2
4886007|NCT00723801|16835843|P2|Overall Study|Lost to Follow-up|2
4886008|NCT00723801|16835844|P1|Overall Study|Lost to Follow-up|1
4886009|NCT00723710|16835869|P1|Overall Study|Physician Decision|2
4886010|NCT00723710|16835869|P1|Overall Study|Withdrawal by Subject|36
4886011|NCT00723710|16835869|P1|Overall Study|Adverse Event|88
4886012|NCT00723710|16835869|P1|Overall Study|Disease progression|48
4886013|NCT00723697|16835873|P1|Overall Study|Other exclusion criteria applied|6
4886014|NCT00723697|16835873|P1|Overall Study|Missing Informed Consent Form|10
4886015|NCT00723697|16835873|P1|Overall Study|Physician questionnaires not received|2
4886016|NCT00723606|16835894|P2|Overall Study|Withdrawal by Subject|2
4886017|NCT00723606|16835895|P1|Overall Study|Withdrawal by Subject|0
4886018|NCT00723606|16835894|P2|Overall Study|Other|0
4886019|NCT00723606|16835895|P1|Overall Study|Other|2
4886020|NCT00723606|16835894|P2|Overall Study|Adverse Event|5
4886021|NCT00723606|16835895|P1|Overall Study|Adverse Event|2
4886022|NCT00723554|16835915|P1|Overall Study|Non-compliance|1
4886023|NCT00723554|16835915|P1|Overall Study|Lost to Follow-up|1
4886024|NCT00723554|16835915|P1|Overall Study|Other|3
4886025|NCT00723554|16835915|P1|Overall Study|Withdrawal of consent|3
4886026|NCT00723554|16835915|P1|Overall Study|Inhaled medication other than iloprost|4
4886027|NCT00723554|16835915|P1|Overall Study|Investigator's judgement|5
4886028|NCT00723554|16835915|P1|Overall Study|Adverse Event|12
4886029|NCT00723528|16835965|P7|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1
4886030|NCT00723528|16835966|P6|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4886031|NCT00723528|16835967|P5|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4886032|NCT00723528|16835968|P4|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4886033|NCT00723528|16835969|P3|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4886034|NCT00723528|16835970|P2|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4886035|NCT00723528|16835971|P1|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0
4886036|NCT00723528|16835965|P7|Period 2: After Controlled Period|Use of prohibited concomitant medication|1
4886037|NCT00723528|16835966|P6|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4886038|NCT00723528|16835967|P5|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4886039|NCT00723528|16835968|P4|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4886040|NCT00723528|16835969|P3|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4886041|NCT00723528|16835970|P2|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4886042|NCT00723528|16835971|P1|Period 2: After Controlled Period|Use of prohibited concomitant medication|0
4886043|NCT00723528|16835965|P7|Period 2: After Controlled Period|Adverse Event|1
4886044|NCT00723528|16835966|P6|Period 2: After Controlled Period|Adverse Event|0
4886045|NCT00723528|16835967|P5|Period 2: After Controlled Period|Adverse Event|1
4886046|NCT00723528|16835968|P4|Period 2: After Controlled Period|Adverse Event|0
4886047|NCT00723528|16835969|P3|Period 2: After Controlled Period|Adverse Event|0
4886048|NCT00723528|16835970|P2|Period 2: After Controlled Period|Adverse Event|0
4886049|NCT00723528|16835971|P1|Period 2: After Controlled Period|Adverse Event|0
4886050|NCT00723528|16835965|P7|Period 2: After Controlled Period|Other|0
4886051|NCT00723528|16835966|P6|Period 2: After Controlled Period|Other|4
4886052|NCT00723528|16835967|P5|Period 2: After Controlled Period|Other|1
4886053|NCT00723528|16835968|P4|Period 2: After Controlled Period|Other|0
4886054|NCT00723528|16835969|P3|Period 2: After Controlled Period|Other|0
4886055|NCT00723528|16835970|P2|Period 2: After Controlled Period|Other|0
4886056|NCT00723528|16835971|P1|Period 2: After Controlled Period|Other|0
4886057|NCT00723528|16835965|P7|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4886058|NCT00723528|16835966|P6|Period 2: After Controlled Period|Onset of tuberculosis infection|1
4886059|NCT00723528|16835967|P5|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4886060|NCT00723528|16835968|P4|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4886061|NCT00723528|16835969|P3|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4886062|NCT00723528|16835970|P2|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4886063|NCT00723528|16835971|P1|Period 2: After Controlled Period|Onset of tuberculosis infection|0
4886064|NCT00723528|16835965|P7|Period 2: After Controlled Period|Withdrawal by Subject|1
4886065|NCT00723528|16835966|P6|Period 2: After Controlled Period|Withdrawal by Subject|1
4886066|NCT00723528|16835967|P5|Period 2: After Controlled Period|Withdrawal by Subject|0
4886067|NCT00723528|16835968|P4|Period 2: After Controlled Period|Withdrawal by Subject|1
4886068|NCT00723528|16835969|P3|Period 2: After Controlled Period|Withdrawal by Subject|0
4886069|NCT00723528|16835970|P2|Period 2: After Controlled Period|Withdrawal by Subject|0
4886070|NCT00723528|16835971|P1|Period 2: After Controlled Period|Withdrawal by Subject|0
4886071|NCT00723528|16835965|P7|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4886072|NCT00723528|16835966|P6|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4886073|NCT00723528|16835967|P5|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4886074|NCT00723528|16835968|P4|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4886075|NCT00723528|16835969|P3|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1
4886076|NCT00723528|16835970|P2|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0
4886077|NCT00723528|16835971|P1|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2
4886078|NCT00723528|16835965|P7|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4886079|NCT00723528|16835966|P6|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4886080|NCT00723528|16835967|P5|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4886081|NCT00723528|16835968|P4|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4886082|NCT00723528|16835969|P3|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1
4886083|NCT00723528|16835970|P2|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4886084|NCT00723528|16835971|P1|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0
4886085|NCT00723528|16835965|P7|Period 1: Controlled Period (CP)|Physician Decision|0
4886086|NCT00723528|16835966|P6|Period 1: Controlled Period (CP)|Physician Decision|0
4886087|NCT00723528|16835967|P5|Period 1: Controlled Period (CP)|Physician Decision|0
4886088|NCT00723528|16835968|P4|Period 1: Controlled Period (CP)|Physician Decision|0
4886089|NCT00723528|16835969|P3|Period 1: Controlled Period (CP)|Physician Decision|1
4886090|NCT00723528|16835970|P2|Period 1: Controlled Period (CP)|Physician Decision|0
4886091|NCT00723528|16835971|P1|Period 1: Controlled Period (CP)|Physician Decision|0
4886092|NCT00723528|16835965|P7|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4886093|NCT00723528|16835966|P6|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4886094|NCT00723528|16835967|P5|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4886095|NCT00723528|16835968|P4|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4886096|NCT00723528|16835969|P3|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4886097|NCT00723528|16835970|P2|Period 1: Controlled Period (CP)|Withdrawal by Subject|0
4886098|NCT00723528|16835971|P1|Period 1: Controlled Period (CP)|Withdrawal by Subject|2
4886099|NCT00723528|16835965|P7|Period 1: Controlled Period (CP)|Adverse Event|0
4886100|NCT00723528|16835966|P6|Period 1: Controlled Period (CP)|Adverse Event|0
4886101|NCT00723528|16835967|P5|Period 1: Controlled Period (CP)|Adverse Event|0
4886102|NCT00723528|16835968|P4|Period 1: Controlled Period (CP)|Adverse Event|0
4886103|NCT00723528|16835969|P3|Period 1: Controlled Period (CP)|Adverse Event|1
4886104|NCT00723528|16835970|P2|Period 1: Controlled Period (CP)|Adverse Event|0
4886105|NCT00723528|16835971|P1|Period 1: Controlled Period (CP)|Adverse Event|0
4886106|NCT00723489|16836033|P4|Overall Study|Samples Collected Out of Window|0
4886107|NCT00723489|16836034|P3|Overall Study|Samples Collected Out of Window|0
4886108|NCT00723489|16836035|P2|Overall Study|Samples Collected Out of Window|3
4886109|NCT00723489|16836036|P1|Overall Study|Samples Collected Out of Window|0
4886110|NCT00723489|16836033|P4|Overall Study|Prohibited Medication|1
4886111|NCT00723489|16836034|P3|Overall Study|Prohibited Medication|0
4886112|NCT00723489|16836035|P2|Overall Study|Prohibited Medication|0
4886113|NCT00723489|16836036|P1|Overall Study|Prohibited Medication|0
4886114|NCT00723489|16836033|P4|Overall Study|Seropositive at baseline|0
4886115|NCT00723489|16836034|P3|Overall Study|Seropositive at baseline|0
4886116|NCT00723489|16836035|P2|Overall Study|Seropositive at baseline|0
4886117|NCT00723489|16836036|P1|Overall Study|Seropositive at baseline|1
4886118|NCT00723489|16836033|P4|Overall Study|Withdrawal by Subject|1
4886119|NCT00723489|16836034|P3|Overall Study|Withdrawal by Subject|0
4886120|NCT00723489|16836035|P2|Overall Study|Withdrawal by Subject|0
4886121|NCT00723489|16836036|P1|Overall Study|Withdrawal by Subject|0
4886122|NCT00723489|16836033|P4|Overall Study|Pregnancy|1
4886123|NCT00723489|16836034|P3|Overall Study|Pregnancy|0
4886124|NCT00723489|16836035|P2|Overall Study|Pregnancy|0
4886125|NCT00723489|16836036|P1|Overall Study|Pregnancy|0
4886126|NCT00723489|16836033|P4|Overall Study|Physician Decision|0
4886127|NCT00723489|16836034|P3|Overall Study|Physician Decision|0
4886128|NCT00723489|16836035|P2|Overall Study|Physician Decision|1
4886129|NCT00723489|16836036|P1|Overall Study|Physician Decision|0
4886130|NCT00723450|16836064|P3|Randomized Phase|Withdrawal by Subject|22
4886131|NCT00723450|16836065|P2|Randomized Phase|Withdrawal by Subject|14
4886132|NCT00723450|16836066|P1|Randomized Phase|Withdrawal by Subject|0
4886133|NCT00723450|16836064|P3|Randomized Phase|Physician Decision|1
4886134|NCT00723450|16836065|P2|Randomized Phase|Physician Decision|3
4886135|NCT00723450|16836066|P1|Randomized Phase|Physician Decision|0
4886136|NCT00723450|16836064|P3|Randomized Phase|Lost to Follow-up|3
4886137|NCT00723450|16836065|P2|Randomized Phase|Lost to Follow-up|2
4886138|NCT00723450|16836066|P1|Randomized Phase|Lost to Follow-up|0
4886139|NCT00723450|16836064|P3|Randomized Phase|Protocol Violation|13
4886140|NCT00723450|16836065|P2|Randomized Phase|Protocol Violation|9
4886141|NCT00723450|16836066|P1|Randomized Phase|Protocol Violation|0
4886142|NCT00723450|16836064|P3|Randomized Phase|Lack of Efficacy|11
4886143|NCT00723450|16836065|P2|Randomized Phase|Lack of Efficacy|11
4886144|NCT00723450|16836066|P1|Randomized Phase|Lack of Efficacy|0
4886145|NCT00723450|16836064|P3|Randomized Phase|Adverse Event|17
4886146|NCT00723450|16836065|P2|Randomized Phase|Adverse Event|26
4886147|NCT00723450|16836066|P1|Randomized Phase|Adverse Event|0
4886148|NCT00723450|16836064|P3|Open-Label Phase|Withdrawal by Subject|0
4886149|NCT00723450|16836065|P2|Open-Label Phase|Withdrawal by Subject|0
4886150|NCT00723450|16836066|P1|Open-Label Phase|Withdrawal by Subject|37
4886151|NCT00723450|16836064|P3|Open-Label Phase|Physician Decision|0
4886152|NCT00723450|16836065|P2|Open-Label Phase|Physician Decision|0
4886153|NCT00723450|16836066|P1|Open-Label Phase|Physician Decision|2
4886154|NCT00723450|16836064|P3|Open-Label Phase|Lost to Follow-up|0
4886155|NCT00723450|16836065|P2|Open-Label Phase|Lost to Follow-up|0
4886156|NCT00723450|16836066|P1|Open-Label Phase|Lost to Follow-up|7
4886157|NCT00723450|16836064|P3|Open-Label Phase|Protocol Violation|0
4886158|NCT00723450|16836065|P2|Open-Label Phase|Protocol Violation|0
4886159|NCT00723450|16836066|P1|Open-Label Phase|Protocol Violation|35
4886160|NCT00723450|16836064|P3|Open-Label Phase|Lack of Efficacy|0
4886161|NCT00723450|16836065|P2|Open-Label Phase|Lack of Efficacy|0
4886162|NCT00723450|16836066|P1|Open-Label Phase|Lack of Efficacy|18
4886163|NCT00723450|16836064|P3|Open-Label Phase|Adverse Event|0
4886164|NCT00723450|16836065|P2|Open-Label Phase|Adverse Event|0
4886165|NCT00723450|16836066|P1|Open-Label Phase|Adverse Event|26
4886166|NCT00723398|16836112|P5|Overall Study|Lost to Follow-up|0
4886167|NCT00723398|16836113|P4|Overall Study|Lost to Follow-up|0
4886168|NCT00723398|16836114|P3|Overall Study|Lost to Follow-up|0
4886169|NCT00723398|16836115|P2|Overall Study|Lost to Follow-up|1
4886170|NCT00723398|16836116|P1|Overall Study|Lost to Follow-up|0
4886171|NCT00723398|16836112|P5|Overall Study|Adverse Event|4
4886172|NCT00723398|16836113|P4|Overall Study|Adverse Event|1
4886173|NCT00723398|16836114|P3|Overall Study|Adverse Event|3
4886174|NCT00723398|16836115|P2|Overall Study|Adverse Event|5
4886175|NCT00723398|16836116|P1|Overall Study|Adverse Event|0
4886176|NCT00723398|16836112|P5|Overall Study|Physician Decision|1
4886177|NCT00723398|16836113|P4|Overall Study|Physician Decision|0
4886178|NCT00723398|16836114|P3|Overall Study|Physician Decision|5
4886179|NCT00723398|16836115|P2|Overall Study|Physician Decision|2
4886180|NCT00723398|16836116|P1|Overall Study|Physician Decision|2
4886181|NCT00723398|16836112|P5|Overall Study|Protocol Violation|0
4886182|NCT00723398|16836113|P4|Overall Study|Protocol Violation|0
4886183|NCT00723398|16836114|P3|Overall Study|Protocol Violation|5
4886184|NCT00723398|16836115|P2|Overall Study|Protocol Violation|1
4886185|NCT00723398|16836116|P1|Overall Study|Protocol Violation|2
4886186|NCT00723398|16836112|P5|Overall Study|Withdrawal by Subject|4
4886187|NCT00723398|16836113|P4|Overall Study|Withdrawal by Subject|4
4886188|NCT00723398|16836114|P3|Overall Study|Withdrawal by Subject|4
4886189|NCT00723398|16836115|P2|Overall Study|Withdrawal by Subject|6
4886190|NCT00723398|16836116|P1|Overall Study|Withdrawal by Subject|2
4886191|NCT00723294|16836178|P1|Overall Study|No treatment due to probe failure|1
4886192|NCT00723294|16836178|P1|Overall Study|Withdrawal by Subject|1
4886193|NCT00723294|16836178|P1|Overall Study|Benign lesion|1
4886194|NCT00723294|16836178|P1|Overall Study|Treated by non-credentialed surgeon|1
4886195|NCT00723294|16836178|P1|Overall Study|Treated prior to registration|1
4886196|NCT00723294|16836178|P1|Overall Study|Did not undergo surgery|1
4886197|NCT00723294|16836178|P1|Overall Study|No cryoabalation|2
4886198|NCT00723294|16836178|P1|Overall Study|1.0-Tesla MRI|1
4886199|NCT00723294|16836178|P1|Overall Study|No MRI tumor enhancement|1
4886200|NCT00723294|16836178|P1|Overall Study|>25% intraductal component|1
4886201|NCT00723294|16836178|P1|Overall Study|Lobular histology|2
4886202|NCT00723255|16836183|P1|Overall Study|Ineligible: Wrong Primary|2
4886203|NCT00723255|16836183|P1|Overall Study|Ineligible: Second primary|1
4886204|NCT00723255|16836183|P1|Overall Study|Ineligible: Inadequate pathology|1
4886205|NCT00723229|16836210|P2|First Intervention|Lost to Follow-up|3
4886206|NCT00723229|16836211|P1|First Intervention|Lost to Follow-up|7
4886207|NCT00723203|16836223|P1|Overall Study|Withdrawal by Subject|3
4886208|NCT00723190|16836227|P1|Overall Study|Other-Not included in safety population|2
4886209|NCT00723190|16836227|P1|Overall Study|Other-Premature Discontinuation|9
4886210|NCT00723190|16836227|P1|Overall Study|Protocol Violation|15
4886211|NCT00723190|16836227|P1|Overall Study|Lack of Efficacy|16
4886212|NCT00723190|16836227|P1|Overall Study|Adverse Event|18
4886213|NCT00723190|16836227|P1|Overall Study|Lost to Follow-up|37
4886214|NCT00723190|16836227|P1|Overall Study|Withdrawal by Subject|45
4886215|NCT00723125|16836260|P2|Overall Study|Adverse Event|0
4886216|NCT00723125|16836261|P1|Overall Study|Adverse Event|2
4886217|NCT00723125|16836260|P2|Overall Study|Withdrawal by Subject|6
4886218|NCT00723125|16836261|P1|Overall Study|Withdrawal by Subject|15
4886219|NCT00723125|16836260|P2|Overall Study|Met Dx|0
4886220|NCT00723125|16836261|P1|Overall Study|Met Dx|1
4886221|NCT00723021|16836310|P5|Intervention Period 4|Adverse Event|1
4886222|NCT00723021|16836311|P4|Intervention Period 4|Adverse Event|0
4886223|NCT00723021|16836312|P3|Intervention Period 4|Adverse Event|0
4886224|NCT00723021|16836313|P2|Intervention Period 4|Adverse Event|0
4886225|NCT00723021|16836314|P1|Intervention Period 4|Adverse Event|0
4886226|NCT00723008|16836368|P2|4-Week Unblinded Treatment|Lost to Follow-up|1
4886227|NCT00723008|16836369|P1|4-Week Unblinded Treatment|Lost to Follow-up|0
4886228|NCT00723008|16836368|P2|4-Week Unblinded Treatment|Adverse Event|0
4886229|NCT00723008|16836369|P1|4-Week Unblinded Treatment|Adverse Event|1
4886230|NCT00723008|16836368|P2|4-Week Double Blinded|Lost to Follow-up|3
4886231|NCT00723008|16836369|P1|4-Week Double Blinded|Lost to Follow-up|4
4886232|NCT00723008|16836368|P2|4-Week Double Blinded|Withdrawal by Subject|1
4886233|NCT00723008|16836369|P1|4-Week Double Blinded|Withdrawal by Subject|1
4886234|NCT00723008|16836368|P2|4-Week Double Blinded|Lack of Efficacy|1
4886235|NCT00723008|16836369|P1|4-Week Double Blinded|Lack of Efficacy|0
4886236|NCT00723008|16836368|P2|Enrollment|Lost to Follow-up|0
4886237|NCT00723008|16836369|P1|Enrollment|Lost to Follow-up|1
4886238|NCT00722800|16836401|P2|Overall Study|Physician Decision|0
4886239|NCT00722800|16836402|P1|Overall Study|Physician Decision|1
4886240|NCT00722800|16836401|P2|Overall Study|Withdrawal by Subject|0
4886241|NCT00722800|16836402|P1|Overall Study|Withdrawal by Subject|1
4886242|NCT00722761|16836414|P2|Overall Study|Withdrawal by Subject|2
4886243|NCT00722761|16836415|P1|Overall Study|Withdrawal by Subject|5
4886244|NCT00722761|16836414|P2|Overall Study|Lost to Follow-up|4
4886245|NCT00722761|16836415|P1|Overall Study|Lost to Follow-up|1
4886246|NCT00722423|16836472|P2|Overall Study|Protocol Violation|1
4886247|NCT00722423|16836473|P1|Overall Study|Protocol Violation|0
4886248|NCT00722371|16836488|P7|Overall Study|Withdrawal by Subject|26
4886249|NCT00722371|16836489|P6|Overall Study|Withdrawal by Subject|18
4886250|NCT00722371|16836490|P5|Overall Study|Withdrawal by Subject|19
4886251|NCT00722371|16836491|P4|Overall Study|Withdrawal by Subject|23
4886252|NCT00722371|16836492|P3|Overall Study|Withdrawal by Subject|19
4886253|NCT00722371|16836493|P2|Overall Study|Withdrawal by Subject|27
4886254|NCT00722371|16836494|P1|Overall Study|Withdrawal by Subject|18
4886255|NCT00722371|16836488|P7|Overall Study|Protocol Violation|1
4886256|NCT00722371|16836489|P6|Overall Study|Protocol Violation|2
4886257|NCT00722371|16836490|P5|Overall Study|Protocol Violation|4
4886258|NCT00722371|16836491|P4|Overall Study|Protocol Violation|1
4886259|NCT00722371|16836492|P3|Overall Study|Protocol Violation|0
4886260|NCT00722371|16836493|P2|Overall Study|Protocol Violation|1
4886261|NCT00722371|16836494|P1|Overall Study|Protocol Violation|6
4886262|NCT00722371|16836488|P7|Overall Study|Pregnancy|0
4886263|NCT00722371|16836489|P6|Overall Study|Pregnancy|1
4886264|NCT00722371|16836490|P5|Overall Study|Pregnancy|0
4886265|NCT00722371|16836491|P4|Overall Study|Pregnancy|0
4886266|NCT00722371|16836492|P3|Overall Study|Pregnancy|0
4886267|NCT00722371|16836493|P2|Overall Study|Pregnancy|1
4886268|NCT00722371|16836494|P1|Overall Study|Pregnancy|1
4886269|NCT00722371|16836488|P7|Overall Study|Physician Decision|4
4886270|NCT00722371|16836489|P6|Overall Study|Physician Decision|3
4886271|NCT00722371|16836490|P5|Overall Study|Physician Decision|2
4886272|NCT00722371|16836491|P4|Overall Study|Physician Decision|5
4886273|NCT00722371|16836492|P3|Overall Study|Physician Decision|2
4886274|NCT00722371|16836493|P2|Overall Study|Physician Decision|2
4886275|NCT00722371|16836494|P1|Overall Study|Physician Decision|5
4886276|NCT00722371|16836488|P7|Overall Study|Lost to Follow-up|13
4886277|NCT00722371|16836489|P6|Overall Study|Lost to Follow-up|16
4886278|NCT00722371|16836490|P5|Overall Study|Lost to Follow-up|8
4886279|NCT00722371|16836491|P4|Overall Study|Lost to Follow-up|13
4886280|NCT00722371|16836492|P3|Overall Study|Lost to Follow-up|21
4886281|NCT00722371|16836493|P2|Overall Study|Lost to Follow-up|14
4886282|NCT00722371|16836494|P1|Overall Study|Lost to Follow-up|11
4886283|NCT00722371|16836488|P7|Overall Study|Lack of Efficacy|0
4886284|NCT00722371|16836489|P6|Overall Study|Lack of Efficacy|3
4886285|NCT00722371|16836490|P5|Overall Study|Lack of Efficacy|2
4886286|NCT00722371|16836491|P4|Overall Study|Lack of Efficacy|6
4886287|NCT00722371|16836492|P3|Overall Study|Lack of Efficacy|6
4886288|NCT00722371|16836493|P2|Overall Study|Lack of Efficacy|6
4886289|NCT00722371|16836494|P1|Overall Study|Lack of Efficacy|4
4886290|NCT00722371|16836488|P7|Overall Study|Hypoglycemia|0
4886291|NCT00722371|16836489|P6|Overall Study|Hypoglycemia|0
4886292|NCT00722371|16836490|P5|Overall Study|Hypoglycemia|0
4886293|NCT00722371|16836491|P4|Overall Study|Hypoglycemia|0
4886294|NCT00722371|16836492|P3|Overall Study|Hypoglycemia|0
4886295|NCT00722371|16836493|P2|Overall Study|Hypoglycemia|0
4886296|NCT00722371|16836494|P1|Overall Study|Hypoglycemia|1
4886297|NCT00722371|16836488|P7|Overall Study|Hyperglycemia|1
4886298|NCT00722371|16836489|P6|Overall Study|Hyperglycemia|1
4886299|NCT00722371|16836490|P5|Overall Study|Hyperglycemia|5
4886300|NCT00722371|16836491|P4|Overall Study|Hyperglycemia|2
4886301|NCT00722371|16836492|P3|Overall Study|Hyperglycemia|4
4886302|NCT00722371|16836493|P2|Overall Study|Hyperglycemia|6
4886303|NCT00722371|16836494|P1|Overall Study|Hyperglycemia|2
4886304|NCT00722371|16836488|P7|Overall Study|Excluded medication|1
4886305|NCT00722371|16836489|P6|Overall Study|Excluded medication|0
4886306|NCT00722371|16836490|P5|Overall Study|Excluded medication|0
4886307|NCT00722371|16836491|P4|Overall Study|Excluded medication|0
4886308|NCT00722371|16836492|P3|Overall Study|Excluded medication|1
4886309|NCT00722371|16836493|P2|Overall Study|Excluded medication|1
4886310|NCT00722371|16836494|P1|Overall Study|Excluded medication|0
4886311|NCT00722371|16836488|P7|Overall Study|Creatinine / Creatinine clearance|1
4886312|NCT00722371|16836489|P6|Overall Study|Creatinine / Creatinine clearance|1
4886313|NCT00722371|16836490|P5|Overall Study|Creatinine / Creatinine clearance|2
4886314|NCT00722371|16836491|P4|Overall Study|Creatinine / Creatinine clearance|3
4886315|NCT00722371|16836492|P3|Overall Study|Creatinine / Creatinine clearance|2
4886316|NCT00722371|16836493|P2|Overall Study|Creatinine / Creatinine clearance|1
4886317|NCT00722371|16836494|P1|Overall Study|Creatinine / Creatinine clearance|2
4886318|NCT00722371|16836488|P7|Overall Study|Contraindication|0
4886319|NCT00722371|16836489|P6|Overall Study|Contraindication|0
4886320|NCT00722371|16836490|P5|Overall Study|Contraindication|0
4886321|NCT00722371|16836491|P4|Overall Study|Contraindication|0
4886322|NCT00722371|16836492|P3|Overall Study|Contraindication|1
4886323|NCT00722371|16836493|P2|Overall Study|Contraindication|0
4886324|NCT00722371|16836494|P1|Overall Study|Contraindication|0
4886325|NCT00722371|16836488|P7|Overall Study|Adverse Event|4
4886326|NCT00722371|16836489|P6|Overall Study|Adverse Event|8
4886327|NCT00722371|16836490|P5|Overall Study|Adverse Event|6
4886328|NCT00722371|16836491|P4|Overall Study|Adverse Event|10
4886329|NCT00722371|16836492|P3|Overall Study|Adverse Event|9
4886330|NCT00722371|16836493|P2|Overall Study|Adverse Event|13
4886331|NCT00722371|16836494|P1|Overall Study|Adverse Event|6
4886332|NCT00722137|16836547|P2|Overall Study|Randomized But Not Treated|3
4886333|NCT00722137|16836548|P1|Overall Study|Randomized But Not Treated|2
4886334|NCT00722137|16836547|P2|Overall Study|Other Reason Unknown|4
4886335|NCT00722137|16836548|P1|Overall Study|Other Reason Unknown|3
4886336|NCT00722137|16836547|P2|Overall Study|Withdrawal by Subject|9
4886337|NCT00722137|16836548|P1|Overall Study|Withdrawal by Subject|6
4886338|NCT00722137|16836547|P2|Overall Study|Death|7
4886339|NCT00722137|16836548|P1|Overall Study|Death|12
4886340|NCT00722137|16836547|P2|Overall Study|Adverse Event|21
4886341|NCT00722137|16836548|P1|Overall Study|Adverse Event|17
4886342|NCT00722137|16836547|P2|Overall Study|Overt Disease Progression|4
4886343|NCT00722137|16836548|P1|Overall Study|Overt Disease Progression|5
4886344|NCT00721968|16836626|P2|Overall Study|Lost to Follow-up|0
4886345|NCT00721968|16836627|P1|Overall Study|Lost to Follow-up|2
4886346|NCT00721955|16836638|P3|Overall Study|Adverse Event|2
4886347|NCT00721955|16836639|P2|Overall Study|Adverse Event|0
4886348|NCT00721955|16836640|P1|Overall Study|Adverse Event|0
4886349|NCT00721799|16836654|P1|Overall Study|withdraw by subject after scan 1|1
4886350|NCT00721799|16836654|P1|Overall Study|Withdrawal by Subject|7
4886351|NCT00721734|16836694|P5|Overall Study|Other|0
4886352|NCT00721734|16836695|P4|Overall Study|Other|1
4886353|NCT00721734|16836696|P3|Overall Study|Other|0
4886354|NCT00721734|16836697|P2|Overall Study|Other|0
4886355|NCT00721734|16836698|P1|Overall Study|Other|0
4886356|NCT00721734|16836694|P5|Overall Study|Withdrawal by Subject|1
4886357|NCT00721734|16836695|P4|Overall Study|Withdrawal by Subject|0
4886358|NCT00721734|16836696|P3|Overall Study|Withdrawal by Subject|0
4886359|NCT00721734|16836697|P2|Overall Study|Withdrawal by Subject|1
4886360|NCT00721734|16836698|P1|Overall Study|Withdrawal by Subject|2
4886361|NCT00721734|16836694|P5|Overall Study|Adverse Event|3
4886362|NCT00721734|16836695|P4|Overall Study|Adverse Event|0
4886363|NCT00721734|16836696|P3|Overall Study|Adverse Event|4
4886364|NCT00721734|16836697|P2|Overall Study|Adverse Event|1
4886365|NCT00721734|16836698|P1|Overall Study|Adverse Event|3
4886366|NCT00721734|16836694|P5|Overall Study|Progressive Disease|2
4886367|NCT00721734|16836695|P4|Overall Study|Progressive Disease|5
4886368|NCT00721734|16836696|P3|Overall Study|Progressive Disease|4
4886369|NCT00721734|16836697|P2|Overall Study|Progressive Disease|10
4886370|NCT00721734|16836698|P1|Overall Study|Progressive Disease|3
4886371|NCT00721630|16836810|P1|Overall Study|Participant found to be ineligible|1
4886372|NCT00721578|16836839|P2|Overall Study|Withdrawal by Subject|1
4886373|NCT00721578|16836840|P1|Overall Study|Withdrawal by Subject|1
4886374|NCT00721578|16836839|P2|Overall Study|Death|1
4886375|NCT00721578|16836840|P1|Overall Study|Death|1
4886376|NCT00721409|16836895|P3|Overall Study|Objective progression or relapse|62
4886377|NCT00721409|16836896|P2|Overall Study|Objective progression or relapse|55
4886378|NCT00721409|16836897|P1|Overall Study|Objective progression or relapse|8
4886379|NCT00721409|16836895|P3|Overall Study|Withdrawal by Subject|5
4886380|NCT00721409|16836896|P2|Overall Study|Withdrawal by Subject|6
4886381|NCT00721409|16836897|P1|Overall Study|Withdrawal by Subject|1
4886382|NCT00721409|16836895|P3|Overall Study|Lost to Follow-up|1
4886383|NCT00721409|16836896|P2|Overall Study|Lost to Follow-up|0
4886384|NCT00721409|16836897|P1|Overall Study|Lost to Follow-up|0
4886385|NCT00721409|16836895|P3|Overall Study|Adverse Event|2
4886386|NCT00721409|16836896|P2|Overall Study|Adverse Event|13
4886387|NCT00721409|16836897|P1|Overall Study|Adverse Event|0
4886388|NCT00721409|16836895|P3|Overall Study|Reason not specified|2
4886389|NCT00721409|16836896|P2|Overall Study|Reason not specified|0
4886390|NCT00721409|16836897|P1|Overall Study|Reason not specified|1
4886391|NCT00721409|16836895|P3|Overall Study|Randomized not Treated|4
4886392|NCT00721409|16836896|P2|Overall Study|Randomized not Treated|1
4886393|NCT00721409|16836897|P1|Overall Study|Randomized not Treated|0
4886394|NCT00721409|16836895|P3|Overall Study|Death|0
4886395|NCT00721409|16836896|P2|Overall Study|Death|1
4886396|NCT00721409|16836897|P1|Overall Study|Death|0
4886397|NCT00721409|16836895|P3|Overall Study|Global deterioration of health status|3
4886398|NCT00721409|16836896|P2|Overall Study|Global deterioration of health status|6
4886399|NCT00721409|16836897|P1|Overall Study|Global deterioration of health status|2
4886400|NCT00721396|16837024|P4|Overall Study|Administrative reason|0
4886401|NCT00721396|16837025|P3|Overall Study|Administrative reason|1
4886402|NCT00721396|16837026|P2|Overall Study|Administrative reason|0
4886403|NCT00721396|16837027|P1|Overall Study|Administrative reason|3
4886404|NCT00721396|16837024|P4|Overall Study|Inappropriate enrollment|0
4886405|NCT00721396|16837025|P3|Overall Study|Inappropriate enrollment|0
4886406|NCT00721396|16837026|P2|Overall Study|Inappropriate enrollment|2
4886407|NCT00721396|16837027|P1|Overall Study|Inappropriate enrollment|0
4886408|NCT00721396|16837024|P4|Overall Study|Protocol Violation|0
4886409|NCT00721396|16837025|P3|Overall Study|Protocol Violation|1
4886410|NCT00721396|16837026|P2|Overall Study|Protocol Violation|3
4886411|NCT00721396|16837027|P1|Overall Study|Protocol Violation|4
4886412|NCT00721396|16837024|P4|Overall Study|Lost to Follow-up|3
4886413|NCT00721396|16837025|P3|Overall Study|Lost to Follow-up|3
4886414|NCT00721396|16837026|P2|Overall Study|Lost to Follow-up|9
4886415|NCT00721396|16837027|P1|Overall Study|Lost to Follow-up|7
4886416|NCT00721396|16837024|P4|Overall Study|Withdrawal by Subject|7
4886417|NCT00721396|16837025|P3|Overall Study|Withdrawal by Subject|3
4886418|NCT00721396|16837026|P2|Overall Study|Withdrawal by Subject|15
4886419|NCT00721396|16837027|P1|Overall Study|Withdrawal by Subject|12
4886420|NCT00721396|16837024|P4|Overall Study|Adverse Event|0
4886421|NCT00721396|16837025|P3|Overall Study|Adverse Event|2
4886422|NCT00721396|16837026|P2|Overall Study|Adverse Event|7
4886423|NCT00721396|16837027|P1|Overall Study|Adverse Event|4
4886424|NCT00721279|16837078|P2|Overall Study|Other|16
4886425|NCT00721279|16837079|P1|Overall Study|Other|12
4886426|NCT00721279|16837078|P2|Overall Study|Withdrawal by Subject|3
4886427|NCT00721279|16837079|P1|Overall Study|Withdrawal by Subject|13
4886428|NCT00721279|16837078|P2|Overall Study|Tolerability insufficient|2
4886429|NCT00721279|16837079|P1|Overall Study|Tolerability insufficient|5
4886430|NCT00721279|16837078|P2|Overall Study|Lack of Efficacy|3
4886431|NCT00721279|16837079|P1|Overall Study|Lack of Efficacy|6
4886432|NCT00721227|16837107|P2|Overall Study|Noncompliance with scheduled visits.|0
4886433|NCT00721227|16837108|P1|Overall Study|Noncompliance with scheduled visits.|1
4886434|NCT00721227|16837107|P2|Overall Study|Lost to Follow-up|0
4886435|NCT00721227|16837108|P1|Overall Study|Lost to Follow-up|3
4886436|NCT00721214|16837118|P1|Overall Study|Death|3
4886437|NCT00721214|16837118|P1|Overall Study|Chose another center for transplant|1
4886438|NCT00721149|16837168|P1|Overall Study|Physician Decision|1
4886439|NCT00721123|16837202|P1|Overall Study|Withdrawal by Subject|5
4886440|NCT00721123|16837202|P1|Overall Study|Failure to Return|9
4886441|NCT00721123|16837202|P1|Overall Study|Refused Treatment|41
4886442|NCT00721123|16837202|P1|Overall Study|Protocol Violation|1
4886443|NCT00721123|16837202|P1|Overall Study|Insufficient Therapeutic Response|21
4886444|NCT00721123|16837202|P1|Overall Study|Death|10
4886445|NCT00721123|16837202|P1|Overall Study|Adverse Event|96
4886446|NCT00721110|16837280|P4|Overall Study|vertical incision|0
4886447|NCT00721110|16837281|P3|Overall Study|vertical incision|1
4886448|NCT00721110|16837282|P2|Overall Study|vertical incision|0
4886449|NCT00721110|16837283|P1|Overall Study|vertical incision|0
4886450|NCT00721110|16837280|P4|Overall Study|Ultram use|0
4886451|NCT00721110|16837281|P3|Overall Study|Ultram use|0
4886452|NCT00721110|16837282|P2|Overall Study|Ultram use|0
4886453|NCT00721110|16837283|P1|Overall Study|Ultram use|1
4886454|NCT00720941|16837311|P2|Overall Study|Ongoing|23
4886455|NCT00720941|16837312|P1|Overall Study|Ongoing|34
4886456|NCT00720941|16837311|P2|Overall Study|Withdrawal by Subject|35
4886457|NCT00720941|16837312|P1|Overall Study|Withdrawal by Subject|27
4886458|NCT00720941|16837311|P2|Overall Study|Physician Decision|5
4886459|NCT00720941|16837312|P1|Overall Study|Physician Decision|1
4886460|NCT00720941|16837311|P2|Overall Study|Lost to Follow-up|15
4886461|NCT00720941|16837312|P1|Overall Study|Lost to Follow-up|17
4886462|NCT00720941|16837311|P2|Overall Study|Protocol Violation|2
4886463|NCT00720941|16837312|P1|Overall Study|Protocol Violation|0
4886464|NCT00720941|16837311|P2|Overall Study|Death|335
4886465|NCT00720941|16837312|P1|Overall Study|Death|334
4886466|NCT00720876|16837352|P1|Overall Study|found to be ineligible after starting tx|2
4886467|NCT00720798|16837358|P1|Overall Study|Reason not Specified|83
4886468|NCT00720798|16837358|P1|Overall Study|Failure to Return|46
4886469|NCT00720798|16837358|P1|Overall Study|Refused Treatment|151
4886470|NCT00720798|16837358|P1|Overall Study|Protocol Violation|4
4886471|NCT00720798|16837358|P1|Overall Study|Insufficient Therapeutic Response|129
4886472|NCT00720798|16837358|P1|Overall Study|Death|39
4886473|NCT00720798|16837358|P1|Overall Study|Adverse Event|304
4886474|NCT00720759|16837381|P4|Overall Study|Lost to Follow-up|0
4886475|NCT00720759|16837382|P3|Overall Study|Lost to Follow-up|1
4886476|NCT00720759|16837383|P2|Overall Study|Lost to Follow-up|1
4886477|NCT00720759|16837384|P1|Overall Study|Lost to Follow-up|0
4886478|NCT00720499|16837404|P2|Treatment Period 2 (4 Weeks)|Adverse Event|3
4886479|NCT00720499|16837405|P1|Treatment Period 2 (4 Weeks)|Adverse Event|2
4886480|NCT00720499|16837404|P2|Treatment Period 1 (4 Weeks)|Protocol Violation|2
4886481|NCT00720499|16837405|P1|Treatment Period 1 (4 Weeks)|Protocol Violation|1
4886482|NCT00720499|16837404|P2|Treatment Period 1 (4 Weeks)|Adverse Event|0
4886483|NCT00720499|16837405|P1|Treatment Period 1 (4 Weeks)|Adverse Event|2
4886484|NCT00720434|16837498|P4|Open-Label Period (Week 5-72)|Other|2
4886485|NCT00720434|16837499|P3|Open-Label Period (Week 5-72)|Other|3
4886486|NCT00720434|16837500|P2|Open-Label Period (Week 5-72)|Other|3
4886487|NCT00720434|16837501|P1|Open-Label Period (Week 5-72)|Other|4
4886488|NCT00720434|16837498|P4|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
4886489|NCT00720434|16837499|P3|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
4886490|NCT00720434|16837500|P2|Open-Label Period (Week 5-72)|Withdrawal by Subject|0
4886491|NCT00720434|16837501|P1|Open-Label Period (Week 5-72)|Withdrawal by Subject|1
4886492|NCT00720434|16837498|P4|Open-Label Period (Week 5-72)|Lost to Follow-up|0
4886493|NCT00720434|16837499|P3|Open-Label Period (Week 5-72)|Lost to Follow-up|0
4886494|NCT00720434|16837500|P2|Open-Label Period (Week 5-72)|Lost to Follow-up|0
4886495|NCT00720434|16837501|P1|Open-Label Period (Week 5-72)|Lost to Follow-up|1
4886496|NCT00720434|16837498|P4|Open-Label Period (Week 5-72)|Adverse Event|2
4886497|NCT00720434|16837499|P3|Open-Label Period (Week 5-72)|Adverse Event|0
4886498|NCT00720434|16837500|P2|Open-Label Period (Week 5-72)|Adverse Event|0
4886499|NCT00720434|16837501|P1|Open-Label Period (Week 5-72)|Adverse Event|0
4886500|NCT00720434|16837498|P4|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
4886501|NCT00720434|16837499|P3|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
4886502|NCT00720434|16837500|P2|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1
4886503|NCT00720434|16837501|P1|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0
4886504|NCT00720382|16837525|P2|Overall Study|administrative|5
4886505|NCT00720382|16837526|P1|Overall Study|administrative|14
4886506|NCT00720382|16837525|P2|Overall Study|Lost to Follow-up|14
4886507|NCT00720382|16837526|P1|Overall Study|Lost to Follow-up|28
4886508|NCT00720382|16837525|P2|Overall Study|Withdrawal by Subject|11
4886509|NCT00720382|16837526|P1|Overall Study|Withdrawal by Subject|47
4886510|NCT00720382|16837525|P2|Overall Study|Non-Compliance|5
4886511|NCT00720382|16837526|P1|Overall Study|Non-Compliance|15
4886512|NCT00720382|16837525|P2|Overall Study|Lack of Efficacy|7
4886513|NCT00720382|16837526|P1|Overall Study|Lack of Efficacy|18
4886514|NCT00720382|16837525|P2|Overall Study|Adverse Event|17
4886515|NCT00720382|16837526|P1|Overall Study|Adverse Event|54
4886516|NCT00720356|16837545|P1|Follow up Until Death|Alive at last data collection|4
4886517|NCT00720356|16837545|P1|Follow up Until Death|Withdrawal by Subject|1
4886518|NCT00720356|16837545|P1|Went on to be Treated Cycle 3|Physician Decision|1
4886519|NCT00720356|16837545|P1|Went on to be Treated Cycle 3|Adverse Event|1
4886520|NCT00720356|16837545|P1|Reached 1st Response/2 Cycles|Withdrawal by Subject|1
4886521|NCT00720356|16837545|P1|Reached 1st Response/2 Cycles|Progressive Disease|1
4886522|NCT00720356|16837545|P1|Registration to Study|Determined to have methylated MGMT|67
4886523|NCT00720343|16837559|P1|Overall Study|No data|3
4886524|NCT00720343|16837559|P1|Overall Study|Physician Decision|3
4886525|NCT00720278|16837593|P3|Overall Study|eligibility criteria violation|1
4886526|NCT00720278|16837594|P2|Overall Study|eligibility criteria violation|0
4886527|NCT00720278|16837595|P1|Overall Study|eligibility criteria violation|1
4886528|NCT00720278|16837593|P3|Overall Study|Non-compliance|0
4886529|NCT00720278|16837594|P2|Overall Study|Non-compliance|0
4886530|NCT00720278|16837595|P1|Overall Study|Non-compliance|1
4886531|NCT00720278|16837593|P3|Overall Study|Lost to Follow-up|1
4886532|NCT00720278|16837594|P2|Overall Study|Lost to Follow-up|0
4886533|NCT00720278|16837595|P1|Overall Study|Lost to Follow-up|0
4886534|NCT00720278|16837593|P3|Overall Study|Withdrawal by Subject|0
4886535|NCT00720278|16837594|P2|Overall Study|Withdrawal by Subject|1
4886536|NCT00720278|16837595|P1|Overall Study|Withdrawal by Subject|0
4886537|NCT00720278|16837593|P3|Overall Study|Adverse Event|4
4886538|NCT00720278|16837594|P2|Overall Study|Adverse Event|3
4886539|NCT00720278|16837595|P1|Overall Study|Adverse Event|5
4886540|NCT00720226|16837617|P2|Overall Study|Withdrawal by Subject|4
4886541|NCT00720226|16837618|P1|Overall Study|Withdrawal by Subject|7
4886542|NCT00720213|16837626|P3|Screening Phase With Diagnostic PSG|Screen Failure|0
4886543|NCT00720213|16837627|P2|Screening Phase With Diagnostic PSG|Screen Failure|0
4886544|NCT00720213|16837628|P1|Screening Phase With Diagnostic PSG|Screen Failure|7
4886545|NCT00720122|16837666|P1|Overall Study|Withdrawal by Subject|7
4886546|NCT00720122|16837666|P1|Overall Study|Physician Decision|1
4886547|NCT00720122|16837666|P1|Overall Study|Lost to Follow-up|1
4886548|NCT00720109|16837670|P3|Risk Stratification Period|Development of second malignant neoplasm|0
4886549|NCT00720109|16837671|P2|Risk Stratification Period|Development of second malignant neoplasm|1
4886550|NCT00720109|16837672|P1|Risk Stratification Period|Development of second malignant neoplasm|0
4886551|NCT00720109|16837670|P3|Risk Stratification Period|Disease progression or relapse|0
4886552|NCT00720109|16837671|P2|Risk Stratification Period|Disease progression or relapse|2
4886553|NCT00720109|16837672|P1|Risk Stratification Period|Disease progression or relapse|0
4886554|NCT00720109|16837670|P3|Risk Stratification Period|Bone marrow transplant|7
4886555|NCT00720109|16837671|P2|Risk Stratification Period|Bone marrow transplant|9
4886556|NCT00720109|16837672|P1|Risk Stratification Period|Bone marrow transplant|0
4886557|NCT00720109|16837670|P3|Risk Stratification Period|Physician Decision|1
4886558|NCT00720109|16837671|P2|Risk Stratification Period|Physician Decision|2
4886559|NCT00720109|16837672|P1|Risk Stratification Period|Physician Decision|0
4886560|NCT00720109|16837670|P3|Risk Stratification Period|Adverse Event|0
4886561|NCT00720109|16837671|P2|Risk Stratification Period|Adverse Event|1
4886562|NCT00720109|16837672|P1|Risk Stratification Period|Adverse Event|0
4886563|NCT00720109|16837670|P3|Induction Period|Physician Decision|0
4886564|NCT00720109|16837671|P2|Induction Period|Physician Decision|0
4886565|NCT00720109|16837672|P1|Induction Period|Physician Decision|1
4886566|NCT00720109|16837670|P3|Induction Period|Bone Marrow Transplant|0
4886567|NCT00720109|16837671|P2|Induction Period|Bone Marrow Transplant|0
4886568|NCT00720109|16837672|P1|Induction Period|Bone Marrow Transplant|2
4886569|NCT00720109|16837670|P3|Induction Period|Did not meet eligibility criteria|0
4886570|NCT00720109|16837671|P2|Induction Period|Did not meet eligibility criteria|0
4886571|NCT00720109|16837672|P1|Induction Period|Did not meet eligibility criteria|3
4886572|NCT00720096|16837692|P2|Overall Study|Withdrawal by Subject|2
4886573|NCT00720096|16837693|P1|Overall Study|Withdrawal by Subject|0
4886574|NCT00720083|16837705|P2|Overall Study|Ineligible|2
4886575|NCT00720083|16837706|P1|Overall Study|Ineligible|1
4886576|NCT00720057|16837714|P2|Overall Study|Withdrawal by Subject|1
4886577|NCT00720057|16837715|P1|Overall Study|Withdrawal by Subject|0
4886578|NCT00720057|16837714|P2|Overall Study|Protocol Violation|0
4886579|NCT00720057|16837715|P1|Overall Study|Protocol Violation|1
4886580|NCT00720057|16837714|P2|Overall Study|Lost to Follow-up|2
4886581|NCT00720057|16837715|P1|Overall Study|Lost to Follow-up|0
4886582|NCT00719953|16837731|P1|Overall Study|Adverse Event|4
4886583|NCT00719901|16837744|P1|Overall Study|Availability of Study Drug|1
4886584|NCT00719901|16837744|P1|Overall Study|Disease Progression|3
4886585|NCT00719901|16837744|P1|Overall Study|Alternate Treatment|1
4886586|NCT00719901|16837744|P1|Overall Study|Withdrawal by Subject|1
4886587|NCT00719901|16837744|P1|Overall Study|Adverse Event|5
4886588|NCT00719862|16837756|P2|Overall Study|Other|3
4886589|NCT00719862|16837757|P1|Overall Study|Other|2
4886590|NCT00719862|16837756|P2|Overall Study|Lost to Follow-up|1
4886591|NCT00719862|16837757|P1|Overall Study|Lost to Follow-up|0
4886592|NCT00719862|16837756|P2|Overall Study|Withdrawal by Subject|0
4886593|NCT00719862|16837757|P1|Overall Study|Withdrawal by Subject|1
4886594|NCT00719862|16837756|P2|Overall Study|Non-Compliance|0
4886595|NCT00719862|16837757|P1|Overall Study|Non-Compliance|1
4886596|NCT00719862|16837756|P2|Overall Study|Lack of Efficacy|0
4886597|NCT00719862|16837757|P1|Overall Study|Lack of Efficacy|3
4886598|NCT00719862|16837756|P2|Overall Study|Adverse Event|2
4886599|NCT00719862|16837757|P1|Overall Study|Adverse Event|1
4886600|NCT00719849|16837775|P2|Overall Study|Death|1
4886601|NCT00719849|16837776|P1|Overall Study|Death|0
4886602|NCT00719810|16837815|P3|Overall Study|Withdrawal by Subject|2
4886603|NCT00719810|16837816|P2|Overall Study|Withdrawal by Subject|1
4886604|NCT00719810|16837817|P1|Overall Study|Withdrawal by Subject|1
4886605|NCT00719810|16837815|P3|Overall Study|Physician Decision|0
4886606|NCT00719810|16837816|P2|Overall Study|Physician Decision|1
4886607|NCT00719810|16837817|P1|Overall Study|Physician Decision|0
4886608|NCT00719810|16837815|P3|Overall Study|Lost to Follow-up|3
4886609|NCT00719810|16837816|P2|Overall Study|Lost to Follow-up|0
4886610|NCT00719810|16837817|P1|Overall Study|Lost to Follow-up|2
4886611|NCT00719810|16837815|P3|Overall Study|Adverse Event|3
4886612|NCT00719810|16837816|P2|Overall Study|Adverse Event|2
4886613|NCT00719810|16837817|P1|Overall Study|Adverse Event|0
4886614|NCT00719732|16837828|P1|Overall Study|Illness not associated with device|1
4886615|NCT00719732|16837828|P1|Overall Study|Unilateral (not bilateral) implantation|1
4886616|NCT00719732|16837828|P1|Overall Study|Lost to Follow-up|20
4886617|NCT00719706|16837834|P2|Overall Study|Protocol Violation|0
4886618|NCT00719706|16837835|P1|Overall Study|Protocol Violation|3
4886619|NCT00719706|16837834|P2|Overall Study|Withdrawal by Subject|2
4886620|NCT00719706|16837835|P1|Overall Study|Withdrawal by Subject|1
4886621|NCT00719706|16837834|P2|Overall Study|Adverse Event|4
4886622|NCT00719706|16837835|P1|Overall Study|Adverse Event|5
4886623|NCT00719680|16837849|P1|Overall Study|Withdrawal by Subject|3
4886624|NCT00719680|16837849|P1|Overall Study|Lost to Follow-up|1
4886625|NCT00719680|16837849|P1|Overall Study|Adverse Event|1
4886626|NCT00719563|16837905|P2|Overall Study|Lost to Follow-up|3
4886627|NCT00719563|16837906|P1|Overall Study|Lost to Follow-up|5
4886628|NCT00719563|16837905|P2|Overall Study|Noncompliant|1
4886629|NCT00719563|16837906|P1|Overall Study|Noncompliant|1
4886630|NCT00719563|16837905|P2|Overall Study|Unknown reasons|6
4886631|NCT00719563|16837906|P1|Overall Study|Unknown reasons|4
4886632|NCT00719563|16837905|P2|Overall Study|Personal reasons|7
4886633|NCT00719563|16837906|P1|Overall Study|Personal reasons|6
4886634|NCT00719563|16837905|P2|Overall Study|Lack of Efficacy|7
4886635|NCT00719563|16837906|P1|Overall Study|Lack of Efficacy|3
4886636|NCT00719563|16837905|P2|Overall Study|Medical condition changed|5
4886637|NCT00719563|16837906|P1|Overall Study|Medical condition changed|3
4886638|NCT00719563|16837905|P2|Overall Study|Adverse Event|13
4886639|NCT00719563|16837906|P1|Overall Study|Adverse Event|16
4886640|NCT00719537|16837938|P2|Overall Study|Lost to Follow-up|1
4886641|NCT00719537|16837939|P1|Overall Study|Lost to Follow-up|0
4886642|NCT00719537|16837938|P2|Overall Study|Withdrawal by Subject|0
4886643|NCT00719537|16837939|P1|Overall Study|Withdrawal by Subject|1
4886644|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Various Reasons|25
4886645|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Subject decision to withdraw|6
4886646|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Physician decision to withdraw patient|13
4886647|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Lost to Follow-up|3
4886648|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Disease progression|3
4886649|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Death|6
4886650|NCT00719472|16837945|P1|Received Cycle 2 Treatment|Adverse Event|12
4886651|NCT00719472|16837945|P1|Received Cycle 1 Treatment|Various Reasons|13
4886652|NCT00719472|16837945|P1|Received Cycle 1 Treatment|Subject decision to withdraw|9
4886653|NCT00719472|16837945|P1|Received Cycle 1 Treatment|Physician decision to withdraw patient|7
4886654|NCT00719472|16837945|P1|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11
4886655|NCT00719472|16837945|P1|Received Cycle 1 Treatment|Death|5
4886656|NCT00719472|16837945|P1|Received Cycle 1 Treatment|Adverse Event|8
4886657|NCT00719472|16837945|P1|Enrolled in Study|Various Reasons|17
4886658|NCT00719472|16837945|P1|Enrolled in Study|Subject decision to withdraw|8
4886659|NCT00719472|16837945|P1|Enrolled in Study|Physician decision to withdraw patient|1
4886660|NCT00719355|16837956|P2|Overall Study|Moved|1
4886661|NCT00719355|16837957|P1|Overall Study|Moved|0
4886662|NCT00719355|16837956|P2|Overall Study|Compliance|6
4886663|NCT00719355|16837957|P1|Overall Study|Compliance|4
4886664|NCT00719355|16837956|P2|Overall Study|Medical|5
4886665|NCT00719355|16837957|P1|Overall Study|Medical|14
4886666|NCT00719355|16837956|P2|Overall Study|Death|1
4886667|NCT00719355|16837957|P1|Overall Study|Death|0
4886668|NCT00719264|16837986|P2|Overall Study|Disease Progression|107
4886669|NCT00719264|16837987|P1|Overall Study|Disease Progression|104
4886670|NCT00719264|16837986|P2|Overall Study|New Cancer Therapy|2
4886671|NCT00719264|16837987|P1|Overall Study|New Cancer Therapy|4
4886672|NCT00719264|16837986|P2|Overall Study|Protocol Deviation|3
4886673|NCT00719264|16837987|P1|Overall Study|Protocol Deviation|1
4886674|NCT00719264|16837986|P2|Overall Study|Withdrawal by Subject|7
4886675|NCT00719264|16837987|P1|Overall Study|Withdrawal by Subject|12
4886676|NCT00719264|16837986|P2|Overall Study|Lost to Follow-up|1
4886677|NCT00719264|16837987|P1|Overall Study|Lost to Follow-up|1
4886678|NCT00719264|16837986|P2|Overall Study|Administrative Problems|4
4886679|NCT00719264|16837987|P1|Overall Study|Administrative Problems|6
4886680|NCT00719264|16837986|P2|Overall Study|Death|10
4886681|NCT00719264|16837987|P1|Overall Study|Death|13
4886682|NCT00719264|16837986|P2|Overall Study|Adverse Event|49
4886683|NCT00719264|16837987|P1|Overall Study|Adverse Event|41
4886684|NCT00719212|16838006|P1|Overall Study|Withdrawal by Subject|1
4886685|NCT00719212|16838006|P1|Overall Study|Lost to Follow-up|2
4886686|NCT00719212|16838006|P1|Overall Study|Death|41
4886687|NCT00719043|16838054|P7|Overall Study|Withdrawal by Subject|14
4886688|NCT00719043|16838055|P6|Overall Study|Withdrawal by Subject|18
4886689|NCT00719043|16838056|P5|Overall Study|Withdrawal by Subject|16
4886690|NCT00719043|16838057|P4|Overall Study|Withdrawal by Subject|10
4886691|NCT00719043|16838058|P3|Overall Study|Withdrawal by Subject|9
4886692|NCT00719043|16838059|P2|Overall Study|Withdrawal by Subject|14
4886693|NCT00719043|16838060|P1|Overall Study|Withdrawal by Subject|12
4886694|NCT00719043|16838054|P7|Overall Study|Other|1
4886695|NCT00719043|16838055|P6|Overall Study|Other|2
4886696|NCT00719043|16838056|P5|Overall Study|Other|0
4886697|NCT00719043|16838057|P4|Overall Study|Other|2
4886698|NCT00719043|16838058|P3|Overall Study|Other|1
4886699|NCT00719043|16838059|P2|Overall Study|Other|0
4886700|NCT00719043|16838060|P1|Overall Study|Other|1
4886701|NCT00719043|16838054|P7|Overall Study|Protocol Violation|0
4886702|NCT00719043|16838055|P6|Overall Study|Protocol Violation|1
4886703|NCT00719043|16838056|P5|Overall Study|Protocol Violation|0
4886704|NCT00719043|16838057|P4|Overall Study|Protocol Violation|0
4886705|NCT00719043|16838058|P3|Overall Study|Protocol Violation|0
4886706|NCT00719043|16838059|P2|Overall Study|Protocol Violation|0
4886707|NCT00719043|16838060|P1|Overall Study|Protocol Violation|0
4886708|NCT00719043|16838054|P7|Overall Study|Lost to Follow-up|9
4886709|NCT00719043|16838055|P6|Overall Study|Lost to Follow-up|9
4886710|NCT00719043|16838056|P5|Overall Study|Lost to Follow-up|10
4886711|NCT00719043|16838057|P4|Overall Study|Lost to Follow-up|9
4886712|NCT00719043|16838058|P3|Overall Study|Lost to Follow-up|8
4886713|NCT00719043|16838059|P2|Overall Study|Lost to Follow-up|10
4886714|NCT00719043|16838060|P1|Overall Study|Lost to Follow-up|14
4886715|NCT00719043|16838054|P7|Overall Study|Adverse Event|4
4886716|NCT00719043|16838055|P6|Overall Study|Adverse Event|4
4886717|NCT00719043|16838056|P5|Overall Study|Adverse Event|1
4886718|NCT00719043|16838057|P4|Overall Study|Adverse Event|2
4886719|NCT00719043|16838058|P3|Overall Study|Adverse Event|2
4886720|NCT00719043|16838059|P2|Overall Study|Adverse Event|1
4886721|NCT00719043|16838060|P1|Overall Study|Adverse Event|5
4886722|NCT00718887|16838184|P2|Overall Study|Not identified|7
4886723|NCT00718887|16838185|P1|Overall Study|Not identified|2
4886724|NCT00718887|16838184|P2|Overall Study|Withdrawal by Subject|2
4886725|NCT00718887|16838185|P1|Overall Study|Withdrawal by Subject|3
4886726|NCT00718861|16838209|P2|Overall Study|Death|5
4886727|NCT00718861|16838210|P1|Overall Study|Death|1
4886728|NCT00718861|16838209|P2|Overall Study|Administrative Problems|1
4886729|NCT00718861|16838210|P1|Overall Study|Administrative Problems|1
4886730|NCT00718861|16838209|P2|Overall Study|Lost to Follow-up|1
4886731|NCT00718861|16838210|P1|Overall Study|Lost to Follow-up|2
4886732|NCT00718861|16838209|P2|Overall Study|Adverse Event|1
4886733|NCT00718861|16838210|P1|Overall Study|Adverse Event|2
4886734|NCT00718861|16838209|P2|Overall Study|Withdrawal by Subject|10
4886735|NCT00718861|16838210|P1|Overall Study|Withdrawal by Subject|15
4886736|NCT00718809|16838238|P2|Overall Study|Noncompliance|0
4886737|NCT00718809|16838239|P1|Overall Study|Noncompliance|1
4886738|NCT00718809|16838238|P2|Overall Study|Lost to Follow-up|0
4886739|NCT00718809|16838239|P1|Overall Study|Lost to Follow-up|1
4886740|NCT00718809|16838238|P2|Overall Study|Withdrawal by Subject|1
4886741|NCT00718809|16838239|P1|Overall Study|Withdrawal by Subject|0
4886742|NCT00718809|16838238|P2|Overall Study|Adverse Event|1
4886743|NCT00718809|16838239|P1|Overall Study|Adverse Event|1
4886744|NCT00718809|16838238|P2|Overall Study|Disease progression|7
4886745|NCT00718809|16838239|P1|Overall Study|Disease progression|9
4886746|NCT00718770|16838253|P1|Overall Study|Adverse Event|1
4886747|NCT00718770|16838253|P1|Overall Study|Lack of Efficacy|1
4886748|NCT00718770|16838253|P1|Overall Study|Adverse Event|1
4886749|NCT00718770|16838253|P1|Overall Study|Lack of Efficacy|1
4886750|NCT00718770|16838253|P1|Overall Study|Adverse Event|1
4886751|NCT00718770|16838253|P1|Overall Study|Lack of Efficacy|1
4886752|NCT00718770|16838253|P1|Overall Study|Lack of Efficacy|1
4886753|NCT00718770|16838253|P1|Overall Study|Adverse Event|1
4886754|NCT00718718|16838264|P10|Week 12 to End of Study|Other|0
4886755|NCT00718718|16838265|P9|Week 12 to End of Study|Other|0
4886756|NCT00718718|16838266|P8|Week 12 to End of Study|Other|0
4886757|NCT00718718|16838267|P7|Week 12 to End of Study|Other|1
4886758|NCT00718718|16838268|P6|Week 12 to End of Study|Other|0
4886759|NCT00718718|16838269|P5|Week 12 to End of Study|Other|0
4886760|NCT00718718|16838270|P4|Week 12 to End of Study|Other|1
4886761|NCT00718718|16838271|P3|Week 12 to End of Study|Other|0
4886762|NCT00718718|16838272|P2|Week 12 to End of Study|Other|1
4886763|NCT00718718|16838273|P1|Week 12 to End of Study|Other|0
4886764|NCT00718718|16838264|P10|Week 12 to End of Study|Lost to Follow-up|0
4886765|NCT00718718|16838265|P9|Week 12 to End of Study|Lost to Follow-up|1
4886766|NCT00718718|16838266|P8|Week 12 to End of Study|Lost to Follow-up|0
4886767|NCT00718718|16838267|P7|Week 12 to End of Study|Lost to Follow-up|0
4886768|NCT00718718|16838268|P6|Week 12 to End of Study|Lost to Follow-up|0
4886769|NCT00718718|16838269|P5|Week 12 to End of Study|Lost to Follow-up|0
4886770|NCT00718718|16838270|P4|Week 12 to End of Study|Lost to Follow-up|0
4886771|NCT00718718|16838271|P3|Week 12 to End of Study|Lost to Follow-up|0
4886772|NCT00718718|16838272|P2|Week 12 to End of Study|Lost to Follow-up|0
4886773|NCT00718718|16838273|P1|Week 12 to End of Study|Lost to Follow-up|0
4886774|NCT00718718|16838264|P10|Week 12 to End of Study|Withdrawal by Subject|0
4886775|NCT00718718|16838265|P9|Week 12 to End of Study|Withdrawal by Subject|0
4886776|NCT00718718|16838266|P8|Week 12 to End of Study|Withdrawal by Subject|0
4886777|NCT00718718|16838267|P7|Week 12 to End of Study|Withdrawal by Subject|1
4886778|NCT00718718|16838268|P6|Week 12 to End of Study|Withdrawal by Subject|2
4886779|NCT00718718|16838269|P5|Week 12 to End of Study|Withdrawal by Subject|0
4886780|NCT00718718|16838270|P4|Week 12 to End of Study|Withdrawal by Subject|0
4886781|NCT00718718|16838271|P3|Week 12 to End of Study|Withdrawal by Subject|0
4886782|NCT00718718|16838272|P2|Week 12 to End of Study|Withdrawal by Subject|0
4886783|NCT00718718|16838273|P1|Week 12 to End of Study|Withdrawal by Subject|0
4886784|NCT00718718|16838264|P10|Week 12 to End of Study|Death|0
4886785|NCT00718718|16838265|P9|Week 12 to End of Study|Death|0
4886786|NCT00718718|16838266|P8|Week 12 to End of Study|Death|0
4886787|NCT00718718|16838267|P7|Week 12 to End of Study|Death|0
4886788|NCT00718718|16838268|P6|Week 12 to End of Study|Death|1
4886789|NCT00718718|16838269|P5|Week 12 to End of Study|Death|0
4886790|NCT00718718|16838270|P4|Week 12 to End of Study|Death|0
4886791|NCT00718718|16838271|P3|Week 12 to End of Study|Death|0
4886792|NCT00718718|16838272|P2|Week 12 to End of Study|Death|0
4886793|NCT00718718|16838273|P1|Week 12 to End of Study|Death|0
4886794|NCT00718718|16838264|P10|Week 12 to End of Study|Adverse Event|0
4886795|NCT00718718|16838265|P9|Week 12 to End of Study|Adverse Event|0
4886796|NCT00718718|16838266|P8|Week 12 to End of Study|Adverse Event|1
4886797|NCT00718718|16838267|P7|Week 12 to End of Study|Adverse Event|0
4886798|NCT00718718|16838268|P6|Week 12 to End of Study|Adverse Event|0
4886799|NCT00718718|16838269|P5|Week 12 to End of Study|Adverse Event|0
4886800|NCT00718718|16838270|P4|Week 12 to End of Study|Adverse Event|0
4886801|NCT00718718|16838271|P3|Week 12 to End of Study|Adverse Event|0
4886802|NCT00718718|16838272|P2|Week 12 to End of Study|Adverse Event|0
4886803|NCT00718718|16838273|P1|Week 12 to End of Study|Adverse Event|0
4886804|NCT00718718|16838264|P10|Prior to Week 12|Other|0
4886805|NCT00718718|16838265|P9|Prior to Week 12|Other|0
4886806|NCT00718718|16838266|P8|Prior to Week 12|Other|0
4886807|NCT00718718|16838267|P7|Prior to Week 12|Other|0
4886808|NCT00718718|16838268|P6|Prior to Week 12|Other|0
4886809|NCT00718718|16838269|P5|Prior to Week 12|Other|0
4886810|NCT00718718|16838270|P4|Prior to Week 12|Other|0
4886811|NCT00718718|16838271|P3|Prior to Week 12|Other|1
4886812|NCT00718718|16838272|P2|Prior to Week 12|Other|0
4886813|NCT00718718|16838273|P1|Prior to Week 12|Other|1
4886814|NCT00718718|16838264|P10|Prior to Week 12|Withdrawal by Subject|0
4886815|NCT00718718|16838265|P9|Prior to Week 12|Withdrawal by Subject|1
4886816|NCT00718718|16838266|P8|Prior to Week 12|Withdrawal by Subject|1
4886817|NCT00718718|16838267|P7|Prior to Week 12|Withdrawal by Subject|1
4886818|NCT00718718|16838268|P6|Prior to Week 12|Withdrawal by Subject|0
4886819|NCT00718718|16838269|P5|Prior to Week 12|Withdrawal by Subject|3
4886820|NCT00718718|16838270|P4|Prior to Week 12|Withdrawal by Subject|0
4886821|NCT00718718|16838271|P3|Prior to Week 12|Withdrawal by Subject|0
4886822|NCT00718718|16838272|P2|Prior to Week 12|Withdrawal by Subject|0
4886823|NCT00718718|16838273|P1|Prior to Week 12|Withdrawal by Subject|0
4886824|NCT00718718|16838264|P10|Prior to Week 12|Adverse Event|0
4886825|NCT00718718|16838265|P9|Prior to Week 12|Adverse Event|1
4886826|NCT00718718|16838266|P8|Prior to Week 12|Adverse Event|1
4886827|NCT00718718|16838267|P7|Prior to Week 12|Adverse Event|0
4886828|NCT00718718|16838268|P6|Prior to Week 12|Adverse Event|0
4886829|NCT00718718|16838269|P5|Prior to Week 12|Adverse Event|0
4886830|NCT00718718|16838270|P4|Prior to Week 12|Adverse Event|0
4886831|NCT00718718|16838271|P3|Prior to Week 12|Adverse Event|0
4886832|NCT00718718|16838272|P2|Prior to Week 12|Adverse Event|0
4886833|NCT00718718|16838273|P1|Prior to Week 12|Adverse Event|0
4886834|NCT00718666|16838316|P3|Booster Phase Year 5|Lost to Follow-up|4
4886835|NCT00718666|16838317|P2|Booster Phase Year 5|Lost to Follow-up|0
4886836|NCT00718666|16838318|P1|Booster Phase Year 5|Lost to Follow-up|1
4886837|NCT00718666|16838316|P3|Booster Phase Year 5|Withdrawal by Subject|1
4886838|NCT00718666|16838317|P2|Booster Phase Year 5|Withdrawal by Subject|0
4886839|NCT00718666|16838318|P1|Booster Phase Year 5|Withdrawal by Subject|0
4886840|NCT00718666|16838316|P3|Booster Phase Year 5|Declined v-4 serology|0
4886841|NCT00718666|16838317|P2|Booster Phase Year 5|Declined v-4 serology|0
4886842|NCT00718666|16838318|P1|Booster Phase Year 5|Declined v-4 serology|1
4886843|NCT00718666|16838316|P3|Booster Phase Year 5|No active participation request|1
4886844|NCT00718666|16838317|P2|Booster Phase Year 5|No active participation request|0
4886845|NCT00718666|16838318|P1|Booster Phase Year 5|No active participation request|0
4886846|NCT00718640|16838402|P1|Overall Study|Unresolved toxicity after 2 weeks|2
4886847|NCT00718640|16838402|P1|Overall Study|Death|1
4886848|NCT00718640|16838402|P1|Overall Study|Adverse Event|4
4886849|NCT00718549|16838414|P3|Maintenance/ Observation Phase|Relapse|2
4886850|NCT00718549|16838415|P2|Maintenance/ Observation Phase|Relapse|3
4886851|NCT00718549|16838416|P1|Maintenance/ Observation Phase|Relapse|0
4886852|NCT00718549|16838414|P3|Maintenance/ Observation Phase|Progression|14
4886853|NCT00718549|16838415|P2|Maintenance/ Observation Phase|Progression|5
4886854|NCT00718549|16838416|P1|Maintenance/ Observation Phase|Progression|0
4886855|NCT00718549|16838414|P3|Maintenance/ Observation Phase|Lost to Follow-up|4
4886856|NCT00718549|16838415|P2|Maintenance/ Observation Phase|Lost to Follow-up|4
4886857|NCT00718549|16838416|P1|Maintenance/ Observation Phase|Lost to Follow-up|0
4886858|NCT00718549|16838414|P3|Maintenance/ Observation Phase|Death|2
4886859|NCT00718549|16838415|P2|Maintenance/ Observation Phase|Death|1
4886860|NCT00718549|16838416|P1|Maintenance/ Observation Phase|Death|0
4886861|NCT00718549|16838414|P3|Maintenance/ Observation Phase|Early Termination - No Additional Info|8
4886862|NCT00718549|16838415|P2|Maintenance/ Observation Phase|Early Termination - No Additional Info|15
4886863|NCT00718549|16838416|P1|Maintenance/ Observation Phase|Early Termination - No Additional Info|0
4886864|NCT00718549|16838414|P3|Induction Phase|Early Termination - No Additional Info|0
4886865|NCT00718549|16838415|P2|Induction Phase|Early Termination - No Additional Info|0
4886866|NCT00718549|16838416|P1|Induction Phase|Early Termination - No Additional Info|59
4886867|NCT00718549|16838414|P3|Induction Phase|Eligibility Criteria Violation|0
4886868|NCT00718549|16838415|P2|Induction Phase|Eligibility Criteria Violation|0
4886869|NCT00718549|16838416|P1|Induction Phase|Eligibility Criteria Violation|2
4886870|NCT00718549|16838414|P3|Induction Phase|Disease Progression|0
4886871|NCT00718549|16838415|P2|Induction Phase|Disease Progression|0
4886872|NCT00718549|16838416|P1|Induction Phase|Disease Progression|1
4886873|NCT00718523|16838441|P2|Overall Study|Death|17
4886874|NCT00718523|16838442|P1|Overall Study|Death|13
4886875|NCT00718523|16838441|P2|Overall Study|Withdrawal by Subject|7
4886876|NCT00718523|16838442|P1|Overall Study|Withdrawal by Subject|5
4886877|NCT00718510|16838454|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|0
4886878|NCT00718510|16838455|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|1
4886879|NCT00718510|16838454|P2|First Intervention (3 Weeks)|Withdrawal by Subject|1
4886880|NCT00718510|16838455|P1|First Intervention (3 Weeks)|Withdrawal by Subject|0
4886881|NCT00718419|16838467|P2|Overall Study|Death Due to Adverse Events|0
4886882|NCT00718419|16838468|P1|Overall Study|Death Due to Adverse Events|1
4886883|NCT00718419|16838467|P2|Overall Study|Death Due to Study Drug Related|1
4886884|NCT00718419|16838468|P1|Overall Study|Death Due to Study Drug Related|0
4886885|NCT00718419|16838467|P2|Overall Study|Death Due to Progressive Disease|0
4886886|NCT00718419|16838468|P1|Overall Study|Death Due to Progressive Disease|2
4886887|NCT00718419|16838467|P2|Overall Study|Progressive Disease|25
4886888|NCT00718419|16838468|P1|Overall Study|Progressive Disease|7
4886889|NCT00718419|16838467|P2|Overall Study|Withdrawal by Subject|5
4886890|NCT00718419|16838468|P1|Overall Study|Withdrawal by Subject|0
4886891|NCT00718419|16838467|P2|Overall Study|Sponsor decision|1
4886892|NCT00718419|16838468|P1|Overall Study|Sponsor decision|0
4886893|NCT00718419|16838467|P2|Overall Study|Physician Decision|6
4886894|NCT00718419|16838468|P1|Overall Study|Physician Decision|1
4886895|NCT00718419|16838467|P2|Overall Study|Adverse Event|1
4886896|NCT00718419|16838468|P1|Overall Study|Adverse Event|2
4886897|NCT00718328|16838484|P2|Overall Study|Lost to Follow-up|0
4886898|NCT00718328|16838485|P1|Overall Study|Lost to Follow-up|1
4886899|NCT00718315|16838494|P3|Overall Study|Use of ATB and Corticoids|2
4886900|NCT00718315|16838495|P2|Overall Study|Use of ATB and Corticoids|1
4886901|NCT00718315|16838496|P1|Overall Study|Use of ATB and Corticoids|0
4886902|NCT00718315|16838494|P3|Overall Study|Other|1
4886903|NCT00718315|16838495|P2|Overall Study|Other|0
4886904|NCT00718315|16838496|P1|Overall Study|Other|0
4886905|NCT00718315|16838494|P3|Overall Study|Disease progression|1
4886906|NCT00718315|16838495|P2|Overall Study|Disease progression|1
4886907|NCT00718315|16838496|P1|Overall Study|Disease progression|0
4886908|NCT00718315|16838494|P3|Overall Study|Use of Minocyclin|1
4886909|NCT00718315|16838495|P2|Overall Study|Use of Minocyclin|1
4886910|NCT00718315|16838496|P1|Overall Study|Use of Minocyclin|1
4886911|NCT00718315|16838494|P3|Overall Study|Erlotinib dose decreased|1
4886912|NCT00718315|16838495|P2|Overall Study|Erlotinib dose decreased|3
4886913|NCT00718315|16838496|P1|Overall Study|Erlotinib dose decreased|4
4886914|NCT00718315|16838494|P3|Overall Study|Protocol Violation|3
4886915|NCT00718315|16838495|P2|Overall Study|Protocol Violation|5
4886916|NCT00718315|16838496|P1|Overall Study|Protocol Violation|5
4886917|NCT00718315|16838494|P3|Overall Study|Lost to Follow-up|4
4886918|NCT00718315|16838495|P2|Overall Study|Lost to Follow-up|3
4886919|NCT00718315|16838496|P1|Overall Study|Lost to Follow-up|2
4886920|NCT00718315|16838494|P3|Overall Study|Death|5
4886921|NCT00718315|16838495|P2|Overall Study|Death|6
4886922|NCT00718315|16838496|P1|Overall Study|Death|6
4886923|NCT00718315|16838494|P3|Overall Study|Adverse Event|3
4886924|NCT00718315|16838495|P2|Overall Study|Adverse Event|2
4886925|NCT00718315|16838496|P1|Overall Study|Adverse Event|1
4886926|NCT00718237|16838547|P2|Overall Study|Withdrawal by Subject|10
4886927|NCT00718237|16838548|P1|Overall Study|Withdrawal by Subject|9
4886928|NCT00718237|16838547|P2|Overall Study|Physician Decision|0
4886929|NCT00718237|16838548|P1|Overall Study|Physician Decision|1
4886930|NCT00718237|16838547|P2|Overall Study|Lost to Follow-up|2
4886931|NCT00718237|16838548|P1|Overall Study|Lost to Follow-up|2
4886932|NCT00718237|16838547|P2|Overall Study|Adverse Event|3
4886933|NCT00718237|16838548|P1|Overall Study|Adverse Event|1
4886934|NCT00718159|16838565|P7|Overall Study|Investigator Decision|1
4886935|NCT00718159|16838566|P6|Overall Study|Investigator Decision|1
4886936|NCT00718159|16838567|P5|Overall Study|Investigator Decision|0
4886937|NCT00718159|16838568|P4|Overall Study|Investigator Decision|0
4886938|NCT00718159|16838569|P3|Overall Study|Investigator Decision|0
4886939|NCT00718159|16838570|P2|Overall Study|Investigator Decision|0
4886940|NCT00718159|16838571|P1|Overall Study|Investigator Decision|0
4886941|NCT00718159|16838565|P7|Overall Study|Death due to Study Drug Toxicity|0
4886942|NCT00718159|16838566|P6|Overall Study|Death due to Study Drug Toxicity|0
4886943|NCT00718159|16838567|P5|Overall Study|Death due to Study Drug Toxicity|0
4886944|NCT00718159|16838568|P4|Overall Study|Death due to Study Drug Toxicity|2
4886945|NCT00718159|16838569|P3|Overall Study|Death due to Study Drug Toxicity|1
4886946|NCT00718159|16838570|P2|Overall Study|Death due to Study Drug Toxicity|0
4886947|NCT00718159|16838571|P1|Overall Study|Death due to Study Drug Toxicity|0
4886948|NCT00718159|16838565|P7|Overall Study|Death due to Adverse Event|0
4886949|NCT00718159|16838566|P6|Overall Study|Death due to Adverse Event|0
4886950|NCT00718159|16838567|P5|Overall Study|Death due to Adverse Event|2
4886951|NCT00718159|16838568|P4|Overall Study|Death due to Adverse Event|2
4886952|NCT00718159|16838569|P3|Overall Study|Death due to Adverse Event|0
4886953|NCT00718159|16838570|P2|Overall Study|Death due to Adverse Event|0
4886954|NCT00718159|16838571|P1|Overall Study|Death due to Adverse Event|0
4886955|NCT00718159|16838565|P7|Overall Study|Progressive Disease|0
4886956|NCT00718159|16838566|P6|Overall Study|Progressive Disease|0
4886957|NCT00718159|16838567|P5|Overall Study|Progressive Disease|6
4886958|NCT00718159|16838568|P4|Overall Study|Progressive Disease|0
4886959|NCT00718159|16838569|P3|Overall Study|Progressive Disease|2
4886960|NCT00718159|16838570|P2|Overall Study|Progressive Disease|3
4886961|NCT00718159|16838571|P1|Overall Study|Progressive Disease|3
4886962|NCT00718081|16838628|P3|Overall Study|Lack of Efficacy|21
4886963|NCT00718081|16838629|P2|Overall Study|Lack of Efficacy|3
4886964|NCT00718081|16838630|P1|Overall Study|Lack of Efficacy|7
4886965|NCT00718081|16838628|P3|Overall Study|Adverse Event|0
4886966|NCT00718081|16838629|P2|Overall Study|Adverse Event|1
4886967|NCT00718081|16838630|P1|Overall Study|Adverse Event|0
4886968|NCT00718042|16838647|P6|Donor Follow-up|Lost to Follow-up|0
4886969|NCT00718042|16838648|P5|Donor Follow-up|Lost to Follow-up|19
4886970|NCT00718042|16838649|P4|Donor Follow-up|Lost to Follow-up|0
4886971|NCT00718042|16838650|P3|Donor Follow-up|Lost to Follow-up|0
4886972|NCT00718042|16838651|P2|Donor Follow-up|Lost to Follow-up|0
4886973|NCT00718042|16838652|P1|Donor Follow-up|Lost to Follow-up|13
4886974|NCT00718042|16838647|P6|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4886975|NCT00718042|16838648|P5|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4886976|NCT00718042|16838649|P4|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4886977|NCT00718042|16838650|P3|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4886978|NCT00718042|16838651|P2|ABBOTT PRISM Chagas Testing|No result on comparator assay|1
4886979|NCT00718042|16838652|P1|ABBOTT PRISM Chagas Testing|No result on comparator assay|0
4886980|NCT00718042|16838647|P6|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4886981|NCT00718042|16838648|P5|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4886982|NCT00718042|16838649|P4|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4886983|NCT00718042|16838650|P3|ABBOTT PRISM Chagas Testing|Insufficient sample|1
4886984|NCT00718042|16838651|P2|ABBOTT PRISM Chagas Testing|Insufficient sample|1
4886985|NCT00718042|16838652|P1|ABBOTT PRISM Chagas Testing|Insufficient sample|0
4886986|NCT00718042|16838647|P6|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4886987|NCT00718042|16838648|P5|ABBOTT PRISM Chagas Testing|Protocol Violation|36
4886988|NCT00718042|16838649|P4|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4886989|NCT00718042|16838650|P3|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4886990|NCT00718042|16838651|P2|ABBOTT PRISM Chagas Testing|Protocol Violation|0
4886991|NCT00718042|16838652|P1|ABBOTT PRISM Chagas Testing|Protocol Violation|64
4886992|NCT00718042|16838647|P6|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4886993|NCT00718042|16838648|P5|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2
4886994|NCT00718042|16838649|P4|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4886995|NCT00718042|16838650|P3|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4886996|NCT00718042|16838651|P2|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4886997|NCT00718042|16838652|P1|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0
4886998|NCT00717886|16838708|P1|Overall Study|Treatment Failure|1
4886999|NCT00717886|16838708|P1|Overall Study|Withdrawal by Subject|3
4887000|NCT00717860|16838723|P2|Overall Study|Withdrew consent|3
4887001|NCT00717860|16838724|P1|Overall Study|Withdrew consent|7
4887002|NCT00717860|16838723|P2|Overall Study|Discontinued for other reason|1
4887003|NCT00717860|16838724|P1|Overall Study|Discontinued for other reason|6
4887004|NCT00717860|16838723|P2|Overall Study|Lack of Efficacy|13
4887005|NCT00717860|16838724|P1|Overall Study|Lack of Efficacy|7
4887006|NCT00717860|16838723|P2|Overall Study|Laboratory adverse experience|2
4887007|NCT00717860|16838724|P1|Overall Study|Laboratory adverse experience|2
4887008|NCT00717860|16838723|P2|Overall Study|Clinical adverse experience|9
4887009|NCT00717860|16838724|P1|Overall Study|Clinical adverse experience|5
4887010|NCT00717756|16838734|P1|Overall Study|Withdrawal by Subject|1
4887011|NCT00717522|16838757|P1|Overall Study|Death|1
4887012|NCT00717522|16838757|P1|Overall Study|Adverse Event|1
4887013|NCT00717522|16838757|P1|Overall Study|Disease Progression|5
4887014|NCT00717366|16838793|P2|Extension Period (52 Weeks)|Withdrew consent|1
4887015|NCT00717366|16838794|P1|Extension Period (52 Weeks)|Withdrew consent|1
4887016|NCT00717366|16838793|P2|Extension Period (52 Weeks)|Admin/Other than specified|2
4887017|NCT00717366|16838794|P1|Extension Period (52 Weeks)|Admin/Other than specified|0
4887018|NCT00717366|16838793|P2|Extension Period (52 Weeks)|Renal transplant|13
4887019|NCT00717366|16838794|P1|Extension Period (52 Weeks)|Renal transplant|3
4887020|NCT00717366|16838793|P2|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1
4887021|NCT00717366|16838794|P1|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0
4887022|NCT00717366|16838793|P2|Core Study Period (20 Weeks)|Death|1
4887023|NCT00717366|16838794|P1|Core Study Period (20 Weeks)|Death|0
4887024|NCT00717366|16838793|P2|Core Study Period (20 Weeks)|Admin/Other than specified|2
4887025|NCT00717366|16838794|P1|Core Study Period (20 Weeks)|Admin/Other than specified|0
4887026|NCT00717366|16838793|P2|Core Study Period (20 Weeks)|Renal transplant|9
4887027|NCT00717366|16838794|P1|Core Study Period (20 Weeks)|Renal transplant|4
4887028|NCT00717314|16838818|P2|Overall Study|Withdrawal by Subject|3
4887029|NCT00717314|16838819|P1|Overall Study|Withdrawal by Subject|1
4887030|NCT00717314|16838818|P2|Overall Study|Lost to Follow-up|5
4887031|NCT00717314|16838819|P1|Overall Study|Lost to Follow-up|1
4887032|NCT00717314|16838818|P2|Overall Study|Protocol Violation|0
4887033|NCT00717314|16838819|P1|Overall Study|Protocol Violation|1
4887034|NCT00717314|16838818|P2|Overall Study|Adverse Event|2
4887035|NCT00717314|16838819|P1|Overall Study|Adverse Event|3
4887036|NCT00717275|16838856|P1|Overall Study|Premature study termination.|3
4887037|NCT00717249|16838862|P2|Overall Study|Headaches|0
4887038|NCT00717249|16838863|P1|Overall Study|Headaches|1
4887039|NCT00717249|16838862|P2|Overall Study|Subject relocated|0
4887040|NCT00717249|16838863|P1|Overall Study|Subject relocated|1
4887041|NCT00717249|16838862|P2|Overall Study|Diagnosed with Multiple Scletosis|0
4887042|NCT00717249|16838863|P1|Overall Study|Diagnosed with Multiple Scletosis|1
4887043|NCT00717249|16838862|P2|Overall Study|Diagnosed with Diabetes|0
4887044|NCT00717249|16838863|P1|Overall Study|Diagnosed with Diabetes|1
4887045|NCT00717249|16838862|P2|Overall Study|Gastric Surgery|1
4887046|NCT00717249|16838863|P1|Overall Study|Gastric Surgery|0
4887047|NCT00717249|16838862|P2|Overall Study|Unsatisfactory Physiological Response|1
4887048|NCT00717249|16838863|P1|Overall Study|Unsatisfactory Physiological Response|0
4887049|NCT00717249|16838862|P2|Overall Study|Subject became Ineligible|1
4887050|NCT00717249|16838863|P1|Overall Study|Subject became Ineligible|1
4887051|NCT00717249|16838862|P2|Overall Study|Protocol Violation|2
4887052|NCT00717249|16838863|P1|Overall Study|Protocol Violation|0
4887053|NCT00717249|16838862|P2|Overall Study|Pregnancy|3
4887054|NCT00717249|16838863|P1|Overall Study|Pregnancy|6
4887055|NCT00717249|16838862|P2|Overall Study|Withdrawal by Subject|2
4887056|NCT00717249|16838863|P1|Overall Study|Withdrawal by Subject|1
4887057|NCT00717249|16838862|P2|Overall Study|Lost to Follow-up|0
4887058|NCT00717249|16838863|P1|Overall Study|Lost to Follow-up|2
4887059|NCT00717249|16838862|P2|Overall Study|Adverse Event|2
4887060|NCT00717249|16838863|P1|Overall Study|Adverse Event|4
4887061|NCT00717249|16838862|P2|Overall Study|Unsatisfactory visual Response|2
4887062|NCT00717249|16838863|P1|Overall Study|Unsatisfactory visual Response|0
4887063|NCT00717249|16838862|P2|Overall Study|Lens Discomfort|1
4887064|NCT00717249|16838863|P1|Overall Study|Lens Discomfort|4
4887065|NCT00717236|16838877|P2|Open-Label Period|Other: Medical Monitor Recommendation|0
4887066|NCT00717236|16838878|P1|Open-Label Period|Other: Medical Monitor Recommendation|1
4887067|NCT00717236|16838877|P2|Open-Label Period|Other: Completion Accidently Performed|0
4887068|NCT00717236|16838878|P1|Open-Label Period|Other: Completion Accidently Performed|1
4887069|NCT00717236|16838877|P2|Open-Label Period|Other: Administration of Golimumab|0
4887070|NCT00717236|16838878|P1|Open-Label Period|Other: Administration of Golimumab|1
4887071|NCT00717236|16838877|P2|Open-Label Period|Other: Cataract Surgery|0
4887072|NCT00717236|16838878|P1|Open-Label Period|Other: Cataract Surgery|1
4887073|NCT00717236|16838877|P2|Open-Label Period|Other: Sponsor Request|0
4887074|NCT00717236|16838878|P1|Open-Label Period|Other: Sponsor Request|3
4887075|NCT00717236|16838877|P2|Open-Label Period|Other: Loss of Staff (unblinded)|0
4887076|NCT00717236|16838878|P1|Open-Label Period|Other: Loss of Staff (unblinded)|1
4887077|NCT00717236|16838877|P2|Open-Label Period|Other: Investigator Decision|0
4887078|NCT00717236|16838878|P1|Open-Label Period|Other: Investigator Decision|1
4887079|NCT00717236|16838877|P2|Open-Label Period|Other: Moved|0
4887080|NCT00717236|16838878|P1|Open-Label Period|Other: Moved|1
4887081|NCT00717236|16838877|P2|Open-Label Period|Other: History of Basal Cell Carcinoma|0
4887082|NCT00717236|16838878|P1|Open-Label Period|Other: History of Basal Cell Carcinoma|1
4887083|NCT00717236|16838877|P2|Open-Label Period|Other: Lack of Compliance|1
4887084|NCT00717236|16838878|P1|Open-Label Period|Other: Lack of Compliance|1
4887085|NCT00717236|16838877|P2|Open-Label Period|Other: Peripheral Neuropathy|1
4887086|NCT00717236|16838878|P1|Open-Label Period|Other: Peripheral Neuropathy|0
4887087|NCT00717236|16838877|P2|Open-Label Period|Loss of Efficacy|1
4887088|NCT00717236|16838878|P1|Open-Label Period|Loss of Efficacy|6
4887089|NCT00717236|16838877|P2|Open-Label Period|Withdrawal by Subject|2
4887090|NCT00717236|16838878|P1|Open-Label Period|Withdrawal by Subject|20
4887091|NCT00717236|16838877|P2|Open-Label Period|Lost to Follow-up|4
4887092|NCT00717236|16838878|P1|Open-Label Period|Lost to Follow-up|28
4887093|NCT00717236|16838877|P2|Open-Label Period|Lack of Efficacy|8
4887094|NCT00717236|16838878|P1|Open-Label Period|Lack of Efficacy|30
4887095|NCT00717236|16838877|P2|Open-Label Period|Adverse Event|4
4887096|NCT00717236|16838878|P1|Open-Label Period|Adverse Event|29
4887097|NCT00717236|16838877|P2|Double-Blind Period|Other: Investigator Decision|1
4887098|NCT00717236|16838878|P1|Double-Blind Period|Other: Investigator Decision|0
4887099|NCT00717236|16838877|P2|Double-Blind Period|Other: Transportation problems|1
4887100|NCT00717236|16838878|P1|Double-Blind Period|Other: Transportation problems|0
4887101|NCT00717236|16838877|P2|Double-Blind Period|Other: Prohibited medication taken|2
4887102|NCT00717236|16838878|P1|Double-Blind Period|Other: Prohibited medication taken|2
4887103|NCT00717236|16838877|P2|Double-Blind Period|Other: Stopped taking DMARD|0
4887104|NCT00717236|16838878|P1|Double-Blind Period|Other: Stopped taking DMARD|1
4887105|NCT00717236|16838877|P2|Double-Blind Period|Other: Subject moved|1
4887106|NCT00717236|16838878|P1|Double-Blind Period|Other: Subject moved|1
4887107|NCT00717236|16838877|P2|Double-Blind Period|Other: Detection of Hepatitis C Virus|0
4887108|NCT00717236|16838878|P1|Double-Blind Period|Other: Detection of Hepatitis C Virus|1
4887109|NCT00717236|16838877|P2|Double-Blind Period|Other: Inappropriate randomization|0
4887110|NCT00717236|16838878|P1|Double-Blind Period|Other: Inappropriate randomization|1
4887111|NCT00717236|16838877|P2|Double-Blind Period|Other: Sponsor request|0
4887112|NCT00717236|16838878|P1|Double-Blind Period|Other: Sponsor request|1
4887113|NCT00717236|16838877|P2|Double-Blind Period|Other: History of cancer|0
4887114|NCT00717236|16838878|P1|Double-Blind Period|Other: History of cancer|1
4887115|NCT00717236|16838877|P2|Double-Blind Period|Other: History of adenoid grown|0
4887116|NCT00717236|16838878|P1|Double-Blind Period|Other: History of adenoid grown|1
4887117|NCT00717236|16838877|P2|Double-Blind Period|Other: Abnormal chest X-ray|1
4887118|NCT00717236|16838878|P1|Double-Blind Period|Other: Abnormal chest X-ray|2
4887119|NCT00717236|16838877|P2|Double-Blind Period|Other: subject withdrew consent|1
4887120|NCT00717236|16838878|P1|Double-Blind Period|Other: subject withdrew consent|1
4887121|NCT00717236|16838877|P2|Double-Blind Period|Other: Screening failure|0
4887122|NCT00717236|16838878|P1|Double-Blind Period|Other: Screening failure|1
4887123|NCT00717236|16838877|P2|Double-Blind Period|Other: Site withdrew|0
4887124|NCT00717236|16838878|P1|Double-Blind Period|Other: Site withdrew|2
4887125|NCT00717236|16838877|P2|Double-Blind Period|Other: Inclusion/Exclusion criteria|2
4887126|NCT00717236|16838878|P1|Double-Blind Period|Other: Inclusion/Exclusion criteria|6
4887127|NCT00717236|16838877|P2|Double-Blind Period|Other: Protocol Violation|0
4887128|NCT00717236|16838878|P1|Double-Blind Period|Other: Protocol Violation|2
4887129|NCT00717236|16838877|P2|Double-Blind Period|Other: Pregnancy|0
4887130|NCT00717236|16838878|P1|Double-Blind Period|Other: Pregnancy|1
4887131|NCT00717236|16838877|P2|Double-Blind Period|Other: Death|0
4887132|NCT00717236|16838878|P1|Double-Blind Period|Other: Death|1
4887133|NCT00717236|16838877|P2|Double-Blind Period|Loss of efficacy|0
4887134|NCT00717236|16838878|P1|Double-Blind Period|Loss of efficacy|3
4887135|NCT00717236|16838877|P2|Double-Blind Period|Withdrawal by Subject|2
4887136|NCT00717236|16838878|P1|Double-Blind Period|Withdrawal by Subject|10
4887137|NCT00717236|16838877|P2|Double-Blind Period|Lost to Follow-up|5
4887138|NCT00717236|16838878|P1|Double-Blind Period|Lost to Follow-up|3
4887139|NCT00717236|16838877|P2|Double-Blind Period|Lack of Efficacy|6
4887140|NCT00717236|16838878|P1|Double-Blind Period|Lack of Efficacy|6
4887141|NCT00717236|16838877|P2|Double-Blind Period|Adverse Event|6
4887142|NCT00717236|16838878|P1|Double-Blind Period|Adverse Event|33
4887143|NCT00717197|16838947|P1|Overall Study|Physician Decision|1
4887144|NCT00717197|16838947|P1|Overall Study|Tumor Progression|1
4887145|NCT00717197|16838947|P1|Overall Study|Unable to purchase study drug|5
4887146|NCT00717093|16838953|P2|Overall Study|Randomized but not treated|0
4887147|NCT00717093|16838954|P1|Overall Study|Randomized but not treated|1
4887148|NCT00717093|16838953|P2|Overall Study|Other|1
4887149|NCT00717093|16838954|P1|Overall Study|Other|0
4887150|NCT00717093|16838953|P2|Overall Study|Withdrawal by Subject|19
4887151|NCT00717093|16838954|P1|Overall Study|Withdrawal by Subject|12
4887152|NCT00717093|16838953|P2|Overall Study|Lost to Follow-up|6
4887153|NCT00717093|16838954|P1|Overall Study|Lost to Follow-up|9
4887154|NCT00717093|16838953|P2|Overall Study|Lack of Efficacy|13
4887155|NCT00717093|16838954|P1|Overall Study|Lack of Efficacy|3
4887156|NCT00717093|16838953|P2|Overall Study|Adverse Event|9
4887157|NCT00717093|16838954|P1|Overall Study|Adverse Event|19
4887158|NCT00717067|16838971|P5|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4887159|NCT00717067|16838972|P4|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4887160|NCT00717067|16838973|P3|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1
4887161|NCT00717067|16838974|P2|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4887162|NCT00717067|16838975|P1|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0
4887163|NCT00716976|16839082|P2|Overall Study|Ineligibles|2
4887164|NCT00716976|16839083|P1|Overall Study|Ineligibles|4
4887165|NCT00716976|16839082|P2|Overall Study|Radiation during protocol|0
4887166|NCT00716976|16839083|P1|Overall Study|Radiation during protocol|1
4887167|NCT00716976|16839082|P2|Overall Study|Premature discontinuation cisplatin|4
4887168|NCT00716976|16839083|P1|Overall Study|Premature discontinuation cisplatin|5
4887169|NCT00716976|16839082|P2|Overall Study|Withdrawal by Subject|1
4887170|NCT00716976|16839083|P1|Overall Study|Withdrawal by Subject|5
4887171|NCT00716976|16839082|P2|Overall Study|Physician Decision|2
4887172|NCT00716976|16839083|P1|Overall Study|Physician Decision|2
4887173|NCT00716976|16839082|P2|Overall Study|Death|0
4887174|NCT00716976|16839083|P1|Overall Study|Death|1
4887175|NCT00716976|16839082|P2|Overall Study|Adverse Event|0
4887176|NCT00716976|16839083|P1|Overall Study|Adverse Event|2
4887177|NCT00716859|16839123|P2|Overall Study|Not treated|1
4887178|NCT00716859|16839124|P1|Overall Study|Not treated|1
4887179|NCT00716859|16839123|P2|Overall Study|Withdrawal by Subject|3
4887180|NCT00716859|16839124|P1|Overall Study|Withdrawal by Subject|1
4887181|NCT00716859|16839123|P2|Overall Study|Lack of Efficacy|0
4887182|NCT00716859|16839124|P1|Overall Study|Lack of Efficacy|3
4887183|NCT00716859|16839123|P2|Overall Study|Adverse Event|1
4887184|NCT00716859|16839124|P1|Overall Study|Adverse Event|4
4887185|NCT00716625|16839209|P1|Overall Study|Safety was not Assessable|1
4887186|NCT00716482|16839234|P1|Overall Study|inclusion/exclusion criteria not met|25
4887187|NCT00716482|16839234|P1|Overall Study|technical/machine error|28
4887188|NCT00716482|16839234|P1|Overall Study|no pathology obtained|10
4887189|NCT00716482|16839234|P1|Overall Study|Inadequate acquisition or analysis|50
4887190|NCT00716482|16839234|P1|Overall Study|Lost to Follow-up|6
4887191|NCT00716456|16839247|P3|Overall Study|Adverse Event|0
4887192|NCT00716456|16839248|P2|Overall Study|Adverse Event|2
4887193|NCT00716456|16839249|P1|Overall Study|Adverse Event|0
4887194|NCT00716417|16839300|P10|Overall Study|On patient request due to toxicities|0
4887195|NCT00716417|16839301|P9|Overall Study|On patient request due to toxicities|0
4887196|NCT00716417|16839302|P8|Overall Study|On patient request due to toxicities|1
4887197|NCT00716417|16839303|P7|Overall Study|On patient request due to toxicities|0
4887198|NCT00716417|16839304|P6|Overall Study|On patient request due to toxicities|0
4887199|NCT00716417|16839305|P5|Overall Study|On patient request due to toxicities|0
4887200|NCT00716417|16839306|P4|Overall Study|On patient request due to toxicities|0
4887201|NCT00716417|16839307|P3|Overall Study|On patient request due to toxicities|0
4887202|NCT00716417|16839308|P2|Overall Study|On patient request due to toxicities|0
4887203|NCT00716417|16839309|P1|Overall Study|On patient request due to toxicities|0
4887204|NCT00716417|16839300|P10|Overall Study|Dose limiting toxicity (DLT)|0
4887205|NCT00716417|16839301|P9|Overall Study|Dose limiting toxicity (DLT)|0
4887206|NCT00716417|16839302|P8|Overall Study|Dose limiting toxicity (DLT)|0
4887207|NCT00716417|16839303|P7|Overall Study|Dose limiting toxicity (DLT)|0
4887208|NCT00716417|16839304|P6|Overall Study|Dose limiting toxicity (DLT)|0
4887209|NCT00716417|16839305|P5|Overall Study|Dose limiting toxicity (DLT)|1
4887210|NCT00716417|16839306|P4|Overall Study|Dose limiting toxicity (DLT)|0
4887211|NCT00716417|16839307|P3|Overall Study|Dose limiting toxicity (DLT)|0
4887212|NCT00716417|16839308|P2|Overall Study|Dose limiting toxicity (DLT)|0
4887213|NCT00716417|16839309|P1|Overall Study|Dose limiting toxicity (DLT)|0
4887214|NCT00716417|16839300|P10|Overall Study|Progressive disease|0
4887215|NCT00716417|16839301|P9|Overall Study|Progressive disease|5
4887216|NCT00716417|16839302|P8|Overall Study|Progressive disease|1
4887217|NCT00716417|16839303|P7|Overall Study|Progressive disease|3
4887218|NCT00716417|16839304|P6|Overall Study|Progressive disease|3
4887219|NCT00716417|16839305|P5|Overall Study|Progressive disease|0
4887220|NCT00716417|16839306|P4|Overall Study|Progressive disease|8
4887221|NCT00716417|16839307|P3|Overall Study|Progressive disease|3
4887222|NCT00716417|16839308|P2|Overall Study|Progressive disease|5
4887223|NCT00716417|16839309|P1|Overall Study|Progressive disease|3
4887224|NCT00716417|16839300|P10|Overall Study|Withdrawal by Subject|0
4887225|NCT00716417|16839301|P9|Overall Study|Withdrawal by Subject|0
4887226|NCT00716417|16839302|P8|Overall Study|Withdrawal by Subject|0
4887227|NCT00716417|16839303|P7|Overall Study|Withdrawal by Subject|1
4887228|NCT00716417|16839304|P6|Overall Study|Withdrawal by Subject|0
4887229|NCT00716417|16839305|P5|Overall Study|Withdrawal by Subject|0
4887230|NCT00716417|16839306|P4|Overall Study|Withdrawal by Subject|2
4887231|NCT00716417|16839307|P3|Overall Study|Withdrawal by Subject|0
4887232|NCT00716417|16839308|P2|Overall Study|Withdrawal by Subject|1
4887233|NCT00716417|16839309|P1|Overall Study|Withdrawal by Subject|0
4887234|NCT00716417|16839300|P10|Overall Study|Adverse Event|3
4887235|NCT00716417|16839301|P9|Overall Study|Adverse Event|0
4887236|NCT00716417|16839302|P8|Overall Study|Adverse Event|1
4887237|NCT00716417|16839303|P7|Overall Study|Adverse Event|3
4887238|NCT00716417|16839304|P6|Overall Study|Adverse Event|0
4887239|NCT00716417|16839305|P5|Overall Study|Adverse Event|0
4887240|NCT00716417|16839306|P4|Overall Study|Adverse Event|1
4887241|NCT00716417|16839307|P3|Overall Study|Adverse Event|2
4887242|NCT00716417|16839308|P2|Overall Study|Adverse Event|0
4887243|NCT00716417|16839309|P1|Overall Study|Adverse Event|0
4887244|NCT00716274|16839356|P6|Study Period III (16-Weeks)|Adverse Event|0
4887245|NCT00716274|16839357|P5|Study Period III (16-Weeks)|Adverse Event|1
4887246|NCT00716274|16839358|P4|Study Period III (16-Weeks)|Adverse Event|0
4887247|NCT00716274|16839359|P3|Study Period III (16-Weeks)|Adverse Event|0
4887248|NCT00716274|16839360|P2|Study Period III (16-Weeks)|Adverse Event|0
4887249|NCT00716274|16839361|P1|Study Period III (16-Weeks)|Adverse Event|0
4887250|NCT00716274|16839356|P6|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4887251|NCT00716274|16839357|P5|Study Period III (16-Weeks)|Parent Caregiver Decision|1
4887252|NCT00716274|16839358|P4|Study Period III (16-Weeks)|Parent Caregiver Decision|1
4887253|NCT00716274|16839359|P3|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4887254|NCT00716274|16839360|P2|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4887255|NCT00716274|16839361|P1|Study Period III (16-Weeks)|Parent Caregiver Decision|0
4887256|NCT00716274|16839356|P6|Study Period III (16-Weeks)|Physician Decision|0
4887257|NCT00716274|16839357|P5|Study Period III (16-Weeks)|Physician Decision|1
4887258|NCT00716274|16839358|P4|Study Period III (16-Weeks)|Physician Decision|0
4887259|NCT00716274|16839359|P3|Study Period III (16-Weeks)|Physician Decision|0
4887260|NCT00716274|16839360|P2|Study Period III (16-Weeks)|Physician Decision|0
4887261|NCT00716274|16839361|P1|Study Period III (16-Weeks)|Physician Decision|0
4887262|NCT00716274|16839356|P6|Study Period III (16-Weeks)|Withdrawal by Subject|0
4887263|NCT00716274|16839357|P5|Study Period III (16-Weeks)|Withdrawal by Subject|0
4887264|NCT00716274|16839358|P4|Study Period III (16-Weeks)|Withdrawal by Subject|0
4887265|NCT00716274|16839359|P3|Study Period III (16-Weeks)|Withdrawal by Subject|2
4887266|NCT00716274|16839360|P2|Study Period III (16-Weeks)|Withdrawal by Subject|0
4887267|NCT00716274|16839361|P1|Study Period III (16-Weeks)|Withdrawal by Subject|0
4887268|NCT00716274|16839356|P6|Study Period II (16-Weeks)|Lost to Follow-up|0
4887269|NCT00716274|16839357|P5|Study Period II (16-Weeks)|Lost to Follow-up|0
4887270|NCT00716274|16839358|P4|Study Period II (16-Weeks)|Lost to Follow-up|0
4887271|NCT00716274|16839359|P3|Study Period II (16-Weeks)|Lost to Follow-up|0
4887272|NCT00716274|16839360|P2|Study Period II (16-Weeks)|Lost to Follow-up|2
4887273|NCT00716274|16839361|P1|Study Period II (16-Weeks)|Lost to Follow-up|0
4887274|NCT00716274|16839356|P6|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4887275|NCT00716274|16839357|P5|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4887276|NCT00716274|16839358|P4|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4887277|NCT00716274|16839359|P3|Study Period II (16-Weeks)|Parent/Caregiver Decision|0
4887278|NCT00716274|16839360|P2|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
4887279|NCT00716274|16839361|P1|Study Period II (16-Weeks)|Parent/Caregiver Decision|3
4887280|NCT00716274|16839356|P6|Study Period II (16-Weeks)|Physician Decision|1
4887281|NCT00716274|16839357|P5|Study Period II (16-Weeks)|Physician Decision|0
4887282|NCT00716274|16839358|P4|Study Period II (16-Weeks)|Physician Decision|0
4887283|NCT00716274|16839359|P3|Study Period II (16-Weeks)|Physician Decision|0
4887284|NCT00716274|16839360|P2|Study Period II (16-Weeks)|Physician Decision|1
4887285|NCT00716274|16839361|P1|Study Period II (16-Weeks)|Physician Decision|3
4887286|NCT00716274|16839356|P6|Study Period II (16-Weeks)|Withdrawal by Subject|0
4887287|NCT00716274|16839357|P5|Study Period II (16-Weeks)|Withdrawal by Subject|0
4887288|NCT00716274|16839358|P4|Study Period II (16-Weeks)|Withdrawal by Subject|0
4887289|NCT00716274|16839359|P3|Study Period II (16-Weeks)|Withdrawal by Subject|0
4887290|NCT00716274|16839360|P2|Study Period II (16-Weeks)|Withdrawal by Subject|0
4887291|NCT00716274|16839361|P1|Study Period II (16-Weeks)|Withdrawal by Subject|1
4887292|NCT00716274|16839356|P6|Study Period II (16-Weeks)|Protocol Violation|1
4887293|NCT00716274|16839357|P5|Study Period II (16-Weeks)|Protocol Violation|0
4887294|NCT00716274|16839358|P4|Study Period II (16-Weeks)|Protocol Violation|0
4887295|NCT00716274|16839359|P3|Study Period II (16-Weeks)|Protocol Violation|0
4887296|NCT00716274|16839360|P2|Study Period II (16-Weeks)|Protocol Violation|3
4887297|NCT00716274|16839361|P1|Study Period II (16-Weeks)|Protocol Violation|0
4887298|NCT00716274|16839356|P6|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4887299|NCT00716274|16839357|P5|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4887300|NCT00716274|16839358|P4|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4887301|NCT00716274|16839359|P3|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4887302|NCT00716274|16839360|P2|Study Period II (16-Weeks)|Entry Criteria Not Met|0
4887303|NCT00716274|16839361|P1|Study Period II (16-Weeks)|Entry Criteria Not Met|2
4887304|NCT00716144|16839495|P4|Overall Study|Clinical Depression|0
4887305|NCT00716144|16839496|P3|Overall Study|Clinical Depression|0
4887306|NCT00716144|16839497|P2|Overall Study|Clinical Depression|1
4887307|NCT00716144|16839498|P1|Overall Study|Clinical Depression|0
4887308|NCT00716144|16839495|P4|Overall Study|Adverse event: left foot pain|0
4887309|NCT00716144|16839496|P3|Overall Study|Adverse event: left foot pain|0
4887310|NCT00716144|16839497|P2|Overall Study|Adverse event: left foot pain|1
4887311|NCT00716144|16839498|P1|Overall Study|Adverse event: left foot pain|0
4887312|NCT00716144|16839495|P4|Overall Study|Withdrew consent, allowed use of data|0
4887313|NCT00716144|16839496|P3|Overall Study|Withdrew consent, allowed use of data|1
4887314|NCT00716144|16839497|P2|Overall Study|Withdrew consent, allowed use of data|0
4887315|NCT00716144|16839498|P1|Overall Study|Withdrew consent, allowed use of data|0
4887316|NCT00716144|16839495|P4|Overall Study|Intercurrent illness|0
4887317|NCT00716144|16839496|P3|Overall Study|Intercurrent illness|1
4887318|NCT00716144|16839497|P2|Overall Study|Intercurrent illness|0
4887319|NCT00716144|16839498|P1|Overall Study|Intercurrent illness|0
4887320|NCT00716144|16839495|P4|Overall Study|Physician Decision|2
4887321|NCT00716144|16839496|P3|Overall Study|Physician Decision|2
4887322|NCT00716144|16839497|P2|Overall Study|Physician Decision|1
4887323|NCT00716144|16839498|P1|Overall Study|Physician Decision|0
4887324|NCT00716144|16839495|P4|Overall Study|Protocol Violation|0
4887325|NCT00716144|16839496|P3|Overall Study|Protocol Violation|1
4887326|NCT00716144|16839497|P2|Overall Study|Protocol Violation|0
4887327|NCT00716144|16839498|P1|Overall Study|Protocol Violation|2
4887328|NCT00716144|16839495|P4|Overall Study|Non-compliance|0
4887329|NCT00716144|16839496|P3|Overall Study|Non-compliance|0
4887330|NCT00716144|16839497|P2|Overall Study|Non-compliance|0
4887331|NCT00716144|16839498|P1|Overall Study|Non-compliance|1
4887332|NCT00716144|16839495|P4|Overall Study|Adverse Event|2
4887333|NCT00716144|16839496|P3|Overall Study|Adverse Event|0
4887334|NCT00716144|16839497|P2|Overall Study|Adverse Event|0
4887335|NCT00716144|16839498|P1|Overall Study|Adverse Event|0
4887336|NCT00716144|16839495|P4|Overall Study|Lost to Follow-up|2
4887337|NCT00716144|16839496|P3|Overall Study|Lost to Follow-up|1
4887338|NCT00716144|16839497|P2|Overall Study|Lost to Follow-up|2
4887339|NCT00716144|16839498|P1|Overall Study|Lost to Follow-up|2
4887340|NCT00716144|16839495|P4|Overall Study|Withdrawal by Subject|6
4887341|NCT00716144|16839496|P3|Overall Study|Withdrawal by Subject|6
4887342|NCT00716144|16839497|P2|Overall Study|Withdrawal by Subject|2
4887343|NCT00716144|16839498|P1|Overall Study|Withdrawal by Subject|4
4887344|NCT00716092|16839523|P3|Overall Study|Other incl. Lack of Efficacy|0
4887345|NCT00716092|16839524|P2|Overall Study|Other incl. Lack of Efficacy|1
4887346|NCT00716092|16839525|P1|Overall Study|Other incl. Lack of Efficacy|2
4887347|NCT00715949|16839578|P1|Overall Study|could not finish first test|4
4887348|NCT00715910|16839586|P6|Booster and ESFU Phase|Other|0
4887349|NCT00715910|16839587|P5|Booster and ESFU Phase|Other|1
4887350|NCT00715910|16839588|P4|Booster and ESFU Phase|Other|5
4887351|NCT00715910|16839589|P3|Booster and ESFU Phase|Other|0
4887352|NCT00715910|16839590|P2|Booster and ESFU Phase|Other|0
4887353|NCT00715910|16839591|P1|Booster and ESFU Phase|Other|0
4887354|NCT00715910|16839586|P6|Booster and ESFU Phase|Lost to Follow-up|13
4887355|NCT00715910|16839587|P5|Booster and ESFU Phase|Lost to Follow-up|1
4887356|NCT00715910|16839588|P4|Booster and ESFU Phase|Lost to Follow-up|6
4887357|NCT00715910|16839589|P3|Booster and ESFU Phase|Lost to Follow-up|0
4887358|NCT00715910|16839590|P2|Booster and ESFU Phase|Lost to Follow-up|0
4887359|NCT00715910|16839591|P1|Booster and ESFU Phase|Lost to Follow-up|0
4887360|NCT00715793|16839710|P2|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2
4887361|NCT00715793|16839711|P1|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0
4887362|NCT00715793|16839710|P2|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0
4887363|NCT00715793|16839711|P1|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1
4887364|NCT00715676|16839772|P3|Overall Study|Elevated Blood Glucose|0
4887365|NCT00715676|16839773|P2|Overall Study|Elevated Blood Glucose|1
4887366|NCT00715676|16839774|P1|Overall Study|Elevated Blood Glucose|0
4887367|NCT00715676|16839772|P3|Overall Study|Use of Exclusionary Medication|1
4887368|NCT00715676|16839773|P2|Overall Study|Use of Exclusionary Medication|0
4887369|NCT00715676|16839774|P1|Overall Study|Use of Exclusionary Medication|0
4887370|NCT00715676|16839772|P3|Overall Study|Did Not Meet Entry Criteria|1
4887371|NCT00715676|16839773|P2|Overall Study|Did Not Meet Entry Criteria|0
4887372|NCT00715676|16839774|P1|Overall Study|Did Not Meet Entry Criteria|0
4887373|NCT00715676|16839772|P3|Overall Study|Terminated by Sponsor|0
4887374|NCT00715676|16839773|P2|Overall Study|Terminated by Sponsor|0
4887375|NCT00715676|16839774|P1|Overall Study|Terminated by Sponsor|1
4887376|NCT00715676|16839772|P3|Overall Study|Lost to Follow-up|1
4887377|NCT00715676|16839773|P2|Overall Study|Lost to Follow-up|2
4887378|NCT00715676|16839774|P1|Overall Study|Lost to Follow-up|1
4887379|NCT00715676|16839772|P3|Overall Study|Withdrawal by Subject|8
4887380|NCT00715676|16839773|P2|Overall Study|Withdrawal by Subject|3
4887381|NCT00715676|16839774|P1|Overall Study|Withdrawal by Subject|1
4887382|NCT00715676|16839772|P3|Overall Study|Adverse Event|21
4887383|NCT00715676|16839773|P2|Overall Study|Adverse Event|5
4887384|NCT00715676|16839774|P1|Overall Study|Adverse Event|3
4887385|NCT00715624|16839817|P2|Overall Study|Other|1
4887386|NCT00715624|16839818|P1|Overall Study|Other|0
4887387|NCT00715624|16839817|P2|Overall Study|Incorrect randomization (not treated)|1
4887388|NCT00715624|16839818|P1|Overall Study|Incorrect randomization (not treated)|0
4887389|NCT00715624|16839817|P2|Overall Study|Sponsor decision|4
4887390|NCT00715624|16839818|P1|Overall Study|Sponsor decision|0
4887391|NCT00715624|16839817|P2|Overall Study|Poor compliance|13
4887392|NCT00715624|16839818|P1|Overall Study|Poor compliance|6
4887393|NCT00715624|16839817|P2|Overall Study|Familial and personal reasons|22
4887394|NCT00715624|16839818|P1|Overall Study|Familial and personal reasons|10
4887395|NCT00715624|16839817|P2|Overall Study|Withdrawal by Subject|25
4887396|NCT00715624|16839818|P1|Overall Study|Withdrawal by Subject|11
4887397|NCT00715624|16839817|P2|Overall Study|Protocol Violation|0
4887398|NCT00715624|16839818|P1|Overall Study|Protocol Violation|1
4887399|NCT00715624|16839817|P2|Overall Study|Lost to Follow-up|2
4887400|NCT00715624|16839818|P1|Overall Study|Lost to Follow-up|1
4887401|NCT00715624|16839817|P2|Overall Study|Lack of Efficacy|11
4887402|NCT00715624|16839818|P1|Overall Study|Lack of Efficacy|11
4887403|NCT00715624|16839817|P2|Overall Study|Adverse Event|37
4887404|NCT00715624|16839818|P1|Overall Study|Adverse Event|12
4887405|NCT00715559|16839846|P1|Overall Study|medication not tolerated - nausea|1
4887406|NCT00715520|16839856|P3|Overall Study|Withdrawal by Subject|1
4887407|NCT00715520|16839857|P2|Overall Study|Withdrawal by Subject|0
4887408|NCT00715520|16839858|P1|Overall Study|Withdrawal by Subject|2
4887409|NCT00715520|16839856|P3|Overall Study|Screen failure|1
4887410|NCT00715520|16839857|P2|Overall Study|Screen failure|1
4887411|NCT00715520|16839858|P1|Overall Study|Screen failure|8
4887412|NCT00715429|16839873|P2|Overall Study|Did not complete the study diary|1
4887413|NCT00715429|16839874|P1|Overall Study|Did not complete the study diary|0
4887414|NCT00715403|16839889|P7|Overall Study|Other reason not defined above|0
4887415|NCT00715403|16839890|P6|Overall Study|Other reason not defined above|1
4887416|NCT00715403|16839891|P5|Overall Study|Other reason not defined above|1
4887417|NCT00715403|16839892|P4|Overall Study|Other reason not defined above|0
4887418|NCT00715403|16839893|P3|Overall Study|Other reason not defined above|1
4887419|NCT00715403|16839894|P2|Overall Study|Other reason not defined above|0
4887420|NCT00715403|16839895|P1|Overall Study|Other reason not defined above|0
4887421|NCT00715403|16839889|P7|Overall Study|Protocol Violation|0
4887422|NCT00715403|16839890|P6|Overall Study|Protocol Violation|1
4887423|NCT00715403|16839891|P5|Overall Study|Protocol Violation|0
4887424|NCT00715403|16839892|P4|Overall Study|Protocol Violation|0
4887425|NCT00715403|16839893|P3|Overall Study|Protocol Violation|0
4887426|NCT00715403|16839894|P2|Overall Study|Protocol Violation|0
4887427|NCT00715403|16839895|P1|Overall Study|Protocol Violation|0
4887428|NCT00715403|16839889|P7|Overall Study|Other Adverse Event than DLT|0
4887429|NCT00715403|16839890|P6|Overall Study|Other Adverse Event than DLT|2
4887430|NCT00715403|16839891|P5|Overall Study|Other Adverse Event than DLT|0
4887431|NCT00715403|16839892|P4|Overall Study|Other Adverse Event than DLT|0
4887432|NCT00715403|16839893|P3|Overall Study|Other Adverse Event than DLT|0
4887433|NCT00715403|16839894|P2|Overall Study|Other Adverse Event than DLT|0
4887434|NCT00715403|16839895|P1|Overall Study|Other Adverse Event than DLT|1
4887435|NCT00715403|16839889|P7|Overall Study|Dose limiting Toxicity (DLT)|0
4887436|NCT00715403|16839890|P6|Overall Study|Dose limiting Toxicity (DLT)|1
4887437|NCT00715403|16839891|P5|Overall Study|Dose limiting Toxicity (DLT)|0
4887438|NCT00715403|16839892|P4|Overall Study|Dose limiting Toxicity (DLT)|0
4887439|NCT00715403|16839893|P3|Overall Study|Dose limiting Toxicity (DLT)|0
4887440|NCT00715403|16839894|P2|Overall Study|Dose limiting Toxicity (DLT)|0
4887441|NCT00715403|16839895|P1|Overall Study|Dose limiting Toxicity (DLT)|0
4887442|NCT00715403|16839889|P7|Overall Study|Progressive disease|1
4887443|NCT00715403|16839890|P6|Overall Study|Progressive disease|14
4887444|NCT00715403|16839891|P5|Overall Study|Progressive disease|5
4887445|NCT00715403|16839892|P4|Overall Study|Progressive disease|9
4887446|NCT00715403|16839893|P3|Overall Study|Progressive disease|3
4887447|NCT00715403|16839894|P2|Overall Study|Progressive disease|1
4887448|NCT00715403|16839895|P1|Overall Study|Progressive disease|0
4887449|NCT00715299|16840034|P1|Overall Study|failed the pre-screen exercise test|2
4887450|NCT00715299|16840034|P1|Overall Study|Adverse Event|3
4887451|NCT00715299|16840034|P1|Overall Study|Withdrawal by Subject|1
4887452|NCT00715208|16840040|P2|Overall Study|Lack of Efficacy|2
4887453|NCT00715208|16840041|P1|Overall Study|Lack of Efficacy|0
4887454|NCT00715208|16840040|P2|Overall Study|Adverse Event|6
4887455|NCT00715208|16840041|P1|Overall Study|Adverse Event|0
4887456|NCT00715208|16840040|P2|Overall Study|Withdrawal by Subject|1
4887457|NCT00715208|16840041|P1|Overall Study|Withdrawal by Subject|1
4887458|NCT00715117|16840057|P2|Overall Study|Crohn's flare and rescue with steroids|1
4887459|NCT00715117|16840058|P1|Overall Study|Crohn's flare and rescue with steroids|0
4887460|NCT00715078|16840126|P3|Overall Study|Unable to start due to disease prog.|1
4887461|NCT00715078|16840127|P2|Overall Study|Unable to start due to disease prog.|0
4887462|NCT00715078|16840128|P1|Overall Study|Unable to start due to disease prog.|0
4887463|NCT00715078|16840126|P3|Overall Study|Withdrawal by Subject|1
4887464|NCT00715078|16840127|P2|Overall Study|Withdrawal by Subject|0
4887465|NCT00715078|16840128|P1|Overall Study|Withdrawal by Subject|1
4887466|NCT00715078|16840126|P3|Overall Study|Death|36
4887467|NCT00715078|16840127|P2|Overall Study|Death|36
4887468|NCT00715078|16840128|P1|Overall Study|Death|29
4887469|NCT00715026|16840136|P1|Overall Study|Surgery done on non-study consented hip|1
4887470|NCT00715026|16840136|P1|Overall Study|Protocol Violation|1
4887471|NCT00715026|16840136|P1|Overall Study|Lost to Follow-up|3
4887472|NCT00715026|16840136|P1|Overall Study|Withdrawal by Subject|5
4887473|NCT00714948|16840141|P1|Overall Study|Adverse Event|2
4887474|NCT00714870|16840147|P2|Overall Study|did not attend minimum of 4 sessions|0
4887475|NCT00714870|16840148|P1|Overall Study|did not attend minimum of 4 sessions|4
4887476|NCT00714870|16840147|P2|Overall Study|patient unable to come b/c back pain|0
4887477|NCT00714870|16840148|P1|Overall Study|patient unable to come b/c back pain|1
4887478|NCT00714870|16840147|P2|Overall Study|Lost to Follow-up|5
4887479|NCT00714870|16840148|P1|Overall Study|Lost to Follow-up|22
4887480|NCT00714714|16840172|P1|Overall Study|Adverse Event|1
4887481|NCT00714688|16840181|P3|Overall Study|Other|5
4887482|NCT00714688|16840182|P2|Overall Study|Other|6
4887483|NCT00714688|16840183|P1|Overall Study|Other|1
4887484|NCT00714688|16840181|P3|Overall Study|Sponsor's Decision|0
4887485|NCT00714688|16840182|P2|Overall Study|Sponsor's Decision|2
4887486|NCT00714688|16840183|P1|Overall Study|Sponsor's Decision|0
4887487|NCT00714688|16840181|P3|Overall Study|Ineligible to Continue the Study|1
4887488|NCT00714688|16840182|P2|Overall Study|Ineligible to Continue the Study|1
4887489|NCT00714688|16840183|P1|Overall Study|Ineligible to Continue the Study|0
4887490|NCT00714688|16840181|P3|Overall Study|Subject Non-compliant|5
4887491|NCT00714688|16840182|P2|Overall Study|Subject Non-compliant|5
4887492|NCT00714688|16840183|P1|Overall Study|Subject Non-compliant|3
4887493|NCT00714688|16840181|P3|Overall Study|Adverse Event|19
4887494|NCT00714688|16840182|P2|Overall Study|Adverse Event|15
4887495|NCT00714688|16840183|P1|Overall Study|Adverse Event|2
4887496|NCT00714688|16840181|P3|Overall Study|Lost to Follow-up|0
4887497|NCT00714688|16840182|P2|Overall Study|Lost to Follow-up|2
4887498|NCT00714688|16840183|P1|Overall Study|Lost to Follow-up|5
4887499|NCT00714688|16840181|P3|Overall Study|Withdrawal by Subject|3
4887500|NCT00714688|16840182|P2|Overall Study|Withdrawal by Subject|3
4887501|NCT00714688|16840183|P1|Overall Study|Withdrawal by Subject|4
4887502|NCT00714688|16840181|P3|Overall Study|Lack of Efficacy|4
4887503|NCT00714688|16840182|P2|Overall Study|Lack of Efficacy|1
4887504|NCT00714688|16840183|P1|Overall Study|Lack of Efficacy|14
4887505|NCT00714493|16840225|P1|Overall Study|OTHER|2
4887506|NCT00714493|16840225|P1|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8
4887507|NCT00714493|16840225|P1|Overall Study|Protocol Violation|12
4887508|NCT00714493|16840225|P1|Overall Study|Lost to Follow-up|3
4887509|NCT00714493|16840225|P1|Overall Study|Lack of Efficacy|10
4887510|NCT00714493|16840225|P1|Overall Study|Death|3
4887511|NCT00714493|16840225|P1|Overall Study|Adverse Event|11
4887512|NCT00714415|16840237|P2|Overall Study|Death|0
4887513|NCT00714415|16840238|P1|Overall Study|Death|1
4887514|NCT00714415|16840237|P2|Overall Study|Lack of Efficacy|0
4887515|NCT00714415|16840238|P1|Overall Study|Lack of Efficacy|1
4887516|NCT00714285|16840288|P4|Overall Study|Migrated/moved from study area|0
4887517|NCT00714285|16840289|P3|Overall Study|Migrated/moved from study area|0
4887518|NCT00714285|16840290|P2|Overall Study|Migrated/moved from study area|1
4887519|NCT00714285|16840291|P1|Overall Study|Migrated/moved from study area|0
4887520|NCT00714285|16840288|P4|Overall Study|Lost to Follow-up|1
4887521|NCT00714285|16840289|P3|Overall Study|Lost to Follow-up|0
4887522|NCT00714285|16840290|P2|Overall Study|Lost to Follow-up|2
4887523|NCT00714285|16840291|P1|Overall Study|Lost to Follow-up|0
4887524|NCT00714259|16840352|P1|Overall Study|Death|2
4887525|NCT00714168|16840398|P2|Overall Study|Non-study medical condition|2
4887526|NCT00714168|16840399|P1|Overall Study|Non-study medical condition|3
4887527|NCT00714168|16840398|P2|Overall Study|Relocation|3
4887528|NCT00714168|16840399|P1|Overall Study|Relocation|4
4887529|NCT00714168|16840398|P2|Overall Study|Lost to Follow-up|50
4887530|NCT00714168|16840399|P1|Overall Study|Lost to Follow-up|32
4887531|NCT00714168|16840398|P2|Overall Study|Pregnancy|4
4887532|NCT00714168|16840399|P1|Overall Study|Pregnancy|5
4887533|NCT00714051|16840415|P2|Overall Study|Death|1
4887534|NCT00714051|16840416|P1|Overall Study|Death|0
4887535|NCT00714051|16840415|P2|Overall Study|Withdrawal by Subject|0
4887536|NCT00714051|16840416|P1|Overall Study|Withdrawal by Subject|1
4887537|NCT00713830|16840424|P2|Overall Study|Sponsor Decision|10
4887538|NCT00713830|16840425|P1|Overall Study|Sponsor Decision|4
4887539|NCT00713830|16840424|P2|Overall Study|Familial and Personal Reasons|34
4887540|NCT00713830|16840425|P1|Overall Study|Familial and Personal Reasons|9
4887541|NCT00713830|16840424|P2|Overall Study|Poor Compliance to Protocol|14
4887542|NCT00713830|16840425|P1|Overall Study|Poor Compliance to Protocol|7
4887543|NCT00713830|16840424|P2|Overall Study|Withdrawal by Subject|23
4887544|NCT00713830|16840425|P1|Overall Study|Withdrawal by Subject|13
4887545|NCT00713830|16840424|P2|Overall Study|Lost to Follow-up|9
4887546|NCT00713830|16840425|P1|Overall Study|Lost to Follow-up|2
4887547|NCT00713830|16840424|P2|Overall Study|Lack of Efficacy|16
4887548|NCT00713830|16840425|P1|Overall Study|Lack of Efficacy|24
4887549|NCT00713830|16840424|P2|Overall Study|Adverse Event|71
4887550|NCT00713830|16840425|P1|Overall Study|Adverse Event|23
4887551|NCT00713700|16840482|P1|Overall Study|Withdrawal by Subject|1
4887552|NCT00713700|16840482|P1|Overall Study|Lost to Follow-up|3
4887553|NCT00713648|16840508|P1|Overall Study|Development of antibodies|3
4887554|NCT00713648|16840508|P1|Overall Study|According to Protocol|2
4887555|NCT00713648|16840508|P1|Overall Study|Unclassified|2
4887556|NCT00713648|16840508|P1|Overall Study|Adverse Event|1
4887557|NCT00713609|16840521|P6|Overall Study|Protocol Violation|0
4887558|NCT00713609|16840522|P5|Overall Study|Protocol Violation|2
4887559|NCT00713609|16840523|P4|Overall Study|Protocol Violation|1
4887560|NCT00713609|16840524|P3|Overall Study|Protocol Violation|1
4887561|NCT00713609|16840525|P2|Overall Study|Protocol Violation|3
4887562|NCT00713609|16840526|P1|Overall Study|Protocol Violation|6
4887563|NCT00713609|16840521|P6|Overall Study|Withdrawal by Subject|7
4887564|NCT00713609|16840522|P5|Overall Study|Withdrawal by Subject|5
4887565|NCT00713609|16840523|P4|Overall Study|Withdrawal by Subject|1
4887566|NCT00713609|16840524|P3|Overall Study|Withdrawal by Subject|5
4887567|NCT00713609|16840525|P2|Overall Study|Withdrawal by Subject|1
4887568|NCT00713609|16840526|P1|Overall Study|Withdrawal by Subject|6
4887569|NCT00713609|16840521|P6|Overall Study|Non-Compliance with Study Treatment|0
4887570|NCT00713609|16840522|P5|Overall Study|Non-Compliance with Study Treatment|1
4887571|NCT00713609|16840523|P4|Overall Study|Non-Compliance with Study Treatment|0
4887572|NCT00713609|16840524|P3|Overall Study|Non-Compliance with Study Treatment|2
4887573|NCT00713609|16840525|P2|Overall Study|Non-Compliance with Study Treatment|1
4887574|NCT00713609|16840526|P1|Overall Study|Non-Compliance with Study Treatment|1
4887575|NCT00713609|16840521|P6|Overall Study|Lack of Efficacy|0
4887576|NCT00713609|16840522|P5|Overall Study|Lack of Efficacy|1
4887577|NCT00713609|16840523|P4|Overall Study|Lack of Efficacy|0
4887578|NCT00713609|16840524|P3|Overall Study|Lack of Efficacy|0
4887579|NCT00713609|16840525|P2|Overall Study|Lack of Efficacy|3
4887580|NCT00713609|16840526|P1|Overall Study|Lack of Efficacy|1
4887581|NCT00713609|16840521|P6|Overall Study|Lost to Follow-up|0
4887582|NCT00713609|16840522|P5|Overall Study|Lost to Follow-up|7
4887583|NCT00713609|16840523|P4|Overall Study|Lost to Follow-up|5
4887584|NCT00713609|16840524|P3|Overall Study|Lost to Follow-up|5
4887585|NCT00713609|16840525|P2|Overall Study|Lost to Follow-up|7
4887586|NCT00713609|16840526|P1|Overall Study|Lost to Follow-up|5
4887587|NCT00713609|16840521|P6|Overall Study|Adverse Event|1
4887588|NCT00713609|16840522|P5|Overall Study|Adverse Event|3
4887589|NCT00713609|16840523|P4|Overall Study|Adverse Event|2
4887590|NCT00713609|16840524|P3|Overall Study|Adverse Event|2
4887591|NCT00713609|16840525|P2|Overall Study|Adverse Event|0
4887592|NCT00713609|16840526|P1|Overall Study|Adverse Event|2
4887593|NCT00713596|16840561|P3|Overall Study|Study was terminated|2
4887594|NCT00713596|16840562|P2|Overall Study|Study was terminated|3
4887595|NCT00713596|16840563|P1|Overall Study|Study was terminated|2
4887596|NCT00713544|16840589|P6|Overall Study|Hepatotoxicity - not an AE|0
4887597|NCT00713544|16840590|P5|Overall Study|Hepatotoxicity - not an AE|1
4887598|NCT00713544|16840591|P4|Overall Study|Hepatotoxicity - not an AE|0
4887599|NCT00713544|16840592|P3|Overall Study|Hepatotoxicity - not an AE|0
4887600|NCT00713544|16840593|P2|Overall Study|Hepatotoxicity - not an AE|0
4887601|NCT00713544|16840594|P1|Overall Study|Hepatotoxicity - not an AE|0
4887602|NCT00713544|16840589|P6|Overall Study|Incorrect enrollment|0
4887603|NCT00713544|16840590|P5|Overall Study|Incorrect enrollment|0
4887604|NCT00713544|16840591|P4|Overall Study|Incorrect enrollment|0
4887605|NCT00713544|16840592|P3|Overall Study|Incorrect enrollment|0
4887606|NCT00713544|16840593|P2|Overall Study|Incorrect enrollment|1
4887607|NCT00713544|16840594|P1|Overall Study|Incorrect enrollment|0
4887608|NCT00713544|16840589|P6|Overall Study|AZ decision - Hepatitis C ab reactive|0
4887609|NCT00713544|16840590|P5|Overall Study|AZ decision - Hepatitis C ab reactive|0
4887610|NCT00713544|16840591|P4|Overall Study|AZ decision - Hepatitis C ab reactive|0
4887611|NCT00713544|16840592|P3|Overall Study|AZ decision - Hepatitis C ab reactive|0
4887612|NCT00713544|16840593|P2|Overall Study|AZ decision - Hepatitis C ab reactive|1
4887613|NCT00713544|16840594|P1|Overall Study|AZ decision - Hepatitis C ab reactive|0
4887614|NCT00713544|16840589|P6|Overall Study|Lost to Follow-up|0
4887615|NCT00713544|16840590|P5|Overall Study|Lost to Follow-up|0
4887616|NCT00713544|16840591|P4|Overall Study|Lost to Follow-up|0
4887617|NCT00713544|16840592|P3|Overall Study|Lost to Follow-up|1
4887618|NCT00713544|16840593|P2|Overall Study|Lost to Follow-up|0
4887619|NCT00713544|16840594|P1|Overall Study|Lost to Follow-up|0
4887620|NCT00713544|16840589|P6|Overall Study|Lack of Efficacy|0
4887621|NCT00713544|16840590|P5|Overall Study|Lack of Efficacy|1
4887622|NCT00713544|16840591|P4|Overall Study|Lack of Efficacy|1
4887623|NCT00713544|16840592|P3|Overall Study|Lack of Efficacy|0
4887624|NCT00713544|16840593|P2|Overall Study|Lack of Efficacy|1
4887625|NCT00713544|16840594|P1|Overall Study|Lack of Efficacy|0
4887626|NCT00713544|16840589|P6|Overall Study|Physician Decision|2
4887627|NCT00713544|16840590|P5|Overall Study|Physician Decision|0
4887628|NCT00713544|16840591|P4|Overall Study|Physician Decision|0
4887629|NCT00713544|16840592|P3|Overall Study|Physician Decision|0
4887630|NCT00713544|16840593|P2|Overall Study|Physician Decision|0
4887631|NCT00713544|16840594|P1|Overall Study|Physician Decision|0
4887632|NCT00713544|16840589|P6|Overall Study|Protocol Violation|1
4887633|NCT00713544|16840590|P5|Overall Study|Protocol Violation|0
4887634|NCT00713544|16840591|P4|Overall Study|Protocol Violation|0
4887635|NCT00713544|16840592|P3|Overall Study|Protocol Violation|0
4887636|NCT00713544|16840593|P2|Overall Study|Protocol Violation|0
4887637|NCT00713544|16840594|P1|Overall Study|Protocol Violation|0
4887638|NCT00713544|16840589|P6|Overall Study|Withdrawal by Subject|1
4887639|NCT00713544|16840590|P5|Overall Study|Withdrawal by Subject|3
4887640|NCT00713544|16840591|P4|Overall Study|Withdrawal by Subject|2
4887641|NCT00713544|16840592|P3|Overall Study|Withdrawal by Subject|3
4887642|NCT00713544|16840593|P2|Overall Study|Withdrawal by Subject|0
4887643|NCT00713544|16840594|P1|Overall Study|Withdrawal by Subject|2
4887644|NCT00713544|16840589|P6|Overall Study|Adverse Event|5
4887645|NCT00713544|16840590|P5|Overall Study|Adverse Event|3
4887646|NCT00713544|16840591|P4|Overall Study|Adverse Event|7
4887647|NCT00713544|16840592|P3|Overall Study|Adverse Event|7
4887648|NCT00713544|16840593|P2|Overall Study|Adverse Event|3
4887649|NCT00713544|16840594|P1|Overall Study|Adverse Event|5
4887650|NCT00713349|16840645|P1|Overall Study|Protocol Violation|1
4887651|NCT00713323|16840651|P1|Overall Study|Treatment that may interact with Sativex|1
4887652|NCT00713323|16840651|P1|Overall Study|Subject travelling to Dominica Republic|1
4887653|NCT00713323|16840651|P1|Overall Study|Subject travelling to USA|1
4887654|NCT00713323|16840651|P1|Overall Study|Pain resolved|1
4887655|NCT00713323|16840651|P1|Overall Study|Non-compliance|1
4887656|NCT00713323|16840651|P1|Overall Study|Pain free|1
4887657|NCT00713323|16840651|P1|Overall Study|Surgery cured allodynic pain|1
4887658|NCT00713323|16840651|P1|Overall Study|Withdrawn due to exclusion criteria 11|1
4887659|NCT00713323|16840651|P1|Overall Study|Low creatine clearance at screening|1
4887660|NCT00713323|16840651|P1|Overall Study|Lack of Efficacy|36
4887661|NCT00713323|16840651|P1|Overall Study|Lost to Follow-up|11
4887662|NCT00713323|16840651|P1|Overall Study|Withdrawal by Subject|15
4887663|NCT00713323|16840651|P1|Overall Study|Adverse Event|75
4887664|NCT00713310|16840664|P2|Overall Study|Withdrawal by Subject|2
4887665|NCT00713310|16840665|P1|Overall Study|Withdrawal by Subject|0
4887666|NCT00713310|16840664|P2|Overall Study|Lack of Efficacy|2
4887667|NCT00713310|16840665|P1|Overall Study|Lack of Efficacy|0
4887668|NCT00713310|16840664|P2|Overall Study|Adverse Event|2
4887669|NCT00713310|16840665|P1|Overall Study|Adverse Event|5
4887670|NCT00713258|16840679|P2|Overall Study|Other|1
4887671|NCT00713258|16840680|P1|Overall Study|Other|1
4887672|NCT00713258|16840679|P2|Overall Study|Non-Compliance|1
4887673|NCT00713258|16840680|P1|Overall Study|Non-Compliance|2
4887674|NCT00713258|16840679|P2|Overall Study|Adverse Event|4
4887675|NCT00713258|16840680|P1|Overall Study|Adverse Event|2
4887676|NCT00713219|16840688|P1|Overall Study|Protocol Violation|1
4887677|NCT00713219|16840688|P1|Overall Study|Death|1
4887678|NCT00713206|16840694|P2|Overall Study|Adverse Event|1
4887679|NCT00713206|16840695|P1|Overall Study|Adverse Event|2
4887680|NCT00713206|16840694|P2|Overall Study|Lost to Follow-up|2
4887681|NCT00713206|16840695|P1|Overall Study|Lost to Follow-up|5
4887682|NCT00712985|16840701|P1|Overall Study|Lack of Efficacy|3
4887683|NCT00712985|16840701|P1|Overall Study|1 patient moved out of state|1
4887684|NCT00712985|16840701|P1|Overall Study|1 withdrew prior to start of drug|1
4887685|NCT00712959|16840707|P2|Overall Study|Withdrawal by Subject|0
4887686|NCT00712959|16840708|P1|Overall Study|Withdrawal by Subject|3
4887687|NCT00712959|16840707|P2|Overall Study|Lost to Follow-up|2
4887688|NCT00712959|16840708|P1|Overall Study|Lost to Follow-up|13
4887689|NCT00712959|16840707|P2|Overall Study|Protocol Violation|1
4887690|NCT00712959|16840708|P1|Overall Study|Protocol Violation|3
4887691|NCT00712933|16840726|P1|Overall Study|Withdrawal by Subject|151
4887692|NCT00712933|16840726|P1|Overall Study|Protocol Violation|4
4887693|NCT00712933|16840726|P1|Overall Study|Physician Decision|36
4887694|NCT00712933|16840726|P1|Overall Study|Participant received medication|1
4887695|NCT00712933|16840726|P1|Overall Study|Not committed to contraception|1
4887696|NCT00712933|16840726|P1|Overall Study|Other Physician decision|1
4887697|NCT00712933|16840726|P1|Overall Study|Death of patient|1
4887698|NCT00712933|16840726|P1|Overall Study|Participant travelled overseas|2
4887699|NCT00712933|16840726|P1|Overall Study|Participant hospitalized|1
4887700|NCT00712933|16840726|P1|Overall Study|Involved in Clinical research|3
4887701|NCT00712933|16840726|P1|Overall Study|Hip replacement surgery|1
4887702|NCT00712933|16840726|P1|Overall Study|Withdrew consent|4
4887703|NCT00712933|16840726|P1|Overall Study|Sponsor decision|14
4887704|NCT00712933|16840726|P1|Overall Study|Other Pregnancy|37
4887705|NCT00712933|16840726|P1|Overall Study|Non-compliance with study drug|13
4887706|NCT00712933|16840726|P1|Overall Study|Lost to Follow-up|22
4887707|NCT00712933|16840726|P1|Overall Study|Lack of Efficacy|6
4887708|NCT00712933|16840726|P1|Overall Study|Adverse Event|69
4887709|NCT00712920|16840756|P3|Overall Study|Non-compliance|0
4887710|NCT00712920|16840757|P2|Overall Study|Non-compliance|0
4887711|NCT00712920|16840758|P1|Overall Study|Non-compliance|3
4887712|NCT00712920|16840756|P3|Overall Study|Other|3
4887713|NCT00712920|16840757|P2|Overall Study|Other|7
4887714|NCT00712920|16840758|P1|Overall Study|Other|5
4887715|NCT00712920|16840756|P3|Overall Study|Lack of Efficacy|1
4887716|NCT00712920|16840757|P2|Overall Study|Lack of Efficacy|0
4887717|NCT00712920|16840758|P1|Overall Study|Lack of Efficacy|1
4887718|NCT00712920|16840756|P3|Overall Study|Lost to Follow-up|0
4887719|NCT00712920|16840757|P2|Overall Study|Lost to Follow-up|4
4887720|NCT00712920|16840758|P1|Overall Study|Lost to Follow-up|1
4887721|NCT00712920|16840756|P3|Overall Study|Withdrawal by Subject|1
4887722|NCT00712920|16840757|P2|Overall Study|Withdrawal by Subject|2
4887723|NCT00712920|16840758|P1|Overall Study|Withdrawal by Subject|4
4887724|NCT00712920|16840756|P3|Overall Study|Adverse Event|7
4887725|NCT00712920|16840757|P2|Overall Study|Adverse Event|4
4887726|NCT00712920|16840758|P1|Overall Study|Adverse Event|3
4887727|NCT00712725|16840786|P8|Overall Study|Protocol Specified Criteria|1
4887728|NCT00712725|16840787|P7|Overall Study|Protocol Specified Criteria|2
4887729|NCT00712725|16840788|P6|Overall Study|Protocol Specified Criteria|0
4887730|NCT00712725|16840789|P5|Overall Study|Protocol Specified Criteria|1
4887731|NCT00712725|16840790|P4|Overall Study|Protocol Specified Criteria|2
4887732|NCT00712725|16840791|P3|Overall Study|Protocol Specified Criteria|1
4887733|NCT00712725|16840792|P2|Overall Study|Protocol Specified Criteria|0
4887734|NCT00712725|16840793|P1|Overall Study|Protocol Specified Criteria|3
4887735|NCT00712725|16840786|P8|Overall Study|Lack of Qualifying Event|6
4887736|NCT00712725|16840787|P7|Overall Study|Lack of Qualifying Event|11
4887737|NCT00712725|16840788|P6|Overall Study|Lack of Qualifying Event|13
4887738|NCT00712725|16840789|P5|Overall Study|Lack of Qualifying Event|11
4887739|NCT00712725|16840790|P4|Overall Study|Lack of Qualifying Event|8
4887740|NCT00712725|16840791|P3|Overall Study|Lack of Qualifying Event|6
4887741|NCT00712725|16840792|P2|Overall Study|Lack of Qualifying Event|2
4887742|NCT00712725|16840793|P1|Overall Study|Lack of Qualifying Event|16
4887743|NCT00712725|16840786|P8|Overall Study|Withdrawal by Subject|2
4887744|NCT00712725|16840787|P7|Overall Study|Withdrawal by Subject|1
4887745|NCT00712725|16840788|P6|Overall Study|Withdrawal by Subject|1
4887746|NCT00712725|16840789|P5|Overall Study|Withdrawal by Subject|1
4887747|NCT00712725|16840790|P4|Overall Study|Withdrawal by Subject|2
4887748|NCT00712725|16840791|P3|Overall Study|Withdrawal by Subject|1
4887749|NCT00712725|16840792|P2|Overall Study|Withdrawal by Subject|1
4887750|NCT00712725|16840793|P1|Overall Study|Withdrawal by Subject|2
4887751|NCT00712725|16840786|P8|Overall Study|Protocol Violation|1
4887752|NCT00712725|16840787|P7|Overall Study|Protocol Violation|1
4887753|NCT00712725|16840788|P6|Overall Study|Protocol Violation|0
4887754|NCT00712725|16840789|P5|Overall Study|Protocol Violation|2
4887755|NCT00712725|16840790|P4|Overall Study|Protocol Violation|3
4887756|NCT00712725|16840791|P3|Overall Study|Protocol Violation|1
4887757|NCT00712725|16840792|P2|Overall Study|Protocol Violation|0
4887758|NCT00712725|16840793|P1|Overall Study|Protocol Violation|2
4887759|NCT00712725|16840786|P8|Overall Study|Pregnancy|0
4887760|NCT00712725|16840787|P7|Overall Study|Pregnancy|2
4887761|NCT00712725|16840788|P6|Overall Study|Pregnancy|0
4887762|NCT00712725|16840789|P5|Overall Study|Pregnancy|1
4887763|NCT00712725|16840790|P4|Overall Study|Pregnancy|0
4887764|NCT00712725|16840791|P3|Overall Study|Pregnancy|0
4887765|NCT00712725|16840792|P2|Overall Study|Pregnancy|1
4887766|NCT00712725|16840793|P1|Overall Study|Pregnancy|0
4887767|NCT00712725|16840786|P8|Overall Study|Physician Decision|0
4887768|NCT00712725|16840787|P7|Overall Study|Physician Decision|2
4887769|NCT00712725|16840788|P6|Overall Study|Physician Decision|0
4887770|NCT00712725|16840789|P5|Overall Study|Physician Decision|1
4887771|NCT00712725|16840790|P4|Overall Study|Physician Decision|0
4887772|NCT00712725|16840791|P3|Overall Study|Physician Decision|0
4887773|NCT00712725|16840792|P2|Overall Study|Physician Decision|0
4887774|NCT00712725|16840793|P1|Overall Study|Physician Decision|2
4887775|NCT00712725|16840786|P8|Overall Study|Lost to Follow-up|1
4887776|NCT00712725|16840787|P7|Overall Study|Lost to Follow-up|3
4887777|NCT00712725|16840788|P6|Overall Study|Lost to Follow-up|2
4887778|NCT00712725|16840789|P5|Overall Study|Lost to Follow-up|2
4887779|NCT00712725|16840790|P4|Overall Study|Lost to Follow-up|1
4887780|NCT00712725|16840791|P3|Overall Study|Lost to Follow-up|1
4887781|NCT00712725|16840792|P2|Overall Study|Lost to Follow-up|2
4887782|NCT00712725|16840793|P1|Overall Study|Lost to Follow-up|3
4887783|NCT00712725|16840786|P8|Overall Study|Adverse Event|0
4887784|NCT00712725|16840787|P7|Overall Study|Adverse Event|0
4887785|NCT00712725|16840788|P6|Overall Study|Adverse Event|0
4887786|NCT00712725|16840789|P5|Overall Study|Adverse Event|0
4887787|NCT00712725|16840790|P4|Overall Study|Adverse Event|1
4887788|NCT00712725|16840791|P3|Overall Study|Adverse Event|0
4887789|NCT00712725|16840792|P2|Overall Study|Adverse Event|0
4887790|NCT00712725|16840793|P1|Overall Study|Adverse Event|1
4887791|NCT00712673|16840854|P4|Overall Study|Protocol Violation|0
4887792|NCT00712673|16840855|P3|Overall Study|Protocol Violation|2
4887793|NCT00712673|16840856|P2|Overall Study|Protocol Violation|0
4887794|NCT00712673|16840857|P1|Overall Study|Protocol Violation|0
4887795|NCT00712673|16840854|P4|Overall Study|Investigator's Decision|0
4887796|NCT00712673|16840855|P3|Overall Study|Investigator's Decision|0
4887797|NCT00712673|16840856|P2|Overall Study|Investigator's Decision|0
4887798|NCT00712673|16840857|P1|Overall Study|Investigator's Decision|1
4887799|NCT00712673|16840854|P4|Overall Study|Familial and Personal Reasons|2
4887800|NCT00712673|16840855|P3|Overall Study|Familial and Personal Reasons|5
4887801|NCT00712673|16840856|P2|Overall Study|Familial and Personal Reasons|0
4887802|NCT00712673|16840857|P1|Overall Study|Familial and Personal Reasons|5
4887803|NCT00712673|16840854|P4|Overall Study|Withdrawal by Subject|20
4887804|NCT00712673|16840855|P3|Overall Study|Withdrawal by Subject|15
4887805|NCT00712673|16840856|P2|Overall Study|Withdrawal by Subject|7
4887806|NCT00712673|16840857|P1|Overall Study|Withdrawal by Subject|6
4887807|NCT00712673|16840854|P4|Overall Study|Lost to Follow-up|0
4887808|NCT00712673|16840855|P3|Overall Study|Lost to Follow-up|2
4887809|NCT00712673|16840856|P2|Overall Study|Lost to Follow-up|0
4887810|NCT00712673|16840857|P1|Overall Study|Lost to Follow-up|1
4887811|NCT00712673|16840854|P4|Overall Study|Poor Compliance to Protocol|16
4887812|NCT00712673|16840855|P3|Overall Study|Poor Compliance to Protocol|4
4887813|NCT00712673|16840856|P2|Overall Study|Poor Compliance to Protocol|3
4887814|NCT00712673|16840857|P1|Overall Study|Poor Compliance to Protocol|3
4887815|NCT00712673|16840854|P4|Overall Study|Lack of Efficacy|6
4887816|NCT00712673|16840855|P3|Overall Study|Lack of Efficacy|8
4887817|NCT00712673|16840856|P2|Overall Study|Lack of Efficacy|8
4887818|NCT00712673|16840857|P1|Overall Study|Lack of Efficacy|2
4887819|NCT00712673|16840854|P4|Overall Study|Adverse Event|26
4887820|NCT00712673|16840855|P3|Overall Study|Adverse Event|21
4887821|NCT00712673|16840856|P2|Overall Study|Adverse Event|3
4887822|NCT00712673|16840857|P1|Overall Study|Adverse Event|3
4887823|NCT00712543|16840921|P2|Day 8-14|Lost to Follow-up|2
4887824|NCT00712543|16840922|P1|Day 8-14|Lost to Follow-up|0
4887825|NCT00712348|16840956|P1|Overall Study|Withdrawal by Subject|1
4887826|NCT00712335|16840968|P5|Overall Study|Other Reason|0
4887827|NCT00712335|16840969|P4|Overall Study|Other Reason|0
4887828|NCT00712335|16840970|P3|Overall Study|Other Reason|1
4887829|NCT00712335|16840971|P2|Overall Study|Other Reason|3
4887830|NCT00712335|16840972|P1|Overall Study|Other Reason|0
4887831|NCT00712335|16840968|P5|Overall Study|Lack of Efficacy|0
4887832|NCT00712335|16840969|P4|Overall Study|Lack of Efficacy|1
4887833|NCT00712335|16840970|P3|Overall Study|Lack of Efficacy|1
4887834|NCT00712335|16840971|P2|Overall Study|Lack of Efficacy|0
4887835|NCT00712335|16840972|P1|Overall Study|Lack of Efficacy|0
4887836|NCT00712335|16840968|P5|Overall Study|Protocol Violation|0
4887837|NCT00712335|16840969|P4|Overall Study|Protocol Violation|0
4887838|NCT00712335|16840970|P3|Overall Study|Protocol Violation|1
4887839|NCT00712335|16840971|P2|Overall Study|Protocol Violation|2
4887840|NCT00712335|16840972|P1|Overall Study|Protocol Violation|1
4887841|NCT00712335|16840968|P5|Overall Study|Lost to Follow-up|0
4887842|NCT00712335|16840969|P4|Overall Study|Lost to Follow-up|1
4887843|NCT00712335|16840970|P3|Overall Study|Lost to Follow-up|0
4887844|NCT00712335|16840971|P2|Overall Study|Lost to Follow-up|5
4887845|NCT00712335|16840972|P1|Overall Study|Lost to Follow-up|2
4887846|NCT00712335|16840968|P5|Overall Study|Withdrawal by Subject|0
4887847|NCT00712335|16840969|P4|Overall Study|Withdrawal by Subject|3
4887848|NCT00712335|16840970|P3|Overall Study|Withdrawal by Subject|2
4887849|NCT00712335|16840971|P2|Overall Study|Withdrawal by Subject|7
4887850|NCT00712335|16840972|P1|Overall Study|Withdrawal by Subject|0
4887851|NCT00712270|16841102|P1|Overall Study|Screen Failure|3
4887852|NCT00712270|16841102|P1|Overall Study|Withdrawal by Subject|11
4887853|NCT00712166|16841166|P2|Overall Study|Noncompliance|1
4887854|NCT00712166|16841167|P1|Overall Study|Noncompliance|0
4887855|NCT00712010|16841210|P1|Washout (7 Days)|Withdrawal by Subject|1
4887856|NCT00711971|16841249|P3|Overall Study|Lost to Follow-up|1
4887857|NCT00711971|16841250|P2|Overall Study|Lost to Follow-up|4
4887858|NCT00711971|16841251|P1|Overall Study|Lost to Follow-up|3
4887859|NCT00711958|16841285|P2|Overall Study|Progression of disease|0
4887860|NCT00711958|16841286|P1|Overall Study|Progression of disease|1
4887861|NCT00711958|16841285|P2|Overall Study|Death|5
4887862|NCT00711958|16841286|P1|Overall Study|Death|10
4887863|NCT00711958|16841285|P2|Overall Study|Lost to Follow-up|2
4887864|NCT00711958|16841286|P1|Overall Study|Lost to Follow-up|2
4887865|NCT00711958|16841285|P2|Overall Study|Protocol Violation|0
4887866|NCT00711958|16841286|P1|Overall Study|Protocol Violation|1
4887867|NCT00711958|16841285|P2|Overall Study|Adverse Event|7
4887868|NCT00711958|16841286|P1|Overall Study|Adverse Event|9
4887869|NCT00711958|16841285|P2|Overall Study|Clinical deterioration|0
4887870|NCT00711958|16841286|P1|Overall Study|Clinical deterioration|1
4887871|NCT00711958|16841285|P2|Overall Study|Lack of Efficacy|1
4887872|NCT00711958|16841286|P1|Overall Study|Lack of Efficacy|3
4887873|NCT00711958|16841285|P2|Overall Study|Withdrawal by Subject|8
4887874|NCT00711958|16841286|P1|Overall Study|Withdrawal by Subject|6
4887875|NCT00711880|16841294|P2|Overall Study|Lack of Efficacy|5
4887876|NCT00711880|16841295|P1|Overall Study|Lack of Efficacy|1
4887877|NCT00711880|16841294|P2|Overall Study|Patient non-compliance|0
4887878|NCT00711880|16841295|P1|Overall Study|Patient non-compliance|1
4887879|NCT00711880|16841294|P2|Overall Study|Adverse Event|2
4887880|NCT00711880|16841295|P1|Overall Study|Adverse Event|11
4887881|NCT00711802|16841357|P8|Overall Study|Reason not reported|0
4887882|NCT00711802|16841358|P7|Overall Study|Reason not reported|1
4887883|NCT00711802|16841359|P6|Overall Study|Reason not reported|0
4887884|NCT00711802|16841360|P5|Overall Study|Reason not reported|1
4887885|NCT00711802|16841361|P4|Overall Study|Reason not reported|0
4887886|NCT00711802|16841362|P3|Overall Study|Reason not reported|1
4887887|NCT00711802|16841363|P2|Overall Study|Reason not reported|1
4887888|NCT00711802|16841364|P1|Overall Study|Reason not reported|0
4887889|NCT00711802|16841357|P8|Overall Study|Lost to Follow-up|2
4887890|NCT00711802|16841358|P7|Overall Study|Lost to Follow-up|4
4887891|NCT00711802|16841359|P6|Overall Study|Lost to Follow-up|6
4887892|NCT00711802|16841360|P5|Overall Study|Lost to Follow-up|10
4887893|NCT00711802|16841361|P4|Overall Study|Lost to Follow-up|1
4887894|NCT00711802|16841362|P3|Overall Study|Lost to Follow-up|3
4887895|NCT00711802|16841363|P2|Overall Study|Lost to Follow-up|0
4887896|NCT00711802|16841364|P1|Overall Study|Lost to Follow-up|0
4887897|NCT00711802|16841357|P8|Overall Study|Withdrawal by Subject|0
4887898|NCT00711802|16841358|P7|Overall Study|Withdrawal by Subject|0
4887899|NCT00711802|16841359|P6|Overall Study|Withdrawal by Subject|0
4887900|NCT00711802|16841360|P5|Overall Study|Withdrawal by Subject|0
4887901|NCT00711802|16841361|P4|Overall Study|Withdrawal by Subject|1
4887902|NCT00711802|16841362|P3|Overall Study|Withdrawal by Subject|0
4887903|NCT00711802|16841363|P2|Overall Study|Withdrawal by Subject|1
4887904|NCT00711802|16841364|P1|Overall Study|Withdrawal by Subject|0
4887905|NCT00711802|16841357|P8|Overall Study|Physician Decision|0
4887906|NCT00711802|16841358|P7|Overall Study|Physician Decision|0
4887907|NCT00711802|16841359|P6|Overall Study|Physician Decision|0
4887908|NCT00711802|16841360|P5|Overall Study|Physician Decision|0
4887909|NCT00711802|16841361|P4|Overall Study|Physician Decision|0
4887910|NCT00711802|16841362|P3|Overall Study|Physician Decision|0
4887911|NCT00711802|16841363|P2|Overall Study|Physician Decision|2
4887912|NCT00711802|16841364|P1|Overall Study|Physician Decision|0
4887913|NCT00711802|16841357|P8|Overall Study|Protocol Violation|0
4887914|NCT00711802|16841358|P7|Overall Study|Protocol Violation|0
4887915|NCT00711802|16841359|P6|Overall Study|Protocol Violation|0
4887916|NCT00711802|16841360|P5|Overall Study|Protocol Violation|0
4887917|NCT00711802|16841361|P4|Overall Study|Protocol Violation|1
4887918|NCT00711802|16841362|P3|Overall Study|Protocol Violation|0
4887919|NCT00711802|16841363|P2|Overall Study|Protocol Violation|0
4887920|NCT00711802|16841364|P1|Overall Study|Protocol Violation|0
4887921|NCT00711802|16841357|P8|Overall Study|Microbiological failure|0
4887922|NCT00711802|16841358|P7|Overall Study|Microbiological failure|0
4887923|NCT00711802|16841359|P6|Overall Study|Microbiological failure|1
4887924|NCT00711802|16841360|P5|Overall Study|Microbiological failure|0
4887925|NCT00711802|16841361|P4|Overall Study|Microbiological failure|0
4887926|NCT00711802|16841362|P3|Overall Study|Microbiological failure|0
4887927|NCT00711802|16841363|P2|Overall Study|Microbiological failure|1
4887928|NCT00711802|16841364|P1|Overall Study|Microbiological failure|0
4887929|NCT00711802|16841357|P8|Overall Study|Adverse Event|0
4887930|NCT00711802|16841358|P7|Overall Study|Adverse Event|0
4887931|NCT00711802|16841359|P6|Overall Study|Adverse Event|1
4887932|NCT00711802|16841360|P5|Overall Study|Adverse Event|1
4887933|NCT00711802|16841361|P4|Overall Study|Adverse Event|0
4887934|NCT00711802|16841362|P3|Overall Study|Adverse Event|0
4887935|NCT00711802|16841363|P2|Overall Study|Adverse Event|0
4887936|NCT00711802|16841364|P1|Overall Study|Adverse Event|0
4887937|NCT00711802|16841357|P8|Overall Study|Not treated (no further detail)|0
4887938|NCT00711802|16841358|P7|Overall Study|Not treated (no further detail)|0
4887939|NCT00711802|16841359|P6|Overall Study|Not treated (no further detail)|0
4887940|NCT00711802|16841360|P5|Overall Study|Not treated (no further detail)|2
4887941|NCT00711802|16841361|P4|Overall Study|Not treated (no further detail)|0
4887942|NCT00711802|16841362|P3|Overall Study|Not treated (no further detail)|2
4887943|NCT00711802|16841363|P2|Overall Study|Not treated (no further detail)|1
4887944|NCT00711802|16841364|P1|Overall Study|Not treated (no further detail)|2
4887945|NCT00711646|16841407|P2|Overall Study|patient non-compliance|0
4887946|NCT00711646|16841408|P1|Overall Study|patient non-compliance|1
4887947|NCT00711646|16841407|P2|Overall Study|administrative decision|1
4887948|NCT00711646|16841408|P1|Overall Study|administrative decision|0
4887949|NCT00711646|16841407|P2|Overall Study|Lost to Follow-up|0
4887950|NCT00711646|16841408|P1|Overall Study|Lost to Follow-up|1
4887951|NCT00711646|16841407|P2|Overall Study|Protocol Violation|1
4887952|NCT00711646|16841408|P1|Overall Study|Protocol Violation|0
4887953|NCT00711646|16841407|P2|Overall Study|Withdrawal by Subject|0
4887954|NCT00711646|16841408|P1|Overall Study|Withdrawal by Subject|4
4887955|NCT00711646|16841407|P2|Overall Study|Adverse Event|1
4887956|NCT00711646|16841408|P1|Overall Study|Adverse Event|6
4887957|NCT00711594|16841430|P4|Overall Study|Withdrawal by Subject|2
4887958|NCT00711594|16841431|P3|Overall Study|Withdrawal by Subject|0
4887959|NCT00711594|16841432|P2|Overall Study|Withdrawal by Subject|1
4887960|NCT00711594|16841433|P1|Overall Study|Withdrawal by Subject|0
4887961|NCT00711594|16841430|P4|Overall Study|Other Adverse Event|16
4887962|NCT00711594|16841431|P3|Overall Study|Other Adverse Event|0
4887963|NCT00711594|16841432|P2|Overall Study|Other Adverse Event|0
4887964|NCT00711594|16841433|P1|Overall Study|Other Adverse Event|1
4887965|NCT00711594|16841430|P4|Overall Study|Progressive disease|44
4887966|NCT00711594|16841431|P3|Overall Study|Progressive disease|6
4887967|NCT00711594|16841432|P2|Overall Study|Progressive disease|2
4887968|NCT00711594|16841433|P1|Overall Study|Progressive disease|2
4887969|NCT00711555|16841470|P1|Overall Study|Adverse Event|3
4887970|NCT00711529|16841479|P2|Overall Study|Withdrawal by Subject|6
4887971|NCT00711529|16841480|P1|Overall Study|Withdrawal by Subject|2
4887972|NCT00711529|16841479|P2|Overall Study|Protocol Violation|0
4887973|NCT00711529|16841480|P1|Overall Study|Protocol Violation|2
4887974|NCT00711516|16841504|P2|Overall Study|Protocol Violation|1
4887975|NCT00711516|16841505|P1|Overall Study|Protocol Violation|0
4887976|NCT00711516|16841504|P2|Overall Study|Withdrawal by Subject|1
4887977|NCT00711516|16841505|P1|Overall Study|Withdrawal by Subject|0
4887978|NCT00711516|16841504|P2|Overall Study|Adverse Event|1
4887979|NCT00711516|16841505|P1|Overall Study|Adverse Event|1
4887980|NCT00711477|16841612|P2|Overall Study|Noncompliance|1
4887981|NCT00711477|16841613|P1|Overall Study|Noncompliance|0
4887982|NCT00711477|16841612|P2|Overall Study|Lost to Follow-up|1
4887983|NCT00711477|16841613|P1|Overall Study|Lost to Follow-up|0
4887984|NCT00711477|16841612|P2|Overall Study|Adverse Event|1
4887985|NCT00711477|16841613|P1|Overall Study|Adverse Event|3
4887986|NCT00711425|16841659|P1|Overall Study|Lost to Follow-up|1
4887987|NCT00711425|16841659|P1|Overall Study|Death|2
4887988|NCT00711425|16841659|P1|Overall Study|Protocol Violation|1
4887989|NCT00711412|16841665|P1|Survival Follow up Until Death|Other|12
4887990|NCT00711412|16841665|P1|Evaluation for Response and Surgery|Death|1
4887991|NCT00711412|16841665|P1|Evaluation for Response and Surgery|Withdrawal by Subject|1
4887992|NCT00711412|16841665|P1|Evaluation for Response and Surgery|Too high risk for surgery|2
4887993|NCT00711412|16841665|P1|Evaluation for Response and Surgery|Progressive Disease|2
4887994|NCT00711412|16841665|P1|Combination Treatment|Progressive Disease|1
4887995|NCT00711412|16841665|P1|Evaluated for Combination Treatment|Progressive disease|2
4887996|NCT00711412|16841665|P1|Evaluated for Combination Treatment|Withdrawal by Subject|1
4887997|NCT00711412|16841665|P1|Evaluated for Combination Treatment|Death|1
4887998|NCT00711412|16841665|P1|Evaluated for Combination Treatment|Adverse Event|2
4887999|NCT00711412|16841665|P1|Induction Treatment|Other|1
4888000|NCT00711412|16841665|P1|Induction Treatment|Adverse Event|1
4888001|NCT00711412|16841665|P1|Induction Treatment|Death|2
4888002|NCT00711243|16841743|P6|Follow up Every 3 Months Until Death|Lost to Follow-up|2
4888003|NCT00711243|16841744|P5|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4888004|NCT00711243|16841745|P4|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4888005|NCT00711243|16841746|P3|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4888006|NCT00711243|16841747|P2|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4888007|NCT00711243|16841748|P1|Follow up Every 3 Months Until Death|Lost to Follow-up|0
4888008|NCT00711243|16841743|P6|Treated Cycle 5 After First Response|Decline in performance status|1
4888009|NCT00711243|16841744|P5|Treated Cycle 5 After First Response|Decline in performance status|0
4888010|NCT00711243|16841745|P4|Treated Cycle 5 After First Response|Decline in performance status|0
4888011|NCT00711243|16841746|P3|Treated Cycle 5 After First Response|Decline in performance status|0
4888012|NCT00711243|16841747|P2|Treated Cycle 5 After First Response|Decline in performance status|0
4888013|NCT00711243|16841748|P1|Treated Cycle 5 After First Response|Decline in performance status|0
4888014|NCT00711243|16841743|P6|Treated Cycle 5 After First Response|Death|2
4888015|NCT00711243|16841744|P5|Treated Cycle 5 After First Response|Death|0
4888016|NCT00711243|16841745|P4|Treated Cycle 5 After First Response|Death|0
4888017|NCT00711243|16841746|P3|Treated Cycle 5 After First Response|Death|0
4888018|NCT00711243|16841747|P2|Treated Cycle 5 After First Response|Death|0
4888019|NCT00711243|16841748|P1|Treated Cycle 5 After First Response|Death|0
4888020|NCT00711243|16841743|P6|Treated Cycle 5 After First Response|Progressive disease|1
4888021|NCT00711243|16841744|P5|Treated Cycle 5 After First Response|Progressive disease|1
4888022|NCT00711243|16841745|P4|Treated Cycle 5 After First Response|Progressive disease|0
4888023|NCT00711243|16841746|P3|Treated Cycle 5 After First Response|Progressive disease|0
4888024|NCT00711243|16841747|P2|Treated Cycle 5 After First Response|Progressive disease|2
4888025|NCT00711243|16841748|P1|Treated Cycle 5 After First Response|Progressive disease|1
4888026|NCT00711243|16841743|P6|Reached First Response/4 Cycles|Progressive disease|0
4888027|NCT00711243|16841744|P5|Reached First Response/4 Cycles|Progressive disease|0
4888028|NCT00711243|16841745|P4|Reached First Response/4 Cycles|Progressive disease|1
4888029|NCT00711243|16841746|P3|Reached First Response/4 Cycles|Progressive disease|0
4888030|NCT00711243|16841747|P2|Reached First Response/4 Cycles|Progressive disease|0
4888031|NCT00711243|16841748|P1|Reached First Response/4 Cycles|Progressive disease|0
4888032|NCT00711243|16841743|P6|Reached First Response/4 Cycles|Death|2
4888033|NCT00711243|16841744|P5|Reached First Response/4 Cycles|Death|0
4888034|NCT00711243|16841745|P4|Reached First Response/4 Cycles|Death|0
4888035|NCT00711243|16841746|P3|Reached First Response/4 Cycles|Death|0
4888036|NCT00711243|16841747|P2|Reached First Response/4 Cycles|Death|0
4888037|NCT00711243|16841748|P1|Reached First Response/4 Cycles|Death|0
4888038|NCT00711243|16841743|P6|Registed and Started Treatment|Withdrawal by Subject|1
4888039|NCT00711243|16841744|P5|Registed and Started Treatment|Withdrawal by Subject|0
4888040|NCT00711243|16841745|P4|Registed and Started Treatment|Withdrawal by Subject|0
4888041|NCT00711243|16841746|P3|Registed and Started Treatment|Withdrawal by Subject|0
4888042|NCT00711243|16841747|P2|Registed and Started Treatment|Withdrawal by Subject|0
4888043|NCT00711243|16841748|P1|Registed and Started Treatment|Withdrawal by Subject|0
4888044|NCT00711191|16841771|P3|Overall Study|Withdrawal by Subject|3
4888045|NCT00711191|16841772|P2|Overall Study|Withdrawal by Subject|1
4888046|NCT00711191|16841773|P1|Overall Study|Withdrawal by Subject|0
4888047|NCT00711191|16841771|P3|Overall Study|Objective progression or relapse|7
4888048|NCT00711191|16841772|P2|Overall Study|Objective progression or relapse|3
4888049|NCT00711191|16841773|P1|Overall Study|Objective progression or relapse|2
4888050|NCT00711191|16841771|P3|Overall Study|Adverse Event|2
4888051|NCT00711191|16841772|P2|Overall Study|Adverse Event|1
4888052|NCT00711191|16841773|P1|Overall Study|Adverse Event|1
4888053|NCT00711113|16841810|P1|Overall Study|Implant lost|2
4888054|NCT00711113|16841810|P1|Overall Study|Lost to Follow-up|9
4888055|NCT00711100|16841816|P1|Overall Study|Withdrawal by Subject|8
4888056|NCT00711100|16841816|P1|Overall Study|Lack of Efficacy|5
4888057|NCT00711087|16841834|P2|Overall Study|Lost to Follow-up|0
4888058|NCT00711087|16841835|P1|Overall Study|Lost to Follow-up|1
4888059|NCT00711009|16841847|P2|Overall Study|Dose adjustment|0
4888060|NCT00711009|16841848|P1|Overall Study|Dose adjustment|1
4888061|NCT00711009|16841847|P2|Overall Study|Site closing|1
4888062|NCT00711009|16841848|P1|Overall Study|Site closing|0
4888063|NCT00711009|16841847|P2|Overall Study|Pregnancy|0
4888064|NCT00711009|16841848|P1|Overall Study|Pregnancy|1
4888065|NCT00711009|16841847|P2|Overall Study|Virologic Failure|1
4888066|NCT00711009|16841848|P1|Overall Study|Virologic Failure|2
4888067|NCT00711009|16841847|P2|Overall Study|Participant Noncompliant|1
4888068|NCT00711009|16841848|P1|Overall Study|Participant Noncompliant|0
4888069|NCT00711009|16841847|P2|Overall Study|Lost to Follow-up|9
4888070|NCT00711009|16841848|P1|Overall Study|Lost to Follow-up|3
4888071|NCT00711009|16841847|P2|Overall Study|Withdrawal by Subject|2
4888072|NCT00711009|16841848|P1|Overall Study|Withdrawal by Subject|4
4888073|NCT00711009|16841847|P2|Overall Study|Adverse Event/HIV-Related Event|5
4888074|NCT00711009|16841848|P1|Overall Study|Adverse Event/HIV-Related Event|4
4888075|NCT00710970|16842029|P1|Overall Study|Never took drug|2
4888076|NCT00710970|16842029|P1|Overall Study|Lost to Follow-up|8
4888077|NCT00710879|16842056|P2|Overall Study|Protocol Violation|3
4888078|NCT00710879|16842057|P1|Overall Study|Protocol Violation|0
4888079|NCT00710879|16842056|P2|Overall Study|Lost to Follow-up|1
4888080|NCT00710879|16842057|P1|Overall Study|Lost to Follow-up|2
4888081|NCT00710866|16842069|P2|Overall Study|Failed to meet eligibility|1
4888082|NCT00710866|16842070|P1|Overall Study|Failed to meet eligibility|1
4888083|NCT00710866|16842069|P2|Overall Study|Lost to Follow-up|0
4888084|NCT00710866|16842070|P1|Overall Study|Lost to Follow-up|1
4888085|NCT00710866|16842069|P2|Overall Study|Withdrawal by Subject|1
4888086|NCT00710866|16842070|P1|Overall Study|Withdrawal by Subject|2
4888087|NCT00710866|16842069|P2|Overall Study|Protocol Violation|4
4888088|NCT00710866|16842070|P1|Overall Study|Protocol Violation|5
4888089|NCT00710762|16842116|P2|Overall Study|Reason other than listed above|2
4888090|NCT00710762|16842117|P1|Overall Study|Reason other than listed above|2
4888091|NCT00710762|16842116|P2|Overall Study|Lost to Follow-up|0
4888092|NCT00710762|16842117|P1|Overall Study|Lost to Follow-up|1
4888093|NCT00710762|16842116|P2|Overall Study|Other Adverse Event|7
4888094|NCT00710762|16842117|P1|Overall Study|Other Adverse Event|7
4888095|NCT00710762|16842116|P2|Overall Study|Adverse Event other disease worsening|1
4888096|NCT00710762|16842117|P1|Overall Study|Adverse Event other disease worsening|2
4888097|NCT00710762|16842116|P2|Overall Study|Progressive disease|30
4888098|NCT00710762|16842117|P1|Overall Study|Progressive disease|27
4888099|NCT00710749|16842133|P2|First Intervention|Withdrawal by Subject|0
4888100|NCT00710749|16842134|P1|First Intervention|Withdrawal by Subject|1
4888101|NCT00710684|16842145|P3|Overall Study|Did not continue after week 24|16
4888102|NCT00710684|16842146|P2|Overall Study|Did not continue after week 24|21
4888103|NCT00710684|16842147|P1|Overall Study|Did not continue after week 24|25
4888104|NCT00710684|16842145|P3|Overall Study|Missing|0
4888105|NCT00710684|16842146|P2|Overall Study|Missing|0
4888106|NCT00710684|16842147|P1|Overall Study|Missing|1
4888107|NCT00710684|16842145|P3|Overall Study|Withdrawal by Subject|11
4888108|NCT00710684|16842146|P2|Overall Study|Withdrawal by Subject|18
4888109|NCT00710684|16842147|P1|Overall Study|Withdrawal by Subject|24
4888110|NCT00710684|16842145|P3|Overall Study|Physician Decision|4
4888111|NCT00710684|16842146|P2|Overall Study|Physician Decision|2
4888112|NCT00710684|16842147|P1|Overall Study|Physician Decision|0
4888113|NCT00710684|16842145|P3|Overall Study|Lost to Follow-up|7
4888114|NCT00710684|16842146|P2|Overall Study|Lost to Follow-up|6
4888115|NCT00710684|16842147|P1|Overall Study|Lost to Follow-up|4
4888116|NCT00710684|16842145|P3|Overall Study|Protocol Violation|5
4888117|NCT00710684|16842146|P2|Overall Study|Protocol Violation|5
4888118|NCT00710684|16842147|P1|Overall Study|Protocol Violation|5
4888119|NCT00710684|16842145|P3|Overall Study|Lack of Efficacy|5
4888120|NCT00710684|16842146|P2|Overall Study|Lack of Efficacy|3
4888121|NCT00710684|16842147|P1|Overall Study|Lack of Efficacy|4
4888122|NCT00710684|16842145|P3|Overall Study|Adverse Event|16
4888123|NCT00710684|16842146|P2|Overall Study|Adverse Event|19
4888124|NCT00710684|16842147|P1|Overall Study|Adverse Event|11
4888125|NCT00710606|16842204|P2|Overall Study|Adverse Event|2
4888126|NCT00710606|16842205|P1|Overall Study|Adverse Event|0
4888127|NCT00710593|16842217|P2|Overall Study|Prem disc vaccine, completed all visits|2
4888128|NCT00710593|16842218|P1|Overall Study|Prem disc vaccine, completed all visits|6
4888129|NCT00710593|16842217|P2|Overall Study|Protocol Violation|1
4888130|NCT00710593|16842218|P1|Overall Study|Protocol Violation|1
4888131|NCT00710593|16842217|P2|Overall Study|Failure to adhere or complete study eval|1
4888132|NCT00710593|16842218|P1|Overall Study|Failure to adhere or complete study eval|1
4888133|NCT00710593|16842217|P2|Overall Study|Moved out of area|0
4888134|NCT00710593|16842218|P1|Overall Study|Moved out of area|1
4888135|NCT00710593|16842217|P2|Overall Study|Lost to Follow-up|1
4888136|NCT00710593|16842218|P1|Overall Study|Lost to Follow-up|3
4888137|NCT00710593|16842217|P2|Overall Study|Unable to complete Wk 48 within window|0
4888138|NCT00710593|16842218|P1|Overall Study|Unable to complete Wk 48 within window|2
4888139|NCT00710593|16842217|P2|Overall Study|Incarceration|0
4888140|NCT00710593|16842218|P1|Overall Study|Incarceration|1
4888141|NCT00710554|16842261|P2|Overall Study|Receiving radiotherapy - prostate cancer|1
4888142|NCT00710554|16842262|P1|Overall Study|Receiving radiotherapy - prostate cancer|0
4888143|NCT00710554|16842261|P2|Overall Study|Lack of Efficacy|12
4888144|NCT00710554|16842262|P1|Overall Study|Lack of Efficacy|11
4888145|NCT00710554|16842261|P2|Overall Study|Lost to Follow-up|1
4888146|NCT00710554|16842262|P1|Overall Study|Lost to Follow-up|7
4888147|NCT00710554|16842261|P2|Overall Study|Withdrawal by Subject|3
4888148|NCT00710554|16842262|P1|Overall Study|Withdrawal by Subject|7
4888149|NCT00710554|16842261|P2|Overall Study|Adverse Event|7
4888150|NCT00710554|16842262|P1|Overall Study|Adverse Event|24
4888151|NCT00710424|16842290|P2|Overall Study|Felt good so stopped treatment|1
4888152|NCT00710424|16842291|P1|Overall Study|Felt good so stopped treatment|0
4888153|NCT00710424|16842290|P2|Overall Study|Subject preferred paracetamol|1
4888154|NCT00710424|16842291|P1|Overall Study|Subject preferred paracetamol|0
4888155|NCT00710424|16842290|P2|Overall Study|Ceased treatment due to travel|0
4888156|NCT00710424|16842291|P1|Overall Study|Ceased treatment due to travel|1
4888157|NCT00710424|16842290|P2|Overall Study|Subject thought medication changed|0
4888158|NCT00710424|16842291|P1|Overall Study|Subject thought medication changed|1
4888159|NCT00710424|16842290|P2|Overall Study|Did not meet entry criteria at visit 1|0
4888160|NCT00710424|16842291|P1|Overall Study|Did not meet entry criteria at visit 1|1
4888161|NCT00710424|16842290|P2|Overall Study|Non-compliance with stable analgesia|0
4888162|NCT00710424|16842291|P1|Overall Study|Non-compliance with stable analgesia|1
4888163|NCT00710424|16842290|P2|Overall Study|Refused medication, no side effects|0
4888164|NCT00710424|16842291|P1|Overall Study|Refused medication, no side effects|1
4888165|NCT00710424|16842290|P2|Overall Study|Lost to Follow-up|1
4888166|NCT00710424|16842291|P1|Overall Study|Lost to Follow-up|0
4888167|NCT00710424|16842290|P2|Overall Study|Withdrawal by Subject|3
4888168|NCT00710424|16842291|P1|Overall Study|Withdrawal by Subject|5
4888169|NCT00710424|16842290|P2|Overall Study|Lack of Efficacy|5
4888170|NCT00710424|16842291|P1|Overall Study|Lack of Efficacy|4
4888171|NCT00710424|16842290|P2|Overall Study|Adverse Event|12
4888172|NCT00710424|16842291|P1|Overall Study|Adverse Event|30
4888173|NCT00710385|16842315|P1|Overall Study|Undisclosed excessive methadone use|1
4888174|NCT00710385|16842315|P1|Overall Study|Physician Decision|1
4888175|NCT00710385|16842315|P1|Overall Study|Undisclosed back pain|1
4888176|NCT00710385|16842315|P1|Overall Study|Withdrawal by Subject|1
4888177|NCT00710385|16842315|P1|Overall Study|Did not qualify|1
4888178|NCT00710034|16842360|P2|Completed 12 Weeks of Treatment|Withdrawal by Subject|2
4888179|NCT00710034|16842361|P1|Completed 12 Weeks of Treatment|Withdrawal by Subject|8
4888180|NCT00710034|16842360|P2|Completed 12 Weeks of Treatment|Product Dissatisfaction|1
4888181|NCT00710034|16842361|P1|Completed 12 Weeks of Treatment|Product Dissatisfaction|0
4888182|NCT00710034|16842360|P2|Completed 12 Weeks of Treatment|Lost to Follow-up|5
4888183|NCT00710034|16842361|P1|Completed 12 Weeks of Treatment|Lost to Follow-up|5
4888184|NCT00710034|16842360|P2|Completed 12 Weeks of Treatment|Lack of Efficacy|2
4888185|NCT00710034|16842361|P1|Completed 12 Weeks of Treatment|Lack of Efficacy|0
4888186|NCT00710034|16842360|P2|Completed 12 Weeks of Treatment|Adverse Event|1
4888187|NCT00710034|16842361|P1|Completed 12 Weeks of Treatment|Adverse Event|0
4888188|NCT00710034|16842360|P2|Completed 6 Weeks of Treatment|Physician Decision|0
4888189|NCT00710034|16842361|P1|Completed 6 Weeks of Treatment|Physician Decision|1
4888190|NCT00710034|16842360|P2|Completed 6 Weeks of Treatment|Withdrawal by Subject|4
4888191|NCT00710034|16842361|P1|Completed 6 Weeks of Treatment|Withdrawal by Subject|6
4888192|NCT00710034|16842360|P2|Completed 6 Weeks of Treatment|Product dissatisfaction|6
4888193|NCT00710034|16842361|P1|Completed 6 Weeks of Treatment|Product dissatisfaction|2
4888194|NCT00710034|16842360|P2|Completed 6 Weeks of Treatment|Lost to Follow-up|17
4888195|NCT00710034|16842361|P1|Completed 6 Weeks of Treatment|Lost to Follow-up|15
4888196|NCT00710034|16842360|P2|Completed 6 Weeks of Treatment|Lack of Efficacy|8
4888197|NCT00710034|16842361|P1|Completed 6 Weeks of Treatment|Lack of Efficacy|12
4888198|NCT00710034|16842360|P2|Completed 6 Weeks of Treatment|Adverse Event|12
4888199|NCT00710034|16842361|P1|Completed 6 Weeks of Treatment|Adverse Event|5
4888200|NCT00710021|16842378|P3|Overall Study|Physician Decision|0
4888201|NCT00710021|16842379|P2|Overall Study|Physician Decision|1
4888202|NCT00710021|16842380|P1|Overall Study|Physician Decision|0
4888203|NCT00710021|16842378|P3|Overall Study|Subject misrandomized|1
4888204|NCT00710021|16842379|P2|Overall Study|Subject misrandomized|1
4888205|NCT00710021|16842380|P1|Overall Study|Subject misrandomized|0
4888206|NCT00710021|16842378|P3|Overall Study|Subject's Decision|0
4888207|NCT00710021|16842379|P2|Overall Study|Subject's Decision|1
4888208|NCT00710021|16842380|P1|Overall Study|Subject's Decision|0
4888209|NCT00710021|16842378|P3|Overall Study|Lost to Follow-up|0
4888210|NCT00710021|16842379|P2|Overall Study|Lost to Follow-up|0
4888211|NCT00710021|16842380|P1|Overall Study|Lost to Follow-up|1
4888212|NCT00709995|16842495|P2|Overall Study|Withdrawal by Subject|3
4888213|NCT00709995|16842496|P1|Overall Study|Withdrawal by Subject|1
4888214|NCT00709995|16842495|P2|Overall Study|Adverse Event|2
4888215|NCT00709995|16842496|P1|Overall Study|Adverse Event|4
4888216|NCT00709956|16842514|P2|Overall Study|Inclusion/exclusion criteria violation|3
4888217|NCT00709956|16842515|P1|Overall Study|Inclusion/exclusion criteria violation|2
4888218|NCT00709956|16842514|P2|Overall Study|Withdrawal by Subject|1
4888219|NCT00709956|16842515|P1|Overall Study|Withdrawal by Subject|1
4888220|NCT00709852|16842545|P2|Period 2|No 72-hour follow-up|0
4888221|NCT00709852|16842546|P1|Period 2|No 72-hour follow-up|3
4888222|NCT00709852|16842545|P2|Period 2|Lost to Follow-up|0
4888223|NCT00709852|16842546|P1|Period 2|Lost to Follow-up|1
4888224|NCT00709852|16842545|P2|Period 2|Adverse Event|1
4888225|NCT00709852|16842546|P1|Period 2|Adverse Event|1
4888226|NCT00709852|16842545|P2|Period 2|Protocol Violation|1
4888227|NCT00709852|16842546|P1|Period 2|Protocol Violation|4
4888228|NCT00709852|16842545|P2|Period 1|Lost to Follow-up|0
4888229|NCT00709852|16842546|P1|Period 1|Lost to Follow-up|1
4888230|NCT00709852|16842545|P2|Period 1|Defective scanner|1
4888231|NCT00709852|16842546|P1|Period 1|Defective scanner|0
4888232|NCT00709852|16842545|P2|Period 1|Protocol Violation|0
4888233|NCT00709852|16842546|P1|Period 1|Protocol Violation|1
4888234|NCT00709852|16842545|P2|Period 1|Withdrawal by Subject|2
4888235|NCT00709852|16842546|P1|Period 1|Withdrawal by Subject|4
4888236|NCT00709852|16842545|P2|Period 1|Adverse Event|0
4888237|NCT00709852|16842546|P1|Period 1|Adverse Event|2
4888238|NCT00709761|16842710|P1|Overall Study|Lost to Follow-up|2
4888239|NCT00709761|16842710|P1|Overall Study|study closed/terminated|17
4888240|NCT00709761|16842710|P1|Overall Study|Withdrawal by Subject|8
4888241|NCT00709735|16842721|P2|Overall Study|Did not meet PTSD Diagnostic Criteria|0
4888242|NCT00709735|16842722|P1|Overall Study|Did not meet PTSD Diagnostic Criteria|2
4888243|NCT00709735|16842721|P2|Overall Study|Relapse into Opioid Abuse|1
4888244|NCT00709735|16842722|P1|Overall Study|Relapse into Opioid Abuse|0
4888245|NCT00709735|16842721|P2|Overall Study|Lost to Follow-up|1
4888246|NCT00709735|16842722|P1|Overall Study|Lost to Follow-up|1
4888247|NCT00709722|16842730|P1|Overall Study|Adverse Event|1
4888248|NCT00709618|16842745|P1|Overall Study|Study Closed/Terminated|25
4888249|NCT00709618|16842745|P1|Overall Study|Lost to Follow-up|1
4888250|NCT00709618|16842745|P1|Overall Study|Withdrawal by Subject|4
4888251|NCT00709592|16842757|P2|Overall Study|Unable to proceed to transplant|1
4888252|NCT00709592|16842758|P1|Overall Study|Unable to proceed to transplant|0
4888253|NCT00709319|16842780|P1|Overall Study|Withdrawal by Subject|2
4888254|NCT00709319|16842780|P1|Overall Study|Death|4
4888255|NCT00709228|16842809|P1|Overall Study|Non-compliance|5
4888256|NCT00709228|16842809|P1|Overall Study|Lost to Follow-up|6
4888257|NCT00709228|16842809|P1|Overall Study|Disease progression|1
4888258|NCT00709228|16842809|P1|Overall Study|Discontinued follow-up|5
4888259|NCT00709228|16842809|P1|Overall Study|Did not enter follow-up|4
4888260|NCT00709228|16842809|P1|Overall Study|Discontinued treatment|14
4888261|NCT00709228|16842809|P1|Overall Study|Adverse events|2
4888262|NCT00709228|16842809|P1|Overall Study|Eligibility criteria not met|281
4888263|NCT00709228|16842809|P1|Overall Study|Not treated|14
4888264|NCT00709202|16842815|P2|Overall Study|Withdrawal by Subject|6
4888265|NCT00709202|16842816|P1|Overall Study|Withdrawal by Subject|6
4888266|NCT00709124|16842844|P2|Overall Study|encephalopathy; can't do assessment|0
4888267|NCT00709124|16842845|P1|Overall Study|encephalopathy; can't do assessment|1
4888268|NCT00709124|16842844|P2|Overall Study|Death|1
4888269|NCT00709124|16842845|P1|Overall Study|Death|3
4888270|NCT00709111|16842879|P1|Overall Study|Unable to attend clinic visits|1
4888271|NCT00709111|16842879|P1|Overall Study|Withdrawal by Subject|1
4888272|NCT00709098|16842920|P3|Open-label Period|Lost to Follow-up|1
4888273|NCT00709098|16842921|P2|Open-label Period|Lost to Follow-up|0
4888274|NCT00709098|16842922|P1|Open-label Period|Lost to Follow-up|0
4888275|NCT00709098|16842920|P3|Open-label Period|Death|1
4888276|NCT00709098|16842921|P2|Open-label Period|Death|0
4888277|NCT00709098|16842922|P1|Open-label Period|Death|0
4888278|NCT00709098|16842920|P3|Open-label Period|Administrative reason|5
4888279|NCT00709098|16842921|P2|Open-label Period|Administrative reason|0
4888280|NCT00709098|16842922|P1|Open-label Period|Administrative reason|0
4888281|NCT00709098|16842920|P3|Open-label Period|Withdrawal of consent|7
4888282|NCT00709098|16842921|P2|Open-label Period|Withdrawal of consent|0
4888283|NCT00709098|16842922|P1|Open-label Period|Withdrawal of consent|0
4888284|NCT00709098|16842920|P3|Double-blind Period|Lost to Follow-up|0
4888285|NCT00709098|16842921|P2|Double-blind Period|Lost to Follow-up|1
4888286|NCT00709098|16842922|P1|Double-blind Period|Lost to Follow-up|1
4888287|NCT00709098|16842920|P3|Double-blind Period|Death|0
4888288|NCT00709098|16842921|P2|Double-blind Period|Death|1
4888289|NCT00709098|16842922|P1|Double-blind Period|Death|1
4888290|NCT00709098|16842920|P3|Double-blind Period|Administrative reason|0
4888291|NCT00709098|16842921|P2|Double-blind Period|Administrative reason|3
4888292|NCT00709098|16842922|P1|Double-blind Period|Administrative reason|1
4888293|NCT00709098|16842920|P3|Double-blind Period|Withdrawal of consent|0
4888294|NCT00709098|16842921|P2|Double-blind Period|Withdrawal of consent|3
4888295|NCT00709098|16842922|P1|Double-blind Period|Withdrawal of consent|3
4888296|NCT00709059|16842941|P1|Overall Study|Serious side effects|11
4888297|NCT00709059|16842941|P1|Overall Study|Side effects|20
4888298|NCT00709059|16842941|P1|Overall Study|Disease complication|3
4888299|NCT00709059|16842941|P1|Overall Study|Physician Decision|7
4888300|NCT00709059|16842941|P1|Overall Study|Withdrawal by Subject|19
4888301|NCT00709059|16842941|P1|Overall Study|Lost to Follow-up|34
4888302|NCT00708734|16842988|P1|Overall Study|leg fracture|1
4888303|NCT00708734|16842988|P1|Overall Study|vertigo|1
4888304|NCT00708734|16842988|P1|Overall Study|knee replacement|1
4888305|NCT00708734|16842988|P1|Overall Study|leg injury|1
4888306|NCT00708734|16842988|P1|Overall Study|moved|1
4888307|NCT00708734|16842988|P1|Overall Study|scheduling conflict|2
4888308|NCT00708708|16843008|P1|Overall Study|Missing values|392
4888309|NCT00708708|16843008|P1|Overall Study|Adverse Event|3
4888310|NCT00708708|16843008|P1|Overall Study|Pregnancy|3
4888311|NCT00708708|16843008|P1|Overall Study|Lack of compliance|3
4888312|NCT00708708|16843008|P1|Overall Study|Lack of effectiveness|4
4888313|NCT00708708|16843008|P1|Overall Study|Administrative reasons|7
4888314|NCT00708708|16843008|P1|Overall Study|Ineffectiveness (no systemic therapy)|9
4888315|NCT00708708|16843008|P1|Overall Study|Good effectiveness|9
4888316|NCT00708708|16843008|P1|Overall Study|Other unspecified|11
4888317|NCT00708708|16843008|P1|Overall Study|Another therapy along with Enbrel|15
4888318|NCT00708708|16843008|P1|Overall Study|Intolerance|42
4888319|NCT00708708|16843008|P1|Overall Study|Withdrawal by Subject|51
4888320|NCT00708708|16843008|P1|Overall Study|Lost to Follow-up|52
4888321|NCT00708708|16843008|P1|Overall Study|Another therapy instead of Enbrel|141
4888322|NCT00708682|16843056|P1|Toddler Dose|Failed to Return|4
4888323|NCT00708682|16843056|P1|Toddler Dose|Lost to Follow-up|3
4888324|NCT00708682|16843056|P1|Toddler Dose|Parent/Legal Guardian Request|1
4888325|NCT00708682|16843056|P1|After Infant Series|Parent/Legal Guardian Request|1
4888326|NCT00708682|16843056|P1|Infant Series|Other|19
4888327|NCT00708682|16843056|P1|Infant Series|Failed to return|2
4888328|NCT00708682|16843056|P1|Infant Series|Parent/legal guardian request|6
4888329|NCT00708682|16843056|P1|Infant Series|Protocol Violation|1
4888330|NCT00708682|16843056|P1|Infant Series|Lost to Follow-up|4
4888331|NCT00708682|16843056|P1|Infant Series|Adverse Event|1
4888332|NCT00708643|16843077|P2|Overall Study|Adverse Event|1
4888333|NCT00708643|16843078|P1|Overall Study|Adverse Event|0
4888334|NCT00708552|16843098|P4|Overall Study|Withdrawal by Subject|10
4888335|NCT00708552|16843099|P3|Overall Study|Withdrawal by Subject|8
4888336|NCT00708552|16843100|P2|Overall Study|Withdrawal by Subject|7
4888337|NCT00708552|16843101|P1|Overall Study|Withdrawal by Subject|12
4888338|NCT00708552|16843098|P4|Overall Study|Physician Decision|0
4888339|NCT00708552|16843099|P3|Overall Study|Physician Decision|0
4888340|NCT00708552|16843100|P2|Overall Study|Physician Decision|2
4888341|NCT00708552|16843101|P1|Overall Study|Physician Decision|1
4888342|NCT00708552|16843098|P4|Overall Study|Lost to Follow-up|1
4888343|NCT00708552|16843099|P3|Overall Study|Lost to Follow-up|0
4888344|NCT00708552|16843100|P2|Overall Study|Lost to Follow-up|2
4888345|NCT00708552|16843101|P1|Overall Study|Lost to Follow-up|4
4888346|NCT00708552|16843098|P4|Overall Study|Protocol Violation|4
4888347|NCT00708552|16843099|P3|Overall Study|Protocol Violation|2
4888348|NCT00708552|16843100|P2|Overall Study|Protocol Violation|0
4888349|NCT00708552|16843101|P1|Overall Study|Protocol Violation|0
4888350|NCT00708552|16843098|P4|Overall Study|Lack of Efficacy|0
4888351|NCT00708552|16843099|P3|Overall Study|Lack of Efficacy|1
4888352|NCT00708552|16843100|P2|Overall Study|Lack of Efficacy|4
4888353|NCT00708552|16843101|P1|Overall Study|Lack of Efficacy|0
4888354|NCT00708552|16843098|P4|Overall Study|Adverse Event|6
4888355|NCT00708552|16843099|P3|Overall Study|Adverse Event|4
4888356|NCT00708552|16843100|P2|Overall Study|Adverse Event|3
4888357|NCT00708552|16843101|P1|Overall Study|Adverse Event|10
4888358|NCT00708500|16843263|P3|FOLLOWUP|Non-compliance with protocol|1
4888359|NCT00708500|16843264|P2|FOLLOWUP|Non-compliance with protocol|0
4888360|NCT00708500|16843265|P1|FOLLOWUP|Non-compliance with protocol|5
4888361|NCT00708500|16843263|P3|FOLLOWUP|Subject withdrew consent|5
4888362|NCT00708500|16843264|P2|FOLLOWUP|Subject withdrew consent|4
4888363|NCT00708500|16843265|P1|FOLLOWUP|Subject withdrew consent|31
4888364|NCT00708500|16843263|P3|FOLLOWUP|Subject withdrawal unrelated to Tx|5
4888365|NCT00708500|16843264|P2|FOLLOWUP|Subject withdrawal unrelated to Tx|4
4888366|NCT00708500|16843265|P1|FOLLOWUP|Subject withdrawal unrelated to Tx|3
4888367|NCT00708500|16843263|P3|FOLLOWUP|Lost to Follow-up|4
4888368|NCT00708500|16843264|P2|FOLLOWUP|Lost to Follow-up|6
4888369|NCT00708500|16843265|P1|FOLLOWUP|Lost to Follow-up|1
4888370|NCT00708500|16843263|P3|FOLLOWUP|Adverse Event|0
4888371|NCT00708500|16843264|P2|FOLLOWUP|Adverse Event|1
4888372|NCT00708500|16843265|P1|FOLLOWUP|Adverse Event|0
4888373|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
4888374|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1
4888375|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0
4888376|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
4888377|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1
4888378|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0
4888379|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1
4888380|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2
4888381|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0
4888382|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1
4888383|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0
4888384|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2
4888385|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4
4888386|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1
4888387|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3
4888388|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
4888389|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1
4888390|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0
4888391|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29
4888392|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36
4888393|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49
4888394|NCT00708500|16843263|P3|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19
4888395|NCT00708500|16843264|P2|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10
4888396|NCT00708500|16843265|P1|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1
4888397|NCT00708500|16843263|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1
4888398|NCT00708500|16843264|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
4888399|NCT00708500|16843265|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0
4888400|NCT00708500|16843263|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
4888401|NCT00708500|16843264|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2
4888402|NCT00708500|16843265|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0
4888403|NCT00708500|16843263|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
4888404|NCT00708500|16843264|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1
4888405|NCT00708500|16843265|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0
4888406|NCT00708500|16843263|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
4888407|NCT00708500|16843264|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0
4888408|NCT00708500|16843265|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1
4888409|NCT00708500|16843263|P3|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
4888410|NCT00708500|16843264|P2|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3
4888411|NCT00708500|16843265|P1|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1
4888412|NCT00708461|16843284|P2|Overall Study|left workforce|180
4888413|NCT00708461|16843285|P1|Overall Study|left workforce|115
4888414|NCT00708461|16843284|P2|Overall Study|Withdrawal by Subject|9
4888415|NCT00708461|16843285|P1|Overall Study|Withdrawal by Subject|8
4888416|NCT00708461|16843284|P2|Overall Study|Lost to Follow-up|11
4888417|NCT00708461|16843285|P1|Overall Study|Lost to Follow-up|18
4888418|NCT00708435|16843293|P2|Overall Study|Refused hospitalization|0
4888419|NCT00708435|16843294|P1|Overall Study|Refused hospitalization|1
4888420|NCT00708435|16843293|P2|Overall Study|Intervention by primary care physician|0
4888421|NCT00708435|16843294|P1|Overall Study|Intervention by primary care physician|1
4888422|NCT00708435|16843293|P2|Overall Study|Protocol Violation|1
4888423|NCT00708435|16843294|P1|Overall Study|Protocol Violation|0
4888424|NCT00708435|16843293|P2|Overall Study|Adverse Event|0
4888425|NCT00708435|16843294|P1|Overall Study|Adverse Event|1
4888426|NCT00708435|16843293|P2|Overall Study|Withdrawal by Subject|7
4888427|NCT00708435|16843294|P1|Overall Study|Withdrawal by Subject|3
4888428|NCT00708435|16843293|P2|Overall Study|Lost to Follow-up|4
4888429|NCT00708435|16843294|P1|Overall Study|Lost to Follow-up|9
4888430|NCT00708435|16843293|P2|Overall Study|Death / Serious Adverse Event|5
4888431|NCT00708435|16843294|P1|Overall Study|Death / Serious Adverse Event|10
4888432|NCT00708422|16843321|P2|Overall Study|Withdrawal by Subject|0
4888433|NCT00708422|16843322|P1|Overall Study|Withdrawal by Subject|1
4888434|NCT00708422|16843321|P2|Overall Study|Adverse Event|1
4888435|NCT00708422|16843322|P1|Overall Study|Adverse Event|3
4888436|NCT00708305|16843330|P4|Period 3|Other Reason|0
4888437|NCT00708305|16843331|P3|Period 3|Other Reason|0
4888438|NCT00708305|16843332|P2|Period 3|Other Reason|0
4888439|NCT00708305|16843333|P1|Period 3|Other Reason|1
4888440|NCT00708305|16843330|P4|Period 3|Protocol Violation|0
4888441|NCT00708305|16843331|P3|Period 3|Protocol Violation|0
4888442|NCT00708305|16843332|P2|Period 3|Protocol Violation|2
4888443|NCT00708305|16843333|P1|Period 3|Protocol Violation|0
4888444|NCT00708305|16843330|P4|Period 2|Other Reason|1
4888445|NCT00708305|16843331|P3|Period 2|Other Reason|0
4888446|NCT00708305|16843332|P2|Period 2|Other Reason|0
4888447|NCT00708305|16843333|P1|Period 2|Other Reason|1
4888448|NCT00708305|16843330|P4|Period 2|Protocol Violation|0
4888449|NCT00708305|16843331|P3|Period 2|Protocol Violation|0
4888450|NCT00708305|16843332|P2|Period 2|Protocol Violation|1
4888451|NCT00708305|16843333|P1|Period 2|Protocol Violation|0
4888452|NCT00708305|16843330|P4|Period 2|Lost to Follow-up|0
4888453|NCT00708305|16843331|P3|Period 2|Lost to Follow-up|0
4888454|NCT00708305|16843332|P2|Period 2|Lost to Follow-up|1
4888455|NCT00708305|16843333|P1|Period 2|Lost to Follow-up|0
4888456|NCT00708305|16843330|P4|Period 1|Other Reason|2
4888457|NCT00708305|16843331|P3|Period 1|Other Reason|0
4888458|NCT00708305|16843332|P2|Period 1|Other Reason|0
4888459|NCT00708305|16843333|P1|Period 1|Other Reason|0
4888460|NCT00708305|16843330|P4|Period 1|Protocol Violation|0
4888461|NCT00708305|16843331|P3|Period 1|Protocol Violation|1
4888462|NCT00708305|16843332|P2|Period 1|Protocol Violation|0
4888463|NCT00708305|16843333|P1|Period 1|Protocol Violation|1
4888464|NCT00708227|16843369|P4|Overall Study|Withdrawal by Subject|1
4888465|NCT00708227|16843370|P3|Overall Study|Withdrawal by Subject|0
4888466|NCT00708227|16843371|P2|Overall Study|Withdrawal by Subject|2
4888467|NCT00708227|16843372|P1|Overall Study|Withdrawal by Subject|1
4888468|NCT00708227|16843369|P4|Overall Study|Physician Decision|2
4888469|NCT00708227|16843370|P3|Overall Study|Physician Decision|1
4888470|NCT00708227|16843371|P2|Overall Study|Physician Decision|3
4888471|NCT00708227|16843372|P1|Overall Study|Physician Decision|0
4888472|NCT00708214|16843405|P3|Overall Study|Progressive Disease|5
4888473|NCT00708214|16843406|P2|Overall Study|Progressive Disease|6
4888474|NCT00708214|16843407|P1|Overall Study|Progressive Disease|4
4888475|NCT00708214|16843405|P3|Overall Study|Other|1
4888476|NCT00708214|16843406|P2|Overall Study|Other|1
4888477|NCT00708214|16843407|P1|Overall Study|Other|0
4888478|NCT00708214|16843405|P3|Overall Study|Other Adverse Event|2
4888479|NCT00708214|16843406|P2|Overall Study|Other Adverse Event|6
4888480|NCT00708214|16843407|P1|Overall Study|Other Adverse Event|3
4888481|NCT00708201|16843450|P2|Overall Study|Protocol Violation|1
4888482|NCT00708201|16843451|P1|Overall Study|Protocol Violation|0
4888483|NCT00708201|16843450|P2|Overall Study|Lost to Follow-up|0
4888484|NCT00708201|16843451|P1|Overall Study|Lost to Follow-up|2
4888485|NCT00708201|16843450|P2|Overall Study|Withdrawal by Subject|1
4888486|NCT00708201|16843451|P1|Overall Study|Withdrawal by Subject|1
4888487|NCT00708201|16843450|P2|Overall Study|Adverse Event|4
4888488|NCT00708201|16843451|P1|Overall Study|Adverse Event|4
4888489|NCT00708175|16843475|P2|Overall Study|BMD loss >7%|3
4888490|NCT00708175|16843476|P1|Overall Study|BMD loss >7%|2
4888491|NCT00708175|16843475|P2|Overall Study|Withdrawal by Subject|7
4888492|NCT00708175|16843476|P1|Overall Study|Withdrawal by Subject|5
4888493|NCT00708175|16843475|P2|Overall Study|Lost to Follow-up|3
4888494|NCT00708175|16843476|P1|Overall Study|Lost to Follow-up|5
4888495|NCT00708175|16843475|P2|Overall Study|Protocol Violation|3
4888496|NCT00708175|16843476|P1|Overall Study|Protocol Violation|2
4888497|NCT00708175|16843475|P2|Overall Study|Adverse Event|5
4888498|NCT00708175|16843476|P1|Overall Study|Adverse Event|4
4888499|NCT00708162|16843492|P2|Open-Label Phase|Other|0
4888500|NCT00708162|16843493|P1|Open-Label Phase|Other|1
4888501|NCT00708162|16843492|P2|Open-Label Phase|Adverse Event|2
4888502|NCT00708162|16843493|P1|Open-Label Phase|Adverse Event|1
4888503|NCT00708162|16843492|P2|Open-Label Phase|Death|1
4888504|NCT00708162|16843493|P1|Open-Label Phase|Death|3
4888505|NCT00708162|16843492|P2|Open-Label Phase|Investigator's Discretion|2
4888506|NCT00708162|16843493|P1|Open-Label Phase|Investigator's Discretion|3
4888507|NCT00708162|16843492|P2|Open-Label Phase|Lack of Efficacy|4
4888508|NCT00708162|16843493|P1|Open-Label Phase|Lack of Efficacy|7
4888509|NCT00708162|16843492|P2|Open-Label Phase|Participant Noncompliance|7
4888510|NCT00708162|16843493|P1|Open-Label Phase|Participant Noncompliance|7
4888511|NCT00708162|16843492|P2|Open-Label Phase|Withdrew Consent|6
4888512|NCT00708162|16843493|P1|Open-Label Phase|Withdrew Consent|12
4888513|NCT00708162|16843492|P2|Open-Label Phase|Lost to Follow-up|8
4888514|NCT00708162|16843493|P1|Open-Label Phase|Lost to Follow-up|10
4888515|NCT00708162|16843492|P2|Randomized Phase|Pregnancy|0
4888516|NCT00708162|16843493|P1|Randomized Phase|Pregnancy|3
4888517|NCT00708162|16843492|P2|Randomized Phase|Death|9
4888518|NCT00708162|16843493|P1|Randomized Phase|Death|2
4888519|NCT00708162|16843492|P2|Randomized Phase|Investigator's Discretion|10
4888520|NCT00708162|16843493|P1|Randomized Phase|Investigator's Discretion|7
4888521|NCT00708162|16843492|P2|Randomized Phase|Adverse Event|12
4888522|NCT00708162|16843493|P1|Randomized Phase|Adverse Event|8
4888523|NCT00708162|16843492|P2|Randomized Phase|Protocol Violation|11
4888524|NCT00708162|16843493|P1|Randomized Phase|Protocol Violation|10
4888525|NCT00708162|16843492|P2|Randomized Phase|Lack of Efficacy|19
4888526|NCT00708162|16843493|P1|Randomized Phase|Lack of Efficacy|14
4888527|NCT00708162|16843492|P2|Randomized Phase|Withdrew Consent|22
4888528|NCT00708162|16843493|P1|Randomized Phase|Withdrew Consent|31
4888529|NCT00708162|16843492|P2|Randomized Phase|Lost to Follow-up|34
4888530|NCT00708162|16843493|P1|Randomized Phase|Lost to Follow-up|34
4888531|NCT00708162|16843492|P2|Randomized Phase|Participant Noncompliance|32
4888532|NCT00708162|16843493|P1|Randomized Phase|Participant Noncompliance|40
4888533|NCT00708162|16843492|P2|Randomized Phase|Randomized but Not Treated|5
4888534|NCT00708162|16843493|P1|Randomized Phase|Randomized but Not Treated|7
4888535|NCT00708123|16843534|P5|Period 4|Protocol Violation|0
4888536|NCT00708123|16843535|P4|Period 4|Protocol Violation|0
4888537|NCT00708123|16843536|P3|Period 4|Protocol Violation|0
4888538|NCT00708123|16843537|P2|Period 4|Protocol Violation|1
4888539|NCT00708123|16843538|P1|Period 4|Protocol Violation|0
4888540|NCT00708123|16843534|P5|Period 3|Lost to Follow-up|0
4888541|NCT00708123|16843535|P4|Period 3|Lost to Follow-up|1
4888542|NCT00708123|16843536|P3|Period 3|Lost to Follow-up|1
4888543|NCT00708123|16843537|P2|Period 3|Lost to Follow-up|0
4888544|NCT00708123|16843538|P1|Period 3|Lost to Follow-up|0
4888545|NCT00708123|16843534|P5|Period 2|Other Reason|0
4888546|NCT00708123|16843535|P4|Period 2|Other Reason|0
4888547|NCT00708123|16843536|P3|Period 2|Other Reason|0
4888548|NCT00708123|16843537|P2|Period 2|Other Reason|0
4888549|NCT00708123|16843538|P1|Period 2|Other Reason|1
4888550|NCT00708123|16843534|P5|Period 2|Protocol Violation|0
4888551|NCT00708123|16843535|P4|Period 2|Protocol Violation|1
4888552|NCT00708123|16843536|P3|Period 2|Protocol Violation|0
4888553|NCT00708123|16843537|P2|Period 2|Protocol Violation|0
4888554|NCT00708123|16843538|P1|Period 2|Protocol Violation|0
4888555|NCT00708123|16843534|P5|Period 1|Adverse Event|0
4888556|NCT00708123|16843535|P4|Period 1|Adverse Event|0
4888557|NCT00708123|16843536|P3|Period 1|Adverse Event|1
4888558|NCT00708123|16843537|P2|Period 1|Adverse Event|0
4888559|NCT00708123|16843538|P1|Period 1|Adverse Event|0
4888560|NCT00708123|16843534|P5|Period 1|Protocol Violation|0
4888561|NCT00708123|16843535|P4|Period 1|Protocol Violation|1
4888562|NCT00708123|16843536|P3|Period 1|Protocol Violation|0
4888563|NCT00708123|16843537|P2|Period 1|Protocol Violation|1
4888564|NCT00708123|16843538|P1|Period 1|Protocol Violation|0
4888565|NCT00708097|16843671|P5|Period 2|Protocol Violation|0
4888566|NCT00708097|16843672|P4|Period 2|Protocol Violation|1
4888567|NCT00708097|16843673|P3|Period 2|Protocol Violation|1
4888568|NCT00708097|16843674|P2|Period 2|Protocol Violation|1
4888569|NCT00708097|16843675|P1|Period 2|Protocol Violation|0
4888570|NCT00708097|16843671|P5|Period 1|Other Reason|1
4888571|NCT00708097|16843672|P4|Period 1|Other Reason|0
4888572|NCT00708097|16843673|P3|Period 1|Other Reason|0
4888573|NCT00708097|16843674|P2|Period 1|Other Reason|0
4888574|NCT00708097|16843675|P1|Period 1|Other Reason|0
4888575|NCT00708097|16843671|P5|Period 1|Protocol Violation|0
4888576|NCT00708097|16843672|P4|Period 1|Protocol Violation|2
4888577|NCT00708097|16843673|P3|Period 1|Protocol Violation|0
4888578|NCT00708097|16843674|P2|Period 1|Protocol Violation|1
4888579|NCT00708097|16843675|P1|Period 1|Protocol Violation|0
4888580|NCT00708032|16843785|P2|Overall Study|Withdrawal by Subject|1
4888581|NCT00708032|16843786|P1|Overall Study|Withdrawal by Subject|0
4888582|NCT00708032|16843785|P2|Overall Study|Protocol Violation|1
4888583|NCT00708032|16843786|P1|Overall Study|Protocol Violation|4
4888584|NCT00708032|16843785|P2|Overall Study|Did not meet protocol criteria|2
4888585|NCT00708032|16843786|P1|Overall Study|Did not meet protocol criteria|1
4888586|NCT00708032|16843785|P2|Overall Study|Visit out of range at month 12|1
4888587|NCT00708032|16843786|P1|Overall Study|Visit out of range at month 12|4
4888588|NCT00708032|16843785|P2|Overall Study|Poor vision|6
4888589|NCT00708032|16843786|P1|Overall Study|Poor vision|0
4888590|NCT00708032|16843785|P2|Overall Study|Pregnancy|1
4888591|NCT00708032|16843786|P1|Overall Study|Pregnancy|0
4888592|NCT00708032|16843785|P2|Overall Study|Lost to Follow-up|2
4888593|NCT00708032|16843786|P1|Overall Study|Lost to Follow-up|1
4888594|NCT00708032|16843785|P2|Overall Study|Adverse Event|2
4888595|NCT00708032|16843786|P1|Overall Study|Adverse Event|0
4888596|NCT00707993|16843813|P2|Overall Study|Other|0
4888597|NCT00707993|16843814|P1|Overall Study|Other|2
4888598|NCT00707993|16843813|P2|Overall Study|Hyperglycemic Rescue|47
4888599|NCT00707993|16843814|P1|Overall Study|Hyperglycemic Rescue|55
4888600|NCT00707993|16843813|P2|Overall Study|Withdrawal by Subject|16
4888601|NCT00707993|16843814|P1|Overall Study|Withdrawal by Subject|12
4888602|NCT00707993|16843813|P2|Overall Study|Lost to Follow-up|4
4888603|NCT00707993|16843814|P1|Overall Study|Lost to Follow-up|0
4888604|NCT00707993|16843813|P2|Overall Study|Protocol Violation|7
4888605|NCT00707993|16843814|P1|Overall Study|Protocol Violation|4
4888606|NCT00707993|16843813|P2|Overall Study|Adverse Event|20
4888607|NCT00707993|16843814|P1|Overall Study|Adverse Event|16
4888608|NCT00707980|16843856|P1|Overall Study|Other|39
4888609|NCT00707980|16843856|P1|Overall Study|Lost to Follow-up|59
4888610|NCT00707980|16843856|P1|Overall Study|Withdrawal of Consent|81
4888611|NCT00707980|16843856|P1|Overall Study|Protocol Deviations|19
4888612|NCT00707980|16843856|P1|Overall Study|Non-Compliance with Study Drug|28
4888613|NCT00707980|16843856|P1|Overall Study|Lack of Efficacy|35
4888614|NCT00707980|16843856|P1|Overall Study|Adverse Event|49
4888615|NCT00707954|16843940|P5|Overall Study|Physician Decision|1
4888616|NCT00707954|16843941|P4|Overall Study|Physician Decision|0
4888617|NCT00707954|16843942|P3|Overall Study|Physician Decision|0
4888618|NCT00707954|16843943|P2|Overall Study|Physician Decision|0
4888619|NCT00707954|16843944|P1|Overall Study|Physician Decision|0
4888620|NCT00707746|16843985|P2|Treatment Period|Ineligibility|1
4888621|NCT00707746|16843986|P1|Treatment Period|Ineligibility|0
4888622|NCT00707746|16843985|P2|Treatment Period|Adverse Event|4
4888623|NCT00707746|16843986|P1|Treatment Period|Adverse Event|2
4888624|NCT00707577|16844047|P2|Overall Study|Pregnancy|1
4888625|NCT00707577|16844048|P1|Overall Study|Pregnancy|4
4888626|NCT00707577|16844047|P2|Overall Study|Left employment|10
4888627|NCT00707577|16844048|P1|Overall Study|Left employment|13
4888628|NCT00707577|16844047|P2|Overall Study|Lost to Follow-up|25
4888629|NCT00707577|16844048|P1|Overall Study|Lost to Follow-up|34
4888630|NCT00707577|16844047|P2|Overall Study|Withdrawal by Subject|2
4888631|NCT00707577|16844048|P1|Overall Study|Withdrawal by Subject|3
4888632|NCT00707486|16844054|P1|Overall Study|Withdrawal by Subject|1
4888633|NCT00707434|16844090|P1|Overall Study|Adverse Event|1
4888634|NCT00707239|16844101|P3|Overall Study|Other|5
4888635|NCT00707239|16844102|P2|Overall Study|Other|3
4888636|NCT00707239|16844103|P1|Overall Study|Other|8
4888637|NCT00707239|16844101|P3|Overall Study|Randomized, but not treated|1
4888638|NCT00707239|16844102|P2|Overall Study|Randomized, but not treated|1
4888639|NCT00707239|16844103|P1|Overall Study|Randomized, but not treated|1
4888640|NCT00707239|16844101|P3|Overall Study|Lack of Efficacy|0
4888641|NCT00707239|16844102|P2|Overall Study|Lack of Efficacy|2
4888642|NCT00707239|16844103|P1|Overall Study|Lack of Efficacy|1
4888643|NCT00707239|16844101|P3|Overall Study|Protocol Violation|1
4888644|NCT00707239|16844102|P2|Overall Study|Protocol Violation|0
4888645|NCT00707239|16844103|P1|Overall Study|Protocol Violation|0
4888646|NCT00707239|16844101|P3|Overall Study|Physician Decision|2
4888647|NCT00707239|16844102|P2|Overall Study|Physician Decision|1
4888648|NCT00707239|16844103|P1|Overall Study|Physician Decision|1
4888649|NCT00707239|16844101|P3|Overall Study|Death|3
4888650|NCT00707239|16844102|P2|Overall Study|Death|1
4888651|NCT00707239|16844103|P1|Overall Study|Death|3
4888652|NCT00707239|16844101|P3|Overall Study|Adverse Event|2
4888653|NCT00707239|16844102|P2|Overall Study|Adverse Event|3
4888654|NCT00707239|16844103|P1|Overall Study|Adverse Event|5
4888655|NCT00707174|16844151|P2|Overall Study|Withdrawal by Subject|1
4888656|NCT00707174|16844152|P1|Overall Study|Withdrawal by Subject|4
4888657|NCT00707174|16844151|P2|Overall Study|Adverse Event|6
4888658|NCT00707174|16844152|P1|Overall Study|Adverse Event|1
4888659|NCT00707161|16844158|P1|Overall Study|Physician Decision|6
4888660|NCT00707057|16844164|P2|Overall Study|Dosed incorrectly|1
4888661|NCT00707057|16844165|P1|Overall Study|Dosed incorrectly|0
4888662|NCT00707057|16844164|P2|Overall Study|Withdrawal by Subject|3
4888663|NCT00707057|16844165|P1|Overall Study|Withdrawal by Subject|8
4888664|NCT00707031|16844199|P2|Overall Study|Sponsor Decision|8
4888665|NCT00707031|16844200|P1|Overall Study|Sponsor Decision|9
4888666|NCT00707031|16844199|P2|Overall Study|Serious Noncompliance|3
4888667|NCT00707031|16844200|P1|Overall Study|Serious Noncompliance|2
4888668|NCT00707031|16844199|P2|Overall Study|Familial or Personal Reasons|15
4888669|NCT00707031|16844200|P1|Overall Study|Familial or Personal Reasons|12
4888670|NCT00707031|16844199|P2|Overall Study|Poor Compliance to Protocol|13
4888671|NCT00707031|16844200|P1|Overall Study|Poor Compliance to Protocol|7
4888672|NCT00707031|16844199|P2|Overall Study|Withdrawal by Subject|8
4888673|NCT00707031|16844200|P1|Overall Study|Withdrawal by Subject|7
4888674|NCT00707031|16844199|P2|Overall Study|Protocol Violation|0
4888675|NCT00707031|16844200|P1|Overall Study|Protocol Violation|1
4888676|NCT00707031|16844199|P2|Overall Study|Lost to Follow-up|1
4888677|NCT00707031|16844200|P1|Overall Study|Lost to Follow-up|2
4888678|NCT00707031|16844199|P2|Overall Study|Lack of Efficacy|6
4888679|NCT00707031|16844200|P1|Overall Study|Lack of Efficacy|19
4888680|NCT00707031|16844199|P2|Overall Study|Adverse Event|45
4888681|NCT00707031|16844200|P1|Overall Study|Adverse Event|45
4888682|NCT00706992|16844229|P7|Overall Study|Disease progression before treatment|0
4888683|NCT00706992|16844230|P6|Overall Study|Disease progression before treatment|0
4888684|NCT00706992|16844231|P5|Overall Study|Disease progression before treatment|1
4888685|NCT00706992|16844232|P4|Overall Study|Disease progression before treatment|0
4888686|NCT00706992|16844233|P3|Overall Study|Disease progression before treatment|0
4888687|NCT00706992|16844234|P2|Overall Study|Disease progression before treatment|0
4888688|NCT00706992|16844235|P1|Overall Study|Disease progression before treatment|0
4888689|NCT00706992|16844229|P7|Overall Study|Study termination|3
4888690|NCT00706992|16844230|P6|Overall Study|Study termination|2
4888691|NCT00706992|16844231|P5|Overall Study|Study termination|3
4888692|NCT00706992|16844232|P4|Overall Study|Study termination|2
4888693|NCT00706992|16844233|P3|Overall Study|Study termination|6
4888694|NCT00706992|16844234|P2|Overall Study|Study termination|5
4888695|NCT00706992|16844235|P1|Overall Study|Study termination|5
4888696|NCT00706966|16844267|P1|Overall Study|Adverse Event|1
4888697|NCT00706914|16844303|P3|Overall Study|Protocol Violation|1
4888698|NCT00706914|16844304|P2|Overall Study|Protocol Violation|1
4888699|NCT00706914|16844305|P1|Overall Study|Protocol Violation|3
4888700|NCT00706914|16844303|P3|Overall Study|Adverse Event|0
4888701|NCT00706914|16844304|P2|Overall Study|Adverse Event|2
4888702|NCT00706914|16844305|P1|Overall Study|Adverse Event|2
4888703|NCT00706914|16844303|P3|Overall Study|Lost to Follow-up|0
4888704|NCT00706914|16844304|P2|Overall Study|Lost to Follow-up|0
4888705|NCT00706914|16844305|P1|Overall Study|Lost to Follow-up|1
4888706|NCT00706914|16844303|P3|Overall Study|Lack of Efficacy|0
4888707|NCT00706914|16844304|P2|Overall Study|Lack of Efficacy|1
4888708|NCT00706914|16844305|P1|Overall Study|Lack of Efficacy|0
4888709|NCT00706901|16844328|P3|Overall Study|Death|0
4888710|NCT00706901|16844329|P2|Overall Study|Death|0
4888711|NCT00706901|16844330|P1|Overall Study|Death|1
4888712|NCT00706901|16844328|P3|Overall Study|In Jail|1
4888713|NCT00706901|16844329|P2|Overall Study|In Jail|0
4888714|NCT00706901|16844330|P1|Overall Study|In Jail|1
4888715|NCT00706901|16844328|P3|Overall Study|Withdrawal by Subject|5
4888716|NCT00706901|16844329|P2|Overall Study|Withdrawal by Subject|2
4888717|NCT00706901|16844330|P1|Overall Study|Withdrawal by Subject|4
4888718|NCT00706901|16844328|P3|Overall Study|Lost to Follow-up|2
4888719|NCT00706901|16844329|P2|Overall Study|Lost to Follow-up|3
4888720|NCT00706901|16844330|P1|Overall Study|Lost to Follow-up|2
4888721|NCT00706849|16844355|P2|Follow-up Period|Protocol non-compliance|1
4888722|NCT00706849|16844356|P1|Follow-up Period|Protocol non-compliance|0
4888723|NCT00706849|16844355|P2|Follow-up Period|Withdrawal by Subject|2
4888724|NCT00706849|16844356|P1|Follow-up Period|Withdrawal by Subject|0
4888725|NCT00706849|16844355|P2|Treatment Period|Other|1
4888726|NCT00706849|16844356|P1|Treatment Period|Other|0
4888727|NCT00706849|16844355|P2|Treatment Period|Adverse Event|9
4888728|NCT00706849|16844356|P1|Treatment Period|Adverse Event|0
4888729|NCT00706797|16844434|P2|Overall Study|Other|0
4888730|NCT00706797|16844435|P1|Overall Study|Other|1
4888731|NCT00706797|16844434|P2|Overall Study|Lost to Follow-up|2
4888732|NCT00706797|16844435|P1|Overall Study|Lost to Follow-up|1
4888733|NCT00706797|16844434|P2|Overall Study|Protocol Violation|2
4888734|NCT00706797|16844435|P1|Overall Study|Protocol Violation|3
4888735|NCT00706797|16844434|P2|Overall Study|Discontinuation of study by sponsor|63
4888736|NCT00706797|16844435|P1|Overall Study|Discontinuation of study by sponsor|52
4888737|NCT00706797|16844434|P2|Overall Study|Death|0
4888738|NCT00706797|16844435|P1|Overall Study|Death|1
4888739|NCT00706797|16844434|P2|Overall Study|Withdrawal by Subject|1
4888740|NCT00706797|16844435|P1|Overall Study|Withdrawal by Subject|8
4888741|NCT00706797|16844434|P2|Overall Study|Adverse Event|3
4888742|NCT00706797|16844435|P1|Overall Study|Adverse Event|0
4888743|NCT00706797|16844434|P2|Overall Study|Lack of Efficacy|0
4888744|NCT00706797|16844435|P1|Overall Study|Lack of Efficacy|3
4888745|NCT00706706|16844504|P1|Overall Study|Study endpoint had reached|45
4888746|NCT00706706|16844504|P1|Overall Study|Lost to Follow-up|7
4888747|NCT00706706|16844504|P1|Overall Study|Death|53
4888748|NCT00706654|16844514|P4|Depot Maintenance Phase|Impending Relapse without Adverse Event|12
4888749|NCT00706654|16844515|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
4888750|NCT00706654|16844516|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|9
4888751|NCT00706654|16844517|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
4888752|NCT00706654|16844514|P4|Depot Maintenance Phase|Impending Relapse with Adverse Event|17
4888753|NCT00706654|16844515|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|12
4888754|NCT00706654|16844516|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
4888755|NCT00706654|16844517|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
4888756|NCT00706654|16844514|P4|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
4888757|NCT00706654|16844515|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|7
4888758|NCT00706654|16844516|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|8
4888759|NCT00706654|16844517|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
4888760|NCT00706654|16844514|P4|Depot Maintenance Phase|Protocol Deviation|1
4888761|NCT00706654|16844515|P3|Depot Maintenance Phase|Protocol Deviation|3
4888762|NCT00706654|16844516|P2|Depot Maintenance Phase|Protocol Deviation|2
4888763|NCT00706654|16844517|P1|Depot Maintenance Phase|Protocol Deviation|0
4888764|NCT00706654|16844514|P4|Depot Maintenance Phase|Withdrew Consent|14
4888765|NCT00706654|16844515|P3|Depot Maintenance Phase|Withdrew Consent|29
4888766|NCT00706654|16844516|P2|Depot Maintenance Phase|Withdrew Consent|21
4888767|NCT00706654|16844517|P1|Depot Maintenance Phase|Withdrew Consent|0
4888768|NCT00706654|16844514|P4|Depot Maintenance Phase|Withdrawn by Investigator|8
4888769|NCT00706654|16844515|P3|Depot Maintenance Phase|Withdrawn by Investigator|12
4888770|NCT00706654|16844516|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
4888771|NCT00706654|16844517|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
4888772|NCT00706654|16844514|P4|Depot Maintenance Phase|Met Withdrawal Criteria|5
4888773|NCT00706654|16844515|P3|Depot Maintenance Phase|Met Withdrawal Criteria|6
4888774|NCT00706654|16844516|P2|Depot Maintenance Phase|Met Withdrawal Criteria|4
4888775|NCT00706654|16844517|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
4888776|NCT00706654|16844514|P4|Depot Maintenance Phase|Lost to Follow-up|6
4888777|NCT00706654|16844515|P3|Depot Maintenance Phase|Lost to Follow-up|10
4888778|NCT00706654|16844516|P2|Depot Maintenance Phase|Lost to Follow-up|4
4888779|NCT00706654|16844517|P1|Depot Maintenance Phase|Lost to Follow-up|0
4888780|NCT00706654|16844514|P4|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4888781|NCT00706654|16844515|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4888782|NCT00706654|16844516|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4888783|NCT00706654|16844517|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10
4888784|NCT00706654|16844514|P4|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4888785|NCT00706654|16844515|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4888786|NCT00706654|16844516|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4888787|NCT00706654|16844517|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20
4888788|NCT00706654|16844514|P4|Oral Stabilization Phase|Adverse Event|0
4888789|NCT00706654|16844515|P3|Oral Stabilization Phase|Adverse Event|0
4888790|NCT00706654|16844516|P2|Oral Stabilization Phase|Adverse Event|0
4888791|NCT00706654|16844517|P1|Oral Stabilization Phase|Adverse Event|21
4888792|NCT00706654|16844514|P4|Oral Stabilization Phase|Protocol Deviation|0
4888793|NCT00706654|16844515|P3|Oral Stabilization Phase|Protocol Deviation|0
4888794|NCT00706654|16844516|P2|Oral Stabilization Phase|Protocol Deviation|0
4888795|NCT00706654|16844517|P1|Oral Stabilization Phase|Protocol Deviation|2
4888796|NCT00706654|16844514|P4|Oral Stabilization Phase|Withdrew consent|0
4888797|NCT00706654|16844515|P3|Oral Stabilization Phase|Withdrew consent|0
4888798|NCT00706654|16844516|P2|Oral Stabilization Phase|Withdrew consent|0
4888799|NCT00706654|16844517|P1|Oral Stabilization Phase|Withdrew consent|55
4888800|NCT00706654|16844514|P4|Oral Stabilization Phase|Withdrawn by Investigator|0
4888801|NCT00706654|16844515|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
4888802|NCT00706654|16844516|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
4888803|NCT00706654|16844517|P1|Oral Stabilization Phase|Withdrawn by Investigator|21
4888804|NCT00706654|16844514|P4|Oral Stabilization Phase|Met Withdrawal Criteria|0
4888805|NCT00706654|16844515|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
4888806|NCT00706654|16844516|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
4888807|NCT00706654|16844517|P1|Oral Stabilization Phase|Met Withdrawal Criteria|15
4888808|NCT00706654|16844514|P4|Oral Stabilization Phase|Sponsor Discontinue Trial|0
4888809|NCT00706654|16844515|P3|Oral Stabilization Phase|Sponsor Discontinue Trial|0
4888810|NCT00706654|16844516|P2|Oral Stabilization Phase|Sponsor Discontinue Trial|0
4888811|NCT00706654|16844517|P1|Oral Stabilization Phase|Sponsor Discontinue Trial|19
4888812|NCT00706654|16844514|P4|Oral Stabilization Phase|Lost to Follow-up|0
4888813|NCT00706654|16844515|P3|Oral Stabilization Phase|Lost to Follow-up|0
4888814|NCT00706654|16844516|P2|Oral Stabilization Phase|Lost to Follow-up|0
4888815|NCT00706654|16844517|P1|Oral Stabilization Phase|Lost to Follow-up|17
4888816|NCT00706654|16844514|P4|Conversion Phase|Lack of Efficacy without Adverse Event|0
4888817|NCT00706654|16844515|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
4888818|NCT00706654|16844516|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
4888819|NCT00706654|16844517|P1|Conversion Phase|Lack of Efficacy without Adverse Event|2
4888820|NCT00706654|16844514|P4|Conversion Phase|Lack of Efficacy with Adverse Event|0
4888821|NCT00706654|16844515|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
4888822|NCT00706654|16844516|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
4888823|NCT00706654|16844517|P1|Conversion Phase|Lack of Efficacy with Adverse Event|9
4888824|NCT00706654|16844514|P4|Conversion Phase|Adverse Event|0
4888825|NCT00706654|16844515|P3|Conversion Phase|Adverse Event|0
4888826|NCT00706654|16844516|P2|Conversion Phase|Adverse Event|0
4888827|NCT00706654|16844517|P1|Conversion Phase|Adverse Event|18
4888828|NCT00706654|16844514|P4|Conversion Phase|Withdrew Consent|0
4888829|NCT00706654|16844515|P3|Conversion Phase|Withdrew Consent|0
4888830|NCT00706654|16844516|P2|Conversion Phase|Withdrew Consent|0
4888831|NCT00706654|16844517|P1|Conversion Phase|Withdrew Consent|38
4888832|NCT00706654|16844514|P4|Conversion Phase|Withdrawn by Investigator|0
4888833|NCT00706654|16844515|P3|Conversion Phase|Withdrawn by Investigator|0
4888834|NCT00706654|16844516|P2|Conversion Phase|Withdrawn by Investigator|0
4888835|NCT00706654|16844517|P1|Conversion Phase|Withdrawn by Investigator|14
4888836|NCT00706654|16844514|P4|Conversion Phase|Met Withdrawal Criteria|0
4888837|NCT00706654|16844515|P3|Conversion Phase|Met Withdrawal Criteria|0
4888838|NCT00706654|16844516|P2|Conversion Phase|Met Withdrawal Criteria|0
4888839|NCT00706654|16844517|P1|Conversion Phase|Met Withdrawal Criteria|2
4888840|NCT00706654|16844514|P4|Conversion Phase|Sponsor Discontinued Trial|0
4888841|NCT00706654|16844515|P3|Conversion Phase|Sponsor Discontinued Trial|0
4888842|NCT00706654|16844516|P2|Conversion Phase|Sponsor Discontinued Trial|0
4888843|NCT00706654|16844517|P1|Conversion Phase|Sponsor Discontinued Trial|8
4888844|NCT00706654|16844514|P4|Conversion Phase|Lost to Follow-up|0
4888845|NCT00706654|16844515|P3|Conversion Phase|Lost to Follow-up|0
4888846|NCT00706654|16844516|P2|Conversion Phase|Lost to Follow-up|0
4888847|NCT00706654|16844517|P1|Conversion Phase|Lost to Follow-up|4
4888848|NCT00706641|16844536|P1|Radical Cystectomy|Deemed unresectable upon exploration|1
4888849|NCT00706641|16844536|P1|Dasatinib Administration|Ineligible after start of therapy|1
4888850|NCT00706641|16844536|P1|Dasatinib Administration|Withdrawal by Subject|1
4888851|NCT00706628|16844550|P4|Overall Study|Not treated|0
4888852|NCT00706628|16844551|P3|Overall Study|Not treated|0
4888853|NCT00706628|16844552|P2|Overall Study|Not treated|1
4888854|NCT00706628|16844553|P1|Overall Study|Not treated|1
4888855|NCT00706628|16844550|P4|Overall Study|Other than those stated above|0
4888856|NCT00706628|16844551|P3|Overall Study|Other than those stated above|0
4888857|NCT00706628|16844552|P2|Overall Study|Other than those stated above|0
4888858|NCT00706628|16844553|P1|Overall Study|Other than those stated above|4
4888859|NCT00706628|16844550|P4|Overall Study|Progressive disease|1
4888860|NCT00706628|16844551|P3|Overall Study|Progressive disease|8
4888861|NCT00706628|16844552|P2|Overall Study|Progressive disease|13
4888862|NCT00706628|16844553|P1|Overall Study|Progressive disease|20
4888863|NCT00706628|16844550|P4|Overall Study|Consent withdrawn|0
4888864|NCT00706628|16844551|P3|Overall Study|Consent withdrawn|3
4888865|NCT00706628|16844552|P2|Overall Study|Consent withdrawn|1
4888866|NCT00706628|16844553|P1|Overall Study|Consent withdrawn|6
4888867|NCT00706628|16844550|P4|Overall Study|Non compliant with protocol|0
4888868|NCT00706628|16844551|P3|Overall Study|Non compliant with protocol|0
4888869|NCT00706628|16844552|P2|Overall Study|Non compliant with protocol|1
4888870|NCT00706628|16844553|P1|Overall Study|Non compliant with protocol|0
4888871|NCT00706628|16844550|P4|Overall Study|Other Adverse Event|2
4888872|NCT00706628|16844551|P3|Overall Study|Other Adverse Event|5
4888873|NCT00706628|16844552|P2|Overall Study|Other Adverse Event|5
4888874|NCT00706628|16844553|P1|Overall Study|Other Adverse Event|16
4888875|NCT00706511|16844658|P4|Overall Study|Withdrawal by Subject|0
4888876|NCT00706511|16844659|P3|Overall Study|Withdrawal by Subject|0
4888877|NCT00706511|16844660|P2|Overall Study|Withdrawal by Subject|0
4888878|NCT00706511|16844661|P1|Overall Study|Withdrawal by Subject|1
4888879|NCT00706433|16844752|P4|Overall Study|new job|1
4888880|NCT00706433|16844753|P3|Overall Study|new job|0
4888881|NCT00706433|16844754|P2|Overall Study|new job|0
4888882|NCT00706433|16844755|P1|Overall Study|new job|0
4888883|NCT00706433|16844752|P4|Overall Study|Protocol Violation|0
4888884|NCT00706433|16844753|P3|Overall Study|Protocol Violation|0
4888885|NCT00706433|16844754|P2|Overall Study|Protocol Violation|0
4888886|NCT00706433|16844755|P1|Overall Study|Protocol Violation|1
4888887|NCT00706433|16844752|P4|Overall Study|Adverse Event|0
4888888|NCT00706433|16844753|P3|Overall Study|Adverse Event|1
4888889|NCT00706433|16844754|P2|Overall Study|Adverse Event|0
4888890|NCT00706433|16844755|P1|Overall Study|Adverse Event|0
4888891|NCT00706433|16844752|P4|Overall Study|Withdrawal by Subject|1
4888892|NCT00706433|16844753|P3|Overall Study|Withdrawal by Subject|3
4888893|NCT00706433|16844754|P2|Overall Study|Withdrawal by Subject|2
4888894|NCT00706433|16844755|P1|Overall Study|Withdrawal by Subject|1
4888895|NCT00706433|16844752|P4|Overall Study|Lost to Follow-up|0
4888896|NCT00706433|16844753|P3|Overall Study|Lost to Follow-up|6
4888897|NCT00706433|16844754|P2|Overall Study|Lost to Follow-up|1
4888898|NCT00706433|16844755|P1|Overall Study|Lost to Follow-up|3
4888899|NCT00706381|16845082|P4|Overall Study|Lost to Follow-up|0
4888900|NCT00706381|16845083|P3|Overall Study|Lost to Follow-up|1
4888901|NCT00706381|16845084|P2|Overall Study|Lost to Follow-up|1
4888902|NCT00706381|16845085|P1|Overall Study|Lost to Follow-up|0
4888903|NCT00706355|16845106|P4|Period 4: PF-04217903 150 mg|Objective progression or relapse|2
4888904|NCT00706355|16845107|P3|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
4888905|NCT00706355|16845108|P2|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
4888906|NCT00706355|16845109|P1|Period 4: PF-04217903 150 mg|Objective progression or relapse|0
4888907|NCT00706355|16845106|P4|Period 4: PF-04217903 150 mg|Adverse Event|2
4888908|NCT00706355|16845107|P3|Period 4: PF-04217903 150 mg|Adverse Event|0
4888909|NCT00706355|16845108|P2|Period 4: PF-04217903 150 mg|Adverse Event|0
4888910|NCT00706355|16845109|P1|Period 4: PF-04217903 150 mg|Adverse Event|0
4888911|NCT00706355|16845106|P4|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
4888912|NCT00706355|16845107|P3|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1
4888913|NCT00706355|16845108|P2|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
4888914|NCT00706355|16845109|P1|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0
4888915|NCT00706355|16845106|P4|Period 3: PF-04217903 200 mg|Adverse Event|0
4888916|NCT00706355|16845107|P3|Period 3: PF-04217903 200 mg|Adverse Event|1
4888917|NCT00706355|16845108|P2|Period 3: PF-04217903 200 mg|Adverse Event|0
4888918|NCT00706355|16845109|P1|Period 3: PF-04217903 200 mg|Adverse Event|0
4888919|NCT00706355|16845106|P4|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
4888920|NCT00706355|16845107|P3|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
4888921|NCT00706355|16845108|P2|Period 2: PF-04217903 100 mg|Objective progression or relapse|5
4888922|NCT00706355|16845109|P1|Period 2: PF-04217903 100 mg|Objective progression or relapse|0
4888923|NCT00706355|16845106|P4|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
4888924|NCT00706355|16845107|P3|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
4888925|NCT00706355|16845108|P2|Period 2: PF-04217903 100 mg|Global deterioration of health status|1
4888926|NCT00706355|16845109|P1|Period 2: PF-04217903 100 mg|Global deterioration of health status|0
4888927|NCT00706355|16845106|P4|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
4888928|NCT00706355|16845107|P3|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
4888929|NCT00706355|16845108|P2|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1
4888930|NCT00706355|16845109|P1|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0
4888931|NCT00706355|16845106|P4|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
4888932|NCT00706355|16845107|P3|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
4888933|NCT00706355|16845108|P2|Period 1: PF-04217903 50 mg|Objective progression or relapse|0
4888934|NCT00706355|16845109|P1|Period 1: PF-04217903 50 mg|Objective progression or relapse|2
4888935|NCT00706355|16845106|P4|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
4888936|NCT00706355|16845107|P3|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
4888937|NCT00706355|16845108|P2|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0
4888938|NCT00706355|16845109|P1|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1
4888939|NCT00706342|16845161|P1|Overall Study|WIthdrawal of consent|1
4888940|NCT00706342|16845161|P1|Overall Study|Ongoing|6
4888941|NCT00706342|16845161|P1|Overall Study|Non-responder Week 12|1
4888942|NCT00706342|16845161|P1|Overall Study|Investigator discretion|2
4888943|NCT00706342|16845161|P1|Overall Study|Withdrew from the study on his own.|1
4888944|NCT00706342|16845161|P1|Overall Study|Death|1
4888945|NCT00706342|16845161|P1|Overall Study|Withdrawn due to failure to respond|1
4888946|NCT00706342|16845161|P1|Overall Study|Not responding to treatment|2
4888947|NCT00706342|16845161|P1|Overall Study|Adverse Event|3
4888948|NCT00706238|16845174|P1|Overall Study|Other|1
4888949|NCT00706238|16845174|P1|Overall Study|Disease progression|4
4888950|NCT00706134|16845191|P4|Overall Study|Did not meet study criteria|0
4888951|NCT00706134|16845192|P3|Overall Study|Did not meet study criteria|0
4888952|NCT00706134|16845193|P2|Overall Study|Did not meet study criteria|0
4888953|NCT00706134|16845194|P1|Overall Study|Did not meet study criteria|2
4888954|NCT00706134|16845191|P4|Overall Study|Unsatisfactory therapeutic effect|5
4888955|NCT00706134|16845192|P3|Overall Study|Unsatisfactory therapeutic effect|3
4888956|NCT00706134|16845193|P2|Overall Study|Unsatisfactory therapeutic effect|3
4888957|NCT00706134|16845194|P1|Overall Study|Unsatisfactory therapeutic effect|9
4888958|NCT00706134|16845191|P4|Overall Study|Withdrawal by Subject|0
4888959|NCT00706134|16845192|P3|Overall Study|Withdrawal by Subject|1
4888960|NCT00706134|16845193|P2|Overall Study|Withdrawal by Subject|2
4888961|NCT00706134|16845194|P1|Overall Study|Withdrawal by Subject|1
4888962|NCT00706134|16845191|P4|Overall Study|Protocol Violation|3
4888963|NCT00706134|16845192|P3|Overall Study|Protocol Violation|0
4888964|NCT00706134|16845193|P2|Overall Study|Protocol Violation|6
4888965|NCT00706134|16845194|P1|Overall Study|Protocol Violation|0
4888966|NCT00706134|16845191|P4|Overall Study|Lost to Follow-up|0
4888967|NCT00706134|16845192|P3|Overall Study|Lost to Follow-up|0
4888968|NCT00706134|16845193|P2|Overall Study|Lost to Follow-up|1
4888969|NCT00706134|16845194|P1|Overall Study|Lost to Follow-up|0
4888970|NCT00706134|16845191|P4|Overall Study|Adverse Event|3
4888971|NCT00706134|16845192|P3|Overall Study|Adverse Event|2
4888972|NCT00706134|16845193|P2|Overall Study|Adverse Event|7
4888973|NCT00706134|16845194|P1|Overall Study|Adverse Event|8
4888974|NCT00706095|16845260|P3|Overall Study|Withdrawal by Subject|0
4888975|NCT00706095|16845261|P2|Overall Study|Withdrawal by Subject|0
4888976|NCT00706095|16845262|P1|Overall Study|Withdrawal by Subject|1
4888977|NCT00706095|16845260|P3|Overall Study|Clinical Progression|2
4888978|NCT00706095|16845261|P2|Overall Study|Clinical Progression|2
4888979|NCT00706095|16845262|P1|Overall Study|Clinical Progression|1
4888980|NCT00706095|16845260|P3|Overall Study|Progressive Disease|3
4888981|NCT00706095|16845261|P2|Overall Study|Progressive Disease|5
4888982|NCT00706095|16845262|P1|Overall Study|Progressive Disease|4
4888983|NCT00706030|16845280|P4|Overall Study|Death|0
4888984|NCT00706030|16845281|P3|Overall Study|Death|1
4888985|NCT00706030|16845282|P2|Overall Study|Death|0
4888986|NCT00706030|16845283|P1|Overall Study|Death|0
4888987|NCT00706030|16845280|P4|Overall Study|No treatment received|1
4888988|NCT00706030|16845281|P3|Overall Study|No treatment received|0
4888989|NCT00706030|16845282|P2|Overall Study|No treatment received|0
4888990|NCT00706030|16845283|P1|Overall Study|No treatment received|0
4888991|NCT00706030|16845280|P4|Overall Study|Symptomatic Deterioration|0
4888992|NCT00706030|16845281|P3|Overall Study|Symptomatic Deterioration|1
4888993|NCT00706030|16845282|P2|Overall Study|Symptomatic Deterioration|0
4888994|NCT00706030|16845283|P1|Overall Study|Symptomatic Deterioration|0
4888995|NCT00706030|16845280|P4|Overall Study|Failed to return|0
4888996|NCT00706030|16845281|P3|Overall Study|Failed to return|1
4888997|NCT00706030|16845282|P2|Overall Study|Failed to return|0
4888998|NCT00706030|16845283|P1|Overall Study|Failed to return|0
4888999|NCT00706030|16845280|P4|Overall Study|Protocol Violation|1
4889000|NCT00706030|16845281|P3|Overall Study|Protocol Violation|1
4889001|NCT00706030|16845282|P2|Overall Study|Protocol Violation|0
4889002|NCT00706030|16845283|P1|Overall Study|Protocol Violation|0
4889003|NCT00706030|16845280|P4|Overall Study|Not recorded|0
4889004|NCT00706030|16845281|P3|Overall Study|Not recorded|2
4889005|NCT00706030|16845282|P2|Overall Study|Not recorded|0
4889006|NCT00706030|16845283|P1|Overall Study|Not recorded|0
4889007|NCT00706030|16845280|P4|Overall Study|Physician Decision|0
4889008|NCT00706030|16845281|P3|Overall Study|Physician Decision|2
4889009|NCT00706030|16845282|P2|Overall Study|Physician Decision|0
4889010|NCT00706030|16845283|P1|Overall Study|Physician Decision|0
4889011|NCT00706030|16845280|P4|Overall Study|Withdrawal by Subject|0
4889012|NCT00706030|16845281|P3|Overall Study|Withdrawal by Subject|2
4889013|NCT00706030|16845282|P2|Overall Study|Withdrawal by Subject|0
4889014|NCT00706030|16845283|P1|Overall Study|Withdrawal by Subject|1
4889015|NCT00706030|16845280|P4|Overall Study|Adverse Event|2
4889016|NCT00706030|16845281|P3|Overall Study|Adverse Event|4
4889017|NCT00706030|16845282|P2|Overall Study|Adverse Event|0
4889018|NCT00706030|16845283|P1|Overall Study|Adverse Event|1
4889019|NCT00706030|16845280|P4|Overall Study|Disease Progression|12
4889020|NCT00706030|16845281|P3|Overall Study|Disease Progression|46
4889021|NCT00706030|16845282|P2|Overall Study|Disease Progression|6
4889022|NCT00706030|16845283|P1|Overall Study|Disease Progression|4
4889023|NCT00706004|16845298|P1|Overall Study|Did not meet eligibility criteria|2
4889024|NCT00705939|16845326|P3|Overall Study|Physician Decision|0
4889025|NCT00705939|16845327|P2|Overall Study|Physician Decision|1
4889026|NCT00705939|16845328|P1|Overall Study|Physician Decision|0
4889027|NCT00705939|16845326|P3|Overall Study|Withdrawal by Subject|3
4889028|NCT00705939|16845327|P2|Overall Study|Withdrawal by Subject|1
4889029|NCT00705939|16845328|P1|Overall Study|Withdrawal by Subject|0
4889030|NCT00705939|16845326|P3|Overall Study|Protocol Violation|1
4889031|NCT00705939|16845327|P2|Overall Study|Protocol Violation|0
4889032|NCT00705939|16845328|P1|Overall Study|Protocol Violation|0
4889033|NCT00705783|16845382|P3|Depot Maintenance Phase|Impending Relapse without Adverse Event|40
4889034|NCT00705783|16845383|P2|Depot Maintenance Phase|Impending Relapse without Adverse Event|16
4889035|NCT00705783|16845384|P1|Depot Maintenance Phase|Impending Relapse without Adverse Event|0
4889036|NCT00705783|16845382|P3|Depot Maintenance Phase|Impending Relapse with Adverse Event|13
4889037|NCT00705783|16845383|P2|Depot Maintenance Phase|Impending Relapse with Adverse Event|11
4889038|NCT00705783|16845384|P1|Depot Maintenance Phase|Impending Relapse with Adverse Event|0
4889039|NCT00705783|16845382|P3|Depot Maintenance Phase|Adverse Event without Impending Relapse|5
4889040|NCT00705783|16845383|P2|Depot Maintenance Phase|Adverse Event without Impending Relapse|9
4889041|NCT00705783|16845384|P1|Depot Maintenance Phase|Adverse Event without Impending Relapse|0
4889042|NCT00705783|16845382|P3|Depot Maintenance Phase|Protocol Deviation|0
4889043|NCT00705783|16845383|P2|Depot Maintenance Phase|Protocol Deviation|2
4889044|NCT00705783|16845384|P1|Depot Maintenance Phase|Protocol Deviation|0
4889045|NCT00705783|16845382|P3|Depot Maintenance Phase|Withdrew Consent|4
4889046|NCT00705783|16845383|P2|Depot Maintenance Phase|Withdrew Consent|14
4889047|NCT00705783|16845384|P1|Depot Maintenance Phase|Withdrew Consent|0
4889048|NCT00705783|16845382|P3|Depot Maintenance Phase|Withdrawn by Investigator|6
4889049|NCT00705783|16845383|P2|Depot Maintenance Phase|Withdrawn by Investigator|8
4889050|NCT00705783|16845384|P1|Depot Maintenance Phase|Withdrawn by Investigator|0
4889051|NCT00705783|16845382|P3|Depot Maintenance Phase|Met Withdrawal Criteria|2
4889052|NCT00705783|16845383|P2|Depot Maintenance Phase|Met Withdrawal Criteria|2
4889053|NCT00705783|16845384|P1|Depot Maintenance Phase|Met Withdrawal Criteria|0
4889054|NCT00705783|16845382|P3|Depot Maintenance Phase|Lost to Follow-up|3
4889055|NCT00705783|16845383|P2|Depot Maintenance Phase|Lost to Follow-up|5
4889056|NCT00705783|16845384|P1|Depot Maintenance Phase|Lost to Follow-up|0
4889057|NCT00705783|16845382|P3|Depot Maintenance Phase|Sponsor Discontinued Study|58
4889058|NCT00705783|16845383|P2|Depot Maintenance Phase|Sponsor Discontinued Study|179
4889059|NCT00705783|16845384|P1|Depot Maintenance Phase|Sponsor Discontinued Study|0
4889060|NCT00705783|16845382|P3|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
4889061|NCT00705783|16845383|P2|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0
4889062|NCT00705783|16845384|P1|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1
4889063|NCT00705783|16845382|P3|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
4889064|NCT00705783|16845383|P2|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0
4889065|NCT00705783|16845384|P1|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12
4889066|NCT00705783|16845382|P3|Depot Stabilization Phase|Adverse Event|0
4889067|NCT00705783|16845383|P2|Depot Stabilization Phase|Adverse Event|0
4889068|NCT00705783|16845384|P1|Depot Stabilization Phase|Adverse Event|17
4889069|NCT00705783|16845382|P3|Depot Stabilization Phase|Withdrew Consent|0
4889070|NCT00705783|16845383|P2|Depot Stabilization Phase|Withdrew Consent|0
4889071|NCT00705783|16845384|P1|Depot Stabilization Phase|Withdrew Consent|29
4889072|NCT00705783|16845382|P3|Depot Stabilization Phase|Withdrawn by Investigator|0
4889073|NCT00705783|16845383|P2|Depot Stabilization Phase|Withdrawn by Investigator|0
4889074|NCT00705783|16845384|P1|Depot Stabilization Phase|Withdrawn by Investigator|9
4889075|NCT00705783|16845382|P3|Depot Stabilization Phase|Met Withdrawal Criteria|0
4889076|NCT00705783|16845383|P2|Depot Stabilization Phase|Met Withdrawal Criteria|0
4889077|NCT00705783|16845384|P1|Depot Stabilization Phase|Met Withdrawal Criteria|8
4889078|NCT00705783|16845382|P3|Depot Stabilization Phase|Lost to Follow-up|0
4889079|NCT00705783|16845383|P2|Depot Stabilization Phase|Lost to Follow-up|0
4889080|NCT00705783|16845384|P1|Depot Stabilization Phase|Lost to Follow-up|11
4889081|NCT00705783|16845382|P3|Depot Stabilization Phase|Sponsor Discontinued Study|0
4889082|NCT00705783|16845383|P2|Depot Stabilization Phase|Sponsor Discontinued Study|0
4889083|NCT00705783|16845384|P1|Depot Stabilization Phase|Sponsor Discontinued Study|86
4889084|NCT00705783|16845382|P3|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4889085|NCT00705783|16845383|P2|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0
4889086|NCT00705783|16845384|P1|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4
4889087|NCT00705783|16845382|P3|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4889088|NCT00705783|16845383|P2|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0
4889089|NCT00705783|16845384|P1|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7
4889090|NCT00705783|16845382|P3|Oral Stabilization Phase|Adverse Event|0
4889091|NCT00705783|16845383|P2|Oral Stabilization Phase|Adverse Event|0
4889092|NCT00705783|16845384|P1|Oral Stabilization Phase|Adverse Event|14
4889093|NCT00705783|16845382|P3|Oral Stabilization Phase|Withdrew Consent|0
4889094|NCT00705783|16845383|P2|Oral Stabilization Phase|Withdrew Consent|0
4889095|NCT00705783|16845384|P1|Oral Stabilization Phase|Withdrew Consent|29
4889096|NCT00705783|16845382|P3|Oral Stabilization Phase|Withdrawn by Investigator|0
4889097|NCT00705783|16845383|P2|Oral Stabilization Phase|Withdrawn by Investigator|0
4889098|NCT00705783|16845384|P1|Oral Stabilization Phase|Withdrawn by Investigator|12
4889099|NCT00705783|16845382|P3|Oral Stabilization Phase|Met Withdrawal Criteria|0
4889100|NCT00705783|16845383|P2|Oral Stabilization Phase|Met Withdrawal Criteria|0
4889101|NCT00705783|16845384|P1|Oral Stabilization Phase|Met Withdrawal Criteria|19
4889102|NCT00705783|16845382|P3|Oral Stabilization Phase|Lost to Follow-up|0
4889103|NCT00705783|16845383|P2|Oral Stabilization Phase|Lost to Follow-up|0
4889104|NCT00705783|16845384|P1|Oral Stabilization Phase|Lost to Follow-up|7
4889105|NCT00705783|16845382|P3|Oral Stabilization Phase|Sponsor Discontinue Study|0
4889106|NCT00705783|16845383|P2|Oral Stabilization Phase|Sponsor Discontinue Study|0
4889107|NCT00705783|16845384|P1|Oral Stabilization Phase|Sponsor Discontinue Study|42
4889108|NCT00705783|16845382|P3|Conversion Phase|Lack of Efficacy without Adverse Event|0
4889109|NCT00705783|16845383|P2|Conversion Phase|Lack of Efficacy without Adverse Event|0
4889110|NCT00705783|16845384|P1|Conversion Phase|Lack of Efficacy without Adverse Event|8
4889111|NCT00705783|16845382|P3|Conversion Phase|Lack of Efficacy with Adverse Event|0
4889112|NCT00705783|16845383|P2|Conversion Phase|Lack of Efficacy with Adverse Event|0
4889113|NCT00705783|16845384|P1|Conversion Phase|Lack of Efficacy with Adverse Event|13
4889114|NCT00705783|16845382|P3|Conversion Phase|Adverse Event|0
4889115|NCT00705783|16845383|P2|Conversion Phase|Adverse Event|0
4889116|NCT00705783|16845384|P1|Conversion Phase|Adverse Event|11
4889117|NCT00705783|16845382|P3|Conversion Phase|Protocol Deviation|0
4889118|NCT00705783|16845383|P2|Conversion Phase|Protocol Deviation|0
4889119|NCT00705783|16845384|P1|Conversion Phase|Protocol Deviation|2
4889120|NCT00705783|16845382|P3|Conversion Phase|Withdrew Consent|0
4889121|NCT00705783|16845383|P2|Conversion Phase|Withdrew Consent|0
4889122|NCT00705783|16845384|P1|Conversion Phase|Withdrew Consent|24
4889123|NCT00705783|16845382|P3|Conversion Phase|Withdrawn by Investigator|0
4889124|NCT00705783|16845383|P2|Conversion Phase|Withdrawn by Investigator|0
4889125|NCT00705783|16845384|P1|Conversion Phase|Withdrawn by Investigator|4
4889126|NCT00705783|16845382|P3|Conversion Phase|Met Withdrawal Criteria|0
4889127|NCT00705783|16845383|P2|Conversion Phase|Met Withdrawal Criteria|0
4889128|NCT00705783|16845384|P1|Conversion Phase|Met Withdrawal Criteria|4
4889129|NCT00705783|16845382|P3|Conversion Phase|Lost to Follow-up|0
4889130|NCT00705783|16845383|P2|Conversion Phase|Lost to Follow-up|0
4889131|NCT00705783|16845384|P1|Conversion Phase|Lost to Follow-up|13
4889132|NCT00705783|16845382|P3|Conversion Phase|Sponsor Discontinued Study|0
4889133|NCT00705783|16845383|P2|Conversion Phase|Sponsor Discontinued Study|0
4889134|NCT00705783|16845384|P1|Conversion Phase|Sponsor Discontinued Study|54
4889135|NCT00705757|16845414|P3|Overall Study|Withdrawal by Subject|2
4889136|NCT00705757|16845415|P2|Overall Study|Withdrawal by Subject|1
4889137|NCT00705757|16845416|P1|Overall Study|Withdrawal by Subject|1
4889138|NCT00705757|16845414|P3|Overall Study|Lost to Follow-up|6
4889139|NCT00705757|16845415|P2|Overall Study|Lost to Follow-up|6
4889140|NCT00705757|16845416|P1|Overall Study|Lost to Follow-up|7
4889141|NCT00705757|16845414|P3|Overall Study|Lack of Efficacy|3
4889142|NCT00705757|16845415|P2|Overall Study|Lack of Efficacy|1
4889143|NCT00705757|16845416|P1|Overall Study|Lack of Efficacy|5
4889144|NCT00705718|16845426|P2|Overall Study|Follow up not done|4
4889145|NCT00705718|16845427|P1|Overall Study|Follow up not done|1
4889146|NCT00705718|16845426|P2|Overall Study|Not due for Visit|12
4889147|NCT00705718|16845427|P1|Overall Study|Not due for Visit|0
4889148|NCT00705718|16845426|P2|Overall Study|Death|6
4889149|NCT00705718|16845427|P1|Overall Study|Death|6
4889150|NCT00705679|16845448|P5|Overall Study|Withdrawal by Subject|33
4889151|NCT00705679|16845449|P4|Overall Study|Withdrawal by Subject|47
4889152|NCT00705679|16845450|P3|Overall Study|Withdrawal by Subject|68
4889153|NCT00705679|16845451|P2|Overall Study|Withdrawal by Subject|77
4889154|NCT00705679|16845452|P1|Overall Study|Withdrawal by Subject|32
4889155|NCT00705679|16845448|P5|Overall Study|Physician Decision|0
4889156|NCT00705679|16845449|P4|Overall Study|Physician Decision|1
4889157|NCT00705679|16845450|P3|Overall Study|Physician Decision|0
4889158|NCT00705679|16845451|P2|Overall Study|Physician Decision|1
4889159|NCT00705679|16845452|P1|Overall Study|Physician Decision|0
4889160|NCT00705679|16845448|P5|Overall Study|Lost to Follow-up|35
4889161|NCT00705679|16845449|P4|Overall Study|Lost to Follow-up|30
4889162|NCT00705679|16845450|P3|Overall Study|Lost to Follow-up|44
4889163|NCT00705679|16845451|P2|Overall Study|Lost to Follow-up|60
4889164|NCT00705679|16845452|P1|Overall Study|Lost to Follow-up|32
4889165|NCT00705679|16845448|P5|Overall Study|Death|1
4889166|NCT00705679|16845449|P4|Overall Study|Death|2
4889167|NCT00705679|16845450|P3|Overall Study|Death|3
4889168|NCT00705679|16845451|P2|Overall Study|Death|0
4889169|NCT00705679|16845452|P1|Overall Study|Death|0
4889170|NCT00705679|16845448|P5|Overall Study|Adverse Event|0
4889171|NCT00705679|16845449|P4|Overall Study|Adverse Event|0
4889172|NCT00705679|16845450|P3|Overall Study|Adverse Event|0
4889173|NCT00705679|16845451|P2|Overall Study|Adverse Event|1
4889174|NCT00705679|16845452|P1|Overall Study|Adverse Event|1
4889175|NCT00705666|16845487|P1|Overall Study|Untreated|5
4889176|NCT00705666|16845487|P1|Overall Study|Lack of data|3
4889177|NCT00705666|16845487|P1|Overall Study|Other|2
4889178|NCT00705666|16845487|P1|Overall Study|Other|12
4889179|NCT00705666|16845487|P1|Overall Study|Adverse Event|4
4889180|NCT00705666|16845487|P1|Overall Study|Death|1
4889181|NCT00705666|16845487|P1|Overall Study|Lost to Follow-up|5
4889182|NCT00705666|16845487|P1|Overall Study|Physician Decision|7
4889183|NCT00705666|16845487|P1|Overall Study|Withdrawal by Subject|21
4889184|NCT00705666|16845487|P1|Overall Study|No post-treatment questionnaire|279
4889185|NCT00705614|16845498|P2|Switch to Remicade|Administrative Reason|9
4889186|NCT00705614|16845499|P1|Switch to Remicade|Administrative Reason|0
4889187|NCT00705614|16845498|P2|Switch to Remicade|Withdrawal by Subject|12
4889188|NCT00705614|16845499|P1|Switch to Remicade|Withdrawal by Subject|0
4889189|NCT00705614|16845498|P2|Switch to Remicade|Lost to Follow-up|23
4889190|NCT00705614|16845499|P1|Switch to Remicade|Lost to Follow-up|0
4889191|NCT00705614|16845498|P2|Switch to Remicade|Adverse Event|5
4889192|NCT00705614|16845499|P1|Switch to Remicade|Adverse Event|0
4889193|NCT00705614|16845498|P2|Initial Intervention|Status completion unknown|0
4889194|NCT00705614|16845499|P1|Initial Intervention|Status completion unknown|3
4889195|NCT00705614|16845498|P2|Initial Intervention|Administrative Reason|38
4889196|NCT00705614|16845499|P1|Initial Intervention|Administrative Reason|51
4889197|NCT00705614|16845498|P2|Initial Intervention|Withdrawal by Subject|71
4889198|NCT00705614|16845499|P1|Initial Intervention|Withdrawal by Subject|114
4889199|NCT00705614|16845498|P2|Initial Intervention|Lost to Follow-up|191
4889200|NCT00705614|16845499|P1|Initial Intervention|Lost to Follow-up|310
4889201|NCT00705614|16845498|P2|Initial Intervention|Adverse Event|21
4889202|NCT00705614|16845499|P1|Initial Intervention|Adverse Event|40
4889203|NCT00705575|16845548|P2|Overall Study|Withdrawal by Subject|10
4889204|NCT00705575|16845549|P1|Overall Study|Withdrawal by Subject|5
4889205|NCT00705575|16845548|P2|Overall Study|Protocol Violation|2
4889206|NCT00705575|16845549|P1|Overall Study|Protocol Violation|2
4889207|NCT00705575|16845548|P2|Overall Study|Lost to Follow-up|4
4889208|NCT00705575|16845549|P1|Overall Study|Lost to Follow-up|3
4889209|NCT00705575|16845548|P2|Overall Study|Adverse Event|15
4889210|NCT00705575|16845549|P1|Overall Study|Adverse Event|11
4889211|NCT00705575|16845548|P2|Overall Study|Abnormal test procedure result(s)|12
4889212|NCT00705575|16845549|P1|Overall Study|Abnormal test procedure result(s)|2
4889213|NCT00705575|16845548|P2|Overall Study|Abnormal laboratory value(s)|3
4889214|NCT00705575|16845549|P1|Overall Study|Abnormal laboratory value(s)|0
4889215|NCT00705536|16845563|P4|Start Period 1|Withdrawal by Subject|1
4889216|NCT00705536|16845564|P3|Start Period 1|Withdrawal by Subject|0
4889217|NCT00705536|16845565|P2|Start Period 1|Withdrawal by Subject|0
4889218|NCT00705536|16845566|P1|Start Period 1|Withdrawal by Subject|0
4889219|NCT00705523|16845627|P2|Overall Study|Lost to Follow-up|3
4889220|NCT00705523|16845628|P1|Overall Study|Lost to Follow-up|2
4889221|NCT00705484|16845638|P2|Overall Study|Administrative|59
4889222|NCT00705484|16845639|P1|Overall Study|Administrative|89
4889223|NCT00705484|16845638|P2|Overall Study|Withdrawal by Subject|72
4889224|NCT00705484|16845639|P1|Overall Study|Withdrawal by Subject|96
4889225|NCT00705484|16845638|P2|Overall Study|Lost to Follow-up|250
4889226|NCT00705484|16845639|P1|Overall Study|Lost to Follow-up|169
4889227|NCT00705484|16845638|P2|Overall Study|Adverse Event|27
4889228|NCT00705484|16845639|P1|Overall Study|Adverse Event|28
4889229|NCT00705432|16845653|P6|Follow-up Period (Upto Week 72)|Non medical reason|7
4889230|NCT00705432|16845654|P5|Follow-up Period (Upto Week 72)|Non medical reason|6
4889231|NCT00705432|16845655|P4|Follow-up Period (Upto Week 72)|Non medical reason|14
4889232|NCT00705432|16845656|P3|Follow-up Period (Upto Week 72)|Non medical reason|24
4889233|NCT00705432|16845657|P2|Follow-up Period (Upto Week 72)|Non medical reason|42
4889234|NCT00705432|16845658|P1|Follow-up Period (Upto Week 72)|Non medical reason|69
4889235|NCT00705432|16845653|P6|Follow-up Period (Upto Week 72)|Adverse Event|0
4889236|NCT00705432|16845654|P5|Follow-up Period (Upto Week 72)|Adverse Event|0
4889237|NCT00705432|16845655|P4|Follow-up Period (Upto Week 72)|Adverse Event|0
4889238|NCT00705432|16845656|P3|Follow-up Period (Upto Week 72)|Adverse Event|1
4889239|NCT00705432|16845657|P2|Follow-up Period (Upto Week 72)|Adverse Event|1
4889240|NCT00705432|16845658|P1|Follow-up Period (Upto Week 72)|Adverse Event|2
4889241|NCT00705432|16845653|P6|Treatment Period|Non medical reason|7
4889242|NCT00705432|16845654|P5|Treatment Period|Non medical reason|7
4889243|NCT00705432|16845655|P4|Treatment Period|Non medical reason|4
4889244|NCT00705432|16845656|P3|Treatment Period|Non medical reason|37
4889245|NCT00705432|16845657|P2|Treatment Period|Non medical reason|32
4889246|NCT00705432|16845658|P1|Treatment Period|Non medical reason|26
4889247|NCT00705432|16845653|P6|Treatment Period|Treatment failure|14
4889248|NCT00705432|16845654|P5|Treatment Period|Treatment failure|13
4889249|NCT00705432|16845655|P4|Treatment Period|Treatment failure|25
4889250|NCT00705432|16845656|P3|Treatment Period|Treatment failure|33
4889251|NCT00705432|16845657|P2|Treatment Period|Treatment failure|42
4889252|NCT00705432|16845658|P1|Treatment Period|Treatment failure|92
4889253|NCT00705432|16845653|P6|Treatment Period|Adverse Event|9
4889254|NCT00705432|16845654|P5|Treatment Period|Adverse Event|8
4889255|NCT00705432|16845655|P4|Treatment Period|Adverse Event|12
4889256|NCT00705432|16845656|P3|Treatment Period|Adverse Event|51
4889257|NCT00705432|16845657|P2|Treatment Period|Adverse Event|37
4889258|NCT00705432|16845658|P1|Treatment Period|Adverse Event|45
4889259|NCT00705406|16845695|P2|Overall Study|Did not receive study drug|2
4889260|NCT00705406|16845696|P1|Overall Study|Did not receive study drug|1
4889261|NCT00705406|16845695|P2|Overall Study|Lost to Follow-up|3
4889262|NCT00705406|16845696|P1|Overall Study|Lost to Follow-up|3
4889263|NCT00705367|16845720|P2|Long-term Extension Period|Administrative reason by sponsor|0
4889264|NCT00705367|16845721|P1|Long-term Extension Period|Administrative reason by sponsor|3
4889265|NCT00705367|16845720|P2|Long-term Extension Period|No longer met study criteria|0
4889266|NCT00705367|16845721|P1|Long-term Extension Period|No longer met study criteria|1
4889267|NCT00705367|16845720|P2|Long-term Extension Period|Lack of Efficacy|0
4889268|NCT00705367|16845721|P1|Long-term Extension Period|Lack of Efficacy|1
4889269|NCT00705367|16845720|P2|Long-term Extension Period|Withdrawal by Subject|0
4889270|NCT00705367|16845721|P1|Long-term Extension Period|Withdrawal by Subject|2
4889271|NCT00705367|16845720|P2|Long-term Extension Period|Adverse Event|0
4889272|NCT00705367|16845721|P1|Long-term Extension Period|Adverse Event|2
4889273|NCT00705341|16845748|P4|Phase 2: Trial|Did not meet post-diluent threshold|0
4889274|NCT00705341|16845749|P3|Phase 2: Trial|Did not meet post-diluent threshold|1
4889275|NCT00705341|16845750|P2|Phase 2: Trial|Did not meet post-diluent threshold|0
4889276|NCT00705341|16845751|P1|Phase 2: Trial|Did not meet post-diluent threshold|0
4889277|NCT00705341|16845748|P4|Phase 2: Trial|Withdrawal by Subject|4
4889278|NCT00705341|16845749|P3|Phase 2: Trial|Withdrawal by Subject|6
4889279|NCT00705341|16845750|P2|Phase 2: Trial|Withdrawal by Subject|0
4889280|NCT00705341|16845751|P1|Phase 2: Trial|Withdrawal by Subject|0
4889281|NCT00705289|16845759|P1|Overall Study|Subject or treating physician's choice|131
4889282|NCT00705263|16845783|P1|Overall Study|Withdrawal by Subject|2
4889283|NCT00705250|16845787|P1|Overall Study|Patient died in car accident|1
4889284|NCT00705250|16845787|P1|Overall Study|Withdrawal by Subject|1
4889285|NCT00705224|16845791|P1|Overall Study|Lost to Follow-up|5
4889286|NCT00705224|16845791|P1|Overall Study|Withdrawal by Subject|3
4889287|NCT00705224|16845791|P1|Overall Study|Lack of Efficacy|2
4889288|NCT00705224|16845791|P1|Overall Study|Adverse Event|1
4889289|NCT00705159|16845807|P4|Overall Study|Screen Failure|1
4889290|NCT00705159|16845808|P3|Overall Study|Screen Failure|0
4889291|NCT00705159|16845809|P2|Overall Study|Screen Failure|0
4889292|NCT00705159|16845810|P1|Overall Study|Screen Failure|0
4889293|NCT00705159|16845807|P4|Overall Study|Lost to Follow-up|2
4889294|NCT00705159|16845808|P3|Overall Study|Lost to Follow-up|3
4889295|NCT00705159|16845809|P2|Overall Study|Lost to Follow-up|0
4889296|NCT00705159|16845810|P1|Overall Study|Lost to Follow-up|0
4889297|NCT00705159|16845807|P4|Overall Study|Adverse Event|0
4889298|NCT00705159|16845808|P3|Overall Study|Adverse Event|1
4889299|NCT00705159|16845809|P2|Overall Study|Adverse Event|0
4889300|NCT00705159|16845810|P1|Overall Study|Adverse Event|0
4889301|NCT00705159|16845807|P4|Overall Study|Protocol Violation|0
4889302|NCT00705159|16845808|P3|Overall Study|Protocol Violation|0
4889303|NCT00705159|16845809|P2|Overall Study|Protocol Violation|1
4889304|NCT00705159|16845810|P1|Overall Study|Protocol Violation|0
4889305|NCT00705159|16845807|P4|Overall Study|Withdrawal by Subject|1
4889306|NCT00705159|16845808|P3|Overall Study|Withdrawal by Subject|1
4889307|NCT00705159|16845809|P2|Overall Study|Withdrawal by Subject|1
4889308|NCT00705159|16845810|P1|Overall Study|Withdrawal by Subject|0
4889309|NCT00705146|16845830|P2|Overall Study|Lost to Follow-up|1
4889310|NCT00705146|16845831|P1|Overall Study|Lost to Follow-up|1
4889311|NCT00705016|16845867|P3|Overall Study|Other|6
4889312|NCT00705016|16845868|P2|Overall Study|Other|6
4889313|NCT00705016|16845869|P1|Overall Study|Other|9
4889314|NCT00705016|16845867|P3|Overall Study|Symptomatic Deterioration|1
4889315|NCT00705016|16845868|P2|Overall Study|Symptomatic Deterioration|1
4889316|NCT00705016|16845869|P1|Overall Study|Symptomatic Deterioration|3
4889317|NCT00705016|16845867|P3|Overall Study|Progressive Disease|33
4889318|NCT00705016|16845868|P2|Overall Study|Progressive Disease|29
4889319|NCT00705016|16845869|P1|Overall Study|Progressive Disease|33
4889320|NCT00705016|16845867|P3|Overall Study|Withdrawal by Subject|2
4889321|NCT00705016|16845868|P2|Overall Study|Withdrawal by Subject|3
4889322|NCT00705016|16845869|P1|Overall Study|Withdrawal by Subject|4
4889323|NCT00705016|16845867|P3|Overall Study|Protocol Violation|1
4889324|NCT00705016|16845868|P2|Overall Study|Protocol Violation|1
4889325|NCT00705016|16845869|P1|Overall Study|Protocol Violation|0
4889326|NCT00705016|16845867|P3|Overall Study|Death|5
4889327|NCT00705016|16845868|P2|Overall Study|Death|7
4889328|NCT00705016|16845869|P1|Overall Study|Death|5
4889329|NCT00705016|16845867|P3|Overall Study|Adverse Event|10
4889330|NCT00705016|16845868|P2|Overall Study|Adverse Event|11
4889331|NCT00705016|16845869|P1|Overall Study|Adverse Event|6
4889332|NCT00704964|16845920|P1|Overall Study|Not completed on time|328
4889333|NCT00704808|16845981|P1|Overall Study|Treatment change|1
4889334|NCT00704808|16845981|P1|Overall Study|Lost to Follow-up|1
4889335|NCT00704808|16845981|P1|Overall Study|Adverse Event|1
4889336|NCT00704808|16845981|P1|Overall Study|Early therapy discontinuation|16
4889337|NCT00704808|16845981|P1|Overall Study|Patient's decision|11
4889338|NCT00704808|16845981|P1|Overall Study|Tumor progression|80
4889339|NCT00704808|16845981|P1|Overall Study|Death|7
4889340|NCT00704808|16845981|P1|Overall Study|Discontinued prior to starting treatment|14
4889341|NCT00704730|16845992|P2|Overall Study|Withdrawal by Subject|13
4889342|NCT00704730|16845993|P1|Overall Study|Withdrawal by Subject|9
4889343|NCT00704730|16845992|P2|Overall Study|data unavailable|0
4889344|NCT00704730|16845993|P1|Overall Study|data unavailable|1
4889345|NCT00704730|16845992|P2|Overall Study|Disease progression per PI|67
4889346|NCT00704730|16845993|P1|Overall Study|Disease progression per PI|58
4889347|NCT00704730|16845992|P2|Overall Study|Did not receive drug|2
4889348|NCT00704730|16845993|P1|Overall Study|Did not receive drug|5
4889349|NCT00704730|16845992|P2|Overall Study|Physician Decision|0
4889350|NCT00704730|16845993|P1|Overall Study|Physician Decision|2
4889351|NCT00704730|16845992|P2|Overall Study|Death|5
4889352|NCT00704730|16845993|P1|Overall Study|Death|11
4889353|NCT00704730|16845992|P2|Overall Study|Adverse Event|9
4889354|NCT00704730|16845993|P1|Overall Study|Adverse Event|35
4889355|NCT00704535|16846013|P1|Overall Study|Completed status not on Case Report Form|124
4889356|NCT00704535|16846013|P1|Overall Study|Protocol Violation|10
4889357|NCT00704535|16846013|P1|Overall Study|Lost to Follow-up|8
4889358|NCT00704535|16846013|P1|Overall Study|Death|2
4889359|NCT00704535|16846013|P1|Overall Study|Adverse Event|2
4889360|NCT00704522|16846026|P2|Overall Study|No information on therapy end|2
4889361|NCT00704522|16846027|P1|Overall Study|No information on therapy end|27
4889362|NCT00704522|16846026|P2|Overall Study|Undefined causes|7
4889363|NCT00704522|16846027|P1|Overall Study|Undefined causes|9
4889364|NCT00704522|16846026|P2|Overall Study|Adverse Event|1
4889365|NCT00704522|16846027|P1|Overall Study|Adverse Event|9
4889366|NCT00704522|16846026|P2|Overall Study|Withdrawal by Subject|8
4889367|NCT00704522|16846027|P1|Overall Study|Withdrawal by Subject|17
4889368|NCT00704522|16846026|P2|Overall Study|Failure to appear again at hospital|10
4889369|NCT00704522|16846027|P1|Overall Study|Failure to appear again at hospital|56
4889370|NCT00704522|16846026|P2|Overall Study|Lack of Efficacy|17
4889371|NCT00704522|16846027|P1|Overall Study|Lack of Efficacy|65
4889372|NCT00704418|16846047|P2|Overall Study|Over-enrolled/surgery postponed|6
4889373|NCT00704418|16846048|P1|Overall Study|Over-enrolled/surgery postponed|3
4889374|NCT00704418|16846047|P2|Overall Study|Withdrawal by Subject|0
4889375|NCT00704418|16846048|P1|Overall Study|Withdrawal by Subject|2
4889376|NCT00704405|16846061|P5|Overall Study (C Population)|Lost to Follow-up|0
4889377|NCT00704405|16846062|P4|Overall Study (C Population)|Lost to Follow-up|0
4889378|NCT00704405|16846063|P3|Overall Study (C Population)|Lost to Follow-up|0
4889379|NCT00704405|16846064|P2|Overall Study (C Population)|Lost to Follow-up|2
4889380|NCT00704405|16846065|P1|Overall Study (C Population)|Lost to Follow-up|0
4889381|NCT00704405|16846061|P5|Overall Study (C Population)|Withdrawal by Subject|0
4889382|NCT00704405|16846062|P4|Overall Study (C Population)|Withdrawal by Subject|1
4889383|NCT00704405|16846063|P3|Overall Study (C Population)|Withdrawal by Subject|1
4889384|NCT00704405|16846064|P2|Overall Study (C Population)|Withdrawal by Subject|1
4889385|NCT00704405|16846065|P1|Overall Study (C Population)|Withdrawal by Subject|1
4889386|NCT00704405|16846061|P5|Overall Study (NC Population)|Other|1
4889387|NCT00704405|16846062|P4|Overall Study (NC Population)|Other|0
4889388|NCT00704405|16846063|P3|Overall Study (NC Population)|Other|0
4889389|NCT00704405|16846064|P2|Overall Study (NC Population)|Other|0
4889390|NCT00704405|16846065|P1|Overall Study (NC Population)|Other|0
4889391|NCT00704405|16846061|P5|Overall Study (NC Population)|Withdrawal by Subject|2
4889392|NCT00704405|16846062|P4|Overall Study (NC Population)|Withdrawal by Subject|2
4889393|NCT00704405|16846063|P3|Overall Study (NC Population)|Withdrawal by Subject|2
4889394|NCT00704405|16846064|P2|Overall Study (NC Population)|Withdrawal by Subject|3
4889395|NCT00704405|16846065|P1|Overall Study (NC Population)|Withdrawal by Subject|2
4889396|NCT00704405|16846061|P5|Overall Study (NC Population)|Lost to Follow-up|2
4889397|NCT00704405|16846062|P4|Overall Study (NC Population)|Lost to Follow-up|2
4889398|NCT00704405|16846063|P3|Overall Study (NC Population)|Lost to Follow-up|1
4889399|NCT00704405|16846064|P2|Overall Study (NC Population)|Lost to Follow-up|1
4889400|NCT00704405|16846065|P1|Overall Study (NC Population)|Lost to Follow-up|2
4889401|NCT00704405|16846061|P5|Overall Study (NC Population)|Adverse Event|0
4889402|NCT00704405|16846062|P4|Overall Study (NC Population)|Adverse Event|0
4889403|NCT00704405|16846063|P3|Overall Study (NC Population)|Adverse Event|0
4889404|NCT00704405|16846064|P2|Overall Study (NC Population)|Adverse Event|0
4889405|NCT00704405|16846065|P1|Overall Study (NC Population)|Adverse Event|1
4889406|NCT00704340|16846123|P2|Overall Study|Death|1
4889407|NCT00704340|16846124|P1|Overall Study|Death|0
4889408|NCT00704340|16846123|P2|Overall Study|Lost to Follow-up|1
4889409|NCT00704340|16846124|P1|Overall Study|Lost to Follow-up|2
4889410|NCT00704184|16846155|P5|Open-Label Treatment|Withdrawal by Subject|0
4889411|NCT00704184|16846156|P4|Open-Label Treatment|Withdrawal by Subject|3
4889412|NCT00704184|16846157|P3|Open-Label Treatment|Withdrawal by Subject|0
4889413|NCT00704184|16846158|P2|Open-Label Treatment|Withdrawal by Subject|0
4889414|NCT00704184|16846159|P1|Open-Label Treatment|Withdrawal by Subject|1
4889415|NCT00704184|16846155|P5|Open-Label Treatment|Physician Decision|1
4889416|NCT00704184|16846156|P4|Open-Label Treatment|Physician Decision|0
4889417|NCT00704184|16846157|P3|Open-Label Treatment|Physician Decision|0
4889418|NCT00704184|16846158|P2|Open-Label Treatment|Physician Decision|0
4889419|NCT00704184|16846159|P1|Open-Label Treatment|Physician Decision|0
4889420|NCT00704184|16846155|P5|Open-Label Treatment|Lack of Efficacy|1
4889421|NCT00704184|16846156|P4|Open-Label Treatment|Lack of Efficacy|2
4889422|NCT00704184|16846157|P3|Open-Label Treatment|Lack of Efficacy|2
4889423|NCT00704184|16846158|P2|Open-Label Treatment|Lack of Efficacy|2
4889424|NCT00704184|16846159|P1|Open-Label Treatment|Lack of Efficacy|0
4889425|NCT00704184|16846155|P5|Open-Label Treatment|Adverse Event|1
4889426|NCT00704184|16846156|P4|Open-Label Treatment|Adverse Event|0
4889427|NCT00704184|16846157|P3|Open-Label Treatment|Adverse Event|2
4889428|NCT00704184|16846158|P2|Open-Label Treatment|Adverse Event|0
4889429|NCT00704184|16846159|P1|Open-Label Treatment|Adverse Event|0
4889430|NCT00704184|16846155|P5|Double-Blind Treatment|Withdrawal by Subject|0
4889431|NCT00704184|16846156|P4|Double-Blind Treatment|Withdrawal by Subject|0
4889432|NCT00704184|16846157|P3|Double-Blind Treatment|Withdrawal by Subject|0
4889433|NCT00704184|16846158|P2|Double-Blind Treatment|Withdrawal by Subject|0
4889434|NCT00704184|16846159|P1|Double-Blind Treatment|Withdrawal by Subject|1
4889435|NCT00704171|16846198|P2|Overall Study|Withdrawal by Subject|0
4889436|NCT00704171|16846199|P1|Overall Study|Withdrawal by Subject|1
4889437|NCT00704132|16846217|P2|Overall Study|Withdrawal by Subject|1
4889438|NCT00704132|16846218|P1|Overall Study|Withdrawal by Subject|0
4889439|NCT00704132|16846217|P2|Overall Study|Lack of Efficacy|1
4889440|NCT00704132|16846218|P1|Overall Study|Lack of Efficacy|0
4889441|NCT00704132|16846217|P2|Overall Study|Clinical Adverse Experience|0
4889442|NCT00704132|16846218|P1|Overall Study|Clinical Adverse Experience|1
4889443|NCT00703963|16846246|P2|Overall Study|Physician Decision|1
4889444|NCT00703963|16846247|P1|Overall Study|Physician Decision|0
4889445|NCT00703963|16846246|P2|Overall Study|Withdrawal by Subject|13
4889446|NCT00703963|16846247|P1|Overall Study|Withdrawal by Subject|7
4889447|NCT00703924|16846268|P2|Overall Study|Withdrawal by Subject|1
4889448|NCT00703924|16846269|P1|Overall Study|Withdrawal by Subject|1
4889449|NCT00703911|16846285|P1|Overall Study|Withdrawal by Subject|2
4889450|NCT00703911|16846285|P1|Overall Study|Lost to Follow-up|1
4889451|NCT00703911|16846285|P1|Overall Study|Physician Decision|6
4889452|NCT00703911|16846285|P1|Overall Study|Death|1
4889453|NCT00703846|16846318|P1|Overall Study|Did Not Receive Study Drug|2
4889454|NCT00703846|16846318|P1|Overall Study|Other|14
4889455|NCT00703846|16846318|P1|Overall Study|Death|1
4889456|NCT00703846|16846318|P1|Overall Study|Withdrawal by Subject|40
4889457|NCT00703846|16846318|P1|Overall Study|Noncompliance with Study Treatment|2
4889458|NCT00703846|16846318|P1|Overall Study|Lack of Efficacy|15
4889459|NCT00703846|16846318|P1|Overall Study|Lost to Follow-up|55
4889460|NCT00703846|16846318|P1|Overall Study|Adverse Event|8
4889461|NCT00703820|16846334|P2|Overall Study|Withdrawal by Subject|1
4889462|NCT00703820|16846335|P1|Overall Study|Withdrawal by Subject|2
4889463|NCT00703820|16846334|P2|Overall Study|Physician Decision|5
4889464|NCT00703820|16846335|P1|Overall Study|Physician Decision|4
4889465|NCT00703820|16846334|P2|Overall Study|Received non-protocol therapy|0
4889466|NCT00703820|16846335|P1|Overall Study|Received non-protocol therapy|1
4889467|NCT00703820|16846334|P2|Overall Study|Lack of Efficacy|11
4889468|NCT00703820|16846335|P1|Overall Study|Lack of Efficacy|11
4889469|NCT00703820|16846334|P2|Overall Study|Death|0
4889470|NCT00703820|16846335|P1|Overall Study|Death|5
4889471|NCT00703820|16846334|P2|Overall Study|Adverse Event|17
4889472|NCT00703820|16846335|P1|Overall Study|Adverse Event|12
4889473|NCT00703781|16846344|P2|Overall Study|Cancelled surgery|0
4889474|NCT00703781|16846345|P1|Overall Study|Cancelled surgery|1
4889475|NCT00703781|16846344|P2|Overall Study|Withdrawal by Subject|2
4889476|NCT00703781|16846345|P1|Overall Study|Withdrawal by Subject|1
4889477|NCT00703677|16846390|P1|Overall Study|Dropout-withdrawal not related to drug|3
4889478|NCT00703534|16846430|P2|Overall Study|Severe Non Compliance|5
4889479|NCT00703534|16846431|P1|Overall Study|Severe Non Compliance|1
4889480|NCT00703534|16846430|P2|Overall Study|Lost to Follow-up|4
4889481|NCT00703534|16846431|P1|Overall Study|Lost to Follow-up|1
4889482|NCT00703534|16846430|P2|Overall Study|Incorrect Enrollment|6
4889483|NCT00703534|16846431|P1|Overall Study|Incorrect Enrollment|6
4889484|NCT00703534|16846430|P2|Overall Study|Withdrawal by Subject|7
4889485|NCT00703534|16846431|P1|Overall Study|Withdrawal by Subject|8
4889486|NCT00703534|16846430|P2|Overall Study|Adverse Event|3
4889487|NCT00703534|16846431|P1|Overall Study|Adverse Event|14
4889488|NCT00703326|16846503|P2|Overall Study|Withdrawal by Subject|20
4889489|NCT00703326|16846504|P1|Overall Study|Withdrawal by Subject|42
4889490|NCT00703326|16846503|P2|Overall Study|Lost to Follow-up|8
4889491|NCT00703326|16846504|P1|Overall Study|Lost to Follow-up|25
4889492|NCT00703326|16846503|P2|Overall Study|Still on study|197
4889493|NCT00703326|16846504|P1|Overall Study|Still on study|380
4889494|NCT00703157|16846536|P2|Overall Study|source data permanently lost/ other|1
4889495|NCT00703157|16846537|P1|Overall Study|source data permanently lost/ other|4
4889496|NCT00703157|16846536|P2|Overall Study|Lost to Follow-up|1
4889497|NCT00703157|16846537|P1|Overall Study|Lost to Follow-up|0
4889498|NCT00703118|16846571|P3|Overall Study|Other|1
4889499|NCT00703118|16846572|P2|Overall Study|Other|0
4889500|NCT00703118|16846573|P1|Overall Study|Other|0
4889501|NCT00703118|16846571|P3|Overall Study|Withdrawal by Subject|13
4889502|NCT00703118|16846572|P2|Overall Study|Withdrawal by Subject|7
4889503|NCT00703118|16846573|P1|Overall Study|Withdrawal by Subject|8
4889504|NCT00703118|16846571|P3|Overall Study|Lost to Follow-up|4
4889505|NCT00703118|16846572|P2|Overall Study|Lost to Follow-up|4
4889506|NCT00703118|16846573|P1|Overall Study|Lost to Follow-up|6
4889507|NCT00703118|16846571|P3|Overall Study|Subject Ineligible To Continue The Trial|2
4889508|NCT00703118|16846572|P2|Overall Study|Subject Ineligible To Continue The Trial|3
4889509|NCT00703118|16846573|P1|Overall Study|Subject Ineligible To Continue The Trial|6
4889510|NCT00703118|16846571|P3|Overall Study|Adverse Event|2
4889511|NCT00703118|16846572|P2|Overall Study|Adverse Event|2
4889512|NCT00703118|16846573|P1|Overall Study|Adverse Event|1
4889513|NCT00703092|16846604|P1|Overall Study|Withdrawal by Subject|2
4889514|NCT00703014|16846812|P4|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42
4889515|NCT00703014|16846813|P3|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47
4889516|NCT00703014|16846814|P2|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
4889517|NCT00703014|16846815|P1|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0
4889518|NCT00703014|16846812|P4|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
4889519|NCT00703014|16846813|P3|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0
4889520|NCT00703014|16846814|P2|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32
4889521|NCT00703014|16846815|P1|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33
4889522|NCT00702962|16846835|P2|Overall Study|Hospitalized for other health disorder|0
4889523|NCT00702962|16846836|P1|Overall Study|Hospitalized for other health disorder|1
4889524|NCT00702962|16846835|P2|Overall Study|Progressive disease|1
4889525|NCT00702962|16846836|P1|Overall Study|Progressive disease|0
4889526|NCT00702949|16846847|P3|Overall Study|Other Medical Reason/unknown|3
4889527|NCT00702949|16846848|P2|Overall Study|Other Medical Reason/unknown|1
4889528|NCT00702949|16846849|P1|Overall Study|Other Medical Reason/unknown|1
4889529|NCT00702949|16846847|P3|Overall Study|Adverse Event|3
4889530|NCT00702949|16846848|P2|Overall Study|Adverse Event|6
4889531|NCT00702949|16846849|P1|Overall Study|Adverse Event|1
4889532|NCT00702949|16846847|P3|Overall Study|Refusal|2
4889533|NCT00702949|16846848|P2|Overall Study|Refusal|2
4889534|NCT00702949|16846849|P1|Overall Study|Refusal|3
4889535|NCT00702923|16846874|P1|Overall Study|Adverse Event|1
4889536|NCT00702845|16846897|P2|Overall Study|Not randomized|1
4889537|NCT00702845|16846898|P1|Overall Study|Not randomized|0
4889538|NCT00702845|16846897|P2|Overall Study|Patient's decision|1
4889539|NCT00702845|16846898|P1|Overall Study|Patient's decision|2
4889540|NCT00702845|16846897|P2|Overall Study|No or abnormal fertilization|2
4889541|NCT00702845|16846898|P1|Overall Study|No or abnormal fertilization|4
4889542|NCT00702845|16846897|P2|Overall Study|No/too few/bad quality embryos retrieved|1
4889543|NCT00702845|16846898|P1|Overall Study|No/too few/bad quality embryos retrieved|7
4889544|NCT00702845|16846897|P2|Overall Study|Insufficient ovarian response|0
4889545|NCT00702845|16846898|P1|Overall Study|Insufficient ovarian response|1
4889546|NCT00702845|16846897|P2|Overall Study|Risk of ovarian hyperstimulation synd.|0
4889547|NCT00702845|16846898|P1|Overall Study|Risk of ovarian hyperstimulation synd.|1
4889548|NCT00702845|16846897|P2|Overall Study|Too high ovarian response|1
4889549|NCT00702845|16846898|P1|Overall Study|Too high ovarian response|5
4889550|NCT00702845|16846897|P2|Overall Study|No/too few/bad quality oocytes retrieved|2
4889551|NCT00702845|16846898|P1|Overall Study|No/too few/bad quality oocytes retrieved|2
4889552|NCT00702715|16846960|P2|Overall Study|Lost to Follow-up|0
4889553|NCT00702715|16846961|P1|Overall Study|Lost to Follow-up|1
4889554|NCT00702702|16846974|P1|Overall Study|Study prematurely terminated|56
4889555|NCT00702689|16846982|P1|Overall Study|Adverse Event|1
4889556|NCT00702689|16846982|P1|Overall Study|Recurrent malignancy|1
4889557|NCT00702689|16846982|P1|Overall Study|Withdrawal by Subject|4
4889558|NCT00702650|16846993|P1|Overall Study|Adverse Event|3
4889559|NCT00702650|16846993|P1|Overall Study|Screening Testosterone Levels >300 ng/dL|1
4889560|NCT00702650|16846993|P1|Overall Study|Sponsor Request|1
4889561|NCT00702650|16846993|P1|Overall Study|Non-Compliance with Site Directives|1
4889562|NCT00702650|16846993|P1|Overall Study|Lost to Follow-up|2
4889563|NCT00702650|16846993|P1|Overall Study|Non-Compliance of Study Drug|3
4889564|NCT00702650|16846993|P1|Overall Study|Withdrawal by Subject|9
4889565|NCT00702520|16847055|P4|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
4889566|NCT00702520|16847056|P3|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0
4889567|NCT00702520|16847057|P2|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10
4889568|NCT00702520|16847058|P1|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15
4889569|NCT00702520|16847055|P4|Base Study P05788 - Embryo Transfer|No embryo transfer|0
4889570|NCT00702520|16847056|P3|Base Study P05788 - Embryo Transfer|No embryo transfer|0
4889571|NCT00702520|16847057|P2|Base Study P05788 - Embryo Transfer|No embryo transfer|6
4889572|NCT00702520|16847058|P1|Base Study P05788 - Embryo Transfer|No embryo transfer|3
4889573|NCT00702520|16847055|P4|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
4889574|NCT00702520|16847056|P3|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
4889575|NCT00702520|16847057|P2|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1
4889576|NCT00702520|16847058|P1|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0
4889577|NCT00702507|16847074|P1|Follow-up Phase|Late Enrollment|1
4889578|NCT00702507|16847074|P1|Follow-up Phase|Lost to Follow-up|23
4889579|NCT00702507|16847074|P1|Follow-up Phase|Protocol Violation|2
4889580|NCT00702507|16847074|P1|Follow-up Phase|Participant's Caretaker Withdrew Consent|1
4889581|NCT00702507|16847074|P1|Initial Treatment Phase|Negative Candida Culture|34
4889582|NCT00702507|16847074|P1|Initial Treatment Phase|Lost to Follow-up|2
4889583|NCT00702507|16847074|P1|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3
4889584|NCT00702507|16847074|P1|Initial Treatment Phase|Adverse Event|2
4889585|NCT00702403|16847111|P1|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5
4889586|NCT00702403|16847111|P1|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1
4889587|NCT00702403|16847111|P1|From Engraftment to Study Completion|Acute respiratory distress syndrome|1
4889588|NCT00702403|16847111|P1|From Engraftment to Study Completion|Suicide|1
4889589|NCT00702403|16847111|P1|From Engraftment to Study Completion|Liver GVHD|1
4889590|NCT00702403|16847111|P1|From Engraftment to Study Completion|Adenocarcinoma|1
4889591|NCT00702403|16847111|P1|From Engraftment to Study Completion|Non-compliance|2
4889592|NCT00702403|16847111|P1|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4
4889593|NCT00702403|16847111|P1|From Engraftment to Study Completion|Failed pre-1st dose criteria|11
4889594|NCT00702403|16847111|P1|From Consent to Engraftment|Miscellaneous (unanticipated) other|2
4889595|NCT00702403|16847111|P1|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4
4889596|NCT00702403|16847111|P1|From Consent to Engraftment|Myocardial infarction|1
4889597|NCT00702403|16847111|P1|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2
4889598|NCT00702403|16847111|P1|From Consent to Engraftment|Critically ill|2
4889599|NCT00702403|16847111|P1|From Consent to Engraftment|Progressive leukemia|6
4889600|NCT00702325|16847165|P2|Overall Study|Incorrectly Discontinued|1
4889601|NCT00702325|16847166|P1|Overall Study|Incorrectly Discontinued|0
4889602|NCT00702325|16847165|P2|Overall Study|Withdrew consent|1
4889603|NCT00702325|16847166|P1|Overall Study|Withdrew consent|0
4889604|NCT00702325|16847165|P2|Overall Study|Didn't follow study medication dosage|2
4889605|NCT00702325|16847166|P1|Overall Study|Didn't follow study medication dosage|0
4889606|NCT00702325|16847165|P2|Overall Study|Termination due to lab results|0
4889607|NCT00702325|16847166|P1|Overall Study|Termination due to lab results|1
4889608|NCT00702325|16847165|P2|Overall Study|Severe noncompliance to protocol|3
4889609|NCT00702325|16847166|P1|Overall Study|Severe noncompliance to protocol|3
4889610|NCT00702325|16847165|P2|Overall Study|Developed study discontinuation criteria|28
4889611|NCT00702325|16847166|P1|Overall Study|Developed study discontinuation criteria|18
4889612|NCT00702325|16847165|P2|Overall Study|Incorrect enrollment|7
4889613|NCT00702325|16847166|P1|Overall Study|Incorrect enrollment|5
4889614|NCT00702325|16847165|P2|Overall Study|Lost to Follow-up|4
4889615|NCT00702325|16847166|P1|Overall Study|Lost to Follow-up|3
4889616|NCT00702325|16847165|P2|Overall Study|Withdrawal by Subject|7
4889617|NCT00702325|16847166|P1|Overall Study|Withdrawal by Subject|7
4889618|NCT00702325|16847165|P2|Overall Study|Adverse Event|0
4889619|NCT00702325|16847166|P1|Overall Study|Adverse Event|1
4889620|NCT00702221|16847262|P2|Overall Study|Adverse Event|3
4889621|NCT00702221|16847263|P1|Overall Study|Adverse Event|4
4889622|NCT00702208|16847269|P1|Overall Study|Unsatisfactory colposcopy|2
4889623|NCT00702208|16847269|P1|Overall Study|Did not self-lavage|1
4889624|NCT00702208|16847269|P1|Overall Study|Lost to Follow-up|28
4889625|NCT00702143|16847278|P3|Overall Study|Lost to Follow-up|1
4889626|NCT00702143|16847279|P2|Overall Study|Lost to Follow-up|0
4889627|NCT00702143|16847280|P1|Overall Study|Lost to Follow-up|0
4889628|NCT00701805|16847329|P4|Overall Study|Resumption criteria were not met|0
4889629|NCT00701805|16847330|P3|Overall Study|Resumption criteria were not met|0
4889630|NCT00701805|16847331|P2|Overall Study|Resumption criteria were not met|1
4889631|NCT00701805|16847332|P1|Overall Study|Resumption criteria were not met|0
4889632|NCT00701805|16847329|P4|Overall Study|Difficult to travel to dialysis site|0
4889633|NCT00701805|16847330|P3|Overall Study|Difficult to travel to dialysis site|1
4889634|NCT00701805|16847331|P2|Overall Study|Difficult to travel to dialysis site|0
4889635|NCT00701805|16847332|P1|Overall Study|Difficult to travel to dialysis site|0
4889636|NCT00701805|16847329|P4|Overall Study|Physician decision, change of therapy|1
4889637|NCT00701805|16847330|P3|Overall Study|Physician decision, change of therapy|0
4889638|NCT00701805|16847331|P2|Overall Study|Physician decision, change of therapy|0
4889639|NCT00701805|16847332|P1|Overall Study|Physician decision, change of therapy|0
4889640|NCT00701805|16847329|P4|Overall Study|Admitted to hospital for 2 weeks|0
4889641|NCT00701805|16847330|P3|Overall Study|Admitted to hospital for 2 weeks|1
4889642|NCT00701805|16847331|P2|Overall Study|Admitted to hospital for 2 weeks|0
4889643|NCT00701805|16847332|P1|Overall Study|Admitted to hospital for 2 weeks|0
4889644|NCT00701805|16847329|P4|Overall Study|Missed 7 consecutive doses|0
4889645|NCT00701805|16847330|P3|Overall Study|Missed 7 consecutive doses|0
4889646|NCT00701805|16847331|P2|Overall Study|Missed 7 consecutive doses|1
4889647|NCT00701805|16847332|P1|Overall Study|Missed 7 consecutive doses|0
4889648|NCT00701805|16847329|P4|Overall Study|Adverse Event|0
4889649|NCT00701805|16847330|P3|Overall Study|Adverse Event|1
4889650|NCT00701805|16847331|P2|Overall Study|Adverse Event|1
4889651|NCT00701805|16847332|P1|Overall Study|Adverse Event|0
4889652|NCT00701805|16847329|P4|Overall Study|Withdrawal by Subject|3
4889653|NCT00701805|16847330|P3|Overall Study|Withdrawal by Subject|4
4889654|NCT00701805|16847331|P2|Overall Study|Withdrawal by Subject|1
4889655|NCT00701805|16847332|P1|Overall Study|Withdrawal by Subject|3
4889656|NCT00701779|16847382|P1|Overall Study|Withdrawal by Subject|2
4889657|NCT00701779|16847382|P1|Overall Study|Lost to Follow-up|1
4889658|NCT00701779|16847382|P1|Overall Study|Adverse Event|6
4889659|NCT00701727|16847394|P2|Second Treatment Period|Withdrawal by Subject|0
4889660|NCT00701727|16847395|P1|Second Treatment Period|Withdrawal by Subject|2
4889661|NCT00701727|16847394|P2|First Treatment Period|Lost to Follow-up|1
4889662|NCT00701727|16847395|P1|First Treatment Period|Lost to Follow-up|0
4889663|NCT00701727|16847394|P2|First Treatment Period|sponsor decision|1
4889664|NCT00701727|16847395|P1|First Treatment Period|sponsor decision|0
4889665|NCT00701727|16847394|P2|First Treatment Period|Withdrawal by Subject|0
4889666|NCT00701727|16847395|P1|First Treatment Period|Withdrawal by Subject|1
4889667|NCT00701727|16847394|P2|First Treatment Period|Adverse Event|0
4889668|NCT00701727|16847395|P1|First Treatment Period|Adverse Event|0
4889669|NCT00701701|16847430|P2|Overall Study|Adverse Event|1
4889670|NCT00701701|16847431|P1|Overall Study|Adverse Event|0
4889671|NCT00701701|16847430|P2|Overall Study|Withdrawal by Subject|1
4889672|NCT00701701|16847431|P1|Overall Study|Withdrawal by Subject|0
4889673|NCT00701662|16847466|P1|Overall Study|Lack of Efficacy|1
4889674|NCT00701558|16847491|P1|Overall Study|Lost to Follow-up|8
4889675|NCT00701558|16847491|P1|Overall Study|Death|7
4889676|NCT00701441|16847499|P2|Overall Study|failure in cpap compliance|4
4889677|NCT00701441|16847500|P1|Overall Study|failure in cpap compliance|0
4889678|NCT00701415|16847512|P2|Overall Study|Social/family issues and needle phobia|0
4889679|NCT00701415|16847513|P1|Overall Study|Social/family issues and needle phobia|1
4889680|NCT00701415|16847512|P2|Overall Study|Adverse Event|1
4889681|NCT00701415|16847513|P1|Overall Study|Adverse Event|0
4889682|NCT00701363|16847572|P4|Treatment Phase 2|Withdrawal by Subject|0
4889683|NCT00701363|16847573|P3|Treatment Phase 2|Withdrawal by Subject|1
4889684|NCT00701363|16847574|P2|Treatment Phase 2|Withdrawal by Subject|0
4889685|NCT00701363|16847575|P1|Treatment Phase 2|Withdrawal by Subject|0
4889686|NCT00701363|16847572|P4|Treatment Phase 2|Adverse Event|0
4889687|NCT00701363|16847573|P3|Treatment Phase 2|Adverse Event|1
4889688|NCT00701363|16847574|P2|Treatment Phase 2|Adverse Event|0
4889689|NCT00701363|16847575|P1|Treatment Phase 2|Adverse Event|0
4889690|NCT00701363|16847572|P4|Treatment Phase 1|Lack of Efficacy|0
4889691|NCT00701363|16847573|P3|Treatment Phase 1|Lack of Efficacy|0
4889692|NCT00701363|16847574|P2|Treatment Phase 1|Lack of Efficacy|0
4889693|NCT00701363|16847575|P1|Treatment Phase 1|Lack of Efficacy|1
4889694|NCT00701363|16847572|P4|Treatment Phase 1|Withdrawal by Subject|0
4889695|NCT00701363|16847573|P3|Treatment Phase 1|Withdrawal by Subject|0
4889696|NCT00701363|16847574|P2|Treatment Phase 1|Withdrawal by Subject|0
4889697|NCT00701363|16847575|P1|Treatment Phase 1|Withdrawal by Subject|5
4889698|NCT00701363|16847572|P4|Treatment Phase 1|Protocol Violation|0
4889699|NCT00701363|16847573|P3|Treatment Phase 1|Protocol Violation|0
4889700|NCT00701363|16847574|P2|Treatment Phase 1|Protocol Violation|0
4889701|NCT00701363|16847575|P1|Treatment Phase 1|Protocol Violation|1
4889702|NCT00701363|16847572|P4|Treatment Phase 1|Adverse Event|0
4889703|NCT00701363|16847573|P3|Treatment Phase 1|Adverse Event|0
4889704|NCT00701363|16847574|P2|Treatment Phase 1|Adverse Event|0
4889705|NCT00701363|16847575|P1|Treatment Phase 1|Adverse Event|7
4889706|NCT00701363|16847572|P4|Treatment Phase 1|Does not meet entry Criteria|0
4889707|NCT00701363|16847573|P3|Treatment Phase 1|Does not meet entry Criteria|0
4889708|NCT00701363|16847574|P2|Treatment Phase 1|Does not meet entry Criteria|0
4889709|NCT00701363|16847575|P1|Treatment Phase 1|Does not meet entry Criteria|1
4889710|NCT00701363|16847572|P4|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
4889711|NCT00701363|16847573|P3|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
4889712|NCT00701363|16847574|P2|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0
4889713|NCT00701363|16847575|P1|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4
4889714|NCT00701311|16847615|P1|Overall Study|Withdrawal by Subject|2
4889715|NCT00701311|16847615|P1|Overall Study|Adverse Event|3
4889716|NCT00701311|16847615|P1|Overall Study|Lack of Efficacy|3
4889717|NCT00701129|16847619|P1|Overall Study|Death|2
4889718|NCT00701103|16847641|P11|Overall Study|Other|0
4889719|NCT00701103|16847642|P10|Overall Study|Other|1
4889720|NCT00701103|16847643|P9|Overall Study|Other|1
4889721|NCT00701103|16847644|P8|Overall Study|Other|0
4889722|NCT00701103|16847645|P7|Overall Study|Other|0
4889723|NCT00701103|16847646|P6|Overall Study|Other|0
4889724|NCT00701103|16847647|P5|Overall Study|Other|0
4889725|NCT00701103|16847648|P4|Overall Study|Other|0
4889726|NCT00701103|16847649|P3|Overall Study|Other|0
4889727|NCT00701103|16847650|P2|Overall Study|Other|0
4889728|NCT00701103|16847651|P1|Overall Study|Other|0
4889729|NCT00701103|16847641|P11|Overall Study|Withdrawal by Subject|0
4889730|NCT00701103|16847642|P10|Overall Study|Withdrawal by Subject|0
4889731|NCT00701103|16847643|P9|Overall Study|Withdrawal by Subject|0
4889732|NCT00701103|16847644|P8|Overall Study|Withdrawal by Subject|0
4889733|NCT00701103|16847645|P7|Overall Study|Withdrawal by Subject|0
4889734|NCT00701103|16847646|P6|Overall Study|Withdrawal by Subject|0
4889735|NCT00701103|16847647|P5|Overall Study|Withdrawal by Subject|0
4889736|NCT00701103|16847648|P4|Overall Study|Withdrawal by Subject|0
4889737|NCT00701103|16847649|P3|Overall Study|Withdrawal by Subject|1
4889738|NCT00701103|16847650|P2|Overall Study|Withdrawal by Subject|1
4889739|NCT00701103|16847651|P1|Overall Study|Withdrawal by Subject|0
4889740|NCT00701103|16847641|P11|Overall Study|Progressive Disease|11
4889741|NCT00701103|16847642|P10|Overall Study|Progressive Disease|8
4889742|NCT00701103|16847643|P9|Overall Study|Progressive Disease|8
4889743|NCT00701103|16847644|P8|Overall Study|Progressive Disease|7
4889744|NCT00701103|16847645|P7|Overall Study|Progressive Disease|7
4889745|NCT00701103|16847646|P6|Overall Study|Progressive Disease|5
4889746|NCT00701103|16847647|P5|Overall Study|Progressive Disease|6
4889747|NCT00701103|16847648|P4|Overall Study|Progressive Disease|5
4889748|NCT00701103|16847649|P3|Overall Study|Progressive Disease|6
4889749|NCT00701103|16847650|P2|Overall Study|Progressive Disease|2
4889750|NCT00701103|16847651|P1|Overall Study|Progressive Disease|5
4889751|NCT00701103|16847641|P11|Overall Study|Adverse Event|0
4889752|NCT00701103|16847642|P10|Overall Study|Adverse Event|2
4889753|NCT00701103|16847643|P9|Overall Study|Adverse Event|0
4889754|NCT00701103|16847644|P8|Overall Study|Adverse Event|0
4889755|NCT00701103|16847645|P7|Overall Study|Adverse Event|1
4889756|NCT00701103|16847646|P6|Overall Study|Adverse Event|1
4889757|NCT00701103|16847647|P5|Overall Study|Adverse Event|0
4889758|NCT00701103|16847648|P4|Overall Study|Adverse Event|1
4889759|NCT00701103|16847649|P3|Overall Study|Adverse Event|1
4889760|NCT00701103|16847650|P2|Overall Study|Adverse Event|0
4889761|NCT00701103|16847651|P1|Overall Study|Adverse Event|0
4889762|NCT00701090|16847757|P2|Overall Study|Other|12
4889763|NCT00701090|16847758|P1|Overall Study|Other|7
4889764|NCT00701090|16847757|P2|Overall Study|Withdrawal by Subject|16
4889765|NCT00701090|16847758|P1|Overall Study|Withdrawal by Subject|11
4889766|NCT00701090|16847757|P2|Overall Study|Protocol Violation|3
4889767|NCT00701090|16847758|P1|Overall Study|Protocol Violation|2
4889768|NCT00701090|16847757|P2|Overall Study|Physician Decision|4
4889769|NCT00701090|16847758|P1|Overall Study|Physician Decision|3
4889770|NCT00701090|16847757|P2|Overall Study|Lost to Follow-up|9
4889771|NCT00701090|16847758|P1|Overall Study|Lost to Follow-up|9
4889772|NCT00701090|16847757|P2|Overall Study|Lack of Efficacy|4
4889773|NCT00701090|16847758|P1|Overall Study|Lack of Efficacy|5
4889774|NCT00701090|16847757|P2|Overall Study|Death|1
4889775|NCT00701090|16847758|P1|Overall Study|Death|0
4889776|NCT00701090|16847757|P2|Overall Study|Adverse Event|2
4889777|NCT00701090|16847758|P1|Overall Study|Adverse Event|11
4889778|NCT00701064|16847776|P2|Overall Study|initiated other PTSD treatment|2
4889779|NCT00701064|16847777|P1|Overall Study|initiated other PTSD treatment|2
4889780|NCT00701064|16847776|P2|Overall Study|Withdrawal by Subject|1
4889781|NCT00701064|16847777|P1|Overall Study|Withdrawal by Subject|1
4889782|NCT00701064|16847776|P2|Overall Study|Protocol Violation|1
4889783|NCT00701064|16847777|P1|Overall Study|Protocol Violation|1
4889784|NCT00701051|16847789|P3|Exercise Intervention|time conflict; non-study related illness|3
4889785|NCT00701051|16847790|P2|Exercise Intervention|time conflict; non-study related illness|5
4889786|NCT00701051|16847791|P1|Exercise Intervention|time conflict; non-study related illness|0
4889787|NCT00701051|16847789|P3|Screening|Time conflicts|0
4889788|NCT00701051|16847790|P2|Screening|Time conflicts|0
4889789|NCT00701051|16847791|P1|Screening|Time conflicts|19
4889790|NCT00701051|16847789|P3|Screening|Failed Screening|0
4889791|NCT00701051|16847790|P2|Screening|Failed Screening|0
4889792|NCT00701051|16847791|P1|Screening|Failed Screening|40
4889793|NCT00701038|16847809|P2|Overall Study|study amended pilot group of patients|4
4889794|NCT00701038|16847810|P1|Overall Study|study amended pilot group of patients|4
4889795|NCT00700999|16847818|P2|Overall Study|Withdrawal by Subject|1
4889796|NCT00700999|16847819|P1|Overall Study|Withdrawal by Subject|8
4889797|NCT00700999|16847818|P2|Overall Study|Excluded - did not meet study criteria|1
4889798|NCT00700999|16847819|P1|Overall Study|Excluded - did not meet study criteria|0
4889799|NCT00700999|16847818|P2|Overall Study|Lost to Follow-up|7
4889800|NCT00700999|16847819|P1|Overall Study|Lost to Follow-up|7
4889801|NCT00700882|16847834|P1|Overall Study|No KIT mutation|51
4889802|NCT00700882|16847834|P1|Overall Study|Ineligible|2
4889803|NCT00700882|16847834|P1|Overall Study|Never received treatment|6
4889804|NCT00700817|16847843|P5|Week 52-78 (Extension Period 2)|Unclassified|1
4889805|NCT00700817|16847844|P4|Week 52-78 (Extension Period 2)|Unclassified|0
4889806|NCT00700817|16847845|P3|Week 52-78 (Extension Period 2)|Unclassified|0
4889807|NCT00700817|16847846|P2|Week 52-78 (Extension Period 2)|Unclassified|4
4889808|NCT00700817|16847847|P1|Week 52-78 (Extension Period 2)|Unclassified|2
4889809|NCT00700817|16847843|P5|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
4889810|NCT00700817|16847844|P4|Week 52-78 (Extension Period 2)|Withdrawal criteria|1
4889811|NCT00700817|16847845|P3|Week 52-78 (Extension Period 2)|Withdrawal criteria|0
4889812|NCT00700817|16847846|P2|Week 52-78 (Extension Period 2)|Withdrawal criteria|3
4889813|NCT00700817|16847847|P1|Week 52-78 (Extension Period 2)|Withdrawal criteria|4
4889814|NCT00700817|16847843|P5|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
4889815|NCT00700817|16847844|P4|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
4889816|NCT00700817|16847845|P3|Week 52-78 (Extension Period 2)|Lack of Efficacy|0
4889817|NCT00700817|16847846|P2|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
4889818|NCT00700817|16847847|P1|Week 52-78 (Extension Period 2)|Lack of Efficacy|3
4889819|NCT00700817|16847843|P5|Week 52-78 (Extension Period 2)|Protocol Violation|1
4889820|NCT00700817|16847844|P4|Week 52-78 (Extension Period 2)|Protocol Violation|1
4889821|NCT00700817|16847845|P3|Week 52-78 (Extension Period 2)|Protocol Violation|0
4889822|NCT00700817|16847846|P2|Week 52-78 (Extension Period 2)|Protocol Violation|2
4889823|NCT00700817|16847847|P1|Week 52-78 (Extension Period 2)|Protocol Violation|1
4889824|NCT00700817|16847843|P5|Week 52-78 (Extension Period 2)|Adverse Event|0
4889825|NCT00700817|16847844|P4|Week 52-78 (Extension Period 2)|Adverse Event|6
4889826|NCT00700817|16847845|P3|Week 52-78 (Extension Period 2)|Adverse Event|0
4889827|NCT00700817|16847846|P2|Week 52-78 (Extension Period 2)|Adverse Event|3
4889828|NCT00700817|16847847|P1|Week 52-78 (Extension Period 2)|Adverse Event|0
4889829|NCT00700817|16847843|P5|Week 26-52 (Extension Period 1)|Unclassified|0
4889830|NCT00700817|16847844|P4|Week 26-52 (Extension Period 1)|Unclassified|0
4889831|NCT00700817|16847845|P3|Week 26-52 (Extension Period 1)|Unclassified|1
4889832|NCT00700817|16847846|P2|Week 26-52 (Extension Period 1)|Unclassified|3
4889833|NCT00700817|16847847|P1|Week 26-52 (Extension Period 1)|Unclassified|4
4889834|NCT00700817|16847843|P5|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
4889835|NCT00700817|16847844|P4|Week 26-52 (Extension Period 1)|Withdrawal criteria|0
4889836|NCT00700817|16847845|P3|Week 26-52 (Extension Period 1)|Withdrawal criteria|2
4889837|NCT00700817|16847846|P2|Week 26-52 (Extension Period 1)|Withdrawal criteria|8
4889838|NCT00700817|16847847|P1|Week 26-52 (Extension Period 1)|Withdrawal criteria|6
4889839|NCT00700817|16847843|P5|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
4889840|NCT00700817|16847844|P4|Week 26-52 (Extension Period 1)|Lack of Efficacy|0
4889841|NCT00700817|16847845|P3|Week 26-52 (Extension Period 1)|Lack of Efficacy|7
4889842|NCT00700817|16847846|P2|Week 26-52 (Extension Period 1)|Lack of Efficacy|3
4889843|NCT00700817|16847847|P1|Week 26-52 (Extension Period 1)|Lack of Efficacy|2
4889844|NCT00700817|16847843|P5|Week 26-52 (Extension Period 1)|Protocol Violation|0
4889845|NCT00700817|16847844|P4|Week 26-52 (Extension Period 1)|Protocol Violation|0
4889846|NCT00700817|16847845|P3|Week 26-52 (Extension Period 1)|Protocol Violation|2
4889847|NCT00700817|16847846|P2|Week 26-52 (Extension Period 1)|Protocol Violation|2
4889848|NCT00700817|16847847|P1|Week 26-52 (Extension Period 1)|Protocol Violation|3
4889849|NCT00700817|16847843|P5|Week 26-52 (Extension Period 1)|Adverse Event|0
4889850|NCT00700817|16847844|P4|Week 26-52 (Extension Period 1)|Adverse Event|0
4889851|NCT00700817|16847845|P3|Week 26-52 (Extension Period 1)|Adverse Event|3
4889852|NCT00700817|16847846|P2|Week 26-52 (Extension Period 1)|Adverse Event|10
4889853|NCT00700817|16847847|P1|Week 26-52 (Extension Period 1)|Adverse Event|5
4889854|NCT00700817|16847843|P5|Week 0-26 (Main Period)|Unclassified|0
4889855|NCT00700817|16847844|P4|Week 0-26 (Main Period)|Unclassified|0
4889856|NCT00700817|16847845|P3|Week 0-26 (Main Period)|Unclassified|8
4889857|NCT00700817|16847846|P2|Week 0-26 (Main Period)|Unclassified|4
4889858|NCT00700817|16847847|P1|Week 0-26 (Main Period)|Unclassified|14
4889859|NCT00700817|16847843|P5|Week 0-26 (Main Period)|Withdrawal criteria|0
4889860|NCT00700817|16847844|P4|Week 0-26 (Main Period)|Withdrawal criteria|0
4889861|NCT00700817|16847845|P3|Week 0-26 (Main Period)|Withdrawal criteria|5
4889862|NCT00700817|16847846|P2|Week 0-26 (Main Period)|Withdrawal criteria|7
4889863|NCT00700817|16847847|P1|Week 0-26 (Main Period)|Withdrawal criteria|10
4889864|NCT00700817|16847843|P5|Week 0-26 (Main Period)|Protocol Violation|0
4889865|NCT00700817|16847844|P4|Week 0-26 (Main Period)|Protocol Violation|0
4889866|NCT00700817|16847845|P3|Week 0-26 (Main Period)|Protocol Violation|4
4889867|NCT00700817|16847846|P2|Week 0-26 (Main Period)|Protocol Violation|4
4889868|NCT00700817|16847847|P1|Week 0-26 (Main Period)|Protocol Violation|14
4889869|NCT00700817|16847843|P5|Week 0-26 (Main Period)|Lack of Efficacy|0
4889870|NCT00700817|16847844|P4|Week 0-26 (Main Period)|Lack of Efficacy|0
4889871|NCT00700817|16847845|P3|Week 0-26 (Main Period)|Lack of Efficacy|4
4889872|NCT00700817|16847846|P2|Week 0-26 (Main Period)|Lack of Efficacy|0
4889873|NCT00700817|16847847|P1|Week 0-26 (Main Period)|Lack of Efficacy|4
4889874|NCT00700817|16847843|P5|Week 0-26 (Main Period)|Adverse Event|0
4889875|NCT00700817|16847844|P4|Week 0-26 (Main Period)|Adverse Event|0
4889876|NCT00700817|16847845|P3|Week 0-26 (Main Period)|Adverse Event|4
4889877|NCT00700817|16847846|P2|Week 0-26 (Main Period)|Adverse Event|15
4889878|NCT00700817|16847847|P1|Week 0-26 (Main Period)|Adverse Event|14
4889879|NCT00700804|16848229|P2|Overall Study|Loose Stools|1
4889880|NCT00700804|16848230|P1|Overall Study|Loose Stools|1
4889881|NCT00700804|16848229|P2|Overall Study|Protocol Violation|1
4889882|NCT00700804|16848230|P1|Overall Study|Protocol Violation|1
4889883|NCT00700804|16848229|P2|Overall Study|Withdrawal by Subject|2
4889884|NCT00700804|16848230|P1|Overall Study|Withdrawal by Subject|1
4889885|NCT00700752|16848238|P2|First Intervention|Withdrawal by Subject|2
4889886|NCT00700752|16848239|P1|First Intervention|Withdrawal by Subject|0
4889887|NCT00700739|16848247|P2|Overall Study|Lost to Follow-up|4
4889888|NCT00700739|16848248|P1|Overall Study|Lost to Follow-up|4
4889889|NCT00700713|16848287|P3|Overall Study|Withdrawal by Subject|1
4889890|NCT00700713|16848288|P2|Overall Study|Withdrawal by Subject|0
4889891|NCT00700713|16848289|P1|Overall Study|Withdrawal by Subject|0
4889892|NCT00700713|16848287|P3|Overall Study|Protocol Violation|1
4889893|NCT00700713|16848288|P2|Overall Study|Protocol Violation|0
4889894|NCT00700713|16848289|P1|Overall Study|Protocol Violation|1
4889895|NCT00700635|16848306|P3|Overall Study|Withdrawal by Subject|1
4889896|NCT00700635|16848307|P2|Overall Study|Withdrawal by Subject|3
4889897|NCT00700635|16848308|P1|Overall Study|Withdrawal by Subject|7
4889898|NCT00700635|16848306|P3|Overall Study|Protocol Violation|0
4889899|NCT00700635|16848307|P2|Overall Study|Protocol Violation|2
4889900|NCT00700635|16848308|P1|Overall Study|Protocol Violation|2
4889901|NCT00700635|16848306|P3|Overall Study|Lost to Follow-up|0
4889902|NCT00700635|16848307|P2|Overall Study|Lost to Follow-up|3
4889903|NCT00700635|16848308|P1|Overall Study|Lost to Follow-up|1
4889904|NCT00700635|16848306|P3|Overall Study|Adverse Event|0
4889905|NCT00700635|16848307|P2|Overall Study|Adverse Event|0
4889906|NCT00700635|16848308|P1|Overall Study|Adverse Event|1
4889907|NCT00700622|16848330|P2|Overall Study|Other|1
4889908|NCT00700622|16848331|P1|Overall Study|Other|3
4889909|NCT00700622|16848330|P2|Overall Study|Withdrawal by Subject|1
4889910|NCT00700622|16848331|P1|Overall Study|Withdrawal by Subject|4
4889911|NCT00700622|16848330|P2|Overall Study|Protocol Violation|1
4889912|NCT00700622|16848331|P1|Overall Study|Protocol Violation|0
4889913|NCT00700622|16848330|P2|Overall Study|Physician Decision|1
4889914|NCT00700622|16848331|P1|Overall Study|Physician Decision|2
4889915|NCT00700622|16848330|P2|Overall Study|Lost to Follow-up|1
4889916|NCT00700622|16848331|P1|Overall Study|Lost to Follow-up|0
4889917|NCT00700622|16848330|P2|Overall Study|Adverse Event|0
4889918|NCT00700622|16848331|P1|Overall Study|Adverse Event|4
4889919|NCT00700570|16848339|P2|Overall Study|Withdrawal by Subject|6
4889920|NCT00700570|16848340|P1|Overall Study|Withdrawal by Subject|1
4889921|NCT00700570|16848339|P2|Overall Study|Disease Progression|11
4889922|NCT00700570|16848340|P1|Overall Study|Disease Progression|8
4889923|NCT00700570|16848339|P2|Overall Study|Discretion of Investigator or Sponsor|3
4889924|NCT00700570|16848340|P1|Overall Study|Discretion of Investigator or Sponsor|0
4889925|NCT00700570|16848339|P2|Overall Study|Adverse Event|6
4889926|NCT00700570|16848340|P1|Overall Study|Adverse Event|2
4889927|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Clinical Relapse|1
4889928|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4889929|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4889930|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4889931|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Clinical Relapse|0
4889932|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11
4889933|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4889934|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4889935|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4889936|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0
4889937|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1
4889938|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4889939|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4889940|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4889941|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0
4889942|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Sponsor Decision|2
4889943|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4889944|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4889945|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4889946|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Sponsor Decision|0
4889947|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Physician Decision|2
4889948|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Physician Decision|0
4889949|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Physician Decision|0
4889950|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Physician Decision|0
4889951|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Physician Decision|0
4889952|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38
4889953|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4889954|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4889955|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4889956|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0
4889957|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Protocol Violation|12
4889958|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4889959|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4889960|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4889961|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Protocol Violation|0
4889962|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Death|1
4889963|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Death|0
4889964|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Death|0
4889965|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Death|0
4889966|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Death|0
4889967|NCT00700427|16848356|P5|Study Period 4 (Open-Label Extension)|Adverse Event|16
4889968|NCT00700427|16848357|P4|Study Period 4 (Open-Label Extension)|Adverse Event|0
4889969|NCT00700427|16848358|P3|Study Period 4 (Open-Label Extension)|Adverse Event|0
4889970|NCT00700427|16848359|P2|Study Period 4 (Open-Label Extension)|Adverse Event|0
4889971|NCT00700427|16848360|P1|Study Period 4 (Open-Label Extension)|Adverse Event|0
4889972|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Death|0
4889973|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Death|0
4889974|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Death|1
4889975|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Death|0
4889976|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Death|0
4889977|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4889978|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4889979|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Physician Decision|2
4889980|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4889981|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Physician Decision|0
4889982|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Missing|0
4889983|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Missing|1
4889984|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Missing|1
4889985|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Missing|0
4889986|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Missing|0
4889987|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4889988|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3
4889989|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4889990|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4889991|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0
4889992|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4889993|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5
4889994|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4889995|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4889996|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0
4889997|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
4889998|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11
4889999|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3
4890000|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
4890001|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0
4890002|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
4890003|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9
4890004|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19
4890005|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
4890006|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0
4890007|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
4890008|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25
4890009|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23
4890010|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
4890011|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0
4890012|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
4890013|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34
4890014|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25
4890015|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
4890016|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0
4890017|NCT00700427|16848356|P5|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
4890018|NCT00700427|16848357|P4|Study Period 3B (Randomized Withdrawal)|Adverse Event|5
4890019|NCT00700427|16848358|P3|Study Period 3B (Randomized Withdrawal)|Adverse Event|8
4890020|NCT00700427|16848359|P2|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
4890021|NCT00700427|16848360|P1|Study Period 3B (Randomized Withdrawal)|Adverse Event|0
4890022|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4890023|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4890024|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4890025|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5
4890026|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0
4890027|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4890028|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4890029|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4890030|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Physician Decision|2
4890031|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Physician Decision|0
4890032|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4890033|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4890034|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4890035|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3
4890036|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0
4890037|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4890038|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4890039|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4890040|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32
4890041|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0
4890042|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4890043|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4890044|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4890045|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41
4890046|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0
4890047|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4890048|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4890049|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4890050|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49
4890051|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0
4890052|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4890053|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4890054|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4890055|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Protocol Violation|56
4890056|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Protocol Violation|0
4890057|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4890058|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4890059|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4890060|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81
4890061|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0
4890062|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4890063|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4890064|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4890065|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162
4890066|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0
4890067|NCT00700427|16848356|P5|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4890068|NCT00700427|16848357|P4|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4890069|NCT00700427|16848358|P3|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4890070|NCT00700427|16848359|P2|Study Period 3A (Blinded Maintenance)|Adverse Event|50
4890071|NCT00700427|16848360|P1|Study Period 3A (Blinded Maintenance)|Adverse Event|0
4890072|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4890073|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4890074|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4890075|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0
4890076|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2
4890077|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4890078|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4890079|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4890080|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0
4890081|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7
4890082|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4890083|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4890084|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4890085|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0
4890086|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8
4890087|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4890088|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4890089|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4890090|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0
4890091|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90
4890092|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4890093|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4890094|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4890095|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0
4890096|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108
4890097|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4890098|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4890099|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4890100|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0
4890101|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161
4890102|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4890103|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4890104|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4890105|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0
4890106|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164
4890107|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4890108|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4890109|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4890110|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0
4890111|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173
4890112|NCT00700427|16848356|P5|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4890113|NCT00700427|16848357|P4|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4890114|NCT00700427|16848358|P3|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4890115|NCT00700427|16848359|P2|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0
4890116|NCT00700427|16848360|P1|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298
4890117|NCT00700401|16848382|P1|Overall Study|Withdrawal by Subject|2
4890118|NCT00700401|16848382|P1|Overall Study|HCV RNA not detected at baseline and SAE|1
4890119|NCT00700401|16848382|P1|Overall Study|Treatment never started|1
4890120|NCT00700401|16848382|P1|Overall Study|Lost to Follow-up|1
4890121|NCT00700401|16848382|P1|Overall Study|Refused Treatment|2
4890122|NCT00700401|16848382|P1|Overall Study|Adverse Event|5
4890123|NCT00700401|16848382|P1|Overall Study|Detectable HCV RNA after Week 4|82
4890124|NCT00700310|16848406|P4|Overall Study|Randomized, Not Treated|2
4890125|NCT00700310|16848407|P3|Overall Study|Randomized, Not Treated|2
4890126|NCT00700310|16848408|P2|Overall Study|Randomized, Not Treated|0
4890127|NCT00700310|16848409|P1|Overall Study|Randomized, Not Treated|2
4890128|NCT00700310|16848406|P4|Overall Study|Administrative/Other|3
4890129|NCT00700310|16848407|P3|Overall Study|Administrative/Other|1
4890130|NCT00700310|16848408|P2|Overall Study|Administrative/Other|3
4890131|NCT00700310|16848409|P1|Overall Study|Administrative/Other|1
4890132|NCT00700310|16848406|P4|Overall Study|Lack of Efficacy|1
4890133|NCT00700310|16848407|P3|Overall Study|Lack of Efficacy|0
4890134|NCT00700310|16848408|P2|Overall Study|Lack of Efficacy|3
4890135|NCT00700310|16848409|P1|Overall Study|Lack of Efficacy|0
4890136|NCT00700310|16848406|P4|Overall Study|Withdrawal by Subject|8
4890137|NCT00700310|16848407|P3|Overall Study|Withdrawal by Subject|8
4890138|NCT00700310|16848408|P2|Overall Study|Withdrawal by Subject|9
4890139|NCT00700310|16848409|P1|Overall Study|Withdrawal by Subject|8
4890140|NCT00700310|16848406|P4|Overall Study|Lost to Follow-up|1
4890141|NCT00700310|16848407|P3|Overall Study|Lost to Follow-up|0
4890142|NCT00700310|16848408|P2|Overall Study|Lost to Follow-up|1
4890143|NCT00700310|16848409|P1|Overall Study|Lost to Follow-up|4
4890144|NCT00700310|16848406|P4|Overall Study|Adverse Event|11
4890145|NCT00700310|16848407|P3|Overall Study|Adverse Event|5
4890146|NCT00700310|16848408|P2|Overall Study|Adverse Event|10
4890147|NCT00700310|16848409|P1|Overall Study|Adverse Event|6
4890148|NCT00700271|16848429|P2|Overall Study|Lost to Follow-up|2
4890149|NCT00700271|16848430|P1|Overall Study|Lost to Follow-up|2
4890150|NCT00700271|16848429|P2|Overall Study|Withdrawal by Subject|4
4890151|NCT00700271|16848430|P1|Overall Study|Withdrawal by Subject|6
4890152|NCT00700271|16848429|P2|Overall Study|Administrative Reasons|0
4890153|NCT00700271|16848430|P1|Overall Study|Administrative Reasons|1
4890154|NCT00700271|16848429|P2|Overall Study|Protocol Violation|0
4890155|NCT00700271|16848430|P1|Overall Study|Protocol Violation|1
4890156|NCT00700271|16848429|P2|Overall Study|Adverse Event|6
4890157|NCT00700271|16848430|P1|Overall Study|Adverse Event|4
4890158|NCT00700180|16848458|P2|Overall Study|Lost to Follow-up|5
4890159|NCT00700180|16848459|P1|Overall Study|Lost to Follow-up|4
4890160|NCT00700180|16848458|P2|Overall Study|Alive in follow-up|27
4890161|NCT00700180|16848459|P1|Overall Study|Alive in follow-up|46
4890162|NCT00700180|16848458|P2|Overall Study|Alive on treatment|3
4890163|NCT00700180|16848459|P1|Overall Study|Alive on treatment|5
4890164|NCT00700180|16848458|P2|Overall Study|Death|114
4890165|NCT00700180|16848459|P1|Overall Study|Death|99
4890166|NCT00700115|16848488|P2|Overall Study|Lost to Follow-up|1
4890167|NCT00700115|16848489|P1|Overall Study|Lost to Follow-up|0
4890168|NCT00700115|16848488|P2|Overall Study|Withdrawal by Subject|0
4890169|NCT00700115|16848489|P1|Overall Study|Withdrawal by Subject|1
4890170|NCT00700102|16848499|P2|Overall Study|Lost to Follow-up|10
4890171|NCT00700102|16848500|P1|Overall Study|Lost to Follow-up|8
4890172|NCT00700102|16848499|P2|Overall Study|Died|385
4890173|NCT00700102|16848500|P1|Overall Study|Died|394
4890174|NCT00700011|16848639|P2|Overall Study|Death|1
4890175|NCT00700011|16848640|P1|Overall Study|Death|0
4890176|NCT00699998|16848656|P4|Overall Study|Lost to Follow-up|1
4890177|NCT00699998|16848657|P3|Overall Study|Lost to Follow-up|3
4890178|NCT00699998|16848658|P2|Overall Study|Lost to Follow-up|1
4890179|NCT00699998|16848659|P1|Overall Study|Lost to Follow-up|2
4890180|NCT00699998|16848656|P4|Overall Study|Physician Decision|1
4890181|NCT00699998|16848657|P3|Overall Study|Physician Decision|1
4890182|NCT00699998|16848658|P2|Overall Study|Physician Decision|2
4890183|NCT00699998|16848659|P1|Overall Study|Physician Decision|3
4890184|NCT00699998|16848656|P4|Overall Study|Withdrawal by Subject|80
4890185|NCT00699998|16848657|P3|Overall Study|Withdrawal by Subject|202
4890186|NCT00699998|16848658|P2|Overall Study|Withdrawal by Subject|83
4890187|NCT00699998|16848659|P1|Overall Study|Withdrawal by Subject|194
4890188|NCT00699972|16848704|P3|Overall Study|Randomized, Not Treated|1
4890189|NCT00699972|16848705|P2|Overall Study|Randomized, Not Treated|0
4890190|NCT00699972|16848706|P1|Overall Study|Randomized, Not Treated|1
4890191|NCT00699972|16848704|P3|Overall Study|Administrative/Other|4
4890192|NCT00699972|16848705|P2|Overall Study|Administrative/Other|1
4890193|NCT00699972|16848706|P1|Overall Study|Administrative/Other|3
4890194|NCT00699972|16848704|P3|Overall Study|Lack of Efficacy|2
4890195|NCT00699972|16848705|P2|Overall Study|Lack of Efficacy|0
4890196|NCT00699972|16848706|P1|Overall Study|Lack of Efficacy|2
4890197|NCT00699972|16848704|P3|Overall Study|Withdrawal by Subject|4
4890198|NCT00699972|16848705|P2|Overall Study|Withdrawal by Subject|7
4890199|NCT00699972|16848706|P1|Overall Study|Withdrawal by Subject|3
4890200|NCT00699972|16848704|P3|Overall Study|Lost to Follow-up|0
4890201|NCT00699972|16848705|P2|Overall Study|Lost to Follow-up|2
4890202|NCT00699972|16848706|P1|Overall Study|Lost to Follow-up|0
4890203|NCT00699972|16848704|P3|Overall Study|Adverse Event|24
4890204|NCT00699972|16848705|P2|Overall Study|Adverse Event|9
4890205|NCT00699972|16848706|P1|Overall Study|Adverse Event|7
4890206|NCT00699907|16848723|P3|Overall Study|No usable sample|8
4890207|NCT00699907|16848724|P2|Overall Study|No usable sample|9
4890208|NCT00699907|16848725|P1|Overall Study|No usable sample|0
4890209|NCT00699907|16848723|P3|Overall Study|Withdrawal by Subject|0
4890210|NCT00699907|16848724|P2|Overall Study|Withdrawal by Subject|1
4890211|NCT00699907|16848725|P1|Overall Study|Withdrawal by Subject|2
4890212|NCT00699842|16848760|P3|Overall Study|Death|0
4890213|NCT00699842|16848761|P2|Overall Study|Death|1
4890214|NCT00699842|16848762|P1|Overall Study|Death|0
4890215|NCT00699816|16848775|P2|Overall Study|Protocol Violation|3
4890216|NCT00699816|16848776|P1|Overall Study|Protocol Violation|1
4890217|NCT00699751|16848803|P2|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4
4890218|NCT00699751|16848804|P1|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0
4890219|NCT00699751|16848803|P2|Period 2:Switched From Placebo to Xofigo|Investigator Request|1
4890220|NCT00699751|16848804|P1|Period 2:Switched From Placebo to Xofigo|Investigator Request|0
4890221|NCT00699751|16848803|P2|Period 2:Switched From Placebo to Xofigo|Adverse Event|4
4890222|NCT00699751|16848804|P1|Period 2:Switched From Placebo to Xofigo|Adverse Event|0
4890223|NCT00699751|16848803|P2|Period 1: Without/Before Drug Switch|Adverse Event|63
4890224|NCT00699751|16848804|P1|Period 1: Without/Before Drug Switch|Adverse Event|97
4890225|NCT00699751|16848803|P2|Period 1: Without/Before Drug Switch|Other|20
4890226|NCT00699751|16848804|P1|Period 1: Without/Before Drug Switch|Other|30
4890227|NCT00699751|16848803|P2|Period 1: Without/Before Drug Switch|Subject Request|23
4890228|NCT00699751|16848804|P1|Period 1: Without/Before Drug Switch|Subject Request|43
4890229|NCT00699751|16848803|P2|Period 1: Without/Before Drug Switch|Death|29
4890230|NCT00699751|16848804|P1|Period 1: Without/Before Drug Switch|Death|28
4890231|NCT00699751|16848803|P2|Period 1: Without/Before Drug Switch|Investigator Request|27
4890232|NCT00699751|16848804|P1|Period 1: Without/Before Drug Switch|Investigator Request|27
4890233|NCT00699699|16848889|P1|Overall Study|Individual different reasons|21
4890234|NCT00699699|16848889|P1|Overall Study|Adverse Event|36
4890235|NCT00699660|16848898|P2|Overall Study|missing reports and recording failures|6
4890236|NCT00699660|16848899|P1|Overall Study|missing reports and recording failures|10
4890237|NCT00699660|16848898|P2|Overall Study|Lost to Follow-up|2
4890238|NCT00699660|16848899|P1|Overall Study|Lost to Follow-up|4
4890239|NCT00699608|16848911|P6|Second Intervention|Withdrawal by Subject|0
4890240|NCT00699608|16848912|P5|Second Intervention|Withdrawal by Subject|0
4890241|NCT00699608|16848913|P4|Second Intervention|Withdrawal by Subject|1
4890242|NCT00699608|16848914|P3|Second Intervention|Withdrawal by Subject|0
4890243|NCT00699608|16848915|P2|Second Intervention|Withdrawal by Subject|0
4890244|NCT00699608|16848916|P1|Second Intervention|Withdrawal by Subject|0
4890245|NCT00699608|16848911|P6|Second Intervention|Adverse Event|0
4890246|NCT00699608|16848912|P5|Second Intervention|Adverse Event|0
4890247|NCT00699608|16848913|P4|Second Intervention|Adverse Event|0
4890248|NCT00699608|16848914|P3|Second Intervention|Adverse Event|1
4890249|NCT00699608|16848915|P2|Second Intervention|Adverse Event|0
4890250|NCT00699608|16848916|P1|Second Intervention|Adverse Event|0
4890251|NCT00699608|16848911|P6|First Intervention|Protocol Violation|0
4890252|NCT00699608|16848912|P5|First Intervention|Protocol Violation|1
4890253|NCT00699608|16848913|P4|First Intervention|Protocol Violation|0
4890254|NCT00699608|16848914|P3|First Intervention|Protocol Violation|0
4890255|NCT00699608|16848915|P2|First Intervention|Protocol Violation|0
4890256|NCT00699608|16848916|P1|First Intervention|Protocol Violation|0
4890257|NCT00699608|16848911|P6|First Intervention|Withdrawal by Subject|0
4890258|NCT00699608|16848912|P5|First Intervention|Withdrawal by Subject|0
4890259|NCT00699608|16848913|P4|First Intervention|Withdrawal by Subject|0
4890260|NCT00699608|16848914|P3|First Intervention|Withdrawal by Subject|1
4890261|NCT00699608|16848915|P2|First Intervention|Withdrawal by Subject|0
4890262|NCT00699608|16848916|P1|First Intervention|Withdrawal by Subject|0
4890263|NCT00699582|16848969|P3|Overall Study|Randomized, Not Treated|0
4890264|NCT00699582|16848970|P2|Overall Study|Randomized, Not Treated|1
4890265|NCT00699582|16848971|P1|Overall Study|Randomized, Not Treated|2
4890266|NCT00699582|16848969|P3|Overall Study|Administrative/Other|0
4890267|NCT00699582|16848970|P2|Overall Study|Administrative/Other|3
4890268|NCT00699582|16848971|P1|Overall Study|Administrative/Other|4
4890269|NCT00699582|16848969|P3|Overall Study|Progressive Disease|0
4890270|NCT00699582|16848970|P2|Overall Study|Progressive Disease|0
4890271|NCT00699582|16848971|P1|Overall Study|Progressive Disease|1
4890272|NCT00699582|16848969|P3|Overall Study|Lack of Efficacy|1
4890273|NCT00699582|16848970|P2|Overall Study|Lack of Efficacy|0
4890274|NCT00699582|16848971|P1|Overall Study|Lack of Efficacy|1
4890275|NCT00699582|16848969|P3|Overall Study|Withdrawal by Subject|4
4890276|NCT00699582|16848970|P2|Overall Study|Withdrawal by Subject|7
4890277|NCT00699582|16848971|P1|Overall Study|Withdrawal by Subject|6
4890278|NCT00699582|16848969|P3|Overall Study|Adverse Event|23
4890279|NCT00699582|16848970|P2|Overall Study|Adverse Event|11
4890280|NCT00699582|16848971|P1|Overall Study|Adverse Event|4
4890281|NCT00699413|16849026|P2|Overall Study|Study terminated by sponsor|2
4890282|NCT00699413|16849027|P1|Overall Study|Study terminated by sponsor|4
4890283|NCT00699413|16849026|P2|Overall Study|Withdrawal by Subject|2
4890284|NCT00699413|16849027|P1|Overall Study|Withdrawal by Subject|0
4890285|NCT00699374|16849081|P2|Overall Study|Died 28 days after last dose|9
4890286|NCT00699374|16849082|P1|Overall Study|Died 28 days after last dose|5
4890287|NCT00699374|16849081|P2|Overall Study|Randomized but not treated|2
4890288|NCT00699374|16849082|P1|Overall Study|Randomized but not treated|4
4890289|NCT00699374|16849081|P2|Overall Study|Study terminated by sponsor|28
4890290|NCT00699374|16849082|P1|Overall Study|Study terminated by sponsor|13
4890291|NCT00699374|16849081|P2|Overall Study|Protocol Violation|6
4890292|NCT00699374|16849082|P1|Overall Study|Protocol Violation|2
4890293|NCT00699374|16849081|P2|Overall Study|Other|15
4890294|NCT00699374|16849082|P1|Overall Study|Other|18
4890295|NCT00699374|16849081|P2|Overall Study|Objective progression or relapse|277
4890296|NCT00699374|16849082|P1|Overall Study|Objective progression or relapse|281
4890297|NCT00699374|16849081|P2|Overall Study|Withdrawal by Subject|44
4890298|NCT00699374|16849082|P1|Overall Study|Withdrawal by Subject|34
4890299|NCT00699374|16849081|P2|Overall Study|Lost to Follow-up|5
4890300|NCT00699374|16849082|P1|Overall Study|Lost to Follow-up|3
4890301|NCT00699374|16849081|P2|Overall Study|Global deterioration of health status|8
4890302|NCT00699374|16849082|P1|Overall Study|Global deterioration of health status|7
4890303|NCT00699374|16849081|P2|Overall Study|Adverse Event|67
4890304|NCT00699374|16849082|P1|Overall Study|Adverse Event|70
4890305|NCT00699374|16849081|P2|Overall Study|Death|83
4890306|NCT00699374|16849082|P1|Overall Study|Death|93
4890307|NCT00699348|16849094|P1|Overall Study|Other|5
4890308|NCT00699348|16849094|P1|Overall Study|Renal transplantation|10
4890309|NCT00699348|16849094|P1|Overall Study|Blood transfusion|24
4890310|NCT00699348|16849094|P1|Overall Study|Failure to return|1
4890311|NCT00699348|16849094|P1|Overall Study|Lack of Efficacy|8
4890312|NCT00699348|16849094|P1|Overall Study|Protocol Violation|10
4890313|NCT00699348|16849094|P1|Overall Study|Withdrawal by Subject|11
4890314|NCT00699348|16849094|P1|Overall Study|Adverse Event|15
4890315|NCT00699348|16849094|P1|Overall Study|Death|6
4890316|NCT00699335|16849103|P1|Overall Study|Missing data|52
4890317|NCT00699335|16849103|P1|Overall Study|Combination of multiple reasons|176
4890318|NCT00699283|16849136|P2|Overall Study|AE of unknown type|0
4890319|NCT00699283|16849137|P1|Overall Study|AE of unknown type|1
4890320|NCT00699283|16849136|P2|Overall Study|AE, non-serious non-fatal|1
4890321|NCT00699283|16849137|P1|Overall Study|AE, non-serious non-fatal|8
4890322|NCT00699283|16849136|P2|Overall Study|SAE, non-fatal|1
4890323|NCT00699283|16849137|P1|Overall Study|SAE, non-fatal|1
4890324|NCT00699283|16849136|P2|Overall Study|Other Reason|1
4890325|NCT00699283|16849137|P1|Overall Study|Other Reason|5
4890326|NCT00699283|16849136|P2|Overall Study|Withdrawal by Subject|0
4890327|NCT00699283|16849137|P1|Overall Study|Withdrawal by Subject|1
4890328|NCT00699283|16849136|P2|Overall Study|Lost to Follow-up|0
4890329|NCT00699283|16849137|P1|Overall Study|Lost to Follow-up|2
4890330|NCT00699283|16849136|P2|Overall Study|Lack of Efficacy|5
4890331|NCT00699283|16849137|P1|Overall Study|Lack of Efficacy|15
4890332|NCT00699192|16849150|P3|Overall Study|Protocol Violation|0
4890333|NCT00699192|16849151|P2|Overall Study|Protocol Violation|2
4890334|NCT00699192|16849152|P1|Overall Study|Protocol Violation|2
4890335|NCT00699192|16849150|P3|Overall Study|Administrative problems|1
4890336|NCT00699192|16849151|P2|Overall Study|Administrative problems|3
4890337|NCT00699192|16849152|P1|Overall Study|Administrative problems|1
4890338|NCT00699192|16849150|P3|Overall Study|Withdrawal by Subject|4
4890339|NCT00699192|16849151|P2|Overall Study|Withdrawal by Subject|2
4890340|NCT00699192|16849152|P1|Overall Study|Withdrawal by Subject|3
4890341|NCT00699192|16849150|P3|Overall Study|Lack of Efficacy|1
4890342|NCT00699192|16849151|P2|Overall Study|Lack of Efficacy|0
4890343|NCT00699192|16849152|P1|Overall Study|Lack of Efficacy|0
4890344|NCT00699192|16849150|P3|Overall Study|Abnormal test procedure result(s)|1
4890345|NCT00699192|16849151|P2|Overall Study|Abnormal test procedure result(s)|0
4890346|NCT00699192|16849152|P1|Overall Study|Abnormal test procedure result(s)|0
4890347|NCT00699192|16849150|P3|Overall Study|Adverse Event|3
4890348|NCT00699192|16849151|P2|Overall Study|Adverse Event|4
4890349|NCT00699192|16849152|P1|Overall Study|Adverse Event|9
4890350|NCT00699192|16849150|P3|Overall Study|Missing|1
4890351|NCT00699192|16849151|P2|Overall Study|Missing|1
4890352|NCT00699192|16849152|P1|Overall Study|Missing|1
4890353|NCT00699153|16849174|P2|Overall Study|Travel Problem|0
4890354|NCT00699153|16849175|P1|Overall Study|Travel Problem|1
4890355|NCT00699153|16849174|P2|Overall Study|Protocol Violation|0
4890356|NCT00699153|16849175|P1|Overall Study|Protocol Violation|1
4890357|NCT00699153|16849174|P2|Overall Study|Adverse Event|2
4890358|NCT00699153|16849175|P1|Overall Study|Adverse Event|0
4890359|NCT00699153|16849174|P2|Overall Study|Lost to Follow-up|0
4890360|NCT00699153|16849175|P1|Overall Study|Lost to Follow-up|1
4890361|NCT00698997|16849210|P2|Overall Study|Withdrawal by Subject|27
4890362|NCT00698997|16849211|P1|Overall Study|Withdrawal by Subject|7
4890363|NCT00698997|16849210|P2|Overall Study|Lost to Follow-up|0
4890364|NCT00698997|16849211|P1|Overall Study|Lost to Follow-up|3
4890365|NCT00698932|16849225|P2|Overall Study|Death|0
4890366|NCT00698932|16849226|P1|Overall Study|Death|1
4890367|NCT00698932|16849225|P2|Overall Study|Safety reasons|2
4890368|NCT00698932|16849226|P1|Overall Study|Safety reasons|0
4890369|NCT00698932|16849225|P2|Overall Study|Severe non-compliance to protocol|2
4890370|NCT00698932|16849226|P1|Overall Study|Severe non-compliance to protocol|1
4890371|NCT00698932|16849225|P2|Overall Study|Lost to Follow-up|1
4890372|NCT00698932|16849226|P1|Overall Study|Lost to Follow-up|6
4890373|NCT00698932|16849225|P2|Overall Study|Withdrawal by Subject|23
4890374|NCT00698932|16849226|P1|Overall Study|Withdrawal by Subject|11
4890375|NCT00698932|16849225|P2|Overall Study|Study specific discontinuation criteria|4
4890376|NCT00698932|16849226|P1|Overall Study|Study specific discontinuation criteria|3
4890377|NCT00698932|16849225|P2|Overall Study|Incorrect enrollment|2
4890378|NCT00698932|16849226|P1|Overall Study|Incorrect enrollment|0
4890379|NCT00698932|16849225|P2|Overall Study|Adverse Event|2
4890380|NCT00698932|16849226|P1|Overall Study|Adverse Event|0
4890381|NCT00698841|16849252|P1|Overall Study|Other|2
4890382|NCT00698841|16849252|P1|Overall Study|Study drug toxicity|2
4890383|NCT00698841|16849252|P1|Overall Study|Failure to meet eligibility criteria|2
4890384|NCT00698841|16849252|P1|Overall Study|Disease progression|7
4890385|NCT00698841|16849252|P1|Overall Study|Adverse Event|3
4890386|NCT00698841|16849252|P1|Overall Study|Withdrawal by Subject|2
4890387|NCT00698815|16849266|P3|Overall Study|Did not receive protocol treatment|2
4890388|NCT00698815|16849267|P2|Overall Study|Did not receive protocol treatment|2
4890389|NCT00698815|16849268|P1|Overall Study|Did not receive protocol treatment|1
4890390|NCT00698815|16849266|P3|Overall Study|MD discretion|2
4890391|NCT00698815|16849267|P2|Overall Study|MD discretion|7
4890392|NCT00698815|16849268|P1|Overall Study|MD discretion|2
4890393|NCT00698815|16849266|P3|Overall Study|Withdrawal by Subject|2
4890394|NCT00698815|16849267|P2|Overall Study|Withdrawal by Subject|3
4890395|NCT00698815|16849268|P1|Overall Study|Withdrawal by Subject|6
4890396|NCT00698815|16849266|P3|Overall Study|Death|4
4890397|NCT00698815|16849267|P2|Overall Study|Death|2
4890398|NCT00698815|16849268|P1|Overall Study|Death|1
4890399|NCT00698685|16849285|P1|Overall Study|Off study pre transplant by clinic MD|1
4890400|NCT00698685|16849285|P1|Overall Study|Sister withdrew as donor|1
4890401|NCT00698646|16849293|P3|Overall Study|Administrative problems|1
4890402|NCT00698646|16849294|P2|Overall Study|Administrative problems|0
4890403|NCT00698646|16849295|P1|Overall Study|Administrative problems|1
4890404|NCT00698646|16849293|P3|Overall Study|Lost to Follow-up|2
4890405|NCT00698646|16849294|P2|Overall Study|Lost to Follow-up|0
4890406|NCT00698646|16849295|P1|Overall Study|Lost to Follow-up|0
4890407|NCT00698646|16849293|P3|Overall Study|Withdrawal by Subject|8
4890408|NCT00698646|16849294|P2|Overall Study|Withdrawal by Subject|11
4890409|NCT00698646|16849295|P1|Overall Study|Withdrawal by Subject|10
4890410|NCT00698646|16849293|P3|Overall Study|Protocol Deviation|3
4890411|NCT00698646|16849294|P2|Overall Study|Protocol Deviation|2
4890412|NCT00698646|16849295|P1|Overall Study|Protocol Deviation|6
4890413|NCT00698646|16849293|P3|Overall Study|Unsatisfactory Therapeutic Effect|7
4890414|NCT00698646|16849294|P2|Overall Study|Unsatisfactory Therapeutic Effect|11
4890415|NCT00698646|16849295|P1|Overall Study|Unsatisfactory Therapeutic Effect|11
4890416|NCT00698646|16849293|P3|Overall Study|Adverse Event|8
4890417|NCT00698646|16849294|P2|Overall Study|Adverse Event|7
4890418|NCT00698646|16849295|P1|Overall Study|Adverse Event|8
4890419|NCT00698581|16849320|P2|Overall Study|AE of unknown type|0
4890420|NCT00698581|16849321|P1|Overall Study|AE of unknown type|1
4890421|NCT00698581|16849320|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4890422|NCT00698581|16849321|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4890423|NCT00698581|16849320|P2|Overall Study|AE, non-serious non-fatal|0
4890424|NCT00698581|16849321|P1|Overall Study|AE, non-serious non-fatal|4
4890425|NCT00698581|16849320|P2|Overall Study|SAE, non-fatal|0
4890426|NCT00698581|16849321|P1|Overall Study|SAE, non-fatal|1
4890427|NCT00698581|16849320|P2|Overall Study|Other reason|1
4890428|NCT00698581|16849321|P1|Overall Study|Other reason|9
4890429|NCT00698581|16849320|P2|Overall Study|Withdrawal by Subject|0
4890430|NCT00698581|16849321|P1|Overall Study|Withdrawal by Subject|6
4890431|NCT00698581|16849320|P2|Overall Study|Lack of Efficacy|11
4890432|NCT00698581|16849321|P1|Overall Study|Lack of Efficacy|23
4890433|NCT00698516|16849332|P1|Overall Study|Withdrawal by Subject|3
4890434|NCT00698516|16849332|P1|Overall Study|Study Termination|2
4890435|NCT00698451|16849350|P1|Overall Study|Disease progression|3
4890436|NCT00698451|16849350|P1|Overall Study|Withdrawal by Subject|6
4890437|NCT00698451|16849350|P1|Overall Study|Protocol Violation|6
4890438|NCT00698451|16849350|P1|Overall Study|Physician Decision|2
4890439|NCT00698451|16849350|P1|Overall Study|Adverse Event|22
4890440|NCT00698204|16849357|P2|Overall Study|Withdrawal by Subject|0
4890441|NCT00698204|16849358|P1|Overall Study|Withdrawal by Subject|1
4890442|NCT00698009|16849418|P1|Overall Study|Withdrawal by Subject|1
4890443|NCT00697827|16849424|P2|Overall Study|enrolled but not treated|1
4890444|NCT00697827|16849425|P1|Overall Study|enrolled but not treated|2
4890445|NCT00697788|16849452|P8|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890446|NCT00697788|16849453|P7|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890447|NCT00697788|16849454|P6|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890448|NCT00697788|16849455|P5|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1
4890449|NCT00697788|16849456|P4|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890450|NCT00697788|16849457|P3|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890451|NCT00697788|16849458|P2|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890452|NCT00697788|16849459|P1|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0
4890453|NCT00697788|16849452|P8|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890454|NCT00697788|16849453|P7|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890455|NCT00697788|16849454|P6|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890456|NCT00697788|16849455|P5|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890457|NCT00697788|16849456|P4|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890458|NCT00697788|16849457|P3|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890459|NCT00697788|16849458|P2|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2
4890460|NCT00697788|16849459|P1|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0
4890461|NCT00697619|16849514|P2|Overall Study|Adverse Event|6
4890462|NCT00697619|16849515|P1|Overall Study|Adverse Event|4
4890463|NCT00697619|16849514|P2|Overall Study|Lack of Efficacy|2
4890464|NCT00697619|16849515|P1|Overall Study|Lack of Efficacy|2
4890465|NCT00697593|16849521|P1|Overall Study|Suspension of the study by sponsor|12
4890466|NCT00697593|16849521|P1|Overall Study|Lack of Efficacy|3
4890467|NCT00697593|16849521|P1|Overall Study|Protocol Violation|1
4890468|NCT00697593|16849521|P1|Overall Study|Adverse Event|3
4890469|NCT00697515|16849565|P2|Second Intervention (Crossover Period)|Withdrawal by Subject|1
4890470|NCT00697515|16849566|P1|Second Intervention (Crossover Period)|Withdrawal by Subject|1
4890471|NCT00697515|16849565|P2|First Intervention (Crossover Period)|Withdrawal by Subject|1
4890472|NCT00697515|16849566|P1|First Intervention (Crossover Period)|Withdrawal by Subject|2
4890473|NCT00697515|16849565|P2|First Intervention (Crossover Period)|Adverse Event|2
4890474|NCT00697515|16849566|P1|First Intervention (Crossover Period)|Adverse Event|0
4890475|NCT00697515|16849565|P2|First Intervention (Crossover Period)|Natural disaster|9
4890476|NCT00697515|16849566|P1|First Intervention (Crossover Period)|Natural disaster|8
4890477|NCT00697515|16849565|P2|Dose Optimization Period|elevated QTc|0
4890478|NCT00697515|16849566|P1|Dose Optimization Period|elevated QTc|1
4890479|NCT00697515|16849565|P2|Dose Optimization Period|called to active duty|0
4890480|NCT00697515|16849566|P1|Dose Optimization Period|called to active duty|1
4890481|NCT00697515|16849565|P2|Dose Optimization Period|sponsor request|0
4890482|NCT00697515|16849566|P1|Dose Optimization Period|sponsor request|2
4890483|NCT00697515|16849565|P2|Dose Optimization Period|Lost to Follow-up|0
4890484|NCT00697515|16849566|P1|Dose Optimization Period|Lost to Follow-up|2
4890485|NCT00697515|16849565|P2|Dose Optimization Period|Withdrawal by Subject|0
4890486|NCT00697515|16849566|P1|Dose Optimization Period|Withdrawal by Subject|5
4890487|NCT00697515|16849565|P2|Dose Optimization Period|Adverse Event|0
4890488|NCT00697515|16849566|P1|Dose Optimization Period|Adverse Event|4
4890489|NCT00697463|16849594|P1|Overall Study|Withdrawal by Subject|1
4890490|NCT00697346|16849601|P3|Overall Study|Reason not Specified|1
4890491|NCT00697346|16849602|P2|Overall Study|Reason not Specified|0
4890492|NCT00697346|16849603|P1|Overall Study|Reason not Specified|3
4890493|NCT00697346|16849601|P3|Overall Study|Withdrawal by Subject|0
4890494|NCT00697346|16849602|P2|Overall Study|Withdrawal by Subject|2
4890495|NCT00697346|16849603|P1|Overall Study|Withdrawal by Subject|2
4890496|NCT00697346|16849601|P3|Overall Study|Symptomatic Deterioration|0
4890497|NCT00697346|16849602|P2|Overall Study|Symptomatic Deterioration|1
4890498|NCT00697346|16849603|P1|Overall Study|Symptomatic Deterioration|0
4890499|NCT00697346|16849601|P3|Overall Study|Progressive Disease|0
4890500|NCT00697346|16849602|P2|Overall Study|Progressive Disease|18
4890501|NCT00697346|16849603|P1|Overall Study|Progressive Disease|19
4890502|NCT00697346|16849601|P3|Overall Study|Adverse Event|0
4890503|NCT00697346|16849602|P2|Overall Study|Adverse Event|5
4890504|NCT00697346|16849603|P1|Overall Study|Adverse Event|4
4890505|NCT00697255|16849711|P2|Stage 1b|Insufficient ovarian response|1
4890506|NCT00697255|16849712|P1|Stage 1b|Insufficient ovarian response|0
4890507|NCT00697255|16849711|P2|Stage 1b|Not growing of dominant follicle|1
4890508|NCT00697255|16849712|P1|Stage 1b|Not growing of dominant follicle|0
4890509|NCT00697255|16849711|P2|Stage 1a|Not growing of dominant follicle|0
4890510|NCT00697255|16849712|P1|Stage 1a|Not growing of dominant follicle|1
4890511|NCT00697255|16849711|P2|Stage 1a|Multifollicular growth|0
4890512|NCT00697255|16849712|P1|Stage 1a|Multifollicular growth|1
4890513|NCT00697255|16849711|P2|Stage 1a|Insufficient ovarian response|0
4890514|NCT00697255|16849712|P1|Stage 1a|Insufficient ovarian response|1
4890515|NCT00697112|16849800|P1|Overall Study|Did not meet inclusion criteria|1
4890516|NCT00697112|16849800|P1|Overall Study|Lost to Follow-up|1
4890517|NCT00697112|16849800|P1|Overall Study|Adverse Event|8
4890518|NCT00697073|16849824|P1|Overall Study|non compliance and other|6
4890519|NCT00697073|16849824|P1|Overall Study|Pregnancy|1
4890520|NCT00697073|16849824|P1|Overall Study|Withdrawal by Subject|2
4890521|NCT00696878|16849828|P1|Overall Study|Other reason (not specified)|55
4890522|NCT00696878|16849828|P1|Overall Study|Trial stopped|32
4890523|NCT00696878|16849828|P1|Overall Study|Pregnant prior to Treat Cycle 3|304
4890524|NCT00696878|16849828|P1|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18
4890525|NCT00696878|16849828|P1|Overall Study|Withdrawal by Subject|87
4890526|NCT00696878|16849828|P1|Overall Study|Adverse Event|8
4890527|NCT00696800|16849902|P2|Overall Study|Not treated|2
4890528|NCT00696800|16849903|P1|Overall Study|Not treated|1
4890529|NCT00696800|16849902|P2|Overall Study|Other Reasons|3
4890530|NCT00696800|16849903|P1|Overall Study|Other Reasons|5
4890531|NCT00696800|16849902|P2|Overall Study|No/too few/bad quality embryos|18
4890532|NCT00696800|16849903|P1|Overall Study|No/too few/bad quality embryos|24
4890533|NCT00696800|16849902|P2|Overall Study|No/abnormal fertilization|13
4890534|NCT00696800|16849903|P1|Overall Study|No/abnormal fertilization|11
4890535|NCT00696800|16849902|P2|Overall Study|No/too few/bad quality oocytes|3
4890536|NCT00696800|16849903|P1|Overall Study|No/too few/bad quality oocytes|4
4890537|NCT00696800|16849902|P2|Overall Study|Too high ovarian response|1
4890538|NCT00696800|16849903|P1|Overall Study|Too high ovarian response|6
4890539|NCT00696800|16849902|P2|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2
4890540|NCT00696800|16849903|P1|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8
4890541|NCT00696800|16849902|P2|Overall Study|Insufficient ovarian response|1
4890542|NCT00696800|16849903|P1|Overall Study|Insufficient ovarian response|4
4890543|NCT00696800|16849902|P2|Overall Study|Insufficient ovarian response on Day 8|1
4890544|NCT00696800|16849903|P1|Overall Study|Insufficient ovarian response on Day 8|4
4890545|NCT00696800|16849902|P2|Overall Study|Insufficient compliance with medication|1
4890546|NCT00696800|16849903|P1|Overall Study|Insufficient compliance with medication|2
4890547|NCT00696800|16849902|P2|Overall Study|Adverse Event|3
4890548|NCT00696800|16849903|P1|Overall Study|Adverse Event|16
4890549|NCT00696787|16849956|P3|Overall Study|Failed to return|1
4890550|NCT00696787|16849957|P2|Overall Study|Failed to return|3
4890551|NCT00696787|16849958|P1|Overall Study|Failed to return|1
4890552|NCT00696787|16849956|P3|Overall Study|Withdrawal by Subject|2
4890553|NCT00696787|16849957|P2|Overall Study|Withdrawal by Subject|3
4890554|NCT00696787|16849958|P1|Overall Study|Withdrawal by Subject|0
4890555|NCT00696787|16849956|P3|Overall Study|Lost to Follow-up|3
4890556|NCT00696787|16849957|P2|Overall Study|Lost to Follow-up|0
4890557|NCT00696787|16849958|P1|Overall Study|Lost to Follow-up|4
4890558|NCT00696787|16849956|P3|Overall Study|Lack of Efficacy|0
4890559|NCT00696787|16849957|P2|Overall Study|Lack of Efficacy|1
4890560|NCT00696787|16849958|P1|Overall Study|Lack of Efficacy|0
4890561|NCT00696787|16849956|P3|Overall Study|Discontinuation by Sponsor|14
4890562|NCT00696787|16849957|P2|Overall Study|Discontinuation by Sponsor|13
4890563|NCT00696787|16849958|P1|Overall Study|Discontinuation by Sponsor|9
4890564|NCT00696787|16849956|P3|Overall Study|Adverse Event|6
4890565|NCT00696787|16849957|P2|Overall Study|Adverse Event|0
4890566|NCT00696787|16849958|P1|Overall Study|Adverse Event|1
4890567|NCT00696774|16849972|P3|Period III|Lack of Efficacy|0
4890568|NCT00696774|16849973|P2|Period III|Lack of Efficacy|2
4890569|NCT00696774|16849974|P1|Period III|Lack of Efficacy|0
4890570|NCT00696774|16849972|P3|Period III|Sponsor Decision|0
4890571|NCT00696774|16849973|P2|Period III|Sponsor Decision|0
4890572|NCT00696774|16849974|P1|Period III|Sponsor Decision|2
4890573|NCT00696774|16849972|P3|Period III|Withdrawal by Subject|0
4890574|NCT00696774|16849973|P2|Period III|Withdrawal by Subject|2
4890575|NCT00696774|16849974|P1|Period III|Withdrawal by Subject|1
4890576|NCT00696774|16849972|P3|Period III|Protocol Violation|0
4890577|NCT00696774|16849973|P2|Period III|Protocol Violation|1
4890578|NCT00696774|16849974|P1|Period III|Protocol Violation|1
4890579|NCT00696774|16849972|P3|Period III|Lost to Follow-up|0
4890580|NCT00696774|16849973|P2|Period III|Lost to Follow-up|1
4890581|NCT00696774|16849974|P1|Period III|Lost to Follow-up|2
4890582|NCT00696774|16849972|P3|Period III|Adverse Event|0
4890583|NCT00696774|16849973|P2|Period III|Adverse Event|1
4890584|NCT00696774|16849974|P1|Period III|Adverse Event|1
4890585|NCT00696774|16849972|P3|Period II|Lack of Efficacy|2
4890586|NCT00696774|16849973|P2|Period II|Lack of Efficacy|0
4890587|NCT00696774|16849974|P1|Period II|Lack of Efficacy|0
4890588|NCT00696774|16849972|P3|Period II|Sponsor Decision|0
4890589|NCT00696774|16849973|P2|Period II|Sponsor Decision|0
4890590|NCT00696774|16849974|P1|Period II|Sponsor Decision|0
4890591|NCT00696774|16849972|P3|Period II|Withdrawal by Subject|4
4890592|NCT00696774|16849973|P2|Period II|Withdrawal by Subject|0
4890593|NCT00696774|16849974|P1|Period II|Withdrawal by Subject|0
4890594|NCT00696774|16849972|P3|Period II|Protocol Violation|11
4890595|NCT00696774|16849973|P2|Period II|Protocol Violation|0
4890596|NCT00696774|16849974|P1|Period II|Protocol Violation|0
4890597|NCT00696774|16849972|P3|Period II|Lost to Follow-up|4
4890598|NCT00696774|16849973|P2|Period II|Lost to Follow-up|0
4890599|NCT00696774|16849974|P1|Period II|Lost to Follow-up|0
4890600|NCT00696774|16849972|P3|Period II|Adverse Event|15
4890601|NCT00696774|16849973|P2|Period II|Adverse Event|0
4890602|NCT00696774|16849974|P1|Period II|Adverse Event|0
4890603|NCT00696709|16850034|P5|Overall Study|Adverse Event|0
4890604|NCT00696709|16850035|P4|Overall Study|Adverse Event|1
4890605|NCT00696709|16850036|P3|Overall Study|Adverse Event|0
4890606|NCT00696709|16850037|P2|Overall Study|Adverse Event|0
4890607|NCT00696709|16850038|P1|Overall Study|Adverse Event|0
4890608|NCT00696709|16850034|P5|Overall Study|Lost to Follow-up|0
4890609|NCT00696709|16850035|P4|Overall Study|Lost to Follow-up|0
4890610|NCT00696709|16850036|P3|Overall Study|Lost to Follow-up|0
4890611|NCT00696709|16850037|P2|Overall Study|Lost to Follow-up|1
4890612|NCT00696709|16850038|P1|Overall Study|Lost to Follow-up|1
4890613|NCT00696709|16850034|P5|Overall Study|Protocol Violation|0
4890614|NCT00696709|16850035|P4|Overall Study|Protocol Violation|0
4890615|NCT00696709|16850036|P3|Overall Study|Protocol Violation|0
4890616|NCT00696709|16850037|P2|Overall Study|Protocol Violation|0
4890617|NCT00696709|16850038|P1|Overall Study|Protocol Violation|1
4890618|NCT00696709|16850034|P5|Overall Study|Withdrawal by Subject|3
4890619|NCT00696709|16850035|P4|Overall Study|Withdrawal by Subject|4
4890620|NCT00696709|16850036|P3|Overall Study|Withdrawal by Subject|1
4890621|NCT00696709|16850037|P2|Overall Study|Withdrawal by Subject|2
4890622|NCT00696709|16850038|P1|Overall Study|Withdrawal by Subject|1
4890623|NCT00696696|16850074|P1|Overall Study|Death|3
4890624|NCT00696696|16850074|P1|Overall Study|Physician Decision|2
4890625|NCT00696696|16850074|P1|Overall Study|Withdrawal by Subject|8
4890626|NCT00696696|16850074|P1|Overall Study|Adverse Event|5
4890627|NCT00696657|16850089|P9|Overall Study|Adverse Event|5
4890628|NCT00696657|16850090|P8|Overall Study|Adverse Event|2
4890629|NCT00696657|16850091|P7|Overall Study|Adverse Event|14
4890630|NCT00696657|16850092|P6|Overall Study|Adverse Event|9
4890631|NCT00696657|16850093|P5|Overall Study|Adverse Event|6
4890632|NCT00696657|16850094|P4|Overall Study|Adverse Event|7
4890633|NCT00696657|16850095|P3|Overall Study|Adverse Event|3
4890634|NCT00696657|16850096|P2|Overall Study|Adverse Event|0
4890635|NCT00696657|16850097|P1|Overall Study|Adverse Event|0
4890636|NCT00696657|16850089|P9|Overall Study|Unclassified|1
4890637|NCT00696657|16850090|P8|Overall Study|Unclassified|0
4890638|NCT00696657|16850091|P7|Overall Study|Unclassified|0
4890639|NCT00696657|16850092|P6|Overall Study|Unclassified|2
4890640|NCT00696657|16850093|P5|Overall Study|Unclassified|4
4890641|NCT00696657|16850094|P4|Overall Study|Unclassified|2
4890642|NCT00696657|16850095|P3|Overall Study|Unclassified|3
4890643|NCT00696657|16850096|P2|Overall Study|Unclassified|1
4890644|NCT00696657|16850097|P1|Overall Study|Unclassified|0
4890645|NCT00696657|16850089|P9|Overall Study|Withdrawal criteria|2
4890646|NCT00696657|16850090|P8|Overall Study|Withdrawal criteria|1
4890647|NCT00696657|16850091|P7|Overall Study|Withdrawal criteria|1
4890648|NCT00696657|16850092|P6|Overall Study|Withdrawal criteria|0
4890649|NCT00696657|16850093|P5|Overall Study|Withdrawal criteria|0
4890650|NCT00696657|16850094|P4|Overall Study|Withdrawal criteria|2
4890651|NCT00696657|16850095|P3|Overall Study|Withdrawal criteria|2
4890652|NCT00696657|16850096|P2|Overall Study|Withdrawal criteria|3
4890653|NCT00696657|16850097|P1|Overall Study|Withdrawal criteria|1
4890654|NCT00696657|16850089|P9|Overall Study|Lack of Efficacy|0
4890655|NCT00696657|16850090|P8|Overall Study|Lack of Efficacy|0
4890656|NCT00696657|16850091|P7|Overall Study|Lack of Efficacy|0
4890657|NCT00696657|16850092|P6|Overall Study|Lack of Efficacy|0
4890658|NCT00696657|16850093|P5|Overall Study|Lack of Efficacy|0
4890659|NCT00696657|16850094|P4|Overall Study|Lack of Efficacy|0
4890660|NCT00696657|16850095|P3|Overall Study|Lack of Efficacy|0
4890661|NCT00696657|16850096|P2|Overall Study|Lack of Efficacy|1
4890662|NCT00696657|16850097|P1|Overall Study|Lack of Efficacy|0
4890663|NCT00696657|16850089|P9|Overall Study|Protocol Violation|1
4890664|NCT00696657|16850090|P8|Overall Study|Protocol Violation|0
4890665|NCT00696657|16850091|P7|Overall Study|Protocol Violation|0
4890666|NCT00696657|16850092|P6|Overall Study|Protocol Violation|1
4890667|NCT00696657|16850093|P5|Overall Study|Protocol Violation|0
4890668|NCT00696657|16850094|P4|Overall Study|Protocol Violation|0
4890669|NCT00696657|16850095|P3|Overall Study|Protocol Violation|0
4890670|NCT00696657|16850096|P2|Overall Study|Protocol Violation|0
4890671|NCT00696657|16850097|P1|Overall Study|Protocol Violation|0
4890672|NCT00696436|16850466|P5|Overall Study|Missing|0
4890673|NCT00696436|16850467|P4|Overall Study|Missing|0
4890674|NCT00696436|16850468|P3|Overall Study|Missing|1
4890675|NCT00696436|16850469|P2|Overall Study|Missing|1
4890676|NCT00696436|16850470|P1|Overall Study|Missing|0
4890677|NCT00696436|16850466|P5|Overall Study|Administrative Decision|0
4890678|NCT00696436|16850467|P4|Overall Study|Administrative Decision|0
4890679|NCT00696436|16850468|P3|Overall Study|Administrative Decision|0
4890680|NCT00696436|16850469|P2|Overall Study|Administrative Decision|0
4890681|NCT00696436|16850470|P1|Overall Study|Administrative Decision|1
4890682|NCT00696436|16850466|P5|Overall Study|Participant Non-compliance|0
4890683|NCT00696436|16850467|P4|Overall Study|Participant Non-compliance|2
4890684|NCT00696436|16850468|P3|Overall Study|Participant Non-compliance|1
4890685|NCT00696436|16850469|P2|Overall Study|Participant Non-compliance|0
4890686|NCT00696436|16850470|P1|Overall Study|Participant Non-compliance|0
4890687|NCT00696436|16850466|P5|Overall Study|Administrative Error|0
4890688|NCT00696436|16850467|P4|Overall Study|Administrative Error|0
4890689|NCT00696436|16850468|P3|Overall Study|Administrative Error|2
4890690|NCT00696436|16850469|P2|Overall Study|Administrative Error|0
4890691|NCT00696436|16850470|P1|Overall Study|Administrative Error|2
4890692|NCT00696436|16850466|P5|Overall Study|Participant Unavailability|0
4890693|NCT00696436|16850467|P4|Overall Study|Participant Unavailability|1
4890694|NCT00696436|16850468|P3|Overall Study|Participant Unavailability|2
4890695|NCT00696436|16850469|P2|Overall Study|Participant Unavailability|0
4890696|NCT00696436|16850470|P1|Overall Study|Participant Unavailability|2
4890697|NCT00696436|16850466|P5|Overall Study|Lack of Efficacy|4
4890698|NCT00696436|16850467|P4|Overall Study|Lack of Efficacy|2
4890699|NCT00696436|16850468|P3|Overall Study|Lack of Efficacy|5
4890700|NCT00696436|16850469|P2|Overall Study|Lack of Efficacy|1
4890701|NCT00696436|16850470|P1|Overall Study|Lack of Efficacy|3
4890702|NCT00696436|16850466|P5|Overall Study|Withdrawal by Subject|1
4890703|NCT00696436|16850467|P4|Overall Study|Withdrawal by Subject|7
4890704|NCT00696436|16850468|P3|Overall Study|Withdrawal by Subject|5
4890705|NCT00696436|16850469|P2|Overall Study|Withdrawal by Subject|11
4890706|NCT00696436|16850470|P1|Overall Study|Withdrawal by Subject|4
4890707|NCT00696436|16850466|P5|Overall Study|Lost to Follow-up|3
4890708|NCT00696436|16850467|P4|Overall Study|Lost to Follow-up|4
4890709|NCT00696436|16850468|P3|Overall Study|Lost to Follow-up|2
4890710|NCT00696436|16850469|P2|Overall Study|Lost to Follow-up|6
4890711|NCT00696436|16850470|P1|Overall Study|Lost to Follow-up|1
4890712|NCT00696436|16850466|P5|Overall Study|Protocol Violation|1
4890713|NCT00696436|16850467|P4|Overall Study|Protocol Violation|0
4890714|NCT00696436|16850468|P3|Overall Study|Protocol Violation|2
4890715|NCT00696436|16850469|P2|Overall Study|Protocol Violation|2
4890716|NCT00696436|16850470|P1|Overall Study|Protocol Violation|3
4890717|NCT00696436|16850466|P5|Overall Study|Adverse Event|4
4890718|NCT00696436|16850467|P4|Overall Study|Adverse Event|6
4890719|NCT00696436|16850468|P3|Overall Study|Adverse Event|8
4890720|NCT00696436|16850469|P2|Overall Study|Adverse Event|9
4890721|NCT00696436|16850470|P1|Overall Study|Adverse Event|7
4890722|NCT00696423|16850554|P2|Overall Study|Lost to Follow-up|5
4890723|NCT00696423|16850555|P1|Overall Study|Lost to Follow-up|0
4890724|NCT00696410|16850587|P2|Overall Study|Physician Decision|0
4890725|NCT00696410|16850588|P1|Overall Study|Physician Decision|3
4890726|NCT00696410|16850587|P2|Overall Study|Withdrawal by Subject|0
4890727|NCT00696410|16850588|P1|Overall Study|Withdrawal by Subject|8
4890728|NCT00696410|16850587|P2|Overall Study|Lost to Follow-up|0
4890729|NCT00696410|16850588|P1|Overall Study|Lost to Follow-up|2
4890730|NCT00696384|16850602|P3|Double Blind Phase|Physician Decision|0
4890731|NCT00696384|16850603|P2|Double Blind Phase|Physician Decision|2
4890732|NCT00696384|16850604|P1|Double Blind Phase|Physician Decision|0
4890733|NCT00696384|16850602|P3|Double Blind Phase|Lack of Efficacy|0
4890734|NCT00696384|16850603|P2|Double Blind Phase|Lack of Efficacy|1
4890735|NCT00696384|16850604|P1|Double Blind Phase|Lack of Efficacy|0
4890736|NCT00696384|16850602|P3|Double Blind Phase|Withdrawal by Subject|3
4890737|NCT00696384|16850603|P2|Double Blind Phase|Withdrawal by Subject|4
4890738|NCT00696384|16850604|P1|Double Blind Phase|Withdrawal by Subject|0
4890739|NCT00696384|16850602|P3|Double Blind Phase|Lost to Follow-up|1
4890740|NCT00696384|16850603|P2|Double Blind Phase|Lost to Follow-up|2
4890741|NCT00696384|16850604|P1|Double Blind Phase|Lost to Follow-up|0
4890742|NCT00696384|16850602|P3|Double Blind Phase|Adverse Event|2
4890743|NCT00696384|16850603|P2|Double Blind Phase|Adverse Event|2
4890744|NCT00696384|16850604|P1|Double Blind Phase|Adverse Event|0
4890745|NCT00696384|16850602|P3|Open Label Phase|Physician Decision|0
4890746|NCT00696384|16850603|P2|Open Label Phase|Physician Decision|0
4890747|NCT00696384|16850604|P1|Open Label Phase|Physician Decision|4
4890748|NCT00696384|16850602|P3|Open Label Phase|Lack of Efficacy|0
4890749|NCT00696384|16850603|P2|Open Label Phase|Lack of Efficacy|0
4890750|NCT00696384|16850604|P1|Open Label Phase|Lack of Efficacy|3
4890751|NCT00696384|16850602|P3|Open Label Phase|Other|0
4890752|NCT00696384|16850603|P2|Open Label Phase|Other|0
4890753|NCT00696384|16850604|P1|Open Label Phase|Other|6
4890754|NCT00696384|16850602|P3|Open Label Phase|Withdrawal by Subject|0
4890755|NCT00696384|16850603|P2|Open Label Phase|Withdrawal by Subject|0
4890756|NCT00696384|16850604|P1|Open Label Phase|Withdrawal by Subject|37
4890757|NCT00696384|16850602|P3|Open Label Phase|Lost to Follow-up|0
4890758|NCT00696384|16850603|P2|Open Label Phase|Lost to Follow-up|0
4890759|NCT00696384|16850604|P1|Open Label Phase|Lost to Follow-up|24
4890760|NCT00696384|16850602|P3|Open Label Phase|Protocol Violation|0
4890761|NCT00696384|16850603|P2|Open Label Phase|Protocol Violation|0
4890762|NCT00696384|16850604|P1|Open Label Phase|Protocol Violation|18
4890763|NCT00696384|16850602|P3|Open Label Phase|Adverse Event|0
4890764|NCT00696384|16850603|P2|Open Label Phase|Adverse Event|0
4890765|NCT00696384|16850604|P1|Open Label Phase|Adverse Event|27
4890766|NCT00696241|16850628|P5|Overall Study|Other|1
4890767|NCT00696241|16850629|P4|Overall Study|Other|2
4890768|NCT00696241|16850630|P3|Overall Study|Other|5
4890769|NCT00696241|16850631|P2|Overall Study|Other|1
4890770|NCT00696241|16850632|P1|Overall Study|Other|6
4890771|NCT00696241|16850628|P5|Overall Study|Lack of Efficacy|3
4890772|NCT00696241|16850629|P4|Overall Study|Lack of Efficacy|5
4890773|NCT00696241|16850630|P3|Overall Study|Lack of Efficacy|4
4890774|NCT00696241|16850631|P2|Overall Study|Lack of Efficacy|5
4890775|NCT00696241|16850632|P1|Overall Study|Lack of Efficacy|1
4890776|NCT00696241|16850628|P5|Overall Study|Withdrawal by Subject|0
4890777|NCT00696241|16850629|P4|Overall Study|Withdrawal by Subject|1
4890778|NCT00696241|16850630|P3|Overall Study|Withdrawal by Subject|6
4890779|NCT00696241|16850631|P2|Overall Study|Withdrawal by Subject|8
4890780|NCT00696241|16850632|P1|Overall Study|Withdrawal by Subject|4
4890781|NCT00696241|16850628|P5|Overall Study|Lost to Follow-up|0
4890782|NCT00696241|16850629|P4|Overall Study|Lost to Follow-up|2
4890783|NCT00696241|16850630|P3|Overall Study|Lost to Follow-up|1
4890784|NCT00696241|16850631|P2|Overall Study|Lost to Follow-up|4
4890785|NCT00696241|16850632|P1|Overall Study|Lost to Follow-up|1
4890786|NCT00696241|16850628|P5|Overall Study|Protocol Violation|3
4890787|NCT00696241|16850629|P4|Overall Study|Protocol Violation|0
4890788|NCT00696241|16850630|P3|Overall Study|Protocol Violation|2
4890789|NCT00696241|16850631|P2|Overall Study|Protocol Violation|1
4890790|NCT00696241|16850632|P1|Overall Study|Protocol Violation|1
4890791|NCT00696241|16850628|P5|Overall Study|Adverse Event|5
4890792|NCT00696241|16850629|P4|Overall Study|Adverse Event|4
4890793|NCT00696241|16850630|P3|Overall Study|Adverse Event|6
4890794|NCT00696241|16850631|P2|Overall Study|Adverse Event|3
4890795|NCT00696241|16850632|P1|Overall Study|Adverse Event|11
4890796|NCT00696137|16850714|P1|Overall Study|Withdrawal by Subject|2
4890797|NCT00696072|16850720|P2|Overall Study|Non-specified|2
4890798|NCT00696072|16850721|P1|Overall Study|Non-specified|1
4890799|NCT00696072|16850720|P2|Overall Study|Disease Progression|30
4890800|NCT00696072|16850721|P1|Overall Study|Disease Progression|32
4890801|NCT00696072|16850720|P2|Overall Study|Sponsor Request|1
4890802|NCT00696072|16850721|P1|Overall Study|Sponsor Request|0
4890803|NCT00696072|16850720|P2|Overall Study|Investigator Request|4
4890804|NCT00696072|16850721|P1|Overall Study|Investigator Request|1
4890805|NCT00696072|16850720|P2|Overall Study|Patient Request|7
4890806|NCT00696072|16850721|P1|Overall Study|Patient Request|3
4890807|NCT00696072|16850720|P2|Overall Study|Adverse Event|6
4890808|NCT00696072|16850721|P1|Overall Study|Adverse Event|10
4890809|NCT00696072|16850720|P2|Overall Study|continuing active treatment|13
4890810|NCT00696072|16850721|P1|Overall Study|continuing active treatment|10
4890811|NCT00696020|16850742|P4|Overall Study|Other not stated above|1
4890812|NCT00696020|16850743|P3|Overall Study|Other not stated above|1
4890813|NCT00696020|16850744|P2|Overall Study|Other not stated above|0
4890814|NCT00696020|16850745|P1|Overall Study|Other not stated above|0
4890815|NCT00696020|16850742|P4|Overall Study|Withdrawal by Subject|1
4890816|NCT00696020|16850743|P3|Overall Study|Withdrawal by Subject|0
4890817|NCT00696020|16850744|P2|Overall Study|Withdrawal by Subject|1
4890818|NCT00696020|16850745|P1|Overall Study|Withdrawal by Subject|0
4890819|NCT00696020|16850742|P4|Overall Study|Protocol Violation|1
4890820|NCT00696020|16850743|P3|Overall Study|Protocol Violation|0
4890821|NCT00696020|16850744|P2|Overall Study|Protocol Violation|0
4890822|NCT00696020|16850745|P1|Overall Study|Protocol Violation|0
4890823|NCT00696020|16850742|P4|Overall Study|Lack of Efficacy|0
4890824|NCT00696020|16850743|P3|Overall Study|Lack of Efficacy|0
4890825|NCT00696020|16850744|P2|Overall Study|Lack of Efficacy|0
4890826|NCT00696020|16850745|P1|Overall Study|Lack of Efficacy|1
4890827|NCT00696020|16850742|P4|Overall Study|Adverse Event|1
4890828|NCT00696020|16850743|P3|Overall Study|Adverse Event|2
4890829|NCT00696020|16850744|P2|Overall Study|Adverse Event|1
4890830|NCT00696020|16850745|P1|Overall Study|Adverse Event|3
4890831|NCT00695955|16850853|P1|Cohort 2|Other|5
4890832|NCT00695955|16850853|P1|Cohort 2|Lack of Efficacy|4
4890833|NCT00695955|16850853|P1|Cohort 2|Withdrawal by Subject|28
4890834|NCT00695955|16850853|P1|Cohort 2|Lost to Follow-up|38
4890835|NCT00695955|16850853|P1|Cohort 2|Protocol Violation|5
4890836|NCT00695955|16850853|P1|Cohort 2|Adverse Event|24
4890837|NCT00695955|16850853|P1|Cohort 1|Other|16
4890838|NCT00695955|16850853|P1|Cohort 1|Lack of Efficacy|3
4890839|NCT00695955|16850853|P1|Cohort 1|Withdrawal by Subject|25
4890840|NCT00695955|16850853|P1|Cohort 1|Lost to Follow-up|30
4890841|NCT00695955|16850853|P1|Cohort 1|Protocol Violation|2
4890842|NCT00695955|16850853|P1|Cohort 1|Adverse Event|26
4890843|NCT00695903|16850865|P2|Had Test of Cure (TOC) Assessment|Adverse Event|1
4890844|NCT00695903|16850866|P1|Had Test of Cure (TOC) Assessment|Adverse Event|0
4890845|NCT00695903|16850865|P2|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0
4890846|NCT00695903|16850866|P1|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1
4890847|NCT00695903|16850865|P2|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0
4890848|NCT00695903|16850866|P1|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1
4890849|NCT00695903|16850865|P2|Had End of Therapy (EOT) Assessment|Protocol Violation|2
4890850|NCT00695903|16850866|P1|Had End of Therapy (EOT) Assessment|Protocol Violation|1
4890851|NCT00695903|16850865|P2|Had End of Therapy (EOT) Assessment|Physician Decision|1
4890852|NCT00695903|16850866|P1|Had End of Therapy (EOT) Assessment|Physician Decision|0
4890853|NCT00695903|16850865|P2|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
4890854|NCT00695903|16850866|P1|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1
4890855|NCT00695903|16850865|P2|Had End of Therapy (EOT) Assessment|Adverse Event|0
4890856|NCT00695903|16850866|P1|Had End of Therapy (EOT) Assessment|Adverse Event|1
4890857|NCT00695903|16850865|P2|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
4890858|NCT00695903|16850866|P1|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9
4890859|NCT00695903|16850865|P2|Had End of Therapy (EOT) Assessment|Randomized not treated|2
4890860|NCT00695903|16850866|P1|Had End of Therapy (EOT) Assessment|Randomized not treated|0
4890861|NCT00695864|16850878|P1|Placebo|Physician Decision|4
4890862|NCT00695864|16850878|P1|Placebo|Withdrawal by Subject|1
4890863|NCT00695669|16850888|P4|Overall Study|Lost to Follow-up|4
4890864|NCT00695669|16850889|P3|Overall Study|Lost to Follow-up|1
4890865|NCT00695669|16850890|P2|Overall Study|Lost to Follow-up|4
4890866|NCT00695669|16850891|P1|Overall Study|Lost to Follow-up|4
4890867|NCT00695669|16850888|P4|Overall Study|Adverse Event|0
4890868|NCT00695669|16850889|P3|Overall Study|Adverse Event|2
4890869|NCT00695669|16850890|P2|Overall Study|Adverse Event|0
4890870|NCT00695669|16850891|P1|Overall Study|Adverse Event|0
4890871|NCT00695565|16850976|P2|Overall Study|Subject did not follow instructions|1
4890872|NCT00695565|16850977|P1|Overall Study|Subject did not follow instructions|1
4890873|NCT00695565|16850976|P2|Overall Study|Lack of Efficacy|1
4890874|NCT00695565|16850977|P1|Overall Study|Lack of Efficacy|1
4890875|NCT00695565|16850976|P2|Overall Study|Withdrawal by Subject|1
4890876|NCT00695565|16850977|P1|Overall Study|Withdrawal by Subject|1
4890877|NCT00695565|16850976|P2|Overall Study|Protocol Violation|1
4890878|NCT00695565|16850977|P1|Overall Study|Protocol Violation|3
4890879|NCT00695565|16850976|P2|Overall Study|Adverse Event|1
4890880|NCT00695565|16850977|P1|Overall Study|Adverse Event|3
4890881|NCT00695565|16850976|P2|Overall Study|Lost to Follow-up|4
4890882|NCT00695565|16850977|P1|Overall Study|Lost to Follow-up|4
4890883|NCT00695396|16851050|P3|Overall Study|Withdrawal by Subject|0
4890884|NCT00695396|16851051|P2|Overall Study|Withdrawal by Subject|2
4890885|NCT00695396|16851052|P1|Overall Study|Withdrawal by Subject|2
4890886|NCT00695396|16851050|P3|Overall Study|Study Closed Prematurely|8
4890887|NCT00695396|16851051|P2|Overall Study|Study Closed Prematurely|6
4890888|NCT00695396|16851052|P1|Overall Study|Study Closed Prematurely|5
4890889|NCT00695318|16851068|P2|Overall Study|Study Terminated|0
4890890|NCT00695318|16851069|P1|Overall Study|Study Terminated|1
4890891|NCT00695318|16851068|P2|Overall Study|Death|1
4890892|NCT00695318|16851069|P1|Overall Study|Death|1
4890893|NCT00695318|16851068|P2|Overall Study|Withdrawal by Subject|0
4890894|NCT00695318|16851069|P1|Overall Study|Withdrawal by Subject|2
4890895|NCT00695318|16851068|P2|Overall Study|Lost to Follow-up|0
4890896|NCT00695318|16851069|P1|Overall Study|Lost to Follow-up|1
4890897|NCT00695136|16851094|P1|Overall Study|unrelated adverse event|1
4890898|NCT00695136|16851094|P1|Overall Study|Withdrawal by Subject|1
4890899|NCT00695019|16851110|P3|Overall Study|Various|4
4890900|NCT00695019|16851111|P2|Overall Study|Various|5
4890901|NCT00695019|16851112|P1|Overall Study|Various|4
4890902|NCT00695019|16851110|P3|Overall Study|Lack of Efficacy|1
4890903|NCT00695019|16851111|P2|Overall Study|Lack of Efficacy|0
4890904|NCT00695019|16851112|P1|Overall Study|Lack of Efficacy|0
4890905|NCT00695019|16851110|P3|Overall Study|Protocol Violation|1
4890906|NCT00695019|16851111|P2|Overall Study|Protocol Violation|3
4890907|NCT00695019|16851112|P1|Overall Study|Protocol Violation|1
4890908|NCT00695019|16851110|P3|Overall Study|Withdrawal by Subject|4
4890909|NCT00695019|16851111|P2|Overall Study|Withdrawal by Subject|6
4890910|NCT00695019|16851112|P1|Overall Study|Withdrawal by Subject|8
4890911|NCT00694707|16851146|P5|Overall Study|Notification of Past Head Injury|0
4890912|NCT00694707|16851147|P4|Overall Study|Notification of Past Head Injury|1
4890913|NCT00694707|16851148|P3|Overall Study|Notification of Past Head Injury|0
4890914|NCT00694707|16851149|P2|Overall Study|Notification of Past Head Injury|0
4890915|NCT00694707|16851150|P1|Overall Study|Notification of Past Head Injury|0
4890916|NCT00694707|16851146|P5|Overall Study|Administrative Reasons|0
4890917|NCT00694707|16851147|P4|Overall Study|Administrative Reasons|2
4890918|NCT00694707|16851148|P3|Overall Study|Administrative Reasons|0
4890919|NCT00694707|16851149|P2|Overall Study|Administrative Reasons|1
4890920|NCT00694707|16851150|P1|Overall Study|Administrative Reasons|0
4890921|NCT00694707|16851146|P5|Overall Study|Arrest by Police|0
4890922|NCT00694707|16851147|P4|Overall Study|Arrest by Police|0
4890923|NCT00694707|16851148|P3|Overall Study|Arrest by Police|0
4890924|NCT00694707|16851149|P2|Overall Study|Arrest by Police|1
4890925|NCT00694707|16851150|P1|Overall Study|Arrest by Police|0
4890926|NCT00694707|16851146|P5|Overall Study|Death in the Family|0
4890927|NCT00694707|16851147|P4|Overall Study|Death in the Family|0
4890928|NCT00694707|16851148|P3|Overall Study|Death in the Family|0
4890929|NCT00694707|16851149|P2|Overall Study|Death in the Family|0
4890930|NCT00694707|16851150|P1|Overall Study|Death in the Family|1
4890931|NCT00694707|16851146|P5|Overall Study|Jeopardizing Parole Status|0
4890932|NCT00694707|16851147|P4|Overall Study|Jeopardizing Parole Status|0
4890933|NCT00694707|16851148|P3|Overall Study|Jeopardizing Parole Status|0
4890934|NCT00694707|16851149|P2|Overall Study|Jeopardizing Parole Status|0
4890935|NCT00694707|16851150|P1|Overall Study|Jeopardizing Parole Status|1
4890936|NCT00694707|16851146|P5|Overall Study|Lost to Follow-up|0
4890937|NCT00694707|16851147|P4|Overall Study|Lost to Follow-up|0
4890938|NCT00694707|16851148|P3|Overall Study|Lost to Follow-up|2
4890939|NCT00694707|16851149|P2|Overall Study|Lost to Follow-up|1
4890940|NCT00694707|16851150|P1|Overall Study|Lost to Follow-up|0
4890941|NCT00694707|16851146|P5|Overall Study|Withdrawal of Consent|15
4890942|NCT00694707|16851147|P4|Overall Study|Withdrawal of Consent|16
4890943|NCT00694707|16851148|P3|Overall Study|Withdrawal of Consent|22
4890944|NCT00694707|16851149|P2|Overall Study|Withdrawal of Consent|18
4890945|NCT00694707|16851150|P1|Overall Study|Withdrawal of Consent|14
4890946|NCT00694707|16851146|P5|Overall Study|Protocol Violation|1
4890947|NCT00694707|16851147|P4|Overall Study|Protocol Violation|3
4890948|NCT00694707|16851148|P3|Overall Study|Protocol Violation|1
4890949|NCT00694707|16851149|P2|Overall Study|Protocol Violation|2
4890950|NCT00694707|16851150|P1|Overall Study|Protocol Violation|1
4890951|NCT00694707|16851146|P5|Overall Study|Insufficient Therapeutic Response|10
4890952|NCT00694707|16851147|P4|Overall Study|Insufficient Therapeutic Response|15
4890953|NCT00694707|16851148|P3|Overall Study|Insufficient Therapeutic Response|17
4890954|NCT00694707|16851149|P2|Overall Study|Insufficient Therapeutic Response|18
4890955|NCT00694707|16851150|P1|Overall Study|Insufficient Therapeutic Response|33
4890956|NCT00694707|16851146|P5|Overall Study|Adverse Event|13
4890957|NCT00694707|16851147|P4|Overall Study|Adverse Event|12
4890958|NCT00694707|16851148|P3|Overall Study|Adverse Event|8
4890959|NCT00694707|16851149|P2|Overall Study|Adverse Event|14
4890960|NCT00694707|16851150|P1|Overall Study|Adverse Event|22
4890961|NCT00694707|16851146|P5|Overall Study|Did Not Receive Treatment|1
4890962|NCT00694707|16851147|P4|Overall Study|Did Not Receive Treatment|1
4890963|NCT00694707|16851148|P3|Overall Study|Did Not Receive Treatment|1
4890964|NCT00694707|16851149|P2|Overall Study|Did Not Receive Treatment|0
4890965|NCT00694707|16851150|P1|Overall Study|Did Not Receive Treatment|0
4890966|NCT00694551|16851179|P3|Overall Study|Disease Progression|1
4890967|NCT00694551|16851180|P2|Overall Study|Disease Progression|0
4890968|NCT00694551|16851181|P1|Overall Study|Disease Progression|1
4890969|NCT00694369|16851210|P5|Overall Study|Withdrawal by Subject|2
4890970|NCT00694369|16851211|P4|Overall Study|Withdrawal by Subject|1
4890971|NCT00694369|16851212|P3|Overall Study|Withdrawal by Subject|1
4890972|NCT00694369|16851213|P2|Overall Study|Withdrawal by Subject|1
4890973|NCT00694369|16851214|P1|Overall Study|Withdrawal by Subject|1
4890974|NCT00694369|16851210|P5|Overall Study|Protocol Violation|0
4890975|NCT00694369|16851211|P4|Overall Study|Protocol Violation|0
4890976|NCT00694369|16851212|P3|Overall Study|Protocol Violation|0
4890977|NCT00694369|16851213|P2|Overall Study|Protocol Violation|1
4890978|NCT00694369|16851214|P1|Overall Study|Protocol Violation|0
4890979|NCT00694369|16851210|P5|Overall Study|Physician Decision|1
4890980|NCT00694369|16851211|P4|Overall Study|Physician Decision|0
4890981|NCT00694369|16851212|P3|Overall Study|Physician Decision|0
4890982|NCT00694369|16851213|P2|Overall Study|Physician Decision|0
4890983|NCT00694369|16851214|P1|Overall Study|Physician Decision|0
4890984|NCT00694369|16851210|P5|Overall Study|Lost to Follow-up|0
4890985|NCT00694369|16851211|P4|Overall Study|Lost to Follow-up|1
4890986|NCT00694369|16851212|P3|Overall Study|Lost to Follow-up|1
4890987|NCT00694369|16851213|P2|Overall Study|Lost to Follow-up|0
4890988|NCT00694369|16851214|P1|Overall Study|Lost to Follow-up|0
4890989|NCT00694369|16851210|P5|Overall Study|Adverse Event|3
4890990|NCT00694369|16851211|P4|Overall Study|Adverse Event|1
4890991|NCT00694369|16851212|P3|Overall Study|Adverse Event|0
4890992|NCT00694369|16851213|P2|Overall Study|Adverse Event|1
4890993|NCT00694369|16851214|P1|Overall Study|Adverse Event|0
4890994|NCT00694356|16851234|P3|Overall Study|Progressive Disease|6
4890995|NCT00694356|16851235|P2|Overall Study|Progressive Disease|6
4890996|NCT00694356|16851236|P1|Overall Study|Progressive Disease|2
4890997|NCT00694356|16851234|P3|Overall Study|Adverse Event|0
4890998|NCT00694356|16851235|P2|Overall Study|Adverse Event|0
4890999|NCT00694356|16851236|P1|Overall Study|Adverse Event|1
4891000|NCT00694304|16851271|P1|Overall Study|Administrative or Other Reasons|32
4891001|NCT00694304|16851271|P1|Overall Study|Lost to Follow-up|15
4891002|NCT00694304|16851271|P1|Overall Study|Withdrawal of Consent|61
4891003|NCT00694304|16851271|P1|Overall Study|Protocol Violation|6
4891004|NCT00694304|16851271|P1|Overall Study|Non-compliance With Study Product|16
4891005|NCT00694304|16851271|P1|Overall Study|Lack of Efficacy|35
4891006|NCT00694304|16851271|P1|Overall Study|Adverse Event|42
4891007|NCT00694161|16851284|P1|Part 2 (After Week 6 up to Month 12)|Death|1
4891008|NCT00694161|16851284|P1|Part 2 (After Week 6 up to Month 12)|Physician Decision|1
4891009|NCT00694161|16851284|P1|Part 2 (After Week 6 up to Month 12)|Adverse Event|1
4891010|NCT00694122|16851323|P2|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1
4891011|NCT00694122|16851324|P1|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2
4891012|NCT00694122|16851323|P2|First Intervention (3-4 Weeks)|Lost to Follow-up|1
4891013|NCT00694122|16851324|P1|First Intervention (3-4 Weeks)|Lost to Follow-up|1
4891014|NCT00694122|16851323|P2|First Intervention (3-4 Weeks)|Withdrawal by Subject|0
4891015|NCT00694122|16851324|P1|First Intervention (3-4 Weeks)|Withdrawal by Subject|7
4891016|NCT00694109|16851340|P1|Overall Study|Consented but no additional treatment|3
4891017|NCT00694109|16851340|P1|Overall Study|Other|2
4891018|NCT00694109|16851340|P1|Overall Study|Enrolled but not treated|1
4891019|NCT00694109|16851340|P1|Overall Study|Pregnancy|1
4891020|NCT00694109|16851340|P1|Overall Study|Withdrawal by Subject|13
4891021|NCT00694109|16851340|P1|Overall Study|Lack of Efficacy|2
4891022|NCT00694109|16851340|P1|Overall Study|Not consent of more 2 years of treatment|18
4891023|NCT00694109|16851340|P1|Overall Study|Adverse Event|74
4891024|NCT00694109|16851340|P1|Overall Study|Physician Decision|3
4891025|NCT00694096|16851364|P1|Overall Study|Withdrawal by Subject|5
4891026|NCT00693784|16851404|P1|Overall Study|Withdrawal by Subject|2
4891027|NCT00693784|16851404|P1|Overall Study|Lost to Follow-up|2
4891028|NCT00693706|16851417|P2|Overall Study|Protocol Violation|1
4891029|NCT00693706|16851418|P1|Overall Study|Protocol Violation|0
4891030|NCT00693693|16851445|P3|Overall Study|Lost to Follow-up|2
4891031|NCT00693693|16851446|P2|Overall Study|Lost to Follow-up|1
4891032|NCT00693693|16851447|P1|Overall Study|Lost to Follow-up|1
4891033|NCT00693472|16851506|P4|Part 2|Withdrew - reason unrelated to treatment|2
4891034|NCT00693472|16851507|P3|Part 2|Withdrew - reason unrelated to treatment|1
4891035|NCT00693472|16851508|P2|Part 2|Withdrew - reason unrelated to treatment|0
4891036|NCT00693472|16851509|P1|Part 2|Withdrew - reason unrelated to treatment|0
4891037|NCT00693472|16851506|P4|Part 2|Adverse Event|0
4891038|NCT00693472|16851507|P3|Part 2|Adverse Event|1
4891039|NCT00693472|16851508|P2|Part 2|Adverse Event|0
4891040|NCT00693472|16851509|P1|Part 2|Adverse Event|0
4891041|NCT00693472|16851506|P4|Part 1|Withdrew - reason unrelated to treatment|0
4891042|NCT00693472|16851507|P3|Part 1|Withdrew - reason unrelated to treatment|0
4891043|NCT00693472|16851508|P2|Part 1|Withdrew - reason unrelated to treatment|2
4891044|NCT00693472|16851509|P1|Part 1|Withdrew - reason unrelated to treatment|5
4891045|NCT00693472|16851506|P4|Part 1|Lost to Follow-up|0
4891046|NCT00693472|16851507|P3|Part 1|Lost to Follow-up|0
4891047|NCT00693472|16851508|P2|Part 1|Lost to Follow-up|1
4891048|NCT00693472|16851509|P1|Part 1|Lost to Follow-up|0
4891049|NCT00693472|16851506|P4|Part 1|Adverse Event|0
4891050|NCT00693472|16851507|P3|Part 1|Adverse Event|0
4891051|NCT00693472|16851508|P2|Part 1|Adverse Event|1
4891052|NCT00693472|16851509|P1|Part 1|Adverse Event|1
4891053|NCT00693420|16851529|P2|Overall Study|Personal Reasons|4
4891054|NCT00693420|16851530|P1|Overall Study|Personal Reasons|1
4891055|NCT00693420|16851529|P2|Overall Study|Sponsor Request - Conflict of Interest|2
4891056|NCT00693420|16851530|P1|Overall Study|Sponsor Request - Conflict of Interest|0
4891057|NCT00693420|16851529|P2|Overall Study|Protocol Violation|2
4891058|NCT00693420|16851530|P1|Overall Study|Protocol Violation|0
4891059|NCT00693420|16851529|P2|Overall Study|Withdrawal by Subject|0
4891060|NCT00693420|16851530|P1|Overall Study|Withdrawal by Subject|1
4891061|NCT00693420|16851529|P2|Overall Study|Lost to Follow-up|3
4891062|NCT00693420|16851530|P1|Overall Study|Lost to Follow-up|0
4891063|NCT00693420|16851529|P2|Overall Study|Adverse Event|4
4891064|NCT00693420|16851530|P1|Overall Study|Adverse Event|4
4891065|NCT00693225|16851569|P2|Overall Study|Adverse Event|3
4891066|NCT00693225|16851570|P1|Overall Study|Adverse Event|1
4891067|NCT00693225|16851569|P2|Overall Study|Lost to Follow-up|2
4891068|NCT00693225|16851570|P1|Overall Study|Lost to Follow-up|1
4891069|NCT00693017|16851593|P2|Overall Study|Death|1
4891070|NCT00693017|16851594|P1|Overall Study|Death|0
4891071|NCT00693017|16851593|P2|Overall Study|Sponsor Decision|1
4891072|NCT00693017|16851594|P1|Overall Study|Sponsor Decision|2
4891073|NCT00692913|16851604|P2|Overall Study|Withdrawal by Subject|20
4891074|NCT00692913|16851605|P1|Overall Study|Withdrawal by Subject|15
4891075|NCT00692913|16851604|P2|Overall Study|Protocol Violation|1
4891076|NCT00692913|16851605|P1|Overall Study|Protocol Violation|1
4891077|NCT00692913|16851604|P2|Overall Study|Physician Decision|0
4891078|NCT00692913|16851605|P1|Overall Study|Physician Decision|2
4891079|NCT00692913|16851604|P2|Overall Study|Lost to Follow-up|5
4891080|NCT00692913|16851605|P1|Overall Study|Lost to Follow-up|3
4891081|NCT00692913|16851604|P2|Overall Study|Adverse Event|4
4891082|NCT00692913|16851605|P1|Overall Study|Adverse Event|8
4891083|NCT00692770|16851627|P2|Overall Study|Randomized but not treated|4
4891084|NCT00692770|16851628|P1|Overall Study|Randomized but not treated|3
4891085|NCT00692770|16851627|P2|Overall Study|Study terminated by sponsor|2
4891086|NCT00692770|16851628|P1|Overall Study|Study terminated by sponsor|2
4891087|NCT00692770|16851627|P2|Overall Study|Clinical endpoint reached|43
4891088|NCT00692770|16851628|P1|Overall Study|Clinical endpoint reached|16
4891089|NCT00692770|16851627|P2|Overall Study|Radiological and clinical progression|8
4891090|NCT00692770|16851628|P1|Overall Study|Radiological and clinical progression|8
4891091|NCT00692770|16851627|P2|Overall Study|Completed all planned assessments|101
4891092|NCT00692770|16851628|P1|Overall Study|Completed all planned assessments|79
4891093|NCT00692770|16851627|P2|Overall Study|Protocol driven decision point|7
4891094|NCT00692770|16851628|P1|Overall Study|Protocol driven decision point|3
4891095|NCT00692770|16851627|P2|Overall Study|Disease progression, recurrence/relapse|279
4891096|NCT00692770|16851628|P1|Overall Study|Disease progression, recurrence/relapse|170
4891097|NCT00692770|16851627|P2|Overall Study|Physician decision not protocol driven|14
4891098|NCT00692770|16851628|P1|Overall Study|Physician decision not protocol driven|10
4891099|NCT00692770|16851627|P2|Overall Study|Progression by clinical judgment|3
4891100|NCT00692770|16851628|P1|Overall Study|Progression by clinical judgment|2
4891101|NCT00692770|16851627|P2|Overall Study|Non-compliant with study medication|5
4891102|NCT00692770|16851628|P1|Overall Study|Non-compliant with study medication|11
4891103|NCT00692770|16851627|P2|Overall Study|Lost to Follow-up|3
4891104|NCT00692770|16851628|P1|Overall Study|Lost to Follow-up|7
4891105|NCT00692770|16851627|P2|Overall Study|Death|5
4891106|NCT00692770|16851628|P1|Overall Study|Death|10
4891107|NCT00692770|16851627|P2|Overall Study|Adverse Event|41
4891108|NCT00692770|16851628|P1|Overall Study|Adverse Event|136
4891109|NCT00692770|16851627|P2|Overall Study|Withdrawal by Subject|36
4891110|NCT00692770|16851628|P1|Overall Study|Withdrawal by Subject|97
4891111|NCT00692770|16851627|P2|Overall Study|Protocol Violation|7
4891112|NCT00692770|16851628|P1|Overall Study|Protocol Violation|2
4891113|NCT00692406|16851674|P1|Overall Study|PI dropped, bad data|57
4891114|NCT00692237|16851745|P2|Overall Study|Adverse Event|1
4891115|NCT00692237|16851746|P1|Overall Study|Adverse Event|0
4891116|NCT00692237|16851745|P2|Overall Study|Withdrawal by Subject|3
4891117|NCT00692237|16851746|P1|Overall Study|Withdrawal by Subject|1
4891118|NCT00692003|16851833|P2|Overall Study|Sponsor Decision|1
4891119|NCT00692003|16851834|P1|Overall Study|Sponsor Decision|5
4891120|NCT00691938|16851849|P7|Overall Study|QTc prolongation|0
4891121|NCT00691938|16851850|P6|Overall Study|QTc prolongation|0
4891122|NCT00691938|16851851|P5|Overall Study|QTc prolongation|0
4891123|NCT00691938|16851852|P4|Overall Study|QTc prolongation|0
4891124|NCT00691938|16851853|P3|Overall Study|QTc prolongation|0
4891125|NCT00691938|16851854|P2|Overall Study|QTc prolongation|0
4891126|NCT00691938|16851855|P1|Overall Study|QTc prolongation|1
4891127|NCT00691704|16851922|P1|Two Years of Maintenance Therapy|Withdrawal by Subject|1
4891128|NCT00691704|16851922|P1|Two Years of Maintenance Therapy|Physician Decision|4
4891129|NCT00691704|16851922|P1|Two Years of Maintenance Therapy|Disease Progression|8
4891130|NCT00691704|16851922|P1|Induction Therapy|Active Hepatitis|1
4891131|NCT00691704|16851922|P1|Induction Therapy|Disease Progression|1
4891132|NCT00691483|16851983|P2|Overall Study|Randomized by not treated|1
4891133|NCT00691483|16851984|P1|Overall Study|Randomized by not treated|7
4891134|NCT00691483|16851983|P2|Overall Study|Other known cause|1
4891135|NCT00691483|16851984|P1|Overall Study|Other known cause|6
4891136|NCT00691483|16851983|P2|Overall Study|Withdrawal by Subject|7
4891137|NCT00691483|16851984|P1|Overall Study|Withdrawal by Subject|24
4891138|NCT00691483|16851983|P2|Overall Study|Lost to Follow-up|10
4891139|NCT00691483|16851984|P1|Overall Study|Lost to Follow-up|17
4891140|NCT00691483|16851983|P2|Overall Study|Adverse Event|6
4891141|NCT00691483|16851984|P1|Overall Study|Adverse Event|14
4891142|NCT00691301|16852027|P1|Overall Study|Did not initiate study treatment|1
4891143|NCT00691301|16852027|P1|Overall Study|other reason|3
4891144|NCT00691301|16852027|P1|Overall Study|Concurrent illness|2
4891145|NCT00691301|16852027|P1|Overall Study|Withdrawal by Subject|4
4891146|NCT00691301|16852027|P1|Overall Study|Lack of Efficacy|32
4891147|NCT00691301|16852027|P1|Overall Study|Death|2
4891148|NCT00691301|16852027|P1|Overall Study|Adverse Event|10
4891149|NCT00691210|16852047|P8|Overall Study|Lack of Efficacy|0
4891150|NCT00691210|16852048|P7|Overall Study|Lack of Efficacy|0
4891151|NCT00691210|16852049|P6|Overall Study|Lack of Efficacy|1
4891152|NCT00691210|16852050|P5|Overall Study|Lack of Efficacy|0
4891153|NCT00691210|16852051|P4|Overall Study|Lack of Efficacy|1
4891154|NCT00691210|16852052|P3|Overall Study|Lack of Efficacy|0
4891155|NCT00691210|16852053|P2|Overall Study|Lack of Efficacy|0
4891156|NCT00691210|16852054|P1|Overall Study|Lack of Efficacy|0
4891157|NCT00691210|16852047|P8|Overall Study|Progression of Disease|0
4891158|NCT00691210|16852048|P7|Overall Study|Progression of Disease|0
4891159|NCT00691210|16852049|P6|Overall Study|Progression of Disease|0
4891160|NCT00691210|16852050|P5|Overall Study|Progression of Disease|0
4891161|NCT00691210|16852051|P4|Overall Study|Progression of Disease|2
4891162|NCT00691210|16852052|P3|Overall Study|Progression of Disease|0
4891163|NCT00691210|16852053|P2|Overall Study|Progression of Disease|0
4891164|NCT00691210|16852054|P1|Overall Study|Progression of Disease|0
4891165|NCT00691132|16852089|P2|Overall Study|Withdrawal by Subject|10
4891166|NCT00691132|16852090|P1|Overall Study|Withdrawal by Subject|10
4891167|NCT00691132|16852089|P2|Overall Study|Adverse Event|3
4891168|NCT00691132|16852090|P1|Overall Study|Adverse Event|2
4891169|NCT00691093|16852109|P1|Overall Study|Ongoing at Date of Cut-Off|4
4891170|NCT00691093|16852109|P1|Overall Study|Lack of Efficacy|1
4891171|NCT00691093|16852109|P1|Overall Study|Lost to Follow-up|1
4891172|NCT00691093|16852109|P1|Overall Study|Adverse Event|1
4891173|NCT00691054|16852143|P1|Overall Study|Withdrawal by Subject|1
4891174|NCT00691028|16852155|P4|Double-blind Period|not come to a hospital.|0
4891175|NCT00691028|16852156|P3|Double-blind Period|not come to a hospital.|0
4891176|NCT00691028|16852157|P2|Double-blind Period|not come to a hospital.|1
4891177|NCT00691028|16852158|P1|Double-blind Period|not come to a hospital.|0
4891178|NCT00691028|16852155|P4|Double-blind Period|Withdrawal by Subject|0
4891179|NCT00691028|16852156|P3|Double-blind Period|Withdrawal by Subject|1
4891180|NCT00691028|16852157|P2|Double-blind Period|Withdrawal by Subject|0
4891181|NCT00691028|16852158|P1|Double-blind Period|Withdrawal by Subject|1
4891182|NCT00691028|16852155|P4|Double-blind Period|Lack of Efficacy|0
4891183|NCT00691028|16852156|P3|Double-blind Period|Lack of Efficacy|2
4891184|NCT00691028|16852157|P2|Double-blind Period|Lack of Efficacy|3
4891185|NCT00691028|16852158|P1|Double-blind Period|Lack of Efficacy|4
4891186|NCT00691028|16852155|P4|Double-blind Period|Adverse Event|0
4891187|NCT00691028|16852156|P3|Double-blind Period|Adverse Event|6
4891188|NCT00691028|16852157|P2|Double-blind Period|Adverse Event|9
4891189|NCT00691028|16852158|P1|Double-blind Period|Adverse Event|8
4891190|NCT00691028|16852155|P4|Open-label Period|not come to a hospital|1
4891191|NCT00691028|16852156|P3|Open-label Period|not come to a hospital|0
4891192|NCT00691028|16852157|P2|Open-label Period|not come to a hospital|0
4891193|NCT00691028|16852158|P1|Open-label Period|not come to a hospital|0
4891194|NCT00691028|16852155|P4|Open-label Period|Withdrawal by Subject|3
4891195|NCT00691028|16852156|P3|Open-label Period|Withdrawal by Subject|0
4891196|NCT00691028|16852157|P2|Open-label Period|Withdrawal by Subject|0
4891197|NCT00691028|16852158|P1|Open-label Period|Withdrawal by Subject|0
4891198|NCT00691028|16852155|P4|Open-label Period|Adverse Event|16
4891199|NCT00691028|16852156|P3|Open-label Period|Adverse Event|0
4891200|NCT00691028|16852157|P2|Open-label Period|Adverse Event|0
4891201|NCT00691028|16852158|P1|Open-label Period|Adverse Event|0
4891202|NCT00691015|16852191|P1|Overall Study|Refused further treatment|1
4891203|NCT00690898|16852206|P1|TREATMENT|Other (not otherwise specified)|1
4891204|NCT00690898|16852206|P1|TREATMENT|Withdrawal by Subject|4
4891205|NCT00690898|16852206|P1|TREATMENT|Lack of Efficacy|18
4891206|NCT00690898|16852206|P1|TREATMENT|Adverse Event|3
4891207|NCT00690898|16852206|P1|SCREENING|Screen failure|18
4891208|NCT00690820|16852226|P2|Period 1|Withdrawal by Subject|1
4891209|NCT00690820|16852227|P1|Period 1|Withdrawal by Subject|0
4891210|NCT00690794|16852249|P2|Overall Study|Other not specified|3
4891211|NCT00690794|16852250|P1|Overall Study|Other not specified|1
4891212|NCT00690794|16852249|P2|Overall Study|Noncompliance|2
4891213|NCT00690794|16852250|P1|Overall Study|Noncompliance|1
4891214|NCT00690794|16852249|P2|Overall Study|Protocol Violation|7
4891215|NCT00690794|16852250|P1|Overall Study|Protocol Violation|6
4891216|NCT00690794|16852249|P2|Overall Study|Withdrawal by Subject|9
4891217|NCT00690794|16852250|P1|Overall Study|Withdrawal by Subject|0
4891218|NCT00690794|16852249|P2|Overall Study|Lost to Follow-up|4
4891219|NCT00690794|16852250|P1|Overall Study|Lost to Follow-up|1
4891220|NCT00690794|16852249|P2|Overall Study|Adverse Event|10
4891221|NCT00690794|16852250|P1|Overall Study|Adverse Event|12
4891222|NCT00690755|16852265|P7|Overall Study|Physician Decision|0
4891223|NCT00690755|16852266|P6|Overall Study|Physician Decision|4
4891224|NCT00690755|16852267|P5|Overall Study|Physician Decision|0
4891225|NCT00690755|16852268|P4|Overall Study|Physician Decision|5
4891226|NCT00690755|16852269|P3|Overall Study|Physician Decision|46
4891227|NCT00690755|16852270|P2|Overall Study|Physician Decision|0
4891228|NCT00690755|16852271|P1|Overall Study|Physician Decision|2
4891229|NCT00690612|16852287|P1|Overall Study|Withdrawal by Subject|2
4891230|NCT00690612|16852287|P1|Overall Study|Adverse Event|1
4891231|NCT00690573|16852292|P1|Overall Study|Withdrawal by Subject|1
4891232|NCT00690573|16852292|P1|Overall Study|Lack of Efficacy|8
4891233|NCT00690482|16852311|P2|Overall Study|withdrew consent at rand.day|1
4891234|NCT00690482|16852312|P1|Overall Study|withdrew consent at rand.day|0
4891235|NCT00690482|16852311|P2|Overall Study|Intake of prohibited medicine|0
4891236|NCT00690482|16852312|P1|Overall Study|Intake of prohibited medicine|1
4891237|NCT00690482|16852311|P2|Overall Study|Study-specific discontinuation criteria|0
4891238|NCT00690482|16852312|P1|Overall Study|Study-specific discontinuation criteria|1
4891239|NCT00690482|16852311|P2|Overall Study|Incorrect enrolment|1
4891240|NCT00690482|16852312|P1|Overall Study|Incorrect enrolment|0
4891241|NCT00690482|16852311|P2|Overall Study|Adverse Event|1
4891242|NCT00690482|16852312|P1|Overall Study|Adverse Event|2
4891243|NCT00690443|16852346|P2|Overall Study|Adverse Event|2
4891244|NCT00690443|16852347|P1|Overall Study|Adverse Event|1
4891245|NCT00690430|16852357|P3|Extension Phase|Early Termination|3
4891246|NCT00690430|16852358|P2|Extension Phase|Early Termination|1
4891247|NCT00690430|16852359|P1|Extension Phase|Early Termination|10
4891248|NCT00690430|16852357|P3|Extension Phase|Withdrawal by Subject|2
4891249|NCT00690430|16852358|P2|Extension Phase|Withdrawal by Subject|0
4891250|NCT00690430|16852359|P1|Extension Phase|Withdrawal by Subject|0
4891251|NCT00690430|16852357|P3|Extension Phase|Death|1
4891252|NCT00690430|16852358|P2|Extension Phase|Death|1
4891253|NCT00690430|16852359|P1|Extension Phase|Death|1
4891254|NCT00690430|16852357|P3|Extension Phase|Adverse Event|2
4891255|NCT00690430|16852358|P2|Extension Phase|Adverse Event|1
4891256|NCT00690430|16852359|P1|Extension Phase|Adverse Event|2
4891257|NCT00690430|16852357|P3|Extension Phase|Administrative Problems|1
4891258|NCT00690430|16852358|P2|Extension Phase|Administrative Problems|1
4891259|NCT00690430|16852359|P1|Extension Phase|Administrative Problems|0
4891260|NCT00690430|16852357|P3|Extension Phase|Abnormal test procedure results|0
4891261|NCT00690430|16852358|P2|Extension Phase|Abnormal test procedure results|0
4891262|NCT00690430|16852359|P1|Extension Phase|Abnormal test procedure results|1
4891263|NCT00690430|16852357|P3|Extension Phase|Abnormal Lab Values|0
4891264|NCT00690430|16852358|P2|Extension Phase|Abnormal Lab Values|0
4891265|NCT00690430|16852359|P1|Extension Phase|Abnormal Lab Values|1
4891266|NCT00690430|16852357|P3|Extension Phase|Lack of Efficacy|4
4891267|NCT00690430|16852358|P2|Extension Phase|Lack of Efficacy|1
4891268|NCT00690430|16852359|P1|Extension Phase|Lack of Efficacy|3
4891269|NCT00690430|16852357|P3|Core Phase|Early Termination|0
4891270|NCT00690430|16852358|P2|Core Phase|Early Termination|5
4891271|NCT00690430|16852359|P1|Core Phase|Early Termination|0
4891272|NCT00690430|16852357|P3|Core Phase|Administrative Problems|0
4891273|NCT00690430|16852358|P2|Core Phase|Administrative Problems|1
4891274|NCT00690430|16852359|P1|Core Phase|Administrative Problems|0
4891275|NCT00690430|16852357|P3|Core Phase|Lack of Efficacy|0
4891276|NCT00690430|16852358|P2|Core Phase|Lack of Efficacy|10
4891277|NCT00690430|16852359|P1|Core Phase|Lack of Efficacy|8
4891278|NCT00690430|16852357|P3|Core Phase|Subject no longer requires study drug|0
4891279|NCT00690430|16852358|P2|Core Phase|Subject no longer requires study drug|0
4891280|NCT00690430|16852359|P1|Core Phase|Subject no longer requires study drug|1
4891281|NCT00690430|16852357|P3|Core Phase|Withdrawal by Subject|0
4891282|NCT00690430|16852358|P2|Core Phase|Withdrawal by Subject|3
4891283|NCT00690430|16852359|P1|Core Phase|Withdrawal by Subject|3
4891284|NCT00690430|16852357|P3|Core Phase|Protocol Violation|0
4891285|NCT00690430|16852358|P2|Core Phase|Protocol Violation|0
4891286|NCT00690430|16852359|P1|Core Phase|Protocol Violation|1
4891287|NCT00690430|16852357|P3|Core Phase|Death|0
4891288|NCT00690430|16852358|P2|Core Phase|Death|2
4891289|NCT00690430|16852359|P1|Core Phase|Death|0
4891290|NCT00690430|16852357|P3|Core Phase|Adverse Event|0
4891291|NCT00690430|16852358|P2|Core Phase|Adverse Event|1
4891292|NCT00690430|16852359|P1|Core Phase|Adverse Event|5
4891293|NCT00690430|16852357|P3|Core Phase|Abnormal Laboratory value|0
4891294|NCT00690430|16852358|P2|Core Phase|Abnormal Laboratory value|1
4891295|NCT00690430|16852359|P1|Core Phase|Abnormal Laboratory value|0
4891296|NCT00690378|16852388|P2|Overall Study|Social problem|0
4891297|NCT00690378|16852389|P1|Overall Study|Social problem|1
4891298|NCT00690378|16852388|P2|Overall Study|Did not meet inc/exc criteria|11
4891299|NCT00690378|16852389|P1|Overall Study|Did not meet inc/exc criteria|13
4891300|NCT00690378|16852388|P2|Overall Study|Lost to Follow-up|3
4891301|NCT00690378|16852389|P1|Overall Study|Lost to Follow-up|2
4891302|NCT00690378|16852388|P2|Overall Study|Protocol Violation|0
4891303|NCT00690378|16852389|P1|Overall Study|Protocol Violation|1
4891304|NCT00690378|16852388|P2|Overall Study|Withdrawal by Subject|0
4891305|NCT00690378|16852389|P1|Overall Study|Withdrawal by Subject|2
4891306|NCT00690378|16852388|P2|Overall Study|Adverse Event|0
4891307|NCT00690378|16852389|P1|Overall Study|Adverse Event|1
4891308|NCT00689936|16852486|P3|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144
4891309|NCT00689936|16852487|P2|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188
4891310|NCT00689936|16852488|P1|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127
4891311|NCT00689936|16852486|P3|Active Treatment Phase|Miscellaneous|47
4891312|NCT00689936|16852487|P2|Active Treatment Phase|Miscellaneous|34
4891313|NCT00689936|16852488|P1|Active Treatment Phase|Miscellaneous|52
4891314|NCT00689936|16852486|P3|Active Treatment Phase|Study Close Out|21
4891315|NCT00689936|16852487|P2|Active Treatment Phase|Study Close Out|26
4891316|NCT00689936|16852488|P1|Active Treatment Phase|Study Close Out|64
4891317|NCT00689936|16852486|P3|Active Treatment Phase|Protocol Violation|4
4891318|NCT00689936|16852487|P2|Active Treatment Phase|Protocol Violation|2
4891319|NCT00689936|16852488|P1|Active Treatment Phase|Protocol Violation|2
4891320|NCT00689936|16852486|P3|Active Treatment Phase|Lost to Follow-up|2
4891321|NCT00689936|16852487|P2|Active Treatment Phase|Lost to Follow-up|2
4891322|NCT00689936|16852488|P1|Active Treatment Phase|Lost to Follow-up|0
4891323|NCT00689936|16852486|P3|Active Treatment Phase|Death|37
4891324|NCT00689936|16852487|P2|Active Treatment Phase|Death|28
4891325|NCT00689936|16852488|P1|Active Treatment Phase|Death|60
4891326|NCT00689936|16852486|P3|Active Treatment Phase|Withdrawal by Subject|21
4891327|NCT00689936|16852487|P2|Active Treatment Phase|Withdrawal by Subject|16
4891328|NCT00689936|16852488|P1|Active Treatment Phase|Withdrawal by Subject|16
4891329|NCT00689936|16852486|P3|Active Treatment Phase|Disease Progression|339
4891330|NCT00689936|16852487|P2|Active Treatment Phase|Disease Progression|362
4891331|NCT00689936|16852488|P1|Active Treatment Phase|Disease Progression|273
4891332|NCT00689936|16852486|P3|Active Treatment Phase|Adverse Event|76
4891333|NCT00689936|16852487|P2|Active Treatment Phase|Adverse Event|71
4891334|NCT00689936|16852488|P1|Active Treatment Phase|Adverse Event|68
4891335|NCT00689871|16852637|P4|Overall Study|Physician Decision|0
4891336|NCT00689871|16852638|P3|Overall Study|Physician Decision|1
4891337|NCT00689871|16852639|P2|Overall Study|Physician Decision|1
4891338|NCT00689871|16852640|P1|Overall Study|Physician Decision|2
4891339|NCT00689871|16852637|P4|Overall Study|Death|2
4891340|NCT00689871|16852638|P3|Overall Study|Death|2
4891341|NCT00689871|16852639|P2|Overall Study|Death|10
4891342|NCT00689871|16852640|P1|Overall Study|Death|1
4891343|NCT00689871|16852637|P4|Overall Study|Withdrawal by Subject|1
4891344|NCT00689871|16852638|P3|Overall Study|Withdrawal by Subject|4
4891345|NCT00689871|16852639|P2|Overall Study|Withdrawal by Subject|3
4891346|NCT00689871|16852640|P1|Overall Study|Withdrawal by Subject|13
4891347|NCT00689871|16852637|P4|Overall Study|Explanted of All Study Devices|3
4891348|NCT00689871|16852638|P3|Overall Study|Explanted of All Study Devices|29
4891349|NCT00689871|16852639|P2|Overall Study|Explanted of All Study Devices|25
4891350|NCT00689871|16852640|P1|Overall Study|Explanted of All Study Devices|36
4891351|NCT00689871|16852637|P4|Overall Study|Lost to Follow-up|1
4891352|NCT00689871|16852638|P3|Overall Study|Lost to Follow-up|37
4891353|NCT00689871|16852639|P2|Overall Study|Lost to Follow-up|13
4891354|NCT00689871|16852640|P1|Overall Study|Lost to Follow-up|123
4891355|NCT00689793|16852667|P2|Overall Study|Lost to Follow-up|5
4891356|NCT00689793|16852668|P1|Overall Study|Lost to Follow-up|4
4891357|NCT00689728|16852687|P3|Optional Follow-Up|Withdrawal by Subject|3
4891358|NCT00689728|16852688|P2|Optional Follow-Up|Withdrawal by Subject|4
4891359|NCT00689728|16852689|P1|Optional Follow-Up|Withdrawal by Subject|2
4891360|NCT00689728|16852687|P3|Optional Follow-Up|Protocol Violation|1
4891361|NCT00689728|16852688|P2|Optional Follow-Up|Protocol Violation|0
4891362|NCT00689728|16852689|P1|Optional Follow-Up|Protocol Violation|0
4891363|NCT00689728|16852687|P3|Optional Follow-Up|Lost to Follow-up|1
4891364|NCT00689728|16852688|P2|Optional Follow-Up|Lost to Follow-up|1
4891365|NCT00689728|16852689|P1|Optional Follow-Up|Lost to Follow-up|0
4891366|NCT00689728|16852687|P3|Optional Follow-Up|Lack of Efficacy|1
4891367|NCT00689728|16852688|P2|Optional Follow-Up|Lack of Efficacy|1
4891368|NCT00689728|16852689|P1|Optional Follow-Up|Lack of Efficacy|0
4891369|NCT00689728|16852687|P3|Optional Follow-Up|Adverse Event|0
4891370|NCT00689728|16852688|P2|Optional Follow-Up|Adverse Event|0
4891371|NCT00689728|16852689|P1|Optional Follow-Up|Adverse Event|1
4891372|NCT00689728|16852687|P3|Rescue|Withdrawal by Subject|1
4891373|NCT00689728|16852688|P2|Rescue|Withdrawal by Subject|1
4891374|NCT00689728|16852689|P1|Rescue|Withdrawal by Subject|1
4891375|NCT00689728|16852687|P3|Rescue|Adverse Event|0
4891376|NCT00689728|16852688|P2|Rescue|Adverse Event|1
4891377|NCT00689728|16852689|P1|Rescue|Adverse Event|0
4891378|NCT00689728|16852687|P3|Double-Blind Treatment|Lack of Efficacy|2
4891379|NCT00689728|16852688|P2|Double-Blind Treatment|Lack of Efficacy|1
4891380|NCT00689728|16852689|P1|Double-Blind Treatment|Lack of Efficacy|0
4891381|NCT00689728|16852687|P3|Double-Blind Treatment|Withdrawal by Subject|2
4891382|NCT00689728|16852688|P2|Double-Blind Treatment|Withdrawal by Subject|3
4891383|NCT00689728|16852689|P1|Double-Blind Treatment|Withdrawal by Subject|3
4891384|NCT00689728|16852687|P3|Double-Blind Treatment|Protocol Violation|1
4891385|NCT00689728|16852688|P2|Double-Blind Treatment|Protocol Violation|0
4891386|NCT00689728|16852689|P1|Double-Blind Treatment|Protocol Violation|0
4891387|NCT00689728|16852687|P3|Double-Blind Treatment|Adverse Event|0
4891388|NCT00689728|16852688|P2|Double-Blind Treatment|Adverse Event|0
4891389|NCT00689728|16852689|P1|Double-Blind Treatment|Adverse Event|1
4891390|NCT00689611|16852772|P2|Overall Study|Lost to Follow-up|28
4891391|NCT00689611|16852773|P1|Overall Study|Lost to Follow-up|27
4891392|NCT00689611|16852772|P2|Overall Study|Withdrawal by Subject|9
4891393|NCT00689611|16852773|P1|Overall Study|Withdrawal by Subject|8
4891394|NCT00689611|16852772|P2|Overall Study|Death|9
4891395|NCT00689611|16852773|P1|Overall Study|Death|6
4891396|NCT00689481|16852783|P2|Overall Study|Subject early term, left on vacation|1
4891397|NCT00689481|16852784|P1|Overall Study|Subject early term, left on vacation|0
4891398|NCT00689481|16852783|P2|Overall Study|Excluded medication started during study|1
4891399|NCT00689481|16852784|P1|Overall Study|Excluded medication started during study|0
4891400|NCT00689481|16852783|P2|Overall Study|Withdrawal by Subject|4
4891401|NCT00689481|16852784|P1|Overall Study|Withdrawal by Subject|8
4891402|NCT00689481|16852783|P2|Overall Study|Non-compliance with study treatment|1
4891403|NCT00689481|16852784|P1|Overall Study|Non-compliance with study treatment|1
4891404|NCT00689481|16852783|P2|Overall Study|Lack of Efficacy|3
4891405|NCT00689481|16852784|P1|Overall Study|Lack of Efficacy|4
4891406|NCT00689481|16852783|P2|Overall Study|Lost to Follow-up|3
4891407|NCT00689481|16852784|P1|Overall Study|Lost to Follow-up|4
4891408|NCT00689481|16852783|P2|Overall Study|Adverse Event|1
4891409|NCT00689481|16852784|P1|Overall Study|Adverse Event|7
4891410|NCT00689390|16852802|P2|Overall Study|Administrative|0
4891411|NCT00689390|16852803|P1|Overall Study|Administrative|37
4891412|NCT00689390|16852802|P2|Overall Study|Did Not Meet Protocol Eligibility|0
4891413|NCT00689390|16852803|P1|Overall Study|Did Not Meet Protocol Eligibility|1
4891414|NCT00689390|16852802|P2|Overall Study|Non-Compliance With Protocol|0
4891415|NCT00689390|16852803|P1|Overall Study|Non-Compliance With Protocol|21
4891416|NCT00689390|16852802|P2|Overall Study|Withdrew Consent-Retreatment Opportunity|0
4891417|NCT00689390|16852803|P1|Overall Study|Withdrew Consent-Retreatment Opportunity|52
4891418|NCT00689390|16852802|P2|Overall Study|Withdrawal by Subject|3
4891419|NCT00689390|16852803|P1|Overall Study|Withdrawal by Subject|117
4891420|NCT00689390|16852802|P2|Overall Study|Lost to Follow-up|7
4891421|NCT00689390|16852803|P1|Overall Study|Lost to Follow-up|179
4891422|NCT00689390|16852802|P2|Overall Study|Adverse Event|0
4891423|NCT00689390|16852803|P1|Overall Study|Adverse Event|19
4891424|NCT00689351|16852821|P2|After Infant Series|Parent/legal guardian request|0
4891425|NCT00689351|16852822|P1|After Infant Series|Parent/legal guardian request|1
4891426|NCT00689351|16852821|P2|Infant Series of Dosing|Lost to Follow-up|1
4891427|NCT00689351|16852822|P1|Infant Series of Dosing|Lost to Follow-up|0
4891428|NCT00689351|16852821|P2|Infant Series of Dosing|Adverse Event|0
4891429|NCT00689351|16852822|P1|Infant Series of Dosing|Adverse Event|1
4891430|NCT00689351|16852821|P2|Infant Series of Dosing|Parent/legal guardian request|0
4891431|NCT00689351|16852822|P1|Infant Series of Dosing|Parent/legal guardian request|5
4891432|NCT00689338|16852854|P1|Overall Study|Protocol Violation|15
4891433|NCT00689338|16852854|P1|Overall Study|Withdrawal by Subject|3
4891434|NCT00689338|16852854|P1|Overall Study|Lost to Follow-up|5
4891435|NCT00689338|16852854|P1|Overall Study|Did not Meet Entrance Criteria|27
4891436|NCT00689338|16852854|P1|Overall Study|Other|8
4891437|NCT00689338|16852854|P1|Overall Study|Lack of Efficacy|6
4891438|NCT00689338|16852854|P1|Overall Study|Insufficient Clinical Response|1
4891439|NCT00689338|16852854|P1|Overall Study|Adverse Event|13
4891440|NCT00689338|16852854|P1|Overall Study|Death|65
4891441|NCT00689299|16852867|P3|Overall Study|Protocol Violation|0
4891442|NCT00689299|16852868|P2|Overall Study|Protocol Violation|0
4891443|NCT00689299|16852869|P1|Overall Study|Protocol Violation|1
4891444|NCT00689299|16852867|P3|Overall Study|Withdrawal by Subject|3
4891445|NCT00689299|16852868|P2|Overall Study|Withdrawal by Subject|1
4891446|NCT00689299|16852869|P1|Overall Study|Withdrawal by Subject|4
4891447|NCT00689299|16852867|P3|Overall Study|Lost to Follow-up|1
4891448|NCT00689299|16852868|P2|Overall Study|Lost to Follow-up|1
4891449|NCT00689299|16852869|P1|Overall Study|Lost to Follow-up|0
4891450|NCT00689299|16852867|P3|Overall Study|Adverse Event|1
4891451|NCT00689299|16852868|P2|Overall Study|Adverse Event|1
4891452|NCT00689299|16852869|P1|Overall Study|Adverse Event|2
4891453|NCT00689221|16852898|P2|Overall Study|Ongoing at cut-off date|36
4891454|NCT00689221|16852899|P1|Overall Study|Ongoing at cut-off date|39
4891455|NCT00689117|16852928|P4|Overall Study|Dispensing Error|0
4891456|NCT00689117|16852929|P3|Overall Study|Dispensing Error|0
4891457|NCT00689117|16852930|P2|Overall Study|Dispensing Error|1
4891458|NCT00689117|16852931|P1|Overall Study|Dispensing Error|0
4891459|NCT00689117|16852928|P4|Overall Study|Personal Reason|0
4891460|NCT00689117|16852929|P3|Overall Study|Personal Reason|0
4891461|NCT00689117|16852930|P2|Overall Study|Personal Reason|1
4891462|NCT00689117|16852931|P1|Overall Study|Personal Reason|0
4891463|NCT00689117|16852928|P4|Overall Study|Patient Withdrew from Study|1
4891464|NCT00689117|16852929|P3|Overall Study|Patient Withdrew from Study|0
4891465|NCT00689117|16852930|P2|Overall Study|Patient Withdrew from Study|0
4891466|NCT00689117|16852931|P1|Overall Study|Patient Withdrew from Study|0
4891467|NCT00689117|16852928|P4|Overall Study|Transportation|0
4891468|NCT00689117|16852929|P3|Overall Study|Transportation|0
4891469|NCT00689117|16852930|P2|Overall Study|Transportation|0
4891470|NCT00689117|16852931|P1|Overall Study|Transportation|1
4891471|NCT00689117|16852928|P4|Overall Study|Fear of Birth Defects|0
4891472|NCT00689117|16852929|P3|Overall Study|Fear of Birth Defects|1
4891473|NCT00689117|16852930|P2|Overall Study|Fear of Birth Defects|0
4891474|NCT00689117|16852931|P1|Overall Study|Fear of Birth Defects|0
4891475|NCT00689117|16852928|P4|Overall Study|Incarceration|0
4891476|NCT00689117|16852929|P3|Overall Study|Incarceration|0
4891477|NCT00689117|16852930|P2|Overall Study|Incarceration|0
4891478|NCT00689117|16852931|P1|Overall Study|Incarceration|2
4891479|NCT00689117|16852928|P4|Overall Study|Pregnancy|2
4891480|NCT00689117|16852929|P3|Overall Study|Pregnancy|0
4891481|NCT00689117|16852930|P2|Overall Study|Pregnancy|2
4891482|NCT00689117|16852931|P1|Overall Study|Pregnancy|0
4891483|NCT00689117|16852928|P4|Overall Study|Use of Prohibitive Medication|0
4891484|NCT00689117|16852929|P3|Overall Study|Use of Prohibitive Medication|3
4891485|NCT00689117|16852930|P2|Overall Study|Use of Prohibitive Medication|1
4891486|NCT00689117|16852931|P1|Overall Study|Use of Prohibitive Medication|2
4891487|NCT00689117|16852928|P4|Overall Study|Change/Discontinuation of Birth Control|0
4891488|NCT00689117|16852929|P3|Overall Study|Change/Discontinuation of Birth Control|1
4891489|NCT00689117|16852930|P2|Overall Study|Change/Discontinuation of Birth Control|1
4891490|NCT00689117|16852931|P1|Overall Study|Change/Discontinuation of Birth Control|1
4891491|NCT00689117|16852928|P4|Overall Study|Non-compliance with Treatment Regimen|0
4891492|NCT00689117|16852929|P3|Overall Study|Non-compliance with Treatment Regimen|0
4891493|NCT00689117|16852930|P2|Overall Study|Non-compliance with Treatment Regimen|1
4891494|NCT00689117|16852931|P1|Overall Study|Non-compliance with Treatment Regimen|0
4891495|NCT00689117|16852928|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4891496|NCT00689117|16852929|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4891497|NCT00689117|16852930|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
4891498|NCT00689117|16852931|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|1
4891499|NCT00689117|16852928|P4|Overall Study|Unable to Comply with Visit Schedule|1
4891500|NCT00689117|16852929|P3|Overall Study|Unable to Comply with Visit Schedule|1
4891501|NCT00689117|16852930|P2|Overall Study|Unable to Comply with Visit Schedule|0
4891502|NCT00689117|16852931|P1|Overall Study|Unable to Comply with Visit Schedule|0
4891503|NCT00689117|16852928|P4|Overall Study|Withdrawal by Subject|13
4891504|NCT00689117|16852929|P3|Overall Study|Withdrawal by Subject|26
4891505|NCT00689117|16852930|P2|Overall Study|Withdrawal by Subject|18
4891506|NCT00689117|16852931|P1|Overall Study|Withdrawal by Subject|19
4891507|NCT00689117|16852928|P4|Overall Study|Non-Compliance with Study Treatment|1
4891508|NCT00689117|16852929|P3|Overall Study|Non-Compliance with Study Treatment|3
4891509|NCT00689117|16852930|P2|Overall Study|Non-Compliance with Study Treatment|3
4891510|NCT00689117|16852931|P1|Overall Study|Non-Compliance with Study Treatment|3
4891511|NCT00689117|16852928|P4|Overall Study|Lack of Efficacy|2
4891512|NCT00689117|16852929|P3|Overall Study|Lack of Efficacy|2
4891513|NCT00689117|16852930|P2|Overall Study|Lack of Efficacy|2
4891514|NCT00689117|16852931|P1|Overall Study|Lack of Efficacy|1
4891515|NCT00689117|16852928|P4|Overall Study|Lost to Follow-up|11
4891516|NCT00689117|16852929|P3|Overall Study|Lost to Follow-up|17
4891517|NCT00689117|16852930|P2|Overall Study|Lost to Follow-up|19
4891518|NCT00689117|16852931|P1|Overall Study|Lost to Follow-up|26
4891519|NCT00689117|16852928|P4|Overall Study|Adverse Event|0
4891520|NCT00689117|16852929|P3|Overall Study|Adverse Event|5
4891521|NCT00689117|16852930|P2|Overall Study|Adverse Event|0
4891522|NCT00689117|16852931|P1|Overall Study|Adverse Event|6
4891523|NCT00689104|16852961|P4|Overall Study|Non-compliance with study procedures|0
4891524|NCT00689104|16852962|P3|Overall Study|Non-compliance with study procedures|1
4891525|NCT00689104|16852963|P2|Overall Study|Non-compliance with study procedures|0
4891526|NCT00689104|16852964|P1|Overall Study|Non-compliance with study procedures|0
4891527|NCT00689104|16852961|P4|Overall Study|Physician Decision|0
4891528|NCT00689104|16852962|P3|Overall Study|Physician Decision|0
4891529|NCT00689104|16852963|P2|Overall Study|Physician Decision|0
4891530|NCT00689104|16852964|P1|Overall Study|Physician Decision|1
4891531|NCT00689104|16852961|P4|Overall Study|Randomized but never received study drug|0
4891532|NCT00689104|16852962|P3|Overall Study|Randomized but never received study drug|1
4891533|NCT00689104|16852963|P2|Overall Study|Randomized but never received study drug|1
4891534|NCT00689104|16852964|P1|Overall Study|Randomized but never received study drug|2
4891535|NCT00689104|16852961|P4|Overall Study|Protocol Violation|3
4891536|NCT00689104|16852962|P3|Overall Study|Protocol Violation|5
4891537|NCT00689104|16852963|P2|Overall Study|Protocol Violation|3
4891538|NCT00689104|16852964|P1|Overall Study|Protocol Violation|2
4891539|NCT00689104|16852961|P4|Overall Study|Lost to Follow-up|5
4891540|NCT00689104|16852962|P3|Overall Study|Lost to Follow-up|2
4891541|NCT00689104|16852963|P2|Overall Study|Lost to Follow-up|3
4891542|NCT00689104|16852964|P1|Overall Study|Lost to Follow-up|4
4891543|NCT00689104|16852961|P4|Overall Study|Withdrawal by Subject|11
4891544|NCT00689104|16852962|P3|Overall Study|Withdrawal by Subject|18
4891545|NCT00689104|16852963|P2|Overall Study|Withdrawal by Subject|11
4891546|NCT00689104|16852964|P1|Overall Study|Withdrawal by Subject|12
4891547|NCT00689104|16852961|P4|Overall Study|Lack of Efficacy|3
4891548|NCT00689104|16852962|P3|Overall Study|Lack of Efficacy|2
4891549|NCT00689104|16852963|P2|Overall Study|Lack of Efficacy|6
4891550|NCT00689104|16852964|P1|Overall Study|Lack of Efficacy|5
4891551|NCT00689104|16852961|P4|Overall Study|Adverse Event|24
4891552|NCT00689104|16852962|P3|Overall Study|Adverse Event|16
4891553|NCT00689104|16852963|P2|Overall Study|Adverse Event|25
4891554|NCT00689104|16852964|P1|Overall Study|Adverse Event|13
4891555|NCT00689104|16852961|P4|Overall Study|Eligibility criterion not met|4
4891556|NCT00689104|16852962|P3|Overall Study|Eligibility criterion not met|0
4891557|NCT00689104|16852963|P2|Overall Study|Eligibility criterion not met|8
4891558|NCT00689104|16852964|P1|Overall Study|Eligibility criterion not met|5
4891559|NCT00689052|16853170|P2|Overall Study|Early termination of the trial|24
4891560|NCT00689052|16853171|P1|Overall Study|Early termination of the trial|22
4891561|NCT00689052|16853170|P2|Overall Study|Withdrawal by Subject|0
4891562|NCT00689052|16853171|P1|Overall Study|Withdrawal by Subject|2
4891563|NCT00689052|16853170|P2|Overall Study|Lost to Follow-up|0
4891564|NCT00689052|16853171|P1|Overall Study|Lost to Follow-up|2
4891565|NCT00689052|16853170|P2|Overall Study|Protocol Violation|0
4891566|NCT00689052|16853171|P1|Overall Study|Protocol Violation|1
4891567|NCT00689052|16853170|P2|Overall Study|Adverse Event|6
4891568|NCT00689052|16853171|P1|Overall Study|Adverse Event|4
4891569|NCT00689026|16853203|P2|Overall Study|Withdrawal by Subject|6
4891570|NCT00689026|16853204|P1|Overall Study|Withdrawal by Subject|13
4891571|NCT00688870|16853217|P2|Infant Series|Parent or legal guardian request|0
4891572|NCT00688870|16853218|P1|Infant Series|Parent or legal guardian request|4
4891573|NCT00688844|16853250|P1|Overall Study|Lost to Follow-up|10
4891574|NCT00688753|16853260|P1|Overall Study|Lost to Follow-up|3
4891575|NCT00688753|16853260|P1|Overall Study|Protocol Violation|1
4891576|NCT00688753|16853260|P1|Overall Study|Adverse Event|20
4891577|NCT00688753|16853260|P1|Overall Study|Withdrawal by Subject|3
4891578|NCT00688753|16853260|P1|Overall Study|Death|9
4891579|NCT00688753|16853260|P1|Overall Study|Missing|1
4891580|NCT00688753|16853260|P1|Overall Study|Disease progression|55
4891581|NCT00688740|16853271|P2|Overall Study|Violation of Inclusion Criteria|3
4891582|NCT00688740|16853272|P1|Overall Study|Violation of Inclusion Criteria|1
4891583|NCT00688740|16853271|P2|Overall Study|Breast Cancer Relapse|4
4891584|NCT00688740|16853272|P1|Overall Study|Breast Cancer Relapse|1
4891585|NCT00688740|16853271|P2|Overall Study|Consent Withdrawn|17
4891586|NCT00688740|16853272|P1|Overall Study|Consent Withdrawn|17
4891587|NCT00688740|16853271|P2|Overall Study|Lost to Follow-up|1
4891588|NCT00688740|16853272|P1|Overall Study|Lost to Follow-up|0
4891589|NCT00688740|16853271|P2|Overall Study|Death|2
4891590|NCT00688740|16853272|P1|Overall Study|Death|2
4891591|NCT00688740|16853271|P2|Overall Study|Adverse Event|8
4891592|NCT00688740|16853272|P1|Overall Study|Adverse Event|45
4891593|NCT00688701|16853285|P4|Overall Study|Poor compliance to protocol|0
4891594|NCT00688701|16853286|P3|Overall Study|Poor compliance to protocol|1
4891595|NCT00688701|16853287|P2|Overall Study|Poor compliance to protocol|1
4891596|NCT00688701|16853288|P1|Overall Study|Poor compliance to protocol|0
4891597|NCT00688701|16853285|P4|Overall Study|Withdrawal by Subject|8
4891598|NCT00688701|16853286|P3|Overall Study|Withdrawal by Subject|4
4891599|NCT00688701|16853287|P2|Overall Study|Withdrawal by Subject|3
4891600|NCT00688701|16853288|P1|Overall Study|Withdrawal by Subject|3
4891601|NCT00688701|16853285|P4|Overall Study|Lack of Efficacy|0
4891602|NCT00688701|16853286|P3|Overall Study|Lack of Efficacy|0
4891603|NCT00688701|16853287|P2|Overall Study|Lack of Efficacy|1
4891604|NCT00688701|16853288|P1|Overall Study|Lack of Efficacy|0
4891605|NCT00688701|16853285|P4|Overall Study|Adverse Event|3
4891606|NCT00688701|16853286|P3|Overall Study|Adverse Event|5
4891607|NCT00688701|16853287|P2|Overall Study|Adverse Event|0
4891608|NCT00688701|16853288|P1|Overall Study|Adverse Event|1
4891609|NCT00688688|16853329|P3|Overall Study|Violation of exclusion criterion|0
4891610|NCT00688688|16853330|P2|Overall Study|Violation of exclusion criterion|1
4891611|NCT00688688|16853331|P1|Overall Study|Violation of exclusion criterion|0
4891612|NCT00688688|16853329|P3|Overall Study|Site closure|0
4891613|NCT00688688|16853330|P2|Overall Study|Site closure|1
4891614|NCT00688688|16853331|P1|Overall Study|Site closure|0
4891615|NCT00688688|16853329|P3|Overall Study|Taking exclusionary medications|0
4891616|NCT00688688|16853330|P2|Overall Study|Taking exclusionary medications|0
4891617|NCT00688688|16853331|P1|Overall Study|Taking exclusionary medications|1
4891618|NCT00688688|16853329|P3|Overall Study|Non-compliance with study procedures|4
4891619|NCT00688688|16853330|P2|Overall Study|Non-compliance with study procedures|3
4891620|NCT00688688|16853331|P1|Overall Study|Non-compliance with study procedures|5
4891621|NCT00688688|16853329|P3|Overall Study|Randomized but never received study drug|0
4891622|NCT00688688|16853330|P2|Overall Study|Randomized but never received study drug|0
4891623|NCT00688688|16853331|P1|Overall Study|Randomized but never received study drug|1
4891624|NCT00688688|16853329|P3|Overall Study|Protocol Violation|11
4891625|NCT00688688|16853330|P2|Overall Study|Protocol Violation|9
4891626|NCT00688688|16853331|P1|Overall Study|Protocol Violation|6
4891627|NCT00688688|16853329|P3|Overall Study|Lost to Follow-up|7
4891628|NCT00688688|16853330|P2|Overall Study|Lost to Follow-up|7
4891629|NCT00688688|16853331|P1|Overall Study|Lost to Follow-up|14
4891630|NCT00688688|16853329|P3|Overall Study|Withdrawal by Subject|65
4891631|NCT00688688|16853330|P2|Overall Study|Withdrawal by Subject|75
4891632|NCT00688688|16853331|P1|Overall Study|Withdrawal by Subject|66
4891633|NCT00688688|16853329|P3|Overall Study|Lack of Efficacy|45
4891634|NCT00688688|16853330|P2|Overall Study|Lack of Efficacy|25
4891635|NCT00688688|16853331|P1|Overall Study|Lack of Efficacy|34
4891636|NCT00688688|16853329|P3|Overall Study|Adverse Event|50
4891637|NCT00688688|16853330|P2|Overall Study|Adverse Event|51
4891638|NCT00688688|16853331|P1|Overall Study|Adverse Event|52
4891639|NCT00688688|16853329|P3|Overall Study|Eligibility criterion not met|10
4891640|NCT00688688|16853330|P2|Overall Study|Eligibility criterion not met|7
4891641|NCT00688688|16853331|P1|Overall Study|Eligibility criterion not met|7
4891642|NCT00688636|16853433|P2|Overall Study|Adverse Event|1
4891643|NCT00688636|16853434|P1|Overall Study|Adverse Event|2
4891644|NCT00688623|16853448|P1|Overall Study|Protocol Violation|2
4891645|NCT00688623|16853448|P1|Overall Study|disease progression|23
4891646|NCT00688623|16853448|P1|Overall Study|Death|3
4891647|NCT00688623|16853448|P1|Overall Study|Withdrawal by Subject|4
4891648|NCT00688623|16853448|P1|Overall Study|abnormal lab value|1
4891649|NCT00688623|16853448|P1|Overall Study|Adverse Event|22
4891650|NCT00688597|16853462|P3|Overall Study|Physician Decision|0
4891651|NCT00688597|16853463|P2|Overall Study|Physician Decision|0
4891652|NCT00688597|16853464|P1|Overall Study|Physician Decision|1
4891653|NCT00688597|16853462|P3|Overall Study|Adverse Event|0
4891654|NCT00688597|16853463|P2|Overall Study|Adverse Event|0
4891655|NCT00688597|16853464|P1|Overall Study|Adverse Event|2
4891656|NCT00688545|16853477|P2|Overall Study|Unspecified, unrelated to AE/Toxicity|7
4891657|NCT00688545|16853478|P1|Overall Study|Unspecified, unrelated to AE/Toxicity|2
4891658|NCT00688545|16853477|P2|Overall Study|Withdrawal by Subject|3
4891659|NCT00688545|16853478|P1|Overall Study|Withdrawal by Subject|2
4891660|NCT00688545|16853477|P2|Overall Study|Insurance/cost of drug|1
4891661|NCT00688545|16853478|P1|Overall Study|Insurance/cost of drug|0
4891662|NCT00688545|16853477|P2|Overall Study|Lost to Follow-up|4
4891663|NCT00688545|16853478|P1|Overall Study|Lost to Follow-up|1
4891664|NCT00688519|16853488|P2|Overall Study|Pregnancy|1
4891665|NCT00688519|16853489|P1|Overall Study|Pregnancy|0
4891666|NCT00688519|16853488|P2|Overall Study|Subject moved out of area|0
4891667|NCT00688519|16853489|P1|Overall Study|Subject moved out of area|1
4891668|NCT00688519|16853488|P2|Overall Study|Investigator decision|0
4891669|NCT00688519|16853489|P1|Overall Study|Investigator decision|1
4891670|NCT00688519|16853488|P2|Overall Study|Subject moved out of state|0
4891671|NCT00688519|16853489|P1|Overall Study|Subject moved out of state|1
4891672|NCT00688519|16853488|P2|Overall Study|Non-compliance|1
4891673|NCT00688519|16853489|P1|Overall Study|Non-compliance|0
4891674|NCT00688519|16853488|P2|Overall Study|Prohibited medication|0
4891675|NCT00688519|16853489|P1|Overall Study|Prohibited medication|1
4891676|NCT00688519|16853488|P2|Overall Study|Withdrawal by Subject|6
4891677|NCT00688519|16853489|P1|Overall Study|Withdrawal by Subject|7
4891678|NCT00688519|16853488|P2|Overall Study|Lack of Efficacy|1
4891679|NCT00688519|16853489|P1|Overall Study|Lack of Efficacy|3
4891680|NCT00688519|16853488|P2|Overall Study|Lost to Follow-up|3
4891681|NCT00688519|16853489|P1|Overall Study|Lost to Follow-up|3
4891682|NCT00688519|16853488|P2|Overall Study|Adverse Event|3
4891683|NCT00688519|16853489|P1|Overall Study|Adverse Event|2
4891684|NCT00688467|16853507|P2|Treatment Period 2|Adverse Event|1
4891685|NCT00688467|16853508|P1|Treatment Period 2|Adverse Event|0
4891686|NCT00688467|16853507|P2|Treatment Period 2|Protocol Violation|1
4891687|NCT00688467|16853508|P1|Treatment Period 2|Protocol Violation|0
4891688|NCT00688467|16853507|P2|Treatment Period 1|Did not meet protocol eligibility|1
4891689|NCT00688467|16853508|P1|Treatment Period 1|Did not meet protocol eligibility|0
4891690|NCT00688467|16853507|P2|Treatment Period 1|Adverse Event|1
4891691|NCT00688467|16853508|P1|Treatment Period 1|Adverse Event|2
4891692|NCT00688376|16853540|P2|Blinded Extension Phase|Other|0
4891693|NCT00688376|16853541|P1|Blinded Extension Phase|Other|1
4891694|NCT00688376|16853540|P2|Blinded Extension Phase|Physician Decision|0
4891695|NCT00688376|16853541|P1|Blinded Extension Phase|Physician Decision|1
4891696|NCT00688376|16853540|P2|Blinded Extension Phase|Withdrawal by Subject|1
4891697|NCT00688376|16853541|P1|Blinded Extension Phase|Withdrawal by Subject|0
4891698|NCT00688376|16853540|P2|Blinded Extension Phase|Adverse Event|4
4891699|NCT00688376|16853541|P1|Blinded Extension Phase|Adverse Event|3
4891700|NCT00688376|16853540|P2|Double-Blind Phase|Not treated|1
4891701|NCT00688376|16853541|P1|Double-Blind Phase|Not treated|0
4891702|NCT00688376|16853540|P2|Double-Blind Phase|Withdrawal by Subject|0
4891703|NCT00688376|16853541|P1|Double-Blind Phase|Withdrawal by Subject|1
4891704|NCT00688376|16853540|P2|Double-Blind Phase|Protocol Violation|2
4891705|NCT00688376|16853541|P1|Double-Blind Phase|Protocol Violation|1
4891706|NCT00688376|16853540|P2|Double-Blind Phase|Adverse Event|4
4891707|NCT00688376|16853541|P1|Double-Blind Phase|Adverse Event|4
4891708|NCT00688324|16853555|P1|Overall Study|Lost to Follow-up|1
4891709|NCT00688324|16853555|P1|Overall Study|Physician Decision|5
4891710|NCT00688324|16853555|P1|Overall Study|Withdrawal by Subject|2
4891711|NCT00688259|16853600|P2|Overall Study|Hospitalized at Follow-up|1
4891712|NCT00688259|16853601|P1|Overall Study|Hospitalized at Follow-up|0
4891713|NCT00688259|16853600|P2|Overall Study|Declined Interview|3
4891714|NCT00688259|16853601|P1|Overall Study|Declined Interview|2
4891715|NCT00688259|16853600|P2|Overall Study|Withdrawal by Subject|0
4891716|NCT00688259|16853601|P1|Overall Study|Withdrawal by Subject|2
4891717|NCT00688259|16853600|P2|Overall Study|Physician Decision|0
4891718|NCT00688259|16853601|P1|Overall Study|Physician Decision|1
4891719|NCT00688259|16853600|P2|Overall Study|Lost to Follow-up|4
4891720|NCT00688259|16853601|P1|Overall Study|Lost to Follow-up|2
4891721|NCT00688155|16853621|P4|Overall Study|Withdrawal by Subject|1
4891722|NCT00688155|16853622|P3|Overall Study|Withdrawal by Subject|1
4891723|NCT00688155|16853623|P2|Overall Study|Withdrawal by Subject|2
4891724|NCT00688155|16853624|P1|Overall Study|Withdrawal by Subject|2
4891725|NCT00688103|16853644|P2|Overall Study|complex reasons|9
4891726|NCT00688103|16853645|P1|Overall Study|complex reasons|11
4891727|NCT00688103|16853644|P2|Overall Study|Withdrawal by Subject|2
4891728|NCT00688103|16853645|P1|Overall Study|Withdrawal by Subject|4
4891729|NCT00688103|16853644|P2|Overall Study|Lack of Efficacy|1
4891730|NCT00688103|16853645|P1|Overall Study|Lack of Efficacy|11
4891731|NCT00688103|16853644|P2|Overall Study|Adverse Event|1
4891732|NCT00688103|16853645|P1|Overall Study|Adverse Event|4
4891733|NCT00688064|16853657|P2|Overall Study|Any other reasons|3
4891734|NCT00688064|16853658|P1|Overall Study|Any other reasons|1
4891735|NCT00688064|16853657|P2|Overall Study|Pregnancy|0
4891736|NCT00688064|16853658|P1|Overall Study|Pregnancy|1
4891737|NCT00688064|16853657|P2|Overall Study|Lack of Efficacy|1
4891738|NCT00688064|16853658|P1|Overall Study|Lack of Efficacy|0
4891739|NCT00688064|16853657|P2|Overall Study|Lost to Follow-up|10
4891740|NCT00688064|16853658|P1|Overall Study|Lost to Follow-up|10
4891741|NCT00688064|16853657|P2|Overall Study|Withdrawal by Subject|7
4891742|NCT00688064|16853658|P1|Overall Study|Withdrawal by Subject|7
4891743|NCT00688064|16853657|P2|Overall Study|Adverse Event|4
4891744|NCT00688064|16853658|P1|Overall Study|Adverse Event|2
4891745|NCT00688064|16853657|P2|Overall Study|Protocol Violation|1
4891746|NCT00688064|16853658|P1|Overall Study|Protocol Violation|0
4891747|NCT00687973|16853674|P2|Overall Study|Withdrawal by Subject|3
4891748|NCT00687973|16853675|P1|Overall Study|Withdrawal by Subject|3
4891749|NCT00687973|16853674|P2|Overall Study|Administrative Reasons|2
4891750|NCT00687973|16853675|P1|Overall Study|Administrative Reasons|0
4891751|NCT00687973|16853674|P2|Overall Study|Protocol Violation|2
4891752|NCT00687973|16853675|P1|Overall Study|Protocol Violation|1
4891753|NCT00687973|16853674|P2|Overall Study|Lack of Efficacy|3
4891754|NCT00687973|16853675|P1|Overall Study|Lack of Efficacy|2
4891755|NCT00687973|16853674|P2|Overall Study|Adverse Event|28
4891756|NCT00687973|16853675|P1|Overall Study|Adverse Event|18
4891757|NCT00687804|16853737|P3|Open-Label Extension Study|Death|3
4891758|NCT00687804|16853738|P2|Open-Label Extension Study|Death|3
4891759|NCT00687804|16853739|P1|Open-Label Extension Study|Death|2
4891760|NCT00687804|16853737|P3|Open-Label Extension Study|Administrative problems|0
4891761|NCT00687804|16853738|P2|Open-Label Extension Study|Administrative problems|1
4891762|NCT00687804|16853739|P1|Open-Label Extension Study|Administrative problems|1
4891763|NCT00687804|16853737|P3|Open-Label Extension Study|Lost to Follow-up|2
4891764|NCT00687804|16853738|P2|Open-Label Extension Study|Lost to Follow-up|1
4891765|NCT00687804|16853739|P1|Open-Label Extension Study|Lost to Follow-up|2
4891766|NCT00687804|16853737|P3|Open-Label Extension Study|Subject withdrew consent|4
4891767|NCT00687804|16853738|P2|Open-Label Extension Study|Subject withdrew consent|4
4891768|NCT00687804|16853739|P1|Open-Label Extension Study|Subject withdrew consent|3
4891769|NCT00687804|16853737|P3|Open-Label Extension Study|Adverse Event|2
4891770|NCT00687804|16853738|P2|Open-Label Extension Study|Adverse Event|2
4891771|NCT00687804|16853739|P1|Open-Label Extension Study|Adverse Event|2
4891772|NCT00687804|16853737|P3|Core Study|Protocol Violation|0
4891773|NCT00687804|16853738|P2|Core Study|Protocol Violation|1
4891774|NCT00687804|16853739|P1|Core Study|Protocol Violation|1
4891775|NCT00687804|16853737|P3|Core Study|Death|2
4891776|NCT00687804|16853738|P2|Core Study|Death|2
4891777|NCT00687804|16853739|P1|Core Study|Death|2
4891778|NCT00687804|16853737|P3|Core Study|Lost to Follow-up|0
4891779|NCT00687804|16853738|P2|Core Study|Lost to Follow-up|1
4891780|NCT00687804|16853739|P1|Core Study|Lost to Follow-up|0
4891781|NCT00687804|16853737|P3|Core Study|Withdrawal by Subject|7
4891782|NCT00687804|16853738|P2|Core Study|Withdrawal by Subject|7
4891783|NCT00687804|16853739|P1|Core Study|Withdrawal by Subject|4
4891784|NCT00687804|16853737|P3|Core Study|Lack of Efficacy|1
4891785|NCT00687804|16853738|P2|Core Study|Lack of Efficacy|1
4891786|NCT00687804|16853739|P1|Core Study|Lack of Efficacy|1
4891787|NCT00687804|16853737|P3|Core Study|Abnormal laboratory value(s)|0
4891788|NCT00687804|16853738|P2|Core Study|Abnormal laboratory value(s)|0
4891789|NCT00687804|16853739|P1|Core Study|Abnormal laboratory value(s)|1
4891790|NCT00687804|16853737|P3|Core Study|Adverse Event|3
4891791|NCT00687804|16853738|P2|Core Study|Adverse Event|3
4891792|NCT00687804|16853739|P1|Core Study|Adverse Event|5
4891793|NCT00687739|16853786|P4|Overall Study|Adverse Event|0
4891794|NCT00687739|16853787|P3|Overall Study|Adverse Event|1
4891795|NCT00687739|16853788|P2|Overall Study|Adverse Event|1
4891796|NCT00687739|16853789|P1|Overall Study|Adverse Event|0
4891797|NCT00687739|16853786|P4|Overall Study|Lost to Follow-up|2
4891798|NCT00687739|16853787|P3|Overall Study|Lost to Follow-up|1
4891799|NCT00687739|16853788|P2|Overall Study|Lost to Follow-up|2
4891800|NCT00687739|16853789|P1|Overall Study|Lost to Follow-up|2
4891801|NCT00687609|16853831|P1|Overall Study|Withdrawal by Subject|2
4891802|NCT00687609|16853831|P1|Overall Study|Physician Decision|1
4891803|NCT00687531|16853854|P1|Overall Study|Lost to Follow-up|26
4891804|NCT00687531|16853854|P1|Overall Study|Adverse Event|5
4891805|NCT00687531|16853854|P1|Overall Study|Did not meet protocol eligibility|104
4891806|NCT00687440|16853877|P1|Overall Study|Missing|1
4891807|NCT00687440|16853877|P1|Overall Study|Other|1
4891808|NCT00687440|16853877|P1|Overall Study|Death|2
4891809|NCT00687440|16853877|P1|Overall Study|Lack of Efficacy|2
4891810|NCT00687440|16853877|P1|Overall Study|Lost to Follow-up|3
4891811|NCT00687440|16853877|P1|Overall Study|Adverse Event|3
4891812|NCT00687401|16853881|P1|Overall Study|For reasons different from those above|4
4891813|NCT00687401|16853881|P1|Overall Study|Did not return for visit|3
4891814|NCT00687401|16853881|P1|Overall Study|Withdrawal by Subject|4
4891815|NCT00687401|16853881|P1|Overall Study|Lack of Efficacy|6
4891816|NCT00687401|16853881|P1|Overall Study|Adverse Event|6
4891817|NCT00687401|16853881|P1|Overall Study|Protocol Violation|7
4891818|NCT00687362|16853886|P1|Overall Study|Withdrawal by Subject|1
4891819|NCT00687362|16853886|P1|Overall Study|Protocol Violation|2
4891820|NCT00687323|16853890|P1|Overall Study|Screen failure|148
4891821|NCT00687323|16853890|P1|Overall Study|Excluded from efficacy evaluations|6
4891822|NCT00687323|16853890|P1|Overall Study|Withdrawal by Subject|1
4891823|NCT00687323|16853890|P1|Overall Study|Death|25
4891824|NCT00687297|16853906|P2|Induction|Other|1
4891825|NCT00687297|16853907|P1|Induction|Other|0
4891826|NCT00687297|16853906|P2|Induction|Physician Decision|2
4891827|NCT00687297|16853907|P1|Induction|Physician Decision|0
4891828|NCT00687297|16853906|P2|Induction|Patient Noncompliance|0
4891829|NCT00687297|16853907|P1|Induction|Patient Noncompliance|1
4891830|NCT00687297|16853906|P2|Induction|Ineligible|1
4891831|NCT00687297|16853907|P1|Induction|Ineligible|0
4891832|NCT00687297|16853906|P2|Induction|Lack of Efficacy|21
4891833|NCT00687297|16853907|P1|Induction|Lack of Efficacy|17
4891834|NCT00687297|16853906|P2|Induction|Death|11
4891835|NCT00687297|16853907|P1|Induction|Death|7
4891836|NCT00687297|16853906|P2|Induction|Adverse Event|15
4891837|NCT00687297|16853907|P1|Induction|Adverse Event|16
4891838|NCT00687297|16853906|P2|Induction|Withdrawal by Subject|4
4891839|NCT00687297|16853907|P1|Induction|Withdrawal by Subject|4
4891840|NCT00687297|16853906|P2|Randomization|Withdrew before treatment, ineligible|1
4891841|NCT00687297|16853907|P1|Randomization|Withdrew before treatment, ineligible|1
4891842|NCT00687297|16853906|P2|Randomization|Withdrawal by Subject|0
4891843|NCT00687297|16853907|P1|Randomization|Withdrawal by Subject|2
4891844|NCT00687271|16853921|P4|Overall Study|Withdrawal by Subject|0
4891845|NCT00687271|16853922|P3|Overall Study|Withdrawal by Subject|3
4891846|NCT00687271|16853923|P2|Overall Study|Withdrawal by Subject|1
4891847|NCT00687271|16853924|P1|Overall Study|Withdrawal by Subject|0
4891848|NCT00687271|16853921|P4|Overall Study|Protocol Violation|0
4891849|NCT00687271|16853922|P3|Overall Study|Protocol Violation|1
4891850|NCT00687271|16853923|P2|Overall Study|Protocol Violation|1
4891851|NCT00687271|16853924|P1|Overall Study|Protocol Violation|2
4891852|NCT00687271|16853921|P4|Overall Study|Lost to Follow-up|0
4891853|NCT00687271|16853922|P3|Overall Study|Lost to Follow-up|0
4891854|NCT00687271|16853923|P2|Overall Study|Lost to Follow-up|1
4891855|NCT00687271|16853924|P1|Overall Study|Lost to Follow-up|0
4891856|NCT00687271|16853921|P4|Overall Study|Adverse Event|0
4891857|NCT00687271|16853922|P3|Overall Study|Adverse Event|1
4891858|NCT00687271|16853923|P2|Overall Study|Adverse Event|3
4891859|NCT00687271|16853924|P1|Overall Study|Adverse Event|1
4891860|NCT00687219|16853962|P1|Overall Study|Lack of Efficacy|1
4891861|NCT00687219|16853962|P1|Overall Study|Withdrawal by Subject|1
4891862|NCT00687219|16853962|P1|Overall Study|HCV-RNA positive conversion|34
4891863|NCT00687219|16853962|P1|Overall Study|Discontinuance criteria met|7
4891864|NCT00687219|16853962|P1|Overall Study|Adverse Event|8
4891865|NCT00687193|16853974|P6|Overall Study|Protocol Violation|0
4891866|NCT00687193|16853975|P5|Overall Study|Protocol Violation|2
4891867|NCT00687193|16853976|P4|Overall Study|Protocol Violation|1
4891868|NCT00687193|16853977|P3|Overall Study|Protocol Violation|0
4891869|NCT00687193|16853978|P2|Overall Study|Protocol Violation|2
4891870|NCT00687193|16853979|P1|Overall Study|Protocol Violation|1
4891871|NCT00687193|16853974|P6|Overall Study|Lack of Efficacy|2
4891872|NCT00687193|16853975|P5|Overall Study|Lack of Efficacy|0
4891873|NCT00687193|16853976|P4|Overall Study|Lack of Efficacy|0
4891874|NCT00687193|16853977|P3|Overall Study|Lack of Efficacy|0
4891875|NCT00687193|16853978|P2|Overall Study|Lack of Efficacy|1
4891876|NCT00687193|16853979|P1|Overall Study|Lack of Efficacy|1
4891877|NCT00687193|16853974|P6|Overall Study|Adverse Event|2
4891878|NCT00687193|16853975|P5|Overall Study|Adverse Event|0
4891879|NCT00687193|16853976|P4|Overall Study|Adverse Event|3
4891880|NCT00687193|16853977|P3|Overall Study|Adverse Event|2
4891881|NCT00687193|16853978|P2|Overall Study|Adverse Event|1
4891882|NCT00687193|16853979|P1|Overall Study|Adverse Event|0
4891883|NCT00686998|16854189|P3|Overall Study|Safety Reasons|0
4891884|NCT00686998|16854190|P2|Overall Study|Safety Reasons|0
4891885|NCT00686998|16854191|P1|Overall Study|Safety Reasons|1
4891886|NCT00686998|16854189|P3|Overall Study|Other|1
4891887|NCT00686998|16854190|P2|Overall Study|Other|0
4891888|NCT00686998|16854191|P1|Overall Study|Other|0
4891889|NCT00686998|16854189|P3|Overall Study|Lack of Efficacy|0
4891890|NCT00686998|16854190|P2|Overall Study|Lack of Efficacy|5
4891891|NCT00686998|16854191|P1|Overall Study|Lack of Efficacy|7
4891892|NCT00686998|16854189|P3|Overall Study|Withdrawal by Subject|2
4891893|NCT00686998|16854190|P2|Overall Study|Withdrawal by Subject|1
4891894|NCT00686998|16854191|P1|Overall Study|Withdrawal by Subject|2
4891895|NCT00686998|16854189|P3|Overall Study|Adverse Event|1
4891896|NCT00686998|16854190|P2|Overall Study|Adverse Event|2
4891897|NCT00686998|16854191|P1|Overall Study|Adverse Event|3
4891898|NCT00686972|16854199|P1|Overall Study|P.I, Left institution. Study terminated|51
4891899|NCT00686959|16854205|P2|Overall Study|Participants censored (no death events)|117
4891900|NCT00686959|16854206|P1|Overall Study|Participants censored (no death events)|124
4891901|NCT00686920|16854226|P2|Overall Study|Principal Investigator Decision|0
4891902|NCT00686920|16854227|P1|Overall Study|Principal Investigator Decision|2
4891903|NCT00686920|16854226|P2|Overall Study|Noncompliance|0
4891904|NCT00686920|16854227|P1|Overall Study|Noncompliance|9
4891905|NCT00686920|16854226|P2|Overall Study|Transferred to Nursing Home|0
4891906|NCT00686920|16854227|P1|Overall Study|Transferred to Nursing Home|1
4891907|NCT00686920|16854226|P2|Overall Study|Moved to Another State|0
4891908|NCT00686920|16854227|P1|Overall Study|Moved to Another State|1
4891909|NCT00686920|16854226|P2|Overall Study|Lost to Follow-up|3
4891910|NCT00686920|16854227|P1|Overall Study|Lost to Follow-up|15
4891911|NCT00686920|16854226|P2|Overall Study|Personal Reason|1
4891912|NCT00686920|16854227|P1|Overall Study|Personal Reason|0
4891913|NCT00686920|16854226|P2|Overall Study|Adverse Event|2
4891914|NCT00686920|16854227|P1|Overall Study|Adverse Event|10
4891915|NCT00686920|16854226|P2|Overall Study|Protocol Violation|1
4891916|NCT00686920|16854227|P1|Overall Study|Protocol Violation|2
4891917|NCT00686920|16854226|P2|Overall Study|Withdrawal by Subject|5
4891918|NCT00686920|16854227|P1|Overall Study|Withdrawal by Subject|23
4891919|NCT00686920|16854226|P2|Overall Study|Recurrent Hepatic Encephalopathy Episode|2
4891920|NCT00686920|16854227|P1|Overall Study|Recurrent Hepatic Encephalopathy Episode|1
4891921|NCT00686920|16854226|P2|Overall Study|Liver Transplant|8
4891922|NCT00686920|16854227|P1|Overall Study|Liver Transplant|23
4891923|NCT00686920|16854226|P2|Overall Study|Death|14
4891924|NCT00686920|16854227|P1|Overall Study|Death|45
4891925|NCT00686894|16854239|P1|Overall Study|Protocol Violation|4
4891926|NCT00686894|16854239|P1|Overall Study|Relapse|2
4891927|NCT00686881|16854245|P2|Overall Study|Never received study drug|6
4891928|NCT00686881|16854246|P1|Overall Study|Never received study drug|2
4891929|NCT00686881|16854245|P2|Overall Study|Study discontinuation|32
4891930|NCT00686881|16854246|P1|Overall Study|Study discontinuation|35
4891931|NCT00686881|16854245|P2|Overall Study|Irregular visits|0
4891932|NCT00686881|16854246|P1|Overall Study|Irregular visits|1
4891933|NCT00686881|16854245|P2|Overall Study|Did not meet protocol eligibility|0
4891934|NCT00686881|16854246|P1|Overall Study|Did not meet protocol eligibility|1
4891935|NCT00686881|16854245|P2|Overall Study|Circumstances of site|1
4891936|NCT00686881|16854246|P1|Overall Study|Circumstances of site|1
4891937|NCT00686881|16854245|P2|Overall Study|Physician Decision|0
4891938|NCT00686881|16854246|P1|Overall Study|Physician Decision|1
4891939|NCT00686881|16854245|P2|Overall Study|Lack of Efficacy|3
4891940|NCT00686881|16854246|P1|Overall Study|Lack of Efficacy|4
4891941|NCT00686881|16854245|P2|Overall Study|Onset of malignant tumor|11
4891942|NCT00686881|16854246|P1|Overall Study|Onset of malignant tumor|11
4891943|NCT00686881|16854245|P2|Overall Study|Met discontinuation criteria|0
4891944|NCT00686881|16854246|P1|Overall Study|Met discontinuation criteria|5
4891945|NCT00686881|16854245|P2|Overall Study|Treatment-related adverse event|9
4891946|NCT00686881|16854246|P1|Overall Study|Treatment-related adverse event|10
4891947|NCT00686881|16854245|P2|Overall Study|Lost to Follow-up|1
4891948|NCT00686881|16854246|P1|Overall Study|Lost to Follow-up|0
4891949|NCT00686881|16854245|P2|Overall Study|Withdrawal by Subject|18
4891950|NCT00686881|16854246|P1|Overall Study|Withdrawal by Subject|11
4891951|NCT00686855|16854258|P2|Overall Study|Progressive GVHD|1
4891952|NCT00686855|16854259|P1|Overall Study|Progressive GVHD|0
4891953|NCT00686855|16854258|P2|Overall Study|Lost to Follow-up|0
4891954|NCT00686855|16854259|P1|Overall Study|Lost to Follow-up|1
4891955|NCT00686790|16854285|P1|Overall Study|Lost to Follow-up|12
4891956|NCT00686790|16854285|P1|Overall Study|Death|1
4891957|NCT00686790|16854285|P1|Overall Study|Withdrawal by Subject|1
4891958|NCT00686790|16854285|P1|Overall Study|Adverse Event|2
4891959|NCT00686777|16854293|P1|Overall Study|No Visit|1
4891960|NCT00686777|16854293|P1|Overall Study|Discontinuance Criteria (specified AEs)|4
4891961|NCT00686777|16854293|P1|Overall Study|Withdrawal by Subject|2
4891962|NCT00686777|16854293|P1|Overall Study|Pregnancy|1
4891963|NCT00686777|16854293|P1|Overall Study|Adverse Event|2
4891964|NCT00686725|16854301|P2|Overall Study|Other|3
4891965|NCT00686725|16854302|P1|Overall Study|Other|1
4891966|NCT00686725|16854301|P2|Overall Study|Protocol Violation|3
4891967|NCT00686725|16854302|P1|Overall Study|Protocol Violation|1
4891968|NCT00686725|16854301|P2|Overall Study|Withdrawal by Subject|4
4891969|NCT00686725|16854302|P1|Overall Study|Withdrawal by Subject|13
4891970|NCT00686725|16854301|P2|Overall Study|Death|3
4891971|NCT00686725|16854302|P1|Overall Study|Death|6
4891972|NCT00686725|16854301|P2|Overall Study|Lost to Follow-up|5
4891973|NCT00686725|16854302|P1|Overall Study|Lost to Follow-up|7
4891974|NCT00686725|16854301|P2|Overall Study|Progressive Disease|23
4891975|NCT00686725|16854302|P1|Overall Study|Progressive Disease|17
4891976|NCT00686725|16854301|P2|Overall Study|Adverse Event|1
4891977|NCT00686725|16854302|P1|Overall Study|Adverse Event|1
4891978|NCT00686712|16854327|P3|Overall Study|Adverse Event|0
4891979|NCT00686712|16854328|P2|Overall Study|Adverse Event|1
4891980|NCT00686712|16854329|P1|Overall Study|Adverse Event|1
4891981|NCT00686712|16854327|P3|Overall Study|Lost to Follow-up|3
4891982|NCT00686712|16854328|P2|Overall Study|Lost to Follow-up|2
4891983|NCT00686712|16854329|P1|Overall Study|Lost to Follow-up|1
4891984|NCT00686712|16854327|P3|Overall Study|Protocol Violation|10
4891985|NCT00686712|16854328|P2|Overall Study|Protocol Violation|8
4891986|NCT00686712|16854329|P1|Overall Study|Protocol Violation|8
4891987|NCT00686699|16854357|P2|Treatment Period 1|Adverse Event|2
4891988|NCT00686699|16854358|P1|Treatment Period 1|Adverse Event|0
4891989|NCT00686686|16854382|P1|Overall Study|Lost to Follow-up|3
4891990|NCT00686686|16854382|P1|Overall Study|Adverse Event|2
4891991|NCT00686686|16854382|P1|Overall Study|Non-compliance|1
4891992|NCT00686647|16854390|P1|Overall Study|Death|1
4891993|NCT00686647|16854390|P1|Overall Study|Lost to Follow-up|1
4891994|NCT00686634|16854396|P1|Overall Study|Protocol Violation|6
4891995|NCT00686595|16854403|P1|Overall Study|Poor Compliance|1
4891996|NCT00686595|16854403|P1|Overall Study|Lack of Efficacy|1
4891997|NCT00686595|16854403|P1|Overall Study|Lost to Follow-up|1
4891998|NCT00686595|16854403|P1|Overall Study|Protocol Violation|1
4891999|NCT00686595|16854403|P1|Overall Study|Adverse Event|3
4892000|NCT00686543|16854463|P4|Overall Study|Protocol Violation|1
4892001|NCT00686543|16854464|P3|Overall Study|Protocol Violation|2
4892002|NCT00686543|16854465|P2|Overall Study|Protocol Violation|0
4892003|NCT00686543|16854466|P1|Overall Study|Protocol Violation|3
4892004|NCT00686543|16854463|P4|Overall Study|Withdrawal by Subject|0
4892005|NCT00686543|16854464|P3|Overall Study|Withdrawal by Subject|0
4892006|NCT00686543|16854465|P2|Overall Study|Withdrawal by Subject|0
4892007|NCT00686543|16854466|P1|Overall Study|Withdrawal by Subject|2
4892008|NCT00686543|16854463|P4|Overall Study|Adverse Event|2
4892009|NCT00686543|16854464|P3|Overall Study|Adverse Event|3
4892010|NCT00686543|16854465|P2|Overall Study|Adverse Event|1
4892011|NCT00686543|16854466|P1|Overall Study|Adverse Event|9
4892012|NCT00686517|16854487|P3|Treatment|Protocol Violation|0
4892013|NCT00686517|16854488|P2|Treatment|Protocol Violation|1
4892014|NCT00686517|16854489|P1|Treatment|Protocol Violation|2
4892015|NCT00686517|16854487|P3|Treatment|Poor Protocol Compliance|0
4892016|NCT00686517|16854488|P2|Treatment|Poor Protocol Compliance|0
4892017|NCT00686517|16854489|P1|Treatment|Poor Protocol Compliance|1
4892018|NCT00686517|16854487|P3|Treatment|Adverse Event|0
4892019|NCT00686517|16854488|P2|Treatment|Adverse Event|0
4892020|NCT00686517|16854489|P1|Treatment|Adverse Event|2
4892021|NCT00686517|16854487|P3|Treatment|Serious Adverse Event|1
4892022|NCT00686517|16854488|P2|Treatment|Serious Adverse Event|2
4892023|NCT00686517|16854489|P1|Treatment|Serious Adverse Event|1
4892024|NCT00686374|16854512|P1|Overall Study|Other, not specified|4
4892025|NCT00686374|16854512|P1|Overall Study|Missing reason|33
4892026|NCT00686374|16854512|P1|Overall Study|Lost to Follow-up|1
4892027|NCT00686374|16854512|P1|Overall Study|Withdrew consent|5
4892028|NCT00686374|16854512|P1|Overall Study|Adverse Event|8
4892029|NCT00686374|16854512|P1|Overall Study|Lack of Efficacy|10
4892030|NCT00686335|16854523|P1|Run-in Period|violation of inclusion/exclusion criteri|3
4892031|NCT00686335|16854523|P1|Run-in Period|asthma exacerbation|1
4892032|NCT00686335|16854523|P1|Run-in Period|Adverse Event|1
4892033|NCT00686205|16854567|P2|Overall Study|Specimens not confirmed HIV positive|981
4892034|NCT00686205|16854568|P1|Overall Study|Specimens not confirmed HIV positive|0
4892035|NCT00686205|16854567|P2|Overall Study|Specimen handling procedure altered|0
4892036|NCT00686205|16854568|P1|Overall Study|Specimen handling procedure altered|5878
4892037|NCT00686205|16854567|P2|Overall Study|Withdrawal by Subject|0
4892038|NCT00686205|16854568|P1|Overall Study|Withdrawal by Subject|2
4892039|NCT00686205|16854567|P2|Overall Study|Protocol Violation|0
4892040|NCT00686205|16854568|P1|Overall Study|Protocol Violation|127
4892041|NCT00686166|16854574|P1|Overall Study|Did not begin protocol therapy|4
4892042|NCT00686166|16854574|P1|Overall Study|Ineligible|5
4892043|NCT00686166|16854574|P1|Overall Study|Not Protocol Specified|1
4892044|NCT00686166|16854574|P1|Overall Study|Death|1
4892045|NCT00686166|16854574|P1|Overall Study|Progression/Relapse|1
4892046|NCT00686166|16854574|P1|Overall Study|Withdrawal by Subject|1
4892047|NCT00686166|16854574|P1|Overall Study|Adverse Event|7
4892048|NCT00686127|16854586|P2|Overall Study|Withdrawal by Subject|6
4892049|NCT00686127|16854587|P1|Overall Study|Withdrawal by Subject|14
4892050|NCT00686075|16854603|P10|Overall Study|Other|1
4892051|NCT00686075|16854604|P9|Overall Study|Other|0
4892052|NCT00686075|16854605|P8|Overall Study|Other|0
4892053|NCT00686075|16854606|P7|Overall Study|Other|0
4892054|NCT00686075|16854607|P6|Overall Study|Other|0
4892055|NCT00686075|16854608|P5|Overall Study|Other|0
4892056|NCT00686075|16854609|P4|Overall Study|Other|0
4892057|NCT00686075|16854610|P3|Overall Study|Other|0
4892058|NCT00686075|16854611|P2|Overall Study|Other|1
4892059|NCT00686075|16854612|P1|Overall Study|Other|1
4892060|NCT00686075|16854603|P10|Overall Study|Lost to Follow-up|3
4892061|NCT00686075|16854604|P9|Overall Study|Lost to Follow-up|2
4892062|NCT00686075|16854605|P8|Overall Study|Lost to Follow-up|0
4892063|NCT00686075|16854606|P7|Overall Study|Lost to Follow-up|0
4892064|NCT00686075|16854607|P6|Overall Study|Lost to Follow-up|3
4892065|NCT00686075|16854608|P5|Overall Study|Lost to Follow-up|3
4892066|NCT00686075|16854609|P4|Overall Study|Lost to Follow-up|2
4892067|NCT00686075|16854610|P3|Overall Study|Lost to Follow-up|3
4892068|NCT00686075|16854611|P2|Overall Study|Lost to Follow-up|6
4892069|NCT00686075|16854612|P1|Overall Study|Lost to Follow-up|3
4892070|NCT00686075|16854603|P10|Overall Study|Withdrawal by Subject|6
4892071|NCT00686075|16854604|P9|Overall Study|Withdrawal by Subject|4
4892072|NCT00686075|16854605|P8|Overall Study|Withdrawal by Subject|2
4892073|NCT00686075|16854606|P7|Overall Study|Withdrawal by Subject|0
4892074|NCT00686075|16854607|P6|Overall Study|Withdrawal by Subject|0
4892075|NCT00686075|16854608|P5|Overall Study|Withdrawal by Subject|1
4892076|NCT00686075|16854609|P4|Overall Study|Withdrawal by Subject|7
4892077|NCT00686075|16854610|P3|Overall Study|Withdrawal by Subject|3
4892078|NCT00686075|16854611|P2|Overall Study|Withdrawal by Subject|3
4892079|NCT00686075|16854612|P1|Overall Study|Withdrawal by Subject|4
4892080|NCT00686036|16854806|P2|Overall Study|Other reasons not identified|4
4892081|NCT00686036|16854807|P1|Overall Study|Other reasons not identified|0
4892082|NCT00686036|16854806|P2|Overall Study|PSA ≥ 10ng/mL|0
4892083|NCT00686036|16854807|P1|Overall Study|PSA ≥ 10ng/mL|1
4892084|NCT00686036|16854806|P2|Overall Study|Study terminated by AstraZeneca|1
4892085|NCT00686036|16854807|P1|Overall Study|Study terminated by AstraZeneca|2
4892086|NCT00686036|16854806|P2|Overall Study|Withdrawal by Subject|1
4892087|NCT00686036|16854807|P1|Overall Study|Withdrawal by Subject|3
4892088|NCT00686036|16854806|P2|Overall Study|Adverse Event|0
4892089|NCT00686036|16854807|P1|Overall Study|Adverse Event|3
4892090|NCT00685945|16854819|P1|L-NMMA + Bradykinin|Physician Decision|1
4892091|NCT00685802|16854854|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4892092|NCT00685802|16854855|P1|Washout Period of 7 Days|Withdrawal by Subject|0
4892093|NCT00685802|16854854|P2|Washout Period of 7 Days|Protocol Violation|0
4892094|NCT00685802|16854855|P1|Washout Period of 7 Days|Protocol Violation|2
4892095|NCT00685763|16854865|P1|Overall Study|Protocol Violation|1
4892096|NCT00685763|16854865|P1|Overall Study|Intercurrent death-incomplete treatment|1
4892097|NCT00685750|16854876|P7|Overall Study|Eligibility criteria not fulfilled|0
4892098|NCT00685750|16854877|P6|Overall Study|Eligibility criteria not fulfilled|0
4892099|NCT00685750|16854878|P5|Overall Study|Eligibility criteria not fulfilled|0
4892100|NCT00685750|16854879|P4|Overall Study|Eligibility criteria not fulfilled|0
4892101|NCT00685750|16854880|P3|Overall Study|Eligibility criteria not fulfilled|1
4892102|NCT00685750|16854881|P2|Overall Study|Eligibility criteria not fulfilled|0
4892103|NCT00685750|16854882|P1|Overall Study|Eligibility criteria not fulfilled|0
4892104|NCT00685750|16854876|P7|Overall Study|Patient didn't receive the treatment|1
4892105|NCT00685750|16854877|P6|Overall Study|Patient didn't receive the treatment|0
4892106|NCT00685750|16854878|P5|Overall Study|Patient didn't receive the treatment|0
4892107|NCT00685750|16854879|P4|Overall Study|Patient didn't receive the treatment|0
4892108|NCT00685750|16854880|P3|Overall Study|Patient didn't receive the treatment|0
4892109|NCT00685750|16854881|P2|Overall Study|Patient didn't receive the treatment|0
4892110|NCT00685750|16854882|P1|Overall Study|Patient didn't receive the treatment|0
4892111|NCT00685750|16854876|P7|Overall Study|Tumor sampling failure|0
4892112|NCT00685750|16854877|P6|Overall Study|Tumor sampling failure|0
4892113|NCT00685750|16854878|P5|Overall Study|Tumor sampling failure|0
4892114|NCT00685750|16854879|P4|Overall Study|Tumor sampling failure|0
4892115|NCT00685750|16854880|P3|Overall Study|Tumor sampling failure|1
4892116|NCT00685750|16854881|P2|Overall Study|Tumor sampling failure|0
4892117|NCT00685750|16854882|P1|Overall Study|Tumor sampling failure|0
4892118|NCT00685698|16854910|P1|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1
4892119|NCT00685698|16854910|P1|Overall Study|CULTURE RESULTS: GRAM-VE|1
4892120|NCT00685698|16854910|P1|Overall Study|CULTURE GRAM NEG SPECIES|1
4892121|NCT00685698|16854910|P1|Overall Study|Adverse Event|3
4892122|NCT00685698|16854910|P1|Overall Study|Protocol Violation|6
4892123|NCT00685698|16854910|P1|Overall Study|Withdrawal by Subject|1
4892124|NCT00685685|16854945|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4892125|NCT00685685|16854946|P1|Washout Period of 7 Days|Withdrawal by Subject|0
4892126|NCT00685685|16854945|P2|Washout Period of 7 Days|Adverse Event|0
4892127|NCT00685685|16854946|P1|Washout Period of 7 Days|Adverse Event|2
4892128|NCT00685399|16855099|P8|Extension|Adverse Event|0
4892129|NCT00685399|16855100|P7|Extension|Adverse Event|0
4892130|NCT00685399|16855101|P6|Extension|Adverse Event|0
4892131|NCT00685399|16855102|P5|Extension|Adverse Event|0
4892132|NCT00685399|16855103|P4|Extension|Adverse Event|2
4892133|NCT00685399|16855104|P3|Extension|Adverse Event|0
4892134|NCT00685399|16855105|P2|Extension|Adverse Event|0
4892135|NCT00685399|16855106|P1|Extension|Adverse Event|0
4892136|NCT00685399|16855099|P8|Extension|Lack of Efficacy|0
4892137|NCT00685399|16855100|P7|Extension|Lack of Efficacy|0
4892138|NCT00685399|16855101|P6|Extension|Lack of Efficacy|0
4892139|NCT00685399|16855102|P5|Extension|Lack of Efficacy|0
4892140|NCT00685399|16855103|P4|Extension|Lack of Efficacy|2
4892141|NCT00685399|16855104|P3|Extension|Lack of Efficacy|0
4892142|NCT00685399|16855105|P2|Extension|Lack of Efficacy|0
4892143|NCT00685399|16855106|P1|Extension|Lack of Efficacy|0
4892144|NCT00685399|16855099|P8|Extension|Protocol Violation|0
4892145|NCT00685399|16855100|P7|Extension|Protocol Violation|0
4892146|NCT00685399|16855101|P6|Extension|Protocol Violation|0
4892147|NCT00685399|16855102|P5|Extension|Protocol Violation|0
4892148|NCT00685399|16855103|P4|Extension|Protocol Violation|1
4892149|NCT00685399|16855104|P3|Extension|Protocol Violation|0
4892150|NCT00685399|16855105|P2|Extension|Protocol Violation|0
4892151|NCT00685399|16855106|P1|Extension|Protocol Violation|0
4892152|NCT00685399|16855099|P8|Extension|Withdrawal by Subject|0
4892153|NCT00685399|16855100|P7|Extension|Withdrawal by Subject|0
4892154|NCT00685399|16855101|P6|Extension|Withdrawal by Subject|0
4892155|NCT00685399|16855102|P5|Extension|Withdrawal by Subject|0
4892156|NCT00685399|16855103|P4|Extension|Withdrawal by Subject|1
4892157|NCT00685399|16855104|P3|Extension|Withdrawal by Subject|0
4892158|NCT00685399|16855105|P2|Extension|Withdrawal by Subject|0
4892159|NCT00685399|16855106|P1|Extension|Withdrawal by Subject|0
4892160|NCT00685399|16855099|P8|Extension|Administrative Issues|0
4892161|NCT00685399|16855100|P7|Extension|Administrative Issues|0
4892162|NCT00685399|16855101|P6|Extension|Administrative Issues|0
4892163|NCT00685399|16855102|P5|Extension|Administrative Issues|0
4892164|NCT00685399|16855103|P4|Extension|Administrative Issues|1
4892165|NCT00685399|16855104|P3|Extension|Administrative Issues|0
4892166|NCT00685399|16855105|P2|Extension|Administrative Issues|0
4892167|NCT00685399|16855106|P1|Extension|Administrative Issues|0
4892168|NCT00685399|16855099|P8|Treatment Period 2|Lack of Efficacy|0
4892169|NCT00685399|16855100|P7|Treatment Period 2|Lack of Efficacy|0
4892170|NCT00685399|16855101|P6|Treatment Period 2|Lack of Efficacy|1
4892171|NCT00685399|16855102|P5|Treatment Period 2|Lack of Efficacy|0
4892172|NCT00685399|16855103|P4|Treatment Period 2|Lack of Efficacy|0
4892173|NCT00685399|16855104|P3|Treatment Period 2|Lack of Efficacy|2
4892174|NCT00685399|16855105|P2|Treatment Period 2|Lack of Efficacy|10
4892175|NCT00685399|16855106|P1|Treatment Period 2|Lack of Efficacy|0
4892176|NCT00685399|16855099|P8|Treatment Period 2|Adverse Event|0
4892177|NCT00685399|16855100|P7|Treatment Period 2|Adverse Event|0
4892178|NCT00685399|16855101|P6|Treatment Period 2|Adverse Event|1
4892179|NCT00685399|16855102|P5|Treatment Period 2|Adverse Event|0
4892180|NCT00685399|16855103|P4|Treatment Period 2|Adverse Event|0
4892181|NCT00685399|16855104|P3|Treatment Period 2|Adverse Event|0
4892182|NCT00685399|16855105|P2|Treatment Period 2|Adverse Event|0
4892183|NCT00685399|16855106|P1|Treatment Period 2|Adverse Event|0
4892184|NCT00685399|16855099|P8|Treatment Period 2|Withdrawal by Subject|2
4892185|NCT00685399|16855100|P7|Treatment Period 2|Withdrawal by Subject|0
4892186|NCT00685399|16855101|P6|Treatment Period 2|Withdrawal by Subject|0
4892187|NCT00685399|16855102|P5|Treatment Period 2|Withdrawal by Subject|0
4892188|NCT00685399|16855103|P4|Treatment Period 2|Withdrawal by Subject|0
4892189|NCT00685399|16855104|P3|Treatment Period 2|Withdrawal by Subject|0
4892190|NCT00685399|16855105|P2|Treatment Period 2|Withdrawal by Subject|0
4892191|NCT00685399|16855106|P1|Treatment Period 2|Withdrawal by Subject|0
4892192|NCT00685399|16855099|P8|Treatment Period 2|Administrative Problems|0
4892193|NCT00685399|16855100|P7|Treatment Period 2|Administrative Problems|0
4892194|NCT00685399|16855101|P6|Treatment Period 2|Administrative Problems|0
4892195|NCT00685399|16855102|P5|Treatment Period 2|Administrative Problems|0
4892196|NCT00685399|16855103|P4|Treatment Period 2|Administrative Problems|0
4892197|NCT00685399|16855104|P3|Treatment Period 2|Administrative Problems|1
4892198|NCT00685399|16855105|P2|Treatment Period 2|Administrative Problems|2
4892199|NCT00685399|16855106|P1|Treatment Period 2|Administrative Problems|0
4892200|NCT00685399|16855099|P8|Treatment Period 1|Lack of Efficacy|0
4892201|NCT00685399|16855100|P7|Treatment Period 1|Lack of Efficacy|0
4892202|NCT00685399|16855101|P6|Treatment Period 1|Lack of Efficacy|0
4892203|NCT00685399|16855102|P5|Treatment Period 1|Lack of Efficacy|0
4892204|NCT00685399|16855103|P4|Treatment Period 1|Lack of Efficacy|0
4892205|NCT00685399|16855104|P3|Treatment Period 1|Lack of Efficacy|0
4892206|NCT00685399|16855105|P2|Treatment Period 1|Lack of Efficacy|0
4892207|NCT00685399|16855106|P1|Treatment Period 1|Lack of Efficacy|1
4892208|NCT00685399|16855099|P8|Treatment Period 1|Administrative|0
4892209|NCT00685399|16855100|P7|Treatment Period 1|Administrative|0
4892210|NCT00685399|16855101|P6|Treatment Period 1|Administrative|0
4892211|NCT00685399|16855102|P5|Treatment Period 1|Administrative|0
4892212|NCT00685399|16855103|P4|Treatment Period 1|Administrative|0
4892213|NCT00685399|16855104|P3|Treatment Period 1|Administrative|0
4892214|NCT00685399|16855105|P2|Treatment Period 1|Administrative|0
4892215|NCT00685399|16855106|P1|Treatment Period 1|Administrative|2
4892216|NCT00685399|16855099|P8|Treatment Period 1|Protocol Violation|0
4892217|NCT00685399|16855100|P7|Treatment Period 1|Protocol Violation|0
4892218|NCT00685399|16855101|P6|Treatment Period 1|Protocol Violation|0
4892219|NCT00685399|16855102|P5|Treatment Period 1|Protocol Violation|0
4892220|NCT00685399|16855103|P4|Treatment Period 1|Protocol Violation|0
4892221|NCT00685399|16855104|P3|Treatment Period 1|Protocol Violation|0
4892222|NCT00685399|16855105|P2|Treatment Period 1|Protocol Violation|0
4892223|NCT00685399|16855106|P1|Treatment Period 1|Protocol Violation|1
4892224|NCT00685399|16855099|P8|Treatment Period 1|Withdrawal by Subject|0
4892225|NCT00685399|16855100|P7|Treatment Period 1|Withdrawal by Subject|0
4892226|NCT00685399|16855101|P6|Treatment Period 1|Withdrawal by Subject|0
4892227|NCT00685399|16855102|P5|Treatment Period 1|Withdrawal by Subject|0
4892228|NCT00685399|16855103|P4|Treatment Period 1|Withdrawal by Subject|0
4892229|NCT00685399|16855104|P3|Treatment Period 1|Withdrawal by Subject|0
4892230|NCT00685399|16855105|P2|Treatment Period 1|Withdrawal by Subject|0
4892231|NCT00685399|16855106|P1|Treatment Period 1|Withdrawal by Subject|2
4892232|NCT00685373|16855139|P1|Overall Study|Protocol Violation|1
4892233|NCT00685373|16855139|P1|Overall Study|Lost to Follow-up|2
4892234|NCT00685373|16855139|P1|Overall Study|Condition no longer requires study drug|1
4892235|NCT00685373|16855139|P1|Overall Study|Lack of Efficacy|3
4892236|NCT00685373|16855139|P1|Overall Study|Withdrawal by Subject|5
4892237|NCT00685373|16855139|P1|Overall Study|Adverse Event|3
4892238|NCT00685334|16855148|P2|Overall Study|Chose to enter hospital|1
4892239|NCT00685334|16855149|P1|Overall Study|Chose to enter hospital|1
4892240|NCT00685334|16855148|P2|Overall Study|Lost to Follow-up|0
4892241|NCT00685334|16855149|P1|Overall Study|Lost to Follow-up|4
4892242|NCT00685334|16855148|P2|Overall Study|Withdrawal by Subject|6
4892243|NCT00685334|16855149|P1|Overall Study|Withdrawal by Subject|5
4892244|NCT00685178|16855174|P4|Overall Study|Pregnancy|1
4892245|NCT00685178|16855175|P3|Overall Study|Pregnancy|0
4892246|NCT00685178|16855176|P2|Overall Study|Pregnancy|0
4892247|NCT00685178|16855177|P1|Overall Study|Pregnancy|0
4892248|NCT00685178|16855174|P4|Overall Study|administrative (disciplinary) discharge|2
4892249|NCT00685178|16855175|P3|Overall Study|administrative (disciplinary) discharge|0
4892250|NCT00685178|16855176|P2|Overall Study|administrative (disciplinary) discharge|1
4892251|NCT00685178|16855177|P1|Overall Study|administrative (disciplinary) discharge|0
4892252|NCT00685178|16855174|P4|Overall Study|incarcerated|0
4892253|NCT00685178|16855175|P3|Overall Study|incarcerated|7
4892254|NCT00685178|16855176|P2|Overall Study|incarcerated|3
4892255|NCT00685178|16855177|P1|Overall Study|incarcerated|1
4892256|NCT00685178|16855174|P4|Overall Study|voluntary study discharge|1
4892257|NCT00685178|16855175|P3|Overall Study|voluntary study discharge|1
4892258|NCT00685178|16855176|P2|Overall Study|voluntary study discharge|5
4892259|NCT00685178|16855177|P1|Overall Study|voluntary study discharge|4
4892260|NCT00685178|16855174|P4|Overall Study|missed 3 consecutive methadone clin days|6
4892261|NCT00685178|16855175|P3|Overall Study|missed 3 consecutive methadone clin days|2
4892262|NCT00685178|16855176|P2|Overall Study|missed 3 consecutive methadone clin days|5
4892263|NCT00685178|16855177|P1|Overall Study|missed 3 consecutive methadone clin days|7
4892264|NCT00685178|16855174|P4|Overall Study|Adverse Event|4
4892265|NCT00685178|16855175|P3|Overall Study|Adverse Event|2
4892266|NCT00685178|16855176|P2|Overall Study|Adverse Event|5
4892267|NCT00685178|16855177|P1|Overall Study|Adverse Event|1
4892268|NCT00685165|16855191|P2|Washout Period of 14 Days|Adverse Event|0
4892269|NCT00685165|16855192|P1|Washout Period of 14 Days|Adverse Event|1
4892270|NCT00685035|16855211|P2|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0
4892271|NCT00685035|16855212|P1|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1
4892272|NCT00684996|16855236|P1|Overall Study|Other reasons not protocol specified|1
4892273|NCT00684996|16855236|P1|Overall Study|Progression/relapse|2
4892274|NCT00684996|16855236|P1|Overall Study|Refusal unrelated to adverse event|1
4892275|NCT00684996|16855236|P1|Overall Study|Adverse Event|1
4892276|NCT00684814|16855268|P2|Second Intervention|Adverse Event|0
4892277|NCT00684814|16855269|P1|Second Intervention|Adverse Event|1
4892278|NCT00684814|16855268|P2|Washout Period of 7 Days|Withdrawal by Subject|2
4892279|NCT00684814|16855269|P1|Washout Period of 7 Days|Withdrawal by Subject|1
4892280|NCT00684814|16855268|P2|Washout Period of 7 Days|Adverse Event|2
4892281|NCT00684814|16855269|P1|Washout Period of 7 Days|Adverse Event|1
4892282|NCT00684762|16855321|P2|Washout Period of 7 Days|Withdrawal by Subject|2
4892283|NCT00684762|16855322|P1|Washout Period of 7 Days|Withdrawal by Subject|2
4892284|NCT00684671|16855350|P3|Overall Study|Alcoholic dependance|0
4892285|NCT00684671|16855351|P2|Overall Study|Alcoholic dependance|0
4892286|NCT00684671|16855352|P1|Overall Study|Alcoholic dependance|1
4892287|NCT00684671|16855350|P3|Overall Study|Lost to Follow-up|0
4892288|NCT00684671|16855351|P2|Overall Study|Lost to Follow-up|0
4892289|NCT00684671|16855352|P1|Overall Study|Lost to Follow-up|1
4892290|NCT00684671|16855350|P3|Overall Study|Adverse Event|0
4892291|NCT00684671|16855351|P2|Overall Study|Adverse Event|0
4892292|NCT00684671|16855352|P1|Overall Study|Adverse Event|1
4892293|NCT00684645|16855381|P1|Overall Study|Other|15
4892294|NCT00684645|16855381|P1|Overall Study|Lost to Follow-up|3
4892295|NCT00684645|16855381|P1|Overall Study|Adverse Event|27
4892296|NCT00684645|16855381|P1|Overall Study|Progressive disease|67
4892297|NCT00684645|16855381|P1|Overall Study|Death|2
4892298|NCT00684593|16855401|P2|Overall Study|Adverse Event|2
4892299|NCT00684593|16855402|P1|Overall Study|Adverse Event|0
4892300|NCT00684567|16855414|P1|Monotherapy Period|Progression of primary disease|11
4892301|NCT00684567|16855414|P1|Monotherapy Period|Death|1
4892302|NCT00684567|16855414|P1|Monotherapy Period|Adverse Event|2
4892303|NCT00684567|16855414|P1|Concomitant Radiotherapy Period|Adverse Event|2
4892304|NCT00684515|16855447|P3|Overall Study|Protocol-Defined Clinical Event|0
4892305|NCT00684515|16855448|P2|Overall Study|Protocol-Defined Clinical Event|0
4892306|NCT00684515|16855449|P1|Overall Study|Protocol-Defined Clinical Event|1
4892307|NCT00684515|16855447|P3|Overall Study|Adverse Event|1
4892308|NCT00684515|16855448|P2|Overall Study|Adverse Event|3
4892309|NCT00684515|16855449|P1|Overall Study|Adverse Event|3
4892310|NCT00684424|16855472|P1|Overall Study|Other|2
4892311|NCT00684424|16855472|P1|Overall Study|Lost to Follow-up|2
4892312|NCT00684424|16855472|P1|Overall Study|Adverse Event|1
4892313|NCT00684411|16855487|P1|Overall Study|Adverse Event|1
4892314|NCT00684411|16855487|P1|Overall Study|Disease Progression|10
4892315|NCT00684411|16855487|P1|Overall Study|New Primary Cancer|1
4892316|NCT00684307|16855509|P5|Overall Study|Criteria from the CSR|3
4892317|NCT00684307|16855510|P4|Overall Study|Criteria from the CSR|3
4892318|NCT00684307|16855511|P3|Overall Study|Criteria from the CSR|1
4892319|NCT00684307|16855512|P2|Overall Study|Criteria from the CSR|0
4892320|NCT00684307|16855513|P1|Overall Study|Criteria from the CSR|0
4892321|NCT00684307|16855509|P5|Overall Study|Participant not willing to continue|8
4892322|NCT00684307|16855510|P4|Overall Study|Participant not willing to continue|5
4892323|NCT00684307|16855511|P3|Overall Study|Participant not willing to continue|11
4892324|NCT00684307|16855512|P2|Overall Study|Participant not willing to continue|10
4892325|NCT00684307|16855513|P1|Overall Study|Participant not willing to continue|7
4892326|NCT00684307|16855509|P5|Overall Study|Severe non compliance to protocol|2
4892327|NCT00684307|16855510|P4|Overall Study|Severe non compliance to protocol|1
4892328|NCT00684307|16855511|P3|Overall Study|Severe non compliance to protocol|0
4892329|NCT00684307|16855512|P2|Overall Study|Severe non compliance to protocol|0
4892330|NCT00684307|16855513|P1|Overall Study|Severe non compliance to protocol|1
4892331|NCT00684307|16855509|P5|Overall Study|Interupted IP for more than 7 days|3
4892332|NCT00684307|16855510|P4|Overall Study|Interupted IP for more than 7 days|3
4892333|NCT00684307|16855511|P3|Overall Study|Interupted IP for more than 7 days|1
4892334|NCT00684307|16855512|P2|Overall Study|Interupted IP for more than 7 days|4
4892335|NCT00684307|16855513|P1|Overall Study|Interupted IP for more than 7 days|0
4892336|NCT00684307|16855509|P5|Overall Study|Incorrect enrolment or randomization|0
4892337|NCT00684307|16855510|P4|Overall Study|Incorrect enrolment or randomization|0
4892338|NCT00684307|16855511|P3|Overall Study|Incorrect enrolment or randomization|0
4892339|NCT00684307|16855512|P2|Overall Study|Incorrect enrolment or randomization|0
4892340|NCT00684307|16855513|P1|Overall Study|Incorrect enrolment or randomization|4
4892341|NCT00684307|16855509|P5|Overall Study|Fullfillment of exclusion criteria|1
4892342|NCT00684307|16855510|P4|Overall Study|Fullfillment of exclusion criteria|3
4892343|NCT00684307|16855511|P3|Overall Study|Fullfillment of exclusion criteria|0
4892344|NCT00684307|16855512|P2|Overall Study|Fullfillment of exclusion criteria|0
4892345|NCT00684307|16855513|P1|Overall Study|Fullfillment of exclusion criteria|1
4892346|NCT00684307|16855509|P5|Overall Study|Development of increasing Liver Function|0
4892347|NCT00684307|16855510|P4|Overall Study|Development of increasing Liver Function|1
4892348|NCT00684307|16855511|P3|Overall Study|Development of increasing Liver Function|0
4892349|NCT00684307|16855512|P2|Overall Study|Development of increasing Liver Function|2
4892350|NCT00684307|16855513|P1|Overall Study|Development of increasing Liver Function|0
4892351|NCT00684307|16855509|P5|Overall Study|Adverse Event|8
4892352|NCT00684307|16855510|P4|Overall Study|Adverse Event|16
4892353|NCT00684307|16855511|P3|Overall Study|Adverse Event|15
4892354|NCT00684307|16855512|P2|Overall Study|Adverse Event|6
4892355|NCT00684307|16855513|P1|Overall Study|Adverse Event|11
4892356|NCT00684203|16855595|P6|Overall Study|Did not meet protocol eligibility|0
4892357|NCT00684203|16855596|P5|Overall Study|Did not meet protocol eligibility|0
4892358|NCT00684203|16855597|P4|Overall Study|Did not meet protocol eligibility|0
4892359|NCT00684203|16855598|P3|Overall Study|Did not meet protocol eligibility|0
4892360|NCT00684203|16855599|P2|Overall Study|Did not meet protocol eligibility|1
4892361|NCT00684203|16855600|P1|Overall Study|Did not meet protocol eligibility|0
4892362|NCT00684203|16855595|P6|Overall Study|Withdrawal by Subject|0
4892363|NCT00684203|16855596|P5|Overall Study|Withdrawal by Subject|0
4892364|NCT00684203|16855597|P4|Overall Study|Withdrawal by Subject|0
4892365|NCT00684203|16855598|P3|Overall Study|Withdrawal by Subject|1
4892366|NCT00684203|16855599|P2|Overall Study|Withdrawal by Subject|2
4892367|NCT00684203|16855600|P1|Overall Study|Withdrawal by Subject|0
4892368|NCT00684203|16855595|P6|Overall Study|Protocol-defined clinical event|0
4892369|NCT00684203|16855596|P5|Overall Study|Protocol-defined clinical event|0
4892370|NCT00684203|16855597|P4|Overall Study|Protocol-defined clinical event|0
4892371|NCT00684203|16855598|P3|Overall Study|Protocol-defined clinical event|0
4892372|NCT00684203|16855599|P2|Overall Study|Protocol-defined clinical event|1
4892373|NCT00684203|16855600|P1|Overall Study|Protocol-defined clinical event|3
4892374|NCT00684203|16855595|P6|Overall Study|Adverse Event|0
4892375|NCT00684203|16855596|P5|Overall Study|Adverse Event|0
4892376|NCT00684203|16855597|P4|Overall Study|Adverse Event|0
4892377|NCT00684203|16855598|P3|Overall Study|Adverse Event|8
4892378|NCT00684203|16855599|P2|Overall Study|Adverse Event|4
4892379|NCT00684203|16855600|P1|Overall Study|Adverse Event|6
4892380|NCT00684177|16855661|P2|Overall Study|Other|2
4892381|NCT00684177|16855662|P1|Overall Study|Other|1
4892382|NCT00684177|16855661|P2|Overall Study|Withdrawal by Subject|2
4892383|NCT00684177|16855662|P1|Overall Study|Withdrawal by Subject|1
4892384|NCT00684177|16855661|P2|Overall Study|Physician Decision|0
4892385|NCT00684177|16855662|P1|Overall Study|Physician Decision|2
4892386|NCT00684177|16855661|P2|Overall Study|Lost to Follow-up|1
4892387|NCT00684177|16855662|P1|Overall Study|Lost to Follow-up|2
4892388|NCT00684177|16855661|P2|Overall Study|Protocol Violation|0
4892389|NCT00684177|16855662|P1|Overall Study|Protocol Violation|1
4892390|NCT00684177|16855661|P2|Overall Study|Lack of Efficacy|15
4892391|NCT00684177|16855662|P1|Overall Study|Lack of Efficacy|10
4892392|NCT00684177|16855661|P2|Overall Study|Adverse Event|3
4892393|NCT00684177|16855662|P1|Overall Study|Adverse Event|4
4892394|NCT00684073|16855697|P1|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1
4892395|NCT00684073|16855697|P1|Selection|request of the sponsor|1
4892396|NCT00684073|16855697|P1|Selection|Lost to Follow-up|1
4892397|NCT00684073|16855697|P1|Selection|noncompliance|1
4892398|NCT00684073|16855697|P1|Selection|Death|1
4892399|NCT00684073|16855697|P1|Selection|Selection/non-selection criteria|3
4892400|NCT00684060|16855707|P2|Overall Study|Death|1
4892401|NCT00684060|16855708|P1|Overall Study|Death|0
4892402|NCT00684060|16855707|P2|Overall Study|Unable to collect MRI|2
4892403|NCT00684060|16855708|P1|Overall Study|Unable to collect MRI|1
4892404|NCT00684060|16855707|P2|Overall Study|New stenosis identified|0
4892405|NCT00684060|16855708|P1|Overall Study|New stenosis identified|1
4892406|NCT00684060|16855707|P2|Overall Study|Lost to Follow-up|0
4892407|NCT00684060|16855708|P1|Overall Study|Lost to Follow-up|1
4892408|NCT00684021|16855747|P4|Overall Study|Death|0
4892409|NCT00684021|16855748|P3|Overall Study|Death|0
4892410|NCT00684021|16855749|P2|Overall Study|Death|0
4892411|NCT00684021|16855750|P1|Overall Study|Death|1
4892412|NCT00684021|16855747|P4|Overall Study|MRI not performed|2
4892413|NCT00684021|16855748|P3|Overall Study|MRI not performed|1
4892414|NCT00684021|16855749|P2|Overall Study|MRI not performed|1
4892415|NCT00684021|16855750|P1|Overall Study|MRI not performed|0
4892416|NCT00684021|16855747|P4|Overall Study|MRI Contraindicated|0
4892417|NCT00684021|16855748|P3|Overall Study|MRI Contraindicated|1
4892418|NCT00684021|16855749|P2|Overall Study|MRI Contraindicated|1
4892419|NCT00684021|16855750|P1|Overall Study|MRI Contraindicated|1
4892420|NCT00683917|16855811|P1|Overall Study|Study prematurely terminated|10
4892421|NCT00683904|16855821|P2|Dose Level 2|Adverse Event|2
4892422|NCT00683904|16855822|P1|Dose Level 2|Adverse Event|0
4892423|NCT00683904|16855821|P2|Dose Level 1|Adverse Event|0
4892424|NCT00683904|16855822|P1|Dose Level 1|Adverse Event|1
4892425|NCT00683904|16855821|P2|Dose Level 1|Disease progression|0
4892426|NCT00683904|16855822|P1|Dose Level 1|Disease progression|2
4892427|NCT00683878|16855858|P3|Overall Study|Non-compliance, not met criteria etc.|0
4892428|NCT00683878|16855859|P2|Overall Study|Non-compliance, not met criteria etc.|2
4892429|NCT00683878|16855860|P1|Overall Study|Non-compliance, not met criteria etc.|3
4892430|NCT00683878|16855858|P3|Overall Study|Lost to Follow-up|4
4892431|NCT00683878|16855859|P2|Overall Study|Lost to Follow-up|2
4892432|NCT00683878|16855860|P1|Overall Study|Lost to Follow-up|4
4892433|NCT00683878|16855858|P3|Overall Study|Death|0
4892434|NCT00683878|16855859|P2|Overall Study|Death|1
4892435|NCT00683878|16855860|P1|Overall Study|Death|0
4892436|NCT00683878|16855858|P3|Overall Study|Withdrawal by Subject|6
4892437|NCT00683878|16855859|P2|Overall Study|Withdrawal by Subject|8
4892438|NCT00683878|16855860|P1|Overall Study|Withdrawal by Subject|9
4892439|NCT00683878|16855858|P3|Overall Study|Adverse Event|3
4892440|NCT00683878|16855859|P2|Overall Study|Adverse Event|3
4892441|NCT00683878|16855860|P1|Overall Study|Adverse Event|4
4892442|NCT00683878|16855858|P3|Overall Study|Lack of Efficacy|1
4892443|NCT00683878|16855859|P2|Overall Study|Lack of Efficacy|0
4892444|NCT00683878|16855860|P1|Overall Study|Lack of Efficacy|3
4892445|NCT00683800|16855934|P2|Overall Study|Randomized, not treated|33
4892446|NCT00683800|16855935|P1|Overall Study|Randomized, not treated|35
4892447|NCT00683800|16855934|P2|Overall Study|Lack of Efficacy|104
4892448|NCT00683800|16855935|P1|Overall Study|Lack of Efficacy|61
4892449|NCT00683800|16855934|P2|Overall Study|Withdrawal by Subject|64
4892450|NCT00683800|16855935|P1|Overall Study|Withdrawal by Subject|66
4892451|NCT00683800|16855934|P2|Overall Study|Protocol Violation|16
4892452|NCT00683800|16855935|P1|Overall Study|Protocol Violation|13
4892453|NCT00683800|16855934|P2|Overall Study|Other|2
4892454|NCT00683800|16855935|P1|Overall Study|Other|5
4892455|NCT00683800|16855934|P2|Overall Study|Lost to Follow-up|44
4892456|NCT00683800|16855935|P1|Overall Study|Lost to Follow-up|57
4892457|NCT00683800|16855934|P2|Overall Study|Death|1
4892458|NCT00683800|16855935|P1|Overall Study|Death|0
4892459|NCT00683800|16855934|P2|Overall Study|Adverse Event|102
4892460|NCT00683800|16855935|P1|Overall Study|Adverse Event|195
4892461|NCT00683787|16856002|P3|Overall Study|Adverse Event|2
4892462|NCT00683787|16856003|P2|Overall Study|Adverse Event|0
4892463|NCT00683787|16856004|P1|Overall Study|Adverse Event|0
4892464|NCT00683787|16856002|P3|Overall Study|Progression|0
4892465|NCT00683787|16856003|P2|Overall Study|Progression|3
4892466|NCT00683787|16856004|P1|Overall Study|Progression|3
4892467|NCT00683774|16856023|P2|Overall Study|Physician Decision|0
4892468|NCT00683774|16856024|P1|Overall Study|Physician Decision|3
4892469|NCT00683774|16856023|P2|Overall Study|Withdrawal by Subject|1
4892470|NCT00683774|16856024|P1|Overall Study|Withdrawal by Subject|0
4892471|NCT00683696|16856034|P2|Overall Study|Death|30
4892472|NCT00683696|16856035|P1|Overall Study|Death|46
4892473|NCT00683696|16856034|P2|Overall Study|Vital status follow-up only|3
4892474|NCT00683696|16856035|P1|Overall Study|Vital status follow-up only|3
4892475|NCT00683696|16856034|P2|Overall Study|Lost to Follow-up|6
4892476|NCT00683696|16856035|P1|Overall Study|Lost to Follow-up|5
4892477|NCT00683696|16856034|P2|Overall Study|Withdrawn prior to study closure|28
4892478|NCT00683696|16856035|P1|Overall Study|Withdrawn prior to study closure|13
4892479|NCT00683696|16856034|P2|Overall Study|Withdrawn due to study closure|338
4892480|NCT00683696|16856035|P1|Overall Study|Withdrawn due to study closure|337
4892481|NCT00683657|16856054|P2|Overall Study|Subject Withdrew Consent|0
4892482|NCT00683657|16856055|P1|Overall Study|Subject Withdrew Consent|1
4892483|NCT00683657|16856054|P2|Overall Study|Adverse Event|1
4892484|NCT00683657|16856055|P1|Overall Study|Adverse Event|0
4892485|NCT00683644|16856071|P2|Overall Study|Low copper, other health problems,|6
4892486|NCT00683644|16856072|P1|Overall Study|Low copper, other health problems,|7
4892487|NCT00683644|16856071|P2|Overall Study|Adverse Event|2
4892488|NCT00683644|16856072|P1|Overall Study|Adverse Event|1
4892489|NCT00683644|16856071|P2|Overall Study|Lost to Follow-up|4
4892490|NCT00683644|16856072|P1|Overall Study|Lost to Follow-up|1
4892491|NCT00683644|16856071|P2|Overall Study|Withdrawal by Subject|2
4892492|NCT00683644|16856072|P1|Overall Study|Withdrawal by Subject|4
4892493|NCT00683618|16856085|P3|Extension Treatment Period|Protocol Violation|0
4892494|NCT00683618|16856086|P2|Extension Treatment Period|Protocol Violation|0
4892495|NCT00683618|16856087|P1|Extension Treatment Period|Protocol Violation|1
4892496|NCT00683618|16856085|P3|Extension Treatment Period|Adverse Event|0
4892497|NCT00683618|16856086|P2|Extension Treatment Period|Adverse Event|0
4892498|NCT00683618|16856087|P1|Extension Treatment Period|Adverse Event|1
4892499|NCT00683618|16856085|P3|Extension Treatment Period|Withdrawal by Subject|0
4892500|NCT00683618|16856086|P2|Extension Treatment Period|Withdrawal by Subject|0
4892501|NCT00683618|16856087|P1|Extension Treatment Period|Withdrawal by Subject|1
4892502|NCT00683618|16856085|P3|Randomised Treatment Period|Reason not provided|2
4892503|NCT00683618|16856086|P2|Randomised Treatment Period|Reason not provided|0
4892504|NCT00683618|16856087|P1|Randomised Treatment Period|Reason not provided|0
4892505|NCT00683618|16856085|P3|Randomised Treatment Period|Adverse Event|2
4892506|NCT00683618|16856086|P2|Randomised Treatment Period|Adverse Event|0
4892507|NCT00683618|16856087|P1|Randomised Treatment Period|Adverse Event|2
4892508|NCT00683618|16856085|P3|Randomised Treatment Period|Protocol Violation|0
4892509|NCT00683618|16856086|P2|Randomised Treatment Period|Protocol Violation|1
4892510|NCT00683618|16856087|P1|Randomised Treatment Period|Protocol Violation|0
4892511|NCT00683618|16856085|P3|Randomised Treatment Period|Withdrawal by Subject|2
4892512|NCT00683618|16856086|P2|Randomised Treatment Period|Withdrawal by Subject|1
4892513|NCT00683618|16856087|P1|Randomised Treatment Period|Withdrawal by Subject|4
4892514|NCT00683592|16856137|P2|Overall Study|Other|1
4892515|NCT00683592|16856138|P1|Overall Study|Other|1
4892516|NCT00683592|16856137|P2|Overall Study|Non-compliance|5
4892517|NCT00683592|16856138|P1|Overall Study|Non-compliance|3
4892518|NCT00683592|16856137|P2|Overall Study|Physician Decision|1
4892519|NCT00683592|16856138|P1|Overall Study|Physician Decision|0
4892520|NCT00683592|16856137|P2|Overall Study|Lack of Efficacy|7
4892521|NCT00683592|16856138|P1|Overall Study|Lack of Efficacy|3
4892522|NCT00683592|16856137|P2|Overall Study|Lost to Follow-up|17
4892523|NCT00683592|16856138|P1|Overall Study|Lost to Follow-up|17
4892524|NCT00683592|16856137|P2|Overall Study|Withdrawal by Subject|11
4892525|NCT00683592|16856138|P1|Overall Study|Withdrawal by Subject|11
4892526|NCT00683592|16856137|P2|Overall Study|Adverse Event|4
4892527|NCT00683592|16856138|P1|Overall Study|Adverse Event|12
4892528|NCT00683475|16856156|P2|Overall Study|Never Treated: Progressive Disease|0
4892529|NCT00683475|16856157|P1|Overall Study|Never Treated: Progressive Disease|1
4892530|NCT00683475|16856156|P2|Overall Study|Never Treated: Adverse Event|3
4892531|NCT00683475|16856157|P1|Overall Study|Never Treated: Adverse Event|2
4892532|NCT00683475|16856156|P2|Overall Study|Withdrawal by Subject|0
4892533|NCT00683475|16856157|P1|Overall Study|Withdrawal by Subject|1
4892534|NCT00683449|16856192|P5|Overall Study|Lost to Follow-up|0
4892535|NCT00683449|16856193|P4|Overall Study|Lost to Follow-up|0
4892536|NCT00683449|16856194|P3|Overall Study|Lost to Follow-up|0
4892537|NCT00683449|16856195|P2|Overall Study|Lost to Follow-up|1
4892538|NCT00683449|16856196|P1|Overall Study|Lost to Follow-up|0
4892539|NCT00683384|16856222|P1|Overall Study|Adverse Event|1
4892540|NCT00683384|16856222|P1|Overall Study|Death|1
4892541|NCT00683293|16856232|P2|Overall Study|Withdrawal by Subject|3
4892542|NCT00683293|16856233|P1|Overall Study|Withdrawal by Subject|2
4892543|NCT00682929|16856296|P3|Overall Study|lag in DEA renewal|0
4892544|NCT00682929|16856297|P2|Overall Study|lag in DEA renewal|0
4892545|NCT00682929|16856298|P1|Overall Study|lag in DEA renewal|1
4892546|NCT00682929|16856296|P3|Overall Study|dosing compliance < 80%|0
4892547|NCT00682929|16856297|P2|Overall Study|dosing compliance < 80%|2
4892548|NCT00682929|16856298|P1|Overall Study|dosing compliance < 80%|0
4892549|NCT00682929|16856296|P3|Overall Study|Withdrawal by Subject|1
4892550|NCT00682929|16856297|P2|Overall Study|Withdrawal by Subject|2
4892551|NCT00682929|16856298|P1|Overall Study|Withdrawal by Subject|1
4892552|NCT00682929|16856296|P3|Overall Study|Adverse Event|1
4892553|NCT00682929|16856297|P2|Overall Study|Adverse Event|1
4892554|NCT00682929|16856298|P1|Overall Study|Adverse Event|4
4892555|NCT00682890|16856467|P2|Overall Study|heavy menstrual bleeding|0
4892556|NCT00682890|16856468|P1|Overall Study|heavy menstrual bleeding|1
4892557|NCT00682890|16856467|P2|Overall Study|subject moved away|1
4892558|NCT00682890|16856468|P1|Overall Study|subject moved away|0
4892559|NCT00682890|16856467|P2|Overall Study|Lost to Follow-up|1
4892560|NCT00682890|16856468|P1|Overall Study|Lost to Follow-up|1
4892561|NCT00682786|16856510|P2|Overall Study|Did not receive irinotecan|1
4892562|NCT00682786|16856511|P1|Overall Study|Did not receive irinotecan|0
4892563|NCT00682786|16856510|P2|Overall Study|Withdrawal by Subject|2
4892564|NCT00682786|16856511|P1|Overall Study|Withdrawal by Subject|2
4892565|NCT00682643|16856560|P2|Overall Study|Did Not Receive Study Drug|1
4892566|NCT00682643|16856561|P1|Overall Study|Did Not Receive Study Drug|1
4892567|NCT00682643|16856560|P2|Overall Study|Withdrawal by Subject|53
4892568|NCT00682643|16856561|P1|Overall Study|Withdrawal by Subject|19
4892569|NCT00682643|16856560|P2|Overall Study|Physician Decision|6
4892570|NCT00682643|16856561|P1|Overall Study|Physician Decision|2
4892571|NCT00682643|16856560|P2|Overall Study|Lost to Follow-up|6
4892572|NCT00682643|16856561|P1|Overall Study|Lost to Follow-up|1
4892573|NCT00682643|16856560|P2|Overall Study|Met Protocol-defined Stopping Criteria|4
4892574|NCT00682643|16856561|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
4892575|NCT00682643|16856560|P2|Overall Study|Protocol Violation|76
4892576|NCT00682643|16856561|P1|Overall Study|Protocol Violation|38
4892577|NCT00682643|16856560|P2|Overall Study|Lack of Efficacy|0
4892578|NCT00682643|16856561|P1|Overall Study|Lack of Efficacy|2
4892579|NCT00682643|16856560|P2|Overall Study|Adverse Event|23
4892580|NCT00682643|16856561|P1|Overall Study|Adverse Event|12
4892581|NCT00682539|16856635|P3|Ranibizumab vs Triamcinolone|Lost to Follow-up|8
4892582|NCT00682539|16856636|P2|Ranibizumab vs Triamcinolone|Lost to Follow-up|3
4892583|NCT00682539|16856637|P1|Ranibizumab vs Triamcinolone|Lost to Follow-up|0
4892584|NCT00682539|16856635|P3|Bevacizumab vs Triamcinolone|Lost to Follow-up|0
4892585|NCT00682539|16856636|P2|Bevacizumab vs Triamcinolone|Lost to Follow-up|1
4892586|NCT00682539|16856637|P1|Bevacizumab vs Triamcinolone|Lost to Follow-up|3
4892587|NCT00682461|16856650|P2|Overall Study|Withdrawal by Subject|19
4892588|NCT00682461|16856651|P1|Overall Study|Withdrawal by Subject|12
4892589|NCT00682461|16856650|P2|Overall Study|Lost to Follow-up|5
4892590|NCT00682461|16856651|P1|Overall Study|Lost to Follow-up|8
4892591|NCT00682461|16856650|P2|Overall Study|Adverse Event|7
4892592|NCT00682461|16856651|P1|Overall Study|Adverse Event|5
4892593|NCT00682435|16856665|P1|Overall Study|Erroneously enrolled twice|2
4892594|NCT00682435|16856665|P1|Overall Study|Insufficient data|5
4892595|NCT00681863|16856698|P1|Overall Study|Other|18
4892596|NCT00681863|16856698|P1|Overall Study|Lack of Efficacy|2
4892597|NCT00681863|16856698|P1|Overall Study|Lost to Follow-up|2
4892598|NCT00681863|16856698|P1|Overall Study|Adverse Event|1
4892599|NCT00681824|16856746|P3|Overall Study|Death|0
4892600|NCT00681824|16856747|P2|Overall Study|Death|1
4892601|NCT00681824|16856748|P1|Overall Study|Death|0
4892602|NCT00681824|16856746|P3|Overall Study|scheduling conflict|0
4892603|NCT00681824|16856747|P2|Overall Study|scheduling conflict|0
4892604|NCT00681824|16856748|P1|Overall Study|scheduling conflict|1
4892605|NCT00681824|16856746|P3|Overall Study|withdrawn by investigator|1
4892606|NCT00681824|16856747|P2|Overall Study|withdrawn by investigator|0
4892607|NCT00681824|16856748|P1|Overall Study|withdrawn by investigator|0
4892608|NCT00681811|16856766|P2|Overall Study|Non-compliance|1
4892609|NCT00681811|16856767|P1|Overall Study|Non-compliance|0
4892610|NCT00681811|16856766|P2|Overall Study|Withdrawal by Subject|2
4892611|NCT00681811|16856767|P1|Overall Study|Withdrawal by Subject|2
4892612|NCT00681811|16856766|P2|Overall Study|Adverse Event|1
4892613|NCT00681811|16856767|P1|Overall Study|Adverse Event|1
4892614|NCT00681668|16856795|P1|Overall Study|Withdrawal by Subject|1
4892615|NCT00681668|16856795|P1|Overall Study|Protocol Violation|1
4892616|NCT00681629|16856804|P2|Overall Study|Adverse Event|0
4892617|NCT00681629|16856805|P1|Overall Study|Adverse Event|1
4892618|NCT00681629|16856804|P2|Overall Study|Study termination|2
4892619|NCT00681629|16856805|P1|Overall Study|Study termination|4
4892620|NCT00681590|16856851|P2|Overall Study|Withdrawal by Subject|12
4892621|NCT00681590|16856852|P1|Overall Study|Withdrawal by Subject|2
4892622|NCT00681564|16856862|P2|Overall Study|Death|1
4892623|NCT00681564|16856863|P1|Overall Study|Death|0
4892624|NCT00681564|16856862|P2|Overall Study|Withdrawal by Subject|1
4892625|NCT00681564|16856863|P1|Overall Study|Withdrawal by Subject|0
4892626|NCT00681564|16856862|P2|Overall Study|Lost to Follow-up|6
4892627|NCT00681564|16856863|P1|Overall Study|Lost to Follow-up|6
4892628|NCT00681187|16856955|P2|Overall Study|Adverse Event|1
4892629|NCT00681187|16856956|P1|Overall Study|Adverse Event|0
4892630|NCT00681187|16856955|P2|Overall Study|Death|1
4892631|NCT00681187|16856956|P1|Overall Study|Death|0
4892632|NCT00681187|16856955|P2|Overall Study|Withdrawal by Subject|0
4892633|NCT00681187|16856956|P1|Overall Study|Withdrawal by Subject|1
4892634|NCT00681109|16856991|P3|Overall Study|Lost to Follow-up|0
4892635|NCT00681109|16856992|P2|Overall Study|Lost to Follow-up|6
4892636|NCT00681109|16856993|P1|Overall Study|Lost to Follow-up|2
4892637|NCT00680992|16857034|P3|Overall Study|Ineligibility Determined|0
4892638|NCT00680992|16857035|P2|Overall Study|Ineligibility Determined|1
4892639|NCT00680992|16857036|P1|Overall Study|Ineligibility Determined|0
4892640|NCT00680992|16857034|P3|Overall Study|Death|0
4892641|NCT00680992|16857035|P2|Overall Study|Death|1
4892642|NCT00680992|16857036|P1|Overall Study|Death|5
4892643|NCT00680992|16857034|P3|Overall Study|Pregnancy|1
4892644|NCT00680992|16857035|P2|Overall Study|Pregnancy|0
4892645|NCT00680992|16857036|P1|Overall Study|Pregnancy|5
4892646|NCT00680992|16857034|P3|Overall Study|Requirement for Alternative Therapy|0
4892647|NCT00680992|16857035|P2|Overall Study|Requirement for Alternative Therapy|2
4892648|NCT00680992|16857036|P1|Overall Study|Requirement for Alternative Therapy|8
4892649|NCT00680992|16857034|P3|Overall Study|Noncompliance|0
4892650|NCT00680992|16857035|P2|Overall Study|Noncompliance|6
4892651|NCT00680992|16857036|P1|Overall Study|Noncompliance|4
4892652|NCT00680992|16857034|P3|Overall Study|Lost to Follow-up|0
4892653|NCT00680992|16857035|P2|Overall Study|Lost to Follow-up|14
4892654|NCT00680992|16857036|P1|Overall Study|Lost to Follow-up|12
4892655|NCT00680992|16857034|P3|Overall Study|Disease Progression|0
4892656|NCT00680992|16857035|P2|Overall Study|Disease Progression|9
4892657|NCT00680992|16857036|P1|Overall Study|Disease Progression|21
4892658|NCT00680992|16857034|P3|Overall Study|Other|1
4892659|NCT00680992|16857035|P2|Overall Study|Other|14
4892660|NCT00680992|16857036|P1|Overall Study|Other|19
4892661|NCT00680992|16857034|P3|Overall Study|Adverse Event|1
4892662|NCT00680992|16857035|P2|Overall Study|Adverse Event|19
4892663|NCT00680992|16857036|P1|Overall Study|Adverse Event|21
4892664|NCT00680992|16857034|P3|Overall Study|Withdrawal by Subject|1
4892665|NCT00680992|16857035|P2|Overall Study|Withdrawal by Subject|11
4892666|NCT00680992|16857036|P1|Overall Study|Withdrawal by Subject|33
4892667|NCT00680992|16857034|P3|Overall Study|End of Trial|3
4892668|NCT00680992|16857035|P2|Overall Study|End of Trial|12
4892669|NCT00680992|16857036|P1|Overall Study|End of Trial|32
4892670|NCT00680992|16857034|P3|Overall Study|Administrative Decision|5
4892671|NCT00680992|16857035|P2|Overall Study|Administrative Decision|42
4892672|NCT00680992|16857036|P1|Overall Study|Administrative Decision|83
4892673|NCT00680992|16857034|P3|Overall Study|Complete Resection (as per protocol)|0
4892674|NCT00680992|16857035|P2|Overall Study|Complete Resection (as per protocol)|121
4892675|NCT00680992|16857036|P1|Overall Study|Complete Resection (as per protocol)|25
4892676|NCT00680914|16857070|P2|Overall Study|serious adverse event (SAE)|1
4892677|NCT00680914|16857071|P1|Overall Study|serious adverse event (SAE)|0
4892678|NCT00680914|16857070|P2|Overall Study|Lost to Follow-up|0
4892679|NCT00680914|16857071|P1|Overall Study|Lost to Follow-up|4
4892680|NCT00680914|16857070|P2|Overall Study|Consent withdrawal|3
4892681|NCT00680914|16857071|P1|Overall Study|Consent withdrawal|6
4892682|NCT00680901|16857105|P2|Overall Study|Ongoing: In Follow Up|41
4892683|NCT00680901|16857106|P1|Overall Study|Ongoing: In Follow Up|45
4892684|NCT00680901|16857105|P2|Overall Study|Ongoing: On Study Treatment|13
4892685|NCT00680901|16857106|P1|Overall Study|Ongoing: On Study Treatment|16
4892686|NCT00680901|16857105|P2|Overall Study|Physician Decision|1
4892687|NCT00680901|16857106|P1|Overall Study|Physician Decision|0
4892688|NCT00680901|16857105|P2|Overall Study|Withdrawal by Subject|13
4892689|NCT00680901|16857106|P1|Overall Study|Withdrawal by Subject|4
4892690|NCT00680901|16857105|P2|Overall Study|Lost to Follow-up|8
4892691|NCT00680901|16857106|P1|Overall Study|Lost to Follow-up|8
4892692|NCT00680836|16857144|P2|Overall Study|Physician Decision|1
4892693|NCT00680836|16857145|P1|Overall Study|Physician Decision|2
4892694|NCT00680836|16857144|P2|Overall Study|Lost to Follow-up|1
4892695|NCT00680836|16857145|P1|Overall Study|Lost to Follow-up|3
4892696|NCT00680836|16857144|P2|Overall Study|Withdrawal by Subject|0
4892697|NCT00680836|16857145|P1|Overall Study|Withdrawal by Subject|3
4892698|NCT00680771|16857199|P2|Overall Study|Prior Exposure to Hepatitus B Vaccine|2
4892699|NCT00680771|16857200|P1|Overall Study|Prior Exposure to Hepatitus B Vaccine|4
4892700|NCT00680771|16857199|P2|Overall Study|Sleep Apnea suspected after PSG|0
4892701|NCT00680771|16857200|P1|Overall Study|Sleep Apnea suspected after PSG|1
4892702|NCT00680771|16857199|P2|Overall Study|Withdrawal by Subject|0
4892703|NCT00680771|16857200|P1|Overall Study|Withdrawal by Subject|1
4892704|NCT00680745|16857210|P4|Overall Study|False Treatment|0
4892705|NCT00680745|16857211|P3|Overall Study|False Treatment|3
4892706|NCT00680745|16857212|P2|Overall Study|False Treatment|1
4892707|NCT00680745|16857213|P1|Overall Study|False Treatment|0
4892708|NCT00680745|16857210|P4|Overall Study|Subject No Longer Meets Study Criteria|2
4892709|NCT00680745|16857211|P3|Overall Study|Subject No Longer Meets Study Criteria|0
4892710|NCT00680745|16857212|P2|Overall Study|Subject No Longer Meets Study Criteria|2
4892711|NCT00680745|16857213|P1|Overall Study|Subject No Longer Meets Study Criteria|0
4892712|NCT00680745|16857210|P4|Overall Study|Poor/Non-compliance|0
4892713|NCT00680745|16857211|P3|Overall Study|Poor/Non-compliance|0
4892714|NCT00680745|16857212|P2|Overall Study|Poor/Non-compliance|3
4892715|NCT00680745|16857213|P1|Overall Study|Poor/Non-compliance|0
4892716|NCT00680745|16857210|P4|Overall Study|Adverse Event|3
4892717|NCT00680745|16857211|P3|Overall Study|Adverse Event|3
4892718|NCT00680745|16857212|P2|Overall Study|Adverse Event|3
4892719|NCT00680745|16857213|P1|Overall Study|Adverse Event|5
4892720|NCT00680745|16857210|P4|Overall Study|Death|0
4892721|NCT00680745|16857211|P3|Overall Study|Death|1
4892722|NCT00680745|16857212|P2|Overall Study|Death|0
4892723|NCT00680745|16857213|P1|Overall Study|Death|1
4892724|NCT00680745|16857210|P4|Overall Study|Lost to Follow-up|0
4892725|NCT00680745|16857211|P3|Overall Study|Lost to Follow-up|1
4892726|NCT00680745|16857212|P2|Overall Study|Lost to Follow-up|1
4892727|NCT00680745|16857213|P1|Overall Study|Lost to Follow-up|0
4892728|NCT00680745|16857210|P4|Overall Study|Withdrawal by Subject|8
4892729|NCT00680745|16857211|P3|Overall Study|Withdrawal by Subject|2
4892730|NCT00680745|16857212|P2|Overall Study|Withdrawal by Subject|3
4892731|NCT00680745|16857213|P1|Overall Study|Withdrawal by Subject|8
4892732|NCT00680407|16857287|P3|Overall Study|Withdrawal by Subject|2
4892733|NCT00680407|16857288|P2|Overall Study|Withdrawal by Subject|2
4892734|NCT00680407|16857289|P1|Overall Study|Withdrawal by Subject|5
4892735|NCT00680407|16857287|P3|Overall Study|Lost to Follow-up|1
4892736|NCT00680407|16857288|P2|Overall Study|Lost to Follow-up|3
4892737|NCT00680407|16857289|P1|Overall Study|Lost to Follow-up|3
4892738|NCT00680368|16857303|P1|Overall Study|not supervised, not eligible|15
4892739|NCT00680186|16857331|P2|Overall Study|Other|1
4892740|NCT00680186|16857332|P1|Overall Study|Other|4
4892741|NCT00680186|16857331|P2|Overall Study|Withdrawal by Subject|39
4892742|NCT00680186|16857332|P1|Overall Study|Withdrawal by Subject|32
4892743|NCT00680186|16857331|P2|Overall Study|Lost to Follow-up|6
4892744|NCT00680186|16857332|P1|Overall Study|Lost to Follow-up|11
4892745|NCT00680186|16857331|P2|Overall Study|Protocol Violation|26
4892746|NCT00680186|16857332|P1|Overall Study|Protocol Violation|31
4892747|NCT00680186|16857331|P2|Overall Study|Adverse Event|44
4892748|NCT00680186|16857332|P1|Overall Study|Adverse Event|47
4892749|NCT00680121|16857358|P2|Overall Study|Lost to Follow-up|23
4892750|NCT00680121|16857359|P1|Overall Study|Lost to Follow-up|27
4892751|NCT00680056|16857373|P2|Second Intervention|Protocol Violation|1
4892752|NCT00680056|16857374|P1|Second Intervention|Protocol Violation|3
4892753|NCT00680056|16857373|P2|First Intervention|Mainly Exacerbation of COPD|2
4892754|NCT00680056|16857374|P1|First Intervention|Mainly Exacerbation of COPD|1
4892755|NCT00680043|16857385|P3|Overall Study|Renal Transplant|4
4892756|NCT00680043|16857386|P2|Overall Study|Renal Transplant|0
4892757|NCT00680043|16857387|P1|Overall Study|Renal Transplant|1
4892758|NCT00680043|16857385|P3|Overall Study|Patient Not Compliant With Study Reqs.|0
4892759|NCT00680043|16857386|P2|Overall Study|Patient Not Compliant With Study Reqs.|1
4892760|NCT00680043|16857387|P1|Overall Study|Patient Not Compliant With Study Reqs.|0
4892761|NCT00680043|16857385|P3|Overall Study|Withdrawal by Subject|0
4892762|NCT00680043|16857386|P2|Overall Study|Withdrawal by Subject|0
4892763|NCT00680043|16857387|P1|Overall Study|Withdrawal by Subject|1
4892764|NCT00680017|16857403|P2|Overall Study|Lost to Follow-up|0
4892765|NCT00680017|16857404|P1|Overall Study|Lost to Follow-up|2
4892766|NCT00680017|16857403|P2|Overall Study|Withdrawal by Subject|5
4892767|NCT00680017|16857404|P1|Overall Study|Withdrawal by Subject|2
4892768|NCT00680017|16857403|P2|Overall Study|Adverse Event|7
4892769|NCT00680017|16857404|P1|Overall Study|Adverse Event|13
4892770|NCT00679939|16857423|P2|24-Week Open-Label (OL) Period|Withdrawal by Subject|1
4892771|NCT00679939|16857424|P1|24-Week Open-Label (OL) Period|Withdrawal by Subject|2
4892772|NCT00679939|16857423|P2|24-Week Open-Label (OL) Period|Physician Decision|0
4892773|NCT00679939|16857424|P1|24-Week Open-Label (OL) Period|Physician Decision|1
4892774|NCT00679939|16857423|P2|24-Week Open-Label (OL) Period|Met Stopping Criteria|1
4892775|NCT00679939|16857424|P1|24-Week Open-Label (OL) Period|Met Stopping Criteria|3
4892776|NCT00679939|16857423|P2|24-Week Open-Label (OL) Period|Protocol Violation|1
4892777|NCT00679939|16857424|P1|24-Week Open-Label (OL) Period|Protocol Violation|1
4892778|NCT00679939|16857423|P2|24-Week Open-Label (OL) Period|Adverse Event|1
4892779|NCT00679939|16857424|P1|24-Week Open-Label (OL) Period|Adverse Event|0
4892780|NCT00679939|16857423|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|2
4892781|NCT00679939|16857424|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
4892782|NCT00679939|16857423|P2|52-Week Double-Blind (DB) Period|Protocol Violation|0
4892783|NCT00679939|16857424|P1|52-Week Double-Blind (DB) Period|Protocol Violation|1
4892784|NCT00679939|16857423|P2|52-Week Double-Blind (DB) Period|Investigator Discretion|0
4892785|NCT00679939|16857424|P1|52-Week Double-Blind (DB) Period|Investigator Discretion|5
4892786|NCT00679939|16857423|P2|52-Week Double-Blind (DB) Period|Adverse Event|12
4892787|NCT00679939|16857424|P1|52-Week Double-Blind (DB) Period|Adverse Event|14
4892788|NCT00679939|16857423|P2|52-Week Double-Blind (DB) Period|Withdrew Consent|13
4892789|NCT00679939|16857424|P1|52-Week Double-Blind (DB) Period|Withdrew Consent|17
4892790|NCT00679913|16857575|P2|Overall Study|Protocol Violation|13
4892791|NCT00679913|16857576|P1|Overall Study|Protocol Violation|18
4892792|NCT00679783|16857591|P7|Overall Study|Ongoing at data cut-off|0
4892793|NCT00679783|16857592|P6|Overall Study|Ongoing at data cut-off|0
4892794|NCT00679783|16857593|P5|Overall Study|Ongoing at data cut-off|1
4892795|NCT00679783|16857594|P4|Overall Study|Ongoing at data cut-off|9
4892796|NCT00679783|16857595|P3|Overall Study|Ongoing at data cut-off|0
4892797|NCT00679783|16857596|P2|Overall Study|Ongoing at data cut-off|2
4892798|NCT00679783|16857597|P1|Overall Study|Ongoing at data cut-off|2
4892799|NCT00679783|16857591|P7|Overall Study|Not Captured|0
4892800|NCT00679783|16857592|P6|Overall Study|Not Captured|0
4892801|NCT00679783|16857593|P5|Overall Study|Not Captured|0
4892802|NCT00679783|16857594|P4|Overall Study|Not Captured|5
4892803|NCT00679783|16857595|P3|Overall Study|Not Captured|0
4892804|NCT00679783|16857596|P2|Overall Study|Not Captured|0
4892805|NCT00679783|16857597|P1|Overall Study|Not Captured|0
4892806|NCT00679783|16857591|P7|Overall Study|Withdrawal by Subject|0
4892807|NCT00679783|16857592|P6|Overall Study|Withdrawal by Subject|0
4892808|NCT00679783|16857593|P5|Overall Study|Withdrawal by Subject|0
4892809|NCT00679783|16857594|P4|Overall Study|Withdrawal by Subject|1
4892810|NCT00679783|16857595|P3|Overall Study|Withdrawal by Subject|1
4892811|NCT00679783|16857596|P2|Overall Study|Withdrawal by Subject|0
4892812|NCT00679783|16857597|P1|Overall Study|Withdrawal by Subject|0
4892813|NCT00679783|16857591|P7|Overall Study|Lack of Efficacy|0
4892814|NCT00679783|16857592|P6|Overall Study|Lack of Efficacy|0
4892815|NCT00679783|16857593|P5|Overall Study|Lack of Efficacy|0
4892816|NCT00679783|16857594|P4|Overall Study|Lack of Efficacy|2
4892817|NCT00679783|16857595|P3|Overall Study|Lack of Efficacy|0
4892818|NCT00679783|16857596|P2|Overall Study|Lack of Efficacy|1
4892819|NCT00679783|16857597|P1|Overall Study|Lack of Efficacy|0
4892820|NCT00679783|16857591|P7|Overall Study|Adverse Event|1
4892821|NCT00679783|16857592|P6|Overall Study|Adverse Event|0
4892822|NCT00679783|16857593|P5|Overall Study|Adverse Event|0
4892823|NCT00679783|16857594|P4|Overall Study|Adverse Event|3
4892824|NCT00679783|16857595|P3|Overall Study|Adverse Event|0
4892825|NCT00679783|16857596|P2|Overall Study|Adverse Event|0
4892826|NCT00679783|16857597|P1|Overall Study|Adverse Event|0
4892827|NCT00679627|16857650|P2|Overall Study|Early Study Closure|405
4892828|NCT00679627|16857651|P1|Overall Study|Early Study Closure|425
4892829|NCT00679627|16857650|P2|Overall Study|Lost to Follow-up|26
4892830|NCT00679627|16857651|P1|Overall Study|Lost to Follow-up|22
4892831|NCT00679627|16857650|P2|Overall Study|Withdrawal by Subject|172
4892832|NCT00679627|16857651|P1|Overall Study|Withdrawal by Subject|168
4892833|NCT00679627|16857650|P2|Overall Study|Adverse Event|53
4892834|NCT00679627|16857651|P1|Overall Study|Adverse Event|43
4892835|NCT00679627|16857650|P2|Overall Study|Death|29
4892836|NCT00679627|16857651|P1|Overall Study|Death|41
4892837|NCT00679549|16857675|P2|Overall Study|missing outcome echocardiograms|5
4892838|NCT00679549|16857676|P1|Overall Study|missing outcome echocardiograms|4
4892839|NCT00679549|16857675|P2|Overall Study|dropout|4
4892840|NCT00679549|16857676|P1|Overall Study|dropout|2
4892841|NCT00679432|16857686|P4|Overall Study|Randomization error, return to prior Rx|0
4892842|NCT00679432|16857687|P3|Overall Study|Randomization error, return to prior Rx|3
4892843|NCT00679432|16857688|P2|Overall Study|Randomization error, return to prior Rx|0
4892844|NCT00679432|16857689|P1|Overall Study|Randomization error, return to prior Rx|0
4892845|NCT00679432|16857686|P4|Overall Study|Infectious colitis, normal histology|3
4892846|NCT00679432|16857687|P3|Overall Study|Infectious colitis, normal histology|8
4892847|NCT00679432|16857688|P2|Overall Study|Infectious colitis, normal histology|4
4892848|NCT00679432|16857689|P1|Overall Study|Infectious colitis, normal histology|5
4892849|NCT00679432|16857686|P4|Overall Study|Lack of Efficacy|8
4892850|NCT00679432|16857687|P3|Overall Study|Lack of Efficacy|14
4892851|NCT00679432|16857688|P2|Overall Study|Lack of Efficacy|9
4892852|NCT00679432|16857689|P1|Overall Study|Lack of Efficacy|13
4892853|NCT00679432|16857686|P4|Overall Study|Sponsor decision|0
4892854|NCT00679432|16857687|P3|Overall Study|Sponsor decision|0
4892855|NCT00679432|16857688|P2|Overall Study|Sponsor decision|0
4892856|NCT00679432|16857689|P1|Overall Study|Sponsor decision|1
4892857|NCT00679432|16857686|P4|Overall Study|Physician Decision|2
4892858|NCT00679432|16857687|P3|Overall Study|Physician Decision|2
4892859|NCT00679432|16857688|P2|Overall Study|Physician Decision|2
4892860|NCT00679432|16857689|P1|Overall Study|Physician Decision|3
4892861|NCT00679432|16857686|P4|Overall Study|Lost to Follow-up|2
4892862|NCT00679432|16857687|P3|Overall Study|Lost to Follow-up|4
4892863|NCT00679432|16857688|P2|Overall Study|Lost to Follow-up|5
4892864|NCT00679432|16857689|P1|Overall Study|Lost to Follow-up|1
4892865|NCT00679432|16857686|P4|Overall Study|Withdrawal by Subject|9
4892866|NCT00679432|16857687|P3|Overall Study|Withdrawal by Subject|10
4892867|NCT00679432|16857688|P2|Overall Study|Withdrawal by Subject|11
4892868|NCT00679432|16857689|P1|Overall Study|Withdrawal by Subject|8
4892869|NCT00679432|16857686|P4|Overall Study|Protocol Violation|1
4892870|NCT00679432|16857687|P3|Overall Study|Protocol Violation|2
4892871|NCT00679432|16857688|P2|Overall Study|Protocol Violation|1
4892872|NCT00679432|16857689|P1|Overall Study|Protocol Violation|1
4892873|NCT00679432|16857686|P4|Overall Study|Adverse Event|7
4892874|NCT00679432|16857687|P3|Overall Study|Adverse Event|10
4892875|NCT00679432|16857688|P2|Overall Study|Adverse Event|6
4892876|NCT00679432|16857689|P1|Overall Study|Adverse Event|5
4892877|NCT00679367|16857732|P1|Overall Study|Withdrawal by Subject|1
4892878|NCT00679367|16857732|P1|Overall Study|Lack of Efficacy|3
4892879|NCT00679367|16857732|P1|Overall Study|inability to swallow oral drugs|1
4892880|NCT00679367|16857732|P1|Overall Study|Adverse Event|7
4892881|NCT00679354|16857738|P1|Overall Study|Ineligible|1
4892882|NCT00679354|16857738|P1|Overall Study|Physician Decision|4
4892883|NCT00679354|16857738|P1|Overall Study|Lack of Efficacy|22
4892884|NCT00679354|16857738|P1|Overall Study|Death|3
4892885|NCT00679341|16857756|P2|Overall Study|Physician/patient decision to withdraw|6
4892886|NCT00679341|16857757|P1|Overall Study|Physician/patient decision to withdraw|0
4892887|NCT00679341|16857756|P2|Overall Study|Not treated|2
4892888|NCT00679341|16857757|P1|Overall Study|Not treated|0
4892889|NCT00679341|16857756|P2|Overall Study|Physician Decision|0
4892890|NCT00679341|16857757|P1|Overall Study|Physician Decision|1
4892891|NCT00679341|16857756|P2|Overall Study|Other|0
4892892|NCT00679341|16857757|P1|Overall Study|Other|1
4892893|NCT00679341|16857756|P2|Overall Study|Death|1
4892894|NCT00679341|16857757|P1|Overall Study|Death|1
4892895|NCT00679341|16857756|P2|Overall Study|Subject/guardian decision to discontinue|0
4892896|NCT00679341|16857757|P1|Overall Study|Subject/guardian decision to discontinue|3
4892897|NCT00679341|16857756|P2|Overall Study|Adverse Event|6
4892898|NCT00679341|16857757|P1|Overall Study|Adverse Event|5
4892899|NCT00679341|16857756|P2|Overall Study|Disease progression|36
4892900|NCT00679341|16857757|P1|Overall Study|Disease progression|42
4892901|NCT00679302|16857777|P2|Overall Study|Lost to Follow-up|4
4892902|NCT00679302|16857778|P1|Overall Study|Lost to Follow-up|8
4892903|NCT00679289|16857789|P3|Overall Study|Physician Decision|1
4892904|NCT00679289|16857790|P2|Overall Study|Physician Decision|0
4892905|NCT00679289|16857791|P1|Overall Study|Physician Decision|1
4892906|NCT00679289|16857789|P3|Overall Study|Adverse Event|3
4892907|NCT00679289|16857790|P2|Overall Study|Adverse Event|0
4892908|NCT00679289|16857791|P1|Overall Study|Adverse Event|0
4892909|NCT00679289|16857789|P3|Overall Study|Withdrawal by Subject|1
4892910|NCT00679289|16857790|P2|Overall Study|Withdrawal by Subject|1
4892911|NCT00679289|16857791|P1|Overall Study|Withdrawal by Subject|0
4892912|NCT00679289|16857789|P3|Overall Study|Progressive disease|18
4892913|NCT00679289|16857790|P2|Overall Study|Progressive disease|5
4892914|NCT00679289|16857791|P1|Overall Study|Progressive disease|4
4892915|NCT00679263|16857813|P3|Visit 2/Dose 1|subject not compliance|0
4892916|NCT00679263|16857814|P2|Visit 2/Dose 1|subject not compliance|1
4892917|NCT00679263|16857815|P1|Visit 2/Dose 1|subject not compliance|1
4892918|NCT00679263|16857813|P3|Visit 2/Dose 1|Adverse Event|0
4892919|NCT00679263|16857814|P2|Visit 2/Dose 1|Adverse Event|0
4892920|NCT00679263|16857815|P1|Visit 2/Dose 1|Adverse Event|1
4892921|NCT00679211|16857826|P1|Overall Study|Other|1
4892922|NCT00679211|16857826|P1|Overall Study|Transferred to extension study TDM4529g|12
4892923|NCT00679211|16857826|P1|Overall Study|Refused to undergo protocol procedures|1
4892924|NCT00679211|16857826|P1|Overall Study|Physician Decision|5
4892925|NCT00679211|16857826|P1|Overall Study|Withdrawal by Subject|2
4892926|NCT00679211|16857826|P1|Overall Study|Adverse Event|7
4892927|NCT00679211|16857826|P1|Overall Study|Progressive disease|82
4892928|NCT00679172|16857843|P5|Overall Study|Other not specified|0
4892929|NCT00679172|16857844|P4|Overall Study|Other not specified|0
4892930|NCT00679172|16857845|P3|Overall Study|Other not specified|1
4892931|NCT00679172|16857846|P2|Overall Study|Other not specified|0
4892932|NCT00679172|16857847|P1|Overall Study|Other not specified|0
4892933|NCT00679172|16857843|P5|Overall Study|Non-compliance|0
4892934|NCT00679172|16857844|P4|Overall Study|Non-compliance|1
4892935|NCT00679172|16857845|P3|Overall Study|Non-compliance|0
4892936|NCT00679172|16857846|P2|Overall Study|Non-compliance|1
4892937|NCT00679172|16857847|P1|Overall Study|Non-compliance|1
4892938|NCT00679081|16857910|P1|Overall Study|Lost to Follow-up|1
4892939|NCT00679055|16857920|P2|Overall Study|Study Terminated|1
4892940|NCT00679055|16857921|P1|Overall Study|Study Terminated|2
4892941|NCT00679055|16857920|P2|Overall Study|Other|3
4892942|NCT00679055|16857921|P1|Overall Study|Other|0
4892943|NCT00679055|16857920|P2|Overall Study|Adverse Event|1
4892944|NCT00679055|16857921|P1|Overall Study|Adverse Event|0
4892945|NCT00679029|16857931|P1|Overall Study|Lost to Follow-up|1
4892946|NCT00679029|16857931|P1|Overall Study|Withdrawal by Subject|1
4892947|NCT00679029|16857931|P1|Overall Study|Adverse Event|3
4892948|NCT00678899|16857938|P1|Overall Study|Adverse Event|1
4892949|NCT00678886|16857947|P4|Overall Study|Other|0
4892950|NCT00678886|16857948|P3|Overall Study|Other|1
4892951|NCT00678886|16857949|P2|Overall Study|Other|0
4892952|NCT00678886|16857950|P1|Overall Study|Other|0
4892953|NCT00678886|16857947|P4|Overall Study|Lost to Follow-up|2
4892954|NCT00678886|16857948|P3|Overall Study|Lost to Follow-up|3
4892955|NCT00678886|16857949|P2|Overall Study|Lost to Follow-up|0
4892956|NCT00678886|16857950|P1|Overall Study|Lost to Follow-up|0
4892957|NCT00678886|16857947|P4|Overall Study|Physician Decision|1
4892958|NCT00678886|16857948|P3|Overall Study|Physician Decision|1
4892959|NCT00678886|16857949|P2|Overall Study|Physician Decision|0
4892960|NCT00678886|16857950|P1|Overall Study|Physician Decision|0
4892961|NCT00678886|16857947|P4|Overall Study|Withdrawal by Subject|6
4892962|NCT00678886|16857948|P3|Overall Study|Withdrawal by Subject|4
4892963|NCT00678886|16857949|P2|Overall Study|Withdrawal by Subject|0
4892964|NCT00678886|16857950|P1|Overall Study|Withdrawal by Subject|0
4892965|NCT00678795|16858019|P2|Overall Study|Lack of Efficacy|1
4892966|NCT00678795|16858020|P1|Overall Study|Lack of Efficacy|1
4892967|NCT00678795|16858019|P2|Overall Study|Lost to Follow-up|1
4892968|NCT00678795|16858020|P1|Overall Study|Lost to Follow-up|0
4892969|NCT00678795|16858019|P2|Overall Study|Protocol Violation|1
4892970|NCT00678795|16858020|P1|Overall Study|Protocol Violation|0
4892971|NCT00678795|16858019|P2|Overall Study|Withdrawal by Subject|0
4892972|NCT00678795|16858020|P1|Overall Study|Withdrawal by Subject|3
4892973|NCT00678795|16858019|P2|Overall Study|Adverse Event|3
4892974|NCT00678795|16858020|P1|Overall Study|Adverse Event|7
4892975|NCT00678691|16858042|P2|Overall Study|Adverse Event|4
4892976|NCT00678691|16858043|P1|Overall Study|Adverse Event|6
4892977|NCT00678652|16858053|P4|Overall Study|Relocation|0
4892978|NCT00678652|16858054|P3|Overall Study|Relocation|0
4892979|NCT00678652|16858055|P2|Overall Study|Relocation|0
4892980|NCT00678652|16858056|P1|Overall Study|Relocation|1
4892981|NCT00678652|16858053|P4|Overall Study|Pregnancy|0
4892982|NCT00678652|16858054|P3|Overall Study|Pregnancy|1
4892983|NCT00678652|16858055|P2|Overall Study|Pregnancy|0
4892984|NCT00678652|16858056|P1|Overall Study|Pregnancy|0
4892985|NCT00678652|16858053|P4|Overall Study|Protocol Violation|0
4892986|NCT00678652|16858054|P3|Overall Study|Protocol Violation|0
4892987|NCT00678652|16858055|P2|Overall Study|Protocol Violation|0
4892988|NCT00678652|16858056|P1|Overall Study|Protocol Violation|2
4892989|NCT00678639|16858080|P2|Overall Study|Lost to Follow-up at 30 days|0
4892990|NCT00678639|16858081|P1|Overall Study|Lost to Follow-up at 30 days|2
4892991|NCT00678587|16858096|P2|Overall Study|Withdrew Consent|3
4892992|NCT00678587|16858097|P1|Overall Study|Withdrew Consent|8
4892993|NCT00678587|16858096|P2|Overall Study|Investigator Discretion|6
4892994|NCT00678587|16858097|P1|Overall Study|Investigator Discretion|2
4892995|NCT00678587|16858096|P2|Overall Study|Lost to Follow-up|5
4892996|NCT00678587|16858097|P1|Overall Study|Lost to Follow-up|3
4892997|NCT00678587|16858096|P2|Overall Study|Study Closed/Terminated|0
4892998|NCT00678587|16858097|P1|Overall Study|Study Closed/Terminated|1
4892999|NCT00678587|16858096|P2|Overall Study|Protocol Violation|1
4893000|NCT00678587|16858097|P1|Overall Study|Protocol Violation|2
4893001|NCT00678587|16858096|P2|Overall Study|Lack of Efficacy|0
4893002|NCT00678587|16858097|P1|Overall Study|Lack of Efficacy|1
4893003|NCT00678587|16858096|P2|Overall Study|Adverse Event|3
4893004|NCT00678587|16858097|P1|Overall Study|Adverse Event|3
4893005|NCT00678392|16858191|P2|Overall Study|Other|53
4893006|NCT00678392|16858192|P1|Overall Study|Other|56
4893007|NCT00678392|16858191|P2|Overall Study|Randomized But Not Treated|7
4893008|NCT00678392|16858192|P1|Overall Study|Randomized But Not Treated|2
4893009|NCT00678392|16858191|P2|Overall Study|Withdrawal by Subject|4
4893010|NCT00678392|16858192|P1|Overall Study|Withdrawal by Subject|4
4893011|NCT00678392|16858191|P2|Overall Study|Sponsor's Decision|2
4893012|NCT00678392|16858192|P1|Overall Study|Sponsor's Decision|1
4893013|NCT00678392|16858191|P2|Overall Study|Objective Progression or Relapse|8
4893014|NCT00678392|16858192|P1|Overall Study|Objective Progression or Relapse|3
4893015|NCT00678392|16858191|P2|Overall Study|Lost to Follow-up|13
4893016|NCT00678392|16858192|P1|Overall Study|Lost to Follow-up|15
4893017|NCT00678392|16858191|P2|Overall Study|Death|269
4893018|NCT00678392|16858192|P1|Overall Study|Death|280
4893019|NCT00678392|16858191|P2|Overall Study|Adverse Event|6
4893020|NCT00678392|16858192|P1|Overall Study|Adverse Event|0
4893021|NCT00678379|16858227|P3|Overall Study|Incomplete Data|3
4893022|NCT00678379|16858228|P2|Overall Study|Incomplete Data|3
4893023|NCT00678379|16858229|P1|Overall Study|Incomplete Data|4
4893024|NCT00678379|16858227|P3|Overall Study|Injection performed after tonsillectomy|1
4893025|NCT00678379|16858228|P2|Overall Study|Injection performed after tonsillectomy|0
4893026|NCT00678379|16858229|P1|Overall Study|Injection performed after tonsillectomy|2
4893027|NCT00678301|16858257|P2|Overall Study|Lost to Follow-up|1
4893028|NCT00678301|16858258|P1|Overall Study|Lost to Follow-up|3
4893029|NCT00678301|16858257|P2|Overall Study|Withdrawal by Subject|0
4893030|NCT00678301|16858258|P1|Overall Study|Withdrawal by Subject|4
4893031|NCT00678301|16858257|P2|Overall Study|Adverse Event|0
4893032|NCT00678301|16858258|P1|Overall Study|Adverse Event|1
4893033|NCT00678301|16858257|P2|Overall Study|Non-compliance with study procedures|1
4893034|NCT00678301|16858258|P1|Overall Study|Non-compliance with study procedures|0
4893035|NCT00678288|16858316|P2|Overall Study|Disease progression/recurrence/relapse|1
4893036|NCT00678288|16858317|P1|Overall Study|Disease progression/recurrence/relapse|6
4893037|NCT00678288|16858316|P2|Overall Study|Reason not reported|0
4893038|NCT00678288|16858317|P1|Overall Study|Reason not reported|1
4893039|NCT00678288|16858316|P2|Overall Study|Switch to commercial drug|1
4893040|NCT00678288|16858317|P1|Overall Study|Switch to commercial drug|0
4893041|NCT00678288|16858316|P2|Overall Study|Not compliant with study medication|1
4893042|NCT00678288|16858317|P1|Overall Study|Not compliant with study medication|0
4893043|NCT00678288|16858316|P2|Overall Study|Study terminated by the sponsor|0
4893044|NCT00678288|16858317|P1|Overall Study|Study terminated by the sponsor|2
4893045|NCT00678288|16858316|P2|Overall Study|Withdrawal by Subject|1
4893046|NCT00678288|16858317|P1|Overall Study|Withdrawal by Subject|1
4893047|NCT00678288|16858316|P2|Overall Study|Adverse Event|2
4893048|NCT00678288|16858317|P1|Overall Study|Adverse Event|0
4893049|NCT00678210|16858372|P4|Overall Study|Other|0
4893050|NCT00678210|16858373|P3|Overall Study|Other|1
4893051|NCT00678210|16858374|P2|Overall Study|Other|0
4893052|NCT00678210|16858375|P1|Overall Study|Other|1
4893053|NCT00678210|16858372|P4|Overall Study|Withdrawal by Subject|7
4893054|NCT00678210|16858373|P3|Overall Study|Withdrawal by Subject|1
4893055|NCT00678210|16858374|P2|Overall Study|Withdrawal by Subject|4
4893056|NCT00678210|16858375|P1|Overall Study|Withdrawal by Subject|3
4893057|NCT00678210|16858372|P4|Overall Study|Lost to Follow-up|1
4893058|NCT00678210|16858373|P3|Overall Study|Lost to Follow-up|0
4893059|NCT00678210|16858374|P2|Overall Study|Lost to Follow-up|2
4893060|NCT00678210|16858375|P1|Overall Study|Lost to Follow-up|4
4893061|NCT00678210|16858372|P4|Overall Study|Lack of Efficacy|9
4893062|NCT00678210|16858373|P3|Overall Study|Lack of Efficacy|1
4893063|NCT00678210|16858374|P2|Overall Study|Lack of Efficacy|3
4893064|NCT00678210|16858375|P1|Overall Study|Lack of Efficacy|2
4893065|NCT00678210|16858372|P4|Overall Study|Adverse Event|3
4893066|NCT00678210|16858373|P3|Overall Study|Adverse Event|3
4893067|NCT00678210|16858374|P2|Overall Study|Adverse Event|2
4893068|NCT00678210|16858375|P1|Overall Study|Adverse Event|1
4893069|NCT00678080|16858411|P2|Overall Study|Withdrawal by Subject|1
4893070|NCT00678080|16858412|P1|Overall Study|Withdrawal by Subject|0
4893071|NCT00678080|16858411|P2|Overall Study|Lost to Follow-up|0
4893072|NCT00678080|16858412|P1|Overall Study|Lost to Follow-up|1
4893073|NCT00678080|16858411|P2|Overall Study|Physician Decision|0
4893074|NCT00678080|16858412|P1|Overall Study|Physician Decision|2
4893075|NCT00678041|16858438|P2|Overall Study|Physician Decision|5
4893076|NCT00678041|16858439|P1|Overall Study|Physician Decision|5
4893077|NCT00677833|16858492|P4|Overall Study|Lost to Follow-up|0
4893078|NCT00677833|16858493|P3|Overall Study|Lost to Follow-up|1
4893079|NCT00677833|16858494|P2|Overall Study|Lost to Follow-up|0
4893080|NCT00677833|16858495|P1|Overall Study|Lost to Follow-up|0
4893081|NCT00677833|16858492|P4|Overall Study|Withdrawal by Subject|3
4893082|NCT00677833|16858493|P3|Overall Study|Withdrawal by Subject|1
4893083|NCT00677833|16858494|P2|Overall Study|Withdrawal by Subject|0
4893084|NCT00677833|16858495|P1|Overall Study|Withdrawal by Subject|4
4893085|NCT00677820|16858545|P2|Overall Study|Lost to Follow-up|0
4893086|NCT00677820|16858546|P1|Overall Study|Lost to Follow-up|1
4893087|NCT00677807|16858567|P3|Overall Study|Protocol Deviation|0
4893088|NCT00677807|16858568|P2|Overall Study|Protocol Deviation|3
4893089|NCT00677807|16858569|P1|Overall Study|Protocol Deviation|1
4893090|NCT00677807|16858567|P3|Overall Study|Death|1
4893091|NCT00677807|16858568|P2|Overall Study|Death|1
4893092|NCT00677807|16858569|P1|Overall Study|Death|0
4893093|NCT00677807|16858567|P3|Overall Study|Administrative problems|2
4893094|NCT00677807|16858568|P2|Overall Study|Administrative problems|1
4893095|NCT00677807|16858569|P1|Overall Study|Administrative problems|1
4893096|NCT00677807|16858567|P3|Overall Study|Lost to Follow-up|2
4893097|NCT00677807|16858568|P2|Overall Study|Lost to Follow-up|2
4893098|NCT00677807|16858569|P1|Overall Study|Lost to Follow-up|2
4893099|NCT00677807|16858567|P3|Overall Study|Withdrawal by Subject|6
4893100|NCT00677807|16858568|P2|Overall Study|Withdrawal by Subject|3
4893101|NCT00677807|16858569|P1|Overall Study|Withdrawal by Subject|10
4893102|NCT00677807|16858567|P3|Overall Study|Participant no longer needs study drug|1
4893103|NCT00677807|16858568|P2|Overall Study|Participant no longer needs study drug|0
4893104|NCT00677807|16858569|P1|Overall Study|Participant no longer needs study drug|0
4893105|NCT00677807|16858567|P3|Overall Study|Lack of Efficacy|2
4893106|NCT00677807|16858568|P2|Overall Study|Lack of Efficacy|0
4893107|NCT00677807|16858569|P1|Overall Study|Lack of Efficacy|0
4893108|NCT00677807|16858567|P3|Overall Study|Adverse Event|6
4893109|NCT00677807|16858568|P2|Overall Study|Adverse Event|1
4893110|NCT00677807|16858569|P1|Overall Study|Adverse Event|4
4893111|NCT00677534|16858615|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
4893112|NCT00677534|16858615|P1|Washout (Weeks 1-4)|Withdrawal by Subject|1
4893113|NCT00677534|16858615|P1|Washout (Weeks 1-4)|did not qualify after signing consent|1
4893114|NCT00677365|16858623|P4|Overall Study|Other reason|1
4893115|NCT00677365|16858624|P3|Overall Study|Other reason|0
4893116|NCT00677365|16858625|P2|Overall Study|Other reason|0
4893117|NCT00677365|16858626|P1|Overall Study|Other reason|0
4893118|NCT00677365|16858623|P4|Overall Study|Withdrawal by Subject|0
4893119|NCT00677365|16858624|P3|Overall Study|Withdrawal by Subject|1
4893120|NCT00677365|16858625|P2|Overall Study|Withdrawal by Subject|0
4893121|NCT00677365|16858626|P1|Overall Study|Withdrawal by Subject|0
4893122|NCT00677365|16858623|P4|Overall Study|Adverse Event|2
4893123|NCT00677365|16858624|P3|Overall Study|Adverse Event|1
4893124|NCT00677365|16858625|P2|Overall Study|Adverse Event|1
4893125|NCT00677365|16858626|P1|Overall Study|Adverse Event|2
4893126|NCT00677352|16858658|P2|Tapering Phase|Job transfer|1
4893127|NCT00677352|16858659|P1|Tapering Phase|Job transfer|0
4893128|NCT00677352|16858658|P2|Tapering Phase|Pregnancy|1
4893129|NCT00677352|16858659|P1|Tapering Phase|Pregnancy|0
4893130|NCT00677352|16858658|P2|Tapering Phase|Withdrawal by Subject|3
4893131|NCT00677352|16858659|P1|Tapering Phase|Withdrawal by Subject|5
4893132|NCT00677352|16858658|P2|Tapering Phase|Adverse Event|5
4893133|NCT00677352|16858659|P1|Tapering Phase|Adverse Event|1
4893134|NCT00677352|16858658|P2|Treatment Phase|Not treated|2
4893135|NCT00677352|16858659|P1|Treatment Phase|Not treated|0
4893136|NCT00677352|16858658|P2|Treatment Phase|Transference or work related matter|5
4893137|NCT00677352|16858659|P1|Treatment Phase|Transference or work related matter|0
4893138|NCT00677352|16858658|P2|Treatment Phase|Protocol Violation|1
4893139|NCT00677352|16858659|P1|Treatment Phase|Protocol Violation|1
4893140|NCT00677352|16858658|P2|Treatment Phase|Pregnancy|1
4893141|NCT00677352|16858659|P1|Treatment Phase|Pregnancy|0
4893142|NCT00677352|16858658|P2|Treatment Phase|Physician Decision|0
4893143|NCT00677352|16858659|P1|Treatment Phase|Physician Decision|1
4893144|NCT00677352|16858658|P2|Treatment Phase|Withdrawal by Subject|7
4893145|NCT00677352|16858659|P1|Treatment Phase|Withdrawal by Subject|7
4893146|NCT00677352|16858658|P2|Treatment Phase|Lost to Follow-up|1
4893147|NCT00677352|16858659|P1|Treatment Phase|Lost to Follow-up|0
4893148|NCT00677352|16858658|P2|Treatment Phase|Lack of Efficacy|3
4893149|NCT00677352|16858659|P1|Treatment Phase|Lack of Efficacy|2
4893150|NCT00677352|16858658|P2|Treatment Phase|Adverse Event|22
4893151|NCT00677352|16858659|P1|Treatment Phase|Adverse Event|14
4893152|NCT00677235|16858679|P2|Overall Study|Adverse Experience|0
4893153|NCT00677235|16858680|P1|Overall Study|Adverse Experience|1
4893154|NCT00677235|16858679|P2|Overall Study|Death|36
4893155|NCT00677235|16858680|P1|Overall Study|Death|37
4893156|NCT00677235|16858679|P2|Overall Study|Lost to Follow-up|1
4893157|NCT00677235|16858680|P1|Overall Study|Lost to Follow-up|2
4893158|NCT00677235|16858679|P2|Overall Study|Withdrawal by Subject|1
4893159|NCT00677235|16858680|P1|Overall Study|Withdrawal by Subject|1
4893160|NCT00677092|16858720|P1|Overall Study|Death Prior to Receiving Treatment|1
4893161|NCT00677092|16858720|P1|Overall Study|Withdrawal by Subject|3
4893162|NCT00677092|16858720|P1|Overall Study|Lost to Follow-up|1
4893163|NCT00677092|16858720|P1|Overall Study|Adverse Event|1
4893164|NCT00677014|16858737|P3|Overall Study|Unavailable or unreadable 6 month LVESV|18
4893165|NCT00677014|16858738|P2|Overall Study|Unavailable or unreadable 6 month LVESV|14
4893166|NCT00677014|16858739|P1|Overall Study|Unavailable or unreadable 6 month LVESV|18
4893167|NCT00677014|16858737|P3|Overall Study|Death|7
4893168|NCT00677014|16858738|P2|Overall Study|Death|15
4893169|NCT00677014|16858739|P1|Overall Study|Death|6
4893170|NCT00677014|16858737|P3|Overall Study|Lost to Follow-up|24
4893171|NCT00677014|16858738|P2|Overall Study|Lost to Follow-up|12
4893172|NCT00677014|16858739|P1|Overall Study|Lost to Follow-up|20
4893173|NCT00676715|16858792|P4|Overall Study|Participants Ongoing|24
4893174|NCT00676715|16858793|P3|Overall Study|Participants Ongoing|17
4893175|NCT00676715|16858794|P2|Overall Study|Participants Ongoing|29
4893176|NCT00676715|16858795|P1|Overall Study|Participants Ongoing|29
4893177|NCT00676715|16858792|P4|Overall Study|Adverse Event|0
4893178|NCT00676715|16858793|P3|Overall Study|Adverse Event|2
4893179|NCT00676715|16858794|P2|Overall Study|Adverse Event|1
4893180|NCT00676715|16858795|P1|Overall Study|Adverse Event|0
4893181|NCT00676715|16858792|P4|Overall Study|Death|0
4893182|NCT00676715|16858793|P3|Overall Study|Death|1
4893183|NCT00676715|16858794|P2|Overall Study|Death|1
4893184|NCT00676715|16858795|P1|Overall Study|Death|1
4893185|NCT00676715|16858792|P4|Overall Study|Lost to Follow-up|3
4893186|NCT00676715|16858793|P3|Overall Study|Lost to Follow-up|7
4893187|NCT00676715|16858794|P2|Overall Study|Lost to Follow-up|1
4893188|NCT00676715|16858795|P1|Overall Study|Lost to Follow-up|1
4893189|NCT00676715|16858792|P4|Overall Study|Other|3
4893190|NCT00676715|16858793|P3|Overall Study|Other|4
4893191|NCT00676715|16858794|P2|Overall Study|Other|6
4893192|NCT00676715|16858795|P1|Overall Study|Other|2
4893193|NCT00676715|16858792|P4|Overall Study|Withdrawal by Subject|10
4893194|NCT00676715|16858793|P3|Overall Study|Withdrawal by Subject|10
4893195|NCT00676715|16858794|P2|Overall Study|Withdrawal by Subject|9
4893196|NCT00676715|16858795|P1|Overall Study|Withdrawal by Subject|7
4893197|NCT00676689|16858825|P1|Overall Study|Continuing FU|49
4893198|NCT00676689|16858825|P1|Overall Study|Withdrawal by Subject|3
4893199|NCT00676689|16858825|P1|Overall Study|Physician Decision|1
4893200|NCT00676689|16858825|P1|Overall Study|Lost to Follow-up|4
4893201|NCT00676689|16858825|P1|Overall Study|Death|2
4893202|NCT00676689|16858825|P1|Overall Study|Screen Failure|2
4893203|NCT00676663|16858837|P2|Overall Study|Lost to Follow-up|3
4893204|NCT00676663|16858838|P1|Overall Study|Lost to Follow-up|1
4893205|NCT00676663|16858837|P2|Overall Study|Withdrew Consent|8
4893206|NCT00676663|16858838|P1|Overall Study|Withdrew Consent|1
4893207|NCT00676663|16858837|P2|Overall Study|Death|27
4893208|NCT00676663|16858838|P1|Overall Study|Death|43
4893209|NCT00676650|16858854|P2|Overall Study|Randomized but not treated|4
4893210|NCT00676650|16858855|P1|Overall Study|Randomized but not treated|3
4893211|NCT00676650|16858854|P2|Overall Study|Withdrawal by Subject|24
4893212|NCT00676650|16858855|P1|Overall Study|Withdrawal by Subject|48
4893213|NCT00676650|16858854|P2|Overall Study|Study terminated by sponsor|43
4893214|NCT00676650|16858855|P1|Overall Study|Study terminated by sponsor|57
4893215|NCT00676650|16858854|P2|Overall Study|Protocol Violation|1
4893216|NCT00676650|16858855|P1|Overall Study|Protocol Violation|3
4893217|NCT00676650|16858854|P2|Overall Study|Other|10
4893218|NCT00676650|16858855|P1|Overall Study|Other|14
4893219|NCT00676650|16858854|P2|Overall Study|Objective progression or relapse|140
4893220|NCT00676650|16858855|P1|Overall Study|Objective progression or relapse|189
4893221|NCT00676650|16858854|P2|Overall Study|Lost to Follow-up|1
4893222|NCT00676650|16858855|P1|Overall Study|Lost to Follow-up|0
4893223|NCT00676650|16858854|P2|Overall Study|Global deterioration of health status|31
4893224|NCT00676650|16858855|P1|Overall Study|Global deterioration of health status|66
4893225|NCT00676650|16858854|P2|Overall Study|Adverse Event|21
4893226|NCT00676650|16858855|P1|Overall Study|Adverse Event|159
4893227|NCT00676650|16858854|P2|Overall Study|Death|14
4893228|NCT00676650|16858855|P1|Overall Study|Death|45
4893229|NCT00676520|16858897|P1|Overall Study|Other Reason|18
4893230|NCT00676520|16858897|P1|Overall Study|Ineligible for Randomization to DAPT|209
4893231|NCT00676520|16858897|P1|Overall Study|Physician Decision|20
4893232|NCT00676520|16858897|P1|Overall Study|Death|159
4893233|NCT00676520|16858897|P1|Overall Study|Lost to Follow-up|162
4893234|NCT00676520|16858897|P1|Overall Study|Withdrawal by Subject|163
4893235|NCT00676494|16858954|P1|Overall Study|Withdrawal by Subject|6
4893236|NCT00676494|16858954|P1|Overall Study|Missed Visit|8
4893237|NCT00676403|16858971|P6|Overall Study|Withdrawal by Subject|1
4893238|NCT00676403|16858972|P5|Overall Study|Withdrawal by Subject|0
4893239|NCT00676403|16858973|P4|Overall Study|Withdrawal by Subject|0
4893240|NCT00676403|16858974|P3|Overall Study|Withdrawal by Subject|0
4893241|NCT00676403|16858975|P2|Overall Study|Withdrawal by Subject|0
4893242|NCT00676403|16858976|P1|Overall Study|Withdrawal by Subject|0
4893243|NCT00676403|16858971|P6|Overall Study|Reason Unspecified|1
4893244|NCT00676403|16858972|P5|Overall Study|Reason Unspecified|0
4893245|NCT00676403|16858973|P4|Overall Study|Reason Unspecified|0
4893246|NCT00676403|16858974|P3|Overall Study|Reason Unspecified|1
4893247|NCT00676403|16858975|P2|Overall Study|Reason Unspecified|0
4893248|NCT00676403|16858976|P1|Overall Study|Reason Unspecified|1
4893249|NCT00676403|16858971|P6|Overall Study|Lost to Follow-up|1
4893250|NCT00676403|16858972|P5|Overall Study|Lost to Follow-up|0
4893251|NCT00676403|16858973|P4|Overall Study|Lost to Follow-up|0
4893252|NCT00676403|16858974|P3|Overall Study|Lost to Follow-up|0
4893253|NCT00676403|16858975|P2|Overall Study|Lost to Follow-up|0
4893254|NCT00676403|16858976|P1|Overall Study|Lost to Follow-up|0
4893255|NCT00676403|16858971|P6|Overall Study|Adverse Event|2
4893256|NCT00676403|16858972|P5|Overall Study|Adverse Event|1
4893257|NCT00676403|16858973|P4|Overall Study|Adverse Event|5
4893258|NCT00676403|16858974|P3|Overall Study|Adverse Event|0
4893259|NCT00676403|16858975|P2|Overall Study|Adverse Event|2
4893260|NCT00676403|16858976|P1|Overall Study|Adverse Event|1
4893261|NCT00676338|16859119|P4|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
4893262|NCT00676338|16859120|P3|Overall Study|Lack of Efficacy-Loss of Glucose Control|5
4893263|NCT00676338|16859121|P2|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
4893264|NCT00676338|16859122|P1|Overall Study|Lack of Efficacy-Loss of Glucose Control|3
4893265|NCT00676338|16859119|P4|Overall Study|Entry Criteria Not Met|1
4893266|NCT00676338|16859120|P3|Overall Study|Entry Criteria Not Met|1
4893267|NCT00676338|16859121|P2|Overall Study|Entry Criteria Not Met|2
4893268|NCT00676338|16859122|P1|Overall Study|Entry Criteria Not Met|0
4893269|NCT00676338|16859119|P4|Overall Study|Withdrawal by Subject|6
4893270|NCT00676338|16859120|P3|Overall Study|Withdrawal by Subject|12
4893271|NCT00676338|16859121|P2|Overall Study|Withdrawal by Subject|9
4893272|NCT00676338|16859122|P1|Overall Study|Withdrawal by Subject|17
4893273|NCT00676338|16859119|P4|Overall Study|Protocol Violation|5
4893274|NCT00676338|16859120|P3|Overall Study|Protocol Violation|2
4893275|NCT00676338|16859121|P2|Overall Study|Protocol Violation|9
4893276|NCT00676338|16859122|P1|Overall Study|Protocol Violation|5
4893277|NCT00676338|16859119|P4|Overall Study|Physician Decision|3
4893278|NCT00676338|16859120|P3|Overall Study|Physician Decision|2
4893279|NCT00676338|16859121|P2|Overall Study|Physician Decision|3
4893280|NCT00676338|16859122|P1|Overall Study|Physician Decision|3
4893281|NCT00676338|16859119|P4|Overall Study|Lost to Follow-up|4
4893282|NCT00676338|16859120|P3|Overall Study|Lost to Follow-up|3
4893283|NCT00676338|16859121|P2|Overall Study|Lost to Follow-up|1
4893284|NCT00676338|16859122|P1|Overall Study|Lost to Follow-up|4
4893285|NCT00676338|16859119|P4|Overall Study|Adverse Event|1
4893286|NCT00676338|16859120|P3|Overall Study|Adverse Event|5
4893287|NCT00676338|16859121|P2|Overall Study|Adverse Event|6
4893288|NCT00676338|16859122|P1|Overall Study|Adverse Event|6
4893289|NCT00676208|16859174|P2|Overall Study|Incomplete data|4
4893290|NCT00676208|16859175|P1|Overall Study|Incomplete data|2
4893291|NCT00676208|16859174|P2|Overall Study|Lost to Follow-up|2
4893292|NCT00676208|16859175|P1|Overall Study|Lost to Follow-up|0
4893293|NCT00676195|16859183|P1|Overall Study|Physician Decision|1
4893294|NCT00676195|16859183|P1|Overall Study|Adverse Event|1
4893295|NCT00676195|16859183|P1|Overall Study|Lost to Follow-up|1
4893296|NCT00676143|16859208|P2|Overall Study|Vasogenic edema recurrence|3
4893297|NCT00676143|16859209|P1|Overall Study|Vasogenic edema recurrence|1
4893298|NCT00676143|16859208|P2|Overall Study|Participant participation unknown|4
4893299|NCT00676143|16859209|P1|Overall Study|Participant participation unknown|1
4893300|NCT00676143|16859208|P2|Overall Study|Other|20
4893301|NCT00676143|16859209|P1|Overall Study|Other|11
4893302|NCT00676143|16859208|P2|Overall Study|Loss of caregiver|3
4893303|NCT00676143|16859209|P1|Overall Study|Loss of caregiver|5
4893304|NCT00676143|16859208|P2|Overall Study|Failed to return|1
4893305|NCT00676143|16859209|P1|Overall Study|Failed to return|2
4893306|NCT00676143|16859208|P2|Overall Study|Discontinuation of study by sponsor|88
4893307|NCT00676143|16859209|P1|Overall Study|Discontinuation of study by sponsor|65
4893308|NCT00676143|16859208|P2|Overall Study|Withdrawal by Subject|42
4893309|NCT00676143|16859209|P1|Overall Study|Withdrawal by Subject|24
4893310|NCT00676143|16859208|P2|Overall Study|Protocol Violation|8
4893311|NCT00676143|16859209|P1|Overall Study|Protocol Violation|4
4893312|NCT00676143|16859208|P2|Overall Study|Physician Decision|8
4893313|NCT00676143|16859209|P1|Overall Study|Physician Decision|5
4893314|NCT00676143|16859208|P2|Overall Study|Lost to Follow-up|13
4893315|NCT00676143|16859209|P1|Overall Study|Lost to Follow-up|0
4893316|NCT00676143|16859208|P2|Overall Study|Lack of Efficacy|6
4893317|NCT00676143|16859209|P1|Overall Study|Lack of Efficacy|0
4893318|NCT00676143|16859208|P2|Overall Study|Death|4
4893319|NCT00676143|16859209|P1|Overall Study|Death|4
4893320|NCT00676143|16859208|P2|Overall Study|Adverse Event|60
4893321|NCT00676143|16859209|P1|Overall Study|Adverse Event|34
4893322|NCT00676130|16859249|P2|Overall Study|Withdrawal by Subject|1
4893323|NCT00676130|16859250|P1|Overall Study|Withdrawal by Subject|0
4893324|NCT00676130|16859249|P2|Overall Study|Found ineligible|2
4893325|NCT00676130|16859250|P1|Overall Study|Found ineligible|3
4893326|NCT00676130|16859249|P2|Overall Study|Lost to Follow-up|1
4893327|NCT00676130|16859250|P1|Overall Study|Lost to Follow-up|0
4893328|NCT00676091|16859260|P2|Toddler Dose|Parent or legal guardian request|0
4893329|NCT00676091|16859261|P1|Toddler Dose|Parent or legal guardian request|1
4893330|NCT00676091|16859260|P2|Toddler Dose|Failed to return|0
4893331|NCT00676091|16859261|P1|Toddler Dose|Failed to return|2
4893332|NCT00676091|16859260|P2|After Infant Series|Failed to return|1
4893333|NCT00676091|16859261|P1|After Infant Series|Failed to return|1
4893334|NCT00676091|16859260|P2|After Infant Series|Protocol Violation|1
4893335|NCT00676091|16859261|P1|After Infant Series|Protocol Violation|0
4893336|NCT00676091|16859260|P2|After Infant Series|Adverse Event|1
4893337|NCT00676091|16859261|P1|After Infant Series|Adverse Event|0
4893338|NCT00676091|16859260|P2|Infant Series|Died prior to receiving 7vPnC|1
4893339|NCT00676091|16859261|P1|Infant Series|Died prior to receiving 7vPnC|0
4893340|NCT00676091|16859260|P2|Infant Series|Lost to Follow-up|0
4893341|NCT00676091|16859261|P1|Infant Series|Lost to Follow-up|1
4893342|NCT00676091|16859260|P2|Infant Series|Failed to return|3
4893343|NCT00676091|16859261|P1|Infant Series|Failed to return|1
4893344|NCT00676091|16859260|P2|Infant Series|Adverse Event|3
4893345|NCT00676091|16859261|P1|Infant Series|Adverse Event|2
4893346|NCT00676091|16859260|P2|Infant Series|Protocol Violation|3
4893347|NCT00676091|16859261|P1|Infant Series|Protocol Violation|6
4893348|NCT00676091|16859260|P2|Infant Series|Parent or legal guardian request|8
4893349|NCT00676091|16859261|P1|Infant Series|Parent or legal guardian request|10
4893350|NCT00676052|16859318|P6|Overall Study|Withdrawal by Subject|0
4893351|NCT00676052|16859319|P5|Overall Study|Withdrawal by Subject|0
4893352|NCT00676052|16859320|P4|Overall Study|Withdrawal by Subject|0
4893353|NCT00676052|16859321|P3|Overall Study|Withdrawal by Subject|1
4893354|NCT00676052|16859322|P2|Overall Study|Withdrawal by Subject|0
4893355|NCT00676052|16859323|P1|Overall Study|Withdrawal by Subject|1
4893356|NCT00676052|16859318|P6|Overall Study|Physician Decision|1
4893357|NCT00676052|16859319|P5|Overall Study|Physician Decision|0
4893358|NCT00676052|16859320|P4|Overall Study|Physician Decision|0
4893359|NCT00676052|16859321|P3|Overall Study|Physician Decision|1
4893360|NCT00676052|16859322|P2|Overall Study|Physician Decision|1
4893361|NCT00676052|16859323|P1|Overall Study|Physician Decision|1
4893362|NCT00676052|16859318|P6|Overall Study|Lost to Follow-up|0
4893363|NCT00676052|16859319|P5|Overall Study|Lost to Follow-up|1
4893364|NCT00676052|16859320|P4|Overall Study|Lost to Follow-up|0
4893365|NCT00676052|16859321|P3|Overall Study|Lost to Follow-up|0
4893366|NCT00676052|16859322|P2|Overall Study|Lost to Follow-up|0
4893367|NCT00676052|16859323|P1|Overall Study|Lost to Follow-up|0
4893368|NCT00676052|16859318|P6|Overall Study|Protocol Violation|2
4893369|NCT00676052|16859319|P5|Overall Study|Protocol Violation|1
4893370|NCT00676052|16859320|P4|Overall Study|Protocol Violation|2
4893371|NCT00676052|16859321|P3|Overall Study|Protocol Violation|2
4893372|NCT00676052|16859322|P2|Overall Study|Protocol Violation|3
4893373|NCT00676052|16859323|P1|Overall Study|Protocol Violation|5
4893374|NCT00676052|16859318|P6|Overall Study|Lack of Efficacy|1
4893375|NCT00676052|16859319|P5|Overall Study|Lack of Efficacy|2
4893376|NCT00676052|16859320|P4|Overall Study|Lack of Efficacy|1
4893377|NCT00676052|16859321|P3|Overall Study|Lack of Efficacy|1
4893378|NCT00676052|16859322|P2|Overall Study|Lack of Efficacy|2
4893379|NCT00676052|16859323|P1|Overall Study|Lack of Efficacy|2
4893380|NCT00676052|16859318|P6|Overall Study|Adverse Event|2
4893381|NCT00676052|16859319|P5|Overall Study|Adverse Event|2
4893382|NCT00676052|16859320|P4|Overall Study|Adverse Event|2
4893383|NCT00676052|16859321|P3|Overall Study|Adverse Event|1
4893384|NCT00676052|16859322|P2|Overall Study|Adverse Event|1
4893385|NCT00676052|16859323|P1|Overall Study|Adverse Event|0
4893386|NCT00675948|16859393|P2|Overall Study|Patient feels unable to take medication|1
4893387|NCT00675948|16859394|P1|Overall Study|Patient feels unable to take medication|0
4893388|NCT00675948|16859393|P2|Overall Study|Patient unable to comply with diaries|0
4893389|NCT00675948|16859394|P1|Overall Study|Patient unable to comply with diaries|1
4893390|NCT00675948|16859393|P2|Overall Study|Patient died|0
4893391|NCT00675948|16859394|P1|Overall Study|Patient died|1
4893392|NCT00675948|16859393|P2|Overall Study|Sponsor decision|1
4893393|NCT00675948|16859394|P1|Overall Study|Sponsor decision|0
4893394|NCT00675948|16859393|P2|Overall Study|Pain under control|0
4893395|NCT00675948|16859394|P1|Overall Study|Pain under control|1
4893396|NCT00675948|16859393|P2|Overall Study|Protocol Violation|0
4893397|NCT00675948|16859394|P1|Overall Study|Protocol Violation|1
4893398|NCT00675948|16859393|P2|Overall Study|Lost to Follow-up|0
4893399|NCT00675948|16859394|P1|Overall Study|Lost to Follow-up|2
4893400|NCT00675948|16859393|P2|Overall Study|Withdrawal by Subject|0
4893401|NCT00675948|16859394|P1|Overall Study|Withdrawal by Subject|7
4893402|NCT00675948|16859393|P2|Overall Study|Lack of Efficacy|0
4893403|NCT00675948|16859394|P1|Overall Study|Lack of Efficacy|3
4893404|NCT00675948|16859393|P2|Overall Study|Adverse Event|1
4893405|NCT00675948|16859394|P1|Overall Study|Adverse Event|23
4893406|NCT00675766|16859457|P4|Overall Study|Lost to Follow-up|26
4893407|NCT00675766|16859458|P3|Overall Study|Lost to Follow-up|21
4893408|NCT00675766|16859459|P2|Overall Study|Lost to Follow-up|5
4893409|NCT00675766|16859460|P1|Overall Study|Lost to Follow-up|6
4893410|NCT00675597|16859470|P1|Overall Study|Withdrawal by Subject|3
4893411|NCT00675506|16859524|P2|Overall Study|Schedule conflict|1
4893412|NCT00675506|16859525|P1|Overall Study|Schedule conflict|0
4893413|NCT00675506|16859524|P2|Overall Study|Declined participation|0
4893414|NCT00675506|16859525|P1|Overall Study|Declined participation|1
4893415|NCT00675506|16859524|P2|Overall Study|Disclosed history of cancer|0
4893416|NCT00675506|16859525|P1|Overall Study|Disclosed history of cancer|1
4893417|NCT00675506|16859524|P2|Overall Study|Hypersensitivity Reaction|0
4893418|NCT00675506|16859525|P1|Overall Study|Hypersensitivity Reaction|1
4893419|NCT00675506|16859524|P2|Overall Study|Elevated IGF-1|0
4893420|NCT00675506|16859525|P1|Overall Study|Elevated IGF-1|2
4893421|NCT00675506|16859524|P2|Overall Study|Elevated IGF-1 prior to treatment|0
4893422|NCT00675506|16859525|P1|Overall Study|Elevated IGF-1 prior to treatment|1
4893423|NCT00675506|16859524|P2|Overall Study|Elevated fasting glucose|1
4893424|NCT00675506|16859525|P1|Overall Study|Elevated fasting glucose|2
4893425|NCT00675506|16859524|P2|Overall Study|Lost interest|5
4893426|NCT00675506|16859525|P1|Overall Study|Lost interest|3
4893427|NCT00675506|16859524|P2|Overall Study|Lost to Follow-up|5
4893428|NCT00675506|16859525|P1|Overall Study|Lost to Follow-up|1
4893429|NCT00675441|16859541|P1|Overall Study|Death|1
4893430|NCT00675441|16859541|P1|Overall Study|Withdrawal by Subject|2
4893431|NCT00675428|16859547|P2|Overall Study|Physician Decision|0
4893432|NCT00675428|16859548|P1|Overall Study|Physician Decision|1
4893433|NCT00675428|16859547|P2|Overall Study|No Disease Response After Cycle 6|1
4893434|NCT00675428|16859548|P1|Overall Study|No Disease Response After Cycle 6|0
4893435|NCT00675428|16859547|P2|Overall Study|Disease Progression|2
4893436|NCT00675428|16859548|P1|Overall Study|Disease Progression|2
4893437|NCT00675103|16859590|P1|Overall Study|Adverse Event|1
4893438|NCT00675103|16859590|P1|Overall Study|Lack of Efficacy|2
4893439|NCT00674986|16859597|P2|Overall Study|Other reasons|8
4893440|NCT00674986|16859598|P1|Overall Study|Other reasons|4
4893441|NCT00674986|16859597|P2|Overall Study|Lost to Follow-up|53
4893442|NCT00674986|16859598|P1|Overall Study|Lost to Follow-up|25
4893443|NCT00674986|16859597|P2|Overall Study|Subject withdrew consent|19
4893444|NCT00674986|16859598|P1|Overall Study|Subject withdrew consent|12
4893445|NCT00674986|16859597|P2|Overall Study|Adverse Event|1
4893446|NCT00674986|16859598|P1|Overall Study|Adverse Event|2
4893447|NCT00674973|16859619|P2|Overall Study|Protocol Violation|1
4893448|NCT00674973|16859620|P1|Overall Study|Protocol Violation|0
4893449|NCT00674973|16859619|P2|Overall Study|Death|15
4893450|NCT00674973|16859620|P1|Overall Study|Death|19
4893451|NCT00674973|16859619|P2|Overall Study|Adverse Event|9
4893452|NCT00674973|16859620|P1|Overall Study|Adverse Event|2
4893453|NCT00674973|16859619|P2|Overall Study|Failure to Return|0
4893454|NCT00674973|16859620|P1|Overall Study|Failure to Return|1
4893455|NCT00674973|16859619|P2|Overall Study|Refused Treatment|5
4893456|NCT00674973|16859620|P1|Overall Study|Refused Treatment|1
4893457|NCT00674973|16859619|P2|Overall Study|Insufficient Therapeutic Response|72
4893458|NCT00674973|16859620|P1|Overall Study|Insufficient Therapeutic Response|77
4893459|NCT00674817|16859634|P1|Period 4|Adverse Event|1
4893460|NCT00674817|16859634|P1|Period 3|Protocol Violation|1
4893461|NCT00674817|16859634|P1|Period 3|Adverse Event|1
4893462|NCT00674817|16859634|P1|Period 1|Protocol Violation|1
4893463|NCT00674817|16859634|P1|Period 1|Withdrawal by Subject|2
4893464|NCT00674700|16859811|P3|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7
4893465|NCT00674700|16859812|P2|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10
4893466|NCT00674700|16859813|P1|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5
4893467|NCT00674700|16859811|P3|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4
4893468|NCT00674700|16859812|P2|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
4893469|NCT00674700|16859813|P1|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1
4893470|NCT00674700|16859811|P3|Year 2 Follow-up Without Treatment|Adverse Event|1
4893471|NCT00674700|16859812|P2|Year 2 Follow-up Without Treatment|Adverse Event|1
4893472|NCT00674700|16859813|P1|Year 2 Follow-up Without Treatment|Adverse Event|0
4893473|NCT00674700|16859811|P3|Year 1|Any other reason not above-mentioned|6
4893474|NCT00674700|16859812|P2|Year 1|Any other reason not above-mentioned|7
4893475|NCT00674700|16859813|P1|Year 1|Any other reason not above-mentioned|7
4893476|NCT00674700|16859811|P3|Year 1|Withdrawal by Subject|6
4893477|NCT00674700|16859812|P2|Year 1|Withdrawal by Subject|7
4893478|NCT00674700|16859813|P1|Year 1|Withdrawal by Subject|7
4893479|NCT00674700|16859811|P3|Year 1|Adverse Event|5
4893480|NCT00674700|16859812|P2|Year 1|Adverse Event|20
4893481|NCT00674700|16859813|P1|Year 1|Adverse Event|17
4893482|NCT00674661|16859826|P2|Overall Study|Withdrawal by Subject|5
4893483|NCT00674661|16859827|P1|Overall Study|Withdrawal by Subject|0
4893484|NCT00674661|16859826|P2|Overall Study|Lost to Follow-up|3
4893485|NCT00674661|16859827|P1|Overall Study|Lost to Follow-up|6
4893486|NCT00674661|16859826|P2|Overall Study|Other|7
4893487|NCT00674661|16859827|P1|Overall Study|Other|5
4893488|NCT00674570|16859925|P3|Overall Study|Withdrawal by Subject|0
4893489|NCT00674570|16859926|P2|Overall Study|Withdrawal by Subject|2
4893490|NCT00674570|16859927|P1|Overall Study|Withdrawal by Subject|0
4893491|NCT00674362|16859966|P2|Open Label|Other: Subject moved to extension study|0
4893492|NCT00674362|16859967|P1|Open Label|Other: Subject moved to extension study|1
4893493|NCT00674362|16859966|P2|Open Label|Adverse Event|0
4893494|NCT00674362|16859967|P1|Open Label|Adverse Event|1
4893495|NCT00674362|16859966|P2|Double Blind|Other: Surgery|1
4893496|NCT00674362|16859967|P1|Double Blind|Other: Surgery|0
4893497|NCT00674362|16859966|P2|Double Blind|Other: Loss of Patient Compliance|1
4893498|NCT00674362|16859967|P1|Double Blind|Other: Loss of Patient Compliance|0
4893499|NCT00674362|16859966|P2|Double Blind|Withdrawal by Subject|3
4893500|NCT00674362|16859967|P1|Double Blind|Withdrawal by Subject|4
4893501|NCT00674362|16859966|P2|Double Blind|Loss of efficacy|1
4893502|NCT00674362|16859967|P1|Double Blind|Loss of efficacy|0
4893503|NCT00674362|16859966|P2|Double Blind|Lack of Efficacy|6
4893504|NCT00674362|16859967|P1|Double Blind|Lack of Efficacy|2
4893505|NCT00674362|16859966|P2|Double Blind|Adverse Event|6
4893506|NCT00674362|16859967|P1|Double Blind|Adverse Event|6
4893507|NCT00674323|16860035|P3|Overall Study|Protocol Violation|0
4893508|NCT00674323|16860036|P2|Overall Study|Protocol Violation|0
4893509|NCT00674323|16860037|P1|Overall Study|Protocol Violation|1
4893510|NCT00674323|16860035|P3|Overall Study|Adverse Event|0
4893511|NCT00674323|16860036|P2|Overall Study|Adverse Event|1
4893512|NCT00674323|16860037|P1|Overall Study|Adverse Event|0
4893513|NCT00674154|16860088|P2|Overall Study|Did not want parathyroidectomy|2
4893514|NCT00674154|16860089|P1|Overall Study|Did not want parathyroidectomy|0
4893515|NCT00674154|16860088|P2|Overall Study|Withdrawal by Subject|1
4893516|NCT00674154|16860089|P1|Overall Study|Withdrawal by Subject|3
4893517|NCT00674128|16860097|P2|Overall Study|Withdrawal by Subject|23
4893518|NCT00674128|16860098|P1|Overall Study|Withdrawal by Subject|25
4893519|NCT00673933|16860123|P1|Overall Study|Lost to Follow-up|1
4893520|NCT00673933|16860123|P1|Overall Study|Withdrawal by Subject|2
4893521|NCT00673894|16860141|P2|First Intervention 4 Weeks|Adverse Event|0
4893522|NCT00673894|16860142|P1|First Intervention 4 Weeks|Adverse Event|1
4893523|NCT00673894|16860141|P2|First Intervention 4 Weeks|Withdrawal by Subject|0
4893524|NCT00673894|16860142|P1|First Intervention 4 Weeks|Withdrawal by Subject|1
4893525|NCT00673881|16860150|P1|Overall Study|Withdrawal by Subject|1
4893526|NCT00673816|16860164|P1|Overall Study|Withdrawal by Subject|1
4893527|NCT00673816|16860164|P1|Overall Study|Adverse Event|1
4893528|NCT00673790|16860174|P3|Overall Study|Randomization criteria not met|0
4893529|NCT00673790|16860175|P2|Overall Study|Randomization criteria not met|1
4893530|NCT00673790|16860176|P1|Overall Study|Randomization criteria not met|0
4893531|NCT00673790|16860174|P3|Overall Study|Unconfirmed pregnancy|0
4893532|NCT00673790|16860175|P2|Overall Study|Unconfirmed pregnancy|1
4893533|NCT00673790|16860176|P1|Overall Study|Unconfirmed pregnancy|0
4893534|NCT00673790|16860174|P3|Overall Study|Participated in two Nebivolol studies|1
4893535|NCT00673790|16860175|P2|Overall Study|Participated in two Nebivolol studies|0
4893536|NCT00673790|16860176|P1|Overall Study|Participated in two Nebivolol studies|0
4893537|NCT00673790|16860174|P3|Overall Study|Poor compliance|0
4893538|NCT00673790|16860175|P2|Overall Study|Poor compliance|0
4893539|NCT00673790|16860176|P1|Overall Study|Poor compliance|1
4893540|NCT00673790|16860174|P3|Overall Study|Sponsor Terminated due to PI oversight|0
4893541|NCT00673790|16860175|P2|Overall Study|Sponsor Terminated due to PI oversight|1
4893542|NCT00673790|16860176|P1|Overall Study|Sponsor Terminated due to PI oversight|0
4893543|NCT00673790|16860174|P3|Overall Study|Lost to Follow-up|5
4893544|NCT00673790|16860175|P2|Overall Study|Lost to Follow-up|6
4893545|NCT00673790|16860176|P1|Overall Study|Lost to Follow-up|6
4893546|NCT00673790|16860174|P3|Overall Study|Withdrawal by Subject|1
4893547|NCT00673790|16860175|P2|Overall Study|Withdrawal by Subject|4
4893548|NCT00673790|16860176|P1|Overall Study|Withdrawal by Subject|7
4893549|NCT00673790|16860174|P3|Overall Study|Protocol Violation|1
4893550|NCT00673790|16860175|P2|Overall Study|Protocol Violation|9
4893551|NCT00673790|16860176|P1|Overall Study|Protocol Violation|6
4893552|NCT00673790|16860174|P3|Overall Study|Lack of Efficacy|2
4893553|NCT00673790|16860175|P2|Overall Study|Lack of Efficacy|2
4893554|NCT00673790|16860176|P1|Overall Study|Lack of Efficacy|2
4893555|NCT00673790|16860174|P3|Overall Study|Adverse Event|2
4893556|NCT00673790|16860175|P2|Overall Study|Adverse Event|14
4893557|NCT00673790|16860176|P1|Overall Study|Adverse Event|23
4893558|NCT00673673|16860214|P1|Overall Study|Investigators' discretion|2
4893559|NCT00673673|16860214|P1|Overall Study|Withdrawal by Subject|3
4893560|NCT00673673|16860214|P1|Overall Study|Adverse Event|4
4893561|NCT00673673|16860214|P1|Overall Study|Progressive disease|27
4893562|NCT00673660|16860220|P1|Overall Study|Lost to Follow-up|107
4893563|NCT00673465|16860242|P12|Part 1/Period 2 (United States)|Protocol Violation|0
4893564|NCT00673465|16860243|P11|Part 1/Period 2 (United States)|Protocol Violation|0
4893565|NCT00673465|16860244|P10|Part 1/Period 2 (United States)|Protocol Violation|0
4893566|NCT00673465|16860245|P9|Part 1/Period 2 (United States)|Protocol Violation|0
4893567|NCT00673465|16860246|P8|Part 1/Period 2 (United States)|Protocol Violation|0
4893568|NCT00673465|16860247|P7|Part 1/Period 2 (United States)|Protocol Violation|0
4893569|NCT00673465|16860248|P6|Part 1/Period 2 (United States)|Protocol Violation|0
4893570|NCT00673465|16860249|P5|Part 1/Period 2 (United States)|Protocol Violation|1
4893571|NCT00673465|16860250|P4|Part 1/Period 2 (United States)|Protocol Violation|0
4893572|NCT00673465|16860251|P3|Part 1/Period 2 (United States)|Protocol Violation|0
4893573|NCT00673465|16860252|P2|Part 1/Period 2 (United States)|Protocol Violation|0
4893574|NCT00673465|16860253|P1|Part 1/Period 2 (United States)|Protocol Violation|0
4893575|NCT00673465|16860242|P12|Part 1/Period 1 (United States)|Protocol Violation|0
4893576|NCT00673465|16860243|P11|Part 1/Period 1 (United States)|Protocol Violation|0
4893577|NCT00673465|16860244|P10|Part 1/Period 1 (United States)|Protocol Violation|0
4893578|NCT00673465|16860245|P9|Part 1/Period 1 (United States)|Protocol Violation|0
4893579|NCT00673465|16860246|P8|Part 1/Period 1 (United States)|Protocol Violation|0
4893580|NCT00673465|16860247|P7|Part 1/Period 1 (United States)|Protocol Violation|0
4893581|NCT00673465|16860248|P6|Part 1/Period 1 (United States)|Protocol Violation|1
4893582|NCT00673465|16860249|P5|Part 1/Period 1 (United States)|Protocol Violation|1
4893583|NCT00673465|16860250|P4|Part 1/Period 1 (United States)|Protocol Violation|0
4893584|NCT00673465|16860251|P3|Part 1/Period 1 (United States)|Protocol Violation|0
4893585|NCT00673465|16860252|P2|Part 1/Period 1 (United States)|Protocol Violation|0
4893586|NCT00673465|16860253|P1|Part 1/Period 1 (United States)|Protocol Violation|0
4893587|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0
4893588|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1
4893589|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Physician Decision|0
4893590|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Physician Decision|2
4893591|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Sponsor Decision|3
4893592|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Sponsor Decision|0
4893593|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Protocol Violation|3
4893594|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Protocol Violation|2
4893595|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Lack of Efficacy|5
4893596|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Lack of Efficacy|2
4893597|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Lost to Follow-up|5
4893598|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Lost to Follow-up|4
4893599|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Withdrawal by Subject|5
4893600|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Withdrawal by Subject|9
4893601|NCT00673452|16860302|P2|Continuation Double-Blind Phase|Adverse Event|13
4893602|NCT00673452|16860303|P1|Continuation Double-Blind Phase|Adverse Event|5
4893603|NCT00673452|16860302|P2|Acute Double-Blind Phase|Withdrawal by Subject|13
4893604|NCT00673452|16860303|P1|Acute Double-Blind Phase|Withdrawal by Subject|16
4893605|NCT00673452|16860302|P2|Acute Double-Blind Phase|Sponsor Decision|1
4893606|NCT00673452|16860303|P1|Acute Double-Blind Phase|Sponsor Decision|0
4893607|NCT00673452|16860302|P2|Acute Double-Blind Phase|Protocol Violation|3
4893608|NCT00673452|16860303|P1|Acute Double-Blind Phase|Protocol Violation|5
4893609|NCT00673452|16860302|P2|Acute Double-Blind Phase|Physician Decision|6
4893610|NCT00673452|16860303|P1|Acute Double-Blind Phase|Physician Decision|0
4893611|NCT00673452|16860302|P2|Acute Double-Blind Phase|Lost to Follow-up|19
4893612|NCT00673452|16860303|P1|Acute Double-Blind Phase|Lost to Follow-up|16
4893613|NCT00673452|16860302|P2|Acute Double-Blind Phase|Lack of Efficacy|14
4893614|NCT00673452|16860303|P1|Acute Double-Blind Phase|Lack of Efficacy|9
4893615|NCT00673452|16860302|P2|Acute Double-Blind Phase|Adverse Event|24
4893616|NCT00673452|16860303|P1|Acute Double-Blind Phase|Adverse Event|41
4893617|NCT00673387|16860367|P8|Overall Study|Lost to Follow-up|5
4893618|NCT00673387|16860368|P7|Overall Study|Lost to Follow-up|8
4893619|NCT00673387|16860369|P6|Overall Study|Lost to Follow-up|5
4893620|NCT00673387|16860370|P5|Overall Study|Lost to Follow-up|6
4893621|NCT00673387|16860371|P4|Overall Study|Lost to Follow-up|6
4893622|NCT00673387|16860372|P3|Overall Study|Lost to Follow-up|5
4893623|NCT00673387|16860373|P2|Overall Study|Lost to Follow-up|6
4893624|NCT00673387|16860374|P1|Overall Study|Lost to Follow-up|8
4893625|NCT00673387|16860367|P8|Overall Study|Protocol Violation|3
4893626|NCT00673387|16860368|P7|Overall Study|Protocol Violation|1
4893627|NCT00673387|16860369|P6|Overall Study|Protocol Violation|1
4893628|NCT00673387|16860370|P5|Overall Study|Protocol Violation|0
4893629|NCT00673387|16860371|P4|Overall Study|Protocol Violation|2
4893630|NCT00673387|16860372|P3|Overall Study|Protocol Violation|1
4893631|NCT00673387|16860373|P2|Overall Study|Protocol Violation|0
4893632|NCT00673387|16860374|P1|Overall Study|Protocol Violation|3
4893633|NCT00673387|16860367|P8|Overall Study|Physician Decision|1
4893634|NCT00673387|16860368|P7|Overall Study|Physician Decision|1
4893635|NCT00673387|16860369|P6|Overall Study|Physician Decision|5
4893636|NCT00673387|16860370|P5|Overall Study|Physician Decision|0
4893637|NCT00673387|16860371|P4|Overall Study|Physician Decision|0
4893638|NCT00673387|16860372|P3|Overall Study|Physician Decision|0
4893639|NCT00673387|16860373|P2|Overall Study|Physician Decision|0
4893640|NCT00673387|16860374|P1|Overall Study|Physician Decision|0
4893641|NCT00673387|16860367|P8|Overall Study|Adverse Event|5
4893642|NCT00673387|16860368|P7|Overall Study|Adverse Event|5
4893643|NCT00673387|16860369|P6|Overall Study|Adverse Event|2
4893644|NCT00673387|16860370|P5|Overall Study|Adverse Event|6
4893645|NCT00673387|16860371|P4|Overall Study|Adverse Event|2
4893646|NCT00673387|16860372|P3|Overall Study|Adverse Event|5
4893647|NCT00673387|16860373|P2|Overall Study|Adverse Event|1
4893648|NCT00673387|16860374|P1|Overall Study|Adverse Event|3
4893649|NCT00673387|16860367|P8|Overall Study|Withdrawal by Subject|21
4893650|NCT00673387|16860368|P7|Overall Study|Withdrawal by Subject|15
4893651|NCT00673387|16860369|P6|Overall Study|Withdrawal by Subject|21
4893652|NCT00673387|16860370|P5|Overall Study|Withdrawal by Subject|18
4893653|NCT00673387|16860371|P4|Overall Study|Withdrawal by Subject|16
4893654|NCT00673387|16860372|P3|Overall Study|Withdrawal by Subject|20
4893655|NCT00673387|16860373|P2|Overall Study|Withdrawal by Subject|16
4893656|NCT00673387|16860374|P1|Overall Study|Withdrawal by Subject|15
4893657|NCT00673361|16860590|P1|Overall Study|Screen Failure|2
4893658|NCT00673257|16860626|P1|Overall Study|Unable to obtain specimen|1
4893659|NCT00673257|16860626|P1|Overall Study|Withdrawal by Subject|4
4893660|NCT00673231|16860635|P4|Overall Study|Study criteria,compliance,safety, other|4
4893661|NCT00673231|16860636|P3|Overall Study|Study criteria,compliance,safety, other|7
4893662|NCT00673231|16860637|P2|Overall Study|Study criteria,compliance,safety, other|5
4893663|NCT00673231|16860638|P1|Overall Study|Study criteria,compliance,safety, other|8
4893664|NCT00673231|16860635|P4|Overall Study|Death|0
4893665|NCT00673231|16860636|P3|Overall Study|Death|1
4893666|NCT00673231|16860637|P2|Overall Study|Death|0
4893667|NCT00673231|16860638|P1|Overall Study|Death|0
4893668|NCT00673231|16860635|P4|Overall Study|Lost to Follow-up|2
4893669|NCT00673231|16860636|P3|Overall Study|Lost to Follow-up|1
4893670|NCT00673231|16860637|P2|Overall Study|Lost to Follow-up|2
4893671|NCT00673231|16860638|P1|Overall Study|Lost to Follow-up|1
4893672|NCT00673231|16860635|P4|Overall Study|Adverse Event|6
4893673|NCT00673231|16860636|P3|Overall Study|Adverse Event|9
4893674|NCT00673231|16860637|P2|Overall Study|Adverse Event|5
4893675|NCT00673231|16860638|P1|Overall Study|Adverse Event|6
4893676|NCT00673231|16860635|P4|Overall Study|Withdrawal by Subject|6
4893677|NCT00673231|16860636|P3|Overall Study|Withdrawal by Subject|8
4893678|NCT00673231|16860637|P2|Overall Study|Withdrawal by Subject|10
4893679|NCT00673231|16860638|P1|Overall Study|Withdrawal by Subject|14
4893680|NCT00673179|16860670|P2|Overall Study|Toxicity/Complications|0
4893681|NCT00673179|16860671|P1|Overall Study|Toxicity/Complications|3
4893682|NCT00673049|16860720|P4|After Progression on Erlotinib|study terminated by sponsor|4
4893683|NCT00673049|16860721|P3|After Progression on Erlotinib|study terminated by sponsor|0
4893684|NCT00673049|16860722|P2|After Progression on Erlotinib|study terminated by sponsor|0
4893685|NCT00673049|16860723|P1|After Progression on Erlotinib|study terminated by sponsor|0
4893686|NCT00673049|16860720|P4|After Progression on Erlotinib|Withdrawal by Subject|5
4893687|NCT00673049|16860721|P3|After Progression on Erlotinib|Withdrawal by Subject|0
4893688|NCT00673049|16860722|P2|After Progression on Erlotinib|Withdrawal by Subject|0
4893689|NCT00673049|16860723|P1|After Progression on Erlotinib|Withdrawal by Subject|0
4893690|NCT00673049|16860720|P4|After Progression on Erlotinib|Lost to Follow-up|3
4893691|NCT00673049|16860721|P3|After Progression on Erlotinib|Lost to Follow-up|0
4893692|NCT00673049|16860722|P2|After Progression on Erlotinib|Lost to Follow-up|0
4893693|NCT00673049|16860723|P1|After Progression on Erlotinib|Lost to Follow-up|0
4893694|NCT00673049|16860720|P4|After Progression on Erlotinib|Death|71
4893695|NCT00673049|16860721|P3|After Progression on Erlotinib|Death|0
4893696|NCT00673049|16860722|P2|After Progression on Erlotinib|Death|0
4893697|NCT00673049|16860723|P1|After Progression on Erlotinib|Death|0
4893698|NCT00673049|16860720|P4|Before Progression on Erlotinib|Switched to figitumumab|0
4893699|NCT00673049|16860721|P3|Before Progression on Erlotinib|Switched to figitumumab|0
4893700|NCT00673049|16860722|P2|Before Progression on Erlotinib|Switched to figitumumab|83
4893701|NCT00673049|16860723|P1|Before Progression on Erlotinib|Switched to figitumumab|0
4893702|NCT00673049|16860720|P4|Before Progression on Erlotinib|study terminated by sponsor|0
4893703|NCT00673049|16860721|P3|Before Progression on Erlotinib|study terminated by sponsor|0
4893704|NCT00673049|16860722|P2|Before Progression on Erlotinib|study terminated by sponsor|14
4893705|NCT00673049|16860723|P1|Before Progression on Erlotinib|study terminated by sponsor|18
4893706|NCT00673049|16860720|P4|Before Progression on Erlotinib|Other|0
4893707|NCT00673049|16860721|P3|Before Progression on Erlotinib|Other|0
4893708|NCT00673049|16860722|P2|Before Progression on Erlotinib|Other|2
4893709|NCT00673049|16860723|P1|Before Progression on Erlotinib|Other|1
4893710|NCT00673049|16860720|P4|Before Progression on Erlotinib|Withdrawal by Subject|0
4893711|NCT00673049|16860721|P3|Before Progression on Erlotinib|Withdrawal by Subject|0
4893712|NCT00673049|16860722|P2|Before Progression on Erlotinib|Withdrawal by Subject|18
4893713|NCT00673049|16860723|P1|Before Progression on Erlotinib|Withdrawal by Subject|26
4893714|NCT00673049|16860720|P4|Before Progression on Erlotinib|Lost to Follow-up|0
4893715|NCT00673049|16860721|P3|Before Progression on Erlotinib|Lost to Follow-up|0
4893716|NCT00673049|16860722|P2|Before Progression on Erlotinib|Lost to Follow-up|5
4893717|NCT00673049|16860723|P1|Before Progression on Erlotinib|Lost to Follow-up|9
4893718|NCT00673049|16860720|P4|Before Progression on Erlotinib|Death|0
4893719|NCT00673049|16860721|P3|Before Progression on Erlotinib|Death|1
4893720|NCT00673049|16860722|P2|Before Progression on Erlotinib|Death|167
4893721|NCT00673049|16860723|P1|Before Progression on Erlotinib|Death|235
4893722|NCT00673049|16860720|P4|Before Progression on Erlotinib|Randomized but not treated|0
4893723|NCT00673049|16860721|P3|Before Progression on Erlotinib|Randomized but not treated|0
4893724|NCT00673049|16860722|P2|Before Progression on Erlotinib|Randomized but not treated|1
4893725|NCT00673049|16860723|P1|Before Progression on Erlotinib|Randomized but not treated|3
4893726|NCT00672984|16860747|P3|Third Intervention|Adverse Event|1
4893727|NCT00672984|16860748|P2|Third Intervention|Adverse Event|0
4893728|NCT00672984|16860749|P1|Third Intervention|Adverse Event|1
4893729|NCT00672984|16860747|P3|Second Intervention|Protocol Violation|1
4893730|NCT00672984|16860748|P2|Second Intervention|Protocol Violation|1
4893731|NCT00672984|16860749|P1|Second Intervention|Protocol Violation|0
4893732|NCT00672984|16860747|P3|Second Intervention|Withdrawal by Subject|0
4893733|NCT00672984|16860748|P2|Second Intervention|Withdrawal by Subject|3
4893734|NCT00672984|16860749|P1|Second Intervention|Withdrawal by Subject|0
4893735|NCT00672984|16860747|P3|Second Intervention|Non-compliance with facility policies|0
4893736|NCT00672984|16860748|P2|Second Intervention|Non-compliance with facility policies|2
4893737|NCT00672984|16860749|P1|Second Intervention|Non-compliance with facility policies|0
4893738|NCT00672984|16860747|P3|First Intervention|Sponsor decision|0
4893739|NCT00672984|16860748|P2|First Intervention|Sponsor decision|0
4893740|NCT00672984|16860749|P1|First Intervention|Sponsor decision|3
4893741|NCT00672984|16860747|P3|First Intervention|Withdrawal by Subject|2
4893742|NCT00672984|16860748|P2|First Intervention|Withdrawal by Subject|2
4893743|NCT00672984|16860749|P1|First Intervention|Withdrawal by Subject|1
4893744|NCT00672984|16860747|P3|First Intervention|Adverse Event|0
4893745|NCT00672984|16860748|P2|First Intervention|Adverse Event|0
4893746|NCT00672984|16860749|P1|First Intervention|Adverse Event|5
4893747|NCT00672958|16860800|P2|Overall Study|Reason not specified|3
4893748|NCT00672958|16860801|P1|Overall Study|Reason not specified|0
4893749|NCT00672958|16860800|P2|Overall Study|Lost to Follow-up|17
4893750|NCT00672958|16860801|P1|Overall Study|Lost to Follow-up|22
4893751|NCT00672958|16860800|P2|Overall Study|Voluntary withdrawal|8
4893752|NCT00672958|16860801|P1|Overall Study|Voluntary withdrawal|12
4893753|NCT00672958|16860800|P2|Overall Study|Protocol deviations|5
4893754|NCT00672958|16860801|P1|Overall Study|Protocol deviations|11
4893755|NCT00672958|16860800|P2|Overall Study|Non-compliance with study drug|3
4893756|NCT00672958|16860801|P1|Overall Study|Non-compliance with study drug|2
4893757|NCT00672958|16860800|P2|Overall Study|Lack of Efficacy|11
4893758|NCT00672958|16860801|P1|Overall Study|Lack of Efficacy|6
4893759|NCT00672958|16860800|P2|Overall Study|Adverse Event|9
4893760|NCT00672958|16860801|P1|Overall Study|Adverse Event|11
4893761|NCT00672841|16860867|P2|Overall Study|Pregnancy|1
4893762|NCT00672841|16860868|P1|Overall Study|Pregnancy|0
4893763|NCT00672841|16860867|P2|Overall Study|Adverse Event|3
4893764|NCT00672841|16860868|P1|Overall Study|Adverse Event|0
4893765|NCT00672841|16860867|P2|Overall Study|Antifungal therapy, negative glucan|4
4893766|NCT00672841|16860868|P1|Overall Study|Antifungal therapy, negative glucan|0
4893767|NCT00672841|16860867|P2|Overall Study|icteric specimens|3
4893768|NCT00672841|16860868|P1|Overall Study|icteric specimens|0
4893769|NCT00672841|16860867|P2|Overall Study|Comfort care|4
4893770|NCT00672841|16860868|P1|Overall Study|Comfort care|1
4893771|NCT00672646|16860890|P3|Overall Study|Withdrawal by Subject|1
4893772|NCT00672646|16860891|P2|Overall Study|Withdrawal by Subject|0
4893773|NCT00672646|16860892|P1|Overall Study|Withdrawal by Subject|0
4893774|NCT00672646|16860890|P3|Overall Study|Lost to Follow-up|2
4893775|NCT00672646|16860891|P2|Overall Study|Lost to Follow-up|1
4893776|NCT00672646|16860892|P1|Overall Study|Lost to Follow-up|0
4893777|NCT00672633|16860917|P2|Overall Study|Withdrawal by Subject|1
4893778|NCT00672633|16860918|P1|Overall Study|Withdrawal by Subject|0
4893779|NCT00672620|16860932|P4|Overall Study|Reason not Specified|1
4893780|NCT00672620|16860933|P3|Overall Study|Reason not Specified|2
4893781|NCT00672620|16860934|P2|Overall Study|Reason not Specified|3
4893782|NCT00672620|16860935|P1|Overall Study|Reason not Specified|3
4893783|NCT00672620|16860932|P4|Overall Study|Lost to Follow-up|11
4893784|NCT00672620|16860933|P3|Overall Study|Lost to Follow-up|8
4893785|NCT00672620|16860934|P2|Overall Study|Lost to Follow-up|19
4893786|NCT00672620|16860935|P1|Overall Study|Lost to Follow-up|8
4893787|NCT00672620|16860932|P4|Overall Study|Withdrawal of Consent|6
4893788|NCT00672620|16860933|P3|Overall Study|Withdrawal of Consent|5
4893789|NCT00672620|16860934|P2|Overall Study|Withdrawal of Consent|12
4893790|NCT00672620|16860935|P1|Overall Study|Withdrawal of Consent|6
4893791|NCT00672620|16860932|P4|Overall Study|Protocol Deviations|5
4893792|NCT00672620|16860933|P3|Overall Study|Protocol Deviations|2
4893793|NCT00672620|16860934|P2|Overall Study|Protocol Deviations|7
4893794|NCT00672620|16860935|P1|Overall Study|Protocol Deviations|5
4893795|NCT00672620|16860932|P4|Overall Study|Noncompliance with Study Drug|2
4893796|NCT00672620|16860933|P3|Overall Study|Noncompliance with Study Drug|0
4893797|NCT00672620|16860934|P2|Overall Study|Noncompliance with Study Drug|4
4893798|NCT00672620|16860935|P1|Overall Study|Noncompliance with Study Drug|3
4893799|NCT00672620|16860932|P4|Overall Study|Lack of Efficacy|0
4893800|NCT00672620|16860933|P3|Overall Study|Lack of Efficacy|2
4893801|NCT00672620|16860934|P2|Overall Study|Lack of Efficacy|2
4893802|NCT00672620|16860935|P1|Overall Study|Lack of Efficacy|1
4893803|NCT00672620|16860932|P4|Overall Study|Adverse Event|17
4893804|NCT00672620|16860933|P3|Overall Study|Adverse Event|12
4893805|NCT00672620|16860934|P2|Overall Study|Adverse Event|7
4893806|NCT00672620|16860935|P1|Overall Study|Adverse Event|7
4893807|NCT00672555|16861000|P1|Overall Study|Did not want to answer questionnaire|2
4893808|NCT00672555|16861000|P1|Overall Study|Lost to Follow-up|4
4893809|NCT00672490|16861011|P2|Overall Study|No reason was provided|2
4893810|NCT00672490|16861012|P1|Overall Study|No reason was provided|6
4893811|NCT00672490|16861011|P2|Overall Study|Lost to Follow-up|5
4893812|NCT00672490|16861012|P1|Overall Study|Lost to Follow-up|1
4893813|NCT00672490|16861011|P2|Overall Study|Intolerance|2
4893814|NCT00672490|16861012|P1|Overall Study|Intolerance|0
4893815|NCT00672490|16861011|P2|Overall Study|Violation of Concomitant Medicine|0
4893816|NCT00672490|16861012|P1|Overall Study|Violation of Concomitant Medicine|1
4893817|NCT00672490|16861011|P2|Overall Study|Adverse Event|8
4893818|NCT00672490|16861012|P1|Overall Study|Adverse Event|5
4893819|NCT00672490|16861011|P2|Overall Study|Mismatch Include/Exclude Criteria|0
4893820|NCT00672490|16861012|P1|Overall Study|Mismatch Include/Exclude Criteria|1
4893821|NCT00672490|16861011|P2|Overall Study|Lack of Compliance|7
4893822|NCT00672490|16861012|P1|Overall Study|Lack of Compliance|2
4893823|NCT00672490|16861011|P2|Overall Study|Withdrawal by Subject|8
4893824|NCT00672490|16861012|P1|Overall Study|Withdrawal by Subject|8
4893825|NCT00672477|16861036|P2|Overall Study|no study drug for low GFR, health cond.|3
4893826|NCT00672477|16861037|P1|Overall Study|no study drug for low GFR, health cond.|1
4893827|NCT00672477|16861036|P2|Overall Study|Lack of Efficacy|1
4893828|NCT00672477|16861037|P1|Overall Study|Lack of Efficacy|1
4893829|NCT00672477|16861036|P2|Overall Study|Withdrawal by Subject|3
4893830|NCT00672477|16861037|P1|Overall Study|Withdrawal by Subject|5
4893831|NCT00672477|16861036|P2|Overall Study|Protocol Violation|1
4893832|NCT00672477|16861037|P1|Overall Study|Protocol Violation|1
4893833|NCT00672477|16861036|P2|Overall Study|Physician Decision|0
4893834|NCT00672477|16861037|P1|Overall Study|Physician Decision|2
4893835|NCT00672477|16861036|P2|Overall Study|Death|11
4893836|NCT00672477|16861037|P1|Overall Study|Death|7
4893837|NCT00672477|16861036|P2|Overall Study|Adverse Event|7
4893838|NCT00672477|16861037|P1|Overall Study|Adverse Event|10
4893839|NCT00672256|16861090|P1|Overall Study|PI dropped, bad data|44
4893840|NCT00672139|16861115|P2|Overall Study|hospice discharge, caregiver requests|2
4893841|NCT00672139|16861116|P1|Overall Study|hospice discharge, caregiver requests|3
4893842|NCT00672139|16861115|P2|Overall Study|Protocol Violation|1
4893843|NCT00672139|16861116|P1|Overall Study|Protocol Violation|1
4893844|NCT00672139|16861115|P2|Overall Study|Lack of Efficacy|1
4893845|NCT00672139|16861116|P1|Overall Study|Lack of Efficacy|4
4893846|NCT00672139|16861115|P2|Overall Study|Physician Decision|0
4893847|NCT00672139|16861116|P1|Overall Study|Physician Decision|2
4893848|NCT00672139|16861115|P2|Overall Study|Adverse Event|7
4893849|NCT00672139|16861116|P1|Overall Study|Adverse Event|4
4893850|NCT00672139|16861115|P2|Overall Study|Withdrawal by Subject|11
4893851|NCT00672139|16861116|P1|Overall Study|Withdrawal by Subject|2
4893852|NCT00672139|16861115|P2|Overall Study|Death|23
4893853|NCT00672139|16861116|P1|Overall Study|Death|14
4893854|NCT00671931|16861173|P5|Overall Study|Physician Decision|1
4893855|NCT00671931|16861174|P4|Overall Study|Physician Decision|2
4893856|NCT00671931|16861175|P3|Overall Study|Physician Decision|0
4893857|NCT00671931|16861176|P2|Overall Study|Physician Decision|0
4893858|NCT00671931|16861177|P1|Overall Study|Physician Decision|1
4893859|NCT00671879|16861197|P3|Overall Study|Withdrawal by Subject|6
4893860|NCT00671879|16861198|P2|Overall Study|Withdrawal by Subject|4
4893861|NCT00671879|16861199|P1|Overall Study|Withdrawal by Subject|0
4893862|NCT00671853|16861212|P2|Overall Study|Non-adherence with study procedures|4
4893863|NCT00671853|16861213|P1|Overall Study|Non-adherence with study procedures|1
4893864|NCT00671853|16861212|P2|Overall Study|Physician Decision|2
4893865|NCT00671853|16861213|P1|Overall Study|Physician Decision|0
4893866|NCT00671853|16861212|P2|Overall Study|Lost to Follow-up|8
4893867|NCT00671853|16861213|P1|Overall Study|Lost to Follow-up|8
4893868|NCT00671853|16861212|P2|Overall Study|Withdrawal by Subject|5
4893869|NCT00671853|16861213|P1|Overall Study|Withdrawal by Subject|1
4893870|NCT00671853|16861212|P2|Overall Study|Adverse Event|1
4893871|NCT00671853|16861213|P1|Overall Study|Adverse Event|7
4893872|NCT00671853|16861212|P2|Overall Study|Lack of Efficacy|7
4893873|NCT00671853|16861213|P1|Overall Study|Lack of Efficacy|3
4893874|NCT00671788|16861229|P1|Overall Study|Other|1
4893875|NCT00671788|16861229|P1|Overall Study|MD Decision|1
4893876|NCT00671788|16861229|P1|Overall Study|Ineligible|1
4893877|NCT00671788|16861229|P1|Overall Study|Refused further treatment|3
4893878|NCT00671788|16861229|P1|Overall Study|Adverse Event|8
4893879|NCT00671749|16861236|P1|Overall Study|Lost to Follow-up|1
4893880|NCT00671749|16861236|P1|Overall Study|Protocol Violation|1
4893881|NCT00671749|16861236|P1|Overall Study|Withdrawal by Subject|4
4893882|NCT00671749|16861236|P1|Overall Study|Adverse Event|2
4893883|NCT00671554|16861295|P1|Overall Study|Disease progression|3
4893884|NCT00671437|16861334|P1|Overall Study|Ineligible post-hoc|1
4893885|NCT00671437|16861334|P1|Overall Study|Adverse Event|3
4893886|NCT00671437|16861334|P1|Overall Study|Cutaneous SCC of head and neck|3
4893887|NCT00671437|16861334|P1|Overall Study|Progressive disease before C1 week 8|8
4893888|NCT00671060|16861368|P2|Overall Study|Physician Decision|1
4893889|NCT00671060|16861369|P1|Overall Study|Physician Decision|0
4893890|NCT00671060|16861368|P2|Overall Study|Protocol Violation|0
4893891|NCT00671060|16861369|P1|Overall Study|Protocol Violation|1
4893892|NCT00671034|16861378|P3|Overall Study|includes Alternative therapy, etc.|7
4893893|NCT00671034|16861379|P2|Overall Study|includes Alternative therapy, etc.|1
4893894|NCT00671034|16861380|P1|Overall Study|includes Alternative therapy, etc.|6
4893895|NCT00671034|16861378|P3|Overall Study|Refusal|5
4893896|NCT00671034|16861379|P2|Overall Study|Refusal|3
4893897|NCT00671034|16861380|P1|Overall Study|Refusal|5
4893898|NCT00671034|16861378|P3|Overall Study|VHR ALL feature|5
4893899|NCT00671034|16861379|P2|Overall Study|VHR ALL feature|3
4893900|NCT00671034|16861380|P1|Overall Study|VHR ALL feature|8
4893901|NCT00671034|16861378|P3|Overall Study|Physician Decision|5
4893902|NCT00671034|16861379|P2|Overall Study|Physician Decision|4
4893903|NCT00671034|16861380|P1|Overall Study|Physician Decision|12
4893904|NCT00671034|16861378|P3|Overall Study|Death|1
4893905|NCT00671034|16861379|P2|Overall Study|Death|2
4893906|NCT00671034|16861380|P1|Overall Study|Death|3
4893907|NCT00671034|16861378|P3|Overall Study|Adverse Event|1
4893908|NCT00671034|16861379|P2|Overall Study|Adverse Event|7
4893909|NCT00671034|16861380|P1|Overall Study|Adverse Event|5
4893910|NCT00670930|16861435|P2|Overall Study|Lost to Follow-up|0
4893911|NCT00670930|16861436|P1|Overall Study|Lost to Follow-up|1
4893912|NCT00670930|16861435|P2|Overall Study|Adminstrative Problem|1
4893913|NCT00670930|16861436|P1|Overall Study|Adminstrative Problem|0
4893914|NCT00670800|16861452|P2|Overall Study|2 controls were insulin resistant|2
4893915|NCT00670800|16861453|P1|Overall Study|2 controls were insulin resistant|0
4893916|NCT00670748|16861484|P4|Overall Study|Not off study|1
4893917|NCT00670748|16861485|P3|Overall Study|Not off study|1
4893918|NCT00670748|16861486|P2|Overall Study|Not off study|1
4893919|NCT00670748|16861487|P1|Overall Study|Not off study|2
4893920|NCT00670748|16861484|P4|Overall Study|Death during treatment|0
4893921|NCT00670748|16861485|P3|Overall Study|Death during treatment|1
4893922|NCT00670748|16861486|P2|Overall Study|Death during treatment|1
4893923|NCT00670748|16861487|P1|Overall Study|Death during treatment|1
4893924|NCT00670540|16861522|P1|Overall Study|missing information inclusion criteria|1
4893925|NCT00670540|16861522|P1|Overall Study|controls randomised for no follow up|2770
4893926|NCT00670540|16861522|P1|Overall Study|refused to participate|189
4893927|NCT00670540|16861522|P1|Overall Study|not living in France|348
4893928|NCT00670540|16861522|P1|Overall Study|ineligible|17
4893929|NCT00670488|16861542|P10|Overall Study|Withdrawal by Subject|0
4893930|NCT00670488|16861543|P9|Overall Study|Withdrawal by Subject|1
4893931|NCT00670488|16861544|P8|Overall Study|Withdrawal by Subject|0
4893932|NCT00670488|16861545|P7|Overall Study|Withdrawal by Subject|1
4893933|NCT00670488|16861546|P6|Overall Study|Withdrawal by Subject|0
4893934|NCT00670488|16861547|P5|Overall Study|Withdrawal by Subject|0
4893935|NCT00670488|16861548|P4|Overall Study|Withdrawal by Subject|1
4893936|NCT00670488|16861549|P3|Overall Study|Withdrawal by Subject|0
4893937|NCT00670488|16861550|P2|Overall Study|Withdrawal by Subject|1
4893938|NCT00670488|16861551|P1|Overall Study|Withdrawal by Subject|0
4893939|NCT00670488|16861542|P10|Overall Study|Progressive Disease|1
4893940|NCT00670488|16861543|P9|Overall Study|Progressive Disease|2
4893941|NCT00670488|16861544|P8|Overall Study|Progressive Disease|2
4893942|NCT00670488|16861545|P7|Overall Study|Progressive Disease|11
4893943|NCT00670488|16861546|P6|Overall Study|Progressive Disease|4
4893944|NCT00670488|16861547|P5|Overall Study|Progressive Disease|2
4893945|NCT00670488|16861548|P4|Overall Study|Progressive Disease|2
4893946|NCT00670488|16861549|P3|Overall Study|Progressive Disease|3
4893947|NCT00670488|16861550|P2|Overall Study|Progressive Disease|41
4893948|NCT00670488|16861551|P1|Overall Study|Progressive Disease|2
4893949|NCT00670488|16861542|P10|Overall Study|Physician Decision|0
4893950|NCT00670488|16861543|P9|Overall Study|Physician Decision|0
4893951|NCT00670488|16861544|P8|Overall Study|Physician Decision|0
4893952|NCT00670488|16861545|P7|Overall Study|Physician Decision|0
4893953|NCT00670488|16861546|P6|Overall Study|Physician Decision|0
4893954|NCT00670488|16861547|P5|Overall Study|Physician Decision|0
4893955|NCT00670488|16861548|P4|Overall Study|Physician Decision|1
4893956|NCT00670488|16861549|P3|Overall Study|Physician Decision|0
4893957|NCT00670488|16861550|P2|Overall Study|Physician Decision|9
4893958|NCT00670488|16861551|P1|Overall Study|Physician Decision|1
4893959|NCT00670488|16861542|P10|Overall Study|Adverse Event|1
4893960|NCT00670488|16861543|P9|Overall Study|Adverse Event|0
4893961|NCT00670488|16861544|P8|Overall Study|Adverse Event|1
4893962|NCT00670488|16861545|P7|Overall Study|Adverse Event|5
4893963|NCT00670488|16861546|P6|Overall Study|Adverse Event|1
4893964|NCT00670488|16861547|P5|Overall Study|Adverse Event|1
4893965|NCT00670488|16861548|P4|Overall Study|Adverse Event|3
4893966|NCT00670488|16861549|P3|Overall Study|Adverse Event|0
4893967|NCT00670488|16861550|P2|Overall Study|Adverse Event|7
4893968|NCT00670488|16861551|P1|Overall Study|Adverse Event|0
4893969|NCT00670449|16861738|P4|Overall Study|Abnormal Laboratory Value(s)|0
4893970|NCT00670449|16861739|P3|Overall Study|Abnormal Laboratory Value(s)|0
4893971|NCT00670449|16861740|P2|Overall Study|Abnormal Laboratory Value(s)|2
4893972|NCT00670449|16861741|P1|Overall Study|Abnormal Laboratory Value(s)|0
4893973|NCT00670449|16861738|P4|Overall Study|Unsatisfactory Therapeutic Effect|0
4893974|NCT00670449|16861739|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
4893975|NCT00670449|16861740|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
4893976|NCT00670449|16861741|P1|Overall Study|Unsatisfactory Therapeutic Effect|2
4893977|NCT00670449|16861738|P4|Overall Study|Subject Withdrew Consent|1
4893978|NCT00670449|16861739|P3|Overall Study|Subject Withdrew Consent|0
4893979|NCT00670449|16861740|P2|Overall Study|Subject Withdrew Consent|2
4893980|NCT00670449|16861741|P1|Overall Study|Subject Withdrew Consent|0
4893981|NCT00670449|16861738|P4|Overall Study|Administrative Problems|1
4893982|NCT00670449|16861739|P3|Overall Study|Administrative Problems|0
4893983|NCT00670449|16861740|P2|Overall Study|Administrative Problems|2
4893984|NCT00670449|16861741|P1|Overall Study|Administrative Problems|0
4893985|NCT00670449|16861738|P4|Overall Study|Protocol Deviation|1
4893986|NCT00670449|16861739|P3|Overall Study|Protocol Deviation|0
4893987|NCT00670449|16861740|P2|Overall Study|Protocol Deviation|2
4893988|NCT00670449|16861741|P1|Overall Study|Protocol Deviation|1
4893989|NCT00670449|16861738|P4|Overall Study|Adverse Event|5
4893990|NCT00670449|16861739|P3|Overall Study|Adverse Event|8
4893991|NCT00670449|16861740|P2|Overall Study|Adverse Event|2
4893992|NCT00670449|16861741|P1|Overall Study|Adverse Event|6
4893993|NCT00670306|16861765|P1|Overall Study|incl/excl criterias did not meet|19
4893994|NCT00670306|16861765|P1|Overall Study|Lost to Follow-up|8
4893995|NCT00670306|16861765|P1|Overall Study|Physician Decision|1
4893996|NCT00670306|16861765|P1|Overall Study|Withdrawal by Subject|9
4893997|NCT00670306|16861765|P1|Overall Study|Lack of Efficacy|10
4893998|NCT00670306|16861765|P1|Overall Study|Adverse Event|8
4893999|NCT00670228|16861804|P2|Overall Study|Not meeting the selection criteria|0
4894000|NCT00670228|16861805|P1|Overall Study|Not meeting the selection criteria|2
4894001|NCT00670228|16861804|P2|Overall Study|Not treated|2
4894002|NCT00670228|16861805|P1|Overall Study|Not treated|2
4894003|NCT00670228|16861804|P2|Overall Study|Death or MACE|1
4894004|NCT00670228|16861805|P1|Overall Study|Death or MACE|0
4894005|NCT00670228|16861804|P2|Overall Study|Adverse Event|0
4894006|NCT00670228|16861805|P1|Overall Study|Adverse Event|1
4894007|NCT00670111|16861829|P3|Enrollment to One Month|Physician Decision|0
4894008|NCT00670111|16861830|P2|Enrollment to One Month|Physician Decision|0
4894009|NCT00670111|16861831|P1|Enrollment to One Month|Physician Decision|1
4894010|NCT00670111|16861829|P3|Enrollment to One Month|Ebrolled Patients but not Implanted|6
4894011|NCT00670111|16861830|P2|Enrollment to One Month|Ebrolled Patients but not Implanted|0
4894012|NCT00670111|16861831|P1|Enrollment to One Month|Ebrolled Patients but not Implanted|0
4894013|NCT00670111|16861829|P3|Enrollment to One Month|Testing Failure|13
4894014|NCT00670111|16861830|P2|Enrollment to One Month|Testing Failure|0
4894015|NCT00670111|16861831|P1|Enrollment to One Month|Testing Failure|0
4894016|NCT00670046|16861841|P2|Overall Study|Withdrawal by Subject|1
4894017|NCT00670046|16861842|P1|Overall Study|Withdrawal by Subject|0
4894018|NCT00670046|16861841|P2|Overall Study|Lost to Follow-up|1
4894019|NCT00670046|16861842|P1|Overall Study|Lost to Follow-up|1
4894020|NCT00670007|16861856|P1|Overall Study|Withdrawal by Subject|4
4894021|NCT00670007|16861856|P1|Overall Study|Adverse Event|1
4894022|NCT00670007|16861856|P1|Overall Study|Adverse event, serious fatal|1
4894023|NCT00670007|16861856|P1|Overall Study|Travel/Vacation|1
4894024|NCT00670007|16861856|P1|Overall Study|Lung transplant|1
4894025|NCT00670007|16861856|P1|Overall Study|Drug abuse|1
4894026|NCT00669955|16861883|P2|Overall Study|not compliant with study drug/visit|3
4894027|NCT00669955|16861884|P1|Overall Study|not compliant with study drug/visit|2
4894028|NCT00669955|16861883|P2|Overall Study|Investigator Sponsor Judgement|1
4894029|NCT00669955|16861884|P1|Overall Study|Investigator Sponsor Judgement|0
4894030|NCT00669955|16861883|P2|Overall Study|Protocol Violation|7
4894031|NCT00669955|16861884|P1|Overall Study|Protocol Violation|2
4894032|NCT00669955|16861883|P2|Overall Study|Lost to Follow-up|7
4894033|NCT00669955|16861884|P1|Overall Study|Lost to Follow-up|5
4894034|NCT00669955|16861883|P2|Overall Study|Withdrawal by Subject|3
4894035|NCT00669955|16861884|P1|Overall Study|Withdrawal by Subject|2
4894036|NCT00669955|16861883|P2|Overall Study|Death|1
4894037|NCT00669955|16861884|P1|Overall Study|Death|0
4894038|NCT00669955|16861883|P2|Overall Study|Adverse Event|5
4894039|NCT00669955|16861884|P1|Overall Study|Adverse Event|3
4894040|NCT00669942|16861914|P12|Parts 2 and 3|Protocol Violation|0
4894041|NCT00669942|16861915|P11|Parts 2 and 3|Protocol Violation|0
4894042|NCT00669942|16861916|P10|Parts 2 and 3|Protocol Violation|0
4894043|NCT00669942|16861917|P9|Parts 2 and 3|Protocol Violation|0
4894044|NCT00669942|16861918|P8|Parts 2 and 3|Protocol Violation|0
4894045|NCT00669942|16861919|P7|Parts 2 and 3|Protocol Violation|0
4894046|NCT00669942|16861920|P6|Parts 2 and 3|Protocol Violation|1
4894047|NCT00669942|16861921|P5|Parts 2 and 3|Protocol Violation|0
4894048|NCT00669942|16861922|P4|Parts 2 and 3|Protocol Violation|0
4894049|NCT00669942|16861923|P3|Parts 2 and 3|Protocol Violation|0
4894050|NCT00669942|16861924|P2|Parts 2 and 3|Protocol Violation|0
4894051|NCT00669942|16861925|P1|Parts 2 and 3|Protocol Violation|0
4894052|NCT00669942|16861914|P12|Parts 2 and 3|Withdrawal by Subject|0
4894053|NCT00669942|16861915|P11|Parts 2 and 3|Withdrawal by Subject|0
4894054|NCT00669942|16861916|P10|Parts 2 and 3|Withdrawal by Subject|0
4894055|NCT00669942|16861917|P9|Parts 2 and 3|Withdrawal by Subject|2
4894056|NCT00669942|16861918|P8|Parts 2 and 3|Withdrawal by Subject|0
4894057|NCT00669942|16861919|P7|Parts 2 and 3|Withdrawal by Subject|0
4894058|NCT00669942|16861920|P6|Parts 2 and 3|Withdrawal by Subject|1
4894059|NCT00669942|16861921|P5|Parts 2 and 3|Withdrawal by Subject|0
4894060|NCT00669942|16861922|P4|Parts 2 and 3|Withdrawal by Subject|0
4894061|NCT00669942|16861923|P3|Parts 2 and 3|Withdrawal by Subject|0
4894062|NCT00669942|16861924|P2|Parts 2 and 3|Withdrawal by Subject|0
4894063|NCT00669942|16861925|P1|Parts 2 and 3|Withdrawal by Subject|0
4894064|NCT00669942|16861914|P12|Parts 2 and 3|Adverse Event|0
4894065|NCT00669942|16861915|P11|Parts 2 and 3|Adverse Event|0
4894066|NCT00669942|16861916|P10|Parts 2 and 3|Adverse Event|0
4894067|NCT00669942|16861917|P9|Parts 2 and 3|Adverse Event|1
4894068|NCT00669942|16861918|P8|Parts 2 and 3|Adverse Event|2
4894069|NCT00669942|16861919|P7|Parts 2 and 3|Adverse Event|0
4894070|NCT00669942|16861920|P6|Parts 2 and 3|Adverse Event|0
4894071|NCT00669942|16861921|P5|Parts 2 and 3|Adverse Event|0
4894072|NCT00669942|16861922|P4|Parts 2 and 3|Adverse Event|0
4894073|NCT00669942|16861923|P3|Parts 2 and 3|Adverse Event|0
4894074|NCT00669942|16861924|P2|Parts 2 and 3|Adverse Event|0
4894075|NCT00669942|16861925|P1|Parts 2 and 3|Adverse Event|0
4894076|NCT00669903|16862008|P4|Overall Study|Protocol Violation|0
4894077|NCT00669903|16862009|P3|Overall Study|Protocol Violation|0
4894078|NCT00669903|16862010|P2|Overall Study|Protocol Violation|1
4894079|NCT00669903|16862011|P1|Overall Study|Protocol Violation|0
4894080|NCT00669903|16862008|P4|Overall Study|Lost to Follow-up|1
4894081|NCT00669903|16862009|P3|Overall Study|Lost to Follow-up|0
4894082|NCT00669903|16862010|P2|Overall Study|Lost to Follow-up|1
4894083|NCT00669903|16862011|P1|Overall Study|Lost to Follow-up|1
4894084|NCT00669903|16862008|P4|Overall Study|Withdrawal by Subject|2
4894085|NCT00669903|16862009|P3|Overall Study|Withdrawal by Subject|2
4894086|NCT00669903|16862010|P2|Overall Study|Withdrawal by Subject|2
4894087|NCT00669903|16862011|P1|Overall Study|Withdrawal by Subject|0
4894088|NCT00669903|16862008|P4|Overall Study|Adverse Event|1
4894089|NCT00669903|16862009|P3|Overall Study|Adverse Event|3
4894090|NCT00669903|16862010|P2|Overall Study|Adverse Event|1
4894091|NCT00669903|16862011|P1|Overall Study|Adverse Event|0
4894092|NCT00669877|16862041|P1|Overall Study|Disease Progression/Death|4
4894093|NCT00669864|16862046|P1|Overall Study|Other|2
4894094|NCT00669864|16862046|P1|Overall Study|Withdrawal by Subject|3
4894095|NCT00669864|16862046|P1|Overall Study|Protocol Violation|2
4894096|NCT00669864|16862046|P1|Overall Study|Lost to Follow-up|2
4894097|NCT00669669|16862060|P1|Overall Study|To late to start treatment|1
4894098|NCT00669617|16862065|P5|Period 3|Lost to Follow-up|0
4894099|NCT00669617|16862066|P4|Period 3|Lost to Follow-up|0
4894100|NCT00669617|16862067|P3|Period 3|Lost to Follow-up|0
4894101|NCT00669617|16862068|P2|Period 3|Lost to Follow-up|0
4894102|NCT00669617|16862069|P1|Period 3|Lost to Follow-up|1
4894103|NCT00669617|16862065|P5|Period 1|Protocol Deviation|1
4894104|NCT00669617|16862066|P4|Period 1|Protocol Deviation|0
4894105|NCT00669617|16862067|P3|Period 1|Protocol Deviation|0
4894106|NCT00669617|16862068|P2|Period 1|Protocol Deviation|0
4894107|NCT00669617|16862069|P1|Period 1|Protocol Deviation|0
4894108|NCT00669617|16862065|P5|Period 1|Withdrawal by Subject|0
4894109|NCT00669617|16862066|P4|Period 1|Withdrawal by Subject|0
4894110|NCT00669617|16862067|P3|Period 1|Withdrawal by Subject|1
4894111|NCT00669617|16862068|P2|Period 1|Withdrawal by Subject|0
4894112|NCT00669617|16862069|P1|Period 1|Withdrawal by Subject|0
4894113|NCT00669396|16862117|P2|Overall Study|Lost to Follow-up|12
4894114|NCT00669396|16862118|P1|Overall Study|Lost to Follow-up|10
4894115|NCT00669331|16862145|P2|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
4894116|NCT00669331|16862146|P1|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2
4894117|NCT00669331|16862145|P2|Blinded Treatment Period|Physician Decision|3
4894118|NCT00669331|16862146|P1|Blinded Treatment Period|Physician Decision|3
4894119|NCT00669331|16862145|P2|Blinded Treatment Period|Death|2
4894120|NCT00669331|16862146|P1|Blinded Treatment Period|Death|0
4894121|NCT00669331|16862145|P2|Blinded Treatment Period|Lost to Follow-up|2
4894122|NCT00669331|16862146|P1|Blinded Treatment Period|Lost to Follow-up|3
4894123|NCT00669331|16862145|P2|Blinded Treatment Period|Withdrawal by Subject|19
4894124|NCT00669331|16862146|P1|Blinded Treatment Period|Withdrawal by Subject|17
4894125|NCT00669331|16862145|P2|Blinded Treatment Period|Protocol Violation|1
4894126|NCT00669331|16862146|P1|Blinded Treatment Period|Protocol Violation|1
4894127|NCT00669331|16862145|P2|Blinded Treatment Period|Adverse Event|10
4894128|NCT00669331|16862146|P1|Blinded Treatment Period|Adverse Event|16
4894129|NCT00669331|16862145|P2|Randomisation to First Dose|Randomised in error|10
4894130|NCT00669331|16862146|P1|Randomisation to First Dose|Randomised in error|3
4894131|NCT00669331|16862145|P2|Randomisation to First Dose|Sponsor decision|1
4894132|NCT00669331|16862146|P1|Randomisation to First Dose|Sponsor decision|0
4894133|NCT00669331|16862145|P2|Randomisation to First Dose|Death|0
4894134|NCT00669331|16862146|P1|Randomisation to First Dose|Death|1
4894135|NCT00669331|16862145|P2|Randomisation to First Dose|Lost to Follow-up|0
4894136|NCT00669331|16862146|P1|Randomisation to First Dose|Lost to Follow-up|2
4894137|NCT00669331|16862145|P2|Randomisation to First Dose|Withdrawal by Subject|2
4894138|NCT00669331|16862146|P1|Randomisation to First Dose|Withdrawal by Subject|3
4894139|NCT00669331|16862145|P2|Randomisation to First Dose|Protocol Violation|0
4894140|NCT00669331|16862146|P1|Randomisation to First Dose|Protocol Violation|1
4894141|NCT00669331|16862145|P2|Randomisation to First Dose|Adverse Event|0
4894142|NCT00669331|16862146|P1|Randomisation to First Dose|Adverse Event|1
4894143|NCT00669318|16862188|P1|Overall Study|Withdrawal by Subject|2
4894144|NCT00669240|16862205|P1|Overall Study|Enrolled but no dosing record|1
4894145|NCT00669240|16862205|P1|Overall Study|Enrolled but not treated|15
4894146|NCT00669240|16862205|P1|Overall Study|Other|19
4894147|NCT00669240|16862205|P1|Overall Study|Adverse Event|21
4894148|NCT00669240|16862205|P1|Overall Study|Lost to Follow-up|34
4894149|NCT00669240|16862205|P1|Overall Study|Withdrawal by Subject|42
4894150|NCT00669240|16862205|P1|Overall Study|Lack of Efficacy|33
4894151|NCT00669162|16862254|P1|Overall Study|Withdrawal by Subject|1
4894152|NCT00669110|16862260|P2|Overall Study|Withdrawal by Subject|2
4894153|NCT00669110|16862261|P1|Overall Study|Withdrawal by Subject|0
4894154|NCT00669110|16862260|P2|Overall Study|Protocol Violation|5
4894155|NCT00669110|16862261|P1|Overall Study|Protocol Violation|0
4894156|NCT00669110|16862260|P2|Overall Study|Lost to Follow-up|0
4894157|NCT00669110|16862261|P1|Overall Study|Lost to Follow-up|1
4894158|NCT00669110|16862260|P2|Overall Study|Physician Decision|1
4894159|NCT00669110|16862261|P1|Overall Study|Physician Decision|0
4894160|NCT00669110|16862260|P2|Overall Study|Caregiver request|2
4894161|NCT00669110|16862261|P1|Overall Study|Caregiver request|3
4894162|NCT00669110|16862260|P2|Overall Study|Adverse Event|3
4894163|NCT00669110|16862261|P1|Overall Study|Adverse Event|4
4894164|NCT00669071|16862297|P1|Overall Study|Final visit 40 days out of window|1
4894165|NCT00669071|16862297|P1|Overall Study|Lost to Follow-up|3
4894166|NCT00669032|16862318|P2|Overall Study|No fulfilment of the selection criteria|5
4894167|NCT00669032|16862319|P1|Overall Study|No fulfilment of the selection criteria|5
4894168|NCT00669032|16862318|P2|Overall Study|Physician Decision|1
4894169|NCT00669032|16862319|P1|Overall Study|Physician Decision|1
4894170|NCT00669032|16862318|P2|Overall Study|Adverse Event|16
4894171|NCT00669032|16862319|P1|Overall Study|Adverse Event|12
4894172|NCT00669032|16862318|P2|Overall Study|Withdrawal by Subject|13
4894173|NCT00669032|16862319|P1|Overall Study|Withdrawal by Subject|12
4894174|NCT00669032|16862318|P2|Overall Study|Lack of Efficacy|19
4894175|NCT00669032|16862319|P1|Overall Study|Lack of Efficacy|8
4894176|NCT00669032|16862318|P2|Overall Study|Lost to Follow-up|5
4894177|NCT00669032|16862319|P1|Overall Study|Lost to Follow-up|6
4894178|NCT00668863|16862365|P1|Overall Study|Physician Decision|1
4894179|NCT00668863|16862365|P1|Overall Study|Subject's work scheduling problem|1
4894180|NCT00668863|16862365|P1|Overall Study|Surgery|1
4894181|NCT00668863|16862365|P1|Overall Study|Withdrawal by Subject|1
4894182|NCT00668863|16862365|P1|Overall Study|Global Deterioration of Health Status|4
4894183|NCT00668863|16862365|P1|Overall Study|Study Terminated by Sponsor|8
4894184|NCT00668863|16862365|P1|Overall Study|Adverse Event|13
4894185|NCT00668863|16862365|P1|Overall Study|Objective Progression or Relapse|42
4894186|NCT00668746|16862397|P2|Overall Study|Lost to Follow-up|1
4894187|NCT00668746|16862398|P1|Overall Study|Lost to Follow-up|2
4894188|NCT00668733|16862418|P2|Overall Study|Withdrawal by Subject|4
4894189|NCT00668733|16862419|P1|Overall Study|Withdrawal by Subject|0
4894190|NCT00668733|16862418|P2|Overall Study|Lost to Follow-up|3
4894191|NCT00668733|16862419|P1|Overall Study|Lost to Follow-up|2
4894192|NCT00668395|16862464|P3|Overall Study|Physician Decision|0
4894193|NCT00668395|16862465|P2|Overall Study|Physician Decision|1
4894194|NCT00668395|16862466|P1|Overall Study|Physician Decision|1
4894195|NCT00668395|16862464|P3|Overall Study|Adverse Event|0
4894196|NCT00668395|16862465|P2|Overall Study|Adverse Event|1
4894197|NCT00668395|16862466|P1|Overall Study|Adverse Event|1
4894198|NCT00668395|16862464|P3|Overall Study|Withdrawal by Subject|1
4894199|NCT00668395|16862465|P2|Overall Study|Withdrawal by Subject|4
4894200|NCT00668395|16862466|P1|Overall Study|Withdrawal by Subject|4
4894201|NCT00668317|16862478|P1|Overall Study|Adverse Event|2
4894202|NCT00668200|16862493|P1|Overall Study|Lost to Follow-up|1
4894203|NCT00668200|16862493|P1|Overall Study|Withdrawal by Subject|2
4894204|NCT00668148|16862499|P1|Overall Study|Withdrawal of Consent|2
4894205|NCT00668148|16862499|P1|Overall Study|Progressive Disease Before Treatment|2
4894206|NCT00668148|16862499|P1|Overall Study|Subject Non-compliance|1
4894207|NCT00668148|16862499|P1|Overall Study|Adverse Event|5
4894208|NCT00667992|16862538|P2|Third Intervention 100 Mcg Twice Daily|Adverse Event|1
4894209|NCT00667992|16862539|P1|Third Intervention 100 Mcg Twice Daily|Adverse Event|0
4894210|NCT00667992|16862538|P2|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
4894211|NCT00667992|16862539|P1|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1
4894212|NCT00667992|16862538|P2|Wash-out|Withdrawal by Subject|0
4894213|NCT00667992|16862539|P1|Wash-out|Withdrawal by Subject|1
4894214|NCT00667992|16862538|P2|Wash-out|Failure to wash-out|2
4894215|NCT00667992|16862539|P1|Wash-out|Failure to wash-out|2
4894216|NCT00667992|16862538|P2|Wash-out|Not within one doubling dilution|3
4894217|NCT00667992|16862539|P1|Wash-out|Not within one doubling dilution|4
4894218|NCT00667992|16862538|P2|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1
4894219|NCT00667992|16862539|P1|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0
4894220|NCT00667992|16862538|P2|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3
4894221|NCT00667992|16862539|P1|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2
4894222|NCT00667992|16862538|P2|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0
4894223|NCT00667992|16862539|P1|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1
4894224|NCT00667992|16862538|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
4894225|NCT00667992|16862539|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
4894226|NCT00667992|16862538|P2|First Intervention 100 Mcg Twice Daily|Pregnancy|0
4894227|NCT00667992|16862539|P1|First Intervention 100 Mcg Twice Daily|Pregnancy|1
4894228|NCT00667992|16862538|P2|First Intervention 100 Mcg Twice Daily|Adverse Event|1
4894229|NCT00667992|16862539|P1|First Intervention 100 Mcg Twice Daily|Adverse Event|0
4894230|NCT00667992|16862538|P2|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0
4894231|NCT00667992|16862539|P1|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2
4894232|NCT00667992|16862538|P2|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3
4894233|NCT00667992|16862539|P1|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2
4894234|NCT00667875|16862596|P3|Overall Study|Withdrawal by Subject|7
4894235|NCT00667875|16862597|P2|Overall Study|Withdrawal by Subject|9
4894236|NCT00667875|16862598|P1|Overall Study|Withdrawal by Subject|10
4894237|NCT00667875|16862596|P3|Overall Study|Adverse Event|6
4894238|NCT00667875|16862597|P2|Overall Study|Adverse Event|2
4894239|NCT00667875|16862598|P1|Overall Study|Adverse Event|0
4894240|NCT00667810|16862632|P4|Overall Study|Other|0
4894241|NCT00667810|16862633|P3|Overall Study|Other|5
4894242|NCT00667810|16862634|P2|Overall Study|Other|6
4894243|NCT00667810|16862635|P1|Overall Study|Other|6
4894244|NCT00667810|16862632|P4|Overall Study|Vasogenic Edema Recurrence|0
4894245|NCT00667810|16862633|P3|Overall Study|Vasogenic Edema Recurrence|0
4894246|NCT00667810|16862634|P2|Overall Study|Vasogenic Edema Recurrence|3
4894247|NCT00667810|16862635|P1|Overall Study|Vasogenic Edema Recurrence|0
4894248|NCT00667810|16862632|P4|Overall Study|Loss of Caregiver|0
4894249|NCT00667810|16862633|P3|Overall Study|Loss of Caregiver|3
4894250|NCT00667810|16862634|P2|Overall Study|Loss of Caregiver|1
4894251|NCT00667810|16862635|P1|Overall Study|Loss of Caregiver|0
4894252|NCT00667810|16862632|P4|Overall Study|Failed to Return|0
4894253|NCT00667810|16862633|P3|Overall Study|Failed to Return|2
4894254|NCT00667810|16862634|P2|Overall Study|Failed to Return|0
4894255|NCT00667810|16862635|P1|Overall Study|Failed to Return|0
4894256|NCT00667810|16862632|P4|Overall Study|Discontinuation of Study by Sponsor|0
4894257|NCT00667810|16862633|P3|Overall Study|Discontinuation of Study by Sponsor|155
4894258|NCT00667810|16862634|P2|Overall Study|Discontinuation of Study by Sponsor|118
4894259|NCT00667810|16862635|P1|Overall Study|Discontinuation of Study by Sponsor|130
4894260|NCT00667810|16862632|P4|Overall Study|Withdrawal by Subject|1
4894261|NCT00667810|16862633|P3|Overall Study|Withdrawal by Subject|29
4894262|NCT00667810|16862634|P2|Overall Study|Withdrawal by Subject|20
4894263|NCT00667810|16862635|P1|Overall Study|Withdrawal by Subject|14
4894264|NCT00667810|16862632|P4|Overall Study|Protocol Violation|0
4894265|NCT00667810|16862633|P3|Overall Study|Protocol Violation|0
4894266|NCT00667810|16862634|P2|Overall Study|Protocol Violation|2
4894267|NCT00667810|16862635|P1|Overall Study|Protocol Violation|0
4894268|NCT00667810|16862632|P4|Overall Study|Physician Decision|0
4894269|NCT00667810|16862633|P3|Overall Study|Physician Decision|2
4894270|NCT00667810|16862634|P2|Overall Study|Physician Decision|1
4894271|NCT00667810|16862635|P1|Overall Study|Physician Decision|1
4894272|NCT00667810|16862632|P4|Overall Study|Lost to Follow-up|0
4894273|NCT00667810|16862633|P3|Overall Study|Lost to Follow-up|2
4894274|NCT00667810|16862634|P2|Overall Study|Lost to Follow-up|4
4894275|NCT00667810|16862635|P1|Overall Study|Lost to Follow-up|1
4894276|NCT00667810|16862632|P4|Overall Study|Lack of Efficacy|0
4894277|NCT00667810|16862633|P3|Overall Study|Lack of Efficacy|2
4894278|NCT00667810|16862634|P2|Overall Study|Lack of Efficacy|0
4894279|NCT00667810|16862635|P1|Overall Study|Lack of Efficacy|1
4894280|NCT00667810|16862632|P4|Overall Study|Death|0
4894281|NCT00667810|16862633|P3|Overall Study|Death|3
4894282|NCT00667810|16862634|P2|Overall Study|Death|1
4894283|NCT00667810|16862635|P1|Overall Study|Death|1
4894284|NCT00667810|16862632|P4|Overall Study|Adverse Event|1
4894285|NCT00667810|16862633|P3|Overall Study|Adverse Event|19
4894286|NCT00667810|16862634|P2|Overall Study|Adverse Event|14
4894287|NCT00667810|16862635|P1|Overall Study|Adverse Event|13
4894288|NCT00667732|16862711|P3|Randomization (24 Weeks)|Withdrawal by Subject|0
4894289|NCT00667732|16862712|P2|Randomization (24 Weeks)|Withdrawal by Subject|1
4894290|NCT00667732|16862713|P1|Randomization (24 Weeks)|Withdrawal by Subject|0
4894291|NCT00667732|16862711|P3|Run -In (8 Weeks)|Withdrawal by Subject|0
4894292|NCT00667732|16862712|P2|Run -In (8 Weeks)|Withdrawal by Subject|0
4894293|NCT00667732|16862713|P1|Run -In (8 Weeks)|Withdrawal by Subject|3
4894294|NCT00667732|16862711|P3|Run -In (8 Weeks)|Adverse Event|0
4894295|NCT00667732|16862712|P2|Run -In (8 Weeks)|Adverse Event|0
4894296|NCT00667732|16862713|P1|Run -In (8 Weeks)|Adverse Event|4
4894297|NCT00667602|16862749|P3|Overall Study|Protocol Violation|0
4894298|NCT00667602|16862750|P2|Overall Study|Protocol Violation|1
4894299|NCT00667602|16862751|P1|Overall Study|Protocol Violation|0
4894300|NCT00667602|16862749|P3|Overall Study|Administrative reason|2
4894301|NCT00667602|16862750|P2|Overall Study|Administrative reason|0
4894302|NCT00667602|16862751|P1|Overall Study|Administrative reason|0
4894303|NCT00667602|16862749|P3|Overall Study|Lost to Follow-up|6
4894304|NCT00667602|16862750|P2|Overall Study|Lost to Follow-up|5
4894305|NCT00667602|16862751|P1|Overall Study|Lost to Follow-up|4
4894306|NCT00667602|16862749|P3|Overall Study|Withdrawal by Subject|10
4894307|NCT00667602|16862750|P2|Overall Study|Withdrawal by Subject|9
4894308|NCT00667602|16862751|P1|Overall Study|Withdrawal by Subject|4
4894309|NCT00667576|16862819|P5|Overall Study|Missed Visit|0
4894310|NCT00667576|16862820|P4|Overall Study|Missed Visit|1
4894311|NCT00667576|16862821|P3|Overall Study|Missed Visit|0
4894312|NCT00667576|16862822|P2|Overall Study|Missed Visit|0
4894313|NCT00667576|16862823|P1|Overall Study|Missed Visit|0
4894314|NCT00667576|16862819|P5|Overall Study|Physician Decision|0
4894315|NCT00667576|16862820|P4|Overall Study|Physician Decision|1
4894316|NCT00667576|16862821|P3|Overall Study|Physician Decision|0
4894317|NCT00667576|16862822|P2|Overall Study|Physician Decision|0
4894318|NCT00667576|16862823|P1|Overall Study|Physician Decision|0
4894319|NCT00667576|16862819|P5|Overall Study|Protocol Violation|0
4894320|NCT00667576|16862820|P4|Overall Study|Protocol Violation|1
4894321|NCT00667576|16862821|P3|Overall Study|Protocol Violation|0
4894322|NCT00667576|16862822|P2|Overall Study|Protocol Violation|0
4894323|NCT00667576|16862823|P1|Overall Study|Protocol Violation|0
4894324|NCT00667576|16862819|P5|Overall Study|Lost to Follow-up|0
4894325|NCT00667576|16862820|P4|Overall Study|Lost to Follow-up|0
4894326|NCT00667576|16862821|P3|Overall Study|Lost to Follow-up|1
4894327|NCT00667576|16862822|P2|Overall Study|Lost to Follow-up|0
4894328|NCT00667576|16862823|P1|Overall Study|Lost to Follow-up|0
4894329|NCT00667576|16862819|P5|Overall Study|Adverse Event|0
4894330|NCT00667576|16862820|P4|Overall Study|Adverse Event|0
4894331|NCT00667576|16862821|P3|Overall Study|Adverse Event|0
4894332|NCT00667576|16862822|P2|Overall Study|Adverse Event|1
4894333|NCT00667576|16862823|P1|Overall Study|Adverse Event|1
4894334|NCT00667576|16862819|P5|Overall Study|Withdrawal by Subject|1
4894335|NCT00667576|16862820|P4|Overall Study|Withdrawal by Subject|1
4894336|NCT00667576|16862821|P3|Overall Study|Withdrawal by Subject|1
4894337|NCT00667576|16862822|P2|Overall Study|Withdrawal by Subject|0
4894338|NCT00667576|16862823|P1|Overall Study|Withdrawal by Subject|1
4894339|NCT00667563|16862870|P1|Overall Study|Protocol Violation|24
4894340|NCT00667459|16862890|P2|Overall Study|Lost to Follow-up|43
4894341|NCT00667459|16862891|P1|Overall Study|Lost to Follow-up|8
4894342|NCT00667459|16862890|P2|Overall Study|Death|2
4894343|NCT00667459|16862891|P1|Overall Study|Death|0
4894344|NCT00667446|16862933|P2|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1
4894345|NCT00667446|16862934|P1|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0
4894346|NCT00667446|16862933|P2|Treatment Period (36 Months)|Therapeutic Failure|1
4894347|NCT00667446|16862934|P1|Treatment Period (36 Months)|Therapeutic Failure|1
4894348|NCT00667446|16862933|P2|Treatment Period (36 Months)|Protocol Violation|1
4894349|NCT00667446|16862934|P1|Treatment Period (36 Months)|Protocol Violation|1
4894350|NCT00667446|16862933|P2|Treatment Period (36 Months)|Lost to Follow-up|0
4894351|NCT00667446|16862934|P1|Treatment Period (36 Months)|Lost to Follow-up|1
4894352|NCT00667446|16862933|P2|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0
4894353|NCT00667446|16862934|P1|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3
4894354|NCT00667446|16862933|P2|Treatment Period (36 Months)|Withdrawal by Subject|4
4894355|NCT00667446|16862934|P1|Treatment Period (36 Months)|Withdrawal by Subject|0
4894356|NCT00667446|16862933|P2|Treatment Period (36 Months)|Personal reasons|2
4894357|NCT00667446|16862934|P1|Treatment Period (36 Months)|Personal reasons|2
4894358|NCT00667446|16862933|P2|Treatment Period (36 Months)|Other|2
4894359|NCT00667446|16862934|P1|Treatment Period (36 Months)|Other|2
4894360|NCT00667446|16862933|P2|Treatment Period (36 Months)|Ready to enter puberty based on age|15
4894361|NCT00667446|16862934|P1|Treatment Period (36 Months)|Ready to enter puberty based on age|13
4894362|NCT00667420|16862956|P1|Overall Study|Withdrawal by Subject|2
4894363|NCT00667420|16862956|P1|Overall Study|Physician Decision|1
4894364|NCT00667420|16862956|P1|Overall Study|Lack of Efficacy|5
4894365|NCT00667420|16862956|P1|Overall Study|Adverse Event|2
4894366|NCT00667394|16862966|P2|Overall Study|Progressive disease|0
4894367|NCT00667394|16862967|P1|Overall Study|Progressive disease|1
4894368|NCT00667394|16862966|P2|Overall Study|Adverse Event|0
4894369|NCT00667394|16862967|P1|Overall Study|Adverse Event|3
4894370|NCT00667368|16862994|P2|Overall Study|Discontinued early|17
4894371|NCT00667368|16862995|P1|Overall Study|Discontinued early|24
4894372|NCT00667368|16862994|P2|Overall Study|Lost to Follow-up|155
4894373|NCT00667368|16862995|P1|Overall Study|Lost to Follow-up|176
4894374|NCT00667355|16863003|P1|Overall Study|Other reason was not specified|5
4894375|NCT00667355|16863003|P1|Overall Study|Lost to Follow-up|1
4894376|NCT00667355|16863003|P1|Overall Study|Adverse Event|5
4894377|NCT00667342|16863028|P3|Overall Study|Ineligible|1
4894378|NCT00667342|16863029|P2|Overall Study|Ineligible|0
4894379|NCT00667342|16863030|P1|Overall Study|Ineligible|0
4894380|NCT00667342|16863028|P3|Overall Study|Adverse Event|1
4894381|NCT00667342|16863029|P2|Overall Study|Adverse Event|0
4894382|NCT00667342|16863030|P1|Overall Study|Adverse Event|0
4894383|NCT00667342|16863028|P3|Overall Study|Relapse or tumor progression|7
4894384|NCT00667342|16863029|P2|Overall Study|Relapse or tumor progression|0
4894385|NCT00667342|16863030|P1|Overall Study|Relapse or tumor progression|9
4894386|NCT00667342|16863028|P3|Overall Study|Physician Decision|0
4894387|NCT00667342|16863029|P2|Overall Study|Physician Decision|0
4894388|NCT00667342|16863030|P1|Overall Study|Physician Decision|3
4894389|NCT00667342|16863028|P3|Overall Study|Withdrawal by Subject|0
4894390|NCT00667342|16863029|P2|Overall Study|Withdrawal by Subject|0
4894391|NCT00667342|16863030|P1|Overall Study|Withdrawal by Subject|1
4894392|NCT00667342|16863028|P3|Overall Study|Protocol Violation|0
4894393|NCT00667342|16863029|P2|Overall Study|Protocol Violation|0
4894394|NCT00667342|16863030|P1|Overall Study|Protocol Violation|1
4894395|NCT00667277|16863068|P1|Overall Study|Withdrawal by Subject|2
4894396|NCT00667251|16863075|P2|Overall Study|Symptomatic progression|2
4894397|NCT00667251|16863076|P1|Overall Study|Symptomatic progression|1
4894398|NCT00667251|16863075|P2|Overall Study|Intercurrent Illness|3
4894399|NCT00667251|16863076|P1|Overall Study|Intercurrent Illness|4
4894400|NCT00667251|16863075|P2|Overall Study|Other/missing|84
4894401|NCT00667251|16863076|P1|Overall Study|Other/missing|46
4894402|NCT00667251|16863075|P2|Overall Study|Withdrawal by Subject|2
4894403|NCT00667251|16863076|P1|Overall Study|Withdrawal by Subject|6
4894404|NCT00667251|16863075|P2|Overall Study|Adverse Event|4
4894405|NCT00667251|16863076|P1|Overall Study|Adverse Event|13
4894406|NCT00667225|16863102|P2|Overall Study|Lost to Follow-up|1
4894407|NCT00667225|16863103|P1|Overall Study|Lost to Follow-up|0
4894408|NCT00667225|16863102|P2|Overall Study|Subject had no more lesions to treat.|0
4894409|NCT00667225|16863103|P1|Overall Study|Subject had no more lesions to treat.|1
4894410|NCT00667095|16863124|P2|Overall Study|Withdrawal by Subject|1
4894411|NCT00667095|16863125|P1|Overall Study|Withdrawal by Subject|0
4894412|NCT00667017|16863141|P1|Overall Study|Withdrawal by Subject|1
4894413|NCT00666965|16863170|P4|Overall Study|Withdrawal by Subject|2
4894414|NCT00666965|16863171|P3|Overall Study|Withdrawal by Subject|0
4894415|NCT00666965|16863172|P2|Overall Study|Withdrawal by Subject|0
4894416|NCT00666965|16863173|P1|Overall Study|Withdrawal by Subject|0
4894417|NCT00666965|16863170|P4|Overall Study|Discontinuation criteria|2
4894418|NCT00666965|16863171|P3|Overall Study|Discontinuation criteria|1
4894419|NCT00666965|16863172|P2|Overall Study|Discontinuation criteria|1
4894420|NCT00666965|16863173|P1|Overall Study|Discontinuation criteria|2
4894421|NCT00666965|16863170|P4|Overall Study|Protocol Violation|2
4894422|NCT00666965|16863171|P3|Overall Study|Protocol Violation|0
4894423|NCT00666965|16863172|P2|Overall Study|Protocol Violation|0
4894424|NCT00666965|16863173|P1|Overall Study|Protocol Violation|0
4894425|NCT00666965|16863170|P4|Overall Study|Lack of Efficacy|0
4894426|NCT00666965|16863171|P3|Overall Study|Lack of Efficacy|0
4894427|NCT00666965|16863172|P2|Overall Study|Lack of Efficacy|1
4894428|NCT00666965|16863173|P1|Overall Study|Lack of Efficacy|1
4894429|NCT00666965|16863170|P4|Overall Study|Adverse Event|9
4894430|NCT00666965|16863171|P3|Overall Study|Adverse Event|1
4894431|NCT00666965|16863172|P2|Overall Study|Adverse Event|2
4894432|NCT00666965|16863173|P1|Overall Study|Adverse Event|0
4894433|NCT00666926|16863203|P16|Overall Study|Death|0
4894434|NCT00666926|16863204|P15|Overall Study|Death|0
4894435|NCT00666926|16863205|P14|Overall Study|Death|0
4894436|NCT00666926|16863206|P13|Overall Study|Death|0
4894437|NCT00666926|16863207|P12|Overall Study|Death|1
4894438|NCT00666926|16863208|P11|Overall Study|Death|0
4894439|NCT00666926|16863209|P10|Overall Study|Death|0
4894440|NCT00666926|16863210|P9|Overall Study|Death|0
4894441|NCT00666926|16863211|P8|Overall Study|Death|0
4894442|NCT00666926|16863212|P7|Overall Study|Death|0
4894443|NCT00666926|16863213|P6|Overall Study|Death|0
4894444|NCT00666926|16863214|P5|Overall Study|Death|0
4894445|NCT00666926|16863215|P4|Overall Study|Death|0
4894446|NCT00666926|16863216|P3|Overall Study|Death|0
4894447|NCT00666926|16863217|P2|Overall Study|Death|0
4894448|NCT00666926|16863218|P1|Overall Study|Death|0
4894449|NCT00666926|16863203|P16|Overall Study|Withdrawal by Subject|3
4894450|NCT00666926|16863204|P15|Overall Study|Withdrawal by Subject|3
4894451|NCT00666926|16863205|P14|Overall Study|Withdrawal by Subject|1
4894452|NCT00666926|16863206|P13|Overall Study|Withdrawal by Subject|0
4894453|NCT00666926|16863207|P12|Overall Study|Withdrawal by Subject|3
4894454|NCT00666926|16863208|P11|Overall Study|Withdrawal by Subject|0
4894455|NCT00666926|16863209|P10|Overall Study|Withdrawal by Subject|3
4894456|NCT00666926|16863210|P9|Overall Study|Withdrawal by Subject|0
4894457|NCT00666926|16863211|P8|Overall Study|Withdrawal by Subject|1
4894458|NCT00666926|16863212|P7|Overall Study|Withdrawal by Subject|0
4894459|NCT00666926|16863213|P6|Overall Study|Withdrawal by Subject|0
4894460|NCT00666926|16863214|P5|Overall Study|Withdrawal by Subject|0
4894461|NCT00666926|16863215|P4|Overall Study|Withdrawal by Subject|0
4894462|NCT00666926|16863216|P3|Overall Study|Withdrawal by Subject|0
4894463|NCT00666926|16863217|P2|Overall Study|Withdrawal by Subject|0
4894464|NCT00666926|16863218|P1|Overall Study|Withdrawal by Subject|0
4894465|NCT00666926|16863203|P16|Overall Study|Other|4
4894466|NCT00666926|16863204|P15|Overall Study|Other|4
4894467|NCT00666926|16863205|P14|Overall Study|Other|2
4894468|NCT00666926|16863206|P13|Overall Study|Other|3
4894469|NCT00666926|16863207|P12|Overall Study|Other|26
4894470|NCT00666926|16863208|P11|Overall Study|Other|3
4894471|NCT00666926|16863209|P10|Overall Study|Other|5
4894472|NCT00666926|16863210|P9|Overall Study|Other|3
4894473|NCT00666926|16863211|P8|Overall Study|Other|0
4894474|NCT00666926|16863212|P7|Overall Study|Other|4
4894475|NCT00666926|16863213|P6|Overall Study|Other|3
4894476|NCT00666926|16863214|P5|Overall Study|Other|3
4894477|NCT00666926|16863215|P4|Overall Study|Other|3
4894478|NCT00666926|16863216|P3|Overall Study|Other|3
4894479|NCT00666926|16863217|P2|Overall Study|Other|4
4894480|NCT00666926|16863218|P1|Overall Study|Other|2
4894481|NCT00666926|16863203|P16|Overall Study|Lost to Follow-up|0
4894482|NCT00666926|16863204|P15|Overall Study|Lost to Follow-up|0
4894483|NCT00666926|16863205|P14|Overall Study|Lost to Follow-up|0
4894484|NCT00666926|16863206|P13|Overall Study|Lost to Follow-up|0
4894485|NCT00666926|16863207|P12|Overall Study|Lost to Follow-up|0
4894486|NCT00666926|16863208|P11|Overall Study|Lost to Follow-up|0
4894487|NCT00666926|16863209|P10|Overall Study|Lost to Follow-up|0
4894488|NCT00666926|16863210|P9|Overall Study|Lost to Follow-up|0
4894489|NCT00666926|16863211|P8|Overall Study|Lost to Follow-up|0
4894490|NCT00666926|16863212|P7|Overall Study|Lost to Follow-up|0
4894491|NCT00666926|16863213|P6|Overall Study|Lost to Follow-up|0
4894492|NCT00666926|16863214|P5|Overall Study|Lost to Follow-up|0
4894493|NCT00666926|16863215|P4|Overall Study|Lost to Follow-up|1
4894494|NCT00666926|16863216|P3|Overall Study|Lost to Follow-up|0
4894495|NCT00666926|16863217|P2|Overall Study|Lost to Follow-up|0
4894496|NCT00666926|16863218|P1|Overall Study|Lost to Follow-up|0
4894497|NCT00666926|16863203|P16|Overall Study|Lack of Efficacy|0
4894498|NCT00666926|16863204|P15|Overall Study|Lack of Efficacy|0
4894499|NCT00666926|16863205|P14|Overall Study|Lack of Efficacy|0
4894500|NCT00666926|16863206|P13|Overall Study|Lack of Efficacy|0
4894501|NCT00666926|16863207|P12|Overall Study|Lack of Efficacy|1
4894502|NCT00666926|16863208|P11|Overall Study|Lack of Efficacy|0
4894503|NCT00666926|16863209|P10|Overall Study|Lack of Efficacy|0
4894504|NCT00666926|16863210|P9|Overall Study|Lack of Efficacy|0
4894505|NCT00666926|16863211|P8|Overall Study|Lack of Efficacy|0
4894506|NCT00666926|16863212|P7|Overall Study|Lack of Efficacy|0
4894507|NCT00666926|16863213|P6|Overall Study|Lack of Efficacy|1
4894508|NCT00666926|16863214|P5|Overall Study|Lack of Efficacy|0
4894509|NCT00666926|16863215|P4|Overall Study|Lack of Efficacy|0
4894510|NCT00666926|16863216|P3|Overall Study|Lack of Efficacy|0
4894511|NCT00666926|16863217|P2|Overall Study|Lack of Efficacy|0
4894512|NCT00666926|16863218|P1|Overall Study|Lack of Efficacy|0
4894513|NCT00666926|16863203|P16|Overall Study|Laboratory abnormality|1
4894514|NCT00666926|16863204|P15|Overall Study|Laboratory abnormality|0
4894515|NCT00666926|16863205|P14|Overall Study|Laboratory abnormality|0
4894516|NCT00666926|16863206|P13|Overall Study|Laboratory abnormality|0
4894517|NCT00666926|16863207|P12|Overall Study|Laboratory abnormality|0
4894518|NCT00666926|16863208|P11|Overall Study|Laboratory abnormality|1
4894519|NCT00666926|16863209|P10|Overall Study|Laboratory abnormality|0
4894520|NCT00666926|16863210|P9|Overall Study|Laboratory abnormality|0
4894521|NCT00666926|16863211|P8|Overall Study|Laboratory abnormality|0
4894522|NCT00666926|16863212|P7|Overall Study|Laboratory abnormality|0
4894523|NCT00666926|16863213|P6|Overall Study|Laboratory abnormality|0
4894524|NCT00666926|16863214|P5|Overall Study|Laboratory abnormality|0
4894525|NCT00666926|16863215|P4|Overall Study|Laboratory abnormality|0
4894526|NCT00666926|16863216|P3|Overall Study|Laboratory abnormality|0
4894527|NCT00666926|16863217|P2|Overall Study|Laboratory abnormality|0
4894528|NCT00666926|16863218|P1|Overall Study|Laboratory abnormality|0
4894529|NCT00666926|16863203|P16|Overall Study|Adverse Event|0
4894530|NCT00666926|16863204|P15|Overall Study|Adverse Event|0
4894531|NCT00666926|16863205|P14|Overall Study|Adverse Event|1
4894532|NCT00666926|16863206|P13|Overall Study|Adverse Event|0
4894533|NCT00666926|16863207|P12|Overall Study|Adverse Event|2
4894534|NCT00666926|16863208|P11|Overall Study|Adverse Event|2
4894535|NCT00666926|16863209|P10|Overall Study|Adverse Event|2
4894536|NCT00666926|16863210|P9|Overall Study|Adverse Event|0
4894537|NCT00666926|16863211|P8|Overall Study|Adverse Event|0
4894538|NCT00666926|16863212|P7|Overall Study|Adverse Event|0
4894539|NCT00666926|16863213|P6|Overall Study|Adverse Event|0
4894540|NCT00666926|16863214|P5|Overall Study|Adverse Event|0
4894541|NCT00666926|16863215|P4|Overall Study|Adverse Event|0
4894542|NCT00666926|16863216|P3|Overall Study|Adverse Event|0
4894543|NCT00666926|16863217|P2|Overall Study|Adverse Event|0
4894544|NCT00666926|16863218|P1|Overall Study|Adverse Event|0
4894545|NCT00666835|16863527|P2|Overall Study|Physician Decision|2
4894546|NCT00666835|16863528|P1|Overall Study|Physician Decision|1
4894547|NCT00666835|16863527|P2|Overall Study|Planned operation|0
4894548|NCT00666835|16863528|P1|Overall Study|Planned operation|2
4894549|NCT00666835|16863527|P2|Overall Study|Hemoglobulin concentration|3
4894550|NCT00666835|16863528|P1|Overall Study|Hemoglobulin concentration|4
4894551|NCT00666835|16863527|P2|Overall Study|Kidney Transplantation (NTX)|2
4894552|NCT00666835|16863528|P1|Overall Study|Kidney Transplantation (NTX)|10
4894553|NCT00666835|16863527|P2|Overall Study|Death|4
4894554|NCT00666835|16863528|P1|Overall Study|Death|15
4894555|NCT00666835|16863527|P2|Overall Study|Protocol Violation|0
4894556|NCT00666835|16863528|P1|Overall Study|Protocol Violation|2
4894557|NCT00666835|16863527|P2|Overall Study|Adverse Event|6
4894558|NCT00666835|16863528|P1|Overall Study|Adverse Event|7
4894559|NCT00666835|16863527|P2|Overall Study|Incl./excl. not fulfilled|2
4894560|NCT00666835|16863528|P1|Overall Study|Incl./excl. not fulfilled|7
4894561|NCT00666835|16863527|P2|Overall Study|Lack of Efficacy|1
4894562|NCT00666835|16863528|P1|Overall Study|Lack of Efficacy|0
4894563|NCT00666835|16863527|P2|Overall Study|Withdrawal by Subject|2
4894564|NCT00666835|16863528|P1|Overall Study|Withdrawal by Subject|5
4894565|NCT00666757|16863538|P2|Overall Study|Sponsor decision|1
4894566|NCT00666757|16863539|P1|Overall Study|Sponsor decision|0
4894567|NCT00666757|16863538|P2|Overall Study|Physician Decision|2
4894568|NCT00666757|16863539|P1|Overall Study|Physician Decision|0
4894569|NCT00666757|16863538|P2|Overall Study|Lack of Efficacy|6
4894570|NCT00666757|16863539|P1|Overall Study|Lack of Efficacy|3
4894571|NCT00666757|16863538|P2|Overall Study|Withdrawal by Subject|17
4894572|NCT00666757|16863539|P1|Overall Study|Withdrawal by Subject|13
4894573|NCT00666757|16863538|P2|Overall Study|Adverse Event|12
4894574|NCT00666757|16863539|P1|Overall Study|Adverse Event|22
4894575|NCT00666757|16863538|P2|Overall Study|Protocol Violation|24
4894576|NCT00666757|16863539|P1|Overall Study|Protocol Violation|23
4894577|NCT00666757|16863538|P2|Overall Study|Lost to Follow-up|35
4894578|NCT00666757|16863539|P1|Overall Study|Lost to Follow-up|39
4894579|NCT00666718|16863598|P2|Overall Study|Physician Decision|2
4894580|NCT00666718|16863599|P1|Overall Study|Physician Decision|0
4894581|NCT00666718|16863598|P2|Overall Study|Withdrawal by Subject|12
4894582|NCT00666718|16863599|P1|Overall Study|Withdrawal by Subject|7
4894583|NCT00666718|16863598|P2|Overall Study|Protocol Violation|3
4894584|NCT00666718|16863599|P1|Overall Study|Protocol Violation|1
4894585|NCT00666718|16863598|P2|Overall Study|Entry Criteria Not Met|0
4894586|NCT00666718|16863599|P1|Overall Study|Entry Criteria Not Met|2
4894587|NCT00666718|16863598|P2|Overall Study|Lost to Follow-up|0
4894588|NCT00666718|16863599|P1|Overall Study|Lost to Follow-up|1
4894589|NCT00666718|16863598|P2|Overall Study|Death|0
4894590|NCT00666718|16863599|P1|Overall Study|Death|1
4894591|NCT00666718|16863598|P2|Overall Study|Adverse Event|1
4894592|NCT00666718|16863599|P1|Overall Study|Adverse Event|0
4894593|NCT00666705|16863625|P1|Overall Study|Withdrawal by Subject|1
4894594|NCT00666679|16863644|P2|Second Intervention|Death|1
4894595|NCT00666679|16863645|P1|Second Intervention|Death|0
4894596|NCT00666679|16863644|P2|Second Intervention|Adverse Event|0
4894597|NCT00666679|16863645|P1|Second Intervention|Adverse Event|1
4894598|NCT00666679|16863644|P2|Washout Period of 1 Week|Protocol Violation|1
4894599|NCT00666679|16863645|P1|Washout Period of 1 Week|Protocol Violation|0
4894600|NCT00666679|16863644|P2|Washout Period of 1 Week|Lost to Follow-up|1
4894601|NCT00666679|16863645|P1|Washout Period of 1 Week|Lost to Follow-up|0
4894602|NCT00666679|16863644|P2|First Intervention|Randomized did not start treatment|1
4894603|NCT00666679|16863645|P1|First Intervention|Randomized did not start treatment|1
4894604|NCT00666679|16863644|P2|First Intervention|Withdrawal by Subject|0
4894605|NCT00666679|16863645|P1|First Intervention|Withdrawal by Subject|1
4894606|NCT00666679|16863644|P2|First Intervention|Protocol Violation|0
4894607|NCT00666679|16863645|P1|First Intervention|Protocol Violation|1
4894608|NCT00666679|16863644|P2|First Intervention|Lost to Follow-up|0
4894609|NCT00666679|16863645|P1|First Intervention|Lost to Follow-up|1
4894610|NCT00666588|16863675|P4|Overall Study|inevaluable|0
4894611|NCT00666588|16863676|P3|Overall Study|inevaluable|0
4894612|NCT00666588|16863677|P2|Overall Study|inevaluable|0
4894613|NCT00666588|16863678|P1|Overall Study|inevaluable|2
4894614|NCT00666588|16863675|P4|Overall Study|ineligible|2
4894615|NCT00666588|16863676|P3|Overall Study|ineligible|0
4894616|NCT00666588|16863677|P2|Overall Study|ineligible|0
4894617|NCT00666588|16863678|P1|Overall Study|ineligible|2
4894618|NCT00666562|16863711|P3|Overall Study|Concomitant Medication|0
4894619|NCT00666562|16863712|P2|Overall Study|Concomitant Medication|1
4894620|NCT00666562|16863713|P1|Overall Study|Concomitant Medication|0
4894621|NCT00666562|16863711|P3|Overall Study|Withdrawal by Subject|0
4894622|NCT00666562|16863712|P2|Overall Study|Withdrawal by Subject|1
4894623|NCT00666562|16863713|P1|Overall Study|Withdrawal by Subject|0
4894624|NCT00666536|16863760|P2|Overall Study|Lost to Follow-up|3
4894625|NCT00666536|16863761|P1|Overall Study|Lost to Follow-up|4
4894626|NCT00666536|16863760|P2|Overall Study|Withdrawal by Subject|9
4894627|NCT00666536|16863761|P1|Overall Study|Withdrawal by Subject|10
4894628|NCT00666536|16863760|P2|Overall Study|Protocol deviation(s)|6
4894629|NCT00666536|16863761|P1|Overall Study|Protocol deviation(s)|8
4894630|NCT00666536|16863760|P2|Overall Study|Unsatisfactory therapeutic effect|0
4894631|NCT00666536|16863761|P1|Overall Study|Unsatisfactory therapeutic effect|2
4894632|NCT00666536|16863760|P2|Overall Study|Adverse Event|19
4894633|NCT00666536|16863761|P1|Overall Study|Adverse Event|9
4894634|NCT00666458|16863779|P2|Overall Study|Medical history of anemia|0
4894635|NCT00666458|16863780|P1|Overall Study|Medical history of anemia|1
4894636|NCT00666458|16863779|P2|Overall Study|Safety reasons|0
4894637|NCT00666458|16863780|P1|Overall Study|Safety reasons|1
4894638|NCT00666458|16863779|P2|Overall Study|Severe non-compliance to the protocol|1
4894639|NCT00666458|16863780|P1|Overall Study|Severe non-compliance to the protocol|1
4894640|NCT00666458|16863779|P2|Overall Study|Study specific discontinuation criteria|7
4894641|NCT00666458|16863780|P1|Overall Study|Study specific discontinuation criteria|14
4894642|NCT00666458|16863779|P2|Overall Study|Incorrect enrollment|1
4894643|NCT00666458|16863780|P1|Overall Study|Incorrect enrollment|7
4894644|NCT00666458|16863779|P2|Overall Study|Administrative reason by sponsor|1
4894645|NCT00666458|16863780|P1|Overall Study|Administrative reason by sponsor|1
4894646|NCT00666458|16863779|P2|Overall Study|Lost to Follow-up|3
4894647|NCT00666458|16863780|P1|Overall Study|Lost to Follow-up|0
4894648|NCT00666458|16863779|P2|Overall Study|Withdrawal by Subject|4
4894649|NCT00666458|16863780|P1|Overall Study|Withdrawal by Subject|5
4894650|NCT00666458|16863779|P2|Overall Study|Adverse Event|7
4894651|NCT00666458|16863780|P1|Overall Study|Adverse Event|8
4894652|NCT00666328|16863868|P1|Overall Study|No longer met eligibility criteria|1
4894653|NCT00666328|16863868|P1|Overall Study|Lost to Follow-up|2
4894654|NCT00666328|16863868|P1|Overall Study|Death|2
4894655|NCT00666276|16863881|P1|Overall Study|Protocol Violation|34
4894656|NCT00666263|16863905|P2|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1
4894657|NCT00666263|16863906|P1|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0
4894658|NCT00666263|16863905|P2|Study Part 4 (Cross-over Period 2)|Adverse Event|0
4894659|NCT00666263|16863906|P1|Study Part 4 (Cross-over Period 2)|Adverse Event|1
4894660|NCT00666263|16863905|P2|Study Part 1 (Stabilization Phase 1)|Adverse Event|1
4894661|NCT00666263|16863906|P1|Study Part 1 (Stabilization Phase 1)|Adverse Event|0
4894662|NCT00666224|16864050|P2|Open-Label|Undefined/Unknown|1
4894663|NCT00666224|16864051|P1|Open-Label|Undefined/Unknown|1
4894664|NCT00666224|16864050|P2|Open-Label|Noncompliance|1
4894665|NCT00666224|16864051|P1|Open-Label|Noncompliance|2
4894666|NCT00666224|16864050|P2|Open-Label|Pregnancy|5
4894667|NCT00666224|16864051|P1|Open-Label|Pregnancy|1
4894668|NCT00666224|16864050|P2|Open-Label|Physician Decision|5
4894669|NCT00666224|16864051|P1|Open-Label|Physician Decision|7
4894670|NCT00666224|16864050|P2|Open-Label|Withdrawal by Subject|25
4894671|NCT00666224|16864051|P1|Open-Label|Withdrawal by Subject|12
4894672|NCT00666224|16864050|P2|Open-Label|Lost to Follow-up|5
4894673|NCT00666224|16864051|P1|Open-Label|Lost to Follow-up|4
4894674|NCT00666224|16864050|P2|Open-Label|Adverse Event|43
4894675|NCT00666224|16864051|P1|Open-Label|Adverse Event|8
4894676|NCT00666224|16864050|P2|Double-Blind|Undefined/Unknown|1
4894677|NCT00666224|16864051|P1|Double-Blind|Undefined/Unknown|4
4894678|NCT00666224|16864050|P2|Double-Blind|Death|0
4894679|NCT00666224|16864051|P1|Double-Blind|Death|1
4894680|NCT00666224|16864050|P2|Double-Blind|Noncompliance|0
4894681|NCT00666224|16864051|P1|Double-Blind|Noncompliance|1
4894682|NCT00666224|16864050|P2|Double-Blind|Pregnancy|2
4894683|NCT00666224|16864051|P1|Double-Blind|Pregnancy|3
4894684|NCT00666224|16864050|P2|Double-Blind|Sponsor decision|0
4894685|NCT00666224|16864051|P1|Double-Blind|Sponsor decision|1
4894686|NCT00666224|16864050|P2|Double-Blind|Physician Decision|3
4894687|NCT00666224|16864051|P1|Double-Blind|Physician Decision|0
4894688|NCT00666224|16864050|P2|Double-Blind|Withdrawal by Subject|14
4894689|NCT00666224|16864051|P1|Double-Blind|Withdrawal by Subject|18
4894690|NCT00666224|16864050|P2|Double-Blind|Lost to Follow-up|2
4894691|NCT00666224|16864051|P1|Double-Blind|Lost to Follow-up|2
4894692|NCT00666224|16864050|P2|Double-Blind|Adverse Event|5
4894693|NCT00666224|16864051|P1|Double-Blind|Adverse Event|15
4894694|NCT00666211|16864070|P2|Overall Study|Physician Decision|1
4894695|NCT00666211|16864071|P1|Overall Study|Physician Decision|0
4894696|NCT00666211|16864070|P2|Overall Study|off tx for other complicating disease|1
4894697|NCT00666211|16864071|P1|Overall Study|off tx for other complicating disease|0
4894698|NCT00666211|16864070|P2|Overall Study|Death|2
4894699|NCT00666211|16864071|P1|Overall Study|Death|0
4894700|NCT00666211|16864070|P2|Overall Study|hospital admission|5
4894701|NCT00666211|16864071|P1|Overall Study|hospital admission|0
4894702|NCT00666211|16864070|P2|Overall Study|toxicity|2
4894703|NCT00666211|16864071|P1|Overall Study|toxicity|0
4894704|NCT00666211|16864070|P2|Overall Study|Lost to Follow-up|0
4894705|NCT00666211|16864071|P1|Overall Study|Lost to Follow-up|2
4894706|NCT00666211|16864070|P2|Overall Study|disease progression|8
4894707|NCT00666211|16864071|P1|Overall Study|disease progression|1
4894708|NCT00666211|16864070|P2|Overall Study|patient non-compliant|6
4894709|NCT00666211|16864071|P1|Overall Study|patient non-compliant|6
4894710|NCT00666211|16864070|P2|Overall Study|went off medication, no more pain|0
4894711|NCT00666211|16864071|P1|Overall Study|went off medication, no more pain|1
4894712|NCT00666211|16864070|P2|Overall Study|Withdrawal by Subject|13
4894713|NCT00666211|16864071|P1|Overall Study|Withdrawal by Subject|10
4894714|NCT00666198|16864089|P1|Overall Study|No Drug Administration|4
4894715|NCT00666198|16864089|P1|Overall Study|Safety Not Assessable|6
4894716|NCT00666198|16864089|P1|Overall Study|No Visit After First Day of Treatment|13
4894717|NCT00666198|16864089|P1|Overall Study|Protocol Violation|10
4894718|NCT00665925|16864117|P4|Overall Study|Due to exclusion criteria|0
4894719|NCT00665925|16864118|P3|Overall Study|Due to exclusion criteria|0
4894720|NCT00665925|16864119|P2|Overall Study|Due to exclusion criteria|0
4894721|NCT00665925|16864120|P1|Overall Study|Due to exclusion criteria|1
4894722|NCT00665925|16864117|P4|Overall Study|Enrolled by mistake|1
4894723|NCT00665925|16864118|P3|Overall Study|Enrolled by mistake|0
4894724|NCT00665925|16864119|P2|Overall Study|Enrolled by mistake|0
4894725|NCT00665925|16864120|P1|Overall Study|Enrolled by mistake|0
4894726|NCT00665925|16864117|P4|Overall Study|Adverse Event|5
4894727|NCT00665925|16864118|P3|Overall Study|Adverse Event|10
4894728|NCT00665925|16864119|P2|Overall Study|Adverse Event|5
4894729|NCT00665925|16864120|P1|Overall Study|Adverse Event|1
4894730|NCT00665925|16864117|P4|Overall Study|Severe Non-Compliance to Protocol|1
4894731|NCT00665925|16864118|P3|Overall Study|Severe Non-Compliance to Protocol|1
4894732|NCT00665925|16864119|P2|Overall Study|Severe Non-Compliance to Protocol|0
4894733|NCT00665925|16864120|P1|Overall Study|Severe Non-Compliance to Protocol|0
4894734|NCT00665925|16864117|P4|Overall Study|Physician Decision|2
4894735|NCT00665925|16864118|P3|Overall Study|Physician Decision|1
4894736|NCT00665925|16864119|P2|Overall Study|Physician Decision|0
4894737|NCT00665925|16864120|P1|Overall Study|Physician Decision|0
4894738|NCT00665925|16864117|P4|Overall Study|Withdrawal by Subject|2
4894739|NCT00665925|16864118|P3|Overall Study|Withdrawal by Subject|3
4894740|NCT00665925|16864119|P2|Overall Study|Withdrawal by Subject|2
4894741|NCT00665925|16864120|P1|Overall Study|Withdrawal by Subject|2
4894742|NCT00665925|16864117|P4|Overall Study|Lost to Follow-up|2
4894743|NCT00665925|16864118|P3|Overall Study|Lost to Follow-up|2
4894744|NCT00665925|16864119|P2|Overall Study|Lost to Follow-up|2
4894745|NCT00665925|16864120|P1|Overall Study|Lost to Follow-up|1
4894746|NCT00665925|16864117|P4|Overall Study|Lack of Efficacy|8
4894747|NCT00665925|16864118|P3|Overall Study|Lack of Efficacy|9
4894748|NCT00665925|16864119|P2|Overall Study|Lack of Efficacy|8
4894749|NCT00665925|16864120|P1|Overall Study|Lack of Efficacy|10
4894750|NCT00665847|16864531|P1|Overall Study|Switch to Commercial Medication|1
4894751|NCT00665847|16864531|P1|Overall Study|Subject ineligible to continue the trial|1
4894752|NCT00665847|16864531|P1|Overall Study|Resistance to TMC125|1
4894753|NCT00665847|16864531|P1|Overall Study|Subject reached a virologic endpoint|4
4894754|NCT00665847|16864531|P1|Overall Study|Subject non-compliant|8
4894755|NCT00665847|16864531|P1|Overall Study|Withdrawal by Subject|2
4894756|NCT00665847|16864531|P1|Overall Study|Adverse Event|8
4894757|NCT00665652|16864548|P1|Overall Study|No longer met inclusion criteria.|1
4894758|NCT00665652|16864548|P1|Overall Study|Death|1
4894759|NCT00665652|16864548|P1|Overall Study|Adverse Event|4
4894760|NCT00665626|16864554|P2|Overall Study|Death|0
4894761|NCT00665626|16864555|P1|Overall Study|Death|1
4894762|NCT00665626|16864554|P2|Overall Study|Unably to comply with dosing regimen|1
4894763|NCT00665626|16864555|P1|Overall Study|Unably to comply with dosing regimen|0
4894764|NCT00665626|16864554|P2|Overall Study|Did not fulfil inclusion criteria|1
4894765|NCT00665626|16864555|P1|Overall Study|Did not fulfil inclusion criteria|0
4894766|NCT00665626|16864554|P2|Overall Study|Due to exclusion criteria|1
4894767|NCT00665626|16864555|P1|Overall Study|Due to exclusion criteria|0
4894768|NCT00665626|16864554|P2|Overall Study|Adverse Event|9
4894769|NCT00665626|16864555|P1|Overall Study|Adverse Event|1
4894770|NCT00665626|16864554|P2|Overall Study|Protocol Violation|2
4894771|NCT00665626|16864555|P1|Overall Study|Protocol Violation|0
4894772|NCT00665626|16864554|P2|Overall Study|Withdrawal by Subject|1
4894773|NCT00665626|16864555|P1|Overall Study|Withdrawal by Subject|0
4894774|NCT00665626|16864554|P2|Overall Study|Lost to Follow-up|2
4894775|NCT00665626|16864555|P1|Overall Study|Lost to Follow-up|0
4894776|NCT00665626|16864554|P2|Overall Study|Lack of Efficacy|5
4894777|NCT00665626|16864555|P1|Overall Study|Lack of Efficacy|8
4894778|NCT00665561|16864623|P2|Overall Study|Withdrawn due to pregnancy|1
4894779|NCT00665561|16864624|P1|Overall Study|Withdrawn due to pregnancy|0
4894780|NCT00665561|16864623|P2|Overall Study|Site closed|0
4894781|NCT00665561|16864624|P1|Overall Study|Site closed|8
4894782|NCT00665561|16864623|P2|Overall Study|Other|108
4894783|NCT00665561|16864624|P1|Overall Study|Other|123
4894784|NCT00665561|16864623|P2|Overall Study|Withdrawal by Subject|65
4894785|NCT00665561|16864624|P1|Overall Study|Withdrawal by Subject|74
4894786|NCT00665561|16864623|P2|Overall Study|Lost to Follow-up|264
4894787|NCT00665561|16864624|P1|Overall Study|Lost to Follow-up|203
4894788|NCT00665561|16864623|P2|Overall Study|Does not meet entrance criteria|21
4894789|NCT00665561|16864624|P1|Overall Study|Does not meet entrance criteria|19
4894790|NCT00665561|16864623|P2|Overall Study|Death recorded on subject summary pages|75
4894791|NCT00665561|16864624|P1|Overall Study|Death recorded on subject summary pages|75
4894792|NCT00665444|16864674|P1|Overall Study|Study Terminated by Study Sponsor|1
4894793|NCT00665444|16864674|P1|Overall Study|Physician Decision|1
4894794|NCT00665431|16864686|P3|Overall Study|Other|2
4894795|NCT00665431|16864687|P2|Overall Study|Other|7
4894796|NCT00665431|16864688|P1|Overall Study|Other|4
4894797|NCT00665431|16864686|P3|Overall Study|Lost to Follow-up|1
4894798|NCT00665431|16864687|P2|Overall Study|Lost to Follow-up|3
4894799|NCT00665431|16864688|P1|Overall Study|Lost to Follow-up|3
4894800|NCT00665431|16864686|P3|Overall Study|Withdrawal by Subject|15
4894801|NCT00665431|16864687|P2|Overall Study|Withdrawal by Subject|25
4894802|NCT00665431|16864688|P1|Overall Study|Withdrawal by Subject|17
4894803|NCT00665431|16864686|P3|Overall Study|Adverse Event|6
4894804|NCT00665431|16864687|P2|Overall Study|Adverse Event|22
4894805|NCT00665431|16864688|P1|Overall Study|Adverse Event|16
4894806|NCT00665366|16864731|P2|Overall Study|Other reasons|1
4894807|NCT00665366|16864732|P1|Overall Study|Other reasons|4
4894808|NCT00665366|16864731|P2|Overall Study|No longer meets study criteria|1
4894809|NCT00665366|16864732|P1|Overall Study|No longer meets study criteria|0
4894810|NCT00665366|16864731|P2|Overall Study|Pregnancy|0
4894811|NCT00665366|16864732|P1|Overall Study|Pregnancy|1
4894812|NCT00665366|16864731|P2|Overall Study|Poor compliance/noncompliance|5
4894813|NCT00665366|16864732|P1|Overall Study|Poor compliance/noncompliance|3
4894814|NCT00665366|16864731|P2|Overall Study|Lost to Follow-up|5
4894815|NCT00665366|16864732|P1|Overall Study|Lost to Follow-up|3
4894816|NCT00665366|16864731|P2|Overall Study|Withdrawal by Subject|14
4894817|NCT00665366|16864732|P1|Overall Study|Withdrawal by Subject|11
4894818|NCT00665366|16864731|P2|Overall Study|Adverse Event|23
4894819|NCT00665366|16864732|P1|Overall Study|Adverse Event|25
4894820|NCT00665366|16864731|P2|Overall Study|Lack of Efficacy|10
4894821|NCT00665366|16864732|P1|Overall Study|Lack of Efficacy|11
4894822|NCT00665353|16864760|P1|Study Step 2|Lack of Efficacy|12
4894823|NCT00665353|16864760|P1|Study Step 2|Lost to Follow-up|2
4894824|NCT00665353|16864760|P1|Study Step 1|Withdrawal by Subject|2
4894825|NCT00665353|16864760|P1|Study Step 1|Adverse Event|1
4894826|NCT00665002|16864777|P1|Overall Study|Cytogenetic resistance|1
4894827|NCT00665002|16864777|P1|Overall Study|Progression/relapse during treatment|11
4894828|NCT00664859|16864785|P3|Overall Study|Other|2
4894829|NCT00664859|16864786|P2|Overall Study|Other|1
4894830|NCT00664859|16864787|P1|Overall Study|Other|0
4894831|NCT00664859|16864785|P3|Overall Study|Lost to Follow-up|1
4894832|NCT00664859|16864786|P2|Overall Study|Lost to Follow-up|2
4894833|NCT00664859|16864787|P1|Overall Study|Lost to Follow-up|2
4894834|NCT00664859|16864785|P3|Overall Study|Withdrawal by Subject|3
4894835|NCT00664859|16864786|P2|Overall Study|Withdrawal by Subject|1
4894836|NCT00664859|16864787|P1|Overall Study|Withdrawal by Subject|4
4894837|NCT00664859|16864785|P3|Overall Study|Laboratory abnormality|4
4894838|NCT00664859|16864786|P2|Overall Study|Laboratory abnormality|1
4894839|NCT00664859|16864787|P1|Overall Study|Laboratory abnormality|2
4894840|NCT00664859|16864785|P3|Overall Study|Noncompliance with protocol|4
4894841|NCT00664859|16864786|P2|Overall Study|Noncompliance with protocol|0
4894842|NCT00664859|16864787|P1|Overall Study|Noncompliance with protocol|1
4894843|NCT00664859|16864785|P3|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
4894844|NCT00664859|16864786|P2|Overall Study|DB Study (LCP-AtorFen-2001) AE|4
4894845|NCT00664859|16864787|P1|Overall Study|DB Study (LCP-AtorFen-2001) AE|6
4894846|NCT00664859|16864785|P3|Overall Study|Adverse Event|3
4894847|NCT00664859|16864786|P2|Overall Study|Adverse Event|1
4894848|NCT00664859|16864787|P1|Overall Study|Adverse Event|2
4894849|NCT00664742|16864807|P1|Overall Study|Lost to Follow-up|92
4894850|NCT00664742|16864807|P1|Overall Study|Withdrawal by Subject|31
4894851|NCT00664742|16864807|P1|Overall Study|Withdrawn due to adverse events|3
4894852|NCT00664560|16864815|P3|Overall Study|Other|5
4894853|NCT00664560|16864816|P2|Overall Study|Other|4
4894854|NCT00664560|16864817|P1|Overall Study|Other|11
4894855|NCT00664560|16864815|P3|Overall Study|Lost to Follow-up|0
4894856|NCT00664560|16864816|P2|Overall Study|Lost to Follow-up|2
4894857|NCT00664560|16864817|P1|Overall Study|Lost to Follow-up|0
4894858|NCT00664560|16864815|P3|Overall Study|Withdrawal by Subject|7
4894859|NCT00664560|16864816|P2|Overall Study|Withdrawal by Subject|13
4894860|NCT00664560|16864817|P1|Overall Study|Withdrawal by Subject|9
4894861|NCT00664560|16864815|P3|Overall Study|Adverse Event|7
4894862|NCT00664560|16864816|P2|Overall Study|Adverse Event|16
4894863|NCT00664560|16864817|P1|Overall Study|Adverse Event|19
4894864|NCT00664534|16864860|P2|Overall Study|Sponsor decision|6
4894865|NCT00664534|16864861|P1|Overall Study|Sponsor decision|8
4894866|NCT00664534|16864860|P2|Overall Study|Physician Decision|0
4894867|NCT00664534|16864861|P1|Overall Study|Physician Decision|8
4894868|NCT00664534|16864860|P2|Overall Study|Withdrawal by Subject|6
4894869|NCT00664534|16864861|P1|Overall Study|Withdrawal by Subject|7
4894870|NCT00664534|16864860|P2|Overall Study|Protocol Violation|8
4894871|NCT00664534|16864861|P1|Overall Study|Protocol Violation|10
4894872|NCT00664534|16864860|P2|Overall Study|Lost to Follow-up|10
4894873|NCT00664534|16864861|P1|Overall Study|Lost to Follow-up|6
4894874|NCT00664534|16864860|P2|Overall Study|Adverse Event|3
4894875|NCT00664534|16864861|P1|Overall Study|Adverse Event|2
4894876|NCT00664521|16864889|P2|Overall Study|Other|0
4894877|NCT00664521|16864890|P1|Overall Study|Other|1
4894878|NCT00664521|16864889|P2|Overall Study|Lost to Follow-up|0
4894879|NCT00664521|16864890|P1|Overall Study|Lost to Follow-up|1
4894880|NCT00664521|16864889|P2|Overall Study|Adverse Event|1
4894881|NCT00664521|16864890|P1|Overall Study|Adverse Event|4
4894882|NCT00664326|16864916|P1|Overall Study|Disease Progression/Recurrence/Relapse|24
4894883|NCT00664326|16864916|P1|Overall Study|Death|2
4894884|NCT00664326|16864916|P1|Overall Study|Other Reasons|3
4894885|NCT00664326|16864916|P1|Overall Study|Physician Decision|1
4894886|NCT00664326|16864916|P1|Overall Study|Withdrawal by Subject|1
4894887|NCT00664326|16864916|P1|Overall Study|Noncompliance with study medication|3
4894888|NCT00664326|16864916|P1|Overall Study|Adverse Event|14
4894889|NCT00664209|16864935|P1|Study Treatment Period|Withdrawal by Subject|2
4894890|NCT00664209|16864935|P1|Study Treatment Period|Physician Decision|4
4894891|NCT00664209|16864935|P1|Motor Fluctuations Screen|Negative for motor fluctuation|7
4894892|NCT00664105|16864943|P1|Overall Study|Disease progression|7
4894893|NCT00664105|16864943|P1|Overall Study|Adverse Event|9
4894894|NCT00664105|16864943|P1|Overall Study|Withdrawal by Subject|5
4894895|NCT00664105|16864943|P1|Overall Study|Death|3
4894896|NCT00664066|16864950|P1|Overall Study|Study terminated|3
4894897|NCT00663962|16864956|P2|Overall Study|somnolence|0
4894898|NCT00663962|16864957|P1|Overall Study|somnolence|1
4894899|NCT00663923|16864963|P1|Overall Study|Lost to Follow-up|2
4894900|NCT00663858|16864980|P3|Overall Study|Other|4
4894901|NCT00663858|16864981|P2|Overall Study|Other|2
4894902|NCT00663858|16864982|P1|Overall Study|Other|8
4894903|NCT00663858|16864980|P3|Overall Study|Protocol Violation|4
4894904|NCT00663858|16864981|P2|Overall Study|Protocol Violation|3
4894905|NCT00663858|16864982|P1|Overall Study|Protocol Violation|5
4894906|NCT00663858|16864980|P3|Overall Study|Withdrawal by Subject|3
4894907|NCT00663858|16864981|P2|Overall Study|Withdrawal by Subject|3
4894908|NCT00663858|16864982|P1|Overall Study|Withdrawal by Subject|7
4894909|NCT00663858|16864980|P3|Overall Study|Lack of Efficacy|3
4894910|NCT00663858|16864981|P2|Overall Study|Lack of Efficacy|1
4894911|NCT00663858|16864982|P1|Overall Study|Lack of Efficacy|5
4894912|NCT00663858|16864980|P3|Overall Study|Adverse Event|6
4894913|NCT00663858|16864981|P2|Overall Study|Adverse Event|1
4894914|NCT00663858|16864982|P1|Overall Study|Adverse Event|9
4894915|NCT00663702|16865020|P2|Overall Study|Lack of Efficacy|3
4894916|NCT00663702|16865021|P1|Overall Study|Lack of Efficacy|3
4894917|NCT00663702|16865020|P2|Overall Study|Death|1
4894918|NCT00663702|16865021|P1|Overall Study|Death|1
4894919|NCT00663702|16865020|P2|Overall Study|Lost to Follow-up|0
4894920|NCT00663702|16865021|P1|Overall Study|Lost to Follow-up|3
4894921|NCT00663702|16865020|P2|Overall Study|Pregnancy|1
4894922|NCT00663702|16865021|P1|Overall Study|Pregnancy|0
4894923|NCT00663702|16865020|P2|Overall Study|Withdrawal by Subject|1
4894924|NCT00663702|16865021|P1|Overall Study|Withdrawal by Subject|3
4894925|NCT00663702|16865020|P2|Overall Study|Adverse Event|4
4894926|NCT00663702|16865021|P1|Overall Study|Adverse Event|8
4894927|NCT00663260|16865057|P3|Overall Study|non-compliance, not met criteria, etc.|3
4894928|NCT00663260|16865058|P2|Overall Study|non-compliance, not met criteria, etc.|2
4894929|NCT00663260|16865059|P1|Overall Study|non-compliance, not met criteria, etc.|3
4894930|NCT00663260|16865057|P3|Overall Study|Lost to Follow-up|0
4894931|NCT00663260|16865058|P2|Overall Study|Lost to Follow-up|1
4894932|NCT00663260|16865059|P1|Overall Study|Lost to Follow-up|0
4894933|NCT00663260|16865057|P3|Overall Study|Death|1
4894934|NCT00663260|16865058|P2|Overall Study|Death|0
4894935|NCT00663260|16865059|P1|Overall Study|Death|1
4894936|NCT00663260|16865057|P3|Overall Study|Withdrawal by Subject|6
4894937|NCT00663260|16865058|P2|Overall Study|Withdrawal by Subject|1
4894938|NCT00663260|16865059|P1|Overall Study|Withdrawal by Subject|3
4894939|NCT00663260|16865057|P3|Overall Study|Adverse Event|6
4894940|NCT00663260|16865058|P2|Overall Study|Adverse Event|7
4894941|NCT00663260|16865059|P1|Overall Study|Adverse Event|12
4894942|NCT00663260|16865057|P3|Overall Study|Lack of Efficacy|0
4894943|NCT00663260|16865058|P2|Overall Study|Lack of Efficacy|0
4894944|NCT00663260|16865059|P1|Overall Study|Lack of Efficacy|2
4894945|NCT00663234|16865073|P1|Overall Study|Not willing to adhere to requirements|1
4894946|NCT00663208|16865106|P7|Follow-up Period|Other reason|1
4894947|NCT00663208|16865107|P6|Follow-up Period|Other reason|0
4894948|NCT00663208|16865108|P5|Follow-up Period|Other reason|0
4894949|NCT00663208|16865109|P4|Follow-up Period|Other reason|0
4894950|NCT00663208|16865110|P3|Follow-up Period|Other reason|0
4894951|NCT00663208|16865111|P2|Follow-up Period|Other reason|0
4894952|NCT00663208|16865112|P1|Follow-up Period|Other reason|1
4894953|NCT00663208|16865106|P7|Follow-up Period|Lost to Follow-up|0
4894954|NCT00663208|16865107|P6|Follow-up Period|Lost to Follow-up|0
4894955|NCT00663208|16865108|P5|Follow-up Period|Lost to Follow-up|0
4894956|NCT00663208|16865109|P4|Follow-up Period|Lost to Follow-up|2
4894957|NCT00663208|16865110|P3|Follow-up Period|Lost to Follow-up|3
4894958|NCT00663208|16865111|P2|Follow-up Period|Lost to Follow-up|0
4894959|NCT00663208|16865112|P1|Follow-up Period|Lost to Follow-up|2
4894960|NCT00663208|16865106|P7|Treatment Period|Lost to Follow-up|0
4894961|NCT00663208|16865107|P6|Treatment Period|Lost to Follow-up|0
4894962|NCT00663208|16865108|P5|Treatment Period|Lost to Follow-up|0
4894963|NCT00663208|16865109|P4|Treatment Period|Lost to Follow-up|0
4894964|NCT00663208|16865110|P3|Treatment Period|Lost to Follow-up|0
4894965|NCT00663208|16865111|P2|Treatment Period|Lost to Follow-up|1
4894966|NCT00663208|16865112|P1|Treatment Period|Lost to Follow-up|0
4894967|NCT00663117|16865290|P2|Overall Study|Lack of Efficacy|0
4894968|NCT00663117|16865291|P1|Overall Study|Lack of Efficacy|1
4894969|NCT00663052|16865305|P2|Overall Study|Other|1
4894970|NCT00663052|16865306|P1|Overall Study|Other|0
4894971|NCT00663052|16865305|P2|Overall Study|Unsatisfactory Response - Efficacy|1
4894972|NCT00663052|16865306|P1|Overall Study|Unsatisfactory Response - Efficacy|1
4894973|NCT00663052|16865305|P2|Overall Study|Withdrawal by Subject|5
4894974|NCT00663052|16865306|P1|Overall Study|Withdrawal by Subject|2
4894975|NCT00663052|16865305|P2|Overall Study|Protocol Violation|0
4894976|NCT00663052|16865306|P1|Overall Study|Protocol Violation|1
4894977|NCT00663052|16865305|P2|Overall Study|Discontinuation of Study by Sponsor|0
4894978|NCT00663052|16865306|P1|Overall Study|Discontinuation of Study by Sponsor|2
4894979|NCT00663052|16865305|P2|Overall Study|Adverse Event|3
4894980|NCT00663052|16865306|P1|Overall Study|Adverse Event|6
4894981|NCT00663026|16865412|P3|Overall Study|Withdrawal by Subject|1
4894982|NCT00663026|16865413|P2|Overall Study|Withdrawal by Subject|0
4894983|NCT00663026|16865414|P1|Overall Study|Withdrawal by Subject|0
4894984|NCT00663026|16865412|P3|Overall Study|Caregiver Request|0
4894985|NCT00663026|16865413|P2|Overall Study|Caregiver Request|2
4894986|NCT00663026|16865414|P1|Overall Study|Caregiver Request|0
4894987|NCT00663026|16865412|P3|Overall Study|Adverse Event|3
4894988|NCT00663026|16865413|P2|Overall Study|Adverse Event|2
4894989|NCT00663026|16865414|P1|Overall Study|Adverse Event|0
4894990|NCT00663026|16865412|P3|Overall Study|Other|0
4894991|NCT00663026|16865413|P2|Overall Study|Other|2
4894992|NCT00663026|16865414|P1|Overall Study|Other|1
4894993|NCT00663026|16865412|P3|Overall Study|Lost to Follow-up|0
4894994|NCT00663026|16865413|P2|Overall Study|Lost to Follow-up|0
4894995|NCT00663026|16865414|P1|Overall Study|Lost to Follow-up|1
4894996|NCT00662909|16865437|P3|Overall Study|Eligibility criterion not met|1
4894997|NCT00662909|16865438|P2|Overall Study|Eligibility criterion not met|1
4894998|NCT00662909|16865439|P1|Overall Study|Eligibility criterion not met|0
4894999|NCT00662909|16865437|P3|Overall Study|Physician Decision|2
4895000|NCT00662909|16865438|P2|Overall Study|Physician Decision|1
4895001|NCT00662909|16865439|P1|Overall Study|Physician Decision|1
4895002|NCT00662909|16865437|P3|Overall Study|Non-compliance with study procedures|2
4895003|NCT00662909|16865438|P2|Overall Study|Non-compliance with study procedures|3
4895004|NCT00662909|16865439|P1|Overall Study|Non-compliance with study procedures|3
4895005|NCT00662909|16865437|P3|Overall Study|Randomized- never received study drug|0
4895006|NCT00662909|16865438|P2|Overall Study|Randomized- never received study drug|0
4895007|NCT00662909|16865439|P1|Overall Study|Randomized- never received study drug|1
4895008|NCT00662909|16865437|P3|Overall Study|Protocol Violation|5
4895009|NCT00662909|16865438|P2|Overall Study|Protocol Violation|4
4895010|NCT00662909|16865439|P1|Overall Study|Protocol Violation|7
4895011|NCT00662909|16865437|P3|Overall Study|Lost to Follow-up|3
4895012|NCT00662909|16865438|P2|Overall Study|Lost to Follow-up|9
4895013|NCT00662909|16865439|P1|Overall Study|Lost to Follow-up|2
4895014|NCT00662909|16865437|P3|Overall Study|Withdrawal by Subject|16
4895015|NCT00662909|16865438|P2|Overall Study|Withdrawal by Subject|22
4895016|NCT00662909|16865439|P1|Overall Study|Withdrawal by Subject|29
4895017|NCT00662909|16865437|P3|Overall Study|Lack of Efficacy|5
4895018|NCT00662909|16865438|P2|Overall Study|Lack of Efficacy|1
4895019|NCT00662909|16865439|P1|Overall Study|Lack of Efficacy|9
4895020|NCT00662909|16865437|P3|Overall Study|Adverse Event|19
4895021|NCT00662909|16865438|P2|Overall Study|Adverse Event|18
4895022|NCT00662909|16865439|P1|Overall Study|Adverse Event|17
4895023|NCT00662857|16865537|P2|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0
4895024|NCT00662857|16865538|P1|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1
4895025|NCT00662857|16865537|P2|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1
4895026|NCT00662857|16865538|P1|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0
4895027|NCT00662857|16865537|P2|Washout 1 (3 - 14 Days)|Physician Decision|1
4895028|NCT00662857|16865538|P1|Washout 1 (3 - 14 Days)|Physician Decision|0
4895029|NCT00662831|16865553|P2|Overall Study|Adverse Event|16
4895030|NCT00662831|16865554|P1|Overall Study|Adverse Event|23
4895031|NCT00662831|16865553|P2|Overall Study|Protocol Violation|4
4895032|NCT00662831|16865554|P1|Overall Study|Protocol Violation|8
4895033|NCT00662831|16865553|P2|Overall Study|Other|31
4895034|NCT00662831|16865554|P1|Overall Study|Other|62
4895035|NCT00662831|16865553|P2|Overall Study|Withdrawal by Subject|1
4895036|NCT00662831|16865554|P1|Overall Study|Withdrawal by Subject|2
4895037|NCT00662831|16865553|P2|Overall Study|Lost to Follow-up|0
4895038|NCT00662831|16865554|P1|Overall Study|Lost to Follow-up|1
4895039|NCT00662831|16865553|P2|Overall Study|Lack of Efficacy|6
4895040|NCT00662831|16865554|P1|Overall Study|Lack of Efficacy|6
4895041|NCT00662831|16865553|P2|Overall Study|Death|1
4895042|NCT00662831|16865554|P1|Overall Study|Death|4
4895043|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
4895044|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
4895045|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0
4895046|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1
4895047|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3
4895048|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4895049|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4895050|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4895051|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1
4895052|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0
4895053|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Subject withdrew consent|9
4895054|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Subject withdrew consent|15
4895055|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Subject withdrew consent|0
4895056|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Subject withdrew consent|23
4895057|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Subject withdrew consent|19
4895058|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Protocol Violation|0
4895059|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Protocol Violation|0
4895060|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Protocol Violation|0
4895061|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Protocol Violation|1
4895062|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Protocol Violation|1
4895063|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Lost to Follow-up|1
4895064|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Lost to Follow-up|1
4895065|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Lost to Follow-up|0
4895066|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Lost to Follow-up|0
4895067|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Lost to Follow-up|2
4895068|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Adverse Event|10
4895069|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Adverse Event|6
4895070|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Adverse Event|0
4895071|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Adverse Event|9
4895072|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Adverse Event|6
4895073|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Administrative problems|0
4895074|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Administrative problems|1
4895075|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Administrative problems|0
4895076|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Administrative problems|0
4895077|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Administrative problems|0
4895078|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
4895079|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
4895080|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0
4895081|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1
4895082|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3
4895083|NCT00662649|16865634|P5|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3
4895084|NCT00662649|16865635|P4|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8
4895085|NCT00662649|16865636|P3|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0
4895086|NCT00662649|16865637|P2|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5
4895087|NCT00662649|16865638|P1|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10
4895088|NCT00662649|16865634|P5|Core Study (24 Months)|Death|0
4895089|NCT00662649|16865635|P4|Core Study (24 Months)|Death|0
4895090|NCT00662649|16865636|P3|Core Study (24 Months)|Death|2
4895091|NCT00662649|16865637|P2|Core Study (24 Months)|Death|0
4895092|NCT00662649|16865638|P1|Core Study (24 Months)|Death|1
4895093|NCT00662649|16865634|P5|Core Study (24 Months)|Abnormal test procedure result(s)|0
4895094|NCT00662649|16865635|P4|Core Study (24 Months)|Abnormal test procedure result(s)|0
4895095|NCT00662649|16865636|P3|Core Study (24 Months)|Abnormal test procedure result(s)|1
4895096|NCT00662649|16865637|P2|Core Study (24 Months)|Abnormal test procedure result(s)|1
4895097|NCT00662649|16865638|P1|Core Study (24 Months)|Abnormal test procedure result(s)|2
4895098|NCT00662649|16865634|P5|Core Study (24 Months)|Protocol Violation|0
4895099|NCT00662649|16865635|P4|Core Study (24 Months)|Protocol Violation|0
4895100|NCT00662649|16865636|P3|Core Study (24 Months)|Protocol Violation|4
4895101|NCT00662649|16865637|P2|Core Study (24 Months)|Protocol Violation|5
4895102|NCT00662649|16865638|P1|Core Study (24 Months)|Protocol Violation|5
4895103|NCT00662649|16865634|P5|Core Study (24 Months)|Lost to Follow-up|0
4895104|NCT00662649|16865635|P4|Core Study (24 Months)|Lost to Follow-up|0
4895105|NCT00662649|16865636|P3|Core Study (24 Months)|Lost to Follow-up|7
4895106|NCT00662649|16865637|P2|Core Study (24 Months)|Lost to Follow-up|5
4895107|NCT00662649|16865638|P1|Core Study (24 Months)|Lost to Follow-up|3
4895108|NCT00662649|16865634|P5|Core Study (24 Months)|Abnormal laboratory value(s)|0
4895109|NCT00662649|16865635|P4|Core Study (24 Months)|Abnormal laboratory value(s)|0
4895110|NCT00662649|16865636|P3|Core Study (24 Months)|Abnormal laboratory value(s)|1
4895111|NCT00662649|16865637|P2|Core Study (24 Months)|Abnormal laboratory value(s)|9
4895112|NCT00662649|16865638|P1|Core Study (24 Months)|Abnormal laboratory value(s)|20
4895113|NCT00662649|16865634|P5|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
4895114|NCT00662649|16865635|P4|Core Study (24 Months)|Unsatisfactory therapeutic effect|0
4895115|NCT00662649|16865636|P3|Core Study (24 Months)|Unsatisfactory therapeutic effect|25
4895116|NCT00662649|16865637|P2|Core Study (24 Months)|Unsatisfactory therapeutic effect|6
4895117|NCT00662649|16865638|P1|Core Study (24 Months)|Unsatisfactory therapeutic effect|13
4895118|NCT00662649|16865634|P5|Core Study (24 Months)|Adverse Event|0
4895119|NCT00662649|16865635|P4|Core Study (24 Months)|Adverse Event|0
4895120|NCT00662649|16865636|P3|Core Study (24 Months)|Adverse Event|18
4895121|NCT00662649|16865637|P2|Core Study (24 Months)|Adverse Event|13
4895122|NCT00662649|16865638|P1|Core Study (24 Months)|Adverse Event|22
4895123|NCT00662649|16865634|P5|Core Study (24 Months)|Withdrawal by Subject|0
4895124|NCT00662649|16865635|P4|Core Study (24 Months)|Withdrawal by Subject|0
4895125|NCT00662649|16865636|P3|Core Study (24 Months)|Withdrawal by Subject|28
4895126|NCT00662649|16865637|P2|Core Study (24 Months)|Withdrawal by Subject|17
4895127|NCT00662649|16865638|P1|Core Study (24 Months)|Withdrawal by Subject|31
4895128|NCT00662558|16865678|P2|Overall Study|Randomized But Did Not Receive Treatment|8
4895129|NCT00662558|16865679|P1|Overall Study|Randomized But Did Not Receive Treatment|2
4895130|NCT00662558|16865678|P2|Overall Study|Withdrawal by Subject|12
4895131|NCT00662558|16865679|P1|Overall Study|Withdrawal by Subject|7
4895132|NCT00662558|16865678|P2|Overall Study|Other|14
4895133|NCT00662558|16865679|P1|Overall Study|Other|9
4895134|NCT00662558|16865678|P2|Overall Study|Lost to Follow-up|10
4895135|NCT00662558|16865679|P1|Overall Study|Lost to Follow-up|13
4895136|NCT00662558|16865678|P2|Overall Study|Lack of Efficacy|7
4895137|NCT00662558|16865679|P1|Overall Study|Lack of Efficacy|4
4895138|NCT00662558|16865678|P2|Overall Study|Adverse Event|59
4895139|NCT00662558|16865679|P1|Overall Study|Adverse Event|21
4895140|NCT00662532|16865730|P2|Overall Study|Lost to Follow-up|1
4895141|NCT00662532|16865731|P1|Overall Study|Lost to Follow-up|0
4895142|NCT00662532|16865730|P2|Overall Study|Adverse Event|1
4895143|NCT00662532|16865731|P1|Overall Study|Adverse Event|0
4895144|NCT00662363|16865746|P2|Overall Study|Protocol Violation|1
4895145|NCT00662363|16865747|P1|Overall Study|Protocol Violation|1
4895146|NCT00662363|16865746|P2|Overall Study|Discharged early from rehab|1
4895147|NCT00662363|16865747|P1|Overall Study|Discharged early from rehab|4
4895148|NCT00662363|16865746|P2|Overall Study|Adverse Event|3
4895149|NCT00662363|16865747|P1|Overall Study|Adverse Event|0
4895150|NCT00662363|16865746|P2|Overall Study|Withdrawal by Subject|5
4895151|NCT00662363|16865747|P1|Overall Study|Withdrawal by Subject|6
4895152|NCT00662311|16865758|P3|Overall Study|Respiratory Infection|0
4895153|NCT00662311|16865759|P2|Overall Study|Respiratory Infection|0
4895154|NCT00662311|16865760|P1|Overall Study|Respiratory Infection|1
4895155|NCT00662259|16865795|P2|Overall Study|Adverse Event|0
4895156|NCT00662259|16865796|P1|Overall Study|Adverse Event|2
4895157|NCT00662129|16865838|P1|Overall Study|Ineligible|1
4895158|NCT00662129|16865838|P1|Overall Study|Cancel prior to beginning treatment|1
4895159|NCT00662129|16865838|P1|Overall Study|Protocol Violation|1
4895160|NCT00662038|16865848|P1|Overall Study|Continued treatment|5
4895161|NCT00662038|16865848|P1|Overall Study|Adverse Event|358
4895162|NCT00662038|16865848|P1|Overall Study|Death|95
4895163|NCT00662038|16865848|P1|Overall Study|Lost to Follow-up|1
4895164|NCT00662038|16865848|P1|Overall Study|Lung transplantation|44
4895165|NCT00662038|16865848|P1|Overall Study|Physician Decision|19
4895166|NCT00662038|16865848|P1|Overall Study|Sponsor decision|1
4895167|NCT00662038|16865848|P1|Overall Study|Withdrawal by Subject|83
4895168|NCT00662038|16865848|P1|Overall Study|Withdrawn consent|22
4895169|NCT00662038|16865848|P1|Overall Study|Reason not specified|3
4895170|NCT00662025|16865852|P1|Overall Study|Domestic circumstances|1
4895171|NCT00662025|16865852|P1|Overall Study|Target lesion cannot be evaluated|1
4895172|NCT00662025|16865852|P1|Overall Study|Results of other clinical study|2
4895173|NCT00662025|16865852|P1|Overall Study|Withdrawal by Subject|1
4895174|NCT00662025|16865852|P1|Overall Study|Adverse Event|7
4895175|NCT00662025|16865852|P1|Overall Study|Objective progression or relapse|51
4895176|NCT00662012|16865872|P1|Overall Study|Withdrawal by Subject|1
4895177|NCT00662012|16865872|P1|Overall Study|Death|1
4895178|NCT00662012|16865872|P1|Overall Study|Lost to Follow-up|85
4895179|NCT00661999|16865880|P3|Overall Study|Other Medical Problems|9
4895180|NCT00661999|16865881|P2|Overall Study|Other Medical Problems|4
4895181|NCT00661999|16865882|P1|Overall Study|Other Medical Problems|4
4895182|NCT00661999|16865880|P3|Overall Study|Alternative Treatment|0
4895183|NCT00661999|16865881|P2|Overall Study|Alternative Treatment|0
4895184|NCT00661999|16865882|P1|Overall Study|Alternative Treatment|1
4895185|NCT00661999|16865880|P3|Overall Study|Withdrawal by Subject|14
4895186|NCT00661999|16865881|P2|Overall Study|Withdrawal by Subject|23
4895187|NCT00661999|16865882|P1|Overall Study|Withdrawal by Subject|30
4895188|NCT00661999|16865880|P3|Overall Study|Other Reasons|23
4895189|NCT00661999|16865881|P2|Overall Study|Other Reasons|12
4895190|NCT00661999|16865882|P1|Overall Study|Other Reasons|5
4895191|NCT00661999|16865880|P3|Overall Study|Death|3
4895192|NCT00661999|16865881|P2|Overall Study|Death|6
4895193|NCT00661999|16865882|P1|Overall Study|Death|8
4895194|NCT00661999|16865880|P3|Overall Study|Adverse Event|8
4895195|NCT00661999|16865881|P2|Overall Study|Adverse Event|5
4895196|NCT00661999|16865882|P1|Overall Study|Adverse Event|11
4895197|NCT00661830|16865959|P2|Overall Study|Other reason|5
4895198|NCT00661830|16865960|P1|Overall Study|Other reason|1
4895199|NCT00661830|16865959|P2|Overall Study|Withdrawal by Subject|1
4895200|NCT00661830|16865960|P1|Overall Study|Withdrawal by Subject|1
4895201|NCT00661830|16865959|P2|Overall Study|Lost to Follow-up|3
4895202|NCT00661830|16865960|P1|Overall Study|Lost to Follow-up|1
4895203|NCT00661830|16865959|P2|Overall Study|Death|33
4895204|NCT00661830|16865960|P1|Overall Study|Death|37
4895205|NCT00661778|16865972|P1|Overall Study|Withdrawal of Consent|1
4895206|NCT00661778|16865972|P1|Overall Study|Protocol Violation|2
4895207|NCT00661778|16865972|P1|Overall Study|Reason not Specified|6
4895208|NCT00661778|16865972|P1|Overall Study|Adverse Event|18
4895209|NCT00661778|16865972|P1|Overall Study|Disease Progression|23
4895210|NCT00661726|16865979|P1|Overall Study|Adverse Event|1
4895211|NCT00661713|16866002|P8|Overall Study|Inappropriate Enrollment|0
4895212|NCT00661713|16866003|P7|Overall Study|Inappropriate Enrollment|1
4895213|NCT00661713|16866004|P6|Overall Study|Inappropriate Enrollment|0
4895214|NCT00661713|16866005|P5|Overall Study|Inappropriate Enrollment|0
4895215|NCT00661713|16866006|P4|Overall Study|Inappropriate Enrollment|0
4895216|NCT00661713|16866007|P3|Overall Study|Inappropriate Enrollment|0
4895217|NCT00661713|16866008|P2|Overall Study|Inappropriate Enrollment|0
4895218|NCT00661713|16866009|P1|Overall Study|Inappropriate Enrollment|0
4895219|NCT00661713|16866002|P8|Overall Study|Adverse Event|0
4895220|NCT00661713|16866003|P7|Overall Study|Adverse Event|1
4895221|NCT00661713|16866004|P6|Overall Study|Adverse Event|0
4895222|NCT00661713|16866005|P5|Overall Study|Adverse Event|0
4895223|NCT00661713|16866006|P4|Overall Study|Adverse Event|0
4895224|NCT00661713|16866007|P3|Overall Study|Adverse Event|0
4895225|NCT00661713|16866008|P2|Overall Study|Adverse Event|0
4895226|NCT00661713|16866009|P1|Overall Study|Adverse Event|0
4895227|NCT00661713|16866002|P8|Overall Study|Administrative Reason|0
4895228|NCT00661713|16866003|P7|Overall Study|Administrative Reason|1
4895229|NCT00661713|16866004|P6|Overall Study|Administrative Reason|2
4895230|NCT00661713|16866005|P5|Overall Study|Administrative Reason|2
4895231|NCT00661713|16866006|P4|Overall Study|Administrative Reason|2
4895232|NCT00661713|16866007|P3|Overall Study|Administrative Reason|0
4895233|NCT00661713|16866008|P2|Overall Study|Administrative Reason|1
4895234|NCT00661713|16866009|P1|Overall Study|Administrative Reason|0
4895235|NCT00661713|16866002|P8|Overall Study|Lost to Follow-up|1
4895236|NCT00661713|16866003|P7|Overall Study|Lost to Follow-up|14
4895237|NCT00661713|16866004|P6|Overall Study|Lost to Follow-up|7
4895238|NCT00661713|16866005|P5|Overall Study|Lost to Follow-up|5
4895239|NCT00661713|16866006|P4|Overall Study|Lost to Follow-up|2
4895240|NCT00661713|16866007|P3|Overall Study|Lost to Follow-up|2
4895241|NCT00661713|16866008|P2|Overall Study|Lost to Follow-up|7
4895242|NCT00661713|16866009|P1|Overall Study|Lost to Follow-up|2
4895243|NCT00661713|16866002|P8|Overall Study|Withdrawal by Subject|9
4895244|NCT00661713|16866003|P7|Overall Study|Withdrawal by Subject|45
4895245|NCT00661713|16866004|P6|Overall Study|Withdrawal by Subject|26
4895246|NCT00661713|16866005|P5|Overall Study|Withdrawal by Subject|12
4895247|NCT00661713|16866006|P4|Overall Study|Withdrawal by Subject|21
4895248|NCT00661713|16866007|P3|Overall Study|Withdrawal by Subject|12
4895249|NCT00661713|16866008|P2|Overall Study|Withdrawal by Subject|25
4895250|NCT00661713|16866009|P1|Overall Study|Withdrawal by Subject|11
4895251|NCT00661713|16866002|P8|Overall Study|Protocol Violation|1
4895252|NCT00661713|16866003|P7|Overall Study|Protocol Violation|2
4895253|NCT00661713|16866004|P6|Overall Study|Protocol Violation|2
4895254|NCT00661713|16866005|P5|Overall Study|Protocol Violation|0
4895255|NCT00661713|16866006|P4|Overall Study|Protocol Violation|3
4895256|NCT00661713|16866007|P3|Overall Study|Protocol Violation|3
4895257|NCT00661713|16866008|P2|Overall Study|Protocol Violation|6
4895258|NCT00661713|16866009|P1|Overall Study|Protocol Violation|1
4895259|NCT00661713|16866002|P8|Overall Study|Unable to Classify|0
4895260|NCT00661713|16866003|P7|Overall Study|Unable to Classify|0
4895261|NCT00661713|16866004|P6|Overall Study|Unable to Classify|0
4895262|NCT00661713|16866005|P5|Overall Study|Unable to Classify|0
4895263|NCT00661713|16866006|P4|Overall Study|Unable to Classify|0
4895264|NCT00661713|16866007|P3|Overall Study|Unable to Classify|0
4895265|NCT00661713|16866008|P2|Overall Study|Unable to Classify|0
4895266|NCT00661713|16866009|P1|Overall Study|Unable to Classify|1
4895267|NCT00661713|16866002|P8|Overall Study|Death|0
4895268|NCT00661713|16866003|P7|Overall Study|Death|0
4895269|NCT00661713|16866004|P6|Overall Study|Death|0
4895270|NCT00661713|16866005|P5|Overall Study|Death|1
4895271|NCT00661713|16866006|P4|Overall Study|Death|0
4895272|NCT00661713|16866007|P3|Overall Study|Death|0
4895273|NCT00661713|16866008|P2|Overall Study|Death|0
4895274|NCT00661713|16866009|P1|Overall Study|Death|1
4895275|NCT00661687|16866101|P1|Overall Study|Adverse Event|2
4895276|NCT00661687|16866101|P1|Overall Study|Physician Decision|1
4895277|NCT00661687|16866101|P1|Overall Study|Inability to maintain wearing schedule|3
4895278|NCT00661687|16866101|P1|Overall Study|Positive slit lamp findings|4
4895279|NCT00661687|16866101|P1|Overall Study|Study related symptoms and complaints|5
4895280|NCT00661661|16866129|P2|Overall Study|Not assigned treatment|0
4895281|NCT00661661|16866130|P1|Overall Study|Not assigned treatment|1
4895282|NCT00661661|16866129|P2|Overall Study|Other|7
4895283|NCT00661661|16866130|P1|Overall Study|Other|22
4895284|NCT00661661|16866129|P2|Overall Study|Withdrawal by Subject|5
4895285|NCT00661661|16866130|P1|Overall Study|Withdrawal by Subject|15
4895286|NCT00661661|16866129|P2|Overall Study|Lost to Follow-up|1
4895287|NCT00661661|16866130|P1|Overall Study|Lost to Follow-up|0
4895288|NCT00661661|16866129|P2|Overall Study|Lack of Efficacy|2
4895289|NCT00661661|16866130|P1|Overall Study|Lack of Efficacy|3
4895290|NCT00661661|16866129|P2|Overall Study|Adverse Event|24
4895291|NCT00661661|16866130|P1|Overall Study|Adverse Event|99
4895292|NCT00661622|16866206|P2|Overall Study|Protocol Violation|0
4895293|NCT00661622|16866207|P1|Overall Study|Protocol Violation|1
4895294|NCT00661609|16866221|P1|Overall Study|Disease progression|3
4895295|NCT00661609|16866221|P1|Overall Study|Survival follow up stage discontinued|11
4895296|NCT00661609|16866221|P1|Overall Study|PI Decision|1
4895297|NCT00661609|16866221|P1|Overall Study|Withdrawal by Subject|2
4895298|NCT00661609|16866221|P1|Overall Study|Death|20
4895299|NCT00661609|16866221|P1|Overall Study|Adverse Event|4
4895300|NCT00661531|16866288|P1|Overall Study|Withdrawal by Subject|3
4895301|NCT00661505|16866293|P1|Overall Study|Other|2
4895302|NCT00661505|16866293|P1|Overall Study|Lost to Follow-up|3
4895303|NCT00661505|16866293|P1|Overall Study|Withdrawal by Subject|8
4895304|NCT00661505|16866293|P1|Overall Study|Protocol Violation|14
4895305|NCT00661505|16866293|P1|Overall Study|Adverse Event|3
4895306|NCT00661492|16866321|P2|Overall Study|Other|0
4895307|NCT00661492|16866322|P1|Overall Study|Other|1
4895308|NCT00661492|16866321|P2|Overall Study|Lost to Follow-up|1
4895309|NCT00661492|16866322|P1|Overall Study|Lost to Follow-up|0
4895310|NCT00661492|16866321|P2|Overall Study|Investigator Request|0
4895311|NCT00661492|16866322|P1|Overall Study|Investigator Request|1
4895312|NCT00661492|16866321|P2|Overall Study|Patient Request|1
4895313|NCT00661492|16866322|P1|Overall Study|Patient Request|6
4895314|NCT00661492|16866321|P2|Overall Study|Disease Progression|14
4895315|NCT00661492|16866322|P1|Overall Study|Disease Progression|44
4895316|NCT00661492|16866321|P2|Overall Study|Adverse Event|13
4895317|NCT00661492|16866322|P1|Overall Study|Adverse Event|16
4895318|NCT00661427|16866368|P2|Overall Study|Patient not treated|2
4895319|NCT00661427|16866369|P1|Overall Study|Patient not treated|0
4895320|NCT00661427|16866368|P2|Overall Study|Adverse Event|5
4895321|NCT00661427|16866369|P1|Overall Study|Adverse Event|5
4895322|NCT00661388|16866377|P1|Overall Study|Administrative reasons|1
4895323|NCT00661388|16866377|P1|Overall Study|Dialysis initiation|1
4895324|NCT00661388|16866377|P1|Overall Study|Renal transplantation|1
4895325|NCT00661388|16866377|P1|Overall Study|Protocol Violation|7
4895326|NCT00661388|16866377|P1|Overall Study|Adverse Event|14
4895327|NCT00661362|16866400|P2|Overall Study|Metformin dose haven't decreasd to 2.5 g|0
4895328|NCT00661362|16866401|P1|Overall Study|Metformin dose haven't decreasd to 2.5 g|1
4895329|NCT00661362|16866400|P2|Overall Study|Safety reasons|0
4895330|NCT00661362|16866401|P1|Overall Study|Safety reasons|1
4895331|NCT00661362|16866400|P2|Overall Study|Severe non-compliance to protocol|1
4895332|NCT00661362|16866401|P1|Overall Study|Severe non-compliance to protocol|0
4895333|NCT00661362|16866400|P2|Overall Study|Lost to Follow-up|1
4895334|NCT00661362|16866401|P1|Overall Study|Lost to Follow-up|3
4895335|NCT00661362|16866400|P2|Overall Study|Withdrawal by Subject|23
4895336|NCT00661362|16866401|P1|Overall Study|Withdrawal by Subject|13
4895337|NCT00661362|16866400|P2|Overall Study|Study specific discontinuation criteria|11
4895338|NCT00661362|16866401|P1|Overall Study|Study specific discontinuation criteria|4
4895339|NCT00661362|16866400|P2|Overall Study|Incorrect enrollment|0
4895340|NCT00661362|16866401|P1|Overall Study|Incorrect enrollment|2
4895341|NCT00661362|16866400|P2|Overall Study|Adverse Event|4
4895342|NCT00661362|16866401|P1|Overall Study|Adverse Event|5
4895343|NCT00661271|16866419|P2|Overall Study|Lost to Follow-up|25
4895344|NCT00661271|16866420|P1|Overall Study|Lost to Follow-up|28
4895345|NCT00661258|16866430|P2|Overall Study|caught by police and in detox center|1
4895346|NCT00661258|16866431|P1|Overall Study|caught by police and in detox center|2
4895347|NCT00661258|16866430|P2|Overall Study|Death|0
4895348|NCT00661258|16866431|P1|Overall Study|Death|1
4895349|NCT00661193|16866441|P2|Overall Study|Not protocol specified|0
4895350|NCT00661193|16866442|P1|Overall Study|Not protocol specified|1
4895351|NCT00661193|16866441|P2|Overall Study|Progression|24
4895352|NCT00661193|16866442|P1|Overall Study|Progression|27
4895353|NCT00661193|16866441|P2|Overall Study|Withdrawal by Subject|1
4895354|NCT00661193|16866442|P1|Overall Study|Withdrawal by Subject|3
4895355|NCT00661193|16866441|P2|Overall Study|Adverse Event|1
4895356|NCT00661193|16866442|P1|Overall Study|Adverse Event|2
4895357|NCT00661089|16866667|P2|Overall Study|death at 8 weeks due to new stroke|1
4895358|NCT00661089|16866668|P1|Overall Study|death at 8 weeks due to new stroke|0
4895359|NCT00661089|16866667|P2|Overall Study|1 subject withdrawal|1
4895360|NCT00661089|16866668|P1|Overall Study|1 subject withdrawal|0
4895361|NCT00660907|16866716|P2|Overall Study|Various|8
4895362|NCT00660907|16866717|P1|Overall Study|Various|11
4895363|NCT00660907|16866716|P2|Overall Study|Death|3
4895364|NCT00660907|16866717|P1|Overall Study|Death|1
4895365|NCT00660907|16866716|P2|Overall Study|Safety|0
4895366|NCT00660907|16866717|P1|Overall Study|Safety|1
4895367|NCT00660907|16866716|P2|Overall Study|Poor/Non-Compliance|1
4895368|NCT00660907|16866717|P1|Overall Study|Poor/Non-Compliance|5
4895369|NCT00660907|16866716|P2|Overall Study|Lost to Follow-up|3
4895370|NCT00660907|16866717|P1|Overall Study|Lost to Follow-up|3
4895371|NCT00660907|16866716|P2|Overall Study|Withdrawal by Subject|32
4895372|NCT00660907|16866717|P1|Overall Study|Withdrawal by Subject|23
4895373|NCT00660907|16866716|P2|Overall Study|Subject No Longer Meets Study Criteria|27
4895374|NCT00660907|16866717|P1|Overall Study|Subject No Longer Meets Study Criteria|6
4895375|NCT00660907|16866716|P2|Overall Study|Adverse Event|19
4895376|NCT00660907|16866717|P1|Overall Study|Adverse Event|33
4895377|NCT00660907|16866716|P2|Overall Study|Incorrect Enrollment|1
4895378|NCT00660907|16866717|P1|Overall Study|Incorrect Enrollment|1
4895379|NCT00660829|16866731|P2|Overall Study|Other|4
4895380|NCT00660829|16866732|P1|Overall Study|Other|9
4895381|NCT00660829|16866731|P2|Overall Study|Lost to Follow-up|2
4895382|NCT00660829|16866732|P1|Overall Study|Lost to Follow-up|3
4895383|NCT00660829|16866731|P2|Overall Study|Withdrawal by Subject|2
4895384|NCT00660829|16866732|P1|Overall Study|Withdrawal by Subject|1
4895385|NCT00660829|16866731|P2|Overall Study|Non-Compliance|4
4895386|NCT00660829|16866732|P1|Overall Study|Non-Compliance|0
4895387|NCT00660829|16866731|P2|Overall Study|Lack of Efficacy|3
4895388|NCT00660829|16866732|P1|Overall Study|Lack of Efficacy|2
4895389|NCT00660829|16866731|P2|Overall Study|Adverse Event|4
4895390|NCT00660829|16866732|P1|Overall Study|Adverse Event|3
4895391|NCT00660816|16866750|P2|Overall Study|Complicating Disease|1
4895392|NCT00660816|16866751|P1|Overall Study|Complicating Disease|0
4895393|NCT00660816|16866750|P2|Overall Study|Disease Progression|12
4895394|NCT00660816|16866751|P1|Overall Study|Disease Progression|16
4895395|NCT00660816|16866750|P2|Overall Study|Protocol Violation|0
4895396|NCT00660816|16866751|P1|Overall Study|Protocol Violation|1
4895397|NCT00660816|16866750|P2|Overall Study|Physician Decision|2
4895398|NCT00660816|16866751|P1|Overall Study|Physician Decision|0
4895399|NCT00660816|16866750|P2|Overall Study|Lack of Efficacy|0
4895400|NCT00660816|16866751|P1|Overall Study|Lack of Efficacy|1
4895401|NCT00660816|16866750|P2|Overall Study|Death|2
4895402|NCT00660816|16866751|P1|Overall Study|Death|0
4895403|NCT00660816|16866750|P2|Overall Study|Withdrawal by Subject|0
4895404|NCT00660816|16866751|P1|Overall Study|Withdrawal by Subject|1
4895405|NCT00660816|16866750|P2|Overall Study|Adverse Event|2
4895406|NCT00660816|16866751|P1|Overall Study|Adverse Event|1
4895407|NCT00660790|16866763|P1|3 Months to 2 Years|Withdrawal by Subject|17
4895408|NCT00660790|16866763|P1|Baseline to 3 Months|Withdrawal by Subject|2
4895409|NCT00660790|16866763|P1|Baseline to 3 Months|Death|1
4895410|NCT00660699|16866767|P1|Overall Study|Withdrawal by Subject|2
4895411|NCT00660660|16866783|P2|Overall Study|New medication after randomization|0
4895412|NCT00660660|16866784|P1|Overall Study|New medication after randomization|1
4895413|NCT00660660|16866783|P2|Overall Study|Incorrect enrollment and other|1
4895414|NCT00660660|16866784|P1|Overall Study|Incorrect enrollment and other|0
4895415|NCT00660660|16866783|P2|Overall Study|Withdrawal by Subject|0
4895416|NCT00660660|16866784|P1|Overall Study|Withdrawal by Subject|3
4895417|NCT00660660|16866783|P2|Overall Study|Lack of Efficacy|2
4895418|NCT00660660|16866784|P1|Overall Study|Lack of Efficacy|0
4895419|NCT00660660|16866783|P2|Overall Study|Lost to Follow-up|6
4895420|NCT00660660|16866784|P1|Overall Study|Lost to Follow-up|0
4895421|NCT00660660|16866783|P2|Overall Study|Adverse Event|0
4895422|NCT00660660|16866784|P1|Overall Study|Adverse Event|1
4895423|NCT00660595|16866884|P2|Overall Study|Non Specified reasons|0
4895424|NCT00660595|16866885|P1|Overall Study|Non Specified reasons|5
4895425|NCT00660595|16866884|P2|Overall Study|Participant left hospital|0
4895426|NCT00660595|16866885|P1|Overall Study|Participant left hospital|1
4895427|NCT00660595|16866884|P2|Overall Study|Did not consent to participate in study|8
4895428|NCT00660595|16866885|P1|Overall Study|Did not consent to participate in study|12
4895429|NCT00660595|16866884|P2|Overall Study|Lost to Follow-up|1
4895430|NCT00660595|16866885|P1|Overall Study|Lost to Follow-up|0
4895431|NCT00660400|16866952|P1|Overall Study|Withdrawal by Subject|1
4895432|NCT00660400|16866952|P1|Overall Study|Intracranial hemorrhage|1
4895433|NCT00660400|16866952|P1|Overall Study|Suboptimal organ function|1
4895434|NCT00660400|16866952|P1|Overall Study|Lack of insurance approval|1
4895435|NCT00660387|16866961|P2|Overall Study|Protocol Violation|0
4895436|NCT00660387|16866962|P1|Overall Study|Protocol Violation|1
4895437|NCT00660387|16866961|P2|Overall Study|Lack of Efficacy|1
4895438|NCT00660387|16866962|P1|Overall Study|Lack of Efficacy|0
4895439|NCT00660387|16866961|P2|Overall Study|Adverse Event|2
4895440|NCT00660387|16866962|P1|Overall Study|Adverse Event|1
4895441|NCT00660348|16867016|P2|Overall Study|Withdrawal by Subject|0
4895442|NCT00660348|16867017|P1|Overall Study|Withdrawal by Subject|1
4895443|NCT00660309|16867025|P2|Overall Study|Withdrawal by Subject|3
4895444|NCT00660309|16867026|P1|Overall Study|Withdrawal by Subject|0
4895445|NCT00660309|16867025|P2|Overall Study|Adverse Event|0
4895446|NCT00660309|16867026|P1|Overall Study|Adverse Event|2
4895447|NCT00660192|16867067|P2|Overall Study|Lost to Follow-up|3
4895448|NCT00660192|16867068|P1|Overall Study|Lost to Follow-up|2
4895449|NCT00660179|16867079|P3|Overall Study|Incorrect randomization|0
4895450|NCT00660179|16867080|P2|Overall Study|Incorrect randomization|0
4895451|NCT00660179|16867081|P1|Overall Study|Incorrect randomization|1
4895452|NCT00660179|16867079|P3|Overall Study|Administrative reason|1
4895453|NCT00660179|16867080|P2|Overall Study|Administrative reason|0
4895454|NCT00660179|16867081|P1|Overall Study|Administrative reason|0
4895455|NCT00660179|16867079|P3|Overall Study|Lost to Follow-up|2
4895456|NCT00660179|16867080|P2|Overall Study|Lost to Follow-up|5
4895457|NCT00660179|16867081|P1|Overall Study|Lost to Follow-up|7
4895458|NCT00660179|16867079|P3|Overall Study|Withdrawal of consent|4
4895459|NCT00660179|16867080|P2|Overall Study|Withdrawal of consent|6
4895460|NCT00660179|16867081|P1|Overall Study|Withdrawal of consent|4
4895461|NCT00660179|16867079|P3|Overall Study|Death|34
4895462|NCT00660179|16867080|P2|Overall Study|Death|47
4895463|NCT00660179|16867081|P1|Overall Study|Death|44
4895464|NCT00660023|16867126|P1|Overall Study|Other Screening Failure|9
4895465|NCT00660023|16867126|P1|Overall Study|Missed Pregnancy Test|1
4895466|NCT00660023|16867126|P1|Overall Study|Withdrawal by Subject|1
4895467|NCT00660023|16867126|P1|Overall Study|Renal Transplantation|3
4895468|NCT00660023|16867126|P1|Overall Study|Blood Transfusion|5
4895469|NCT00660023|16867126|P1|Overall Study|Death|8
4895470|NCT00660023|16867126|P1|Overall Study|Adverse Event|2
4895471|NCT00660010|16867137|P1|Overall Study|Noncompliance with visit schedule|3
4895472|NCT00660010|16867137|P1|Overall Study|Adverse Event|1
4895473|NCT00660010|16867137|P1|Overall Study|Lost to Follow-up|3
4895474|NCT00660010|16867137|P1|Overall Study|Withdrawal by Subject|2
4895475|NCT00659984|16867151|P1|Overall Study|Adverse Event|1
4895476|NCT00659880|16867171|P1|Overall Study|Lost to Follow-up|5
4895477|NCT00659815|16867184|P2|Overall Study|Withdrawal by Subject|1
4895478|NCT00659815|16867185|P1|Overall Study|Withdrawal by Subject|1
4895479|NCT00659815|16867184|P2|Overall Study|Inability to maintain wearing schedule|2
4895480|NCT00659815|16867185|P1|Overall Study|Inability to maintain wearing schedule|1
4895481|NCT00659815|16867184|P2|Overall Study|Study related symptoms and complaints|1
4895482|NCT00659815|16867185|P1|Overall Study|Study related symptoms and complaints|2
4895483|NCT00659607|16867264|P1|Overall Study|Inconsistent BP measuring date|2
4895484|NCT00659607|16867264|P1|Overall Study|No recorded efficacy data|15
4895485|NCT00659607|16867264|P1|Overall Study|'Unable to evaluate' for the final asses|67
4895486|NCT00659607|16867264|P1|Overall Study|Unknown measuring date of blood pressure|85
4895487|NCT00659607|16867264|P1|Overall Study|No blood pressure recorded|147
4895488|NCT00659581|16867282|P1|Overall Study|Other|6393
4895489|NCT00659581|16867282|P1|Overall Study|Lack of Efficacy|1183
4895490|NCT00659581|16867282|P1|Overall Study|Adverse Event|1006
4895491|NCT00659529|16867294|P1|Overall Study|Screen failure|9
4895492|NCT00659529|16867294|P1|Overall Study|Protocol Violation|3
4895493|NCT00659529|16867294|P1|Overall Study|Withdrawal by Subject|4
4895494|NCT00659490|16867301|P3|Overall Study|Lost to Follow-up|1
4895495|NCT00659490|16867302|P2|Overall Study|Lost to Follow-up|0
4895496|NCT00659490|16867303|P1|Overall Study|Lost to Follow-up|2
4895497|NCT00659438|16867376|P2|Overall Study|Lost to Follow-up|0
4895498|NCT00659438|16867377|P1|Overall Study|Lost to Follow-up|1
4895499|NCT00659438|16867376|P2|Overall Study|Death|6
4895500|NCT00659438|16867377|P1|Overall Study|Death|11
4895501|NCT00659438|16867376|P2|Overall Study|Withdrawal by Subject|2
4895502|NCT00659438|16867377|P1|Overall Study|Withdrawal by Subject|2
4895503|NCT00659425|16867409|P10|Overall Study|Other|6
4895504|NCT00659425|16867410|P9|Overall Study|Other|0
4895505|NCT00659425|16867411|P8|Overall Study|Other|2
4895506|NCT00659425|16867412|P7|Overall Study|Other|3
4895507|NCT00659425|16867413|P6|Overall Study|Other|0
4895508|NCT00659425|16867414|P5|Overall Study|Other|4
4895509|NCT00659425|16867415|P4|Overall Study|Other|2
4895510|NCT00659425|16867416|P3|Overall Study|Other|1
4895511|NCT00659425|16867417|P2|Overall Study|Other|1
4895512|NCT00659425|16867418|P1|Overall Study|Other|0
4895513|NCT00659425|16867409|P10|Overall Study|Investigator Discretion|0
4895514|NCT00659425|16867410|P9|Overall Study|Investigator Discretion|0
4895515|NCT00659425|16867411|P8|Overall Study|Investigator Discretion|3
4895516|NCT00659425|16867412|P7|Overall Study|Investigator Discretion|0
4895517|NCT00659425|16867413|P6|Overall Study|Investigator Discretion|1
4895518|NCT00659425|16867414|P5|Overall Study|Investigator Discretion|0
4895519|NCT00659425|16867415|P4|Overall Study|Investigator Discretion|0
4895520|NCT00659425|16867416|P3|Overall Study|Investigator Discretion|0
4895521|NCT00659425|16867417|P2|Overall Study|Investigator Discretion|0
4895522|NCT00659425|16867418|P1|Overall Study|Investigator Discretion|0
4895523|NCT00659425|16867409|P10|Overall Study|Adverse Event|4
4895524|NCT00659425|16867410|P9|Overall Study|Adverse Event|1
4895525|NCT00659425|16867411|P8|Overall Study|Adverse Event|3
4895526|NCT00659425|16867412|P7|Overall Study|Adverse Event|0
4895527|NCT00659425|16867413|P6|Overall Study|Adverse Event|1
4895528|NCT00659425|16867414|P5|Overall Study|Adverse Event|0
4895529|NCT00659425|16867415|P4|Overall Study|Adverse Event|0
4895530|NCT00659425|16867416|P3|Overall Study|Adverse Event|0
4895531|NCT00659425|16867417|P2|Overall Study|Adverse Event|0
4895532|NCT00659425|16867418|P1|Overall Study|Adverse Event|0
4895533|NCT00659425|16867409|P10|Overall Study|Death|0
4895534|NCT00659425|16867410|P9|Overall Study|Death|0
4895535|NCT00659425|16867411|P8|Overall Study|Death|0
4895536|NCT00659425|16867412|P7|Overall Study|Death|1
4895537|NCT00659425|16867413|P6|Overall Study|Death|0
4895538|NCT00659425|16867414|P5|Overall Study|Death|0
4895539|NCT00659425|16867415|P4|Overall Study|Death|1
4895540|NCT00659425|16867416|P3|Overall Study|Death|0
4895541|NCT00659425|16867417|P2|Overall Study|Death|0
4895542|NCT00659425|16867418|P1|Overall Study|Death|0
4895543|NCT00659425|16867409|P10|Overall Study|Disease progression|3
4895544|NCT00659425|16867410|P9|Overall Study|Disease progression|5
4895545|NCT00659425|16867411|P8|Overall Study|Disease progression|3
4895546|NCT00659425|16867412|P7|Overall Study|Disease progression|4
4895547|NCT00659425|16867413|P6|Overall Study|Disease progression|2
4895548|NCT00659425|16867414|P5|Overall Study|Disease progression|0
4895549|NCT00659425|16867415|P4|Overall Study|Disease progression|1
4895550|NCT00659425|16867416|P3|Overall Study|Disease progression|0
4895551|NCT00659425|16867417|P2|Overall Study|Disease progression|0
4895552|NCT00659425|16867418|P1|Overall Study|Disease progression|1
4895553|NCT00659373|16867649|P2|Overall Study|Assessment Missed|2
4895554|NCT00659373|16867650|P1|Overall Study|Assessment Missed|2
4895555|NCT00659373|16867649|P2|Overall Study|Withdrawal by Subject|5
4895556|NCT00659373|16867650|P1|Overall Study|Withdrawal by Subject|3
4895557|NCT00659334|16867672|P7|Overall Study|Screen Failure|1
4895558|NCT00659334|16867673|P6|Overall Study|Screen Failure|0
4895559|NCT00659334|16867674|P5|Overall Study|Screen Failure|0
4895560|NCT00659334|16867675|P4|Overall Study|Screen Failure|0
4895561|NCT00659334|16867676|P3|Overall Study|Screen Failure|0
4895562|NCT00659334|16867677|P2|Overall Study|Screen Failure|5
4895563|NCT00659334|16867678|P1|Overall Study|Screen Failure|8
4895564|NCT00659269|16867705|P2|Overall Study|Physician Decision|1
4895565|NCT00659269|16867706|P1|Overall Study|Physician Decision|1
4895566|NCT00659230|16867736|P2|Overall Study|Did not return post-randomization|3
4895567|NCT00659230|16867737|P1|Overall Study|Did not return post-randomization|2
4895568|NCT00659230|16867736|P2|Overall Study|Lost source documentation|4
4895569|NCT00659230|16867737|P1|Overall Study|Lost source documentation|5
4895570|NCT00659230|16867736|P2|Overall Study|Lost to Follow-up|5
4895571|NCT00659230|16867737|P1|Overall Study|Lost to Follow-up|2
4895572|NCT00659061|16867760|P2|Overall Study|Migration due to political unrest|15
4895573|NCT00659061|16867761|P1|Overall Study|Migration due to political unrest|21
4895574|NCT00658996|16867779|P2|Second Intervention|Positive slit lamp finding|1
4895575|NCT00658996|16867780|P1|Second Intervention|Positive slit lamp finding|0
4895576|NCT00658996|16867779|P2|Second Intervention|Developed a stye on upper lid|0
4895577|NCT00658996|16867780|P1|Second Intervention|Developed a stye on upper lid|1
4895578|NCT00658996|16867779|P2|Crossover Period|Ineligible|1
4895579|NCT00658996|16867780|P1|Crossover Period|Ineligible|1
4895580|NCT00658996|16867779|P2|Crossover Period|Physician Decision|0
4895581|NCT00658996|16867780|P1|Crossover Period|Physician Decision|1
4895582|NCT00658996|16867779|P2|First Intervention|Lack of lenses|1
4895583|NCT00658996|16867780|P1|First Intervention|Lack of lenses|0
4895584|NCT00658996|16867779|P2|First Intervention|Positive slit lamp finding|0
4895585|NCT00658996|16867780|P1|First Intervention|Positive slit lamp finding|1
4895586|NCT00658879|16867790|P1|Overall Study|Protocol Violation|1
4895587|NCT00658814|16867807|P2|Maintenance Therapy|Not eligible|0
4895588|NCT00658814|16867808|P1|Maintenance Therapy|Not eligible|1
4895589|NCT00658814|16867807|P2|Maintenance Therapy|Not protocol specified|0
4895590|NCT00658814|16867808|P1|Maintenance Therapy|Not protocol specified|1
4895591|NCT00658814|16867807|P2|Maintenance Therapy|Adverse Event|1
4895592|NCT00658814|16867808|P1|Maintenance Therapy|Adverse Event|1
4895593|NCT00658814|16867807|P2|Consolidation Therapy|Not eligible|2
4895594|NCT00658814|16867808|P1|Consolidation Therapy|Not eligible|2
4895595|NCT00658814|16867807|P2|Consolidation Therapy|Not protocol specified|1
4895596|NCT00658814|16867808|P1|Consolidation Therapy|Not protocol specified|0
4895597|NCT00658814|16867807|P2|Remission Induction Chemotherapy|Not eligible|2
4895598|NCT00658814|16867808|P1|Remission Induction Chemotherapy|Not eligible|1
4895599|NCT00658814|16867807|P2|Remission Induction Chemotherapy|Not protocol specified|4
4895600|NCT00658814|16867808|P1|Remission Induction Chemotherapy|Not protocol specified|2
4895601|NCT00658814|16867807|P2|Remission Induction Chemotherapy|Death|4
4895602|NCT00658814|16867808|P1|Remission Induction Chemotherapy|Death|1
4895603|NCT00658814|16867807|P2|Remission Induction Chemotherapy|Progression/Relapse|1
4895604|NCT00658814|16867808|P1|Remission Induction Chemotherapy|Progression/Relapse|0
4895605|NCT00658814|16867807|P2|Remission Induction Chemotherapy|Withdrawal by Subject|4
4895606|NCT00658814|16867808|P1|Remission Induction Chemotherapy|Withdrawal by Subject|3
4895607|NCT00658814|16867807|P2|Remission Induction Chemotherapy|Adverse Event|3
4895608|NCT00658814|16867808|P1|Remission Induction Chemotherapy|Adverse Event|1
4895609|NCT00658788|16867822|P1|Overall Study|Treatment Discontinuation|32
4895610|NCT00658788|16867822|P1|Overall Study|Lost to Follow-up|18
4895611|NCT00658788|16867822|P1|Overall Study|Withdrawal by Subject|13
4895612|NCT00658788|16867822|P1|Overall Study|Adverse Event|11
4895613|NCT00658775|16867877|P2|Overall Study|Other|8
4895614|NCT00658775|16867878|P1|Overall Study|Other|7
4895615|NCT00658775|16867877|P2|Overall Study|Withdrawal of consent|7
4895616|NCT00658775|16867878|P1|Overall Study|Withdrawal of consent|8
4895617|NCT00658775|16867877|P2|Overall Study|Withdrawal by Subject|4
4895618|NCT00658775|16867878|P1|Overall Study|Withdrawal by Subject|6
4895619|NCT00658775|16867877|P2|Overall Study|Lost to Follow-up|18
4895620|NCT00658775|16867878|P1|Overall Study|Lost to Follow-up|17
4895621|NCT00658775|16867877|P2|Overall Study|Adverse Event|6
4895622|NCT00658775|16867878|P1|Overall Study|Adverse Event|4
4895623|NCT00658723|16867901|P3|Overall Study|Withdrawal by Subject|1
4895624|NCT00658723|16867902|P2|Overall Study|Withdrawal by Subject|0
4895625|NCT00658723|16867903|P1|Overall Study|Withdrawal by Subject|1
4895626|NCT00658723|16867901|P3|Overall Study|Scheduling Issue|0
4895627|NCT00658723|16867902|P2|Overall Study|Scheduling Issue|1
4895628|NCT00658723|16867903|P1|Overall Study|Scheduling Issue|1
4895629|NCT00658723|16867901|P3|Overall Study|Death|4
4895630|NCT00658723|16867902|P2|Overall Study|Death|1
4895631|NCT00658723|16867903|P1|Overall Study|Death|2
4895632|NCT00658723|16867901|P3|Overall Study|Lost to Follow-up|2
4895633|NCT00658723|16867902|P2|Overall Study|Lost to Follow-up|2
4895634|NCT00658723|16867903|P1|Overall Study|Lost to Follow-up|0
4895635|NCT00658684|16867941|P4|Overall Study|Pregnancy|0
4895636|NCT00658684|16867942|P3|Overall Study|Pregnancy|0
4895637|NCT00658684|16867943|P2|Overall Study|Pregnancy|1
4895638|NCT00658684|16867944|P1|Overall Study|Pregnancy|1
4895639|NCT00658684|16867941|P4|Overall Study|Protocol Violation|0
4895640|NCT00658684|16867942|P3|Overall Study|Protocol Violation|0
4895641|NCT00658684|16867943|P2|Overall Study|Protocol Violation|1
4895642|NCT00658684|16867944|P1|Overall Study|Protocol Violation|1
4895643|NCT00658684|16867941|P4|Overall Study|Lack of Efficacy|0
4895644|NCT00658684|16867942|P3|Overall Study|Lack of Efficacy|0
4895645|NCT00658684|16867943|P2|Overall Study|Lack of Efficacy|1
4895646|NCT00658684|16867944|P1|Overall Study|Lack of Efficacy|1
4895647|NCT00658684|16867941|P4|Overall Study|Withdrawal by Subject|1
4895648|NCT00658684|16867942|P3|Overall Study|Withdrawal by Subject|1
4895649|NCT00658684|16867943|P2|Overall Study|Withdrawal by Subject|4
4895650|NCT00658684|16867944|P1|Overall Study|Withdrawal by Subject|6
4895651|NCT00658684|16867941|P4|Overall Study|Adverse Event|0
4895652|NCT00658684|16867942|P3|Overall Study|Adverse Event|2
4895653|NCT00658684|16867943|P2|Overall Study|Adverse Event|8
4895654|NCT00658684|16867944|P1|Overall Study|Adverse Event|10
4895655|NCT00658658|16867999|P5|Overall Study|Other|1
4895656|NCT00658658|16868000|P4|Overall Study|Other|0
4895657|NCT00658658|16868001|P3|Overall Study|Other|0
4895658|NCT00658658|16868002|P2|Overall Study|Other|0
4895659|NCT00658658|16868003|P1|Overall Study|Other|0
4895660|NCT00658658|16867999|P5|Overall Study|Protocol-specified Criteria|0
4895661|NCT00658658|16868000|P4|Overall Study|Protocol-specified Criteria|0
4895662|NCT00658658|16868001|P3|Overall Study|Protocol-specified Criteria|0
4895663|NCT00658658|16868002|P2|Overall Study|Protocol-specified Criteria|0
4895664|NCT00658658|16868003|P1|Overall Study|Protocol-specified Criteria|1
4895665|NCT00658658|16867999|P5|Overall Study|Disease Progression|3
4895666|NCT00658658|16868000|P4|Overall Study|Disease Progression|1
4895667|NCT00658658|16868001|P3|Overall Study|Disease Progression|0
4895668|NCT00658658|16868002|P2|Overall Study|Disease Progression|1
4895669|NCT00658658|16868003|P1|Overall Study|Disease Progression|0
4895670|NCT00658658|16867999|P5|Overall Study|Death|1
4895671|NCT00658658|16868000|P4|Overall Study|Death|1
4895672|NCT00658658|16868001|P3|Overall Study|Death|0
4895673|NCT00658658|16868002|P2|Overall Study|Death|0
4895674|NCT00658658|16868003|P1|Overall Study|Death|4
4895675|NCT00658658|16867999|P5|Overall Study|Withdrawal by Subject|0
4895676|NCT00658658|16868000|P4|Overall Study|Withdrawal by Subject|0
4895677|NCT00658658|16868001|P3|Overall Study|Withdrawal by Subject|0
4895678|NCT00658658|16868002|P2|Overall Study|Withdrawal by Subject|1
4895679|NCT00658658|16868003|P1|Overall Study|Withdrawal by Subject|0
4895680|NCT00658632|16868062|P2|Overall Study|Other|8
4895681|NCT00658632|16868063|P1|Overall Study|Other|7
4895682|NCT00658632|16868062|P2|Overall Study|Pregnancy|1
4895683|NCT00658632|16868063|P1|Overall Study|Pregnancy|1
4895684|NCT00658632|16868062|P2|Overall Study|Withdrawal of consent|14
4895685|NCT00658632|16868063|P1|Overall Study|Withdrawal of consent|8
4895686|NCT00658632|16868062|P2|Overall Study|Lack of Efficacy|1
4895687|NCT00658632|16868063|P1|Overall Study|Lack of Efficacy|0
4895688|NCT00658632|16868062|P2|Overall Study|Withdrawal by Subject|7
4895689|NCT00658632|16868063|P1|Overall Study|Withdrawal by Subject|10
4895690|NCT00658632|16868062|P2|Overall Study|Lost to Follow-up|23
4895691|NCT00658632|16868063|P1|Overall Study|Lost to Follow-up|25
4895692|NCT00658632|16868062|P2|Overall Study|Adverse Event|11
4895693|NCT00658632|16868063|P1|Overall Study|Adverse Event|13
4895694|NCT00658606|16868104|P2|Overall Study|Lack of Compliance|3
4895695|NCT00658606|16868105|P1|Overall Study|Lack of Compliance|0
4895696|NCT00658606|16868104|P2|Overall Study|Withdrawal by Subject|16
4895697|NCT00658606|16868105|P1|Overall Study|Withdrawal by Subject|7
4895698|NCT00658606|16868104|P2|Overall Study|Lost to Follow-up|0
4895699|NCT00658606|16868105|P1|Overall Study|Lost to Follow-up|1
4895700|NCT00658606|16868104|P2|Overall Study|Lack of Efficacy|3
4895701|NCT00658606|16868105|P1|Overall Study|Lack of Efficacy|6
4895702|NCT00658606|16868104|P2|Overall Study|Adverse Event|1
4895703|NCT00658606|16868105|P1|Overall Study|Adverse Event|2
4895704|NCT00658567|16868134|P3|Overall Study|At Discretion of Sponsor|1
4895705|NCT00658567|16868135|P2|Overall Study|At Discretion of Sponsor|1
4895706|NCT00658567|16868136|P1|Overall Study|At Discretion of Sponsor|1
4895707|NCT00658567|16868134|P3|Overall Study|Physician Decision|0
4895708|NCT00658567|16868135|P2|Overall Study|Physician Decision|1
4895709|NCT00658567|16868136|P1|Overall Study|Physician Decision|0
4895710|NCT00658567|16868134|P3|Overall Study|Voluntary Withdrawal of Consent|2
4895711|NCT00658567|16868135|P2|Overall Study|Voluntary Withdrawal of Consent|0
4895712|NCT00658567|16868136|P1|Overall Study|Voluntary Withdrawal of Consent|2
4895713|NCT00658567|16868134|P3|Overall Study|Adverse Event|3
4895714|NCT00658567|16868135|P2|Overall Study|Adverse Event|2
4895715|NCT00658567|16868136|P1|Overall Study|Adverse Event|5
4895716|NCT00658541|16868147|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4895717|NCT00658541|16868148|P1|Washout Period of 7 Days|Withdrawal by Subject|0
4895718|NCT00658541|16868147|P2|Washout Period of 7 Days|Withdrawal by Subject|1
4895719|NCT00658541|16868148|P1|Washout Period of 7 Days|Withdrawal by Subject|1
4895720|NCT00658528|16868160|P2|Overall Study|Other|4
4895721|NCT00658528|16868161|P1|Overall Study|Other|8
4895722|NCT00658528|16868160|P2|Overall Study|Withdrawal of consent|6
4895723|NCT00658528|16868161|P1|Overall Study|Withdrawal of consent|5
4895724|NCT00658528|16868160|P2|Overall Study|Withdrawal by Subject|6
4895725|NCT00658528|16868161|P1|Overall Study|Withdrawal by Subject|8
4895726|NCT00658528|16868160|P2|Overall Study|Lost to Follow-up|22
4895727|NCT00658528|16868161|P1|Overall Study|Lost to Follow-up|14
4895728|NCT00658528|16868160|P2|Overall Study|Adverse Event|7
4895729|NCT00658528|16868161|P1|Overall Study|Adverse Event|5
4895730|NCT00658359|16868201|P3|Overall Study|Lack of Efficacy|0
4895731|NCT00658359|16868202|P2|Overall Study|Lack of Efficacy|1
4895732|NCT00658359|16868203|P1|Overall Study|Lack of Efficacy|0
4895733|NCT00658359|16868201|P3|Overall Study|Lost to Follow-up|4
4895734|NCT00658359|16868202|P2|Overall Study|Lost to Follow-up|2
4895735|NCT00658359|16868203|P1|Overall Study|Lost to Follow-up|2
4895736|NCT00658359|16868201|P3|Overall Study|Withdrawal by Subject|2
4895737|NCT00658359|16868202|P2|Overall Study|Withdrawal by Subject|4
4895738|NCT00658359|16868203|P1|Overall Study|Withdrawal by Subject|7
4895739|NCT00658359|16868201|P3|Overall Study|Includes protocol Amendments 3 and 4|29
4895740|NCT00658359|16868202|P2|Overall Study|Includes protocol Amendments 3 and 4|31
4895741|NCT00658359|16868203|P1|Overall Study|Includes protocol Amendments 3 and 4|2
4895742|NCT00658359|16868201|P3|Overall Study|Protocol Violation|0
4895743|NCT00658359|16868202|P2|Overall Study|Protocol Violation|0
4895744|NCT00658359|16868203|P1|Overall Study|Protocol Violation|1
4895745|NCT00658359|16868201|P3|Overall Study|Adverse Event|9
4895746|NCT00658359|16868202|P2|Overall Study|Adverse Event|6
4895747|NCT00658359|16868203|P1|Overall Study|Adverse Event|13
4895748|NCT00658359|16868201|P3|Overall Study|Death|2
4895749|NCT00658359|16868202|P2|Overall Study|Death|1
4895750|NCT00658359|16868203|P1|Overall Study|Death|3
4895751|NCT00658333|16868291|P2|Overall Study|Adverse Event|1
4895752|NCT00658333|16868292|P1|Overall Study|Adverse Event|2
4895753|NCT00658320|16868302|P2|Extension Study: After Month 24|Subject withdrew consent|0
4895754|NCT00658320|16868303|P1|Extension Study: After Month 24|Subject withdrew consent|2
4895755|NCT00658320|16868302|P2|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7
4895756|NCT00658320|16868303|P1|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3
4895757|NCT00658320|16868302|P2|Extension Study: Month 12 to Month 24|Subject withdrew consent|0
4895758|NCT00658320|16868303|P1|Extension Study: Month 12 to Month 24|Subject withdrew consent|3
4895759|NCT00658320|16868302|P2|Core Study: 12 Months|Subject withdrew consent|3
4895760|NCT00658320|16868303|P1|Core Study: 12 Months|Subject withdrew consent|5
4895761|NCT00657709|16868346|P5|Overall Study|Protocol Violation|2
4895762|NCT00657709|16868347|P4|Overall Study|Protocol Violation|1
4895763|NCT00657709|16868348|P3|Overall Study|Protocol Violation|0
4895764|NCT00657709|16868349|P2|Overall Study|Protocol Violation|2
4895765|NCT00657709|16868350|P1|Overall Study|Protocol Violation|0
4895766|NCT00657709|16868346|P5|Overall Study|Lost to Follow-up|21
4895767|NCT00657709|16868347|P4|Overall Study|Lost to Follow-up|1
4895768|NCT00657709|16868348|P3|Overall Study|Lost to Follow-up|7
4895769|NCT00657709|16868349|P2|Overall Study|Lost to Follow-up|9
4895770|NCT00657709|16868350|P1|Overall Study|Lost to Follow-up|9
4895771|NCT00657709|16868346|P5|Overall Study|Withdrawal by Subject|9
4895772|NCT00657709|16868347|P4|Overall Study|Withdrawal by Subject|5
4895773|NCT00657709|16868348|P3|Overall Study|Withdrawal by Subject|15
4895774|NCT00657709|16868349|P2|Overall Study|Withdrawal by Subject|15
4895775|NCT00657709|16868350|P1|Overall Study|Withdrawal by Subject|7
4895776|NCT00657709|16868346|P5|Overall Study|AE or Death|1
4895777|NCT00657709|16868347|P4|Overall Study|AE or Death|7
4895778|NCT00657709|16868348|P3|Overall Study|AE or Death|6
4895779|NCT00657709|16868349|P2|Overall Study|AE or Death|7
4895780|NCT00657709|16868350|P1|Overall Study|AE or Death|7
4895781|NCT00657618|16868399|P1|Overall Study|didn't start due to schedule conflicts|1
4895782|NCT00657618|16868399|P1|Overall Study|negative for leishmaniasis|2
4895783|NCT00657618|16868399|P1|Overall Study|Withdrawal by Subject|8
4895784|NCT00657618|16868399|P1|Overall Study|Adverse Event|32
4895785|NCT00657553|16868411|P2|Overall Study|low accrual, no analysis run|5
4895786|NCT00657553|16868412|P1|Overall Study|low accrual, no analysis run|5
4895787|NCT00657540|16868420|P2|Overall Study|Lost to Follow-up|4
4895788|NCT00657540|16868421|P1|Overall Study|Lost to Follow-up|1
4895789|NCT00657371|16868435|P1|Overall Study|Pre-existing medical condition|4
4895790|NCT00657371|16868435|P1|Overall Study|Device- related reasons|13
4895791|NCT00657371|16868435|P1|Overall Study|Protocol Violation|2
4895792|NCT00657371|16868435|P1|Overall Study|Unable to intubate the cecum|5
4895793|NCT00657371|16868435|P1|Overall Study|Poor bowel preparation|15
4895794|NCT00657358|16868440|P1|Overall Study|Lack of Efficacy|6
4895795|NCT00657267|16868452|P1|Overall Study|Adverse Event|9
4895796|NCT00657267|16868452|P1|Overall Study|Progressive disease|45
4895797|NCT00657150|16868462|P2|Treatment|Other|15
4895798|NCT00657150|16868463|P1|Treatment|Other|13
4895799|NCT00657150|16868462|P2|Treatment|Withdrawal by Subject|20
4895800|NCT00657150|16868463|P1|Treatment|Withdrawal by Subject|23
4895801|NCT00657150|16868462|P2|Treatment|Lost to Follow-up|0
4895802|NCT00657150|16868463|P1|Treatment|Lost to Follow-up|1
4895803|NCT00657150|16868462|P2|Treatment|Non-compliant with protocol|9
4895804|NCT00657150|16868463|P1|Treatment|Non-compliant with protocol|10
4895805|NCT00657150|16868462|P2|Treatment|Adverse Event|53
4895806|NCT00657150|16868463|P1|Treatment|Adverse Event|60
4895807|NCT00657150|16868462|P2|Overall Study|Other|38
4895808|NCT00657150|16868463|P1|Overall Study|Other|38
4895809|NCT00657150|16868462|P2|Overall Study|Withdrawal by Subject|36
4895810|NCT00657150|16868463|P1|Overall Study|Withdrawal by Subject|51
4895811|NCT00657150|16868462|P2|Overall Study|Lost to Follow-up|0
4895812|NCT00657150|16868463|P1|Overall Study|Lost to Follow-up|2
4895813|NCT00657150|16868462|P2|Overall Study|Non-compliant with protocol|9
4895814|NCT00657150|16868463|P1|Overall Study|Non-compliant with protocol|5
4895815|NCT00657150|16868462|P2|Overall Study|Adverse Event|10
4895816|NCT00657150|16868463|P1|Overall Study|Adverse Event|19
4895817|NCT00657046|16868494|P3|Overall Study|Surgery|1
4895818|NCT00657046|16868495|P2|Overall Study|Surgery|0
4895819|NCT00657046|16868496|P1|Overall Study|Surgery|0
4895820|NCT00657046|16868494|P3|Overall Study|Death|1
4895821|NCT00657046|16868495|P2|Overall Study|Death|0
4895822|NCT00657046|16868496|P1|Overall Study|Death|0
4895823|NCT00657046|16868494|P3|Overall Study|Withdrawal by Subject|0
4895824|NCT00657046|16868495|P2|Overall Study|Withdrawal by Subject|0
4895825|NCT00657046|16868496|P1|Overall Study|Withdrawal by Subject|1
4895826|NCT00657046|16868494|P3|Overall Study|Protocol Violation|0
4895827|NCT00657046|16868495|P2|Overall Study|Protocol Violation|2
4895828|NCT00657046|16868496|P1|Overall Study|Protocol Violation|2
4895829|NCT00657046|16868494|P3|Overall Study|Adverse Event|0
4895830|NCT00657046|16868495|P2|Overall Study|Adverse Event|1
4895831|NCT00657046|16868496|P1|Overall Study|Adverse Event|1
4895832|NCT00657020|16868528|P2|PERIOD 1|Adverse Event|1
4895833|NCT00657020|16868529|P1|PERIOD 1|Adverse Event|0
4895834|NCT00656851|16868579|P2|Overall Study|Withdrawal by Subject|4
4895835|NCT00656851|16868580|P1|Overall Study|Withdrawal by Subject|0
4895836|NCT00656799|16868602|P1|Overall Study|Death|2
4895837|NCT00656669|16868624|P1|AC (Cycles 6-9)|Did not start segment 3|1
4895838|NCT00656669|16868624|P1|AC (Cycles 6-9)|Adverse Event|1
4895839|NCT00656669|16868624|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2
4895840|NCT00656669|16868624|P1|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4
4895841|NCT00656617|16868663|P1|Overall Study|Move to different clinical trial|2
4895842|NCT00656617|16868663|P1|Overall Study|Insurance Issues|2
4895843|NCT00656617|16868663|P1|Overall Study|Death|2
4895844|NCT00656617|16868663|P1|Overall Study|Adverse Event|1
4895845|NCT00656513|16868672|P3|Overall Study|Missing baseline form|5
4895846|NCT00656513|16868673|P2|Overall Study|Missing baseline form|5
4895847|NCT00656513|16868674|P1|Overall Study|Missing baseline form|0
4895848|NCT00656513|16868672|P3|Overall Study|Treatment completed outside of timeframe|1
4895849|NCT00656513|16868673|P2|Overall Study|Treatment completed outside of timeframe|3
4895850|NCT00656513|16868674|P1|Overall Study|Treatment completed outside of timeframe|0
4895851|NCT00656513|16868672|P3|Overall Study|Incomplete treatment|0
4895852|NCT00656513|16868673|P2|Overall Study|Incomplete treatment|0
4895853|NCT00656513|16868674|P1|Overall Study|Incomplete treatment|3
4895854|NCT00656513|16868672|P3|Overall Study|Missing data|9
4895855|NCT00656513|16868673|P2|Overall Study|Missing data|11
4895856|NCT00656513|16868674|P1|Overall Study|Missing data|0
4895857|NCT00656513|16868672|P3|Overall Study|Death|1
4895858|NCT00656513|16868673|P2|Overall Study|Death|0
4895859|NCT00656513|16868674|P1|Overall Study|Death|0
4895860|NCT00656513|16868672|P3|Overall Study|Withdrawal by Subject|4
4895861|NCT00656513|16868673|P2|Overall Study|Withdrawal by Subject|11
4895862|NCT00656513|16868674|P1|Overall Study|Withdrawal by Subject|0
4895863|NCT00656513|16868672|P3|Overall Study|Protocol Violation|2
4895864|NCT00656513|16868673|P2|Overall Study|Protocol Violation|0
4895865|NCT00656513|16868674|P1|Overall Study|Protocol Violation|1
4895866|NCT00656474|16868721|P1|Overall Study|Other Reason|1
4895867|NCT00656370|16868739|P1|Overall Study|Alternates|3
4895868|NCT00656370|16868739|P1|Overall Study|Screen Failures|7
4895869|NCT00656292|16868768|P2|Overall Study|Screen failure|2
4895870|NCT00656292|16868769|P1|Overall Study|Screen failure|1
4895871|NCT00656292|16868768|P2|Overall Study|Withdrawal by Subject|3
4895872|NCT00656292|16868769|P1|Overall Study|Withdrawal by Subject|2
4895873|NCT00656175|16868796|P2|Overall Study|Transportation issues|1
4895874|NCT00656175|16868797|P1|Overall Study|Transportation issues|0
4895875|NCT00656175|16868796|P2|Overall Study|Adverse Event|0
4895876|NCT00656175|16868797|P1|Overall Study|Adverse Event|1
4895877|NCT00656136|16868805|P2|Overall Study|Unknown and others|4
4895878|NCT00656136|16868806|P1|Overall Study|Unknown and others|4
4895879|NCT00656136|16868805|P2|Overall Study|Patient refused to take study medication|10
4895880|NCT00656136|16868806|P1|Overall Study|Patient refused to take study medication|7
4895881|NCT00656136|16868805|P2|Overall Study|Protocol Violation|3
4895882|NCT00656136|16868806|P1|Overall Study|Protocol Violation|2
4895883|NCT00656136|16868805|P2|Overall Study|Other Adverse Event|51
4895884|NCT00656136|16868806|P1|Overall Study|Other Adverse Event|5
4895885|NCT00656136|16868805|P2|Overall Study|Progressive disease|322
4895886|NCT00656136|16868806|P1|Overall Study|Progressive disease|177
4895887|NCT00656084|16868816|P1|Overall Study|Investigator Request|1
4895888|NCT00656084|16868816|P1|Overall Study|Patient Request|1
4895889|NCT00656084|16868816|P1|Overall Study|Withdrawal by Subject|1
4895890|NCT00656084|16868816|P1|Overall Study|Adverse Event|4
4895891|NCT00656058|16868823|P1|Overall Study|Withdrawal by Subject|4
4895892|NCT00656058|16868823|P1|Overall Study|Withdrawal by Subject|2
4895893|NCT00656019|16868836|P4|Overall Study|Lost to Follow-up|0
4895894|NCT00656019|16868837|P3|Overall Study|Lost to Follow-up|0
4895895|NCT00656019|16868838|P2|Overall Study|Lost to Follow-up|1
4895896|NCT00656019|16868839|P1|Overall Study|Lost to Follow-up|2
4895897|NCT00656019|16868836|P4|Overall Study|Withdrawal by Subject|0
4895898|NCT00656019|16868837|P3|Overall Study|Withdrawal by Subject|0
4895899|NCT00656019|16868838|P2|Overall Study|Withdrawal by Subject|0
4895900|NCT00656019|16868839|P1|Overall Study|Withdrawal by Subject|2
4895901|NCT00656019|16868836|P4|Overall Study|Not Eligible|0
4895902|NCT00656019|16868837|P3|Overall Study|Not Eligible|0
4895903|NCT00656019|16868838|P2|Overall Study|Not Eligible|0
4895904|NCT00656019|16868839|P1|Overall Study|Not Eligible|10
4895905|NCT00655980|16868852|P3|Overall Study|surgery canceled; or subject or anesthes|5
4895906|NCT00655980|16868853|P2|Overall Study|surgery canceled; or subject or anesthes|31
4895907|NCT00655980|16868854|P1|Overall Study|surgery canceled; or subject or anesthes|26
4895908|NCT00655928|16868867|P2|Overall Study|Physician Decision|1
4895909|NCT00655928|16868868|P1|Overall Study|Physician Decision|1
4895910|NCT00655928|16868867|P2|Overall Study|Withdrawal by Subject|1
4895911|NCT00655928|16868868|P1|Overall Study|Withdrawal by Subject|2
4895912|NCT00655889|16868874|P1|Overall Study|Protocol Violation|1
4895913|NCT00655889|16868874|P1|Overall Study|Inadequate cell growth|1
4895914|NCT00655876|16868881|P2|Overall Study|Protocol Violation|7
4895915|NCT00655876|16868882|P1|Overall Study|Protocol Violation|9
4895916|NCT00655863|16868901|P3|Overall Study|Lost to Follow-up|1
4895917|NCT00655863|16868902|P2|Overall Study|Lost to Follow-up|0
4895918|NCT00655863|16868903|P1|Overall Study|Lost to Follow-up|0
4895919|NCT00655850|16868962|P1|Overall Study|Withdrawal by Subject|1
4895920|NCT00655850|16868962|P1|Overall Study|Death|2
4895921|NCT00655824|16868969|P1|Overall Study|Deterioration of Trial Disease|2
4895922|NCT00655824|16868969|P1|Overall Study|Withdrawal by Subject|4
4895923|NCT00655824|16868969|P1|Overall Study|Protocol Violation|1
4895924|NCT00655824|16868969|P1|Overall Study|Early Termination of Study by Sponsor|74
4895925|NCT00655824|16868969|P1|Overall Study|Adverse Event|3
4895926|NCT00655746|16869017|P1|Overall Study|Withdrawal by Subject|1
4895927|NCT00655733|16869036|P2|Overall Study|Physician Decision|1
4895928|NCT00655733|16869037|P1|Overall Study|Physician Decision|0
4895929|NCT00655733|16869036|P2|Overall Study|Withdrawal by Subject|3
4895930|NCT00655733|16869037|P1|Overall Study|Withdrawal by Subject|3
4895931|NCT00655733|16869036|P2|Overall Study|Adverse Event|2
4895932|NCT00655733|16869037|P1|Overall Study|Adverse Event|2
4895933|NCT00655733|16869036|P2|Overall Study|Lost to Follow-up|2
4895934|NCT00655733|16869037|P1|Overall Study|Lost to Follow-up|2
4895935|NCT00655668|16869070|P1|Overall Study|Withdrawal by Subject|2
4895936|NCT00655668|16869070|P1|Overall Study|New Lymphoma Treatment Started|4
4895937|NCT00655668|16869070|P1|Overall Study|Other|1
4895938|NCT00655668|16869070|P1|Overall Study|Study Terminated|9
4895939|NCT00655668|16869070|P1|Overall Study|Disease Progression|27
4895940|NCT00655668|16869070|P1|Overall Study|Death|5
4895941|NCT00655668|16869070|P1|Overall Study|Adverse Event|6
4895942|NCT00655629|16869097|P2|Overall Study|consent withdrawn|4
4895943|NCT00655629|16869098|P1|Overall Study|consent withdrawn|6
4895944|NCT00655629|16869097|P2|Overall Study|Protocol Violation|3
4895945|NCT00655629|16869098|P1|Overall Study|Protocol Violation|5
4895946|NCT00655629|16869097|P2|Overall Study|Lost to Follow-up|3
4895947|NCT00655629|16869098|P1|Overall Study|Lost to Follow-up|4
4895948|NCT00655629|16869097|P2|Overall Study|Lack of Efficacy|12
4895949|NCT00655629|16869098|P1|Overall Study|Lack of Efficacy|2
4895950|NCT00655629|16869097|P2|Overall Study|Adverse Event|1
4895951|NCT00655629|16869098|P1|Overall Study|Adverse Event|4
4895952|NCT00655564|16869134|P1|Overall Study|Desired Alternate Therapy|1
4895953|NCT00655564|16869134|P1|Overall Study|Lost to Follow-up|1
4895954|NCT00655564|16869134|P1|Overall Study|Adverse Event|1
4895955|NCT00655551|16869142|P3|Period 4 (up to 7 Days)|Adverse Event|0
4895956|NCT00655551|16869143|P2|Period 4 (up to 7 Days)|Adverse Event|2
4895957|NCT00655551|16869144|P1|Period 4 (up to 7 Days)|Adverse Event|0
4895958|NCT00655551|16869142|P3|Period 3 (up to 7 Days)|Adverse Event|4
4895959|NCT00655551|16869143|P2|Period 3 (up to 7 Days)|Adverse Event|0
4895960|NCT00655551|16869144|P1|Period 3 (up to 7 Days)|Adverse Event|0
4895961|NCT00655551|16869142|P3|Period 2 (up to 7 Days)|Adverse Event|0
4895962|NCT00655551|16869143|P2|Period 2 (up to 7 Days)|Adverse Event|1
4895963|NCT00655551|16869144|P1|Period 2 (up to 7 Days)|Adverse Event|0
4895964|NCT00655551|16869142|P3|All Periods Combined|Adverse Event|4
4895965|NCT00655551|16869143|P2|All Periods Combined|Adverse Event|3
4895966|NCT00655551|16869144|P1|All Periods Combined|Adverse Event|0
4895967|NCT00655486|16869181|P1|Overall Study|Other: Abnormal electrocardiogram (ECG)|1
4895968|NCT00655486|16869181|P1|Overall Study|Other: Could not tolerate BID dosing|1
4895969|NCT00655486|16869181|P1|Overall Study|Other: Pregnancy|1
4895970|NCT00655486|16869181|P1|Overall Study|Unsatisfactory compliance|2
4895971|NCT00655486|16869181|P1|Overall Study|Protocol Violation|1
4895972|NCT00655486|16869181|P1|Overall Study|Withdrawal by Subject|4
4895973|NCT00655486|16869181|P1|Overall Study|Lack of Efficacy|8
4895974|NCT00655486|16869181|P1|Overall Study|Adverse Event|10
4895975|NCT00655356|16869209|P2|Overall Study|Other Reason|0
4895976|NCT00655356|16869210|P1|Overall Study|Other Reason|1
4895977|NCT00655356|16869209|P2|Overall Study|Protocol Violation|1
4895978|NCT00655356|16869210|P1|Overall Study|Protocol Violation|2
4895979|NCT00655356|16869209|P2|Overall Study|Adverse Event|1
4895980|NCT00655356|16869210|P1|Overall Study|Adverse Event|1
4895981|NCT00655356|16869209|P2|Overall Study|Sponsor Request|4
4895982|NCT00655356|16869210|P1|Overall Study|Sponsor Request|10
4895983|NCT00655356|16869209|P2|Overall Study|Withdrawal by Subject|4
4895984|NCT00655356|16869210|P1|Overall Study|Withdrawal by Subject|3
4895985|NCT00654940|16869274|P2|Period 1|Intolerable Pain Level|0
4895986|NCT00654940|16869275|P1|Period 1|Intolerable Pain Level|1
4895987|NCT00654940|16869274|P2|Period 1|Adverse Event|1
4895988|NCT00654940|16869275|P1|Period 1|Adverse Event|0
4895989|NCT00654901|16869299|P4|Overall Study|Withdrawal by Subject|0
4895990|NCT00654901|16869300|P3|Overall Study|Withdrawal by Subject|1
4895991|NCT00654901|16869301|P2|Overall Study|Withdrawal by Subject|0
4895992|NCT00654901|16869302|P1|Overall Study|Withdrawal by Subject|3
4895993|NCT00654901|16869299|P4|Overall Study|Lost to Follow-up|0
4895994|NCT00654901|16869300|P3|Overall Study|Lost to Follow-up|1
4895995|NCT00654901|16869301|P2|Overall Study|Lost to Follow-up|0
4895996|NCT00654901|16869302|P1|Overall Study|Lost to Follow-up|1
4895997|NCT00654875|16869322|P2|Overall Study|Administrative Problems|0
4895998|NCT00654875|16869323|P1|Overall Study|Administrative Problems|1
4895999|NCT00654875|16869322|P2|Overall Study|Abnormal Test Procedure Result(s)|0
4896000|NCT00654875|16869323|P1|Overall Study|Abnormal Test Procedure Result(s)|1
4896001|NCT00654875|16869322|P2|Overall Study|Lost to Follow-up|3
4896002|NCT00654875|16869323|P1|Overall Study|Lost to Follow-up|1
4896003|NCT00654875|16869322|P2|Overall Study|Lack of Efficacy|2
4896004|NCT00654875|16869323|P1|Overall Study|Lack of Efficacy|2
4896005|NCT00654875|16869322|P2|Overall Study|Protocol Violation|3
4896006|NCT00654875|16869323|P1|Overall Study|Protocol Violation|3
4896007|NCT00654875|16869322|P2|Overall Study|Withdrawal by Subject|4
4896008|NCT00654875|16869323|P1|Overall Study|Withdrawal by Subject|4
4896009|NCT00654875|16869322|P2|Overall Study|Adverse Event|5
4896010|NCT00654875|16869323|P1|Overall Study|Adverse Event|5
4896011|NCT00654745|16869356|P1|Overall Study|poor ABPM, noncompliance, lab MAs|3
4896012|NCT00654745|16869356|P1|Overall Study|Withdrawal by Subject|10
4896013|NCT00654745|16869356|P1|Overall Study|Protocol Violation|11
4896014|NCT00654745|16869356|P1|Overall Study|Lost to Follow-up|7
4896015|NCT00654745|16869356|P1|Overall Study|Adverse Event|12
4896016|NCT00654732|16869396|P2|Overall Study|Adverse Event|6
4896017|NCT00654732|16869397|P1|Overall Study|Adverse Event|4
4896018|NCT00654641|16869410|P2|Overall Study|Lost to Follow-up|3
4896019|NCT00654641|16869411|P1|Overall Study|Lost to Follow-up|2
4896020|NCT00654628|16869417|P1|6 -Week Extension Period (Single Site)|Lost to Follow-up|1
4896021|NCT00654628|16869417|P1|6 -Week Extension Period (Single Site)|Adverse Event|4
4896022|NCT00654628|16869417|P1|6-week Active Treatment Period|Out of window period|1
4896023|NCT00654628|16869417|P1|6-week Active Treatment Period|Transferred to branch hospital|1
4896024|NCT00654628|16869417|P1|6-week Active Treatment Period|Lost to Follow-up|10
4896025|NCT00654628|16869417|P1|6-week Active Treatment Period|Adverse Event|9
4896026|NCT00654498|16869466|P2|Overall Study|Other reason not defined above|5
4896027|NCT00654498|16869467|P1|Overall Study|Other reason not defined above|4
4896028|NCT00654498|16869466|P2|Overall Study|Withdrawal by Subject|0
4896029|NCT00654498|16869467|P1|Overall Study|Withdrawal by Subject|1
4896030|NCT00654498|16869466|P2|Overall Study|Lost to Follow-up|5
4896031|NCT00654498|16869467|P1|Overall Study|Lost to Follow-up|1
4896032|NCT00654498|16869466|P2|Overall Study|Protocol Violation|1
4896033|NCT00654498|16869467|P1|Overall Study|Protocol Violation|1
4896034|NCT00654498|16869466|P2|Overall Study|Adverse Event|1
4896035|NCT00654498|16869467|P1|Overall Study|Adverse Event|6
4896036|NCT00654498|16869466|P2|Overall Study|Not Treated|0
4896037|NCT00654498|16869467|P1|Overall Study|Not Treated|1
4896038|NCT00654420|16869499|P4|Phase II|Missing Disposition Record|0
4896039|NCT00654420|16869500|P3|Phase II|Missing Disposition Record|1
4896040|NCT00654420|16869501|P2|Phase II|Missing Disposition Record|0
4896041|NCT00654420|16869502|P1|Phase II|Missing Disposition Record|0
4896042|NCT00654420|16869499|P4|Phase II|Withdrawal by Subject|1
4896043|NCT00654420|16869500|P3|Phase II|Withdrawal by Subject|4
4896044|NCT00654420|16869501|P2|Phase II|Withdrawal by Subject|0
4896045|NCT00654420|16869502|P1|Phase II|Withdrawal by Subject|0
4896046|NCT00654420|16869499|P4|Phase II|Progressive Disease|29
4896047|NCT00654420|16869500|P3|Phase II|Progressive Disease|29
4896048|NCT00654420|16869501|P2|Phase II|Progressive Disease|0
4896049|NCT00654420|16869502|P1|Phase II|Progressive Disease|0
4896050|NCT00654420|16869499|P4|Phase II|Physician Decision|4
4896051|NCT00654420|16869500|P3|Phase II|Physician Decision|0
4896052|NCT00654420|16869501|P2|Phase II|Physician Decision|0
4896053|NCT00654420|16869502|P1|Phase II|Physician Decision|0
4896054|NCT00654420|16869499|P4|Phase II|Lost to Follow-up|1
4896055|NCT00654420|16869500|P3|Phase II|Lost to Follow-up|0
4896056|NCT00654420|16869501|P2|Phase II|Lost to Follow-up|0
4896057|NCT00654420|16869502|P1|Phase II|Lost to Follow-up|0
4896058|NCT00654420|16869499|P4|Phase II|Adverse Event|3
4896059|NCT00654420|16869500|P3|Phase II|Adverse Event|3
4896060|NCT00654420|16869501|P2|Phase II|Adverse Event|0
4896061|NCT00654420|16869502|P1|Phase II|Adverse Event|0
4896062|NCT00654420|16869499|P4|Phase I (Dose Escalation)|Progressive Disease|0
4896063|NCT00654420|16869500|P3|Phase I (Dose Escalation)|Progressive Disease|0
4896064|NCT00654420|16869501|P2|Phase I (Dose Escalation)|Progressive Disease|15
4896065|NCT00654420|16869502|P1|Phase I (Dose Escalation)|Progressive Disease|4
4896066|NCT00654420|16869499|P4|Phase I (Dose Escalation)|Adverse Event|0
4896067|NCT00654420|16869500|P3|Phase I (Dose Escalation)|Adverse Event|0
4896068|NCT00654420|16869501|P2|Phase I (Dose Escalation)|Adverse Event|1
4896069|NCT00654420|16869502|P1|Phase I (Dose Escalation)|Adverse Event|0
4896070|NCT00654381|16869528|P6|Extension Stage|Closure of the trial site|1
4896071|NCT00654381|16869529|P5|Extension Stage|Closure of the trial site|1
4896072|NCT00654381|16869530|P4|Extension Stage|Closure of the trial site|0
4896073|NCT00654381|16869531|P3|Extension Stage|Closure of the trial site|0
4896074|NCT00654381|16869532|P2|Extension Stage|Closure of the trial site|0
4896075|NCT00654381|16869533|P1|Extension Stage|Closure of the trial site|0
4896076|NCT00654381|16869528|P6|Extension Stage|Withdrawal by Subject|1
4896077|NCT00654381|16869529|P5|Extension Stage|Withdrawal by Subject|1
4896078|NCT00654381|16869530|P4|Extension Stage|Withdrawal by Subject|1
4896079|NCT00654381|16869531|P3|Extension Stage|Withdrawal by Subject|1
4896080|NCT00654381|16869532|P2|Extension Stage|Withdrawal by Subject|0
4896081|NCT00654381|16869533|P1|Extension Stage|Withdrawal by Subject|0
4896082|NCT00654381|16869528|P6|Extension Stage|Lack of Efficacy|0
4896083|NCT00654381|16869529|P5|Extension Stage|Lack of Efficacy|0
4896084|NCT00654381|16869530|P4|Extension Stage|Lack of Efficacy|0
4896085|NCT00654381|16869531|P3|Extension Stage|Lack of Efficacy|1
4896086|NCT00654381|16869532|P2|Extension Stage|Lack of Efficacy|0
4896087|NCT00654381|16869533|P1|Extension Stage|Lack of Efficacy|0
4896088|NCT00654381|16869528|P6|Extension Stage|Protocol Violation|0
4896089|NCT00654381|16869529|P5|Extension Stage|Protocol Violation|0
4896090|NCT00654381|16869530|P4|Extension Stage|Protocol Violation|1
4896091|NCT00654381|16869531|P3|Extension Stage|Protocol Violation|0
4896092|NCT00654381|16869532|P2|Extension Stage|Protocol Violation|0
4896093|NCT00654381|16869533|P1|Extension Stage|Protocol Violation|0
4896094|NCT00654381|16869528|P6|Extension Stage|Adverse Event|1
4896095|NCT00654381|16869529|P5|Extension Stage|Adverse Event|1
4896096|NCT00654381|16869530|P4|Extension Stage|Adverse Event|7
4896097|NCT00654381|16869531|P3|Extension Stage|Adverse Event|9
4896098|NCT00654381|16869532|P2|Extension Stage|Adverse Event|2
4896099|NCT00654381|16869533|P1|Extension Stage|Adverse Event|1
4896100|NCT00654381|16869528|P6|2nd Stage|Investigator's decision|0
4896101|NCT00654381|16869529|P5|2nd Stage|Investigator's decision|0
4896102|NCT00654381|16869530|P4|2nd Stage|Investigator's decision|1
4896103|NCT00654381|16869531|P3|2nd Stage|Investigator's decision|1
4896104|NCT00654381|16869532|P2|2nd Stage|Investigator's decision|0
4896105|NCT00654381|16869533|P1|2nd Stage|Investigator's decision|0
4896106|NCT00654381|16869528|P6|2nd Stage|Withdrawal by Subject|1
4896107|NCT00654381|16869529|P5|2nd Stage|Withdrawal by Subject|1
4896108|NCT00654381|16869530|P4|2nd Stage|Withdrawal by Subject|0
4896109|NCT00654381|16869531|P3|2nd Stage|Withdrawal by Subject|0
4896110|NCT00654381|16869532|P2|2nd Stage|Withdrawal by Subject|0
4896111|NCT00654381|16869533|P1|2nd Stage|Withdrawal by Subject|0
4896112|NCT00654381|16869528|P6|2nd Stage|Adverse Event|2
4896113|NCT00654381|16869529|P5|2nd Stage|Adverse Event|7
4896114|NCT00654381|16869530|P4|2nd Stage|Adverse Event|3
4896115|NCT00654381|16869531|P3|2nd Stage|Adverse Event|2
4896116|NCT00654381|16869532|P2|2nd Stage|Adverse Event|0
4896117|NCT00654381|16869533|P1|2nd Stage|Adverse Event|2
4896118|NCT00654381|16869528|P6|1st Stage|Investigator's decision|0
4896119|NCT00654381|16869529|P5|1st Stage|Investigator's decision|0
4896120|NCT00654381|16869530|P4|1st Stage|Investigator's decision|1
4896121|NCT00654381|16869531|P3|1st Stage|Investigator's decision|0
4896122|NCT00654381|16869532|P2|1st Stage|Investigator's decision|0
4896123|NCT00654381|16869533|P1|1st Stage|Investigator's decision|0
4896124|NCT00654381|16869528|P6|1st Stage|Withdrawal by Subject|1
4896125|NCT00654381|16869529|P5|1st Stage|Withdrawal by Subject|0
4896126|NCT00654381|16869530|P4|1st Stage|Withdrawal by Subject|1
4896127|NCT00654381|16869531|P3|1st Stage|Withdrawal by Subject|0
4896128|NCT00654381|16869532|P2|1st Stage|Withdrawal by Subject|0
4896129|NCT00654381|16869533|P1|1st Stage|Withdrawal by Subject|0
4896130|NCT00654381|16869528|P6|1st Stage|Adverse Event|1
4896131|NCT00654381|16869529|P5|1st Stage|Adverse Event|2
4896132|NCT00654381|16869530|P4|1st Stage|Adverse Event|3
4896133|NCT00654381|16869531|P3|1st Stage|Adverse Event|3
4896134|NCT00654381|16869532|P2|1st Stage|Adverse Event|3
4896135|NCT00654381|16869533|P1|1st Stage|Adverse Event|3
4896136|NCT00654368|16869570|P3|Overall Study|Adverse Event|6
4896137|NCT00654368|16869571|P2|Overall Study|Adverse Event|9
4896138|NCT00654368|16869572|P1|Overall Study|Adverse Event|14
4896139|NCT00654368|16869570|P3|Overall Study|Other|3
4896140|NCT00654368|16869571|P2|Overall Study|Other|2
4896141|NCT00654368|16869572|P1|Overall Study|Other|0
4896142|NCT00654368|16869570|P3|Overall Study|Pregnancy|2
4896143|NCT00654368|16869571|P2|Overall Study|Pregnancy|0
4896144|NCT00654368|16869572|P1|Overall Study|Pregnancy|0
4896145|NCT00654368|16869570|P3|Overall Study|Death|0
4896146|NCT00654368|16869571|P2|Overall Study|Death|0
4896147|NCT00654368|16869572|P1|Overall Study|Death|1
4896148|NCT00654368|16869570|P3|Overall Study|Physician Decision|2
4896149|NCT00654368|16869571|P2|Overall Study|Physician Decision|0
4896150|NCT00654368|16869572|P1|Overall Study|Physician Decision|0
4896151|NCT00654368|16869570|P3|Overall Study|Requirement for alternative therapy|1
4896152|NCT00654368|16869571|P2|Overall Study|Requirement for alternative therapy|1
4896153|NCT00654368|16869572|P1|Overall Study|Requirement for alternative therapy|1
4896154|NCT00654368|16869570|P3|Overall Study|Disease progression|13
4896155|NCT00654368|16869571|P2|Overall Study|Disease progression|31
4896156|NCT00654368|16869572|P1|Overall Study|Disease progression|21
4896157|NCT00654368|16869570|P3|Overall Study|Withdrawal by Subject|2
4896158|NCT00654368|16869571|P2|Overall Study|Withdrawal by Subject|2
4896159|NCT00654368|16869572|P1|Overall Study|Withdrawal by Subject|5
4896160|NCT00654368|16869570|P3|Overall Study|Non-compliance|2
4896161|NCT00654368|16869571|P2|Overall Study|Non-compliance|1
4896162|NCT00654368|16869572|P1|Overall Study|Non-compliance|2
4896163|NCT00654368|16869570|P3|Overall Study|Protocol deviation|1
4896164|NCT00654368|16869571|P2|Overall Study|Protocol deviation|2
4896165|NCT00654368|16869572|P1|Overall Study|Protocol deviation|3
4896166|NCT00654368|16869570|P3|Overall Study|Ineligibility determined|0
4896167|NCT00654368|16869571|P2|Overall Study|Ineligibility determined|0
4896168|NCT00654368|16869572|P1|Overall Study|Ineligibility determined|6
4896169|NCT00654355|16869605|P2|Overall Study|Lost to Follow-up|2
4896170|NCT00654355|16869606|P1|Overall Study|Lost to Follow-up|2
4896171|NCT00654238|16869637|P1|Overall Study|Screen Failures|4
4896172|NCT00654186|16869642|P1|Overall Study|Withdrawal by Subject|5
4896173|NCT00654095|16869667|P1|Overall Study|Did not meet inclusion criteria|1
4896174|NCT00654095|16869667|P1|Overall Study|Adverse reaction did not improve (5)|4
4896175|NCT00654095|16869667|P1|Overall Study|Elevated alanine aminotransferase (4)|7
4896176|NCT00654095|16869667|P1|Overall Study|Withdrawal by Subject|5
4896177|NCT00654095|16869667|P1|Overall Study|Adverse Event|11
4896178|NCT00654095|16869667|P1|Overall Study|Elevated alanine aminotransferase (3)|1
4896179|NCT00654095|16869667|P1|Overall Study|Elevated triglyceride level (2)|1
4896180|NCT00654095|16869667|P1|Overall Study|Drop in low density lipoprotein (1)|2
4896181|NCT00654004|16869690|P2|Overall Study|Lost to Follow-up|0
4896182|NCT00654004|16869691|P1|Overall Study|Lost to Follow-up|1
4896183|NCT00653991|16869707|P2|6 Month Follow-up|Participant would not respond|141
4896184|NCT00653991|16869708|P1|6 Month Follow-up|Participant would not respond|133
4896185|NCT00653991|16869707|P2|3 Month Follow-up|Participant would not respond|157
4896186|NCT00653991|16869708|P1|3 Month Follow-up|Participant would not respond|150
4896187|NCT00653939|16869720|P2|Overall Study|Other|6
4896188|NCT00653939|16869721|P1|Overall Study|Other|2
4896189|NCT00653939|16869720|P2|Overall Study|Disease Progression|3
4896190|NCT00653939|16869721|P1|Overall Study|Disease Progression|2
4896191|NCT00653939|16869720|P2|Overall Study|Physician Decision|0
4896192|NCT00653939|16869721|P1|Overall Study|Physician Decision|4
4896193|NCT00653939|16869720|P2|Overall Study|Withdrawal by Subject|3
4896194|NCT00653939|16869721|P1|Overall Study|Withdrawal by Subject|3
4896195|NCT00653939|16869720|P2|Overall Study|Adverse Event|3
4896196|NCT00653939|16869721|P1|Overall Study|Adverse Event|1
4896197|NCT00653523|16869746|P1|Overall Study|Adverse reaction did not improve (4)|1
4896198|NCT00653523|16869746|P1|Overall Study|Elevated alanine aminotransferase (3)|2
4896199|NCT00653523|16869746|P1|Overall Study|Withdrawal by Subject|6
4896200|NCT00653523|16869746|P1|Overall Study|Adverse Event|7
4896201|NCT00653523|16869746|P1|Overall Study|Elevated creatine phosphokinase (2)|1
4896202|NCT00653523|16869746|P1|Overall Study|Drop in low density lipoprotein (1)|2
4896203|NCT00653432|16869752|P2|Overall Study|Other - Reason Not Provided|3
4896204|NCT00653432|16869753|P1|Overall Study|Other - Reason Not Provided|5
4896205|NCT00653432|16869752|P2|Overall Study|Use/Need of Con Therapy|1
4896206|NCT00653432|16869753|P1|Overall Study|Use/Need of Con Therapy|2
4896207|NCT00653432|16869752|P2|Overall Study|Lost to Follow-up|6
4896208|NCT00653432|16869753|P1|Overall Study|Lost to Follow-up|7
4896209|NCT00653432|16869752|P2|Overall Study|Withdrawal by Subject|5
4896210|NCT00653432|16869753|P1|Overall Study|Withdrawal by Subject|4
4896211|NCT00653432|16869752|P2|Overall Study|Adverse Event|1
4896212|NCT00653432|16869753|P1|Overall Study|Adverse Event|4
4896213|NCT00653328|16869777|P1|Overall Study|Drug manufacturer no longing making drug|2
4896214|NCT00653328|16869777|P1|Overall Study|Disease progression|10
4896215|NCT00653328|16869777|P1|Overall Study|Adverse Event|2
4896216|NCT00653328|16869777|P1|Overall Study|Withdrawal by Subject|1
4896217|NCT00653263|16869784|P1|Overall Study|Physician Decision|1
4896218|NCT00653263|16869784|P1|Overall Study|Withdrawal by Subject|1
4896219|NCT00653224|16869792|P2|Overall Study|Other|4
4896220|NCT00653224|16869793|P1|Overall Study|Other|2
4896221|NCT00653224|16869792|P2|Overall Study|Lost to Follow-up|0
4896222|NCT00653224|16869793|P1|Overall Study|Lost to Follow-up|1
4896223|NCT00653224|16869792|P2|Overall Study|Loss of efficacy|0
4896224|NCT00653224|16869793|P1|Overall Study|Loss of efficacy|1
4896225|NCT00653224|16869792|P2|Overall Study|Lack of Efficacy|2
4896226|NCT00653224|16869793|P1|Overall Study|Lack of Efficacy|1
4896227|NCT00653224|16869792|P2|Overall Study|Adverse Event|1
4896228|NCT00653224|16869793|P1|Overall Study|Adverse Event|2
4896229|NCT00653159|16869979|P2|Overall Study|Lost to Follow-up|2
4896230|NCT00653159|16869980|P1|Overall Study|Lost to Follow-up|1
4896231|NCT00653159|16869979|P2|Overall Study|Adverse Event|1
4896232|NCT00653159|16869980|P1|Overall Study|Adverse Event|4
4896233|NCT00653068|16870007|P1|Overall Study|Ineligible|2
4896234|NCT00653068|16870007|P1|Overall Study|Withdrawal by Subject|1
4896235|NCT00653068|16870007|P1|Overall Study|Physician Decision|4
4896236|NCT00653068|16870007|P1|Overall Study|Lack of Efficacy|34
4896237|NCT00653068|16870007|P1|Overall Study|Death|9
4896238|NCT00652951|16870021|P3|Booster Phase|Other|0
4896239|NCT00652951|16870022|P2|Booster Phase|Other|0
4896240|NCT00652951|16870023|P1|Booster Phase|Other|1
4896241|NCT00652951|16870021|P3|Booster Phase|Adverse event, non-fatal|0
4896242|NCT00652951|16870022|P2|Booster Phase|Adverse event, non-fatal|1
4896243|NCT00652951|16870023|P1|Booster Phase|Adverse event, non-fatal|0
4896244|NCT00652938|16870160|P3|Overall Study|fear of blood sampling|0
4896245|NCT00652938|16870161|P2|Overall Study|fear of blood sampling|1
4896246|NCT00652938|16870162|P1|Overall Study|fear of blood sampling|0
4896247|NCT00652938|16870160|P3|Overall Study|Lost to Follow-up|2
4896248|NCT00652938|16870161|P2|Overall Study|Lost to Follow-up|0
4896249|NCT00652938|16870162|P1|Overall Study|Lost to Follow-up|0
4896250|NCT00652938|16870160|P3|Overall Study|Withdrawal by Subject|1
4896251|NCT00652938|16870161|P2|Overall Study|Withdrawal by Subject|6
4896252|NCT00652938|16870162|P1|Overall Study|Withdrawal by Subject|0
4896253|NCT00652938|16870160|P3|Overall Study|Adverse Event|2
4896254|NCT00652938|16870161|P2|Overall Study|Adverse Event|0
4896255|NCT00652938|16870162|P1|Overall Study|Adverse Event|1
4896256|NCT00652899|16870227|P1|Overall Study|Treating physician decision|1
4896257|NCT00652899|16870227|P1|Overall Study|Death|1
4896258|NCT00652834|16870237|P1|Overall Study|Lost to Follow-up|2
4896259|NCT00652834|16870237|P1|Overall Study|Withdrawal by Subject|3
4896260|NCT00652743|16870244|P3|Months 36-42|Other|8
4896261|NCT00652743|16870245|P2|Months 36-42|Other|2
4896262|NCT00652743|16870246|P1|Months 36-42|Other|4
4896263|NCT00652743|16870244|P3|Months 36-42|Migrated/moved from study area|0
4896264|NCT00652743|16870245|P2|Months 36-42|Migrated/moved from study area|0
4896265|NCT00652743|16870246|P1|Months 36-42|Migrated/moved from study area|1
4896266|NCT00652743|16870244|P3|Months 36-42|Lost to Follow-up|0
4896267|NCT00652743|16870245|P2|Months 36-42|Lost to Follow-up|1
4896268|NCT00652743|16870246|P1|Months 36-42|Lost to Follow-up|0
4896269|NCT00652743|16870244|P3|Months 36-42|Withdrawal by Subject|0
4896270|NCT00652743|16870245|P2|Months 36-42|Withdrawal by Subject|1
4896271|NCT00652743|16870246|P1|Months 36-42|Withdrawal by Subject|1
4896272|NCT00652743|16870244|P3|Months 36-42|Serious Adverse Events|1
4896273|NCT00652743|16870245|P2|Months 36-42|Serious Adverse Events|1
4896274|NCT00652743|16870246|P1|Months 36-42|Serious Adverse Events|0
4896275|NCT00652743|16870244|P3|Months 24-30|Other|11
4896276|NCT00652743|16870245|P2|Months 24-30|Other|1
4896277|NCT00652743|16870246|P1|Months 24-30|Other|5
4896278|NCT00652743|16870244|P3|Months 12-18|Lost to Follow-up|7
4896279|NCT00652743|16870245|P2|Months 12-18|Lost to Follow-up|2
4896280|NCT00652743|16870246|P1|Months 12-18|Lost to Follow-up|1
4896281|NCT00652626|16870328|P7|Extension Phase|Death|1
4896282|NCT00652626|16870329|P6|Extension Phase|Death|1
4896283|NCT00652626|16870330|P5|Extension Phase|Death|0
4896284|NCT00652626|16870331|P4|Extension Phase|Death|0
4896285|NCT00652626|16870332|P3|Extension Phase|Death|0
4896286|NCT00652626|16870333|P2|Extension Phase|Death|0
4896287|NCT00652626|16870334|P1|Extension Phase|Death|0
4896288|NCT00652626|16870328|P7|Extension Phase|Physician Decision|1
4896289|NCT00652626|16870329|P6|Extension Phase|Physician Decision|1
4896290|NCT00652626|16870330|P5|Extension Phase|Physician Decision|0
4896291|NCT00652626|16870331|P4|Extension Phase|Physician Decision|0
4896292|NCT00652626|16870332|P3|Extension Phase|Physician Decision|0
4896293|NCT00652626|16870333|P2|Extension Phase|Physician Decision|0
4896294|NCT00652626|16870334|P1|Extension Phase|Physician Decision|0
4896295|NCT00652626|16870328|P7|Extension Phase|No Longer Receiving Clinical Benefit|0
4896296|NCT00652626|16870329|P6|Extension Phase|No Longer Receiving Clinical Benefit|6
4896297|NCT00652626|16870330|P5|Extension Phase|No Longer Receiving Clinical Benefit|0
4896298|NCT00652626|16870331|P4|Extension Phase|No Longer Receiving Clinical Benefit|0
4896299|NCT00652626|16870332|P3|Extension Phase|No Longer Receiving Clinical Benefit|0
4896300|NCT00652626|16870333|P2|Extension Phase|No Longer Receiving Clinical Benefit|0
4896301|NCT00652626|16870334|P1|Extension Phase|No Longer Receiving Clinical Benefit|0
4896302|NCT00652626|16870328|P7|Extension Phase|Adverse Event|1
4896303|NCT00652626|16870329|P6|Extension Phase|Adverse Event|2
4896304|NCT00652626|16870330|P5|Extension Phase|Adverse Event|0
4896305|NCT00652626|16870331|P4|Extension Phase|Adverse Event|0
4896306|NCT00652626|16870332|P3|Extension Phase|Adverse Event|0
4896307|NCT00652626|16870333|P2|Extension Phase|Adverse Event|0
4896308|NCT00652626|16870334|P1|Extension Phase|Adverse Event|0
4896309|NCT00652626|16870328|P7|Extension Phase|Withdrawal by Subject|0
4896310|NCT00652626|16870329|P6|Extension Phase|Withdrawal by Subject|2
4896311|NCT00652626|16870330|P5|Extension Phase|Withdrawal by Subject|0
4896312|NCT00652626|16870331|P4|Extension Phase|Withdrawal by Subject|0
4896313|NCT00652626|16870332|P3|Extension Phase|Withdrawal by Subject|0
4896314|NCT00652626|16870333|P2|Extension Phase|Withdrawal by Subject|0
4896315|NCT00652626|16870334|P1|Extension Phase|Withdrawal by Subject|0
4896316|NCT00652626|16870328|P7|Initial Treatment Phase|Lost to Follow-up|0
4896317|NCT00652626|16870329|P6|Initial Treatment Phase|Lost to Follow-up|0
4896318|NCT00652626|16870330|P5|Initial Treatment Phase|Lost to Follow-up|1
4896319|NCT00652626|16870331|P4|Initial Treatment Phase|Lost to Follow-up|0
4896320|NCT00652626|16870332|P3|Initial Treatment Phase|Lost to Follow-up|0
4896321|NCT00652626|16870333|P2|Initial Treatment Phase|Lost to Follow-up|0
4896322|NCT00652626|16870334|P1|Initial Treatment Phase|Lost to Follow-up|0
4896323|NCT00652626|16870328|P7|Initial Treatment Phase|Sponsor Request|0
4896324|NCT00652626|16870329|P6|Initial Treatment Phase|Sponsor Request|0
4896325|NCT00652626|16870330|P5|Initial Treatment Phase|Sponsor Request|0
4896326|NCT00652626|16870331|P4|Initial Treatment Phase|Sponsor Request|0
4896327|NCT00652626|16870332|P3|Initial Treatment Phase|Sponsor Request|1
4896328|NCT00652626|16870333|P2|Initial Treatment Phase|Sponsor Request|0
4896329|NCT00652626|16870334|P1|Initial Treatment Phase|Sponsor Request|0
4896330|NCT00652626|16870328|P7|Initial Treatment Phase|Physician Decision|0
4896331|NCT00652626|16870329|P6|Initial Treatment Phase|Physician Decision|0
4896332|NCT00652626|16870330|P5|Initial Treatment Phase|Physician Decision|1
4896333|NCT00652626|16870331|P4|Initial Treatment Phase|Physician Decision|0
4896334|NCT00652626|16870332|P3|Initial Treatment Phase|Physician Decision|0
4896335|NCT00652626|16870333|P2|Initial Treatment Phase|Physician Decision|0
4896336|NCT00652626|16870334|P1|Initial Treatment Phase|Physician Decision|0
4896337|NCT00652626|16870328|P7|Initial Treatment Phase|Protocol Violation|0
4896338|NCT00652626|16870329|P6|Initial Treatment Phase|Protocol Violation|0
4896339|NCT00652626|16870330|P5|Initial Treatment Phase|Protocol Violation|0
4896340|NCT00652626|16870331|P4|Initial Treatment Phase|Protocol Violation|1
4896341|NCT00652626|16870332|P3|Initial Treatment Phase|Protocol Violation|0
4896342|NCT00652626|16870333|P2|Initial Treatment Phase|Protocol Violation|0
4896343|NCT00652626|16870334|P1|Initial Treatment Phase|Protocol Violation|0
4896344|NCT00652626|16870328|P7|Initial Treatment Phase|Adverse Event|0
4896345|NCT00652626|16870329|P6|Initial Treatment Phase|Adverse Event|0
4896346|NCT00652626|16870330|P5|Initial Treatment Phase|Adverse Event|1
4896347|NCT00652626|16870331|P4|Initial Treatment Phase|Adverse Event|0
4896348|NCT00652626|16870332|P3|Initial Treatment Phase|Adverse Event|0
4896349|NCT00652626|16870333|P2|Initial Treatment Phase|Adverse Event|0
4896350|NCT00652626|16870334|P1|Initial Treatment Phase|Adverse Event|0
4896351|NCT00652366|16870403|P5|Overall Study|Other|0
4896352|NCT00652366|16870404|P4|Overall Study|Other|4
4896353|NCT00652366|16870405|P3|Overall Study|Other|3
4896354|NCT00652366|16870406|P2|Overall Study|Other|2
4896355|NCT00652366|16870407|P1|Overall Study|Other|5
4896356|NCT00652366|16870403|P5|Overall Study|Refused treatment|5
4896357|NCT00652366|16870404|P4|Overall Study|Refused treatment|17
4896358|NCT00652366|16870405|P3|Overall Study|Refused treatment|6
4896359|NCT00652366|16870406|P2|Overall Study|Refused treatment|7
4896360|NCT00652366|16870407|P1|Overall Study|Refused treatment|3
4896361|NCT00652366|16870403|P5|Overall Study|Protocol Violation|0
4896362|NCT00652366|16870404|P4|Overall Study|Protocol Violation|0
4896363|NCT00652366|16870405|P3|Overall Study|Protocol Violation|0
4896364|NCT00652366|16870406|P2|Overall Study|Protocol Violation|0
4896365|NCT00652366|16870407|P1|Overall Study|Protocol Violation|1
4896366|NCT00652366|16870403|P5|Overall Study|Violation of Selection Criteria|0
4896367|NCT00652366|16870404|P4|Overall Study|Violation of Selection Criteria|0
4896368|NCT00652366|16870405|P3|Overall Study|Violation of Selection Criteria|1
4896369|NCT00652366|16870406|P2|Overall Study|Violation of Selection Criteria|0
4896370|NCT00652366|16870407|P1|Overall Study|Violation of Selection Criteria|0
4896371|NCT00652366|16870403|P5|Overall Study|Lack of Efficacy|13
4896372|NCT00652366|16870404|P4|Overall Study|Lack of Efficacy|133
4896373|NCT00652366|16870405|P3|Overall Study|Lack of Efficacy|53
4896374|NCT00652366|16870406|P2|Overall Study|Lack of Efficacy|58
4896375|NCT00652366|16870407|P1|Overall Study|Lack of Efficacy|84
4896376|NCT00652366|16870403|P5|Overall Study|Death|5
4896377|NCT00652366|16870404|P4|Overall Study|Death|8
4896378|NCT00652366|16870405|P3|Overall Study|Death|1
4896379|NCT00652366|16870406|P2|Overall Study|Death|4
4896380|NCT00652366|16870407|P1|Overall Study|Death|5
4896381|NCT00652366|16870403|P5|Overall Study|Adverse Event|13
4896382|NCT00652366|16870404|P4|Overall Study|Adverse Event|17
4896383|NCT00652366|16870405|P3|Overall Study|Adverse Event|7
4896384|NCT00652366|16870406|P2|Overall Study|Adverse Event|4
4896385|NCT00652366|16870407|P1|Overall Study|Adverse Event|8
4896386|NCT00652340|16870442|P2|Overall Study|Had not progressed.|3
4896387|NCT00652340|16870443|P1|Overall Study|Had not progressed.|4
4896388|NCT00652327|16870453|P2|Overall Study|Lost to Follow-up|3
4896389|NCT00652327|16870454|P1|Overall Study|Lost to Follow-up|0
4896390|NCT00652327|16870453|P2|Overall Study|Adverse Event|2
4896391|NCT00652327|16870454|P1|Overall Study|Adverse Event|0
4896392|NCT00652093|16870496|P6|Overall Study|Physician Decision|0
4896393|NCT00652093|16870497|P5|Overall Study|Physician Decision|1
4896394|NCT00652093|16870498|P4|Overall Study|Physician Decision|0
4896395|NCT00652093|16870499|P3|Overall Study|Physician Decision|0
4896396|NCT00652093|16870500|P2|Overall Study|Physician Decision|0
4896397|NCT00652093|16870501|P1|Overall Study|Physician Decision|0
4896398|NCT00652093|16870496|P6|Overall Study|Withdrawal by Subject|0
4896399|NCT00652093|16870497|P5|Overall Study|Withdrawal by Subject|1
4896400|NCT00652093|16870498|P4|Overall Study|Withdrawal by Subject|0
4896401|NCT00652093|16870499|P3|Overall Study|Withdrawal by Subject|1
4896402|NCT00652093|16870500|P2|Overall Study|Withdrawal by Subject|0
4896403|NCT00652093|16870501|P1|Overall Study|Withdrawal by Subject|0
4896404|NCT00652028|16870591|P4|Overall Study|Physician Decision|0
4896405|NCT00652028|16870592|P3|Overall Study|Physician Decision|1
4896406|NCT00652028|16870593|P2|Overall Study|Physician Decision|0
4896407|NCT00652028|16870594|P1|Overall Study|Physician Decision|0
4896408|NCT00652028|16870591|P4|Overall Study|No Longer Meets Entry Criteria|0
4896409|NCT00652028|16870592|P3|Overall Study|No Longer Meets Entry Criteria|0
4896410|NCT00652028|16870593|P2|Overall Study|No Longer Meets Entry Criteria|1
4896411|NCT00652028|16870594|P1|Overall Study|No Longer Meets Entry Criteria|0
4896412|NCT00652028|16870591|P4|Overall Study|Adverse Event|0
4896413|NCT00652028|16870592|P3|Overall Study|Adverse Event|0
4896414|NCT00652028|16870593|P2|Overall Study|Adverse Event|0
4896415|NCT00652028|16870594|P1|Overall Study|Adverse Event|1
4896416|NCT00651937|16870638|P2|Overall Study|Withdrawal by Subject|1
4896417|NCT00651937|16870639|P1|Overall Study|Withdrawal by Subject|4
4896418|NCT00651924|16870649|P2|Overall Study|Withdrawal by Subject|5
4896419|NCT00651924|16870650|P1|Overall Study|Withdrawal by Subject|0
4896420|NCT00651924|16870649|P2|Overall Study|Withdrawal by PI|2
4896421|NCT00651924|16870650|P1|Overall Study|Withdrawal by PI|0
4896422|NCT00651820|16870656|P1|Overall Study|Lost to Follow-up|2
4896423|NCT00651755|16870688|P2|Cycle 2 (Second 21 Days)|Not Evaluable|1
4896424|NCT00651755|16870689|P1|Cycle 2 (Second 21 Days)|Not Evaluable|0
4896425|NCT00651755|16870688|P2|Cycle 1 (First 21 Days)|Withdrawal by Subject|0
4896426|NCT00651755|16870689|P1|Cycle 1 (First 21 Days)|Withdrawal by Subject|1
4896427|NCT00651664|16870715|P10|Overall Study|Reason not Specified|0
4896428|NCT00651664|16870716|P9|Overall Study|Reason not Specified|0
4896429|NCT00651664|16870717|P8|Overall Study|Reason not Specified|0
4896430|NCT00651664|16870718|P7|Overall Study|Reason not Specified|1
4896431|NCT00651664|16870719|P6|Overall Study|Reason not Specified|0
4896432|NCT00651664|16870720|P5|Overall Study|Reason not Specified|0
4896433|NCT00651664|16870721|P4|Overall Study|Reason not Specified|0
4896434|NCT00651664|16870722|P3|Overall Study|Reason not Specified|0
4896435|NCT00651664|16870723|P2|Overall Study|Reason not Specified|0
4896436|NCT00651664|16870724|P1|Overall Study|Reason not Specified|0
4896437|NCT00651664|16870715|P10|Overall Study|Symptomatic Deterioration|0
4896438|NCT00651664|16870716|P9|Overall Study|Symptomatic Deterioration|1
4896439|NCT00651664|16870717|P8|Overall Study|Symptomatic Deterioration|0
4896440|NCT00651664|16870718|P7|Overall Study|Symptomatic Deterioration|1
4896441|NCT00651664|16870719|P6|Overall Study|Symptomatic Deterioration|0
4896442|NCT00651664|16870720|P5|Overall Study|Symptomatic Deterioration|0
4896443|NCT00651664|16870721|P4|Overall Study|Symptomatic Deterioration|1
4896444|NCT00651664|16870722|P3|Overall Study|Symptomatic Deterioration|0
4896445|NCT00651664|16870723|P2|Overall Study|Symptomatic Deterioration|0
4896446|NCT00651664|16870724|P1|Overall Study|Symptomatic Deterioration|0
4896447|NCT00651664|16870715|P10|Overall Study|Patient Declined Further Treatment|1
4896448|NCT00651664|16870716|P9|Overall Study|Patient Declined Further Treatment|0
4896449|NCT00651664|16870717|P8|Overall Study|Patient Declined Further Treatment|0
4896450|NCT00651664|16870718|P7|Overall Study|Patient Declined Further Treatment|0
4896451|NCT00651664|16870719|P6|Overall Study|Patient Declined Further Treatment|1
4896452|NCT00651664|16870720|P5|Overall Study|Patient Declined Further Treatment|1
4896453|NCT00651664|16870721|P4|Overall Study|Patient Declined Further Treatment|1
4896454|NCT00651664|16870722|P3|Overall Study|Patient Declined Further Treatment|0
4896455|NCT00651664|16870723|P2|Overall Study|Patient Declined Further Treatment|0
4896456|NCT00651664|16870724|P1|Overall Study|Patient Declined Further Treatment|0
4896457|NCT00651664|16870715|P10|Overall Study|Progressive Disease|5
4896458|NCT00651664|16870716|P9|Overall Study|Progressive Disease|5
4896459|NCT00651664|16870717|P8|Overall Study|Progressive Disease|6
4896460|NCT00651664|16870718|P7|Overall Study|Progressive Disease|3
4896461|NCT00651664|16870719|P6|Overall Study|Progressive Disease|1
4896462|NCT00651664|16870720|P5|Overall Study|Progressive Disease|4
4896463|NCT00651664|16870721|P4|Overall Study|Progressive Disease|12
4896464|NCT00651664|16870722|P3|Overall Study|Progressive Disease|3
4896465|NCT00651664|16870723|P2|Overall Study|Progressive Disease|3
4896466|NCT00651664|16870724|P1|Overall Study|Progressive Disease|3
4896467|NCT00651664|16870715|P10|Overall Study|Unsatisfactory Therapeutic Response|1
4896468|NCT00651664|16870716|P9|Overall Study|Unsatisfactory Therapeutic Response|0
4896469|NCT00651664|16870717|P8|Overall Study|Unsatisfactory Therapeutic Response|1
4896470|NCT00651664|16870718|P7|Overall Study|Unsatisfactory Therapeutic Response|0
4896471|NCT00651664|16870719|P6|Overall Study|Unsatisfactory Therapeutic Response|1
4896472|NCT00651664|16870720|P5|Overall Study|Unsatisfactory Therapeutic Response|1
4896473|NCT00651664|16870721|P4|Overall Study|Unsatisfactory Therapeutic Response|0
4896474|NCT00651664|16870722|P3|Overall Study|Unsatisfactory Therapeutic Response|0
4896475|NCT00651664|16870723|P2|Overall Study|Unsatisfactory Therapeutic Response|0
4896476|NCT00651664|16870724|P1|Overall Study|Unsatisfactory Therapeutic Response|0
4896477|NCT00651664|16870715|P10|Overall Study|Occurrence of Adverse Event(s)|0
4896478|NCT00651664|16870716|P9|Overall Study|Occurrence of Adverse Event(s)|1
4896479|NCT00651664|16870717|P8|Overall Study|Occurrence of Adverse Event(s)|0
4896480|NCT00651664|16870718|P7|Overall Study|Occurrence of Adverse Event(s)|1
4896481|NCT00651664|16870719|P6|Overall Study|Occurrence of Adverse Event(s)|0
4896482|NCT00651664|16870720|P5|Overall Study|Occurrence of Adverse Event(s)|0
4896483|NCT00651664|16870721|P4|Overall Study|Occurrence of Adverse Event(s)|0
4896484|NCT00651664|16870722|P3|Overall Study|Occurrence of Adverse Event(s)|0
4896485|NCT00651664|16870723|P2|Overall Study|Occurrence of Adverse Event(s)|0
4896486|NCT00651664|16870724|P1|Overall Study|Occurrence of Adverse Event(s)|0
4896487|NCT00651313|16870896|P2|Overall Study|Adminstrative Discontinuation|3
4896488|NCT00651313|16870897|P1|Overall Study|Adminstrative Discontinuation|2
4896489|NCT00651313|16870896|P2|Overall Study|Lost to Follow-up|1
4896490|NCT00651313|16870897|P1|Overall Study|Lost to Follow-up|1
4896491|NCT00651313|16870896|P2|Overall Study|Withdrawal by Subject|1
4896492|NCT00651313|16870897|P1|Overall Study|Withdrawal by Subject|3
4896493|NCT00651313|16870896|P2|Overall Study|Adverse Event|1
4896494|NCT00651313|16870897|P1|Overall Study|Adverse Event|0
4896495|NCT00651261|16870905|P2|Overall Study|Never treated|3
4896496|NCT00651261|16870906|P1|Overall Study|Never treated|5
4896497|NCT00651261|16870905|P2|Overall Study|Other disease or participant decisions|23
4896498|NCT00651261|16870906|P1|Overall Study|Other disease or participant decisions|23
4896499|NCT00651261|16870905|P2|Overall Study|Alternative therapy|107
4896500|NCT00651261|16870906|P1|Overall Study|Alternative therapy|109
4896501|NCT00651261|16870905|P2|Overall Study|Disease progression|58
4896502|NCT00651261|16870906|P1|Overall Study|Disease progression|58
4896503|NCT00651261|16870905|P2|Overall Study|Induction failure|35
4896504|NCT00651261|16870906|P1|Overall Study|Induction failure|24
4896505|NCT00651261|16870905|P2|Overall Study|Withdrawal by Subject|40
4896506|NCT00651261|16870906|P1|Overall Study|Withdrawal by Subject|22
4896507|NCT00651261|16870905|P2|Overall Study|Death|18
4896508|NCT00651261|16870906|P1|Overall Study|Death|18
4896509|NCT00651261|16870905|P2|Overall Study|Adverse Event|22
4896510|NCT00651261|16870906|P1|Overall Study|Adverse Event|32
4896511|NCT00651183|16870922|P2|Overall Study|missing|0
4896512|NCT00651183|16870923|P1|Overall Study|missing|1
4896513|NCT00651183|16870922|P2|Overall Study|Other reasons|2
4896514|NCT00651183|16870923|P1|Overall Study|Other reasons|4
4896515|NCT00651183|16870922|P2|Overall Study|Lost to Follow-up|1
4896516|NCT00651183|16870923|P1|Overall Study|Lost to Follow-up|3
4896517|NCT00651183|16870922|P2|Overall Study|Withdrawal by Subject|3
4896518|NCT00651183|16870923|P1|Overall Study|Withdrawal by Subject|6
4896519|NCT00651183|16870922|P2|Overall Study|Tolerability insufficient +Patients wish|1
4896520|NCT00651183|16870923|P1|Overall Study|Tolerability insufficient +Patients wish|0
4896521|NCT00651183|16870922|P2|Overall Study|Tolerability insufficient|2
4896522|NCT00651183|16870923|P1|Overall Study|Tolerability insufficient|5
4896523|NCT00651183|16870922|P2|Overall Study|Efficacy insufficient + patients wish|1
4896524|NCT00651183|16870923|P1|Overall Study|Efficacy insufficient + patients wish|0
4896525|NCT00651183|16870922|P2|Overall Study|Lack of Efficacy|0
4896526|NCT00651183|16870923|P1|Overall Study|Lack of Efficacy|1
4896527|NCT00651157|16870935|P1|Overall Study|Protocol Violation|1
4896528|NCT00651157|16870935|P1|Overall Study|Death|1
4896529|NCT00651118|16870945|P4|Overall Study|Withdrawal by Subject|1
4896530|NCT00651118|16870946|P3|Overall Study|Withdrawal by Subject|1
4896531|NCT00651118|16870947|P2|Overall Study|Withdrawal by Subject|1
4896532|NCT00651118|16870948|P1|Overall Study|Withdrawal by Subject|0
4896533|NCT00651118|16870945|P4|Overall Study|administrative|1
4896534|NCT00651118|16870946|P3|Overall Study|administrative|2
4896535|NCT00651118|16870947|P2|Overall Study|administrative|4
4896536|NCT00651118|16870948|P1|Overall Study|administrative|1
4896537|NCT00651118|16870945|P4|Overall Study|Lost to Follow-up|2
4896538|NCT00651118|16870946|P3|Overall Study|Lost to Follow-up|1
4896539|NCT00651118|16870947|P2|Overall Study|Lost to Follow-up|0
4896540|NCT00651118|16870948|P1|Overall Study|Lost to Follow-up|2
4896541|NCT00651118|16870945|P4|Overall Study|Protocol Violation|2
4896542|NCT00651118|16870946|P3|Overall Study|Protocol Violation|6
4896543|NCT00651118|16870947|P2|Overall Study|Protocol Violation|2
4896544|NCT00651118|16870948|P1|Overall Study|Protocol Violation|2
4896545|NCT00651118|16870945|P4|Overall Study|Adverse Event|1
4896546|NCT00651118|16870946|P3|Overall Study|Adverse Event|1
4896547|NCT00651118|16870947|P2|Overall Study|Adverse Event|0
4896548|NCT00651118|16870948|P1|Overall Study|Adverse Event|4
4896549|NCT00650845|16871017|P2|Overall Study|Protocol Violation|13
4896550|NCT00650845|16871018|P1|Overall Study|Protocol Violation|0
4896551|NCT00650845|16871017|P2|Overall Study|Withdrawal by Subject|0
4896552|NCT00650845|16871018|P1|Overall Study|Withdrawal by Subject|5
4896553|NCT00650806|16871038|P4|Overall Study|Other|0
4896554|NCT00650806|16871039|P3|Overall Study|Other|2
4896555|NCT00650806|16871040|P2|Overall Study|Other|1
4896556|NCT00650806|16871041|P1|Overall Study|Other|1
4896557|NCT00650806|16871038|P4|Overall Study|Study terminated by sponsor|4
4896558|NCT00650806|16871039|P3|Overall Study|Study terminated by sponsor|5
4896559|NCT00650806|16871040|P2|Overall Study|Study terminated by sponsor|3
4896560|NCT00650806|16871041|P1|Overall Study|Study terminated by sponsor|2
4896561|NCT00650806|16871038|P4|Overall Study|Noncompliance with study drug regimen|0
4896562|NCT00650806|16871039|P3|Overall Study|Noncompliance with study drug regimen|0
4896563|NCT00650806|16871040|P2|Overall Study|Noncompliance with study drug regimen|1
4896564|NCT00650806|16871041|P1|Overall Study|Noncompliance with study drug regimen|1
4896565|NCT00650806|16871038|P4|Overall Study|Withdrawal by Subject|6
4896566|NCT00650806|16871039|P3|Overall Study|Withdrawal by Subject|8
4896567|NCT00650806|16871040|P2|Overall Study|Withdrawal by Subject|5
4896568|NCT00650806|16871041|P1|Overall Study|Withdrawal by Subject|7
4896569|NCT00650806|16871038|P4|Overall Study|Pregnancy|1
4896570|NCT00650806|16871039|P3|Overall Study|Pregnancy|0
4896571|NCT00650806|16871040|P2|Overall Study|Pregnancy|0
4896572|NCT00650806|16871041|P1|Overall Study|Pregnancy|0
4896573|NCT00650806|16871038|P4|Overall Study|Protocol Violation|1
4896574|NCT00650806|16871039|P3|Overall Study|Protocol Violation|0
4896575|NCT00650806|16871040|P2|Overall Study|Protocol Violation|0
4896576|NCT00650806|16871041|P1|Overall Study|Protocol Violation|0
4896577|NCT00650806|16871038|P4|Overall Study|Lost to Follow-up|10
4896578|NCT00650806|16871039|P3|Overall Study|Lost to Follow-up|11
4896579|NCT00650806|16871040|P2|Overall Study|Lost to Follow-up|6
4896580|NCT00650806|16871041|P1|Overall Study|Lost to Follow-up|7
4896581|NCT00650806|16871038|P4|Overall Study|Adverse Event|4
4896582|NCT00650806|16871039|P3|Overall Study|Adverse Event|3
4896583|NCT00650806|16871040|P2|Overall Study|Adverse Event|5
4896584|NCT00650806|16871041|P1|Overall Study|Adverse Event|0
4896585|NCT00650767|16871083|P4|Overall Study|Other|0
4896586|NCT00650767|16871084|P3|Overall Study|Other|0
4896587|NCT00650767|16871085|P2|Overall Study|Other|1
4896588|NCT00650767|16871086|P1|Overall Study|Other|1
4896589|NCT00650767|16871083|P4|Overall Study|Lost to Follow-up|0
4896590|NCT00650767|16871084|P3|Overall Study|Lost to Follow-up|1
4896591|NCT00650767|16871085|P2|Overall Study|Lost to Follow-up|1
4896592|NCT00650767|16871086|P1|Overall Study|Lost to Follow-up|1
4896593|NCT00650767|16871083|P4|Overall Study|Withdrawal by Subject|3
4896594|NCT00650767|16871084|P3|Overall Study|Withdrawal by Subject|3
4896595|NCT00650767|16871085|P2|Overall Study|Withdrawal by Subject|4
4896596|NCT00650767|16871086|P1|Overall Study|Withdrawal by Subject|2
4896597|NCT00650767|16871083|P4|Overall Study|Death|0
4896598|NCT00650767|16871084|P3|Overall Study|Death|0
4896599|NCT00650767|16871085|P2|Overall Study|Death|0
4896600|NCT00650767|16871086|P1|Overall Study|Death|1
4896601|NCT00650767|16871083|P4|Overall Study|Adverse Event|8
4896602|NCT00650767|16871084|P3|Overall Study|Adverse Event|10
4896603|NCT00650767|16871085|P2|Overall Study|Adverse Event|3
4896604|NCT00650767|16871086|P1|Overall Study|Adverse Event|0
4896605|NCT00650585|16871590|P2|Overall Study|Excluded/ruled ineligible|129
4896606|NCT00650585|16871591|P1|Overall Study|Excluded/ruled ineligible|357
4896607|NCT00650585|16871590|P2|Overall Study|No parental consent|866
4896608|NCT00650585|16871591|P1|Overall Study|No parental consent|935
4896609|NCT00650585|16871590|P2|Overall Study|Lost to Follow-up|482
4896610|NCT00650585|16871591|P1|Overall Study|Lost to Follow-up|505
4896611|NCT00650104|16871635|P1|Overall Study|Sponsor Terminated Dosing|1
4896612|NCT00650104|16871635|P1|Overall Study|Non-compliance|2
4896613|NCT00650104|16871635|P1|Overall Study|Lost to Follow-up|1
4896614|NCT00650104|16871635|P1|Overall Study|Physician Decision|7
4896615|NCT00650104|16871635|P1|Overall Study|Withdrawal by Subject|11
4896616|NCT00650104|16871635|P1|Overall Study|Death|2
4896617|NCT00650104|16871635|P1|Overall Study|Adverse Event|17
4896618|NCT00650091|16871650|P3|Amended Study Design|Other|0
4896619|NCT00650091|16871651|P2|Amended Study Design|Other|3
4896620|NCT00650091|16871652|P1|Amended Study Design|Other|1
4896621|NCT00650091|16871650|P3|Amended Study Design|Lung transplantation|0
4896622|NCT00650091|16871651|P2|Amended Study Design|Lung transplantation|2
4896623|NCT00650091|16871652|P1|Amended Study Design|Lung transplantation|4
4896624|NCT00650091|16871650|P3|Amended Study Design|Adverse Event|0
4896625|NCT00650091|16871651|P2|Amended Study Design|Adverse Event|4
4896626|NCT00650091|16871652|P1|Amended Study Design|Adverse Event|1
4896627|NCT00650091|16871650|P3|Amended Study Design|Physician Decision|0
4896628|NCT00650091|16871651|P2|Amended Study Design|Physician Decision|0
4896629|NCT00650091|16871652|P1|Amended Study Design|Physician Decision|5
4896630|NCT00650091|16871650|P3|Amended Study Design|Withdrawal by Subject|0
4896631|NCT00650091|16871651|P2|Amended Study Design|Withdrawal by Subject|11
4896632|NCT00650091|16871652|P1|Amended Study Design|Withdrawal by Subject|12
4896633|NCT00649428|16871695|P2|Overall Study|Physician Decision|1
4896634|NCT00649428|16871696|P1|Overall Study|Physician Decision|0
4896635|NCT00649428|16871695|P2|Overall Study|Protocol Violation|2
4896636|NCT00649428|16871696|P1|Overall Study|Protocol Violation|6
4896637|NCT00649428|16871695|P2|Overall Study|Insufficient manufacturing yield|1
4896638|NCT00649428|16871696|P1|Overall Study|Insufficient manufacturing yield|5
4896639|NCT00649428|16871695|P2|Overall Study|Lost to Follow-up|3
4896640|NCT00649428|16871696|P1|Overall Study|Lost to Follow-up|1
4896641|NCT00649428|16871695|P2|Overall Study|Withdrawal by Subject|6
4896642|NCT00649428|16871696|P1|Overall Study|Withdrawal by Subject|6
4896643|NCT00649428|16871695|P2|Overall Study|Adverse Event|2
4896644|NCT00649428|16871696|P1|Overall Study|Adverse Event|2
4896645|NCT00649389|16871712|P4|Overall Study|Other|6
4896646|NCT00649389|16871713|P3|Overall Study|Other|1
4896647|NCT00649389|16871714|P2|Overall Study|Other|9
4896648|NCT00649389|16871715|P1|Overall Study|Other|3
4896649|NCT00649389|16871712|P4|Overall Study|Withdrawal by Subject|23
4896650|NCT00649389|16871713|P3|Overall Study|Withdrawal by Subject|19
4896651|NCT00649389|16871714|P2|Overall Study|Withdrawal by Subject|21
4896652|NCT00649389|16871715|P1|Overall Study|Withdrawal by Subject|20
4896653|NCT00649389|16871712|P4|Overall Study|Protocol Violation|8
4896654|NCT00649389|16871713|P3|Overall Study|Protocol Violation|9
4896655|NCT00649389|16871714|P2|Overall Study|Protocol Violation|13
4896656|NCT00649389|16871715|P1|Overall Study|Protocol Violation|11
4896657|NCT00649389|16871712|P4|Overall Study|Lost to Follow-up|26
4896658|NCT00649389|16871713|P3|Overall Study|Lost to Follow-up|21
4896659|NCT00649389|16871714|P2|Overall Study|Lost to Follow-up|17
4896660|NCT00649389|16871715|P1|Overall Study|Lost to Follow-up|15
4896661|NCT00649389|16871712|P4|Overall Study|Adverse Event|48
4896662|NCT00649389|16871713|P3|Overall Study|Adverse Event|38
4896663|NCT00649389|16871714|P2|Overall Study|Adverse Event|46
4896664|NCT00649389|16871715|P1|Overall Study|Adverse Event|22
4896665|NCT00649220|16871737|P1|Overall Study|Withdrawal by Subject|1
4896666|NCT00649220|16871737|P1|Overall Study|Adverse Event|2
4896667|NCT00648895|16871758|P2|Overall Study|Lack of Efficacy|1
4896668|NCT00648895|16871759|P1|Overall Study|Lack of Efficacy|0
4896669|NCT00648739|16871765|P7|Overall Study|Follow-up Visits Not Completed|0
4896670|NCT00648739|16871766|P6|Overall Study|Follow-up Visits Not Completed|0
4896671|NCT00648739|16871767|P5|Overall Study|Follow-up Visits Not Completed|0
4896672|NCT00648739|16871768|P4|Overall Study|Follow-up Visits Not Completed|0
4896673|NCT00648739|16871769|P3|Overall Study|Follow-up Visits Not Completed|0
4896674|NCT00648739|16871770|P2|Overall Study|Follow-up Visits Not Completed|1
4896675|NCT00648739|16871771|P1|Overall Study|Follow-up Visits Not Completed|0
4896676|NCT00648739|16871765|P7|Overall Study|Positive Human Anti-human Antibody|0
4896677|NCT00648739|16871766|P6|Overall Study|Positive Human Anti-human Antibody|0
4896678|NCT00648739|16871767|P5|Overall Study|Positive Human Anti-human Antibody|0
4896679|NCT00648739|16871768|P4|Overall Study|Positive Human Anti-human Antibody|0
4896680|NCT00648739|16871769|P3|Overall Study|Positive Human Anti-human Antibody|1
4896681|NCT00648739|16871770|P2|Overall Study|Positive Human Anti-human Antibody|0
4896682|NCT00648739|16871771|P1|Overall Study|Positive Human Anti-human Antibody|0
4896683|NCT00648739|16871765|P7|Overall Study|Death|0
4896684|NCT00648739|16871766|P6|Overall Study|Death|0
4896685|NCT00648739|16871767|P5|Overall Study|Death|0
4896686|NCT00648739|16871768|P4|Overall Study|Death|0
4896687|NCT00648739|16871769|P3|Overall Study|Death|0
4896688|NCT00648739|16871770|P2|Overall Study|Death|1
4896689|NCT00648739|16871771|P1|Overall Study|Death|0
4896690|NCT00648739|16871765|P7|Overall Study|Investigator Considered it Advisable|1
4896691|NCT00648739|16871766|P6|Overall Study|Investigator Considered it Advisable|1
4896692|NCT00648739|16871767|P5|Overall Study|Investigator Considered it Advisable|0
4896693|NCT00648739|16871768|P4|Overall Study|Investigator Considered it Advisable|0
4896694|NCT00648739|16871769|P3|Overall Study|Investigator Considered it Advisable|0
4896695|NCT00648739|16871770|P2|Overall Study|Investigator Considered it Advisable|0
4896696|NCT00648739|16871771|P1|Overall Study|Investigator Considered it Advisable|0
4896697|NCT00648739|16871765|P7|Overall Study|Lack of Efficacy|0
4896698|NCT00648739|16871766|P6|Overall Study|Lack of Efficacy|2
4896699|NCT00648739|16871767|P5|Overall Study|Lack of Efficacy|1
4896700|NCT00648739|16871768|P4|Overall Study|Lack of Efficacy|0
4896701|NCT00648739|16871769|P3|Overall Study|Lack of Efficacy|0
4896702|NCT00648739|16871770|P2|Overall Study|Lack of Efficacy|0
4896703|NCT00648739|16871771|P1|Overall Study|Lack of Efficacy|0
4896704|NCT00648739|16871765|P7|Overall Study|Withdrawal by Subject|0
4896705|NCT00648739|16871766|P6|Overall Study|Withdrawal by Subject|2
4896706|NCT00648739|16871767|P5|Overall Study|Withdrawal by Subject|0
4896707|NCT00648739|16871768|P4|Overall Study|Withdrawal by Subject|0
4896708|NCT00648739|16871769|P3|Overall Study|Withdrawal by Subject|1
4896709|NCT00648739|16871770|P2|Overall Study|Withdrawal by Subject|0
4896710|NCT00648739|16871771|P1|Overall Study|Withdrawal by Subject|1
4896711|NCT00648739|16871765|P7|Overall Study|Adverse Event|0
4896712|NCT00648739|16871766|P6|Overall Study|Adverse Event|0
4896713|NCT00648739|16871767|P5|Overall Study|Adverse Event|1
4896714|NCT00648739|16871768|P4|Overall Study|Adverse Event|2
4896715|NCT00648739|16871769|P3|Overall Study|Adverse Event|1
4896716|NCT00648739|16871770|P2|Overall Study|Adverse Event|0
4896717|NCT00648739|16871771|P1|Overall Study|Adverse Event|1
4896718|NCT00648167|16872105|P1|Overall Study|unable to swallow tablets|1
4896719|NCT00648167|16872105|P1|Overall Study|Adverse Event|6
4896720|NCT00648037|16872125|P1|Overall Study|Other|1
4896721|NCT00648037|16872125|P1|Overall Study|Relapse|2
4896722|NCT00648037|16872125|P1|Overall Study|Adverse Event|11
4896723|NCT00648037|16872125|P1|Overall Study|Withdrawal by Subject|1
4896724|NCT00648037|16872125|P1|Overall Study|Not Treated|1
4896725|NCT00647699|16872144|P2|Overall Study|Withdrawal by Subject|8
4896726|NCT00647699|16872145|P1|Overall Study|Withdrawal by Subject|3
4896727|NCT00647699|16872144|P2|Overall Study|Lost to Follow-up|4
4896728|NCT00647699|16872145|P1|Overall Study|Lost to Follow-up|5
4896729|NCT00647556|16872153|P2|Overall Study|Surgery for pre-existing neck pain|0
4896730|NCT00647556|16872154|P1|Overall Study|Surgery for pre-existing neck pain|1
4896731|NCT00647556|16872153|P2|Overall Study|Withdrawal by Subject|0
4896732|NCT00647556|16872154|P1|Overall Study|Withdrawal by Subject|1
4896733|NCT00647556|16872153|P2|Overall Study|Protocol Violation|1
4896734|NCT00647556|16872154|P1|Overall Study|Protocol Violation|0
4896735|NCT00647556|16872153|P2|Overall Study|Lost to Follow-up|0
4896736|NCT00647556|16872154|P1|Overall Study|Lost to Follow-up|1
4896737|NCT00647556|16872153|P2|Overall Study|Adverse Event|1
4896738|NCT00647556|16872154|P1|Overall Study|Adverse Event|0
4896739|NCT00647426|16872168|P1|Overall Study|Withdrawal by Subject|2
4896740|NCT00647348|16872190|P2|Overall Study|Lost to Follow-up|6
4896741|NCT00647348|16872191|P1|Overall Study|Lost to Follow-up|3
4896742|NCT00647270|16872216|P3|Period 2, Placebo Switched to Adalimumab|Other|0
4896743|NCT00647270|16872217|P2|Period 2, Placebo Switched to Adalimumab|Other|6
4896744|NCT00647270|16872218|P1|Period 2, Placebo Switched to Adalimumab|Other|2
4896745|NCT00647270|16872216|P3|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4
4896746|NCT00647270|16872217|P2|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
4896747|NCT00647270|16872218|P1|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0
4896748|NCT00647270|16872216|P3|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
4896749|NCT00647270|16872217|P2|Period 2, Placebo Switched to Adalimumab|Adverse Event|3
4896750|NCT00647270|16872218|P1|Period 2, Placebo Switched to Adalimumab|Adverse Event|1
4896751|NCT00647270|16872216|P3|Period 1, Placebo-control (12 Weeks)|Other|8
4896752|NCT00647270|16872217|P2|Period 1, Placebo-control (12 Weeks)|Other|4
4896753|NCT00647270|16872218|P1|Period 1, Placebo-control (12 Weeks)|Other|4
4896754|NCT00647270|16872216|P3|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7
4896755|NCT00647270|16872217|P2|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1
4896756|NCT00647270|16872218|P1|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2
4896757|NCT00647270|16872216|P3|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
4896758|NCT00647270|16872217|P2|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1
4896759|NCT00647270|16872218|P1|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0
4896760|NCT00647270|16872216|P3|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
4896761|NCT00647270|16872217|P2|Period 1, Placebo-control (12 Weeks)|Adverse Event|7
4896762|NCT00647270|16872218|P1|Period 1, Placebo-control (12 Weeks)|Adverse Event|2
4896763|NCT00646958|16872244|P3|Overall Study|Did not receive study drug|2
4896764|NCT00646958|16872245|P2|Overall Study|Did not receive study drug|0
4896765|NCT00646958|16872246|P1|Overall Study|Did not receive study drug|2
4896766|NCT00646958|16872244|P3|Overall Study|Withdrawal by Subject|0
4896767|NCT00646958|16872245|P2|Overall Study|Withdrawal by Subject|2
4896768|NCT00646958|16872246|P1|Overall Study|Withdrawal by Subject|1
4896769|NCT00646958|16872244|P3|Overall Study|Abnormal screening lab tests|0
4896770|NCT00646958|16872245|P2|Overall Study|Abnormal screening lab tests|1
4896771|NCT00646958|16872246|P1|Overall Study|Abnormal screening lab tests|1
4896772|NCT00646958|16872244|P3|Overall Study|Protocol Violation|0
4896773|NCT00646958|16872245|P2|Overall Study|Protocol Violation|1
4896774|NCT00646958|16872246|P1|Overall Study|Protocol Violation|1
4896775|NCT00646958|16872244|P3|Overall Study|Lost to Follow-up|7
4896776|NCT00646958|16872245|P2|Overall Study|Lost to Follow-up|5
4896777|NCT00646958|16872246|P1|Overall Study|Lost to Follow-up|1
4896778|NCT00646958|16872244|P3|Overall Study|Adverse Event|0
4896779|NCT00646958|16872245|P2|Overall Study|Adverse Event|0
4896780|NCT00646958|16872246|P1|Overall Study|Adverse Event|4
4896781|NCT00646958|16872244|P3|Overall Study|Lack of Efficacy|0
4896782|NCT00646958|16872245|P2|Overall Study|Lack of Efficacy|0
4896783|NCT00646958|16872246|P1|Overall Study|Lack of Efficacy|1
4896784|NCT00646906|16872261|P7|Crossover Period 2|Physician Decision|1
4896785|NCT00646906|16872262|P6|Crossover Period 2|Physician Decision|0
4896786|NCT00646906|16872263|P5|Crossover Period 2|Physician Decision|0
4896787|NCT00646906|16872264|P4|Crossover Period 2|Physician Decision|0
4896788|NCT00646906|16872265|P3|Crossover Period 2|Physician Decision|0
4896789|NCT00646906|16872266|P2|Crossover Period 2|Physician Decision|0
4896790|NCT00646906|16872267|P1|Crossover Period 2|Physician Decision|0
4896791|NCT00646906|16872261|P7|Crossover Period 2|Withdrawal by Subject|0
4896792|NCT00646906|16872262|P6|Crossover Period 2|Withdrawal by Subject|0
4896793|NCT00646906|16872263|P5|Crossover Period 2|Withdrawal by Subject|0
4896794|NCT00646906|16872264|P4|Crossover Period 2|Withdrawal by Subject|1
4896795|NCT00646906|16872265|P3|Crossover Period 2|Withdrawal by Subject|2
4896796|NCT00646906|16872266|P2|Crossover Period 2|Withdrawal by Subject|1
4896797|NCT00646906|16872267|P1|Crossover Period 2|Withdrawal by Subject|0
4896798|NCT00646906|16872261|P7|Crossover Period 1|Withdrawal by Subject|0
4896799|NCT00646906|16872262|P6|Crossover Period 1|Withdrawal by Subject|1
4896800|NCT00646906|16872263|P5|Crossover Period 1|Withdrawal by Subject|0
4896801|NCT00646906|16872264|P4|Crossover Period 1|Withdrawal by Subject|0
4896802|NCT00646906|16872265|P3|Crossover Period 1|Withdrawal by Subject|0
4896803|NCT00646906|16872266|P2|Crossover Period 1|Withdrawal by Subject|0
4896804|NCT00646906|16872267|P1|Crossover Period 1|Withdrawal by Subject|1
4896805|NCT00646776|16872286|P2|Overall Study|Investigator discretion|4
4896806|NCT00646776|16872287|P1|Overall Study|Investigator discretion|0
4896807|NCT00646776|16872286|P2|Overall Study|Adverse Event|9
4896808|NCT00646776|16872287|P1|Overall Study|Adverse Event|1
4896809|NCT00646399|16872385|P2|Overall Study|Other Reason|11
4896810|NCT00646399|16872386|P1|Overall Study|Other Reason|11
4896811|NCT00646399|16872385|P2|Overall Study|Withdrawal by Subject|10
4896812|NCT00646399|16872386|P1|Overall Study|Withdrawal by Subject|9
4896813|NCT00646399|16872385|P2|Overall Study|Death|53
4896814|NCT00646399|16872386|P1|Overall Study|Death|63
4896815|NCT00646282|16872394|P2|Overall Study|Protocol terminated|4
4896816|NCT00646282|16872395|P1|Overall Study|Protocol terminated|4
4896817|NCT00646113|16872401|P1|Overall Study|Adverse Event|3
4896818|NCT00646113|16872401|P1|Overall Study|Lost to Follow-up|5
4896819|NCT00645944|16872422|P2|Received Medication|Protocol Violation|1
4896820|NCT00645944|16872423|P1|Received Medication|Protocol Violation|2
4896821|NCT00645944|16872422|P2|Received Medication|Lost to Follow-up|0
4896822|NCT00645944|16872423|P1|Received Medication|Lost to Follow-up|1
4896823|NCT00645944|16872422|P2|Received Medication|Withdrawal by Subject|1
4896824|NCT00645944|16872423|P1|Received Medication|Withdrawal by Subject|1
4896825|NCT00645944|16872422|P2|Received Medication|Adverse Event|1
4896826|NCT00645944|16872423|P1|Received Medication|Adverse Event|2
4896827|NCT00645944|16872422|P2|Randomized|Withdrawal by Subject|2
4896828|NCT00645944|16872423|P1|Randomized|Withdrawal by Subject|1
4896829|NCT00645853|16872431|P2|Overall Study|recall of ICF, planned operation, death|4
4896830|NCT00645853|16872432|P1|Overall Study|recall of ICF, planned operation, death|7
4896831|NCT00645853|16872431|P2|Overall Study|Discontinuation criteria|2
4896832|NCT00645853|16872432|P1|Overall Study|Discontinuation criteria|2
4896833|NCT00645853|16872431|P2|Overall Study|Protocol Violation|2
4896834|NCT00645853|16872432|P1|Overall Study|Protocol Violation|0
4896835|NCT00645853|16872431|P2|Overall Study|Withdrawal by Subject|2
4896836|NCT00645853|16872432|P1|Overall Study|Withdrawal by Subject|5
4896837|NCT00645853|16872431|P2|Overall Study|AZ study closure in Hungary|40
4896838|NCT00645853|16872432|P1|Overall Study|AZ study closure in Hungary|60
4896839|NCT00645853|16872431|P2|Overall Study|Adverse Event|7
4896840|NCT00645853|16872432|P1|Overall Study|Adverse Event|18
4896841|NCT00645840|16872450|P1|Overall Study|Protocol Violation|3
4896842|NCT00645788|16872468|P4|Overall Study|Pulmonary exacerbation|9
4896843|NCT00645788|16872469|P3|Overall Study|Pulmonary exacerbation|11
4896844|NCT00645788|16872470|P2|Overall Study|Pulmonary exacerbation|16
4896845|NCT00645788|16872471|P1|Overall Study|Pulmonary exacerbation|13
4896846|NCT00645788|16872468|P4|Overall Study|Withdrawal by Subject|2
4896847|NCT00645788|16872469|P3|Overall Study|Withdrawal by Subject|0
4896848|NCT00645788|16872470|P2|Overall Study|Withdrawal by Subject|1
4896849|NCT00645788|16872471|P1|Overall Study|Withdrawal by Subject|0
4896850|NCT00645788|16872468|P4|Overall Study|Protocol Violation|0
4896851|NCT00645788|16872469|P3|Overall Study|Protocol Violation|2
4896852|NCT00645788|16872470|P2|Overall Study|Protocol Violation|0
4896853|NCT00645788|16872471|P1|Overall Study|Protocol Violation|1
4896854|NCT00645788|16872468|P4|Overall Study|Lost to Follow-up|0
4896855|NCT00645788|16872469|P3|Overall Study|Lost to Follow-up|0
4896856|NCT00645788|16872470|P2|Overall Study|Lost to Follow-up|0
4896857|NCT00645788|16872471|P1|Overall Study|Lost to Follow-up|1
4896858|NCT00645788|16872468|P4|Overall Study|Adverse Event|3
4896859|NCT00645788|16872469|P3|Overall Study|Adverse Event|5
4896860|NCT00645788|16872470|P2|Overall Study|Adverse Event|9
4896861|NCT00645788|16872471|P1|Overall Study|Adverse Event|4
4896862|NCT00645788|16872468|P4|Overall Study|Did not receive study drug|0
4896863|NCT00645788|16872469|P3|Overall Study|Did not receive study drug|0
4896864|NCT00645788|16872470|P2|Overall Study|Did not receive study drug|1
4896865|NCT00645788|16872471|P1|Overall Study|Did not receive study drug|1
4896866|NCT00645671|16872549|P2|Overall Study|Physician Decision|1
4896867|NCT00645671|16872550|P1|Overall Study|Physician Decision|0
4896868|NCT00645671|16872549|P2|Overall Study|Adverse Event|1
4896869|NCT00645671|16872550|P1|Overall Study|Adverse Event|0
4896870|NCT00645671|16872549|P2|Overall Study|Withdrawal by Subject|4
4896871|NCT00645671|16872550|P1|Overall Study|Withdrawal by Subject|0
4896872|NCT00645671|16872549|P2|Overall Study|Protocol Violation|0
4896873|NCT00645671|16872550|P1|Overall Study|Protocol Violation|1
4896874|NCT00645593|16872564|P2|Overall Study|Later found to be ineligible|0
4896875|NCT00645593|16872565|P1|Overall Study|Later found to be ineligible|1
4896876|NCT00645567|16872577|P1|Overall Study|Adverse Event|1
4896877|NCT00645528|16872585|P1|Overall Study|Did not show up for Visit 2|7
4896878|NCT00645411|16872607|P4|Overall Study|Unable to classify|4
4896879|NCT00645411|16872608|P3|Overall Study|Unable to classify|3
4896880|NCT00645411|16872609|P2|Overall Study|Unable to classify|0
4896881|NCT00645411|16872610|P1|Overall Study|Unable to classify|0
4896882|NCT00645411|16872607|P4|Overall Study|Inappropriate enrollment|1
4896883|NCT00645411|16872608|P3|Overall Study|Inappropriate enrollment|4
4896884|NCT00645411|16872609|P2|Overall Study|Inappropriate enrollment|0
4896885|NCT00645411|16872610|P1|Overall Study|Inappropriate enrollment|0
4896886|NCT00645411|16872607|P4|Overall Study|Protocol Violation|0
4896887|NCT00645411|16872608|P3|Overall Study|Protocol Violation|1
4896888|NCT00645411|16872609|P2|Overall Study|Protocol Violation|0
4896889|NCT00645411|16872610|P1|Overall Study|Protocol Violation|1
4896890|NCT00645411|16872607|P4|Overall Study|Lost to Follow-up|75
4896891|NCT00645411|16872608|P3|Overall Study|Lost to Follow-up|124
4896892|NCT00645411|16872609|P2|Overall Study|Lost to Follow-up|5
4896893|NCT00645411|16872610|P1|Overall Study|Lost to Follow-up|10
4896894|NCT00645411|16872607|P4|Overall Study|Withdrawal by Subject|21
4896895|NCT00645411|16872608|P3|Overall Study|Withdrawal by Subject|19
4896896|NCT00645411|16872609|P2|Overall Study|Withdrawal by Subject|1
4896897|NCT00645411|16872610|P1|Overall Study|Withdrawal by Subject|2
4896898|NCT00645411|16872607|P4|Overall Study|Adverse Event|2
4896899|NCT00645411|16872608|P3|Overall Study|Adverse Event|0
4896900|NCT00645411|16872609|P2|Overall Study|Adverse Event|0
4896901|NCT00645411|16872610|P1|Overall Study|Adverse Event|0
4896902|NCT00645164|16872652|P1|Overall Study|Protocol Violation|1
4896903|NCT00645164|16872652|P1|Overall Study|Withdrawal by Subject|4
4896904|NCT00645164|16872652|P1|Overall Study|Lost to Follow-up|2
4896905|NCT00645099|16872658|P2|Overall Study|Other|5
4896906|NCT00645099|16872659|P1|Overall Study|Other|9
4896907|NCT00645099|16872658|P2|Overall Study|Adverse Event|5
4896908|NCT00645099|16872659|P1|Overall Study|Adverse Event|11
4896909|NCT00645099|16872658|P2|Overall Study|Lost to Follow-up|4
4896910|NCT00645099|16872659|P1|Overall Study|Lost to Follow-up|6
4896911|NCT00645099|16872658|P2|Overall Study|Withdrawal by Subject|22
4896912|NCT00645099|16872659|P1|Overall Study|Withdrawal by Subject|30
4896913|NCT00645099|16872658|P2|Overall Study|Lack of Efficacy|6
4896914|NCT00645099|16872659|P1|Overall Study|Lack of Efficacy|15
4896915|NCT00644995|16872728|P2|Overall Study|Refused|0
4896916|NCT00644995|16872729|P1|Overall Study|Refused|1
4896917|NCT00644995|16872728|P2|Overall Study|Lost to Follow-up|4
4896918|NCT00644995|16872729|P1|Overall Study|Lost to Follow-up|1
4896919|NCT00644969|16872749|P2|Post Treatment Phase|Other|0
4896920|NCT00644969|16872750|P1|Post Treatment Phase|Other|1
4896921|NCT00644969|16872749|P2|Post Treatment Phase|Lost to Follow-up|1
4896922|NCT00644969|16872750|P1|Post Treatment Phase|Lost to Follow-up|4
4896923|NCT00644969|16872749|P2|Post Treatment Phase|Withdrawal by Subject|2
4896924|NCT00644969|16872750|P1|Post Treatment Phase|Withdrawal by Subject|4
4896925|NCT00644969|16872749|P2|Post Treatment Phase|Death|0
4896926|NCT00644969|16872750|P1|Post Treatment Phase|Death|1
4896927|NCT00644969|16872749|P2|Treatment Phase|Other|1
4896928|NCT00644969|16872750|P1|Treatment Phase|Other|4
4896929|NCT00644969|16872749|P2|Treatment Phase|Lost to Follow-up|2
4896930|NCT00644969|16872750|P1|Treatment Phase|Lost to Follow-up|2
4896931|NCT00644969|16872749|P2|Treatment Phase|Withdrawal by Subject|0
4896932|NCT00644969|16872750|P1|Treatment Phase|Withdrawal by Subject|4
4896933|NCT00644969|16872749|P2|Treatment Phase|Adverse Event|0
4896934|NCT00644969|16872750|P1|Treatment Phase|Adverse Event|3
4896935|NCT00644969|16872749|P2|Treatment Phase|Randomized, not treated|0
4896936|NCT00644969|16872750|P1|Treatment Phase|Randomized, not treated|1
4896937|NCT00644917|16872796|P1|Overall Study|Withdrawal by Subject|2
4896938|NCT00644787|16872804|P3|Period 2: Double Blind Phase|Worsening of symptoms|1
4896939|NCT00644787|16872805|P2|Period 2: Double Blind Phase|Worsening of symptoms|0
4896940|NCT00644787|16872806|P1|Period 2: Double Blind Phase|Worsening of symptoms|0
4896941|NCT00644787|16872804|P3|Period 2: Double Blind Phase|Worsening of underlying disease|2
4896942|NCT00644787|16872805|P2|Period 2: Double Blind Phase|Worsening of underlying disease|6
4896943|NCT00644787|16872806|P1|Period 2: Double Blind Phase|Worsening of underlying disease|0
4896944|NCT00644787|16872804|P3|Period 2: Double Blind Phase|Withdrawal by Subject|0
4896945|NCT00644787|16872805|P2|Period 2: Double Blind Phase|Withdrawal by Subject|1
4896946|NCT00644787|16872806|P1|Period 2: Double Blind Phase|Withdrawal by Subject|0
4896947|NCT00644787|16872804|P3|Period 2: Double Blind Phase|Adverse Event|4
4896948|NCT00644787|16872805|P2|Period 2: Double Blind Phase|Adverse Event|2
4896949|NCT00644787|16872806|P1|Period 2: Double Blind Phase|Adverse Event|0
4896950|NCT00644787|16872804|P3|Period 1: Titration Phase|Participant was judged as ineligible|0
4896951|NCT00644787|16872805|P2|Period 1: Titration Phase|Participant was judged as ineligible|0
4896952|NCT00644787|16872806|P1|Period 1: Titration Phase|Participant was judged as ineligible|3
4896953|NCT00644787|16872804|P3|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
4896954|NCT00644787|16872805|P2|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0
4896955|NCT00644787|16872806|P1|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3
4896956|NCT00644787|16872804|P3|Period 1: Titration Phase|Worsening of symptoms|0
4896957|NCT00644787|16872805|P2|Period 1: Titration Phase|Worsening of symptoms|0
4896958|NCT00644787|16872806|P1|Period 1: Titration Phase|Worsening of symptoms|1
4896959|NCT00644787|16872804|P3|Period 1: Titration Phase|Worsening of complications|0
4896960|NCT00644787|16872805|P2|Period 1: Titration Phase|Worsening of complications|0
4896961|NCT00644787|16872806|P1|Period 1: Titration Phase|Worsening of complications|1
4896962|NCT00644787|16872804|P3|Period 1: Titration Phase|Worsening of underlying disease|0
4896963|NCT00644787|16872805|P2|Period 1: Titration Phase|Worsening of underlying disease|0
4896964|NCT00644787|16872806|P1|Period 1: Titration Phase|Worsening of underlying disease|5
4896965|NCT00644787|16872804|P3|Period 1: Titration Phase|Physician Decision|0
4896966|NCT00644787|16872805|P2|Period 1: Titration Phase|Physician Decision|0
4896967|NCT00644787|16872806|P1|Period 1: Titration Phase|Physician Decision|1
4896968|NCT00644787|16872804|P3|Period 1: Titration Phase|Withdrawal by Subject|0
4896969|NCT00644787|16872805|P2|Period 1: Titration Phase|Withdrawal by Subject|0
4896970|NCT00644787|16872806|P1|Period 1: Titration Phase|Withdrawal by Subject|2
4896971|NCT00644787|16872804|P3|Period 1: Titration Phase|Adverse Event|0
4896972|NCT00644787|16872805|P2|Period 1: Titration Phase|Adverse Event|0
4896973|NCT00644787|16872806|P1|Period 1: Titration Phase|Adverse Event|11
4896974|NCT00644423|16872850|P2|Overall Study|Lost to Follow-up|1
4896975|NCT00644423|16872851|P1|Overall Study|Lost to Follow-up|1
4896976|NCT00644358|16872869|P1|Overall Study|Other Unspecified|11
4896977|NCT00644358|16872869|P1|Overall Study|Noncompliance|14
4896978|NCT00644358|16872869|P1|Overall Study|Protocol Violation|5
4896979|NCT00644358|16872869|P1|Overall Study|Lack of Effectiveness|39
4896980|NCT00644358|16872869|P1|Overall Study|Consent Withdrawal|64
4896981|NCT00644358|16872869|P1|Overall Study|Lost to Follow-up|105
4896982|NCT00644358|16872869|P1|Overall Study|Adverse Event|124
4896983|NCT00644332|16872876|P1|Overall Study|Could Not Attend Scheduled Visits|1
4896984|NCT00644332|16872876|P1|Overall Study|Did Not Meet Eligibility Requirements|1
4896985|NCT00644332|16872876|P1|Overall Study|Completion Status Unknown|2
4896986|NCT00644332|16872876|P1|Overall Study|Withdrawal by Subject|6
4896987|NCT00644332|16872876|P1|Overall Study|Adverse Event|11
4896988|NCT00644228|16872902|P2|Maintenance|On Treatment|40
4896989|NCT00644228|16872903|P1|Maintenance|On Treatment|26
4896990|NCT00644228|16872902|P2|Maintenance|Not Protocol-Specified|15
4896991|NCT00644228|16872903|P1|Maintenance|Not Protocol-Specified|14
4896992|NCT00644228|16872902|P2|Maintenance|Death|3
4896993|NCT00644228|16872903|P1|Maintenance|Death|3
4896994|NCT00644228|16872902|P2|Maintenance|Progression/Relapse|42
4896995|NCT00644228|16872903|P1|Maintenance|Progression/Relapse|67
4896996|NCT00644228|16872902|P2|Maintenance|Withdrawal by Subject|4
4896997|NCT00644228|16872903|P1|Maintenance|Withdrawal by Subject|6
4896998|NCT00644228|16872902|P2|Maintenance|Adverse Event|31
4896999|NCT00644228|16872903|P1|Maintenance|Adverse Event|27
4897000|NCT00644228|16872902|P2|Induction Therapy|Not Protocol-Specified|28
4897001|NCT00644228|16872903|P1|Induction Therapy|Not Protocol-Specified|24
4897002|NCT00644228|16872902|P2|Induction Therapy|Death|7
4897003|NCT00644228|16872903|P1|Induction Therapy|Death|3
4897004|NCT00644228|16872902|P2|Induction Therapy|Progression/Relapse|12
4897005|NCT00644228|16872903|P1|Induction Therapy|Progression/Relapse|24
4897006|NCT00644228|16872902|P2|Induction Therapy|Withdrawal by Subject|3
4897007|NCT00644228|16872903|P1|Induction Therapy|Withdrawal by Subject|10
4897008|NCT00644228|16872902|P2|Induction Therapy|Adverse Event|55
4897009|NCT00644228|16872903|P1|Induction Therapy|Adverse Event|22
4897010|NCT00644228|16872902|P2|Randomization & Eligibility|Invalid Consent|1
4897011|NCT00644228|16872903|P1|Randomization & Eligibility|Invalid Consent|0
4897012|NCT00644228|16872902|P2|Randomization & Eligibility|Withdrew Consent prior to therapy start|0
4897013|NCT00644228|16872903|P1|Randomization & Eligibility|Withdrew Consent prior to therapy start|1
4897014|NCT00644228|16872902|P2|Randomization & Eligibility|Ineligible|21
4897015|NCT00644228|16872903|P1|Randomization & Eligibility|Ineligible|31
4897016|NCT00644059|16872932|P3|Overall Study|Unable to classify|3
4897017|NCT00644059|16872933|P2|Overall Study|Unable to classify|2
4897018|NCT00644059|16872934|P1|Overall Study|Unable to classify|6
4897019|NCT00644059|16872932|P3|Overall Study|Protocol Deviation/violation|15
4897020|NCT00644059|16872933|P2|Overall Study|Protocol Deviation/violation|19
4897021|NCT00644059|16872934|P1|Overall Study|Protocol Deviation/violation|20
4897022|NCT00644059|16872932|P3|Overall Study|Inappropriate Enrollment|0
4897023|NCT00644059|16872933|P2|Overall Study|Inappropriate Enrollment|3
4897024|NCT00644059|16872934|P1|Overall Study|Inappropriate Enrollment|1
4897025|NCT00644059|16872932|P3|Overall Study|Adverse Event|1
4897026|NCT00644059|16872933|P2|Overall Study|Adverse Event|5
4897027|NCT00644059|16872934|P1|Overall Study|Adverse Event|8
4897028|NCT00644059|16872932|P3|Overall Study|Withdrawal by Subject|30
4897029|NCT00644059|16872933|P2|Overall Study|Withdrawal by Subject|60
4897030|NCT00644059|16872934|P1|Overall Study|Withdrawal by Subject|52
4897031|NCT00644059|16872932|P3|Overall Study|Lost to Follow-up|16
4897032|NCT00644059|16872933|P2|Overall Study|Lost to Follow-up|34
4897033|NCT00644059|16872934|P1|Overall Study|Lost to Follow-up|37
4897034|NCT00643916|16873024|P6|Overall Study|Not Vaccinated|0
4897035|NCT00643916|16873025|P5|Overall Study|Not Vaccinated|2
4897036|NCT00643916|16873026|P4|Overall Study|Not Vaccinated|0
4897037|NCT00643916|16873027|P3|Overall Study|Not Vaccinated|3
4897038|NCT00643916|16873028|P2|Overall Study|Not Vaccinated|2
4897039|NCT00643916|16873029|P1|Overall Study|Not Vaccinated|2
4897040|NCT00643916|16873024|P6|Overall Study|Withdrawal by Subject|1
4897041|NCT00643916|16873025|P5|Overall Study|Withdrawal by Subject|0
4897042|NCT00643916|16873026|P4|Overall Study|Withdrawal by Subject|1
4897043|NCT00643916|16873027|P3|Overall Study|Withdrawal by Subject|2
4897044|NCT00643916|16873028|P2|Overall Study|Withdrawal by Subject|2
4897045|NCT00643916|16873029|P1|Overall Study|Withdrawal by Subject|2
4897046|NCT00643916|16873024|P6|Overall Study|Lost to Follow-up|0
4897047|NCT00643916|16873025|P5|Overall Study|Lost to Follow-up|0
4897048|NCT00643916|16873026|P4|Overall Study|Lost to Follow-up|0
4897049|NCT00643916|16873027|P3|Overall Study|Lost to Follow-up|0
4897050|NCT00643916|16873028|P2|Overall Study|Lost to Follow-up|1
4897051|NCT00643916|16873029|P1|Overall Study|Lost to Follow-up|0
4897052|NCT00643916|16873024|P6|Overall Study|Protocol Violation|0
4897053|NCT00643916|16873025|P5|Overall Study|Protocol Violation|0
4897054|NCT00643916|16873026|P4|Overall Study|Protocol Violation|1
4897055|NCT00643916|16873027|P3|Overall Study|Protocol Violation|1
4897056|NCT00643916|16873028|P2|Overall Study|Protocol Violation|1
4897057|NCT00643916|16873029|P1|Overall Study|Protocol Violation|0
4897058|NCT00643851|16873058|P3|Overall Study|Non-compl., not met criteria, etc.|6
4897059|NCT00643851|16873059|P2|Overall Study|Non-compl., not met criteria, etc.|4
4897060|NCT00643851|16873060|P1|Overall Study|Non-compl., not met criteria, etc.|3
4897061|NCT00643851|16873058|P3|Overall Study|Withdrawal by Subject|9
4897062|NCT00643851|16873059|P2|Overall Study|Withdrawal by Subject|15
4897063|NCT00643851|16873060|P1|Overall Study|Withdrawal by Subject|8
4897064|NCT00643851|16873058|P3|Overall Study|Lost to Follow-up|9
4897065|NCT00643851|16873059|P2|Overall Study|Lost to Follow-up|6
4897066|NCT00643851|16873060|P1|Overall Study|Lost to Follow-up|4
4897067|NCT00643851|16873058|P3|Overall Study|Adverse Event|6
4897068|NCT00643851|16873059|P2|Overall Study|Adverse Event|6
4897069|NCT00643851|16873060|P1|Overall Study|Adverse Event|2
4897070|NCT00643851|16873058|P3|Overall Study|Lack of Efficacy|0
4897071|NCT00643851|16873059|P2|Overall Study|Lack of Efficacy|1
4897072|NCT00643851|16873060|P1|Overall Study|Lack of Efficacy|0
4897073|NCT00643851|16873058|P3|Overall Study|Death|0
4897074|NCT00643851|16873059|P2|Overall Study|Death|1
4897075|NCT00643851|16873060|P1|Overall Study|Death|0
4897076|NCT00643760|16873088|P5|Overall Study|Withdrawal by Subject|1
4897077|NCT00643760|16873089|P4|Overall Study|Withdrawal by Subject|4
4897078|NCT00643760|16873090|P3|Overall Study|Withdrawal by Subject|2
4897079|NCT00643760|16873091|P2|Overall Study|Withdrawal by Subject|1
4897080|NCT00643760|16873092|P1|Overall Study|Withdrawal by Subject|3
4897081|NCT00643760|16873088|P5|Overall Study|Investigator Discretion|0
4897082|NCT00643760|16873089|P4|Overall Study|Investigator Discretion|2
4897083|NCT00643760|16873090|P3|Overall Study|Investigator Discretion|0
4897084|NCT00643760|16873091|P2|Overall Study|Investigator Discretion|0
4897085|NCT00643760|16873092|P1|Overall Study|Investigator Discretion|0
4897086|NCT00643760|16873088|P5|Overall Study|Lost to Follow-up|3
4897087|NCT00643760|16873089|P4|Overall Study|Lost to Follow-up|3
4897088|NCT00643760|16873090|P3|Overall Study|Lost to Follow-up|1
4897089|NCT00643760|16873091|P2|Overall Study|Lost to Follow-up|2
4897090|NCT00643760|16873092|P1|Overall Study|Lost to Follow-up|6
4897091|NCT00643760|16873088|P5|Overall Study|Protocol Violation|6
4897092|NCT00643760|16873089|P4|Overall Study|Protocol Violation|4
4897093|NCT00643760|16873090|P3|Overall Study|Protocol Violation|4
4897094|NCT00643760|16873091|P2|Overall Study|Protocol Violation|6
4897095|NCT00643760|16873092|P1|Overall Study|Protocol Violation|7
4897096|NCT00643760|16873088|P5|Overall Study|Lack of Efficacy|3
4897097|NCT00643760|16873089|P4|Overall Study|Lack of Efficacy|4
4897098|NCT00643760|16873090|P3|Overall Study|Lack of Efficacy|0
4897099|NCT00643760|16873091|P2|Overall Study|Lack of Efficacy|1
4897100|NCT00643760|16873092|P1|Overall Study|Lack of Efficacy|3
4897101|NCT00643760|16873088|P5|Overall Study|Adverse Event|6
4897102|NCT00643760|16873089|P4|Overall Study|Adverse Event|21
4897103|NCT00643760|16873090|P3|Overall Study|Adverse Event|12
4897104|NCT00643760|16873091|P2|Overall Study|Adverse Event|5
4897105|NCT00643760|16873092|P1|Overall Study|Adverse Event|11
4897106|NCT00643682|16873196|P2|Overall Study|did not keep appointment|509
4897107|NCT00643682|16873197|P1|Overall Study|did not keep appointment|522
4897108|NCT00643604|16873209|P1|Overall Study|Death|1
4897109|NCT00643565|16873237|P2|Overall Study|Adverse Event|8
4897110|NCT00643565|16873238|P1|Overall Study|Adverse Event|5
4897111|NCT00643565|16873237|P2|Overall Study|Administrative|16
4897112|NCT00643565|16873238|P1|Overall Study|Administrative|22
4897113|NCT00643565|16873237|P2|Overall Study|Did Not Cooperate|1
4897114|NCT00643565|16873238|P1|Overall Study|Did Not Cooperate|0
4897115|NCT00643565|16873237|P2|Overall Study|Protocol Violation|0
4897116|NCT00643565|16873238|P1|Overall Study|Protocol Violation|3
4897117|NCT00643565|16873237|P2|Overall Study|Progression of Disease|14
4897118|NCT00643565|16873238|P1|Overall Study|Progression of Disease|18
4897119|NCT00643565|16873237|P2|Overall Study|Recurrence of Disease|1
4897120|NCT00643565|16873238|P1|Overall Study|Recurrence of Disease|2
4897121|NCT00643565|16873237|P2|Overall Study|Refused Treatment / Did Not Cooperate|1
4897122|NCT00643565|16873238|P1|Overall Study|Refused Treatment / Did Not Cooperate|0
4897123|NCT00643565|16873237|P2|Overall Study|Other|8
4897124|NCT00643565|16873238|P1|Overall Study|Other|7
4897125|NCT00643565|16873237|P2|Overall Study|Lost to Follow-up|6
4897126|NCT00643565|16873238|P1|Overall Study|Lost to Follow-up|0
4897127|NCT00643565|16873237|P2|Overall Study|Withdrawal by Subject|1
4897128|NCT00643565|16873238|P1|Overall Study|Withdrawal by Subject|4
4897129|NCT00643565|16873237|P2|Overall Study|Death|11
4897130|NCT00643565|16873238|P1|Overall Study|Death|12
4897131|NCT00643487|16873260|P1|Overall Study|Technical difficulty|3
4897132|NCT00643448|16873267|P3|Overall Study|QTcF>550 ms|0
4897133|NCT00643448|16873268|P2|Overall Study|QTcF>550 ms|3
4897134|NCT00643448|16873269|P1|Overall Study|QTcF>550 ms|0
4897135|NCT00643448|16873267|P3|Overall Study|Adverse Event|2
4897136|NCT00643448|16873268|P2|Overall Study|Adverse Event|2
4897137|NCT00643448|16873269|P1|Overall Study|Adverse Event|2
4897138|NCT00643448|16873267|P3|Overall Study|Lack of Efficacy|4
4897139|NCT00643448|16873268|P2|Overall Study|Lack of Efficacy|0
4897140|NCT00643448|16873269|P1|Overall Study|Lack of Efficacy|2
4897141|NCT00643279|16873286|P2|Overall Study|Physician Decision|1
4897142|NCT00643279|16873287|P1|Overall Study|Physician Decision|0
4897143|NCT00643279|16873286|P2|Overall Study|Lost to Follow-up|1
4897144|NCT00643279|16873287|P1|Overall Study|Lost to Follow-up|0
4897145|NCT00643279|16873286|P2|Overall Study|Withdrawal by Subject|0
4897146|NCT00643279|16873287|P1|Overall Study|Withdrawal by Subject|3
4897147|NCT00643279|16873286|P2|Overall Study|Death|11
4897148|NCT00643279|16873287|P1|Overall Study|Death|13
4897149|NCT00643201|16873309|P2|Completed Study Follow Up|non-specified|0
4897150|NCT00643201|16873310|P1|Completed Study Follow Up|non-specified|1
4897151|NCT00643201|16873309|P2|Completed Study Follow Up|Lost to Follow-up|16
4897152|NCT00643201|16873310|P1|Completed Study Follow Up|Lost to Follow-up|18
4897153|NCT00643201|16873309|P2|Completed Study Follow Up|Withdrawal by Subject|29
4897154|NCT00643201|16873310|P1|Completed Study Follow Up|Withdrawal by Subject|23
4897155|NCT00643201|16873309|P2|Completed Study Follow Up|Death|34
4897156|NCT00643201|16873310|P1|Completed Study Follow Up|Death|28
4897157|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Other|107
4897158|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Other|107
4897159|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Administrative reason|1
4897160|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Administrative reason|1
4897161|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9
4897162|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13
4897163|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Pregnancy|2
4897164|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Pregnancy|3
4897165|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Poor or non-compliance|23
4897166|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Poor or non-compliance|20
4897167|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
4897168|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Lost to Follow-up|14
4897169|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
4897170|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49
4897171|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Adverse Event|182
4897172|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Adverse Event|150
4897173|NCT00643201|16873309|P2|Randomized, Completed 6 Months of Study|Death|26
4897174|NCT00643201|16873310|P1|Randomized, Completed 6 Months of Study|Death|20
4897175|NCT00643162|16873358|P2|Overall Study|Withdrawal by Subject|1
4897176|NCT00643162|16873359|P1|Overall Study|Withdrawal by Subject|1
4897177|NCT00643123|16873371|P2|Overall Study|Withdrawal by Subject|1
4897178|NCT00643123|16873372|P1|Overall Study|Withdrawal by Subject|1
4897179|NCT00643123|16873371|P2|Overall Study|Lost to Follow-up|0
4897180|NCT00643123|16873372|P1|Overall Study|Lost to Follow-up|4
4897181|NCT00643006|16873404|P2|Overall Study|Lost to Follow-up|4
4897182|NCT00643006|16873405|P1|Overall Study|Lost to Follow-up|5
4897183|NCT00642993|16873415|P2|Overall Study|Administrative|0
4897184|NCT00642993|16873416|P1|Overall Study|Administrative|1
4897185|NCT00642993|16873415|P2|Overall Study|Did not meet protocol eligibility|1
4897186|NCT00642993|16873416|P1|Overall Study|Did not meet protocol eligibility|0
4897187|NCT00642993|16873415|P2|Overall Study|Protocol Violation|4
4897188|NCT00642993|16873416|P1|Overall Study|Protocol Violation|1
4897189|NCT00642993|16873415|P2|Overall Study|Withdrew - reason unrelated to treatment|3
4897190|NCT00642993|16873416|P1|Overall Study|Withdrew - reason unrelated to treatment|11
4897191|NCT00642993|16873415|P2|Overall Study|Lost to Follow-up|4
4897192|NCT00642993|16873416|P1|Overall Study|Lost to Follow-up|8
4897193|NCT00642993|16873415|P2|Overall Study|Adverse Event|4
4897194|NCT00642993|16873416|P1|Overall Study|Adverse Event|85
4897195|NCT00642902|16873434|P4|Overall Study|Other|4
4897196|NCT00642902|16873435|P3|Overall Study|Other|1
4897197|NCT00642902|16873436|P2|Overall Study|Other|5
4897198|NCT00642902|16873437|P1|Overall Study|Other|1
4897199|NCT00642902|16873434|P4|Overall Study|Randomized, but not treated|0
4897200|NCT00642902|16873435|P3|Overall Study|Randomized, but not treated|1
4897201|NCT00642902|16873436|P2|Overall Study|Randomized, but not treated|0
4897202|NCT00642902|16873437|P1|Overall Study|Randomized, but not treated|0
4897203|NCT00642902|16873434|P4|Overall Study|Premature termination of clinical trial|35
4897204|NCT00642902|16873435|P3|Overall Study|Premature termination of clinical trial|35
4897205|NCT00642902|16873436|P2|Overall Study|Premature termination of clinical trial|32
4897206|NCT00642902|16873437|P1|Overall Study|Premature termination of clinical trial|37
4897207|NCT00642902|16873434|P4|Overall Study|Death|0
4897208|NCT00642902|16873435|P3|Overall Study|Death|0
4897209|NCT00642902|16873436|P2|Overall Study|Death|0
4897210|NCT00642902|16873437|P1|Overall Study|Death|1
4897211|NCT00642902|16873434|P4|Overall Study|Lack of Efficacy|0
4897212|NCT00642902|16873435|P3|Overall Study|Lack of Efficacy|3
4897213|NCT00642902|16873436|P2|Overall Study|Lack of Efficacy|3
4897214|NCT00642902|16873437|P1|Overall Study|Lack of Efficacy|0
4897215|NCT00642902|16873434|P4|Overall Study|Lost to Follow-up|0
4897216|NCT00642902|16873435|P3|Overall Study|Lost to Follow-up|0
4897217|NCT00642902|16873436|P2|Overall Study|Lost to Follow-up|1
4897218|NCT00642902|16873437|P1|Overall Study|Lost to Follow-up|1
4897219|NCT00642902|16873434|P4|Overall Study|Adverse Event|1
4897220|NCT00642902|16873435|P3|Overall Study|Adverse Event|3
4897221|NCT00642902|16873436|P2|Overall Study|Adverse Event|1
4897222|NCT00642902|16873437|P1|Overall Study|Adverse Event|0
4897223|NCT00642850|16873459|P1|Overall Study|Other reasons|7
4897224|NCT00642850|16873459|P1|Overall Study|Blood transfusion|6
4897225|NCT00642850|16873459|P1|Overall Study|Kidney transplantation|8
4897226|NCT00642850|16873459|P1|Overall Study|Protocol Violation|2
4897227|NCT00642850|16873459|P1|Overall Study|Lack of Efficacy|1
4897228|NCT00642850|16873459|P1|Overall Study|Adverse Event|2
4897229|NCT00642850|16873459|P1|Overall Study|Death|7
4897230|NCT00642811|16873475|P6|Overall Study|Other|0
4897231|NCT00642811|16873476|P5|Overall Study|Other|0
4897232|NCT00642811|16873477|P4|Overall Study|Other|1
4897233|NCT00642811|16873478|P3|Overall Study|Other|0
4897234|NCT00642811|16873479|P2|Overall Study|Other|1
4897235|NCT00642811|16873480|P1|Overall Study|Other|0
4897236|NCT00642811|16873475|P6|Overall Study|Severe Non-compliance to protocol|0
4897237|NCT00642811|16873476|P5|Overall Study|Severe Non-compliance to protocol|0
4897238|NCT00642811|16873477|P4|Overall Study|Severe Non-compliance to protocol|0
4897239|NCT00642811|16873478|P3|Overall Study|Severe Non-compliance to protocol|0
4897240|NCT00642811|16873479|P2|Overall Study|Severe Non-compliance to protocol|0
4897241|NCT00642811|16873480|P1|Overall Study|Severe Non-compliance to protocol|1
4897242|NCT00642811|16873475|P6|Overall Study|Developement of discontinuation criteria|0
4897243|NCT00642811|16873476|P5|Overall Study|Developement of discontinuation criteria|1
4897244|NCT00642811|16873477|P4|Overall Study|Developement of discontinuation criteria|0
4897245|NCT00642811|16873478|P3|Overall Study|Developement of discontinuation criteria|0
4897246|NCT00642811|16873479|P2|Overall Study|Developement of discontinuation criteria|0
4897247|NCT00642811|16873480|P1|Overall Study|Developement of discontinuation criteria|0
4897248|NCT00642811|16873475|P6|Overall Study|Adverse Event|1
4897249|NCT00642811|16873476|P5|Overall Study|Adverse Event|0
4897250|NCT00642811|16873477|P4|Overall Study|Adverse Event|0
4897251|NCT00642811|16873478|P3|Overall Study|Adverse Event|0
4897252|NCT00642811|16873479|P2|Overall Study|Adverse Event|3
4897253|NCT00642811|16873480|P1|Overall Study|Adverse Event|2
4897254|NCT00642772|16873502|P1|Overall Study|Withdrawal by Subject|7
4897255|NCT00642772|16873502|P1|Overall Study|Lost to Follow-up|3
4897256|NCT00642759|16873506|P1|Overall Study|Protocol Violation|1
4897257|NCT00642746|16873515|P2|Overall Study|Patient unevaluable|0
4897258|NCT00642746|16873516|P1|Overall Study|Patient unevaluable|1
4897259|NCT00642707|16873530|P4|Overall Study|Withdrawal by Subject|0
4897260|NCT00642707|16873531|P3|Overall Study|Withdrawal by Subject|0
4897261|NCT00642707|16873532|P2|Overall Study|Withdrawal by Subject|0
4897262|NCT00642707|16873533|P1|Overall Study|Withdrawal by Subject|1
4897263|NCT00642707|16873530|P4|Overall Study|Adverse Event|2
4897264|NCT00642707|16873531|P3|Overall Study|Adverse Event|0
4897265|NCT00642707|16873532|P2|Overall Study|Adverse Event|0
4897266|NCT00642707|16873533|P1|Overall Study|Adverse Event|0
4897267|NCT00642668|16873568|P1|Overall Study|Blood Transfusion|2
4897268|NCT00642668|16873568|P1|Overall Study|Dialysis Initiation|5
4897269|NCT00642668|16873568|P1|Overall Study|Failure to Return|1
4897270|NCT00642668|16873568|P1|Overall Study|Insufficient Therapeutic Response|1
4897271|NCT00642668|16873568|P1|Overall Study|Death|2
4897272|NCT00642668|16873568|P1|Overall Study|Adverse Event|2
4897273|NCT00642668|16873568|P1|Overall Study|Lost to Follow-up|1
4897274|NCT00642642|16873576|P1|Treatment & Follow Up|Lost to Follow-up|10
4897275|NCT00642642|16873576|P1|Treatment & Follow Up|Withdrawal by Subject|5
4897276|NCT00642642|16873576|P1|Treatment & Follow Up|Adverse Event|2
4897277|NCT00642616|16873593|P4|Overall Study|Physician Decision|1
4897278|NCT00642616|16873594|P3|Overall Study|Physician Decision|1
4897279|NCT00642616|16873595|P2|Overall Study|Physician Decision|0
4897280|NCT00642616|16873596|P1|Overall Study|Physician Decision|0
4897281|NCT00642616|16873593|P4|Overall Study|Protocol Violation|0
4897282|NCT00642616|16873594|P3|Overall Study|Protocol Violation|2
4897283|NCT00642616|16873595|P2|Overall Study|Protocol Violation|0
4897284|NCT00642616|16873596|P1|Overall Study|Protocol Violation|0
4897285|NCT00642616|16873593|P4|Overall Study|Withdrawal by Subject|1
4897286|NCT00642616|16873594|P3|Overall Study|Withdrawal by Subject|1
4897287|NCT00642616|16873595|P2|Overall Study|Withdrawal by Subject|1
4897288|NCT00642616|16873596|P1|Overall Study|Withdrawal by Subject|0
4897289|NCT00642616|16873593|P4|Overall Study|Study Terminated by Sponsor|5
4897290|NCT00642616|16873594|P3|Overall Study|Study Terminated by Sponsor|4
4897291|NCT00642616|16873595|P2|Overall Study|Study Terminated by Sponsor|6
4897292|NCT00642616|16873596|P1|Overall Study|Study Terminated by Sponsor|7
4897293|NCT00642616|16873593|P4|Overall Study|Adverse Event|0
4897294|NCT00642616|16873594|P3|Overall Study|Adverse Event|1
4897295|NCT00642616|16873595|P2|Overall Study|Adverse Event|0
4897296|NCT00642616|16873596|P1|Overall Study|Adverse Event|2
4897297|NCT00642473|16873629|P2|Overall Study|Other|2
4897298|NCT00642473|16873630|P1|Overall Study|Other|2
4897299|NCT00642473|16873629|P2|Overall Study|Progression or death|4
4897300|NCT00642473|16873630|P1|Overall Study|Progression or death|2
4897301|NCT00642473|16873629|P2|Overall Study|Withdrawal by Subject|5
4897302|NCT00642473|16873630|P1|Overall Study|Withdrawal by Subject|0
4897303|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Refused treatment|3
4897304|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Refused treatment|8
4897305|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Refused treatment|0
4897306|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Refused treatment|0
4897307|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Refused treatment|0
4897308|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Refused treatment|0
4897309|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Administrative reason|1
4897310|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Administrative reason|0
4897311|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Administrative reason|0
4897312|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Administrative reason|0
4897313|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Administrative reason|0
4897314|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Administrative reason|0
4897315|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Death|3
4897316|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Death|0
4897317|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Death|0
4897318|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Death|0
4897319|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Death|0
4897320|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Death|0
4897321|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Other|2
4897322|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Other|2
4897323|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Other|0
4897324|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Other|0
4897325|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Other|0
4897326|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Other|0
4897327|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
4897328|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Lost to Follow-up|1
4897329|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4897330|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4897331|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4897332|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Lost to Follow-up|0
4897333|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1
4897334|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4
4897335|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4897336|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4897337|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4897338|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0
4897339|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4
4897340|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3
4897341|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4897342|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4897343|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4897344|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0
4897345|NCT00642460|16873644|P6|Part III: Open-Label Up to Week 260|Adverse Event|6
4897346|NCT00642460|16873645|P5|Part III: Open-Label Up to Week 260|Adverse Event|7
4897347|NCT00642460|16873646|P4|Part III: Open-Label Up to Week 260|Adverse Event|0
4897348|NCT00642460|16873647|P3|Part III: Open-Label Up to Week 260|Adverse Event|0
4897349|NCT00642460|16873648|P2|Part III: Open-Label Up to Week 260|Adverse Event|0
4897350|NCT00642460|16873649|P1|Part III: Open-Label Up to Week 260|Adverse Event|0
4897351|NCT00642460|16873644|P6|Part II: Open-Label Up to Week 92|Administrative reasons|0
4897352|NCT00642460|16873645|P5|Part II: Open-Label Up to Week 92|Administrative reasons|0
4897353|NCT00642460|16873646|P4|Part II: Open-Label Up to Week 92|Administrative reasons|1
4897354|NCT00642460|16873647|P3|Part II: Open-Label Up to Week 92|Administrative reasons|0
4897355|NCT00642460|16873648|P2|Part II: Open-Label Up to Week 92|Administrative reasons|0
4897356|NCT00642460|16873649|P1|Part II: Open-Label Up to Week 92|Administrative reasons|0
4897357|NCT00642460|16873644|P6|Part II: Open-Label Up to Week 92|Failure to return|0
4897358|NCT00642460|16873645|P5|Part II: Open-Label Up to Week 92|Failure to return|0
4897359|NCT00642460|16873646|P4|Part II: Open-Label Up to Week 92|Failure to return|0
4897360|NCT00642460|16873647|P3|Part II: Open-Label Up to Week 92|Failure to return|0
4897361|NCT00642460|16873648|P2|Part II: Open-Label Up to Week 92|Failure to return|1
4897362|NCT00642460|16873649|P1|Part II: Open-Label Up to Week 92|Failure to return|0
4897363|NCT00642460|16873644|P6|Part II: Open-Label Up to Week 92|Refused treatment|0
4897364|NCT00642460|16873645|P5|Part II: Open-Label Up to Week 92|Refused treatment|0
4897365|NCT00642460|16873646|P4|Part II: Open-Label Up to Week 92|Refused treatment|0
4897366|NCT00642460|16873647|P3|Part II: Open-Label Up to Week 92|Refused treatment|0
4897367|NCT00642460|16873648|P2|Part II: Open-Label Up to Week 92|Refused treatment|1
4897368|NCT00642460|16873649|P1|Part II: Open-Label Up to Week 92|Refused treatment|3
4897369|NCT00642460|16873644|P6|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4897370|NCT00642460|16873645|P5|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4897371|NCT00642460|16873646|P4|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4897372|NCT00642460|16873647|P3|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0
4897373|NCT00642460|16873648|P2|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3
4897374|NCT00642460|16873649|P1|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2
4897375|NCT00642460|16873644|P6|Part II: Open-Label Up to Week 92|Death|0
4897376|NCT00642460|16873645|P5|Part II: Open-Label Up to Week 92|Death|0
4897377|NCT00642460|16873646|P4|Part II: Open-Label Up to Week 92|Death|2
4897378|NCT00642460|16873647|P3|Part II: Open-Label Up to Week 92|Death|0
4897379|NCT00642460|16873648|P2|Part II: Open-Label Up to Week 92|Death|1
4897380|NCT00642460|16873649|P1|Part II: Open-Label Up to Week 92|Death|0
4897381|NCT00642460|16873644|P6|Part II: Open-Label Up to Week 92|Adverse Event|0
4897382|NCT00642460|16873645|P5|Part II: Open-Label Up to Week 92|Adverse Event|0
4897383|NCT00642460|16873646|P4|Part II: Open-Label Up to Week 92|Adverse Event|0
4897384|NCT00642460|16873647|P3|Part II: Open-Label Up to Week 92|Adverse Event|0
4897385|NCT00642460|16873648|P2|Part II: Open-Label Up to Week 92|Adverse Event|2
4897386|NCT00642460|16873649|P1|Part II: Open-Label Up to Week 92|Adverse Event|4
4897387|NCT00642460|16873644|P6|Part I: 12 Week Double-Blind|Refused Treatment|0
4897388|NCT00642460|16873645|P5|Part I: 12 Week Double-Blind|Refused Treatment|0
4897389|NCT00642460|16873646|P4|Part I: 12 Week Double-Blind|Refused Treatment|0
4897390|NCT00642460|16873647|P3|Part I: 12 Week Double-Blind|Refused Treatment|0
4897391|NCT00642460|16873648|P2|Part I: 12 Week Double-Blind|Refused Treatment|0
4897392|NCT00642460|16873649|P1|Part I: 12 Week Double-Blind|Refused Treatment|1
4897393|NCT00642460|16873644|P6|Part I: 12 Week Double-Blind|Adverse Event|0
4897394|NCT00642460|16873645|P5|Part I: 12 Week Double-Blind|Adverse Event|0
4897395|NCT00642460|16873646|P4|Part I: 12 Week Double-Blind|Adverse Event|0
4897396|NCT00642460|16873647|P3|Part I: 12 Week Double-Blind|Adverse Event|1
4897397|NCT00642460|16873648|P2|Part I: 12 Week Double-Blind|Adverse Event|1
4897398|NCT00642460|16873649|P1|Part I: 12 Week Double-Blind|Adverse Event|0
4897399|NCT00642369|16873724|P2|Overall Study|Lack of Efficacy|2
4897400|NCT00642369|16873725|P1|Overall Study|Lack of Efficacy|2
4897401|NCT00642369|16873724|P2|Overall Study|misdiagnosis|1
4897402|NCT00642369|16873725|P1|Overall Study|misdiagnosis|0
4897403|NCT00642369|16873724|P2|Overall Study|Withdrawal by Subject|0
4897404|NCT00642369|16873725|P1|Overall Study|Withdrawal by Subject|1
4897405|NCT00642369|16873724|P2|Overall Study|Adverse Event|3
4897406|NCT00642369|16873725|P1|Overall Study|Adverse Event|2
4897407|NCT00642356|16873735|P2|Overall Study|Lack of Efficacy|0
4897408|NCT00642356|16873736|P1|Overall Study|Lack of Efficacy|1
4897409|NCT00642356|16873735|P2|Overall Study|Protocol Violation|3
4897410|NCT00642356|16873736|P1|Overall Study|Protocol Violation|0
4897411|NCT00642356|16873735|P2|Overall Study|Adverse Event|0
4897412|NCT00642356|16873736|P1|Overall Study|Adverse Event|1
4897413|NCT00642304|16873744|P1|Overall Study|Transplantation|1
4897414|NCT00642304|16873744|P1|Overall Study|Erythropoiesis Stimulating Agent Use.|1
4897415|NCT00642304|16873744|P1|Overall Study|Blood transfusion|2
4897416|NCT00642304|16873744|P1|Overall Study|Death|1
4897417|NCT00642304|16873744|P1|Overall Study|Adverse Event|1
4897418|NCT00642278|16873760|P7|Overall Study|Other|0
4897419|NCT00642278|16873761|P6|Overall Study|Other|1
4897420|NCT00642278|16873762|P5|Overall Study|Other|0
4897421|NCT00642278|16873763|P4|Overall Study|Other|1
4897422|NCT00642278|16873764|P3|Overall Study|Other|0
4897423|NCT00642278|16873765|P2|Overall Study|Other|1
4897424|NCT00642278|16873766|P1|Overall Study|Other|2
4897425|NCT00642278|16873760|P7|Overall Study|Noncompliance with study drug regimen|0
4897426|NCT00642278|16873761|P6|Overall Study|Noncompliance with study drug regimen|0
4897427|NCT00642278|16873762|P5|Overall Study|Noncompliance with study drug regimen|0
4897428|NCT00642278|16873763|P4|Overall Study|Noncompliance with study drug regimen|1
4897429|NCT00642278|16873764|P3|Overall Study|Noncompliance with study drug regimen|0
4897430|NCT00642278|16873765|P2|Overall Study|Noncompliance with study drug regimen|0
4897431|NCT00642278|16873766|P1|Overall Study|Noncompliance with study drug regimen|0
4897432|NCT00642278|16873760|P7|Overall Study|Withdrawal by Subject|2
4897433|NCT00642278|16873761|P6|Overall Study|Withdrawal by Subject|2
4897434|NCT00642278|16873762|P5|Overall Study|Withdrawal by Subject|6
4897435|NCT00642278|16873763|P4|Overall Study|Withdrawal by Subject|3
4897436|NCT00642278|16873764|P3|Overall Study|Withdrawal by Subject|1
4897437|NCT00642278|16873765|P2|Overall Study|Withdrawal by Subject|1
4897438|NCT00642278|16873766|P1|Overall Study|Withdrawal by Subject|1
4897439|NCT00642278|16873760|P7|Overall Study|Protocol Violation|2
4897440|NCT00642278|16873761|P6|Overall Study|Protocol Violation|1
4897441|NCT00642278|16873762|P5|Overall Study|Protocol Violation|0
4897442|NCT00642278|16873763|P4|Overall Study|Protocol Violation|1
4897443|NCT00642278|16873764|P3|Overall Study|Protocol Violation|1
4897444|NCT00642278|16873765|P2|Overall Study|Protocol Violation|0
4897445|NCT00642278|16873766|P1|Overall Study|Protocol Violation|0
4897446|NCT00642278|16873760|P7|Overall Study|Physician Decision|0
4897447|NCT00642278|16873761|P6|Overall Study|Physician Decision|0
4897448|NCT00642278|16873762|P5|Overall Study|Physician Decision|0
4897449|NCT00642278|16873763|P4|Overall Study|Physician Decision|1
4897450|NCT00642278|16873764|P3|Overall Study|Physician Decision|0
4897451|NCT00642278|16873765|P2|Overall Study|Physician Decision|0
4897452|NCT00642278|16873766|P1|Overall Study|Physician Decision|0
4897453|NCT00642278|16873760|P7|Overall Study|Lost to Follow-up|1
4897454|NCT00642278|16873761|P6|Overall Study|Lost to Follow-up|1
4897455|NCT00642278|16873762|P5|Overall Study|Lost to Follow-up|0
4897456|NCT00642278|16873763|P4|Overall Study|Lost to Follow-up|1
4897457|NCT00642278|16873764|P3|Overall Study|Lost to Follow-up|0
4897458|NCT00642278|16873765|P2|Overall Study|Lost to Follow-up|1
4897459|NCT00642278|16873766|P1|Overall Study|Lost to Follow-up|5
4897460|NCT00642278|16873760|P7|Overall Study|Lack of Efficacy|0
4897461|NCT00642278|16873761|P6|Overall Study|Lack of Efficacy|0
4897462|NCT00642278|16873762|P5|Overall Study|Lack of Efficacy|0
4897463|NCT00642278|16873763|P4|Overall Study|Lack of Efficacy|0
4897464|NCT00642278|16873764|P3|Overall Study|Lack of Efficacy|0
4897465|NCT00642278|16873765|P2|Overall Study|Lack of Efficacy|1
4897466|NCT00642278|16873766|P1|Overall Study|Lack of Efficacy|0
4897467|NCT00642278|16873760|P7|Overall Study|Adverse Event|0
4897468|NCT00642278|16873761|P6|Overall Study|Adverse Event|2
4897469|NCT00642278|16873762|P5|Overall Study|Adverse Event|2
4897470|NCT00642278|16873763|P4|Overall Study|Adverse Event|1
4897471|NCT00642278|16873764|P3|Overall Study|Adverse Event|3
4897472|NCT00642278|16873765|P2|Overall Study|Adverse Event|1
4897473|NCT00642278|16873766|P1|Overall Study|Adverse Event|2
4897474|NCT00642174|16873819|P2|Period 1 - Initial Drug|Entry Criteria Not Met|1
4897475|NCT00642174|16873820|P1|Period 1 - Initial Drug|Entry Criteria Not Met|0
4897476|NCT00642018|16873836|P2|Overall Study|Entry Criteria Not Met|1
4897477|NCT00642018|16873837|P1|Overall Study|Entry Criteria Not Met|0
4897478|NCT00642018|16873836|P2|Overall Study|Death|3
4897479|NCT00642018|16873837|P1|Overall Study|Death|0
4897480|NCT00642018|16873836|P2|Overall Study|Protocol Violation|1
4897481|NCT00642018|16873837|P1|Overall Study|Protocol Violation|0
4897482|NCT00642018|16873836|P2|Overall Study|Physician Decision|10
4897483|NCT00642018|16873837|P1|Overall Study|Physician Decision|0
4897484|NCT00642018|16873836|P2|Overall Study|Progressive Disease|18
4897485|NCT00642018|16873837|P1|Overall Study|Progressive Disease|13
4897486|NCT00642018|16873836|P2|Overall Study|Withdrawal by Subject|10
4897487|NCT00642018|16873837|P1|Overall Study|Withdrawal by Subject|4
4897488|NCT00642018|16873836|P2|Overall Study|Adverse Event|36
4897489|NCT00642018|16873837|P1|Overall Study|Adverse Event|11
4897490|NCT00641719|16873904|P2|Overall Study|Reason Not Specified|2
4897491|NCT00641719|16873905|P1|Overall Study|Reason Not Specified|1
4897492|NCT00641719|16873904|P2|Overall Study|Withdrawal by Subject|4
4897493|NCT00641719|16873905|P1|Overall Study|Withdrawal by Subject|4
4897494|NCT00641719|16873904|P2|Overall Study|Adverse Event|29
4897495|NCT00641719|16873905|P1|Overall Study|Adverse Event|24
4897496|NCT00641719|16873904|P2|Overall Study|Lack of Efficacy|2
4897497|NCT00641719|16873905|P1|Overall Study|Lack of Efficacy|1
4897498|NCT00641706|16873929|P2|Overall Study|Lead Investigator Decision|1
4897499|NCT00641706|16873930|P1|Overall Study|Lead Investigator Decision|0
4897500|NCT00641706|16873929|P2|Overall Study|Clinical Decline|0
4897501|NCT00641706|16873930|P1|Overall Study|Clinical Decline|1
4897502|NCT00641706|16873929|P2|Overall Study|Withdrawal by Subject|1
4897503|NCT00641706|16873930|P1|Overall Study|Withdrawal by Subject|6
4897504|NCT00641706|16873929|P2|Overall Study|Adverse Event|1
4897505|NCT00641706|16873930|P1|Overall Study|Adverse Event|2
4897506|NCT00641667|16873942|P1|Overall Study|Worsening of underlying disease|3
4897507|NCT00641667|16873942|P1|Overall Study|Physician Decision|1
4897508|NCT00641667|16873942|P1|Overall Study|Adverse Event|1
4897509|NCT00641667|16873942|P1|Overall Study|Withdrawal by Subject|1
4897510|NCT00641537|16873970|P8|24-Week Supplemental Follow-up Period|Other|1
4897511|NCT00641537|16873971|P7|24-Week Supplemental Follow-up Period|Other|1
4897512|NCT00641537|16873972|P6|24-Week Supplemental Follow-up Period|Other|0
4897513|NCT00641537|16873973|P5|24-Week Supplemental Follow-up Period|Other|3
4897514|NCT00641537|16873974|P4|24-Week Supplemental Follow-up Period|Other|1
4897515|NCT00641537|16873975|P3|24-Week Supplemental Follow-up Period|Other|2
4897516|NCT00641537|16873976|P2|24-Week Supplemental Follow-up Period|Other|2
4897517|NCT00641537|16873977|P1|24-Week Supplemental Follow-up Period|Other|0
4897518|NCT00641537|16873970|P8|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
4897519|NCT00641537|16873971|P7|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
4897520|NCT00641537|16873972|P6|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
4897521|NCT00641537|16873973|P5|24-Week Supplemental Follow-up Period|Lost to Follow-up|2
4897522|NCT00641537|16873974|P4|24-Week Supplemental Follow-up Period|Lost to Follow-up|3
4897523|NCT00641537|16873975|P3|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
4897524|NCT00641537|16873976|P2|24-Week Supplemental Follow-up Period|Lost to Follow-up|1
4897525|NCT00641537|16873977|P1|24-Week Supplemental Follow-up Period|Lost to Follow-up|0
4897526|NCT00641537|16873970|P8|96-week Period|Other|6
4897527|NCT00641537|16873971|P7|96-week Period|Other|4
4897528|NCT00641537|16873972|P6|96-week Period|Other|6
4897529|NCT00641537|16873973|P5|96-week Period|Other|12
4897530|NCT00641537|16873974|P4|96-week Period|Other|9
4897531|NCT00641537|16873975|P3|96-week Period|Other|14
4897532|NCT00641537|16873976|P2|96-week Period|Other|7
4897533|NCT00641537|16873977|P1|96-week Period|Other|4
4897534|NCT00641537|16873970|P8|96-week Period|Death|0
4897535|NCT00641537|16873971|P7|96-week Period|Death|0
4897536|NCT00641537|16873972|P6|96-week Period|Death|0
4897537|NCT00641537|16873973|P5|96-week Period|Death|0
4897538|NCT00641537|16873974|P4|96-week Period|Death|0
4897539|NCT00641537|16873975|P3|96-week Period|Death|1
4897540|NCT00641537|16873976|P2|96-week Period|Death|0
4897541|NCT00641537|16873977|P1|96-week Period|Death|2
4897542|NCT00641537|16873970|P8|96-week Period|Protocol Violation|0
4897543|NCT00641537|16873971|P7|96-week Period|Protocol Violation|0
4897544|NCT00641537|16873972|P6|96-week Period|Protocol Violation|1
4897545|NCT00641537|16873973|P5|96-week Period|Protocol Violation|0
4897546|NCT00641537|16873974|P4|96-week Period|Protocol Violation|1
4897547|NCT00641537|16873975|P3|96-week Period|Protocol Violation|0
4897548|NCT00641537|16873976|P2|96-week Period|Protocol Violation|1
4897549|NCT00641537|16873977|P1|96-week Period|Protocol Violation|0
4897550|NCT00641537|16873970|P8|96-week Period|Lost to Follow-up|0
4897551|NCT00641537|16873971|P7|96-week Period|Lost to Follow-up|1
4897552|NCT00641537|16873972|P6|96-week Period|Lost to Follow-up|0
4897553|NCT00641537|16873973|P5|96-week Period|Lost to Follow-up|4
4897554|NCT00641537|16873974|P4|96-week Period|Lost to Follow-up|2
4897555|NCT00641537|16873975|P3|96-week Period|Lost to Follow-up|2
4897556|NCT00641537|16873976|P2|96-week Period|Lost to Follow-up|1
4897557|NCT00641537|16873977|P1|96-week Period|Lost to Follow-up|3
4897558|NCT00641537|16873970|P8|96-week Period|Adverse Event|0
4897559|NCT00641537|16873971|P7|96-week Period|Adverse Event|0
4897560|NCT00641537|16873972|P6|96-week Period|Adverse Event|0
4897561|NCT00641537|16873973|P5|96-week Period|Adverse Event|2
4897562|NCT00641537|16873974|P4|96-week Period|Adverse Event|0
4897563|NCT00641537|16873975|P3|96-week Period|Adverse Event|3
4897564|NCT00641537|16873976|P2|96-week Period|Adverse Event|1
4897565|NCT00641537|16873977|P1|96-week Period|Adverse Event|0
4897566|NCT00641147|16874032|P2|Completed 16 Months.|Lost to Follow-up|0
4897567|NCT00641147|16874033|P1|Completed 16 Months.|Lost to Follow-up|1
4897568|NCT00641147|16874032|P2|Completed 16 Months.|Physician Decision|0
4897569|NCT00641147|16874033|P1|Completed 16 Months.|Physician Decision|1
4897570|NCT00641147|16874032|P2|Completed 12 Months.|Withdrawal by Subject|1
4897571|NCT00641147|16874033|P1|Completed 12 Months.|Withdrawal by Subject|0
4897572|NCT00641147|16874032|P2|Completed 12 Months.|Physician Decision|1
4897573|NCT00641147|16874033|P1|Completed 12 Months.|Physician Decision|1
4897574|NCT00641147|16874032|P2|Completed 8 Months.|Withdrawal by Subject|1
4897575|NCT00641147|16874033|P1|Completed 8 Months.|Withdrawal by Subject|0
4897576|NCT00641147|16874032|P2|Completed 8 Months.|non compliance|0
4897577|NCT00641147|16874033|P1|Completed 8 Months.|non compliance|1
4897578|NCT00641147|16874032|P2|Completed 8 Months.|Physician Decision|1
4897579|NCT00641147|16874033|P1|Completed 8 Months.|Physician Decision|2
4897580|NCT00641147|16874032|P2|Completed 4 Months.|Adverse Event|0
4897581|NCT00641147|16874033|P1|Completed 4 Months.|Adverse Event|1
4897582|NCT00641147|16874032|P2|Completed 4 Months.|Physician Decision|0
4897583|NCT00641147|16874033|P1|Completed 4 Months.|Physician Decision|1
4897584|NCT00641056|16874086|P2|Overall Study|Sponsor Decision|2
4897585|NCT00641056|16874087|P1|Overall Study|Sponsor Decision|1
4897586|NCT00641056|16874086|P2|Overall Study|Subject Decision|19
4897587|NCT00641056|16874087|P1|Overall Study|Subject Decision|6
4897588|NCT00641056|16874086|P2|Overall Study|Entry Criteria Not Met|0
4897589|NCT00641056|16874087|P1|Overall Study|Entry Criteria Not Met|3
4897590|NCT00641056|16874086|P2|Overall Study|Protocol Violation|0
4897591|NCT00641056|16874087|P1|Overall Study|Protocol Violation|2
4897592|NCT00641056|16874086|P2|Overall Study|Physician Decision|1
4897593|NCT00641056|16874087|P1|Overall Study|Physician Decision|3
4897594|NCT00641056|16874086|P2|Overall Study|Lost to Follow-up|1
4897595|NCT00641056|16874087|P1|Overall Study|Lost to Follow-up|2
4897596|NCT00641056|16874086|P2|Overall Study|Adverse Event|2
4897597|NCT00641056|16874087|P1|Overall Study|Adverse Event|12
4897598|NCT00641043|16874115|P2|Overall Study|Other incl. lack of efficacy|2
4897599|NCT00641043|16874116|P1|Overall Study|Other incl. lack of efficacy|4
4897600|NCT00641043|16874115|P2|Overall Study|Withdrawal by Subject|4
4897601|NCT00641043|16874116|P1|Overall Study|Withdrawal by Subject|4
4897602|NCT00641043|16874115|P2|Overall Study|Lost to Follow-up|2
4897603|NCT00641043|16874116|P1|Overall Study|Lost to Follow-up|3
4897604|NCT00641043|16874115|P2|Overall Study|Protocol Violation|3
4897605|NCT00641043|16874116|P1|Overall Study|Protocol Violation|2
4897606|NCT00641043|16874115|P2|Overall Study|Adverse Event|4
4897607|NCT00641043|16874116|P1|Overall Study|Adverse Event|6
4897608|NCT00640926|16874153|P3|Overall Study|Withdrawal by Subject|1
4897609|NCT00640926|16874154|P2|Overall Study|Withdrawal by Subject|0
4897610|NCT00640926|16874155|P1|Overall Study|Withdrawal by Subject|1
4897611|NCT00640926|16874153|P3|Overall Study|Lost to Follow-up|2
4897612|NCT00640926|16874154|P2|Overall Study|Lost to Follow-up|1
4897613|NCT00640926|16874155|P1|Overall Study|Lost to Follow-up|3
4897614|NCT00640926|16874153|P3|Overall Study|Protocol Violation|2
4897615|NCT00640926|16874154|P2|Overall Study|Protocol Violation|0
4897616|NCT00640926|16874155|P1|Overall Study|Protocol Violation|2
4897617|NCT00640926|16874153|P3|Overall Study|Lack of Efficacy|1
4897618|NCT00640926|16874154|P2|Overall Study|Lack of Efficacy|2
4897619|NCT00640926|16874155|P1|Overall Study|Lack of Efficacy|0
4897620|NCT00640926|16874153|P3|Overall Study|Adverse Event|2
4897621|NCT00640926|16874154|P2|Overall Study|Adverse Event|3
4897622|NCT00640926|16874155|P1|Overall Study|Adverse Event|2
4897623|NCT00640835|16874168|P2|Overall Study|Other Reason|4
4897624|NCT00640835|16874169|P1|Overall Study|Other Reason|19
4897625|NCT00640835|16874168|P2|Overall Study|Lost to Follow-up|13
4897626|NCT00640835|16874169|P1|Overall Study|Lost to Follow-up|17
4897627|NCT00640835|16874168|P2|Overall Study|Protocol Violation|2
4897628|NCT00640835|16874169|P1|Overall Study|Protocol Violation|2
4897629|NCT00640835|16874168|P2|Overall Study|Sponsor's Decision|7
4897630|NCT00640835|16874169|P1|Overall Study|Sponsor's Decision|11
4897631|NCT00640835|16874168|P2|Overall Study|Physician Decision|14
4897632|NCT00640835|16874169|P1|Overall Study|Physician Decision|10
4897633|NCT00640835|16874168|P2|Overall Study|Withdrawal by Subject|14
4897634|NCT00640835|16874169|P1|Overall Study|Withdrawal by Subject|12
4897635|NCT00640835|16874168|P2|Overall Study|Adverse Event|3
4897636|NCT00640835|16874169|P1|Overall Study|Adverse Event|5
4897637|NCT00640614|16874233|P2|Overall Study|Lost to Follow-up|0
4897638|NCT00640614|16874234|P1|Overall Study|Lost to Follow-up|1
4897639|NCT00640601|16874276|P1|Overall Study|treatment naive, combination therapy|10
4897640|NCT00640601|16874276|P1|Overall Study|Physician Decision|8
4897641|NCT00640601|16874276|P1|Overall Study|Lost to Follow-up|9
4897642|NCT00640601|16874276|P1|Overall Study|Lack of Efficacy|16
4897643|NCT00640601|16874276|P1|Overall Study|Protocol Violation|6
4897644|NCT00640601|16874276|P1|Overall Study|Withdrawal by Subject|20
4897645|NCT00640601|16874276|P1|Overall Study|Adverse Event|43
4897646|NCT00640562|16874292|P2|Overall Study|Glycosylated Hemoglobin >8|0
4897647|NCT00640562|16874293|P1|Overall Study|Glycosylated Hemoglobin >8|1
4897648|NCT00640562|16874292|P2|Overall Study|Low study drug dose|1
4897649|NCT00640562|16874293|P1|Overall Study|Low study drug dose|0
4897650|NCT00640562|16874292|P2|Overall Study|Past use of Seroquel -stopped due to AE|1
4897651|NCT00640562|16874293|P1|Overall Study|Past use of Seroquel -stopped due to AE|0
4897652|NCT00640562|16874292|P2|Overall Study|Known risperidone intolerance|1
4897653|NCT00640562|16874293|P1|Overall Study|Known risperidone intolerance|0
4897654|NCT00640562|16874292|P2|Overall Study|Withdrawal by Subject|10
4897655|NCT00640562|16874293|P1|Overall Study|Withdrawal by Subject|6
4897656|NCT00640562|16874292|P2|Overall Study|Protocol Violation|4
4897657|NCT00640562|16874293|P1|Overall Study|Protocol Violation|2
4897658|NCT00640562|16874292|P2|Overall Study|Lack of Efficacy|4
4897659|NCT00640562|16874293|P1|Overall Study|Lack of Efficacy|1
4897660|NCT00640562|16874292|P2|Overall Study|Adverse Event|5
4897661|NCT00640562|16874293|P1|Overall Study|Adverse Event|8
4897662|NCT00640510|16874321|P2|Overall Study|Physician Decision|1
4897663|NCT00640510|16874322|P1|Overall Study|Physician Decision|0
4897664|NCT00640510|16874321|P2|Overall Study|Protocol Violation|0
4897665|NCT00640510|16874322|P1|Overall Study|Protocol Violation|1
4897666|NCT00640510|16874321|P2|Overall Study|Lack of Efficacy|1
4897667|NCT00640510|16874322|P1|Overall Study|Lack of Efficacy|0
4897668|NCT00640393|16874334|P3|Part 2|Adverse Event|0
4897669|NCT00640393|16874335|P2|Part 2|Adverse Event|1
4897670|NCT00640393|16874336|P1|Part 2|Adverse Event|0
4897671|NCT00640393|16874334|P3|Part 2|Non-adherence|0
4897672|NCT00640393|16874335|P2|Part 2|Non-adherence|1
4897673|NCT00640393|16874336|P1|Part 2|Non-adherence|0
4897674|NCT00640393|16874334|P3|Part 2|Withdrawal by Subject|1
4897675|NCT00640393|16874335|P2|Part 2|Withdrawal by Subject|6
4897676|NCT00640393|16874336|P1|Part 2|Withdrawal by Subject|0
4897677|NCT00640393|16874334|P3|Part 2|Lost to Follow-up|2
4897678|NCT00640393|16874335|P2|Part 2|Lost to Follow-up|2
4897679|NCT00640393|16874336|P1|Part 2|Lost to Follow-up|0
4897680|NCT00640393|16874334|P3|Randomization|Never randomized by site|0
4897681|NCT00640393|16874335|P2|Randomization|Never randomized by site|0
4897682|NCT00640393|16874336|P1|Randomization|Never randomized by site|2
4897683|NCT00640393|16874334|P3|Randomization|Withdrawn per protocol|0
4897684|NCT00640393|16874335|P2|Randomization|Withdrawn per protocol|0
4897685|NCT00640393|16874336|P1|Randomization|Withdrawn per protocol|17
4897686|NCT00640393|16874334|P3|Part 1|Withdrawal by Subject|0
4897687|NCT00640393|16874335|P2|Part 1|Withdrawal by Subject|0
4897688|NCT00640393|16874336|P1|Part 1|Withdrawal by Subject|3
4897689|NCT00640393|16874334|P3|Part 1|Lost to Follow-up|0
4897690|NCT00640393|16874335|P2|Part 1|Lost to Follow-up|0
4897691|NCT00640393|16874336|P1|Part 1|Lost to Follow-up|2
4897692|NCT00640341|16874401|P3|Overall Study|Adverse event and positive slit lamp|0
4897693|NCT00640341|16874402|P2|Overall Study|Adverse event and positive slit lamp|0
4897694|NCT00640341|16874403|P1|Overall Study|Adverse event and positive slit lamp|1
4897695|NCT00640341|16874401|P3|Overall Study|Ineligable at Baseline|2
4897696|NCT00640341|16874402|P2|Overall Study|Ineligable at Baseline|3
4897697|NCT00640341|16874403|P1|Overall Study|Ineligable at Baseline|5
4897698|NCT00640341|16874401|P3|Overall Study|Poor fit/Uncomfortable|0
4897699|NCT00640341|16874402|P2|Overall Study|Poor fit/Uncomfortable|0
4897700|NCT00640341|16874403|P1|Overall Study|Poor fit/Uncomfortable|4
4897701|NCT00640341|16874401|P3|Overall Study|Unacceptable Lens Movement|0
4897702|NCT00640341|16874402|P2|Overall Study|Unacceptable Lens Movement|0
4897703|NCT00640341|16874403|P1|Overall Study|Unacceptable Lens Movement|1
4897704|NCT00640341|16874401|P3|Overall Study|Withdrawal by Subject|1
4897705|NCT00640341|16874402|P2|Overall Study|Withdrawal by Subject|0
4897706|NCT00640341|16874403|P1|Overall Study|Withdrawal by Subject|4
4897707|NCT00640341|16874401|P3|Overall Study|Lost to Follow-up|0
4897708|NCT00640341|16874402|P2|Overall Study|Lost to Follow-up|0
4897709|NCT00640341|16874403|P1|Overall Study|Lost to Follow-up|2
4897710|NCT00640341|16874401|P3|Overall Study|Failure to Follow Subject Instructions|0
4897711|NCT00640341|16874402|P2|Overall Study|Failure to Follow Subject Instructions|0
4897712|NCT00640341|16874403|P1|Overall Study|Failure to Follow Subject Instructions|1
4897713|NCT00640341|16874401|P3|Overall Study|Inability to Maintain Wearing Schedule|0
4897714|NCT00640341|16874402|P2|Overall Study|Inability to Maintain Wearing Schedule|1
4897715|NCT00640341|16874403|P1|Overall Study|Inability to Maintain Wearing Schedule|1
4897716|NCT00640341|16874401|P3|Overall Study|Study Related Symptoms/Complaints|2
4897717|NCT00640341|16874402|P2|Overall Study|Study Related Symptoms/Complaints|1
4897718|NCT00640341|16874403|P1|Overall Study|Study Related Symptoms/Complaints|2
4897719|NCT00640341|16874401|P3|Overall Study|Positive Slit Lamp Findings|1
4897720|NCT00640341|16874402|P2|Overall Study|Positive Slit Lamp Findings|0
4897721|NCT00640341|16874403|P1|Overall Study|Positive Slit Lamp Findings|0
4897722|NCT00640341|16874401|P3|Overall Study|Adverse Event|1
4897723|NCT00640341|16874402|P2|Overall Study|Adverse Event|0
4897724|NCT00640341|16874403|P1|Overall Study|Adverse Event|0
4897725|NCT00640328|16874423|P6|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4897726|NCT00640328|16874424|P5|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4897727|NCT00640328|16874425|P4|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
4897728|NCT00640328|16874426|P3|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4897729|NCT00640328|16874427|P2|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1
4897730|NCT00640328|16874428|P1|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0
4897731|NCT00640328|16874423|P6|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4897732|NCT00640328|16874424|P5|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4897733|NCT00640328|16874425|P4|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4897734|NCT00640328|16874426|P3|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1
4897735|NCT00640328|16874427|P2|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4897736|NCT00640328|16874428|P1|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0
4897737|NCT00640328|16874423|P6|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4897738|NCT00640328|16874424|P5|Second Treatment Period (Weeks 24-48)|Adverse Event|1
4897739|NCT00640328|16874425|P4|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4897740|NCT00640328|16874426|P3|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4897741|NCT00640328|16874427|P2|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4897742|NCT00640328|16874428|P1|Second Treatment Period (Weeks 24-48)|Adverse Event|0
4897743|NCT00640328|16874423|P6|First Treatment Period (Weeks 0-24)|Adverse Event|0
4897744|NCT00640328|16874424|P5|First Treatment Period (Weeks 0-24)|Adverse Event|0
4897745|NCT00640328|16874425|P4|First Treatment Period (Weeks 0-24)|Adverse Event|0
4897746|NCT00640328|16874426|P3|First Treatment Period (Weeks 0-24)|Adverse Event|0
4897747|NCT00640328|16874427|P2|First Treatment Period (Weeks 0-24)|Adverse Event|1
4897748|NCT00640328|16874428|P1|First Treatment Period (Weeks 0-24)|Adverse Event|0
4897749|NCT00640315|16874594|P2|Overall Study|Withdrawal by Subject|1
4897750|NCT00640315|16874595|P1|Overall Study|Withdrawal by Subject|0
4897751|NCT00640289|16874721|P1|Overall Study|Missing status|5
4897752|NCT00640289|16874721|P1|Overall Study|Transferred to another center|1
4897753|NCT00640289|16874721|P1|Overall Study|Data collected under different amendment|2
4897754|NCT00640289|16874721|P1|Overall Study|Lost to Follow-up|1
4897755|NCT00640289|16874721|P1|Overall Study|Withdrawal by Subject|1
4897756|NCT00640289|16874721|P1|Overall Study|Death|3
4897757|NCT00640224|16874833|P4|Overall Study|Headaches|0
4897758|NCT00640224|16874834|P3|Overall Study|Headaches|0
4897759|NCT00640224|16874835|P2|Overall Study|Headaches|1
4897760|NCT00640224|16874836|P1|Overall Study|Headaches|0
4897761|NCT00640224|16874833|P4|Overall Study|Withdrawal by Subject|0
4897762|NCT00640224|16874834|P3|Overall Study|Withdrawal by Subject|0
4897763|NCT00640224|16874835|P2|Overall Study|Withdrawal by Subject|0
4897764|NCT00640224|16874836|P1|Overall Study|Withdrawal by Subject|1
4897765|NCT00640224|16874833|P4|Overall Study|Lost to Follow-up|0
4897766|NCT00640224|16874834|P3|Overall Study|Lost to Follow-up|0
4897767|NCT00640224|16874835|P2|Overall Study|Lost to Follow-up|2
4897768|NCT00640224|16874836|P1|Overall Study|Lost to Follow-up|5
4897769|NCT00640146|16874936|P2|Overall Study|Randomized but not treated|3
4897770|NCT00640146|16874937|P1|Overall Study|Randomized but not treated|1
4897771|NCT00640146|16874936|P2|Overall Study|Withdrawal by Subject|1
4897772|NCT00640146|16874937|P1|Overall Study|Withdrawal by Subject|1
4897773|NCT00640146|16874936|P2|Overall Study|Lack of Efficacy|1
4897774|NCT00640146|16874937|P1|Overall Study|Lack of Efficacy|0
4897775|NCT00640146|16874936|P2|Overall Study|Lost to Follow-up|1
4897776|NCT00640146|16874937|P1|Overall Study|Lost to Follow-up|0
4897777|NCT00640146|16874936|P2|Overall Study|Adverse Event|0
4897778|NCT00640146|16874937|P1|Overall Study|Adverse Event|2
4897779|NCT00640133|16874949|P2|Open Label Phase (Month 4-12)|Adverse Event|0
4897780|NCT00640133|16874950|P1|Open Label Phase (Month 4-12)|Adverse Event|1
4897781|NCT00640133|16874949|P2|Open Label Phase (Month 4-12)|Withdrawal by Subject|0
4897782|NCT00640133|16874950|P1|Open Label Phase (Month 4-12)|Withdrawal by Subject|1
4897783|NCT00640133|16874949|P2|Open Label Phase (Month 4-12)|Lack of Efficacy|0
4897784|NCT00640133|16874950|P1|Open Label Phase (Month 4-12)|Lack of Efficacy|1
4897785|NCT00640042|16874970|P1|Enrollment|Did not receive study drug|83
4897786|NCT00640016|16874986|P4|Overall Study|Adverse Event|1
4897787|NCT00640016|16874987|P3|Overall Study|Adverse Event|0
4897788|NCT00640016|16874988|P2|Overall Study|Adverse Event|0
4897789|NCT00640016|16874989|P1|Overall Study|Adverse Event|0
4897790|NCT00640016|16874986|P4|Overall Study|Study termination|2
4897791|NCT00640016|16874987|P3|Overall Study|Study termination|3
4897792|NCT00640016|16874988|P2|Overall Study|Study termination|1
4897793|NCT00640016|16874989|P1|Overall Study|Study termination|2
4897794|NCT00640016|16874986|P4|Overall Study|Withdrawal by Subject|0
4897795|NCT00640016|16874987|P3|Overall Study|Withdrawal by Subject|0
4897796|NCT00640016|16874988|P2|Overall Study|Withdrawal by Subject|1
4897797|NCT00640016|16874989|P1|Overall Study|Withdrawal by Subject|0
4897798|NCT00639769|16875041|P1|Overall Study|Withdrawal by Subject|4
4897799|NCT00639769|16875041|P1|Overall Study|Disease progression|26
4897800|NCT00639769|16875041|P1|Overall Study|Lack of Efficacy|1
4897801|NCT00639769|16875041|P1|Overall Study|Adverse Event|7
4897802|NCT00639769|16875041|P1|Overall Study|Death|2
4897803|NCT00639678|16875058|P4|Overall Study|Lack of Compliance|0
4897804|NCT00639678|16875059|P3|Overall Study|Lack of Compliance|1
4897805|NCT00639678|16875060|P2|Overall Study|Lack of Compliance|0
4897806|NCT00639678|16875061|P1|Overall Study|Lack of Compliance|0
4897807|NCT00639678|16875058|P4|Overall Study|Adverse Event|0
4897808|NCT00639678|16875059|P3|Overall Study|Adverse Event|0
4897809|NCT00639678|16875060|P2|Overall Study|Adverse Event|1
4897810|NCT00639678|16875061|P1|Overall Study|Adverse Event|0
4897811|NCT00639678|16875058|P4|Overall Study|Lost to Follow-up|0
4897812|NCT00639678|16875059|P3|Overall Study|Lost to Follow-up|6
4897813|NCT00639678|16875060|P2|Overall Study|Lost to Follow-up|0
4897814|NCT00639678|16875061|P1|Overall Study|Lost to Follow-up|1
4897815|NCT00639678|16875058|P4|Overall Study|Withdrawal by Subject|0
4897816|NCT00639678|16875059|P3|Overall Study|Withdrawal by Subject|4
4897817|NCT00639678|16875060|P2|Overall Study|Withdrawal by Subject|0
4897818|NCT00639678|16875061|P1|Overall Study|Withdrawal by Subject|3
4897819|NCT00639509|16875126|P1|Overall Study|Death|1
4897820|NCT00639457|16875134|P2|Overall Study|Withdrawal by Subject|3
4897821|NCT00639457|16875135|P1|Overall Study|Withdrawal by Subject|2
4897822|NCT00639379|16875194|P2|Period 1 - 2 Weeks|lens issue|0
4897823|NCT00639379|16875195|P1|Period 1 - 2 Weeks|lens issue|3
4897824|NCT00639379|16875194|P2|Period 1 - 2 Weeks|Lost to Follow-up|0
4897825|NCT00639379|16875195|P1|Period 1 - 2 Weeks|Lost to Follow-up|2
4897826|NCT00639223|16875211|P2|Overall Study|Lost to Follow-up|2
4897827|NCT00639223|16875212|P1|Overall Study|Lost to Follow-up|0
4897828|NCT00639002|16875252|P1|Overall Study|Lack of Efficacy|1
4897829|NCT00639002|16875252|P1|Overall Study|Physician Decision|6
4897830|NCT00639002|16875252|P1|Overall Study|Disease progression|3
4897831|NCT00639002|16875252|P1|Overall Study|Protocol Violation|1
4897832|NCT00639002|16875252|P1|Overall Study|Adverse Event|1
4897833|NCT00639002|16875252|P1|Overall Study|Death|1
4897834|NCT00638989|16875261|P3|Overall Study|Lost to Follow-up|1
4897835|NCT00638989|16875262|P2|Overall Study|Lost to Follow-up|0
4897836|NCT00638989|16875263|P1|Overall Study|Lost to Follow-up|0
4897837|NCT00638963|16875303|P2|Overall Study|Withdrawal by Subject|0
4897838|NCT00638963|16875304|P1|Overall Study|Withdrawal by Subject|1
4897839|NCT00638846|16875345|P2|Overall Study|lens issue|3
4897840|NCT00638846|16875346|P1|Overall Study|lens issue|1
4897841|NCT00638846|16875345|P2|Overall Study|Lost to Follow-up|2
4897842|NCT00638846|16875346|P1|Overall Study|Lost to Follow-up|3
4897843|NCT00638846|16875345|P2|Overall Study|Adverse Event|1
4897844|NCT00638846|16875346|P1|Overall Study|Adverse Event|0
4897845|NCT00638690|16875390|P2|Overall Study|Lost to Follow-up|2
4897846|NCT00638690|16875391|P1|Overall Study|Lost to Follow-up|4
4897847|NCT00638690|16875390|P2|Overall Study|Withdrawal by Subject|5
4897848|NCT00638690|16875391|P1|Overall Study|Withdrawal by Subject|22
4897849|NCT00638690|16875390|P2|Overall Study|Death|335
4897850|NCT00638690|16875391|P1|Overall Study|Death|655
4897851|NCT00638508|16875411|P2|Overall Study|Physician Decision|2
4897852|NCT00638508|16875412|P1|Overall Study|Physician Decision|5
4897853|NCT00638456|16875458|P2|Overall Study|Withdrawal by Subject|2
4897854|NCT00638456|16875459|P1|Overall Study|Withdrawal by Subject|6
4897855|NCT00638443|16875469|P2|First Intervention|Adverse Event|1
4897856|NCT00638443|16875470|P1|First Intervention|Adverse Event|2
4897857|NCT00638404|16875500|P2|Overall Study|Physician Decision|0
4897858|NCT00638404|16875501|P1|Overall Study|Physician Decision|8
4897859|NCT00638378|16875513|P1|Overall Study|Physician Decision|4
4897860|NCT00638378|16875513|P1|Overall Study|Disease progression|15
4897861|NCT00638378|16875513|P1|Overall Study|Adverse Event|1
4897862|NCT00638378|16875513|P1|Overall Study|Death|2
4897863|NCT00638235|16875553|P9|Overall Study|Lost to Follow-up|18
4897864|NCT00638235|16875554|P8|Overall Study|Lost to Follow-up|1
4897865|NCT00638235|16875555|P7|Overall Study|Lost to Follow-up|0
4897866|NCT00638235|16875556|P6|Overall Study|Lost to Follow-up|26
4897867|NCT00638235|16875557|P5|Overall Study|Lost to Follow-up|13
4897868|NCT00638235|16875558|P4|Overall Study|Lost to Follow-up|10
4897869|NCT00638235|16875559|P3|Overall Study|Lost to Follow-up|18
4897870|NCT00638235|16875560|P2|Overall Study|Lost to Follow-up|3
4897871|NCT00638235|16875561|P1|Overall Study|Lost to Follow-up|31
4897872|NCT00638183|16875971|P1|Overall Study|Other reason not defined above|27
4897873|NCT00638183|16875971|P1|Overall Study|Lost to Follow-up|46
4897874|NCT00638183|16875971|P1|Overall Study|Physician Decision|9
4897875|NCT00638183|16875971|P1|Overall Study|Lack of Efficacy|14
4897876|NCT00638183|16875971|P1|Overall Study|Adverse Event|23
4897877|NCT00638157|16875980|P2|Overall Study|Randomized, not treated|0
4897878|NCT00638157|16875981|P1|Overall Study|Randomized, not treated|2
4897879|NCT00638157|16875980|P2|Overall Study|Other|2
4897880|NCT00638157|16875981|P1|Overall Study|Other|1
4897881|NCT00638157|16875980|P2|Overall Study|Physician Decision|0
4897882|NCT00638157|16875981|P1|Overall Study|Physician Decision|1
4897883|NCT00638157|16875980|P2|Overall Study|Lost to Follow-up|0
4897884|NCT00638157|16875981|P1|Overall Study|Lost to Follow-up|1
4897885|NCT00638157|16875980|P2|Overall Study|Microbiological failure|0
4897886|NCT00638157|16875981|P1|Overall Study|Microbiological failure|1
4897887|NCT00638157|16875980|P2|Overall Study|Clinical (symptomatic) failure|1
4897888|NCT00638157|16875981|P1|Overall Study|Clinical (symptomatic) failure|1
4897889|NCT00638157|16875980|P2|Overall Study|Adverse Event|1
4897890|NCT00638157|16875981|P1|Overall Study|Adverse Event|0
4897891|NCT00638027|16875991|P2|Overall Study|Adverse Event|2
4897892|NCT00638027|16875992|P1|Overall Study|Adverse Event|0
4897893|NCT00637806|16876039|P4|Extension Phase|Study Discontinued|1
4897894|NCT00637806|16876040|P3|Extension Phase|Study Discontinued|0
4897895|NCT00637806|16876041|P2|Extension Phase|Study Discontinued|0
4897896|NCT00637806|16876042|P1|Extension Phase|Study Discontinued|0
4897897|NCT00637806|16876039|P4|Double-blind Phase|Study Discontinued|0
4897898|NCT00637806|16876040|P3|Double-blind Phase|Study Discontinued|1
4897899|NCT00637806|16876041|P2|Double-blind Phase|Study Discontinued|0
4897900|NCT00637806|16876042|P1|Double-blind Phase|Study Discontinued|2
4897901|NCT00637728|16876077|P3|Double-blind Phase|Study Discontinued|0
4897902|NCT00637728|16876078|P2|Double-blind Phase|Study Discontinued|1
4897903|NCT00637728|16876079|P1|Double-blind Phase|Study Discontinued|1
4897904|NCT00637728|16876077|P3|Double-blind Phase|Non-compliance|0
4897905|NCT00637728|16876078|P2|Double-blind Phase|Non-compliance|0
4897906|NCT00637728|16876079|P1|Double-blind Phase|Non-compliance|2
4897907|NCT00637728|16876077|P3|Double-blind Phase|Adverse Event|0
4897908|NCT00637728|16876078|P2|Double-blind Phase|Adverse Event|0
4897909|NCT00637728|16876079|P1|Double-blind Phase|Adverse Event|1
4897910|NCT00637572|16876094|P2|Overall Study|Illicit Drug Use|0
4897911|NCT00637572|16876095|P1|Overall Study|Illicit Drug Use|1
4897912|NCT00637572|16876094|P2|Overall Study|Withdrawal by Subject|2
4897913|NCT00637572|16876095|P1|Overall Study|Withdrawal by Subject|0
4897914|NCT00637572|16876094|P2|Overall Study|Physician Decision|1
4897915|NCT00637572|16876095|P1|Overall Study|Physician Decision|1
4897916|NCT00637572|16876094|P2|Overall Study|Lost to Follow-up|1
4897917|NCT00637572|16876095|P1|Overall Study|Lost to Follow-up|0
4897918|NCT00637572|16876094|P2|Overall Study|Death|1
4897919|NCT00637572|16876095|P1|Overall Study|Death|0
4897920|NCT00637572|16876094|P2|Overall Study|Adverse Event|2
4897921|NCT00637572|16876095|P1|Overall Study|Adverse Event|1
4897922|NCT00637416|16876134|P2|Overall Study|Unable to take study drug|1
4897923|NCT00637416|16876135|P1|Overall Study|Unable to take study drug|0
4897924|NCT00637416|16876134|P2|Overall Study|Lost to Follow-up|1
4897925|NCT00637416|16876135|P1|Overall Study|Lost to Follow-up|1
4897926|NCT00637377|16876145|P4|Overall Study|Other (no further information available)|5
4897927|NCT00637377|16876146|P3|Overall Study|Other (no further information available)|10
4897928|NCT00637377|16876147|P2|Overall Study|Other (no further information available)|6
4897929|NCT00637377|16876148|P1|Overall Study|Other (no further information available)|7
4897930|NCT00637377|16876145|P4|Overall Study|Withdrawal by Subject|11
4897931|NCT00637377|16876146|P3|Overall Study|Withdrawal by Subject|13
4897932|NCT00637377|16876147|P2|Overall Study|Withdrawal by Subject|15
4897933|NCT00637377|16876148|P1|Overall Study|Withdrawal by Subject|11
4897934|NCT00637377|16876145|P4|Overall Study|Protocol Violation|0
4897935|NCT00637377|16876146|P3|Overall Study|Protocol Violation|1
4897936|NCT00637377|16876147|P2|Overall Study|Protocol Violation|1
4897937|NCT00637377|16876148|P1|Overall Study|Protocol Violation|2
4897938|NCT00637377|16876145|P4|Overall Study|Lost to Follow-up|2
4897939|NCT00637377|16876146|P3|Overall Study|Lost to Follow-up|2
4897940|NCT00637377|16876147|P2|Overall Study|Lost to Follow-up|1
4897941|NCT00637377|16876148|P1|Overall Study|Lost to Follow-up|4
4897942|NCT00637377|16876145|P4|Overall Study|Lack of Efficacy|1
4897943|NCT00637377|16876146|P3|Overall Study|Lack of Efficacy|1
4897944|NCT00637377|16876147|P2|Overall Study|Lack of Efficacy|0
4897945|NCT00637377|16876148|P1|Overall Study|Lack of Efficacy|0
4897946|NCT00637377|16876145|P4|Overall Study|Death|1
4897947|NCT00637377|16876146|P3|Overall Study|Death|2
4897948|NCT00637377|16876147|P2|Overall Study|Death|3
4897949|NCT00637377|16876148|P1|Overall Study|Death|1
4897950|NCT00637377|16876145|P4|Overall Study|Adverse Event|9
4897951|NCT00637377|16876146|P3|Overall Study|Adverse Event|8
4897952|NCT00637377|16876147|P2|Overall Study|Adverse Event|6
4897953|NCT00637377|16876148|P1|Overall Study|Adverse Event|2
4897954|NCT00637273|16876197|P3|Overall Study|Loss of Glucose Control|1
4897955|NCT00637273|16876198|P2|Overall Study|Loss of Glucose Control|1
4897956|NCT00637273|16876199|P1|Overall Study|Loss of Glucose Control|1
4897957|NCT00637273|16876197|P3|Overall Study|Administrative|0
4897958|NCT00637273|16876198|P2|Overall Study|Administrative|0
4897959|NCT00637273|16876199|P1|Overall Study|Administrative|2
4897960|NCT00637273|16876197|P3|Overall Study|Investigator Decision|1
4897961|NCT00637273|16876198|P2|Overall Study|Investigator Decision|3
4897962|NCT00637273|16876199|P1|Overall Study|Investigator Decision|1
4897963|NCT00637273|16876197|P3|Overall Study|Withdrawal of Consent|18
4897964|NCT00637273|16876198|P2|Overall Study|Withdrawal of Consent|6
4897965|NCT00637273|16876199|P1|Overall Study|Withdrawal of Consent|18
4897966|NCT00637273|16876197|P3|Overall Study|Protocol Violation|1
4897967|NCT00637273|16876198|P2|Overall Study|Protocol Violation|4
4897968|NCT00637273|16876199|P1|Overall Study|Protocol Violation|2
4897969|NCT00637273|16876197|P3|Overall Study|Lost to Follow-up|13
4897970|NCT00637273|16876198|P2|Overall Study|Lost to Follow-up|9
4897971|NCT00637273|16876199|P1|Overall Study|Lost to Follow-up|8
4897972|NCT00637273|16876197|P3|Overall Study|Adverse Event|7
4897973|NCT00637273|16876198|P2|Overall Study|Adverse Event|5
4897974|NCT00637273|16876199|P1|Overall Study|Adverse Event|11
4897975|NCT00637195|16876257|P2|Overall Study|Withdrawal by Subject|1
4897976|NCT00637195|16876258|P1|Overall Study|Withdrawal by Subject|0
4897977|NCT00637195|16876257|P2|Overall Study|Other|0
4897978|NCT00637195|16876258|P1|Overall Study|Other|2
4897979|NCT00637195|16876257|P2|Overall Study|Lost to Follow-up|0
4897980|NCT00637195|16876258|P1|Overall Study|Lost to Follow-up|1
4897981|NCT00637156|16876294|P2|Overall Study|Lost to Follow-up|16
4897982|NCT00637156|16876295|P1|Overall Study|Lost to Follow-up|10
4897983|NCT00637156|16876294|P2|Overall Study|Death|1
4897984|NCT00637156|16876295|P1|Overall Study|Death|0
4897985|NCT00637156|16876294|P2|Overall Study|Withdrawal by Subject|7
4897986|NCT00637156|16876295|P1|Overall Study|Withdrawal by Subject|0
4897987|NCT00637000|16876337|P2|Overall Study|Withdrawal by Subject|3
4897988|NCT00637000|16876338|P1|Overall Study|Withdrawal by Subject|4
4897989|NCT00636987|16876378|P1|Overall Study|5 year visit window not complete|69
4897990|NCT00636987|16876378|P1|Overall Study|Lost to Follow-up|63
4897991|NCT00636987|16876378|P1|Overall Study|Explanted|13
4897992|NCT00636987|16876378|P1|Overall Study|Death|44
4897993|NCT00636961|16876388|P2|Period 2|Adverse Event|0
4897994|NCT00636961|16876389|P1|Period 2|Adverse Event|1
4897995|NCT00636961|16876388|P2|Period 1|Administrative problems|1
4897996|NCT00636961|16876389|P1|Period 1|Administrative problems|1
4897997|NCT00636818|16876403|P1|Overall Study|Withdrawal by Subject|4
4897998|NCT00636818|16876403|P1|Overall Study|Protocol Violation|1
4897999|NCT00636818|16876403|P1|Overall Study|Entry Criteria Exclusion|3
4898000|NCT00636818|16876403|P1|Overall Study|Lost to Follow-up|2
4898001|NCT00636818|16876403|P1|Overall Study|Adverse Event|1
4898002|NCT00636792|16876428|P1|Overall Study|Other|3
4898003|NCT00636792|16876428|P1|Overall Study|Withdrawal by Subject|3
4898004|NCT00636792|16876428|P1|Overall Study|Progressive Disease|4
4898005|NCT00636792|16876428|P1|Overall Study|Physician Decision|7
4898006|NCT00636792|16876428|P1|Overall Study|Adverse Event|16
4898007|NCT00636675|16876444|P2|Overall Study|Withdrawal by Subject|10
4898008|NCT00636675|16876445|P1|Overall Study|Withdrawal by Subject|19
4898009|NCT00636675|16876444|P2|Overall Study|Lost to Follow-up|31
4898010|NCT00636675|16876445|P1|Overall Study|Lost to Follow-up|121
4898011|NCT00636636|16876488|P2|Overall Study|Withdrawal by Subject|9
4898012|NCT00636636|16876489|P1|Overall Study|Withdrawal by Subject|4
4898013|NCT00636636|16876488|P2|Overall Study|Death|1
4898014|NCT00636636|16876489|P1|Overall Study|Death|0
4898015|NCT00636636|16876488|P2|Overall Study|Lost to Follow-up|1
4898016|NCT00636636|16876489|P1|Overall Study|Lost to Follow-up|0
4898017|NCT00636636|16876488|P2|Overall Study|Protocol Violation|2
4898018|NCT00636636|16876489|P1|Overall Study|Protocol Violation|2
4898019|NCT00636636|16876488|P2|Overall Study|Lack of Efficacy|12
4898020|NCT00636636|16876489|P1|Overall Study|Lack of Efficacy|7
4898021|NCT00636636|16876488|P2|Overall Study|Adverse Event|8
4898022|NCT00636636|16876489|P1|Overall Study|Adverse Event|19
4898023|NCT00636636|16876488|P2|Overall Study|Other reason|6
4898024|NCT00636636|16876489|P1|Overall Study|Other reason|4
4898025|NCT00636610|16876505|P2|Overall Study|Reason for discontinuation not available|2
4898026|NCT00636610|16876506|P1|Overall Study|Reason for discontinuation not available|3
4898027|NCT00636610|16876505|P2|Overall Study|Disease progression - clinical|3
4898028|NCT00636610|16876506|P1|Overall Study|Disease progression - clinical|8
4898029|NCT00636610|16876505|P2|Overall Study|Disease progression - radiographic|51
4898030|NCT00636610|16876506|P1|Overall Study|Disease progression - radiographic|41
4898031|NCT00636610|16876505|P2|Overall Study|Subject decision to withdraw|11
4898032|NCT00636610|16876506|P1|Overall Study|Subject decision to withdraw|15
4898033|NCT00636610|16876505|P2|Overall Study|Physician decision to withdraw patient|9
4898034|NCT00636610|16876506|P1|Overall Study|Physician decision to withdraw patient|15
4898035|NCT00636610|16876505|P2|Overall Study|Death|3
4898036|NCT00636610|16876506|P1|Overall Study|Death|6
4898037|NCT00636610|16876505|P2|Overall Study|Adverse Event|4
4898038|NCT00636610|16876506|P1|Overall Study|Adverse Event|4
4898039|NCT00636506|16876516|P1|Overall Study|Procedure aborted|1
4898040|NCT00636506|16876516|P1|Overall Study|Withdrawal by Subject|6
4898041|NCT00636506|16876516|P1|Overall Study|Explanted|1
4898042|NCT00636506|16876516|P1|Overall Study|Lost to Follow-up|8
4898043|NCT00636441|16876563|P7|Overall Study|Screen Failure|17
4898044|NCT00636441|16876564|P6|Overall Study|Screen Failure|0
4898045|NCT00636441|16876565|P5|Overall Study|Screen Failure|0
4898046|NCT00636441|16876566|P4|Overall Study|Screen Failure|0
4898047|NCT00636441|16876567|P3|Overall Study|Screen Failure|0
4898048|NCT00636441|16876568|P2|Overall Study|Screen Failure|0
4898049|NCT00636441|16876569|P1|Overall Study|Screen Failure|0
4898050|NCT00636441|16876563|P7|Overall Study|Late, ineligible|1
4898051|NCT00636441|16876564|P6|Overall Study|Late, ineligible|0
4898052|NCT00636441|16876565|P5|Overall Study|Late, ineligible|0
4898053|NCT00636441|16876566|P4|Overall Study|Late, ineligible|0
4898054|NCT00636441|16876567|P3|Overall Study|Late, ineligible|0
4898055|NCT00636441|16876568|P2|Overall Study|Late, ineligible|0
4898056|NCT00636441|16876569|P1|Overall Study|Late, ineligible|0
4898057|NCT00636441|16876563|P7|Overall Study|Adverse Event|0
4898058|NCT00636441|16876564|P6|Overall Study|Adverse Event|1
4898059|NCT00636441|16876565|P5|Overall Study|Adverse Event|0
4898060|NCT00636441|16876566|P4|Overall Study|Adverse Event|0
4898061|NCT00636441|16876567|P3|Overall Study|Adverse Event|1
4898062|NCT00636441|16876568|P2|Overall Study|Adverse Event|1
4898063|NCT00636441|16876569|P1|Overall Study|Adverse Event|0
4898064|NCT00636363|16876612|P3|Overall Study|Withdrawal by Subject|2
4898065|NCT00636363|16876613|P2|Overall Study|Withdrawal by Subject|3
4898066|NCT00636363|16876614|P1|Overall Study|Withdrawal by Subject|1
4898067|NCT00636363|16876612|P3|Overall Study|Lost to Follow-up|2
4898068|NCT00636363|16876613|P2|Overall Study|Lost to Follow-up|4
4898069|NCT00636363|16876614|P1|Overall Study|Lost to Follow-up|3
4898070|NCT00636363|16876612|P3|Overall Study|Protocol Violation|0
4898071|NCT00636363|16876613|P2|Overall Study|Protocol Violation|3
4898072|NCT00636363|16876614|P1|Overall Study|Protocol Violation|0
4898073|NCT00636363|16876612|P3|Overall Study|Lack of motivation|1
4898074|NCT00636363|16876613|P2|Overall Study|Lack of motivation|0
4898075|NCT00636363|16876614|P1|Overall Study|Lack of motivation|1
4898076|NCT00636363|16876612|P3|Overall Study|Missed > 1 visit|3
4898077|NCT00636363|16876613|P2|Overall Study|Missed > 1 visit|1
4898078|NCT00636363|16876614|P1|Overall Study|Missed > 1 visit|0
4898079|NCT00636363|16876612|P3|Overall Study|Met ineligibility criteria|3
4898080|NCT00636363|16876613|P2|Overall Study|Met ineligibility criteria|0
4898081|NCT00636363|16876614|P1|Overall Study|Met ineligibility criteria|0
4898082|NCT00636363|16876612|P3|Overall Study|Study related symptoms/complaints|4
4898083|NCT00636363|16876613|P2|Overall Study|Study related symptoms/complaints|7
4898084|NCT00636363|16876614|P1|Overall Study|Study related symptoms/complaints|8
4898085|NCT00636363|16876612|P3|Overall Study|Positive slit lamp finding|1
4898086|NCT00636363|16876613|P2|Overall Study|Positive slit lamp finding|2
4898087|NCT00636363|16876614|P1|Overall Study|Positive slit lamp finding|0
4898088|NCT00636363|16876612|P3|Overall Study|Adverse Event|1
4898089|NCT00636363|16876613|P2|Overall Study|Adverse Event|0
4898090|NCT00636363|16876614|P1|Overall Study|Adverse Event|0
4898091|NCT00636363|16876612|P3|Overall Study|Conjunctivitis|1
4898092|NCT00636363|16876613|P2|Overall Study|Conjunctivitis|0
4898093|NCT00636363|16876614|P1|Overall Study|Conjunctivitis|0
4898094|NCT00636207|16876635|P7|Overall Study|Withdrawal by Subject|0
4898095|NCT00636207|16876636|P6|Overall Study|Withdrawal by Subject|0
4898096|NCT00636207|16876637|P5|Overall Study|Withdrawal by Subject|1
4898097|NCT00636207|16876638|P4|Overall Study|Withdrawal by Subject|0
4898098|NCT00636207|16876639|P3|Overall Study|Withdrawal by Subject|0
4898099|NCT00636207|16876640|P2|Overall Study|Withdrawal by Subject|1
4898100|NCT00636207|16876641|P1|Overall Study|Withdrawal by Subject|0
4898101|NCT00636207|16876635|P7|Overall Study|Adverse Event|0
4898102|NCT00636207|16876636|P6|Overall Study|Adverse Event|0
4898103|NCT00636207|16876637|P5|Overall Study|Adverse Event|0
4898104|NCT00636207|16876638|P4|Overall Study|Adverse Event|0
4898105|NCT00636207|16876639|P3|Overall Study|Adverse Event|0
4898106|NCT00636207|16876640|P2|Overall Study|Adverse Event|0
4898107|NCT00636207|16876641|P1|Overall Study|Adverse Event|1
4898108|NCT00636194|16876705|P2|Overall Study|Protocol Violation|0
4898109|NCT00636194|16876706|P1|Overall Study|Protocol Violation|2
4898110|NCT00636194|16876705|P2|Overall Study|Study related symptoms and complaints|0
4898111|NCT00636194|16876706|P1|Overall Study|Study related symptoms and complaints|1
4898112|NCT00636181|16876719|P3|Overall Study|Withdrawal by Subject|10
4898113|NCT00636181|16876720|P2|Overall Study|Withdrawal by Subject|6
4898114|NCT00636181|16876721|P1|Overall Study|Withdrawal by Subject|8
4898115|NCT00636168|16876749|P2|Long Term Follow-Up|Death|9
4898116|NCT00636168|16876750|P1|Long Term Follow-Up|Death|8
4898117|NCT00636168|16876749|P2|Long Term Follow-Up|Participant withdrew consent|2
4898118|NCT00636168|16876750|P1|Long Term Follow-Up|Participant withdrew consent|0
4898119|NCT00636168|16876749|P2|Long Term Follow-Up|Lost to Follow-up|3
4898120|NCT00636168|16876750|P1|Long Term Follow-Up|Lost to Follow-up|3
4898121|NCT00636168|16876749|P2|Treated With Study Drug|Other reason|3
4898122|NCT00636168|16876750|P1|Treated With Study Drug|Other reason|1
4898123|NCT00636168|16876749|P2|Treated With Study Drug|No longer meets study criteria|0
4898124|NCT00636168|16876750|P1|Treated With Study Drug|No longer meets study criteria|1
4898125|NCT00636168|16876749|P2|Treated With Study Drug|Pregnancy|0
4898126|NCT00636168|16876750|P1|Treated With Study Drug|Pregnancy|1
4898127|NCT00636168|16876749|P2|Treated With Study Drug|Death|0
4898128|NCT00636168|16876750|P1|Treated With Study Drug|Death|3
4898129|NCT00636168|16876749|P2|Treated With Study Drug|Poor/non-compliance|3
4898130|NCT00636168|16876750|P1|Treated With Study Drug|Poor/non-compliance|1
4898131|NCT00636168|16876749|P2|Treated With Study Drug|Participant withdrew consent|21
4898132|NCT00636168|16876750|P1|Treated With Study Drug|Participant withdrew consent|16
4898133|NCT00636168|16876749|P2|Treated With Study Drug|Adverse Event|22
4898134|NCT00636168|16876750|P1|Treated With Study Drug|Adverse Event|250
4898135|NCT00636168|16876749|P2|Treated With Study Drug|Recurrence of disease|282
4898136|NCT00636168|16876750|P1|Treated With Study Drug|Recurrence of disease|135
4898137|NCT00636168|16876749|P2|Randomized to Study Drug|No longer meets study criteria|0
4898138|NCT00636168|16876750|P1|Randomized to Study Drug|No longer meets study criteria|1
4898139|NCT00636168|16876749|P2|Randomized to Study Drug|Adverse Event|0
4898140|NCT00636168|16876750|P1|Randomized to Study Drug|Adverse Event|1
4898141|NCT00636168|16876749|P2|Randomized to Study Drug|Withdrawal by Subject|2
4898142|NCT00636168|16876750|P1|Randomized to Study Drug|Withdrawal by Subject|2
4898143|NCT00636155|16876778|P1|Overall Study|Physician Decision|5
4898144|NCT00636155|16876778|P1|Overall Study|Stem cell transplant|1
4898145|NCT00636155|16876778|P1|Overall Study|Withdrawal by Subject|3
4898146|NCT00636155|16876778|P1|Overall Study|Lack of Efficacy|1
4898147|NCT00636155|16876778|P1|Overall Study|Adverse Event|8
4898148|NCT00635999|16876820|P3|Overall Study|Withdrawal by Subject|1
4898149|NCT00635999|16876821|P2|Overall Study|Withdrawal by Subject|2
4898150|NCT00635999|16876822|P1|Overall Study|Withdrawal by Subject|4
4898151|NCT00635882|16876839|P6|Overall Study|Protocol Violation|0
4898152|NCT00635882|16876840|P5|Overall Study|Protocol Violation|0
4898153|NCT00635882|16876841|P4|Overall Study|Protocol Violation|0
4898154|NCT00635882|16876842|P3|Overall Study|Protocol Violation|0
4898155|NCT00635882|16876843|P2|Overall Study|Protocol Violation|0
4898156|NCT00635882|16876844|P1|Overall Study|Protocol Violation|1
4898157|NCT00635804|16876974|P8|Overall Study|Withdrawal by Subject|0
4898158|NCT00635804|16876975|P7|Overall Study|Withdrawal by Subject|0
4898159|NCT00635804|16876976|P6|Overall Study|Withdrawal by Subject|0
4898160|NCT00635804|16876977|P5|Overall Study|Withdrawal by Subject|0
4898161|NCT00635804|16876978|P4|Overall Study|Withdrawal by Subject|0
4898162|NCT00635804|16876979|P3|Overall Study|Withdrawal by Subject|0
4898163|NCT00635804|16876980|P2|Overall Study|Withdrawal by Subject|0
4898164|NCT00635804|16876981|P1|Overall Study|Withdrawal by Subject|1
4898165|NCT00635804|16876974|P8|Overall Study|Adverse Event|0
4898166|NCT00635804|16876975|P7|Overall Study|Adverse Event|0
4898167|NCT00635804|16876976|P6|Overall Study|Adverse Event|1
4898168|NCT00635804|16876977|P5|Overall Study|Adverse Event|0
4898169|NCT00635804|16876978|P4|Overall Study|Adverse Event|0
4898170|NCT00635804|16876979|P3|Overall Study|Adverse Event|0
4898171|NCT00635804|16876980|P2|Overall Study|Adverse Event|0
4898172|NCT00635804|16876981|P1|Overall Study|Adverse Event|0
4898173|NCT00635778|16877085|P7|Overall Study|Progressive disease|4
4898174|NCT00635778|16877086|P6|Overall Study|Progressive disease|14
4898175|NCT00635778|16877087|P5|Overall Study|Progressive disease|5
4898176|NCT00635778|16877088|P4|Overall Study|Progressive disease|4
4898177|NCT00635778|16877089|P3|Overall Study|Progressive disease|3
4898178|NCT00635778|16877090|P2|Overall Study|Progressive disease|3
4898179|NCT00635778|16877091|P1|Overall Study|Progressive disease|0
4898180|NCT00635778|16877085|P7|Overall Study|Withdrawal by Subject|1
4898181|NCT00635778|16877086|P6|Overall Study|Withdrawal by Subject|1
4898182|NCT00635778|16877087|P5|Overall Study|Withdrawal by Subject|0
4898183|NCT00635778|16877088|P4|Overall Study|Withdrawal by Subject|1
4898184|NCT00635778|16877089|P3|Overall Study|Withdrawal by Subject|0
4898185|NCT00635778|16877090|P2|Overall Study|Withdrawal by Subject|0
4898186|NCT00635778|16877091|P1|Overall Study|Withdrawal by Subject|0
4898187|NCT00635778|16877085|P7|Overall Study|Adverse Event|1
4898188|NCT00635778|16877086|P6|Overall Study|Adverse Event|6
4898189|NCT00635778|16877087|P5|Overall Study|Adverse Event|3
4898190|NCT00635778|16877088|P4|Overall Study|Adverse Event|3
4898191|NCT00635778|16877089|P3|Overall Study|Adverse Event|0
4898192|NCT00635778|16877090|P2|Overall Study|Adverse Event|0
4898193|NCT00635778|16877091|P1|Overall Study|Adverse Event|1
4898194|NCT00635661|16877162|P1|Overall Study|Withdrawal by Subject|4
4898195|NCT00635648|16877166|P1|Overall Study|Other reason|2
4898196|NCT00635648|16877166|P1|Overall Study|Noncompliance with protocol|1
4898197|NCT00635648|16877166|P1|Overall Study|No improvement after 7-10 days treatment|4
4898198|NCT00635648|16877166|P1|Overall Study|Use of other antifungal agent needed|1
4898199|NCT00635648|16877166|P1|Overall Study|Rapid progression of baseline disease|4
4898200|NCT00635648|16877166|P1|Overall Study|Physician Decision|4
4898201|NCT00635648|16877166|P1|Overall Study|Withdrawal by Subject|9
4898202|NCT00635648|16877166|P1|Overall Study|Adverse Event|12
4898203|NCT00635570|16877188|P2|Overall Study|Early termination(No sexual activity)|1
4898204|NCT00635570|16877189|P1|Overall Study|Early termination(No sexual activity)|1
4898205|NCT00635570|16877188|P2|Overall Study|Did not complete survey|1
4898206|NCT00635570|16877189|P1|Overall Study|Did not complete survey|2
4898207|NCT00635570|16877188|P2|Overall Study|Physician Decision|0
4898208|NCT00635570|16877189|P1|Overall Study|Physician Decision|1
4898209|NCT00635570|16877188|P2|Overall Study|Adverse Event|0
4898210|NCT00635570|16877189|P1|Overall Study|Adverse Event|2
4898211|NCT00635570|16877188|P2|Overall Study|Withdrawal by Subject|1
4898212|NCT00635570|16877189|P1|Overall Study|Withdrawal by Subject|1
4898213|NCT00635570|16877188|P2|Overall Study|Lost to Follow-up|8
4898214|NCT00635570|16877189|P1|Overall Study|Lost to Follow-up|8
4898215|NCT00635492|16877203|P2|Overall Study|Withdrawal by Subject|45
4898216|NCT00635492|16877204|P1|Overall Study|Withdrawal by Subject|82
4898217|NCT00635492|16877203|P2|Overall Study|Sponsor decision|3
4898218|NCT00635492|16877204|P1|Overall Study|Sponsor decision|2
4898219|NCT00635492|16877203|P2|Overall Study|Physician Decision|22
4898220|NCT00635492|16877204|P1|Overall Study|Physician Decision|32
4898221|NCT00635492|16877203|P2|Overall Study|Lost to Follow-up|172
4898222|NCT00635492|16877204|P1|Overall Study|Lost to Follow-up|151
4898223|NCT00635492|16877203|P2|Overall Study|Death|40
4898224|NCT00635492|16877204|P1|Overall Study|Death|12
4898225|NCT00635427|16877277|P5|Overall Study|Withdrawal Of Consent|2
4898226|NCT00635427|16877278|P4|Overall Study|Withdrawal Of Consent|2
4898227|NCT00635427|16877279|P3|Overall Study|Withdrawal Of Consent|0
4898228|NCT00635427|16877280|P2|Overall Study|Withdrawal Of Consent|0
4898229|NCT00635427|16877281|P1|Overall Study|Withdrawal Of Consent|0
4898230|NCT00635427|16877277|P5|Overall Study|Termination Of Study By Sponsor|6
4898231|NCT00635427|16877278|P4|Overall Study|Termination Of Study By Sponsor|6
4898232|NCT00635427|16877279|P3|Overall Study|Termination Of Study By Sponsor|10
4898233|NCT00635427|16877280|P2|Overall Study|Termination Of Study By Sponsor|6
4898234|NCT00635427|16877281|P1|Overall Study|Termination Of Study By Sponsor|12
4898235|NCT00635427|16877277|P5|Overall Study|Death|0
4898236|NCT00635427|16877278|P4|Overall Study|Death|1
4898237|NCT00635427|16877279|P3|Overall Study|Death|0
4898238|NCT00635427|16877280|P2|Overall Study|Death|0
4898239|NCT00635427|16877281|P1|Overall Study|Death|0
4898240|NCT00635427|16877277|P5|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4898241|NCT00635427|16877278|P4|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4898242|NCT00635427|16877279|P3|Overall Study|Refusal Of Required DiagnosticEvaluation|1
4898243|NCT00635427|16877280|P2|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4898244|NCT00635427|16877281|P1|Overall Study|Refusal Of Required DiagnosticEvaluation|0
4898245|NCT00635349|16877320|P2|Overall Study|Adverse Event|9
4898246|NCT00635349|16877321|P1|Overall Study|Adverse Event|11
4898247|NCT00635349|16877320|P2|Overall Study|Lost to Follow-up|3
4898248|NCT00635349|16877321|P1|Overall Study|Lost to Follow-up|4
4898249|NCT00635349|16877320|P2|Overall Study|Withdrawal by Subject|8
4898250|NCT00635349|16877321|P1|Overall Study|Withdrawal by Subject|3
4898251|NCT00635349|16877320|P2|Overall Study|Protocol Violation|22
4898252|NCT00635349|16877321|P1|Overall Study|Protocol Violation|18
4898253|NCT00635349|16877320|P2|Overall Study|Other|6
4898254|NCT00635349|16877321|P1|Overall Study|Other|8
4898255|NCT00635219|16877375|P5|Overall Study|Administrative or Other Reasons|1
4898256|NCT00635219|16877376|P4|Overall Study|Administrative or Other Reasons|0
4898257|NCT00635219|16877377|P3|Overall Study|Administrative or Other Reasons|1
4898258|NCT00635219|16877378|P2|Overall Study|Administrative or Other Reasons|1
4898259|NCT00635219|16877379|P1|Overall Study|Administrative or Other Reasons|0
4898260|NCT00635219|16877375|P5|Overall Study|Lost to Follow-up|3
4898261|NCT00635219|16877376|P4|Overall Study|Lost to Follow-up|0
4898262|NCT00635219|16877377|P3|Overall Study|Lost to Follow-up|2
4898263|NCT00635219|16877378|P2|Overall Study|Lost to Follow-up|0
4898264|NCT00635219|16877379|P1|Overall Study|Lost to Follow-up|0
4898265|NCT00635219|16877375|P5|Overall Study|Withdrawal of Consent|8
4898266|NCT00635219|16877376|P4|Overall Study|Withdrawal of Consent|11
4898267|NCT00635219|16877377|P3|Overall Study|Withdrawal of Consent|8
4898268|NCT00635219|16877378|P2|Overall Study|Withdrawal of Consent|6
4898269|NCT00635219|16877379|P1|Overall Study|Withdrawal of Consent|8
4898270|NCT00635219|16877375|P5|Overall Study|Protocol Violation|4
4898271|NCT00635219|16877376|P4|Overall Study|Protocol Violation|2
4898272|NCT00635219|16877377|P3|Overall Study|Protocol Violation|3
4898273|NCT00635219|16877378|P2|Overall Study|Protocol Violation|2
4898274|NCT00635219|16877379|P1|Overall Study|Protocol Violation|0
4898275|NCT00635219|16877375|P5|Overall Study|Non-compliance With Study Product|1
4898276|NCT00635219|16877376|P4|Overall Study|Non-compliance With Study Product|2
4898277|NCT00635219|16877377|P3|Overall Study|Non-compliance With Study Product|0
4898278|NCT00635219|16877378|P2|Overall Study|Non-compliance With Study Product|0
4898279|NCT00635219|16877379|P1|Overall Study|Non-compliance With Study Product|0
4898280|NCT00635219|16877375|P5|Overall Study|Lack of Efficacy|6
4898281|NCT00635219|16877376|P4|Overall Study|Lack of Efficacy|4
4898282|NCT00635219|16877377|P3|Overall Study|Lack of Efficacy|3
4898283|NCT00635219|16877378|P2|Overall Study|Lack of Efficacy|6
4898284|NCT00635219|16877379|P1|Overall Study|Lack of Efficacy|5
4898285|NCT00635219|16877375|P5|Overall Study|Adverse Event|19
4898286|NCT00635219|16877376|P4|Overall Study|Adverse Event|15
4898287|NCT00635219|16877377|P3|Overall Study|Adverse Event|18
4898288|NCT00635219|16877378|P2|Overall Study|Adverse Event|10
4898289|NCT00635219|16877379|P1|Overall Study|Adverse Event|12
4898290|NCT00635154|16877442|P1|Overall Study|Still on treatment|21
4898291|NCT00635154|16877442|P1|Overall Study|Other|4
4898292|NCT00635154|16877442|P1|Overall Study|Alternative Treatment|8
4898293|NCT00635102|16877485|P2|Overall Study|Withdrawal by Subject|8
4898294|NCT00635102|16877486|P1|Overall Study|Withdrawal by Subject|7
4898295|NCT00635089|16877580|P1|Overall Study|Other|31
4898296|NCT00635089|16877580|P1|Overall Study|Lost to Follow-up|8
4898297|NCT00635089|16877580|P1|Overall Study|Protocol Deviation|4
4898298|NCT00635089|16877580|P1|Overall Study|Lack of Efficacy|28
4898299|NCT00635089|16877580|P1|Overall Study|Adverse Event|7
4898300|NCT00635050|16877607|P1|Overall Study|Withdrawal by Subject|1
4898301|NCT00635024|16877614|P1|Overall Study|Adverse Event|1
4898302|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Other|1
4898303|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Other|0
4898304|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Other|5
4898305|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Other|0
4898306|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Other|0
4898307|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Lack of Efficacy|0
4898308|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Lack of Efficacy|0
4898309|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Lack of Efficacy|1
4898310|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Lack of Efficacy|1
4898311|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Lack of Efficacy|0
4898312|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Withdrawal by Subject|1
4898313|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Withdrawal by Subject|2
4898314|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Withdrawal by Subject|0
4898315|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Withdrawal by Subject|0
4898316|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Withdrawal by Subject|0
4898317|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Protocol Violation|1
4898318|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Protocol Violation|0
4898319|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Protocol Violation|0
4898320|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Protocol Violation|0
4898321|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Protocol Violation|0
4898322|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Physician Decision|0
4898323|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Physician Decision|0
4898324|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Physician Decision|1
4898325|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Physician Decision|1
4898326|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Physician Decision|0
4898327|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7
4898328|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3
4898329|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14
4898330|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11
4898331|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0
4898332|NCT00634933|16877625|P5|Part B: Week 24 to Week 52|Adverse Event|0
4898333|NCT00634933|16877626|P4|Part B: Week 24 to Week 52|Adverse Event|1
4898334|NCT00634933|16877627|P3|Part B: Week 24 to Week 52|Adverse Event|1
4898335|NCT00634933|16877628|P2|Part B: Week 24 to Week 52|Adverse Event|1
4898336|NCT00634933|16877629|P1|Part B: Week 24 to Week 52|Adverse Event|0
4898337|NCT00634933|16877625|P5|Between Part A and Part B|Physician Decision|0
4898338|NCT00634933|16877626|P4|Between Part A and Part B|Physician Decision|0
4898339|NCT00634933|16877627|P3|Between Part A and Part B|Physician Decision|0
4898340|NCT00634933|16877628|P2|Between Part A and Part B|Physician Decision|1
4898341|NCT00634933|16877629|P1|Between Part A and Part B|Physician Decision|0
4898342|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Other|0
4898343|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Other|0
4898344|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Other|5
4898345|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Other|8
4898346|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Other|1
4898347|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Lack of Efficacy|0
4898348|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Lack of Efficacy|0
4898349|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Lack of Efficacy|0
4898350|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Lack of Efficacy|1
4898351|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Lack of Efficacy|3
4898352|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Withdrawal by Subject|0
4898353|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Withdrawal by Subject|0
4898354|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Withdrawal by Subject|3
4898355|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Withdrawal by Subject|3
4898356|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Withdrawal by Subject|0
4898357|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Lost to Follow-up|0
4898358|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Lost to Follow-up|0
4898359|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Lost to Follow-up|1
4898360|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Lost to Follow-up|1
4898361|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Lost to Follow-up|0
4898362|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Investigator Request|0
4898363|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Investigator Request|0
4898364|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Investigator Request|1
4898365|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Investigator Request|1
4898366|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Investigator Request|1
4898367|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Failed to Return|0
4898368|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Failed to Return|0
4898369|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Failed to Return|0
4898370|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Failed to Return|0
4898371|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Failed to Return|1
4898372|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Death|0
4898373|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Death|0
4898374|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Death|0
4898375|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Death|0
4898376|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Death|1
4898377|NCT00634933|16877625|P5|Part A: Baseline to Week 24|Adverse Event|0
4898378|NCT00634933|16877626|P4|Part A: Baseline to Week 24|Adverse Event|0
4898379|NCT00634933|16877627|P3|Part A: Baseline to Week 24|Adverse Event|8
4898380|NCT00634933|16877628|P2|Part A: Baseline to Week 24|Adverse Event|4
4898381|NCT00634933|16877629|P1|Part A: Baseline to Week 24|Adverse Event|4
4898382|NCT00634920|16877698|P3|Period 2 - Post-Randomization|Patients did not receive study drug|0
4898383|NCT00634920|16877699|P2|Period 2 - Post-Randomization|Patients did not receive study drug|0
4898384|NCT00634920|16877700|P1|Period 2 - Post-Randomization|Patients did not receive study drug|2
4898385|NCT00634920|16877698|P3|Period 2 - Post-Randomization|consent withdrawal, non compliance|0
4898386|NCT00634920|16877699|P2|Period 2 - Post-Randomization|consent withdrawal, non compliance|13
4898387|NCT00634920|16877700|P1|Period 2 - Post-Randomization|consent withdrawal, non compliance|9
4898388|NCT00634920|16877698|P3|Period 2 - Post-Randomization|Death|0
4898389|NCT00634920|16877699|P2|Period 2 - Post-Randomization|Death|5
4898390|NCT00634920|16877700|P1|Period 2 - Post-Randomization|Death|2
4898391|NCT00634920|16877698|P3|Period 2 - Post-Randomization|Rejection|0
4898392|NCT00634920|16877699|P2|Period 2 - Post-Randomization|Rejection|5
4898393|NCT00634920|16877700|P1|Period 2 - Post-Randomization|Rejection|11
4898394|NCT00634920|16877698|P3|Period 2 - Post-Randomization|Adverse Event|0
4898395|NCT00634920|16877699|P2|Period 2 - Post-Randomization|Adverse Event|9
4898396|NCT00634920|16877700|P1|Period 2 - Post-Randomization|Adverse Event|37
4898397|NCT00634920|16877698|P3|Period 1 - Pre-Randomization|Other issues|6
4898398|NCT00634920|16877699|P2|Period 1 - Pre-Randomization|Other issues|0
4898399|NCT00634920|16877700|P1|Period 1 - Pre-Randomization|Other issues|0
4898400|NCT00634920|16877698|P3|Period 1 - Pre-Randomization|Non-Compliance|3
4898401|NCT00634920|16877699|P2|Period 1 - Pre-Randomization|Non-Compliance|0
4898402|NCT00634920|16877700|P1|Period 1 - Pre-Randomization|Non-Compliance|0
4898403|NCT00634920|16877698|P3|Period 1 - Pre-Randomization|Withdrawal by Subject|21
4898404|NCT00634920|16877699|P2|Period 1 - Pre-Randomization|Withdrawal by Subject|0
4898405|NCT00634920|16877700|P1|Period 1 - Pre-Randomization|Withdrawal by Subject|0
4898406|NCT00634920|16877698|P3|Period 1 - Pre-Randomization|Rejections|55
4898407|NCT00634920|16877699|P2|Period 1 - Pre-Randomization|Rejections|0
4898408|NCT00634920|16877700|P1|Period 1 - Pre-Randomization|Rejections|0
4898409|NCT00634920|16877698|P3|Period 1 - Pre-Randomization|Wound healing problems|16
4898410|NCT00634920|16877699|P2|Period 1 - Pre-Randomization|Wound healing problems|0
4898411|NCT00634920|16877700|P1|Period 1 - Pre-Randomization|Wound healing problems|0
4898412|NCT00634920|16877698|P3|Period 1 - Pre-Randomization|Adverse Event|36
4898413|NCT00634920|16877699|P2|Period 1 - Pre-Randomization|Adverse Event|0
4898414|NCT00634920|16877700|P1|Period 1 - Pre-Randomization|Adverse Event|0
4898415|NCT00634907|16877744|P2|Overall Study|Withdrawal by Subject|8
4898416|NCT00634907|16877745|P1|Overall Study|Withdrawal by Subject|11
4898417|NCT00634907|16877744|P2|Overall Study|Physician Decision|9
4898418|NCT00634907|16877745|P1|Overall Study|Physician Decision|3
4898419|NCT00634907|16877744|P2|Overall Study|Withdrawal by Subject|0
4898420|NCT00634907|16877745|P1|Overall Study|Withdrawal by Subject|3
4898421|NCT00634842|16877769|P2|Overall Study|Subject off study drug for too long|1
4898422|NCT00634842|16877770|P1|Overall Study|Subject off study drug for too long|0
4898423|NCT00634842|16877769|P2|Overall Study|No wish to keep taking Avandia|1
4898424|NCT00634842|16877770|P1|Overall Study|No wish to keep taking Avandia|0
4898425|NCT00634842|16877769|P2|Overall Study|No need of study drug to treat diabetes|1
4898426|NCT00634842|16877770|P1|Overall Study|No need of study drug to treat diabetes|0
4898427|NCT00634842|16877769|P2|Overall Study|Discontinued due to injection|2
4898428|NCT00634842|16877770|P1|Overall Study|Discontinued due to injection|0
4898429|NCT00634842|16877769|P2|Overall Study|Lack of time and intolerance to drug|1
4898430|NCT00634842|16877770|P1|Overall Study|Lack of time and intolerance to drug|0
4898431|NCT00634842|16877769|P2|Overall Study|Withdrawal by Subject|3
4898432|NCT00634842|16877770|P1|Overall Study|Withdrawal by Subject|1
4898433|NCT00634842|16877769|P2|Overall Study|Physician Decision|0
4898434|NCT00634842|16877770|P1|Overall Study|Physician Decision|1
4898435|NCT00634842|16877769|P2|Overall Study|Lost to Follow-up|2
4898436|NCT00634842|16877770|P1|Overall Study|Lost to Follow-up|1
4898437|NCT00634842|16877769|P2|Overall Study|Inclusion criteria were not met|0
4898438|NCT00634842|16877770|P1|Overall Study|Inclusion criteria were not met|1
4898439|NCT00634842|16877769|P2|Overall Study|Move to another state|0
4898440|NCT00634842|16877770|P1|Overall Study|Move to another state|1
4898441|NCT00634842|16877769|P2|Overall Study|Protocol Violation|4
4898442|NCT00634842|16877770|P1|Overall Study|Protocol Violation|8
4898443|NCT00634842|16877769|P2|Overall Study|Adverse Event|3
4898444|NCT00634842|16877770|P1|Overall Study|Adverse Event|2
4898445|NCT00634803|16877785|P3|Overall Study|Lost to Follow-up|7
4898446|NCT00634803|16877786|P2|Overall Study|Lost to Follow-up|7
4898447|NCT00634803|16877787|P1|Overall Study|Lost to Follow-up|6
4898448|NCT00634751|16877805|P4|Pancreatic and Bilial Tract Cancer|Death|1
4898449|NCT00634751|16877806|P3|Pancreatic and Bilial Tract Cancer|Death|1
4898450|NCT00634751|16877807|P2|Pancreatic and Bilial Tract Cancer|Death|0
4898451|NCT00634751|16877808|P1|Pancreatic and Bilial Tract Cancer|Death|0
4898452|NCT00634751|16877805|P4|Phase I: 400mg Sorafenib BID+2DOC|Death|0
4898453|NCT00634751|16877806|P3|Phase I: 400mg Sorafenib BID+2DOC|Death|0
4898454|NCT00634751|16877807|P2|Phase I: 400mg Sorafenib BID+2DOC|Death|1
4898455|NCT00634751|16877808|P1|Phase I: 400mg Sorafenib BID+2DOC|Death|0
4898456|NCT00634751|16877805|P4|Phase I: 200mg Sorafenib+2DOC|Death|0
4898457|NCT00634751|16877806|P3|Phase I: 200mg Sorafenib+2DOC|Death|0
4898458|NCT00634751|16877807|P2|Phase I: 200mg Sorafenib+2DOC|Death|0
4898459|NCT00634751|16877808|P1|Phase I: 200mg Sorafenib+2DOC|Death|1
4898460|NCT00634647|16877826|P1|Overall Study|declined to participate before treatment|1
4898461|NCT00634647|16877826|P1|Overall Study|refused further treatment|3
4898462|NCT00634647|16877826|P1|Overall Study|death on study|3
4898463|NCT00634569|16877846|P2|Overall Study|Physician Decision|1
4898464|NCT00634569|16877847|P1|Overall Study|Physician Decision|0
4898465|NCT00634569|16877846|P2|Overall Study|Withdrawal by Subject|4
4898466|NCT00634569|16877847|P1|Overall Study|Withdrawal by Subject|0
4898467|NCT00634543|16877861|P2|Overall Study|Lost to Follow-up|1
4898468|NCT00634543|16877862|P1|Overall Study|Lost to Follow-up|0
4898469|NCT00634543|16877861|P2|Overall Study|Withdrawal by Subject|4
4898470|NCT00634543|16877862|P1|Overall Study|Withdrawal by Subject|4
4898471|NCT00634543|16877861|P2|Overall Study|Adverse Event|11
4898472|NCT00634543|16877862|P1|Overall Study|Adverse Event|11
4898473|NCT00634543|16877861|P2|Overall Study|Protocol Violation|3
4898474|NCT00634543|16877862|P1|Overall Study|Protocol Violation|3
4898475|NCT00634543|16877861|P2|Overall Study|Other|2
4898476|NCT00634543|16877862|P1|Overall Study|Other|1
4898477|NCT00634504|16877880|P2|Overall Study|Protocol Violation|0
4898478|NCT00634504|16877881|P1|Overall Study|Protocol Violation|1
4898479|NCT00634244|16877940|P3|Overall Study|Other complicating disease|0
4898480|NCT00634244|16877941|P2|Overall Study|Other complicating disease|1
4898481|NCT00634244|16877942|P1|Overall Study|Other complicating disease|0
4898482|NCT00634244|16877940|P3|Overall Study|Disease progression/relapse|0
4898483|NCT00634244|16877941|P2|Overall Study|Disease progression/relapse|1
4898484|NCT00634244|16877942|P1|Overall Study|Disease progression/relapse|0
4898485|NCT00634244|16877940|P3|Overall Study|Physician Decision|0
4898486|NCT00634244|16877941|P2|Overall Study|Physician Decision|1
4898487|NCT00634244|16877942|P1|Overall Study|Physician Decision|0
4898488|NCT00634244|16877940|P3|Overall Study|Withdrawal by Subject|0
4898489|NCT00634244|16877941|P2|Overall Study|Withdrawal by Subject|1
4898490|NCT00634244|16877942|P1|Overall Study|Withdrawal by Subject|0
4898491|NCT00634244|16877940|P3|Overall Study|Adverse Event|0
4898492|NCT00634244|16877941|P2|Overall Study|Adverse Event|2
4898493|NCT00634244|16877942|P1|Overall Study|Adverse Event|0
4898494|NCT00634244|16877940|P3|Overall Study|Death|0
4898495|NCT00634244|16877941|P2|Overall Study|Death|6
4898496|NCT00634244|16877942|P1|Overall Study|Death|1
4898497|NCT00634244|16877940|P3|Overall Study|Never started treatment|0
4898498|NCT00634244|16877941|P2|Overall Study|Never started treatment|1
4898499|NCT00634244|16877942|P1|Overall Study|Never started treatment|0
4898500|NCT00634179|16877953|P1|Phase II: Maintenance|Diagnosis changed after re-review|1
4898501|NCT00634114|16877972|P3|Overall Study|Other reason|1
4898502|NCT00634114|16877973|P2|Overall Study|Other reason|1
4898503|NCT00634114|16877974|P1|Overall Study|Other reason|1
4898504|NCT00634114|16877972|P3|Overall Study|Difficult to continue|1
4898505|NCT00634114|16877973|P2|Overall Study|Difficult to continue|1
4898506|NCT00634114|16877974|P1|Overall Study|Difficult to continue|3
4898507|NCT00634114|16877972|P3|Overall Study|Recurrence of reflux esophagitis|21
4898508|NCT00634114|16877973|P2|Overall Study|Recurrence of reflux esophagitis|15
4898509|NCT00634114|16877974|P1|Overall Study|Recurrence of reflux esophagitis|5
4898510|NCT00634114|16877972|P3|Overall Study|Incorrect enrolment|0
4898511|NCT00634114|16877973|P2|Overall Study|Incorrect enrolment|1
4898512|NCT00634114|16877974|P1|Overall Study|Incorrect enrolment|0
4898513|NCT00634114|16877972|P3|Overall Study|Pregnancy|0
4898514|NCT00634114|16877973|P2|Overall Study|Pregnancy|0
4898515|NCT00634114|16877974|P1|Overall Study|Pregnancy|1
4898516|NCT00634114|16877972|P3|Overall Study|Protocol Violation|1
4898517|NCT00634114|16877973|P2|Overall Study|Protocol Violation|3
4898518|NCT00634114|16877974|P1|Overall Study|Protocol Violation|3
4898519|NCT00634114|16877972|P3|Overall Study|Lost to Follow-up|1
4898520|NCT00634114|16877973|P2|Overall Study|Lost to Follow-up|0
4898521|NCT00634114|16877974|P1|Overall Study|Lost to Follow-up|0
4898522|NCT00634114|16877972|P3|Overall Study|Withdrawal by Subject|11
4898523|NCT00634114|16877973|P2|Overall Study|Withdrawal by Subject|6
4898524|NCT00634114|16877974|P1|Overall Study|Withdrawal by Subject|9
4898525|NCT00634114|16877972|P3|Overall Study|Adverse Event|3
4898526|NCT00634114|16877973|P2|Overall Study|Adverse Event|8
4898527|NCT00634114|16877974|P1|Overall Study|Adverse Event|6
4898528|NCT00634101|16877990|P2|Overall Study|Lost to Follow-up|0
4898529|NCT00634101|16877991|P1|Overall Study|Lost to Follow-up|2
4898530|NCT00634101|16877990|P2|Overall Study|Study Terminated|3
4898531|NCT00634101|16877991|P1|Overall Study|Study Terminated|3
4898532|NCT00634088|16878025|P4|Time Period 3: Dose Level 3|Progressive disease|0
4898533|NCT00634088|16878026|P3|Time Period 3: Dose Level 3|Progressive disease|1
4898534|NCT00634088|16878027|P2|Time Period 3: Dose Level 3|Progressive disease|0
4898535|NCT00634088|16878028|P1|Time Period 3: Dose Level 3|Progressive disease|0
4898536|NCT00634088|16878025|P4|Time Period 2: Dose Level 2|Progressive disease|0
4898537|NCT00634088|16878026|P3|Time Period 2: Dose Level 2|Progressive disease|0
4898538|NCT00634088|16878027|P2|Time Period 2: Dose Level 2|Progressive disease|1
4898539|NCT00634088|16878028|P1|Time Period 2: Dose Level 2|Progressive disease|0
4898540|NCT00634088|16878025|P4|Time Period 2: Dose Level 2|Adverse Event|0
4898541|NCT00634088|16878026|P3|Time Period 2: Dose Level 2|Adverse Event|0
4898542|NCT00634088|16878027|P2|Time Period 2: Dose Level 2|Adverse Event|2
4898543|NCT00634088|16878028|P1|Time Period 2: Dose Level 2|Adverse Event|0
4898544|NCT00634088|16878025|P4|Time Period 1: Dose Level 1|Adverse Event|0
4898545|NCT00634088|16878026|P3|Time Period 1: Dose Level 1|Adverse Event|0
4898546|NCT00634088|16878027|P2|Time Period 1: Dose Level 1|Adverse Event|0
4898547|NCT00634088|16878028|P1|Time Period 1: Dose Level 1|Adverse Event|3
4898548|NCT00634088|16878025|P4|Time Period 1: Dose Level 1|Physician Decision|0
4898549|NCT00634088|16878026|P3|Time Period 1: Dose Level 1|Physician Decision|0
4898550|NCT00634088|16878027|P2|Time Period 1: Dose Level 1|Physician Decision|0
4898551|NCT00634088|16878028|P1|Time Period 1: Dose Level 1|Physician Decision|1
4898552|NCT00634088|16878025|P4|Time Period 1: Dose Level 1|Disease progression|0
4898553|NCT00634088|16878026|P3|Time Period 1: Dose Level 1|Disease progression|0
4898554|NCT00634088|16878027|P2|Time Period 1: Dose Level 1|Disease progression|0
4898555|NCT00634088|16878028|P1|Time Period 1: Dose Level 1|Disease progression|2
4898556|NCT00634049|16878079|P1|Overall Study|Screening failure|1
4898557|NCT00634049|16878079|P1|Overall Study|Died prior to receiving study drug|1
4898558|NCT00634049|16878079|P1|Overall Study|Never received study drug|1
4898559|NCT00634036|16878158|P2|Overall Study|Withdrawal by Subject|1
4898560|NCT00634036|16878159|P1|Overall Study|Withdrawal by Subject|1
4898561|NCT00634036|16878158|P2|Overall Study|Lost to Follow-up|1
4898562|NCT00634036|16878159|P1|Overall Study|Lost to Follow-up|1
4898563|NCT00634010|16878173|P2|Overall Study|Non-Compliant|1
4898564|NCT00634010|16878174|P1|Overall Study|Non-Compliant|1
4898565|NCT00634010|16878173|P2|Overall Study|Disease Progression|1
4898566|NCT00634010|16878174|P1|Overall Study|Disease Progression|1
4898567|NCT00634010|16878173|P2|Overall Study|Physician Decision|1
4898568|NCT00634010|16878174|P1|Overall Study|Physician Decision|1
4898569|NCT00634010|16878173|P2|Overall Study|Withdrawal by Subject|6
4898570|NCT00634010|16878174|P1|Overall Study|Withdrawal by Subject|5
4898571|NCT00634010|16878173|P2|Overall Study|Adverse Event|5
4898572|NCT00634010|16878174|P1|Overall Study|Adverse Event|2
4898573|NCT00633984|16878182|P2|Overall Study|Hospitalized|0
4898574|NCT00633984|16878183|P1|Overall Study|Hospitalized|1
4898575|NCT00633984|16878182|P2|Overall Study|Withdrawal by Subject|7
4898576|NCT00633984|16878183|P1|Overall Study|Withdrawal by Subject|8
4898577|NCT00633984|16878182|P2|Overall Study|Lost to Follow-up|6
4898578|NCT00633984|16878183|P1|Overall Study|Lost to Follow-up|0
4898579|NCT00633945|16878191|P1|Overall Study|Physician Decision|2
4898580|NCT00633932|16878207|P3|Overall Study|Moved Away|0
4898581|NCT00633932|16878208|P2|Overall Study|Moved Away|0
4898582|NCT00633932|16878209|P1|Overall Study|Moved Away|1
4898583|NCT00633932|16878207|P3|Overall Study|Doctor's judgement|0
4898584|NCT00633932|16878208|P2|Overall Study|Doctor's judgement|0
4898585|NCT00633932|16878209|P1|Overall Study|Doctor's judgement|1
4898586|NCT00633932|16878207|P3|Overall Study|Physician Decision|1
4898587|NCT00633932|16878208|P2|Overall Study|Physician Decision|0
4898588|NCT00633932|16878209|P1|Overall Study|Physician Decision|0
4898589|NCT00633932|16878207|P3|Overall Study|Protocol Violation|3
4898590|NCT00633932|16878208|P2|Overall Study|Protocol Violation|2
4898591|NCT00633932|16878209|P1|Overall Study|Protocol Violation|5
4898592|NCT00633932|16878207|P3|Overall Study|Lost to Follow-up|2
4898593|NCT00633932|16878208|P2|Overall Study|Lost to Follow-up|0
4898594|NCT00633932|16878209|P1|Overall Study|Lost to Follow-up|1
4898595|NCT00633932|16878207|P3|Overall Study|Withdrawal by Subject|1
4898596|NCT00633932|16878208|P2|Overall Study|Withdrawal by Subject|9
4898597|NCT00633932|16878209|P1|Overall Study|Withdrawal by Subject|3
4898598|NCT00633932|16878207|P3|Overall Study|Adverse Event|4
4898599|NCT00633932|16878208|P2|Overall Study|Adverse Event|3
4898600|NCT00633932|16878209|P1|Overall Study|Adverse Event|1
4898601|NCT00633893|16878240|P3|Overall Study|Other|31
4898602|NCT00633893|16878241|P2|Overall Study|Other|33
4898603|NCT00633893|16878242|P1|Overall Study|Other|28
4898604|NCT00633893|16878240|P3|Overall Study|Not meet/no longer meets criteria|4
4898605|NCT00633893|16878241|P2|Overall Study|Not meet/no longer meets criteria|6
4898606|NCT00633893|16878242|P1|Overall Study|Not meet/no longer meets criteria|4
4898607|NCT00633893|16878240|P3|Overall Study|Pregnancy|1
4898608|NCT00633893|16878241|P2|Overall Study|Pregnancy|1
4898609|NCT00633893|16878242|P1|Overall Study|Pregnancy|2
4898610|NCT00633893|16878240|P3|Overall Study|Poor/non-compliance|3
4898611|NCT00633893|16878241|P2|Overall Study|Poor/non-compliance|12
4898612|NCT00633893|16878242|P1|Overall Study|Poor/non-compliance|5
4898613|NCT00633893|16878240|P3|Overall Study|Lost to Follow-up|8
4898614|NCT00633893|16878241|P2|Overall Study|Lost to Follow-up|4
4898615|NCT00633893|16878242|P1|Overall Study|Lost to Follow-up|2
4898616|NCT00633893|16878240|P3|Overall Study|Withdrawal by Subject|6
4898617|NCT00633893|16878241|P2|Overall Study|Withdrawal by Subject|12
4898618|NCT00633893|16878242|P1|Overall Study|Withdrawal by Subject|7
4898619|NCT00633893|16878240|P3|Overall Study|Adverse Event|126
4898620|NCT00633893|16878241|P2|Overall Study|Adverse Event|58
4898621|NCT00633893|16878242|P1|Overall Study|Adverse Event|65
4898622|NCT00633893|16878240|P3|Overall Study|Death|9
4898623|NCT00633893|16878241|P2|Overall Study|Death|3
4898624|NCT00633893|16878242|P1|Overall Study|Death|1
4898625|NCT00633880|16878316|P3|Open Label Titration|Withdrawal by Subject|0
4898626|NCT00633880|16878317|P2|Open Label Titration|Withdrawal by Subject|0
4898627|NCT00633880|16878318|P1|Open Label Titration|Withdrawal by Subject|4
4898628|NCT00633880|16878316|P3|Open Label Titration|Physician Decision|0
4898629|NCT00633880|16878317|P2|Open Label Titration|Physician Decision|0
4898630|NCT00633880|16878318|P1|Open Label Titration|Physician Decision|1
4898631|NCT00633880|16878316|P3|Open Label Titration|Protocol Violation|0
4898632|NCT00633880|16878317|P2|Open Label Titration|Protocol Violation|0
4898633|NCT00633880|16878318|P1|Open Label Titration|Protocol Violation|6
4898634|NCT00633880|16878316|P3|Open Label Titration|Treatment Failure|0
4898635|NCT00633880|16878317|P2|Open Label Titration|Treatment Failure|0
4898636|NCT00633880|16878318|P1|Open Label Titration|Treatment Failure|55
4898637|NCT00633880|16878316|P3|Open Label Titration|Adverse Event|0
4898638|NCT00633880|16878317|P2|Open Label Titration|Adverse Event|0
4898639|NCT00633880|16878318|P1|Open Label Titration|Adverse Event|13
4898640|NCT00633880|16878316|P3|Open Label Titration|Lack of Efficacy|0
4898641|NCT00633880|16878317|P2|Open Label Titration|Lack of Efficacy|0
4898642|NCT00633880|16878318|P1|Open Label Titration|Lack of Efficacy|1
4898643|NCT00633750|16878354|P1|Overall Study|Withdrawal by Subject|3
4898644|NCT00633750|16878354|P1|Overall Study|Adverse Event|2
4898645|NCT00633594|16878363|P3|Overall Study|Disease Progression|1
4898646|NCT00633594|16878364|P2|Overall Study|Disease Progression|0
4898647|NCT00633594|16878365|P1|Overall Study|Disease Progression|0
4898648|NCT00633594|16878363|P3|Overall Study|Death|2
4898649|NCT00633594|16878364|P2|Overall Study|Death|1
4898650|NCT00633594|16878365|P1|Overall Study|Death|0
4898651|NCT00633594|16878363|P3|Overall Study|Adverse Event|7
4898652|NCT00633594|16878364|P2|Overall Study|Adverse Event|4
4898653|NCT00633594|16878365|P1|Overall Study|Adverse Event|0
4898654|NCT00633477|16878394|P2|Overall Study|Randomized but not treated|0
4898655|NCT00633477|16878395|P1|Overall Study|Randomized but not treated|1
4898656|NCT00633477|16878394|P2|Overall Study|Death|0
4898657|NCT00633477|16878395|P1|Overall Study|Death|1
4898658|NCT00633464|16878411|P2|Overall Study|Never Treated (Randomized in error)|1
4898659|NCT00633464|16878412|P1|Overall Study|Never Treated (Randomized in error)|0
4898660|NCT00633464|16878411|P2|Overall Study|Never Treated (Not met study criteria)|1
4898661|NCT00633464|16878412|P1|Overall Study|Never Treated (Not met study criteria)|0
4898662|NCT00633360|16878447|P2|Overall Study|Protocol Violation|1
4898663|NCT00633360|16878448|P1|Overall Study|Protocol Violation|0
4898664|NCT00633360|16878447|P2|Overall Study|Adverse Event|1
4898665|NCT00633360|16878448|P1|Overall Study|Adverse Event|3
4898666|NCT00633360|16878447|P2|Overall Study|Lost to Follow-up|1
4898667|NCT00633360|16878448|P1|Overall Study|Lost to Follow-up|1
4898668|NCT00633243|16878471|P2|Overall Study|Couldn't tolerate side-effects|1
4898669|NCT00633243|16878472|P1|Overall Study|Couldn't tolerate side-effects|1
4898670|NCT00633243|16878471|P2|Overall Study|Mental Health--Depression|1
4898671|NCT00633243|16878472|P1|Overall Study|Mental Health--Depression|0
4898672|NCT00633243|16878471|P2|Overall Study|Not comfortable with self-injecting|1
4898673|NCT00633243|16878472|P1|Overall Study|Not comfortable with self-injecting|0
4898674|NCT00633243|16878471|P2|Overall Study|Homeless--no refrigeration for meds|1
4898675|NCT00633243|16878472|P1|Overall Study|Homeless--no refrigeration for meds|0
4898676|NCT00633243|16878471|P2|Overall Study|incarceration|2
4898677|NCT00633243|16878472|P1|Overall Study|incarceration|0
4898678|NCT00633243|16878471|P2|Overall Study|Withdrawal by Subject|1
4898679|NCT00633243|16878472|P1|Overall Study|Withdrawal by Subject|0
4898680|NCT00633217|16878480|P2|Overall Study|Withdrew Consent|3
4898681|NCT00633217|16878481|P1|Overall Study|Withdrew Consent|3
4898682|NCT00633217|16878480|P2|Overall Study|Investigator Discretion|0
4898683|NCT00633217|16878481|P1|Overall Study|Investigator Discretion|2
4898684|NCT00633217|16878480|P2|Overall Study|Lost to Follow-up|2
4898685|NCT00633217|16878481|P1|Overall Study|Lost to Follow-up|2
4898686|NCT00633217|16878480|P2|Overall Study|Protocol Violation|7
4898687|NCT00633217|16878481|P1|Overall Study|Protocol Violation|3
4898688|NCT00633217|16878480|P2|Overall Study|Lack of Efficacy|2
4898689|NCT00633217|16878481|P1|Overall Study|Lack of Efficacy|0
4898690|NCT00633217|16878480|P2|Overall Study|Adverse Event|9
4898691|NCT00633217|16878481|P1|Overall Study|Adverse Event|5
4898692|NCT00633152|16878493|P2|Overall Study|Miscellaneous Other|2
4898693|NCT00633152|16878494|P1|Overall Study|Miscellaneous Other|3
4898694|NCT00633152|16878493|P2|Overall Study|Lost to Follow-up|1
4898695|NCT00633152|16878494|P1|Overall Study|Lost to Follow-up|4
4898696|NCT00633152|16878493|P2|Overall Study|Withdrawal by Subject|1
4898697|NCT00633152|16878494|P1|Overall Study|Withdrawal by Subject|1
4898698|NCT00633152|16878493|P2|Overall Study|Randomized, did not receive study drug|2
4898699|NCT00633152|16878494|P1|Overall Study|Randomized, did not receive study drug|5
4898700|NCT00633152|16878493|P2|Overall Study|Adverse Event|0
4898701|NCT00633152|16878494|P1|Overall Study|Adverse Event|1
4898702|NCT00633139|16878505|P3|Overall Study|Withdrawal by Subject|0
4898703|NCT00633139|16878506|P2|Overall Study|Withdrawal by Subject|1
4898704|NCT00633139|16878507|P1|Overall Study|Withdrawal by Subject|0
4898705|NCT00633139|16878505|P3|Overall Study|Non compliance|1
4898706|NCT00633139|16878506|P2|Overall Study|Non compliance|0
4898707|NCT00633139|16878507|P1|Overall Study|Non compliance|0
4898708|NCT00633126|16878521|P1|Overall Study|Did not receive full dose|1
4898709|NCT00633074|16878535|P2|Overall Study|Adverse Event|0
4898710|NCT00633074|16878536|P1|Overall Study|Adverse Event|1
4898711|NCT00633061|16878566|P2|Overall Study|Study closed|0
4898712|NCT00633061|16878567|P1|Overall Study|Study closed|86
4898713|NCT00633022|16878578|P3|Overall Study|Physician Decision|0
4898714|NCT00633022|16878579|P2|Overall Study|Physician Decision|1
4898715|NCT00633022|16878580|P1|Overall Study|Physician Decision|0
4898716|NCT00633022|16878578|P3|Overall Study|Adverse Event|5
4898717|NCT00633022|16878579|P2|Overall Study|Adverse Event|0
4898718|NCT00633022|16878580|P1|Overall Study|Adverse Event|1
4898719|NCT00632931|16878642|P3|Part 2|Withdrawal by Subject|3
4898720|NCT00632931|16878643|P2|Part 2|Withdrawal by Subject|0
4898721|NCT00632931|16878644|P1|Part 2|Withdrawal by Subject|0
4898722|NCT00632931|16878642|P3|Part 2|Lack of Efficacy|17
4898723|NCT00632931|16878643|P2|Part 2|Lack of Efficacy|0
4898724|NCT00632931|16878644|P1|Part 2|Lack of Efficacy|0
4898725|NCT00632931|16878642|P3|Part 2|Death|1
4898726|NCT00632931|16878643|P2|Part 2|Death|0
4898727|NCT00632931|16878644|P1|Part 2|Death|0
4898728|NCT00632931|16878642|P3|Part 2|Adverse Event|3
4898729|NCT00632931|16878643|P2|Part 2|Adverse Event|0
4898730|NCT00632931|16878644|P1|Part 2|Adverse Event|0
4898731|NCT00632931|16878642|P3|Part 1, Period 1|Withdrawal by Subject|0
4898732|NCT00632931|16878643|P2|Part 1, Period 1|Withdrawal by Subject|0
4898733|NCT00632931|16878644|P1|Part 1, Period 1|Withdrawal by Subject|1
4898734|NCT00632931|16878642|P3|Part 1, Period 1|Protocol Violation|0
4898735|NCT00632931|16878643|P2|Part 1, Period 1|Protocol Violation|0
4898736|NCT00632931|16878644|P1|Part 1, Period 1|Protocol Violation|1
4898737|NCT00632827|16878663|P1|Overall Study|Lost to Follow-up|1
4898738|NCT00632827|16878663|P1|Overall Study|Adverse Event|5
4898739|NCT00632827|16878663|P1|Overall Study|Death|2
4898740|NCT00632827|16878663|P1|Overall Study|Excluded after GVD (Not evaluable)|2
4898741|NCT00632749|16878721|P14|Overall Study|Reason other than those specified above|2
4898742|NCT00632749|16878722|P13|Overall Study|Reason other than those specified above|0
4898743|NCT00632749|16878723|P12|Overall Study|Reason other than those specified above|1
4898744|NCT00632749|16878724|P11|Overall Study|Reason other than those specified above|2
4898745|NCT00632749|16878725|P10|Overall Study|Reason other than those specified above|0
4898746|NCT00632749|16878726|P9|Overall Study|Reason other than those specified above|0
4898747|NCT00632749|16878727|P8|Overall Study|Reason other than those specified above|0
4898748|NCT00632749|16878728|P7|Overall Study|Reason other than those specified above|1
4898749|NCT00632749|16878729|P6|Overall Study|Reason other than those specified above|0
4898750|NCT00632749|16878730|P5|Overall Study|Reason other than those specified above|1
4898751|NCT00632749|16878731|P4|Overall Study|Reason other than those specified above|0
4898752|NCT00632749|16878732|P3|Overall Study|Reason other than those specified above|0
4898753|NCT00632749|16878733|P2|Overall Study|Reason other than those specified above|2
4898754|NCT00632749|16878734|P1|Overall Study|Reason other than those specified above|0
4898755|NCT00632749|16878721|P14|Overall Study|Refuse to continue medication|0
4898756|NCT00632749|16878722|P13|Overall Study|Refuse to continue medication|0
4898757|NCT00632749|16878723|P12|Overall Study|Refuse to continue medication|0
4898758|NCT00632749|16878724|P11|Overall Study|Refuse to continue medication|0
4898759|NCT00632749|16878725|P10|Overall Study|Refuse to continue medication|1
4898760|NCT00632749|16878726|P9|Overall Study|Refuse to continue medication|0
4898761|NCT00632749|16878727|P8|Overall Study|Refuse to continue medication|0
4898762|NCT00632749|16878728|P7|Overall Study|Refuse to continue medication|0
4898763|NCT00632749|16878729|P6|Overall Study|Refuse to continue medication|0
4898764|NCT00632749|16878730|P5|Overall Study|Refuse to continue medication|0
4898765|NCT00632749|16878731|P4|Overall Study|Refuse to continue medication|1
4898766|NCT00632749|16878732|P3|Overall Study|Refuse to continue medication|0
4898767|NCT00632749|16878733|P2|Overall Study|Refuse to continue medication|0
4898768|NCT00632749|16878734|P1|Overall Study|Refuse to continue medication|0
4898769|NCT00632749|16878721|P14|Overall Study|Other Adverse event|0
4898770|NCT00632749|16878722|P13|Overall Study|Other Adverse event|1
4898771|NCT00632749|16878723|P12|Overall Study|Other Adverse event|0
4898772|NCT00632749|16878724|P11|Overall Study|Other Adverse event|1
4898773|NCT00632749|16878725|P10|Overall Study|Other Adverse event|0
4898774|NCT00632749|16878726|P9|Overall Study|Other Adverse event|2
4898775|NCT00632749|16878727|P8|Overall Study|Other Adverse event|2
4898776|NCT00632749|16878728|P7|Overall Study|Other Adverse event|1
4898777|NCT00632749|16878729|P6|Overall Study|Other Adverse event|4
4898778|NCT00632749|16878730|P5|Overall Study|Other Adverse event|2
4898779|NCT00632749|16878731|P4|Overall Study|Other Adverse event|1
4898780|NCT00632749|16878732|P3|Overall Study|Other Adverse event|1
4898781|NCT00632749|16878733|P2|Overall Study|Other Adverse event|1
4898782|NCT00632749|16878734|P1|Overall Study|Other Adverse event|1
4898783|NCT00632749|16878721|P14|Overall Study|Progressive disease|4
4898784|NCT00632749|16878722|P13|Overall Study|Progressive disease|2
4898785|NCT00632749|16878723|P12|Overall Study|Progressive disease|3
4898786|NCT00632749|16878724|P11|Overall Study|Progressive disease|4
4898787|NCT00632749|16878725|P10|Overall Study|Progressive disease|2
4898788|NCT00632749|16878726|P9|Overall Study|Progressive disease|3
4898789|NCT00632749|16878727|P8|Overall Study|Progressive disease|2
4898790|NCT00632749|16878728|P7|Overall Study|Progressive disease|3
4898791|NCT00632749|16878729|P6|Overall Study|Progressive disease|4
4898792|NCT00632749|16878730|P5|Overall Study|Progressive disease|4
4898793|NCT00632749|16878731|P4|Overall Study|Progressive disease|2
4898794|NCT00632749|16878732|P3|Overall Study|Progressive disease|2
4898795|NCT00632749|16878733|P2|Overall Study|Progressive disease|2
4898796|NCT00632749|16878734|P1|Overall Study|Progressive disease|3
4898797|NCT00632736|16879028|P1|Overall Study|Other|16
4898798|NCT00632736|16879028|P1|Overall Study|Non-compliance|10
4898799|NCT00632736|16879028|P1|Overall Study|Sponsor terminated study|5
4898800|NCT00632736|16879028|P1|Overall Study|Lack of Efficacy|5
4898801|NCT00632736|16879028|P1|Overall Study|Withdrawal by Subject|99
4898802|NCT00632736|16879028|P1|Overall Study|Protocol Violation|14
4898803|NCT00632736|16879028|P1|Overall Study|Lost to Follow-up|15
4898804|NCT00632736|16879028|P1|Overall Study|Adverse Event|104
4898805|NCT00632541|16879063|P1|Overall Study|Adverse Event|7
4898806|NCT00632502|16879072|P2|Overall Study|Randomized not treated|0
4898807|NCT00632502|16879073|P1|Overall Study|Randomized not treated|3
4898808|NCT00632502|16879072|P2|Overall Study|Adverse Event|1
4898809|NCT00632502|16879073|P1|Overall Study|Adverse Event|0
4898810|NCT00632463|16879117|P3|Overall Study|Adverse Event|0
4898811|NCT00632463|16879118|P2|Overall Study|Adverse Event|1
4898812|NCT00632463|16879119|P1|Overall Study|Adverse Event|0
4898813|NCT00632424|16879136|P1|Overall Study|Study Drug Toxicity|1
4898814|NCT00632424|16879136|P1|Overall Study|Disease Progression|17
4898815|NCT00632359|16879167|P1|Overall Study|Withdrawal by Subject|2
4898816|NCT00632229|16879180|P2|Overall Study|Undisclosed reasons within the first wee|1
4898817|NCT00632229|16879181|P1|Overall Study|Undisclosed reasons within the first wee|0
4898818|NCT00632229|16879180|P2|Overall Study|Lack of Efficacy|2
4898819|NCT00632229|16879181|P1|Overall Study|Lack of Efficacy|0
4898820|NCT00632229|16879180|P2|Overall Study|Lost to Follow-up|3
4898821|NCT00632229|16879181|P1|Overall Study|Lost to Follow-up|0
4898822|NCT00632229|16879180|P2|Overall Study|Adverse Event|0
4898823|NCT00632229|16879181|P1|Overall Study|Adverse Event|6
4898824|NCT00632203|16879191|P2|Overall Study|Did not start study treatment|0
4898825|NCT00632203|16879192|P1|Overall Study|Did not start study treatment|1
4898826|NCT00632125|16879210|P1|Overall Study|Moved to other dialysis unit, etc.|102
4898827|NCT00632125|16879210|P1|Overall Study|Development of uncontrolled hypertension|5
4898828|NCT00632125|16879210|P1|Overall Study|Non-compliance|8
4898829|NCT00632125|16879210|P1|Overall Study|Need for systemic immunosuppressive medi|8
4898830|NCT00632125|16879210|P1|Overall Study|Renal transplantation|17
4898831|NCT00632125|16879210|P1|Overall Study|Adverse Event|36
4898832|NCT00632125|16879210|P1|Overall Study|Withdrawal by Subject|44
4898833|NCT00632125|16879210|P1|Overall Study|Death|82
4898834|NCT00632099|16879216|P2|Overall Study|Lost to Follow-up|3
4898835|NCT00632099|16879217|P1|Overall Study|Lost to Follow-up|3
4898836|NCT00632021|16879225|P2|Overall Study|Withdrawal/death|7
4898837|NCT00632021|16879226|P1|Overall Study|Withdrawal/death|4
4898838|NCT00631969|16879236|P2|Overall Study|No Drug Exposure|2
4898839|NCT00631969|16879237|P1|Overall Study|No Drug Exposure|2
4898840|NCT00631969|16879236|P2|Overall Study|Noncompliant With Study Medication|1
4898841|NCT00631969|16879237|P1|Overall Study|Noncompliant With Study Medication|0
4898842|NCT00631969|16879236|P2|Overall Study|Consent Withdrawn|7
4898843|NCT00631969|16879237|P1|Overall Study|Consent Withdrawn|5
4898844|NCT00631969|16879236|P2|Overall Study|Protocol Violation|1
4898845|NCT00631969|16879237|P1|Overall Study|Protocol Violation|1
4898846|NCT00631969|16879236|P2|Overall Study|Lost to Follow-up|1
4898847|NCT00631969|16879237|P1|Overall Study|Lost to Follow-up|2
4898848|NCT00631969|16879236|P2|Overall Study|Lack of Efficacy|8
4898849|NCT00631969|16879237|P1|Overall Study|Lack of Efficacy|2
4898850|NCT00631969|16879236|P2|Overall Study|Adverse Event|1
4898851|NCT00631969|16879237|P1|Overall Study|Adverse Event|3
4898852|NCT00631917|16879283|P2|Overall Study|Death|0
4898853|NCT00631917|16879284|P1|Overall Study|Death|1
4898854|NCT00631917|16879283|P2|Overall Study|Administrative problems|0
4898855|NCT00631917|16879284|P1|Overall Study|Administrative problems|2
4898856|NCT00631917|16879283|P2|Overall Study|Lost to Follow-up|7
4898857|NCT00631917|16879284|P1|Overall Study|Lost to Follow-up|7
4898858|NCT00631917|16879283|P2|Overall Study|Subject withdrew consent|33
4898859|NCT00631917|16879284|P1|Overall Study|Subject withdrew consent|25
4898860|NCT00631917|16879283|P2|Overall Study|Protocol deviation|5
4898861|NCT00631917|16879284|P1|Overall Study|Protocol deviation|6
4898862|NCT00631917|16879283|P2|Overall Study|No longer required study drug|1
4898863|NCT00631917|16879284|P1|Overall Study|No longer required study drug|0
4898864|NCT00631917|16879283|P2|Overall Study|Unsatisfactory therapeutic effect|14
4898865|NCT00631917|16879284|P1|Overall Study|Unsatisfactory therapeutic effect|8
4898866|NCT00631917|16879283|P2|Overall Study|Abnormal test procedure result(s)|2
4898867|NCT00631917|16879284|P1|Overall Study|Abnormal test procedure result(s)|3
4898868|NCT00631917|16879283|P2|Overall Study|Abnormal laboratory value(s)|1
4898869|NCT00631917|16879284|P1|Overall Study|Abnormal laboratory value(s)|2
4898870|NCT00631917|16879283|P2|Overall Study|Adverse Event|45
4898871|NCT00631917|16879284|P1|Overall Study|Adverse Event|34
4898872|NCT00631696|16879311|P2|Overall Study|Adverse Event|0
4898873|NCT00631696|16879312|P1|Overall Study|Adverse Event|5
4898874|NCT00631696|16879311|P2|Overall Study|Study terminated by sponsor|3
4898875|NCT00631696|16879312|P1|Overall Study|Study terminated by sponsor|3
4898876|NCT00631696|16879311|P2|Overall Study|Protocol Violation|9
4898877|NCT00631696|16879312|P1|Overall Study|Protocol Violation|9
4898878|NCT00631696|16879311|P2|Overall Study|Other|8
4898879|NCT00631696|16879312|P1|Overall Study|Other|8
4898880|NCT00631696|16879311|P2|Overall Study|Withdrawal by Subject|9
4898881|NCT00631696|16879312|P1|Overall Study|Withdrawal by Subject|2
4898882|NCT00631696|16879311|P2|Overall Study|Lost to Follow-up|10
4898883|NCT00631696|16879312|P1|Overall Study|Lost to Follow-up|7
4898884|NCT00631696|16879311|P2|Overall Study|Follow up after database release date|0
4898885|NCT00631696|16879312|P1|Overall Study|Follow up after database release date|1
4898886|NCT00631696|16879311|P2|Overall Study|Discontinued after database release date|0
4898887|NCT00631696|16879312|P1|Overall Study|Discontinued after database release date|1
4898888|NCT00631696|16879311|P2|Overall Study|Entered, not randomized to treatment|1
4898889|NCT00631696|16879312|P1|Overall Study|Entered, not randomized to treatment|1
4898890|NCT00631657|16879355|P3|7-Day Discontinuation Period|Other|0
4898891|NCT00631657|16879356|P2|7-Day Discontinuation Period|Other|0
4898892|NCT00631657|16879357|P1|7-Day Discontinuation Period|Other|1
4898893|NCT00631657|16879355|P3|7-Day Discontinuation Period|Not Treated|1
4898894|NCT00631657|16879356|P2|7-Day Discontinuation Period|Not Treated|1
4898895|NCT00631657|16879357|P1|7-Day Discontinuation Period|Not Treated|1
4898896|NCT00631657|16879355|P3|6-Month Treatment Period|Not Treated|1
4898897|NCT00631657|16879356|P2|6-Month Treatment Period|Not Treated|0
4898898|NCT00631657|16879357|P1|6-Month Treatment Period|Not Treated|2
4898899|NCT00631657|16879355|P3|6-Month Treatment Period|Other|4
4898900|NCT00631657|16879356|P2|6-Month Treatment Period|Other|0
4898901|NCT00631657|16879357|P1|6-Month Treatment Period|Other|16
4898902|NCT00631657|16879355|P3|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6
4898903|NCT00631657|16879356|P2|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0
4898904|NCT00631657|16879357|P1|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21
4898905|NCT00631657|16879355|P3|6-Month Treatment Period|Lost to Follow-up|2
4898906|NCT00631657|16879356|P2|6-Month Treatment Period|Lost to Follow-up|0
4898907|NCT00631657|16879357|P1|6-Month Treatment Period|Lost to Follow-up|7
4898908|NCT00631657|16879355|P3|6-Month Treatment Period|Lack of Efficacy|25
4898909|NCT00631657|16879356|P2|6-Month Treatment Period|Lack of Efficacy|0
4898910|NCT00631657|16879357|P1|6-Month Treatment Period|Lack of Efficacy|34
4898911|NCT00631657|16879355|P3|6-Month Treatment Period|Withdrawal by Subject|5
4898912|NCT00631657|16879356|P2|6-Month Treatment Period|Withdrawal by Subject|0
4898913|NCT00631657|16879357|P1|6-Month Treatment Period|Withdrawal by Subject|14
4898914|NCT00631657|16879355|P3|6-Month Treatment Period|Adverse Event|7
4898915|NCT00631657|16879356|P2|6-Month Treatment Period|Adverse Event|0
4898916|NCT00631657|16879357|P1|6-Month Treatment Period|Adverse Event|47
4898917|NCT00631540|16879406|P1|Overall Study|Core Lab Data Unavailable|3
4898918|NCT00631540|16879406|P1|Overall Study|Lost to Follow-up|2
4898919|NCT00631540|16879406|P1|Overall Study|Death|4
4898920|NCT00631540|16879406|P1|Overall Study|Withdrawal by Subject|5
4898921|NCT00631488|16879418|P3|Overall Study|Protocol Violation|1
4898922|NCT00631488|16879419|P2|Overall Study|Protocol Violation|0
4898923|NCT00631488|16879420|P1|Overall Study|Protocol Violation|0
4898924|NCT00631488|16879418|P3|Overall Study|Physician Decision|1
4898925|NCT00631488|16879419|P2|Overall Study|Physician Decision|0
4898926|NCT00631488|16879420|P1|Overall Study|Physician Decision|1
4898927|NCT00631488|16879418|P3|Overall Study|Lost to Follow-up|0
4898928|NCT00631488|16879419|P2|Overall Study|Lost to Follow-up|2
4898929|NCT00631488|16879420|P1|Overall Study|Lost to Follow-up|2
4898930|NCT00631488|16879418|P3|Overall Study|Adverse Event|0
4898931|NCT00631488|16879419|P2|Overall Study|Adverse Event|0
4898932|NCT00631488|16879420|P1|Overall Study|Adverse Event|1
4898933|NCT00631475|16879440|P1|Overall Study|Preparation for lung transplant|8
4898934|NCT00631475|16879440|P1|Overall Study|Withdrew consent|5
4898935|NCT00631475|16879440|P1|Overall Study|Adverse Event|14
4898936|NCT00631475|16879440|P1|Overall Study|Death|18
4898937|NCT00631410|16879461|P2|Overall Study|Surgery|0
4898938|NCT00631410|16879462|P1|Overall Study|Surgery|1
4898939|NCT00631410|16879461|P2|Overall Study|Objective Progression or Relapse|3
4898940|NCT00631410|16879462|P1|Overall Study|Objective Progression or Relapse|4
4898941|NCT00631410|16879461|P2|Overall Study|Adverse Event|3
4898942|NCT00631410|16879462|P1|Overall Study|Adverse Event|1
4898943|NCT00631371|16879481|P2|Overall Study|Death|239
4898944|NCT00631371|16879482|P1|Overall Study|Death|263
4898945|NCT00631371|16879481|P2|Overall Study|Discontinuation of study by Sponsor|76
4898946|NCT00631371|16879482|P1|Overall Study|Discontinuation of study by Sponsor|70
4898947|NCT00631371|16879481|P2|Overall Study|subject request|45
4898948|NCT00631371|16879482|P1|Overall Study|subject request|38
4898949|NCT00631371|16879481|P2|Overall Study|Other reason|12
4898950|NCT00631371|16879482|P1|Overall Study|Other reason|5
4898951|NCT00631371|16879481|P2|Overall Study|Lost to Follow-up|19
4898952|NCT00631371|16879482|P1|Overall Study|Lost to Follow-up|24
4898953|NCT00631189|16879525|P4|Treatment Phase|patient did not take pravastatin|0
4898954|NCT00631189|16879526|P3|Treatment Phase|patient did not take pravastatin|1
4898955|NCT00631189|16879527|P2|Treatment Phase|patient did not take pravastatin|0
4898956|NCT00631189|16879528|P1|Treatment Phase|patient did not take pravastatin|0
4898957|NCT00631189|16879525|P4|Treatment Phase|Pregnancy|0
4898958|NCT00631189|16879526|P3|Treatment Phase|Pregnancy|1
4898959|NCT00631189|16879527|P2|Treatment Phase|Pregnancy|0
4898960|NCT00631189|16879528|P1|Treatment Phase|Pregnancy|0
4898961|NCT00631189|16879525|P4|Treatment Phase|Lost to Follow-up|0
4898962|NCT00631189|16879526|P3|Treatment Phase|Lost to Follow-up|0
4898963|NCT00631189|16879527|P2|Treatment Phase|Lost to Follow-up|1
4898964|NCT00631189|16879528|P1|Treatment Phase|Lost to Follow-up|0
4898965|NCT00631189|16879525|P4|Treatment Phase|Adverse Event|4
4898966|NCT00631189|16879526|P3|Treatment Phase|Adverse Event|2
4898967|NCT00631189|16879527|P2|Treatment Phase|Adverse Event|3
4898968|NCT00631189|16879528|P1|Treatment Phase|Adverse Event|0
4898969|NCT00631189|16879525|P4|Treatment Phase|Protocol Violation|2
4898970|NCT00631189|16879526|P3|Treatment Phase|Protocol Violation|6
4898971|NCT00631189|16879527|P2|Treatment Phase|Protocol Violation|1
4898972|NCT00631189|16879528|P1|Treatment Phase|Protocol Violation|0
4898973|NCT00631189|16879525|P4|Treatment Phase|Withdrawal by Subject|1
4898974|NCT00631189|16879526|P3|Treatment Phase|Withdrawal by Subject|1
4898975|NCT00631189|16879527|P2|Treatment Phase|Withdrawal by Subject|2
4898976|NCT00631189|16879528|P1|Treatment Phase|Withdrawal by Subject|0
4898977|NCT00631189|16879525|P4|Initial Phase|Withdrawal by Subject|0
4898978|NCT00631189|16879526|P3|Initial Phase|Withdrawal by Subject|0
4898979|NCT00631189|16879527|P2|Initial Phase|Withdrawal by Subject|0
4898980|NCT00631189|16879528|P1|Initial Phase|Withdrawal by Subject|4
4898981|NCT00631189|16879525|P4|Initial Phase|Protocol Violation|0
4898982|NCT00631189|16879526|P3|Initial Phase|Protocol Violation|0
4898983|NCT00631189|16879527|P2|Initial Phase|Protocol Violation|0
4898984|NCT00631189|16879528|P1|Initial Phase|Protocol Violation|347
4898985|NCT00631137|16879572|P2|Overall Study|Withdrawal by Subject|0
4898986|NCT00631137|16879573|P1|Overall Study|Withdrawal by Subject|1
4898987|NCT00631020|16879591|P1|Overall Study|Incarcerated|1
4898988|NCT00631020|16879591|P1|Overall Study|Lost to Follow-up|7
4898989|NCT00631007|16879606|P6|Overall Study|Other|0
4898990|NCT00631007|16879607|P5|Overall Study|Other|1
4898991|NCT00631007|16879608|P4|Overall Study|Other|0
4898992|NCT00631007|16879609|P3|Overall Study|Other|0
4898993|NCT00631007|16879610|P2|Overall Study|Other|1
4898994|NCT00631007|16879611|P1|Overall Study|Other|2
4898995|NCT00631007|16879606|P6|Overall Study|Withdrawal by Subject|3
4898996|NCT00631007|16879607|P5|Overall Study|Withdrawal by Subject|1
4898997|NCT00631007|16879608|P4|Overall Study|Withdrawal by Subject|2
4898998|NCT00631007|16879609|P3|Overall Study|Withdrawal by Subject|2
4898999|NCT00631007|16879610|P2|Overall Study|Withdrawal by Subject|5
4899000|NCT00631007|16879611|P1|Overall Study|Withdrawal by Subject|4
4899001|NCT00631007|16879606|P6|Overall Study|Persistent Hyperglycemia|5
4899002|NCT00631007|16879607|P5|Overall Study|Persistent Hyperglycemia|2
4899003|NCT00631007|16879608|P4|Overall Study|Persistent Hyperglycemia|1
4899004|NCT00631007|16879609|P3|Overall Study|Persistent Hyperglycemia|5
4899005|NCT00631007|16879610|P2|Overall Study|Persistent Hyperglycemia|2
4899006|NCT00631007|16879611|P1|Overall Study|Persistent Hyperglycemia|2
4899007|NCT00631007|16879606|P6|Overall Study|Physician Decision|2
4899008|NCT00631007|16879607|P5|Overall Study|Physician Decision|0
4899009|NCT00631007|16879608|P4|Overall Study|Physician Decision|0
4899010|NCT00631007|16879609|P3|Overall Study|Physician Decision|1
4899011|NCT00631007|16879610|P2|Overall Study|Physician Decision|0
4899012|NCT00631007|16879611|P1|Overall Study|Physician Decision|1
4899013|NCT00631007|16879606|P6|Overall Study|Lost to Follow-up|3
4899014|NCT00631007|16879607|P5|Overall Study|Lost to Follow-up|5
4899015|NCT00631007|16879608|P4|Overall Study|Lost to Follow-up|4
4899016|NCT00631007|16879609|P3|Overall Study|Lost to Follow-up|2
4899017|NCT00631007|16879610|P2|Overall Study|Lost to Follow-up|1
4899018|NCT00631007|16879611|P1|Overall Study|Lost to Follow-up|2
4899019|NCT00631007|16879606|P6|Overall Study|Adverse Event|2
4899020|NCT00631007|16879607|P5|Overall Study|Adverse Event|3
4899021|NCT00631007|16879608|P4|Overall Study|Adverse Event|2
4899022|NCT00631007|16879609|P3|Overall Study|Adverse Event|0
4899023|NCT00631007|16879610|P2|Overall Study|Adverse Event|2
4899024|NCT00631007|16879611|P1|Overall Study|Adverse Event|0
4899025|NCT00630994|16879631|P1|Overall Study|Other|1
4899026|NCT00630994|16879631|P1|Overall Study|Lack of Efficacy|1
4899027|NCT00630994|16879631|P1|Overall Study|Disease Progression|1
4899028|NCT00630994|16879631|P1|Overall Study|Adverse Event|1
4899029|NCT00630916|16879661|P1|Overall Study|Lack of Efficacy|3
4899030|NCT00630916|16879661|P1|Overall Study|Physician Decision|47
4899031|NCT00630916|16879661|P1|Overall Study|Protocol Violation|7
4899032|NCT00630916|16879661|P1|Overall Study|Withdrawal by Subject|30
4899033|NCT00630916|16879661|P1|Overall Study|Lost to Follow-up|5
4899034|NCT00630916|16879661|P1|Overall Study|Explant|8
4899035|NCT00630916|16879661|P1|Overall Study|Death|110
4899036|NCT00630877|16879671|P3|Overall Study|Personal reasons|1
4899037|NCT00630877|16879672|P2|Overall Study|Personal reasons|0
4899038|NCT00630877|16879673|P1|Overall Study|Personal reasons|0
4899039|NCT00630877|16879671|P3|Overall Study|Protocol violation|1
4899040|NCT00630877|16879672|P2|Overall Study|Protocol violation|0
4899041|NCT00630877|16879673|P1|Overall Study|Protocol violation|1
4899042|NCT00630877|16879671|P3|Overall Study|Noncompliance|1
4899043|NCT00630877|16879672|P2|Overall Study|Noncompliance|3
4899044|NCT00630877|16879673|P1|Overall Study|Noncompliance|2
4899045|NCT00630877|16879671|P3|Overall Study|Lost to Follow-up|0
4899046|NCT00630877|16879672|P2|Overall Study|Lost to Follow-up|0
4899047|NCT00630877|16879673|P1|Overall Study|Lost to Follow-up|2
4899048|NCT00630877|16879671|P3|Overall Study|Withdrawal by Subject|0
4899049|NCT00630877|16879672|P2|Overall Study|Withdrawal by Subject|4
4899050|NCT00630877|16879673|P1|Overall Study|Withdrawal by Subject|3
4899051|NCT00630877|16879671|P3|Overall Study|Adverse Event|7
4899052|NCT00630877|16879672|P2|Overall Study|Adverse Event|8
4899053|NCT00630877|16879673|P1|Overall Study|Adverse Event|11
4899054|NCT00630864|16879691|P1|Part 2 (After Week 6 up to Month 12)|Liver transplant|2
4899055|NCT00630864|16879691|P1|Part 1 (up to Week 6)|Adverse Event|1
4899056|NCT00630838|16879730|P2|Overall Study|Lost to Follow-up|1
4899057|NCT00630838|16879731|P1|Overall Study|Lost to Follow-up|0
4899058|NCT00630838|16879730|P2|Overall Study|Death|1
4899059|NCT00630838|16879731|P1|Overall Study|Death|0
4899060|NCT00630825|16879743|P4|Overall Study|Withdrawal by Subject|3
4899061|NCT00630825|16879744|P3|Overall Study|Withdrawal by Subject|2
4899062|NCT00630825|16879745|P2|Overall Study|Withdrawal by Subject|2
4899063|NCT00630825|16879746|P1|Overall Study|Withdrawal by Subject|2
4899064|NCT00630825|16879743|P4|Overall Study|Physician Decision|0
4899065|NCT00630825|16879744|P3|Overall Study|Physician Decision|0
4899066|NCT00630825|16879745|P2|Overall Study|Physician Decision|0
4899067|NCT00630825|16879746|P1|Overall Study|Physician Decision|1
4899068|NCT00630825|16879743|P4|Overall Study|Lost to Follow-up|1
4899069|NCT00630825|16879744|P3|Overall Study|Lost to Follow-up|1
4899070|NCT00630825|16879745|P2|Overall Study|Lost to Follow-up|1
4899071|NCT00630825|16879746|P1|Overall Study|Lost to Follow-up|1
4899072|NCT00630825|16879743|P4|Overall Study|Entry Criteria Not Met|1
4899073|NCT00630825|16879744|P3|Overall Study|Entry Criteria Not Met|2
4899074|NCT00630825|16879745|P2|Overall Study|Entry Criteria Not Met|0
4899075|NCT00630825|16879746|P1|Overall Study|Entry Criteria Not Met|1
4899076|NCT00630825|16879743|P4|Overall Study|Adverse Event|1
4899077|NCT00630825|16879744|P3|Overall Study|Adverse Event|3
4899078|NCT00630825|16879745|P2|Overall Study|Adverse Event|4
4899079|NCT00630825|16879746|P1|Overall Study|Adverse Event|4
4899080|NCT00630812|16879817|P2|Double Blind Treatment Period|Non-compliance|1
4899081|NCT00630812|16879818|P1|Double Blind Treatment Period|Non-compliance|0
4899082|NCT00630812|16879817|P2|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0
4899083|NCT00630812|16879818|P1|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1
4899084|NCT00630812|16879817|P2|Double Blind Treatment Period|Withdrawal by Subject|7
4899085|NCT00630812|16879818|P1|Double Blind Treatment Period|Withdrawal by Subject|13
4899086|NCT00630812|16879817|P2|Double Blind Treatment Period|Protocol Violation|0
4899087|NCT00630812|16879818|P1|Double Blind Treatment Period|Protocol Violation|1
4899088|NCT00630812|16879817|P2|Double Blind Treatment Period|Physician Decision|1
4899089|NCT00630812|16879818|P1|Double Blind Treatment Period|Physician Decision|2
4899090|NCT00630812|16879817|P2|Double Blind Treatment Period|Lost to Follow-up|0
4899091|NCT00630812|16879818|P1|Double Blind Treatment Period|Lost to Follow-up|1
4899092|NCT00630812|16879817|P2|Double Blind Treatment Period|Adverse Event|5
4899093|NCT00630812|16879818|P1|Double Blind Treatment Period|Adverse Event|13
4899094|NCT00630812|16879817|P2|Randomisation to First Dose|Protocol Violation|1
4899095|NCT00630812|16879818|P1|Randomisation to First Dose|Protocol Violation|4
4899096|NCT00630812|16879817|P2|Randomisation to First Dose|Lost to Follow-up|0
4899097|NCT00630812|16879818|P1|Randomisation to First Dose|Lost to Follow-up|1
4899098|NCT00630812|16879817|P2|Randomisation to First Dose|Withdrawal by Subject|3
4899099|NCT00630812|16879818|P1|Randomisation to First Dose|Withdrawal by Subject|2
4899100|NCT00630812|16879817|P2|Randomisation to First Dose|Adverse Event|1
4899101|NCT00630812|16879818|P1|Randomisation to First Dose|Adverse Event|1
4899102|NCT00630786|16879843|P3|Overall Study|Other|0
4899103|NCT00630786|16879844|P2|Overall Study|Other|0
4899104|NCT00630786|16879845|P1|Overall Study|Other|1
4899105|NCT00630786|16879843|P3|Overall Study|Lost to Follow-up|0
4899106|NCT00630786|16879844|P2|Overall Study|Lost to Follow-up|1
4899107|NCT00630786|16879845|P1|Overall Study|Lost to Follow-up|0
4899108|NCT00630786|16879843|P3|Overall Study|Withdrawal by Subject|1
4899109|NCT00630786|16879844|P2|Overall Study|Withdrawal by Subject|1
4899110|NCT00630786|16879845|P1|Overall Study|Withdrawal by Subject|0
4899111|NCT00630786|16879843|P3|Overall Study|Physician Decision|1
4899112|NCT00630786|16879844|P2|Overall Study|Physician Decision|0
4899113|NCT00630786|16879845|P1|Overall Study|Physician Decision|0
4899114|NCT00630747|16879864|P1|Overall Study|Returned to country of origin|1
4899115|NCT00630747|16879864|P1|Overall Study|Transferred to Study TKT031NPU|7
4899116|NCT00630747|16879864|P1|Overall Study|Death|1
4899117|NCT00630539|16879917|P4|Overall Study|Withdrawal by Subject|1
4899118|NCT00630539|16879918|P3|Overall Study|Withdrawal by Subject|0
4899119|NCT00630539|16879919|P2|Overall Study|Withdrawal by Subject|1
4899120|NCT00630539|16879920|P1|Overall Study|Withdrawal by Subject|0
4899121|NCT00630539|16879917|P4|Overall Study|Adverse Event|2
4899122|NCT00630539|16879918|P3|Overall Study|Adverse Event|1
4899123|NCT00630539|16879919|P2|Overall Study|Adverse Event|3
4899124|NCT00630539|16879920|P1|Overall Study|Adverse Event|1
4899125|NCT00630396|16880016|P1|Overall Study|Lost to Follow-up|3
4899126|NCT00630396|16880016|P1|Overall Study|Death|4
4899127|NCT00630344|16880022|P1|Overall Study|Other|1
4899128|NCT00630344|16880022|P1|Overall Study|Intercurrent Illness|1
4899129|NCT00630344|16880022|P1|Overall Study|Withdrawal by Subject|1
4899130|NCT00630344|16880022|P1|Overall Study|Physician Decision|9
4899131|NCT00630344|16880022|P1|Overall Study|Progressive Disease|19
4899132|NCT00630344|16880022|P1|Overall Study|Adverse Event|5
4899133|NCT00630331|16880034|P3|Overall Study|Protocol Violation|6
4899134|NCT00630331|16880035|P2|Overall Study|Protocol Violation|5
4899135|NCT00630331|16880036|P1|Overall Study|Protocol Violation|4
4899136|NCT00630331|16880034|P3|Overall Study|Unable to classify|3
4899137|NCT00630331|16880035|P2|Overall Study|Unable to classify|4
4899138|NCT00630331|16880036|P1|Overall Study|Unable to classify|9
4899139|NCT00630331|16880034|P3|Overall Study|Inappropriate enrollment|3
4899140|NCT00630331|16880035|P2|Overall Study|Inappropriate enrollment|6
4899141|NCT00630331|16880036|P1|Overall Study|Inappropriate enrollment|3
4899142|NCT00630331|16880034|P3|Overall Study|Lost to Follow-up|170
4899143|NCT00630331|16880035|P2|Overall Study|Lost to Follow-up|143
4899144|NCT00630331|16880036|P1|Overall Study|Lost to Follow-up|175
4899145|NCT00630331|16880034|P3|Overall Study|Withdrawal by Subject|5
4899146|NCT00630331|16880035|P2|Overall Study|Withdrawal by Subject|7
4899147|NCT00630331|16880036|P1|Overall Study|Withdrawal by Subject|12
4899148|NCT00630331|16880034|P3|Overall Study|Adverse Event|0
4899149|NCT00630331|16880035|P2|Overall Study|Adverse Event|0
4899150|NCT00630331|16880036|P1|Overall Study|Adverse Event|1
4899151|NCT00630331|16880034|P3|Overall Study|Death|1
4899152|NCT00630331|16880035|P2|Overall Study|Death|1
4899153|NCT00630331|16880036|P1|Overall Study|Death|2
4899154|NCT00630305|16880077|P1|Overall Study|Inability to insert contact lens|1
4899155|NCT00630305|16880077|P1|Overall Study|Withdrawal by Subject|1
4899156|NCT00630292|16880099|P1|Overall Study|Withdrawal by Subject|1
4899157|NCT00630058|16880105|P2|Overall Study|stopping criteria|2
4899158|NCT00630058|16880106|P1|Overall Study|stopping criteria|3
4899159|NCT00630058|16880105|P2|Overall Study|Withdrawal by Subject|1
4899160|NCT00630058|16880106|P1|Overall Study|Withdrawal by Subject|0
4899161|NCT00630058|16880105|P2|Overall Study|Adverse Event|1
4899162|NCT00630058|16880106|P1|Overall Study|Adverse Event|1
4899163|NCT00629772|16880137|P2|Second Intervention Week 14 - Week 26|Lack of Efficacy|1
4899164|NCT00629772|16880138|P1|Second Intervention Week 14 - Week 26|Lack of Efficacy|0
4899165|NCT00629772|16880137|P2|Second Intervention Week 14 - Week 26|Adverse Event|1
4899166|NCT00629772|16880138|P1|Second Intervention Week 14 - Week 26|Adverse Event|1
4899167|NCT00629707|16880158|P2|Overall Study|Physician Decision|1
4899168|NCT00629707|16880159|P1|Overall Study|Physician Decision|0
4899169|NCT00629707|16880158|P2|Overall Study|Withdrawal by Subject|1
4899170|NCT00629707|16880159|P1|Overall Study|Withdrawal by Subject|0
4899171|NCT00629265|16880179|P2|Overall Study|Unknown Reason|2
4899172|NCT00629265|16880180|P1|Overall Study|Unknown Reason|2
4899173|NCT00629265|16880179|P2|Overall Study|Unrelated Medical Complications|1
4899174|NCT00629265|16880180|P1|Overall Study|Unrelated Medical Complications|3
4899175|NCT00629265|16880179|P2|Overall Study|Needed Esophageal Dilation|1
4899176|NCT00629265|16880180|P1|Overall Study|Needed Esophageal Dilation|4
4899177|NCT00629265|16880179|P2|Overall Study|Other CA Requiring Treatment|3
4899178|NCT00629265|16880180|P1|Overall Study|Other CA Requiring Treatment|1
4899179|NCT00629265|16880179|P2|Overall Study|HNC Recurrence|0
4899180|NCT00629265|16880180|P1|Overall Study|HNC Recurrence|4
4899181|NCT00629265|16880179|P2|Overall Study|Adverse Event|0
4899182|NCT00629265|16880180|P1|Overall Study|Adverse Event|2
4899183|NCT00629265|16880179|P2|Overall Study|Death|0
4899184|NCT00629265|16880180|P1|Overall Study|Death|1
4899185|NCT00629265|16880179|P2|Overall Study|Withdrawal by Subject|8
4899186|NCT00629265|16880180|P1|Overall Study|Withdrawal by Subject|11
4899187|NCT00629265|16880179|P2|Overall Study|Lost to Follow-up|5
4899188|NCT00629265|16880180|P1|Overall Study|Lost to Follow-up|4
4899189|NCT00629239|16880190|P2|Overall Study|Physician Decision|0
4899190|NCT00629239|16880191|P1|Overall Study|Physician Decision|1
4899191|NCT00629239|16880190|P2|Overall Study|Adverse Event|4
4899192|NCT00629239|16880191|P1|Overall Study|Adverse Event|7
4899193|NCT00629083|16880244|P2|Overall Study|Refused to return for 12 month visit|0
4899194|NCT00629083|16880245|P1|Overall Study|Refused to return for 12 month visit|1
4899195|NCT00629083|16880244|P2|Overall Study|Moved out of country/state|1
4899196|NCT00629083|16880245|P1|Overall Study|Moved out of country/state|2
4899197|NCT00629083|16880244|P2|Overall Study|Lost to Follow-up|8
4899198|NCT00629083|16880245|P1|Overall Study|Lost to Follow-up|12
4899199|NCT00629083|16880244|P2|Overall Study|Withdrawal by Subject|2
4899200|NCT00629083|16880245|P1|Overall Study|Withdrawal by Subject|10
4899201|NCT00629083|16880244|P2|Overall Study|Lack of Efficacy|1
4899202|NCT00629083|16880245|P1|Overall Study|Lack of Efficacy|3
4899203|NCT00629083|16880244|P2|Overall Study|Adverse Event|2
4899204|NCT00629083|16880245|P1|Overall Study|Adverse Event|0
4899205|NCT00628927|16880276|P2|Overall Study|Equipment failure|0
4899206|NCT00628927|16880277|P1|Overall Study|Equipment failure|1
4899207|NCT00628927|16880276|P2|Overall Study|Lost to Follow-up|0
4899208|NCT00628927|16880277|P1|Overall Study|Lost to Follow-up|1
4899209|NCT00628927|16880276|P2|Overall Study|Problems performing blood draw|0
4899210|NCT00628927|16880277|P1|Overall Study|Problems performing blood draw|6
4899211|NCT00628862|16880322|P3|Overall Study|COPD Exacerbation|0
4899212|NCT00628862|16880323|P2|Overall Study|COPD Exacerbation|1
4899213|NCT00628862|16880324|P1|Overall Study|COPD Exacerbation|0
4899214|NCT00628862|16880322|P3|Overall Study|Protocol Violation|0
4899215|NCT00628862|16880323|P2|Overall Study|Protocol Violation|0
4899216|NCT00628862|16880324|P1|Overall Study|Protocol Violation|1
4899217|NCT00628862|16880322|P3|Overall Study|Lost to Follow-up|1
4899218|NCT00628862|16880323|P2|Overall Study|Lost to Follow-up|2
4899219|NCT00628862|16880324|P1|Overall Study|Lost to Follow-up|0
4899220|NCT00628862|16880322|P3|Overall Study|Withdrawal by Subject|11
4899221|NCT00628862|16880323|P2|Overall Study|Withdrawal by Subject|6
4899222|NCT00628862|16880324|P1|Overall Study|Withdrawal by Subject|4
4899223|NCT00628862|16880322|P3|Overall Study|Adverse Event|10
4899224|NCT00628862|16880323|P2|Overall Study|Adverse Event|8
4899225|NCT00628862|16880324|P1|Overall Study|Adverse Event|6
4899226|NCT00628758|16880370|P2|Overall Study|Treatment Failure|2
4899227|NCT00628758|16880371|P1|Overall Study|Treatment Failure|0
4899228|NCT00628758|16880370|P2|Overall Study|Investigator Moved|0
4899229|NCT00628758|16880371|P1|Overall Study|Investigator Moved|3
4899230|NCT00628758|16880370|P2|Overall Study|Pregnancy|2
4899231|NCT00628758|16880371|P1|Overall Study|Pregnancy|2
4899232|NCT00628758|16880370|P2|Overall Study|Lost to Follow-up|31
4899233|NCT00628758|16880371|P1|Overall Study|Lost to Follow-up|25
4899234|NCT00628758|16880370|P2|Overall Study|Protocol Violation|1
4899235|NCT00628758|16880371|P1|Overall Study|Protocol Violation|5
4899236|NCT00628758|16880370|P2|Overall Study|Death|0
4899237|NCT00628758|16880371|P1|Overall Study|Death|1
4899238|NCT00628758|16880370|P2|Overall Study|Withdrawal by Subject|3
4899239|NCT00628758|16880371|P1|Overall Study|Withdrawal by Subject|6
4899240|NCT00628758|16880370|P2|Overall Study|Adverse Event|3
4899241|NCT00628758|16880371|P1|Overall Study|Adverse Event|2
4899242|NCT00628446|16880415|P1|Overall Study|Protocol Violation|3
4899243|NCT00628446|16880415|P1|Overall Study|Withdrawal by Subject|1
4899244|NCT00628446|16880415|P1|Overall Study|Lost to Follow-up|3
4899245|NCT00628355|16880447|P2|Overall Study|Withdrawal by Subject|1
4899246|NCT00628355|16880448|P1|Overall Study|Withdrawal by Subject|1
4899247|NCT00628251|16880459|P3|Ongoing Initial Study Treatment at DCO|Other|2
4899248|NCT00628251|16880460|P2|Ongoing Initial Study Treatment at DCO|Other|0
4899249|NCT00628251|16880461|P1|Ongoing Initial Study Treatment at DCO|Other|1
4899250|NCT00628251|16880459|P3|Ongoing Initial Study Treatment at DCO|Other reason|6
4899251|NCT00628251|16880460|P2|Ongoing Initial Study Treatment at DCO|Other reason|1
4899252|NCT00628251|16880461|P1|Ongoing Initial Study Treatment at DCO|Other reason|0
4899253|NCT00628251|16880459|P3|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
4899254|NCT00628251|16880460|P2|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2
4899255|NCT00628251|16880461|P1|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1
4899256|NCT00628251|16880459|P3|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13
4899257|NCT00628251|16880460|P2|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15
4899258|NCT00628251|16880461|P1|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19
4899259|NCT00628251|16880459|P3|Ongoing Initial Study Treatment at DCO|Adverse Event|3
4899260|NCT00628251|16880460|P2|Ongoing Initial Study Treatment at DCO|Adverse Event|2
4899261|NCT00628251|16880461|P1|Ongoing Initial Study Treatment at DCO|Adverse Event|1
4899262|NCT00628251|16880459|P3|Randomised Part|Withdrawal by Subject|1
4899263|NCT00628251|16880460|P2|Randomised Part|Withdrawal by Subject|0
4899264|NCT00628251|16880461|P1|Randomised Part|Withdrawal by Subject|0
4899265|NCT00628212|16880507|P4|Overall Study|Physician Decision|3
4899266|NCT00628212|16880508|P3|Overall Study|Physician Decision|2
4899267|NCT00628212|16880509|P2|Overall Study|Physician Decision|1
4899268|NCT00628212|16880510|P1|Overall Study|Physician Decision|1
4899269|NCT00628212|16880507|P4|Overall Study|Adverse Event|2
4899270|NCT00628212|16880508|P3|Overall Study|Adverse Event|1
4899271|NCT00628212|16880509|P2|Overall Study|Adverse Event|0
4899272|NCT00628212|16880510|P1|Overall Study|Adverse Event|2
4899273|NCT00628108|16880558|P2|Overall Study|Withdrawal by Subject|0
4899274|NCT00628108|16880559|P1|Overall Study|Withdrawal by Subject|1
4899275|NCT00628108|16880558|P2|Overall Study|Adverse Event|3
4899276|NCT00628108|16880559|P1|Overall Study|Adverse Event|0
4899277|NCT00628030|16880591|P2|Post to 6 Month Follow-up|Lost to Follow-up|30
4899278|NCT00628030|16880592|P1|Post to 6 Month Follow-up|Lost to Follow-up|32
4899279|NCT00628030|16880591|P2|Baseline to Post-Assessment|Withdrawal by Subject|0
4899280|NCT00628030|16880592|P1|Baseline to Post-Assessment|Withdrawal by Subject|5
4899281|NCT00628030|16880591|P2|Baseline to Post-Assessment|Lost to Follow-up|29
4899282|NCT00628030|16880592|P1|Baseline to Post-Assessment|Lost to Follow-up|28
4899283|NCT00627926|16880618|P3|Overall Study|Noncompliance/unspecified|17
4899284|NCT00627926|16880619|P2|Overall Study|Noncompliance/unspecified|23
4899285|NCT00627926|16880620|P1|Overall Study|Noncompliance/unspecified|8
4899286|NCT00627926|16880618|P3|Overall Study|Lack of Efficacy|38
4899287|NCT00627926|16880619|P2|Overall Study|Lack of Efficacy|40
4899288|NCT00627926|16880620|P1|Overall Study|Lack of Efficacy|118
4899289|NCT00627926|16880618|P3|Overall Study|Withdrawal by Subject|0
4899290|NCT00627926|16880619|P2|Overall Study|Withdrawal by Subject|1
4899291|NCT00627926|16880620|P1|Overall Study|Withdrawal by Subject|2
4899292|NCT00627926|16880618|P3|Overall Study|Lost to Follow-up|4
4899293|NCT00627926|16880619|P2|Overall Study|Lost to Follow-up|3
4899294|NCT00627926|16880620|P1|Overall Study|Lost to Follow-up|4
4899295|NCT00627926|16880618|P3|Overall Study|Death|0
4899296|NCT00627926|16880619|P2|Overall Study|Death|0
4899297|NCT00627926|16880620|P1|Overall Study|Death|1
4899298|NCT00627926|16880618|P3|Overall Study|Adverse Event|36
4899299|NCT00627926|16880619|P2|Overall Study|Adverse Event|37
4899300|NCT00627926|16880620|P1|Overall Study|Adverse Event|26
4899301|NCT00627705|16880672|P2|Overall Study|Lost to Follow-up|1
4899302|NCT00627705|16880673|P1|Overall Study|Lost to Follow-up|0
4899303|NCT00627705|16880672|P2|Overall Study|Withdrawal by Subject|2
4899304|NCT00627705|16880673|P1|Overall Study|Withdrawal by Subject|0
4899305|NCT00627705|16880672|P2|Overall Study|Adverse Event|0
4899306|NCT00627705|16880673|P1|Overall Study|Adverse Event|1
4899307|NCT00627705|16880672|P2|Overall Study|Unwilling to take the compound (taste)|3
4899308|NCT00627705|16880673|P1|Overall Study|Unwilling to take the compound (taste)|1
4899309|NCT00627523|16880724|P2|Overall Study|Other|0
4899310|NCT00627523|16880725|P1|Overall Study|Other|1
4899311|NCT00627523|16880724|P2|Overall Study|Withdrawal by Subject|2
4899312|NCT00627523|16880725|P1|Overall Study|Withdrawal by Subject|0
4899313|NCT00627523|16880724|P2|Overall Study|Lack of Efficacy|0
4899314|NCT00627523|16880725|P1|Overall Study|Lack of Efficacy|1
4899315|NCT00627497|16880753|P4|Overall Study|Lost to Follow-up|0
4899316|NCT00627497|16880754|P3|Overall Study|Lost to Follow-up|0
4899317|NCT00627497|16880755|P2|Overall Study|Lost to Follow-up|1
4899318|NCT00627497|16880756|P1|Overall Study|Lost to Follow-up|1
4899319|NCT00627458|16880817|P3|Overall Study|Lost to Follow-up|0
4899320|NCT00627458|16880818|P2|Overall Study|Lost to Follow-up|1
4899321|NCT00627458|16880819|P1|Overall Study|Lost to Follow-up|1
4899322|NCT00627458|16880817|P3|Overall Study|Withdrawal by Subject|5
4899323|NCT00627458|16880818|P2|Overall Study|Withdrawal by Subject|6
4899324|NCT00627458|16880819|P1|Overall Study|Withdrawal by Subject|2
4899325|NCT00627458|16880817|P3|Overall Study|Migrated from study area|1
4899326|NCT00627458|16880818|P2|Overall Study|Migrated from study area|0
4899327|NCT00627458|16880819|P1|Overall Study|Migrated from study area|1
4899328|NCT00627445|16880894|P2|Overall Study|Other|8
4899329|NCT00627445|16880895|P1|Overall Study|Other|6
4899330|NCT00627445|16880894|P2|Overall Study|Lack of Efficacy|1
4899331|NCT00627445|16880895|P1|Overall Study|Lack of Efficacy|0
4899332|NCT00627445|16880894|P2|Overall Study|Adverse Event|3
4899333|NCT00627445|16880895|P1|Overall Study|Adverse Event|3
4899334|NCT00627393|16880938|P2|Per-Protocol Analysis|Withdrawal by patient/family/physician|10
4899335|NCT00627393|16880939|P1|Per-Protocol Analysis|Withdrawal by patient/family/physician|4
4899336|NCT00627393|16880938|P2|Per-Protocol Analysis|Received unstimulated/no granulocytes|3
4899337|NCT00627393|16880939|P1|Per-Protocol Analysis|Received unstimulated/no granulocytes|6
4899338|NCT00627393|16880938|P2|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5
4899339|NCT00627393|16880939|P1|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4
4899340|NCT00627393|16880938|P2|Intention-To-Treat Analysis|Adjudication indeterminate|3
4899341|NCT00627393|16880939|P1|Intention-To-Treat Analysis|Adjudication indeterminate|5
4899342|NCT00627094|16880975|P2|Overall Study|Other reason|0
4899343|NCT00627094|16880976|P1|Overall Study|Other reason|1
4899344|NCT00627094|16880975|P2|Overall Study|ulcer healed|7
4899345|NCT00627094|16880976|P1|Overall Study|ulcer healed|1
4899346|NCT00627094|16880975|P2|Overall Study|Withdrawal by Subject|1
4899347|NCT00627094|16880976|P1|Overall Study|Withdrawal by Subject|1
4899348|NCT00627094|16880975|P2|Overall Study|Lost to Follow-up|0
4899349|NCT00627094|16880976|P1|Overall Study|Lost to Follow-up|1
4899350|NCT00627094|16880975|P2|Overall Study|Adverse Event|7
4899351|NCT00627094|16880976|P1|Overall Study|Adverse Event|8
4899352|NCT00627042|16880988|P1|Overall Study|Withdrawal by Subject|2
4899353|NCT00627016|16881000|P2|Overall Study|Pregnancy|0
4899354|NCT00627016|16881001|P1|Overall Study|Pregnancy|1
4899355|NCT00627016|16881000|P2|Overall Study|Placed on Excluded Drugs|0
4899356|NCT00627016|16881001|P1|Overall Study|Placed on Excluded Drugs|1
4899357|NCT00627016|16881000|P2|Overall Study|Lack of Efficacy|0
4899358|NCT00627016|16881001|P1|Overall Study|Lack of Efficacy|1
4899359|NCT00627016|16881000|P2|Overall Study|Failed Inclusion/Exclusion Criteria|1
4899360|NCT00627016|16881001|P1|Overall Study|Failed Inclusion/Exclusion Criteria|0
4899361|NCT00627016|16881000|P2|Overall Study|Withdrawal by Subject|1
4899362|NCT00627016|16881001|P1|Overall Study|Withdrawal by Subject|2
4899363|NCT00627016|16881000|P2|Overall Study|Lost to Follow-up|1
4899364|NCT00627016|16881001|P1|Overall Study|Lost to Follow-up|0
4899365|NCT00627016|16881000|P2|Overall Study|Protocol Violation|2
4899366|NCT00627016|16881001|P1|Overall Study|Protocol Violation|0
4899367|NCT00627016|16881000|P2|Overall Study|Adverse Event|1
4899368|NCT00627016|16881001|P1|Overall Study|Adverse Event|1
4899369|NCT00626925|16881013|P2|Overall Study|Time constraints|1
4899370|NCT00626925|16881014|P1|Overall Study|Time constraints|3
4899371|NCT00626925|16881013|P2|Overall Study|Lack of Efficacy|4
4899372|NCT00626925|16881014|P1|Overall Study|Lack of Efficacy|1
4899373|NCT00626925|16881013|P2|Overall Study|Adverse effect|2
4899374|NCT00626925|16881014|P1|Overall Study|Adverse effect|6
4899375|NCT00626925|16881013|P2|Overall Study|relapse|0
4899376|NCT00626925|16881014|P1|Overall Study|relapse|1
4899377|NCT00626925|16881013|P2|Overall Study|Lost to Follow-up|2
4899378|NCT00626925|16881014|P1|Overall Study|Lost to Follow-up|1
4899379|NCT00626821|16881061|P1|Overall Study|other/unknown reason|104
4899380|NCT00626821|16881061|P1|Overall Study|Product dysfunction|21
4899381|NCT00626821|16881061|P1|Overall Study|Physician Decision|9
4899382|NCT00626821|16881061|P1|Overall Study|Withdrawal by Subject|10
4899383|NCT00626821|16881061|P1|Overall Study|Protocol Violation|33
4899384|NCT00626821|16881061|P1|Overall Study|Adverse Event|44
4899385|NCT00626795|16881141|P3|Blinded Treatment|Missing reason for withdrawal|5
4899386|NCT00626795|16881142|P2|Blinded Treatment|Missing reason for withdrawal|3
4899387|NCT00626795|16881143|P1|Blinded Treatment|Missing reason for withdrawal|5
4899388|NCT00626795|16881141|P3|Blinded Treatment|Other reasons|2
4899389|NCT00626795|16881142|P2|Blinded Treatment|Other reasons|0
4899390|NCT00626795|16881143|P1|Blinded Treatment|Other reasons|2
4899391|NCT00626795|16881141|P3|Blinded Treatment|Withdrawal by Subject|0
4899392|NCT00626795|16881142|P2|Blinded Treatment|Withdrawal by Subject|1
4899393|NCT00626795|16881143|P1|Blinded Treatment|Withdrawal by Subject|1
4899394|NCT00626795|16881141|P3|Blinded Treatment|Protocol Violation|1
4899395|NCT00626795|16881142|P2|Blinded Treatment|Protocol Violation|1
4899396|NCT00626795|16881143|P1|Blinded Treatment|Protocol Violation|0
4899397|NCT00626795|16881141|P3|Blinded Treatment|Unacceptable adverse event|1
4899398|NCT00626795|16881142|P2|Blinded Treatment|Unacceptable adverse event|0
4899399|NCT00626795|16881143|P1|Blinded Treatment|Unacceptable adverse event|0
4899400|NCT00626795|16881141|P3|Blinded Treatment|Lack of Efficacy|0
4899401|NCT00626795|16881142|P2|Blinded Treatment|Lack of Efficacy|0
4899402|NCT00626795|16881143|P1|Blinded Treatment|Lack of Efficacy|2
4899403|NCT00626795|16881141|P3|Open-label TD1414 Cream TID Treatment|Adverse Event|0
4899404|NCT00626795|16881142|P2|Open-label TD1414 Cream TID Treatment|Adverse Event|1
4899405|NCT00626795|16881143|P1|Open-label TD1414 Cream TID Treatment|Adverse Event|0
4899406|NCT00626639|16881194|P2|Overall Study|Occurrence of grade 3 oral mucositis|2
4899407|NCT00626639|16881195|P1|Overall Study|Occurrence of grade 3 oral mucositis|2
4899408|NCT00626561|16881241|P1|Overall Study|Disease Progression|2
4899409|NCT00626561|16881241|P1|Overall Study|Withdrawal by Subject|2
4899410|NCT00626548|16881247|P2|Overall Study|Other termination reason|613
4899411|NCT00626548|16881248|P1|Overall Study|Other termination reason|493
4899412|NCT00626548|16881247|P2|Overall Study|Lost to Follow-up|2
4899413|NCT00626548|16881248|P1|Overall Study|Lost to Follow-up|2
4899414|NCT00626548|16881247|P2|Overall Study|Protocol Violation|11
4899415|NCT00626548|16881248|P1|Overall Study|Protocol Violation|4
4899416|NCT00626548|16881247|P2|Overall Study|Withdrawal by Subject|46
4899417|NCT00626548|16881248|P1|Overall Study|Withdrawal by Subject|42
4899418|NCT00626548|16881247|P2|Overall Study|Adverse Event|44
4899419|NCT00626548|16881248|P1|Overall Study|Adverse Event|164
4899420|NCT00626522|16881262|P6|Overall Study|Non-fulfilment of in/exclusion criteria|0
4899421|NCT00626522|16881263|P5|Overall Study|Non-fulfilment of in/exclusion criteria|0
4899422|NCT00626522|16881264|P4|Overall Study|Non-fulfilment of in/exclusion criteria|1
4899423|NCT00626522|16881265|P3|Overall Study|Non-fulfilment of in/exclusion criteria|1
4899424|NCT00626522|16881266|P2|Overall Study|Non-fulfilment of in/exclusion criteria|0
4899425|NCT00626522|16881267|P1|Overall Study|Non-fulfilment of in/exclusion criteria|1
4899426|NCT00626522|16881262|P6|Overall Study|Inconsistent reason reported|0
4899427|NCT00626522|16881263|P5|Overall Study|Inconsistent reason reported|0
4899428|NCT00626522|16881264|P4|Overall Study|Inconsistent reason reported|0
4899429|NCT00626522|16881265|P3|Overall Study|Inconsistent reason reported|0
4899430|NCT00626522|16881266|P2|Overall Study|Inconsistent reason reported|0
4899431|NCT00626522|16881267|P1|Overall Study|Inconsistent reason reported|1
4899432|NCT00626522|16881262|P6|Overall Study|Lost to Follow-up|0
4899433|NCT00626522|16881263|P5|Overall Study|Lost to Follow-up|0
4899434|NCT00626522|16881264|P4|Overall Study|Lost to Follow-up|0
4899435|NCT00626522|16881265|P3|Overall Study|Lost to Follow-up|0
4899436|NCT00626522|16881266|P2|Overall Study|Lost to Follow-up|1
4899437|NCT00626522|16881267|P1|Overall Study|Lost to Follow-up|0
4899438|NCT00626522|16881262|P6|Overall Study|COPD exacerbation|0
4899439|NCT00626522|16881263|P5|Overall Study|COPD exacerbation|1
4899440|NCT00626522|16881264|P4|Overall Study|COPD exacerbation|1
4899441|NCT00626522|16881265|P3|Overall Study|COPD exacerbation|0
4899442|NCT00626522|16881266|P2|Overall Study|COPD exacerbation|0
4899443|NCT00626522|16881267|P1|Overall Study|COPD exacerbation|0
4899444|NCT00626522|16881262|P6|Overall Study|Withdrawal by Subject|1
4899445|NCT00626522|16881263|P5|Overall Study|Withdrawal by Subject|4
4899446|NCT00626522|16881264|P4|Overall Study|Withdrawal by Subject|0
4899447|NCT00626522|16881265|P3|Overall Study|Withdrawal by Subject|5
4899448|NCT00626522|16881266|P2|Overall Study|Withdrawal by Subject|5
4899449|NCT00626522|16881267|P1|Overall Study|Withdrawal by Subject|2
4899450|NCT00626522|16881262|P6|Overall Study|Adverse Event|1
4899451|NCT00626522|16881263|P5|Overall Study|Adverse Event|1
4899452|NCT00626522|16881264|P4|Overall Study|Adverse Event|0
4899453|NCT00626522|16881265|P3|Overall Study|Adverse Event|2
4899454|NCT00626522|16881266|P2|Overall Study|Adverse Event|1
4899455|NCT00626522|16881267|P1|Overall Study|Adverse Event|2
4899456|NCT00626522|16881262|P6|Overall Study|Protocol Violation|0
4899457|NCT00626522|16881263|P5|Overall Study|Protocol Violation|1
4899458|NCT00626522|16881264|P4|Overall Study|Protocol Violation|0
4899459|NCT00626522|16881265|P3|Overall Study|Protocol Violation|0
4899460|NCT00626522|16881266|P2|Overall Study|Protocol Violation|0
4899461|NCT00626522|16881267|P1|Overall Study|Protocol Violation|0
4899462|NCT00626405|16881330|P2|Overall Study|Withdrawal by Subject|1
4899463|NCT00626405|16881331|P1|Overall Study|Withdrawal by Subject|0
4899464|NCT00626405|16881330|P2|Overall Study|Deemed Ineligible|0
4899465|NCT00626405|16881331|P1|Overall Study|Deemed Ineligible|1
4899466|NCT00626392|16881347|P6|Coadministration Period|Other|1
4899467|NCT00626392|16881348|P5|Coadministration Period|Other|1
4899468|NCT00626392|16881349|P4|Coadministration Period|Other|1
4899469|NCT00626392|16881350|P3|Coadministration Period|Other|3
4899470|NCT00626392|16881351|P2|Coadministration Period|Other|2
4899471|NCT00626392|16881352|P1|Coadministration Period|Other|0
4899472|NCT00626392|16881347|P6|Coadministration Period|Protocol Violation|0
4899473|NCT00626392|16881348|P5|Coadministration Period|Protocol Violation|1
4899474|NCT00626392|16881349|P4|Coadministration Period|Protocol Violation|1
4899475|NCT00626392|16881350|P3|Coadministration Period|Protocol Violation|0
4899476|NCT00626392|16881351|P2|Coadministration Period|Protocol Violation|1
4899477|NCT00626392|16881352|P1|Coadministration Period|Protocol Violation|0
4899478|NCT00626392|16881347|P6|Coadministration Period|Withdrawal by Subject|1
4899479|NCT00626392|16881348|P5|Coadministration Period|Withdrawal by Subject|0
4899480|NCT00626392|16881349|P4|Coadministration Period|Withdrawal by Subject|1
4899481|NCT00626392|16881350|P3|Coadministration Period|Withdrawal by Subject|0
4899482|NCT00626392|16881351|P2|Coadministration Period|Withdrawal by Subject|1
4899483|NCT00626392|16881352|P1|Coadministration Period|Withdrawal by Subject|1
4899484|NCT00626392|16881347|P6|Coadministration Period|Adverse Event|4
4899485|NCT00626392|16881348|P5|Coadministration Period|Adverse Event|3
4899486|NCT00626392|16881349|P4|Coadministration Period|Adverse Event|4
4899487|NCT00626392|16881350|P3|Coadministration Period|Adverse Event|7
4899488|NCT00626392|16881351|P2|Coadministration Period|Adverse Event|1
4899489|NCT00626392|16881352|P1|Coadministration Period|Adverse Event|3
4899490|NCT00626392|16881347|P6|Run-in Period|Noncompliance|0
4899491|NCT00626392|16881348|P5|Run-in Period|Noncompliance|0
4899492|NCT00626392|16881349|P4|Run-in Period|Noncompliance|0
4899493|NCT00626392|16881350|P3|Run-in Period|Noncompliance|1
4899494|NCT00626392|16881351|P2|Run-in Period|Noncompliance|0
4899495|NCT00626392|16881352|P1|Run-in Period|Noncompliance|1
4899496|NCT00626392|16881347|P6|Run-in Period|Withdrawal by Subject|1
4899497|NCT00626392|16881348|P5|Run-in Period|Withdrawal by Subject|3
4899498|NCT00626392|16881349|P4|Run-in Period|Withdrawal by Subject|1
4899499|NCT00626392|16881350|P3|Run-in Period|Withdrawal by Subject|1
4899500|NCT00626392|16881351|P2|Run-in Period|Withdrawal by Subject|1
4899501|NCT00626392|16881352|P1|Run-in Period|Withdrawal by Subject|0
4899502|NCT00626392|16881347|P6|Run-in Period|Adverse Event|0
4899503|NCT00626392|16881348|P5|Run-in Period|Adverse Event|1
4899504|NCT00626392|16881349|P4|Run-in Period|Adverse Event|0
4899505|NCT00626392|16881350|P3|Run-in Period|Adverse Event|1
4899506|NCT00626392|16881351|P2|Run-in Period|Adverse Event|0
4899507|NCT00626392|16881352|P1|Run-in Period|Adverse Event|0
4899508|NCT00626327|16881380|P3|Overall Study|Protocol Violation|26
4899509|NCT00626327|16881381|P2|Overall Study|Protocol Violation|4
4899510|NCT00626327|16881382|P1|Overall Study|Protocol Violation|26
4899511|NCT00626327|16881380|P3|Overall Study|Administrative Reason|6
4899512|NCT00626327|16881381|P2|Overall Study|Administrative Reason|0
4899513|NCT00626327|16881382|P1|Overall Study|Administrative Reason|2
4899514|NCT00626327|16881380|P3|Overall Study|Inappropriate enrollment|3
4899515|NCT00626327|16881381|P2|Overall Study|Inappropriate enrollment|5
4899516|NCT00626327|16881382|P1|Overall Study|Inappropriate enrollment|4
4899517|NCT00626327|16881380|P3|Overall Study|Lost to Follow-up|23
4899518|NCT00626327|16881381|P2|Overall Study|Lost to Follow-up|21
4899519|NCT00626327|16881382|P1|Overall Study|Lost to Follow-up|24
4899520|NCT00626327|16881380|P3|Overall Study|Adverse Event|0
4899521|NCT00626327|16881381|P2|Overall Study|Adverse Event|0
4899522|NCT00626327|16881382|P1|Overall Study|Adverse Event|1
4899523|NCT00626327|16881380|P3|Overall Study|Withdrawal by Subject|30
4899524|NCT00626327|16881381|P2|Overall Study|Withdrawal by Subject|29
4899525|NCT00626327|16881382|P1|Overall Study|Withdrawal by Subject|21
4899526|NCT00626275|16881408|P8|Part B|Withdrawal by Subject|1
4899527|NCT00626275|16881409|P7|Part B|Withdrawal by Subject|0
4899528|NCT00626275|16881410|P6|Part B|Withdrawal by Subject|0
4899529|NCT00626275|16881411|P5|Part B|Withdrawal by Subject|0
4899530|NCT00626275|16881412|P4|Part B|Withdrawal by Subject|0
4899531|NCT00626275|16881413|P3|Part B|Withdrawal by Subject|0
4899532|NCT00626275|16881414|P2|Part B|Withdrawal by Subject|0
4899533|NCT00626275|16881415|P1|Part B|Withdrawal by Subject|0
4899534|NCT00626275|16881408|P8|Part B|Lost to Follow-up|0
4899535|NCT00626275|16881409|P7|Part B|Lost to Follow-up|1
4899536|NCT00626275|16881410|P6|Part B|Lost to Follow-up|0
4899537|NCT00626275|16881411|P5|Part B|Lost to Follow-up|0
4899538|NCT00626275|16881412|P4|Part B|Lost to Follow-up|0
4899539|NCT00626275|16881413|P3|Part B|Lost to Follow-up|0
4899540|NCT00626275|16881414|P2|Part B|Lost to Follow-up|0
4899541|NCT00626275|16881415|P1|Part B|Lost to Follow-up|0
4899542|NCT00626275|16881408|P8|Part A - Treatment Period 1|Withdrawal by Subject|0
4899543|NCT00626275|16881409|P7|Part A - Treatment Period 1|Withdrawal by Subject|0
4899544|NCT00626275|16881410|P6|Part A - Treatment Period 1|Withdrawal by Subject|0
4899545|NCT00626275|16881411|P5|Part A - Treatment Period 1|Withdrawal by Subject|0
4899546|NCT00626275|16881412|P4|Part A - Treatment Period 1|Withdrawal by Subject|0
4899547|NCT00626275|16881413|P3|Part A - Treatment Period 1|Withdrawal by Subject|1
4899548|NCT00626275|16881414|P2|Part A - Treatment Period 1|Withdrawal by Subject|0
4899549|NCT00626275|16881415|P1|Part A - Treatment Period 1|Withdrawal by Subject|0
4899550|NCT00626275|16881408|P8|Part A - Treatment Period 1|Adverse Event|0
4899551|NCT00626275|16881409|P7|Part A - Treatment Period 1|Adverse Event|0
4899552|NCT00626275|16881410|P6|Part A - Treatment Period 1|Adverse Event|0
4899553|NCT00626275|16881411|P5|Part A - Treatment Period 1|Adverse Event|0
4899554|NCT00626275|16881412|P4|Part A - Treatment Period 1|Adverse Event|0
4899555|NCT00626275|16881413|P3|Part A - Treatment Period 1|Adverse Event|0
4899556|NCT00626275|16881414|P2|Part A - Treatment Period 1|Adverse Event|0
4899557|NCT00626275|16881415|P1|Part A - Treatment Period 1|Adverse Event|1
4899558|NCT00626093|16881459|P1|Overall Study|One of the required devices not implante|6
4899559|NCT00626093|16881459|P1|Overall Study|Protocol Violation|1
4899560|NCT00626093|16881459|P1|Overall Study|Withdrawal by Subject|6
4899561|NCT00626093|16881459|P1|Overall Study|Physician Decision|4
4899562|NCT00626093|16881459|P1|Overall Study|Death|1
4899563|NCT00626093|16881459|P1|Overall Study|Lost to Follow-up|5
4899564|NCT00626028|16881466|P2|Overall Study|Inclusion/Exclusion Criteria|6
4899565|NCT00626028|16881467|P1|Overall Study|Inclusion/Exclusion Criteria|3
4899566|NCT00626028|16881466|P2|Overall Study|Physician Decision|1
4899567|NCT00626028|16881467|P1|Overall Study|Physician Decision|2
4899568|NCT00626028|16881466|P2|Overall Study|Device Failure|1
4899569|NCT00626028|16881467|P1|Overall Study|Device Failure|0
4899570|NCT00626028|16881466|P2|Overall Study|Adverse Event|1
4899571|NCT00626028|16881467|P1|Overall Study|Adverse Event|1
4899572|NCT00625872|16881491|P2|Overall Study|Randomized but not treated|1
4899573|NCT00625872|16881492|P1|Overall Study|Randomized but not treated|0
4899574|NCT00625872|16881491|P2|Overall Study|Terminated by sponsor|5
4899575|NCT00625872|16881492|P1|Overall Study|Terminated by sponsor|2
4899576|NCT00625872|16881491|P2|Overall Study|Does not meet inclusion criteria|0
4899577|NCT00625872|16881492|P1|Overall Study|Does not meet inclusion criteria|1
4899578|NCT00625872|16881491|P2|Overall Study|Withdrawal by Subject|0
4899579|NCT00625872|16881492|P1|Overall Study|Withdrawal by Subject|1
4899580|NCT00625846|16881606|P4|Overall Study|Withdrawal by Subject|2
4899581|NCT00625846|16881607|P3|Overall Study|Withdrawal by Subject|1
4899582|NCT00625846|16881608|P2|Overall Study|Withdrawal by Subject|0
4899583|NCT00625846|16881609|P1|Overall Study|Withdrawal by Subject|2
4899584|NCT00625820|16881635|P1|Overall Study|Withdrawal by Subject|1
4899585|NCT00625807|16881643|P2|Overall Study|schedule conflict|8
4899586|NCT00625807|16881644|P1|Overall Study|schedule conflict|2
4899587|NCT00625742|16881660|P1|Overall Study|Ineligible|1
4899588|NCT00625742|16881660|P1|Overall Study|Lost to Follow-up|4
4899589|NCT00625742|16881660|P1|Overall Study|Adverse Event|4
4899590|NCT00625742|16881660|P1|Overall Study|Withdrawal by Subject|1
4899591|NCT00625742|16881660|P1|Overall Study|Disease Progression|2
4899592|NCT00625586|16881679|P1|Overall Study|Adverse Event|1
4899593|NCT00625443|16881692|P3|Overall Study|Other|1
4899594|NCT00625443|16881693|P2|Overall Study|Other|1
4899595|NCT00625443|16881694|P1|Overall Study|Other|0
4899596|NCT00625443|16881692|P3|Overall Study|Physician Decision|2
4899597|NCT00625443|16881693|P2|Overall Study|Physician Decision|4
4899598|NCT00625443|16881694|P1|Overall Study|Physician Decision|0
4899599|NCT00625443|16881692|P3|Overall Study|Withdrawal by Subject|2
4899600|NCT00625443|16881693|P2|Overall Study|Withdrawal by Subject|1
4899601|NCT00625443|16881694|P1|Overall Study|Withdrawal by Subject|0
4899602|NCT00625443|16881692|P3|Overall Study|Platelet count increase >=500,000/mm3|0
4899603|NCT00625443|16881693|P2|Overall Study|Platelet count increase >=500,000/mm3|0
4899604|NCT00625443|16881694|P1|Overall Study|Platelet count increase >=500,000/mm3|1
4899605|NCT00625443|16881692|P3|Overall Study|Non-compliance with protocol|0
4899606|NCT00625443|16881693|P2|Overall Study|Non-compliance with protocol|1
4899607|NCT00625443|16881694|P1|Overall Study|Non-compliance with protocol|0
4899608|NCT00625443|16881692|P3|Overall Study|Adverse Event|0
4899609|NCT00625443|16881693|P2|Overall Study|Adverse Event|4
4899610|NCT00625443|16881694|P1|Overall Study|Adverse Event|1
4899611|NCT00625365|16881774|P1|Overall Study|VSD|1
4899612|NCT00625365|16881774|P1|Overall Study|No IV access|5
4899613|NCT00625365|16881774|P1|Overall Study|Withdrawal by Subject|1
4899614|NCT00625183|16881780|P1|Overall Study|Disease Progression|1
4899615|NCT00625131|16881791|P3|Overall Study|Withdrawal by Subject|5
4899616|NCT00625131|16881792|P2|Overall Study|Withdrawal by Subject|0
4899617|NCT00625131|16881793|P1|Overall Study|Withdrawal by Subject|1
4899618|NCT00625131|16881791|P3|Overall Study|Lost to Follow-up|0
4899619|NCT00625131|16881792|P2|Overall Study|Lost to Follow-up|2
4899620|NCT00625131|16881793|P1|Overall Study|Lost to Follow-up|3
4899621|NCT00624832|16881822|P4|Overall Study|Abnormal Laboratory Value|0
4899622|NCT00624832|16881823|P3|Overall Study|Abnormal Laboratory Value|0
4899623|NCT00624832|16881824|P2|Overall Study|Abnormal Laboratory Value|0
4899624|NCT00624832|16881825|P1|Overall Study|Abnormal Laboratory Value|2
4899625|NCT00624832|16881822|P4|Overall Study|Adverse Event|1
4899626|NCT00624832|16881823|P3|Overall Study|Adverse Event|0
4899627|NCT00624832|16881824|P2|Overall Study|Adverse Event|1
4899628|NCT00624832|16881825|P1|Overall Study|Adverse Event|0
4899629|NCT00624819|16881841|P4|Follow-up Period: Year 4|Lost to Follow-up|0
4899630|NCT00624819|16881842|P3|Follow-up Period: Year 4|Lost to Follow-up|0
4899631|NCT00624819|16881843|P2|Follow-up Period: Year 4|Lost to Follow-up|1
4899632|NCT00624819|16881844|P1|Follow-up Period: Year 4|Lost to Follow-up|1
4899633|NCT00624819|16881841|P4|Follow-up Period: Year 4|Parents decision|0
4899634|NCT00624819|16881842|P3|Follow-up Period: Year 4|Parents decision|1
4899635|NCT00624819|16881843|P2|Follow-up Period: Year 4|Parents decision|0
4899636|NCT00624819|16881844|P1|Follow-up Period: Year 4|Parents decision|0
4899637|NCT00624780|16882021|P6|Follow-up (Week 26)|Other|0
4899638|NCT00624780|16882022|P5|Follow-up (Week 26)|Other|0
4899639|NCT00624780|16882023|P4|Follow-up (Week 26)|Other|0
4899640|NCT00624780|16882024|P3|Follow-up (Week 26)|Other|0
4899641|NCT00624780|16882025|P2|Follow-up (Week 26)|Other|1
4899642|NCT00624780|16882026|P1|Follow-up (Week 26)|Other|1
4899643|NCT00624780|16882021|P6|Follow-up (Week 26)|Withdrawal by Subject|0
4899644|NCT00624780|16882022|P5|Follow-up (Week 26)|Withdrawal by Subject|0
4899645|NCT00624780|16882023|P4|Follow-up (Week 26)|Withdrawal by Subject|0
4899646|NCT00624780|16882024|P3|Follow-up (Week 26)|Withdrawal by Subject|0
4899647|NCT00624780|16882025|P2|Follow-up (Week 26)|Withdrawal by Subject|0
4899648|NCT00624780|16882026|P1|Follow-up (Week 26)|Withdrawal by Subject|1
4899649|NCT00624780|16882021|P6|Follow-up (Week 26)|Lost to Follow-up|0
4899650|NCT00624780|16882022|P5|Follow-up (Week 26)|Lost to Follow-up|1
4899651|NCT00624780|16882023|P4|Follow-up (Week 26)|Lost to Follow-up|0
4899652|NCT00624780|16882024|P3|Follow-up (Week 26)|Lost to Follow-up|1
4899653|NCT00624780|16882025|P2|Follow-up (Week 26)|Lost to Follow-up|0
4899654|NCT00624780|16882026|P1|Follow-up (Week 26)|Lost to Follow-up|0
4899655|NCT00624780|16882021|P6|Follow-up (Week 26)|Adverse Event|0
4899656|NCT00624780|16882022|P5|Follow-up (Week 26)|Adverse Event|1
4899657|NCT00624780|16882023|P4|Follow-up (Week 26)|Adverse Event|0
4899658|NCT00624780|16882024|P3|Follow-up (Week 26)|Adverse Event|0
4899659|NCT00624780|16882025|P2|Follow-up (Week 26)|Adverse Event|0
4899660|NCT00624780|16882026|P1|Follow-up (Week 26)|Adverse Event|0
4899661|NCT00624780|16882021|P6|Follow-up (Week 26)|Death|0
4899662|NCT00624780|16882022|P5|Follow-up (Week 26)|Death|0
4899663|NCT00624780|16882023|P4|Follow-up (Week 26)|Death|0
4899664|NCT00624780|16882024|P3|Follow-up (Week 26)|Death|1
4899665|NCT00624780|16882025|P2|Follow-up (Week 26)|Death|0
4899666|NCT00624780|16882026|P1|Follow-up (Week 26)|Death|0
4899667|NCT00624780|16882021|P6|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4899668|NCT00624780|16882022|P5|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4899669|NCT00624780|16882023|P4|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4899670|NCT00624780|16882024|P3|Treatment Discontinuation (Week 25)|Lost to Follow-up|1
4899671|NCT00624780|16882025|P2|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4899672|NCT00624780|16882026|P1|Treatment Discontinuation (Week 25)|Lost to Follow-up|0
4899673|NCT00624780|16882021|P6|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4899674|NCT00624780|16882022|P5|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4899675|NCT00624780|16882023|P4|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4899676|NCT00624780|16882024|P3|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4899677|NCT00624780|16882025|P2|Treatment Discontinuation (Week 25)|Lack of Efficacy|0
4899678|NCT00624780|16882026|P1|Treatment Discontinuation (Week 25)|Lack of Efficacy|1
4899679|NCT00624780|16882021|P6|Treatment Discontinuation (Week 25)|Adverse Event|1
4899680|NCT00624780|16882022|P5|Treatment Discontinuation (Week 25)|Adverse Event|0
4899681|NCT00624780|16882023|P4|Treatment Discontinuation (Week 25)|Adverse Event|1
4899682|NCT00624780|16882024|P3|Treatment Discontinuation (Week 25)|Adverse Event|2
4899683|NCT00624780|16882025|P2|Treatment Discontinuation (Week 25)|Adverse Event|0
4899684|NCT00624780|16882026|P1|Treatment Discontinuation (Week 25)|Adverse Event|1
4899685|NCT00624780|16882021|P6|Fixed Dosing (Week 13 to Week 24)|Other|3
4899686|NCT00624780|16882022|P5|Fixed Dosing (Week 13 to Week 24)|Other|4
4899687|NCT00624780|16882023|P4|Fixed Dosing (Week 13 to Week 24)|Other|1
4899688|NCT00624780|16882024|P3|Fixed Dosing (Week 13 to Week 24)|Other|4
4899689|NCT00624780|16882025|P2|Fixed Dosing (Week 13 to Week 24)|Other|3
4899690|NCT00624780|16882026|P1|Fixed Dosing (Week 13 to Week 24)|Other|5
4899691|NCT00624780|16882021|P6|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
4899692|NCT00624780|16882022|P5|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
4899693|NCT00624780|16882023|P4|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
4899694|NCT00624780|16882024|P3|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6
4899695|NCT00624780|16882025|P2|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3
4899696|NCT00624780|16882026|P1|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2
4899697|NCT00624780|16882021|P6|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4899698|NCT00624780|16882022|P5|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4899699|NCT00624780|16882023|P4|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
4899700|NCT00624780|16882024|P3|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4899701|NCT00624780|16882025|P2|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0
4899702|NCT00624780|16882026|P1|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1
4899703|NCT00624780|16882021|P6|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
4899704|NCT00624780|16882022|P5|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
4899705|NCT00624780|16882023|P4|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5
4899706|NCT00624780|16882024|P3|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
4899707|NCT00624780|16882025|P2|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1
4899708|NCT00624780|16882026|P1|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2
4899709|NCT00624780|16882021|P6|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1
4899710|NCT00624780|16882022|P5|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3
4899711|NCT00624780|16882023|P4|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2
4899712|NCT00624780|16882024|P3|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
4899713|NCT00624780|16882025|P2|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4
4899714|NCT00624780|16882026|P1|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5
4899715|NCT00624780|16882021|P6|Treatment Optimization (Up to Week 12)|Other|0
4899716|NCT00624780|16882022|P5|Treatment Optimization (Up to Week 12)|Other|9
4899717|NCT00624780|16882023|P4|Treatment Optimization (Up to Week 12)|Other|2
4899718|NCT00624780|16882024|P3|Treatment Optimization (Up to Week 12)|Other|8
4899719|NCT00624780|16882025|P2|Treatment Optimization (Up to Week 12)|Other|4
4899720|NCT00624780|16882026|P1|Treatment Optimization (Up to Week 12)|Other|10
4899721|NCT00624780|16882021|P6|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
4899722|NCT00624780|16882022|P5|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
4899723|NCT00624780|16882023|P4|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4
4899724|NCT00624780|16882024|P3|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7
4899725|NCT00624780|16882025|P2|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2
4899726|NCT00624780|16882026|P1|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10
4899727|NCT00624780|16882021|P6|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
4899728|NCT00624780|16882022|P5|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
4899729|NCT00624780|16882023|P4|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
4899730|NCT00624780|16882024|P3|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2
4899731|NCT00624780|16882025|P2|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0
4899732|NCT00624780|16882026|P1|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1
4899733|NCT00624780|16882021|P6|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1
4899734|NCT00624780|16882022|P5|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9
4899735|NCT00624780|16882023|P4|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
4899736|NCT00624780|16882024|P3|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10
4899737|NCT00624780|16882025|P2|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2
4899738|NCT00624780|16882026|P1|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5
4899739|NCT00624780|16882021|P6|Treatment Optimization (Up to Week 12)|Adverse Event|5
4899740|NCT00624780|16882022|P5|Treatment Optimization (Up to Week 12)|Adverse Event|9
4899741|NCT00624780|16882023|P4|Treatment Optimization (Up to Week 12)|Adverse Event|3
4899742|NCT00624780|16882024|P3|Treatment Optimization (Up to Week 12)|Adverse Event|15
4899743|NCT00624780|16882025|P2|Treatment Optimization (Up to Week 12)|Adverse Event|5
4899744|NCT00624780|16882026|P1|Treatment Optimization (Up to Week 12)|Adverse Event|7
4899745|NCT00624585|16882217|P1|Overall Study|Adverse Event|3
4899746|NCT00624585|16882217|P1|Overall Study|Disease Progression|6
4899747|NCT00624585|16882217|P1|Overall Study|Death|3
4899748|NCT00624520|16882247|P2|Overall Study|Death|1
4899749|NCT00624520|16882248|P1|Overall Study|Death|0
4899750|NCT00624520|16882247|P2|Overall Study|Withdrawal by Subject|7
4899751|NCT00624520|16882248|P1|Overall Study|Withdrawal by Subject|12
4899752|NCT00624468|16882275|P4|Safety Follow-up (SFU) Period|Other|1
4899753|NCT00624468|16882276|P3|Safety Follow-up (SFU) Period|Other|1
4899754|NCT00624468|16882277|P2|Safety Follow-up (SFU) Period|Other|0
4899755|NCT00624468|16882278|P1|Safety Follow-up (SFU) Period|Other|0
4899756|NCT00624468|16882275|P4|Safety Follow-up (SFU) Period|Lost to Follow-up|2
4899757|NCT00624468|16882276|P3|Safety Follow-up (SFU) Period|Lost to Follow-up|1
4899758|NCT00624468|16882277|P2|Safety Follow-up (SFU) Period|Lost to Follow-up|0
4899759|NCT00624468|16882278|P1|Safety Follow-up (SFU) Period|Lost to Follow-up|0
4899760|NCT00624468|16882275|P4|Double-blind Period|Withdrew Prematurely|0
4899761|NCT00624468|16882276|P3|Double-blind Period|Withdrew Prematurely|0
4899762|NCT00624468|16882277|P2|Double-blind Period|Withdrew Prematurely|1
4899763|NCT00624468|16882278|P1|Double-blind Period|Withdrew Prematurely|1
4899764|NCT00624468|16882275|P4|Double-blind Period|Early Termination Initiated by Sponsor|0
4899765|NCT00624468|16882276|P3|Double-blind Period|Early Termination Initiated by Sponsor|0
4899766|NCT00624468|16882277|P2|Double-blind Period|Early Termination Initiated by Sponsor|12
4899767|NCT00624468|16882278|P1|Double-blind Period|Early Termination Initiated by Sponsor|13
4899768|NCT00624377|16882345|P1|Overall Study|Non-evaluable population|84
4899769|NCT00624377|16882345|P1|Overall Study|Other|91
4899770|NCT00624377|16882345|P1|Overall Study|Adverse Event|14
4899771|NCT00624377|16882345|P1|Overall Study|Withdrawal by Subject|100
4899772|NCT00624377|16882345|P1|Overall Study|Lost to Follow-up|355
4899773|NCT00624338|16882359|P3|Overall Study|Randomized but not treated|3
4899774|NCT00624338|16882360|P2|Overall Study|Randomized but not treated|1
4899775|NCT00624338|16882361|P1|Overall Study|Randomized but not treated|2
4899776|NCT00624338|16882359|P3|Overall Study|Other|9
4899777|NCT00624338|16882360|P2|Overall Study|Other|5
4899778|NCT00624338|16882361|P1|Overall Study|Other|15
4899779|NCT00624338|16882359|P3|Overall Study|Termination of 150 mg group by Sponsor|0
4899780|NCT00624338|16882360|P2|Overall Study|Termination of 150 mg group by Sponsor|55
4899781|NCT00624338|16882361|P1|Overall Study|Termination of 150 mg group by Sponsor|0
4899782|NCT00624338|16882359|P3|Overall Study|Immunoglobulin less than 3gram per liter|0
4899783|NCT00624338|16882360|P2|Overall Study|Immunoglobulin less than 3gram per liter|0
4899784|NCT00624338|16882361|P1|Overall Study|Immunoglobulin less than 3gram per liter|1
4899785|NCT00624338|16882359|P3|Overall Study|Death|0
4899786|NCT00624338|16882360|P2|Overall Study|Death|2
4899787|NCT00624338|16882361|P1|Overall Study|Death|0
4899788|NCT00624338|16882359|P3|Overall Study|Protocol Violation|2
4899789|NCT00624338|16882360|P2|Overall Study|Protocol Violation|3
4899790|NCT00624338|16882361|P1|Overall Study|Protocol Violation|3
4899791|NCT00624338|16882359|P3|Overall Study|Lack of Efficacy|14
4899792|NCT00624338|16882360|P2|Overall Study|Lack of Efficacy|3
4899793|NCT00624338|16882361|P1|Overall Study|Lack of Efficacy|11
4899794|NCT00624338|16882359|P3|Overall Study|Lost to Follow-up|0
4899795|NCT00624338|16882360|P2|Overall Study|Lost to Follow-up|0
4899796|NCT00624338|16882361|P1|Overall Study|Lost to Follow-up|1
4899797|NCT00624338|16882359|P3|Overall Study|Adverse Event|18
4899798|NCT00624338|16882360|P2|Overall Study|Adverse Event|14
4899799|NCT00624338|16882361|P1|Overall Study|Adverse Event|14
4899800|NCT00624286|16882383|P2|Overall Study|Death|1
4899801|NCT00624286|16882384|P1|Overall Study|Death|0
4899802|NCT00624286|16882383|P2|Overall Study|Abnormal test procedure result(s)|1
4899803|NCT00624286|16882384|P1|Overall Study|Abnormal test procedure result(s)|0
4899804|NCT00624286|16882383|P2|Overall Study|Not stated|1
4899805|NCT00624286|16882384|P1|Overall Study|Not stated|0
4899806|NCT00624286|16882383|P2|Overall Study|Lack of Efficacy|6
4899807|NCT00624286|16882384|P1|Overall Study|Lack of Efficacy|1
4899808|NCT00624286|16882383|P2|Overall Study|Administrative problems|0
4899809|NCT00624286|16882384|P1|Overall Study|Administrative problems|3
4899810|NCT00624286|16882383|P2|Overall Study|Lost to Follow-up|2
4899811|NCT00624286|16882384|P1|Overall Study|Lost to Follow-up|3
4899812|NCT00624286|16882383|P2|Overall Study|Withdrawal by Subject|4
4899813|NCT00624286|16882384|P1|Overall Study|Withdrawal by Subject|5
4899814|NCT00624286|16882383|P2|Overall Study|Adverse Event|3
4899815|NCT00624286|16882384|P1|Overall Study|Adverse Event|6
4899816|NCT00624286|16882383|P2|Overall Study|Protocol Deviation|9
4899817|NCT00624286|16882384|P1|Overall Study|Protocol Deviation|7
4899818|NCT00624065|16882437|P2|Overall Study|Met protocol-defined stopping criteria|9
4899819|NCT00624065|16882438|P1|Overall Study|Met protocol-defined stopping criteria|4
4899820|NCT00624065|16882437|P2|Overall Study|Lack of Efficacy|3
4899821|NCT00624065|16882438|P1|Overall Study|Lack of Efficacy|0
4899822|NCT00624065|16882437|P2|Overall Study|Consent withdrawn|5
4899823|NCT00624065|16882438|P1|Overall Study|Consent withdrawn|6
4899824|NCT00624065|16882437|P2|Overall Study|Lost to Follow-up|1
4899825|NCT00624065|16882438|P1|Overall Study|Lost to Follow-up|4
4899826|NCT00624065|16882437|P2|Overall Study|Adverse Event|6
4899827|NCT00624065|16882438|P1|Overall Study|Adverse Event|5
4899828|NCT00624052|16882450|P4|Overall Study|Changed job/ran out if meds|0
4899829|NCT00624052|16882451|P3|Overall Study|Changed job/ran out if meds|0
4899830|NCT00624052|16882452|P2|Overall Study|Changed job/ran out if meds|2
4899831|NCT00624052|16882453|P1|Overall Study|Changed job/ran out if meds|0
4899832|NCT00624052|16882450|P4|Overall Study|Consent withdrawn|0
4899833|NCT00624052|16882451|P3|Overall Study|Consent withdrawn|1
4899834|NCT00624052|16882452|P2|Overall Study|Consent withdrawn|1
4899835|NCT00624052|16882453|P1|Overall Study|Consent withdrawn|3
4899836|NCT00624052|16882450|P4|Overall Study|Non compliant with the protocol|1
4899837|NCT00624052|16882451|P3|Overall Study|Non compliant with the protocol|1
4899838|NCT00624052|16882452|P2|Overall Study|Non compliant with the protocol|1
4899839|NCT00624052|16882453|P1|Overall Study|Non compliant with the protocol|2
4899840|NCT00624052|16882450|P4|Overall Study|Lost to Follow-up|0
4899841|NCT00624052|16882451|P3|Overall Study|Lost to Follow-up|1
4899842|NCT00624052|16882452|P2|Overall Study|Lost to Follow-up|3
4899843|NCT00624052|16882453|P1|Overall Study|Lost to Follow-up|2
4899844|NCT00624052|16882450|P4|Overall Study|Lack of Efficacy|0
4899845|NCT00624052|16882451|P3|Overall Study|Lack of Efficacy|0
4899846|NCT00624052|16882452|P2|Overall Study|Lack of Efficacy|1
4899847|NCT00624052|16882453|P1|Overall Study|Lack of Efficacy|1
4899848|NCT00624052|16882450|P4|Overall Study|Adverse Event|3
4899849|NCT00624052|16882451|P3|Overall Study|Adverse Event|0
4899850|NCT00624052|16882452|P2|Overall Study|Adverse Event|6
4899851|NCT00624052|16882453|P1|Overall Study|Adverse Event|7
4899852|NCT00623935|16882530|P1|Overall Study|Patient Declined Transplant|1
4899853|NCT00623935|16882530|P1|Overall Study|Death|1
4899854|NCT00623831|16882537|P2|Overall Study|Progressive Disease|1
4899855|NCT00623831|16882538|P1|Overall Study|Progressive Disease|0
4899856|NCT00623831|16882537|P2|Overall Study|Withdrawal by Subject|0
4899857|NCT00623831|16882538|P1|Overall Study|Withdrawal by Subject|1
4899858|NCT00623805|16882550|P2|Overall Study|Reason not Specified|6
4899859|NCT00623805|16882551|P1|Overall Study|Reason not Specified|3
4899860|NCT00623805|16882550|P2|Overall Study|Protocol Violation|1
4899861|NCT00623805|16882551|P1|Overall Study|Protocol Violation|1
4899862|NCT00623805|16882550|P2|Overall Study|Lost to Follow-up|2
4899863|NCT00623805|16882551|P1|Overall Study|Lost to Follow-up|2
4899864|NCT00623805|16882550|P2|Overall Study|Lack of Efficacy|7
4899865|NCT00623805|16882551|P1|Overall Study|Lack of Efficacy|3
4899866|NCT00623805|16882550|P2|Overall Study|Death|0
4899867|NCT00623805|16882551|P1|Overall Study|Death|2
4899868|NCT00623805|16882550|P2|Overall Study|Adverse Event|6
4899869|NCT00623805|16882551|P1|Overall Study|Adverse Event|9
4899870|NCT00623779|16882568|P3|Overall Study|Criteria from CSR|1
4899871|NCT00623779|16882569|P2|Overall Study|Criteria from CSR|0
4899872|NCT00623779|16882570|P1|Overall Study|Criteria from CSR|2
4899873|NCT00623779|16882568|P3|Overall Study|Adverse Event|0
4899874|NCT00623779|16882569|P2|Overall Study|Adverse Event|3
4899875|NCT00623779|16882570|P1|Overall Study|Adverse Event|1
4899876|NCT00623766|16882619|P2|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0
4899877|NCT00623766|16882620|P1|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1
4899878|NCT00623766|16882619|P2|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2
4899879|NCT00623766|16882620|P1|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1
4899880|NCT00623766|16882619|P2|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0
4899881|NCT00623766|16882620|P1|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4
4899882|NCT00623766|16882619|P2|Maintenance Phase (Week 24 to Year 2)|Disease progression|0
4899883|NCT00623766|16882620|P1|Maintenance Phase (Week 24 to Year 2)|Disease progression|4
4899884|NCT00623766|16882619|P2|Induction Phase (Day 1 to Week 24)|Off treatment|16
4899885|NCT00623766|16882620|P1|Induction Phase (Day 1 to Week 24)|Off treatment|36
4899886|NCT00623727|16882644|P2|Open Label Follow-up|Participant convenience|1
4899887|NCT00623727|16882645|P1|Open Label Follow-up|Participant convenience|0
4899888|NCT00623727|16882644|P2|Open Label Follow-up|Study termination|6
4899889|NCT00623727|16882645|P1|Open Label Follow-up|Study termination|0
4899890|NCT00623727|16882644|P2|Open Label Follow-up|Withdrawal by Subject|1
4899891|NCT00623727|16882645|P1|Open Label Follow-up|Withdrawal by Subject|0
4899892|NCT00623727|16882644|P2|Double Blind (DB)|Protocol Violation|2
4899893|NCT00623727|16882645|P1|Double Blind (DB)|Protocol Violation|2
4899894|NCT00623727|16882644|P2|Double Blind (DB)|Lost to Follow-up|1
4899895|NCT00623727|16882645|P1|Double Blind (DB)|Lost to Follow-up|1
4899896|NCT00623727|16882644|P2|Double Blind (DB)|Termination of the double-blind period|21
4899897|NCT00623727|16882645|P1|Double Blind (DB)|Termination of the double-blind period|22
4899898|NCT00623727|16882644|P2|Double Blind (DB)|Lack of Efficacy|2
4899899|NCT00623727|16882645|P1|Double Blind (DB)|Lack of Efficacy|2
4899900|NCT00623727|16882644|P2|Double Blind (DB)|Withdrawal by Subject|2
4899901|NCT00623727|16882645|P1|Double Blind (DB)|Withdrawal by Subject|8
4899902|NCT00623727|16882644|P2|Double Blind (DB)|Physician Decision|1
4899903|NCT00623727|16882645|P1|Double Blind (DB)|Physician Decision|0
4899904|NCT00623727|16882644|P2|Double Blind (DB)|Adverse Event|3
4899905|NCT00623727|16882645|P1|Double Blind (DB)|Adverse Event|1
4899906|NCT00623623|16882700|P2|Overall Study|Previous enrolment into this study|1
4899907|NCT00623623|16882701|P1|Overall Study|Previous enrolment into this study|1
4899908|NCT00623597|16882757|P2|Overall Study|Failed to return|0
4899909|NCT00623597|16882758|P1|Overall Study|Failed to return|1
4899910|NCT00623545|16882821|P1|Overall Study|Withdrawal by Subject|4
4899911|NCT00623545|16882821|P1|Overall Study|Adverse Event|6
4899912|NCT00623480|16882841|P2|Overall Study|Site closed by sponsor|1
4899913|NCT00623480|16882842|P1|Overall Study|Site closed by sponsor|0
4899914|NCT00623480|16882841|P2|Overall Study|Protocol Violation|1
4899915|NCT00623480|16882842|P1|Overall Study|Protocol Violation|0
4899916|NCT00623480|16882841|P2|Overall Study|Non-compliant with study medication|0
4899917|NCT00623480|16882842|P1|Overall Study|Non-compliant with study medication|4
4899918|NCT00623480|16882841|P2|Overall Study|Lack of Efficacy|0
4899919|NCT00623480|16882842|P1|Overall Study|Lack of Efficacy|1
4899920|NCT00623480|16882841|P2|Overall Study|Withdrawal by Subject|4
4899921|NCT00623480|16882842|P1|Overall Study|Withdrawal by Subject|2
4899922|NCT00623480|16882841|P2|Overall Study|Lost to Follow-up|1
4899923|NCT00623480|16882842|P1|Overall Study|Lost to Follow-up|0
4899924|NCT00623467|16882854|P1|Overall Study|Withdrawal by Subject|2
4899925|NCT00623467|16882854|P1|Overall Study|Protocol Violation|4
4899926|NCT00623467|16882854|P1|Overall Study|Lost to Follow-up|1
4899927|NCT00623428|16882924|P2|Follow-up Period|Death|1
4899928|NCT00623428|16882925|P1|Follow-up Period|Death|0
4899929|NCT00623428|16882924|P2|Follow-up Period|Reason not specified|1
4899930|NCT00623428|16882925|P1|Follow-up Period|Reason not specified|1
4899931|NCT00623428|16882924|P2|Follow-up Period|Did not cooperate|3
4899932|NCT00623428|16882925|P1|Follow-up Period|Did not cooperate|0
4899933|NCT00623428|16882924|P2|Follow-up Period|HCV-RNA detectable at end of treatment|1
4899934|NCT00623428|16882925|P1|Follow-up Period|HCV-RNA detectable at end of treatment|2
4899935|NCT00623428|16882924|P2|Follow-up Period|Patient withdrew consent|4
4899936|NCT00623428|16882925|P1|Follow-up Period|Patient withdrew consent|5
4899937|NCT00623428|16882924|P2|Follow-up Period|Failure to return|2
4899938|NCT00623428|16882925|P1|Follow-up Period|Failure to return|10
4899939|NCT00623428|16882924|P2|Follow-up Period|Relapse post-treatment|3
4899940|NCT00623428|16882925|P1|Follow-up Period|Relapse post-treatment|11
4899941|NCT00623428|16882924|P2|Treatment Period|Withdrawal by Subject|1
4899942|NCT00623428|16882925|P1|Treatment Period|Withdrawal by Subject|0
4899943|NCT00623428|16882924|P2|Treatment Period|Other|1
4899944|NCT00623428|16882925|P1|Treatment Period|Other|0
4899945|NCT00623428|16882924|P2|Treatment Period|Insufficient therapeutic response|2
4899946|NCT00623428|16882925|P1|Treatment Period|Insufficient therapeutic response|0
4899947|NCT00623428|16882924|P2|Treatment Period|Did not cooperate / refused treatment|13
4899948|NCT00623428|16882925|P1|Treatment Period|Did not cooperate / refused treatment|0
4899949|NCT00623428|16882924|P2|Treatment Period|Death|1
4899950|NCT00623428|16882925|P1|Treatment Period|Death|0
4899951|NCT00623428|16882924|P2|Treatment Period|Adverse event/intercurrent illness|9
4899952|NCT00623428|16882925|P1|Treatment Period|Adverse event/intercurrent illness|0
4899953|NCT00623233|16882943|P1|Overall Study|Withdrawal by Subject|3
4899954|NCT00623233|16882943|P1|Overall Study|Lost to Follow-up|1
4899955|NCT00623233|16882943|P1|Overall Study|Physician Decision|10
4899956|NCT00623233|16882943|P1|Overall Study|Adverse Event|10
4899957|NCT00623194|16882950|P1|Overall Study|Unclassified|1
4899958|NCT00623194|16882950|P1|Overall Study|Protocol Violation|3
4899959|NCT00623194|16882950|P1|Overall Study|Lack of Efficacy|1
4899960|NCT00623103|16882987|P2|Overall Study|Protocol deviation|1
4899961|NCT00623103|16882988|P1|Overall Study|Protocol deviation|2
4899962|NCT00623103|16882987|P2|Overall Study|Death|11
4899963|NCT00623103|16882988|P1|Overall Study|Death|11
4899964|NCT00623103|16882987|P2|Overall Study|Administrative problems|4
4899965|NCT00623103|16882988|P1|Overall Study|Administrative problems|2
4899966|NCT00623103|16882987|P2|Overall Study|Lost to Follow-up|1
4899967|NCT00623103|16882988|P1|Overall Study|Lost to Follow-up|4
4899968|NCT00623103|16882987|P2|Overall Study|Withdrawal by Subject|24
4899969|NCT00623103|16882988|P1|Overall Study|Withdrawal by Subject|18
4899970|NCT00623103|16882987|P2|Overall Study|Unsatisfactory therapeutic effect|12
4899971|NCT00623103|16882988|P1|Overall Study|Unsatisfactory therapeutic effect|4
4899972|NCT00623103|16882987|P2|Overall Study|Adverse Event|60
4899973|NCT00623103|16882988|P1|Overall Study|Adverse Event|70
4899974|NCT00622908|16883016|P2|Overall Study|Termination by study sponser|1
4899975|NCT00622908|16883017|P1|Overall Study|Termination by study sponser|0
4899976|NCT00622908|16883016|P2|Overall Study|Refusal|1
4899977|NCT00622908|16883017|P1|Overall Study|Refusal|0
4899978|NCT00622908|16883016|P2|Overall Study|Lost to Follow-up|0
4899979|NCT00622908|16883017|P1|Overall Study|Lost to Follow-up|1
4899980|NCT00622908|16883016|P2|Overall Study|Lack of Efficacy|7
4899981|NCT00622908|16883017|P1|Overall Study|Lack of Efficacy|1
4899982|NCT00622908|16883016|P2|Overall Study|Adverse Event|1
4899983|NCT00622908|16883017|P1|Overall Study|Adverse Event|0
4899984|NCT00622908|16883016|P2|Overall Study|Protocol Violation|0
4899985|NCT00622908|16883017|P1|Overall Study|Protocol Violation|1
4899986|NCT00622869|16883047|P3|Overall Study|Missing|1
4899987|NCT00622869|16883048|P2|Overall Study|Missing|1
4899988|NCT00622869|16883049|P1|Overall Study|Missing|0
4899989|NCT00622869|16883047|P3|Overall Study|Graft Loss|2
4899990|NCT00622869|16883048|P2|Overall Study|Graft Loss|3
4899991|NCT00622869|16883049|P1|Overall Study|Graft Loss|5
4899992|NCT00622869|16883047|P3|Overall Study|Lost to Follow-up|2
4899993|NCT00622869|16883048|P2|Overall Study|Lost to Follow-up|4
4899994|NCT00622869|16883049|P1|Overall Study|Lost to Follow-up|2
4899995|NCT00622869|16883047|P3|Overall Study|Death|10
4899996|NCT00622869|16883048|P2|Overall Study|Death|15
4899997|NCT00622869|16883049|P1|Overall Study|Death|12
4899998|NCT00622869|16883047|P3|Overall Study|Administrative Problems|13
4899999|NCT00622869|16883048|P2|Overall Study|Administrative Problems|17
4900000|NCT00622869|16883049|P1|Overall Study|Administrative Problems|11
4900001|NCT00622869|16883047|P3|Overall Study|Subject Withdrew Consent|11
4900002|NCT00622869|16883048|P2|Overall Study|Subject Withdrew Consent|17
4900003|NCT00622869|16883049|P1|Overall Study|Subject Withdrew Consent|13
4900004|NCT00622739|16883068|P2|Overall Study|Lost to Follow-up|1
4900005|NCT00622739|16883069|P1|Overall Study|Lost to Follow-up|0
4900006|NCT00622739|16883068|P2|Overall Study|Withdrawal by Subject|1
4900007|NCT00622739|16883069|P1|Overall Study|Withdrawal by Subject|0
4900008|NCT00622739|16883068|P2|Overall Study|Lack of Efficacy|2
4900009|NCT00622739|16883069|P1|Overall Study|Lack of Efficacy|0
4900010|NCT00622739|16883068|P2|Overall Study|Adverse Event|2
4900011|NCT00622739|16883069|P1|Overall Study|Adverse Event|1
4900012|NCT00622739|16883068|P2|Overall Study|Physician Decision|0
4900013|NCT00622739|16883069|P1|Overall Study|Physician Decision|1
4900014|NCT00622726|16883087|P2|August, 2010 to April, 2013|Death|5
4900015|NCT00622726|16883088|P1|August, 2010 to April, 2013|Death|1
4900016|NCT00622726|16883087|P2|March, 2008 to August, 2010|Death|2
4900017|NCT00622726|16883088|P1|March, 2008 to August, 2010|Death|5
4900018|NCT00622713|16883098|P1|Overall Study|Did not meet eligibility criteria|1
4900019|NCT00622713|16883098|P1|Overall Study|Subject no longer required study drug|1
4900020|NCT00622713|16883098|P1|Overall Study|Death|2
4900021|NCT00622713|16883098|P1|Overall Study|Lost to Follow-up|5
4900022|NCT00622713|16883098|P1|Overall Study|Withdrawal by Subject|11
4900023|NCT00622713|16883098|P1|Overall Study|Administrative problems|4
4900024|NCT00622713|16883098|P1|Overall Study|Adverse Event|35
4900025|NCT00622700|16883109|P7|Extension Treatment Period|Other than specified above|1
4900026|NCT00622700|16883110|P6|Extension Treatment Period|Other than specified above|1
4900027|NCT00622700|16883111|P5|Extension Treatment Period|Other than specified above|0
4900028|NCT00622700|16883112|P4|Extension Treatment Period|Other than specified above|0
4900029|NCT00622700|16883113|P3|Extension Treatment Period|Other than specified above|0
4900030|NCT00622700|16883114|P2|Extension Treatment Period|Other than specified above|0
4900031|NCT00622700|16883115|P1|Extension Treatment Period|Other than specified above|0
4900032|NCT00622700|16883109|P7|Extension Treatment Period|Missing|0
4900033|NCT00622700|16883110|P6|Extension Treatment Period|Missing|1
4900034|NCT00622700|16883111|P5|Extension Treatment Period|Missing|3
4900035|NCT00622700|16883112|P4|Extension Treatment Period|Missing|2
4900036|NCT00622700|16883113|P3|Extension Treatment Period|Missing|0
4900037|NCT00622700|16883114|P2|Extension Treatment Period|Missing|0
4900038|NCT00622700|16883115|P1|Extension Treatment Period|Missing|0
4900039|NCT00622700|16883109|P7|Extension Treatment Period|Withdrawal by Subject|10
4900040|NCT00622700|16883110|P6|Extension Treatment Period|Withdrawal by Subject|6
4900041|NCT00622700|16883111|P5|Extension Treatment Period|Withdrawal by Subject|16
4900042|NCT00622700|16883112|P4|Extension Treatment Period|Withdrawal by Subject|11
4900043|NCT00622700|16883113|P3|Extension Treatment Period|Withdrawal by Subject|0
4900044|NCT00622700|16883114|P2|Extension Treatment Period|Withdrawal by Subject|0
4900045|NCT00622700|16883115|P1|Extension Treatment Period|Withdrawal by Subject|0
4900046|NCT00622700|16883109|P7|Extension Treatment Period|Progressive Disease|2
4900047|NCT00622700|16883110|P6|Extension Treatment Period|Progressive Disease|0
4900048|NCT00622700|16883111|P5|Extension Treatment Period|Progressive Disease|2
4900049|NCT00622700|16883112|P4|Extension Treatment Period|Progressive Disease|1
4900050|NCT00622700|16883113|P3|Extension Treatment Period|Progressive Disease|0
4900051|NCT00622700|16883114|P2|Extension Treatment Period|Progressive Disease|0
4900052|NCT00622700|16883115|P1|Extension Treatment Period|Progressive Disease|0
4900053|NCT00622700|16883109|P7|Extension Treatment Period|Lost to Follow-up|0
4900054|NCT00622700|16883110|P6|Extension Treatment Period|Lost to Follow-up|0
4900055|NCT00622700|16883111|P5|Extension Treatment Period|Lost to Follow-up|1
4900056|NCT00622700|16883112|P4|Extension Treatment Period|Lost to Follow-up|0
4900057|NCT00622700|16883113|P3|Extension Treatment Period|Lost to Follow-up|0
4900058|NCT00622700|16883114|P2|Extension Treatment Period|Lost to Follow-up|0
4900059|NCT00622700|16883115|P1|Extension Treatment Period|Lost to Follow-up|0
4900060|NCT00622700|16883109|P7|Extension Treatment Period|Protocol Violation|0
4900061|NCT00622700|16883110|P6|Extension Treatment Period|Protocol Violation|2
4900062|NCT00622700|16883111|P5|Extension Treatment Period|Protocol Violation|0
4900063|NCT00622700|16883112|P4|Extension Treatment Period|Protocol Violation|0
4900064|NCT00622700|16883113|P3|Extension Treatment Period|Protocol Violation|0
4900065|NCT00622700|16883114|P2|Extension Treatment Period|Protocol Violation|0
4900066|NCT00622700|16883115|P1|Extension Treatment Period|Protocol Violation|0
4900067|NCT00622700|16883109|P7|Extension Treatment Period|Lack of Efficacy|9
4900068|NCT00622700|16883110|P6|Extension Treatment Period|Lack of Efficacy|1
4900069|NCT00622700|16883111|P5|Extension Treatment Period|Lack of Efficacy|8
4900070|NCT00622700|16883112|P4|Extension Treatment Period|Lack of Efficacy|2
4900071|NCT00622700|16883113|P3|Extension Treatment Period|Lack of Efficacy|0
4900072|NCT00622700|16883114|P2|Extension Treatment Period|Lack of Efficacy|0
4900073|NCT00622700|16883115|P1|Extension Treatment Period|Lack of Efficacy|0
4900074|NCT00622700|16883109|P7|Extension Treatment Period|Adverse Event|8
4900075|NCT00622700|16883110|P6|Extension Treatment Period|Adverse Event|6
4900076|NCT00622700|16883111|P5|Extension Treatment Period|Adverse Event|9
4900077|NCT00622700|16883112|P4|Extension Treatment Period|Adverse Event|5
4900078|NCT00622700|16883113|P3|Extension Treatment Period|Adverse Event|0
4900079|NCT00622700|16883114|P2|Extension Treatment Period|Adverse Event|0
4900080|NCT00622700|16883115|P1|Extension Treatment Period|Adverse Event|0
4900081|NCT00622700|16883109|P7|Core Treatment Period|Other than specified above|0
4900082|NCT00622700|16883110|P6|Core Treatment Period|Other than specified above|0
4900083|NCT00622700|16883111|P5|Core Treatment Period|Other than specified above|0
4900084|NCT00622700|16883112|P4|Core Treatment Period|Other than specified above|0
4900085|NCT00622700|16883113|P3|Core Treatment Period|Other than specified above|5
4900086|NCT00622700|16883114|P2|Core Treatment Period|Other than specified above|2
4900087|NCT00622700|16883115|P1|Core Treatment Period|Other than specified above|2
4900088|NCT00622700|16883109|P7|Core Treatment Period|Withdrawal by Subject|0
4900089|NCT00622700|16883110|P6|Core Treatment Period|Withdrawal by Subject|0
4900090|NCT00622700|16883111|P5|Core Treatment Period|Withdrawal by Subject|0
4900091|NCT00622700|16883112|P4|Core Treatment Period|Withdrawal by Subject|0
4900092|NCT00622700|16883113|P3|Core Treatment Period|Withdrawal by Subject|15
4900093|NCT00622700|16883114|P2|Core Treatment Period|Withdrawal by Subject|18
4900094|NCT00622700|16883115|P1|Core Treatment Period|Withdrawal by Subject|12
4900095|NCT00622700|16883109|P7|Core Treatment Period|Progressive Disease|0
4900096|NCT00622700|16883110|P6|Core Treatment Period|Progressive Disease|0
4900097|NCT00622700|16883111|P5|Core Treatment Period|Progressive Disease|0
4900098|NCT00622700|16883112|P4|Core Treatment Period|Progressive Disease|0
4900099|NCT00622700|16883113|P3|Core Treatment Period|Progressive Disease|0
4900100|NCT00622700|16883114|P2|Core Treatment Period|Progressive Disease|1
4900101|NCT00622700|16883115|P1|Core Treatment Period|Progressive Disease|3
4900102|NCT00622700|16883109|P7|Core Treatment Period|Death|0
4900103|NCT00622700|16883110|P6|Core Treatment Period|Death|0
4900104|NCT00622700|16883111|P5|Core Treatment Period|Death|0
4900105|NCT00622700|16883112|P4|Core Treatment Period|Death|0
4900106|NCT00622700|16883113|P3|Core Treatment Period|Death|0
4900107|NCT00622700|16883114|P2|Core Treatment Period|Death|0
4900108|NCT00622700|16883115|P1|Core Treatment Period|Death|1
4900109|NCT00622700|16883109|P7|Core Treatment Period|Lost to Follow-up|0
4900110|NCT00622700|16883110|P6|Core Treatment Period|Lost to Follow-up|0
4900111|NCT00622700|16883111|P5|Core Treatment Period|Lost to Follow-up|0
4900112|NCT00622700|16883112|P4|Core Treatment Period|Lost to Follow-up|0
4900113|NCT00622700|16883113|P3|Core Treatment Period|Lost to Follow-up|1
4900114|NCT00622700|16883114|P2|Core Treatment Period|Lost to Follow-up|1
4900115|NCT00622700|16883115|P1|Core Treatment Period|Lost to Follow-up|1
4900116|NCT00622700|16883109|P7|Core Treatment Period|Lack of Efficacy|0
4900117|NCT00622700|16883110|P6|Core Treatment Period|Lack of Efficacy|0
4900118|NCT00622700|16883111|P5|Core Treatment Period|Lack of Efficacy|0
4900119|NCT00622700|16883112|P4|Core Treatment Period|Lack of Efficacy|0
4900120|NCT00622700|16883113|P3|Core Treatment Period|Lack of Efficacy|12
4900121|NCT00622700|16883114|P2|Core Treatment Period|Lack of Efficacy|6
4900122|NCT00622700|16883115|P1|Core Treatment Period|Lack of Efficacy|19
4900123|NCT00622700|16883109|P7|Core Treatment Period|Adverse Event|0
4900124|NCT00622700|16883110|P6|Core Treatment Period|Adverse Event|0
4900125|NCT00622700|16883111|P5|Core Treatment Period|Adverse Event|0
4900126|NCT00622700|16883112|P4|Core Treatment Period|Adverse Event|0
4900127|NCT00622700|16883113|P3|Core Treatment Period|Adverse Event|18
4900128|NCT00622700|16883114|P2|Core Treatment Period|Adverse Event|25
4900129|NCT00622700|16883115|P1|Core Treatment Period|Adverse Event|18
4900130|NCT00622700|16883109|P7|Core Treatment Period|Randomized but Not Treated|0
4900131|NCT00622700|16883110|P6|Core Treatment Period|Randomized but Not Treated|0
4900132|NCT00622700|16883111|P5|Core Treatment Period|Randomized but Not Treated|0
4900133|NCT00622700|16883112|P4|Core Treatment Period|Randomized but Not Treated|0
4900134|NCT00622700|16883113|P3|Core Treatment Period|Randomized but Not Treated|2
4900135|NCT00622700|16883114|P2|Core Treatment Period|Randomized but Not Treated|2
4900136|NCT00622700|16883115|P1|Core Treatment Period|Randomized but Not Treated|0
4900137|NCT00622635|16883174|P6|Treatment Period 3|Withdrawal by Subject|0
4900138|NCT00622635|16883175|P5|Treatment Period 3|Withdrawal by Subject|0
4900139|NCT00622635|16883176|P4|Treatment Period 3|Withdrawal by Subject|1
4900140|NCT00622635|16883177|P3|Treatment Period 3|Withdrawal by Subject|0
4900141|NCT00622635|16883178|P2|Treatment Period 3|Withdrawal by Subject|0
4900142|NCT00622635|16883179|P1|Treatment Period 3|Withdrawal by Subject|0
4900143|NCT00622635|16883174|P6|Treatment Period 3|Adverse Event|0
4900144|NCT00622635|16883175|P5|Treatment Period 3|Adverse Event|0
4900145|NCT00622635|16883176|P4|Treatment Period 3|Adverse Event|2
4900146|NCT00622635|16883177|P3|Treatment Period 3|Adverse Event|0
4900147|NCT00622635|16883178|P2|Treatment Period 3|Adverse Event|0
4900148|NCT00622635|16883179|P1|Treatment Period 3|Adverse Event|0
4900149|NCT00622635|16883174|P6|Treatment Period 2|Adverse Event|0
4900150|NCT00622635|16883175|P5|Treatment Period 2|Adverse Event|0
4900151|NCT00622635|16883176|P4|Treatment Period 2|Adverse Event|0
4900152|NCT00622635|16883177|P3|Treatment Period 2|Adverse Event|0
4900153|NCT00622635|16883178|P2|Treatment Period 2|Adverse Event|0
4900154|NCT00622635|16883179|P1|Treatment Period 2|Adverse Event|1
4900155|NCT00622635|16883174|P6|Treatment Period 1|Abnormal test procedure result(s)|0
4900156|NCT00622635|16883175|P5|Treatment Period 1|Abnormal test procedure result(s)|1
4900157|NCT00622635|16883176|P4|Treatment Period 1|Abnormal test procedure result(s)|0
4900158|NCT00622635|16883177|P3|Treatment Period 1|Abnormal test procedure result(s)|0
4900159|NCT00622635|16883178|P2|Treatment Period 1|Abnormal test procedure result(s)|0
4900160|NCT00622635|16883179|P1|Treatment Period 1|Abnormal test procedure result(s)|0
4900161|NCT00622635|16883174|P6|Treatment Period 1|Withdrawal by Subject|0
4900162|NCT00622635|16883175|P5|Treatment Period 1|Withdrawal by Subject|0
4900163|NCT00622635|16883176|P4|Treatment Period 1|Withdrawal by Subject|0
4900164|NCT00622635|16883177|P3|Treatment Period 1|Withdrawal by Subject|0
4900165|NCT00622635|16883178|P2|Treatment Period 1|Withdrawal by Subject|1
4900166|NCT00622635|16883179|P1|Treatment Period 1|Withdrawal by Subject|0
4900167|NCT00622635|16883174|P6|Treatment Period 1|Adverse Event|0
4900168|NCT00622635|16883175|P5|Treatment Period 1|Adverse Event|0
4900169|NCT00622635|16883176|P4|Treatment Period 1|Adverse Event|0
4900170|NCT00622635|16883177|P3|Treatment Period 1|Adverse Event|1
4900171|NCT00622635|16883178|P2|Treatment Period 1|Adverse Event|0
4900172|NCT00622635|16883179|P1|Treatment Period 1|Adverse Event|0
4900173|NCT00622466|16883260|P1|Overall Study|Withdrawal by Subject|2
4900174|NCT00622466|16883260|P1|Overall Study|Adverse Event|1
4900175|NCT00622466|16883260|P1|Overall Study|Death|1
4900176|NCT00622440|16883273|P2|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1
4900177|NCT00622440|16883274|P1|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0
4900178|NCT00622440|16883273|P2|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1
4900179|NCT00622440|16883274|P1|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0
4900180|NCT00622440|16883273|P2|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5
4900181|NCT00622440|16883274|P1|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3
4900182|NCT00622440|16883273|P2|Baseline - Week 12 (Treatment)|Received cream but did not return|1
4900183|NCT00622440|16883274|P1|Baseline - Week 12 (Treatment)|Received cream but did not return|4
4900184|NCT00622401|16883300|P3|Overall Study|Disease progression prior to treatment|0
4900185|NCT00622401|16883301|P2|Overall Study|Disease progression prior to treatment|2
4900186|NCT00622401|16883302|P1|Overall Study|Disease progression prior to treatment|3
4900187|NCT00622388|16883309|P1|Overall Study|Insurance Expired|1
4900188|NCT00622388|16883309|P1|Overall Study|Withdrew Consent|1
4900189|NCT00622388|16883309|P1|Overall Study|Took Prohibited Medication|2
4900190|NCT00622388|16883309|P1|Overall Study|Received Alternate Anticancer Therapy|8
4900191|NCT00622388|16883309|P1|Overall Study|Death|3
4900192|NCT00622388|16883309|P1|Overall Study|Participant Refusal|1
4900193|NCT00622388|16883309|P1|Overall Study|Protocol Violation|3
4900194|NCT00622388|16883309|P1|Overall Study|Adverse Event|6
4900195|NCT00622388|16883309|P1|Overall Study|Disease Progression|47
4900196|NCT00622336|16883327|P1|Extension Phase|Other|9
4900197|NCT00622336|16883327|P1|Extension Phase|Lost to Follow-up|1
4900198|NCT00622336|16883327|P1|Extension Phase|Withdrawal by Subject|1
4900199|NCT00622336|16883327|P1|Extension Phase|Lack of therapeutic effect|2
4900200|NCT00622336|16883327|P1|Extension Phase|Progressive Disease|6
4900201|NCT00622336|16883327|P1|Extension Phase|Adverse Event|2
4900202|NCT00622336|16883327|P1|Treatment Phase|Lost to Follow-up|2
4900203|NCT00622336|16883327|P1|Treatment Phase|Withdrawal by Subject|13
4900204|NCT00622336|16883327|P1|Treatment Phase|Lack of therapeutic effect|13
4900205|NCT00622336|16883327|P1|Treatment Phase|Death|14
4900206|NCT00622336|16883327|P1|Treatment Phase|Other|40
4900207|NCT00622336|16883327|P1|Treatment Phase|Adverse Event|46
4900208|NCT00622336|16883327|P1|Treatment Phase|Progression of Disease|181
4900209|NCT00622284|16883338|P2|Overall Study|Other reason (not specified)|24
4900210|NCT00622284|16883339|P1|Overall Study|Other reason (not specified)|33
4900211|NCT00622284|16883338|P2|Overall Study|Withdrawal by Subject|24
4900212|NCT00622284|16883339|P1|Overall Study|Withdrawal by Subject|27
4900213|NCT00622284|16883338|P2|Overall Study|Lost to Follow-up|13
4900214|NCT00622284|16883339|P1|Overall Study|Lost to Follow-up|11
4900215|NCT00622284|16883338|P2|Overall Study|Protocol Violation|5
4900216|NCT00622284|16883339|P1|Overall Study|Protocol Violation|12
4900217|NCT00622284|16883338|P2|Overall Study|Adverse Event|90
4900218|NCT00622284|16883339|P1|Overall Study|Adverse Event|61
4900219|NCT00622284|16883338|P2|Overall Study|Lack of Efficacy|15
4900220|NCT00622284|16883339|P1|Overall Study|Lack of Efficacy|45
4900221|NCT00622180|16883401|P2|Overall Study|Lost to Follow-up|2
4900222|NCT00622180|16883402|P1|Overall Study|Lost to Follow-up|1
4900223|NCT00622167|16883408|P1|Overall Study|Did not meet angiographic criteria|20
4900224|NCT00621985|16883412|P1|Dexamethasone Admission|Adverse Event|1
4900225|NCT00621959|16883420|P2|Overall Study|Other|3
4900226|NCT00621959|16883421|P1|Overall Study|Other|1
4900227|NCT00621959|16883420|P2|Overall Study|Withdrawal by Subject|1
4900228|NCT00621959|16883421|P1|Overall Study|Withdrawal by Subject|1
4900229|NCT00621959|16883420|P2|Overall Study|Lost to Follow-up|2
4900230|NCT00621959|16883421|P1|Overall Study|Lost to Follow-up|0
4900231|NCT00621959|16883420|P2|Overall Study|Lack of Efficacy|1
4900232|NCT00621959|16883421|P1|Overall Study|Lack of Efficacy|1
4900233|NCT00621959|16883420|P2|Overall Study|Adverse Event|2
4900234|NCT00621959|16883421|P1|Overall Study|Adverse Event|4
4900235|NCT00621855|16883460|P5|Overall Study|Patients did not receive study drug|2
4900236|NCT00621855|16883461|P4|Overall Study|Patients did not receive study drug|4
4900237|NCT00621855|16883462|P3|Overall Study|Patients did not receive study drug|5
4900238|NCT00621855|16883463|P2|Overall Study|Patients did not receive study drug|3
4900239|NCT00621855|16883464|P1|Overall Study|Patients did not receive study drug|3
4900240|NCT00621855|16883460|P5|Overall Study|Other|4
4900241|NCT00621855|16883461|P4|Overall Study|Other|5
4900242|NCT00621855|16883462|P3|Overall Study|Other|6
4900243|NCT00621855|16883463|P2|Overall Study|Other|7
4900244|NCT00621855|16883464|P1|Overall Study|Other|9
4900245|NCT00621855|16883460|P5|Overall Study|Withdrawal by Subject|9
4900246|NCT00621855|16883461|P4|Overall Study|Withdrawal by Subject|13
4900247|NCT00621855|16883462|P3|Overall Study|Withdrawal by Subject|13
4900248|NCT00621855|16883463|P2|Overall Study|Withdrawal by Subject|11
4900249|NCT00621855|16883464|P1|Overall Study|Withdrawal by Subject|16
4900250|NCT00621855|16883460|P5|Overall Study|Protocol Violation|8
4900251|NCT00621855|16883461|P4|Overall Study|Protocol Violation|7
4900252|NCT00621855|16883462|P3|Overall Study|Protocol Violation|6
4900253|NCT00621855|16883463|P2|Overall Study|Protocol Violation|8
4900254|NCT00621855|16883464|P1|Overall Study|Protocol Violation|16
4900255|NCT00621855|16883460|P5|Overall Study|Lost to Follow-up|1
4900256|NCT00621855|16883461|P4|Overall Study|Lost to Follow-up|4
4900257|NCT00621855|16883462|P3|Overall Study|Lost to Follow-up|3
4900258|NCT00621855|16883463|P2|Overall Study|Lost to Follow-up|1
4900259|NCT00621855|16883464|P1|Overall Study|Lost to Follow-up|0
4900260|NCT00621855|16883460|P5|Overall Study|Adverse Event|31
4900261|NCT00621855|16883461|P4|Overall Study|Adverse Event|34
4900262|NCT00621855|16883462|P3|Overall Study|Adverse Event|48
4900263|NCT00621855|16883463|P2|Overall Study|Adverse Event|31
4900264|NCT00621855|16883464|P1|Overall Study|Adverse Event|32
4900265|NCT00621842|16883506|P1|Overall Study|Lack of Efficacy|2
4900266|NCT00621842|16883506|P1|Overall Study|Protocol Violation|4
4900267|NCT00621842|16883506|P1|Overall Study|Withdrawal by Subject|7
4900268|NCT00621842|16883506|P1|Overall Study|Adverse Event|6
4900269|NCT00621777|16883523|P2|Randomized Phase|Death|1
4900270|NCT00621777|16883524|P1|Randomized Phase|Death|0
4900271|NCT00621777|16883523|P2|Randomized Phase|administrative|3
4900272|NCT00621777|16883524|P1|Randomized Phase|administrative|0
4900273|NCT00621777|16883523|P2|Randomized Phase|Withdrawal by Subject|9
4900274|NCT00621777|16883524|P1|Randomized Phase|Withdrawal by Subject|1
4900275|NCT00621777|16883523|P2|Randomized Phase|Lost to Follow-up|3
4900276|NCT00621777|16883524|P1|Randomized Phase|Lost to Follow-up|3
4900277|NCT00621777|16883523|P2|Randomized Phase|Adverse Event|3
4900278|NCT00621777|16883524|P1|Randomized Phase|Adverse Event|3
4900279|NCT00621777|16883523|P2|Open Phase|Lost to Follow-up|0
4900280|NCT00621777|16883524|P1|Open Phase|Lost to Follow-up|10
4900281|NCT00621777|16883523|P2|Open Phase|administrative|0
4900282|NCT00621777|16883524|P1|Open Phase|administrative|13
4900283|NCT00621777|16883523|P2|Open Phase|Withdrawal by Subject|0
4900284|NCT00621777|16883524|P1|Open Phase|Withdrawal by Subject|17
4900285|NCT00621777|16883523|P2|Open Phase|Did not abstain during open phase|0
4900286|NCT00621777|16883524|P1|Open Phase|Did not abstain during open phase|56
4900287|NCT00621777|16883523|P2|Open Phase|Adverse Event|0
4900288|NCT00621777|16883524|P1|Open Phase|Adverse Event|20
4900289|NCT00621764|16883539|P4|Overall Study|Protocol Violation|1
4900290|NCT00621764|16883540|P3|Overall Study|Protocol Violation|0
4900291|NCT00621764|16883541|P2|Overall Study|Protocol Violation|0
4900292|NCT00621764|16883542|P1|Overall Study|Protocol Violation|0
4900293|NCT00621621|16883588|P2|Overall Study|Subjects were exited at EP study|0
4900294|NCT00621621|16883589|P1|Overall Study|Subjects were exited at EP study|30
4900295|NCT00621582|16883597|P1|Overall Study|issues not identified by investigators|18
4900296|NCT00621582|16883597|P1|Overall Study|Lost to Follow-up|24
4900297|NCT00621582|16883597|P1|Overall Study|Protocol Violation|57
4900298|NCT00621582|16883597|P1|Overall Study|Adverse Event|7
4900299|NCT00621543|16883604|P1|Overall Study|Lost to Follow-up|23
4900300|NCT00621517|16883628|P2|Overall Study|Adverse Event|0
4900301|NCT00621517|16883629|P1|Overall Study|Adverse Event|1
4900302|NCT00621517|16883628|P2|Overall Study|Withdrawal by Subject|4
4900303|NCT00621517|16883629|P1|Overall Study|Withdrawal by Subject|3
4900304|NCT00621517|16883628|P2|Overall Study|Lost to Follow-up|3
4900305|NCT00621517|16883629|P1|Overall Study|Lost to Follow-up|3
4900306|NCT00621504|16883641|P2|Overall Study|Death|6
4900307|NCT00621504|16883642|P1|Overall Study|Death|6
4900308|NCT00621504|16883641|P2|Overall Study|Other|0
4900309|NCT00621504|16883642|P1|Overall Study|Other|1
4900310|NCT00621504|16883641|P2|Overall Study|Lost to Follow-up|10
4900311|NCT00621504|16883642|P1|Overall Study|Lost to Follow-up|8
4900312|NCT00621504|16883641|P2|Overall Study|Withdrew consent|6
4900313|NCT00621504|16883642|P1|Overall Study|Withdrew consent|9
4900314|NCT00621504|16883641|P2|Overall Study|At the request of sponsor/investigator|0
4900315|NCT00621504|16883642|P1|Overall Study|At the request of sponsor/investigator|1
4900316|NCT00621504|16883641|P2|Overall Study|Adverse Event|3
4900317|NCT00621504|16883642|P1|Overall Study|Adverse Event|1
4900318|NCT00621322|16883676|P6|Overall Study|Migrated/moved from study area|2
4900319|NCT00621322|16883677|P5|Overall Study|Migrated/moved from study area|0
4900320|NCT00621322|16883678|P4|Overall Study|Migrated/moved from study area|1
4900321|NCT00621322|16883679|P3|Overall Study|Migrated/moved from study area|1
4900322|NCT00621322|16883680|P2|Overall Study|Migrated/moved from study area|0
4900323|NCT00621322|16883681|P1|Overall Study|Migrated/moved from study area|1
4900324|NCT00621322|16883676|P6|Overall Study|Withdrawal by Subject|2
4900325|NCT00621322|16883677|P5|Overall Study|Withdrawal by Subject|0
4900326|NCT00621322|16883678|P4|Overall Study|Withdrawal by Subject|1
4900327|NCT00621322|16883679|P3|Overall Study|Withdrawal by Subject|0
4900328|NCT00621322|16883680|P2|Overall Study|Withdrawal by Subject|0
4900329|NCT00621322|16883681|P1|Overall Study|Withdrawal by Subject|0
4900330|NCT00621322|16883676|P6|Overall Study|Physician Decision|0
4900331|NCT00621322|16883677|P5|Overall Study|Physician Decision|0
4900332|NCT00621322|16883678|P4|Overall Study|Physician Decision|1
4900333|NCT00621322|16883679|P3|Overall Study|Physician Decision|1
4900334|NCT00621322|16883680|P2|Overall Study|Physician Decision|0
4900335|NCT00621322|16883681|P1|Overall Study|Physician Decision|0
4900336|NCT00621322|16883676|P6|Overall Study|Lost to Follow-up|0
4900337|NCT00621322|16883677|P5|Overall Study|Lost to Follow-up|1
4900338|NCT00621322|16883678|P4|Overall Study|Lost to Follow-up|0
4900339|NCT00621322|16883679|P3|Overall Study|Lost to Follow-up|0
4900340|NCT00621322|16883680|P2|Overall Study|Lost to Follow-up|0
4900341|NCT00621322|16883681|P1|Overall Study|Lost to Follow-up|0
4900342|NCT00621309|16883761|P6|Overall Study|Withdrawal by Subject|1
4900343|NCT00621309|16883762|P5|Overall Study|Withdrawal by Subject|1
4900344|NCT00621309|16883763|P4|Overall Study|Withdrawal by Subject|1
4900345|NCT00621309|16883764|P3|Overall Study|Withdrawal by Subject|1
4900346|NCT00621309|16883765|P2|Overall Study|Withdrawal by Subject|0
4900347|NCT00621309|16883766|P1|Overall Study|Withdrawal by Subject|2
4900348|NCT00621296|16883772|P1|Overall Study|Stopping Criteria|3
4900349|NCT00621296|16883772|P1|Overall Study|Unmatch Criteria|1
4900350|NCT00621296|16883772|P1|Overall Study|Physician Decision|7
4900351|NCT00621296|16883772|P1|Overall Study|Lack of Efficacy|1
4900352|NCT00621296|16883772|P1|Overall Study|Adverse Event|2
4900353|NCT00621257|16883781|P5|Overall Study|Withdrawal by Subject|1
4900354|NCT00621257|16883782|P4|Overall Study|Withdrawal by Subject|1
4900355|NCT00621257|16883783|P3|Overall Study|Withdrawal by Subject|0
4900356|NCT00621257|16883784|P2|Overall Study|Withdrawal by Subject|0
4900357|NCT00621257|16883785|P1|Overall Study|Withdrawal by Subject|0
4900358|NCT00621257|16883781|P5|Overall Study|Physician Decision|1
4900359|NCT00621257|16883782|P4|Overall Study|Physician Decision|1
4900360|NCT00621257|16883783|P3|Overall Study|Physician Decision|0
4900361|NCT00621257|16883784|P2|Overall Study|Physician Decision|2
4900362|NCT00621257|16883785|P1|Overall Study|Physician Decision|0
4900363|NCT00621257|16883781|P5|Overall Study|Adverse Event|0
4900364|NCT00621257|16883782|P4|Overall Study|Adverse Event|0
4900365|NCT00621257|16883783|P3|Overall Study|Adverse Event|1
4900366|NCT00621257|16883784|P2|Overall Study|Adverse Event|1
4900367|NCT00621257|16883785|P1|Overall Study|Adverse Event|0
4900368|NCT00621257|16883781|P5|Overall Study|Lost to Follow-up|7
4900369|NCT00621257|16883782|P4|Overall Study|Lost to Follow-up|4
4900370|NCT00621257|16883783|P3|Overall Study|Lost to Follow-up|2
4900371|NCT00621257|16883784|P2|Overall Study|Lost to Follow-up|0
4900372|NCT00621257|16883785|P1|Overall Study|Lost to Follow-up|4
4900373|NCT00621244|16883801|P4|Overall Study|Administrative problems|2
4900374|NCT00621244|16883802|P3|Overall Study|Administrative problems|0
4900375|NCT00621244|16883803|P2|Overall Study|Administrative problems|1
4900376|NCT00621244|16883804|P1|Overall Study|Administrative problems|5
4900377|NCT00621244|16883801|P4|Overall Study|Adverse Event|2
4900378|NCT00621244|16883802|P3|Overall Study|Adverse Event|9
4900379|NCT00621244|16883803|P2|Overall Study|Adverse Event|7
4900380|NCT00621244|16883804|P1|Overall Study|Adverse Event|27
4900381|NCT00621244|16883801|P4|Overall Study|Death|1
4900382|NCT00621244|16883802|P3|Overall Study|Death|1
4900383|NCT00621244|16883803|P2|Overall Study|Death|3
4900384|NCT00621244|16883804|P1|Overall Study|Death|3
4900385|NCT00621244|16883801|P4|Overall Study|Disease progression|15
4900386|NCT00621244|16883802|P3|Overall Study|Disease progression|20
4900387|NCT00621244|16883803|P2|Overall Study|Disease progression|20
4900388|NCT00621244|16883804|P1|Overall Study|Disease progression|44
4900389|NCT00621244|16883801|P4|Overall Study|Withdrawal by Subject|3
4900390|NCT00621244|16883802|P3|Overall Study|Withdrawal by Subject|3
4900391|NCT00621244|16883803|P2|Overall Study|Withdrawal by Subject|3
4900392|NCT00621244|16883804|P1|Overall Study|Withdrawal by Subject|7
4900393|NCT00621192|16883908|P4|Overall Study|Final Assessments not Completed|1
4900394|NCT00621192|16883909|P3|Overall Study|Final Assessments not Completed|3
4900395|NCT00621192|16883910|P2|Overall Study|Final Assessments not Completed|0
4900396|NCT00621192|16883911|P1|Overall Study|Final Assessments not Completed|0
4900397|NCT00621192|16883908|P4|Overall Study|Death|0
4900398|NCT00621192|16883909|P3|Overall Study|Death|0
4900399|NCT00621192|16883910|P2|Overall Study|Death|5
4900400|NCT00621192|16883911|P1|Overall Study|Death|2
4900401|NCT00621192|16883908|P4|Overall Study|Adverse Event|1
4900402|NCT00621192|16883909|P3|Overall Study|Adverse Event|0
4900403|NCT00621192|16883910|P2|Overall Study|Adverse Event|1
4900404|NCT00621192|16883911|P1|Overall Study|Adverse Event|0
4900405|NCT00621192|16883908|P4|Overall Study|Protocol Violation|1
4900406|NCT00621192|16883909|P3|Overall Study|Protocol Violation|0
4900407|NCT00621192|16883910|P2|Overall Study|Protocol Violation|0
4900408|NCT00621192|16883911|P1|Overall Study|Protocol Violation|1
4900409|NCT00621192|16883908|P4|Overall Study|Physician Decision|0
4900410|NCT00621192|16883909|P3|Overall Study|Physician Decision|0
4900411|NCT00621192|16883910|P2|Overall Study|Physician Decision|3
4900412|NCT00621192|16883911|P1|Overall Study|Physician Decision|1
4900413|NCT00621192|16883908|P4|Overall Study|Withdrawal by Subject|0
4900414|NCT00621192|16883909|P3|Overall Study|Withdrawal by Subject|2
4900415|NCT00621192|16883910|P2|Overall Study|Withdrawal by Subject|0
4900416|NCT00621192|16883911|P1|Overall Study|Withdrawal by Subject|0
4900417|NCT00621153|16883952|P2|Overall Study|Withdrawal by Subject|5
4900418|NCT00621153|16883953|P1|Overall Study|Withdrawal by Subject|4
4900419|NCT00621153|16883952|P2|Overall Study|Lost to Follow-up|1
4900420|NCT00621153|16883953|P1|Overall Study|Lost to Follow-up|5
4900421|NCT00621153|16883952|P2|Overall Study|Adverse Event|2
4900422|NCT00621153|16883953|P1|Overall Study|Adverse Event|3
4900423|NCT00621153|16883952|P2|Overall Study|Safety Reason|7
4900424|NCT00621153|16883953|P1|Overall Study|Safety Reason|8
4900425|NCT00621140|16883961|P2|Overall Study|Other incl. lack of efficacy|5
4900426|NCT00621140|16883962|P1|Overall Study|Other incl. lack of efficacy|6
4900427|NCT00621140|16883961|P2|Overall Study|Withdrawal by Subject|6
4900428|NCT00621140|16883962|P1|Overall Study|Withdrawal by Subject|4
4900429|NCT00621140|16883961|P2|Overall Study|Lost to Follow-up|2
4900430|NCT00621140|16883962|P1|Overall Study|Lost to Follow-up|1
4900431|NCT00621140|16883961|P2|Overall Study|Adverse Event|5
4900432|NCT00621140|16883962|P1|Overall Study|Adverse Event|4
4900433|NCT00621023|16884009|P1|Overall Study|Follow up discontinued|1
4900434|NCT00621023|16884009|P1|Overall Study|Death|5
4900435|NCT00620854|16884026|P6|Washout 1|Withdrawal by Subject|0
4900436|NCT00620854|16884027|P5|Washout 1|Withdrawal by Subject|0
4900437|NCT00620854|16884028|P4|Washout 1|Withdrawal by Subject|1
4900438|NCT00620854|16884029|P3|Washout 1|Withdrawal by Subject|1
4900439|NCT00620854|16884030|P2|Washout 1|Withdrawal by Subject|0
4900440|NCT00620854|16884031|P1|Washout 1|Withdrawal by Subject|0
4900441|NCT00620815|16884062|P3|Overall Study|Protocol Violation|1
4900442|NCT00620815|16884063|P2|Overall Study|Protocol Violation|2
4900443|NCT00620815|16884064|P1|Overall Study|Protocol Violation|1
4900444|NCT00620815|16884062|P3|Overall Study|Inappropriate enrolment|1
4900445|NCT00620815|16884063|P2|Overall Study|Inappropriate enrolment|0
4900446|NCT00620815|16884064|P1|Overall Study|Inappropriate enrolment|0
4900447|NCT00620815|16884062|P3|Overall Study|Lost to Follow-up|3
4900448|NCT00620815|16884063|P2|Overall Study|Lost to Follow-up|6
4900449|NCT00620815|16884064|P1|Overall Study|Lost to Follow-up|1
4900450|NCT00620815|16884062|P3|Overall Study|Withdrawal by Subject|0
4900451|NCT00620815|16884063|P2|Overall Study|Withdrawal by Subject|2
4900452|NCT00620815|16884064|P1|Overall Study|Withdrawal by Subject|1
4900453|NCT00620815|16884062|P3|Overall Study|Adverse Event|2
4900454|NCT00620815|16884063|P2|Overall Study|Adverse Event|1
4900455|NCT00620815|16884064|P1|Overall Study|Adverse Event|1
4900456|NCT00620776|16884104|P2|Overall Study|Withdrawal by Subject|2
4900457|NCT00620776|16884105|P1|Overall Study|Withdrawal by Subject|3
4900458|NCT00620776|16884104|P2|Overall Study|Lost to Follow-up|5
4900459|NCT00620776|16884105|P1|Overall Study|Lost to Follow-up|2
4900460|NCT00620776|16884104|P2|Overall Study|Lack of Efficacy|1
4900461|NCT00620776|16884105|P1|Overall Study|Lack of Efficacy|2
4900462|NCT00620776|16884104|P2|Overall Study|Adverse Event|3
4900463|NCT00620776|16884105|P1|Overall Study|Adverse Event|2
4900464|NCT00620776|16884104|P2|Overall Study|Did not receive treatment|5
4900465|NCT00620776|16884105|P1|Overall Study|Did not receive treatment|3
4900466|NCT00620763|16884133|P2|Period: Second Intervention|Withdrawal by Subject|0
4900467|NCT00620763|16884134|P1|Period: Second Intervention|Withdrawal by Subject|1
4900468|NCT00620763|16884133|P2|Period: First Intervention|Protocol Violation|3
4900469|NCT00620763|16884134|P1|Period: First Intervention|Protocol Violation|0
4900470|NCT00620763|16884133|P2|Period: First Intervention|Withdrawal by Subject|2
4900471|NCT00620763|16884134|P1|Period: First Intervention|Withdrawal by Subject|0
4900472|NCT00620750|16884140|P1|Overall Study|Lost to Follow-up|25
4900473|NCT00620659|16884155|P6|Treatment Period 3|Withdrawal by Subject|0
4900474|NCT00620659|16884156|P5|Treatment Period 3|Withdrawal by Subject|0
4900475|NCT00620659|16884157|P4|Treatment Period 3|Withdrawal by Subject|1
4900476|NCT00620659|16884158|P3|Treatment Period 3|Withdrawal by Subject|0
4900477|NCT00620659|16884159|P2|Treatment Period 3|Withdrawal by Subject|0
4900478|NCT00620659|16884160|P1|Treatment Period 3|Withdrawal by Subject|0
4900479|NCT00620659|16884155|P6|Treatment Period 3|Adverse Event|0
4900480|NCT00620659|16884156|P5|Treatment Period 3|Adverse Event|0
4900481|NCT00620659|16884157|P4|Treatment Period 3|Adverse Event|0
4900482|NCT00620659|16884158|P3|Treatment Period 3|Adverse Event|0
4900483|NCT00620659|16884159|P2|Treatment Period 3|Adverse Event|2
4900484|NCT00620659|16884160|P1|Treatment Period 3|Adverse Event|0
4900485|NCT00620659|16884155|P6|Placebo Washout Period 2|Adverse Event|0
4900486|NCT00620659|16884156|P5|Placebo Washout Period 2|Adverse Event|0
4900487|NCT00620659|16884157|P4|Placebo Washout Period 2|Adverse Event|0
4900488|NCT00620659|16884158|P3|Placebo Washout Period 2|Adverse Event|0
4900489|NCT00620659|16884159|P2|Placebo Washout Period 2|Adverse Event|0
4900490|NCT00620659|16884160|P1|Placebo Washout Period 2|Adverse Event|2
4900491|NCT00620659|16884155|P6|Treatment Period 2|Withdrawal by Subject|0
4900492|NCT00620659|16884156|P5|Treatment Period 2|Withdrawal by Subject|3
4900493|NCT00620659|16884157|P4|Treatment Period 2|Withdrawal by Subject|0
4900494|NCT00620659|16884158|P3|Treatment Period 2|Withdrawal by Subject|1
4900495|NCT00620659|16884159|P2|Treatment Period 2|Withdrawal by Subject|0
4900496|NCT00620659|16884160|P1|Treatment Period 2|Withdrawal by Subject|0
4900497|NCT00620659|16884155|P6|Treatment Period 2|Adverse Event|0
4900498|NCT00620659|16884156|P5|Treatment Period 2|Adverse Event|2
4900499|NCT00620659|16884157|P4|Treatment Period 2|Adverse Event|0
4900500|NCT00620659|16884158|P3|Treatment Period 2|Adverse Event|0
4900501|NCT00620659|16884159|P2|Treatment Period 2|Adverse Event|3
4900502|NCT00620659|16884160|P1|Treatment Period 2|Adverse Event|0
4900503|NCT00620659|16884155|P6|Placebo Washout Period 1|Withdrawal by Subject|0
4900504|NCT00620659|16884156|P5|Placebo Washout Period 1|Withdrawal by Subject|0
4900505|NCT00620659|16884157|P4|Placebo Washout Period 1|Withdrawal by Subject|1
4900506|NCT00620659|16884158|P3|Placebo Washout Period 1|Withdrawal by Subject|0
4900507|NCT00620659|16884159|P2|Placebo Washout Period 1|Withdrawal by Subject|0
4900508|NCT00620659|16884160|P1|Placebo Washout Period 1|Withdrawal by Subject|0
4900509|NCT00620659|16884155|P6|Treatment Period 1|Withdrawal by Subject|0
4900510|NCT00620659|16884156|P5|Treatment Period 1|Withdrawal by Subject|1
4900511|NCT00620659|16884157|P4|Treatment Period 1|Withdrawal by Subject|0
4900512|NCT00620659|16884158|P3|Treatment Period 1|Withdrawal by Subject|1
4900513|NCT00620659|16884159|P2|Treatment Period 1|Withdrawal by Subject|0
4900514|NCT00620659|16884160|P1|Treatment Period 1|Withdrawal by Subject|1
4900515|NCT00620659|16884155|P6|Treatment Period 1|Protocol Violation|0
4900516|NCT00620659|16884156|P5|Treatment Period 1|Protocol Violation|0
4900517|NCT00620659|16884157|P4|Treatment Period 1|Protocol Violation|0
4900518|NCT00620659|16884158|P3|Treatment Period 1|Protocol Violation|0
4900519|NCT00620659|16884159|P2|Treatment Period 1|Protocol Violation|0
4900520|NCT00620659|16884160|P1|Treatment Period 1|Protocol Violation|1
4900521|NCT00620659|16884155|P6|Treatment Period 1|Adverse Event|0
4900522|NCT00620659|16884156|P5|Treatment Period 1|Adverse Event|0
4900523|NCT00620659|16884157|P4|Treatment Period 1|Adverse Event|3
4900524|NCT00620659|16884158|P3|Treatment Period 1|Adverse Event|0
4900525|NCT00620659|16884159|P2|Treatment Period 1|Adverse Event|0
4900526|NCT00620659|16884160|P1|Treatment Period 1|Adverse Event|1
4900527|NCT00620555|16884178|P1|Overall Study|Visit failure against planned|1
4900528|NCT00620555|16884178|P1|Overall Study|Choice of other treatment|1
4900529|NCT00620555|16884178|P1|Overall Study|Withdrawal by Subject|1
4900530|NCT00620555|16884178|P1|Overall Study|Lack of Efficacy|12
4900531|NCT00620555|16884178|P1|Overall Study|Protocol Violation|2
4900532|NCT00620555|16884178|P1|Overall Study|Adverse Event|4
4900533|NCT00620542|16884187|P4|Part B (2 Year Core Study)|IVUS not available|2
4900534|NCT00620542|16884188|P3|Part B (2 Year Core Study)|IVUS not available|3
4900535|NCT00620542|16884189|P2|Part B (2 Year Core Study)|IVUS not available|0
4900536|NCT00620542|16884190|P1|Part B (2 Year Core Study)|IVUS not available|0
4900537|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
4900538|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Study specific discontinuation criteris|6
4900539|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
4900540|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Study specific discontinuation criteris|0
4900541|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Safety reasons|3
4900542|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Safety reasons|2
4900543|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Safety reasons|0
4900544|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Safety reasons|0
4900545|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Protocol Violation|16
4900546|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Protocol Violation|13
4900547|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Protocol Violation|0
4900548|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Protocol Violation|0
4900549|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Lost to Follow-up|9
4900550|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Lost to Follow-up|20
4900551|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Lost to Follow-up|0
4900552|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Lost to Follow-up|0
4900553|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Withdrawal by Subject|54
4900554|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Withdrawal by Subject|55
4900555|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Withdrawal by Subject|0
4900556|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Withdrawal by Subject|0
4900557|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Protocol Violation|5
4900558|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Protocol Violation|3
4900559|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Protocol Violation|0
4900560|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Protocol Violation|0
4900561|NCT00620542|16884187|P4|Part B (2 Year Core Study)|Adverse Event|49
4900562|NCT00620542|16884188|P3|Part B (2 Year Core Study)|Adverse Event|46
4900563|NCT00620542|16884189|P2|Part B (2 Year Core Study)|Adverse Event|0
4900564|NCT00620542|16884190|P1|Part B (2 Year Core Study)|Adverse Event|0
4900565|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|IVUS not available|0
4900566|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|IVUS not available|0
4900567|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|IVUS not available|4
4900568|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|IVUS not available|4
4900569|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|Safety reasons|0
4900570|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|Safety reasons|0
4900571|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|Safety reasons|1
4900572|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|Safety reasons|0
4900573|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4900574|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4900575|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|1
4900576|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4900577|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
4900578|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0
4900579|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6
4900580|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7
4900581|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
4900582|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0
4900583|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40
4900584|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43
4900585|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4900586|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|Protocol Violation|0
4900587|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|Protocol Violation|409
4900588|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|Protocol Violation|406
4900589|NCT00620542|16884187|P4|Part A (Run-in - 2 Weeks)|Adverse Event|0
4900590|NCT00620542|16884188|P3|Part A (Run-in - 2 Weeks)|Adverse Event|0
4900591|NCT00620542|16884189|P2|Part A (Run-in - 2 Weeks)|Adverse Event|15
4900592|NCT00620542|16884190|P1|Part A (Run-in - 2 Weeks)|Adverse Event|12
4900593|NCT00620464|16884255|P2|Overall Study|Used prohibited medication|0
4900594|NCT00620464|16884256|P1|Overall Study|Used prohibited medication|1
4900595|NCT00620464|16884255|P2|Overall Study|Personal|2
4900596|NCT00620464|16884256|P1|Overall Study|Personal|2
4900597|NCT00620464|16884255|P2|Overall Study|Planning Pregnancy|4
4900598|NCT00620464|16884256|P1|Overall Study|Planning Pregnancy|1
4900599|NCT00620464|16884255|P2|Overall Study|Lost to Follow-up|1
4900600|NCT00620464|16884256|P1|Overall Study|Lost to Follow-up|1
4900601|NCT00620464|16884255|P2|Overall Study|Adverse Event|17
4900602|NCT00620464|16884256|P1|Overall Study|Adverse Event|15
4900603|NCT00620373|16884275|P1|Overall Study|Unverified cancer status|33
4900604|NCT00620321|16884293|P2|Overall Study|Withdrawal by Subject|1
4900605|NCT00620321|16884294|P1|Overall Study|Withdrawal by Subject|1
4900606|NCT00620321|16884293|P2|Overall Study|Sponsor Decision|1
4900607|NCT00620321|16884294|P1|Overall Study|Sponsor Decision|0
4900608|NCT00620321|16884293|P2|Overall Study|Progressive Disease|5
4900609|NCT00620321|16884294|P1|Overall Study|Progressive Disease|5
4900610|NCT00620321|16884293|P2|Overall Study|Physician Decision|7
4900611|NCT00620321|16884294|P1|Overall Study|Physician Decision|0
4900612|NCT00620321|16884293|P2|Overall Study|Death|1
4900613|NCT00620321|16884294|P1|Overall Study|Death|1
4900614|NCT00620321|16884293|P2|Overall Study|Adverse Event|1
4900615|NCT00620321|16884294|P1|Overall Study|Adverse Event|1
4900616|NCT00620282|16884313|P3|Overall Study|Withdrawal by Subject|0
4900617|NCT00620282|16884314|P2|Overall Study|Withdrawal by Subject|1
4900618|NCT00620282|16884315|P1|Overall Study|Withdrawal by Subject|0
4900619|NCT00620282|16884313|P3|Overall Study|Arterial line unable to be placed|1
4900620|NCT00620282|16884314|P2|Overall Study|Arterial line unable to be placed|0
4900621|NCT00620282|16884315|P1|Overall Study|Arterial line unable to be placed|0
4900622|NCT00620282|16884313|P3|Overall Study|Adverse Event|0
4900623|NCT00620282|16884314|P2|Overall Study|Adverse Event|1
4900624|NCT00620282|16884315|P1|Overall Study|Adverse Event|0
4900625|NCT00620113|16884394|P4|Overall Study|Withdrawal by Subject|5
4900626|NCT00620113|16884395|P3|Overall Study|Withdrawal by Subject|3
4900627|NCT00620113|16884396|P2|Overall Study|Withdrawal by Subject|1
4900628|NCT00620113|16884397|P1|Overall Study|Withdrawal by Subject|5
4900629|NCT00620113|16884394|P4|Overall Study|Protocol Violation|0
4900630|NCT00620113|16884395|P3|Overall Study|Protocol Violation|0
4900631|NCT00620113|16884396|P2|Overall Study|Protocol Violation|1
4900632|NCT00620113|16884397|P1|Overall Study|Protocol Violation|2
4900633|NCT00620113|16884394|P4|Overall Study|Physician Decision|2
4900634|NCT00620113|16884395|P3|Overall Study|Physician Decision|0
4900635|NCT00620113|16884396|P2|Overall Study|Physician Decision|0
4900636|NCT00620113|16884397|P1|Overall Study|Physician Decision|1
4900637|NCT00620113|16884394|P4|Overall Study|Lack of Efficacy|2
4900638|NCT00620113|16884395|P3|Overall Study|Lack of Efficacy|0
4900639|NCT00620113|16884396|P2|Overall Study|Lack of Efficacy|3
4900640|NCT00620113|16884397|P1|Overall Study|Lack of Efficacy|2
4900641|NCT00620113|16884394|P4|Overall Study|Adverse Event|1
4900642|NCT00620113|16884395|P3|Overall Study|Adverse Event|2
4900643|NCT00620113|16884396|P2|Overall Study|Adverse Event|2
4900644|NCT00620113|16884397|P1|Overall Study|Adverse Event|3
4900645|NCT00620074|16884447|P1|Overall Study|Adverse Event|1
4900646|NCT00620035|16884470|P1|Overall Study|Other Reason|38
4900647|NCT00620035|16884470|P1|Overall Study|Withdrawal of Informed Consent|1
4900648|NCT00620035|16884470|P1|Overall Study|Adverse Event|106
4900649|NCT00620022|16884480|P2|Treatment Period 2|Adverse Event|2
4900650|NCT00620022|16884481|P1|Treatment Period 2|Adverse Event|2
4900651|NCT00620022|16884480|P2|Treatment Period 1|Subject withdrew consent|0
4900652|NCT00620022|16884481|P1|Treatment Period 1|Subject withdrew consent|1
4900653|NCT00620022|16884480|P2|Treatment Period 1|Adverse Event|6
4900654|NCT00620022|16884481|P1|Treatment Period 1|Adverse Event|4
4900655|NCT00619983|16884493|P4|Test Drug Alone|Failure of daily diary device|2
4900656|NCT00619983|16884494|P3|Test Drug Alone|Failure of daily diary device|2
4900657|NCT00619983|16884495|P2|Test Drug Alone|Failure of daily diary device|1
4900658|NCT00619983|16884496|P1|Test Drug Alone|Failure of daily diary device|1
4900659|NCT00619983|16884493|P4|Test Drug Alone|Withdrawal by Subject|1
4900660|NCT00619983|16884494|P3|Test Drug Alone|Withdrawal by Subject|0
4900661|NCT00619983|16884495|P2|Test Drug Alone|Withdrawal by Subject|0
4900662|NCT00619983|16884496|P1|Test Drug Alone|Withdrawal by Subject|1
4900663|NCT00619957|16884523|P2|Month 48 Open-Label|Withdrawal by Subject|9
4900664|NCT00619957|16884524|P1|Month 48 Open-Label|Withdrawal by Subject|6
4900665|NCT00619957|16884523|P2|Month 48 Open-Label|Lost to Follow-up|4
4900666|NCT00619957|16884524|P1|Month 48 Open-Label|Lost to Follow-up|2
4900667|NCT00619957|16884523|P2|Month 48 Open-Label|Adverse Event|4
4900668|NCT00619957|16884524|P1|Month 48 Open-Label|Adverse Event|4
4900669|NCT00619957|16884523|P2|Month 24 Double-Blind|Did not take any study medication|1
4900670|NCT00619957|16884524|P1|Month 24 Double-Blind|Did not take any study medication|0
4900671|NCT00619957|16884523|P2|Month 24 Double-Blind|Lost to Follow-up|0
4900672|NCT00619957|16884524|P1|Month 24 Double-Blind|Lost to Follow-up|1
4900673|NCT00619957|16884523|P2|Month 24 Double-Blind|Withdrawal by Subject|9
4900674|NCT00619957|16884524|P1|Month 24 Double-Blind|Withdrawal by Subject|7
4900675|NCT00619957|16884523|P2|Month 24 Double-Blind|Protocol Violation|0
4900676|NCT00619957|16884524|P1|Month 24 Double-Blind|Protocol Violation|1
4900677|NCT00619957|16884523|P2|Month 24 Double-Blind|Adverse Event|7
4900678|NCT00619957|16884524|P1|Month 24 Double-Blind|Adverse Event|9
4900679|NCT00619918|16884606|P2|Overall Study|Left before receiving first dose|8
4900680|NCT00619918|16884607|P1|Overall Study|Left before receiving first dose|5
4900681|NCT00619918|16884606|P2|Overall Study|Transfer to outside facility|3
4900682|NCT00619918|16884607|P1|Overall Study|Transfer to outside facility|3
4900683|NCT00619918|16884606|P2|Overall Study|Physician Decision|8
4900684|NCT00619918|16884607|P1|Overall Study|Physician Decision|8
4900685|NCT00619918|16884606|P2|Overall Study|Withdrawal by Subject|3
4900686|NCT00619918|16884607|P1|Overall Study|Withdrawal by Subject|4
4900687|NCT00619892|16884617|P2|Overall Study|Intercurrent illness|1
4900688|NCT00619892|16884618|P1|Overall Study|Intercurrent illness|0
4900689|NCT00619892|16884617|P2|Overall Study|Lost to Follow-up|1
4900690|NCT00619892|16884618|P1|Overall Study|Lost to Follow-up|0
4900691|NCT00619892|16884617|P2|Overall Study|Adverse Event|0
4900692|NCT00619892|16884618|P1|Overall Study|Adverse Event|3
4900693|NCT00619866|16884629|P5|Weeks 13 - 24|Lost to Follow-up|0
4900694|NCT00619866|16884630|P4|Weeks 13 - 24|Lost to Follow-up|0
4900695|NCT00619866|16884631|P3|Weeks 13 - 24|Lost to Follow-up|0
4900696|NCT00619866|16884632|P2|Weeks 13 - 24|Lost to Follow-up|3
4900697|NCT00619866|16884633|P1|Weeks 13 - 24|Lost to Follow-up|0
4900698|NCT00619866|16884629|P5|Weeks 13 - 24|Non-compliance|0
4900699|NCT00619866|16884630|P4|Weeks 13 - 24|Non-compliance|0
4900700|NCT00619866|16884631|P3|Weeks 13 - 24|Non-compliance|1
4900701|NCT00619866|16884632|P2|Weeks 13 - 24|Non-compliance|1
4900702|NCT00619866|16884633|P1|Weeks 13 - 24|Non-compliance|0
4900703|NCT00619866|16884629|P5|Weeks 13 - 24|Withdrawal by Subject|2
4900704|NCT00619866|16884630|P4|Weeks 13 - 24|Withdrawal by Subject|2
4900705|NCT00619866|16884631|P3|Weeks 13 - 24|Withdrawal by Subject|2
4900706|NCT00619866|16884632|P2|Weeks 13 - 24|Withdrawal by Subject|3
4900707|NCT00619866|16884633|P1|Weeks 13 - 24|Withdrawal by Subject|0
4900708|NCT00619866|16884629|P5|Weeks 13 - 24|Protocol Deviation|0
4900709|NCT00619866|16884630|P4|Weeks 13 - 24|Protocol Deviation|1
4900710|NCT00619866|16884631|P3|Weeks 13 - 24|Protocol Deviation|0
4900711|NCT00619866|16884632|P2|Weeks 13 - 24|Protocol Deviation|0
4900712|NCT00619866|16884633|P1|Weeks 13 - 24|Protocol Deviation|0
4900713|NCT00619866|16884629|P5|Weeks 13 - 24|Adverse Event|0
4900714|NCT00619866|16884630|P4|Weeks 13 - 24|Adverse Event|1
4900715|NCT00619866|16884631|P3|Weeks 13 - 24|Adverse Event|2
4900716|NCT00619866|16884632|P2|Weeks 13 - 24|Adverse Event|0
4900717|NCT00619866|16884633|P1|Weeks 13 - 24|Adverse Event|0
4900718|NCT00619866|16884629|P5|Weeks 1 - 12|Sponsor Decision|0
4900719|NCT00619866|16884630|P4|Weeks 1 - 12|Sponsor Decision|0
4900720|NCT00619866|16884631|P3|Weeks 1 - 12|Sponsor Decision|0
4900721|NCT00619866|16884632|P2|Weeks 1 - 12|Sponsor Decision|1
4900722|NCT00619866|16884633|P1|Weeks 1 - 12|Sponsor Decision|0
4900723|NCT00619866|16884629|P5|Weeks 1 - 12|Lost to Follow-up|0
4900724|NCT00619866|16884630|P4|Weeks 1 - 12|Lost to Follow-up|0
4900725|NCT00619866|16884631|P3|Weeks 1 - 12|Lost to Follow-up|2
4900726|NCT00619866|16884632|P2|Weeks 1 - 12|Lost to Follow-up|0
4900727|NCT00619866|16884633|P1|Weeks 1 - 12|Lost to Follow-up|4
4900728|NCT00619866|16884629|P5|Weeks 1 - 12|Lack of Efficacy|0
4900729|NCT00619866|16884630|P4|Weeks 1 - 12|Lack of Efficacy|0
4900730|NCT00619866|16884631|P3|Weeks 1 - 12|Lack of Efficacy|1
4900731|NCT00619866|16884632|P2|Weeks 1 - 12|Lack of Efficacy|2
4900732|NCT00619866|16884633|P1|Weeks 1 - 12|Lack of Efficacy|3
4900733|NCT00619866|16884629|P5|Weeks 1 - 12|Withdrawal by Subject|0
4900734|NCT00619866|16884630|P4|Weeks 1 - 12|Withdrawal by Subject|0
4900735|NCT00619866|16884631|P3|Weeks 1 - 12|Withdrawal by Subject|4
4900736|NCT00619866|16884632|P2|Weeks 1 - 12|Withdrawal by Subject|2
4900737|NCT00619866|16884633|P1|Weeks 1 - 12|Withdrawal by Subject|7
4900738|NCT00619866|16884629|P5|Weeks 1 - 12|Non-compliance|0
4900739|NCT00619866|16884630|P4|Weeks 1 - 12|Non-compliance|0
4900740|NCT00619866|16884631|P3|Weeks 1 - 12|Non-compliance|1
4900741|NCT00619866|16884632|P2|Weeks 1 - 12|Non-compliance|0
4900742|NCT00619866|16884633|P1|Weeks 1 - 12|Non-compliance|0
4900743|NCT00619866|16884629|P5|Weeks 1 - 12|Adverse Event|0
4900744|NCT00619866|16884630|P4|Weeks 1 - 12|Adverse Event|0
4900745|NCT00619866|16884631|P3|Weeks 1 - 12|Adverse Event|2
4900746|NCT00619866|16884632|P2|Weeks 1 - 12|Adverse Event|1
4900747|NCT00619866|16884633|P1|Weeks 1 - 12|Adverse Event|0
4900748|NCT00619827|16884720|P2|Overall Study|Withdrawal by Subject|2
4900749|NCT00619827|16884721|P1|Overall Study|Withdrawal by Subject|2
4900750|NCT00619827|16884720|P2|Overall Study|Adverse Event|2
4900751|NCT00619827|16884721|P1|Overall Study|Adverse Event|1
4900752|NCT00619801|16884729|P2|Overall Study|Loss of efficacy|1
4900753|NCT00619801|16884730|P1|Overall Study|Loss of efficacy|0
4900754|NCT00619801|16884729|P2|Overall Study|Withdrawal by Subject|1
4900755|NCT00619801|16884730|P1|Overall Study|Withdrawal by Subject|1
4900756|NCT00619801|16884729|P2|Overall Study|Lack of Efficacy|1
4900757|NCT00619801|16884730|P1|Overall Study|Lack of Efficacy|0
4900758|NCT00619645|16884787|P1|Overall Study|Adverse Event|1
4900759|NCT00619619|16884801|P8|Overall Study|Adverse Event|2
4900760|NCT00619619|16884802|P7|Overall Study|Adverse Event|0
4900761|NCT00619619|16884803|P6|Overall Study|Adverse Event|0
4900762|NCT00619619|16884804|P5|Overall Study|Adverse Event|2
4900763|NCT00619619|16884805|P4|Overall Study|Adverse Event|0
4900764|NCT00619619|16884806|P3|Overall Study|Adverse Event|0
4900765|NCT00619619|16884807|P2|Overall Study|Adverse Event|0
4900766|NCT00619619|16884808|P1|Overall Study|Adverse Event|0
4900767|NCT00619619|16884801|P8|Overall Study|Protocol Violation|1
4900768|NCT00619619|16884802|P7|Overall Study|Protocol Violation|1
4900769|NCT00619619|16884803|P6|Overall Study|Protocol Violation|0
4900770|NCT00619619|16884804|P5|Overall Study|Protocol Violation|0
4900771|NCT00619619|16884805|P4|Overall Study|Protocol Violation|1
4900772|NCT00619619|16884806|P3|Overall Study|Protocol Violation|0
4900773|NCT00619619|16884807|P2|Overall Study|Protocol Violation|0
4900774|NCT00619619|16884808|P1|Overall Study|Protocol Violation|0
4900775|NCT00619619|16884801|P8|Overall Study|Physician Decision|0
4900776|NCT00619619|16884802|P7|Overall Study|Physician Decision|0
4900777|NCT00619619|16884803|P6|Overall Study|Physician Decision|0
4900778|NCT00619619|16884804|P5|Overall Study|Physician Decision|0
4900779|NCT00619619|16884805|P4|Overall Study|Physician Decision|0
4900780|NCT00619619|16884806|P3|Overall Study|Physician Decision|1
4900781|NCT00619619|16884807|P2|Overall Study|Physician Decision|0
4900782|NCT00619619|16884808|P1|Overall Study|Physician Decision|0
4900783|NCT00619515|16884893|P1|Overall Study|Study Termination by IRB|73
4900784|NCT00619502|16884907|P2|Overall Study|Lost to Follow-up|10
4900785|NCT00619502|16884908|P1|Overall Study|Lost to Follow-up|8
4900786|NCT00619489|16884920|P2|Overall Study|Rolled over to Study C13008 (NCT00790933|15
4900787|NCT00619489|16884921|P1|Overall Study|Rolled over to Study C13008 (NCT00790933|22
4900788|NCT00619489|16884920|P2|Overall Study|Lack of Efficacy|11
4900789|NCT00619489|16884921|P1|Overall Study|Lack of Efficacy|0
4900790|NCT00619489|16884920|P2|Overall Study|Withdrawal by Subject|1
4900791|NCT00619489|16884921|P1|Overall Study|Withdrawal by Subject|1
4900792|NCT00619489|16884920|P2|Overall Study|Adverse Event|7
4900793|NCT00619489|16884921|P1|Overall Study|Adverse Event|0
4900794|NCT00619476|16884943|P4|Overall Study|Withdrawal by Subject|4
4900795|NCT00619476|16884944|P3|Overall Study|Withdrawal by Subject|5
4900796|NCT00619476|16884945|P2|Overall Study|Withdrawal by Subject|7
4900797|NCT00619476|16884946|P1|Overall Study|Withdrawal by Subject|5
4900798|NCT00619476|16884943|P4|Overall Study|Investigator Discretion|0
4900799|NCT00619476|16884944|P3|Overall Study|Investigator Discretion|2
4900800|NCT00619476|16884945|P2|Overall Study|Investigator Discretion|2
4900801|NCT00619476|16884946|P1|Overall Study|Investigator Discretion|2
4900802|NCT00619476|16884943|P4|Overall Study|Lost to Follow-up|1
4900803|NCT00619476|16884944|P3|Overall Study|Lost to Follow-up|0
4900804|NCT00619476|16884945|P2|Overall Study|Lost to Follow-up|2
4900805|NCT00619476|16884946|P1|Overall Study|Lost to Follow-up|1
4900806|NCT00619476|16884943|P4|Overall Study|Protocol Violation|9
4900807|NCT00619476|16884944|P3|Overall Study|Protocol Violation|4
4900808|NCT00619476|16884945|P2|Overall Study|Protocol Violation|4
4900809|NCT00619476|16884946|P1|Overall Study|Protocol Violation|5
4900810|NCT00619476|16884943|P4|Overall Study|Lack of Efficacy|4
4900811|NCT00619476|16884944|P3|Overall Study|Lack of Efficacy|1
4900812|NCT00619476|16884945|P2|Overall Study|Lack of Efficacy|1
4900813|NCT00619476|16884946|P1|Overall Study|Lack of Efficacy|6
4900814|NCT00619476|16884943|P4|Overall Study|Adverse Event|16
4900815|NCT00619476|16884944|P3|Overall Study|Adverse Event|12
4900816|NCT00619476|16884945|P2|Overall Study|Adverse Event|6
4900817|NCT00619476|16884946|P1|Overall Study|Adverse Event|12
4900818|NCT00619385|16885031|P3|Overall Study|Other|1
4900819|NCT00619385|16885032|P2|Overall Study|Other|2
4900820|NCT00619385|16885033|P1|Overall Study|Other|1
4900821|NCT00619385|16885031|P3|Overall Study|Adverse Event|3
4900822|NCT00619385|16885032|P2|Overall Study|Adverse Event|0
4900823|NCT00619385|16885033|P1|Overall Study|Adverse Event|0
4900824|NCT00619359|16885048|P2|Overall Study|Progressive Disease|1
4900825|NCT00619359|16885049|P1|Overall Study|Progressive Disease|3
4900826|NCT00619359|16885048|P2|Overall Study|Withdrawal by Subject|20
4900827|NCT00619359|16885049|P1|Overall Study|Withdrawal by Subject|19
4900828|NCT00619359|16885048|P2|Overall Study|Protocol Violation|1
4900829|NCT00619359|16885049|P1|Overall Study|Protocol Violation|1
4900830|NCT00619359|16885048|P2|Overall Study|Physician Decision|7
4900831|NCT00619359|16885049|P1|Overall Study|Physician Decision|0
4900832|NCT00619359|16885048|P2|Overall Study|Lost to Follow-up|16
4900833|NCT00619359|16885049|P1|Overall Study|Lost to Follow-up|12
4900834|NCT00619359|16885048|P2|Overall Study|Adverse Event|36
4900835|NCT00619359|16885049|P1|Overall Study|Adverse Event|32
4900836|NCT00619307|16885061|P2|Overall Study|MS attack plus steroids|1
4900837|NCT00619307|16885062|P1|Overall Study|MS attack plus steroids|0
4900838|NCT00619307|16885061|P2|Overall Study|Severe migraine|1
4900839|NCT00619307|16885062|P1|Overall Study|Severe migraine|0
4900840|NCT00619307|16885061|P2|Overall Study|Withdrew consent|0
4900841|NCT00619307|16885062|P1|Overall Study|Withdrew consent|1
4900842|NCT00619307|16885061|P2|Overall Study|Protocol Violation|0
4900843|NCT00619307|16885062|P1|Overall Study|Protocol Violation|3
4900844|NCT00619307|16885061|P2|Overall Study|Lost to Follow-up|1
4900845|NCT00619307|16885062|P1|Overall Study|Lost to Follow-up|0
4900846|NCT00619307|16885061|P2|Overall Study|Adverse Event|1
4900847|NCT00619307|16885062|P1|Overall Study|Adverse Event|0
4900848|NCT00619229|16885099|P2|Overall Study|Investigator planned Cataract Operation|0
4900849|NCT00619229|16885100|P1|Overall Study|Investigator planned Cataract Operation|1
4900850|NCT00619229|16885099|P2|Overall Study|Termination of the Study by the Sponsor|1
4900851|NCT00619229|16885100|P1|Overall Study|Termination of the Study by the Sponsor|1
4900852|NCT00619229|16885099|P2|Overall Study|Lost to Follow-up|0
4900853|NCT00619229|16885100|P1|Overall Study|Lost to Follow-up|1
4900854|NCT00619229|16885099|P2|Overall Study|Withdrawal by Subject|1
4900855|NCT00619229|16885100|P1|Overall Study|Withdrawal by Subject|1
4900856|NCT00619177|16885139|P1|Overall Study|Not specified reasons|6
4900857|NCT00619177|16885139|P1|Overall Study|Missing termination information|481
4900858|NCT00619177|16885139|P1|Overall Study|Lack of Efficacy|1
4900859|NCT00619177|16885139|P1|Overall Study|Lost to Follow-up|2
4900860|NCT00619177|16885139|P1|Overall Study|Adverse Event|18
4900861|NCT00619151|16885149|P2|Overall Study|Study terminated prior to followup|0
4900862|NCT00619151|16885150|P1|Overall Study|Study terminated prior to followup|1
4900863|NCT00619112|16885160|P2|Overall Study|Adverse Event|2
4900864|NCT00619112|16885161|P1|Overall Study|Adverse Event|1
4900865|NCT00619099|16885182|P2|Overall Study|Physician Decision|6
4900866|NCT00619099|16885183|P1|Overall Study|Physician Decision|9
4900867|NCT00619099|16885182|P2|Overall Study|Withdrawal by Subject|2
4900868|NCT00619099|16885183|P1|Overall Study|Withdrawal by Subject|10
4900869|NCT00619099|16885182|P2|Overall Study|Emergence of Clinically Significant Lab|2
4900870|NCT00619099|16885183|P1|Overall Study|Emergence of Clinically Significant Lab|1
4900871|NCT00619099|16885182|P2|Overall Study|Adverse Event|3
4900872|NCT00619099|16885183|P1|Overall Study|Adverse Event|4
4900873|NCT00619099|16885182|P2|Overall Study|Allogeneic Bone Marrow Transplantation|1
4900874|NCT00619099|16885183|P1|Overall Study|Allogeneic Bone Marrow Transplantation|2
4900875|NCT00619099|16885182|P2|Overall Study|Progressive Disease|5
4900876|NCT00619099|16885183|P1|Overall Study|Progressive Disease|7
4900877|NCT00618995|16885205|P4|Period 4|Adverse Event|0
4900878|NCT00618995|16885206|P3|Period 4|Adverse Event|0
4900879|NCT00618995|16885207|P2|Period 4|Adverse Event|0
4900880|NCT00618995|16885208|P1|Period 4|Adverse Event|1
4900881|NCT00618995|16885205|P4|Period 2|Protocol Violation|0
4900882|NCT00618995|16885206|P3|Period 2|Protocol Violation|1
4900883|NCT00618995|16885207|P2|Period 2|Protocol Violation|0
4900884|NCT00618995|16885208|P1|Period 2|Protocol Violation|0
4900885|NCT00618995|16885205|P4|Period 1|Protocol Violation|0
4900886|NCT00618995|16885206|P3|Period 1|Protocol Violation|1
4900887|NCT00618995|16885207|P2|Period 1|Protocol Violation|1
4900888|NCT00618995|16885208|P1|Period 1|Protocol Violation|0
4900889|NCT00618995|16885205|P4|Period 1|Adverse Event|0
4900890|NCT00618995|16885206|P3|Period 1|Adverse Event|1
4900891|NCT00618995|16885207|P2|Period 1|Adverse Event|0
4900892|NCT00618995|16885208|P1|Period 1|Adverse Event|0
4900893|NCT00618982|16885222|P1|Overall Study|ongoing, still treated with study med.|25
4900894|NCT00618982|16885222|P1|Overall Study|Protocol Violation|1
4900895|NCT00618982|16885222|P1|Overall Study|Withdrawal by Subject|1
4900896|NCT00618982|16885222|P1|Overall Study|Adverse Event|23
4900897|NCT00618956|16885245|P2|Overall Study|did not meet criteria, non-compliance|1
4900898|NCT00618956|16885246|P1|Overall Study|did not meet criteria, non-compliance|2
4900899|NCT00618956|16885245|P2|Overall Study|Protocol Violation|2
4900900|NCT00618956|16885246|P1|Overall Study|Protocol Violation|2
4900901|NCT00618956|16885245|P2|Overall Study|Lost to Follow-up|5
4900902|NCT00618956|16885246|P1|Overall Study|Lost to Follow-up|4
4900903|NCT00618956|16885245|P2|Overall Study|Withdrawal by Subject|7
4900904|NCT00618956|16885246|P1|Overall Study|Withdrawal by Subject|5
4900905|NCT00618956|16885245|P2|Overall Study|Lack of Efficacy|1
4900906|NCT00618956|16885246|P1|Overall Study|Lack of Efficacy|2
4900907|NCT00618956|16885245|P2|Overall Study|Adverse Event|34
4900908|NCT00618956|16885246|P1|Overall Study|Adverse Event|10
4900909|NCT00618826|16885271|P1|Overall Study|Adverse Event|1
4900910|NCT00618813|16885276|P1|Overall Study|Withdrawal by Subject|1
4900911|NCT00618813|16885276|P1|Overall Study|Physician Decision|2
4900912|NCT00618813|16885276|P1|Overall Study|Lack of Efficacy|1
4900913|NCT00618787|16885286|P2|Overall Study|Lost to Follow-up|0
4900914|NCT00618787|16885287|P1|Overall Study|Lost to Follow-up|1
4900915|NCT00618787|16885286|P2|Overall Study|Withdrawal by Subject|1
4900916|NCT00618787|16885287|P1|Overall Study|Withdrawal by Subject|2
4900917|NCT00618787|16885286|P2|Overall Study|Adverse Event|1
4900918|NCT00618787|16885287|P1|Overall Study|Adverse Event|0
4900919|NCT00618774|16885295|P2|Overall Study|Withdrawal by Subject|0
4900920|NCT00618774|16885296|P1|Overall Study|Withdrawal by Subject|1
4900921|NCT00618774|16885295|P2|Overall Study|Adverse Event|3
4900922|NCT00618774|16885296|P1|Overall Study|Adverse Event|5
4900923|NCT00618748|16885329|P3|Overall Study|Withdrawal by Subject|5
4900924|NCT00618748|16885330|P2|Overall Study|Withdrawal by Subject|1
4900925|NCT00618748|16885331|P1|Overall Study|Withdrawal by Subject|4
4900926|NCT00618748|16885329|P3|Overall Study|Physician Decision|1
4900927|NCT00618748|16885330|P2|Overall Study|Physician Decision|1
4900928|NCT00618748|16885331|P1|Overall Study|Physician Decision|3
4900929|NCT00618748|16885329|P3|Overall Study|Adverse Event|8
4900930|NCT00618748|16885330|P2|Overall Study|Adverse Event|3
4900931|NCT00618748|16885331|P1|Overall Study|Adverse Event|4
4900932|NCT00618722|16885376|P4|Overall Study|Miscellaneous Reasons|1
4900933|NCT00618722|16885377|P3|Overall Study|Miscellaneous Reasons|1
4900934|NCT00618722|16885378|P2|Overall Study|Miscellaneous Reasons|0
4900935|NCT00618722|16885379|P1|Overall Study|Miscellaneous Reasons|0
4900936|NCT00618722|16885376|P4|Overall Study|Lost to Follow-up|2
4900937|NCT00618722|16885377|P3|Overall Study|Lost to Follow-up|0
4900938|NCT00618722|16885378|P2|Overall Study|Lost to Follow-up|0
4900939|NCT00618722|16885379|P1|Overall Study|Lost to Follow-up|2
4900940|NCT00618722|16885376|P4|Overall Study|Inability to Complete Study Procedure|0
4900941|NCT00618722|16885377|P3|Overall Study|Inability to Complete Study Procedure|0
4900942|NCT00618722|16885378|P2|Overall Study|Inability to Complete Study Procedure|1
4900943|NCT00618722|16885379|P1|Overall Study|Inability to Complete Study Procedure|0
4900944|NCT00618722|16885376|P4|Overall Study|Patient Request|1
4900945|NCT00618722|16885377|P3|Overall Study|Patient Request|1
4900946|NCT00618722|16885378|P2|Overall Study|Patient Request|1
4900947|NCT00618722|16885379|P1|Overall Study|Patient Request|1
4900948|NCT00618722|16885376|P4|Overall Study|Refusal of Treatment|0
4900949|NCT00618722|16885377|P3|Overall Study|Refusal of Treatment|1
4900950|NCT00618722|16885378|P2|Overall Study|Refusal of Treatment|0
4900951|NCT00618722|16885379|P1|Overall Study|Refusal of Treatment|0
4900952|NCT00618618|16885417|P4|Overall Study|Death|0
4900953|NCT00618618|16885418|P3|Overall Study|Death|0
4900954|NCT00618618|16885419|P2|Overall Study|Death|1
4900955|NCT00618618|16885420|P1|Overall Study|Death|0
4900956|NCT00618618|16885417|P4|Overall Study|Did Not Meet Entry Criteria|0
4900957|NCT00618618|16885418|P3|Overall Study|Did Not Meet Entry Criteria|1
4900958|NCT00618618|16885419|P2|Overall Study|Did Not Meet Entry Criteria|0
4900959|NCT00618618|16885420|P1|Overall Study|Did Not Meet Entry Criteria|0
4900960|NCT00618618|16885417|P4|Overall Study|Non-compliance|0
4900961|NCT00618618|16885418|P3|Overall Study|Non-compliance|0
4900962|NCT00618618|16885419|P2|Overall Study|Non-compliance|1
4900963|NCT00618618|16885420|P1|Overall Study|Non-compliance|1
4900964|NCT00618618|16885417|P4|Overall Study|Lost to Follow-up|1
4900965|NCT00618618|16885418|P3|Overall Study|Lost to Follow-up|0
4900966|NCT00618618|16885419|P2|Overall Study|Lost to Follow-up|0
4900967|NCT00618618|16885420|P1|Overall Study|Lost to Follow-up|3
4900968|NCT00618618|16885417|P4|Overall Study|Inability to Complete Study Procedures|0
4900969|NCT00618618|16885418|P3|Overall Study|Inability to Complete Study Procedures|0
4900970|NCT00618618|16885419|P2|Overall Study|Inability to Complete Study Procedures|1
4900971|NCT00618618|16885420|P1|Overall Study|Inability to Complete Study Procedures|0
4900972|NCT00618618|16885417|P4|Overall Study|Patient Request|0
4900973|NCT00618618|16885418|P3|Overall Study|Patient Request|2
4900974|NCT00618618|16885419|P2|Overall Study|Patient Request|0
4900975|NCT00618618|16885420|P1|Overall Study|Patient Request|0
4900976|NCT00618514|16885479|P3|Overall Study|Lost to Follow-up|4
4900977|NCT00618514|16885480|P2|Overall Study|Lost to Follow-up|12
4900978|NCT00618514|16885481|P1|Overall Study|Lost to Follow-up|11
4900979|NCT00618449|16885501|P2|Overall Study|Lost to Follow-up|110
4900980|NCT00618449|16885502|P1|Overall Study|Lost to Follow-up|98
4900981|NCT00618410|16885521|P2|Washout Period (2 Weeks)|Physician Decision|1
4900982|NCT00618410|16885522|P1|Washout Period (2 Weeks)|Physician Decision|0
4900983|NCT00618371|16885538|P1|Overall Study|Withdrawal by Subject|2
4900984|NCT00618072|16885571|P3|Overall Study|Physician Decision|1
4900985|NCT00618072|16885572|P2|Overall Study|Physician Decision|1
4900986|NCT00618072|16885573|P1|Overall Study|Physician Decision|0
4900987|NCT00618072|16885571|P3|Overall Study|Lost to Follow-up|3
4900988|NCT00618072|16885572|P2|Overall Study|Lost to Follow-up|0
4900989|NCT00618072|16885573|P1|Overall Study|Lost to Follow-up|2
4900990|NCT00617929|16885629|P1|Overall Study|Physician Decision|1
4900991|NCT00617903|16885641|P2|Overall Study|noncompliance|1
4900992|NCT00617903|16885642|P1|Overall Study|noncompliance|0
4900993|NCT00617903|16885641|P2|Overall Study|Adverse Event|1
4900994|NCT00617903|16885642|P1|Overall Study|Adverse Event|0
4900995|NCT00617903|16885641|P2|Overall Study|Lack of Efficacy|1
4900996|NCT00617903|16885642|P1|Overall Study|Lack of Efficacy|0
4900997|NCT00617903|16885641|P2|Overall Study|Lost to Follow-up|1
4900998|NCT00617903|16885642|P1|Overall Study|Lost to Follow-up|1
4900999|NCT00617903|16885641|P2|Overall Study|Withdrawal by Subject|3
4901000|NCT00617903|16885642|P1|Overall Study|Withdrawal by Subject|2
4901001|NCT00617890|16885688|P4|Overall Study|Not treated|1
4901002|NCT00617890|16885689|P3|Overall Study|Not treated|1
4901003|NCT00617890|16885690|P2|Overall Study|Not treated|0
4901004|NCT00617890|16885691|P1|Overall Study|Not treated|1
4901005|NCT00617890|16885688|P4|Overall Study|Adverse Event|8
4901006|NCT00617890|16885689|P3|Overall Study|Adverse Event|3
4901007|NCT00617890|16885690|P2|Overall Study|Adverse Event|0
4901008|NCT00617890|16885691|P1|Overall Study|Adverse Event|1
4901009|NCT00617890|16885688|P4|Overall Study|Protocol Violation|0
4901010|NCT00617890|16885689|P3|Overall Study|Protocol Violation|0
4901011|NCT00617890|16885690|P2|Overall Study|Protocol Violation|1
4901012|NCT00617890|16885691|P1|Overall Study|Protocol Violation|2
4901013|NCT00617890|16885688|P4|Overall Study|Withdrawal by Subject|2
4901014|NCT00617890|16885689|P3|Overall Study|Withdrawal by Subject|0
4901015|NCT00617890|16885690|P2|Overall Study|Withdrawal by Subject|1
4901016|NCT00617890|16885691|P1|Overall Study|Withdrawal by Subject|4
4901017|NCT00617890|16885688|P4|Overall Study|Lost to Follow-up|2
4901018|NCT00617890|16885689|P3|Overall Study|Lost to Follow-up|1
4901019|NCT00617890|16885690|P2|Overall Study|Lost to Follow-up|0
4901020|NCT00617890|16885691|P1|Overall Study|Lost to Follow-up|0
4901021|NCT00617890|16885688|P4|Overall Study|Lack of Efficacy|97
4901022|NCT00617890|16885689|P3|Overall Study|Lack of Efficacy|30
4901023|NCT00617890|16885690|P2|Overall Study|Lack of Efficacy|26
4901024|NCT00617890|16885691|P1|Overall Study|Lack of Efficacy|23
4901025|NCT00617890|16885688|P4|Overall Study|Treatment ongoing at data cut-off|5
4901026|NCT00617890|16885689|P3|Overall Study|Treatment ongoing at data cut-off|0
4901027|NCT00617890|16885690|P2|Overall Study|Treatment ongoing at data cut-off|0
4901028|NCT00617890|16885691|P1|Overall Study|Treatment ongoing at data cut-off|0
4901029|NCT00617851|16885727|P4|Overall Study|Unable to classify|0
4901030|NCT00617851|16885728|P3|Overall Study|Unable to classify|1
4901031|NCT00617851|16885729|P2|Overall Study|Unable to classify|0
4901032|NCT00617851|16885730|P1|Overall Study|Unable to classify|1
4901033|NCT00617851|16885727|P4|Overall Study|Inappropriate Enrollment|1
4901034|NCT00617851|16885728|P3|Overall Study|Inappropriate Enrollment|1
4901035|NCT00617851|16885729|P2|Overall Study|Inappropriate Enrollment|4
4901036|NCT00617851|16885730|P1|Overall Study|Inappropriate Enrollment|5
4901037|NCT00617851|16885727|P4|Overall Study|Lost to Follow-up|19
4901038|NCT00617851|16885728|P3|Overall Study|Lost to Follow-up|31
4901039|NCT00617851|16885729|P2|Overall Study|Lost to Follow-up|29
4901040|NCT00617851|16885730|P1|Overall Study|Lost to Follow-up|27
4901041|NCT00617851|16885727|P4|Overall Study|Withdrawal by Subject|4
4901042|NCT00617851|16885728|P3|Overall Study|Withdrawal by Subject|12
4901043|NCT00617851|16885729|P2|Overall Study|Withdrawal by Subject|7
4901044|NCT00617851|16885730|P1|Overall Study|Withdrawal by Subject|14
4901045|NCT00617851|16885727|P4|Overall Study|Death|1
4901046|NCT00617851|16885728|P3|Overall Study|Death|0
4901047|NCT00617851|16885729|P2|Overall Study|Death|0
4901048|NCT00617851|16885730|P1|Overall Study|Death|0
4901049|NCT00617773|16885768|P1|Overall Study|Protocol Violation|1
4901050|NCT00617773|16885768|P1|Overall Study|Progressive disease|19
4901051|NCT00617773|16885768|P1|Overall Study|Death|1
4901052|NCT00617773|16885768|P1|Overall Study|Withdrawal by Subject|1
4901053|NCT00617773|16885768|P1|Overall Study|Lack of compliance with the protocol|1
4901054|NCT00617773|16885768|P1|Overall Study|Physician Decision|1
4901055|NCT00617734|16885785|P2|Overall Study|Lost to Follow-up|1
4901056|NCT00617734|16885786|P1|Overall Study|Lost to Follow-up|0
4901057|NCT00617734|16885785|P2|Overall Study|Found Ineligible After Randomization|4
4901058|NCT00617734|16885786|P1|Overall Study|Found Ineligible After Randomization|1
4901059|NCT00617734|16885785|P2|Overall Study|Protocol Violation|0
4901060|NCT00617734|16885786|P1|Overall Study|Protocol Violation|1
4901061|NCT00617734|16885785|P2|Overall Study|Adverse Event|1
4901062|NCT00617734|16885786|P1|Overall Study|Adverse Event|4
4901063|NCT00617734|16885785|P2|Overall Study|Withdrew Consent|0
4901064|NCT00617734|16885786|P1|Overall Study|Withdrew Consent|2
4901065|NCT00617708|16885807|P3|Overall Study|Not eligible|5
4901066|NCT00617708|16885808|P2|Overall Study|Not eligible|3
4901067|NCT00617708|16885809|P1|Overall Study|Not eligible|1
4901068|NCT00617708|16885807|P3|Overall Study|Not protocol specified|2
4901069|NCT00617708|16885808|P2|Overall Study|Not protocol specified|4
4901070|NCT00617708|16885809|P1|Overall Study|Not protocol specified|1
4901071|NCT00617708|16885807|P3|Overall Study|Progression/Relapse|36
4901072|NCT00617708|16885808|P2|Overall Study|Progression/Relapse|40
4901073|NCT00617708|16885809|P1|Overall Study|Progression/Relapse|7
4901074|NCT00617708|16885807|P3|Overall Study|Death|5
4901075|NCT00617708|16885808|P2|Overall Study|Death|6
4901076|NCT00617708|16885809|P1|Overall Study|Death|0
4901077|NCT00617708|16885807|P3|Overall Study|Withdrawal by Subject|7
4901078|NCT00617708|16885808|P2|Overall Study|Withdrawal by Subject|1
4901079|NCT00617708|16885809|P1|Overall Study|Withdrawal by Subject|1
4901080|NCT00617708|16885807|P3|Overall Study|Adverse Event|9
4901081|NCT00617708|16885808|P2|Overall Study|Adverse Event|6
4901082|NCT00617708|16885809|P1|Overall Study|Adverse Event|0
4901083|NCT00617669|16885826|P2|Overall Study|Patients randomized but not treated|3
4901084|NCT00617669|16885827|P1|Overall Study|Patients randomized but not treated|2
4901085|NCT00617669|16885826|P2|Overall Study|Reason not otherwise captured, eg; death|290
4901086|NCT00617669|16885827|P1|Overall Study|Reason not otherwise captured, eg; death|265
4901087|NCT00617669|16885826|P2|Overall Study|Protocol Violation|3
4901088|NCT00617669|16885827|P1|Overall Study|Protocol Violation|2
4901089|NCT00617669|16885826|P2|Overall Study|Adverse Event|76
4901090|NCT00617669|16885827|P1|Overall Study|Adverse Event|87
4901091|NCT00617669|16885826|P2|Overall Study|Lost to Follow-up|2
4901092|NCT00617669|16885827|P1|Overall Study|Lost to Follow-up|3
4901093|NCT00617669|16885826|P2|Overall Study|Withdrawal by Subject|77
4901094|NCT00617669|16885827|P1|Overall Study|Withdrawal by Subject|71
4901095|NCT00617604|16885849|P2|Overall Study|Randomized but Never Received Study Drug|3
4901096|NCT00617604|16885850|P1|Overall Study|Randomized but Never Received Study Drug|3
4901097|NCT00617604|16885849|P2|Overall Study|Withdrawal by Subject|6
4901098|NCT00617604|16885850|P1|Overall Study|Withdrawal by Subject|4
4901099|NCT00617604|16885849|P2|Overall Study|Miscellaneous Reasons|10
4901100|NCT00617604|16885850|P1|Overall Study|Miscellaneous Reasons|8
4901101|NCT00617604|16885849|P2|Overall Study|Lost to Follow-up|0
4901102|NCT00617604|16885850|P1|Overall Study|Lost to Follow-up|1
4901103|NCT00617604|16885849|P2|Overall Study|Death|1
4901104|NCT00617604|16885850|P1|Overall Study|Death|2
4901105|NCT00617591|16885894|P1|Overall Study|Withdrew consent during Maintenance|6
4901106|NCT00617591|16885894|P1|Overall Study|Withdrew consent during Induction|4
4901107|NCT00617461|16885910|P2|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2
4901108|NCT00617461|16885911|P1|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1
4901109|NCT00617461|16885910|P2|6-Day Down-Titration Period|Withdrawal by Subject|0
4901110|NCT00617461|16885911|P1|6-Day Down-Titration Period|Withdrawal by Subject|1
4901111|NCT00617461|16885910|P2|Second Treatment Intervention Period|Lack of Efficacy|3
4901112|NCT00617461|16885911|P1|Second Treatment Intervention Period|Lack of Efficacy|0
4901113|NCT00617461|16885910|P2|Second Treatment Intervention Period|Adverse Event|1
4901114|NCT00617461|16885911|P1|Second Treatment Intervention Period|Adverse Event|0
4901115|NCT00617461|16885910|P2|4-Day Crossover Period|Withdrawal by Subject|0
4901116|NCT00617461|16885911|P1|4-Day Crossover Period|Withdrawal by Subject|1
4901117|NCT00617461|16885910|P2|First Treatment Intervention Period|Withdrawal by Subject|0
4901118|NCT00617461|16885911|P1|First Treatment Intervention Period|Withdrawal by Subject|4
4901119|NCT00617461|16885910|P2|First Treatment Intervention Period|Investigator Discretion|1
4901120|NCT00617461|16885911|P1|First Treatment Intervention Period|Investigator Discretion|1
4901121|NCT00617461|16885910|P2|First Treatment Intervention Period|Lost to Follow-up|1
4901122|NCT00617461|16885911|P1|First Treatment Intervention Period|Lost to Follow-up|0
4901123|NCT00617461|16885910|P2|First Treatment Intervention Period|Protocol Violation|1
4901124|NCT00617461|16885911|P1|First Treatment Intervention Period|Protocol Violation|2
4901125|NCT00617461|16885910|P2|First Treatment Intervention Period|Lack of Efficacy|0
4901126|NCT00617461|16885911|P1|First Treatment Intervention Period|Lack of Efficacy|1
4901127|NCT00617461|16885910|P2|First Treatment Intervention Period|Adverse Event|0
4901128|NCT00617461|16885911|P1|First Treatment Intervention Period|Adverse Event|2
4901129|NCT00617409|16885967|P3|Overall Study|Alternative Therapy|0
4901130|NCT00617409|16885968|P2|Overall Study|Alternative Therapy|2
4901131|NCT00617409|16885969|P1|Overall Study|Alternative Therapy|1
4901132|NCT00617409|16885967|P3|Overall Study|Death|4
4901133|NCT00617409|16885968|P2|Overall Study|Death|5
4901134|NCT00617409|16885969|P1|Overall Study|Death|3
4901135|NCT00617409|16885967|P3|Overall Study|Disease Progression|18
4901136|NCT00617409|16885968|P2|Overall Study|Disease Progression|8
4901137|NCT00617409|16885969|P1|Overall Study|Disease Progression|8
4901138|NCT00617409|16885967|P3|Overall Study|Adverse Event|3
4901139|NCT00617409|16885968|P2|Overall Study|Adverse Event|2
4901140|NCT00617409|16885969|P1|Overall Study|Adverse Event|0
4901141|NCT00617409|16885967|P3|Overall Study|Withdrawal by Subject|2
4901142|NCT00617409|16885968|P2|Overall Study|Withdrawal by Subject|1
4901143|NCT00617409|16885969|P1|Overall Study|Withdrawal by Subject|4
4901144|NCT00617357|16885984|P1|Overall Study|Physician Decision|1
4901145|NCT00617357|16885984|P1|Overall Study|Withdrawal by Subject|1
4901146|NCT00617357|16885984|P1|Overall Study|insurance concerns|2
4901147|NCT00617357|16885984|P1|Overall Study|Death|5
4901148|NCT00617357|16885984|P1|Overall Study|Lost to Follow-up|7
4901149|NCT00617344|16885997|P3|Overall Study|Withdrawal by Subject|2
4901150|NCT00617344|16885998|P2|Overall Study|Withdrawal by Subject|9
4901151|NCT00617344|16885999|P1|Overall Study|Withdrawal by Subject|8
4901152|NCT00617344|16885997|P3|Overall Study|Lost to Follow-up|1
4901153|NCT00617344|16885998|P2|Overall Study|Lost to Follow-up|4
4901154|NCT00617344|16885999|P1|Overall Study|Lost to Follow-up|5
4901155|NCT00617344|16885997|P3|Overall Study|Protocol Violation|5
4901156|NCT00617344|16885998|P2|Overall Study|Protocol Violation|8
4901157|NCT00617344|16885999|P1|Overall Study|Protocol Violation|10
4901158|NCT00617344|16885997|P3|Overall Study|Other Adverse Event|0
4901159|NCT00617344|16885998|P2|Overall Study|Other Adverse Event|1
4901160|NCT00617344|16885999|P1|Overall Study|Other Adverse Event|1
4901161|NCT00617344|16885997|P3|Overall Study|Serious adverse event|0
4901162|NCT00617344|16885998|P2|Overall Study|Serious adverse event|0
4901163|NCT00617344|16885999|P1|Overall Study|Serious adverse event|1
4901164|NCT00617305|16886027|P3|Overall Study|Withdrawal by Subject|0
4901165|NCT00617305|16886028|P2|Overall Study|Withdrawal by Subject|0
4901166|NCT00617305|16886029|P1|Overall Study|Withdrawal by Subject|1
4901167|NCT00617305|16886027|P3|Overall Study|Protocol Violation|1
4901168|NCT00617305|16886028|P2|Overall Study|Protocol Violation|0
4901169|NCT00617305|16886029|P1|Overall Study|Protocol Violation|1
4901170|NCT00617305|16886027|P3|Overall Study|Physician Decision|0
4901171|NCT00617305|16886028|P2|Overall Study|Physician Decision|0
4901172|NCT00617305|16886029|P1|Overall Study|Physician Decision|1
4901173|NCT00617305|16886027|P3|Overall Study|Death|0
4901174|NCT00617305|16886028|P2|Overall Study|Death|0
4901175|NCT00617305|16886029|P1|Overall Study|Death|1
4901176|NCT00617305|16886027|P3|Overall Study|Adverse Event|0
4901177|NCT00617305|16886028|P2|Overall Study|Adverse Event|0
4901178|NCT00617305|16886029|P1|Overall Study|Adverse Event|4
4901179|NCT00617279|16886085|P2|Overall Study|Death|2
4901180|NCT00617279|16886086|P1|Overall Study|Death|1
4901181|NCT00617279|16886085|P2|Overall Study|Lost to Follow-up|0
4901182|NCT00617279|16886086|P1|Overall Study|Lost to Follow-up|1
4901183|NCT00617279|16886085|P2|Overall Study|Graft abandonment|0
4901184|NCT00617279|16886086|P1|Overall Study|Graft abandonment|2
4901185|NCT00617279|16886085|P2|Overall Study|Study terminated by Sponsor|15
4901186|NCT00617279|16886086|P1|Overall Study|Study terminated by Sponsor|10
4901187|NCT00617240|16886142|P2|Overall Study|Lack of Efficacy|0
4901188|NCT00617240|16886143|P1|Overall Study|Lack of Efficacy|1
4901189|NCT00617201|16886163|P2|Overall Study|Lost to Follow-up|13
4901190|NCT00617201|16886164|P1|Overall Study|Lost to Follow-up|9
4901191|NCT00617123|16886192|P2|Study Treatment Period|Noncompliance with Protocol|1
4901192|NCT00617123|16886193|P1|Study Treatment Period|Noncompliance with Protocol|0
4901193|NCT00617123|16886192|P2|Study Treatment Period|Did Not Meet Protocol Eligibility|0
4901194|NCT00617123|16886193|P1|Study Treatment Period|Did Not Meet Protocol Eligibility|2
4901195|NCT00617123|16886192|P2|Study Treatment Period|Adverse Event|3
4901196|NCT00617123|16886193|P1|Study Treatment Period|Adverse Event|7
4901197|NCT00617123|16886192|P2|Study Treatment Period|Withdrawal by Subject|12
4901198|NCT00617123|16886193|P1|Study Treatment Period|Withdrawal by Subject|8
4901199|NCT00617123|16886192|P2|Referral Screening Period|Adverse Event|1
4901200|NCT00617123|16886193|P1|Referral Screening Period|Adverse Event|0
4901201|NCT00617123|16886192|P2|Referral Screening Period|Did Not Wish To Continue|1
4901202|NCT00617123|16886193|P1|Referral Screening Period|Did Not Wish To Continue|3
4901203|NCT00617123|16886192|P2|Referral Screening Period|Did Not Meet Protocol Eligibility|24
4901204|NCT00617123|16886193|P1|Referral Screening Period|Did Not Meet Protocol Eligibility|36
4901205|NCT00617084|16886224|P2|Overall Study|Missed 12 Months visit|19
4901206|NCT00617084|16886225|P1|Overall Study|Missed 12 Months visit|16
4901207|NCT00617084|16886224|P2|Overall Study|Withdrawal by Subject|7
4901208|NCT00617084|16886225|P1|Overall Study|Withdrawal by Subject|5
4901209|NCT00616967|16886278|P3|Overall Study|Withdrawal by Subject|1
4901210|NCT00616967|16886279|P2|Overall Study|Withdrawal by Subject|0
4901211|NCT00616967|16886280|P1|Overall Study|Withdrawal by Subject|0
4901212|NCT00616941|16886305|P3|Overall Study|Vaccination Suspended|3
4901213|NCT00616941|16886306|P2|Overall Study|Vaccination Suspended|0
4901214|NCT00616941|16886307|P1|Overall Study|Vaccination Suspended|0
4901215|NCT00616941|16886305|P3|Overall Study|Unrelated Medical Illness/Complication|0
4901216|NCT00616941|16886306|P2|Overall Study|Unrelated Medical Illness/Complication|2
4901217|NCT00616941|16886307|P1|Overall Study|Unrelated Medical Illness/Complication|0
4901218|NCT00616941|16886305|P3|Overall Study|Subject Non-compliance|1
4901219|NCT00616941|16886306|P2|Overall Study|Subject Non-compliance|0
4901220|NCT00616941|16886307|P1|Overall Study|Subject Non-compliance|0
4901221|NCT00616941|16886305|P3|Overall Study|Adverse Event|1
4901222|NCT00616941|16886306|P2|Overall Study|Adverse Event|1
4901223|NCT00616941|16886307|P1|Overall Study|Adverse Event|0
4901224|NCT00616941|16886305|P3|Overall Study|Progressive Disease|1
4901225|NCT00616941|16886306|P2|Overall Study|Progressive Disease|2
4901226|NCT00616941|16886307|P1|Overall Study|Progressive Disease|1
4901227|NCT00616928|16886334|P4|Overall Study|Lost to Follow-up|0
4901228|NCT00616928|16886335|P3|Overall Study|Lost to Follow-up|0
4901229|NCT00616928|16886336|P2|Overall Study|Lost to Follow-up|7
4901230|NCT00616928|16886337|P1|Overall Study|Lost to Follow-up|5
4901231|NCT00616928|16886334|P4|Overall Study|Other|5
4901232|NCT00616928|16886335|P3|Overall Study|Other|15
4901233|NCT00616928|16886336|P2|Overall Study|Other|8
4901234|NCT00616928|16886337|P1|Overall Study|Other|51
4901235|NCT00616928|16886334|P4|Overall Study|Adverse Event|2
4901236|NCT00616928|16886335|P3|Overall Study|Adverse Event|2
4901237|NCT00616928|16886336|P2|Overall Study|Adverse Event|3
4901238|NCT00616928|16886337|P1|Overall Study|Adverse Event|6
4901239|NCT00616902|16886401|P2|Overall Study|Termination of study|6
4901240|NCT00616902|16886402|P1|Overall Study|Termination of study|6
4901241|NCT00616759|16886445|P2|Overall Study|Withdrawal by Subject|2
4901242|NCT00616759|16886446|P1|Overall Study|Withdrawal by Subject|1
4901243|NCT00616759|16886445|P2|Overall Study|Physician Decision|0
4901244|NCT00616759|16886446|P1|Overall Study|Physician Decision|2
4901245|NCT00616655|16886455|P3|Overall Study|Other|5
4901246|NCT00616655|16886456|P2|Overall Study|Other|6
4901247|NCT00616655|16886457|P1|Overall Study|Other|6
4901248|NCT00616655|16886455|P3|Overall Study|Does not meet in/ex criteria|2
4901249|NCT00616655|16886456|P2|Overall Study|Does not meet in/ex criteria|0
4901250|NCT00616655|16886457|P1|Overall Study|Does not meet in/ex criteria|0
4901251|NCT00616655|16886455|P3|Overall Study|Withdrawal by Subject|11
4901252|NCT00616655|16886456|P2|Overall Study|Withdrawal by Subject|7
4901253|NCT00616655|16886457|P1|Overall Study|Withdrawal by Subject|9
4901254|NCT00616655|16886455|P3|Overall Study|Protocol Violation|3
4901255|NCT00616655|16886456|P2|Overall Study|Protocol Violation|4
4901256|NCT00616655|16886457|P1|Overall Study|Protocol Violation|2
4901257|NCT00616655|16886455|P3|Overall Study|Lost to Follow-up|10
4901258|NCT00616655|16886456|P2|Overall Study|Lost to Follow-up|12
4901259|NCT00616655|16886457|P1|Overall Study|Lost to Follow-up|3
4901260|NCT00616655|16886455|P3|Overall Study|Lack of Efficacy|5
4901261|NCT00616655|16886456|P2|Overall Study|Lack of Efficacy|5
4901262|NCT00616655|16886457|P1|Overall Study|Lack of Efficacy|5
4901263|NCT00616655|16886455|P3|Overall Study|Adverse Event|12
4901264|NCT00616655|16886456|P2|Overall Study|Adverse Event|7
4901265|NCT00616655|16886457|P1|Overall Study|Adverse Event|10
4901266|NCT00616642|16886497|P2|Overall Study|Withdrawal by Subject|1
4901267|NCT00616642|16886498|P1|Overall Study|Withdrawal by Subject|0
4901268|NCT00616629|16886509|P5|Overall Study|AV-block|0
4901269|NCT00616629|16886510|P4|Overall Study|AV-block|0
4901270|NCT00616629|16886511|P3|Overall Study|AV-block|0
4901271|NCT00616629|16886512|P2|Overall Study|AV-block|0
4901272|NCT00616629|16886513|P1|Overall Study|AV-block|1
4901273|NCT00616629|16886509|P5|Overall Study|Protocol Violation|0
4901274|NCT00616629|16886510|P4|Overall Study|Protocol Violation|0
4901275|NCT00616629|16886511|P3|Overall Study|Protocol Violation|1
4901276|NCT00616629|16886512|P2|Overall Study|Protocol Violation|2
4901277|NCT00616629|16886513|P1|Overall Study|Protocol Violation|1
4901278|NCT00616603|16886558|P3|Overall Study|Physician Decision|2
4901279|NCT00616603|16886559|P2|Overall Study|Physician Decision|0
4901280|NCT00616603|16886560|P1|Overall Study|Physician Decision|2
4901281|NCT00616434|16886583|P2|Overall Study|Protocol deviation|1
4901282|NCT00616434|16886584|P1|Overall Study|Protocol deviation|0
4901283|NCT00616434|16886583|P2|Overall Study|Withdrawal by Subject|1
4901284|NCT00616434|16886584|P1|Overall Study|Withdrawal by Subject|1
4901285|NCT00616434|16886583|P2|Overall Study|Physician Decision|4
4901286|NCT00616434|16886584|P1|Overall Study|Physician Decision|0
4901287|NCT00616434|16886583|P2|Overall Study|Adverse Event|2
4901288|NCT00616434|16886584|P1|Overall Study|Adverse Event|5
4901289|NCT00616421|16886597|P3|Overall Study|Unable to classify|0
4901290|NCT00616421|16886598|P2|Overall Study|Unable to classify|0
4901291|NCT00616421|16886599|P1|Overall Study|Unable to classify|1
4901292|NCT00616421|16886597|P3|Overall Study|Protocol Violation|2
4901293|NCT00616421|16886598|P2|Overall Study|Protocol Violation|1
4901294|NCT00616421|16886599|P1|Overall Study|Protocol Violation|0
4901295|NCT00616421|16886597|P3|Overall Study|Administrative reason|0
4901296|NCT00616421|16886598|P2|Overall Study|Administrative reason|0
4901297|NCT00616421|16886599|P1|Overall Study|Administrative reason|1
4901298|NCT00616421|16886597|P3|Overall Study|Inappropriate enrollment|1
4901299|NCT00616421|16886598|P2|Overall Study|Inappropriate enrollment|0
4901300|NCT00616421|16886599|P1|Overall Study|Inappropriate enrollment|3
4901301|NCT00616421|16886597|P3|Overall Study|Lost to Follow-up|30
4901302|NCT00616421|16886598|P2|Overall Study|Lost to Follow-up|26
4901303|NCT00616421|16886599|P1|Overall Study|Lost to Follow-up|12
4901304|NCT00616421|16886597|P3|Overall Study|Withdrawal by Subject|8
4901305|NCT00616421|16886598|P2|Overall Study|Withdrawal by Subject|11
4901306|NCT00616421|16886599|P1|Overall Study|Withdrawal by Subject|9
4901307|NCT00616239|16886640|P1|Overall Study|Withdrawal by Subject|2
4901308|NCT00616018|16886670|P1|Overall Study|Protocol Violation|3
4901309|NCT00615992|16886675|P1|Overall Study|Protocol Violation|67
4901310|NCT00615914|16886701|P1|Overall Study|Irregularly enrolled patients|10
4901311|NCT00615914|16886701|P1|Overall Study|No treatment|2
4901312|NCT00615914|16886701|P1|Overall Study|No data was collected.|65
4901313|NCT00615914|16886701|P1|Overall Study|Physician Decision|4
4901314|NCT00615914|16886701|P1|Overall Study|Withdrawal by Subject|16
4901315|NCT00615914|16886701|P1|Overall Study|Lost to Follow-up|187
4901316|NCT00615914|16886701|P1|Overall Study|Lack of Efficacy|59
4901317|NCT00615914|16886701|P1|Overall Study|Death|20
4901318|NCT00615914|16886701|P1|Overall Study|Adverse Event|274
4901319|NCT00615901|16886708|P1|Overall Study|Adverse Event|7
4901320|NCT00615901|16886708|P1|Overall Study|Withdrawal by Subject|2
4901321|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4901322|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4901323|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4901324|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0
4901325|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65
4901326|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Not reported|0
4901327|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Not reported|4
4901328|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Not reported|1
4901329|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Not reported|4
4901330|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Not reported|6
4901331|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Other|0
4901332|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Other|8
4901333|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Other|8
4901334|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Other|7
4901335|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Other|10
4901336|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Lost to Follow-up|0
4901337|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Lost to Follow-up|10
4901338|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Lost to Follow-up|5
4901339|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Lost to Follow-up|14
4901340|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Lost to Follow-up|10
4901341|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Withdrawal by Subject|0
4901342|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Withdrawal by Subject|43
4901343|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Withdrawal by Subject|38
4901344|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Withdrawal by Subject|42
4901345|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Withdrawal by Subject|37
4901346|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Protocol Violation|0
4901347|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Protocol Violation|3
4901348|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Protocol Violation|2
4901349|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Protocol Violation|5
4901350|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Protocol Violation|4
4901351|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
4901352|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Use of exclusionary medication|0
4901353|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
4901354|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Use of exclusionary medication|2
4901355|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Use of exclusionary medication|1
4901356|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
4901357|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
4901358|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3
4901359|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0
4901360|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1
4901361|NCT00615836|16886716|P5|Extension Study (FE992026 CS31)|Adverse Event|0
4901362|NCT00615836|16886717|P4|Extension Study (FE992026 CS31)|Adverse Event|13
4901363|NCT00615836|16886718|P3|Extension Study (FE992026 CS31)|Adverse Event|15
4901364|NCT00615836|16886719|P2|Extension Study (FE992026 CS31)|Adverse Event|12
4901365|NCT00615836|16886720|P1|Extension Study (FE992026 CS31)|Adverse Event|7
4901366|NCT00615719|16886780|P1|Overall Study|Physician Decision|5
4901367|NCT00615550|16886794|P2|Overall Study|Lost to Follow-up|1
4901368|NCT00615550|16886795|P1|Overall Study|Lost to Follow-up|6
4901369|NCT00615459|16886818|P4|Period III|Unsatisfactory therapeutic effect|0
4901370|NCT00615459|16886819|P3|Period III|Unsatisfactory therapeutic effect|0
4901371|NCT00615459|16886820|P2|Period III|Unsatisfactory therapeutic effect|1
4901372|NCT00615459|16886821|P1|Period III|Unsatisfactory therapeutic effect|0
4901373|NCT00615459|16886818|P4|Period III|Administrative problems|0
4901374|NCT00615459|16886819|P3|Period III|Administrative problems|1
4901375|NCT00615459|16886820|P2|Period III|Administrative problems|1
4901376|NCT00615459|16886821|P1|Period III|Administrative problems|0
4901377|NCT00615459|16886818|P4|Period III|Adverse Event|0
4901378|NCT00615459|16886819|P3|Period III|Adverse Event|0
4901379|NCT00615459|16886820|P2|Period III|Adverse Event|1
4901380|NCT00615459|16886821|P1|Period III|Adverse Event|0
4901381|NCT00615459|16886818|P4|Period II|Lost to Follow-up|1
4901382|NCT00615459|16886819|P3|Period II|Lost to Follow-up|0
4901383|NCT00615459|16886820|P2|Period II|Lost to Follow-up|0
4901384|NCT00615459|16886821|P1|Period II|Lost to Follow-up|0
4901385|NCT00615459|16886818|P4|Period II|Adverse Event|0
4901386|NCT00615459|16886819|P3|Period II|Adverse Event|0
4901387|NCT00615459|16886820|P2|Period II|Adverse Event|0
4901388|NCT00615459|16886821|P1|Period II|Adverse Event|1
4901389|NCT00615459|16886818|P4|Period I|Abnormal test procedure results|0
4901390|NCT00615459|16886819|P3|Period I|Abnormal test procedure results|1
4901391|NCT00615459|16886820|P2|Period I|Abnormal test procedure results|1
4901392|NCT00615459|16886821|P1|Period I|Abnormal test procedure results|1
4901393|NCT00615459|16886818|P4|Period I|Subject withdrew consent|1
4901394|NCT00615459|16886819|P3|Period I|Subject withdrew consent|0
4901395|NCT00615459|16886820|P2|Period I|Subject withdrew consent|0
4901396|NCT00615459|16886821|P1|Period I|Subject withdrew consent|1
4901397|NCT00615459|16886818|P4|Period I|Adverse Event|0
4901398|NCT00615459|16886819|P3|Period I|Adverse Event|1
4901399|NCT00615459|16886820|P2|Period I|Adverse Event|0
4901400|NCT00615459|16886821|P1|Period I|Adverse Event|2
4901401|NCT00615290|16886867|P1|Overall Study|Other|2
4901402|NCT00615290|16886867|P1|Overall Study|Withdrawal by Subject|1
4901403|NCT00615290|16886867|P1|Overall Study|Lost to Follow-up|3
4901404|NCT00615290|16886867|P1|Overall Study|Adverse Event|2
4901405|NCT00615264|16886881|P2|Overall Study|Dermal Hypersensitivity|3
4901406|NCT00615264|16886882|P1|Overall Study|Dermal Hypersensitivity|0
4901407|NCT00615264|16886881|P2|Overall Study|Not defined|4
4901408|NCT00615264|16886882|P1|Overall Study|Not defined|7
4901409|NCT00615264|16886881|P2|Overall Study|Protocol Violation|7
4901410|NCT00615264|16886882|P1|Overall Study|Protocol Violation|11
4901411|NCT00615264|16886881|P2|Overall Study|Death|1
4901412|NCT00615264|16886882|P1|Overall Study|Death|1
4901413|NCT00615264|16886881|P2|Overall Study|Adverse Event|5
4901414|NCT00615264|16886882|P1|Overall Study|Adverse Event|8
4901415|NCT00615264|16886881|P2|Overall Study|Lost to Follow-up|13
4901416|NCT00615264|16886882|P1|Overall Study|Lost to Follow-up|6
4901417|NCT00615264|16886881|P2|Overall Study|Withdrawal by Subject|19
4901418|NCT00615264|16886882|P1|Overall Study|Withdrawal by Subject|17
4901419|NCT00615199|16886894|P4|Overall Study|Withdrawal by Subject|0
4901420|NCT00615199|16886895|P3|Overall Study|Withdrawal by Subject|0
4901421|NCT00615199|16886896|P2|Overall Study|Withdrawal by Subject|1
4901422|NCT00615199|16886897|P1|Overall Study|Withdrawal by Subject|2
4901423|NCT00615199|16886894|P4|Overall Study|Other|1
4901424|NCT00615199|16886895|P3|Overall Study|Other|0
4901425|NCT00615199|16886896|P2|Overall Study|Other|0
4901426|NCT00615199|16886897|P1|Overall Study|Other|0
4901427|NCT00615199|16886894|P4|Overall Study|Lost to Follow-up|0
4901428|NCT00615199|16886895|P3|Overall Study|Lost to Follow-up|0
4901429|NCT00615199|16886896|P2|Overall Study|Lost to Follow-up|0
4901430|NCT00615199|16886897|P1|Overall Study|Lost to Follow-up|1
4901431|NCT00615199|16886894|P4|Overall Study|Lack of Efficacy|1
4901432|NCT00615199|16886895|P3|Overall Study|Lack of Efficacy|0
4901433|NCT00615199|16886896|P2|Overall Study|Lack of Efficacy|0
4901434|NCT00615199|16886897|P1|Overall Study|Lack of Efficacy|2
4901435|NCT00615199|16886894|P4|Overall Study|Adverse Event|0
4901436|NCT00615199|16886895|P3|Overall Study|Adverse Event|1
4901437|NCT00615199|16886896|P2|Overall Study|Adverse Event|1
4901438|NCT00615199|16886897|P1|Overall Study|Adverse Event|3
4901439|NCT00615108|16886931|P1|Overall Study|Lost to Follow-up|15
4901440|NCT00615108|16886931|P1|Overall Study|Other|370
4901441|NCT00615108|16886931|P1|Overall Study|Adverse Event|122
4901442|NCT00615069|16886946|P1|Overall Study|Withdrawal by Subject|4
4901443|NCT00615069|16886946|P1|Overall Study|Physician Decision|2
4901444|NCT00615069|16886946|P1|Overall Study|Death|10
4901445|NCT00615056|16886955|P4|Overall Study|Randomized but not treated|0
4901446|NCT00615056|16886956|P3|Overall Study|Randomized but not treated|0
4901447|NCT00615056|16886957|P2|Overall Study|Randomized but not treated|0
4901448|NCT00615056|16886958|P1|Overall Study|Randomized but not treated|3
4901449|NCT00615056|16886955|P4|Overall Study|Discontinued by Sponsor|0
4901450|NCT00615056|16886956|P3|Overall Study|Discontinued by Sponsor|0
4901451|NCT00615056|16886957|P2|Overall Study|Discontinued by Sponsor|0
4901452|NCT00615056|16886958|P1|Overall Study|Discontinued by Sponsor|1
4901453|NCT00615056|16886955|P4|Overall Study|Withdrawal by Subject|0
4901454|NCT00615056|16886956|P3|Overall Study|Withdrawal by Subject|1
4901455|NCT00615056|16886957|P2|Overall Study|Withdrawal by Subject|1
4901456|NCT00615056|16886958|P1|Overall Study|Withdrawal by Subject|0
4901457|NCT00615056|16886955|P4|Overall Study|Objective progression or relapse|0
4901458|NCT00615056|16886956|P3|Overall Study|Objective progression or relapse|0
4901459|NCT00615056|16886957|P2|Overall Study|Objective progression or relapse|2
4901460|NCT00615056|16886958|P1|Overall Study|Objective progression or relapse|0
4901461|NCT00615056|16886955|P4|Overall Study|Other|7
4901462|NCT00615056|16886956|P3|Overall Study|Other|10
4901463|NCT00615056|16886957|P2|Overall Study|Other|15
4901464|NCT00615056|16886958|P1|Overall Study|Other|13
4901465|NCT00615056|16886955|P4|Overall Study|Lost to Follow-up|5
4901466|NCT00615056|16886956|P3|Overall Study|Lost to Follow-up|4
4901467|NCT00615056|16886957|P2|Overall Study|Lost to Follow-up|2
4901468|NCT00615056|16886958|P1|Overall Study|Lost to Follow-up|1
4901469|NCT00615056|16886955|P4|Overall Study|Death|23
4901470|NCT00615056|16886956|P3|Overall Study|Death|21
4901471|NCT00615056|16886957|P2|Overall Study|Death|31
4901472|NCT00615056|16886958|P1|Overall Study|Death|31
4901473|NCT00615030|16886988|P12|Period III|Administrative problems|0
4901474|NCT00615030|16886989|P11|Period III|Administrative problems|0
4901475|NCT00615030|16886990|P10|Period III|Administrative problems|0
4901476|NCT00615030|16886991|P9|Period III|Administrative problems|0
4901477|NCT00615030|16886992|P8|Period III|Administrative problems|0
4901478|NCT00615030|16886993|P7|Period III|Administrative problems|0
4901479|NCT00615030|16886994|P6|Period III|Administrative problems|0
4901480|NCT00615030|16886995|P5|Period III|Administrative problems|0
4901481|NCT00615030|16886996|P4|Period III|Administrative problems|1
4901482|NCT00615030|16886997|P3|Period III|Administrative problems|0
4901483|NCT00615030|16886998|P2|Period III|Administrative problems|0
4901484|NCT00615030|16886999|P1|Period III|Administrative problems|1
4901485|NCT00615030|16886988|P12|Period II|Subject withdrew consent|0
4901486|NCT00615030|16886989|P11|Period II|Subject withdrew consent|0
4901487|NCT00615030|16886990|P10|Period II|Subject withdrew consent|0
4901488|NCT00615030|16886991|P9|Period II|Subject withdrew consent|0
4901489|NCT00615030|16886992|P8|Period II|Subject withdrew consent|0
4901490|NCT00615030|16886993|P7|Period II|Subject withdrew consent|1
4901491|NCT00615030|16886994|P6|Period II|Subject withdrew consent|0
4901492|NCT00615030|16886995|P5|Period II|Subject withdrew consent|0
4901493|NCT00615030|16886996|P4|Period II|Subject withdrew consent|1
4901494|NCT00615030|16886997|P3|Period II|Subject withdrew consent|0
4901495|NCT00615030|16886998|P2|Period II|Subject withdrew consent|0
4901496|NCT00615030|16886999|P1|Period II|Subject withdrew consent|0
4901497|NCT00615030|16886988|P12|Period II|Adverse Event|0
4901498|NCT00615030|16886989|P11|Period II|Adverse Event|0
4901499|NCT00615030|16886990|P10|Period II|Adverse Event|0
4901500|NCT00615030|16886991|P9|Period II|Adverse Event|1
4901501|NCT00615030|16886992|P8|Period II|Adverse Event|0
4901502|NCT00615030|16886993|P7|Period II|Adverse Event|0
4901503|NCT00615030|16886994|P6|Period II|Adverse Event|0
4901504|NCT00615030|16886995|P5|Period II|Adverse Event|0
4901505|NCT00615030|16886996|P4|Period II|Adverse Event|0
4901506|NCT00615030|16886997|P3|Period II|Adverse Event|1
4901507|NCT00615030|16886998|P2|Period II|Adverse Event|0
4901508|NCT00615030|16886999|P1|Period II|Adverse Event|0
4901509|NCT00615030|16886988|P12|Period I|Abnormal laboratory value(s)|0
4901510|NCT00615030|16886989|P11|Period I|Abnormal laboratory value(s)|0
4901511|NCT00615030|16886990|P10|Period I|Abnormal laboratory value(s)|0
4901512|NCT00615030|16886991|P9|Period I|Abnormal laboratory value(s)|0
4901513|NCT00615030|16886992|P8|Period I|Abnormal laboratory value(s)|0
4901514|NCT00615030|16886993|P7|Period I|Abnormal laboratory value(s)|0
4901515|NCT00615030|16886994|P6|Period I|Abnormal laboratory value(s)|1
4901516|NCT00615030|16886995|P5|Period I|Abnormal laboratory value(s)|0
4901517|NCT00615030|16886996|P4|Period I|Abnormal laboratory value(s)|0
4901518|NCT00615030|16886997|P3|Period I|Abnormal laboratory value(s)|0
4901519|NCT00615030|16886998|P2|Period I|Abnormal laboratory value(s)|0
4901520|NCT00615030|16886999|P1|Period I|Abnormal laboratory value(s)|0
4901521|NCT00615030|16886988|P12|Period I|Subject withdrew consent|1
4901522|NCT00615030|16886989|P11|Period I|Subject withdrew consent|1
4901523|NCT00615030|16886990|P10|Period I|Subject withdrew consent|0
4901524|NCT00615030|16886991|P9|Period I|Subject withdrew consent|1
4901525|NCT00615030|16886992|P8|Period I|Subject withdrew consent|0
4901526|NCT00615030|16886993|P7|Period I|Subject withdrew consent|0
4901527|NCT00615030|16886994|P6|Period I|Subject withdrew consent|0
4901528|NCT00615030|16886995|P5|Period I|Subject withdrew consent|0
4901529|NCT00615030|16886996|P4|Period I|Subject withdrew consent|0
4901530|NCT00615030|16886997|P3|Period I|Subject withdrew consent|0
4901531|NCT00615030|16886998|P2|Period I|Subject withdrew consent|0
4901532|NCT00615030|16886999|P1|Period I|Subject withdrew consent|0
4901533|NCT00615030|16886988|P12|Period I|Protocol deviation|0
4901534|NCT00615030|16886989|P11|Period I|Protocol deviation|0
4901535|NCT00615030|16886990|P10|Period I|Protocol deviation|0
4901536|NCT00615030|16886991|P9|Period I|Protocol deviation|0
4901537|NCT00615030|16886992|P8|Period I|Protocol deviation|0
4901538|NCT00615030|16886993|P7|Period I|Protocol deviation|0
4901539|NCT00615030|16886994|P6|Period I|Protocol deviation|0
4901540|NCT00615030|16886995|P5|Period I|Protocol deviation|0
4901541|NCT00615030|16886996|P4|Period I|Protocol deviation|0
4901542|NCT00615030|16886997|P3|Period I|Protocol deviation|0
4901543|NCT00615030|16886998|P2|Period I|Protocol deviation|0
4901544|NCT00615030|16886999|P1|Period I|Protocol deviation|1
4901545|NCT00615030|16886988|P12|Period I|Administrative problem|0
4901546|NCT00615030|16886989|P11|Period I|Administrative problem|0
4901547|NCT00615030|16886990|P10|Period I|Administrative problem|0
4901548|NCT00615030|16886991|P9|Period I|Administrative problem|0
4901549|NCT00615030|16886992|P8|Period I|Administrative problem|0
4901550|NCT00615030|16886993|P7|Period I|Administrative problem|0
4901551|NCT00615030|16886994|P6|Period I|Administrative problem|0
4901552|NCT00615030|16886995|P5|Period I|Administrative problem|1
4901553|NCT00615030|16886996|P4|Period I|Administrative problem|0
4901554|NCT00615030|16886997|P3|Period I|Administrative problem|0
4901555|NCT00615030|16886998|P2|Period I|Administrative problem|0
4901556|NCT00615030|16886999|P1|Period I|Administrative problem|0
4901557|NCT00615017|16887019|P6|Overall Study|Physician discontinued drug|1
4901558|NCT00615017|16887020|P5|Overall Study|Physician discontinued drug|0
4901559|NCT00615017|16887021|P4|Overall Study|Physician discontinued drug|0
4901560|NCT00615017|16887022|P3|Overall Study|Physician discontinued drug|0
4901561|NCT00615017|16887023|P2|Overall Study|Physician discontinued drug|0
4901562|NCT00615017|16887024|P1|Overall Study|Physician discontinued drug|0
4901563|NCT00615017|16887019|P6|Overall Study|Transferred out of Intensive Care Unit|0
4901564|NCT00615017|16887020|P5|Overall Study|Transferred out of Intensive Care Unit|0
4901565|NCT00615017|16887021|P4|Overall Study|Transferred out of Intensive Care Unit|1
4901566|NCT00615017|16887022|P3|Overall Study|Transferred out of Intensive Care Unit|0
4901567|NCT00615017|16887023|P2|Overall Study|Transferred out of Intensive Care Unit|0
4901568|NCT00615017|16887024|P1|Overall Study|Transferred out of Intensive Care Unit|0
4901569|NCT00615017|16887019|P6|Overall Study|Sepsis resolved|0
4901570|NCT00615017|16887020|P5|Overall Study|Sepsis resolved|0
4901571|NCT00615017|16887021|P4|Overall Study|Sepsis resolved|0
4901572|NCT00615017|16887022|P3|Overall Study|Sepsis resolved|1
4901573|NCT00615017|16887023|P2|Overall Study|Sepsis resolved|0
4901574|NCT00615017|16887024|P1|Overall Study|Sepsis resolved|0
4901575|NCT00615017|16887019|P6|Overall Study|Death|1
4901576|NCT00615017|16887020|P5|Overall Study|Death|1
4901577|NCT00615017|16887021|P4|Overall Study|Death|0
4901578|NCT00615017|16887022|P3|Overall Study|Death|2
4901579|NCT00615017|16887023|P2|Overall Study|Death|0
4901580|NCT00615017|16887024|P1|Overall Study|Death|0
4901581|NCT00615017|16887019|P6|Overall Study|Adverse Event|1
4901582|NCT00615017|16887020|P5|Overall Study|Adverse Event|0
4901583|NCT00615017|16887021|P4|Overall Study|Adverse Event|0
4901584|NCT00615017|16887022|P3|Overall Study|Adverse Event|2
4901585|NCT00615017|16887023|P2|Overall Study|Adverse Event|1
4901586|NCT00615017|16887024|P1|Overall Study|Adverse Event|0
4901587|NCT00614991|16887182|P6|Overall Study|Adverse Event|0
4901588|NCT00614991|16887183|P5|Overall Study|Adverse Event|1
4901589|NCT00614991|16887184|P4|Overall Study|Adverse Event|0
4901590|NCT00614991|16887185|P3|Overall Study|Adverse Event|0
4901591|NCT00614991|16887186|P2|Overall Study|Adverse Event|3
4901592|NCT00614991|16887187|P1|Overall Study|Adverse Event|3
4901593|NCT00614939|16887221|P2|Overall Study|Hospitalized due to kidney transplant|0
4901594|NCT00614939|16887222|P1|Overall Study|Hospitalized due to kidney transplant|1
4901595|NCT00614939|16887221|P2|Overall Study|Poor/non-compliance|0
4901596|NCT00614939|16887222|P1|Overall Study|Poor/non-compliance|4
4901597|NCT00614939|16887221|P2|Overall Study|Death|3
4901598|NCT00614939|16887222|P1|Overall Study|Death|4
4901599|NCT00614939|16887221|P2|Overall Study|Incorrect enrollment|2
4901600|NCT00614939|16887222|P1|Overall Study|Incorrect enrollment|1
4901601|NCT00614939|16887221|P2|Overall Study|Adverse Event|5
4901602|NCT00614939|16887222|P1|Overall Study|Adverse Event|2
4901603|NCT00614939|16887221|P2|Overall Study|Study specific discontinuation criteris|16
4901604|NCT00614939|16887222|P1|Overall Study|Study specific discontinuation criteris|13
4901605|NCT00614939|16887221|P2|Overall Study|Withdrawal by Subject|17
4901606|NCT00614939|16887222|P1|Overall Study|Withdrawal by Subject|10
4901607|NCT00614926|16887256|P2|Overall Study|Adverse Event|0
4901608|NCT00614926|16887257|P1|Overall Study|Adverse Event|3
4901609|NCT00614926|16887256|P2|Overall Study|Burden of travel|0
4901610|NCT00614926|16887257|P1|Overall Study|Burden of travel|1
4901611|NCT00614874|16887270|P1|Overall Study|Withdrawal by Subject|1
4901612|NCT00614874|16887270|P1|Overall Study|Protocol Violation|1
4901613|NCT00614822|16887277|P1|Overall Study|Adverse Event|3
4901614|NCT00614744|16887286|P2|Overall Study|Incomplete for Behavior Issues|2
4901615|NCT00614744|16887287|P1|Overall Study|Incomplete for Behavior Issues|0
4901616|NCT00614744|16887286|P2|Overall Study|Lost to Follow-up|4
4901617|NCT00614744|16887287|P1|Overall Study|Lost to Follow-up|5
4901618|NCT00614614|16887313|P5|Booster Vaccination Phase|Other|1
4901619|NCT00614614|16887314|P4|Booster Vaccination Phase|Other|2
4901620|NCT00614614|16887315|P3|Booster Vaccination Phase|Other|3
4901621|NCT00614614|16887316|P2|Booster Vaccination Phase|Other|1
4901622|NCT00614614|16887317|P1|Booster Vaccination Phase|Other|0
4901623|NCT00614614|16887313|P5|Booster Vaccination Phase|Protocol Violation|0
4901624|NCT00614614|16887314|P4|Booster Vaccination Phase|Protocol Violation|3
4901625|NCT00614614|16887315|P3|Booster Vaccination Phase|Protocol Violation|2
4901626|NCT00614614|16887316|P2|Booster Vaccination Phase|Protocol Violation|0
4901627|NCT00614614|16887317|P1|Booster Vaccination Phase|Protocol Violation|0
4901628|NCT00614614|16887313|P5|Booster Vaccination Phase|Lost to Follow-up|8
4901629|NCT00614614|16887314|P4|Booster Vaccination Phase|Lost to Follow-up|10
4901630|NCT00614614|16887315|P3|Booster Vaccination Phase|Lost to Follow-up|17
4901631|NCT00614614|16887316|P2|Booster Vaccination Phase|Lost to Follow-up|5
4901632|NCT00614614|16887317|P1|Booster Vaccination Phase|Lost to Follow-up|0
4901633|NCT00614614|16887313|P5|Booster Vaccination Phase|Withdrawal by Subject|4
4901634|NCT00614614|16887314|P4|Booster Vaccination Phase|Withdrawal by Subject|3
4901635|NCT00614614|16887315|P3|Booster Vaccination Phase|Withdrawal by Subject|4
4901636|NCT00614614|16887316|P2|Booster Vaccination Phase|Withdrawal by Subject|0
4901637|NCT00614614|16887317|P1|Booster Vaccination Phase|Withdrawal by Subject|0
4901638|NCT00614614|16887313|P5|Booster Vaccination Phase|Adverse Event|0
4901639|NCT00614614|16887314|P4|Booster Vaccination Phase|Adverse Event|1
4901640|NCT00614614|16887315|P3|Booster Vaccination Phase|Adverse Event|1
4901641|NCT00614614|16887316|P2|Booster Vaccination Phase|Adverse Event|0
4901642|NCT00614614|16887317|P1|Booster Vaccination Phase|Adverse Event|0
4901643|NCT00614614|16887313|P5|Primary Vaccination Phase|Other|0
4901644|NCT00614614|16887314|P4|Primary Vaccination Phase|Other|0
4901645|NCT00614614|16887315|P3|Primary Vaccination Phase|Other|0
4901646|NCT00614614|16887316|P2|Primary Vaccination Phase|Other|0
4901647|NCT00614614|16887317|P1|Primary Vaccination Phase|Other|4
4901648|NCT00614614|16887313|P5|Primary Vaccination Phase|Protocol Violation|0
4901649|NCT00614614|16887314|P4|Primary Vaccination Phase|Protocol Violation|0
4901650|NCT00614614|16887315|P3|Primary Vaccination Phase|Protocol Violation|0
4901651|NCT00614614|16887316|P2|Primary Vaccination Phase|Protocol Violation|3
4901652|NCT00614614|16887317|P1|Primary Vaccination Phase|Protocol Violation|9
4901653|NCT00614614|16887313|P5|Primary Vaccination Phase|Lost to Follow-up|0
4901654|NCT00614614|16887314|P4|Primary Vaccination Phase|Lost to Follow-up|0
4901655|NCT00614614|16887315|P3|Primary Vaccination Phase|Lost to Follow-up|0
4901656|NCT00614614|16887316|P2|Primary Vaccination Phase|Lost to Follow-up|8
4901657|NCT00614614|16887317|P1|Primary Vaccination Phase|Lost to Follow-up|26
4901658|NCT00614614|16887313|P5|Primary Vaccination Phase|Withdrawal by Subject|0
4901659|NCT00614614|16887314|P4|Primary Vaccination Phase|Withdrawal by Subject|0
4901660|NCT00614614|16887315|P3|Primary Vaccination Phase|Withdrawal by Subject|0
4901661|NCT00614614|16887316|P2|Primary Vaccination Phase|Withdrawal by Subject|6
4901662|NCT00614614|16887317|P1|Primary Vaccination Phase|Withdrawal by Subject|45
4901663|NCT00614614|16887313|P5|Primary Vaccination Phase|Adverse Event|0
4901664|NCT00614614|16887314|P4|Primary Vaccination Phase|Adverse Event|0
4901665|NCT00614614|16887315|P3|Primary Vaccination Phase|Adverse Event|0
4901666|NCT00614614|16887316|P2|Primary Vaccination Phase|Adverse Event|0
4901667|NCT00614614|16887317|P1|Primary Vaccination Phase|Adverse Event|6
4901668|NCT00614575|16887440|P1|Overall Study|No treatment|1
4901669|NCT00614575|16887440|P1|Overall Study|Irregularly enrolled patients|23
4901670|NCT00614575|16887440|P1|Overall Study|No data were collected.|18
4901671|NCT00614575|16887440|P1|Overall Study|Physician Decision|2
4901672|NCT00614575|16887440|P1|Overall Study|Death|3
4901673|NCT00614575|16887440|P1|Overall Study|Withdrawal by Subject|6
4901674|NCT00614575|16887440|P1|Overall Study|Lack of Efficacy|14
4901675|NCT00614575|16887440|P1|Overall Study|Lost to Follow-up|55
4901676|NCT00614575|16887440|P1|Overall Study|Adverse Event|106
4901677|NCT00614523|16887451|P2|Overall Study|Administrative Decision|46
4901678|NCT00614523|16887452|P1|Overall Study|Administrative Decision|23
4901679|NCT00614523|16887451|P2|Overall Study|Disease Progression|8
4901680|NCT00614523|16887452|P1|Overall Study|Disease Progression|0
4901681|NCT00614523|16887451|P2|Overall Study|Ineligibility Determined|2
4901682|NCT00614523|16887452|P1|Overall Study|Ineligibility Determined|1
4901683|NCT00614523|16887451|P2|Overall Study|Other|11
4901684|NCT00614523|16887452|P1|Overall Study|Other|6
4901685|NCT00614523|16887451|P2|Overall Study|Withdrawal by Subject|22
4901686|NCT00614523|16887452|P1|Overall Study|Withdrawal by Subject|12
4901687|NCT00614523|16887451|P2|Overall Study|Protocol Violation|2
4901688|NCT00614523|16887452|P1|Overall Study|Protocol Violation|3
4901689|NCT00614523|16887451|P2|Overall Study|Lost to Follow-up|1
4901690|NCT00614523|16887452|P1|Overall Study|Lost to Follow-up|0
4901691|NCT00614523|16887451|P2|Overall Study|Lack of Efficacy|11
4901692|NCT00614523|16887452|P1|Overall Study|Lack of Efficacy|9
4901693|NCT00614523|16887451|P2|Overall Study|Death|8
4901694|NCT00614523|16887452|P1|Overall Study|Death|5
4901695|NCT00614523|16887451|P2|Overall Study|Adverse Event|20
4901696|NCT00614523|16887452|P1|Overall Study|Adverse Event|4
4901697|NCT00614393|16887517|P5|Overall Study|Not Treated|2
4901698|NCT00614393|16887518|P4|Overall Study|Not Treated|0
4901699|NCT00614393|16887519|P3|Overall Study|Not Treated|0
4901700|NCT00614393|16887520|P2|Overall Study|Not Treated|0
4901701|NCT00614393|16887521|P1|Overall Study|Not Treated|0
4901702|NCT00614393|16887517|P5|Overall Study|Other|2
4901703|NCT00614393|16887518|P4|Overall Study|Other|4
4901704|NCT00614393|16887519|P3|Overall Study|Other|0
4901705|NCT00614393|16887520|P2|Overall Study|Other|0
4901706|NCT00614393|16887521|P1|Overall Study|Other|4
4901707|NCT00614393|16887517|P5|Overall Study|Withdrawal by Subject|13
4901708|NCT00614393|16887518|P4|Overall Study|Withdrawal by Subject|16
4901709|NCT00614393|16887519|P3|Overall Study|Withdrawal by Subject|1
4901710|NCT00614393|16887520|P2|Overall Study|Withdrawal by Subject|1
4901711|NCT00614393|16887521|P1|Overall Study|Withdrawal by Subject|20
4901712|NCT00614393|16887517|P5|Overall Study|Terminated by Sponsor|1
4901713|NCT00614393|16887518|P4|Overall Study|Terminated by Sponsor|0
4901714|NCT00614393|16887519|P3|Overall Study|Terminated by Sponsor|0
4901715|NCT00614393|16887520|P2|Overall Study|Terminated by Sponsor|0
4901716|NCT00614393|16887521|P1|Overall Study|Terminated by Sponsor|0
4901717|NCT00614393|16887517|P5|Overall Study|Protocol Violation|0
4901718|NCT00614393|16887518|P4|Overall Study|Protocol Violation|0
4901719|NCT00614393|16887519|P3|Overall Study|Protocol Violation|0
4901720|NCT00614393|16887520|P2|Overall Study|Protocol Violation|0
4901721|NCT00614393|16887521|P1|Overall Study|Protocol Violation|1
4901722|NCT00614393|16887517|P5|Overall Study|Progressive Disease|130
4901723|NCT00614393|16887518|P4|Overall Study|Progressive Disease|138
4901724|NCT00614393|16887519|P3|Overall Study|Progressive Disease|5
4901725|NCT00614393|16887520|P2|Overall Study|Progressive Disease|5
4901726|NCT00614393|16887521|P1|Overall Study|Progressive Disease|118
4901727|NCT00614393|16887517|P5|Overall Study|Physician Decision|9
4901728|NCT00614393|16887518|P4|Overall Study|Physician Decision|8
4901729|NCT00614393|16887519|P3|Overall Study|Physician Decision|1
4901730|NCT00614393|16887520|P2|Overall Study|Physician Decision|0
4901731|NCT00614393|16887521|P1|Overall Study|Physician Decision|17
4901732|NCT00614393|16887517|P5|Overall Study|Lost to Follow-up|2
4901733|NCT00614393|16887518|P4|Overall Study|Lost to Follow-up|1
4901734|NCT00614393|16887519|P3|Overall Study|Lost to Follow-up|0
4901735|NCT00614393|16887520|P2|Overall Study|Lost to Follow-up|0
4901736|NCT00614393|16887521|P1|Overall Study|Lost to Follow-up|0
4901737|NCT00614393|16887517|P5|Overall Study|Adverse Event|21
4901738|NCT00614393|16887518|P4|Overall Study|Adverse Event|13
4901739|NCT00614393|16887519|P3|Overall Study|Adverse Event|3
4901740|NCT00614393|16887520|P2|Overall Study|Adverse Event|2
4901741|NCT00614393|16887521|P1|Overall Study|Adverse Event|20
4901742|NCT00614380|16887567|P4|Overall Study|Consent withdrawn|0
4901743|NCT00614380|16887568|P3|Overall Study|Consent withdrawn|0
4901744|NCT00614380|16887569|P2|Overall Study|Consent withdrawn|1
4901745|NCT00614380|16887570|P1|Overall Study|Consent withdrawn|3
4901746|NCT00614380|16887567|P4|Overall Study|Non compliant with the protocol|2
4901747|NCT00614380|16887568|P3|Overall Study|Non compliant with the protocol|1
4901748|NCT00614380|16887569|P2|Overall Study|Non compliant with the protocol|2
4901749|NCT00614380|16887570|P1|Overall Study|Non compliant with the protocol|12
4901750|NCT00614380|16887567|P4|Overall Study|Lost to Follow-up|0
4901751|NCT00614380|16887568|P3|Overall Study|Lost to Follow-up|0
4901752|NCT00614380|16887569|P2|Overall Study|Lost to Follow-up|1
4901753|NCT00614380|16887570|P1|Overall Study|Lost to Follow-up|6
4901754|NCT00614380|16887567|P4|Overall Study|Adverse Event|0
4901755|NCT00614380|16887568|P3|Overall Study|Adverse Event|0
4901756|NCT00614380|16887569|P2|Overall Study|Adverse Event|4
4901757|NCT00614380|16887570|P1|Overall Study|Adverse Event|14
4901758|NCT00614120|16887637|P4|Overall Study|Lost to Follow-up|4
4901759|NCT00614120|16887638|P3|Overall Study|Lost to Follow-up|3
4901760|NCT00614120|16887639|P2|Overall Study|Lost to Follow-up|2
4901761|NCT00614120|16887640|P1|Overall Study|Lost to Follow-up|1
4901762|NCT00614120|16887637|P4|Overall Study|Taken inhibition medication eg Prandin|1
4901763|NCT00614120|16887638|P3|Overall Study|Taken inhibition medication eg Prandin|1
4901764|NCT00614120|16887639|P2|Overall Study|Taken inhibition medication eg Prandin|0
4901765|NCT00614120|16887640|P1|Overall Study|Taken inhibition medication eg Prandin|0
4901766|NCT00614120|16887637|P4|Overall Study|Late syphilis, latent|0
4901767|NCT00614120|16887638|P3|Overall Study|Late syphilis, latent|0
4901768|NCT00614120|16887639|P2|Overall Study|Late syphilis, latent|0
4901769|NCT00614120|16887640|P1|Overall Study|Late syphilis, latent|1
4901770|NCT00614120|16887637|P4|Overall Study|Lack of trial product|0
4901771|NCT00614120|16887638|P3|Overall Study|Lack of trial product|2
4901772|NCT00614120|16887639|P2|Overall Study|Lack of trial product|3
4901773|NCT00614120|16887640|P1|Overall Study|Lack of trial product|3
4901774|NCT00614120|16887637|P4|Overall Study|Hypoglycaemia|1
4901775|NCT00614120|16887638|P3|Overall Study|Hypoglycaemia|0
4901776|NCT00614120|16887639|P2|Overall Study|Hypoglycaemia|0
4901777|NCT00614120|16887640|P1|Overall Study|Hypoglycaemia|0
4901778|NCT00614120|16887637|P4|Overall Study|hCG positive (not pregnant)|0
4901779|NCT00614120|16887638|P3|Overall Study|hCG positive (not pregnant)|1
4901780|NCT00614120|16887639|P2|Overall Study|hCG positive (not pregnant)|0
4901781|NCT00614120|16887640|P1|Overall Study|hCG positive (not pregnant)|0
4901782|NCT00614120|16887637|P4|Overall Study|Did not meet trial criteria|1
4901783|NCT00614120|16887638|P3|Overall Study|Did not meet trial criteria|1
4901784|NCT00614120|16887639|P2|Overall Study|Did not meet trial criteria|1
4901785|NCT00614120|16887640|P1|Overall Study|Did not meet trial criteria|0
4901786|NCT00614120|16887637|P4|Overall Study|Withdrawal by Subject|3
4901787|NCT00614120|16887638|P3|Overall Study|Withdrawal by Subject|16
4901788|NCT00614120|16887639|P2|Overall Study|Withdrawal by Subject|10
4901789|NCT00614120|16887640|P1|Overall Study|Withdrawal by Subject|9
4901790|NCT00614120|16887637|P4|Overall Study|Withdrawal criteria|0
4901791|NCT00614120|16887638|P3|Overall Study|Withdrawal criteria|0
4901792|NCT00614120|16887639|P2|Overall Study|Withdrawal criteria|0
4901793|NCT00614120|16887640|P1|Overall Study|Withdrawal criteria|1
4901794|NCT00614120|16887637|P4|Overall Study|Protocol Violation|1
4901795|NCT00614120|16887638|P3|Overall Study|Protocol Violation|3
4901796|NCT00614120|16887639|P2|Overall Study|Protocol Violation|5
4901797|NCT00614120|16887640|P1|Overall Study|Protocol Violation|2
4901798|NCT00614120|16887637|P4|Overall Study|Lack of Efficacy|2
4901799|NCT00614120|16887638|P3|Overall Study|Lack of Efficacy|2
4901800|NCT00614120|16887639|P2|Overall Study|Lack of Efficacy|3
4901801|NCT00614120|16887640|P1|Overall Study|Lack of Efficacy|3
4901802|NCT00614120|16887637|P4|Overall Study|Adverse Event|3
4901803|NCT00614120|16887638|P3|Overall Study|Adverse Event|30
4901804|NCT00614120|16887639|P2|Overall Study|Adverse Event|22
4901805|NCT00614120|16887640|P1|Overall Study|Adverse Event|9
4901806|NCT00614055|16887681|P3|Overall Study|Unclassified|2
4901807|NCT00614055|16887682|P2|Overall Study|Unclassified|4
4901808|NCT00614055|16887683|P1|Overall Study|Unclassified|1
4901809|NCT00614055|16887681|P3|Overall Study|Lack of Efficacy|2
4901810|NCT00614055|16887682|P2|Overall Study|Lack of Efficacy|0
4901811|NCT00614055|16887683|P1|Overall Study|Lack of Efficacy|0
4901812|NCT00614055|16887681|P3|Overall Study|Protocol Violation|1
4901813|NCT00614055|16887682|P2|Overall Study|Protocol Violation|2
4901814|NCT00614055|16887683|P1|Overall Study|Protocol Violation|2
4901815|NCT00614055|16887681|P3|Overall Study|Adverse Event|0
4901816|NCT00614055|16887682|P2|Overall Study|Adverse Event|0
4901817|NCT00614055|16887683|P1|Overall Study|Adverse Event|1
4901818|NCT00613951|16887730|P3|Overall Study|Unclassified|2
4901819|NCT00613951|16887731|P2|Overall Study|Unclassified|3
4901820|NCT00613951|16887732|P1|Overall Study|Unclassified|5
4901821|NCT00613951|16887730|P3|Overall Study|Protocol Violation|1
4901822|NCT00613951|16887731|P2|Overall Study|Protocol Violation|1
4901823|NCT00613951|16887732|P1|Overall Study|Protocol Violation|1
4901824|NCT00613951|16887730|P3|Overall Study|Lack of Efficacy|1
4901825|NCT00613951|16887731|P2|Overall Study|Lack of Efficacy|1
4901826|NCT00613951|16887732|P1|Overall Study|Lack of Efficacy|0
4901827|NCT00613951|16887730|P3|Overall Study|Adverse Event|1
4901828|NCT00613951|16887731|P2|Overall Study|Adverse Event|0
4901829|NCT00613951|16887732|P1|Overall Study|Adverse Event|1
4901830|NCT00613938|16887777|P4|Overall Study|Other|3
4901831|NCT00613938|16887778|P3|Overall Study|Other|1
4901832|NCT00613938|16887779|P2|Overall Study|Other|2
4901833|NCT00613938|16887780|P1|Overall Study|Other|1
4901834|NCT00613938|16887777|P4|Overall Study|Lack of Efficacy|9
4901835|NCT00613938|16887778|P3|Overall Study|Lack of Efficacy|5
4901836|NCT00613938|16887779|P2|Overall Study|Lack of Efficacy|18
4901837|NCT00613938|16887780|P1|Overall Study|Lack of Efficacy|16
4901838|NCT00613938|16887777|P4|Overall Study|Adverse Event|5
4901839|NCT00613938|16887778|P3|Overall Study|Adverse Event|8
4901840|NCT00613938|16887779|P2|Overall Study|Adverse Event|4
4901841|NCT00613938|16887780|P1|Overall Study|Adverse Event|1
4901842|NCT00613938|16887777|P4|Overall Study|Withdrawal by Subject|9
4901843|NCT00613938|16887778|P3|Overall Study|Withdrawal by Subject|9
4901844|NCT00613938|16887779|P2|Overall Study|Withdrawal by Subject|4
4901845|NCT00613938|16887780|P1|Overall Study|Withdrawal by Subject|2
4901846|NCT00613925|16887812|P2|Overall Study|1 did not tolerate outpatient biopsy|1
4901847|NCT00613925|16887813|P1|Overall Study|1 did not tolerate outpatient biopsy|0
4901848|NCT00613834|16887823|P2|Overall Study|Withdrawal by Subject|3
4901849|NCT00613834|16887824|P1|Overall Study|Withdrawal by Subject|0
4901850|NCT00613821|16887836|P2|Overall Study|Physician Decision|1
4901851|NCT00613821|16887837|P1|Overall Study|Physician Decision|1
4901852|NCT00613821|16887836|P2|Overall Study|Withdrawal by Subject|0
4901853|NCT00613821|16887837|P1|Overall Study|Withdrawal by Subject|1
4901854|NCT00613730|16887843|P1|Overall Study|Administrative decision|1
4901855|NCT00613730|16887843|P1|Overall Study|Disease progression|2
4901856|NCT00613626|16887852|P3|Overall Study|Ineligible|0
4901857|NCT00613626|16887853|P2|Overall Study|Ineligible|1
4901858|NCT00613626|16887854|P1|Overall Study|Ineligible|0
4901859|NCT00613574|16887870|P1|Overall Study|Other|1
4901860|NCT00613574|16887870|P1|Overall Study|Lost to Follow-up|2
4901861|NCT00613574|16887870|P1|Overall Study|Adverse Event|3
4901862|NCT00613509|16887882|P2|Cycle 1|Other administrative reason|1
4901863|NCT00613509|16887883|P1|Cycle 1|Other administrative reason|0
4901864|NCT00613509|16887882|P2|Cycle 1|Unacceptable Toxicity|0
4901865|NCT00613509|16887883|P1|Cycle 1|Unacceptable Toxicity|1
4901866|NCT00613509|16887882|P2|Cycle 1|Disease Progression|6
4901867|NCT00613509|16887883|P1|Cycle 1|Disease Progression|2
4901868|NCT00613509|16887882|P2|Cycle 1|Adverse Event|1
4901869|NCT00613509|16887883|P1|Cycle 1|Adverse Event|2
4901870|NCT00613366|16887929|P2|Overall Study|Withdrawal by Subject|2
4901871|NCT00613366|16887930|P1|Overall Study|Withdrawal by Subject|3
4901872|NCT00613327|16887938|P1|Overall Study|Other|47
4901873|NCT00613327|16887938|P1|Overall Study|Protocol Violation|2
4901874|NCT00613327|16887938|P1|Overall Study|Withdrawal by Subject|6
4901875|NCT00613327|16887938|P1|Overall Study|Lost to Follow-up|8
4901876|NCT00613327|16887938|P1|Overall Study|Adverse Event|38
4901877|NCT00613314|16887957|P1|Overall Study|Other reason not defined above|90
4901878|NCT00613314|16887957|P1|Overall Study|Lost to Follow-up|46
4901879|NCT00613314|16887957|P1|Overall Study|Protocol Violation|14
4901880|NCT00613314|16887957|P1|Overall Study|Adverse Event|5
4901881|NCT00613301|16887965|P1|Overall Study|Irregularly enrolled patients|12
4901882|NCT00613301|16887965|P1|Overall Study|No data was collected|53
4901883|NCT00613301|16887965|P1|Overall Study|Physician Decision|2
4901884|NCT00613301|16887965|P1|Overall Study|Lack of Efficacy|13
4901885|NCT00613301|16887965|P1|Overall Study|Death|6
4901886|NCT00613301|16887965|P1|Overall Study|Withdrawal by Subject|5
4901887|NCT00613301|16887965|P1|Overall Study|Lost to Follow-up|88
4901888|NCT00613301|16887965|P1|Overall Study|Adverse Event|49
4901889|NCT00613106|16887974|P2|Overall Study|misc|3
4901890|NCT00613106|16887975|P1|Overall Study|misc|4
4901891|NCT00613106|16887974|P2|Overall Study|Lost to Follow-up|2
4901892|NCT00613106|16887975|P1|Overall Study|Lost to Follow-up|7
4901893|NCT00613106|16887974|P2|Overall Study|Withdrawal by Subject|3
4901894|NCT00613106|16887975|P1|Overall Study|Withdrawal by Subject|6
4901895|NCT00613106|16887974|P2|Overall Study|Adverse Event|1
4901896|NCT00613106|16887975|P1|Overall Study|Adverse Event|3
4901897|NCT00613080|16887981|P1|Overall Study|Ineligible / no protocol treatment|11
4901898|NCT00613015|16888016|P6|Overall Study|Lost to Follow-up|3
4901899|NCT00613015|16888017|P5|Overall Study|Lost to Follow-up|2
4901900|NCT00613015|16888018|P4|Overall Study|Lost to Follow-up|3
4901901|NCT00613015|16888019|P3|Overall Study|Lost to Follow-up|3
4901902|NCT00613015|16888020|P2|Overall Study|Lost to Follow-up|1
4901903|NCT00613015|16888021|P1|Overall Study|Lost to Follow-up|0
4901904|NCT00612807|16888057|P2|Overall Study|Withdrawal by Subject|0
4901905|NCT00612807|16888058|P1|Overall Study|Withdrawal by Subject|2
4901906|NCT00612690|16888093|P2|Overall Study|Withdrawal by Site|0
4901907|NCT00612690|16888094|P1|Overall Study|Withdrawal by Site|11
4901908|NCT00612690|16888093|P2|Overall Study|Withdrawal by Subject|20
4901909|NCT00612690|16888094|P1|Overall Study|Withdrawal by Subject|32
4901910|NCT00612690|16888093|P2|Overall Study|Lost to Follow-up|98
4901911|NCT00612690|16888094|P1|Overall Study|Lost to Follow-up|72
4901912|NCT00612677|16888102|P1|Overall Study|study closed before treatment started|1
4901913|NCT00612586|16888110|P2|Overall Study|Randomized and Not Treated|1
4901914|NCT00612586|16888111|P1|Overall Study|Randomized and Not Treated|1
4901915|NCT00612586|16888110|P2|Overall Study|Progressive Disease|24
4901916|NCT00612586|16888111|P1|Overall Study|Progressive Disease|26
4901917|NCT00612586|16888110|P2|Overall Study|Sponsor Decision|1
4901918|NCT00612586|16888111|P1|Overall Study|Sponsor Decision|1
4901919|NCT00612586|16888110|P2|Overall Study|Physician Decision|2
4901920|NCT00612586|16888111|P1|Overall Study|Physician Decision|1
4901921|NCT00612586|16888110|P2|Overall Study|Withdrawal by Subject|9
4901922|NCT00612586|16888111|P1|Overall Study|Withdrawal by Subject|7
4901923|NCT00612586|16888110|P2|Overall Study|Entry Criteria Not Met|2
4901924|NCT00612586|16888111|P1|Overall Study|Entry Criteria Not Met|0
4901925|NCT00612586|16888110|P2|Overall Study|Death|0
4901926|NCT00612586|16888111|P1|Overall Study|Death|1
4901927|NCT00612586|16888110|P2|Overall Study|Adverse Event|2
4901928|NCT00612586|16888111|P1|Overall Study|Adverse Event|6
4901929|NCT00612534|16888187|P4|Overall Study|Other Reason|0
4901930|NCT00612534|16888188|P3|Overall Study|Other Reason|0
4901931|NCT00612534|16888189|P2|Overall Study|Other Reason|1
4901932|NCT00612534|16888190|P1|Overall Study|Other Reason|0
4901933|NCT00612534|16888187|P4|Overall Study|Lack of Efficacy|16
4901934|NCT00612534|16888188|P3|Overall Study|Lack of Efficacy|5
4901935|NCT00612534|16888189|P2|Overall Study|Lack of Efficacy|12
4901936|NCT00612534|16888190|P1|Overall Study|Lack of Efficacy|13
4901937|NCT00612534|16888187|P4|Overall Study|Adverse Event|1
4901938|NCT00612534|16888188|P3|Overall Study|Adverse Event|2
4901939|NCT00612534|16888189|P2|Overall Study|Adverse Event|4
4901940|NCT00612534|16888190|P1|Overall Study|Adverse Event|0
4901941|NCT00612508|16888202|P2|Overall Study|Withdrawal by Subject|4
4901942|NCT00612508|16888203|P1|Overall Study|Withdrawal by Subject|3
4901943|NCT00612456|16888214|P3|Overall Study|Withdrawal by Subject|0
4901944|NCT00612456|16888215|P2|Overall Study|Withdrawal by Subject|1
4901945|NCT00612456|16888216|P1|Overall Study|Withdrawal by Subject|0
4901946|NCT00612456|16888214|P3|Overall Study|Lack of Efficacy|0
4901947|NCT00612456|16888215|P2|Overall Study|Lack of Efficacy|1
4901948|NCT00612456|16888216|P1|Overall Study|Lack of Efficacy|1
4901949|NCT00612456|16888214|P3|Overall Study|Adverse Event|0
4901950|NCT00612456|16888215|P2|Overall Study|Adverse Event|0
4901951|NCT00612456|16888216|P1|Overall Study|Adverse Event|1
4901952|NCT00612352|16888279|P2|Overall Study|didn't return calls/show up on test date|1
4901953|NCT00612352|16888280|P1|Overall Study|didn't return calls/show up on test date|4
4901954|NCT00612352|16888279|P2|Overall Study|moved out of state|0
4901955|NCT00612352|16888280|P1|Overall Study|moved out of state|1
4901956|NCT00612352|16888279|P2|Overall Study|Withdrawal by Subject|5
4901957|NCT00612352|16888280|P1|Overall Study|Withdrawal by Subject|3
4901958|NCT00612352|16888279|P2|Overall Study|Adverse Event|0
4901959|NCT00612352|16888280|P1|Overall Study|Adverse Event|1
4901960|NCT00612313|16888400|P2|Overall Study|Lost to Follow-up|4
4901961|NCT00612313|16888401|P1|Overall Study|Lost to Follow-up|11
4901962|NCT00612313|16888400|P2|Overall Study|Withdrawal by Subject|9
4901963|NCT00612313|16888401|P1|Overall Study|Withdrawal by Subject|6
4901964|NCT00612105|16888443|P2|Period Title 3: 3-Week Taper Phase|Other|0
4901965|NCT00612105|16888444|P1|Period Title 3: 3-Week Taper Phase|Other|1
4901966|NCT00612105|16888443|P2|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0
4901967|NCT00612105|16888444|P1|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1
4901968|NCT00612105|16888443|P2|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
4901969|NCT00612105|16888444|P1|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1
4901970|NCT00612105|16888443|P2|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1
4901971|NCT00612105|16888444|P1|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9
4901972|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Other|1
4901973|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Other|0
4901974|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0
4901975|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5
4901976|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1
4901977|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3
4901978|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Protocol Violation|0
4901979|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Protocol Violation|1
4901980|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Physician Decision|1
4901981|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Physician Decision|1
4901982|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0
4901983|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2
4901984|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1
4901985|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6
4901986|NCT00612105|16888443|P2|Period Title 1: 6-Week Titration Phase|Adverse Event|1
4901987|NCT00612105|16888444|P1|Period Title 1: 6-Week Titration Phase|Adverse Event|18
4901988|NCT00612066|16888494|P1|Overall Study|Adverse Event|1
4901989|NCT00612040|16888501|P3|Overall Study|Unclassified|5
4901990|NCT00612040|16888502|P2|Overall Study|Unclassified|2
4901991|NCT00612040|16888503|P1|Overall Study|Unclassified|2
4901992|NCT00612040|16888501|P3|Overall Study|Lack of Efficacy|0
4901993|NCT00612040|16888502|P2|Overall Study|Lack of Efficacy|1
4901994|NCT00612040|16888503|P1|Overall Study|Lack of Efficacy|2
4901995|NCT00612040|16888501|P3|Overall Study|Protocol Violation|1
4901996|NCT00612040|16888502|P2|Overall Study|Protocol Violation|2
4901997|NCT00612040|16888503|P1|Overall Study|Protocol Violation|1
4901998|NCT00612040|16888501|P3|Overall Study|Adverse Event|1
4901999|NCT00612040|16888502|P2|Overall Study|Adverse Event|2
4902000|NCT00612040|16888503|P1|Overall Study|Adverse Event|0
4902001|NCT00611923|16888549|P2|Overall Study|Withdrawal by Subject|2
4902002|NCT00611923|16888550|P1|Overall Study|Withdrawal by Subject|2
4902003|NCT00611884|16888595|P4|Overall Study|Unclassified|3
4902004|NCT00611884|16888596|P3|Overall Study|Unclassified|2
4902005|NCT00611884|16888597|P2|Overall Study|Unclassified|4
4902006|NCT00611884|16888598|P1|Overall Study|Unclassified|7
4902007|NCT00611884|16888595|P4|Overall Study|Lack of Efficacy|0
4902008|NCT00611884|16888596|P3|Overall Study|Lack of Efficacy|0
4902009|NCT00611884|16888597|P2|Overall Study|Lack of Efficacy|1
4902010|NCT00611884|16888598|P1|Overall Study|Lack of Efficacy|0
4902011|NCT00611884|16888595|P4|Overall Study|Non-Compliance|2
4902012|NCT00611884|16888596|P3|Overall Study|Non-Compliance|2
4902013|NCT00611884|16888597|P2|Overall Study|Non-Compliance|4
4902014|NCT00611884|16888598|P1|Overall Study|Non-Compliance|1
4902015|NCT00611884|16888595|P4|Overall Study|Adverse Event|1
4902016|NCT00611884|16888596|P3|Overall Study|Adverse Event|0
4902017|NCT00611884|16888597|P2|Overall Study|Adverse Event|0
4902018|NCT00611884|16888598|P1|Overall Study|Adverse Event|1
4902019|NCT00611858|16888652|P1|Overall Study|Withdrawal by Subject|2
4902020|NCT00611858|16888652|P1|Overall Study|Adverse Event|2
4902021|NCT00611806|16888664|P2|Overall Study|Lost to Follow-up|0
4902022|NCT00611806|16888665|P1|Overall Study|Lost to Follow-up|6
4902023|NCT00611806|16888664|P2|Overall Study|Adverse Event|1
4902024|NCT00611806|16888665|P1|Overall Study|Adverse Event|2
4902025|NCT00611806|16888664|P2|Overall Study|Withdrawal by Subject|2
4902026|NCT00611806|16888665|P1|Overall Study|Withdrawal by Subject|8
4902027|NCT00611767|16888679|P2|Overall Study|Physician Decision|0
4902028|NCT00611767|16888680|P1|Overall Study|Physician Decision|1
4902029|NCT00611767|16888679|P2|Overall Study|didn't like the medication|1
4902030|NCT00611767|16888680|P1|Overall Study|didn't like the medication|1
4902031|NCT00611767|16888679|P2|Overall Study|Thiopental not available|0
4902032|NCT00611767|16888680|P1|Overall Study|Thiopental not available|3
4902033|NCT00611767|16888679|P2|Overall Study|Withdrawal by Subject|1
4902034|NCT00611767|16888680|P1|Overall Study|Withdrawal by Subject|4
4902035|NCT00611715|16888842|P2|Overall Study|two patients are still on treatment|0
4902036|NCT00611715|16888843|P1|Overall Study|two patients are still on treatment|2
4902037|NCT00611715|16888842|P2|Overall Study|Death|0
4902038|NCT00611715|16888843|P1|Overall Study|Death|1
4902039|NCT00611715|16888842|P2|Overall Study|Adverse Event|1
4902040|NCT00611715|16888843|P1|Overall Study|Adverse Event|9
4902041|NCT00611715|16888842|P2|Overall Study|Withdrawal by Subject|1
4902042|NCT00611715|16888843|P1|Overall Study|Withdrawal by Subject|5
4902043|NCT00611715|16888842|P2|Overall Study|Disease Progression|4
4902044|NCT00611715|16888843|P1|Overall Study|Disease Progression|24
4902045|NCT00611559|16888863|P3|Overall Study|Protocol Violation|1
4902046|NCT00611559|16888864|P2|Overall Study|Protocol Violation|0
4902047|NCT00611559|16888865|P1|Overall Study|Protocol Violation|1
4902048|NCT00611559|16888863|P3|Overall Study|Lost to Follow-up|0
4902049|NCT00611559|16888864|P2|Overall Study|Lost to Follow-up|1
4902050|NCT00611559|16888865|P1|Overall Study|Lost to Follow-up|0
4902051|NCT00611533|16888924|P2|Second Intervention (6 Weeks)|Adverse Event|2
4902052|NCT00611533|16888925|P1|Second Intervention (6 Weeks)|Adverse Event|0
4902053|NCT00611533|16888924|P2|First Intervention (6 Weeks)|Adverse Event|1
4902054|NCT00611533|16888925|P1|First Intervention (6 Weeks)|Adverse Event|0
4902055|NCT00611533|16888924|P2|First Intervention (6 Weeks)|Never started study|1
4902056|NCT00611533|16888925|P1|First Intervention (6 Weeks)|Never started study|0
4902057|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49
4902058|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
4902059|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0
4902060|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13
4902061|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
4902062|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0
4902063|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80
4902064|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
4902065|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0
4902066|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23
4902067|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
4902068|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0
4902069|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Protocol Violation|4
4902070|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
4902071|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Protocol Violation|0
4902072|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12
4902073|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
4902074|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0
4902075|NCT00611455|16888959|P3|Follow-up Period (Approximately 2 Years)|Adverse Event|30
4902076|NCT00611455|16888960|P2|Follow-up Period (Approximately 2 Years)|Adverse Event|0
4902077|NCT00611455|16888961|P1|Follow-up Period (Approximately 2 Years)|Adverse Event|0
4902078|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4902079|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18
4902080|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4902081|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
4902082|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Physician Decision|5
4902083|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
4902084|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
4902085|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Lost to Follow-up|5
4902086|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Lost to Follow-up|0
4902087|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4902088|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110
4902089|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4902090|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4902091|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12
4902092|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4902093|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
4902094|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Protocol Violation|3
4902095|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
4902096|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4902097|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|9
4902098|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4902099|NCT00611455|16888959|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
4902100|NCT00611455|16888960|P2|OL Treatment Period (120 Weeks)|Adverse Event|17
4902101|NCT00611455|16888961|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
4902102|NCT00611455|16888959|P3|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
4902103|NCT00611455|16888960|P2|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0
4902104|NCT00611455|16888961|P1|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1
4902105|NCT00611455|16888959|P3|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0
4902106|NCT00611455|16888960|P2|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
4902107|NCT00611455|16888961|P1|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2
4902108|NCT00611455|16888959|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
4902109|NCT00611455|16888960|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3
4902110|NCT00611455|16888961|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2
4902111|NCT00611455|16888959|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
4902112|NCT00611455|16888960|P2|DB Treatment Period (24 Weeks)|Protocol Violation|1
4902113|NCT00611455|16888961|P1|DB Treatment Period (24 Weeks)|Protocol Violation|4
4902114|NCT00611455|16888959|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4902115|NCT00611455|16888960|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4902116|NCT00611455|16888961|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|2
4902117|NCT00611455|16888959|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
4902118|NCT00611455|16888960|P2|DB Treatment Period (24 Weeks)|Adverse Event|8
4902119|NCT00611455|16888961|P1|DB Treatment Period (24 Weeks)|Adverse Event|2
4902120|NCT00611247|16889141|P2|Overall Study|Lack of Efficacy|16
4902121|NCT00611247|16889142|P1|Overall Study|Lack of Efficacy|1
4902122|NCT00611247|16889141|P2|Overall Study|Death|5
4902123|NCT00611247|16889142|P1|Overall Study|Death|1
4902124|NCT00611130|16889154|P2|Overall Study|Death|0
4902125|NCT00611130|16889155|P1|Overall Study|Death|1
4902126|NCT00611130|16889154|P2|Overall Study|Adverse Event|0
4902127|NCT00611130|16889155|P1|Overall Study|Adverse Event|1
4902128|NCT00611130|16889154|P2|Overall Study|Administrative|1
4902129|NCT00611130|16889155|P1|Overall Study|Administrative|1
4902130|NCT00611130|16889154|P2|Overall Study|Incarceration|2
4902131|NCT00611130|16889155|P1|Overall Study|Incarceration|3
4902132|NCT00611130|16889154|P2|Overall Study|Other|4
4902133|NCT00611130|16889155|P1|Overall Study|Other|5
4902134|NCT00611130|16889154|P2|Overall Study|Withdrawal by Subject|5
4902135|NCT00611130|16889155|P1|Overall Study|Withdrawal by Subject|6
4902136|NCT00611130|16889154|P2|Overall Study|Protocol noncompliance|6
4902137|NCT00611130|16889155|P1|Overall Study|Protocol noncompliance|7
4902138|NCT00611130|16889154|P2|Overall Study|Lost to Follow-up|29
4902139|NCT00611130|16889155|P1|Overall Study|Lost to Follow-up|25
4902140|NCT00611026|16889165|P3|Double-blind Treatment Period|Other|18
4902141|NCT00611026|16889166|P2|Double-blind Treatment Period|Other|20
4902142|NCT00611026|16889167|P1|Double-blind Treatment Period|Other|13
4902143|NCT00611026|16889165|P3|Double-blind Treatment Period|Withdrawal by Subject|16
4902144|NCT00611026|16889166|P2|Double-blind Treatment Period|Withdrawal by Subject|19
4902145|NCT00611026|16889167|P1|Double-blind Treatment Period|Withdrawal by Subject|7
4902146|NCT00611026|16889165|P3|Double-blind Treatment Period|Lost to Follow-up|14
4902147|NCT00611026|16889166|P2|Double-blind Treatment Period|Lost to Follow-up|11
4902148|NCT00611026|16889167|P1|Double-blind Treatment Period|Lost to Follow-up|6
4902149|NCT00611026|16889165|P3|Double-blind Treatment Period|Lack of Efficacy|4
4902150|NCT00611026|16889166|P2|Double-blind Treatment Period|Lack of Efficacy|10
4902151|NCT00611026|16889167|P1|Double-blind Treatment Period|Lack of Efficacy|11
4902152|NCT00611026|16889165|P3|Double-blind Treatment Period|Adverse Event|46
4902153|NCT00611026|16889166|P2|Double-blind Treatment Period|Adverse Event|28
4902154|NCT00611026|16889167|P1|Double-blind Treatment Period|Adverse Event|9
4902155|NCT00611026|16889165|P3|Double-blind Treatment Period|Death|0
4902156|NCT00611026|16889166|P2|Double-blind Treatment Period|Death|0
4902157|NCT00611026|16889167|P1|Double-blind Treatment Period|Death|1
4902158|NCT00611026|16889165|P3|Randomized to Double-blind Treatment|Not treated|3
4902159|NCT00611026|16889166|P2|Randomized to Double-blind Treatment|Not treated|1
4902160|NCT00611026|16889167|P1|Randomized to Double-blind Treatment|Not treated|2
4902161|NCT00610857|16889244|P1|Overall Study|Not evaluable for response|2
4902162|NCT00610714|16889259|P2|Overall Study|Study completion at 120 PFS events|2
4902163|NCT00610714|16889260|P1|Overall Study|Study completion at 120 PFS events|2
4902164|NCT00610714|16889259|P2|Overall Study|Withdrawal by Subject|3
4902165|NCT00610714|16889260|P1|Overall Study|Withdrawal by Subject|9
4902166|NCT00610714|16889259|P2|Overall Study|Death|18
4902167|NCT00610714|16889260|P1|Overall Study|Death|12
4902168|NCT00610714|16889259|P2|Overall Study|Adverse Event|1
4902169|NCT00610714|16889260|P1|Overall Study|Adverse Event|3
4902170|NCT00610675|16889298|P1|Overall Study|Other reason (not specified)|25
4902171|NCT00610675|16889298|P1|Overall Study|Lost to Follow-up|31
4902172|NCT00610675|16889298|P1|Overall Study|Lack of Compliance|7
4902173|NCT00610675|16889298|P1|Overall Study|Reasons unrelated to trial|27
4902174|NCT00610675|16889298|P1|Overall Study|Withdrawal by Subject|28
4902175|NCT00610675|16889298|P1|Overall Study|Insufficient Effect|31
4902176|NCT00610675|16889298|P1|Overall Study|Adverse Event|67
4902177|NCT00610675|16889298|P1|Overall Study|Untreated|4
4902178|NCT00610649|16889320|P11|Overall Study|Withdrawal by Subject|0
4902179|NCT00610649|16889321|P10|Overall Study|Withdrawal by Subject|1
4902180|NCT00610649|16889322|P9|Overall Study|Withdrawal by Subject|0
4902181|NCT00610649|16889323|P8|Overall Study|Withdrawal by Subject|0
4902182|NCT00610649|16889324|P7|Overall Study|Withdrawal by Subject|0
4902183|NCT00610649|16889325|P6|Overall Study|Withdrawal by Subject|0
4902184|NCT00610649|16889326|P5|Overall Study|Withdrawal by Subject|0
4902185|NCT00610649|16889327|P4|Overall Study|Withdrawal by Subject|0
4902186|NCT00610649|16889328|P3|Overall Study|Withdrawal by Subject|0
4902187|NCT00610649|16889329|P2|Overall Study|Withdrawal by Subject|0
4902188|NCT00610649|16889330|P1|Overall Study|Withdrawal by Subject|0
4902189|NCT00610649|16889320|P11|Overall Study|Family Emergency|0
4902190|NCT00610649|16889321|P10|Overall Study|Family Emergency|0
4902191|NCT00610649|16889322|P9|Overall Study|Family Emergency|0
4902192|NCT00610649|16889323|P8|Overall Study|Family Emergency|0
4902193|NCT00610649|16889324|P7|Overall Study|Family Emergency|0
4902194|NCT00610649|16889325|P6|Overall Study|Family Emergency|0
4902195|NCT00610649|16889326|P5|Overall Study|Family Emergency|0
4902196|NCT00610649|16889327|P4|Overall Study|Family Emergency|0
4902197|NCT00610649|16889328|P3|Overall Study|Family Emergency|0
4902198|NCT00610649|16889329|P2|Overall Study|Family Emergency|1
4902199|NCT00610649|16889330|P1|Overall Study|Family Emergency|0
4902200|NCT00610649|16889320|P11|Overall Study|Adverse Event|1
4902201|NCT00610649|16889321|P10|Overall Study|Adverse Event|0
4902202|NCT00610649|16889322|P9|Overall Study|Adverse Event|0
4902203|NCT00610649|16889323|P8|Overall Study|Adverse Event|0
4902204|NCT00610649|16889324|P7|Overall Study|Adverse Event|0
4902205|NCT00610649|16889325|P6|Overall Study|Adverse Event|0
4902206|NCT00610649|16889326|P5|Overall Study|Adverse Event|0
4902207|NCT00610649|16889327|P4|Overall Study|Adverse Event|0
4902208|NCT00610649|16889328|P3|Overall Study|Adverse Event|0
4902209|NCT00610649|16889329|P2|Overall Study|Adverse Event|0
4902210|NCT00610649|16889330|P1|Overall Study|Adverse Event|1
4902211|NCT00610441|16889416|P4|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
4902212|NCT00610441|16889417|P3|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
4902213|NCT00610441|16889418|P2|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0
4902214|NCT00610441|16889419|P1|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1
4902215|NCT00610441|16889416|P4|Treatment Period 2 - 3 Weeks|Adverse Event|1
4902216|NCT00610441|16889417|P3|Treatment Period 2 - 3 Weeks|Adverse Event|0
4902217|NCT00610441|16889418|P2|Treatment Period 2 - 3 Weeks|Adverse Event|0
4902218|NCT00610441|16889419|P1|Treatment Period 2 - 3 Weeks|Adverse Event|0
4902219|NCT00610441|16889416|P4|Treatment Period 2 - 3 Weeks|Other|1
4902220|NCT00610441|16889417|P3|Treatment Period 2 - 3 Weeks|Other|0
4902221|NCT00610441|16889418|P2|Treatment Period 2 - 3 Weeks|Other|1
4902222|NCT00610441|16889419|P1|Treatment Period 2 - 3 Weeks|Other|1
4902223|NCT00610441|16889416|P4|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
4902224|NCT00610441|16889417|P3|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
4902225|NCT00610441|16889418|P2|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1
4902226|NCT00610441|16889419|P1|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0
4902227|NCT00610441|16889416|P4|Placebo Washout Period - 2 Weeks|Adverse Event|0
4902228|NCT00610441|16889417|P3|Placebo Washout Period - 2 Weeks|Adverse Event|2
4902229|NCT00610441|16889418|P2|Placebo Washout Period - 2 Weeks|Adverse Event|0
4902230|NCT00610441|16889419|P1|Placebo Washout Period - 2 Weeks|Adverse Event|0
4902231|NCT00610441|16889416|P4|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
4902232|NCT00610441|16889417|P3|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
4902233|NCT00610441|16889418|P2|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0
4902234|NCT00610441|16889419|P1|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1
4902235|NCT00610441|16889416|P4|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0
4902236|NCT00610441|16889417|P3|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
4902237|NCT00610441|16889418|P2|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
4902238|NCT00610441|16889419|P1|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1
4902239|NCT00610441|16889416|P4|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
4902240|NCT00610441|16889417|P3|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1
4902241|NCT00610441|16889418|P2|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
4902242|NCT00610441|16889419|P1|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0
4902243|NCT00610441|16889416|P4|Treatment Period 1 - 3 Weeks|Adverse Event|1
4902244|NCT00610441|16889417|P3|Treatment Period 1 - 3 Weeks|Adverse Event|4
4902245|NCT00610441|16889418|P2|Treatment Period 1 - 3 Weeks|Adverse Event|1
4902246|NCT00610441|16889419|P1|Treatment Period 1 - 3 Weeks|Adverse Event|1
4902247|NCT00610363|16889528|P2|Overall Study|Other than specified above|1
4902248|NCT00610363|16889529|P1|Overall Study|Other than specified above|1
4902249|NCT00610363|16889528|P2|Overall Study|Withdrawal by Subject|0
4902250|NCT00610363|16889529|P1|Overall Study|Withdrawal by Subject|1
4902251|NCT00610363|16889528|P2|Overall Study|Lost to Follow-up|0
4902252|NCT00610363|16889529|P1|Overall Study|Lost to Follow-up|4
4902253|NCT00610363|16889528|P2|Overall Study|Lack of Efficacy|0
4902254|NCT00610363|16889529|P1|Overall Study|Lack of Efficacy|2
4902255|NCT00610363|16889528|P2|Overall Study|Adverse Event|1
4902256|NCT00610363|16889529|P1|Overall Study|Adverse Event|3
4902257|NCT00610363|16889528|P2|Overall Study|Non-compliance with protocol|1
4902258|NCT00610363|16889529|P1|Overall Study|Non-compliance with protocol|0
4902259|NCT00610207|16889554|P1|Overall Study|Lost to Follow-up|3
4902260|NCT00610168|16889561|P2|Overall Study|Withdrawal by Subject|0
4902261|NCT00610168|16889562|P1|Overall Study|Withdrawal by Subject|2
4902262|NCT00610155|16889581|P6|Period 3|Adverse Event|0
4902263|NCT00610155|16889582|P5|Period 3|Adverse Event|0
4902264|NCT00610155|16889583|P4|Period 3|Adverse Event|0
4902265|NCT00610155|16889584|P3|Period 3|Adverse Event|0
4902266|NCT00610155|16889585|P2|Period 3|Adverse Event|0
4902267|NCT00610155|16889586|P1|Period 3|Adverse Event|1
4902268|NCT00610155|16889581|P6|Period 1|Withdrawal by Subject|0
4902269|NCT00610155|16889582|P5|Period 1|Withdrawal by Subject|0
4902270|NCT00610155|16889583|P4|Period 1|Withdrawal by Subject|0
4902271|NCT00610155|16889584|P3|Period 1|Withdrawal by Subject|1
4902272|NCT00610155|16889585|P2|Period 1|Withdrawal by Subject|0
4902273|NCT00610155|16889586|P1|Period 1|Withdrawal by Subject|0
4902274|NCT00610129|16889633|P1|Overall Study|Not treated since patients ineligible|3
4902275|NCT00609986|16889639|P2|Overall Study|Did not receive transplant or treatment|3
4902276|NCT00609986|16889640|P1|Overall Study|Did not receive transplant or treatment|8
4902277|NCT00609973|16889654|P2|Overall Study|Withdrawal by Subject|1
4902278|NCT00609973|16889655|P1|Overall Study|Withdrawal by Subject|0
4902279|NCT00609973|16889654|P2|Overall Study|Lost to Follow-up|1
4902280|NCT00609973|16889655|P1|Overall Study|Lost to Follow-up|2
4902281|NCT00609973|16889654|P2|Overall Study|Protocol Violation|3
4902282|NCT00609973|16889655|P1|Overall Study|Protocol Violation|4
4902283|NCT00609973|16889654|P2|Overall Study|Adverse Event|1
4902284|NCT00609973|16889655|P1|Overall Study|Adverse Event|2
4902285|NCT00609947|16889663|P1|Overall Study|Death|1
4902286|NCT00609869|16889668|P1|Overall Study|Mantle cell: not evaluable|4
4902287|NCT00609869|16889668|P1|Overall Study|Rituximab reaction prior to lenalidomide|1
4902288|NCT00609869|16889668|P1|Overall Study|Hepatitis B infection|1
4902289|NCT00609869|16889668|P1|Overall Study|Severe tumor flare reaction|1
4902290|NCT00609869|16889668|P1|Overall Study|Seizures|1
4902291|NCT00609869|16889668|P1|Overall Study|Withdrawal by Subject|1
4902292|NCT00609869|16889668|P1|Overall Study|Severe hematologic toxicity|1
4902293|NCT00609869|16889668|P1|Overall Study|Withdrawn, ischemic stroke|1
4902294|NCT00609765|16889687|P1|Overall Study|Study ended prior to 12 months|1
4902295|NCT00609674|16889701|P2|Overall Study|Withdrew consent|1
4902296|NCT00609674|16889702|P1|Overall Study|Withdrew consent|2
4902297|NCT00609674|16889701|P2|Overall Study|Lost to Follow-up|0
4902298|NCT00609674|16889702|P1|Overall Study|Lost to Follow-up|1
4902299|NCT00609674|16889701|P2|Overall Study|Protocol Violation|5
4902300|NCT00609674|16889702|P1|Overall Study|Protocol Violation|3
4902301|NCT00609674|16889701|P2|Overall Study|Adverse Event|1
4902302|NCT00609674|16889702|P1|Overall Study|Adverse Event|1
4902303|NCT00609622|16889738|P2|Overall Study|Global deterioration of health status|2
4902304|NCT00609622|16889739|P1|Overall Study|Global deterioration of health status|6
4902305|NCT00609622|16889738|P2|Overall Study|Other|14
4902306|NCT00609622|16889739|P1|Overall Study|Other|7
4902307|NCT00609622|16889738|P2|Overall Study|Study terminated by sponsor|3
4902308|NCT00609622|16889739|P1|Overall Study|Study terminated by sponsor|16
4902309|NCT00609622|16889738|P2|Overall Study|Objective progression or relapse|41
4902310|NCT00609622|16889739|P1|Overall Study|Objective progression or relapse|47
4902311|NCT00609622|16889738|P2|Overall Study|Protocol Violation|1
4902312|NCT00609622|16889739|P1|Overall Study|Protocol Violation|1
4902313|NCT00609622|16889738|P2|Overall Study|Death|4
4902314|NCT00609622|16889739|P1|Overall Study|Death|1
4902315|NCT00609622|16889738|P2|Overall Study|Withdrawal by Subject|20
4902316|NCT00609622|16889739|P1|Overall Study|Withdrawal by Subject|4
4902317|NCT00609622|16889738|P2|Overall Study|Adverse Event|10
4902318|NCT00609622|16889739|P1|Overall Study|Adverse Event|14
4902319|NCT00609609|16889761|P2|Overall Study|Progression|2
4902320|NCT00609609|16889762|P1|Overall Study|Progression|4
4902321|NCT00609609|16889761|P2|Overall Study|Withdrawal by Subject|0
4902322|NCT00609609|16889762|P1|Overall Study|Withdrawal by Subject|2
4902323|NCT00609518|16889774|P2|Overall Study|Death from Adverse Event|2
4902324|NCT00609518|16889775|P1|Overall Study|Death from Adverse Event|2
4902325|NCT00609518|16889774|P2|Overall Study|Physician Decision|3
4902326|NCT00609518|16889775|P1|Overall Study|Physician Decision|1
4902327|NCT00609518|16889774|P2|Overall Study|Lost to Follow-up|0
4902328|NCT00609518|16889775|P1|Overall Study|Lost to Follow-up|3
4902329|NCT00609518|16889774|P2|Overall Study|Withdrawal by Subject|3
4902330|NCT00609518|16889775|P1|Overall Study|Withdrawal by Subject|5
4902331|NCT00609518|16889774|P2|Overall Study|Death from Study Disease|32
4902332|NCT00609518|16889775|P1|Overall Study|Death from Study Disease|32
4902333|NCT00609492|16889790|P3|Overall Study|Lost to Follow-up|4
4902334|NCT00609492|16889791|P2|Overall Study|Lost to Follow-up|1
4902335|NCT00609492|16889792|P1|Overall Study|Lost to Follow-up|1
4902336|NCT00609492|16889790|P3|Overall Study|Withdrawal by Subject|3
4902337|NCT00609492|16889791|P2|Overall Study|Withdrawal by Subject|2
4902338|NCT00609492|16889792|P1|Overall Study|Withdrawal by Subject|0
4902339|NCT00609466|16889877|P3|Overall Study|Lack of Efficacy|2
4902340|NCT00609466|16889878|P2|Overall Study|Lack of Efficacy|2
4902341|NCT00609466|16889879|P1|Overall Study|Lack of Efficacy|0
4902342|NCT00609466|16889877|P3|Overall Study|Adverse Event|1
4902343|NCT00609466|16889878|P2|Overall Study|Adverse Event|3
4902344|NCT00609466|16889879|P1|Overall Study|Adverse Event|2
4902345|NCT00609466|16889877|P3|Overall Study|Withdrawal by Subject|1
4902346|NCT00609466|16889878|P2|Overall Study|Withdrawal by Subject|1
4902347|NCT00609466|16889879|P1|Overall Study|Withdrawal by Subject|0
4902348|NCT00609362|16889907|P2|Overall Study|Adverse Event|0
4902349|NCT00609362|16889908|P1|Overall Study|Adverse Event|1
4902350|NCT00609362|16889907|P2|Overall Study|Withdrawal by Subject|1
4902351|NCT00609362|16889908|P1|Overall Study|Withdrawal by Subject|2
4902352|NCT00609336|16889918|P1|Overall Study|LA or Met at Surgery|9
4902353|NCT00609336|16889918|P1|Overall Study|Death|1
4902354|NCT00609336|16889918|P1|Overall Study|Protocol Violation|3
4902355|NCT00609245|16889969|P1|Overall Study|Adverse Event|1
4902356|NCT00609167|16889977|P2|Overall Study|Stem Cell Transplant|6
4902357|NCT00609167|16889978|P1|Overall Study|Stem Cell Transplant|0
4902358|NCT00609167|16889977|P2|Overall Study|Disease Progression|0
4902359|NCT00609167|16889978|P1|Overall Study|Disease Progression|1
4902360|NCT00609167|16889977|P2|Overall Study|Adverse Event|1
4902361|NCT00609167|16889978|P1|Overall Study|Adverse Event|5
4902362|NCT00609167|16889977|P2|Overall Study|Lack of Efficacy|0
4902363|NCT00609167|16889978|P1|Overall Study|Lack of Efficacy|1
4902364|NCT00609167|16889977|P2|Overall Study|Withdrawal by Subject|0
4902365|NCT00609167|16889978|P1|Overall Study|Withdrawal by Subject|1
4902366|NCT00608985|16890009|P4|Overall Study|Lost to Follow-up|0
4902367|NCT00608985|16890010|P3|Overall Study|Lost to Follow-up|0
4902368|NCT00608985|16890011|P2|Overall Study|Lost to Follow-up|1
4902369|NCT00608985|16890012|P1|Overall Study|Lost to Follow-up|2
4902370|NCT00608985|16890009|P4|Overall Study|Withdrawal of Consent|1
4902371|NCT00608985|16890010|P3|Overall Study|Withdrawal of Consent|1
4902372|NCT00608985|16890011|P2|Overall Study|Withdrawal of Consent|1
4902373|NCT00608985|16890012|P1|Overall Study|Withdrawal of Consent|5
4902374|NCT00608985|16890009|P4|Overall Study|Administrative/Other|2
4902375|NCT00608985|16890010|P3|Overall Study|Administrative/Other|1
4902376|NCT00608985|16890011|P2|Overall Study|Administrative/Other|4
4902377|NCT00608985|16890012|P1|Overall Study|Administrative/Other|7
4902378|NCT00608985|16890009|P4|Overall Study|Adverse Event|6
4902379|NCT00608985|16890010|P3|Overall Study|Adverse Event|4
4902380|NCT00608985|16890011|P2|Overall Study|Adverse Event|7
4902381|NCT00608985|16890012|P1|Overall Study|Adverse Event|2
4902382|NCT00608959|16890044|P1|Part 1|Did not meet eligibility criteria|1
4902383|NCT00608907|16890057|P3|Overall Study|Progressive Disease|0
4902384|NCT00608907|16890058|P2|Overall Study|Progressive Disease|0
4902385|NCT00608907|16890059|P1|Overall Study|Progressive Disease|1
4902386|NCT00608907|16890057|P3|Overall Study|Withdrawal by Subject|0
4902387|NCT00608907|16890058|P2|Overall Study|Withdrawal by Subject|0
4902388|NCT00608907|16890059|P1|Overall Study|Withdrawal by Subject|4
4902389|NCT00608907|16890057|P3|Overall Study|Death|0
4902390|NCT00608907|16890058|P2|Overall Study|Death|0
4902391|NCT00608907|16890059|P1|Overall Study|Death|1
4902392|NCT00608907|16890057|P3|Overall Study|Adverse Event|1
4902393|NCT00608907|16890058|P2|Overall Study|Adverse Event|0
4902394|NCT00608907|16890059|P1|Overall Study|Adverse Event|6
4902395|NCT00608894|16890069|P2|Overall Study|Withdrawal by Subject|2
4902396|NCT00608894|16890070|P1|Overall Study|Withdrawal by Subject|0
4902397|NCT00608881|16890082|P2|Overall Study|Institutionalized|2
4902398|NCT00608881|16890083|P1|Overall Study|Institutionalized|1
4902399|NCT00608881|16890082|P2|Overall Study|Physician Decision|5
4902400|NCT00608881|16890083|P1|Overall Study|Physician Decision|5
4902401|NCT00608881|16890082|P2|Overall Study|Withdrawal by Subject|29
4902402|NCT00608881|16890083|P1|Overall Study|Withdrawal by Subject|18
4902403|NCT00608881|16890082|P2|Overall Study|Lost to Follow-up|14
4902404|NCT00608881|16890083|P1|Overall Study|Lost to Follow-up|28
4902405|NCT00608881|16890082|P2|Overall Study|Adverse Event|3
4902406|NCT00608881|16890083|P1|Overall Study|Adverse Event|5
4902407|NCT00608881|16890082|P2|Overall Study|Death|13
4902408|NCT00608881|16890083|P1|Overall Study|Death|22
4902409|NCT00608868|16890117|P1|Overall Study|Physician Decision|2
4902410|NCT00608868|16890117|P1|Overall Study|Adverse Event|1
4902411|NCT00608868|16890117|P1|Overall Study|Lost to Follow-up|2
4902412|NCT00608868|16890117|P1|Overall Study|Protocol Violation|3
4902413|NCT00608868|16890117|P1|Overall Study|Withdrawal by Subject|7
4902414|NCT00608842|16890128|P4|Overall Study|Lost to Follow-up|0
4902415|NCT00608842|16890129|P3|Overall Study|Lost to Follow-up|0
4902416|NCT00608842|16890130|P2|Overall Study|Lost to Follow-up|0
4902417|NCT00608842|16890131|P1|Overall Study|Lost to Follow-up|1
4902418|NCT00608842|16890128|P4|Overall Study|Participant's Request|1
4902419|NCT00608842|16890129|P3|Overall Study|Participant's Request|2
4902420|NCT00608842|16890130|P2|Overall Study|Participant's Request|1
4902421|NCT00608842|16890131|P1|Overall Study|Participant's Request|0
4902422|NCT00608829|16890165|P1|Overall Study|Subject refuses to follow up or return.|5
4902423|NCT00608829|16890165|P1|Overall Study|Withdrawal by Subject|4
4902424|NCT00608829|16890165|P1|Overall Study|Death|6
4902425|NCT00608582|16890191|P2|Overall Study|Early stage Design Change|3
4902426|NCT00608582|16890192|P1|Overall Study|Early stage Design Change|0
4902427|NCT00608582|16890191|P2|Overall Study|Illicit Drug Use|0
4902428|NCT00608582|16890192|P1|Overall Study|Illicit Drug Use|1
4902429|NCT00608582|16890191|P2|Overall Study|No Best Response in Phase 1 located|1
4902430|NCT00608582|16890192|P1|Overall Study|No Best Response in Phase 1 located|1
4902431|NCT00608582|16890191|P2|Overall Study|Lost to Follow-up|0
4902432|NCT00608582|16890192|P1|Overall Study|Lost to Follow-up|2
4902433|NCT00608569|16890202|P2|Overall Study|Unable to adhere with study requirements|1
4902434|NCT00608569|16890203|P1|Overall Study|Unable to adhere with study requirements|0
4902435|NCT00608569|16890202|P2|Overall Study|Adverse Event|0
4902436|NCT00608569|16890203|P1|Overall Study|Adverse Event|1
4902437|NCT00608569|16890202|P2|Overall Study|Withdrawal by Subject|0
4902438|NCT00608569|16890203|P1|Overall Study|Withdrawal by Subject|1
4902439|NCT00608569|16890202|P2|Overall Study|Lost to Follow-up|5
4902440|NCT00608569|16890203|P1|Overall Study|Lost to Follow-up|4
4902441|NCT00608569|16890202|P2|Overall Study|Death|3
4902442|NCT00608569|16890203|P1|Overall Study|Death|4
4902443|NCT00608543|16890223|P1|Overall Study|Adverse Event|4
4902444|NCT00608530|16890236|P4|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
4902445|NCT00608530|16890237|P3|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1
4902446|NCT00608530|16890238|P2|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
4902447|NCT00608530|16890239|P1|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0
4902448|NCT00608530|16890236|P4|Study 2 Nurse-delivered Treatments|Time demands of study|1
4902449|NCT00608530|16890237|P3|Study 2 Nurse-delivered Treatments|Time demands of study|4
4902450|NCT00608530|16890238|P2|Study 2 Nurse-delivered Treatments|Time demands of study|0
4902451|NCT00608530|16890239|P1|Study 2 Nurse-delivered Treatments|Time demands of study|0
4902452|NCT00608530|16890236|P4|Study 2 Nurse-delivered Treatments|Protocol Violation|0
4902453|NCT00608530|16890237|P3|Study 2 Nurse-delivered Treatments|Protocol Violation|2
4902454|NCT00608530|16890238|P2|Study 2 Nurse-delivered Treatments|Protocol Violation|0
4902455|NCT00608530|16890239|P1|Study 2 Nurse-delivered Treatments|Protocol Violation|0
4902456|NCT00608530|16890236|P4|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3
4902457|NCT00608530|16890237|P3|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2
4902458|NCT00608530|16890238|P2|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
4902459|NCT00608530|16890239|P1|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0
4902460|NCT00608530|16890236|P4|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
4902461|NCT00608530|16890237|P3|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3
4902462|NCT00608530|16890238|P2|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
4902463|NCT00608530|16890239|P1|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0
4902464|NCT00608530|16890236|P4|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
4902465|NCT00608530|16890237|P3|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0
4902466|NCT00608530|16890238|P2|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5
4902467|NCT00608530|16890239|P1|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11
4902468|NCT00608517|16890260|P3|Overall Study|Death|0
4902469|NCT00608517|16890261|P2|Overall Study|Death|0
4902470|NCT00608517|16890262|P1|Overall Study|Death|1
4902471|NCT00608426|16890442|P2|Overall Study|refused, health issues, wrong address|348
4902472|NCT00608426|16890443|P1|Overall Study|refused, health issues, wrong address|319
4902473|NCT00608426|16890442|P2|Overall Study|Lost to Follow-up|521
4902474|NCT00608426|16890443|P1|Overall Study|Lost to Follow-up|485
4902475|NCT00608426|16890442|P2|Overall Study|Death|36
4902476|NCT00608426|16890443|P1|Overall Study|Death|32
4902477|NCT00608322|16890455|P2|Overall Study|Death|1
4902478|NCT00608322|16890456|P1|Overall Study|Death|2
4902479|NCT00608244|16890462|P1|Overall Study|Low trough levels|1
4902480|NCT00608244|16890462|P1|Overall Study|Adverse Event|1
4902481|NCT00608205|16890473|P2|Overall Study|Patient non-compliant|1
4902482|NCT00608205|16890474|P1|Overall Study|Patient non-compliant|0
4902483|NCT00608205|16890473|P2|Overall Study|Adverse Event|2
4902484|NCT00608205|16890474|P1|Overall Study|Adverse Event|3
4902485|NCT00608023|16890591|P3|Overall Study|Unknown reason|0
4902486|NCT00608023|16890592|P2|Overall Study|Unknown reason|3
4902487|NCT00608023|16890593|P1|Overall Study|Unknown reason|0
4902488|NCT00608023|16890591|P3|Overall Study|Protocol Violation|1
4902489|NCT00608023|16890592|P2|Overall Study|Protocol Violation|3
4902490|NCT00608023|16890593|P1|Overall Study|Protocol Violation|1
4902491|NCT00608023|16890591|P3|Overall Study|Lost to Follow-up|1
4902492|NCT00608023|16890592|P2|Overall Study|Lost to Follow-up|2
4902493|NCT00608023|16890593|P1|Overall Study|Lost to Follow-up|2
4902494|NCT00608023|16890591|P3|Overall Study|Adverse Event|5
4902495|NCT00608023|16890592|P2|Overall Study|Adverse Event|4
4902496|NCT00608023|16890593|P1|Overall Study|Adverse Event|1
4902497|NCT00608023|16890591|P3|Overall Study|Withdrawal by Subject|7
4902498|NCT00608023|16890592|P2|Overall Study|Withdrawal by Subject|10
4902499|NCT00608023|16890593|P1|Overall Study|Withdrawal by Subject|8
4902500|NCT00607997|16890617|P4|Overall Study|Other without explanation|1
4902501|NCT00607997|16890618|P3|Overall Study|Other without explanation|4
4902502|NCT00607997|16890619|P2|Overall Study|Other without explanation|0
4902503|NCT00607997|16890620|P1|Overall Study|Other without explanation|2
4902504|NCT00607997|16890617|P4|Overall Study|Relapse, recurrent illness|0
4902505|NCT00607997|16890618|P3|Overall Study|Relapse, recurrent illness|2
4902506|NCT00607997|16890619|P2|Overall Study|Relapse, recurrent illness|0
4902507|NCT00607997|16890620|P1|Overall Study|Relapse, recurrent illness|4
4902508|NCT00607997|16890617|P4|Overall Study|Physician Decision|0
4902509|NCT00607997|16890618|P3|Overall Study|Physician Decision|0
4902510|NCT00607997|16890619|P2|Overall Study|Physician Decision|1
4902511|NCT00607997|16890620|P1|Overall Study|Physician Decision|4
4902512|NCT00607997|16890617|P4|Overall Study|Adverse Event|0
4902513|NCT00607997|16890618|P3|Overall Study|Adverse Event|2
4902514|NCT00607997|16890619|P2|Overall Study|Adverse Event|1
4902515|NCT00607997|16890620|P1|Overall Study|Adverse Event|3
4902516|NCT00607997|16890617|P4|Overall Study|Death|5
4902517|NCT00607997|16890618|P3|Overall Study|Death|2
4902518|NCT00607997|16890619|P2|Overall Study|Death|5
4902519|NCT00607997|16890620|P1|Overall Study|Death|8
4902520|NCT00607997|16890617|P4|Overall Study|Lack of Efficacy|10
4902521|NCT00607997|16890618|P3|Overall Study|Lack of Efficacy|14
4902522|NCT00607997|16890619|P2|Overall Study|Lack of Efficacy|20
4902523|NCT00607997|16890620|P1|Overall Study|Lack of Efficacy|6
4902524|NCT00607919|16890678|P2|Open-Label Phase|Parent/Caregiver Decision|2
4902525|NCT00607919|16890679|P1|Open-Label Phase|Parent/Caregiver Decision|1
4902526|NCT00607919|16890678|P2|Open-Label Phase|Withdrawal by Subject|2
4902527|NCT00607919|16890679|P1|Open-Label Phase|Withdrawal by Subject|2
4902528|NCT00607919|16890678|P2|Open-Label Phase|Protocol Violation|2
4902529|NCT00607919|16890679|P1|Open-Label Phase|Protocol Violation|2
4902530|NCT00607919|16890678|P2|Open-Label Phase|Lost to Follow-up|1
4902531|NCT00607919|16890679|P1|Open-Label Phase|Lost to Follow-up|4
4902532|NCT00607919|16890678|P2|Open-Label Phase|Adverse Event|5
4902533|NCT00607919|16890679|P1|Open-Label Phase|Adverse Event|1
4902534|NCT00607919|16890678|P2|Acute Phase|Withdrawal by Subject|3
4902535|NCT00607919|16890679|P1|Acute Phase|Withdrawal by Subject|3
4902536|NCT00607919|16890678|P2|Acute Phase|Protocol Violation|1
4902537|NCT00607919|16890679|P1|Acute Phase|Protocol Violation|5
4902538|NCT00607919|16890678|P2|Acute Phase|Parent/Caregiver Decision|4
4902539|NCT00607919|16890679|P1|Acute Phase|Parent/Caregiver Decision|6
4902540|NCT00607919|16890678|P2|Acute Phase|Lost to Follow-up|3
4902541|NCT00607919|16890679|P1|Acute Phase|Lost to Follow-up|9
4902542|NCT00607919|16890678|P2|Acute Phase|Lack of Efficacy|2
4902543|NCT00607919|16890679|P1|Acute Phase|Lack of Efficacy|1
4902544|NCT00607919|16890678|P2|Acute Phase|Entry Criteria Not Met|1
4902545|NCT00607919|16890679|P1|Acute Phase|Entry Criteria Not Met|1
4902546|NCT00607919|16890678|P2|Acute Phase|Adverse Event|2
4902547|NCT00607919|16890679|P1|Acute Phase|Adverse Event|9
4902548|NCT00607893|16890737|P2|Overall Study|Withdrew due to hypertensive urgency|1
4902549|NCT00607893|16890738|P1|Overall Study|Withdrew due to hypertensive urgency|1
4902550|NCT00607893|16890737|P2|Overall Study|Declined to be treated|0
4902551|NCT00607893|16890738|P1|Overall Study|Declined to be treated|1
4902552|NCT00607893|16890737|P2|Overall Study|withdrew could not tolerate CPAP|1
4902553|NCT00607893|16890738|P1|Overall Study|withdrew could not tolerate CPAP|0
4902554|NCT00607893|16890737|P2|Overall Study|Withdrew due to osteomyelitis surgery|1
4902555|NCT00607893|16890738|P1|Overall Study|Withdrew due to osteomyelitis surgery|0
4902556|NCT00607893|16890737|P2|Overall Study|withdrew due to loss of interest|1
4902557|NCT00607893|16890738|P1|Overall Study|withdrew due to loss of interest|0
4902558|NCT00607893|16890737|P2|Overall Study|Lost to Follow-up|0
4902559|NCT00607893|16890738|P1|Overall Study|Lost to Follow-up|4
4902560|NCT00607880|16890766|P2|Overall Study|Unable to place port due to occlusion|0
4902561|NCT00607880|16890767|P1|Overall Study|Unable to place port due to occlusion|1
4902562|NCT00607789|16890817|P2|Overall Study|Withdrawal by Subject|0
4902563|NCT00607789|16890818|P1|Overall Study|Withdrawal by Subject|1
4902564|NCT00607789|16890817|P2|Overall Study|Lost to Follow-up|5
4902565|NCT00607789|16890818|P1|Overall Study|Lost to Follow-up|0
4902566|NCT00607789|16890817|P2|Overall Study|Inadequate adherence|0
4902567|NCT00607789|16890818|P1|Overall Study|Inadequate adherence|3
4902568|NCT00607789|16890817|P2|Overall Study|Lack of Efficacy|1
4902569|NCT00607789|16890818|P1|Overall Study|Lack of Efficacy|0
4902570|NCT00607789|16890817|P2|Overall Study|Adverse Event|0
4902571|NCT00607789|16890818|P1|Overall Study|Adverse Event|3
4902572|NCT00607724|16890833|P7|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4902573|NCT00607724|16890834|P6|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4902574|NCT00607724|16890835|P5|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4902575|NCT00607724|16890836|P4|Stage 2: Expanded Cohort|Withdrawal by Subject|1
4902576|NCT00607724|16890837|P3|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4902577|NCT00607724|16890838|P2|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4902578|NCT00607724|16890839|P1|Stage 2: Expanded Cohort|Withdrawal by Subject|0
4902579|NCT00607724|16890833|P7|Stage 2: Expanded Cohort|Physician Decision|0
4902580|NCT00607724|16890834|P6|Stage 2: Expanded Cohort|Physician Decision|1
4902581|NCT00607724|16890835|P5|Stage 2: Expanded Cohort|Physician Decision|1
4902582|NCT00607724|16890836|P4|Stage 2: Expanded Cohort|Physician Decision|0
4902583|NCT00607724|16890837|P3|Stage 2: Expanded Cohort|Physician Decision|0
4902584|NCT00607724|16890838|P2|Stage 2: Expanded Cohort|Physician Decision|0
4902585|NCT00607724|16890839|P1|Stage 2: Expanded Cohort|Physician Decision|0
4902586|NCT00607724|16890833|P7|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10
4902587|NCT00607724|16890834|P6|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11
4902588|NCT00607724|16890835|P5|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8
4902589|NCT00607724|16890836|P4|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4
4902590|NCT00607724|16890837|P3|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
4902591|NCT00607724|16890838|P2|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
4902592|NCT00607724|16890839|P1|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0
4902593|NCT00607724|16890833|P7|Stage 2: Expanded Cohort|Adverse Event|1
4902594|NCT00607724|16890834|P6|Stage 2: Expanded Cohort|Adverse Event|0
4902595|NCT00607724|16890835|P5|Stage 2: Expanded Cohort|Adverse Event|0
4902596|NCT00607724|16890836|P4|Stage 2: Expanded Cohort|Adverse Event|0
4902597|NCT00607724|16890837|P3|Stage 2: Expanded Cohort|Adverse Event|0
4902598|NCT00607724|16890838|P2|Stage 2: Expanded Cohort|Adverse Event|0
4902599|NCT00607724|16890839|P1|Stage 2: Expanded Cohort|Adverse Event|0
4902600|NCT00607724|16890833|P7|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4902601|NCT00607724|16890834|P6|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4902602|NCT00607724|16890835|P5|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4902603|NCT00607724|16890836|P4|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0
4902604|NCT00607724|16890837|P3|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4
4902605|NCT00607724|16890838|P2|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8
4902606|NCT00607724|16890839|P1|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7
4902607|NCT00607386|16891002|P1|Overall Study|Physician Decision|1
4902608|NCT00607373|16891017|P2|Follow-up Period|Withdrawal by Subject|3
4902609|NCT00607373|16891018|P1|Follow-up Period|Withdrawal by Subject|1
4902610|NCT00607373|16891017|P2|Follow-up Period|Protocol Violation|1
4902611|NCT00607373|16891018|P1|Follow-up Period|Protocol Violation|0
4902612|NCT00607373|16891017|P2|Follow-up Period|Other|1
4902613|NCT00607373|16891018|P1|Follow-up Period|Other|0
4902614|NCT00607373|16891017|P2|Treatment Period|Withdrawal by Subject|1
4902615|NCT00607373|16891018|P1|Treatment Period|Withdrawal by Subject|0
4902616|NCT00607373|16891017|P2|Treatment Period|Physician Decision|1
4902617|NCT00607373|16891018|P1|Treatment Period|Physician Decision|0
4902618|NCT00607373|16891017|P2|Treatment Period|Adverse Event|4
4902619|NCT00607373|16891018|P1|Treatment Period|Adverse Event|0
4902620|NCT00607087|16891120|P3|Period 3|Adverse Event|0
4902621|NCT00607087|16891121|P2|Period 3|Adverse Event|1
4902622|NCT00607087|16891122|P1|Period 3|Adverse Event|0
4902623|NCT00607087|16891120|P3|Period 3|Withdrawal by Subject|0
4902624|NCT00607087|16891121|P2|Period 3|Withdrawal by Subject|1
4902625|NCT00607087|16891122|P1|Period 3|Withdrawal by Subject|2
4902626|NCT00607087|16891120|P3|Period 2|Poor compliance to protocol|1
4902627|NCT00607087|16891121|P2|Period 2|Poor compliance to protocol|0
4902628|NCT00607087|16891122|P1|Period 2|Poor compliance to protocol|0
4902629|NCT00607087|16891120|P3|Period 2|Adverse Event|3
4902630|NCT00607087|16891121|P2|Period 2|Adverse Event|1
4902631|NCT00607087|16891122|P1|Period 2|Adverse Event|0
4902632|NCT00607087|16891120|P3|Period 2|Other reason|0
4902633|NCT00607087|16891121|P2|Period 2|Other reason|1
4902634|NCT00607087|16891122|P1|Period 2|Other reason|1
4902635|NCT00607087|16891120|P3|Period 2|Withdrawal by Subject|1
4902636|NCT00607087|16891121|P2|Period 2|Withdrawal by Subject|1
4902637|NCT00607087|16891122|P1|Period 2|Withdrawal by Subject|0
4902638|NCT00607087|16891120|P3|Period 1|Other reason|2
4902639|NCT00607087|16891121|P2|Period 1|Other reason|4
4902640|NCT00607087|16891122|P1|Period 1|Other reason|0
4902641|NCT00607087|16891120|P3|Period 1|Lost to Follow-up|0
4902642|NCT00607087|16891121|P2|Period 1|Lost to Follow-up|0
4902643|NCT00607087|16891122|P1|Period 1|Lost to Follow-up|1
4902644|NCT00607087|16891120|P3|Period 1|Poor compliance to protocol|0
4902645|NCT00607087|16891121|P2|Period 1|Poor compliance to protocol|0
4902646|NCT00607087|16891122|P1|Period 1|Poor compliance to protocol|1
4902647|NCT00607087|16891120|P3|Period 1|Adverse Event|0
4902648|NCT00607087|16891121|P2|Period 1|Adverse Event|0
4902649|NCT00607087|16891122|P1|Period 1|Adverse Event|3
4902650|NCT00607087|16891120|P3|Period 1|Withdrawal by Subject|3
4902651|NCT00607087|16891121|P2|Period 1|Withdrawal by Subject|2
4902652|NCT00607087|16891122|P1|Period 1|Withdrawal by Subject|7
4902653|NCT00607087|16891120|P3|Overall Study|Lost to Follow-up|0
4902654|NCT00607087|16891121|P2|Overall Study|Lost to Follow-up|0
4902655|NCT00607087|16891122|P1|Overall Study|Lost to Follow-up|1
4902656|NCT00607087|16891120|P3|Overall Study|Poor compliance to protocol|1
4902657|NCT00607087|16891121|P2|Overall Study|Poor compliance to protocol|0
4902658|NCT00607087|16891122|P1|Overall Study|Poor compliance to protocol|1
4902659|NCT00607087|16891120|P3|Overall Study|Other reason|2
4902660|NCT00607087|16891121|P2|Overall Study|Other reason|5
4902661|NCT00607087|16891122|P1|Overall Study|Other reason|1
4902662|NCT00607087|16891120|P3|Overall Study|Adverse Event|3
4902663|NCT00607087|16891121|P2|Overall Study|Adverse Event|2
4902664|NCT00607087|16891122|P1|Overall Study|Adverse Event|3
4902665|NCT00607087|16891120|P3|Overall Study|Withdrawal by Subject|4
4902666|NCT00607087|16891121|P2|Overall Study|Withdrawal by Subject|4
4902667|NCT00607087|16891122|P1|Overall Study|Withdrawal by Subject|9
4902668|NCT00607048|16891180|P6|Overall Study|Other|1
4902669|NCT00607048|16891181|P5|Overall Study|Other|0
4902670|NCT00607048|16891182|P4|Overall Study|Other|0
4902671|NCT00607048|16891183|P3|Overall Study|Other|0
4902672|NCT00607048|16891184|P2|Overall Study|Other|1
4902673|NCT00607048|16891185|P1|Overall Study|Other|1
4902674|NCT00607048|16891180|P6|Overall Study|Withdrawal by Subject|2
4902675|NCT00607048|16891181|P5|Overall Study|Withdrawal by Subject|0
4902676|NCT00607048|16891182|P4|Overall Study|Withdrawal by Subject|1
4902677|NCT00607048|16891183|P3|Overall Study|Withdrawal by Subject|0
4902678|NCT00607048|16891184|P2|Overall Study|Withdrawal by Subject|0
4902679|NCT00607048|16891185|P1|Overall Study|Withdrawal by Subject|0
4902680|NCT00607048|16891180|P6|Overall Study|Objective disease progression - relapse|2
4902681|NCT00607048|16891181|P5|Overall Study|Objective disease progression - relapse|2
4902682|NCT00607048|16891182|P4|Overall Study|Objective disease progression - relapse|2
4902683|NCT00607048|16891183|P3|Overall Study|Objective disease progression - relapse|4
4902684|NCT00607048|16891184|P2|Overall Study|Objective disease progression - relapse|2
4902685|NCT00607048|16891185|P1|Overall Study|Objective disease progression - relapse|1
4902686|NCT00607048|16891180|P6|Overall Study|Global deterioration of health|0
4902687|NCT00607048|16891181|P5|Overall Study|Global deterioration of health|0
4902688|NCT00607048|16891182|P4|Overall Study|Global deterioration of health|0
4902689|NCT00607048|16891183|P3|Overall Study|Global deterioration of health|0
4902690|NCT00607048|16891184|P2|Overall Study|Global deterioration of health|0
4902691|NCT00607048|16891185|P1|Overall Study|Global deterioration of health|1
4902692|NCT00607048|16891180|P6|Overall Study|Adverse Event|0
4902693|NCT00607048|16891181|P5|Overall Study|Adverse Event|4
4902694|NCT00607048|16891182|P4|Overall Study|Adverse Event|0
4902695|NCT00607048|16891183|P3|Overall Study|Adverse Event|0
4902696|NCT00607048|16891184|P2|Overall Study|Adverse Event|1
4902697|NCT00607048|16891185|P1|Overall Study|Adverse Event|0
4902698|NCT00607022|16891270|P3|Overall Study|Withdrawal by Subject|0
4902699|NCT00607022|16891271|P2|Overall Study|Withdrawal by Subject|0
4902700|NCT00607022|16891272|P1|Overall Study|Withdrawal by Subject|1
4902701|NCT00606931|16891289|P1|Overall Study|Withdrawal by Subject|3
4902702|NCT00606905|16891297|P2|Overall Study|Withdrew|5
4902703|NCT00606905|16891298|P1|Overall Study|Withdrew|5
4902704|NCT00606905|16891297|P2|Overall Study|Non-Index Pregnancy|4
4902705|NCT00606905|16891298|P1|Overall Study|Non-Index Pregnancy|1
4902706|NCT00606905|16891297|P2|Overall Study|No Pregnancy|6
4902707|NCT00606905|16891298|P1|Overall Study|No Pregnancy|9
4902708|NCT00606892|16891304|P2|First Intervention|Protocol Violation|4
4902709|NCT00606892|16891305|P1|First Intervention|Protocol Violation|1
4902710|NCT00606801|16891339|P2|Intervention|Protocol Violation|3
4902711|NCT00606801|16891340|P1|Intervention|Protocol Violation|3
4902712|NCT00606684|16891368|P7|Double-Blind Treatment Period|Withdrawal by Subject|0
4902713|NCT00606684|16891369|P6|Double-Blind Treatment Period|Withdrawal by Subject|2
4902714|NCT00606684|16891370|P5|Double-Blind Treatment Period|Withdrawal by Subject|1
4902715|NCT00606684|16891371|P4|Double-Blind Treatment Period|Withdrawal by Subject|2
4902716|NCT00606684|16891372|P3|Double-Blind Treatment Period|Withdrawal by Subject|1
4902717|NCT00606684|16891373|P2|Double-Blind Treatment Period|Withdrawal by Subject|1
4902718|NCT00606684|16891374|P1|Double-Blind Treatment Period|Withdrawal by Subject|0
4902719|NCT00606684|16891368|P7|Double-Blind Treatment Period|Physician Decision|2
4902720|NCT00606684|16891369|P6|Double-Blind Treatment Period|Physician Decision|1
4902721|NCT00606684|16891370|P5|Double-Blind Treatment Period|Physician Decision|3
4902722|NCT00606684|16891371|P4|Double-Blind Treatment Period|Physician Decision|0
4902723|NCT00606684|16891372|P3|Double-Blind Treatment Period|Physician Decision|1
4902724|NCT00606684|16891373|P2|Double-Blind Treatment Period|Physician Decision|5
4902725|NCT00606684|16891374|P1|Double-Blind Treatment Period|Physician Decision|0
4902726|NCT00606684|16891368|P7|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
4902727|NCT00606684|16891369|P6|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3
4902728|NCT00606684|16891370|P5|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
4902729|NCT00606684|16891371|P4|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
4902730|NCT00606684|16891372|P3|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2
4902731|NCT00606684|16891373|P2|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1
4902732|NCT00606684|16891374|P1|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0
4902733|NCT00606684|16891368|P7|Double-Blind Treatment Period|Protocol Violation|4
4902734|NCT00606684|16891369|P6|Double-Blind Treatment Period|Protocol Violation|3
4902735|NCT00606684|16891370|P5|Double-Blind Treatment Period|Protocol Violation|0
4902736|NCT00606684|16891371|P4|Double-Blind Treatment Period|Protocol Violation|3
4902737|NCT00606684|16891372|P3|Double-Blind Treatment Period|Protocol Violation|5
4902738|NCT00606684|16891373|P2|Double-Blind Treatment Period|Protocol Violation|5
4902739|NCT00606684|16891374|P1|Double-Blind Treatment Period|Protocol Violation|0
4902740|NCT00606684|16891368|P7|Double-Blind Treatment Period|Lack of Efficacy|0
4902741|NCT00606684|16891369|P6|Double-Blind Treatment Period|Lack of Efficacy|0
4902742|NCT00606684|16891370|P5|Double-Blind Treatment Period|Lack of Efficacy|1
4902743|NCT00606684|16891371|P4|Double-Blind Treatment Period|Lack of Efficacy|0
4902744|NCT00606684|16891372|P3|Double-Blind Treatment Period|Lack of Efficacy|0
4902745|NCT00606684|16891373|P2|Double-Blind Treatment Period|Lack of Efficacy|1
4902746|NCT00606684|16891374|P1|Double-Blind Treatment Period|Lack of Efficacy|0
4902747|NCT00606684|16891368|P7|Double-Blind Treatment Period|Adverse Event|1
4902748|NCT00606684|16891369|P6|Double-Blind Treatment Period|Adverse Event|0
4902749|NCT00606684|16891370|P5|Double-Blind Treatment Period|Adverse Event|2
4902750|NCT00606684|16891371|P4|Double-Blind Treatment Period|Adverse Event|4
4902751|NCT00606684|16891372|P3|Double-Blind Treatment Period|Adverse Event|2
4902752|NCT00606684|16891373|P2|Double-Blind Treatment Period|Adverse Event|3
4902753|NCT00606684|16891374|P1|Double-Blind Treatment Period|Adverse Event|0
4902754|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4902755|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4902756|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4902757|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4902758|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4902759|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Received Study Medication in Error|0
4902760|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Received Study Medication in Error|1
4902761|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Adverse Event|0
4902762|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Adverse Event|0
4902763|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Adverse Event|0
4902764|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Adverse Event|0
4902765|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Adverse Event|0
4902766|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Adverse Event|0
4902767|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Adverse Event|2
4902768|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4902769|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4902770|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4902771|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4902772|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4902773|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Lost to Follow-up|0
4902774|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Lost to Follow-up|5
4902775|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4902776|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4902777|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4902778|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4902779|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4902780|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Withdrawal by Subject|0
4902781|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Withdrawal by Subject|15
4902782|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Physician Decision|0
4902783|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Physician Decision|0
4902784|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Physician Decision|0
4902785|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Physician Decision|0
4902786|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Physician Decision|0
4902787|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Physician Decision|0
4902788|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Physician Decision|18
4902789|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4902790|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4902791|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4902792|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4902793|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4902794|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Study Closed/Terminated|0
4902795|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Study Closed/Terminated|32
4902796|NCT00606684|16891368|P7|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4902797|NCT00606684|16891369|P6|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4902798|NCT00606684|16891370|P5|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4902799|NCT00606684|16891371|P4|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4902800|NCT00606684|16891372|P3|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4902801|NCT00606684|16891373|P2|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0
4902802|NCT00606684|16891374|P1|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173
4902803|NCT00606632|16891406|P1|Overall Study|Miscellaneous reasons|9
4902804|NCT00606632|16891406|P1|Overall Study|Withdrawal by Subject|13
4902805|NCT00606593|16891419|P10|Overall Study|Administrative/Other|0
4902806|NCT00606593|16891420|P9|Overall Study|Administrative/Other|0
4902807|NCT00606593|16891421|P8|Overall Study|Administrative/Other|0
4902808|NCT00606593|16891422|P7|Overall Study|Administrative/Other|0
4902809|NCT00606593|16891423|P6|Overall Study|Administrative/Other|0
4902810|NCT00606593|16891424|P5|Overall Study|Administrative/Other|0
4902811|NCT00606593|16891425|P4|Overall Study|Administrative/Other|0
4902812|NCT00606593|16891426|P3|Overall Study|Administrative/Other|1
4902813|NCT00606593|16891427|P2|Overall Study|Administrative/Other|0
4902814|NCT00606593|16891428|P1|Overall Study|Administrative/Other|0
4902815|NCT00606593|16891419|P10|Overall Study|Withdrawal of consent|0
4902816|NCT00606593|16891420|P9|Overall Study|Withdrawal of consent|0
4902817|NCT00606593|16891421|P8|Overall Study|Withdrawal of consent|0
4902818|NCT00606593|16891422|P7|Overall Study|Withdrawal of consent|0
4902819|NCT00606593|16891423|P6|Overall Study|Withdrawal of consent|0
4902820|NCT00606593|16891424|P5|Overall Study|Withdrawal of consent|0
4902821|NCT00606593|16891425|P4|Overall Study|Withdrawal of consent|0
4902822|NCT00606593|16891426|P3|Overall Study|Withdrawal of consent|1
4902823|NCT00606593|16891427|P2|Overall Study|Withdrawal of consent|0
4902824|NCT00606593|16891428|P1|Overall Study|Withdrawal of consent|1
4902825|NCT00606593|16891419|P10|Overall Study|Adverse Event|0
4902826|NCT00606593|16891420|P9|Overall Study|Adverse Event|1
4902827|NCT00606593|16891421|P8|Overall Study|Adverse Event|2
4902828|NCT00606593|16891422|P7|Overall Study|Adverse Event|1
4902829|NCT00606593|16891423|P6|Overall Study|Adverse Event|0
4902830|NCT00606593|16891424|P5|Overall Study|Adverse Event|1
4902831|NCT00606593|16891425|P4|Overall Study|Adverse Event|1
4902832|NCT00606593|16891426|P3|Overall Study|Adverse Event|0
4902833|NCT00606593|16891427|P2|Overall Study|Adverse Event|0
4902834|NCT00606593|16891428|P1|Overall Study|Adverse Event|0
4902835|NCT00606580|16891449|P3|Overall Study|Withdrawal by Subject|0
4902836|NCT00606580|16891450|P2|Overall Study|Withdrawal by Subject|1
4902837|NCT00606580|16891451|P1|Overall Study|Withdrawal by Subject|0
4902838|NCT00606580|16891449|P3|Overall Study|Withdrawal by investigator|6
4902839|NCT00606580|16891450|P2|Overall Study|Withdrawal by investigator|1
4902840|NCT00606580|16891451|P1|Overall Study|Withdrawal by investigator|0
4902841|NCT00606580|16891449|P3|Overall Study|Clinical failures|12
4902842|NCT00606580|16891450|P2|Overall Study|Clinical failures|0
4902843|NCT00606580|16891451|P1|Overall Study|Clinical failures|1
4902844|NCT00606580|16891449|P3|Overall Study|Lost to Follow-up|4
4902845|NCT00606580|16891450|P2|Overall Study|Lost to Follow-up|1
4902846|NCT00606580|16891451|P1|Overall Study|Lost to Follow-up|1
4902847|NCT00606502|16891517|P2|Treatment|Treatment ongoing at time of data cutoff|3
4902848|NCT00606502|16891518|P1|Treatment|Treatment ongoing at time of data cutoff|0
4902849|NCT00606502|16891517|P2|Randomization|Randomized but not treated|0
4902850|NCT00606502|16891518|P1|Randomization|Randomized but not treated|3
4902851|NCT00606320|16891539|P1|Overall Study|Progression to depressive phase|4
4902852|NCT00606320|16891539|P1|Overall Study|Withdrawal by Subject|10
4902853|NCT00606320|16891539|P1|Overall Study|Protocol Violation|8
4902854|NCT00606320|16891539|P1|Overall Study|Physician Decision|7
4902855|NCT00606320|16891539|P1|Overall Study|Lack of Efficacy|5
4902856|NCT00606320|16891539|P1|Overall Study|Adverse Event|3
4902857|NCT00606307|16891544|P1|Overall Study|QTc prolongation|1
4902858|NCT00606307|16891544|P1|Overall Study|Disease progression|6
4902859|NCT00606307|16891544|P1|Overall Study|Withdrawal by Subject|2
4902860|NCT00606307|16891544|P1|Overall Study|Adverse Event|2
4902861|NCT00606294|16891552|P2|Overall Study|Withdrawal by Subject|0
4902862|NCT00606294|16891553|P1|Overall Study|Withdrawal by Subject|36
4902863|NCT00606281|16891567|P2|Overall Study|Change of residence or other commitments|1
4902864|NCT00606281|16891568|P1|Overall Study|Change of residence or other commitments|1
4902865|NCT00606281|16891567|P2|Overall Study|Progression to depressive phase|1
4902866|NCT00606281|16891568|P1|Overall Study|Progression to depressive phase|1
4902867|NCT00606281|16891567|P2|Overall Study|Withdrawal by Subject|13
4902868|NCT00606281|16891568|P1|Overall Study|Withdrawal by Subject|11
4902869|NCT00606281|16891567|P2|Overall Study|Protocol Violation|3
4902870|NCT00606281|16891568|P1|Overall Study|Protocol Violation|3
4902871|NCT00606281|16891567|P2|Overall Study|Physician Decision|1
4902872|NCT00606281|16891568|P1|Overall Study|Physician Decision|0
4902873|NCT00606281|16891567|P2|Overall Study|Lack of Efficacy|35
4902874|NCT00606281|16891568|P1|Overall Study|Lack of Efficacy|28
4902875|NCT00606281|16891567|P2|Overall Study|Death|0
4902876|NCT00606281|16891568|P1|Overall Study|Death|1
4902877|NCT00606281|16891567|P2|Overall Study|Adverse Event|12
4902878|NCT00606281|16891568|P1|Overall Study|Adverse Event|11
4902879|NCT00606229|16891576|P1|Overall Study|change of residence or other commitments|2
4902880|NCT00606229|16891576|P1|Overall Study|does not meet inclusion criterion 1-3|4
4902881|NCT00606229|16891576|P1|Overall Study|Withdrawal by Subject|4
4902882|NCT00606229|16891576|P1|Overall Study|Lack of Efficacy|1
4902883|NCT00606229|16891576|P1|Overall Study|Adverse Event|11
4902884|NCT00606177|16891583|P2|Overall Study|Change of residence or other commitments|1
4902885|NCT00606177|16891584|P1|Overall Study|Change of residence or other commitments|1
4902886|NCT00606177|16891583|P2|Overall Study|Diabetic blood glucose level/ High HbA1c|1
4902887|NCT00606177|16891584|P1|Overall Study|Diabetic blood glucose level/ High HbA1c|1
4902888|NCT00606177|16891583|P2|Overall Study|Progression to depressive phase|1
4902889|NCT00606177|16891584|P1|Overall Study|Progression to depressive phase|6
4902890|NCT00606177|16891583|P2|Overall Study|Withdrawal by Subject|6
4902891|NCT00606177|16891584|P1|Overall Study|Withdrawal by Subject|5
4902892|NCT00606177|16891583|P2|Overall Study|Protocol Violation|4
4902893|NCT00606177|16891584|P1|Overall Study|Protocol Violation|1
4902894|NCT00606177|16891583|P2|Overall Study|Physician Decision|0
4902895|NCT00606177|16891584|P1|Overall Study|Physician Decision|1
4902896|NCT00606177|16891583|P2|Overall Study|Lack of Efficacy|7
4902897|NCT00606177|16891584|P1|Overall Study|Lack of Efficacy|3
4902898|NCT00606177|16891583|P2|Overall Study|Adverse Event|5
4902899|NCT00606177|16891584|P1|Overall Study|Adverse Event|9
4902900|NCT00606086|16891611|P2|Overall Study|Randomized, not treated|2
4902901|NCT00606086|16891612|P1|Overall Study|Randomized, not treated|1
4902902|NCT00606086|16891611|P2|Overall Study|Non-compliance|1
4902903|NCT00606086|16891612|P1|Overall Study|Non-compliance|0
4902904|NCT00606086|16891611|P2|Overall Study|Withdrawal by Subject|3
4902905|NCT00606086|16891612|P1|Overall Study|Withdrawal by Subject|5
4902906|NCT00606086|16891611|P2|Overall Study|Protocol Violation|0
4902907|NCT00606086|16891612|P1|Overall Study|Protocol Violation|1
4902908|NCT00606086|16891611|P2|Overall Study|Lost to Follow-up|8
4902909|NCT00606086|16891612|P1|Overall Study|Lost to Follow-up|4
4902910|NCT00606086|16891611|P2|Overall Study|Adverse Event|1
4902911|NCT00606086|16891612|P1|Overall Study|Adverse Event|1
4902912|NCT00606034|16891622|P1|Overall Study|incarceration|1
4902913|NCT00606021|16891630|P3|Maintenance Phase|Lost to Follow-up|2
4902914|NCT00606021|16891631|P2|Maintenance Phase|Lost to Follow-up|5
4902915|NCT00606021|16891632|P1|Maintenance Phase|Lost to Follow-up|0
4902916|NCT00606021|16891630|P3|Maintenance Phase|Physician Decision|0
4902917|NCT00606021|16891631|P2|Maintenance Phase|Physician Decision|1
4902918|NCT00606021|16891632|P1|Maintenance Phase|Physician Decision|0
4902919|NCT00606021|16891630|P3|Maintenance Phase|Death|15
4902920|NCT00606021|16891631|P2|Maintenance Phase|Death|17
4902921|NCT00606021|16891632|P1|Maintenance Phase|Death|0
4902922|NCT00606021|16891630|P3|Induction Phase|Lost to Follow-up|0
4902923|NCT00606021|16891631|P2|Induction Phase|Lost to Follow-up|0
4902924|NCT00606021|16891632|P1|Induction Phase|Lost to Follow-up|10
4902925|NCT00606021|16891630|P3|Induction Phase|Withdrawal by Subject|0
4902926|NCT00606021|16891631|P2|Induction Phase|Withdrawal by Subject|0
4902927|NCT00606021|16891632|P1|Induction Phase|Withdrawal by Subject|2
4902928|NCT00606021|16891630|P3|Induction Phase|Physician Decision|0
4902929|NCT00606021|16891631|P2|Induction Phase|Physician Decision|0
4902930|NCT00606021|16891632|P1|Induction Phase|Physician Decision|2
4902931|NCT00606021|16891630|P3|Induction Phase|Death|0
4902932|NCT00606021|16891631|P2|Induction Phase|Death|0
4902933|NCT00606021|16891632|P1|Induction Phase|Death|73
4902934|NCT00606008|16891650|P1|Overall Study|Withdrawal by Subject|4
4902935|NCT00606008|16891650|P1|Overall Study|Adverse Event|1
4902936|NCT00605917|16891664|P1|Overall Study|Protocol Violation|79
4902937|NCT00605865|16891716|P1|Overall Study|Protocol Violation|115
4902938|NCT00605839|16891758|P3|Overall Study|Protocol Violation|0
4902939|NCT00605839|16891759|P2|Overall Study|Protocol Violation|0
4902940|NCT00605839|16891760|P1|Overall Study|Protocol Violation|1
4902941|NCT00605813|16891783|P1|Overall Study|Protocol Violation|25
4902942|NCT00605722|16891796|P1|Overall Study|Failure to return|1
4902943|NCT00605722|16891796|P1|Overall Study|Insufficient therapeutic response|44
4902944|NCT00605722|16891796|P1|Overall Study|Adverse Event|6
4902945|NCT00605657|16891817|P1|Overall Study|Protocol Violation|1
4902946|NCT00605657|16891817|P1|Overall Study|Adverse Event|1
4902947|NCT00605566|16891843|P1|Overall Study|Poor compliance in run-in period|1
4902948|NCT00605566|16891843|P1|Overall Study|Clinical deterioration|1
4902949|NCT00605566|16891843|P1|Overall Study|Adverse Event|1
4902950|NCT00605540|16891851|P1|Overall Study|Lost to Follow-up|23
4902951|NCT00605540|16891851|P1|Overall Study|Death|15
4902952|NCT00605475|16891869|P10|Overall Study|Withdrawal by Subject|1
4902953|NCT00605475|16891870|P9|Overall Study|Withdrawal by Subject|0
4902954|NCT00605475|16891871|P8|Overall Study|Withdrawal by Subject|0
4902955|NCT00605475|16891872|P7|Overall Study|Withdrawal by Subject|0
4902956|NCT00605475|16891873|P6|Overall Study|Withdrawal by Subject|2
4902957|NCT00605475|16891874|P5|Overall Study|Withdrawal by Subject|0
4902958|NCT00605475|16891875|P4|Overall Study|Withdrawal by Subject|0
4902959|NCT00605475|16891876|P3|Overall Study|Withdrawal by Subject|0
4902960|NCT00605475|16891877|P2|Overall Study|Withdrawal by Subject|0
4902961|NCT00605475|16891878|P1|Overall Study|Withdrawal by Subject|0
4902962|NCT00605475|16891869|P10|Overall Study|Protocol Violation|0
4902963|NCT00605475|16891870|P9|Overall Study|Protocol Violation|0
4902964|NCT00605475|16891871|P8|Overall Study|Protocol Violation|0
4902965|NCT00605475|16891872|P7|Overall Study|Protocol Violation|0
4902966|NCT00605475|16891873|P6|Overall Study|Protocol Violation|0
4902967|NCT00605475|16891874|P5|Overall Study|Protocol Violation|1
4902968|NCT00605475|16891875|P4|Overall Study|Protocol Violation|0
4902969|NCT00605475|16891876|P3|Overall Study|Protocol Violation|0
4902970|NCT00605475|16891877|P2|Overall Study|Protocol Violation|0
4902971|NCT00605475|16891878|P1|Overall Study|Protocol Violation|0
4902972|NCT00605475|16891869|P10|Overall Study|Lost to Follow-up|1
4902973|NCT00605475|16891870|P9|Overall Study|Lost to Follow-up|1
4902974|NCT00605475|16891871|P8|Overall Study|Lost to Follow-up|0
4902975|NCT00605475|16891872|P7|Overall Study|Lost to Follow-up|0
4902976|NCT00605475|16891873|P6|Overall Study|Lost to Follow-up|0
4902977|NCT00605475|16891874|P5|Overall Study|Lost to Follow-up|0
4902978|NCT00605475|16891875|P4|Overall Study|Lost to Follow-up|0
4902979|NCT00605475|16891876|P3|Overall Study|Lost to Follow-up|0
4902980|NCT00605475|16891877|P2|Overall Study|Lost to Follow-up|0
4902981|NCT00605475|16891878|P1|Overall Study|Lost to Follow-up|0
4902982|NCT00605475|16891869|P10|Overall Study|Administrative problems|0
4902983|NCT00605475|16891870|P9|Overall Study|Administrative problems|0
4902984|NCT00605475|16891871|P8|Overall Study|Administrative problems|0
4902985|NCT00605475|16891872|P7|Overall Study|Administrative problems|1
4902986|NCT00605475|16891873|P6|Overall Study|Administrative problems|0
4902987|NCT00605475|16891874|P5|Overall Study|Administrative problems|0
4902988|NCT00605475|16891875|P4|Overall Study|Administrative problems|0
4902989|NCT00605475|16891876|P3|Overall Study|Administrative problems|0
4902990|NCT00605475|16891877|P2|Overall Study|Administrative problems|0
4902991|NCT00605475|16891878|P1|Overall Study|Administrative problems|0
4902992|NCT00605475|16891869|P10|Overall Study|Abnormal Laboratory Values|0
4902993|NCT00605475|16891870|P9|Overall Study|Abnormal Laboratory Values|1
4902994|NCT00605475|16891871|P8|Overall Study|Abnormal Laboratory Values|0
4902995|NCT00605475|16891872|P7|Overall Study|Abnormal Laboratory Values|0
4902996|NCT00605475|16891873|P6|Overall Study|Abnormal Laboratory Values|0
4902997|NCT00605475|16891874|P5|Overall Study|Abnormal Laboratory Values|0
4902998|NCT00605475|16891875|P4|Overall Study|Abnormal Laboratory Values|0
4902999|NCT00605475|16891876|P3|Overall Study|Abnormal Laboratory Values|0
4903000|NCT00605475|16891877|P2|Overall Study|Abnormal Laboratory Values|0
4903001|NCT00605475|16891878|P1|Overall Study|Abnormal Laboratory Values|0
4903002|NCT00605345|16892055|P2|Overall Study|Protocol Violation|2
4903003|NCT00605345|16892056|P1|Overall Study|Protocol Violation|0
4903004|NCT00605345|16892055|P2|Overall Study|Adverse Event|1
4903005|NCT00605345|16892056|P1|Overall Study|Adverse Event|0
4903006|NCT00605345|16892055|P2|Overall Study|Withdrawal by Subject|0
4903007|NCT00605345|16892056|P1|Overall Study|Withdrawal by Subject|1
4903008|NCT00605319|16892072|P1|Overall Study|Adverse Event|6
4903009|NCT00605306|16892084|P2|Overall Study|Adverse Event|1
4903010|NCT00605306|16892085|P1|Overall Study|Adverse Event|0
4903011|NCT00605293|16892099|P2|Overall Study|Principal Investigator Decision|1
4903012|NCT00605293|16892100|P1|Overall Study|Principal Investigator Decision|0
4903013|NCT00605293|16892099|P2|Overall Study|Dialysis Out of Centre for 3 Months|1
4903014|NCT00605293|16892100|P1|Overall Study|Dialysis Out of Centre for 3 Months|0
4903015|NCT00605293|16892099|P2|Overall Study|Incorrect Epoetin Beta Administration|0
4903016|NCT00605293|16892100|P1|Overall Study|Incorrect Epoetin Beta Administration|1
4903017|NCT00605293|16892099|P2|Overall Study|Renal Transplantation|1
4903018|NCT00605293|16892100|P1|Overall Study|Renal Transplantation|3
4903019|NCT00605293|16892099|P2|Overall Study|Blood Transfusion|1
4903020|NCT00605293|16892100|P1|Overall Study|Blood Transfusion|7
4903021|NCT00605293|16892099|P2|Overall Study|Holidays Dialysis Out|0
4903022|NCT00605293|16892100|P1|Overall Study|Holidays Dialysis Out|1
4903023|NCT00605293|16892099|P2|Overall Study|Adverse Event|0
4903024|NCT00605293|16892100|P1|Overall Study|Adverse Event|1
4903025|NCT00605293|16892099|P2|Overall Study|Insufficient Therapeutic Response|0
4903026|NCT00605293|16892100|P1|Overall Study|Insufficient Therapeutic Response|2
4903027|NCT00605293|16892099|P2|Overall Study|Death|1
4903028|NCT00605293|16892100|P1|Overall Study|Death|2
4903029|NCT00605280|16892120|P4|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
4903030|NCT00605280|16892121|P3|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
4903031|NCT00605280|16892122|P2|Year 3 Extension|Lost to Follow-up or Patient non-comply|0
4903032|NCT00605280|16892123|P1|Year 3 Extension|Lost to Follow-up or Patient non-comply|2
4903033|NCT00605280|16892120|P4|Year 3 Extension|Other|0
4903034|NCT00605280|16892121|P3|Year 3 Extension|Other|0
4903035|NCT00605280|16892122|P2|Year 3 Extension|Other|0
4903036|NCT00605280|16892123|P1|Year 3 Extension|Other|2
4903037|NCT00605280|16892120|P4|Year 3 Extension|Withdrawal by Subject|5
4903038|NCT00605280|16892121|P3|Year 3 Extension|Withdrawal by Subject|0
4903039|NCT00605280|16892122|P2|Year 3 Extension|Withdrawal by Subject|0
4903040|NCT00605280|16892123|P1|Year 3 Extension|Withdrawal by Subject|2
4903041|NCT00605280|16892120|P4|Year 3 Extension|Physician Decision|2
4903042|NCT00605280|16892121|P3|Year 3 Extension|Physician Decision|0
4903043|NCT00605280|16892122|P2|Year 3 Extension|Physician Decision|0
4903044|NCT00605280|16892123|P1|Year 3 Extension|Physician Decision|0
4903045|NCT00605280|16892120|P4|Year 3 Extension|Adverse Event|2
4903046|NCT00605280|16892121|P3|Year 3 Extension|Adverse Event|0
4903047|NCT00605280|16892122|P2|Year 3 Extension|Adverse Event|0
4903048|NCT00605280|16892123|P1|Year 3 Extension|Adverse Event|2
4903049|NCT00605280|16892120|P4|Year 2|Lost to Follow-up or Patient non-comply|2
4903050|NCT00605280|16892121|P3|Year 2|Lost to Follow-up or Patient non-comply|0
4903051|NCT00605280|16892122|P2|Year 2|Lost to Follow-up or Patient non-comply|0
4903052|NCT00605280|16892123|P1|Year 2|Lost to Follow-up or Patient non-comply|4
4903053|NCT00605280|16892120|P4|Year 2|Other|1
4903054|NCT00605280|16892121|P3|Year 2|Other|0
4903055|NCT00605280|16892122|P2|Year 2|Other|0
4903056|NCT00605280|16892123|P1|Year 2|Other|1
4903057|NCT00605280|16892120|P4|Year 2|Withdrawal by Subject|4
4903058|NCT00605280|16892121|P3|Year 2|Withdrawal by Subject|0
4903059|NCT00605280|16892122|P2|Year 2|Withdrawal by Subject|0
4903060|NCT00605280|16892123|P1|Year 2|Withdrawal by Subject|4
4903061|NCT00605280|16892120|P4|Year 2|Physician Decision|11
4903062|NCT00605280|16892121|P3|Year 2|Physician Decision|4
4903063|NCT00605280|16892122|P2|Year 2|Physician Decision|6
4903064|NCT00605280|16892123|P1|Year 2|Physician Decision|11
4903065|NCT00605280|16892120|P4|Year 2|Adverse Event|4
4903066|NCT00605280|16892121|P3|Year 2|Adverse Event|2
4903067|NCT00605280|16892122|P2|Year 2|Adverse Event|0
4903068|NCT00605280|16892123|P1|Year 2|Adverse Event|4
4903069|NCT00605280|16892120|P4|Year 1|Lost to Follow-up or Patient non-comply|2
4903070|NCT00605280|16892121|P3|Year 1|Lost to Follow-up or Patient non-comply|0
4903071|NCT00605280|16892122|P2|Year 1|Lost to Follow-up or Patient non-comply|1
4903072|NCT00605280|16892123|P1|Year 1|Lost to Follow-up or Patient non-comply|5
4903073|NCT00605280|16892120|P4|Year 1|Other|1
4903074|NCT00605280|16892121|P3|Year 1|Other|0
4903075|NCT00605280|16892122|P2|Year 1|Other|1
4903076|NCT00605280|16892123|P1|Year 1|Other|2
4903077|NCT00605280|16892120|P4|Year 1|Withdrawal by Subject|4
4903078|NCT00605280|16892121|P3|Year 1|Withdrawal by Subject|0
4903079|NCT00605280|16892122|P2|Year 1|Withdrawal by Subject|4
4903080|NCT00605280|16892123|P1|Year 1|Withdrawal by Subject|2
4903081|NCT00605280|16892120|P4|Year 1|Physician Decision|6
4903082|NCT00605280|16892121|P3|Year 1|Physician Decision|0
4903083|NCT00605280|16892122|P2|Year 1|Physician Decision|4
4903084|NCT00605280|16892123|P1|Year 1|Physician Decision|7
4903085|NCT00605280|16892120|P4|Year 1|Adverse Event|5
4903086|NCT00605280|16892121|P3|Year 1|Adverse Event|1
4903087|NCT00605280|16892122|P2|Year 1|Adverse Event|1
4903088|NCT00605280|16892123|P1|Year 1|Adverse Event|3
4903089|NCT00605280|16892120|P4|Year 1|Protocol Violation|1
4903090|NCT00605280|16892121|P3|Year 1|Protocol Violation|0
4903091|NCT00605280|16892122|P2|Year 1|Protocol Violation|0
4903092|NCT00605280|16892123|P1|Year 1|Protocol Violation|0
4903093|NCT00605267|16892157|P2|Overall Study|Withdrawal by Subject|3
4903094|NCT00605267|16892158|P1|Overall Study|Withdrawal by Subject|2
4903095|NCT00605267|16892157|P2|Overall Study|Lack of Efficacy|5
4903096|NCT00605267|16892158|P1|Overall Study|Lack of Efficacy|1
4903097|NCT00605267|16892157|P2|Overall Study|Adverse Event|1
4903098|NCT00605267|16892158|P1|Overall Study|Adverse Event|0
4903099|NCT00605189|16892206|P3|Overall Study|Other|0
4903100|NCT00605189|16892207|P2|Overall Study|Other|2
4903101|NCT00605189|16892208|P1|Overall Study|Other|2
4903102|NCT00605189|16892206|P3|Overall Study|Adverse Event|0
4903103|NCT00605189|16892207|P2|Overall Study|Adverse Event|0
4903104|NCT00605189|16892208|P1|Overall Study|Adverse Event|1
4903105|NCT00605176|16892219|P3|Overall Study|Other (not due to AE)|0
4903106|NCT00605176|16892220|P2|Overall Study|Other (not due to AE)|1
4903107|NCT00605176|16892221|P1|Overall Study|Other (not due to AE)|1
4903108|NCT00605176|16892219|P3|Overall Study|Use of concomitant therapy|1
4903109|NCT00605176|16892220|P2|Overall Study|Use of concomitant therapy|0
4903110|NCT00605176|16892221|P1|Overall Study|Use of concomitant therapy|1
4903111|NCT00605176|16892219|P3|Overall Study|Non-complicance with study procedures|0
4903112|NCT00605176|16892220|P2|Overall Study|Non-complicance with study procedures|0
4903201|NCT00604383|16892645|P1|Overall Study|Physician Decision|0
4903113|NCT00605176|16892221|P1|Overall Study|Non-complicance with study procedures|1
4903114|NCT00605176|16892219|P3|Overall Study|Lost to Follow-up|1
4903115|NCT00605176|16892220|P2|Overall Study|Lost to Follow-up|2
4903116|NCT00605176|16892221|P1|Overall Study|Lost to Follow-up|2
4903117|NCT00605176|16892219|P3|Overall Study|Withdrawal by Subject|4
4903118|NCT00605176|16892220|P2|Overall Study|Withdrawal by Subject|2
4903119|NCT00605176|16892221|P1|Overall Study|Withdrawal by Subject|4
4903120|NCT00605176|16892219|P3|Overall Study|Adverse Event|3
4903121|NCT00605176|16892220|P2|Overall Study|Adverse Event|1
4903122|NCT00605176|16892221|P1|Overall Study|Adverse Event|2
4903123|NCT00605085|16892245|P2|Overall Study|administrative reasons|8
4903124|NCT00605085|16892246|P1|Overall Study|administrative reasons|18
4903125|NCT00605085|16892245|P2|Overall Study|Lost to Follow-up|5
4903126|NCT00605085|16892246|P1|Overall Study|Lost to Follow-up|10
4903127|NCT00605085|16892245|P2|Overall Study|Protocol Violation|2
4903128|NCT00605085|16892246|P1|Overall Study|Protocol Violation|3
4903129|NCT00605085|16892245|P2|Overall Study|Pregnancy|0
4903130|NCT00605085|16892246|P1|Overall Study|Pregnancy|2
4903131|NCT00605085|16892245|P2|Overall Study|Adverse Event|5
4903132|NCT00605085|16892246|P1|Overall Study|Adverse Event|9
4903133|NCT00605085|16892245|P2|Overall Study|Withdrawal by Subject|5
4903134|NCT00605085|16892246|P1|Overall Study|Withdrawal by Subject|8
4903135|NCT00605033|16892279|P2|Overall Study|Protocol Violation|1
4903136|NCT00605033|16892280|P1|Overall Study|Protocol Violation|1
4903137|NCT00605033|16892279|P2|Overall Study|Withdrawal by Subject|4
4903138|NCT00605033|16892280|P1|Overall Study|Withdrawal by Subject|3
4903139|NCT00605033|16892279|P2|Overall Study|Lost to Follow-up|1
4903140|NCT00605033|16892280|P1|Overall Study|Lost to Follow-up|1
4903141|NCT00605033|16892279|P2|Overall Study|Adverse Event|2
4903142|NCT00605033|16892280|P1|Overall Study|Adverse Event|2
4903143|NCT00604825|16892324|P4|Overall Study|Exclusion criterion met|1
4903144|NCT00604825|16892325|P3|Overall Study|Exclusion criterion met|0
4903145|NCT00604825|16892326|P2|Overall Study|Exclusion criterion met|0
4903146|NCT00604825|16892327|P1|Overall Study|Exclusion criterion met|0
4903147|NCT00604825|16892324|P4|Overall Study|Physician Decision|1
4903148|NCT00604825|16892325|P3|Overall Study|Physician Decision|0
4903149|NCT00604825|16892326|P2|Overall Study|Physician Decision|0
4903150|NCT00604825|16892327|P1|Overall Study|Physician Decision|0
4903151|NCT00604825|16892324|P4|Overall Study|Did not meet eligibility criteria|0
4903152|NCT00604825|16892325|P3|Overall Study|Did not meet eligibility criteria|2
4903153|NCT00604825|16892326|P2|Overall Study|Did not meet eligibility criteria|0
4903154|NCT00604825|16892327|P1|Overall Study|Did not meet eligibility criteria|0
4903155|NCT00604825|16892324|P4|Overall Study|Lack of Efficacy|0
4903156|NCT00604825|16892325|P3|Overall Study|Lack of Efficacy|1
4903157|NCT00604825|16892326|P2|Overall Study|Lack of Efficacy|2
4903158|NCT00604825|16892327|P1|Overall Study|Lack of Efficacy|3
4903159|NCT00604825|16892324|P4|Overall Study|Withdrawal by Subject|5
4903160|NCT00604825|16892325|P3|Overall Study|Withdrawal by Subject|5
4903161|NCT00604825|16892326|P2|Overall Study|Withdrawal by Subject|3
4903162|NCT00604825|16892327|P1|Overall Study|Withdrawal by Subject|4
4903163|NCT00604825|16892324|P4|Overall Study|Protocol Violation|0
4903164|NCT00604825|16892325|P3|Overall Study|Protocol Violation|0
4903165|NCT00604825|16892326|P2|Overall Study|Protocol Violation|1
4903166|NCT00604825|16892327|P1|Overall Study|Protocol Violation|0
4903167|NCT00604825|16892324|P4|Overall Study|Lost to Follow-up|0
4903168|NCT00604825|16892325|P3|Overall Study|Lost to Follow-up|1
4903169|NCT00604825|16892326|P2|Overall Study|Lost to Follow-up|3
4903170|NCT00604825|16892327|P1|Overall Study|Lost to Follow-up|0
4903171|NCT00604825|16892324|P4|Overall Study|Adverse Event|4
4903172|NCT00604825|16892325|P3|Overall Study|Adverse Event|7
4903173|NCT00604825|16892326|P2|Overall Study|Adverse Event|6
4903174|NCT00604825|16892327|P1|Overall Study|Adverse Event|2
4903175|NCT00604786|16892555|P2|Overall Study|Lost to Follow-up|0
4903176|NCT00604786|16892556|P1|Overall Study|Lost to Follow-up|2
4903177|NCT00604721|16892562|P1|Overall Study|Withdrawal by Subject|1
4903178|NCT00604721|16892562|P1|Overall Study|Physician Decision|1
4903179|NCT00604708|16892570|P2|Overall Study|Adverse Event|6
4903180|NCT00604708|16892571|P1|Overall Study|Adverse Event|6
4903181|NCT00604708|16892570|P2|Overall Study|administrative reasons|11
4903182|NCT00604708|16892571|P1|Overall Study|administrative reasons|9
4903183|NCT00604708|16892570|P2|Overall Study|Lost to Follow-up|5
4903184|NCT00604708|16892571|P1|Overall Study|Lost to Follow-up|5
4903185|NCT00604708|16892570|P2|Overall Study|Protocol Violation|8
4903186|NCT00604708|16892571|P1|Overall Study|Protocol Violation|2
4903187|NCT00604708|16892570|P2|Overall Study|Withdrawal by Subject|10
4903188|NCT00604708|16892571|P1|Overall Study|Withdrawal by Subject|9
4903189|NCT00604695|16892581|P2|Overall Study|Did not receive first bolus.|4
4903190|NCT00604695|16892582|P1|Overall Study|Did not receive first bolus.|0
4903191|NCT00604669|16892604|P1|Overall Study|lack of information in chart|7
4903192|NCT00604565|16892610|P2|Overall Study|Study terminated|3
4903193|NCT00604565|16892611|P1|Overall Study|Study terminated|0
4903194|NCT00604500|16892630|P1|Overall Study|Did not meet protocol eligibility|1
4903195|NCT00604500|16892630|P1|Overall Study|Administrative|1
4903196|NCT00604500|16892630|P1|Overall Study|Withdrawal by Subject|4
4903197|NCT00604500|16892630|P1|Overall Study|Treatment Failure|1
4903198|NCT00604500|16892630|P1|Overall Study|Protocol Violation|2
4903199|NCT00604500|16892630|P1|Overall Study|Adverse Event|2
4903200|NCT00604383|16892644|P2|Overall Study|Physician Decision|3
4903202|NCT00604383|16892644|P2|Overall Study|Adverse Event|9
4903203|NCT00604383|16892645|P1|Overall Study|Adverse Event|16
4903204|NCT00604383|16892644|P2|Overall Study|Death|22
4903205|NCT00604383|16892645|P1|Overall Study|Death|14
4903206|NCT00604383|16892644|P2|Overall Study|Lost to Follow-up|19
4903207|NCT00604383|16892645|P1|Overall Study|Lost to Follow-up|24
4903208|NCT00604383|16892644|P2|Overall Study|Withdrawal by Subject|31
4903209|NCT00604383|16892645|P1|Overall Study|Withdrawal by Subject|33
4903210|NCT00604279|16892661|P2|Overall Study|Other|4
4903211|NCT00604279|16892662|P1|Overall Study|Other|8
4903212|NCT00604279|16892661|P2|Overall Study|Adverse Event|5
4903213|NCT00604279|16892662|P1|Overall Study|Adverse Event|4
4903214|NCT00604279|16892661|P2|Overall Study|Withdrawal by Subject|5
4903215|NCT00604279|16892662|P1|Overall Study|Withdrawal by Subject|16
4903216|NCT00604279|16892661|P2|Overall Study|Protocol Violation|1
4903217|NCT00604279|16892662|P1|Overall Study|Protocol Violation|3
4903218|NCT00604279|16892661|P2|Overall Study|Pregnancy|0
4903219|NCT00604279|16892662|P1|Overall Study|Pregnancy|2
4903220|NCT00604279|16892661|P2|Overall Study|Lost to Follow-up|14
4903221|NCT00604279|16892662|P1|Overall Study|Lost to Follow-up|9
4903222|NCT00604279|16892661|P2|Overall Study|Lack of Efficacy|9
4903223|NCT00604279|16892662|P1|Overall Study|Lack of Efficacy|22
4903224|NCT00604214|16892678|P2|Day 91 to Day 180|Withdrawal by Subject|1
4903225|NCT00604214|16892679|P1|Day 91 to Day 180|Withdrawal by Subject|1
4903226|NCT00604214|16892678|P2|Day 91 to Day 180|Lost to Follow-up|8
4903227|NCT00604214|16892679|P1|Day 91 to Day 180|Lost to Follow-up|6
4903228|NCT00604214|16892678|P2|Day 91 to Day 180|Death|23
4903229|NCT00604214|16892679|P1|Day 91 to Day 180|Death|19
4903230|NCT00604214|16892678|P2|Day 29 to Day 90|Withdrawal by Subject|6
4903231|NCT00604214|16892679|P1|Day 29 to Day 90|Withdrawal by Subject|0
4903232|NCT00604214|16892678|P2|Day 29 to Day 90|Lost to Follow-up|6
4903233|NCT00604214|16892679|P1|Day 29 to Day 90|Lost to Follow-up|4
4903234|NCT00604214|16892678|P2|Day 29 to Day 90|Death|67
4903235|NCT00604214|16892679|P1|Day 29 to Day 90|Death|64
4903236|NCT00604214|16892678|P2|Baseline to Day 28|Withdrawal by Subject|7
4903237|NCT00604214|16892679|P1|Baseline to Day 28|Withdrawal by Subject|3
4903238|NCT00604214|16892678|P2|Baseline to Day 28|Lost to Follow-up|4
4903239|NCT00604214|16892679|P1|Baseline to Day 28|Lost to Follow-up|2
4903240|NCT00604214|16892678|P2|Baseline to Day 28|Death|202
4903241|NCT00604214|16892679|P1|Baseline to Day 28|Death|223
4903242|NCT00604188|16892727|P2|Overall Study|Did not receive study drug|1
4903243|NCT00604188|16892728|P1|Overall Study|Did not receive study drug|0
4903244|NCT00604188|16892727|P2|Overall Study|Non-compliance with protocol|4
4903245|NCT00604188|16892728|P1|Overall Study|Non-compliance with protocol|4
4903246|NCT00604188|16892727|P2|Overall Study|Withdrawal by Subject|1
4903247|NCT00604188|16892728|P1|Overall Study|Withdrawal by Subject|5
4903248|NCT00604188|16892727|P2|Overall Study|Lost to Follow-up|15
4903249|NCT00604188|16892728|P1|Overall Study|Lost to Follow-up|17
4903250|NCT00604188|16892727|P2|Overall Study|Adverse Event|4
4903251|NCT00604188|16892728|P1|Overall Study|Adverse Event|1
4903252|NCT00604175|16892751|P3|Week 29 Through Week 72|Non-adherence to study requirements|1
4903253|NCT00604175|16892752|P2|Week 29 Through Week 72|Non-adherence to study requirements|0
4903254|NCT00604175|16892753|P1|Week 29 Through Week 72|Non-adherence to study requirements|0
4903255|NCT00604175|16892751|P3|Week 29 Through Week 72|Site closure|0
4903256|NCT00604175|16892752|P2|Week 29 Through Week 72|Site closure|1
4903257|NCT00604175|16892753|P1|Week 29 Through Week 72|Site closure|0
4903258|NCT00604175|16892751|P3|Week 29 Through Week 72|Lost to Follow-up|2
4903259|NCT00604175|16892752|P2|Week 29 Through Week 72|Lost to Follow-up|6
4903260|NCT00604175|16892753|P1|Week 29 Through Week 72|Lost to Follow-up|12
4903261|NCT00604175|16892751|P3|Week 29 Through Week 72|Death|1
4903262|NCT00604175|16892752|P2|Week 29 Through Week 72|Death|0
4903263|NCT00604175|16892753|P1|Week 29 Through Week 72|Death|0
4903264|NCT00604175|16892751|P3|Entry Through Week 28|Did not start intervention|1
4903265|NCT00604175|16892752|P2|Entry Through Week 28|Did not start intervention|0
4903266|NCT00604175|16892753|P1|Entry Through Week 28|Did not start intervention|2
4903267|NCT00604175|16892751|P3|Entry Through Week 28|Ineligible|0
4903268|NCT00604175|16892752|P2|Entry Through Week 28|Ineligible|0
4903269|NCT00604175|16892753|P1|Entry Through Week 28|Ineligible|1
4903270|NCT00604175|16892751|P3|Entry Through Week 28|Lost to Follow-up|0
4903271|NCT00604175|16892752|P2|Entry Through Week 28|Lost to Follow-up|3
4903272|NCT00604175|16892753|P1|Entry Through Week 28|Lost to Follow-up|4
4903273|NCT00604175|16892751|P3|Entry Through Week 28|Withdrawal by Subject|0
4903274|NCT00604175|16892752|P2|Entry Through Week 28|Withdrawal by Subject|0
4903275|NCT00604175|16892753|P1|Entry Through Week 28|Withdrawal by Subject|1
4903276|NCT00604175|16892751|P3|Entry Through Week 28|Death|0
4903277|NCT00604175|16892752|P2|Entry Through Week 28|Death|0
4903278|NCT00604175|16892753|P1|Entry Through Week 28|Death|2
4903279|NCT00604162|16892806|P1|Overall Study|Withdrawal by Subject|1
4903280|NCT00604162|16892806|P1|Overall Study|Physician Decision|3
4903281|NCT00603980|16892848|P1|Main Study|14th subject completed trial|1
4903282|NCT00603980|16892848|P1|Study Qualification|Inconsistent data reporting|13
4903283|NCT00603980|16892848|P1|Study Qualification|Protocol Violation|3
4903284|NCT00603941|16892967|P3|Overall Study|Withdrawal by Subject|0
4903285|NCT00603941|16892968|P2|Overall Study|Withdrawal by Subject|2
4903286|NCT00603941|16892969|P1|Overall Study|Withdrawal by Subject|0
4903287|NCT00603941|16892967|P3|Overall Study|Physician Decision|0
4903288|NCT00603941|16892968|P2|Overall Study|Physician Decision|1
4903289|NCT00603941|16892969|P1|Overall Study|Physician Decision|0
4903290|NCT00603941|16892967|P3|Overall Study|Adverse Event|1
4903291|NCT00603941|16892968|P2|Overall Study|Adverse Event|0
4903292|NCT00603941|16892969|P1|Overall Study|Adverse Event|1
4903293|NCT00603941|16892967|P3|Overall Study|Disease progression|1
4903294|NCT00603941|16892968|P2|Overall Study|Disease progression|7
4903295|NCT00603941|16892969|P1|Overall Study|Disease progression|6
4903296|NCT00603915|16892980|P1|Overall Study|Physician Decision|1
4903297|NCT00603837|16893010|P2|Overall Study|Physician Decision|0
4903298|NCT00603837|16893011|P1|Overall Study|Physician Decision|3
4903299|NCT00603798|16893020|P3|Overall Study|Not due to AE|4
4903300|NCT00603798|16893021|P2|Overall Study|Not due to AE|1
4903301|NCT00603798|16893022|P1|Overall Study|Not due to AE|1
4903302|NCT00603798|16893020|P3|Overall Study|Non-compliance with study procedures|0
4903303|NCT00603798|16893021|P2|Overall Study|Non-compliance with study procedures|1
4903304|NCT00603798|16893022|P1|Overall Study|Non-compliance with study procedures|0
4903305|NCT00603798|16893020|P3|Overall Study|Lost to Follow-up|1
4903306|NCT00603798|16893021|P2|Overall Study|Lost to Follow-up|0
4903307|NCT00603798|16893022|P1|Overall Study|Lost to Follow-up|1
4903308|NCT00603798|16893020|P3|Overall Study|Withdrawal by Subject|4
4903309|NCT00603798|16893021|P2|Overall Study|Withdrawal by Subject|3
4903310|NCT00603798|16893022|P1|Overall Study|Withdrawal by Subject|4
4903311|NCT00603798|16893020|P3|Overall Study|Adverse Event|1
4903312|NCT00603798|16893021|P2|Overall Study|Adverse Event|2
4903313|NCT00603798|16893022|P1|Overall Study|Adverse Event|4
4903314|NCT00603746|16893045|P6|Overall Study|Withdrawal by Subject|1
4903315|NCT00603746|16893046|P5|Overall Study|Withdrawal by Subject|3
4903316|NCT00603746|16893047|P4|Overall Study|Withdrawal by Subject|1
4903317|NCT00603746|16893048|P3|Overall Study|Withdrawal by Subject|0
4903318|NCT00603746|16893049|P2|Overall Study|Withdrawal by Subject|0
4903319|NCT00603746|16893050|P1|Overall Study|Withdrawal by Subject|1
4903320|NCT00603746|16893045|P6|Overall Study|Physician Decision|0
4903321|NCT00603746|16893046|P5|Overall Study|Physician Decision|1
4903322|NCT00603746|16893047|P4|Overall Study|Physician Decision|0
4903323|NCT00603746|16893048|P3|Overall Study|Physician Decision|0
4903324|NCT00603746|16893049|P2|Overall Study|Physician Decision|0
4903325|NCT00603746|16893050|P1|Overall Study|Physician Decision|1
4903326|NCT00603746|16893045|P6|Overall Study|Lost to Follow-up|0
4903327|NCT00603746|16893046|P5|Overall Study|Lost to Follow-up|0
4903328|NCT00603746|16893047|P4|Overall Study|Lost to Follow-up|0
4903329|NCT00603746|16893048|P3|Overall Study|Lost to Follow-up|1
4903330|NCT00603746|16893049|P2|Overall Study|Lost to Follow-up|1
4903331|NCT00603746|16893050|P1|Overall Study|Lost to Follow-up|0
4903332|NCT00603746|16893045|P6|Overall Study|Protocol Violation|0
4903333|NCT00603746|16893046|P5|Overall Study|Protocol Violation|1
4903334|NCT00603746|16893047|P4|Overall Study|Protocol Violation|0
4903335|NCT00603746|16893048|P3|Overall Study|Protocol Violation|1
4903336|NCT00603746|16893049|P2|Overall Study|Protocol Violation|3
4903337|NCT00603746|16893050|P1|Overall Study|Protocol Violation|0
4903338|NCT00603746|16893045|P6|Overall Study|Lack of Efficacy|8
4903339|NCT00603746|16893046|P5|Overall Study|Lack of Efficacy|12
4903340|NCT00603746|16893047|P4|Overall Study|Lack of Efficacy|11
4903341|NCT00603746|16893048|P3|Overall Study|Lack of Efficacy|6
4903342|NCT00603746|16893049|P2|Overall Study|Lack of Efficacy|11
4903343|NCT00603746|16893050|P1|Overall Study|Lack of Efficacy|34
4903344|NCT00603746|16893045|P6|Overall Study|Adverse Event|4
4903345|NCT00603746|16893046|P5|Overall Study|Adverse Event|0
4903346|NCT00603746|16893047|P4|Overall Study|Adverse Event|1
4903347|NCT00603746|16893048|P3|Overall Study|Adverse Event|0
4903348|NCT00603746|16893049|P2|Overall Study|Adverse Event|3
4903349|NCT00603746|16893050|P1|Overall Study|Adverse Event|2
4903350|NCT00603733|16893198|P2|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5
4903351|NCT00603733|16893199|P1|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3
4903352|NCT00603733|16893198|P2|Maintenance Phase ITT|Physician Decision|1
4903353|NCT00603733|16893199|P1|Maintenance Phase ITT|Physician Decision|0
4903354|NCT00603733|16893198|P2|Maintenance Phase ITT|Lack of Efficacy|2
4903355|NCT00603733|16893199|P1|Maintenance Phase ITT|Lack of Efficacy|2
4903356|NCT00603733|16893198|P2|Maintenance Phase ITT|Lost to Follow-up|1
4903357|NCT00603733|16893199|P1|Maintenance Phase ITT|Lost to Follow-up|0
4903358|NCT00603733|16893198|P2|Maintenance Phase ITT|Protocol Violation|1
4903359|NCT00603733|16893199|P1|Maintenance Phase ITT|Protocol Violation|1
4903360|NCT00603733|16893198|P2|Maintenance Phase ITT|Withdrawal by Subject|0
4903361|NCT00603733|16893199|P1|Maintenance Phase ITT|Withdrawal by Subject|1
4903362|NCT00603733|16893198|P2|Maintenance Phase ITT|Adverse Event|6
4903363|NCT00603733|16893199|P1|Maintenance Phase ITT|Adverse Event|3
4903364|NCT00603733|16893198|P2|Run-In Phase - 4 Weeks|Lack of Efficacy|1
4903365|NCT00603733|16893199|P1|Run-In Phase - 4 Weeks|Lack of Efficacy|2
4903366|NCT00603733|16893198|P2|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10
4903367|NCT00603733|16893199|P1|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5
4903368|NCT00603733|16893198|P2|Run-In Phase - 4 Weeks|Lost to Follow-up|0
4903369|NCT00603733|16893199|P1|Run-In Phase - 4 Weeks|Lost to Follow-up|1
4903370|NCT00603733|16893198|P2|Run-In Phase - 4 Weeks|Withdrawal by Subject|1
4903371|NCT00603733|16893199|P1|Run-In Phase - 4 Weeks|Withdrawal by Subject|4
4903372|NCT00603733|16893198|P2|Run-In Phase - 4 Weeks|Adverse Event|1
4903373|NCT00603733|16893199|P1|Run-In Phase - 4 Weeks|Adverse Event|2
4903374|NCT00603733|16893198|P2|Active Phase ITT|Subject moved, site closed|1
4903375|NCT00603733|16893199|P1|Active Phase ITT|Subject moved, site closed|1
4903376|NCT00603733|16893198|P2|Active Phase ITT|Lack of Efficacy|2
4903377|NCT00603733|16893199|P1|Active Phase ITT|Lack of Efficacy|1
4903378|NCT00603733|16893198|P2|Active Phase ITT|Did not meet inclusion/exclusion|3
4903379|NCT00603733|16893199|P1|Active Phase ITT|Did not meet inclusion/exclusion|1
4903380|NCT00603733|16893198|P2|Active Phase ITT|Lost to Follow-up|1
4903381|NCT00603733|16893199|P1|Active Phase ITT|Lost to Follow-up|0
4903382|NCT00603733|16893198|P2|Active Phase ITT|Withdrawal by Subject|3
4903383|NCT00603733|16893199|P1|Active Phase ITT|Withdrawal by Subject|0
4903384|NCT00603733|16893198|P2|Active Phase ITT|Adverse Event|7
4903385|NCT00603733|16893199|P1|Active Phase ITT|Adverse Event|8
4903386|NCT00603590|16893249|P2|Overall Study|Cardiovascular event|1
4903387|NCT00603590|16893250|P1|Overall Study|Cardiovascular event|0
4903388|NCT00603590|16893249|P2|Overall Study|Lost to Follow-up|4
4903389|NCT00603590|16893250|P1|Overall Study|Lost to Follow-up|8
4903390|NCT00603590|16893249|P2|Overall Study|Adverse Event|0
4903391|NCT00603590|16893250|P1|Overall Study|Adverse Event|2
4903392|NCT00603590|16893249|P2|Overall Study|Patient discontinued study drug|15
4903393|NCT00603590|16893250|P1|Overall Study|Patient discontinued study drug|22
4903394|NCT00603590|16893249|P2|Overall Study|Refused blood test|1
4903395|NCT00603590|16893250|P1|Overall Study|Refused blood test|5
4903396|NCT00603590|16893249|P2|Overall Study|Did not attend study clinic|30
4903397|NCT00603590|16893250|P1|Overall Study|Did not attend study clinic|39
4903398|NCT00603538|16893274|P3|Overall Study|Objective progression or relapse|0
4903399|NCT00603538|16893275|P2|Overall Study|Objective progression or relapse|0
4903400|NCT00603538|16893276|P1|Overall Study|Objective progression or relapse|3
4903401|NCT00603538|16893274|P3|Overall Study|Adverse Event|2
4903402|NCT00603538|16893275|P2|Overall Study|Adverse Event|4
4903403|NCT00603538|16893276|P1|Overall Study|Adverse Event|0
4903404|NCT00603525|16893316|P3|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111
4903405|NCT00603525|16893317|P2|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
4903406|NCT00603525|16893318|P1|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0
4903407|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4903408|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8
4903409|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0
4903410|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Physician Decision|0
4903411|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Physician Decision|2
4903412|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Physician Decision|0
4903413|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4903414|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71
4903415|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0
4903416|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4903417|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5
4903418|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0
4903419|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Protocol Violation|0
4903420|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Protocol Violation|1
4903421|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Protocol Violation|0
4903422|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4903423|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Lack of Efficacy|13
4903424|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Lack of Efficacy|0
4903425|NCT00603525|16893316|P3|OL Treatment Period (120 Weeks)|Adverse Event|0
4903426|NCT00603525|16893317|P2|OL Treatment Period (120 Weeks)|Adverse Event|12
4903427|NCT00603525|16893318|P1|OL Treatment Period (120 Weeks)|Adverse Event|0
4903428|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
4903429|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1
4903430|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0
4903431|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Physician Decision|0
4903432|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Physician Decision|1
4903433|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Physician Decision|0
4903434|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0
4903435|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6
4903436|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5
4903437|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Lost to Follow-up|0
4903438|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Lost to Follow-up|3
4903439|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Lost to Follow-up|1
4903440|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Protocol Violation|0
4903441|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Protocol Violation|2
4903442|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Protocol Violation|1
4903443|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4903444|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Lack of Efficacy|0
4903445|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Lack of Efficacy|7
4903446|NCT00603525|16893316|P3|DB Treatment Period (24 Weeks)|Adverse Event|0
4903447|NCT00603525|16893317|P2|DB Treatment Period (24 Weeks)|Adverse Event|9
4903448|NCT00603525|16893318|P1|DB Treatment Period (24 Weeks)|Adverse Event|3
4903449|NCT00603512|16893450|P5|Overall Study|Randomized but not treated|0
4903450|NCT00603512|16893451|P4|Overall Study|Randomized but not treated|2
4903451|NCT00603512|16893452|P3|Overall Study|Randomized but not treated|1
4903452|NCT00603512|16893453|P2|Overall Study|Randomized but not treated|1
4903453|NCT00603512|16893454|P1|Overall Study|Randomized but not treated|0
4903454|NCT00603512|16893450|P5|Overall Study|Withdrawal by Subject|1
4903455|NCT00603512|16893451|P4|Overall Study|Withdrawal by Subject|0
4903456|NCT00603512|16893452|P3|Overall Study|Withdrawal by Subject|0
4903457|NCT00603512|16893453|P2|Overall Study|Withdrawal by Subject|0
4903458|NCT00603512|16893454|P1|Overall Study|Withdrawal by Subject|0
4903459|NCT00603512|16893450|P5|Overall Study|Other|1
4903460|NCT00603512|16893451|P4|Overall Study|Other|1
4903461|NCT00603512|16893452|P3|Overall Study|Other|0
4903462|NCT00603512|16893453|P2|Overall Study|Other|1
4903463|NCT00603512|16893454|P1|Overall Study|Other|2
4903464|NCT00603512|16893450|P5|Overall Study|Lack of Efficacy|1
4903465|NCT00603512|16893451|P4|Overall Study|Lack of Efficacy|0
4903466|NCT00603512|16893452|P3|Overall Study|Lack of Efficacy|0
4903467|NCT00603512|16893453|P2|Overall Study|Lack of Efficacy|1
4903468|NCT00603512|16893454|P1|Overall Study|Lack of Efficacy|0
4903469|NCT00603512|16893450|P5|Overall Study|Adverse Event|2
4903470|NCT00603512|16893451|P4|Overall Study|Adverse Event|4
4903471|NCT00603512|16893452|P3|Overall Study|Adverse Event|4
4903472|NCT00603512|16893453|P2|Overall Study|Adverse Event|2
4903473|NCT00603512|16893454|P1|Overall Study|Adverse Event|0
4903474|NCT00603473|16893596|P1|Overall Study|Protocol Violation|1
4903475|NCT00603473|16893596|P1|Overall Study|Lack of Efficacy|4
4903476|NCT00603473|16893596|P1|Overall Study|Adverse Event|4
4903477|NCT00603447|16893609|P7|Overall Study|Withdrew Consent|1
4903478|NCT00603447|16893610|P6|Overall Study|Withdrew Consent|0
4903479|NCT00603447|16893611|P5|Overall Study|Withdrew Consent|1
4903480|NCT00603447|16893612|P4|Overall Study|Withdrew Consent|0
4903481|NCT00603447|16893613|P3|Overall Study|Withdrew Consent|0
4903482|NCT00603447|16893614|P2|Overall Study|Withdrew Consent|2
4903483|NCT00603447|16893615|P1|Overall Study|Withdrew Consent|0
4903484|NCT00603447|16893609|P7|Overall Study|Other|13
4903485|NCT00603447|16893610|P6|Overall Study|Other|0
4903486|NCT00603447|16893611|P5|Overall Study|Other|3
4903487|NCT00603447|16893612|P4|Overall Study|Other|0
4903488|NCT00603447|16893613|P3|Overall Study|Other|1
4903489|NCT00603447|16893614|P2|Overall Study|Other|0
4903490|NCT00603447|16893615|P1|Overall Study|Other|0
4903491|NCT00603447|16893609|P7|Overall Study|Adverse Event|10
4903492|NCT00603447|16893610|P6|Overall Study|Adverse Event|2
4903493|NCT00603447|16893611|P5|Overall Study|Adverse Event|1
4903494|NCT00603447|16893612|P4|Overall Study|Adverse Event|2
4903495|NCT00603447|16893613|P3|Overall Study|Adverse Event|1
4903496|NCT00603447|16893614|P2|Overall Study|Adverse Event|1
4903497|NCT00603447|16893615|P1|Overall Study|Adverse Event|0
4903498|NCT00603382|16893654|P6|Overall Study|Withdrawal by Subject|1
4903499|NCT00603382|16893655|P5|Overall Study|Withdrawal by Subject|0
4903500|NCT00603382|16893656|P4|Overall Study|Withdrawal by Subject|1
4903501|NCT00603382|16893657|P3|Overall Study|Withdrawal by Subject|1
4903502|NCT00603382|16893658|P2|Overall Study|Withdrawal by Subject|3
4903503|NCT00603382|16893659|P1|Overall Study|Withdrawal by Subject|3
4903504|NCT00603382|16893654|P6|Overall Study|Physician Decision|3
4903505|NCT00603382|16893655|P5|Overall Study|Physician Decision|1
4903506|NCT00603382|16893656|P4|Overall Study|Physician Decision|0
4903507|NCT00603382|16893657|P3|Overall Study|Physician Decision|2
4903508|NCT00603382|16893658|P2|Overall Study|Physician Decision|0
4903509|NCT00603382|16893659|P1|Overall Study|Physician Decision|0
4903510|NCT00603382|16893654|P6|Overall Study|Lost to Follow-up|1
4903511|NCT00603382|16893655|P5|Overall Study|Lost to Follow-up|0
4903512|NCT00603382|16893656|P4|Overall Study|Lost to Follow-up|1
4903513|NCT00603382|16893657|P3|Overall Study|Lost to Follow-up|1
4903514|NCT00603382|16893658|P2|Overall Study|Lost to Follow-up|1
4903515|NCT00603382|16893659|P1|Overall Study|Lost to Follow-up|0
4903516|NCT00603382|16893654|P6|Overall Study|Protocol Violation|0
4903517|NCT00603382|16893655|P5|Overall Study|Protocol Violation|1
4903518|NCT00603382|16893656|P4|Overall Study|Protocol Violation|2
4903519|NCT00603382|16893657|P3|Overall Study|Protocol Violation|1
4903520|NCT00603382|16893658|P2|Overall Study|Protocol Violation|0
4903521|NCT00603382|16893659|P1|Overall Study|Protocol Violation|1
4903522|NCT00603382|16893654|P6|Overall Study|Lack of Efficacy|11
4903523|NCT00603382|16893655|P5|Overall Study|Lack of Efficacy|6
4903524|NCT00603382|16893656|P4|Overall Study|Lack of Efficacy|6
4903525|NCT00603382|16893657|P3|Overall Study|Lack of Efficacy|3
4903526|NCT00603382|16893658|P2|Overall Study|Lack of Efficacy|9
4903527|NCT00603382|16893659|P1|Overall Study|Lack of Efficacy|14
4903528|NCT00603382|16893654|P6|Overall Study|Adverse Event|2
4903529|NCT00603382|16893655|P5|Overall Study|Adverse Event|1
4903530|NCT00603382|16893656|P4|Overall Study|Adverse Event|2
4903531|NCT00603382|16893657|P3|Overall Study|Adverse Event|1
4903532|NCT00603382|16893658|P2|Overall Study|Adverse Event|1
4903533|NCT00603382|16893659|P1|Overall Study|Adverse Event|0
4903534|NCT00603304|16893807|P2|Overall Study|Patient Decision|0
4903535|NCT00603304|16893808|P1|Overall Study|Patient Decision|2
4903536|NCT00603304|16893807|P2|Overall Study|Other|0
4903537|NCT00603304|16893808|P1|Overall Study|Other|2
4903538|NCT00603304|16893807|P2|Overall Study|Moved Away|2
4903539|NCT00603304|16893808|P1|Overall Study|Moved Away|0
4903540|NCT00603304|16893807|P2|Overall Study|Non-Compliant|1
4903541|NCT00603304|16893808|P1|Overall Study|Non-Compliant|0
4903542|NCT00603304|16893807|P2|Overall Study|Exclusionary Medication|3
4903543|NCT00603304|16893808|P1|Overall Study|Exclusionary Medication|2
4903544|NCT00603304|16893807|P2|Overall Study|Crossed Over to Open Label Therapy|3
4903545|NCT00603304|16893808|P1|Overall Study|Crossed Over to Open Label Therapy|3
4903546|NCT00603304|16893807|P2|Overall Study|Unacceptable Treatment Toxicity|8
4903547|NCT00603304|16893808|P1|Overall Study|Unacceptable Treatment Toxicity|5
4903548|NCT00603304|16893807|P2|Overall Study|Adverse Event|2
4903549|NCT00603304|16893808|P1|Overall Study|Adverse Event|4
4903550|NCT00603304|16893807|P2|Overall Study|Protocol Violation|0
4903551|NCT00603304|16893808|P1|Overall Study|Protocol Violation|1
4903552|NCT00603304|16893807|P2|Overall Study|Withdrawal by Subject|5
4903553|NCT00603304|16893808|P1|Overall Study|Withdrawal by Subject|8
4903554|NCT00603304|16893807|P2|Overall Study|Lost to Follow-up|7
4903555|NCT00603304|16893808|P1|Overall Study|Lost to Follow-up|5
4903556|NCT00603278|16893864|P6|Overall Study|Lost to Follow-up|0
4903557|NCT00603278|16893865|P5|Overall Study|Lost to Follow-up|1
4903558|NCT00603278|16893866|P4|Overall Study|Lost to Follow-up|0
4903559|NCT00603278|16893867|P3|Overall Study|Lost to Follow-up|0
4903560|NCT00603278|16893868|P2|Overall Study|Lost to Follow-up|0
4903561|NCT00603278|16893869|P1|Overall Study|Lost to Follow-up|1
4903562|NCT00603278|16893864|P6|Overall Study|Physician Decision|1
4903563|NCT00603278|16893865|P5|Overall Study|Physician Decision|2
4903564|NCT00603278|16893866|P4|Overall Study|Physician Decision|0
4903565|NCT00603278|16893867|P3|Overall Study|Physician Decision|0
4903566|NCT00603278|16893868|P2|Overall Study|Physician Decision|1
4903567|NCT00603278|16893869|P1|Overall Study|Physician Decision|0
4903568|NCT00603278|16893864|P6|Overall Study|Protocol Violation|1
4903569|NCT00603278|16893865|P5|Overall Study|Protocol Violation|0
4903570|NCT00603278|16893866|P4|Overall Study|Protocol Violation|1
4903571|NCT00603278|16893867|P3|Overall Study|Protocol Violation|1
4903572|NCT00603278|16893868|P2|Overall Study|Protocol Violation|0
4903573|NCT00603278|16893869|P1|Overall Study|Protocol Violation|3
4903574|NCT00603278|16893864|P6|Overall Study|Withdrawal by Subject|2
4903575|NCT00603278|16893865|P5|Overall Study|Withdrawal by Subject|1
4903576|NCT00603278|16893866|P4|Overall Study|Withdrawal by Subject|2
4903577|NCT00603278|16893867|P3|Overall Study|Withdrawal by Subject|1
4903578|NCT00603278|16893868|P2|Overall Study|Withdrawal by Subject|3
4903579|NCT00603278|16893869|P1|Overall Study|Withdrawal by Subject|2
4903580|NCT00603278|16893864|P6|Overall Study|Adverse Event|1
4903581|NCT00603278|16893865|P5|Overall Study|Adverse Event|2
4903582|NCT00603278|16893866|P4|Overall Study|Adverse Event|0
4903583|NCT00603278|16893867|P3|Overall Study|Adverse Event|1
4903584|NCT00603278|16893868|P2|Overall Study|Adverse Event|3
4903585|NCT00603278|16893869|P1|Overall Study|Adverse Event|0
4903586|NCT00603278|16893864|P6|Overall Study|Lack of Efficacy|14
4903587|NCT00603278|16893865|P5|Overall Study|Lack of Efficacy|7
4903588|NCT00603278|16893866|P4|Overall Study|Lack of Efficacy|8
4903589|NCT00603278|16893867|P3|Overall Study|Lack of Efficacy|11
4903590|NCT00603278|16893868|P2|Overall Study|Lack of Efficacy|10
4903591|NCT00603278|16893869|P1|Overall Study|Lack of Efficacy|35
4903592|NCT00603265|16894018|P3|Overall Study|Protocol Violation|0
4903593|NCT00603265|16894019|P2|Overall Study|Protocol Violation|0
4903594|NCT00603265|16894020|P1|Overall Study|Protocol Violation|1
4903595|NCT00603265|16894018|P3|Overall Study|Participant Left Country, No Responses|0
4903596|NCT00603265|16894019|P2|Overall Study|Participant Left Country, No Responses|1
4903597|NCT00603265|16894020|P1|Overall Study|Participant Left Country, No Responses|0
4903598|NCT00603265|16894018|P3|Overall Study|Out of Town, Ran Out of Study Drug|0
4903599|NCT00603265|16894019|P2|Overall Study|Out of Town, Ran Out of Study Drug|1
4903600|NCT00603265|16894020|P1|Overall Study|Out of Town, Ran Out of Study Drug|0
4903601|NCT00603265|16894018|P3|Overall Study|Lost to Follow-up|0
4903602|NCT00603265|16894019|P2|Overall Study|Lost to Follow-up|1
4903603|NCT00603265|16894020|P1|Overall Study|Lost to Follow-up|0
4903604|NCT00603265|16894018|P3|Overall Study|Lack of Efficacy|3
4903605|NCT00603265|16894019|P2|Overall Study|Lack of Efficacy|0
4903606|NCT00603265|16894020|P1|Overall Study|Lack of Efficacy|3
4903607|NCT00603265|16894018|P3|Overall Study|Withdrawal by Subject|1
4903608|NCT00603265|16894019|P2|Overall Study|Withdrawal by Subject|2
4903609|NCT00603265|16894020|P1|Overall Study|Withdrawal by Subject|1
4903610|NCT00603265|16894018|P3|Overall Study|Adverse Event|1
4903611|NCT00603265|16894019|P2|Overall Study|Adverse Event|11
4903612|NCT00603265|16894020|P1|Overall Study|Adverse Event|2
4903613|NCT00603239|16894048|P2|Overall Study|Subject decision|1
4903614|NCT00603239|16894049|P1|Overall Study|Subject decision|2
4903615|NCT00603239|16894048|P2|Overall Study|Protocol Violation|0
4903616|NCT00603239|16894049|P1|Overall Study|Protocol Violation|2
4903617|NCT00603239|16894048|P2|Overall Study|Physician Decision|0
4903618|NCT00603239|16894049|P1|Overall Study|Physician Decision|2
4903619|NCT00603239|16894048|P2|Overall Study|Lost to Follow-up|1
4903620|NCT00603239|16894049|P1|Overall Study|Lost to Follow-up|2
4903621|NCT00603239|16894048|P2|Overall Study|Loss of glucose control|0
4903622|NCT00603239|16894049|P1|Overall Study|Loss of glucose control|3
4903623|NCT00603239|16894048|P2|Overall Study|Entry criteria not met|1
4903624|NCT00603239|16894049|P1|Overall Study|Entry criteria not met|0
4903625|NCT00603239|16894048|P2|Overall Study|Adverse Event|1
4903626|NCT00603239|16894049|P1|Overall Study|Adverse Event|4
4903627|NCT00602979|16894110|P5|Overall Study|Failed Intubation|0
4903628|NCT00602979|16894111|P4|Overall Study|Failed Intubation|1
4903629|NCT00602979|16894112|P3|Overall Study|Failed Intubation|0
4903630|NCT00602979|16894113|P2|Overall Study|Failed Intubation|1
4903631|NCT00602979|16894114|P1|Overall Study|Failed Intubation|0
4903632|NCT00602979|16894110|P5|Overall Study|Lost to Follow-up|3
4903633|NCT00602979|16894111|P4|Overall Study|Lost to Follow-up|2
4903634|NCT00602979|16894112|P3|Overall Study|Lost to Follow-up|3
4903635|NCT00602979|16894113|P2|Overall Study|Lost to Follow-up|2
4903636|NCT00602979|16894114|P1|Overall Study|Lost to Follow-up|3
4903637|NCT00602927|16894164|P2|Period 3: 13 Days|MRI data quality|2
4903638|NCT00602927|16894165|P1|Period 3: 13 Days|MRI data quality|2
4903639|NCT00602927|16894164|P2|Period 3: 13 Days|Protocol Violation|1
4903640|NCT00602927|16894165|P1|Period 3: 13 Days|Protocol Violation|0
4903641|NCT00602927|16894164|P2|Period 2: 14 Days|Protocol Violation|2
4903642|NCT00602927|16894165|P1|Period 2: 14 Days|Protocol Violation|0
4903643|NCT00602927|16894164|P2|Period 1: 13 Days|Claustrophobia|1
4903644|NCT00602927|16894165|P1|Period 1: 13 Days|Claustrophobia|0
4903645|NCT00602927|16894164|P2|Period 1: 13 Days|Time|0
4903646|NCT00602927|16894165|P1|Period 1: 13 Days|Time|1
4903647|NCT00602927|16894164|P2|Period 1: 13 Days|MRI scanner technical issue|0
4903648|NCT00602927|16894165|P1|Period 1: 13 Days|MRI scanner technical issue|1
4903649|NCT00602927|16894164|P2|Period 1: 13 Days|Protocol Violation|4
4903650|NCT00602927|16894165|P1|Period 1: 13 Days|Protocol Violation|2
4903651|NCT00602797|16894182|P1|Overall Study|Adverse Event|1
4903652|NCT00602667|16894200|P3|Overall Study|Progressive disease prior to therapy|1
4903653|NCT00602667|16894201|P2|Overall Study|Progressive disease prior to therapy|0
4903654|NCT00602667|16894202|P1|Overall Study|Progressive disease prior to therapy|0
4903655|NCT00602667|16894200|P3|Overall Study|Progressive disease|45
4903656|NCT00602667|16894201|P2|Overall Study|Progressive disease|48
4903657|NCT00602667|16894202|P1|Overall Study|Progressive disease|13
4903658|NCT00602667|16894200|P3|Overall Study|Physician Decision|8
4903659|NCT00602667|16894201|P2|Overall Study|Physician Decision|3
4903660|NCT00602667|16894202|P1|Overall Study|Physician Decision|2
4903661|NCT00602667|16894200|P3|Overall Study|Second malignancy|0
4903662|NCT00602667|16894201|P2|Overall Study|Second malignancy|1
4903663|NCT00602667|16894202|P1|Overall Study|Second malignancy|0
4903664|NCT00602667|16894200|P3|Overall Study|Excessive toxicity|0
4903665|NCT00602667|16894201|P2|Overall Study|Excessive toxicity|1
4903666|NCT00602667|16894202|P1|Overall Study|Excessive toxicity|1
4903667|NCT00602667|16894200|P3|Overall Study|Family request|6
4903668|NCT00602667|16894201|P2|Overall Study|Family request|25
4903669|NCT00602667|16894202|P1|Overall Study|Family request|3
4903670|NCT00602667|16894200|P3|Overall Study|Death|1
4903671|NCT00602667|16894201|P2|Overall Study|Death|1
4903672|NCT00602667|16894202|P1|Overall Study|Death|0
4903673|NCT00602667|16894200|P3|Overall Study|Still on Therapy|2
4903674|NCT00602667|16894201|P2|Overall Study|Still on Therapy|2
4903675|NCT00602667|16894202|P1|Overall Study|Still on Therapy|0
4903676|NCT00602641|16894381|P2|Overall Study|Other|1
4903677|NCT00602641|16894382|P1|Overall Study|Other|3
4903678|NCT00602641|16894381|P2|Overall Study|Administrative Closure|1
4903679|NCT00602641|16894382|P1|Overall Study|Administrative Closure|1
4903680|NCT00602641|16894381|P2|Overall Study|Physician Decision|4
4903681|NCT00602641|16894382|P1|Overall Study|Physician Decision|5
4903682|NCT00602641|16894381|P2|Overall Study|Other Complicating Disease|2
4903683|NCT00602641|16894382|P1|Overall Study|Other Complicating Disease|5
4903684|NCT00602641|16894381|P2|Overall Study|Alternative therapy|2
4903685|NCT00602641|16894382|P1|Overall Study|Alternative therapy|5
4903686|NCT00602641|16894381|P2|Overall Study|Withdrawal by Subject|12
4903687|NCT00602641|16894382|P1|Overall Study|Withdrawal by Subject|15
4903688|NCT00602641|16894381|P2|Overall Study|Death|5
4903689|NCT00602641|16894382|P1|Overall Study|Death|6
4903690|NCT00602641|16894381|P2|Overall Study|Disease progression|55
4903691|NCT00602641|16894382|P1|Overall Study|Disease progression|38
4903692|NCT00602641|16894381|P2|Overall Study|Adverse Event|53
4903693|NCT00602641|16894382|P1|Overall Study|Adverse Event|62
4903694|NCT00602641|16894381|P2|Overall Study|Still on treatment at time of analysis|15
4903695|NCT00602641|16894382|P1|Overall Study|Still on treatment at time of analysis|8
4903696|NCT00602641|16894381|P2|Overall Study|Never started protocol therapy|2
4903697|NCT00602641|16894382|P1|Overall Study|Never started protocol therapy|6
4903698|NCT00602537|16894396|P2|Follow Up Study Comparison|Withdrawal by Subject|2
4903699|NCT00602537|16894397|P1|Follow Up Study Comparison|Withdrawal by Subject|2
4903700|NCT00602537|16894396|P2|Follow Up Study Comparison|Lost to Follow-up|1
4903701|NCT00602537|16894397|P1|Follow Up Study Comparison|Lost to Follow-up|8
4903702|NCT00602537|16894396|P2|Follow Up Study Comparison|Adverse Event|0
4903703|NCT00602537|16894397|P1|Follow Up Study Comparison|Adverse Event|1
4903704|NCT00602537|16894396|P2|12 Week Double Blind Comparison|Withdrawal by Subject|13
4903705|NCT00602537|16894397|P1|12 Week Double Blind Comparison|Withdrawal by Subject|3
4903706|NCT00602537|16894396|P2|12 Week Double Blind Comparison|Lost to Follow-up|6
4903707|NCT00602537|16894397|P1|12 Week Double Blind Comparison|Lost to Follow-up|5
4903708|NCT00602537|16894396|P2|12 Week Double Blind Comparison|Lack of Efficacy|23
4903709|NCT00602537|16894397|P1|12 Week Double Blind Comparison|Lack of Efficacy|13
4903710|NCT00602537|16894396|P2|12 Week Double Blind Comparison|Adverse Event|5
4903711|NCT00602537|16894397|P1|12 Week Double Blind Comparison|Adverse Event|2
4903712|NCT00602472|16894407|P2|Overall Study|Other incl. lack of efficacy|2
4903713|NCT00602472|16894408|P1|Overall Study|Other incl. lack of efficacy|4
4903714|NCT00602472|16894407|P2|Overall Study|Withdrawal by Subject|14
4903715|NCT00602472|16894408|P1|Overall Study|Withdrawal by Subject|8
4903716|NCT00602472|16894407|P2|Overall Study|Protocol Violation|19
4903717|NCT00602472|16894408|P1|Overall Study|Protocol Violation|4
4903718|NCT00602472|16894407|P2|Overall Study|Adverse Event|23
4903719|NCT00602472|16894408|P1|Overall Study|Adverse Event|5
4903720|NCT00602420|16894473|P2|Overall Study|Adverse Event|0
4903721|NCT00602420|16894474|P1|Overall Study|Adverse Event|1
4903722|NCT00602420|16894473|P2|Overall Study|Withdrawal by Subject|17
4903723|NCT00602420|16894474|P1|Overall Study|Withdrawal by Subject|18
4903724|NCT00602420|16894473|P2|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3
4903725|NCT00602420|16894474|P1|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5
4903726|NCT00602420|16894473|P2|Overall Study|Death|4
4903727|NCT00602420|16894474|P1|Overall Study|Death|1
4903728|NCT00601900|16894582|P2|Overall Study|Withdrawal by Subject|3
4903729|NCT00601900|16894583|P1|Overall Study|Withdrawal by Subject|0
4903730|NCT00601835|16894599|P2|Overall Study|Relocate|2
4903731|NCT00601835|16894600|P1|Overall Study|Relocate|12
4903732|NCT00601835|16894599|P2|Overall Study|Adverse Event|1
4903733|NCT00601835|16894600|P1|Overall Study|Adverse Event|1
4903734|NCT00601835|16894599|P2|Overall Study|Lost to Follow-up|5
4903735|NCT00601835|16894600|P1|Overall Study|Lost to Follow-up|37
4903736|NCT00601835|16894599|P2|Overall Study|Physician Decision|0
4903737|NCT00601835|16894600|P1|Overall Study|Physician Decision|1
4903738|NCT00601835|16894599|P2|Overall Study|Withdrawal by Subject|6
4903739|NCT00601835|16894600|P1|Overall Study|Withdrawal by Subject|9
4903740|NCT00601705|16894689|P1|Overall Study|Withdrawal by Subject|1
4903741|NCT00601640|16894701|P3|Overall Study|change in eligibility status|1
4903742|NCT00601640|16894702|P2|Overall Study|change in eligibility status|1
4903743|NCT00601640|16894703|P1|Overall Study|change in eligibility status|0
4903744|NCT00601640|16894701|P3|Overall Study|intercurrent illness|0
4903745|NCT00601640|16894702|P2|Overall Study|intercurrent illness|0
4903746|NCT00601640|16894703|P1|Overall Study|intercurrent illness|1
4903747|NCT00601640|16894701|P3|Overall Study|Adverse Event|2
4903748|NCT00601640|16894702|P2|Overall Study|Adverse Event|4
4903749|NCT00601640|16894703|P1|Overall Study|Adverse Event|0
4903750|NCT00601640|16894701|P3|Overall Study|Death|0
4903751|NCT00601640|16894702|P2|Overall Study|Death|0
4903752|NCT00601640|16894703|P1|Overall Study|Death|1
4903753|NCT00601640|16894701|P3|Overall Study|Withdrawal by Subject|7
4903754|NCT00601640|16894702|P2|Overall Study|Withdrawal by Subject|0
4903755|NCT00601640|16894703|P1|Overall Study|Withdrawal by Subject|3
4903756|NCT00601523|16894728|P2|Overall Study|Other|1
4903757|NCT00601523|16894729|P1|Overall Study|Other|9
4903758|NCT00601523|16894728|P2|Overall Study|Withdrawal by Subject|9
4903759|NCT00601523|16894729|P1|Overall Study|Withdrawal by Subject|18
4903760|NCT00601523|16894728|P2|Overall Study|Lost to Follow-up|1
4903761|NCT00601523|16894729|P1|Overall Study|Lost to Follow-up|0
4903762|NCT00601523|16894728|P2|Overall Study|Protocol Violation|1
4903763|NCT00601523|16894729|P1|Overall Study|Protocol Violation|5
4903764|NCT00601523|16894728|P2|Overall Study|Lack of Efficacy|0
4903765|NCT00601523|16894729|P1|Overall Study|Lack of Efficacy|3
4903766|NCT00601523|16894728|P2|Overall Study|Adverse Event|14
4903767|NCT00601523|16894729|P1|Overall Study|Adverse Event|42
4903768|NCT00601458|16894764|P3|Overall Study|Early Termination|1
4903769|NCT00601458|16894765|P2|Overall Study|Early Termination|1
4903770|NCT00601458|16894766|P1|Overall Study|Early Termination|0
4903771|NCT00601458|16894764|P3|Overall Study|Protocol Violation|1
4903772|NCT00601458|16894765|P2|Overall Study|Protocol Violation|2
4903773|NCT00601458|16894766|P1|Overall Study|Protocol Violation|3
4903774|NCT00601458|16894764|P3|Overall Study|Incomplete Data|0
4903775|NCT00601458|16894765|P2|Overall Study|Incomplete Data|2
4903776|NCT00601458|16894766|P1|Overall Study|Incomplete Data|0
4903777|NCT00601458|16894764|P3|Overall Study|Dosing Error|0
4903778|NCT00601458|16894765|P2|Overall Study|Dosing Error|0
4903779|NCT00601458|16894766|P1|Overall Study|Dosing Error|1
4903780|NCT00601419|16894777|P1|Overall Study|Missed Visits|1
4903781|NCT00601419|16894777|P1|Overall Study|Lost to Follow-up|3
4903782|NCT00601354|16894807|P2|Overall Study|Lost to Follow-up|5
4903783|NCT00601354|16894808|P1|Overall Study|Lost to Follow-up|4
4903784|NCT00601250|16894820|P2|Overall Study|Other incl. lack of efficacy|9
4903785|NCT00601250|16894821|P1|Overall Study|Other incl. lack of efficacy|2
4903786|NCT00601250|16894820|P2|Overall Study|Withdrawal by Subject|13
4903787|NCT00601250|16894821|P1|Overall Study|Withdrawal by Subject|4
4903788|NCT00601250|16894820|P2|Overall Study|Lost to Follow-up|6
4903789|NCT00601250|16894821|P1|Overall Study|Lost to Follow-up|2
4903790|NCT00601250|16894820|P2|Overall Study|Protocol Violation|2
4903791|NCT00601250|16894821|P1|Overall Study|Protocol Violation|3
4903792|NCT00601250|16894820|P2|Overall Study|Adverse Event|9
4903793|NCT00601250|16894821|P1|Overall Study|Adverse Event|3
4903794|NCT00601172|16894857|P2|Overall Study|Did not meet continuation criteria|20
4903795|NCT00601172|16894858|P1|Overall Study|Did not meet continuation criteria|19
4903796|NCT00601172|16894857|P2|Overall Study|Withdrawal by Subject|27
4903797|NCT00601172|16894858|P1|Overall Study|Withdrawal by Subject|35
4903798|NCT00601172|16894857|P2|Overall Study|Physician Decision|28
4903799|NCT00601172|16894858|P1|Overall Study|Physician Decision|27
4903800|NCT00601172|16894857|P2|Overall Study|Lost to Follow-up|3
4903801|NCT00601172|16894858|P1|Overall Study|Lost to Follow-up|4
4903802|NCT00601172|16894857|P2|Overall Study|Protocol Violation|5
4903803|NCT00601172|16894858|P1|Overall Study|Protocol Violation|2
4903804|NCT00601172|16894857|P2|Overall Study|Lack of Efficacy|12
4903805|NCT00601172|16894858|P1|Overall Study|Lack of Efficacy|11
4903806|NCT00601172|16894857|P2|Overall Study|Adverse Event|32
4903807|NCT00601172|16894858|P1|Overall Study|Adverse Event|43
4903808|NCT00601107|16894915|P4|Overall Study|Undefined|0
4903809|NCT00601107|16894916|P3|Overall Study|Undefined|1
4903810|NCT00601107|16894917|P2|Overall Study|Undefined|0
4903811|NCT00601107|16894918|P1|Overall Study|Undefined|1
4903812|NCT00601107|16894915|P4|Overall Study|Worsening of Psoriasis|4
4903813|NCT00601107|16894916|P3|Overall Study|Worsening of Psoriasis|1
4903814|NCT00601107|16894917|P2|Overall Study|Worsening of Psoriasis|1
4903815|NCT00601107|16894918|P1|Overall Study|Worsening of Psoriasis|4
4903816|NCT00601107|16894915|P4|Overall Study|Serum Calcium >11.5 milligram/deciliter|1
4903817|NCT00601107|16894916|P3|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
4903818|NCT00601107|16894917|P2|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
4903819|NCT00601107|16894918|P1|Overall Study|Serum Calcium >11.5 milligram/deciliter|0
4903820|NCT00601107|16894915|P4|Overall Study|Lost to Follow-up|3
4903821|NCT00601107|16894916|P3|Overall Study|Lost to Follow-up|0
4903822|NCT00601107|16894917|P2|Overall Study|Lost to Follow-up|3
4903823|NCT00601107|16894918|P1|Overall Study|Lost to Follow-up|3
4903824|NCT00601107|16894915|P4|Overall Study|Withdrawal by Subject|4
4903825|NCT00601107|16894916|P3|Overall Study|Withdrawal by Subject|7
4903826|NCT00601107|16894917|P2|Overall Study|Withdrawal by Subject|4
4903827|NCT00601107|16894918|P1|Overall Study|Withdrawal by Subject|5
4903828|NCT00601107|16894915|P4|Overall Study|Adverse Event|0
4903829|NCT00601107|16894916|P3|Overall Study|Adverse Event|3
4903830|NCT00601107|16894917|P2|Overall Study|Adverse Event|1
4903831|NCT00601107|16894918|P1|Overall Study|Adverse Event|0
4903832|NCT00600938|16894938|P4|Extension Study|Death|0
4903833|NCT00600938|16894939|P3|Extension Study|Death|0
4903834|NCT00600938|16894940|P2|Extension Study|Death|0
4903835|NCT00600938|16894941|P1|Extension Study|Death|1
4903836|NCT00600938|16894938|P4|Extension Study|Lost to Follow-up|0
4903837|NCT00600938|16894939|P3|Extension Study|Lost to Follow-up|2
4903838|NCT00600938|16894940|P2|Extension Study|Lost to Follow-up|1
4903839|NCT00600938|16894941|P1|Extension Study|Lost to Follow-up|1
4903840|NCT00600938|16894938|P4|Extension Study|Withdrawal by Subject|0
4903841|NCT00600938|16894939|P3|Extension Study|Withdrawal by Subject|3
4903842|NCT00600938|16894940|P2|Extension Study|Withdrawal by Subject|2
4903843|NCT00600938|16894941|P1|Extension Study|Withdrawal by Subject|2
4903844|NCT00600938|16894938|P4|Extension Study|Unsatisfactory therapeutic effect|0
4903845|NCT00600938|16894939|P3|Extension Study|Unsatisfactory therapeutic effect|1
4903846|NCT00600938|16894940|P2|Extension Study|Unsatisfactory therapeutic effect|1
4903847|NCT00600938|16894941|P1|Extension Study|Unsatisfactory therapeutic effect|4
4903848|NCT00600938|16894938|P4|Extension Study|Abnormal test procedure results|1
4903849|NCT00600938|16894939|P3|Extension Study|Abnormal test procedure results|1
4903850|NCT00600938|16894940|P2|Extension Study|Abnormal test procedure results|1
4903851|NCT00600938|16894941|P1|Extension Study|Abnormal test procedure results|0
4903852|NCT00600938|16894938|P4|Extension Study|Adverse Event|0
4903853|NCT00600938|16894939|P3|Extension Study|Adverse Event|2
4903854|NCT00600938|16894940|P2|Extension Study|Adverse Event|0
4903855|NCT00600938|16894941|P1|Extension Study|Adverse Event|1
4903856|NCT00600938|16894938|P4|Core Study|Protocol Violation|0
4903857|NCT00600938|16894939|P3|Core Study|Protocol Violation|0
4903858|NCT00600938|16894940|P2|Core Study|Protocol Violation|2
4903859|NCT00600938|16894941|P1|Core Study|Protocol Violation|1
4903860|NCT00600938|16894938|P4|Core Study|Death|0
4903861|NCT00600938|16894939|P3|Core Study|Death|0
4903862|NCT00600938|16894940|P2|Core Study|Death|1
4903863|NCT00600938|16894941|P1|Core Study|Death|1
4903864|NCT00600938|16894938|P4|Core Study|Lost to Follow-up|0
4903865|NCT00600938|16894939|P3|Core Study|Lost to Follow-up|0
4903866|NCT00600938|16894940|P2|Core Study|Lost to Follow-up|2
4903867|NCT00600938|16894941|P1|Core Study|Lost to Follow-up|3
4903868|NCT00600938|16894938|P4|Core Study|Patient withdrew consent|0
4903869|NCT00600938|16894939|P3|Core Study|Patient withdrew consent|0
4903870|NCT00600938|16894940|P2|Core Study|Patient withdrew consent|12
4903871|NCT00600938|16894941|P1|Core Study|Patient withdrew consent|7
4903872|NCT00600938|16894938|P4|Core Study|Unsatisfactory therapeutic effect|0
4903873|NCT00600938|16894939|P3|Core Study|Unsatisfactory therapeutic effect|0
4903874|NCT00600938|16894940|P2|Core Study|Unsatisfactory therapeutic effect|2
4903875|NCT00600938|16894941|P1|Core Study|Unsatisfactory therapeutic effect|1
4903876|NCT00600938|16894938|P4|Core Study|Abnormal test procedure result(s)|0
4903877|NCT00600938|16894939|P3|Core Study|Abnormal test procedure result(s)|0
4903878|NCT00600938|16894940|P2|Core Study|Abnormal test procedure result(s)|2
4903879|NCT00600938|16894941|P1|Core Study|Abnormal test procedure result(s)|3
4903880|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Death|0
4903881|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Death|1
4903882|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0
4903883|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3
4903884|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Subject no longer requires study drug|0
4903885|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Subject no longer requires study drug|3
4903886|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Administrative Problems|4
4903887|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Administrative Problems|4
4903888|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Lack of Efficacy|4
4903889|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Lack of Efficacy|13
4903890|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Withdrawal by Subject|4
4903891|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Withdrawal by Subject|19
4903892|NCT00600886|16895005|P2|Extension - After Crossover (CAS)|Adverse Event|1
4903893|NCT00600886|16895006|P1|Extension - After Crossover (CAS)|Adverse Event|19
4903894|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0
4903895|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6
4903896|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Death|1
4903897|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Death|1
4903898|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0
4903899|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4
4903900|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Adverse Event|1
4903901|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Adverse Event|4
4903902|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Lost to Follow-up|1
4903903|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Lost to Follow-up|3
4903904|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Administrative Problems|3
4903905|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Administrative Problems|9
4903906|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Lack of Efficacy|3
4903907|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Lack of Efficacy|3
4903908|NCT00600886|16895005|P2|Extension - Same Treatment (FAS)|Withdrawal by Subject|2
4903909|NCT00600886|16895006|P1|Extension - Same Treatment (FAS)|Withdrawal by Subject|16
4903910|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Death|1
4903911|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Death|0
4903912|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0
4903913|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1
4903914|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0
4903915|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1
4903916|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0
4903917|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2
4903918|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3
4903919|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5
4903920|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8
4903921|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5
4903922|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8
4903923|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7
4903924|NCT00600886|16895005|P2|Core Phase - Full Analysis Set (FAS)|Adverse Event|6
4903925|NCT00600886|16895006|P1|Core Phase - Full Analysis Set (FAS)|Adverse Event|14
4903926|NCT00600821|16895070|P2|Overall Study|Other|3
4903927|NCT00600821|16895071|P1|Overall Study|Other|2
4903928|NCT00600821|16895070|P2|Overall Study|Randomized but not treated|1
4903929|NCT00600821|16895071|P1|Overall Study|Randomized but not treated|0
4903930|NCT00600821|16895070|P2|Overall Study|Objective progression or relapse|1
4903931|NCT00600821|16895071|P1|Overall Study|Objective progression or relapse|0
4903932|NCT00600821|16895070|P2|Overall Study|Terminated by sponsor|6
4903933|NCT00600821|16895071|P1|Overall Study|Terminated by sponsor|8
4903934|NCT00600821|16895070|P2|Overall Study|Withdrawal by Subject|1
4903935|NCT00600821|16895071|P1|Overall Study|Withdrawal by Subject|1
4903936|NCT00600821|16895070|P2|Overall Study|Lost to Follow-up|2
4903937|NCT00600821|16895071|P1|Overall Study|Lost to Follow-up|2
4903938|NCT00600821|16895070|P2|Overall Study|Death|46
4903939|NCT00600821|16895071|P1|Overall Study|Death|45
4903940|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
4903941|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9
4903942|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|Lost to Follow-up|13
4903943|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|Lost to Follow-up|16
4903944|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20
4903945|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16
4903946|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20
4903947|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17
4903948|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|Incorrect enrollment|29
4903949|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|Incorrect enrollment|21
4903950|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|Withdrawal by Subject|41
4903951|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|Withdrawal by Subject|51
4903952|NCT00600756|16895099|P2|Overall Study Analysis After 12 Months|Adverse Event|44
4903953|NCT00600756|16895100|P1|Overall Study Analysis After 12 Months|Adverse Event|53
4903954|NCT00600756|16895099|P2|Analysis After 6 Months|Study-specific discontinuation criteria|3
4903955|NCT00600756|16895100|P1|Analysis After 6 Months|Study-specific discontinuation criteria|6
4903956|NCT00600756|16895099|P2|Analysis After 6 Months|Lost to Follow-up|8
4903957|NCT00600756|16895100|P1|Analysis After 6 Months|Lost to Follow-up|10
4903958|NCT00600756|16895099|P2|Analysis After 6 Months|Severe non-compliance to protocol|11
4903959|NCT00600756|16895100|P1|Analysis After 6 Months|Severe non-compliance to protocol|11
4903960|NCT00600756|16895099|P2|Analysis After 6 Months|worsening symptom, lack of efficacy|14
4903961|NCT00600756|16895100|P1|Analysis After 6 Months|worsening symptom, lack of efficacy|11
4903962|NCT00600756|16895099|P2|Analysis After 6 Months|Incorrect Enrollment|21
4903963|NCT00600756|16895100|P1|Analysis After 6 Months|Incorrect Enrollment|12
4903964|NCT00600756|16895099|P2|Analysis After 6 Months|Withdrawal by Subject|30
4903965|NCT00600756|16895100|P1|Analysis After 6 Months|Withdrawal by Subject|38
4903966|NCT00600756|16895099|P2|Analysis After 6 Months|Adverse Event|33
4903967|NCT00600756|16895100|P1|Analysis After 6 Months|Adverse Event|43
4903968|NCT00600613|16895209|P1|Overall Study|Protocol Deviation|1
4903969|NCT00600353|16895215|P2|Overall Study|History of prepartive regimen|1
4903970|NCT00600353|16895216|P1|Overall Study|History of prepartive regimen|0
4903971|NCT00600353|16895215|P2|Overall Study|history of malignancy within 5 years|0
4903972|NCT00600353|16895216|P1|Overall Study|history of malignancy within 5 years|1
4903973|NCT00600171|16895279|P6|Overall Study|Lost to Follow-up|0
4903974|NCT00600171|16895280|P5|Overall Study|Lost to Follow-up|0
4903975|NCT00600171|16895281|P4|Overall Study|Lost to Follow-up|1
4903976|NCT00600171|16895282|P3|Overall Study|Lost to Follow-up|0
4903977|NCT00600171|16895283|P2|Overall Study|Lost to Follow-up|0
4903978|NCT00600171|16895284|P1|Overall Study|Lost to Follow-up|0
4903979|NCT00600171|16895279|P6|Overall Study|Physician Decision|2
4903980|NCT00600171|16895280|P5|Overall Study|Physician Decision|0
4903981|NCT00600171|16895281|P4|Overall Study|Physician Decision|1
4903982|NCT00600171|16895282|P3|Overall Study|Physician Decision|0
4903983|NCT00600171|16895283|P2|Overall Study|Physician Decision|1
4903984|NCT00600171|16895284|P1|Overall Study|Physician Decision|0
4903985|NCT00600171|16895279|P6|Overall Study|Withdrawal by Subject|1
4903986|NCT00600171|16895280|P5|Overall Study|Withdrawal by Subject|1
4903987|NCT00600171|16895281|P4|Overall Study|Withdrawal by Subject|1
4903988|NCT00600171|16895282|P3|Overall Study|Withdrawal by Subject|0
4903989|NCT00600171|16895283|P2|Overall Study|Withdrawal by Subject|0
4903990|NCT00600171|16895284|P1|Overall Study|Withdrawal by Subject|3
4903991|NCT00600171|16895279|P6|Overall Study|Met Protocol-defined Stopping Criteria|2
4903992|NCT00600171|16895280|P5|Overall Study|Met Protocol-defined Stopping Criteria|2
4903993|NCT00600171|16895281|P4|Overall Study|Met Protocol-defined Stopping Criteria|3
4903994|NCT00600171|16895282|P3|Overall Study|Met Protocol-defined Stopping Criteria|7
4903995|NCT00600171|16895283|P2|Overall Study|Met Protocol-defined Stopping Criteria|1
4903996|NCT00600171|16895284|P1|Overall Study|Met Protocol-defined Stopping Criteria|3
4903997|NCT00600171|16895279|P6|Overall Study|Protocol Violation|0
4903998|NCT00600171|16895280|P5|Overall Study|Protocol Violation|0
4903999|NCT00600171|16895281|P4|Overall Study|Protocol Violation|1
4904000|NCT00600171|16895282|P3|Overall Study|Protocol Violation|0
4904001|NCT00600171|16895283|P2|Overall Study|Protocol Violation|2
4904002|NCT00600171|16895284|P1|Overall Study|Protocol Violation|1
4904003|NCT00600171|16895279|P6|Overall Study|Lack of Efficacy|0
4904004|NCT00600171|16895280|P5|Overall Study|Lack of Efficacy|4
4904005|NCT00600171|16895281|P4|Overall Study|Lack of Efficacy|5
4904006|NCT00600171|16895282|P3|Overall Study|Lack of Efficacy|3
4904007|NCT00600171|16895283|P2|Overall Study|Lack of Efficacy|12
4904008|NCT00600171|16895284|P1|Overall Study|Lack of Efficacy|9
4904009|NCT00600171|16895279|P6|Overall Study|Adverse Event|0
4904010|NCT00600171|16895280|P5|Overall Study|Adverse Event|1
4904011|NCT00600171|16895281|P4|Overall Study|Adverse Event|0
4904012|NCT00600171|16895282|P3|Overall Study|Adverse Event|0
4904013|NCT00600171|16895283|P2|Overall Study|Adverse Event|1
4904014|NCT00600171|16895284|P1|Overall Study|Adverse Event|0
4904015|NCT00600119|16895358|P6|Follow-up Period|Other|0
4904016|NCT00600119|16895359|P5|Follow-up Period|Other|0
4904017|NCT00600119|16895360|P4|Follow-up Period|Other|0
4904018|NCT00600119|16895361|P3|Follow-up Period|Other|0
4904019|NCT00600119|16895362|P2|Follow-up Period|Other|0
4904020|NCT00600119|16895363|P1|Follow-up Period|Other|1
4904021|NCT00600119|16895358|P6|Follow-up Period|Adverse Event|1
4904022|NCT00600119|16895359|P5|Follow-up Period|Adverse Event|0
4904023|NCT00600119|16895360|P4|Follow-up Period|Adverse Event|0
4904024|NCT00600119|16895361|P3|Follow-up Period|Adverse Event|0
4904025|NCT00600119|16895362|P2|Follow-up Period|Adverse Event|0
4904026|NCT00600119|16895363|P1|Follow-up Period|Adverse Event|0
4904027|NCT00600119|16895358|P6|Double-blind Treatment Period|Adverse Event|10
4904028|NCT00600119|16895359|P5|Double-blind Treatment Period|Adverse Event|2
4904029|NCT00600119|16895360|P4|Double-blind Treatment Period|Adverse Event|1
4904030|NCT00600119|16895361|P3|Double-blind Treatment Period|Adverse Event|0
4904031|NCT00600119|16895362|P2|Double-blind Treatment Period|Adverse Event|1
4904032|NCT00600119|16895363|P1|Double-blind Treatment Period|Adverse Event|1
4904033|NCT00600119|16895358|P6|Double-blind Treatment Period|Lost to Follow-up|0
4904034|NCT00600119|16895359|P5|Double-blind Treatment Period|Lost to Follow-up|0
4904035|NCT00600119|16895360|P4|Double-blind Treatment Period|Lost to Follow-up|0
4904036|NCT00600119|16895361|P3|Double-blind Treatment Period|Lost to Follow-up|0
4904037|NCT00600119|16895362|P2|Double-blind Treatment Period|Lost to Follow-up|1
4904038|NCT00600119|16895363|P1|Double-blind Treatment Period|Lost to Follow-up|0
4904039|NCT00600119|16895358|P6|Double-blind Treatment Period|Physician Decision|0
4904040|NCT00600119|16895359|P5|Double-blind Treatment Period|Physician Decision|0
4904041|NCT00600119|16895360|P4|Double-blind Treatment Period|Physician Decision|0
4904042|NCT00600119|16895361|P3|Double-blind Treatment Period|Physician Decision|0
4904043|NCT00600119|16895362|P2|Double-blind Treatment Period|Physician Decision|0
4904044|NCT00600119|16895363|P1|Double-blind Treatment Period|Physician Decision|2
4904045|NCT00600119|16895358|P6|Double-blind Treatment Period|Sponsor Decision|0
4904046|NCT00600119|16895359|P5|Double-blind Treatment Period|Sponsor Decision|1
4904047|NCT00600119|16895360|P4|Double-blind Treatment Period|Sponsor Decision|0
4904048|NCT00600119|16895361|P3|Double-blind Treatment Period|Sponsor Decision|0
4904049|NCT00600119|16895362|P2|Double-blind Treatment Period|Sponsor Decision|1
4904050|NCT00600119|16895363|P1|Double-blind Treatment Period|Sponsor Decision|0
4904051|NCT00600119|16895358|P6|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4904052|NCT00600119|16895359|P5|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4904053|NCT00600119|16895360|P4|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4904054|NCT00600119|16895361|P3|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4904055|NCT00600119|16895362|P2|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1
4904056|NCT00600119|16895363|P1|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0
4904057|NCT00600119|16895358|P6|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4904058|NCT00600119|16895359|P5|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
4904059|NCT00600119|16895360|P4|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4904060|NCT00600119|16895361|P3|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4904061|NCT00600119|16895362|P2|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1
4904062|NCT00600119|16895363|P1|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0
4904063|NCT00600119|16895358|P6|Double-blind Treatment Period|Other|1
4904064|NCT00600119|16895359|P5|Double-blind Treatment Period|Other|2
4904065|NCT00600119|16895360|P4|Double-blind Treatment Period|Other|0
4904066|NCT00600119|16895361|P3|Double-blind Treatment Period|Other|0
4904067|NCT00600119|16895362|P2|Double-blind Treatment Period|Other|0
4904068|NCT00600119|16895363|P1|Double-blind Treatment Period|Other|0
4904069|NCT00600119|16895358|P6|Double-blind Treatment Period|Withdrawal by Subject|3
4904070|NCT00600119|16895359|P5|Double-blind Treatment Period|Withdrawal by Subject|0
4904071|NCT00600119|16895360|P4|Double-blind Treatment Period|Withdrawal by Subject|1
4904072|NCT00600119|16895361|P3|Double-blind Treatment Period|Withdrawal by Subject|0
4904073|NCT00600119|16895362|P2|Double-blind Treatment Period|Withdrawal by Subject|0
4904074|NCT00600119|16895363|P1|Double-blind Treatment Period|Withdrawal by Subject|2
4904075|NCT00600119|16895358|P6|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4904076|NCT00600119|16895359|P5|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4904077|NCT00600119|16895360|P4|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4904078|NCT00600119|16895361|P3|Single-blind Placebo run-in Period|Withdrawal by Subject|0
4904079|NCT00600119|16895362|P2|Single-blind Placebo run-in Period|Withdrawal by Subject|1
4904080|NCT00600119|16895363|P1|Single-blind Placebo run-in Period|Withdrawal by Subject|2
4904081|NCT00600119|16895358|P6|Single-blind Placebo run-in Period|Adverse Event|1
4904082|NCT00600119|16895359|P5|Single-blind Placebo run-in Period|Adverse Event|0
4904083|NCT00600119|16895360|P4|Single-blind Placebo run-in Period|Adverse Event|1
4904084|NCT00600119|16895361|P3|Single-blind Placebo run-in Period|Adverse Event|0
4904085|NCT00600119|16895362|P2|Single-blind Placebo run-in Period|Adverse Event|0
4904086|NCT00600119|16895363|P1|Single-blind Placebo run-in Period|Adverse Event|0
4904087|NCT00600119|16895358|P6|Single-blind Placebo run-in Period|Lost to Follow-up|0
4904088|NCT00600119|16895359|P5|Single-blind Placebo run-in Period|Lost to Follow-up|0
4904089|NCT00600119|16895360|P4|Single-blind Placebo run-in Period|Lost to Follow-up|0
4904090|NCT00600119|16895361|P3|Single-blind Placebo run-in Period|Lost to Follow-up|0
4904091|NCT00600119|16895362|P2|Single-blind Placebo run-in Period|Lost to Follow-up|0
4904092|NCT00600119|16895363|P1|Single-blind Placebo run-in Period|Lost to Follow-up|1
4904093|NCT00600119|16895358|P6|Single-blind Placebo run-in Period|Sponsor Decision|0
4904094|NCT00600119|16895359|P5|Single-blind Placebo run-in Period|Sponsor Decision|1
4904095|NCT00600119|16895360|P4|Single-blind Placebo run-in Period|Sponsor Decision|0
4904096|NCT00600119|16895361|P3|Single-blind Placebo run-in Period|Sponsor Decision|1
4904097|NCT00600119|16895362|P2|Single-blind Placebo run-in Period|Sponsor Decision|0
4904098|NCT00600119|16895363|P1|Single-blind Placebo run-in Period|Sponsor Decision|0
4904099|NCT00600119|16895358|P6|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4904100|NCT00600119|16895359|P5|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4904101|NCT00600119|16895360|P4|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4904102|NCT00600119|16895361|P3|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
4904103|NCT00600119|16895362|P2|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1
4904104|NCT00600119|16895363|P1|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0
4904105|NCT00600119|16895358|P6|Single-blind Placebo run-in Period|Other - Not specified|1
4904106|NCT00600119|16895359|P5|Single-blind Placebo run-in Period|Other - Not specified|1
4904107|NCT00600119|16895360|P4|Single-blind Placebo run-in Period|Other - Not specified|0
4904108|NCT00600119|16895361|P3|Single-blind Placebo run-in Period|Other - Not specified|0
4904109|NCT00600119|16895362|P2|Single-blind Placebo run-in Period|Other - Not specified|0
4904110|NCT00600119|16895363|P1|Single-blind Placebo run-in Period|Other - Not specified|1
4904111|NCT00600106|16895397|P2|Overall Study|Withdrawal by Subject|1
4904112|NCT00600106|16895398|P1|Overall Study|Withdrawal by Subject|1
4904113|NCT00600067|16895445|P2|Overall Study|Lack of Efficacy|0
4904114|NCT00600067|16895446|P1|Overall Study|Lack of Efficacy|1
4904115|NCT00600067|16895445|P2|Overall Study|protocol non-compliance|3
4904116|NCT00600067|16895446|P1|Overall Study|protocol non-compliance|0
4904117|NCT00600067|16895445|P2|Overall Study|Lost to Follow-up|3
4904118|NCT00600067|16895446|P1|Overall Study|Lost to Follow-up|2
4904119|NCT00600067|16895445|P2|Overall Study|Adverse Event|1
4904120|NCT00600067|16895446|P1|Overall Study|Adverse Event|0
4904121|NCT00600028|16895456|P2|Second Intervention (12 Weeks)|Adverse Event|2
4904122|NCT00600028|16895457|P1|Second Intervention (12 Weeks)|Adverse Event|0
4904123|NCT00600028|16895456|P2|First Intervention (12 Weeks)|Adverse Event|1
4904124|NCT00600028|16895457|P1|First Intervention (12 Weeks)|Adverse Event|0
4904125|NCT00600028|16895456|P2|First Intervention (12 Weeks)|Withdrawal by Subject|0
4904126|NCT00600028|16895457|P1|First Intervention (12 Weeks)|Withdrawal by Subject|1
4904127|NCT00599924|16895487|P7|Overall Study|Other|2
4904128|NCT00599924|16895488|P6|Overall Study|Other|0
4904129|NCT00599924|16895489|P5|Overall Study|Other|2
4904130|NCT00599924|16895490|P4|Overall Study|Other|1
4904131|NCT00599924|16895491|P3|Overall Study|Other|0
4904132|NCT00599924|16895492|P2|Overall Study|Other|0
4904133|NCT00599924|16895493|P1|Overall Study|Other|0
4904134|NCT00599924|16895487|P7|Overall Study|Withdrawal by Subject|0
4904135|NCT00599924|16895488|P6|Overall Study|Withdrawal by Subject|0
4904136|NCT00599924|16895489|P5|Overall Study|Withdrawal by Subject|1
4904137|NCT00599924|16895490|P4|Overall Study|Withdrawal by Subject|0
4904138|NCT00599924|16895491|P3|Overall Study|Withdrawal by Subject|1
4904139|NCT00599924|16895492|P2|Overall Study|Withdrawal by Subject|0
4904140|NCT00599924|16895493|P1|Overall Study|Withdrawal by Subject|0
4904141|NCT00599924|16895487|P7|Overall Study|Protocol Violation|0
4904142|NCT00599924|16895488|P6|Overall Study|Protocol Violation|0
4904143|NCT00599924|16895489|P5|Overall Study|Protocol Violation|0
4904144|NCT00599924|16895490|P4|Overall Study|Protocol Violation|1
4904145|NCT00599924|16895491|P3|Overall Study|Protocol Violation|0
4904146|NCT00599924|16895492|P2|Overall Study|Protocol Violation|0
4904147|NCT00599924|16895493|P1|Overall Study|Protocol Violation|0
4904148|NCT00599924|16895487|P7|Overall Study|Death|1
4904149|NCT00599924|16895488|P6|Overall Study|Death|2
4904150|NCT00599924|16895489|P5|Overall Study|Death|0
4904151|NCT00599924|16895490|P4|Overall Study|Death|2
4904152|NCT00599924|16895491|P3|Overall Study|Death|0
4904153|NCT00599924|16895492|P2|Overall Study|Death|0
4904154|NCT00599924|16895493|P1|Overall Study|Death|0
4904155|NCT00599924|16895487|P7|Overall Study|Adverse Event|2
4904156|NCT00599924|16895488|P6|Overall Study|Adverse Event|0
4904157|NCT00599924|16895489|P5|Overall Study|Adverse Event|0
4904158|NCT00599924|16895490|P4|Overall Study|Adverse Event|2
4904159|NCT00599924|16895491|P3|Overall Study|Adverse Event|0
4904160|NCT00599924|16895492|P2|Overall Study|Adverse Event|0
4904161|NCT00599924|16895493|P1|Overall Study|Adverse Event|0
4904162|NCT00599924|16895487|P7|Overall Study|Lack of Efficacy|0
4904163|NCT00599924|16895488|P6|Overall Study|Lack of Efficacy|2
4904164|NCT00599924|16895489|P5|Overall Study|Lack of Efficacy|3
4904165|NCT00599924|16895490|P4|Overall Study|Lack of Efficacy|2
4904166|NCT00599924|16895491|P3|Overall Study|Lack of Efficacy|1
4904167|NCT00599924|16895492|P2|Overall Study|Lack of Efficacy|5
4904168|NCT00599924|16895493|P1|Overall Study|Lack of Efficacy|3
4904169|NCT00599755|16895597|P1|Overall Study|No data available|1
4904170|NCT00599755|16895597|P1|Overall Study|Other Reason|2
4904171|NCT00599755|16895597|P1|Overall Study|Progression of Disease|3
4904172|NCT00599755|16895597|P1|Overall Study|Withdrawal by Subject|2
4904173|NCT00599755|16895597|P1|Overall Study|Adverse Event|11
4904174|NCT00599521|16895608|P2|Overall Study|Pregnancy|2
4904175|NCT00599521|16895609|P1|Overall Study|Pregnancy|0
4904176|NCT00599521|16895608|P2|Overall Study|Lost to Follow-up|23
4904177|NCT00599521|16895609|P1|Overall Study|Lost to Follow-up|23
4904178|NCT00599521|16895608|P2|Overall Study|Protocol Violation|1
4904179|NCT00599521|16895609|P1|Overall Study|Protocol Violation|1
4904180|NCT00599521|16895608|P2|Overall Study|Withdrawal by Subject|34
4904181|NCT00599521|16895609|P1|Overall Study|Withdrawal by Subject|28
4904182|NCT00599521|16895608|P2|Overall Study|Adverse Event|1
4904183|NCT00599521|16895609|P1|Overall Study|Adverse Event|4
4904184|NCT00599521|16895608|P2|Overall Study|Lack of Efficacy|8
4904185|NCT00599521|16895609|P1|Overall Study|Lack of Efficacy|4
4904186|NCT00599339|16895623|P1|Overall Study|Study Termination Status Unknown|12
4904187|NCT00599339|16895623|P1|Overall Study|No valid data consent|36
4904188|NCT00599339|16895623|P1|Overall Study|Lost to Follow-up|221
4904189|NCT00599339|16895623|P1|Overall Study|Other Reason|179
4904190|NCT00599339|16895623|P1|Overall Study|Withdrawal by Subject|137
4904191|NCT00599339|16895623|P1|Overall Study|Adverse Event|79
4904192|NCT00599326|16895725|P1|Overall Study|Noncompliant|1
4904193|NCT00599326|16895725|P1|Overall Study|Lost to Follow-up|1
4904194|NCT00599313|16895730|P1|Overall Study|Ineligible|1
4904195|NCT00599313|16895730|P1|Overall Study|Patient Request|4
4904196|NCT00599313|16895730|P1|Overall Study|Disease Progression|12
4904197|NCT00599313|16895730|P1|Overall Study|Adverse Event|19
4904198|NCT00599196|16895772|P1|Overall Study|Other: Inv Switched Dopamine Agonist|1
4904199|NCT00599196|16895772|P1|Overall Study|Other: Patient Stopped Due To Moving|1
4904200|NCT00599196|16895772|P1|Overall Study|Other: Pt Moved To Australia|1
4904201|NCT00599196|16895772|P1|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1
4904202|NCT00599196|16895772|P1|Overall Study|Other: Spouse Withdrew Consent|1
4904203|NCT00599196|16895772|P1|Overall Study|Other: Patient Leaving For Israel|1
4904204|NCT00599196|16895772|P1|Overall Study|Lost to Follow-up|17
4904205|NCT00599196|16895772|P1|Overall Study|Study ended per sponsor|197
4904206|NCT00599196|16895772|P1|Overall Study|Subject withdrew consent|43
4904207|NCT00599196|16895772|P1|Overall Study|Unsatisfactory compliance of subject|3
4904208|NCT00599196|16895772|P1|Overall Study|Adverse Event|93
4904209|NCT00599196|16895772|P1|Overall Study|Lack of Efficacy|22
4904210|NCT00599027|16895803|P2|Overall Study|Treatment Failure|1
4904211|NCT00599027|16895804|P1|Overall Study|Treatment Failure|0
4904212|NCT00599027|16895803|P2|Overall Study|Adverse Event|1
4904213|NCT00599027|16895804|P1|Overall Study|Adverse Event|0
4904214|NCT00599027|16895803|P2|Overall Study|Withdrawal by Subject|1
4904215|NCT00599027|16895804|P1|Overall Study|Withdrawal by Subject|1
4904216|NCT00598871|16895817|P2|Overall Study|Adverse Event|1
4904217|NCT00598871|16895818|P1|Overall Study|Adverse Event|0
4904218|NCT00598832|16895828|P2|Overall Study|Non compliance|0
4904219|NCT00598832|16895829|P1|Overall Study|Non compliance|1
4904220|NCT00598832|16895828|P2|Overall Study|Physician Decision|4
4904221|NCT00598832|16895829|P1|Overall Study|Physician Decision|1
4904222|NCT00598832|16895828|P2|Overall Study|Pregnancy|2
4904223|NCT00598832|16895829|P1|Overall Study|Pregnancy|2
4904224|NCT00598832|16895828|P2|Overall Study|Lost to Follow-up|29
4904225|NCT00598832|16895829|P1|Overall Study|Lost to Follow-up|24
4904226|NCT00598832|16895828|P2|Overall Study|Protocol Violation|2
4904227|NCT00598832|16895829|P1|Overall Study|Protocol Violation|0
4904228|NCT00598832|16895828|P2|Overall Study|Withdrawal by Subject|36
4904229|NCT00598832|16895829|P1|Overall Study|Withdrawal by Subject|25
4904230|NCT00598832|16895828|P2|Overall Study|Adverse Event|2
4904231|NCT00598832|16895829|P1|Overall Study|Adverse Event|6
4904232|NCT00598832|16895828|P2|Overall Study|Lack of Efficacy|7
4904233|NCT00598832|16895829|P1|Overall Study|Lack of Efficacy|3
4904234|NCT00598702|16895882|P8|Overall Study|Dose limiting toxicity|0
4904235|NCT00598702|16895883|P7|Overall Study|Dose limiting toxicity|0
4904236|NCT00598702|16895884|P6|Overall Study|Dose limiting toxicity|1
4904237|NCT00598702|16895885|P5|Overall Study|Dose limiting toxicity|1
4904238|NCT00598702|16895886|P4|Overall Study|Dose limiting toxicity|1
4904239|NCT00598702|16895887|P3|Overall Study|Dose limiting toxicity|0
4904240|NCT00598702|16895888|P2|Overall Study|Dose limiting toxicity|0
4904241|NCT00598702|16895889|P1|Overall Study|Dose limiting toxicity|0
4904242|NCT00598702|16895882|P8|Overall Study|Physician Decision|0
4904243|NCT00598702|16895883|P7|Overall Study|Physician Decision|0
4904244|NCT00598702|16895884|P6|Overall Study|Physician Decision|0
4904245|NCT00598702|16895885|P5|Overall Study|Physician Decision|1
4904246|NCT00598702|16895886|P4|Overall Study|Physician Decision|0
4904247|NCT00598702|16895887|P3|Overall Study|Physician Decision|0
4904248|NCT00598702|16895888|P2|Overall Study|Physician Decision|0
4904249|NCT00598702|16895889|P1|Overall Study|Physician Decision|0
4904250|NCT00598702|16895882|P8|Overall Study|Withdrawal by Subject|0
4904251|NCT00598702|16895883|P7|Overall Study|Withdrawal by Subject|0
4904252|NCT00598702|16895884|P6|Overall Study|Withdrawal by Subject|0
4904253|NCT00598702|16895885|P5|Overall Study|Withdrawal by Subject|1
4904254|NCT00598702|16895886|P4|Overall Study|Withdrawal by Subject|1
4904255|NCT00598702|16895887|P3|Overall Study|Withdrawal by Subject|0
4904256|NCT00598702|16895888|P2|Overall Study|Withdrawal by Subject|0
4904257|NCT00598702|16895889|P1|Overall Study|Withdrawal by Subject|0
4904258|NCT00598702|16895882|P8|Overall Study|Adverse Event|0
4904259|NCT00598702|16895883|P7|Overall Study|Adverse Event|0
4904260|NCT00598702|16895884|P6|Overall Study|Adverse Event|0
4904261|NCT00598702|16895885|P5|Overall Study|Adverse Event|0
4904262|NCT00598702|16895886|P4|Overall Study|Adverse Event|1
4904263|NCT00598702|16895887|P3|Overall Study|Adverse Event|0
4904264|NCT00598702|16895888|P2|Overall Study|Adverse Event|0
4904265|NCT00598702|16895889|P1|Overall Study|Adverse Event|0
4904266|NCT00598702|16895882|P8|Overall Study|Early discharge from hospital|0
4904267|NCT00598702|16895883|P7|Overall Study|Early discharge from hospital|1
4904268|NCT00598702|16895884|P6|Overall Study|Early discharge from hospital|10
4904269|NCT00598702|16895885|P5|Overall Study|Early discharge from hospital|0
4904270|NCT00598702|16895886|P4|Overall Study|Early discharge from hospital|5
4904271|NCT00598702|16895887|P3|Overall Study|Early discharge from hospital|2
4904272|NCT00598702|16895888|P2|Overall Study|Early discharge from hospital|0
4904273|NCT00598702|16895889|P1|Overall Study|Early discharge from hospital|0
4904274|NCT00598702|16895882|P8|Overall Study|Other|0
4904275|NCT00598702|16895883|P7|Overall Study|Other|0
4904276|NCT00598702|16895884|P6|Overall Study|Other|1
4904277|NCT00598702|16895885|P5|Overall Study|Other|0
4904278|NCT00598702|16895886|P4|Overall Study|Other|0
4904279|NCT00598702|16895887|P3|Overall Study|Other|0
4904280|NCT00598702|16895888|P2|Overall Study|Other|2
4904281|NCT00598702|16895889|P1|Overall Study|Other|0
4904282|NCT00598650|16895965|P1|Overall Study|Physician Decision|2
4904283|NCT00598650|16895965|P1|Overall Study|Prohibited Concomitant Medication|2
4904284|NCT00598650|16895965|P1|Overall Study|Not eligible|1
4904285|NCT00598650|16895965|P1|Overall Study|No treatment for 3 weeks|1
4904286|NCT00598650|16895965|P1|Overall Study|Adverse Event|18
4904287|NCT00598650|16895965|P1|Overall Study|Withdrawal by Subject|3
4904288|NCT00598585|16895974|P2|Overall Study|Lost to Follow-up|0
4904289|NCT00598585|16895975|P1|Overall Study|Lost to Follow-up|1
4904290|NCT00598559|16895984|P3|Overall Study|Subject unable/unwilling to attend visit|0
4904291|NCT00598559|16895985|P2|Overall Study|Subject unable/unwilling to attend visit|7
4904292|NCT00598559|16895986|P1|Overall Study|Subject unable/unwilling to attend visit|4
4904293|NCT00598559|16895984|P3|Overall Study|Early discharge from hospital|3
4904294|NCT00598559|16895985|P2|Overall Study|Early discharge from hospital|12
4904295|NCT00598559|16895986|P1|Overall Study|Early discharge from hospital|9
4904296|NCT00598559|16895984|P3|Overall Study|Protocol Non-compliance|0
4904297|NCT00598559|16895985|P2|Overall Study|Protocol Non-compliance|0
4904298|NCT00598559|16895986|P1|Overall Study|Protocol Non-compliance|1
4904299|NCT00598559|16895984|P3|Overall Study|Withdrawal by Subject|0
4904300|NCT00598559|16895985|P2|Overall Study|Withdrawal by Subject|2
4904301|NCT00598559|16895986|P1|Overall Study|Withdrawal by Subject|2
4904302|NCT00598559|16895984|P3|Overall Study|Adverse Event|0
4904303|NCT00598559|16895985|P2|Overall Study|Adverse Event|7
4904304|NCT00598559|16895986|P1|Overall Study|Adverse Event|11
4904305|NCT00598481|16896010|P1|Treatment|Physician Decision|1
4904306|NCT00598442|16896020|P3|Overall Study|Started dialysis|0
4904307|NCT00598442|16896021|P2|Overall Study|Started dialysis|0
4904308|NCT00598442|16896022|P1|Overall Study|Started dialysis|1
4904309|NCT00598442|16896020|P3|Overall Study|Site closed by sponsor|1
4904310|NCT00598442|16896021|P2|Overall Study|Site closed by sponsor|2
4904311|NCT00598442|16896022|P1|Overall Study|Site closed by sponsor|5
4904312|NCT00598442|16896020|P3|Overall Study|Renal transplant|1
4904313|NCT00598442|16896021|P2|Overall Study|Renal transplant|0
4904314|NCT00598442|16896022|P1|Overall Study|Renal transplant|0
4904315|NCT00598442|16896020|P3|Overall Study|Relocation|0
4904316|NCT00598442|16896021|P2|Overall Study|Relocation|4
4904317|NCT00598442|16896022|P1|Overall Study|Relocation|1
4904318|NCT00598442|16896020|P3|Overall Study|Noncompliance|1
4904319|NCT00598442|16896021|P2|Overall Study|Noncompliance|2
4904320|NCT00598442|16896022|P1|Overall Study|Noncompliance|0
4904321|NCT00598442|16896020|P3|Overall Study|Withdrawal by Subject|6
4904322|NCT00598442|16896021|P2|Overall Study|Withdrawal by Subject|16
4904323|NCT00598442|16896022|P1|Overall Study|Withdrawal by Subject|8
4904324|NCT00598442|16896020|P3|Overall Study|Physician Decision|1
4904325|NCT00598442|16896021|P2|Overall Study|Physician Decision|1
4904326|NCT00598442|16896022|P1|Overall Study|Physician Decision|2
4904327|NCT00598442|16896020|P3|Overall Study|Lost to Follow-up|3
4904328|NCT00598442|16896021|P2|Overall Study|Lost to Follow-up|3
4904329|NCT00598442|16896022|P1|Overall Study|Lost to Follow-up|4
4904330|NCT00598442|16896020|P3|Overall Study|Death|11
4904331|NCT00598442|16896021|P2|Overall Study|Death|11
4904332|NCT00598442|16896022|P1|Overall Study|Death|19
4904333|NCT00598442|16896020|P3|Overall Study|Adverse Event|0
4904334|NCT00598442|16896021|P2|Overall Study|Adverse Event|0
4904335|NCT00598442|16896022|P1|Overall Study|Adverse Event|3
4904336|NCT00598273|16896039|P3|Overall Study|Started dialysis|5
4904337|NCT00598273|16896040|P2|Overall Study|Started dialysis|4
4904338|NCT00598273|16896041|P1|Overall Study|Started dialysis|6
4904339|NCT00598273|16896039|P3|Overall Study|Site elected to close|0
4904340|NCT00598273|16896040|P2|Overall Study|Site elected to close|0
4904341|NCT00598273|16896041|P1|Overall Study|Site elected to close|1
4904342|NCT00598273|16896039|P3|Overall Study|Renal transplant|1
4904343|NCT00598273|16896040|P2|Overall Study|Renal transplant|0
4904344|NCT00598273|16896041|P1|Overall Study|Renal transplant|1
4904345|NCT00598273|16896039|P3|Overall Study|Relocation|4
4904346|NCT00598273|16896040|P2|Overall Study|Relocation|2
4904347|NCT00598273|16896041|P1|Overall Study|Relocation|0
4904348|NCT00598273|16896039|P3|Overall Study|Noncompliance|3
4904349|NCT00598273|16896040|P2|Overall Study|Noncompliance|2
4904350|NCT00598273|16896041|P1|Overall Study|Noncompliance|3
4904351|NCT00598273|16896039|P3|Overall Study|Withdrawal by Subject|10
4904352|NCT00598273|16896040|P2|Overall Study|Withdrawal by Subject|10
4904353|NCT00598273|16896041|P1|Overall Study|Withdrawal by Subject|12
4904354|NCT00598273|16896039|P3|Overall Study|Physician Decision|1
4904355|NCT00598273|16896040|P2|Overall Study|Physician Decision|0
4904356|NCT00598273|16896041|P1|Overall Study|Physician Decision|0
4904357|NCT00598273|16896039|P3|Overall Study|Lost to Follow-up|5
4904358|NCT00598273|16896040|P2|Overall Study|Lost to Follow-up|3
4904359|NCT00598273|16896041|P1|Overall Study|Lost to Follow-up|8
4904360|NCT00598273|16896039|P3|Overall Study|Death|8
4904361|NCT00598273|16896040|P2|Overall Study|Death|12
4904362|NCT00598273|16896041|P1|Overall Study|Death|6
4904363|NCT00598273|16896039|P3|Overall Study|Adverse Event|2
4904364|NCT00598273|16896040|P2|Overall Study|Adverse Event|5
4904365|NCT00598273|16896041|P1|Overall Study|Adverse Event|4
4904366|NCT00598078|16896055|P2|Period 2 (Day 2)|Adverse Event|0
4904367|NCT00598078|16896056|P1|Period 2 (Day 2)|Adverse Event|1
4904368|NCT00597766|16896199|P3|Follow-up 2, Week 8|Lost to Follow-up|1
4904369|NCT00597766|16896200|P2|Follow-up 2, Week 8|Lost to Follow-up|0
4904370|NCT00597766|16896201|P1|Follow-up 2, Week 8|Lost to Follow-up|0
4904371|NCT00597766|16896199|P3|Follow-up 1, Week 4|Withdrawal by Subject|0
4904372|NCT00597766|16896200|P2|Follow-up 1, Week 4|Withdrawal by Subject|0
4904373|NCT00597766|16896201|P1|Follow-up 1, Week 4|Withdrawal by Subject|1
4904374|NCT00597753|16896220|P2|Overall Study|Site elected to close|4
4904375|NCT00597753|16896221|P1|Overall Study|Site elected to close|2
4904376|NCT00597753|16896220|P2|Overall Study|Site closed by sponsor|7
4904377|NCT00597753|16896221|P1|Overall Study|Site closed by sponsor|19
4904378|NCT00597753|16896220|P2|Overall Study|Renal transplant|3
4904379|NCT00597753|16896221|P1|Overall Study|Renal transplant|10
4904380|NCT00597753|16896220|P2|Overall Study|Relocation|6
4904381|NCT00597753|16896221|P1|Overall Study|Relocation|17
4904382|NCT00597753|16896220|P2|Overall Study|Noncompliance|1
4904383|NCT00597753|16896221|P1|Overall Study|Noncompliance|2
4904384|NCT00597753|16896220|P2|Overall Study|Never dosed|0
4904385|NCT00597753|16896221|P1|Overall Study|Never dosed|2
4904386|NCT00597753|16896220|P2|Overall Study|Discontinued Dialysis|1
4904387|NCT00597753|16896221|P1|Overall Study|Discontinued Dialysis|0
4904388|NCT00597753|16896220|P2|Overall Study|Withdrawal by Subject|12
4904389|NCT00597753|16896221|P1|Overall Study|Withdrawal by Subject|35
4904390|NCT00597753|16896220|P2|Overall Study|Pregnancy|0
4904391|NCT00597753|16896221|P1|Overall Study|Pregnancy|1
4904392|NCT00597753|16896220|P2|Overall Study|Physician Decision|1
4904393|NCT00597753|16896221|P1|Overall Study|Physician Decision|5
4904394|NCT00597753|16896220|P2|Overall Study|Lost to Follow-up|3
4904395|NCT00597753|16896221|P1|Overall Study|Lost to Follow-up|10
4904396|NCT00597753|16896220|P2|Overall Study|Lack of Efficacy|0
4904397|NCT00597753|16896221|P1|Overall Study|Lack of Efficacy|2
4904398|NCT00597753|16896220|P2|Overall Study|Death|29
4904399|NCT00597753|16896221|P1|Overall Study|Death|55
4904400|NCT00597753|16896220|P2|Overall Study|Adverse Event|2
4904401|NCT00597753|16896221|P1|Overall Study|Adverse Event|6
4904402|NCT00597714|16896255|P3|Overall Study|Recipient death|10
4904403|NCT00597714|16896256|P2|Overall Study|Recipient death|0
4904404|NCT00597714|16896257|P1|Overall Study|Recipient death|0
4904405|NCT00597714|16896255|P3|Overall Study|Death|0
4904406|NCT00597714|16896256|P2|Overall Study|Death|46
4904407|NCT00597714|16896257|P1|Overall Study|Death|56
4904408|NCT00597701|16896269|P2|Overall Study|Did not start intervention (pharmacy er)|2
4904409|NCT00597701|16896270|P1|Overall Study|Did not start intervention (pharmacy er)|0
4904410|NCT00597701|16896269|P2|Overall Study|Physician Decision|0
4904411|NCT00597701|16896270|P1|Overall Study|Physician Decision|2
4904412|NCT00597701|16896269|P2|Overall Study|Death|1
4904413|NCT00597701|16896270|P1|Overall Study|Death|0
4904414|NCT00597701|16896269|P2|Overall Study|Withdrawal by Subject|5
4904415|NCT00597701|16896270|P1|Overall Study|Withdrawal by Subject|5
4904416|NCT00597584|16896292|P2|Overall Study|Renal transplant|7
4904417|NCT00597584|16896293|P1|Overall Study|Renal transplant|9
4904418|NCT00597584|16896292|P2|Overall Study|Relocation|6
4904419|NCT00597584|16896293|P1|Overall Study|Relocation|8
4904420|NCT00597584|16896292|P2|Overall Study|Never dosed|0
4904421|NCT00597584|16896293|P1|Overall Study|Never dosed|1
4904422|NCT00597584|16896292|P2|Overall Study|Lost ability to consent|1
4904423|NCT00597584|16896293|P1|Overall Study|Lost ability to consent|1
4904424|NCT00597584|16896292|P2|Overall Study|Discontinued Dialysis|1
4904425|NCT00597584|16896293|P1|Overall Study|Discontinued Dialysis|0
4904426|NCT00597584|16896292|P2|Overall Study|Withdrawal by Subject|12
4904427|NCT00597584|16896293|P1|Overall Study|Withdrawal by Subject|44
4904428|NCT00597584|16896292|P2|Overall Study|Pregnancy|0
4904429|NCT00597584|16896293|P1|Overall Study|Pregnancy|2
4904430|NCT00597584|16896292|P2|Overall Study|Physician Decision|0
4904431|NCT00597584|16896293|P1|Overall Study|Physician Decision|3
4904432|NCT00597584|16896292|P2|Overall Study|Lost to Follow-up|4
4904433|NCT00597584|16896293|P1|Overall Study|Lost to Follow-up|2
4904434|NCT00597584|16896292|P2|Overall Study|Lack of Efficacy|0
4904435|NCT00597584|16896293|P1|Overall Study|Lack of Efficacy|1
4904436|NCT00597584|16896292|P2|Overall Study|Death|30
4904437|NCT00597584|16896293|P1|Overall Study|Death|53
4904438|NCT00597584|16896292|P2|Overall Study|Adverse Event|2
4904439|NCT00597584|16896293|P1|Overall Study|Adverse Event|4
4904440|NCT00597519|16896318|P1|Overall Study|Death|1
4904441|NCT00597506|16896322|P1|Overall Study|Subject is being followed for survival|1
4904442|NCT00597376|16896372|P2|Overall Study|Adverse Event|1
4904443|NCT00597376|16896373|P1|Overall Study|Adverse Event|4
4904444|NCT00597376|16896372|P2|Overall Study|Withdrawal by Subject|3
4904445|NCT00597376|16896373|P1|Overall Study|Withdrawal by Subject|4
4904446|NCT00597207|16896414|P2|Overall Study|Lost to Follow-up|7
4904447|NCT00597207|16896415|P1|Overall Study|Lost to Follow-up|5
4904448|NCT00597116|16896423|P2|Overall Study|Progressive disease|6
4904449|NCT00597116|16896424|P1|Overall Study|Progressive disease|11
4904450|NCT00597116|16896423|P2|Overall Study|Lost to Follow-up|0
4904451|NCT00597116|16896424|P1|Overall Study|Lost to Follow-up|1
4904452|NCT00597116|16896423|P2|Overall Study|Death|1
4904453|NCT00597116|16896424|P1|Overall Study|Death|0
4904454|NCT00597116|16896423|P2|Overall Study|Physician Decision|1
4904455|NCT00597116|16896424|P1|Overall Study|Physician Decision|0
4904456|NCT00597116|16896423|P2|Overall Study|Withdrawal by Subject|2
4904457|NCT00597116|16896424|P1|Overall Study|Withdrawal by Subject|0
4904458|NCT00597116|16896423|P2|Overall Study|Adverse Event|1
4904459|NCT00597116|16896424|P1|Overall Study|Adverse Event|2
4904460|NCT00596960|16896450|P2|Overall Study|No alcohol use data|1
4904461|NCT00596960|16896451|P1|Overall Study|No alcohol use data|0
4904462|NCT00596960|16896450|P2|Overall Study|Protocol Violation|1
4904463|NCT00596960|16896451|P1|Overall Study|Protocol Violation|0
4904464|NCT00596960|16896450|P2|Overall Study|Physician Decision|0
4904465|NCT00596960|16896451|P1|Overall Study|Physician Decision|1
4904466|NCT00596960|16896450|P2|Overall Study|Incarcerated|0
4904467|NCT00596960|16896451|P1|Overall Study|Incarcerated|2
4904468|NCT00596960|16896450|P2|Overall Study|Withdrawal by Subject|0
4904469|NCT00596960|16896451|P1|Overall Study|Withdrawal by Subject|1
4904470|NCT00596960|16896450|P2|Overall Study|Lost to Follow-up|5
4904471|NCT00596960|16896451|P1|Overall Study|Lost to Follow-up|6
4904472|NCT00596960|16896450|P2|Overall Study|Death|2
4904473|NCT00596960|16896451|P1|Overall Study|Death|1
4904474|NCT00596947|16896463|P2|Overall Study|Lost to Follow-up|0
4904475|NCT00596947|16896464|P1|Overall Study|Lost to Follow-up|1
4904476|NCT00596947|16896463|P2|Overall Study|study halted due to low enrollment|3
4904477|NCT00596947|16896464|P1|Overall Study|study halted due to low enrollment|5
4904478|NCT00596934|16896504|P1|Overall Study|Withdrawal by Subject|1
4904479|NCT00596934|16896504|P1|Overall Study|Protocol Violation|1
4904480|NCT00596830|16896517|P2|Overall Study|Randomized but not treated|7
4904481|NCT00596830|16896518|P1|Overall Study|Randomized but not treated|3
4904482|NCT00596830|16896517|P2|Overall Study|Follow-up was discontinued|0
4904483|NCT00596830|16896518|P1|Overall Study|Follow-up was discontinued|1
4904484|NCT00596830|16896517|P2|Overall Study|Study terminated by sponsor|62
4904485|NCT00596830|16896518|P1|Overall Study|Study terminated by sponsor|51
4904486|NCT00596830|16896517|P2|Overall Study|Withdrawal by Subject|12
4904487|NCT00596830|16896518|P1|Overall Study|Withdrawal by Subject|22
4904488|NCT00596830|16896517|P2|Overall Study|Lost to Follow-up|11
4904489|NCT00596830|16896518|P1|Overall Study|Lost to Follow-up|7
4904490|NCT00596830|16896517|P2|Overall Study|Death|247
4904491|NCT00596830|16896518|P1|Overall Study|Death|258
4904492|NCT00596817|16896544|P2|Double-blind Period|Other Reasons|18
4904493|NCT00596817|16896545|P1|Double-blind Period|Other Reasons|10
4904494|NCT00596817|16896544|P2|Double-blind Period|Lost to Follow-up|2
4904495|NCT00596817|16896545|P1|Double-blind Period|Lost to Follow-up|0
4904496|NCT00596817|16896544|P2|Double-blind Period|Withdrawal of Consent|3
4904497|NCT00596817|16896545|P1|Double-blind Period|Withdrawal of Consent|7
4904498|NCT00596817|16896544|P2|Double-blind Period|Protocol Violation|8
4904499|NCT00596817|16896545|P1|Double-blind Period|Protocol Violation|11
4904500|NCT00596817|16896544|P2|Double-blind Period|Non-compliance With Study Product|4
4904501|NCT00596817|16896545|P1|Double-blind Period|Non-compliance With Study Product|3
4904502|NCT00596817|16896544|P2|Double-blind Period|Lack of Efficacy|28
4904503|NCT00596817|16896545|P1|Double-blind Period|Lack of Efficacy|52
4904504|NCT00596817|16896544|P2|Double-blind Period|Adverse Event|16
4904505|NCT00596817|16896545|P1|Double-blind Period|Adverse Event|5
4904506|NCT00596817|16896544|P2|Open-label Period to Double-blind Period|Other Reasons|14
4904507|NCT00596817|16896545|P1|Open-label Period to Double-blind Period|Other Reasons|0
4904508|NCT00596817|16896544|P2|Open-label Period to Double-blind Period|Not Eligible|49
4904509|NCT00596817|16896545|P1|Open-label Period to Double-blind Period|Not Eligible|0
4904510|NCT00596817|16896544|P2|Open-label Period to Double-blind Period|Lack of Efficacy|24
4904511|NCT00596817|16896545|P1|Open-label Period to Double-blind Period|Lack of Efficacy|0
4904512|NCT00596817|16896544|P2|Open-label Period to Double-blind Period|Adverse Event|5
4904513|NCT00596817|16896545|P1|Open-label Period to Double-blind Period|Adverse Event|0
4904514|NCT00596817|16896544|P2|Open-label Period|Other Reasons|65
4904515|NCT00596817|16896545|P1|Open-label Period|Other Reasons|0
4904516|NCT00596817|16896544|P2|Open-label Period|Lack of Efficacy|33
4904517|NCT00596817|16896545|P1|Open-label Period|Lack of Efficacy|0
4904518|NCT00596817|16896544|P2|Open-label Period|Adverse Event|49
4904519|NCT00596817|16896545|P1|Open-label Period|Adverse Event|0
4904520|NCT00596752|16896570|P2|Overall Study|Protocol Violation|0
4904521|NCT00596752|16896571|P1|Overall Study|Protocol Violation|1
4904522|NCT00596752|16896570|P2|Overall Study|Lack of Efficacy|7
4904523|NCT00596752|16896571|P1|Overall Study|Lack of Efficacy|4
4904524|NCT00596752|16896570|P2|Overall Study|Unsatisfactory Compliance|6
4904525|NCT00596752|16896571|P1|Overall Study|Unsatisfactory Compliance|9
4904526|NCT00596752|16896570|P2|Overall Study|Withdrawal by Subject|9
4904527|NCT00596752|16896571|P1|Overall Study|Withdrawal by Subject|12
4904528|NCT00596752|16896570|P2|Overall Study|Lost to Follow-up|38
4904529|NCT00596752|16896571|P1|Overall Study|Lost to Follow-up|22
4904530|NCT00596752|16896570|P2|Overall Study|Adverse Event|34
4904531|NCT00596752|16896571|P1|Overall Study|Adverse Event|34
4904532|NCT00596752|16896570|P2|Overall Study|Other Reason|49
4904533|NCT00596752|16896571|P1|Overall Study|Other Reason|44
4904534|NCT00596687|16896601|P2|Overall Study|cancelled surgery|1
4904535|NCT00596687|16896602|P1|Overall Study|cancelled surgery|1
4904536|NCT00596687|16896601|P2|Overall Study|Withdrawal by Subject|1
4904537|NCT00596687|16896602|P1|Overall Study|Withdrawal by Subject|3
4904538|NCT00596687|16896601|P2|Overall Study|continuous insulin infusion during TPN|1
4904539|NCT00596687|16896602|P1|Overall Study|continuous insulin infusion during TPN|2
4904540|NCT00596687|16896601|P2|Overall Study|< 24 hours of insulin treatment|6
4904541|NCT00596687|16896602|P1|Overall Study|< 24 hours of insulin treatment|8
4904542|NCT00596635|16896613|P3|Overall Study|Could not provide urine specimen|2
4904543|NCT00596635|16896614|P2|Overall Study|Could not provide urine specimen|2
4904544|NCT00596635|16896615|P1|Overall Study|Could not provide urine specimen|1
4904545|NCT00596635|16896613|P3|Overall Study|Hip fracture|3
4904546|NCT00596635|16896614|P2|Overall Study|Hip fracture|3
4904547|NCT00596635|16896615|P1|Overall Study|Hip fracture|2
4904548|NCT00596635|16896613|P3|Overall Study|Treatment for symptomatic UTI|3
4904549|NCT00596635|16896614|P2|Overall Study|Treatment for symptomatic UTI|6
4904550|NCT00596635|16896615|P1|Overall Study|Treatment for symptomatic UTI|4
4904551|NCT00596635|16896613|P3|Overall Study|Lost to Follow-up|0
4904552|NCT00596635|16896614|P2|Overall Study|Lost to Follow-up|2
4904553|NCT00596635|16896615|P1|Overall Study|Lost to Follow-up|0
4904554|NCT00596466|16896641|P1|Overall Study|Enrolled, not treated|2
4904555|NCT00596466|16896641|P1|Overall Study|Unpecified|2
4904556|NCT00596466|16896641|P1|Overall Study|Protocol Violation|2
4904557|NCT00596466|16896641|P1|Overall Study|Withdrawal by Subject|2
4904558|NCT00596466|16896641|P1|Overall Study|Adverse Event|4
4904559|NCT00596466|16896641|P1|Overall Study|Lack of Efficacy|5
4904560|NCT00596427|16896671|P2|Overall Study|Protocol Violation|0
4904561|NCT00596427|16896672|P1|Overall Study|Protocol Violation|1
4904562|NCT00596427|16896671|P2|Overall Study|Increased Fasting Triacylglycerol level|0
4904563|NCT00596427|16896672|P1|Overall Study|Increased Fasting Triacylglycerol level|1
4904564|NCT00596427|16896671|P2|Overall Study|Withdrawal by Subject|2
4904565|NCT00596427|16896672|P1|Overall Study|Withdrawal by Subject|2
4904566|NCT00596362|16896700|P1|Overall Study|Progressive Disease|1
4904567|NCT00596011|16896736|P2|Overall Study|Adverse Event|7
4904568|NCT00596011|16896737|P1|Overall Study|Adverse Event|11
4904569|NCT00596011|16896736|P2|Overall Study|Withdrawal by Subject|3
4904570|NCT00596011|16896737|P1|Overall Study|Withdrawal by Subject|2
4904571|NCT00595959|16896753|P1|Overall Study|Lost to Follow-up|1
4904572|NCT00595959|16896753|P1|Overall Study|Withdrawal by Subject|1
4904573|NCT00595920|16896787|P1|Overall Study|The OLTERMS study was discontinued by th|116
4904574|NCT00595868|16896798|P2|Overall Study|Lost to Follow-up|50
4904575|NCT00595868|16896799|P1|Overall Study|Lost to Follow-up|45
4904576|NCT00595764|16896822|P2|Overall Study|Withdrawal by Subject|0
4904577|NCT00595764|16896823|P1|Overall Study|Withdrawal by Subject|4
4904578|NCT00595764|16896822|P2|Overall Study|Missed 3 PM visits|7
4904579|NCT00595764|16896823|P1|Overall Study|Missed 3 PM visits|1
4904580|NCT00595764|16896822|P2|Overall Study|Missed Medication >1 week|17
4904581|NCT00595764|16896823|P1|Overall Study|Missed Medication >1 week|10
4904582|NCT00595764|16896822|P2|Overall Study|Protocol Violation|19
4904583|NCT00595764|16896823|P1|Overall Study|Protocol Violation|24
4904584|NCT00595621|16896839|P2|Randomization and Study|Withdrawal by Subject|1
4904585|NCT00595621|16896840|P1|Randomization and Study|Withdrawal by Subject|0
4904586|NCT00595621|16896839|P2|Randomization and Study|Adverse Event|0
4904587|NCT00595621|16896840|P1|Randomization and Study|Adverse Event|2
4904588|NCT00595621|16896839|P2|Open Label Run in|Withdrawal by Subject|0
4904589|NCT00595621|16896840|P1|Open Label Run in|Withdrawal by Subject|1
4904590|NCT00595621|16896839|P2|Open Label Run in|Physician Decision|0
4904591|NCT00595621|16896840|P1|Open Label Run in|Physician Decision|1
4904592|NCT00595621|16896839|P2|Open Label Run in|Adverse Event|0
4904593|NCT00595621|16896840|P1|Open Label Run in|Adverse Event|1
4904594|NCT00595582|16896857|P1|Overall Study|Physician Decision|5
4904595|NCT00595582|16896857|P1|Overall Study|Adverse Event|2
4904596|NCT00595582|16896857|P1|Overall Study|Lost to Follow-up|1
4904597|NCT00595582|16896857|P1|Overall Study|Pilot study that PI terminated|2
4904598|NCT00595517|16896883|P1|Overall Study|No intention to attend regularly|1
4904599|NCT00595517|16896883|P1|Overall Study|usage of prohibited treatment|1
4904600|NCT00595517|16896883|P1|Overall Study|Recurrence of ulcer|5
4904601|NCT00595517|16896883|P1|Overall Study|Protocol Violation|2
4904602|NCT00595517|16896883|P1|Overall Study|Withdrawal by Subject|4
4904603|NCT00595517|16896883|P1|Overall Study|Adverse Event|6
4904604|NCT00595504|16896892|P2|Overall Study|Physician Decision|0
4904605|NCT00595504|16896893|P1|Overall Study|Physician Decision|1
4904606|NCT00595504|16896892|P2|Overall Study|Withdrawal by Subject|3
4904607|NCT00595504|16896893|P1|Overall Study|Withdrawal by Subject|1
4904608|NCT00595478|16896905|P2|36-week Follow-up Period|Withdrawal by Subject|4
4904609|NCT00595478|16896906|P1|36-week Follow-up Period|Withdrawal by Subject|4
4904610|NCT00595478|16896905|P2|36-week Follow-up Period|Lost to Follow-up|4
4904611|NCT00595478|16896906|P1|36-week Follow-up Period|Lost to Follow-up|5
4904612|NCT00595465|16896917|P3|Overall Study|administrative reason|1
4904613|NCT00595465|16896918|P2|Overall Study|administrative reason|0
4904614|NCT00595465|16896919|P1|Overall Study|administrative reason|0
4904615|NCT00595465|16896917|P3|Overall Study|Lost to Follow-up|2
4904616|NCT00595465|16896918|P2|Overall Study|Lost to Follow-up|0
4904617|NCT00595465|16896919|P1|Overall Study|Lost to Follow-up|0
4904618|NCT00595465|16896917|P3|Overall Study|Protocol Violation|0
4904619|NCT00595465|16896918|P2|Overall Study|Protocol Violation|1
4904620|NCT00595465|16896919|P1|Overall Study|Protocol Violation|2
4904621|NCT00595465|16896917|P3|Overall Study|Pregnancy|1
4904622|NCT00595465|16896918|P2|Overall Study|Pregnancy|0
4904623|NCT00595465|16896919|P1|Overall Study|Pregnancy|0
4904624|NCT00595465|16896917|P3|Overall Study|Adverse Event|3
4904625|NCT00595465|16896918|P2|Overall Study|Adverse Event|3
4904626|NCT00595465|16896919|P1|Overall Study|Adverse Event|4
4904627|NCT00595413|16896931|P4|Overall Study|Other|0
4904628|NCT00595413|16896932|P3|Overall Study|Other|5
4904629|NCT00595413|16896933|P2|Overall Study|Other|1
4904630|NCT00595413|16896934|P1|Overall Study|Other|5
4904631|NCT00595413|16896931|P4|Overall Study|Death|0
4904632|NCT00595413|16896932|P3|Overall Study|Death|1
4904633|NCT00595413|16896933|P2|Overall Study|Death|0
4904634|NCT00595413|16896934|P1|Overall Study|Death|0
4904635|NCT00595413|16896931|P4|Overall Study|Lost to Follow-up|3
4904636|NCT00595413|16896932|P3|Overall Study|Lost to Follow-up|1
4904637|NCT00595413|16896933|P2|Overall Study|Lost to Follow-up|2
4904638|NCT00595413|16896934|P1|Overall Study|Lost to Follow-up|2
4904639|NCT00595413|16896931|P4|Overall Study|Adverse Event|1
4904640|NCT00595413|16896932|P3|Overall Study|Adverse Event|1
4904641|NCT00595413|16896933|P2|Overall Study|Adverse Event|2
4904642|NCT00595413|16896934|P1|Overall Study|Adverse Event|0
4904643|NCT00595335|16896975|P2|Six Months to Twelve Months|Disease Progression|0
4904644|NCT00595335|16896976|P1|Six Months to Twelve Months|Disease Progression|1
4904645|NCT00595335|16896975|P2|Six Months to Twelve Months|Withdrawal by Subject|1
4904646|NCT00595335|16896976|P1|Six Months to Twelve Months|Withdrawal by Subject|0
4904647|NCT00595335|16896975|P2|Baseline to Six Months|Adverse Event|0
4904648|NCT00595335|16896976|P1|Baseline to Six Months|Adverse Event|1
4904649|NCT00595335|16896975|P2|Baseline to Six Months|Disease Progression|1
4904650|NCT00595335|16896976|P1|Baseline to Six Months|Disease Progression|1
4904651|NCT00595335|16896975|P2|Baseline to Six Months|Withdrawal by Subject|1
4904652|NCT00595335|16896976|P1|Baseline to Six Months|Withdrawal by Subject|0
4904653|NCT00595309|16896996|P1|Overall Study|personal reason|1
4904654|NCT00595309|16896996|P1|Overall Study|acute infection after V0|1
4904655|NCT00595309|16896996|P1|Overall Study|planned vaccination against yellow fever|1
4904656|NCT00595309|16896996|P1|Overall Study|Lost to Follow-up|1
4904657|NCT00595127|16897045|P1|Overall Study|joined another trial|1
4904658|NCT00595127|16897045|P1|Overall Study|Relapsed|3
4904659|NCT00595127|16897045|P1|Overall Study|Death|6
4904660|NCT00595075|16897091|P2|Overall Study|Withdrawal by Subject|0
4904661|NCT00595075|16897092|P1|Overall Study|Withdrawal by Subject|1
4904662|NCT00594958|16897113|P3|Overall Study|administrative|2
4904663|NCT00594958|16897114|P2|Overall Study|administrative|0
4904664|NCT00594958|16897115|P1|Overall Study|administrative|3
4904665|NCT00594958|16897113|P3|Overall Study|Lost to Follow-up|3
4904666|NCT00594958|16897114|P2|Overall Study|Lost to Follow-up|0
4904667|NCT00594958|16897115|P1|Overall Study|Lost to Follow-up|5
4904668|NCT00594958|16897113|P3|Overall Study|Protocol Violation|2
4904669|NCT00594958|16897114|P2|Overall Study|Protocol Violation|0
4904670|NCT00594958|16897115|P1|Overall Study|Protocol Violation|1
4904671|NCT00594958|16897113|P3|Overall Study|Pregnancy|0
4904672|NCT00594958|16897114|P2|Overall Study|Pregnancy|2
4904673|NCT00594958|16897115|P1|Overall Study|Pregnancy|0
4904674|NCT00594958|16897113|P3|Overall Study|Adverse Event|2
4904675|NCT00594958|16897114|P2|Overall Study|Adverse Event|1
4904676|NCT00594958|16897115|P1|Overall Study|Adverse Event|4
4904677|NCT00594958|16897113|P3|Overall Study|Withdrawal by Subject|1
4904678|NCT00594958|16897114|P2|Overall Study|Withdrawal by Subject|0
4904679|NCT00594958|16897115|P1|Overall Study|Withdrawal by Subject|1
4904680|NCT00594932|16897136|P2|Final 3 Months|Withdrawal by Subject|3
4904681|NCT00594932|16897137|P1|Final 3 Months|Withdrawal by Subject|4
4904682|NCT00594932|16897136|P2|First 3 Months|Withdrawal by Subject|3
4904683|NCT00594932|16897137|P1|First 3 Months|Withdrawal by Subject|1
4904684|NCT00594906|16897149|P2|Overall Study|Death|1
4904685|NCT00594906|16897150|P1|Overall Study|Death|0
4904686|NCT00594906|16897149|P2|Overall Study|Physician Decision|1
4904687|NCT00594906|16897150|P1|Overall Study|Physician Decision|0
4904688|NCT00594906|16897149|P2|Overall Study|Physician Decision|0
4904689|NCT00594906|16897150|P1|Overall Study|Physician Decision|1
4904690|NCT00594880|16897158|P2|Overall Study|Lost to Follow-up|0
4904691|NCT00594880|16897159|P1|Overall Study|Lost to Follow-up|1
4904692|NCT00594880|16897158|P2|Overall Study|Withdrawal by Subject|1
4904693|NCT00594880|16897159|P1|Overall Study|Withdrawal by Subject|1
4904694|NCT00594854|16897171|P2|Overall Study|Study terminated|10
4904695|NCT00594854|16897172|P1|Overall Study|Study terminated|7
4904696|NCT00594815|16897182|P1|Overall Study|Toxicity|4
4904697|NCT00594815|16897182|P1|Overall Study|Withdrawal by Subject|2
4904698|NCT00594815|16897182|P1|Overall Study|Never Treated|3
4904699|NCT00594659|16897207|P3|Overall Study|Lost to Follow-up|7
4904700|NCT00594659|16897208|P2|Overall Study|Lost to Follow-up|9
4904701|NCT00594659|16897209|P1|Overall Study|Lost to Follow-up|13
4904702|NCT00594646|16897220|P1|Overall Study|Lost to Follow-up|15
4904703|NCT00594646|16897220|P1|Overall Study|Withdrawal by Subject|1
4904704|NCT00594568|16897228|P3|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18
4904705|NCT00594568|16897229|P2|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22
4904706|NCT00594568|16897230|P1|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25
4904707|NCT00594568|16897228|P3|Safety Follow Up (SFU)-Optional|Caregiver Decision|9
4904708|NCT00594568|16897229|P2|Safety Follow Up (SFU)-Optional|Caregiver Decision|16
4904709|NCT00594568|16897230|P1|Safety Follow Up (SFU)-Optional|Caregiver Decision|17
4904710|NCT00594568|16897228|P3|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
4904711|NCT00594568|16897229|P2|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1
4904712|NCT00594568|16897230|P1|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2
4904713|NCT00594568|16897228|P3|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13
4904714|NCT00594568|16897229|P2|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15
4904715|NCT00594568|16897230|P1|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12
4904716|NCT00594568|16897228|P3|Safety Follow Up (SFU)-Optional|Adverse Event|0
4904717|NCT00594568|16897229|P2|Safety Follow Up (SFU)-Optional|Adverse Event|0
4904718|NCT00594568|16897230|P1|Safety Follow Up (SFU)-Optional|Adverse Event|5
4904719|NCT00594568|16897228|P3|Safety Follow Up (SFU)-Optional|Death|0
4904720|NCT00594568|16897229|P2|Safety Follow Up (SFU)-Optional|Death|1
4904721|NCT00594568|16897230|P1|Safety Follow Up (SFU)-Optional|Death|0
4904722|NCT00594568|16897228|P3|Delayed Start|Sponsor Decision|59
4904723|NCT00594568|16897229|P2|Delayed Start|Sponsor Decision|66
4904724|NCT00594568|16897230|P1|Delayed Start|Sponsor Decision|77
4904725|NCT00594568|16897228|P3|Delayed Start|Caregiver Decision|2
4904726|NCT00594568|16897229|P2|Delayed Start|Caregiver Decision|6
4904727|NCT00594568|16897230|P1|Delayed Start|Caregiver Decision|5
4904728|NCT00594568|16897228|P3|Delayed Start|Lost to Follow-up|1
4904729|NCT00594568|16897229|P2|Delayed Start|Lost to Follow-up|0
4904730|NCT00594568|16897230|P1|Delayed Start|Lost to Follow-up|0
4904731|NCT00594568|16897228|P3|Delayed Start|Physician Decision|1
4904732|NCT00594568|16897229|P2|Delayed Start|Physician Decision|0
4904733|NCT00594568|16897230|P1|Delayed Start|Physician Decision|0
4904734|NCT00594568|16897228|P3|Delayed Start|Withdrawal by Subject|0
4904735|NCT00594568|16897229|P2|Delayed Start|Withdrawal by Subject|3
4904736|NCT00594568|16897230|P1|Delayed Start|Withdrawal by Subject|4
4904737|NCT00594568|16897228|P3|Delayed Start|Adverse Event|2
4904738|NCT00594568|16897229|P2|Delayed Start|Adverse Event|2
4904739|NCT00594568|16897230|P1|Delayed Start|Adverse Event|12
4904740|NCT00594568|16897228|P3|Delayed Start|Death|1
4904741|NCT00594568|16897229|P2|Delayed Start|Death|0
4904742|NCT00594568|16897230|P1|Delayed Start|Death|0
4904743|NCT00594568|16897228|P3|Initial Treatment|Entry criteria exclusion|1
4904744|NCT00594568|16897229|P2|Initial Treatment|Entry criteria exclusion|1
4904745|NCT00594568|16897230|P1|Initial Treatment|Entry criteria exclusion|0
4904746|NCT00594568|16897228|P3|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6
4904747|NCT00594568|16897229|P2|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
4904748|NCT00594568|16897230|P1|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7
4904749|NCT00594568|16897228|P3|Initial Treatment|Caregiver decision|36
4904750|NCT00594568|16897229|P2|Initial Treatment|Caregiver decision|36
4904751|NCT00594568|16897230|P1|Initial Treatment|Caregiver decision|21
4904752|NCT00594568|16897228|P3|Initial Treatment|Sponsor decision|147
4904753|NCT00594568|16897229|P2|Initial Treatment|Sponsor decision|142
4904754|NCT00594568|16897230|P1|Initial Treatment|Sponsor decision|193
4904755|NCT00594568|16897228|P3|Initial Treatment|Withdrawal by Subject|46
4904756|NCT00594568|16897229|P2|Initial Treatment|Withdrawal by Subject|31
4904757|NCT00594568|16897230|P1|Initial Treatment|Withdrawal by Subject|25
4904758|NCT00594568|16897228|P3|Initial Treatment|Protocol Violation|5
4904759|NCT00594568|16897229|P2|Initial Treatment|Protocol Violation|2
4904760|NCT00594568|16897230|P1|Initial Treatment|Protocol Violation|2
4904761|NCT00594568|16897228|P3|Initial Treatment|Physician Decision|4
4904762|NCT00594568|16897229|P2|Initial Treatment|Physician Decision|2
4904763|NCT00594568|16897230|P1|Initial Treatment|Physician Decision|3
4904764|NCT00594568|16897228|P3|Initial Treatment|Lost to Follow-up|4
4904765|NCT00594568|16897229|P2|Initial Treatment|Lost to Follow-up|1
4904766|NCT00594568|16897230|P1|Initial Treatment|Lost to Follow-up|4
4904767|NCT00594568|16897228|P3|Initial Treatment|Death|15
4904768|NCT00594568|16897229|P2|Initial Treatment|Death|11
4904769|NCT00594568|16897230|P1|Initial Treatment|Death|6
4904770|NCT00594568|16897228|P3|Initial Treatment|Adverse Event|144
4904771|NCT00594568|16897229|P2|Initial Treatment|Adverse Event|121
4904772|NCT00594568|16897230|P1|Initial Treatment|Adverse Event|51
4904773|NCT00594516|16897318|P3|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2
4904774|NCT00594516|16897319|P2|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
4904775|NCT00594516|16897320|P1|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0
4904776|NCT00594516|16897318|P3|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
4904777|NCT00594516|16897319|P2|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1
4904778|NCT00594516|16897320|P1|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0
4904779|NCT00594516|16897318|P3|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2
4904780|NCT00594516|16897319|P2|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3
4904781|NCT00594516|16897320|P1|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0
4904782|NCT00594516|16897318|P3|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
4904783|NCT00594516|16897319|P2|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3
4904784|NCT00594516|16897320|P1|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0
4904785|NCT00594516|16897318|P3|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
4904786|NCT00594516|16897319|P2|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0
4904787|NCT00594516|16897320|P1|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6
4904788|NCT00594516|16897318|P3|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
4904789|NCT00594516|16897319|P2|Open Label (OL): Tapentadol IR|Lack of Efficacy|0
4904790|NCT00594516|16897320|P1|Open Label (OL): Tapentadol IR|Lack of Efficacy|1
4904791|NCT00594516|16897318|P3|Open Label (OL): Tapentadol IR|Adverse Event|0
4904792|NCT00594516|16897319|P2|Open Label (OL): Tapentadol IR|Adverse Event|0
4904793|NCT00594516|16897320|P1|Open Label (OL): Tapentadol IR|Adverse Event|16
4904794|NCT00594516|16897318|P3|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
4904795|NCT00594516|16897319|P2|Open Label (OL): Tapentadol IR|Lost to Follow-up|0
4904796|NCT00594516|16897320|P1|Open Label (OL): Tapentadol IR|Lost to Follow-up|2
4904797|NCT00594516|16897318|P3|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
4904798|NCT00594516|16897319|P2|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0
4904799|NCT00594516|16897320|P1|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4
4904800|NCT00594464|16897328|P1|Overall Study|Delay in operation|2
4904801|NCT00594464|16897328|P1|Overall Study|Withdrawal by Subject|1
4904802|NCT00594399|16897457|P3|Rerandomization Arm 1 Only|Withdrawal by Subject|0
4904803|NCT00594399|16897458|P2|Rerandomization Arm 1 Only|Withdrawal by Subject|3
4904804|NCT00594399|16897459|P1|Rerandomization Arm 1 Only|Withdrawal by Subject|0
4904805|NCT00594399|16897457|P3|Rerandomization Arm 1 Only|Death|0
4904806|NCT00594399|16897458|P2|Rerandomization Arm 1 Only|Death|1
4904807|NCT00594399|16897459|P1|Rerandomization Arm 1 Only|Death|2
4904808|NCT00594399|16897457|P3|Initial 3 Month Counseling|Family illness|0
4904809|NCT00594399|16897458|P2|Initial 3 Month Counseling|Family illness|0
4904810|NCT00594399|16897459|P1|Initial 3 Month Counseling|Family illness|1
4904811|NCT00594399|16897457|P3|Initial 3 Month Counseling|Moved|0
4904812|NCT00594399|16897458|P2|Initial 3 Month Counseling|Moved|0
4904813|NCT00594399|16897459|P1|Initial 3 Month Counseling|Moved|1
4904814|NCT00594399|16897457|P3|Initial 3 Month Counseling|Pain|0
4904815|NCT00594399|16897458|P2|Initial 3 Month Counseling|Pain|0
4904816|NCT00594399|16897459|P1|Initial 3 Month Counseling|Pain|2
4904817|NCT00594399|16897457|P3|Initial 3 Month Counseling|Too busy|0
4904818|NCT00594399|16897458|P2|Initial 3 Month Counseling|Too busy|1
4904819|NCT00594399|16897459|P1|Initial 3 Month Counseling|Too busy|7
4904820|NCT00594399|16897457|P3|Initial 3 Month Counseling|Personal issues|0
4904821|NCT00594399|16897458|P2|Initial 3 Month Counseling|Personal issues|0
4904822|NCT00594399|16897459|P1|Initial 3 Month Counseling|Personal issues|2
4904823|NCT00594399|16897457|P3|Initial 3 Month Counseling|Lack of Interest|0
4904824|NCT00594399|16897458|P2|Initial 3 Month Counseling|Lack of Interest|3
4904825|NCT00594399|16897459|P1|Initial 3 Month Counseling|Lack of Interest|3
4904826|NCT00594399|16897457|P3|Initial 3 Month Counseling|Not ready to exercise|0
4904827|NCT00594399|16897458|P2|Initial 3 Month Counseling|Not ready to exercise|0
4904828|NCT00594399|16897459|P1|Initial 3 Month Counseling|Not ready to exercise|1
4904829|NCT00594386|16897481|P1|Overall Study|Other: Loss of drivers license|1
4904830|NCT00594386|16897481|P1|Overall Study|Other: Patient wants prescription Neupro|1
4904831|NCT00594386|16897481|P1|Overall Study|Other: Site terminated participation|1
4904832|NCT00594386|16897481|P1|Overall Study|Other: Sponsor closure of study|1
4904833|NCT00594386|16897481|P1|Overall Study|Other: Study terminated per investigator|2
4904834|NCT00594386|16897481|P1|Overall Study|Other: Subject admitted to nursing home|1
4904835|NCT00594386|16897481|P1|Overall Study|Other: Subject moved to Seattle|1
4904836|NCT00594386|16897481|P1|Overall Study|Other: Patient went off patch (hospital)|1
4904837|NCT00594386|16897481|P1|Overall Study|Lost to Follow-up|6
4904838|NCT00594386|16897481|P1|Overall Study|Study ended per sponsor|115
4904839|NCT00594386|16897481|P1|Overall Study|Subject withdrew consent|35
4904840|NCT00594386|16897481|P1|Overall Study|Unsatisfactory compliance of subject|11
4904841|NCT00594386|16897481|P1|Overall Study|Adverse Event|68
4904842|NCT00594386|16897481|P1|Overall Study|Lack of Efficacy|12
4904843|NCT00594386|16897481|P1|Overall Study|Major protocol violation|2
4904844|NCT00594204|16897514|P2|Overall Study|Randomized but not treated|1
4904845|NCT00594204|16897515|P1|Overall Study|Randomized but not treated|4
4904846|NCT00594204|16897514|P2|Overall Study|Lack of Efficacy|4
4904847|NCT00594204|16897515|P1|Overall Study|Lack of Efficacy|3
4904848|NCT00594204|16897514|P2|Overall Study|Other|3
4904849|NCT00594204|16897515|P1|Overall Study|Other|4
4904850|NCT00594204|16897514|P2|Overall Study|Withdrawal by Subject|29
4904851|NCT00594204|16897515|P1|Overall Study|Withdrawal by Subject|23
4904852|NCT00594204|16897514|P2|Overall Study|Lost to Follow-up|5
4904853|NCT00594204|16897515|P1|Overall Study|Lost to Follow-up|9
4904854|NCT00594204|16897514|P2|Overall Study|Adverse Event|3
4904855|NCT00594204|16897515|P1|Overall Study|Adverse Event|15
4904856|NCT00594178|16897525|P1|Overall Study|Physician Decision|5
4904857|NCT00594165|16897530|P1|Overall Study|Other: Site terminated participation|2
4904858|NCT00594165|16897530|P1|Overall Study|Other: Subject enrolled in other trial|1
4904859|NCT00594165|16897530|P1|Overall Study|Other: House bound; can't get to clinic|1
4904860|NCT00594165|16897530|P1|Overall Study|Other: Brain surgery controlled symptoms|1
4904861|NCT00594165|16897530|P1|Overall Study|Other: Subject moving|3
4904862|NCT00594165|16897530|P1|Overall Study|Other: PI discretion|5
4904863|NCT00594165|16897530|P1|Overall Study|Lost to Follow-up|4
4904864|NCT00594165|16897530|P1|Overall Study|Study ended per sponsor|102
4904865|NCT00594165|16897530|P1|Overall Study|Subject withdrew consent|27
4904866|NCT00594165|16897530|P1|Overall Study|Unsatisfactory compliance of subject|6
4904867|NCT00594165|16897530|P1|Overall Study|Adverse Event|52
4904868|NCT00594165|16897530|P1|Overall Study|Lack of Efficacy|12
4904869|NCT00594165|16897530|P1|Overall Study|Major protocol violation|1
4904870|NCT00594100|16897536|P1|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4
4904871|NCT00594100|16897536|P1|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6
4904872|NCT00594100|16897536|P1|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2
4904873|NCT00594100|16897536|P1|Procedure|Technical Failure|9
4904874|NCT00594035|16897552|P2|Overall Study|Subject couldn't return due to job|1
4904875|NCT00594035|16897553|P1|Overall Study|Subject couldn't return due to job|0
4904876|NCT00594035|16897552|P2|Overall Study|Subject transferred to nursing home|1
4904877|NCT00594035|16897553|P1|Overall Study|Subject transferred to nursing home|0
4904878|NCT00594035|16897552|P2|Overall Study|Withdrawal by Subject|0
4904879|NCT00594035|16897553|P1|Overall Study|Withdrawal by Subject|1
4904880|NCT00594035|16897552|P2|Overall Study|Lost to Follow-up|1
4904881|NCT00594035|16897553|P1|Overall Study|Lost to Follow-up|1
4904882|NCT00593957|16897583|P3|Overall Study|Physician Decision|2
4904883|NCT00593957|16897584|P2|Overall Study|Physician Decision|1
4904884|NCT00593957|16897585|P1|Overall Study|Physician Decision|0
4904885|NCT00593918|16897609|P2|Overall Study|Withdrawal by Subject|24
4904886|NCT00593918|16897610|P1|Overall Study|Withdrawal by Subject|5
4904887|NCT00593840|16897623|P1|Overall Study|Withdrawal by Subject|1
4904888|NCT00593827|16897635|P2|Overall Study|On Active Treatment/Pending|2
4904889|NCT00593827|16897636|P1|Overall Study|On Active Treatment/Pending|0
4904890|NCT00593814|16897660|P2|Overall Study|Physician Decision|0
4904891|NCT00593814|16897661|P1|Overall Study|Physician Decision|3
4904892|NCT00593814|16897660|P2|Overall Study|Lost to Follow-up|0
4904893|NCT00593814|16897661|P1|Overall Study|Lost to Follow-up|7
4904894|NCT00593814|16897660|P2|Overall Study|Withdrawal by Subject|0
4904895|NCT00593814|16897661|P1|Overall Study|Withdrawal by Subject|7
4904896|NCT00593814|16897660|P2|Overall Study|Death|0
4904897|NCT00593814|16897661|P1|Overall Study|Death|7
4904898|NCT00593736|16897673|P4|Treatment Period and Placebo Run-out|Various|0
4904899|NCT00593736|16897674|P3|Treatment Period and Placebo Run-out|Various|1
4904900|NCT00593736|16897675|P2|Treatment Period and Placebo Run-out|Various|1
4904901|NCT00593736|16897676|P1|Treatment Period and Placebo Run-out|Various|1
4904902|NCT00593736|16897673|P4|Treatment Period and Placebo Run-out|Withdrawal by Subject|3
4904903|NCT00593736|16897674|P3|Treatment Period and Placebo Run-out|Withdrawal by Subject|1
4904904|NCT00593736|16897675|P2|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
4904905|NCT00593736|16897676|P1|Treatment Period and Placebo Run-out|Withdrawal by Subject|0
4904906|NCT00593736|16897673|P4|Treatment Period and Placebo Run-out|Protocol Violation|1
4904907|NCT00593736|16897674|P3|Treatment Period and Placebo Run-out|Protocol Violation|1
4904908|NCT00593736|16897675|P2|Treatment Period and Placebo Run-out|Protocol Violation|0
4904909|NCT00593736|16897676|P1|Treatment Period and Placebo Run-out|Protocol Violation|0
4904910|NCT00593736|16897673|P4|Treatment Period and Placebo Run-out|Lost to Follow-up|0
4904911|NCT00593736|16897674|P3|Treatment Period and Placebo Run-out|Lost to Follow-up|2
4904912|NCT00593736|16897675|P2|Treatment Period and Placebo Run-out|Lost to Follow-up|1
4904913|NCT00593736|16897676|P1|Treatment Period and Placebo Run-out|Lost to Follow-up|2
4904914|NCT00593736|16897673|P4|Screening Period and Placebo Run-in|Various|25
4904915|NCT00593736|16897674|P3|Screening Period and Placebo Run-in|Various|0
4904916|NCT00593736|16897675|P2|Screening Period and Placebo Run-in|Various|0
4904917|NCT00593736|16897676|P1|Screening Period and Placebo Run-in|Various|0
4904918|NCT00593736|16897673|P4|Screening Period and Placebo Run-in|Did Not Meet Criteria|322
4904919|NCT00593736|16897674|P3|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
4904920|NCT00593736|16897675|P2|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
4904921|NCT00593736|16897676|P1|Screening Period and Placebo Run-in|Did Not Meet Criteria|0
4904922|NCT00593736|16897673|P4|Screening Period and Placebo Run-in|Study Termination|15
4904923|NCT00593736|16897674|P3|Screening Period and Placebo Run-in|Study Termination|0
4904924|NCT00593736|16897675|P2|Screening Period and Placebo Run-in|Study Termination|0
4904925|NCT00593736|16897676|P1|Screening Period and Placebo Run-in|Study Termination|0
4904926|NCT00593736|16897673|P4|Screening Period and Placebo Run-in|Withdrawal by Subject|43
4904927|NCT00593736|16897674|P3|Screening Period and Placebo Run-in|Withdrawal by Subject|0
4904928|NCT00593736|16897675|P2|Screening Period and Placebo Run-in|Withdrawal by Subject|0
4904929|NCT00593736|16897676|P1|Screening Period and Placebo Run-in|Withdrawal by Subject|0
4904930|NCT00593736|16897673|P4|Screening Period and Placebo Run-in|Lost to Follow-up|9
4904931|NCT00593736|16897674|P3|Screening Period and Placebo Run-in|Lost to Follow-up|0
4904932|NCT00593736|16897675|P2|Screening Period and Placebo Run-in|Lost to Follow-up|0
4904933|NCT00593736|16897676|P1|Screening Period and Placebo Run-in|Lost to Follow-up|0
4904934|NCT00593736|16897673|P4|Screening Period and Placebo Run-in|Adverse Event|3
4904935|NCT00593736|16897674|P3|Screening Period and Placebo Run-in|Adverse Event|0
4904936|NCT00593736|16897675|P2|Screening Period and Placebo Run-in|Adverse Event|0
4904937|NCT00593736|16897676|P1|Screening Period and Placebo Run-in|Adverse Event|0
4904938|NCT00593684|16897924|P2|Overall Study|Death|1
4904939|NCT00593684|16897925|P1|Overall Study|Death|2
4904940|NCT00593606|16897951|P1|Overall Study|Screen Failure|3
4904941|NCT00593606|16897951|P1|Overall Study|Run-In Failure|5
4904942|NCT00593606|16897951|P1|Overall Study|Lost to Follow-up|2
4904943|NCT00593606|16897951|P1|Overall Study|Protocol Violation|3
4904944|NCT00593606|16897951|P1|Overall Study|Withdrawal by Subject|1
4904945|NCT00593606|16897951|P1|Overall Study|Adverse Event|13
4904946|NCT00593554|16898049|P2|Overall Study|Disease Progression|2
4904947|NCT00593554|16898050|P1|Overall Study|Disease Progression|1
4904948|NCT00593554|16898049|P2|Overall Study|Withdrawal by Subject|0
4904949|NCT00593554|16898050|P1|Overall Study|Withdrawal by Subject|1
4904950|NCT00593554|16898049|P2|Overall Study|Physician Decision|1
4904951|NCT00593554|16898050|P1|Overall Study|Physician Decision|0
4904952|NCT00593554|16898049|P2|Overall Study|Death|2
4904953|NCT00593554|16898050|P1|Overall Study|Death|1
4904954|NCT00593385|16898145|P1|Overall Study|Withdrawal by Subject|9
4904955|NCT00593385|16898145|P1|Overall Study|Lost to Follow-up|17
4904956|NCT00593385|16898145|P1|Overall Study|Death|14
4904957|NCT00593333|16898206|P2|Overall Study|Lost to Follow-up|11
4904958|NCT00593333|16898207|P1|Overall Study|Lost to Follow-up|10
4904959|NCT00593112|16898230|P2|Overall Study|Withdrawal by Subject|0
4904960|NCT00593112|16898231|P1|Overall Study|Withdrawal by Subject|5
4904961|NCT00593112|16898230|P2|Overall Study|Unreadable Scan|0
4904962|NCT00593112|16898231|P1|Overall Study|Unreadable Scan|1
4904963|NCT00593112|16898230|P2|Overall Study|Abnormal Scan|0
4904964|NCT00593112|16898231|P1|Overall Study|Abnormal Scan|1
4904965|NCT00593112|16898230|P2|Overall Study|Scan Anxiety|0
4904966|NCT00593112|16898231|P1|Overall Study|Scan Anxiety|3
4904967|NCT00592904|16898258|P4|Overall Study|Other|0
4904968|NCT00592904|16898259|P3|Overall Study|Other|0
4904969|NCT00592904|16898260|P2|Overall Study|Other|3
4904970|NCT00592904|16898261|P1|Overall Study|Other|3
4904971|NCT00592904|16898258|P4|Overall Study|Physician Decision|0
4904972|NCT00592904|16898259|P3|Overall Study|Physician Decision|1
4904973|NCT00592904|16898260|P2|Overall Study|Physician Decision|3
4904974|NCT00592904|16898261|P1|Overall Study|Physician Decision|0
4904975|NCT00592904|16898258|P4|Overall Study|Lack of Efficacy|3
4904976|NCT00592904|16898259|P3|Overall Study|Lack of Efficacy|2
4904977|NCT00592904|16898260|P2|Overall Study|Lack of Efficacy|7
4904978|NCT00592904|16898261|P1|Overall Study|Lack of Efficacy|2
4904979|NCT00592904|16898258|P4|Overall Study|Withdrawal by Subject|2
4904980|NCT00592904|16898259|P3|Overall Study|Withdrawal by Subject|1
4904981|NCT00592904|16898260|P2|Overall Study|Withdrawal by Subject|16
4904982|NCT00592904|16898261|P1|Overall Study|Withdrawal by Subject|4
4904983|NCT00592904|16898258|P4|Overall Study|Protocol Violation|1
4904984|NCT00592904|16898259|P3|Overall Study|Protocol Violation|0
4904985|NCT00592904|16898260|P2|Overall Study|Protocol Violation|1
4904986|NCT00592904|16898261|P1|Overall Study|Protocol Violation|1
4904987|NCT00592904|16898258|P4|Overall Study|Adverse Event|5
4904988|NCT00592904|16898259|P3|Overall Study|Adverse Event|13
4904989|NCT00592904|16898260|P2|Overall Study|Adverse Event|25
4904990|NCT00592904|16898261|P1|Overall Study|Adverse Event|15
4904991|NCT00592852|16898287|P1|Overall Study|Withdrawal by Subject|1
4904992|NCT00592852|16898287|P1|Overall Study|Found ineligible|1
4904993|NCT00592852|16898287|P1|Overall Study|Adverse Event|3
4904994|NCT00592852|16898287|P1|Overall Study|Non-compliance|1
4904995|NCT00592839|16898295|P3|Overall Study|Lost to Follow-up|1
4904996|NCT00592839|16898296|P2|Overall Study|Lost to Follow-up|1
4904997|NCT00592839|16898297|P1|Overall Study|Lost to Follow-up|0
4904998|NCT00592839|16898295|P3|Overall Study|Adverse Event|0
4904999|NCT00592839|16898296|P2|Overall Study|Adverse Event|1
4905000|NCT00592839|16898297|P1|Overall Study|Adverse Event|0
4905001|NCT00592839|16898295|P3|Overall Study|Protocol Violation|2
4905002|NCT00592839|16898296|P2|Overall Study|Protocol Violation|1
4905003|NCT00592839|16898297|P1|Overall Study|Protocol Violation|1
4905004|NCT00592839|16898295|P3|Overall Study|Withdrawal by Subject|3
4905005|NCT00592839|16898296|P2|Overall Study|Withdrawal by Subject|1
4905006|NCT00592839|16898297|P1|Overall Study|Withdrawal by Subject|1
4905007|NCT00592774|16898325|P5|Overall Study|Other|2
4905008|NCT00592774|16898326|P4|Overall Study|Other|0
4905009|NCT00592774|16898327|P3|Overall Study|Other|1
4905010|NCT00592774|16898328|P2|Overall Study|Other|1
4905011|NCT00592774|16898329|P1|Overall Study|Other|0
4905012|NCT00592774|16898325|P5|Overall Study|Physician Decision|1
4905013|NCT00592774|16898326|P4|Overall Study|Physician Decision|0
4905014|NCT00592774|16898327|P3|Overall Study|Physician Decision|1
4905015|NCT00592774|16898328|P2|Overall Study|Physician Decision|1
4905016|NCT00592774|16898329|P1|Overall Study|Physician Decision|0
4905017|NCT00592774|16898325|P5|Overall Study|Lack of Efficacy|2
4905018|NCT00592774|16898326|P4|Overall Study|Lack of Efficacy|0
4905019|NCT00592774|16898327|P3|Overall Study|Lack of Efficacy|0
4905020|NCT00592774|16898328|P2|Overall Study|Lack of Efficacy|3
4905021|NCT00592774|16898329|P1|Overall Study|Lack of Efficacy|3
4905022|NCT00592774|16898325|P5|Overall Study|Withdrawal by Subject|0
4905023|NCT00592774|16898326|P4|Overall Study|Withdrawal by Subject|0
4905024|NCT00592774|16898327|P3|Overall Study|Withdrawal by Subject|0
4905025|NCT00592774|16898328|P2|Overall Study|Withdrawal by Subject|7
4905026|NCT00592774|16898329|P1|Overall Study|Withdrawal by Subject|3
4905027|NCT00592774|16898325|P5|Overall Study|Protocol Violation|1
4905028|NCT00592774|16898326|P4|Overall Study|Protocol Violation|0
4905029|NCT00592774|16898327|P3|Overall Study|Protocol Violation|0
4905030|NCT00592774|16898328|P2|Overall Study|Protocol Violation|1
4905031|NCT00592774|16898329|P1|Overall Study|Protocol Violation|0
4905032|NCT00592774|16898325|P5|Overall Study|Adverse Event|8
4905033|NCT00592774|16898326|P4|Overall Study|Adverse Event|14
4905034|NCT00592774|16898327|P3|Overall Study|Adverse Event|2
4905035|NCT00592774|16898328|P2|Overall Study|Adverse Event|19
4905036|NCT00592774|16898329|P1|Overall Study|Adverse Event|5
4905037|NCT00592683|16898401|P2|Overall Study|Lost to Follow-up|1
4905038|NCT00592683|16898402|P1|Overall Study|Lost to Follow-up|0
4905039|NCT00592683|16898401|P2|Overall Study|Other|0
4905040|NCT00592683|16898402|P1|Overall Study|Other|1
4905041|NCT00592683|16898401|P2|Overall Study|Study drug expired|0
4905042|NCT00592683|16898402|P1|Overall Study|Study drug expired|1
4905043|NCT00592683|16898401|P2|Overall Study|Protocol Violation|0
4905044|NCT00592683|16898402|P1|Overall Study|Protocol Violation|1
4905045|NCT00592683|16898401|P2|Overall Study|Adverse Event|2
4905046|NCT00592683|16898402|P1|Overall Study|Adverse Event|0
4905047|NCT00592683|16898401|P2|Overall Study|Withdrawal by Subject|0
4905048|NCT00592683|16898402|P1|Overall Study|Withdrawal by Subject|1
4905049|NCT00592683|16898401|P2|Overall Study|Found ineligible|1
4905050|NCT00592683|16898402|P1|Overall Study|Found ineligible|0
4905051|NCT00592631|16898412|P2|Overall Study|Lost to Follow-up|2
4905052|NCT00592631|16898413|P1|Overall Study|Lost to Follow-up|0
4905053|NCT00592553|16898422|P3|Overall Study|Protocol Noncompliance|0
4905054|NCT00592553|16898423|P2|Overall Study|Protocol Noncompliance|0
4905055|NCT00592553|16898424|P1|Overall Study|Protocol Noncompliance|1
4905056|NCT00592384|16898541|P2|Overall Study|Withdrawal by Subject|6
4905057|NCT00592384|16898542|P1|Overall Study|Withdrawal by Subject|5
4905058|NCT00592358|16898550|P1|Overall Study|Inability to swallow pills|1
4905059|NCT00592358|16898550|P1|Overall Study|Lack of Efficacy|2
4905060|NCT00592358|16898550|P1|Overall Study|Adverse Event|1
4905061|NCT00592358|16898550|P1|Overall Study|Withdrawal by Subject|2
4905062|NCT00592319|16898557|P2|Overall Study|Lost to Follow-up|3
4905063|NCT00592319|16898558|P1|Overall Study|Lost to Follow-up|0
4905064|NCT00592072|16898633|P2|Wash Out Period|Lost to Follow-up|1
4905065|NCT00592072|16898634|P1|Wash Out Period|Lost to Follow-up|1
4905066|NCT00592007|16898656|P1|Overall Study|patient ineligible (out of lab range)|1
4905067|NCT00592007|16898656|P1|Overall Study|Withdrawal by Subject|1
4905068|NCT00591864|16898668|P1|Overall Study|Incomplete Imaging|5
4905069|NCT00591851|16898674|P1|Overall Study|Progressive Disease|1
4905070|NCT00591851|16898674|P1|Overall Study|Adverse Event|2
4905071|NCT00591851|16898674|P1|Overall Study|Withdrawal by Subject|3
4905072|NCT00591838|16898683|P5|Overall Study|Withdrawal by Subject|0
4905073|NCT00591838|16898684|P4|Overall Study|Withdrawal by Subject|1
4905074|NCT00591838|16898685|P3|Overall Study|Withdrawal by Subject|0
4905075|NCT00591838|16898686|P2|Overall Study|Withdrawal by Subject|0
4905076|NCT00591838|16898687|P1|Overall Study|Withdrawal by Subject|0
4905077|NCT00591786|16898751|P10|Overall Study|Withdrawal of Informed Consent|0
4905078|NCT00591786|16898752|P9|Overall Study|Withdrawal of Informed Consent|0
4905079|NCT00591786|16898753|P8|Overall Study|Withdrawal of Informed Consent|0
4905080|NCT00591786|16898754|P7|Overall Study|Withdrawal of Informed Consent|0
4905081|NCT00591786|16898755|P6|Overall Study|Withdrawal of Informed Consent|0
4905082|NCT00591786|16898756|P5|Overall Study|Withdrawal of Informed Consent|0
4905083|NCT00591786|16898757|P4|Overall Study|Withdrawal of Informed Consent|0
4905084|NCT00591786|16898758|P3|Overall Study|Withdrawal of Informed Consent|1
4905085|NCT00591786|16898759|P2|Overall Study|Withdrawal of Informed Consent|0
4905086|NCT00591786|16898760|P1|Overall Study|Withdrawal of Informed Consent|0
4905087|NCT00591773|16898805|P3|Overall Study|Other|4
4905088|NCT00591773|16898806|P2|Overall Study|Other|1
4905089|NCT00591773|16898807|P1|Overall Study|Other|1
4905090|NCT00591773|16898805|P3|Overall Study|Lack of Efficacy|2
4905091|NCT00591773|16898806|P2|Overall Study|Lack of Efficacy|2
4905092|NCT00591773|16898807|P1|Overall Study|Lack of Efficacy|1
4905093|NCT00591773|16898805|P3|Overall Study|Withdrawal by Subject|3
4905094|NCT00591773|16898806|P2|Overall Study|Withdrawal by Subject|5
4905095|NCT00591773|16898807|P1|Overall Study|Withdrawal by Subject|2
4905096|NCT00591773|16898805|P3|Overall Study|Lost to Follow-up|1
4905097|NCT00591773|16898806|P2|Overall Study|Lost to Follow-up|4
4905098|NCT00591773|16898807|P1|Overall Study|Lost to Follow-up|1
4905099|NCT00591773|16898805|P3|Overall Study|Protocol Violation|0
4905100|NCT00591773|16898806|P2|Overall Study|Protocol Violation|3
4905101|NCT00591773|16898807|P1|Overall Study|Protocol Violation|2
4905102|NCT00591773|16898805|P3|Overall Study|Adverse Event|6
4905103|NCT00591773|16898806|P2|Overall Study|Adverse Event|9
4905104|NCT00591773|16898807|P1|Overall Study|Adverse Event|9
4905105|NCT00591734|16898866|P1|Overall Study|Intercurrent Illness|8
4905106|NCT00591734|16898866|P1|Overall Study|Physician Decision|5
4905107|NCT00591734|16898866|P1|Overall Study|Adverse Event|5
4905108|NCT00591734|16898866|P1|Overall Study|Lack of Efficacy|35
4905109|NCT00591721|16898872|P2|Overall Study|Intervention not received|8
4905110|NCT00591721|16898873|P1|Overall Study|Intervention not received|10
4905111|NCT00591721|16898872|P2|Overall Study|Lost to Follow-up|4
4905112|NCT00591721|16898873|P1|Overall Study|Lost to Follow-up|1
4905113|NCT00591721|16898872|P2|Overall Study|Withdrawal by Subject|10
4905114|NCT00591721|16898873|P1|Overall Study|Withdrawal by Subject|10
4905115|NCT00591591|16898881|P2|Overall Study|Lack of Efficacy|2
4905116|NCT00591591|16898882|P1|Overall Study|Lack of Efficacy|10
4905117|NCT00591591|16898881|P2|Overall Study|Withdrawal by Subject|37
4905118|NCT00591591|16898882|P1|Overall Study|Withdrawal by Subject|1
4905119|NCT00591578|16898899|P3|Open-Label Extension Phase|Other|0
4905120|NCT00591578|16898900|P2|Open-Label Extension Phase|Other|0
4905121|NCT00591578|16898901|P1|Open-Label Extension Phase|Other|1
4905122|NCT00591578|16898899|P3|Open-Label Extension Phase|Withdrawal by Subject|0
4905123|NCT00591578|16898900|P2|Open-Label Extension Phase|Withdrawal by Subject|1
4905124|NCT00591578|16898901|P1|Open-Label Extension Phase|Withdrawal by Subject|1
4905125|NCT00591578|16898899|P3|Open-Label Extension Phase|Lost to Follow-up|0
4905126|NCT00591578|16898900|P2|Open-Label Extension Phase|Lost to Follow-up|4
4905127|NCT00591578|16898901|P1|Open-Label Extension Phase|Lost to Follow-up|1
4905128|NCT00591578|16898899|P3|Open-Label Extension Phase|Adverse Event|0
4905129|NCT00591578|16898900|P2|Open-Label Extension Phase|Adverse Event|5
4905130|NCT00591578|16898901|P1|Open-Label Extension Phase|Adverse Event|3
4905131|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Other|4
4905132|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Other|9
4905133|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Other|4
4905134|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Lack of Efficacy|25
4905135|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Lack of Efficacy|9
4905136|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Lack of Efficacy|16
4905137|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Pregnancy|0
4905138|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Pregnancy|0
4905139|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Pregnancy|1
4905140|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Withdrawal by Subject|22
4905141|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Withdrawal by Subject|22
4905142|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Withdrawal by Subject|22
4905143|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Lost to Follow-up|11
4905144|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Lost to Follow-up|12
4905145|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Lost to Follow-up|12
4905146|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Protocol Violation|3
4905147|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Protocol Violation|2
4905148|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Protocol Violation|3
4905149|NCT00591578|16898899|P3|Double-Blind Treatment Phase|Adverse Event|19
4905150|NCT00591578|16898900|P2|Double-Blind Treatment Phase|Adverse Event|26
4905151|NCT00591578|16898901|P1|Double-Blind Treatment Phase|Adverse Event|20
4905152|NCT00591565|16898952|P1|Overall Study|lost follow up, withdrawn|5
4905153|NCT00591409|16898966|P10|Overall Study|Not Treated|1
4905154|NCT00591409|16898967|P9|Overall Study|Not Treated|0
4905155|NCT00591409|16898968|P8|Overall Study|Not Treated|0
4905156|NCT00591409|16898969|P7|Overall Study|Not Treated|0
4905157|NCT00591409|16898970|P6|Overall Study|Not Treated|0
4905158|NCT00591409|16898971|P5|Overall Study|Not Treated|1
4905159|NCT00591409|16898972|P4|Overall Study|Not Treated|0
4905160|NCT00591409|16898973|P3|Overall Study|Not Treated|0
4905161|NCT00591409|16898974|P2|Overall Study|Not Treated|0
4905162|NCT00591409|16898975|P1|Overall Study|Not Treated|0
4905163|NCT00591370|16899017|P1|Overall Study|Not Treated|2
4905164|NCT00591344|16899025|P2|Overall Study|Did not want to come off medication|1
4905165|NCT00591344|16899026|P1|Overall Study|Did not want to come off medication|0
4905166|NCT00591344|16899025|P2|Overall Study|Lost to Follow-up|1
4905167|NCT00591344|16899026|P1|Overall Study|Lost to Follow-up|0
4905168|NCT00591344|16899025|P2|Overall Study|Death|1
4905169|NCT00591344|16899026|P1|Overall Study|Death|0
4905170|NCT00591344|16899025|P2|Overall Study|Underwent DBS|2
4905171|NCT00591344|16899026|P1|Overall Study|Underwent DBS|2
4905172|NCT00591344|16899025|P2|Overall Study|Medical complications|3
4905173|NCT00591344|16899026|P1|Overall Study|Medical complications|1
4905174|NCT00591344|16899025|P2|Overall Study|Moved out of state|0
4905175|NCT00591344|16899026|P1|Overall Study|Moved out of state|1
4905176|NCT00591344|16899025|P2|Overall Study|Transportation issues|0
4905177|NCT00591344|16899026|P1|Overall Study|Transportation issues|1
4905178|NCT00591266|16899052|P3|Overall Study|Other|5
4905179|NCT00591266|16899053|P2|Overall Study|Other|4
4905180|NCT00591266|16899054|P1|Overall Study|Other|1
4905181|NCT00591266|16899052|P3|Overall Study|Lack of Efficacy|0
4905182|NCT00591266|16899053|P2|Overall Study|Lack of Efficacy|2
4905183|NCT00591266|16899054|P1|Overall Study|Lack of Efficacy|0
4905184|NCT00591266|16899052|P3|Overall Study|Withdrawal by Subject|5
4905185|NCT00591266|16899053|P2|Overall Study|Withdrawal by Subject|2
4905186|NCT00591266|16899054|P1|Overall Study|Withdrawal by Subject|6
4905187|NCT00591266|16899052|P3|Overall Study|Protocol Violation|1
4905188|NCT00591266|16899053|P2|Overall Study|Protocol Violation|0
4905189|NCT00591266|16899054|P1|Overall Study|Protocol Violation|0
4905190|NCT00591266|16899052|P3|Overall Study|Lost to Follow-up|0
4905191|NCT00591266|16899053|P2|Overall Study|Lost to Follow-up|1
4905192|NCT00591266|16899054|P1|Overall Study|Lost to Follow-up|0
4905193|NCT00591266|16899052|P3|Overall Study|Adverse Event|3
4905194|NCT00591266|16899053|P2|Overall Study|Adverse Event|2
4905195|NCT00591266|16899054|P1|Overall Study|Adverse Event|2
4905196|NCT00591253|16899107|P3|Overall Study|Other|3
4905197|NCT00591253|16899108|P2|Overall Study|Other|5
4905198|NCT00591253|16899109|P1|Overall Study|Other|5
4905199|NCT00591253|16899107|P3|Overall Study|Lack of Efficacy|3
4905200|NCT00591253|16899108|P2|Overall Study|Lack of Efficacy|0
4905201|NCT00591253|16899109|P1|Overall Study|Lack of Efficacy|1
4905202|NCT00591253|16899107|P3|Overall Study|Withdrawal by Subject|6
4905203|NCT00591253|16899108|P2|Overall Study|Withdrawal by Subject|7
4905204|NCT00591253|16899109|P1|Overall Study|Withdrawal by Subject|1
4905205|NCT00591253|16899107|P3|Overall Study|Lost to Follow-up|0
4905206|NCT00591253|16899108|P2|Overall Study|Lost to Follow-up|4
4905207|NCT00591253|16899109|P1|Overall Study|Lost to Follow-up|2
4905208|NCT00591253|16899107|P3|Overall Study|Protocol Violation|2
4905209|NCT00591253|16899108|P2|Overall Study|Protocol Violation|2
4905210|NCT00591253|16899109|P1|Overall Study|Protocol Violation|2
4905211|NCT00591253|16899107|P3|Overall Study|Adverse Event|1
4905212|NCT00591253|16899108|P2|Overall Study|Adverse Event|3
4905213|NCT00591253|16899109|P1|Overall Study|Adverse Event|3
4905214|NCT00591214|16899177|P1|Overall Study|Withdrawal by Subject|1
4905215|NCT00591214|16899177|P1|Overall Study|Physician Decision|7
4905216|NCT00591149|16899186|P1|Overall Study|Withdrawal by Subject|1
4905217|NCT00591149|16899186|P1|Overall Study|Adverse Event|4
4905218|NCT00591006|16899202|P24|Overall Study|Adverse Event|0
4905219|NCT00591006|16899203|P23|Overall Study|Adverse Event|1
4905220|NCT00591006|16899204|P22|Overall Study|Adverse Event|0
4905221|NCT00591006|16899205|P21|Overall Study|Adverse Event|0
4905222|NCT00591006|16899206|P20|Overall Study|Adverse Event|0
4905223|NCT00591006|16899207|P19|Overall Study|Adverse Event|0
4905224|NCT00591006|16899208|P18|Overall Study|Adverse Event|0
4905225|NCT00591006|16899209|P17|Overall Study|Adverse Event|0
4905226|NCT00591006|16899210|P16|Overall Study|Adverse Event|0
4905227|NCT00591006|16899211|P15|Overall Study|Adverse Event|0
4905228|NCT00591006|16899212|P14|Overall Study|Adverse Event|0
4905229|NCT00591006|16899213|P13|Overall Study|Adverse Event|0
4905230|NCT00591006|16899214|P12|Overall Study|Adverse Event|0
4905231|NCT00591006|16899215|P11|Overall Study|Adverse Event|0
4905232|NCT00591006|16899216|P10|Overall Study|Adverse Event|0
4905233|NCT00591006|16899217|P9|Overall Study|Adverse Event|0
4905234|NCT00591006|16899218|P8|Overall Study|Adverse Event|0
4905235|NCT00591006|16899219|P7|Overall Study|Adverse Event|0
4905236|NCT00591006|16899220|P6|Overall Study|Adverse Event|0
4905237|NCT00591006|16899221|P5|Overall Study|Adverse Event|0
4905238|NCT00591006|16899222|P4|Overall Study|Adverse Event|0
4905239|NCT00591006|16899223|P3|Overall Study|Adverse Event|0
4905240|NCT00591006|16899224|P2|Overall Study|Adverse Event|0
4905241|NCT00591006|16899225|P1|Overall Study|Adverse Event|0
4905242|NCT00591006|16899202|P24|Overall Study|Withdrawal by Subject|1
4905243|NCT00591006|16899203|P23|Overall Study|Withdrawal by Subject|0
4905244|NCT00591006|16899204|P22|Overall Study|Withdrawal by Subject|0
4905245|NCT00591006|16899205|P21|Overall Study|Withdrawal by Subject|0
4905246|NCT00591006|16899206|P20|Overall Study|Withdrawal by Subject|0
4905247|NCT00591006|16899207|P19|Overall Study|Withdrawal by Subject|0
4905248|NCT00591006|16899208|P18|Overall Study|Withdrawal by Subject|0
4905249|NCT00591006|16899209|P17|Overall Study|Withdrawal by Subject|0
4905250|NCT00591006|16899210|P16|Overall Study|Withdrawal by Subject|1
4905251|NCT00591006|16899211|P15|Overall Study|Withdrawal by Subject|0
4905252|NCT00591006|16899212|P14|Overall Study|Withdrawal by Subject|0
4905253|NCT00591006|16899213|P13|Overall Study|Withdrawal by Subject|0
4905254|NCT00591006|16899214|P12|Overall Study|Withdrawal by Subject|0
4905255|NCT00591006|16899215|P11|Overall Study|Withdrawal by Subject|0
4905256|NCT00591006|16899216|P10|Overall Study|Withdrawal by Subject|0
4905257|NCT00591006|16899217|P9|Overall Study|Withdrawal by Subject|0
4905258|NCT00591006|16899218|P8|Overall Study|Withdrawal by Subject|0
4905259|NCT00591006|16899219|P7|Overall Study|Withdrawal by Subject|0
4905260|NCT00591006|16899220|P6|Overall Study|Withdrawal by Subject|0
4905261|NCT00591006|16899221|P5|Overall Study|Withdrawal by Subject|0
4905262|NCT00591006|16899222|P4|Overall Study|Withdrawal by Subject|0
4905263|NCT00591006|16899223|P3|Overall Study|Withdrawal by Subject|0
4905264|NCT00591006|16899224|P2|Overall Study|Withdrawal by Subject|0
4905265|NCT00591006|16899225|P1|Overall Study|Withdrawal by Subject|0
4905266|NCT00590980|16899243|P1|Overall Study|Did not meet all inclusion criteria|10
4905267|NCT00590967|16899249|P2|Overall Study|Did not receive chemo per protocol|0
4905268|NCT00590967|16899250|P1|Overall Study|Did not receive chemo per protocol|1
4905269|NCT00590967|16899249|P2|Overall Study|Did not sign consent form|1
4905270|NCT00590967|16899250|P1|Overall Study|Did not sign consent form|0
4905271|NCT00590967|16899249|P2|Overall Study|Non-compliant|2
4905272|NCT00590967|16899250|P1|Overall Study|Non-compliant|0
4905273|NCT00590967|16899249|P2|Overall Study|Poor performance status|1
4905274|NCT00590967|16899250|P1|Overall Study|Poor performance status|0
4905275|NCT00590967|16899249|P2|Overall Study|Ineligible|0
4905276|NCT00590967|16899250|P1|Overall Study|Ineligible|1
4905277|NCT00590967|16899249|P2|Overall Study|Withdrawal by Subject|1
4905278|NCT00590967|16899250|P1|Overall Study|Withdrawal by Subject|1
4905279|NCT00590954|16899262|P1|Overall Study|Inevaluable|2
4905280|NCT00590902|16899268|P1|Overall Study|Death|1
4905281|NCT00590824|16899301|P4|Overall Study|Adverse Event|1
4905282|NCT00590824|16899302|P3|Overall Study|Adverse Event|0
4905283|NCT00590824|16899303|P2|Overall Study|Adverse Event|0
4905284|NCT00590824|16899304|P1|Overall Study|Adverse Event|0
4905285|NCT00590824|16899301|P4|Overall Study|Disease could not be resected|0
4905286|NCT00590824|16899302|P3|Overall Study|Disease could not be resected|1
4905287|NCT00590824|16899303|P2|Overall Study|Disease could not be resected|2
4905288|NCT00590824|16899304|P1|Overall Study|Disease could not be resected|0
4905289|NCT00590759|16899330|P1|Overall Study|Lost to Follow-up|28
4905290|NCT00590759|16899330|P1|Overall Study|Death|52
4905291|NCT00590720|16899337|P2|Overall Study|Withdrawal by Subject|1
4905292|NCT00590720|16899338|P1|Overall Study|Withdrawal by Subject|0
4905293|NCT00590720|16899337|P2|Overall Study|Lost to Follow-up|0
4905294|NCT00590720|16899338|P1|Overall Study|Lost to Follow-up|1
4905295|NCT00590590|16899400|P3|Overall Study|Did not complete study|0
4905296|NCT00590590|16899401|P2|Overall Study|Did not complete study|1
4905297|NCT00590590|16899402|P1|Overall Study|Did not complete study|0
4905298|NCT00590590|16899400|P3|Overall Study|Did not complete due to study closure|1
4905299|NCT00590590|16899401|P2|Overall Study|Did not complete due to study closure|1
4905300|NCT00590590|16899402|P1|Overall Study|Did not complete due to study closure|1
4905301|NCT00590590|16899400|P3|Overall Study|Withdrawal by Subject|1
4905302|NCT00590590|16899401|P2|Overall Study|Withdrawal by Subject|1
4905303|NCT00590590|16899402|P1|Overall Study|Withdrawal by Subject|0
4905304|NCT00590590|16899400|P3|Overall Study|Lost to Follow-up|2
4905305|NCT00590590|16899401|P2|Overall Study|Lost to Follow-up|1
4905306|NCT00590590|16899402|P1|Overall Study|Lost to Follow-up|4
4905307|NCT00590590|16899400|P3|Overall Study|Protocol Violation|2
4905308|NCT00590590|16899401|P2|Overall Study|Protocol Violation|0
4905309|NCT00590590|16899402|P1|Overall Study|Protocol Violation|0
4905310|NCT00590590|16899400|P3|Overall Study|Adverse Event|0
4905311|NCT00590590|16899401|P2|Overall Study|Adverse Event|0
4905312|NCT00590590|16899402|P1|Overall Study|Adverse Event|1
4905313|NCT00590590|16899400|P3|Overall Study|Lack of Efficacy|0
4905314|NCT00590590|16899401|P2|Overall Study|Lack of Efficacy|2
4905315|NCT00590590|16899402|P1|Overall Study|Lack of Efficacy|1
4905316|NCT00590577|16899429|P4|Overall Study|Various reasons|2
4905317|NCT00590577|16899430|P3|Overall Study|Various reasons|1
4905318|NCT00590577|16899431|P2|Overall Study|Various reasons|3
4905319|NCT00590577|16899432|P1|Overall Study|Various reasons|1
4905320|NCT00590577|16899429|P4|Overall Study|Pregnancy|0
4905321|NCT00590577|16899430|P3|Overall Study|Pregnancy|0
4905322|NCT00590577|16899431|P2|Overall Study|Pregnancy|1
4905323|NCT00590577|16899432|P1|Overall Study|Pregnancy|0
4905324|NCT00590577|16899429|P4|Overall Study|Lost to Follow-up|9
4905325|NCT00590577|16899430|P3|Overall Study|Lost to Follow-up|6
4905326|NCT00590577|16899431|P2|Overall Study|Lost to Follow-up|6
4905327|NCT00590577|16899432|P1|Overall Study|Lost to Follow-up|12
4905328|NCT00590577|16899429|P4|Overall Study|Adverse Event|11
4905329|NCT00590577|16899430|P3|Overall Study|Adverse Event|13
4905330|NCT00590577|16899431|P2|Overall Study|Adverse Event|10
4905331|NCT00590577|16899432|P1|Overall Study|Adverse Event|10
4905332|NCT00590577|16899429|P4|Overall Study|Withdrawal by Subject|26
4905333|NCT00590577|16899430|P3|Overall Study|Withdrawal by Subject|30
4905334|NCT00590577|16899431|P2|Overall Study|Withdrawal by Subject|28
4905335|NCT00590577|16899432|P1|Overall Study|Withdrawal by Subject|23
4905336|NCT00590577|16899429|P4|Overall Study|Lack of Efficacy|45
4905337|NCT00590577|16899430|P3|Overall Study|Lack of Efficacy|23
4905338|NCT00590577|16899431|P2|Overall Study|Lack of Efficacy|28
4905339|NCT00590577|16899432|P1|Overall Study|Lack of Efficacy|31
4905340|NCT00590564|16899450|P1|Overall Study|Patient Non-compliance|6
4905341|NCT00590564|16899450|P1|Overall Study|Patient Found to be Ineligible|1
4905342|NCT00590564|16899450|P1|Overall Study|Protocol Violation|1
4905343|NCT00590564|16899450|P1|Overall Study|Lost to Follow-up|6
4905344|NCT00590564|16899450|P1|Overall Study|Withdrawal by Subject|4
4905345|NCT00590538|16899454|P1|Overall Study|Study terminated before completed|2
4905346|NCT00590317|16899500|P2|Overall Study|Lack of Efficacy|5
4905347|NCT00590317|16899501|P1|Overall Study|Lack of Efficacy|1
4905348|NCT00590135|16899531|P1|Overall Study|Primary endpoint measure not obtainable|59
4905349|NCT00590044|16899541|P2|Overall Study|Protocol Violation|0
4905350|NCT00590044|16899542|P1|Overall Study|Protocol Violation|1
4905351|NCT00590044|16899541|P2|Overall Study|wrong insulin arm assigned|0
4905352|NCT00590044|16899542|P1|Overall Study|wrong insulin arm assigned|1
4905353|NCT00590044|16899541|P2|Overall Study|Withdrawal by Subject|2
4905354|NCT00590044|16899542|P1|Overall Study|Withdrawal by Subject|2
4905355|NCT00590031|16899554|P1|Overall Study|Admin Hold|1
4905356|NCT00590031|16899554|P1|Overall Study|Metastatic Disease|1
4905357|NCT00590031|16899554|P1|Overall Study|Withdrawal by Subject|1
4905358|NCT00590031|16899554|P1|Overall Study|Adverse Event|3
4905359|NCT00589979|16899581|P3|Double-Blind Treatment Period 3|Withdrawal by Subject|1
4905360|NCT00589979|16899582|P2|Double-Blind Treatment Period 3|Withdrawal by Subject|0
4905361|NCT00589979|16899583|P1|Double-Blind Treatment Period 3|Withdrawal by Subject|0
4905362|NCT00589979|16899581|P3|Double-Blind Treatment Period 3|Protocol Violation|0
4905363|NCT00589979|16899582|P2|Double-Blind Treatment Period 3|Protocol Violation|1
4905364|NCT00589979|16899583|P1|Double-Blind Treatment Period 3|Protocol Violation|0
4905365|NCT00589979|16899581|P3|Double-Blind Treatment Period 2|Other|1
4905366|NCT00589979|16899582|P2|Double-Blind Treatment Period 2|Other|0
4905367|NCT00589979|16899583|P1|Double-Blind Treatment Period 2|Other|0
4905368|NCT00589979|16899581|P3|Double-Blind Treatment Period 2|Withdrawal by Subject|1
4905369|NCT00589979|16899582|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|0
4905370|NCT00589979|16899583|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
4905371|NCT00589979|16899581|P3|Double-Blind Treatment Period 2|Adverse Event|0
4905372|NCT00589979|16899582|P2|Double-Blind Treatment Period 2|Adverse Event|1
4905373|NCT00589979|16899583|P1|Double-Blind Treatment Period 2|Adverse Event|0
4905374|NCT00589979|16899581|P3|Double-Blind Treatment Period 1|Withdrawal by Subject|1
4905375|NCT00589979|16899582|P2|Double-Blind Treatment Period 1|Withdrawal by Subject|0
4905376|NCT00589979|16899583|P1|Double-Blind Treatment Period 1|Withdrawal by Subject|0
4905377|NCT00589979|16899581|P3|Double-Blind Treatment Period 1|Protocol Violation|1
4905378|NCT00589979|16899582|P2|Double-Blind Treatment Period 1|Protocol Violation|1
4905379|NCT00589979|16899583|P1|Double-Blind Treatment Period 1|Protocol Violation|0
4905380|NCT00589979|16899581|P3|Double-Blind Treatment Period 1|Adverse Event|0
4905381|NCT00589979|16899582|P2|Double-Blind Treatment Period 1|Adverse Event|1
4905382|NCT00589979|16899583|P1|Double-Blind Treatment Period 1|Adverse Event|0
4905383|NCT00589979|16899581|P3|Run-In Period|Informed Consent Withdrawn|0
4905384|NCT00589979|16899582|P2|Run-In Period|Informed Consent Withdrawn|0
4905385|NCT00589979|16899583|P1|Run-In Period|Informed Consent Withdrawn|4
4905386|NCT00589979|16899581|P3|Run-In Period|Withdrawal by Subject|0
4905387|NCT00589979|16899582|P2|Run-In Period|Withdrawal by Subject|0
4905388|NCT00589979|16899583|P1|Run-In Period|Withdrawal by Subject|10
4905389|NCT00589979|16899581|P3|Run-In Period|Did not qualify for randomization|0
4905390|NCT00589979|16899582|P2|Run-In Period|Did not qualify for randomization|0
4905391|NCT00589979|16899583|P1|Run-In Period|Did not qualify for randomization|54
4905392|NCT00589979|16899581|P3|Run-In Period|Protocol Violation|0
4905393|NCT00589979|16899582|P2|Run-In Period|Protocol Violation|0
4905394|NCT00589979|16899583|P1|Run-In Period|Protocol Violation|3
4905395|NCT00589979|16899581|P3|Run-In Period|Adverse Event|0
4905396|NCT00589979|16899582|P2|Run-In Period|Adverse Event|0
4905397|NCT00589979|16899583|P1|Run-In Period|Adverse Event|5
4905398|NCT00589914|16899622|P2|Overall Study|Other|17
4905399|NCT00589914|16899623|P1|Overall Study|Other|22
4905400|NCT00589914|16899622|P2|Overall Study|Withdrawal by Subject|49
4905401|NCT00589914|16899623|P1|Overall Study|Withdrawal by Subject|55
4905402|NCT00589914|16899622|P2|Overall Study|Pregnancy|0
4905403|NCT00589914|16899623|P1|Overall Study|Pregnancy|1
4905404|NCT00589914|16899622|P2|Overall Study|Lost to Follow-up|18
4905405|NCT00589914|16899623|P1|Overall Study|Lost to Follow-up|11
4905406|NCT00589914|16899622|P2|Overall Study|Lack of Efficacy|43
4905407|NCT00589914|16899623|P1|Overall Study|Lack of Efficacy|40
4905408|NCT00589914|16899622|P2|Overall Study|Death|0
4905409|NCT00589914|16899623|P1|Overall Study|Death|2
4905410|NCT00589914|16899622|P2|Overall Study|Adverse Event|10
4905411|NCT00589914|16899623|P1|Overall Study|Adverse Event|19
4905412|NCT00589797|16899679|P2|Overall Study|Non-Randomized Training Subjects|6
4905413|NCT00589797|16899680|P1|Overall Study|Non-Randomized Training Subjects|46
4905414|NCT00589797|16899679|P2|Overall Study|Withdrawal by Subject|5
4905415|NCT00589797|16899680|P1|Overall Study|Withdrawal by Subject|6
4905416|NCT00589797|16899679|P2|Overall Study|Physician Decision|3
4905417|NCT00589797|16899680|P1|Overall Study|Physician Decision|8
4905418|NCT00589797|16899679|P2|Overall Study|Lost to Follow-up|9
4905419|NCT00589797|16899680|P1|Overall Study|Lost to Follow-up|12
4905420|NCT00589797|16899679|P2|Overall Study|Death|0
4905421|NCT00589797|16899680|P1|Overall Study|Death|1
4905422|NCT00589784|16899704|P2|Overall Study|Adverse Event|4
4905423|NCT00589784|16899705|P1|Overall Study|Adverse Event|0
4905424|NCT00589784|16899704|P2|Overall Study|Patient inevaluable|0
4905425|NCT00589784|16899705|P1|Overall Study|Patient inevaluable|1
4905426|NCT00589784|16899704|P2|Overall Study|Withdrawal by Subject|6
4905427|NCT00589784|16899705|P1|Overall Study|Withdrawal by Subject|0
4905428|NCT00589693|16899712|P2|Overall Study|Protocol Violation|1
4905429|NCT00589693|16899713|P1|Overall Study|Protocol Violation|1
4905430|NCT00589693|16899712|P2|Overall Study|Physician Decision|1
4905431|NCT00589693|16899713|P1|Overall Study|Physician Decision|0
4905432|NCT00589693|16899712|P2|Overall Study|Lost to Follow-up|0
4905433|NCT00589693|16899713|P1|Overall Study|Lost to Follow-up|1
4905434|NCT00589693|16899712|P2|Overall Study|Lack of Efficacy|1
4905435|NCT00589693|16899713|P1|Overall Study|Lack of Efficacy|0
4905436|NCT00589693|16899712|P2|Overall Study|Death|16
4905437|NCT00589693|16899713|P1|Overall Study|Death|26
4905438|NCT00589693|16899712|P2|Overall Study|Adverse Event|4
4905439|NCT00589693|16899713|P1|Overall Study|Adverse Event|4
4905440|NCT00589693|16899712|P2|Overall Study|randomized in error|6
4905441|NCT00589693|16899713|P1|Overall Study|randomized in error|12
4905442|NCT00589667|16899727|P1|Overall Study|Withdrawal by Subject|1
4905443|NCT00589667|16899727|P1|Overall Study|Adverse Event|2
4905444|NCT00589628|16899734|P2|Overall Study|Lost to Follow-up|1
4905445|NCT00589628|16899735|P1|Overall Study|Lost to Follow-up|0
4905446|NCT00589602|16899741|P1|Overall Study|Did not collect enough CD34+ cells|1
4905447|NCT00589472|16899776|P1|Overall Study|Adverse Event|1
4905448|NCT00589303|16899799|P2|Overall Study|Withdrawal by Subject|1
4905449|NCT00589303|16899800|P1|Overall Study|Withdrawal by Subject|2
4905450|NCT00589290|16899806|P1|Overall Study|Withdrawal by Subject|1
4905451|NCT00589121|16899829|P2|Overall Study|No protocol treatment received|1
4905452|NCT00589121|16899830|P1|Overall Study|No protocol treatment received|0
4905453|NCT00589121|16899829|P2|Overall Study|Protocol Violation|6
4905454|NCT00589121|16899830|P1|Overall Study|Protocol Violation|2
4905455|NCT00589108|16899852|P3|Overall Study|Death|4
4905456|NCT00589108|16899853|P2|Overall Study|Death|3
4905457|NCT00589108|16899854|P1|Overall Study|Death|3
4905458|NCT00589108|16899852|P3|Overall Study|Lost to Follow-up|1
4905459|NCT00589108|16899853|P2|Overall Study|Lost to Follow-up|1
4905460|NCT00589108|16899854|P1|Overall Study|Lost to Follow-up|1
4905461|NCT00588952|16899890|P2|Overall Study|Withdrawal by Subject|5
4905462|NCT00588952|16899891|P1|Overall Study|Withdrawal by Subject|3
4905463|NCT00588952|16899890|P2|Overall Study|Adverse Event|2
4905464|NCT00588952|16899891|P1|Overall Study|Adverse Event|0
4905465|NCT00588861|16899919|P2|10 Years|Incomplete due to study termination|114
4905466|NCT00588861|16899920|P1|10 Years|Incomplete due to study termination|107
4905467|NCT00588861|16899919|P2|8 Years|Patients did not return for follow-up|114
4905468|NCT00588861|16899920|P1|8 Years|Patients did not return for follow-up|105
4905469|NCT00588861|16899919|P2|6 Years|Patients did not return for follow-up|109
4905470|NCT00588861|16899920|P1|6 Years|Patients did not return for follow-up|104
4905471|NCT00588861|16899919|P2|4 Years|Patients did not return for follow-up|103
4905472|NCT00588861|16899920|P1|4 Years|Patients did not return for follow-up|91
4905473|NCT00588861|16899919|P2|2 Years|Patients did not return for follow-up|87
4905474|NCT00588861|16899920|P1|2 Years|Patients did not return for follow-up|92
4905475|NCT00588861|16899919|P2|1 Year|Patients did not return for follow-up|82
4905476|NCT00588861|16899920|P1|1 Year|Patients did not return for follow-up|89
4905477|NCT00588861|16899919|P2|6 Months|Patients did not return for follow-up|73
4905478|NCT00588861|16899920|P1|6 Months|Patients did not return for follow-up|98
4905479|NCT00588861|16899919|P2|Pre-Operative|Patients Did Not Complete Preop Data|86
4905480|NCT00588861|16899920|P1|Pre-Operative|Patients Did Not Complete Preop Data|95
4905481|NCT00588848|16899930|P2|Overall Study|Physician Decision|3
4905482|NCT00588848|16899931|P1|Overall Study|Physician Decision|0
4905483|NCT00588822|16899941|P1|Overall Study|progression of disease|8
4905484|NCT00588770|16899961|P2|Overall Study|Patient non-compliance|2
4905485|NCT00588770|16899962|P1|Overall Study|Patient non-compliance|2
4905486|NCT00588770|16899961|P2|Overall Study|Physician discretion|0
4905487|NCT00588770|16899962|P1|Overall Study|Physician discretion|2
4905488|NCT00588770|16899961|P2|Overall Study|Lack of Efficacy|10
4905489|NCT00588770|16899962|P1|Overall Study|Lack of Efficacy|8
4905490|NCT00588770|16899961|P2|Overall Study|Not start protocol therapy|9
4905491|NCT00588770|16899962|P1|Overall Study|Not start protocol therapy|0
4905492|NCT00588770|16899961|P2|Overall Study|Other complicating disease|2
4905493|NCT00588770|16899962|P1|Overall Study|Other complicating disease|3
4905494|NCT00588770|16899961|P2|Overall Study|Alternative therapy|4
4905495|NCT00588770|16899962|P1|Overall Study|Alternative therapy|2
4905496|NCT00588770|16899961|P2|Overall Study|Withdrawal by Subject|25
4905497|NCT00588770|16899962|P1|Overall Study|Withdrawal by Subject|15
4905498|NCT00588770|16899961|P2|Overall Study|Death|22
4905499|NCT00588770|16899962|P1|Overall Study|Death|13
4905500|NCT00588770|16899961|P2|Overall Study|Adverse Event|58
4905501|NCT00588770|16899962|P1|Overall Study|Adverse Event|29
4905502|NCT00588770|16899961|P2|Overall Study|Disease progression|68
4905503|NCT00588770|16899962|P1|Overall Study|Disease progression|85
4905504|NCT00588731|16899974|P2|Overall Study|Withdrawal by Subject|2
4905505|NCT00588731|16899975|P1|Overall Study|Withdrawal by Subject|3
4905506|NCT00588692|16899985|P2|Overall Study|Death|0
4905507|NCT00588692|16899986|P1|Overall Study|Death|1
4905508|NCT00588692|16899985|P2|Overall Study|Cancer|0
4905509|NCT00588692|16899986|P1|Overall Study|Cancer|1
4905510|NCT00588692|16899985|P2|Overall Study|Severe Peptic Ulcer Disease|0
4905511|NCT00588692|16899986|P1|Overall Study|Severe Peptic Ulcer Disease|1
4905512|NCT00588692|16899985|P2|Overall Study|Hip Surgery|1
4905513|NCT00588692|16899986|P1|Overall Study|Hip Surgery|0
4905514|NCT00588692|16899985|P2|Overall Study|Withdrawal by Subject|2
4905515|NCT00588692|16899986|P1|Overall Study|Withdrawal by Subject|4
4905516|NCT00588666|16900022|P1|Overall Study|Adverse Event|4
4905517|NCT00588640|16900027|P1|Overall Study|Ineligible Patient|1
4905518|NCT00588640|16900027|P1|Overall Study|Physician Decision|1
4905519|NCT00588445|16900046|P1|Overall Study|Not Treated|10
4905520|NCT00588445|16900046|P1|Overall Study|Disease Progression|1
4905521|NCT00588445|16900046|P1|Overall Study|Withdrawal by Subject|3
4905522|NCT00588445|16900046|P1|Overall Study|Protocol Violation|1
4905523|NCT00588354|16900070|P2|Baseline to 4 Weeks|Lost to Follow-up|1
4905524|NCT00588354|16900071|P1|Baseline to 4 Weeks|Lost to Follow-up|0
4905525|NCT00588354|16900070|P2|Baseline to 2 Weeks|Lack of Efficacy|0
4905526|NCT00588354|16900071|P1|Baseline to 2 Weeks|Lack of Efficacy|1
4905527|NCT00588354|16900070|P2|Baseline to 2 Weeks|Adverse Event|0
4905528|NCT00588354|16900071|P1|Baseline to 2 Weeks|Adverse Event|1
4905529|NCT00588341|16900091|P1|Overall Study|Patient ineligible|1
4905530|NCT00588341|16900091|P1|Overall Study|Not treated due to metastatic disease|1
4905531|NCT00588341|16900091|P1|Overall Study|Withdrawal by Subject|3
4905532|NCT00588237|16900095|P1|Overall Study|Patien not treated|1
4905533|NCT00588237|16900095|P1|Overall Study|Evaluable for toxicity only|3
4905534|NCT00588146|16900118|P2|First Intervention (Baseline to 6 mo)|Adverse Event|3
4905535|NCT00588146|16900119|P1|First Intervention (Baseline to 6 mo)|Adverse Event|4
4905536|NCT00588094|16900125|P1|Overall Study|Progression of Disease|2
4905537|NCT00588094|16900125|P1|Overall Study|Adverse Event|3
4905538|NCT00587990|16900132|P3|Overall Study|Death|1
4905539|NCT00587990|16900133|P2|Overall Study|Death|0
4905540|NCT00587990|16900134|P1|Overall Study|Death|0
4905541|NCT00587964|16900177|P1|Overall Study|Progression of Disease|4
4905542|NCT00587964|16900177|P1|Overall Study|Patient did not receive intervention|5
4905543|NCT00587964|16900177|P1|Overall Study|Patient found to be ineligible|1
4905544|NCT00587964|16900177|P1|Overall Study|Lost to Follow-up|1
4905545|NCT00587964|16900177|P1|Overall Study|Withdrawal by Subject|1
4905546|NCT00587860|16900183|P2|Overall Study|Withdrawal by Subject|3
4905547|NCT00587860|16900184|P1|Overall Study|Withdrawal by Subject|3
4905548|NCT00587860|16900183|P2|Overall Study|Lost to Follow-up|2
4905549|NCT00587860|16900184|P1|Overall Study|Lost to Follow-up|2
4905550|NCT00587847|16900204|P1|Overall Study|Adverse Event|2
4905551|NCT00587847|16900204|P1|Overall Study|Lack of Efficacy|5
4905552|NCT00587795|16900227|P2|Overall Study|Withdrawal by Subject|0
4905553|NCT00587795|16900228|P1|Overall Study|Withdrawal by Subject|1
4905554|NCT00587639|16900282|P1|Overall Study|Withdrawal by Subject|1
4905555|NCT00587587|16900289|P2|Overall Study|Lost to Follow-up|1
4905556|NCT00587587|16900290|P1|Overall Study|Lost to Follow-up|6
4905557|NCT00587457|16900344|P3|Overall Study|Development of neutralizing Abs|1
4905558|NCT00587457|16900345|P2|Overall Study|Development of neutralizing Abs|0
4905559|NCT00587457|16900346|P1|Overall Study|Development of neutralizing Abs|0
4905560|NCT00587457|16900344|P3|Overall Study|Undefined|1
4905561|NCT00587457|16900345|P2|Overall Study|Undefined|0
4905562|NCT00587457|16900346|P1|Overall Study|Undefined|0
4905563|NCT00587457|16900344|P3|Overall Study|Initiation of alternative therapy|0
4905564|NCT00587457|16900345|P2|Overall Study|Initiation of alternative therapy|1
4905565|NCT00587457|16900346|P1|Overall Study|Initiation of alternative therapy|0
4905566|NCT00587457|16900344|P3|Overall Study|Disease progression|2
4905567|NCT00587457|16900345|P2|Overall Study|Disease progression|0
4905568|NCT00587457|16900346|P1|Overall Study|Disease progression|2
4905569|NCT00587457|16900344|P3|Overall Study|Adverse Event|1
4905570|NCT00587457|16900345|P2|Overall Study|Adverse Event|2
4905571|NCT00587457|16900346|P1|Overall Study|Adverse Event|1
4905572|NCT00587431|16900383|P2|Overall Study|Withdrawal by Subject|1
4905573|NCT00587431|16900384|P1|Overall Study|Withdrawal by Subject|0
4905574|NCT00587431|16900383|P2|Overall Study|Adverse Event|0
4905575|NCT00587431|16900384|P1|Overall Study|Adverse Event|1
4905576|NCT00587288|16900395|P2|Overall Study|Protocol Violation|0
4905577|NCT00587288|16900396|P1|Overall Study|Protocol Violation|1
4905578|NCT00587288|16900395|P2|Overall Study|Lack of Efficacy|8
4905579|NCT00587288|16900396|P1|Overall Study|Lack of Efficacy|2
4905580|NCT00587288|16900395|P2|Overall Study|Adverse Event|1
4905581|NCT00587288|16900396|P1|Overall Study|Adverse Event|0
4905582|NCT00587223|16900414|P1|Overall Study|Adverse Event|1
4905583|NCT00587171|16900431|P2|Overall Study|Lost to Follow-up|1
4905584|NCT00587171|16900432|P1|Overall Study|Lost to Follow-up|1
4905585|NCT00587158|16900462|P2|Overall Study|Subject did not want to take study med|1
4905586|NCT00587158|16900463|P1|Overall Study|Subject did not want to take study med|0
4905587|NCT00587158|16900462|P2|Overall Study|Death|1
4905588|NCT00587158|16900463|P1|Overall Study|Death|0
4905589|NCT00587158|16900462|P2|Overall Study|Lost to Follow-up|2
4905590|NCT00587158|16900463|P1|Overall Study|Lost to Follow-up|1
4905591|NCT00587158|16900462|P2|Overall Study|Physician Decision|1
4905592|NCT00587158|16900463|P1|Overall Study|Physician Decision|0
4905593|NCT00587158|16900462|P2|Overall Study|Did not want to do 24 hr urine collect.|3
4905594|NCT00587158|16900463|P1|Overall Study|Did not want to do 24 hr urine collect.|4
4905595|NCT00587054|16900516|P1|Overall Study|Patient not treated|9
4905596|NCT00586924|16900542|P6|Overall Study|Other|6
4905597|NCT00586924|16900543|P5|Overall Study|Other|1
4905598|NCT00586924|16900544|P4|Overall Study|Other|1
4905599|NCT00586924|16900545|P3|Overall Study|Other|1
4905600|NCT00586924|16900546|P2|Overall Study|Other|0
4905601|NCT00586924|16900547|P1|Overall Study|Other|1
4905602|NCT00586924|16900542|P6|Overall Study|Complete response|2
4905603|NCT00586924|16900543|P5|Overall Study|Complete response|2
4905604|NCT00586924|16900544|P4|Overall Study|Complete response|0
4905605|NCT00586924|16900545|P3|Overall Study|Complete response|0
4905606|NCT00586924|16900546|P2|Overall Study|Complete response|1
4905607|NCT00586924|16900547|P1|Overall Study|Complete response|0
4905608|NCT00586924|16900542|P6|Overall Study|Development of neutralizing antibodies|22
4905609|NCT00586924|16900543|P5|Overall Study|Development of neutralizing antibodies|0
4905610|NCT00586924|16900544|P4|Overall Study|Development of neutralizing antibodies|0
4905611|NCT00586924|16900545|P3|Overall Study|Development of neutralizing antibodies|2
4905612|NCT00586924|16900546|P2|Overall Study|Development of neutralizing antibodies|2
4905613|NCT00586924|16900547|P1|Overall Study|Development of neutralizing antibodies|2
4905614|NCT00586924|16900542|P6|Overall Study|Disease progression|0
4905615|NCT00586924|16900543|P5|Overall Study|Disease progression|1
4905616|NCT00586924|16900544|P4|Overall Study|Disease progression|1
4905617|NCT00586924|16900545|P3|Overall Study|Disease progression|0
4905618|NCT00586924|16900546|P2|Overall Study|Disease progression|0
4905619|NCT00586924|16900547|P1|Overall Study|Disease progression|0
4905620|NCT00586924|16900542|P6|Overall Study|Initiation of alternative cancer therapy|1
4905621|NCT00586924|16900543|P5|Overall Study|Initiation of alternative cancer therapy|0
4905622|NCT00586924|16900544|P4|Overall Study|Initiation of alternative cancer therapy|0
4905623|NCT00586924|16900545|P3|Overall Study|Initiation of alternative cancer therapy|0
4905624|NCT00586924|16900546|P2|Overall Study|Initiation of alternative cancer therapy|0
4905625|NCT00586924|16900547|P1|Overall Study|Initiation of alternative cancer therapy|0
4905626|NCT00586924|16900542|P6|Overall Study|Adverse event/serious adverse event|2
4905627|NCT00586924|16900543|P5|Overall Study|Adverse event/serious adverse event|0
4905628|NCT00586924|16900544|P4|Overall Study|Adverse event/serious adverse event|1
4905629|NCT00586924|16900545|P3|Overall Study|Adverse event/serious adverse event|0
4905630|NCT00586924|16900546|P2|Overall Study|Adverse event/serious adverse event|0
4905631|NCT00586924|16900547|P1|Overall Study|Adverse event/serious adverse event|0
4905632|NCT00586898|16900747|P1|Overall Study|Evaluable for Toxicity Only|5
4905633|NCT00586898|16900747|P1|Overall Study|Patiemt Non-compliance|1
4905634|NCT00586898|16900747|P1|Overall Study|Adverse Event|1
4905635|NCT00586846|16900751|P1|Overall Study|Evaluable for Toxicity Only|4
4905636|NCT00586846|16900751|P1|Overall Study|Death|1
4905637|NCT00586846|16900751|P1|Overall Study|Physician Decision|1
4905638|NCT00586820|16900757|P2|Overall Study|Unsuccessful PCI|0
4905639|NCT00586820|16900758|P1|Overall Study|Unsuccessful PCI|1
4905640|NCT00586703|16900789|P1|Overall Study|Death|12
4905641|NCT00586690|16900796|P2|Overall Study|Lab can't accommodate|0
4905642|NCT00586690|16900797|P1|Overall Study|Lab can't accommodate|1
4905643|NCT00586690|16900796|P2|Overall Study|Lack of Efficacy|0
4905644|NCT00586690|16900797|P1|Overall Study|Lack of Efficacy|2
4905645|NCT00586690|16900796|P2|Overall Study|Adverse Event|0
4905646|NCT00586690|16900797|P1|Overall Study|Adverse Event|1
4905647|NCT00586690|16900796|P2|Overall Study|Disease Progression|0
4905648|NCT00586690|16900797|P1|Overall Study|Disease Progression|10
4905649|NCT00586690|16900796|P2|Overall Study|Death|0
4905650|NCT00586690|16900797|P1|Overall Study|Death|2
4905651|NCT00586664|16900807|P3|Overall Study|Exclusion criteria met|0
4905652|NCT00586664|16900808|P2|Overall Study|Exclusion criteria met|0
4905653|NCT00586664|16900809|P1|Overall Study|Exclusion criteria met|2
4905654|NCT00586664|16900807|P3|Overall Study|Withdrawal by Subject|1
4905655|NCT00586664|16900808|P2|Overall Study|Withdrawal by Subject|7
4905656|NCT00586664|16900809|P1|Overall Study|Withdrawal by Subject|3
4905657|NCT00586625|16900855|P2|Overall Study|Subject unable to return for visit|0
4905658|NCT00586625|16900856|P1|Overall Study|Subject unable to return for visit|2
4905659|NCT00586625|16900855|P2|Overall Study|Subject non-compliance|1
4905660|NCT00586625|16900856|P1|Overall Study|Subject non-compliance|0
4905661|NCT00586625|16900855|P2|Overall Study|Withdrawal by Subject|10
4905662|NCT00586625|16900856|P1|Overall Study|Withdrawal by Subject|32
4905663|NCT00586625|16900855|P2|Overall Study|Protocol Violation|0
4905664|NCT00586625|16900856|P1|Overall Study|Protocol Violation|3
4905665|NCT00586625|16900855|P2|Overall Study|Adverse Event|6
4905666|NCT00586625|16900856|P1|Overall Study|Adverse Event|6
4905667|NCT00586612|16900864|P2|Booster Phase|Lost to Follow-up|1
4905668|NCT00586612|16900865|P1|Booster Phase|Lost to Follow-up|3
4905669|NCT00586612|16900864|P2|Primary Phase|Withdrawal by Subject|2
4905670|NCT00586612|16900865|P1|Primary Phase|Withdrawal by Subject|0
4905671|NCT00586612|16900864|P2|Primary Phase|Lost to Follow-up|1
4905672|NCT00586612|16900865|P1|Primary Phase|Lost to Follow-up|0
4905673|NCT00586612|16900864|P2|Primary Phase|Protocol Violation|0
4905674|NCT00586612|16900865|P1|Primary Phase|Protocol Violation|1
4905675|NCT00586521|16900935|P1|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1
4905676|NCT00586508|16900944|P2|Overall Study|Withdrawal by Subject|0
4905677|NCT00586508|16900945|P1|Overall Study|Withdrawal by Subject|4
4905678|NCT00586508|16900944|P2|Overall Study|Adverse Event|4
4905679|NCT00586508|16900945|P1|Overall Study|Adverse Event|12
4905680|NCT00586508|16900944|P2|Overall Study|Death|1
4905681|NCT00586508|16900945|P1|Overall Study|Death|0
4905682|NCT00586508|16900944|P2|Overall Study|Progressive disease|8
4905683|NCT00586508|16900945|P1|Overall Study|Progressive disease|52
4905684|NCT00586495|16900961|P1|Follow-up|Switch to commercial drug|10
4905685|NCT00586495|16900961|P1|Follow-up|Protocol driven decision point|37
4905686|NCT00586495|16900961|P1|Follow-up|Withdrawal by Subject|4
4905687|NCT00586495|16900961|P1|Follow-up|Lost to Follow-up|1
4905688|NCT00586495|16900961|P1|Follow-up|Death|40
4905689|NCT00586495|16900961|P1|Treatment Period|Switch to commercial drug|10
4905846|NCT00585052|16901523|P1|Overall Study|Withdrawal by Subject|1
4905690|NCT00586495|16900961|P1|Treatment Period|Disease progression, recurrence/relapse|71
4905691|NCT00586495|16900961|P1|Treatment Period|Withdrawal by Subject|1
4905692|NCT00586495|16900961|P1|Treatment Period|Protocol Violation|1
4905693|NCT00586495|16900961|P1|Treatment Period|Death|1
4905694|NCT00586495|16900961|P1|Treatment Period|Adverse Event|11
4905695|NCT00586469|16900990|P2|Overall Study|Adverse Event|1
4905696|NCT00586469|16900991|P1|Overall Study|Adverse Event|0
4905697|NCT00586339|16901018|P3|Overall Study|Lost to Follow-up|1
4905698|NCT00586339|16901019|P2|Overall Study|Lost to Follow-up|2
4905699|NCT00586339|16901020|P1|Overall Study|Lost to Follow-up|3
4905700|NCT00586339|16901018|P3|Overall Study|Migrated/moved from study area|4
4905701|NCT00586339|16901019|P2|Overall Study|Migrated/moved from study area|2
4905702|NCT00586339|16901020|P1|Overall Study|Migrated/moved from study area|3
4905703|NCT00586339|16901018|P3|Overall Study|Withdrawal by Subject|1
4905704|NCT00586339|16901019|P2|Overall Study|Withdrawal by Subject|3
4905705|NCT00586339|16901020|P1|Overall Study|Withdrawal by Subject|1
4905706|NCT00586326|16901121|P1|Treated Through 5-yr Follow Up-Treated|Other|2
4905707|NCT00586326|16901121|P1|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14
4905708|NCT00586326|16901121|P1|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5
4905709|NCT00586326|16901121|P1|Treated Through 5-yr Follow Up-Treated|Medical Reason|2
4905710|NCT00586326|16901121|P1|Treated Through 5-yr Follow Up-Treated|Death|2
4905711|NCT00586326|16901121|P1|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1
4905712|NCT00586326|16901121|P1|Device Placed toTreatment-ITT|Physician Decision|1
4905713|NCT00586326|16901121|P1|Device Placed toTreatment-ITT|Positive Margins|3
4905714|NCT00586326|16901121|P1|Device Placed toTreatment-ITT|Microinvasion|1
4905715|NCT00586326|16901121|P1|Device Placed toTreatment-ITT|Cavity Conformance|6
4905716|NCT00586326|16901121|P1|Device Placed toTreatment-ITT|Skin Distance|7
4905717|NCT00586326|16901121|P1|Enrollment to Device Placement-Enrolled|Other|1
4905718|NCT00586326|16901121|P1|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1
4905719|NCT00586326|16901121|P1|Enrollment to Device Placement-Enrolled|Physician Decision|1
4905720|NCT00586326|16901121|P1|Enrollment to Device Placement-Enrolled|Microinvasion|2
4905721|NCT00586326|16901121|P1|Enrollment to Device Placement-Enrolled|Cavity Conformance|4
4905722|NCT00586326|16901121|P1|Enrollment to Device Placement-Enrolled|Skin Distance|6
4905723|NCT00586313|16901132|P1|Overall Study|Lack of Efficacy|2
4905724|NCT00586157|16901168|P2|Second Intervention|Adverse Event|1
4905725|NCT00586157|16901169|P1|Second Intervention|Adverse Event|0
4905726|NCT00586157|16901168|P2|Second Intervention|Worsening behavior|0
4905727|NCT00586157|16901169|P1|Second Intervention|Worsening behavior|1
4905728|NCT00586157|16901168|P2|Second Intervention|Withdrawal by Subject|0
4905729|NCT00586157|16901169|P1|Second Intervention|Withdrawal by Subject|1
4905730|NCT00586157|16901168|P2|First Intervention|Worsening behavior|0
4905731|NCT00586157|16901169|P1|First Intervention|Worsening behavior|1
4905732|NCT00586105|16901179|P1|Overall Study|Reason not reported|1
4905733|NCT00586105|16901179|P1|Overall Study|Switched to commercial drug|9
4905734|NCT00586105|16901179|P1|Overall Study|Disease progression|19
4905735|NCT00586105|16901179|P1|Overall Study|Withdrawal by Subject|3
4905736|NCT00586105|16901179|P1|Overall Study|Protocol Violation|1
4905737|NCT00586105|16901179|P1|Overall Study|Death|2
4905738|NCT00586105|16901179|P1|Overall Study|Adverse Event|4
4905739|NCT00586066|16901194|P2|Overall Study|Withdrawal of consent|2
4905740|NCT00586066|16901195|P1|Overall Study|Withdrawal of consent|4
4905741|NCT00586066|16901194|P2|Overall Study|Physician Decision|0
4905742|NCT00586066|16901195|P1|Overall Study|Physician Decision|1
4905743|NCT00586066|16901194|P2|Overall Study|Adverse Event|2
4905744|NCT00586066|16901195|P1|Overall Study|Adverse Event|2
4905745|NCT00586066|16901194|P2|Overall Study|Lack of Efficacy|3
4905746|NCT00586066|16901195|P1|Overall Study|Lack of Efficacy|5
4905747|NCT00586066|16901194|P2|Overall Study|Lost to Follow-up|3
4905748|NCT00586066|16901195|P1|Overall Study|Lost to Follow-up|6
4905749|NCT00585975|16901252|P2|Overall Study|Enrollment met/over-enrolled|9
4905750|NCT00585975|16901253|P1|Overall Study|Enrollment met/over-enrolled|10
4905751|NCT00585975|16901252|P2|Overall Study|Lost to Follow-up|1
4905752|NCT00585975|16901253|P1|Overall Study|Lost to Follow-up|2
4905753|NCT00585975|16901252|P2|Overall Study|Withdrawal by Subject|3
4905754|NCT00585975|16901253|P1|Overall Study|Withdrawal by Subject|3
4905755|NCT00585923|16901263|P2|Overall Study|Physician decided not to continue|33
4905756|NCT00585923|16901264|P1|Overall Study|Physician decided not to continue|31
4905757|NCT00585689|16901316|P1|Overall Study|Death|1
4905758|NCT00585689|16901316|P1|Overall Study|Patient had unresectable disease|1
4905759|NCT00585689|16901316|P1|Overall Study|Patient Declined Surgery|1
4905760|NCT00585689|16901316|P1|Overall Study|Adverse Event|1
4905761|NCT00585689|16901316|P1|Overall Study|Received different ABI-007 schedule|3
4905762|NCT00585585|16901375|P1|Overall Study|Adverse Event|1
4905763|NCT00585546|16901379|P1|Clenbuterol Treatment - up to 12 Months|Adverse Event|3
4905764|NCT00585546|16901379|P1|Clenbuterol Treatment - up to 12 Months|Death|1
4905765|NCT00585533|16901393|P1|Overall Study|objective or symptomatic progression|9
4905766|NCT00585468|16901402|P2|First Intervention|Withdrawal by Subject|1
4905767|NCT00585468|16901403|P1|First Intervention|Withdrawal by Subject|1
4905768|NCT00585351|16901435|P8|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4905769|NCT00585351|16901436|P7|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4905770|NCT00585351|16901437|P6|Enrollment Period (Intervention)|Unknown if alive or deceased|2
4905771|NCT00585351|16901438|P5|Enrollment Period (Intervention)|Unknown if alive or deceased|1
4905772|NCT00585351|16901439|P4|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4905773|NCT00585351|16901440|P3|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4905774|NCT00585351|16901441|P2|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4905775|NCT00585351|16901442|P1|Enrollment Period (Intervention)|Unknown if alive or deceased|0
4905776|NCT00585351|16901435|P8|Enrollment Period (Intervention)|Death|0
4905777|NCT00585351|16901436|P7|Enrollment Period (Intervention)|Death|1
4905778|NCT00585351|16901437|P6|Enrollment Period (Intervention)|Death|0
4905779|NCT00585351|16901438|P5|Enrollment Period (Intervention)|Death|1
4905780|NCT00585351|16901439|P4|Enrollment Period (Intervention)|Death|0
4905781|NCT00585351|16901440|P3|Enrollment Period (Intervention)|Death|0
4905782|NCT00585351|16901441|P2|Enrollment Period (Intervention)|Death|0
4905783|NCT00585351|16901442|P1|Enrollment Period (Intervention)|Death|0
4905784|NCT00585351|16901435|P8|Enrollment Period (Intervention)|Lost to Follow-up|1
4905785|NCT00585351|16901436|P7|Enrollment Period (Intervention)|Lost to Follow-up|1
4905786|NCT00585351|16901437|P6|Enrollment Period (Intervention)|Lost to Follow-up|0
4905787|NCT00585351|16901438|P5|Enrollment Period (Intervention)|Lost to Follow-up|0
4905788|NCT00585351|16901439|P4|Enrollment Period (Intervention)|Lost to Follow-up|0
4905789|NCT00585351|16901440|P3|Enrollment Period (Intervention)|Lost to Follow-up|0
4905790|NCT00585351|16901441|P2|Enrollment Period (Intervention)|Lost to Follow-up|0
4905791|NCT00585351|16901442|P1|Enrollment Period (Intervention)|Lost to Follow-up|0
4905792|NCT00585351|16901435|P8|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4905793|NCT00585351|16901436|P7|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4905794|NCT00585351|16901437|P6|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4905795|NCT00585351|16901438|P5|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4905796|NCT00585351|16901439|P4|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4905797|NCT00585351|16901440|P3|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0
4905798|NCT00585351|16901441|P2|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
4905799|NCT00585351|16901442|P1|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21
4905800|NCT00585351|16901435|P8|Notification Period (Informed Consent)|No study medication on flight|0
4905801|NCT00585351|16901436|P7|Notification Period (Informed Consent)|No study medication on flight|0
4905802|NCT00585351|16901437|P6|Notification Period (Informed Consent)|No study medication on flight|0
4905803|NCT00585351|16901438|P5|Notification Period (Informed Consent)|No study medication on flight|0
4905804|NCT00585351|16901439|P4|Notification Period (Informed Consent)|No study medication on flight|0
4905805|NCT00585351|16901440|P3|Notification Period (Informed Consent)|No study medication on flight|0
4905806|NCT00585351|16901441|P2|Notification Period (Informed Consent)|No study medication on flight|1
4905807|NCT00585351|16901442|P1|Notification Period (Informed Consent)|No study medication on flight|0
4905808|NCT00585351|16901435|P8|Notification Period (Informed Consent)|Flight aborted|0
4905809|NCT00585351|16901436|P7|Notification Period (Informed Consent)|Flight aborted|0
4905810|NCT00585351|16901437|P6|Notification Period (Informed Consent)|Flight aborted|0
4905811|NCT00585351|16901438|P5|Notification Period (Informed Consent)|Flight aborted|0
4905812|NCT00585351|16901439|P4|Notification Period (Informed Consent)|Flight aborted|0
4905813|NCT00585351|16901440|P3|Notification Period (Informed Consent)|Flight aborted|0
4905814|NCT00585351|16901441|P2|Notification Period (Informed Consent)|Flight aborted|1
4905815|NCT00585351|16901442|P1|Notification Period (Informed Consent)|Flight aborted|2
4905816|NCT00585351|16901435|P8|Notification Period (Informed Consent)|Physician Decision|0
4905817|NCT00585351|16901436|P7|Notification Period (Informed Consent)|Physician Decision|0
4905818|NCT00585351|16901437|P6|Notification Period (Informed Consent)|Physician Decision|0
4905819|NCT00585351|16901438|P5|Notification Period (Informed Consent)|Physician Decision|0
4905820|NCT00585351|16901439|P4|Notification Period (Informed Consent)|Physician Decision|0
4905821|NCT00585351|16901440|P3|Notification Period (Informed Consent)|Physician Decision|0
4905822|NCT00585351|16901441|P2|Notification Period (Informed Consent)|Physician Decision|2
4905823|NCT00585351|16901442|P1|Notification Period (Informed Consent)|Physician Decision|0
4905824|NCT00585325|16901458|P2|Overall Study|Withdrawal by Subject|1
4905825|NCT00585325|16901459|P1|Overall Study|Withdrawal by Subject|1
4905826|NCT00585312|16901467|P2|Overall Study|Study terminated by the sponsor|31
4905827|NCT00585312|16901468|P1|Overall Study|Study terminated by the sponsor|34
4905828|NCT00585312|16901467|P2|Overall Study|Withdrawal by Subject|1
4905829|NCT00585312|16901468|P1|Overall Study|Withdrawal by Subject|5
4905830|NCT00585312|16901467|P2|Overall Study|Reason not specified|0
4905831|NCT00585312|16901468|P1|Overall Study|Reason not specified|2
4905832|NCT00585312|16901467|P2|Overall Study|Lost to Follow-up|1
4905833|NCT00585312|16901468|P1|Overall Study|Lost to Follow-up|1
4905834|NCT00585312|16901467|P2|Overall Study|Lack of Efficacy|11
4905835|NCT00585312|16901468|P1|Overall Study|Lack of Efficacy|6
4905836|NCT00585312|16901467|P2|Overall Study|Adverse Event|0
4905837|NCT00585312|16901468|P1|Overall Study|Adverse Event|3
4905838|NCT00585286|16901480|P1|Overall Study|Lost to Follow-up|1
4905839|NCT00585221|16901496|P1|Overall Study|Protocol Violation|8
4905840|NCT00585169|16901506|P1|Overall Study|Withdrawal by Subject|1
4905841|NCT00585078|16901516|P1|Overall Study|Death|1
4905842|NCT00585078|16901516|P1|Overall Study|Adverse Event|10
4905843|NCT00585078|16901516|P1|Overall Study|Disease Progression|24
4905844|NCT00585078|16901516|P1|Overall Study|Poor performance status|1
4905845|NCT00585078|16901516|P1|Overall Study|Withdrawal by Subject|4
4905847|NCT00585039|16901530|P2|Overall Study|medication spilled|0
4905848|NCT00585039|16901531|P1|Overall Study|medication spilled|2
4905849|NCT00584987|16901560|P4|Overall Study|Adverse Event|1
4905850|NCT00584987|16901561|P3|Overall Study|Adverse Event|0
4905851|NCT00584987|16901562|P2|Overall Study|Adverse Event|0
4905852|NCT00584987|16901563|P1|Overall Study|Adverse Event|0
4905853|NCT00584987|16901560|P4|Overall Study|Protocol Violation|0
4905854|NCT00584987|16901561|P3|Overall Study|Protocol Violation|1
4905855|NCT00584987|16901562|P2|Overall Study|Protocol Violation|1
4905856|NCT00584987|16901563|P1|Overall Study|Protocol Violation|1
4905857|NCT00584909|16901615|P1|Overall Study|Adverse Event|4
4905858|NCT00584844|16901625|P1|Overall Study|Screen Failure|20
4905859|NCT00584844|16901625|P1|Overall Study|Withdrawal by Subject|59
4905860|NCT00584805|16901675|P1|Overall Study|Screen failures|2
4905861|NCT00584805|16901675|P1|Overall Study|Lost to follow up|3
4905862|NCT00584805|16901675|P1|Overall Study|Non-compliance|1
4905863|NCT00584805|16901675|P1|Overall Study|Withdrawal by Subject|18
4905864|NCT00584805|16901675|P1|Overall Study|Relocation|36
4905865|NCT00584805|16901675|P1|Overall Study|No longer at risk of exposure|39
4905866|NCT00584740|16901688|P2|Overall Study|Lost to Follow-up|1
4905867|NCT00584740|16901689|P1|Overall Study|Lost to Follow-up|0
4905868|NCT00584740|16901688|P2|Overall Study|Withdrawal by Subject|2
4905869|NCT00584740|16901689|P1|Overall Study|Withdrawal by Subject|3
4905870|NCT00584740|16901688|P2|Overall Study|Lack of Efficacy|2
4905871|NCT00584740|16901689|P1|Overall Study|Lack of Efficacy|8
4905872|NCT00584740|16901688|P2|Overall Study|Adverse Event|1
4905873|NCT00584740|16901689|P1|Overall Study|Adverse Event|1
4905874|NCT00584727|16901707|P6|Third Intervention|Protocol Violation|2
4905875|NCT00584727|16901708|P5|Third Intervention|Protocol Violation|4
4905876|NCT00584727|16901709|P4|Third Intervention|Protocol Violation|0
4905877|NCT00584727|16901710|P3|Third Intervention|Protocol Violation|1
4905878|NCT00584727|16901711|P2|Third Intervention|Protocol Violation|0
4905879|NCT00584727|16901712|P1|Third Intervention|Protocol Violation|0
4905880|NCT00584727|16901707|P6|First Intervention|Discontinuation|0
4905881|NCT00584727|16901708|P5|First Intervention|Discontinuation|0
4905882|NCT00584727|16901709|P4|First Intervention|Discontinuation|0
4905883|NCT00584727|16901710|P3|First Intervention|Discontinuation|1
4905884|NCT00584727|16901711|P2|First Intervention|Discontinuation|0
4905885|NCT00584727|16901712|P1|First Intervention|Discontinuation|0
4905886|NCT00584454|16901750|P1|Overall Study|Clinical Hold|2
4905887|NCT00584454|16901750|P1|Overall Study|Relocation|1
4905888|NCT00584454|16901750|P1|Overall Study|Adverse Event|1
4905889|NCT00584415|16901754|P1|Overall Study|Adverse Event|7
4905890|NCT00584194|16901777|P1|Overall Study|Other|135
4905891|NCT00584012|16901790|P1|Overall Study|Withdrawal by Subject|1
4905892|NCT00583947|16901796|P2|Cross-over Period|Other|1
4905893|NCT00583947|16901797|P1|Cross-over Period|Other|1
4905894|NCT00583947|16901796|P2|Cross-over Period|Did not meet-no longer met entry criteri|1
4905895|NCT00583947|16901797|P1|Cross-over Period|Did not meet-no longer met entry criteri|0
4905896|NCT00583947|16901796|P2|Cross-over Period|Withdrawal by Subject|0
4905897|NCT00583947|16901797|P1|Cross-over Period|Withdrawal by Subject|2
4905898|NCT00583947|16901796|P2|Cross-over Period|Adverse Event|0
4905899|NCT00583947|16901797|P1|Cross-over Period|Adverse Event|2
4905900|NCT00583791|16901918|P1|Overall Study|Death|6
4905901|NCT00583791|16901918|P1|Overall Study|Other|67
4905902|NCT00583596|16901973|P1|Overall Study|Outside f-up window|26
4905903|NCT00583596|16901973|P1|Overall Study|Not consented|15
4905904|NCT00583596|16901973|P1|Overall Study|Data not complete|1
4905905|NCT00583596|16901973|P1|Overall Study|Lost to Follow-up|94
4905906|NCT00583596|16901973|P1|Overall Study|Withdrawal by Subject|6
4905907|NCT00583596|16901973|P1|Overall Study|Death|2
4905908|NCT00583596|16901973|P1|Overall Study|Excluded due to Hurricane Katrina|30
4905909|NCT00583596|16901973|P1|Overall Study|Lost to Follow-up|110
4905910|NCT00583557|16901978|P1|Overall Study|Did not receive belimumab in LBRA99|2
4905911|NCT00583557|16901978|P1|Overall Study|Other|5
4905912|NCT00583557|16901978|P1|Overall Study|Lack of Compliance|5
4905913|NCT00583557|16901978|P1|Overall Study|Lack of Efficacy|31
4905914|NCT00583557|16901978|P1|Overall Study|Adverse Event|9
4905915|NCT00583557|16901978|P1|Overall Study|Withdrawal by Subject|18
4905916|NCT00583453|16902009|P2|Overall Study|discontinued intervention|2
4905917|NCT00583453|16902010|P1|Overall Study|discontinued intervention|0
4905918|NCT00583362|16902047|P1|Overall Study|Withdrawal by Subject|57
4905919|NCT00583362|16902047|P1|Overall Study|Protocol Violation|2
4905920|NCT00583362|16902047|P1|Overall Study|Physician Decision|19
4905921|NCT00583362|16902047|P1|Overall Study|Sponsor request due to missed doses|1
4905922|NCT00583362|16902047|P1|Overall Study|Behavioral problems and non-compliance|1
4905923|NCT00583362|16902047|P1|Overall Study|Misunderstanding of protocol|1
4905924|NCT00583362|16902047|P1|Overall Study|Missed visits due to staff changes|1
4905925|NCT00583362|16902047|P1|Overall Study|Subject moved out of the country/state|2
4905926|NCT00583362|16902047|P1|Overall Study|Subject not dosed in LBSL99|1
4905927|NCT00583362|16902047|P1|Overall Study|Current site closed|7
4905928|NCT00583362|16902047|P1|Overall Study|Miscommunication of visit window|5
4905929|NCT00583362|16902047|P1|Overall Study|Pregnancy|7
4905930|NCT00583362|16902047|P1|Overall Study|Non-compliance with study drug|28
4905931|NCT00583362|16902047|P1|Overall Study|Lost to Follow-up|4
4905932|NCT00583362|16902047|P1|Overall Study|Lack of Efficacy|22
4905933|NCT00583362|16902047|P1|Overall Study|Adverse Event|44
4905934|NCT00583219|16902071|P1|Phase 2|Withdrawal by Subject|1
4905935|NCT00583115|16902088|P1|Overall Study|Death|1
4905936|NCT00583102|16902093|P1|Overall Study|Adverse Event|3
4905937|NCT00582972|16902110|P1|Overall Study|Protocol Violation|2
4905938|NCT00582933|16902119|P1|Overall Study|Physician Decision|3
4905939|NCT00582907|16902123|P4|2nd Course|Lack of Efficacy|0
4905940|NCT00582907|16902124|P3|2nd Course|Lack of Efficacy|0
4905941|NCT00582907|16902125|P2|2nd Course|Lack of Efficacy|0
4905942|NCT00582907|16902126|P1|2nd Course|Lack of Efficacy|1
4905943|NCT00582907|16902123|P4|1st Course|Lost to Follow-up|1
4905944|NCT00582907|16902124|P3|1st Course|Lost to Follow-up|0
4905945|NCT00582907|16902125|P2|1st Course|Lost to Follow-up|0
4905946|NCT00582907|16902126|P1|1st Course|Lost to Follow-up|0
4905947|NCT00582907|16902123|P4|1st Course|Withdrawal by Subject|0
4905948|NCT00582907|16902124|P3|1st Course|Withdrawal by Subject|0
4905949|NCT00582907|16902125|P2|1st Course|Withdrawal by Subject|0
4905950|NCT00582907|16902126|P1|1st Course|Withdrawal by Subject|1
4905951|NCT00582816|16902165|P1|Overall Study|Engraftment Failure|3
4905952|NCT00582790|16902175|P1|Overall Study|Rapid progression of disease|1
4905953|NCT00582738|16902184|P2|Overall Study|Withdrawal by Subject|3
4905954|NCT00582738|16902185|P1|Overall Study|Withdrawal by Subject|0
4905955|NCT00582738|16902184|P2|Overall Study|Protocol Violation|1
4905956|NCT00582738|16902185|P1|Overall Study|Protocol Violation|1
4905957|NCT00582738|16902184|P2|Overall Study|Other|0
4905958|NCT00582738|16902185|P1|Overall Study|Other|1
4905959|NCT00582738|16902184|P2|Overall Study|Graft Lost|1
4905960|NCT00582738|16902185|P1|Overall Study|Graft Lost|0
4905961|NCT00582738|16902184|P2|Overall Study|Adverse Event|5
4905962|NCT00582738|16902185|P1|Overall Study|Adverse Event|0
4905963|NCT00582738|16902184|P2|Overall Study|Administrative Problems|8
4905964|NCT00582738|16902185|P1|Overall Study|Administrative Problems|7
4905965|NCT00582712|16902209|P1|Overall Study|Complicating disease requiring treatment|1
4905966|NCT00582712|16902209|P1|Overall Study|Withdrawal by Subject|1
4905967|NCT00582712|16902209|P1|Overall Study|Lack of Efficacy|1
4905968|NCT00582712|16902209|P1|Overall Study|Adverse Event|1
4905969|NCT00582608|16902224|P1|Overall Study|Lack of accrual|4
4905970|NCT00582608|16902224|P1|Overall Study|Patient Ineligible|1
4905971|NCT00582608|16902224|P1|Overall Study|Not Treated|7
4905972|NCT00582556|16902231|P3|Overall Study|Physician Decision|1
4905973|NCT00582556|16902232|P2|Overall Study|Physician Decision|0
4905974|NCT00582556|16902233|P1|Overall Study|Physician Decision|0
4905975|NCT00582556|16902231|P3|Overall Study|Withdrawal by Subject|1
4905976|NCT00582556|16902232|P2|Overall Study|Withdrawal by Subject|1
4905977|NCT00582556|16902233|P1|Overall Study|Withdrawal by Subject|0
4905978|NCT00582491|16902261|P2|Overall Study|Withdrawal by Subject|0
4905979|NCT00582491|16902262|P1|Overall Study|Withdrawal by Subject|1
4905980|NCT00582426|16902286|P2|Overall Study|Use of illicit drugs|0
4905981|NCT00582426|16902287|P1|Overall Study|Use of illicit drugs|1
4905982|NCT00582426|16902286|P2|Overall Study|Disease Progression|2
4905983|NCT00582426|16902287|P1|Overall Study|Disease Progression|2
4905984|NCT00582426|16902286|P2|Overall Study|Withdrawal by Subject|2
4905985|NCT00582426|16902287|P1|Overall Study|Withdrawal by Subject|3
4905986|NCT00582426|16902286|P2|Overall Study|Death|3
4905987|NCT00582426|16902287|P1|Overall Study|Death|4
4905988|NCT00582426|16902286|P2|Overall Study|Protocol Violation|2
4905989|NCT00582426|16902287|P1|Overall Study|Protocol Violation|6
4905990|NCT00582426|16902286|P2|Overall Study|Adverse Event|2
4905991|NCT00582426|16902287|P1|Overall Study|Adverse Event|4
4905992|NCT00582426|16902286|P2|Overall Study|Lost to Follow-up|2
4905993|NCT00582426|16902287|P1|Overall Study|Lost to Follow-up|0
4905994|NCT00582309|16902334|P3|Overall Study|Protocol Violation|2
4905995|NCT00582309|16902335|P2|Overall Study|Protocol Violation|0
4905996|NCT00582309|16902336|P1|Overall Study|Protocol Violation|0
4905997|NCT00582166|16902349|P1|Overall Study|Ineligible pathology|1
4905998|NCT00582166|16902349|P1|Overall Study|Death|1
4905999|NCT00582114|16902359|P2|Overall Study|Stopped by data safety monitoring board|20
4906000|NCT00582114|16902360|P1|Overall Study|Stopped by data safety monitoring board|19
4906001|NCT00582114|16902359|P2|Overall Study|Physician Decision|6
4906002|NCT00582114|16902360|P1|Overall Study|Physician Decision|0
4906003|NCT00582114|16902359|P2|Overall Study|Adverse Event|1
4906004|NCT00582114|16902360|P1|Overall Study|Adverse Event|1
4906005|NCT00582114|16902359|P2|Overall Study|Withdrawal by Subject|16
4906006|NCT00582114|16902360|P1|Overall Study|Withdrawal by Subject|8
4906007|NCT00582114|16902359|P2|Overall Study|Lost to Follow-up|6
4906008|NCT00582114|16902360|P1|Overall Study|Lost to Follow-up|7
4906009|NCT00582114|16902359|P2|Overall Study|Kidney Transplant|1
4906010|NCT00582114|16902360|P1|Overall Study|Kidney Transplant|3
4906011|NCT00582114|16902359|P2|Overall Study|Death|4
4906012|NCT00582114|16902360|P1|Overall Study|Death|4
4906013|NCT00582036|16902375|P2|Overall Study|Withdrawal by Subject|1
4906014|NCT00582036|16902376|P1|Overall Study|Withdrawal by Subject|0
4906015|NCT00582010|16902384|P2|Overall Study|Death|1
4906016|NCT00582010|16902385|P1|Overall Study|Death|0
4906017|NCT00581945|16902414|P2|Overall Study|Death|0
4906018|NCT00581945|16902415|P1|Overall Study|Death|1
4906019|NCT00581945|16902414|P2|Overall Study|Withdrawal by Subject|6
4906020|NCT00581945|16902415|P1|Overall Study|Withdrawal by Subject|2
4906021|NCT00581945|16902414|P2|Overall Study|Unsatisfactory therapeutic effect|0
4906022|NCT00581945|16902415|P1|Overall Study|Unsatisfactory therapeutic effect|2
4906023|NCT00581945|16902414|P2|Overall Study|Adverse Event|4
4906024|NCT00581945|16902415|P1|Overall Study|Adverse Event|4
4906025|NCT00581919|16902431|P1|Overall Study|Withdrawal by Subject|1
4906026|NCT00581919|16902431|P1|Overall Study|Started Non-Protocol Therapy|2
4906027|NCT00581919|16902431|P1|Overall Study|Other Complicating Disease|1
4906028|NCT00581919|16902431|P1|Overall Study|Physician Decision|1
4906029|NCT00581919|16902431|P1|Overall Study|Disease Progression|10
4906030|NCT00581919|16902431|P1|Overall Study|Death|1
4906031|NCT00581919|16902431|P1|Overall Study|Adverse Event|8
4906032|NCT00581828|16902450|P1|Overall Study|Protocol Violation|1
4906033|NCT00581776|16902454|P1|Overall Study|Disease progression or no response|3
4906034|NCT00581555|16902472|P2|Overall Study|Other reasons|4
4906035|NCT00581555|16902473|P1|Overall Study|Other reasons|16
4906036|NCT00581555|16902472|P2|Overall Study|Lost to Follow-up|2
4906037|NCT00581555|16902473|P1|Overall Study|Lost to Follow-up|2
4906038|NCT00581555|16902472|P2|Overall Study|Withdrawal by Subject|9
4906039|NCT00581555|16902473|P1|Overall Study|Withdrawal by Subject|18
4906040|NCT00581555|16902472|P2|Overall Study|Physician Decision|2
4906041|NCT00581555|16902473|P1|Overall Study|Physician Decision|3
4906042|NCT00581555|16902472|P2|Overall Study|Adverse Event|3
4906043|NCT00581555|16902473|P1|Overall Study|Adverse Event|4
4906044|NCT00581542|16902497|P2|Overall Study|Lost to Follow-up|21
4906045|NCT00581542|16902498|P1|Overall Study|Lost to Follow-up|9
4906046|NCT00581542|16902497|P2|Overall Study|they met an exclusion criteria|2
4906047|NCT00581542|16902498|P1|Overall Study|they met an exclusion criteria|2
4906048|NCT00581360|16902552|P1|Overall Study|Withdrawal by Subject|1
4906049|NCT00581308|16902571|P1|Month 12|Other|1
4906050|NCT00581308|16902571|P1|Month 12|Device Removed|1
4906051|NCT00581308|16902571|P1|Month 12|Withdrawal by Subject|3
4906052|NCT00581308|16902571|P1|Month 12|Lost to Follow-up|14
4906053|NCT00581308|16902571|P1|Month 12|Death|1
4906054|NCT00581308|16902571|P1|Month 6|Withdrawal by Subject|2
4906055|NCT00581308|16902571|P1|Month 6|Lost to Follow-up|1
4906056|NCT00581308|16902571|P1|Month 1|Uknown|1
4906057|NCT00581308|16902571|P1|Month 1|Device Removed|2
4906058|NCT00581308|16902571|P1|Month 1|Withdrawal by Subject|2
4906059|NCT00581308|16902571|P1|Month 1|Lost to Follow-up|3
4906060|NCT00581308|16902571|P1|Pre Discharge|Device Removed|1
4906061|NCT00581308|16902571|P1|Pre Discharge|Lost to Follow-up|1
4906062|NCT00581113|16902602|P2|Overall Study|Withdrawal by Subject|1
4906063|NCT00581113|16902603|P1|Overall Study|Withdrawal by Subject|0
4906064|NCT00581100|16902613|P2|Overall Study|Other|0
4906065|NCT00581100|16902614|P1|Overall Study|Other|3
4906066|NCT00581100|16902613|P2|Overall Study|Withdrawal by Subject|4
4906067|NCT00581100|16902614|P1|Overall Study|Withdrawal by Subject|1
4906068|NCT00581100|16902613|P2|Overall Study|Adverse Event|1
4906069|NCT00581100|16902614|P1|Overall Study|Adverse Event|2
4906070|NCT00581100|16902613|P2|Overall Study|Death|0
4906071|NCT00581100|16902614|P1|Overall Study|Death|1
4906072|NCT00580983|16902667|P1|Overall Study|Did not complete 12 mon post RT studies|7
4906073|NCT00580970|16902674|P1|Treatment (Lovastatin)|Death|1
4906074|NCT00580970|16902674|P1|Treatment (Lovastatin)|Development of metastatic second primary|1
4906075|NCT00580970|16902674|P1|Treatment (Lovastatin)|Physician Decision|4
4906076|NCT00580970|16902674|P1|Treatment (Lovastatin)|Intolerance of Lovastatin|7
4906077|NCT00580970|16902674|P1|Treatment (Lovastatin)|Non-compliance|6
4906078|NCT00580970|16902674|P1|Pre-treatment|Non-compliance|1
4906079|NCT00580866|16902689|P2|Overall Study|Lost to Follow-up|2
4906080|NCT00580866|16902690|P1|Overall Study|Lost to Follow-up|2
4906081|NCT00580840|16902714|P4|Double-Blind|Other: Forbidden Medication|0
4906082|NCT00580840|16902715|P3|Double-Blind|Other: Forbidden Medication|1
4906083|NCT00580840|16902716|P2|Double-Blind|Other: Forbidden Medication|0
4906084|NCT00580840|16902717|P1|Double-Blind|Other: Forbidden Medication|0
4906085|NCT00580840|16902714|P4|Double-Blind|Other: Discontinued Methotrexate|0
4906086|NCT00580840|16902715|P3|Double-Blind|Other: Discontinued Methotrexate|0
4906087|NCT00580840|16902716|P2|Double-Blind|Other: Discontinued Methotrexate|1
4906088|NCT00580840|16902717|P1|Double-Blind|Other: Discontinued Methotrexate|0
4906089|NCT00580840|16902714|P4|Double-Blind|Withdrawal by Subject|2
4906090|NCT00580840|16902715|P3|Double-Blind|Withdrawal by Subject|2
4906091|NCT00580840|16902716|P2|Double-Blind|Withdrawal by Subject|1
4906092|NCT00580840|16902717|P1|Double-Blind|Withdrawal by Subject|0
4906093|NCT00580840|16902714|P4|Double-Blind|Lost to Follow-up|2
4906094|NCT00580840|16902715|P3|Double-Blind|Lost to Follow-up|0
4906095|NCT00580840|16902716|P2|Double-Blind|Lost to Follow-up|1
4906096|NCT00580840|16902717|P1|Double-Blind|Lost to Follow-up|0
4906097|NCT00580840|16902714|P4|Double-Blind|Loss of Efficacy|10
4906098|NCT00580840|16902715|P3|Double-Blind|Loss of Efficacy|2
4906099|NCT00580840|16902716|P2|Double-Blind|Loss of Efficacy|1
4906100|NCT00580840|16902717|P1|Double-Blind|Loss of Efficacy|0
4906101|NCT00580840|16902714|P4|Double-Blind|Adverse Event|1
4906102|NCT00580840|16902715|P3|Double-Blind|Adverse Event|4
4906103|NCT00580840|16902716|P2|Double-Blind|Adverse Event|3
4906104|NCT00580840|16902717|P1|Double-Blind|Adverse Event|0
4906105|NCT00580840|16902714|P4|Run-in|Other: Exclusionary Lab Value|0
4906106|NCT00580840|16902715|P3|Run-in|Other: Exclusionary Lab Value|0
4906107|NCT00580840|16902716|P2|Run-in|Other: Exclusionary Lab Value|0
4906108|NCT00580840|16902717|P1|Run-in|Other: Exclusionary Lab Value|1
4906109|NCT00580840|16902714|P4|Run-in|Other: Did Not Meet Joint Count Criteria|0
4906110|NCT00580840|16902715|P3|Run-in|Other: Did Not Meet Joint Count Criteria|0
4906111|NCT00580840|16902716|P2|Run-in|Other: Did Not Meet Joint Count Criteria|0
4906112|NCT00580840|16902717|P1|Run-in|Other: Did Not Meet Joint Count Criteria|1
4906113|NCT00580840|16902714|P4|Run-in|Other: Per Sponsor Request|0
4906114|NCT00580840|16902715|P3|Run-in|Other: Per Sponsor Request|0
4906115|NCT00580840|16902716|P2|Run-in|Other: Per Sponsor Request|0
4906116|NCT00580840|16902717|P1|Run-in|Other: Per Sponsor Request|2
4906117|NCT00580840|16902714|P4|Run-in|Withdrawal by Subject|0
4906118|NCT00580840|16902715|P3|Run-in|Withdrawal by Subject|0
4906119|NCT00580840|16902716|P2|Run-in|Withdrawal by Subject|0
4906120|NCT00580840|16902717|P1|Run-in|Withdrawal by Subject|5
4906121|NCT00580840|16902714|P4|Run-in|Lost to Follow-up|0
4906122|NCT00580840|16902715|P3|Run-in|Lost to Follow-up|0
4906123|NCT00580840|16902716|P2|Run-in|Lost to Follow-up|0
4906124|NCT00580840|16902717|P1|Run-in|Lost to Follow-up|4
4906125|NCT00580840|16902714|P4|Run-in|Loss of Efficacy|0
4906126|NCT00580840|16902715|P3|Run-in|Loss of Efficacy|0
4906127|NCT00580840|16902716|P2|Run-in|Loss of Efficacy|0
4906128|NCT00580840|16902717|P1|Run-in|Loss of Efficacy|1
4906129|NCT00580840|16902714|P4|Run-in|Lack of Efficacy|0
4906130|NCT00580840|16902715|P3|Run-in|Lack of Efficacy|0
4906131|NCT00580840|16902716|P2|Run-in|Lack of Efficacy|0
4906132|NCT00580840|16902717|P1|Run-in|Lack of Efficacy|93
4906133|NCT00580840|16902714|P4|Run-in|Adverse Event|0
4906134|NCT00580840|16902715|P3|Run-in|Adverse Event|0
4906135|NCT00580840|16902716|P2|Run-in|Adverse Event|0
4906136|NCT00580840|16902717|P1|Run-in|Adverse Event|17
4906137|NCT00580801|16902825|P3|Overall Study|Travel|0
4906138|NCT00580801|16902826|P2|Overall Study|Travel|0
4906139|NCT00580801|16902827|P1|Overall Study|Travel|1
4906140|NCT00580801|16902825|P3|Overall Study|Participant non-compliant|1
4906141|NCT00580801|16902826|P2|Overall Study|Participant non-compliant|0
4906142|NCT00580801|16902827|P1|Overall Study|Participant non-compliant|0
4906143|NCT00580801|16902825|P3|Overall Study|Reached a virologic endpoint|2
4906144|NCT00580801|16902826|P2|Overall Study|Reached a virologic endpoint|1
4906145|NCT00580801|16902827|P1|Overall Study|Reached a virologic endpoint|0
4906146|NCT00580801|16902825|P3|Overall Study|Lost to Follow-up|0
4906147|NCT00580801|16902826|P2|Overall Study|Lost to Follow-up|0
4906148|NCT00580801|16902827|P1|Overall Study|Lost to Follow-up|2
4906149|NCT00580801|16902825|P3|Overall Study|Adverse Event|0
4906150|NCT00580801|16902826|P2|Overall Study|Adverse Event|0
4906151|NCT00580801|16902827|P1|Overall Study|Adverse Event|2
4906152|NCT00580801|16902825|P3|Overall Study|Physician Decision|0
4906153|NCT00580801|16902826|P2|Overall Study|Physician Decision|0
4906154|NCT00580801|16902827|P1|Overall Study|Physician Decision|1
4906155|NCT00580788|16902866|P4|Overall Study|Adverse Event|1
4906156|NCT00580788|16902867|P3|Overall Study|Adverse Event|0
4906157|NCT00580788|16902868|P2|Overall Study|Adverse Event|0
4906158|NCT00580788|16902869|P1|Overall Study|Adverse Event|0
4906159|NCT00580723|16902927|P1|Overall Study|Lost to Follow-up|5
4906160|NCT00580723|16902927|P1|Overall Study|Did not want to participate in extension|3
4906161|NCT00580606|16902970|P2|Open Label (OL)|Needed Prohibited Medication|1
4906162|NCT00580606|16902971|P1|Open Label (OL)|Needed Prohibited Medication|0
4906163|NCT00580606|16902970|P2|Open Label (OL)|Physician Decision|1
4906164|NCT00580606|16902971|P1|Open Label (OL)|Physician Decision|1
4906165|NCT00580606|16902970|P2|Open Label (OL)|Non-compliance|0
4906166|NCT00580606|16902971|P1|Open Label (OL)|Non-compliance|2
4906167|NCT00580606|16902970|P2|Open Label (OL)|Pregnancy|1
4906168|NCT00580606|16902971|P1|Open Label (OL)|Pregnancy|0
4906169|NCT00580606|16902970|P2|Open Label (OL)|Lost to Follow-up|1
4906170|NCT00580606|16902971|P1|Open Label (OL)|Lost to Follow-up|0
4906171|NCT00580606|16902970|P2|Open Label (OL)|Dosing Symptoms|1
4906172|NCT00580606|16902971|P1|Open Label (OL)|Dosing Symptoms|0
4906173|NCT00580606|16902970|P2|Open Label (OL)|Withdrawal by Subject|6
4906174|NCT00580606|16902971|P1|Open Label (OL)|Withdrawal by Subject|4
4906175|NCT00580606|16902970|P2|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1
4906176|NCT00580606|16902971|P1|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2
4906177|NCT00580047|16903052|P3|Overall Study|Withdrawal by Subject|0
4906178|NCT00580047|16903053|P2|Overall Study|Withdrawal by Subject|0
4906179|NCT00580047|16903054|P1|Overall Study|Withdrawal by Subject|1
4906180|NCT00580047|16903052|P3|Overall Study|Withdrawal by Subject|2
4906181|NCT00580047|16903053|P2|Overall Study|Withdrawal by Subject|1
4906182|NCT00580047|16903054|P1|Overall Study|Withdrawal by Subject|1
4906183|NCT00580047|16903052|P3|Overall Study|Lost to Follow-up|0
4906184|NCT00580047|16903053|P2|Overall Study|Lost to Follow-up|1
4906185|NCT00580047|16903054|P1|Overall Study|Lost to Follow-up|1
4906186|NCT00580034|16903065|P2|Overall Study|Toxicity|0
4906187|NCT00580034|16903066|P1|Overall Study|Toxicity|10
4906188|NCT00579982|16903072|P1|Overall Study|Protocol Violation|4
4906189|NCT00579982|16903072|P1|Overall Study|Adverse Event|4
4906190|NCT00579826|16903106|P2|Overall Study|Withdrawal by Subject|3
4906191|NCT00579826|16903107|P1|Overall Study|Withdrawal by Subject|5
4906192|NCT00579670|16903141|P5|Overall Study|Withdrawal by Subject|0
4906193|NCT00579670|16903142|P4|Overall Study|Withdrawal by Subject|0
4906194|NCT00579670|16903143|P3|Overall Study|Withdrawal by Subject|1
4906195|NCT00579670|16903144|P2|Overall Study|Withdrawal by Subject|0
4906196|NCT00579670|16903145|P1|Overall Study|Withdrawal by Subject|0
4906197|NCT00579670|16903141|P5|Overall Study|Other|0
4906198|NCT00579670|16903142|P4|Overall Study|Other|2
4906199|NCT00579670|16903143|P3|Overall Study|Other|1
4906200|NCT00579670|16903144|P2|Overall Study|Other|0
4906201|NCT00579670|16903145|P1|Overall Study|Other|0
4906202|NCT00579670|16903141|P5|Overall Study|Lost to Follow-up|0
4906203|NCT00579670|16903142|P4|Overall Study|Lost to Follow-up|4
4906204|NCT00579670|16903143|P3|Overall Study|Lost to Follow-up|0
4906205|NCT00579670|16903144|P2|Overall Study|Lost to Follow-up|1
4906206|NCT00579670|16903145|P1|Overall Study|Lost to Follow-up|0
4906207|NCT00579670|16903141|P5|Overall Study|Lack of Efficacy|0
4906208|NCT00579670|16903142|P4|Overall Study|Lack of Efficacy|14
4906209|NCT00579670|16903143|P3|Overall Study|Lack of Efficacy|1
4906210|NCT00579670|16903144|P2|Overall Study|Lack of Efficacy|0
4906211|NCT00579670|16903145|P1|Overall Study|Lack of Efficacy|0
4906212|NCT00579670|16903141|P5|Overall Study|Adverse Event|0
4906213|NCT00579670|16903142|P4|Overall Study|Adverse Event|2
4906214|NCT00579670|16903143|P3|Overall Study|Adverse Event|1
4906215|NCT00579670|16903144|P2|Overall Study|Adverse Event|0
4906216|NCT00579670|16903145|P1|Overall Study|Adverse Event|1
4906217|NCT00579670|16903141|P5|Overall Study|Death|0
4906218|NCT00579670|16903142|P4|Overall Study|Death|0
4906219|NCT00579670|16903143|P3|Overall Study|Death|0
4906220|NCT00579670|16903144|P2|Overall Study|Death|0
4906221|NCT00579670|16903145|P1|Overall Study|Death|1
4906222|NCT00579527|16903357|P1|Overall Study|Death|4
4906223|NCT00579501|16903369|P1|Overall Study|Radiation therapy before surgery|1
4906224|NCT00579501|16903369|P1|Overall Study|Secondary lesion|1
4906225|NCT00579501|16903369|P1|Overall Study|toxicity|1
4906226|NCT00579501|16903369|P1|Overall Study|End of neoadjuvant therapy|25
4906227|NCT00579501|16903369|P1|Overall Study|Death|1
4906228|NCT00579345|16903397|P8|Overall Study|Death|0
4906229|NCT00579345|16903398|P7|Overall Study|Death|0
4906230|NCT00579345|16903399|P6|Overall Study|Death|0
4906231|NCT00579345|16903400|P5|Overall Study|Death|0
4906232|NCT00579345|16903401|P4|Overall Study|Death|1
4906233|NCT00579345|16903402|P3|Overall Study|Death|1
4906234|NCT00579345|16903403|P2|Overall Study|Death|1
4906235|NCT00579345|16903404|P1|Overall Study|Death|1
4906236|NCT00579345|16903397|P8|Overall Study|Protocol Violation|1
4906237|NCT00579345|16903398|P7|Overall Study|Protocol Violation|0
4906238|NCT00579345|16903399|P6|Overall Study|Protocol Violation|0
4906239|NCT00579345|16903400|P5|Overall Study|Protocol Violation|0
4906240|NCT00579345|16903401|P4|Overall Study|Protocol Violation|0
4906241|NCT00579345|16903402|P3|Overall Study|Protocol Violation|0
4906242|NCT00579345|16903403|P2|Overall Study|Protocol Violation|0
4906243|NCT00579345|16903404|P1|Overall Study|Protocol Violation|1
4906244|NCT00579345|16903397|P8|Overall Study|Adverse Event|0
4906245|NCT00579345|16903398|P7|Overall Study|Adverse Event|0
4906246|NCT00579345|16903399|P6|Overall Study|Adverse Event|0
4906247|NCT00579345|16903400|P5|Overall Study|Adverse Event|0
4906248|NCT00579345|16903401|P4|Overall Study|Adverse Event|0
4906249|NCT00579345|16903402|P3|Overall Study|Adverse Event|1
4906250|NCT00579345|16903403|P2|Overall Study|Adverse Event|0
4906251|NCT00579345|16903404|P1|Overall Study|Adverse Event|0
4906252|NCT00579345|16903397|P8|Overall Study|Lost to Follow-up|0
4906253|NCT00579345|16903398|P7|Overall Study|Lost to Follow-up|0
4906254|NCT00579345|16903399|P6|Overall Study|Lost to Follow-up|0
4906255|NCT00579345|16903400|P5|Overall Study|Lost to Follow-up|0
4906256|NCT00579345|16903401|P4|Overall Study|Lost to Follow-up|0
4906257|NCT00579345|16903402|P3|Overall Study|Lost to Follow-up|0
4906258|NCT00579345|16903403|P2|Overall Study|Lost to Follow-up|0
4906259|NCT00579345|16903404|P1|Overall Study|Lost to Follow-up|1
4906260|NCT00579345|16903397|P8|Overall Study|Withdrawal by Subject|1
4906261|NCT00579345|16903398|P7|Overall Study|Withdrawal by Subject|0
4906262|NCT00579345|16903399|P6|Overall Study|Withdrawal by Subject|0
4906263|NCT00579345|16903400|P5|Overall Study|Withdrawal by Subject|0
4906264|NCT00579345|16903401|P4|Overall Study|Withdrawal by Subject|0
4906265|NCT00579345|16903402|P3|Overall Study|Withdrawal by Subject|0
4906266|NCT00579345|16903403|P2|Overall Study|Withdrawal by Subject|0
4906267|NCT00579345|16903404|P1|Overall Study|Withdrawal by Subject|2
4906268|NCT00579254|16903479|P1|Overall Study|Discontinued when study terminated|73
4906269|NCT00579254|16903479|P1|Overall Study|Lost to Follow-up|39
4906270|NCT00579098|16903503|P2|Overall Study|AF returned after ablation|2
4906271|NCT00579098|16903504|P1|Overall Study|AF returned after ablation|3
4906272|NCT00579098|16903503|P2|Overall Study|Withdrawal by Subject|3
4906273|NCT00579098|16903504|P1|Overall Study|Withdrawal by Subject|2
4906274|NCT00579098|16903503|P2|Overall Study|Adverse Event|3
4906275|NCT00579098|16903504|P1|Overall Study|Adverse Event|2
4906276|NCT00579098|16903503|P2|Overall Study|Lost to Follow-up|0
4906277|NCT00579098|16903504|P1|Overall Study|Lost to Follow-up|2
4906278|NCT00579059|16903520|P2|Overall Study|Study Canceled at 1 Year|10
4906279|NCT00579059|16903521|P1|Overall Study|Study Canceled at 1 Year|21
4906280|NCT00578942|16903595|P1|Overall Study|Lost to Follow-up|1
4906281|NCT00578877|16903634|P2|Overall Study|did not provide follow-up data|17
4906282|NCT00578877|16903635|P1|Overall Study|did not provide follow-up data|12
4906283|NCT00578877|16903634|P2|Overall Study|early discontinue|101
4906284|NCT00578877|16903635|P1|Overall Study|early discontinue|61
4906285|NCT00578877|16903634|P2|Overall Study|Lost to Follow-up|10
4906286|NCT00578877|16903635|P1|Overall Study|Lost to Follow-up|8
4906287|NCT00578864|16903643|P2|Overall Study|Death|0
4906288|NCT00578864|16903644|P1|Overall Study|Death|1
4906289|NCT00578812|16903660|P2|Overall Study|Not treated|7
4906290|NCT00578812|16903661|P1|Overall Study|Not treated|6
4906291|NCT00578786|16903700|P3|Overall Study|Qualified but Not Enrolled in Extension|0
4906292|NCT00578786|16903701|P2|Overall Study|Qualified but Not Enrolled in Extension|3
4906293|NCT00578786|16903702|P1|Overall Study|Qualified but Not Enrolled in Extension|0
4906294|NCT00578786|16903700|P3|Overall Study|Not Otherwise Specified|1
4906295|NCT00578786|16903701|P2|Overall Study|Not Otherwise Specified|4
4906296|NCT00578786|16903702|P1|Overall Study|Not Otherwise Specified|0
4906297|NCT00578786|16903700|P3|Overall Study|Pregnancy|0
4906298|NCT00578786|16903701|P2|Overall Study|Pregnancy|1
4906299|NCT00578786|16903702|P1|Overall Study|Pregnancy|0
4906300|NCT00578786|16903700|P3|Overall Study|Lost to Follow-up|0
4906301|NCT00578786|16903701|P2|Overall Study|Lost to Follow-up|4
4906302|NCT00578786|16903702|P1|Overall Study|Lost to Follow-up|0
4906303|NCT00578786|16903700|P3|Overall Study|Sponsor Decision|1
4906304|NCT00578786|16903701|P2|Overall Study|Sponsor Decision|0
4906305|NCT00578786|16903702|P1|Overall Study|Sponsor Decision|0
4906306|NCT00578786|16903700|P3|Overall Study|Physician Decision|1
4906307|NCT00578786|16903701|P2|Overall Study|Physician Decision|0
4906308|NCT00578786|16903702|P1|Overall Study|Physician Decision|1
4906309|NCT00578786|16903700|P3|Overall Study|Protocol Violation|1
4906310|NCT00578786|16903701|P2|Overall Study|Protocol Violation|3
4906311|NCT00578786|16903702|P1|Overall Study|Protocol Violation|0
4906312|NCT00578786|16903700|P3|Overall Study|Withdrawal by Subject|5
4906313|NCT00578786|16903701|P2|Overall Study|Withdrawal by Subject|8
4906314|NCT00578786|16903702|P1|Overall Study|Withdrawal by Subject|7
4906315|NCT00578786|16903700|P3|Overall Study|Early Escape from Prior Study|2
4906316|NCT00578786|16903701|P2|Overall Study|Early Escape from Prior Study|1
4906317|NCT00578786|16903702|P1|Overall Study|Early Escape from Prior Study|2
4906318|NCT00578786|16903700|P3|Overall Study|Lack of Efficacy|2
4906319|NCT00578786|16903701|P2|Overall Study|Lack of Efficacy|5
4906320|NCT00578786|16903702|P1|Overall Study|Lack of Efficacy|2
4906321|NCT00578786|16903700|P3|Overall Study|Adverse Event|17
4906322|NCT00578786|16903701|P2|Overall Study|Adverse Event|37
4906323|NCT00578786|16903702|P1|Overall Study|Adverse Event|27
4906324|NCT00578643|16903803|P1|Overall Study|Lost to Follow-up|1
4906325|NCT00578643|16903803|P1|Overall Study|Death|1
4906326|NCT00578565|16903819|P1|Overall Study|Adverse Event|3
4906327|NCT00578448|16903849|P1|1 Year Long Term Extension (LTE)|Adverse Event|1
4906328|NCT00578448|16903849|P1|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1
4906329|NCT00578448|16903849|P1|Day 1 up to 3 Years of Planned Study|Adverse Event|1
4906330|NCT00578448|16903849|P1|Day 1 up to 3 Years of Planned Study|Death|1
4906331|NCT00578344|16903900|P1|Overall Study|Graft failure|1
4906332|NCT00578344|16903900|P1|Overall Study|Insurance problems|1
4906333|NCT00578318|16903919|P2|Overall Study|Physician Decision|0
4906334|NCT00578318|16903920|P1|Overall Study|Physician Decision|1
4906335|NCT00578318|16903919|P2|Overall Study|Lost to Follow-up|0
4906336|NCT00578318|16903920|P1|Overall Study|Lost to Follow-up|2
4906337|NCT00578292|16903990|P1|Overall Study|Graft failure|2
4906338|NCT00578292|16903990|P1|Overall Study|Death|1
4906339|NCT00578227|16904014|P3|Overall Study|Withdrawal by Subject|3
4906340|NCT00578227|16904015|P2|Overall Study|Withdrawal by Subject|1
4906341|NCT00578227|16904016|P1|Overall Study|Withdrawal by Subject|5
4906342|NCT00578227|16904014|P3|Overall Study|Lost to Follow-up|1
4906343|NCT00578227|16904015|P2|Overall Study|Lost to Follow-up|1
4906344|NCT00578227|16904016|P1|Overall Study|Lost to Follow-up|0
4906345|NCT00578175|16904141|P3|Overall Study|Other reasons|23
4906346|NCT00578175|16904142|P2|Overall Study|Other reasons|42
4906347|NCT00578175|16904143|P1|Overall Study|Other reasons|70
4906348|NCT00578175|16904141|P3|Overall Study|Adverse Event|1
4906349|NCT00578175|16904142|P2|Overall Study|Adverse Event|1
4906350|NCT00578175|16904143|P1|Overall Study|Adverse Event|0
4906351|NCT00578136|16904222|P2|Overall Study|Not given intervention|1
4906352|NCT00578136|16904223|P1|Overall Study|Not given intervention|1
4906353|NCT00577889|16904241|P3|Overall Study|Withdrawal by Subject|0
4906354|NCT00577889|16904242|P2|Overall Study|Withdrawal by Subject|0
4906355|NCT00577889|16904243|P1|Overall Study|Withdrawal by Subject|1
4906356|NCT00577863|16904262|P2|Overall Study|Did Not Receive at Least One Injection|1
4906357|NCT00577863|16904263|P1|Overall Study|Did Not Receive at Least One Injection|0
4906358|NCT00577863|16904262|P2|Overall Study|Sponsor Decision|7
4906359|NCT00577863|16904263|P1|Overall Study|Sponsor Decision|2
4906360|NCT00577863|16904262|P2|Overall Study|Withdrawal by Subject|2
4906361|NCT00577863|16904263|P1|Overall Study|Withdrawal by Subject|0
4906362|NCT00577863|16904262|P2|Overall Study|Entry Criteria Exclusion|0
4906363|NCT00577863|16904263|P1|Overall Study|Entry Criteria Exclusion|1
4906364|NCT00577863|16904262|P2|Overall Study|Lost to Follow-up|2
4906365|NCT00577863|16904263|P1|Overall Study|Lost to Follow-up|2
4906366|NCT00577863|16904262|P2|Overall Study|Death|0
4906367|NCT00577863|16904263|P1|Overall Study|Death|1
4906368|NCT00577863|16904262|P2|Overall Study|Adverse Event|2
4906369|NCT00577863|16904263|P1|Overall Study|Adverse Event|4
4906370|NCT00577824|16904305|P3|Overall Study|Protocol Violation|0
4906371|NCT00577824|16904306|P2|Overall Study|Protocol Violation|1
4906372|NCT00577824|16904307|P1|Overall Study|Protocol Violation|1
4906373|NCT00577824|16904305|P3|Overall Study|Patient decision|1
4906374|NCT00577824|16904306|P2|Overall Study|Patient decision|1
4906375|NCT00577824|16904307|P1|Overall Study|Patient decision|0
4906376|NCT00577824|16904305|P3|Overall Study|Adverse Event|1
4906377|NCT00577824|16904306|P2|Overall Study|Adverse Event|18
4906378|NCT00577824|16904307|P1|Overall Study|Adverse Event|6
4906379|NCT00577772|16904365|P2|Overall Study|Lost to Follow-up|1
4906380|NCT00577772|16904366|P1|Overall Study|Lost to Follow-up|0
4906381|NCT00577720|16904376|P4|Overall Study|Withdrawal by Subject|2
4906382|NCT00577720|16904377|P3|Overall Study|Withdrawal by Subject|0
4906383|NCT00577720|16904378|P2|Overall Study|Withdrawal by Subject|0
4906384|NCT00577720|16904379|P1|Overall Study|Withdrawal by Subject|2
4906385|NCT00577720|16904376|P4|Overall Study|Protocol Violation|1
4906386|NCT00577720|16904377|P3|Overall Study|Protocol Violation|0
4906387|NCT00577720|16904378|P2|Overall Study|Protocol Violation|0
4906388|NCT00577720|16904379|P1|Overall Study|Protocol Violation|0
4906389|NCT00577720|16904376|P4|Overall Study|Lost to Follow-up|0
4906390|NCT00577720|16904377|P3|Overall Study|Lost to Follow-up|1
4906391|NCT00577720|16904378|P2|Overall Study|Lost to Follow-up|0
4906392|NCT00577720|16904379|P1|Overall Study|Lost to Follow-up|0
4906393|NCT00577720|16904376|P4|Overall Study|Adverse Event|4
4906394|NCT00577720|16904377|P3|Overall Study|Adverse Event|0
4906395|NCT00577720|16904378|P2|Overall Study|Adverse Event|1
4906396|NCT00577720|16904379|P1|Overall Study|Adverse Event|2
4906397|NCT00577707|16904397|P1|Overall Study|Withdrawal by Subject|3
4906398|NCT00577655|16904405|P2|Overall Study|Lost to Follow-up|1
4906399|NCT00577655|16904406|P1|Overall Study|Lost to Follow-up|1
4906400|NCT00577655|16904405|P2|Overall Study|Protocol Violation|1
4906401|NCT00577655|16904406|P1|Overall Study|Protocol Violation|0
4906402|NCT00577655|16904405|P2|Overall Study|Patient Request|2
4906403|NCT00577655|16904406|P1|Overall Study|Patient Request|0
4906404|NCT00577642|16904444|P1|Overall Study|Clinical Disease Progression|1
4906405|NCT00577629|16904448|P1|Long Term Follow-Up|Physician Decision|1
4906406|NCT00577629|16904448|P1|Long Term Follow-Up|Withdrawal by Subject|4
4906407|NCT00577629|16904448|P1|Long Term Follow-Up|Lost to Follow-up|5
4906408|NCT00577629|16904448|P1|Long Term Follow-Up|Death|15
4906409|NCT00577629|16904448|P1|Treatment Period|Death|1
4906410|NCT00577473|16904475|P2|Overall Study|Lack of Efficacy|7
4906411|NCT00577473|16904476|P1|Overall Study|Lack of Efficacy|8
4906412|NCT00577473|16904475|P2|Overall Study|Physician Decision|2
4906413|NCT00577473|16904476|P1|Overall Study|Physician Decision|2
4906414|NCT00577473|16904475|P2|Overall Study|Withdrawal by Subject|6
4906415|NCT00577473|16904476|P1|Overall Study|Withdrawal by Subject|2
4906416|NCT00577473|16904475|P2|Overall Study|Adverse Event|5
4906417|NCT00577473|16904476|P1|Overall Study|Adverse Event|8
4906418|NCT00577473|16904475|P2|Overall Study|Protocol Violation|4
4906419|NCT00577473|16904476|P1|Overall Study|Protocol Violation|1
4906420|NCT00577460|16904507|P3|Overall Study|Other|2
4906421|NCT00577460|16904508|P2|Overall Study|Other|3
4906422|NCT00577460|16904509|P1|Overall Study|Other|0
4906423|NCT00577460|16904507|P3|Overall Study|Withdrawal by Subject|6
4906424|NCT00577460|16904508|P2|Overall Study|Withdrawal by Subject|5
4906425|NCT00577460|16904509|P1|Overall Study|Withdrawal by Subject|5
4906426|NCT00577460|16904507|P3|Overall Study|Lost to Follow-up|4
4906427|NCT00577460|16904508|P2|Overall Study|Lost to Follow-up|3
4906428|NCT00577460|16904509|P1|Overall Study|Lost to Follow-up|0
4906429|NCT00577460|16904507|P3|Overall Study|Protocol Violation|1
4906430|NCT00577460|16904508|P2|Overall Study|Protocol Violation|1
4906431|NCT00577460|16904509|P1|Overall Study|Protocol Violation|0
4906432|NCT00577460|16904507|P3|Overall Study|Adverse Event|14
4906433|NCT00577460|16904508|P2|Overall Study|Adverse Event|7
4906434|NCT00577460|16904509|P1|Overall Study|Adverse Event|11
4906435|NCT00577408|16904618|P2|Overall Study|Psychiatric hospitalization|1
4906436|NCT00577408|16904619|P1|Overall Study|Psychiatric hospitalization|0
4906437|NCT00577408|16904618|P2|Overall Study|Death|1
4906438|NCT00577408|16904619|P1|Overall Study|Death|0
4906439|NCT00577408|16904618|P2|Overall Study|Scheduling Issues|3
4906440|NCT00577408|16904619|P1|Overall Study|Scheduling Issues|0
4906441|NCT00577408|16904618|P2|Overall Study|Moved out of state|1
4906442|NCT00577408|16904619|P1|Overall Study|Moved out of state|0
4906443|NCT00577408|16904618|P2|Overall Study|Refused Oral Naltrexone|1
4906444|NCT00577408|16904619|P1|Overall Study|Refused Oral Naltrexone|0
4906445|NCT00577408|16904618|P2|Overall Study|Non-compliance with study meds|3
4906446|NCT00577408|16904619|P1|Overall Study|Non-compliance with study meds|0
4906447|NCT00577408|16904618|P2|Overall Study|Continued opioid use|2
4906448|NCT00577408|16904619|P1|Overall Study|Continued opioid use|3
4906449|NCT00577408|16904618|P2|Overall Study|Stopped attending study visits|11
4906450|NCT00577408|16904619|P1|Overall Study|Stopped attending study visits|9
4906451|NCT00577395|16904627|P2|Overall Study|Study was terminated early by Sponsor|6
4906452|NCT00577395|16904628|P1|Overall Study|Study was terminated early by Sponsor|7
4906453|NCT00577382|16904638|P2|Overall Study|Lost to Follow-up|2
4906454|NCT00577382|16904639|P1|Overall Study|Lost to Follow-up|2
4906455|NCT00577382|16904638|P2|Overall Study|Death|1
4906456|NCT00577382|16904639|P1|Overall Study|Death|1
4906457|NCT00577382|16904638|P2|Overall Study|Intercurrent Illness|2
4906458|NCT00577382|16904639|P1|Overall Study|Intercurrent Illness|1
4906459|NCT00577382|16904638|P2|Overall Study|Progressive Disease|19
4906460|NCT00577382|16904639|P1|Overall Study|Progressive Disease|17
4906461|NCT00577382|16904638|P2|Overall Study|Withdrawal by Subject|1
4906462|NCT00577382|16904639|P1|Overall Study|Withdrawal by Subject|0
4906463|NCT00577382|16904638|P2|Overall Study|Adverse Event|6
4906464|NCT00577382|16904639|P1|Overall Study|Adverse Event|0
4906465|NCT00577122|16904782|P2|Overall Study|Alternative Therapy|1
4906466|NCT00577122|16904783|P1|Overall Study|Alternative Therapy|0
4906467|NCT00577122|16904782|P2|Overall Study|Prog, refract disease during active trt|5
4906468|NCT00577122|16904783|P1|Overall Study|Prog, refract disease during active trt|8
4906469|NCT00577122|16904782|P2|Overall Study|Progression, relapse during active trt|8
4906470|NCT00577122|16904783|P1|Overall Study|Progression, relapse during active trt|6
4906471|NCT00577122|16904782|P2|Overall Study|Adverse Event|2
4906472|NCT00577122|16904783|P1|Overall Study|Adverse Event|0
4906473|NCT00577096|16904797|P2|Short Term Participation|Death|1
4906474|NCT00577096|16904798|P1|Short Term Participation|Death|1
4906475|NCT00577096|16904797|P2|Short Term Participation|Withdrawal by Subject|5
4906476|NCT00577096|16904798|P1|Short Term Participation|Withdrawal by Subject|3
4906477|NCT00577096|16904797|P2|Short Term Participation|withdrew from multiple myeloma treatment|2
4906478|NCT00577096|16904798|P1|Short Term Participation|withdrew from multiple myeloma treatment|3
4906479|NCT00577031|16904837|P1|Overall Study|Death|6
4906480|NCT00577031|16904837|P1|Overall Study|Medical decision|14
4906481|NCT00577031|16904837|P1|Overall Study|Need for surgery|17
4906482|NCT00577031|16904837|P1|Overall Study|Participant non-compliance|5
4906483|NCT00577031|16904837|P1|Overall Study|Participant withdrew consent|13
4906484|NCT00577031|16904837|P1|Overall Study|Protocol Violation|5
4906485|NCT00577031|16904837|P1|Overall Study|Progression of disease|93
4906486|NCT00577031|16904837|P1|Overall Study|Adverse Event|52
4906487|NCT00577005|16904858|P2|Overall Study|Withdrawal by Subject|1
4906488|NCT00577005|16904859|P1|Overall Study|Withdrawal by Subject|2
4906489|NCT00577005|16904858|P2|Overall Study|Lost to Follow-up|2
4906490|NCT00577005|16904859|P1|Overall Study|Lost to Follow-up|3
4906491|NCT00576927|16904873|P1|Sleep Hygiene With the Placebo|Withdrawal by Subject|1
4906492|NCT00576927|16904873|P1|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1
4906493|NCT00576927|16904873|P1|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1
4906494|NCT00576927|16904873|P1|Sleep Hygiene Behavioral Intervention|Death|1
4906495|NCT00576927|16904873|P1|Sleep Hygiene Behavioral Intervention|Responded to intervention|4
4906496|NCT00576927|16904873|P1|Baseline|Withdrawal by Subject|3
4906497|NCT00576927|16904873|P1|Baseline|Medication Change by PCP of subject|1
4906498|NCT00576927|16904873|P1|Baseline|Physician Decision|9
4906499|NCT00576927|16904873|P1|Clinical Assessment|Physician Decision|1
4906500|NCT00576927|16904873|P1|Clinical Assessment|Withdrawal by Subject|10
4906501|NCT00576927|16904873|P1|Clinical Assessment|Death|1
4906502|NCT00576927|16904873|P1|Clinical Assessment|Lack of Efficacy|24
4906503|NCT00576901|16904885|P1|Overall Study|Protocol Violation|1
4906504|NCT00576901|16904885|P1|Overall Study|Disease course|1
4906505|NCT00576901|16904885|P1|Overall Study|Withdrawal by Subject|1
4906506|NCT00576836|16904893|P2|Overall Study|Physician Decision|1
4906507|NCT00576836|16904894|P1|Overall Study|Physician Decision|0
4906508|NCT00576836|16904893|P2|Overall Study|Death|1
4906509|NCT00576836|16904894|P1|Overall Study|Death|0
4906510|NCT00576823|16904909|P3|40-week Safety Extension Phase|Lack of Efficacy|0
4906511|NCT00576823|16904910|P2|40-week Safety Extension Phase|Lack of Efficacy|0
4906512|NCT00576823|16904911|P1|40-week Safety Extension Phase|Lack of Efficacy|1
4906513|NCT00576823|16904909|P3|12-week Efficacy Phase|Parent's schedule issue|0
4906514|NCT00576823|16904910|P2|12-week Efficacy Phase|Parent's schedule issue|0
4906515|NCT00576823|16904911|P1|12-week Efficacy Phase|Parent's schedule issue|1
4906516|NCT00576758|16904927|P2|Follow-up Period|Withdrew consent|1
4906517|NCT00576758|16904928|P1|Follow-up Period|Withdrew consent|2
4906518|NCT00576758|16904927|P2|Follow-up Period|Insufficient therapeutic response|5
4906519|NCT00576758|16904928|P1|Follow-up Period|Insufficient therapeutic response|16
4906520|NCT00576758|16904927|P2|Follow-up Period|Death|3
4906521|NCT00576758|16904928|P1|Follow-up Period|Death|3
4906522|NCT00576758|16904927|P2|Follow-up Period|Administrative/Other|8
4906523|NCT00576758|16904928|P1|Follow-up Period|Administrative/Other|6
4906524|NCT00576758|16904927|P2|Extension Treatment Period|Administrative/Other|1
4906525|NCT00576758|16904928|P1|Extension Treatment Period|Administrative/Other|3
4906526|NCT00576758|16904927|P2|Extension Treatment Period|Insufficient therapeutic response|33
4906527|NCT00576758|16904928|P1|Extension Treatment Period|Insufficient therapeutic response|30
4906528|NCT00576758|16904927|P2|Extension Treatment Period|Refused treatment/did not cooperate|1
4906529|NCT00576758|16904928|P1|Extension Treatment Period|Refused treatment/did not cooperate|2
4906530|NCT00576758|16904927|P2|Extension Treatment Period|Death|1
4906531|NCT00576758|16904928|P1|Extension Treatment Period|Death|1
4906532|NCT00576758|16904927|P2|Extension Treatment Period|Adverse event or Intercurrent illness|7
4906533|NCT00576758|16904928|P1|Extension Treatment Period|Adverse event or Intercurrent illness|6
4906534|NCT00576758|16904927|P2|Induction Treatment Period|Withdrew consent|0
4906535|NCT00576758|16904928|P1|Induction Treatment Period|Withdrew consent|1
4906536|NCT00576758|16904927|P2|Induction Treatment Period|Refused treatment/ Did not Cooperate|1
4906537|NCT00576758|16904928|P1|Induction Treatment Period|Refused treatment/ Did not Cooperate|0
4906538|NCT00576758|16904927|P2|Induction Treatment Period|Death|0
4906539|NCT00576758|16904928|P1|Induction Treatment Period|Death|1
4906540|NCT00576758|16904927|P2|Induction Treatment Period|Violation of selection criteria at entry|1
4906541|NCT00576758|16904928|P1|Induction Treatment Period|Violation of selection criteria at entry|1
4906542|NCT00576758|16904927|P2|Induction Treatment Period|Insufficient therapeutic response|0
4906543|NCT00576758|16904928|P1|Induction Treatment Period|Insufficient therapeutic response|2
4906544|NCT00576758|16904927|P2|Induction Treatment Period|Adverse event or Intercurrent illness|3
4906545|NCT00576758|16904928|P1|Induction Treatment Period|Adverse event or Intercurrent illness|3
4906546|NCT00576732|16904974|P6|OPEN LABEL|Protocol Violation|0
4906547|NCT00576732|16904975|P5|OPEN LABEL|Protocol Violation|1
4906548|NCT00576732|16904976|P4|OPEN LABEL|Protocol Violation|2
4906549|NCT00576732|16904977|P3|OPEN LABEL|Protocol Violation|0
4906550|NCT00576732|16904978|P2|OPEN LABEL|Protocol Violation|0
4906551|NCT00576732|16904979|P1|OPEN LABEL|Protocol Violation|0
4906552|NCT00576732|16904974|P6|OPEN LABEL|Lack of Efficacy|3
4906553|NCT00576732|16904975|P5|OPEN LABEL|Lack of Efficacy|2
4906554|NCT00576732|16904976|P4|OPEN LABEL|Lack of Efficacy|2
4906555|NCT00576732|16904977|P3|OPEN LABEL|Lack of Efficacy|0
4906556|NCT00576732|16904978|P2|OPEN LABEL|Lack of Efficacy|0
4906557|NCT00576732|16904979|P1|OPEN LABEL|Lack of Efficacy|0
4906558|NCT00576732|16904974|P6|OPEN LABEL|OTHER|2
4906559|NCT00576732|16904975|P5|OPEN LABEL|OTHER|0
4906560|NCT00576732|16904976|P4|OPEN LABEL|OTHER|0
4906561|NCT00576732|16904977|P3|OPEN LABEL|OTHER|0
4906562|NCT00576732|16904978|P2|OPEN LABEL|OTHER|0
4906563|NCT00576732|16904979|P1|OPEN LABEL|OTHER|0
4906564|NCT00576732|16904974|P6|OPEN LABEL|Withdrawal by Subject|1
4906565|NCT00576732|16904975|P5|OPEN LABEL|Withdrawal by Subject|0
4906566|NCT00576732|16904976|P4|OPEN LABEL|Withdrawal by Subject|1
4906567|NCT00576732|16904977|P3|OPEN LABEL|Withdrawal by Subject|0
4906568|NCT00576732|16904978|P2|OPEN LABEL|Withdrawal by Subject|0
4906569|NCT00576732|16904979|P1|OPEN LABEL|Withdrawal by Subject|0
4906570|NCT00576732|16904974|P6|OPEN LABEL|Lost to Follow-up|1
4906571|NCT00576732|16904975|P5|OPEN LABEL|Lost to Follow-up|1
4906572|NCT00576732|16904976|P4|OPEN LABEL|Lost to Follow-up|2
4906573|NCT00576732|16904977|P3|OPEN LABEL|Lost to Follow-up|0
4906574|NCT00576732|16904978|P2|OPEN LABEL|Lost to Follow-up|0
4906575|NCT00576732|16904979|P1|OPEN LABEL|Lost to Follow-up|0
4906576|NCT00576732|16904974|P6|OPEN LABEL|Adverse Event|1
4906577|NCT00576732|16904975|P5|OPEN LABEL|Adverse Event|0
4906578|NCT00576732|16904976|P4|OPEN LABEL|Adverse Event|4
4906579|NCT00576732|16904977|P3|OPEN LABEL|Adverse Event|0
4906580|NCT00576732|16904978|P2|OPEN LABEL|Adverse Event|0
4906581|NCT00576732|16904979|P1|OPEN LABEL|Adverse Event|0
4906582|NCT00576732|16904974|P6|DOUBLE BLIND|Protocol Violation|0
4906583|NCT00576732|16904975|P5|DOUBLE BLIND|Protocol Violation|0
4906584|NCT00576732|16904976|P4|DOUBLE BLIND|Protocol Violation|0
4906585|NCT00576732|16904977|P3|DOUBLE BLIND|Protocol Violation|0
4906586|NCT00576732|16904978|P2|DOUBLE BLIND|Protocol Violation|0
4906587|NCT00576732|16904979|P1|DOUBLE BLIND|Protocol Violation|1
4906588|NCT00576732|16904974|P6|DOUBLE BLIND|Lack of Efficacy|0
4906589|NCT00576732|16904975|P5|DOUBLE BLIND|Lack of Efficacy|0
4906590|NCT00576732|16904976|P4|DOUBLE BLIND|Lack of Efficacy|0
4906591|NCT00576732|16904977|P3|DOUBLE BLIND|Lack of Efficacy|0
4906592|NCT00576732|16904978|P2|DOUBLE BLIND|Lack of Efficacy|1
4906593|NCT00576732|16904979|P1|DOUBLE BLIND|Lack of Efficacy|6
4906594|NCT00576732|16904974|P6|DOUBLE BLIND|OTHER|0
4906595|NCT00576732|16904975|P5|DOUBLE BLIND|OTHER|0
4906596|NCT00576732|16904976|P4|DOUBLE BLIND|OTHER|0
4906597|NCT00576732|16904977|P3|DOUBLE BLIND|OTHER|1
4906598|NCT00576732|16904978|P2|DOUBLE BLIND|OTHER|2
4906599|NCT00576732|16904979|P1|DOUBLE BLIND|OTHER|0
4906600|NCT00576732|16904974|P6|DOUBLE BLIND|Withdrawal by Subject|0
4906601|NCT00576732|16904975|P5|DOUBLE BLIND|Withdrawal by Subject|0
4906602|NCT00576732|16904976|P4|DOUBLE BLIND|Withdrawal by Subject|0
4906603|NCT00576732|16904977|P3|DOUBLE BLIND|Withdrawal by Subject|3
4906604|NCT00576732|16904978|P2|DOUBLE BLIND|Withdrawal by Subject|1
4906605|NCT00576732|16904979|P1|DOUBLE BLIND|Withdrawal by Subject|1
4906606|NCT00576732|16904974|P6|DOUBLE BLIND|Lost to Follow-up|0
4906607|NCT00576732|16904975|P5|DOUBLE BLIND|Lost to Follow-up|0
4906608|NCT00576732|16904976|P4|DOUBLE BLIND|Lost to Follow-up|0
4906609|NCT00576732|16904977|P3|DOUBLE BLIND|Lost to Follow-up|1
4906610|NCT00576732|16904978|P2|DOUBLE BLIND|Lost to Follow-up|1
4906611|NCT00576732|16904979|P1|DOUBLE BLIND|Lost to Follow-up|0
4906612|NCT00576732|16904974|P6|DOUBLE BLIND|Adverse Event|0
4906613|NCT00576732|16904975|P5|DOUBLE BLIND|Adverse Event|0
4906614|NCT00576732|16904976|P4|DOUBLE BLIND|Adverse Event|0
4906615|NCT00576732|16904977|P3|DOUBLE BLIND|Adverse Event|1
4906616|NCT00576732|16904978|P2|DOUBLE BLIND|Adverse Event|0
4906617|NCT00576732|16904979|P1|DOUBLE BLIND|Adverse Event|0
4906618|NCT00576693|16905011|P2|Overall Study|Withdrawal by Subject|13
4906619|NCT00576693|16905012|P1|Overall Study|Withdrawal by Subject|3
4906620|NCT00576693|16905011|P2|Overall Study|Lost to Follow-up|11
4906621|NCT00576693|16905012|P1|Overall Study|Lost to Follow-up|7
4906622|NCT00576628|16905024|P1|Overall Study|Dialysis|15
4906623|NCT00576628|16905024|P1|Overall Study|Transplantation|1
4906624|NCT00576628|16905024|P1|Overall Study|The patient move into other town|1
4906625|NCT00576628|16905024|P1|Overall Study|Progression of Renal Failure|1
4906626|NCT00576628|16905024|P1|Overall Study|Progression of Kidney Disease|1
4906627|NCT00576628|16905024|P1|Overall Study|RBC transfusion|1
4906628|NCT00576628|16905024|P1|Overall Study|Pregnancy|1
4906629|NCT00576628|16905024|P1|Overall Study|Refused Treatment|8
4906630|NCT00576628|16905024|P1|Overall Study|Failure to return|1
4906631|NCT00576628|16905024|P1|Overall Study|Death|2
4906632|NCT00576628|16905024|P1|Overall Study|Adverse Event|11
4906633|NCT00576576|16905044|P1|Overall Study|Protocol Violation|1
4906634|NCT00576576|16905044|P1|Overall Study|Lost to Follow-up|6
4906635|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Lost to Follow-up|3
4906636|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Lost to Follow-up|0
4906637|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Lost to Follow-up|0
4906638|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Lost to Follow-up|0
4906639|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Lost to Follow-up|0
4906640|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Lost to Follow-up|0
4906641|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Lost to Follow-up|0
4906642|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Lost to Follow-up|0
4906643|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Lost to Follow-up|0
4906644|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Lost to Follow-up|0
4906645|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Lost to Follow-up|0
4906646|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Lost to Follow-up|0
4906647|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Lost to Follow-up|0
4906648|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Lost to Follow-up|0
4906649|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Lost to Follow-up|0
4906650|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Medical reasons|6
4906651|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Medical reasons|0
4906652|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Medical reasons|0
4906653|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Medical reasons|0
4906654|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Medical reasons|0
4906655|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Medical reasons|0
4906656|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Medical reasons|0
4906657|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Medical reasons|0
4906658|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Medical reasons|0
4906659|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Medical reasons|0
4906660|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Medical reasons|0
4906661|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Medical reasons|0
4906662|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Medical reasons|0
4906663|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Medical reasons|0
4906664|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Medical reasons|0
4906665|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Withdrawal by Subject|6
4906666|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906667|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906668|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906669|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906670|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906671|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906672|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906673|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906674|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906675|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906676|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906677|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906678|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906679|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Withdrawal by Subject|0
4906680|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Side effects|8
4906681|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Side effects|0
4906682|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Side effects|0
4906683|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Side effects|0
4906684|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Side effects|0
4906685|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Side effects|0
4906686|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Side effects|0
4906687|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Side effects|0
4906688|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Side effects|0
4906689|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Side effects|0
4906690|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Side effects|0
4906691|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Side effects|0
4906692|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Side effects|0
4906693|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Side effects|0
4906694|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Side effects|0
4906695|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Insufficient data|0
4906696|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Insufficient data|4
4906697|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Insufficient data|0
4906698|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Insufficient data|0
4906699|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Insufficient data|0
4906700|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Insufficient data|0
4906701|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Insufficient data|0
4906702|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Insufficient data|0
4906703|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Insufficient data|0
4906704|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Insufficient data|0
4906705|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Insufficient data|0
4906706|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Insufficient data|0
4906707|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Insufficient data|0
4906708|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Insufficient data|0
4906709|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Insufficient data|0
4906710|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Declined to participate|0
4906711|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Declined to participate|7
4906712|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Declined to participate|0
4906713|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Declined to participate|0
4906714|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Declined to participate|0
4906715|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Declined to participate|0
4906716|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Declined to participate|0
4906717|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Declined to participate|0
4906718|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Declined to participate|0
4906719|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Declined to participate|0
4906720|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Declined to participate|0
4906721|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Declined to participate|0
4906722|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Declined to participate|0
4906723|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Declined to participate|0
4906724|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Declined to participate|0
4906725|NCT00576472|16905078|P15|MPH Home Maintenance Phase|Did not meet response criteria|0
4906726|NCT00576472|16905079|P14|MPH Home Maintenance Phase|Did not meet response criteria|16
4906727|NCT00576472|16905080|P13|MPH Home Maintenance Phase|Did not meet response criteria|0
4906728|NCT00576472|16905081|P12|MPH Home Maintenance Phase|Did not meet response criteria|0
4906729|NCT00576472|16905082|P11|MPH Home Maintenance Phase|Did not meet response criteria|0
4906730|NCT00576472|16905083|P10|MPH Home Maintenance Phase|Did not meet response criteria|0
4906731|NCT00576472|16905084|P9|MPH Home Maintenance Phase|Did not meet response criteria|0
4906732|NCT00576472|16905085|P8|MPH Home Maintenance Phase|Did not meet response criteria|0
4906733|NCT00576472|16905086|P7|MPH Home Maintenance Phase|Did not meet response criteria|0
4906734|NCT00576472|16905087|P6|MPH Home Maintenance Phase|Did not meet response criteria|0
4906735|NCT00576472|16905088|P5|MPH Home Maintenance Phase|Did not meet response criteria|0
4906736|NCT00576472|16905089|P4|MPH Home Maintenance Phase|Did not meet response criteria|0
4906737|NCT00576472|16905090|P3|MPH Home Maintenance Phase|Did not meet response criteria|0
4906738|NCT00576472|16905091|P2|MPH Home Maintenance Phase|Did not meet response criteria|0
4906739|NCT00576472|16905092|P1|MPH Home Maintenance Phase|Did not meet response criteria|0
4906740|NCT00576472|16905078|P15|MPH Cross Over Phase|Did not complete cross over phase|0
4906741|NCT00576472|16905079|P14|MPH Cross Over Phase|Did not complete cross over phase|0
4906742|NCT00576472|16905080|P13|MPH Cross Over Phase|Did not complete cross over phase|0
4906743|NCT00576472|16905081|P12|MPH Cross Over Phase|Did not complete cross over phase|1
4906744|NCT00576472|16905082|P11|MPH Cross Over Phase|Did not complete cross over phase|1
4906745|NCT00576472|16905083|P10|MPH Cross Over Phase|Did not complete cross over phase|0
4906746|NCT00576472|16905084|P9|MPH Cross Over Phase|Did not complete cross over phase|2
4906747|NCT00576472|16905085|P8|MPH Cross Over Phase|Did not complete cross over phase|0
4906748|NCT00576472|16905086|P7|MPH Cross Over Phase|Did not complete cross over phase|0
4906749|NCT00576472|16905087|P6|MPH Cross Over Phase|Did not complete cross over phase|0
4906750|NCT00576472|16905088|P5|MPH Cross Over Phase|Did not complete cross over phase|0
4906751|NCT00576472|16905089|P4|MPH Cross Over Phase|Did not complete cross over phase|0
4906752|NCT00576472|16905090|P3|MPH Cross Over Phase|Did not complete cross over phase|0
4906753|NCT00576472|16905091|P2|MPH Cross Over Phase|Did not complete cross over phase|0
4906754|NCT00576472|16905092|P1|MPH Cross Over Phase|Did not complete cross over phase|0
4906755|NCT00576472|16905078|P15|MPH Cross Over Phase|Physician Decision|0
4906756|NCT00576472|16905079|P14|MPH Cross Over Phase|Physician Decision|0
4906757|NCT00576472|16905080|P13|MPH Cross Over Phase|Physician Decision|0
4906758|NCT00576472|16905081|P12|MPH Cross Over Phase|Physician Decision|0
4906759|NCT00576472|16905082|P11|MPH Cross Over Phase|Physician Decision|0
4906760|NCT00576472|16905083|P10|MPH Cross Over Phase|Physician Decision|0
4906761|NCT00576472|16905084|P9|MPH Cross Over Phase|Physician Decision|0
4906762|NCT00576472|16905085|P8|MPH Cross Over Phase|Physician Decision|0
4906763|NCT00576472|16905086|P7|MPH Cross Over Phase|Physician Decision|4
4906764|NCT00576472|16905087|P6|MPH Cross Over Phase|Physician Decision|0
4906765|NCT00576472|16905088|P5|MPH Cross Over Phase|Physician Decision|0
4906766|NCT00576472|16905089|P4|MPH Cross Over Phase|Physician Decision|0
4906767|NCT00576472|16905090|P3|MPH Cross Over Phase|Physician Decision|0
4906768|NCT00576472|16905091|P2|MPH Cross Over Phase|Physician Decision|0
4906769|NCT00576472|16905092|P1|MPH Cross Over Phase|Physician Decision|0
4906770|NCT00576472|16905078|P15|MPH Cross Over Phase|Ineligible due to disease|0
4906771|NCT00576472|16905079|P14|MPH Cross Over Phase|Ineligible due to disease|0
4906772|NCT00576472|16905080|P13|MPH Cross Over Phase|Ineligible due to disease|0
4906773|NCT00576472|16905081|P12|MPH Cross Over Phase|Ineligible due to disease|0
4906774|NCT00576472|16905082|P11|MPH Cross Over Phase|Ineligible due to disease|0
4906775|NCT00576472|16905083|P10|MPH Cross Over Phase|Ineligible due to disease|0
4906776|NCT00576472|16905084|P9|MPH Cross Over Phase|Ineligible due to disease|0
4906777|NCT00576472|16905085|P8|MPH Cross Over Phase|Ineligible due to disease|0
4906778|NCT00576472|16905086|P7|MPH Cross Over Phase|Ineligible due to disease|2
4906779|NCT00576472|16905087|P6|MPH Cross Over Phase|Ineligible due to disease|0
4906780|NCT00576472|16905088|P5|MPH Cross Over Phase|Ineligible due to disease|0
4906781|NCT00576472|16905089|P4|MPH Cross Over Phase|Ineligible due to disease|0
4906782|NCT00576472|16905090|P3|MPH Cross Over Phase|Ineligible due to disease|0
4906783|NCT00576472|16905091|P2|MPH Cross Over Phase|Ineligible due to disease|0
4906784|NCT00576472|16905092|P1|MPH Cross Over Phase|Ineligible due to disease|0
4906785|NCT00576472|16905078|P15|MPH Cross Over Phase|Withdrawal by Subject|0
4906786|NCT00576472|16905079|P14|MPH Cross Over Phase|Withdrawal by Subject|0
4906787|NCT00576472|16905080|P13|MPH Cross Over Phase|Withdrawal by Subject|0
4906788|NCT00576472|16905081|P12|MPH Cross Over Phase|Withdrawal by Subject|0
4906789|NCT00576472|16905082|P11|MPH Cross Over Phase|Withdrawal by Subject|0
4906790|NCT00576472|16905083|P10|MPH Cross Over Phase|Withdrawal by Subject|0
4906791|NCT00576472|16905084|P9|MPH Cross Over Phase|Withdrawal by Subject|0
4906792|NCT00576472|16905085|P8|MPH Cross Over Phase|Withdrawal by Subject|0
4906793|NCT00576472|16905086|P7|MPH Cross Over Phase|Withdrawal by Subject|6
4906794|NCT00576472|16905087|P6|MPH Cross Over Phase|Withdrawal by Subject|0
4906795|NCT00576472|16905088|P5|MPH Cross Over Phase|Withdrawal by Subject|0
4906796|NCT00576472|16905089|P4|MPH Cross Over Phase|Withdrawal by Subject|0
4906797|NCT00576472|16905090|P3|MPH Cross Over Phase|Withdrawal by Subject|0
4906798|NCT00576472|16905091|P2|MPH Cross Over Phase|Withdrawal by Subject|0
4906799|NCT00576472|16905092|P1|MPH Cross Over Phase|Withdrawal by Subject|0
4906800|NCT00576472|16905078|P15|MPH In-Lab Phase|Psychiatric exclusion|0
4906801|NCT00576472|16905079|P14|MPH In-Lab Phase|Psychiatric exclusion|0
4906802|NCT00576472|16905080|P13|MPH In-Lab Phase|Psychiatric exclusion|0
4906803|NCT00576472|16905081|P12|MPH In-Lab Phase|Psychiatric exclusion|0
4906804|NCT00576472|16905082|P11|MPH In-Lab Phase|Psychiatric exclusion|0
4906805|NCT00576472|16905083|P10|MPH In-Lab Phase|Psychiatric exclusion|0
4906806|NCT00576472|16905084|P9|MPH In-Lab Phase|Psychiatric exclusion|0
4906807|NCT00576472|16905085|P8|MPH In-Lab Phase|Psychiatric exclusion|0
4906808|NCT00576472|16905086|P7|MPH In-Lab Phase|Psychiatric exclusion|0
4906809|NCT00576472|16905087|P6|MPH In-Lab Phase|Psychiatric exclusion|0
4906810|NCT00576472|16905088|P5|MPH In-Lab Phase|Psychiatric exclusion|0
4906811|NCT00576472|16905089|P4|MPH In-Lab Phase|Psychiatric exclusion|10
4906812|NCT00576472|16905090|P3|MPH In-Lab Phase|Psychiatric exclusion|0
4906813|NCT00576472|16905091|P2|MPH In-Lab Phase|Psychiatric exclusion|0
4906814|NCT00576472|16905092|P1|MPH In-Lab Phase|Psychiatric exclusion|0
4906815|NCT00576472|16905078|P15|MPH In-Lab Phase|No attention/academic problems|0
4906816|NCT00576472|16905079|P14|MPH In-Lab Phase|No attention/academic problems|0
4906817|NCT00576472|16905080|P13|MPH In-Lab Phase|No attention/academic problems|0
4906818|NCT00576472|16905081|P12|MPH In-Lab Phase|No attention/academic problems|0
4906819|NCT00576472|16905082|P11|MPH In-Lab Phase|No attention/academic problems|0
4906820|NCT00576472|16905083|P10|MPH In-Lab Phase|No attention/academic problems|0
4906821|NCT00576472|16905084|P9|MPH In-Lab Phase|No attention/academic problems|0
4906822|NCT00576472|16905085|P8|MPH In-Lab Phase|No attention/academic problems|0
4906823|NCT00576472|16905086|P7|MPH In-Lab Phase|No attention/academic problems|0
4906824|NCT00576472|16905087|P6|MPH In-Lab Phase|No attention/academic problems|0
4906825|NCT00576472|16905088|P5|MPH In-Lab Phase|No attention/academic problems|0
4906826|NCT00576472|16905089|P4|MPH In-Lab Phase|No attention/academic problems|245
4906827|NCT00576472|16905090|P3|MPH In-Lab Phase|No attention/academic problems|0
4906828|NCT00576472|16905091|P2|MPH In-Lab Phase|No attention/academic problems|0
4906829|NCT00576472|16905092|P1|MPH In-Lab Phase|No attention/academic problems|0
4906830|NCT00576472|16905078|P15|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906831|NCT00576472|16905079|P14|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906832|NCT00576472|16905080|P13|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906833|NCT00576472|16905081|P12|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906834|NCT00576472|16905082|P11|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906835|NCT00576472|16905083|P10|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906836|NCT00576472|16905084|P9|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906837|NCT00576472|16905085|P8|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906838|NCT00576472|16905086|P7|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906839|NCT00576472|16905087|P6|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906840|NCT00576472|16905088|P5|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906841|NCT00576472|16905089|P4|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4
4906842|NCT00576472|16905090|P3|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906843|NCT00576472|16905091|P2|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906844|NCT00576472|16905092|P1|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0
4906845|NCT00576472|16905078|P15|MPH In-Lab Phase|Lost to Follow-up|0
4906846|NCT00576472|16905079|P14|MPH In-Lab Phase|Lost to Follow-up|0
4906847|NCT00576472|16905080|P13|MPH In-Lab Phase|Lost to Follow-up|0
4906848|NCT00576472|16905081|P12|MPH In-Lab Phase|Lost to Follow-up|0
4906849|NCT00576472|16905082|P11|MPH In-Lab Phase|Lost to Follow-up|0
4906850|NCT00576472|16905083|P10|MPH In-Lab Phase|Lost to Follow-up|0
4906851|NCT00576472|16905084|P9|MPH In-Lab Phase|Lost to Follow-up|0
4906852|NCT00576472|16905085|P8|MPH In-Lab Phase|Lost to Follow-up|0
4906853|NCT00576472|16905086|P7|MPH In-Lab Phase|Lost to Follow-up|0
4906854|NCT00576472|16905087|P6|MPH In-Lab Phase|Lost to Follow-up|0
4906855|NCT00576472|16905088|P5|MPH In-Lab Phase|Lost to Follow-up|0
4906856|NCT00576472|16905089|P4|MPH In-Lab Phase|Lost to Follow-up|1
4906857|NCT00576472|16905090|P3|MPH In-Lab Phase|Lost to Follow-up|0
4906858|NCT00576472|16905091|P2|MPH In-Lab Phase|Lost to Follow-up|0
4906859|NCT00576472|16905092|P1|MPH In-Lab Phase|Lost to Follow-up|0
4906860|NCT00576472|16905078|P15|MPH In-Lab Phase|Declined participation in medication pha|0
4906861|NCT00576472|16905079|P14|MPH In-Lab Phase|Declined participation in medication pha|0
4906862|NCT00576472|16905080|P13|MPH In-Lab Phase|Declined participation in medication pha|0
4906863|NCT00576472|16905081|P12|MPH In-Lab Phase|Declined participation in medication pha|0
4906864|NCT00576472|16905082|P11|MPH In-Lab Phase|Declined participation in medication pha|0
4906865|NCT00576472|16905083|P10|MPH In-Lab Phase|Declined participation in medication pha|0
4906866|NCT00576472|16905084|P9|MPH In-Lab Phase|Declined participation in medication pha|0
4906867|NCT00576472|16905085|P8|MPH In-Lab Phase|Declined participation in medication pha|0
4906868|NCT00576472|16905086|P7|MPH In-Lab Phase|Declined participation in medication pha|0
4906869|NCT00576472|16905087|P6|MPH In-Lab Phase|Declined participation in medication pha|0
4906870|NCT00576472|16905088|P5|MPH In-Lab Phase|Declined participation in medication pha|0
4906871|NCT00576472|16905089|P4|MPH In-Lab Phase|Declined participation in medication pha|75
4906872|NCT00576472|16905090|P3|MPH In-Lab Phase|Declined participation in medication pha|0
4906873|NCT00576472|16905091|P2|MPH In-Lab Phase|Declined participation in medication pha|0
4906874|NCT00576472|16905092|P1|MPH In-Lab Phase|Declined participation in medication pha|0
4906875|NCT00576420|16905185|P3|Overall Study|Death|1
4906876|NCT00576420|16905186|P2|Overall Study|Death|0
4906877|NCT00576420|16905187|P1|Overall Study|Death|0
4906878|NCT00576407|16905352|P1|Overall Study|Physician Decision|1
4906879|NCT00576407|16905352|P1|Overall Study|Death|7
4906880|NCT00576381|16905364|P1|Overall Study|Adverse Event|4
4906881|NCT00576381|16905364|P1|Overall Study|Reoperation|3
4906882|NCT00576316|16905368|P1|Overall Study|Protocol Violation|9
4906883|NCT00576316|16905368|P1|Overall Study|Withdrawal by Subject|2
4906884|NCT00576316|16905368|P1|Overall Study|Adverse Event|9
4906885|NCT00576303|16905373|P1|Long Term Safety Period|Early withdrawal|16
4906886|NCT00576303|16905373|P1|Efficacy Evaluation Period|Early withdrawal|5
4906887|NCT00576303|16905373|P1|Dose Titration Period|Early withdrawal|17
4906888|NCT00576199|16905391|P1|Overall Study|Reason Unspecified|2
4906889|NCT00576199|16905391|P1|Overall Study|Refused Treatment|2
4906890|NCT00576199|16905391|P1|Overall Study|Insufficient Therapeutic Response|14
4906891|NCT00576199|16905391|P1|Overall Study|Adverse Event|12
4906892|NCT00576056|16905404|P1|Overall Study|Physician Decision|1
4906893|NCT00576056|16905404|P1|Overall Study|did not meet eligibility criteria|8
4906894|NCT00576056|16905404|P1|Overall Study|Withdrawal by Subject|2
4906895|NCT00576056|16905404|P1|Overall Study|Lack of Efficacy|1
4906896|NCT00576056|16905404|P1|Overall Study|Death|1
4906897|NCT00576056|16905404|P1|Overall Study|Adverse Event|1
4906898|NCT00575666|16905420|P2|Overall Study|Physician Decision|1
4906899|NCT00575666|16905421|P1|Overall Study|Physician Decision|1
4906900|NCT00575666|16905420|P2|Overall Study|Withdrawal by Subject|2
4906901|NCT00575666|16905421|P1|Overall Study|Withdrawal by Subject|3
4906902|NCT00575588|16905461|P2|Overall Study|Impossible to determine HbA1c|1
4906903|NCT00575588|16905462|P1|Overall Study|Impossible to determine HbA1c|0
4906904|NCT00575588|16905461|P2|Overall Study|Patient moved|3
4906905|NCT00575588|16905462|P1|Overall Study|Patient moved|1
4906906|NCT00575588|16905461|P2|Overall Study|Elevated triglyceride|0
4906907|NCT00575588|16905462|P1|Overall Study|Elevated triglyceride|1
4906908|NCT00575588|16905461|P2|Overall Study|Safety reasons|1
4906909|NCT00575588|16905462|P1|Overall Study|Safety reasons|2
4906910|NCT00575588|16905461|P2|Overall Study|Severe non-compliance to protocol|7
4906911|NCT00575588|16905462|P1|Overall Study|Severe non-compliance to protocol|5
4906912|NCT00575588|16905461|P2|Overall Study|Study specific discontinuation criteria|218
4906913|NCT00575588|16905462|P1|Overall Study|Study specific discontinuation criteria|203
4906914|NCT00575588|16905461|P2|Overall Study|Incorrect enrollment|4
4906915|NCT00575588|16905462|P1|Overall Study|Incorrect enrollment|8
4906916|NCT00575588|16905461|P2|Overall Study|Death|2
4906917|NCT00575588|16905462|P1|Overall Study|Death|4
4906918|NCT00575588|16905461|P2|Overall Study|Lost to Follow-up|3
4906919|NCT00575588|16905462|P1|Overall Study|Lost to Follow-up|1
4906920|NCT00575588|16905461|P2|Overall Study|Withdrawal by Subject|31
4906921|NCT00575588|16905462|P1|Overall Study|Withdrawal by Subject|27
4906922|NCT00575588|16905461|P2|Overall Study|Adverse Event|13
4906923|NCT00575588|16905462|P1|Overall Study|Adverse Event|11
4906924|NCT00575510|16905485|P3|Overall Study|Pregnancy|1
4906925|NCT00575510|16905486|P2|Overall Study|Pregnancy|0
4906926|NCT00575510|16905487|P1|Overall Study|Pregnancy|0
4906927|NCT00575510|16905485|P3|Overall Study|Clinic Called Patient|7
4906928|NCT00575510|16905486|P2|Overall Study|Clinic Called Patient|7
4906929|NCT00575510|16905487|P1|Overall Study|Clinic Called Patient|7
4906930|NCT00575510|16905485|P3|Overall Study|Withdrawal by Subject|0
4906931|NCT00575510|16905486|P2|Overall Study|Withdrawal by Subject|0
4906932|NCT00575510|16905487|P1|Overall Study|Withdrawal by Subject|1
4906933|NCT00575510|16905485|P3|Overall Study|Lost to Follow-up|9
4906934|NCT00575510|16905486|P2|Overall Study|Lost to Follow-up|6
4906935|NCT00575510|16905487|P1|Overall Study|Lost to Follow-up|4
4906936|NCT00575380|16905500|P2|Overall Study|Various|2
4906937|NCT00575380|16905501|P1|Overall Study|Various|0
4906938|NCT00575380|16905500|P2|Overall Study|Adverse Event|1
4906939|NCT00575380|16905501|P1|Overall Study|Adverse Event|0
4906940|NCT00575380|16905500|P2|Overall Study|Withdrawal by Subject|0
4906941|NCT00575380|16905501|P1|Overall Study|Withdrawal by Subject|1
4906942|NCT00575328|16905520|P2|Overall Study|Lost to Follow-up|1
4906943|NCT00575328|16905521|P1|Overall Study|Lost to Follow-up|2
4906944|NCT00575328|16905520|P2|Overall Study|Adverse Event|1
4906945|NCT00575328|16905521|P1|Overall Study|Adverse Event|1
4906946|NCT00575094|16905654|P1|Overall Study|Withdrawal by Subject|1
4906947|NCT00575094|16905654|P1|Overall Study|Adverse Event|2
4906948|NCT00575042|16905658|P1|Overall Study|Lost to Follow-up|1
4906949|NCT00575042|16905658|P1|Overall Study|Adverse Event|2
4906950|NCT00574951|16905709|P1|Overall Study|Ineligible - improper prior treatment|1
4906951|NCT00574912|16905717|P1|Overall Study|Physician Decision|2
4906952|NCT00574912|16905717|P1|Overall Study|scheduling conflicts|3
4906953|NCT00574912|16905717|P1|Overall Study|Could not place IV lines.|3
4906954|NCT00574873|16905731|P2|Overall Study|Extension Study|0
4906955|NCT00574873|16905732|P1|Overall Study|Extension Study|126
4906956|NCT00574873|16905731|P2|Overall Study|Blank, site closed per local regulations|2
4906957|NCT00574873|16905732|P1|Overall Study|Blank, site closed per local regulations|2
4906958|NCT00574873|16905731|P2|Overall Study|Discontinuation of study by sponsor|199
4906959|NCT00574873|16905732|P1|Overall Study|Discontinuation of study by sponsor|5
4906960|NCT00574873|16905731|P2|Overall Study|Other|4
4906961|NCT00574873|16905732|P1|Overall Study|Other|40
4906962|NCT00574873|16905731|P2|Overall Study|Lost to Follow-up|5
4906963|NCT00574873|16905732|P1|Overall Study|Lost to Follow-up|14
4906964|NCT00574873|16905731|P2|Overall Study|Death|14
4906965|NCT00574873|16905732|P1|Overall Study|Death|15
4906966|NCT00574873|16905731|P2|Overall Study|Investigator request|8
4906967|NCT00574873|16905732|P1|Overall Study|Investigator request|18
4906968|NCT00574873|16905731|P2|Overall Study|Withdrawal by Subject|19
4906969|NCT00574873|16905732|P1|Overall Study|Withdrawal by Subject|18
4906970|NCT00574847|16905750|P2|Overall Study|Did not receive medication (declined)|5
4906971|NCT00574847|16905751|P1|Overall Study|Did not receive medication (declined)|2
4906972|NCT00574847|16905750|P2|Overall Study|Physician Decision|0
4906973|NCT00574847|16905751|P1|Overall Study|Physician Decision|1
4906974|NCT00574847|16905750|P2|Overall Study|Withdrawal by Subject|2
4906975|NCT00574847|16905751|P1|Overall Study|Withdrawal by Subject|2
4906976|NCT00574847|16905750|P2|Overall Study|Death|0
4906977|NCT00574847|16905751|P1|Overall Study|Death|1
4906978|NCT00574847|16905750|P2|Overall Study|Adverse Event|0
4906979|NCT00574847|16905751|P1|Overall Study|Adverse Event|2
4906980|NCT00574795|16905796|P1|Toddler Dose|Withdrawal by Subject|1
4906981|NCT00574795|16905796|P1|After Infant Series|Adverse Event|2
4906982|NCT00574795|16905796|P1|After Infant Series|Withdrawal by Subject|1
4906983|NCT00574795|16905796|P1|Infant Series|Adverse Event|1
4906984|NCT00574795|16905796|P1|Infant Series|Protocol Violation|2
4906985|NCT00574795|16905796|P1|Infant Series|Withdrawal by Subject|2
4906986|NCT00574405|16905897|P2|Overall Study|Withdrawal by Subject|2
4906987|NCT00574405|16905898|P1|Overall Study|Withdrawal by Subject|3
4906988|NCT00574288|16905918|P7|Overall Study|Other|0
4906989|NCT00574288|16905919|P6|Overall Study|Other|0
4906990|NCT00574288|16905920|P5|Overall Study|Other|0
4906991|NCT00574288|16905921|P4|Overall Study|Other|0
4906992|NCT00574288|16905922|P3|Overall Study|Other|0
4906993|NCT00574288|16905923|P2|Overall Study|Other|1
4906994|NCT00574288|16905924|P1|Overall Study|Other|1
4906995|NCT00574288|16905918|P7|Overall Study|Progressive Disease|0
4906996|NCT00574288|16905919|P6|Overall Study|Progressive Disease|0
4906997|NCT00574288|16905920|P5|Overall Study|Progressive Disease|1
4906998|NCT00574288|16905921|P4|Overall Study|Progressive Disease|2
4906999|NCT00574288|16905922|P3|Overall Study|Progressive Disease|3
4907000|NCT00574288|16905923|P2|Overall Study|Progressive Disease|2
4907001|NCT00574288|16905924|P1|Overall Study|Progressive Disease|17
4907002|NCT00574288|16905918|P7|Overall Study|Study Terminated By Sponsor|5
4907003|NCT00574288|16905919|P6|Overall Study|Study Terminated By Sponsor|0
4907004|NCT00574288|16905920|P5|Overall Study|Study Terminated By Sponsor|0
4907005|NCT00574288|16905921|P4|Overall Study|Study Terminated By Sponsor|0
4907006|NCT00574288|16905922|P3|Overall Study|Study Terminated By Sponsor|0
4907007|NCT00574288|16905923|P2|Overall Study|Study Terminated By Sponsor|0
4907008|NCT00574288|16905924|P1|Overall Study|Study Terminated By Sponsor|0
4907009|NCT00574288|16905918|P7|Overall Study|Lost to Follow-up|2
4907010|NCT00574288|16905919|P6|Overall Study|Lost to Follow-up|1
4907011|NCT00574288|16905920|P5|Overall Study|Lost to Follow-up|0
4907012|NCT00574288|16905921|P4|Overall Study|Lost to Follow-up|0
4907013|NCT00574288|16905922|P3|Overall Study|Lost to Follow-up|0
4907014|NCT00574288|16905923|P2|Overall Study|Lost to Follow-up|0
4907015|NCT00574288|16905924|P1|Overall Study|Lost to Follow-up|0
4907016|NCT00574288|16905918|P7|Overall Study|Death|21
4907017|NCT00574288|16905919|P6|Overall Study|Death|25
4907018|NCT00574288|16905920|P5|Overall Study|Death|0
4907019|NCT00574288|16905921|P4|Overall Study|Death|0
4907020|NCT00574288|16905922|P3|Overall Study|Death|0
4907021|NCT00574288|16905923|P2|Overall Study|Death|0
4907022|NCT00574288|16905924|P1|Overall Study|Death|0
4907023|NCT00574288|16905918|P7|Overall Study|Adverse Event|0
4907024|NCT00574288|16905919|P6|Overall Study|Adverse Event|0
4907025|NCT00574288|16905920|P5|Overall Study|Adverse Event|1
4907026|NCT00574288|16905921|P4|Overall Study|Adverse Event|0
4907027|NCT00574288|16905922|P3|Overall Study|Adverse Event|0
4907028|NCT00574288|16905923|P2|Overall Study|Adverse Event|0
4907029|NCT00574288|16905924|P1|Overall Study|Adverse Event|2
4907030|NCT00574275|16905962|P2|Overall Study|Operation for curative intent|1
4907031|NCT00574275|16905963|P1|Overall Study|Operation for curative intent|0
4907032|NCT00574275|16905962|P2|Overall Study|Insurance change|1
4907033|NCT00574275|16905963|P1|Overall Study|Insurance change|0
4907034|NCT00574275|16905962|P2|Overall Study|Patient and Investigator decision|1
4907035|NCT00574275|16905963|P1|Overall Study|Patient and Investigator decision|0
4907036|NCT00574275|16905962|P2|Overall Study|Protocol Violation|1
4907037|NCT00574275|16905963|P1|Overall Study|Protocol Violation|0
4907038|NCT00574275|16905962|P2|Overall Study|Physician Decision|1
4907039|NCT00574275|16905963|P1|Overall Study|Physician Decision|1
4907040|NCT00574275|16905962|P2|Overall Study|Error calculating tumor measurement|0
4907041|NCT00574275|16905963|P1|Overall Study|Error calculating tumor measurement|1
4907042|NCT00574275|16905962|P2|Overall Study|Withdrawal by Subject|17
4907043|NCT00574275|16905963|P1|Overall Study|Withdrawal by Subject|15
4907044|NCT00574275|16905962|P2|Overall Study|Study stopped based on DMC decision|23
4907045|NCT00574275|16905963|P1|Overall Study|Study stopped based on DMC decision|62
4907046|NCT00574275|16905962|P2|Overall Study|Lost to Follow-up|1
4907047|NCT00574275|16905963|P1|Overall Study|Lost to Follow-up|2
4907048|NCT00574275|16905962|P2|Overall Study|Disease progression|146
4907049|NCT00574275|16905963|P1|Overall Study|Disease progression|160
4907050|NCT00574275|16905962|P2|Overall Study|Adverse Event|76
4907051|NCT00574275|16905963|P1|Overall Study|Adverse Event|32
4907052|NCT00574275|16905962|P2|Overall Study|Randomized but not treated|3
4907053|NCT00574275|16905963|P1|Overall Study|Randomized but not treated|2
4907054|NCT00574249|16905981|P2|Overall Study|PPD test taken twice|1
4907055|NCT00574249|16905982|P1|Overall Study|PPD test taken twice|0
4907056|NCT00574249|16905981|P2|Overall Study|Excluded by company|1
4907057|NCT00574249|16905982|P1|Overall Study|Excluded by company|0
4907058|NCT00574249|16905981|P2|Overall Study|Pregnancy|0
4907059|NCT00574249|16905982|P1|Overall Study|Pregnancy|1
4907060|NCT00574249|16905981|P2|Overall Study|Physician Decision|0
4907061|NCT00574249|16905982|P1|Overall Study|Physician Decision|1
4907062|NCT00574249|16905981|P2|Overall Study|Withdrawal by Subject|0
4907063|NCT00574249|16905982|P1|Overall Study|Withdrawal by Subject|3
4907064|NCT00574249|16905981|P2|Overall Study|History of carcinoma|0
4907065|NCT00574249|16905982|P1|Overall Study|History of carcinoma|1
4907066|NCT00574249|16905981|P2|Overall Study|Protocol Violation|2
4907067|NCT00574249|16905982|P1|Overall Study|Protocol Violation|5
4907068|NCT00574249|16905981|P2|Overall Study|Lost to Follow-up|3
4907069|NCT00574249|16905982|P1|Overall Study|Lost to Follow-up|4
4907070|NCT00574249|16905981|P2|Overall Study|Lack of Efficacy|3
4907071|NCT00574249|16905982|P1|Overall Study|Lack of Efficacy|5
4907072|NCT00574249|16905981|P2|Overall Study|Adverse Event|18
4907073|NCT00574249|16905982|P1|Overall Study|Adverse Event|6
4907074|NCT00574145|16906038|P2|Overall Study|Withdrawal by Subject|1
4907075|NCT00574145|16906039|P1|Overall Study|Withdrawal by Subject|2
4907076|NCT00574119|16906049|P1|Overall Study|Physician Decision|1
4907077|NCT00574119|16906049|P1|Overall Study|Withdrawal by Subject|1
4907078|NCT00574119|16906049|P1|Overall Study|Protocol Violation|1
4907079|NCT00574119|16906049|P1|Overall Study|Adverse Event|1
4907080|NCT00574080|16906063|P2|Overall Study|Death|10
4907081|NCT00574080|16906064|P1|Overall Study|Death|10
4907082|NCT00573937|16906133|P2|Overall Study|Study Terminated|1
4907083|NCT00573937|16906134|P1|Overall Study|Study Terminated|0
4907084|NCT00573859|16906148|P1|Smoking Versus Abstinence|Scheduling conflicts|12
4907085|NCT00573859|16906148|P1|Medication Versus Placebo|Scheduling conflicts|12
4907086|NCT00573833|16906154|P1|Overall Study|Not Treated|2
4907087|NCT00573794|16906161|P1|Overall Study|Other|46
4907088|NCT00573794|16906161|P1|Overall Study|Lack of Efficacy|94
4907089|NCT00573794|16906161|P1|Overall Study|Protocol Violation|6
4907090|NCT00573794|16906161|P1|Overall Study|Lost to Follow-up|13
4907091|NCT00573794|16906161|P1|Overall Study|Withdrew Consent|90
4907092|NCT00573794|16906161|P1|Overall Study|Adverse Event|81
4907093|NCT00573768|16906192|P3|Overall Study|Lost to Follow-up|1
4907094|NCT00573768|16906193|P2|Overall Study|Lost to Follow-up|0
4907095|NCT00573768|16906194|P1|Overall Study|Lost to Follow-up|0
4907096|NCT00573768|16906192|P3|Overall Study|Withdrawal by Subject|0
4907097|NCT00573768|16906193|P2|Overall Study|Withdrawal by Subject|1
4907098|NCT00573768|16906194|P1|Overall Study|Withdrawal by Subject|0
4907099|NCT00573768|16906192|P3|Overall Study|Protocol Violation|1
4907100|NCT00573768|16906193|P2|Overall Study|Protocol Violation|0
4907101|NCT00573768|16906194|P1|Overall Study|Protocol Violation|1
4907102|NCT00573768|16906192|P3|Overall Study|Adverse Event|2
4907103|NCT00573768|16906193|P2|Overall Study|Adverse Event|1
4907104|NCT00573768|16906194|P1|Overall Study|Adverse Event|1
4907105|NCT00573755|16906204|P2|Overall Study|Still receiving treatment|0
4907106|NCT00573755|16906205|P1|Overall Study|Still receiving treatment|1
4907107|NCT00573534|16906221|P1|Overall Study|oppositional behavior|3
4907108|NCT00573469|16906262|P3|Overall Study|Other|3
4907109|NCT00573469|16906263|P2|Overall Study|Other|1
4907110|NCT00573469|16906264|P1|Overall Study|Other|5
4907111|NCT00573469|16906262|P3|Overall Study|Withdrawal by Subject|0
4907112|NCT00573469|16906263|P2|Overall Study|Withdrawal by Subject|2
4907113|NCT00573469|16906264|P1|Overall Study|Withdrawal by Subject|0
4907114|NCT00573469|16906262|P3|Overall Study|Adverse Event|1
4907115|NCT00573469|16906263|P2|Overall Study|Adverse Event|1
4907116|NCT00573469|16906264|P1|Overall Study|Adverse Event|1
4907117|NCT00573443|16906287|P3|Open-Label Extension Phase|Other|0
4907118|NCT00573443|16906288|P2|Open-Label Extension Phase|Other|0
4907119|NCT00573443|16906289|P1|Open-Label Extension Phase|Other|2
4907120|NCT00573443|16906287|P3|Open-Label Extension Phase|Protocol Violation|0
4907121|NCT00573443|16906288|P2|Open-Label Extension Phase|Protocol Violation|0
4907122|NCT00573443|16906289|P1|Open-Label Extension Phase|Protocol Violation|2
4907123|NCT00573443|16906287|P3|Open-Label Extension Phase|Withdrawal by Subject|0
4907124|NCT00573443|16906288|P2|Open-Label Extension Phase|Withdrawal by Subject|0
4907125|NCT00573443|16906289|P1|Open-Label Extension Phase|Withdrawal by Subject|3
4907126|NCT00573443|16906287|P3|Open-Label Extension Phase|Serious Adverse Event|0
4907127|NCT00573443|16906288|P2|Open-Label Extension Phase|Serious Adverse Event|0
4907128|NCT00573443|16906289|P1|Open-Label Extension Phase|Serious Adverse Event|5
4907129|NCT00573443|16906287|P3|Open-Label Extension Phase|Adverse Event|0
4907130|NCT00573443|16906288|P2|Open-Label Extension Phase|Adverse Event|0
4907131|NCT00573443|16906289|P1|Open-Label Extension Phase|Adverse Event|3
4907132|NCT00573443|16906287|P3|Open-Label Extension Phase|Exacerbation of MS symptoms|0
4907133|NCT00573443|16906288|P2|Open-Label Extension Phase|Exacerbation of MS symptoms|0
4907134|NCT00573443|16906289|P1|Open-Label Extension Phase|Exacerbation of MS symptoms|2
4907135|NCT00573443|16906287|P3|Open-Label Extension Phase|Lost to Follow-up|0
4907136|NCT00573443|16906288|P2|Open-Label Extension Phase|Lost to Follow-up|0
4907137|NCT00573443|16906289|P1|Open-Label Extension Phase|Lost to Follow-up|1
4907138|NCT00573443|16906287|P3|Double-Blind Phase|Other|3
4907139|NCT00573443|16906288|P2|Double-Blind Phase|Other|2
4907140|NCT00573443|16906289|P1|Double-Blind Phase|Other|0
4907141|NCT00573443|16906287|P3|Double-Blind Phase|Protocol Violation|1
4907142|NCT00573443|16906288|P2|Double-Blind Phase|Protocol Violation|2
4907143|NCT00573443|16906289|P1|Double-Blind Phase|Protocol Violation|0
4907144|NCT00573443|16906287|P3|Double-Blind Phase|Withdrawal by Subject|7
4907145|NCT00573443|16906288|P2|Double-Blind Phase|Withdrawal by Subject|2
4907146|NCT00573443|16906289|P1|Double-Blind Phase|Withdrawal by Subject|2
4907147|NCT00573443|16906287|P3|Double-Blind Phase|Medication refusal due to AE|0
4907148|NCT00573443|16906288|P2|Double-Blind Phase|Medication refusal due to AE|2
4907149|NCT00573443|16906289|P1|Double-Blind Phase|Medication refusal due to AE|2
4907150|NCT00573443|16906287|P3|Double-Blind Phase|Serious Adverse Event (AE)|1
4907151|NCT00573443|16906288|P2|Double-Blind Phase|Serious Adverse Event (AE)|3
4907152|NCT00573443|16906289|P1|Double-Blind Phase|Serious Adverse Event (AE)|2
4907153|NCT00573443|16906287|P3|Double-Blind Phase|Adverse Event|0
4907154|NCT00573443|16906288|P2|Double-Blind Phase|Adverse Event|5
4907155|NCT00573443|16906289|P1|Double-Blind Phase|Adverse Event|1
4907156|NCT00573443|16906287|P3|Double-Blind Phase|Exacerbation of MS symptoms|1
4907157|NCT00573443|16906288|P2|Double-Blind Phase|Exacerbation of MS symptoms|0
4907158|NCT00573443|16906289|P1|Double-Blind Phase|Exacerbation of MS symptoms|1
4907159|NCT00573443|16906287|P3|Double-Blind Phase|Lost to Follow-up|2
4907160|NCT00573443|16906288|P2|Double-Blind Phase|Lost to Follow-up|3
4907161|NCT00573443|16906289|P1|Double-Blind Phase|Lost to Follow-up|1
4907162|NCT00573430|16906319|P3|Overall Study|Eligibility criteria not fulfilled|3
4907163|NCT00573430|16906320|P2|Overall Study|Eligibility criteria not fulfilled|0
4907164|NCT00573430|16906321|P1|Overall Study|Eligibility criteria not fulfilled|0
4907165|NCT00573430|16906319|P3|Overall Study|Protocol Violation|1
4907166|NCT00573430|16906320|P2|Overall Study|Protocol Violation|1
4907167|NCT00573430|16906321|P1|Overall Study|Protocol Violation|0
4907168|NCT00573430|16906319|P3|Overall Study|Withdrawal by Subject|1
4907169|NCT00573430|16906320|P2|Overall Study|Withdrawal by Subject|0
4907170|NCT00573430|16906321|P1|Overall Study|Withdrawal by Subject|1
4907171|NCT00573430|16906319|P3|Overall Study|Adverse Event|2
4907172|NCT00573430|16906320|P2|Overall Study|Adverse Event|0
4907173|NCT00573430|16906321|P1|Overall Study|Adverse Event|0
4907174|NCT00573430|16906319|P3|Overall Study|Incorrect enrollment of randomization|3
4907175|NCT00573430|16906320|P2|Overall Study|Incorrect enrollment of randomization|4
4907176|NCT00573430|16906321|P1|Overall Study|Incorrect enrollment of randomization|0
4907177|NCT00573391|16906343|P2|Overall Study|Death|0
4907178|NCT00573391|16906344|P1|Overall Study|Death|1
4907179|NCT00573391|16906343|P2|Overall Study|study stopped|2
4907180|NCT00573391|16906344|P1|Overall Study|study stopped|2
4907181|NCT00573313|16906354|P4|Overall Study|Protocol Violation|0
4907182|NCT00573313|16906355|P3|Overall Study|Protocol Violation|6
4907183|NCT00573313|16906356|P2|Overall Study|Protocol Violation|0
4907184|NCT00573313|16906357|P1|Overall Study|Protocol Violation|5
4907185|NCT00573248|16906407|P2|Overall Study|scheduling conflicts|11
4907186|NCT00573248|16906408|P1|Overall Study|scheduling conflicts|15
4907187|NCT00573183|16906422|P2|Overall Study|Other|2
4907188|NCT00573183|16906423|P1|Overall Study|Other|5
4907189|NCT00573183|16906422|P2|Overall Study|Incarceration|8
4907190|NCT00573183|16906423|P1|Overall Study|Incarceration|5
4907191|NCT00573183|16906422|P2|Overall Study|Adverse Event|0
4907192|NCT00573183|16906423|P1|Overall Study|Adverse Event|2
4907193|NCT00573183|16906422|P2|Overall Study|Death|1
4907194|NCT00573183|16906423|P1|Overall Study|Death|0
4907195|NCT00573183|16906422|P2|Overall Study|Withdrawal by Subject|2
4907196|NCT00573183|16906423|P1|Overall Study|Withdrawal by Subject|8
4907197|NCT00573183|16906422|P2|Overall Study|Lost to Follow-up|50
4907198|NCT00573183|16906423|P1|Overall Study|Lost to Follow-up|52
4907199|NCT00573170|16906431|P6|Third Treatment Period|Lost to Follow-up|2
4907200|NCT00573170|16906432|P5|Third Treatment Period|Lost to Follow-up|0
4907201|NCT00573170|16906433|P4|Third Treatment Period|Lost to Follow-up|0
4907202|NCT00573170|16906434|P3|Third Treatment Period|Lost to Follow-up|0
4907203|NCT00573170|16906435|P2|Third Treatment Period|Lost to Follow-up|0
4907204|NCT00573170|16906436|P1|Third Treatment Period|Lost to Follow-up|0
4907205|NCT00573170|16906431|P6|Third Treatment Period|Withdrawal by Subject|0
4907206|NCT00573170|16906432|P5|Third Treatment Period|Withdrawal by Subject|0
4907207|NCT00573170|16906433|P4|Third Treatment Period|Withdrawal by Subject|0
4907208|NCT00573170|16906434|P3|Third Treatment Period|Withdrawal by Subject|0
4907209|NCT00573170|16906435|P2|Third Treatment Period|Withdrawal by Subject|0
4907210|NCT00573170|16906436|P1|Third Treatment Period|Withdrawal by Subject|1
4907211|NCT00573170|16906431|P6|Second Washout Period|Other|2
4907212|NCT00573170|16906432|P5|Second Washout Period|Other|6
4907213|NCT00573170|16906433|P4|Second Washout Period|Other|4
4907214|NCT00573170|16906434|P3|Second Washout Period|Other|1
4907215|NCT00573170|16906435|P2|Second Washout Period|Other|2
4907216|NCT00573170|16906436|P1|Second Washout Period|Other|1
4907217|NCT00573170|16906431|P6|Second Washout Period|Lost to Follow-up|0
4907218|NCT00573170|16906432|P5|Second Washout Period|Lost to Follow-up|0
4907219|NCT00573170|16906433|P4|Second Washout Period|Lost to Follow-up|1
4907220|NCT00573170|16906434|P3|Second Washout Period|Lost to Follow-up|0
4907221|NCT00573170|16906435|P2|Second Washout Period|Lost to Follow-up|0
4907222|NCT00573170|16906436|P1|Second Washout Period|Lost to Follow-up|0
4907223|NCT00573170|16906431|P6|Second Washout Period|Withdrawal by Subject|0
4907224|NCT00573170|16906432|P5|Second Washout Period|Withdrawal by Subject|1
4907225|NCT00573170|16906433|P4|Second Washout Period|Withdrawal by Subject|0
4907226|NCT00573170|16906434|P3|Second Washout Period|Withdrawal by Subject|2
4907227|NCT00573170|16906435|P2|Second Washout Period|Withdrawal by Subject|1
4907228|NCT00573170|16906436|P1|Second Washout Period|Withdrawal by Subject|1
4907229|NCT00573170|16906431|P6|Second Washout Period|Protocol Violation|0
4907230|NCT00573170|16906432|P5|Second Washout Period|Protocol Violation|0
4907231|NCT00573170|16906433|P4|Second Washout Period|Protocol Violation|0
4907232|NCT00573170|16906434|P3|Second Washout Period|Protocol Violation|1
4907233|NCT00573170|16906435|P2|Second Washout Period|Protocol Violation|1
4907234|NCT00573170|16906436|P1|Second Washout Period|Protocol Violation|2
4907235|NCT00573170|16906431|P6|Second Washout Period|Adverse Event|0
4907236|NCT00573170|16906432|P5|Second Washout Period|Adverse Event|1
4907237|NCT00573170|16906433|P4|Second Washout Period|Adverse Event|0
4907238|NCT00573170|16906434|P3|Second Washout Period|Adverse Event|0
4907239|NCT00573170|16906435|P2|Second Washout Period|Adverse Event|0
4907240|NCT00573170|16906436|P1|Second Washout Period|Adverse Event|1
4907241|NCT00573170|16906431|P6|First Washout Period|Other|0
4907242|NCT00573170|16906432|P5|First Washout Period|Other|0
4907243|NCT00573170|16906433|P4|First Washout Period|Other|1
4907244|NCT00573170|16906434|P3|First Washout Period|Other|1
4907245|NCT00573170|16906435|P2|First Washout Period|Other|0
4907246|NCT00573170|16906436|P1|First Washout Period|Other|4
4907247|NCT00573170|16906431|P6|First Washout Period|Withdrawal by Subject|3
4907248|NCT00573170|16906432|P5|First Washout Period|Withdrawal by Subject|3
4907249|NCT00573170|16906433|P4|First Washout Period|Withdrawal by Subject|2
4907250|NCT00573170|16906434|P3|First Washout Period|Withdrawal by Subject|0
4907251|NCT00573170|16906435|P2|First Washout Period|Withdrawal by Subject|0
4907252|NCT00573170|16906436|P1|First Washout Period|Withdrawal by Subject|2
4907253|NCT00573170|16906431|P6|First Washout Period|Lost to Follow-up|2
4907254|NCT00573170|16906432|P5|First Washout Period|Lost to Follow-up|0
4907255|NCT00573170|16906433|P4|First Washout Period|Lost to Follow-up|2
4907256|NCT00573170|16906434|P3|First Washout Period|Lost to Follow-up|0
4907257|NCT00573170|16906435|P2|First Washout Period|Lost to Follow-up|1
4907258|NCT00573170|16906436|P1|First Washout Period|Lost to Follow-up|1
4907259|NCT00573170|16906431|P6|First Washout Period|Lack of Efficacy|1
4907260|NCT00573170|16906432|P5|First Washout Period|Lack of Efficacy|0
4907261|NCT00573170|16906433|P4|First Washout Period|Lack of Efficacy|0
4907262|NCT00573170|16906434|P3|First Washout Period|Lack of Efficacy|0
4907263|NCT00573170|16906435|P2|First Washout Period|Lack of Efficacy|0
4907264|NCT00573170|16906436|P1|First Washout Period|Lack of Efficacy|0
4907265|NCT00573170|16906431|P6|First Washout Period|Adverse Event|1
4907266|NCT00573170|16906432|P5|First Washout Period|Adverse Event|0
4907267|NCT00573170|16906433|P4|First Washout Period|Adverse Event|0
4907268|NCT00573170|16906434|P3|First Washout Period|Adverse Event|0
4907269|NCT00573170|16906435|P2|First Washout Period|Adverse Event|1
4907270|NCT00573170|16906436|P1|First Washout Period|Adverse Event|1
4907271|NCT00573170|16906431|P6|First Treatment Period|Did Not Treat Attack 1|0
4907272|NCT00573170|16906432|P5|First Treatment Period|Did Not Treat Attack 1|1
4907273|NCT00573170|16906433|P4|First Treatment Period|Did Not Treat Attack 1|0
4907274|NCT00573170|16906434|P3|First Treatment Period|Did Not Treat Attack 1|0
4907275|NCT00573170|16906435|P2|First Treatment Period|Did Not Treat Attack 1|0
4907276|NCT00573170|16906436|P1|First Treatment Period|Did Not Treat Attack 1|0
4907277|NCT00573157|16906512|P2|Overall Study|Other|1
4907278|NCT00573157|16906513|P1|Overall Study|Other|1
4907279|NCT00573157|16906512|P2|Overall Study|Adverse Event|1
4907280|NCT00573157|16906513|P1|Overall Study|Adverse Event|3
4907281|NCT00573144|16906525|P2|Overall Study|Withdrawal by Subject|3
4907282|NCT00573144|16906526|P1|Overall Study|Withdrawal by Subject|2
4907283|NCT00573131|16906538|P2|Overall Study|Withdrawal by Subject|8
4907284|NCT00573131|16906539|P1|Overall Study|Withdrawal by Subject|10
4907285|NCT00573066|16906545|P1|Overall Study|Postoperative bleeding|1
4907286|NCT00573066|16906545|P1|Overall Study|IV malfunction|1
4907287|NCT00573066|16906545|P1|Overall Study|Exclusion criteria|18
4907288|NCT00572910|16906589|P11|Overall Study|Withdrawal by Subject|1
4907289|NCT00572910|16906590|P10|Overall Study|Withdrawal by Subject|2
4907290|NCT00572910|16906591|P9|Overall Study|Withdrawal by Subject|2
4907291|NCT00572910|16906592|P8|Overall Study|Withdrawal by Subject|2
4907292|NCT00572910|16906593|P7|Overall Study|Withdrawal by Subject|0
4907293|NCT00572910|16906594|P6|Overall Study|Withdrawal by Subject|3
4907294|NCT00572910|16906595|P5|Overall Study|Withdrawal by Subject|1
4907295|NCT00572910|16906596|P4|Overall Study|Withdrawal by Subject|0
4907296|NCT00572910|16906597|P3|Overall Study|Withdrawal by Subject|1
4907297|NCT00572910|16906598|P2|Overall Study|Withdrawal by Subject|0
4907298|NCT00572910|16906599|P1|Overall Study|Withdrawal by Subject|3
4907299|NCT00572910|16906589|P11|Overall Study|Lost to Follow-up|0
4907300|NCT00572910|16906590|P10|Overall Study|Lost to Follow-up|1
4907301|NCT00572910|16906591|P9|Overall Study|Lost to Follow-up|0
4907302|NCT00572910|16906592|P8|Overall Study|Lost to Follow-up|0
4907303|NCT00572910|16906593|P7|Overall Study|Lost to Follow-up|0
4907304|NCT00572910|16906594|P6|Overall Study|Lost to Follow-up|0
4907305|NCT00572910|16906595|P5|Overall Study|Lost to Follow-up|1
4907306|NCT00572910|16906596|P4|Overall Study|Lost to Follow-up|2
4907307|NCT00572910|16906597|P3|Overall Study|Lost to Follow-up|1
4907308|NCT00572910|16906598|P2|Overall Study|Lost to Follow-up|1
4907309|NCT00572910|16906599|P1|Overall Study|Lost to Follow-up|0
4907310|NCT00572910|16906589|P11|Overall Study|Adverse Event|2
4907311|NCT00572910|16906590|P10|Overall Study|Adverse Event|3
4907312|NCT00572910|16906591|P9|Overall Study|Adverse Event|1
4907313|NCT00572910|16906592|P8|Overall Study|Adverse Event|2
4907314|NCT00572910|16906593|P7|Overall Study|Adverse Event|4
4907315|NCT00572910|16906594|P6|Overall Study|Adverse Event|0
4907316|NCT00572910|16906595|P5|Overall Study|Adverse Event|0
4907317|NCT00572910|16906596|P4|Overall Study|Adverse Event|2
4907318|NCT00572910|16906597|P3|Overall Study|Adverse Event|0
4907319|NCT00572910|16906598|P2|Overall Study|Adverse Event|2
4907320|NCT00572910|16906599|P1|Overall Study|Adverse Event|1
4907321|NCT00572832|16906666|P2|Overall Study|Pregnancy|1
4907322|NCT00572832|16906667|P1|Overall Study|Pregnancy|0
4907323|NCT00572832|16906666|P2|Overall Study|Lost to Follow-up|11
4907324|NCT00572832|16906667|P1|Overall Study|Lost to Follow-up|0
4907325|NCT00572728|16906673|P1|Overall Study|Pathology missing|1
4907326|NCT00572728|16906673|P1|Overall Study|FLT2 after second chemotherapy initiated|7
4907327|NCT00572728|16906673|P1|Overall Study|Second chemotherapy not initiated|1
4907328|NCT00572728|16906673|P1|Overall Study|FLT2 not completed|5
4907329|NCT00572728|16906673|P1|Overall Study|First Chemotherapy not initiated|2
4907330|NCT00572728|16906673|P1|Overall Study|FLT1 not completed|4
4907331|NCT00572728|16906673|P1|Overall Study|Offstudy due to complicating disease|1
4907332|NCT00572728|16906673|P1|Overall Study|Enrolled under Amendment 4|5
4907333|NCT00572728|16906673|P1|Overall Study|Ineligible|3
4907334|NCT00572728|16906673|P1|Overall Study|Withdrawal by Subject|10
4907335|NCT00572624|16906687|P2|Overall Study|Health issues unrelated to the study|0
4907336|NCT00572624|16906688|P1|Overall Study|Health issues unrelated to the study|1
4907337|NCT00572624|16906687|P2|Overall Study|Problem with vascular access|0
4907338|NCT00572624|16906688|P1|Overall Study|Problem with vascular access|1
4907339|NCT00572624|16906687|P2|Overall Study|Refused to do the stress test|0
4907340|NCT00572624|16906688|P1|Overall Study|Refused to do the stress test|1
4907341|NCT00572624|16906687|P2|Overall Study|Admitted to being a smoker|0
4907342|NCT00572624|16906688|P1|Overall Study|Admitted to being a smoker|1
4907343|NCT00572624|16906687|P2|Overall Study|Started a new job-- no time for study|0
4907344|NCT00572624|16906688|P1|Overall Study|Started a new job-- no time for study|1
4907345|NCT00572624|16906687|P2|Overall Study|Medication change|0
4907346|NCT00572624|16906688|P1|Overall Study|Medication change|1
4907347|NCT00572624|16906687|P2|Overall Study|Wanted to do a different diet program|0
4907348|NCT00572624|16906688|P1|Overall Study|Wanted to do a different diet program|1
4907349|NCT00572624|16906687|P2|Overall Study|Lost to Follow-up|4
4907350|NCT00572624|16906688|P1|Overall Study|Lost to Follow-up|10
4907351|NCT00572572|16906716|P2|Overall Study|Withdrawal by Subject|6
4907352|NCT00572572|16906717|P1|Overall Study|Withdrawal by Subject|3
4907353|NCT00572533|16906735|P2|Overall Study|Transfer out of Facility|1
4907354|NCT00572533|16906736|P1|Overall Study|Transfer out of Facility|0
4907355|NCT00572533|16906735|P2|Overall Study|Social Issues|0
4907356|NCT00572533|16906736|P1|Overall Study|Social Issues|1
4907357|NCT00572533|16906735|P2|Overall Study|Received Kidney Transplant|1
4907358|NCT00572533|16906736|P1|Overall Study|Received Kidney Transplant|2
4907359|NCT00572533|16906735|P2|Overall Study|Death|1
4907360|NCT00572533|16906736|P1|Overall Study|Death|4
4907361|NCT00572195|16906780|P1|Overall Study|Lost to Follow-up|5
4907362|NCT00572195|16906780|P1|Overall Study|Adverse Event|4
4907363|NCT00572195|16906780|P1|Overall Study|Death|9
4907364|NCT00572195|16906780|P1|Overall Study|Withdrawal by Subject|50
4907365|NCT00572156|16906792|P4|Overall Study|Sponsor Decision|19
4907366|NCT00572156|16906793|P3|Overall Study|Sponsor Decision|17
4907367|NCT00572156|16906794|P2|Overall Study|Sponsor Decision|16
4907368|NCT00572156|16906795|P1|Overall Study|Sponsor Decision|20
4907369|NCT00572156|16906792|P4|Overall Study|Patient/Parent Decision|3
4907370|NCT00572156|16906793|P3|Overall Study|Patient/Parent Decision|4
4907371|NCT00572156|16906794|P2|Overall Study|Patient/Parent Decision|6
4907372|NCT00572156|16906795|P1|Overall Study|Patient/Parent Decision|1
4907373|NCT00572156|16906792|P4|Overall Study|Protocol Violation|2
4907374|NCT00572156|16906793|P3|Overall Study|Protocol Violation|0
4907375|NCT00572156|16906794|P2|Overall Study|Protocol Violation|2
4907376|NCT00572156|16906795|P1|Overall Study|Protocol Violation|1
4907377|NCT00572156|16906792|P4|Overall Study|Lost to Follow-up|0
4907378|NCT00572156|16906793|P3|Overall Study|Lost to Follow-up|1
4907379|NCT00572156|16906794|P2|Overall Study|Lost to Follow-up|1
4907380|NCT00572156|16906795|P1|Overall Study|Lost to Follow-up|1
4907381|NCT00572156|16906792|P4|Overall Study|Adverse Event|1
4907382|NCT00572156|16906793|P3|Overall Study|Adverse Event|5
4907383|NCT00572156|16906794|P2|Overall Study|Adverse Event|1
4907384|NCT00572156|16906795|P1|Overall Study|Adverse Event|3
4907385|NCT00572039|16906866|P2|Overall Study|Ill|1
4907386|NCT00572039|16906867|P1|Overall Study|Ill|5
4907387|NCT00572039|16906866|P2|Overall Study|Death|3
4907388|NCT00572039|16906867|P1|Overall Study|Death|2
4907389|NCT00572039|16906866|P2|Overall Study|Withdrawal by Subject|6
4907390|NCT00572039|16906867|P1|Overall Study|Withdrawal by Subject|9
4907391|NCT00571948|16906899|P2|Overall Study|Parent were afraid of blood colection|5
4907392|NCT00571948|16906900|P1|Overall Study|Parent were afraid of blood colection|2
4907393|NCT00571948|16906899|P2|Overall Study|infant refused study meal|4
4907394|NCT00571948|16906900|P1|Overall Study|infant refused study meal|3
4907395|NCT00571948|16906899|P2|Overall Study|Protocol Violation|3
4907396|NCT00571948|16906900|P1|Overall Study|Protocol Violation|3
4907397|NCT00571948|16906899|P2|Overall Study|Withdrawal by Subject|2
4907398|NCT00571948|16906900|P1|Overall Study|Withdrawal by Subject|1
4907399|NCT00571948|16906899|P2|Overall Study|Lost to Follow-up|0
4907400|NCT00571948|16906900|P1|Overall Study|Lost to Follow-up|2
4907401|NCT00571922|16906908|P2|Overall Study|Completion unknown|36
4907402|NCT00571922|16906909|P1|Overall Study|Completion unknown|36
4907403|NCT00571701|16906919|P2|Second Intervention 12 Months|Withdrawal by Subject|0
4907404|NCT00571701|16906920|P1|Second Intervention 12 Months|Withdrawal by Subject|3
4907405|NCT00571701|16906919|P2|Second Intervention 12 Months|Adverse Event|1
4907406|NCT00571701|16906920|P1|Second Intervention 12 Months|Adverse Event|0
4907407|NCT00571701|16906919|P2|First Intervention 12 Months|Death|0
4907408|NCT00571701|16906920|P1|First Intervention 12 Months|Death|1
4907409|NCT00571701|16906919|P2|First Intervention 12 Months|Withdrawal by Subject|1
4907410|NCT00571701|16906920|P1|First Intervention 12 Months|Withdrawal by Subject|2
4907411|NCT00571688|16906946|P2|Overall Study|subject moved out of the area|0
4907412|NCT00571688|16906947|P1|Overall Study|subject moved out of the area|1
4907413|NCT00571688|16906946|P2|Overall Study|subject did not tolerate Consta|0
4907414|NCT00571688|16906947|P1|Overall Study|subject did not tolerate Consta|1
4907415|NCT00571688|16906946|P2|Overall Study|Lost to Follow-up|6
4907416|NCT00571688|16906947|P1|Overall Study|Lost to Follow-up|3
4907417|NCT00571662|16906953|P1|Overall Study|Adverse Event|5
4907418|NCT00571662|16906953|P1|Overall Study|psychiatric instability|1
4907419|NCT00571662|16906953|P1|Overall Study|Withdrawal by Subject|2
4907420|NCT00571649|16906964|P2|Follow-up Period|Protocol Violation|12
4907421|NCT00571649|16906965|P1|Follow-up Period|Protocol Violation|5
4907422|NCT00571649|16906964|P2|Follow-up Period|Patient convenience|121
4907423|NCT00571649|16906965|P1|Follow-up Period|Patient convenience|136
4907424|NCT00571649|16906964|P2|Follow-up Period|Lost to Follow-up|92
4907425|NCT00571649|16906965|P1|Follow-up Period|Lost to Follow-up|95
4907426|NCT00571649|16906964|P2|Follow-up Period|Physician Decision|13
4907427|NCT00571649|16906965|P1|Follow-up Period|Physician Decision|7
4907428|NCT00571649|16906964|P2|Follow-up Period|Death|133
4907429|NCT00571649|16906965|P1|Follow-up Period|Death|132
4907430|NCT00571649|16906964|P2|Follow-up Period|Withdrawal by Subject|115
4907431|NCT00571649|16906965|P1|Follow-up Period|Withdrawal by Subject|119
4907432|NCT00571649|16906964|P2|Follow-up Period|Clinical endpoint reached|2
4907433|NCT00571649|16906965|P1|Follow-up Period|Clinical endpoint reached|5
4907434|NCT00571649|16906964|P2|Follow-up Period|Adverse Event|40
4907435|NCT00571649|16906965|P1|Follow-up Period|Adverse Event|46
4907436|NCT00571649|16906964|P2|Treatment Period|Technical problems|5
4907437|NCT00571649|16906965|P1|Treatment Period|Technical problems|3
4907438|NCT00571649|16906964|P2|Treatment Period|Protocol Violation|92
4907439|NCT00571649|16906965|P1|Treatment Period|Protocol Violation|90
4907440|NCT00571649|16906964|P2|Treatment Period|Patient convenience|13
4907441|NCT00571649|16906965|P1|Treatment Period|Patient convenience|11
4907442|NCT00571649|16906964|P2|Treatment Period|Non-compliant with study medication|89
4907443|NCT00571649|16906965|P1|Treatment Period|Non-compliant with study medication|88
4907444|NCT00571649|16906964|P2|Treatment Period|Lost to Follow-up|41
4907445|NCT00571649|16906965|P1|Treatment Period|Lost to Follow-up|43
4907446|NCT00571649|16906964|P2|Treatment Period|Physician Decision|9
4907447|NCT00571649|16906965|P1|Treatment Period|Physician Decision|8
4907448|NCT00571649|16906964|P2|Treatment Period|Death|59
4907449|NCT00571649|16906965|P1|Treatment Period|Death|76
4907450|NCT00571649|16906964|P2|Treatment Period|Withdrawal by Subject|255
4907451|NCT00571649|16906965|P1|Treatment Period|Withdrawal by Subject|285
4907452|NCT00571649|16906964|P2|Treatment Period|Clinical endpoint reached|56
4907453|NCT00571649|16906965|P1|Treatment Period|Clinical endpoint reached|50
4907454|NCT00571649|16906964|P2|Treatment Period|Adverse Event|385
4907455|NCT00571649|16906965|P1|Treatment Period|Adverse Event|438
4907456|NCT00571103|16907063|P1|Overall Study|Lost to Follow-up|1
4907457|NCT00571103|16907063|P1|Overall Study|Withdrawal by Subject|1
4907458|NCT00571064|16907068|P1|Overall Study|Other|2
4907459|NCT00571064|16907068|P1|Overall Study|Withdrawal by Subject|2
4907460|NCT00571064|16907068|P1|Overall Study|Protocol Violation|4
4907461|NCT00571064|16907068|P1|Overall Study|Adverse Event|13
4907462|NCT00571038|16907083|P2|Overall Study|Moved out of state|2
4907463|NCT00571038|16907084|P1|Overall Study|Moved out of state|2
4907464|NCT00571038|16907083|P2|Overall Study|Withdrawal by Subject|3
4907465|NCT00571038|16907084|P1|Overall Study|Withdrawal by Subject|1
4907466|NCT00571038|16907083|P2|Overall Study|Death|5
4907467|NCT00571038|16907084|P1|Overall Study|Death|7
4907468|NCT00571038|16907083|P2|Overall Study|Lost to Follow-up|4
4907469|NCT00571038|16907084|P1|Overall Study|Lost to Follow-up|1
4907470|NCT00570921|16907139|P1|Overall Study|Physician Decision|1
4907471|NCT00570921|16907139|P1|Overall Study|Protocol Violation|1
4907472|NCT00570908|16907145|P1|Overall Study|Withdrawal by Subject|2
4907473|NCT00570908|16907145|P1|Overall Study|Adverse Event|5
4907474|NCT00570778|16907149|P4|Overall Study|Subject no longer requires study drug|0
4907475|NCT00570778|16907150|P3|Overall Study|Subject no longer requires study drug|0
4907476|NCT00570778|16907151|P2|Overall Study|Subject no longer requires study drug|1
4907477|NCT00570778|16907152|P1|Overall Study|Subject no longer requires study drug|0
4907478|NCT00570778|16907149|P4|Overall Study|Lost to Follow-up|0
4907479|NCT00570778|16907150|P3|Overall Study|Lost to Follow-up|1
4907480|NCT00570778|16907151|P2|Overall Study|Lost to Follow-up|0
4907481|NCT00570778|16907152|P1|Overall Study|Lost to Follow-up|0
4907482|NCT00570778|16907149|P4|Overall Study|Unsatisfactory therapeutic effect|0
4907483|NCT00570778|16907150|P3|Overall Study|Unsatisfactory therapeutic effect|0
4907484|NCT00570778|16907151|P2|Overall Study|Unsatisfactory therapeutic effect|0
4907485|NCT00570778|16907152|P1|Overall Study|Unsatisfactory therapeutic effect|1
4907486|NCT00570778|16907149|P4|Overall Study|Abnormal test procedure|0
4907487|NCT00570778|16907150|P3|Overall Study|Abnormal test procedure|0
4907488|NCT00570778|16907151|P2|Overall Study|Abnormal test procedure|0
4907489|NCT00570778|16907152|P1|Overall Study|Abnormal test procedure|1
4907490|NCT00570778|16907149|P4|Overall Study|Subject withdrew consent|1
4907491|NCT00570778|16907150|P3|Overall Study|Subject withdrew consent|0
4907492|NCT00570778|16907151|P2|Overall Study|Subject withdrew consent|1
4907493|NCT00570778|16907152|P1|Overall Study|Subject withdrew consent|0
4907494|NCT00570778|16907149|P4|Overall Study|Adverse Event|1
4907495|NCT00570778|16907150|P3|Overall Study|Adverse Event|4
4907496|NCT00570778|16907151|P2|Overall Study|Adverse Event|1
4907497|NCT00570778|16907152|P1|Overall Study|Adverse Event|0
4907498|NCT00570778|16907149|P4|Overall Study|Protocol deviation|2
4907499|NCT00570778|16907150|P3|Overall Study|Protocol deviation|2
4907500|NCT00570778|16907151|P2|Overall Study|Protocol deviation|1
4907501|NCT00570778|16907152|P1|Overall Study|Protocol deviation|2
4907502|NCT00570739|16907193|P4|Overall Study|Other|3
4907503|NCT00570739|16907194|P3|Overall Study|Other|5
4907504|NCT00570739|16907195|P2|Overall Study|Other|2
4907505|NCT00570739|16907196|P1|Overall Study|Other|0
4907506|NCT00570739|16907193|P4|Overall Study|Met discontinuation criteria|1
4907507|NCT00570739|16907194|P3|Overall Study|Met discontinuation criteria|1
4907508|NCT00570739|16907195|P2|Overall Study|Met discontinuation criteria|0
4907509|NCT00570739|16907196|P1|Overall Study|Met discontinuation criteria|1
4907510|NCT00570739|16907193|P4|Overall Study|Required restricted medication|0
4907511|NCT00570739|16907194|P3|Overall Study|Required restricted medication|1
4907512|NCT00570739|16907195|P2|Overall Study|Required restricted medication|0
4907513|NCT00570739|16907196|P1|Overall Study|Required restricted medication|0
4907514|NCT00570739|16907193|P4|Overall Study|Withdrawal by Subject|5
4907515|NCT00570739|16907194|P3|Overall Study|Withdrawal by Subject|3
4907516|NCT00570739|16907195|P2|Overall Study|Withdrawal by Subject|7
4907517|NCT00570739|16907196|P1|Overall Study|Withdrawal by Subject|7
4907518|NCT00570739|16907193|P4|Overall Study|Physician Decision|0
4907519|NCT00570739|16907194|P3|Overall Study|Physician Decision|0
4907520|NCT00570739|16907195|P2|Overall Study|Physician Decision|1
4907521|NCT00570739|16907196|P1|Overall Study|Physician Decision|1
4907522|NCT00570739|16907193|P4|Overall Study|Lost to Follow-up|1
4907523|NCT00570739|16907194|P3|Overall Study|Lost to Follow-up|4
4907524|NCT00570739|16907195|P2|Overall Study|Lost to Follow-up|5
4907525|NCT00570739|16907196|P1|Overall Study|Lost to Follow-up|4
4907526|NCT00570739|16907193|P4|Overall Study|Adverse Event|2
4907527|NCT00570739|16907194|P3|Overall Study|Adverse Event|2
4907528|NCT00570739|16907195|P2|Overall Study|Adverse Event|6
4907529|NCT00570739|16907196|P1|Overall Study|Adverse Event|8
4907530|NCT00570713|16907348|P2|Overall Study|Discontinuation of Study by the Sponsor|7
4907531|NCT00570713|16907349|P1|Overall Study|Discontinuation of Study by the Sponsor|10
4907532|NCT00570713|16907348|P2|Overall Study|Withdrawal by Subject|3
4907533|NCT00570713|16907349|P1|Overall Study|Withdrawal by Subject|3
4907534|NCT00570713|16907348|P2|Overall Study|Physician Decision|2
4907535|NCT00570713|16907349|P1|Overall Study|Physician Decision|2
4907536|NCT00570713|16907348|P2|Overall Study|Lack of Efficacy|49
4907537|NCT00570713|16907349|P1|Overall Study|Lack of Efficacy|40
4907538|NCT00570713|16907348|P2|Overall Study|Death|7
4907539|NCT00570713|16907349|P1|Overall Study|Death|7
4907540|NCT00570713|16907348|P2|Overall Study|Adverse Event|9
4907541|NCT00570713|16907349|P1|Overall Study|Adverse Event|16
4907542|NCT00570687|16907367|P10|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907543|NCT00570687|16907368|P9|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907544|NCT00570687|16907369|P8|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907545|NCT00570687|16907370|P7|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1
4907546|NCT00570687|16907371|P6|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907547|NCT00570687|16907372|P5|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907548|NCT00570687|16907373|P4|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907549|NCT00570687|16907374|P3|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907550|NCT00570687|16907375|P2|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907551|NCT00570687|16907376|P1|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907552|NCT00570687|16907367|P10|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907553|NCT00570687|16907368|P9|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1
4907554|NCT00570687|16907369|P8|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907555|NCT00570687|16907370|P7|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907556|NCT00570687|16907371|P6|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907557|NCT00570687|16907372|P5|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907558|NCT00570687|16907373|P4|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907559|NCT00570687|16907374|P3|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907560|NCT00570687|16907375|P2|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907561|NCT00570687|16907376|P1|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907562|NCT00570687|16907367|P10|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4907563|NCT00570687|16907368|P9|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
4907564|NCT00570687|16907369|P8|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4907565|NCT00570687|16907370|P7|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2
4907566|NCT00570687|16907371|P6|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4907567|NCT00570687|16907372|P5|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3
4907640|NCT00570310|16907531|P2|Overall Study|Adverse Event|2
4907568|NCT00570687|16907373|P4|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907569|NCT00570687|16907374|P3|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907570|NCT00570687|16907375|P2|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907571|NCT00570687|16907376|P1|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0
4907572|NCT00570674|16907402|P7|Overall Study|Withdrawal by Subject|0
4907573|NCT00570674|16907403|P6|Overall Study|Withdrawal by Subject|0
4907574|NCT00570674|16907404|P5|Overall Study|Withdrawal by Subject|0
4907575|NCT00570674|16907405|P4|Overall Study|Withdrawal by Subject|0
4907576|NCT00570674|16907406|P3|Overall Study|Withdrawal by Subject|1
4907577|NCT00570674|16907407|P2|Overall Study|Withdrawal by Subject|0
4907578|NCT00570674|16907408|P1|Overall Study|Withdrawal by Subject|0
4907579|NCT00570505|16907431|P1|Overall Study|Other loss to follow-up|4
4907580|NCT00570505|16907431|P1|Overall Study|Lost to Follow-up|23
4907581|NCT00570505|16907431|P1|Overall Study|Withdrawal by Subject|7
4907582|NCT00570505|16907431|P1|Overall Study|Adverse Event|7
4907583|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
4907584|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3
4907585|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0
4907586|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Lack of Efficacy|0
4907587|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Lack of Efficacy|3
4907588|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Lack of Efficacy|0
4907589|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Physician Decision|4
4907590|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Physician Decision|2
4907591|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Physician Decision|0
4907592|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Adverse Event|5
4907593|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Adverse Event|5
4907594|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Adverse Event|0
4907595|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Lost to Follow-up|7
4907596|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Lost to Follow-up|5
4907597|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Lost to Follow-up|0
4907598|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Protocol Violation|15
4907599|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Protocol Violation|12
4907600|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Protocol Violation|0
4907601|NCT00570492|16907444|P3|52-week Double-blind Treatment Period|Withdrawal by Subject|20
4907602|NCT00570492|16907445|P2|52-week Double-blind Treatment Period|Withdrawal by Subject|20
4907603|NCT00570492|16907446|P1|52-week Double-blind Treatment Period|Withdrawal by Subject|0
4907604|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
4907605|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0
4907606|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1
4907607|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Adverse Event|0
4907608|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Adverse Event|0
4907609|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Adverse Event|1
4907610|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Lost to Follow-up|0
4907611|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Lost to Follow-up|0
4907612|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Lost to Follow-up|2
4907613|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Protocol Violation|0
4907614|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Protocol Violation|0
4907615|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Protocol Violation|15
4907616|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Withdrawal by Subject|0
4907617|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Withdrawal by Subject|0
4907618|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Withdrawal by Subject|56
4907619|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
4907620|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0
4907621|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263
4907622|NCT00570492|16907444|P3|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
4907623|NCT00570492|16907445|P2|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0
4907624|NCT00570492|16907446|P1|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98
4907625|NCT00570401|16907484|P1|Overall Study|Adverse Event|2
4907626|NCT00570323|16907518|P2|Complete Study After Start|Physician Decision|0
4907627|NCT00570323|16907519|P1|Complete Study After Start|Physician Decision|1
4907628|NCT00570323|16907518|P2|Complete Study After Start|Withdrawal by Subject|0
4907629|NCT00570323|16907519|P1|Complete Study After Start|Withdrawal by Subject|2
4907630|NCT00570323|16907518|P2|Complete Study After Start|Lost to Follow-up|1
4907631|NCT00570323|16907519|P1|Complete Study After Start|Lost to Follow-up|0
4907632|NCT00570323|16907518|P2|Started Treatment After Randomization|Physician Decision|0
4907633|NCT00570323|16907519|P1|Started Treatment After Randomization|Physician Decision|1
4907634|NCT00570323|16907518|P2|Started Treatment After Randomization|Protocol Violation|0
4907635|NCT00570323|16907519|P1|Started Treatment After Randomization|Protocol Violation|1
4907636|NCT00570323|16907518|P2|Started Treatment After Randomization|Withdrawal by Subject|1
4907637|NCT00570323|16907519|P1|Started Treatment After Randomization|Withdrawal by Subject|0
4907638|NCT00570310|16907531|P2|Overall Study|Lack of Efficacy|4
4907639|NCT00570310|16907532|P1|Overall Study|Lack of Efficacy|1
4907641|NCT00570310|16907532|P1|Overall Study|Adverse Event|1
4907642|NCT00570232|16907551|P1|Overall Study|discontinued due to noncompliance|2
4907643|NCT00570232|16907551|P1|Overall Study|discontinued due to recurrence|8
4907644|NCT00570232|16907551|P1|Overall Study|discontinued due to medical condition|3
4907645|NCT00570232|16907551|P1|Overall Study|Adverse Event|10
4907646|NCT00570141|16907557|P1|Overall Study|Lost to Follow-up|1
4907647|NCT00570141|16907557|P1|Overall Study|Missed visits|1
4907648|NCT00570141|16907557|P1|Overall Study|Adverse Event|1
4907649|NCT00570063|16907573|P2|Overall Study|Sponsor's Decision|3
4907650|NCT00570063|16907574|P1|Overall Study|Sponsor's Decision|7
4907651|NCT00570063|16907573|P2|Overall Study|Withdrawal by Subject|3
4907652|NCT00570063|16907574|P1|Overall Study|Withdrawal by Subject|4
4907653|NCT00570063|16907573|P2|Overall Study|Lack of Efficacy|1
4907654|NCT00570063|16907574|P1|Overall Study|Lack of Efficacy|0
4907655|NCT00570063|16907573|P2|Overall Study|Adverse Event|1
4907656|NCT00570063|16907574|P1|Overall Study|Adverse Event|4
4907657|NCT00570037|16907640|P2|Overall Study|Could not reach for 6-8 week contact|69
4907658|NCT00570037|16907641|P1|Overall Study|Could not reach for 6-8 week contact|44
4907659|NCT00569946|16907651|P1|Overall Study|Global Deterioration of Health Status|1
4907660|NCT00569946|16907651|P1|Overall Study|Objective Progression or Relapse|42
4907661|NCT00569946|16907651|P1|Overall Study|Adverse Event|16
4907662|NCT00569803|16907683|P8|Overall Study|Withdrawal by Subject|1
4907663|NCT00569803|16907684|P7|Overall Study|Withdrawal by Subject|0
4907664|NCT00569803|16907685|P6|Overall Study|Withdrawal by Subject|0
4907665|NCT00569803|16907686|P5|Overall Study|Withdrawal by Subject|0
4907666|NCT00569803|16907687|P4|Overall Study|Withdrawal by Subject|0
4907667|NCT00569803|16907688|P3|Overall Study|Withdrawal by Subject|0
4907668|NCT00569803|16907689|P2|Overall Study|Withdrawal by Subject|0
4907669|NCT00569803|16907690|P1|Overall Study|Withdrawal by Subject|0
4907670|NCT00569803|16907683|P8|Overall Study|injection syringe leaked during dosing|0
4907671|NCT00569803|16907684|P7|Overall Study|injection syringe leaked during dosing|0
4907672|NCT00569803|16907685|P6|Overall Study|injection syringe leaked during dosing|0
4907673|NCT00569803|16907686|P5|Overall Study|injection syringe leaked during dosing|0
4907674|NCT00569803|16907687|P4|Overall Study|injection syringe leaked during dosing|1
4907675|NCT00569803|16907688|P3|Overall Study|injection syringe leaked during dosing|0
4907676|NCT00569803|16907689|P2|Overall Study|injection syringe leaked during dosing|0
4907677|NCT00569803|16907690|P1|Overall Study|injection syringe leaked during dosing|0
4907678|NCT00569803|16907683|P8|Overall Study|Lost to Follow-up|0
4907679|NCT00569803|16907684|P7|Overall Study|Lost to Follow-up|0
4907680|NCT00569803|16907685|P6|Overall Study|Lost to Follow-up|0
4907681|NCT00569803|16907686|P5|Overall Study|Lost to Follow-up|0
4907682|NCT00569803|16907687|P4|Overall Study|Lost to Follow-up|0
4907683|NCT00569803|16907688|P3|Overall Study|Lost to Follow-up|0
4907684|NCT00569803|16907689|P2|Overall Study|Lost to Follow-up|0
4907685|NCT00569803|16907690|P1|Overall Study|Lost to Follow-up|1
4907686|NCT00569777|16907817|P2|Overall Study|pregnant|0
4907687|NCT00569777|16907818|P1|Overall Study|pregnant|1
4907688|NCT00569777|16907817|P2|Overall Study|did not meet exclusion criteria|2
4907689|NCT00569777|16907818|P1|Overall Study|did not meet exclusion criteria|1
4907690|NCT00569777|16907817|P2|Overall Study|scheduled eye surgery|1
4907691|NCT00569777|16907818|P1|Overall Study|scheduled eye surgery|0
4907692|NCT00569777|16907817|P2|Overall Study|Lost to Follow-up|0
4907693|NCT00569777|16907818|P1|Overall Study|Lost to Follow-up|1
4907694|NCT00569777|16907817|P2|Overall Study|Adverse Event|0
4907695|NCT00569777|16907818|P1|Overall Study|Adverse Event|3
4907696|NCT00569777|16907817|P2|Overall Study|Withdrawal by Subject|0
4907697|NCT00569777|16907818|P1|Overall Study|Withdrawal by Subject|4
4907698|NCT00569582|16907869|P1|Overall Study|Subject was non-compliant.|1
4907699|NCT00569582|16907869|P1|Overall Study|Subject was too ill to travel.|1
4907700|NCT00569582|16907869|P1|Overall Study|Adverse Event|7
4907701|NCT00569582|16907869|P1|Overall Study|Death|2
4907702|NCT00569582|16907869|P1|Overall Study|Withdrawal by Subject|5
4907703|NCT00569374|16907885|P1|Overall Study|Withdrawal by Subject|4
4907704|NCT00569270|16907904|P2|Period: First Intervention|Protocol Violation|1
4907705|NCT00569270|16907905|P1|Period: First Intervention|Protocol Violation|0
4907706|NCT00569231|16907940|P1|Overall Study|Non-compliance|2
4907707|NCT00569231|16907940|P1|Overall Study|Car accident injury|1
4907708|NCT00569231|16907940|P1|Overall Study|Withdrawal by Subject|1
4907709|NCT00569231|16907940|P1|Overall Study|Airfare expense|2
4907710|NCT00569231|16907940|P1|Overall Study|Study unrelated surgery|1
4907711|NCT00569166|16907978|P3|Overall Study|Lost to Follow-up|1
4907712|NCT00569166|16907979|P2|Overall Study|Lost to Follow-up|1
4907713|NCT00569166|16907980|P1|Overall Study|Lost to Follow-up|2
4907714|NCT00569166|16907978|P3|Overall Study|Withdrawal by Subject|3
4907715|NCT00569166|16907979|P2|Overall Study|Withdrawal by Subject|5
4907716|NCT00569166|16907980|P1|Overall Study|Withdrawal by Subject|7
4907717|NCT00569127|16908014|P2|Overall Study|Still on Treatment|3
4907718|NCT00569127|16908015|P1|Overall Study|Still on Treatment|7
4907719|NCT00569127|16908014|P2|Overall Study|Not Eligible|11
4907720|NCT00569127|16908015|P1|Overall Study|Not Eligible|14
4907721|NCT00569127|16908014|P2|Overall Study|Lost to Follow-up|3
4907722|NCT00569127|16908015|P1|Overall Study|Lost to Follow-up|0
4907723|NCT00569127|16908014|P2|Overall Study|Other|19
4907724|NCT00569127|16908015|P1|Overall Study|Other|20
4907725|NCT00569127|16908014|P2|Overall Study|Death|3
4907726|NCT00569127|16908015|P1|Overall Study|Death|4
4907727|NCT00569127|16908014|P2|Overall Study|Progression|100
4907728|NCT00569127|16908015|P1|Overall Study|Progression|99
4907729|NCT00569127|16908014|P2|Overall Study|Withdrawal by Subject|27
4907730|NCT00569127|16908015|P1|Overall Study|Withdrawal by Subject|13
4907731|NCT00569127|16908014|P2|Overall Study|Adverse Event|47
4907732|NCT00569127|16908015|P1|Overall Study|Adverse Event|57
4907733|NCT00568958|16908050|P2|Follow-Up|Adverse Event|0
4907734|NCT00568958|16908051|P1|Follow-Up|Adverse Event|1
4907735|NCT00568958|16908050|P2|Follow-Up|Family Emergency|0
4907736|NCT00568958|16908051|P1|Follow-Up|Family Emergency|1
4907737|NCT00568958|16908050|P2|Follow-Up|Physician Decision|1
4907738|NCT00568958|16908051|P1|Follow-Up|Physician Decision|1
4907739|NCT00568958|16908050|P2|Follow-Up|Withdrawal by Subject|6
4907740|NCT00568958|16908051|P1|Follow-Up|Withdrawal by Subject|6
4907741|NCT00568958|16908050|P2|Allocation|Physician Decision|0
4907742|NCT00568958|16908051|P1|Allocation|Physician Decision|2
4907743|NCT00568958|16908050|P2|Allocation|Withdrawal by Subject|3
4907744|NCT00568958|16908051|P1|Allocation|Withdrawal by Subject|7
4907745|NCT00568776|16908098|P4|Overall Study|Miscellaeneous|4
4907746|NCT00568776|16908099|P3|Overall Study|Miscellaeneous|1
4907747|NCT00568776|16908100|P2|Overall Study|Miscellaeneous|3
4907748|NCT00568776|16908101|P1|Overall Study|Miscellaeneous|3
4907749|NCT00568776|16908098|P4|Overall Study|Sponsor Decision|42
4907750|NCT00568776|16908099|P3|Overall Study|Sponsor Decision|41
4907751|NCT00568776|16908100|P2|Overall Study|Sponsor Decision|2
4907752|NCT00568776|16908101|P1|Overall Study|Sponsor Decision|2
4907753|NCT00568776|16908098|P4|Overall Study|Loss of Caregiver|2
4907754|NCT00568776|16908099|P3|Overall Study|Loss of Caregiver|1
4907755|NCT00568776|16908100|P2|Overall Study|Loss of Caregiver|2
4907756|NCT00568776|16908101|P1|Overall Study|Loss of Caregiver|0
4907757|NCT00568776|16908098|P4|Overall Study|Withdrawal by Subject|7
4907758|NCT00568776|16908099|P3|Overall Study|Withdrawal by Subject|13
4907759|NCT00568776|16908100|P2|Overall Study|Withdrawal by Subject|15
4907760|NCT00568776|16908101|P1|Overall Study|Withdrawal by Subject|13
4907761|NCT00568776|16908098|P4|Overall Study|Protocol Violation|1
4907762|NCT00568776|16908099|P3|Overall Study|Protocol Violation|1
4907763|NCT00568776|16908100|P2|Overall Study|Protocol Violation|0
4907764|NCT00568776|16908101|P1|Overall Study|Protocol Violation|1
4907765|NCT00568776|16908098|P4|Overall Study|Lost to Follow-up|1
4907766|NCT00568776|16908099|P3|Overall Study|Lost to Follow-up|1
4907767|NCT00568776|16908100|P2|Overall Study|Lost to Follow-up|1
4907768|NCT00568776|16908101|P1|Overall Study|Lost to Follow-up|1
4907769|NCT00568776|16908098|P4|Overall Study|Lack of Efficacy|4
4907770|NCT00568776|16908099|P3|Overall Study|Lack of Efficacy|2
4907771|NCT00568776|16908100|P2|Overall Study|Lack of Efficacy|2
4907772|NCT00568776|16908101|P1|Overall Study|Lack of Efficacy|2
4907773|NCT00568776|16908098|P4|Overall Study|Physician Decision|0
4907774|NCT00568776|16908099|P3|Overall Study|Physician Decision|0
4907775|NCT00568776|16908100|P2|Overall Study|Physician Decision|2
4907776|NCT00568776|16908101|P1|Overall Study|Physician Decision|0
4907777|NCT00568776|16908098|P4|Overall Study|Death|3
4907778|NCT00568776|16908099|P3|Overall Study|Death|4
4907779|NCT00568776|16908100|P2|Overall Study|Death|1
4907780|NCT00568776|16908101|P1|Overall Study|Death|0
4907781|NCT00568776|16908098|P4|Overall Study|Adverse Event|8
4907782|NCT00568776|16908099|P3|Overall Study|Adverse Event|10
4907783|NCT00568776|16908100|P2|Overall Study|Adverse Event|8
4907784|NCT00568776|16908101|P1|Overall Study|Adverse Event|8
4907785|NCT00568685|16908150|P3|Overall Study|Protocol Violation|0
4907786|NCT00568685|16908151|P2|Overall Study|Protocol Violation|0
4907787|NCT00568685|16908152|P1|Overall Study|Protocol Violation|1
4907788|NCT00568685|16908150|P3|Overall Study|Withdrawal by Subject|2
4907789|NCT00568685|16908151|P2|Overall Study|Withdrawal by Subject|2
4907790|NCT00568685|16908152|P1|Overall Study|Withdrawal by Subject|7
4907791|NCT00568685|16908150|P3|Overall Study|Adverse Event|3
4907792|NCT00568685|16908151|P2|Overall Study|Adverse Event|3
4907793|NCT00568685|16908152|P1|Overall Study|Adverse Event|2
4907794|NCT00568555|16908209|P2|Overall Study|Withdrawal by Subject|1
4907795|NCT00568555|16908210|P1|Overall Study|Withdrawal by Subject|1
4907796|NCT00568451|16908228|P4|Overall Study|Disease Progression|7
4907797|NCT00568451|16908229|P3|Overall Study|Disease Progression|2
4907798|NCT00568451|16908230|P2|Overall Study|Disease Progression|0
4907799|NCT00568451|16908231|P1|Overall Study|Disease Progression|0
4907800|NCT00568399|16908247|P1|Overall Study|Withdrawal by Subject|8
4907801|NCT00568399|16908247|P1|Overall Study|Adverse Event|5
4907802|NCT00568399|16908247|P1|Overall Study|Death|2
4907803|NCT00568334|16908262|P2|Overall Study|Lost to Follow-up|0
4907804|NCT00568334|16908263|P1|Overall Study|Lost to Follow-up|1
4907805|NCT00568334|16908262|P2|Overall Study|Withdrawal by Subject|1
4907806|NCT00568334|16908263|P1|Overall Study|Withdrawal by Subject|0
4907807|NCT00568178|16908289|P6|Open Label Extension|Withdrawal by Subject|4
4907808|NCT00568178|16908290|P5|Open Label Extension|Withdrawal by Subject|4
4907809|NCT00568178|16908291|P4|Open Label Extension|Withdrawal by Subject|0
4907810|NCT00568178|16908292|P3|Open Label Extension|Withdrawal by Subject|0
4907811|NCT00568178|16908293|P2|Open Label Extension|Withdrawal by Subject|0
4907812|NCT00568178|16908294|P1|Open Label Extension|Withdrawal by Subject|0
4907813|NCT00568178|16908289|P6|Open Label Extension|Termination of Trial|47
4907814|NCT00568178|16908290|P5|Open Label Extension|Termination of Trial|45
4907815|NCT00568178|16908291|P4|Open Label Extension|Termination of Trial|0
4907816|NCT00568178|16908292|P3|Open Label Extension|Termination of Trial|0
4907817|NCT00568178|16908293|P2|Open Label Extension|Termination of Trial|0
4907818|NCT00568178|16908294|P1|Open Label Extension|Termination of Trial|0
4907819|NCT00568178|16908289|P6|Open Label Extension|Progressive Disease|1
4907820|NCT00568178|16908290|P5|Open Label Extension|Progressive Disease|3
4907821|NCT00568178|16908291|P4|Open Label Extension|Progressive Disease|0
4907822|NCT00568178|16908292|P3|Open Label Extension|Progressive Disease|0
4907823|NCT00568178|16908293|P2|Open Label Extension|Progressive Disease|0
4907824|NCT00568178|16908294|P1|Open Label Extension|Progressive Disease|0
4907825|NCT00568178|16908289|P6|Open Label Extension|Pregnancy|1
4907826|NCT00568178|16908290|P5|Open Label Extension|Pregnancy|0
4907827|NCT00568178|16908291|P4|Open Label Extension|Pregnancy|0
4907828|NCT00568178|16908292|P3|Open Label Extension|Pregnancy|0
4907829|NCT00568178|16908293|P2|Open Label Extension|Pregnancy|0
4907830|NCT00568178|16908294|P1|Open Label Extension|Pregnancy|0
4907831|NCT00568178|16908289|P6|Open Label Extension|Physician Decision|8
4907832|NCT00568178|16908290|P5|Open Label Extension|Physician Decision|9
4907833|NCT00568178|16908291|P4|Open Label Extension|Physician Decision|0
4907834|NCT00568178|16908292|P3|Open Label Extension|Physician Decision|0
4907835|NCT00568178|16908293|P2|Open Label Extension|Physician Decision|0
4907836|NCT00568178|16908294|P1|Open Label Extension|Physician Decision|0
4907837|NCT00568178|16908289|P6|Open Label Extension|Lost to Follow-up|11
4907838|NCT00568178|16908290|P5|Open Label Extension|Lost to Follow-up|6
4907839|NCT00568178|16908291|P4|Open Label Extension|Lost to Follow-up|0
4907840|NCT00568178|16908292|P3|Open Label Extension|Lost to Follow-up|0
4907841|NCT00568178|16908293|P2|Open Label Extension|Lost to Follow-up|0
4907842|NCT00568178|16908294|P1|Open Label Extension|Lost to Follow-up|0
4907843|NCT00568178|16908289|P6|Open Label Extension|Protocol Violation|0
4907844|NCT00568178|16908290|P5|Open Label Extension|Protocol Violation|1
4907845|NCT00568178|16908291|P4|Open Label Extension|Protocol Violation|0
4907846|NCT00568178|16908292|P3|Open Label Extension|Protocol Violation|0
4907847|NCT00568178|16908293|P2|Open Label Extension|Protocol Violation|0
4907848|NCT00568178|16908294|P1|Open Label Extension|Protocol Violation|0
4907849|NCT00568178|16908289|P6|Open Label Extension|Adverse Event|8
4907850|NCT00568178|16908290|P5|Open Label Extension|Adverse Event|11
4907851|NCT00568178|16908291|P4|Open Label Extension|Adverse Event|0
4907852|NCT00568178|16908292|P3|Open Label Extension|Adverse Event|0
4907853|NCT00568178|16908293|P2|Open Label Extension|Adverse Event|0
4907854|NCT00568178|16908294|P1|Open Label Extension|Adverse Event|0
4907855|NCT00568178|16908289|P6|Double Blind Base Study|Progressive Disease|0
4907856|NCT00568178|16908290|P5|Double Blind Base Study|Progressive Disease|0
4907857|NCT00568178|16908291|P4|Double Blind Base Study|Progressive Disease|1
4907858|NCT00568178|16908292|P3|Double Blind Base Study|Progressive Disease|0
4907859|NCT00568178|16908293|P2|Double Blind Base Study|Progressive Disease|0
4907860|NCT00568178|16908294|P1|Double Blind Base Study|Progressive Disease|0
4907861|NCT00568178|16908289|P6|Double Blind Base Study|Withdrawal by Subject|0
4907862|NCT00568178|16908290|P5|Double Blind Base Study|Withdrawal by Subject|0
4907863|NCT00568178|16908291|P4|Double Blind Base Study|Withdrawal by Subject|0
4907864|NCT00568178|16908292|P3|Double Blind Base Study|Withdrawal by Subject|0
4907865|NCT00568178|16908293|P2|Double Blind Base Study|Withdrawal by Subject|1
4907866|NCT00568178|16908294|P1|Double Blind Base Study|Withdrawal by Subject|1
4907867|NCT00568178|16908289|P6|Double Blind Base Study|Protocol Violation|0
4907868|NCT00568178|16908290|P5|Double Blind Base Study|Protocol Violation|0
4907869|NCT00568178|16908291|P4|Double Blind Base Study|Protocol Violation|0
4907870|NCT00568178|16908292|P3|Double Blind Base Study|Protocol Violation|0
4907871|NCT00568178|16908293|P2|Double Blind Base Study|Protocol Violation|2
4907872|NCT00568178|16908294|P1|Double Blind Base Study|Protocol Violation|3
4907873|NCT00568178|16908289|P6|Double Blind Base Study|Physician Decision|0
4907874|NCT00568178|16908290|P5|Double Blind Base Study|Physician Decision|0
4907875|NCT00568178|16908291|P4|Double Blind Base Study|Physician Decision|1
4907876|NCT00568178|16908292|P3|Double Blind Base Study|Physician Decision|0
4907877|NCT00568178|16908293|P2|Double Blind Base Study|Physician Decision|1
4907878|NCT00568178|16908294|P1|Double Blind Base Study|Physician Decision|1
4907879|NCT00568178|16908289|P6|Double Blind Base Study|Lost to Follow-up|0
4907880|NCT00568178|16908290|P5|Double Blind Base Study|Lost to Follow-up|0
4907881|NCT00568178|16908291|P4|Double Blind Base Study|Lost to Follow-up|1
4907882|NCT00568178|16908292|P3|Double Blind Base Study|Lost to Follow-up|0
4907883|NCT00568178|16908293|P2|Double Blind Base Study|Lost to Follow-up|0
4907884|NCT00568178|16908294|P1|Double Blind Base Study|Lost to Follow-up|1
4907885|NCT00568178|16908289|P6|Double Blind Base Study|Adverse Event|0
4907886|NCT00568178|16908290|P5|Double Blind Base Study|Adverse Event|0
4907887|NCT00568178|16908291|P4|Double Blind Base Study|Adverse Event|2
4907888|NCT00568178|16908292|P3|Double Blind Base Study|Adverse Event|1
4907889|NCT00568178|16908293|P2|Double Blind Base Study|Adverse Event|2
4907890|NCT00568178|16908294|P1|Double Blind Base Study|Adverse Event|0
4907891|NCT00568126|16908312|P2|Overall Study|Physician Decision|2
4907892|NCT00568126|16908313|P1|Overall Study|Physician Decision|2
4907893|NCT00568126|16908312|P2|Overall Study|Lack of Efficacy|1
4907894|NCT00568126|16908313|P1|Overall Study|Lack of Efficacy|0
4907895|NCT00568126|16908312|P2|Overall Study|Lost to Follow-up|3
4907896|NCT00568126|16908313|P1|Overall Study|Lost to Follow-up|4
4907897|NCT00568126|16908312|P2|Overall Study|Withdrawal by Subject|3
4907898|NCT00568126|16908313|P1|Overall Study|Withdrawal by Subject|2
4907899|NCT00568126|16908312|P2|Overall Study|Adverse Event|0
4907900|NCT00568126|16908313|P1|Overall Study|Adverse Event|3
4907901|NCT00568061|16908338|P2|Overall Study|Adverse Event|1
4907902|NCT00568061|16908339|P1|Overall Study|Adverse Event|0
4907903|NCT00568061|16908338|P2|Overall Study|Inclusion / exclusion criteria|1
4907904|NCT00568061|16908339|P1|Overall Study|Inclusion / exclusion criteria|5
4907905|NCT00567996|16908402|P3|Overall Study|Patient's inability to use the device|0
4907906|NCT00567996|16908403|P2|Overall Study|Patient's inability to use the device|1
4907907|NCT00567996|16908404|P1|Overall Study|Patient's inability to use the device|0
4907908|NCT00567996|16908402|P3|Overall Study|Death|2
4907909|NCT00567996|16908403|P2|Overall Study|Death|0
4907910|NCT00567996|16908404|P1|Overall Study|Death|1
4907911|NCT00567996|16908402|P3|Overall Study|Administrative problems|0
4907912|NCT00567996|16908403|P2|Overall Study|Administrative problems|1
4907913|NCT00567996|16908404|P1|Overall Study|Administrative problems|1
4907914|NCT00567996|16908402|P3|Overall Study|Unsatisfactory therapeutic effect|15
4907915|NCT00567996|16908403|P2|Overall Study|Unsatisfactory therapeutic effect|2
4907916|NCT00567996|16908404|P1|Overall Study|Unsatisfactory therapeutic effect|1
4907917|NCT00567996|16908402|P3|Overall Study|Lost to Follow-up|2
4907918|NCT00567996|16908403|P2|Overall Study|Lost to Follow-up|5
4907919|NCT00567996|16908404|P1|Overall Study|Lost to Follow-up|2
4907920|NCT00567996|16908402|P3|Overall Study|Abnormal test procedure result(s)|1
4907921|NCT00567996|16908403|P2|Overall Study|Abnormal test procedure result(s)|1
4907922|NCT00567996|16908404|P1|Overall Study|Abnormal test procedure result(s)|2
4907923|NCT00567996|16908402|P3|Overall Study|Abnormal Lab value(s)|2
4907924|NCT00567996|16908403|P2|Overall Study|Abnormal Lab value(s)|1
4907925|NCT00567996|16908404|P1|Overall Study|Abnormal Lab value(s)|2
4907926|NCT00567996|16908402|P3|Overall Study|Withdrawal by Subject|22
4907927|NCT00567996|16908403|P2|Overall Study|Withdrawal by Subject|12
4907928|NCT00567996|16908404|P1|Overall Study|Withdrawal by Subject|8
4907929|NCT00567996|16908402|P3|Overall Study|Protocol Deviation|13
4907930|NCT00567996|16908403|P2|Overall Study|Protocol Deviation|11
4907931|NCT00567996|16908404|P1|Overall Study|Protocol Deviation|9
4907932|NCT00567996|16908402|P3|Overall Study|Adverse Event|13
4907933|NCT00567996|16908403|P2|Overall Study|Adverse Event|16
4907934|NCT00567996|16908404|P1|Overall Study|Adverse Event|18
4907935|NCT00567892|16908420|P4|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
4907936|NCT00567892|16908421|P3|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4907937|NCT00567892|16908422|P2|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4907938|NCT00567892|16908423|P1|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4907939|NCT00567892|16908420|P4|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4
4907940|NCT00567892|16908421|P3|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1
4907941|NCT00567892|16908422|P2|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4907942|NCT00567892|16908423|P1|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0
4907943|NCT00567879|16908441|P6|Overall Study|Disease progression|3
4907944|NCT00567879|16908442|P5|Overall Study|Disease progression|11
4907945|NCT00567879|16908443|P4|Overall Study|Disease progression|5
4907946|NCT00567879|16908444|P3|Overall Study|Disease progression|15
4907947|NCT00567879|16908445|P2|Overall Study|Disease progression|7
4907948|NCT00567879|16908446|P1|Overall Study|Disease progression|5
4907949|NCT00567879|16908441|P6|Overall Study|New cancer therapy|0
4907950|NCT00567879|16908442|P5|Overall Study|New cancer therapy|0
4907951|NCT00567879|16908443|P4|Overall Study|New cancer therapy|0
4907952|NCT00567879|16908444|P3|Overall Study|New cancer therapy|1
4907953|NCT00567879|16908445|P2|Overall Study|New cancer therapy|0
4907954|NCT00567879|16908446|P1|Overall Study|New cancer therapy|0
4907955|NCT00567879|16908441|P6|Overall Study|Withdrawal by Subject|0
4907956|NCT00567879|16908442|P5|Overall Study|Withdrawal by Subject|0
4907957|NCT00567879|16908443|P4|Overall Study|Withdrawal by Subject|1
4907958|NCT00567879|16908444|P3|Overall Study|Withdrawal by Subject|3
4907959|NCT00567879|16908445|P2|Overall Study|Withdrawal by Subject|0
4907960|NCT00567879|16908446|P1|Overall Study|Withdrawal by Subject|0
4907961|NCT00567879|16908441|P6|Overall Study|Abnormal test procedure(s)|0
4907962|NCT00567879|16908442|P5|Overall Study|Abnormal test procedure(s)|0
4907963|NCT00567879|16908443|P4|Overall Study|Abnormal test procedure(s)|0
4907964|NCT00567879|16908444|P3|Overall Study|Abnormal test procedure(s)|1
4907965|NCT00567879|16908445|P2|Overall Study|Abnormal test procedure(s)|0
4907966|NCT00567879|16908446|P1|Overall Study|Abnormal test procedure(s)|0
4907967|NCT00567879|16908441|P6|Overall Study|Adverse Event|0
4907968|NCT00567879|16908442|P5|Overall Study|Adverse Event|1
4907969|NCT00567879|16908443|P4|Overall Study|Adverse Event|0
4907970|NCT00567879|16908444|P3|Overall Study|Adverse Event|1
4907971|NCT00567879|16908445|P2|Overall Study|Adverse Event|0
4907972|NCT00567879|16908446|P1|Overall Study|Adverse Event|2
4907973|NCT00567593|16908513|P1|Overall Study|Physician Decision|1
4907974|NCT00567593|16908513|P1|Overall Study|Adverse Event|1
4907975|NCT00567567|16908520|P3|Overall Study|Unable adequate stem cell for transplant|2
4907976|NCT00567567|16908521|P2|Overall Study|Unable adequate stem cell for transplant|0
4907977|NCT00567567|16908522|P1|Overall Study|Unable adequate stem cell for transplant|0
4907978|NCT00567567|16908520|P3|Overall Study|Enrolled another COG therapeutic study|0
4907979|NCT00567567|16908521|P2|Overall Study|Enrolled another COG therapeutic study|80
4907980|NCT00567567|16908522|P1|Overall Study|Enrolled another COG therapeutic study|99
4907981|NCT00567567|16908520|P3|Overall Study|Refusal by patient/parent/guardian|122
4907982|NCT00567567|16908521|P2|Overall Study|Refusal by patient/parent/guardian|16
4907983|NCT00567567|16908522|P1|Overall Study|Refusal by patient/parent/guardian|9
4907984|NCT00567567|16908520|P3|Overall Study|Ineligible|9
4907985|NCT00567567|16908521|P2|Overall Study|Ineligible|0
4907986|NCT00567567|16908522|P1|Overall Study|Ineligible|4
4907987|NCT00567567|16908520|P3|Overall Study|Withdrawal by Subject|2
4907988|NCT00567567|16908521|P2|Overall Study|Withdrawal by Subject|0
4907989|NCT00567567|16908522|P1|Overall Study|Withdrawal by Subject|0
4907990|NCT00567567|16908520|P3|Overall Study|Physician Decision|84
4907991|NCT00567567|16908521|P2|Overall Study|Physician Decision|18
4907992|NCT00567567|16908522|P1|Overall Study|Physician Decision|16
4907993|NCT00567567|16908520|P3|Overall Study|Lost to Follow-up|1
4907994|NCT00567567|16908521|P2|Overall Study|Lost to Follow-up|0
4907995|NCT00567567|16908522|P1|Overall Study|Lost to Follow-up|0
4907996|NCT00567567|16908520|P3|Overall Study|Lack of Efficacy|48
4907997|NCT00567567|16908521|P2|Overall Study|Lack of Efficacy|17
4907998|NCT00567567|16908522|P1|Overall Study|Lack of Efficacy|16
4907999|NCT00567567|16908520|P3|Overall Study|Death|5
4908000|NCT00567567|16908521|P2|Overall Study|Death|1
4908001|NCT00567567|16908522|P1|Overall Study|Death|8
4908002|NCT00567567|16908520|P3|Overall Study|Adverse Event|5
4908003|NCT00567567|16908521|P2|Overall Study|Adverse Event|2
4908004|NCT00567567|16908522|P1|Overall Study|Adverse Event|0
4908005|NCT00567541|16908570|P2|Overall Study|Adverse Event|1
4908006|NCT00567541|16908571|P1|Overall Study|Adverse Event|0
4908007|NCT00567502|16908581|P4|Overall Study|Never Initiated Treatment|72
4908008|NCT00567502|16908582|P3|Overall Study|Never Initiated Treatment|0
4908009|NCT00567502|16908583|P2|Overall Study|Never Initiated Treatment|0
4908010|NCT00567502|16908584|P1|Overall Study|Never Initiated Treatment|0
4908011|NCT00567502|16908581|P4|Overall Study|Sponsor request|1
4908012|NCT00567502|16908582|P3|Overall Study|Sponsor request|30
4908013|NCT00567502|16908583|P2|Overall Study|Sponsor request|0
4908014|NCT00567502|16908584|P1|Overall Study|Sponsor request|9
4908015|NCT00567502|16908581|P4|Overall Study|Participant request|1
4908016|NCT00567502|16908582|P3|Overall Study|Participant request|33
4908017|NCT00567502|16908583|P2|Overall Study|Participant request|1
4908018|NCT00567502|16908584|P1|Overall Study|Participant request|12
4908019|NCT00567502|16908581|P4|Overall Study|Other|6
4908020|NCT00567502|16908582|P3|Overall Study|Other|134
4908021|NCT00567502|16908583|P2|Overall Study|Other|2
4908022|NCT00567502|16908584|P1|Overall Study|Other|64
4908023|NCT00567502|16908581|P4|Overall Study|Death|5
4908024|NCT00567502|16908582|P3|Overall Study|Death|360
4908025|NCT00567502|16908583|P2|Overall Study|Death|16
4908026|NCT00567502|16908584|P1|Overall Study|Death|65
4908027|NCT00567502|16908581|P4|Overall Study|Lost to Follow-up|2
4908028|NCT00567502|16908582|P3|Overall Study|Lost to Follow-up|351
4908029|NCT00567502|16908583|P2|Overall Study|Lost to Follow-up|14
4908030|NCT00567502|16908584|P1|Overall Study|Lost to Follow-up|91
4908031|NCT00567489|16908621|P2|Overall Study|Other|0
4908032|NCT00567489|16908622|P1|Overall Study|Other|1
4908033|NCT00567489|16908621|P2|Overall Study|Renal Transplantation|3
4908034|NCT00567489|16908622|P1|Overall Study|Renal Transplantation|0
4908035|NCT00567489|16908621|P2|Overall Study|Withdrawal by Subject|2
4908036|NCT00567489|16908622|P1|Overall Study|Withdrawal by Subject|0
4908037|NCT00567489|16908621|P2|Overall Study|Physician Decision|4
4908038|NCT00567489|16908622|P1|Overall Study|Physician Decision|0
4908039|NCT00567489|16908621|P2|Overall Study|Adverse Event|14
4908040|NCT00567489|16908622|P1|Overall Study|Adverse Event|6
4908041|NCT00567476|16908672|P2|Overall Study|Non-adherence to protocol|1
4908042|NCT00567476|16908673|P1|Overall Study|Non-adherence to protocol|0
4908043|NCT00567476|16908672|P2|Overall Study|Medical Decision|1
4908044|NCT00567476|16908673|P1|Overall Study|Medical Decision|0
4908045|NCT00567476|16908672|P2|Overall Study|Administrative issues|0
4908046|NCT00567476|16908673|P1|Overall Study|Administrative issues|1
4908047|NCT00567476|16908672|P2|Overall Study|Lost to Follow-up|1
4908048|NCT00567476|16908673|P1|Overall Study|Lost to Follow-up|0
4908049|NCT00567476|16908672|P2|Overall Study|Protocol Violation|1
4908050|NCT00567476|16908673|P1|Overall Study|Protocol Violation|4
4908051|NCT00567476|16908672|P2|Overall Study|Pregnancy|0
4908052|NCT00567476|16908673|P1|Overall Study|Pregnancy|1
4908053|NCT00567476|16908672|P2|Overall Study|Adverse Event|0
4908054|NCT00567476|16908673|P1|Overall Study|Adverse Event|2
4908055|NCT00567398|16908699|P2|Overall Study|Other|0
4908056|NCT00567398|16908700|P1|Overall Study|Other|1
4908057|NCT00567398|16908699|P2|Overall Study|Renal Transplantation|3
4908058|NCT00567398|16908700|P1|Overall Study|Renal Transplantation|0
4908059|NCT00567398|16908699|P2|Overall Study|Withdrawal by Subject|2
4908060|NCT00567398|16908700|P1|Overall Study|Withdrawal by Subject|0
4908061|NCT00567398|16908699|P2|Overall Study|Physician Decision|4
4908062|NCT00567398|16908700|P1|Overall Study|Physician Decision|0
4908063|NCT00567398|16908699|P2|Overall Study|Adverse Event|14
4908064|NCT00567398|16908700|P1|Overall Study|Adverse Event|6
4908065|NCT00567359|16908748|P1|Overall Study|Withdrawal by Subject|1
4908066|NCT00567268|16908773|P1|Overall Study|"Safety Evaluation Not Assessable"|1
4908067|NCT00567268|16908773|P1|Overall Study|No Drug Administration|4
4908068|NCT00567268|16908773|P1|Overall Study|No Visit After First Day of Treatment|2
4908069|NCT00567268|16908773|P1|Overall Study|Lost to Follow-up|36
4908070|NCT00567268|16908773|P1|Overall Study|Protocol Violation|7
4908071|NCT00567255|16908824|P2|Overall Study|Drug noncompliance,moved,other|15
4908072|NCT00567255|16908825|P1|Overall Study|Drug noncompliance,moved,other|25
4908073|NCT00567255|16908824|P2|Overall Study|Pregnancy|0
4908074|NCT00567255|16908825|P1|Overall Study|Pregnancy|6
4908075|NCT00567255|16908824|P2|Overall Study|Protocol Violation|8
4908076|NCT00567255|16908825|P1|Overall Study|Protocol Violation|20
4908077|NCT00567255|16908824|P2|Overall Study|Lack of Efficacy|33
4908078|NCT00567255|16908825|P1|Overall Study|Lack of Efficacy|19
4908079|NCT00567255|16908824|P2|Overall Study|Withdrawal by Subject|56
4908080|NCT00567255|16908825|P1|Overall Study|Withdrawal by Subject|75
4908081|NCT00567255|16908824|P2|Overall Study|Lost to Follow-up|48
4908082|NCT00567255|16908825|P1|Overall Study|Lost to Follow-up|77
4908083|NCT00567255|16908824|P2|Overall Study|Adverse Event|68
4908084|NCT00567255|16908825|P1|Overall Study|Adverse Event|241
4908085|NCT00567190|16908888|P2|Overall Study|Withdrew Consent or Lost to Follow-up|53
4908086|NCT00567190|16908889|P1|Overall Study|Withdrew Consent or Lost to Follow-up|48
4908087|NCT00567190|16908888|P2|Overall Study|Death|280
4908088|NCT00567190|16908889|P1|Overall Study|Death|235
4908089|NCT00567164|16908940|P3|Overall Study|Missing|0
4908090|NCT00567164|16908941|P2|Overall Study|Missing|0
4908091|NCT00567164|16908942|P1|Overall Study|Missing|1
4908092|NCT00567164|16908940|P3|Overall Study|Primary Reason coded as 'Other'|16
4908093|NCT00567164|16908941|P2|Overall Study|Primary Reason coded as 'Other'|8
4908094|NCT00567164|16908942|P1|Overall Study|Primary Reason coded as 'Other'|37
4908095|NCT00567164|16908940|P3|Overall Study|Pregnancy|6
4908096|NCT00567164|16908941|P2|Overall Study|Pregnancy|4
4908097|NCT00567164|16908942|P1|Overall Study|Pregnancy|20
4908098|NCT00567164|16908940|P3|Overall Study|Lost to Follow-up|21
4908099|NCT00567164|16908941|P2|Overall Study|Lost to Follow-up|23
4908100|NCT00567164|16908942|P1|Overall Study|Lost to Follow-up|202
4908101|NCT00567164|16908940|P3|Overall Study|Death|1
4908102|NCT00567164|16908941|P2|Overall Study|Death|0
4908103|NCT00567164|16908942|P1|Overall Study|Death|0
4908104|NCT00567164|16908940|P3|Overall Study|Adverse Event|9
4908105|NCT00567164|16908941|P2|Overall Study|Adverse Event|13
4908106|NCT00567164|16908942|P1|Overall Study|Adverse Event|92
4908107|NCT00567164|16908940|P3|Overall Study|Protocol Violation|2
4908108|NCT00567164|16908941|P2|Overall Study|Protocol Violation|4
4908109|NCT00567164|16908942|P1|Overall Study|Protocol Violation|23
4908110|NCT00567164|16908940|P3|Overall Study|Withdrawal by Subject|17
4908111|NCT00567164|16908941|P2|Overall Study|Withdrawal by Subject|21
4908112|NCT00567164|16908942|P1|Overall Study|Withdrawal by Subject|171
4908113|NCT00567112|16909014|P3|Washout Period 3 (3 Days)|Protocol Violation|0
4908114|NCT00567112|16909015|P2|Washout Period 3 (3 Days)|Protocol Violation|0
4908115|NCT00567112|16909016|P1|Washout Period 3 (3 Days)|Protocol Violation|1
4908116|NCT00567112|16909014|P3|Washout Period 3 (3 Days)|Lost to Follow-up|0
4908117|NCT00567112|16909015|P2|Washout Period 3 (3 Days)|Lost to Follow-up|0
4908118|NCT00567112|16909016|P1|Washout Period 3 (3 Days)|Lost to Follow-up|2
4908119|NCT00567112|16909014|P3|Treatment Period 2 (3 Days)|Protocol Violation|0
4908120|NCT00567112|16909015|P2|Treatment Period 2 (3 Days)|Protocol Violation|1
4908121|NCT00567112|16909016|P1|Treatment Period 2 (3 Days)|Protocol Violation|0
4908122|NCT00566995|16909047|P1|Overall Study|Withdrew consent|3
4908123|NCT00566995|16909047|P1|Overall Study|Toxicity|4
4908124|NCT00566982|16909062|P2|Overall Study|Other-family problems & doctor's request|2
4908125|NCT00566982|16909063|P1|Overall Study|Other-family problems & doctor's request|0
4908126|NCT00566982|16909062|P2|Overall Study|Lost to Follow-up|1
4908127|NCT00566982|16909063|P1|Overall Study|Lost to Follow-up|0
4908128|NCT00566982|16909062|P2|Overall Study|Protocol Violation|4
4908129|NCT00566982|16909063|P1|Overall Study|Protocol Violation|1
4908130|NCT00566982|16909062|P2|Overall Study|Withdrawal by Subject|14
4908131|NCT00566982|16909063|P1|Overall Study|Withdrawal by Subject|1
4908132|NCT00566982|16909062|P2|Overall Study|Adverse Event|48
4908133|NCT00566982|16909063|P1|Overall Study|Adverse Event|6
4908134|NCT00566852|16909128|P2|Overall Study|Missing reason not reported|20
4908135|NCT00566852|16909129|P1|Overall Study|Missing reason not reported|16
4908136|NCT00566852|16909128|P2|Overall Study|Missing reason not specified|2
4908137|NCT00566852|16909129|P1|Overall Study|Missing reason not specified|1
4908138|NCT00566852|16909128|P2|Overall Study|Not tested due to disability|12
4908139|NCT00566852|16909129|P1|Overall Study|Not tested due to disability|6
4908140|NCT00566852|16909128|P2|Overall Study|Patient refusal|37
4908141|NCT00566852|16909129|P1|Overall Study|Patient refusal|37
4908142|NCT00566852|16909128|P2|Overall Study|Withdrawal by Subject|25
4908143|NCT00566852|16909129|P1|Overall Study|Withdrawal by Subject|30
4908144|NCT00566852|16909128|P2|Overall Study|Death|78
4908145|NCT00566852|16909129|P1|Overall Study|Death|95
4908146|NCT00566852|16909128|P2|Overall Study|Protocol Violation|24
4908147|NCT00566852|16909129|P1|Overall Study|Protocol Violation|22
4908148|NCT00566735|16909160|P2|Overall Study|Switched into a manic episode|1
4908149|NCT00566735|16909161|P1|Overall Study|Switched into a manic episode|0
4908150|NCT00566735|16909160|P2|Overall Study|Refused neuropsychological testing|5
4908151|NCT00566735|16909161|P1|Overall Study|Refused neuropsychological testing|2
4908152|NCT00566735|16909160|P2|Overall Study|Withdrawal by Subject|1
4908153|NCT00566735|16909161|P1|Overall Study|Withdrawal by Subject|0
4908154|NCT00566722|16909174|P3|Overall Study|Noncompliant with drug administration|1
4908155|NCT00566722|16909175|P2|Overall Study|Noncompliant with drug administration|0
4908156|NCT00566722|16909176|P1|Overall Study|Noncompliant with drug administration|0
4908157|NCT00566722|16909174|P3|Overall Study|Serious adverse event|0
4908158|NCT00566722|16909175|P2|Overall Study|Serious adverse event|1
4908159|NCT00566722|16909176|P1|Overall Study|Serious adverse event|0
4908160|NCT00566722|16909174|P3|Overall Study|Did not meet exclusion criteria|2
4908161|NCT00566722|16909175|P2|Overall Study|Did not meet exclusion criteria|0
4908162|NCT00566722|16909176|P1|Overall Study|Did not meet exclusion criteria|0
4908163|NCT00566722|16909174|P3|Overall Study|Lack of Efficacy|4
4908164|NCT00566722|16909175|P2|Overall Study|Lack of Efficacy|2
4908165|NCT00566722|16909176|P1|Overall Study|Lack of Efficacy|1
4908166|NCT00566722|16909174|P3|Overall Study|Lost to Follow-up|1
4908167|NCT00566722|16909175|P2|Overall Study|Lost to Follow-up|1
4908168|NCT00566722|16909176|P1|Overall Study|Lost to Follow-up|1
4908169|NCT00566722|16909174|P3|Overall Study|Withdrawal by Subject|1
4908170|NCT00566722|16909175|P2|Overall Study|Withdrawal by Subject|0
4908171|NCT00566722|16909176|P1|Overall Study|Withdrawal by Subject|0
4908172|NCT00566722|16909174|P3|Overall Study|Adverse Event|0
4908173|NCT00566722|16909175|P2|Overall Study|Adverse Event|1
4908174|NCT00566722|16909176|P1|Overall Study|Adverse Event|0
4908175|NCT00566709|16909222|P2|Overall Study|Protocol Violation|0
4908176|NCT00566709|16909223|P1|Overall Study|Protocol Violation|5
4908177|NCT00566696|16909239|P1|Overall Study|Non-Patient Donors|37
4908178|NCT00566696|16909239|P1|Overall Study|Physician Decision|1
4908179|NCT00566696|16909239|P1|Overall Study|Health Status Change|1
4908180|NCT00566696|16909239|P1|Overall Study|Muromonab not available|1
4908181|NCT00566696|16909239|P1|Overall Study|Met Exclusion Criteria|2
4908182|NCT00566631|16909249|P1|Part 2: Extension Phase|Other|5
4908183|NCT00566631|16909249|P1|Part 2: Extension Phase|Death|1
4908184|NCT00566631|16909249|P1|Part 2: Extension Phase|Lost to Follow-up|6
4908185|NCT00566631|16909249|P1|Part 2: Extension Phase|Adverse Event|11
4908186|NCT00566631|16909249|P1|Part 2: Extension Phase|Withdrawal by Subject|34
4908187|NCT00566631|16909249|P1|Part 2: Extension Phase|Lack of Efficacy|25
4908188|NCT00566631|16909249|P1|Between Treatment and Extension Phase|Participants not willing to participate|95
4908189|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Met exclusion criteria|1
4908190|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1
4908191|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Withdrawal by Subject|26
4908192|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Lost to Follow-up|4
4908193|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Adverse Event|9
4908194|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Physician Decision|1
4908195|NCT00566631|16909249|P1|Part 1: Core Treatment Phase|Lack of Efficacy|18
4908196|NCT00566527|16909276|P3|Overall Study|Withdrawal by Subject|43
4908197|NCT00566527|16909277|P2|Overall Study|Withdrawal by Subject|43
4908198|NCT00566527|16909278|P1|Overall Study|Withdrawal by Subject|6
4908199|NCT00566527|16909276|P3|Overall Study|Lost to Follow-up|4
4908200|NCT00566527|16909277|P2|Overall Study|Lost to Follow-up|4
4908201|NCT00566527|16909278|P1|Overall Study|Lost to Follow-up|3
4908202|NCT00566527|16909276|P3|Overall Study|Physician Decision|20
4908203|NCT00566527|16909277|P2|Overall Study|Physician Decision|8
4908204|NCT00566527|16909278|P1|Overall Study|Physician Decision|3
4908205|NCT00566527|16909276|P3|Overall Study|Adverse Event|1
4908206|NCT00566527|16909277|P2|Overall Study|Adverse Event|0
4908207|NCT00566527|16909278|P1|Overall Study|Adverse Event|2
4908208|NCT00566527|16909276|P3|Overall Study|Reason not provided|10
4908209|NCT00566527|16909277|P2|Overall Study|Reason not provided|11
4908210|NCT00566527|16909278|P1|Overall Study|Reason not provided|3
4908211|NCT00566254|16909339|P2|Overall Study|Other|2
4908212|NCT00566254|16909340|P1|Overall Study|Other|0
4908213|NCT00566254|16909339|P2|Overall Study|Lack of Efficacy|6
4908214|NCT00566254|16909340|P1|Overall Study|Lack of Efficacy|5
4908215|NCT00566254|16909339|P2|Overall Study|Withdrawal by Subject|2
4908216|NCT00566254|16909340|P1|Overall Study|Withdrawal by Subject|1
4908217|NCT00566254|16909339|P2|Overall Study|Protocol Violation|3
4908218|NCT00566254|16909340|P1|Overall Study|Protocol Violation|1
4908219|NCT00566254|16909339|P2|Overall Study|Adverse Event|1
4908220|NCT00566254|16909340|P1|Overall Study|Adverse Event|3
4908221|NCT00566228|16909354|P2|Overall Study|progressed before infusion could occur|1
4908222|NCT00566228|16909355|P1|Overall Study|progressed before infusion could occur|0
4908223|NCT00566228|16909354|P2|Overall Study|Unable to collect sufficient CD34 cells|2
4908224|NCT00566228|16909355|P1|Overall Study|Unable to collect sufficient CD34 cells|3
4908225|NCT00566228|16909354|P2|Overall Study|Attempt to mobilize stem cells failed|2
4908226|NCT00566228|16909355|P1|Overall Study|Attempt to mobilize stem cells failed|2
4908227|NCT00566228|16909354|P2|Overall Study|Withdrawal by Subject|0
4908228|NCT00566228|16909355|P1|Overall Study|Withdrawal by Subject|1
4908229|NCT00566111|16909388|P2|Overall Study|Adverse Event|2
4908230|NCT00566111|16909389|P1|Overall Study|Adverse Event|0
4908231|NCT00566098|16909403|P1|Administration of ASCT+MILs|Lack of Efficacy|8
4908232|NCT00566098|16909403|P1|Administration of ASCT+MILs|Death|10
4908233|NCT00566098|16909403|P1|Generation of MILs Product|Relapsed|1
4908234|NCT00566098|16909403|P1|Collection of MILs|Relapsed|1
4908235|NCT00566098|16909403|P1|Collection of MILs|Withdrawal by Subject|1
4908236|NCT00566020|16909413|P2|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1
4908237|NCT00566020|16909414|P1|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0
4908238|NCT00566020|16909413|P2|46-week Long-term Administration Phase|Lost to Follow-up|2
4908239|NCT00566020|16909414|P1|46-week Long-term Administration Phase|Lost to Follow-up|0
4908240|NCT00566020|16909413|P2|46-week Long-term Administration Phase|Physician Decision|7
4908241|NCT00566020|16909414|P1|46-week Long-term Administration Phase|Physician Decision|0
4908242|NCT00566020|16909413|P2|46-week Long-term Administration Phase|Adverse Event|7
4908243|NCT00566020|16909414|P1|46-week Long-term Administration Phase|Adverse Event|0
4908244|NCT00566020|16909413|P2|6-week Dosage Adjustment Phase|Lack of Efficacy|0
4908245|NCT00566020|16909414|P1|6-week Dosage Adjustment Phase|Lack of Efficacy|2
4908246|NCT00566020|16909413|P2|6-week Dosage Adjustment Phase|Adverse Event|0
4908247|NCT00566020|16909414|P1|6-week Dosage Adjustment Phase|Adverse Event|5
4908248|NCT00565812|16909503|P3|Overall Study|Physician Decision|0
4908249|NCT00565812|16909504|P2|Overall Study|Physician Decision|0
4908250|NCT00565812|16909505|P1|Overall Study|Physician Decision|2
4908251|NCT00565812|16909503|P3|Overall Study|Follow-up Visit Not Completed|1
4908252|NCT00565812|16909504|P2|Overall Study|Follow-up Visit Not Completed|0
4908253|NCT00565812|16909505|P1|Overall Study|Follow-up Visit Not Completed|2
4908254|NCT00565812|16909503|P3|Overall Study|Low Compliance|1
4908255|NCT00565812|16909504|P2|Overall Study|Low Compliance|0
4908256|NCT00565812|16909505|P1|Overall Study|Low Compliance|1
4908257|NCT00565812|16909503|P3|Overall Study|Surgical Intervention|2
4908258|NCT00565812|16909504|P2|Overall Study|Surgical Intervention|1
4908259|NCT00565812|16909505|P1|Overall Study|Surgical Intervention|0
4908260|NCT00565812|16909503|P3|Overall Study|Research Site Closure|8
4908261|NCT00565812|16909504|P2|Overall Study|Research Site Closure|1
4908262|NCT00565812|16909505|P1|Overall Study|Research Site Closure|6
4908263|NCT00565812|16909503|P3|Overall Study|Domestic Reasons|3
4908264|NCT00565812|16909504|P2|Overall Study|Domestic Reasons|1
4908265|NCT00565812|16909505|P1|Overall Study|Domestic Reasons|7
4908266|NCT00565812|16909503|P3|Overall Study|Sponsor Decision|1
4908267|NCT00565812|16909504|P2|Overall Study|Sponsor Decision|5
4908268|NCT00565812|16909505|P1|Overall Study|Sponsor Decision|1
4908269|NCT00565812|16909503|P3|Overall Study|Relocated Out of Area|9
4908270|NCT00565812|16909504|P2|Overall Study|Relocated Out of Area|8
4908271|NCT00565812|16909505|P1|Overall Study|Relocated Out of Area|5
4908272|NCT00565812|16909503|P3|Overall Study|Jury Duty|0
4908273|NCT00565812|16909504|P2|Overall Study|Jury Duty|0
4908274|NCT00565812|16909505|P1|Overall Study|Jury Duty|1
4908275|NCT00565812|16909503|P3|Overall Study|Adverse Event|40
4908276|NCT00565812|16909504|P2|Overall Study|Adverse Event|54
4908277|NCT00565812|16909505|P1|Overall Study|Adverse Event|41
4908278|NCT00565812|16909503|P3|Overall Study|Protocol Violation|4
4908279|NCT00565812|16909504|P2|Overall Study|Protocol Violation|6
4908280|NCT00565812|16909505|P1|Overall Study|Protocol Violation|2
4908281|NCT00565812|16909503|P3|Overall Study|Work Schedule|1
4908282|NCT00565812|16909504|P2|Overall Study|Work Schedule|3
4908283|NCT00565812|16909505|P1|Overall Study|Work Schedule|5
4908284|NCT00565812|16909503|P3|Overall Study|Withdrawal by Subject|48
4908285|NCT00565812|16909504|P2|Overall Study|Withdrawal by Subject|47
4908286|NCT00565812|16909505|P1|Overall Study|Withdrawal by Subject|58
4908287|NCT00565812|16909503|P3|Overall Study|Lost to Follow-up|8
4908288|NCT00565812|16909504|P2|Overall Study|Lost to Follow-up|8
4908289|NCT00565812|16909505|P1|Overall Study|Lost to Follow-up|10
4908290|NCT00565812|16909503|P3|Overall Study|Did not Meet Entrance Criteria|1
4908291|NCT00565812|16909504|P2|Overall Study|Did not Meet Entrance Criteria|0
4908292|NCT00565812|16909505|P1|Overall Study|Did not Meet Entrance Criteria|1
4908293|NCT00565812|16909503|P3|Overall Study|Death|3
4908294|NCT00565812|16909504|P2|Overall Study|Death|1
4908295|NCT00565812|16909505|P1|Overall Study|Death|2
4908296|NCT00565773|16909642|P1|Overall Study|Physician Decision|1
4908297|NCT00565773|16909642|P1|Overall Study|Withdrawal by Subject|1
4908298|NCT00565747|16909654|P2|Overall Study|No embryo transfer|73
4908299|NCT00565747|16909655|P1|Overall Study|No embryo transfer|67
4908300|NCT00565721|16909665|P1|Overall Study|Other reasons|6
4908301|NCT00565721|16909665|P1|Overall Study|Physician Decision|2
4908302|NCT00565721|16909665|P1|Overall Study|Technical Problems|1
4908303|NCT00565721|16909665|P1|Overall Study|Lost to Follow-up|6
4908304|NCT00565721|16909665|P1|Overall Study|Screen Failure|2
4908305|NCT00565617|16909714|P1|Overall Study|Withdrawal by Subject|1
4908306|NCT00565604|16909718|P1|Overall Study|Lost to Follow-up|2
4908307|NCT00565604|16909718|P1|Overall Study|Failure to treat|2
4908308|NCT00565448|16909764|P2|Overall Study|Withdrawal by Subject|0
4908309|NCT00565448|16909765|P1|Overall Study|Withdrawal by Subject|1
4908310|NCT00565448|16909764|P2|Overall Study|Disease progression|0
4908311|NCT00565448|16909765|P1|Overall Study|Disease progression|1
4908312|NCT00565448|16909764|P2|Overall Study|Adverse Event|2
4908313|NCT00565448|16909765|P1|Overall Study|Adverse Event|1
4908314|NCT00565409|16909776|P4|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43
4908315|NCT00565409|16909777|P3|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11
4908316|NCT00565409|16909778|P2|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4
4908317|NCT00565409|16909779|P1|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0
4908318|NCT00565409|16909776|P4|Period 2 Double-Blind|Other|9
4908319|NCT00565409|16909777|P3|Period 2 Double-Blind|Other|5
4908320|NCT00565409|16909778|P2|Period 2 Double-Blind|Other|4
4908321|NCT00565409|16909779|P1|Period 2 Double-Blind|Other|0
4908322|NCT00565409|16909776|P4|Period 2 Double-Blind|Lost to Follow-up|0
4908323|NCT00565409|16909777|P3|Period 2 Double-Blind|Lost to Follow-up|1
4908324|NCT00565409|16909778|P2|Period 2 Double-Blind|Lost to Follow-up|0
4908325|NCT00565409|16909779|P1|Period 2 Double-Blind|Lost to Follow-up|0
4908326|NCT00565409|16909776|P4|Period 2 Double-Blind|Protocol Violation|2
4908327|NCT00565409|16909777|P3|Period 2 Double-Blind|Protocol Violation|6
4908328|NCT00565409|16909778|P2|Period 2 Double-Blind|Protocol Violation|4
4908329|NCT00565409|16909779|P1|Period 2 Double-Blind|Protocol Violation|0
4908330|NCT00565409|16909776|P4|Period 2 Double-Blind|Death|0
4908331|NCT00565409|16909777|P3|Period 2 Double-Blind|Death|0
4908332|NCT00565409|16909778|P2|Period 2 Double-Blind|Death|2
4908333|NCT00565409|16909779|P1|Period 2 Double-Blind|Death|0
4908334|NCT00565409|16909776|P4|Period 2 Double-Blind|Adverse Event|5
4908335|NCT00565409|16909777|P3|Period 2 Double-Blind|Adverse Event|4
4908336|NCT00565409|16909778|P2|Period 2 Double-Blind|Adverse Event|7
4908337|NCT00565409|16909779|P1|Period 2 Double-Blind|Adverse Event|0
4908338|NCT00565409|16909776|P4|After Period 1, Prior to Period 2|did not meet criteria|0
4908339|NCT00565409|16909777|P3|After Period 1, Prior to Period 2|did not meet criteria|0
4908340|NCT00565409|16909778|P2|After Period 1, Prior to Period 2|did not meet criteria|0
4908341|NCT00565409|16909779|P1|After Period 1, Prior to Period 2|did not meet criteria|152
4908342|NCT00565409|16909776|P4|Period 1 Open Label|no conclusion of participation record|0
4908343|NCT00565409|16909777|P3|Period 1 Open Label|no conclusion of participation record|0
4908344|NCT00565409|16909778|P2|Period 1 Open Label|no conclusion of participation record|0
4908345|NCT00565409|16909779|P1|Period 1 Open Label|no conclusion of participation record|1
4908346|NCT00565409|16909776|P4|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
4908347|NCT00565409|16909777|P3|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
4908348|NCT00565409|16909778|P2|Period 1 Open Label|Unsatisfactory Response-Efficacy|0
4908349|NCT00565409|16909779|P1|Period 1 Open Label|Unsatisfactory Response-Efficacy|22
4908350|NCT00565409|16909776|P4|Period 1 Open Label|Protocol Violation|0
4908351|NCT00565409|16909777|P3|Period 1 Open Label|Protocol Violation|0
4908352|NCT00565409|16909778|P2|Period 1 Open Label|Protocol Violation|0
4908353|NCT00565409|16909779|P1|Period 1 Open Label|Protocol Violation|14
4908354|NCT00565409|16909776|P4|Period 1 Open Label|Other|0
4908355|NCT00565409|16909777|P3|Period 1 Open Label|Other|0
4908356|NCT00565409|16909778|P2|Period 1 Open Label|Other|0
4908357|NCT00565409|16909779|P1|Period 1 Open Label|Other|21
4908358|NCT00565409|16909776|P4|Period 1 Open Label|Lost to Follow-up|0
4908359|NCT00565409|16909777|P3|Period 1 Open Label|Lost to Follow-up|0
4908360|NCT00565409|16909778|P2|Period 1 Open Label|Lost to Follow-up|0
4908361|NCT00565409|16909779|P1|Period 1 Open Label|Lost to Follow-up|1
4908362|NCT00565409|16909776|P4|Period 1 Open Label|Death|0
4908363|NCT00565409|16909777|P3|Period 1 Open Label|Death|0
4908364|NCT00565409|16909778|P2|Period 1 Open Label|Death|0
4908365|NCT00565409|16909779|P1|Period 1 Open Label|Death|2
4908366|NCT00565409|16909776|P4|Period 1 Open Label|Adverse Event|0
4908367|NCT00565409|16909777|P3|Period 1 Open Label|Adverse Event|0
4908368|NCT00565409|16909778|P2|Period 1 Open Label|Adverse Event|0
4908369|NCT00565409|16909779|P1|Period 1 Open Label|Adverse Event|17
4908370|NCT00565136|16909915|P1|Overall Study|Protocol Violation|1
4908371|NCT00565136|16909915|P1|Overall Study|Withdrawal by Subject|1
4908372|NCT00565136|16909915|P1|Overall Study|Lost to Follow-up|1
4908373|NCT00565058|16909956|P2|Overall Study|Adverse Event|0
4908374|NCT00565058|16909957|P1|Overall Study|Adverse Event|1
4908375|NCT00564902|16910004|P3|Overall Study|Death|0
4908376|NCT00564902|16910005|P2|Overall Study|Death|1
4908377|NCT00564902|16910006|P1|Overall Study|Death|1
4908378|NCT00564902|16910004|P3|Overall Study|Withdrawal by Subject|4
4908379|NCT00564902|16910005|P2|Overall Study|Withdrawal by Subject|3
4908380|NCT00564902|16910006|P1|Overall Study|Withdrawal by Subject|0
4908381|NCT00564889|16910038|P1|Overall Study|Other, not specified|4
4908382|NCT00564889|16910038|P1|Overall Study|Disease progression|3
4908383|NCT00564889|16910038|P1|Overall Study|Alternative treatment|3
4908384|NCT00564889|16910038|P1|Overall Study|Adverse Event|12
4908385|NCT00564889|16910038|P1|Overall Study|Death|7
4908386|NCT00564850|16910053|P1|Overall Study|Protocol Violation|2
4908387|NCT00564733|16910071|P1|Overall Study|Ineligible|5
4908388|NCT00564733|16910071|P1|Overall Study|Withdrawal by Subject|4
4908389|NCT00564629|16910105|P2|Overall Study|Vomited within 2 hours of receiving drug|9
4908390|NCT00564629|16910106|P1|Overall Study|Vomited within 2 hours of receiving drug|15
4908391|NCT00564486|16910131|P4|Overall Study|Lost to Follow-up|2
4908392|NCT00564486|16910132|P3|Overall Study|Lost to Follow-up|2
4908393|NCT00564486|16910133|P2|Overall Study|Lost to Follow-up|0
4908394|NCT00564486|16910134|P1|Overall Study|Lost to Follow-up|3
4908395|NCT00564486|16910131|P4|Overall Study|Subject refused to have blood drawn|0
4908396|NCT00564486|16910132|P3|Overall Study|Subject refused to have blood drawn|1
4908397|NCT00564486|16910133|P2|Overall Study|Subject refused to have blood drawn|0
4908398|NCT00564486|16910134|P1|Overall Study|Subject refused to have blood drawn|0
4908399|NCT00564486|16910131|P4|Overall Study|Withdrawal by Subject|5
4908400|NCT00564486|16910132|P3|Overall Study|Withdrawal by Subject|0
4908401|NCT00564486|16910133|P2|Overall Study|Withdrawal by Subject|0
4908402|NCT00564486|16910134|P1|Overall Study|Withdrawal by Subject|4
4908403|NCT00564486|16910131|P4|Overall Study|Adverse Event|0
4908404|NCT00564486|16910132|P3|Overall Study|Adverse Event|0
4908405|NCT00564486|16910133|P2|Overall Study|Adverse Event|1
4908406|NCT00564486|16910134|P1|Overall Study|Adverse Event|0
4908407|NCT00564395|16910183|P2|First Intervention (10 Days)|Trouble with the CGM tracing|2
4908408|NCT00564395|16910184|P1|First Intervention (10 Days)|Trouble with the CGM tracing|1
4908409|NCT00564395|16910183|P2|First Intervention (10 Days)|Withdrawal by Subject|0
4908410|NCT00564395|16910184|P1|First Intervention (10 Days)|Withdrawal by Subject|1
4908411|NCT00564278|16910192|P2|Overall Study|Withdrawal by Subject|7
4908412|NCT00564278|16910193|P1|Overall Study|Withdrawal by Subject|11
4908413|NCT00564278|16910192|P2|Overall Study|Physician Decision|2
4908414|NCT00564278|16910193|P1|Overall Study|Physician Decision|1
4908415|NCT00564278|16910192|P2|Overall Study|Lost to Follow-up|33
4908416|NCT00564278|16910193|P1|Overall Study|Lost to Follow-up|35
4908417|NCT00564070|16910215|P2|Overall Study|Worsening depression, referred to care|0
4908418|NCT00564070|16910216|P1|Overall Study|Worsening depression, referred to care|3
4908419|NCT00564070|16910215|P2|Overall Study|Lost to Follow-up|7
4908420|NCT00564070|16910216|P1|Overall Study|Lost to Follow-up|9
4908421|NCT00564018|16910243|P3|Overall Study|Withdrawal by Subject|1
4908422|NCT00564018|16910244|P2|Overall Study|Withdrawal by Subject|3
4908423|NCT00564018|16910245|P1|Overall Study|Withdrawal by Subject|2
4908424|NCT00563797|16910258|P2|Overall Study|Lost to Follow-up|2
4908425|NCT00563797|16910259|P1|Overall Study|Lost to Follow-up|7
4908426|NCT00563784|16910271|P1|Overall Study|Screen Failures|20
4908427|NCT00563784|16910271|P1|Overall Study|Withdrawal by Subject|2
4908428|NCT00563706|16910285|P9|DB Treatment Period (Day 1 up to Day 28)|Other|2
4908429|NCT00563706|16910286|P8|DB Treatment Period (Day 1 up to Day 28)|Other|1
4908430|NCT00563706|16910287|P7|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908431|NCT00563706|16910288|P6|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908432|NCT00563706|16910289|P5|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908433|NCT00563706|16910290|P4|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908434|NCT00563706|16910291|P3|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908435|NCT00563706|16910292|P2|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908436|NCT00563706|16910293|P1|DB Treatment Period (Day 1 up to Day 28)|Other|0
4908437|NCT00563706|16910285|P9|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908438|NCT00563706|16910286|P8|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1
4908439|NCT00563706|16910287|P7|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908440|NCT00563706|16910288|P6|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908441|NCT00563706|16910289|P5|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908442|NCT00563706|16910290|P4|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908443|NCT00563706|16910291|P3|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908444|NCT00563706|16910292|P2|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0
4908445|NCT00563706|16910293|P1|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2
4908446|NCT00563706|16910285|P9|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
4908447|NCT00563706|16910286|P8|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6
4908448|NCT00563706|16910287|P7|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1
4908449|NCT00563706|16910288|P6|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
4908450|NCT00563706|16910289|P5|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4
4908451|NCT00563706|16910290|P4|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5
4908452|NCT00563706|16910291|P3|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2
4908453|NCT00563706|16910292|P2|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3
4908454|NCT00563706|16910293|P1|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9
4908455|NCT00563706|16910285|P9|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
4908456|NCT00563706|16910286|P8|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5
4908457|NCT00563706|16910287|P7|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4908458|NCT00563706|16910288|P6|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4908459|NCT00563706|16910289|P5|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
4908460|NCT00563706|16910290|P4|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4
4908461|NCT00563706|16910291|P3|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4908462|NCT00563706|16910292|P2|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1
4908463|NCT00563706|16910293|P1|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2
4908464|NCT00563706|16910285|P9|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5
4908465|NCT00563706|16910286|P8|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4908466|NCT00563706|16910287|P7|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
4908467|NCT00563706|16910288|P6|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
4908468|NCT00563706|16910289|P5|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0
4908469|NCT00563706|16910290|P4|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4908470|NCT00563706|16910291|P3|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4908471|NCT00563706|16910292|P2|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1
4908472|NCT00563706|16910293|P1|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4
4908473|NCT00563381|16910411|P2|Overall Study|Individual different reasons|34
4908474|NCT00563381|16910412|P1|Overall Study|Individual different reasons|24
4908475|NCT00563381|16910411|P2|Overall Study|Lack of Efficacy|24
4908476|NCT00563381|16910412|P1|Overall Study|Lack of Efficacy|32
4908477|NCT00563381|16910411|P2|Overall Study|Withdrawal by Subject|209
4908478|NCT00563381|16910412|P1|Overall Study|Withdrawal by Subject|192
4908479|NCT00563381|16910411|P2|Overall Study|Lost to Follow-up|15
4908480|NCT00563381|16910412|P1|Overall Study|Lost to Follow-up|7
4908481|NCT00563381|16910411|P2|Overall Study|Protocol Violation|74
4908482|NCT00563381|16910412|P1|Overall Study|Protocol Violation|66
4908483|NCT00563381|16910411|P2|Overall Study|Adverse Event|292
4908484|NCT00563381|16910412|P1|Overall Study|Adverse Event|264
4908485|NCT00563368|16910485|P7|Overall Study|Other|0
4908486|NCT00563368|16910486|P6|Overall Study|Other|4
4908487|NCT00563368|16910487|P5|Overall Study|Other|4
4908488|NCT00563368|16910488|P4|Overall Study|Other|4
4908489|NCT00563368|16910489|P3|Overall Study|Other|3
4908490|NCT00563368|16910490|P2|Overall Study|Other|5
4908491|NCT00563368|16910491|P1|Overall Study|Other|5
4908492|NCT00563368|16910485|P7|Overall Study|requirement for restricted medication|0
4908493|NCT00563368|16910486|P6|Overall Study|requirement for restricted medication|0
4908494|NCT00563368|16910487|P5|Overall Study|requirement for restricted medication|0
4908495|NCT00563368|16910488|P4|Overall Study|requirement for restricted medication|0
4908496|NCT00563368|16910489|P3|Overall Study|requirement for restricted medication|2
4908497|NCT00563368|16910490|P2|Overall Study|requirement for restricted medication|0
4908498|NCT00563368|16910491|P1|Overall Study|requirement for restricted medication|0
4908499|NCT00563368|16910485|P7|Overall Study|Pregnancy|0
4908500|NCT00563368|16910486|P6|Overall Study|Pregnancy|2
4908501|NCT00563368|16910487|P5|Overall Study|Pregnancy|1
4908502|NCT00563368|16910488|P4|Overall Study|Pregnancy|2
4908503|NCT00563368|16910489|P3|Overall Study|Pregnancy|1
4908504|NCT00563368|16910490|P2|Overall Study|Pregnancy|0
4908505|NCT00563368|16910491|P1|Overall Study|Pregnancy|1
4908506|NCT00563368|16910485|P7|Overall Study|protocol non-compliance|3
4908507|NCT00563368|16910486|P6|Overall Study|protocol non-compliance|1
4908508|NCT00563368|16910487|P5|Overall Study|protocol non-compliance|0
4908509|NCT00563368|16910488|P4|Overall Study|protocol non-compliance|1
4908510|NCT00563368|16910489|P3|Overall Study|protocol non-compliance|2
4908511|NCT00563368|16910490|P2|Overall Study|protocol non-compliance|1
4908512|NCT00563368|16910491|P1|Overall Study|protocol non-compliance|1
4908513|NCT00563368|16910485|P7|Overall Study|Withdrawal by Subject|4
4908514|NCT00563368|16910486|P6|Overall Study|Withdrawal by Subject|5
4908515|NCT00563368|16910487|P5|Overall Study|Withdrawal by Subject|8
4908516|NCT00563368|16910488|P4|Overall Study|Withdrawal by Subject|7
4908517|NCT00563368|16910489|P3|Overall Study|Withdrawal by Subject|5
4908518|NCT00563368|16910490|P2|Overall Study|Withdrawal by Subject|6
4908519|NCT00563368|16910491|P1|Overall Study|Withdrawal by Subject|11
4908520|NCT00563368|16910485|P7|Overall Study|Adverse Event|17
4908521|NCT00563368|16910486|P6|Overall Study|Adverse Event|10
4908522|NCT00563368|16910487|P5|Overall Study|Adverse Event|6
4908523|NCT00563368|16910488|P4|Overall Study|Adverse Event|9
4908524|NCT00563368|16910489|P3|Overall Study|Adverse Event|5
4908525|NCT00563368|16910490|P2|Overall Study|Adverse Event|4
4908526|NCT00563368|16910491|P1|Overall Study|Adverse Event|3
4908527|NCT00563368|16910485|P7|Overall Study|Lost to Follow-up|9
4908528|NCT00563368|16910486|P6|Overall Study|Lost to Follow-up|8
4908529|NCT00563368|16910487|P5|Overall Study|Lost to Follow-up|9
4908530|NCT00563368|16910488|P4|Overall Study|Lost to Follow-up|6
4908531|NCT00563368|16910489|P3|Overall Study|Lost to Follow-up|12
4908532|NCT00563368|16910490|P2|Overall Study|Lost to Follow-up|14
4908533|NCT00563368|16910491|P1|Overall Study|Lost to Follow-up|14
4908534|NCT00563316|16910514|P1|Overall Study|Other|1
4908535|NCT00563316|16910514|P1|Overall Study|On-going in study as of 16 July 2009.|5
4908536|NCT00563316|16910514|P1|Overall Study|Death|1
4908537|NCT00563316|16910514|P1|Overall Study|Lost to Follow-up|2
4908538|NCT00563316|16910514|P1|Overall Study|Physician Decision|1
4908539|NCT00563316|16910514|P1|Overall Study|Adverse Event|2
4908540|NCT00563186|16910539|P2|Overall Study|Incomplete data|1
4908541|NCT00563186|16910540|P1|Overall Study|Incomplete data|1
4908542|NCT00563186|16910539|P2|Overall Study|LOS<48 hours|74
4908543|NCT00563186|16910540|P1|Overall Study|LOS<48 hours|97
4908544|NCT00562965|16910551|P2|Overall Study|Other|1
4908545|NCT00562965|16910552|P1|Overall Study|Other|0
4908546|NCT00562965|16910551|P2|Overall Study|Lost to Follow-up|0
4908547|NCT00562965|16910552|P1|Overall Study|Lost to Follow-up|1
4908548|NCT00562965|16910551|P2|Overall Study|Death|4
4908549|NCT00562965|16910552|P1|Overall Study|Death|2
4908550|NCT00562965|16910551|P2|Overall Study|Withdrawal by Subject|1
4908551|NCT00562965|16910552|P1|Overall Study|Withdrawal by Subject|0
4908552|NCT00562861|16910573|P2|Overall Study|Lost to Follow-up|3
4908553|NCT00562861|16910574|P1|Overall Study|Lost to Follow-up|7
4908554|NCT00562861|16910573|P2|Overall Study|noncompliance, moved|2
4908555|NCT00562861|16910574|P1|Overall Study|noncompliance, moved|7
4908556|NCT00562861|16910573|P2|Overall Study|Lack of Efficacy|5
4908557|NCT00562861|16910574|P1|Overall Study|Lack of Efficacy|5
4908558|NCT00562861|16910573|P2|Overall Study|Adverse Event|1
4908559|NCT00562861|16910574|P1|Overall Study|Adverse Event|1
4908560|NCT00562718|16910580|P1|Overall Study|not stated|1
4908561|NCT00562718|16910580|P1|Overall Study|Lack of Efficacy|2
4908562|NCT00562718|16910580|P1|Overall Study|Adverse Event|4
4908563|NCT00562718|16910580|P1|Overall Study|Withdrawal by Subject|3
4908564|NCT00562718|16910580|P1|Overall Study|Death|1
4908565|NCT00562627|16910589|P3|Overall Study|Protocol Violation|1
4908566|NCT00562627|16910590|P2|Overall Study|Protocol Violation|1
4908567|NCT00562627|16910591|P1|Overall Study|Protocol Violation|1
4908568|NCT00562588|16910607|P2|Overall Study|Other|2
4908569|NCT00562588|16910608|P1|Overall Study|Other|0
4908570|NCT00562588|16910607|P2|Overall Study|Withdrawal by Subject|9
4908571|NCT00562588|16910608|P1|Overall Study|Withdrawal by Subject|10
4908572|NCT00562588|16910607|P2|Overall Study|Lost to Follow-up|4
4908573|NCT00562588|16910608|P1|Overall Study|Lost to Follow-up|12
4908574|NCT00562588|16910607|P2|Overall Study|Protocol Violation|26
4908575|NCT00562588|16910608|P1|Overall Study|Protocol Violation|30
4908576|NCT00562588|16910607|P2|Overall Study|Adverse Event|58
4908577|NCT00562588|16910608|P1|Overall Study|Adverse Event|40
4908578|NCT00562484|16910638|P2|Overall Study|Reason not provided or not specified|12
4908579|NCT00562484|16910639|P1|Overall Study|Reason not provided or not specified|25
4908580|NCT00562484|16910638|P2|Overall Study|Lost to Follow-up|71
4908581|NCT00562484|16910639|P1|Overall Study|Lost to Follow-up|132
4908582|NCT00562484|16910638|P2|Overall Study|Moved away from the study area|9
4908583|NCT00562484|16910639|P1|Overall Study|Moved away from the study area|20
4908584|NCT00562484|16910638|P2|Overall Study|Withdrawal by Subject|9
4908585|NCT00562484|16910639|P1|Overall Study|Withdrawal by Subject|12
4908586|NCT00562484|16910638|P2|Overall Study|Protocol Violation|2
4908587|NCT00562484|16910639|P1|Overall Study|Protocol Violation|11
4908588|NCT00562484|16910638|P2|Overall Study|Adverse Event|1
4908589|NCT00562484|16910639|P1|Overall Study|Adverse Event|6
4908590|NCT00562354|16910671|P2|Overall Study|Lost to Follow-up|1
4908591|NCT00562354|16910672|P1|Overall Study|Lost to Follow-up|0
4908592|NCT00562354|16910671|P2|Overall Study|Physician Decision|1
4908593|NCT00562354|16910672|P1|Overall Study|Physician Decision|0
4908594|NCT00562302|16910738|P2|Overall Study|Not stated|4
4908595|NCT00562302|16910739|P1|Overall Study|Not stated|1
4908596|NCT00562302|16910738|P2|Overall Study|Lung resection prior to study completion|7
4908597|NCT00562302|16910739|P1|Overall Study|Lung resection prior to study completion|7
4908598|NCT00562302|16910738|P2|Overall Study|Death|2
4908599|NCT00562302|16910739|P1|Overall Study|Death|1
4908600|NCT00562302|16910738|P2|Overall Study|Withdrawal by Subject|8
4908601|NCT00562302|16910739|P1|Overall Study|Withdrawal by Subject|7
4908602|NCT00562302|16910738|P2|Overall Study|Non-compliance|2
4908603|NCT00562302|16910739|P1|Overall Study|Non-compliance|1
4908604|NCT00562302|16910738|P2|Overall Study|Adverse Event|6
4908605|NCT00562302|16910739|P1|Overall Study|Adverse Event|0
4908606|NCT00562302|16910738|P2|Overall Study|Lost to Follow-up|3
4908607|NCT00562302|16910739|P1|Overall Study|Lost to Follow-up|3
4908608|NCT00562159|16910761|P2|Overall Study|Did not meet protocol eligibility|1
4908609|NCT00562159|16910762|P1|Overall Study|Did not meet protocol eligibility|1
4908610|NCT00562159|16910761|P2|Overall Study|Protocol Violation|12
4908611|NCT00562159|16910762|P1|Overall Study|Protocol Violation|12
4908612|NCT00562159|16910761|P2|Overall Study|Withdrawal by Subject|8
4908613|NCT00562159|16910762|P1|Overall Study|Withdrawal by Subject|9
4908614|NCT00562159|16910761|P2|Overall Study|Lost to Follow-up|4
4908615|NCT00562159|16910762|P1|Overall Study|Lost to Follow-up|5
4908616|NCT00562159|16910761|P2|Overall Study|Adverse Event|8
4908617|NCT00562159|16910762|P1|Overall Study|Adverse Event|11
4908618|NCT00562120|16910774|P4|First Intervention Period|Randomized but not Treated|0
4908619|NCT00562120|16910775|P3|First Intervention Period|Randomized but not Treated|0
4908620|NCT00562120|16910776|P2|First Intervention Period|Randomized but not Treated|0
4908621|NCT00562120|16910777|P1|First Intervention Period|Randomized but not Treated|1
4908622|NCT00562120|16910774|P4|First Intervention Period|Adverse Event|0
4908623|NCT00562120|16910775|P3|First Intervention Period|Adverse Event|0
4908624|NCT00562120|16910776|P2|First Intervention Period|Adverse Event|0
4908625|NCT00562120|16910777|P1|First Intervention Period|Adverse Event|1
4908626|NCT00562094|16910809|P1|Overall Study|Lost to Follow-up|62
4908627|NCT00561977|16910824|P3|Overall Study|Pregnancy|1
4908628|NCT00561977|16910825|P2|Overall Study|Pregnancy|1
4908629|NCT00561977|16910826|P1|Overall Study|Pregnancy|0
4908630|NCT00561977|16910824|P3|Overall Study|Withdrawal by Subject|1
4908631|NCT00561977|16910825|P2|Overall Study|Withdrawal by Subject|2
4908632|NCT00561977|16910826|P1|Overall Study|Withdrawal by Subject|0
4908633|NCT00561951|16910852|P3|Overall Study|Adverse Event Occured Before Treatment|1
4908634|NCT00561951|16910853|P2|Overall Study|Adverse Event Occured Before Treatment|2
4908635|NCT00561951|16910854|P1|Overall Study|Adverse Event Occured Before Treatment|1
4908636|NCT00561951|16910852|P3|Overall Study|Meet Withdrawal Criterion|1
4908637|NCT00561951|16910853|P2|Overall Study|Meet Withdrawal Criterion|1
4908638|NCT00561951|16910854|P1|Overall Study|Meet Withdrawal Criterion|0
4908639|NCT00561951|16910852|P3|Overall Study|Pregnancy|0
4908640|NCT00561951|16910853|P2|Overall Study|Pregnancy|1
4908641|NCT00561951|16910854|P1|Overall Study|Pregnancy|0
4908642|NCT00561951|16910852|P3|Overall Study|Physician Decision|0
4908643|NCT00561951|16910853|P2|Overall Study|Physician Decision|0
4908644|NCT00561951|16910854|P1|Overall Study|Physician Decision|1
4908645|NCT00561951|16910852|P3|Overall Study|Protocol Violation|4
4908646|NCT00561951|16910853|P2|Overall Study|Protocol Violation|3
4908647|NCT00561951|16910854|P1|Overall Study|Protocol Violation|4
4908648|NCT00561951|16910852|P3|Overall Study|Withdrawal by Subject|10
4908649|NCT00561951|16910853|P2|Overall Study|Withdrawal by Subject|9
4908650|NCT00561951|16910854|P1|Overall Study|Withdrawal by Subject|10
4908651|NCT00561951|16910852|P3|Overall Study|Lost to Follow-up|0
4908652|NCT00561951|16910853|P2|Overall Study|Lost to Follow-up|1
4908653|NCT00561951|16910854|P1|Overall Study|Lost to Follow-up|1
4908654|NCT00561951|16910852|P3|Overall Study|Lack of Efficacy|2
4908655|NCT00561951|16910853|P2|Overall Study|Lack of Efficacy|3
4908656|NCT00561951|16910854|P1|Overall Study|Lack of Efficacy|5
4908657|NCT00561951|16910852|P3|Overall Study|Adverse Event|14
4908658|NCT00561951|16910853|P2|Overall Study|Adverse Event|14
4908659|NCT00561951|16910854|P1|Overall Study|Adverse Event|11
4908660|NCT00561925|16910910|P5|Open-Label Extension Period|Declined entry into extension period|50
4908661|NCT00561925|16910911|P4|Open-Label Extension Period|Declined entry into extension period|43
4908662|NCT00561925|16910912|P3|Open-Label Extension Period|Declined entry into extension period|0
4908663|NCT00561925|16910913|P2|Open-Label Extension Period|Declined entry into extension period|0
4908664|NCT00561925|16910914|P1|Open-Label Extension Period|Declined entry into extension period|0
4908665|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Other|0
4908666|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Other|0
4908667|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Other|11
4908668|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Other|8
4908669|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Other|0
4908670|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Not treated with study drug|0
4908671|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Not treated with study drug|0
4908672|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Not treated with study drug|0
4908673|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Not treated with study drug|2
4908674|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Not treated with study drug|0
4908675|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Death|0
4908676|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Death|0
4908677|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Death|3
4908678|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Death|6
4908679|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Death|0
4908680|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Pregnancy|0
4908681|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Pregnancy|0
4908682|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Pregnancy|9
4908683|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Pregnancy|1
4908684|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Pregnancy|0
4908685|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Lack of Efficacy|0
4908686|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Lack of Efficacy|0
4908687|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Lack of Efficacy|33
4908688|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Lack of Efficacy|36
4908689|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Lack of Efficacy|0
4908690|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
4908691|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
4908692|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Withdrawal by Subject|7
4908693|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Withdrawal by Subject|19
4908694|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Withdrawal by Subject|0
4908695|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Lost to Follow-up|0
4908696|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Lost to Follow-up|0
4908697|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Lost to Follow-up|12
4908698|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Lost to Follow-up|15
4908699|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Lost to Follow-up|0
4908700|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Protocol Violation|0
4908701|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Protocol Violation|0
4908702|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Protocol Violation|9
4908703|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Protocol Violation|15
4908704|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Protocol Violation|0
4908705|NCT00561925|16910910|P5|144-week Double-blind, Double-dummy|Adverse Event|0
4908706|NCT00561925|16910911|P4|144-week Double-blind, Double-dummy|Adverse Event|0
4908707|NCT00561925|16910912|P3|144-week Double-blind, Double-dummy|Adverse Event|43
4908708|NCT00561925|16910913|P2|144-week Double-blind, Double-dummy|Adverse Event|48
4908709|NCT00561925|16910914|P1|144-week Double-blind, Double-dummy|Adverse Event|0
4908710|NCT00561925|16910910|P5|14 Day Lead-In Period|Other|0
4908711|NCT00561925|16910911|P4|14 Day Lead-In Period|Other|0
4908712|NCT00561925|16910912|P3|14 Day Lead-In Period|Other|0
4908713|NCT00561925|16910913|P2|14 Day Lead-In Period|Other|0
4908714|NCT00561925|16910914|P1|14 Day Lead-In Period|Other|5
4908715|NCT00561925|16910910|P5|14 Day Lead-In Period|Withdrawal by Subject|0
4908716|NCT00561925|16910911|P4|14 Day Lead-In Period|Withdrawal by Subject|0
4908717|NCT00561925|16910912|P3|14 Day Lead-In Period|Withdrawal by Subject|0
4908718|NCT00561925|16910913|P2|14 Day Lead-In Period|Withdrawal by Subject|0
4908719|NCT00561925|16910914|P1|14 Day Lead-In Period|Withdrawal by Subject|4
4908720|NCT00561925|16910910|P5|14 Day Lead-In Period|Lost to Follow-up|0
4908721|NCT00561925|16910911|P4|14 Day Lead-In Period|Lost to Follow-up|0
4908722|NCT00561925|16910912|P3|14 Day Lead-In Period|Lost to Follow-up|0
4908723|NCT00561925|16910913|P2|14 Day Lead-In Period|Lost to Follow-up|0
4908724|NCT00561925|16910914|P1|14 Day Lead-In Period|Lost to Follow-up|4
4908725|NCT00561925|16910910|P5|14 Day Lead-In Period|In/Exclusion criteria|0
4908726|NCT00561925|16910911|P4|14 Day Lead-In Period|In/Exclusion criteria|0
4908727|NCT00561925|16910912|P3|14 Day Lead-In Period|In/Exclusion criteria|0
4908728|NCT00561925|16910913|P2|14 Day Lead-In Period|In/Exclusion criteria|0
4908729|NCT00561925|16910914|P1|14 Day Lead-In Period|In/Exclusion criteria|4
4908730|NCT00561925|16910910|P5|14 Day Lead-In Period|Adverse Event|0
4908731|NCT00561925|16910911|P4|14 Day Lead-In Period|Adverse Event|0
4908732|NCT00561925|16910912|P3|14 Day Lead-In Period|Adverse Event|0
4908733|NCT00561925|16910913|P2|14 Day Lead-In Period|Adverse Event|0
4908734|NCT00561925|16910914|P1|14 Day Lead-In Period|Adverse Event|38
4908735|NCT00561912|16910963|P1|Overall Study|ineligible|1
4908736|NCT00561821|16910975|P4|Overall Study|Adverse Event|1
4908737|NCT00561821|16910976|P3|Overall Study|Adverse Event|1
4908738|NCT00561821|16910977|P2|Overall Study|Adverse Event|3
4908739|NCT00561821|16910978|P1|Overall Study|Adverse Event|2
4908740|NCT00561821|16910975|P4|Overall Study|Other (reason not specified)|0
4908741|NCT00561821|16910976|P3|Overall Study|Other (reason not specified)|0
4908742|NCT00561821|16910977|P2|Overall Study|Other (reason not specified)|1
4908743|NCT00561821|16910978|P1|Overall Study|Other (reason not specified)|1
4908744|NCT00561821|16910975|P4|Overall Study|Reasons not related to trial|0
4908745|NCT00561821|16910976|P3|Overall Study|Reasons not related to trial|0
4908746|NCT00561821|16910977|P2|Overall Study|Reasons not related to trial|1
4908747|NCT00561821|16910978|P1|Overall Study|Reasons not related to trial|2
4908748|NCT00561821|16910975|P4|Overall Study|Withdrawal by Subject|2
4908749|NCT00561821|16910976|P3|Overall Study|Withdrawal by Subject|0
4908750|NCT00561821|16910977|P2|Overall Study|Withdrawal by Subject|1
4908751|NCT00561821|16910978|P1|Overall Study|Withdrawal by Subject|0
4908752|NCT00561821|16910975|P4|Overall Study|Not treated|0
4908753|NCT00561821|16910976|P3|Overall Study|Not treated|1
4908754|NCT00561821|16910977|P2|Overall Study|Not treated|0
4908755|NCT00561821|16910978|P1|Overall Study|Not treated|0
4908756|NCT00561795|16911054|P4|Overall Study|Physician Decision|0
4908757|NCT00561795|16911055|P3|Overall Study|Physician Decision|0
4908758|NCT00561795|16911056|P2|Overall Study|Physician Decision|0
4908759|NCT00561795|16911057|P1|Overall Study|Physician Decision|1
4908760|NCT00561795|16911054|P4|Overall Study|Study Closed/Terminated|0
4908761|NCT00561795|16911055|P3|Overall Study|Study Closed/Terminated|0
4908762|NCT00561795|16911056|P2|Overall Study|Study Closed/Terminated|3
4908763|NCT00561795|16911057|P1|Overall Study|Study Closed/Terminated|0
4908764|NCT00561795|16911054|P4|Overall Study|Adverse Event|0
4908765|NCT00561795|16911055|P3|Overall Study|Adverse Event|0
4908766|NCT00561795|16911056|P2|Overall Study|Adverse Event|3
4908767|NCT00561795|16911057|P1|Overall Study|Adverse Event|3
4908768|NCT00561730|16911077|P1|Overall Study|Not specified reasons|1
4908769|NCT00561730|16911077|P1|Overall Study|Lost to Follow-up|5
4908770|NCT00561730|16911077|P1|Overall Study|Handling of the drug|1
4908771|NCT00561730|16911077|P1|Overall Study|Adverse Event|2
4908772|NCT00561678|16911093|P2|Overall Study|anesthesia provider refusal|0
4908773|NCT00561678|16911094|P1|Overall Study|anesthesia provider refusal|1
4908774|NCT00561678|16911093|P2|Overall Study|surgery rescheduled to different site|2
4908775|NCT00561678|16911094|P1|Overall Study|surgery rescheduled to different site|2
4908776|NCT00561678|16911093|P2|Overall Study|surgery cancelled|1
4908777|NCT00561678|16911094|P1|Overall Study|surgery cancelled|1
4908778|NCT00561678|16911093|P2|Overall Study|Withdrawal by Subject|3
4908779|NCT00561678|16911094|P1|Overall Study|Withdrawal by Subject|4
4908780|NCT00561652|16911112|P2|Overall Study|Withdrawal by Subject|1
4908781|NCT00561652|16911113|P1|Overall Study|Withdrawal by Subject|0
4908782|NCT00561574|16911196|P2|Overall Study|Other|7
4908783|NCT00561574|16911197|P1|Overall Study|Other|5
4908784|NCT00561574|16911196|P2|Overall Study|Lost to Follow-up|0
4908785|NCT00561574|16911197|P1|Overall Study|Lost to Follow-up|1
4908786|NCT00561574|16911196|P2|Overall Study|Reason Unrelated to Trial|2
4908787|NCT00561574|16911197|P1|Overall Study|Reason Unrelated to Trial|6
4908788|NCT00561574|16911196|P2|Overall Study|Withdrawal by Subject|4
4908789|NCT00561574|16911197|P1|Overall Study|Withdrawal by Subject|4
4908790|NCT00561574|16911196|P2|Overall Study|Lack of Efficacy|21
4908791|NCT00561574|16911197|P1|Overall Study|Lack of Efficacy|11
4908792|NCT00561574|16911196|P2|Overall Study|Adverse Event|24
4908793|NCT00561574|16911197|P1|Overall Study|Adverse Event|21
4908794|NCT00561470|16911223|P2|Overall Study|Ongoing Treatment|14
4908795|NCT00561470|16911224|P1|Overall Study|Ongoing Treatment|11
4908796|NCT00561470|16911223|P2|Overall Study|Planning surgery|1
4908797|NCT00561470|16911224|P1|Overall Study|Planning surgery|1
4908798|NCT00561470|16911223|P2|Overall Study|Missed visit window|4
4908799|NCT00561470|16911224|P1|Overall Study|Missed visit window|1
4908800|NCT00561470|16911223|P2|Overall Study|Randomized but not treated|5
4908801|NCT00561470|16911224|P1|Overall Study|Randomized but not treated|5
4908802|NCT00561470|16911223|P2|Overall Study|Unauthorized procedure|1
4908803|NCT00561470|16911224|P1|Overall Study|Unauthorized procedure|3
4908804|NCT00561470|16911223|P2|Overall Study|Metastatic surgery|12
4908805|NCT00561470|16911224|P1|Overall Study|Metastatic surgery|10
4908806|NCT00561470|16911223|P2|Overall Study|Subject request|77
4908807|NCT00561470|16911224|P1|Overall Study|Subject request|43
4908808|NCT00561470|16911223|P2|Overall Study|Consent Withdrawn|6
4908809|NCT00561470|16911224|P1|Overall Study|Consent Withdrawn|2
4908810|NCT00561470|16911223|P2|Overall Study|Physician Decision|20
4908811|NCT00561470|16911224|P1|Overall Study|Physician Decision|21
4908812|NCT00561470|16911223|P2|Overall Study|Lost to Follow-up|0
4908813|NCT00561470|16911224|P1|Overall Study|Lost to Follow-up|2
4908814|NCT00561470|16911223|P2|Overall Study|poor compliance to protocol|4
4908815|NCT00561470|16911224|P1|Overall Study|poor compliance to protocol|4
4908816|NCT00561470|16911223|P2|Overall Study|Disease progression|305
4908817|NCT00561470|16911224|P1|Overall Study|Disease progression|437
4908818|NCT00561470|16911223|P2|Overall Study|Adverse Event|163
4908819|NCT00561470|16911224|P1|Overall Study|Adverse Event|74
4908820|NCT00561392|16911260|P1|Overall Study|Administrative problems|4
4908821|NCT00561392|16911260|P1|Overall Study|Withdrawal by Subject|8
4908822|NCT00561392|16911260|P1|Overall Study|Protocol Violation|1
4908823|NCT00561392|16911260|P1|Overall Study|Lack of Efficacy|2
4908824|NCT00561392|16911260|P1|Overall Study|Adverse Event|38
4908825|NCT00561353|16911282|P10|Overall Study|Withdrawal by Subject|0
4908826|NCT00561353|16911283|P9|Overall Study|Withdrawal by Subject|0
4908827|NCT00561353|16911284|P8|Overall Study|Withdrawal by Subject|0
4908828|NCT00561353|16911285|P7|Overall Study|Withdrawal by Subject|0
4908829|NCT00561353|16911286|P6|Overall Study|Withdrawal by Subject|0
4908830|NCT00561353|16911287|P5|Overall Study|Withdrawal by Subject|0
4908831|NCT00561353|16911288|P4|Overall Study|Withdrawal by Subject|0
4908832|NCT00561353|16911289|P3|Overall Study|Withdrawal by Subject|0
4908833|NCT00561353|16911290|P2|Overall Study|Withdrawal by Subject|2
4908834|NCT00561353|16911291|P1|Overall Study|Withdrawal by Subject|0
4908835|NCT00561353|16911282|P10|Overall Study|Lost to Follow-up|0
4908836|NCT00561353|16911283|P9|Overall Study|Lost to Follow-up|0
4908837|NCT00561353|16911284|P8|Overall Study|Lost to Follow-up|0
4908838|NCT00561353|16911285|P7|Overall Study|Lost to Follow-up|0
4908839|NCT00561353|16911286|P6|Overall Study|Lost to Follow-up|0
4908840|NCT00561353|16911287|P5|Overall Study|Lost to Follow-up|0
4908841|NCT00561353|16911288|P4|Overall Study|Lost to Follow-up|0
4908842|NCT00561353|16911289|P3|Overall Study|Lost to Follow-up|1
4908843|NCT00561353|16911290|P2|Overall Study|Lost to Follow-up|0
4908844|NCT00561353|16911291|P1|Overall Study|Lost to Follow-up|2
4908845|NCT00561353|16911282|P10|Overall Study|Adverse Event|1
4908846|NCT00561353|16911283|P9|Overall Study|Adverse Event|0
4908847|NCT00561353|16911284|P8|Overall Study|Adverse Event|0
4908848|NCT00561353|16911285|P7|Overall Study|Adverse Event|1
4908849|NCT00561353|16911286|P6|Overall Study|Adverse Event|0
4908850|NCT00561353|16911287|P5|Overall Study|Adverse Event|0
4908851|NCT00561353|16911288|P4|Overall Study|Adverse Event|2
4908852|NCT00561353|16911289|P3|Overall Study|Adverse Event|0
4908853|NCT00561353|16911290|P2|Overall Study|Adverse Event|0
4908854|NCT00561353|16911291|P1|Overall Study|Adverse Event|0
4908855|NCT00561353|16911282|P10|Overall Study|Other|0
4908856|NCT00561353|16911283|P9|Overall Study|Other|0
4908857|NCT00561353|16911284|P8|Overall Study|Other|0
4908858|NCT00561353|16911285|P7|Overall Study|Other|0
4908859|NCT00561353|16911286|P6|Overall Study|Other|2
4908860|NCT00561353|16911287|P5|Overall Study|Other|0
4908861|NCT00561353|16911288|P4|Overall Study|Other|0
4908862|NCT00561353|16911289|P3|Overall Study|Other|1
4908863|NCT00561353|16911290|P2|Overall Study|Other|0
4908864|NCT00561353|16911291|P1|Overall Study|Other|1
4908865|NCT00561353|16911282|P10|Overall Study|Subject ineligible to continue the trial|1
4908866|NCT00561353|16911283|P9|Overall Study|Subject ineligible to continue the trial|2
4908867|NCT00561353|16911284|P8|Overall Study|Subject ineligible to continue the trial|0
4908868|NCT00561353|16911285|P7|Overall Study|Subject ineligible to continue the trial|1
4908869|NCT00561353|16911286|P6|Overall Study|Subject ineligible to continue the trial|1
4908870|NCT00561353|16911287|P5|Overall Study|Subject ineligible to continue the trial|0
4908871|NCT00561353|16911288|P4|Overall Study|Subject ineligible to continue the trial|0
4908872|NCT00561353|16911289|P3|Overall Study|Subject ineligible to continue the trial|0
4908873|NCT00561353|16911290|P2|Overall Study|Subject ineligible to continue the trial|0
4908874|NCT00561353|16911291|P1|Overall Study|Subject ineligible to continue the trial|0
4908875|NCT00561353|16911282|P10|Overall Study|Subject reached a virologic endpoint|0
4908876|NCT00561353|16911283|P9|Overall Study|Subject reached a virologic endpoint|5
4908877|NCT00561353|16911284|P8|Overall Study|Subject reached a virologic endpoint|4
4908878|NCT00561353|16911285|P7|Overall Study|Subject reached a virologic endpoint|4
4908879|NCT00561353|16911286|P6|Overall Study|Subject reached a virologic endpoint|3
4908880|NCT00561353|16911287|P5|Overall Study|Subject reached a virologic endpoint|1
4908881|NCT00561353|16911288|P4|Overall Study|Subject reached a virologic endpoint|4
4908882|NCT00561353|16911289|P3|Overall Study|Subject reached a virologic endpoint|1
4908883|NCT00561353|16911290|P2|Overall Study|Subject reached a virologic endpoint|1
4908884|NCT00561353|16911291|P1|Overall Study|Subject reached a virologic endpoint|2
4908885|NCT00561340|16911446|P2|Overall Study|refused to drink pediasure|0
4908886|NCT00561340|16911447|P1|Overall Study|refused to drink pediasure|6
4908887|NCT00561080|16911467|P3|12-month Post Last Dose Follow-up|Lost to Follow-up|0
4908888|NCT00561080|16911468|P2|12-month Post Last Dose Follow-up|Lost to Follow-up|0
4908889|NCT00561080|16911469|P1|12-month Post Last Dose Follow-up|Lost to Follow-up|2
4908890|NCT00561080|16911467|P3|12-month Post Last Dose Follow-up|Withdrawal by Subject|5
4908891|NCT00561080|16911468|P2|12-month Post Last Dose Follow-up|Withdrawal by Subject|6
4908892|NCT00561080|16911469|P1|12-month Post Last Dose Follow-up|Withdrawal by Subject|2
4908893|NCT00561080|16911467|P3|12-month Post Last Dose Follow-up|Protocol Violation|4
4908894|NCT00561080|16911468|P2|12-month Post Last Dose Follow-up|Protocol Violation|0
4908895|NCT00561080|16911469|P1|12-month Post Last Dose Follow-up|Protocol Violation|0
4908896|NCT00561080|16911467|P3|12-month Post Last Dose Follow-up|Adverse Event|1
4908897|NCT00561080|16911468|P2|12-month Post Last Dose Follow-up|Adverse Event|3
4908898|NCT00561080|16911469|P1|12-month Post Last Dose Follow-up|Adverse Event|3
4908899|NCT00561080|16911467|P3|Vaccination Period (up to Month 4)|Other|1
4908900|NCT00561080|16911468|P2|Vaccination Period (up to Month 4)|Other|2
4908901|NCT00561080|16911469|P1|Vaccination Period (up to Month 4)|Other|0
4908902|NCT00561080|16911467|P3|Vaccination Period (up to Month 4)|Lost to Follow-up|0
4908903|NCT00561080|16911468|P2|Vaccination Period (up to Month 4)|Lost to Follow-up|1
4908904|NCT00561080|16911469|P1|Vaccination Period (up to Month 4)|Lost to Follow-up|0
4908905|NCT00561080|16911467|P3|Vaccination Period (up to Month 4)|Withdrawal by Subject|13
4908906|NCT00561080|16911468|P2|Vaccination Period (up to Month 4)|Withdrawal by Subject|16
4908907|NCT00561080|16911469|P1|Vaccination Period (up to Month 4)|Withdrawal by Subject|3
4908908|NCT00561080|16911467|P3|Vaccination Period (up to Month 4)|Protocol Violation|3
4908909|NCT00561080|16911468|P2|Vaccination Period (up to Month 4)|Protocol Violation|1
4908910|NCT00561080|16911469|P1|Vaccination Period (up to Month 4)|Protocol Violation|0
4908911|NCT00561080|16911467|P3|Vaccination Period (up to Month 4)|Definitive Contra-indication|3
4908912|NCT00561080|16911468|P2|Vaccination Period (up to Month 4)|Definitive Contra-indication|2
4908913|NCT00561080|16911469|P1|Vaccination Period (up to Month 4)|Definitive Contra-indication|0
4908914|NCT00561080|16911467|P3|Vaccination Period (up to Month 4)|Adverse Event|6
4908915|NCT00561080|16911468|P2|Vaccination Period (up to Month 4)|Adverse Event|4
4908916|NCT00561080|16911469|P1|Vaccination Period (up to Month 4)|Adverse Event|0
4908917|NCT00561015|16911546|P6|Overall Study|Participant non-compliance|0
4908918|NCT00561015|16911547|P5|Overall Study|Participant non-compliance|0
4908919|NCT00561015|16911548|P4|Overall Study|Participant non-compliance|0
4908920|NCT00561015|16911549|P3|Overall Study|Participant non-compliance|0
4908921|NCT00561015|16911550|P2|Overall Study|Participant non-compliance|0
4908922|NCT00561015|16911551|P1|Overall Study|Participant non-compliance|2
4908923|NCT00561015|16911546|P6|Overall Study|Lost to Follow-up|3
4908924|NCT00561015|16911547|P5|Overall Study|Lost to Follow-up|0
4908925|NCT00561015|16911548|P4|Overall Study|Lost to Follow-up|1
4908926|NCT00561015|16911549|P3|Overall Study|Lost to Follow-up|0
4908927|NCT00561015|16911550|P2|Overall Study|Lost to Follow-up|0
4908928|NCT00561015|16911551|P1|Overall Study|Lost to Follow-up|2
4908929|NCT00561015|16911546|P6|Overall Study|Adverse Event|0
4908930|NCT00561015|16911547|P5|Overall Study|Adverse Event|1
4908931|NCT00561015|16911548|P4|Overall Study|Adverse Event|0
4908932|NCT00561015|16911549|P3|Overall Study|Adverse Event|0
4908933|NCT00561015|16911550|P2|Overall Study|Adverse Event|0
4908934|NCT00561015|16911551|P1|Overall Study|Adverse Event|0
4908935|NCT00560950|16911642|P2|Overall Study|Lost to Follow-up|0
4908936|NCT00560950|16911643|P1|Overall Study|Lost to Follow-up|1
4908937|NCT00560937|16911681|P2|Overall Study|Physician Decision|1
4908938|NCT00560937|16911682|P1|Overall Study|Physician Decision|1
4908939|NCT00560937|16911681|P2|Overall Study|Withdrawal by Subject|1
4908940|NCT00560937|16911682|P1|Overall Study|Withdrawal by Subject|0
4908941|NCT00560885|16911698|P1|Overall Study|Withdrawal by Subject|1
4908942|NCT00560885|16911698|P1|Overall Study|Death|7
4908943|NCT00560833|16911723|P5|Overall Study|Never received drug|1
4908944|NCT00560833|16911724|P4|Overall Study|Never received drug|0
4908945|NCT00560833|16911725|P3|Overall Study|Never received drug|0
4908946|NCT00560833|16911726|P2|Overall Study|Never received drug|1
4908947|NCT00560833|16911727|P1|Overall Study|Never received drug|0
4908948|NCT00560833|16911723|P5|Overall Study|Other|0
4908949|NCT00560833|16911724|P4|Overall Study|Other|0
4908950|NCT00560833|16911725|P3|Overall Study|Other|3
4908951|NCT00560833|16911726|P2|Overall Study|Other|1
4908952|NCT00560833|16911727|P1|Overall Study|Other|1
4908953|NCT00560833|16911723|P5|Overall Study|Participant uncooperative|2
4908954|NCT00560833|16911724|P4|Overall Study|Participant uncooperative|4
4908955|NCT00560833|16911725|P3|Overall Study|Participant uncooperative|4
4908956|NCT00560833|16911726|P2|Overall Study|Participant uncooperative|5
4908957|NCT00560833|16911727|P1|Overall Study|Participant uncooperative|5
4908958|NCT00560833|16911723|P5|Overall Study|Lack of Efficacy|4
4908959|NCT00560833|16911724|P4|Overall Study|Lack of Efficacy|4
4908960|NCT00560833|16911725|P3|Overall Study|Lack of Efficacy|6
4908961|NCT00560833|16911726|P2|Overall Study|Lack of Efficacy|9
4908962|NCT00560833|16911727|P1|Overall Study|Lack of Efficacy|22
4908963|NCT00560833|16911723|P5|Overall Study|Lost to Follow-up|0
4908964|NCT00560833|16911724|P4|Overall Study|Lost to Follow-up|0
4908965|NCT00560833|16911725|P3|Overall Study|Lost to Follow-up|1
4908966|NCT00560833|16911726|P2|Overall Study|Lost to Follow-up|0
4908967|NCT00560833|16911727|P1|Overall Study|Lost to Follow-up|0
4908968|NCT00560833|16911723|P5|Overall Study|Adverse Event|35
4908969|NCT00560833|16911724|P4|Overall Study|Adverse Event|23
4908970|NCT00560833|16911725|P3|Overall Study|Adverse Event|25
4908971|NCT00560833|16911726|P2|Overall Study|Adverse Event|10
4908972|NCT00560833|16911727|P1|Overall Study|Adverse Event|16
4908973|NCT00560794|16911759|P1|Overall Study|Received Bone Marrow Transplant|6
4908974|NCT00560794|16911759|P1|Overall Study|Hematological Relapse|1
4908975|NCT00560794|16911759|P1|Overall Study|Minimal Residual Disease Relapse|1
4908976|NCT00560794|16911759|P1|Overall Study|Patient was not Compliant|1
4908977|NCT00560794|16911759|P1|Overall Study|Adverse Event|2
4908978|NCT00560755|16911776|P1|Overall Study|Physician Decision|2
4908979|NCT00560755|16911776|P1|Overall Study|Adverse Event|8
4908980|NCT00560755|16911776|P1|Overall Study|Lost to Follow-up|9
4908981|NCT00560755|16911776|P1|Overall Study|Withdrawal by Subject|26
4908982|NCT00560755|16911776|P1|Overall Study|Protocol Violation|15
4908983|NCT00560703|16911797|P2|Overall Study|non-compliance|1
4908984|NCT00560703|16911798|P1|Overall Study|non-compliance|0
4908985|NCT00560703|16911797|P2|Overall Study|Withdrawal by Subject|1
4908986|NCT00560703|16911798|P1|Overall Study|Withdrawal by Subject|0
4908987|NCT00560703|16911797|P2|Overall Study|Protocol Violation|2
4908988|NCT00560703|16911798|P1|Overall Study|Protocol Violation|0
4908989|NCT00560703|16911797|P2|Overall Study|Adverse Event|2
4908990|NCT00560703|16911798|P1|Overall Study|Adverse Event|0
4908991|NCT00560573|16911821|P6|Overall Study|Enrolled, not treated|0
4908992|NCT00560573|16911822|P5|Overall Study|Enrolled, not treated|1
4908993|NCT00560573|16911823|P4|Overall Study|Enrolled, not treated|0
4908994|NCT00560573|16911824|P3|Overall Study|Enrolled, not treated|0
4908995|NCT00560573|16911825|P2|Overall Study|Enrolled, not treated|0
4908996|NCT00560573|16911826|P1|Overall Study|Enrolled, not treated|0
4908997|NCT00560573|16911821|P6|Overall Study|Other|3
4908998|NCT00560573|16911822|P5|Overall Study|Other|3
4908999|NCT00560573|16911823|P4|Overall Study|Other|3
4909000|NCT00560573|16911824|P3|Overall Study|Other|2
4909001|NCT00560573|16911825|P2|Overall Study|Other|2
4909002|NCT00560573|16911826|P1|Overall Study|Other|2
4909003|NCT00560573|16911821|P6|Overall Study|Withdrawal by Subject|0
4909004|NCT00560573|16911822|P5|Overall Study|Withdrawal by Subject|1
4909005|NCT00560573|16911823|P4|Overall Study|Withdrawal by Subject|1
4909006|NCT00560573|16911824|P3|Overall Study|Withdrawal by Subject|0
4909007|NCT00560573|16911825|P2|Overall Study|Withdrawal by Subject|0
4909008|NCT00560573|16911826|P1|Overall Study|Withdrawal by Subject|0
4909009|NCT00560573|16911821|P6|Overall Study|Lost to Follow-up|0
4909010|NCT00560573|16911822|P5|Overall Study|Lost to Follow-up|1
4909011|NCT00560573|16911823|P4|Overall Study|Lost to Follow-up|1
4909012|NCT00560573|16911824|P3|Overall Study|Lost to Follow-up|0
4909013|NCT00560573|16911825|P2|Overall Study|Lost to Follow-up|0
4909014|NCT00560573|16911826|P1|Overall Study|Lost to Follow-up|0
4909015|NCT00560573|16911821|P6|Overall Study|Death|10
4909016|NCT00560573|16911822|P5|Overall Study|Death|1
4909017|NCT00560573|16911823|P4|Overall Study|Death|5
4909018|NCT00560573|16911824|P3|Overall Study|Death|4
4909019|NCT00560573|16911825|P2|Overall Study|Death|1
4909020|NCT00560573|16911826|P1|Overall Study|Death|4
4909021|NCT00560508|16911903|P2|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
4909022|NCT00560508|16911904|P1|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1
4909023|NCT00560508|16911903|P2|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3
4909024|NCT00560508|16911904|P1|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0
4909025|NCT00560508|16911903|P2|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
4909026|NCT00560508|16911904|P1|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1
4909027|NCT00560508|16911903|P2|52-week Open-label Period Pramipexole ER|Adverse Event|6
4909028|NCT00560508|16911904|P1|52-week Open-label Period Pramipexole ER|Adverse Event|6
4909029|NCT00560508|16911903|P2|12 Week Double-blind Period|Withdrawal by Subject|1
4909030|NCT00560508|16911904|P1|12 Week Double-blind Period|Withdrawal by Subject|1
4909031|NCT00560508|16911903|P2|12 Week Double-blind Period|Protocol Violation|0
4909032|NCT00560508|16911904|P1|12 Week Double-blind Period|Protocol Violation|1
4909033|NCT00560508|16911903|P2|12 Week Double-blind Period|Adverse Event|2
4909034|NCT00560508|16911904|P1|12 Week Double-blind Period|Adverse Event|3
4909035|NCT00560417|16911963|P2|Overall Study|Withdrawal by Subject|3
4909036|NCT00560417|16911964|P1|Overall Study|Withdrawal by Subject|3
4909037|NCT00560417|16911963|P2|Overall Study|Sponsor Decision|0
4909038|NCT00560417|16911964|P1|Overall Study|Sponsor Decision|2
4909039|NCT00560417|16911963|P2|Overall Study|Protocol Violation|5
4909040|NCT00560417|16911964|P1|Overall Study|Protocol Violation|6
4909041|NCT00560417|16911963|P2|Overall Study|Physician Decision|6
4909042|NCT00560417|16911964|P1|Overall Study|Physician Decision|2
4909043|NCT00560417|16911963|P2|Overall Study|Lost to Follow-up|1
4909044|NCT00560417|16911964|P1|Overall Study|Lost to Follow-up|0
4909045|NCT00560417|16911963|P2|Overall Study|Entry Criteria Not Met|0
4909046|NCT00560417|16911964|P1|Overall Study|Entry Criteria Not Met|1
4909047|NCT00560417|16911963|P2|Overall Study|Adverse Event|2
4909048|NCT00560417|16911964|P1|Overall Study|Adverse Event|3
4909049|NCT00560404|16911992|P2|Overall Study|Other withdrawal reason|5
4909050|NCT00560404|16911993|P1|Overall Study|Other withdrawal reason|13
4909051|NCT00560404|16911992|P2|Overall Study|Failure to return|2
4909052|NCT00560404|16911993|P1|Overall Study|Failure to return|1
4909053|NCT00560404|16911992|P2|Overall Study|Withdrew Consent|0
4909054|NCT00560404|16911993|P1|Overall Study|Withdrew Consent|4
4909055|NCT00560404|16911992|P2|Overall Study|Administrative Reasons|1
4909056|NCT00560404|16911993|P1|Overall Study|Administrative Reasons|1
4909057|NCT00560404|16911992|P2|Overall Study|Protocol Violation|7
4909058|NCT00560404|16911993|P1|Overall Study|Protocol Violation|12
4909059|NCT00560404|16911992|P2|Overall Study|Death|3
4909060|NCT00560404|16911993|P1|Overall Study|Death|3
4909061|NCT00560404|16911992|P2|Overall Study|Adverse Event|3
4909062|NCT00560404|16911993|P1|Overall Study|Adverse Event|2
4909063|NCT00560391|16912040|P5|Overall Study|Still on treatment|2
4909064|NCT00560391|16912041|P4|Overall Study|Still on treatment|1
4909065|NCT00560391|16912042|P3|Overall Study|Still on treatment|0
4909066|NCT00560391|16912043|P2|Overall Study|Still on treatment|0
4909067|NCT00560391|16912044|P1|Overall Study|Still on treatment|0
4909068|NCT00560352|16912100|P3|Overall Study|Maximum clinical benefit|0
4909069|NCT00560352|16912101|P2|Overall Study|Maximum clinical benefit|0
4909070|NCT00560352|16912102|P1|Overall Study|Maximum clinical benefit|1
4909071|NCT00560352|16912100|P3|Overall Study|Withdrawal by Subject|1
4909072|NCT00560352|16912101|P2|Overall Study|Withdrawal by Subject|1
4909073|NCT00560352|16912102|P1|Overall Study|Withdrawal by Subject|1
4909074|NCT00560352|16912100|P3|Overall Study|Disease progression|1
4909075|NCT00560352|16912101|P2|Overall Study|Disease progression|1
4909076|NCT00560352|16912102|P1|Overall Study|Disease progression|0
4909077|NCT00560352|16912100|P3|Overall Study|Study drug toxicity|1
4909078|NCT00560352|16912101|P2|Overall Study|Study drug toxicity|0
4909079|NCT00560352|16912102|P1|Overall Study|Study drug toxicity|3
4909080|NCT00560352|16912100|P3|Overall Study|Adverse event unrelated to study drug|1
4909081|NCT00560352|16912101|P2|Overall Study|Adverse event unrelated to study drug|1
4909082|NCT00560352|16912102|P1|Overall Study|Adverse event unrelated to study drug|2
4909083|NCT00560313|16912119|P1|Overall Study|Protocol Violation|1
4909084|NCT00560313|16912119|P1|Overall Study|Lost to Follow-up|1
4909085|NCT00560313|16912119|P1|Overall Study|Withdrawal by Subject|2
4909086|NCT00560313|16912119|P1|Overall Study|Adverse Events or Death|2
4909087|NCT00560235|16912146|P3|Phase 2|Ongoing at Date of Cut-Off|1
4909088|NCT00560235|16912147|P2|Phase 2|Ongoing at Date of Cut-Off|0
4909089|NCT00560235|16912148|P1|Phase 2|Ongoing at Date of Cut-Off|0
4909090|NCT00560235|16912146|P3|Phase 2|Discontinued|96
4909091|NCT00560235|16912147|P2|Phase 2|Discontinued|0
4909092|NCT00560235|16912148|P1|Phase 2|Discontinued|0
4909093|NCT00560235|16912146|P3|Phase 1B|Discontinued|0
4909094|NCT00560235|16912147|P2|Phase 1B|Discontinued|19
4909095|NCT00560235|16912148|P1|Phase 1B|Discontinued|0
4909096|NCT00560235|16912146|P3|Phase 1|Discontinued|0
4909097|NCT00560235|16912147|P2|Phase 1|Discontinued|0
4909098|NCT00560235|16912148|P1|Phase 1|Discontinued|8
4909099|NCT00560105|16912179|P2|Overall Study|musculoskeletal chest discomfort with us|2
4909100|NCT00560105|16912180|P1|Overall Study|musculoskeletal chest discomfort with us|1
4909101|NCT00560066|16912194|P2|Overall Study|Missing primary reason|2
4909102|NCT00560066|16912195|P1|Overall Study|Missing primary reason|0
4909103|NCT00560066|16912194|P2|Overall Study|Administrative reason|5
4909104|NCT00560066|16912195|P1|Overall Study|Administrative reason|0
4909105|NCT00560066|16912194|P2|Overall Study|Protocol Violation|1
4909106|NCT00560066|16912195|P1|Overall Study|Protocol Violation|0
4909107|NCT00560066|16912194|P2|Overall Study|Lost to Follow-up|10
4909108|NCT00560066|16912195|P1|Overall Study|Lost to Follow-up|4
4909109|NCT00560066|16912194|P2|Overall Study|Withdrawal by Subject|3
4909110|NCT00560066|16912195|P1|Overall Study|Withdrawal by Subject|0
4909111|NCT00560066|16912194|P2|Overall Study|Death|1
4909112|NCT00560066|16912195|P1|Overall Study|Death|2
4909113|NCT00559988|16912227|P2|Overall Study|ICD device explanted|17
4909114|NCT00559988|16912228|P1|Overall Study|ICD device explanted|10
4909115|NCT00559988|16912227|P2|Overall Study|Lost to Follow-up|56
4909116|NCT00559988|16912228|P1|Overall Study|Lost to Follow-up|42
4909117|NCT00559988|16912227|P2|Overall Study|Withdrawal by Subject|139
4909118|NCT00559988|16912228|P1|Overall Study|Withdrawal by Subject|152
4909119|NCT00559988|16912227|P2|Overall Study|Death|140
4909120|NCT00559988|16912228|P1|Overall Study|Death|147
4909121|NCT00559962|16912258|P8|Overall Study|Inclusion/exclusion criteria not met|0
4909122|NCT00559962|16912259|P7|Overall Study|Inclusion/exclusion criteria not met|1
4909123|NCT00559962|16912260|P6|Overall Study|Inclusion/exclusion criteria not met|0
4909124|NCT00559962|16912261|P5|Overall Study|Inclusion/exclusion criteria not met|0
4909125|NCT00559962|16912262|P4|Overall Study|Inclusion/exclusion criteria not met|0
4909126|NCT00559962|16912263|P3|Overall Study|Inclusion/exclusion criteria not met|0
4909127|NCT00559962|16912264|P2|Overall Study|Inclusion/exclusion criteria not met|0
4909128|NCT00559962|16912265|P1|Overall Study|Inclusion/exclusion criteria not met|0
4909129|NCT00559962|16912258|P8|Overall Study|Withdrawal by Subject|2
4909130|NCT00559962|16912259|P7|Overall Study|Withdrawal by Subject|0
4909131|NCT00559962|16912260|P6|Overall Study|Withdrawal by Subject|1
4909132|NCT00559962|16912261|P5|Overall Study|Withdrawal by Subject|3
4909133|NCT00559962|16912262|P4|Overall Study|Withdrawal by Subject|0
4909134|NCT00559962|16912263|P3|Overall Study|Withdrawal by Subject|2
4909135|NCT00559962|16912264|P2|Overall Study|Withdrawal by Subject|1
4909136|NCT00559962|16912265|P1|Overall Study|Withdrawal by Subject|1
4909137|NCT00559962|16912258|P8|Overall Study|Lost to Follow-up|0
4909138|NCT00559962|16912259|P7|Overall Study|Lost to Follow-up|0
4909139|NCT00559962|16912260|P6|Overall Study|Lost to Follow-up|0
4909140|NCT00559962|16912261|P5|Overall Study|Lost to Follow-up|0
4909141|NCT00559962|16912262|P4|Overall Study|Lost to Follow-up|0
4909142|NCT00559962|16912263|P3|Overall Study|Lost to Follow-up|0
4909143|NCT00559962|16912264|P2|Overall Study|Lost to Follow-up|1
4909144|NCT00559962|16912265|P1|Overall Study|Lost to Follow-up|0
4909145|NCT00559962|16912258|P8|Overall Study|Adverse Event|2
4909146|NCT00559962|16912259|P7|Overall Study|Adverse Event|4
4909147|NCT00559962|16912260|P6|Overall Study|Adverse Event|4
4909148|NCT00559962|16912261|P5|Overall Study|Adverse Event|11
4909149|NCT00559962|16912262|P4|Overall Study|Adverse Event|5
4909150|NCT00559962|16912263|P3|Overall Study|Adverse Event|8
4909151|NCT00559962|16912264|P2|Overall Study|Adverse Event|7
4909152|NCT00559962|16912265|P1|Overall Study|Adverse Event|1
4909153|NCT00559949|16912285|P1|Overall Study|No disease evaluation per protocol|1
4909154|NCT00559949|16912285|P1|Overall Study|Withdrawal by Subject|4
4909155|NCT00559949|16912285|P1|Overall Study|Adverse Event|1
4909156|NCT00559949|16912285|P1|Overall Study|Progressive Disease during cycle 1|1
4909157|NCT00559845|16912301|P1|Overall Study|Premature Surgery-Investigator Decision|1
4909158|NCT00559845|16912301|P1|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1
4909159|NCT00559845|16912301|P1|Overall Study|Adverse Event|3
4909160|NCT00559845|16912301|P1|Overall Study|Disease Progression|1
4909161|NCT00559845|16912301|P1|Overall Study|Withdrew Consent|1
4909162|NCT00559754|16912310|P1|Overall Study|Withdrawal by Subject|2
4909163|NCT00559754|16912310|P1|Overall Study|Investigator criteria|2
4909164|NCT00559754|16912310|P1|Overall Study|Protocol Violation|1
4909165|NCT00559754|16912310|P1|Overall Study|Adverse Event|5
4909166|NCT00559754|16912310|P1|Overall Study|Disease progression|1
4909167|NCT00559637|16912334|P1|Overall Study|Inclusion or exclusion criteria violated|2
4909168|NCT00559637|16912334|P1|Overall Study|Change of home|1
4909169|NCT00559637|16912334|P1|Overall Study|Change of center|1
4909170|NCT00559637|16912334|P1|Overall Study|Delayed administration of C.E.R.A|1
4909171|NCT00559637|16912334|P1|Overall Study|Participation in another study|1
4909172|NCT00559637|16912334|P1|Overall Study|Suspected lung cancer|1
4909173|NCT00559637|16912334|P1|Overall Study|Started requiring dialysis after month 7|2
4909174|NCT00559637|16912334|P1|Overall Study|Insufficient response|3
4909175|NCT00559637|16912334|P1|Overall Study|Failure to return|6
4909176|NCT00559637|16912334|P1|Overall Study|Withdrawal criteria fulfilled|4
4909177|NCT00559637|16912334|P1|Overall Study|Protocol Violation|6
4909178|NCT00559637|16912334|P1|Overall Study|Withdrawal by Subject|4
4909179|NCT00559637|16912334|P1|Overall Study|Adverse Event|22
4909180|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|no end of study status page|0
4909181|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|no end of study status page|1
4909182|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|non-specified|0
4909183|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|non-specified|71
4909184|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0
4909185|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8
4909186|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0
4909187|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89
4909188|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|No longer met criteria|0
4909189|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|No longer met criteria|1
4909190|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Death|0
4909191|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Death|20
4909192|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0
4909193|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9
4909194|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0
4909195|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32
4909196|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Pregnancy|0
4909197|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Pregnancy|16
4909198|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0
4909199|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81
4909200|NCT00559585|16912347|P2|Open Label LT Period Main + Sub-Study|Adverse Event|0
4909201|NCT00559585|16912348|P1|Open Label LT Period Main + Sub-Study|Adverse Event|100
4909202|NCT00559585|16912347|P2|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
4909203|NCT00559585|16912348|P1|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1
4909204|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Ongoing Infection Risk|0
4909205|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Ongoing Infection Risk|1
4909206|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Investigator Decision|1
4909207|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Investigator Decision|0
4909208|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1
4909209|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0
4909210|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Participant Weight Gain|0
4909211|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Participant Weight Gain|1
4909212|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Early Discontinuation|1
4909213|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Early Discontinuation|0
4909214|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1
4909215|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0
4909216|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Incomplete Breast Exam|1
4909217|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Incomplete Breast Exam|0
4909218|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Missed Doses|1
4909219|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Missed Doses|0
4909220|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Poor/Non-Compliance|0
4909221|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Poor/Non-Compliance|3
4909222|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Lack of Efficacy|1
4909223|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Lack of Efficacy|6
4909224|NCT00559585|16912347|P2|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1
4909225|NCT00559585|16912348|P1|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2
4909226|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Death|1
4909227|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Death|1
4909228|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0
4909229|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1
4909230|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Lost to Follow-up|6
4909231|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Lost to Follow-up|0
4909232|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Withdrawal by Subject|5
4909233|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Withdrawal by Subject|11
4909234|NCT00559585|16912347|P2|Double Blind ST Period Main Study|Adverse Event|25
4909235|NCT00559585|16912348|P1|Double Blind ST Period Main Study|Adverse Event|17
4909236|NCT00559507|16912408|P1|Overall Study|Not treated, patient ineligible|3
4909237|NCT00559377|16912427|P1|Overall Study|Withdrawal by Subject|9
4909238|NCT00559364|16912437|P2|Overall Study|Inclusion/exclusion criteria failure|0
4909239|NCT00559364|16912438|P1|Overall Study|Inclusion/exclusion criteria failure|1
4909240|NCT00559273|16912450|P2|Evaluation Period (8 Weeks)|Physician Decision|1
4909241|NCT00559273|16912451|P1|Evaluation Period (8 Weeks)|Physician Decision|0
4909242|NCT00559273|16912450|P2|Evaluation Period (8 Weeks)|Withdrawal by Subject|0
4909243|NCT00559273|16912451|P1|Evaluation Period (8 Weeks)|Withdrawal by Subject|2
4909244|NCT00559273|16912450|P2|Evaluation Period (8 Weeks)|Adverse Event|1
4909245|NCT00559273|16912451|P1|Evaluation Period (8 Weeks)|Adverse Event|0
4909246|NCT00559273|16912450|P2|Evaluation Period (8 Weeks)|Death|3
4909247|NCT00559273|16912451|P1|Evaluation Period (8 Weeks)|Death|1
4909248|NCT00559273|16912450|P2|Correction Period (20 Weeks)|Did not received study treatment|0
4909249|NCT00559273|16912451|P1|Correction Period (20 Weeks)|Did not received study treatment|2
4909250|NCT00559273|16912450|P2|Correction Period (20 Weeks)|Participant treated by another center|1
4909251|NCT00559273|16912451|P1|Correction Period (20 Weeks)|Participant treated by another center|0
4909252|NCT00559273|16912450|P2|Correction Period (20 Weeks)|Withdrawal by Subject|6
4909253|NCT00559273|16912451|P1|Correction Period (20 Weeks)|Withdrawal by Subject|2
4909254|NCT00559273|16912450|P2|Correction Period (20 Weeks)|Adverse Event|1
4909255|NCT00559273|16912451|P1|Correction Period (20 Weeks)|Adverse Event|2
4909256|NCT00559273|16912450|P2|Correction Period (20 Weeks)|Death|4
4909257|NCT00559273|16912451|P1|Correction Period (20 Weeks)|Death|3
4909258|NCT00559104|16912473|P2|Overall Study|Lack of Efficacy|0
4909259|NCT00559104|16912474|P1|Overall Study|Lack of Efficacy|9
4909260|NCT00558896|16912495|P7|Overall Study|Continues on treatment|6
4909261|NCT00558896|16912496|P6|Overall Study|Continues on treatment|25
4909262|NCT00558896|16912497|P5|Overall Study|Continues on treatment|9
4909263|NCT00558896|16912498|P4|Overall Study|Continues on treatment|1
4909264|NCT00558896|16912499|P3|Overall Study|Continues on treatment|0
4909265|NCT00558896|16912500|P2|Overall Study|Continues on treatment|1
4909266|NCT00558896|16912501|P1|Overall Study|Continues on treatment|10
4909267|NCT00558896|16912495|P7|Overall Study|Physician discretion|3
4909268|NCT00558896|16912496|P6|Overall Study|Physician discretion|3
4909269|NCT00558896|16912497|P5|Overall Study|Physician discretion|1
4909270|NCT00558896|16912498|P4|Overall Study|Physician discretion|2
4909271|NCT00558896|16912499|P3|Overall Study|Physician discretion|1
4909272|NCT00558896|16912500|P2|Overall Study|Physician discretion|2
4909273|NCT00558896|16912501|P1|Overall Study|Physician discretion|3
4909274|NCT00558896|16912495|P7|Overall Study|Alternative Treatment|1
4909275|NCT00558896|16912496|P6|Overall Study|Alternative Treatment|7
4909276|NCT00558896|16912497|P5|Overall Study|Alternative Treatment|6
4909277|NCT00558896|16912498|P4|Overall Study|Alternative Treatment|2
4909278|NCT00558896|16912499|P3|Overall Study|Alternative Treatment|0
4909279|NCT00558896|16912500|P2|Overall Study|Alternative Treatment|2
4909280|NCT00558896|16912501|P1|Overall Study|Alternative Treatment|2
4909281|NCT00558896|16912495|P7|Overall Study|Withdrawal by Subject|5
4909282|NCT00558896|16912496|P6|Overall Study|Withdrawal by Subject|5
4909283|NCT00558896|16912497|P5|Overall Study|Withdrawal by Subject|1
4909284|NCT00558896|16912498|P4|Overall Study|Withdrawal by Subject|1
4909285|NCT00558896|16912499|P3|Overall Study|Withdrawal by Subject|1
4909286|NCT00558896|16912500|P2|Overall Study|Withdrawal by Subject|1
4909287|NCT00558896|16912501|P1|Overall Study|Withdrawal by Subject|2
4909288|NCT00558896|16912495|P7|Overall Study|Death|6
4909289|NCT00558896|16912496|P6|Overall Study|Death|2
4909290|NCT00558896|16912497|P5|Overall Study|Death|2
4909291|NCT00558896|16912498|P4|Overall Study|Death|3
4909292|NCT00558896|16912499|P3|Overall Study|Death|2
4909293|NCT00558896|16912500|P2|Overall Study|Death|0
4909294|NCT00558896|16912501|P1|Overall Study|Death|3
4909295|NCT00558896|16912495|P7|Overall Study|Adverse Event|3
4909296|NCT00558896|16912496|P6|Overall Study|Adverse Event|10
4909297|NCT00558896|16912497|P5|Overall Study|Adverse Event|4
4909298|NCT00558896|16912498|P4|Overall Study|Adverse Event|3
4909299|NCT00558896|16912499|P3|Overall Study|Adverse Event|1
4909300|NCT00558896|16912500|P2|Overall Study|Adverse Event|1
4909301|NCT00558896|16912501|P1|Overall Study|Adverse Event|1
4909302|NCT00558831|16912603|P1|Overall Study|Lost to Follow-up|1
4909303|NCT00558753|16912660|P2|Overall Study|Lost to Follow-up|7
4909304|NCT00558753|16912661|P1|Overall Study|Lost to Follow-up|5
4909305|NCT00558701|16912673|P2|Overall Study|Protocol Deviations|4
4909306|NCT00558701|16912674|P1|Overall Study|Protocol Deviations|1
4909307|NCT00558636|16912682|P2|Follow-up|Premature termination of the study|7
4909308|NCT00558636|16912683|P1|Follow-up|Premature termination of the study|12
4909309|NCT00558636|16912682|P2|Treatment|Disease progression|5
4909310|NCT00558636|16912683|P1|Treatment|Disease progression|1
4909311|NCT00558636|16912682|P2|Treatment|Premature termination of the study|37
4909312|NCT00558636|16912683|P1|Treatment|Premature termination of the study|35
4909313|NCT00558636|16912682|P2|Treatment|Withdrawal by Subject|0
4909314|NCT00558636|16912683|P1|Treatment|Withdrawal by Subject|2
4909315|NCT00558636|16912682|P2|Treatment|Adverse Event|2
4909316|NCT00558636|16912683|P1|Treatment|Adverse Event|9
4909317|NCT00558558|16912783|P1|Overall Study|Lack of Efficacy|4
4909318|NCT00558558|16912783|P1|Overall Study|Withdrawal by Subject|1
4909319|NCT00558558|16912783|P1|Overall Study|Unable to swallow|1
4909320|NCT00558519|16912787|P1|Overall Study|Never received treatment|1
4909321|NCT00558519|16912787|P1|Overall Study|Insufficient data|1
4909322|NCT00558519|16912787|P1|Overall Study|Ineligible|1
4909323|NCT00558519|16912787|P1|Overall Study|Ph+|20
4909324|NCT00558467|16912797|P2|Overall Study|Patient moving out of state|1
4909325|NCT00558467|16912798|P1|Overall Study|Patient moving out of state|0
4909326|NCT00558467|16912797|P2|Overall Study|Lack of Efficacy|1
4909327|NCT00558467|16912798|P1|Overall Study|Lack of Efficacy|0
4909328|NCT00558467|16912797|P2|Overall Study|Adverse Event|2
4909329|NCT00558467|16912798|P1|Overall Study|Adverse Event|1
4909330|NCT00558428|16912858|P4|Overall Study|Other|1
4909331|NCT00558428|16912859|P3|Overall Study|Other|0
4909332|NCT00558428|16912860|P2|Overall Study|Other|0
4909333|NCT00558428|16912861|P1|Overall Study|Other|3
4909334|NCT00558428|16912858|P4|Overall Study|Consent withdrawn|1
4909335|NCT00558428|16912859|P3|Overall Study|Consent withdrawn|0
4909336|NCT00558428|16912860|P2|Overall Study|Consent withdrawn|1
4909337|NCT00558428|16912861|P1|Overall Study|Consent withdrawn|2
4909338|NCT00558428|16912858|P4|Overall Study|Non compliant with protocol|3
4909339|NCT00558428|16912859|P3|Overall Study|Non compliant with protocol|0
4909340|NCT00558428|16912860|P2|Overall Study|Non compliant with protocol|0
4909341|NCT00558428|16912861|P1|Overall Study|Non compliant with protocol|1
4909342|NCT00558428|16912858|P4|Overall Study|Lack of Efficacy|2
4909343|NCT00558428|16912859|P3|Overall Study|Lack of Efficacy|1
4909344|NCT00558428|16912860|P2|Overall Study|Lack of Efficacy|0
4909345|NCT00558428|16912861|P1|Overall Study|Lack of Efficacy|0
4909346|NCT00558428|16912858|P4|Overall Study|Lost to Follow-up|0
4909347|NCT00558428|16912859|P3|Overall Study|Lost to Follow-up|0
4909348|NCT00558428|16912860|P2|Overall Study|Lost to Follow-up|1
4909349|NCT00558428|16912861|P1|Overall Study|Lost to Follow-up|0
4909350|NCT00558428|16912858|P4|Overall Study|Adverse Event|4
4909351|NCT00558428|16912859|P3|Overall Study|Adverse Event|3
4909352|NCT00558428|16912860|P2|Overall Study|Adverse Event|22
4909353|NCT00558428|16912861|P1|Overall Study|Adverse Event|6
4909354|NCT00558363|16912901|P2|Overall Study|Hospitalized; Unable to Continue|1
4909355|NCT00558363|16912902|P1|Overall Study|Hospitalized; Unable to Continue|0
4909356|NCT00558363|16912901|P2|Overall Study|Randomized in Error|2
4909357|NCT00558363|16912902|P1|Overall Study|Randomized in Error|1
4909358|NCT00558363|16912901|P2|Overall Study|Met Protocol-defined Stopping Criteria|16
4909359|NCT00558363|16912902|P1|Overall Study|Met Protocol-defined Stopping Criteria|32
4909360|NCT00558363|16912901|P2|Overall Study|Lost to Follow-up|1
4909361|NCT00558363|16912902|P1|Overall Study|Lost to Follow-up|0
4909362|NCT00558363|16912901|P2|Overall Study|Protocol Violation|1
4909363|NCT00558363|16912902|P1|Overall Study|Protocol Violation|2
4909364|NCT00558363|16912901|P2|Overall Study|Lack of Efficacy|2
4909365|NCT00558363|16912902|P1|Overall Study|Lack of Efficacy|2
4909366|NCT00558363|16912901|P2|Overall Study|Adverse Event|5
4909367|NCT00558363|16912902|P1|Overall Study|Adverse Event|5
4909368|NCT00558363|16912901|P2|Overall Study|Withdrawal by Subject|4
4909369|NCT00558363|16912902|P1|Overall Study|Withdrawal by Subject|11
4909370|NCT00558363|16912901|P2|Overall Study|Physician Decision|4
4909371|NCT00558363|16912902|P1|Overall Study|Physician Decision|18
4909372|NCT00558285|16912957|P5|Overall Study|Protocol deviation|0
4909373|NCT00558285|16912958|P4|Overall Study|Protocol deviation|1
4909374|NCT00558285|16912959|P3|Overall Study|Protocol deviation|0
4909375|NCT00558285|16912960|P2|Overall Study|Protocol deviation|1
4909376|NCT00558285|16912961|P1|Overall Study|Protocol deviation|1
4909377|NCT00558285|16912957|P5|Overall Study|Administrative problems|1
4909378|NCT00558285|16912958|P4|Overall Study|Administrative problems|1
4909379|NCT00558285|16912959|P3|Overall Study|Administrative problems|0
4909380|NCT00558285|16912960|P2|Overall Study|Administrative problems|0
4909381|NCT00558285|16912961|P1|Overall Study|Administrative problems|0
4909382|NCT00558285|16912957|P5|Overall Study|Lost to Follow-up|0
4909383|NCT00558285|16912958|P4|Overall Study|Lost to Follow-up|0
4909384|NCT00558285|16912959|P3|Overall Study|Lost to Follow-up|0
4909385|NCT00558285|16912960|P2|Overall Study|Lost to Follow-up|1
4909386|NCT00558285|16912961|P1|Overall Study|Lost to Follow-up|1
4909387|NCT00558285|16912957|P5|Overall Study|Subject withdrew consent|1
4909388|NCT00558285|16912958|P4|Overall Study|Subject withdrew consent|1
4909389|NCT00558285|16912959|P3|Overall Study|Subject withdrew consent|1
4909390|NCT00558285|16912960|P2|Overall Study|Subject withdrew consent|0
4909391|NCT00558285|16912961|P1|Overall Study|Subject withdrew consent|2
4909392|NCT00558285|16912957|P5|Overall Study|Abnormal test procedure result(s)|0
4909393|NCT00558285|16912958|P4|Overall Study|Abnormal test procedure result(s)|0
4909394|NCT00558285|16912959|P3|Overall Study|Abnormal test procedure result(s)|0
4909395|NCT00558285|16912960|P2|Overall Study|Abnormal test procedure result(s)|0
4909396|NCT00558285|16912961|P1|Overall Study|Abnormal test procedure result(s)|1
4909397|NCT00558285|16912957|P5|Overall Study|Adverse Event|2
4909398|NCT00558285|16912958|P4|Overall Study|Adverse Event|1
4909399|NCT00558285|16912959|P3|Overall Study|Adverse Event|4
4909400|NCT00558285|16912960|P2|Overall Study|Adverse Event|1
4909401|NCT00558285|16912961|P1|Overall Study|Adverse Event|1
4909402|NCT00558272|16913005|P2|Overall Study|Withdrawal by Subject|1
4909403|NCT00558272|16913006|P1|Overall Study|Withdrawal by Subject|0
4909404|NCT00558272|16913005|P2|Overall Study|Incorrectly enrolled|0
4909405|NCT00558272|16913006|P1|Overall Study|Incorrectly enrolled|1
4909406|NCT00558272|16913005|P2|Overall Study|AZ study team decision|1
4909407|NCT00558272|16913006|P1|Overall Study|AZ study team decision|0
4909408|NCT00558272|16913005|P2|Overall Study|Dev. of study specific discon. criteria|0
4909409|NCT00558272|16913006|P1|Overall Study|Dev. of study specific discon. criteria|1
4909410|NCT00558272|16913005|P2|Overall Study|Death|0
4909411|NCT00558272|16913006|P1|Overall Study|Death|1
4909412|NCT00558272|16913005|P2|Overall Study|Adverse Event|0
4909413|NCT00558272|16913006|P1|Overall Study|Adverse Event|10
4909414|NCT00558259|16913046|P2|Overall Study|Withdrawal by Subject|13
4909415|NCT00558259|16913047|P1|Overall Study|Withdrawal by Subject|12
4909416|NCT00558259|16913046|P2|Overall Study|Protocol Violation|5
4909417|NCT00558259|16913047|P1|Overall Study|Protocol Violation|9
4909418|NCT00558259|16913046|P2|Overall Study|Adverse Event|81
4909419|NCT00558259|16913047|P1|Overall Study|Adverse Event|50
4909420|NCT00558103|16913087|P6|Monotherapy Extension Phase|Disease Progression|8
4909421|NCT00558103|16913088|P5|Monotherapy Extension Phase|Disease Progression|0
4909422|NCT00558103|16913089|P4|Monotherapy Extension Phase|Disease Progression|0
4909423|NCT00558103|16913090|P3|Monotherapy Extension Phase|Disease Progression|0
4909424|NCT00558103|16913091|P2|Monotherapy Extension Phase|Disease Progression|0
4909425|NCT00558103|16913092|P1|Monotherapy Extension Phase|Disease Progression|0
4909426|NCT00558103|16913087|P6|Monotherapy Extension Phase|Protocol Violation|1
4909427|NCT00558103|16913088|P5|Monotherapy Extension Phase|Protocol Violation|0
4909428|NCT00558103|16913089|P4|Monotherapy Extension Phase|Protocol Violation|0
4909429|NCT00558103|16913090|P3|Monotherapy Extension Phase|Protocol Violation|0
4909430|NCT00558103|16913091|P2|Monotherapy Extension Phase|Protocol Violation|0
4909431|NCT00558103|16913092|P1|Monotherapy Extension Phase|Protocol Violation|0
4909432|NCT00558103|16913087|P6|Randomized Treatment Phase|Adverse Event|0
4909433|NCT00558103|16913088|P5|Randomized Treatment Phase|Adverse Event|1
4909434|NCT00558103|16913089|P4|Randomized Treatment Phase|Adverse Event|1
4909435|NCT00558103|16913090|P3|Randomized Treatment Phase|Adverse Event|0
4909436|NCT00558103|16913091|P2|Randomized Treatment Phase|Adverse Event|0
4909437|NCT00558103|16913092|P1|Randomized Treatment Phase|Adverse Event|0
4909438|NCT00558103|16913087|P6|Randomized Treatment Phase|Disease Progression|0
4909439|NCT00558103|16913088|P5|Randomized Treatment Phase|Disease Progression|0
4909440|NCT00558103|16913089|P4|Randomized Treatment Phase|Disease Progression|0
4909441|NCT00558103|16913090|P3|Randomized Treatment Phase|Disease Progression|1
4909442|NCT00558103|16913091|P2|Randomized Treatment Phase|Disease Progression|0
4909443|NCT00558103|16913092|P1|Randomized Treatment Phase|Disease Progression|1
4909444|NCT00558103|16913087|P6|Randomized Treatment Phase|Withdrawal by Subject|0
4909445|NCT00558103|16913088|P5|Randomized Treatment Phase|Withdrawal by Subject|1
4909446|NCT00558103|16913089|P4|Randomized Treatment Phase|Withdrawal by Subject|0
4909447|NCT00558103|16913090|P3|Randomized Treatment Phase|Withdrawal by Subject|0
4909448|NCT00558103|16913091|P2|Randomized Treatment Phase|Withdrawal by Subject|2
4909449|NCT00558103|16913092|P1|Randomized Treatment Phase|Withdrawal by Subject|2
4909450|NCT00558103|16913087|P6|Randomized Treatment Phase|Lost to Follow-up|0
4909451|NCT00558103|16913088|P5|Randomized Treatment Phase|Lost to Follow-up|3
4909452|NCT00558103|16913089|P4|Randomized Treatment Phase|Lost to Follow-up|1
4909453|NCT00558103|16913090|P3|Randomized Treatment Phase|Lost to Follow-up|2
4909454|NCT00558103|16913091|P2|Randomized Treatment Phase|Lost to Follow-up|2
4909455|NCT00558103|16913092|P1|Randomized Treatment Phase|Lost to Follow-up|2
4909456|NCT00558064|16913122|P2|Overall Study|No visit within allowance period|0
4909457|NCT00558064|16913123|P1|Overall Study|No visit within allowance period|1
4909458|NCT00558064|16913122|P2|Overall Study|Withdrawal by Subject|1
4909459|NCT00558064|16913123|P1|Overall Study|Withdrawal by Subject|0
4909460|NCT00558064|16913122|P2|Overall Study|Lost to Follow-up|1
4909461|NCT00558064|16913123|P1|Overall Study|Lost to Follow-up|0
4909462|NCT00558064|16913122|P2|Overall Study|Protocol Violation|0
4909463|NCT00558064|16913123|P1|Overall Study|Protocol Violation|1
4909464|NCT00558064|16913122|P2|Overall Study|Lack of Efficacy|1
4909465|NCT00558064|16913123|P1|Overall Study|Lack of Efficacy|0
4909466|NCT00558064|16913122|P2|Overall Study|Adverse Event|2
4909467|NCT00558064|16913123|P1|Overall Study|Adverse Event|3
4909468|NCT00558025|16913145|P2|Overall Study|Protocol Violation|0
4909469|NCT00558025|16913146|P1|Overall Study|Protocol Violation|1
4909470|NCT00558025|16913145|P2|Overall Study|Withdrawal by Subject|2
4909471|NCT00558025|16913146|P1|Overall Study|Withdrawal by Subject|2
4909472|NCT00558025|16913145|P2|Overall Study|Adverse Event|1
4909473|NCT00558025|16913146|P1|Overall Study|Adverse Event|1
4909474|NCT00557856|16913193|P9|Part 2: Exploratory Phase|global deterioration of health status|1
4909475|NCT00557856|16913194|P8|Part 2: Exploratory Phase|global deterioration of health status|0
4909476|NCT00557856|16913195|P7|Part 2: Exploratory Phase|global deterioration of health status|0
4909477|NCT00557856|16913196|P6|Part 2: Exploratory Phase|global deterioration of health status|0
4909478|NCT00557856|16913197|P5|Part 2: Exploratory Phase|global deterioration of health status|0
4909479|NCT00557856|16913198|P4|Part 2: Exploratory Phase|global deterioration of health status|0
4909480|NCT00557856|16913199|P3|Part 2: Exploratory Phase|global deterioration of health status|0
4909481|NCT00557856|16913200|P2|Part 2: Exploratory Phase|global deterioration of health status|0
4909482|NCT00557856|16913201|P1|Part 2: Exploratory Phase|global deterioration of health status|0
4909483|NCT00557856|16913193|P9|Part 2: Exploratory Phase|Death|2
4909484|NCT00557856|16913194|P8|Part 2: Exploratory Phase|Death|0
4909485|NCT00557856|16913195|P7|Part 2: Exploratory Phase|Death|0
4909486|NCT00557856|16913196|P6|Part 2: Exploratory Phase|Death|0
4909487|NCT00557856|16913197|P5|Part 2: Exploratory Phase|Death|0
4909488|NCT00557856|16913198|P4|Part 2: Exploratory Phase|Death|0
4909489|NCT00557856|16913199|P3|Part 2: Exploratory Phase|Death|0
4909490|NCT00557856|16913200|P2|Part 2: Exploratory Phase|Death|0
4909491|NCT00557856|16913201|P1|Part 2: Exploratory Phase|Death|0
4909492|NCT00557856|16913193|P9|Part 2: Exploratory Phase|Other|1
4909493|NCT00557856|16913194|P8|Part 2: Exploratory Phase|Other|0
4909494|NCT00557856|16913195|P7|Part 2: Exploratory Phase|Other|0
4909495|NCT00557856|16913196|P6|Part 2: Exploratory Phase|Other|0
4909496|NCT00557856|16913197|P5|Part 2: Exploratory Phase|Other|0
4909497|NCT00557856|16913198|P4|Part 2: Exploratory Phase|Other|0
4909498|NCT00557856|16913199|P3|Part 2: Exploratory Phase|Other|0
4909499|NCT00557856|16913200|P2|Part 2: Exploratory Phase|Other|0
4909500|NCT00557856|16913201|P1|Part 2: Exploratory Phase|Other|0
4909501|NCT00557856|16913193|P9|Part 2: Exploratory Phase|Adverse Event|4
4909502|NCT00557856|16913194|P8|Part 2: Exploratory Phase|Adverse Event|0
4909503|NCT00557856|16913195|P7|Part 2: Exploratory Phase|Adverse Event|0
4909504|NCT00557856|16913196|P6|Part 2: Exploratory Phase|Adverse Event|0
4909505|NCT00557856|16913197|P5|Part 2: Exploratory Phase|Adverse Event|0
4909506|NCT00557856|16913198|P4|Part 2: Exploratory Phase|Adverse Event|0
4909507|NCT00557856|16913199|P3|Part 2: Exploratory Phase|Adverse Event|0
4909508|NCT00557856|16913200|P2|Part 2: Exploratory Phase|Adverse Event|0
4909509|NCT00557856|16913201|P1|Part 2: Exploratory Phase|Adverse Event|0
4909510|NCT00557856|16913193|P9|Part 2: Exploratory Phase|Withdrawal by Subject|1
4909511|NCT00557856|16913194|P8|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909512|NCT00557856|16913195|P7|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909513|NCT00557856|16913196|P6|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909514|NCT00557856|16913197|P5|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909515|NCT00557856|16913198|P4|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909516|NCT00557856|16913199|P3|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909517|NCT00557856|16913200|P2|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909518|NCT00557856|16913201|P1|Part 2: Exploratory Phase|Withdrawal by Subject|0
4909519|NCT00557856|16913193|P9|Part 2: Exploratory Phase|objective progression or relapse|15
4909520|NCT00557856|16913194|P8|Part 2: Exploratory Phase|objective progression or relapse|0
4909521|NCT00557856|16913195|P7|Part 2: Exploratory Phase|objective progression or relapse|0
4909522|NCT00557856|16913196|P6|Part 2: Exploratory Phase|objective progression or relapse|0
4909523|NCT00557856|16913197|P5|Part 2: Exploratory Phase|objective progression or relapse|0
4909524|NCT00557856|16913198|P4|Part 2: Exploratory Phase|objective progression or relapse|0
4909525|NCT00557856|16913199|P3|Part 2: Exploratory Phase|objective progression or relapse|0
4909526|NCT00557856|16913200|P2|Part 2: Exploratory Phase|objective progression or relapse|0
4909527|NCT00557856|16913201|P1|Part 2: Exploratory Phase|objective progression or relapse|0
4909528|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|randomized but not treated|0
4909529|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|randomized but not treated|0
4909530|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|randomized but not treated|0
4909531|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|randomized but not treated|0
4909532|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|randomized but not treated|0
4909533|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|randomized but not treated|0
4909534|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|randomized but not treated|0
4909535|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|randomized but not treated|0
4909536|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|randomized but not treated|2
4909537|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909538|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909539|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|global deterioration of health status|1
4909540|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|global deterioration of health status|2
4909541|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909542|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909543|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909544|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909545|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|global deterioration of health status|0
4909546|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|Death|0
4909547|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|Death|0
4909548|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|Death|0
4909549|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|Death|1
4909550|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|Death|0
4909551|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|Death|0
4909552|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|Death|0
4909553|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|Death|0
4909554|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|Death|0
4909555|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|Other|0
4909556|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|Other|1
4909557|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|Other|0
4909558|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|Other|0
4909559|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|Other|0
4909560|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|Other|1
4909561|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|Other|1
4909562|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|Other|0
4909563|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|Other|0
4909564|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|Adverse Event|0
4909565|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|Adverse Event|2
4909566|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|Adverse Event|1
4909567|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|Adverse Event|3
4909568|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|Adverse Event|1
4909569|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|Adverse Event|1
4909570|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|Adverse Event|1
4909571|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|Adverse Event|0
4909572|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|Adverse Event|1
4909573|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909574|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909575|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909576|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909577|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909578|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909579|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
4909580|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|Withdrawal by Subject|0
4909581|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|Withdrawal by Subject|1
4909582|NCT00557856|16913193|P9|Part 1: Dose Escalation Phase|objective progression or relapse|0
4909583|NCT00557856|16913194|P8|Part 1: Dose Escalation Phase|objective progression or relapse|3
4909584|NCT00557856|16913195|P7|Part 1: Dose Escalation Phase|objective progression or relapse|5
4909585|NCT00557856|16913196|P6|Part 1: Dose Escalation Phase|objective progression or relapse|2
4909586|NCT00557856|16913197|P5|Part 1: Dose Escalation Phase|objective progression or relapse|3
4909587|NCT00557856|16913198|P4|Part 1: Dose Escalation Phase|objective progression or relapse|1
4909588|NCT00557856|16913199|P3|Part 1: Dose Escalation Phase|objective progression or relapse|3
4909589|NCT00557856|16913200|P2|Part 1: Dose Escalation Phase|objective progression or relapse|5
4909590|NCT00557856|16913201|P1|Part 1: Dose Escalation Phase|objective progression or relapse|3
4909591|NCT00557830|16913400|P3|Screening Treatment Phase|Unable to tolerate standard dose|0
4909592|NCT00557830|16913401|P2|Screening Treatment Phase|Unable to tolerate standard dose|0
4909593|NCT00557830|16913402|P1|Screening Treatment Phase|Unable to tolerate standard dose|3
4909594|NCT00557830|16913400|P3|Screening Treatment Phase|Adverse Event|0
4909595|NCT00557830|16913401|P2|Screening Treatment Phase|Adverse Event|0
4909596|NCT00557830|16913402|P1|Screening Treatment Phase|Adverse Event|2
4909597|NCT00557830|16913400|P3|Screening Treatment Phase|Withdrawal by Subject|0
4909598|NCT00557830|16913401|P2|Screening Treatment Phase|Withdrawal by Subject|0
4909599|NCT00557830|16913402|P1|Screening Treatment Phase|Withdrawal by Subject|1
4909600|NCT00557622|16913424|P2|12-Week Treatment Phase|Lost to Follow-up|1
4909601|NCT00557622|16913425|P1|12-Week Treatment Phase|Lost to Follow-up|0
4909602|NCT00557622|16913424|P2|4-Week Run-in Phase|Protocol-defined stopping criteria|0
4909603|NCT00557622|16913425|P1|4-Week Run-in Phase|Protocol-defined stopping criteria|1
4909604|NCT00557622|16913424|P2|4-Week Run-in Phase|Withdrawal by Subject|0
4909605|NCT00557622|16913425|P1|4-Week Run-in Phase|Withdrawal by Subject|1
4909606|NCT00557505|16913454|P9|Overall Study|Withdrawal by Subject|1
4909607|NCT00557505|16913455|P8|Overall Study|Withdrawal by Subject|0
4909608|NCT00557505|16913456|P7|Overall Study|Withdrawal by Subject|0
4909609|NCT00557505|16913457|P6|Overall Study|Withdrawal by Subject|0
4909610|NCT00557505|16913458|P5|Overall Study|Withdrawal by Subject|0
4909611|NCT00557505|16913459|P4|Overall Study|Withdrawal by Subject|1
4909612|NCT00557505|16913460|P3|Overall Study|Withdrawal by Subject|0
4909613|NCT00557505|16913461|P2|Overall Study|Withdrawal by Subject|0
4909614|NCT00557505|16913462|P1|Overall Study|Withdrawal by Subject|0
4909615|NCT00557505|16913454|P9|Overall Study|Objective progression or relapse|15
4909616|NCT00557505|16913455|P8|Overall Study|Objective progression or relapse|5
4909617|NCT00557505|16913456|P7|Overall Study|Objective progression or relapse|2
4909618|NCT00557505|16913457|P6|Overall Study|Objective progression or relapse|3
4909619|NCT00557505|16913458|P5|Overall Study|Objective progression or relapse|2
4909620|NCT00557505|16913459|P4|Overall Study|Objective progression or relapse|2
4909621|NCT00557505|16913460|P3|Overall Study|Objective progression or relapse|3
4909622|NCT00557505|16913461|P2|Overall Study|Objective progression or relapse|3
4909623|NCT00557505|16913462|P1|Overall Study|Objective progression or relapse|2
4909624|NCT00557505|16913454|P9|Overall Study|Global deterioration of health|0
4909625|NCT00557505|16913455|P8|Overall Study|Global deterioration of health|0
4909626|NCT00557505|16913456|P7|Overall Study|Global deterioration of health|0
4909627|NCT00557505|16913457|P6|Overall Study|Global deterioration of health|0
4909628|NCT00557505|16913458|P5|Overall Study|Global deterioration of health|0
4909629|NCT00557505|16913459|P4|Overall Study|Global deterioration of health|0
4909630|NCT00557505|16913460|P3|Overall Study|Global deterioration of health|0
4909631|NCT00557505|16913461|P2|Overall Study|Global deterioration of health|0
4909632|NCT00557505|16913462|P1|Overall Study|Global deterioration of health|1
4909633|NCT00557505|16913454|P9|Overall Study|Adverse Event|0
4909634|NCT00557505|16913455|P8|Overall Study|Adverse Event|0
4909635|NCT00557505|16913456|P7|Overall Study|Adverse Event|1
4909636|NCT00557505|16913457|P6|Overall Study|Adverse Event|0
4909637|NCT00557505|16913458|P5|Overall Study|Adverse Event|0
4909638|NCT00557505|16913459|P4|Overall Study|Adverse Event|0
4909639|NCT00557505|16913460|P3|Overall Study|Adverse Event|1
4909640|NCT00557505|16913461|P2|Overall Study|Adverse Event|0
4909641|NCT00557505|16913462|P1|Overall Study|Adverse Event|0
4909642|NCT00557505|16913454|P9|Overall Study|Death|1
4909643|NCT00557505|16913455|P8|Overall Study|Death|0
4909644|NCT00557505|16913456|P7|Overall Study|Death|0
4909645|NCT00557505|16913457|P6|Overall Study|Death|0
4909646|NCT00557505|16913458|P5|Overall Study|Death|0
4909647|NCT00557505|16913459|P4|Overall Study|Death|0
4909648|NCT00557505|16913460|P3|Overall Study|Death|0
4909649|NCT00557505|16913461|P2|Overall Study|Death|0
4909650|NCT00557505|16913462|P1|Overall Study|Death|0
4909651|NCT00557492|16913626|P1|Overall Study|Change in health insurance|1
4909652|NCT00557466|16913644|P6|Overall Study|Lost to Follow-up|0
4909653|NCT00557466|16913645|P5|Overall Study|Lost to Follow-up|0
4909654|NCT00557466|16913646|P4|Overall Study|Lost to Follow-up|1
4909655|NCT00557466|16913647|P3|Overall Study|Lost to Follow-up|0
4909656|NCT00557466|16913648|P2|Overall Study|Lost to Follow-up|0
4909657|NCT00557466|16913649|P1|Overall Study|Lost to Follow-up|0
4909658|NCT00557466|16913644|P6|Overall Study|Abnormal test procedure results|0
4909659|NCT00557466|16913645|P5|Overall Study|Abnormal test procedure results|0
4909660|NCT00557466|16913646|P4|Overall Study|Abnormal test procedure results|0
4909661|NCT00557466|16913647|P3|Overall Study|Abnormal test procedure results|1
4909662|NCT00557466|16913648|P2|Overall Study|Abnormal test procedure results|0
4909663|NCT00557466|16913649|P1|Overall Study|Abnormal test procedure results|0
4909664|NCT00557466|16913644|P6|Overall Study|Administrative problems|0
4909665|NCT00557466|16913645|P5|Overall Study|Administrative problems|0
4909666|NCT00557466|16913646|P4|Overall Study|Administrative problems|0
4909667|NCT00557466|16913647|P3|Overall Study|Administrative problems|1
4909668|NCT00557466|16913648|P2|Overall Study|Administrative problems|1
4909669|NCT00557466|16913649|P1|Overall Study|Administrative problems|0
4909670|NCT00557466|16913644|P6|Overall Study|Subject withdrew consent|2
4909671|NCT00557466|16913645|P5|Overall Study|Subject withdrew consent|1
4909672|NCT00557466|16913646|P4|Overall Study|Subject withdrew consent|0
4909673|NCT00557466|16913647|P3|Overall Study|Subject withdrew consent|0
4909674|NCT00557466|16913648|P2|Overall Study|Subject withdrew consent|0
4909675|NCT00557466|16913649|P1|Overall Study|Subject withdrew consent|0
4909676|NCT00557466|16913644|P6|Overall Study|Protocol deviation|0
4909677|NCT00557466|16913645|P5|Overall Study|Protocol deviation|0
4909678|NCT00557466|16913646|P4|Overall Study|Protocol deviation|2
4909679|NCT00557466|16913647|P3|Overall Study|Protocol deviation|0
4909680|NCT00557466|16913648|P2|Overall Study|Protocol deviation|1
4909681|NCT00557466|16913649|P1|Overall Study|Protocol deviation|0
4909682|NCT00557466|16913644|P6|Overall Study|Abnormal laboratory value(s)|0
4909683|NCT00557466|16913645|P5|Overall Study|Abnormal laboratory value(s)|0
4909684|NCT00557466|16913646|P4|Overall Study|Abnormal laboratory value(s)|0
4909685|NCT00557466|16913647|P3|Overall Study|Abnormal laboratory value(s)|0
4909686|NCT00557466|16913648|P2|Overall Study|Abnormal laboratory value(s)|2
4909687|NCT00557466|16913649|P1|Overall Study|Abnormal laboratory value(s)|1
4909688|NCT00557466|16913644|P6|Overall Study|Adverse Event|4
4909689|NCT00557466|16913645|P5|Overall Study|Adverse Event|2
4909690|NCT00557466|16913646|P4|Overall Study|Adverse Event|1
4909691|NCT00557466|16913647|P3|Overall Study|Adverse Event|4
4909692|NCT00557466|16913648|P2|Overall Study|Adverse Event|1
4909693|NCT00557466|16913649|P1|Overall Study|Adverse Event|3
4909694|NCT00557440|16913702|P3|Treatment Period 1|Adverse Event|1
4909695|NCT00557440|16913703|P2|Treatment Period 1|Adverse Event|0
4909696|NCT00557440|16913704|P1|Treatment Period 1|Adverse Event|0
4909697|NCT00557323|16913758|P1|Overall Study|Administrative change|2
4909698|NCT00557323|16913758|P1|Overall Study|Withdrawal by Subject|2
4909699|NCT00557323|16913758|P1|Overall Study|Death|3
4909700|NCT00557310|16913763|P1|Extension Phase (18 - 24 Months)|Protocol Violation|1
4909701|NCT00557310|16913763|P1|Extension Phase (18 - 24 Months)|Physician Decision|2
4909702|NCT00557310|16913763|P1|Extension Phase (18 - 24 Months)|Lost to Follow-up|1
4909703|NCT00557310|16913763|P1|Extension Phase (18 - 24 Months)|Adverse Event|1
4909704|NCT00557310|16913763|P1|Main Study (0 - 18 Months)|Withdrawal by Subject|1
4909705|NCT00557310|16913763|P1|Main Study (0 - 18 Months)|Adverse Event|4
4909706|NCT00557245|16913809|P3|Overall Study|Ineligible|2
4909707|NCT00557245|16913810|P2|Overall Study|Ineligible|4
4909708|NCT00557245|16913811|P1|Overall Study|Ineligible|5
4909709|NCT00557245|16913809|P3|Overall Study|Lost to Follow-up|10
4909710|NCT00557245|16913810|P2|Overall Study|Lost to Follow-up|8
4909711|NCT00557245|16913811|P1|Overall Study|Lost to Follow-up|7
4909712|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Induction Failure|5
4909713|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Induction Failure|0
4909714|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Induction Failure|0
4909715|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Induction Failure|4
4909716|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Induction Failure|0
4909717|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Induction Failure|0
4909718|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4909719|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4909720|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4909721|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2
4909722|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4909723|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0
4909724|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4909725|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4909726|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4909727|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1
4909728|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4909729|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0
4909730|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Relapse|20
4909731|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Relapse|1
4909732|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Relapse|3
4909733|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Relapse|16
4909734|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Relapse|5
4909735|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Relapse|0
4909736|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5
4909737|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
4909738|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2
4909739|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
4909740|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1
4909741|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0
4909742|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Physician Decision|2
4909743|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Physician Decision|2
4909744|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Physician Decision|1
4909745|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Physician Decision|5
4909746|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Physician Decision|3
4909747|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
4909748|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Death|2
4909749|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Death|2
4909750|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Death|0
4909751|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Death|2
4909752|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Death|0
4909753|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Death|0
4909754|NCT00557193|16913849|P6|Post Induction Therapy by Tx Assignment|Adverse Event|3
4909755|NCT00557193|16913850|P5|Post Induction Therapy by Tx Assignment|Adverse Event|0
4909756|NCT00557193|16913851|P4|Post Induction Therapy by Tx Assignment|Adverse Event|1
4909757|NCT00557193|16913852|P3|Post Induction Therapy by Tx Assignment|Adverse Event|2
4909758|NCT00557193|16913853|P2|Post Induction Therapy by Tx Assignment|Adverse Event|1
4909759|NCT00557193|16913854|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
4909760|NCT00557193|16913849|P6|Induction|Unable to receive Lestaurtinib-Not in US|0
4909761|NCT00557193|16913850|P5|Induction|Unable to receive Lestaurtinib-Not in US|0
4909762|NCT00557193|16913851|P4|Induction|Unable to receive Lestaurtinib-Not in US|0
4909763|NCT00557193|16913852|P3|Induction|Unable to receive Lestaurtinib-Not in US|0
4909764|NCT00557193|16913853|P2|Induction|Unable to receive Lestaurtinib-Not in US|0
4909765|NCT00557193|16913854|P1|Induction|Unable to receive Lestaurtinib-Not in US|2
4909766|NCT00557193|16913849|P6|Induction|Inevaluable for post Induction|0
4909767|NCT00557193|16913850|P5|Induction|Inevaluable for post Induction|0
4909768|NCT00557193|16913851|P4|Induction|Inevaluable for post Induction|0
4909769|NCT00557193|16913852|P3|Induction|Inevaluable for post Induction|0
4909770|NCT00557193|16913853|P2|Induction|Inevaluable for post Induction|0
4909771|NCT00557193|16913854|P1|Induction|Inevaluable for post Induction|2
4909772|NCT00557193|16913849|P6|Induction|Ineligible|0
4909773|NCT00557193|16913850|P5|Induction|Ineligible|0
4909774|NCT00557193|16913851|P4|Induction|Ineligible|0
4909775|NCT00557193|16913852|P3|Induction|Ineligible|0
4909776|NCT00557193|16913853|P2|Induction|Ineligible|0
4909777|NCT00557193|16913854|P1|Induction|Ineligible|8
4909778|NCT00557193|16913849|P6|Induction|Refusal of Further Protocol Therapy|0
4909779|NCT00557193|16913850|P5|Induction|Refusal of Further Protocol Therapy|0
4909780|NCT00557193|16913851|P4|Induction|Refusal of Further Protocol Therapy|0
4909781|NCT00557193|16913852|P3|Induction|Refusal of Further Protocol Therapy|0
4909782|NCT00557193|16913853|P2|Induction|Refusal of Further Protocol Therapy|0
4909783|NCT00557193|16913854|P1|Induction|Refusal of Further Protocol Therapy|2
4909784|NCT00557193|16913849|P6|Induction|Withdrawal by Subject|0
4909785|NCT00557193|16913850|P5|Induction|Withdrawal by Subject|0
4909786|NCT00557193|16913851|P4|Induction|Withdrawal by Subject|0
4909787|NCT00557193|16913852|P3|Induction|Withdrawal by Subject|0
4909788|NCT00557193|16913853|P2|Induction|Withdrawal by Subject|0
4909789|NCT00557193|16913854|P1|Induction|Withdrawal by Subject|1
4909790|NCT00557193|16913849|P6|Induction|Physician Decision|0
4909791|NCT00557193|16913850|P5|Induction|Physician Decision|0
4909792|NCT00557193|16913851|P4|Induction|Physician Decision|0
4909793|NCT00557193|16913852|P3|Induction|Physician Decision|0
4909794|NCT00557193|16913853|P2|Induction|Physician Decision|0
4909795|NCT00557193|16913854|P1|Induction|Physician Decision|3
4909796|NCT00557193|16913849|P6|Induction|Death|0
4909797|NCT00557193|16913850|P5|Induction|Death|0
4909798|NCT00557193|16913851|P4|Induction|Death|0
4909799|NCT00557193|16913852|P3|Induction|Death|0
4909800|NCT00557193|16913853|P2|Induction|Death|0
4909801|NCT00557193|16913854|P1|Induction|Death|6
4909802|NCT00557193|16913849|P6|Induction|Adverse Event|0
4909803|NCT00557193|16913850|P5|Induction|Adverse Event|0
4909804|NCT00557193|16913851|P4|Induction|Adverse Event|0
4909805|NCT00557193|16913852|P3|Induction|Adverse Event|0
4909806|NCT00557193|16913853|P2|Induction|Adverse Event|0
4909807|NCT00557193|16913854|P1|Induction|Adverse Event|2
4909808|NCT00557076|16913894|P2|Overall Study|Unblinding|1
4909809|NCT00557076|16913895|P1|Overall Study|Unblinding|0
4909810|NCT00556998|16913903|P1|Voriconazole Oral|Intolerant of oral treatment|1
4909811|NCT00556998|16913903|P1|Voriconazole Oral|Adverse Event|1
4909812|NCT00556998|16913903|P1|Voriconazole Intravenous (IV)|Other|4
4909813|NCT00556998|16913903|P1|Voriconazole Intravenous (IV)|Adverse Event|1
4909814|NCT00556933|16913938|P4|CNI Withdrawal vs. Minimization|Death|1
4909815|NCT00556933|16913939|P3|CNI Withdrawal vs. Minimization|Death|0
4909816|NCT00556933|16913940|P2|CNI Withdrawal vs. Minimization|Death|0
4909817|NCT00556933|16913941|P1|CNI Withdrawal vs. Minimization|Death|0
4909818|NCT00556933|16913938|P4|CNI Withdrawal vs. Minimization|Graft loss|0
4909819|NCT00556933|16913939|P3|CNI Withdrawal vs. Minimization|Graft loss|2
4909820|NCT00556933|16913940|P2|CNI Withdrawal vs. Minimization|Graft loss|1
4909821|NCT00556933|16913941|P1|CNI Withdrawal vs. Minimization|Graft loss|0
4909822|NCT00556933|16913938|P4|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
4909823|NCT00556933|16913939|P3|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
4909824|NCT00556933|16913940|P2|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1
4909825|NCT00556933|16913941|P1|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0
4909826|NCT00556933|16913938|P4|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
4909827|NCT00556933|16913939|P3|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
4909828|NCT00556933|16913940|P2|CNI Withdrawal vs. Minimization|Lost to Follow-up|1
4909829|NCT00556933|16913941|P1|CNI Withdrawal vs. Minimization|Lost to Follow-up|0
4909830|NCT00556933|16913938|P4|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
4909831|NCT00556933|16913939|P3|CNI Withdrawal vs. Minimization|Pancreas transplantation|0
4909832|NCT00556933|16913940|P2|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
4909833|NCT00556933|16913941|P1|CNI Withdrawal vs. Minimization|Pancreas transplantation|1
4909834|NCT00556933|16913938|P4|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
4909835|NCT00556933|16913939|P3|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
4909836|NCT00556933|16913940|P2|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1
4909837|NCT00556933|16913941|P1|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0
4909838|NCT00556933|16913938|P4|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
4909839|NCT00556933|16913939|P3|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
4909840|NCT00556933|16913940|P2|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1
4909841|NCT00556933|16913941|P1|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0
4909842|NCT00556933|16913938|P4|Single vs. Divided-dose rATG Induction|Death|0
4909843|NCT00556933|16913939|P3|Single vs. Divided-dose rATG Induction|Death|0
4909844|NCT00556933|16913940|P2|Single vs. Divided-dose rATG Induction|Death|1
4909845|NCT00556933|16913941|P1|Single vs. Divided-dose rATG Induction|Death|0
4909846|NCT00556933|16913938|P4|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
4909847|NCT00556933|16913939|P3|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
4909848|NCT00556933|16913940|P2|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2
4909849|NCT00556933|16913941|P1|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0
4909850|NCT00556933|16913938|P4|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
4909851|NCT00556933|16913939|P3|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1
4909852|NCT00556933|16913940|P2|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
4909853|NCT00556933|16913941|P1|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0
4909854|NCT00556933|16913938|P4|Single vs. Divided-dose rATG Induction|Protocol Violation|0
4909855|NCT00556933|16913939|P3|Single vs. Divided-dose rATG Induction|Protocol Violation|3
4909856|NCT00556933|16913940|P2|Single vs. Divided-dose rATG Induction|Protocol Violation|3
4909857|NCT00556933|16913941|P1|Single vs. Divided-dose rATG Induction|Protocol Violation|2
4909858|NCT00556894|16913998|P3|Overall Study|Withdrawal by Subject|1
4909859|NCT00556894|16913999|P2|Overall Study|Withdrawal by Subject|1
4909860|NCT00556894|16914000|P1|Overall Study|Withdrawal by Subject|1
4909861|NCT00556894|16913998|P3|Overall Study|Change in therapy|2
4909862|NCT00556894|16913999|P2|Overall Study|Change in therapy|1
4909863|NCT00556894|16914000|P1|Overall Study|Change in therapy|2
4909864|NCT00556894|16913998|P3|Overall Study|regulatory decision in Bulgaria|13
4909865|NCT00556894|16913999|P2|Overall Study|regulatory decision in Bulgaria|14
4909866|NCT00556894|16914000|P1|Overall Study|regulatory decision in Bulgaria|10
4909867|NCT00556894|16913998|P3|Overall Study|Death|0
4909868|NCT00556894|16913999|P2|Overall Study|Death|0
4909869|NCT00556894|16914000|P1|Overall Study|Death|1
4909870|NCT00556894|16913998|P3|Overall Study|Adverse Event|3
4909871|NCT00556894|16913999|P2|Overall Study|Adverse Event|3
4909872|NCT00556894|16914000|P1|Overall Study|Adverse Event|2
4909873|NCT00556712|16914029|P2|Overall Study|Ongoing at Data Cutoff|66
4909874|NCT00556712|16914030|P1|Overall Study|Ongoing at Data Cutoff|32
4909875|NCT00556712|16914029|P2|Overall Study|Other|2
4909876|NCT00556712|16914030|P1|Overall Study|Other|2
4909877|NCT00556712|16914029|P2|Overall Study|Failure to Return|3
4909878|NCT00556712|16914030|P1|Overall Study|Failure to Return|2
4909879|NCT00556712|16914029|P2|Overall Study|Refused Treatment|16
4909880|NCT00556712|16914030|P1|Overall Study|Refused Treatment|17
4909881|NCT00556712|16914029|P2|Overall Study|Protocol Violation|2
4909882|NCT00556712|16914030|P1|Overall Study|Protocol Violation|3
4909883|NCT00556712|16914029|P2|Overall Study|Progressive Disease|320
4909884|NCT00556712|16914030|P1|Overall Study|Progressive Disease|383
4909885|NCT00556712|16914029|P2|Overall Study|Death|10
4909886|NCT00556712|16914030|P1|Overall Study|Death|5
4909887|NCT00556712|16914029|P2|Overall Study|Adverse Event|19
4909888|NCT00556712|16914030|P1|Overall Study|Adverse Event|7
4909889|NCT00556673|16914108|P2|Overall Study|Protocol deviation|2
4909890|NCT00556673|16914109|P1|Overall Study|Protocol deviation|3
4909891|NCT00556439|16914245|P4|After Week 12 (Randomized Study Period)|Severe infection|0
4909892|NCT00556439|16914246|P3|After Week 12 (Randomized Study Period)|Severe infection|0
4909893|NCT00556439|16914247|P2|After Week 12 (Randomized Study Period)|Severe infection|0
4909894|NCT00556439|16914248|P1|After Week 12 (Randomized Study Period)|Severe infection|1
4909895|NCT00556439|16914245|P4|After Week 12 (Randomized Study Period)|Malignancy|1
4909896|NCT00556439|16914246|P3|After Week 12 (Randomized Study Period)|Malignancy|0
4909897|NCT00556439|16914247|P2|After Week 12 (Randomized Study Period)|Malignancy|1
4909898|NCT00556439|16914248|P1|After Week 12 (Randomized Study Period)|Malignancy|0
4909899|NCT00556439|16914245|P4|After Week 12 (Randomized Study Period)|Physician Decision|0
4909900|NCT00556439|16914246|P3|After Week 12 (Randomized Study Period)|Physician Decision|0
4909901|NCT00556439|16914247|P2|After Week 12 (Randomized Study Period)|Physician Decision|0
4909902|NCT00556439|16914248|P1|After Week 12 (Randomized Study Period)|Physician Decision|1
4909903|NCT00556439|16914245|P4|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
4909904|NCT00556439|16914246|P3|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0
4909905|NCT00556439|16914247|P2|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3
4909906|NCT00556439|16914248|P1|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1
4909907|NCT00556439|16914245|P4|Study Entry to Week 12|Malignancy|0
4909908|NCT00556439|16914246|P3|Study Entry to Week 12|Malignancy|1
4909909|NCT00556439|16914247|P2|Study Entry to Week 12|Malignancy|0
4909910|NCT00556439|16914248|P1|Study Entry to Week 12|Malignancy|0
4909911|NCT00556439|16914245|P4|Study Entry to Week 12|Recurrent infection|0
4909912|NCT00556439|16914246|P3|Study Entry to Week 12|Recurrent infection|0
4909913|NCT00556439|16914247|P2|Study Entry to Week 12|Recurrent infection|0
4909914|NCT00556439|16914248|P1|Study Entry to Week 12|Recurrent infection|1
4909915|NCT00556439|16914245|P4|Study Entry to Week 12|Withdrawal by Subject|0
4909916|NCT00556439|16914246|P3|Study Entry to Week 12|Withdrawal by Subject|1
4909917|NCT00556439|16914247|P2|Study Entry to Week 12|Withdrawal by Subject|0
4909918|NCT00556439|16914248|P1|Study Entry to Week 12|Withdrawal by Subject|1
4909919|NCT00556439|16914245|P4|Study Entry to Week 12|Physician Decision|0
4909920|NCT00556439|16914246|P3|Study Entry to Week 12|Physician Decision|0
4909921|NCT00556439|16914247|P2|Study Entry to Week 12|Physician Decision|0
4909922|NCT00556439|16914248|P1|Study Entry to Week 12|Physician Decision|1
4909923|NCT00556439|16914245|P4|Study Entry to Week 12|Lack of Efficacy|0
4909924|NCT00556439|16914246|P3|Study Entry to Week 12|Lack of Efficacy|6
4909925|NCT00556439|16914247|P2|Study Entry to Week 12|Lack of Efficacy|0
4909926|NCT00556439|16914248|P1|Study Entry to Week 12|Lack of Efficacy|5
4909927|NCT00556426|16914258|P1|Overall Study|Death|6
4909928|NCT00556426|16914258|P1|Overall Study|Withdrawal by Subject|3
4909929|NCT00556374|16914280|P2|Overall Study|Lost to Follow-up|5
4909930|NCT00556374|16914281|P1|Overall Study|Lost to Follow-up|7
4909931|NCT00556374|16914280|P2|Overall Study|Death|43
4909932|NCT00556374|16914281|P1|Overall Study|Death|50
4909933|NCT00556374|16914280|P2|Overall Study|Withdrawal by Subject|172
4909934|NCT00556374|16914281|P1|Overall Study|Withdrawal by Subject|190
4909935|NCT00556322|16914301|P2|Overall Study|Death|14
4909936|NCT00556322|16914302|P1|Overall Study|Death|20
4909937|NCT00556322|16914301|P2|Overall Study|Ongoing at data cutoff|5
4909938|NCT00556322|16914302|P1|Overall Study|Ongoing at data cutoff|3
4909939|NCT00556322|16914301|P2|Overall Study|Protocol Violation|1
4909940|NCT00556322|16914302|P1|Overall Study|Protocol Violation|5
4909941|NCT00556322|16914301|P2|Overall Study|Withdrawal by Subject|7
4909942|NCT00556322|16914302|P1|Overall Study|Withdrawal by Subject|19
4909943|NCT00556322|16914301|P2|Overall Study|Lost to Follow-up|3
4909944|NCT00556322|16914302|P1|Overall Study|Lost to Follow-up|5
4909945|NCT00556322|16914301|P2|Overall Study|Other|1
4909946|NCT00556322|16914302|P1|Overall Study|Other|4
4909947|NCT00556322|16914301|P2|Overall Study|Adverse Event|4
4909948|NCT00556322|16914302|P1|Overall Study|Adverse Event|7
4909949|NCT00556322|16914301|P2|Overall Study|Insufficient therapeutic response|168
4909950|NCT00556322|16914302|P1|Overall Study|Insufficient therapeutic response|158
4909951|NCT00556166|16914350|P1|Overall Study|Withdrawal by Subject|1
4909952|NCT00556075|16914363|P3|Overall Study|Endometrial stripe not viewed on 2 tvu|0
4909953|NCT00556075|16914364|P2|Overall Study|Endometrial stripe not viewed on 2 tvu|1
4909954|NCT00556075|16914365|P1|Overall Study|Endometrial stripe not viewed on 2 tvu|0
4909955|NCT00556075|16914363|P3|Overall Study|Personal issues|0
4909956|NCT00556075|16914364|P2|Overall Study|Personal issues|1
4909957|NCT00556075|16914365|P1|Overall Study|Personal issues|4
4909958|NCT00556075|16914363|P3|Overall Study|Adverse Event|0
4909959|NCT00556075|16914364|P2|Overall Study|Adverse Event|2
4909960|NCT00556075|16914365|P1|Overall Study|Adverse Event|1
4909961|NCT00556075|16914363|P3|Overall Study|Not eligible|2
4909962|NCT00556075|16914364|P2|Overall Study|Not eligible|1
4909963|NCT00556075|16914365|P1|Overall Study|Not eligible|1
4909964|NCT00556075|16914363|P3|Overall Study|Protocol Violation|3
4909965|NCT00556075|16914364|P2|Overall Study|Protocol Violation|1
4909966|NCT00556075|16914365|P1|Overall Study|Protocol Violation|1
4909967|NCT00556075|16914363|P3|Overall Study|Withdrawal by Subject|0
4909968|NCT00556075|16914364|P2|Overall Study|Withdrawal by Subject|3
4909969|NCT00556075|16914365|P1|Overall Study|Withdrawal by Subject|3
4909970|NCT00556075|16914363|P3|Overall Study|Lost to Follow-up|3
4909971|NCT00556075|16914364|P2|Overall Study|Lost to Follow-up|0
4909972|NCT00556075|16914365|P1|Overall Study|Lost to Follow-up|3
4909973|NCT00555971|16914416|P2|Overall Study|Adverse Event|1
4909974|NCT00555971|16914417|P1|Overall Study|Adverse Event|1
4909975|NCT00555906|16914428|P5|Phase 2|Randomized but not Treated|2
4909976|NCT00555906|16914429|P4|Phase 2|Randomized but not Treated|0
4909977|NCT00555906|16914430|P3|Phase 2|Randomized but not Treated|0
4909978|NCT00555906|16914431|P2|Phase 2|Randomized but not Treated|0
4909979|NCT00555906|16914432|P1|Phase 2|Randomized but not Treated|0
4909980|NCT00555906|16914428|P5|Phase 2|Other|6
4909981|NCT00555906|16914429|P4|Phase 2|Other|0
4909982|NCT00555906|16914430|P3|Phase 2|Other|0
4909983|NCT00555906|16914431|P2|Phase 2|Other|0
4909984|NCT00555906|16914432|P1|Phase 2|Other|0
4909985|NCT00555906|16914428|P5|Phase 2|Withdrawal by Subject|2
4909986|NCT00555906|16914429|P4|Phase 2|Withdrawal by Subject|0
4909987|NCT00555906|16914430|P3|Phase 2|Withdrawal by Subject|0
4909988|NCT00555906|16914431|P2|Phase 2|Withdrawal by Subject|0
4909989|NCT00555906|16914432|P1|Phase 2|Withdrawal by Subject|0
4909990|NCT00555906|16914428|P5|Phase 2|Objective Progression or Relapse|16
4909991|NCT00555906|16914429|P4|Phase 2|Objective Progression or Relapse|0
4909992|NCT00555906|16914430|P3|Phase 2|Objective Progression or Relapse|0
4909993|NCT00555906|16914431|P2|Phase 2|Objective Progression or Relapse|0
4909994|NCT00555906|16914432|P1|Phase 2|Objective Progression or Relapse|0
4909995|NCT00555906|16914428|P5|Phase 2|Global Deterioration of Health Status|2
4909996|NCT00555906|16914429|P4|Phase 2|Global Deterioration of Health Status|0
4909997|NCT00555906|16914430|P3|Phase 2|Global Deterioration of Health Status|0
4909998|NCT00555906|16914431|P2|Phase 2|Global Deterioration of Health Status|0
4909999|NCT00555906|16914432|P1|Phase 2|Global Deterioration of Health Status|0
4910000|NCT00555906|16914428|P5|Phase 2|Adverse Event|4
4910001|NCT00555906|16914429|P4|Phase 2|Adverse Event|0
4910002|NCT00555906|16914430|P3|Phase 2|Adverse Event|0
4910003|NCT00555906|16914431|P2|Phase 2|Adverse Event|0
4910004|NCT00555906|16914432|P1|Phase 2|Adverse Event|0
4910005|NCT00555906|16914428|P5|Phase 1|Withdrawal by Subject|0
4910006|NCT00555906|16914429|P4|Phase 1|Withdrawal by Subject|1
4910007|NCT00555906|16914430|P3|Phase 1|Withdrawal by Subject|0
4910008|NCT00555906|16914431|P2|Phase 1|Withdrawal by Subject|0
4910009|NCT00555906|16914432|P1|Phase 1|Withdrawal by Subject|0
4910010|NCT00555906|16914428|P5|Phase 1|Adverse Event|0
4910011|NCT00555906|16914429|P4|Phase 1|Adverse Event|2
4910012|NCT00555906|16914430|P3|Phase 1|Adverse Event|3
4910013|NCT00555906|16914431|P2|Phase 1|Adverse Event|0
4910014|NCT00555906|16914432|P1|Phase 1|Adverse Event|0
4910015|NCT00555906|16914428|P5|Phase 1|Global Deterioration of Health Status|0
4910016|NCT00555906|16914429|P4|Phase 1|Global Deterioration of Health Status|1
4910017|NCT00555906|16914430|P3|Phase 1|Global Deterioration of Health Status|1
4910018|NCT00555906|16914431|P2|Phase 1|Global Deterioration of Health Status|1
4910019|NCT00555906|16914432|P1|Phase 1|Global Deterioration of Health Status|0
4910020|NCT00555906|16914428|P5|Phase 1|Objective Progression or Relapse|0
4910021|NCT00555906|16914429|P4|Phase 1|Objective Progression or Relapse|1
4910022|NCT00555906|16914430|P3|Phase 1|Objective Progression or Relapse|3
4910023|NCT00555906|16914431|P2|Phase 1|Objective Progression or Relapse|5
4910024|NCT00555906|16914432|P1|Phase 1|Objective Progression or Relapse|3
4910025|NCT00555672|16914554|P2|Overall Study|Participant refused|0
4910026|NCT00555672|16914555|P1|Overall Study|Participant refused|2
4910027|NCT00555672|16914554|P2|Overall Study|Other|1
4910028|NCT00555672|16914555|P1|Overall Study|Other|3
4910029|NCT00555672|16914554|P2|Overall Study|Objective progression or relapse|5
4910030|NCT00555672|16914555|P1|Overall Study|Objective progression or relapse|11
4910031|NCT00555672|16914554|P2|Overall Study|Adverse Event|2
4910032|NCT00555672|16914555|P1|Overall Study|Adverse Event|8
4910033|NCT00555672|16914554|P2|Overall Study|Death|2
4910034|NCT00555672|16914555|P1|Overall Study|Death|0
4910035|NCT00555620|16914580|P6|Overall Study|Other|3
4910036|NCT00555620|16914581|P5|Overall Study|Other|0
4910037|NCT00555620|16914582|P4|Overall Study|Other|1
4910038|NCT00555620|16914583|P3|Overall Study|Other|0
4910039|NCT00555620|16914584|P2|Overall Study|Other|0
4910040|NCT00555620|16914585|P1|Overall Study|Other|0
4910041|NCT00555620|16914580|P6|Overall Study|Participant refused treatment|1
4910042|NCT00555620|16914581|P5|Overall Study|Participant refused treatment|0
4910043|NCT00555620|16914582|P4|Overall Study|Participant refused treatment|0
4910044|NCT00555620|16914583|P3|Overall Study|Participant refused treatment|1
4910045|NCT00555620|16914584|P2|Overall Study|Participant refused treatment|1
4910046|NCT00555620|16914585|P1|Overall Study|Participant refused treatment|0
4910047|NCT00555620|16914580|P6|Overall Study|Objective progression or relapse|16
4910048|NCT00555620|16914581|P5|Overall Study|Objective progression or relapse|3
4910049|NCT00555620|16914582|P4|Overall Study|Objective progression or relapse|17
4910050|NCT00555620|16914583|P3|Overall Study|Objective progression or relapse|12
4910051|NCT00555620|16914584|P2|Overall Study|Objective progression or relapse|5
4910052|NCT00555620|16914585|P1|Overall Study|Objective progression or relapse|6
4910053|NCT00555620|16914580|P6|Overall Study|Adverse Event|1
4910054|NCT00555620|16914581|P5|Overall Study|Adverse Event|0
4910055|NCT00555620|16914582|P4|Overall Study|Adverse Event|5
4910056|NCT00555620|16914583|P3|Overall Study|Adverse Event|1
4910057|NCT00555620|16914584|P2|Overall Study|Adverse Event|0
4910058|NCT00555620|16914585|P1|Overall Study|Adverse Event|0
4910059|NCT00555620|16914580|P6|Overall Study|Study terminated by sponsor|0
4910060|NCT00555620|16914581|P5|Overall Study|Study terminated by sponsor|0
4910061|NCT00555620|16914582|P4|Overall Study|Study terminated by sponsor|0
4910062|NCT00555620|16914583|P3|Overall Study|Study terminated by sponsor|1
4910063|NCT00555620|16914584|P2|Overall Study|Study terminated by sponsor|0
4910064|NCT00555620|16914585|P1|Overall Study|Study terminated by sponsor|0
4910065|NCT00555620|16914580|P6|Overall Study|Death|1
4910066|NCT00555620|16914581|P5|Overall Study|Death|0
4910067|NCT00555620|16914582|P4|Overall Study|Death|0
4910068|NCT00555620|16914583|P3|Overall Study|Death|0
4910069|NCT00555620|16914584|P2|Overall Study|Death|1
4910070|NCT00555620|16914585|P1|Overall Study|Death|0
4910071|NCT00555568|16914709|P3|Overall Study|Lost to Follow-up|16
4910072|NCT00555568|16914710|P2|Overall Study|Lost to Follow-up|16
4910073|NCT00555568|16914711|P1|Overall Study|Lost to Follow-up|26
4910074|NCT00555477|16914733|P2|Overall Study|Physician Decision|2
4910075|NCT00555477|16914734|P1|Overall Study|Physician Decision|1
4910076|NCT00555477|16914733|P2|Overall Study|Withdrawal by Subject|2
4910077|NCT00555477|16914734|P1|Overall Study|Withdrawal by Subject|1
4910078|NCT00555477|16914733|P2|Overall Study|Adverse Event|9
4910079|NCT00555477|16914734|P1|Overall Study|Adverse Event|0
4910080|NCT00555438|16914750|P1|Between 10 Days and 30 Days Postoperativ|Death|5
4910081|NCT00555438|16914750|P1|10 Days Post-operative|Death|4
4910082|NCT00555425|16914760|P2|Overall Study|Became pregnant and transferred care|1
4910083|NCT00555425|16914761|P1|Overall Study|Became pregnant and transferred care|0
4910084|NCT00555425|16914760|P2|Overall Study|Met criteria for protective transfer|3
4910085|NCT00555425|16914761|P1|Overall Study|Met criteria for protective transfer|16
4910086|NCT00555425|16914760|P2|Overall Study|Missed 3 physician management visits|0
4910087|NCT00555425|16914761|P1|Overall Study|Missed 3 physician management visits|1
4910088|NCT00555425|16914760|P2|Overall Study|Missed Medication > 1 wk|15
4910089|NCT00555425|16914761|P1|Overall Study|Missed Medication > 1 wk|34
4910090|NCT00555321|16914797|P5|Long-term Extension Phase|Other Reason|0
4910091|NCT00555321|16914798|P4|Long-term Extension Phase|Other Reason|0
4910092|NCT00555321|16914799|P3|Long-term Extension Phase|Other Reason|2
4910093|NCT00555321|16914800|P2|Long-term Extension Phase|Other Reason|0
4910094|NCT00555321|16914801|P1|Long-term Extension Phase|Other Reason|1
4910095|NCT00555321|16914797|P5|Long-term Extension Phase|Participant did not meet study criteria|1
4910096|NCT00555321|16914798|P4|Long-term Extension Phase|Participant did not meet study criteria|0
4910097|NCT00555321|16914799|P3|Long-term Extension Phase|Participant did not meet study criteria|0
4910098|NCT00555321|16914800|P2|Long-term Extension Phase|Participant did not meet study criteria|0
4910099|NCT00555321|16914801|P1|Long-term Extension Phase|Participant did not meet study criteria|0
4910100|NCT00555321|16914797|P5|Long-term Extension Phase|Death|0
4910101|NCT00555321|16914798|P4|Long-term Extension Phase|Death|3
4910102|NCT00555321|16914799|P3|Long-term Extension Phase|Death|0
4910103|NCT00555321|16914800|P2|Long-term Extension Phase|Death|0
4910104|NCT00555321|16914801|P1|Long-term Extension Phase|Death|2
4910105|NCT00555321|16914797|P5|Long-term Extension Phase|Administrative reason by sponsor|23
4910106|NCT00555321|16914798|P4|Long-term Extension Phase|Administrative reason by sponsor|31
4910107|NCT00555321|16914799|P3|Long-term Extension Phase|Administrative reason by sponsor|18
4910108|NCT00555321|16914800|P2|Long-term Extension Phase|Administrative reason by sponsor|21
4910109|NCT00555321|16914801|P1|Long-term Extension Phase|Administrative reason by sponsor|23
4910110|NCT00555321|16914797|P5|Long-term Extension Phase|Withdrawal by Subject|2
4910111|NCT00555321|16914798|P4|Long-term Extension Phase|Withdrawal by Subject|3
4910112|NCT00555321|16914799|P3|Long-term Extension Phase|Withdrawal by Subject|2
4910113|NCT00555321|16914800|P2|Long-term Extension Phase|Withdrawal by Subject|1
4910114|NCT00555321|16914801|P1|Long-term Extension Phase|Withdrawal by Subject|2
4910115|NCT00555321|16914797|P5|Long-term Extension Phase|Adverse Event|0
4910116|NCT00555321|16914798|P4|Long-term Extension Phase|Adverse Event|1
4910117|NCT00555321|16914799|P3|Long-term Extension Phase|Adverse Event|2
4910118|NCT00555321|16914800|P2|Long-term Extension Phase|Adverse Event|5
4910119|NCT00555321|16914801|P1|Long-term Extension Phase|Adverse Event|2
4910120|NCT00555321|16914797|P5|Treatment Phase up to 12-months|Never treated|4
4910121|NCT00555321|16914798|P4|Treatment Phase up to 12-months|Never treated|0
4910122|NCT00555321|16914799|P3|Treatment Phase up to 12-months|Never treated|1
4910123|NCT00555321|16914800|P2|Treatment Phase up to 12-months|Never treated|3
4910124|NCT00555321|16914801|P1|Treatment Phase up to 12-months|Never treated|2
4910125|NCT00555321|16914797|P5|Treatment Phase up to 12-months|Other Reason|0
4910126|NCT00555321|16914798|P4|Treatment Phase up to 12-months|Other Reason|0
4910127|NCT00555321|16914799|P3|Treatment Phase up to 12-months|Other Reason|2
4910128|NCT00555321|16914800|P2|Treatment Phase up to 12-months|Other Reason|3
4910129|NCT00555321|16914801|P1|Treatment Phase up to 12-months|Other Reason|1
4910130|NCT00555321|16914797|P5|Treatment Phase up to 12-months|Lack of Efficacy|0
4910131|NCT00555321|16914798|P4|Treatment Phase up to 12-months|Lack of Efficacy|0
4910132|NCT00555321|16914799|P3|Treatment Phase up to 12-months|Lack of Efficacy|5
4910133|NCT00555321|16914800|P2|Treatment Phase up to 12-months|Lack of Efficacy|8
4910134|NCT00555321|16914801|P1|Treatment Phase up to 12-months|Lack of Efficacy|9
4910135|NCT00555321|16914797|P5|Treatment Phase up to 12-months|Death|0
4910136|NCT00555321|16914798|P4|Treatment Phase up to 12-months|Death|0
4910137|NCT00555321|16914799|P3|Treatment Phase up to 12-months|Death|4
4910138|NCT00555321|16914800|P2|Treatment Phase up to 12-months|Death|1
4910139|NCT00555321|16914801|P1|Treatment Phase up to 12-months|Death|2
4910140|NCT00555321|16914797|P5|Treatment Phase up to 12-months|Withdrawal by Subject|0
4910141|NCT00555321|16914798|P4|Treatment Phase up to 12-months|Withdrawal by Subject|0
4910142|NCT00555321|16914799|P3|Treatment Phase up to 12-months|Withdrawal by Subject|1
4910143|NCT00555321|16914800|P2|Treatment Phase up to 12-months|Withdrawal by Subject|0
4910144|NCT00555321|16914801|P1|Treatment Phase up to 12-months|Withdrawal by Subject|1
4910145|NCT00555321|16914797|P5|Treatment Phase up to 12-months|Adverse Event|18
4910146|NCT00555321|16914798|P4|Treatment Phase up to 12-months|Adverse Event|7
4910147|NCT00555321|16914799|P3|Treatment Phase up to 12-months|Adverse Event|11
4910148|NCT00555321|16914800|P2|Treatment Phase up to 12-months|Adverse Event|7
4910149|NCT00555321|16914801|P1|Treatment Phase up to 12-months|Adverse Event|6
4910150|NCT00555217|16915105|P2|Overall Study|close out sites|17
4910151|NCT00555217|16915106|P1|Overall Study|close out sites|21
4910152|NCT00555217|16915105|P2|Overall Study|Lost to Follow-up|20
4910153|NCT00555217|16915106|P1|Overall Study|Lost to Follow-up|19
4910154|NCT00555217|16915105|P2|Overall Study|Withdrawal by Subject|31
4910155|NCT00555217|16915106|P1|Overall Study|Withdrawal by Subject|35
4910156|NCT00555061|16915143|P1|Overall Study|Participant enrolled, but never treated|1
4910157|NCT00555061|16915143|P1|Overall Study|Withdrawal by Subject|2
4910158|NCT00555061|16915143|P1|Overall Study|Lost to Follow-up|2
4910159|NCT00555061|16915143|P1|Overall Study|Protocol Violation|1
4910160|NCT00555061|16915143|P1|Overall Study|Adverse Event|3
4910161|NCT00555009|16915162|P2|Overall Study|Terminated by Sponsor|5
4910162|NCT00555009|16915163|P1|Overall Study|Terminated by Sponsor|2
4910163|NCT00555009|16915162|P2|Overall Study|Withdrawal by Subject|1
4910164|NCT00555009|16915163|P1|Overall Study|Withdrawal by Subject|0
4910165|NCT00554840|16915243|P2|Overall Study|Physician Decision|1
4910166|NCT00554840|16915244|P1|Overall Study|Physician Decision|0
4910167|NCT00554801|16915262|P2|Overall Study|Withdrawal by Subject|0
4910168|NCT00554801|16915263|P1|Overall Study|Withdrawal by Subject|14
4910169|NCT00554801|16915262|P2|Overall Study|left area before completion|0
4910170|NCT00554801|16915263|P1|Overall Study|left area before completion|5
4910171|NCT00554788|16915274|P3|Overall Study|Ineligible|1
4910172|NCT00554788|16915275|P2|Overall Study|Ineligible|0
4910173|NCT00554788|16915276|P1|Overall Study|Ineligible|2
4910174|NCT00554788|16915274|P3|Overall Study|Progressive disease|3
4910175|NCT00554788|16915275|P2|Overall Study|Progressive disease|0
4910176|NCT00554788|16915276|P1|Overall Study|Progressive disease|0
4910177|NCT00554788|16915274|P3|Overall Study|Refusal of further protocol therapy|1
4910178|NCT00554788|16915275|P2|Overall Study|Refusal of further protocol therapy|1
4910179|NCT00554788|16915276|P1|Overall Study|Refusal of further protocol therapy|0
4910180|NCT00554788|16915274|P3|Overall Study|Withdrawal by Subject|1
4910181|NCT00554788|16915275|P2|Overall Study|Withdrawal by Subject|0
4910182|NCT00554788|16915276|P1|Overall Study|Withdrawal by Subject|0
4910183|NCT00554788|16915274|P3|Overall Study|Physician Decision|3
4910184|NCT00554788|16915275|P2|Overall Study|Physician Decision|1
4910185|NCT00554788|16915276|P1|Overall Study|Physician Decision|1
4910186|NCT00554788|16915274|P3|Overall Study|Lost to Follow-up|3
4910187|NCT00554788|16915275|P2|Overall Study|Lost to Follow-up|3
4910188|NCT00554788|16915276|P1|Overall Study|Lost to Follow-up|4
4910189|NCT00554788|16915274|P3|Overall Study|Adverse Event|2
4910190|NCT00554788|16915275|P2|Overall Study|Adverse Event|1
4910191|NCT00554788|16915276|P1|Overall Study|Adverse Event|0
4910192|NCT00554619|16915308|P1|Overall Study|Liver Function Test Abnormality|1
4910193|NCT00554619|16915308|P1|Overall Study|Physician Decision|1
4910194|NCT00554619|16915308|P1|Overall Study|Adverse Event|1
4910195|NCT00554515|16915320|P1|Overall Study|Misc|15
4910196|NCT00554515|16915320|P1|Overall Study|Other|1
4910197|NCT00554515|16915320|P1|Overall Study|Achieved Stable Disease|7
4910198|NCT00554515|16915320|P1|Overall Study|Death|2
4910199|NCT00554515|16915320|P1|Overall Study|Adverse Event|9
4910200|NCT00554515|16915320|P1|Overall Study|Withdrawal by Subject|11
4910201|NCT00554515|16915320|P1|Overall Study|Physician Decision|18
4910202|NCT00554515|16915320|P1|Overall Study|Disease progression|52
4910203|NCT00554515|16915320|P1|Overall Study|Withdrawal by Subject|3
4910204|NCT00554229|16915383|P2|Overall Study|Randomised but no treatment received|0
4910205|NCT00554229|16915384|P1|Overall Study|Randomised but no treatment received|1
4910206|NCT00554229|16915383|P2|Overall Study|Reason not otherwise captured, eg; death|140
4910207|NCT00554229|16915384|P1|Overall Study|Reason not otherwise captured, eg; death|119
4910208|NCT00554229|16915383|P2|Overall Study|Protocol Violation|3
4910209|NCT00554229|16915384|P1|Overall Study|Protocol Violation|3
4910210|NCT00554229|16915383|P2|Overall Study|Adverse Event|39
4910211|NCT00554229|16915384|P1|Overall Study|Adverse Event|71
4910212|NCT00554229|16915383|P2|Overall Study|Withdrawal by Subject|37
4910213|NCT00554229|16915384|P1|Overall Study|Withdrawal by Subject|29
4910214|NCT00554229|16915383|P2|Overall Study|Lost to Follow-up|6
4910215|NCT00554229|16915384|P1|Overall Study|Lost to Follow-up|3
4910216|NCT00554216|16915409|P3|Overall Study|Lack of Efficacy|0
4910217|NCT00554216|16915410|P2|Overall Study|Lack of Efficacy|3
4910218|NCT00554216|16915411|P1|Overall Study|Lack of Efficacy|15
4910219|NCT00554216|16915409|P3|Overall Study|Other|10
4910220|NCT00554216|16915410|P2|Overall Study|Other|7
4910221|NCT00554216|16915411|P1|Overall Study|Other|12
4910222|NCT00554216|16915409|P3|Overall Study|Restricted med|1
4910223|NCT00554216|16915410|P2|Overall Study|Restricted med|1
4910224|NCT00554216|16915411|P1|Overall Study|Restricted med|3
4910225|NCT00554216|16915409|P3|Overall Study|Pregnancy|14
4910226|NCT00554216|16915410|P2|Overall Study|Pregnancy|1
4910227|NCT00554216|16915411|P1|Overall Study|Pregnancy|2
4910228|NCT00554216|16915409|P3|Overall Study|Non compliance|5
4910229|NCT00554216|16915410|P2|Overall Study|Non compliance|4
4910230|NCT00554216|16915411|P1|Overall Study|Non compliance|10
4910231|NCT00554216|16915409|P3|Overall Study|Withdrawal by Subject|43
4910232|NCT00554216|16915410|P2|Overall Study|Withdrawal by Subject|31
4910233|NCT00554216|16915411|P1|Overall Study|Withdrawal by Subject|92
4910234|NCT00554216|16915409|P3|Overall Study|Adverse Event|36
4910235|NCT00554216|16915410|P2|Overall Study|Adverse Event|16
4910236|NCT00554216|16915411|P1|Overall Study|Adverse Event|16
4910237|NCT00554216|16915409|P3|Overall Study|Lost to Follow-up|63
4910238|NCT00554216|16915410|P2|Overall Study|Lost to Follow-up|31
4910239|NCT00554216|16915411|P1|Overall Study|Lost to Follow-up|92
4910240|NCT00554190|16915422|P1|Overall Study|Termination forms not completed|10
4910241|NCT00554099|16915431|P3|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
4910242|NCT00554099|16915432|P2|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2
4910243|NCT00554099|16915433|P1|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4
4910244|NCT00554099|16915431|P3|Non-Treatment Phase (9 Months)|Relapse|1
4910245|NCT00554099|16915432|P2|Non-Treatment Phase (9 Months)|Relapse|1
4910246|NCT00554099|16915433|P1|Non-Treatment Phase (9 Months)|Relapse|2
4910247|NCT00554099|16915431|P3|Non-Treatment Phase (9 Months)|Lost to Follow-up|0
4910248|NCT00554099|16915432|P2|Non-Treatment Phase (9 Months)|Lost to Follow-up|2
4910249|NCT00554099|16915433|P1|Non-Treatment Phase (9 Months)|Lost to Follow-up|1
4910250|NCT00554099|16915431|P3|Treatment Period (12 Weeks)|Withdrawal by Subject|4
4910251|NCT00554099|16915432|P2|Treatment Period (12 Weeks)|Withdrawal by Subject|1
4910252|NCT00554099|16915433|P1|Treatment Period (12 Weeks)|Withdrawal by Subject|4
4910253|NCT00554099|16915431|P3|Treatment Period (12 Weeks)|Protocol Violation|2
4910254|NCT00554099|16915432|P2|Treatment Period (12 Weeks)|Protocol Violation|0
4910255|NCT00554099|16915433|P1|Treatment Period (12 Weeks)|Protocol Violation|0
4910256|NCT00554099|16915431|P3|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0
4910257|NCT00554099|16915432|P2|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2
4910258|NCT00554099|16915433|P1|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1
4910259|NCT00554099|16915431|P3|Treatment Period (12 Weeks)|Lost to Follow-up|2
4910260|NCT00554099|16915432|P2|Treatment Period (12 Weeks)|Lost to Follow-up|0
4910261|NCT00554099|16915433|P1|Treatment Period (12 Weeks)|Lost to Follow-up|1
4910262|NCT00554099|16915431|P3|Treatment Period (12 Weeks)|Physician Decision|0
4910263|NCT00554099|16915432|P2|Treatment Period (12 Weeks)|Physician Decision|0
4910264|NCT00554099|16915433|P1|Treatment Period (12 Weeks)|Physician Decision|3
4910265|NCT00554099|16915431|P3|Treatment Period (12 Weeks)|Adverse Event|1
4910266|NCT00554099|16915432|P2|Treatment Period (12 Weeks)|Adverse Event|5
4910267|NCT00554099|16915433|P1|Treatment Period (12 Weeks)|Adverse Event|3
4910268|NCT00553787|16915488|P3|Overall Study|Other|13
4910269|NCT00553787|16915489|P2|Overall Study|Other|10
4910270|NCT00553787|16915490|P1|Overall Study|Other|18
4910271|NCT00553787|16915488|P3|Overall Study|Requirement for restricted medication|5
4910272|NCT00553787|16915489|P2|Overall Study|Requirement for restricted medication|7
4910273|NCT00553787|16915490|P1|Overall Study|Requirement for restricted medication|8
4910274|NCT00553787|16915488|P3|Overall Study|non compliance|11
4910275|NCT00553787|16915489|P2|Overall Study|non compliance|0
4910276|NCT00553787|16915490|P1|Overall Study|non compliance|4
4910277|NCT00553787|16915488|P3|Overall Study|Pregnancy|2
4910278|NCT00553787|16915489|P2|Overall Study|Pregnancy|1
4910279|NCT00553787|16915490|P1|Overall Study|Pregnancy|0
4910280|NCT00553787|16915488|P3|Overall Study|Lack of Efficacy|3
4910281|NCT00553787|16915489|P2|Overall Study|Lack of Efficacy|1
4910282|NCT00553787|16915490|P1|Overall Study|Lack of Efficacy|31
4910283|NCT00553787|16915488|P3|Overall Study|Withdrawal by Subject|83
4910284|NCT00553787|16915489|P2|Overall Study|Withdrawal by Subject|40
4910285|NCT00553787|16915490|P1|Overall Study|Withdrawal by Subject|151
4910286|NCT00553787|16915488|P3|Overall Study|Lost to Follow-up|78
4910287|NCT00553787|16915489|P2|Overall Study|Lost to Follow-up|44
4910288|NCT00553787|16915490|P1|Overall Study|Lost to Follow-up|132
4910289|NCT00553787|16915488|P3|Overall Study|Adverse Event|67
4910290|NCT00553787|16915489|P2|Overall Study|Adverse Event|21
4910291|NCT00553787|16915490|P1|Overall Study|Adverse Event|34
4910292|NCT00553696|16915522|P4|Overall Study|Withdrawal by Subject|0
4910293|NCT00553696|16915523|P3|Overall Study|Withdrawal by Subject|0
4910294|NCT00553696|16915524|P2|Overall Study|Withdrawal by Subject|1
4910295|NCT00553696|16915525|P1|Overall Study|Withdrawal by Subject|0
4910296|NCT00553696|16915522|P4|Overall Study|Objective progression or relapse|0
4910297|NCT00553696|16915523|P3|Overall Study|Objective progression or relapse|6
4910298|NCT00553696|16915524|P2|Overall Study|Objective progression or relapse|9
4910299|NCT00553696|16915525|P1|Overall Study|Objective progression or relapse|2
4910300|NCT00553696|16915522|P4|Overall Study|Global deterioration of health status|0
4910301|NCT00553696|16915523|P3|Overall Study|Global deterioration of health status|0
4910302|NCT00553696|16915524|P2|Overall Study|Global deterioration of health status|2
4910303|NCT00553696|16915525|P1|Overall Study|Global deterioration of health status|0
4910304|NCT00553696|16915522|P4|Overall Study|Adverse Event|1
4910305|NCT00553696|16915523|P3|Overall Study|Adverse Event|0
4910306|NCT00553696|16915524|P2|Overall Study|Adverse Event|4
4910307|NCT00553696|16915525|P1|Overall Study|Adverse Event|2
4910308|NCT00553644|16915563|P1|Overall Study|Alternative therapy|6
4910309|NCT00553644|16915563|P1|Overall Study|Physician Decision|1
4910310|NCT00553644|16915563|P1|Overall Study|Withdrawal by Subject|4
4910311|NCT00553644|16915563|P1|Overall Study|Adverse Event|17
4910312|NCT00553631|16915572|P2|Overall Study|Lost to Follow-up|0
4910313|NCT00553631|16915573|P1|Overall Study|Lost to Follow-up|1
4910314|NCT00553631|16915572|P2|Overall Study|Withdrawal by Subject|1
4910315|NCT00553631|16915573|P1|Overall Study|Withdrawal by Subject|0
4910316|NCT00553605|16915595|P2|Overall Study|Randomized but not treated|0
4910317|NCT00553605|16915596|P1|Overall Study|Randomized but not treated|2
4910318|NCT00553605|16915595|P2|Overall Study|Did not receive full dose|0
4910319|NCT00553605|16915596|P1|Overall Study|Did not receive full dose|1
4910320|NCT00553605|16915595|P2|Overall Study|Did not meet entrance criteria|3
4910321|NCT00553605|16915596|P1|Overall Study|Did not meet entrance criteria|1
4910322|NCT00553540|16915622|P2|Overall Study|discharged after first visit|5
4910323|NCT00553540|16915623|P1|Overall Study|discharged after first visit|2
4910324|NCT00553514|16915634|P5|Overall Study|Other|1
4910325|NCT00553514|16915635|P4|Overall Study|Other|0
4910326|NCT00553514|16915636|P3|Overall Study|Other|0
4910327|NCT00553514|16915637|P2|Overall Study|Other|1
4910328|NCT00553514|16915638|P1|Overall Study|Other|1
4910329|NCT00553514|16915634|P5|Overall Study|Risk of multiple pregnancy|0
4910330|NCT00553514|16915635|P4|Overall Study|Risk of multiple pregnancy|1
4910331|NCT00553514|16915636|P3|Overall Study|Risk of multiple pregnancy|0
4910332|NCT00553514|16915637|P2|Overall Study|Risk of multiple pregnancy|2
4910333|NCT00553514|16915638|P1|Overall Study|Risk of multiple pregnancy|0
4910334|NCT00553514|16915634|P5|Overall Study|Ovarian hyperstimulation syndrome risk|0
4910335|NCT00553514|16915635|P4|Overall Study|Ovarian hyperstimulation syndrome risk|0
4910336|NCT00553514|16915636|P3|Overall Study|Ovarian hyperstimulation syndrome risk|1
4910337|NCT00553514|16915637|P2|Overall Study|Ovarian hyperstimulation syndrome risk|0
4910338|NCT00553514|16915638|P1|Overall Study|Ovarian hyperstimulation syndrome risk|3
4910339|NCT00553514|16915634|P5|Overall Study|Lack of ovarian response|6
4910340|NCT00553514|16915635|P4|Overall Study|Lack of ovarian response|5
4910341|NCT00553514|16915636|P3|Overall Study|Lack of ovarian response|5
4910342|NCT00553514|16915637|P2|Overall Study|Lack of ovarian response|5
4910343|NCT00553514|16915638|P1|Overall Study|Lack of ovarian response|4
4910344|NCT00553514|16915634|P5|Overall Study|Protocol deviation|0
4910345|NCT00553514|16915635|P4|Overall Study|Protocol deviation|1
4910346|NCT00553514|16915636|P3|Overall Study|Protocol deviation|0
4910347|NCT00553514|16915637|P2|Overall Study|Protocol deviation|0
4910348|NCT00553514|16915638|P1|Overall Study|Protocol deviation|0
4910349|NCT00553501|16915675|P1|Overall Study|Progression|1
4910350|NCT00553501|16915675|P1|Overall Study|Death|1
4910351|NCT00553501|16915675|P1|Overall Study|Adverse Event|2
4910352|NCT00553475|16915684|P3|Overall Study|Due to moving|0
4910353|NCT00553475|16915685|P2|Overall Study|Due to moving|1
4910354|NCT00553475|16915686|P1|Overall Study|Due to moving|0
4910355|NCT00553475|16915684|P3|Overall Study|Physician Decision|0
4910356|NCT00553475|16915685|P2|Overall Study|Physician Decision|0
4910357|NCT00553475|16915686|P1|Overall Study|Physician Decision|1
4910358|NCT00553475|16915684|P3|Overall Study|Withdrawal by Subject|0
4910359|NCT00553475|16915685|P2|Overall Study|Withdrawal by Subject|1
4910360|NCT00553475|16915686|P1|Overall Study|Withdrawal by Subject|1
4910361|NCT00553475|16915684|P3|Overall Study|Lack of Efficacy|0
4910362|NCT00553475|16915685|P2|Overall Study|Lack of Efficacy|1
4910363|NCT00553475|16915686|P1|Overall Study|Lack of Efficacy|7
4910364|NCT00553475|16915684|P3|Overall Study|Adverse Event|13
4910365|NCT00553475|16915685|P2|Overall Study|Adverse Event|17
4910366|NCT00553475|16915686|P1|Overall Study|Adverse Event|7
4910367|NCT00553462|16915808|P1|Overall Study|Physician Decision|1
4910368|NCT00553462|16915808|P1|Overall Study|Withdrawal by Subject|5
4910369|NCT00553462|16915808|P1|Overall Study|Progression|4
4910370|NCT00553462|16915808|P1|Overall Study|Adverse Event|4
4910371|NCT00553436|16915814|P1|Overall Study|Conversion to another procedure|1
4910372|NCT00553358|16915838|P3|Overall Study|Other: Reason Not Specified|20
4910373|NCT00553358|16915839|P2|Overall Study|Other: Reason Not Specified|4
4910374|NCT00553358|16915840|P1|Overall Study|Other: Reason Not Specified|15
4910375|NCT00553358|16915838|P3|Overall Study|Missing|1
4910376|NCT00553358|16915839|P2|Overall Study|Missing|1
4910377|NCT00553358|16915840|P1|Overall Study|Missing|1
4910378|NCT00553358|16915838|P3|Overall Study|Participant Withdrawal from Drug|3
4910379|NCT00553358|16915839|P2|Overall Study|Participant Withdrawal from Drug|0
4910380|NCT00553358|16915840|P1|Overall Study|Participant Withdrawal from Drug|0
4910381|NCT00553358|16915838|P3|Overall Study|Recurrence of Disease|1
4910382|NCT00553358|16915839|P2|Overall Study|Recurrence of Disease|4
4910383|NCT00553358|16915840|P1|Overall Study|Recurrence of Disease|3
4910384|NCT00553358|16915838|P3|Overall Study|Withdrawal by Subject|1
4910385|NCT00553358|16915839|P2|Overall Study|Withdrawal by Subject|0
4910386|NCT00553358|16915840|P1|Overall Study|Withdrawal by Subject|5
4910387|NCT00553358|16915838|P3|Overall Study|Protocol Violation|1
4910388|NCT00553358|16915839|P2|Overall Study|Protocol Violation|1
4910389|NCT00553358|16915840|P1|Overall Study|Protocol Violation|0
4910390|NCT00553358|16915838|P3|Overall Study|Lost to Follow-up|1
4910391|NCT00553358|16915839|P2|Overall Study|Lost to Follow-up|0
4910392|NCT00553358|16915840|P1|Overall Study|Lost to Follow-up|0
4910393|NCT00553358|16915838|P3|Overall Study|Adverse Event|32
4910394|NCT00553358|16915839|P2|Overall Study|Adverse Event|2
4910395|NCT00553358|16915840|P1|Overall Study|Adverse Event|29
4910396|NCT00553332|16915866|P1|Overall Study|ineligible, incorrect diagnosis|1
4910397|NCT00553319|16915878|P3|Overall Study|moved|1
4910398|NCT00553319|16915879|P2|Overall Study|moved|0
4910399|NCT00553319|16915880|P1|Overall Study|moved|1
4910400|NCT00553319|16915878|P3|Overall Study|incarceration|0
4910401|NCT00553319|16915879|P2|Overall Study|incarceration|0
4910402|NCT00553319|16915880|P1|Overall Study|incarceration|1
4910403|NCT00553319|16915878|P3|Overall Study|non-compliance|2
4910404|NCT00553319|16915879|P2|Overall Study|non-compliance|0
4910405|NCT00553319|16915880|P1|Overall Study|non-compliance|0
4910406|NCT00553319|16915878|P3|Overall Study|wanted treatment elsewhere|1
4910407|NCT00553319|16915879|P2|Overall Study|wanted treatment elsewhere|1
4910408|NCT00553319|16915880|P1|Overall Study|wanted treatment elsewhere|2
4910409|NCT00553319|16915878|P3|Overall Study|Lost to Follow-up|5
4910410|NCT00553319|16915879|P2|Overall Study|Lost to Follow-up|9
4910411|NCT00553319|16915880|P1|Overall Study|Lost to Follow-up|10
4910412|NCT00553280|16915891|P1|Overall Study|Physician Decision|1
4910413|NCT00553280|16915891|P1|Overall Study|Withdrawal by Subject|3
4910414|NCT00553280|16915891|P1|Overall Study|Lack of Efficacy|3
4910415|NCT00553280|16915891|P1|Overall Study|Adverse Event|19
4910416|NCT00553267|16915903|P3|Overall Study|Specified category|1
4910417|NCT00553267|16915904|P2|Overall Study|Specified category|2
4910418|NCT00553267|16915905|P1|Overall Study|Specified category|1
4910419|NCT00553267|16915903|P3|Overall Study|Consent withdrawn|1
4910420|NCT00553267|16915904|P2|Overall Study|Consent withdrawn|3
4910421|NCT00553267|16915905|P1|Overall Study|Consent withdrawn|2
4910422|NCT00553267|16915903|P3|Overall Study|Lost to Follow-up|1
4910423|NCT00553267|16915904|P2|Overall Study|Lost to Follow-up|0
4910424|NCT00553267|16915905|P1|Overall Study|Lost to Follow-up|0
4910425|NCT00553267|16915903|P3|Overall Study|Non compliant with protocol|2
4910426|NCT00553267|16915904|P2|Overall Study|Non compliant with protocol|3
4910427|NCT00553267|16915905|P1|Overall Study|Non compliant with protocol|3
4910428|NCT00553267|16915903|P3|Overall Study|Adverse Event|5
4910429|NCT00553267|16915904|P2|Overall Study|Adverse Event|10
4910430|NCT00553267|16915905|P1|Overall Study|Adverse Event|8
4910431|NCT00553254|16915942|P3|Overall Study|Other|13
4910432|NCT00553254|16915943|P2|Overall Study|Other|0
4910433|NCT00553254|16915944|P1|Overall Study|Other|1
4910434|NCT00553254|16915942|P3|Overall Study|Study terminated by Sponsor|1
4910435|NCT00553254|16915943|P2|Overall Study|Study terminated by Sponsor|0
4910436|NCT00553254|16915944|P1|Overall Study|Study terminated by Sponsor|0
4910437|NCT00553254|16915942|P3|Overall Study|Withdrawal by Subject|2
4910438|NCT00553254|16915943|P2|Overall Study|Withdrawal by Subject|0
4910439|NCT00553254|16915944|P1|Overall Study|Withdrawal by Subject|2
4910440|NCT00553254|16915942|P3|Overall Study|Lost to Follow-up|2
4910441|NCT00553254|16915943|P2|Overall Study|Lost to Follow-up|0
4910442|NCT00553254|16915944|P1|Overall Study|Lost to Follow-up|0
4910443|NCT00553254|16915942|P3|Overall Study|Death|25
4910444|NCT00553254|16915943|P2|Overall Study|Death|6
4910445|NCT00553254|16915944|P1|Overall Study|Death|3
4910446|NCT00553202|16915986|P1|Overall Study|Fails to meet organ function|6
4910447|NCT00553202|16915986|P1|Overall Study|No donor identified|16
4910448|NCT00553202|16915986|P1|Overall Study|Withdrawal by Subject|1
4910449|NCT00553202|16915986|P1|Overall Study|Physician Decision|28
4910450|NCT00553202|16915986|P1|Overall Study|Lost to Follow-up|1
4910451|NCT00553202|16915986|P1|Overall Study|Death|16
4910452|NCT00553150|16916013|P4|Overall Study|Ineligible|1
4910453|NCT00553150|16916014|P3|Overall Study|Ineligible|0
4910454|NCT00553150|16916015|P2|Overall Study|Ineligible|0
4910455|NCT00553150|16916016|P1|Overall Study|Ineligible|0
4910456|NCT00553150|16916013|P4|Overall Study|Protocol Violation|1
4910457|NCT00553150|16916014|P3|Overall Study|Protocol Violation|0
4910458|NCT00553150|16916015|P2|Overall Study|Protocol Violation|0
4910459|NCT00553150|16916016|P1|Overall Study|Protocol Violation|0
4910460|NCT00553150|16916013|P4|Overall Study|Withdrawal by Subject|2
4910461|NCT00553150|16916014|P3|Overall Study|Withdrawal by Subject|0
4910462|NCT00553150|16916015|P2|Overall Study|Withdrawal by Subject|0
4910463|NCT00553150|16916016|P1|Overall Study|Withdrawal by Subject|0
4910464|NCT00553059|16916044|P2|Overall Study|Drug supply not available|1
4910465|NCT00553059|16916045|P1|Overall Study|Drug supply not available|0
4910466|NCT00553059|16916044|P2|Overall Study|Deemed ineligible|1
4910467|NCT00553059|16916045|P1|Overall Study|Deemed ineligible|1
4910468|NCT00552929|16916073|P10|Overall Study|Not Eligible|0
4910469|NCT00552929|16916074|P9|Overall Study|Not Eligible|0
4910470|NCT00552929|16916075|P8|Overall Study|Not Eligible|0
4910471|NCT00552929|16916076|P7|Overall Study|Not Eligible|0
4910472|NCT00552929|16916077|P6|Overall Study|Not Eligible|1
4910473|NCT00552929|16916078|P5|Overall Study|Not Eligible|0
4910474|NCT00552929|16916079|P4|Overall Study|Not Eligible|0
4910475|NCT00552929|16916080|P3|Overall Study|Not Eligible|0
4910476|NCT00552929|16916081|P2|Overall Study|Not Eligible|0
4910477|NCT00552929|16916082|P1|Overall Study|Not Eligible|0
4910478|NCT00552929|16916073|P10|Overall Study|Lost to Follow-up|0
4910479|NCT00552929|16916074|P9|Overall Study|Lost to Follow-up|1
4910480|NCT00552929|16916075|P8|Overall Study|Lost to Follow-up|0
4910481|NCT00552929|16916076|P7|Overall Study|Lost to Follow-up|0
4910482|NCT00552929|16916077|P6|Overall Study|Lost to Follow-up|0
4910483|NCT00552929|16916078|P5|Overall Study|Lost to Follow-up|0
4910484|NCT00552929|16916079|P4|Overall Study|Lost to Follow-up|0
4910485|NCT00552929|16916080|P3|Overall Study|Lost to Follow-up|0
4910486|NCT00552929|16916081|P2|Overall Study|Lost to Follow-up|0
4910487|NCT00552929|16916082|P1|Overall Study|Lost to Follow-up|0
4910488|NCT00552760|16916153|P2|Overall Study|Medication Change|0
4910489|NCT00552760|16916154|P1|Overall Study|Medication Change|1
4910490|NCT00552760|16916153|P2|Overall Study|Withdrawal by Subject|0
4910491|NCT00552760|16916154|P1|Overall Study|Withdrawal by Subject|3
4910492|NCT00552760|16916153|P2|Overall Study|Medical Condition|1
4910493|NCT00552760|16916154|P1|Overall Study|Medical Condition|1
4910494|NCT00552760|16916153|P2|Overall Study|Non-compliance|1
4910495|NCT00552760|16916154|P1|Overall Study|Non-compliance|1
4910496|NCT00552760|16916153|P2|Overall Study|Lost to Follow-up|1
4910497|NCT00552760|16916154|P1|Overall Study|Lost to Follow-up|1
4910498|NCT00552760|16916153|P2|Overall Study|Protocol Violation|1
4910499|NCT00552760|16916154|P1|Overall Study|Protocol Violation|0
4910500|NCT00552760|16916153|P2|Overall Study|Relapsed- Mixed Event|5
4910501|NCT00552760|16916154|P1|Overall Study|Relapsed- Mixed Event|3
4910502|NCT00552760|16916153|P2|Overall Study|Relapse- Manic Event|3
4910503|NCT00552760|16916154|P1|Overall Study|Relapse- Manic Event|3
4910504|NCT00552760|16916153|P2|Overall Study|Relapsed- Depressed Event|16
4910505|NCT00552760|16916154|P1|Overall Study|Relapsed- Depressed Event|10
4910506|NCT00552760|16916153|P2|Overall Study|Adverse Event|5
4910507|NCT00552760|16916154|P1|Overall Study|Adverse Event|3
4910508|NCT00552669|16916181|P2|Overall Study|Death|7
4910509|NCT00552669|16916182|P1|Overall Study|Death|3
4910510|NCT00552617|16916202|P10|Overall Study|Lost to Follow-up|0
4910511|NCT00552617|16916203|P9|Overall Study|Lost to Follow-up|2
4910512|NCT00552617|16916204|P8|Overall Study|Lost to Follow-up|0
4910513|NCT00552617|16916205|P7|Overall Study|Lost to Follow-up|0
4910514|NCT00552617|16916206|P6|Overall Study|Lost to Follow-up|2
4910515|NCT00552617|16916207|P5|Overall Study|Lost to Follow-up|0
4910516|NCT00552617|16916208|P4|Overall Study|Lost to Follow-up|1
4910517|NCT00552617|16916209|P3|Overall Study|Lost to Follow-up|0
4910518|NCT00552617|16916210|P2|Overall Study|Lost to Follow-up|0
4910519|NCT00552617|16916211|P1|Overall Study|Lost to Follow-up|0
4910520|NCT00552617|16916202|P10|Overall Study|Not Treated|1
4910521|NCT00552617|16916203|P9|Overall Study|Not Treated|0
4910522|NCT00552617|16916204|P8|Overall Study|Not Treated|0
4910523|NCT00552617|16916205|P7|Overall Study|Not Treated|0
4910524|NCT00552617|16916206|P6|Overall Study|Not Treated|0
4910525|NCT00552617|16916207|P5|Overall Study|Not Treated|0
4910526|NCT00552617|16916208|P4|Overall Study|Not Treated|0
4910527|NCT00552617|16916209|P3|Overall Study|Not Treated|1
4910528|NCT00552617|16916210|P2|Overall Study|Not Treated|0
4910529|NCT00552617|16916211|P1|Overall Study|Not Treated|0
4910530|NCT00552578|16916255|P2|Overall Study|Lost to Follow-up|1
4910531|NCT00552578|16916256|P1|Overall Study|Lost to Follow-up|1
4910532|NCT00552513|16916268|P2|Overall Study|Lost to Follow-up|1
4910533|NCT00552513|16916269|P1|Overall Study|Lost to Follow-up|5
4910534|NCT00552396|16916314|P7|Overall Study|protocol withdrawal criteria|9
4910535|NCT00552396|16916315|P6|Overall Study|protocol withdrawal criteria|3
4910536|NCT00552396|16916316|P5|Overall Study|protocol withdrawal criteria|3
4910537|NCT00552396|16916317|P4|Overall Study|protocol withdrawal criteria|6
4910538|NCT00552396|16916318|P3|Overall Study|protocol withdrawal criteria|3
4910539|NCT00552396|16916319|P2|Overall Study|protocol withdrawal criteria|3
4910540|NCT00552396|16916320|P1|Overall Study|protocol withdrawal criteria|3
4910541|NCT00552344|16916357|P1|Overall Study|Other Reason|22
4910542|NCT00552344|16916357|P1|Overall Study|SAE, fatal + AE, non-serious non-fatal|1
4910543|NCT00552344|16916357|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62
4910544|NCT00552344|16916357|P1|Overall Study|AE, non-serious non-fatal|38
4910545|NCT00552344|16916357|P1|Overall Study|SAE, non-fatal|6
4910546|NCT00552344|16916357|P1|Overall Study|Withdrawal by Subject|48
4910547|NCT00552344|16916357|P1|Overall Study|Lost to Follow-up|8
4910548|NCT00552344|16916357|P1|Overall Study|Loss of efficacy|75
4910549|NCT00552344|16916357|P1|Overall Study|Lack of Efficacy|55
4910550|NCT00552305|16916366|P1|Overall Study|Other: Subject went to rehab|1
4910551|NCT00552305|16916366|P1|Overall Study|Other: Subject incarcerated|1
4910552|NCT00552305|16916366|P1|Overall Study|Other: Subject moved from area|2
4910553|NCT00552305|16916366|P1|Overall Study|Other: Health problems, not drug related|1
4910554|NCT00552305|16916366|P1|Overall Study|Other: Subject became pregnant|1
4910555|NCT00552305|16916366|P1|Overall Study|Other: Subject underwent surgery|4
4910556|NCT00552305|16916366|P1|Overall Study|Other: Unable to attend visits|1
4910557|NCT00552305|16916366|P1|Overall Study|Other: Personal problems|1
4910558|NCT00552305|16916366|P1|Overall Study|Other: Site closed|4
4910559|NCT00552305|16916366|P1|Overall Study|LoE/WD consent/Other: cannot make visits|1
4910560|NCT00552305|16916366|P1|Overall Study|AE/Other: prohibited drug required|1
4910561|NCT00552305|16916366|P1|Overall Study|Poor compliance/lost to follow-up|1
4910562|NCT00552305|16916366|P1|Overall Study|Unsatisfactory compliance|11
4910563|NCT00552305|16916366|P1|Overall Study|Adverse event (AE)/withdrew (WD) consent|2
4910564|NCT00552305|16916366|P1|Overall Study|Lack of efficacy (LoE)/adverse event|3
4910565|NCT00552305|16916366|P1|Overall Study|Lack of efficacy/withdrew consent|1
4910566|NCT00552305|16916366|P1|Overall Study|Withdrawal by Subject|44
4910567|NCT00552305|16916366|P1|Overall Study|Protocol Violation|3
4910568|NCT00552305|16916366|P1|Overall Study|Lost to Follow-up|4
4910569|NCT00552305|16916366|P1|Overall Study|Lack of Efficacy|120
4910570|NCT00552305|16916366|P1|Overall Study|Adverse Event|43
4910571|NCT00552279|16916376|P2|Overall Study|Other|1
4910572|NCT00552279|16916377|P1|Overall Study|Other|1
4910573|NCT00552279|16916376|P2|Overall Study|Lost to Follow-up|0
4910574|NCT00552279|16916377|P1|Overall Study|Lost to Follow-up|1
4910575|NCT00552279|16916376|P2|Overall Study|Withdrawal by Subject|1
4910576|NCT00552279|16916377|P1|Overall Study|Withdrawal by Subject|12
4910577|NCT00552279|16916376|P2|Overall Study|Adverse Event|1
4910578|NCT00552279|16916377|P1|Overall Study|Adverse Event|0
4910579|NCT00552240|16916403|P2|Overall Study|Other|0
4910580|NCT00552240|16916404|P1|Overall Study|Other|1
4910581|NCT00552240|16916403|P2|Overall Study|Lack of Efficacy|0
4910582|NCT00552240|16916404|P1|Overall Study|Lack of Efficacy|6
4910583|NCT00552240|16916403|P2|Overall Study|Withdrawal by Subject|2
4910584|NCT00552240|16916404|P1|Overall Study|Withdrawal by Subject|2
4910585|NCT00552240|16916403|P2|Overall Study|Lost to Follow-up|6
4910586|NCT00552240|16916404|P1|Overall Study|Lost to Follow-up|5
4910587|NCT00552240|16916403|P2|Overall Study|Protocol Violation|1
4910588|NCT00552240|16916404|P1|Overall Study|Protocol Violation|1
4910589|NCT00552240|16916403|P2|Overall Study|Adverse Event|9
4910590|NCT00552240|16916404|P1|Overall Study|Adverse Event|9
4910591|NCT00552188|16916506|P2|Overall Study|Subject returned to home country|1
4910592|NCT00552188|16916507|P1|Overall Study|Subject returned to home country|0
4910593|NCT00552188|16916506|P2|Overall Study|Withdrawal of consent|1
4910594|NCT00552188|16916507|P1|Overall Study|Withdrawal of consent|0
4910595|NCT00552188|16916506|P2|Overall Study|Lost to Follow-up|1
4910596|NCT00552188|16916507|P1|Overall Study|Lost to Follow-up|2
4910597|NCT00552188|16916506|P2|Overall Study|Adverse Event|2
4910598|NCT00552188|16916507|P1|Overall Study|Adverse Event|0
4910599|NCT00552175|16916518|P3|Overall Study|Reason Not Specified|1
4910600|NCT00552175|16916519|P2|Overall Study|Reason Not Specified|1
4910601|NCT00552175|16916520|P1|Overall Study|Reason Not Specified|3
4910602|NCT00552175|16916518|P3|Overall Study|Entry Criteria Not Met|0
4910603|NCT00552175|16916519|P2|Overall Study|Entry Criteria Not Met|1
4910604|NCT00552175|16916520|P1|Overall Study|Entry Criteria Not Met|1
4910605|NCT00552175|16916518|P3|Overall Study|Lost to Follow-up|1
4910606|NCT00552175|16916519|P2|Overall Study|Lost to Follow-up|0
4910607|NCT00552175|16916520|P1|Overall Study|Lost to Follow-up|0
4910608|NCT00552175|16916518|P3|Overall Study|Withdrawal by Subject|1
4910609|NCT00552175|16916519|P2|Overall Study|Withdrawal by Subject|2
4910610|NCT00552175|16916520|P1|Overall Study|Withdrawal by Subject|2
4910611|NCT00552175|16916518|P3|Overall Study|Adverse Event|10
4910612|NCT00552175|16916519|P2|Overall Study|Adverse Event|9
4910613|NCT00552175|16916520|P1|Overall Study|Adverse Event|9
4910614|NCT00552175|16916518|P3|Overall Study|Lack of Efficacy|1
4910615|NCT00552175|16916519|P2|Overall Study|Lack of Efficacy|0
4910616|NCT00552175|16916520|P1|Overall Study|Lack of Efficacy|2
4910617|NCT00552110|16916560|P5|Overall Study|Nonserious Adverse Event (AE)|0
4910618|NCT00552110|16916561|P4|Overall Study|Nonserious Adverse Event (AE)|1
4910619|NCT00552110|16916562|P3|Overall Study|Nonserious Adverse Event (AE)|0
4910620|NCT00552110|16916563|P2|Overall Study|Nonserious Adverse Event (AE)|0
4910621|NCT00552110|16916564|P1|Overall Study|Nonserious Adverse Event (AE)|1
4910622|NCT00552110|16916560|P5|Overall Study|Increased Blood Pressure at Visit 2|0
4910623|NCT00552110|16916561|P4|Overall Study|Increased Blood Pressure at Visit 2|1
4910624|NCT00552110|16916562|P3|Overall Study|Increased Blood Pressure at Visit 2|0
4910625|NCT00552110|16916563|P2|Overall Study|Increased Blood Pressure at Visit 2|0
4910626|NCT00552110|16916564|P1|Overall Study|Increased Blood Pressure at Visit 2|0
4910627|NCT00552110|16916560|P5|Overall Study|Delay of Study due to Relabeling|0
4910628|NCT00552110|16916561|P4|Overall Study|Delay of Study due to Relabeling|1
4910629|NCT00552110|16916562|P3|Overall Study|Delay of Study due to Relabeling|0
4910630|NCT00552110|16916563|P2|Overall Study|Delay of Study due to Relabeling|0
4910631|NCT00552110|16916564|P1|Overall Study|Delay of Study due to Relabeling|0
4910632|NCT00552110|16916560|P5|Overall Study|Use of Prohibited Medication|0
4910633|NCT00552110|16916561|P4|Overall Study|Use of Prohibited Medication|0
4910634|NCT00552110|16916562|P3|Overall Study|Use of Prohibited Medication|0
4910635|NCT00552110|16916563|P2|Overall Study|Use of Prohibited Medication|1
4910636|NCT00552110|16916564|P1|Overall Study|Use of Prohibited Medication|1
4910637|NCT00552110|16916560|P5|Overall Study|Withdrawn per Sponsor|1
4910638|NCT00552110|16916561|P4|Overall Study|Withdrawn per Sponsor|0
4910639|NCT00552110|16916562|P3|Overall Study|Withdrawn per Sponsor|0
4910640|NCT00552110|16916563|P2|Overall Study|Withdrawn per Sponsor|1
4910641|NCT00552110|16916564|P1|Overall Study|Withdrawn per Sponsor|0
4910642|NCT00552110|16916560|P5|Overall Study|Failed to Comply With Study Requirements|1
4910643|NCT00552110|16916561|P4|Overall Study|Failed to Comply With Study Requirements|0
4910644|NCT00552110|16916562|P3|Overall Study|Failed to Comply With Study Requirements|1
4910645|NCT00552110|16916563|P2|Overall Study|Failed to Comply With Study Requirements|1
4910646|NCT00552110|16916564|P1|Overall Study|Failed to Comply With Study Requirements|1
4910647|NCT00552110|16916560|P5|Overall Study|Lost to Follow-up|1
4910648|NCT00552110|16916561|P4|Overall Study|Lost to Follow-up|1
4910649|NCT00552110|16916562|P3|Overall Study|Lost to Follow-up|0
4910650|NCT00552110|16916563|P2|Overall Study|Lost to Follow-up|0
4910651|NCT00552110|16916564|P1|Overall Study|Lost to Follow-up|0
4910652|NCT00552110|16916560|P5|Overall Study|Withdrawal by Subject|2
4910653|NCT00552110|16916561|P4|Overall Study|Withdrawal by Subject|3
4910654|NCT00552110|16916562|P3|Overall Study|Withdrawal by Subject|0
4910655|NCT00552110|16916563|P2|Overall Study|Withdrawal by Subject|2
4910656|NCT00552110|16916564|P1|Overall Study|Withdrawal by Subject|0
4910657|NCT00552110|16916560|P5|Overall Study|Lack of Efficacy|4
4910658|NCT00552110|16916561|P4|Overall Study|Lack of Efficacy|1
4910659|NCT00552110|16916562|P3|Overall Study|Lack of Efficacy|0
4910660|NCT00552110|16916563|P2|Overall Study|Lack of Efficacy|0
4910661|NCT00552110|16916564|P1|Overall Study|Lack of Efficacy|1
4910662|NCT00552110|16916560|P5|Overall Study|Serious or Life-Threatening AE|0
4910663|NCT00552110|16916561|P4|Overall Study|Serious or Life-Threatening AE|0
4910664|NCT00552110|16916562|P3|Overall Study|Serious or Life-Threatening AE|1
4910665|NCT00552110|16916563|P2|Overall Study|Serious or Life-Threatening AE|0
4910666|NCT00552110|16916564|P1|Overall Study|Serious or Life-Threatening AE|0
4910667|NCT00552084|16916583|P2|Overall Study|change in anti-arrythmic drug|1
4910668|NCT00552084|16916584|P1|Overall Study|change in anti-arrythmic drug|1
4910669|NCT00552084|16916583|P2|Overall Study|Protocol Violation|0
4910670|NCT00552084|16916584|P1|Overall Study|Protocol Violation|1
4910671|NCT00552084|16916583|P2|Overall Study|Withdrawal by Subject|5
4910672|NCT00552084|16916584|P1|Overall Study|Withdrawal by Subject|4
4910673|NCT00552084|16916583|P2|Overall Study|Adverse Event|3
4910674|NCT00552084|16916584|P1|Overall Study|Adverse Event|2
4910675|NCT00552071|16916592|P2|Overall Study|Withdrawal by Subject|1
4910676|NCT00552071|16916593|P1|Overall Study|Withdrawal by Subject|0
4910677|NCT00552071|16916592|P2|Overall Study|Death|1
4910678|NCT00552071|16916593|P1|Overall Study|Death|0
4910679|NCT00552071|16916592|P2|Overall Study|Pregnancy|0
4910680|NCT00552071|16916593|P1|Overall Study|Pregnancy|1
4910681|NCT00552071|16916592|P2|Overall Study|Physician Decision|0
4910682|NCT00552071|16916593|P1|Overall Study|Physician Decision|1
4910683|NCT00552071|16916592|P2|Overall Study|Lack of Efficacy|0
4910684|NCT00552071|16916593|P1|Overall Study|Lack of Efficacy|1
4910685|NCT00552071|16916592|P2|Overall Study|Adverse Event|0
4910686|NCT00552071|16916593|P1|Overall Study|Adverse Event|1
4910687|NCT00552058|16916603|P2|Overall Study|Other: Early Roll Over|0
4910688|NCT00552058|16916604|P1|Overall Study|Other: Early Roll Over|1
4910689|NCT00552058|16916603|P2|Overall Study|Other: Sponsors Decision|1
4910690|NCT00552058|16916604|P1|Overall Study|Other: Sponsors Decision|0
4910691|NCT00552058|16916603|P2|Overall Study|Other: Randomized in error|1
4910692|NCT00552058|16916604|P1|Overall Study|Other: Randomized in error|0
4910693|NCT00552058|16916603|P2|Overall Study|Other: Positive Stool Result|1
4910694|NCT00552058|16916604|P1|Overall Study|Other: Positive Stool Result|0
4910695|NCT00552058|16916603|P2|Overall Study|Other: Low CDAI score, entry violation|1
4910696|NCT00552058|16916604|P1|Overall Study|Other: Low CDAI score, entry violation|0
4910697|NCT00552058|16916603|P2|Overall Study|Other: Crossed Over to a Follow-up Study|1
4910698|NCT00552058|16916604|P1|Overall Study|Other: Crossed Over to a Follow-up Study|0
4910699|NCT00552058|16916603|P2|Overall Study|Other: Non Compliance|2
4910700|NCT00552058|16916604|P1|Overall Study|Other: Non Compliance|1
4910701|NCT00552058|16916603|P2|Overall Study|Other: Protocol Violation|1
4910702|NCT00552058|16916604|P1|Overall Study|Other: Protocol Violation|0
4910703|NCT00552058|16916603|P2|Overall Study|Withdrawal by Subject|4
4910704|NCT00552058|16916604|P1|Overall Study|Withdrawal by Subject|4
4910705|NCT00552058|16916603|P2|Overall Study|Lost to Follow-up|0
4910706|NCT00552058|16916604|P1|Overall Study|Lost to Follow-up|1
4910707|NCT00552058|16916603|P2|Overall Study|Lack of Efficacy|5
4910708|NCT00552058|16916604|P1|Overall Study|Lack of Efficacy|1
4910709|NCT00552058|16916603|P2|Overall Study|Adverse Event|7
4910710|NCT00552058|16916604|P1|Overall Study|Adverse Event|8
4910711|NCT00552032|16916644|P2|Overall Study|Lost to Follow-up|5
4910712|NCT00552032|16916645|P1|Overall Study|Lost to Follow-up|8
4910713|NCT00552032|16916644|P2|Overall Study|Protocol Violation|12
4910714|NCT00552032|16916645|P1|Overall Study|Protocol Violation|7
4910715|NCT00552032|16916644|P2|Overall Study|Withdrawal by Subject|2
4910716|NCT00552032|16916645|P1|Overall Study|Withdrawal by Subject|2
4910717|NCT00551759|16916689|P1|Overall Study|Ineligible|1
4910718|NCT00551759|16916689|P1|Overall Study|Death|5
4910719|NCT00551759|16916689|P1|Overall Study|Adverse Event|7
4910720|NCT00551642|16916730|P2|Overall Study|Inclusion/Exclusion criteria|4
4910721|NCT00551642|16916731|P1|Overall Study|Inclusion/Exclusion criteria|4
4910722|NCT00551642|16916730|P2|Overall Study|Delivery device failure|3
4910723|NCT00551642|16916731|P1|Overall Study|Delivery device failure|1
4910724|NCT00551642|16916730|P2|Overall Study|Physician Decision|1
4910725|NCT00551642|16916731|P1|Overall Study|Physician Decision|0
4910726|NCT00551642|16916730|P2|Overall Study|Protocol Violation|11
4910727|NCT00551642|16916731|P1|Overall Study|Protocol Violation|6
4910728|NCT00551642|16916730|P2|Overall Study|Death|31
4910729|NCT00551642|16916731|P1|Overall Study|Death|33
4910730|NCT00551642|16916730|P2|Overall Study|Adverse Event|12
4910731|NCT00551642|16916731|P1|Overall Study|Adverse Event|15
4910732|NCT00551642|16916730|P2|Overall Study|Withdrawal by Subject|1
4910733|NCT00551642|16916731|P1|Overall Study|Withdrawal by Subject|2
4910734|NCT00551525|16916737|P1|Overall Study|Protocol Violation|5
4910735|NCT00551460|16916746|P1|Overall Study|Not analyzable (did not start treatment)|4
4910736|NCT00551460|16916746|P1|Overall Study|Ineligible|4
4910737|NCT00551460|16916746|P1|Overall Study|Death|7
4910738|NCT00551460|16916746|P1|Overall Study|Physician Decision|1
4910739|NCT00551460|16916746|P1|Overall Study|Withdrawal by Subject|1
4910740|NCT00551460|16916746|P1|Overall Study|Adverse Event|1
4910741|NCT00551421|16916752|P1|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1
4910742|NCT00551369|16916759|P1|Overall Study|Not treated per protocol and re|1
4910743|NCT00551369|16916759|P1|Overall Study|Withdrawal by Subject|1
4910744|NCT00551369|16916759|P1|Overall Study|Protocol Violation|5
4910745|NCT00551291|16916768|P1|Overall Study|Physician Decision|1
4910746|NCT00551213|16916776|P2|Overall Study|Not Treated|2
4910747|NCT00551213|16916777|P1|Overall Study|Not Treated|1
4910748|NCT00551213|16916776|P2|Overall Study|Withdrawal by Subject|0
4910749|NCT00551213|16916777|P1|Overall Study|Withdrawal by Subject|2
4910750|NCT00551213|16916776|P2|Overall Study|Progressive Disease|12
4910751|NCT00551213|16916777|P1|Overall Study|Progressive Disease|41
4910752|NCT00551213|16916776|P2|Overall Study|Adverse Event|3
4910753|NCT00551213|16916777|P1|Overall Study|Adverse Event|6
4910754|NCT00551161|16916821|P1|Overall Study|Withdrawal by Subject|1
4910755|NCT00551135|16916829|P4|Overall Study|Withdrawal by Subject|1
4910756|NCT00551135|16916830|P3|Overall Study|Withdrawal by Subject|3
4910757|NCT00551135|16916831|P2|Overall Study|Withdrawal by Subject|0
4910758|NCT00551135|16916832|P1|Overall Study|Withdrawal by Subject|1
4910759|NCT00551135|16916829|P4|Overall Study|Other|2
4910760|NCT00551135|16916830|P3|Overall Study|Other|1
4910761|NCT00551135|16916831|P2|Overall Study|Other|2
4910762|NCT00551135|16916832|P1|Overall Study|Other|3
4910763|NCT00551135|16916829|P4|Overall Study|Lost to Follow-up|1
4910764|NCT00551135|16916830|P3|Overall Study|Lost to Follow-up|0
4910765|NCT00551135|16916831|P2|Overall Study|Lost to Follow-up|0
4910766|NCT00551135|16916832|P1|Overall Study|Lost to Follow-up|0
4910767|NCT00551135|16916829|P4|Overall Study|Adverse Event|1
4910768|NCT00551135|16916830|P3|Overall Study|Adverse Event|1
4910769|NCT00551135|16916831|P2|Overall Study|Adverse Event|0
4910770|NCT00551135|16916832|P1|Overall Study|Adverse Event|1
4910771|NCT00551031|16916961|P5|Overall Study|Did not receive vaccine|0
4910772|NCT00551031|16916962|P4|Overall Study|Did not receive vaccine|0
4910773|NCT00551031|16916963|P3|Overall Study|Did not receive vaccine|0
4910774|NCT00551031|16916964|P2|Overall Study|Did not receive vaccine|2
4910775|NCT00551031|16916965|P1|Overall Study|Did not receive vaccine|1
4910776|NCT00551031|16916961|P5|Overall Study|Serious Adverse Event|0
4910777|NCT00551031|16916962|P4|Overall Study|Serious Adverse Event|0
4910778|NCT00551031|16916963|P3|Overall Study|Serious Adverse Event|1
4910779|NCT00551031|16916964|P2|Overall Study|Serious Adverse Event|2
4910780|NCT00551031|16916965|P1|Overall Study|Serious Adverse Event|0
4910781|NCT00551031|16916961|P5|Overall Study|Withdrawal by Subject|0
4910782|NCT00551031|16916962|P4|Overall Study|Withdrawal by Subject|2
4910783|NCT00551031|16916963|P3|Overall Study|Withdrawal by Subject|1
4910784|NCT00551031|16916964|P2|Overall Study|Withdrawal by Subject|4
4910785|NCT00551031|16916965|P1|Overall Study|Withdrawal by Subject|0
4910786|NCT00551031|16916961|P5|Overall Study|Lost to Follow-up|1
4910787|NCT00551031|16916962|P4|Overall Study|Lost to Follow-up|1
4910788|NCT00551031|16916963|P3|Overall Study|Lost to Follow-up|0
4910789|NCT00551031|16916964|P2|Overall Study|Lost to Follow-up|1
4910790|NCT00551031|16916965|P1|Overall Study|Lost to Follow-up|0
4910791|NCT00551031|16916961|P5|Overall Study|Protocol Violation|0
4910792|NCT00551031|16916962|P4|Overall Study|Protocol Violation|0
4910793|NCT00551031|16916963|P3|Overall Study|Protocol Violation|0
4910794|NCT00551031|16916964|P2|Overall Study|Protocol Violation|1
4910795|NCT00551031|16916965|P1|Overall Study|Protocol Violation|1
4910796|NCT00551031|16916961|P5|Overall Study|Adverse Event|0
4910797|NCT00551031|16916962|P4|Overall Study|Adverse Event|0
4910798|NCT00551031|16916963|P3|Overall Study|Adverse Event|0
4910799|NCT00551031|16916964|P2|Overall Study|Adverse Event|1
4910800|NCT00551031|16916965|P1|Overall Study|Adverse Event|0
4910801|NCT00550953|16916994|P2|Overall Study|Not able to visit the site|3
4910802|NCT00550953|16916995|P1|Overall Study|Not able to visit the site|2
4910803|NCT00550953|16916994|P2|Overall Study|Adverse Event|3
4910804|NCT00550953|16916995|P1|Overall Study|Adverse Event|4
4910805|NCT00550836|16917042|P2|Overall Study|Withdrawal by Subject|9
4910806|NCT00550836|16917043|P1|Overall Study|Withdrawal by Subject|3
4910807|NCT00550771|16917059|P2|Overall Study|Protocol Violation|5
4910808|NCT00550771|16917060|P1|Overall Study|Protocol Violation|4
4910809|NCT00550771|16917059|P2|Overall Study|Withdrawal by Subject|1
4910810|NCT00550771|16917060|P1|Overall Study|Withdrawal by Subject|0
4910811|NCT00550771|16917059|P2|Overall Study|Physician Decision|0
4910812|NCT00550771|16917060|P1|Overall Study|Physician Decision|2
4910813|NCT00550771|16917059|P2|Overall Study|Discontinued for study-related reasons|1
4910814|NCT00550771|16917060|P1|Overall Study|Discontinued for study-related reasons|0
4910815|NCT00550771|16917059|P2|Overall Study|Adverse Event|3
4910816|NCT00550771|16917060|P1|Overall Study|Adverse Event|11
4910817|NCT00550745|16917074|P2|Overall Study|Screen failure|0
4910818|NCT00550745|16917075|P1|Overall Study|Screen failure|1
4910819|NCT00550745|16917074|P2|Overall Study|Withdrawal by Subject|10
4910820|NCT00550745|16917075|P1|Overall Study|Withdrawal by Subject|17
4910821|NCT00550745|16917074|P2|Overall Study|Protocol Violation|2
4910822|NCT00550745|16917075|P1|Overall Study|Protocol Violation|4
4910823|NCT00550745|16917074|P2|Overall Study|Physician Decision|2
4910824|NCT00550745|16917075|P1|Overall Study|Physician Decision|0
4910825|NCT00550745|16917074|P2|Overall Study|Lost to Follow-up|30
4910826|NCT00550745|16917075|P1|Overall Study|Lost to Follow-up|45
4910827|NCT00550745|16917074|P2|Overall Study|Death|16
4910828|NCT00550745|16917075|P1|Overall Study|Death|20
4910829|NCT00550732|16917083|P1|Overall Study|Adverse Event|1
4910830|NCT00550732|16917083|P1|Overall Study|Palliative care|1
4910831|NCT00550732|16917083|P1|Overall Study|Lost to Follow-up|1
4910832|NCT00550732|16917083|P1|Overall Study|Physician Decision|2
4910833|NCT00550732|16917083|P1|Overall Study|Withdrawal by Subject|2
4910834|NCT00550732|16917083|P1|Overall Study|Death|4
4910835|NCT00550680|16917094|P1|Overall Study|Screen Failure|6
4910836|NCT00550680|16917094|P1|Overall Study|Refused Treatment|19
4910837|NCT00550680|16917094|P1|Overall Study|Protocol Violation|7
4910838|NCT00550680|16917094|P1|Overall Study|Other|10
4910839|NCT00550680|16917094|P1|Overall Study|Lack of Efficacy|1
4910840|NCT00550680|16917094|P1|Overall Study|Lost to Follow-up|3
4910841|NCT00550680|16917094|P1|Overall Study|Early Improvement|1
4910842|NCT00550680|16917094|P1|Overall Study|Death|3
4910843|NCT00550680|16917094|P1|Overall Study|Adverse Event|5
4910844|NCT00550680|16917094|P1|Overall Study|Administrative Reasons|1
4910845|NCT00550615|16917115|P4|Overall Study|Not evaluable|7
4910846|NCT00550615|16917116|P3|Overall Study|Not evaluable|2
4910847|NCT00550615|16917117|P2|Overall Study|Not evaluable|0
4910848|NCT00550615|16917118|P1|Overall Study|Not evaluable|0
4910849|NCT00550615|16917115|P4|Overall Study|Withdrawal by Subject|3
4910850|NCT00550615|16917116|P3|Overall Study|Withdrawal by Subject|2
4910851|NCT00550615|16917117|P2|Overall Study|Withdrawal by Subject|0
4910852|NCT00550615|16917118|P1|Overall Study|Withdrawal by Subject|0
4910853|NCT00550550|16917137|P2|Overall Study|Randomized But Not Treated|0
4910854|NCT00550550|16917138|P1|Overall Study|Randomized But Not Treated|1
4910855|NCT00550550|16917137|P2|Overall Study|Did Not Meet Protocol Eligibility|1
4910856|NCT00550550|16917138|P1|Overall Study|Did Not Meet Protocol Eligibility|1
4910857|NCT00550550|16917137|P2|Overall Study|Protocol Violation|14
4910858|NCT00550550|16917138|P1|Overall Study|Protocol Violation|5
4910859|NCT00550550|16917137|P2|Overall Study|Withdrawal by Subject|8
4910860|NCT00550550|16917138|P1|Overall Study|Withdrawal by Subject|10
4910861|NCT00550550|16917137|P2|Overall Study|Lost to Follow-up|0
4910862|NCT00550550|16917138|P1|Overall Study|Lost to Follow-up|4
4910863|NCT00550550|16917137|P2|Overall Study|Treatment Failure|1
4910864|NCT00550550|16917138|P1|Overall Study|Treatment Failure|0
4910865|NCT00550550|16917137|P2|Overall Study|Adverse Event|5
4910866|NCT00550550|16917138|P1|Overall Study|Adverse Event|13
4910867|NCT00550537|16917150|P1|Overall Study|Treated closer to home|4
4910868|NCT00550537|16917150|P1|Overall Study|Declining performance status|2
4910869|NCT00550537|16917150|P1|Overall Study|Other complicating ilness|3
4910870|NCT00550537|16917150|P1|Overall Study|Change in treatment plan|4
4910871|NCT00550537|16917150|P1|Overall Study|Withdrawal by Subject|7
4910872|NCT00550537|16917150|P1|Overall Study|Disease progression before|46
4910873|NCT00550537|16917150|P1|Overall Study|Adverse Event|20
4910874|NCT00550537|16917150|P1|Overall Study|Death|18
4910875|NCT00550459|16917167|P2|Overall Study|Withdrawal by Subject|1
4910876|NCT00550459|16917168|P1|Overall Study|Withdrawal by Subject|1
4910877|NCT00550459|16917167|P2|Overall Study|Adverse Event|2
4910878|NCT00550459|16917168|P1|Overall Study|Adverse Event|0
4910879|NCT00550446|16917237|P11|Post Week 12|Other|0
4910880|NCT00550446|16917238|P10|Post Week 12|Other|1
4910881|NCT00550446|16917239|P9|Post Week 12|Other|1
4910882|NCT00550446|16917240|P8|Post Week 12|Other|0
4910883|NCT00550446|16917241|P7|Post Week 12|Other|1
4910884|NCT00550446|16917242|P6|Post Week 12|Other|0
4910885|NCT00550446|16917243|P5|Post Week 12|Other|0
4910886|NCT00550446|16917244|P4|Post Week 12|Other|1
4910887|NCT00550446|16917245|P3|Post Week 12|Other|0
4910888|NCT00550446|16917246|P2|Post Week 12|Other|1
4910889|NCT00550446|16917247|P1|Post Week 12|Other|1
4910890|NCT00550446|16917237|P11|Post Week 12|Withdrawal by Subject|0
4910891|NCT00550446|16917238|P10|Post Week 12|Withdrawal by Subject|0
4910892|NCT00550446|16917239|P9|Post Week 12|Withdrawal by Subject|0
4910893|NCT00550446|16917240|P8|Post Week 12|Withdrawal by Subject|0
4910894|NCT00550446|16917241|P7|Post Week 12|Withdrawal by Subject|0
4910895|NCT00550446|16917242|P6|Post Week 12|Withdrawal by Subject|0
4910896|NCT00550446|16917243|P5|Post Week 12|Withdrawal by Subject|1
4910897|NCT00550446|16917244|P4|Post Week 12|Withdrawal by Subject|0
4910898|NCT00550446|16917245|P3|Post Week 12|Withdrawal by Subject|0
4910899|NCT00550446|16917246|P2|Post Week 12|Withdrawal by Subject|0
4910900|NCT00550446|16917247|P1|Post Week 12|Withdrawal by Subject|0
4910901|NCT00550446|16917237|P11|Post Week 12|Lost to Follow-up|0
4910902|NCT00550446|16917238|P10|Post Week 12|Lost to Follow-up|0
4910903|NCT00550446|16917239|P9|Post Week 12|Lost to Follow-up|0
4910904|NCT00550446|16917240|P8|Post Week 12|Lost to Follow-up|0
4910905|NCT00550446|16917241|P7|Post Week 12|Lost to Follow-up|1
4910906|NCT00550446|16917242|P6|Post Week 12|Lost to Follow-up|0
4910907|NCT00550446|16917243|P5|Post Week 12|Lost to Follow-up|0
4910908|NCT00550446|16917244|P4|Post Week 12|Lost to Follow-up|1
4910909|NCT00550446|16917245|P3|Post Week 12|Lost to Follow-up|1
4910910|NCT00550446|16917246|P2|Post Week 12|Lost to Follow-up|0
4910911|NCT00550446|16917247|P1|Post Week 12|Lost to Follow-up|0
4910912|NCT00550446|16917237|P11|Post Week 12|Lack of Efficacy|1
4910913|NCT00550446|16917238|P10|Post Week 12|Lack of Efficacy|2
4910914|NCT00550446|16917239|P9|Post Week 12|Lack of Efficacy|1
4910915|NCT00550446|16917240|P8|Post Week 12|Lack of Efficacy|1
4910916|NCT00550446|16917241|P7|Post Week 12|Lack of Efficacy|0
4910917|NCT00550446|16917242|P6|Post Week 12|Lack of Efficacy|0
4910918|NCT00550446|16917243|P5|Post Week 12|Lack of Efficacy|0
4910919|NCT00550446|16917244|P4|Post Week 12|Lack of Efficacy|0
4910920|NCT00550446|16917245|P3|Post Week 12|Lack of Efficacy|1
4910921|NCT00550446|16917246|P2|Post Week 12|Lack of Efficacy|0
4910922|NCT00550446|16917247|P1|Post Week 12|Lack of Efficacy|0
4910923|NCT00550446|16917237|P11|Post Week 12|Adverse Event|0
4910924|NCT00550446|16917238|P10|Post Week 12|Adverse Event|4
4910925|NCT00550446|16917239|P9|Post Week 12|Adverse Event|0
4910926|NCT00550446|16917240|P8|Post Week 12|Adverse Event|0
4910927|NCT00550446|16917241|P7|Post Week 12|Adverse Event|0
4910928|NCT00550446|16917242|P6|Post Week 12|Adverse Event|1
4910929|NCT00550446|16917243|P5|Post Week 12|Adverse Event|1
4910930|NCT00550446|16917244|P4|Post Week 12|Adverse Event|1
4910931|NCT00550446|16917245|P3|Post Week 12|Adverse Event|1
4910932|NCT00550446|16917246|P2|Post Week 12|Adverse Event|1
4910933|NCT00550446|16917247|P1|Post Week 12|Adverse Event|2
4910934|NCT00550446|16917237|P11|Up To Week 12|Randomized not treated|0
4910935|NCT00550446|16917238|P10|Up To Week 12|Randomized not treated|0
4910936|NCT00550446|16917239|P9|Up To Week 12|Randomized not treated|0
4910937|NCT00550446|16917240|P8|Up To Week 12|Randomized not treated|0
4910938|NCT00550446|16917241|P7|Up To Week 12|Randomized not treated|0
4910939|NCT00550446|16917242|P6|Up To Week 12|Randomized not treated|0
4910940|NCT00550446|16917243|P5|Up To Week 12|Randomized not treated|0
4910941|NCT00550446|16917244|P4|Up To Week 12|Randomized not treated|0
4910942|NCT00550446|16917245|P3|Up To Week 12|Randomized not treated|1
4910943|NCT00550446|16917246|P2|Up To Week 12|Randomized not treated|1
4910944|NCT00550446|16917247|P1|Up To Week 12|Randomized not treated|0
4910945|NCT00550446|16917237|P11|Up To Week 12|Other|0
4910946|NCT00550446|16917238|P10|Up To Week 12|Other|0
4910947|NCT00550446|16917239|P9|Up To Week 12|Other|0
4910948|NCT00550446|16917240|P8|Up To Week 12|Other|0
4910949|NCT00550446|16917241|P7|Up To Week 12|Other|4
4910950|NCT00550446|16917242|P6|Up To Week 12|Other|1
4910951|NCT00550446|16917243|P5|Up To Week 12|Other|0
4910952|NCT00550446|16917244|P4|Up To Week 12|Other|0
4910953|NCT00550446|16917245|P3|Up To Week 12|Other|0
4910954|NCT00550446|16917246|P2|Up To Week 12|Other|0
4910955|NCT00550446|16917247|P1|Up To Week 12|Other|3
4910956|NCT00550446|16917237|P11|Up To Week 12|Withdrawal by Subject|0
4910957|NCT00550446|16917238|P10|Up To Week 12|Withdrawal by Subject|0
4910958|NCT00550446|16917239|P9|Up To Week 12|Withdrawal by Subject|0
4910959|NCT00550446|16917240|P8|Up To Week 12|Withdrawal by Subject|0
4910960|NCT00550446|16917241|P7|Up To Week 12|Withdrawal by Subject|3
4910961|NCT00550446|16917242|P6|Up To Week 12|Withdrawal by Subject|1
4910962|NCT00550446|16917243|P5|Up To Week 12|Withdrawal by Subject|0
4910963|NCT00550446|16917244|P4|Up To Week 12|Withdrawal by Subject|2
4910964|NCT00550446|16917245|P3|Up To Week 12|Withdrawal by Subject|3
4910965|NCT00550446|16917246|P2|Up To Week 12|Withdrawal by Subject|0
4910966|NCT00550446|16917247|P1|Up To Week 12|Withdrawal by Subject|2
4910967|NCT00550446|16917237|P11|Up To Week 12|Lost to Follow-up|0
4910968|NCT00550446|16917238|P10|Up To Week 12|Lost to Follow-up|0
4910969|NCT00550446|16917239|P9|Up To Week 12|Lost to Follow-up|0
4910970|NCT00550446|16917240|P8|Up To Week 12|Lost to Follow-up|0
4910971|NCT00550446|16917241|P7|Up To Week 12|Lost to Follow-up|2
4910972|NCT00550446|16917242|P6|Up To Week 12|Lost to Follow-up|1
4910973|NCT00550446|16917243|P5|Up To Week 12|Lost to Follow-up|1
4910974|NCT00550446|16917244|P4|Up To Week 12|Lost to Follow-up|0
4910975|NCT00550446|16917245|P3|Up To Week 12|Lost to Follow-up|0
4910976|NCT00550446|16917246|P2|Up To Week 12|Lost to Follow-up|1
4910977|NCT00550446|16917247|P1|Up To Week 12|Lost to Follow-up|0
4910978|NCT00550446|16917237|P11|Up To Week 12|Lack of Efficacy|0
4910979|NCT00550446|16917238|P10|Up To Week 12|Lack of Efficacy|0
4910980|NCT00550446|16917239|P9|Up To Week 12|Lack of Efficacy|0
4910981|NCT00550446|16917240|P8|Up To Week 12|Lack of Efficacy|0
4910982|NCT00550446|16917241|P7|Up To Week 12|Lack of Efficacy|3
4910983|NCT00550446|16917242|P6|Up To Week 12|Lack of Efficacy|3
4910984|NCT00550446|16917243|P5|Up To Week 12|Lack of Efficacy|0
4910985|NCT00550446|16917244|P4|Up To Week 12|Lack of Efficacy|1
4910986|NCT00550446|16917245|P3|Up To Week 12|Lack of Efficacy|0
4910987|NCT00550446|16917246|P2|Up To Week 12|Lack of Efficacy|1
4910988|NCT00550446|16917247|P1|Up To Week 12|Lack of Efficacy|3
4910989|NCT00550446|16917237|P11|Up To Week 12|Adverse Event|0
4910990|NCT00550446|16917238|P10|Up To Week 12|Adverse Event|0
4910991|NCT00550446|16917239|P9|Up To Week 12|Adverse Event|0
4910992|NCT00550446|16917240|P8|Up To Week 12|Adverse Event|0
4910993|NCT00550446|16917241|P7|Up To Week 12|Adverse Event|1
4910994|NCT00550446|16917242|P6|Up To Week 12|Adverse Event|2
4910995|NCT00550446|16917243|P5|Up To Week 12|Adverse Event|2
4910996|NCT00550446|16917244|P4|Up To Week 12|Adverse Event|0
4910997|NCT00550446|16917245|P3|Up To Week 12|Adverse Event|0
4910998|NCT00550446|16917246|P2|Up To Week 12|Adverse Event|2
4910999|NCT00550446|16917247|P1|Up To Week 12|Adverse Event|2
4911000|NCT00550420|16917679|P1|Overall Study|Prohibited medicine|1
4911001|NCT00550420|16917679|P1|Overall Study|Exclusion criteria|1
4911002|NCT00550420|16917679|P1|Overall Study|Out of Electrocardiogram criteria|1
4911003|NCT00550420|16917679|P1|Overall Study|Caregiver's decision to withdraw|1
4911004|NCT00550420|16917679|P1|Overall Study|Unethical stop of enrollment|2
4911005|NCT00550420|16917679|P1|Overall Study|Lack of curative effect|1
4911006|NCT00550420|16917679|P1|Overall Study|Investigators opinion|1
4911007|NCT00550420|16917679|P1|Overall Study|Prolonged QT Interval Electrocardiogram|12
4911008|NCT00550420|16917679|P1|Overall Study|Missing|2
4911009|NCT00550420|16917679|P1|Overall Study|Still in study at termination|206
4911010|NCT00550420|16917679|P1|Overall Study|Withdrawal by Subject|30
4911011|NCT00550420|16917679|P1|Overall Study|Protocol Violation|11
4911012|NCT00550420|16917679|P1|Overall Study|Lost to Follow-up|8
4911013|NCT00550420|16917679|P1|Overall Study|Adverse Event|28
4911014|NCT00550407|16917702|P3|26-Week Randomized Phase|Withdrawal by Subject|3
4911015|NCT00550407|16917703|P2|26-Week Randomized Phase|Withdrawal by Subject|1
4911016|NCT00550407|16917704|P1|26-Week Randomized Phase|Withdrawal by Subject|0
4911017|NCT00550407|16917702|P3|26-Week Randomized Phase|Investigator Discretion|0
4911018|NCT00550407|16917703|P2|26-Week Randomized Phase|Investigator Discretion|1
4911019|NCT00550407|16917704|P1|26-Week Randomized Phase|Investigator Discretion|0
4911020|NCT00550407|16917702|P3|26-Week Randomized Phase|Lack of Efficacy|19
4911021|NCT00550407|16917703|P2|26-Week Randomized Phase|Lack of Efficacy|36
4911022|NCT00550407|16917704|P1|26-Week Randomized Phase|Lack of Efficacy|0
4911023|NCT00550407|16917702|P3|26-Week Randomized Phase|Adverse Event|2
4911024|NCT00550407|16917703|P2|26-Week Randomized Phase|Adverse Event|5
4911025|NCT00550407|16917704|P1|26-Week Randomized Phase|Adverse Event|0
4911026|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
4911027|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0
4911028|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1
4911029|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
4911030|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0
4911031|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6
4911032|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
4911033|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0
4911034|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8
4911035|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
4911036|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0
4911037|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1
4911038|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
4911039|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0
4911040|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1
4911041|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
4911042|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0
4911043|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1
4911044|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
4911045|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0
4911046|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39
4911047|NCT00550407|16917702|P3|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
4911048|NCT00550407|16917703|P2|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0
4911049|NCT00550407|16917704|P1|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55
4911050|NCT00550238|16917776|P1|Overall Study|Sponsor decision|55
4911051|NCT00550238|16917776|P1|Overall Study|Lost to Follow-up|13
4911052|NCT00550238|16917776|P1|Overall Study|Patient noncompliance|25
4911053|NCT00550238|16917776|P1|Overall Study|Physician Decision|31
4911054|NCT00550238|16917776|P1|Overall Study|Withdrawal by Subject|167
4911055|NCT00550238|16917776|P1|Overall Study|Disease progression|46
4911056|NCT00550238|16917776|P1|Overall Study|Death|34
4911057|NCT00550238|16917776|P1|Overall Study|Adverse Event|88
4911058|NCT00550173|16917783|P3|Overall Study|Lost to Follow-up|3
4911059|NCT00550173|16917784|P2|Overall Study|Lost to Follow-up|4
4911060|NCT00550173|16917785|P1|Overall Study|Lost to Follow-up|4
4911061|NCT00550173|16917783|P3|Overall Study|Sponsor Decision|1
4911062|NCT00550173|16917784|P2|Overall Study|Sponsor Decision|7
4911063|NCT00550173|16917785|P1|Overall Study|Sponsor Decision|13
4911064|NCT00550173|16917783|P3|Overall Study|Withdrawal by Subject|17
4911065|NCT00550173|16917784|P2|Overall Study|Withdrawal by Subject|12
4911066|NCT00550173|16917785|P1|Overall Study|Withdrawal by Subject|9
4911067|NCT00550173|16917783|P3|Overall Study|Physician Decision|2
4911068|NCT00550173|16917784|P2|Overall Study|Physician Decision|2
4911069|NCT00550173|16917785|P1|Overall Study|Physician Decision|1
4911070|NCT00550173|16917783|P3|Overall Study|Death|50
4911071|NCT00550173|16917784|P2|Overall Study|Death|38
4911072|NCT00550173|16917785|P1|Overall Study|Death|45
4911073|NCT00550147|16917814|P1|Quetiapine Addition Treatment Period|Moved out of state|1
4911074|NCT00550147|16917814|P1|Quetiapine Addition Treatment Period|Noncompliance|2
4911075|NCT00550147|16917814|P1|Quetiapine Addition Treatment Period|Adverse Event|3
4911076|NCT00550147|16917814|P1|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2
4911077|NCT00550147|16917814|P1|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4
4911078|NCT00550043|16917837|P5|Overall Study|Other Reasons- Unspecified|0
4911079|NCT00550043|16917838|P4|Overall Study|Other Reasons- Unspecified|1
4911080|NCT00550043|16917839|P3|Overall Study|Other Reasons- Unspecified|0
4911081|NCT00550043|16917840|P2|Overall Study|Other Reasons- Unspecified|1
4911082|NCT00550043|16917841|P1|Overall Study|Other Reasons- Unspecified|0
4911083|NCT00550043|16917837|P5|Overall Study|Subject Withdrew Consent|0
4911084|NCT00550043|16917838|P4|Overall Study|Subject Withdrew Consent|0
4911085|NCT00550043|16917839|P3|Overall Study|Subject Withdrew Consent|1
4911086|NCT00550043|16917840|P2|Overall Study|Subject Withdrew Consent|2
4911087|NCT00550043|16917841|P1|Overall Study|Subject Withdrew Consent|0
4911088|NCT00550043|16917837|P5|Overall Study|Adverse Event|1
4911089|NCT00550043|16917838|P4|Overall Study|Adverse Event|1
4911090|NCT00550043|16917839|P3|Overall Study|Adverse Event|0
4911091|NCT00550043|16917840|P2|Overall Study|Adverse Event|0
4911092|NCT00550043|16917841|P1|Overall Study|Adverse Event|0
4911093|NCT00549939|16917896|P3|40-week Open Label Treatment Period|Other|4
4911094|NCT00549939|16917897|P2|40-week Open Label Treatment Period|Other|1
4911095|NCT00549939|16917898|P1|40-week Open Label Treatment Period|Other|0
4911096|NCT00549939|16917896|P3|40-week Open Label Treatment Period|Protocol Violation|0
4911097|NCT00549939|16917897|P2|40-week Open Label Treatment Period|Protocol Violation|1
4911098|NCT00549939|16917898|P1|40-week Open Label Treatment Period|Protocol Violation|0
4911099|NCT00549939|16917896|P3|40-week Open Label Treatment Period|Lack of Efficacy|0
4911100|NCT00549939|16917897|P2|40-week Open Label Treatment Period|Lack of Efficacy|1
4911101|NCT00549939|16917898|P1|40-week Open Label Treatment Period|Lack of Efficacy|0
4911102|NCT00549939|16917896|P3|40-week Open Label Treatment Period|Adverse Event|1
4911103|NCT00549939|16917897|P2|40-week Open Label Treatment Period|Adverse Event|2
4911104|NCT00549939|16917898|P1|40-week Open Label Treatment Period|Adverse Event|0
4911105|NCT00549939|16917896|P3|12-week Double Blind Treatment Period|Too many blood draws|0
4911106|NCT00549939|16917897|P2|12-week Double Blind Treatment Period|Too many blood draws|1
4911107|NCT00549939|16917898|P1|12-week Double Blind Treatment Period|Too many blood draws|0
4911108|NCT00549939|16917896|P3|12-week Double Blind Treatment Period|Adverse Event|2
4911109|NCT00549939|16917897|P2|12-week Double Blind Treatment Period|Adverse Event|1
4911110|NCT00549939|16917898|P1|12-week Double Blind Treatment Period|Adverse Event|1
4911111|NCT00549900|16917925|P1|Overall Study|Adverse Event|1
4911112|NCT00549770|16917981|P8|Overall Study|Adverse Event|4
4911113|NCT00549770|16917982|P7|Overall Study|Adverse Event|5
4911114|NCT00549770|16917983|P6|Overall Study|Adverse Event|0
4911115|NCT00549770|16917984|P5|Overall Study|Adverse Event|1
4911116|NCT00549770|16917985|P4|Overall Study|Adverse Event|2
4911117|NCT00549770|16917986|P3|Overall Study|Adverse Event|1
4911118|NCT00549770|16917987|P2|Overall Study|Adverse Event|3
4911119|NCT00549770|16917988|P1|Overall Study|Adverse Event|1
4911120|NCT00549770|16917981|P8|Overall Study|Abnormal laboratory values|0
4911121|NCT00549770|16917982|P7|Overall Study|Abnormal laboratory values|0
4911122|NCT00549770|16917983|P6|Overall Study|Abnormal laboratory values|1
4911123|NCT00549770|16917984|P5|Overall Study|Abnormal laboratory values|0
4911124|NCT00549770|16917985|P4|Overall Study|Abnormal laboratory values|0
4911125|NCT00549770|16917986|P3|Overall Study|Abnormal laboratory values|0
4911126|NCT00549770|16917987|P2|Overall Study|Abnormal laboratory values|0
4911127|NCT00549770|16917988|P1|Overall Study|Abnormal laboratory values|0
4911128|NCT00549770|16917981|P8|Overall Study|Abnormal test procedure results|1
4911129|NCT00549770|16917982|P7|Overall Study|Abnormal test procedure results|1
4911130|NCT00549770|16917983|P6|Overall Study|Abnormal test procedure results|1
4911131|NCT00549770|16917984|P5|Overall Study|Abnormal test procedure results|0
4911132|NCT00549770|16917985|P4|Overall Study|Abnormal test procedure results|2
4911133|NCT00549770|16917986|P3|Overall Study|Abnormal test procedure results|0
4911134|NCT00549770|16917987|P2|Overall Study|Abnormal test procedure results|0
4911135|NCT00549770|16917988|P1|Overall Study|Abnormal test procedure results|0
4911136|NCT00549770|16917981|P8|Overall Study|Lack of Efficacy|8
4911137|NCT00549770|16917982|P7|Overall Study|Lack of Efficacy|3
4911138|NCT00549770|16917983|P6|Overall Study|Lack of Efficacy|1
4911139|NCT00549770|16917984|P5|Overall Study|Lack of Efficacy|5
4911140|NCT00549770|16917985|P4|Overall Study|Lack of Efficacy|3
4911141|NCT00549770|16917986|P3|Overall Study|Lack of Efficacy|2
4911142|NCT00549770|16917987|P2|Overall Study|Lack of Efficacy|0
4911143|NCT00549770|16917988|P1|Overall Study|Lack of Efficacy|1
4911144|NCT00549770|16917981|P8|Overall Study|Withdrawal by Subject|9
4911145|NCT00549770|16917982|P7|Overall Study|Withdrawal by Subject|4
4911146|NCT00549770|16917983|P6|Overall Study|Withdrawal by Subject|6
4911147|NCT00549770|16917984|P5|Overall Study|Withdrawal by Subject|6
4911148|NCT00549770|16917985|P4|Overall Study|Withdrawal by Subject|5
4911149|NCT00549770|16917986|P3|Overall Study|Withdrawal by Subject|4
4911150|NCT00549770|16917987|P2|Overall Study|Withdrawal by Subject|6
4911151|NCT00549770|16917988|P1|Overall Study|Withdrawal by Subject|4
4911152|NCT00549770|16917981|P8|Overall Study|Lost to Follow-up|0
4911153|NCT00549770|16917982|P7|Overall Study|Lost to Follow-up|0
4911154|NCT00549770|16917983|P6|Overall Study|Lost to Follow-up|2
4911155|NCT00549770|16917984|P5|Overall Study|Lost to Follow-up|3
4911156|NCT00549770|16917985|P4|Overall Study|Lost to Follow-up|2
4911157|NCT00549770|16917986|P3|Overall Study|Lost to Follow-up|2
4911158|NCT00549770|16917987|P2|Overall Study|Lost to Follow-up|0
4911159|NCT00549770|16917988|P1|Overall Study|Lost to Follow-up|0
4911160|NCT00549770|16917981|P8|Overall Study|Administrative problems|1
4911161|NCT00549770|16917982|P7|Overall Study|Administrative problems|0
4911162|NCT00549770|16917983|P6|Overall Study|Administrative problems|0
4911163|NCT00549770|16917984|P5|Overall Study|Administrative problems|0
4911164|NCT00549770|16917985|P4|Overall Study|Administrative problems|0
4911165|NCT00549770|16917986|P3|Overall Study|Administrative problems|0
4911166|NCT00549770|16917987|P2|Overall Study|Administrative problems|1
4911167|NCT00549770|16917988|P1|Overall Study|Administrative problems|0
4911168|NCT00549770|16917981|P8|Overall Study|Protocol deviation|2
4911169|NCT00549770|16917982|P7|Overall Study|Protocol deviation|1
4911170|NCT00549770|16917983|P6|Overall Study|Protocol deviation|2
4911171|NCT00549770|16917984|P5|Overall Study|Protocol deviation|2
4911172|NCT00549770|16917985|P4|Overall Study|Protocol deviation|2
4911173|NCT00549770|16917986|P3|Overall Study|Protocol deviation|1
4911174|NCT00549770|16917987|P2|Overall Study|Protocol deviation|1
4911175|NCT00549770|16917988|P1|Overall Study|Protocol deviation|1
4911176|NCT00549757|16918072|P2|Extension Period (in Average 9 Months)|Patient's request|436
4911177|NCT00549757|16918073|P1|Extension Period (in Average 9 Months)|Patient's request|421
4911178|NCT00549757|16918072|P2|Extension Period (in Average 9 Months)|Withdrawal by Subject|16
4911179|NCT00549757|16918073|P1|Extension Period (in Average 9 Months)|Withdrawal by Subject|9
4911180|NCT00549757|16918072|P2|Extension Period (in Average 9 Months)|Lost to Follow-up|47
4911181|NCT00549757|16918073|P1|Extension Period (in Average 9 Months)|Lost to Follow-up|52
4911182|NCT00549757|16918072|P2|Extension Period (in Average 9 Months)|Death|136
4911183|NCT00549757|16918073|P1|Extension Period (in Average 9 Months)|Death|143
4911184|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Missing data|9
4911185|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Missing data|8
4911186|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55
4911187|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69
4911188|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Patient's request|380
4911189|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Patient's request|353
4911190|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Death|200
4911191|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Death|188
4911192|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Administrative problems|3019
4911193|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Administrative problems|2857
4911194|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29
4911195|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41
4911196|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
4911197|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38
4911198|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53
4911199|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47
4911200|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
4911201|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7
4911202|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58
4911203|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98
4911204|NCT00549757|16918072|P2|Active Treatment Phase: Max. 50 Months|Adverse Event|462
4911205|NCT00549757|16918073|P1|Active Treatment Phase: Max. 50 Months|Adverse Event|590
4911206|NCT00549718|16918135|P4|Overall Study|Administrative|1
4911207|NCT00549718|16918136|P3|Overall Study|Administrative|2
4911208|NCT00549718|16918137|P2|Overall Study|Administrative|2
4911209|NCT00549718|16918138|P1|Overall Study|Administrative|2
4911210|NCT00549718|16918135|P4|Overall Study|Withdrawal by Subject|13
4911211|NCT00549718|16918136|P3|Overall Study|Withdrawal by Subject|12
4911212|NCT00549718|16918137|P2|Overall Study|Withdrawal by Subject|18
4911213|NCT00549718|16918138|P1|Overall Study|Withdrawal by Subject|9
4911214|NCT00549718|16918135|P4|Overall Study|Lost to Follow-up|6
4911215|NCT00549718|16918136|P3|Overall Study|Lost to Follow-up|0
4911216|NCT00549718|16918137|P2|Overall Study|Lost to Follow-up|2
4911217|NCT00549718|16918138|P1|Overall Study|Lost to Follow-up|4
4911218|NCT00549718|16918135|P4|Overall Study|Adverse Event|3
4911219|NCT00549718|16918136|P3|Overall Study|Adverse Event|7
4911220|NCT00549718|16918137|P2|Overall Study|Adverse Event|8
4911221|NCT00549718|16918138|P1|Overall Study|Adverse Event|6
4911222|NCT00549718|16918135|P4|Overall Study|Insufficient clinical response|32
4911223|NCT00549718|16918136|P3|Overall Study|Insufficient clinical response|18
4911224|NCT00549718|16918137|P2|Overall Study|Insufficient clinical response|7
4911225|NCT00549718|16918138|P1|Overall Study|Insufficient clinical response|20
4911226|NCT00549640|16918154|P2|Overall Study|Lost to Follow-up|4
4911227|NCT00549640|16918155|P1|Overall Study|Lost to Follow-up|7
4911228|NCT00549640|16918154|P2|Overall Study|Adverse Event|0
4911229|NCT00549640|16918155|P1|Overall Study|Adverse Event|5
4911230|NCT00549640|16918154|P2|Overall Study|Withdrawal by Subject|12
4911231|NCT00549640|16918155|P1|Overall Study|Withdrawal by Subject|6
4911232|NCT00549601|16918168|P3|Received Study Drug|Withdrawal by Subject|1
4911233|NCT00549601|16918169|P2|Received Study Drug|Withdrawal by Subject|0
4911234|NCT00549601|16918170|P1|Received Study Drug|Withdrawal by Subject|2
4911235|NCT00549601|16918168|P3|Received Study Drug|Protocol Violation|1
4911236|NCT00549601|16918169|P2|Received Study Drug|Protocol Violation|4
4911237|NCT00549601|16918170|P1|Received Study Drug|Protocol Violation|3
4911238|NCT00549601|16918168|P3|Received Study Drug|Lost to Follow-up|1
4911239|NCT00549601|16918169|P2|Received Study Drug|Lost to Follow-up|1
4911240|NCT00549601|16918170|P1|Received Study Drug|Lost to Follow-up|0
4911241|NCT00549601|16918168|P3|Received Study Drug|Death|0
4911242|NCT00549601|16918169|P2|Received Study Drug|Death|1
4911243|NCT00549601|16918170|P1|Received Study Drug|Death|0
4911244|NCT00549601|16918168|P3|Received Study Drug|Adverse Event|1
4911245|NCT00549601|16918169|P2|Received Study Drug|Adverse Event|5
4911246|NCT00549601|16918170|P1|Received Study Drug|Adverse Event|2
4911247|NCT00549601|16918168|P3|Randomized|Withdrawal by Subject|1
4911248|NCT00549601|16918169|P2|Randomized|Withdrawal by Subject|1
4911249|NCT00549601|16918170|P1|Randomized|Withdrawal by Subject|0
4911250|NCT00549601|16918168|P3|Randomized|Protocol Violation|1
4911251|NCT00549601|16918169|P2|Randomized|Protocol Violation|0
4911252|NCT00549601|16918170|P1|Randomized|Protocol Violation|0
4911253|NCT00549562|16918192|P1|Overall Study|Lack of Efficacy|1
4911254|NCT00549562|16918192|P1|Overall Study|Adverse Event|1
4911255|NCT00549549|16918204|P4|Overall Study|Randomized but not treated|1
4911256|NCT00549549|16918205|P3|Overall Study|Randomized but not treated|1
4911257|NCT00549549|16918206|P2|Overall Study|Randomized but not treated|0
4911258|NCT00549549|16918207|P1|Overall Study|Randomized but not treated|0
4911259|NCT00549549|16918204|P4|Overall Study|Other|11
4911260|NCT00549549|16918205|P3|Overall Study|Other|9
4911261|NCT00549549|16918206|P2|Overall Study|Other|9
4911262|NCT00549549|16918207|P1|Overall Study|Other|9
4911263|NCT00549549|16918204|P4|Overall Study|Withdrawal by Subject|0
4911264|NCT00549549|16918205|P3|Overall Study|Withdrawal by Subject|1
4911265|NCT00549549|16918206|P2|Overall Study|Withdrawal by Subject|4
4911266|NCT00549549|16918207|P1|Overall Study|Withdrawal by Subject|0
4911267|NCT00549549|16918204|P4|Overall Study|Lost to Follow-up|2
4911268|NCT00549549|16918205|P3|Overall Study|Lost to Follow-up|1
4911269|NCT00549549|16918206|P2|Overall Study|Lost to Follow-up|0
4911270|NCT00549549|16918207|P1|Overall Study|Lost to Follow-up|1
4911271|NCT00549549|16918204|P4|Overall Study|Lack of Efficacy|2
4911272|NCT00549549|16918205|P3|Overall Study|Lack of Efficacy|4
4911273|NCT00549549|16918206|P2|Overall Study|Lack of Efficacy|6
4911274|NCT00549549|16918207|P1|Overall Study|Lack of Efficacy|9
4911275|NCT00549549|16918204|P4|Overall Study|Adverse Event|9
4911276|NCT00549549|16918205|P3|Overall Study|Adverse Event|1
4911277|NCT00549549|16918206|P2|Overall Study|Adverse Event|3
4911278|NCT00549549|16918207|P1|Overall Study|Adverse Event|5
4911279|NCT00549445|16918275|P2|Overall Study|Sputum & Blood Samples Not Available|17
4911280|NCT00549445|16918276|P1|Overall Study|Sputum & Blood Samples Not Available|15
4911281|NCT00549328|16918295|P1|Overall Study|Use of Prohibited Medication|1
4911282|NCT00549328|16918295|P1|Overall Study|Death|1
4911283|NCT00549328|16918295|P1|Overall Study|Disease Progression|10
4911284|NCT00549328|16918295|P1|Overall Study|Adverse Event|2
4911285|NCT00549302|16918306|P3|Open-Label|Withdrawal by Subject|6
4911286|NCT00549302|16918307|P2|Open-Label|Withdrawal by Subject|0
4911287|NCT00549302|16918308|P1|Open-Label|Withdrawal by Subject|0
4911288|NCT00549302|16918306|P3|Open-Label|New drug pulmonary atrial hypertension|2
4911289|NCT00549302|16918307|P2|Open-Label|New drug pulmonary atrial hypertension|0
4911290|NCT00549302|16918308|P1|Open-Label|New drug pulmonary atrial hypertension|0
4911291|NCT00549302|16918306|P3|Open-Label|Other|3
4911292|NCT00549302|16918307|P2|Open-Label|Other|0
4911293|NCT00549302|16918308|P1|Open-Label|Other|0
4911294|NCT00549302|16918306|P3|Open-Label|Lost to Follow-up|2
4911295|NCT00549302|16918307|P2|Open-Label|Lost to Follow-up|0
4911296|NCT00549302|16918308|P1|Open-Label|Lost to Follow-up|0
4911297|NCT00549302|16918306|P3|Open-Label|Investigator Decision|5
4911298|NCT00549302|16918307|P2|Open-Label|Investigator Decision|0
4911299|NCT00549302|16918308|P1|Open-Label|Investigator Decision|0
4911300|NCT00549302|16918306|P3|Open-Label|Death|40
4911301|NCT00549302|16918307|P2|Open-Label|Death|0
4911302|NCT00549302|16918308|P1|Open-Label|Death|0
4911303|NCT00549302|16918306|P3|Open-Label|Adverse Event|11
4911304|NCT00549302|16918307|P2|Open-Label|Adverse Event|0
4911305|NCT00549302|16918308|P1|Open-Label|Adverse Event|0
4911306|NCT00549302|16918306|P3|Double-Blind|New condition or starts new therapy|0
4911307|NCT00549302|16918307|P2|Double-Blind|New condition or starts new therapy|2
4911308|NCT00549302|16918308|P1|Double-Blind|New condition or starts new therapy|0
4911309|NCT00549302|16918306|P3|Double-Blind|New Drug Pulmonary Atrial Hypertension|0
4911310|NCT00549302|16918307|P2|Double-Blind|New Drug Pulmonary Atrial Hypertension|10
4911311|NCT00549302|16918308|P1|Double-Blind|New Drug Pulmonary Atrial Hypertension|1
4911312|NCT00549302|16918306|P3|Double-Blind|Lost to Follow-up|0
4911313|NCT00549302|16918307|P2|Double-Blind|Lost to Follow-up|2
4911314|NCT00549302|16918308|P1|Double-Blind|Lost to Follow-up|1
4911315|NCT00549302|16918306|P3|Double-Blind|Sponsor Decision|0
4911316|NCT00549302|16918307|P2|Double-Blind|Sponsor Decision|1
4911317|NCT00549302|16918308|P1|Double-Blind|Sponsor Decision|0
4911318|NCT00549302|16918306|P3|Double-Blind|Investigator Decision|0
4911319|NCT00549302|16918307|P2|Double-Blind|Investigator Decision|5
4911320|NCT00549302|16918308|P1|Double-Blind|Investigator Decision|1
4911321|NCT00549302|16918306|P3|Double-Blind|Withdrawal by Subject|0
4911322|NCT00549302|16918307|P2|Double-Blind|Withdrawal by Subject|8
4911323|NCT00549302|16918308|P1|Double-Blind|Withdrawal by Subject|3
4911324|NCT00549302|16918306|P3|Double-Blind|Adverse Event|0
4911325|NCT00549302|16918307|P2|Double-Blind|Adverse Event|16
4911326|NCT00549302|16918308|P1|Double-Blind|Adverse Event|3
4911327|NCT00549302|16918306|P3|Double-Blind|Death|0
4911328|NCT00549302|16918307|P2|Double-Blind|Death|9
4911329|NCT00549302|16918308|P1|Double-Blind|Death|2
4911330|NCT00549198|16918320|P2|Overall Study|Not Exposed to Study Drug|4
4911331|NCT00549198|16918321|P1|Overall Study|Not Exposed to Study Drug|3
4911332|NCT00549198|16918320|P2|Overall Study|Pregnancy|3
4911333|NCT00549198|16918321|P1|Overall Study|Pregnancy|0
4911334|NCT00549198|16918320|P2|Overall Study|No scan facilities|2
4911335|NCT00549198|16918321|P1|Overall Study|No scan facilities|0
4911336|NCT00549198|16918320|P2|Overall Study|Participant overweight, no scan possible|0
4911337|NCT00549198|16918321|P1|Overall Study|Participant overweight, no scan possible|1
4911338|NCT00549198|16918320|P2|Overall Study|Participant planning pregnancy|0
4911339|NCT00549198|16918321|P1|Overall Study|Participant planning pregnancy|1
4911340|NCT00549198|16918320|P2|Overall Study|Prohibited Medication|2
4911341|NCT00549198|16918321|P1|Overall Study|Prohibited Medication|1
4911342|NCT00549198|16918320|P2|Overall Study|Participant moved.Week 96 visit, no scan|0
4911343|NCT00549198|16918321|P1|Overall Study|Participant moved.Week 96 visit, no scan|1
4911344|NCT00549198|16918320|P2|Overall Study|Participant not able to perform Week 96|0
4911345|NCT00549198|16918321|P1|Overall Study|Participant not able to perform Week 96|1
4911346|NCT00549198|16918320|P2|Overall Study|Participant Moved|0
4911347|NCT00549198|16918321|P1|Overall Study|Participant Moved|2
4911348|NCT00549198|16918320|P2|Overall Study|Disease Progression|0
4911349|NCT00549198|16918321|P1|Overall Study|Disease Progression|1
4911350|NCT00549198|16918320|P2|Overall Study|Withdrawal by Subject|7
4911351|NCT00549198|16918321|P1|Overall Study|Withdrawal by Subject|7
4911352|NCT00549198|16918320|P2|Overall Study|Investigator Decision|3
4911353|NCT00549198|16918321|P1|Overall Study|Investigator Decision|4
4911354|NCT00549198|16918320|P2|Overall Study|Protocol Violation|2
4911355|NCT00549198|16918321|P1|Overall Study|Protocol Violation|7
4911356|NCT00549198|16918320|P2|Overall Study|Treatment Eligibility Criteria Not Met|0
4911357|NCT00549198|16918321|P1|Overall Study|Treatment Eligibility Criteria Not Met|3
4911358|NCT00549198|16918320|P2|Overall Study|Lost to Follow-up|8
4911359|NCT00549198|16918321|P1|Overall Study|Lost to Follow-up|7
4911360|NCT00549198|16918320|P2|Overall Study|Non-compliance|4
4911361|NCT00549198|16918321|P1|Overall Study|Non-compliance|2
4911362|NCT00549198|16918320|P2|Overall Study|Protocol-defined Virological Failure|0
4911363|NCT00549198|16918321|P1|Overall Study|Protocol-defined Virological Failure|7
4911364|NCT00549198|16918320|P2|Overall Study|Insufficient Viral Load Response|2
4911365|NCT00549198|16918321|P1|Overall Study|Insufficient Viral Load Response|4
4911366|NCT00549198|16918320|P2|Overall Study|Adverse Event|26
4911367|NCT00549198|16918321|P1|Overall Study|Adverse Event|28
4911368|NCT00549055|16918458|P1|Overall Study|Very low visual acuity (VA)|1
4911369|NCT00549055|16918458|P1|Overall Study|Choroidal neovascularization|1
4911370|NCT00549055|16918458|P1|Overall Study|Growth choroidal neovascularisation|1
4911371|NCT00549055|16918458|P1|Overall Study|Vitreous hemorrhage|1
4911372|NCT00549055|16918458|P1|Overall Study|Active choroidal neovascula increased|1
4911373|NCT00549055|16918458|P1|Overall Study|Decrease of size|1
4911374|NCT00549055|16918458|P1|Overall Study|Progression to fibrosis|2
4911375|NCT00549055|16918458|P1|Overall Study|Stabilization|5
4911376|NCT00549055|16918458|P1|Overall Study|Lack of Efficacy|18
4911377|NCT00549055|16918458|P1|Overall Study|Adverse Event|4
4911378|NCT00548847|16918502|P1|Overall Study|Disease progression|7
4911379|NCT00548808|16918509|P2|Overall Study|Sponsor Decision|1
4911380|NCT00548808|16918510|P1|Overall Study|Sponsor Decision|1
4911381|NCT00548808|16918509|P2|Overall Study|Lack of Efficacy|0
4911382|NCT00548808|16918510|P1|Overall Study|Lack of Efficacy|2
4911383|NCT00548808|16918509|P2|Overall Study|Entry Criteria Not Met|2
4911384|NCT00548808|16918510|P1|Overall Study|Entry Criteria Not Met|2
4911385|NCT00548808|16918509|P2|Overall Study|Death|0
4911386|NCT00548808|16918510|P1|Overall Study|Death|2
4911387|NCT00548808|16918509|P2|Overall Study|Adverse Event|5
4911388|NCT00548808|16918510|P1|Overall Study|Adverse Event|4
4911389|NCT00548808|16918509|P2|Overall Study|Physician Decision|3
4911390|NCT00548808|16918510|P1|Overall Study|Physician Decision|6
4911391|NCT00548808|16918509|P2|Overall Study|Withdrawal by Subject|4
4911392|NCT00548808|16918510|P1|Overall Study|Withdrawal by Subject|8
4911393|NCT00548808|16918509|P2|Overall Study|Protocol Violation|8
4911394|NCT00548808|16918510|P1|Overall Study|Protocol Violation|8
4911395|NCT00548808|16918509|P2|Overall Study|Lost to Follow-up|3
4911396|NCT00548808|16918510|P1|Overall Study|Lost to Follow-up|9
4911397|NCT00548717|16918534|P2|Overall Study|Alternative treatment for GVHD|0
4911398|NCT00548717|16918535|P1|Overall Study|Alternative treatment for GVHD|1
4911399|NCT00548717|16918534|P2|Overall Study|Relapse|0
4911400|NCT00548717|16918535|P1|Overall Study|Relapse|3
4911401|NCT00548717|16918534|P2|Overall Study|Death|2
4911402|NCT00548717|16918535|P1|Overall Study|Death|5
4911403|NCT00548548|16918579|P2|Overall Study|Lost to Follow-up|18
4911404|NCT00548548|16918580|P1|Overall Study|Lost to Follow-up|17
4911405|NCT00548548|16918579|P2|Overall Study|Death|348
4911406|NCT00548548|16918580|P1|Overall Study|Death|345
4911407|NCT00548405|16918623|P3|Overall Study|Randomized but not treated|0
4911408|NCT00548405|16918624|P2|Overall Study|Randomized but not treated|0
4911409|NCT00548405|16918625|P1|Overall Study|Randomized but not treated|1
4911410|NCT00548405|16918623|P3|Overall Study|Sponsor decision|0
4911411|NCT00548405|16918624|P2|Overall Study|Sponsor decision|0
4911412|NCT00548405|16918625|P1|Overall Study|Sponsor decision|1
4911413|NCT00548405|16918623|P3|Overall Study|Death|1
4911414|NCT00548405|16918624|P2|Overall Study|Death|1
4911415|NCT00548405|16918625|P1|Overall Study|Death|0
4911416|NCT00548405|16918623|P3|Overall Study|Lost to Follow-up|2
4911417|NCT00548405|16918624|P2|Overall Study|Lost to Follow-up|1
4911418|NCT00548405|16918625|P1|Overall Study|Lost to Follow-up|1
4911419|NCT00548405|16918623|P3|Overall Study|Withdrawal by Subject|5
4911420|NCT00548405|16918624|P2|Overall Study|Withdrawal by Subject|12
4911421|NCT00548405|16918625|P1|Overall Study|Withdrawal by Subject|36
4911422|NCT00548405|16918623|P3|Overall Study|Protocol Violation|0
4911423|NCT00548405|16918624|P2|Overall Study|Protocol Violation|0
4911424|NCT00548405|16918625|P1|Overall Study|Protocol Violation|1
4911425|NCT00548405|16918623|P3|Overall Study|Pregnancy|0
4911426|NCT00548405|16918624|P2|Overall Study|Pregnancy|0
4911427|NCT00548405|16918625|P1|Overall Study|Pregnancy|1
4911428|NCT00548405|16918623|P3|Overall Study|Physician Decision|1
4911429|NCT00548405|16918624|P2|Overall Study|Physician Decision|4
4911430|NCT00548405|16918625|P1|Overall Study|Physician Decision|3
4911431|NCT00548405|16918623|P3|Overall Study|Lack of Efficacy|0
4911432|NCT00548405|16918624|P2|Overall Study|Lack of Efficacy|0
4911433|NCT00548405|16918625|P1|Overall Study|Lack of Efficacy|6
4911434|NCT00548405|16918623|P3|Overall Study|Adverse Event|0
4911435|NCT00548405|16918624|P2|Overall Study|Adverse Event|2
4911436|NCT00548405|16918625|P1|Overall Study|Adverse Event|6
4911437|NCT00548340|16918646|P3|Overall Study|Other|1
4911438|NCT00548340|16918647|P2|Overall Study|Other|1
4911439|NCT00548340|16918648|P1|Overall Study|Other|1
4911440|NCT00548340|16918646|P3|Overall Study|Withdrawal by Subject|3
4911441|NCT00548340|16918647|P2|Overall Study|Withdrawal by Subject|4
4911442|NCT00548340|16918648|P1|Overall Study|Withdrawal by Subject|2
4911443|NCT00548340|16918646|P3|Overall Study|Lost to Follow-up|0
4911444|NCT00548340|16918647|P2|Overall Study|Lost to Follow-up|1
4911445|NCT00548340|16918648|P1|Overall Study|Lost to Follow-up|1
4911446|NCT00548340|16918646|P3|Overall Study|Adverse Event|2
4911447|NCT00548340|16918647|P2|Overall Study|Adverse Event|2
4911448|NCT00548340|16918648|P1|Overall Study|Adverse Event|2
4911449|NCT00548340|16918646|P3|Overall Study|Protocol Violation|3
4911450|NCT00548340|16918647|P2|Overall Study|Protocol Violation|3
4911451|NCT00548340|16918648|P1|Overall Study|Protocol Violation|2
4911452|NCT00548327|16918667|P2|Overall Study|Adverse Event|1
4911453|NCT00548327|16918668|P1|Overall Study|Adverse Event|0
4911454|NCT00548262|16918686|P1|Overall Study|Withdrawal by Subject|1
4911455|NCT00548262|16918686|P1|Overall Study|Other|3
4911456|NCT00548262|16918686|P1|Overall Study|Lost to Follow-up|1
4911457|NCT00548262|16918686|P1|Overall Study|Lack of Efficacy|4
4911458|NCT00548262|16918686|P1|Overall Study|Adverse Event|2
4911459|NCT00548262|16918686|P1|Overall Study|Death|21
4911460|NCT00548249|16918716|P5|Overall Study|Sponsor's request|0
4911461|NCT00548249|16918717|P4|Overall Study|Sponsor's request|1
4911462|NCT00548249|16918718|P3|Overall Study|Sponsor's request|0
4911463|NCT00548249|16918719|P2|Overall Study|Sponsor's request|0
4911464|NCT00548249|16918720|P1|Overall Study|Sponsor's request|0
4911465|NCT00548249|16918716|P5|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
4911466|NCT00548249|16918717|P4|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
4911467|NCT00548249|16918718|P3|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
4911468|NCT00548249|16918719|P2|Overall Study|Corrected Q-wave T-wave (QTc) increase|1
4911469|NCT00548249|16918720|P1|Overall Study|Corrected Q-wave T-wave (QTc) increase|0
4911470|NCT00548249|16918716|P5|Overall Study|Withdrawal by Subject|0
4911471|NCT00548249|16918717|P4|Overall Study|Withdrawal by Subject|0
4911472|NCT00548249|16918718|P3|Overall Study|Withdrawal by Subject|0
4911473|NCT00548249|16918719|P2|Overall Study|Withdrawal by Subject|0
4911474|NCT00548249|16918720|P1|Overall Study|Withdrawal by Subject|2
4911475|NCT00548249|16918716|P5|Overall Study|Prolonged hospitalization|0
4911476|NCT00548249|16918717|P4|Overall Study|Prolonged hospitalization|1
4911477|NCT00548249|16918718|P3|Overall Study|Prolonged hospitalization|2
4911478|NCT00548249|16918719|P2|Overall Study|Prolonged hospitalization|0
4911479|NCT00548249|16918720|P1|Overall Study|Prolonged hospitalization|0
4911480|NCT00548249|16918716|P5|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0
4911481|NCT00548249|16918717|P4|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4911482|NCT00548249|16918718|P3|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4911483|NCT00548249|16918719|P2|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4911484|NCT00548249|16918720|P1|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1
4911485|NCT00548249|16918716|P5|Overall Study|Erythropoietin (ESA)Dose Change Required|2
4911486|NCT00548249|16918717|P4|Overall Study|Erythropoietin (ESA)Dose Change Required|2
4911487|NCT00548249|16918718|P3|Overall Study|Erythropoietin (ESA)Dose Change Required|1
4911488|NCT00548249|16918719|P2|Overall Study|Erythropoietin (ESA)Dose Change Required|0
4911489|NCT00548249|16918720|P1|Overall Study|Erythropoietin (ESA)Dose Change Required|0
4911490|NCT00548249|16918716|P5|Overall Study|Post-dialysis high TSAT or low UIBC|2
4911491|NCT00548249|16918717|P4|Overall Study|Post-dialysis high TSAT or low UIBC|3
4911492|NCT00548249|16918718|P3|Overall Study|Post-dialysis high TSAT or low UIBC|1
4911493|NCT00548249|16918719|P2|Overall Study|Post-dialysis high TSAT or low UIBC|0
4911494|NCT00548249|16918720|P1|Overall Study|Post-dialysis high TSAT or low UIBC|0
4911495|NCT00548249|16918716|P5|Overall Study|Adverse Event|1
4911496|NCT00548249|16918717|P4|Overall Study|Adverse Event|1
4911497|NCT00548249|16918718|P3|Overall Study|Adverse Event|0
4911498|NCT00548249|16918719|P2|Overall Study|Adverse Event|2
4911499|NCT00548249|16918720|P1|Overall Study|Adverse Event|2
4911500|NCT00548249|16918716|P5|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4
4911501|NCT00548249|16918717|P4|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1
4911502|NCT00548249|16918718|P3|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2
4911503|NCT00548249|16918719|P2|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
4911504|NCT00548249|16918720|P1|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0
4911505|NCT00548249|16918716|P5|Overall Study|Miscellaneous|2
4911506|NCT00548249|16918717|P4|Overall Study|Miscellaneous|0
4911507|NCT00548249|16918718|P3|Overall Study|Miscellaneous|2
4911508|NCT00548249|16918719|P2|Overall Study|Miscellaneous|3
4911509|NCT00548249|16918720|P1|Overall Study|Miscellaneous|2
4911510|NCT00548249|16918716|P5|Overall Study|Protocol Violation|3
4911511|NCT00548249|16918717|P4|Overall Study|Protocol Violation|0
4911512|NCT00548249|16918718|P3|Overall Study|Protocol Violation|4
4911513|NCT00548249|16918719|P2|Overall Study|Protocol Violation|1
4911514|NCT00548249|16918720|P1|Overall Study|Protocol Violation|1
4911515|NCT00548249|16918716|P5|Overall Study|Transferrin Saturation (TSAT) <20%|2
4911516|NCT00548249|16918717|P4|Overall Study|Transferrin Saturation (TSAT) <20%|1
4911517|NCT00548249|16918718|P3|Overall Study|Transferrin Saturation (TSAT) <20%|3
4911518|NCT00548249|16918719|P2|Overall Study|Transferrin Saturation (TSAT) <20%|1
4911519|NCT00548249|16918720|P1|Overall Study|Transferrin Saturation (TSAT) <20%|5
4911520|NCT00548249|16918716|P5|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
4911521|NCT00548249|16918717|P4|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2
4911522|NCT00548249|16918718|P3|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
4911523|NCT00548249|16918719|P2|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4
4911524|NCT00548249|16918720|P1|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3
4911525|NCT00548184|16918768|P1|Overall Study|Found Her2 negative|1
4911526|NCT00548184|16918768|P1|Overall Study|took other drug|1
4911527|NCT00548184|16918768|P1|Overall Study|Adverse Event|3
4911528|NCT00548145|16918816|P2|Overall Study|Physician Decision|1
4911529|NCT00548145|16918817|P1|Overall Study|Physician Decision|1
4911530|NCT00548145|16918816|P2|Overall Study|Withdrawal by Subject|2
4911531|NCT00548145|16918817|P1|Overall Study|Withdrawal by Subject|0
4911532|NCT00548145|16918816|P2|Overall Study|Death|1
4911533|NCT00548145|16918817|P1|Overall Study|Death|0
4911534|NCT00548093|16918836|P2|Overall Study|Completed post-treatment follow-up|0
4911535|NCT00548093|16918837|P1|Overall Study|Completed post-treatment follow-up|1
4911536|NCT00548093|16918836|P2|Overall Study|Withdrawal by Subject|0
4911537|NCT00548093|16918837|P1|Overall Study|Withdrawal by Subject|1
4911538|NCT00548093|16918836|P2|Overall Study|Other|1
4911539|NCT00548093|16918837|P1|Overall Study|Other|11
4911540|NCT00548093|16918836|P2|Overall Study|Objective progression or relapse|1
4911541|NCT00548093|16918837|P1|Overall Study|Objective progression or relapse|1
4911542|NCT00548093|16918836|P2|Overall Study|Lost to Follow-up|1
4911543|NCT00548093|16918837|P1|Overall Study|Lost to Follow-up|3
4911544|NCT00548093|16918836|P2|Overall Study|Death|13
4911545|NCT00548093|16918837|P1|Overall Study|Death|33
4911546|NCT00547911|16918875|P6|Overall Study|Adverse Event|0
4911547|NCT00547911|16918876|P5|Overall Study|Adverse Event|0
4911548|NCT00547911|16918877|P4|Overall Study|Adverse Event|1
4911549|NCT00547911|16918878|P3|Overall Study|Adverse Event|0
4911550|NCT00547911|16918879|P2|Overall Study|Adverse Event|0
4911551|NCT00547911|16918880|P1|Overall Study|Adverse Event|0
4911552|NCT00547703|16918930|P2|Overall Study|Lost to Follow-up|0
4911553|NCT00547703|16918931|P1|Overall Study|Lost to Follow-up|1
4911554|NCT00547534|16918977|P1|Overall Study|Disease Progression|4
4911555|NCT00547534|16918977|P1|Overall Study|Adverse Event|7
4911556|NCT00547521|16918985|P2|Long Term Extension (LTE) Study|Poor/Non-Compliance|1
4911557|NCT00547521|16918986|P1|Long Term Extension (LTE) Study|Poor/Non-Compliance|0
4911558|NCT00547521|16918985|P2|Long Term Extension (LTE) Study|Other|2
4911559|NCT00547521|16918986|P1|Long Term Extension (LTE) Study|Other|0
4911560|NCT00547521|16918985|P2|Long Term Extension (LTE) Study|Withdrawal by Subject|2
4911561|NCT00547521|16918986|P1|Long Term Extension (LTE) Study|Withdrawal by Subject|0
4911562|NCT00547521|16918985|P2|Long Term Extension (LTE) Study|Lost to Follow-up|3
4911563|NCT00547521|16918986|P1|Long Term Extension (LTE) Study|Lost to Follow-up|0
4911564|NCT00547521|16918985|P2|Long Term Extension (LTE) Study|Adverse Event|9
4911565|NCT00547521|16918986|P1|Long Term Extension (LTE) Study|Adverse Event|0
4911566|NCT00547521|16918985|P2|Long Term Extension (LTE) Study|Lack of Efficacy|14
4911567|NCT00547521|16918986|P1|Long Term Extension (LTE) Study|Lack of Efficacy|0
4911568|NCT00547521|16918985|P2|Short Term Study (4 Months)|primary endpoint evaluation not complete|1
4911569|NCT00547521|16918986|P1|Short Term Study (4 Months)|primary endpoint evaluation not complete|0
4911570|NCT00547521|16918985|P2|Short Term Study (4 Months)|Withdrawal of consent|1
4911571|NCT00547521|16918986|P1|Short Term Study (4 Months)|Withdrawal of consent|0
4911572|NCT00547521|16918985|P2|Short Term Study (4 Months)|Lack of Efficacy|2
4911573|NCT00547521|16918986|P1|Short Term Study (4 Months)|Lack of Efficacy|0
4911574|NCT00547521|16918985|P2|Short Term Study (4 Months)|Adverse Event|0
4911575|NCT00547521|16918986|P1|Short Term Study (4 Months)|Adverse Event|1
4911576|NCT00547378|16919063|P3|All Implanted Cohort|Other reasons|1
4911577|NCT00547378|16919064|P2|All Implanted Cohort|Other reasons|0
4911578|NCT00547378|16919065|P1|All Implanted Cohort|Other reasons|1
4911579|NCT00547378|16919063|P3|All Implanted Cohort|Site closure|1
4911580|NCT00547378|16919064|P2|All Implanted Cohort|Site closure|0
4911581|NCT00547378|16919065|P1|All Implanted Cohort|Site closure|2
4911582|NCT00547378|16919063|P3|All Implanted Cohort|Physician Decision|6
4911583|NCT00547378|16919064|P2|All Implanted Cohort|Physician Decision|2
4911584|NCT00547378|16919065|P1|All Implanted Cohort|Physician Decision|0
4911585|NCT00547378|16919063|P3|All Implanted Cohort|Death|4
4911586|NCT00547378|16919064|P2|All Implanted Cohort|Death|1
4911587|NCT00547378|16919065|P1|All Implanted Cohort|Death|3
4911588|NCT00547378|16919063|P3|All Implanted Cohort|Lost to Follow-up|14
4911589|NCT00547378|16919064|P2|All Implanted Cohort|Lost to Follow-up|1
4911590|NCT00547378|16919065|P1|All Implanted Cohort|Lost to Follow-up|0
4911591|NCT00547378|16919063|P3|All Implanted Cohort|Adverse Event|17
4911592|NCT00547378|16919064|P2|All Implanted Cohort|Adverse Event|10
4911593|NCT00547378|16919065|P1|All Implanted Cohort|Adverse Event|4
4911594|NCT00547378|16919063|P3|All Implanted Cohort|Withdrawal by Subject|27
4911595|NCT00547378|16919064|P2|All Implanted Cohort|Withdrawal by Subject|4
4911596|NCT00547378|16919065|P1|All Implanted Cohort|Withdrawal by Subject|5
4911597|NCT00547378|16919063|P3|Randomized Cohort|Other reasons|0
4911598|NCT00547378|16919064|P2|Randomized Cohort|Other reasons|0
4911599|NCT00547378|16919065|P1|Randomized Cohort|Other reasons|2
4911600|NCT00547378|16919063|P3|Randomized Cohort|Adverse Event|0
4911601|NCT00547378|16919064|P2|Randomized Cohort|Adverse Event|0
4911602|NCT00547378|16919065|P1|Randomized Cohort|Adverse Event|1
4911603|NCT00547378|16919063|P3|Randomized Cohort|Lost to Follow-up|0
4911604|NCT00547378|16919064|P2|Randomized Cohort|Lost to Follow-up|0
4911605|NCT00547378|16919065|P1|Randomized Cohort|Lost to Follow-up|1
4911606|NCT00547378|16919063|P3|Randomized Cohort|Death|0
4911607|NCT00547378|16919064|P2|Randomized Cohort|Death|1
4911608|NCT00547378|16919065|P1|Randomized Cohort|Death|0
4911609|NCT00547378|16919063|P3|Randomized Cohort|Withdrawal by Subject|0
4911610|NCT00547378|16919064|P2|Randomized Cohort|Withdrawal by Subject|5
4911611|NCT00547378|16919065|P1|Randomized Cohort|Withdrawal by Subject|7
4911612|NCT00547365|16919075|P1|Overall Study|death (not related to study)|4
4911613|NCT00547365|16919075|P1|Overall Study|Protocol Violation|2
4911614|NCT00547365|16919075|P1|Overall Study|Lost to Follow-up|1
4911615|NCT00547365|16919075|P1|Overall Study|Physician Decision|1
4911616|NCT00547300|16919082|P2|Overall Study|Did not Meet Entry Criteria|2
4911617|NCT00547300|16919083|P1|Overall Study|Did not Meet Entry Criteria|0
4911618|NCT00547300|16919082|P2|Overall Study|Study was Administratively Terminated|24
4911619|NCT00547300|16919083|P1|Overall Study|Study was Administratively Terminated|25
4911620|NCT00547248|16919097|P4|Overall Study|Withdrawal by Subject|1
4911621|NCT00547248|16919098|P3|Overall Study|Withdrawal by Subject|7
4911622|NCT00547248|16919099|P2|Overall Study|Withdrawal by Subject|0
4911623|NCT00547248|16919100|P1|Overall Study|Withdrawal by Subject|0
4911624|NCT00547248|16919097|P4|Overall Study|Migrated/moved from study area|0
4911625|NCT00547248|16919098|P3|Overall Study|Migrated/moved from study area|2
4911626|NCT00547248|16919099|P2|Overall Study|Migrated/moved from study area|0
4911627|NCT00547248|16919100|P1|Overall Study|Migrated/moved from study area|0
4911628|NCT00547248|16919097|P4|Overall Study|Protocol Violation|1
4911629|NCT00547248|16919098|P3|Overall Study|Protocol Violation|1
4911630|NCT00547248|16919099|P2|Overall Study|Protocol Violation|0
4911631|NCT00547248|16919100|P1|Overall Study|Protocol Violation|0
4911632|NCT00547157|16919218|P2|Overall Study|Lost to Follow-up|2
4911633|NCT00547157|16919219|P1|Overall Study|Lost to Follow-up|4
4911634|NCT00547157|16919218|P2|Overall Study|Administrative decision|2
4911635|NCT00547157|16919219|P1|Overall Study|Administrative decision|3
4911636|NCT00547157|16919218|P2|Overall Study|Withdrawal by Subject|1
4911637|NCT00547157|16919219|P1|Overall Study|Withdrawal by Subject|3
4911638|NCT00547157|16919218|P2|Overall Study|Death|18
4911639|NCT00547157|16919219|P1|Overall Study|Death|38
4911640|NCT00547157|16919218|P2|Overall Study|Other|0
4911641|NCT00547157|16919219|P1|Overall Study|Other|1
4911642|NCT00547118|16919237|P2|Overall Study|Study suspended|8
4911643|NCT00547118|16919238|P1|Overall Study|Study suspended|7
4911644|NCT00547118|16919237|P2|Overall Study|Did not qualify prior to starting drug|1
4911645|NCT00547118|16919238|P1|Overall Study|Did not qualify prior to starting drug|1
4911646|NCT00546910|16919282|P2|Overall Study|Withdrawal by Subject|0
4911647|NCT00546910|16919283|P1|Overall Study|Withdrawal by Subject|2
4911648|NCT00546910|16919282|P2|Overall Study|Physician Decision|1
4911649|NCT00546910|16919283|P1|Overall Study|Physician Decision|0
4911650|NCT00546910|16919282|P2|Overall Study|Lack of Efficacy|7
4911651|NCT00546910|16919283|P1|Overall Study|Lack of Efficacy|5
4911652|NCT00546910|16919282|P2|Overall Study|Adverse Event|3
4911653|NCT00546910|16919283|P1|Overall Study|Adverse Event|2
4911654|NCT00546871|16919349|P2|Study Extension Period|Withdrawal by Subject|1
4911655|NCT00546871|16919350|P1|Study Extension Period|Withdrawal by Subject|0
4911656|NCT00546871|16919349|P2|Study Extension Period|Protocol Violation|0
4911657|NCT00546871|16919350|P1|Study Extension Period|Protocol Violation|1
4911658|NCT00546871|16919349|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1
4911659|NCT00546871|16919350|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0
4911660|NCT00546871|16919349|P2|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2
4911661|NCT00546871|16919350|P1|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1
4911662|NCT00546871|16919349|P2|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0
4911663|NCT00546871|16919350|P1|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1
4911664|NCT00546819|16919455|P2|Overall Study|Withdrawal by Subject|2
4911665|NCT00546819|16919456|P1|Overall Study|Withdrawal by Subject|4
4911666|NCT00546819|16919455|P2|Overall Study|Lost to Follow-up|1
4911667|NCT00546819|16919456|P1|Overall Study|Lost to Follow-up|2
4911668|NCT00546819|16919455|P2|Overall Study|Adverse Event|3
4911669|NCT00546819|16919456|P1|Overall Study|Adverse Event|2
4911670|NCT00546754|16919468|P2|Overall Study|Missing|7
4911671|NCT00546754|16919469|P1|Overall Study|Missing|14
4911672|NCT00546754|16919468|P2|Overall Study|Patient's Decision|1
4911673|NCT00546754|16919469|P1|Overall Study|Patient's Decision|0
4911674|NCT00546754|16919468|P2|Overall Study|Elevated Creatinine and Potassium levels|1
4911675|NCT00546754|16919469|P1|Overall Study|Elevated Creatinine and Potassium levels|0
4911676|NCT00546754|16919468|P2|Overall Study|Missing Cooperation|0
4911677|NCT00546754|16919469|P1|Overall Study|Missing Cooperation|1
4911678|NCT00546754|16919468|P2|Overall Study|Suicide|0
4911679|NCT00546754|16919469|P1|Overall Study|Suicide|1
4911680|NCT00546754|16919468|P2|Overall Study|Hip Replacement|0
4911681|NCT00546754|16919469|P1|Overall Study|Hip Replacement|1
4911682|NCT00546754|16919468|P2|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0
4911683|NCT00546754|16919469|P1|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1
4911684|NCT00546754|16919468|P2|Overall Study|Dyspnea|0
4911685|NCT00546754|16919469|P1|Overall Study|Dyspnea|1
4911686|NCT00546754|16919468|P2|Overall Study|Withdrawal by Subject|7
4911687|NCT00546754|16919469|P1|Overall Study|Withdrawal by Subject|6
4911688|NCT00546754|16919468|P2|Overall Study|Protocol Violation|0
4911689|NCT00546754|16919469|P1|Overall Study|Protocol Violation|3
4911690|NCT00546754|16919468|P2|Overall Study|Lost to Follow-up|15
4911691|NCT00546754|16919469|P1|Overall Study|Lost to Follow-up|9
4911692|NCT00546754|16919468|P2|Overall Study|Lack of Efficacy|1
4911693|NCT00546754|16919469|P1|Overall Study|Lack of Efficacy|1
4911694|NCT00546754|16919468|P2|Overall Study|Adverse Event|16
4911695|NCT00546754|16919469|P1|Overall Study|Adverse Event|11
4911696|NCT00546754|16919468|P2|Overall Study|Serious Adverse Event|1
4911697|NCT00546754|16919469|P1|Overall Study|Serious Adverse Event|1
4911698|NCT00546715|16919512|P4|Overall Study|Withdrawal by Subject|0
4911699|NCT00546715|16919513|P3|Overall Study|Withdrawal by Subject|0
4911700|NCT00546715|16919514|P2|Overall Study|Withdrawal by Subject|1
4911701|NCT00546715|16919515|P1|Overall Study|Withdrawal by Subject|0
4911702|NCT00546637|16919570|P2|Overall Study|Randomized, but not treated|1
4911703|NCT00546637|16919571|P1|Overall Study|Randomized, but not treated|3
4911704|NCT00546637|16919570|P2|Overall Study|Withdrawal by Subject|9
4911705|NCT00546637|16919571|P1|Overall Study|Withdrawal by Subject|7
4911706|NCT00546637|16919570|P2|Overall Study|Other|12
4911707|NCT00546637|16919571|P1|Overall Study|Other|10
4911708|NCT00546637|16919570|P2|Overall Study|Lost to Follow-up|2
4911709|NCT00546637|16919571|P1|Overall Study|Lost to Follow-up|2
4911710|NCT00546637|16919570|P2|Overall Study|Lack of Efficacy|5
4911711|NCT00546637|16919571|P1|Overall Study|Lack of Efficacy|5
4911712|NCT00546637|16919570|P2|Overall Study|Adverse Event|20
4911713|NCT00546637|16919571|P1|Overall Study|Adverse Event|46
4911714|NCT00546572|16919645|P2|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1
4911715|NCT00546572|16919646|P1|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2
4911716|NCT00546572|16919645|P2|Vax 2 / Year 1|Adverse Event|0
4911717|NCT00546572|16919646|P1|Vax 2 / Year 1|Adverse Event|1
4911718|NCT00546572|16919645|P2|Vax 2 / Year 1|Other|1
4911719|NCT00546572|16919646|P1|Vax 2 / Year 1|Other|1
4911720|NCT00546572|16919645|P2|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59
4911721|NCT00546572|16919646|P1|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64
4911722|NCT00546572|16919645|P2|Vax 1 / Year 0|Lost to Follow-up|1
4911723|NCT00546572|16919646|P1|Vax 1 / Year 0|Lost to Follow-up|0
4911724|NCT00546572|16919645|P2|Vax 1 / Year 0|Adverse Event|1
4911725|NCT00546572|16919646|P1|Vax 1 / Year 0|Adverse Event|0
4911726|NCT00546572|16919645|P2|Vax 1 / Year 0|Death|2
4911727|NCT00546572|16919646|P1|Vax 1 / Year 0|Death|2
4911728|NCT00546572|16919645|P2|Vax 1 / Year 0|Protocol Violation|4
4911729|NCT00546572|16919646|P1|Vax 1 / Year 0|Protocol Violation|3
4911730|NCT00546572|16919645|P2|Vax 1 / Year 0|Withdrawal by Subject|2
4911731|NCT00546572|16919646|P1|Vax 1 / Year 0|Withdrawal by Subject|3
4911732|NCT00546572|16919645|P2|Vax 1 / Year 0|Randomized, not treated|1
4911733|NCT00546572|16919646|P1|Vax 1 / Year 0|Randomized, not treated|1
4911734|NCT00546481|16919690|P3|Maintenance Phase (CERA)|Other Reason|1
4911735|NCT00546481|16919691|P2|Maintenance Phase (CERA)|Other Reason|0
4911736|NCT00546481|16919692|P1|Maintenance Phase (CERA)|Other Reason|0
4911737|NCT00546481|16919690|P3|Maintenance Phase (CERA)|Kidney transplantation|1
4911738|NCT00546481|16919691|P2|Maintenance Phase (CERA)|Kidney transplantation|0
4911739|NCT00546481|16919692|P1|Maintenance Phase (CERA)|Kidney transplantation|0
4911740|NCT00546481|16919690|P3|Maintenance Phase (CERA)|Withdrawal by Subject|2
4911741|NCT00546481|16919691|P2|Maintenance Phase (CERA)|Withdrawal by Subject|0
4911742|NCT00546481|16919692|P1|Maintenance Phase (CERA)|Withdrawal by Subject|0
4911743|NCT00546481|16919690|P3|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
4911744|NCT00546481|16919691|P2|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1
4911745|NCT00546481|16919692|P1|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0
4911746|NCT00546481|16919690|P3|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0
4911747|NCT00546481|16919691|P2|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
4911748|NCT00546481|16919692|P1|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1
4911749|NCT00546481|16919690|P3|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
4911750|NCT00546481|16919691|P2|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0
4911751|NCT00546481|16919692|P1|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2
4911752|NCT00546481|16919690|P3|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
4911753|NCT00546481|16919691|P2|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0
4911754|NCT00546481|16919692|P1|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1
4911755|NCT00546481|16919690|P3|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0
4911756|NCT00546481|16919691|P2|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3
4911757|NCT00546481|16919692|P1|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1
4911758|NCT00546481|16919690|P3|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
4911759|NCT00546481|16919691|P2|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0
4911760|NCT00546481|16919692|P1|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1
4911761|NCT00546377|16919730|P1|Overall Study|Adverse Event|6
4911762|NCT00546377|16919730|P1|Overall Study|Deemed ineligible|1
4911763|NCT00546364|16919738|P3|Overall Study|Sponsor decision|1
4911764|NCT00546364|16919739|P2|Overall Study|Sponsor decision|0
4911765|NCT00546364|16919740|P1|Overall Study|Sponsor decision|0
4911766|NCT00546364|16919738|P3|Overall Study|Physician Decision|1
4911767|NCT00546364|16919739|P2|Overall Study|Physician Decision|0
4911768|NCT00546364|16919740|P1|Overall Study|Physician Decision|0
4911769|NCT00546364|16919738|P3|Overall Study|Target lesions resected|0
4911770|NCT00546364|16919739|P2|Overall Study|Target lesions resected|0
4911771|NCT00546364|16919740|P1|Overall Study|Target lesions resected|1
4911772|NCT00546364|16919738|P3|Overall Study|Palliative treatment|1
4911773|NCT00546364|16919739|P2|Overall Study|Palliative treatment|0
4911774|NCT00546364|16919740|P1|Overall Study|Palliative treatment|1
4911775|NCT00546364|16919738|P3|Overall Study|Mixed response|0
4911776|NCT00546364|16919739|P2|Overall Study|Mixed response|0
4911777|NCT00546364|16919740|P1|Overall Study|Mixed response|1
4911778|NCT00546364|16919738|P3|Overall Study|Prior taxotere|0
4911779|NCT00546364|16919739|P2|Overall Study|Prior taxotere|0
4911780|NCT00546364|16919740|P1|Overall Study|Prior taxotere|1
4911781|NCT00546364|16919738|P3|Overall Study|Withdrawal by Subject|3
4911782|NCT00546364|16919739|P2|Overall Study|Withdrawal by Subject|6
4911783|NCT00546364|16919740|P1|Overall Study|Withdrawal by Subject|5
4911784|NCT00546364|16919738|P3|Overall Study|No longer meets study criteria|0
4911785|NCT00546364|16919739|P2|Overall Study|No longer meets study criteria|1
4911786|NCT00546364|16919740|P1|Overall Study|No longer meets study criteria|1
4911787|NCT00546364|16919738|P3|Overall Study|Poor compliance/noncompliance|1
4911788|NCT00546364|16919739|P2|Overall Study|Poor compliance/noncompliance|0
4911789|NCT00546364|16919740|P1|Overall Study|Poor compliance/noncompliance|0
4911790|NCT00546364|16919738|P3|Overall Study|Administrative reason by sponsor|0
4911791|NCT00546364|16919739|P2|Overall Study|Administrative reason by sponsor|0
4911792|NCT00546364|16919740|P1|Overall Study|Administrative reason by sponsor|1
4911793|NCT00546364|16919738|P3|Overall Study|Completed and off treatment|2
4911794|NCT00546364|16919739|P2|Overall Study|Completed and off treatment|0
4911795|NCT00546364|16919740|P1|Overall Study|Completed and off treatment|1
4911796|NCT00546364|16919738|P3|Overall Study|Disease progression|8
4911797|NCT00546364|16919739|P2|Overall Study|Disease progression|11
4911798|NCT00546364|16919740|P1|Overall Study|Disease progression|5
4911799|NCT00546351|16919775|P1|Overall Study|Other reasons for premature termination|17
4911800|NCT00546351|16919775|P1|Overall Study|Unsatisfactory compliance|9
4911801|NCT00546351|16919775|P1|Overall Study|Protocol Deviation|1
4911802|NCT00546351|16919775|P1|Overall Study|Lost to Follow-up|9
4911803|NCT00546351|16919775|P1|Overall Study|Withdrawal by Subject|109
4911804|NCT00546351|16919775|P1|Overall Study|Lack of Efficacy|15
4911805|NCT00546351|16919775|P1|Overall Study|Adverse Event|76
4911806|NCT00546260|16919821|P2|Overall Study|Drug not given pre diagnostic angiogr|2
4911807|NCT00546260|16919822|P1|Overall Study|Drug not given pre diagnostic angiogr|8
4911808|NCT00546117|16919844|P2|Overall Study|Inability to schedule follow-up visit|0
4911809|NCT00546117|16919845|P1|Overall Study|Inability to schedule follow-up visit|1
4911810|NCT00546117|16919844|P2|Overall Study|Withdrawal by Subject|0
4911811|NCT00546117|16919845|P1|Overall Study|Withdrawal by Subject|3
4911812|NCT00546078|16919870|P2|Overall Study|Other reason|1
4911813|NCT00546078|16919871|P1|Overall Study|Other reason|1
4911814|NCT00546078|16919870|P2|Overall Study|Withdrawal by Subject|3
4911815|NCT00546078|16919871|P1|Overall Study|Withdrawal by Subject|2
4911816|NCT00546078|16919870|P2|Overall Study|Lost to Follow-up|3
4911817|NCT00546078|16919871|P1|Overall Study|Lost to Follow-up|1
4911818|NCT00546052|16919909|P1|Overall Study|Non Compliance|7
4911819|NCT00546052|16919909|P1|Overall Study|Withdrawal by Subject|20
4911820|NCT00546052|16919909|P1|Overall Study|Protocol Violation|9
4911821|NCT00546052|16919909|P1|Overall Study|Lost to Follow-up|144
4911822|NCT00546052|16919909|P1|Overall Study|Adverse Event|47
4911823|NCT00546000|16919927|P1|Overall Study|Baseline HPA Axis Supression|2
4911824|NCT00546000|16919927|P1|Overall Study|Lost to Follow-up|1
4911825|NCT00546000|16919927|P1|Overall Study|Adverse Event|1
4911826|NCT00545948|16919946|P3|Overall Study|Not Treated|7
4911827|NCT00545948|16919947|P2|Overall Study|Not Treated|1
4911828|NCT00545948|16919948|P1|Overall Study|Not Treated|1
4911829|NCT00545844|16919958|P1|Overall Study|Withdrawal by Subject|2
4911830|NCT00545844|16919958|P1|Overall Study|Protocol Violation|1
4911831|NCT00545844|16919958|P1|Overall Study|Lost to Follow-up|9
4911832|NCT00545818|16919974|P2|Overall Study|Lost to Follow-up|6
4911833|NCT00545818|16919975|P1|Overall Study|Lost to Follow-up|1
4911834|NCT00545818|16919974|P2|Overall Study|Adverse Event|1
4911835|NCT00545818|16919975|P1|Overall Study|Adverse Event|1
4911836|NCT00545818|16919974|P2|Overall Study|Protocol Violation|0
4911837|NCT00545818|16919975|P1|Overall Study|Protocol Violation|1
4911838|NCT00545792|16919989|P1|Overall Study|Withdrawal by Subject|1
4911839|NCT00545779|16919994|P1|Overall Study|Failure to return|3
4911840|NCT00545779|16919994|P1|Overall Study|Adverse Event/intercurrent illness|5
4911841|NCT00545779|16919994|P1|Overall Study|Withdrawal by Subject|20
4911842|NCT00545779|16919994|P1|Overall Study|Did not cooperate|7
4911843|NCT00545779|16919994|P1|Overall Study|Other protocol violation|1
4911844|NCT00545779|16919994|P1|Overall Study|Violation of selection criteria at entry|8
4911845|NCT00545753|16920014|P3|Overall Study|Protocol Violation|4
4911846|NCT00545753|16920015|P2|Overall Study|Protocol Violation|1
4911847|NCT00545753|16920016|P1|Overall Study|Protocol Violation|3
4911848|NCT00545753|16920014|P3|Overall Study|Lost to Follow-up|12
4911849|NCT00545753|16920015|P2|Overall Study|Lost to Follow-up|3
4911850|NCT00545753|16920016|P1|Overall Study|Lost to Follow-up|13
4911851|NCT00545753|16920014|P3|Overall Study|Withdrawal by Subject|10
4911852|NCT00545753|16920015|P2|Overall Study|Withdrawal by Subject|1
4911853|NCT00545753|16920016|P1|Overall Study|Withdrawal by Subject|0
4911854|NCT00545740|16920029|P4|Overall Study|Husband against study|0
4911855|NCT00545740|16920030|P3|Overall Study|Husband against study|1
4911856|NCT00545740|16920031|P2|Overall Study|Husband against study|0
4911857|NCT00545740|16920032|P1|Overall Study|Husband against study|0
4911858|NCT00545740|16920029|P4|Overall Study|Patient difficulties|0
4911859|NCT00545740|16920030|P3|Overall Study|Patient difficulties|0
4911860|NCT00545740|16920031|P2|Overall Study|Patient difficulties|1
4911861|NCT00545740|16920032|P1|Overall Study|Patient difficulties|0
4911862|NCT00545740|16920029|P4|Overall Study|Non-adherence to visits|0
4911863|NCT00545740|16920030|P3|Overall Study|Non-adherence to visits|0
4911864|NCT00545740|16920031|P2|Overall Study|Non-adherence to visits|1
4911865|NCT00545740|16920032|P1|Overall Study|Non-adherence to visits|0
4911866|NCT00545740|16920029|P4|Overall Study|Lack of time|0
4911867|NCT00545740|16920030|P3|Overall Study|Lack of time|0
4911868|NCT00545740|16920031|P2|Overall Study|Lack of time|1
4911869|NCT00545740|16920032|P1|Overall Study|Lack of time|0
4911870|NCT00545740|16920029|P4|Overall Study|Sponsor decision|0
4911871|NCT00545740|16920030|P3|Overall Study|Sponsor decision|0
4911872|NCT00545740|16920031|P2|Overall Study|Sponsor decision|1
4911873|NCT00545740|16920032|P1|Overall Study|Sponsor decision|0
4911874|NCT00545740|16920029|P4|Overall Study|Accepted only monthly telephone calls|0
4911875|NCT00545740|16920030|P3|Overall Study|Accepted only monthly telephone calls|0
4911876|NCT00545740|16920031|P2|Overall Study|Accepted only monthly telephone calls|0
4911877|NCT00545740|16920032|P1|Overall Study|Accepted only monthly telephone calls|1
4911878|NCT00545740|16920029|P4|Overall Study|Physician Decision|0
4911879|NCT00545740|16920030|P3|Overall Study|Physician Decision|3
4911880|NCT00545740|16920031|P2|Overall Study|Physician Decision|0
4911881|NCT00545740|16920032|P1|Overall Study|Physician Decision|0
4911882|NCT00545740|16920029|P4|Overall Study|Missed visit|0
4911883|NCT00545740|16920030|P3|Overall Study|Missed visit|0
4911884|NCT00545740|16920031|P2|Overall Study|Missed visit|0
4911885|NCT00545740|16920032|P1|Overall Study|Missed visit|1
4911886|NCT00545740|16920029|P4|Overall Study|Site closure|0
4911887|NCT00545740|16920030|P3|Overall Study|Site closure|0
4911888|NCT00545740|16920031|P2|Overall Study|Site closure|0
4911889|NCT00545740|16920032|P1|Overall Study|Site closure|1
4911890|NCT00545740|16920029|P4|Overall Study|Suspected Diverticulitis Recurrence|1
4911891|NCT00545740|16920030|P3|Overall Study|Suspected Diverticulitis Recurrence|1
4911892|NCT00545740|16920031|P2|Overall Study|Suspected Diverticulitis Recurrence|1
4911893|NCT00545740|16920032|P1|Overall Study|Suspected Diverticulitis Recurrence|1
4911894|NCT00545740|16920029|P4|Overall Study|Diverticulitis attack|1
4911895|NCT00545740|16920030|P3|Overall Study|Diverticulitis attack|1
4911896|NCT00545740|16920031|P2|Overall Study|Diverticulitis attack|0
4911897|NCT00545740|16920032|P1|Overall Study|Diverticulitis attack|0
4911898|NCT00545740|16920029|P4|Overall Study|Moved|0
4911899|NCT00545740|16920030|P3|Overall Study|Moved|1
4911900|NCT00545740|16920031|P2|Overall Study|Moved|0
4911901|NCT00545740|16920032|P1|Overall Study|Moved|2
4911902|NCT00545740|16920029|P4|Overall Study|Non-compliance|0
4911903|NCT00545740|16920030|P3|Overall Study|Non-compliance|1
4911904|NCT00545740|16920031|P2|Overall Study|Non-compliance|2
4911905|NCT00545740|16920032|P1|Overall Study|Non-compliance|0
4911906|NCT00545740|16920029|P4|Overall Study|Protocol Violation|0
4911907|NCT00545740|16920030|P3|Overall Study|Protocol Violation|1
4911908|NCT00545740|16920031|P2|Overall Study|Protocol Violation|3
4911909|NCT00545740|16920032|P1|Overall Study|Protocol Violation|1
4911910|NCT00545740|16920029|P4|Overall Study|Lost to Follow-up|6
4911911|NCT00545740|16920030|P3|Overall Study|Lost to Follow-up|5
4911912|NCT00545740|16920031|P2|Overall Study|Lost to Follow-up|5
4911913|NCT00545740|16920032|P1|Overall Study|Lost to Follow-up|7
4911914|NCT00545740|16920029|P4|Overall Study|Adverse Event|9
4911915|NCT00545740|16920030|P3|Overall Study|Adverse Event|19
4911916|NCT00545740|16920031|P2|Overall Study|Adverse Event|18
4911917|NCT00545740|16920032|P1|Overall Study|Adverse Event|10
4911918|NCT00545740|16920029|P4|Overall Study|Withdrawal by Subject|18
4911919|NCT00545740|16920030|P3|Overall Study|Withdrawal by Subject|16
4911920|NCT00545740|16920031|P2|Overall Study|Withdrawal by Subject|15
4911921|NCT00545740|16920032|P1|Overall Study|Withdrawal by Subject|17
4911922|NCT00545740|16920029|P4|Overall Study|Lack of Efficacy|36
4911923|NCT00545740|16920030|P3|Overall Study|Lack of Efficacy|47
4911924|NCT00545740|16920031|P2|Overall Study|Lack of Efficacy|35
4911925|NCT00545740|16920032|P1|Overall Study|Lack of Efficacy|34
4911926|NCT00545714|16920066|P1|Maintenance Phase (36 Months)|Death|2
4911927|NCT00545714|16920066|P1|Maintenance Phase (36 Months)|Withdrawal by Subject|3
4911928|NCT00545714|16920066|P1|Maintenance Phase (36 Months)|Protocol Violation|1
4911929|NCT00545714|16920066|P1|Maintenance Phase (36 Months)|Physician Decision|1
4911930|NCT00545714|16920066|P1|Maintenance Phase (36 Months)|Disease Progression|9
4911931|NCT00545714|16920066|P1|Maintenance Phase (36 Months)|Unacceptable Toxicity|16
4911932|NCT00545714|16920066|P1|Induction Phase (6 Months)|Eligibility Criteria Violation|2
4911933|NCT00545714|16920066|P1|Induction Phase (6 Months)|Disease Progression|1
4911934|NCT00545714|16920066|P1|Induction Phase (6 Months)|Unacceptable Toxicity|6
4911935|NCT00545714|16920066|P1|Induction Phase (6 Months)|Physician Decision|3
4911936|NCT00545688|16920087|P4|Follow-Up Period|Violation of Selection Criteria at Entry|1
4911937|NCT00545688|16920088|P3|Follow-Up Period|Violation of Selection Criteria at Entry|0
4911938|NCT00545688|16920089|P2|Follow-Up Period|Violation of Selection Criteria at Entry|2
4911939|NCT00545688|16920090|P1|Follow-Up Period|Violation of Selection Criteria at Entry|0
4911940|NCT00545688|16920087|P4|Follow-Up Period|Unspecified Reason|8
4911941|NCT00545688|16920088|P3|Follow-Up Period|Unspecified Reason|6
4911942|NCT00545688|16920089|P2|Follow-Up Period|Unspecified Reason|5
4911943|NCT00545688|16920090|P1|Follow-Up Period|Unspecified Reason|2
4911944|NCT00545688|16920087|P4|Follow-Up Period|Lost to Follow-up|1
4911945|NCT00545688|16920088|P3|Follow-Up Period|Lost to Follow-up|3
4911946|NCT00545688|16920089|P2|Follow-Up Period|Lost to Follow-up|3
4911947|NCT00545688|16920090|P1|Follow-Up Period|Lost to Follow-up|3
4911948|NCT00545688|16920087|P4|Follow-Up Period|Refused Treatment|2
4911949|NCT00545688|16920088|P3|Follow-Up Period|Refused Treatment|0
4911950|NCT00545688|16920089|P2|Follow-Up Period|Refused Treatment|2
4911951|NCT00545688|16920090|P1|Follow-Up Period|Refused Treatment|6
4911952|NCT00545688|16920087|P4|Follow-Up Period|Disease Progression|9
4911953|NCT00545688|16920088|P3|Follow-Up Period|Disease Progression|9
4911954|NCT00545688|16920089|P2|Follow-Up Period|Disease Progression|5
4911955|NCT00545688|16920090|P1|Follow-Up Period|Disease Progression|6
4911956|NCT00545688|16920087|P4|Follow-Up Period|Death|6
4911957|NCT00545688|16920088|P3|Follow-Up Period|Death|2
4911958|NCT00545688|16920089|P2|Follow-Up Period|Death|2
4911959|NCT00545688|16920090|P1|Follow-Up Period|Death|4
4911960|NCT00545688|16920087|P4|Adjuvant Treatment Period|Unknown Reason|0
4911961|NCT00545688|16920088|P3|Adjuvant Treatment Period|Unknown Reason|0
4911962|NCT00545688|16920089|P2|Adjuvant Treatment Period|Unknown Reason|1
4911963|NCT00545688|16920090|P1|Adjuvant Treatment Period|Unknown Reason|0
4911964|NCT00545688|16920087|P4|Adjuvant Treatment Period|Adverse Event|2
4911965|NCT00545688|16920088|P3|Adjuvant Treatment Period|Adverse Event|2
4911966|NCT00545688|16920089|P2|Adjuvant Treatment Period|Adverse Event|3
4911967|NCT00545688|16920090|P1|Adjuvant Treatment Period|Adverse Event|0
4911968|NCT00545688|16920087|P4|Adjuvant Treatment Period|Lost to Follow-up|0
4911969|NCT00545688|16920088|P3|Adjuvant Treatment Period|Lost to Follow-up|1
4911970|NCT00545688|16920089|P2|Adjuvant Treatment Period|Lost to Follow-up|0
4911971|NCT00545688|16920090|P1|Adjuvant Treatment Period|Lost to Follow-up|1
4911972|NCT00545688|16920087|P4|Adjuvant Treatment Period|Refused Treatment|5
4911973|NCT00545688|16920088|P3|Adjuvant Treatment Period|Refused Treatment|1
4911974|NCT00545688|16920089|P2|Adjuvant Treatment Period|Refused Treatment|1
4911975|NCT00545688|16920090|P1|Adjuvant Treatment Period|Refused Treatment|1
4911976|NCT00545688|16920087|P4|Adjuvant Treatment Period|Disease Progression|7
4911977|NCT00545688|16920088|P3|Adjuvant Treatment Period|Disease Progression|0
4911978|NCT00545688|16920089|P2|Adjuvant Treatment Period|Disease Progression|3
4911979|NCT00545688|16920090|P1|Adjuvant Treatment Period|Disease Progression|3
4911980|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Adverse Event|2
4911981|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Adverse Event|2
4911982|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Adverse Event|0
4911983|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Adverse Event|0
4911984|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Unknown Reason|0
4911985|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Unknown Reason|0
4911986|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Unknown Reason|0
4911987|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Unknown Reason|1
4911988|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Disease Progression|2
4911989|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Disease Progression|7
4911990|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Disease Progression|1
4911991|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Disease Progression|0
4911992|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Death|0
4911993|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Death|0
4911994|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Death|1
4911995|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Death|0
4911996|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
4911997|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
4911998|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Lost to Follow-up|0
4911999|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Lost to Follow-up|1
4912000|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Refused Treatment|1
4912001|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Refused Treatment|4
4912002|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Refused Treatment|1
4912003|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Refused Treatment|1
4912004|NCT00545688|16920087|P4|Neo-Adjuvant Treatment Period|Protocol Violation|1
4912005|NCT00545688|16920088|P3|Neo-Adjuvant Treatment Period|Protocol Violation|1
4912006|NCT00545688|16920089|P2|Neo-Adjuvant Treatment Period|Protocol Violation|2
4912007|NCT00545688|16920090|P1|Neo-Adjuvant Treatment Period|Protocol Violation|1
4912008|NCT00545584|16920189|P3|Overall Study|Two or more reasons for discontinuation|8
4912009|NCT00545584|16920190|P2|Overall Study|Two or more reasons for discontinuation|19
4912010|NCT00545584|16920191|P1|Overall Study|Two or more reasons for discontinuation|17
4912011|NCT00545584|16920189|P3|Overall Study|Only one reason for discontinuation|48
4912012|NCT00545584|16920190|P2|Overall Study|Only one reason for discontinuation|61
4912013|NCT00545584|16920191|P1|Overall Study|Only one reason for discontinuation|62
4912014|NCT00545571|16920202|P1|Overall Study|Kidney Transplantation|3
4912015|NCT00545571|16920202|P1|Overall Study|Early Termination of Study|24
4912016|NCT00545571|16920202|P1|Overall Study|Transfusion|12
4912017|NCT00545571|16920202|P1|Overall Study|Screen Failure|16
4912018|NCT00545571|16920202|P1|Overall Study|Refused Treatment|1
4912019|NCT00545571|16920202|P1|Overall Study|Protocol Violation|2
4912020|NCT00545571|16920202|P1|Overall Study|Lack of Efficacy|1
4912021|NCT00545571|16920202|P1|Overall Study|Death|5
4912022|NCT00545571|16920202|P1|Overall Study|Adverse Event|2
4912023|NCT00545571|16920202|P1|Overall Study|Administrative Reasons|1
4912024|NCT00545532|16920217|P2|Overall Study|Death|1
4912025|NCT00545532|16920218|P1|Overall Study|Death|0
4912026|NCT00545532|16920217|P2|Overall Study|Lost to Follow-up|6
4912027|NCT00545532|16920218|P1|Overall Study|Lost to Follow-up|5
4912028|NCT00545532|16920217|P2|Overall Study|Withdrawal by Subject|3
4912029|NCT00545532|16920218|P1|Overall Study|Withdrawal by Subject|1
4912030|NCT00545441|16920309|P2|Overall Study|Patients were not treated|3
4912031|NCT00545441|16920310|P1|Overall Study|Patients were not treated|1
4912032|NCT00545441|16920309|P2|Overall Study|Persistence or recurrence of fistula|2
4912033|NCT00545441|16920310|P1|Overall Study|Persistence or recurrence of fistula|5
4912034|NCT00545441|16920309|P2|Overall Study|Withdrawal by Subject|1
4912035|NCT00545441|16920310|P1|Overall Study|Withdrawal by Subject|1
4912036|NCT00545441|16920309|P2|Overall Study|Technical failure|1
4912037|NCT00545441|16920310|P1|Overall Study|Technical failure|0
4912038|NCT00545441|16920309|P2|Overall Study|Lost to Follow-up|5
4912039|NCT00545441|16920310|P1|Overall Study|Lost to Follow-up|9
4912040|NCT00545441|16920309|P2|Overall Study|Fistula draining at 6 months|4
4912041|NCT00545441|16920310|P1|Overall Study|Fistula draining at 6 months|2
4912042|NCT00545402|16920318|P2|Overall Study|Reason not specified|1
4912043|NCT00545402|16920319|P1|Overall Study|Reason not specified|1
4912044|NCT00545402|16920318|P2|Overall Study|Protocol Violation|0
4912045|NCT00545402|16920319|P1|Overall Study|Protocol Violation|1
4912046|NCT00545402|16920318|P2|Overall Study|Withdrawal by Subject|1
4912047|NCT00545402|16920319|P1|Overall Study|Withdrawal by Subject|0
4912048|NCT00545402|16920318|P2|Overall Study|Graft loss|4
4912049|NCT00545402|16920319|P1|Overall Study|Graft loss|2
4912050|NCT00545402|16920318|P2|Overall Study|Death|7
4912051|NCT00545402|16920319|P1|Overall Study|Death|5
4912052|NCT00545402|16920318|P2|Overall Study|Use of unauthorized immunosuppressant|7
4912053|NCT00545402|16920319|P1|Overall Study|Use of unauthorized immunosuppressant|8
4912054|NCT00545402|16920318|P2|Overall Study|Discontinuation of treatment|9
4912055|NCT00545402|16920319|P1|Overall Study|Discontinuation of treatment|17
4912056|NCT00545363|16920337|P2|Overall Study|Other|1
4912057|NCT00545363|16920338|P1|Overall Study|Other|1
4912058|NCT00545363|16920337|P2|Overall Study|Lost to Follow-up|0
4912059|NCT00545363|16920338|P1|Overall Study|Lost to Follow-up|2
4912060|NCT00545363|16920337|P2|Overall Study|Did not meet entry criteria|1
4912061|NCT00545363|16920338|P1|Overall Study|Did not meet entry criteria|1
4912062|NCT00545363|16920337|P2|Overall Study|Non-compliance|1
4912063|NCT00545363|16920338|P1|Overall Study|Non-compliance|3
4912064|NCT00545363|16920337|P2|Overall Study|Withdrawal by Subject|5
4912065|NCT00545363|16920338|P1|Overall Study|Withdrawal by Subject|6
4912066|NCT00545363|16920337|P2|Overall Study|Adverse Event|7
4912067|NCT00545363|16920338|P1|Overall Study|Adverse Event|6
4912068|NCT00545298|16920353|P3|Overall Study|Issues with Standard of Care|1
4912069|NCT00545298|16920354|P2|Overall Study|Issues with Standard of Care|0
4912070|NCT00545298|16920355|P1|Overall Study|Issues with Standard of Care|2
4912071|NCT00545272|16920372|P6|Overall Study|Lost to Follow-up|0
4912072|NCT00545272|16920373|P5|Overall Study|Lost to Follow-up|1
4912073|NCT00545272|16920374|P4|Overall Study|Lost to Follow-up|0
4912074|NCT00545272|16920375|P3|Overall Study|Lost to Follow-up|0
4912075|NCT00545272|16920376|P2|Overall Study|Lost to Follow-up|0
4912076|NCT00545272|16920377|P1|Overall Study|Lost to Follow-up|0
4912077|NCT00545272|16920372|P6|Overall Study|Abnormal test procedure result(s)|0
4912078|NCT00545272|16920373|P5|Overall Study|Abnormal test procedure result(s)|1
4912079|NCT00545272|16920374|P4|Overall Study|Abnormal test procedure result(s)|0
4912080|NCT00545272|16920375|P3|Overall Study|Abnormal test procedure result(s)|0
4912081|NCT00545272|16920376|P2|Overall Study|Abnormal test procedure result(s)|0
4912082|NCT00545272|16920377|P1|Overall Study|Abnormal test procedure result(s)|0
4912083|NCT00545272|16920372|P6|Overall Study|Abnormal laboratory value(s)|1
4912084|NCT00545272|16920373|P5|Overall Study|Abnormal laboratory value(s)|0
4912085|NCT00545272|16920374|P4|Overall Study|Abnormal laboratory value(s)|0
4912086|NCT00545272|16920375|P3|Overall Study|Abnormal laboratory value(s)|0
4912087|NCT00545272|16920376|P2|Overall Study|Abnormal laboratory value(s)|0
4912088|NCT00545272|16920377|P1|Overall Study|Abnormal laboratory value(s)|0
4912089|NCT00545272|16920372|P6|Overall Study|Adverse Event|1
4912090|NCT00545272|16920373|P5|Overall Study|Adverse Event|0
4912091|NCT00545272|16920374|P4|Overall Study|Adverse Event|0
4912092|NCT00545272|16920375|P3|Overall Study|Adverse Event|1
4912093|NCT00545272|16920376|P2|Overall Study|Adverse Event|0
4912094|NCT00545272|16920377|P1|Overall Study|Adverse Event|0
4912095|NCT00545272|16920372|P6|Overall Study|Protocol deviation|1
4912096|NCT00545272|16920373|P5|Overall Study|Protocol deviation|0
4912097|NCT00545272|16920374|P4|Overall Study|Protocol deviation|1
4912098|NCT00545272|16920375|P3|Overall Study|Protocol deviation|0
4912099|NCT00545272|16920376|P2|Overall Study|Protocol deviation|1
4912100|NCT00545272|16920377|P1|Overall Study|Protocol deviation|0
4912101|NCT00545233|16920429|P2|Overall Study|Physician Decision|1
4912102|NCT00545233|16920430|P1|Overall Study|Physician Decision|2
4912103|NCT00545233|16920429|P2|Overall Study|Insufficient response|15
4912104|NCT00545233|16920430|P1|Overall Study|Insufficient response|14
4912105|NCT00545233|16920429|P2|Overall Study|Failure to Return|6
4912106|NCT00545233|16920430|P1|Overall Study|Failure to Return|4
4912107|NCT00545233|16920429|P2|Overall Study|Refused Treatment|7
4912108|NCT00545233|16920430|P1|Overall Study|Refused Treatment|9
4912109|NCT00545233|16920429|P2|Overall Study|Protocol Violation|0
4912110|NCT00545233|16920430|P1|Overall Study|Protocol Violation|2
4912111|NCT00545233|16920429|P2|Overall Study|Violation of Selection Criteria at Entry|1
4912112|NCT00545233|16920430|P1|Overall Study|Violation of Selection Criteria at Entry|5
4912113|NCT00545233|16920429|P2|Overall Study|Adverse Event|5
4912114|NCT00545233|16920430|P1|Overall Study|Adverse Event|10
4912115|NCT00545168|16920489|P3|Overall Study|Visit for Day 21 was not done in error|2
4912116|NCT00545168|16920490|P2|Overall Study|Visit for Day 21 was not done in error|0
4912117|NCT00545168|16920491|P1|Overall Study|Visit for Day 21 was not done in error|1
4912118|NCT00545168|16920489|P3|Overall Study|Protocol Violation|1
4912119|NCT00545168|16920490|P2|Overall Study|Protocol Violation|0
4912120|NCT00545168|16920491|P1|Overall Study|Protocol Violation|1
4912121|NCT00545168|16920489|P3|Overall Study|Withdrawal by Subject|13
4912122|NCT00545168|16920490|P2|Overall Study|Withdrawal by Subject|0
4912123|NCT00545168|16920491|P1|Overall Study|Withdrawal by Subject|9
4912124|NCT00545168|16920489|P3|Overall Study|Lost to Follow-up|5
4912125|NCT00545168|16920490|P2|Overall Study|Lost to Follow-up|5
4912126|NCT00545168|16920491|P1|Overall Study|Lost to Follow-up|5
4912127|NCT00545103|16920517|P4|Overall Study|Death|0
4912128|NCT00545103|16920518|P3|Overall Study|Death|0
4912129|NCT00545103|16920519|P2|Overall Study|Death|1
4912130|NCT00545103|16920520|P1|Overall Study|Death|0
4912131|NCT00545103|16920517|P4|Overall Study|Subject met endpoint under protocol v. 1|0
4912132|NCT00545103|16920518|P3|Overall Study|Subject met endpoint under protocol v. 1|1
4912133|NCT00545103|16920519|P2|Overall Study|Subject met endpoint under protocol v. 1|0
4912134|NCT00545103|16920520|P1|Overall Study|Subject met endpoint under protocol v. 1|0
4912135|NCT00545103|16920517|P4|Overall Study|Does not want to take study drug anymore|0
4912136|NCT00545103|16920518|P3|Overall Study|Does not want to take study drug anymore|1
4912137|NCT00545103|16920519|P2|Overall Study|Does not want to take study drug anymore|0
4912138|NCT00545103|16920520|P1|Overall Study|Does not want to take study drug anymore|1
4912139|NCT00545103|16920517|P4|Overall Study|Use of prohibited medication|0
4912140|NCT00545103|16920518|P3|Overall Study|Use of prohibited medication|1
4912141|NCT00545103|16920519|P2|Overall Study|Use of prohibited medication|0
4912142|NCT00545103|16920520|P1|Overall Study|Use of prohibited medication|0
4912143|NCT00545103|16920517|P4|Overall Study|Subject moved|0
4912144|NCT00545103|16920518|P3|Overall Study|Subject moved|0
4912145|NCT00545103|16920519|P2|Overall Study|Subject moved|1
4912146|NCT00545103|16920520|P1|Overall Study|Subject moved|0
4912147|NCT00545103|16920517|P4|Overall Study|Investigator decision|0
4912148|NCT00545103|16920518|P3|Overall Study|Investigator decision|1
4912149|NCT00545103|16920519|P2|Overall Study|Investigator decision|0
4912150|NCT00545103|16920520|P1|Overall Study|Investigator decision|0
4912151|NCT00545103|16920517|P4|Overall Study|Noncompliance|0
4912152|NCT00545103|16920518|P3|Overall Study|Noncompliance|0
4912153|NCT00545103|16920519|P2|Overall Study|Noncompliance|1
4912154|NCT00545103|16920520|P1|Overall Study|Noncompliance|0
4912155|NCT00545103|16920517|P4|Overall Study|Subject's decision|0
4912156|NCT00545103|16920518|P3|Overall Study|Subject's decision|0
4912157|NCT00545103|16920519|P2|Overall Study|Subject's decision|0
4912158|NCT00545103|16920520|P1|Overall Study|Subject's decision|1
4912159|NCT00545103|16920517|P4|Overall Study|Personal reasons|0
4912160|NCT00545103|16920518|P3|Overall Study|Personal reasons|0
4912161|NCT00545103|16920519|P2|Overall Study|Personal reasons|0
4912162|NCT00545103|16920520|P1|Overall Study|Personal reasons|1
4912163|NCT00545103|16920517|P4|Overall Study|Diverticulitis crisis|1
4912164|NCT00545103|16920518|P3|Overall Study|Diverticulitis crisis|0
4912165|NCT00545103|16920519|P2|Overall Study|Diverticulitis crisis|0
4912166|NCT00545103|16920520|P1|Overall Study|Diverticulitis crisis|0
4912167|NCT00545103|16920517|P4|Overall Study|Wish to start a family|1
4912168|NCT00545103|16920518|P3|Overall Study|Wish to start a family|0
4912169|NCT00545103|16920519|P2|Overall Study|Wish to start a family|0
4912170|NCT00545103|16920520|P1|Overall Study|Wish to start a family|0
4912171|NCT00545103|16920517|P4|Overall Study|Investigational product not taken|1
4912172|NCT00545103|16920518|P3|Overall Study|Investigational product not taken|0
4912173|NCT00545103|16920519|P2|Overall Study|Investigational product not taken|0
4912174|NCT00545103|16920520|P1|Overall Study|Investigational product not taken|1
4912175|NCT00545103|16920517|P4|Overall Study|Difficult to open package|1
4912176|NCT00545103|16920518|P3|Overall Study|Difficult to open package|0
4912177|NCT00545103|16920519|P2|Overall Study|Difficult to open package|0
4912178|NCT00545103|16920520|P1|Overall Study|Difficult to open package|0
4912179|NCT00545103|16920517|P4|Overall Study|Suspected recurrence of diverticulitis|3
4912180|NCT00545103|16920518|P3|Overall Study|Suspected recurrence of diverticulitis|0
4912181|NCT00545103|16920519|P2|Overall Study|Suspected recurrence of diverticulitis|0
4912182|NCT00545103|16920520|P1|Overall Study|Suspected recurrence of diverticulitis|1
4912183|NCT00545103|16920517|P4|Overall Study|Protocol Violation|0
4912184|NCT00545103|16920518|P3|Overall Study|Protocol Violation|3
4912185|NCT00545103|16920519|P2|Overall Study|Protocol Violation|2
4912186|NCT00545103|16920520|P1|Overall Study|Protocol Violation|1
4912187|NCT00545103|16920517|P4|Overall Study|Lost to Follow-up|4
4912188|NCT00545103|16920518|P3|Overall Study|Lost to Follow-up|3
4912189|NCT00545103|16920519|P2|Overall Study|Lost to Follow-up|6
4912190|NCT00545103|16920520|P1|Overall Study|Lost to Follow-up|4
4912191|NCT00545103|16920517|P4|Overall Study|Adverse Event|10
4912192|NCT00545103|16920518|P3|Overall Study|Adverse Event|17
4912193|NCT00545103|16920519|P2|Overall Study|Adverse Event|12
4912194|NCT00545103|16920520|P1|Overall Study|Adverse Event|11
4912195|NCT00545103|16920517|P4|Overall Study|Withdrawal by Subject|22
4912196|NCT00545103|16920518|P3|Overall Study|Withdrawal by Subject|18
4912197|NCT00545103|16920519|P2|Overall Study|Withdrawal by Subject|10
4912198|NCT00545103|16920520|P1|Overall Study|Withdrawal by Subject|6
4912199|NCT00545103|16920517|P4|Overall Study|Lack of Efficacy|27
4912200|NCT00545103|16920518|P3|Overall Study|Lack of Efficacy|31
4912201|NCT00545103|16920519|P2|Overall Study|Lack of Efficacy|45
4912202|NCT00545103|16920520|P1|Overall Study|Lack of Efficacy|48
4912203|NCT00545077|16920556|P2|Overall Study|Death|8
4912204|NCT00545077|16920557|P1|Overall Study|Death|0
4912205|NCT00545077|16920556|P2|Overall Study|Adverse Event|31
4912206|NCT00545077|16920557|P1|Overall Study|Adverse Event|0
4912207|NCT00545077|16920556|P2|Overall Study|Protocol Violation|0
4912208|NCT00545077|16920557|P1|Overall Study|Protocol Violation|1
4912209|NCT00545077|16920556|P2|Overall Study|Lost to Follow-up|0
4912210|NCT00545077|16920557|P1|Overall Study|Lost to Follow-up|2
4912211|NCT00545077|16920556|P2|Overall Study|Physician Decision|3
4912212|NCT00545077|16920557|P1|Overall Study|Physician Decision|6
4912213|NCT00545077|16920556|P2|Overall Study|Withdrawal by Subject|14
4912214|NCT00545077|16920557|P1|Overall Study|Withdrawal by Subject|3
4912215|NCT00545077|16920556|P2|Overall Study|Disease Progression|98
4912216|NCT00545077|16920557|P1|Overall Study|Disease Progression|131
4912217|NCT00545077|16920556|P2|Overall Study|Treatment not received|1
4912218|NCT00545077|16920557|P1|Overall Study|Treatment not received|5
4912219|NCT00545064|16920573|P1|Overall Study|inclement weather|1
4912220|NCT00545064|16920573|P1|Overall Study|cancel all appointments, no rebooking|1
4912221|NCT00545064|16920573|P1|Overall Study|did not complete course of treatment|1
4912222|NCT00545064|16920573|P1|Overall Study|Withdrawal by Subject|2
4912223|NCT00545064|16920573|P1|Overall Study|Lost to Follow-up|3
4912224|NCT00545051|16920584|P2|Overall Study|Administrative reasons|1
4912225|NCT00545051|16920585|P1|Overall Study|Administrative reasons|0
4912226|NCT00545051|16920584|P2|Overall Study|Withdrawal by Subject|1
4912227|NCT00545051|16920585|P1|Overall Study|Withdrawal by Subject|0
4912228|NCT00545051|16920584|P2|Overall Study|Protocol Violation|0
4912229|NCT00545051|16920585|P1|Overall Study|Protocol Violation|1
4912230|NCT00545051|16920584|P2|Overall Study|Violation of inclusion/exclusion|2
4912231|NCT00545051|16920585|P1|Overall Study|Violation of inclusion/exclusion|0
4912232|NCT00545051|16920584|P2|Overall Study|Death|0
4912233|NCT00545051|16920585|P1|Overall Study|Death|1
4912234|NCT00545051|16920584|P2|Overall Study|Adverse Event|3
4912235|NCT00545051|16920585|P1|Overall Study|Adverse Event|7
4912236|NCT00544882|16920629|P3|Cycle 3: Follow-up|Pregnancy|0
4912237|NCT00544882|16920630|P2|Cycle 3: Follow-up|Pregnancy|1
4912238|NCT00544882|16920631|P1|Cycle 3: Follow-up|Pregnancy|0
4912239|NCT00544882|16920629|P3|Cycle 3: Follow-up|Noncompliance|0
4912240|NCT00544882|16920630|P2|Cycle 3: Follow-up|Noncompliance|1
4912241|NCT00544882|16920631|P1|Cycle 3: Follow-up|Noncompliance|0
4912242|NCT00544882|16920629|P3|Cycle 2: Randomized Treatment Cycle|Noncompliance|1
4912243|NCT00544882|16920630|P2|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
4912244|NCT00544882|16920631|P1|Cycle 2: Randomized Treatment Cycle|Noncompliance|0
4912245|NCT00544882|16920629|P3|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
4912246|NCT00544882|16920630|P2|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1
4912247|NCT00544882|16920631|P1|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0
4912248|NCT00544882|16920629|P3|Cycle 1: Run-in Cycle|Adverse Event|0
4912249|NCT00544882|16920630|P2|Cycle 1: Run-in Cycle|Adverse Event|0
4912250|NCT00544882|16920631|P1|Cycle 1: Run-in Cycle|Adverse Event|1
4912251|NCT00544882|16920629|P3|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
4912252|NCT00544882|16920630|P2|Cycle 1: Run-in Cycle|Withdrawal by Subject|0
4912253|NCT00544882|16920631|P1|Cycle 1: Run-in Cycle|Withdrawal by Subject|2
4912254|NCT00544869|16920656|P3|Overall Study|Physician Decision|0
4912255|NCT00544869|16920657|P2|Overall Study|Physician Decision|0
4912256|NCT00544869|16920658|P1|Overall Study|Physician Decision|2
4912257|NCT00544869|16920656|P3|Overall Study|Lack of Efficacy|0
4912258|NCT00544869|16920657|P2|Overall Study|Lack of Efficacy|1
4912259|NCT00544869|16920658|P1|Overall Study|Lack of Efficacy|1
4912260|NCT00544869|16920656|P3|Overall Study|Adverse Event|0
4912261|NCT00544869|16920657|P2|Overall Study|Adverse Event|1
4912262|NCT00544869|16920658|P1|Overall Study|Adverse Event|6
4912263|NCT00544869|16920656|P3|Overall Study|Rsolution of congenitive symptoms|0
4912264|NCT00544869|16920657|P2|Overall Study|Rsolution of congenitive symptoms|0
4912265|NCT00544869|16920658|P1|Overall Study|Rsolution of congenitive symptoms|3
4912266|NCT00544817|16920666|P1|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1
4912267|NCT00544817|16920666|P1|Follow-up Systemic Therapy|Physician Decision|3
4912268|NCT00544817|16920666|P1|Follow-up Systemic Therapy|Lack of Efficacy|15
4912269|NCT00544817|16920666|P1|No Treatment Interval|Adverse Event|1
4912270|NCT00544817|16920666|P1|No Treatment Interval|Physician Decision|3
4912271|NCT00544817|16920666|P1|No Treatment Interval|Lack of Efficacy|8
4912272|NCT00544817|16920666|P1|Combined Modality|Intercurrent Illness - Pneumonia|1
4912273|NCT00544817|16920666|P1|Combined Modality|Adverse Event|2
4912274|NCT00544817|16920666|P1|Combined Modality|Worsening Neurologic Symptoms|2
4912275|NCT00544817|16920666|P1|Combined Modality|Lack of Efficacy|2
4912276|NCT00544648|16920715|P2|Overall Study|progression of disease|0
4912277|NCT00544648|16920716|P1|Overall Study|progression of disease|1
4912278|NCT00544648|16920715|P2|Overall Study|Adverse Event|1
4912279|NCT00544648|16920716|P1|Overall Study|Adverse Event|1
4912280|NCT00544648|16920715|P2|Overall Study|Withdrawal by Subject|0
4912281|NCT00544648|16920716|P1|Overall Study|Withdrawal by Subject|1
4912282|NCT00544557|16920730|P1|Overall Study|Other|98
4912283|NCT00544557|16920730|P1|Overall Study|Lack of Efficacy|196
4912284|NCT00544557|16920730|P1|Overall Study|Adverse Event|140
4912285|NCT00544544|16920761|P1|Overall Study|Lost to Follow-up|1
4912286|NCT00544544|16920761|P1|Overall Study|Adverse Event|1
4912287|NCT00544544|16920761|P1|Overall Study|Withdrawal by Subject|1
4912288|NCT00544440|16920768|P1|Overall Study|Other|5
4912289|NCT00544440|16920768|P1|Overall Study|Progressive Disease|47
4912290|NCT00544440|16920768|P1|Overall Study|Subject Non-compliance|1
4912291|NCT00544440|16920768|P1|Overall Study|Withdrawal by Subject|2
4912292|NCT00544440|16920768|P1|Overall Study|Adverse Event|1
4912293|NCT00544440|16920768|P1|Overall Study|Other|1
4912294|NCT00544167|16920775|P1|Overall Study|Physician Decision|8
4912295|NCT00544167|16920775|P1|Overall Study|Adverse Event|21
4912296|NCT00543985|16920801|P1|Overall Study|Withdrawal by Subject|4
4912297|NCT00543855|16920812|P4|Overall Study|Protocol Violation|0
4912298|NCT00543855|16920813|P3|Overall Study|Protocol Violation|0
4912299|NCT00543855|16920814|P2|Overall Study|Protocol Violation|0
4912300|NCT00543855|16920815|P1|Overall Study|Protocol Violation|1
4912301|NCT00543855|16920812|P4|Overall Study|Withdrawal by Subject|0
4912302|NCT00543855|16920813|P3|Overall Study|Withdrawal by Subject|2
4912303|NCT00543855|16920814|P2|Overall Study|Withdrawal by Subject|1
4912304|NCT00543855|16920815|P1|Overall Study|Withdrawal by Subject|0
4912305|NCT00543855|16920812|P4|Overall Study|Lost to Follow-up|0
4912306|NCT00543855|16920813|P3|Overall Study|Lost to Follow-up|1
4912307|NCT00543855|16920814|P2|Overall Study|Lost to Follow-up|0
4912308|NCT00543855|16920815|P1|Overall Study|Lost to Follow-up|0
4912309|NCT00543855|16920812|P4|Overall Study|Adverse Event|4
4912310|NCT00543855|16920813|P3|Overall Study|Adverse Event|3
4912311|NCT00543855|16920814|P2|Overall Study|Adverse Event|1
4912312|NCT00543855|16920815|P1|Overall Study|Adverse Event|3
4912313|NCT00543803|16920837|P1|Overall Study|Other|86
4912314|NCT00543803|16920837|P1|Overall Study|Lost to Follow-up|20
4912315|NCT00543803|16920837|P1|Overall Study|Lack of Efficacy|22
4912316|NCT00543803|16920837|P1|Overall Study|Adverse Event|14
4912317|NCT00543725|16920865|P2|Overall Study|Other|3
4912318|NCT00543725|16920866|P1|Overall Study|Other|3
4912319|NCT00543725|16920865|P2|Overall Study|Lost to Follow-up|11
4912320|NCT00543725|16920866|P1|Overall Study|Lost to Follow-up|15
4912321|NCT00543725|16920865|P2|Overall Study|Withdrawal by Subject|13
4912322|NCT00543725|16920866|P1|Overall Study|Withdrawal by Subject|4
4912323|NCT00543725|16920865|P2|Overall Study|Protocol Violation|1
4912324|NCT00543725|16920866|P1|Overall Study|Protocol Violation|0
4912325|NCT00543725|16920865|P2|Overall Study|Subject Reached A Virologic Endpoint|14
4912326|NCT00543725|16920866|P1|Overall Study|Subject Reached A Virologic Endpoint|22
4912327|NCT00543725|16920865|P2|Overall Study|Subject Ineligible To Continue The Trial|0
4912328|NCT00543725|16920866|P1|Overall Study|Subject Ineligible To Continue The Trial|2
4912329|NCT00543725|16920865|P2|Overall Study|Subject Non-Compliant|4
4912330|NCT00543725|16920866|P1|Overall Study|Subject Non-Compliant|4
4912331|NCT00543725|16920865|P2|Overall Study|Sponsor's Decision|1
4912332|NCT00543725|16920866|P1|Overall Study|Sponsor's Decision|0
4912333|NCT00543725|16920865|P2|Overall Study|Adverse Event|27
4912334|NCT00543725|16920866|P1|Overall Study|Adverse Event|18
4912335|NCT00543569|16920892|P4|Overall Study|Randomized but never received study drug|3
4912336|NCT00543569|16920893|P3|Overall Study|Randomized but never received study drug|5
4912337|NCT00543569|16920894|P2|Overall Study|Randomized but never received study drug|3
4912338|NCT00543569|16920895|P1|Overall Study|Randomized but never received study drug|3
4912339|NCT00543569|16920892|P4|Overall Study|Miscellaneous Reasons|4
4912340|NCT00543569|16920893|P3|Overall Study|Miscellaneous Reasons|11
4912341|NCT00543569|16920894|P2|Overall Study|Miscellaneous Reasons|3
4912342|NCT00543569|16920895|P1|Overall Study|Miscellaneous Reasons|7
4912343|NCT00543569|16920892|P4|Overall Study|Lost to Follow-up|1
4912344|NCT00543569|16920893|P3|Overall Study|Lost to Follow-up|1
4912345|NCT00543569|16920894|P2|Overall Study|Lost to Follow-up|0
4912346|NCT00543569|16920895|P1|Overall Study|Lost to Follow-up|0
4912347|NCT00543569|16920892|P4|Overall Study|Death|1
4912348|NCT00543569|16920893|P3|Overall Study|Death|3
4912349|NCT00543569|16920894|P2|Overall Study|Death|2
4912350|NCT00543569|16920895|P1|Overall Study|Death|2
4912351|NCT00543543|16921001|P4|Extension Study|Withdrawal by Subject|120
4912352|NCT00543543|16921002|P3|Extension Study|Withdrawal by Subject|0
4912353|NCT00543543|16921003|P2|Extension Study|Withdrawal by Subject|0
4912354|NCT00543543|16921004|P1|Extension Study|Withdrawal by Subject|0
4912355|NCT00543543|16921001|P4|Extension Study|Protocol Violation|11
4912356|NCT00543543|16921002|P3|Extension Study|Protocol Violation|0
4912357|NCT00543543|16921003|P2|Extension Study|Protocol Violation|0
4912358|NCT00543543|16921004|P1|Extension Study|Protocol Violation|0
4912359|NCT00543543|16921001|P4|Extension Study|Pregnancy|6
4912360|NCT00543543|16921002|P3|Extension Study|Pregnancy|0
4912361|NCT00543543|16921003|P2|Extension Study|Pregnancy|0
4912362|NCT00543543|16921004|P1|Extension Study|Pregnancy|0
4912363|NCT00543543|16921001|P4|Extension Study|Physician Decision|7
4912364|NCT00543543|16921002|P3|Extension Study|Physician Decision|0
4912365|NCT00543543|16921003|P2|Extension Study|Physician Decision|0
4912366|NCT00543543|16921004|P1|Extension Study|Physician Decision|0
4912367|NCT00543543|16921001|P4|Extension Study|Lost to Follow-up|77
4912368|NCT00543543|16921002|P3|Extension Study|Lost to Follow-up|0
4912369|NCT00543543|16921003|P2|Extension Study|Lost to Follow-up|0
4912370|NCT00543543|16921004|P1|Extension Study|Lost to Follow-up|0
4912371|NCT00543543|16921001|P4|Extension Study|Adverse Event|5
4912372|NCT00543543|16921002|P3|Extension Study|Adverse Event|0
4912373|NCT00543543|16921003|P2|Extension Study|Adverse Event|0
4912374|NCT00543543|16921004|P1|Extension Study|Adverse Event|0
4912375|NCT00543543|16921001|P4|Base Study|Withdrawal by Subject|503
4912376|NCT00543543|16921002|P3|Base Study|Withdrawal by Subject|5
4912377|NCT00543543|16921003|P2|Base Study|Withdrawal by Subject|482
4912378|NCT00543543|16921004|P1|Base Study|Withdrawal by Subject|7
4912379|NCT00543543|16921001|P4|Base Study|Protocol Violation|6
4912380|NCT00543543|16921002|P3|Base Study|Protocol Violation|0
4912381|NCT00543543|16921003|P2|Base Study|Protocol Violation|6
4912382|NCT00543543|16921004|P1|Base Study|Protocol Violation|0
4912383|NCT00543543|16921001|P4|Base Study|Physician Decision|7
4912384|NCT00543543|16921002|P3|Base Study|Physician Decision|0
4912385|NCT00543543|16921003|P2|Base Study|Physician Decision|4
4912386|NCT00543543|16921004|P1|Base Study|Physician Decision|0
4912387|NCT00543543|16921001|P4|Base Study|Lost to Follow-up|701
4912388|NCT00543543|16921002|P3|Base Study|Lost to Follow-up|9
4912389|NCT00543543|16921003|P2|Base Study|Lost to Follow-up|749
4912390|NCT00543543|16921004|P1|Base Study|Lost to Follow-up|12
4912391|NCT00543543|16921001|P4|Base Study|Adverse Event|5
4912392|NCT00543543|16921002|P3|Base Study|Adverse Event|0
4912393|NCT00543543|16921003|P2|Base Study|Adverse Event|11
4912394|NCT00543543|16921004|P1|Base Study|Adverse Event|1
4912395|NCT00543439|16921048|P3|Period 2|Adverse Event|1
4912396|NCT00543439|16921049|P2|Period 2|Adverse Event|1
4912397|NCT00543439|16921050|P1|Period 2|Adverse Event|0
4912398|NCT00543439|16921048|P3|Period 2|Protocol Violation|1
4912399|NCT00543439|16921049|P2|Period 2|Protocol Violation|0
4912400|NCT00543439|16921050|P1|Period 2|Protocol Violation|1
4912401|NCT00543439|16921048|P3|Period 1|Physician Decision|1
4912402|NCT00543439|16921049|P2|Period 1|Physician Decision|0
4912403|NCT00543439|16921050|P1|Period 1|Physician Decision|0
4912404|NCT00543439|16921048|P3|Period 1|Withdrawal by Subject|0
4912405|NCT00543439|16921049|P2|Period 1|Withdrawal by Subject|1
4912406|NCT00543439|16921050|P1|Period 1|Withdrawal by Subject|1
4912407|NCT00543439|16921048|P3|Period 1|Adverse Event|1
4912408|NCT00543439|16921049|P2|Period 1|Adverse Event|2
4912409|NCT00543439|16921050|P1|Period 1|Adverse Event|0
4912410|NCT00543387|16921119|P11|Crossover Participants|Study Terminated by Sponsor|1
4912411|NCT00543387|16921120|P10|Crossover Participants|Study Terminated by Sponsor|0
4912412|NCT00543387|16921121|P9|Crossover Participants|Study Terminated by Sponsor|0
4912413|NCT00543387|16921122|P8|Crossover Participants|Study Terminated by Sponsor|0
4912414|NCT00543387|16921123|P7|Crossover Participants|Study Terminated by Sponsor|0
4912415|NCT00543387|16921124|P6|Crossover Participants|Study Terminated by Sponsor|0
4912416|NCT00543387|16921125|P5|Crossover Participants|Study Terminated by Sponsor|0
4912417|NCT00543387|16921126|P4|Crossover Participants|Study Terminated by Sponsor|0
4912418|NCT00543387|16921127|P3|Crossover Participants|Study Terminated by Sponsor|0
4912419|NCT00543387|16921128|P2|Crossover Participants|Study Terminated by Sponsor|0
4912420|NCT00543387|16921129|P1|Crossover Participants|Study Terminated by Sponsor|0
4912421|NCT00543387|16921119|P11|Crossover Participants|Progressive Disease|2
4912422|NCT00543387|16921120|P10|Crossover Participants|Progressive Disease|1
4912423|NCT00543387|16921121|P9|Crossover Participants|Progressive Disease|0
4912424|NCT00543387|16921122|P8|Crossover Participants|Progressive Disease|0
4912425|NCT00543387|16921123|P7|Crossover Participants|Progressive Disease|0
4912426|NCT00543387|16921124|P6|Crossover Participants|Progressive Disease|0
4912427|NCT00543387|16921125|P5|Crossover Participants|Progressive Disease|0
4912428|NCT00543387|16921126|P4|Crossover Participants|Progressive Disease|0
4912429|NCT00543387|16921127|P3|Crossover Participants|Progressive Disease|0
4912430|NCT00543387|16921128|P2|Crossover Participants|Progressive Disease|0
4912431|NCT00543387|16921129|P1|Crossover Participants|Progressive Disease|0
4912432|NCT00543387|16921119|P11|Panel 1 + Panel 2|Withdrawal by Subject|0
4912433|NCT00543387|16921120|P10|Panel 1 + Panel 2|Withdrawal by Subject|0
4912434|NCT00543387|16921121|P9|Panel 1 + Panel 2|Withdrawal by Subject|0
4912435|NCT00543387|16921122|P8|Panel 1 + Panel 2|Withdrawal by Subject|0
4912436|NCT00543387|16921123|P7|Panel 1 + Panel 2|Withdrawal by Subject|1
4912437|NCT00543387|16921124|P6|Panel 1 + Panel 2|Withdrawal by Subject|0
4912438|NCT00543387|16921125|P5|Panel 1 + Panel 2|Withdrawal by Subject|0
4912439|NCT00543387|16921126|P4|Panel 1 + Panel 2|Withdrawal by Subject|0
4912440|NCT00543387|16921127|P3|Panel 1 + Panel 2|Withdrawal by Subject|0
4912441|NCT00543387|16921128|P2|Panel 1 + Panel 2|Withdrawal by Subject|0
4912442|NCT00543387|16921129|P1|Panel 1 + Panel 2|Withdrawal by Subject|0
4912443|NCT00543387|16921119|P11|Panel 1 + Panel 2|Progressive Disease (PD)|0
4912444|NCT00543387|16921120|P10|Panel 1 + Panel 2|Progressive Disease (PD)|0
4912445|NCT00543387|16921121|P9|Panel 1 + Panel 2|Progressive Disease (PD)|4
4912446|NCT00543387|16921122|P8|Panel 1 + Panel 2|Progressive Disease (PD)|4
4912447|NCT00543387|16921123|P7|Panel 1 + Panel 2|Progressive Disease (PD)|5
4912448|NCT00543387|16921124|P6|Panel 1 + Panel 2|Progressive Disease (PD)|3
4912449|NCT00543387|16921125|P5|Panel 1 + Panel 2|Progressive Disease (PD)|3
4912450|NCT00543387|16921126|P4|Panel 1 + Panel 2|Progressive Disease (PD)|3
4912451|NCT00543387|16921127|P3|Panel 1 + Panel 2|Progressive Disease (PD)|2
4912452|NCT00543387|16921128|P2|Panel 1 + Panel 2|Progressive Disease (PD)|2
4912453|NCT00543387|16921129|P1|Panel 1 + Panel 2|Progressive Disease (PD)|3
4912454|NCT00543387|16921119|P11|Panel 1 + Panel 2|Physician Decision|0
4912455|NCT00543387|16921120|P10|Panel 1 + Panel 2|Physician Decision|0
4912456|NCT00543387|16921121|P9|Panel 1 + Panel 2|Physician Decision|0
4912457|NCT00543387|16921122|P8|Panel 1 + Panel 2|Physician Decision|1
4912458|NCT00543387|16921123|P7|Panel 1 + Panel 2|Physician Decision|0
4912459|NCT00543387|16921124|P6|Panel 1 + Panel 2|Physician Decision|0
4912460|NCT00543387|16921125|P5|Panel 1 + Panel 2|Physician Decision|0
4912461|NCT00543387|16921126|P4|Panel 1 + Panel 2|Physician Decision|0
4912462|NCT00543387|16921127|P3|Panel 1 + Panel 2|Physician Decision|1
4912463|NCT00543387|16921128|P2|Panel 1 + Panel 2|Physician Decision|0
4912464|NCT00543387|16921129|P1|Panel 1 + Panel 2|Physician Decision|0
4912465|NCT00543387|16921119|P11|Panel 1 + Panel 2|Adverse Event|0
4912466|NCT00543387|16921120|P10|Panel 1 + Panel 2|Adverse Event|0
4912467|NCT00543387|16921121|P9|Panel 1 + Panel 2|Adverse Event|1
4912468|NCT00543387|16921122|P8|Panel 1 + Panel 2|Adverse Event|1
4912469|NCT00543387|16921123|P7|Panel 1 + Panel 2|Adverse Event|0
4912470|NCT00543387|16921124|P6|Panel 1 + Panel 2|Adverse Event|0
4912471|NCT00543387|16921125|P5|Panel 1 + Panel 2|Adverse Event|0
4912472|NCT00543387|16921126|P4|Panel 1 + Panel 2|Adverse Event|0
4912473|NCT00543387|16921127|P3|Panel 1 + Panel 2|Adverse Event|0
4912474|NCT00543387|16921128|P2|Panel 1 + Panel 2|Adverse Event|1
4912475|NCT00543387|16921129|P1|Panel 1 + Panel 2|Adverse Event|0
4912476|NCT00543309|16921167|P3|Overall Study|Physician Decision|0
4912477|NCT00543309|16921168|P2|Overall Study|Physician Decision|1
4912478|NCT00543309|16921169|P1|Overall Study|Physician Decision|0
4912479|NCT00543296|16921219|P1|Overall Study|Physician Decision|7
4912480|NCT00543140|16921226|P1|Overall Study|Conversion to different procedure|1
4912481|NCT00543140|16921226|P1|Overall Study|Subject moved|1
4912482|NCT00543140|16921226|P1|Overall Study|Death|1
4912483|NCT00543140|16921226|P1|Overall Study|SAE leading to explant of SAGB|3
4912484|NCT00543140|16921226|P1|Overall Study|Insufficient weight loss|10
4912485|NCT00543140|16921226|P1|Overall Study|Protocol Violation|10
4912486|NCT00543140|16921226|P1|Overall Study|Withdrawal by Subject|13
4912487|NCT00543140|16921226|P1|Overall Study|Lost to Follow-up|33
4912488|NCT00543062|16921264|P4|Overall Study|Protocol Violation|0
4912489|NCT00543062|16921265|P3|Overall Study|Protocol Violation|0
4912490|NCT00543062|16921266|P2|Overall Study|Protocol Violation|0
4912491|NCT00543062|16921267|P1|Overall Study|Protocol Violation|1
4912492|NCT00543062|16921264|P4|Overall Study|Adverse Event|1
4912493|NCT00543062|16921265|P3|Overall Study|Adverse Event|1
4912494|NCT00543062|16921266|P2|Overall Study|Adverse Event|1
4912495|NCT00543062|16921267|P1|Overall Study|Adverse Event|0
4912496|NCT00543062|16921264|P4|Overall Study|Withdrawal by Subject|0
4912497|NCT00543062|16921265|P3|Overall Study|Withdrawal by Subject|2
4912498|NCT00543062|16921266|P2|Overall Study|Withdrawal by Subject|0
4912499|NCT00543062|16921267|P1|Overall Study|Withdrawal by Subject|1
4912500|NCT00542997|16921289|P1|Efficacy Period|Adverse Event|3
4912501|NCT00542997|16921289|P1|Wash in / Wash Out Period|Adverse Event|3
4912502|NCT00542997|16921289|P1|Wash in / Wash Out Period|Withdrawal by Subject|2
4912503|NCT00542919|16921312|P3|Overall Study|Lost to Follow-up|1
4912504|NCT00542919|16921313|P2|Overall Study|Lost to Follow-up|0
4912505|NCT00542919|16921314|P1|Overall Study|Lost to Follow-up|2
4912506|NCT00542919|16921312|P3|Overall Study|Sponsor Decision|0
4912507|NCT00542919|16921313|P2|Overall Study|Sponsor Decision|0
4912508|NCT00542919|16921314|P1|Overall Study|Sponsor Decision|1
4912509|NCT00542919|16921312|P3|Overall Study|Physician Decision|1
4912510|NCT00542919|16921313|P2|Overall Study|Physician Decision|2
4912511|NCT00542919|16921314|P1|Overall Study|Physician Decision|2
4912512|NCT00542919|16921312|P3|Overall Study|Withdrawal by Subject|3
4912513|NCT00542919|16921313|P2|Overall Study|Withdrawal by Subject|0
4912514|NCT00542919|16921314|P1|Overall Study|Withdrawal by Subject|1
4912515|NCT00542919|16921312|P3|Overall Study|Adverse Event|1
4912516|NCT00542919|16921313|P2|Overall Study|Adverse Event|5
4912517|NCT00542919|16921314|P1|Overall Study|Adverse Event|1
4912518|NCT00542880|16921359|P2|Period 3|Adverse Event|2
4912519|NCT00542880|16921360|P1|Period 3|Adverse Event|0
4912520|NCT00542880|16921359|P2|Period 2|Other|1
4912521|NCT00542880|16921360|P1|Period 2|Other|0
4912522|NCT00542880|16921359|P2|Period 2|Severe non-compliance|1
4912523|NCT00542880|16921360|P1|Period 2|Severe non-compliance|0
4912524|NCT00542880|16921359|P2|Period 2|Discontinuation criteria|0
4912525|NCT00542880|16921360|P1|Period 2|Discontinuation criteria|2
4912526|NCT00542880|16921359|P2|Period 2|Eligibility not fulfilled|1
4912527|NCT00542880|16921360|P1|Period 2|Eligibility not fulfilled|0
4912528|NCT00542880|16921359|P2|Period 2|Adverse Event|7
4912529|NCT00542880|16921360|P1|Period 2|Adverse Event|5
4912530|NCT00542880|16921359|P2|Period 1|Protocol Violation|1
4912531|NCT00542880|16921360|P1|Period 1|Protocol Violation|0
4912532|NCT00542880|16921359|P2|Period 1|Withdrawal by Subject|1
4912533|NCT00542880|16921360|P1|Period 1|Withdrawal by Subject|1
4912534|NCT00542880|16921359|P2|Period 1|Development of study-specific criteria|2
4912535|NCT00542880|16921360|P1|Period 1|Development of study-specific criteria|1
4912536|NCT00542880|16921359|P2|Period 1|Adverse Event|2
4912537|NCT00542880|16921360|P1|Period 1|Adverse Event|2
4912538|NCT00542880|16921359|P2|Period 1|Eligibility criteria not fulfilled|6
4912539|NCT00542880|16921360|P1|Period 1|Eligibility criteria not fulfilled|2
4912540|NCT00542828|16921396|P1|Overall Study|Did Not Receive Thymoglobulin Treatment|2
4912541|NCT00542828|16921396|P1|Overall Study|Study Prematurely Discontinued|7
4912542|NCT00542828|16921396|P1|Overall Study|Need for Prohibited Treatment|3
4912543|NCT00542828|16921396|P1|Overall Study|Physician Decision|1
4912544|NCT00542815|16921414|P3|Overall Study|Other reasons|10
4912545|NCT00542815|16921415|P2|Overall Study|Other reasons|10
4912546|NCT00542815|16921416|P1|Overall Study|Other reasons|24
4912547|NCT00542815|16921414|P3|Overall Study|Withdrawal by Subject|8
4912548|NCT00542815|16921415|P2|Overall Study|Withdrawal by Subject|5
4912549|NCT00542815|16921416|P1|Overall Study|Withdrawal by Subject|41
4912550|NCT00542815|16921414|P3|Overall Study|Protocol Violation|2
4912551|NCT00542815|16921415|P2|Overall Study|Protocol Violation|1
4912552|NCT00542815|16921416|P1|Overall Study|Protocol Violation|1
4912553|NCT00542815|16921414|P3|Overall Study|Physician Decision|0
4912554|NCT00542815|16921415|P2|Overall Study|Physician Decision|1
4912555|NCT00542815|16921416|P1|Overall Study|Physician Decision|2
4912556|NCT00542815|16921414|P3|Overall Study|Lack of Efficacy|0
4912557|NCT00542815|16921415|P2|Overall Study|Lack of Efficacy|2
4912558|NCT00542815|16921416|P1|Overall Study|Lack of Efficacy|9
4912559|NCT00542815|16921414|P3|Overall Study|Death|3
4912560|NCT00542815|16921415|P2|Overall Study|Death|7
4912561|NCT00542815|16921416|P1|Overall Study|Death|10
4912562|NCT00542815|16921414|P3|Overall Study|Adverse Event|9
4912563|NCT00542815|16921415|P2|Overall Study|Adverse Event|6
4912564|NCT00542815|16921416|P1|Overall Study|Adverse Event|19
4912565|NCT00542789|16921429|P2|Overall Study|Recurrence of Gastric Ulcer|57
4912566|NCT00542789|16921430|P1|Overall Study|Recurrence of Gastric Ulcer|8
4912567|NCT00542789|16921429|P2|Overall Study|Protocol Violation|1
4912568|NCT00542789|16921430|P1|Overall Study|Protocol Violation|8
4912569|NCT00542789|16921429|P2|Overall Study|Withdrawal by Subject|3
4912570|NCT00542789|16921430|P1|Overall Study|Withdrawal by Subject|7
4912571|NCT00542789|16921429|P2|Overall Study|Adverse Event|17
4912572|NCT00542789|16921430|P1|Overall Study|Adverse Event|18
4912573|NCT00542425|16921530|P5|Extended 24 Weeks of Treatment|Other|1
4912574|NCT00542425|16921531|P4|Extended 24 Weeks of Treatment|Other|0
4912575|NCT00542425|16921532|P3|Extended 24 Weeks of Treatment|Other|0
4912576|NCT00542425|16921533|P2|Extended 24 Weeks of Treatment|Other|1
4912577|NCT00542425|16921534|P1|Extended 24 Weeks of Treatment|Other|1
4912578|NCT00542425|16921530|P5|Extended 24 Weeks of Treatment|Refusal of treatment|0
4912579|NCT00542425|16921531|P4|Extended 24 Weeks of Treatment|Refusal of treatment|0
4912580|NCT00542425|16921532|P3|Extended 24 Weeks of Treatment|Refusal of treatment|0
4912581|NCT00542425|16921533|P2|Extended 24 Weeks of Treatment|Refusal of treatment|1
4912582|NCT00542425|16921534|P1|Extended 24 Weeks of Treatment|Refusal of treatment|0
4912583|NCT00542425|16921530|P5|Extended 24 Weeks of Treatment|Protocol Violation|0
4912584|NCT00542425|16921531|P4|Extended 24 Weeks of Treatment|Protocol Violation|0
4912585|NCT00542425|16921532|P3|Extended 24 Weeks of Treatment|Protocol Violation|1
4912586|NCT00542425|16921533|P2|Extended 24 Weeks of Treatment|Protocol Violation|0
4912587|NCT00542425|16921534|P1|Extended 24 Weeks of Treatment|Protocol Violation|0
4912588|NCT00542425|16921530|P5|Extended 24 Weeks of Treatment|Adverse Event|0
4912589|NCT00542425|16921531|P4|Extended 24 Weeks of Treatment|Adverse Event|1
4912590|NCT00542425|16921532|P3|Extended 24 Weeks of Treatment|Adverse Event|1
4912591|NCT00542425|16921533|P2|Extended 24 Weeks of Treatment|Adverse Event|0
4912592|NCT00542425|16921534|P1|Extended 24 Weeks of Treatment|Adverse Event|0
4912593|NCT00542425|16921530|P5|Initial 24 Weeks|Other|0
4912594|NCT00542425|16921531|P4|Initial 24 Weeks|Other|0
4912595|NCT00542425|16921532|P3|Initial 24 Weeks|Other|1
4912596|NCT00542425|16921533|P2|Initial 24 Weeks|Other|2
4912597|NCT00542425|16921534|P1|Initial 24 Weeks|Other|0
4912598|NCT00542425|16921530|P5|Initial 24 Weeks|Refusal of treatment|1
4912599|NCT00542425|16921531|P4|Initial 24 Weeks|Refusal of treatment|4
4912600|NCT00542425|16921532|P3|Initial 24 Weeks|Refusal of treatment|1
4912601|NCT00542425|16921533|P2|Initial 24 Weeks|Refusal of treatment|2
4912602|NCT00542425|16921534|P1|Initial 24 Weeks|Refusal of treatment|2
4912603|NCT00542425|16921530|P5|Initial 24 Weeks|Protocol Violation|0
4912604|NCT00542425|16921531|P4|Initial 24 Weeks|Protocol Violation|1
4912605|NCT00542425|16921532|P3|Initial 24 Weeks|Protocol Violation|0
4912606|NCT00542425|16921533|P2|Initial 24 Weeks|Protocol Violation|0
4912607|NCT00542425|16921534|P1|Initial 24 Weeks|Protocol Violation|0
4912608|NCT00542425|16921530|P5|Initial 24 Weeks|Non-compliance|1
4912609|NCT00542425|16921531|P4|Initial 24 Weeks|Non-compliance|1
4912610|NCT00542425|16921532|P3|Initial 24 Weeks|Non-compliance|0
4912611|NCT00542425|16921533|P2|Initial 24 Weeks|Non-compliance|0
4912612|NCT00542425|16921534|P1|Initial 24 Weeks|Non-compliance|0
4912613|NCT00542425|16921530|P5|Initial 24 Weeks|Lost to Follow-up|0
4912614|NCT00542425|16921531|P4|Initial 24 Weeks|Lost to Follow-up|0
4912615|NCT00542425|16921532|P3|Initial 24 Weeks|Lost to Follow-up|1
4912616|NCT00542425|16921533|P2|Initial 24 Weeks|Lost to Follow-up|2
4912617|NCT00542425|16921534|P1|Initial 24 Weeks|Lost to Follow-up|2
4912618|NCT00542425|16921530|P5|Initial 24 Weeks|Inability to complete procedures|2
4912619|NCT00542425|16921531|P4|Initial 24 Weeks|Inability to complete procedures|1
4912620|NCT00542425|16921532|P3|Initial 24 Weeks|Inability to complete procedures|2
4912621|NCT00542425|16921533|P2|Initial 24 Weeks|Inability to complete procedures|3
4912622|NCT00542425|16921534|P1|Initial 24 Weeks|Inability to complete procedures|0
4912623|NCT00542425|16921530|P5|Initial 24 Weeks|Adverse Event|2
4912624|NCT00542425|16921531|P4|Initial 24 Weeks|Adverse Event|3
4912625|NCT00542425|16921532|P3|Initial 24 Weeks|Adverse Event|1
4912626|NCT00542425|16921533|P2|Initial 24 Weeks|Adverse Event|1
4912627|NCT00542425|16921534|P1|Initial 24 Weeks|Adverse Event|0
4912628|NCT00542425|16921530|P5|Initial 24 Weeks|Administrative reasons|0
4912629|NCT00542425|16921531|P4|Initial 24 Weeks|Administrative reasons|1
4912630|NCT00542425|16921532|P3|Initial 24 Weeks|Administrative reasons|1
4912631|NCT00542425|16921533|P2|Initial 24 Weeks|Administrative reasons|0
4912632|NCT00542425|16921534|P1|Initial 24 Weeks|Administrative reasons|0
4912633|NCT00542386|16921572|P6|Overall Study|Other Reasons|2
4912634|NCT00542386|16921573|P5|Overall Study|Other Reasons|4
4912635|NCT00542386|16921574|P4|Overall Study|Other Reasons|3
4912636|NCT00542386|16921575|P3|Overall Study|Other Reasons|4
4912637|NCT00542386|16921576|P2|Overall Study|Other Reasons|1
4912638|NCT00542386|16921577|P1|Overall Study|Other Reasons|4
4912639|NCT00542386|16921572|P6|Overall Study|Withdrawal by Subject|7
4912640|NCT00542386|16921573|P5|Overall Study|Withdrawal by Subject|15
4912641|NCT00542386|16921574|P4|Overall Study|Withdrawal by Subject|11
4912642|NCT00542386|16921575|P3|Overall Study|Withdrawal by Subject|10
4912643|NCT00542386|16921576|P2|Overall Study|Withdrawal by Subject|8
4912644|NCT00542386|16921577|P1|Overall Study|Withdrawal by Subject|5
4912645|NCT00542386|16921572|P6|Overall Study|Protocol Violation|4
4912646|NCT00542386|16921573|P5|Overall Study|Protocol Violation|0
4912647|NCT00542386|16921574|P4|Overall Study|Protocol Violation|0
4912648|NCT00542386|16921575|P3|Overall Study|Protocol Violation|1
4912649|NCT00542386|16921576|P2|Overall Study|Protocol Violation|0
4912650|NCT00542386|16921577|P1|Overall Study|Protocol Violation|0
4912651|NCT00542386|16921572|P6|Overall Study|Physician Decision|0
4912652|NCT00542386|16921573|P5|Overall Study|Physician Decision|0
4912653|NCT00542386|16921574|P4|Overall Study|Physician Decision|1
4912654|NCT00542386|16921575|P3|Overall Study|Physician Decision|0
4912655|NCT00542386|16921576|P2|Overall Study|Physician Decision|0
4912656|NCT00542386|16921577|P1|Overall Study|Physician Decision|1
4912657|NCT00542386|16921572|P6|Overall Study|Lack of Efficacy|31
4912658|NCT00542386|16921573|P5|Overall Study|Lack of Efficacy|7
4912659|NCT00542386|16921574|P4|Overall Study|Lack of Efficacy|13
4912660|NCT00542386|16921575|P3|Overall Study|Lack of Efficacy|10
4912661|NCT00542386|16921576|P2|Overall Study|Lack of Efficacy|12
4912662|NCT00542386|16921577|P1|Overall Study|Lack of Efficacy|32
4912663|NCT00542386|16921572|P6|Overall Study|Death|2
4912664|NCT00542386|16921573|P5|Overall Study|Death|1
4912665|NCT00542386|16921574|P4|Overall Study|Death|2
4912666|NCT00542386|16921575|P3|Overall Study|Death|1
4912667|NCT00542386|16921576|P2|Overall Study|Death|0
4912668|NCT00542386|16921577|P1|Overall Study|Death|0
4912669|NCT00542386|16921572|P6|Overall Study|Adverse Event|4
4912670|NCT00542386|16921573|P5|Overall Study|Adverse Event|13
4912671|NCT00542386|16921574|P4|Overall Study|Adverse Event|8
4912672|NCT00542386|16921575|P3|Overall Study|Adverse Event|7
4912673|NCT00542386|16921576|P2|Overall Study|Adverse Event|7
4912674|NCT00542386|16921577|P1|Overall Study|Adverse Event|1
4912675|NCT00542321|16921599|P2|Overall Study|Death|1
4912676|NCT00542321|16921600|P1|Overall Study|Death|0
4912677|NCT00542269|16921622|P3|Overall Study|Administrative problems|1
4912678|NCT00542269|16921623|P2|Overall Study|Administrative problems|1
4912679|NCT00542269|16921624|P1|Overall Study|Administrative problems|1
4912680|NCT00542269|16921622|P3|Overall Study|Withdrawal by Subject|0
4912681|NCT00542269|16921623|P2|Overall Study|Withdrawal by Subject|0
4912682|NCT00542269|16921624|P1|Overall Study|Withdrawal by Subject|1
4912683|NCT00542269|16921622|P3|Overall Study|Protocol Violation|0
4912684|NCT00542269|16921623|P2|Overall Study|Protocol Violation|1
4912685|NCT00542269|16921624|P1|Overall Study|Protocol Violation|1
4912686|NCT00542269|16921622|P3|Overall Study|Adverse Event|5
4912687|NCT00542269|16921623|P2|Overall Study|Adverse Event|4
4912688|NCT00542269|16921624|P1|Overall Study|Adverse Event|10
4912689|NCT00542191|16921653|P1|Overall Study|Death|3
4912690|NCT00542178|16921663|P8|Overall Study|did not complete year 4 follow-up|85
4912691|NCT00542178|16921664|P7|Overall Study|did not complete year 4 follow-up|87
4912692|NCT00542178|16921665|P6|Overall Study|did not complete year 4 follow-up|89
4912693|NCT00542178|16921666|P5|Overall Study|did not complete year 4 follow-up|64
4912694|NCT00542178|16921667|P4|Overall Study|did not complete year 4 follow-up|62
4912695|NCT00542178|16921668|P3|Overall Study|did not complete year 4 follow-up|74
4912696|NCT00542178|16921669|P2|Overall Study|did not complete year 4 follow-up|80
4912697|NCT00542178|16921670|P1|Overall Study|did not complete year 4 follow-up|75
4912698|NCT00541970|16921706|P4|Month 60|Protocol Violation|72
4912699|NCT00541970|16921707|P3|Month 60|Protocol Violation|82
4912700|NCT00541970|16921708|P2|Month 60|Protocol Violation|77
4912701|NCT00541970|16921709|P1|Month 60|Protocol Violation|78
4912702|NCT00541970|16921706|P4|Month 48|Lost to Follow-up|73
4912703|NCT00541970|16921707|P3|Month 48|Lost to Follow-up|68
4912704|NCT00541970|16921708|P2|Month 48|Lost to Follow-up|68
4912705|NCT00541970|16921709|P1|Month 48|Lost to Follow-up|66
4912706|NCT00541970|16921706|P4|Month 48|Other|0
4912707|NCT00541970|16921707|P3|Month 48|Other|1
4912708|NCT00541970|16921708|P2|Month 48|Other|1
4912709|NCT00541970|16921709|P1|Month 48|Other|3
4912710|NCT00541970|16921706|P4|Month 48|Withdrawal by Subject|2
4912711|NCT00541970|16921707|P3|Month 48|Withdrawal by Subject|4
4912712|NCT00541970|16921708|P2|Month 48|Withdrawal by Subject|4
4912713|NCT00541970|16921709|P1|Month 48|Withdrawal by Subject|2
4912714|NCT00541970|16921706|P4|Month 36|Protocol Violation|60
4912715|NCT00541970|16921707|P3|Month 36|Protocol Violation|66
4912716|NCT00541970|16921708|P2|Month 36|Protocol Violation|66
4912717|NCT00541970|16921709|P1|Month 36|Protocol Violation|61
4912718|NCT00541970|16921706|P4|Month 24|Protocol Violation|21
4912719|NCT00541970|16921707|P3|Month 24|Protocol Violation|31
4912720|NCT00541970|16921708|P2|Month 24|Protocol Violation|31
4912721|NCT00541970|16921709|P1|Month 24|Protocol Violation|29
4912722|NCT00541970|16921706|P4|Month 24|Adverse Event|1
4912723|NCT00541970|16921707|P3|Month 24|Adverse Event|1
4912724|NCT00541970|16921708|P2|Month 24|Adverse Event|1
4912725|NCT00541970|16921709|P1|Month 24|Adverse Event|0
4912726|NCT00541970|16921706|P4|Month 18|Protocol Violation|16
4912727|NCT00541970|16921707|P3|Month 18|Protocol Violation|24
4912728|NCT00541970|16921708|P2|Month 18|Protocol Violation|23
4912729|NCT00541970|16921709|P1|Month 18|Protocol Violation|14
4912730|NCT00541970|16921706|P4|Month 18|Adverse Event|1
4912731|NCT00541970|16921707|P3|Month 18|Adverse Event|1
4912732|NCT00541970|16921708|P2|Month 18|Adverse Event|1
4912733|NCT00541970|16921709|P1|Month 18|Adverse Event|0
4912734|NCT00541970|16921706|P4|Month 12|Protocol Violation|15
4912735|NCT00541970|16921707|P3|Month 12|Protocol Violation|20
4912736|NCT00541970|16921708|P2|Month 12|Protocol Violation|21
4912737|NCT00541970|16921709|P1|Month 12|Protocol Violation|12
4912738|NCT00541970|16921706|P4|Month 12|Adverse Event|1
4912739|NCT00541970|16921707|P3|Month 12|Adverse Event|1
4912740|NCT00541970|16921708|P2|Month 12|Adverse Event|1
4912741|NCT00541970|16921709|P1|Month 12|Adverse Event|0
4912742|NCT00541970|16921706|P4|Month 7|Protocol Violation|5
4912743|NCT00541970|16921707|P3|Month 7|Protocol Violation|11
4912744|NCT00541970|16921708|P2|Month 7|Protocol Violation|13
4912745|NCT00541970|16921709|P1|Month 7|Protocol Violation|9
4912746|NCT00541931|16921860|P2|Overall Study|Transportation Issue|1
4912747|NCT00541931|16921861|P1|Overall Study|Transportation Issue|0
4912748|NCT00541931|16921860|P2|Overall Study|Withdrawal by Subject|0
4912749|NCT00541931|16921861|P1|Overall Study|Withdrawal by Subject|1
4912750|NCT00541931|16921860|P2|Overall Study|Lost to Follow-up|3
4912751|NCT00541931|16921861|P1|Overall Study|Lost to Follow-up|3
4912752|NCT00541931|16921860|P2|Overall Study|Adverse Event|0
4912753|NCT00541931|16921861|P1|Overall Study|Adverse Event|1
4912754|NCT00541866|16921874|P5|Overall Study|Physician Decision|0
4912755|NCT00541866|16921875|P4|Overall Study|Physician Decision|1
4912756|NCT00541866|16921876|P3|Overall Study|Physician Decision|2
4912757|NCT00541866|16921877|P2|Overall Study|Physician Decision|0
4912758|NCT00541866|16921878|P1|Overall Study|Physician Decision|0
4912759|NCT00541866|16921874|P5|Overall Study|Not Reported or Other|1
4912760|NCT00541866|16921875|P4|Overall Study|Not Reported or Other|3
4912761|NCT00541866|16921876|P3|Overall Study|Not Reported or Other|3
4912762|NCT00541866|16921877|P2|Overall Study|Not Reported or Other|3
4912763|NCT00541866|16921878|P1|Overall Study|Not Reported or Other|11
4912764|NCT00541866|16921874|P5|Overall Study|Lack of Efficacy|14
4912765|NCT00541866|16921875|P4|Overall Study|Lack of Efficacy|12
4912766|NCT00541866|16921876|P3|Overall Study|Lack of Efficacy|10
4912767|NCT00541866|16921877|P2|Overall Study|Lack of Efficacy|15
4912768|NCT00541866|16921878|P1|Overall Study|Lack of Efficacy|19
4912769|NCT00541866|16921874|P5|Overall Study|Death|0
4912770|NCT00541866|16921875|P4|Overall Study|Death|0
4912771|NCT00541866|16921876|P3|Overall Study|Death|0
4912772|NCT00541866|16921877|P2|Overall Study|Death|0
4912773|NCT00541866|16921878|P1|Overall Study|Death|1
4912774|NCT00541866|16921874|P5|Overall Study|Adverse Event|0
4912775|NCT00541866|16921875|P4|Overall Study|Adverse Event|0
4912776|NCT00541866|16921876|P3|Overall Study|Adverse Event|0
4912777|NCT00541866|16921877|P2|Overall Study|Adverse Event|0
4912778|NCT00541866|16921878|P1|Overall Study|Adverse Event|3
4912779|NCT00541775|16921919|P3|Overall Study|Withdrawal by Subject and Other|2
4912780|NCT00541775|16921920|P2|Overall Study|Withdrawal by Subject and Other|0
4912781|NCT00541775|16921921|P1|Overall Study|Withdrawal by Subject and Other|5
4912782|NCT00541775|16921919|P3|Overall Study|Protocol Violation|0
4912783|NCT00541775|16921920|P2|Overall Study|Protocol Violation|0
4912784|NCT00541775|16921921|P1|Overall Study|Protocol Violation|1
4912785|NCT00541775|16921919|P3|Overall Study|Lost to Follow-up|2
4912786|NCT00541775|16921920|P2|Overall Study|Lost to Follow-up|0
4912787|NCT00541775|16921921|P1|Overall Study|Lost to Follow-up|0
4912788|NCT00541775|16921919|P3|Overall Study|Lack of Efficacy|3
4912789|NCT00541775|16921920|P2|Overall Study|Lack of Efficacy|0
4912790|NCT00541775|16921921|P1|Overall Study|Lack of Efficacy|0
4912791|NCT00541775|16921919|P3|Overall Study|Adverse Event|1
4912792|NCT00541775|16921920|P2|Overall Study|Adverse Event|2
4912793|NCT00541775|16921921|P1|Overall Study|Adverse Event|3
4912794|NCT00541658|16921947|P3|Overall Study|Took No Study Drug|0
4912795|NCT00541658|16921948|P2|Overall Study|Took No Study Drug|0
4912796|NCT00541658|16921949|P1|Overall Study|Took No Study Drug|1
4912797|NCT00541658|16921947|P3|Overall Study|Withdrawal by Subject|32
4912798|NCT00541658|16921948|P2|Overall Study|Withdrawal by Subject|32
4912799|NCT00541658|16921949|P1|Overall Study|Withdrawal by Subject|28
4912800|NCT00541658|16921947|P3|Overall Study|Protocol Violation|1
4912801|NCT00541658|16921948|P2|Overall Study|Protocol Violation|1
4912802|NCT00541658|16921949|P1|Overall Study|Protocol Violation|0
4912803|NCT00541658|16921947|P3|Overall Study|Lost to Follow-up|6
4912804|NCT00541658|16921948|P2|Overall Study|Lost to Follow-up|3
4912805|NCT00541658|16921949|P1|Overall Study|Lost to Follow-up|3
4912806|NCT00541658|16921947|P3|Overall Study|Physician Decision|4
4912807|NCT00541658|16921948|P2|Overall Study|Physician Decision|0
4912808|NCT00541658|16921949|P1|Overall Study|Physician Decision|0
4912809|NCT00541658|16921947|P3|Overall Study|Adverse Event|25
4912810|NCT00541658|16921948|P2|Overall Study|Adverse Event|37
4912811|NCT00541658|16921949|P1|Overall Study|Adverse Event|28
4912812|NCT00541450|16922112|P2|Phase B|Withdrawal by Subject|6
4912813|NCT00541450|16922113|P1|Phase B|Withdrawal by Subject|8
4912814|NCT00541450|16922112|P2|Phase B|Protocol Violation|3
4912815|NCT00541450|16922113|P1|Phase B|Protocol Violation|3
4912816|NCT00541450|16922112|P2|Phase B|Pregnancy|1
4912817|NCT00541450|16922113|P1|Phase B|Pregnancy|0
4912818|NCT00541450|16922112|P2|Phase B|Physician Decision|2
4912819|NCT00541450|16922113|P1|Phase B|Physician Decision|4
4912820|NCT00541450|16922112|P2|Phase B|Lost to Follow-up|4
4912821|NCT00541450|16922113|P1|Phase B|Lost to Follow-up|6
4912822|NCT00541450|16922112|P2|Phase B|Hyperglycemia|9
4912823|NCT00541450|16922113|P1|Phase B|Hyperglycemia|10
4912824|NCT00541450|16922112|P2|Phase B|Adverse Event|6
4912825|NCT00541450|16922113|P1|Phase B|Adverse Event|6
4912826|NCT00541450|16922112|P2|Phase A|Withdrawal by Subject|7
4912827|NCT00541450|16922113|P1|Phase A|Withdrawal by Subject|7
4912828|NCT00541450|16922112|P2|Phase A|Protocol Violation|3
4912829|NCT00541450|16922113|P1|Phase A|Protocol Violation|2
4912830|NCT00541450|16922112|P2|Phase A|Physician Decision|0
4912831|NCT00541450|16922113|P1|Phase A|Physician Decision|2
4912832|NCT00541450|16922112|P2|Phase A|Lost to Follow-up|4
4912833|NCT00541450|16922113|P1|Phase A|Lost to Follow-up|6
4912834|NCT00541450|16922112|P2|Phase A|Hyperglycemia|1
4912835|NCT00541450|16922113|P1|Phase A|Hyperglycemia|0
4912836|NCT00541450|16922112|P2|Phase A|Creatinine/CrCl -Increase in creatinine|2
4912837|NCT00541450|16922113|P1|Phase A|Creatinine/CrCl -Increase in creatinine|0
4912838|NCT00541450|16922112|P2|Phase A|Adverse Event|0
4912839|NCT00541450|16922113|P1|Phase A|Adverse Event|3
4912840|NCT00541346|16922131|P1|Follow-up|Adverse Event|1
4912841|NCT00541307|16922145|P1|Overall Study|Surgical Bypass|5
4912916|NCT00541229|16922173|P3|Washout Period I (Week 2-5)|Adverse Event|1
4912842|NCT00541307|16922145|P1|Overall Study|Subject returned early (outside window)|1
4912843|NCT00541307|16922145|P1|Overall Study|Lost to Follow-up|4
4912844|NCT00541307|16922145|P1|Overall Study|Withdrawal by Subject|6
4912845|NCT00541307|16922145|P1|Overall Study|Physician Decision|3
4912846|NCT00541307|16922145|P1|Overall Study|Death|5
4912847|NCT00541229|16922170|P6|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4912848|NCT00541229|16922171|P5|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4912849|NCT00541229|16922172|P4|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4912850|NCT00541229|16922173|P3|Treatment Period III (Week 11)|Study Terminated by Sponsor|1
4912851|NCT00541229|16922174|P2|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4912852|NCT00541229|16922175|P1|Treatment Period III (Week 11)|Study Terminated by Sponsor|0
4912853|NCT00541229|16922170|P6|Treatment Period III (Week 11)|Protocol Specified Criteria|1
4912854|NCT00541229|16922171|P5|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4912855|NCT00541229|16922172|P4|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4912856|NCT00541229|16922173|P3|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4912857|NCT00541229|16922174|P2|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4912858|NCT00541229|16922175|P1|Treatment Period III (Week 11)|Protocol Specified Criteria|0
4912859|NCT00541229|16922170|P6|Treatment Period III (Week 11)|Adverse Event|0
4912860|NCT00541229|16922171|P5|Treatment Period III (Week 11)|Adverse Event|1
4912861|NCT00541229|16922172|P4|Treatment Period III (Week 11)|Adverse Event|0
4912862|NCT00541229|16922173|P3|Treatment Period III (Week 11)|Adverse Event|0
4912863|NCT00541229|16922174|P2|Treatment Period III (Week 11)|Adverse Event|0
4912864|NCT00541229|16922175|P1|Treatment Period III (Week 11)|Adverse Event|0
4912865|NCT00541229|16922170|P6|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
4912866|NCT00541229|16922171|P5|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
4912867|NCT00541229|16922172|P4|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
4912868|NCT00541229|16922173|P3|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2
4912869|NCT00541229|16922174|P2|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4
4912870|NCT00541229|16922175|P1|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3
4912871|NCT00541229|16922170|P6|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4912872|NCT00541229|16922171|P5|Washout Period II (Week 7-10)|Withdrawal by Subject|1
4912873|NCT00541229|16922172|P4|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4912874|NCT00541229|16922173|P3|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4912875|NCT00541229|16922174|P2|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4912876|NCT00541229|16922175|P1|Washout Period II (Week 7-10)|Withdrawal by Subject|0
4912877|NCT00541229|16922170|P6|Washout Period II (Week 7-10)|Protocol Violation|0
4912878|NCT00541229|16922171|P5|Washout Period II (Week 7-10)|Protocol Violation|0
4912879|NCT00541229|16922172|P4|Washout Period II (Week 7-10)|Protocol Violation|0
4912880|NCT00541229|16922173|P3|Washout Period II (Week 7-10)|Protocol Violation|0
4912881|NCT00541229|16922174|P2|Washout Period II (Week 7-10)|Protocol Violation|0
4912882|NCT00541229|16922175|P1|Washout Period II (Week 7-10)|Protocol Violation|1
4912883|NCT00541229|16922170|P6|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
4912884|NCT00541229|16922171|P5|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4912885|NCT00541229|16922172|P4|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4912886|NCT00541229|16922173|P3|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4912887|NCT00541229|16922174|P2|Treatment Period II (Week 6)|Study Terminated by Sponsor|1
4912888|NCT00541229|16922175|P1|Treatment Period II (Week 6)|Study Terminated by Sponsor|2
4912889|NCT00541229|16922170|P6|Treatment Period II (Week 6)|Protocol Violation|1
4912890|NCT00541229|16922171|P5|Treatment Period II (Week 6)|Protocol Violation|1
4912891|NCT00541229|16922172|P4|Treatment Period II (Week 6)|Protocol Violation|0
4912892|NCT00541229|16922173|P3|Treatment Period II (Week 6)|Protocol Violation|0
4912893|NCT00541229|16922174|P2|Treatment Period II (Week 6)|Protocol Violation|0
4912894|NCT00541229|16922175|P1|Treatment Period II (Week 6)|Protocol Violation|0
4912895|NCT00541229|16922170|P6|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4
4912896|NCT00541229|16922171|P5|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1
4912897|NCT00541229|16922172|P4|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
4912898|NCT00541229|16922173|P3|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
4912899|NCT00541229|16922174|P2|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2
4912900|NCT00541229|16922175|P1|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3
4912901|NCT00541229|16922170|P6|Washout Period I (Week 2-5)|Protocol Violation|1
4912902|NCT00541229|16922171|P5|Washout Period I (Week 2-5)|Protocol Violation|0
4912903|NCT00541229|16922172|P4|Washout Period I (Week 2-5)|Protocol Violation|0
4912904|NCT00541229|16922173|P3|Washout Period I (Week 2-5)|Protocol Violation|0
4912905|NCT00541229|16922174|P2|Washout Period I (Week 2-5)|Protocol Violation|0
4912906|NCT00541229|16922175|P1|Washout Period I (Week 2-5)|Protocol Violation|0
4912907|NCT00541229|16922170|P6|Washout Period I (Week 2-5)|Physician Decision|0
4912908|NCT00541229|16922171|P5|Washout Period I (Week 2-5)|Physician Decision|0
4912909|NCT00541229|16922172|P4|Washout Period I (Week 2-5)|Physician Decision|1
4912910|NCT00541229|16922173|P3|Washout Period I (Week 2-5)|Physician Decision|0
4912911|NCT00541229|16922174|P2|Washout Period I (Week 2-5)|Physician Decision|0
4912912|NCT00541229|16922175|P1|Washout Period I (Week 2-5)|Physician Decision|0
4912913|NCT00541229|16922170|P6|Washout Period I (Week 2-5)|Adverse Event|0
4912914|NCT00541229|16922171|P5|Washout Period I (Week 2-5)|Adverse Event|0
4912915|NCT00541229|16922172|P4|Washout Period I (Week 2-5)|Adverse Event|0
4912917|NCT00541229|16922174|P2|Washout Period I (Week 2-5)|Adverse Event|0
4912918|NCT00541229|16922175|P1|Washout Period I (Week 2-5)|Adverse Event|1
4912919|NCT00541229|16922170|P6|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
4912920|NCT00541229|16922171|P5|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
4912921|NCT00541229|16922172|P4|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
4912922|NCT00541229|16922173|P3|Treatment Period I (Week 1)|Study Terminated by Sponsor|2
4912923|NCT00541229|16922174|P2|Treatment Period I (Week 1)|Study Terminated by Sponsor|1
4912924|NCT00541229|16922175|P1|Treatment Period I (Week 1)|Study Terminated by Sponsor|0
4912925|NCT00541229|16922170|P6|Treatment Period I (Week 1)|Protocol Specified Criteria|1
4912926|NCT00541229|16922171|P5|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4912927|NCT00541229|16922172|P4|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4912928|NCT00541229|16922173|P3|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4912929|NCT00541229|16922174|P2|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4912930|NCT00541229|16922175|P1|Treatment Period I (Week 1)|Protocol Specified Criteria|0
4912931|NCT00541229|16922170|P6|Treatment Period I (Week 1)|Withdrawal by Subject|1
4912932|NCT00541229|16922171|P5|Treatment Period I (Week 1)|Withdrawal by Subject|0
4912933|NCT00541229|16922172|P4|Treatment Period I (Week 1)|Withdrawal by Subject|0
4912934|NCT00541229|16922173|P3|Treatment Period I (Week 1)|Withdrawal by Subject|0
4912935|NCT00541229|16922174|P2|Treatment Period I (Week 1)|Withdrawal by Subject|0
4912936|NCT00541229|16922175|P1|Treatment Period I (Week 1)|Withdrawal by Subject|0
4912937|NCT00541229|16922170|P6|Treatment Period I (Week 1)|Physician Decision|0
4912938|NCT00541229|16922171|P5|Treatment Period I (Week 1)|Physician Decision|0
4912939|NCT00541229|16922172|P4|Treatment Period I (Week 1)|Physician Decision|0
4912940|NCT00541229|16922173|P3|Treatment Period I (Week 1)|Physician Decision|1
4912941|NCT00541229|16922174|P2|Treatment Period I (Week 1)|Physician Decision|0
4912942|NCT00541229|16922175|P1|Treatment Period I (Week 1)|Physician Decision|0
4912943|NCT00541099|16922194|P1|Overall Study|Ineligible|3
4912944|NCT00541034|16922202|P1|Overall Study|Non-Compliance|3
4912945|NCT00540644|16922251|P2|Overall Study|Noncomplilance|0
4912946|NCT00540644|16922252|P1|Overall Study|Noncomplilance|1
4912947|NCT00540644|16922251|P2|Overall Study|Withdrawal by Subject|2
4912948|NCT00540644|16922252|P1|Overall Study|Withdrawal by Subject|2
4912949|NCT00540644|16922251|P2|Overall Study|Physician Decision|5
4912950|NCT00540644|16922252|P1|Overall Study|Physician Decision|0
4912951|NCT00540644|16922251|P2|Overall Study|Disease Progression|1
4912952|NCT00540644|16922252|P1|Overall Study|Disease Progression|3
4912953|NCT00540644|16922251|P2|Overall Study|Adverse Event|1
4912954|NCT00540644|16922252|P1|Overall Study|Adverse Event|3
4912955|NCT00540592|16922272|P10|Overall Study|Withdrawal by Subject|0
4912956|NCT00540592|16922273|P9|Overall Study|Withdrawal by Subject|0
4912957|NCT00540592|16922274|P8|Overall Study|Withdrawal by Subject|0
4912958|NCT00540592|16922275|P7|Overall Study|Withdrawal by Subject|0
4912959|NCT00540592|16922276|P6|Overall Study|Withdrawal by Subject|0
4912960|NCT00540592|16922277|P5|Overall Study|Withdrawal by Subject|0
4912961|NCT00540592|16922278|P4|Overall Study|Withdrawal by Subject|1
4912962|NCT00540592|16922279|P3|Overall Study|Withdrawal by Subject|1
4912963|NCT00540592|16922280|P2|Overall Study|Withdrawal by Subject|0
4912964|NCT00540592|16922281|P1|Overall Study|Withdrawal by Subject|0
4912965|NCT00540592|16922272|P10|Overall Study|Lost to Follow-up|0
4912966|NCT00540592|16922273|P9|Overall Study|Lost to Follow-up|0
4912967|NCT00540592|16922274|P8|Overall Study|Lost to Follow-up|0
4912968|NCT00540592|16922275|P7|Overall Study|Lost to Follow-up|0
4912969|NCT00540592|16922276|P6|Overall Study|Lost to Follow-up|0
4912970|NCT00540592|16922277|P5|Overall Study|Lost to Follow-up|0
4912971|NCT00540592|16922278|P4|Overall Study|Lost to Follow-up|0
4912972|NCT00540592|16922279|P3|Overall Study|Lost to Follow-up|0
4912973|NCT00540592|16922280|P2|Overall Study|Lost to Follow-up|0
4912974|NCT00540592|16922281|P1|Overall Study|Lost to Follow-up|2
4912975|NCT00540592|16922272|P10|Overall Study|Adverse Event|2
4912976|NCT00540592|16922273|P9|Overall Study|Adverse Event|1
4912977|NCT00540592|16922274|P8|Overall Study|Adverse Event|1
4912978|NCT00540592|16922275|P7|Overall Study|Adverse Event|0
4912979|NCT00540592|16922276|P6|Overall Study|Adverse Event|0
4912980|NCT00540592|16922277|P5|Overall Study|Adverse Event|1
4912981|NCT00540592|16922278|P4|Overall Study|Adverse Event|0
4912982|NCT00540592|16922279|P3|Overall Study|Adverse Event|0
4912983|NCT00540592|16922280|P2|Overall Study|Adverse Event|1
4912984|NCT00540592|16922281|P1|Overall Study|Adverse Event|0
4912985|NCT00540514|16922520|P2|Overall Study|Paclitaxel not available|2
4912986|NCT00540514|16922521|P1|Overall Study|Paclitaxel not available|0
4912987|NCT00540514|16922520|P2|Overall Study|Excluded prior to treatment|7
4912988|NCT00540514|16922521|P1|Overall Study|Excluded prior to treatment|7
4912989|NCT00540514|16922520|P2|Overall Study|Withdrawal by Subject|67
4912990|NCT00540514|16922521|P1|Overall Study|Withdrawal by Subject|65
4912991|NCT00540514|16922520|P2|Overall Study|Lost to Follow-up|1
4912992|NCT00540514|16922521|P1|Overall Study|Lost to Follow-up|1
4912993|NCT00540514|16922520|P2|Overall Study|Protocol Deviation|4
4912994|NCT00540514|16922521|P1|Overall Study|Protocol Deviation|3
4912995|NCT00540514|16922520|P2|Overall Study|Physician Decision|99
4912996|NCT00540514|16922521|P1|Overall Study|Physician Decision|86
4912997|NCT00540514|16922520|P2|Overall Study|Adverse Event|24
4912998|NCT00540514|16922521|P1|Overall Study|Adverse Event|20
4912999|NCT00540514|16922520|P2|Overall Study|Unacceptable Toxicity|62
4913000|NCT00540514|16922521|P1|Overall Study|Unacceptable Toxicity|61
4913001|NCT00540514|16922520|P2|Overall Study|Still on treatment|0
4913002|NCT00540514|16922521|P1|Overall Study|Still on treatment|3
4913003|NCT00540449|16922553|P2|Overall Study|Other|4
4913004|NCT00540449|16922554|P1|Overall Study|Other|1
4913005|NCT00540449|16922553|P2|Overall Study|Withdrawal by Subject|10
4913006|NCT00540449|16922554|P1|Overall Study|Withdrawal by Subject|10
4913007|NCT00540449|16922553|P2|Overall Study|Subject Reached A Virologic Endpoint|8
4913008|NCT00540449|16922554|P1|Overall Study|Subject Reached A Virologic Endpoint|32
4913009|NCT00540449|16922553|P2|Overall Study|Subject Non-Compliant|5
4913010|NCT00540449|16922554|P1|Overall Study|Subject Non-Compliant|7
4913011|NCT00540449|16922553|P2|Overall Study|Lost to Follow-up|17
4913012|NCT00540449|16922554|P1|Overall Study|Lost to Follow-up|19
4913013|NCT00540449|16922553|P2|Overall Study|Subject Ineligible To Continue The Trial|1
4913014|NCT00540449|16922554|P1|Overall Study|Subject Ineligible To Continue The Trial|2
4913015|NCT00540449|16922553|P2|Overall Study|Sponsor's Decision|1
4913016|NCT00540449|16922554|P1|Overall Study|Sponsor's Decision|1
4913017|NCT00540449|16922553|P2|Overall Study|Adverse Event|32
4913018|NCT00540449|16922554|P1|Overall Study|Adverse Event|12
4913019|NCT00540436|16922576|P1|Second 12-Week Treatment Period|Adverse Event|1
4913020|NCT00540436|16922576|P1|First 12-Week Treatment Period|Initiation of prohibited medication|1
4913021|NCT00540436|16922576|P1|First 12-Week Treatment Period|Withdrawal by Subject|1
4913022|NCT00540436|16922576|P1|First 12-Week Treatment Period|Adverse Event|1
4913023|NCT00540423|16922591|P3|Open-Label Treatment Period|Lack of Efficacy|2
4913024|NCT00540423|16922592|P2|Open-Label Treatment Period|Lack of Efficacy|0
4913025|NCT00540423|16922593|P1|Open-Label Treatment Period|Lack of Efficacy|0
4913026|NCT00540423|16922591|P3|Double-Blind Treatment Period|Adverse Event|0
4913027|NCT00540423|16922592|P2|Double-Blind Treatment Period|Adverse Event|1
4913028|NCT00540423|16922593|P1|Double-Blind Treatment Period|Adverse Event|0
4913029|NCT00540293|16922643|P1|Overall Study|Protocol violation, & subject schedule|12
4913030|NCT00540293|16922643|P1|Overall Study|Withdrawal by Subject|6
4913031|NCT00540293|16922643|P1|Overall Study|Adverse event not related to study drug|7
4913032|NCT00540293|16922643|P1|Overall Study|Adverse event related to study drug|10
4913033|NCT00540228|16922691|P5|Overall Study|Lost to Follow-up|0
4913034|NCT00540228|16922692|P4|Overall Study|Lost to Follow-up|0
4913035|NCT00540228|16922693|P3|Overall Study|Lost to Follow-up|0
4913036|NCT00540228|16922694|P2|Overall Study|Lost to Follow-up|1
4913037|NCT00540228|16922695|P1|Overall Study|Lost to Follow-up|1
4913038|NCT00540228|16922691|P5|Overall Study|Adverse Event|0
4913039|NCT00540228|16922692|P4|Overall Study|Adverse Event|0
4913040|NCT00540228|16922693|P3|Overall Study|Adverse Event|0
4913041|NCT00540228|16922694|P2|Overall Study|Adverse Event|0
4913042|NCT00540228|16922695|P1|Overall Study|Adverse Event|2
4913043|NCT00540124|16922765|P3|Overall Study|Withdrawal by Subject|0
4913044|NCT00540124|16922766|P2|Overall Study|Withdrawal by Subject|1
4913045|NCT00540124|16922767|P1|Overall Study|Withdrawal by Subject|1
4913046|NCT00540124|16922765|P3|Overall Study|Lack of Efficacy|0
4913047|NCT00540124|16922766|P2|Overall Study|Lack of Efficacy|0
4913048|NCT00540124|16922767|P1|Overall Study|Lack of Efficacy|1
4913049|NCT00540124|16922765|P3|Overall Study|Entry Criteria Not Met|0
4913050|NCT00540124|16922766|P2|Overall Study|Entry Criteria Not Met|0
4913051|NCT00540124|16922767|P1|Overall Study|Entry Criteria Not Met|2
4913052|NCT00540124|16922765|P3|Overall Study|Adverse Event|1
4913053|NCT00540124|16922766|P2|Overall Study|Adverse Event|2
4913054|NCT00540124|16922767|P1|Overall Study|Adverse Event|0
4913055|NCT00540046|16922813|P2|Overall Study|Lost to Follow-up|23
4913056|NCT00540046|16922814|P1|Overall Study|Lost to Follow-up|33
4913057|NCT00539994|16922850|P3|Overall Study|Physician Decision|1
4913058|NCT00539994|16922851|P2|Overall Study|Physician Decision|0
4913059|NCT00539994|16922852|P1|Overall Study|Physician Decision|0
4913060|NCT00539994|16922850|P3|Overall Study|Withdrawal by Subject|1
4913061|NCT00539994|16922851|P2|Overall Study|Withdrawal by Subject|0
4913062|NCT00539994|16922852|P1|Overall Study|Withdrawal by Subject|1
4913063|NCT00539994|16922850|P3|Overall Study|Lost to Follow-up|0
4913064|NCT00539994|16922851|P2|Overall Study|Lost to Follow-up|1
4913065|NCT00539994|16922852|P1|Overall Study|Lost to Follow-up|2
4913066|NCT00539864|16922902|P2|Overall Study|Withdrawal by Subject|1
4913067|NCT00539864|16922903|P1|Overall Study|Withdrawal by Subject|1
4913068|NCT00539864|16922902|P2|Overall Study|Lost to Follow-up|1
4913069|NCT00539864|16922903|P1|Overall Study|Lost to Follow-up|0
4913070|NCT00539838|16922918|P3|Overall Study|Administrative|8
4913071|NCT00539838|16922919|P2|Overall Study|Administrative|0
4913072|NCT00539838|16922920|P1|Overall Study|Administrative|4
4913073|NCT00539838|16922918|P3|Overall Study|Did not cooperate|1
4913074|NCT00539838|16922919|P2|Overall Study|Did not cooperate|0
4913075|NCT00539838|16922920|P1|Overall Study|Did not cooperate|1
4913076|NCT00539838|16922918|P3|Overall Study|Death|0
4913077|NCT00539838|16922919|P2|Overall Study|Death|2
4913078|NCT00539838|16922920|P1|Overall Study|Death|0
4913079|NCT00539838|16922918|P3|Overall Study|Withdrawal by Subject|0
4913080|NCT00539838|16922919|P2|Overall Study|Withdrawal by Subject|4
4913081|NCT00539838|16922920|P1|Overall Study|Withdrawal by Subject|0
4913082|NCT00539838|16922918|P3|Overall Study|Fail to return|0
4913083|NCT00539838|16922919|P2|Overall Study|Fail to return|0
4913084|NCT00539838|16922920|P1|Overall Study|Fail to return|2
4913085|NCT00539734|16922970|P1|Overall Study|Protocol Violation|1
4913086|NCT00539591|16922996|P3|Overall Study|Disease progression|3
4913087|NCT00539591|16922997|P2|Overall Study|Disease progression|2
4913088|NCT00539591|16922998|P1|Overall Study|Disease progression|2
4913089|NCT00539591|16922996|P3|Overall Study|Toxicity|0
4913090|NCT00539591|16922997|P2|Overall Study|Toxicity|0
4913091|NCT00539591|16922998|P1|Overall Study|Toxicity|3
4913092|NCT00539513|16923150|P2|Overall Study|Lost to Follow-up|1
4913093|NCT00539513|16923151|P1|Overall Study|Lost to Follow-up|0
4913094|NCT00539513|16923150|P2|Overall Study|Withdrawal by Subject|1
4913095|NCT00539513|16923151|P1|Overall Study|Withdrawal by Subject|2
4913096|NCT00539500|16923163|P1|Overall Study|Lost to Follow-up|2
4913097|NCT00539500|16923163|P1|Overall Study|Disease Progression|1
4913098|NCT00539305|16923171|P2|Overall Study|Withdrawal by Subject|1
4913099|NCT00539305|16923172|P1|Overall Study|Withdrawal by Subject|0
4913100|NCT00539305|16923171|P2|Overall Study|Substance Use|1
4913101|NCT00539305|16923172|P1|Overall Study|Substance Use|0
4913102|NCT00539305|16923171|P2|Overall Study|Adverse Event|0
4913103|NCT00539305|16923172|P1|Overall Study|Adverse Event|1
4913104|NCT00539279|16923186|P2|6-Month Follow-Up Assessment|Lost to Follow-up|7
4913105|NCT00539279|16923187|P1|6-Month Follow-Up Assessment|Lost to Follow-up|1
4913106|NCT00539279|16923186|P2|Post-Treatment Assessment|Lost to Follow-up|9
4913107|NCT00539279|16923187|P1|Post-Treatment Assessment|Lost to Follow-up|12
4913108|NCT00539279|16923186|P2|Treatment|Death|0
4913109|NCT00539279|16923187|P1|Treatment|Death|1
4913110|NCT00539279|16923186|P2|Treatment|Withdrawal by Subject|8
4913111|NCT00539279|16923187|P1|Treatment|Withdrawal by Subject|10
4913112|NCT00539240|16923213|P3|Overall Study|Adverse Event|10
4913113|NCT00539240|16923214|P2|Overall Study|Adverse Event|1
4913114|NCT00539240|16923215|P1|Overall Study|Adverse Event|3
4913115|NCT00539240|16923213|P3|Overall Study|Lost to Follow-up|1
4913116|NCT00539240|16923214|P2|Overall Study|Lost to Follow-up|3
4913117|NCT00539240|16923215|P1|Overall Study|Lost to Follow-up|2
4913118|NCT00539240|16923213|P3|Overall Study|Protocol Violation|4
4913119|NCT00539240|16923214|P2|Overall Study|Protocol Violation|1
4913120|NCT00539240|16923215|P1|Overall Study|Protocol Violation|1
4913121|NCT00539240|16923213|P3|Overall Study|Withdrawal by Subject|0
4913122|NCT00539240|16923214|P2|Overall Study|Withdrawal by Subject|2
4913123|NCT00539240|16923215|P1|Overall Study|Withdrawal by Subject|0
4913124|NCT00539188|16923234|P2|Overall Study|Lost to Follow-up|1
4913125|NCT00539188|16923235|P1|Overall Study|Lost to Follow-up|2
4913126|NCT00539188|16923234|P2|Overall Study|Withdrawal by Subject|0
4913127|NCT00539188|16923235|P1|Overall Study|Withdrawal by Subject|1
4913128|NCT00539032|16923258|P2|Overall Study|Withdrawal by Subject|1
4913129|NCT00539032|16923259|P1|Overall Study|Withdrawal by Subject|2
4913130|NCT00539006|16923273|P4|Treatment Period 2|Other|0
4913131|NCT00539006|16923274|P3|Treatment Period 2|Other|0
4913132|NCT00539006|16923275|P2|Treatment Period 2|Other|1
4913133|NCT00539006|16923276|P1|Treatment Period 2|Other|0
4913134|NCT00539006|16923273|P4|Treatment Period 2|Protocol Violation|0
4913135|NCT00539006|16923274|P3|Treatment Period 2|Protocol Violation|0
4913136|NCT00539006|16923275|P2|Treatment Period 2|Protocol Violation|0
4913137|NCT00539006|16923276|P1|Treatment Period 2|Protocol Violation|1
4913138|NCT00539006|16923273|P4|Washout|Other|3
4913139|NCT00539006|16923274|P3|Washout|Other|2
4913140|NCT00539006|16923275|P2|Washout|Other|1
4913141|NCT00539006|16923276|P1|Washout|Other|1
4913142|NCT00539006|16923273|P4|Washout|Failed to meet continuation criteria|6
4913143|NCT00539006|16923274|P3|Washout|Failed to meet continuation criteria|14
4913144|NCT00539006|16923275|P2|Washout|Failed to meet continuation criteria|5
4913145|NCT00539006|16923276|P1|Washout|Failed to meet continuation criteria|16
4913146|NCT00539006|16923273|P4|Washout|Withdrawal by Subject|0
4913147|NCT00539006|16923274|P3|Washout|Withdrawal by Subject|0
4913148|NCT00539006|16923275|P2|Washout|Withdrawal by Subject|2
4913149|NCT00539006|16923276|P1|Washout|Withdrawal by Subject|0
4913150|NCT00539006|16923273|P4|Washout|Protocol Violation|0
4913151|NCT00539006|16923274|P3|Washout|Protocol Violation|0
4913152|NCT00539006|16923275|P2|Washout|Protocol Violation|1
4913153|NCT00539006|16923276|P1|Washout|Protocol Violation|1
4913154|NCT00539006|16923273|P4|Washout|Adverse Event|0
4913155|NCT00539006|16923274|P3|Washout|Adverse Event|0
4913156|NCT00539006|16923275|P2|Washout|Adverse Event|1
4913157|NCT00539006|16923276|P1|Washout|Adverse Event|2
4913158|NCT00539006|16923273|P4|Treatment Period 1|Lack of Efficacy|1
4913159|NCT00539006|16923274|P3|Treatment Period 1|Lack of Efficacy|0
4913160|NCT00539006|16923275|P2|Treatment Period 1|Lack of Efficacy|0
4913161|NCT00539006|16923276|P1|Treatment Period 1|Lack of Efficacy|0
4913162|NCT00539006|16923273|P4|Treatment Period 1|Protocol Violation|0
4913163|NCT00539006|16923274|P3|Treatment Period 1|Protocol Violation|1
4913164|NCT00539006|16923275|P2|Treatment Period 1|Protocol Violation|0
4913165|NCT00539006|16923276|P1|Treatment Period 1|Protocol Violation|0
4913166|NCT00539006|16923273|P4|Treatment Period 1|Lost to Follow-up|0
4913167|NCT00539006|16923274|P3|Treatment Period 1|Lost to Follow-up|1
4913168|NCT00539006|16923275|P2|Treatment Period 1|Lost to Follow-up|0
4913169|NCT00539006|16923276|P1|Treatment Period 1|Lost to Follow-up|0
4913170|NCT00539006|16923273|P4|Pre-treatment|Other|0
4913171|NCT00539006|16923274|P3|Pre-treatment|Other|0
4913172|NCT00539006|16923275|P2|Pre-treatment|Other|1
4913173|NCT00539006|16923276|P1|Pre-treatment|Other|0
4913174|NCT00538902|16923321|P3|OL Wk 24 to End (Primary D/C Reasons)|Various|22
4913175|NCT00538902|16923322|P2|OL Wk 24 to End (Primary D/C Reasons)|Various|25
4913176|NCT00538902|16923323|P1|OL Wk 24 to End (Primary D/C Reasons)|Various|18
4913177|NCT00538902|16923321|P3|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6
4913263|NCT00537771|16923799|P2|Overall Study|Protocol Violation|6
4913178|NCT00538902|16923322|P2|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10
4913179|NCT00538902|16923323|P1|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1
4913180|NCT00538902|16923321|P3|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25
4913181|NCT00538902|16923322|P2|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19
4913182|NCT00538902|16923323|P1|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15
4913183|NCT00538902|16923321|P3|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11
4913184|NCT00538902|16923322|P2|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10
4913185|NCT00538902|16923323|P1|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2
4913186|NCT00538902|16923321|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
4913187|NCT00538902|16923322|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
4913188|NCT00538902|16923323|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0
4913189|NCT00538902|16923321|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1
4913190|NCT00538902|16923322|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
4913191|NCT00538902|16923323|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0
4913192|NCT00538902|16923321|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1
4913193|NCT00538902|16923322|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
4913194|NCT00538902|16923323|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0
4913195|NCT00538902|16923321|P3|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3
4913196|NCT00538902|16923322|P2|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2
4913197|NCT00538902|16923323|P1|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1
4913198|NCT00538785|16923384|P2|Overall Study|Lost to Follow-up|0
4913199|NCT00538785|16923385|P1|Overall Study|Lost to Follow-up|1
4913200|NCT00538785|16923384|P2|Overall Study|Withdrawal of consent|7
4913201|NCT00538785|16923385|P1|Overall Study|Withdrawal of consent|9
4913202|NCT00538785|16923384|P2|Overall Study|Death|10
4913203|NCT00538785|16923385|P1|Overall Study|Death|9
4913204|NCT00538733|16923427|P1|Overall Study|still on therapy|1
4913205|NCT00538733|16923427|P1|Overall Study|declined to participate|2
4913206|NCT00538733|16923427|P1|Overall Study|Death|1
4913207|NCT00538733|16923427|P1|Overall Study|Adverse Event|8
4913208|NCT00538629|16923477|P1|Overall Study|Subject's untimely distrust of medicine|1
4913209|NCT00538629|16923477|P1|Overall Study|Lost to Follow-up|6
4913210|NCT00538629|16923477|P1|Overall Study|Lack of Efficacy|12
4913211|NCT00538629|16923477|P1|Overall Study|Adverse Event|2
4913212|NCT00538629|16923477|P1|Overall Study|At subject's request|1
4913213|NCT00538590|16923533|P2|Overall Study|Death|0
4913214|NCT00538590|16923534|P1|Overall Study|Death|1
4913215|NCT00538473|16923572|P2|Overall Study|Adverse Event|0
4913216|NCT00538473|16923573|P1|Overall Study|Adverse Event|1
4913217|NCT00538291|16923653|P1|Overall Study|Withdrawal by Subject|1
4913218|NCT00538291|16923653|P1|Overall Study|Adverse Event|2
4913219|NCT00537979|16923711|P2|Overall Study|Heart failure|1
4913220|NCT00537979|16923712|P1|Overall Study|Heart failure|0
4913221|NCT00537979|16923711|P2|Overall Study|Kidney transplant|3
4913222|NCT00537979|16923712|P1|Overall Study|Kidney transplant|0
4913223|NCT00537979|16923711|P2|Overall Study|Death|3
4913224|NCT00537979|16923712|P1|Overall Study|Death|0
4913225|NCT00537979|16923711|P2|Overall Study|Non-compliance with treatment/procedure|2
4913226|NCT00537979|16923712|P1|Overall Study|Non-compliance with treatment/procedure|2
4913227|NCT00537979|16923711|P2|Overall Study|Lack of Efficacy|1
4913228|NCT00537979|16923712|P1|Overall Study|Lack of Efficacy|0
4913229|NCT00537979|16923711|P2|Overall Study|Lost to Follow-up|4
4913230|NCT00537979|16923712|P1|Overall Study|Lost to Follow-up|1
4913231|NCT00537979|16923711|P2|Overall Study|Withdrawal by Subject|4
4913232|NCT00537979|16923712|P1|Overall Study|Withdrawal by Subject|1
4913233|NCT00537979|16923711|P2|Overall Study|Adverse Event|2
4913234|NCT00537979|16923712|P1|Overall Study|Adverse Event|2
4913235|NCT00537940|16923728|P2|Overall Study|Other|12
4913236|NCT00537940|16923729|P1|Overall Study|Other|10
4913237|NCT00537940|16923728|P2|Overall Study|Study terminated by sponsor|3
4913238|NCT00537940|16923729|P1|Overall Study|Study terminated by sponsor|2
4913239|NCT00537940|16923728|P2|Overall Study|Pregnancy|1
4913240|NCT00537940|16923729|P1|Overall Study|Pregnancy|1
4913241|NCT00537940|16923728|P2|Overall Study|Protocol Violation|4
4913242|NCT00537940|16923729|P1|Overall Study|Protocol Violation|6
4913243|NCT00537940|16923728|P2|Overall Study|Withdrawal by Subject|95
4913244|NCT00537940|16923729|P1|Overall Study|Withdrawal by Subject|113
4913245|NCT00537940|16923728|P2|Overall Study|Lost to Follow-up|29
4913246|NCT00537940|16923729|P1|Overall Study|Lost to Follow-up|23
4913247|NCT00537940|16923728|P2|Overall Study|Lack of Efficacy|16
4913248|NCT00537940|16923729|P1|Overall Study|Lack of Efficacy|8
4913249|NCT00537940|16923728|P2|Overall Study|Adverse Event|19
4913250|NCT00537940|16923729|P1|Overall Study|Adverse Event|20
4913251|NCT00537823|16923753|P2|Overall Study|Adverse Event|0
4913252|NCT00537823|16923754|P1|Overall Study|Adverse Event|2
4913253|NCT00537810|16923780|P4|Overall Study|Medically withdrawn|1
4913254|NCT00537810|16923781|P3|Overall Study|Medically withdrawn|0
4913255|NCT00537810|16923782|P2|Overall Study|Medically withdrawn|2
4913256|NCT00537810|16923783|P1|Overall Study|Medically withdrawn|2
4913257|NCT00537810|16923780|P4|Overall Study|Withdrawal by Subject|3
4913258|NCT00537810|16923781|P3|Overall Study|Withdrawal by Subject|4
4913259|NCT00537810|16923782|P2|Overall Study|Withdrawal by Subject|11
4913260|NCT00537810|16923783|P1|Overall Study|Withdrawal by Subject|4
4913261|NCT00537771|16923799|P2|Overall Study|Severe Non-Compliance to Protocol|2
4913262|NCT00537771|16923800|P1|Overall Study|Severe Non-Compliance to Protocol|4
4913264|NCT00537771|16923800|P1|Overall Study|Protocol Violation|2
4913265|NCT00537771|16923799|P2|Overall Study|Lost to Follow-up|15
4913266|NCT00537771|16923800|P1|Overall Study|Lost to Follow-up|9
4913267|NCT00537771|16923799|P2|Overall Study|Adverse Event|15
4913268|NCT00537771|16923800|P1|Overall Study|Adverse Event|8
4913269|NCT00537771|16923799|P2|Overall Study|Withdrawal by Subject|23
4913270|NCT00537771|16923800|P1|Overall Study|Withdrawal by Subject|6
4913271|NCT00537745|16923810|P1|Overall Study|Subject unable to provide Interlock info|1
4913272|NCT00537745|16923810|P1|Overall Study|Withdrawal by Subject|2
4913273|NCT00537745|16923810|P1|Overall Study|Did not meet eligibility criteria|2
4913274|NCT00537485|16923892|P2|Overall Study|Physician Decision|0
4913275|NCT00537485|16923893|P1|Overall Study|Physician Decision|1
4913276|NCT00537485|16923892|P2|Overall Study|Withdrawal by Subject|3
4913277|NCT00537485|16923893|P1|Overall Study|Withdrawal by Subject|1
4913278|NCT00537485|16923892|P2|Overall Study|Withdrawal by Subject|2
4913279|NCT00537485|16923893|P1|Overall Study|Withdrawal by Subject|3
4913280|NCT00537485|16923892|P2|Overall Study|Adverse Event|5
4913281|NCT00537485|16923893|P1|Overall Study|Adverse Event|10
4913282|NCT00537394|16923966|P3|2nd Year of Follow-up|Clinic site closure|0
4913283|NCT00537394|16923967|P2|2nd Year of Follow-up|Clinic site closure|0
4913284|NCT00537394|16923968|P1|2nd Year of Follow-up|Clinic site closure|1
4913285|NCT00537394|16923966|P3|2nd Year of Follow-up|Lost to Follow-up|2
4913286|NCT00537394|16923967|P2|2nd Year of Follow-up|Lost to Follow-up|7
4913287|NCT00537394|16923968|P1|2nd Year of Follow-up|Lost to Follow-up|6
4913288|NCT00537394|16923966|P3|2nd Year of Follow-up|Withdrawal by Subject|2
4913289|NCT00537394|16923967|P2|2nd Year of Follow-up|Withdrawal by Subject|1
4913290|NCT00537394|16923968|P1|2nd Year of Follow-up|Withdrawal by Subject|0
4913291|NCT00537394|16923966|P3|2nd Year of Follow-up|Death|2
4913292|NCT00537394|16923967|P2|2nd Year of Follow-up|Death|1
4913293|NCT00537394|16923968|P1|2nd Year of Follow-up|Death|4
4913294|NCT00537394|16923966|P3|First Year of Follow-up|Lost to Follow-up|1
4913295|NCT00537394|16923967|P2|First Year of Follow-up|Lost to Follow-up|5
4913296|NCT00537394|16923968|P1|First Year of Follow-up|Lost to Follow-up|1
4913297|NCT00537394|16923966|P3|First Year of Follow-up|Withdrawal by Subject|1
4913298|NCT00537394|16923967|P2|First Year of Follow-up|Withdrawal by Subject|6
4913299|NCT00537394|16923968|P1|First Year of Follow-up|Withdrawal by Subject|3
4913300|NCT00537394|16923966|P3|First Year of Follow-up|Severe debilitation|1
4913301|NCT00537394|16923967|P2|First Year of Follow-up|Severe debilitation|0
4913302|NCT00537394|16923968|P1|First Year of Follow-up|Severe debilitation|1
4913303|NCT00537394|16923966|P3|First Year of Follow-up|Death|0
4913304|NCT00537394|16923967|P2|First Year of Follow-up|Death|0
4913305|NCT00537394|16923968|P1|First Year of Follow-up|Death|7
4913306|NCT00537381|16924004|P2|Overall Study|Other|3
4913307|NCT00537381|16924005|P1|Overall Study|Other|5
4913308|NCT00537381|16924004|P2|Overall Study|Sponsor decision|9
4913309|NCT00537381|16924005|P1|Overall Study|Sponsor decision|14
4913310|NCT00537381|16924004|P2|Overall Study|Disease Progression|18
4913311|NCT00537381|16924005|P1|Overall Study|Disease Progression|9
4913312|NCT00537381|16924004|P2|Overall Study|Physician Decision|6
4913313|NCT00537381|16924005|P1|Overall Study|Physician Decision|7
4913314|NCT00537381|16924004|P2|Overall Study|Withdrawal by Subject|14
4913315|NCT00537381|16924005|P1|Overall Study|Withdrawal by Subject|5
4913316|NCT00537381|16924004|P2|Overall Study|Death|3
4913317|NCT00537381|16924005|P1|Overall Study|Death|3
4913318|NCT00537381|16924004|P2|Overall Study|Adverse Event|9
4913319|NCT00537381|16924005|P1|Overall Study|Adverse Event|13
4913320|NCT00537329|16924025|P1|Overall Study|Other|1
4913321|NCT00537329|16924025|P1|Overall Study|Withdrawal by Subject|4
4913322|NCT00537329|16924025|P1|Overall Study|Lost to Follow-up|6
4913323|NCT00537329|16924025|P1|Overall Study|Lack of Efficacy|2
4913324|NCT00537329|16924025|P1|Overall Study|Adverse Event|3
4913325|NCT00537329|16924025|P1|Overall Study|Death|10
4913326|NCT00537316|16924045|P7|Part 2|Administrative|1
4913327|NCT00537316|16924046|P6|Part 2|Administrative|4
4913328|NCT00537316|16924047|P5|Part 2|Administrative|1
4913329|NCT00537316|16924048|P4|Part 2|Administrative|3
4913330|NCT00537316|16924049|P3|Part 2|Administrative|24
4913331|NCT00537316|16924050|P2|Part 2|Administrative|8
4913332|NCT00537316|16924051|P1|Part 2|Administrative|16
4913333|NCT00537316|16924045|P7|Part 2|Withdrawal by Subject|0
4913334|NCT00537316|16924046|P6|Part 2|Withdrawal by Subject|0
4913335|NCT00537316|16924047|P5|Part 2|Withdrawal by Subject|0
4913336|NCT00537316|16924048|P4|Part 2|Withdrawal by Subject|0
4913337|NCT00537316|16924049|P3|Part 2|Withdrawal by Subject|4
4913338|NCT00537316|16924050|P2|Part 2|Withdrawal by Subject|1
4913339|NCT00537316|16924051|P1|Part 2|Withdrawal by Subject|5
4913340|NCT00537316|16924045|P7|Part 2|Lost to Follow-up|0
4913341|NCT00537316|16924046|P6|Part 2|Lost to Follow-up|0
4913342|NCT00537316|16924047|P5|Part 2|Lost to Follow-up|0
4913343|NCT00537316|16924048|P4|Part 2|Lost to Follow-up|0
4913344|NCT00537316|16924049|P3|Part 2|Lost to Follow-up|2
4913345|NCT00537316|16924050|P2|Part 2|Lost to Follow-up|0
4913346|NCT00537316|16924051|P1|Part 2|Lost to Follow-up|1
4913347|NCT00537316|16924045|P7|Part 2|Adverse Event|0
4913348|NCT00537316|16924046|P6|Part 2|Adverse Event|0
4913349|NCT00537316|16924047|P5|Part 2|Adverse Event|0
4913350|NCT00537316|16924048|P4|Part 2|Adverse Event|0
4913351|NCT00537316|16924049|P3|Part 2|Adverse Event|2
4913352|NCT00537316|16924050|P2|Part 2|Adverse Event|0
4913353|NCT00537316|16924051|P1|Part 2|Adverse Event|4
4913354|NCT00537316|16924045|P7|Part 2|Never entered follow-up|1
4913355|NCT00537316|16924046|P6|Part 2|Never entered follow-up|0
4913356|NCT00537316|16924047|P5|Part 2|Never entered follow-up|0
4913357|NCT00537316|16924048|P4|Part 2|Never entered follow-up|0
4913358|NCT00537316|16924049|P3|Part 2|Never entered follow-up|0
4913359|NCT00537316|16924050|P2|Part 2|Never entered follow-up|0
4913360|NCT00537316|16924051|P1|Part 2|Never entered follow-up|0
4913361|NCT00537316|16924045|P7|Part 1|Administrative|0
4913362|NCT00537316|16924046|P6|Part 1|Administrative|0
4913363|NCT00537316|16924047|P5|Part 1|Administrative|0
4913364|NCT00537316|16924048|P4|Part 1|Administrative|0
4913365|NCT00537316|16924049|P3|Part 1|Administrative|2
4913366|NCT00537316|16924050|P2|Part 1|Administrative|0
4913367|NCT00537316|16924051|P1|Part 1|Administrative|0
4913368|NCT00537316|16924045|P7|Part 1|Did not meet protocol eligibility|0
4913369|NCT00537316|16924046|P6|Part 1|Did not meet protocol eligibility|0
4913370|NCT00537316|16924047|P5|Part 1|Did not meet protocol eligibility|0
4913371|NCT00537316|16924048|P4|Part 1|Did not meet protocol eligibility|0
4913372|NCT00537316|16924049|P3|Part 1|Did not meet protocol eligibility|2
4913373|NCT00537316|16924050|P2|Part 1|Did not meet protocol eligibility|3
4913374|NCT00537316|16924051|P1|Part 1|Did not meet protocol eligibility|1
4913375|NCT00537316|16924045|P7|Part 1|Protocol Violation|0
4913376|NCT00537316|16924046|P6|Part 1|Protocol Violation|0
4913377|NCT00537316|16924047|P5|Part 1|Protocol Violation|0
4913378|NCT00537316|16924048|P4|Part 1|Protocol Violation|0
4913379|NCT00537316|16924049|P3|Part 1|Protocol Violation|1
4913380|NCT00537316|16924050|P2|Part 1|Protocol Violation|5
4913381|NCT00537316|16924051|P1|Part 1|Protocol Violation|1
4913382|NCT00537316|16924045|P7|Part 1|Withdrawal by Subject|0
4913383|NCT00537316|16924046|P6|Part 1|Withdrawal by Subject|0
4913384|NCT00537316|16924047|P5|Part 1|Withdrawal by Subject|0
4913385|NCT00537316|16924048|P4|Part 1|Withdrawal by Subject|0
4913386|NCT00537316|16924049|P3|Part 1|Withdrawal by Subject|4
4913387|NCT00537316|16924050|P2|Part 1|Withdrawal by Subject|8
4913388|NCT00537316|16924051|P1|Part 1|Withdrawal by Subject|3
4913389|NCT00537316|16924045|P7|Part 1|Lost to Follow-up|0
4913390|NCT00537316|16924046|P6|Part 1|Lost to Follow-up|0
4913391|NCT00537316|16924047|P5|Part 1|Lost to Follow-up|0
4913392|NCT00537316|16924048|P4|Part 1|Lost to Follow-up|0
4913393|NCT00537316|16924049|P3|Part 1|Lost to Follow-up|0
4913394|NCT00537316|16924050|P2|Part 1|Lost to Follow-up|0
4913395|NCT00537316|16924051|P1|Part 1|Lost to Follow-up|1
4913396|NCT00537316|16924045|P7|Part 1|Protocol defined clinical event|0
4913397|NCT00537316|16924046|P6|Part 1|Protocol defined clinical event|0
4913398|NCT00537316|16924047|P5|Part 1|Protocol defined clinical event|0
4913399|NCT00537316|16924048|P4|Part 1|Protocol defined clinical event|0
4913400|NCT00537316|16924049|P3|Part 1|Protocol defined clinical event|0
4913401|NCT00537316|16924050|P2|Part 1|Protocol defined clinical event|0
4913402|NCT00537316|16924051|P1|Part 1|Protocol defined clinical event|1
4913403|NCT00537316|16924045|P7|Part 1|Adverse Event|0
4913404|NCT00537316|16924046|P6|Part 1|Adverse Event|0
4913405|NCT00537316|16924047|P5|Part 1|Adverse Event|0
4913406|NCT00537316|16924048|P4|Part 1|Adverse Event|0
4913407|NCT00537316|16924049|P3|Part 1|Adverse Event|8
4913408|NCT00537316|16924050|P2|Part 1|Adverse Event|11
4913409|NCT00537316|16924051|P1|Part 1|Adverse Event|7
4913410|NCT00537303|16924078|P2|Overall Study|Unclassified|7
4913411|NCT00537303|16924079|P1|Overall Study|Unclassified|8
4913412|NCT00537303|16924078|P2|Overall Study|Withdrawal criteria|3
4913413|NCT00537303|16924079|P1|Overall Study|Withdrawal criteria|3
4913414|NCT00537303|16924078|P2|Overall Study|Protocol Violation|4
4913415|NCT00537303|16924079|P1|Overall Study|Protocol Violation|8
4913416|NCT00537303|16924078|P2|Overall Study|Lack of Efficacy|7
4913417|NCT00537303|16924079|P1|Overall Study|Lack of Efficacy|6
4913418|NCT00537303|16924078|P2|Overall Study|Adverse Event|4
4913419|NCT00537303|16924079|P1|Overall Study|Adverse Event|1
4913420|NCT00537277|16924100|P1|Overall Study|Non-compliance with trial procedures|15
4913421|NCT00537277|16924100|P1|Overall Study|Inability to tolerate trial medication|4
4913422|NCT00537277|16924100|P1|Overall Study|Unclassified|4
4913423|NCT00537277|16924100|P1|Overall Study|Protocol Violation|11
4913424|NCT00537277|16924100|P1|Overall Study|Lost to Follow-up|12
4913425|NCT00537277|16924100|P1|Overall Study|Lack of Efficacy|2
4913426|NCT00537277|16924100|P1|Overall Study|Adverse Event|1
4913427|NCT00537238|16924111|P2|Overall Study|Other|52
4913428|NCT00537238|16924112|P1|Overall Study|Other|44
4913429|NCT00537238|16924111|P2|Overall Study|Does not meet entrance criteria|2
4913430|NCT00537238|16924112|P1|Overall Study|Does not meet entrance criteria|0
4913431|NCT00537238|16924111|P2|Overall Study|Protocol Violation|19
4913432|NCT00537238|16924112|P1|Overall Study|Protocol Violation|15
4913433|NCT00537238|16924111|P2|Overall Study|Withdrawal by Subject|47
4913434|NCT00537238|16924112|P1|Overall Study|Withdrawal by Subject|51
4913435|NCT00537238|16924111|P2|Overall Study|Lost to Follow-up|8
4913436|NCT00537238|16924112|P1|Overall Study|Lost to Follow-up|12
4913437|NCT00537238|16924111|P2|Overall Study|Lack of Efficacy|21
4913438|NCT00537238|16924112|P1|Overall Study|Lack of Efficacy|20
4913439|NCT00537238|16924111|P2|Overall Study|Adverse Event|22
4913440|NCT00537238|16924112|P1|Overall Study|Adverse Event|31
4913441|NCT00537238|16924111|P2|Overall Study|Death|2
4913442|NCT00537238|16924112|P1|Overall Study|Death|1
4913443|NCT00537199|16924132|P1|Overall Study|Study Terminated|1
4913444|NCT00537095|16924138|P2|Overall Study|Incorrect enrolment|1
4913445|NCT00537095|16924139|P1|Overall Study|Incorrect enrolment|0
4913446|NCT00537095|16924138|P2|Overall Study|subjective disease progression|1
4913447|NCT00537095|16924139|P1|Overall Study|subjective disease progression|0
4913448|NCT00537095|16924138|P2|Overall Study|Withdrawal by Subject|2
4913449|NCT00537095|16924139|P1|Overall Study|Withdrawal by Subject|2
4913450|NCT00537095|16924138|P2|Overall Study|Death|1
4913451|NCT00537095|16924139|P1|Overall Study|Death|3
4913452|NCT00537095|16924138|P2|Overall Study|disease progression|48
4913453|NCT00537095|16924139|P1|Overall Study|disease progression|21
4913454|NCT00537095|16924138|P2|Overall Study|Adverse Event|4
4913455|NCT00537095|16924139|P1|Overall Study|Adverse Event|24
4913456|NCT00537095|16924138|P2|Overall Study|surgery|0
4913457|NCT00537095|16924139|P1|Overall Study|surgery|1
4913458|NCT00537082|16924154|P3|Overall Study|Discontinued before initiating treatment|0
4913459|NCT00537082|16924155|P2|Overall Study|Discontinued before initiating treatment|0
4913460|NCT00537082|16924156|P1|Overall Study|Discontinued before initiating treatment|3
4913461|NCT00537082|16924154|P3|Overall Study|Withdrawal by Subject|0
4913462|NCT00537082|16924155|P2|Overall Study|Withdrawal by Subject|1
4913463|NCT00537082|16924156|P1|Overall Study|Withdrawal by Subject|0
4913464|NCT00537082|16924154|P3|Overall Study|Lack of Efficacy|2
4913465|NCT00537082|16924155|P2|Overall Study|Lack of Efficacy|0
4913466|NCT00537082|16924156|P1|Overall Study|Lack of Efficacy|0
4913467|NCT00537082|16924154|P3|Overall Study|Protocol Violation|1
4913468|NCT00537082|16924155|P2|Overall Study|Protocol Violation|2
4913469|NCT00537082|16924156|P1|Overall Study|Protocol Violation|0
4913470|NCT00537082|16924154|P3|Overall Study|Adverse Event|3
4913471|NCT00537082|16924155|P2|Overall Study|Adverse Event|6
4913472|NCT00537082|16924156|P1|Overall Study|Adverse Event|6
4913473|NCT00537056|16924173|P1|Interim PET/CT|scheduling conflicts and/or exposure|5
4913474|NCT00537030|16924185|P1|Overall Study|Inevaluable|2
4913475|NCT00537030|16924185|P1|Overall Study|Ineligible|2
4913476|NCT00537030|16924185|P1|Overall Study|Disease progression/ relapse during Tx|1
4913477|NCT00537030|16924185|P1|Overall Study|≥ Grade 2 allergy|7
4913478|NCT00537030|16924185|P1|Overall Study|Withdrawal by Subject|2
4913479|NCT00537030|16924185|P1|Overall Study|Physician Decision|2
4913480|NCT00537017|16924192|P1|Follow-up Phase|Withdrawal by Subject|9
4913481|NCT00537017|16924192|P1|Treatment Phase|Protocol Violation|2
4913482|NCT00537017|16924192|P1|Treatment Phase|Withdrawal by Subject|13
4913483|NCT00537017|16924192|P1|Treatment Phase|Adverse Event|19
4913484|NCT00536991|16924203|P1|Overall Study|patient ineligible|2
4913485|NCT00536991|16924203|P1|Overall Study|Physician Decision|1
4913486|NCT00536991|16924203|P1|Overall Study|Withdrawal by Subject|10
4913487|NCT00536978|16924210|P1|Overall Study|Not eligible for Adback Infusion|22
4913488|NCT00536939|16924214|P2|Overall Study|Other Complicating Disease|0
4913489|NCT00536939|16924215|P1|Overall Study|Other Complicating Disease|1
4913490|NCT00536939|16924214|P2|Overall Study|Withdrawal by Subject|0
4913491|NCT00536939|16924215|P1|Overall Study|Withdrawal by Subject|1
4913492|NCT00536874|16924246|P1|Overall Study|Withdrawal by Subject|1
4913493|NCT00536874|16924246|P1|Overall Study|Death|2
4913494|NCT00536874|16924246|P1|Overall Study|Adverse Event|1
4913495|NCT00536809|16924256|P1|Phase II|Referred for surgical resection|1
4913496|NCT00536809|16924256|P1|Phase II|Adverse Event|1
4913497|NCT00536744|16924279|P2|Overall Study|PI tried alternative treatment|3
4913498|NCT00536744|16924280|P1|Overall Study|PI tried alternative treatment|1
4913499|NCT00536744|16924279|P2|Overall Study|Withdrawal by Subject|8
4913500|NCT00536744|16924280|P1|Overall Study|Withdrawal by Subject|7
4913501|NCT00536744|16924279|P2|Overall Study|Lost to Follow-up|5
4913502|NCT00536744|16924280|P1|Overall Study|Lost to Follow-up|3
4913503|NCT00536744|16924279|P2|Overall Study|Physician Decision|1
4913504|NCT00536744|16924280|P1|Overall Study|Physician Decision|3
4913505|NCT00536744|16924279|P2|Overall Study|Death|1
4913506|NCT00536744|16924280|P1|Overall Study|Death|2
4913507|NCT00536744|16924279|P2|Overall Study|Adverse Event|10
4913508|NCT00536744|16924280|P1|Overall Study|Adverse Event|13
4913509|NCT00536731|16924289|P3|Overall Study|Other|0
4913510|NCT00536731|16924290|P2|Overall Study|Other|1
4913511|NCT00536731|16924291|P1|Overall Study|Other|1
4913512|NCT00536731|16924289|P3|Overall Study|Safety reasons|1
4913513|NCT00536731|16924290|P2|Overall Study|Safety reasons|0
4913514|NCT00536731|16924291|P1|Overall Study|Safety reasons|0
4913515|NCT00536731|16924289|P3|Overall Study|Intake of prohibited conc. medication|1
4913516|NCT00536731|16924290|P2|Overall Study|Intake of prohibited conc. medication|0
4913517|NCT00536731|16924291|P1|Overall Study|Intake of prohibited conc. medication|0
4913518|NCT00536731|16924289|P3|Overall Study|Withdrawal by Subject|0
4913519|NCT00536731|16924290|P2|Overall Study|Withdrawal by Subject|2
4913520|NCT00536731|16924291|P1|Overall Study|Withdrawal by Subject|0
4913521|NCT00536731|16924289|P3|Overall Study|Adverse Event|3
4913522|NCT00536731|16924290|P2|Overall Study|Adverse Event|2
4913523|NCT00536731|16924291|P1|Overall Study|Adverse Event|3
4913524|NCT00536575|16924335|P1|Overall Study|Death|1
4913525|NCT00536575|16924335|P1|Overall Study|Withdrawal by Subject|1
4913526|NCT00536510|16924341|P2|Overall Study|Patient Discontinued for Other Reasons|2
4913527|NCT00536510|16924342|P1|Overall Study|Patient Discontinued for Other Reasons|2
4913528|NCT00536510|16924341|P2|Overall Study|Laboratory Adverse Event|1
4913529|NCT00536510|16924342|P1|Overall Study|Laboratory Adverse Event|2
4913530|NCT00536510|16924341|P2|Overall Study|Flushing with Product|0
4913531|NCT00536510|16924342|P1|Overall Study|Flushing with Product|20
4913532|NCT00536510|16924341|P2|Overall Study|Withdrawal by Subject|9
4913533|NCT00536510|16924342|P1|Overall Study|Withdrawal by Subject|16
4913534|NCT00536510|16924341|P2|Overall Study|Protocol Violation|5
4913535|NCT00536510|16924342|P1|Overall Study|Protocol Violation|4
4913536|NCT00536510|16924341|P2|Overall Study|Lost to Follow-up|8
4913537|NCT00536510|16924342|P1|Overall Study|Lost to Follow-up|11
4913538|NCT00536510|16924341|P2|Overall Study|Adverse Event|4
4913539|NCT00536510|16924342|P1|Overall Study|Adverse Event|27
4913540|NCT00536484|16924352|P2|Overall Study|Other|0
4913541|NCT00536484|16924353|P1|Overall Study|Other|4
4913542|NCT00536484|16924352|P2|Overall Study|Lack of Efficacy|5
4913543|NCT00536484|16924353|P1|Overall Study|Lack of Efficacy|16
4913544|NCT00536484|16924352|P2|Overall Study|Lost to Follow-up|6
4913545|NCT00536484|16924353|P1|Overall Study|Lost to Follow-up|8
4913546|NCT00536484|16924352|P2|Overall Study|Withdrawal by Subject|11
4913547|NCT00536484|16924353|P1|Overall Study|Withdrawal by Subject|11
4913548|NCT00536484|16924352|P2|Overall Study|Adverse Event|34
4913549|NCT00536484|16924353|P1|Overall Study|Adverse Event|21
4913550|NCT00536471|16924387|P4|Overall Study|Sponsor Decision|2
4913551|NCT00536471|16924388|P3|Overall Study|Sponsor Decision|3
4913552|NCT00536471|16924389|P2|Overall Study|Sponsor Decision|1
4913553|NCT00536471|16924390|P1|Overall Study|Sponsor Decision|0
4913554|NCT00536471|16924387|P4|Overall Study|Death|2
4913555|NCT00536471|16924388|P3|Overall Study|Death|1
4913556|NCT00536471|16924389|P2|Overall Study|Death|0
4913557|NCT00536471|16924390|P1|Overall Study|Death|0
4913558|NCT00536471|16924387|P4|Overall Study|Physician Decision|2
4913559|NCT00536471|16924388|P3|Overall Study|Physician Decision|3
4913560|NCT00536471|16924389|P2|Overall Study|Physician Decision|1
4913561|NCT00536471|16924390|P1|Overall Study|Physician Decision|11
4913562|NCT00536471|16924387|P4|Overall Study|Protocol Violation|3
4913563|NCT00536471|16924388|P3|Overall Study|Protocol Violation|2
4913564|NCT00536471|16924389|P2|Overall Study|Protocol Violation|1
4913565|NCT00536471|16924390|P1|Overall Study|Protocol Violation|8
4913566|NCT00536471|16924387|P4|Overall Study|Lack of Efficacy|9
4913567|NCT00536471|16924388|P3|Overall Study|Lack of Efficacy|11
4913568|NCT00536471|16924389|P2|Overall Study|Lack of Efficacy|18
4913569|NCT00536471|16924390|P1|Overall Study|Lack of Efficacy|17
4913570|NCT00536471|16924387|P4|Overall Study|Withdrawal by Subject|21
4913571|NCT00536471|16924388|P3|Overall Study|Withdrawal by Subject|43
4913572|NCT00536471|16924389|P2|Overall Study|Withdrawal by Subject|24
4913573|NCT00536471|16924390|P1|Overall Study|Withdrawal by Subject|40
4913574|NCT00536471|16924387|P4|Overall Study|Adverse Event|13
4913575|NCT00536471|16924388|P3|Overall Study|Adverse Event|28
4913576|NCT00536471|16924389|P2|Overall Study|Adverse Event|16
4913577|NCT00536471|16924390|P1|Overall Study|Adverse Event|32
4913578|NCT00536471|16924387|P4|Overall Study|Lost to Follow-up|22
4913579|NCT00536471|16924388|P3|Overall Study|Lost to Follow-up|48
4913580|NCT00536471|16924389|P2|Overall Study|Lost to Follow-up|23
4913581|NCT00536471|16924390|P1|Overall Study|Lost to Follow-up|48
4913582|NCT00536380|16924635|P3|Overall Study|Administrative|1
4913583|NCT00536380|16924636|P2|Overall Study|Administrative|0
4913584|NCT00536380|16924637|P1|Overall Study|Administrative|0
4913585|NCT00536380|16924635|P3|Overall Study|Did not meet protocol eligibility|1
4913586|NCT00536380|16924636|P2|Overall Study|Did not meet protocol eligibility|0
4913587|NCT00536380|16924637|P1|Overall Study|Did not meet protocol eligibility|0
4913588|NCT00536380|16924635|P3|Overall Study|Noncompliance with protocol|2
4913589|NCT00536380|16924636|P2|Overall Study|Noncompliance with protocol|2
4913590|NCT00536380|16924637|P1|Overall Study|Noncompliance with protocol|3
4913591|NCT00536380|16924635|P3|Overall Study|Withdrawal related to study drug|2
4913592|NCT00536380|16924636|P2|Overall Study|Withdrawal related to study drug|5
4913593|NCT00536380|16924637|P1|Overall Study|Withdrawal related to study drug|7
4913594|NCT00536380|16924635|P3|Overall Study|Withdrawal unrelated to study drug|1
4913595|NCT00536380|16924636|P2|Overall Study|Withdrawal unrelated to study drug|0
4913596|NCT00536380|16924637|P1|Overall Study|Withdrawal unrelated to study drug|2
4913597|NCT00536380|16924635|P3|Overall Study|Lost to Follow-up|1
4913598|NCT00536380|16924636|P2|Overall Study|Lost to Follow-up|0
4913599|NCT00536380|16924637|P1|Overall Study|Lost to Follow-up|0
4913600|NCT00536380|16924635|P3|Overall Study|Adverse Event|2
4913601|NCT00536380|16924636|P2|Overall Study|Adverse Event|2
4913602|NCT00536380|16924637|P1|Overall Study|Adverse Event|0
4913603|NCT00536263|16924661|P3|Overall Study|Did not meet protocol eligibility|2
4913604|NCT00536263|16924662|P2|Overall Study|Did not meet protocol eligibility|2
4913605|NCT00536263|16924663|P1|Overall Study|Did not meet protocol eligibility|1
4913606|NCT00536263|16924661|P3|Overall Study|Noncompliance with protocol|1
4913607|NCT00536263|16924662|P2|Overall Study|Noncompliance with protocol|0
4913608|NCT00536263|16924663|P1|Overall Study|Noncompliance with protocol|0
4913609|NCT00536263|16924661|P3|Overall Study|Subject withdrew - treatment related|2
4913610|NCT00536263|16924662|P2|Overall Study|Subject withdrew - treatment related|3
4913611|NCT00536263|16924663|P1|Overall Study|Subject withdrew - treatment related|0
4913612|NCT00536263|16924661|P3|Overall Study|Subject withdrew - not treatment related|5
4913613|NCT00536263|16924662|P2|Overall Study|Subject withdrew - not treatment related|0
4913614|NCT00536263|16924663|P1|Overall Study|Subject withdrew - not treatment related|2
4913615|NCT00536263|16924661|P3|Overall Study|Lost to Follow-up|4
4913616|NCT00536263|16924662|P2|Overall Study|Lost to Follow-up|4
4913617|NCT00536263|16924663|P1|Overall Study|Lost to Follow-up|3
4913618|NCT00536263|16924661|P3|Overall Study|Adverse Event|7
4913619|NCT00536263|16924662|P2|Overall Study|Adverse Event|5
4913620|NCT00536263|16924663|P1|Overall Study|Adverse Event|5
4913621|NCT00536198|16924703|P2|Overall Study|Protocol Violation|1
4913622|NCT00536198|16924704|P1|Overall Study|Protocol Violation|0
4913623|NCT00536198|16924703|P2|Overall Study|Pregnancy|1
4913624|NCT00536198|16924704|P1|Overall Study|Pregnancy|1
4913625|NCT00536198|16924703|P2|Overall Study|Rescue|9
4913626|NCT00536198|16924704|P1|Overall Study|Rescue|3
4913627|NCT00536198|16924703|P2|Overall Study|Adverse Event|2
4913628|NCT00536198|16924704|P1|Overall Study|Adverse Event|2
4913629|NCT00536198|16924703|P2|Overall Study|Withdrawal by Subject|12
4913630|NCT00536198|16924704|P1|Overall Study|Withdrawal by Subject|16
4913631|NCT00536198|16924703|P2|Overall Study|Lost to Follow-up|14
4913632|NCT00536198|16924704|P1|Overall Study|Lost to Follow-up|15
4913633|NCT00536120|16924743|P2|Overall Study|Missed Study Visit|1
4913634|NCT00536120|16924744|P1|Overall Study|Missed Study Visit|0
4913635|NCT00536120|16924743|P2|Overall Study|Steroid Use|2
4913636|NCT00536120|16924744|P1|Overall Study|Steroid Use|0
4913637|NCT00536120|16924743|P2|Overall Study|Sponsor Decision Due to Lab Values|0
4913638|NCT00536120|16924744|P1|Overall Study|Sponsor Decision Due to Lab Values|1
4913639|NCT00536120|16924743|P2|Overall Study|Non-compliance|0
4913640|NCT00536120|16924744|P1|Overall Study|Non-compliance|1
4913641|NCT00536120|16924743|P2|Overall Study|Positive for Anti-natalizumab Antibodies|0
4913642|NCT00536120|16924744|P1|Overall Study|Positive for Anti-natalizumab Antibodies|3
4913643|NCT00536120|16924743|P2|Overall Study|Lost to Follow-up|0
4913644|NCT00536120|16924744|P1|Overall Study|Lost to Follow-up|1
4913645|NCT00536107|16924758|P2|Overall Study|Study Termination|4
4913646|NCT00536107|16924759|P1|Overall Study|Study Termination|2
4913647|NCT00536107|16924758|P2|Overall Study|Withdrawal by Subject|1
4913648|NCT00536107|16924759|P1|Overall Study|Withdrawal by Subject|0
4913649|NCT00536107|16924758|P2|Overall Study|Incorrect enrolment|0
4913650|NCT00536107|16924759|P1|Overall Study|Incorrect enrolment|1
4913651|NCT00536107|16924758|P2|Overall Study|Death|1
4913652|NCT00536107|16924759|P1|Overall Study|Death|5
4913653|NCT00535847|16924824|P3|Overall Study|Protocol-defined Virologic Stopping Rule|0
4913654|NCT00535847|16924825|P2|Overall Study|Protocol-defined Virologic Stopping Rule|10
4913655|NCT00535847|16924826|P1|Overall Study|Protocol-defined Virologic Stopping Rule|16
4913656|NCT00535847|16924824|P3|Overall Study|Non compliance|0
4913657|NCT00535847|16924825|P2|Overall Study|Non compliance|1
4913658|NCT00535847|16924826|P1|Overall Study|Non compliance|1
4913659|NCT00535847|16924824|P3|Overall Study|Adverse Event|2
4913660|NCT00535847|16924825|P2|Overall Study|Adverse Event|3
4913661|NCT00535847|16924826|P1|Overall Study|Adverse Event|5
4913662|NCT00535730|16925061|P2|Overall Study|Withdrawal by Subject|4
4913663|NCT00535730|16925062|P1|Overall Study|Withdrawal by Subject|0
4913664|NCT00535730|16925061|P2|Overall Study|Protocol Violation|0
4913665|NCT00535730|16925062|P1|Overall Study|Protocol Violation|1
4913666|NCT00535730|16925061|P2|Overall Study|Physician Decision|1
4913667|NCT00535730|16925062|P1|Overall Study|Physician Decision|0
4913668|NCT00535730|16925061|P2|Overall Study|Lost to Follow-up|1
4913669|NCT00535730|16925062|P1|Overall Study|Lost to Follow-up|0
4913670|NCT00535730|16925061|P2|Overall Study|Adverse Event|1
4913671|NCT00535730|16925062|P1|Overall Study|Adverse Event|1
4913672|NCT00535626|16925083|P1|Overall Study|Unable to return|2
4913673|NCT00535626|16925083|P1|Overall Study|Subject terminated|31
4913674|NCT00535626|16925083|P1|Overall Study|Removal/revision of study component|8
4913675|NCT00535626|16925083|P1|Overall Study|Withdrawal by Subject|20
4913676|NCT00535626|16925083|P1|Overall Study|Lost to Follow-up|29
4913677|NCT00535626|16925083|P1|Overall Study|Death|15
4913678|NCT00535496|16925123|P4|Overall Study|Not treated with sugammadex|0
4913679|NCT00535496|16925124|P3|Overall Study|Not treated with sugammadex|0
4913680|NCT00535496|16925125|P2|Overall Study|Not treated with sugammadex|1
4913681|NCT00535496|16925126|P1|Overall Study|Not treated with sugammadex|0
4913682|NCT00535496|16925123|P4|Overall Study|Lost to Follow-up|0
4913683|NCT00535496|16925124|P3|Overall Study|Lost to Follow-up|0
4913684|NCT00535496|16925125|P2|Overall Study|Lost to Follow-up|1
4913685|NCT00535496|16925126|P1|Overall Study|Lost to Follow-up|0
4913686|NCT00535405|16925146|P5|Overall Study|Withdrawal by Subject|8
4913687|NCT00535405|16925147|P4|Overall Study|Withdrawal by Subject|10
4913688|NCT00535405|16925148|P3|Overall Study|Withdrawal by Subject|10
4913689|NCT00535405|16925149|P2|Overall Study|Withdrawal by Subject|11
4913690|NCT00535405|16925150|P1|Overall Study|Withdrawal by Subject|5
4913691|NCT00535405|16925146|P5|Overall Study|Protocol Violation|0
4913692|NCT00535405|16925147|P4|Overall Study|Protocol Violation|1
4913693|NCT00535405|16925148|P3|Overall Study|Protocol Violation|2
4913694|NCT00535405|16925149|P2|Overall Study|Protocol Violation|2
4913695|NCT00535405|16925150|P1|Overall Study|Protocol Violation|2
4913696|NCT00535405|16925146|P5|Overall Study|Physician Decision|1
4913697|NCT00535405|16925147|P4|Overall Study|Physician Decision|1
4913698|NCT00535405|16925148|P3|Overall Study|Physician Decision|0
4913699|NCT00535405|16925149|P2|Overall Study|Physician Decision|2
4913700|NCT00535405|16925150|P1|Overall Study|Physician Decision|3
4913701|NCT00535405|16925146|P5|Overall Study|Lost to Follow-up|1
4913702|NCT00535405|16925147|P4|Overall Study|Lost to Follow-up|2
4913703|NCT00535405|16925148|P3|Overall Study|Lost to Follow-up|3
4913704|NCT00535405|16925149|P2|Overall Study|Lost to Follow-up|3
4913705|NCT00535405|16925150|P1|Overall Study|Lost to Follow-up|1
4913706|NCT00535405|16925146|P5|Overall Study|Adverse Event|6
4913707|NCT00535405|16925147|P4|Overall Study|Adverse Event|8
4913708|NCT00535405|16925148|P3|Overall Study|Adverse Event|3
4913709|NCT00535405|16925149|P2|Overall Study|Adverse Event|8
4913710|NCT00535405|16925150|P1|Overall Study|Adverse Event|6
4913711|NCT00535288|16925211|P5|Overall Study|Other|1
4913712|NCT00535288|16925212|P4|Overall Study|Other|2
4913713|NCT00535288|16925213|P3|Overall Study|Other|1
4913714|NCT00535288|16925214|P2|Overall Study|Other|1
4913715|NCT00535288|16925215|P1|Overall Study|Other|2
4913716|NCT00535288|16925211|P5|Overall Study|Unwilling to cooperate|4
4913717|NCT00535288|16925212|P4|Overall Study|Unwilling to cooperate|3
4913718|NCT00535288|16925213|P3|Overall Study|Unwilling to cooperate|3
4913719|NCT00535288|16925214|P2|Overall Study|Unwilling to cooperate|6
4913720|NCT00535288|16925215|P1|Overall Study|Unwilling to cooperate|6
4913721|NCT00535288|16925211|P5|Overall Study|Lack of Efficacy|7
4913722|NCT00535288|16925212|P4|Overall Study|Lack of Efficacy|4
4913723|NCT00535288|16925213|P3|Overall Study|Lack of Efficacy|4
4913724|NCT00535288|16925214|P2|Overall Study|Lack of Efficacy|3
4913725|NCT00535288|16925215|P1|Overall Study|Lack of Efficacy|26
4913726|NCT00535288|16925211|P5|Overall Study|Lost to Follow-up|0
4913727|NCT00535288|16925212|P4|Overall Study|Lost to Follow-up|0
4913728|NCT00535288|16925213|P3|Overall Study|Lost to Follow-up|0
4913729|NCT00535288|16925214|P2|Overall Study|Lost to Follow-up|3
4913730|NCT00535288|16925215|P1|Overall Study|Lost to Follow-up|0
4913731|NCT00535288|16925211|P5|Overall Study|Adverse Event|30
4913732|NCT00535288|16925212|P4|Overall Study|Adverse Event|20
4913733|NCT00535288|16925213|P3|Overall Study|Adverse Event|25
4913734|NCT00535288|16925214|P2|Overall Study|Adverse Event|19
4913735|NCT00535288|16925215|P1|Overall Study|Adverse Event|20
4913736|NCT00535262|16925292|P1|Overall Study|No funding|3
4913737|NCT00535236|16925306|P10|Overall Study|Withdrawal by Subject|2
4913738|NCT00535236|16925307|P9|Overall Study|Withdrawal by Subject|4
4913739|NCT00535236|16925308|P8|Overall Study|Withdrawal by Subject|0
4913740|NCT00535236|16925309|P7|Overall Study|Withdrawal by Subject|5
4913741|NCT00535236|16925310|P6|Overall Study|Withdrawal by Subject|1
4913742|NCT00535236|16925311|P5|Overall Study|Withdrawal by Subject|6
4913743|NCT00535236|16925312|P4|Overall Study|Withdrawal by Subject|1
4913744|NCT00535236|16925313|P3|Overall Study|Withdrawal by Subject|2
4913745|NCT00535236|16925314|P2|Overall Study|Withdrawal by Subject|0
4913746|NCT00535236|16925315|P1|Overall Study|Withdrawal by Subject|3
4913747|NCT00535236|16925306|P10|Overall Study|Protocol Violation|0
4913748|NCT00535236|16925307|P9|Overall Study|Protocol Violation|1
4913749|NCT00535236|16925308|P8|Overall Study|Protocol Violation|0
4913750|NCT00535236|16925309|P7|Overall Study|Protocol Violation|0
4913751|NCT00535236|16925310|P6|Overall Study|Protocol Violation|0
4913752|NCT00535236|16925311|P5|Overall Study|Protocol Violation|0
4913753|NCT00535236|16925312|P4|Overall Study|Protocol Violation|0
4913754|NCT00535236|16925313|P3|Overall Study|Protocol Violation|1
4913755|NCT00535236|16925314|P2|Overall Study|Protocol Violation|0
4913756|NCT00535236|16925315|P1|Overall Study|Protocol Violation|2
4913757|NCT00535236|16925306|P10|Overall Study|Physician Decision|0
4913758|NCT00535236|16925307|P9|Overall Study|Physician Decision|0
4913759|NCT00535236|16925308|P8|Overall Study|Physician Decision|0
4913760|NCT00535236|16925309|P7|Overall Study|Physician Decision|1
4913761|NCT00535236|16925310|P6|Overall Study|Physician Decision|0
4913762|NCT00535236|16925311|P5|Overall Study|Physician Decision|1
4913763|NCT00535236|16925312|P4|Overall Study|Physician Decision|0
4913764|NCT00535236|16925313|P3|Overall Study|Physician Decision|0
4913765|NCT00535236|16925314|P2|Overall Study|Physician Decision|0
4913766|NCT00535236|16925315|P1|Overall Study|Physician Decision|0
4913767|NCT00535236|16925306|P10|Overall Study|Lost to Follow-up|1
4913768|NCT00535236|16925307|P9|Overall Study|Lost to Follow-up|6
4913769|NCT00535236|16925308|P8|Overall Study|Lost to Follow-up|0
4913770|NCT00535236|16925309|P7|Overall Study|Lost to Follow-up|0
4913771|NCT00535236|16925310|P6|Overall Study|Lost to Follow-up|0
4913772|NCT00535236|16925311|P5|Overall Study|Lost to Follow-up|2
4913773|NCT00535236|16925312|P4|Overall Study|Lost to Follow-up|0
4913774|NCT00535236|16925313|P3|Overall Study|Lost to Follow-up|0
4913775|NCT00535236|16925314|P2|Overall Study|Lost to Follow-up|2
4913776|NCT00535236|16925315|P1|Overall Study|Lost to Follow-up|1
4913777|NCT00535236|16925306|P10|Overall Study|Adverse Event|1
4913778|NCT00535236|16925307|P9|Overall Study|Adverse Event|2
4913779|NCT00535236|16925308|P8|Overall Study|Adverse Event|1
4913780|NCT00535236|16925309|P7|Overall Study|Adverse Event|5
4913781|NCT00535236|16925310|P6|Overall Study|Adverse Event|0
4913782|NCT00535236|16925311|P5|Overall Study|Adverse Event|3
4913783|NCT00535236|16925312|P4|Overall Study|Adverse Event|3
4913784|NCT00535236|16925313|P3|Overall Study|Adverse Event|9
4913785|NCT00535236|16925314|P2|Overall Study|Adverse Event|0
4913786|NCT00535236|16925315|P1|Overall Study|Adverse Event|1
4913787|NCT00535223|16925375|P2|Overall Study|Withdrawal by Subject|1
4913788|NCT00535223|16925376|P1|Overall Study|Withdrawal by Subject|4
4913789|NCT00535145|16925384|P1|Phase II|Subject non-compliance|2
4913790|NCT00535145|16925384|P1|Phase II|Withdrawal by Subject|5
4913791|NCT00535145|16925384|P1|Phase II|Lost to Follow-up|5
4913792|NCT00535145|16925384|P1|Phase II|Lack of Efficacy|1
4913793|NCT00535145|16925384|P1|Phase II|Adverse Event|2
4913794|NCT00535145|16925384|P1|Phase I|(diagnosis)|3
4913795|NCT00535145|16925384|P1|Phase I|(PI decision)|1
4913796|NCT00535145|16925384|P1|Phase I|(protocol violation)|1
4913797|NCT00535145|16925384|P1|Phase I|(eligibility)|8
4913798|NCT00535145|16925384|P1|Phase I|Withdrawal by Subject|6
4913799|NCT00535145|16925384|P1|Phase I|Lost to Follow-up|7
4913800|NCT00535145|16925384|P1|Phase I|Adverse Event|3
4913801|NCT00535132|16925396|P2|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
4913802|NCT00535132|16925397|P1|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3
4913803|NCT00535132|16925396|P2|Safety Analysis Set|Did Not Receive Study Medication|2
4913804|NCT00535132|16925397|P1|Safety Analysis Set|Did Not Receive Study Medication|2
4913805|NCT00534976|16925478|P2|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0
4913806|NCT00534976|16925479|P1|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1
4913807|NCT00534976|16925478|P2|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0
4913808|NCT00534976|16925479|P1|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1
4913809|NCT00534976|16925478|P2|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1
4913810|NCT00534976|16925479|P1|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0
4913811|NCT00534638|16925559|P2|Overall Study|Other|902
4913812|NCT00534638|16925560|P1|Overall Study|Other|1685
4913813|NCT00534638|16925559|P2|Overall Study|Lost to follow-up, complete vaccination|10757
4913814|NCT00534638|16925560|P1|Overall Study|Lost to follow-up, complete vaccination|4707
4913815|NCT00534638|16925559|P2|Overall Study|Lost to follow-up,incomplete vaccination|117
4913816|NCT00534638|16925560|P1|Overall Study|Lost to follow-up,incomplete vaccination|83
4913817|NCT00534638|16925559|P2|Overall Study|Migrated/moved from study area|11
4913818|NCT00534638|16925560|P1|Overall Study|Migrated/moved from study area|13
4913819|NCT00534638|16925559|P2|Overall Study|Withdrawal by Subject|4
4913820|NCT00534638|16925560|P1|Overall Study|Withdrawal by Subject|3
4913821|NCT00534599|16925598|P2|Overall Study|Other|0
4913822|NCT00534599|16925599|P1|Overall Study|Other|7
4913823|NCT00534599|16925598|P2|Overall Study|Withdrawal by Subject|6
4913824|NCT00534599|16925599|P1|Overall Study|Withdrawal by Subject|4
4913825|NCT00534599|16925598|P2|Overall Study|Lost to Follow-up|14
4913826|NCT00534599|16925599|P1|Overall Study|Lost to Follow-up|11
4913827|NCT00534599|16925598|P2|Overall Study|Protocol Violation|3
4913828|NCT00534599|16925599|P1|Overall Study|Protocol Violation|1
4913829|NCT00534599|16925598|P2|Overall Study|Generalized anxiety disorder worsened|1
4913830|NCT00534599|16925599|P1|Overall Study|Generalized anxiety disorder worsened|0
4913831|NCT00534599|16925598|P2|Overall Study|Lack of Efficacy|1
4913832|NCT00534599|16925599|P1|Overall Study|Lack of Efficacy|0
4913833|NCT00534599|16925598|P2|Overall Study|Developed study-specific d/c criteria|0
4913834|NCT00534599|16925599|P1|Overall Study|Developed study-specific d/c criteria|5
4913835|NCT00534599|16925598|P2|Overall Study|Mis-randomization|2
4913836|NCT00534599|16925599|P1|Overall Study|Mis-randomization|2
4913837|NCT00534599|16925598|P2|Overall Study|Incorrect enrollment|1
4913838|NCT00534599|16925599|P1|Overall Study|Incorrect enrollment|2
4913839|NCT00534599|16925598|P2|Overall Study|Adverse Event|4
4913840|NCT00534599|16925599|P1|Overall Study|Adverse Event|25
4913841|NCT00534495|16925635|P3|Long Term Ext. Phase Week 24-month 21|non compliance|2
4913842|NCT00534495|16925636|P2|Long Term Ext. Phase Week 24-month 21|non compliance|0
4913843|NCT00534495|16925637|P1|Long Term Ext. Phase Week 24-month 21|non compliance|0
4913844|NCT00534495|16925635|P3|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3
4913845|NCT00534495|16925636|P2|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
4913846|NCT00534495|16925637|P1|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0
4913847|NCT00534495|16925635|P3|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5
4913848|NCT00534495|16925636|P2|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
4913849|NCT00534495|16925637|P1|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0
4913850|NCT00534495|16925635|P3|Long Term Ext. Phase Week 24-month 21|Adverse Event|1
4913851|NCT00534495|16925636|P2|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
4913852|NCT00534495|16925637|P1|Long Term Ext. Phase Week 24-month 21|Adverse Event|0
4913853|NCT00534495|16925635|P3|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0
4913854|NCT00534495|16925636|P2|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
4913855|NCT00534495|16925637|P1|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1
4913856|NCT00534495|16925635|P3|All Active Treatment Phase Week 4-24|Lost to Follow-up|0
4913857|NCT00534495|16925636|P2|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
4913858|NCT00534495|16925637|P1|All Active Treatment Phase Week 4-24|Lost to Follow-up|1
4913859|NCT00534495|16925635|P3|All Active Treatment Phase Week 4-24|Lack of Efficacy|0
4913860|NCT00534495|16925636|P2|All Active Treatment Phase Week 4-24|Lack of Efficacy|7
4913861|NCT00534495|16925637|P1|All Active Treatment Phase Week 4-24|Lack of Efficacy|1
4913862|NCT00534495|16925635|P3|All Active Treatment Phase Week 4-24|Adverse Event|0
4913863|NCT00534495|16925636|P2|All Active Treatment Phase Week 4-24|Adverse Event|0
4913864|NCT00534495|16925637|P1|All Active Treatment Phase Week 4-24|Adverse Event|1
4913865|NCT00534495|16925635|P3|Double Blind Placebo Phase Week 0-4|randomized in error|0
4913866|NCT00534495|16925636|P2|Double Blind Placebo Phase Week 0-4|randomized in error|1
4913867|NCT00534495|16925637|P1|Double Blind Placebo Phase Week 0-4|randomized in error|0
4913868|NCT00534404|16925675|P3|Overall Study|Lost to Follow-up|201
4913869|NCT00534404|16925676|P2|Overall Study|Lost to Follow-up|138
4913870|NCT00534404|16925677|P1|Overall Study|Lost to Follow-up|170
4913871|NCT00534404|16925675|P3|Overall Study|Removed by study staff|1
4913872|NCT00534404|16925676|P2|Overall Study|Removed by study staff|3
4913873|NCT00534404|16925677|P1|Overall Study|Removed by study staff|2
4913874|NCT00534404|16925675|P3|Overall Study|Withdrawal by Subject|38
4913875|NCT00534404|16925676|P2|Overall Study|Withdrawal by Subject|2
4913876|NCT00534404|16925677|P1|Overall Study|Withdrawal by Subject|8
4913877|NCT00534404|16925675|P3|Overall Study|Death|2
4913878|NCT00534404|16925676|P2|Overall Study|Death|0
4913879|NCT00534404|16925677|P1|Overall Study|Death|0
4913880|NCT00534352|16925708|P1|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1
4913881|NCT00534352|16925708|P1|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2
4913882|NCT00534352|16925708|P1|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1
4913883|NCT00534352|16925708|P1|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1
4913884|NCT00534352|16925708|P1|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1
4913885|NCT00534352|16925708|P1|Treatment A: TMC125 + TDF/FTC|Physician Decision|1
4913886|NCT00534313|16925752|P4|Long-term Period|Other|2
4913887|NCT00534313|16925753|P3|Long-term Period|Other|2
4913888|NCT00534313|16925754|P2|Long-term Period|Other|2
4913889|NCT00534313|16925755|P1|Long-term Period|Other|1
4913890|NCT00534313|16925752|P4|Long-term Period|Administrative reason by sponsor|18
4913891|NCT00534313|16925753|P3|Long-term Period|Administrative reason by sponsor|26
4913892|NCT00534313|16925754|P2|Long-term Period|Administrative reason by sponsor|15
4913893|NCT00534313|16925755|P1|Long-term Period|Administrative reason by sponsor|17
4913894|NCT00534313|16925752|P4|Long-term Period|Poor compliance/noncompliance|0
4913895|NCT00534313|16925753|P3|Long-term Period|Poor compliance/noncompliance|1
4913896|NCT00534313|16925754|P2|Long-term Period|Poor compliance/noncompliance|1
4913897|NCT00534313|16925755|P1|Long-term Period|Poor compliance/noncompliance|0
4913898|NCT00534313|16925752|P4|Long-term Period|No longer meets study criteria|0
4913899|NCT00534313|16925753|P3|Long-term Period|No longer meets study criteria|0
4913900|NCT00534313|16925754|P2|Long-term Period|No longer meets study criteria|1
4913901|NCT00534313|16925755|P1|Long-term Period|No longer meets study criteria|0
4913902|NCT00534313|16925752|P4|Long-term Period|Withdrawal by Subject|0
4913903|NCT00534313|16925753|P3|Long-term Period|Withdrawal by Subject|0
4913904|NCT00534313|16925754|P2|Long-term Period|Withdrawal by Subject|2
4913905|NCT00534313|16925755|P1|Long-term Period|Withdrawal by Subject|2
4913906|NCT00534313|16925752|P4|Long-term Period|Lost to Follow-up|0
4913907|NCT00534313|16925753|P3|Long-term Period|Lost to Follow-up|0
4913908|NCT00534313|16925754|P2|Long-term Period|Lost to Follow-up|2
4913909|NCT00534313|16925755|P1|Long-term Period|Lost to Follow-up|1
4913910|NCT00534313|16925752|P4|Long-term Period|Lack of Efficacy|12
4913911|NCT00534313|16925753|P3|Long-term Period|Lack of Efficacy|14
4913912|NCT00534313|16925754|P2|Long-term Period|Lack of Efficacy|10
4913913|NCT00534313|16925755|P1|Long-term Period|Lack of Efficacy|14
4913914|NCT00534313|16925752|P4|Long-term Period|Adverse Event|1
4913915|NCT00534313|16925753|P3|Long-term Period|Adverse Event|0
4913916|NCT00534313|16925754|P2|Long-term Period|Adverse Event|1
4913917|NCT00534313|16925755|P1|Long-term Period|Adverse Event|2
4913918|NCT00534313|16925752|P4|Short-term Period|Pregnancy|0
4913919|NCT00534313|16925753|P3|Short-term Period|Pregnancy|1
4913920|NCT00534313|16925754|P2|Short-term Period|Pregnancy|0
4913921|NCT00534313|16925755|P1|Short-term Period|Pregnancy|0
4913922|NCT00534313|16925752|P4|Short-term Period|Participant withdrew consent|2
4913923|NCT00534313|16925753|P3|Short-term Period|Participant withdrew consent|0
4913924|NCT00534313|16925754|P2|Short-term Period|Participant withdrew consent|0
4913925|NCT00534313|16925755|P1|Short-term Period|Participant withdrew consent|2
4913926|NCT00534313|16925752|P4|Short-term Period|Participant not meeting study criteria|1
4913927|NCT00534313|16925753|P3|Short-term Period|Participant not meeting study criteria|0
4913928|NCT00534313|16925754|P2|Short-term Period|Participant not meeting study criteria|0
4913929|NCT00534313|16925755|P1|Short-term Period|Participant not meeting study criteria|0
4913930|NCT00534313|16925752|P4|Short-term Period|Lack of Efficacy|3
4913931|NCT00534313|16925753|P3|Short-term Period|Lack of Efficacy|0
4913932|NCT00534313|16925754|P2|Short-term Period|Lack of Efficacy|4
4913933|NCT00534313|16925755|P1|Short-term Period|Lack of Efficacy|3
4913934|NCT00534313|16925752|P4|Short-term Period|Adverse Event|3
4913935|NCT00534313|16925753|P3|Short-term Period|Adverse Event|1
4913936|NCT00534313|16925754|P2|Short-term Period|Adverse Event|2
4913937|NCT00534313|16925755|P1|Short-term Period|Adverse Event|1
4913938|NCT00534248|16925850|P2|Overall Study|Withdrawal by Subject|255
4913939|NCT00534248|16925851|P1|Overall Study|Withdrawal by Subject|263
4913940|NCT00534248|16925850|P2|Overall Study|Protocol Violation|4
4913941|NCT00534248|16925851|P1|Overall Study|Protocol Violation|3
4913942|NCT00534248|16925850|P2|Overall Study|Physician Decision|7
4913943|NCT00534248|16925851|P1|Overall Study|Physician Decision|10
4913944|NCT00534248|16925850|P2|Overall Study|Other protocol specified criteria|3
4913945|NCT00534248|16925851|P1|Overall Study|Other protocol specified criteria|13
4913946|NCT00534248|16925850|P2|Overall Study|Lost to Follow-up|375
4913947|NCT00534248|16925851|P1|Overall Study|Lost to Follow-up|353
4913948|NCT00534248|16925850|P2|Overall Study|Adverse Event|29
4913949|NCT00534248|16925851|P1|Overall Study|Adverse Event|19
4913950|NCT00534105|16926021|P2|Overall Study|Lost to Follow-up|39
4913951|NCT00534105|16926022|P1|Overall Study|Lost to Follow-up|23
4913952|NCT00534092|16926036|P2|Overall Study|personal reasons/family concerns|0
4913953|NCT00534092|16926037|P1|Overall Study|personal reasons/family concerns|1
4913954|NCT00534092|16926036|P2|Overall Study|Lost to Follow-up|0
4913955|NCT00534092|16926037|P1|Overall Study|Lost to Follow-up|1
4913956|NCT00533949|16926075|P4|Overall Study|Withdrawal by Subject|1
4913957|NCT00533949|16926076|P3|Overall Study|Withdrawal by Subject|1
4913958|NCT00533949|16926077|P2|Overall Study|Withdrawal by Subject|2
4913959|NCT00533949|16926078|P1|Overall Study|Withdrawal by Subject|3
4913960|NCT00533949|16926075|P4|Overall Study|Protocol Violation|9
4913961|NCT00533949|16926076|P3|Overall Study|Protocol Violation|9
4913962|NCT00533949|16926077|P2|Overall Study|Protocol Violation|12
4913963|NCT00533949|16926078|P1|Overall Study|Protocol Violation|12
4913964|NCT00533897|16926119|P8|Long Term Extension (LTE)|Other|6
4913965|NCT00533897|16926120|P7|Long Term Extension (LTE)|Other|1
4913966|NCT00533897|16926121|P6|Long Term Extension (LTE)|Other|0
4913967|NCT00533897|16926122|P5|Long Term Extension (LTE)|Other|0
4913968|NCT00533897|16926123|P4|Long Term Extension (LTE)|Other|0
4913969|NCT00533897|16926124|P3|Long Term Extension (LTE)|Other|0
4913970|NCT00533897|16926125|P2|Long Term Extension (LTE)|Other|0
4913971|NCT00533897|16926126|P1|Long Term Extension (LTE)|Other|0
4913972|NCT00533897|16926119|P8|Long Term Extension (LTE)|Lost to Follow-up|1
4913973|NCT00533897|16926120|P7|Long Term Extension (LTE)|Lost to Follow-up|1
4913974|NCT00533897|16926121|P6|Long Term Extension (LTE)|Lost to Follow-up|0
4913975|NCT00533897|16926122|P5|Long Term Extension (LTE)|Lost to Follow-up|0
4913976|NCT00533897|16926123|P4|Long Term Extension (LTE)|Lost to Follow-up|0
4913977|NCT00533897|16926124|P3|Long Term Extension (LTE)|Lost to Follow-up|0
4913978|NCT00533897|16926125|P2|Long Term Extension (LTE)|Lost to Follow-up|0
4913979|NCT00533897|16926126|P1|Long Term Extension (LTE)|Lost to Follow-up|0
4913980|NCT00533897|16926119|P8|Long Term Extension (LTE)|Pregnancy|2
4913981|NCT00533897|16926120|P7|Long Term Extension (LTE)|Pregnancy|0
4913982|NCT00533897|16926121|P6|Long Term Extension (LTE)|Pregnancy|0
4913983|NCT00533897|16926122|P5|Long Term Extension (LTE)|Pregnancy|0
4913984|NCT00533897|16926123|P4|Long Term Extension (LTE)|Pregnancy|0
4913985|NCT00533897|16926124|P3|Long Term Extension (LTE)|Pregnancy|0
4913986|NCT00533897|16926125|P2|Long Term Extension (LTE)|Pregnancy|0
4913987|NCT00533897|16926126|P1|Long Term Extension (LTE)|Pregnancy|0
4913988|NCT00533897|16926119|P8|Long Term Extension (LTE)|Adverse Event|5
4913989|NCT00533897|16926120|P7|Long Term Extension (LTE)|Adverse Event|2
4913990|NCT00533897|16926121|P6|Long Term Extension (LTE)|Adverse Event|0
4913991|NCT00533897|16926122|P5|Long Term Extension (LTE)|Adverse Event|0
4913992|NCT00533897|16926123|P4|Long Term Extension (LTE)|Adverse Event|0
4913993|NCT00533897|16926124|P3|Long Term Extension (LTE)|Adverse Event|0
4913994|NCT00533897|16926125|P2|Long Term Extension (LTE)|Adverse Event|0
4913995|NCT00533897|16926126|P1|Long Term Extension (LTE)|Adverse Event|0
4913996|NCT00533897|16926119|P8|Long Term Extension (LTE)|Poor/Non-compliance|0
4913997|NCT00533897|16926120|P7|Long Term Extension (LTE)|Poor/Non-compliance|1
4913998|NCT00533897|16926121|P6|Long Term Extension (LTE)|Poor/Non-compliance|0
4913999|NCT00533897|16926122|P5|Long Term Extension (LTE)|Poor/Non-compliance|0
4914000|NCT00533897|16926123|P4|Long Term Extension (LTE)|Poor/Non-compliance|0
4914001|NCT00533897|16926124|P3|Long Term Extension (LTE)|Poor/Non-compliance|0
4914002|NCT00533897|16926125|P2|Long Term Extension (LTE)|Poor/Non-compliance|0
4914003|NCT00533897|16926126|P1|Long Term Extension (LTE)|Poor/Non-compliance|0
4914004|NCT00533897|16926119|P8|Long Term Extension (LTE)|Lack of Efficacy|3
4914005|NCT00533897|16926120|P7|Long Term Extension (LTE)|Lack of Efficacy|5
4914006|NCT00533897|16926121|P6|Long Term Extension (LTE)|Lack of Efficacy|0
4914007|NCT00533897|16926122|P5|Long Term Extension (LTE)|Lack of Efficacy|0
4914008|NCT00533897|16926123|P4|Long Term Extension (LTE)|Lack of Efficacy|0
4914009|NCT00533897|16926124|P3|Long Term Extension (LTE)|Lack of Efficacy|0
4914010|NCT00533897|16926125|P2|Long Term Extension (LTE)|Lack of Efficacy|0
4914011|NCT00533897|16926126|P1|Long Term Extension (LTE)|Lack of Efficacy|0
4914012|NCT00533897|16926119|P8|Long Term Extension (LTE)|Death|3
4914013|NCT00533897|16926120|P7|Long Term Extension (LTE)|Death|1
4914014|NCT00533897|16926121|P6|Long Term Extension (LTE)|Death|0
4914015|NCT00533897|16926122|P5|Long Term Extension (LTE)|Death|0
4914016|NCT00533897|16926123|P4|Long Term Extension (LTE)|Death|0
4914017|NCT00533897|16926124|P3|Long Term Extension (LTE)|Death|0
4914018|NCT00533897|16926125|P2|Long Term Extension (LTE)|Death|0
4914019|NCT00533897|16926126|P1|Long Term Extension (LTE)|Death|0
4914020|NCT00533897|16926119|P8|Long Term Extension (LTE)|Participant Withdrew Consent|5
4914021|NCT00533897|16926120|P7|Long Term Extension (LTE)|Participant Withdrew Consent|2
4914022|NCT00533897|16926121|P6|Long Term Extension (LTE)|Participant Withdrew Consent|0
4914023|NCT00533897|16926122|P5|Long Term Extension (LTE)|Participant Withdrew Consent|0
4914024|NCT00533897|16926123|P4|Long Term Extension (LTE)|Participant Withdrew Consent|0
4914025|NCT00533897|16926124|P3|Long Term Extension (LTE)|Participant Withdrew Consent|0
4914026|NCT00533897|16926125|P2|Long Term Extension (LTE)|Participant Withdrew Consent|0
4914027|NCT00533897|16926126|P1|Long Term Extension (LTE)|Participant Withdrew Consent|0
4914028|NCT00533897|16926119|P8|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914029|NCT00533897|16926120|P7|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914030|NCT00533897|16926121|P6|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1
4914031|NCT00533897|16926122|P5|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914032|NCT00533897|16926123|P4|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914033|NCT00533897|16926124|P3|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914034|NCT00533897|16926125|P2|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914035|NCT00533897|16926126|P1|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0
4914036|NCT00533897|16926119|P8|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914037|NCT00533897|16926120|P7|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914038|NCT00533897|16926121|P6|Re-introduction (RI) Period 3|Participant Withdrew Consent|1
4914039|NCT00533897|16926122|P5|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914040|NCT00533897|16926123|P4|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914041|NCT00533897|16926124|P3|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914042|NCT00533897|16926125|P2|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914043|NCT00533897|16926126|P1|Re-introduction (RI) Period 3|Participant Withdrew Consent|0
4914044|NCT00533897|16926119|P8|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914045|NCT00533897|16926120|P7|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914046|NCT00533897|16926121|P6|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914047|NCT00533897|16926122|P5|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914048|NCT00533897|16926123|P4|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914049|NCT00533897|16926124|P3|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1
4914050|NCT00533897|16926125|P2|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914051|NCT00533897|16926126|P1|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0
4914052|NCT00533897|16926119|P8|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4914053|NCT00533897|16926120|P7|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4914054|NCT00533897|16926121|P6|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4914055|NCT00533897|16926122|P5|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4914056|NCT00533897|16926123|P4|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4914057|NCT00533897|16926124|P3|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2
4914058|NCT00533897|16926125|P2|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1
4914059|NCT00533897|16926126|P1|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0
4914060|NCT00533897|16926119|P8|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914061|NCT00533897|16926120|P7|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914062|NCT00533897|16926121|P6|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914063|NCT00533897|16926122|P5|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914064|NCT00533897|16926123|P4|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914065|NCT00533897|16926124|P3|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914066|NCT00533897|16926125|P2|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0
4914067|NCT00533897|16926126|P1|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1
4914068|NCT00533897|16926119|P8|Lead-in (LI) Period 1|Lack of Efficacy|0
4914069|NCT00533897|16926120|P7|Lead-in (LI) Period 1|Lack of Efficacy|0
4914070|NCT00533897|16926121|P6|Lead-in (LI) Period 1|Lack of Efficacy|0
4914071|NCT00533897|16926122|P5|Lead-in (LI) Period 1|Lack of Efficacy|0
4914072|NCT00533897|16926123|P4|Lead-in (LI) Period 1|Lack of Efficacy|0
4914073|NCT00533897|16926124|P3|Lead-in (LI) Period 1|Lack of Efficacy|0
4914074|NCT00533897|16926125|P2|Lead-in (LI) Period 1|Lack of Efficacy|0
4914075|NCT00533897|16926126|P1|Lead-in (LI) Period 1|Lack of Efficacy|3
4914076|NCT00533897|16926119|P8|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914077|NCT00533897|16926120|P7|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914078|NCT00533897|16926121|P6|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914079|NCT00533897|16926122|P5|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914080|NCT00533897|16926123|P4|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914081|NCT00533897|16926124|P3|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914082|NCT00533897|16926125|P2|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0
4914083|NCT00533897|16926126|P1|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2
4914084|NCT00533897|16926119|P8|Lead-in (LI) Period 1|Lost to Follow-up|0
4914085|NCT00533897|16926120|P7|Lead-in (LI) Period 1|Lost to Follow-up|0
4914086|NCT00533897|16926121|P6|Lead-in (LI) Period 1|Lost to Follow-up|0
4914087|NCT00533897|16926122|P5|Lead-in (LI) Period 1|Lost to Follow-up|0
4914088|NCT00533897|16926123|P4|Lead-in (LI) Period 1|Lost to Follow-up|0
4914089|NCT00533897|16926124|P3|Lead-in (LI) Period 1|Lost to Follow-up|0
4914090|NCT00533897|16926125|P2|Lead-in (LI) Period 1|Lost to Follow-up|0
4914091|NCT00533897|16926126|P1|Lead-in (LI) Period 1|Lost to Follow-up|1
4914092|NCT00533897|16926119|P8|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914093|NCT00533897|16926120|P7|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914094|NCT00533897|16926121|P6|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914095|NCT00533897|16926122|P5|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914096|NCT00533897|16926123|P4|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914097|NCT00533897|16926124|P3|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914098|NCT00533897|16926125|P2|Lead-in (LI) Period 1|Participant Withdrew Consent|0
4914099|NCT00533897|16926126|P1|Lead-in (LI) Period 1|Participant Withdrew Consent|2
4914100|NCT00533897|16926119|P8|Lead-in (LI) Period 1|Adverse Event|0
4914101|NCT00533897|16926120|P7|Lead-in (LI) Period 1|Adverse Event|0
4914102|NCT00533897|16926121|P6|Lead-in (LI) Period 1|Adverse Event|0
4914103|NCT00533897|16926122|P5|Lead-in (LI) Period 1|Adverse Event|0
4914104|NCT00533897|16926123|P4|Lead-in (LI) Period 1|Adverse Event|0
4914105|NCT00533897|16926124|P3|Lead-in (LI) Period 1|Adverse Event|0
4914106|NCT00533897|16926125|P2|Lead-in (LI) Period 1|Adverse Event|0
4914107|NCT00533897|16926126|P1|Lead-in (LI) Period 1|Adverse Event|1
4914108|NCT00533845|16926266|P2|Overall Study|Physician Decision|0
4914109|NCT00533845|16926267|P1|Overall Study|Physician Decision|1
4914110|NCT00533702|16926275|P2|Overall Study|Found ineligible after randomization|1
4914111|NCT00533702|16926276|P1|Overall Study|Found ineligible after randomization|2
4914112|NCT00533702|16926275|P2|Overall Study|Withdrawal by Subject|1
4914113|NCT00533702|16926276|P1|Overall Study|Withdrawal by Subject|3
4914114|NCT00533507|16926307|P1|Overall Study|Withdrawal by Subject|1
4914115|NCT00533273|16926352|P2|Open-label|Withdrawal by Subject|0
4914116|NCT00533273|16926353|P1|Open-label|Withdrawal by Subject|6
4914117|NCT00533273|16926352|P2|Double-blind|Withdrew consent|2
4914118|NCT00533273|16926353|P1|Double-blind|Withdrew consent|0
4914119|NCT00532948|16926404|P3|Overall Study|Failure to return|0
4914120|NCT00532948|16926405|P2|Overall Study|Failure to return|1
4914121|NCT00532948|16926406|P1|Overall Study|Failure to return|0
4914122|NCT00532948|16926404|P3|Overall Study|Violation of selection criteria at entry|0
4914123|NCT00532948|16926405|P2|Overall Study|Violation of selection criteria at entry|1
4914124|NCT00532948|16926406|P1|Overall Study|Violation of selection criteria at entry|0
4914125|NCT00532948|16926404|P3|Overall Study|Death|4
4914126|NCT00532948|16926405|P2|Overall Study|Death|3
4914127|NCT00532948|16926406|P1|Overall Study|Death|3
4914128|NCT00532948|16926404|P3|Overall Study|Protocol Violation|0
4914129|NCT00532948|16926405|P2|Overall Study|Protocol Violation|0
4914130|NCT00532948|16926406|P1|Overall Study|Protocol Violation|1
4914131|NCT00532935|16926438|P2|Overall Study|Protocol Specific Criteria|15
4914132|NCT00532935|16926439|P1|Overall Study|Protocol Specific Criteria|11
4914133|NCT00532935|16926438|P2|Overall Study|Withdrawal by Subject|9
4914134|NCT00532935|16926439|P1|Overall Study|Withdrawal by Subject|10
4914135|NCT00532935|16926438|P2|Overall Study|Protocol Violation|2
4914136|NCT00532935|16926439|P1|Overall Study|Protocol Violation|4
4914137|NCT00532935|16926438|P2|Overall Study|Pregnancy|0
4914138|NCT00532935|16926439|P1|Overall Study|Pregnancy|1
4914139|NCT00532935|16926438|P2|Overall Study|Physician Decision|5
4914140|NCT00532935|16926439|P1|Overall Study|Physician Decision|4
4914141|NCT00532935|16926438|P2|Overall Study|Lost to Follow-up|6
4914142|NCT00532935|16926439|P1|Overall Study|Lost to Follow-up|10
4914143|NCT00532935|16926438|P2|Overall Study|Lack of Efficacy|3
4914144|NCT00532935|16926439|P1|Overall Study|Lack of Efficacy|0
4914145|NCT00532935|16926438|P2|Overall Study|Adverse Event|12
4914146|NCT00532935|16926439|P1|Overall Study|Adverse Event|11
4914147|NCT00532883|16926457|P4|Overall Study|Early Study Termination|4
4914148|NCT00532883|16926458|P3|Overall Study|Early Study Termination|1
4914149|NCT00532883|16926459|P2|Overall Study|Early Study Termination|4
4914150|NCT00532883|16926460|P1|Overall Study|Early Study Termination|4
4914151|NCT00532883|16926457|P4|Overall Study|Subject was Nonadherent|0
4914152|NCT00532883|16926458|P3|Overall Study|Subject was Nonadherent|1
4914153|NCT00532883|16926459|P2|Overall Study|Subject was Nonadherent|1
4914154|NCT00532883|16926460|P1|Overall Study|Subject was Nonadherent|0
4914155|NCT00532883|16926457|P4|Overall Study|Withdrawal by Subject|0
4914156|NCT00532883|16926458|P3|Overall Study|Withdrawal by Subject|1
4914157|NCT00532883|16926459|P2|Overall Study|Withdrawal by Subject|1
4914158|NCT00532883|16926460|P1|Overall Study|Withdrawal by Subject|0
4914159|NCT00532883|16926457|P4|Overall Study|Lost to Follow-up|0
4914160|NCT00532883|16926458|P3|Overall Study|Lost to Follow-up|1
4914161|NCT00532883|16926459|P2|Overall Study|Lost to Follow-up|1
4914162|NCT00532883|16926460|P1|Overall Study|Lost to Follow-up|1
4914163|NCT00532883|16926457|P4|Overall Study|Adverse Event|1
4914164|NCT00532883|16926458|P3|Overall Study|Adverse Event|0
4914165|NCT00532883|16926459|P2|Overall Study|Adverse Event|0
4914166|NCT00532883|16926460|P1|Overall Study|Adverse Event|1
4914167|NCT00532779|16926473|P3|Overall Study|Drug noncompliance, moved, other|29
4914168|NCT00532779|16926474|P2|Overall Study|Drug noncompliance, moved, other|23
4914169|NCT00532779|16926475|P1|Overall Study|Drug noncompliance, moved, other|14
4914170|NCT00532779|16926473|P3|Overall Study|Death|0
4914171|NCT00532779|16926474|P2|Overall Study|Death|1
4914172|NCT00532779|16926475|P1|Overall Study|Death|0
4914173|NCT00532779|16926473|P3|Overall Study|Pregnancy|3
4914174|NCT00532779|16926474|P2|Overall Study|Pregnancy|5
4914175|NCT00532779|16926475|P1|Overall Study|Pregnancy|2
4914176|NCT00532779|16926473|P3|Overall Study|Protocol Violation|7
4914177|NCT00532779|16926474|P2|Overall Study|Protocol Violation|9
4914178|NCT00532779|16926475|P1|Overall Study|Protocol Violation|5
4914179|NCT00532779|16926473|P3|Overall Study|Lack of Efficacy|40
4914180|NCT00532779|16926474|P2|Overall Study|Lack of Efficacy|12
4914181|NCT00532779|16926475|P1|Overall Study|Lack of Efficacy|12
4914182|NCT00532779|16926473|P3|Overall Study|Withdrawal by Subject|90
4914183|NCT00532779|16926474|P2|Overall Study|Withdrawal by Subject|60
4914184|NCT00532779|16926475|P1|Overall Study|Withdrawal by Subject|63
4914185|NCT00532779|16926473|P3|Overall Study|Lost to Follow-up|66
4914186|NCT00532779|16926474|P2|Overall Study|Lost to Follow-up|65
4914187|NCT00532779|16926475|P1|Overall Study|Lost to Follow-up|76
4914188|NCT00532779|16926473|P3|Overall Study|Adverse Event|56
4914189|NCT00532779|16926474|P2|Overall Study|Adverse Event|112
4914190|NCT00532779|16926475|P1|Overall Study|Adverse Event|122
4914191|NCT00532493|16926536|P2|Overall Study|Contraindicative Medication|0
4914192|NCT00532493|16926537|P1|Overall Study|Contraindicative Medication|1
4914193|NCT00532493|16926536|P2|Overall Study|Subject Moved Away|1
4914194|NCT00532493|16926537|P1|Overall Study|Subject Moved Away|3
4914195|NCT00532493|16926536|P2|Overall Study|Protocol Deviation|0
4914196|NCT00532493|16926537|P1|Overall Study|Protocol Deviation|1
4914197|NCT00532493|16926536|P2|Overall Study|Adverse Event|5
4914198|NCT00532493|16926537|P1|Overall Study|Adverse Event|6
4914199|NCT00532493|16926536|P2|Overall Study|Physician Decision|6
4914200|NCT00532493|16926537|P1|Overall Study|Physician Decision|1
4914201|NCT00532493|16926536|P2|Overall Study|Withdrawal by Subject|9
4914202|NCT00532493|16926537|P1|Overall Study|Withdrawal by Subject|7
4914203|NCT00532493|16926536|P2|Overall Study|Lost to Follow-up|7
4914204|NCT00532493|16926537|P1|Overall Study|Lost to Follow-up|10
4914205|NCT00532493|16926536|P2|Overall Study|Death|1
4914206|NCT00532493|16926537|P1|Overall Study|Death|1
4914207|NCT00532441|16926571|P2|Overall Study|Death|0
4914208|NCT00532441|16926572|P1|Overall Study|Death|1
4914209|NCT00532298|16926587|P6|Overall Study|Lost to Follow-up|1
4914210|NCT00532298|16926588|P5|Overall Study|Lost to Follow-up|0
4914211|NCT00532298|16926589|P4|Overall Study|Lost to Follow-up|0
4914212|NCT00532298|16926590|P3|Overall Study|Lost to Follow-up|1
4914213|NCT00532298|16926591|P2|Overall Study|Lost to Follow-up|1
4914214|NCT00532298|16926592|P1|Overall Study|Lost to Follow-up|1
4914215|NCT00532298|16926587|P6|Overall Study|Adverse Event|1
4914216|NCT00532298|16926588|P5|Overall Study|Adverse Event|1
4914217|NCT00532298|16926589|P4|Overall Study|Adverse Event|0
4914218|NCT00532298|16926590|P3|Overall Study|Adverse Event|0
4914219|NCT00532298|16926591|P2|Overall Study|Adverse Event|0
4914220|NCT00532298|16926592|P1|Overall Study|Adverse Event|1
4914221|NCT00532259|16926672|P1|Overall Study|Protocol Violation|1
4914222|NCT00532259|16926672|P1|Overall Study|Physician Decision|3
4914223|NCT00532259|16926672|P1|Overall Study|Lost to Follow-up|3
4914224|NCT00532259|16926672|P1|Overall Study|Lack of Efficacy|21
4914225|NCT00532259|16926672|P1|Overall Study|Death|1
4914226|NCT00532259|16926672|P1|Overall Study|Adverse Event|1
4914227|NCT00532259|16926672|P1|Overall Study|Withdrawal by Subject|2
4914228|NCT00532155|16926679|P2|Overall Study|Did not receive study medication|6
4914229|NCT00532155|16926680|P1|Overall Study|Did not receive study medication|2
4914230|NCT00532155|16926679|P2|Overall Study|Study termination stop further treatment|0
4914231|NCT00532155|16926680|P1|Overall Study|Study termination stop further treatment|4
4914232|NCT00532155|16926679|P2|Overall Study|Study terminated by sponsor|0
4914233|NCT00532155|16926680|P1|Overall Study|Study terminated by sponsor|1
4914234|NCT00532155|16926679|P2|Overall Study|Study stopped|0
4914235|NCT00532155|16926680|P1|Overall Study|Study stopped|1
4914236|NCT00532155|16926679|P2|Overall Study|Had brain metastasis, was mis-randomized|0
4914237|NCT00532155|16926680|P1|Overall Study|Had brain metastasis, was mis-randomized|1
4914238|NCT00532155|16926679|P2|Overall Study|Progressive disease (by incorrect scan)|1
4914239|NCT00532155|16926680|P1|Overall Study|Progressive disease (by incorrect scan)|0
4914240|NCT00532155|16926679|P2|Overall Study|Promotor ended study|0
4914241|NCT00532155|16926680|P1|Overall Study|Promotor ended study|1
4914242|NCT00532155|16926679|P2|Overall Study|Occurence of a secondary cancer|1
4914243|NCT00532155|16926680|P1|Overall Study|Occurence of a secondary cancer|0
4914244|NCT00532155|16926679|P2|Overall Study|Occurence of a second cancer|1
4914245|NCT00532155|16926680|P1|Overall Study|Occurence of a second cancer|0
4914246|NCT00532155|16926679|P2|Overall Study|Pre-existing brain metastasis (by MRI)|0
4914247|NCT00532155|16926680|P1|Overall Study|Pre-existing brain metastasis (by MRI)|1
4914248|NCT00532155|16926679|P2|Overall Study|Moved|0
4914249|NCT00532155|16926680|P1|Overall Study|Moved|1
4914250|NCT00532155|16926679|P2|Overall Study|Consent withdrawn|7
4914251|NCT00532155|16926680|P1|Overall Study|Consent withdrawn|5
4914252|NCT00532155|16926679|P2|Overall Study|Withdrawal by Subject|44
4914253|NCT00532155|16926680|P1|Overall Study|Withdrawal by Subject|23
4914254|NCT00532155|16926679|P2|Overall Study|Physician Decision|15
4914255|NCT00532155|16926680|P1|Overall Study|Physician Decision|16
4914256|NCT00532155|16926679|P2|Overall Study|Lost to Follow-up|0
4914257|NCT00532155|16926680|P1|Overall Study|Lost to Follow-up|2
4914258|NCT00532155|16926679|P2|Overall Study|Protocol Violation|3
4914259|NCT00532155|16926680|P1|Overall Study|Protocol Violation|1
4914260|NCT00532155|16926679|P2|Overall Study|Lack of Efficacy|255
4914261|NCT00532155|16926680|P1|Overall Study|Lack of Efficacy|332
4914262|NCT00532155|16926679|P2|Overall Study|Adverse Event|123
4914263|NCT00532155|16926680|P1|Overall Study|Adverse Event|66
4914264|NCT00532129|16926694|P1|Follow-up Period|Other|6
4914265|NCT00532129|16926694|P1|Follow-up Period|Lost to Follow-up|1
4914266|NCT00532129|16926694|P1|Follow-up Period|Disease progression|57
4914267|NCT00532129|16926694|P1|Follow-up Period|Adverse event/Serious adverse event|1
4914268|NCT00532129|16926694|P1|Treatment Period|Other|5
4914269|NCT00532129|16926694|P1|Treatment Period|Protocol Violation|1
4914270|NCT00532129|16926694|P1|Treatment Period|Disease progression|3
4914271|NCT00532129|16926694|P1|Treatment Period|Physician Decision|15
4914272|NCT00532129|16926694|P1|Treatment Period|Adverse event/Serious adverse event|25
4914273|NCT00531960|16926714|P2|Overall Study|Other|10
4914274|NCT00531960|16926715|P1|Overall Study|Other|4
4914275|NCT00531960|16926714|P2|Overall Study|Refused Treatment|6
4914276|NCT00531960|16926715|P1|Overall Study|Refused Treatment|5
4914277|NCT00531960|16926714|P2|Overall Study|Violation of Selection Criteria|0
4914278|NCT00531960|16926715|P1|Overall Study|Violation of Selection Criteria|2
4914279|NCT00531960|16926714|P2|Overall Study|Lack of Efficacy|41
4914280|NCT00531960|16926715|P1|Overall Study|Lack of Efficacy|42
4914281|NCT00531960|16926714|P2|Overall Study|Death|2
4914282|NCT00531960|16926715|P1|Overall Study|Death|3
4914283|NCT00531960|16926714|P2|Overall Study|Adverse Event|4
4914284|NCT00531960|16926715|P1|Overall Study|Adverse Event|5
4914285|NCT00531947|16926733|P2|Overall Study|Other (e.g., Lack of Efficacy)|5
4914286|NCT00531947|16926734|P1|Overall Study|Other (e.g., Lack of Efficacy)|5
4914287|NCT00531947|16926733|P2|Overall Study|Non-Compliance|7
4914288|NCT00531947|16926734|P1|Overall Study|Non-Compliance|4
4914289|NCT00531947|16926733|P2|Overall Study|Protocol Violation|1
4914290|NCT00531947|16926734|P1|Overall Study|Protocol Violation|2
4914291|NCT00531947|16926733|P2|Overall Study|Withdrawal by Subject|19
4914292|NCT00531947|16926734|P1|Overall Study|Withdrawal by Subject|14
4914293|NCT00531947|16926733|P2|Overall Study|Lost to Follow-up|9
4914294|NCT00531947|16926734|P1|Overall Study|Lost to Follow-up|12
4914295|NCT00531947|16926733|P2|Overall Study|Adverse Event|10
4914296|NCT00531947|16926734|P1|Overall Study|Adverse Event|5
4914297|NCT00531934|16926778|P2|Overall Study|Other|2
4914298|NCT00531934|16926779|P1|Overall Study|Other|2
4914299|NCT00531934|16926778|P2|Overall Study|Withdrawal by Subject|1
4914300|NCT00531934|16926779|P1|Overall Study|Withdrawal by Subject|1
4914301|NCT00531934|16926778|P2|Overall Study|Death|10
4914302|NCT00531934|16926779|P1|Overall Study|Death|7
4914303|NCT00531934|16926778|P2|Overall Study|Progression|42
4914304|NCT00531934|16926779|P1|Overall Study|Progression|52
4914305|NCT00531934|16926778|P2|Overall Study|Adverse Event|8
4914306|NCT00531934|16926779|P1|Overall Study|Adverse Event|4
4914307|NCT00531752|16926907|P4|Second Double-blind Intervention Period|Lost to Follow-up|1
4914308|NCT00531752|16926908|P3|Second Double-blind Intervention Period|Lost to Follow-up|0
4914309|NCT00531752|16926909|P2|Second Double-blind Intervention Period|Lost to Follow-up|0
4914310|NCT00531752|16926910|P1|Second Double-blind Intervention Period|Lost to Follow-up|0
4914311|NCT00531752|16926907|P4|Second Double-blind Intervention Period|Withdrawal by Subject|1
4914312|NCT00531752|16926908|P3|Second Double-blind Intervention Period|Withdrawal by Subject|0
4914313|NCT00531752|16926909|P2|Second Double-blind Intervention Period|Withdrawal by Subject|0
4914314|NCT00531752|16926910|P1|Second Double-blind Intervention Period|Withdrawal by Subject|0
4914315|NCT00531752|16926907|P4|Second Double-blind Intervention Period|Other|0
4914316|NCT00531752|16926908|P3|Second Double-blind Intervention Period|Other|0
4914317|NCT00531752|16926909|P2|Second Double-blind Intervention Period|Other|1
4914318|NCT00531752|16926910|P1|Second Double-blind Intervention Period|Other|1
4914319|NCT00531752|16926907|P4|Second Double-blind Intervention Period|Adverse Event|0
4914320|NCT00531752|16926908|P3|Second Double-blind Intervention Period|Adverse Event|0
4914321|NCT00531752|16926909|P2|Second Double-blind Intervention Period|Adverse Event|1
4914322|NCT00531752|16926910|P1|Second Double-blind Intervention Period|Adverse Event|1
4914323|NCT00531752|16926907|P4|First Double-blind Intervention Period|Randomized but not treated|0
4914324|NCT00531752|16926908|P3|First Double-blind Intervention Period|Randomized but not treated|0
4914325|NCT00531752|16926909|P2|First Double-blind Intervention Period|Randomized but not treated|0
4914326|NCT00531752|16926910|P1|First Double-blind Intervention Period|Randomized but not treated|1
4914327|NCT00531752|16926907|P4|First Double-blind Intervention Period|Lost to Follow-up|1
4914328|NCT00531752|16926908|P3|First Double-blind Intervention Period|Lost to Follow-up|1
4914329|NCT00531752|16926909|P2|First Double-blind Intervention Period|Lost to Follow-up|0
4914330|NCT00531752|16926910|P1|First Double-blind Intervention Period|Lost to Follow-up|0
4914331|NCT00531752|16926907|P4|First Double-blind Intervention Period|Withdrawal by Subject|1
4914332|NCT00531752|16926908|P3|First Double-blind Intervention Period|Withdrawal by Subject|1
4914333|NCT00531752|16926909|P2|First Double-blind Intervention Period|Withdrawal by Subject|0
4914334|NCT00531752|16926910|P1|First Double-blind Intervention Period|Withdrawal by Subject|2
4914335|NCT00531752|16926907|P4|First Double-blind Intervention Period|Other|0
4914336|NCT00531752|16926908|P3|First Double-blind Intervention Period|Other|4
4914337|NCT00531752|16926909|P2|First Double-blind Intervention Period|Other|4
4914338|NCT00531752|16926910|P1|First Double-blind Intervention Period|Other|1
4914339|NCT00531752|16926907|P4|First Double-blind Intervention Period|Adverse Event|1
4914340|NCT00531752|16926908|P3|First Double-blind Intervention Period|Adverse Event|1
4914341|NCT00531752|16926909|P2|First Double-blind Intervention Period|Adverse Event|0
4914342|NCT00531752|16926910|P1|First Double-blind Intervention Period|Adverse Event|2
4914343|NCT00531479|16927021|P2|Overall Study|Did not receive treatment|3
4914344|NCT00531479|16927022|P1|Overall Study|Did not receive treatment|2
4914345|NCT00531479|16927021|P2|Overall Study|Withdrawal by Subject|6
4914346|NCT00531479|16927022|P1|Overall Study|Withdrawal by Subject|6
4914347|NCT00531479|16927021|P2|Overall Study|Other|1
4914348|NCT00531479|16927022|P1|Overall Study|Other|0
4914349|NCT00531479|16927021|P2|Overall Study|Lost to Follow-up|2
4914350|NCT00531479|16927022|P1|Overall Study|Lost to Follow-up|0
4914351|NCT00531479|16927021|P2|Overall Study|Death|71
4914352|NCT00531479|16927022|P1|Overall Study|Death|68
4914353|NCT00531427|16927053|P2|Overall Study|Administrative|9
4914354|NCT00531427|16927054|P1|Overall Study|Administrative|4
4914355|NCT00531427|16927053|P2|Overall Study|Lack of Efficacy|39
4914356|NCT00531427|16927054|P1|Overall Study|Lack of Efficacy|14
4914357|NCT00531427|16927053|P2|Overall Study|Lost to Follow-up|3
4914358|NCT00531427|16927054|P1|Overall Study|Lost to Follow-up|4
4914359|NCT00531427|16927053|P2|Overall Study|Adverse Event|30
4914360|NCT00531427|16927054|P1|Overall Study|Adverse Event|44
4914361|NCT00531427|16927053|P2|Overall Study|Withdrawal by Subject|13
4914362|NCT00531427|16927054|P1|Overall Study|Withdrawal by Subject|7
4914363|NCT00531284|16927082|P17|Overall Study|Other|0
4914364|NCT00531284|16927083|P16|Overall Study|Other|0
4914365|NCT00531284|16927084|P15|Overall Study|Other|1
4914366|NCT00531284|16927085|P14|Overall Study|Other|0
4914367|NCT00531284|16927086|P13|Overall Study|Other|0
4914368|NCT00531284|16927087|P12|Overall Study|Other|2
4914369|NCT00531284|16927088|P11|Overall Study|Other|0
4914370|NCT00531284|16927089|P10|Overall Study|Other|1
4914371|NCT00531284|16927090|P9|Overall Study|Other|2
4914372|NCT00531284|16927091|P8|Overall Study|Other|0
4914373|NCT00531284|16927092|P7|Overall Study|Other|0
4914374|NCT00531284|16927093|P6|Overall Study|Other|1
4914375|NCT00531284|16927094|P5|Overall Study|Other|2
4914376|NCT00531284|16927095|P4|Overall Study|Other|10
4914377|NCT00531284|16927096|P3|Overall Study|Other|0
4914378|NCT00531284|16927097|P2|Overall Study|Other|0
4914379|NCT00531284|16927098|P1|Overall Study|Other|1
4914380|NCT00531284|16927082|P17|Overall Study|Withdrawal by Subject|1
4914381|NCT00531284|16927083|P16|Overall Study|Withdrawal by Subject|1
4914382|NCT00531284|16927084|P15|Overall Study|Withdrawal by Subject|0
4914383|NCT00531284|16927085|P14|Overall Study|Withdrawal by Subject|1
4914384|NCT00531284|16927086|P13|Overall Study|Withdrawal by Subject|0
4914385|NCT00531284|16927087|P12|Overall Study|Withdrawal by Subject|3
4914386|NCT00531284|16927088|P11|Overall Study|Withdrawal by Subject|0
4914387|NCT00531284|16927089|P10|Overall Study|Withdrawal by Subject|0
4914388|NCT00531284|16927090|P9|Overall Study|Withdrawal by Subject|0
4914389|NCT00531284|16927091|P8|Overall Study|Withdrawal by Subject|0
4914390|NCT00531284|16927092|P7|Overall Study|Withdrawal by Subject|0
4914391|NCT00531284|16927093|P6|Overall Study|Withdrawal by Subject|0
4914392|NCT00531284|16927094|P5|Overall Study|Withdrawal by Subject|0
4914393|NCT00531284|16927095|P4|Overall Study|Withdrawal by Subject|4
4914394|NCT00531284|16927096|P3|Overall Study|Withdrawal by Subject|0
4914395|NCT00531284|16927097|P2|Overall Study|Withdrawal by Subject|0
4914396|NCT00531284|16927098|P1|Overall Study|Withdrawal by Subject|1
4914397|NCT00531284|16927082|P17|Overall Study|Adverse Event|2
4914398|NCT00531284|16927083|P16|Overall Study|Adverse Event|0
4914399|NCT00531284|16927084|P15|Overall Study|Adverse Event|1
4914400|NCT00531284|16927085|P14|Overall Study|Adverse Event|1
4914401|NCT00531284|16927086|P13|Overall Study|Adverse Event|0
4914402|NCT00531284|16927087|P12|Overall Study|Adverse Event|5
4914403|NCT00531284|16927088|P11|Overall Study|Adverse Event|0
4914404|NCT00531284|16927089|P10|Overall Study|Adverse Event|0
4914405|NCT00531284|16927090|P9|Overall Study|Adverse Event|3
4914406|NCT00531284|16927091|P8|Overall Study|Adverse Event|2
4914407|NCT00531284|16927092|P7|Overall Study|Adverse Event|3
4914408|NCT00531284|16927093|P6|Overall Study|Adverse Event|2
4914409|NCT00531284|16927094|P5|Overall Study|Adverse Event|0
4914410|NCT00531284|16927095|P4|Overall Study|Adverse Event|7
4914411|NCT00531284|16927096|P3|Overall Study|Adverse Event|1
4914412|NCT00531284|16927097|P2|Overall Study|Adverse Event|1
4914413|NCT00531284|16927098|P1|Overall Study|Adverse Event|0
4914414|NCT00531284|16927082|P17|Overall Study|Progressive Disease|5
4914415|NCT00531284|16927083|P16|Overall Study|Progressive Disease|11
4914416|NCT00531284|16927084|P15|Overall Study|Progressive Disease|2
4914417|NCT00531284|16927085|P14|Overall Study|Progressive Disease|1
4914418|NCT00531284|16927086|P13|Overall Study|Progressive Disease|2
4914419|NCT00531284|16927087|P12|Overall Study|Progressive Disease|14
4914420|NCT00531284|16927088|P11|Overall Study|Progressive Disease|3
4914421|NCT00531284|16927089|P10|Overall Study|Progressive Disease|3
4914422|NCT00531284|16927090|P9|Overall Study|Progressive Disease|6
4914423|NCT00531284|16927091|P8|Overall Study|Progressive Disease|8
4914424|NCT00531284|16927092|P7|Overall Study|Progressive Disease|3
4914425|NCT00531284|16927093|P6|Overall Study|Progressive Disease|4
4914426|NCT00531284|16927094|P5|Overall Study|Progressive Disease|4
4914427|NCT00531284|16927095|P4|Overall Study|Progressive Disease|42
4914428|NCT00531284|16927096|P3|Overall Study|Progressive Disease|5
4914429|NCT00531284|16927097|P2|Overall Study|Progressive Disease|3
4914430|NCT00531284|16927098|P1|Overall Study|Progressive Disease|1
4914431|NCT00531206|16927248|P1|Overall Study|including non-related adverse events|8
4914432|NCT00531206|16927248|P1|Overall Study|Lost to Follow-up|5
4914433|NCT00531206|16927248|P1|Overall Study|Lack of Efficacy|2
4914434|NCT00531206|16927248|P1|Overall Study|Adverse Event related|5
4914435|NCT00531050|16927278|P6|Part 2: Period 3|Abnormal test procedure|1
4914436|NCT00531050|16927279|P5|Part 2: Period 3|Abnormal test procedure|0
4914437|NCT00531050|16927280|P4|Part 2: Period 3|Abnormal test procedure|0
4914438|NCT00531050|16927281|P3|Part 2: Period 3|Abnormal test procedure|0
4914439|NCT00531050|16927282|P2|Part 2: Period 3|Abnormal test procedure|0
4914440|NCT00531050|16927283|P1|Part 2: Period 3|Abnormal test procedure|1
4914441|NCT00531050|16927278|P6|Part 2: Period 1|Adverse Event|1
4914442|NCT00531050|16927279|P5|Part 2: Period 1|Adverse Event|0
4914443|NCT00531050|16927280|P4|Part 2: Period 1|Adverse Event|0
4914444|NCT00531050|16927281|P3|Part 2: Period 1|Adverse Event|0
4914445|NCT00531050|16927282|P2|Part 2: Period 1|Adverse Event|0
4914446|NCT00531050|16927283|P1|Part 2: Period 1|Adverse Event|0
4914447|NCT00531050|16927278|P6|Part 1: Period 3|Adverse Event|0
4914448|NCT00531050|16927279|P5|Part 1: Period 3|Adverse Event|0
4914449|NCT00531050|16927280|P4|Part 1: Period 3|Adverse Event|0
4914450|NCT00531050|16927281|P3|Part 1: Period 3|Adverse Event|0
4914451|NCT00531050|16927282|P2|Part 1: Period 3|Adverse Event|0
4914452|NCT00531050|16927283|P1|Part 1: Period 3|Adverse Event|1
4914453|NCT00531050|16927278|P6|Part 1: Period 1|Protocol Deviation|0
4914454|NCT00531050|16927279|P5|Part 1: Period 1|Protocol Deviation|0
4914455|NCT00531050|16927280|P4|Part 1: Period 1|Protocol Deviation|1
4914456|NCT00531050|16927281|P3|Part 1: Period 1|Protocol Deviation|0
4914457|NCT00531050|16927282|P2|Part 1: Period 1|Protocol Deviation|0
4914458|NCT00531050|16927283|P1|Part 1: Period 1|Protocol Deviation|0
4914459|NCT00531050|16927278|P6|Part 1: Period 1|Adverse Event|0
4914460|NCT00531050|16927279|P5|Part 1: Period 1|Adverse Event|0
4914461|NCT00531050|16927280|P4|Part 1: Period 1|Adverse Event|0
4914462|NCT00531050|16927281|P3|Part 1: Period 1|Adverse Event|0
4914463|NCT00531050|16927282|P2|Part 1: Period 1|Adverse Event|1
4914464|NCT00531050|16927283|P1|Part 1: Period 1|Adverse Event|0
4914465|NCT00531011|16927312|P2|Overall Study|Physician Decision|3
4914466|NCT00531011|16927313|P1|Overall Study|Physician Decision|0
4914467|NCT00531011|16927312|P2|Overall Study|Lost to Follow-up|0
4914468|NCT00531011|16927313|P1|Overall Study|Lost to Follow-up|1
4914469|NCT00531011|16927312|P2|Overall Study|Death|0
4914470|NCT00531011|16927313|P1|Overall Study|Death|1
4914471|NCT00531011|16927312|P2|Overall Study|Withdrawal by Subject|4
4914472|NCT00531011|16927313|P1|Overall Study|Withdrawal by Subject|2
4914473|NCT00530946|16927359|P4|Overall Study|Noncompliance|0
4914474|NCT00530946|16927360|P3|Overall Study|Noncompliance|0
4914475|NCT00530946|16927361|P2|Overall Study|Noncompliance|0
4914476|NCT00530946|16927362|P1|Overall Study|Noncompliance|1
4914477|NCT00530946|16927359|P4|Overall Study|Protocol Violation|1
4914478|NCT00530946|16927360|P3|Overall Study|Protocol Violation|0
4914479|NCT00530946|16927361|P2|Overall Study|Protocol Violation|0
4914480|NCT00530946|16927362|P1|Overall Study|Protocol Violation|0
4914481|NCT00530946|16927359|P4|Overall Study|Adverse Event|1
4914482|NCT00530946|16927360|P3|Overall Study|Adverse Event|1
4914483|NCT00530946|16927361|P2|Overall Study|Adverse Event|2
4914484|NCT00530946|16927362|P1|Overall Study|Adverse Event|1
4914485|NCT00530920|16927415|P3|Overall Study|Withdrawal by Subject|1
4914486|NCT00530920|16927416|P2|Overall Study|Withdrawal by Subject|0
4914487|NCT00530920|16927417|P1|Overall Study|Withdrawal by Subject|0
4914488|NCT00530920|16927415|P3|Overall Study|Adverse Event|3
4914489|NCT00530920|16927416|P2|Overall Study|Adverse Event|0
4914490|NCT00530920|16927417|P1|Overall Study|Adverse Event|0
4914491|NCT00530920|16927415|P3|Overall Study|Randomized but not treated|0
4914492|NCT00530920|16927416|P2|Overall Study|Randomized but not treated|2
4914493|NCT00530920|16927417|P1|Overall Study|Randomized but not treated|0
4914494|NCT00530894|16927477|P4|Overall Study|Alive and censored prior to 1 year|0
4914495|NCT00530894|16927478|P3|Overall Study|Alive and censored prior to 1 year|0
4914496|NCT00530894|16927479|P2|Overall Study|Alive and censored prior to 1 year|0
4914497|NCT00530894|16927480|P1|Overall Study|Alive and censored prior to 1 year|2
4914498|NCT00530894|16927477|P4|Overall Study|Withdrawal by Subject|5
4914499|NCT00530894|16927478|P3|Overall Study|Withdrawal by Subject|0
4914500|NCT00530894|16927479|P2|Overall Study|Withdrawal by Subject|23
4914501|NCT00530894|16927480|P1|Overall Study|Withdrawal by Subject|1
4914502|NCT00530894|16927477|P4|Overall Study|Lost to Follow-up|0
4914503|NCT00530894|16927478|P3|Overall Study|Lost to Follow-up|0
4914504|NCT00530894|16927479|P2|Overall Study|Lost to Follow-up|3
4914505|NCT00530894|16927480|P1|Overall Study|Lost to Follow-up|1
4914506|NCT00530894|16927477|P4|Overall Study|Death|89
4914507|NCT00530894|16927478|P3|Overall Study|Death|55
4914508|NCT00530894|16927479|P2|Overall Study|Death|89
4914509|NCT00530894|16927480|P1|Overall Study|Death|84
4914510|NCT00530855|16927508|P1|Overall Study|Other reason for premature termination|17
4914511|NCT00530855|16927508|P1|Overall Study|Lost to Follow-up|9
4914512|NCT00530855|16927508|P1|Overall Study|Unsatisfactory compliance of subject|11
4914513|NCT00530855|16927508|P1|Overall Study|Protocol Violation|3
4914514|NCT00530855|16927508|P1|Overall Study|Non Fatal Non Serious AE|12
4914515|NCT00530855|16927508|P1|Overall Study|Non Fatal Serious AE|7
4914516|NCT00530855|16927508|P1|Overall Study|Fatal Serious AE|3
4914517|NCT00530855|16927508|P1|Overall Study|Withdrawal by Subject|30
4914518|NCT00530855|16927508|P1|Overall Study|Lack of Efficacy|20
4914519|NCT00530842|16927517|P2|Period 2|Individual different reasons|0
4914520|NCT00530842|16927518|P1|Period 2|Individual different reasons|2
4914521|NCT00530842|16927517|P2|Period 2|Withdrawal by Subject|2
4914522|NCT00530842|16927518|P1|Period 2|Withdrawal by Subject|1
4914523|NCT00530842|16927517|P2|Period 2|Protocol Violation|0
4914524|NCT00530842|16927518|P1|Period 2|Protocol Violation|1
4914525|NCT00530842|16927517|P2|Period 2|Lost to Follow-up|4
4914526|NCT00530842|16927518|P1|Period 2|Lost to Follow-up|0
4914527|NCT00530842|16927517|P2|Period 2|Lack of Efficacy|0
4914528|NCT00530842|16927518|P1|Period 2|Lack of Efficacy|1
4914529|NCT00530842|16927517|P2|Period 2|Adverse Event|3
4914530|NCT00530842|16927518|P1|Period 2|Adverse Event|3
4914531|NCT00530842|16927517|P2|Period 1|Individual different reasons|3
4914532|NCT00530842|16927518|P1|Period 1|Individual different reasons|2
4914533|NCT00530842|16927517|P2|Period 1|Withdrawal by Subject|3
4914534|NCT00530842|16927518|P1|Period 1|Withdrawal by Subject|2
4914535|NCT00530842|16927517|P2|Period 1|Protocol Violation|1
4914536|NCT00530842|16927518|P1|Period 1|Protocol Violation|2
4914537|NCT00530842|16927517|P2|Period 1|Lack of Efficacy|1
4914538|NCT00530842|16927518|P1|Period 1|Lack of Efficacy|1
4914539|NCT00530842|16927517|P2|Period 1|Adverse Event|3
4914540|NCT00530842|16927518|P1|Period 1|Adverse Event|7
4914541|NCT00530842|16927517|P2|Overall Study|Individual different reasons|3
4914542|NCT00530842|16927518|P1|Overall Study|Individual different reasons|4
4914543|NCT00530842|16927517|P2|Overall Study|Withdrawal by Subject|5
4914544|NCT00530842|16927518|P1|Overall Study|Withdrawal by Subject|4
4914545|NCT00530842|16927517|P2|Overall Study|Protocol Violation|2
4914546|NCT00530842|16927518|P1|Overall Study|Protocol Violation|3
4914547|NCT00530842|16927517|P2|Overall Study|Lost to Follow-up|4
4914548|NCT00530842|16927518|P1|Overall Study|Lost to Follow-up|0
4914549|NCT00530842|16927517|P2|Overall Study|Lack of Efficacy|1
4914550|NCT00530842|16927518|P1|Overall Study|Lack of Efficacy|2
4914551|NCT00530842|16927517|P2|Overall Study|Adverse Event|6
4914552|NCT00530842|16927518|P1|Overall Study|Adverse Event|10
4914553|NCT00530816|16927645|P3|Overall Study|Withdrawal by Subject|6
4914554|NCT00530816|16927646|P2|Overall Study|Withdrawal by Subject|2
4914555|NCT00530816|16927647|P1|Overall Study|Withdrawal by Subject|1
4914556|NCT00530816|16927645|P3|Overall Study|Other|4
4914557|NCT00530816|16927646|P2|Overall Study|Other|3
4914558|NCT00530816|16927647|P1|Overall Study|Other|3
4914559|NCT00530816|16927645|P3|Overall Study|Adverse Event|7
4914560|NCT00530816|16927646|P2|Overall Study|Adverse Event|13
4914561|NCT00530816|16927647|P1|Overall Study|Adverse Event|6
4914562|NCT00530816|16927645|P3|Overall Study|Progressive Disease|24
4914563|NCT00530816|16927646|P2|Overall Study|Progressive Disease|24
4914564|NCT00530816|16927647|P1|Overall Study|Progressive Disease|16
4914565|NCT00530790|16927690|P1|Overall Study|Physician Decision|1
4914566|NCT00530790|16927690|P1|Overall Study|Withdrawal by Subject|2
4914567|NCT00530790|16927690|P1|Overall Study|Adverse Event|2
4914568|NCT00530777|16927712|P2|Overall Study|Unable to adhere to visit schedule|1
4914569|NCT00530777|16927713|P1|Overall Study|Unable to adhere to visit schedule|5
4914570|NCT00530777|16927712|P2|Overall Study|Withdrawal by Subject|1
4914571|NCT00530777|16927713|P1|Overall Study|Withdrawal by Subject|0
4914572|NCT00530777|16927712|P2|Overall Study|Physician Decision|0
4914573|NCT00530777|16927713|P1|Overall Study|Physician Decision|1
4914574|NCT00530777|16927712|P2|Overall Study|Death|2
4914575|NCT00530777|16927713|P1|Overall Study|Death|1
4914576|NCT00530777|16927712|P2|Overall Study|Lost to Follow-up|1
4914577|NCT00530777|16927713|P1|Overall Study|Lost to Follow-up|0
4914578|NCT00530712|16927770|P1|12 Month Follow-up Visit|Death|9
4914579|NCT00530712|16927770|P1|12 Month Follow-up Visit|Lost to Follow-up|7
4914580|NCT00530712|16927770|P1|12 Month Follow-up Visit|Missed Visit|3
4914581|NCT00530712|16927770|P1|12 Month Follow-up Visit|Withdrawal by Subject|5
4914582|NCT00530712|16927770|P1|6 Month Follow-up Visit|Death|2
4914583|NCT00530712|16927770|P1|6 Month Follow-up Visit|Lost to Follow-up|3
4914584|NCT00530712|16927770|P1|6 Month Follow-up Visit|Missed Visit|3
4914585|NCT00530712|16927770|P1|6 Month Follow-up Visit|Withdrawal by Subject|4
4914586|NCT00530712|16927770|P1|30 Day Follow-up Visit|Missed Visit|5
4914587|NCT00530712|16927770|P1|30 Day Follow-up Visit|Withdrawal by Subject|2
4914588|NCT00530621|16927793|P2|Overall Study|Not Treated Due to PD Prior to Dosing|0
4914589|NCT00530621|16927794|P1|Overall Study|Not Treated Due to PD Prior to Dosing|1
4914590|NCT00530621|16927793|P2|Overall Study|Death|6
4914591|NCT00530621|16927794|P1|Overall Study|Death|3
4914592|NCT00530621|16927793|P2|Overall Study|Subject Decision|7
4914593|NCT00530621|16927794|P1|Overall Study|Subject Decision|4
4914594|NCT00530621|16927793|P2|Overall Study|Sponsor Decision|15
4914595|NCT00530621|16927794|P1|Overall Study|Sponsor Decision|12
4914596|NCT00530621|16927793|P2|Overall Study|Progressive Disease (PD)|40
4914597|NCT00530621|16927794|P1|Overall Study|Progressive Disease (PD)|47
4914598|NCT00530621|16927793|P2|Overall Study|Physician Decision|4
4914599|NCT00530621|16927794|P1|Overall Study|Physician Decision|2
4914600|NCT00530621|16927793|P2|Overall Study|Adverse Event|8
4914601|NCT00530621|16927794|P1|Overall Study|Adverse Event|11
4914602|NCT00530504|16927815|P1|Overall Study|Exited study due to other reasons|33
4914603|NCT00530504|16927815|P1|Overall Study|Withdrawal by Subject|39
4914604|NCT00530504|16927815|P1|Overall Study|Lost to Follow-up|26
4914605|NCT00530504|16927815|P1|Overall Study|Death|54
4914606|NCT00530439|16927821|P2|Overall Study|Severe malformation/abortion|3
4914607|NCT00530439|16927822|P1|Overall Study|Severe malformation/abortion|0
4914608|NCT00530439|16927821|P2|Overall Study|Twin pregnancy|2
4914609|NCT00530439|16927822|P1|Overall Study|Twin pregnancy|0
4914610|NCT00530439|16927821|P2|Overall Study|Misclassification|0
4914611|NCT00530439|16927822|P1|Overall Study|Misclassification|2
4914612|NCT00530439|16927821|P2|Overall Study|Missed abortion|4
4914613|NCT00530439|16927822|P1|Overall Study|Missed abortion|1
4914614|NCT00530439|16927821|P2|Overall Study|Withdraw|14
4914615|NCT00530439|16927822|P1|Overall Study|Withdraw|18
4914616|NCT00530439|16927821|P2|Overall Study|GDM|3
4914617|NCT00530439|16927822|P1|Overall Study|GDM|9
4914618|NCT00530348|16927830|P2|Overall Study|Noncompliance with inclusion criterion 3|1
4914619|NCT00530348|16927831|P1|Overall Study|Noncompliance with inclusion criterion 3|0
4914620|NCT00530348|16927830|P2|Overall Study|Randomised in error|0
4914621|NCT00530348|16927831|P1|Overall Study|Randomised in error|1
4914622|NCT00530348|16927830|P2|Overall Study|Withdrawal by Subject|12
4914623|NCT00530348|16927831|P1|Overall Study|Withdrawal by Subject|12
4914624|NCT00530348|16927830|P2|Overall Study|Pregnancy|0
4914625|NCT00530348|16927831|P1|Overall Study|Pregnancy|1
4914626|NCT00530348|16927830|P2|Overall Study|Physician Decision|2
4914627|NCT00530348|16927831|P1|Overall Study|Physician Decision|1
4914628|NCT00530348|16927830|P2|Overall Study|Lost to Follow-up|2
4914629|NCT00530348|16927831|P1|Overall Study|Lost to Follow-up|0
4914630|NCT00530348|16927830|P2|Overall Study|Lack of Efficacy|0
4914631|NCT00530348|16927831|P1|Overall Study|Lack of Efficacy|2
4914632|NCT00530348|16927830|P2|Overall Study|Death|1
4914633|NCT00530348|16927831|P1|Overall Study|Death|0
4914634|NCT00530348|16927830|P2|Overall Study|Adverse Event|1
4914635|NCT00530348|16927831|P1|Overall Study|Adverse Event|5
4914636|NCT00530335|16927847|P1|Overall Study|Physician Decision|1
4914637|NCT00530335|16927847|P1|Overall Study|Withdrawal by Subject|1
4914638|NCT00530335|16927847|P1|Overall Study|Protocol Violation|1
4914639|NCT00530335|16927847|P1|Overall Study|Adverse Event|3
4914640|NCT00530270|16927864|P2|Overall Study|Protocol Violation|0
4914641|NCT00530270|16927865|P1|Overall Study|Protocol Violation|1
4914642|NCT00530257|16927879|P1|Overall Study|Lost to Follow-up|1
4914643|NCT00530218|16927907|P1|Overall Study|Death|12
4914644|NCT00530218|16927907|P1|Overall Study|CMV Not Detected|13
4914645|NCT00530088|16927914|P1|Overall Study|Other Not Specified|2
4914646|NCT00530088|16927914|P1|Overall Study|Physician Decision|4
4914647|NCT00530088|16927914|P1|Overall Study|Disease Progression|4
4914648|NCT00530075|16927919|P1|Overall Study|Withdrawal by Subject|1
4914649|NCT00530075|16927919|P1|Overall Study|Protocol Violation|1
4914650|NCT00530075|16927919|P1|Overall Study|Lack of Efficacy|3
4914651|NCT00530075|16927919|P1|Overall Study|Death|1
4914652|NCT00530075|16927919|P1|Overall Study|Adverse Event|1
4914653|NCT00530023|16927932|P2|Overall Study|Withdrawal by Subject|1
4914654|NCT00530023|16927933|P1|Overall Study|Withdrawal by Subject|0
4914655|NCT00529958|16927950|P3|5-Year Follow-up|Withdrawal by Subject|0
4914656|NCT00529958|16927951|P2|5-Year Follow-up|Withdrawal by Subject|0
4914657|NCT00529958|16927952|P1|5-Year Follow-up|Withdrawal by Subject|1
4914658|NCT00529958|16927950|P3|5-Year Follow-up|Lost to Follow-up|1
4914659|NCT00529958|16927951|P2|5-Year Follow-up|Lost to Follow-up|3
4914660|NCT00529958|16927952|P1|5-Year Follow-up|Lost to Follow-up|2
4914661|NCT00529958|16927950|P3|2-Year Follow-up|Withdrawal by Subject|0
4914662|NCT00529958|16927951|P2|2-Year Follow-up|Withdrawal by Subject|0
4914663|NCT00529958|16927952|P1|2-Year Follow-up|Withdrawal by Subject|3
4914664|NCT00529958|16927950|P3|2-Year Follow-up|Lost to Follow-up|2
4914665|NCT00529958|16927951|P2|2-Year Follow-up|Lost to Follow-up|2
4914666|NCT00529958|16927952|P1|2-Year Follow-up|Lost to Follow-up|1
4914667|NCT00529802|16927993|P1|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2
4914668|NCT00529802|16927993|P1|Evaluable for Primary Endpoint|Lost to Follow-up|1
4914669|NCT00529802|16927993|P1|Evaluable for Primary Endpoint|Lack of Efficacy|1
4914670|NCT00529802|16927993|P1|Evaluable for Primary Endpoint|Death|1
4914671|NCT00529802|16927993|P1|Evaluable for Primary Endpoint|Adverse Event|2
4914672|NCT00529802|16927993|P1|Evaluable for Primary Endpoint|Worsening performance status|2
4914673|NCT00529802|16927993|P1|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3
4914674|NCT00529789|16927999|P1|Study Period IV|Lost to Follow-up|3
4914675|NCT00529789|16927999|P1|Study Period IV|Lack of Efficacy|1
4914676|NCT00529789|16927999|P1|Study Period IV|Adverse Event|1
4914677|NCT00529789|16927999|P1|Study Period IV|Parent/Caregiver Decision|1
4914678|NCT00529789|16927999|P1|Study Period II/III|Lost to Follow-up|3
4914679|NCT00529789|16927999|P1|Study Period II/III|Physician Decision|3
4914680|NCT00529789|16927999|P1|Study Period II/III|Protocol Violation|3
4914681|NCT00529789|16927999|P1|Study Period II/III|Withdrawal by Subject|1
4914682|NCT00529789|16927999|P1|Study Period II/III|Lack of Efficacy|2
4914683|NCT00529789|16927999|P1|Study Period II/III|Adverse Event|3
4914684|NCT00529789|16927999|P1|Study Period II/III|Parent/Caregiver Decision|9
4914685|NCT00529763|16928024|P3|Overall Study|Patient Withdrew Consent|2
4914686|NCT00529763|16928025|P2|Overall Study|Patient Withdrew Consent|3
4914687|NCT00529763|16928026|P1|Overall Study|Patient Withdrew Consent|2
4914688|NCT00529763|16928024|P3|Overall Study|Study Drug Toxicity|1
4914689|NCT00529763|16928025|P2|Overall Study|Study Drug Toxicity|6
4914690|NCT00529763|16928026|P1|Overall Study|Study Drug Toxicity|1
4914691|NCT00529763|16928024|P3|Overall Study|Stem Cell Transplant|0
4914692|NCT00529763|16928025|P2|Overall Study|Stem Cell Transplant|3
4914693|NCT00529763|16928026|P1|Overall Study|Stem Cell Transplant|0
4914694|NCT00529763|16928024|P3|Overall Study|Lost to Follow-up|1
4914695|NCT00529763|16928025|P2|Overall Study|Lost to Follow-up|1
4914696|NCT00529763|16928026|P1|Overall Study|Lost to Follow-up|0
4914697|NCT00529763|16928024|P3|Overall Study|Disease Progression|1
4914698|NCT00529763|16928025|P2|Overall Study|Disease Progression|16
4914699|NCT00529763|16928026|P1|Overall Study|Disease Progression|6
4914700|NCT00529763|16928024|P3|Overall Study|Death|1
4914701|NCT00529763|16928025|P2|Overall Study|Death|1
4914702|NCT00529763|16928026|P1|Overall Study|Death|0
4914703|NCT00529763|16928024|P3|Overall Study|Adverse Event Unrelated to Study Drug|1
4914704|NCT00529763|16928025|P2|Overall Study|Adverse Event Unrelated to Study Drug|3
4914705|NCT00529763|16928026|P1|Overall Study|Adverse Event Unrelated to Study Drug|1
4914706|NCT00529659|16928064|P2|Overall Study|Withdrawal by Subject|6
4914707|NCT00529659|16928065|P1|Overall Study|Withdrawal by Subject|1
4914708|NCT00529659|16928064|P2|Overall Study|Protocol Violation|6
4914709|NCT00529659|16928065|P1|Overall Study|Protocol Violation|2
4914710|NCT00529659|16928064|P2|Overall Study|Physician Decision|2
4914711|NCT00529659|16928065|P1|Overall Study|Physician Decision|0
4914712|NCT00529659|16928064|P2|Overall Study|Lost to Follow-up|2
4914713|NCT00529659|16928065|P1|Overall Study|Lost to Follow-up|0
4914714|NCT00529659|16928064|P2|Overall Study|Adverse Event|7
4914715|NCT00529659|16928065|P1|Overall Study|Adverse Event|8
4914716|NCT00529633|16928083|P2|Overall Study|Withdrawal by Subject|1
4914717|NCT00529633|16928084|P1|Overall Study|Withdrawal by Subject|1
4914718|NCT00529568|16928096|P3|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19
4914719|NCT00529568|16928097|P2|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17
4914720|NCT00529568|16928098|P1|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0
4914721|NCT00529568|16928096|P3|Double-bilnd Antiviral Treatment Phase|Physician Decision|8
4914722|NCT00529568|16928097|P2|Double-bilnd Antiviral Treatment Phase|Physician Decision|5
4914723|NCT00529568|16928098|P1|Double-bilnd Antiviral Treatment Phase|Physician Decision|0
4914724|NCT00529568|16928096|P3|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48
4914725|NCT00529568|16928097|P2|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15
4914726|NCT00529568|16928098|P1|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0
4914727|NCT00529568|16928096|P3|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
4914728|NCT00529568|16928097|P2|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1
4914729|NCT00529568|16928098|P1|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0
4914730|NCT00529568|16928096|P3|Double-bilnd Antiviral Treatment Phase|Adverse Event|27
4914731|NCT00529568|16928097|P2|Double-bilnd Antiviral Treatment Phase|Adverse Event|10
4914732|NCT00529568|16928098|P1|Double-bilnd Antiviral Treatment Phase|Adverse Event|0
4914733|NCT00529568|16928096|P3|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
4914734|NCT00529568|16928097|P2|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0
4914735|NCT00529568|16928098|P1|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3
4914736|NCT00529568|16928096|P3|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
4914737|NCT00529568|16928097|P2|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0
4914738|NCT00529568|16928098|P1|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13
4914739|NCT00529568|16928096|P3|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
4914740|NCT00529568|16928097|P2|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0
4914741|NCT00529568|16928098|P1|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8
4914742|NCT00529568|16928096|P3|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
4914743|NCT00529568|16928097|P2|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0
4914744|NCT00529568|16928098|P1|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5
4914745|NCT00529568|16928096|P3|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
4914746|NCT00529568|16928097|P2|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0
4914747|NCT00529568|16928098|P1|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12
4914748|NCT00529568|16928096|P3|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
4914749|NCT00529568|16928097|P2|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0
4914750|NCT00529568|16928098|P1|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5
4914751|NCT00529542|16928161|P2|Overall Study|Lost to Follow-up|1
4914752|NCT00529542|16928162|P1|Overall Study|Lost to Follow-up|0
4914753|NCT00529542|16928161|P2|Overall Study|Withdrawal by Subject|0
4914754|NCT00529542|16928162|P1|Overall Study|Withdrawal by Subject|1
4914755|NCT00529529|16928205|P3|Overall Study|Administrative problems|3
4914756|NCT00529529|16928206|P2|Overall Study|Administrative problems|0
4914757|NCT00529529|16928207|P1|Overall Study|Administrative problems|1
4914758|NCT00529529|16928205|P3|Overall Study|Abnormal test procedure result(s)|0
4914759|NCT00529529|16928206|P2|Overall Study|Abnormal test procedure result(s)|0
4914760|NCT00529529|16928207|P1|Overall Study|Abnormal test procedure result(s)|1
4914761|NCT00529529|16928205|P3|Overall Study|Death|0
4914762|NCT00529529|16928206|P2|Overall Study|Death|0
4914763|NCT00529529|16928207|P1|Overall Study|Death|2
4914764|NCT00529529|16928205|P3|Overall Study|Unsatisfactory therapeutic effect|2
4914765|NCT00529529|16928206|P2|Overall Study|Unsatisfactory therapeutic effect|2
4914766|NCT00529529|16928207|P1|Overall Study|Unsatisfactory therapeutic effect|2
4914767|NCT00529529|16928205|P3|Overall Study|Lost to Follow-up|1
4914768|NCT00529529|16928206|P2|Overall Study|Lost to Follow-up|3
4914769|NCT00529529|16928207|P1|Overall Study|Lost to Follow-up|5
4914770|NCT00529529|16928205|P3|Overall Study|Protocol deviation|5
4914771|NCT00529529|16928206|P2|Overall Study|Protocol deviation|12
4914772|NCT00529529|16928207|P1|Overall Study|Protocol deviation|8
4914773|NCT00529529|16928205|P3|Overall Study|Subject withdrew consent|12
4914774|NCT00529529|16928206|P2|Overall Study|Subject withdrew consent|9
4914775|NCT00529529|16928207|P1|Overall Study|Subject withdrew consent|12
4914776|NCT00529529|16928205|P3|Overall Study|Adverse Event|8
4914777|NCT00529529|16928206|P2|Overall Study|Adverse Event|17
4914778|NCT00529529|16928207|P1|Overall Study|Adverse Event|12
4914779|NCT00529516|16928266|P3|Overall Study|Lost to Follow-up|1
4914780|NCT00529516|16928267|P2|Overall Study|Lost to Follow-up|0
4914781|NCT00529516|16928268|P1|Overall Study|Lost to Follow-up|0
4914782|NCT00529516|16928266|P3|Overall Study|Withdrawal by Subject|0
4914783|NCT00529516|16928267|P2|Overall Study|Withdrawal by Subject|1
4914784|NCT00529516|16928268|P1|Overall Study|Withdrawal by Subject|1
4914785|NCT00529516|16928266|P3|Overall Study|Adverse Event|0
4914786|NCT00529516|16928267|P2|Overall Study|Adverse Event|1
4914787|NCT00529516|16928268|P1|Overall Study|Adverse Event|2
4914788|NCT00529451|16928353|P4|Overall Study|Administrative problems|2
4914789|NCT00529451|16928354|P3|Overall Study|Administrative problems|0
4914790|NCT00529451|16928355|P2|Overall Study|Administrative problems|1
4914791|NCT00529451|16928356|P1|Overall Study|Administrative problems|1
4914792|NCT00529451|16928353|P4|Overall Study|Protocol deviation|1
4914793|NCT00529451|16928354|P3|Overall Study|Protocol deviation|4
4914794|NCT00529451|16928355|P2|Overall Study|Protocol deviation|1
4914795|NCT00529451|16928356|P1|Overall Study|Protocol deviation|1
4914796|NCT00529451|16928353|P4|Overall Study|Lost to Follow-up|4
4914797|NCT00529451|16928354|P3|Overall Study|Lost to Follow-up|4
4914798|NCT00529451|16928355|P2|Overall Study|Lost to Follow-up|7
4914799|NCT00529451|16928356|P1|Overall Study|Lost to Follow-up|4
4914800|NCT00529451|16928353|P4|Overall Study|Unsatisfactory therapeutic response|4
4914801|NCT00529451|16928354|P3|Overall Study|Unsatisfactory therapeutic response|5
4914802|NCT00529451|16928355|P2|Overall Study|Unsatisfactory therapeutic response|2
4914803|NCT00529451|16928356|P1|Overall Study|Unsatisfactory therapeutic response|6
4914804|NCT00529451|16928353|P4|Overall Study|Adverse Event|8
4914805|NCT00529451|16928354|P3|Overall Study|Adverse Event|14
4914806|NCT00529451|16928355|P2|Overall Study|Adverse Event|16
4914807|NCT00529451|16928356|P1|Overall Study|Adverse Event|9
4914808|NCT00529451|16928353|P4|Overall Study|Subject withdrew consent|12
4914809|NCT00529451|16928354|P3|Overall Study|Subject withdrew consent|13
4914810|NCT00529451|16928355|P2|Overall Study|Subject withdrew consent|21
4914811|NCT00529451|16928356|P1|Overall Study|Subject withdrew consent|16
4914812|NCT00529399|16928383|P3|Overall Study|Non-compliant|0
4914813|NCT00529399|16928384|P2|Overall Study|Non-compliant|1
4914814|NCT00529399|16928385|P1|Overall Study|Non-compliant|0
4914815|NCT00529399|16928383|P3|Overall Study|Withdrawal by Subject|1
4914816|NCT00529399|16928384|P2|Overall Study|Withdrawal by Subject|0
4914817|NCT00529399|16928385|P1|Overall Study|Withdrawal by Subject|1
4914818|NCT00529399|16928383|P3|Overall Study|Lost to Follow-up|1
4914819|NCT00529399|16928384|P2|Overall Study|Lost to Follow-up|0
4914820|NCT00529399|16928385|P1|Overall Study|Lost to Follow-up|1
4914821|NCT00529386|16928393|P1|Overall Study|Lost to Follow-up|1
4914822|NCT00529373|16928399|P2|Second Extension Study|Status Missing|5
4914823|NCT00529373|16928400|P1|Second Extension Study|Status Missing|5
4914824|NCT00529373|16928399|P2|Second Extension Study|Withdrawal by Subject|75
4914825|NCT00529373|16928400|P1|Second Extension Study|Withdrawal by Subject|97
4914826|NCT00529373|16928399|P2|Second Extension Study|Protocol Violation|1
4914827|NCT00529373|16928400|P1|Second Extension Study|Protocol Violation|2
4914828|NCT00529373|16928399|P2|Second Extension Study|Physician Decision|26
4914829|NCT00529373|16928400|P1|Second Extension Study|Physician Decision|63
4914830|NCT00529373|16928399|P2|Second Extension Study|Other|12
4914831|NCT00529373|16928400|P1|Second Extension Study|Other|7
4914832|NCT00529373|16928399|P2|Second Extension Study|Lost to Follow-up|12
4914833|NCT00529373|16928400|P1|Second Extension Study|Lost to Follow-up|18
4914834|NCT00529373|16928399|P2|Second Extension Study|Lack of Efficacy|15
4914835|NCT00529373|16928400|P1|Second Extension Study|Lack of Efficacy|7
4914836|NCT00529373|16928399|P2|Second Extension Study|Adverse Event|51
4914837|NCT00529373|16928400|P1|Second Extension Study|Adverse Event|101
4914838|NCT00529373|16928399|P2|First Extension Study|Did not cont. into 2nd Ext (unknown)|25
4914839|NCT00529373|16928400|P1|First Extension Study|Did not cont. into 2nd Ext (unknown)|32
4914840|NCT00529373|16928399|P2|First Extension Study|Did not cont. into 2nd Ext (verified)|281
4914841|NCT00529373|16928400|P1|First Extension Study|Did not cont. into 2nd Ext (verified)|256
4914842|NCT00529373|16928399|P2|First Extension Study|Discontinued after 5 years completion|346
4914843|NCT00529373|16928400|P1|First Extension Study|Discontinued after 5 years completion|208
4914844|NCT00529373|16928399|P2|First Extension Study|Disposition record non-existing|1
4914845|NCT00529373|16928400|P1|First Extension Study|Disposition record non-existing|0
4914846|NCT00529373|16928399|P2|First Extension Study|Withdrawal by Subject|287
4914847|NCT00529373|16928400|P1|First Extension Study|Withdrawal by Subject|296
4914848|NCT00529373|16928399|P2|First Extension Study|Protocol Violation|13
4914849|NCT00529373|16928400|P1|First Extension Study|Protocol Violation|16
4914850|NCT00529373|16928399|P2|First Extension Study|Physician Decision|45
4914851|NCT00529373|16928400|P1|First Extension Study|Physician Decision|50
4914852|NCT00529373|16928399|P2|First Extension Study|Other|47
4914853|NCT00529373|16928400|P1|First Extension Study|Other|27
4914854|NCT00529373|16928399|P2|First Extension Study|Lost to Follow-up|37
4914855|NCT00529373|16928400|P1|First Extension Study|Lost to Follow-up|41
4914856|NCT00529373|16928399|P2|First Extension Study|Lack of Efficacy|427
4914857|NCT00529373|16928400|P1|First Extension Study|Lack of Efficacy|65
4914858|NCT00529373|16928399|P2|First Extension Study|Adverse Event|142
4914859|NCT00529373|16928400|P1|First Extension Study|Adverse Event|162
4914860|NCT00529373|16928399|P2|Base Study|Did not continue into Extension|2238
4914861|NCT00529373|16928400|P1|Base Study|Did not continue into Extension|1795
4914862|NCT00529373|16928399|P2|Base Study|Withdrawal by Subject|967
4914863|NCT00529373|16928400|P1|Base Study|Withdrawal by Subject|1062
4914864|NCT00529373|16928399|P2|Base Study|Protocol Violation|38
4914865|NCT00529373|16928400|P1|Base Study|Protocol Violation|48
4914866|NCT00529373|16928399|P2|Base Study|Physician Decision|52
4914867|NCT00529373|16928400|P1|Base Study|Physician Decision|60
4914868|NCT00529373|16928399|P2|Base Study|Other Protocol Specified Criteria|20
4914869|NCT00529373|16928400|P1|Base Study|Other Protocol Specified Criteria|19
4914870|NCT00529373|16928399|P2|Base Study|Lost to Follow-up|208
4914871|NCT00529373|16928400|P1|Base Study|Lost to Follow-up|221
4914872|NCT00529373|16928399|P2|Base Study|Lack of Efficacy|75
4914873|NCT00529373|16928400|P1|Base Study|Lack of Efficacy|16
4914874|NCT00529373|16928399|P2|Base Study|Adverse Event|470
4914875|NCT00529373|16928400|P1|Base Study|Adverse Event|525
4914876|NCT00529308|16928594|P2|Overall Study|Withdrawal by Subject|1
4914877|NCT00529308|16928595|P1|Overall Study|Withdrawal by Subject|1
4914878|NCT00529243|16928624|P1|Overall Study|Relocated|1
4914879|NCT00529243|16928624|P1|Overall Study|Death|1
4914880|NCT00529243|16928624|P1|Overall Study|Adverse Event|1
4914881|NCT00529217|16928629|P1|Overall Study|Unable to adhere to study schedule|2
4914882|NCT00529217|16928629|P1|Overall Study|Lack of Efficacy|2
4914883|NCT00529152|16928665|P1|Overall Study|Lost to Follow-up|1
4914884|NCT00529152|16928665|P1|Overall Study|Withdrawal by Subject|2
4914885|NCT00529152|16928665|P1|Overall Study|Adverse Event|2
4914886|NCT00529100|16928689|P2|Overall Study|Participant Ineligibility|1
4914887|NCT00529100|16928690|P1|Overall Study|Participant Ineligibility|0
4914888|NCT00529100|16928689|P2|Overall Study|Withdrawal by Subject|1
4914889|NCT00529100|16928690|P1|Overall Study|Withdrawal by Subject|0
4914890|NCT00529100|16928689|P2|Overall Study|Progressive Disease|1
4914891|NCT00529100|16928690|P1|Overall Study|Progressive Disease|0
4914892|NCT00529100|16928689|P2|Overall Study|Protocol Violation|1
4914893|NCT00529100|16928690|P1|Overall Study|Protocol Violation|0
4914894|NCT00529100|16928689|P2|Overall Study|Adverse Event|5
4914895|NCT00529100|16928690|P1|Overall Study|Adverse Event|0
4914896|NCT00529087|16928707|P3|Overall Study|Protocol deviation|2
4914897|NCT00529087|16928708|P2|Overall Study|Protocol deviation|1
4914898|NCT00529087|16928709|P1|Overall Study|Protocol deviation|1
4914899|NCT00529087|16928707|P3|Overall Study|Withdrawal by Subject|3
4914900|NCT00529087|16928708|P2|Overall Study|Withdrawal by Subject|3
4914901|NCT00529087|16928709|P1|Overall Study|Withdrawal by Subject|3
4914902|NCT00529087|16928707|P3|Overall Study|Protocol Violation|6
4914903|NCT00529087|16928708|P2|Overall Study|Protocol Violation|7
4914904|NCT00529087|16928709|P1|Overall Study|Protocol Violation|8
4914905|NCT00529087|16928707|P3|Overall Study|Lost to Follow-up|1
4914906|NCT00529087|16928708|P2|Overall Study|Lost to Follow-up|4
4914907|NCT00529087|16928709|P1|Overall Study|Lost to Follow-up|6
4914908|NCT00529087|16928707|P3|Overall Study|Adverse Event|4
4914909|NCT00529087|16928708|P2|Overall Study|Adverse Event|13
4914910|NCT00529087|16928709|P1|Overall Study|Adverse Event|10
4914911|NCT00529035|16928773|P1|Overall Study|Withdrawal by Subject|1
4914912|NCT00528970|16928787|P3|Overall Study|Randomized but not treated|1
4914913|NCT00528970|16928788|P2|Overall Study|Randomized but not treated|0
4914914|NCT00528970|16928789|P1|Overall Study|Randomized but not treated|0
4914915|NCT00528970|16928787|P3|Overall Study|Withdrawal by Subject|5
4914916|NCT00528970|16928788|P2|Overall Study|Withdrawal by Subject|3
4914917|NCT00528970|16928789|P1|Overall Study|Withdrawal by Subject|4
4914918|NCT00528970|16928787|P3|Overall Study|Lack of Efficacy|1
4914919|NCT00528970|16928788|P2|Overall Study|Lack of Efficacy|0
4914920|NCT00528970|16928789|P1|Overall Study|Lack of Efficacy|0
4914921|NCT00528970|16928787|P3|Overall Study|Protocol Violation|4
4914922|NCT00528970|16928788|P2|Overall Study|Protocol Violation|1
4914923|NCT00528970|16928789|P1|Overall Study|Protocol Violation|2
4914924|NCT00528970|16928787|P3|Overall Study|Other than specified|3
4914925|NCT00528970|16928788|P2|Overall Study|Other than specified|3
4914926|NCT00528970|16928789|P1|Overall Study|Other than specified|2
4914927|NCT00528970|16928787|P3|Overall Study|Lost to Follow-up|1
4914928|NCT00528970|16928788|P2|Overall Study|Lost to Follow-up|0
4914929|NCT00528970|16928789|P1|Overall Study|Lost to Follow-up|0
4914930|NCT00528970|16928787|P3|Overall Study|Adverse Event|5
4914931|NCT00528970|16928788|P2|Overall Study|Adverse Event|8
4914932|NCT00528970|16928789|P1|Overall Study|Adverse Event|6
4914933|NCT00528957|16928808|P2|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
4914934|NCT00528957|16928809|P1|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1
4914935|NCT00528957|16928808|P2|Long-Term Extension (Week 336 and On)|Withdrew Consent|1
4914936|NCT00528957|16928809|P1|Long-Term Extension (Week 336 and On)|Withdrew Consent|2
4914937|NCT00528957|16928808|P2|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5
4914938|NCT00528957|16928809|P1|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3
4914939|NCT00528957|16928808|P2|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10
4914940|NCT00528957|16928809|P1|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4
4914941|NCT00528957|16928808|P2|Third Extension (Week 240 to Week 336)|Withdrew Consent|1
4914942|NCT00528957|16928809|P1|Third Extension (Week 240 to Week 336)|Withdrew Consent|0
4914943|NCT00528957|16928808|P2|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1
4914944|NCT00528957|16928809|P1|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0
4914945|NCT00528957|16928808|P2|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
4914946|NCT00528957|16928809|P1|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1
4914947|NCT00528957|16928808|P2|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3
4914948|NCT00528957|16928809|P1|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0
4914949|NCT00528957|16928808|P2|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4
4914950|NCT00528957|16928809|P1|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5
4914951|NCT00528957|16928808|P2|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0
4914952|NCT00528957|16928809|P1|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3
4914953|NCT00528957|16928808|P2|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3
4914954|NCT00528957|16928809|P1|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4
4914955|NCT00528957|16928808|P2|First Extension (Week 48 to Week 144)|Withdrew Consent|1
4914956|NCT00528957|16928809|P1|First Extension (Week 48 to Week 144)|Withdrew Consent|0
4914957|NCT00528957|16928808|P2|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0
4914958|NCT00528957|16928809|P1|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1
4914959|NCT00528957|16928808|P2|First Extension (Week 48 to Week 144)|Investigator's Discretion|0
4914960|NCT00528957|16928809|P1|First Extension (Week 48 to Week 144)|Investigator's Discretion|2
4914961|NCT00528957|16928808|P2|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0
4914962|NCT00528957|16928809|P1|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2
4914963|NCT00528957|16928808|P2|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1
4914964|NCT00528957|16928809|P1|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2
4914965|NCT00528931|16928950|P1|Overall Study|Lost to Follow-up|1
4914966|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0
4914967|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
4914968|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
4914969|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1
4914970|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Pregnancy|0
4914971|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Pregnancy|0
4914972|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Pregnancy|0
4914973|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Pregnancy|1
4914974|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2
4914975|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1
4914976|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5
4914977|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0
4914978|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7
4914979|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3
4914980|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5
4914981|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4
4914982|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Death|0
4914983|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Death|0
4914984|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Death|1
4914985|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Death|0
4914986|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
4914987|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8
4914988|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6
4914989|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4
4914990|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Adverse Event|2
4914991|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Adverse Event|3
4914992|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Adverse Event|4
4914993|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Adverse Event|5
4914994|NCT00528879|16928962|P4|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9
4914995|NCT00528879|16928963|P3|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17
4914996|NCT00528879|16928964|P2|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16
4914997|NCT00528879|16928965|P1|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27
4914998|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Other|1
4914999|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Other|1
4915000|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Other|0
4915001|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Other|0
4915002|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
4915003|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0
4915004|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
4915005|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1
4915006|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
4915007|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0
4915008|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3
4915009|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2
4915010|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
4915011|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2
4915012|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
4915013|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0
4915014|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
4915015|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4915016|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4
4915017|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5
4915018|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3
4915019|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
4915020|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5
4915021|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7
4915022|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Adverse Event|4
4915023|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Adverse Event|2
4915024|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Adverse Event|4
4915025|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Adverse Event|4
4915026|NCT00528879|16928962|P4|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
4915027|NCT00528879|16928963|P3|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1
4915028|NCT00528879|16928964|P2|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0
4915029|NCT00528879|16928965|P1|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3
4915030|NCT00528866|16929031|P1|Overall Study|Protocol Violation|6
4915031|NCT00528840|16929044|P1|Overall Study|Other|2
4915032|NCT00528840|16929044|P1|Overall Study|Administrative Reasons|1
4915033|NCT00528840|16929044|P1|Overall Study|Death|2
4915034|NCT00528840|16929044|P1|Overall Study|Withdrawal by Subject|17
4915035|NCT00528840|16929044|P1|Overall Study|Adverse Event|1
4915036|NCT00528840|16929044|P1|Overall Study|Lost to Follow-up|10
4915037|NCT00528801|16929058|P2|Overall Study|Administrative Reasons|1
4915038|NCT00528801|16929059|P1|Overall Study|Administrative Reasons|0
4915039|NCT00528801|16929058|P2|Overall Study|Lost to Follow-up|4
4915040|NCT00528801|16929059|P1|Overall Study|Lost to Follow-up|15
4915041|NCT00528801|16929058|P2|Overall Study|Protocol Violation|5
4915042|NCT00528801|16929059|P1|Overall Study|Protocol Violation|11
4915043|NCT00528801|16929058|P2|Overall Study|Withdrawal by Subject|1
4915044|NCT00528801|16929059|P1|Overall Study|Withdrawal by Subject|1
4915045|NCT00528775|16929073|P1|Overall Study|Other not specified|1
4915046|NCT00528645|16929081|P1|Overall Study|Adverse Event|3
4915047|NCT00528606|16929090|P2|Overall Study|Other|0
4915048|NCT00528606|16929091|P1|Overall Study|Other|2
4915049|NCT00528606|16929090|P2|Overall Study|Adverse Event|0
4915050|NCT00528606|16929091|P1|Overall Study|Adverse Event|3
4915051|NCT00528606|16929090|P2|Overall Study|Lost to Follow-up|1
4915052|NCT00528606|16929091|P1|Overall Study|Lost to Follow-up|4
4915053|NCT00528606|16929090|P2|Overall Study|Withdrew consent|3
4915054|NCT00528606|16929091|P1|Overall Study|Withdrew consent|4
4915055|NCT00528567|16929124|P2|Overall Study|Administrative/Other|75
4915056|NCT00528567|16929125|P1|Overall Study|Administrative/Other|22
4915057|NCT00528567|16929124|P2|Overall Study|Other Protocol Violation|21
4915058|NCT00528567|16929125|P1|Overall Study|Other Protocol Violation|5
4915059|NCT00528567|16929124|P2|Overall Study|Failure to Return|4
4915060|NCT00528567|16929125|P1|Overall Study|Failure to Return|1
4915061|NCT00528567|16929124|P2|Overall Study|Refused Treatment/Did Not Cooperate|42
4915062|NCT00528567|16929125|P1|Overall Study|Refused Treatment/Did Not Cooperate|52
4915063|NCT00528567|16929124|P2|Overall Study|Withdrew Consent|55
4915064|NCT00528567|16929125|P1|Overall Study|Withdrew Consent|59
4915065|NCT00528567|16929124|P2|Overall Study|Violation Criteria at Entry|17
4915066|NCT00528567|16929125|P1|Overall Study|Violation Criteria at Entry|3
4915067|NCT00528567|16929124|P2|Overall Study|Adverse Event/Intermittent Illness|29
4915068|NCT00528567|16929125|P1|Overall Study|Adverse Event/Intermittent Illness|255
4915069|NCT00528567|16929124|P2|Overall Study|Breast Cancer Recurrence/2nd Primary|60
4915070|NCT00528567|16929125|P1|Overall Study|Breast Cancer Recurrence/2nd Primary|30
4915071|NCT00528567|16929124|P2|Overall Study|Death|5
4915072|NCT00528567|16929125|P1|Overall Study|Death|4
4915073|NCT00528528|16929192|P4|Overall Study|Ongoing participant|0
4915074|NCT00528528|16929193|P3|Overall Study|Ongoing participant|1
4915075|NCT00528528|16929194|P2|Overall Study|Ongoing participant|0
4915076|NCT00528528|16929195|P1|Overall Study|Ongoing participant|0
4915077|NCT00528528|16929192|P4|Overall Study|Withdrawal by Subject|1
4915078|NCT00528528|16929193|P3|Overall Study|Withdrawal by Subject|1
4915079|NCT00528528|16929194|P2|Overall Study|Withdrawal by Subject|2
4915080|NCT00528528|16929195|P1|Overall Study|Withdrawal by Subject|3
4915081|NCT00528528|16929192|P4|Overall Study|Other|0
4915082|NCT00528528|16929193|P3|Overall Study|Other|0
4915083|NCT00528528|16929194|P2|Overall Study|Other|1
4915084|NCT00528528|16929195|P1|Overall Study|Other|0
4915085|NCT00528528|16929192|P4|Overall Study|Ineligible to continue the trial|1
4915086|NCT00528528|16929193|P3|Overall Study|Ineligible to continue the trial|0
4915087|NCT00528528|16929194|P2|Overall Study|Ineligible to continue the trial|0
4915088|NCT00528528|16929195|P1|Overall Study|Ineligible to continue the trial|0
4915089|NCT00528528|16929192|P4|Overall Study|Lost to Follow-up|1
4915090|NCT00528528|16929193|P3|Overall Study|Lost to Follow-up|1
4915091|NCT00528528|16929194|P2|Overall Study|Lost to Follow-up|0
4915092|NCT00528528|16929195|P1|Overall Study|Lost to Follow-up|0
4915093|NCT00528424|16929233|P1|Overall Study|Other|12
4915094|NCT00528424|16929233|P1|Overall Study|Administrative reason|2
4915095|NCT00528424|16929233|P1|Overall Study|Withdrew consent|2
4915096|NCT00528424|16929233|P1|Overall Study|Lost to Follow-up|13
4915097|NCT00528411|16929248|P3|Overall Study|Prior commitment medication|0
4915098|NCT00528411|16929249|P2|Overall Study|Prior commitment medication|1
4915099|NCT00528411|16929250|P1|Overall Study|Prior commitment medication|0
4915100|NCT00528411|16929248|P3|Overall Study|Severe non-compliance to protocol|0
4915101|NCT00528411|16929249|P2|Overall Study|Severe non-compliance to protocol|1
4915102|NCT00528411|16929250|P1|Overall Study|Severe non-compliance to protocol|0
4915103|NCT00528411|16929248|P3|Overall Study|Incorrect Enrolment|0
4915104|NCT00528411|16929249|P2|Overall Study|Incorrect Enrolment|1
4915105|NCT00528411|16929250|P1|Overall Study|Incorrect Enrolment|1
4915106|NCT00528411|16929248|P3|Overall Study|Adverse Event|1
4915107|NCT00528411|16929249|P2|Overall Study|Adverse Event|0
4915108|NCT00528411|16929250|P1|Overall Study|Adverse Event|4
4915109|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Other|0
4915110|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Other|1
4915111|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Other|3
4915112|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Other|0
4915113|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Other|3
4915114|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Other|2
4915115|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Other|1
4915116|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Other|2
4915117|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Other|2
4915118|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
4915119|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4915120|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
4915121|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4915122|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4915123|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4915124|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4915125|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1
4915126|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0
4915127|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915128|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915129|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915130|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1
4915131|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2
4915132|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915133|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915134|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915135|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0
4915136|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4915137|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4915138|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4915139|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4915140|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4915141|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4915142|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4915143|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1
4915144|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0
4915145|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
4915146|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
4915147|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
4915148|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4
4915149|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0
4915150|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
4915151|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1
4915152|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2
4915153|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3
4915154|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
4915155|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2
4915156|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4
4915157|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0
4915158|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7
4915159|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
4915160|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3
4915161|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
4915162|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6
4915163|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
4915164|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
4915165|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4
4915166|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
4915167|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2
4915168|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0
4915169|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
4915170|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1
4915171|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3
4915172|NCT00528372|16929387|P9|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
4915173|NCT00528372|16929388|P8|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0
4915174|NCT00528372|16929389|P7|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2
4915175|NCT00528372|16929390|P6|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
4915176|NCT00528372|16929391|P5|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
4915177|NCT00528372|16929392|P4|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7
4915178|NCT00528372|16929393|P3|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1
4915179|NCT00528372|16929394|P2|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
4915180|NCT00528372|16929395|P1|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6
4915181|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Other|0
4915182|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Other|1
4915183|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Other|0
4915184|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Other|0
4915185|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Other|0
4915186|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Other|1
4915187|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Other|0
4915188|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Other|0
4915189|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Other|3
4915190|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4915191|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4915192|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4915193|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
4915194|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4915195|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4915196|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
4915197|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0
4915198|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1
4915199|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915200|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915201|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915202|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1
4915203|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915204|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2
4915205|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915206|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915207|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0
4915208|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
4915209|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
4915210|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
4915211|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
4915212|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
4915213|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3
4915214|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2
4915215|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1
4915216|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5
4915217|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
4915218|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
4915219|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
4915220|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4
4915221|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6
4915222|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
4915223|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7
4915224|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2
4915225|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1
4915226|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4915227|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4915228|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
4915229|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3
4915230|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4915231|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6
4915232|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
4915233|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2
4915234|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0
4915235|NCT00528372|16929387|P9|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915236|NCT00528372|16929388|P8|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915237|NCT00528372|16929389|P7|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915238|NCT00528372|16929390|P6|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915239|NCT00528372|16929391|P5|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915240|NCT00528372|16929392|P4|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915241|NCT00528372|16929393|P3|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915242|NCT00528372|16929394|P2|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0
4915243|NCT00528372|16929395|P1|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2
4915244|NCT00528112|16929527|P2|Extension Phase|Protocol Violation|2
4915245|NCT00528112|16929528|P1|Extension Phase|Protocol Violation|0
4915246|NCT00528112|16929527|P2|Extension Phase|Adverse Event|36
4915247|NCT00528112|16929528|P1|Extension Phase|Adverse Event|0
4915248|NCT00528112|16929527|P2|Extension Phase|Death|1
4915249|NCT00528112|16929528|P1|Extension Phase|Death|0
4915250|NCT00528112|16929527|P2|Extension Phase|Lost to Follow-up|12
4915251|NCT00528112|16929528|P1|Extension Phase|Lost to Follow-up|0
4915252|NCT00528112|16929527|P2|Extension Phase|Pregnancy|3
4915253|NCT00528112|16929528|P1|Extension Phase|Pregnancy|0
4915254|NCT00528112|16929527|P2|Extension Phase|Other reasons|100
4915255|NCT00528112|16929528|P1|Extension Phase|Other reasons|0
4915256|NCT00528112|16929527|P2|Extension Phase|Withdrawal by Subject|3
4915257|NCT00528112|16929528|P1|Extension Phase|Withdrawal by Subject|0
4915258|NCT00528112|16929527|P2|Treatment up to 3 Years|Other reasons|186
4915259|NCT00528112|16929528|P1|Treatment up to 3 Years|Other reasons|186
4915260|NCT00528112|16929527|P2|Treatment up to 3 Years|Pregnancy|10
4915261|NCT00528112|16929528|P1|Treatment up to 3 Years|Pregnancy|9
4915262|NCT00528112|16929527|P2|Treatment up to 3 Years|Lost to Follow-up|61
4915263|NCT00528112|16929528|P1|Treatment up to 3 Years|Lost to Follow-up|63
4915264|NCT00528112|16929527|P2|Treatment up to 3 Years|Death|1
4915265|NCT00528112|16929528|P1|Treatment up to 3 Years|Death|0
4915266|NCT00528112|16929527|P2|Treatment up to 3 Years|Protocol Violation|16
4915267|NCT00528112|16929528|P1|Treatment up to 3 Years|Protocol Violation|16
4915268|NCT00528112|16929527|P2|Treatment up to 3 Years|Withdrawal by Subject|31
4915269|NCT00528112|16929528|P1|Treatment up to 3 Years|Withdrawal by Subject|26
4915270|NCT00528112|16929527|P2|Treatment up to 3 Years|Adverse Event|278
4915271|NCT00528112|16929528|P1|Treatment up to 3 Years|Adverse Event|313
4915272|NCT00528021|16929586|P4|Overall Study|Lack of Efficacy|9
4915273|NCT00528021|16929587|P3|Overall Study|Lack of Efficacy|7
4915274|NCT00528021|16929588|P2|Overall Study|Lack of Efficacy|13
4915275|NCT00528021|16929589|P1|Overall Study|Lack of Efficacy|17
4915276|NCT00527982|16929601|P2|Overall Study|Physician Decision|0
4915277|NCT00527982|16929602|P1|Overall Study|Physician Decision|1
4915278|NCT00527904|16929643|P1|Overall Study|misc|22
4915279|NCT00527904|16929643|P1|Overall Study|Lost to Follow-up|8
4915280|NCT00527904|16929643|P1|Overall Study|Withdrawal by Subject|21
4915281|NCT00527904|16929643|P1|Overall Study|Adverse Event|45
4915282|NCT00527826|16929662|P2|Overall Study|Participant moved away|1
4915283|NCT00527826|16929663|P1|Overall Study|Participant moved away|0
4915284|NCT00527826|16929662|P2|Overall Study|Additional Intake of Viani forte|1
4915285|NCT00527826|16929663|P1|Overall Study|Additional Intake of Viani forte|0
4915286|NCT00527826|16929662|P2|Overall Study|Alpha-1 Antitrypsin Deficiency|1
4915287|NCT00527826|16929663|P1|Overall Study|Alpha-1 Antitrypsin Deficiency|0
4915288|NCT00527826|16929662|P2|Overall Study|Inclusion Criteria Not Met|3
4915289|NCT00527826|16929663|P1|Overall Study|Inclusion Criteria Not Met|3
4915290|NCT00527826|16929662|P2|Overall Study|Withdrawal by Subject|8
4915291|NCT00527826|16929663|P1|Overall Study|Withdrawal by Subject|5
4915292|NCT00527826|16929662|P2|Overall Study|Lost to Follow-up|2
4915293|NCT00527826|16929663|P1|Overall Study|Lost to Follow-up|3
4915294|NCT00527826|16929662|P2|Overall Study|Adverse Event|10
4915295|NCT00527826|16929663|P1|Overall Study|Adverse Event|10
4915296|NCT00527787|16929712|P2|Overall Study|misc|2
4915297|NCT00527787|16929713|P1|Overall Study|misc|5
4915298|NCT00527787|16929712|P2|Overall Study|Duodenal Ulcer|10
4915299|NCT00527787|16929713|P1|Overall Study|Duodenal Ulcer|1
4915300|NCT00527787|16929712|P2|Overall Study|Lost to Follow-up|2
4915301|NCT00527787|16929713|P1|Overall Study|Lost to Follow-up|5
4915302|NCT00527787|16929712|P2|Overall Study|Withdrawal by Subject|25
4915303|NCT00527787|16929713|P1|Overall Study|Withdrawal by Subject|13
4915304|NCT00527787|16929712|P2|Overall Study|Adverse Event|24
4915305|NCT00527787|16929713|P1|Overall Study|Adverse Event|14
4915306|NCT00527748|16929735|P1|Overall Study|Other|3
4915307|NCT00527735|16929742|P3|Overall Study|Completed treatment during maintenance|1
4915308|NCT00527735|16929743|P2|Overall Study|Completed treatment during maintenance|2
4915309|NCT00527735|16929744|P1|Overall Study|Completed treatment during maintenance|2
4915310|NCT00527735|16929742|P3|Overall Study|Poor compliance or noncompliance|1
4915311|NCT00527735|16929743|P2|Overall Study|Poor compliance or noncompliance|1
4915312|NCT00527735|16929744|P1|Overall Study|Poor compliance or noncompliance|0
4915313|NCT00527735|16929742|P3|Overall Study|Lost to Follow-up|3
4915314|NCT00527735|16929743|P2|Overall Study|Lost to Follow-up|0
4915315|NCT00527735|16929744|P1|Overall Study|Lost to Follow-up|0
4915316|NCT00527735|16929742|P3|Overall Study|No longer met study criteria|1
4915317|NCT00527735|16929743|P2|Overall Study|No longer met study criteria|2
4915318|NCT00527735|16929744|P1|Overall Study|No longer met study criteria|2
4915319|NCT00527735|16929742|P3|Overall Study|Withdrawal by Subject|3
4915320|NCT00527735|16929743|P2|Overall Study|Withdrawal by Subject|4
4915321|NCT00527735|16929744|P1|Overall Study|Withdrawal by Subject|5
4915322|NCT00527735|16929742|P3|Overall Study|Not identified|5
4915323|NCT00527735|16929743|P2|Overall Study|Not identified|5
4915324|NCT00527735|16929744|P1|Overall Study|Not identified|5
4915325|NCT00527735|16929742|P3|Overall Study|Adverse Event|7
4915326|NCT00527735|16929743|P2|Overall Study|Adverse Event|6
4915327|NCT00527735|16929744|P1|Overall Study|Adverse Event|10
4915328|NCT00527735|16929742|P3|Overall Study|Completed treatment in treatment phase|18
4915329|NCT00527735|16929743|P2|Overall Study|Completed treatment in treatment phase|13
4915330|NCT00527735|16929744|P1|Overall Study|Completed treatment in treatment phase|14
4915331|NCT00527735|16929742|P3|Overall Study|Death|15
4915332|NCT00527735|16929743|P2|Overall Study|Death|13
4915333|NCT00527735|16929744|P1|Overall Study|Death|23
4915334|NCT00527735|16929742|P3|Overall Study|Disease progression|53
4915335|NCT00527735|16929743|P2|Overall Study|Disease progression|61
4915336|NCT00527735|16929744|P1|Overall Study|Disease progression|47
4915337|NCT00527618|16929830|P2|Week 15-18 (Second Intervention)|Withdrawal by Subject|1
4915338|NCT00527618|16929831|P1|Week 15-18 (Second Intervention)|Withdrawal by Subject|0
4915339|NCT00527618|16929830|P2|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1
4915340|NCT00527618|16929831|P1|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0
4915341|NCT00527618|16929830|P2|Week 15-18 (Second Intervention)|Lost to Follow-up|1
4915342|NCT00527618|16929831|P1|Week 15-18 (Second Intervention)|Lost to Follow-up|0
4915343|NCT00527618|16929830|P2|Week 13-14 (Washout)|Lost to Follow-up|0
4915344|NCT00527618|16929831|P1|Week 13-14 (Washout)|Lost to Follow-up|1
4915345|NCT00527618|16929830|P2|Week 1-12 (First Intervention)|Adverse Event|1
4915346|NCT00527618|16929831|P1|Week 1-12 (First Intervention)|Adverse Event|0
4915347|NCT00527618|16929830|P2|Week 1-12 (First Intervention)|Lost to Follow-up|1
4915348|NCT00527618|16929831|P1|Week 1-12 (First Intervention)|Lost to Follow-up|3
4915349|NCT00527605|16929846|P2|Overall Study|Protocol Violation|2
4915350|NCT00527605|16929847|P1|Overall Study|Protocol Violation|1
4915351|NCT00527605|16929846|P2|Overall Study|Lost to Follow-up|2
4915352|NCT00527605|16929847|P1|Overall Study|Lost to Follow-up|6
4915353|NCT00527605|16929846|P2|Overall Study|Withdrawal by Subject|7
4915354|NCT00527605|16929847|P1|Overall Study|Withdrawal by Subject|3
4915355|NCT00527605|16929846|P2|Overall Study|Adverse Event|0
4915356|NCT00527605|16929847|P1|Overall Study|Adverse Event|3
4915357|NCT00527514|16929898|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1
4915358|NCT00527514|16929898|P1|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1
4915359|NCT00527514|16929898|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1
4915360|NCT00527514|16929898|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1
4915361|NCT00527514|16929898|P1|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1
4915362|NCT00527514|16929898|P1|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2
4915363|NCT00527514|16929898|P1|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1
4915364|NCT00527488|16929914|P4|Overall Study|Withdrawn prior to dosing|0
4915365|NCT00527488|16929915|P3|Overall Study|Withdrawn prior to dosing|1
4915366|NCT00527488|16929916|P2|Overall Study|Withdrawn prior to dosing|1
4915367|NCT00527488|16929917|P1|Overall Study|Withdrawn prior to dosing|0
4915368|NCT00527423|16930000|P1|Overall Study|Death|9
4915369|NCT00527423|16930000|P1|Overall Study|OTHER|4
4915370|NCT00527423|16930000|P1|Overall Study|Lost to Follow-up|4
4915371|NCT00527423|16930000|P1|Overall Study|Withdrawal by Subject|10
4915372|NCT00527423|16930000|P1|Overall Study|Physician Decision|4
4915373|NCT00527423|16930000|P1|Overall Study|Adverse Event|5
4915374|NCT00527423|16930000|P1|Overall Study|Protocol Violation|1
4915375|NCT00527397|16930006|P1|Overall Study|Study terminated by sponsor|13
4915376|NCT00527397|16930006|P1|Overall Study|Withdrawal by Subject|6
4915377|NCT00527397|16930006|P1|Overall Study|Protocol Violation|1
4915378|NCT00527397|16930006|P1|Overall Study|Lack of Efficacy|1
4915379|NCT00527397|16930006|P1|Overall Study|Adverse Event|3
4915380|NCT00527332|16930032|P2|Overall Study|Withdrew consent|1
4915381|NCT00527332|16930033|P1|Overall Study|Withdrew consent|5
4915382|NCT00527332|16930032|P2|Overall Study|Protocol Violation|8
4915383|NCT00527332|16930033|P1|Overall Study|Protocol Violation|4
4915384|NCT00527319|16930042|P3|Overall Study|Adverse Event|1
4915385|NCT00527319|16930043|P2|Overall Study|Adverse Event|0
4915386|NCT00527319|16930044|P1|Overall Study|Adverse Event|0
4915387|NCT00527319|16930042|P3|Overall Study|Intercurrent Medical Illness|3
4915388|NCT00527319|16930043|P2|Overall Study|Intercurrent Medical Illness|1
4915389|NCT00527319|16930044|P1|Overall Study|Intercurrent Medical Illness|0
4915390|NCT00527319|16930042|P3|Overall Study|Death|1
4915391|NCT00527319|16930043|P2|Overall Study|Death|3
4915392|NCT00527319|16930044|P1|Overall Study|Death|0
4915393|NCT00527319|16930042|P3|Overall Study|Lost to Follow-up|0
4915394|NCT00527319|16930043|P2|Overall Study|Lost to Follow-up|0
4915395|NCT00527319|16930044|P1|Overall Study|Lost to Follow-up|1
4915396|NCT00527319|16930042|P3|Overall Study|Withdrawal by Subject|1
4915397|NCT00527319|16930043|P2|Overall Study|Withdrawal by Subject|0
4915398|NCT00527319|16930044|P1|Overall Study|Withdrawal by Subject|5
4915399|NCT00527111|16930074|P2|Overall Study|Other|2
4915400|NCT00527111|16930075|P1|Overall Study|Other|2
4915401|NCT00527111|16930074|P2|Overall Study|Patient Request|5
4915402|NCT00527111|16930075|P1|Overall Study|Patient Request|2
4915403|NCT00527111|16930074|P2|Overall Study|Investigator Request|1
4915404|NCT00527111|16930075|P1|Overall Study|Investigator Request|2
4915405|NCT00527111|16930074|P2|Overall Study|Death|1
4915406|NCT00527111|16930075|P1|Overall Study|Death|0
4915407|NCT00527111|16930074|P2|Overall Study|Adverse Event|13
4915408|NCT00527111|16930075|P1|Overall Study|Adverse Event|14
4915409|NCT00527072|16930097|P1|Overall Study|Withdrawal by Subject|7
4915410|NCT00527072|16930097|P1|Overall Study|Protocol Violation|2
4915411|NCT00527072|16930097|P1|Overall Study|Lost to Follow-up|3
4915412|NCT00527072|16930097|P1|Overall Study|Lack of Efficacy|11
4915413|NCT00527072|16930097|P1|Overall Study|Adverse Event|13
4915414|NCT00526994|16930106|P3|Overall Study|incarcerated, impaired, incomplete|3
4915415|NCT00526994|16930107|P2|Overall Study|incarcerated, impaired, incomplete|3
4915416|NCT00526994|16930108|P1|Overall Study|incarcerated, impaired, incomplete|4
4915417|NCT00526994|16930106|P3|Overall Study|Withdrawal by Subject|5
4915418|NCT00526994|16930107|P2|Overall Study|Withdrawal by Subject|7
4915419|NCT00526994|16930108|P1|Overall Study|Withdrawal by Subject|2
4915420|NCT00526994|16930106|P3|Overall Study|Death|3
4915421|NCT00526994|16930107|P2|Overall Study|Death|3
4915422|NCT00526994|16930108|P1|Overall Study|Death|4
4915423|NCT00526994|16930106|P3|Overall Study|Lost to Follow-up|96
4915424|NCT00526994|16930107|P2|Overall Study|Lost to Follow-up|108
4915425|NCT00526994|16930108|P1|Overall Study|Lost to Follow-up|98
4915426|NCT00526890|16930125|P1|Overall Study|Adverse Event|2
4915427|NCT00526799|16930137|P2|Overall Study|Intercurrent Complicating Disease|1
4915428|NCT00526799|16930138|P1|Overall Study|Intercurrent Complicating Disease|0
4915429|NCT00526799|16930137|P2|Overall Study|Withdrawal by Subject|0
4915430|NCT00526799|16930138|P1|Overall Study|Withdrawal by Subject|1
4915431|NCT00526669|16930146|P2|Combined Treatment Phase|Death|2
4915432|NCT00526669|16930147|P1|Combined Treatment Phase|Death|0
4915433|NCT00526669|16930146|P2|Combined Treatment Phase|Sponsor Terminated Study|2
4915434|NCT00526669|16930147|P1|Combined Treatment Phase|Sponsor Terminated Study|0
4915435|NCT00526669|16930146|P2|Combined Treatment Phase|Withdrawal by Subject|2
4915436|NCT00526669|16930147|P1|Combined Treatment Phase|Withdrawal by Subject|0
4915437|NCT00526669|16930146|P2|Combined Treatment Phase|Lost to Follow-up|2
4915438|NCT00526669|16930147|P1|Combined Treatment Phase|Lost to Follow-up|0
4915439|NCT00526656|16930176|P1|Overall Study|Refused surgery|1
4915440|NCT00526656|16930176|P1|Overall Study|Death|1
4915441|NCT00526630|16930182|P2|Second Intervention Period - 12 Weeks|Withdrawn|1
4915442|NCT00526630|16930183|P1|Second Intervention Period - 12 Weeks|Withdrawn|2
4915443|NCT00526630|16930182|P2|First Intervention Period - 12 Weeks|Withdrawn|3
4915444|NCT00526630|16930183|P1|First Intervention Period - 12 Weeks|Withdrawn|0
4915445|NCT00526331|16930295|P1|Overall Study|Sponsor Termination|55
4915446|NCT00526227|16930303|P1|Overall Study|Death|1
4915447|NCT00526227|16930303|P1|Overall Study|Device not implanted|1
4915448|NCT00526162|16930314|P1|Overall Study|Device not implanted|3
4915449|NCT00526110|16930347|P2|Overall Study|Poor Tolerance|5
4915450|NCT00526110|16930348|P1|Overall Study|Poor Tolerance|0
4915451|NCT00526110|16930347|P2|Overall Study|Withdrawal by Subject|2
4915452|NCT00526110|16930348|P1|Overall Study|Withdrawal by Subject|0
4915453|NCT00526110|16930347|P2|Overall Study|Maximal Response|6
4915454|NCT00526110|16930348|P1|Overall Study|Maximal Response|0
4915455|NCT00526110|16930347|P2|Overall Study|Disease Progression|19
4915456|NCT00526110|16930348|P1|Overall Study|Disease Progression|0
4915457|NCT00526110|16930347|P2|Overall Study|Adverse Event|9
4915458|NCT00526110|16930348|P1|Overall Study|Adverse Event|2
4915459|NCT00526097|16930357|P2|Overall Study|Other|1
4915460|NCT00526097|16930358|P1|Overall Study|Other|2
4915461|NCT00526097|16930357|P2|Overall Study|Withdrawal by Subject|1
4915462|NCT00526097|16930358|P1|Overall Study|Withdrawal by Subject|3
4915463|NCT00526097|16930357|P2|Overall Study|Protocol Violation|10
4915464|NCT00526097|16930358|P1|Overall Study|Protocol Violation|4
4915465|NCT00526097|16930357|P2|Overall Study|Adverse Event|44
4915466|NCT00526097|16930358|P1|Overall Study|Adverse Event|6
4915467|NCT00526071|16930534|P1|Overall Study|Lack of Response to Study Drug|4
4915468|NCT00526071|16930534|P1|Overall Study|Withdrawal by Subject|1
4915469|NCT00526071|16930534|P1|Overall Study|Adverse Event|1
4915470|NCT00525915|16930560|P2|Overall Study|Unrelated illness|0
4915471|NCT00525915|16930561|P1|Overall Study|Unrelated illness|1
4915472|NCT00525915|16930560|P2|Overall Study|Refused Surgery|2
4915473|NCT00525915|16930561|P1|Overall Study|Refused Surgery|1
4915474|NCT00525915|16930560|P2|Overall Study|Withdrawal by Subject|0
4915475|NCT00525915|16930561|P1|Overall Study|Withdrawal by Subject|1
4915476|NCT00525915|16930560|P2|Overall Study|Disease Progression|6
4915477|NCT00525915|16930561|P1|Overall Study|Disease Progression|5
4915478|NCT00525915|16930560|P2|Overall Study|Non-Compliance|1
4915479|NCT00525915|16930561|P1|Overall Study|Non-Compliance|0
4915480|NCT00525902|16930567|P1|Overall Study|Lack of Efficacy|1
4915481|NCT00525824|16930591|P4|Overall Study|Other|1
4915482|NCT00525824|16930592|P3|Overall Study|Other|3
4915483|NCT00525824|16930593|P2|Overall Study|Other|3
4915484|NCT00525824|16930594|P1|Overall Study|Other|1
4915485|NCT00525824|16930591|P4|Overall Study|Safety reasons|0
4915486|NCT00525824|16930592|P3|Overall Study|Safety reasons|1
4915487|NCT00525824|16930593|P2|Overall Study|Safety reasons|0
4915488|NCT00525824|16930594|P1|Overall Study|Safety reasons|1
4915489|NCT00525824|16930591|P4|Overall Study|Severe non-compliance|1
4915490|NCT00525824|16930592|P3|Overall Study|Severe non-compliance|1
4915491|NCT00525824|16930593|P2|Overall Study|Severe non-compliance|1
4915492|NCT00525824|16930594|P1|Overall Study|Severe non-compliance|0
4915493|NCT00525824|16930591|P4|Overall Study|Incorrect enrolment/mis-randomisation|2
4915494|NCT00525824|16930592|P3|Overall Study|Incorrect enrolment/mis-randomisation|1
4915495|NCT00525824|16930593|P2|Overall Study|Incorrect enrolment/mis-randomisation|2
4915496|NCT00525824|16930594|P1|Overall Study|Incorrect enrolment/mis-randomisation|1
4915497|NCT00525824|16930591|P4|Overall Study|Lost to Follow-up|0
4915498|NCT00525824|16930592|P3|Overall Study|Lost to Follow-up|4
4915499|NCT00525824|16930593|P2|Overall Study|Lost to Follow-up|2
4915500|NCT00525824|16930594|P1|Overall Study|Lost to Follow-up|4
4915501|NCT00525824|16930591|P4|Overall Study|Withdrawal by Subject|4
4915502|NCT00525824|16930592|P3|Overall Study|Withdrawal by Subject|3
4915503|NCT00525824|16930593|P2|Overall Study|Withdrawal by Subject|9
4915504|NCT00525824|16930594|P1|Overall Study|Withdrawal by Subject|5
4915505|NCT00525824|16930591|P4|Overall Study|Adverse Event|7
4915506|NCT00525824|16930592|P3|Overall Study|Adverse Event|6
4915507|NCT00525824|16930593|P2|Overall Study|Adverse Event|11
4915508|NCT00525824|16930594|P1|Overall Study|Adverse Event|7
4915509|NCT00525785|16930667|P1|Overall Study|Physician Decision|1
4915510|NCT00525785|16930667|P1|Overall Study|Lack of Efficacy|1
4915511|NCT00525785|16930667|P1|Overall Study|Withdrawal by Subject|1
4915512|NCT00525590|16930691|P1|Overall Study|Other|13
4915513|NCT00525590|16930691|P1|Overall Study|Death|9
4915514|NCT00525590|16930691|P1|Overall Study|Lost to Follow-up|1
4915515|NCT00525590|16930691|P1|Overall Study|Withdrawal by Subject|16
4915516|NCT00525590|16930691|P1|Overall Study|Physician Decision|3
4915517|NCT00525590|16930691|P1|Overall Study|Adverse Event|3
4915518|NCT00525512|16930719|P4|Open-Label Phase|Other reason (not specified)|5
4915519|NCT00525512|16930720|P3|Open-Label Phase|Other reason (not specified)|4
4915520|NCT00525512|16930721|P2|Open-Label Phase|Other reason (not specified)|0
4915521|NCT00525512|16930722|P1|Open-Label Phase|Other reason (not specified)|0
4915522|NCT00525512|16930719|P4|Open-Label Phase|Lost to Follow-up|0
4915523|NCT00525512|16930720|P3|Open-Label Phase|Lost to Follow-up|1
4915524|NCT00525512|16930721|P2|Open-Label Phase|Lost to Follow-up|0
4915525|NCT00525512|16930722|P1|Open-Label Phase|Lost to Follow-up|0
4915526|NCT00525512|16930719|P4|Open-Label Phase|Adverse Event|0
4915527|NCT00525512|16930720|P3|Open-Label Phase|Adverse Event|1
4915528|NCT00525512|16930721|P2|Open-Label Phase|Adverse Event|0
4915529|NCT00525512|16930722|P1|Open-Label Phase|Adverse Event|0
4915530|NCT00525512|16930719|P4|Double-Blind Phase|Other reason (not specified)|0
4915531|NCT00525512|16930720|P3|Double-Blind Phase|Other reason (not specified)|0
4915532|NCT00525512|16930721|P2|Double-Blind Phase|Other reason (not specified)|13
4915533|NCT00525512|16930722|P1|Double-Blind Phase|Other reason (not specified)|12
4915534|NCT00525512|16930719|P4|Double-Blind Phase|Lack of Efficacy|0
4915535|NCT00525512|16930720|P3|Double-Blind Phase|Lack of Efficacy|0
4915536|NCT00525512|16930721|P2|Double-Blind Phase|Lack of Efficacy|5
4915537|NCT00525512|16930722|P1|Double-Blind Phase|Lack of Efficacy|13
4915538|NCT00525512|16930719|P4|Double-Blind Phase|Withdrawal by Subject|0
4915539|NCT00525512|16930720|P3|Double-Blind Phase|Withdrawal by Subject|0
4915540|NCT00525512|16930721|P2|Double-Blind Phase|Withdrawal by Subject|12
4915541|NCT00525512|16930722|P1|Double-Blind Phase|Withdrawal by Subject|17
4915542|NCT00525512|16930719|P4|Double-Blind Phase|Lost to Follow-up|0
4915543|NCT00525512|16930720|P3|Double-Blind Phase|Lost to Follow-up|0
4915544|NCT00525512|16930721|P2|Double-Blind Phase|Lost to Follow-up|7
4915545|NCT00525512|16930722|P1|Double-Blind Phase|Lost to Follow-up|3
4915546|NCT00525512|16930719|P4|Double-Blind Phase|Protocol Violation|0
4915547|NCT00525512|16930720|P3|Double-Blind Phase|Protocol Violation|0
4915548|NCT00525512|16930721|P2|Double-Blind Phase|Protocol Violation|1
4915549|NCT00525512|16930722|P1|Double-Blind Phase|Protocol Violation|3
4915550|NCT00525512|16930719|P4|Double-Blind Phase|Adverse Event|0
4915551|NCT00525512|16930720|P3|Double-Blind Phase|Adverse Event|0
4915552|NCT00525512|16930721|P2|Double-Blind Phase|Adverse Event|28
4915553|NCT00525512|16930722|P1|Double-Blind Phase|Adverse Event|48
4915554|NCT00525499|16930864|P4|Overall Study|Protocol Violation|0
4915555|NCT00525499|16930865|P3|Overall Study|Protocol Violation|1
4915556|NCT00525499|16930866|P2|Overall Study|Protocol Violation|1
4915557|NCT00525499|16930867|P1|Overall Study|Protocol Violation|0
4915558|NCT00525499|16930864|P4|Overall Study|Withdrawal by Subject|2
4915559|NCT00525499|16930865|P3|Overall Study|Withdrawal by Subject|5
4915560|NCT00525499|16930866|P2|Overall Study|Withdrawal by Subject|1
4915561|NCT00525499|16930867|P1|Overall Study|Withdrawal by Subject|5
4915562|NCT00525499|16930864|P4|Overall Study|Adverse Event|1
4915563|NCT00525499|16930865|P3|Overall Study|Adverse Event|0
4915564|NCT00525499|16930866|P2|Overall Study|Adverse Event|1
4915565|NCT00525499|16930867|P1|Overall Study|Adverse Event|0
4915566|NCT00525499|16930864|P4|Overall Study|Lost to Follow-up|4
4915567|NCT00525499|16930865|P3|Overall Study|Lost to Follow-up|1
4915568|NCT00525499|16930866|P2|Overall Study|Lost to Follow-up|4
4915569|NCT00525499|16930867|P1|Overall Study|Lost to Follow-up|2
4915570|NCT00525265|16930894|P2|Overall Study|Protocol Violation|0
4915571|NCT00525265|16930895|P1|Overall Study|Protocol Violation|1
4915572|NCT00525161|16930952|P1|Overall Study|Adverse Event|1
4915573|NCT00525148|16930962|P4|Overall Study|Other than stated|3
4915574|NCT00525148|16930963|P3|Overall Study|Other than stated|0
4915575|NCT00525148|16930964|P2|Overall Study|Other than stated|1
4915576|NCT00525148|16930965|P1|Overall Study|Other than stated|2
4915577|NCT00525148|16930962|P4|Overall Study|Refused continuation of study medication|1
4915578|NCT00525148|16930963|P3|Overall Study|Refused continuation of study medication|0
4915579|NCT00525148|16930964|P2|Overall Study|Refused continuation of study medication|2
4915580|NCT00525148|16930965|P1|Overall Study|Refused continuation of study medication|0
4915581|NCT00525148|16930962|P4|Overall Study|Progressive disease|49
4915582|NCT00525148|16930963|P3|Overall Study|Progressive disease|6
4915583|NCT00525148|16930964|P2|Overall Study|Progressive disease|30
4915584|NCT00525148|16930965|P1|Overall Study|Progressive disease|18
4915585|NCT00525148|16930962|P4|Overall Study|Other Adverse Event|8
4915586|NCT00525148|16930963|P3|Overall Study|Other Adverse Event|1
4915587|NCT00525148|16930964|P2|Overall Study|Other Adverse Event|5
4915588|NCT00525148|16930965|P1|Overall Study|Other Adverse Event|3
4915589|NCT00525044|16930993|P2|Overall Study|Lost to Follow-up|1
4915590|NCT00525044|16930994|P1|Overall Study|Lost to Follow-up|0
4915591|NCT00525031|16931010|P2|Overall Study|Disease Progression|1
4915592|NCT00525031|16931011|P1|Overall Study|Disease Progression|1
4915593|NCT00524771|16931025|P2|Overall Study|Protocol Violation|585
4915594|NCT00524771|16931026|P1|Overall Study|Protocol Violation|220
4915595|NCT00524745|16931040|P4|Overall Study|subject withdrawal or lost to follow up|22
4915596|NCT00524745|16931041|P3|Overall Study|subject withdrawal or lost to follow up|29
4915597|NCT00524745|16931042|P2|Overall Study|subject withdrawal or lost to follow up|13
4915598|NCT00524745|16931043|P1|Overall Study|subject withdrawal or lost to follow up|34
4915599|NCT00524680|16931069|P4|Overall Study|Withdrawal by Subject|1
4915600|NCT00524680|16931070|P3|Overall Study|Withdrawal by Subject|1
4915601|NCT00524680|16931071|P2|Overall Study|Withdrawal by Subject|0
4915602|NCT00524680|16931072|P1|Overall Study|Withdrawal by Subject|1
4915603|NCT00524680|16931069|P4|Overall Study|Other|3
4915604|NCT00524680|16931070|P3|Overall Study|Other|2
4915605|NCT00524680|16931071|P2|Overall Study|Other|1
4915606|NCT00524680|16931072|P1|Overall Study|Other|0
4915607|NCT00524680|16931069|P4|Overall Study|Adverse Event|1
4915608|NCT00524680|16931070|P3|Overall Study|Adverse Event|0
4915609|NCT00524680|16931071|P2|Overall Study|Adverse Event|0
4915610|NCT00524680|16931072|P1|Overall Study|Adverse Event|2
4915611|NCT00524680|16931069|P4|Overall Study|progression|1
4915612|NCT00524680|16931070|P3|Overall Study|progression|0
4915613|NCT00524680|16931071|P2|Overall Study|progression|0
4915614|NCT00524680|16931072|P1|Overall Study|progression|0
4915615|NCT00524589|16931094|P1|Overall Study|Disease Progression|16
4915616|NCT00524589|16931094|P1|Overall Study|Withdrawal by Subject|2
4915617|NCT00524485|16931145|P1|Overall Study|Withdrawal by Subject|5
4915618|NCT00524459|16931174|P1|Overall Study|Other|1
4915619|NCT00524459|16931174|P1|Overall Study|Withdrawal by Subject|1
4915620|NCT00524420|16931184|P2|Overall Study|Lack of Efficacy|0
4915621|NCT00524420|16931185|P1|Overall Study|Lack of Efficacy|1
4915622|NCT00524368|16931203|P2|Overall Study|Other|2
4915623|NCT00524368|16931204|P1|Overall Study|Other|3
4915624|NCT00524368|16931203|P2|Overall Study|Ineligible to Continue the study|5
4915625|NCT00524368|16931204|P1|Overall Study|Ineligible to Continue the study|2
4915626|NCT00524368|16931203|P2|Overall Study|Sponsor's Decision|0
4915627|NCT00524368|16931204|P1|Overall Study|Sponsor's Decision|2
4915628|NCT00524368|16931203|P2|Overall Study|Reached a Virologic Endpoint|2
4915629|NCT00524368|16931204|P1|Overall Study|Reached a Virologic Endpoint|3
4915630|NCT00524368|16931203|P2|Overall Study|Non-compliant|9
4915631|NCT00524368|16931204|P1|Overall Study|Non-compliant|8
4915632|NCT00524368|16931203|P2|Overall Study|Withdrawal by Subject|5
4915633|NCT00524368|16931204|P1|Overall Study|Withdrawal by Subject|4
4915634|NCT00524368|16931203|P2|Overall Study|Lost to Follow-up|13
4915635|NCT00524368|16931204|P1|Overall Study|Lost to Follow-up|9
4915636|NCT00524368|16931203|P2|Overall Study|Adverse Event|12
4915637|NCT00524368|16931204|P1|Overall Study|Adverse Event|10
4915638|NCT00524316|16931238|P1|Overall Study|Disease Progression|7
4915639|NCT00524316|16931238|P1|Overall Study|Adverse Event|7
4915640|NCT00524316|16931238|P1|Overall Study|Withdrawal by Subject|2
4915641|NCT00524303|16931250|P3|Overall Study|Completed 5 years|1
4915642|NCT00524303|16931251|P2|Overall Study|Completed 5 years|0
4915643|NCT00524303|16931252|P1|Overall Study|Completed 5 years|0
4915644|NCT00524303|16931250|P3|Overall Study|Physician Decision|1
4915645|NCT00524303|16931251|P2|Overall Study|Physician Decision|0
4915646|NCT00524303|16931252|P1|Overall Study|Physician Decision|0
4915647|NCT00524303|16931250|P3|Overall Study|Sponsor Request|1
4915648|NCT00524303|16931251|P2|Overall Study|Sponsor Request|0
4915649|NCT00524303|16931252|P1|Overall Study|Sponsor Request|0
4915650|NCT00524303|16931250|P3|Overall Study|Disease Recurrence|0
4915651|NCT00524303|16931251|P2|Overall Study|Disease Recurrence|1
4915652|NCT00524303|16931252|P1|Overall Study|Disease Recurrence|0
4915653|NCT00524303|16931250|P3|Overall Study|Disease Progression|1
4915654|NCT00524303|16931251|P2|Overall Study|Disease Progression|4
4915655|NCT00524303|16931252|P1|Overall Study|Disease Progression|0
4915656|NCT00524303|16931250|P3|Overall Study|Worsening Peripheral Neuropathy|0
4915657|NCT00524303|16931251|P2|Overall Study|Worsening Peripheral Neuropathy|0
4915658|NCT00524303|16931252|P1|Overall Study|Worsening Peripheral Neuropathy|1
4915659|NCT00524303|16931250|P3|Overall Study|Did not Complete Study Dosing|0
4915660|NCT00524303|16931251|P2|Overall Study|Did not Complete Study Dosing|0
4915661|NCT00524303|16931252|P1|Overall Study|Did not Complete Study Dosing|1
4915662|NCT00524303|16931250|P3|Overall Study|Adverse Event|3
4915663|NCT00524303|16931251|P2|Overall Study|Adverse Event|2
4915664|NCT00524303|16931252|P1|Overall Study|Adverse Event|1
4915665|NCT00524303|16931250|P3|Overall Study|Death|3
4915666|NCT00524303|16931251|P2|Overall Study|Death|2
4915667|NCT00524303|16931252|P1|Overall Study|Death|0
4915668|NCT00524303|16931250|P3|Overall Study|Withdrawal by Subject|4
4915669|NCT00524303|16931251|P2|Overall Study|Withdrawal by Subject|0
4915670|NCT00524303|16931252|P1|Overall Study|Withdrawal by Subject|3
4915671|NCT00524303|16931250|P3|Overall Study|Protocol Violation|1
4915672|NCT00524303|16931251|P2|Overall Study|Protocol Violation|1
4915673|NCT00524303|16931252|P1|Overall Study|Protocol Violation|0
4915674|NCT00524303|16931250|P3|Overall Study|Lost to Follow-up|3
4915675|NCT00524303|16931251|P2|Overall Study|Lost to Follow-up|0
4915676|NCT00524303|16931252|P1|Overall Study|Lost to Follow-up|6
4915677|NCT00524173|16931304|P2|Overall Study|Had not reached endpoint at study close|1
4915678|NCT00524173|16931305|P1|Overall Study|Had not reached endpoint at study close|4
4915679|NCT00524173|16931304|P2|Overall Study|Death|0
4915680|NCT00524173|16931305|P1|Overall Study|Death|1
4915681|NCT00524173|16931304|P2|Overall Study|Lost to Follow-up|1
4915682|NCT00524173|16931305|P1|Overall Study|Lost to Follow-up|0
4915683|NCT00524134|16931317|P1|Overall Study|Physician Decision|1
4915684|NCT00524134|16931317|P1|Overall Study|Withdrawal by Subject|1
4915685|NCT00524121|16931324|P1|Overall Study|Not treated (changed mind)|1
4915686|NCT00524121|16931324|P1|Overall Study|Not treated (became ineligible)|4
4915687|NCT00524121|16931324|P1|Overall Study|Death|1
4915688|NCT00524121|16931324|P1|Overall Study|Other|1
4915689|NCT00524121|16931324|P1|Overall Study|Patient refused|2
4915690|NCT00524121|16931324|P1|Overall Study|Adverse Event|4
4915691|NCT00524121|16931324|P1|Overall Study|Disease progression|6
4915692|NCT00524043|16931344|P3|Overall Study|Various (eg, incarceration)|0
4915693|NCT00524043|16931345|P2|Overall Study|Various (eg, incarceration)|1
4915694|NCT00524043|16931346|P1|Overall Study|Various (eg, incarceration)|2
4915695|NCT00524043|16931344|P3|Overall Study|Lost to Follow-up|3
4915696|NCT00524043|16931345|P2|Overall Study|Lost to Follow-up|5
4915697|NCT00524043|16931346|P1|Overall Study|Lost to Follow-up|3
4915698|NCT00524043|16931344|P3|Overall Study|Adverse Event|7
4915699|NCT00524043|16931345|P2|Overall Study|Adverse Event|2
4915700|NCT00524043|16931346|P1|Overall Study|Adverse Event|5
4915701|NCT00524043|16931344|P3|Overall Study|Withdrawal by Subject|7
4915702|NCT00524043|16931345|P2|Overall Study|Withdrawal by Subject|7
4915703|NCT00524043|16931346|P1|Overall Study|Withdrawal by Subject|5
4915704|NCT00524043|16931344|P3|Overall Study|Lack of Efficacy|14
4915705|NCT00524043|16931345|P2|Overall Study|Lack of Efficacy|13
4915706|NCT00524043|16931346|P1|Overall Study|Lack of Efficacy|15
4915707|NCT00524030|16931368|P2|Overall Study|Death|1
4915708|NCT00524030|16931369|P1|Overall Study|Death|0
4915709|NCT00524030|16931368|P2|Overall Study|Adverse Event|21
4915710|NCT00524030|16931369|P1|Overall Study|Adverse Event|3
4915711|NCT00524030|16931368|P2|Overall Study|Pregnancy|0
4915712|NCT00524030|16931369|P1|Overall Study|Pregnancy|1
4915713|NCT00524030|16931368|P2|Overall Study|Protocol Violation|1
4915714|NCT00524030|16931369|P1|Overall Study|Protocol Violation|0
4915715|NCT00524030|16931368|P2|Overall Study|Noncompliance/Investigator discretion|2
4915716|NCT00524030|16931369|P1|Overall Study|Noncompliance/Investigator discretion|0
4915717|NCT00524030|16931368|P2|Overall Study|Withdrawal by Subject|8
4915718|NCT00524030|16931369|P1|Overall Study|Withdrawal by Subject|3
4915719|NCT00524030|16931368|P2|Overall Study|Lost to Follow-up|2
4915720|NCT00524030|16931369|P1|Overall Study|Lost to Follow-up|0
4915721|NCT00524030|16931368|P2|Overall Study|Lack of Efficacy|24
4915722|NCT00524030|16931369|P1|Overall Study|Lack of Efficacy|10
4915723|NCT00523991|16931408|P2|Overall Study|Other reason (not specified)|0
4915724|NCT00523991|16931409|P1|Overall Study|Other reason (not specified)|3
4915725|NCT00523991|16931408|P2|Overall Study|Withdrawal by Subject|17
4915726|NCT00523991|16931409|P1|Overall Study|Withdrawal by Subject|7
4915727|NCT00523991|16931408|P2|Overall Study|Lost to Follow-up|1
4915728|NCT00523991|16931409|P1|Overall Study|Lost to Follow-up|4
4915729|NCT00523991|16931408|P2|Overall Study|Protocol Violation|4
4915730|NCT00523991|16931409|P1|Overall Study|Protocol Violation|1
4915731|NCT00523991|16931408|P2|Overall Study|Adverse Event|5
4915732|NCT00523991|16931409|P1|Overall Study|Adverse Event|6
4915733|NCT00523978|16931689|P2|Overall Study|Death|0
4915734|NCT00523978|16931690|P1|Overall Study|Death|1
4915735|NCT00523978|16931689|P2|Overall Study|Screen Failures|1
4915736|NCT00523978|16931690|P1|Overall Study|Screen Failures|5
4915737|NCT00523978|16931689|P2|Overall Study|Withdrawal by Subject|7
4915738|NCT00523978|16931690|P1|Overall Study|Withdrawal by Subject|3
4915739|NCT00523848|16931712|P1|Overall Study|Other, unspecified|4
4915740|NCT00523848|16931712|P1|Overall Study|Disease Progression|5
4915741|NCT00523848|16931712|P1|Overall Study|NOT TREATED (Became ineligible)|2
4915742|NCT00523848|16931712|P1|Overall Study|Withdrawal by Subject|2
4915743|NCT00523848|16931712|P1|Overall Study|Adverse Event|11
4915744|NCT00523744|16931722|P1|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1
4915745|NCT00523744|16931722|P1|Phase 2 - Amlodipine+Valsartan|Adverse Event|2
4915746|NCT00523744|16931722|P1|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1
4915747|NCT00523744|16931722|P1|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2
4915748|NCT00523744|16931722|P1|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1
4915749|NCT00523744|16931722|P1|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2
4915750|NCT00523718|16931741|P2|Overall Study|Protocol Violation|0
4915751|NCT00523718|16931742|P1|Overall Study|Protocol Violation|2
4915752|NCT00523718|16931741|P2|Overall Study|Withdrawal by Subject|0
4915753|NCT00523718|16931742|P1|Overall Study|Withdrawal by Subject|1
4915754|NCT00523705|16931756|P2|Overall Study|No time for study.|1
4915755|NCT00523705|16931757|P1|Overall Study|No time for study.|0
4915756|NCT00523640|16931769|P1|Overall Study|Death|1
4915757|NCT00523549|16931786|P2|Overall Study|Lost to Follow-up|5
4915758|NCT00523549|16931787|P1|Overall Study|Lost to Follow-up|3
4915759|NCT00523549|16931786|P2|Overall Study|Patient withdrew consent|6
4915760|NCT00523549|16931787|P1|Overall Study|Patient withdrew consent|7
4915761|NCT00523549|16931786|P2|Overall Study|Protocol Deviation|1
4915762|NCT00523549|16931787|P1|Overall Study|Protocol Deviation|3
4915763|NCT00523549|16931786|P2|Overall Study|Unsatisfactory therapeutic effect|1
4915764|NCT00523549|16931787|P1|Overall Study|Unsatisfactory therapeutic effect|0
4915765|NCT00523549|16931786|P2|Overall Study|Adverse Event|3
4915766|NCT00523549|16931787|P1|Overall Study|Adverse Event|6
4915767|NCT00523419|16931805|P1|Overall Study|Death due to Adverse Event|2
4915768|NCT00523419|16931805|P1|Overall Study|Death due to Study Disease|4
4915769|NCT00523419|16931805|P1|Overall Study|Progressive Disease|22
4915770|NCT00523419|16931805|P1|Overall Study|Physician Decision|2
4915771|NCT00523419|16931805|P1|Overall Study|Withdrawal by Subject|1
4915772|NCT00523419|16931805|P1|Overall Study|Adverse Event|1
4915773|NCT00523367|16931815|P1|Overall Study|4 Withdrawn by PI|4
4915774|NCT00523367|16931815|P1|Overall Study|19 screen failures|19
4915775|NCT00523341|16931821|P2|Overall Study|Disease Progression|0
4915776|NCT00523341|16931822|P1|Overall Study|Disease Progression|1
4915777|NCT00523341|16931821|P2|Overall Study|Ineligibility Determined|4
4915778|NCT00523341|16931822|P1|Overall Study|Ineligibility Determined|3
4915779|NCT00523341|16931821|P2|Overall Study|Protocol Deviation|5
4915780|NCT00523341|16931822|P1|Overall Study|Protocol Deviation|6
4915781|NCT00523341|16931821|P2|Overall Study|Requirement for Alternative Therapy|14
4915782|NCT00523341|16931822|P1|Overall Study|Requirement for Alternative Therapy|4
4915783|NCT00523341|16931821|P2|Overall Study|Physician Decision|13
4915784|NCT00523341|16931822|P1|Overall Study|Physician Decision|14
4915785|NCT00523341|16931821|P2|Overall Study|Non-compliance|13
4915786|NCT00523341|16931822|P1|Overall Study|Non-compliance|20
4915787|NCT00523341|16931821|P2|Overall Study|Lost to Follow-up|61
4915788|NCT00523341|16931822|P1|Overall Study|Lost to Follow-up|73
4915789|NCT00523341|16931821|P2|Overall Study|Death|110
4915790|NCT00523341|16931822|P1|Overall Study|Death|101
4915791|NCT00523341|16931821|P2|Overall Study|Adverse Event|155
4915792|NCT00523341|16931822|P1|Overall Study|Adverse Event|122
4915793|NCT00523341|16931821|P2|Overall Study|Other|198
4915794|NCT00523341|16931822|P1|Overall Study|Other|181
4915795|NCT00523341|16931821|P2|Overall Study|Withdrawal by Subject|427
4915796|NCT00523341|16931822|P1|Overall Study|Withdrawal by Subject|399
4915797|NCT00522951|16931939|P2|Period 2|residual contrast medium|1
4915798|NCT00522951|16931940|P1|Period 2|residual contrast medium|1
4915799|NCT00522951|16931939|P2|Period 2|Withdrawal by Subject|0
4915800|NCT00522951|16931940|P1|Period 2|Withdrawal by Subject|1
4915801|NCT00522951|16931939|P2|Washout Period|Death|1
4915802|NCT00522951|16931940|P1|Washout Period|Death|0
4915803|NCT00522951|16931939|P2|Washout Period|Adverse Event|1
4915804|NCT00522951|16931940|P1|Washout Period|Adverse Event|0
4915805|NCT00522951|16931939|P2|Period 1|body motion|1
4915806|NCT00522951|16931940|P1|Period 1|body motion|0
4915807|NCT00522873|16931995|P2|Overall Study|Never Received Medication|0
4915808|NCT00522873|16931996|P1|Overall Study|Never Received Medication|1
4915809|NCT00522873|16931995|P2|Overall Study|Medication Errors|1
4915810|NCT00522873|16931996|P1|Overall Study|Medication Errors|1
4915811|NCT00522873|16931995|P2|Overall Study|Personal Reasons|1
4915812|NCT00522873|16931996|P1|Overall Study|Personal Reasons|8
4915813|NCT00522873|16931995|P2|Overall Study|Lost to Follow-up|3
4915814|NCT00522873|16931996|P1|Overall Study|Lost to Follow-up|11
4915815|NCT00522873|16931995|P2|Overall Study|Protocol Violation|4
4915816|NCT00522873|16931996|P1|Overall Study|Protocol Violation|14
4915817|NCT00522873|16931995|P2|Overall Study|Withdrawal by Subject|9
4915818|NCT00522873|16931996|P1|Overall Study|Withdrawal by Subject|20
4915819|NCT00522873|16931995|P2|Overall Study|Adverse Event|26
4915820|NCT00522873|16931996|P1|Overall Study|Adverse Event|41
4915821|NCT00522626|16932009|P1|Overall Study|Lost to Follow-up|7
4915822|NCT00522548|16932015|P2|Overall Study|Withdrawal by Subject|2
4915823|NCT00522548|16932016|P1|Overall Study|Withdrawal by Subject|0
4915824|NCT00522548|16932015|P2|Overall Study|Adverse Event|2
4915825|NCT00522548|16932016|P1|Overall Study|Adverse Event|2
4915826|NCT00522457|16932044|P1|Overall Study|Adverse Event|2
4915827|NCT00522457|16932044|P1|Overall Study|Due to disease progression|16
4915828|NCT00522431|16932050|P1|Overall Study|Other/unknown|1
4915829|NCT00522431|16932050|P1|Overall Study|Subject non-compliance|1
4915830|NCT00522431|16932050|P1|Overall Study|Withdrawal by Subject|2
4915831|NCT00522431|16932050|P1|Overall Study|Protocol Violation|2
4915832|NCT00522431|16932050|P1|Overall Study|Adverse Event|5
4915833|NCT00522418|16932057|P2|Overall Study|Lack of Efficacy|1
4915834|NCT00522418|16932058|P1|Overall Study|Lack of Efficacy|0
4915835|NCT00522418|16932057|P2|Overall Study|Consent Withdraw|2
4915836|NCT00522418|16932058|P1|Overall Study|Consent Withdraw|1
4915837|NCT00522418|16932057|P2|Overall Study|Reason Not Specified|1
4915838|NCT00522418|16932058|P1|Overall Study|Reason Not Specified|3
4915839|NCT00522418|16932057|P2|Overall Study|Noncompliance|2
4915840|NCT00522418|16932058|P1|Overall Study|Noncompliance|2
4915841|NCT00522418|16932057|P2|Overall Study|Early Study Termination|47
4915842|NCT00522418|16932058|P1|Overall Study|Early Study Termination|46
4915843|NCT00522418|16932057|P2|Overall Study|Local IRB Consent Violation|5
4915844|NCT00522418|16932058|P1|Overall Study|Local IRB Consent Violation|5
4915845|NCT00522392|16932106|P2|Overall Study|Non-compliance|1
4915846|NCT00522392|16932107|P1|Overall Study|Non-compliance|0
4915847|NCT00522392|16932106|P2|Overall Study|Physician Decision|1
4915848|NCT00522392|16932107|P1|Overall Study|Physician Decision|0
4915849|NCT00522392|16932106|P2|Overall Study|Withdrawal by Subject|1
4915850|NCT00522392|16932107|P1|Overall Study|Withdrawal by Subject|1
4915851|NCT00522392|16932106|P2|Overall Study|Adverse Event|7
4915852|NCT00522392|16932107|P1|Overall Study|Adverse Event|7
4915853|NCT00522392|16932106|P2|Overall Study|Disease progression|3
4915854|NCT00522392|16932107|P1|Overall Study|Disease progression|0
4915855|NCT00522379|16932124|P5|Overall Study|Subject Withdrawal|0
4915856|NCT00522379|16932125|P4|Overall Study|Subject Withdrawal|1
4915857|NCT00522379|16932126|P3|Overall Study|Subject Withdrawal|0
4915858|NCT00522379|16932127|P2|Overall Study|Subject Withdrawal|0
4915859|NCT00522379|16932128|P1|Overall Study|Subject Withdrawal|0
4915860|NCT00522379|16932124|P5|Overall Study|Site Closed|0
4915861|NCT00522379|16932125|P4|Overall Study|Site Closed|1
4915862|NCT00522379|16932126|P3|Overall Study|Site Closed|0
4915863|NCT00522379|16932127|P2|Overall Study|Site Closed|0
4915864|NCT00522379|16932128|P1|Overall Study|Site Closed|0
4915865|NCT00522379|16932124|P5|Overall Study|Family Problem|0
4915866|NCT00522379|16932125|P4|Overall Study|Family Problem|0
4915867|NCT00522379|16932126|P3|Overall Study|Family Problem|1
4915868|NCT00522379|16932127|P2|Overall Study|Family Problem|0
4915869|NCT00522379|16932128|P1|Overall Study|Family Problem|0
4915870|NCT00522379|16932124|P5|Overall Study|Sponsor Request|0
4915871|NCT00522379|16932125|P4|Overall Study|Sponsor Request|0
4915872|NCT00522379|16932126|P3|Overall Study|Sponsor Request|0
4915873|NCT00522379|16932127|P2|Overall Study|Sponsor Request|1
4915874|NCT00522379|16932128|P1|Overall Study|Sponsor Request|0
4915875|NCT00522379|16932124|P5|Overall Study|Subject Moved|0
4915876|NCT00522379|16932125|P4|Overall Study|Subject Moved|0
4915877|NCT00522379|16932126|P3|Overall Study|Subject Moved|0
4915878|NCT00522379|16932127|P2|Overall Study|Subject Moved|1
4915879|NCT00522379|16932128|P1|Overall Study|Subject Moved|1
4915880|NCT00522379|16932124|P5|Overall Study|Dispensing error|0
4915881|NCT00522379|16932125|P4|Overall Study|Dispensing error|1
4915882|NCT00522379|16932126|P3|Overall Study|Dispensing error|0
4915883|NCT00522379|16932127|P2|Overall Study|Dispensing error|0
4915884|NCT00522379|16932128|P1|Overall Study|Dispensing error|1
4915885|NCT00522379|16932124|P5|Overall Study|Randomization error|1
4915886|NCT00522379|16932125|P4|Overall Study|Randomization error|0
4915887|NCT00522379|16932126|P3|Overall Study|Randomization error|0
4915888|NCT00522379|16932127|P2|Overall Study|Randomization error|0
4915889|NCT00522379|16932128|P1|Overall Study|Randomization error|0
4915890|NCT00522379|16932124|P5|Overall Study|Lost to Follow-up|2
4915891|NCT00522379|16932125|P4|Overall Study|Lost to Follow-up|2
4915892|NCT00522379|16932126|P3|Overall Study|Lost to Follow-up|4
4915893|NCT00522379|16932127|P2|Overall Study|Lost to Follow-up|0
4915894|NCT00522379|16932128|P1|Overall Study|Lost to Follow-up|1
4915895|NCT00522379|16932124|P5|Overall Study|Unsatisfactory Subject Compliance|0
4915896|NCT00522379|16932125|P4|Overall Study|Unsatisfactory Subject Compliance|0
4915897|NCT00522379|16932126|P3|Overall Study|Unsatisfactory Subject Compliance|0
4915898|NCT00522379|16932127|P2|Overall Study|Unsatisfactory Subject Compliance|2
4915899|NCT00522379|16932128|P1|Overall Study|Unsatisfactory Subject Compliance|1
4915900|NCT00522379|16932124|P5|Overall Study|Protocol Violation|0
4915901|NCT00522379|16932125|P4|Overall Study|Protocol Violation|0
4915902|NCT00522379|16932126|P3|Overall Study|Protocol Violation|2
4915903|NCT00522379|16932127|P2|Overall Study|Protocol Violation|1
4915904|NCT00522379|16932128|P1|Overall Study|Protocol Violation|1
4915905|NCT00522379|16932124|P5|Overall Study|Withdrawal by Subject|0
4915906|NCT00522379|16932125|P4|Overall Study|Withdrawal by Subject|2
4915907|NCT00522379|16932126|P3|Overall Study|Withdrawal by Subject|1
4915908|NCT00522379|16932127|P2|Overall Study|Withdrawal by Subject|3
4915909|NCT00522379|16932128|P1|Overall Study|Withdrawal by Subject|2
4915910|NCT00522379|16932124|P5|Overall Study|Lack of Efficacy|7
4915911|NCT00522379|16932125|P4|Overall Study|Lack of Efficacy|2
4915912|NCT00522379|16932126|P3|Overall Study|Lack of Efficacy|2
4915913|NCT00522379|16932127|P2|Overall Study|Lack of Efficacy|0
4915914|NCT00522379|16932128|P1|Overall Study|Lack of Efficacy|3
4915915|NCT00522379|16932124|P5|Overall Study|Adverse Event|17
4915916|NCT00522379|16932125|P4|Overall Study|Adverse Event|5
4915917|NCT00522379|16932126|P3|Overall Study|Adverse Event|12
4915918|NCT00522379|16932127|P2|Overall Study|Adverse Event|15
4915919|NCT00522379|16932128|P1|Overall Study|Adverse Event|12
4915920|NCT00522301|16932230|P1|Overall Study|Adverse Event|5
4915921|NCT00522301|16932230|P1|Overall Study|Withdrawal by Subject|1
4915922|NCT00522275|16932234|P1|Overall Study|Other: Subject had surgery for epilepsy|2
4915923|NCT00522275|16932234|P1|Overall Study|Other: Subject ran out of medication|1
4915924|NCT00522275|16932234|P1|Overall Study|Other: Sponsor request|2
4915925|NCT00522275|16932234|P1|Overall Study|Other: Travel to / from site difficulty|3
4915926|NCT00522275|16932234|P1|Overall Study|Other: Site / clinic closed|4
4915927|NCT00522275|16932234|P1|Overall Study|Other: Subject arrested|1
4915928|NCT00522275|16932234|P1|Overall Study|Other: Subject relocated|2
4915929|NCT00522275|16932234|P1|Overall Study|Other: Subject is pregnant|2
4915930|NCT00522275|16932234|P1|Overall Study|Other: Subject wants to become pregnant|2
4915931|NCT00522275|16932234|P1|Overall Study|Lost to Follow-up|8
4915932|NCT00522275|16932234|P1|Overall Study|Unsatisfactory compliance|11
4915933|NCT00522275|16932234|P1|Overall Study|Protocol deviation|1
4915934|NCT00522275|16932234|P1|Overall Study|Subject withdrew consent|16
4915935|NCT00522275|16932234|P1|Overall Study|Lack of Efficacy|80
4915936|NCT00522275|16932234|P1|Overall Study|Adverse Event|35
4915937|NCT00522041|16932255|P2|Overall Study|Did not receive treatment|1
4915938|NCT00522041|16932256|P1|Overall Study|Did not receive treatment|0
4915939|NCT00522041|16932255|P2|Overall Study|Voluntary withdrawal|4
4915940|NCT00522041|16932256|P1|Overall Study|Voluntary withdrawal|5
4915941|NCT00522041|16932255|P2|Overall Study|Lost to Follow-up|4
4915942|NCT00522041|16932256|P1|Overall Study|Lost to Follow-up|1
4915943|NCT00522041|16932255|P2|Overall Study|Protocol Violation|0
4915944|NCT00522041|16932256|P1|Overall Study|Protocol Violation|2
4915945|NCT00522041|16932255|P2|Overall Study|Adverse Event|3
4915946|NCT00522041|16932256|P1|Overall Study|Adverse Event|9
4915947|NCT00521599|16932315|P3|Overall Study|Did not meet protocol eligibility|1
4915948|NCT00521599|16932316|P2|Overall Study|Did not meet protocol eligibility|2
4915949|NCT00521599|16932317|P1|Overall Study|Did not meet protocol eligibility|2
4915950|NCT00521599|16932315|P3|Overall Study|Protocol Violation|2
4915951|NCT00521599|16932316|P2|Overall Study|Protocol Violation|4
4915952|NCT00521599|16932317|P1|Overall Study|Protocol Violation|2
4915953|NCT00521599|16932315|P3|Overall Study|Withdrawal by subject treatment related|2
4915954|NCT00521599|16932316|P2|Overall Study|Withdrawal by subject treatment related|1
4915955|NCT00521599|16932317|P1|Overall Study|Withdrawal by subject treatment related|3
4915956|NCT00521599|16932315|P3|Overall Study|Withdrawal by Subject|1
4915957|NCT00521599|16932316|P2|Overall Study|Withdrawal by Subject|5
4915958|NCT00521599|16932317|P1|Overall Study|Withdrawal by Subject|3
4915959|NCT00521599|16932315|P3|Overall Study|Lost to Follow-up|2
4915960|NCT00521599|16932316|P2|Overall Study|Lost to Follow-up|1
4915961|NCT00521599|16932317|P1|Overall Study|Lost to Follow-up|2
4915962|NCT00521599|16932315|P3|Overall Study|Treatment Failure|22
4915963|NCT00521599|16932316|P2|Overall Study|Treatment Failure|9
4915964|NCT00521599|16932317|P1|Overall Study|Treatment Failure|8
4915965|NCT00521599|16932315|P3|Overall Study|Adverse Event|6
4915966|NCT00521599|16932316|P2|Overall Study|Adverse Event|7
4915967|NCT00521599|16932317|P1|Overall Study|Adverse Event|5
4915968|NCT00521586|16932328|P2|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7
4915969|NCT00521586|16932329|P1|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2
4915970|NCT00521586|16932328|P2|Revaccination With 13vPnC (Year 5)|Failed to return|4
4915971|NCT00521586|16932329|P1|Revaccination With 13vPnC (Year 5)|Failed to return|1
4915972|NCT00521586|16932328|P2|Revaccination With 13vPnC (Year 5)|Subject request|1
4915973|NCT00521586|16932329|P1|Revaccination With 13vPnC (Year 5)|Subject request|0
4915974|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57
4915975|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54
4915976|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22
4915977|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18
4915978|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Other|26
4915979|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Other|22
4915980|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56
4915981|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55
4915982|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
4915983|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3
4915984|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3
4915985|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7
4915986|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Death|2
4915987|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Death|5
4915988|NCT00521586|16932328|P2|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1
4915989|NCT00521586|16932329|P1|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5
4915990|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Failed to return|1
4915991|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Failed to return|0
4915992|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Death|0
4915993|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Death|1
4915994|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Adverse Event|1
4915995|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Adverse Event|0
4915996|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Investigator request|0
4915997|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Investigator request|2
4915998|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Other, unspecified|1
4915999|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Other, unspecified|3
4916000|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Protocol Violation|5
4916001|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Protocol Violation|2
4916002|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Lost to Follow-up|10
4916003|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Lost to Follow-up|5
4916004|NCT00521586|16932328|P2|Initial Vaccination (Year 0)|Subject request|11
4916005|NCT00521586|16932329|P1|Initial Vaccination (Year 0)|Subject request|8
4916006|NCT00521365|16932402|P1|Overall Study|Usage of not allowed drugs|6
4916007|NCT00521365|16932402|P1|Overall Study|Drug compliance|3
4916008|NCT00521365|16932402|P1|Overall Study|Protocol deviation|2
4916009|NCT00521365|16932402|P1|Overall Study|Lost to Follow-up|6
4916010|NCT00521365|16932402|P1|Overall Study|Adverse Event|3
4916011|NCT00521339|16932432|P3|Treatment Extension Phase|Death|1
4916012|NCT00521339|16932433|P2|Treatment Extension Phase|Death|0
4916013|NCT00521339|16932434|P1|Treatment Extension Phase|Death|0
4916014|NCT00521339|16932432|P3|Treatment Extension Phase|Withdrawal by Subject|2
4916015|NCT00521339|16932433|P2|Treatment Extension Phase|Withdrawal by Subject|0
4916016|NCT00521339|16932434|P1|Treatment Extension Phase|Withdrawal by Subject|0
4916017|NCT00521339|16932432|P3|Treatment Phase|Protocol Violation|0
4916018|NCT00521339|16932433|P2|Treatment Phase|Protocol Violation|0
4916019|NCT00521339|16932434|P1|Treatment Phase|Protocol Violation|1
4916020|NCT00521339|16932432|P3|Treatment Phase|Lost to Follow-up|0
4916021|NCT00521339|16932433|P2|Treatment Phase|Lost to Follow-up|0
4916022|NCT00521339|16932434|P1|Treatment Phase|Lost to Follow-up|1
4916023|NCT00521339|16932432|P3|Treatment Phase|Withdrawal by Subject|0
4916024|NCT00521339|16932433|P2|Treatment Phase|Withdrawal by Subject|0
4916025|NCT00521339|16932434|P1|Treatment Phase|Withdrawal by Subject|3
4916026|NCT00521339|16932432|P3|Treatment Phase|Lack of Efficacy|0
4916027|NCT00521339|16932433|P2|Treatment Phase|Lack of Efficacy|0
4916028|NCT00521339|16932434|P1|Treatment Phase|Lack of Efficacy|3
4916029|NCT00521339|16932432|P3|Treatment Phase|Intolerability to study drug|0
4916030|NCT00521339|16932433|P2|Treatment Phase|Intolerability to study drug|0
4916031|NCT00521339|16932434|P1|Treatment Phase|Intolerability to study drug|2
4916032|NCT00521339|16932432|P3|Treatment Phase|Adverse Event|0
4916033|NCT00521339|16932433|P2|Treatment Phase|Adverse Event|0
4916034|NCT00521339|16932434|P1|Treatment Phase|Adverse Event|2
4916035|NCT00521144|16932502|P5|Overall Study|Progressive Disease|6
4916036|NCT00521144|16932503|P4|Overall Study|Progressive Disease|0
4916037|NCT00521144|16932504|P3|Overall Study|Progressive Disease|2
4916038|NCT00521144|16932505|P2|Overall Study|Progressive Disease|2
4916039|NCT00521144|16932506|P1|Overall Study|Progressive Disease|4
4916040|NCT00521144|16932502|P5|Overall Study|Adverse Event|1
4916041|NCT00521144|16932503|P4|Overall Study|Adverse Event|0
4916042|NCT00521144|16932504|P3|Overall Study|Adverse Event|0
4916043|NCT00521144|16932505|P2|Overall Study|Adverse Event|1
4916044|NCT00521144|16932506|P1|Overall Study|Adverse Event|0
4916045|NCT00521144|16932502|P5|Overall Study|Not Treated|0
4916046|NCT00521144|16932503|P4|Overall Study|Not Treated|1
4916047|NCT00521144|16932504|P3|Overall Study|Not Treated|0
4916048|NCT00521144|16932505|P2|Overall Study|Not Treated|0
4916049|NCT00521144|16932506|P1|Overall Study|Not Treated|0
4916050|NCT00521079|16932520|P2|Overall Study|Withdrawal by Subject|3
4916051|NCT00521079|16932521|P1|Overall Study|Withdrawal by Subject|5
4916052|NCT00521079|16932520|P2|Overall Study|Lost to Follow-up|1
4916053|NCT00521079|16932521|P1|Overall Study|Lost to Follow-up|2
4916054|NCT00521079|16932520|P2|Overall Study|Adverse Event|1
4916055|NCT00521079|16932521|P1|Overall Study|Adverse Event|7
4916056|NCT00521053|16932531|P1|Observation Phase|Physician Decision|1
4916057|NCT00521053|16932531|P1|Observation Phase|Other non-study melanoma treatment|1
4916058|NCT00521053|16932531|P1|Observation Phase|Adverse Event|1
4916059|NCT00521053|16932531|P1|Observation Phase|Death|2
4916060|NCT00521053|16932531|P1|Observation Phase|Additional PV-10 via alternate protocol|8
4916061|NCT00521053|16932531|P1|Observation Phase|Disease Progression|55
4916062|NCT00521014|16932541|P1|Overall Study|Inevaluable, not treated|1
4916063|NCT00521001|16932545|P1|Overall Study|Ineligible|1
4916064|NCT00520975|16932554|P2|Overall Study|Not start protocol therapy|2
4916065|NCT00520975|16932555|P1|Overall Study|Not start protocol therapy|1
4916066|NCT00520975|16932554|P2|Overall Study|Other reasons|2
4916067|NCT00520975|16932555|P1|Overall Study|Other reasons|4
4916068|NCT00520975|16932554|P2|Overall Study|Other therapy|4
4916069|NCT00520975|16932555|P1|Overall Study|Other therapy|2
4916070|NCT00520975|16932554|P2|Overall Study|Withdrawal by Subject|5
4916071|NCT00520975|16932555|P1|Overall Study|Withdrawal by Subject|3
4916072|NCT00520975|16932554|P2|Overall Study|Death|2
4916073|NCT00520975|16932555|P1|Overall Study|Death|0
4916074|NCT00520975|16932554|P2|Overall Study|Adverse Event|10
4916075|NCT00520975|16932555|P1|Overall Study|Adverse Event|7
4916076|NCT00520975|16932554|P2|Overall Study|Disease progression|23
4916077|NCT00520975|16932555|P1|Overall Study|Disease progression|31
4916078|NCT00520936|16932587|P8|Overall Study|Protocol Violation|0
4916079|NCT00520936|16932588|P7|Overall Study|Protocol Violation|1
4916080|NCT00520936|16932589|P6|Overall Study|Protocol Violation|0
4916081|NCT00520936|16932590|P5|Overall Study|Protocol Violation|1
4916082|NCT00520936|16932591|P4|Overall Study|Protocol Violation|0
4916083|NCT00520936|16932592|P3|Overall Study|Protocol Violation|1
4916084|NCT00520936|16932593|P2|Overall Study|Protocol Violation|1
4916085|NCT00520936|16932594|P1|Overall Study|Protocol Violation|0
4916086|NCT00520936|16932587|P8|Overall Study|Death|0
4916087|NCT00520936|16932588|P7|Overall Study|Death|1
4916088|NCT00520936|16932589|P6|Overall Study|Death|0
4916089|NCT00520936|16932590|P5|Overall Study|Death|0
4916090|NCT00520936|16932591|P4|Overall Study|Death|0
4916091|NCT00520936|16932592|P3|Overall Study|Death|0
4916092|NCT00520936|16932593|P2|Overall Study|Death|0
4916093|NCT00520936|16932594|P1|Overall Study|Death|0
4916094|NCT00520936|16932587|P8|Overall Study|Toxicity Requiring Removal from Study|0
4916095|NCT00520936|16932588|P7|Overall Study|Toxicity Requiring Removal from Study|2
4916096|NCT00520936|16932589|P6|Overall Study|Toxicity Requiring Removal from Study|0
4916097|NCT00520936|16932590|P5|Overall Study|Toxicity Requiring Removal from Study|0
4916098|NCT00520936|16932591|P4|Overall Study|Toxicity Requiring Removal from Study|0
4916099|NCT00520936|16932592|P3|Overall Study|Toxicity Requiring Removal from Study|0
4916100|NCT00520936|16932593|P2|Overall Study|Toxicity Requiring Removal from Study|1
4916101|NCT00520936|16932594|P1|Overall Study|Toxicity Requiring Removal from Study|0
4916102|NCT00520936|16932587|P8|Overall Study|Withdrawal by Subject|1
4916103|NCT00520936|16932588|P7|Overall Study|Withdrawal by Subject|0
4916104|NCT00520936|16932589|P6|Overall Study|Withdrawal by Subject|0
4916105|NCT00520936|16932590|P5|Overall Study|Withdrawal by Subject|0
4916106|NCT00520936|16932591|P4|Overall Study|Withdrawal by Subject|0
4916107|NCT00520936|16932592|P3|Overall Study|Withdrawal by Subject|0
4916108|NCT00520936|16932593|P2|Overall Study|Withdrawal by Subject|0
4916109|NCT00520936|16932594|P1|Overall Study|Withdrawal by Subject|0
4916110|NCT00520936|16932587|P8|Overall Study|Physician Decision|0
4916111|NCT00520936|16932588|P7|Overall Study|Physician Decision|0
4916112|NCT00520936|16932589|P6|Overall Study|Physician Decision|0
4916113|NCT00520936|16932590|P5|Overall Study|Physician Decision|0
4916114|NCT00520936|16932591|P4|Overall Study|Physician Decision|0
4916115|NCT00520936|16932592|P3|Overall Study|Physician Decision|1
4916116|NCT00520936|16932593|P2|Overall Study|Physician Decision|2
4916117|NCT00520936|16932594|P1|Overall Study|Physician Decision|0
4916118|NCT00520845|16932649|P1|Overall Study|Alternative Therapy|1
4916119|NCT00520845|16932649|P1|Overall Study|Withdrawal by Subject|1
4916120|NCT00520845|16932649|P1|Overall Study|Disease Progression, relapse|13
4916121|NCT00520845|16932649|P1|Overall Study|Adverse Event|4
4916122|NCT00520845|16932649|P1|Overall Study|Death|3
4916123|NCT00520767|16932657|P1|Overall Study|Death|2
4916124|NCT00520741|16932663|P2|Overall Study|Other reasons for premature termination|6
4916125|NCT00520741|16932664|P1|Overall Study|Other reasons for premature termination|0
4916126|NCT00520741|16932663|P2|Overall Study|Lost to Follow-up|4
4916127|NCT00520741|16932664|P1|Overall Study|Lost to Follow-up|4
4916128|NCT00520741|16932663|P2|Overall Study|Unsatisfactory compliance of subject|3
4916129|NCT00520741|16932664|P1|Overall Study|Unsatisfactory compliance of subject|4
4916130|NCT00520741|16932663|P2|Overall Study|Protocol Violation|15
4916131|NCT00520741|16932664|P1|Overall Study|Protocol Violation|2
4916132|NCT00520741|16932663|P2|Overall Study|Withdrawal by Subject|11
4916133|NCT00520741|16932664|P1|Overall Study|Withdrawal by Subject|0
4916134|NCT00520741|16932663|P2|Overall Study|Lack of Efficacy|30
4916135|NCT00520741|16932664|P1|Overall Study|Lack of Efficacy|11
4916136|NCT00520741|16932663|P2|Overall Study|Adverse Event|56
4916137|NCT00520741|16932664|P1|Overall Study|Adverse Event|16
4916138|NCT00520676|16932682|P2|Overall Study|Withdrawal by Subject|11
4916139|NCT00520676|16932683|P1|Overall Study|Withdrawal by Subject|7
4916140|NCT00520676|16932682|P2|Overall Study|Physician Decision|1
4916141|NCT00520676|16932683|P1|Overall Study|Physician Decision|4
4916142|NCT00520676|16932682|P2|Overall Study|Lost to Follow-up|10
4916143|NCT00520676|16932683|P1|Overall Study|Lost to Follow-up|6
4916144|NCT00520676|16932682|P2|Overall Study|Death|81
4916145|NCT00520676|16932683|P1|Overall Study|Death|84
4916146|NCT00520572|16932709|P6|Overall Study|Did not receive Treatment|0
4916147|NCT00520572|16932710|P5|Overall Study|Did not receive Treatment|0
4916148|NCT00520572|16932711|P4|Overall Study|Did not receive Treatment|0
4916149|NCT00520572|16932712|P3|Overall Study|Did not receive Treatment|1
4916150|NCT00520572|16932713|P2|Overall Study|Did not receive Treatment|0
4916151|NCT00520572|16932714|P1|Overall Study|Did not receive Treatment|1
4916152|NCT00520572|16932709|P6|Overall Study|Long break in taking Medication|0
4916153|NCT00520572|16932710|P5|Overall Study|Long break in taking Medication|0
4916154|NCT00520572|16932711|P4|Overall Study|Long break in taking Medication|1
4916155|NCT00520572|16932712|P3|Overall Study|Long break in taking Medication|0
4916156|NCT00520572|16932713|P2|Overall Study|Long break in taking Medication|0
4916157|NCT00520572|16932714|P1|Overall Study|Long break in taking Medication|0
4916158|NCT00520572|16932709|P6|Overall Study|Oral corticotherapy for acute urticaria|0
4916159|NCT00520572|16932710|P5|Overall Study|Oral corticotherapy for acute urticaria|0
4916160|NCT00520572|16932711|P4|Overall Study|Oral corticotherapy for acute urticaria|0
4916161|NCT00520572|16932712|P3|Overall Study|Oral corticotherapy for acute urticaria|0
4916162|NCT00520572|16932713|P2|Overall Study|Oral corticotherapy for acute urticaria|1
4916163|NCT00520572|16932714|P1|Overall Study|Oral corticotherapy for acute urticaria|0
4916164|NCT00520572|16932709|P6|Overall Study|Incorrect enrollment|0
4916165|NCT00520572|16932710|P5|Overall Study|Incorrect enrollment|1
4916166|NCT00520572|16932711|P4|Overall Study|Incorrect enrollment|0
4916167|NCT00520572|16932712|P3|Overall Study|Incorrect enrollment|1
4916168|NCT00520572|16932713|P2|Overall Study|Incorrect enrollment|0
4916169|NCT00520572|16932714|P1|Overall Study|Incorrect enrollment|1
4916170|NCT00520572|16932709|P6|Overall Study|Lost to Follow-up|0
4916171|NCT00520572|16932710|P5|Overall Study|Lost to Follow-up|1
4916172|NCT00520572|16932711|P4|Overall Study|Lost to Follow-up|0
4916173|NCT00520572|16932712|P3|Overall Study|Lost to Follow-up|0
4916174|NCT00520572|16932713|P2|Overall Study|Lost to Follow-up|0
4916175|NCT00520572|16932714|P1|Overall Study|Lost to Follow-up|0
4916176|NCT00520572|16932709|P6|Overall Study|Lack of Efficacy|0
4916177|NCT00520572|16932710|P5|Overall Study|Lack of Efficacy|1
4916178|NCT00520572|16932711|P4|Overall Study|Lack of Efficacy|2
4916179|NCT00520572|16932712|P3|Overall Study|Lack of Efficacy|1
4916180|NCT00520572|16932713|P2|Overall Study|Lack of Efficacy|1
4916181|NCT00520572|16932714|P1|Overall Study|Lack of Efficacy|1
4916182|NCT00520572|16932709|P6|Overall Study|Protocol Violation|0
4916183|NCT00520572|16932710|P5|Overall Study|Protocol Violation|0
4916184|NCT00520572|16932711|P4|Overall Study|Protocol Violation|0
4916185|NCT00520572|16932712|P3|Overall Study|Protocol Violation|1
4916186|NCT00520572|16932713|P2|Overall Study|Protocol Violation|0
4916187|NCT00520572|16932714|P1|Overall Study|Protocol Violation|0
4916188|NCT00520572|16932709|P6|Overall Study|Withdrawal by Subject|0
4916189|NCT00520572|16932710|P5|Overall Study|Withdrawal by Subject|2
4916190|NCT00520572|16932711|P4|Overall Study|Withdrawal by Subject|2
4916191|NCT00520572|16932712|P3|Overall Study|Withdrawal by Subject|5
4916192|NCT00520572|16932713|P2|Overall Study|Withdrawal by Subject|9
4916193|NCT00520572|16932714|P1|Overall Study|Withdrawal by Subject|0
4916194|NCT00520572|16932709|P6|Overall Study|Adverse Event|2
4916195|NCT00520572|16932710|P5|Overall Study|Adverse Event|7
4916196|NCT00520572|16932711|P4|Overall Study|Adverse Event|9
4916197|NCT00520572|16932712|P3|Overall Study|Adverse Event|6
4916198|NCT00520572|16932713|P2|Overall Study|Adverse Event|3
4916199|NCT00520572|16932714|P1|Overall Study|Adverse Event|9
4916200|NCT00520546|16932752|P1|Overall Study|failed radiopharmaceut. synthesis of FEC|5
4916201|NCT00520546|16932752|P1|Overall Study|Withdrawal by Subject|1
4916202|NCT00520494|16932767|P1|Overall Study|Withdrawal by Subject|1
4916203|NCT00520481|16932792|P2|Overall Study|Withdrawal by Subject|0
4916204|NCT00520481|16932793|P1|Overall Study|Withdrawal by Subject|3
4916205|NCT00520481|16932792|P2|Overall Study|Adverse Event|1
4916206|NCT00520481|16932793|P1|Overall Study|Adverse Event|4
4916207|NCT00520403|16932817|P1|Bevacizumab Monotherapy|Symptomatic progression of cancer|1
4916208|NCT00520403|16932817|P1|Bevacizumab Monotherapy|Radiological progression of cancer|1
4916209|NCT00520403|16932817|P1|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1
4916210|NCT00520403|16932817|P1|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1
4916211|NCT00520403|16932817|P1|Bevacizumab + IFN/Vinblastine|Death|2
4916212|NCT00520403|16932817|P1|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4
4916213|NCT00520403|16932817|P1|Bevacizumab + IFN/Vinblastine|Adverse Event|4
4916214|NCT00520403|16932817|P1|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6
4916215|NCT00520351|16932826|P2|First Intervention|Withdrawal by Subject|1
4916216|NCT00520351|16932827|P1|First Intervention|Withdrawal by Subject|1
4916217|NCT00520299|16932842|P3|Overall Study|Progressive disease|4
4916218|NCT00520299|16932843|P2|Overall Study|Progressive disease|3
4916219|NCT00520299|16932844|P1|Overall Study|Progressive disease|0
4916220|NCT00520299|16932842|P3|Overall Study|Withdrawal by Subject|2
4916221|NCT00520299|16932843|P2|Overall Study|Withdrawal by Subject|0
4916222|NCT00520299|16932844|P1|Overall Study|Withdrawal by Subject|0
4916223|NCT00520130|16932899|P2|Overall Study|Physician Decision|1
4916224|NCT00520130|16932900|P1|Overall Study|Physician Decision|1
4916225|NCT00520130|16932899|P2|Overall Study|Disease progression on study|0
4916226|NCT00520130|16932900|P1|Overall Study|Disease progression on study|4
4916227|NCT00520039|16932942|P2|Overall Study|Exclusion criteria met at first visit|5
4916228|NCT00520039|16932943|P1|Overall Study|Exclusion criteria met at first visit|7
4916229|NCT00520013|16932956|P3|Overall Study|Physician Decision|3
4916230|NCT00520013|16932957|P2|Overall Study|Physician Decision|0
4916231|NCT00520013|16932958|P1|Overall Study|Physician Decision|0
4916232|NCT00520013|16932956|P3|Overall Study|Death|0
4916233|NCT00520013|16932957|P2|Overall Study|Death|1
4916234|NCT00520013|16932958|P1|Overall Study|Death|0
4916235|NCT00520013|16932956|P3|Overall Study|Clinical Progression|0
4916236|NCT00520013|16932957|P2|Overall Study|Clinical Progression|1
4916237|NCT00520013|16932958|P1|Overall Study|Clinical Progression|3
4916238|NCT00520013|16932956|P3|Overall Study|Progressive Disease|0
4916239|NCT00520013|16932957|P2|Overall Study|Progressive Disease|3
4916240|NCT00520013|16932958|P1|Overall Study|Progressive Disease|7
4916241|NCT00520013|16932956|P3|Overall Study|Adverse Event|7
4916242|NCT00520013|16932957|P2|Overall Study|Adverse Event|10
4916243|NCT00520013|16932958|P1|Overall Study|Adverse Event|2
4916244|NCT00520013|16932956|P3|Overall Study|Withdrawal by Subject|1
4916245|NCT00520013|16932957|P2|Overall Study|Withdrawal by Subject|0
4916246|NCT00520013|16932958|P1|Overall Study|Withdrawal by Subject|0
4916247|NCT00519896|16932968|P1|Overall Study|Adverse Event|1
4916248|NCT00519896|16932968|P1|Overall Study|Protocol Violation|1
4916249|NCT00519831|16932974|P1|Overall Study|Adverse Event|3
4916250|NCT00519779|16932991|P2|Overall Study|Withdrawal by Subject|1
4916251|NCT00519779|16932992|P1|Overall Study|Withdrawal by Subject|0
4916252|NCT00519649|16933008|P1|Overall Study|Withdrawal by Subject|1
4916253|NCT00519636|16933021|P4|Post Study Period|Subject randomized in error|1
4916254|NCT00519636|16933022|P3|Post Study Period|Subject randomized in error|0
4916255|NCT00519636|16933023|P2|Post Study Period|Subject randomized in error|0
4916256|NCT00519636|16933024|P1|Post Study Period|Subject randomized in error|0
4916257|NCT00519636|16933021|P4|Treatment Period 2|Subject misrandomized|1
4916258|NCT00519636|16933022|P3|Treatment Period 2|Subject misrandomized|0
4916259|NCT00519636|16933023|P2|Treatment Period 2|Subject misrandomized|0
4916260|NCT00519636|16933024|P1|Treatment Period 2|Subject misrandomized|0
4916261|NCT00519636|16933021|P4|Treatment Period 2|Per doctors request|0
4916262|NCT00519636|16933022|P3|Treatment Period 2|Per doctors request|1
4916263|NCT00519636|16933023|P2|Treatment Period 2|Per doctors request|0
4916264|NCT00519636|16933024|P1|Treatment Period 2|Per doctors request|0
4916265|NCT00519636|16933021|P4|Treatment Period 2|Subject randomized in error|0
4916266|NCT00519636|16933022|P3|Treatment Period 2|Subject randomized in error|0
4916267|NCT00519636|16933023|P2|Treatment Period 2|Subject randomized in error|1
4916268|NCT00519636|16933024|P1|Treatment Period 2|Subject randomized in error|0
4916269|NCT00519636|16933021|P4|Treatment Period 2|Failed To Meet Continuation Criteria|1
4916270|NCT00519636|16933022|P3|Treatment Period 2|Failed To Meet Continuation Criteria|0
4916271|NCT00519636|16933023|P2|Treatment Period 2|Failed To Meet Continuation Criteria|0
4916272|NCT00519636|16933024|P1|Treatment Period 2|Failed To Meet Continuation Criteria|0
4916273|NCT00519636|16933021|P4|Washout Period|Prohibited medications|0
4916274|NCT00519636|16933022|P3|Washout Period|Prohibited medications|1
4916275|NCT00519636|16933023|P2|Washout Period|Prohibited medications|0
4916276|NCT00519636|16933024|P1|Washout Period|Prohibited medications|0
4916277|NCT00519636|16933021|P4|Washout Period|Subject randomized in error|0
4916278|NCT00519636|16933022|P3|Washout Period|Subject randomized in error|1
4916279|NCT00519636|16933023|P2|Washout Period|Subject randomized in error|0
4916280|NCT00519636|16933024|P1|Washout Period|Subject randomized in error|0
4916281|NCT00519636|16933021|P4|Washout Period|Per doctors request|0
4916282|NCT00519636|16933022|P3|Washout Period|Per doctors request|0
4916283|NCT00519636|16933023|P2|Washout Period|Per doctors request|1
4916284|NCT00519636|16933024|P1|Washout Period|Per doctors request|0
4916285|NCT00519636|16933021|P4|Washout Period|Non-compliant|0
4916286|NCT00519636|16933022|P3|Washout Period|Non-compliant|0
4916287|NCT00519636|16933023|P2|Washout Period|Non-compliant|1
4916288|NCT00519636|16933024|P1|Washout Period|Non-compliant|0
4916289|NCT00519636|16933021|P4|Washout Period|Participating in study at another site|0
4916290|NCT00519636|16933022|P3|Washout Period|Participating in study at another site|0
4916291|NCT00519636|16933023|P2|Washout Period|Participating in study at another site|0
4916292|NCT00519636|16933024|P1|Washout Period|Participating in study at another site|1
4916293|NCT00519636|16933021|P4|Washout Period|Out of pollen area > 48 hours|0
4916294|NCT00519636|16933022|P3|Washout Period|Out of pollen area > 48 hours|0
4916295|NCT00519636|16933023|P2|Washout Period|Out of pollen area > 48 hours|0
4916296|NCT00519636|16933024|P1|Washout Period|Out of pollen area > 48 hours|1
4916297|NCT00519636|16933021|P4|Washout Period|Failed to meet continuation criteria|3
4916298|NCT00519636|16933022|P3|Washout Period|Failed to meet continuation criteria|9
4916299|NCT00519636|16933023|P2|Washout Period|Failed to meet continuation criteria|11
4916300|NCT00519636|16933024|P1|Washout Period|Failed to meet continuation criteria|14
4916301|NCT00519636|16933021|P4|Washout Period|Withdrawal by Subject|0
4916302|NCT00519636|16933022|P3|Washout Period|Withdrawal by Subject|1
4916303|NCT00519636|16933023|P2|Washout Period|Withdrawal by Subject|0
4916304|NCT00519636|16933024|P1|Washout Period|Withdrawal by Subject|1
4916305|NCT00519636|16933021|P4|Washout Period|Protocol Violation|2
4916306|NCT00519636|16933022|P3|Washout Period|Protocol Violation|1
4916307|NCT00519636|16933023|P2|Washout Period|Protocol Violation|0
4916308|NCT00519636|16933024|P1|Washout Period|Protocol Violation|0
4916309|NCT00519636|16933021|P4|Washout Period|Lost to Follow-up|0
4916310|NCT00519636|16933022|P3|Washout Period|Lost to Follow-up|0
4916311|NCT00519636|16933023|P2|Washout Period|Lost to Follow-up|0
4916312|NCT00519636|16933024|P1|Washout Period|Lost to Follow-up|1
4916313|NCT00519636|16933021|P4|Washout Period|Adverse Event|0
4916314|NCT00519636|16933022|P3|Washout Period|Adverse Event|1
4916315|NCT00519636|16933023|P2|Washout Period|Adverse Event|1
4916316|NCT00519636|16933024|P1|Washout Period|Adverse Event|2
4916317|NCT00519636|16933021|P4|Treatment Period 1|Sponsor request due to missed visit|0
4916318|NCT00519636|16933022|P3|Treatment Period 1|Sponsor request due to missed visit|0
4916319|NCT00519636|16933023|P2|Treatment Period 1|Sponsor request due to missed visit|0
4916320|NCT00519636|16933024|P1|Treatment Period 1|Sponsor request due to missed visit|1
4916321|NCT00519636|16933021|P4|Treatment Period 1|Adverse Event|0
4916322|NCT00519636|16933022|P3|Treatment Period 1|Adverse Event|1
4916323|NCT00519636|16933023|P2|Treatment Period 1|Adverse Event|0
4916324|NCT00519636|16933024|P1|Treatment Period 1|Adverse Event|1
4916325|NCT00519623|16933054|P1|Overall Study|Adverse Event|1
4916326|NCT00519532|16933088|P1|Overall Study|Lost to Follow-up|2
4916327|NCT00519532|16933088|P1|Overall Study|Withdrawal by Subject|5
4916328|NCT00519532|16933088|P1|Overall Study|Adverse Event|11
4916329|NCT00519428|16933098|P3|Overall Study|unstated|2
4916330|NCT00519428|16933099|P2|Overall Study|unstated|3
4916331|NCT00519428|16933100|P1|Overall Study|unstated|1
4916332|NCT00519428|16933098|P3|Overall Study|Withdrawal by Subject|7
4916333|NCT00519428|16933099|P2|Overall Study|Withdrawal by Subject|3
4916334|NCT00519428|16933100|P1|Overall Study|Withdrawal by Subject|8
4916335|NCT00519428|16933098|P3|Overall Study|Lost to Follow-up|6
4916336|NCT00519428|16933099|P2|Overall Study|Lost to Follow-up|7
4916337|NCT00519428|16933100|P1|Overall Study|Lost to Follow-up|7
4916338|NCT00519428|16933098|P3|Overall Study|Adverse Event|10
4916339|NCT00519428|16933099|P2|Overall Study|Adverse Event|2
4916340|NCT00519428|16933100|P1|Overall Study|Adverse Event|5
4916341|NCT00519376|16933120|P16|Treatment Period 4|Lost to Follow-up|0
4916342|NCT00519376|16933121|P15|Treatment Period 4|Lost to Follow-up|0
4916343|NCT00519376|16933122|P14|Treatment Period 4|Lost to Follow-up|0
4916344|NCT00519376|16933123|P13|Treatment Period 4|Lost to Follow-up|0
4916345|NCT00519376|16933124|P12|Treatment Period 4|Lost to Follow-up|0
4916346|NCT00519376|16933125|P11|Treatment Period 4|Lost to Follow-up|0
4916347|NCT00519376|16933126|P10|Treatment Period 4|Lost to Follow-up|0
4916348|NCT00519376|16933127|P9|Treatment Period 4|Lost to Follow-up|0
4916349|NCT00519376|16933128|P8|Treatment Period 4|Lost to Follow-up|0
4916350|NCT00519376|16933129|P7|Treatment Period 4|Lost to Follow-up|0
4916351|NCT00519376|16933130|P6|Treatment Period 4|Lost to Follow-up|0
4916352|NCT00519376|16933131|P5|Treatment Period 4|Lost to Follow-up|0
4916353|NCT00519376|16933132|P4|Treatment Period 4|Lost to Follow-up|0
4916354|NCT00519376|16933133|P3|Treatment Period 4|Lost to Follow-up|1
4916355|NCT00519376|16933134|P2|Treatment Period 4|Lost to Follow-up|0
4916356|NCT00519376|16933135|P1|Treatment Period 4|Lost to Follow-up|0
4916357|NCT00519376|16933120|P16|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916358|NCT00519376|16933121|P15|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916359|NCT00519376|16933122|P14|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916360|NCT00519376|16933123|P13|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1
4916361|NCT00519376|16933124|P12|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916362|NCT00519376|16933125|P11|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916363|NCT00519376|16933126|P10|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916364|NCT00519376|16933127|P9|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916365|NCT00519376|16933128|P8|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916366|NCT00519376|16933129|P7|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916367|NCT00519376|16933130|P6|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916368|NCT00519376|16933131|P5|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916369|NCT00519376|16933132|P4|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916370|NCT00519376|16933133|P3|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916371|NCT00519376|16933134|P2|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916372|NCT00519376|16933135|P1|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0
4916373|NCT00519285|16933259|P2|Overall Study|Treatment ongoing|2
4916374|NCT00519285|16933260|P1|Overall Study|Treatment ongoing|1
4916375|NCT00519285|16933259|P2|Overall Study|Not treated|7
4916376|NCT00519285|16933260|P1|Overall Study|Not treated|8
4916377|NCT00519285|16933259|P2|Overall Study|Reason unspecified|8
4916378|NCT00519285|16933260|P1|Overall Study|Reason unspecified|5
4916379|NCT00519285|16933259|P2|Overall Study|Poor compliance to protocol|7
4916380|NCT00519285|16933260|P1|Overall Study|Poor compliance to protocol|5
4916381|NCT00519285|16933259|P2|Overall Study|Consent withdrawn|5
4916382|NCT00519285|16933260|P1|Overall Study|Consent withdrawn|4
4916383|NCT00519285|16933259|P2|Overall Study|Participant's request|84
4916384|NCT00519285|16933260|P1|Overall Study|Participant's request|53
4916385|NCT00519285|16933259|P2|Overall Study|Physician Decision|47
4916386|NCT00519285|16933260|P1|Overall Study|Physician Decision|75
4916387|NCT00519285|16933259|P2|Overall Study|Disease progression|186
4916388|NCT00519285|16933260|P1|Overall Study|Disease progression|334
4916389|NCT00519285|16933259|P2|Overall Study|Adverse Event|266
4916390|NCT00519285|16933260|P1|Overall Study|Adverse Event|127
4916391|NCT00519194|16933286|P1|Overall Study|Lost to Follow-up|3
4916392|NCT00519194|16933286|P1|Overall Study|Death|9
4916393|NCT00519194|16933286|P1|Overall Study|Withdrawal by Subject|9
4916394|NCT00519077|16933301|P1|Overall Study|Other|2
4916395|NCT00519077|16933301|P1|Overall Study|Death|6
4916396|NCT00518986|16933308|P2|Overall Study|Non-Specific|1
4916397|NCT00518986|16933309|P1|Overall Study|Non-Specific|2
4916398|NCT00518986|16933308|P2|Overall Study|Withdrawal by Subject|4
4916399|NCT00518986|16933309|P1|Overall Study|Withdrawal by Subject|4
4916400|NCT00518986|16933308|P2|Overall Study|Protocol Violation|7
4916401|NCT00518986|16933309|P1|Overall Study|Protocol Violation|5
4916402|NCT00518986|16933308|P2|Overall Study|Physician Decision|3
4916403|NCT00518986|16933309|P1|Overall Study|Physician Decision|0
4916404|NCT00518986|16933308|P2|Overall Study|Lost to Follow-up|2
4916405|NCT00518986|16933309|P1|Overall Study|Lost to Follow-up|3
4916406|NCT00518986|16933308|P2|Overall Study|Lack of Efficacy|2
4916407|NCT00518986|16933309|P1|Overall Study|Lack of Efficacy|0
4916408|NCT00518986|16933308|P2|Overall Study|Adverse Event|7
4916409|NCT00518986|16933309|P1|Overall Study|Adverse Event|12
4916410|NCT00518973|16933435|P2|Overall Study|Withdrawal by Subject|2
4916411|NCT00518973|16933436|P1|Overall Study|Withdrawal by Subject|3
4916412|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25
4916413|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18
4916414|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Subject decision|0
4916415|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Subject decision|2
4916416|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Exclusion criteria|0
4916417|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Exclusion criteria|2
4916418|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Decreased kidney function|0
4916419|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Decreased kidney function|1
4916420|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Creatine increased|0
4916421|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Creatine increased|1
4916422|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Change in treatment|1
4916423|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Change in treatment|1
4916424|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Consent withdrawn|1
4916425|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Consent withdrawn|2
4916426|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Lost to follow up|1
4916427|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Lost to follow up|1
4916428|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Hypoglycaemia|1
4916429|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Hypoglycaemia|0
4916430|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Withdrawel criteria|2
4916431|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Withdrawel criteria|1
4916432|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Protocol Violation|4
4916433|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Protocol Violation|3
4916434|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Lack of Efficacy|5
4916435|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Lack of Efficacy|6
4916436|NCT00518882|16933452|P2|Open-Label Extension, Week 26-78|Adverse Event|9
4916437|NCT00518882|16933453|P1|Open-Label Extension, Week 26-78|Adverse Event|3
4916438|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Mutual consent|1
4916439|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Mutual consent|0
4916440|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Hypoglycaemia|2
4916441|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Hypoglycaemia|0
4916442|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Fear of hypoglycaemia|1
4916443|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Fear of hypoglycaemia|0
4916444|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Loss of trust|1
4916445|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Loss of trust|0
4916446|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Withdrawal of consent|3
4916447|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Withdrawal of consent|1
4916448|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Subject decision|1
4916449|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Subject decision|1
4916450|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Lost to follow up|1
4916451|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Lost to follow up|2
4916452|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Withdrawal criteria|1
4916453|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Withdrawal criteria|1
4916454|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Protocol Violation|3
4916455|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Protocol Violation|4
4916456|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Lack of Efficacy|0
4916457|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Lack of Efficacy|1
4916458|NCT00518882|16933452|P2|Double-Blind, Week 0-26|Adverse Event|31
4916459|NCT00518882|16933453|P1|Double-Blind, Week 0-26|Adverse Event|23
4916460|NCT00518687|16933634|P2|Overall Study|Withdrawal by Subject|110
4916461|NCT00518687|16933635|P1|Overall Study|Withdrawal by Subject|110
4916462|NCT00518687|16933634|P2|Overall Study|Study terminated by sponsor|918
4916463|NCT00518687|16933635|P1|Overall Study|Study terminated by sponsor|930
4916464|NCT00518687|16933634|P2|Overall Study|Protocol Violation|10
4916465|NCT00518687|16933635|P1|Overall Study|Protocol Violation|8
4916466|NCT00518687|16933634|P2|Overall Study|Progressive disease|2
4916467|NCT00518687|16933635|P1|Overall Study|Progressive disease|2
4916468|NCT00518687|16933634|P2|Overall Study|Physician Decision|48
4916469|NCT00518687|16933635|P1|Overall Study|Physician Decision|42
4916470|NCT00518687|16933634|P2|Overall Study|Lost to Follow-up|155
4916471|NCT00518687|16933635|P1|Overall Study|Lost to Follow-up|144
4916472|NCT00518687|16933634|P2|Overall Study|Adverse Event|177
4916473|NCT00518687|16933635|P1|Overall Study|Adverse Event|201
4916474|NCT00518622|16933655|P8|Overall Study|Study medication taken incorrectly|0
4916475|NCT00518622|16933656|P7|Overall Study|Study medication taken incorrectly|0
4916476|NCT00518622|16933657|P6|Overall Study|Study medication taken incorrectly|0
4916477|NCT00518622|16933658|P5|Overall Study|Study medication taken incorrectly|0
4916478|NCT00518622|16933659|P4|Overall Study|Study medication taken incorrectly|0
4916479|NCT00518622|16933660|P3|Overall Study|Study medication taken incorrectly|0
4916480|NCT00518622|16933661|P2|Overall Study|Study medication taken incorrectly|1
4916481|NCT00518622|16933662|P1|Overall Study|Study medication taken incorrectly|0
4916482|NCT00518622|16933655|P8|Overall Study|Lost to Follow-up|0
4916483|NCT00518622|16933656|P7|Overall Study|Lost to Follow-up|0
4916484|NCT00518622|16933657|P6|Overall Study|Lost to Follow-up|0
4916485|NCT00518622|16933658|P5|Overall Study|Lost to Follow-up|0
4916486|NCT00518622|16933659|P4|Overall Study|Lost to Follow-up|0
4916487|NCT00518622|16933660|P3|Overall Study|Lost to Follow-up|1
4916488|NCT00518622|16933661|P2|Overall Study|Lost to Follow-up|0
4916489|NCT00518622|16933662|P1|Overall Study|Lost to Follow-up|0
4916490|NCT00518531|16933690|P2|Treatment Period 2|Non-compliance|2
4916491|NCT00518531|16933691|P1|Treatment Period 2|Non-compliance|1
4916492|NCT00518531|16933690|P2|Treatment Period 2|Protocol-specified criteria|1
4916493|NCT00518531|16933691|P1|Treatment Period 2|Protocol-specified criteria|0
4916494|NCT00518531|16933690|P2|Treatment Period 2|Adverse Event|7
4916495|NCT00518531|16933691|P1|Treatment Period 2|Adverse Event|1
4916496|NCT00518531|16933690|P2|Treatment Period 2|Complete out of scheduled visit window|2
4916497|NCT00518531|16933691|P1|Treatment Period 2|Complete out of scheduled visit window|1
4916498|NCT00518531|16933690|P2|Treatment Period 2|Withdrawal by Subject|8
4916499|NCT00518531|16933691|P1|Treatment Period 2|Withdrawal by Subject|0
4916500|NCT00518531|16933690|P2|Treatment Period 1|Early crossover|3
4916501|NCT00518531|16933691|P1|Treatment Period 1|Early crossover|1
4916502|NCT00518531|16933690|P2|Treatment Period 1|Withdrawal by Subject|6
4916503|NCT00518531|16933691|P1|Treatment Period 1|Withdrawal by Subject|4
4916504|NCT00518531|16933690|P2|Treatment Period 1|Protocol Violation|0
4916505|NCT00518531|16933691|P1|Treatment Period 1|Protocol Violation|2
4916506|NCT00518531|16933690|P2|Treatment Period 1|Physician Decision|0
4916507|NCT00518531|16933691|P1|Treatment Period 1|Physician Decision|1
4916508|NCT00518531|16933690|P2|Treatment Period 1|Lost to Follow-up|3
4916509|NCT00518531|16933691|P1|Treatment Period 1|Lost to Follow-up|5
4916510|NCT00518531|16933690|P2|Treatment Period 1|Adverse Event|0
4916511|NCT00518531|16933691|P1|Treatment Period 1|Adverse Event|5
4916512|NCT00518336|16933736|P2|Year 9|Personal reasons|0
4916513|NCT00518336|16933737|P1|Year 9|Personal reasons|1
4916514|NCT00518336|16933736|P2|Year 9|Lost to Follow-up|0
4916515|NCT00518336|16933737|P1|Year 9|Lost to Follow-up|3
4916516|NCT00518336|16933736|P2|Year 9|Migrated/moved from study area|1
4916517|NCT00518336|16933737|P1|Year 9|Migrated/moved from study area|1
4916518|NCT00518336|16933736|P2|Year 8|Could not attend in time|1
4916519|NCT00518336|16933737|P1|Year 8|Could not attend in time|0
4916520|NCT00518336|16933736|P2|Year 8|Lost to Follow-up|1
4916521|NCT00518336|16933737|P1|Year 8|Lost to Follow-up|1
4916522|NCT00518336|16933736|P2|Year 7|Could not attend in time|3
4916523|NCT00518336|16933737|P1|Year 7|Could not attend in time|0
4916524|NCT00518336|16933736|P2|Year 7|Lost to Follow-up|0
4916525|NCT00518336|16933737|P1|Year 7|Lost to Follow-up|2
4916526|NCT00518323|16933903|P4|Overall Study|Prohibited medication and others|0
4916527|NCT00518323|16933904|P3|Overall Study|Prohibited medication and others|1
4916528|NCT00518323|16933905|P2|Overall Study|Prohibited medication and others|1
4916529|NCT00518323|16933906|P1|Overall Study|Prohibited medication and others|3
4916530|NCT00518323|16933903|P4|Overall Study|Adverse Event|0
4916531|NCT00518323|16933904|P3|Overall Study|Adverse Event|1
4916532|NCT00518323|16933905|P2|Overall Study|Adverse Event|1
4916533|NCT00518323|16933906|P1|Overall Study|Adverse Event|1
4916534|NCT00518323|16933903|P4|Overall Study|Lost to Follow-up|3
4916535|NCT00518323|16933904|P3|Overall Study|Lost to Follow-up|1
4916536|NCT00518323|16933905|P2|Overall Study|Lost to Follow-up|2
4916537|NCT00518323|16933906|P1|Overall Study|Lost to Follow-up|0
4916538|NCT00518323|16933903|P4|Overall Study|Withdrawal by Subject|2
4916539|NCT00518323|16933904|P3|Overall Study|Withdrawal by Subject|4
4916540|NCT00518323|16933905|P2|Overall Study|Withdrawal by Subject|2
4916541|NCT00518323|16933906|P1|Overall Study|Withdrawal by Subject|1
4916542|NCT00518323|16933903|P4|Overall Study|Lack of Efficacy|20
4916543|NCT00518323|16933904|P3|Overall Study|Lack of Efficacy|4
4916544|NCT00518323|16933905|P2|Overall Study|Lack of Efficacy|2
4916545|NCT00518323|16933906|P1|Overall Study|Lack of Efficacy|14
4916546|NCT00518284|16933936|P4|Overall Study|Study Termination|2
4916547|NCT00518284|16933937|P3|Overall Study|Study Termination|1
4916548|NCT00518284|16933938|P2|Overall Study|Study Termination|2
4916549|NCT00518284|16933939|P1|Overall Study|Study Termination|0
4916550|NCT00518284|16933936|P4|Overall Study|Adverse Event|0
4916551|NCT00518284|16933937|P3|Overall Study|Adverse Event|0
4916552|NCT00518284|16933938|P2|Overall Study|Adverse Event|1
4916553|NCT00518284|16933939|P1|Overall Study|Adverse Event|0
4916554|NCT00518206|16933995|P2|Overall Study|Completion Status Unknown|0
4916555|NCT00518206|16933996|P1|Overall Study|Completion Status Unknown|1
4916556|NCT00518206|16933995|P2|Overall Study|Reason Unknown|0
4916557|NCT00518206|16933996|P1|Overall Study|Reason Unknown|1
4916558|NCT00518206|16933995|P2|Overall Study|Drug Supply Issue|0
4916559|NCT00518206|16933996|P1|Overall Study|Drug Supply Issue|1
4916560|NCT00518206|16933995|P2|Overall Study|Withdrawal by Subject|0
4916561|NCT00518206|16933996|P1|Overall Study|Withdrawal by Subject|2
4916562|NCT00518206|16933995|P2|Overall Study|Disease Progression Requiring Therapy|6
4916563|NCT00518206|16933996|P1|Overall Study|Disease Progression Requiring Therapy|6
4916564|NCT00518180|16934013|P3|Overall Study|Adverse Event|0
4916565|NCT00518180|16934014|P2|Overall Study|Adverse Event|0
4916566|NCT00518180|16934015|P1|Overall Study|Adverse Event|1
4916567|NCT00518180|16934013|P3|Overall Study|Unable to classify|0
4916568|NCT00518180|16934014|P2|Overall Study|Unable to classify|2
4916569|NCT00518180|16934015|P1|Overall Study|Unable to classify|0
4916570|NCT00518180|16934013|P3|Overall Study|Protocol Violation|4
4916571|NCT00518180|16934014|P2|Overall Study|Protocol Violation|7
4916572|NCT00518180|16934015|P1|Overall Study|Protocol Violation|5
4916573|NCT00518180|16934013|P3|Overall Study|Administrative reason|2
4916574|NCT00518180|16934014|P2|Overall Study|Administrative reason|2
4916575|NCT00518180|16934015|P1|Overall Study|Administrative reason|0
4916576|NCT00518180|16934013|P3|Overall Study|Lost to Follow-up|34
4916577|NCT00518180|16934014|P2|Overall Study|Lost to Follow-up|28
4916578|NCT00518180|16934015|P1|Overall Study|Lost to Follow-up|30
4916579|NCT00518180|16934013|P3|Overall Study|Withdrawal by Subject|42
4916580|NCT00518180|16934014|P2|Overall Study|Withdrawal by Subject|30
4916581|NCT00518180|16934015|P1|Overall Study|Withdrawal by Subject|29
4916582|NCT00518115|16934071|P10|Overall Study|Moved Out of State|1
4916583|NCT00518115|16934072|P9|Overall Study|Moved Out of State|0
4916584|NCT00518115|16934073|P8|Overall Study|Moved Out of State|0
4916585|NCT00518115|16934074|P7|Overall Study|Moved Out of State|0
4916586|NCT00518115|16934075|P6|Overall Study|Moved Out of State|0
4916587|NCT00518115|16934076|P5|Overall Study|Moved Out of State|0
4916588|NCT00518115|16934077|P4|Overall Study|Moved Out of State|0
4916589|NCT00518115|16934078|P3|Overall Study|Moved Out of State|0
4916590|NCT00518115|16934079|P2|Overall Study|Moved Out of State|0
4916591|NCT00518115|16934080|P1|Overall Study|Moved Out of State|0
4916592|NCT00518115|16934071|P10|Overall Study|Withdrew Consent|0
4916593|NCT00518115|16934072|P9|Overall Study|Withdrew Consent|0
4916594|NCT00518115|16934073|P8|Overall Study|Withdrew Consent|0
4916595|NCT00518115|16934074|P7|Overall Study|Withdrew Consent|0
4916596|NCT00518115|16934075|P6|Overall Study|Withdrew Consent|1
4916597|NCT00518115|16934076|P5|Overall Study|Withdrew Consent|0
4916598|NCT00518115|16934077|P4|Overall Study|Withdrew Consent|0
4916599|NCT00518115|16934078|P3|Overall Study|Withdrew Consent|0
4916600|NCT00518115|16934079|P2|Overall Study|Withdrew Consent|0
4916601|NCT00518115|16934080|P1|Overall Study|Withdrew Consent|0
4916602|NCT00518115|16934071|P10|Overall Study|Family Emergency; Had to Go to England|0
4916603|NCT00518115|16934072|P9|Overall Study|Family Emergency; Had to Go to England|0
4916604|NCT00518115|16934073|P8|Overall Study|Family Emergency; Had to Go to England|0
4916605|NCT00518115|16934074|P7|Overall Study|Family Emergency; Had to Go to England|0
4916606|NCT00518115|16934075|P6|Overall Study|Family Emergency; Had to Go to England|0
4916607|NCT00518115|16934076|P5|Overall Study|Family Emergency; Had to Go to England|1
4916608|NCT00518115|16934077|P4|Overall Study|Family Emergency; Had to Go to England|0
4916609|NCT00518115|16934078|P3|Overall Study|Family Emergency; Had to Go to England|0
4916610|NCT00518115|16934079|P2|Overall Study|Family Emergency; Had to Go to England|0
4916611|NCT00518115|16934080|P1|Overall Study|Family Emergency; Had to Go to England|0
4916612|NCT00518115|16934071|P10|Overall Study|Violation of Exclusion Criteria|0
4916613|NCT00518115|16934072|P9|Overall Study|Violation of Exclusion Criteria|0
4916614|NCT00518115|16934073|P8|Overall Study|Violation of Exclusion Criteria|0
4916615|NCT00518115|16934074|P7|Overall Study|Violation of Exclusion Criteria|1
4916616|NCT00518115|16934075|P6|Overall Study|Violation of Exclusion Criteria|0
4916617|NCT00518115|16934076|P5|Overall Study|Violation of Exclusion Criteria|0
4916618|NCT00518115|16934077|P4|Overall Study|Violation of Exclusion Criteria|1
4916619|NCT00518115|16934078|P3|Overall Study|Violation of Exclusion Criteria|0
4916620|NCT00518115|16934079|P2|Overall Study|Violation of Exclusion Criteria|0
4916621|NCT00518115|16934080|P1|Overall Study|Violation of Exclusion Criteria|0
4916622|NCT00518115|16934071|P10|Overall Study|Wrong Monotherapy Administered|0
4916623|NCT00518115|16934072|P9|Overall Study|Wrong Monotherapy Administered|0
4916624|NCT00518115|16934073|P8|Overall Study|Wrong Monotherapy Administered|0
4916625|NCT00518115|16934074|P7|Overall Study|Wrong Monotherapy Administered|1
4916626|NCT00518115|16934075|P6|Overall Study|Wrong Monotherapy Administered|0
4916627|NCT00518115|16934076|P5|Overall Study|Wrong Monotherapy Administered|0
4916628|NCT00518115|16934077|P4|Overall Study|Wrong Monotherapy Administered|0
4916629|NCT00518115|16934078|P3|Overall Study|Wrong Monotherapy Administered|1
4916630|NCT00518115|16934079|P2|Overall Study|Wrong Monotherapy Administered|0
4916631|NCT00518115|16934080|P1|Overall Study|Wrong Monotherapy Administered|0
4916632|NCT00518115|16934071|P10|Overall Study|Different Monotherapy Diabetic Drug|0
4916633|NCT00518115|16934072|P9|Overall Study|Different Monotherapy Diabetic Drug|1
4916634|NCT00518115|16934073|P8|Overall Study|Different Monotherapy Diabetic Drug|0
4916635|NCT00518115|16934074|P7|Overall Study|Different Monotherapy Diabetic Drug|0
4916636|NCT00518115|16934075|P6|Overall Study|Different Monotherapy Diabetic Drug|0
4916637|NCT00518115|16934076|P5|Overall Study|Different Monotherapy Diabetic Drug|0
4916638|NCT00518115|16934077|P4|Overall Study|Different Monotherapy Diabetic Drug|0
4916639|NCT00518115|16934078|P3|Overall Study|Different Monotherapy Diabetic Drug|1
4916640|NCT00518115|16934079|P2|Overall Study|Different Monotherapy Diabetic Drug|0
4916641|NCT00518115|16934080|P1|Overall Study|Different Monotherapy Diabetic Drug|0
4916642|NCT00518115|16934071|P10|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916643|NCT00518115|16934072|P9|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916644|NCT00518115|16934073|P8|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916645|NCT00518115|16934074|P7|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916646|NCT00518115|16934075|P6|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916647|NCT00518115|16934076|P5|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916648|NCT00518115|16934077|P4|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916649|NCT00518115|16934078|P3|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916650|NCT00518115|16934079|P2|Overall Study|Physician Prescribed Antidiabetic Drug|0
4916651|NCT00518115|16934080|P1|Overall Study|Physician Prescribed Antidiabetic Drug|1
4916652|NCT00518115|16934071|P10|Overall Study|Treatment Eligibility Criteria Not Met|0
4916653|NCT00518115|16934072|P9|Overall Study|Treatment Eligibility Criteria Not Met|0
4916654|NCT00518115|16934073|P8|Overall Study|Treatment Eligibility Criteria Not Met|0
4916655|NCT00518115|16934074|P7|Overall Study|Treatment Eligibility Criteria Not Met|0
4916656|NCT00518115|16934075|P6|Overall Study|Treatment Eligibility Criteria Not Met|4
4916657|NCT00518115|16934076|P5|Overall Study|Treatment Eligibility Criteria Not Met|0
4916658|NCT00518115|16934077|P4|Overall Study|Treatment Eligibility Criteria Not Met|0
4916659|NCT00518115|16934078|P3|Overall Study|Treatment Eligibility Criteria Not Met|0
4916660|NCT00518115|16934079|P2|Overall Study|Treatment Eligibility Criteria Not Met|1
4916661|NCT00518115|16934080|P1|Overall Study|Treatment Eligibility Criteria Not Met|1
4916662|NCT00518115|16934071|P10|Overall Study|Non-Compliance|1
4916663|NCT00518115|16934072|P9|Overall Study|Non-Compliance|0
4916664|NCT00518115|16934073|P8|Overall Study|Non-Compliance|1
4916665|NCT00518115|16934074|P7|Overall Study|Non-Compliance|1
4916666|NCT00518115|16934075|P6|Overall Study|Non-Compliance|1
4916667|NCT00518115|16934076|P5|Overall Study|Non-Compliance|1
4916668|NCT00518115|16934077|P4|Overall Study|Non-Compliance|0
4916669|NCT00518115|16934078|P3|Overall Study|Non-Compliance|1
4916670|NCT00518115|16934079|P2|Overall Study|Non-Compliance|0
4916671|NCT00518115|16934080|P1|Overall Study|Non-Compliance|1
4916672|NCT00518115|16934071|P10|Overall Study|Lack of Efficacy|0
4916673|NCT00518115|16934072|P9|Overall Study|Lack of Efficacy|0
4916674|NCT00518115|16934073|P8|Overall Study|Lack of Efficacy|1
4916675|NCT00518115|16934074|P7|Overall Study|Lack of Efficacy|0
4916676|NCT00518115|16934075|P6|Overall Study|Lack of Efficacy|0
4916677|NCT00518115|16934076|P5|Overall Study|Lack of Efficacy|0
4916678|NCT00518115|16934077|P4|Overall Study|Lack of Efficacy|1
4916679|NCT00518115|16934078|P3|Overall Study|Lack of Efficacy|1
4916680|NCT00518115|16934079|P2|Overall Study|Lack of Efficacy|0
4916681|NCT00518115|16934080|P1|Overall Study|Lack of Efficacy|1
4916682|NCT00518115|16934071|P10|Overall Study|Withdrawal by Subject|3
4916683|NCT00518115|16934072|P9|Overall Study|Withdrawal by Subject|1
4916684|NCT00518115|16934073|P8|Overall Study|Withdrawal by Subject|2
4916685|NCT00518115|16934074|P7|Overall Study|Withdrawal by Subject|0
4916686|NCT00518115|16934075|P6|Overall Study|Withdrawal by Subject|1
4916687|NCT00518115|16934076|P5|Overall Study|Withdrawal by Subject|2
4916688|NCT00518115|16934077|P4|Overall Study|Withdrawal by Subject|0
4916689|NCT00518115|16934078|P3|Overall Study|Withdrawal by Subject|5
4916690|NCT00518115|16934079|P2|Overall Study|Withdrawal by Subject|1
4916691|NCT00518115|16934080|P1|Overall Study|Withdrawal by Subject|1
4916692|NCT00518115|16934071|P10|Overall Study|Protocol Violation|0
4916693|NCT00518115|16934072|P9|Overall Study|Protocol Violation|0
4916694|NCT00518115|16934073|P8|Overall Study|Protocol Violation|0
4916695|NCT00518115|16934074|P7|Overall Study|Protocol Violation|0
4916696|NCT00518115|16934075|P6|Overall Study|Protocol Violation|0
4916697|NCT00518115|16934076|P5|Overall Study|Protocol Violation|0
4916698|NCT00518115|16934077|P4|Overall Study|Protocol Violation|0
4916699|NCT00518115|16934078|P3|Overall Study|Protocol Violation|1
4916700|NCT00518115|16934079|P2|Overall Study|Protocol Violation|3
4916701|NCT00518115|16934080|P1|Overall Study|Protocol Violation|1
4916702|NCT00518115|16934071|P10|Overall Study|Lost to Follow-up|1
4916703|NCT00518115|16934072|P9|Overall Study|Lost to Follow-up|1
4916704|NCT00518115|16934073|P8|Overall Study|Lost to Follow-up|1
4916705|NCT00518115|16934074|P7|Overall Study|Lost to Follow-up|0
4916706|NCT00518115|16934075|P6|Overall Study|Lost to Follow-up|3
4916707|NCT00518115|16934076|P5|Overall Study|Lost to Follow-up|1
4916708|NCT00518115|16934077|P4|Overall Study|Lost to Follow-up|3
4916709|NCT00518115|16934078|P3|Overall Study|Lost to Follow-up|2
4916710|NCT00518115|16934079|P2|Overall Study|Lost to Follow-up|0
4916711|NCT00518115|16934080|P1|Overall Study|Lost to Follow-up|0
4916712|NCT00518115|16934071|P10|Overall Study|Adverse Event|9
4916713|NCT00518115|16934072|P9|Overall Study|Adverse Event|2
4916714|NCT00518115|16934073|P8|Overall Study|Adverse Event|10
4916715|NCT00518115|16934074|P7|Overall Study|Adverse Event|5
4916716|NCT00518115|16934075|P6|Overall Study|Adverse Event|5
4916717|NCT00518115|16934076|P5|Overall Study|Adverse Event|5
4916718|NCT00518115|16934077|P4|Overall Study|Adverse Event|6
4916719|NCT00518115|16934078|P3|Overall Study|Adverse Event|5
4916720|NCT00518115|16934079|P2|Overall Study|Adverse Event|1
4916721|NCT00518115|16934080|P1|Overall Study|Adverse Event|6
4916722|NCT00518011|16934255|P2|Overall Study|Withdrawal by Subject|0
4916723|NCT00518011|16934256|P1|Overall Study|Withdrawal by Subject|1
4916724|NCT00518011|16934255|P2|Overall Study|Other Reasons|2
4916725|NCT00518011|16934256|P1|Overall Study|Other Reasons|3
4916726|NCT00518011|16934255|P2|Overall Study|Disease Progression|2
4916727|NCT00518011|16934256|P1|Overall Study|Disease Progression|2
4916728|NCT00518011|16934255|P2|Overall Study|Adverse Event|3
4916729|NCT00518011|16934256|P1|Overall Study|Adverse Event|2
4916730|NCT00518011|16934255|P2|Overall Study|Death|1
4916731|NCT00518011|16934256|P1|Overall Study|Death|1
4916732|NCT00517933|16934278|P2|Period 2|Underwent lung transplant|2
4916733|NCT00517933|16934279|P1|Period 2|Underwent lung transplant|0
4916734|NCT00517933|16934278|P2|Period 2|Withdrawal by Subject|3
4916735|NCT00517933|16934279|P1|Period 2|Withdrawal by Subject|1
4916736|NCT00517933|16934278|P2|Period 2|Physician Decision|0
4916737|NCT00517933|16934279|P1|Period 2|Physician Decision|1
4916738|NCT00517933|16934278|P2|Period 2|Adverse Event|4
4916739|NCT00517933|16934279|P1|Period 2|Adverse Event|2
4916740|NCT00517933|16934278|P2|Period 2|Death|4
4916741|NCT00517933|16934279|P1|Period 2|Death|2
4916742|NCT00517933|16934278|P2|Period 1|Underwent lung transplant|1
4916743|NCT00517933|16934279|P1|Period 1|Underwent lung transplant|0
4916744|NCT00517933|16934278|P2|Period 1|Lost to Follow-up|0
4916745|NCT00517933|16934279|P1|Period 1|Lost to Follow-up|2
4916746|NCT00517933|16934278|P2|Period 1|Adverse Event|4
4916747|NCT00517933|16934279|P1|Period 1|Adverse Event|4
4916748|NCT00517933|16934278|P2|Period 1|Death|1
4916749|NCT00517933|16934279|P1|Period 1|Death|2
4916750|NCT00517881|16934343|P1|Overall Study|Renal transplantation|2
4916751|NCT00517881|16934343|P1|Overall Study|Adverse Event|1
4916752|NCT00517881|16934343|P1|Overall Study|Protocol Violation|2
4916753|NCT00517829|16934355|P2|Overall Study|Other|1
4916754|NCT00517829|16934356|P1|Overall Study|Other|3
4916755|NCT00517829|16934355|P2|Overall Study|Investigator Request|3
4916756|NCT00517829|16934356|P1|Overall Study|Investigator Request|5
4916757|NCT00517829|16934355|P2|Overall Study|Patient Request|5
4916758|NCT00517829|16934356|P1|Overall Study|Patient Request|6
4916759|NCT00517829|16934355|P2|Overall Study|Disease Progression|32
4916760|NCT00517829|16934356|P1|Overall Study|Disease Progression|39
4916761|NCT00517829|16934355|P2|Overall Study|Adverse Event|34
4916762|NCT00517829|16934356|P1|Overall Study|Adverse Event|22
4916763|NCT00517751|16934370|P1|Overall Study|Missing|3
4916764|NCT00517751|16934370|P1|Overall Study|Patient not due for visit|76
4916765|NCT00517751|16934370|P1|Overall Study|patient not over due|6
4916766|NCT00517751|16934370|P1|Overall Study|Lost to Follow-up|4
4916767|NCT00517751|16934370|P1|Overall Study|Withdrawal by Subject|37
4916768|NCT00517751|16934370|P1|Overall Study|Death|3
4916769|NCT00517699|16934393|P1|Overall Study|Study terminated by Sponsor|2
4916770|NCT00517699|16934393|P1|Overall Study|Administrative error|1
4916771|NCT00517699|16934393|P1|Overall Study|Lack of Efficacy|1
4916772|NCT00517699|16934393|P1|Overall Study|Withdrawal by Subject|1
4916773|NCT00517634|16934401|P6|Second Treatment Period|Withdrawal by Subject|0
4916774|NCT00517634|16934402|P5|Second Treatment Period|Withdrawal by Subject|1
4916775|NCT00517634|16934403|P4|Second Treatment Period|Withdrawal by Subject|0
4916776|NCT00517634|16934404|P3|Second Treatment Period|Withdrawal by Subject|0
4916777|NCT00517634|16934405|P2|Second Treatment Period|Withdrawal by Subject|0
4916778|NCT00517634|16934406|P1|Second Treatment Period|Withdrawal by Subject|0
4916779|NCT00517413|16934508|P1|Overall Study|Other-Reasons|23
4916780|NCT00517413|16934508|P1|Overall Study|Failure to return|1
4916781|NCT00517413|16934508|P1|Overall Study|Withdrawal by Subject|2
4916782|NCT00517413|16934508|P1|Overall Study|Protocol Violation|15
4916783|NCT00517413|16934508|P1|Overall Study|Death|13
4916784|NCT00517413|16934508|P1|Overall Study|Adverse Event|7
4916785|NCT00517361|16934529|P1|Overall Study|The study was terminated|5
4916786|NCT00517361|16934529|P1|Overall Study|Death|6
4916787|NCT00517296|16934538|P2|Overall Study|Withdrawal by Subject|0
4916788|NCT00517296|16934539|P1|Overall Study|Withdrawal by Subject|1
4916789|NCT00517192|16934551|P2|Overall Study|Early termination of the trial|18
4916790|NCT00517192|16934552|P1|Overall Study|Early termination of the trial|16
4916791|NCT00517192|16934551|P2|Overall Study|Withdrawal by Subject|0
4916792|NCT00517192|16934552|P1|Overall Study|Withdrawal by Subject|1
4916793|NCT00517192|16934551|P2|Overall Study|Lost to Follow-up|1
4916794|NCT00517192|16934552|P1|Overall Study|Lost to Follow-up|1
4916795|NCT00517192|16934551|P2|Overall Study|Adverse Event|1
4916796|NCT00517192|16934552|P1|Overall Study|Adverse Event|1
4916797|NCT00516906|16934659|P2|Overall Study|Final Dressing Removal Data not captured|2
4916798|NCT00516906|16934660|P1|Overall Study|Final Dressing Removal Data not captured|6
4916799|NCT00516893|16934670|P1|Overall Study|Received Medication From Another Study|1
4916800|NCT00516893|16934670|P1|Overall Study|Pregnancy|1
4916801|NCT00516893|16934670|P1|Overall Study|Relocated|1
4916802|NCT00516893|16934670|P1|Overall Study|Persistent Antibodies per Protocol|6
4916803|NCT00516893|16934670|P1|Overall Study|Death|1
4916804|NCT00516893|16934670|P1|Overall Study|Noncompliance|2
4916805|NCT00516893|16934670|P1|Overall Study|Withdrawal by Subject|2
4916806|NCT00516893|16934670|P1|Overall Study|Adverse Event|3
4916807|NCT00516893|16934670|P1|Overall Study|Lost to Follow-up|4
4916808|NCT00516737|16934679|P2|Overall Study|Lack of Qualifying Event|6
4916809|NCT00516737|16934680|P1|Overall Study|Lack of Qualifying Event|9
4916810|NCT00516737|16934679|P2|Overall Study|Withdrawal by Subject|1
4916811|NCT00516737|16934680|P1|Overall Study|Withdrawal by Subject|0
4916812|NCT00516737|16934679|P2|Overall Study|Physician Decision|1
4916813|NCT00516737|16934680|P1|Overall Study|Physician Decision|0
4916814|NCT00516737|16934679|P2|Overall Study|Lost to Follow-up|0
4916815|NCT00516737|16934680|P1|Overall Study|Lost to Follow-up|2
4916816|NCT00516386|16934719|P1|Overall Study|Lost to Follow-up|2
4916817|NCT00516386|16934719|P1|Overall Study|not interested in the study|4
4916818|NCT00516321|16934726|P3|Double-blind (DB) Antiviral Treatment|Physician Decision|0
4916819|NCT00516321|16934727|P2|Double-blind (DB) Antiviral Treatment|Physician Decision|2
4916820|NCT00516321|16934728|P1|Double-blind (DB) Antiviral Treatment|Physician Decision|0
4916821|NCT00516321|16934726|P3|Double-blind (DB) Antiviral Treatment|Protocol Violation|1
4916822|NCT00516321|16934727|P2|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
4916823|NCT00516321|16934728|P1|Double-blind (DB) Antiviral Treatment|Protocol Violation|0
4916824|NCT00516321|16934726|P3|Double-blind (DB) Antiviral Treatment|Adverse Event|13
4916825|NCT00516321|16934727|P2|Double-blind (DB) Antiviral Treatment|Adverse Event|8
4916826|NCT00516321|16934728|P1|Double-blind (DB) Antiviral Treatment|Adverse Event|0
4916827|NCT00516321|16934726|P3|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18
4916828|NCT00516321|16934727|P2|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13
4916829|NCT00516321|16934728|P1|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0
4916830|NCT00516321|16934726|P3|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22
4916831|NCT00516321|16934727|P2|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12
4916832|NCT00516321|16934728|P1|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0
4916833|NCT00516321|16934726|P3|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
4916834|NCT00516321|16934727|P2|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0
4916835|NCT00516321|16934728|P1|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3
4916836|NCT00516321|16934726|P3|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
4916837|NCT00516321|16934727|P2|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0
4916838|NCT00516321|16934728|P1|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7
4916839|NCT00516321|16934726|P3|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
4916840|NCT00516321|16934727|P2|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0
4916841|NCT00516321|16934728|P1|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2
4916842|NCT00516321|16934726|P3|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
4916843|NCT00516321|16934727|P2|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0
4916844|NCT00516321|16934728|P1|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1
4916845|NCT00516321|16934726|P3|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
4916846|NCT00516321|16934727|P2|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0
4916847|NCT00516321|16934728|P1|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9
4916848|NCT00516321|16934726|P3|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
4916849|NCT00516321|16934727|P2|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0
4916850|NCT00516321|16934728|P1|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11
4916851|NCT00516295|16934779|P3|Overall Study|Ineligible|0
4916852|NCT00516295|16934780|P2|Overall Study|Ineligible|0
4916853|NCT00516295|16934781|P1|Overall Study|Ineligible|1
4916854|NCT00516295|16934779|P3|Overall Study|Lack of Efficacy|0
4916855|NCT00516295|16934780|P2|Overall Study|Lack of Efficacy|0
4916856|NCT00516295|16934781|P1|Overall Study|Lack of Efficacy|2
4916857|NCT00516269|16934794|P2|Overall Study|Protocol Violation|1
4916858|NCT00516269|16934795|P1|Overall Study|Protocol Violation|0
4916859|NCT00516269|16934794|P2|Overall Study|Lost to Follow-up|1
4916860|NCT00516269|16934795|P1|Overall Study|Lost to Follow-up|0
4916861|NCT00516269|16934794|P2|Overall Study|Adverse Event|1
4916862|NCT00516269|16934795|P1|Overall Study|Adverse Event|2
4916863|NCT00516139|16934816|P1|Overall Study|Lack of Efficacy|1
4916864|NCT00516139|16934816|P1|Overall Study|Withdrawal by Subject|8
4916865|NCT00516139|16934816|P1|Overall Study|Protocol Violation|1
4916866|NCT00516139|16934816|P1|Overall Study|Lost to Follow-up|1
4916867|NCT00516139|16934816|P1|Overall Study|Adverse Event|27
4916868|NCT00516074|16934847|P2|Overall Study|Loss of Glucose Control|0
4916869|NCT00516074|16934848|P1|Overall Study|Loss of Glucose Control|2
4916870|NCT00516074|16934847|P2|Overall Study|Subject Decision|2
4916871|NCT00516074|16934848|P1|Overall Study|Subject Decision|4
4916872|NCT00516074|16934847|P2|Overall Study|Adverse Event|1
4916873|NCT00516074|16934848|P1|Overall Study|Adverse Event|0
4916874|NCT00516048|16934866|P3|Overall Study|Subject Decision|0
4916875|NCT00516048|16934867|P2|Overall Study|Subject Decision|2
4916876|NCT00516048|16934868|P1|Overall Study|Subject Decision|0
4916877|NCT00516048|16934866|P3|Overall Study|Death|1
4916878|NCT00516048|16934867|P2|Overall Study|Death|0
4916879|NCT00516048|16934868|P1|Overall Study|Death|0
4916880|NCT00515827|16934903|P2|Second Intervention (12 Weeks)|Consent withdraw|0
4916881|NCT00515827|16934904|P1|Second Intervention (12 Weeks)|Consent withdraw|1
4916882|NCT00515827|16934903|P2|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
4916883|NCT00515827|16934904|P1|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1
4916884|NCT00515671|16934962|P2|Overall Study|incarcerated|2
4916885|NCT00515671|16934963|P1|Overall Study|incarcerated|1
4916886|NCT00515671|16934962|P2|Overall Study|Withdrawal by Subject|5
4916887|NCT00515671|16934963|P1|Overall Study|Withdrawal by Subject|3
4916888|NCT00515671|16934962|P2|Overall Study|Lost to Follow-up|10
4916889|NCT00515671|16934963|P1|Overall Study|Lost to Follow-up|13
4916890|NCT00515619|16934971|P1|Overall Study|Other: Subject interested in other AED|1
4916891|NCT00515619|16934971|P1|Overall Study|Other: Drug available on license|1
4916892|NCT00515619|16934971|P1|Overall Study|Other: Request from sponsor|1
4916893|NCT00515619|16934971|P1|Overall Study|Other: Subject became pregnant|1
4916894|NCT00515619|16934971|P1|Overall Study|Other: Investigator decision|1
4916895|NCT00515619|16934971|P1|Overall Study|Other: Subject moved to another country|1
4916896|NCT00515619|16934971|P1|Overall Study|Other: Subject required surgery|1
4916897|NCT00515619|16934971|P1|Overall Study|Other: Subject cannot attend visits|2
4916898|NCT00515619|16934971|P1|Overall Study|Other: Site discontinuing trials|2
4916899|NCT00515619|16934971|P1|Overall Study|Unsatisfactory compliance|6
4916900|NCT00515619|16934971|P1|Overall Study|Lost to Follow-up|4
4916901|NCT00515619|16934971|P1|Overall Study|Protocol Violation|3
4916902|NCT00515619|16934971|P1|Overall Study|Withdrawal by Subject|66
4916903|NCT00515619|16934971|P1|Overall Study|Lack of Efficacy|92
4916904|NCT00515619|16934971|P1|Overall Study|Adverse Event|34
4916905|NCT00515541|16934983|P4|Overall Study|Withdrawal by Subject|2
4916906|NCT00515541|16934984|P3|Overall Study|Withdrawal by Subject|0
4916907|NCT00515541|16934985|P2|Overall Study|Withdrawal by Subject|2
4916908|NCT00515541|16934986|P1|Overall Study|Withdrawal by Subject|0
4916909|NCT00515541|16934983|P4|Overall Study|No show for appointments|2
4916910|NCT00515541|16934984|P3|Overall Study|No show for appointments|0
4916911|NCT00515541|16934985|P2|Overall Study|No show for appointments|1
4916912|NCT00515541|16934986|P1|Overall Study|No show for appointments|0
4916913|NCT00515541|16934983|P4|Overall Study|Physician Decision|1
4916914|NCT00515541|16934984|P3|Overall Study|Physician Decision|0
4916915|NCT00515541|16934985|P2|Overall Study|Physician Decision|2
4916916|NCT00515541|16934986|P1|Overall Study|Physician Decision|0
4916917|NCT00515502|16935008|P12|Treatment Period 2|Adverse Event|0
4916918|NCT00515502|16935009|P11|Treatment Period 2|Adverse Event|0
4916919|NCT00515502|16935010|P10|Treatment Period 2|Adverse Event|0
4916920|NCT00515502|16935011|P9|Treatment Period 2|Adverse Event|0
4916921|NCT00515502|16935012|P8|Treatment Period 2|Adverse Event|0
4916922|NCT00515502|16935013|P7|Treatment Period 2|Adverse Event|0
4916923|NCT00515502|16935014|P6|Treatment Period 2|Adverse Event|0
4916924|NCT00515502|16935015|P5|Treatment Period 2|Adverse Event|0
4916925|NCT00515502|16935016|P4|Treatment Period 2|Adverse Event|0
4916926|NCT00515502|16935017|P3|Treatment Period 2|Adverse Event|0
4916927|NCT00515502|16935018|P2|Treatment Period 2|Adverse Event|1
4916928|NCT00515502|16935019|P1|Treatment Period 2|Adverse Event|0
4916929|NCT00515502|16935008|P12|Treatment Period 1|Adverse Event|1
4916930|NCT00515502|16935009|P11|Treatment Period 1|Adverse Event|0
4916931|NCT00515502|16935010|P10|Treatment Period 1|Adverse Event|0
4916932|NCT00515502|16935011|P9|Treatment Period 1|Adverse Event|1
4916933|NCT00515502|16935012|P8|Treatment Period 1|Adverse Event|0
4916934|NCT00515502|16935013|P7|Treatment Period 1|Adverse Event|1
4916935|NCT00515502|16935014|P6|Treatment Period 1|Adverse Event|0
4916936|NCT00515502|16935015|P5|Treatment Period 1|Adverse Event|0
4916937|NCT00515502|16935016|P4|Treatment Period 1|Adverse Event|0
4916938|NCT00515502|16935017|P3|Treatment Period 1|Adverse Event|0
4916939|NCT00515502|16935018|P2|Treatment Period 1|Adverse Event|0
4916940|NCT00515502|16935019|P1|Treatment Period 1|Adverse Event|0
4916941|NCT00515463|16935179|P2|Overall Study|Other|1
4916942|NCT00515463|16935180|P1|Overall Study|Other|0
4916943|NCT00515463|16935179|P2|Overall Study|Lost to Follow-up|5
4916944|NCT00515463|16935180|P1|Overall Study|Lost to Follow-up|6
4916945|NCT00515463|16935179|P2|Overall Study|Withdrawal by Subject|4
4916946|NCT00515463|16935180|P1|Overall Study|Withdrawal by Subject|3
4916947|NCT00515463|16935179|P2|Overall Study|Adverse Event|2
4916948|NCT00515463|16935180|P1|Overall Study|Adverse Event|1
4916949|NCT00515463|16935179|P2|Overall Study|Physician Decision|2
4916950|NCT00515463|16935180|P1|Overall Study|Physician Decision|4
4916951|NCT00515294|16935379|P4|Overall Study|Caffeine amount inaccurate|0
4916952|NCT00515294|16935380|P3|Overall Study|Caffeine amount inaccurate|7
4916953|NCT00515294|16935381|P2|Overall Study|Caffeine amount inaccurate|0
4916954|NCT00515294|16935382|P1|Overall Study|Caffeine amount inaccurate|5
4916955|NCT00515294|16935379|P4|Overall Study|Driver simulator problems|3
4916956|NCT00515294|16935380|P3|Overall Study|Driver simulator problems|1
4916957|NCT00515294|16935381|P2|Overall Study|Driver simulator problems|1
4916958|NCT00515294|16935382|P1|Overall Study|Driver simulator problems|1
4916959|NCT00515294|16935379|P4|Overall Study|Lost to Follow-up|1
4916960|NCT00515294|16935380|P3|Overall Study|Lost to Follow-up|3
4916961|NCT00515294|16935381|P2|Overall Study|Lost to Follow-up|2
4916962|NCT00515294|16935382|P1|Overall Study|Lost to Follow-up|3
4916963|NCT00515216|16935396|P1|Overall Study|Withdrawal by Subject|1
4916964|NCT00515112|16935458|P2|Overall Study|The study was terminated|2
4916965|NCT00515112|16935459|P1|Overall Study|The study was terminated|3
4916966|NCT00515112|16935458|P2|Overall Study|Death|1
4916967|NCT00515112|16935459|P1|Overall Study|Death|0
4916968|NCT00515099|16935469|P2|Overall Study|IRB Recommendation|0
4916969|NCT00515099|16935470|P1|Overall Study|IRB Recommendation|1
4916970|NCT00515099|16935469|P2|Overall Study|Withdrawal by Subject|0
4916971|NCT00515099|16935470|P1|Overall Study|Withdrawal by Subject|2
4916972|NCT00515099|16935469|P2|Overall Study|Lost to Follow-up|4
4916973|NCT00515099|16935470|P1|Overall Study|Lost to Follow-up|0
4916974|NCT00515086|16935492|P4|Overall Study|Death|0
4916975|NCT00515086|16935493|P3|Overall Study|Death|0
4916976|NCT00515086|16935494|P2|Overall Study|Death|0
4916977|NCT00515086|16935495|P1|Overall Study|Death|2
4916978|NCT00515086|16935492|P4|Overall Study|Study drug no longer required|0
4916979|NCT00515086|16935493|P3|Overall Study|Study drug no longer required|0
4916980|NCT00515086|16935494|P2|Overall Study|Study drug no longer required|1
4916981|NCT00515086|16935495|P1|Overall Study|Study drug no longer required|0
4916982|NCT00515086|16935492|P4|Overall Study|Lost to Follow-up|0
4916983|NCT00515086|16935493|P3|Overall Study|Lost to Follow-up|0
4916984|NCT00515086|16935494|P2|Overall Study|Lost to Follow-up|0
4916985|NCT00515086|16935495|P1|Overall Study|Lost to Follow-up|1
4916986|NCT00515086|16935492|P4|Overall Study|Unsatisfactory therapeutic effect|2
4916987|NCT00515086|16935493|P3|Overall Study|Unsatisfactory therapeutic effect|3
4916988|NCT00515086|16935494|P2|Overall Study|Unsatisfactory therapeutic effect|3
4916989|NCT00515086|16935495|P1|Overall Study|Unsatisfactory therapeutic effect|18
4916990|NCT00515086|16935492|P4|Overall Study|Withdrawal by Subject|1
4916991|NCT00515086|16935493|P3|Overall Study|Withdrawal by Subject|0
4916992|NCT00515086|16935494|P2|Overall Study|Withdrawal by Subject|0
4916993|NCT00515086|16935495|P1|Overall Study|Withdrawal by Subject|1
4916994|NCT00515086|16935492|P4|Overall Study|Administrative|0
4916995|NCT00515086|16935493|P3|Overall Study|Administrative|0
4916996|NCT00515086|16935494|P2|Overall Study|Administrative|1
4916997|NCT00515086|16935495|P1|Overall Study|Administrative|1
4916998|NCT00515086|16935492|P4|Overall Study|Adverse Event|3
4916999|NCT00515086|16935493|P3|Overall Study|Adverse Event|2
4917000|NCT00515086|16935494|P2|Overall Study|Adverse Event|1
4917001|NCT00515086|16935495|P1|Overall Study|Adverse Event|1
4917002|NCT00515073|16935522|P1|Overall Study|Physician Decision|1
4917003|NCT00515073|16935522|P1|Overall Study|Withdrawal by Subject|1
4917004|NCT00515034|16935530|P4|Overall Study|Other|1
4917005|NCT00515034|16935531|P3|Overall Study|Other|2
4917006|NCT00515034|16935532|P2|Overall Study|Other|0
4917007|NCT00515034|16935533|P1|Overall Study|Other|1
4917008|NCT00515034|16935530|P4|Overall Study|Physician Decision|1
4917009|NCT00515034|16935531|P3|Overall Study|Physician Decision|1
4917010|NCT00515034|16935532|P2|Overall Study|Physician Decision|0
4917011|NCT00515034|16935533|P1|Overall Study|Physician Decision|0
4917012|NCT00515034|16935530|P4|Overall Study|Withdrawal by Subject|0
4917013|NCT00515034|16935531|P3|Overall Study|Withdrawal by Subject|3
4917014|NCT00515034|16935532|P2|Overall Study|Withdrawal by Subject|0
4917015|NCT00515034|16935533|P1|Overall Study|Withdrawal by Subject|1
4917016|NCT00515034|16935530|P4|Overall Study|Death|3
4917017|NCT00515034|16935531|P3|Overall Study|Death|1
4917018|NCT00515034|16935532|P2|Overall Study|Death|2
4917019|NCT00515034|16935533|P1|Overall Study|Death|4
4917020|NCT00515034|16935530|P4|Overall Study|Adverse Event|0
4917021|NCT00515034|16935531|P3|Overall Study|Adverse Event|1
4917022|NCT00515034|16935532|P2|Overall Study|Adverse Event|0
4917023|NCT00515034|16935533|P1|Overall Study|Adverse Event|2
4917024|NCT00515008|16935564|P2|Overall Study|Scheduling conflict|0
4917025|NCT00515008|16935565|P1|Overall Study|Scheduling conflict|1
4917026|NCT00515008|16935564|P2|Overall Study|Left the Boston Area|1
4917027|NCT00515008|16935565|P1|Overall Study|Left the Boston Area|1
4917028|NCT00515008|16935564|P2|Overall Study|Declined|3
4917029|NCT00515008|16935565|P1|Overall Study|Declined|0
4917030|NCT00515008|16935564|P2|Overall Study|Lost to Follow-up|0
4917031|NCT00515008|16935565|P1|Overall Study|Lost to Follow-up|1
4917032|NCT00514943|16935589|P2|Stage 2|Other than stated above|2
4917033|NCT00514943|16935590|P1|Stage 2|Other than stated above|0
4917034|NCT00514943|16935589|P2|Stage 2|Patient refused to continue study meds|0
4917035|NCT00514943|16935590|P1|Stage 2|Patient refused to continue study meds|2
4917036|NCT00514943|16935589|P2|Stage 2|Other Adverse Event|10
4917037|NCT00514943|16935590|P1|Stage 2|Other Adverse Event|3
4917038|NCT00514943|16935589|P2|Stage 2|Progressive disease|24
4917039|NCT00514943|16935590|P1|Stage 2|Progressive disease|27
4917040|NCT00514943|16935589|P2|Stage 1|Other than stated above|7
4917041|NCT00514943|16935590|P1|Stage 1|Other than stated above|1
4917042|NCT00514943|16935589|P2|Stage 1|Patient refused to continue study meds|3
4917043|NCT00514943|16935590|P1|Stage 1|Patient refused to continue study meds|8
4917044|NCT00514943|16935589|P2|Stage 1|Not treated|2
4917045|NCT00514943|16935590|P1|Stage 1|Not treated|1
4917046|NCT00514943|16935589|P2|Stage 1|Other Adverse Event|6
4917047|NCT00514943|16935590|P1|Stage 1|Other Adverse Event|16
4917048|NCT00514943|16935589|P2|Stage 1|Progressive disease|8
4917049|NCT00514943|16935590|P1|Stage 1|Progressive disease|4
4917050|NCT00514917|16935648|P2|Overall Study|Undefined|5
4917051|NCT00514917|16935649|P1|Overall Study|Undefined|11
4917052|NCT00514917|16935648|P2|Overall Study|Discontinued due to study closure|81
4917053|NCT00514917|16935649|P1|Overall Study|Discontinued due to study closure|88
4917054|NCT00514917|16935648|P2|Overall Study|Withdrawal by Subject|16
4917055|NCT00514917|16935649|P1|Overall Study|Withdrawal by Subject|18
4917056|NCT00514917|16935648|P2|Overall Study|Lost to Follow-up|3
4917057|NCT00514917|16935649|P1|Overall Study|Lost to Follow-up|4
4917058|NCT00514917|16935648|P2|Overall Study|Protocol Violation|0
4917059|NCT00514917|16935649|P1|Overall Study|Protocol Violation|1
4917060|NCT00514917|16935648|P2|Overall Study|Death|10
4917061|NCT00514917|16935649|P1|Overall Study|Death|4
4917062|NCT00514904|16935677|P2|Overall Study|Lost to Follow-up|3
4917063|NCT00514904|16935678|P1|Overall Study|Lost to Follow-up|21
4917064|NCT00514904|16935677|P2|Overall Study|Withdrawal by Subject|2
4917065|NCT00514904|16935678|P1|Overall Study|Withdrawal by Subject|3
4917066|NCT00514813|16935743|P4|Overall Study|Death|2
4917067|NCT00514813|16935744|P3|Overall Study|Death|3
4917068|NCT00514813|16935745|P2|Overall Study|Death|2
4917069|NCT00514813|16935746|P1|Overall Study|Death|0
4917070|NCT00514813|16935743|P4|Overall Study|Kidney transplant|0
4917071|NCT00514813|16935744|P3|Overall Study|Kidney transplant|2
4917072|NCT00514813|16935745|P2|Overall Study|Kidney transplant|6
4917073|NCT00514813|16935746|P1|Overall Study|Kidney transplant|0
4917074|NCT00514813|16935743|P4|Overall Study|Lack of Efficacy|0
4917075|NCT00514813|16935744|P3|Overall Study|Lack of Efficacy|0
4917076|NCT00514813|16935745|P2|Overall Study|Lack of Efficacy|1
4917077|NCT00514813|16935746|P1|Overall Study|Lack of Efficacy|0
4917078|NCT00514813|16935743|P4|Overall Study|Withdrawal by Subject|0
4917079|NCT00514813|16935744|P3|Overall Study|Withdrawal by Subject|0
4917080|NCT00514813|16935745|P2|Overall Study|Withdrawal by Subject|1
4917081|NCT00514813|16935746|P1|Overall Study|Withdrawal by Subject|0
4917082|NCT00514813|16935743|P4|Overall Study|Protocol Violation|0
4917083|NCT00514813|16935744|P3|Overall Study|Protocol Violation|0
4917084|NCT00514813|16935745|P2|Overall Study|Protocol Violation|0
4917085|NCT00514813|16935746|P1|Overall Study|Protocol Violation|1
4917086|NCT00514813|16935743|P4|Overall Study|Adverse Event|0
4917087|NCT00514813|16935744|P3|Overall Study|Adverse Event|2
4917088|NCT00514813|16935745|P2|Overall Study|Adverse Event|2
4917089|NCT00514813|16935746|P1|Overall Study|Adverse Event|0
4917090|NCT00514813|16935743|P4|Overall Study|Study terminated|2
4917091|NCT00514813|16935744|P3|Overall Study|Study terminated|40
4917092|NCT00514813|16935745|P2|Overall Study|Study terminated|74
4917093|NCT00514813|16935746|P1|Overall Study|Study terminated|14
4917094|NCT00514735|16935766|P2|Overall Study|Lost to Follow-up|1
4917095|NCT00514735|16935767|P1|Overall Study|Lost to Follow-up|0
4917096|NCT00514735|16935766|P2|Overall Study|Death|0
4917097|NCT00514735|16935767|P1|Overall Study|Death|1
4917098|NCT00514735|16935766|P2|Overall Study|Withdrawal by Subject|5
4917099|NCT00514735|16935767|P1|Overall Study|Withdrawal by Subject|13
4917100|NCT00514683|16935803|P5|Overall Study|Reason other than listed above|1
4917101|NCT00514683|16935804|P4|Overall Study|Reason other than listed above|0
4917102|NCT00514683|16935805|P3|Overall Study|Reason other than listed above|2
4917103|NCT00514683|16935806|P2|Overall Study|Reason other than listed above|1
4917104|NCT00514683|16935807|P1|Overall Study|Reason other than listed above|0
4917105|NCT00514683|16935803|P5|Overall Study|Withdrawal by Subject|4
4917106|NCT00514683|16935804|P4|Overall Study|Withdrawal by Subject|0
4917107|NCT00514683|16935805|P3|Overall Study|Withdrawal by Subject|1
4917108|NCT00514683|16935806|P2|Overall Study|Withdrawal by Subject|2
4917109|NCT00514683|16935807|P1|Overall Study|Withdrawal by Subject|2
4917110|NCT00514683|16935803|P5|Overall Study|Protocol Violation|0
4917111|NCT00514683|16935804|P4|Overall Study|Protocol Violation|1
4917112|NCT00514683|16935805|P3|Overall Study|Protocol Violation|0
4917113|NCT00514683|16935806|P2|Overall Study|Protocol Violation|1
4917114|NCT00514683|16935807|P1|Overall Study|Protocol Violation|1
4917115|NCT00514683|16935803|P5|Overall Study|Adverse Event|27
4917116|NCT00514683|16935804|P4|Overall Study|Adverse Event|13
4917117|NCT00514683|16935805|P3|Overall Study|Adverse Event|15
4917118|NCT00514683|16935806|P2|Overall Study|Adverse Event|20
4917119|NCT00514683|16935807|P1|Overall Study|Adverse Event|21
4917120|NCT00514683|16935803|P5|Overall Study|Not treated|1
4917121|NCT00514683|16935804|P4|Overall Study|Not treated|0
4917122|NCT00514683|16935805|P3|Overall Study|Not treated|0
4917123|NCT00514683|16935806|P2|Overall Study|Not treated|1
4917124|NCT00514683|16935807|P1|Overall Study|Not treated|2
4917125|NCT00514540|16936003|P1|Second-Line|Physician/Patient Decision|31
4917126|NCT00514540|16936003|P1|First-Line Chemo|Protocol Violation|7
4917127|NCT00514540|16936003|P1|First-Line Chemo|Withdrawal by Subject|1
4917128|NCT00514514|16936014|P3|Extension - 4 Years|Adverse Event|3
4917129|NCT00514514|16936015|P2|Extension - 4 Years|Adverse Event|6
4917130|NCT00514514|16936016|P1|Extension - 4 Years|Adverse Event|9
4917131|NCT00514514|16936014|P3|Extension - 4 Years|Death|6
4917132|NCT00514514|16936015|P2|Extension - 4 Years|Death|3
4917133|NCT00514514|16936016|P1|Extension - 4 Years|Death|8
4917134|NCT00514514|16936014|P3|Extension - 4 Years|Administrative problems|1
4917135|NCT00514514|16936015|P2|Extension - 4 Years|Administrative problems|1
4917136|NCT00514514|16936016|P1|Extension - 4 Years|Administrative problems|3
4917137|NCT00514514|16936014|P3|Extension - 4 Years|Lost to Follow-up|9
4917138|NCT00514514|16936015|P2|Extension - 4 Years|Lost to Follow-up|10
4917139|NCT00514514|16936016|P1|Extension - 4 Years|Lost to Follow-up|12
4917140|NCT00514514|16936014|P3|Extension - 4 Years|Withdrawal by Subject|2
4917141|NCT00514514|16936015|P2|Extension - 4 Years|Withdrawal by Subject|2
4917142|NCT00514514|16936016|P1|Extension - 4 Years|Withdrawal by Subject|5
4917143|NCT00514514|16936014|P3|Randomized - 9 Month|Adverse Event|27
4917144|NCT00514514|16936015|P2|Randomized - 9 Month|Adverse Event|44
4917145|NCT00514514|16936016|P1|Randomized - 9 Month|Adverse Event|25
4917146|NCT00514514|16936014|P3|Randomized - 9 Month|Abnormal laboratory values|1
4917147|NCT00514514|16936015|P2|Randomized - 9 Month|Abnormal laboratory values|3
4917148|NCT00514514|16936016|P1|Randomized - 9 Month|Abnormal laboratory values|0
4917149|NCT00514514|16936014|P3|Randomized - 9 Month|Lack of Efficacy|1
4917150|NCT00514514|16936015|P2|Randomized - 9 Month|Lack of Efficacy|3
4917151|NCT00514514|16936016|P1|Randomized - 9 Month|Lack of Efficacy|2
4917152|NCT00514514|16936014|P3|Randomized - 9 Month|Protocol Violation|0
4917153|NCT00514514|16936015|P2|Randomized - 9 Month|Protocol Violation|1
4917154|NCT00514514|16936016|P1|Randomized - 9 Month|Protocol Violation|1
4917155|NCT00514514|16936014|P3|Randomized - 9 Month|Withdrawal by Subject|5
4917156|NCT00514514|16936015|P2|Randomized - 9 Month|Withdrawal by Subject|7
4917157|NCT00514514|16936016|P1|Randomized - 9 Month|Withdrawal by Subject|7
4917158|NCT00514514|16936014|P3|Randomized - 9 Month|Administrative problems|2
4917159|NCT00514514|16936015|P2|Randomized - 9 Month|Administrative problems|1
4917160|NCT00514514|16936016|P1|Randomized - 9 Month|Administrative problems|1
4917161|NCT00514514|16936014|P3|Randomized - 9 Month|Death|2
4917162|NCT00514514|16936015|P2|Randomized - 9 Month|Death|2
4917163|NCT00514514|16936016|P1|Randomized - 9 Month|Death|3
4917164|NCT00514514|16936014|P3|Pre-phase|Withdrawal by Subject|0
4917165|NCT00514514|16936015|P2|Pre-phase|Withdrawal by Subject|0
4917166|NCT00514514|16936016|P1|Pre-phase|Withdrawal by Subject|66
4917167|NCT00514514|16936014|P3|Pre-phase|Adverse Event|0
4917168|NCT00514514|16936015|P2|Pre-phase|Adverse Event|0
4917169|NCT00514514|16936016|P1|Pre-phase|Adverse Event|137
4917170|NCT00514514|16936014|P3|Pre-phase|Lack of Efficacy|0
4917171|NCT00514514|16936015|P2|Pre-phase|Lack of Efficacy|0
4917172|NCT00514514|16936016|P1|Pre-phase|Lack of Efficacy|35
4917173|NCT00514514|16936014|P3|Pre-phase|abnormal lab values|0
4917174|NCT00514514|16936015|P2|Pre-phase|abnormal lab values|0
4917175|NCT00514514|16936016|P1|Pre-phase|abnormal lab values|23
4917176|NCT00514514|16936014|P3|Pre-phase|Lost to Follow-up|0
4917177|NCT00514514|16936015|P2|Pre-phase|Lost to Follow-up|0
4917178|NCT00514514|16936016|P1|Pre-phase|Lost to Follow-up|2
4917179|NCT00514514|16936014|P3|Pre-phase|abnormal test procedure results|0
4917180|NCT00514514|16936015|P2|Pre-phase|abnormal test procedure results|0
4917181|NCT00514514|16936016|P1|Pre-phase|abnormal test procedure results|15
4917182|NCT00514514|16936014|P3|Pre-phase|condition no longer requires study drug|0
4917183|NCT00514514|16936015|P2|Pre-phase|condition no longer requires study drug|0
4917184|NCT00514514|16936016|P1|Pre-phase|condition no longer requires study drug|7
4917185|NCT00514514|16936014|P3|Pre-phase|Protocol Violation|0
4917186|NCT00514514|16936015|P2|Pre-phase|Protocol Violation|0
4917187|NCT00514514|16936016|P1|Pre-phase|Protocol Violation|6
4917188|NCT00514514|16936014|P3|Pre-phase|administrative problems|0
4917189|NCT00514514|16936015|P2|Pre-phase|administrative problems|0
4917190|NCT00514514|16936016|P1|Pre-phase|administrative problems|2
4917191|NCT00514514|16936014|P3|Pre-phase|Death|0
4917192|NCT00514514|16936015|P2|Pre-phase|Death|0
4917193|NCT00514514|16936016|P1|Pre-phase|Death|10
4917194|NCT00514449|16936068|P2|Overall Study|Lost to Follow-up|0
4917195|NCT00514449|16936069|P1|Overall Study|Lost to Follow-up|1
4917196|NCT00514449|16936068|P2|Overall Study|Protocol Violation|2
4917197|NCT00514449|16936069|P1|Overall Study|Protocol Violation|1
4917198|NCT00514449|16936068|P2|Overall Study|Withdrawal by Subject|2
4917199|NCT00514449|16936069|P1|Overall Study|Withdrawal by Subject|1
4917200|NCT00514020|16936093|P1|Overall Study|"patients moved to the no tx group"|6
4917201|NCT00514020|16936093|P1|Overall Study|patient went to radiation treatment|1
4917202|NCT00514020|16936093|P1|Overall Study|other complicating disease|2
4917203|NCT00514020|16936093|P1|Overall Study|disease progression|9
4917204|NCT00514020|16936093|P1|Overall Study|Physician Decision|1
4917205|NCT00514020|16936093|P1|Overall Study|Withdrawal by Subject|3
4917206|NCT00514020|16936093|P1|Overall Study|Adverse Event|6
4917207|NCT00513708|16936147|P3|Overall Study|Lost to Follow-up|4
4917208|NCT00513708|16936148|P2|Overall Study|Lost to Follow-up|4
4917209|NCT00513708|16936149|P1|Overall Study|Lost to Follow-up|4
4917210|NCT00513695|16936163|P1|Overall Study|Progression prior to surgery|3
4917211|NCT00513695|16936163|P1|Overall Study|Discontinued therapy|2
4917212|NCT00513682|16936172|P1|Washout Phase|Adverse Event|2
4917213|NCT00513604|16936202|P5|Overall Study|Death during treatment|0
4917214|NCT00513604|16936203|P4|Overall Study|Death during treatment|0
4917215|NCT00513604|16936204|P3|Overall Study|Death during treatment|2
4917216|NCT00513604|16936205|P2|Overall Study|Death during treatment|3
4917217|NCT00513604|16936206|P1|Overall Study|Death during treatment|0
4917218|NCT00513604|16936202|P5|Overall Study|Not treated|0
4917219|NCT00513604|16936203|P4|Overall Study|Not treated|0
4917220|NCT00513604|16936204|P3|Overall Study|Not treated|1
4917221|NCT00513604|16936205|P2|Overall Study|Not treated|0
4917222|NCT00513604|16936206|P1|Overall Study|Not treated|2
4917223|NCT00513500|16936240|P2|Overall Study|Hospitalized|14
4917224|NCT00513500|16936241|P1|Overall Study|Hospitalized|4
4917225|NCT00513500|16936240|P2|Overall Study|Death|1
4917226|NCT00513500|16936241|P1|Overall Study|Death|2
4917227|NCT00513500|16936240|P2|Overall Study|Lost to Follow-up|39
4917228|NCT00513500|16936241|P1|Overall Study|Lost to Follow-up|35
4917229|NCT00513474|16936253|P2|Overall Study|Participant Withdrew Consent|0
4917230|NCT00513474|16936254|P1|Overall Study|Participant Withdrew Consent|1
4917231|NCT00513474|16936253|P2|Overall Study|Death|9
4917232|NCT00513474|16936254|P1|Overall Study|Death|6
4917233|NCT00513409|16936310|P2|Overall Study|Visit 3 not done|2
4917234|NCT00513409|16936311|P1|Overall Study|Visit 3 not done|1
4917235|NCT00513409|16936310|P2|Overall Study|Physician Decision|0
4917236|NCT00513409|16936311|P1|Overall Study|Physician Decision|1
4917237|NCT00513409|16936310|P2|Overall Study|Lost to Follow-up|1
4917238|NCT00513409|16936311|P1|Overall Study|Lost to Follow-up|0
4917239|NCT00513409|16936310|P2|Overall Study|Withdrawal by Subject|2
4917240|NCT00513409|16936311|P1|Overall Study|Withdrawal by Subject|0
4917241|NCT00513409|16936310|P2|Overall Study|Adverse Event|1
4917242|NCT00513409|16936311|P1|Overall Study|Adverse Event|0
4917243|NCT00513357|16936367|P2|Overall Study|Disease Progression|1
4917244|NCT00513357|16936368|P1|Overall Study|Disease Progression|2
4917245|NCT00513357|16936367|P2|Overall Study|Withdrawal by Subject|4
4917246|NCT00513357|16936368|P1|Overall Study|Withdrawal by Subject|5
4917247|NCT00513357|16936367|P2|Overall Study|Death|0
4917248|NCT00513357|16936368|P1|Overall Study|Death|2
4917249|NCT00513357|16936367|P2|Overall Study|Adverse Event|2
4917250|NCT00513357|16936368|P1|Overall Study|Adverse Event|4
4917251|NCT00513357|16936367|P2|Overall Study|did not receive allocated placebo|3
4917252|NCT00513357|16936368|P1|Overall Study|did not receive allocated placebo|2
4917253|NCT00513305|16936387|P2|Overall Study|Sponsor Decision|2
4917254|NCT00513305|16936388|P1|Overall Study|Sponsor Decision|0
4917255|NCT00513305|16936387|P2|Overall Study|Persistent hypocellularity|1
4917256|NCT00513305|16936388|P1|Overall Study|Persistent hypocellularity|0
4917257|NCT00513305|16936387|P2|Overall Study|Physician Decision|0
4917258|NCT00513305|16936388|P1|Overall Study|Physician Decision|1
4917259|NCT00513305|16936387|P2|Overall Study|Hematologic counts did not recover|0
4917260|NCT00513305|16936388|P1|Overall Study|Hematologic counts did not recover|1
4917261|NCT00513305|16936387|P2|Overall Study|Eligible for stem cell transplant|0
4917262|NCT00513305|16936388|P1|Overall Study|Eligible for stem cell transplant|1
4917263|NCT00513305|16936387|P2|Overall Study|Disease progression|5
4917264|NCT00513305|16936388|P1|Overall Study|Disease progression|8
4917265|NCT00513305|16936387|P2|Overall Study|Withdrawal by Subject|2
4917266|NCT00513305|16936388|P1|Overall Study|Withdrawal by Subject|1
4917267|NCT00513305|16936387|P2|Overall Study|Lack of Efficacy|13
4917268|NCT00513305|16936388|P1|Overall Study|Lack of Efficacy|8
4917269|NCT00513305|16936387|P2|Overall Study|Death (through Consolidation Treatment)|2
4917270|NCT00513305|16936388|P1|Overall Study|Death (through Consolidation Treatment)|2
4917271|NCT00513305|16936387|P2|Overall Study|Adverse Event|2
4917272|NCT00513305|16936388|P1|Overall Study|Adverse Event|6
4917273|NCT00513240|16936431|P2|Overall Study|Withdrawal by Subject|4
4917274|NCT00513240|16936432|P1|Overall Study|Withdrawal by Subject|7
4917275|NCT00513240|16936431|P2|Overall Study|Death|3
4917276|NCT00513240|16936432|P1|Overall Study|Death|3
4917277|NCT00513240|16936431|P2|Overall Study|Did not have intended surgery|0
4917278|NCT00513240|16936432|P1|Overall Study|Did not have intended surgery|3
4917279|NCT00513071|16936445|P1|Overall Study|Physician Decision|3
4917280|NCT00513071|16936445|P1|Overall Study|Withdrawal by Subject|1
4917281|NCT00513071|16936445|P1|Overall Study|Adverse Event|1
4917282|NCT00513019|16936457|P2|Overall Study|Withdrawal by Subject|5
4917283|NCT00513019|16936458|P1|Overall Study|Withdrawal by Subject|4
4917284|NCT00513019|16936457|P2|Overall Study|Adverse Event|0
4917285|NCT00513019|16936458|P1|Overall Study|Adverse Event|1
4917286|NCT00512902|16936464|P1|Overall Study|Lost to Follow-up|1
4917287|NCT00512902|16936464|P1|Overall Study|Adverse Event|7
4917288|NCT00512798|16936479|P2|Overall Study|Withdrawal by Subject|0
4917289|NCT00512798|16936480|P1|Overall Study|Withdrawal by Subject|3
4917290|NCT00512798|16936479|P2|Overall Study|Progression of disease|20
4917291|NCT00512798|16936480|P1|Overall Study|Progression of disease|14
4917292|NCT00512798|16936479|P2|Overall Study|Adverse Event|4
4917293|NCT00512798|16936480|P1|Overall Study|Adverse Event|2
4917294|NCT00512798|16936479|P2|Overall Study|Death|3
4917295|NCT00512798|16936480|P1|Overall Study|Death|0
4917296|NCT00512707|16936491|P2|Overall Study|Unable to tolerate the smell of the gel|0
4917297|NCT00512707|16936492|P1|Overall Study|Unable to tolerate the smell of the gel|1
4917298|NCT00512707|16936491|P2|Overall Study|Developed a hematocrit exceeding 0.54|0
4917299|NCT00512707|16936492|P1|Overall Study|Developed a hematocrit exceeding 0.54|2
4917300|NCT00512707|16936491|P2|Overall Study|Developed skin irritation|1
4917301|NCT00512707|16936492|P1|Overall Study|Developed skin irritation|2
4917302|NCT00512707|16936491|P2|Overall Study|Lost to Follow-up|11
4917303|NCT00512707|16936492|P1|Overall Study|Lost to Follow-up|5
4917304|NCT00512252|16936542|P3|Overall Study|Death|1
4917305|NCT00512252|16936543|P2|Overall Study|Death|0
4917306|NCT00512252|16936544|P1|Overall Study|Death|0
4917307|NCT00512252|16936542|P3|Overall Study|Protocol Violation|1
4917308|NCT00512252|16936543|P2|Overall Study|Protocol Violation|0
4917309|NCT00512252|16936544|P1|Overall Study|Protocol Violation|0
4917310|NCT00512252|16936542|P3|Overall Study|Lost to Follow-up|1
4917311|NCT00512252|16936543|P2|Overall Study|Lost to Follow-up|0
4917312|NCT00512252|16936544|P1|Overall Study|Lost to Follow-up|0
4917313|NCT00512148|16936572|P1|Primay Study Period|Withdrawal by Subject|1
4917314|NCT00512096|16936578|P1|Overall Study|Lack of Efficacy|3
4917315|NCT00512096|16936578|P1|Overall Study|Withdrawal by Subject|2
4917316|NCT00512096|16936578|P1|Overall Study|Adverse Event|2
4917317|NCT00511901|16936606|P2|Overall Study|Withdrawal by Subject|3
4917318|NCT00511901|16936607|P1|Overall Study|Withdrawal by Subject|1
4917319|NCT00511875|16936629|P2|Overall Study|Missing variables|0
4917320|NCT00511875|16936630|P1|Overall Study|Missing variables|1
4917321|NCT00511875|16936629|P2|Overall Study|Lost to Follow-up|0
4917322|NCT00511875|16936630|P1|Overall Study|Lost to Follow-up|4
4917323|NCT00511836|16936670|P2|Double-blind Period|Lost to Follow-up|0
4917324|NCT00511836|16936671|P1|Double-blind Period|Lost to Follow-up|1
4917325|NCT00511810|16936688|P2|Overall Study|Refused second scn|1
4917326|NCT00511810|16936689|P1|Overall Study|Refused second scn|0
4917327|NCT00511810|16936688|P2|Overall Study|Lack of Efficacy|2
4917328|NCT00511810|16936689|P1|Overall Study|Lack of Efficacy|0
4917329|NCT00511810|16936688|P2|Overall Study|Lost to Follow-up|2
4917330|NCT00511810|16936689|P1|Overall Study|Lost to Follow-up|1
4917331|NCT00511797|16936699|P4|Overall Study|Other (moving etc)|2
4917332|NCT00511797|16936700|P3|Overall Study|Other (moving etc)|1
4917333|NCT00511797|16936701|P2|Overall Study|Other (moving etc)|0
4917334|NCT00511797|16936702|P1|Overall Study|Other (moving etc)|1
4917335|NCT00511797|16936699|P4|Overall Study|Partially missing diary|0
4917336|NCT00511797|16936700|P3|Overall Study|Partially missing diary|1
4917337|NCT00511797|16936701|P2|Overall Study|Partially missing diary|0
4917338|NCT00511797|16936702|P1|Overall Study|Partially missing diary|0
4917339|NCT00511797|16936699|P4|Overall Study|Study drug not taken|1
4917340|NCT00511797|16936700|P3|Overall Study|Study drug not taken|0
4917341|NCT00511797|16936701|P2|Overall Study|Study drug not taken|1
4917342|NCT00511797|16936702|P1|Overall Study|Study drug not taken|0
4917343|NCT00511797|16936699|P4|Overall Study|Never dispensed|3
4917344|NCT00511797|16936700|P3|Overall Study|Never dispensed|1
4917345|NCT00511797|16936701|P2|Overall Study|Never dispensed|0
4917346|NCT00511797|16936702|P1|Overall Study|Never dispensed|1
4917347|NCT00511797|16936699|P4|Overall Study|Withdrawal by Subject|2
4917348|NCT00511797|16936700|P3|Overall Study|Withdrawal by Subject|4
4917349|NCT00511797|16936701|P2|Overall Study|Withdrawal by Subject|3
4917350|NCT00511797|16936702|P1|Overall Study|Withdrawal by Subject|3
4917351|NCT00511797|16936699|P4|Overall Study|Protocol Violation|3
4917352|NCT00511797|16936700|P3|Overall Study|Protocol Violation|2
4917353|NCT00511797|16936701|P2|Overall Study|Protocol Violation|2
4917354|NCT00511797|16936702|P1|Overall Study|Protocol Violation|0
4917355|NCT00511797|16936699|P4|Overall Study|Pregnancy|1
4917356|NCT00511797|16936700|P3|Overall Study|Pregnancy|0
4917357|NCT00511797|16936701|P2|Overall Study|Pregnancy|0
4917358|NCT00511797|16936702|P1|Overall Study|Pregnancy|0
4917359|NCT00511797|16936699|P4|Overall Study|Lost to Follow-up|1
4917360|NCT00511797|16936700|P3|Overall Study|Lost to Follow-up|0
4917361|NCT00511797|16936701|P2|Overall Study|Lost to Follow-up|0
4917362|NCT00511797|16936702|P1|Overall Study|Lost to Follow-up|1
4917363|NCT00511797|16936699|P4|Overall Study|Adverse Event|2
4917364|NCT00511797|16936700|P3|Overall Study|Adverse Event|2
4917365|NCT00511797|16936701|P2|Overall Study|Adverse Event|2
4917366|NCT00511797|16936702|P1|Overall Study|Adverse Event|1
4917367|NCT00511667|16936821|P2|Overall Study|Other|1
4917368|NCT00511667|16936822|P1|Overall Study|Other|2
4917369|NCT00511667|16936821|P2|Overall Study|Site terminated|1
4917370|NCT00511667|16936822|P1|Overall Study|Site terminated|6
4917371|NCT00511667|16936821|P2|Overall Study|Withdrawal by Subject|0
4917372|NCT00511667|16936822|P1|Overall Study|Withdrawal by Subject|2
4917373|NCT00511667|16936821|P2|Overall Study|Protocol Violation|1
4917374|NCT00511667|16936822|P1|Overall Study|Protocol Violation|1
4917375|NCT00511667|16936821|P2|Overall Study|Adverse Event|0
4917376|NCT00511667|16936822|P1|Overall Study|Adverse Event|1
4917377|NCT00511472|16936857|P2|Overall Study|Not reported|2
4917378|NCT00511472|16936858|P1|Overall Study|Not reported|2
4917379|NCT00511472|16936857|P2|Overall Study|Laboratory Adverse Event|2
4917380|NCT00511472|16936858|P1|Overall Study|Laboratory Adverse Event|0
4917381|NCT00511472|16936857|P2|Overall Study|Clinical Adverse Event|2
4917382|NCT00511472|16936858|P1|Overall Study|Clinical Adverse Event|1
4917383|NCT00511433|16936877|P2|Overall Study|Other Reason|1
4917384|NCT00511433|16936878|P1|Overall Study|Other Reason|1
4917385|NCT00511433|16936877|P2|Overall Study|Adverse Event|0
4917386|NCT00511433|16936878|P1|Overall Study|Adverse Event|5
4917387|NCT00511355|16936918|P2|Overall Study|Other reason pre-treatment|1
4917388|NCT00511355|16936919|P1|Overall Study|Other reason pre-treatment|0
4917389|NCT00511355|16936918|P2|Overall Study|Withdrawal of informed consent|1
4917390|NCT00511355|16936919|P1|Overall Study|Withdrawal of informed consent|0
4917391|NCT00511355|16936918|P2|Overall Study|Pre-treatment (serious) adverse event|1
4917392|NCT00511355|16936919|P1|Overall Study|Pre-treatment (serious) adverse event|0
4917393|NCT00511355|16936918|P2|Overall Study|Other Reason|1
4917394|NCT00511355|16936919|P1|Overall Study|Other Reason|0
4917395|NCT00511355|16936918|P2|Overall Study|Lost to Follow-up|1
4917396|NCT00511355|16936919|P1|Overall Study|Lost to Follow-up|2
4917397|NCT00511355|16936918|P2|Overall Study|Pregnancy Wish|0
4917398|NCT00511355|16936919|P1|Overall Study|Pregnancy Wish|1
4917399|NCT00511355|16936918|P2|Overall Study|Adverse Event|4
4917400|NCT00511355|16936919|P1|Overall Study|Adverse Event|4
4917401|NCT00511342|16937019|P2|Overall Study|Other Reason|2
4917402|NCT00511342|16937020|P1|Overall Study|Other Reason|2
4917403|NCT00511342|16937019|P2|Overall Study|Lost to Follow-up|5
4917404|NCT00511342|16937020|P1|Overall Study|Lost to Follow-up|1
4917405|NCT00511342|16937019|P2|Overall Study|Pregnancy wish|1
4917406|NCT00511342|16937020|P1|Overall Study|Pregnancy wish|0
4917407|NCT00511342|16937019|P2|Overall Study|Pregnancy|1
4917408|NCT00511342|16937020|P1|Overall Study|Pregnancy|0
4917409|NCT00511342|16937019|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|12
4917410|NCT00511342|16937020|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|8
4917411|NCT00511342|16937019|P2|Overall Study|Unacceptable vaginal bleeding|1
4917412|NCT00511342|16937020|P1|Overall Study|Unacceptable vaginal bleeding|2
4917413|NCT00511238|16937051|P2|Overall Study|various reasons|14
4917414|NCT00511238|16937052|P1|Overall Study|various reasons|4
4917415|NCT00511238|16937051|P2|Overall Study|Progressive Disease|157
4917416|NCT00511238|16937052|P1|Overall Study|Progressive Disease|23
4917417|NCT00511238|16937051|P2|Overall Study|Withdrawal by Subject|22
4917418|NCT00511238|16937052|P1|Overall Study|Withdrawal by Subject|2
4917419|NCT00511238|16937051|P2|Overall Study|Adverse Event|33
4917420|NCT00511238|16937052|P1|Overall Study|Adverse Event|13
4917421|NCT00511199|16937071|P2|Overall Study|Other Reason|37
4917422|NCT00511199|16937072|P1|Overall Study|Other Reason|78
4917423|NCT00511199|16937071|P2|Overall Study|Lost to Follow-up|17
4917424|NCT00511199|16937072|P1|Overall Study|Lost to Follow-up|40
4917425|NCT00511199|16937071|P2|Overall Study|Pregnancy Wish|8
4917426|NCT00511199|16937072|P1|Overall Study|Pregnancy Wish|16
4917427|NCT00511199|16937071|P2|Overall Study|Pregnancy|3
4917428|NCT00511199|16937072|P1|Overall Study|Pregnancy|6
4917429|NCT00511199|16937071|P2|Overall Study|Withdrawal of Informed Consent|4
4917430|NCT00511199|16937072|P1|Overall Study|Withdrawal of Informed Consent|19
4917431|NCT00511199|16937071|P2|Overall Study|Other Adverse Event (AE)/ Serious AE|52
4917432|NCT00511199|16937072|P1|Overall Study|Other Adverse Event (AE)/ Serious AE|227
4917433|NCT00511199|16937071|P2|Overall Study|Unacceptable Vaginal Bleeding|4
4917434|NCT00511199|16937072|P1|Overall Study|Unacceptable Vaginal Bleeding|63
4917435|NCT00511147|16937101|P1|Overall Study|Required platelet transfusion|1
4917436|NCT00511147|16937101|P1|Overall Study|Disease progression|5
4917437|NCT00511147|16937101|P1|Overall Study|Withdrawal by Subject|1
4917438|NCT00511134|16937110|P2|Overall Study|Withdrawal by Subject|2
4917439|NCT00511134|16937111|P1|Overall Study|Withdrawal by Subject|0
4917440|NCT00511108|16937123|P4|Overall Study|Withdrawal by Subject|2
4917441|NCT00511108|16937124|P3|Overall Study|Withdrawal by Subject|3
4917442|NCT00511108|16937125|P2|Overall Study|Withdrawal by Subject|0
4917443|NCT00511108|16937126|P1|Overall Study|Withdrawal by Subject|4
4917444|NCT00511108|16937123|P4|Overall Study|Physician Decision|1
4917445|NCT00511108|16937124|P3|Overall Study|Physician Decision|0
4917446|NCT00511108|16937125|P2|Overall Study|Physician Decision|0
4917447|NCT00511108|16937126|P1|Overall Study|Physician Decision|0
4917448|NCT00511108|16937123|P4|Overall Study|Lost to Follow-up|0
4917449|NCT00511108|16937124|P3|Overall Study|Lost to Follow-up|1
4917450|NCT00511108|16937125|P2|Overall Study|Lost to Follow-up|2
4917451|NCT00511108|16937126|P1|Overall Study|Lost to Follow-up|0
4917452|NCT00511108|16937123|P4|Overall Study|Adverse Event|2
4917453|NCT00511108|16937124|P3|Overall Study|Adverse Event|1
4917454|NCT00511108|16937125|P2|Overall Study|Adverse Event|0
4917455|NCT00511108|16937126|P1|Overall Study|Adverse Event|2
4917456|NCT00511004|16937157|P3|Overall Study|Lost to Follow-up|4
4917457|NCT00511004|16937158|P2|Overall Study|Lost to Follow-up|0
4917458|NCT00511004|16937159|P1|Overall Study|Lost to Follow-up|0
4917459|NCT00510952|16937178|P2|Overall Study|Did Not Receive Study Drug|0
4917460|NCT00510952|16937179|P1|Overall Study|Did Not Receive Study Drug|2
4917461|NCT00510952|16937178|P2|Overall Study|Withdrawal by Subject|7
4917462|NCT00510952|16937179|P1|Overall Study|Withdrawal by Subject|6
4917463|NCT00510952|16937178|P2|Overall Study|Sponsor Decision|0
4917464|NCT00510952|16937179|P1|Overall Study|Sponsor Decision|1
4917465|NCT00510952|16937178|P2|Overall Study|Protocol Violation|4
4917466|NCT00510952|16937179|P1|Overall Study|Protocol Violation|7
4917467|NCT00510952|16937178|P2|Overall Study|Physician Decision|1
4917468|NCT00510952|16937179|P1|Overall Study|Physician Decision|1
4917469|NCT00510952|16937178|P2|Overall Study|Lost to Follow-up|3
4917470|NCT00510952|16937179|P1|Overall Study|Lost to Follow-up|5
4917471|NCT00510952|16937178|P2|Overall Study|Entry Criteria Not Met|1
4917472|NCT00510952|16937179|P1|Overall Study|Entry Criteria Not Met|3
4917473|NCT00510952|16937178|P2|Overall Study|Adverse Event|0
4917474|NCT00510952|16937179|P1|Overall Study|Adverse Event|1
4917475|NCT00510887|16937205|P1|Overall Study|Lost to Follow-up|1
4917476|NCT00510874|16937221|P7|Overall Study|Lost to Follow-up|1
4917477|NCT00510874|16937222|P6|Overall Study|Lost to Follow-up|0
4917478|NCT00510874|16937223|P5|Overall Study|Lost to Follow-up|4
4917479|NCT00510874|16937224|P4|Overall Study|Lost to Follow-up|3
4917480|NCT00510874|16937225|P3|Overall Study|Lost to Follow-up|1
4917481|NCT00510874|16937226|P2|Overall Study|Lost to Follow-up|3
4917482|NCT00510874|16937227|P1|Overall Study|Lost to Follow-up|2
4917483|NCT00510874|16937221|P7|Overall Study|Withdrawal by Subject|0
4917484|NCT00510874|16937222|P6|Overall Study|Withdrawal by Subject|0
4917485|NCT00510874|16937223|P5|Overall Study|Withdrawal by Subject|3
4917486|NCT00510874|16937224|P4|Overall Study|Withdrawal by Subject|0
4917487|NCT00510874|16937225|P3|Overall Study|Withdrawal by Subject|0
4917488|NCT00510874|16937226|P2|Overall Study|Withdrawal by Subject|1
4917489|NCT00510874|16937227|P1|Overall Study|Withdrawal by Subject|1
4917490|NCT00510835|16937330|P3|Overall Study|Withdrawal by Subject|2
4917491|NCT00510835|16937331|P2|Overall Study|Withdrawal by Subject|2
4917492|NCT00510835|16937332|P1|Overall Study|Withdrawal by Subject|6
4917493|NCT00510783|16937358|P2|Overall Study|Protocol Violation|1
4917494|NCT00510783|16937359|P1|Overall Study|Protocol Violation|0
4917495|NCT00510783|16937358|P2|Overall Study|Withdrawal by Subject|3
4917496|NCT00510783|16937359|P1|Overall Study|Withdrawal by Subject|2
4917497|NCT00510783|16937358|P2|Overall Study|Lost to Follow-up|25
4917498|NCT00510783|16937359|P1|Overall Study|Lost to Follow-up|29
4917499|NCT00510718|16937376|P2|Multiple Dose Period: 12 Weeks|Other|1
4917500|NCT00510718|16937377|P1|Multiple Dose Period: 12 Weeks|Other|1
4917501|NCT00510718|16937376|P2|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3
4917502|NCT00510718|16937377|P1|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1
4917503|NCT00510718|16937376|P2|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3
4917504|NCT00510718|16937377|P1|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1
4917505|NCT00510718|16937376|P2|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11
4917506|NCT00510718|16937377|P1|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8
4917507|NCT00510718|16937376|P2|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6
4917508|NCT00510718|16937377|P1|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3
4917509|NCT00510718|16937376|P2|Multiple Dose Period: 12 Weeks|Adverse Event|8
4917510|NCT00510718|16937377|P1|Multiple Dose Period: 12 Weeks|Adverse Event|1
4917511|NCT00510692|16937503|P2|Overall Study|Withdrawal by Subject|0
4917512|NCT00510692|16937504|P1|Overall Study|Withdrawal by Subject|1
4917513|NCT00510692|16937503|P2|Overall Study|Adverse Event|3
4917514|NCT00510692|16937504|P1|Overall Study|Adverse Event|1
4917515|NCT00510653|16937518|P1|Overall Study|Monetary|3
4917516|NCT00510653|16937518|P1|Overall Study|Withdrawal by Subject|8
4917517|NCT00510510|16937525|P3|Overall Study|Protocol Violation|4
4917518|NCT00510510|16937526|P2|Overall Study|Protocol Violation|3
4917519|NCT00510510|16937527|P1|Overall Study|Protocol Violation|0
4917520|NCT00510510|16937525|P3|Overall Study|Lost to Follow-up|1
4917521|NCT00510510|16937526|P2|Overall Study|Lost to Follow-up|0
4917522|NCT00510510|16937527|P1|Overall Study|Lost to Follow-up|0
4917523|NCT00510510|16937525|P3|Overall Study|Withdrawal by Subject|3
4917524|NCT00510510|16937526|P2|Overall Study|Withdrawal by Subject|2
4917525|NCT00510510|16937527|P1|Overall Study|Withdrawal by Subject|1
4917526|NCT00510510|16937525|P3|Overall Study|Subjects no longer requires study drug|2
4917527|NCT00510510|16937526|P2|Overall Study|Subjects no longer requires study drug|0
4917528|NCT00510510|16937527|P1|Overall Study|Subjects no longer requires study drug|0
4917529|NCT00510510|16937525|P3|Overall Study|Lack of Efficacy|1
4917530|NCT00510510|16937526|P2|Overall Study|Lack of Efficacy|1
4917531|NCT00510510|16937527|P1|Overall Study|Lack of Efficacy|0
4917532|NCT00510510|16937525|P3|Overall Study|Adverse Event|6
4917533|NCT00510510|16937526|P2|Overall Study|Adverse Event|3
4917534|NCT00510510|16937527|P1|Overall Study|Adverse Event|4
4917535|NCT00510484|16937545|P2|Wash-out Period|Adverse Event|1
4917536|NCT00510484|16937546|P1|Wash-out Period|Adverse Event|0
4917537|NCT00510458|16937566|P1|Overall Study|Revision|2
4917538|NCT00510458|16937566|P1|Overall Study|Withdrawal by Subject|3
4917539|NCT00510458|16937566|P1|Overall Study|Lost to Follow-up|6
4917540|NCT00510458|16937566|P1|Overall Study|Terminated|14
4917541|NCT00510458|16937566|P1|Overall Study|Death|1
4917542|NCT00510458|16937566|P1|Overall Study|5 year not evaluable/missed|21
4917543|NCT00510289|16937579|P1|Overall Study|Progressed prior to starting drug|2
4917544|NCT00510289|16937579|P1|Overall Study|Lost to Follow-up|1
4917545|NCT00510289|16937579|P1|Overall Study|Refused bone marrow biopsy|2
4917546|NCT00510289|16937579|P1|Overall Study|Withdrawal by Subject|7
4917547|NCT00510276|16937589|P2|Extension Open-Label Phase|Subject Decision|9
4917548|NCT00510276|16937590|P1|Extension Open-Label Phase|Subject Decision|7
4917549|NCT00510276|16937589|P2|Extension Open-Label Phase|Sponsor Decision|0
4917550|NCT00510276|16937590|P1|Extension Open-Label Phase|Sponsor Decision|1
4917551|NCT00510276|16937589|P2|Extension Open-Label Phase|Protocol Violation|1
4917552|NCT00510276|16937590|P1|Extension Open-Label Phase|Protocol Violation|0
4917553|NCT00510276|16937589|P2|Extension Open-Label Phase|Physician Decision|3
4917554|NCT00510276|16937590|P1|Extension Open-Label Phase|Physician Decision|2
4917555|NCT00510276|16937589|P2|Extension Open-Label Phase|Lost to Follow-up|10
4917556|NCT00510276|16937590|P1|Extension Open-Label Phase|Lost to Follow-up|12
4917557|NCT00510276|16937589|P2|Extension Open-Label Phase|Lack of Efficacy|7
4917558|NCT00510276|16937590|P1|Extension Open-Label Phase|Lack of Efficacy|2
4917559|NCT00510276|16937589|P2|Extension Open-Label Phase|Adverse Event|18
4917560|NCT00510276|16937590|P1|Extension Open-Label Phase|Adverse Event|9
4917561|NCT00510276|16937589|P2|Acute Double-Blind Phase|Subject Decision|28
4917562|NCT00510276|16937590|P1|Acute Double-Blind Phase|Subject Decision|26
4917563|NCT00510276|16937589|P2|Acute Double-Blind Phase|Sponsor Decision|1
4917564|NCT00510276|16937590|P1|Acute Double-Blind Phase|Sponsor Decision|2
4917565|NCT00510276|16937589|P2|Acute Double-Blind Phase|Protocol Violation|3
4917566|NCT00510276|16937590|P1|Acute Double-Blind Phase|Protocol Violation|4
4917567|NCT00510276|16937589|P2|Acute Double-Blind Phase|Physician Decision|3
4917568|NCT00510276|16937590|P1|Acute Double-Blind Phase|Physician Decision|0
4917569|NCT00510276|16937589|P2|Acute Double-Blind Phase|Lost to Follow-up|49
4917570|NCT00510276|16937590|P1|Acute Double-Blind Phase|Lost to Follow-up|48
4917571|NCT00510276|16937589|P2|Acute Double-Blind Phase|Lack of Efficacy|4
4917572|NCT00510276|16937590|P1|Acute Double-Blind Phase|Lack of Efficacy|3
4917573|NCT00510276|16937589|P2|Acute Double-Blind Phase|Entry Criteria Not Met|1
4917574|NCT00510276|16937590|P1|Acute Double-Blind Phase|Entry Criteria Not Met|1
4917575|NCT00510276|16937589|P2|Acute Double-Blind Phase|Adverse Event|6
4917576|NCT00510276|16937590|P1|Acute Double-Blind Phase|Adverse Event|21
4917577|NCT00510198|16937684|P2|Overall Study|Withdrawal by Subject|4
4917578|NCT00510198|16937685|P1|Overall Study|Withdrawal by Subject|5
4917579|NCT00510146|16937699|P2|Open-Label Treatment|Sponsor Decision|0
4917580|NCT00510146|16937700|P1|Open-Label Treatment|Sponsor Decision|2
4917581|NCT00510146|16937699|P2|Open-Label Treatment|Clinical Relapse|1
4917582|NCT00510146|16937700|P1|Open-Label Treatment|Clinical Relapse|1
4917583|NCT00510146|16937699|P2|Open-Label Treatment|Withdrawal by Subject|12
4917584|NCT00510146|16937700|P1|Open-Label Treatment|Withdrawal by Subject|24
4917585|NCT00510146|16937699|P2|Open-Label Treatment|Protocol Violation|2
4917586|NCT00510146|16937700|P1|Open-Label Treatment|Protocol Violation|4
4917587|NCT00510146|16937699|P2|Open-Label Treatment|Physician Decision|1
4917588|NCT00510146|16937700|P1|Open-Label Treatment|Physician Decision|3
4917589|NCT00510146|16937699|P2|Open-Label Treatment|Lost to Follow-up|1
4917590|NCT00510146|16937700|P1|Open-Label Treatment|Lost to Follow-up|10
4917591|NCT00510146|16937699|P2|Open-Label Treatment|Lack of Efficacy|0
4917592|NCT00510146|16937700|P1|Open-Label Treatment|Lack of Efficacy|4
4917593|NCT00510146|16937699|P2|Open-Label Treatment|Death|1
4917594|NCT00510146|16937700|P1|Open-Label Treatment|Death|1
4917595|NCT00510146|16937699|P2|Open-Label Treatment|Adverse Event|8
4917596|NCT00510146|16937700|P1|Open-Label Treatment|Adverse Event|22
4917597|NCT00510146|16937699|P2|Double-Blind Treatment|Entry Criteria Not Met|0
4917598|NCT00510146|16937700|P1|Double-Blind Treatment|Entry Criteria Not Met|3
4917599|NCT00510146|16937699|P2|Double-Blind Treatment|Clinical Relapse|1
4917600|NCT00510146|16937700|P1|Double-Blind Treatment|Clinical Relapse|0
4917601|NCT00510146|16937699|P2|Double-Blind Treatment|Withdrawal by Subject|13
4917602|NCT00510146|16937700|P1|Double-Blind Treatment|Withdrawal by Subject|27
4917603|NCT00510146|16937699|P2|Double-Blind Treatment|Protocol Violation|2
4917604|NCT00510146|16937700|P1|Double-Blind Treatment|Protocol Violation|1
4917605|NCT00510146|16937699|P2|Double-Blind Treatment|Physician Decision|0
4917606|NCT00510146|16937700|P1|Double-Blind Treatment|Physician Decision|6
4917607|NCT00510146|16937699|P2|Double-Blind Treatment|Lost to Follow-up|7
4917608|NCT00510146|16937700|P1|Double-Blind Treatment|Lost to Follow-up|3
4917609|NCT00510146|16937699|P2|Double-Blind Treatment|Lack of Efficacy|13
4917610|NCT00510146|16937700|P1|Double-Blind Treatment|Lack of Efficacy|6
4917611|NCT00510146|16937699|P2|Double-Blind Treatment|Adverse Event|13
4917612|NCT00510146|16937700|P1|Double-Blind Treatment|Adverse Event|30
4917613|NCT00510068|16937789|P2|Open-label Period|Abnormal laboratory value (s)|0
4917614|NCT00510068|16937790|P1|Open-label Period|Abnormal laboratory value (s)|1
4917615|NCT00510068|16937789|P2|Open-label Period|Protocol Violation|0
4917616|NCT00510068|16937790|P1|Open-label Period|Protocol Violation|2
4917617|NCT00510068|16937789|P2|Open-label Period|New cancer therapy|0
4917618|NCT00510068|16937790|P1|Open-label Period|New cancer therapy|7
4917619|NCT00510068|16937789|P2|Open-label Period|Death|0
4917620|NCT00510068|16937790|P1|Open-label Period|Death|7
4917621|NCT00510068|16937789|P2|Open-label Period|Administrative problems|0
4917622|NCT00510068|16937790|P1|Open-label Period|Administrative problems|17
4917623|NCT00510068|16937789|P2|Open-label Period|Withdrawal by Subject|0
4917624|NCT00510068|16937790|P1|Open-label Period|Withdrawal by Subject|21
4917625|NCT00510068|16937789|P2|Open-label Period|Adverse Event|0
4917626|NCT00510068|16937790|P1|Open-label Period|Adverse Event|46
4917627|NCT00510068|16937789|P2|Open-label Period|Disease Progression|0
4917628|NCT00510068|16937790|P1|Open-label Period|Disease Progression|124
4917629|NCT00510068|16937789|P2|Double-blind Period|Protocol Violation|0
4917630|NCT00510068|16937790|P1|Double-blind Period|Protocol Violation|6
4917631|NCT00510068|16937789|P2|Double-blind Period|Lost to Follow-up|0
4917632|NCT00510068|16937790|P1|Double-blind Period|Lost to Follow-up|1
4917633|NCT00510068|16937789|P2|Double-blind Period|Abnormal test result (s)|0
4917634|NCT00510068|16937790|P1|Double-blind Period|Abnormal test result (s)|1
4917635|NCT00510068|16937789|P2|Double-blind Period|Death|3
4917636|NCT00510068|16937790|P1|Double-blind Period|Death|4
4917637|NCT00510068|16937789|P2|Double-blind Period|Withdrawal by Subject|6
4917638|NCT00510068|16937790|P1|Double-blind Period|Withdrawal by Subject|8
4917639|NCT00510068|16937789|P2|Double-blind Period|Adverse Event|7
4917640|NCT00510068|16937790|P1|Double-blind Period|Adverse Event|37
4917641|NCT00510068|16937789|P2|Double-blind Period|Final primary analysis|18
4917642|NCT00510068|16937790|P1|Double-blind Period|Final primary analysis|52
4917643|NCT00510068|16937789|P2|Double-blind Period|Disease progression|169
4917644|NCT00510068|16937790|P1|Double-blind Period|Disease progression|98
4917645|NCT00509925|16937831|P2|Overall Study|Personal reasons|1
4917646|NCT00509925|16937832|P1|Overall Study|Personal reasons|0
4917647|NCT00509899|16937880|P8|Overall Study|Lack of Efficacy|0
4917648|NCT00509899|16937881|P7|Overall Study|Lack of Efficacy|0
4917649|NCT00509899|16937882|P6|Overall Study|Lack of Efficacy|1
4917650|NCT00509899|16937883|P5|Overall Study|Lack of Efficacy|0
4917651|NCT00509899|16937884|P4|Overall Study|Lack of Efficacy|0
4917652|NCT00509899|16937885|P3|Overall Study|Lack of Efficacy|2
4917653|NCT00509899|16937886|P2|Overall Study|Lack of Efficacy|0
4917654|NCT00509899|16937887|P1|Overall Study|Lack of Efficacy|1
4917655|NCT00509899|16937880|P8|Overall Study|Death|1
4917656|NCT00509899|16937881|P7|Overall Study|Death|1
4917657|NCT00509899|16937882|P6|Overall Study|Death|1
4917658|NCT00509899|16937883|P5|Overall Study|Death|1
4917659|NCT00509899|16937884|P4|Overall Study|Death|0
4917660|NCT00509899|16937885|P3|Overall Study|Death|3
4917661|NCT00509899|16937886|P2|Overall Study|Death|2
4917662|NCT00509899|16937887|P1|Overall Study|Death|2
4917663|NCT00509899|16937880|P8|Overall Study|Intercurrent Illness|0
4917664|NCT00509899|16937881|P7|Overall Study|Intercurrent Illness|0
4917665|NCT00509899|16937882|P6|Overall Study|Intercurrent Illness|1
4917666|NCT00509899|16937883|P5|Overall Study|Intercurrent Illness|0
4917667|NCT00509899|16937884|P4|Overall Study|Intercurrent Illness|1
4917668|NCT00509899|16937885|P3|Overall Study|Intercurrent Illness|0
4917669|NCT00509899|16937886|P2|Overall Study|Intercurrent Illness|0
4917670|NCT00509899|16937887|P1|Overall Study|Intercurrent Illness|1
4917671|NCT00509899|16937880|P8|Overall Study|Physician Decision|0
4917672|NCT00509899|16937881|P7|Overall Study|Physician Decision|0
4917673|NCT00509899|16937882|P6|Overall Study|Physician Decision|4
4917674|NCT00509899|16937883|P5|Overall Study|Physician Decision|1
4917675|NCT00509899|16937884|P4|Overall Study|Physician Decision|0
4917676|NCT00509899|16937885|P3|Overall Study|Physician Decision|7
4917677|NCT00509899|16937886|P2|Overall Study|Physician Decision|2
4917678|NCT00509899|16937887|P1|Overall Study|Physician Decision|4
4917679|NCT00509899|16937880|P8|Overall Study|Withdrawal by Subject|0
4917680|NCT00509899|16937881|P7|Overall Study|Withdrawal by Subject|0
4917681|NCT00509899|16937882|P6|Overall Study|Withdrawal by Subject|2
4917682|NCT00509899|16937883|P5|Overall Study|Withdrawal by Subject|3
4917683|NCT00509899|16937884|P4|Overall Study|Withdrawal by Subject|0
4917684|NCT00509899|16937885|P3|Overall Study|Withdrawal by Subject|3
4917685|NCT00509899|16937886|P2|Overall Study|Withdrawal by Subject|2
4917686|NCT00509899|16937887|P1|Overall Study|Withdrawal by Subject|6
4917687|NCT00509899|16937880|P8|Overall Study|Unacceptable Toxicity|0
4917688|NCT00509899|16937881|P7|Overall Study|Unacceptable Toxicity|0
4917689|NCT00509899|16937882|P6|Overall Study|Unacceptable Toxicity|0
4917690|NCT00509899|16937883|P5|Overall Study|Unacceptable Toxicity|0
4917691|NCT00509899|16937884|P4|Overall Study|Unacceptable Toxicity|2
4917692|NCT00509899|16937885|P3|Overall Study|Unacceptable Toxicity|0
4917693|NCT00509899|16937886|P2|Overall Study|Unacceptable Toxicity|0
4917694|NCT00509899|16937887|P1|Overall Study|Unacceptable Toxicity|1
4917695|NCT00509899|16937880|P8|Overall Study|Progressive disease|0
4917696|NCT00509899|16937881|P7|Overall Study|Progressive disease|0
4917697|NCT00509899|16937882|P6|Overall Study|Progressive disease|1
4917698|NCT00509899|16937883|P5|Overall Study|Progressive disease|0
4917699|NCT00509899|16937884|P4|Overall Study|Progressive disease|1
4917700|NCT00509899|16937885|P3|Overall Study|Progressive disease|5
4917701|NCT00509899|16937886|P2|Overall Study|Progressive disease|3
4917702|NCT00509899|16937887|P1|Overall Study|Progressive disease|1
4917703|NCT00509821|16937944|P2|Study Period 1 (Induction)|Progressive Disease|1
4917704|NCT00509821|16937945|P1|Study Period 1 (Induction)|Progressive Disease|0
4917705|NCT00509821|16937944|P2|Study Period 1 (Induction)|Adverse Event|2
4917706|NCT00509821|16937945|P1|Study Period 1 (Induction)|Adverse Event|0
4917707|NCT00509821|16937944|P2|Study Period 1 (Induction)|Death|1
4917708|NCT00509821|16937945|P1|Study Period 1 (Induction)|Death|0
4917709|NCT00509795|16937963|P4|Overall Study|Withdrawal by Subject|8
4917710|NCT00509795|16937964|P3|Overall Study|Withdrawal by Subject|7
4917711|NCT00509795|16937965|P2|Overall Study|Withdrawal by Subject|5
4917712|NCT00509795|16937966|P1|Overall Study|Withdrawal by Subject|10
4917713|NCT00509795|16937963|P4|Overall Study|Protocol Violation|1
4917714|NCT00509795|16937964|P3|Overall Study|Protocol Violation|3
4917715|NCT00509795|16937965|P2|Overall Study|Protocol Violation|0
4917716|NCT00509795|16937966|P1|Overall Study|Protocol Violation|3
4917717|NCT00509795|16937963|P4|Overall Study|OTHER|1
4917718|NCT00509795|16937964|P3|Overall Study|OTHER|4
4917719|NCT00509795|16937965|P2|Overall Study|OTHER|0
4917720|NCT00509795|16937966|P1|Overall Study|OTHER|1
4917721|NCT00509795|16937963|P4|Overall Study|Lost to Follow-up|4
4917722|NCT00509795|16937964|P3|Overall Study|Lost to Follow-up|4
4917723|NCT00509795|16937965|P2|Overall Study|Lost to Follow-up|2
4917724|NCT00509795|16937966|P1|Overall Study|Lost to Follow-up|1
4917725|NCT00509795|16937963|P4|Overall Study|Lack of Efficacy|2
4917726|NCT00509795|16937964|P3|Overall Study|Lack of Efficacy|2
4917727|NCT00509795|16937965|P2|Overall Study|Lack of Efficacy|0
4917728|NCT00509795|16937966|P1|Overall Study|Lack of Efficacy|0
4917729|NCT00509795|16937963|P4|Overall Study|Death|7
4917730|NCT00509795|16937964|P3|Overall Study|Death|2
4917731|NCT00509795|16937965|P2|Overall Study|Death|1
4917732|NCT00509795|16937966|P1|Overall Study|Death|3
4917733|NCT00509795|16937963|P4|Overall Study|Adverse Event|4
4917734|NCT00509795|16937964|P3|Overall Study|Adverse Event|5
4917735|NCT00509795|16937965|P2|Overall Study|Adverse Event|3
4917736|NCT00509795|16937966|P1|Overall Study|Adverse Event|4
4917737|NCT00509769|16937997|P1|Overall Study|Use of prohibited therapies during study|1
4917738|NCT00509769|16937997|P1|Overall Study|Physician Decision|8
4917739|NCT00509769|16937997|P1|Overall Study|Patient's decision|1
4917740|NCT00509769|16937997|P1|Overall Study|Adverse Event|4
4917741|NCT00509769|16937997|P1|Overall Study|Progressive disease|77
4917742|NCT00509600|16938016|P1|Overall Study|Adverse Event|1
4917743|NCT00509366|16938095|P5|Overall Study|Not Treated (Screen Failure)|0
4917744|NCT00509366|16938096|P4|Overall Study|Not Treated (Screen Failure)|0
4917745|NCT00509366|16938097|P3|Overall Study|Not Treated (Screen Failure)|1
4917746|NCT00509366|16938098|P2|Overall Study|Not Treated (Screen Failure)|1
4917747|NCT00509366|16938099|P1|Overall Study|Not Treated (Screen Failure)|1
4917748|NCT00509262|16938123|P2|Overall Study|Withdrawal by Subject|11
4917749|NCT00509262|16938124|P1|Overall Study|Withdrawal by Subject|24
4917750|NCT00509262|16938123|P2|Overall Study|Protocol Violation|2
4917751|NCT00509262|16938124|P1|Overall Study|Protocol Violation|2
4917752|NCT00509262|16938123|P2|Overall Study|Physician Decision|3
4917753|NCT00509262|16938124|P1|Overall Study|Physician Decision|1
4917754|NCT00509262|16938123|P2|Overall Study|Lost to Follow-up|6
4917755|NCT00509262|16938124|P1|Overall Study|Lost to Follow-up|1
4917756|NCT00509262|16938123|P2|Overall Study|Lack of Efficacy|0
4917757|NCT00509262|16938124|P1|Overall Study|Lack of Efficacy|1
4917758|NCT00509262|16938123|P2|Overall Study|Other|2
4917759|NCT00509262|16938124|P1|Overall Study|Other|2
4917760|NCT00509262|16938123|P2|Overall Study|Adverse Event|18
4917761|NCT00509262|16938124|P1|Overall Study|Adverse Event|16
4917762|NCT00509236|16938142|P2|Overall Study|Scheduled Kidney Transplant|0
4917763|NCT00509236|16938143|P1|Overall Study|Scheduled Kidney Transplant|1
4917764|NCT00509236|16938142|P2|Overall Study|Excluded Medication|1
4917765|NCT00509236|16938143|P1|Overall Study|Excluded Medication|1
4917766|NCT00509236|16938142|P2|Overall Study|Protocol Violation|0
4917767|NCT00509236|16938143|P1|Overall Study|Protocol Violation|3
4917768|NCT00509236|16938142|P2|Overall Study|Withdrawal by Subject|10
4917769|NCT00509236|16938143|P1|Overall Study|Withdrawal by Subject|5
4917770|NCT00509236|16938142|P2|Overall Study|Adverse Event|9
4917771|NCT00509236|16938143|P1|Overall Study|Adverse Event|7
4917772|NCT00509223|16938158|P2|Overall Study|Did not meet revised inclusion criteria|62
4917773|NCT00509223|16938159|P1|Overall Study|Did not meet revised inclusion criteria|56
4917774|NCT00509223|16938158|P2|Overall Study|Including: subject change of address|2
4917775|NCT00509223|16938159|P1|Overall Study|Including: subject change of address|5
4917776|NCT00509223|16938158|P2|Overall Study|Withdrawal by Subject|6
4917777|NCT00509223|16938159|P1|Overall Study|Withdrawal by Subject|25
4917778|NCT00509223|16938158|P2|Overall Study|Adverse Event|1
4917779|NCT00509223|16938159|P1|Overall Study|Adverse Event|1
4917780|NCT00509223|16938158|P2|Overall Study|Lost to Follow-up|1
4917781|NCT00509223|16938159|P1|Overall Study|Lost to Follow-up|1
4917782|NCT00509106|16938191|P2|Overall Study|Death|6
4917783|NCT00509106|16938192|P1|Overall Study|Death|6
4917784|NCT00509106|16938191|P2|Overall Study|Other|0
4917785|NCT00509106|16938192|P1|Overall Study|Other|1
4917786|NCT00509106|16938191|P2|Overall Study|Lost to Follow-up|10
4917787|NCT00509106|16938192|P1|Overall Study|Lost to Follow-up|16
4917788|NCT00509106|16938191|P2|Overall Study|Withdrew consent|8
4917789|NCT00509106|16938192|P1|Overall Study|Withdrew consent|4
4917790|NCT00509106|16938191|P2|Overall Study|At the request of sponsor/investigator|2
4917791|NCT00509106|16938192|P1|Overall Study|At the request of sponsor/investigator|1
4917792|NCT00509106|16938191|P2|Overall Study|Noncompliance|1
4917793|NCT00509106|16938192|P1|Overall Study|Noncompliance|0
4917794|NCT00509106|16938191|P2|Overall Study|Adverse Event|2
4917795|NCT00509106|16938192|P1|Overall Study|Adverse Event|3
4917796|NCT00509093|16938198|P1|Overall Study|Physician Decision|1
4917797|NCT00509093|16938198|P1|Overall Study|Withdrawal by Subject|3
4917798|NCT00509093|16938198|P1|Overall Study|Transformed into MDS|1
4917799|NCT00509093|16938198|P1|Overall Study|Disease Progression|9
4917800|NCT00509093|16938198|P1|Overall Study|Adverse Event|10
4917801|NCT00509067|16938208|P2|Overall Study|Protocol Violation|3
4917802|NCT00509067|16938209|P1|Overall Study|Protocol Violation|0
4917803|NCT00509067|16938208|P2|Overall Study|Adverse Event|1
4917804|NCT00509067|16938209|P1|Overall Study|Adverse Event|3
4917805|NCT00509067|16938208|P2|Overall Study|Lost to Follow-up|1
4917806|NCT00509067|16938209|P1|Overall Study|Lost to Follow-up|1
4917807|NCT00509028|16938228|P2|Overall Study|Non-compliance|1
4917808|NCT00509028|16938229|P1|Overall Study|Non-compliance|2
4917809|NCT00509028|16938228|P2|Overall Study|Protocol Violation|2
4917810|NCT00509028|16938229|P1|Overall Study|Protocol Violation|4
4917811|NCT00509028|16938228|P2|Overall Study|Lost to Follow-up|1
4917812|NCT00509028|16938229|P1|Overall Study|Lost to Follow-up|0
4917813|NCT00509028|16938228|P2|Overall Study|Withdrawal by Subject|3
4917814|NCT00509028|16938229|P1|Overall Study|Withdrawal by Subject|4
4917815|NCT00509028|16938228|P2|Overall Study|Adverse Event|0
4917816|NCT00509028|16938229|P1|Overall Study|Adverse Event|2
4917817|NCT00508924|16938269|P4|Overall Study|Protocol Violation|1
4917818|NCT00508924|16938270|P3|Overall Study|Protocol Violation|1
4917819|NCT00508924|16938271|P2|Overall Study|Protocol Violation|0
4917820|NCT00508924|16938272|P1|Overall Study|Protocol Violation|0
4917821|NCT00508872|16938286|P1|Overall Study|Physician Decision|1
4917822|NCT00508872|16938286|P1|Overall Study|Lost to Follow-up|1
4917823|NCT00508820|16938292|P2|Overall Study|Protocol-specified Criteria|12
4917824|NCT00508820|16938293|P1|Overall Study|Protocol-specified Criteria|3
4917825|NCT00508820|16938292|P2|Overall Study|Requirement for alternative therapy|15
4917826|NCT00508820|16938293|P1|Overall Study|Requirement for alternative therapy|7
4917827|NCT00508820|16938292|P2|Overall Study|Noncompliance|0
4917828|NCT00508820|16938293|P1|Overall Study|Noncompliance|1
4917829|NCT00508820|16938292|P2|Overall Study|Other|2
4917830|NCT00508820|16938293|P1|Overall Study|Other|11
4917831|NCT00508820|16938292|P2|Overall Study|Withdrawal by Subject|12
4917832|NCT00508820|16938293|P1|Overall Study|Withdrawal by Subject|10
4917833|NCT00508820|16938292|P2|Overall Study|Protocol Violation|0
4917834|NCT00508820|16938293|P1|Overall Study|Protocol Violation|2
4917835|NCT00508820|16938292|P2|Overall Study|Pregnancy|2
4917836|NCT00508820|16938293|P1|Overall Study|Pregnancy|0
4917837|NCT00508820|16938292|P2|Overall Study|Physician Decision|2
4917838|NCT00508820|16938293|P1|Overall Study|Physician Decision|8
4917839|NCT00508820|16938292|P2|Overall Study|Lost to Follow-up|1
4917840|NCT00508820|16938293|P1|Overall Study|Lost to Follow-up|1
4917841|NCT00508820|16938292|P2|Overall Study|Death|8
4917842|NCT00508820|16938293|P1|Overall Study|Death|6
4917843|NCT00508820|16938292|P2|Overall Study|Adverse Event|10
4917844|NCT00508820|16938293|P1|Overall Study|Adverse Event|6
4917845|NCT00508755|16938303|P1|Overall Study|Withdrawal by Subject|1
4917846|NCT00508742|16938311|P2|Period 3: Toddler Dose|Other|4
4917847|NCT00508742|16938312|P1|Period 3: Toddler Dose|Other|5
4917848|NCT00508742|16938311|P2|Period 3: Toddler Dose|Parent/Legal Guardian Request|8
4917849|NCT00508742|16938312|P1|Period 3: Toddler Dose|Parent/Legal Guardian Request|17
4917850|NCT00508742|16938311|P2|Period 3: Toddler Dose|Lost to Follow-up|3
4917851|NCT00508742|16938312|P1|Period 3: Toddler Dose|Lost to Follow-up|2
4917852|NCT00508742|16938311|P2|Period 3: Toddler Dose|Adverse Event|0
4917853|NCT00508742|16938312|P1|Period 3: Toddler Dose|Adverse Event|1
4917854|NCT00508742|16938311|P2|Period 2: After Infant Series|Other|1
4917855|NCT00508742|16938312|P1|Period 2: After Infant Series|Other|2
4917856|NCT00508742|16938311|P2|Period 2: After Infant Series|Failed to Return|0
4917857|NCT00508742|16938312|P1|Period 2: After Infant Series|Failed to Return|1
4917858|NCT00508742|16938311|P2|Period 2: After Infant Series|Parent/Legal Guardian Request|3
4917859|NCT00508742|16938312|P1|Period 2: After Infant Series|Parent/Legal Guardian Request|0
4917860|NCT00508742|16938311|P2|Period 2: After Infant Series|Protocol Violation|0
4917861|NCT00508742|16938312|P1|Period 2: After Infant Series|Protocol Violation|1
4917862|NCT00508742|16938311|P2|Period 2: After Infant Series|Lost to Follow-up|1
4917863|NCT00508742|16938312|P1|Period 2: After Infant Series|Lost to Follow-up|1
4917864|NCT00508742|16938311|P2|Period 2: After Infant Series|Adverse Event|6
4917865|NCT00508742|16938312|P1|Period 2: After Infant Series|Adverse Event|2
4917866|NCT00508742|16938311|P2|Period 1: Infant Series|Other|1
4917867|NCT00508742|16938312|P1|Period 1: Infant Series|Other|4
4917868|NCT00508742|16938311|P2|Period 1: Infant Series|Physician Decision|0
4917869|NCT00508742|16938312|P1|Period 1: Infant Series|Physician Decision|1
4917870|NCT00508742|16938311|P2|Period 1: Infant Series|Parent/Legal Guardian Request|40
4917871|NCT00508742|16938312|P1|Period 1: Infant Series|Parent/Legal Guardian Request|31
4917872|NCT00508742|16938311|P2|Period 1: Infant Series|Protocol Violation|0
4917873|NCT00508742|16938312|P1|Period 1: Infant Series|Protocol Violation|1
4917874|NCT00508742|16938311|P2|Period 1: Infant Series|Adverse Event|4
4917875|NCT00508742|16938312|P1|Period 1: Infant Series|Adverse Event|5
4917876|NCT00508651|16938337|P2|Overall Study|Withdrawal by Subject|1
4917877|NCT00508651|16938338|P1|Overall Study|Withdrawal by Subject|1
4917878|NCT00508651|16938337|P2|Overall Study|Lost to Follow-up|1
4917879|NCT00508651|16938338|P1|Overall Study|Lost to Follow-up|3
4917880|NCT00508482|16938419|P3|at the 4th Week of Follow-up|Lost to Follow-up|1
4917881|NCT00508482|16938420|P2|at the 4th Week of Follow-up|Lost to Follow-up|6
4917882|NCT00508482|16938421|P1|at the 4th Week of Follow-up|Lost to Follow-up|20
4917883|NCT00508482|16938419|P3|Over 4 Weeks of Treatment|Lost to Follow-up|16
4917884|NCT00508482|16938420|P2|Over 4 Weeks of Treatment|Lost to Follow-up|10
4917885|NCT00508482|16938421|P1|Over 4 Weeks of Treatment|Lost to Follow-up|12
4917886|NCT00508482|16938419|P3|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4
4917887|NCT00508482|16938420|P2|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7
4917888|NCT00508482|16938421|P1|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9
4917889|NCT00508404|16938465|P1|Overall Study|Other - Not Specified|3
4917890|NCT00508404|16938465|P1|Overall Study|Lost to Follow-up|2
4917891|NCT00508404|16938465|P1|Overall Study|Protocol-specified Criteria|2
4917892|NCT00508404|16938465|P1|Overall Study|Withdrawal by Subject|3
4917893|NCT00508404|16938465|P1|Overall Study|Physician Decision|2
4917894|NCT00508404|16938465|P1|Overall Study|Death|16
4917895|NCT00508404|16938465|P1|Overall Study|Adverse Event|2
4917896|NCT00508404|16938465|P1|Overall Study|Ongoing at Data Cut-off|12
4917897|NCT00508391|16938492|P2|Second Treatment|Withdrawal by Subject|0
4917898|NCT00508391|16938493|P1|Second Treatment|Withdrawal by Subject|2
4917899|NCT00508391|16938492|P2|First Treatment|Withdrawal by Subject|3
4917900|NCT00508391|16938493|P1|First Treatment|Withdrawal by Subject|6
4917901|NCT00508274|16938513|P1|Overall Study|Withdrawal by Subject|1
4917902|NCT00508274|16938513|P1|Overall Study|Adverse Event|1
4917903|NCT00508261|16938526|P4|Overall Study|Lost to Follow-up|1
4917904|NCT00508261|16938527|P3|Overall Study|Lost to Follow-up|1
4917905|NCT00508261|16938528|P2|Overall Study|Lost to Follow-up|1
4917906|NCT00508261|16938529|P1|Overall Study|Lost to Follow-up|0
4917907|NCT00508261|16938526|P4|Overall Study|Migrated/ moved from study area|0
4917908|NCT00508261|16938527|P3|Overall Study|Migrated/ moved from study area|0
4917909|NCT00508261|16938528|P2|Overall Study|Migrated/ moved from study area|1
4917910|NCT00508261|16938529|P1|Overall Study|Migrated/ moved from study area|0
4917911|NCT00508261|16938526|P4|Overall Study|Withdrawal by Subject|0
4917912|NCT00508261|16938527|P3|Overall Study|Withdrawal by Subject|4
4917913|NCT00508261|16938528|P2|Overall Study|Withdrawal by Subject|4
4917914|NCT00508261|16938529|P1|Overall Study|Withdrawal by Subject|3
4917915|NCT00508261|16938526|P4|Overall Study|Serious Adverse Event|0
4917916|NCT00508261|16938527|P3|Overall Study|Serious Adverse Event|0
4917917|NCT00508261|16938528|P2|Overall Study|Serious Adverse Event|1
4917918|NCT00508261|16938529|P1|Overall Study|Serious Adverse Event|0
4917919|NCT00508261|16938526|P4|Overall Study|Other|0
4917920|NCT00508261|16938527|P3|Overall Study|Other|1
4917921|NCT00508261|16938528|P2|Overall Study|Other|1
4917922|NCT00508261|16938529|P1|Overall Study|Other|0
4917923|NCT00508157|16938669|P2|Overall Study|Other known cause|1
4917924|NCT00508157|16938670|P1|Overall Study|Other known cause|0
4917925|NCT00508157|16938669|P2|Overall Study|Subject no longer met study criteria|1
4917926|NCT00508157|16938670|P1|Overall Study|Subject no longer met study criteria|0
4917927|NCT00508157|16938669|P2|Overall Study|Lost to Follow-up|0
4917928|NCT00508157|16938670|P1|Overall Study|Lost to Follow-up|1
4917929|NCT00508157|16938669|P2|Overall Study|Subject Withdrew Consent|0
4917930|NCT00508157|16938670|P1|Overall Study|Subject Withdrew Consent|1
4917931|NCT00508157|16938669|P2|Overall Study|Adverse Event|1
4917932|NCT00508157|16938670|P1|Overall Study|Adverse Event|0
4917933|NCT00508144|16938692|P1|Overall Study|Death|5
4917934|NCT00508144|16938692|P1|Overall Study|Not eligible|6
4917935|NCT00508027|16938731|P1|Dose Level 2|Withdrawal by Subject|2
4917936|NCT00508027|16938731|P1|Dose Level 2|Lost to Follow-up|2
4917937|NCT00508027|16938731|P1|Dose Level 1|Physician Decision|2
4917938|NCT00508027|16938731|P1|Dose Level 1|Withdrawal by Subject|2
4917939|NCT00508027|16938731|P1|Dose Level 1|Lost to Follow-up|4
4917940|NCT00508001|16938772|P3|Overall Study|Withdrawal by Subject|1
4917941|NCT00508001|16938773|P2|Overall Study|Withdrawal by Subject|4
4917942|NCT00508001|16938774|P1|Overall Study|Withdrawal by Subject|4
4917943|NCT00508001|16938772|P3|Overall Study|Death|1
4917944|NCT00508001|16938773|P2|Overall Study|Death|1
4917945|NCT00508001|16938774|P1|Overall Study|Death|0
4917946|NCT00508001|16938772|P3|Overall Study|condition under investigation worsened|1
4917947|NCT00508001|16938773|P2|Overall Study|condition under investigation worsened|7
4917948|NCT00508001|16938774|P1|Overall Study|condition under investigation worsened|13
4917949|NCT00508001|16938772|P3|Overall Study|Adverse Event|4
4917950|NCT00508001|16938773|P2|Overall Study|Adverse Event|0
4917951|NCT00508001|16938774|P1|Overall Study|Adverse Event|2
4917952|NCT00507819|16938791|P2|Washout (6 Weeks)|Withdrawal by Subject|0
4917953|NCT00507819|16938792|P1|Washout (6 Weeks)|Withdrawal by Subject|1
4917954|NCT00507689|16938811|P2|Randomized Period|Withdrawal by Subject|1
4917955|NCT00507689|16938812|P1|Randomized Period|Withdrawal by Subject|0
4917956|NCT00507689|16938811|P2|Randomized Period|Adverse Event|1
4917957|NCT00507689|16938812|P1|Randomized Period|Adverse Event|1
4917958|NCT00507689|16938811|P2|Pre-Randomization Period|Withdrawal by Subject|0
4917959|NCT00507689|16938812|P1|Pre-Randomization Period|Withdrawal by Subject|1
4917960|NCT00507689|16938811|P2|Pre-Randomization Period|Physician Decision|0
4917961|NCT00507689|16938812|P1|Pre-Randomization Period|Physician Decision|1
4917962|NCT00507689|16938811|P2|Pre-Randomization Period|Adverse Event|0
4917963|NCT00507689|16938812|P1|Pre-Randomization Period|Adverse Event|1
4917964|NCT00507546|16938844|P2|Overall Study|Physician Decision|1
4917965|NCT00507546|16938845|P1|Overall Study|Physician Decision|0
4917966|NCT00507546|16938844|P2|Overall Study|Protocol Violation|0
4917967|NCT00507546|16938845|P1|Overall Study|Protocol Violation|1
4917968|NCT00507546|16938844|P2|Overall Study|Withdrawal by Subject|0
4917969|NCT00507546|16938845|P1|Overall Study|Withdrawal by Subject|1
4917970|NCT00507507|16938855|P2|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16
4917971|NCT00507507|16938856|P1|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9
4917972|NCT00507507|16938855|P2|24-week Treatment-free Follow-up Period|Adverse Event|1
4917973|NCT00507507|16938856|P1|24-week Treatment-free Follow-up Period|Adverse Event|0
4917974|NCT00507507|16938855|P2|24-week Treatment-free Follow-up Period|Physician Decision|0
4917975|NCT00507507|16938856|P1|24-week Treatment-free Follow-up Period|Physician Decision|1
4917976|NCT00507507|16938855|P2|Treatment Period|Withdrawal by Subject|47
4917977|NCT00507507|16938856|P1|Treatment Period|Withdrawal by Subject|46
4917978|NCT00507507|16938855|P2|Treatment Period|Adverse Event|1
4917979|NCT00507507|16938856|P1|Treatment Period|Adverse Event|1
4917980|NCT00507507|16938855|P2|Treatment Period|Protocol Violation|2
4917981|NCT00507507|16938856|P1|Treatment Period|Protocol Violation|1
4917982|NCT00507507|16938855|P2|Treatment Period|Physician Decision|1
4917983|NCT00507507|16938856|P1|Treatment Period|Physician Decision|4
4917984|NCT00507507|16938855|P2|Treatment Period|Lost to Follow-up|2
4917985|NCT00507507|16938856|P1|Treatment Period|Lost to Follow-up|0
4917986|NCT00507455|16938891|P3|Overall Study|Other - miscellaneous reason|1
4917987|NCT00507455|16938892|P2|Overall Study|Other - miscellaneous reason|0
4917988|NCT00507455|16938893|P1|Overall Study|Other - miscellaneous reason|1
4917989|NCT00507455|16938891|P3|Overall Study|Lack of Efficacy|0
4917990|NCT00507455|16938892|P2|Overall Study|Lack of Efficacy|1
4917991|NCT00507455|16938893|P1|Overall Study|Lack of Efficacy|0
4917992|NCT00507455|16938891|P3|Overall Study|Lost to Follow-up|2
4917993|NCT00507455|16938892|P2|Overall Study|Lost to Follow-up|0
4917994|NCT00507455|16938893|P1|Overall Study|Lost to Follow-up|2
4917995|NCT00507455|16938891|P3|Overall Study|Protocol Violation|1
4917996|NCT00507455|16938892|P2|Overall Study|Protocol Violation|1
4917997|NCT00507455|16938893|P1|Overall Study|Protocol Violation|4
4917998|NCT00507455|16938891|P3|Overall Study|Withdrawal by Subject|2
4917999|NCT00507455|16938892|P2|Overall Study|Withdrawal by Subject|1
4918000|NCT00507455|16938893|P1|Overall Study|Withdrawal by Subject|2
4918001|NCT00507455|16938891|P3|Overall Study|Adverse Event|6
4918002|NCT00507455|16938892|P2|Overall Study|Adverse Event|3
4918003|NCT00507455|16938893|P1|Overall Study|Adverse Event|3
4918004|NCT00507442|16938956|P4|Overall Study|Other|2
4918005|NCT00507442|16938957|P3|Overall Study|Other|2
4918006|NCT00507442|16938958|P2|Overall Study|Other|5
4918007|NCT00507442|16938959|P1|Overall Study|Other|2
4918008|NCT00507442|16938956|P4|Overall Study|Withdrawal by Subject|1
4918009|NCT00507442|16938957|P3|Overall Study|Withdrawal by Subject|2
4918010|NCT00507442|16938958|P2|Overall Study|Withdrawal by Subject|4
4918011|NCT00507442|16938959|P1|Overall Study|Withdrawal by Subject|4
4918012|NCT00507442|16938956|P4|Overall Study|Progressive Disease|0
4918013|NCT00507442|16938957|P3|Overall Study|Progressive Disease|2
4918014|NCT00507442|16938958|P2|Overall Study|Progressive Disease|4
4918015|NCT00507442|16938959|P1|Overall Study|Progressive Disease|2
4918016|NCT00507442|16938956|P4|Overall Study|Physician Decision|1
4918017|NCT00507442|16938957|P3|Overall Study|Physician Decision|4
4918018|NCT00507442|16938958|P2|Overall Study|Physician Decision|2
4918019|NCT00507442|16938959|P1|Overall Study|Physician Decision|0
4918020|NCT00507442|16938956|P4|Overall Study|Lost to Follow-up|0
4918021|NCT00507442|16938957|P3|Overall Study|Lost to Follow-up|1
4918022|NCT00507442|16938958|P2|Overall Study|Lost to Follow-up|0
4918023|NCT00507442|16938959|P1|Overall Study|Lost to Follow-up|0
4918024|NCT00507442|16938956|P4|Overall Study|Protocol Violation|0
4918025|NCT00507442|16938957|P3|Overall Study|Protocol Violation|0
4918026|NCT00507442|16938958|P2|Overall Study|Protocol Violation|1
4918027|NCT00507442|16938959|P1|Overall Study|Protocol Violation|0
4918028|NCT00507442|16938956|P4|Overall Study|Adverse Event|1
4918029|NCT00507442|16938957|P3|Overall Study|Adverse Event|4
4918030|NCT00507442|16938958|P2|Overall Study|Adverse Event|11
4918031|NCT00507442|16938959|P1|Overall Study|Adverse Event|8
4918032|NCT00507429|16939011|P2|Maintenance Phase|Progressive Disease|0
4918033|NCT00507429|16939012|P1|Maintenance Phase|Progressive Disease|14
4918034|NCT00507429|16939011|P2|Treatment Phase|Other|3
4918035|NCT00507429|16939012|P1|Treatment Phase|Other|6
4918036|NCT00507429|16939011|P2|Treatment Phase|Physician Decision|2
4918037|NCT00507429|16939012|P1|Treatment Phase|Physician Decision|4
4918038|NCT00507429|16939011|P2|Treatment Phase|Withdrawal by Subject|3
4918039|NCT00507429|16939012|P1|Treatment Phase|Withdrawal by Subject|3
4918040|NCT00507429|16939011|P2|Treatment Phase|Adverse Event|5
4918041|NCT00507429|16939012|P1|Treatment Phase|Adverse Event|12
4918042|NCT00507429|16939011|P2|Treatment Phase|Disease Progression|5
4918043|NCT00507429|16939012|P1|Treatment Phase|Disease Progression|12
4918044|NCT00507416|16939023|P3|Overall Study|Did not Receive Study Treatment|4
4918045|NCT00507416|16939024|P2|Overall Study|Did not Receive Study Treatment|9
4918046|NCT00507416|16939025|P1|Overall Study|Did not Receive Study Treatment|3
4918047|NCT00507416|16939023|P3|Overall Study|Other|13
4918048|NCT00507416|16939024|P2|Overall Study|Other|16
4918049|NCT00507416|16939025|P1|Overall Study|Other|11
4918050|NCT00507416|16939023|P3|Overall Study|Patient declined further treatment|11
4918051|NCT00507416|16939024|P2|Overall Study|Patient declined further treatment|14
4918052|NCT00507416|16939025|P1|Overall Study|Patient declined further treatment|18
4918053|NCT00507416|16939023|P3|Overall Study|Progressive Disease|13
4918054|NCT00507416|16939024|P2|Overall Study|Progressive Disease|10
4918055|NCT00507416|16939025|P1|Overall Study|Progressive Disease|20
4918056|NCT00507416|16939023|P3|Overall Study|Lack ofEfficacy / Physician Decision|8
4918057|NCT00507416|16939024|P2|Overall Study|Lack ofEfficacy / Physician Decision|7
4918058|NCT00507416|16939025|P1|Overall Study|Lack ofEfficacy / Physician Decision|7
4918059|NCT00507416|16939023|P3|Overall Study|Protocol Violation|0
4918060|NCT00507416|16939024|P2|Overall Study|Protocol Violation|2
4918061|NCT00507416|16939025|P1|Overall Study|Protocol Violation|1
4918062|NCT00507416|16939023|P3|Overall Study|Adverse Event|65
4918063|NCT00507416|16939024|P2|Overall Study|Adverse Event|67
4918064|NCT00507416|16939025|P1|Overall Study|Adverse Event|58
4918065|NCT00507130|16939067|P4|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
4918066|NCT00507130|16939068|P3|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
4918067|NCT00507130|16939069|P2|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0
4918068|NCT00507130|16939070|P1|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1
4918069|NCT00507130|16939067|P4|Overall Study|Lost to Follow-up|1
4918070|NCT00507130|16939068|P3|Overall Study|Lost to Follow-up|1
4918071|NCT00507130|16939069|P2|Overall Study|Lost to Follow-up|0
4918072|NCT00507130|16939070|P1|Overall Study|Lost to Follow-up|0
4918073|NCT00506948|16939112|P1|Overall Study|Physician Decision|1
4918074|NCT00506948|16939112|P1|Overall Study|Adverse Event|5
4918075|NCT00506948|16939112|P1|Overall Study|Death|4
4918076|NCT00506922|16939121|P5|Overall Study|Withdrawal by Subject|1
4918077|NCT00506922|16939122|P4|Overall Study|Withdrawal by Subject|0
4918078|NCT00506922|16939123|P3|Overall Study|Withdrawal by Subject|0
4918079|NCT00506922|16939124|P2|Overall Study|Withdrawal by Subject|0
4918080|NCT00506922|16939125|P1|Overall Study|Withdrawal by Subject|0
4918081|NCT00506922|16939121|P5|Overall Study|Physician Decision|0
4918082|NCT00506922|16939122|P4|Overall Study|Physician Decision|2
4918083|NCT00506922|16939123|P3|Overall Study|Physician Decision|0
4918084|NCT00506922|16939124|P2|Overall Study|Physician Decision|0
4918085|NCT00506922|16939125|P1|Overall Study|Physician Decision|0
4918086|NCT00506883|16939152|P3|Overall Study|Other|1
4918087|NCT00506883|16939153|P2|Overall Study|Other|1
4918088|NCT00506883|16939154|P1|Overall Study|Other|5
4918089|NCT00506883|16939152|P3|Overall Study|Lack of Efficacy|1
4918090|NCT00506883|16939153|P2|Overall Study|Lack of Efficacy|1
4918091|NCT00506883|16939154|P1|Overall Study|Lack of Efficacy|0
4918092|NCT00506883|16939152|P3|Overall Study|Withdrawal by Subject|1
4918093|NCT00506883|16939153|P2|Overall Study|Withdrawal by Subject|0
4918094|NCT00506883|16939154|P1|Overall Study|Withdrawal by Subject|1
4918095|NCT00506883|16939152|P3|Overall Study|Lost to Follow-up|1
4918096|NCT00506883|16939153|P2|Overall Study|Lost to Follow-up|1
4918097|NCT00506883|16939154|P1|Overall Study|Lost to Follow-up|1
4918098|NCT00506831|16939167|P1|Overall Study|Withdrawal by Subject|1
4918099|NCT00506831|16939167|P1|Overall Study|Death|1
4918100|NCT00506753|16939180|P2|Overall Study|Lost to Follow-up|15
4918101|NCT00506753|16939181|P1|Overall Study|Lost to Follow-up|21
4918102|NCT00506662|16939219|P2|Overall Study|Not recorded|6
4918103|NCT00506662|16939220|P1|Overall Study|Not recorded|4
4918104|NCT00506662|16939219|P2|Overall Study|Trial terminated|16
4918105|NCT00506662|16939220|P1|Overall Study|Trial terminated|10
4918106|NCT00506662|16939219|P2|Overall Study|Protocol Violation|4
4918107|NCT00506662|16939220|P1|Overall Study|Protocol Violation|2
4918108|NCT00506662|16939219|P2|Overall Study|Lack of Efficacy|0
4918109|NCT00506662|16939220|P1|Overall Study|Lack of Efficacy|1
4918110|NCT00506662|16939219|P2|Overall Study|Adverse Event|2
4918111|NCT00506662|16939220|P1|Overall Study|Adverse Event|0
4918112|NCT00506493|16939254|P1|Overall Study|Withdrawal by Subject|5
4918113|NCT00506493|16939254|P1|Overall Study|Death|6
4918114|NCT00506454|16939263|P2|Overall Study|Withdrawal by Subject|1
4918115|NCT00506454|16939264|P1|Overall Study|Withdrawal by Subject|1
4918116|NCT00506441|16939270|P2|Period 2; Double-blind Period|Other Reason|1
4918117|NCT00506441|16939271|P1|Period 2; Double-blind Period|Other Reason|1
4918118|NCT00506441|16939270|P2|Period 2; Double-blind Period|Withdrawal by Subject|0
4918119|NCT00506441|16939271|P1|Period 2; Double-blind Period|Withdrawal by Subject|1
4918120|NCT00506441|16939270|P2|Period 2; Double-blind Period|Physician Decision|1
4918121|NCT00506441|16939271|P1|Period 2; Double-blind Period|Physician Decision|1
4918122|NCT00506441|16939270|P2|Period 2; Double-blind Period|Lack of Efficacy|2
4918123|NCT00506441|16939271|P1|Period 2; Double-blind Period|Lack of Efficacy|0
4918124|NCT00506441|16939270|P2|Period 2; Double-blind Period|Adverse Event|1
4918125|NCT00506441|16939271|P1|Period 2; Double-blind Period|Adverse Event|0
4918126|NCT00506441|16939270|P2|Period 1; Open-label Period|Other Reasons|0
4918127|NCT00506441|16939271|P1|Period 1; Open-label Period|Other Reasons|13
4918128|NCT00506441|16939270|P2|Period 1; Open-label Period|Withdrawal by Subject|0
4918129|NCT00506441|16939271|P1|Period 1; Open-label Period|Withdrawal by Subject|13
4918130|NCT00506441|16939270|P2|Period 1; Open-label Period|Protocol Violation|0
4918131|NCT00506441|16939271|P1|Period 1; Open-label Period|Protocol Violation|9
4918132|NCT00506441|16939270|P2|Period 1; Open-label Period|Physician Decision|0
4918133|NCT00506441|16939271|P1|Period 1; Open-label Period|Physician Decision|5
4918134|NCT00506441|16939270|P2|Period 1; Open-label Period|Lost to Follow-up|0
4918135|NCT00506441|16939271|P1|Period 1; Open-label Period|Lost to Follow-up|2
4918136|NCT00506441|16939270|P2|Period 1; Open-label Period|Lack of Efficacy|0
4918137|NCT00506441|16939271|P1|Period 1; Open-label Period|Lack of Efficacy|13
4918138|NCT00506441|16939270|P2|Period 1; Open-label Period|Adverse Event|0
4918139|NCT00506441|16939271|P1|Period 1; Open-label Period|Adverse Event|21
4918140|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Death|7
4918141|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Death|0
4918142|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Death|0
4918143|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Death|0
4918144|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6
4918145|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4918146|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4918147|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4918148|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5
4918149|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
4918150|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
4918151|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0
4918152|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14
4918153|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4918154|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4918155|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4918156|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8
4918157|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4918158|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4918159|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4918160|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18
4918161|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
4918162|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
4918163|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0
4918164|NCT00506415|16939279|P4|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4
4918165|NCT00506415|16939280|P3|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
4918166|NCT00506415|16939281|P2|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
4918167|NCT00506415|16939282|P1|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0
4918168|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
4918169|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1
4918170|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
4918171|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0
4918172|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Administrative problems|0
4918173|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Administrative problems|2
4918174|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Administrative problems|3
4918175|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Administrative problems|0
4918176|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
4918177|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17
4918178|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20
4918179|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0
4918180|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
4918181|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6
4918182|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4
4918183|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0
4918184|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
4918185|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Protocol Violation|3
4918186|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Protocol Violation|5
4918187|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Protocol Violation|0
4918188|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
4918189|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
4918190|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13
4918191|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0
4918192|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Death|0
4918193|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Death|3
4918194|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Death|5
4918195|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Death|0
4918196|NCT00506415|16939279|P4|Double Blind (Maximum 48 Weeks )|Adverse Event|0
4918197|NCT00506415|16939280|P3|Double Blind (Maximum 48 Weeks )|Adverse Event|28
4918198|NCT00506415|16939281|P2|Double Blind (Maximum 48 Weeks )|Adverse Event|33
4918199|NCT00506415|16939282|P1|Double Blind (Maximum 48 Weeks )|Adverse Event|0
4918200|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
4918280|NCT00506350|16939337|P7|Overall Study|Lost to Follow-up|0
4918201|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
4918202|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0
4918203|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28
4918204|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Death|0
4918205|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Death|0
4918206|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Death|0
4918207|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Death|22
4918208|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
4918209|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
4918210|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0
4918211|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7
4918212|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4918213|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4918214|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0
4918215|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22
4918216|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4918217|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4918218|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0
4918219|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88
4918220|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4918221|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4918222|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0
4918223|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58
4918224|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
4918225|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
4918226|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0
4918227|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1
4918228|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
4918229|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
4918230|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0
4918231|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1
4918232|NCT00506415|16939279|P4|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
4918233|NCT00506415|16939280|P3|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
4918234|NCT00506415|16939281|P2|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0
4918235|NCT00506415|16939282|P1|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272
4918236|NCT00506389|16939307|P3|In-treatment Period|Randomized but not treated|1
4918237|NCT00506389|16939308|P2|In-treatment Period|Randomized but not treated|1
4918238|NCT00506389|16939309|P1|In-treatment Period|Randomized but not treated|4
4918239|NCT00506389|16939307|P3|In-treatment Period|Adverse Event|2
4918240|NCT00506389|16939308|P2|In-treatment Period|Adverse Event|5
4918241|NCT00506389|16939309|P1|In-treatment Period|Adverse Event|11
4918242|NCT00506389|16939307|P3|In-treatment Period|Lack of Efficacy|0
4918243|NCT00506389|16939308|P2|In-treatment Period|Lack of Efficacy|2
4918244|NCT00506389|16939309|P1|In-treatment Period|Lack of Efficacy|0
4918245|NCT00506389|16939307|P3|In-treatment Period|Withdrawal by Subject|4
4918246|NCT00506389|16939308|P2|In-treatment Period|Withdrawal by Subject|3
4918247|NCT00506389|16939309|P1|In-treatment Period|Withdrawal by Subject|3
4918248|NCT00506389|16939307|P3|In-treatment Period|Reasons not related to trial|0
4918249|NCT00506389|16939308|P2|In-treatment Period|Reasons not related to trial|1
4918250|NCT00506389|16939309|P1|In-treatment Period|Reasons not related to trial|4
4918251|NCT00506389|16939307|P3|In-treatment Period|Lack of compliance|0
4918252|NCT00506389|16939308|P2|In-treatment Period|Lack of compliance|0
4918253|NCT00506389|16939309|P1|In-treatment Period|Lack of compliance|1
4918254|NCT00506389|16939307|P3|In-treatment Period|Lost to Follow-up|1
4918255|NCT00506389|16939308|P2|In-treatment Period|Lost to Follow-up|0
4918256|NCT00506389|16939309|P1|In-treatment Period|Lost to Follow-up|0
4918257|NCT00506389|16939307|P3|In-treatment Period|Other|4
4918258|NCT00506389|16939308|P2|In-treatment Period|Other|3
4918259|NCT00506389|16939309|P1|In-treatment Period|Other|3
4918260|NCT00506350|16939335|P9|Overall Study|Other|2
4918261|NCT00506350|16939336|P8|Overall Study|Other|2
4918262|NCT00506350|16939337|P7|Overall Study|Other|0
4918263|NCT00506350|16939338|P6|Overall Study|Other|0
4918264|NCT00506350|16939339|P5|Overall Study|Other|3
4918265|NCT00506350|16939340|P4|Overall Study|Other|0
4918266|NCT00506350|16939341|P3|Overall Study|Other|3
4918267|NCT00506350|16939342|P2|Overall Study|Other|1
4918268|NCT00506350|16939343|P1|Overall Study|Other|1
4918269|NCT00506350|16939335|P9|Overall Study|Medical Reason|0
4918270|NCT00506350|16939336|P8|Overall Study|Medical Reason|0
4918271|NCT00506350|16939337|P7|Overall Study|Medical Reason|0
4918272|NCT00506350|16939338|P6|Overall Study|Medical Reason|0
4918273|NCT00506350|16939339|P5|Overall Study|Medical Reason|1
4918274|NCT00506350|16939340|P4|Overall Study|Medical Reason|0
4918275|NCT00506350|16939341|P3|Overall Study|Medical Reason|0
4918276|NCT00506350|16939342|P2|Overall Study|Medical Reason|0
4918277|NCT00506350|16939343|P1|Overall Study|Medical Reason|0
4918278|NCT00506350|16939335|P9|Overall Study|Lost to Follow-up|2
4918279|NCT00506350|16939336|P8|Overall Study|Lost to Follow-up|0
4918281|NCT00506350|16939338|P6|Overall Study|Lost to Follow-up|1
4918282|NCT00506350|16939339|P5|Overall Study|Lost to Follow-up|2
4918283|NCT00506350|16939340|P4|Overall Study|Lost to Follow-up|1
4918284|NCT00506350|16939341|P3|Overall Study|Lost to Follow-up|1
4918285|NCT00506350|16939342|P2|Overall Study|Lost to Follow-up|1
4918286|NCT00506350|16939343|P1|Overall Study|Lost to Follow-up|1
4918287|NCT00506350|16939335|P9|Overall Study|Withdrawal by Subject|0
4918288|NCT00506350|16939336|P8|Overall Study|Withdrawal by Subject|2
4918289|NCT00506350|16939337|P7|Overall Study|Withdrawal by Subject|1
4918290|NCT00506350|16939338|P6|Overall Study|Withdrawal by Subject|1
4918291|NCT00506350|16939339|P5|Overall Study|Withdrawal by Subject|4
4918292|NCT00506350|16939340|P4|Overall Study|Withdrawal by Subject|1
4918293|NCT00506350|16939341|P3|Overall Study|Withdrawal by Subject|1
4918294|NCT00506350|16939342|P2|Overall Study|Withdrawal by Subject|1
4918295|NCT00506350|16939343|P1|Overall Study|Withdrawal by Subject|0
4918296|NCT00506350|16939335|P9|Overall Study|Protocol Violation|0
4918297|NCT00506350|16939336|P8|Overall Study|Protocol Violation|0
4918298|NCT00506350|16939337|P7|Overall Study|Protocol Violation|1
4918299|NCT00506350|16939338|P6|Overall Study|Protocol Violation|0
4918300|NCT00506350|16939339|P5|Overall Study|Protocol Violation|0
4918301|NCT00506350|16939340|P4|Overall Study|Protocol Violation|0
4918302|NCT00506350|16939341|P3|Overall Study|Protocol Violation|1
4918303|NCT00506350|16939342|P2|Overall Study|Protocol Violation|0
4918304|NCT00506350|16939343|P1|Overall Study|Protocol Violation|0
4918305|NCT00506350|16939335|P9|Overall Study|Adverse Event|1
4918306|NCT00506350|16939336|P8|Overall Study|Adverse Event|1
4918307|NCT00506350|16939337|P7|Overall Study|Adverse Event|0
4918308|NCT00506350|16939338|P6|Overall Study|Adverse Event|0
4918309|NCT00506350|16939339|P5|Overall Study|Adverse Event|0
4918310|NCT00506350|16939340|P4|Overall Study|Adverse Event|0
4918311|NCT00506350|16939341|P3|Overall Study|Adverse Event|0
4918312|NCT00506350|16939342|P2|Overall Study|Adverse Event|0
4918313|NCT00506350|16939343|P1|Overall Study|Adverse Event|0
4918314|NCT00506350|16939335|P9|Overall Study|Serious Adverse Event|0
4918315|NCT00506350|16939336|P8|Overall Study|Serious Adverse Event|0
4918316|NCT00506350|16939337|P7|Overall Study|Serious Adverse Event|0
4918317|NCT00506350|16939338|P6|Overall Study|Serious Adverse Event|0
4918318|NCT00506350|16939339|P5|Overall Study|Serious Adverse Event|0
4918319|NCT00506350|16939340|P4|Overall Study|Serious Adverse Event|0
4918320|NCT00506350|16939341|P3|Overall Study|Serious Adverse Event|0
4918321|NCT00506350|16939342|P2|Overall Study|Serious Adverse Event|0
4918322|NCT00506350|16939343|P1|Overall Study|Serious Adverse Event|1
4918323|NCT00506285|16939490|P2|6-month Open Label Phase|Withdrawal by Subject|5
4918324|NCT00506285|16939491|P1|6-month Open Label Phase|Withdrawal by Subject|9
4918325|NCT00506285|16939490|P2|6-month Open Label Phase|Lost to Follow-up|7
4918326|NCT00506285|16939491|P1|6-month Open Label Phase|Lost to Follow-up|1
4918327|NCT00506285|16939490|P2|Double Blind Cross-Over Phase|Lost to Follow-up|2
4918328|NCT00506285|16939491|P1|Double Blind Cross-Over Phase|Lost to Follow-up|5
4918329|NCT00506285|16939490|P2|Double Blind Cross-Over Phase|Withdrawal by Subject|3
4918330|NCT00506285|16939491|P1|Double Blind Cross-Over Phase|Withdrawal by Subject|4
4918331|NCT00506285|16939490|P2|3 Week Screening Phase|Withdrawal by Subject|10
4918332|NCT00506285|16939491|P1|3 Week Screening Phase|Withdrawal by Subject|17
4918333|NCT00506142|16939506|P2|Overall Study|New health condition|0
4918334|NCT00506142|16939507|P1|Overall Study|New health condition|1
4918335|NCT00506142|16939506|P2|Overall Study|Physician Decision|0
4918336|NCT00506142|16939507|P1|Overall Study|Physician Decision|1
4918337|NCT00506142|16939506|P2|Overall Study|Withdrawal by Subject|5
4918338|NCT00506142|16939507|P1|Overall Study|Withdrawal by Subject|4
4918339|NCT00506142|16939506|P2|Overall Study|Lack of Efficacy|7
4918340|NCT00506142|16939507|P1|Overall Study|Lack of Efficacy|21
4918341|NCT00506142|16939506|P2|Overall Study|Adverse Event|7
4918342|NCT00506142|16939507|P1|Overall Study|Adverse Event|8
4918343|NCT00506077|16939515|P2|Treatment Period 2|Withdrawal by Subject|0
4918344|NCT00506077|16939516|P1|Treatment Period 2|Withdrawal by Subject|1
4918345|NCT00506077|16939515|P2|Treatment Period 2|Adverse Event|1
4918346|NCT00506077|16939516|P1|Treatment Period 2|Adverse Event|0
4918347|NCT00506077|16939515|P2|Treatment Period 1|Withdrawal by Subject|0
4918348|NCT00506077|16939516|P1|Treatment Period 1|Withdrawal by Subject|2
4918349|NCT00506077|16939515|P2|Treatment Period 1|Lost to Follow-up|2
4918350|NCT00506077|16939516|P1|Treatment Period 1|Lost to Follow-up|0
4918351|NCT00506077|16939515|P2|Treatment Period 1|Adverse Event|1
4918352|NCT00506077|16939516|P1|Treatment Period 1|Adverse Event|2
4918353|NCT00505934|16939558|P1|Overall Study|Other: IV dose needed to be changed|1
4918354|NCT00505934|16939558|P1|Overall Study|Other: Unable to obtain IV & PK samples|1
4918355|NCT00505934|16939558|P1|Overall Study|Adverse Event|1
4918356|NCT00505921|16939564|P1|Overall Study|Failed to Mobilize|8
4918357|NCT00505921|16939564|P1|Overall Study|Ineligible|1
4918358|NCT00505778|16939581|P2|Overall Study|Took No Study Drug|2
4918359|NCT00505778|16939582|P1|Overall Study|Took No Study Drug|2
4918360|NCT00505778|16939581|P2|Overall Study|Relapse|65
4918361|NCT00505778|16939582|P1|Overall Study|Relapse|65
4918362|NCT00505778|16939581|P2|Overall Study|Withdrawal by Subject|14
4918363|NCT00505778|16939582|P1|Overall Study|Withdrawal by Subject|29
4918364|NCT00505778|16939581|P2|Overall Study|Protocol Violation|9
4918365|NCT00505778|16939582|P1|Overall Study|Protocol Violation|7
4918366|NCT00505778|16939581|P2|Overall Study|Unable to Meet Protocol Criteria|1
4918367|NCT00505778|16939582|P1|Overall Study|Unable to Meet Protocol Criteria|4
4918368|NCT00505778|16939581|P2|Overall Study|Lost to Follow-up|23
4918369|NCT00505778|16939582|P1|Overall Study|Lost to Follow-up|17
4918370|NCT00505778|16939581|P2|Overall Study|Physician Decision|14
4918371|NCT00505778|16939582|P1|Overall Study|Physician Decision|8
4918372|NCT00505778|16939581|P2|Overall Study|Adverse Event|7
4918373|NCT00505778|16939582|P1|Overall Study|Adverse Event|2
4918374|NCT00505765|16939601|P3|Overall Study|Noncompliance|3
4918375|NCT00505765|16939602|P2|Overall Study|Noncompliance|1
4918376|NCT00505765|16939603|P1|Overall Study|Noncompliance|0
4918377|NCT00505765|16939601|P3|Overall Study|Adverse Event|0
4918378|NCT00505765|16939602|P2|Overall Study|Adverse Event|2
4918379|NCT00505765|16939603|P1|Overall Study|Adverse Event|1
4918380|NCT00505765|16939601|P3|Overall Study|Withdrawal by Subject|0
4918381|NCT00505765|16939602|P2|Overall Study|Withdrawal by Subject|0
4918382|NCT00505765|16939603|P1|Overall Study|Withdrawal by Subject|1
4918383|NCT00505752|16939630|P4|Overall Study|Other|2
4918384|NCT00505752|16939631|P3|Overall Study|Other|1
4918385|NCT00505752|16939632|P2|Overall Study|Other|2
4918386|NCT00505752|16939633|P1|Overall Study|Other|1
4918387|NCT00505752|16939630|P4|Overall Study|All embryos/blastocysts discarded|1
4918388|NCT00505752|16939631|P3|Overall Study|All embryos/blastocysts discarded|1
4918389|NCT00505752|16939632|P2|Overall Study|All embryos/blastocysts discarded|0
4918390|NCT00505752|16939633|P1|Overall Study|All embryos/blastocysts discarded|0
4918391|NCT00505752|16939630|P4|Overall Study|No Fertilization|1
4918392|NCT00505752|16939631|P3|Overall Study|No Fertilization|2
4918393|NCT00505752|16939632|P2|Overall Study|No Fertilization|1
4918394|NCT00505752|16939633|P1|Overall Study|No Fertilization|1
4918395|NCT00505752|16939630|P4|Overall Study|No oocytes retrieved|1
4918396|NCT00505752|16939631|P3|Overall Study|No oocytes retrieved|0
4918397|NCT00505752|16939632|P2|Overall Study|No oocytes retrieved|2
4918398|NCT00505752|16939633|P1|Overall Study|No oocytes retrieved|0
4918399|NCT00505752|16939630|P4|Overall Study|Ovarian hyperstimulation syndrome risk|1
4918400|NCT00505752|16939631|P3|Overall Study|Ovarian hyperstimulation syndrome risk|3
4918401|NCT00505752|16939632|P2|Overall Study|Ovarian hyperstimulation syndrome risk|1
4918402|NCT00505752|16939633|P1|Overall Study|Ovarian hyperstimulation syndrome risk|1
4918403|NCT00505752|16939630|P4|Overall Study|Lack of ovarian response|0
4918404|NCT00505752|16939631|P3|Overall Study|Lack of ovarian response|0
4918405|NCT00505752|16939632|P2|Overall Study|Lack of ovarian response|3
4918406|NCT00505752|16939633|P1|Overall Study|Lack of ovarian response|1
4918407|NCT00505752|16939630|P4|Overall Study|Lost to Follow-up|0
4918408|NCT00505752|16939631|P3|Overall Study|Lost to Follow-up|0
4918409|NCT00505752|16939632|P2|Overall Study|Lost to Follow-up|0
4918410|NCT00505752|16939633|P1|Overall Study|Lost to Follow-up|1
4918411|NCT00505752|16939630|P4|Overall Study|Adverse Event|0
4918412|NCT00505752|16939631|P3|Overall Study|Adverse Event|1
4918413|NCT00505752|16939632|P2|Overall Study|Adverse Event|0
4918414|NCT00505752|16939633|P1|Overall Study|Adverse Event|1
4918415|NCT00505687|16939647|P1|Overall Study|Other: As Per Sponsor|8
4918416|NCT00505687|16939647|P1|Overall Study|Other: Disease Progression|1
4918417|NCT00505687|16939647|P1|Overall Study|Other: Neupro Given In Hospital|1
4918418|NCT00505687|16939647|P1|Overall Study|Other: Patches Would Not Stick D/T Sweat|1
4918419|NCT00505687|16939647|P1|Overall Study|Other: Prolonged Hospitalization|1
4918420|NCT00505687|16939647|P1|Overall Study|Other: Scheduled DBS Surgery|1
4918421|NCT00505687|16939647|P1|Overall Study|Other: Underwent Implantation Of DBS|1
4918422|NCT00505687|16939647|P1|Overall Study|Lost to Follow-up|1
4918423|NCT00505687|16939647|P1|Overall Study|Subject withdrew consent|15
4918424|NCT00505687|16939647|P1|Overall Study|Adverse Event|48
4918425|NCT00505687|16939647|P1|Overall Study|Lack of Efficacy|15
4918426|NCT00505687|16939647|P1|Overall Study|Important protocol violation|2
4918427|NCT00505661|16939653|P1|Overall Study|Not Eligible|4
4918428|NCT00505622|16939664|P3|Overall Study|Study termination by sponsor|90
4918429|NCT00505622|16939665|P2|Overall Study|Study termination by sponsor|98
4918430|NCT00505622|16939666|P1|Overall Study|Study termination by sponsor|115
4918431|NCT00505622|16939664|P3|Overall Study|Withdrawal by Subject|2
4918432|NCT00505622|16939665|P2|Overall Study|Withdrawal by Subject|3
4918433|NCT00505622|16939666|P1|Overall Study|Withdrawal by Subject|0
4918434|NCT00505622|16939664|P3|Overall Study|Protocol Violation|0
4918435|NCT00505622|16939665|P2|Overall Study|Protocol Violation|1
4918436|NCT00505622|16939666|P1|Overall Study|Protocol Violation|1
4918437|NCT00505622|16939664|P3|Overall Study|Adverse Event|4
4918438|NCT00505622|16939665|P2|Overall Study|Adverse Event|6
4918439|NCT00505622|16939666|P1|Overall Study|Adverse Event|5
4918440|NCT00505414|16939691|P5|Maintenance Phase|underlying disease and therapy required|0
4918441|NCT00505414|16939692|P4|Maintenance Phase|underlying disease and therapy required|0
4918442|NCT00505414|16939693|P3|Maintenance Phase|underlying disease and therapy required|2
4918443|NCT00505414|16939694|P2|Maintenance Phase|underlying disease and therapy required|2
4918444|NCT00505414|16939695|P1|Maintenance Phase|underlying disease and therapy required|0
4918445|NCT00505414|16939691|P5|Maintenance Phase|Withdrawal by Subject|0
4918446|NCT00505414|16939692|P4|Maintenance Phase|Withdrawal by Subject|0
4918447|NCT00505414|16939693|P3|Maintenance Phase|Withdrawal by Subject|1
4918448|NCT00505414|16939694|P2|Maintenance Phase|Withdrawal by Subject|0
4918449|NCT00505414|16939695|P1|Maintenance Phase|Withdrawal by Subject|0
4918450|NCT00505414|16939691|P5|Maintenance Phase|Lack of Efficacy|0
4918451|NCT00505414|16939692|P4|Maintenance Phase|Lack of Efficacy|0
4918452|NCT00505414|16939693|P3|Maintenance Phase|Lack of Efficacy|1
4918453|NCT00505414|16939694|P2|Maintenance Phase|Lack of Efficacy|1
4918454|NCT00505414|16939695|P1|Maintenance Phase|Lack of Efficacy|2
4918455|NCT00505414|16939691|P5|Maintenance Phase|Death|0
4918456|NCT00505414|16939692|P4|Maintenance Phase|Death|0
4918457|NCT00505414|16939693|P3|Maintenance Phase|Death|1
4918458|NCT00505414|16939694|P2|Maintenance Phase|Death|0
4918459|NCT00505414|16939695|P1|Maintenance Phase|Death|2
4918460|NCT00505414|16939691|P5|Maintenance Phase|Adverse Event|0
4918461|NCT00505414|16939692|P4|Maintenance Phase|Adverse Event|0
4918462|NCT00505414|16939693|P3|Maintenance Phase|Adverse Event|3
4918463|NCT00505414|16939694|P2|Maintenance Phase|Adverse Event|2
4918464|NCT00505414|16939695|P1|Maintenance Phase|Adverse Event|2
4918465|NCT00505414|16939691|P5|Titration Phase|Underlying disease and therapy required|3
4918466|NCT00505414|16939692|P4|Titration Phase|Underlying disease and therapy required|7
4918467|NCT00505414|16939693|P3|Titration Phase|Underlying disease and therapy required|0
4918468|NCT00505414|16939694|P2|Titration Phase|Underlying disease and therapy required|0
4918469|NCT00505414|16939695|P1|Titration Phase|Underlying disease and therapy required|0
4918470|NCT00505414|16939691|P5|Titration Phase|Withdrawal by Subject|4
4918471|NCT00505414|16939692|P4|Titration Phase|Withdrawal by Subject|3
4918472|NCT00505414|16939693|P3|Titration Phase|Withdrawal by Subject|0
4918473|NCT00505414|16939694|P2|Titration Phase|Withdrawal by Subject|0
4918474|NCT00505414|16939695|P1|Titration Phase|Withdrawal by Subject|0
4918475|NCT00505414|16939691|P5|Titration Phase|Protocol Violation|1
4918476|NCT00505414|16939692|P4|Titration Phase|Protocol Violation|0
4918477|NCT00505414|16939693|P3|Titration Phase|Protocol Violation|0
4918478|NCT00505414|16939694|P2|Titration Phase|Protocol Violation|0
4918479|NCT00505414|16939695|P1|Titration Phase|Protocol Violation|0
4918480|NCT00505414|16939691|P5|Titration Phase|Lack of Efficacy|1
4918481|NCT00505414|16939692|P4|Titration Phase|Lack of Efficacy|10
4918482|NCT00505414|16939693|P3|Titration Phase|Lack of Efficacy|0
4918483|NCT00505414|16939694|P2|Titration Phase|Lack of Efficacy|0
4918484|NCT00505414|16939695|P1|Titration Phase|Lack of Efficacy|0
4918485|NCT00505414|16939691|P5|Titration Phase|Death|0
4918486|NCT00505414|16939692|P4|Titration Phase|Death|2
4918487|NCT00505414|16939693|P3|Titration Phase|Death|0
4918488|NCT00505414|16939694|P2|Titration Phase|Death|0
4918489|NCT00505414|16939695|P1|Titration Phase|Death|0
4918490|NCT00505414|16939691|P5|Titration Phase|Adverse Event|3
4918491|NCT00505414|16939692|P4|Titration Phase|Adverse Event|8
4918492|NCT00505414|16939693|P3|Titration Phase|Adverse Event|0
4918493|NCT00505414|16939694|P2|Titration Phase|Adverse Event|0
4918494|NCT00505414|16939695|P1|Titration Phase|Adverse Event|0
4918495|NCT00505375|16939712|P2|Overall Study|Travel issues|1
4918496|NCT00505375|16939713|P1|Overall Study|Travel issues|0
4918497|NCT00505375|16939712|P2|Overall Study|Pregnancy|0
4918498|NCT00505375|16939713|P1|Overall Study|Pregnancy|1
4918499|NCT00505375|16939712|P2|Overall Study|Lost to Follow-up|2
4918500|NCT00505375|16939713|P1|Overall Study|Lost to Follow-up|0
4918501|NCT00505375|16939712|P2|Overall Study|Withdrawal by Subject|2
4918502|NCT00505375|16939713|P1|Overall Study|Withdrawal by Subject|2
4918503|NCT00505375|16939712|P2|Overall Study|Death|0
4918504|NCT00505375|16939713|P1|Overall Study|Death|1
4918505|NCT00505284|16939735|P5|Overall Study|Other|4
4918506|NCT00505284|16939736|P4|Overall Study|Other|4
4918507|NCT00505284|16939737|P3|Overall Study|Other|0
4918508|NCT00505284|16939738|P2|Overall Study|Other|0
4918509|NCT00505284|16939739|P1|Overall Study|Other|5
4918510|NCT00505284|16939735|P5|Overall Study|Physician Decision|0
4918511|NCT00505284|16939736|P4|Overall Study|Physician Decision|0
4918512|NCT00505284|16939737|P3|Overall Study|Physician Decision|0
4918513|NCT00505284|16939738|P2|Overall Study|Physician Decision|1
4918514|NCT00505284|16939739|P1|Overall Study|Physician Decision|0
4918515|NCT00505284|16939735|P5|Overall Study|Lack of Efficacy|1
4918516|NCT00505284|16939736|P4|Overall Study|Lack of Efficacy|1
4918517|NCT00505284|16939737|P3|Overall Study|Lack of Efficacy|1
4918518|NCT00505284|16939738|P2|Overall Study|Lack of Efficacy|1
4918519|NCT00505284|16939739|P1|Overall Study|Lack of Efficacy|0
4918520|NCT00505284|16939735|P5|Overall Study|Withdrawal by Subject|6
4918521|NCT00505284|16939736|P4|Overall Study|Withdrawal by Subject|0
4918522|NCT00505284|16939737|P3|Overall Study|Withdrawal by Subject|1
4918523|NCT00505284|16939738|P2|Overall Study|Withdrawal by Subject|6
4918524|NCT00505284|16939739|P1|Overall Study|Withdrawal by Subject|2
4918525|NCT00505284|16939735|P5|Overall Study|Protocol Violation|0
4918526|NCT00505284|16939736|P4|Overall Study|Protocol Violation|0
4918527|NCT00505284|16939737|P3|Overall Study|Protocol Violation|1
4918528|NCT00505284|16939738|P2|Overall Study|Protocol Violation|1
4918529|NCT00505284|16939739|P1|Overall Study|Protocol Violation|0
4918530|NCT00505284|16939735|P5|Overall Study|Adverse Event|22
4918531|NCT00505284|16939736|P4|Overall Study|Adverse Event|14
4918532|NCT00505284|16939737|P3|Overall Study|Adverse Event|9
4918533|NCT00505284|16939738|P2|Overall Study|Adverse Event|7
4918534|NCT00505284|16939739|P1|Overall Study|Adverse Event|3
4918535|NCT00505076|16939809|P3|Overall Study|Withdrawal by Subject|2
4918536|NCT00505076|16939810|P2|Overall Study|Withdrawal by Subject|1
4918537|NCT00505076|16939811|P1|Overall Study|Withdrawal by Subject|0
4918538|NCT00505076|16939809|P3|Overall Study|Protocol Violation|2
4918539|NCT00505076|16939810|P2|Overall Study|Protocol Violation|1
4918540|NCT00505076|16939811|P1|Overall Study|Protocol Violation|2
4918541|NCT00505076|16939809|P3|Overall Study|Adverse Event|1
4918542|NCT00505076|16939810|P2|Overall Study|Adverse Event|0
4918543|NCT00505076|16939811|P1|Overall Study|Adverse Event|1
4918544|NCT00504881|16939840|P2|Overall Study|AE of unknown type|0
4918545|NCT00504881|16939841|P1|Overall Study|AE of unknown type|1
4918546|NCT00504881|16939840|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2
4918547|NCT00504881|16939841|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4918548|NCT00504881|16939840|P2|Overall Study|AE, non-serious non-fatal|14
4918549|NCT00504881|16939841|P1|Overall Study|AE, non-serious non-fatal|4
4918550|NCT00504881|16939840|P2|Overall Study|SAE, non-fatal|6
4918551|NCT00504881|16939841|P1|Overall Study|SAE, non-fatal|2
4918552|NCT00504881|16939840|P2|Overall Study|AE, serious fatal|1
4918553|NCT00504881|16939841|P1|Overall Study|AE, serious fatal|0
4918554|NCT00504881|16939840|P2|Overall Study|Safety Visit not performed|1
4918555|NCT00504881|16939841|P1|Overall Study|Safety Visit not performed|0
4918556|NCT00504881|16939840|P2|Overall Study|No Birth Control|1
4918557|NCT00504881|16939841|P1|Overall Study|No Birth Control|0
4918558|NCT00504881|16939840|P2|Overall Study|Non-Compliance|0
4918559|NCT00504881|16939841|P1|Overall Study|Non-Compliance|1
4918560|NCT00504881|16939840|P2|Overall Study|Withdrawal by Subject|4
4918561|NCT00504881|16939841|P1|Overall Study|Withdrawal by Subject|1
4918562|NCT00504881|16939840|P2|Overall Study|Lost to Follow-up|2
4918563|NCT00504881|16939841|P1|Overall Study|Lost to Follow-up|0
4918564|NCT00504881|16939840|P2|Overall Study|Lack of Efficacy|5
4918565|NCT00504881|16939841|P1|Overall Study|Lack of Efficacy|1
4918566|NCT00504829|16939894|P3|Overall Study|Protocol Violation|10
4918567|NCT00504829|16939895|P2|Overall Study|Protocol Violation|4
4918568|NCT00504829|16939896|P1|Overall Study|Protocol Violation|6
4918569|NCT00504777|16939905|P1|Overall Study|Adverse Event|1
4918570|NCT00504725|16939918|P2|Overall Study|Protocol Violation|0
4918571|NCT00504725|16939919|P1|Overall Study|Protocol Violation|1
4918572|NCT00504595|16939942|P4|Overall Study|Other|0
4918573|NCT00504595|16939943|P3|Overall Study|Other|2
4918574|NCT00504595|16939944|P2|Overall Study|Other|0
4918575|NCT00504595|16939945|P1|Overall Study|Other|0
4918576|NCT00504595|16939942|P4|Overall Study|Lack of Efficacy|0
4918577|NCT00504595|16939943|P3|Overall Study|Lack of Efficacy|0
4918578|NCT00504595|16939944|P2|Overall Study|Lack of Efficacy|0
4918579|NCT00504595|16939945|P1|Overall Study|Lack of Efficacy|1
4918580|NCT00504556|16939962|P5|Overall Study|not in safety analysis set|1
4918581|NCT00504556|16939963|P4|Overall Study|not in safety analysis set|0
4918582|NCT00504556|16939964|P3|Overall Study|not in safety analysis set|1
4918583|NCT00504556|16939965|P2|Overall Study|not in safety analysis set|1
4918584|NCT00504556|16939966|P1|Overall Study|not in safety analysis set|0
4918585|NCT00504556|16939962|P5|Overall Study|Other|0
4918586|NCT00504556|16939963|P4|Overall Study|Other|3
4918587|NCT00504556|16939964|P3|Overall Study|Other|2
4918588|NCT00504556|16939965|P2|Overall Study|Other|2
4918589|NCT00504556|16939966|P1|Overall Study|Other|2
4918590|NCT00504556|16939962|P5|Overall Study|data monitor committee decision|0
4918591|NCT00504556|16939963|P4|Overall Study|data monitor committee decision|100
4918592|NCT00504556|16939964|P3|Overall Study|data monitor committee decision|0
4918593|NCT00504556|16939965|P2|Overall Study|data monitor committee decision|0
4918594|NCT00504556|16939966|P1|Overall Study|data monitor committee decision|0
4918595|NCT00504556|16939962|P5|Overall Study|did not meet entry criteria|0
4918596|NCT00504556|16939963|P4|Overall Study|did not meet entry criteria|1
4918597|NCT00504556|16939964|P3|Overall Study|did not meet entry criteria|1
4918598|NCT00504556|16939965|P2|Overall Study|did not meet entry criteria|0
4918599|NCT00504556|16939966|P1|Overall Study|did not meet entry criteria|2
4918600|NCT00504556|16939962|P5|Overall Study|administrative reasons|2
4918601|NCT00504556|16939963|P4|Overall Study|administrative reasons|1
4918602|NCT00504556|16939964|P3|Overall Study|administrative reasons|2
4918603|NCT00504556|16939965|P2|Overall Study|administrative reasons|2
4918604|NCT00504556|16939966|P1|Overall Study|administrative reasons|0
4918605|NCT00504556|16939962|P5|Overall Study|Withdrawal by Subject|12
4918606|NCT00504556|16939963|P4|Overall Study|Withdrawal by Subject|8
4918607|NCT00504556|16939964|P3|Overall Study|Withdrawal by Subject|7
4918608|NCT00504556|16939965|P2|Overall Study|Withdrawal by Subject|16
4918609|NCT00504556|16939966|P1|Overall Study|Withdrawal by Subject|16
4918610|NCT00504556|16939962|P5|Overall Study|Lost to Follow-up|1
4918611|NCT00504556|16939963|P4|Overall Study|Lost to Follow-up|1
4918612|NCT00504556|16939964|P3|Overall Study|Lost to Follow-up|1
4918613|NCT00504556|16939965|P2|Overall Study|Lost to Follow-up|0
4918614|NCT00504556|16939966|P1|Overall Study|Lost to Follow-up|0
4918615|NCT00504556|16939962|P5|Overall Study|Protocol Violation|2
4918616|NCT00504556|16939963|P4|Overall Study|Protocol Violation|1
4918617|NCT00504556|16939964|P3|Overall Study|Protocol Violation|2
4918618|NCT00504556|16939965|P2|Overall Study|Protocol Violation|3
4918619|NCT00504556|16939966|P1|Overall Study|Protocol Violation|1
4918620|NCT00504556|16939962|P5|Overall Study|Death|2
4918621|NCT00504556|16939963|P4|Overall Study|Death|0
4918622|NCT00504556|16939964|P3|Overall Study|Death|1
4918623|NCT00504556|16939965|P2|Overall Study|Death|3
4918624|NCT00504556|16939966|P1|Overall Study|Death|3
4918625|NCT00504556|16939962|P5|Overall Study|Adverse Event|5
4918626|NCT00504556|16939963|P4|Overall Study|Adverse Event|13
4918627|NCT00504556|16939964|P3|Overall Study|Adverse Event|14
4918628|NCT00504556|16939965|P2|Overall Study|Adverse Event|11
4918629|NCT00504556|16939966|P1|Overall Study|Adverse Event|11
4918630|NCT00504426|16940034|P4|Overall Study|Withdrawal by Subject|0
4918631|NCT00504426|16940035|P3|Overall Study|Withdrawal by Subject|0
4918632|NCT00504426|16940036|P2|Overall Study|Withdrawal by Subject|0
4918633|NCT00504426|16940037|P1|Overall Study|Withdrawal by Subject|2
4918634|NCT00504426|16940034|P4|Overall Study|Protocol Violation|0
4918635|NCT00504426|16940035|P3|Overall Study|Protocol Violation|2
4918636|NCT00504426|16940036|P2|Overall Study|Protocol Violation|1
4918637|NCT00504426|16940037|P1|Overall Study|Protocol Violation|1
4918638|NCT00504426|16940034|P4|Overall Study|Adverse Event|0
4918639|NCT00504426|16940035|P3|Overall Study|Adverse Event|2
4918640|NCT00504426|16940036|P2|Overall Study|Adverse Event|0
4918641|NCT00504426|16940037|P1|Overall Study|Adverse Event|0
4918642|NCT00504348|16940051|P1|Overall Study|Physician Decision|1
4918643|NCT00504348|16940051|P1|Overall Study|Lack of Efficacy|4
4918644|NCT00504348|16940051|P1|Overall Study|Adverse Event|3
4918645|NCT00504309|16940062|P6|Overall Study|Withdrawal by Subject|0
4918646|NCT00504309|16940063|P5|Overall Study|Withdrawal by Subject|0
4918647|NCT00504309|16940064|P4|Overall Study|Withdrawal by Subject|0
4918648|NCT00504309|16940065|P3|Overall Study|Withdrawal by Subject|1
4918649|NCT00504309|16940066|P2|Overall Study|Withdrawal by Subject|0
4918650|NCT00504309|16940067|P1|Overall Study|Withdrawal by Subject|0
4918651|NCT00504309|16940062|P6|Overall Study|Death|0
4918652|NCT00504309|16940063|P5|Overall Study|Death|1
4918653|NCT00504309|16940064|P4|Overall Study|Death|0
4918654|NCT00504309|16940065|P3|Overall Study|Death|0
4918655|NCT00504309|16940066|P2|Overall Study|Death|0
4918656|NCT00504309|16940067|P1|Overall Study|Death|0
4918657|NCT00504257|16940105|P1|Overall Study|ineligible histology|2
4918658|NCT00504257|16940105|P1|Overall Study|Withdrawal by Subject|2
4918659|NCT00504231|16940117|P4|Overall Study|Discrepant chart documentation re route|0
4918660|NCT00504231|16940118|P3|Overall Study|Discrepant chart documentation re route|1
4918661|NCT00504231|16940119|P2|Overall Study|Discrepant chart documentation re route|0
4918662|NCT00504231|16940120|P1|Overall Study|Discrepant chart documentation re route|0
4918663|NCT00504166|16940140|P2|Overall Study|Lost to Follow-up|3
4918664|NCT00504166|16940141|P1|Overall Study|Lost to Follow-up|1
4918665|NCT00504166|16940140|P2|Overall Study|Physician Decision|1
4918666|NCT00504166|16940141|P1|Overall Study|Physician Decision|1
4918667|NCT00504166|16940140|P2|Overall Study|Withdrawal by Subject|6
4918668|NCT00504166|16940141|P1|Overall Study|Withdrawal by Subject|3
4918669|NCT00504166|16940140|P2|Overall Study|Adverse Event|4
4918670|NCT00504166|16940141|P1|Overall Study|Adverse Event|1
4918671|NCT00504153|16940147|P1|Overall Study|Death|1
4918672|NCT00504153|16940147|P1|Overall Study|Adverse Event|4
4918673|NCT00504153|16940147|P1|Overall Study|Withdrawal by Subject|1
4918674|NCT00504075|16940155|P1|Overall Study|Required other therapeutic intervention|1
4918675|NCT00504075|16940155|P1|Overall Study|Withdrawal by Subject|1
4918676|NCT00504075|16940155|P1|Overall Study|Lost to Follow-up|5
4918677|NCT00504075|16940155|P1|Overall Study|Adverse Event|1
4918678|NCT00503997|16940165|P1|Overall Study|Withdrawal by Subject|1
4918679|NCT00503997|16940165|P1|Overall Study|Death|1
4918680|NCT00503997|16940165|P1|Overall Study|Adverse Event|5
4918681|NCT00503997|16940165|P1|Overall Study|disease progression|1
4918682|NCT00503984|16940171|P6|Overall Study|Death|0
4918683|NCT00503984|16940172|P5|Overall Study|Death|1
4918684|NCT00503984|16940173|P4|Overall Study|Death|0
4918685|NCT00503984|16940174|P3|Overall Study|Death|0
4918686|NCT00503984|16940175|P2|Overall Study|Death|0
4918687|NCT00503984|16940176|P1|Overall Study|Death|0
4918688|NCT00503984|16940171|P6|Overall Study|Adverse Event|0
4918689|NCT00503984|16940172|P5|Overall Study|Adverse Event|0
4918690|NCT00503984|16940173|P4|Overall Study|Adverse Event|0
4918691|NCT00503984|16940174|P3|Overall Study|Adverse Event|0
4918692|NCT00503984|16940175|P2|Overall Study|Adverse Event|1
4918693|NCT00503984|16940176|P1|Overall Study|Adverse Event|0
4918694|NCT00503984|16940171|P6|Overall Study|Protocol Violation|0
4918695|NCT00503984|16940172|P5|Overall Study|Protocol Violation|0
4918696|NCT00503984|16940173|P4|Overall Study|Protocol Violation|0
4918697|NCT00503984|16940174|P3|Overall Study|Protocol Violation|0
4918698|NCT00503984|16940175|P2|Overall Study|Protocol Violation|1
4918699|NCT00503984|16940176|P1|Overall Study|Protocol Violation|0
4918700|NCT00503906|16940202|P1|Overall Study|Withdrawal by Subject|1
4918701|NCT00503841|16940224|P1|Overall Study|All screen failures|44
4918702|NCT00503776|16940235|P4|Overall Study|Physician Decision|1
4918703|NCT00503776|16940236|P3|Overall Study|Physician Decision|1
4918704|NCT00503776|16940237|P2|Overall Study|Physician Decision|0
4918705|NCT00503776|16940238|P1|Overall Study|Physician Decision|0
4918706|NCT00503776|16940235|P4|Overall Study|Withdrawal by Subject|1
4918707|NCT00503776|16940236|P3|Overall Study|Withdrawal by Subject|1
4918708|NCT00503776|16940237|P2|Overall Study|Withdrawal by Subject|0
4918709|NCT00503776|16940238|P1|Overall Study|Withdrawal by Subject|1
4918710|NCT00503698|16940271|P2|Overall Study|Not exposed to trial drug|6
4918711|NCT00503698|16940272|P1|Overall Study|Not exposed to trial drug|11
4918712|NCT00503698|16940271|P2|Overall Study|Unclassified|32
4918713|NCT00503698|16940272|P1|Overall Study|Unclassified|48
4918714|NCT00503698|16940271|P2|Overall Study|Critically ill|0
4918715|NCT00503698|16940272|P1|Overall Study|Critically ill|2
4918716|NCT00503698|16940271|P2|Overall Study|Move to nonparticipating dialysis center|1
4918717|NCT00503698|16940272|P1|Overall Study|Move to nonparticipating dialysis center|2
4918718|NCT00503698|16940271|P2|Overall Study|Switch to peritoneal or home dialysis|2
4918719|NCT00503698|16940272|P1|Overall Study|Switch to peritoneal or home dialysis|2
4918720|NCT00503698|16940271|P2|Overall Study|Any condition in exclusion criteria|6
4918721|NCT00503698|16940272|P1|Overall Study|Any condition in exclusion criteria|4
4918722|NCT00503698|16940271|P2|Overall Study|Pregnancy/intention to become pregnant|0
4918723|NCT00503698|16940272|P1|Overall Study|Pregnancy/intention to become pregnant|1
4918724|NCT00503698|16940271|P2|Overall Study|End hemodialysis due to renal transplant|4
4918725|NCT00503698|16940272|P1|Overall Study|End hemodialysis due to renal transplant|10
4918726|NCT00503698|16940271|P2|Overall Study|Trial terminated|253
4918727|NCT00503698|16940272|P1|Overall Study|Trial terminated|216
4918728|NCT00503698|16940271|P2|Overall Study|Lack of Efficacy|4
4918729|NCT00503698|16940272|P1|Overall Study|Lack of Efficacy|3
4918730|NCT00503698|16940271|P2|Overall Study|Death|0
4918731|NCT00503698|16940272|P1|Overall Study|Death|1
4918732|NCT00503698|16940271|P2|Overall Study|Adverse Event|41
4918733|NCT00503698|16940272|P1|Overall Study|Adverse Event|52
4918734|NCT00503698|16940271|P2|Overall Study|Protocol Violation|6
4918735|NCT00503698|16940272|P1|Overall Study|Protocol Violation|5
4918736|NCT00503685|16940289|P3|Overall Study|Eligibility Criteria Not Met|0
4918737|NCT00503685|16940290|P2|Overall Study|Eligibility Criteria Not Met|1
4918738|NCT00503685|16940291|P1|Overall Study|Eligibility Criteria Not Met|0
4918739|NCT00503685|16940289|P3|Overall Study|Protocol Violation|0
4918740|NCT00503685|16940290|P2|Overall Study|Protocol Violation|1
4918741|NCT00503685|16940291|P1|Overall Study|Protocol Violation|0
4918742|NCT00503685|16940289|P3|Overall Study|Withdrawal by Subject|0
4918743|NCT00503685|16940290|P2|Overall Study|Withdrawal by Subject|1
4918744|NCT00503685|16940291|P1|Overall Study|Withdrawal by Subject|0
4918745|NCT00503685|16940289|P3|Overall Study|Adverse Event|2
4918746|NCT00503685|16940290|P2|Overall Study|Adverse Event|0
4918747|NCT00503685|16940291|P1|Overall Study|Adverse Event|0
4918748|NCT00503581|16940336|P3|Overall Study|Study closed|2
4918749|NCT00503581|16940337|P2|Overall Study|Study closed|4
4918750|NCT00503581|16940338|P1|Overall Study|Study closed|3
4918751|NCT00503425|16940349|P1|Overall Study|Missing Data/Unknown|4
4918752|NCT00503425|16940349|P1|Overall Study|Death|3
4918753|NCT00503425|16940349|P1|Overall Study|Lost to Follow-up|3
4918754|NCT00503425|16940349|P1|Overall Study|Withdrawal by Subject|8
4918755|NCT00503425|16940349|P1|Overall Study|Lack of Efficacy|25
4918756|NCT00503425|16940349|P1|Overall Study|Adverse Event|5
4918757|NCT00503425|16940349|P1|Overall Study|Participant files lost|6
4918758|NCT00503399|16940359|P2|Overall Study|Lost to Follow-up|2
4918759|NCT00503399|16940360|P1|Overall Study|Lost to Follow-up|0
4918760|NCT00503399|16940359|P2|Overall Study|Adverse Event|3
4918761|NCT00503399|16940360|P1|Overall Study|Adverse Event|0
4918762|NCT00503399|16940359|P2|Overall Study|Withdrawal by Subject|2
4918763|NCT00503399|16940360|P1|Overall Study|Withdrawal by Subject|4
4918764|NCT00503399|16940359|P2|Overall Study|Protocol Violation|0
4918765|NCT00503399|16940360|P1|Overall Study|Protocol Violation|1
4918766|NCT00503399|16940359|P2|Overall Study|Death|1
4918767|NCT00503399|16940360|P1|Overall Study|Death|2
4918768|NCT00503308|16940384|P2|Overall Study|Protocol Violation|1
4918769|NCT00503308|16940385|P1|Overall Study|Protocol Violation|2
4918770|NCT00503139|16940391|P1|Overall Study|Protocol Violation|4
4918771|NCT00503139|16940391|P1|Overall Study|Case Report Forms were not collected|4
4918772|NCT00503009|16940439|P3|Overall Study|Physician Decision|1
4918773|NCT00503009|16940440|P2|Overall Study|Physician Decision|1
4918774|NCT00503009|16940441|P1|Overall Study|Physician Decision|0
4918775|NCT00503009|16940439|P3|Overall Study|Withdrawal by Subject|1
4918776|NCT00503009|16940440|P2|Overall Study|Withdrawal by Subject|1
4918777|NCT00503009|16940441|P1|Overall Study|Withdrawal by Subject|0
4918778|NCT00503009|16940439|P3|Overall Study|Protocol Violation|1
4918779|NCT00503009|16940440|P2|Overall Study|Protocol Violation|0
4918780|NCT00503009|16940441|P1|Overall Study|Protocol Violation|1
4918781|NCT00502996|16940458|P1|Overall Study|Adverse Event|2
4918782|NCT00502996|16940458|P1|Overall Study|Withdrawal Informed Consent|6
4918783|NCT00502996|16940458|P1|Overall Study|Treatment failure|25
4918784|NCT00502996|16940458|P1|Overall Study|Protocol Violation|2
4918785|NCT00502996|16940458|P1|Overall Study|Lost to Follow-up|9
4918786|NCT00502840|16940526|P1|Overall Study|Other|20
4918787|NCT00502840|16940526|P1|Overall Study|Administrative problems|1
4918788|NCT00502840|16940526|P1|Overall Study|Lost to Follow-up|6
4918789|NCT00502840|16940526|P1|Overall Study|Withdrawal by Subject|5
4918790|NCT00502840|16940526|P1|Overall Study|Protocol Violation|4
4918791|NCT00502840|16940526|P1|Overall Study|Lack of Efficacy|11
4918792|NCT00502840|16940526|P1|Overall Study|Additional or changed therapy|48
4918793|NCT00502840|16940526|P1|Overall Study|Adverse Event|5
4918794|NCT00502801|16940554|P1|End of Therapy to Test of Cure|OTHER|2
4918795|NCT00502801|16940554|P1|End of Therapy to Test of Cure|Death|3
4918796|NCT00502801|16940554|P1|End of Therapy to Test of Cure|Lost to Follow-up|2
4918797|NCT00502801|16940554|P1|End of Therapy to Test of Cure|Withdrawal by Subject|1
4918798|NCT00502801|16940554|P1|Treatment Period|OTHER|30
4918799|NCT00502801|16940554|P1|Treatment Period|Death|14
4918800|NCT00502801|16940554|P1|Treatment Period|Adverse Event|7
4918801|NCT00502801|16940554|P1|Treatment Period|Withdrawal by Subject|3
4918802|NCT00502775|16940562|P3|Overall Study|Subject took disallowed drug|1
4918803|NCT00502775|16940563|P2|Overall Study|Subject took disallowed drug|0
4918804|NCT00502775|16940564|P1|Overall Study|Subject took disallowed drug|0
4918805|NCT00502775|16940562|P3|Overall Study|Subject in jail|0
4918806|NCT00502775|16940563|P2|Overall Study|Subject in jail|1
4918807|NCT00502775|16940564|P1|Overall Study|Subject in jail|0
4918808|NCT00502775|16940562|P3|Overall Study|Declining pollen counts|1
4918809|NCT00502775|16940563|P2|Overall Study|Declining pollen counts|1
4918810|NCT00502775|16940564|P1|Overall Study|Declining pollen counts|0
4918811|NCT00502775|16940562|P3|Overall Study|Outside pollen area more than 48 hours|0
4918812|NCT00502775|16940563|P2|Overall Study|Outside pollen area more than 48 hours|1
4918813|NCT00502775|16940564|P1|Overall Study|Outside pollen area more than 48 hours|0
4918814|NCT00502775|16940562|P3|Overall Study|Non-compliance|2
4918815|NCT00502775|16940563|P2|Overall Study|Non-compliance|2
4918816|NCT00502775|16940564|P1|Overall Study|Non-compliance|0
4918817|NCT00502775|16940562|P3|Overall Study|Randomized in error|1
4918818|NCT00502775|16940563|P2|Overall Study|Randomized in error|1
4918819|NCT00502775|16940564|P1|Overall Study|Randomized in error|0
4918820|NCT00502775|16940562|P3|Overall Study|Logpad compliance <80%|0
4918821|NCT00502775|16940563|P2|Overall Study|Logpad compliance <80%|0
4918822|NCT00502775|16940564|P1|Overall Study|Logpad compliance <80%|1
4918823|NCT00502775|16940562|P3|Overall Study|Subject unable to swallow capsule|1
4918824|NCT00502775|16940563|P2|Overall Study|Subject unable to swallow capsule|0
4918825|NCT00502775|16940564|P1|Overall Study|Subject unable to swallow capsule|1
4918826|NCT00502775|16940562|P3|Overall Study|Non-compliance with eDiary|1
4918827|NCT00502775|16940563|P2|Overall Study|Non-compliance with eDiary|1
4918828|NCT00502775|16940564|P1|Overall Study|Non-compliance with eDiary|4
4918829|NCT00502775|16940562|P3|Overall Study|Sponsor Terminated Study|1
4918830|NCT00502775|16940563|P2|Overall Study|Sponsor Terminated Study|0
4918831|NCT00502775|16940564|P1|Overall Study|Sponsor Terminated Study|1
4918832|NCT00502775|16940562|P3|Overall Study|Withdrawal by Subject|2
4918833|NCT00502775|16940563|P2|Overall Study|Withdrawal by Subject|1
4918834|NCT00502775|16940564|P1|Overall Study|Withdrawal by Subject|1
4918835|NCT00502775|16940562|P3|Overall Study|Protocol Violation|2
4918836|NCT00502775|16940563|P2|Overall Study|Protocol Violation|5
4918837|NCT00502775|16940564|P1|Overall Study|Protocol Violation|1
4918838|NCT00502775|16940562|P3|Overall Study|Adverse Event|1
4918839|NCT00502775|16940563|P2|Overall Study|Adverse Event|2
4918840|NCT00502775|16940564|P1|Overall Study|Adverse Event|1
4918841|NCT00502697|16940607|P2|Overall Study|did not meet assignment criteria|2
4918842|NCT00502697|16940608|P1|Overall Study|did not meet assignment criteria|4
4918843|NCT00502697|16940607|P2|Overall Study|found not to meet eligibility criteria|4
4918844|NCT00502697|16940608|P1|Overall Study|found not to meet eligibility criteria|3
4918845|NCT00502697|16940607|P2|Overall Study|disenrolled due to pregnancy loss|5
4918846|NCT00502697|16940608|P1|Overall Study|disenrolled due to pregnancy loss|3
4918847|NCT00502697|16940607|P2|Overall Study|Withdrawal by Subject|1
4918848|NCT00502697|16940608|P1|Overall Study|Withdrawal by Subject|3
4918849|NCT00502671|16940616|P1|Overall Study|Adverse Event|19
4918850|NCT00502671|16940616|P1|Overall Study|Protocol Violation|16
4918851|NCT00502671|16940616|P1|Overall Study|Lost to Follow-up|7
4918852|NCT00502671|16940616|P1|Overall Study|Personal Reasons|22
4918853|NCT00502671|16940616|P1|Overall Study|Disease Progression|13
4918854|NCT00502593|16940633|P12|Overall Study|Lost to Follow-up|0
4918855|NCT00502593|16940634|P11|Overall Study|Lost to Follow-up|1
4918856|NCT00502593|16940635|P10|Overall Study|Lost to Follow-up|0
4918857|NCT00502593|16940636|P9|Overall Study|Lost to Follow-up|3
4918858|NCT00502593|16940637|P8|Overall Study|Lost to Follow-up|0
4918859|NCT00502593|16940638|P7|Overall Study|Lost to Follow-up|0
4918860|NCT00502593|16940639|P6|Overall Study|Lost to Follow-up|0
4918861|NCT00502593|16940640|P5|Overall Study|Lost to Follow-up|0
4918862|NCT00502593|16940641|P4|Overall Study|Lost to Follow-up|1
4918863|NCT00502593|16940642|P3|Overall Study|Lost to Follow-up|1
4918864|NCT00502593|16940643|P2|Overall Study|Lost to Follow-up|1
4918865|NCT00502593|16940644|P1|Overall Study|Lost to Follow-up|2
4918866|NCT00502593|16940633|P12|Overall Study|Withdrawal by Subject|0
4918867|NCT00502593|16940634|P11|Overall Study|Withdrawal by Subject|1
4918868|NCT00502593|16940635|P10|Overall Study|Withdrawal by Subject|0
4918869|NCT00502593|16940636|P9|Overall Study|Withdrawal by Subject|3
4918870|NCT00502593|16940637|P8|Overall Study|Withdrawal by Subject|0
4918871|NCT00502593|16940638|P7|Overall Study|Withdrawal by Subject|3
4918872|NCT00502593|16940639|P6|Overall Study|Withdrawal by Subject|0
4918873|NCT00502593|16940640|P5|Overall Study|Withdrawal by Subject|2
4918874|NCT00502593|16940641|P4|Overall Study|Withdrawal by Subject|2
4918875|NCT00502593|16940642|P3|Overall Study|Withdrawal by Subject|6
4918876|NCT00502593|16940643|P2|Overall Study|Withdrawal by Subject|0
4918877|NCT00502593|16940644|P1|Overall Study|Withdrawal by Subject|0
4918878|NCT00502593|16940633|P12|Overall Study|Withdrawn unspecified reason|0
4918879|NCT00502593|16940634|P11|Overall Study|Withdrawn unspecified reason|0
4918880|NCT00502593|16940635|P10|Overall Study|Withdrawn unspecified reason|0
4918881|NCT00502593|16940636|P9|Overall Study|Withdrawn unspecified reason|0
4918882|NCT00502593|16940637|P8|Overall Study|Withdrawn unspecified reason|0
4918883|NCT00502593|16940638|P7|Overall Study|Withdrawn unspecified reason|2
4918884|NCT00502593|16940639|P6|Overall Study|Withdrawn unspecified reason|0
4918885|NCT00502593|16940640|P5|Overall Study|Withdrawn unspecified reason|2
4918886|NCT00502593|16940641|P4|Overall Study|Withdrawn unspecified reason|1
4918887|NCT00502593|16940642|P3|Overall Study|Withdrawn unspecified reason|3
4918888|NCT00502593|16940643|P2|Overall Study|Withdrawn unspecified reason|1
4918889|NCT00502593|16940644|P1|Overall Study|Withdrawn unspecified reason|1
4918890|NCT00502320|16941160|P2|Overall Study|Adverse Event|5
4918891|NCT00502320|16941161|P1|Overall Study|Adverse Event|3
4918892|NCT00502320|16941160|P2|Overall Study|Screen Failure|1
4918893|NCT00502320|16941161|P1|Overall Study|Screen Failure|0
4918894|NCT00502320|16941160|P2|Overall Study|No longer met criteria|0
4918895|NCT00502320|16941161|P1|Overall Study|No longer met criteria|1
4918896|NCT00502320|16941160|P2|Overall Study|Withdrew Consent|0
4918897|NCT00502320|16941161|P1|Overall Study|Withdrew Consent|1
4918898|NCT00502320|16941160|P2|Overall Study|Lost to Follow-up|1
4918899|NCT00502320|16941161|P1|Overall Study|Lost to Follow-up|1
4918900|NCT00502307|16941171|P3|Maintenance Period|Discontinued due to other reasons|0
4918901|NCT00502307|16941172|P2|Maintenance Period|Discontinued due to other reasons|0
4918902|NCT00502307|16941173|P1|Maintenance Period|Discontinued due to other reasons|68
4918903|NCT00502307|16941171|P3|Maintenance Period|Progressive disease|0
4918904|NCT00502307|16941172|P2|Maintenance Period|Progressive disease|0
4918905|NCT00502307|16941173|P1|Maintenance Period|Progressive disease|80
4918906|NCT00502307|16941171|P3|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7
4918907|NCT00502307|16941172|P2|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3
4918908|NCT00502307|16941173|P1|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0
4918909|NCT00502307|16941171|P3|Double-Blind Period (12 Weeks)|Progressive disease|2
4918910|NCT00502307|16941172|P2|Double-Blind Period (12 Weeks)|Progressive disease|23
4918911|NCT00502307|16941173|P1|Double-Blind Period (12 Weeks)|Progressive disease|0
4918912|NCT00502307|16941171|P3|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
4918913|NCT00502307|16941172|P2|Open Label Period (16 Weeks)|Discontinued due to other reasons|0
4918914|NCT00502307|16941173|P1|Open Label Period (16 Weeks)|Discontinued due to other reasons|26
4918915|NCT00502307|16941171|P3|Open Label Period (16 Weeks)|Progressive disease|0
4918916|NCT00502307|16941172|P2|Open Label Period (16 Weeks)|Progressive disease|0
4918917|NCT00502307|16941173|P1|Open Label Period (16 Weeks)|Progressive disease|50
4918918|NCT00502242|16941200|P2|Overall Study|Withdrawal by Subject|7
4918919|NCT00502242|16941201|P1|Overall Study|Withdrawal by Subject|6
4918920|NCT00502242|16941200|P2|Overall Study|Protocol Violation|1
4918921|NCT00502242|16941201|P1|Overall Study|Protocol Violation|3
4918922|NCT00502242|16941200|P2|Overall Study|Other - Unspecified|14
4918923|NCT00502242|16941201|P1|Overall Study|Other - Unspecified|8
4918924|NCT00502242|16941200|P2|Overall Study|Physician Decision|3
4918925|NCT00502242|16941201|P1|Overall Study|Physician Decision|2
4918926|NCT00502242|16941200|P2|Overall Study|Adverse Event|20
4918927|NCT00502242|16941201|P1|Overall Study|Adverse Event|31
4918928|NCT00502242|16941200|P2|Overall Study|Lack of Efficacy|11
4918929|NCT00502242|16941201|P1|Overall Study|Lack of Efficacy|1
4918930|NCT00502203|16941265|P1|Overall Study|Inevaluable|1
4918931|NCT00501969|16941274|P1|Overall Study|Other: Sponsor Termination/Commercial RX|1
4918932|NCT00501969|16941274|P1|Overall Study|Other: Admin Request from the Sponsor|3
4918933|NCT00501969|16941274|P1|Overall Study|Other: As Required by Local EC|2
4918934|NCT00501969|16941274|P1|Overall Study|Other: DX Changed - Parkinsons to PSNP|1
4918935|NCT00501969|16941274|P1|Overall Study|Other: Pat Pending Surgery for PD|1
4918936|NCT00501969|16941274|P1|Overall Study|Other: Patient is Going to Have DBS|1
4918937|NCT00501969|16941274|P1|Overall Study|Other: Patients + Investigator Agreement|1
4918938|NCT00501969|16941274|P1|Overall Study|Other: Severe Dementia Unable Sign PIC|1
4918939|NCT00501969|16941274|P1|Overall Study|Other: Sponsor Stopped Study|12
4918940|NCT00501969|16941274|P1|Overall Study|Other: Sponsor Termination at Site|1
4918941|NCT00501969|16941274|P1|Overall Study|Other: Sponsors Request|10
4918942|NCT00501969|16941274|P1|Overall Study|Other: Tired Of Clinical Trial Process|1
4918943|NCT00501969|16941274|P1|Overall Study|Lost to Follow-up|4
4918944|NCT00501969|16941274|P1|Overall Study|Subject withdrew consent|51
4918945|NCT00501969|16941274|P1|Overall Study|Unsatisfactory compliance of subject|7
4918946|NCT00501969|16941274|P1|Overall Study|Adverse Event|76
4918947|NCT00501969|16941274|P1|Overall Study|Lack of Efficacy|29
4918948|NCT00501969|16941274|P1|Overall Study|Major Protocol Violation|4
4918949|NCT00501852|16941306|P1|Overall Study|Withdrawal by Subject|2
4918950|NCT00501852|16941306|P1|Overall Study|Adverse Event|3
4918951|NCT00501644|16941326|P1|Overall Study|Withdrawal by Subject|1
4918952|NCT00501644|16941326|P1|Overall Study|Adverse Event|4
4918953|NCT00501540|16941355|P1|Overall Study|Death|5
4918954|NCT00501293|16941367|P2|Maintenance Period|Application site reaction|0
4918955|NCT00501293|16941368|P1|Maintenance Period|Application site reaction|1
4918956|NCT00501293|16941367|P2|Maintenance Period|Would not wear patch|0
4918957|NCT00501293|16941368|P1|Maintenance Period|Would not wear patch|1
4918958|NCT00501293|16941367|P2|Maintenance Period|Went into rehabilitation|0
4918959|NCT00501293|16941368|P1|Maintenance Period|Went into rehabilitation|1
4918960|NCT00501293|16941367|P2|Maintenance Period|Noncompliant with study medication|0
4918961|NCT00501293|16941368|P1|Maintenance Period|Noncompliant with study medication|5
4918962|NCT00501293|16941367|P2|Maintenance Period|Lack of Efficacy|1
4918963|NCT00501293|16941368|P1|Maintenance Period|Lack of Efficacy|4
4918964|NCT00501293|16941367|P2|Maintenance Period|Protocol Violation|1
4918965|NCT00501293|16941368|P1|Maintenance Period|Protocol Violation|2
4918966|NCT00501293|16941367|P2|Maintenance Period|Adverse Event|6
4918967|NCT00501293|16941368|P1|Maintenance Period|Adverse Event|6
4918968|NCT00501293|16941367|P2|Maintenance Period|Lost to Follow-up|7
4918969|NCT00501293|16941368|P1|Maintenance Period|Lost to Follow-up|12
4918970|NCT00501293|16941367|P2|Maintenance Period|Withdrawal by Subject|13
4918971|NCT00501293|16941368|P1|Maintenance Period|Withdrawal by Subject|14
4918972|NCT00501293|16941367|P2|Optimization Period|Enrolled in error|0
4918973|NCT00501293|16941368|P1|Optimization Period|Enrolled in error|1
4918974|NCT00501228|16941395|P1|Overall Study|Withdrawal by Subject|1
4918975|NCT00501085|16941399|P1|Overall Study|Other loss to follow-up|32
4918976|NCT00501085|16941399|P1|Overall Study|Study closed by sponsor|109
4918977|NCT00501085|16941399|P1|Overall Study|Non-Compliance|24
4918978|NCT00501085|16941399|P1|Overall Study|Adverse Event|4
4918979|NCT00501085|16941399|P1|Overall Study|Explantation Surgery|26
4918980|NCT00501085|16941399|P1|Overall Study|Revision Surgery|7
4918981|NCT00501085|16941399|P1|Overall Study|Subject Decision|1
4918982|NCT00501085|16941399|P1|Overall Study|Withdrawal by Subject|34
4918983|NCT00501085|16941399|P1|Overall Study|Lost to Follow-up|195
4918984|NCT00501059|16941409|P2|Overall Study|Not treated|17
4918985|NCT00501059|16941410|P1|Overall Study|Not treated|25
4918986|NCT00501059|16941409|P2|Overall Study|Lost to Follow-up|198
4918987|NCT00501059|16941410|P1|Overall Study|Lost to Follow-up|210
4918988|NCT00501059|16941409|P2|Overall Study|Adverse Event|122
4918989|NCT00501059|16941410|P1|Overall Study|Adverse Event|129
4918990|NCT00501059|16941409|P2|Overall Study|Reason not given|1
4918991|NCT00501059|16941410|P1|Overall Study|Reason not given|3
4918992|NCT00501059|16941409|P2|Overall Study|Non-compliant with study treatment|16
4918993|NCT00501059|16941410|P1|Overall Study|Non-compliant with study treatment|23
4918994|NCT00501059|16941409|P2|Overall Study|Consent withdrawn by subject|873
4918995|NCT00501059|16941410|P1|Overall Study|Consent withdrawn by subject|817
4918996|NCT00501059|16941409|P2|Overall Study|Insufficient therapeutic effect|5
4918997|NCT00501059|16941410|P1|Overall Study|Insufficient therapeutic effect|4
4918998|NCT00501059|16941409|P2|Overall Study|Clinical endpoint reached|123
4918999|NCT00501059|16941410|P1|Overall Study|Clinical endpoint reached|110
4919000|NCT00501059|16941409|P2|Overall Study|Missing end-of-study page|92
4919001|NCT00501059|16941410|P1|Overall Study|Missing end-of-study page|91
4919002|NCT00501059|16941409|P2|Overall Study|Other|239
4919003|NCT00501059|16941410|P1|Overall Study|Other|236
4919004|NCT00501059|16941409|P2|Overall Study|Death|137
4919005|NCT00501059|16941410|P1|Overall Study|Death|140
4919006|NCT00501059|16941409|P2|Overall Study|Protocol Violation|69
4919007|NCT00501059|16941410|P1|Overall Study|Protocol Violation|80
4919008|NCT00501046|16941434|P2|Overall Study|Reaching endpoints,Noncompliance,etc|137
4919009|NCT00501046|16941435|P1|Overall Study|Reaching endpoints,Noncompliance,etc|119
4919010|NCT00501046|16941434|P2|Overall Study|Withdrawal by Subject|83
4919011|NCT00501046|16941435|P1|Overall Study|Withdrawal by Subject|84
4919012|NCT00501046|16941434|P2|Overall Study|Protocol Violation|1
4919013|NCT00501046|16941435|P1|Overall Study|Protocol Violation|2
4919014|NCT00501046|16941434|P2|Overall Study|Pregnancy|3
4919015|NCT00501046|16941435|P1|Overall Study|Pregnancy|0
4919016|NCT00501046|16941434|P2|Overall Study|Physician Decision|2
4919017|NCT00501046|16941435|P1|Overall Study|Physician Decision|7
4919018|NCT00501046|16941434|P2|Overall Study|Lost to Follow-up|13
4919019|NCT00501046|16941435|P1|Overall Study|Lost to Follow-up|14
4919020|NCT00501046|16941434|P2|Overall Study|Death|30
4919021|NCT00501046|16941435|P1|Overall Study|Death|23
4919022|NCT00501046|16941434|P2|Overall Study|Adverse Event|25
4919023|NCT00501046|16941435|P1|Overall Study|Adverse Event|21
4919024|NCT00501007|16941441|P2|Overall Study|Inclusion criteria not met.|25
4919025|NCT00501007|16941442|P1|Overall Study|Inclusion criteria not met.|29
4919026|NCT00500903|16941451|P3|Overall Study|Reason Not Specified|2
4919027|NCT00500903|16941452|P2|Overall Study|Reason Not Specified|0
4919028|NCT00500903|16941453|P1|Overall Study|Reason Not Specified|10
4919029|NCT00500903|16941451|P3|Overall Study|Symptomatic Deterioration|0
4919030|NCT00500903|16941452|P2|Overall Study|Symptomatic Deterioration|0
4919031|NCT00500903|16941453|P1|Overall Study|Symptomatic Deterioration|2
4919032|NCT00500903|16941451|P3|Overall Study|Patient Declined Further Treatment|3
4919033|NCT00500903|16941452|P2|Overall Study|Patient Declined Further Treatment|0
4919034|NCT00500903|16941453|P1|Overall Study|Patient Declined Further Treatment|0
4919035|NCT00500903|16941451|P3|Overall Study|Progressive Disease|15
4919036|NCT00500903|16941452|P2|Overall Study|Progressive Disease|2
4919037|NCT00500903|16941453|P1|Overall Study|Progressive Disease|41
4919038|NCT00500903|16941451|P3|Overall Study|Unsatisfactory Therapeutic Response|0
4919039|NCT00500903|16941452|P2|Overall Study|Unsatisfactory Therapeutic Response|0
4919040|NCT00500903|16941453|P1|Overall Study|Unsatisfactory Therapeutic Response|2
4919041|NCT00500903|16941451|P3|Overall Study|Occurrence of Adverse Event(s)|0
4919042|NCT00500903|16941452|P2|Overall Study|Occurrence of Adverse Event(s)|0
4919043|NCT00500903|16941453|P1|Overall Study|Occurrence of Adverse Event(s)|10
4919044|NCT00500760|16941649|P2|Overall Study|Other|2
4919045|NCT00500760|16941650|P1|Overall Study|Other|1
4919046|NCT00500760|16941649|P2|Overall Study|Lost to Follow-up|0
4919047|NCT00500760|16941650|P1|Overall Study|Lost to Follow-up|3
4919048|NCT00500760|16941649|P2|Overall Study|Administrative decision|0
4919049|NCT00500760|16941650|P1|Overall Study|Administrative decision|2
4919050|NCT00500760|16941649|P2|Overall Study|Withdrawal by Subject|7
4919051|NCT00500760|16941650|P1|Overall Study|Withdrawal by Subject|5
4919052|NCT00500760|16941649|P2|Overall Study|Death|15
4919053|NCT00500760|16941650|P1|Overall Study|Death|32
4919054|NCT00500682|16941670|P2|Overall Study|Reaching endpoints, Noncompliance, etc|144
4919055|NCT00500682|16941671|P1|Overall Study|Reaching endpoints, Noncompliance, etc|144
4919056|NCT00500682|16941670|P2|Overall Study|Withdrawal by Subject|74
4919057|NCT00500682|16941671|P1|Overall Study|Withdrawal by Subject|80
4919058|NCT00500682|16941670|P2|Overall Study|Protocol Violation|3
4919059|NCT00500682|16941671|P1|Overall Study|Protocol Violation|1
4919060|NCT00500682|16941670|P2|Overall Study|Pregnancy|0
4919061|NCT00500682|16941671|P1|Overall Study|Pregnancy|2
4919062|NCT00500682|16941670|P2|Overall Study|Physician Decision|10
4919063|NCT00500682|16941671|P1|Overall Study|Physician Decision|6
4919064|NCT00500682|16941670|P2|Overall Study|Lost to Follow-up|11
4919065|NCT00500682|16941671|P1|Overall Study|Lost to Follow-up|11
4919066|NCT00500682|16941670|P2|Overall Study|Death|16
4919067|NCT00500682|16941671|P1|Overall Study|Death|25
4919068|NCT00500682|16941670|P2|Overall Study|Adverse Event|29
4919069|NCT00500682|16941671|P1|Overall Study|Adverse Event|37
4919070|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Missing|3
4919071|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Protocol Deviation|1
4919072|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Death|1
4919073|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Administrative problems|1
4919074|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Lost to Follow-up|3
4919075|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Subject withdrew consent|2
4919076|NCT00500539|16941705|P1|Follow-up Period (16 Weeks)|Adverse Event|1
4919077|NCT00500539|16941705|P1|Treatment Period (24 Weeks)|Protocol Deviation|5
4919078|NCT00500539|16941705|P1|Treatment Period (24 Weeks)|Administrative problems|2
4919079|NCT00500539|16941705|P1|Treatment Period (24 Weeks)|Lost to Follow-up|2
4919080|NCT00500539|16941705|P1|Treatment Period (24 Weeks)|Subject withdrew consent|1
4919081|NCT00500539|16941705|P1|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1
4919082|NCT00500539|16941705|P1|Treatment Period (24 Weeks)|Adverse Event|4
4919083|NCT00500370|16941731|P2|Overall Study|Subject Decision|17
4919084|NCT00500370|16941732|P1|Overall Study|Subject Decision|10
4919085|NCT00500370|16941731|P2|Overall Study|Sponsor Decision|0
4919086|NCT00500370|16941732|P1|Overall Study|Sponsor Decision|2
4919087|NCT00500370|16941731|P2|Overall Study|Protocol Violation|4
4919088|NCT00500370|16941732|P1|Overall Study|Protocol Violation|2
4919089|NCT00500370|16941731|P2|Overall Study|Lost to Follow-up|10
4919090|NCT00500370|16941732|P1|Overall Study|Lost to Follow-up|10
4919091|NCT00500370|16941731|P2|Overall Study|Adverse Event|3
4919092|NCT00500370|16941732|P1|Overall Study|Adverse Event|9
4919093|NCT00500357|16941768|P1|Overall Study|Death|1
4919094|NCT00500331|16941794|P7|Overall Study|Protocol violated|0
4919095|NCT00500331|16941795|P6|Overall Study|Protocol violated|0
4919096|NCT00500331|16941796|P5|Overall Study|Protocol violated|0
4919097|NCT00500331|16941797|P4|Overall Study|Protocol violated|1
4919098|NCT00500331|16941798|P3|Overall Study|Protocol violated|0
4919099|NCT00500331|16941799|P2|Overall Study|Protocol violated|0
4919100|NCT00500331|16941800|P1|Overall Study|Protocol violated|0
4919101|NCT00500331|16941794|P7|Overall Study|State ban of biological samples export|0
4919102|NCT00500331|16941795|P6|Overall Study|State ban of biological samples export|0
4919103|NCT00500331|16941796|P5|Overall Study|State ban of biological samples export|0
4919104|NCT00500331|16941797|P4|Overall Study|State ban of biological samples export|1
4919105|NCT00500331|16941798|P3|Overall Study|State ban of biological samples export|0
4919106|NCT00500331|16941799|P2|Overall Study|State ban of biological samples export|0
4919107|NCT00500331|16941800|P1|Overall Study|State ban of biological samples export|0
4919108|NCT00500331|16941794|P7|Overall Study|Diabetologist nurse in the study|0
4919109|NCT00500331|16941795|P6|Overall Study|Diabetologist nurse in the study|0
4919110|NCT00500331|16941796|P5|Overall Study|Diabetologist nurse in the study|0
4919111|NCT00500331|16941797|P4|Overall Study|Diabetologist nurse in the study|0
4919112|NCT00500331|16941798|P3|Overall Study|Diabetologist nurse in the study|1
4919113|NCT00500331|16941799|P2|Overall Study|Diabetologist nurse in the study|0
4919114|NCT00500331|16941800|P1|Overall Study|Diabetologist nurse in the study|0
4919115|NCT00500331|16941794|P7|Overall Study|Participant was randomized by mistake|0
4919116|NCT00500331|16941795|P6|Overall Study|Participant was randomized by mistake|0
4919117|NCT00500331|16941796|P5|Overall Study|Participant was randomized by mistake|0
4919118|NCT00500331|16941797|P4|Overall Study|Participant was randomized by mistake|0
4919119|NCT00500331|16941798|P3|Overall Study|Participant was randomized by mistake|0
4919120|NCT00500331|16941799|P2|Overall Study|Participant was randomized by mistake|0
4919121|NCT00500331|16941800|P1|Overall Study|Participant was randomized by mistake|1
4919122|NCT00500331|16941794|P7|Overall Study|Sponsor decided to withdraw participant|0
4919123|NCT00500331|16941795|P6|Overall Study|Sponsor decided to withdraw participant|0
4919124|NCT00500331|16941796|P5|Overall Study|Sponsor decided to withdraw participant|0
4919125|NCT00500331|16941797|P4|Overall Study|Sponsor decided to withdraw participant|0
4919126|NCT00500331|16941798|P3|Overall Study|Sponsor decided to withdraw participant|0
4919127|NCT00500331|16941799|P2|Overall Study|Sponsor decided to withdraw participant|0
4919128|NCT00500331|16941800|P1|Overall Study|Sponsor decided to withdraw participant|1
4919129|NCT00500331|16941794|P7|Overall Study|Exclusion citeria not met on Visit 4|0
4919130|NCT00500331|16941795|P6|Overall Study|Exclusion citeria not met on Visit 4|0
4919131|NCT00500331|16941796|P5|Overall Study|Exclusion citeria not met on Visit 4|0
4919132|NCT00500331|16941797|P4|Overall Study|Exclusion citeria not met on Visit 4|0
4919133|NCT00500331|16941798|P3|Overall Study|Exclusion citeria not met on Visit 4|0
4919134|NCT00500331|16941799|P2|Overall Study|Exclusion citeria not met on Visit 4|0
4919135|NCT00500331|16941800|P1|Overall Study|Exclusion citeria not met on Visit 4|1
4919136|NCT00500331|16941794|P7|Overall Study|Didn't return for continuation of study|0
4919137|NCT00500331|16941795|P6|Overall Study|Didn't return for continuation of study|0
4919138|NCT00500331|16941796|P5|Overall Study|Didn't return for continuation of study|0
4919139|NCT00500331|16941797|P4|Overall Study|Didn't return for continuation of study|0
4919140|NCT00500331|16941798|P3|Overall Study|Didn't return for continuation of study|0
4919141|NCT00500331|16941799|P2|Overall Study|Didn't return for continuation of study|0
4919142|NCT00500331|16941800|P1|Overall Study|Didn't return for continuation of study|1
4919313|NCT00499369|16942304|P1|Overall Study|Ineligible|2
4919143|NCT00500331|16941794|P7|Overall Study|Increased serum creatinine from Baseline|0
4919144|NCT00500331|16941795|P6|Overall Study|Increased serum creatinine from Baseline|1
4919145|NCT00500331|16941796|P5|Overall Study|Increased serum creatinine from Baseline|0
4919146|NCT00500331|16941797|P4|Overall Study|Increased serum creatinine from Baseline|0
4919147|NCT00500331|16941798|P3|Overall Study|Increased serum creatinine from Baseline|0
4919148|NCT00500331|16941799|P2|Overall Study|Increased serum creatinine from Baseline|0
4919149|NCT00500331|16941800|P1|Overall Study|Increased serum creatinine from Baseline|0
4919150|NCT00500331|16941794|P7|Overall Study|Liver function test abnormality|0
4919151|NCT00500331|16941795|P6|Overall Study|Liver function test abnormality|0
4919152|NCT00500331|16941796|P5|Overall Study|Liver function test abnormality|0
4919153|NCT00500331|16941797|P4|Overall Study|Liver function test abnormality|0
4919154|NCT00500331|16941798|P3|Overall Study|Liver function test abnormality|1
4919155|NCT00500331|16941799|P2|Overall Study|Liver function test abnormality|0
4919156|NCT00500331|16941800|P1|Overall Study|Liver function test abnormality|0
4919157|NCT00500331|16941794|P7|Overall Study|Lack of Efficacy|0
4919158|NCT00500331|16941795|P6|Overall Study|Lack of Efficacy|0
4919159|NCT00500331|16941796|P5|Overall Study|Lack of Efficacy|0
4919160|NCT00500331|16941797|P4|Overall Study|Lack of Efficacy|0
4919161|NCT00500331|16941798|P3|Overall Study|Lack of Efficacy|0
4919162|NCT00500331|16941799|P2|Overall Study|Lack of Efficacy|1
4919163|NCT00500331|16941800|P1|Overall Study|Lack of Efficacy|3
4919164|NCT00500331|16941794|P7|Overall Study|Withdrawal by Subject|1
4919165|NCT00500331|16941795|P6|Overall Study|Withdrawal by Subject|1
4919166|NCT00500331|16941796|P5|Overall Study|Withdrawal by Subject|0
4919167|NCT00500331|16941797|P4|Overall Study|Withdrawal by Subject|5
4919168|NCT00500331|16941798|P3|Overall Study|Withdrawal by Subject|1
4919169|NCT00500331|16941799|P2|Overall Study|Withdrawal by Subject|0
4919170|NCT00500331|16941800|P1|Overall Study|Withdrawal by Subject|4
4919171|NCT00500331|16941794|P7|Overall Study|Protocol Violation|1
4919172|NCT00500331|16941795|P6|Overall Study|Protocol Violation|1
4919173|NCT00500331|16941796|P5|Overall Study|Protocol Violation|1
4919174|NCT00500331|16941797|P4|Overall Study|Protocol Violation|0
4919175|NCT00500331|16941798|P3|Overall Study|Protocol Violation|1
4919176|NCT00500331|16941799|P2|Overall Study|Protocol Violation|1
4919177|NCT00500331|16941800|P1|Overall Study|Protocol Violation|3
4919178|NCT00500331|16941794|P7|Overall Study|Lost to Follow-up|0
4919179|NCT00500331|16941795|P6|Overall Study|Lost to Follow-up|0
4919180|NCT00500331|16941796|P5|Overall Study|Lost to Follow-up|1
4919181|NCT00500331|16941797|P4|Overall Study|Lost to Follow-up|2
4919182|NCT00500331|16941798|P3|Overall Study|Lost to Follow-up|1
4919183|NCT00500331|16941799|P2|Overall Study|Lost to Follow-up|1
4919184|NCT00500331|16941800|P1|Overall Study|Lost to Follow-up|1
4919185|NCT00500331|16941794|P7|Overall Study|Adverse Event|0
4919186|NCT00500331|16941795|P6|Overall Study|Adverse Event|2
4919187|NCT00500331|16941796|P5|Overall Study|Adverse Event|2
4919188|NCT00500331|16941797|P4|Overall Study|Adverse Event|1
4919189|NCT00500331|16941798|P3|Overall Study|Adverse Event|0
4919190|NCT00500331|16941799|P2|Overall Study|Adverse Event|2
4919191|NCT00500331|16941800|P1|Overall Study|Adverse Event|0
4919192|NCT00500318|16941937|P2|Overall Study|Other Reason|1
4919193|NCT00500318|16941938|P1|Overall Study|Other Reason|0
4919194|NCT00500318|16941937|P2|Overall Study|Lack of Efficacy|3
4919195|NCT00500318|16941938|P1|Overall Study|Lack of Efficacy|0
4919196|NCT00500318|16941937|P2|Overall Study|Withdrawal by Subject|2
4919197|NCT00500318|16941938|P1|Overall Study|Withdrawal by Subject|1
4919198|NCT00500318|16941937|P2|Overall Study|Protocol Violation|3
4919199|NCT00500318|16941938|P1|Overall Study|Protocol Violation|1
4919200|NCT00500318|16941937|P2|Overall Study|Adverse Event|8
4919201|NCT00500318|16941938|P1|Overall Study|Adverse Event|3
4919202|NCT00500292|16941955|P3|Overall Study|Other|4
4919203|NCT00500292|16941956|P2|Overall Study|Other|1
4919204|NCT00500292|16941957|P1|Overall Study|Other|1
4919205|NCT00500292|16941955|P3|Overall Study|Withdrawal by Subject|0
4919206|NCT00500292|16941956|P2|Overall Study|Withdrawal by Subject|1
4919207|NCT00500292|16941957|P1|Overall Study|Withdrawal by Subject|0
4919208|NCT00500292|16941955|P3|Overall Study|Condition under investigation worsened|19
4919209|NCT00500292|16941956|P2|Overall Study|Condition under investigation worsened|23
4919210|NCT00500292|16941957|P1|Overall Study|Condition under investigation worsened|21
4919211|NCT00500292|16941955|P3|Overall Study|Adverse Event|4
4919212|NCT00500292|16941956|P2|Overall Study|Adverse Event|6
4919213|NCT00500292|16941957|P1|Overall Study|Adverse Event|3
4919214|NCT00500149|16941978|P2|Second Intervention (Cross-over Phase)|Lost to Follow-up|0
4919215|NCT00500149|16941979|P1|Second Intervention (Cross-over Phase)|Lost to Follow-up|2
4919216|NCT00500149|16941978|P2|First Intervention (Cross-over Phase)|Protocol Violation|0
4919217|NCT00500149|16941979|P1|First Intervention (Cross-over Phase)|Protocol Violation|1
4919218|NCT00500149|16941978|P2|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
4919219|NCT00500149|16941979|P1|First Intervention (Cross-over Phase)|Withdrawal by Subject|1
4919220|NCT00500149|16941978|P2|First Intervention (Cross-over Phase)|Adverse Event|1
4919221|NCT00500149|16941979|P1|First Intervention (Cross-over Phase)|Adverse Event|0
4919222|NCT00500149|16941978|P2|Enrolled (Dose-optimization Phase)|Protocol Violation|0
4919223|NCT00500149|16941979|P1|Enrolled (Dose-optimization Phase)|Protocol Violation|1
4919224|NCT00500149|16941978|P2|Enrolled (Dose-optimization Phase)|Adverse Event|0
4919225|NCT00500149|16941979|P1|Enrolled (Dose-optimization Phase)|Adverse Event|8
4919314|NCT00499369|16942300|P5|Overall Study|Not protocol specified|0
4919226|NCT00500149|16941978|P2|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0
4919227|NCT00500149|16941979|P1|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3
4919228|NCT00500110|16941987|P1|Overall Study|Withdrawal by Subject|3
4919229|NCT00500071|16941991|P1|30-day Safety Follow-up|Lost to Follow-up|17
4919230|NCT00500071|16941991|P1|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4
4919231|NCT00500071|16941991|P1|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1
4919232|NCT00500071|16941991|P1|Dose-optimization and Maintenance Phase|Lack of Efficacy|2
4919233|NCT00500071|16941991|P1|Dose-optimization and Maintenance Phase|Protocol Violation|2
4919234|NCT00500071|16941991|P1|Dose-optimization and Maintenance Phase|Adverse Event|13
4919235|NCT00500071|16941991|P1|Screening and Washout Phase|Protocol Violation|1
4919236|NCT00499889|16942014|P1|Overall Study|Infection prior to treatment|1
4919237|NCT00499863|16942022|P2|Overall Study|Lost to Follow-up|1
4919238|NCT00499863|16942023|P1|Overall Study|Lost to Follow-up|1
4919239|NCT00499863|16942022|P2|Overall Study|Sponsor decision|2
4919240|NCT00499863|16942023|P1|Overall Study|Sponsor decision|2
4919241|NCT00499863|16942022|P2|Overall Study|Adverse Event|2
4919242|NCT00499863|16942023|P1|Overall Study|Adverse Event|8
4919243|NCT00499863|16942022|P2|Overall Study|Withdrawal by Subject|4
4919244|NCT00499863|16942023|P1|Overall Study|Withdrawal by Subject|6
4919245|NCT00499863|16942022|P2|Overall Study|Protocol Violation|7
4919246|NCT00499863|16942023|P1|Overall Study|Protocol Violation|12
4919247|NCT00499863|16942022|P2|Overall Study|Lack of Efficacy|27
4919248|NCT00499863|16942023|P1|Overall Study|Lack of Efficacy|21
4919249|NCT00500266|16942051|P1|Overall Study|Assigned, not treated|4
4919250|NCT00500266|16942051|P1|Overall Study|Withdrawal by Subject|3
4919251|NCT00500266|16942051|P1|Overall Study|Lost to Follow-up|3
4919252|NCT00500266|16942051|P1|Overall Study|Death|3
4919253|NCT00499746|16942058|P1|Phase 1(6-9 One Day Sessions)|Unable to determine|1
4919254|NCT00499746|16942058|P1|Phase 1(6-9 One Day Sessions)|Investigator decision|1
4919255|NCT00499746|16942058|P1|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3
4919256|NCT00499746|16942058|P1|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7
4919257|NCT00499694|16942127|P1|Overall Study|Patient never received treatment.|1
4919258|NCT00499681|16942136|P2|Overall Study|disease progression|1
4919259|NCT00499681|16942137|P1|Overall Study|disease progression|0
4919260|NCT00499681|16942136|P2|Overall Study|toxicity|1
4919261|NCT00499681|16942137|P1|Overall Study|toxicity|0
4919262|NCT00499616|16942164|P4|Overall Study|Patient/Parent Refusal|0
4919263|NCT00499616|16942165|P3|Overall Study|Patient/Parent Refusal|3
4919264|NCT00499616|16942166|P2|Overall Study|Patient/Parent Refusal|5
4919265|NCT00499616|16942167|P1|Overall Study|Patient/Parent Refusal|1
4919266|NCT00499616|16942164|P4|Overall Study|Not evaluable|41
4919267|NCT00499616|16942165|P3|Overall Study|Not evaluable|0
4919268|NCT00499616|16942166|P2|Overall Study|Not evaluable|0
4919269|NCT00499616|16942167|P1|Overall Study|Not evaluable|0
4919270|NCT00499616|16942164|P4|Overall Study|Ineligible|15
4919271|NCT00499616|16942165|P3|Overall Study|Ineligible|0
4919272|NCT00499616|16942166|P2|Overall Study|Ineligible|2
4919273|NCT00499616|16942167|P1|Overall Study|Ineligible|1
4919274|NCT00499616|16942164|P4|Overall Study|Withdrawal by Subject|0
4919275|NCT00499616|16942165|P3|Overall Study|Withdrawal by Subject|1
4919276|NCT00499616|16942166|P2|Overall Study|Withdrawal by Subject|0
4919277|NCT00499616|16942167|P1|Overall Study|Withdrawal by Subject|1
4919278|NCT00499616|16942164|P4|Overall Study|Physician Decision|0
4919279|NCT00499616|16942165|P3|Overall Study|Physician Decision|9
4919280|NCT00499616|16942166|P2|Overall Study|Physician Decision|16
4919281|NCT00499616|16942167|P1|Overall Study|Physician Decision|6
4919282|NCT00499616|16942164|P4|Overall Study|Lost to Follow-up|0
4919283|NCT00499616|16942165|P3|Overall Study|Lost to Follow-up|1
4919284|NCT00499616|16942166|P2|Overall Study|Lost to Follow-up|0
4919285|NCT00499616|16942167|P1|Overall Study|Lost to Follow-up|0
4919286|NCT00499616|16942164|P4|Overall Study|Lack of Efficacy|0
4919287|NCT00499616|16942165|P3|Overall Study|Lack of Efficacy|19
4919288|NCT00499616|16942166|P2|Overall Study|Lack of Efficacy|0
4919289|NCT00499616|16942167|P1|Overall Study|Lack of Efficacy|5
4919290|NCT00499616|16942164|P4|Overall Study|Death|1
4919291|NCT00499616|16942165|P3|Overall Study|Death|3
4919292|NCT00499616|16942166|P2|Overall Study|Death|5
4919293|NCT00499616|16942167|P1|Overall Study|Death|1
4919294|NCT00499603|16942212|P2|Overall Study|Adverse Event|1
4919295|NCT00499603|16942213|P1|Overall Study|Adverse Event|0
4919296|NCT00499590|16942226|P3|Overall Study|Not treated|1
4919297|NCT00499590|16942227|P2|Overall Study|Not treated|0
4919298|NCT00499590|16942228|P1|Overall Study|Not treated|1
4919299|NCT00499590|16942226|P3|Overall Study|Study Terminated|112
4919300|NCT00499590|16942227|P2|Overall Study|Study Terminated|112
4919301|NCT00499590|16942228|P1|Overall Study|Study Terminated|112
4919302|NCT00499486|16942239|P1|Overall Study|Withdrawal by Subject|16
4919303|NCT00499460|16942266|P2|Intervention 2 (30 Days)|Withdrawal by Subject|1
4919304|NCT00499460|16942267|P1|Intervention 2 (30 Days)|Withdrawal by Subject|0
4919305|NCT00499460|16942266|P2|Intervention 1 (30 Days)|Fainting upon Blood Draw|0
4919306|NCT00499460|16942267|P1|Intervention 1 (30 Days)|Fainting upon Blood Draw|1
4919307|NCT00499460|16942266|P2|Intervention 1 (30 Days)|Withdrawal by Subject|0
4919308|NCT00499460|16942267|P1|Intervention 1 (30 Days)|Withdrawal by Subject|1
4919309|NCT00499369|16942300|P5|Overall Study|Ineligible|0
4919310|NCT00499369|16942301|P4|Overall Study|Ineligible|1
4919311|NCT00499369|16942302|P3|Overall Study|Ineligible|1
4919312|NCT00499369|16942303|P2|Overall Study|Ineligible|2
4919315|NCT00499369|16942301|P4|Overall Study|Not protocol specified|1
4919316|NCT00499369|16942302|P3|Overall Study|Not protocol specified|3
4919317|NCT00499369|16942303|P2|Overall Study|Not protocol specified|0
4919318|NCT00499369|16942304|P1|Overall Study|Not protocol specified|2
4919319|NCT00499369|16942300|P5|Overall Study|Death|0
4919320|NCT00499369|16942301|P4|Overall Study|Death|0
4919321|NCT00499369|16942302|P3|Overall Study|Death|0
4919322|NCT00499369|16942303|P2|Overall Study|Death|1
4919323|NCT00499369|16942304|P1|Overall Study|Death|0
4919324|NCT00499369|16942300|P5|Overall Study|Progression|10
4919325|NCT00499369|16942301|P4|Overall Study|Progression|6
4919326|NCT00499369|16942302|P3|Overall Study|Progression|9
4919327|NCT00499369|16942303|P2|Overall Study|Progression|12
4919328|NCT00499369|16942304|P1|Overall Study|Progression|10
4919329|NCT00499369|16942300|P5|Overall Study|Withdrawal by Subject|0
4919330|NCT00499369|16942301|P4|Overall Study|Withdrawal by Subject|0
4919331|NCT00499369|16942302|P3|Overall Study|Withdrawal by Subject|1
4919332|NCT00499369|16942303|P2|Overall Study|Withdrawal by Subject|1
4919333|NCT00499369|16942304|P1|Overall Study|Withdrawal by Subject|0
4919334|NCT00499369|16942300|P5|Overall Study|Adverse Event|2
4919335|NCT00499369|16942301|P4|Overall Study|Adverse Event|1
4919336|NCT00499369|16942302|P3|Overall Study|Adverse Event|3
4919337|NCT00499369|16942303|P2|Overall Study|Adverse Event|2
4919338|NCT00499369|16942304|P1|Overall Study|Adverse Event|2
4919339|NCT00499252|16942340|P1|Overall Study|<no further label>|3
4919340|NCT00499252|16942340|P1|Overall Study|Ineligible|4
4919341|NCT00499252|16942340|P1|Overall Study|Refused further treatment|2
4919342|NCT00499252|16942340|P1|Overall Study|Adverse Event|3
4919343|NCT00499122|16942350|P1|Overall Study|Withdrawal by Subject|2
4919344|NCT00499083|16942393|P1|Overall Study|Not evaluable|3
4919345|NCT00499031|16942400|P1|Overall Study|Never treated|1
4919346|NCT00499031|16942400|P1|Overall Study|Required test not done|1
4919347|NCT00499031|16942400|P1|Overall Study|Improper pre-protocol treatment|1
4919348|NCT00498797|16942423|P2|Overall Study|Other|1
4919349|NCT00498797|16942424|P1|Overall Study|Other|3
4919350|NCT00498797|16942423|P2|Overall Study|Condition under investigation worsened|21
4919351|NCT00498797|16942424|P1|Overall Study|Condition under investigation worsened|19
4919352|NCT00498797|16942423|P2|Overall Study|Adverse Event|5
4919353|NCT00498797|16942424|P1|Overall Study|Adverse Event|12
4919354|NCT00498797|16942423|P2|Overall Study|Withdrawal by Subject|2
4919355|NCT00498797|16942424|P1|Overall Study|Withdrawal by Subject|4
4919356|NCT00498602|16942508|P7|Overall Study|Other|0
4919357|NCT00498602|16942509|P6|Overall Study|Other|3
4919358|NCT00498602|16942510|P5|Overall Study|Other|0
4919359|NCT00498602|16942511|P4|Overall Study|Other|0
4919360|NCT00498602|16942512|P3|Overall Study|Other|1
4919361|NCT00498602|16942513|P2|Overall Study|Other|3
4919362|NCT00498602|16942514|P1|Overall Study|Other|2
4919363|NCT00498602|16942508|P7|Overall Study|Subject Request|1
4919364|NCT00498602|16942509|P6|Overall Study|Subject Request|4
4919365|NCT00498602|16942510|P5|Overall Study|Subject Request|1
4919366|NCT00498602|16942511|P4|Overall Study|Subject Request|1
4919367|NCT00498602|16942512|P3|Overall Study|Subject Request|1
4919368|NCT00498602|16942513|P2|Overall Study|Subject Request|0
4919369|NCT00498602|16942514|P1|Overall Study|Subject Request|3
4919370|NCT00498602|16942508|P7|Overall Study|Investigator Request|0
4919371|NCT00498602|16942509|P6|Overall Study|Investigator Request|0
4919372|NCT00498602|16942510|P5|Overall Study|Investigator Request|0
4919373|NCT00498602|16942511|P4|Overall Study|Investigator Request|0
4919374|NCT00498602|16942512|P3|Overall Study|Investigator Request|1
4919375|NCT00498602|16942513|P2|Overall Study|Investigator Request|0
4919376|NCT00498602|16942514|P1|Overall Study|Investigator Request|0
4919377|NCT00498602|16942508|P7|Overall Study|Caregiver Request|0
4919378|NCT00498602|16942509|P6|Overall Study|Caregiver Request|2
4919379|NCT00498602|16942510|P5|Overall Study|Caregiver Request|1
4919380|NCT00498602|16942511|P4|Overall Study|Caregiver Request|0
4919381|NCT00498602|16942512|P3|Overall Study|Caregiver Request|2
4919382|NCT00498602|16942513|P2|Overall Study|Caregiver Request|2
4919383|NCT00498602|16942514|P1|Overall Study|Caregiver Request|2
4919384|NCT00498602|16942508|P7|Overall Study|AE not related to Study Drug|1
4919385|NCT00498602|16942509|P6|Overall Study|AE not related to Study Drug|2
4919386|NCT00498602|16942510|P5|Overall Study|AE not related to Study Drug|2
4919387|NCT00498602|16942511|P4|Overall Study|AE not related to Study Drug|0
4919388|NCT00498602|16942512|P3|Overall Study|AE not related to Study Drug|0
4919389|NCT00498602|16942513|P2|Overall Study|AE not related to Study Drug|3
4919390|NCT00498602|16942514|P1|Overall Study|AE not related to Study Drug|1
4919391|NCT00498602|16942508|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
4919392|NCT00498602|16942509|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
4919393|NCT00498602|16942510|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
4919394|NCT00498602|16942511|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
4919395|NCT00498602|16942512|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
4919396|NCT00498602|16942513|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
4919397|NCT00498602|16942514|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
4919398|NCT00498602|16942508|P7|Overall Study|Lost to Follow-up|0
4919399|NCT00498602|16942509|P6|Overall Study|Lost to Follow-up|0
4919400|NCT00498602|16942510|P5|Overall Study|Lost to Follow-up|0
4919401|NCT00498602|16942511|P4|Overall Study|Lost to Follow-up|2
4919402|NCT00498602|16942512|P3|Overall Study|Lost to Follow-up|0
4919403|NCT00498602|16942513|P2|Overall Study|Lost to Follow-up|2
4919404|NCT00498602|16942514|P1|Overall Study|Lost to Follow-up|0
4919405|NCT00498602|16942508|P7|Overall Study|Lack of Efficacy|0
4919406|NCT00498602|16942509|P6|Overall Study|Lack of Efficacy|0
4919407|NCT00498602|16942510|P5|Overall Study|Lack of Efficacy|0
4919408|NCT00498602|16942511|P4|Overall Study|Lack of Efficacy|0
4919409|NCT00498602|16942512|P3|Overall Study|Lack of Efficacy|0
4919410|NCT00498602|16942513|P2|Overall Study|Lack of Efficacy|0
4919411|NCT00498602|16942514|P1|Overall Study|Lack of Efficacy|1
4919412|NCT00498602|16942508|P7|Overall Study|Death|0
4919413|NCT00498602|16942509|P6|Overall Study|Death|1
4919414|NCT00498602|16942510|P5|Overall Study|Death|0
4919415|NCT00498602|16942511|P4|Overall Study|Death|0
4919416|NCT00498602|16942512|P3|Overall Study|Death|0
4919417|NCT00498602|16942513|P2|Overall Study|Death|0
4919418|NCT00498602|16942514|P1|Overall Study|Death|0
4919419|NCT00498485|16942562|P2|Overall Study|Adverse Event|5
4919420|NCT00498485|16942563|P1|Overall Study|Adverse Event|1
4919421|NCT00498433|16942574|P3|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
4919422|NCT00498433|16942575|P2|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0
4919423|NCT00498433|16942576|P1|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1
4919424|NCT00498433|16942574|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
4919425|NCT00498433|16942575|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0
4919426|NCT00498433|16942576|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15
4919427|NCT00498433|16942574|P3|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
4919428|NCT00498433|16942575|P2|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0
4919429|NCT00498433|16942576|P1|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2
4919430|NCT00498433|16942574|P3|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
4919431|NCT00498433|16942575|P2|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0
4919432|NCT00498433|16942576|P1|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2
4919433|NCT00498368|16942621|P2|Overall Study|Withdrawal by Subject|2
4919434|NCT00498368|16942622|P1|Overall Study|Withdrawal by Subject|3
4919435|NCT00498355|16942634|P1|Overall Study|Lost to Follow-up|1
4919436|NCT00498186|16942642|P1|Overall Study|Other|10
4919437|NCT00498186|16942642|P1|Overall Study|Lost to Follow-up|3
4919438|NCT00498186|16942642|P1|Overall Study|Withdrawal by Subject|18
4919439|NCT00498186|16942642|P1|Overall Study|Unsatisfactory compliance of subject|12
4919440|NCT00498186|16942642|P1|Overall Study|Adverse Event|89
4919441|NCT00498186|16942642|P1|Overall Study|Lack of Efficacy|31
4919442|NCT00498186|16942642|P1|Overall Study|Protocol Violation|10
4919443|NCT00498173|16942649|P3|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|0
4919444|NCT00498173|16942650|P2|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|1
4919445|NCT00498173|16942651|P1|Phase 1-Blinded Randomization (8 Weeks)|no post-baseline ratings|2
4919446|NCT00497874|16942681|P2|Overall Study|Unable to schedule|24
4919447|NCT00497874|16942682|P1|Overall Study|Unable to schedule|37
4919448|NCT00497874|16942681|P2|Overall Study|Unable to contact|67
4919449|NCT00497874|16942682|P1|Overall Study|Unable to contact|52
4919450|NCT00497874|16942681|P2|Overall Study|Death|4
4919451|NCT00497874|16942682|P1|Overall Study|Death|2
4919452|NCT00497874|16942681|P2|Overall Study|Illness|4
4919453|NCT00497874|16942682|P1|Overall Study|Illness|8
4919454|NCT00497874|16942681|P2|Overall Study|Withdrawal by Subject|17
4919455|NCT00497874|16942682|P1|Overall Study|Withdrawal by Subject|48
4919456|NCT00497796|16942700|P2|Overall Study|Not applicable (randomized not treated)|4
4919457|NCT00497796|16942701|P1|Overall Study|Not applicable (randomized not treated)|0
4919458|NCT00497796|16942700|P2|Overall Study|Lost to Follow-up|1
4919459|NCT00497796|16942701|P1|Overall Study|Lost to Follow-up|0
4919460|NCT00497796|16942700|P2|Overall Study|Investigator/sponsor discretion|34
4919461|NCT00497796|16942701|P1|Overall Study|Investigator/sponsor discretion|31
4919462|NCT00497796|16942700|P2|Overall Study|Consent withdrawn|3
4919463|NCT00497796|16942701|P1|Overall Study|Consent withdrawn|10
4919464|NCT00497796|16942700|P2|Overall Study|CMV infection or disease treatment|4
4919465|NCT00497796|16942701|P1|Overall Study|CMV infection or disease treatment|30
4919466|NCT00497796|16942700|P2|Overall Study|Adverse event (related)|4
4919467|NCT00497796|16942701|P1|Overall Study|Adverse event (related)|5
4919468|NCT00497796|16942700|P2|Overall Study|Adverse event (not related)|9
4919469|NCT00497796|16942701|P1|Overall Study|Adverse event (not related)|9
4919470|NCT00497198|16942788|P2|Overall Study|Withdrawal by Subject|1
4919471|NCT00497198|16942789|P1|Overall Study|Withdrawal by Subject|0
4919472|NCT00497198|16942788|P2|Overall Study|Physician Decision|2
4919473|NCT00497198|16942789|P1|Overall Study|Physician Decision|1
4919474|NCT00497198|16942788|P2|Overall Study|Adverse Event|2
4919475|NCT00497198|16942789|P1|Overall Study|Adverse Event|4
4919476|NCT00497146|16942805|P2|Long-term Follow-up Period|Other|1
4919477|NCT00497146|16942806|P1|Long-term Follow-up Period|Other|0
4919478|NCT00497146|16942805|P2|Long-term Follow-up Period|Lost to Follow-up|1
4919479|NCT00497146|16942806|P1|Long-term Follow-up Period|Lost to Follow-up|5
4919480|NCT00497146|16942805|P2|Long-term Follow-up Period|Withdrawal by Subject|2
4919481|NCT00497146|16942806|P1|Long-term Follow-up Period|Withdrawal by Subject|8
4919482|NCT00497146|16942805|P2|Long-term Follow-up Period|Adverse Event|2
4919483|NCT00497146|16942806|P1|Long-term Follow-up Period|Adverse Event|2
4919484|NCT00497146|16942805|P2|Treatment Period|Other Reason|3
4919485|NCT00497146|16942806|P1|Treatment Period|Other Reason|2
4919486|NCT00497146|16942805|P2|Treatment Period|Unable to dose reduce per protocol|1
4919487|NCT00497146|16942806|P1|Treatment Period|Unable to dose reduce per protocol|4
4919488|NCT00497146|16942805|P2|Treatment Period|Change in RAAS inhibitor therapy|2
4919489|NCT00497146|16942806|P1|Treatment Period|Change in RAAS inhibitor therapy|5
4919490|NCT00497146|16942805|P2|Treatment Period|Required dialysis|1
4919491|NCT00497146|16942806|P1|Treatment Period|Required dialysis|4
4919492|NCT00497146|16942805|P2|Treatment Period|Lost to Follow-up|3
4919493|NCT00497146|16942806|P1|Treatment Period|Lost to Follow-up|1
4919494|NCT00497146|16942805|P2|Treatment Period|Withdrawal by Subject|9
4919495|NCT00497146|16942806|P1|Treatment Period|Withdrawal by Subject|5
4919496|NCT00497146|16942805|P2|Treatment Period|Adverse Event|2
4919497|NCT00497146|16942806|P1|Treatment Period|Adverse Event|6
4919498|NCT00496964|16942874|P2|Overall Study|Withdrawal by Subject|1
4919499|NCT00496964|16942875|P1|Overall Study|Withdrawal by Subject|0
4919500|NCT00496873|16942893|P1|Overall Study|Withdrawal by Subject|3
4919501|NCT00496873|16942893|P1|Overall Study|Death|2
4919502|NCT00496873|16942893|P1|Overall Study|Ineligible|2
4919503|NCT00496834|16942926|P2|Overall Study|Blood Pressure control failure|1
4919504|NCT00496834|16942927|P1|Overall Study|Blood Pressure control failure|2
4919505|NCT00496834|16942926|P2|Overall Study|Lost to Follow-up|0
4919506|NCT00496834|16942927|P1|Overall Study|Lost to Follow-up|2
4919507|NCT00496834|16942926|P2|Overall Study|IP administration violation|0
4919508|NCT00496834|16942927|P1|Overall Study|IP administration violation|2
4919509|NCT00496834|16942926|P2|Overall Study|Adverse Event|3
4919510|NCT00496834|16942927|P1|Overall Study|Adverse Event|5
4919511|NCT00496834|16942926|P2|Overall Study|Inclusion/exclusion criteria not met|2
4919512|NCT00496834|16942927|P1|Overall Study|Inclusion/exclusion criteria not met|3
4919513|NCT00496834|16942926|P2|Overall Study|Contraindicated medication administered|1
4919514|NCT00496834|16942927|P1|Overall Study|Contraindicated medication administered|0
4919515|NCT00496834|16942926|P2|Overall Study|Withdrawal by Subject|6
4919516|NCT00496834|16942927|P1|Overall Study|Withdrawal by Subject|4
4919517|NCT00496782|16942946|P2|Overall Study|Protocol Violation|2
4919518|NCT00496782|16942947|P1|Overall Study|Protocol Violation|1
4919519|NCT00496769|16942981|P3|Open Label|>=1 reason assigned per patient|1011
4919520|NCT00496769|16942982|P2|Open Label|>=1 reason assigned per patient|0
4919521|NCT00496769|16942983|P1|Open Label|>=1 reason assigned per patient|0
4919522|NCT00496769|16942981|P3|Double Blind|>=1 reason assigned per patient|0
4919523|NCT00496769|16942982|P2|Double Blind|>=1 reason assigned per patient|649
4919524|NCT00496769|16942983|P1|Double Blind|>=1 reason assigned per patient|558
4919525|NCT00496730|16943013|P2|Overall Study|Withdrawal by Subject|2
4919526|NCT00496730|16943014|P1|Overall Study|Withdrawal by Subject|2
4919527|NCT00496730|16943013|P2|Overall Study|Lost to Follow-up|3
4919528|NCT00496730|16943014|P1|Overall Study|Lost to Follow-up|4
4919529|NCT00496626|16943026|P2|Overall Study|Relocated|1
4919530|NCT00496626|16943027|P1|Overall Study|Relocated|0
4919531|NCT00496626|16943026|P2|Overall Study|Withdrawal by Subject|4
4919532|NCT00496626|16943027|P1|Overall Study|Withdrawal by Subject|5
4919533|NCT00496626|16943026|P2|Overall Study|Protocol Violation|0
4919534|NCT00496626|16943027|P1|Overall Study|Protocol Violation|1
4919535|NCT00496626|16943026|P2|Overall Study|Lost to Follow-up|1
4919536|NCT00496626|16943027|P1|Overall Study|Lost to Follow-up|0
4919537|NCT00496587|16943039|P1|Overall Study|Complications unrelated|2
4919538|NCT00496587|16943039|P1|Overall Study|Death|1
4919539|NCT00496587|16943039|P1|Overall Study|Withdrawal by Subject|2
4919540|NCT00496587|16943039|P1|Overall Study|Progressive Disease|24
4919541|NCT00496587|16943039|P1|Overall Study|Adverse Event|2
4919542|NCT00496483|16943045|P1|Overall Study|Lack of Efficacy|1
4919543|NCT00496483|16943045|P1|Overall Study|Adverse Event|2
4919544|NCT00496483|16943045|P1|Overall Study|Not dosed|9
4919545|NCT00496470|16943062|P2|Overall Study|Other reason|2
4919546|NCT00496470|16943063|P1|Overall Study|Other reason|0
4919547|NCT00496470|16943062|P2|Overall Study|Incorrectly enrolled|5
4919548|NCT00496470|16943063|P1|Overall Study|Incorrectly enrolled|13
4919549|NCT00496470|16943062|P2|Overall Study|Withdrawal by Subject|12
4919550|NCT00496470|16943063|P1|Overall Study|Withdrawal by Subject|5
4919551|NCT00496470|16943062|P2|Overall Study|Adverse Event|10
4919552|NCT00496470|16943063|P1|Overall Study|Adverse Event|8
4919553|NCT00496366|16943149|P1|Overall Study|Death|1
4919554|NCT00496197|16943180|P1|Overall Study|Protocol Violation|8
4919555|NCT00496197|16943180|P1|Overall Study|Other|14
4919556|NCT00496197|16943180|P1|Overall Study|Pathogen not isolated baseline specimen|4
4919557|NCT00496197|16943180|P1|Overall Study|Withdrawal by Subject|11
4919558|NCT00496197|16943180|P1|Overall Study|Lost to Follow-up|11
4919559|NCT00496197|16943180|P1|Overall Study|Insufficient bacteriological response|10
4919560|NCT00496197|16943180|P1|Overall Study|Insufficient clinical response|3
4919561|NCT00496197|16943180|P1|Overall Study|Does not meet entrance criteria|5
4919562|NCT00496197|16943180|P1|Overall Study|Adverse Event|13
4919563|NCT00496197|16943180|P1|Overall Study|Discontinued study due to death|43
4919564|NCT00496080|16943207|P1|Overall Study|Physician Decision|6
4919565|NCT00496080|16943207|P1|Overall Study|Withdrawal by Subject|5
4919566|NCT00496080|16943207|P1|Overall Study|Surgical re-intervention|7
4919567|NCT00496080|16943207|P1|Overall Study|Lost to Follow-up|9
4919568|NCT00496054|16943217|P1|Overall Study|Lost to Follow-up|7
4919569|NCT00496054|16943217|P1|Overall Study|Adverse Event|1
4919570|NCT00496015|16943249|P5|Overall Study|Other|0
4919571|NCT00496015|16943250|P4|Overall Study|Other|1
4919572|NCT00496015|16943251|P3|Overall Study|Other|0
4919573|NCT00496015|16943252|P2|Overall Study|Other|0
4919574|NCT00496015|16943253|P1|Overall Study|Other|1
4919575|NCT00495820|16943377|P2|Overall Study|Adverse Event|1
4919576|NCT00495820|16943378|P1|Overall Study|Adverse Event|1
4919577|NCT00495794|16943390|P2|Overall Study|Pharmacist did not activate patient|0
4919578|NCT00495794|16943391|P1|Overall Study|Pharmacist did not activate patient|522
4919579|NCT00495755|16943401|P1|Overall Study|Adverse Event|3
4919580|NCT00495677|16943422|P7|Stage 1 (25 Days)|Adverse Event|0
4919581|NCT00495677|16943423|P6|Stage 1 (25 Days)|Adverse Event|0
4919582|NCT00495677|16943424|P5|Stage 1 (25 Days)|Adverse Event|0
4919583|NCT00495677|16943425|P4|Stage 1 (25 Days)|Adverse Event|0
4919584|NCT00495677|16943426|P3|Stage 1 (25 Days)|Adverse Event|1
4919585|NCT00495677|16943427|P2|Stage 1 (25 Days)|Adverse Event|0
4919586|NCT00495677|16943428|P1|Stage 1 (25 Days)|Adverse Event|0
4919587|NCT00495625|16943483|P1|Overall Study|Did not complete at least 1 42 day cycle|10
4919588|NCT00495612|16943494|P2|Overall Study|Subject's Decision to Withdraw|0
4919589|NCT00495612|16943495|P1|Overall Study|Subject's Decision to Withdraw|3
4919590|NCT00495612|16943494|P2|Overall Study|Lost to Follow-up|0
4919591|NCT00495612|16943495|P1|Overall Study|Lost to Follow-up|1
4919592|NCT00495586|16943513|P2|Overall Study|Withdrawal by Subject|4
4919593|NCT00495586|16943514|P1|Overall Study|Withdrawal by Subject|4
4919594|NCT00495521|16943524|P2|Overall Study|Physician Decision|1
4919595|NCT00495521|16943525|P1|Overall Study|Physician Decision|0
4919596|NCT00495495|16943555|P1|Overall Study|Protocol Violation|99
4919597|NCT00495469|16943575|P7|Overall Study|ST depression at randomisation in ECG|0
4919598|NCT00495469|16943576|P6|Overall Study|ST depression at randomisation in ECG|0
4919599|NCT00495469|16943577|P5|Overall Study|ST depression at randomisation in ECG|0
4919600|NCT00495469|16943578|P4|Overall Study|ST depression at randomisation in ECG|0
4919601|NCT00495469|16943579|P3|Overall Study|ST depression at randomisation in ECG|0
4919602|NCT00495469|16943580|P2|Overall Study|ST depression at randomisation in ECG|1
4919603|NCT00495469|16943581|P1|Overall Study|ST depression at randomisation in ECG|0
4919604|NCT00495469|16943575|P7|Overall Study|Liver function test abnormality|0
4919605|NCT00495469|16943576|P6|Overall Study|Liver function test abnormality|0
4919606|NCT00495469|16943577|P5|Overall Study|Liver function test abnormality|0
4919607|NCT00495469|16943578|P4|Overall Study|Liver function test abnormality|0
4919608|NCT00495469|16943579|P3|Overall Study|Liver function test abnormality|0
4919609|NCT00495469|16943580|P2|Overall Study|Liver function test abnormality|1
4919610|NCT00495469|16943581|P1|Overall Study|Liver function test abnormality|0
4919611|NCT00495469|16943575|P7|Overall Study|Lack of Efficacy|1
4919612|NCT00495469|16943576|P6|Overall Study|Lack of Efficacy|0
4919613|NCT00495469|16943577|P5|Overall Study|Lack of Efficacy|0
4919614|NCT00495469|16943578|P4|Overall Study|Lack of Efficacy|0
4919615|NCT00495469|16943579|P3|Overall Study|Lack of Efficacy|0
4919616|NCT00495469|16943580|P2|Overall Study|Lack of Efficacy|0
4919617|NCT00495469|16943581|P1|Overall Study|Lack of Efficacy|0
4919618|NCT00495469|16943575|P7|Overall Study|Withdrawal by Subject|3
4919619|NCT00495469|16943576|P6|Overall Study|Withdrawal by Subject|2
4919620|NCT00495469|16943577|P5|Overall Study|Withdrawal by Subject|3
4919621|NCT00495469|16943578|P4|Overall Study|Withdrawal by Subject|3
4919622|NCT00495469|16943579|P3|Overall Study|Withdrawal by Subject|1
4919623|NCT00495469|16943580|P2|Overall Study|Withdrawal by Subject|3
4919624|NCT00495469|16943581|P1|Overall Study|Withdrawal by Subject|5
4919625|NCT00495469|16943575|P7|Overall Study|Protocol Violation|0
4919626|NCT00495469|16943576|P6|Overall Study|Protocol Violation|2
4919627|NCT00495469|16943577|P5|Overall Study|Protocol Violation|1
4919628|NCT00495469|16943578|P4|Overall Study|Protocol Violation|0
4919629|NCT00495469|16943579|P3|Overall Study|Protocol Violation|0
4919630|NCT00495469|16943580|P2|Overall Study|Protocol Violation|0
4919631|NCT00495469|16943581|P1|Overall Study|Protocol Violation|0
4919632|NCT00495469|16943575|P7|Overall Study|Lost to Follow-up|0
4919633|NCT00495469|16943576|P6|Overall Study|Lost to Follow-up|0
4919634|NCT00495469|16943577|P5|Overall Study|Lost to Follow-up|0
4919635|NCT00495469|16943578|P4|Overall Study|Lost to Follow-up|1
4919636|NCT00495469|16943579|P3|Overall Study|Lost to Follow-up|3
4919637|NCT00495469|16943580|P2|Overall Study|Lost to Follow-up|1
4919638|NCT00495469|16943581|P1|Overall Study|Lost to Follow-up|1
4919639|NCT00495469|16943575|P7|Overall Study|Adverse Event|1
4919640|NCT00495469|16943576|P6|Overall Study|Adverse Event|1
4919641|NCT00495469|16943577|P5|Overall Study|Adverse Event|1
4919642|NCT00495469|16943578|P4|Overall Study|Adverse Event|0
4919643|NCT00495469|16943579|P3|Overall Study|Adverse Event|3
4919644|NCT00495469|16943580|P2|Overall Study|Adverse Event|1
4919645|NCT00495469|16943581|P1|Overall Study|Adverse Event|0
4919646|NCT00495391|16943725|P2|Overall Study|Withdrawal by Subject|3
4919647|NCT00495391|16943726|P1|Overall Study|Withdrawal by Subject|2
4919648|NCT00495391|16943725|P2|Overall Study|Lack of Efficacy|18
4919649|NCT00495391|16943726|P1|Overall Study|Lack of Efficacy|34
4919650|NCT00495170|16943749|P1|Overall Study|Inappropriate staging|8
4919651|NCT00495170|16943749|P1|Overall Study|Withdrawal by Subject|3
4919652|NCT00495170|16943749|P1|Overall Study|Lost to Follow-up|9
4919653|NCT00495131|16943768|P2|Overall Study|Withdrawal by Subject|0
4919654|NCT00495131|16943769|P1|Overall Study|Withdrawal by Subject|1
4919655|NCT00495131|16943768|P2|Overall Study|Lost to Follow-up|2
4919656|NCT00495131|16943769|P1|Overall Study|Lost to Follow-up|0
4919657|NCT00495131|16943768|P2|Overall Study|Lack of Efficacy|2
4919658|NCT00495131|16943769|P1|Overall Study|Lack of Efficacy|0
4919659|NCT00495131|16943768|P2|Overall Study|Adverse Event|2
4919660|NCT00495131|16943769|P1|Overall Study|Adverse Event|6
4919661|NCT00495040|16943786|P1|Overall Study|Withdrawal by Subject|3
4919662|NCT00494871|16943801|P2|Follow-up (FU) Period|Clinical Endpoint Reached|2
4919663|NCT00494871|16943802|P1|Follow-up (FU) Period|Clinical Endpoint Reached|3
4919664|NCT00494871|16943801|P2|Follow-up (FU) Period|Withdrawal by Subject|5
4919665|NCT00494871|16943802|P1|Follow-up (FU) Period|Withdrawal by Subject|5
4919666|NCT00494871|16943801|P2|Follow-up (FU) Period|Protocol Violation|0
4919667|NCT00494871|16943802|P1|Follow-up (FU) Period|Protocol Violation|1
4919668|NCT00494871|16943801|P2|Follow-up (FU) Period|Physician Decision|1
4919669|NCT00494871|16943802|P1|Follow-up (FU) Period|Physician Decision|0
4919670|NCT00494871|16943801|P2|Follow-up (FU) Period|Lost to Follow-up|2
4919671|NCT00494871|16943802|P1|Follow-up (FU) Period|Lost to Follow-up|6
4919672|NCT00494871|16943801|P2|Follow-up (FU) Period|Death|12
4919673|NCT00494871|16943802|P1|Follow-up (FU) Period|Death|13
4919674|NCT00494871|16943801|P2|Follow-up (FU) Period|Adverse Event|1
4919675|NCT00494871|16943802|P1|Follow-up (FU) Period|Adverse Event|1
4919676|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
4919677|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1
4919678|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
4919679|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1
4919680|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Site Closed by Investigator|2
4919681|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Site Closed by Investigator|1
4919682|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8
4919683|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12
4919684|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1
4919685|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3
4919686|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28
4919687|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18
4919688|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Protocol Violation|9
4919689|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Protocol Violation|9
4919690|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Lost to Follow-up|1
4919691|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Lost to Follow-up|4
4919692|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Physician Decision|13
4919693|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Physician Decision|4
4919694|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Death|3
4919695|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Death|8
4919696|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Withdrawal by Subject|35
4919697|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Withdrawal by Subject|26
4919698|NCT00494871|16943801|P2|Double-blind (DB) Treatment Period|Adverse Event|70
4919699|NCT00494871|16943802|P1|Double-blind (DB) Treatment Period|Adverse Event|73
4919700|NCT00494780|16943843|P2|Overall Study|Insurance Issues|1
4919701|NCT00494780|16943844|P1|Overall Study|Insurance Issues|0
4919702|NCT00494780|16943843|P2|Overall Study|Residual Tumour Mass|1
4919703|NCT00494780|16943844|P1|Overall Study|Residual Tumour Mass|0
4919704|NCT00494780|16943843|P2|Overall Study|Non-compliance|0
4919705|NCT00494780|16943844|P1|Overall Study|Non-compliance|1
4919706|NCT00494780|16943843|P2|Overall Study|New Treatment|2
4919707|NCT00494780|16943844|P1|Overall Study|New Treatment|2
4919708|NCT00494780|16943843|P2|Overall Study|Progression of Study Disease|8
4919709|NCT00494780|16943844|P1|Overall Study|Progression of Study Disease|7
4919710|NCT00494780|16943843|P2|Overall Study|Withdrew before Dosed|1
4919711|NCT00494780|16943844|P1|Overall Study|Withdrew before Dosed|0
4919712|NCT00494780|16943843|P2|Overall Study|Adverse Event|0
4919713|NCT00494780|16943844|P1|Overall Study|Adverse Event|1
4919714|NCT00494676|16943882|P2|Second Intervention|Withdrawal by Subject|1
4919715|NCT00494676|16943883|P1|Second Intervention|Withdrawal by Subject|1
4919716|NCT00494676|16943882|P2|First Intervention|Withdrawal by Subject|3
4919717|NCT00494676|16943883|P1|First Intervention|Withdrawal by Subject|1
4919718|NCT00494676|16943882|P2|Allocation|Withdrawal by Subject|4
4919719|NCT00494676|16943883|P1|Allocation|Withdrawal by Subject|2
4919720|NCT00494507|16943898|P4|Open-Label Phase|Worsening Disease|2
4919721|NCT00494507|16943899|P3|Open-Label Phase|Worsening Disease|0
4919722|NCT00494507|16943900|P2|Open-Label Phase|Worsening Disease|0
4919723|NCT00494507|16943901|P1|Open-Label Phase|Worsening Disease|0
4919724|NCT00494507|16943898|P4|Open-Label Phase|Adverse Event|3
4919725|NCT00494507|16943899|P3|Open-Label Phase|Adverse Event|5
4919726|NCT00494507|16943900|P2|Open-Label Phase|Adverse Event|1
4919727|NCT00494507|16943901|P1|Open-Label Phase|Adverse Event|0
4919728|NCT00494507|16943898|P4|Double-Blind Phase|Negative DNA test|1
4919729|NCT00494507|16943899|P3|Double-Blind Phase|Negative DNA test|0
4919730|NCT00494507|16943900|P2|Double-Blind Phase|Negative DNA test|0
4919731|NCT00494507|16943901|P1|Double-Blind Phase|Negative DNA test|0
4919732|NCT00494507|16943898|P4|Double-Blind Phase|Subject Non-compliance|0
4919733|NCT00494507|16943899|P3|Double-Blind Phase|Subject Non-compliance|1
4919734|NCT00494507|16943900|P2|Double-Blind Phase|Subject Non-compliance|0
4919735|NCT00494507|16943901|P1|Double-Blind Phase|Subject Non-compliance|0
4919736|NCT00494507|16943898|P4|Double-Blind Phase|Withdrawal by Subject|0
4919737|NCT00494507|16943899|P3|Double-Blind Phase|Withdrawal by Subject|0
4919738|NCT00494507|16943900|P2|Double-Blind Phase|Withdrawal by Subject|0
4919739|NCT00494507|16943901|P1|Double-Blind Phase|Withdrawal by Subject|1
4919740|NCT00494507|16943898|P4|Double-Blind Phase|Adverse Event|0
4919741|NCT00494507|16943899|P3|Double-Blind Phase|Adverse Event|1
4919742|NCT00494507|16943900|P2|Double-Blind Phase|Adverse Event|0
4919743|NCT00494507|16943901|P1|Double-Blind Phase|Adverse Event|2
4919744|NCT00494481|16943968|P2|Overall Study|Never received IP|0
4919745|NCT00494481|16943969|P1|Overall Study|Never received IP|2
4919746|NCT00494481|16943968|P2|Overall Study|Other|0
4919747|NCT00494481|16943969|P1|Overall Study|Other|1
4919748|NCT00494481|16943968|P2|Overall Study|Adverse Event|11
4919749|NCT00494481|16943969|P1|Overall Study|Adverse Event|15
4919750|NCT00494481|16943968|P2|Overall Study|Condition under investigation worsened|13
4919751|NCT00494481|16943969|P1|Overall Study|Condition under investigation worsened|11
4919752|NCT00494442|16943977|P2|Overall Study|Intercurrent illness|1
4919753|NCT00494442|16943978|P1|Overall Study|Intercurrent illness|0
4919754|NCT00494442|16943977|P2|Overall Study|Non-compliance|1
4919755|NCT00494442|16943978|P1|Overall Study|Non-compliance|0
4919756|NCT00494442|16943977|P2|Overall Study|Physician Decision|1
4919757|NCT00494442|16943978|P1|Overall Study|Physician Decision|0
4919758|NCT00494442|16943977|P2|Overall Study|Adverse Event|2
4919759|NCT00494442|16943978|P1|Overall Study|Adverse Event|0
4919760|NCT00494442|16943977|P2|Overall Study|Lack of Efficacy|10
4919761|NCT00494442|16943978|P1|Overall Study|Lack of Efficacy|16
4919762|NCT00494442|16943977|P2|Overall Study|Death|1
4919763|NCT00494442|16943978|P1|Overall Study|Death|1
4919764|NCT00494299|16943994|P2|Overall Study|Protocol Driven Decision Point|22
4919765|NCT00494299|16943995|P1|Overall Study|Protocol Driven Decision Point|11
4919766|NCT00494299|16943994|P2|Overall Study|Site Closed by Sponsor|0
4919767|NCT00494299|16943995|P1|Overall Study|Site Closed by Sponsor|6
4919768|NCT00494299|16943994|P2|Overall Study|Participant Did Not Take Study Drug|2
4919769|NCT00494299|16943995|P1|Overall Study|Participant Did Not Take Study Drug|0
4919770|NCT00494299|16943994|P2|Overall Study|Disease Progression, Recurrence/Relapse|185
4919771|NCT00494299|16943995|P1|Overall Study|Disease Progression, Recurrence/Relapse|109
4919772|NCT00494299|16943994|P2|Overall Study|Withdrawal by Subject|3
4919773|NCT00494299|16943995|P1|Overall Study|Withdrawal by Subject|8
4919774|NCT00494299|16943994|P2|Overall Study|Protocol Violation|2
4919775|NCT00494299|16943995|P1|Overall Study|Protocol Violation|1
4919776|NCT00494299|16943994|P2|Overall Study|Physician Decision|2
4919777|NCT00494299|16943995|P1|Overall Study|Physician Decision|0
4919778|NCT00494299|16943994|P2|Overall Study|Lost to Follow-up|0
4919779|NCT00494299|16943995|P1|Overall Study|Lost to Follow-up|1
4919780|NCT00494299|16943994|P2|Overall Study|Adverse Event|13
4919781|NCT00494299|16943995|P1|Overall Study|Adverse Event|93
4919782|NCT00494234|16944007|P2|Overall Study|Death|1
4919783|NCT00494234|16944008|P1|Overall Study|Death|2
4919784|NCT00494234|16944007|P2|Overall Study|Withdrawal by Subject|0
4919785|NCT00494234|16944008|P1|Overall Study|Withdrawal by Subject|1
4919786|NCT00494234|16944007|P2|Overall Study|Lack of Efficacy|9
4919787|NCT00494234|16944008|P1|Overall Study|Lack of Efficacy|12
4919788|NCT00494221|16944027|P3|Overall Study|Withdrawal by Subject|0
4919789|NCT00494221|16944028|P2|Overall Study|Withdrawal by Subject|2
4919790|NCT00494221|16944029|P1|Overall Study|Withdrawal by Subject|1
4919791|NCT00494221|16944027|P3|Overall Study|Death|14
4919792|NCT00494221|16944028|P2|Overall Study|Death|9
4919793|NCT00494221|16944029|P1|Overall Study|Death|15
4919794|NCT00494091|16944070|P2|Overall Study|Withdrawal by Subject|7
4919795|NCT00494091|16944071|P1|Overall Study|Withdrawal by Subject|0
4919796|NCT00494091|16944070|P2|Overall Study|Other|11
4919797|NCT00494091|16944071|P1|Overall Study|Other|1
4919798|NCT00494091|16944070|P2|Overall Study|Lost to Follow-up|4
4919799|NCT00494091|16944071|P1|Overall Study|Lost to Follow-up|0
4919800|NCT00494091|16944070|P2|Overall Study|Death|54
4919801|NCT00494091|16944071|P1|Overall Study|Death|5
4919802|NCT00494026|16944093|P1|Overall Study|Sponsor Decision|4
4919803|NCT00494013|16944103|P2|Overall Study|Sponsor Decision|1
4919804|NCT00494013|16944104|P1|Overall Study|Sponsor Decision|0
4919805|NCT00494013|16944103|P2|Overall Study|Withdrawal by Subject|14
4919806|NCT00494013|16944104|P1|Overall Study|Withdrawal by Subject|13
4919807|NCT00494013|16944103|P2|Overall Study|Protocol Violation|5
4919808|NCT00494013|16944104|P1|Overall Study|Protocol Violation|8
4919809|NCT00494013|16944103|P2|Overall Study|Physician Decision|5
4919810|NCT00494013|16944104|P1|Overall Study|Physician Decision|3
4919811|NCT00494013|16944103|P2|Overall Study|Lost to Follow-up|6
4919812|NCT00494013|16944104|P1|Overall Study|Lost to Follow-up|5
4919813|NCT00494013|16944103|P2|Overall Study|Entry Criteria Not Met|4
4919814|NCT00494013|16944104|P1|Overall Study|Entry Criteria Not Met|1
4919815|NCT00494013|16944103|P2|Overall Study|Adverse Event|1
4919816|NCT00494013|16944104|P1|Overall Study|Adverse Event|0
4919817|NCT00493974|16944134|P2|Overall Study|Lost to Follow-up|6
4919818|NCT00493974|16944135|P1|Overall Study|Lost to Follow-up|4
4919819|NCT00493974|16944134|P2|Overall Study|Withdrawal by Subject|6
4919820|NCT00493974|16944135|P1|Overall Study|Withdrawal by Subject|8
4919821|NCT00493974|16944134|P2|Overall Study|Death|2
4919822|NCT00493974|16944135|P1|Overall Study|Death|1
4919823|NCT00493779|16944162|P1|Overall Study|Logistical issue at site|1
4919824|NCT00493649|16944169|P1|Overall Study|Other|13
4919825|NCT00493649|16944169|P1|Overall Study|Lost to Follow-up|1
4919826|NCT00493649|16944169|P1|Overall Study|Disease Progression|1
4919827|NCT00493649|16944169|P1|Overall Study|Investigator Request|2
4919828|NCT00493649|16944169|P1|Overall Study|Patient Request|21
4919829|NCT00493649|16944169|P1|Overall Study|Adverse Event|44
4919830|NCT00493636|16944182|P2|Overall Study|Mis-randomization|1
4919831|NCT00493636|16944183|P1|Overall Study|Mis-randomization|1
4919832|NCT00493636|16944182|P2|Overall Study|Disease progression/recurrence/relapse|1
4919833|NCT00493636|16944183|P1|Overall Study|Disease progression/recurrence/relapse|0
4919834|NCT00493636|16944182|P2|Overall Study|Withdrawal by Subject|0
4919835|NCT00493636|16944183|P1|Overall Study|Withdrawal by Subject|1
4919836|NCT00493467|16944197|P1|Overall Study|Death|1
4919837|NCT00493454|16944202|P1|Overall Study|Withdrawal by Subject|1
4919838|NCT00493311|16944208|P2|Overall Study|Need for rescue medication|2
4919839|NCT00493311|16944209|P1|Overall Study|Need for rescue medication|2
4919840|NCT00493285|16944229|P6|Overall Study|Lost to Follow-up|0
4919841|NCT00493285|16944230|P5|Overall Study|Lost to Follow-up|1
4919842|NCT00493285|16944231|P4|Overall Study|Lost to Follow-up|0
4919843|NCT00493285|16944232|P3|Overall Study|Lost to Follow-up|0
4919844|NCT00493285|16944233|P2|Overall Study|Lost to Follow-up|0
4919845|NCT00493285|16944234|P1|Overall Study|Lost to Follow-up|0
4919846|NCT00493246|16944466|P8|Overall Study|Lost to Follow-up|0
4919847|NCT00493246|16944467|P7|Overall Study|Lost to Follow-up|1
4919848|NCT00493246|16944468|P6|Overall Study|Lost to Follow-up|0
4919849|NCT00493246|16944469|P5|Overall Study|Lost to Follow-up|0
4919850|NCT00493246|16944470|P4|Overall Study|Lost to Follow-up|0
4919851|NCT00493246|16944471|P3|Overall Study|Lost to Follow-up|0
4919852|NCT00493246|16944472|P2|Overall Study|Lost to Follow-up|0
4919853|NCT00493246|16944473|P1|Overall Study|Lost to Follow-up|0
4919854|NCT00493246|16944466|P8|Overall Study|No access to draw blood|0
4919855|NCT00493246|16944467|P7|Overall Study|No access to draw blood|0
4919856|NCT00493246|16944468|P6|Overall Study|No access to draw blood|1
4919857|NCT00493246|16944469|P5|Overall Study|No access to draw blood|0
4919858|NCT00493246|16944470|P4|Overall Study|No access to draw blood|0
4919859|NCT00493246|16944471|P3|Overall Study|No access to draw blood|0
4919860|NCT00493246|16944472|P2|Overall Study|No access to draw blood|0
4919861|NCT00493246|16944473|P1|Overall Study|No access to draw blood|0
4919862|NCT00493246|16944466|P8|Overall Study|Withdrawal by Subject|0
4919863|NCT00493246|16944467|P7|Overall Study|Withdrawal by Subject|0
4919864|NCT00493246|16944468|P6|Overall Study|Withdrawal by Subject|0
4919865|NCT00493246|16944469|P5|Overall Study|Withdrawal by Subject|1
4919866|NCT00493246|16944470|P4|Overall Study|Withdrawal by Subject|0
4919867|NCT00493246|16944471|P3|Overall Study|Withdrawal by Subject|0
4919868|NCT00493246|16944472|P2|Overall Study|Withdrawal by Subject|0
4919869|NCT00493246|16944473|P1|Overall Study|Withdrawal by Subject|0
4919870|NCT00493220|16944537|P6|Third Intervention|Withdrawal by Subject|0
4919871|NCT00493220|16944538|P5|Third Intervention|Withdrawal by Subject|0
4919872|NCT00493220|16944539|P4|Third Intervention|Withdrawal by Subject|0
4919873|NCT00493220|16944540|P3|Third Intervention|Withdrawal by Subject|0
4919874|NCT00493220|16944541|P2|Third Intervention|Withdrawal by Subject|0
4919875|NCT00493220|16944542|P1|Third Intervention|Withdrawal by Subject|1
4919876|NCT00493038|16944570|P2|Follow-up|Lost to Follow-up|0
4919877|NCT00493038|16944571|P1|Follow-up|Lost to Follow-up|1
4919878|NCT00493038|16944570|P2|Treatment|Other|1
4919879|NCT00493038|16944571|P1|Treatment|Other|0
4919880|NCT00493038|16944570|P2|Treatment|Withdrawal by Subject|12
4919881|NCT00493038|16944571|P1|Treatment|Withdrawal by Subject|11
4919882|NCT00493038|16944570|P2|Treatment|Lost to Follow-up|3
4919883|NCT00493038|16944571|P1|Treatment|Lost to Follow-up|5
4919884|NCT00493038|16944570|P2|Treatment|Adverse Event|4
4919885|NCT00493038|16944571|P1|Treatment|Adverse Event|8
4919886|NCT00493025|16944585|P1|Overall Study|Physician Decision|19
4919887|NCT00493012|16944596|P2|Overall Study|Lost to Follow-up|17
4919888|NCT00493012|16944597|P1|Overall Study|Lost to Follow-up|18
4919889|NCT00492921|16944640|P3|Overall Study|Death|1
4919890|NCT00492921|16944641|P2|Overall Study|Death|0
4919891|NCT00492921|16944642|P1|Overall Study|Death|1
4919892|NCT00492856|16944653|P4|Post-consolidation|Observation Arm|0
4919893|NCT00492856|16944654|P3|Post-consolidation|Observation Arm|27
4919894|NCT00492856|16944655|P2|Post-consolidation|Observation Arm|0
4919895|NCT00492856|16944656|P1|Post-consolidation|Observation Arm|0
4919896|NCT00492856|16944653|P4|Post-consolidation|Lost to Follow-up|0
4919897|NCT00492856|16944654|P3|Post-consolidation|Lost to Follow-up|0
4919898|NCT00492856|16944655|P2|Post-consolidation|Lost to Follow-up|2
4919899|NCT00492856|16944656|P1|Post-consolidation|Lost to Follow-up|0
4919900|NCT00492856|16944653|P4|Post-consolidation|Not protocol specified|0
4919901|NCT00492856|16944654|P3|Post-consolidation|Not protocol specified|0
4919902|NCT00492856|16944655|P2|Post-consolidation|Not protocol specified|1
4919903|NCT00492856|16944656|P1|Post-consolidation|Not protocol specified|0
4919904|NCT00492856|16944653|P4|Post-consolidation|Death|0
4919905|NCT00492856|16944654|P3|Post-consolidation|Death|0
4919906|NCT00492856|16944655|P2|Post-consolidation|Death|1
4919907|NCT00492856|16944656|P1|Post-consolidation|Death|0
4919908|NCT00492856|16944653|P4|Post-consolidation|Withdrawal by Subject|0
4919909|NCT00492856|16944654|P3|Post-consolidation|Withdrawal by Subject|0
4919910|NCT00492856|16944655|P2|Post-consolidation|Withdrawal by Subject|4
4919911|NCT00492856|16944656|P1|Post-consolidation|Withdrawal by Subject|0
4919912|NCT00492856|16944653|P4|Post-consolidation|Adverse Event|1
4919913|NCT00492856|16944654|P3|Post-consolidation|Adverse Event|0
4919914|NCT00492856|16944655|P2|Post-consolidation|Adverse Event|4
4919915|NCT00492856|16944656|P1|Post-consolidation|Adverse Event|0
4919916|NCT00492856|16944653|P4|Consolidation|Lost to Follow-up|0
4919917|NCT00492856|16944654|P3|Consolidation|Lost to Follow-up|0
4919918|NCT00492856|16944655|P2|Consolidation|Lost to Follow-up|0
4919919|NCT00492856|16944656|P1|Consolidation|Lost to Follow-up|1
4919920|NCT00492856|16944653|P4|Consolidation|Not protocol specified|0
4919921|NCT00492856|16944654|P3|Consolidation|Not protocol specified|0
4919922|NCT00492856|16944655|P2|Consolidation|Not protocol specified|0
4919923|NCT00492856|16944656|P1|Consolidation|Not protocol specified|2
4919924|NCT00492856|16944653|P4|Consolidation|Adverse Event|0
4919925|NCT00492856|16944654|P3|Consolidation|Adverse Event|0
4919926|NCT00492856|16944655|P2|Consolidation|Adverse Event|0
4919927|NCT00492856|16944656|P1|Consolidation|Adverse Event|6
4919928|NCT00492856|16944653|P4|Induction|Death|0
4919929|NCT00492856|16944654|P3|Induction|Death|0
4919930|NCT00492856|16944655|P2|Induction|Death|0
4919931|NCT00492856|16944656|P1|Induction|Death|3
4919932|NCT00492856|16944653|P4|Induction|Withdrawal by Subject|0
4919933|NCT00492856|16944654|P3|Induction|Withdrawal by Subject|0
4919934|NCT00492856|16944655|P2|Induction|Withdrawal by Subject|0
4919935|NCT00492856|16944656|P1|Induction|Withdrawal by Subject|1
4919936|NCT00492856|16944653|P4|Induction|Adverse Event|0
4919937|NCT00492856|16944654|P3|Induction|Adverse Event|0
4919938|NCT00492856|16944655|P2|Induction|Adverse Event|0
4919939|NCT00492856|16944656|P1|Induction|Adverse Event|2
4919940|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
4919941|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
4919942|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0
4919943|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1
4919944|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
4919945|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
4919946|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6
4919947|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0
4919948|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1
4919949|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
4919950|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
4919951|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0
4919952|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2
4919953|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
4919954|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1
4919955|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0
4919956|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
4919957|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0
4919958|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1
4919959|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2
4919960|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0
4919961|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2
4919962|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1
4919963|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8
4919964|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Death|1
4919965|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Death|45
4919966|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Death|5
4919967|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Death|75
4919968|NCT00492752|16944670|P4|Follow-up and/or Open Label Sorafenib|Adverse Event|2
4919969|NCT00492752|16944671|P3|Follow-up and/or Open Label Sorafenib|Adverse Event|0
4919970|NCT00492752|16944672|P2|Follow-up and/or Open Label Sorafenib|Adverse Event|2
4919971|NCT00492752|16944673|P1|Follow-up and/or Open Label Sorafenib|Adverse Event|0
4919972|NCT00492752|16944670|P4|Double Blind Treatment|Protocol Violation|0
4919973|NCT00492752|16944671|P3|Double Blind Treatment|Protocol Violation|1
4919974|NCT00492752|16944672|P2|Double Blind Treatment|Protocol Violation|0
4919975|NCT00492752|16944673|P1|Double Blind Treatment|Protocol Violation|0
4919976|NCT00492752|16944670|P4|Double Blind Treatment|Adverse Event|0
4919977|NCT00492752|16944671|P3|Double Blind Treatment|Adverse Event|0
4919978|NCT00492752|16944672|P2|Double Blind Treatment|Adverse Event|0
4919979|NCT00492752|16944673|P1|Double Blind Treatment|Adverse Event|1
4919980|NCT00492752|16944670|P4|Double Blind Treatment|Death|0
4919981|NCT00492752|16944671|P3|Double Blind Treatment|Death|2
4919982|NCT00492752|16944672|P2|Double Blind Treatment|Death|0
4919983|NCT00492752|16944673|P1|Double Blind Treatment|Death|13
4919984|NCT00492726|16944708|P2|Overall Study|Non compliant with study medication|3
4919985|NCT00492726|16944709|P1|Overall Study|Non compliant with study medication|0
4919986|NCT00492726|16944708|P2|Overall Study|Withdrawal by Subject|3
4919987|NCT00492726|16944709|P1|Overall Study|Withdrawal by Subject|6
4919988|NCT00492726|16944708|P2|Overall Study|Physician Decision|1
4919989|NCT00492726|16944709|P1|Overall Study|Physician Decision|0
4919990|NCT00492726|16944708|P2|Overall Study|Lost to Follow-up|19
4919991|NCT00492726|16944709|P1|Overall Study|Lost to Follow-up|27
4919992|NCT00492726|16944708|P2|Overall Study|Lack of Efficacy|2
4919993|NCT00492726|16944709|P1|Overall Study|Lack of Efficacy|0
4919994|NCT00492726|16944708|P2|Overall Study|Death|2
4919995|NCT00492726|16944709|P1|Overall Study|Death|7
4919996|NCT00492726|16944708|P2|Overall Study|Adverse Event|6
4919997|NCT00492726|16944709|P1|Overall Study|Adverse Event|10
4919998|NCT00492648|16944735|P2|Month 30 (109671 Study)|Protocol Violation|1
4919999|NCT00492648|16944736|P1|Month 30 (109671 Study)|Protocol Violation|0
4920000|NCT00492557|16944783|P2|Overall Study|Lost to Follow-up|1
4920001|NCT00492557|16944784|P1|Overall Study|Lost to Follow-up|0
4920002|NCT00492557|16944783|P2|Overall Study|Failed to return|0
4920003|NCT00492557|16944784|P1|Overall Study|Failed to return|1
4920004|NCT00492557|16944783|P2|Overall Study|Adverse Event|0
4920005|NCT00492557|16944784|P1|Overall Study|Adverse Event|1
4920006|NCT00492557|16944783|P2|Overall Study|Death|1
4920007|NCT00492557|16944784|P1|Overall Study|Death|1
4920008|NCT00492557|16944783|P2|Overall Study|Other|2
4920009|NCT00492557|16944784|P1|Overall Study|Other|2
4920010|NCT00492557|16944783|P2|Overall Study|Protocol Violation|8
4920011|NCT00492557|16944784|P1|Overall Study|Protocol Violation|7
4920012|NCT00492557|16944783|P2|Overall Study|Subject request|11
4920013|NCT00492557|16944784|P1|Overall Study|Subject request|12
4920014|NCT00492531|16944814|P2|Overall Study|Withdrawn(More than one reason selected)|23
4920015|NCT00492531|16944815|P1|Overall Study|Withdrawn(More than one reason selected)|22
4920016|NCT00492297|16944888|P1|Survival Only Follow-up|Study terminated by sponsor|12
4920017|NCT00492297|16944888|P1|Survival Only Follow-up|Lack of Efficacy|1
4920018|NCT00492297|16944888|P1|Survival Only Follow-up|Death|46
4920019|NCT00492297|16944888|P1|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2
4920020|NCT00492297|16944888|P1|Active Follow-up 30(+4) Days Duration|Death|17
4920021|NCT00492297|16944888|P1|Treatment|Study terminated by sponsor|3
4920022|NCT00492297|16944888|P1|Treatment|Death|2
4920023|NCT00492284|16944906|P4|Overall Study|Withdrawal by Subject|2
4920024|NCT00492284|16944907|P3|Overall Study|Withdrawal by Subject|0
4920025|NCT00492284|16944908|P2|Overall Study|Withdrawal by Subject|0
4920026|NCT00492284|16944909|P1|Overall Study|Withdrawal by Subject|1
4920027|NCT00492284|16944906|P4|Overall Study|Death|5
4920028|NCT00492284|16944907|P3|Overall Study|Death|2
4920029|NCT00492284|16944908|P2|Overall Study|Death|3
4920030|NCT00492284|16944909|P1|Overall Study|Death|0
4920031|NCT00492284|16944906|P4|Overall Study|Lost to Follow-up|1
4920032|NCT00492284|16944907|P3|Overall Study|Lost to Follow-up|3
4920033|NCT00492284|16944908|P2|Overall Study|Lost to Follow-up|0
4920034|NCT00492284|16944909|P1|Overall Study|Lost to Follow-up|0
4920035|NCT00492284|16944906|P4|Overall Study|Adverse Event|2
4920036|NCT00492284|16944907|P3|Overall Study|Adverse Event|1
4920037|NCT00492284|16944908|P2|Overall Study|Adverse Event|1
4920038|NCT00492284|16944909|P1|Overall Study|Adverse Event|0
4920039|NCT00492232|16944953|P2|Open-Label Treatment|Withdrawal by Subject|0
4920040|NCT00492232|16944954|P1|Open-Label Treatment|Withdrawal by Subject|1
4920041|NCT00492232|16944953|P2|Double-Blind Treatment|Randomized not treated|0
4920042|NCT00492232|16944954|P1|Double-Blind Treatment|Randomized not treated|1
4920043|NCT00492232|16944953|P2|Double-Blind Treatment|Other|5
4920044|NCT00492232|16944954|P1|Double-Blind Treatment|Other|6
4920045|NCT00492232|16944953|P2|Double-Blind Treatment|Lack of Efficacy|0
4920046|NCT00492232|16944954|P1|Double-Blind Treatment|Lack of Efficacy|1
4920047|NCT00492232|16944953|P2|Double-Blind Treatment|Withdrawal by Subject|8
4920048|NCT00492232|16944954|P1|Double-Blind Treatment|Withdrawal by Subject|4
4920049|NCT00492232|16944953|P2|Double-Blind Treatment|Lost to Follow-up|3
4920050|NCT00492232|16944954|P1|Double-Blind Treatment|Lost to Follow-up|2
4920051|NCT00492232|16944953|P2|Double-Blind Treatment|Protocol Violation|7
4920052|NCT00492232|16944954|P1|Double-Blind Treatment|Protocol Violation|3
4920053|NCT00492232|16944953|P2|Double-Blind Treatment|Adverse Event|2
4920054|NCT00492232|16944954|P1|Double-Blind Treatment|Adverse Event|1
4920055|NCT00492232|16944953|P2|Placebo Run-in|Missing|2
4920056|NCT00492232|16944954|P1|Placebo Run-in|Missing|0
4920057|NCT00492232|16944953|P2|Placebo Run-in|Other|6
4920058|NCT00492232|16944954|P1|Placebo Run-in|Other|0
4920059|NCT00492232|16944953|P2|Placebo Run-in|Entrance criteria not met|45
4920060|NCT00492232|16944954|P1|Placebo Run-in|Entrance criteria not met|0
4920061|NCT00492232|16944953|P2|Placebo Run-in|Pregnancy|1
4920062|NCT00492232|16944954|P1|Placebo Run-in|Pregnancy|0
4920063|NCT00492232|16944953|P2|Placebo Run-in|Withdrawal by Subject|8
4920064|NCT00492232|16944954|P1|Placebo Run-in|Withdrawal by Subject|0
4920065|NCT00492232|16944953|P2|Placebo Run-in|Lost to Follow-up|3
4920066|NCT00492232|16944954|P1|Placebo Run-in|Lost to Follow-up|0
4920067|NCT00492232|16944953|P2|Placebo Run-in|Protocol Violation|3
4920068|NCT00492232|16944954|P1|Placebo Run-in|Protocol Violation|0
4920069|NCT00492232|16944953|P2|Placebo Run-in|Adverse Event|2
4920070|NCT00492232|16944954|P1|Placebo Run-in|Adverse Event|0
4920071|NCT00492115|16944995|P2|Overall Study|Withdrawal by Subject|4
4920072|NCT00492115|16944996|P1|Overall Study|Withdrawal by Subject|3
4920073|NCT00492063|16945017|P4|Overall Study|Protocol Violation|1
4920074|NCT00492063|16945018|P3|Overall Study|Protocol Violation|0
4920075|NCT00492063|16945019|P2|Overall Study|Protocol Violation|0
4920076|NCT00492063|16945020|P1|Overall Study|Protocol Violation|0
4920077|NCT00492063|16945017|P4|Overall Study|Lost to Follow-up|3
4920078|NCT00492063|16945018|P3|Overall Study|Lost to Follow-up|5
4920079|NCT00492063|16945019|P2|Overall Study|Lost to Follow-up|11
4920080|NCT00492063|16945020|P1|Overall Study|Lost to Follow-up|6
4920081|NCT00492063|16945017|P4|Overall Study|Withdrawal by Subject|4
4920082|NCT00492063|16945018|P3|Overall Study|Withdrawal by Subject|5
4920083|NCT00492063|16945019|P2|Overall Study|Withdrawal by Subject|3
4920084|NCT00492063|16945020|P1|Overall Study|Withdrawal by Subject|4
4920085|NCT00492063|16945017|P4|Overall Study|Death|2
4920086|NCT00492063|16945018|P3|Overall Study|Death|1
4920087|NCT00492063|16945019|P2|Overall Study|Death|0
4920088|NCT00492063|16945020|P1|Overall Study|Death|0
4920089|NCT00492024|16945044|P2|Follow up|Lost to Follow-up|1
4920090|NCT00492024|16945045|P1|Follow up|Lost to Follow-up|1
4920091|NCT00492024|16945044|P2|Follow up|Lack of Efficacy|1
4920092|NCT00492024|16945045|P1|Follow up|Lack of Efficacy|0
4920093|NCT00492024|16945044|P2|Treatment|Withdrawal by Subject|0
4920094|NCT00492024|16945045|P1|Treatment|Withdrawal by Subject|2
4920095|NCT00492024|16945044|P2|Treatment|Lost to Follow-up|1
4920096|NCT00492024|16945045|P1|Treatment|Lost to Follow-up|3
4920097|NCT00492024|16945044|P2|Treatment|Lack of Efficacy|20
4920098|NCT00492024|16945045|P1|Treatment|Lack of Efficacy|21
4920099|NCT00492024|16945044|P2|Treatment|Adverse Event|1
4920100|NCT00492024|16945045|P1|Treatment|Adverse Event|3
4920101|NCT00491894|16945061|P1|Overall Study|Other-Intake of prohibited medication|1
4920102|NCT00491894|16945061|P1|Overall Study|Protocol Violation|2
4920103|NCT00491894|16945061|P1|Overall Study|Physician Decision|2
4920104|NCT00491894|16945061|P1|Overall Study|Other-Failed to meet any criteria|2
4920105|NCT00491894|16945061|P1|Overall Study|Lack of Efficacy|2
4920106|NCT00491894|16945061|P1|Overall Study|Lost to Follow-up|3
4920107|NCT00491894|16945061|P1|Overall Study|Death|3
4920108|NCT00491894|16945061|P1|Overall Study|Withdrawal by Subject|5
4920109|NCT00491894|16945061|P1|Overall Study|Adverse Event|14
4920110|NCT00491764|16945088|P6|Overall Study|Administrative|0
4920111|NCT00491764|16945089|P5|Overall Study|Administrative|0
4920112|NCT00491764|16945090|P4|Overall Study|Administrative|1
4920113|NCT00491764|16945091|P3|Overall Study|Administrative|2
4920114|NCT00491764|16945092|P2|Overall Study|Administrative|0
4920115|NCT00491764|16945093|P1|Overall Study|Administrative|1
4920116|NCT00491764|16945088|P6|Overall Study|Did not Meet Protocol Eligibility|1
4920117|NCT00491764|16945089|P5|Overall Study|Did not Meet Protocol Eligibility|1
4920118|NCT00491764|16945090|P4|Overall Study|Did not Meet Protocol Eligibility|0
4920119|NCT00491764|16945091|P3|Overall Study|Did not Meet Protocol Eligibility|1
4920120|NCT00491764|16945092|P2|Overall Study|Did not Meet Protocol Eligibility|1
4920121|NCT00491764|16945093|P1|Overall Study|Did not Meet Protocol Eligibility|0
4920122|NCT00491764|16945088|P6|Overall Study|Non Compliance with the Protocol|0
4920123|NCT00491764|16945089|P5|Overall Study|Non Compliance with the Protocol|0
4920124|NCT00491764|16945090|P4|Overall Study|Non Compliance with the Protocol|0
4920125|NCT00491764|16945091|P3|Overall Study|Non Compliance with the Protocol|0
4920126|NCT00491764|16945092|P2|Overall Study|Non Compliance with the Protocol|0
4920127|NCT00491764|16945093|P1|Overall Study|Non Compliance with the Protocol|1
4920128|NCT00491764|16945088|P6|Overall Study|Withdrawal by Subject|4
4920129|NCT00491764|16945089|P5|Overall Study|Withdrawal by Subject|2
4920130|NCT00491764|16945090|P4|Overall Study|Withdrawal by Subject|2
4920131|NCT00491764|16945091|P3|Overall Study|Withdrawal by Subject|1
4920132|NCT00491764|16945092|P2|Overall Study|Withdrawal by Subject|3
4920133|NCT00491764|16945093|P1|Overall Study|Withdrawal by Subject|2
4920134|NCT00491764|16945088|P6|Overall Study|Lost to Follow-up|3
4920135|NCT00491764|16945089|P5|Overall Study|Lost to Follow-up|0
4920136|NCT00491764|16945090|P4|Overall Study|Lost to Follow-up|1
4920137|NCT00491764|16945091|P3|Overall Study|Lost to Follow-up|0
4920138|NCT00491764|16945092|P2|Overall Study|Lost to Follow-up|1
4920139|NCT00491764|16945093|P1|Overall Study|Lost to Follow-up|0
4920140|NCT00491764|16945088|P6|Overall Study|Adverse Event|1
4920141|NCT00491764|16945089|P5|Overall Study|Adverse Event|0
4920142|NCT00491764|16945090|P4|Overall Study|Adverse Event|4
4920143|NCT00491764|16945091|P3|Overall Study|Adverse Event|4
4920144|NCT00491764|16945092|P2|Overall Study|Adverse Event|2
4920145|NCT00491764|16945093|P1|Overall Study|Adverse Event|1
4920146|NCT00491608|16945141|P1|Overall Study|Withdrawal by Subject|1
4920147|NCT00491608|16945141|P1|Overall Study|Death|2
4920148|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1
4920149|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0
4920150|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1
4920151|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0
4920152|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0
4920153|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2
4920154|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0
4920155|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2
4920156|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0
4920157|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2
4920158|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0
4920159|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5
4920160|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0
4920161|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2
4920162|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0
4920163|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5
4920164|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1
4920165|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2
4920166|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0
4920167|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2
4920168|NCT00491556|16945152|P2|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
4920169|NCT00491556|16945153|P1|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2
4920170|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Other|0
4920171|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Other|3
4920172|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0
4920173|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3
4920174|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0
4920175|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2
4920176|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0
4920177|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2
4920178|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0
4920179|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11
4920180|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0
4920181|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2
4920182|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0
4920183|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1
4920184|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0
4920185|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1
4920186|NCT00491556|16945152|P2|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0
4920187|NCT00491556|16945153|P1|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1
4920188|NCT00491530|16945212|P3|Overall Study|Use of Prohibited Medication|1
4920189|NCT00491530|16945213|P2|Overall Study|Use of Prohibited Medication|0
4920190|NCT00491530|16945214|P1|Overall Study|Use of Prohibited Medication|0
4920191|NCT00491530|16945212|P3|Overall Study|Patient Request|0
4920192|NCT00491530|16945213|P2|Overall Study|Patient Request|1
4920193|NCT00491530|16945214|P1|Overall Study|Patient Request|0
4920194|NCT00491530|16945212|P3|Overall Study|Investigator Discretion|0
4920195|NCT00491530|16945213|P2|Overall Study|Investigator Discretion|1
4920196|NCT00491530|16945214|P1|Overall Study|Investigator Discretion|0
4920197|NCT00491530|16945212|P3|Overall Study|Lack of Efficacy|0
4920198|NCT00491530|16945213|P2|Overall Study|Lack of Efficacy|1
4920199|NCT00491530|16945214|P1|Overall Study|Lack of Efficacy|0
4920200|NCT00491530|16945212|P3|Overall Study|Lost to Follow-up|2
4920201|NCT00491530|16945213|P2|Overall Study|Lost to Follow-up|2
4920202|NCT00491530|16945214|P1|Overall Study|Lost to Follow-up|3
4920203|NCT00491530|16945212|P3|Overall Study|Withdrawal by Subject|0
4920204|NCT00491530|16945213|P2|Overall Study|Withdrawal by Subject|0
4920205|NCT00491530|16945214|P1|Overall Study|Withdrawal by Subject|3
4920206|NCT00491530|16945212|P3|Overall Study|Adverse Event|2
4920207|NCT00491530|16945213|P2|Overall Study|Adverse Event|1
4920208|NCT00491530|16945214|P1|Overall Study|Adverse Event|6
4920209|NCT00491504|16945244|P4|Overall Study|Protocol Violation|2
4920210|NCT00491504|16945245|P3|Overall Study|Protocol Violation|3
4920211|NCT00491504|16945246|P2|Overall Study|Protocol Violation|0
4920212|NCT00491504|16945247|P1|Overall Study|Protocol Violation|0
4920213|NCT00491504|16945244|P4|Overall Study|Withdrawal by Subject|2
4920214|NCT00491504|16945245|P3|Overall Study|Withdrawal by Subject|1
4920215|NCT00491504|16945246|P2|Overall Study|Withdrawal by Subject|0
4920216|NCT00491504|16945247|P1|Overall Study|Withdrawal by Subject|0
4920217|NCT00491504|16945244|P4|Overall Study|Adverse Event|0
4920218|NCT00491504|16945245|P3|Overall Study|Adverse Event|0
4920219|NCT00491504|16945246|P2|Overall Study|Adverse Event|1
4920220|NCT00491504|16945247|P1|Overall Study|Adverse Event|0
4920221|NCT00491400|16945276|P2|Overall Study|Withdrawal by Subject|4
4920222|NCT00491400|16945277|P1|Overall Study|Withdrawal by Subject|5
4920223|NCT00491387|16945285|P1|Overall Study|study terminated|20
4920224|NCT00491322|16945300|P2|Overall Study|Pregnancy|1
4920225|NCT00491322|16945301|P1|Overall Study|Pregnancy|0
4920226|NCT00491322|16945300|P2|Overall Study|Protocol Violation|0
4920227|NCT00491322|16945301|P1|Overall Study|Protocol Violation|1
4920228|NCT00491179|16945320|P2|Overall Study|Withdrawal by Subject|1
4920229|NCT00491179|16945321|P1|Overall Study|Withdrawal by Subject|2
4920230|NCT00491179|16945320|P2|Overall Study|Adverse Event|1
4920231|NCT00491179|16945321|P1|Overall Study|Adverse Event|5
4920232|NCT00491075|16945329|P1|Overall Study|Physician Decision|1
4920233|NCT00491075|16945329|P1|Overall Study|Withdrawal by Subject|1
4920234|NCT00490971|16945335|P5|Maintenance|Other|3
4920235|NCT00490971|16945336|P4|Maintenance|Other|9
4920236|NCT00490971|16945337|P3|Maintenance|Other|11
4920237|NCT00490971|16945338|P2|Maintenance|Other|0
4920238|NCT00490971|16945339|P1|Maintenance|Other|0
4920239|NCT00490971|16945335|P5|Maintenance|Withdrawal by Subject|18
4920240|NCT00490971|16945336|P4|Maintenance|Withdrawal by Subject|28
4920241|NCT00490971|16945337|P3|Maintenance|Withdrawal by Subject|26
4920242|NCT00490971|16945338|P2|Maintenance|Withdrawal by Subject|0
4920243|NCT00490971|16945339|P1|Maintenance|Withdrawal by Subject|0
4920244|NCT00490971|16945335|P5|Maintenance|Protocol Violation|1
4920245|NCT00490971|16945336|P4|Maintenance|Protocol Violation|1
4920246|NCT00490971|16945337|P3|Maintenance|Protocol Violation|4
4920247|NCT00490971|16945338|P2|Maintenance|Protocol Violation|0
4920248|NCT00490971|16945339|P1|Maintenance|Protocol Violation|0
4920249|NCT00490971|16945335|P5|Maintenance|Pregnancy|0
4920250|NCT00490971|16945336|P4|Maintenance|Pregnancy|0
4920251|NCT00490971|16945337|P3|Maintenance|Pregnancy|1
4920252|NCT00490971|16945338|P2|Maintenance|Pregnancy|0
4920253|NCT00490971|16945339|P1|Maintenance|Pregnancy|0
4920254|NCT00490971|16945335|P5|Maintenance|Lost to Follow-up|10
4920255|NCT00490971|16945336|P4|Maintenance|Lost to Follow-up|8
4920256|NCT00490971|16945337|P3|Maintenance|Lost to Follow-up|5
4920257|NCT00490971|16945338|P2|Maintenance|Lost to Follow-up|0
4920258|NCT00490971|16945339|P1|Maintenance|Lost to Follow-up|0
4920259|NCT00490971|16945335|P5|Maintenance|Death|0
4920260|NCT00490971|16945336|P4|Maintenance|Death|2
4920261|NCT00490971|16945337|P3|Maintenance|Death|0
4920262|NCT00490971|16945338|P2|Maintenance|Death|0
4920263|NCT00490971|16945339|P1|Maintenance|Death|0
4920264|NCT00490971|16945335|P5|Maintenance|Adverse Event|7
4920265|NCT00490971|16945336|P4|Maintenance|Adverse Event|5
4920266|NCT00490971|16945337|P3|Maintenance|Adverse Event|4
4920267|NCT00490971|16945338|P2|Maintenance|Adverse Event|0
4920268|NCT00490971|16945339|P1|Maintenance|Adverse Event|0
4920269|NCT00490971|16945335|P5|Acute/Continuation|Other|0
4920270|NCT00490971|16945336|P4|Acute/Continuation|Other|0
4920271|NCT00490971|16945337|P3|Acute/Continuation|Other|0
4920272|NCT00490971|16945338|P2|Acute/Continuation|Other|4
4920273|NCT00490971|16945339|P1|Acute/Continuation|Other|11
4920274|NCT00490971|16945335|P5|Acute/Continuation|Withdrawal by Subject|0
4920275|NCT00490971|16945336|P4|Acute/Continuation|Withdrawal by Subject|0
4920276|NCT00490971|16945337|P3|Acute/Continuation|Withdrawal by Subject|0
4920277|NCT00490971|16945338|P2|Acute/Continuation|Withdrawal by Subject|24
4920278|NCT00490971|16945339|P1|Acute/Continuation|Withdrawal by Subject|92
4920279|NCT00490971|16945335|P5|Acute/Continuation|Protocol Violation|0
4920280|NCT00490971|16945336|P4|Acute/Continuation|Protocol Violation|0
4920281|NCT00490971|16945337|P3|Acute/Continuation|Protocol Violation|0
4920282|NCT00490971|16945338|P2|Acute/Continuation|Protocol Violation|2
4920283|NCT00490971|16945339|P1|Acute/Continuation|Protocol Violation|10
4920284|NCT00490971|16945335|P5|Acute/Continuation|Lost to Follow-up|0
4920285|NCT00490971|16945336|P4|Acute/Continuation|Lost to Follow-up|0
4920286|NCT00490971|16945337|P3|Acute/Continuation|Lost to Follow-up|0
4920287|NCT00490971|16945338|P2|Acute/Continuation|Lost to Follow-up|7
4920288|NCT00490971|16945339|P1|Acute/Continuation|Lost to Follow-up|23
4920289|NCT00490971|16945335|P5|Acute/Continuation|Lack of Efficacy|0
4920290|NCT00490971|16945336|P4|Acute/Continuation|Lack of Efficacy|0
4920291|NCT00490971|16945337|P3|Acute/Continuation|Lack of Efficacy|0
4920292|NCT00490971|16945338|P2|Acute/Continuation|Lack of Efficacy|12
4920293|NCT00490971|16945339|P1|Acute/Continuation|Lack of Efficacy|106
4920294|NCT00490971|16945335|P5|Acute/Continuation|Death|0
4920295|NCT00490971|16945336|P4|Acute/Continuation|Death|0
4920296|NCT00490971|16945337|P3|Acute/Continuation|Death|0
4920297|NCT00490971|16945338|P2|Acute/Continuation|Death|0
4920298|NCT00490971|16945339|P1|Acute/Continuation|Death|2
4920299|NCT00490971|16945335|P5|Acute/Continuation|Adverse Event|0
4920300|NCT00490971|16945336|P4|Acute/Continuation|Adverse Event|0
4920301|NCT00490971|16945337|P3|Acute/Continuation|Adverse Event|0
4920302|NCT00490971|16945338|P2|Acute/Continuation|Adverse Event|13
4920303|NCT00490971|16945339|P1|Acute/Continuation|Adverse Event|62
4920304|NCT00490945|16945386|P5|Overall Study|Adverse Event|0
4920305|NCT00490945|16945387|P4|Overall Study|Adverse Event|0
4920306|NCT00490945|16945388|P3|Overall Study|Adverse Event|0
4920307|NCT00490945|16945389|P2|Overall Study|Adverse Event|1
4920308|NCT00490945|16945390|P1|Overall Study|Adverse Event|0
4920309|NCT00490919|16945426|P3|Double-blind Phase|Administrative|6
4920310|NCT00490919|16945427|P2|Double-blind Phase|Administrative|6
4920311|NCT00490919|16945428|P1|Double-blind Phase|Administrative|0
4920312|NCT00490919|16945426|P3|Double-blind Phase|Lack of Efficacy|36
4920313|NCT00490919|16945427|P2|Double-blind Phase|Lack of Efficacy|22
4920314|NCT00490919|16945428|P1|Double-blind Phase|Lack of Efficacy|0
4920315|NCT00490919|16945426|P3|Double-blind Phase|Lost to Follow-up|11
4920316|NCT00490919|16945427|P2|Double-blind Phase|Lost to Follow-up|8
4920317|NCT00490919|16945428|P1|Double-blind Phase|Lost to Follow-up|0
4920318|NCT00490919|16945426|P3|Double-blind Phase|Withdrawal by Subject|11
4920319|NCT00490919|16945427|P2|Double-blind Phase|Withdrawal by Subject|10
4920320|NCT00490919|16945428|P1|Double-blind Phase|Withdrawal by Subject|0
4920321|NCT00490919|16945426|P3|Double-blind Phase|Adverse Event|20
4920322|NCT00490919|16945427|P2|Double-blind Phase|Adverse Event|40
4920323|NCT00490919|16945428|P1|Double-blind Phase|Adverse Event|0
4920324|NCT00490919|16945426|P3|Open-label Run-in Period|Confirmed or suspected diversion|0
4920325|NCT00490919|16945427|P2|Open-label Run-in Period|Confirmed or suspected diversion|0
4920326|NCT00490919|16945428|P1|Open-label Run-in Period|Confirmed or suspected diversion|3
4920327|NCT00490919|16945426|P3|Open-label Run-in Period|Administrative|0
4920328|NCT00490919|16945427|P2|Open-label Run-in Period|Administrative|0
4920329|NCT00490919|16945428|P1|Open-label Run-in Period|Administrative|40
4920330|NCT00490919|16945426|P3|Open-label Run-in Period|Lack of Efficacy|0
4920331|NCT00490919|16945427|P2|Open-label Run-in Period|Lack of Efficacy|0
4920332|NCT00490919|16945428|P1|Open-label Run-in Period|Lack of Efficacy|143
4920333|NCT00490919|16945426|P3|Open-label Run-in Period|Lost to Follow-up|0
4920334|NCT00490919|16945427|P2|Open-label Run-in Period|Lost to Follow-up|0
4920335|NCT00490919|16945428|P1|Open-label Run-in Period|Lost to Follow-up|21
4920336|NCT00490919|16945426|P3|Open-label Run-in Period|Withdrawal by Subject|0
4920337|NCT00490919|16945427|P2|Open-label Run-in Period|Withdrawal by Subject|0
4920338|NCT00490919|16945428|P1|Open-label Run-in Period|Withdrawal by Subject|37
4920339|NCT00490919|16945426|P3|Open-label Run-in Period|Adverse Event|0
4920340|NCT00490919|16945427|P2|Open-label Run-in Period|Adverse Event|0
4920341|NCT00490919|16945428|P1|Open-label Run-in Period|Adverse Event|239
4920342|NCT00490841|16945439|P1|Overall Study|30 day f/u, only non-study stent used|3
4920343|NCT00490841|16945439|P1|Overall Study|Lost to Follow-up|1
4920344|NCT00490841|16945439|P1|Overall Study|Withdrawal by Subject|4
4920345|NCT00490841|16945439|P1|Overall Study|Death|5
4920346|NCT00490815|16945461|P2|Overall Study|Death|3
4920347|NCT00490815|16945462|P1|Overall Study|Death|1
4920348|NCT00490815|16945461|P2|Overall Study|Lost to Follow-up|3
4920349|NCT00490815|16945462|P1|Overall Study|Lost to Follow-up|1
4920350|NCT00490815|16945461|P2|Overall Study|Withdrawal by Subject|0
4920351|NCT00490815|16945462|P1|Overall Study|Withdrawal by Subject|4
4920352|NCT00490815|16945461|P2|Overall Study|Adverse Event|3
4920353|NCT00490815|16945462|P1|Overall Study|Adverse Event|2
4920354|NCT00490724|16945490|P3|Period II|Treatment Discontinuation|3
4920355|NCT00490724|16945491|P2|Period II|Treatment Discontinuation|1
4920356|NCT00490724|16945492|P1|Period II|Treatment Discontinuation|3
4920357|NCT00490724|16945490|P3|Period I|Physician Decision|1
4920358|NCT00490724|16945491|P2|Period I|Physician Decision|0
4920359|NCT00490724|16945492|P1|Period I|Physician Decision|0
4920360|NCT00490698|16945557|P1|Overall Study|Physician Decision|2
4920361|NCT00490698|16945557|P1|Overall Study|Disease Progression|7
4920362|NCT00490698|16945557|P1|Overall Study|Withdrawal by Subject|1
4920363|NCT00490646|16945563|P2|Overall Study|Never Treated (withdrew consent)|1
4920364|NCT00490646|16945564|P1|Overall Study|Never Treated (withdrew consent)|0
4920365|NCT00490646|16945563|P2|Overall Study|Never Treated (had an adverse event)|0
4920366|NCT00490646|16945564|P1|Overall Study|Never Treated (had an adverse event)|1
4920367|NCT00490646|16945563|P2|Overall Study|Still on trastuzumab monotherapy|1
4920368|NCT00490646|16945564|P1|Overall Study|Still on trastuzumab monotherapy|1
4920369|NCT00490568|16945584|P1|Overall Study|Participant withdrawal due to surgery|1
4920370|NCT00490568|16945584|P1|Overall Study|Participant died|1
4920371|NCT00490568|16945584|P1|Overall Study|Efficacy related|3
4920372|NCT00490568|16945584|P1|Overall Study|Non-Compliance|7
4920373|NCT00490568|16945584|P1|Overall Study|Investigator decision|3
4920374|NCT00490568|16945584|P1|Overall Study|Unmet inclusion-exclusion criteria|5
4920375|NCT00490568|16945584|P1|Overall Study|Disease progression|4
4920376|NCT00490568|16945584|P1|Overall Study|Legal representative withdrew consent|1
4920377|NCT00490568|16945584|P1|Overall Study|Participant refused follow-up|9
4920378|NCT00490568|16945584|P1|Overall Study|Abnormal ECG|25
4920379|NCT00490568|16945584|P1|Overall Study|Caregiver related|20
4920380|NCT00490568|16945584|P1|Overall Study|Exclusion criteria met|1
4920381|NCT00490568|16945584|P1|Overall Study|Other|1
4920382|NCT00490568|16945584|P1|Overall Study|Still in the study at termination|974
4920383|NCT00490568|16945584|P1|Overall Study|Withdrawal by Subject|135
4920384|NCT00490568|16945584|P1|Overall Study|Protocol Violation|45
4920385|NCT00490568|16945584|P1|Overall Study|Lost to Follow-up|13
4920386|NCT00490568|16945584|P1|Overall Study|Adverse Event|116
4920387|NCT00490555|16945608|P4|Overall Study|noncompliant with drug administration|0
4920388|NCT00490555|16945609|P3|Overall Study|noncompliant with drug administration|2
4920389|NCT00490555|16945610|P2|Overall Study|noncompliant with drug administration|0
4920390|NCT00490555|16945611|P1|Overall Study|noncompliant with drug administration|0
4920391|NCT00490542|16945639|P2|Overall Study|Lack of Efficacy|1
4920392|NCT00490542|16945640|P1|Overall Study|Lack of Efficacy|1
4920393|NCT00490542|16945639|P2|Overall Study|Adverse Event|3
4920394|NCT00490542|16945640|P1|Overall Study|Adverse Event|3
4920395|NCT00490542|16945639|P2|Overall Study|Lost to Follow-up|0
4920396|NCT00490542|16945640|P1|Overall Study|Lost to Follow-up|3
4920397|NCT00490529|16945646|P1|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1
4920398|NCT00490529|16945646|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1
4920399|NCT00490529|16945646|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1
4920400|NCT00490529|16945646|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1
4920401|NCT00490529|16945646|P1|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4
4920402|NCT00490529|16945646|P1|Completed Pre-CpG-MCL Vaccine Procedures|Death|4
4920403|NCT00490490|16945654|P1|Completed Assessment for TTP|Lost to Follow-up|2
4920404|NCT00490490|16945654|P1|Completed Assessment for TTP|Withdrawal by Subject|1
4920405|NCT00490451|16945671|P2|Overall Study|Progressive Disease|34
4920406|NCT00490451|16945672|P1|Overall Study|Progressive Disease|53
4920407|NCT00490451|16945671|P2|Overall Study|Protocol Violation|0
4920408|NCT00490451|16945672|P1|Overall Study|Protocol Violation|1
4920409|NCT00490451|16945671|P2|Overall Study|Investigator Decision|0
4920410|NCT00490451|16945672|P1|Overall Study|Investigator Decision|1
4920411|NCT00490451|16945671|P2|Overall Study|Withdrawal by Subject|0
4920412|NCT00490451|16945672|P1|Overall Study|Withdrawal by Subject|2
4920413|NCT00490451|16945671|P2|Overall Study|Death|1
4920414|NCT00490451|16945672|P1|Overall Study|Death|3
4920415|NCT00490451|16945671|P2|Overall Study|Adverse Event|3
4920416|NCT00490451|16945672|P1|Overall Study|Adverse Event|3
4920417|NCT00490139|16945714|P4|Overall Study|Participant Withdrew Consent|116
4920418|NCT00490139|16945715|P3|Overall Study|Participant Withdrew Consent|208
4920419|NCT00490139|16945716|P2|Overall Study|Participant Withdrew Consent|110
4920420|NCT00490139|16945717|P1|Overall Study|Participant Withdrew Consent|146
4920421|NCT00490139|16945714|P4|Overall Study|Lost to Follow-up|56
4920422|NCT00490139|16945715|P3|Overall Study|Lost to Follow-up|58
4920423|NCT00490139|16945716|P2|Overall Study|Lost to Follow-up|46
4920424|NCT00490139|16945717|P1|Overall Study|Lost to Follow-up|56
4920425|NCT00490139|16945714|P4|Overall Study|Death|135
4920426|NCT00490139|16945715|P3|Overall Study|Death|168
4920427|NCT00490139|16945716|P2|Overall Study|Death|119
4920428|NCT00490139|16945717|P1|Overall Study|Death|106
4920429|NCT00490061|16945752|P1|Overall Study|Physician Decision|1
4920430|NCT00490035|16945761|P4|Overall Study|AE of unknown type|0
4920431|NCT00490035|16945762|P3|Overall Study|AE of unknown type|2
4920432|NCT00490035|16945763|P2|Overall Study|AE of unknown type|0
4920433|NCT00490035|16945764|P1|Overall Study|AE of unknown type|0
4920434|NCT00490035|16945761|P4|Overall Study|Serious adverse event (SAE), non-fatal|0
4920435|NCT00490035|16945762|P3|Overall Study|Serious adverse event (SAE), non-fatal|1
4920436|NCT00490035|16945763|P2|Overall Study|Serious adverse event (SAE), non-fatal|0
4920437|NCT00490035|16945764|P1|Overall Study|Serious adverse event (SAE), non-fatal|0
4920438|NCT00490035|16945761|P4|Overall Study|AE, serious fatal|0
4920439|NCT00490035|16945762|P3|Overall Study|AE, serious fatal|0
4920440|NCT00490035|16945763|P2|Overall Study|AE, serious fatal|0
4920441|NCT00490035|16945764|P1|Overall Study|AE, serious fatal|1
4920442|NCT00490035|16945761|P4|Overall Study|Other reason|1
4920443|NCT00490035|16945762|P3|Overall Study|Other reason|3
4920444|NCT00490035|16945763|P2|Overall Study|Other reason|1
4920445|NCT00490035|16945764|P1|Overall Study|Other reason|0
4920446|NCT00490035|16945761|P4|Overall Study|Withdrawal by Subject|0
4920447|NCT00490035|16945762|P3|Overall Study|Withdrawal by Subject|1
4920448|NCT00490035|16945763|P2|Overall Study|Withdrawal by Subject|1
4920449|NCT00490035|16945764|P1|Overall Study|Withdrawal by Subject|2
4920450|NCT00490035|16945761|P4|Overall Study|Lost to Follow-up|0
4920451|NCT00490035|16945762|P3|Overall Study|Lost to Follow-up|1
4920452|NCT00490035|16945763|P2|Overall Study|Lost to Follow-up|0
4920453|NCT00490035|16945764|P1|Overall Study|Lost to Follow-up|2
4920454|NCT00490035|16945761|P4|Overall Study|AE, non-serious non-fatal|5
4920455|NCT00490035|16945762|P3|Overall Study|AE, non-serious non-fatal|4
4920456|NCT00490035|16945763|P2|Overall Study|AE, non-serious non-fatal|4
4920457|NCT00490035|16945764|P1|Overall Study|AE, non-serious non-fatal|3
4920458|NCT00490022|16945864|P2|Overall Study|Subject failed to disclose concommitant|1
4920459|NCT00490022|16945865|P1|Overall Study|Subject failed to disclose concommitant|0
4920460|NCT00490022|16945864|P2|Overall Study|Withdrawal by Subject|0
4920461|NCT00490022|16945865|P1|Overall Study|Withdrawal by Subject|1
4920462|NCT00490022|16945864|P2|Overall Study|Adverse Event|2
4920463|NCT00490022|16945865|P1|Overall Study|Adverse Event|0
4920464|NCT00489970|16945882|P3|Persistence Year 9|Other|2
4920465|NCT00489970|16945883|P2|Persistence Year 9|Other|0
4920466|NCT00489970|16945884|P1|Persistence Year 9|Other|1
4920467|NCT00489970|16945882|P3|Persistence Year 9|Lost to Follow-up|3
4920468|NCT00489970|16945883|P2|Persistence Year 9|Lost to Follow-up|2
4920469|NCT00489970|16945884|P1|Persistence Year 9|Lost to Follow-up|2
4920470|NCT00489918|16945988|P5|Overall Study|Physician Decision|0
4920471|NCT00489918|16945989|P4|Overall Study|Physician Decision|0
4920472|NCT00489918|16945990|P3|Overall Study|Physician Decision|1
4920473|NCT00489918|16945991|P2|Overall Study|Physician Decision|0
4920474|NCT00489918|16945992|P1|Overall Study|Physician Decision|0
4920475|NCT00489918|16945988|P5|Overall Study|Lost to Follow-up|0
4920476|NCT00489918|16945989|P4|Overall Study|Lost to Follow-up|1
4920477|NCT00489918|16945990|P3|Overall Study|Lost to Follow-up|1
4920478|NCT00489918|16945991|P2|Overall Study|Lost to Follow-up|0
4920479|NCT00489918|16945992|P1|Overall Study|Lost to Follow-up|0
4920480|NCT00489918|16945988|P5|Overall Study|Adverse Event|0
4920481|NCT00489918|16945989|P4|Overall Study|Adverse Event|0
4920482|NCT00489918|16945990|P3|Overall Study|Adverse Event|1
4920483|NCT00489918|16945991|P2|Overall Study|Adverse Event|1
4920484|NCT00489918|16945992|P1|Overall Study|Adverse Event|0
4920485|NCT00489918|16945988|P5|Overall Study|Withdrawal by Subject|1
4920486|NCT00489918|16945989|P4|Overall Study|Withdrawal by Subject|0
4920487|NCT00489918|16945990|P3|Overall Study|Withdrawal by Subject|1
4920488|NCT00489918|16945991|P2|Overall Study|Withdrawal by Subject|1
4920489|NCT00489918|16945992|P1|Overall Study|Withdrawal by Subject|2
4920490|NCT00489853|16946041|P3|Treatment Period 3|Study specific discontinuation criteria|0
4920491|NCT00489853|16946042|P2|Treatment Period 3|Study specific discontinuation criteria|1
4920492|NCT00489853|16946043|P1|Treatment Period 3|Study specific discontinuation criteria|0
4920493|NCT00489853|16946041|P3|Wash-out Period 2|Study specific discontinuation criteria|2
4920494|NCT00489853|16946042|P2|Wash-out Period 2|Study specific discontinuation criteria|2
4920495|NCT00489853|16946043|P1|Wash-out Period 2|Study specific discontinuation criteria|3
4920496|NCT00489853|16946041|P3|Wash-out Period 2|Adverse Event|0
4920497|NCT00489853|16946042|P2|Wash-out Period 2|Adverse Event|1
4920498|NCT00489853|16946043|P1|Wash-out Period 2|Adverse Event|1
4920499|NCT00489853|16946041|P3|Wash-out Period 1|Study-specific discontinuation criteria|4
4920500|NCT00489853|16946042|P2|Wash-out Period 1|Study-specific discontinuation criteria|1
4920501|NCT00489853|16946043|P1|Wash-out Period 1|Study-specific discontinuation criteria|0
4920502|NCT00489853|16946041|P3|Wash-out Period 1|Protocol Violation|1
4920503|NCT00489853|16946042|P2|Wash-out Period 1|Protocol Violation|1
4920504|NCT00489853|16946043|P1|Wash-out Period 1|Protocol Violation|0
4920505|NCT00489853|16946041|P3|Wash-out Period 1|Adverse Event|1
4920506|NCT00489853|16946042|P2|Wash-out Period 1|Adverse Event|1
4920507|NCT00489853|16946043|P1|Wash-out Period 1|Adverse Event|0
4920508|NCT00489853|16946041|P3|Wash-out Period 1|Withdrawal by Subject|0
4920509|NCT00489853|16946042|P2|Wash-out Period 1|Withdrawal by Subject|0
4920510|NCT00489853|16946043|P1|Wash-out Period 1|Withdrawal by Subject|1
4920511|NCT00489827|16946140|P2|Overall Study|Intraoperative exclusion criteria|1
4920512|NCT00489827|16946141|P1|Overall Study|Intraoperative exclusion criteria|1
4920513|NCT00489827|16946140|P2|Overall Study|Intraoperative exclusion criteria|1
4920514|NCT00489827|16946141|P1|Overall Study|Intraoperative exclusion criteria|1
4920515|NCT00489736|16946165|P2|Overall Study|Not coded/ Not pre-specified|8
4920516|NCT00489736|16946166|P1|Overall Study|Not coded/ Not pre-specified|5
4920517|NCT00489736|16946165|P2|Overall Study|Poor compliance|2
4920518|NCT00489736|16946166|P1|Overall Study|Poor compliance|6
4920519|NCT00489736|16946165|P2|Overall Study|Adverse Event|45
4920520|NCT00489736|16946166|P1|Overall Study|Adverse Event|32
4920521|NCT00489736|16946165|P2|Overall Study|Lack of Efficacy|14
4920522|NCT00489736|16946166|P1|Overall Study|Lack of Efficacy|53
4920523|NCT00489554|16946176|P1|Overall Study|Lost to Follow-up|1
4920524|NCT00489554|16946176|P1|Overall Study|Withdrawal by Subject|1
4920525|NCT00489554|16946176|P1|Overall Study|Adverse Event|2
4920526|NCT00489541|16946196|P2|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5
4920527|NCT00489541|16946197|P1|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4
4920528|NCT00489541|16946196|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12
4920529|NCT00489541|16946197|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23
4920530|NCT00489541|16946196|P2|12-Month Clinical Follow-up|Death|2
4920531|NCT00489541|16946197|P1|12-Month Clinical Follow-up|Death|3
4920532|NCT00489541|16946196|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|0
4920533|NCT00489541|16946197|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|2
4920534|NCT00489541|16946196|P2|12-Month Clinical Follow-up|Lost to Follow-up|0
4920535|NCT00489541|16946197|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
4920536|NCT00489541|16946196|P2|12-Month Clinical Follow-up|Withdrawal by Subject|3
4920537|NCT00489541|16946197|P1|12-Month Clinical Follow-up|Withdrawal by Subject|2
4920538|NCT00489489|16946208|P3|Overall Study|Other than above|0
4920539|NCT00489489|16946209|P2|Overall Study|Other than above|1
4920540|NCT00489489|16946210|P1|Overall Study|Other than above|0
4920541|NCT00489489|16946208|P3|Overall Study|Participant did not wish to continue|0
4920542|NCT00489489|16946209|P2|Overall Study|Participant did not wish to continue|1
4920543|NCT00489489|16946210|P1|Overall Study|Participant did not wish to continue|1
4920544|NCT00489489|16946208|P3|Overall Study|Progressive disease|0
4920545|NCT00489489|16946209|P2|Overall Study|Progressive disease|1
4920546|NCT00489489|16946210|P1|Overall Study|Progressive disease|0
4920547|NCT00489489|16946208|P3|Overall Study|Protocol Violation|1
4920548|NCT00489489|16946209|P2|Overall Study|Protocol Violation|0
4920549|NCT00489489|16946210|P1|Overall Study|Protocol Violation|1
4920550|NCT00489489|16946208|P3|Overall Study|Adverse Event|1
4920551|NCT00489489|16946209|P2|Overall Study|Adverse Event|1
4920552|NCT00489489|16946210|P1|Overall Study|Adverse Event|1
4920553|NCT00489489|16946208|P3|Overall Study|Not treated due to protocol violation|1
4920554|NCT00489489|16946209|P2|Overall Study|Not treated due to protocol violation|1
4920555|NCT00489489|16946210|P1|Overall Study|Not treated due to protocol violation|0
4920556|NCT00489476|16946242|P4|Overall Study|Lost to Follow-up|0
4920557|NCT00489476|16946243|P3|Overall Study|Lost to Follow-up|0
4920558|NCT00489476|16946244|P2|Overall Study|Lost to Follow-up|1
4920559|NCT00489476|16946245|P1|Overall Study|Lost to Follow-up|0
4920560|NCT00489424|16946266|P3|Overall Study|Administrative problems|1
4920561|NCT00489424|16946267|P2|Overall Study|Administrative problems|2
4920562|NCT00489424|16946268|P1|Overall Study|Administrative problems|0
4920563|NCT00489424|16946266|P3|Overall Study|Lack of Efficacy|0
4920564|NCT00489424|16946267|P2|Overall Study|Lack of Efficacy|0
4920565|NCT00489424|16946268|P1|Overall Study|Lack of Efficacy|1
4920566|NCT00489424|16946266|P3|Overall Study|Adverse Event|4
4920567|NCT00489424|16946267|P2|Overall Study|Adverse Event|3
4920568|NCT00489424|16946268|P1|Overall Study|Adverse Event|3
4920569|NCT00489411|16946299|P2|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
4920570|NCT00489411|16946300|P1|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7
4920571|NCT00489411|16946299|P2|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12
4920572|NCT00489411|16946300|P1|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11
4920573|NCT00489411|16946299|P2|Initial Treatment Period (Weeks 1-5)|Incomplete data|5
4920574|NCT00489411|16946300|P1|Initial Treatment Period (Weeks 1-5)|Incomplete data|1
4920575|NCT00489411|16946299|P2|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12
4920576|NCT00489411|16946300|P1|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21
4920577|NCT00489411|16946299|P2|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5
4920578|NCT00489411|16946300|P1|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6
4920579|NCT00489359|16946314|P2|Overall Study|Adverse Event|16
4920580|NCT00489359|16946315|P1|Overall Study|Adverse Event|0
4920581|NCT00489359|16946314|P2|Overall Study|Withdrawal by Subject|5
4920582|NCT00489359|16946315|P1|Overall Study|Withdrawal by Subject|1
4920583|NCT00489359|16946314|P2|Overall Study|Lost to Follow-up|0
4920584|NCT00489359|16946315|P1|Overall Study|Lost to Follow-up|1
4920585|NCT00489359|16946314|P2|Overall Study|Progressive Disease|6
4920586|NCT00489359|16946315|P1|Overall Study|Progressive Disease|5
4920587|NCT00489359|16946314|P2|Overall Study|Death|2
4920588|NCT00489359|16946315|P1|Overall Study|Death|0
4920589|NCT00489255|16946391|P2|Period 3: Days 57 to 84|Lost to Follow-up|1
4920590|NCT00489255|16946392|P1|Period 3: Days 57 to 84|Lost to Follow-up|0
4920591|NCT00489255|16946391|P2|Period 3: Days 57 to 84|Withdrawal by Subject|0
4920592|NCT00489255|16946392|P1|Period 3: Days 57 to 84|Withdrawal by Subject|1
4920593|NCT00489255|16946391|P2|Period 3: Days 57 to 84|Adverse Event|3
4920594|NCT00489255|16946392|P1|Period 3: Days 57 to 84|Adverse Event|3
4920595|NCT00489255|16946391|P2|Period 2: Days 29 to 56|Withdrawal by Subject|3
4920596|NCT00489255|16946392|P1|Period 2: Days 29 to 56|Withdrawal by Subject|0
4920597|NCT00489255|16946391|P2|Period 2: Days 29 to 56|Adverse Event|1
4920598|NCT00489255|16946392|P1|Period 2: Days 29 to 56|Adverse Event|3
4920599|NCT00489255|16946391|P2|Period 1: Days 1 to 28|Noncompliance|0
4920600|NCT00489255|16946392|P1|Period 1: Days 1 to 28|Noncompliance|2
4920601|NCT00489255|16946391|P2|Period 1: Days 1 to 28|Physician Decision|4
4920602|NCT00489255|16946392|P1|Period 1: Days 1 to 28|Physician Decision|1
4920603|NCT00489255|16946391|P2|Period 1: Days 1 to 28|Withdrawal by Subject|0
4920604|NCT00489255|16946392|P1|Period 1: Days 1 to 28|Withdrawal by Subject|5
4920605|NCT00489255|16946391|P2|Period 1: Days 1 to 28|Adverse Event|8
4920606|NCT00489255|16946392|P1|Period 1: Days 1 to 28|Adverse Event|21
4920607|NCT00489255|16946391|P2|Screening and Initial Randomization|Discontinued prior to taking study drug|3
4920608|NCT00489255|16946392|P1|Screening and Initial Randomization|Discontinued prior to taking study drug|9
4920609|NCT00489216|16946440|P1|Overall Study|Adverse Event|1
4920610|NCT00488982|16946449|P3|Course 1|Adverse Event|6
4920611|NCT00488982|16946450|P2|Course 1|Adverse Event|0
4920612|NCT00488982|16946451|P1|Course 1|Adverse Event|0
4920613|NCT00488982|16946449|P3|Course 1|nonprotocol therapy|2
4920614|NCT00488982|16946450|P2|Course 1|nonprotocol therapy|2
4920615|NCT00488982|16946451|P1|Course 1|nonprotocol therapy|0
4920616|NCT00488982|16946449|P3|Course 1|Withdrawal by Subject|2
4920617|NCT00488982|16946450|P2|Course 1|Withdrawal by Subject|8
4920618|NCT00488982|16946451|P1|Course 1|Withdrawal by Subject|0
4920619|NCT00488982|16946449|P3|Course 1|Physician Decision|4
4920620|NCT00488982|16946450|P2|Course 1|Physician Decision|2
4920621|NCT00488982|16946451|P1|Course 1|Physician Decision|0
4920622|NCT00488826|16946474|P3|Overall Study|Protocol Deviations|1
4920623|NCT00488826|16946475|P2|Overall Study|Protocol Deviations|1
4920624|NCT00488826|16946476|P1|Overall Study|Protocol Deviations|2
4920625|NCT00488826|16946474|P3|Overall Study|Lost to Follow-up|0
4920626|NCT00488826|16946475|P2|Overall Study|Lost to Follow-up|1
4920627|NCT00488826|16946476|P1|Overall Study|Lost to Follow-up|5
4920628|NCT00488826|16946474|P3|Overall Study|Adverse Event|4
4920629|NCT00488826|16946475|P2|Overall Study|Adverse Event|15
4920630|NCT00488826|16946476|P1|Overall Study|Adverse Event|9
4920631|NCT00488826|16946474|P3|Overall Study|Protocol Violation|2
4920632|NCT00488826|16946475|P2|Overall Study|Protocol Violation|0
4920633|NCT00488826|16946476|P1|Overall Study|Protocol Violation|0
4920634|NCT00488826|16946474|P3|Overall Study|Withdrawal by Subject|19
4920635|NCT00488826|16946475|P2|Overall Study|Withdrawal by Subject|35
4920636|NCT00488826|16946476|P1|Overall Study|Withdrawal by Subject|40
4920637|NCT00488774|16946491|P4|Overall Study|Lost to Follow-up|1
4920638|NCT00488774|16946492|P3|Overall Study|Lost to Follow-up|1
4920639|NCT00488774|16946493|P2|Overall Study|Lost to Follow-up|0
4920640|NCT00488774|16946494|P1|Overall Study|Lost to Follow-up|0
4920641|NCT00488774|16946491|P4|Overall Study|Other|2
4920642|NCT00488774|16946492|P3|Overall Study|Other|2
4920643|NCT00488774|16946493|P2|Overall Study|Other|3
4920644|NCT00488774|16946494|P1|Overall Study|Other|6
4920645|NCT00488774|16946491|P4|Overall Study|Withdrawal of consent|0
4920646|NCT00488774|16946492|P3|Overall Study|Withdrawal of consent|2
4920647|NCT00488774|16946493|P2|Overall Study|Withdrawal of consent|2
4920648|NCT00488774|16946494|P1|Overall Study|Withdrawal of consent|2
4920649|NCT00488683|16946511|P3|Overall Study|Unable to Classify|0
4920650|NCT00488683|16946512|P2|Overall Study|Unable to Classify|0
4920651|NCT00488683|16946513|P1|Overall Study|Unable to Classify|1
4920652|NCT00488683|16946511|P3|Overall Study|Protocol Violation|0
4920653|NCT00488683|16946512|P2|Overall Study|Protocol Violation|1
4920654|NCT00488683|16946513|P1|Overall Study|Protocol Violation|5
4920655|NCT00488683|16946511|P3|Overall Study|Lost to Follow-up|0
4920656|NCT00488683|16946512|P2|Overall Study|Lost to Follow-up|3
4920657|NCT00488683|16946513|P1|Overall Study|Lost to Follow-up|5
4920658|NCT00488683|16946511|P3|Overall Study|Withdrawal by Subject|2
4920659|NCT00488683|16946512|P2|Overall Study|Withdrawal by Subject|2
4920660|NCT00488683|16946513|P1|Overall Study|Withdrawal by Subject|1
4920661|NCT00488644|16946572|P1|Overall Study|Not Evaluable|1
4920662|NCT00488644|16946572|P1|Overall Study|Not Eligible|1
4920663|NCT00488631|16946582|P10|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920664|NCT00488631|16946583|P9|Open Label Study Extension (Week 54-228)|Unspecified reasons|87
4920665|NCT00488631|16946584|P8|Open Label Study Extension (Week 54-228)|Unspecified reasons|14
4920666|NCT00488631|16946585|P7|Open Label Study Extension (Week 54-228)|Unspecified reasons|63
4920667|NCT00488631|16946586|P6|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920668|NCT00488631|16946587|P5|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920669|NCT00488631|16946588|P4|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920670|NCT00488631|16946589|P3|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920671|NCT00488631|16946590|P2|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920672|NCT00488631|16946591|P1|Open Label Study Extension (Week 54-228)|Unspecified reasons|0
4920673|NCT00488631|16946582|P10|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920674|NCT00488631|16946583|P9|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6
4920675|NCT00488631|16946584|P8|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920676|NCT00488631|16946585|P7|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2
4920677|NCT00488631|16946586|P6|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920678|NCT00488631|16946587|P5|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920679|NCT00488631|16946588|P4|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920680|NCT00488631|16946589|P3|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920681|NCT00488631|16946590|P2|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920682|NCT00488631|16946591|P1|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0
4920683|NCT00488631|16946582|P10|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3
4920684|NCT00488631|16946583|P9|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34
4920685|NCT00488631|16946584|P8|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
4920686|NCT00488631|16946585|P7|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5
4920687|NCT00488631|16946586|P6|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4920688|NCT00488631|16946587|P5|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4920689|NCT00488631|16946588|P4|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4920690|NCT00488631|16946589|P3|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4920691|NCT00488631|16946590|P2|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4920692|NCT00488631|16946591|P1|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0
4920693|NCT00488631|16946582|P10|Open Label Study Extension (Week 54-228)|Death|0
4920694|NCT00488631|16946583|P9|Open Label Study Extension (Week 54-228)|Death|1
4920695|NCT00488631|16946584|P8|Open Label Study Extension (Week 54-228)|Death|0
4920696|NCT00488631|16946585|P7|Open Label Study Extension (Week 54-228)|Death|0
4920697|NCT00488631|16946586|P6|Open Label Study Extension (Week 54-228)|Death|0
4920698|NCT00488631|16946587|P5|Open Label Study Extension (Week 54-228)|Death|0
4920699|NCT00488631|16946588|P4|Open Label Study Extension (Week 54-228)|Death|0
4920700|NCT00488631|16946589|P3|Open Label Study Extension (Week 54-228)|Death|0
4920701|NCT00488631|16946590|P2|Open Label Study Extension (Week 54-228)|Death|0
4920702|NCT00488631|16946591|P1|Open Label Study Extension (Week 54-228)|Death|0
4920703|NCT00488631|16946582|P10|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920704|NCT00488631|16946583|P9|Open Label Study Extension (Week 54-228)|Adverse Event|54
4920705|NCT00488631|16946584|P8|Open Label Study Extension (Week 54-228)|Adverse Event|8
4920706|NCT00488631|16946585|P7|Open Label Study Extension (Week 54-228)|Adverse Event|10
4920707|NCT00488631|16946586|P6|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920708|NCT00488631|16946587|P5|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920709|NCT00488631|16946588|P4|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920710|NCT00488631|16946589|P3|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920711|NCT00488631|16946590|P2|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920712|NCT00488631|16946591|P1|Open Label Study Extension (Week 54-228)|Adverse Event|0
4920713|NCT00488631|16946582|P10|Double Blind Period (Week 0-54)|Other|0
4920714|NCT00488631|16946583|P9|Double Blind Period (Week 0-54)|Other|0
4920715|NCT00488631|16946584|P8|Double Blind Period (Week 0-54)|Other|0
4920716|NCT00488631|16946585|P7|Double Blind Period (Week 0-54)|Other|0
4920717|NCT00488631|16946586|P6|Double Blind Period (Week 0-54)|Other|34
4920718|NCT00488631|16946587|P5|Double Blind Period (Week 0-54)|Other|14
4920719|NCT00488631|16946588|P4|Double Blind Period (Week 0-54)|Other|11
4920720|NCT00488631|16946589|P3|Double Blind Period (Week 0-54)|Other|10
4920721|NCT00488631|16946590|P2|Double Blind Period (Week 0-54)|Other|12
4920722|NCT00488631|16946591|P1|Double Blind Period (Week 0-54)|Other|6
4920723|NCT00488631|16946582|P10|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4920724|NCT00488631|16946583|P9|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4920725|NCT00488631|16946584|P8|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4920726|NCT00488631|16946585|P7|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4920727|NCT00488631|16946586|P6|Double Blind Period (Week 0-54)|Lost to Follow-up|7
4920728|NCT00488631|16946587|P5|Double Blind Period (Week 0-54)|Lost to Follow-up|3
4920729|NCT00488631|16946588|P4|Double Blind Period (Week 0-54)|Lost to Follow-up|0
4920730|NCT00488631|16946589|P3|Double Blind Period (Week 0-54)|Lost to Follow-up|1
4920731|NCT00488631|16946590|P2|Double Blind Period (Week 0-54)|Lost to Follow-up|2
4920732|NCT00488631|16946591|P1|Double Blind Period (Week 0-54)|Lost to Follow-up|1
4920733|NCT00488631|16946582|P10|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4920734|NCT00488631|16946583|P9|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4920735|NCT00488631|16946584|P8|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4920736|NCT00488631|16946585|P7|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0
4920737|NCT00488631|16946586|P6|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124
4920738|NCT00488631|16946587|P5|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56
4920739|NCT00488631|16946588|P4|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18
4920740|NCT00488631|16946589|P3|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22
4920741|NCT00488631|16946590|P2|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17
4920742|NCT00488631|16946591|P1|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19
4920743|NCT00488631|16946582|P10|Double Blind Period (Week 0-54)|Death|0
4920744|NCT00488631|16946583|P9|Double Blind Period (Week 0-54)|Death|0
4920745|NCT00488631|16946584|P8|Double Blind Period (Week 0-54)|Death|0
4920746|NCT00488631|16946585|P7|Double Blind Period (Week 0-54)|Death|0
4920747|NCT00488631|16946586|P6|Double Blind Period (Week 0-54)|Death|1
4920748|NCT00488631|16946587|P5|Double Blind Period (Week 0-54)|Death|0
4920749|NCT00488631|16946588|P4|Double Blind Period (Week 0-54)|Death|0
4920750|NCT00488631|16946589|P3|Double Blind Period (Week 0-54)|Death|0
4920751|NCT00488631|16946590|P2|Double Blind Period (Week 0-54)|Death|0
4920752|NCT00488631|16946591|P1|Double Blind Period (Week 0-54)|Death|0
4920753|NCT00488631|16946582|P10|Double Blind Period (Week 0-54)|Adverse Event|0
4920754|NCT00488631|16946583|P9|Double Blind Period (Week 0-54)|Adverse Event|0
4920755|NCT00488631|16946584|P8|Double Blind Period (Week 0-54)|Adverse Event|0
4920756|NCT00488631|16946585|P7|Double Blind Period (Week 0-54)|Adverse Event|0
4920757|NCT00488631|16946586|P6|Double Blind Period (Week 0-54)|Adverse Event|50
4920758|NCT00488631|16946587|P5|Double Blind Period (Week 0-54)|Adverse Event|30
4920759|NCT00488631|16946588|P4|Double Blind Period (Week 0-54)|Adverse Event|12
4920760|NCT00488631|16946589|P3|Double Blind Period (Week 0-54)|Adverse Event|12
4920761|NCT00488631|16946590|P2|Double Blind Period (Week 0-54)|Adverse Event|12
4920762|NCT00488631|16946591|P1|Double Blind Period (Week 0-54)|Adverse Event|17
4920763|NCT00488618|16946628|P2|Overall Study|Lost to Follow-up|0
4920764|NCT00488618|16946629|P1|Overall Study|Lost to Follow-up|1
4920765|NCT00488618|16946628|P2|Overall Study|Withdrawal of Consent|13
4920766|NCT00488618|16946629|P1|Overall Study|Withdrawal of Consent|15
4920767|NCT00488618|16946628|P2|Overall Study|Protocol Violation|2
4920768|NCT00488618|16946629|P1|Overall Study|Protocol Violation|0
4920769|NCT00488618|16946628|P2|Overall Study|Insufficient Therapeutic Response|11
4920770|NCT00488618|16946629|P1|Overall Study|Insufficient Therapeutic Response|18
4920771|NCT00488618|16946628|P2|Overall Study|Adverse Event|17
4920772|NCT00488618|16946629|P1|Overall Study|Adverse Event|13
4920773|NCT00488592|16946637|P1|Overall Study|Enrolled but not treated|1
4920774|NCT00488592|16946637|P1|Overall Study|Disease progression|1
4920775|NCT00488592|16946637|P1|Overall Study|Withdrawal by Subject|1
4920776|NCT00488514|16946641|P1|Overall Study|Increased use of concomitant medication|1
4920777|NCT00488514|16946641|P1|Overall Study|Increase in number of migraines|2
4920778|NCT00488514|16946641|P1|Overall Study|Participant had too few migraines|5
4920779|NCT00488514|16946641|P1|Overall Study|Investigator decision|1
4920780|NCT00488514|16946641|P1|Overall Study|Withdrawn per medical monitor decision|2
4920781|NCT00488514|16946641|P1|Overall Study|Postive drug screen|1
4920782|NCT00488514|16946641|P1|Overall Study|Did not meet criteria for treatment|30
4920783|NCT00488514|16946641|P1|Overall Study|Lack of Efficacy|28
4920784|NCT00488514|16946641|P1|Overall Study|Withdrawal by Subject|106
4920785|NCT00488514|16946641|P1|Overall Study|Protocol Violation|32
4920786|NCT00488514|16946641|P1|Overall Study|Lost to Follow-up|44
4920787|NCT00488514|16946641|P1|Overall Study|Adverse Event|41
4920788|NCT00488475|16946729|P1|Overall Study|Other|1754
4920789|NCT00488345|16946758|P3|Overall Study|Parent/legal guardian request|1
4920790|NCT00488345|16946759|P2|Overall Study|Parent/legal guardian request|1
4920791|NCT00488345|16946760|P1|Overall Study|Parent/legal guardian request|0
4920792|NCT00488345|16946758|P3|Overall Study|Surgical team recommendation|0
4920793|NCT00488345|16946759|P2|Overall Study|Surgical team recommendation|1
4920794|NCT00488345|16946760|P1|Overall Study|Surgical team recommendation|0
4920795|NCT00488345|16946758|P3|Overall Study|Institutional Review Board review|1
4920796|NCT00488345|16946759|P2|Overall Study|Institutional Review Board review|0
4920797|NCT00488345|16946760|P1|Overall Study|Institutional Review Board review|0
4920798|NCT00488345|16946758|P3|Overall Study|Unable to administer antibiotics at home|0
4920799|NCT00488345|16946759|P2|Overall Study|Unable to administer antibiotics at home|1
4920800|NCT00488345|16946760|P1|Overall Study|Unable to administer antibiotics at home|0
4920801|NCT00488345|16946758|P3|Overall Study|Adverse Event|1
4920802|NCT00488345|16946759|P2|Overall Study|Adverse Event|1
4920803|NCT00488345|16946760|P1|Overall Study|Adverse Event|0
4920804|NCT00488319|16946786|P3|Overall Study|Other reasons for withdrawal|12
4920805|NCT00488319|16946787|P2|Overall Study|Other reasons for withdrawal|4
4920806|NCT00488319|16946788|P1|Overall Study|Other reasons for withdrawal|0
4920807|NCT00488319|16946786|P3|Overall Study|Withdrawal by Subject|44
4920808|NCT00488319|16946787|P2|Overall Study|Withdrawal by Subject|20
4920809|NCT00488319|16946788|P1|Overall Study|Withdrawal by Subject|5
4920810|NCT00488319|16946786|P3|Overall Study|Lost to Follow-up|16
4920811|NCT00488319|16946787|P2|Overall Study|Lost to Follow-up|5
4920812|NCT00488319|16946788|P1|Overall Study|Lost to Follow-up|3
4920813|NCT00488319|16946786|P3|Overall Study|Lack of Efficacy|27
4920814|NCT00488319|16946787|P2|Overall Study|Lack of Efficacy|12
4920815|NCT00488319|16946788|P1|Overall Study|Lack of Efficacy|6
4920816|NCT00488319|16946786|P3|Overall Study|Adverse Event|23
4920817|NCT00488319|16946787|P2|Overall Study|Adverse Event|2
4920818|NCT00488319|16946788|P1|Overall Study|Adverse Event|1
4920819|NCT00488293|16946875|P2|Overall Study|Misrandomization/Other Unspecified|1
4920820|NCT00488293|16946876|P1|Overall Study|Misrandomization/Other Unspecified|1
4920821|NCT00488293|16946875|P2|Overall Study|Death|1
4920822|NCT00488293|16946876|P1|Overall Study|Death|2
4920823|NCT00488293|16946875|P2|Overall Study|Withdrawal by Subject|3
4920824|NCT00488293|16946876|P1|Overall Study|Withdrawal by Subject|5
4920825|NCT00488293|16946875|P2|Overall Study|Lost to Follow-up|25
4920826|NCT00488293|16946876|P1|Overall Study|Lost to Follow-up|28
4920827|NCT00488033|16946921|P2|Overall Study|Withdrawal by Subject|0
4920828|NCT00488033|16946922|P1|Overall Study|Withdrawal by Subject|1
4920829|NCT00487981|16946938|P1|Overall Study|Hypothyroidism diagnosis|1
4920830|NCT00487942|16946946|P4|Overall Study|Withdrawal by Subject|0
4920831|NCT00487942|16946947|P3|Overall Study|Withdrawal by Subject|2
4920832|NCT00487942|16946948|P2|Overall Study|Withdrawal by Subject|1
4920833|NCT00487942|16946949|P1|Overall Study|Withdrawal by Subject|0
4920834|NCT00487942|16946946|P4|Overall Study|Protocol Violation|0
4920835|NCT00487942|16946947|P3|Overall Study|Protocol Violation|0
4920836|NCT00487942|16946948|P2|Overall Study|Protocol Violation|1
4920837|NCT00487942|16946949|P1|Overall Study|Protocol Violation|1
4920838|NCT00487942|16946946|P4|Overall Study|Lost to Follow-up|1
4920839|NCT00487942|16946947|P3|Overall Study|Lost to Follow-up|0
4920840|NCT00487942|16946948|P2|Overall Study|Lost to Follow-up|0
4920841|NCT00487942|16946949|P1|Overall Study|Lost to Follow-up|1
4920842|NCT00487942|16946946|P4|Overall Study|Adverse Event|1
4920843|NCT00487942|16946947|P3|Overall Study|Adverse Event|1
4920844|NCT00487942|16946948|P2|Overall Study|Adverse Event|1
4920845|NCT00487942|16946949|P1|Overall Study|Adverse Event|1
4920846|NCT00487825|16947333|P2|Overall Study|Other|2
4920847|NCT00487825|16947334|P1|Overall Study|Other|3
4920848|NCT00487825|16947333|P2|Overall Study|Lack of Efficacy|1
4920849|NCT00487825|16947334|P1|Overall Study|Lack of Efficacy|1
4920850|NCT00487825|16947333|P2|Overall Study|Adverse Event|2
4920851|NCT00487825|16947334|P1|Overall Study|Adverse Event|2
4920852|NCT00487747|16947346|P1|Overall Study|Lack of Efficacy|1
4920853|NCT00487747|16947346|P1|Overall Study|Lost to Follow-up|9
4920854|NCT00487747|16947346|P1|Overall Study|Adverse Event|1
4920855|NCT00487695|16947363|P2|Second Procedure|Withdrawal by Subject|2
4920856|NCT00487695|16947364|P1|Second Procedure|Withdrawal by Subject|1
4920857|NCT00487695|16947363|P2|Second Procedure|active wheezing|1
4920858|NCT00487695|16947364|P1|Second Procedure|active wheezing|0
4920859|NCT00487695|16947363|P2|First Procedure|esophageal stricture found (excl crit)|0
4920860|NCT00487695|16947364|P1|First Procedure|esophageal stricture found (excl crit)|1
4920861|NCT00487695|16947363|P2|First Procedure|active wheezing (did not have procedure)|0
4920862|NCT00487695|16947364|P1|First Procedure|active wheezing (did not have procedure)|1
4920863|NCT00487695|16947363|P2|First Procedure|invasive cancer on EGD (excl criteria)|0
4920864|NCT00487695|16947364|P1|First Procedure|invasive cancer on EGD (excl criteria)|1
4920865|NCT00487578|16947392|P2|Overall Study|Lost to Follow-up|1
4920866|NCT00487578|16947393|P1|Overall Study|Lost to Follow-up|0
4920867|NCT00487578|16947392|P2|Overall Study|Lack of Efficacy|1
4920868|NCT00487578|16947393|P1|Overall Study|Lack of Efficacy|0
4920869|NCT00487578|16947392|P2|Overall Study|Adverse Event|2
4920870|NCT00487578|16947393|P1|Overall Study|Adverse Event|1
4920871|NCT00487552|16947413|P1|Overall Study|Stent not placed|1
4920872|NCT00487552|16947413|P1|Overall Study|Death due to progressive malignancy|2
4920873|NCT00487552|16947413|P1|Overall Study|Unsuccessful magnet placements|3
4920874|NCT00487539|16947422|P4|Overall Study|Other|2
4920875|NCT00487539|16947423|P3|Overall Study|Other|2
4920876|NCT00487539|16947424|P2|Overall Study|Other|1
4920877|NCT00487539|16947425|P1|Overall Study|Other|3
4920878|NCT00487539|16947422|P4|Overall Study|Unsatisfactory therapeutic effect|1
4920879|NCT00487539|16947423|P3|Overall Study|Unsatisfactory therapeutic effect|0
4920880|NCT00487539|16947424|P2|Overall Study|Unsatisfactory therapeutic effect|0
4920881|NCT00487539|16947425|P1|Overall Study|Unsatisfactory therapeutic effect|1
4920882|NCT00487539|16947422|P4|Overall Study|Adverse Event|1
4920883|NCT00487539|16947423|P3|Overall Study|Adverse Event|1
4920884|NCT00487539|16947424|P2|Overall Study|Adverse Event|2
4920885|NCT00487539|16947425|P1|Overall Study|Adverse Event|3
4920886|NCT00487435|16947459|P1|Overall Study|Other|83
4920887|NCT00487435|16947459|P1|Overall Study|Study Medication Non-Compliant|32
4920888|NCT00487435|16947459|P1|Overall Study|Resolution Of Pain|1
4920889|NCT00487435|16947459|P1|Overall Study|Withdrawal by Subject|132
4920890|NCT00487435|16947459|P1|Overall Study|Pregnancy|2
4920891|NCT00487435|16947459|P1|Overall Study|Lost to Follow-up|54
4920892|NCT00487435|16947459|P1|Overall Study|Lack of Efficacy|33
4920893|NCT00487435|16947459|P1|Overall Study|Death|2
4920894|NCT00487435|16947459|P1|Overall Study|Adverse Event|146
4920895|NCT00487279|16947475|P2|Overall Study|Withdrawal by Subject|2
4920896|NCT00487279|16947476|P1|Overall Study|Withdrawal by Subject|0
4920897|NCT00487279|16947475|P2|Overall Study|Death|0
4920898|NCT00487279|16947476|P1|Overall Study|Death|1
4920899|NCT00487240|16947486|P2|Overall Study|Physician Decision|0
4920900|NCT00487240|16947487|P1|Overall Study|Physician Decision|2
4920901|NCT00487240|16947486|P2|Overall Study|Sponsor Decision|1
4920902|NCT00487240|16947487|P1|Overall Study|Sponsor Decision|2
4920903|NCT00487240|16947486|P2|Overall Study|Entry Criteria Not Met|4
4920904|NCT00487240|16947487|P1|Overall Study|Entry Criteria Not Met|3
4920905|NCT00487240|16947486|P2|Overall Study|Protocol Violation|5
4920906|NCT00487240|16947487|P1|Overall Study|Protocol Violation|5
4920907|NCT00487240|16947486|P2|Overall Study|Adverse Event|4
4920908|NCT00487240|16947487|P1|Overall Study|Adverse Event|0
4920909|NCT00487240|16947486|P2|Overall Study|Lost to Follow-up|6
4920910|NCT00487240|16947487|P1|Overall Study|Lost to Follow-up|7
4920911|NCT00487240|16947486|P2|Overall Study|Withdrawal by Subject|6
4920912|NCT00487240|16947487|P1|Overall Study|Withdrawal by Subject|12
4920913|NCT00487188|16947515|P3|Maintenance Phase|Administrative|1
4920914|NCT00487188|16947516|P2|Maintenance Phase|Administrative|0
4920915|NCT00487188|16947517|P1|Maintenance Phase|Administrative|0
4920916|NCT00487188|16947515|P3|Maintenance Phase|Lost to Follow-up|0
4920917|NCT00487188|16947516|P2|Maintenance Phase|Lost to Follow-up|0
4920918|NCT00487188|16947517|P1|Maintenance Phase|Lost to Follow-up|1
4920919|NCT00487188|16947515|P3|Maintenance Phase|Death|0
4920920|NCT00487188|16947516|P2|Maintenance Phase|Death|0
4920921|NCT00487188|16947517|P1|Maintenance Phase|Death|1
4920922|NCT00487188|16947515|P3|Maintenance Phase|Adverse Event|0
4920923|NCT00487188|16947516|P2|Maintenance Phase|Adverse Event|0
4920924|NCT00487188|16947517|P1|Maintenance Phase|Adverse Event|1
4920925|NCT00487188|16947515|P3|Induction Phase|Administrative|0
4920926|NCT00487188|16947516|P2|Induction Phase|Administrative|1
4920927|NCT00487188|16947517|P1|Induction Phase|Administrative|0
4920928|NCT00487188|16947515|P3|Induction Phase|Lost to Follow-up|0
4920929|NCT00487188|16947516|P2|Induction Phase|Lost to Follow-up|2
4920930|NCT00487188|16947517|P1|Induction Phase|Lost to Follow-up|2
4920931|NCT00487188|16947515|P3|Induction Phase|Refused Treatment|0
4920932|NCT00487188|16947516|P2|Induction Phase|Refused Treatment|2
4920933|NCT00487188|16947517|P1|Induction Phase|Refused Treatment|1
4920934|NCT00487188|16947515|P3|Induction Phase|Protocol Violation|0
4920935|NCT00487188|16947516|P2|Induction Phase|Protocol Violation|0
4920936|NCT00487188|16947517|P1|Induction Phase|Protocol Violation|1
4920937|NCT00487188|16947515|P3|Induction Phase|Lack of Efficacy|0
4920938|NCT00487188|16947516|P2|Induction Phase|Lack of Efficacy|1
4920939|NCT00487188|16947517|P1|Induction Phase|Lack of Efficacy|0
4920940|NCT00487188|16947515|P3|Induction Phase|Adverse Event|0
4920941|NCT00487188|16947516|P2|Induction Phase|Adverse Event|0
4920942|NCT00487188|16947517|P1|Induction Phase|Adverse Event|5
4920943|NCT00487188|16947515|P3|Induction Phase|Abnormality of Laboratory Test|0
4920944|NCT00487188|16947516|P2|Induction Phase|Abnormality of Laboratory Test|1
4920945|NCT00487188|16947517|P1|Induction Phase|Abnormality of Laboratory Test|0
4920946|NCT00487162|16947556|P2|Overall Study|Withdrawal by Subject|3
4920947|NCT00487162|16947557|P1|Overall Study|Withdrawal by Subject|2
4920948|NCT00487162|16947556|P2|Overall Study|Physician Decision|1
4920949|NCT00487162|16947557|P1|Overall Study|Physician Decision|0
4920950|NCT00487162|16947556|P2|Overall Study|Adverse Event|1
4920951|NCT00487162|16947557|P1|Overall Study|Adverse Event|0
4920952|NCT00487084|16947568|P3|Overall Study|Did not receive intervention|5
4920953|NCT00487084|16947569|P2|Overall Study|Did not receive intervention|3
4920954|NCT00487084|16947570|P1|Overall Study|Did not receive intervention|4
4920955|NCT00486954|16947591|P5|Randomized Part|Sponsor Terminated Study|13
4920956|NCT00486954|16947592|P4|Randomized Part|Sponsor Terminated Study|19
4920957|NCT00486954|16947593|P3|Randomized Part|Sponsor Terminated Study|0
4920958|NCT00486954|16947594|P2|Randomized Part|Sponsor Terminated Study|0
4920959|NCT00486954|16947595|P1|Randomized Part|Sponsor Terminated Study|0
4920960|NCT00486954|16947591|P5|Randomized Part|Withdrawal by Subject|0
4920961|NCT00486954|16947592|P4|Randomized Part|Withdrawal by Subject|1
4920962|NCT00486954|16947593|P3|Randomized Part|Withdrawal by Subject|0
4920963|NCT00486954|16947594|P2|Randomized Part|Withdrawal by Subject|0
4920964|NCT00486954|16947595|P1|Randomized Part|Withdrawal by Subject|0
4920965|NCT00486954|16947591|P5|Randomized Part|Lost to Follow-up|1
4920966|NCT00486954|16947592|P4|Randomized Part|Lost to Follow-up|0
4920967|NCT00486954|16947593|P3|Randomized Part|Lost to Follow-up|0
4920968|NCT00486954|16947594|P2|Randomized Part|Lost to Follow-up|0
4920969|NCT00486954|16947595|P1|Randomized Part|Lost to Follow-up|0
4920970|NCT00486954|16947591|P5|Pilot Part|Disease Progression|0
4920971|NCT00486954|16947592|P4|Pilot Part|Disease Progression|0
4920972|NCT00486954|16947593|P3|Pilot Part|Disease Progression|1
4920973|NCT00486954|16947594|P2|Pilot Part|Disease Progression|0
4920974|NCT00486954|16947595|P1|Pilot Part|Disease Progression|2
4920975|NCT00486954|16947591|P5|Pilot Part|Adverse Event|0
4920976|NCT00486954|16947592|P4|Pilot Part|Adverse Event|0
4920977|NCT00486954|16947593|P3|Pilot Part|Adverse Event|5
4920978|NCT00486954|16947594|P2|Pilot Part|Adverse Event|0
4920979|NCT00486954|16947595|P1|Pilot Part|Adverse Event|4
4920980|NCT00486902|16947693|P2|Overall Study|No toradol due to hemmorhage or allergy|1
4920981|NCT00486902|16947694|P1|Overall Study|No toradol due to hemmorhage or allergy|3
4920982|NCT00486902|16947693|P2|Overall Study|Did not meet inclusion criteria|0
4920983|NCT00486902|16947694|P1|Overall Study|Did not meet inclusion criteria|1
4920984|NCT00486902|16947693|P2|Overall Study|spinal anesthetic protocal violation|1
4920985|NCT00486902|16947694|P1|Overall Study|spinal anesthetic protocal violation|1
4920986|NCT00486902|16947693|P2|Overall Study|decision for postpartum tubal ligation|1
4920987|NCT00486902|16947694|P1|Overall Study|decision for postpartum tubal ligation|3
4920988|NCT00486902|16947693|P2|Overall Study|Withdrawal by Subject|2
4920989|NCT00486902|16947694|P1|Overall Study|Withdrawal by Subject|1
4920990|NCT00486837|16947761|P2|Overall Study|No sputum, devise issues, exacerbation|4
4920991|NCT00486837|16947762|P1|Overall Study|No sputum, devise issues, exacerbation|3
4920992|NCT00486837|16947761|P2|Overall Study|Protocol Violation|2
4920993|NCT00486837|16947762|P1|Overall Study|Protocol Violation|4
4920994|NCT00486837|16947761|P2|Overall Study|Adverse Event|1
4920995|NCT00486837|16947762|P1|Overall Study|Adverse Event|1
4920996|NCT00486837|16947761|P2|Overall Study|Withdrawal by Subject|0
4920997|NCT00486837|16947762|P1|Overall Study|Withdrawal by Subject|1
4920998|NCT00486811|16947802|P3|Overall Study|All other|7
4920999|NCT00486811|16947803|P2|Overall Study|All other|11
4921000|NCT00486811|16947804|P1|Overall Study|All other|18
4921001|NCT00486811|16947802|P3|Overall Study|Study drug non-compliant|3
4921002|NCT00486811|16947803|P2|Overall Study|Study drug non-compliant|6
4921003|NCT00486811|16947804|P1|Overall Study|Study drug non-compliant|5
4921004|NCT00486811|16947802|P3|Overall Study|Withdrawal by Subject|58
4921005|NCT00486811|16947803|P2|Overall Study|Withdrawal by Subject|44
4921006|NCT00486811|16947804|P1|Overall Study|Withdrawal by Subject|33
4921007|NCT00486811|16947802|P3|Overall Study|Lost to Follow-up|4
4921008|NCT00486811|16947803|P2|Overall Study|Lost to Follow-up|6
4921009|NCT00486811|16947804|P1|Overall Study|Lost to Follow-up|4
4921010|NCT00486811|16947802|P3|Overall Study|Lack of Efficacy|7
4921011|NCT00486811|16947803|P2|Overall Study|Lack of Efficacy|14
4921012|NCT00486811|16947804|P1|Overall Study|Lack of Efficacy|34
4921013|NCT00486811|16947802|P3|Overall Study|Adverse Event|135
4921014|NCT00486811|16947803|P2|Overall Study|Adverse Event|60
4921015|NCT00486811|16947804|P1|Overall Study|Adverse Event|28
4921016|NCT00486759|16947847|P2|Safety Follow-up|Adverse event/intercurrent illness|0
4921017|NCT00486759|16947848|P1|Safety Follow-up|Adverse event/intercurrent illness|4
4921018|NCT00486759|16947847|P2|Safety Follow-up|Refused treatment/did not cooperate|4
4921019|NCT00486759|16947848|P1|Safety Follow-up|Refused treatment/did not cooperate|6
4921020|NCT00486759|16947847|P2|Safety Follow-up|Administrative/not specified|6
4921021|NCT00486759|16947848|P1|Safety Follow-up|Administrative/not specified|8
4921022|NCT00486759|16947847|P2|Safety Follow-up|Failure to return|6
4921023|NCT00486759|16947848|P1|Safety Follow-up|Failure to return|9
4921024|NCT00486759|16947847|P2|Safety Follow-up|Withdrew consent|23
4921025|NCT00486759|16947848|P1|Safety Follow-up|Withdrew consent|32
4921026|NCT00486759|16947847|P2|Safety Follow-up|Death|29
4921027|NCT00486759|16947848|P1|Safety Follow-up|Death|40
4921028|NCT00486759|16947847|P2|Safety Follow-up|Insufficient therapeutic response|50
4921029|NCT00486759|16947848|P1|Safety Follow-up|Insufficient therapeutic response|40
4921030|NCT00486759|16947847|P2|Treatment|Failure to return|1
4921031|NCT00486759|16947848|P1|Treatment|Failure to return|1
4921032|NCT00486759|16947847|P2|Treatment|Other protocol violation|5
4921033|NCT00486759|16947848|P1|Treatment|Other protocol violation|1
4921034|NCT00486759|16947847|P2|Treatment|Violation of selection criteria at entry|3
4921035|NCT00486759|16947848|P1|Treatment|Violation of selection criteria at entry|3
4921036|NCT00486759|16947847|P2|Treatment|Refused treatment|7
4921037|NCT00486759|16947848|P1|Treatment|Refused treatment|10
4921038|NCT00486759|16947847|P2|Treatment|Administrative/reason not specified|21
4921039|NCT00486759|16947848|P1|Treatment|Administrative/reason not specified|17
4921040|NCT00486759|16947847|P2|Treatment|Withdrew consent|12
4921041|NCT00486759|16947848|P1|Treatment|Withdrew consent|15
4921042|NCT00486759|16947847|P2|Treatment|Death|10
4921043|NCT00486759|16947848|P1|Treatment|Death|17
4921044|NCT00486759|16947847|P2|Treatment|Insufficient therapeutic response|39
4921045|NCT00486759|16947848|P1|Treatment|Insufficient therapeutic response|37
4921046|NCT00486759|16947847|P2|Treatment|Adverse event/intercurrent illness|39
4921047|NCT00486759|16947848|P1|Treatment|Adverse event/intercurrent illness|86
4921048|NCT00486720|16947860|P2|Overall Study|Progressive Disease|1
4921049|NCT00486720|16947861|P1|Overall Study|Progressive Disease|0
4921050|NCT00486720|16947860|P2|Overall Study|Withdrawal by Subject|1
4921051|NCT00486720|16947861|P1|Overall Study|Withdrawal by Subject|3
4921052|NCT00486720|16947860|P2|Overall Study|Protocol Violation|0
4921053|NCT00486720|16947861|P1|Overall Study|Protocol Violation|1
4921054|NCT00486720|16947860|P2|Overall Study|Physician Decision|2
4921055|NCT00486720|16947861|P1|Overall Study|Physician Decision|1
4921056|NCT00486720|16947860|P2|Overall Study|Lack of Efficacy|6
4921057|NCT00486720|16947861|P1|Overall Study|Lack of Efficacy|4
4921058|NCT00486720|16947860|P2|Overall Study|Adverse Event|2
4921059|NCT00486720|16947861|P1|Overall Study|Adverse Event|1
4921060|NCT00486603|16947896|P5|Overall Study|Physician Decision|0
4921061|NCT00486603|16947897|P4|Overall Study|Physician Decision|0
4921062|NCT00486603|16947898|P3|Overall Study|Physician Decision|0
4921063|NCT00486603|16947899|P2|Overall Study|Physician Decision|1
4921064|NCT00486603|16947900|P1|Overall Study|Physician Decision|0
4921065|NCT00486603|16947896|P5|Overall Study|Withdrawal by Subject|0
4921066|NCT00486603|16947897|P4|Overall Study|Withdrawal by Subject|0
4921067|NCT00486603|16947898|P3|Overall Study|Withdrawal by Subject|0
4921068|NCT00486603|16947899|P2|Overall Study|Withdrawal by Subject|0
4921069|NCT00486603|16947900|P1|Overall Study|Withdrawal by Subject|1
4921070|NCT00486434|16947948|P2|Overall Study|Personal reasons|6
4921071|NCT00486434|16947949|P1|Overall Study|Personal reasons|5
4921072|NCT00486434|16947948|P2|Overall Study|Death|2
4921073|NCT00486434|16947949|P1|Overall Study|Death|1
4921074|NCT00486434|16947948|P2|Overall Study|Lost to Follow-up|3
4921075|NCT00486434|16947949|P1|Overall Study|Lost to Follow-up|2
4921076|NCT00486434|16947948|P2|Overall Study|Lack of Efficacy|19
4921077|NCT00486434|16947949|P1|Overall Study|Lack of Efficacy|12
4921078|NCT00486434|16947948|P2|Overall Study|Protocol Violation|21
4921079|NCT00486434|16947949|P1|Overall Study|Protocol Violation|22
4921080|NCT00486434|16947948|P2|Overall Study|Adverse Event|44
4921081|NCT00486434|16947949|P1|Overall Study|Adverse Event|118
4921082|NCT00486434|16947948|P2|Overall Study|Withdrawal by Subject|39
4921083|NCT00486434|16947949|P1|Overall Study|Withdrawal by Subject|34
4921084|NCT00486330|16947968|P1|Overall Study|Adverse Event|2
4921085|NCT00486291|16947974|P2|Overall Study|requirement for restricted medication|3
4921086|NCT00486291|16947975|P1|Overall Study|requirement for restricted medication|0
4921087|NCT00486291|16947974|P2|Overall Study|protocol non-compliance|15
4921088|NCT00486291|16947975|P1|Overall Study|protocol non-compliance|10
4921089|NCT00486291|16947974|P2|Overall Study|Lost to Follow-up|7
4921090|NCT00486291|16947975|P1|Overall Study|Lost to Follow-up|3
4921091|NCT00486291|16947974|P2|Overall Study|Adverse Event|4
4921092|NCT00486291|16947975|P1|Overall Study|Adverse Event|3
4921093|NCT00486278|16947983|P1|Overall Study|Physician Decision|2
4921094|NCT00486278|16947983|P1|Overall Study|Withdrawal by Subject|2
4921095|NCT00486278|16947983|P1|Overall Study|Adverse Event|5
4921096|NCT00486265|16948117|P1|Overall Study|Lack of Efficacy|8
4921097|NCT00486265|16948117|P1|Overall Study|Adverse Event|1
4921098|NCT00486252|16948121|P1|Overall Study|Other|18
4921099|NCT00486252|16948121|P1|Overall Study|Lost to Follow-up|24
4921100|NCT00486252|16948121|P1|Overall Study|Lack of Efficacy|9
4921101|NCT00486252|16948121|P1|Overall Study|Adverse Event|7
4921102|NCT00486226|16948136|P1|Overall Study|Lost to Follow-up|8
4921103|NCT00486226|16948136|P1|Overall Study|Withdrawal by Subject|1
4921104|NCT00486226|16948136|P1|Overall Study|Adverse Event|1
4921105|NCT00486226|16948136|P1|Overall Study|Death|3
4921106|NCT00486044|16948146|P2|Overall Study|Lost to Follow-up|1
4921107|NCT00486044|16948147|P1|Overall Study|Lost to Follow-up|0
4921108|NCT00486044|16948146|P2|Overall Study|Adverse Event|1
4921109|NCT00486044|16948147|P1|Overall Study|Adverse Event|0
4921110|NCT00486044|16948146|P2|Overall Study|Withdrawal by Subject|1
4921111|NCT00486044|16948147|P1|Overall Study|Withdrawal by Subject|2
4921112|NCT00485758|16948241|P2|Overall Study|Study Terminated by Sponsor|0
4921113|NCT00485758|16948242|P1|Overall Study|Study Terminated by Sponsor|3
4921114|NCT00485758|16948241|P2|Overall Study|Withdrawal by Subject|27
4921115|NCT00485758|16948242|P1|Overall Study|Withdrawal by Subject|32
4921116|NCT00485758|16948241|P2|Overall Study|Protocol Violation|2
4921117|NCT00485758|16948242|P1|Overall Study|Protocol Violation|11
4921118|NCT00485758|16948241|P2|Overall Study|Physician Decision|3
4921119|NCT00485758|16948242|P1|Overall Study|Physician Decision|3
4921120|NCT00485758|16948241|P2|Overall Study|Lost to Follow-up|1
4921121|NCT00485758|16948242|P1|Overall Study|Lost to Follow-up|5
4921122|NCT00485758|16948241|P2|Overall Study|Death|1
4921123|NCT00485758|16948242|P1|Overall Study|Death|0
4921124|NCT00485758|16948241|P2|Overall Study|Adverse Event|31
4921125|NCT00485758|16948242|P1|Overall Study|Adverse Event|102
4921126|NCT00485732|16948254|P2|Overall Study|Lost to Follow-up|2
4921127|NCT00485732|16948255|P1|Overall Study|Lost to Follow-up|2
4921128|NCT00485732|16948254|P2|Overall Study|Withdrawal by Subject|4
4921129|NCT00485732|16948255|P1|Overall Study|Withdrawal by Subject|5
4921130|NCT00485732|16948254|P2|Overall Study|Protocol Violation|3
4921131|NCT00485732|16948255|P1|Overall Study|Protocol Violation|1
4921132|NCT00485472|16948293|P2|Overall Study|Lost to Follow-up|1
4921133|NCT00485472|16948294|P1|Overall Study|Lost to Follow-up|0
4921134|NCT00485472|16948293|P2|Overall Study|Other|1
4921135|NCT00485472|16948294|P1|Overall Study|Other|2
4921136|NCT00485472|16948293|P2|Overall Study|Protocol Violation|1
4921137|NCT00485472|16948294|P1|Overall Study|Protocol Violation|0
4921138|NCT00485472|16948293|P2|Overall Study|Withdrawal by Subject|0
4921139|NCT00485472|16948294|P1|Overall Study|Withdrawal by Subject|1
4921140|NCT00485472|16948293|P2|Overall Study|Lack of Efficacy|4
4921141|NCT00485472|16948294|P1|Overall Study|Lack of Efficacy|5
4921142|NCT00485472|16948293|P2|Overall Study|Adverse Event|5
4921143|NCT00485472|16948294|P1|Overall Study|Adverse Event|8
4921144|NCT00485303|16948331|P1|Overall Study|Treatment ongoing at cutoff date|2
4921145|NCT00485303|16948331|P1|Overall Study|Initiation of new anti-cancer treatment|2
4921146|NCT00485303|16948331|P1|Overall Study|Other|3
4921147|NCT00485303|16948331|P1|Overall Study|Progressive Disease|44
4921148|NCT00485303|16948331|P1|Overall Study|Adverse Event|5
4921149|NCT00485264|16948349|P6|Overall Study|Other Reason|0
4921150|NCT00485264|16948350|P5|Overall Study|Other Reason|0
4921151|NCT00485264|16948351|P4|Overall Study|Other Reason|0
4921152|NCT00485264|16948352|P3|Overall Study|Other Reason|0
4921153|NCT00485264|16948353|P2|Overall Study|Other Reason|0
4921154|NCT00485264|16948354|P1|Overall Study|Other Reason|3
4921155|NCT00485264|16948349|P6|Overall Study|Lost to Follow-up|1
4921156|NCT00485264|16948350|P5|Overall Study|Lost to Follow-up|0
4921157|NCT00485264|16948351|P4|Overall Study|Lost to Follow-up|0
4921158|NCT00485264|16948352|P3|Overall Study|Lost to Follow-up|1
4921159|NCT00485264|16948353|P2|Overall Study|Lost to Follow-up|1
4921160|NCT00485264|16948354|P1|Overall Study|Lost to Follow-up|2
4921161|NCT00485264|16948349|P6|Overall Study|Non-Compliant|0
4921162|NCT00485264|16948350|P5|Overall Study|Non-Compliant|1
4921163|NCT00485264|16948351|P4|Overall Study|Non-Compliant|0
4921164|NCT00485264|16948352|P3|Overall Study|Non-Compliant|1
4921165|NCT00485264|16948353|P2|Overall Study|Non-Compliant|2
4921166|NCT00485264|16948354|P1|Overall Study|Non-Compliant|17
4921167|NCT00485264|16948349|P6|Overall Study|Not Able to Attend Clinic|2
4921168|NCT00485264|16948350|P5|Overall Study|Not Able to Attend Clinic|1
4921169|NCT00485264|16948351|P4|Overall Study|Not Able to Attend Clinic|1
4921170|NCT00485264|16948352|P3|Overall Study|Not Able to Attend Clinic|0
4921171|NCT00485264|16948353|P2|Overall Study|Not Able to Attend Clinic|0
4921172|NCT00485264|16948354|P1|Overall Study|Not Able to Attend Clinic|5
4921173|NCT00485264|16948349|P6|Overall Study|Intolerance/Unable to Tolerate Dose|0
4921174|NCT00485264|16948350|P5|Overall Study|Intolerance/Unable to Tolerate Dose|0
4921175|NCT00485264|16948351|P4|Overall Study|Intolerance/Unable to Tolerate Dose|0
4921176|NCT00485264|16948352|P3|Overall Study|Intolerance/Unable to Tolerate Dose|1
4921177|NCT00485264|16948353|P2|Overall Study|Intolerance/Unable to Tolerate Dose|0
4921178|NCT00485264|16948354|P1|Overall Study|Intolerance/Unable to Tolerate Dose|0
4921179|NCT00485264|16948349|P6|Overall Study|Physician Decision|0
4921180|NCT00485264|16948350|P5|Overall Study|Physician Decision|0
4921181|NCT00485264|16948351|P4|Overall Study|Physician Decision|0
4921182|NCT00485264|16948352|P3|Overall Study|Physician Decision|0
4921183|NCT00485264|16948353|P2|Overall Study|Physician Decision|2
4921184|NCT00485264|16948354|P1|Overall Study|Physician Decision|0
4921185|NCT00485264|16948349|P6|Overall Study|Guardian Consent Withdrawn|0
4921186|NCT00485264|16948350|P5|Overall Study|Guardian Consent Withdrawn|1
4921187|NCT00485264|16948351|P4|Overall Study|Guardian Consent Withdrawn|0
4921188|NCT00485264|16948352|P3|Overall Study|Guardian Consent Withdrawn|0
4921189|NCT00485264|16948353|P2|Overall Study|Guardian Consent Withdrawn|0
4921190|NCT00485264|16948354|P1|Overall Study|Guardian Consent Withdrawn|1
4921191|NCT00485264|16948349|P6|Overall Study|Lack of Efficacy|0
4921192|NCT00485264|16948350|P5|Overall Study|Lack of Efficacy|0
4921193|NCT00485264|16948351|P4|Overall Study|Lack of Efficacy|0
4921194|NCT00485264|16948352|P3|Overall Study|Lack of Efficacy|0
4921195|NCT00485264|16948353|P2|Overall Study|Lack of Efficacy|1
4921196|NCT00485264|16948354|P1|Overall Study|Lack of Efficacy|0
4921197|NCT00485264|16948349|P6|Overall Study|Number/Volume/Timing of Study Meds|0
4921198|NCT00485264|16948350|P5|Overall Study|Number/Volume/Timing of Study Meds|0
4921199|NCT00485264|16948351|P4|Overall Study|Number/Volume/Timing of Study Meds|0
4921200|NCT00485264|16948352|P3|Overall Study|Number/Volume/Timing of Study Meds|1
4921201|NCT00485264|16948353|P2|Overall Study|Number/Volume/Timing of Study Meds|1
4921202|NCT00485264|16948354|P1|Overall Study|Number/Volume/Timing of Study Meds|2
4921203|NCT00485264|16948349|P6|Overall Study|Disallowed Medication|1
4921204|NCT00485264|16948350|P5|Overall Study|Disallowed Medication|0
4921205|NCT00485264|16948351|P4|Overall Study|Disallowed Medication|0
4921206|NCT00485264|16948352|P3|Overall Study|Disallowed Medication|0
4921207|NCT00485264|16948353|P2|Overall Study|Disallowed Medication|0
4921208|NCT00485264|16948354|P1|Overall Study|Disallowed Medication|0
4921209|NCT00485264|16948349|P6|Overall Study|Pregnancy|0
4921210|NCT00485264|16948350|P5|Overall Study|Pregnancy|0
4921211|NCT00485264|16948351|P4|Overall Study|Pregnancy|0
4921212|NCT00485264|16948352|P3|Overall Study|Pregnancy|0
4921213|NCT00485264|16948353|P2|Overall Study|Pregnancy|0
4921214|NCT00485264|16948354|P1|Overall Study|Pregnancy|4
4921215|NCT00485264|16948349|P6|Overall Study|Adverse Event|3
4921216|NCT00485264|16948350|P5|Overall Study|Adverse Event|1
4921217|NCT00485264|16948351|P4|Overall Study|Adverse Event|3
4921218|NCT00485264|16948352|P3|Overall Study|Adverse Event|2
4921219|NCT00485264|16948353|P2|Overall Study|Adverse Event|0
4921220|NCT00485264|16948354|P1|Overall Study|Adverse Event|1
4921221|NCT00485264|16948349|P6|Overall Study|Death|0
4921222|NCT00485264|16948350|P5|Overall Study|Death|1
4921223|NCT00485264|16948351|P4|Overall Study|Death|0
4921224|NCT00485264|16948352|P3|Overall Study|Death|0
4921225|NCT00485264|16948353|P2|Overall Study|Death|0
4921226|NCT00485264|16948354|P1|Overall Study|Death|1
4921227|NCT00485264|16948349|P6|Overall Study|Enrolled But Not Given Treatment|0
4921228|NCT00485264|16948350|P5|Overall Study|Enrolled But Not Given Treatment|1
4921229|NCT00485264|16948351|P4|Overall Study|Enrolled But Not Given Treatment|0
4921230|NCT00485264|16948352|P3|Overall Study|Enrolled But Not Given Treatment|0
4921231|NCT00485264|16948353|P2|Overall Study|Enrolled But Not Given Treatment|0
4921232|NCT00485264|16948354|P1|Overall Study|Enrolled But Not Given Treatment|0
4921233|NCT00485173|16948442|P2|Overall Study|Lost to Follow-up|61
4921234|NCT00485173|16948443|P1|Overall Study|Lost to Follow-up|32
4921235|NCT00485173|16948442|P2|Overall Study|Death|3
4921236|NCT00485173|16948443|P1|Overall Study|Death|4
4921237|NCT00485134|16948491|P8|Overall Study|Pregnancy|0
4921238|NCT00485134|16948492|P7|Overall Study|Pregnancy|1
4921239|NCT00485134|16948493|P6|Overall Study|Pregnancy|0
4921240|NCT00485134|16948494|P5|Overall Study|Pregnancy|0
4921241|NCT00485134|16948495|P4|Overall Study|Pregnancy|0
4921242|NCT00485134|16948496|P3|Overall Study|Pregnancy|0
4921243|NCT00485134|16948497|P2|Overall Study|Pregnancy|0
4921244|NCT00485134|16948498|P1|Overall Study|Pregnancy|0
4921245|NCT00485134|16948491|P8|Overall Study|Unable to comply with study schedule|1
4921246|NCT00485134|16948492|P7|Overall Study|Unable to comply with study schedule|0
4921247|NCT00485134|16948493|P6|Overall Study|Unable to comply with study schedule|0
4921248|NCT00485134|16948494|P5|Overall Study|Unable to comply with study schedule|0
4921249|NCT00485134|16948495|P4|Overall Study|Unable to comply with study schedule|0
4921250|NCT00485134|16948496|P3|Overall Study|Unable to comply with study schedule|0
4921251|NCT00485134|16948497|P2|Overall Study|Unable to comply with study schedule|0
4921252|NCT00485134|16948498|P1|Overall Study|Unable to comply with study schedule|0
4921253|NCT00485134|16948491|P8|Overall Study|Non-compliance|0
4921254|NCT00485134|16948492|P7|Overall Study|Non-compliance|2
4921255|NCT00485134|16948493|P6|Overall Study|Non-compliance|2
4921256|NCT00485134|16948494|P5|Overall Study|Non-compliance|1
4921257|NCT00485134|16948495|P4|Overall Study|Non-compliance|0
4921258|NCT00485134|16948496|P3|Overall Study|Non-compliance|0
4921259|NCT00485134|16948497|P2|Overall Study|Non-compliance|0
4921260|NCT00485134|16948498|P1|Overall Study|Non-compliance|0
4921261|NCT00485134|16948491|P8|Overall Study|Positive drug test|0
4921262|NCT00485134|16948492|P7|Overall Study|Positive drug test|0
4921263|NCT00485134|16948493|P6|Overall Study|Positive drug test|1
4921264|NCT00485134|16948494|P5|Overall Study|Positive drug test|2
4921265|NCT00485134|16948495|P4|Overall Study|Positive drug test|0
4921266|NCT00485134|16948496|P3|Overall Study|Positive drug test|0
4921267|NCT00485134|16948497|P2|Overall Study|Positive drug test|0
4921268|NCT00485134|16948498|P1|Overall Study|Positive drug test|0
4921269|NCT00485134|16948491|P8|Overall Study|Withdrew for adverse event|0
4921270|NCT00485134|16948492|P7|Overall Study|Withdrew for adverse event|0
4921271|NCT00485134|16948493|P6|Overall Study|Withdrew for adverse event|0
4921272|NCT00485134|16948494|P5|Overall Study|Withdrew for adverse event|0
4921273|NCT00485134|16948495|P4|Overall Study|Withdrew for adverse event|0
4921274|NCT00485134|16948496|P3|Overall Study|Withdrew for adverse event|1
4921275|NCT00485134|16948497|P2|Overall Study|Withdrew for adverse event|0
4921276|NCT00485134|16948498|P1|Overall Study|Withdrew for adverse event|0
4921277|NCT00485134|16948491|P8|Overall Study|Change in health status|0
4921278|NCT00485134|16948492|P7|Overall Study|Change in health status|0
4921279|NCT00485134|16948493|P6|Overall Study|Change in health status|1
4921280|NCT00485134|16948494|P5|Overall Study|Change in health status|0
4921281|NCT00485134|16948495|P4|Overall Study|Change in health status|1
4921282|NCT00485134|16948496|P3|Overall Study|Change in health status|2
4921283|NCT00485134|16948497|P2|Overall Study|Change in health status|1
4921284|NCT00485134|16948498|P1|Overall Study|Change in health status|0
4921285|NCT00485134|16948491|P8|Overall Study|Withdrawal by Subject|0
4921286|NCT00485134|16948492|P7|Overall Study|Withdrawal by Subject|0
4921287|NCT00485134|16948493|P6|Overall Study|Withdrawal by Subject|0
4921288|NCT00485134|16948494|P5|Overall Study|Withdrawal by Subject|0
4921289|NCT00485134|16948495|P4|Overall Study|Withdrawal by Subject|0
4921290|NCT00485134|16948496|P3|Overall Study|Withdrawal by Subject|0
4921291|NCT00485134|16948497|P2|Overall Study|Withdrawal by Subject|1
4921292|NCT00485134|16948498|P1|Overall Study|Withdrawal by Subject|0
4921293|NCT00485134|16948491|P8|Overall Study|Lost to Follow-up|0
4921294|NCT00485134|16948492|P7|Overall Study|Lost to Follow-up|0
4921295|NCT00485134|16948493|P6|Overall Study|Lost to Follow-up|0
4921296|NCT00485134|16948494|P5|Overall Study|Lost to Follow-up|0
4921297|NCT00485134|16948495|P4|Overall Study|Lost to Follow-up|0
4921298|NCT00485134|16948496|P3|Overall Study|Lost to Follow-up|0
4921299|NCT00485134|16948497|P2|Overall Study|Lost to Follow-up|0
4921300|NCT00485134|16948498|P1|Overall Study|Lost to Follow-up|1
4921301|NCT00485069|16948520|P2|Overall Study|Withdrawal by Subject|6
4921302|NCT00485069|16948521|P1|Overall Study|Withdrawal by Subject|6
4921303|NCT00485069|16948520|P2|Overall Study|Protocol Violation|1
4921304|NCT00485069|16948521|P1|Overall Study|Protocol Violation|0
4921305|NCT00485069|16948520|P2|Overall Study|Lack of Efficacy|1
4921306|NCT00485069|16948521|P1|Overall Study|Lack of Efficacy|2
4921307|NCT00485069|16948520|P2|Overall Study|Adverse Event|4
4921308|NCT00485069|16948521|P1|Overall Study|Adverse Event|10
4921309|NCT00484939|16948566|P2|Overall Study|Reason Not Specified|6
4921310|NCT00484939|16948567|P1|Overall Study|Reason Not Specified|11
4921311|NCT00484939|16948566|P2|Overall Study|Screen Failure|2
4921312|NCT00484939|16948567|P1|Overall Study|Screen Failure|2
4921313|NCT00484939|16948566|P2|Overall Study|Disease progression|88
4921314|NCT00484939|16948567|P1|Overall Study|Disease progression|67
4921315|NCT00484939|16948566|P2|Overall Study|Discretion of Investigator or Sponsor|3
4921316|NCT00484939|16948567|P1|Overall Study|Discretion of Investigator or Sponsor|7
4921317|NCT00484939|16948566|P2|Overall Study|Lost to Follow-up|3
4921318|NCT00484939|16948567|P1|Overall Study|Lost to Follow-up|0
4921319|NCT00484939|16948566|P2|Overall Study|Protocol Violation|3
4921320|NCT00484939|16948567|P1|Overall Study|Protocol Violation|3
4921321|NCT00484939|16948566|P2|Overall Study|Patient Withdrew Consent|10
4921322|NCT00484939|16948567|P1|Overall Study|Patient Withdrew Consent|19
4921323|NCT00484939|16948566|P2|Overall Study|Adverse Event|12
4921324|NCT00484939|16948567|P1|Overall Study|Adverse Event|22
4921325|NCT00484939|16948566|P2|Overall Study|Death|13
4921326|NCT00484939|16948567|P1|Overall Study|Death|9
4921327|NCT00484679|16948594|P1|Overall Study|Withdrawal by Subject|3
4921328|NCT00484419|16948601|P3|Overall Study|sponsor decision, randomized in error|2
4921329|NCT00484419|16948602|P2|Overall Study|sponsor decision, randomized in error|0
4921330|NCT00484419|16948603|P1|Overall Study|sponsor decision, randomized in error|0
4921331|NCT00484419|16948601|P3|Overall Study|subject relocated|0
4921332|NCT00484419|16948602|P2|Overall Study|subject relocated|1
4921333|NCT00484419|16948603|P1|Overall Study|subject relocated|0
4921334|NCT00484419|16948601|P3|Overall Study|subject unable to receive medication|0
4921335|NCT00484419|16948602|P2|Overall Study|subject unable to receive medication|0
4921336|NCT00484419|16948603|P1|Overall Study|subject unable to receive medication|1
4921337|NCT00484419|16948601|P3|Overall Study|Physician Decision|1
4921338|NCT00484419|16948602|P2|Overall Study|Physician Decision|1
4921339|NCT00484419|16948603|P1|Overall Study|Physician Decision|1
4921340|NCT00484419|16948601|P3|Overall Study|required restricted medication|1
4921341|NCT00484419|16948602|P2|Overall Study|required restricted medication|0
4921342|NCT00484419|16948603|P1|Overall Study|required restricted medication|1
4921343|NCT00484419|16948601|P3|Overall Study|subject met discontinuation criteria|4
4921344|NCT00484419|16948602|P2|Overall Study|subject met discontinuation criteria|2
4921345|NCT00484419|16948603|P1|Overall Study|subject met discontinuation criteria|2
4921346|NCT00484419|16948601|P3|Overall Study|Withdrawal by Subject|1
4921347|NCT00484419|16948602|P2|Overall Study|Withdrawal by Subject|1
4921348|NCT00484419|16948603|P1|Overall Study|Withdrawal by Subject|3
4921349|NCT00484419|16948601|P3|Overall Study|Lost to Follow-up|2
4921350|NCT00484419|16948602|P2|Overall Study|Lost to Follow-up|0
4921351|NCT00484419|16948603|P1|Overall Study|Lost to Follow-up|1
4921352|NCT00484419|16948601|P3|Overall Study|Adverse Event|0
4921353|NCT00484419|16948602|P2|Overall Study|Adverse Event|0
4921354|NCT00484419|16948603|P1|Overall Study|Adverse Event|3
4921355|NCT00484315|16948687|P2|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2
4921356|NCT00484315|16948688|P1|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3
4921357|NCT00484315|16948687|P2|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11
4921358|NCT00484315|16948688|P1|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25
4921359|NCT00484315|16948687|P2|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2
4921360|NCT00484315|16948688|P1|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3
4921361|NCT00484315|16948687|P2|12-Month Clinical Follow-up|Missed 12-Month Visit|4
4921362|NCT00484315|16948688|P1|12-Month Clinical Follow-up|Missed 12-Month Visit|13
4921363|NCT00484315|16948687|P2|12-Month Clinical Follow-up|Lost to Follow-up|1
4921364|NCT00484315|16948688|P1|12-Month Clinical Follow-up|Lost to Follow-up|2
4921365|NCT00484315|16948687|P2|12-Month Clinical Follow-up|Withdrawal by Subject|0
4921366|NCT00484315|16948688|P1|12-Month Clinical Follow-up|Withdrawal by Subject|4
4921367|NCT00484315|16948687|P2|12-Month Clinical Follow-up|Death|2
4921368|NCT00484315|16948688|P1|12-Month Clinical Follow-up|Death|6
4921369|NCT00484289|16948699|P3|Post Marketing Phase|Adverse Event|0
4921370|NCT00484289|16948700|P2|Post Marketing Phase|Adverse Event|1
4921371|NCT00484289|16948701|P1|Post Marketing Phase|Adverse Event|0
4921372|NCT00484289|16948699|P3|Long Term Phase|Other Reason|1
4921373|NCT00484289|16948700|P2|Long Term Phase|Other Reason|5
4921374|NCT00484289|16948701|P1|Long Term Phase|Other Reason|0
4921375|NCT00484289|16948699|P3|Long Term Phase|Inadequate response|4
4921376|NCT00484289|16948700|P2|Long Term Phase|Inadequate response|7
4921377|NCT00484289|16948701|P1|Long Term Phase|Inadequate response|2
4921378|NCT00484289|16948699|P3|Long Term Phase|Withdrawal by Subject|6
4921379|NCT00484289|16948700|P2|Long Term Phase|Withdrawal by Subject|7
4921380|NCT00484289|16948701|P1|Long Term Phase|Withdrawal by Subject|0
4921381|NCT00484289|16948699|P3|Long Term Phase|Adverse Event|5
4921382|NCT00484289|16948700|P2|Long Term Phase|Adverse Event|17
4921383|NCT00484289|16948701|P1|Long Term Phase|Adverse Event|1
4921384|NCT00484185|16948773|P1|Overall Study|Death|2
4921385|NCT00484185|16948773|P1|Overall Study|Randomized but not treated|5
4921386|NCT00484185|16948773|P1|Overall Study|Other|20
4921387|NCT00484185|16948773|P1|Overall Study|Lost to Follow-up|44
4921388|NCT00484159|16948795|P3|Overall Study|Lost to Follow-up|0
4921389|NCT00484159|16948796|P2|Overall Study|Lost to Follow-up|1
4921390|NCT00484159|16948797|P1|Overall Study|Lost to Follow-up|1
4921391|NCT00484094|16948808|P1|Overall Study|Other|3
4921392|NCT00484094|16948808|P1|Overall Study|Discontinued|39
4921393|NCT00483938|16948824|P7|Overall Study|Other|32
4921394|NCT00483938|16948825|P6|Overall Study|Other|4
4921395|NCT00483938|16948826|P5|Overall Study|Other|0
4921396|NCT00483938|16948827|P4|Overall Study|Other|4
4921397|NCT00483938|16948828|P3|Overall Study|Other|0
4921398|NCT00483938|16948829|P2|Overall Study|Other|9
4921399|NCT00483938|16948830|P1|Overall Study|Other|3
4921400|NCT00483938|16948824|P7|Overall Study|Death|0
4921401|NCT00483938|16948825|P6|Overall Study|Death|0
4921402|NCT00483938|16948826|P5|Overall Study|Death|0
4921403|NCT00483938|16948827|P4|Overall Study|Death|0
4921404|NCT00483938|16948828|P3|Overall Study|Death|0
4921405|NCT00483938|16948829|P2|Overall Study|Death|2
4921406|NCT00483938|16948830|P1|Overall Study|Death|0
4921407|NCT00483938|16948824|P7|Overall Study|Lost to Follow-up|3
4921408|NCT00483938|16948825|P6|Overall Study|Lost to Follow-up|1
4921409|NCT00483938|16948826|P5|Overall Study|Lost to Follow-up|1
4921410|NCT00483938|16948827|P4|Overall Study|Lost to Follow-up|2
4921411|NCT00483938|16948828|P3|Overall Study|Lost to Follow-up|0
4921412|NCT00483938|16948829|P2|Overall Study|Lost to Follow-up|2
4921413|NCT00483938|16948830|P1|Overall Study|Lost to Follow-up|1
4921414|NCT00483938|16948824|P7|Overall Study|Withdrawal by Subject|2
4921415|NCT00483938|16948825|P6|Overall Study|Withdrawal by Subject|3
4921416|NCT00483938|16948826|P5|Overall Study|Withdrawal by Subject|1
4921417|NCT00483938|16948827|P4|Overall Study|Withdrawal by Subject|0
4921418|NCT00483938|16948828|P3|Overall Study|Withdrawal by Subject|0
4921419|NCT00483938|16948829|P2|Overall Study|Withdrawal by Subject|6
4921420|NCT00483938|16948830|P1|Overall Study|Withdrawal by Subject|1
4921421|NCT00483938|16948824|P7|Overall Study|Protocol Violation|3
4921422|NCT00483938|16948825|P6|Overall Study|Protocol Violation|0
4921423|NCT00483938|16948826|P5|Overall Study|Protocol Violation|0
4921424|NCT00483938|16948827|P4|Overall Study|Protocol Violation|0
4921425|NCT00483938|16948828|P3|Overall Study|Protocol Violation|0
4921426|NCT00483938|16948829|P2|Overall Study|Protocol Violation|0
4921427|NCT00483938|16948830|P1|Overall Study|Protocol Violation|0
4921428|NCT00483756|16948854|P3|Overall Study|Randomized, Not Treated|4
4921429|NCT00483756|16948855|P2|Overall Study|Randomized, Not Treated|4
4921430|NCT00483756|16948856|P1|Overall Study|Randomized, Not Treated|1
4921431|NCT00483756|16948854|P3|Overall Study|Other|3
4921432|NCT00483756|16948855|P2|Overall Study|Other|4
4921433|NCT00483756|16948856|P1|Overall Study|Other|2
4921434|NCT00483756|16948854|P3|Overall Study|Withdrawal by Subject|4
4921435|NCT00483756|16948855|P2|Overall Study|Withdrawal by Subject|3
4921436|NCT00483756|16948856|P1|Overall Study|Withdrawal by Subject|5
4921437|NCT00483756|16948854|P3|Overall Study|Lost to Follow-up|0
4921438|NCT00483756|16948855|P2|Overall Study|Lost to Follow-up|1
4921439|NCT00483756|16948856|P1|Overall Study|Lost to Follow-up|3
4921440|NCT00483756|16948854|P3|Overall Study|Lack of Efficacy|0
4921441|NCT00483756|16948855|P2|Overall Study|Lack of Efficacy|0
4921442|NCT00483756|16948856|P1|Overall Study|Lack of Efficacy|1
4921443|NCT00483756|16948854|P3|Overall Study|Adverse Event|40
4921444|NCT00483756|16948855|P2|Overall Study|Adverse Event|38
4921445|NCT00483756|16948856|P1|Overall Study|Adverse Event|19
4921446|NCT00483756|16948854|P3|Overall Study|Death|1
4921447|NCT00483756|16948855|P2|Overall Study|Death|0
4921448|NCT00483756|16948856|P1|Overall Study|Death|2
4921449|NCT00483717|16948920|P2|Overall Study|Withdrawal by Subject|0
4921450|NCT00483717|16948921|P1|Overall Study|Withdrawal by Subject|1
4921451|NCT00483717|16948920|P2|Overall Study|Lost to Follow-up|0
4921452|NCT00483717|16948921|P1|Overall Study|Lost to Follow-up|1
4921453|NCT00483717|16948920|P2|Overall Study|No treatment for migraine|13
4921454|NCT00483717|16948921|P1|Overall Study|No treatment for migraine|16
4921455|NCT00483717|16948920|P2|Overall Study|Time of dosing missing|1
4921456|NCT00483717|16948921|P1|Overall Study|Time of dosing missing|1
4921457|NCT00483717|16948920|P2|Overall Study|Protocol Violation|7
4921458|NCT00483717|16948921|P1|Overall Study|Protocol Violation|5
4921459|NCT00483704|16948944|P3|Treatment|Physician Decision|4
4921460|NCT00483704|16948945|P2|Treatment|Physician Decision|1
4921461|NCT00483704|16948946|P1|Treatment|Physician Decision|0
4921462|NCT00483704|16948944|P3|Treatment|Pregnancy|0
4921463|NCT00483704|16948945|P2|Treatment|Pregnancy|1
4921464|NCT00483704|16948946|P1|Treatment|Pregnancy|0
4921465|NCT00483704|16948944|P3|Treatment|Lack of Efficacy|1
4921466|NCT00483704|16948945|P2|Treatment|Lack of Efficacy|1
4921467|NCT00483704|16948946|P1|Treatment|Lack of Efficacy|1
4921468|NCT00483704|16948944|P3|Treatment|Lost to Follow-up|5
4921469|NCT00483704|16948945|P2|Treatment|Lost to Follow-up|7
4921470|NCT00483704|16948946|P1|Treatment|Lost to Follow-up|2
4921471|NCT00483704|16948944|P3|Treatment|Protocol Violation|5
4921472|NCT00483704|16948945|P2|Treatment|Protocol Violation|3
4921473|NCT00483704|16948946|P1|Treatment|Protocol Violation|6
4921474|NCT00483704|16948944|P3|Treatment|Withdrawal by Subject|21
4921475|NCT00483704|16948945|P2|Treatment|Withdrawal by Subject|12
4921476|NCT00483704|16948946|P1|Treatment|Withdrawal by Subject|16
4921477|NCT00483704|16948944|P3|Treatment|Adverse Event|4
4921478|NCT00483704|16948945|P2|Treatment|Adverse Event|5
4921479|NCT00483704|16948946|P1|Treatment|Adverse Event|3
4921480|NCT00483704|16948944|P3|Treatment|Lack of qualifying migraines|116
4921481|NCT00483704|16948945|P2|Treatment|Lack of qualifying migraines|99
4921482|NCT00483704|16948946|P1|Treatment|Lack of qualifying migraines|101
4921483|NCT00483704|16948944|P3|Randomization|Lack of qualifying migraines|31
4921484|NCT00483704|16948945|P2|Randomization|Lack of qualifying migraines|25
4921485|NCT00483704|16948946|P1|Randomization|Lack of qualifying migraines|21
4921486|NCT00483704|16948944|P3|Randomization|Progressive disease|1
4921487|NCT00483704|16948945|P2|Randomization|Progressive disease|0
4921488|NCT00483704|16948946|P1|Randomization|Progressive disease|0
4921489|NCT00483704|16948944|P3|Randomization|Physician Decision|0
4921490|NCT00483704|16948945|P2|Randomization|Physician Decision|4
4921491|NCT00483704|16948946|P1|Randomization|Physician Decision|2
4921492|NCT00483704|16948944|P3|Randomization|Pregnancy|0
4921493|NCT00483704|16948945|P2|Randomization|Pregnancy|0
4921494|NCT00483704|16948946|P1|Randomization|Pregnancy|1
4921495|NCT00483704|16948944|P3|Randomization|Lost to Follow-up|19
4921496|NCT00483704|16948945|P2|Randomization|Lost to Follow-up|14
4921497|NCT00483704|16948946|P1|Randomization|Lost to Follow-up|14
4921498|NCT00483704|16948944|P3|Randomization|Protocol Violation|22
4921499|NCT00483704|16948945|P2|Randomization|Protocol Violation|25
4921500|NCT00483704|16948946|P1|Randomization|Protocol Violation|14
4921501|NCT00483704|16948944|P3|Randomization|Withdrawal by Subject|18
4921502|NCT00483704|16948945|P2|Randomization|Withdrawal by Subject|28
4921503|NCT00483704|16948946|P1|Randomization|Withdrawal by Subject|19
4921504|NCT00483652|16948992|P2|Double-blind Treatment Period|Withdrawal due to AE before study began|0
4921505|NCT00483652|16948993|P1|Double-blind Treatment Period|Withdrawal due to AE before study began|1
4921506|NCT00483652|16948992|P2|Double-blind Treatment Period|Protocol inclusion deviation|0
4921507|NCT00483652|16948993|P1|Double-blind Treatment Period|Protocol inclusion deviation|1
4921508|NCT00483652|16948992|P2|Double-blind Treatment Period|Adverse Event|4
4921509|NCT00483652|16948993|P1|Double-blind Treatment Period|Adverse Event|3
4921510|NCT00483652|16948992|P2|Double-blind Treatment Period|Protocol Violation|1
4921511|NCT00483652|16948993|P1|Double-blind Treatment Period|Protocol Violation|2
4921512|NCT00483574|16949003|P2|Overall Study|Withdrawal by Subject|0
4921513|NCT00483574|16949004|P1|Overall Study|Withdrawal by Subject|52
4921514|NCT00483574|16949003|P2|Overall Study|Lost to Follow-up|4
4921515|NCT00483574|16949004|P1|Overall Study|Lost to Follow-up|16
4921516|NCT00483574|16949003|P2|Overall Study|Protocol Violation|9
4921517|NCT00483574|16949004|P1|Overall Study|Protocol Violation|28
4921518|NCT00483574|16949003|P2|Overall Study|Adverse Event|0
4921519|NCT00483574|16949004|P1|Overall Study|Adverse Event|6
4921520|NCT00483548|16949019|P2|Overall Study|Withdrawal by Subject|2
4921521|NCT00483548|16949020|P1|Overall Study|Withdrawal by Subject|5
4921522|NCT00483548|16949019|P2|Overall Study|Lost to Follow-up|4
4921523|NCT00483548|16949020|P1|Overall Study|Lost to Follow-up|3
4921524|NCT00483548|16949019|P2|Overall Study|Non-compliance with medication|0
4921525|NCT00483548|16949020|P1|Overall Study|Non-compliance with medication|2
4921526|NCT00483548|16949019|P2|Overall Study|Unable to comply with protocol schedule|0
4921527|NCT00483548|16949020|P1|Overall Study|Unable to comply with protocol schedule|1
4921528|NCT00483548|16949019|P2|Overall Study|Protocol required discontinuation|6
4921529|NCT00483548|16949020|P1|Overall Study|Protocol required discontinuation|6
4921530|NCT00483548|16949019|P2|Overall Study|Pregnancy|0
4921531|NCT00483548|16949020|P1|Overall Study|Pregnancy|1
4921532|NCT00483548|16949019|P2|Overall Study|Protocol Violation|7
4921533|NCT00483548|16949020|P1|Overall Study|Protocol Violation|11
4921534|NCT00483548|16949019|P2|Overall Study|Lack of Efficacy|8
4921535|NCT00483548|16949020|P1|Overall Study|Lack of Efficacy|4
4921536|NCT00483548|16949019|P2|Overall Study|Laboratory abnormality|2
4921537|NCT00483548|16949020|P1|Overall Study|Laboratory abnormality|1
4921538|NCT00483548|16949019|P2|Overall Study|Adverse Event|14
4921539|NCT00483548|16949020|P1|Overall Study|Adverse Event|25
4921540|NCT00483548|16949019|P2|Overall Study|Randomized; not treated with study drug|3
4921541|NCT00483548|16949020|P1|Overall Study|Randomized; not treated with study drug|1
4921542|NCT00483405|16949078|P1|Overall Study|Other complicating disease|1
4921543|NCT00483405|16949078|P1|Overall Study|Withdrawal by Subject|2
4921544|NCT00483405|16949078|P1|Overall Study|Death|3
4921545|NCT00483405|16949078|P1|Overall Study|Lack of Efficacy|14
4921546|NCT00483405|16949078|P1|Overall Study|Adverse Event|8
4921547|NCT00483379|16949087|P2|Treatment Period|Withdrawal by Subject|0
4921548|NCT00483379|16949088|P1|Treatment Period|Withdrawal by Subject|1
4921549|NCT00483379|16949087|P2|Treatment Period|Adverse Event|0
4921550|NCT00483379|16949088|P1|Treatment Period|Adverse Event|1
4921551|NCT00483327|16949124|P1|Overall Study|Patient Non Compliance|2
4921552|NCT00483327|16949124|P1|Overall Study|Lost to Follow-up|4
4921553|NCT00483327|16949124|P1|Overall Study|Withdrawal by Subject|3
4921554|NCT00483327|16949124|P1|Overall Study|Adverse Event|1
4921555|NCT00483184|16949156|P3|Overall Study|Protocol Violation|1
4921556|NCT00483184|16949157|P2|Overall Study|Protocol Violation|0
4921557|NCT00483184|16949158|P1|Overall Study|Protocol Violation|1
4921558|NCT00483184|16949156|P3|Overall Study|Adverse Event|2
4921559|NCT00483184|16949157|P2|Overall Study|Adverse Event|2
4921560|NCT00483184|16949158|P1|Overall Study|Adverse Event|1
4921561|NCT00483184|16949156|P3|Overall Study|Lost to Follow-up|0
4921562|NCT00483184|16949157|P2|Overall Study|Lost to Follow-up|0
4921563|NCT00483184|16949158|P1|Overall Study|Lost to Follow-up|1
4921564|NCT00483184|16949156|P3|Overall Study|Withdrawal by Subject|0
4921565|NCT00483184|16949157|P2|Overall Study|Withdrawal by Subject|2
4921566|NCT00483184|16949158|P1|Overall Study|Withdrawal by Subject|2
4921567|NCT00483119|16949168|P2|Overall Study|Physician Decision|0
4921568|NCT00483119|16949169|P1|Overall Study|Physician Decision|1
4921569|NCT00483119|16949168|P2|Overall Study|Adverse Event|1
4921570|NCT00483119|16949169|P1|Overall Study|Adverse Event|0
4921571|NCT00483041|16949183|P2|Overall Study|ABNORMAL LAB DATA AT SCREENING|1
4921572|NCT00483041|16949184|P1|Overall Study|ABNORMAL LAB DATA AT SCREENING|0
4921573|NCT00483002|16949214|P1|Overall Study|Other|967
4921574|NCT00483002|16949214|P1|Overall Study|Other|2
4921575|NCT00483002|16949214|P1|Overall Study|Lost to Follow-up|962
4921576|NCT00483002|16949214|P1|Overall Study|Lack of Efficacy|555
4921577|NCT00483002|16949214|P1|Overall Study|Adverse Event|68
4921578|NCT00482729|16949239|P2|Overall Study|Withdrawal by Subject|69
4921579|NCT00482729|16949240|P1|Overall Study|Withdrawal by Subject|67
4921580|NCT00482729|16949239|P2|Overall Study|Protocol Violation|18
4921581|NCT00482729|16949240|P1|Overall Study|Protocol Violation|10
4921582|NCT00482729|16949239|P2|Overall Study|Pregnancy|2
4921583|NCT00482729|16949240|P1|Overall Study|Pregnancy|4
4921584|NCT00482729|16949239|P2|Overall Study|Physician Decision|7
4921585|NCT00482729|16949240|P1|Overall Study|Physician Decision|10
4921586|NCT00482729|16949239|P2|Overall Study|Lost to Follow-up|66
4921587|NCT00482729|16949240|P1|Overall Study|Lost to Follow-up|86
4921588|NCT00482729|16949239|P2|Overall Study|Lack of Efficacy|16
4921589|NCT00482729|16949240|P1|Overall Study|Lack of Efficacy|4
4921590|NCT00482729|16949239|P2|Overall Study|Hyperglycemia Criteria|5
4921591|NCT00482729|16949240|P1|Overall Study|Hyperglycemia Criteria|7
4921592|NCT00482729|16949239|P2|Overall Study|Creatinine/Creatinine Clearance Criteria|2
4921593|NCT00482729|16949240|P1|Overall Study|Creatinine/Creatinine Clearance Criteria|0
4921594|NCT00482729|16949239|P2|Overall Study|Adverse Event|33
4921595|NCT00482729|16949240|P1|Overall Study|Adverse Event|29
4921596|NCT00482703|16949256|P2|Overall Study|Poor compliance|0
4921597|NCT00482703|16949257|P1|Overall Study|Poor compliance|1
4921598|NCT00482612|16949328|P4|Follow-up Period|Reasons not related to trial|3
4921599|NCT00482612|16949329|P3|Follow-up Period|Reasons not related to trial|1
4921600|NCT00482612|16949330|P2|Follow-up Period|Reasons not related to trial|0
4921601|NCT00482612|16949331|P1|Follow-up Period|Reasons not related to trial|1
4921602|NCT00482612|16949328|P4|Follow-up Period|Withdrawal by Subject|2
4921603|NCT00482612|16949329|P3|Follow-up Period|Withdrawal by Subject|7
4921604|NCT00482612|16949330|P2|Follow-up Period|Withdrawal by Subject|5
4921605|NCT00482612|16949331|P1|Follow-up Period|Withdrawal by Subject|3
4921606|NCT00482612|16949328|P4|Follow-up Period|Lack of Efficacy|0
4921607|NCT00482612|16949329|P3|Follow-up Period|Lack of Efficacy|1
4921608|NCT00482612|16949330|P2|Follow-up Period|Lack of Efficacy|0
4921609|NCT00482612|16949331|P1|Follow-up Period|Lack of Efficacy|2
4921610|NCT00482612|16949328|P4|Follow-up Period|Adverse Event|0
4921611|NCT00482612|16949329|P3|Follow-up Period|Adverse Event|9
4921612|NCT00482612|16949330|P2|Follow-up Period|Adverse Event|7
4921613|NCT00482612|16949331|P1|Follow-up Period|Adverse Event|4
4921614|NCT00482612|16949328|P4|Follow-up Period|Lost to Follow-up|1
4921615|NCT00482612|16949329|P3|Follow-up Period|Lost to Follow-up|2
4921616|NCT00482612|16949330|P2|Follow-up Period|Lost to Follow-up|4
4921617|NCT00482612|16949331|P1|Follow-up Period|Lost to Follow-up|0
4921618|NCT00482612|16949328|P4|Follow-up Period|Lack of compliance|0
4921619|NCT00482612|16949329|P3|Follow-up Period|Lack of compliance|1
4921620|NCT00482612|16949330|P2|Follow-up Period|Lack of compliance|0
4921621|NCT00482612|16949331|P1|Follow-up Period|Lack of compliance|0
4921622|NCT00482612|16949328|P4|Follow-up Period|Other|2
4921623|NCT00482612|16949329|P3|Follow-up Period|Other|1
4921624|NCT00482612|16949330|P2|Follow-up Period|Other|2
4921625|NCT00482612|16949331|P1|Follow-up Period|Other|4
4921626|NCT00482612|16949328|P4|In-treatment Period|No study medication administered|0
4921627|NCT00482612|16949329|P3|In-treatment Period|No study medication administered|1
4921628|NCT00482612|16949330|P2|In-treatment Period|No study medication administered|0
4921629|NCT00482612|16949331|P1|In-treatment Period|No study medication administered|0
4921630|NCT00482391|16949380|P1|Overall Study|Death|1
4921631|NCT00482391|16949380|P1|Overall Study|Adverse Event|1
4921632|NCT00482391|16949380|P1|Overall Study|Withdrawal by Subject|1
4921633|NCT00482274|16949385|P1|Overall Study|Adverse Event|1
4921634|NCT00482170|16949395|P2|Overall Study|Unspecified reason|2
4921635|NCT00482170|16949396|P1|Overall Study|Unspecified reason|0
4921636|NCT00482170|16949395|P2|Overall Study|Lost to Follow-up|0
4921637|NCT00482170|16949396|P1|Overall Study|Lost to Follow-up|2
4921638|NCT00482170|16949395|P2|Overall Study|Protocol Violation|3
4921639|NCT00482170|16949396|P1|Overall Study|Protocol Violation|2
4921640|NCT00482170|16949395|P2|Overall Study|Withdrawal by Subject|1
4921641|NCT00482170|16949396|P1|Overall Study|Withdrawal by Subject|6
4921642|NCT00482170|16949395|P2|Overall Study|Adverse Event|14
4921643|NCT00482170|16949396|P1|Overall Study|Adverse Event|5
4921644|NCT00482053|16949514|P1|Inter-treatment Period|Disease progression|1
4921645|NCT00482014|16949528|P4|Overall Study|Sponsor Decision|1
4921646|NCT00482014|16949529|P3|Overall Study|Sponsor Decision|1
4921647|NCT00482014|16949530|P2|Overall Study|Sponsor Decision|2
4921648|NCT00482014|16949531|P1|Overall Study|Sponsor Decision|1
4921649|NCT00482014|16949528|P4|Overall Study|Lack of Efficacy|6
4921650|NCT00482014|16949529|P3|Overall Study|Lack of Efficacy|4
4921651|NCT00482014|16949530|P2|Overall Study|Lack of Efficacy|0
4921652|NCT00482014|16949531|P1|Overall Study|Lack of Efficacy|1
4921653|NCT00482014|16949528|P4|Overall Study|Death|4
4921654|NCT00482014|16949529|P3|Overall Study|Death|1
4921655|NCT00482014|16949530|P2|Overall Study|Death|2
4921656|NCT00482014|16949531|P1|Overall Study|Death|1
4921657|NCT00482014|16949528|P4|Overall Study|Adverse Event|8
4921658|NCT00482014|16949529|P3|Overall Study|Adverse Event|2
4921659|NCT00482014|16949530|P2|Overall Study|Adverse Event|0
4921660|NCT00482014|16949531|P1|Overall Study|Adverse Event|3
4921661|NCT00482014|16949528|P4|Overall Study|Withdrawal by Subject|4
4921662|NCT00482014|16949529|P3|Overall Study|Withdrawal by Subject|3
4921663|NCT00482014|16949530|P2|Overall Study|Withdrawal by Subject|2
4921664|NCT00482014|16949531|P1|Overall Study|Withdrawal by Subject|1
4921665|NCT00482001|16949555|P2|Overall Study|Protocol Violation|1
4921666|NCT00482001|16949556|P1|Overall Study|Protocol Violation|1
4921667|NCT00481988|16949576|P2|Overall Study|Withdrawal by Subject|1
4921668|NCT00481988|16949577|P1|Overall Study|Withdrawal by Subject|1
4921669|NCT00481871|16949590|P5|Overall Study|Progressive Disease - pt withdrew|0
4921670|NCT00481871|16949591|P4|Overall Study|Progressive Disease - pt withdrew|0
4921671|NCT00481871|16949592|P3|Overall Study|Progressive Disease - pt withdrew|1
4921672|NCT00481871|16949593|P2|Overall Study|Progressive Disease - pt withdrew|0
4921673|NCT00481871|16949594|P1|Overall Study|Progressive Disease - pt withdrew|0
4921674|NCT00481832|16949619|P1|Inter-transplant Period|Lack of allogeneic donor|5
4921675|NCT00481832|16949619|P1|Inter-transplant Period|Disease relapse|11
4921676|NCT00481832|16949619|P1|Inter-transplant Period|Physician Decision|4
4921677|NCT00481832|16949619|P1|Inter-transplant Period|Death|3
4921678|NCT00481832|16949619|P1|Inter-transplant Period|Adverse Event|4
4921679|NCT00481832|16949619|P1|Enrollment|Unable to collect enough stem cells|2
4921680|NCT00481832|16949619|P1|Enrollment|Physician Decision|8
4921681|NCT00481767|16949634|P2|Overall Study|Lost to Follow-up|10
4921682|NCT00481767|16949635|P1|Overall Study|Lost to Follow-up|16
4921683|NCT00481767|16949634|P2|Overall Study|Withdrawal by Subject|11
4921684|NCT00481767|16949635|P1|Overall Study|Withdrawal by Subject|16
4921685|NCT00481676|16949669|P2|Overall Study|Administrative problem|0
4921686|NCT00481676|16949670|P1|Overall Study|Administrative problem|1
4921687|NCT00481676|16949669|P2|Overall Study|Unsatisfactory therapeutic effect|4
4921688|NCT00481676|16949670|P1|Overall Study|Unsatisfactory therapeutic effect|1
4921689|NCT00481676|16949669|P2|Overall Study|Adverse Event|1
4921690|NCT00481676|16949670|P1|Overall Study|Adverse Event|0
4921691|NCT00481247|16949722|P2|Overall Study|Did not receive treatment|2
4921692|NCT00481247|16949723|P1|Overall Study|Did not receive treatment|1
4921693|NCT00481247|16949722|P2|Overall Study|Varied|15
4921694|NCT00481247|16949723|P1|Overall Study|Varied|6
4921695|NCT00481247|16949722|P2|Overall Study|Administrative reason by sponsor|162
4921696|NCT00481247|16949723|P1|Overall Study|Administrative reason by sponsor|157
4921697|NCT00481247|16949722|P2|Overall Study|Poor compliance/noncompliance|7
4921698|NCT00481247|16949723|P1|Overall Study|Poor compliance/noncompliance|1
4921699|NCT00481247|16949722|P2|Overall Study|Lost to Follow-up|2
4921700|NCT00481247|16949723|P1|Overall Study|Lost to Follow-up|1
4921701|NCT00481247|16949722|P2|Overall Study|Pregnancy|1
4921702|NCT00481247|16949723|P1|Overall Study|Pregnancy|2
4921703|NCT00481247|16949722|P2|Overall Study|Withdrawal by Subject|13
4921704|NCT00481247|16949723|P1|Overall Study|Withdrawal by Subject|8
4921705|NCT00481247|16949722|P2|Overall Study|AE unrelated to study drug|4
4921706|NCT00481247|16949723|P1|Overall Study|AE unrelated to study drug|13
4921707|NCT00481247|16949722|P2|Overall Study|Treatment failure|14
4921708|NCT00481247|16949723|P1|Overall Study|Treatment failure|10
4921709|NCT00481247|16949722|P2|Overall Study|Intolerance|17
4921710|NCT00481247|16949723|P1|Overall Study|Intolerance|42
4921711|NCT00481247|16949722|P2|Overall Study|Disease progression|22
4921712|NCT00481247|16949723|P1|Overall Study|Disease progression|18
4921713|NCT00481247|16949722|P2|Overall Study|Death|1
4921714|NCT00481247|16949723|P1|Overall Study|Death|0
4921715|NCT00481195|16949747|P2|Overall Study|Miscellaneous|2
4921716|NCT00481195|16949748|P1|Overall Study|Miscellaneous|2
4921717|NCT00481195|16949747|P2|Overall Study|Withdrawal by Subject|9
4921718|NCT00481195|16949748|P1|Overall Study|Withdrawal by Subject|3
4921719|NCT00481195|16949747|P2|Overall Study|Protocol Violation|7
4921720|NCT00481195|16949748|P1|Overall Study|Protocol Violation|10
4921721|NCT00481195|16949747|P2|Overall Study|Physician Decision|1
4921722|NCT00481195|16949748|P1|Overall Study|Physician Decision|3
4921723|NCT00481195|16949747|P2|Overall Study|Lost to Follow-up|6
4921724|NCT00481195|16949748|P1|Overall Study|Lost to Follow-up|4
4921725|NCT00481195|16949747|P2|Overall Study|Lack of Efficacy|3
4921726|NCT00481195|16949748|P1|Overall Study|Lack of Efficacy|1
4921727|NCT00481195|16949747|P2|Overall Study|Adverse Event|11
4921728|NCT00481195|16949748|P1|Overall Study|Adverse Event|16
4921729|NCT00481078|16949834|P2|Overall Study|Brain metastasis|1
4921730|NCT00481078|16949835|P1|Overall Study|Brain metastasis|0
4921731|NCT00481078|16949834|P2|Overall Study|Received other treatment|1
4921732|NCT00481078|16949835|P1|Overall Study|Received other treatment|2
4921733|NCT00481078|16949834|P2|Overall Study|Information not available|0
4921734|NCT00481078|16949835|P1|Overall Study|Information not available|1
4921735|NCT00481078|16949834|P2|Overall Study|Withdrawal by Subject|1
4921736|NCT00481078|16949835|P1|Overall Study|Withdrawal by Subject|7
4921737|NCT00481078|16949834|P2|Overall Study|Intercurrent illness|0
4921738|NCT00481078|16949835|P1|Overall Study|Intercurrent illness|1
4921739|NCT00481078|16949834|P2|Overall Study|Death|3
4921740|NCT00481078|16949835|P1|Overall Study|Death|5
4921741|NCT00481078|16949834|P2|Overall Study|Adverse Event|3
4921742|NCT00481078|16949835|P1|Overall Study|Adverse Event|15
4921743|NCT00481078|16949834|P2|Overall Study|Progression of disease|11
4921744|NCT00481078|16949835|P1|Overall Study|Progression of disease|11
4921745|NCT00481065|16949853|P8|Overall Study|Unable to classify|0
4921746|NCT00481065|16949854|P7|Overall Study|Unable to classify|0
4921747|NCT00481065|16949855|P6|Overall Study|Unable to classify|0
4921748|NCT00481065|16949856|P5|Overall Study|Unable to classify|1
4921749|NCT00481065|16949857|P4|Overall Study|Unable to classify|0
4921750|NCT00481065|16949858|P3|Overall Study|Unable to classify|2
4921751|NCT00481065|16949859|P2|Overall Study|Unable to classify|1
4921752|NCT00481065|16949860|P1|Overall Study|Unable to classify|0
4921753|NCT00481065|16949853|P8|Overall Study|Protocol Violation|2
4921754|NCT00481065|16949854|P7|Overall Study|Protocol Violation|3
4921755|NCT00481065|16949855|P6|Overall Study|Protocol Violation|6
4921756|NCT00481065|16949856|P5|Overall Study|Protocol Violation|2
4921757|NCT00481065|16949857|P4|Overall Study|Protocol Violation|1
4921758|NCT00481065|16949858|P3|Overall Study|Protocol Violation|1
4921759|NCT00481065|16949859|P2|Overall Study|Protocol Violation|1
4921760|NCT00481065|16949860|P1|Overall Study|Protocol Violation|2
4921761|NCT00481065|16949853|P8|Overall Study|Administrative reason|0
4921762|NCT00481065|16949854|P7|Overall Study|Administrative reason|1
4921763|NCT00481065|16949855|P6|Overall Study|Administrative reason|2
4921764|NCT00481065|16949856|P5|Overall Study|Administrative reason|0
4921765|NCT00481065|16949857|P4|Overall Study|Administrative reason|0
4921766|NCT00481065|16949858|P3|Overall Study|Administrative reason|0
4921767|NCT00481065|16949859|P2|Overall Study|Administrative reason|0
4921768|NCT00481065|16949860|P1|Overall Study|Administrative reason|0
4921769|NCT00481065|16949853|P8|Overall Study|Inappropriate enrollment|1
4921770|NCT00481065|16949854|P7|Overall Study|Inappropriate enrollment|0
4921771|NCT00481065|16949855|P6|Overall Study|Inappropriate enrollment|1
4921772|NCT00481065|16949856|P5|Overall Study|Inappropriate enrollment|2
4921773|NCT00481065|16949857|P4|Overall Study|Inappropriate enrollment|0
4921774|NCT00481065|16949858|P3|Overall Study|Inappropriate enrollment|2
4921775|NCT00481065|16949859|P2|Overall Study|Inappropriate enrollment|0
4921776|NCT00481065|16949860|P1|Overall Study|Inappropriate enrollment|4
4921777|NCT00481065|16949853|P8|Overall Study|Lost to Follow-up|5
4921778|NCT00481065|16949854|P7|Overall Study|Lost to Follow-up|2
4921779|NCT00481065|16949855|P6|Overall Study|Lost to Follow-up|3
4921780|NCT00481065|16949856|P5|Overall Study|Lost to Follow-up|3
4921781|NCT00481065|16949857|P4|Overall Study|Lost to Follow-up|3
4921782|NCT00481065|16949858|P3|Overall Study|Lost to Follow-up|4
4921783|NCT00481065|16949859|P2|Overall Study|Lost to Follow-up|2
4921784|NCT00481065|16949860|P1|Overall Study|Lost to Follow-up|4
4921785|NCT00481065|16949853|P8|Overall Study|Withdrawal by Subject|10
4921786|NCT00481065|16949854|P7|Overall Study|Withdrawal by Subject|9
4921787|NCT00481065|16949855|P6|Overall Study|Withdrawal by Subject|12
4921788|NCT00481065|16949856|P5|Overall Study|Withdrawal by Subject|13
4921789|NCT00481065|16949857|P4|Overall Study|Withdrawal by Subject|11
4921790|NCT00481065|16949858|P3|Overall Study|Withdrawal by Subject|7
4921791|NCT00481065|16949859|P2|Overall Study|Withdrawal by Subject|12
4921792|NCT00481065|16949860|P1|Overall Study|Withdrawal by Subject|11
4921793|NCT00481065|16949853|P8|Overall Study|Adverse event or death|1
4921794|NCT00481065|16949854|P7|Overall Study|Adverse event or death|1
4921795|NCT00481065|16949855|P6|Overall Study|Adverse event or death|0
4921796|NCT00481065|16949856|P5|Overall Study|Adverse event or death|2
4921797|NCT00481065|16949857|P4|Overall Study|Adverse event or death|0
4921798|NCT00481065|16949858|P3|Overall Study|Adverse event or death|3
4921799|NCT00481065|16949859|P2|Overall Study|Adverse event or death|1
4921800|NCT00481065|16949860|P1|Overall Study|Adverse event or death|1
4921801|NCT00480857|16949950|P1|Overall Study|Lack of Efficacy|2
4921802|NCT00480779|16949960|P2|Overall Study|Job and Health-related|3
4921803|NCT00480779|16949961|P1|Overall Study|Job and Health-related|0
4921804|NCT00480779|16949960|P2|Overall Study|Other|0
4921805|NCT00480779|16949961|P1|Overall Study|Other|2
4921806|NCT00480636|16949998|P1|Overall Study|Lost to follow-up; subsequently died|1
4921807|NCT00480636|16949998|P1|Overall Study|Other|2
4921808|NCT00480636|16949998|P1|Overall Study|Lost to Follow-up|4
4921809|NCT00480636|16949998|P1|Overall Study|Death|12
4921810|NCT00480532|16950010|P4|Overall Study|Protocol Violation|0
4921811|NCT00480532|16950011|P3|Overall Study|Protocol Violation|1
4921812|NCT00480532|16950012|P2|Overall Study|Protocol Violation|0
4921813|NCT00480532|16950013|P1|Overall Study|Protocol Violation|0
4921814|NCT00480532|16950010|P4|Overall Study|Withdrawal by Subject|1
4921815|NCT00480532|16950011|P3|Overall Study|Withdrawal by Subject|3
4921816|NCT00480532|16950012|P2|Overall Study|Withdrawal by Subject|4
4921817|NCT00480532|16950013|P1|Overall Study|Withdrawal by Subject|2
4921818|NCT00480493|16950033|P2|Overall Study|moved|7
4921819|NCT00480493|16950034|P1|Overall Study|moved|2
4921820|NCT00480441|16950046|P3|Randomization|Lost to Follow-up|2
4921821|NCT00480441|16950047|P2|Randomization|Lost to Follow-up|7
4921822|NCT00480441|16950048|P1|Randomization|Lost to Follow-up|0
4921823|NCT00480441|16950046|P3|Baseline Functional MRI|physical contraindication|0
4921824|NCT00480441|16950047|P2|Baseline Functional MRI|physical contraindication|0
4921825|NCT00480441|16950048|P1|Baseline Functional MRI|physical contraindication|4
4921826|NCT00480441|16950046|P3|Baseline Functional MRI|Lost to Follow-up|0
4921827|NCT00480441|16950047|P2|Baseline Functional MRI|Lost to Follow-up|0
4921828|NCT00480441|16950048|P1|Baseline Functional MRI|Lost to Follow-up|4
4921829|NCT00480441|16950046|P3|Baseline Functional MRI|Functional MRI data not usable|0
4921830|NCT00480441|16950047|P2|Baseline Functional MRI|Functional MRI data not usable|0
4921831|NCT00480441|16950048|P1|Baseline Functional MRI|Functional MRI data not usable|4
4921832|NCT00480441|16950046|P3|Screening|Not Eligible|0
4921833|NCT00480441|16950047|P2|Screening|Not Eligible|0
4921834|NCT00480441|16950048|P1|Screening|Not Eligible|37
4921835|NCT00480324|16950057|P2|Overall Study|Subject's mother pregnant|1
4921836|NCT00480324|16950058|P1|Overall Study|Subject's mother pregnant|0
4921837|NCT00480324|16950057|P2|Overall Study|Lost to Follow-up|8
4921838|NCT00480324|16950058|P1|Overall Study|Lost to Follow-up|17
4921839|NCT00480324|16950057|P2|Overall Study|Withdrawal by Subject|5
4921840|NCT00480324|16950058|P1|Overall Study|Withdrawal by Subject|14
4921841|NCT00480324|16950057|P2|Overall Study|Protocol Violation|1
4921842|NCT00480324|16950058|P1|Overall Study|Protocol Violation|0
4921843|NCT00480324|16950057|P2|Overall Study|Adverse Event|1
4921844|NCT00480324|16950058|P1|Overall Study|Adverse Event|1
4921845|NCT00480077|16950086|P2|Overall Study|early exit|11
4921846|NCT00480077|16950087|P1|Overall Study|early exit|12
4921847|NCT00480077|16950086|P2|Overall Study|Death|15
4921848|NCT00480077|16950087|P1|Overall Study|Death|19
4921849|NCT00480025|16950095|P2|Overall Study|SAE including intercurrent illness|42
4921850|NCT00480025|16950096|P1|Overall Study|SAE including intercurrent illness|76
4921851|NCT00480025|16950095|P2|Overall Study|Other|29
4921852|NCT00480025|16950096|P1|Overall Study|Other|70
4921853|NCT00480025|16950095|P2|Overall Study|Adverse Event|12
4921854|NCT00480025|16950096|P1|Overall Study|Adverse Event|44
4921855|NCT00480025|16950095|P2|Overall Study|Disease Progression / Recurrence|224
4921856|NCT00480025|16950096|P1|Overall Study|Disease Progression / Recurrence|449
4921857|NCT00480025|16950095|P2|Overall Study|Patients remaining ongoing at Data Lock|55
4921858|NCT00480025|16950096|P1|Overall Study|Patients remaining ongoing at Data Lock|101
4921859|NCT00480025|16950095|P2|Overall Study|Protocol Violation|7
4921860|NCT00480025|16950096|P1|Overall Study|Protocol Violation|12
4921861|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
4921862|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Protocol Violation|1
4921863|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
4921864|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Protocol Violation|0
4921865|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
4921866|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1
4921867|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
4921868|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3
4921869|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Participant moved|0
4921870|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Participant moved|1
4921871|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Participant moved|2
4921872|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Participant moved|1
4921873|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Other|2
4921874|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Other|2
4921875|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Other|0
4921876|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Other|5
4921877|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
4921878|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
4921879|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2
4921880|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1
4921881|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
4921882|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2
4921964|NCT00479557|16950357|P6|Overall Study|AE not related to Study Drug|2
4921883|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1
4921884|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3
4921885|NCT00479882|16950168|P4|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10
4921886|NCT00479882|16950169|P3|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
4921887|NCT00479882|16950170|P2|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13
4921888|NCT00479882|16950171|P1|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12
4921889|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
4921890|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5
4921891|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7
4921892|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2
4921893|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25
4921894|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30
4921895|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33
4921896|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24
4921897|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1
4921898|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2
4921899|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4
4921900|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0
4921901|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Other|5
4921902|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Other|9
4921903|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Other|6
4921904|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Other|4
4921905|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11
4921906|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
4921907|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9
4921908|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12
4921909|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
4921910|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
4921911|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4
4921912|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0
4921913|NCT00479882|16950168|P4|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87
4921914|NCT00479882|16950169|P3|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98
4921915|NCT00479882|16950170|P2|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99
4921916|NCT00479882|16950171|P1|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96
4921917|NCT00479856|16950301|P1|Overall Study|Physician Decision|1
4921918|NCT00479856|16950301|P1|Overall Study|Withdrawal by Subject|1
4921919|NCT00479856|16950301|P1|Overall Study|Adverse Event|1
4921920|NCT00479765|16950310|P1|Overall Study|study terminated|4
4921921|NCT00479713|16950316|P2|Overall Study|Withdrawal by Subject|1
4921922|NCT00479713|16950317|P1|Overall Study|Withdrawal by Subject|4
4921923|NCT00479713|16950316|P2|Overall Study|Protocol Violation|1
4921924|NCT00479713|16950317|P1|Overall Study|Protocol Violation|0
4921925|NCT00479713|16950316|P2|Overall Study|Lost to Follow-up|1
4921926|NCT00479713|16950317|P1|Overall Study|Lost to Follow-up|0
4921927|NCT00479713|16950316|P2|Overall Study|Death|0
4921928|NCT00479713|16950317|P1|Overall Study|Death|1
4921929|NCT00479713|16950316|P2|Overall Study|Adverse Event|6
4921930|NCT00479713|16950317|P1|Overall Study|Adverse Event|8
4921931|NCT00479674|16950341|P1|Overall Study|none provided|3
4921932|NCT00479674|16950341|P1|Overall Study|Physician Decision|14
4921933|NCT00479674|16950341|P1|Overall Study|Withdrawal by Subject|6
4921934|NCT00479674|16950341|P1|Overall Study|Adverse Event|18
4921935|NCT00479557|16950356|P7|Overall Study|Other|0
4921936|NCT00479557|16950357|P6|Overall Study|Other|3
4921937|NCT00479557|16950358|P5|Overall Study|Other|0
4921938|NCT00479557|16950359|P4|Overall Study|Other|0
4921939|NCT00479557|16950360|P3|Overall Study|Other|1
4921940|NCT00479557|16950361|P2|Overall Study|Other|3
4921941|NCT00479557|16950362|P1|Overall Study|Other|2
4921942|NCT00479557|16950356|P7|Overall Study|Subject Request|1
4921943|NCT00479557|16950357|P6|Overall Study|Subject Request|4
4921944|NCT00479557|16950358|P5|Overall Study|Subject Request|1
4921945|NCT00479557|16950359|P4|Overall Study|Subject Request|1
4921946|NCT00479557|16950360|P3|Overall Study|Subject Request|1
4921947|NCT00479557|16950361|P2|Overall Study|Subject Request|0
4921948|NCT00479557|16950362|P1|Overall Study|Subject Request|3
4921949|NCT00479557|16950356|P7|Overall Study|Investigator Request|0
4921950|NCT00479557|16950357|P6|Overall Study|Investigator Request|0
4921951|NCT00479557|16950358|P5|Overall Study|Investigator Request|0
4921952|NCT00479557|16950359|P4|Overall Study|Investigator Request|0
4921953|NCT00479557|16950360|P3|Overall Study|Investigator Request|1
4921954|NCT00479557|16950361|P2|Overall Study|Investigator Request|0
4921955|NCT00479557|16950362|P1|Overall Study|Investigator Request|0
4921956|NCT00479557|16950356|P7|Overall Study|Caregiver Request|0
4921957|NCT00479557|16950357|P6|Overall Study|Caregiver Request|2
4921958|NCT00479557|16950358|P5|Overall Study|Caregiver Request|1
4921959|NCT00479557|16950359|P4|Overall Study|Caregiver Request|0
4921960|NCT00479557|16950360|P3|Overall Study|Caregiver Request|2
4921961|NCT00479557|16950361|P2|Overall Study|Caregiver Request|2
4921962|NCT00479557|16950362|P1|Overall Study|Caregiver Request|2
4921963|NCT00479557|16950356|P7|Overall Study|AE not related to Study Drug|1
4921965|NCT00479557|16950358|P5|Overall Study|AE not related to Study Drug|2
4921966|NCT00479557|16950359|P4|Overall Study|AE not related to Study Drug|0
4921967|NCT00479557|16950360|P3|Overall Study|AE not related to Study Drug|0
4921968|NCT00479557|16950361|P2|Overall Study|AE not related to Study Drug|3
4921969|NCT00479557|16950362|P1|Overall Study|AE not related to Study Drug|1
4921970|NCT00479557|16950356|P7|Overall Study|Adverse Event (AE) related to Study Drug|0
4921971|NCT00479557|16950357|P6|Overall Study|Adverse Event (AE) related to Study Drug|1
4921972|NCT00479557|16950358|P5|Overall Study|Adverse Event (AE) related to Study Drug|0
4921973|NCT00479557|16950359|P4|Overall Study|Adverse Event (AE) related to Study Drug|2
4921974|NCT00479557|16950360|P3|Overall Study|Adverse Event (AE) related to Study Drug|3
4921975|NCT00479557|16950361|P2|Overall Study|Adverse Event (AE) related to Study Drug|0
4921976|NCT00479557|16950362|P1|Overall Study|Adverse Event (AE) related to Study Drug|1
4921977|NCT00479557|16950356|P7|Overall Study|Lost to Follow-up|0
4921978|NCT00479557|16950357|P6|Overall Study|Lost to Follow-up|0
4921979|NCT00479557|16950358|P5|Overall Study|Lost to Follow-up|0
4921980|NCT00479557|16950359|P4|Overall Study|Lost to Follow-up|2
4921981|NCT00479557|16950360|P3|Overall Study|Lost to Follow-up|0
4921982|NCT00479557|16950361|P2|Overall Study|Lost to Follow-up|2
4921983|NCT00479557|16950362|P1|Overall Study|Lost to Follow-up|0
4921984|NCT00479557|16950356|P7|Overall Study|Lack of Efficacy|0
4921985|NCT00479557|16950357|P6|Overall Study|Lack of Efficacy|0
4921986|NCT00479557|16950358|P5|Overall Study|Lack of Efficacy|0
4921987|NCT00479557|16950359|P4|Overall Study|Lack of Efficacy|0
4921988|NCT00479557|16950360|P3|Overall Study|Lack of Efficacy|0
4921989|NCT00479557|16950361|P2|Overall Study|Lack of Efficacy|0
4921990|NCT00479557|16950362|P1|Overall Study|Lack of Efficacy|1
4921991|NCT00479557|16950356|P7|Overall Study|Death|0
4921992|NCT00479557|16950357|P6|Overall Study|Death|1
4921993|NCT00479557|16950358|P5|Overall Study|Death|0
4921994|NCT00479557|16950359|P4|Overall Study|Death|0
4921995|NCT00479557|16950360|P3|Overall Study|Death|0
4921996|NCT00479557|16950361|P2|Overall Study|Death|0
4921997|NCT00479557|16950362|P1|Overall Study|Death|0
4921998|NCT00479466|16950405|P6|Overall Study|Withdrawal by Subject|1
4921999|NCT00479466|16950406|P5|Overall Study|Withdrawal by Subject|3
4922000|NCT00479466|16950407|P4|Overall Study|Withdrawal by Subject|2
4922001|NCT00479466|16950408|P3|Overall Study|Withdrawal by Subject|0
4922002|NCT00479466|16950409|P2|Overall Study|Withdrawal by Subject|5
4922003|NCT00479466|16950410|P1|Overall Study|Withdrawal by Subject|3
4922004|NCT00479466|16950405|P6|Overall Study|Protocol Violation|0
4922005|NCT00479466|16950406|P5|Overall Study|Protocol Violation|0
4922006|NCT00479466|16950407|P4|Overall Study|Protocol Violation|0
4922007|NCT00479466|16950408|P3|Overall Study|Protocol Violation|0
4922008|NCT00479466|16950409|P2|Overall Study|Protocol Violation|0
4922009|NCT00479466|16950410|P1|Overall Study|Protocol Violation|1
4922010|NCT00479466|16950405|P6|Overall Study|Pregnancy|0
4922011|NCT00479466|16950406|P5|Overall Study|Pregnancy|1
4922012|NCT00479466|16950407|P4|Overall Study|Pregnancy|0
4922013|NCT00479466|16950408|P3|Overall Study|Pregnancy|0
4922014|NCT00479466|16950409|P2|Overall Study|Pregnancy|0
4922015|NCT00479466|16950410|P1|Overall Study|Pregnancy|0
4922016|NCT00479466|16950405|P6|Overall Study|Physician Decision|0
4922017|NCT00479466|16950406|P5|Overall Study|Physician Decision|0
4922018|NCT00479466|16950407|P4|Overall Study|Physician Decision|0
4922019|NCT00479466|16950408|P3|Overall Study|Physician Decision|1
4922020|NCT00479466|16950409|P2|Overall Study|Physician Decision|1
4922021|NCT00479466|16950410|P1|Overall Study|Physician Decision|2
4922022|NCT00479466|16950405|P6|Overall Study|Lost to Follow-up|2
4922023|NCT00479466|16950406|P5|Overall Study|Lost to Follow-up|2
4922024|NCT00479466|16950407|P4|Overall Study|Lost to Follow-up|0
4922025|NCT00479466|16950408|P3|Overall Study|Lost to Follow-up|1
4922026|NCT00479466|16950409|P2|Overall Study|Lost to Follow-up|1
4922027|NCT00479466|16950410|P1|Overall Study|Lost to Follow-up|0
4922028|NCT00479466|16950405|P6|Overall Study|Lack of Efficacy|0
4922029|NCT00479466|16950406|P5|Overall Study|Lack of Efficacy|0
4922030|NCT00479466|16950407|P4|Overall Study|Lack of Efficacy|0
4922031|NCT00479466|16950408|P3|Overall Study|Lack of Efficacy|1
4922032|NCT00479466|16950409|P2|Overall Study|Lack of Efficacy|0
4922033|NCT00479466|16950410|P1|Overall Study|Lack of Efficacy|2
4922034|NCT00479466|16950405|P6|Overall Study|Hyperglycemia|1
4922035|NCT00479466|16950406|P5|Overall Study|Hyperglycemia|0
4922036|NCT00479466|16950407|P4|Overall Study|Hyperglycemia|0
4922037|NCT00479466|16950408|P3|Overall Study|Hyperglycemia|0
4922038|NCT00479466|16950409|P2|Overall Study|Hyperglycemia|0
4922039|NCT00479466|16950410|P1|Overall Study|Hyperglycemia|0
4922040|NCT00479466|16950405|P6|Overall Study|Adverse Event|0
4922041|NCT00479466|16950406|P5|Overall Study|Adverse Event|2
4922042|NCT00479466|16950407|P4|Overall Study|Adverse Event|1
4922043|NCT00479466|16950408|P3|Overall Study|Adverse Event|0
4922044|NCT00479466|16950409|P2|Overall Study|Adverse Event|1
4922045|NCT00479466|16950410|P1|Overall Study|Adverse Event|5
4922046|NCT00479401|16950439|P3|Overall Study|Exclusion criteria, relocation|0
4922047|NCT00479401|16950440|P2|Overall Study|Exclusion criteria, relocation|3
4922048|NCT00479401|16950441|P1|Overall Study|Exclusion criteria, relocation|4
4922049|NCT00479401|16950439|P3|Overall Study|Withdrawal by Subject|2
4922050|NCT00479401|16950440|P2|Overall Study|Withdrawal by Subject|10
4922051|NCT00479401|16950441|P1|Overall Study|Withdrawal by Subject|16
4922052|NCT00479401|16950439|P3|Overall Study|Lost to Follow-up|1
4922053|NCT00479401|16950440|P2|Overall Study|Lost to Follow-up|1
4922054|NCT00479401|16950441|P1|Overall Study|Lost to Follow-up|1
4922055|NCT00479401|16950439|P3|Overall Study|Protocol Violation|1
4922056|NCT00479401|16950440|P2|Overall Study|Protocol Violation|1
4922057|NCT00479401|16950441|P1|Overall Study|Protocol Violation|2
4922058|NCT00479401|16950439|P3|Overall Study|Lack of Efficacy|4
4922059|NCT00479401|16950440|P2|Overall Study|Lack of Efficacy|2
4922060|NCT00479401|16950441|P1|Overall Study|Lack of Efficacy|2
4922061|NCT00479401|16950439|P3|Overall Study|Adverse Event|4
4922062|NCT00479401|16950440|P2|Overall Study|Adverse Event|20
4922063|NCT00479401|16950441|P1|Overall Study|Adverse Event|24
4922064|NCT00479388|16950496|P2|Overall Study|Withdrawal by Subject|17
4922065|NCT00479388|16950497|P1|Overall Study|Withdrawal by Subject|32
4922066|NCT00479388|16950496|P2|Overall Study|Protocol Violation|9
4922067|NCT00479388|16950497|P1|Overall Study|Protocol Violation|10
4922068|NCT00479388|16950496|P2|Overall Study|Lost to Follow-up|2
4922069|NCT00479388|16950497|P1|Overall Study|Lost to Follow-up|0
4922070|NCT00479388|16950496|P2|Overall Study|Adverse Event|45
4922071|NCT00479388|16950497|P1|Overall Study|Adverse Event|90
4922072|NCT00479336|16950511|P4|Overall Study|Resolution of all hepatic edema findings|0
4922073|NCT00479336|16950512|P3|Overall Study|Resolution of all hepatic edema findings|0
4922074|NCT00479336|16950513|P2|Overall Study|Resolution of all hepatic edema findings|1
4922075|NCT00479336|16950514|P1|Overall Study|Resolution of all hepatic edema findings|1
4922076|NCT00479336|16950511|P4|Overall Study|Physician Decision|2
4922077|NCT00479336|16950512|P3|Overall Study|Physician Decision|0
4922078|NCT00479336|16950513|P2|Overall Study|Physician Decision|1
4922079|NCT00479336|16950514|P1|Overall Study|Physician Decision|0
4922080|NCT00479336|16950511|P4|Overall Study|Withdrawal by Subject|0
4922081|NCT00479336|16950512|P3|Overall Study|Withdrawal by Subject|0
4922082|NCT00479336|16950513|P2|Overall Study|Withdrawal by Subject|2
4922083|NCT00479336|16950514|P1|Overall Study|Withdrawal by Subject|1
4922084|NCT00479336|16950511|P4|Overall Study|Protocol Violation|0
4922085|NCT00479336|16950512|P3|Overall Study|Protocol Violation|0
4922086|NCT00479336|16950513|P2|Overall Study|Protocol Violation|1
4922087|NCT00479336|16950514|P1|Overall Study|Protocol Violation|0
4922088|NCT00479336|16950511|P4|Overall Study|Lack of Efficacy|0
4922089|NCT00479336|16950512|P3|Overall Study|Lack of Efficacy|0
4922090|NCT00479336|16950513|P2|Overall Study|Lack of Efficacy|0
4922091|NCT00479336|16950514|P1|Overall Study|Lack of Efficacy|1
4922092|NCT00479336|16950511|P4|Overall Study|Adverse Event|3
4922093|NCT00479336|16950512|P3|Overall Study|Adverse Event|1
4922094|NCT00479336|16950513|P2|Overall Study|Adverse Event|1
4922095|NCT00479336|16950514|P1|Overall Study|Adverse Event|1
4922096|NCT00479232|16950537|P6|Overall Study|Withdrew Consent|3
4922097|NCT00479232|16950538|P5|Overall Study|Withdrew Consent|1
4922098|NCT00479232|16950539|P4|Overall Study|Withdrew Consent|0
4922099|NCT00479232|16950540|P3|Overall Study|Withdrew Consent|6
4922100|NCT00479232|16950541|P2|Overall Study|Withdrew Consent|2
4922101|NCT00479232|16950542|P1|Overall Study|Withdrew Consent|0
4922102|NCT00479232|16950537|P6|Overall Study|Progressive Disease|12
4922103|NCT00479232|16950538|P5|Overall Study|Progressive Disease|3
4922104|NCT00479232|16950539|P4|Overall Study|Progressive Disease|3
4922105|NCT00479232|16950540|P3|Overall Study|Progressive Disease|12
4922106|NCT00479232|16950541|P2|Overall Study|Progressive Disease|1
4922107|NCT00479232|16950542|P1|Overall Study|Progressive Disease|3
4922108|NCT00479232|16950537|P6|Overall Study|Physician Decision|1
4922109|NCT00479232|16950538|P5|Overall Study|Physician Decision|0
4922110|NCT00479232|16950539|P4|Overall Study|Physician Decision|0
4922111|NCT00479232|16950540|P3|Overall Study|Physician Decision|2
4922112|NCT00479232|16950541|P2|Overall Study|Physician Decision|0
4922113|NCT00479232|16950542|P1|Overall Study|Physician Decision|0
4922114|NCT00479232|16950537|P6|Overall Study|Lack of Efficacy|4
4922115|NCT00479232|16950538|P5|Overall Study|Lack of Efficacy|0
4922116|NCT00479232|16950539|P4|Overall Study|Lack of Efficacy|0
4922117|NCT00479232|16950540|P3|Overall Study|Lack of Efficacy|2
4922118|NCT00479232|16950541|P2|Overall Study|Lack of Efficacy|0
4922119|NCT00479232|16950542|P1|Overall Study|Lack of Efficacy|0
4922120|NCT00479232|16950537|P6|Overall Study|Deviation from Protocol|0
4922121|NCT00479232|16950538|P5|Overall Study|Deviation from Protocol|0
4922122|NCT00479232|16950539|P4|Overall Study|Deviation from Protocol|0
4922123|NCT00479232|16950540|P3|Overall Study|Deviation from Protocol|1
4922124|NCT00479232|16950541|P2|Overall Study|Deviation from Protocol|0
4922125|NCT00479232|16950542|P1|Overall Study|Deviation from Protocol|0
4922126|NCT00479232|16950537|P6|Overall Study|Adverse Event|10
4922127|NCT00479232|16950538|P5|Overall Study|Adverse Event|0
4922128|NCT00479232|16950539|P4|Overall Study|Adverse Event|0
4922129|NCT00479232|16950540|P3|Overall Study|Adverse Event|5
4922130|NCT00479232|16950541|P2|Overall Study|Adverse Event|0
4922131|NCT00479232|16950542|P1|Overall Study|Adverse Event|0
4922132|NCT00478933|16950595|P1|Overall Study|Inadequate data available|53
4922133|NCT00478933|16950595|P1|Overall Study|Informed consent not verified|3
4922134|NCT00478933|16950595|P1|Overall Study|Protocol Violation|22
4922135|NCT00478881|16950621|P2|Overall Study|Non-Compliance with Study Medication|2
4922136|NCT00478881|16950622|P1|Overall Study|Non-Compliance with Study Medication|0
4922137|NCT00478881|16950621|P2|Overall Study|Withdrawal by Subject|2
4922138|NCT00478881|16950622|P1|Overall Study|Withdrawal by Subject|6
4922139|NCT00478881|16950621|P2|Overall Study|Protocol Violation|2
4922140|NCT00478881|16950622|P1|Overall Study|Protocol Violation|2
4922141|NCT00478881|16950621|P2|Overall Study|Lost to Follow-up|1
4922142|NCT00478881|16950622|P1|Overall Study|Lost to Follow-up|0
4922143|NCT00478881|16950621|P2|Overall Study|Lack of Efficacy|3
4922144|NCT00478881|16950622|P1|Overall Study|Lack of Efficacy|0
4922145|NCT00478881|16950621|P2|Overall Study|Adverse Event|12
4922146|NCT00478881|16950622|P1|Overall Study|Adverse Event|31
4922147|NCT00478777|16950646|P1|Overall Study|Not treated with lenalidomide|6
4922148|NCT00478777|16950646|P1|Overall Study|End of therapy|2
4922149|NCT00478777|16950646|P1|Overall Study|Lymphocytes infusion|1
4922150|NCT00478777|16950646|P1|Overall Study|Lack of compliance|1
4922151|NCT00478777|16950646|P1|Overall Study|Intolerance of therapy|1
4922152|NCT00478777|16950646|P1|Overall Study|Physician Decision|1
4922153|NCT00478777|16950646|P1|Overall Study|Lost to Follow-up|3
4922154|NCT00478777|16950646|P1|Overall Study|Protocol Violation|3
4922155|NCT00478777|16950646|P1|Overall Study|Death|3
4922156|NCT00478777|16950646|P1|Overall Study|Withdrawal by Subject|4
4922157|NCT00478777|16950646|P1|Overall Study|Lack of Efficacy|23
4922158|NCT00478777|16950646|P1|Overall Study|Adverse Event|29
4922159|NCT00478673|16950653|P1|12-Months Post-Procedure|Visit Not Required by Protocol|6
4922160|NCT00478673|16950653|P1|12-Months Post-Procedure|Missed Visit|25
4922161|NCT00478673|16950653|P1|12-Months Post-Procedure|Withdrawal by Subject|6
4922162|NCT00478673|16950653|P1|12-Months Post-Procedure|Lost to Follow-up|4
4922163|NCT00478673|16950653|P1|12-Months Post-Procedure|Death|23
4922164|NCT00478673|16950653|P1|30-Days Post-Procedure|Missed Visit|7
4922165|NCT00478673|16950653|P1|30-Days Post-Procedure|Withdrawal by Subject|1
4922166|NCT00478673|16950653|P1|30-Days Post-Procedure|Death|2
4922167|NCT00478647|16950658|P1|Overall Study|Withdrawal by Subject|1
4922168|NCT00478647|16950658|P1|Overall Study|Adverse Event|1
4922169|NCT00478608|16950666|P1|Overall Study|Protocol Violation|3
4922170|NCT00478608|16950666|P1|Overall Study|Withdrawal by Subject|2
4922171|NCT00478608|16950666|P1|Overall Study|Serious Adverse Event|14
4922172|NCT00478608|16950666|P1|Overall Study|Adverse Event|1
4922173|NCT00478426|16950699|P1|Overall Study|Withdrawal by Subject|1
4922174|NCT00478257|16950724|P2|Overall Study|Withdrawal by Subject|3
4922175|NCT00478257|16950725|P1|Overall Study|Withdrawal by Subject|8
4922176|NCT00478244|16950731|P1|Overall Study|Did not receive transplant|1
4922177|NCT00478231|16950744|P1|Overall Study|Randomized, not treated|3
4922178|NCT00478231|16950744|P1|Overall Study|Adverse Event|5
4922179|NCT00478231|16950744|P1|Overall Study|Other|9
4922180|NCT00478231|16950744|P1|Overall Study|Withdrawal by Subject|6
4922181|NCT00478231|16950744|P1|Overall Study|Lost to Follow-up|7
4922182|NCT00478231|16950744|P1|Overall Study|Lack of Efficacy|47
4922183|NCT00478231|16950744|P1|Overall Study|Death|7
4922184|NCT00478205|16950780|P2|Overall Study|Other|12
4922185|NCT00478205|16950781|P1|Overall Study|Other|24
4922186|NCT00478205|16950780|P2|Overall Study|Lack of Efficacy|0
4922187|NCT00478205|16950781|P1|Overall Study|Lack of Efficacy|1
4922188|NCT00478205|16950780|P2|Overall Study|Withdrawal by Subject|22
4922189|NCT00478205|16950781|P1|Overall Study|Withdrawal by Subject|61
4922190|NCT00478205|16950780|P2|Overall Study|Request of Investigator or Sponsor|5
4922191|NCT00478205|16950781|P1|Overall Study|Request of Investigator or Sponsor|4
4922192|NCT00478205|16950780|P2|Overall Study|Protocol Violation|5
4922193|NCT00478205|16950781|P1|Overall Study|Protocol Violation|15
4922194|NCT00478205|16950780|P2|Overall Study|Medication Non-compliance|4
4922195|NCT00478205|16950781|P1|Overall Study|Medication Non-compliance|9
4922196|NCT00478205|16950780|P2|Overall Study|Adverse Event|39
4922197|NCT00478205|16950781|P1|Overall Study|Adverse Event|182
4922198|NCT00478140|16950825|P1|Overall Study|Clinical Disease Progression|1
4922199|NCT00478023|16950857|P5|Overall Study|Lack of pain, Technical difficulties|3
4922200|NCT00478023|16950858|P4|Overall Study|Lack of pain, Technical difficulties|6
4922201|NCT00478023|16950859|P3|Overall Study|Lack of pain, Technical difficulties|5
4922202|NCT00478023|16950860|P2|Overall Study|Lack of pain, Technical difficulties|3
4922203|NCT00478023|16950861|P1|Overall Study|Lack of pain, Technical difficulties|7
4922204|NCT00478023|16950857|P5|Overall Study|Withdrawal by Subject|5
4922205|NCT00478023|16950858|P4|Overall Study|Withdrawal by Subject|4
4922206|NCT00478023|16950859|P3|Overall Study|Withdrawal by Subject|2
4922207|NCT00478023|16950860|P2|Overall Study|Withdrawal by Subject|3
4922208|NCT00478023|16950861|P1|Overall Study|Withdrawal by Subject|2
4922209|NCT00478023|16950857|P5|Overall Study|Lost to Follow-up|0
4922210|NCT00478023|16950858|P4|Overall Study|Lost to Follow-up|1
4922211|NCT00478023|16950859|P3|Overall Study|Lost to Follow-up|1
4922212|NCT00478023|16950860|P2|Overall Study|Lost to Follow-up|1
4922213|NCT00478023|16950861|P1|Overall Study|Lost to Follow-up|3
4922214|NCT00478023|16950857|P5|Overall Study|Lack of Efficacy|41
4922215|NCT00478023|16950858|P4|Overall Study|Lack of Efficacy|5
4922216|NCT00478023|16950859|P3|Overall Study|Lack of Efficacy|4
4922217|NCT00478023|16950860|P2|Overall Study|Lack of Efficacy|10
4922218|NCT00478023|16950861|P1|Overall Study|Lack of Efficacy|11
4922219|NCT00478023|16950857|P5|Overall Study|Death|0
4922220|NCT00478023|16950858|P4|Overall Study|Death|0
4922221|NCT00478023|16950859|P3|Overall Study|Death|0
4922222|NCT00478023|16950860|P2|Overall Study|Death|0
4922223|NCT00478023|16950861|P1|Overall Study|Death|1
4922224|NCT00478023|16950857|P5|Overall Study|Adverse Event|6
4922225|NCT00478023|16950858|P4|Overall Study|Adverse Event|14
4922226|NCT00478023|16950859|P3|Overall Study|Adverse Event|8
4922227|NCT00478023|16950860|P2|Overall Study|Adverse Event|7
4922228|NCT00478023|16950861|P1|Overall Study|Adverse Event|11
4922229|NCT00477971|16950880|P2|Overall Study|Alternative treatment|1
4922230|NCT00477971|16950881|P1|Overall Study|Alternative treatment|3
4922231|NCT00477971|16950880|P2|Overall Study|Death|4
4922232|NCT00477971|16950881|P1|Overall Study|Death|2
4922233|NCT00477971|16950880|P2|Overall Study|Adverse Event|0
4922234|NCT00477971|16950881|P1|Overall Study|Adverse Event|3
4922235|NCT00477971|16950880|P2|Overall Study|Withdrawal by Subject|1
4922236|NCT00477971|16950881|P1|Overall Study|Withdrawal by Subject|3
4922237|NCT00477971|16950880|P2|Overall Study|Disease progression|0
4922238|NCT00477971|16950881|P1|Overall Study|Disease progression|6
4922239|NCT00477750|16950893|P1|Overall Study|Currently Receiving Treatment|11
4922240|NCT00477672|16950909|P3|Overall Study|Discretion of Sponsor|0
4922241|NCT00477672|16950910|P2|Overall Study|Discretion of Sponsor|2
4922242|NCT00477672|16950911|P1|Overall Study|Discretion of Sponsor|1
4922243|NCT00477672|16950909|P3|Overall Study|Consent withdrawn|10
4922244|NCT00477672|16950910|P2|Overall Study|Consent withdrawn|5
4922245|NCT00477672|16950911|P1|Overall Study|Consent withdrawn|2
4922246|NCT00477672|16950909|P3|Overall Study|Protocol noncompliance|0
4922247|NCT00477672|16950910|P2|Overall Study|Protocol noncompliance|2
4922248|NCT00477672|16950911|P1|Overall Study|Protocol noncompliance|0
4922249|NCT00477672|16950909|P3|Overall Study|Physician Decision|0
4922250|NCT00477672|16950910|P2|Overall Study|Physician Decision|0
4922251|NCT00477672|16950911|P1|Overall Study|Physician Decision|1
4922252|NCT00477672|16950909|P3|Overall Study|Disease progression|0
4922253|NCT00477672|16950910|P2|Overall Study|Disease progression|1
4922254|NCT00477672|16950911|P1|Overall Study|Disease progression|0
4922255|NCT00477672|16950909|P3|Overall Study|Death|0
4922256|NCT00477672|16950910|P2|Overall Study|Death|1
4922257|NCT00477672|16950911|P1|Overall Study|Death|0
4922258|NCT00477672|16950909|P3|Overall Study|Adverse Event|6
4922259|NCT00477672|16950910|P2|Overall Study|Adverse Event|5
4922260|NCT00477672|16950911|P1|Overall Study|Adverse Event|3
4922261|NCT00477633|16950922|P1|Overall Study|Various (Moving, Enrollment closed)|75
4922262|NCT00477633|16950922|P1|Overall Study|Protocol Violation|25
4922263|NCT00477633|16950922|P1|Overall Study|Withdrawal by Subject|149
4922264|NCT00477633|16950922|P1|Overall Study|Lost to Follow-up|271
4922265|NCT00477633|16950922|P1|Overall Study|Pregnancy|23
4922266|NCT00477633|16950922|P1|Overall Study|Adverse Event|143
4922267|NCT00477633|16950922|P1|Overall Study|Did not receive treatment|23
4922268|NCT00477607|16950930|P2|Overall Study|Lost to Follow-up|7
4922269|NCT00477607|16950931|P1|Overall Study|Lost to Follow-up|7
4922270|NCT00477594|16950943|P2|Follow-up Period|Other|0
4922271|NCT00477594|16950944|P1|Follow-up Period|Other|1
4922272|NCT00477594|16950943|P2|Follow-up Period|Withdrawal by Subject|1
4922273|NCT00477594|16950944|P1|Follow-up Period|Withdrawal by Subject|2
4922274|NCT00477594|16950943|P2|Year 3|Withdrawal by Subject|0
4922275|NCT00477594|16950944|P1|Year 3|Withdrawal by Subject|1
4922276|NCT00477594|16950943|P2|Year 3|Adverse Event|0
4922277|NCT00477594|16950944|P1|Year 3|Adverse Event|1
4922278|NCT00477594|16950943|P2|Year 1 and Year 2|Other|0
4922279|NCT00477594|16950944|P1|Year 1 and Year 2|Other|1
4922280|NCT00477594|16950943|P2|Year 1 and Year 2|Withdrawal by Subject|1
4922281|NCT00477594|16950944|P1|Year 1 and Year 2|Withdrawal by Subject|2
4922282|NCT00477594|16950943|P2|Year 1 and Year 2|Physician Decision|1
4922283|NCT00477594|16950944|P1|Year 1 and Year 2|Physician Decision|2
4922284|NCT00477594|16950943|P2|Year 1 and Year 2|Adverse Event|2
4922285|NCT00477594|16950944|P1|Year 1 and Year 2|Adverse Event|4
4922286|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Not reported|0
4922287|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Not reported|0
4922288|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Not reported|0
4922289|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Not reported|0
4922290|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Not reported|1
4922291|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Not reported|0
4922292|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Not reported|1
4922293|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Not reported|3
4922294|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Not reported|0
4922295|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Other, not specified|1
4922296|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Other, not specified|0
4922297|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Other, not specified|1
4922298|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Other, not specified|1
4922299|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Other, not specified|2
4922300|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Other, not specified|4
4922301|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Other, not specified|2
4922302|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Other, not specified|4
4922303|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Other, not specified|0
4922304|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922305|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922306|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922307|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922308|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922309|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922310|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922311|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Excluded medication|1
4922312|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Excluded medication|0
4922313|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
4922314|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
4922315|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4922316|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4922317|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Decreased sodium|1
4922318|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4922319|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4922320|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4922321|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Decreased sodium|0
4922322|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4922323|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4922324|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1
4922325|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4922326|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5
4922327|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4922328|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2
4922329|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3
4922330|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0
4922331|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Adverse Event|4
4922332|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4922333|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4922334|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4922335|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4922336|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Adverse Event|1
4922337|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Adverse Event|3
4922338|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Adverse Event|2
4922339|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Adverse Event|0
4922340|NCT00477490|16951005|P9|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
4922341|NCT00477490|16951006|P8|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3
4922342|NCT00477490|16951007|P7|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2
4922343|NCT00477490|16951008|P6|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4
4922344|NCT00477490|16951009|P5|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10
4922345|NCT00477490|16951010|P4|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
4922346|NCT00477490|16951011|P3|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7
4922347|NCT00477490|16951012|P2|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15
4922348|NCT00477490|16951013|P1|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0
4922349|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Not Reported|0
4922350|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Not Reported|0
4922351|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Not Reported|0
4922352|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Not Reported|0
4922353|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Not Reported|1
4922354|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Not Reported|0
4922355|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Not Reported|3
4922356|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Not Reported|2
4922357|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Not Reported|1
4922358|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Other, not specified|0
4922359|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Other, not specified|0
4922360|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Other, not specified|0
4922361|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Other, not specified|0
4922362|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Other, not specified|1
4922363|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Other, not specified|1
4922364|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Other, not specified|0
4922365|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Other, not specified|4
4922366|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Other, not specified|2
4922367|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Lost to Follow-up|0
4922368|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Lost to Follow-up|0
4922369|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Lost to Follow-up|0
4922370|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Lost to Follow-up|0
4922371|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Lost to Follow-up|3
4922372|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Lost to Follow-up|5
4922373|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Lost to Follow-up|1
4922374|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Lost to Follow-up|4
4922375|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Lost to Follow-up|2
4922376|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4922377|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4922378|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4922379|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Withdrawal by Subject|0
4922380|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Withdrawal by Subject|9
4922381|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Withdrawal by Subject|4
4922382|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Withdrawal by Subject|6
4922383|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Withdrawal by Subject|5
4922384|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Withdrawal by Subject|6
4922385|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Protocol Violation|0
4922386|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Protocol Violation|0
4922387|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Protocol Violation|0
4922388|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Protocol Violation|0
4922389|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Protocol Violation|1
4922390|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Protocol Violation|0
4922391|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Protocol Violation|0
4922392|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Protocol Violation|0
4922393|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Protocol Violation|2
4922394|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4922395|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4922396|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4922397|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4922398|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4
4922399|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5
4922400|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4922401|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0
4922402|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1
4922403|NCT00477490|16951005|P9|Part I: 4 Week Efficacy|Adverse Event|0
4922404|NCT00477490|16951006|P8|Part I: 4 Week Efficacy|Adverse Event|0
4922405|NCT00477490|16951007|P7|Part I: 4 Week Efficacy|Adverse Event|0
4922406|NCT00477490|16951008|P6|Part I: 4 Week Efficacy|Adverse Event|0
4922407|NCT00477490|16951009|P5|Part I: 4 Week Efficacy|Adverse Event|6
4922408|NCT00477490|16951010|P4|Part I: 4 Week Efficacy|Adverse Event|5
4922409|NCT00477490|16951011|P3|Part I: 4 Week Efficacy|Adverse Event|0
4922410|NCT00477490|16951012|P2|Part I: 4 Week Efficacy|Adverse Event|4
4922411|NCT00477490|16951013|P1|Part I: 4 Week Efficacy|Adverse Event|1
4922412|NCT00477464|16951097|P1|Overall Study|Completion of protocol-defined follow-up|14
4922413|NCT00477464|16951097|P1|Overall Study|Death|36
4922414|NCT00477464|16951097|P1|Overall Study|Lost to Follow-up|1
4922415|NCT00477386|16951141|P2|Overall Study|Withdrawal by Subject|0
4922416|NCT00477386|16951142|P1|Overall Study|Withdrawal by Subject|1
4922417|NCT00477386|16951141|P2|Overall Study|Physician Decision|0
4922418|NCT00477386|16951142|P1|Overall Study|Physician Decision|1
4922419|NCT00477386|16951141|P2|Overall Study|Other|2
4922420|NCT00477386|16951142|P1|Overall Study|Other|1
4922421|NCT00477386|16951141|P2|Overall Study|Disease progression, refractory|3
4922422|NCT00477386|16951142|P1|Overall Study|Disease progression, refractory|1
4922423|NCT00477386|16951141|P2|Overall Study|Disease progression, relapse|4
4922424|NCT00477386|16951142|P1|Overall Study|Disease progression, relapse|3
4922425|NCT00477386|16951141|P2|Overall Study|Adverse Event|8
4922426|NCT00477386|16951142|P1|Overall Study|Adverse Event|4
4922427|NCT00477334|16951152|P2|Overall Study|Protocol Violation|1
4922428|NCT00477334|16951153|P1|Overall Study|Protocol Violation|7
4922429|NCT00477334|16951152|P2|Overall Study|Administrative Problems|15
4922430|NCT00477334|16951153|P1|Overall Study|Administrative Problems|39
4922431|NCT00477334|16951152|P2|Overall Study|Lost to Follow-up|4
4922432|NCT00477334|16951153|P1|Overall Study|Lost to Follow-up|15
4922433|NCT00477334|16951152|P2|Overall Study|Withdrawal by Subject|1
4922434|NCT00477334|16951153|P1|Overall Study|Withdrawal by Subject|2
4922435|NCT00477334|16951152|P2|Overall Study|Adverse Event|2
4922436|NCT00477334|16951153|P1|Overall Study|Adverse Event|1
4922437|NCT00477334|16951152|P2|Overall Study|Discontinued prior to taking study drug|53
4922438|NCT00477334|16951153|P1|Overall Study|Discontinued prior to taking study drug|106
4922439|NCT00477295|16951179|P2|Overall Study|Other|3
4922440|NCT00477295|16951180|P1|Overall Study|Other|4
4922441|NCT00477295|16951179|P2|Overall Study|Lost to Follow-up|11
4922442|NCT00477295|16951180|P1|Overall Study|Lost to Follow-up|21
4922443|NCT00477295|16951179|P2|Overall Study|Physician Decision|5
4922444|NCT00477295|16951180|P1|Overall Study|Physician Decision|4
4922445|NCT00477295|16951179|P2|Overall Study|Protocol Violation|8
4922446|NCT00477295|16951180|P1|Overall Study|Protocol Violation|3
4922447|NCT00477295|16951179|P2|Overall Study|Lack of Efficacy|23
4922448|NCT00477295|16951180|P1|Overall Study|Lack of Efficacy|23
4922449|NCT00477295|16951179|P2|Overall Study|Withdrawal by Subject|24
4922450|NCT00477295|16951180|P1|Overall Study|Withdrawal by Subject|35
4922451|NCT00477295|16951179|P2|Overall Study|Adverse Event|35
4922452|NCT00477295|16951180|P1|Overall Study|Adverse Event|31
4922453|NCT00477269|16951208|P3|Open Label Extension|Death|4
4922454|NCT00477269|16951209|P2|Open Label Extension|Death|0
4922455|NCT00477269|16951210|P1|Open Label Extension|Death|0
4922456|NCT00477269|16951208|P3|Open Label Extension|Adminiatrative problems|2
4922457|NCT00477269|16951209|P2|Open Label Extension|Adminiatrative problems|0
4922458|NCT00477269|16951210|P1|Open Label Extension|Adminiatrative problems|0
4922459|NCT00477269|16951208|P3|Open Label Extension|unsatisfactory therapeutic effects|2
4922460|NCT00477269|16951209|P2|Open Label Extension|unsatisfactory therapeutic effects|0
4922461|NCT00477269|16951210|P1|Open Label Extension|unsatisfactory therapeutic effects|0
4922462|NCT00477269|16951208|P3|Open Label Extension|Abnormal laboratory values|1
4922463|NCT00477269|16951209|P2|Open Label Extension|Abnormal laboratory values|0
4922464|NCT00477269|16951210|P1|Open Label Extension|Abnormal laboratory values|0
4922465|NCT00477269|16951208|P3|Open Label Extension|Adverse Event|4
4922466|NCT00477269|16951209|P2|Open Label Extension|Adverse Event|0
4922467|NCT00477269|16951210|P1|Open Label Extension|Adverse Event|0
4922468|NCT00477269|16951208|P3|Core Study|Withdrawn Consent|0
4922469|NCT00477269|16951209|P2|Core Study|Withdrawn Consent|1
4922470|NCT00477269|16951210|P1|Core Study|Withdrawn Consent|0
4922471|NCT00477269|16951208|P3|Core Study|Death|0
4922472|NCT00477269|16951209|P2|Core Study|Death|3
4922473|NCT00477269|16951210|P1|Core Study|Death|3
4922474|NCT00477269|16951208|P3|Core Study|Adverse Event|0
4922475|NCT00477269|16951209|P2|Core Study|Adverse Event|4
4922476|NCT00477269|16951210|P1|Core Study|Adverse Event|6
4922477|NCT00477165|16951289|P2|Overall Study|Adverse Event|2
4922478|NCT00477165|16951290|P1|Overall Study|Adverse Event|7
4922479|NCT00477152|16951302|P1|Overall Study|Adverse Event|1
4922480|NCT00477152|16951302|P1|Overall Study|Parent withdrew consent|2
4922481|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Early termination of the study|578
4922482|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Early termination of the study|0
4922483|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Early termination of the study|0
4922484|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Early termination of the study|0
4922485|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4
4922486|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
4922487|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
4922488|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0
4922489|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Lost to Follow-up|4
4922490|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Lost to Follow-up|0
4922491|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Lost to Follow-up|0
4922492|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Lost to Follow-up|0
4922493|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Lack of Efficacy|13
4922494|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Lack of Efficacy|0
4922495|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Lack of Efficacy|0
4922496|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Lack of Efficacy|0
4922497|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Death|7
4922498|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Death|0
4922499|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Death|0
4922500|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Death|0
4922501|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Adverse Event|8
4922502|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Adverse Event|0
4922503|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Adverse Event|0
4922504|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Adverse Event|0
4922505|NCT00476996|16951318|P4|OLE Phase (From Week 48)|Withdrawal by Subject|50
4922506|NCT00476996|16951319|P3|OLE Phase (From Week 48)|Withdrawal by Subject|0
4922507|NCT00476996|16951320|P2|OLE Phase (From Week 48)|Withdrawal by Subject|0
4922508|NCT00476996|16951321|P1|OLE Phase (From Week 48)|Withdrawal by Subject|0
4922509|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Adverse Event|0
4922510|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Adverse Event|7
4922511|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Adverse Event|13
4922512|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Adverse Event|11
4922513|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Death|0
4922514|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Death|1
4922515|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Death|1
4922516|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Death|2
4922517|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0
4922518|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6
4922519|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5
4922520|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22
4922521|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
4922522|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3
4922523|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4
4922524|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0
4922525|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
4922526|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
4922527|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2
4922528|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0
4922529|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0
4922530|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21
4922531|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20
4922532|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24
4922533|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
4922534|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0
4922535|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3
4922536|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1
4922537|NCT00476996|16951318|P4|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0
4922538|NCT00476996|16951319|P3|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
4922539|NCT00476996|16951320|P2|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7
4922540|NCT00476996|16951321|P1|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12
4922541|NCT00476957|16951353|P2|Overall Study|Lost to Follow-up|193
4922542|NCT00476957|16951354|P1|Overall Study|Lost to Follow-up|176
4922543|NCT00476593|16951418|P4|Overall Study|Lost to Follow-up|22
4922544|NCT00476593|16951419|P3|Overall Study|Lost to Follow-up|8
4922545|NCT00476593|16951420|P2|Overall Study|Lost to Follow-up|2
4922546|NCT00476593|16951421|P1|Overall Study|Lost to Follow-up|10
4922547|NCT00476476|16951433|P2|Overall Study|Progressive Disease|17
4922548|NCT00476476|16951434|P1|Overall Study|Progressive Disease|0
4922549|NCT00476476|16951433|P2|Overall Study|Adverse Event|7
4922550|NCT00476476|16951434|P1|Overall Study|Adverse Event|2
4922551|NCT00476229|16951452|P1|Overall Study|Progressive shortness of breath|1
4922552|NCT00476151|16951458|P2|Overall Study|Physician Decision|2
4922553|NCT00476151|16951459|P1|Overall Study|Physician Decision|0
4922554|NCT00476151|16951458|P2|Overall Study|Withdrawal by Subject|0
4922555|NCT00476151|16951459|P1|Overall Study|Withdrawal by Subject|2
4922556|NCT00476151|16951458|P2|Overall Study|Protocol Violation|3
4922557|NCT00476151|16951459|P1|Overall Study|Protocol Violation|1
4922558|NCT00476151|16951458|P2|Overall Study|Adverse Event|2
4922559|NCT00476151|16951459|P1|Overall Study|Adverse Event|0
4922560|NCT00476086|16951465|P1|Overall Study|Progressive Disease|4
4922561|NCT00476086|16951465|P1|Overall Study|Alternative therapy|1
4922562|NCT00476047|16951471|P1|Overall Study|Lost to Follow-up|1
4922563|NCT00476008|16951497|P2|Overall Study|Death|0
4922564|NCT00476008|16951498|P1|Overall Study|Death|1
4922565|NCT00476008|16951497|P2|Overall Study|Withdrawal by Subject|1
4922566|NCT00476008|16951498|P1|Overall Study|Withdrawal by Subject|0
4922567|NCT00476008|16951497|P2|Overall Study|Physician Decision: Medication Noncompli|1
4922568|NCT00476008|16951498|P1|Overall Study|Physician Decision: Medication Noncompli|2
4922569|NCT00476008|16951497|P2|Overall Study|Placebo concerns|2
4922570|NCT00476008|16951498|P1|Overall Study|Placebo concerns|2
4922571|NCT00476008|16951497|P2|Overall Study|Adverse Event|4
4922572|NCT00476008|16951498|P1|Overall Study|Adverse Event|4
4922573|NCT00475982|16951524|P2|Overall Study|surgery rescheduled|3
4922574|NCT00475982|16951525|P1|Overall Study|surgery rescheduled|7
4922575|NCT00475865|16951573|P3|Overall Study|Other than above|0
4922576|NCT00475865|16951574|P2|Overall Study|Other than above|1
4922577|NCT00475865|16951575|P1|Overall Study|Other than above|0
4922578|NCT00475865|16951573|P3|Overall Study|Participant did not wish to continue|0
4922579|NCT00475865|16951574|P2|Overall Study|Participant did not wish to continue|0
4922580|NCT00475865|16951575|P1|Overall Study|Participant did not wish to continue|1
4922581|NCT00475865|16951573|P3|Overall Study|Progressive disease|2
4922582|NCT00475865|16951574|P2|Overall Study|Progressive disease|1
4922583|NCT00475865|16951575|P1|Overall Study|Progressive disease|0
4922584|NCT00475865|16951573|P3|Overall Study|Lack of Efficacy|0
4922585|NCT00475865|16951574|P2|Overall Study|Lack of Efficacy|0
4922586|NCT00475865|16951575|P1|Overall Study|Lack of Efficacy|1
4922587|NCT00475865|16951573|P3|Overall Study|Adverse Event|4
4922588|NCT00475865|16951574|P2|Overall Study|Adverse Event|3
4922589|NCT00475865|16951575|P1|Overall Study|Adverse Event|0
4922590|NCT00475852|16951605|P2|Overall Study|Lost to Follow-up|68
4922591|NCT00475852|16951606|P1|Overall Study|Lost to Follow-up|54
4922592|NCT00475852|16951605|P2|Overall Study|Withdrawal by Subject|24
4922593|NCT00475852|16951606|P1|Overall Study|Withdrawal by Subject|19
4922594|NCT00475852|16951605|P2|Overall Study|Death|456
4922595|NCT00475852|16951606|P1|Overall Study|Death|444
4922596|NCT00475735|16951657|P6|Treatment Period 2|Withdrawal by Subject|0
4922597|NCT00475735|16951658|P5|Treatment Period 2|Withdrawal by Subject|1
4922598|NCT00475735|16951659|P4|Treatment Period 2|Withdrawal by Subject|0
4922599|NCT00475735|16951660|P3|Treatment Period 2|Withdrawal by Subject|0
4922600|NCT00475735|16951661|P2|Treatment Period 2|Withdrawal by Subject|0
4922601|NCT00475735|16951662|P1|Treatment Period 2|Withdrawal by Subject|0
4922602|NCT00475735|16951657|P6|Treatment Period 2|Lack of Efficacy|1
4922603|NCT00475735|16951658|P5|Treatment Period 2|Lack of Efficacy|0
4922604|NCT00475735|16951659|P4|Treatment Period 2|Lack of Efficacy|0
4922605|NCT00475735|16951660|P3|Treatment Period 2|Lack of Efficacy|0
4922606|NCT00475735|16951661|P2|Treatment Period 2|Lack of Efficacy|0
4922607|NCT00475735|16951662|P1|Treatment Period 2|Lack of Efficacy|0
4922608|NCT00475735|16951657|P6|Treatment Period 2|Adverse Event|0
4922609|NCT00475735|16951658|P5|Treatment Period 2|Adverse Event|0
4922610|NCT00475735|16951659|P4|Treatment Period 2|Adverse Event|2
4922611|NCT00475735|16951660|P3|Treatment Period 2|Adverse Event|0
4922612|NCT00475735|16951661|P2|Treatment Period 2|Adverse Event|1
4922613|NCT00475735|16951662|P1|Treatment Period 2|Adverse Event|0
4922614|NCT00475735|16951657|P6|Treatment Washout|Protocol Violation|0
4922615|NCT00475735|16951658|P5|Treatment Washout|Protocol Violation|0
4922616|NCT00475735|16951659|P4|Treatment Washout|Protocol Violation|0
4922617|NCT00475735|16951660|P3|Treatment Washout|Protocol Violation|0
4922618|NCT00475735|16951661|P2|Treatment Washout|Protocol Violation|1
4922619|NCT00475735|16951662|P1|Treatment Washout|Protocol Violation|0
4922620|NCT00475735|16951657|P6|Treatment Washout|Lost to Follow-up|0
4922621|NCT00475735|16951658|P5|Treatment Washout|Lost to Follow-up|0
4922622|NCT00475735|16951659|P4|Treatment Washout|Lost to Follow-up|0
4922623|NCT00475735|16951660|P3|Treatment Washout|Lost to Follow-up|0
4922624|NCT00475735|16951661|P2|Treatment Washout|Lost to Follow-up|1
4922625|NCT00475735|16951662|P1|Treatment Washout|Lost to Follow-up|0
4922626|NCT00475735|16951657|P6|Treatment Period 1|DC due to no efficacy but Continuing|0
4922627|NCT00475735|16951658|P5|Treatment Period 1|DC due to no efficacy but Continuing|0
4922628|NCT00475735|16951659|P4|Treatment Period 1|DC due to no efficacy but Continuing|0
4922629|NCT00475735|16951660|P3|Treatment Period 1|DC due to no efficacy but Continuing|0
4922630|NCT00475735|16951661|P2|Treatment Period 1|DC due to no efficacy but Continuing|1
4922631|NCT00475735|16951662|P1|Treatment Period 1|DC due to no efficacy but Continuing|0
4922632|NCT00475735|16951657|P6|Treatment Period 1|DC due to AE but continuing|2
4922633|NCT00475735|16951658|P5|Treatment Period 1|DC due to AE but continuing|2
4922634|NCT00475735|16951659|P4|Treatment Period 1|DC due to AE but continuing|1
4922635|NCT00475735|16951660|P3|Treatment Period 1|DC due to AE but continuing|0
4922636|NCT00475735|16951661|P2|Treatment Period 1|DC due to AE but continuing|0
4922637|NCT00475735|16951662|P1|Treatment Period 1|DC due to AE but continuing|0
4922638|NCT00475735|16951657|P6|Treatment Period 1|Withdrawal by Subject|0
4922639|NCT00475735|16951658|P5|Treatment Period 1|Withdrawal by Subject|0
4922640|NCT00475735|16951659|P4|Treatment Period 1|Withdrawal by Subject|0
4922641|NCT00475735|16951660|P3|Treatment Period 1|Withdrawal by Subject|0
4922642|NCT00475735|16951661|P2|Treatment Period 1|Withdrawal by Subject|1
4922643|NCT00475735|16951662|P1|Treatment Period 1|Withdrawal by Subject|1
4922644|NCT00475735|16951657|P6|Treatment Period 1|Protocol Violation|0
4922645|NCT00475735|16951658|P5|Treatment Period 1|Protocol Violation|0
4922646|NCT00475735|16951659|P4|Treatment Period 1|Protocol Violation|1
4922647|NCT00475735|16951660|P3|Treatment Period 1|Protocol Violation|0
4922648|NCT00475735|16951661|P2|Treatment Period 1|Protocol Violation|0
4922649|NCT00475735|16951662|P1|Treatment Period 1|Protocol Violation|0
4922650|NCT00475735|16951657|P6|Treatment Period 1|Lost to Follow-up|1
4922651|NCT00475735|16951658|P5|Treatment Period 1|Lost to Follow-up|0
4922652|NCT00475735|16951659|P4|Treatment Period 1|Lost to Follow-up|0
4922653|NCT00475735|16951660|P3|Treatment Period 1|Lost to Follow-up|0
4922654|NCT00475735|16951661|P2|Treatment Period 1|Lost to Follow-up|0
4922655|NCT00475735|16951662|P1|Treatment Period 1|Lost to Follow-up|0
4922656|NCT00475735|16951657|P6|Treatment Period 1|Lack of Efficacy|0
4922657|NCT00475735|16951658|P5|Treatment Period 1|Lack of Efficacy|0
4922658|NCT00475735|16951659|P4|Treatment Period 1|Lack of Efficacy|0
4922659|NCT00475735|16951660|P3|Treatment Period 1|Lack of Efficacy|0
4922660|NCT00475735|16951661|P2|Treatment Period 1|Lack of Efficacy|0
4922661|NCT00475735|16951662|P1|Treatment Period 1|Lack of Efficacy|1
4922662|NCT00475735|16951657|P6|Treatment Period 1|Adverse Event|0
4922663|NCT00475735|16951658|P5|Treatment Period 1|Adverse Event|0
4922664|NCT00475735|16951659|P4|Treatment Period 1|Adverse Event|0
4922665|NCT00475735|16951660|P3|Treatment Period 1|Adverse Event|0
4922666|NCT00475735|16951661|P2|Treatment Period 1|Adverse Event|0
4922667|NCT00475735|16951662|P1|Treatment Period 1|Adverse Event|2
4922668|NCT00475722|16951675|P2|Overall Study|Protocol Violation|0
4922669|NCT00475722|16951676|P1|Overall Study|Protocol Violation|3
4922670|NCT00475722|16951675|P2|Overall Study|Withdrawal by Subject|12
4922671|NCT00475722|16951676|P1|Overall Study|Withdrawal by Subject|12
4922672|NCT00475709|16951682|P1|Overall Study|Lost to Follow-up|21
4922673|NCT00475709|16951682|P1|Overall Study|Device Explant|6
4922674|NCT00475709|16951682|P1|Overall Study|Death|41
4922675|NCT00475709|16951682|P1|Overall Study|Did not meet eligibility criteria|8
4922676|NCT00475670|16951690|P2|Overall Study|Other|3
4922677|NCT00475670|16951691|P1|Overall Study|Other|0
4922678|NCT00475670|16951690|P2|Overall Study|Failure to Return|1
4922679|NCT00475670|16951691|P1|Overall Study|Failure to Return|0
4922680|NCT00475670|16951690|P2|Overall Study|Refused treatment|2
4922681|NCT00475670|16951691|P1|Overall Study|Refused treatment|0
4922682|NCT00475670|16951690|P2|Overall Study|Lack of Efficacy|34
4922683|NCT00475670|16951691|P1|Overall Study|Lack of Efficacy|3
4922684|NCT00475670|16951690|P2|Overall Study|Death|1
4922685|NCT00475670|16951691|P1|Overall Study|Death|0
4922686|NCT00475657|16951715|P1|Overall Study|Sponsor's Decision|3
4922687|NCT00475657|16951715|P1|Overall Study|Death|1
4922688|NCT00475644|16951723|P1|Overall Study|Protocol Violation|13
4922689|NCT00475423|16951788|P1|Overall Study|Lost to Follow-up|7
4922690|NCT00475423|16951788|P1|Overall Study|Reason not specified|1
4922691|NCT00475423|16951788|P1|Overall Study|Death|1
4922692|NCT00475423|16951788|P1|Overall Study|Lack of Efficacy|8
4922693|NCT00475423|16951788|P1|Overall Study|Withdrawal by Subject|6
4922694|NCT00475423|16951788|P1|Overall Study|Adverse Event|4
4922695|NCT00475423|16951788|P1|Overall Study|Protocol Violation|5
4922696|NCT00475306|16951834|P4|Overall Study|Protocol Violation|1
4922697|NCT00475306|16951835|P3|Overall Study|Protocol Violation|0
4922698|NCT00475306|16951836|P2|Overall Study|Protocol Violation|1
4922699|NCT00475306|16951837|P1|Overall Study|Protocol Violation|1
4922700|NCT00475228|16951868|P2|Overall Study|Lost to Follow-up|17
4922701|NCT00475228|16951869|P1|Overall Study|Lost to Follow-up|17
4922702|NCT00475176|16951908|P1|Overall Study|Protocol Violation|1
4922703|NCT00475176|16951908|P1|Overall Study|Withdrawal by Subject|1
4922704|NCT00475176|16951908|P1|Overall Study|Adverse Event|2
4922705|NCT00475033|16951948|P2|Toddler Dose|Lost to Follow-up|0
4922706|NCT00475033|16951949|P1|Toddler Dose|Lost to Follow-up|1
4922707|NCT00475033|16951948|P2|Toddler Dose|Failed to return|0
4922708|NCT00475033|16951949|P1|Toddler Dose|Failed to return|1
4922709|NCT00475033|16951948|P2|Toddler Dose|Parent or legal guardian request|0
4922710|NCT00475033|16951949|P1|Toddler Dose|Parent or legal guardian request|2
4922711|NCT00475033|16951948|P2|After the Infant Series|Other|1
4922712|NCT00475033|16951949|P1|After the Infant Series|Other|0
4922713|NCT00475033|16951948|P2|After the Infant Series|Lost to Follow-up|0
4922714|NCT00475033|16951949|P1|After the Infant Series|Lost to Follow-up|1
4922715|NCT00475033|16951948|P2|After the Infant Series|Protocol Violation|0
4922716|NCT00475033|16951949|P1|After the Infant Series|Protocol Violation|1
4922717|NCT00475033|16951948|P2|After the Infant Series|Failed to return|1
4922718|NCT00475033|16951949|P1|After the Infant Series|Failed to return|2
4922719|NCT00475033|16951948|P2|After the Infant Series|Parent or legal guardian request|2
4922720|NCT00475033|16951949|P1|After the Infant Series|Parent or legal guardian request|2
4922721|NCT00475033|16951948|P2|After the Infant Series|Adverse Event|4
4922722|NCT00475033|16951949|P1|After the Infant Series|Adverse Event|0
4922723|NCT00475033|16951948|P2|Infant Series|Adverse Event|2
4922724|NCT00475033|16951949|P1|Infant Series|Adverse Event|0
4922725|NCT00475033|16951948|P2|Infant Series|Lost to Follow-up|0
4922726|NCT00475033|16951949|P1|Infant Series|Lost to Follow-up|2
4922727|NCT00475033|16951948|P2|Infant Series|Protocol Violation|2
4922728|NCT00475033|16951949|P1|Infant Series|Protocol Violation|1
4922729|NCT00475033|16951948|P2|Infant Series|Parent or legal guardian request|5
4922730|NCT00475033|16951949|P1|Infant Series|Parent or legal guardian request|1
4922731|NCT00475033|16951948|P2|Infant Series|Failed to return|4
4922732|NCT00475033|16951949|P1|Infant Series|Failed to return|3
4922733|NCT00475020|16951997|P1|Overall Study|Donor not able to donate the last minute|1
4922734|NCT00475020|16951997|P1|Overall Study|Insurance Denial|1
4922735|NCT00475020|16951997|P1|Overall Study|Physician Decision|3
4922736|NCT00474994|16952002|P1|Overall Study|Patient found to be ineligible|1
4922737|NCT00474994|16952002|P1|Overall Study|Patient evaluable for toxicity only|3
4922738|NCT00474994|16952002|P1|Overall Study|Patient Not treated|1
4922739|NCT00474968|16952008|P2|Overall Study|Sample not collected|1
4922740|NCT00474968|16952009|P1|Overall Study|Sample not collected|1
4922741|NCT00474968|16952008|P2|Overall Study|Protocol Violation|8
4922742|NCT00474968|16952009|P1|Overall Study|Protocol Violation|9
4922743|NCT00474968|16952008|P2|Overall Study|Withdrawal by Subject|7
4922744|NCT00474968|16952009|P1|Overall Study|Withdrawal by Subject|8
4922745|NCT00474955|16952019|P1|Overall Study|Personal reasons|5
4922746|NCT00474955|16952019|P1|Overall Study|Drug unavailability|1
4922747|NCT00474955|16952019|P1|Overall Study|Adverse Event|2
4922748|NCT00474929|16952035|P5|Overall Study|Physician Decision|0
4922749|NCT00474929|16952036|P4|Overall Study|Physician Decision|2
4922750|NCT00474929|16952037|P3|Overall Study|Physician Decision|1
4922751|NCT00474929|16952038|P2|Overall Study|Physician Decision|0
4922752|NCT00474929|16952039|P1|Overall Study|Physician Decision|0
4922753|NCT00474929|16952035|P5|Overall Study|Unrelated medical condition|0
4922754|NCT00474929|16952036|P4|Overall Study|Unrelated medical condition|0
4922755|NCT00474929|16952037|P3|Overall Study|Unrelated medical condition|1
4922756|NCT00474929|16952038|P2|Overall Study|Unrelated medical condition|0
4922757|NCT00474929|16952039|P1|Overall Study|Unrelated medical condition|0
4922758|NCT00474929|16952035|P5|Overall Study|Withdrawal by Subject|0
4922759|NCT00474929|16952036|P4|Overall Study|Withdrawal by Subject|0
4922760|NCT00474929|16952037|P3|Overall Study|Withdrawal by Subject|0
4922761|NCT00474929|16952038|P2|Overall Study|Withdrawal by Subject|1
4922762|NCT00474929|16952039|P1|Overall Study|Withdrawal by Subject|0
4922763|NCT00474903|16952056|P3|Overall Study|Protocol Violation|2
4922764|NCT00474903|16952057|P2|Overall Study|Protocol Violation|5
4922765|NCT00474903|16952058|P1|Overall Study|Protocol Violation|1
4922766|NCT00474812|16952080|P1|Overall Study|No Initiation of treatment|2
4922767|NCT00474812|16952080|P1|Overall Study|Withdrawal by Subject|5
4922768|NCT00474786|16952090|P2|Overall Study|Other|0
4922769|NCT00474786|16952091|P1|Overall Study|Other|5
4922770|NCT00474786|16952090|P2|Overall Study|Withdrawal by Subject|15
4922771|NCT00474786|16952091|P1|Overall Study|Withdrawal by Subject|15
4922772|NCT00474786|16952090|P2|Overall Study|Protocol Violation|0
4922773|NCT00474786|16952091|P1|Overall Study|Protocol Violation|2
4922774|NCT00474786|16952090|P2|Overall Study|Lost to Follow-up|7
4922775|NCT00474786|16952091|P1|Overall Study|Lost to Follow-up|4
4922776|NCT00474786|16952090|P2|Overall Study|Discontinuation of Study by Sponsor|59
4922777|NCT00474786|16952091|P1|Overall Study|Discontinuation of Study by Sponsor|42
4922778|NCT00474786|16952090|P2|Overall Study|Death|170
4922779|NCT00474786|16952091|P1|Overall Study|Death|189
4922780|NCT00474786|16952090|P2|Overall Study|Investigator Request|1
4922781|NCT00474786|16952091|P1|Overall Study|Investigator Request|2
4922782|NCT00474786|16952090|P2|Overall Study|Not Meeting Study Criteria|1
4922783|NCT00474786|16952091|P1|Overall Study|Not Meeting Study Criteria|0
4922784|NCT00474760|16952116|P7|Overall Study|Terminated by sponsor|2
4922785|NCT00474760|16952117|P6|Overall Study|Terminated by sponsor|0
4922786|NCT00474760|16952118|P5|Overall Study|Terminated by sponsor|0
4922787|NCT00474760|16952119|P4|Overall Study|Terminated by sponsor|0
4922788|NCT00474760|16952120|P3|Overall Study|Terminated by sponsor|0
4922789|NCT00474760|16952121|P2|Overall Study|Terminated by sponsor|0
4922790|NCT00474760|16952122|P1|Overall Study|Terminated by sponsor|0
4922791|NCT00474760|16952116|P7|Overall Study|Progressive disease|7
4922792|NCT00474760|16952117|P6|Overall Study|Progressive disease|20
4922793|NCT00474760|16952118|P5|Overall Study|Progressive disease|8
4922794|NCT00474760|16952119|P4|Overall Study|Progressive disease|2
4922795|NCT00474760|16952120|P3|Overall Study|Progressive disease|3
4922796|NCT00474760|16952121|P2|Overall Study|Progressive disease|2
4922797|NCT00474760|16952122|P1|Overall Study|Progressive disease|3
4922798|NCT00474760|16952116|P7|Overall Study|Other|0
4922799|NCT00474760|16952117|P6|Overall Study|Other|0
4922800|NCT00474760|16952118|P5|Overall Study|Other|1
4922801|NCT00474760|16952119|P4|Overall Study|Other|0
4922802|NCT00474760|16952120|P3|Overall Study|Other|0
4922803|NCT00474760|16952121|P2|Overall Study|Other|1
4922804|NCT00474760|16952122|P1|Overall Study|Other|0
4922805|NCT00474760|16952116|P7|Overall Study|Withdrawal by Subject|1
4922806|NCT00474760|16952117|P6|Overall Study|Withdrawal by Subject|1
4922807|NCT00474760|16952118|P5|Overall Study|Withdrawal by Subject|0
4922808|NCT00474760|16952119|P4|Overall Study|Withdrawal by Subject|1
4922809|NCT00474760|16952120|P3|Overall Study|Withdrawal by Subject|0
4922810|NCT00474760|16952121|P2|Overall Study|Withdrawal by Subject|0
4922811|NCT00474760|16952122|P1|Overall Study|Withdrawal by Subject|0
4922812|NCT00474760|16952116|P7|Overall Study|Laboratory abnormality|0
4922813|NCT00474760|16952117|P6|Overall Study|Laboratory abnormality|1
4922814|NCT00474760|16952118|P5|Overall Study|Laboratory abnormality|0
4922815|NCT00474760|16952119|P4|Overall Study|Laboratory abnormality|0
4922816|NCT00474760|16952120|P3|Overall Study|Laboratory abnormality|0
4922817|NCT00474760|16952121|P2|Overall Study|Laboratory abnormality|0
4922818|NCT00474760|16952122|P1|Overall Study|Laboratory abnormality|0
4922819|NCT00474760|16952116|P7|Overall Study|Adverse Event|0
4922820|NCT00474760|16952117|P6|Overall Study|Adverse Event|7
4922821|NCT00474760|16952118|P5|Overall Study|Adverse Event|1
4922822|NCT00474760|16952119|P4|Overall Study|Adverse Event|0
4922823|NCT00474760|16952120|P3|Overall Study|Adverse Event|0
4922824|NCT00474760|16952121|P2|Overall Study|Adverse Event|0
4922825|NCT00474760|16952122|P1|Overall Study|Adverse Event|0
4922826|NCT00474760|16952116|P7|Overall Study|Death|0
4922827|NCT00474760|16952117|P6|Overall Study|Death|0
4922828|NCT00474760|16952118|P5|Overall Study|Death|2
4922829|NCT00474760|16952119|P4|Overall Study|Death|0
4922830|NCT00474760|16952120|P3|Overall Study|Death|0
4922831|NCT00474760|16952121|P2|Overall Study|Death|0
4922832|NCT00474760|16952122|P1|Overall Study|Death|0
4922833|NCT00474708|16952229|P2|Overall Study|Physician Decision|6
4922834|NCT00474708|16952230|P1|Overall Study|Physician Decision|9
4922835|NCT00474708|16952229|P2|Overall Study|Lost to Follow-up|9
4922836|NCT00474708|16952230|P1|Overall Study|Lost to Follow-up|18
4922837|NCT00474708|16952229|P2|Overall Study|Lack of compliance|4
4922838|NCT00474708|16952230|P1|Overall Study|Lack of compliance|12
4922839|NCT00474708|16952229|P2|Overall Study|Withdrawal by Subject|0
4922840|NCT00474708|16952230|P1|Overall Study|Withdrawal by Subject|7
4922841|NCT00474708|16952229|P2|Overall Study|Suicide ideation/behavior|1
4922842|NCT00474708|16952230|P1|Overall Study|Suicide ideation/behavior|0
4922843|NCT00474708|16952229|P2|Overall Study|Lack of Efficacy|5
4922844|NCT00474708|16952230|P1|Overall Study|Lack of Efficacy|11
4922845|NCT00474630|16952240|P2|Overall Study|Drug noncompliance, other|4
4922846|NCT00474630|16952241|P1|Overall Study|Drug noncompliance, other|11
4922847|NCT00474630|16952240|P2|Overall Study|Lack of Efficacy|6
4922848|NCT00474630|16952241|P1|Overall Study|Lack of Efficacy|5
4922849|NCT00474630|16952240|P2|Overall Study|Protocol Violation|4
4922850|NCT00474630|16952241|P1|Overall Study|Protocol Violation|3
4922851|NCT00474630|16952240|P2|Overall Study|Withdrawal by Subject|15
4922852|NCT00474630|16952241|P1|Overall Study|Withdrawal by Subject|21
4922853|NCT00474630|16952240|P2|Overall Study|Lost to Follow-up|15
4922854|NCT00474630|16952241|P1|Overall Study|Lost to Follow-up|22
4922855|NCT00474630|16952240|P2|Overall Study|Adverse Event|26
4922856|NCT00474630|16952241|P1|Overall Study|Adverse Event|98
4922857|NCT00474539|16952334|P2|Toddler Dose|Protocol Violation|0
4922858|NCT00474539|16952335|P1|Toddler Dose|Protocol Violation|1
4922859|NCT00474539|16952334|P2|After Infant Series|Withdrawal by Subject|0
4922860|NCT00474539|16952335|P1|After Infant Series|Withdrawal by Subject|1
4922861|NCT00474539|16952334|P2|After Infant Series|Lost to Follow-up|0
4922862|NCT00474539|16952335|P1|After Infant Series|Lost to Follow-up|3
4922863|NCT00474539|16952334|P2|Infant Series|Protocol Violation|1
4922864|NCT00474539|16952335|P1|Infant Series|Protocol Violation|0
4922865|NCT00474539|16952334|P2|Infant Series|Lost to Follow-up|1
4922866|NCT00474539|16952335|P1|Infant Series|Lost to Follow-up|2
4922867|NCT00474539|16952334|P2|Infant Series|Randomization error|0
4922868|NCT00474539|16952335|P1|Infant Series|Randomization error|5
4922869|NCT00474539|16952334|P2|Infant Series|Withdrawal by Subject|4
4922870|NCT00474539|16952335|P1|Infant Series|Withdrawal by Subject|3
4922871|NCT00474526|16952400|P17|Overall Study|Withdrawal by Subject|1
4922872|NCT00474526|16952401|P16|Overall Study|Withdrawal by Subject|1
4922873|NCT00474526|16952402|P15|Overall Study|Withdrawal by Subject|22
4922874|NCT00474526|16952403|P14|Overall Study|Withdrawal by Subject|37
4922875|NCT00474526|16952404|P13|Overall Study|Withdrawal by Subject|4
4922876|NCT00474526|16952405|P12|Overall Study|Withdrawal by Subject|4
4922877|NCT00474526|16952406|P11|Overall Study|Withdrawal by Subject|5
4922878|NCT00474526|16952407|P10|Overall Study|Withdrawal by Subject|13
4922879|NCT00474526|16952408|P9|Overall Study|Withdrawal by Subject|4
4922880|NCT00474526|16952409|P8|Overall Study|Withdrawal by Subject|4
4922881|NCT00474526|16952410|P7|Overall Study|Withdrawal by Subject|12
4922882|NCT00474526|16952411|P6|Overall Study|Withdrawal by Subject|6
4922883|NCT00474526|16952412|P5|Overall Study|Withdrawal by Subject|38
4922884|NCT00474526|16952413|P4|Overall Study|Withdrawal by Subject|52
4922885|NCT00474526|16952414|P3|Overall Study|Withdrawal by Subject|21
4922886|NCT00474526|16952415|P2|Overall Study|Withdrawal by Subject|24
4922887|NCT00474526|16952416|P1|Overall Study|Withdrawal by Subject|9
4922888|NCT00474526|16952400|P17|Overall Study|UNABLE TO CLASSIFY|1
4922889|NCT00474526|16952401|P16|Overall Study|UNABLE TO CLASSIFY|6
4922890|NCT00474526|16952402|P15|Overall Study|UNABLE TO CLASSIFY|12
4922891|NCT00474526|16952403|P14|Overall Study|UNABLE TO CLASSIFY|20
4922892|NCT00474526|16952404|P13|Overall Study|UNABLE TO CLASSIFY|0
4922893|NCT00474526|16952405|P12|Overall Study|UNABLE TO CLASSIFY|0
4922894|NCT00474526|16952406|P11|Overall Study|UNABLE TO CLASSIFY|0
4922895|NCT00474526|16952407|P10|Overall Study|UNABLE TO CLASSIFY|3
4922896|NCT00474526|16952408|P9|Overall Study|UNABLE TO CLASSIFY|0
4922897|NCT00474526|16952409|P8|Overall Study|UNABLE TO CLASSIFY|1
4922898|NCT00474526|16952410|P7|Overall Study|UNABLE TO CLASSIFY|0
4922899|NCT00474526|16952411|P6|Overall Study|UNABLE TO CLASSIFY|2
4922900|NCT00474526|16952412|P5|Overall Study|UNABLE TO CLASSIFY|3
4922901|NCT00474526|16952413|P4|Overall Study|UNABLE TO CLASSIFY|1
4922902|NCT00474526|16952414|P3|Overall Study|UNABLE TO CLASSIFY|0
4922903|NCT00474526|16952415|P2|Overall Study|UNABLE TO CLASSIFY|0
4922904|NCT00474526|16952416|P1|Overall Study|UNABLE TO CLASSIFY|1
4922905|NCT00474526|16952400|P17|Overall Study|Protocol Violation|2
4922906|NCT00474526|16952401|P16|Overall Study|Protocol Violation|6
4922907|NCT00474526|16952402|P15|Overall Study|Protocol Violation|9
4922908|NCT00474526|16952403|P14|Overall Study|Protocol Violation|19
4922909|NCT00474526|16952404|P13|Overall Study|Protocol Violation|4
4922910|NCT00474526|16952405|P12|Overall Study|Protocol Violation|2
4922911|NCT00474526|16952406|P11|Overall Study|Protocol Violation|2
4922912|NCT00474526|16952407|P10|Overall Study|Protocol Violation|4
4922913|NCT00474526|16952408|P9|Overall Study|Protocol Violation|0
4922914|NCT00474526|16952409|P8|Overall Study|Protocol Violation|0
4922915|NCT00474526|16952410|P7|Overall Study|Protocol Violation|3
4922916|NCT00474526|16952411|P6|Overall Study|Protocol Violation|1
4922917|NCT00474526|16952412|P5|Overall Study|Protocol Violation|3
4922918|NCT00474526|16952413|P4|Overall Study|Protocol Violation|12
4922919|NCT00474526|16952414|P3|Overall Study|Protocol Violation|4
4922920|NCT00474526|16952415|P2|Overall Study|Protocol Violation|6
4922921|NCT00474526|16952416|P1|Overall Study|Protocol Violation|2
4922922|NCT00474526|16952400|P17|Overall Study|Lost to Follow-up|5
4922923|NCT00474526|16952401|P16|Overall Study|Lost to Follow-up|4
4922924|NCT00474526|16952402|P15|Overall Study|Lost to Follow-up|29
4922925|NCT00474526|16952403|P14|Overall Study|Lost to Follow-up|74
4922926|NCT00474526|16952404|P13|Overall Study|Lost to Follow-up|6
4922927|NCT00474526|16952405|P12|Overall Study|Lost to Follow-up|4
4922928|NCT00474526|16952406|P11|Overall Study|Lost to Follow-up|2
4922929|NCT00474526|16952407|P10|Overall Study|Lost to Follow-up|6
4922930|NCT00474526|16952408|P9|Overall Study|Lost to Follow-up|0
4922931|NCT00474526|16952409|P8|Overall Study|Lost to Follow-up|1
4922932|NCT00474526|16952410|P7|Overall Study|Lost to Follow-up|8
4922933|NCT00474526|16952411|P6|Overall Study|Lost to Follow-up|5
4922934|NCT00474526|16952412|P5|Overall Study|Lost to Follow-up|11
4922935|NCT00474526|16952413|P4|Overall Study|Lost to Follow-up|29
4922936|NCT00474526|16952414|P3|Overall Study|Lost to Follow-up|13
4922937|NCT00474526|16952415|P2|Overall Study|Lost to Follow-up|6
4922938|NCT00474526|16952416|P1|Overall Study|Lost to Follow-up|8
4922939|NCT00474526|16952400|P17|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922940|NCT00474526|16952401|P16|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922941|NCT00474526|16952402|P15|Overall Study|INAPPROPRIATE ENROLLMENT|2
4922942|NCT00474526|16952403|P14|Overall Study|INAPPROPRIATE ENROLLMENT|2
4922943|NCT00474526|16952404|P13|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922944|NCT00474526|16952405|P12|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922945|NCT00474526|16952406|P11|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922946|NCT00474526|16952407|P10|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922947|NCT00474526|16952408|P9|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922948|NCT00474526|16952409|P8|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922949|NCT00474526|16952410|P7|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922950|NCT00474526|16952411|P6|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922951|NCT00474526|16952412|P5|Overall Study|INAPPROPRIATE ENROLLMENT|2
4922952|NCT00474526|16952413|P4|Overall Study|INAPPROPRIATE ENROLLMENT|1
4922953|NCT00474526|16952414|P3|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922954|NCT00474526|16952415|P2|Overall Study|INAPPROPRIATE ENROLLMENT|1
4922955|NCT00474526|16952416|P1|Overall Study|INAPPROPRIATE ENROLLMENT|0
4922956|NCT00474526|16952400|P17|Overall Study|Death|0
4922957|NCT00474526|16952401|P16|Overall Study|Death|0
4922958|NCT00474526|16952402|P15|Overall Study|Death|0
4922959|NCT00474526|16952403|P14|Overall Study|Death|3
4922960|NCT00474526|16952404|P13|Overall Study|Death|0
4922961|NCT00474526|16952405|P12|Overall Study|Death|0
4922962|NCT00474526|16952406|P11|Overall Study|Death|0
4922963|NCT00474526|16952407|P10|Overall Study|Death|0
4922964|NCT00474526|16952408|P9|Overall Study|Death|0
4922965|NCT00474526|16952409|P8|Overall Study|Death|0
4922966|NCT00474526|16952410|P7|Overall Study|Death|0
4922967|NCT00474526|16952411|P6|Overall Study|Death|0
4922968|NCT00474526|16952412|P5|Overall Study|Death|0
4922969|NCT00474526|16952413|P4|Overall Study|Death|0
4922970|NCT00474526|16952414|P3|Overall Study|Death|0
4922971|NCT00474526|16952415|P2|Overall Study|Death|0
4922972|NCT00474526|16952416|P1|Overall Study|Death|0
4922973|NCT00474526|16952400|P17|Overall Study|Adverse Event|0
4922974|NCT00474526|16952401|P16|Overall Study|Adverse Event|1
4922975|NCT00474526|16952402|P15|Overall Study|Adverse Event|1
4922976|NCT00474526|16952403|P14|Overall Study|Adverse Event|0
4922977|NCT00474526|16952404|P13|Overall Study|Adverse Event|0
4922978|NCT00474526|16952405|P12|Overall Study|Adverse Event|0
4922979|NCT00474526|16952406|P11|Overall Study|Adverse Event|0
4922980|NCT00474526|16952407|P10|Overall Study|Adverse Event|0
4922981|NCT00474526|16952408|P9|Overall Study|Adverse Event|0
4922982|NCT00474526|16952409|P8|Overall Study|Adverse Event|0
4922983|NCT00474526|16952410|P7|Overall Study|Adverse Event|1
4922984|NCT00474526|16952411|P6|Overall Study|Adverse Event|1
4922985|NCT00474526|16952412|P5|Overall Study|Adverse Event|2
4922986|NCT00474526|16952413|P4|Overall Study|Adverse Event|4
4922987|NCT00474526|16952414|P3|Overall Study|Adverse Event|2
4922988|NCT00474526|16952415|P2|Overall Study|Adverse Event|0
4922989|NCT00474526|16952416|P1|Overall Study|Adverse Event|2
4922990|NCT00474526|16952400|P17|Overall Study|ADMINISTRATIVE REASON|0
4922991|NCT00474526|16952401|P16|Overall Study|ADMINISTRATIVE REASON|0
4922992|NCT00474526|16952402|P15|Overall Study|ADMINISTRATIVE REASON|2
4922993|NCT00474526|16952403|P14|Overall Study|ADMINISTRATIVE REASON|1
4922994|NCT00474526|16952404|P13|Overall Study|ADMINISTRATIVE REASON|1
4922995|NCT00474526|16952405|P12|Overall Study|ADMINISTRATIVE REASON|1
4922996|NCT00474526|16952406|P11|Overall Study|ADMINISTRATIVE REASON|1
4922997|NCT00474526|16952407|P10|Overall Study|ADMINISTRATIVE REASON|1
4922998|NCT00474526|16952408|P9|Overall Study|ADMINISTRATIVE REASON|2
4922999|NCT00474526|16952409|P8|Overall Study|ADMINISTRATIVE REASON|0
4923000|NCT00474526|16952410|P7|Overall Study|ADMINISTRATIVE REASON|1
4923001|NCT00474526|16952411|P6|Overall Study|ADMINISTRATIVE REASON|1
4923002|NCT00474526|16952412|P5|Overall Study|ADMINISTRATIVE REASON|9
4923003|NCT00474526|16952413|P4|Overall Study|ADMINISTRATIVE REASON|20
4923004|NCT00474526|16952414|P3|Overall Study|ADMINISTRATIVE REASON|9
4923005|NCT00474526|16952415|P2|Overall Study|ADMINISTRATIVE REASON|9
4923006|NCT00474526|16952416|P1|Overall Study|ADMINISTRATIVE REASON|11
4923007|NCT00474487|16952581|P4|Overall Study|Death|0
4923008|NCT00474487|16952582|P3|Overall Study|Death|0
4923009|NCT00474487|16952583|P2|Overall Study|Death|1
4923010|NCT00474487|16952584|P1|Overall Study|Death|0
4923011|NCT00474487|16952581|P4|Overall Study|Inappropriate enrollment|0
4923012|NCT00474487|16952582|P3|Overall Study|Inappropriate enrollment|7
4923013|NCT00474487|16952583|P2|Overall Study|Inappropriate enrollment|0
4923014|NCT00474487|16952584|P1|Overall Study|Inappropriate enrollment|4
4923015|NCT00474487|16952581|P4|Overall Study|Lost to Follow-up|0
4923016|NCT00474487|16952582|P3|Overall Study|Lost to Follow-up|7
4923017|NCT00474487|16952583|P2|Overall Study|Lost to Follow-up|1
4923018|NCT00474487|16952584|P1|Overall Study|Lost to Follow-up|20
4923019|NCT00474487|16952581|P4|Overall Study|Withdrawal by Subject|0
4923020|NCT00474487|16952582|P3|Overall Study|Withdrawal by Subject|0
4923021|NCT00474487|16952583|P2|Overall Study|Withdrawal by Subject|0
4923022|NCT00474487|16952584|P1|Overall Study|Withdrawal by Subject|6
4923023|NCT00474383|16952604|P2|Extension|Progressive Disease|5
4923024|NCT00474383|16952605|P1|Extension|Progressive Disease|0
4923025|NCT00474383|16952604|P2|Between Main Study and Extension|Did Not Enter Extension Phase|0
4923026|NCT00474383|16952605|P1|Between Main Study and Extension|Did Not Enter Extension Phase|6
4923027|NCT00474383|16952604|P2|Main Study|Other|0
4923028|NCT00474383|16952605|P1|Main Study|Other|1
4923029|NCT00474383|16952604|P2|Main Study|Progressive Disease|0
4923030|NCT00474383|16952605|P1|Main Study|Progressive Disease|23
4923031|NCT00474383|16952604|P2|Main Study|Symptomatic Deterioration|0
4923032|NCT00474383|16952605|P1|Main Study|Symptomatic Deterioration|1
4923033|NCT00474383|16952604|P2|Main Study|Adverse Event|0
4923034|NCT00474383|16952605|P1|Main Study|Adverse Event|11
4923035|NCT00474266|16952620|P4|Overall Study|Withdrawal by Subject|7
4923036|NCT00474266|16952621|P3|Overall Study|Withdrawal by Subject|4
4923037|NCT00474266|16952622|P2|Overall Study|Withdrawal by Subject|20
4923038|NCT00474266|16952623|P1|Overall Study|Withdrawal by Subject|7
4923039|NCT00474253|16952727|P2|Overall Study|Discharged prior to study completion|1
4923040|NCT00474253|16952728|P1|Overall Study|Discharged prior to study completion|0
4923041|NCT00474253|16952727|P2|Overall Study|Lost to Follow-up|0
4923042|NCT00474253|16952728|P1|Overall Study|Lost to Follow-up|1
4923043|NCT00474253|16952727|P2|Overall Study|Withdrew due to surgery-related issues|3
4923044|NCT00474253|16952728|P1|Overall Study|Withdrew due to surgery-related issues|0
4923045|NCT00474253|16952727|P2|Overall Study|Withdrew consent|0
4923046|NCT00474253|16952728|P1|Overall Study|Withdrew consent|2
4923047|NCT00474240|16952752|P6|Overall Study|Removed due to lab value|1
4923048|NCT00474240|16952753|P5|Overall Study|Removed due to lab value|0
4923049|NCT00474240|16952754|P4|Overall Study|Removed due to lab value|0
4923050|NCT00474240|16952755|P3|Overall Study|Removed due to lab value|0
4923051|NCT00474240|16952756|P2|Overall Study|Removed due to lab value|0
4923052|NCT00474240|16952757|P1|Overall Study|Removed due to lab value|0
4923053|NCT00474240|16952752|P6|Overall Study|Adverse Event|16
4923054|NCT00474240|16952753|P5|Overall Study|Adverse Event|5
4923055|NCT00474240|16952754|P4|Overall Study|Adverse Event|14
4923056|NCT00474240|16952755|P3|Overall Study|Adverse Event|9
4923057|NCT00474240|16952756|P2|Overall Study|Adverse Event|0
4923058|NCT00474240|16952757|P1|Overall Study|Adverse Event|0
4923059|NCT00474240|16952752|P6|Overall Study|Withdrawal by Subject|1
4923060|NCT00474240|16952753|P5|Overall Study|Withdrawal by Subject|3
4923061|NCT00474240|16952754|P4|Overall Study|Withdrawal by Subject|2
4923062|NCT00474240|16952755|P3|Overall Study|Withdrawal by Subject|0
4923063|NCT00474240|16952756|P2|Overall Study|Withdrawal by Subject|1
4923064|NCT00474240|16952757|P1|Overall Study|Withdrawal by Subject|1
4923065|NCT00474188|16952782|P1|Overall Study|Study discontinued by sponsor|5
4923066|NCT00474188|16952782|P1|Overall Study|Withdrawal by Subject|1
4923067|NCT00474175|16952792|P3|Overall Study|Administrative|0
4923068|NCT00474175|16952793|P2|Overall Study|Administrative|1
4923069|NCT00474175|16952794|P1|Overall Study|Administrative|0
4923070|NCT00474175|16952792|P3|Overall Study|Protocol Violation|1
4923071|NCT00474175|16952793|P2|Overall Study|Protocol Violation|2
4923072|NCT00474175|16952794|P1|Overall Study|Protocol Violation|0
4923073|NCT00474175|16952792|P3|Overall Study|Ineligible|1
4923074|NCT00474175|16952793|P2|Overall Study|Ineligible|3
4923075|NCT00474175|16952794|P1|Overall Study|Ineligible|1
4923076|NCT00474175|16952792|P3|Overall Study|Withdrawal by Subject|1
4923077|NCT00474175|16952793|P2|Overall Study|Withdrawal by Subject|1
4923078|NCT00474175|16952794|P1|Overall Study|Withdrawal by Subject|0
4923079|NCT00474175|16952792|P3|Overall Study|Lack of Efficacy|1
4923080|NCT00474175|16952793|P2|Overall Study|Lack of Efficacy|0
4923081|NCT00474175|16952794|P1|Overall Study|Lack of Efficacy|0
4923082|NCT00474058|16952858|P2|Overall Study|Other|0
4923083|NCT00474058|16952859|P1|Overall Study|Other|2
4923084|NCT00474058|16952858|P2|Overall Study|Withdrawal by Subject|7
4923085|NCT00474058|16952859|P1|Overall Study|Withdrawal by Subject|11
4923086|NCT00474058|16952858|P2|Overall Study|Lack of Efficacy|4
4923087|NCT00474058|16952859|P1|Overall Study|Lack of Efficacy|0
4923088|NCT00474058|16952858|P2|Overall Study|Adverse Event|6
4923089|NCT00474058|16952859|P1|Overall Study|Adverse Event|11
4923090|NCT00474045|16952873|P2|Overall Study|Withdrawal criteria|50
4923091|NCT00474045|16952874|P1|Overall Study|Withdrawal criteria|60
4923092|NCT00474045|16952873|P2|Overall Study|Withdrawal by Subject|18
4923093|NCT00474045|16952874|P1|Overall Study|Withdrawal by Subject|16
4923094|NCT00474045|16952873|P2|Overall Study|Protocol Violation|12
4923095|NCT00474045|16952874|P1|Overall Study|Protocol Violation|10
4923096|NCT00474045|16952873|P2|Overall Study|Lost to Follow-up|1
4923097|NCT00474045|16952874|P1|Overall Study|Lost to Follow-up|1
4923098|NCT00474045|16952873|P2|Overall Study|Lack of Efficacy|9
4923099|NCT00474045|16952874|P1|Overall Study|Lack of Efficacy|0
4923100|NCT00474045|16952873|P2|Overall Study|Unclassified|3
4923101|NCT00474045|16952874|P1|Overall Study|Unclassified|1
4923102|NCT00474045|16952873|P2|Overall Study|Adverse Event|8
4923103|NCT00474045|16952874|P1|Overall Study|Adverse Event|18
4923104|NCT00473889|16952974|P2|Overall Study|Withdrawal by Subject|0
4923105|NCT00473889|16952975|P1|Overall Study|Withdrawal by Subject|5
4923106|NCT00473889|16952974|P2|Overall Study|Trial Terminated|6
4923107|NCT00473889|16952975|P1|Overall Study|Trial Terminated|3
4923108|NCT00473889|16952974|P2|Overall Study|Physician Decision|5
4923109|NCT00473889|16952975|P1|Overall Study|Physician Decision|10
4923110|NCT00473889|16952974|P2|Overall Study|Lost to Follow-up|1
4923111|NCT00473889|16952975|P1|Overall Study|Lost to Follow-up|2
4923112|NCT00473889|16952974|P2|Overall Study|Lack of Efficacy|29
4923113|NCT00473889|16952975|P1|Overall Study|Lack of Efficacy|28
4923114|NCT00473889|16952974|P2|Overall Study|Protocol Violation|2
4923115|NCT00473889|16952975|P1|Overall Study|Protocol Violation|4
4923116|NCT00473889|16952974|P2|Overall Study|Adverse Event|17
4923117|NCT00473889|16952975|P1|Overall Study|Adverse Event|30
4923118|NCT00473889|16952974|P2|Overall Study|Did not receive study medication|4
4923119|NCT00473889|16952975|P1|Overall Study|Did not receive study medication|1
4923120|NCT00473876|16952987|P2|Overall Study|Lost to Follow-up|1
4923121|NCT00473876|16952988|P1|Overall Study|Lost to Follow-up|3
4923122|NCT00473824|16953007|P2|Overall Study|Withdrawal by physician|0
4923123|NCT00473824|16953008|P1|Overall Study|Withdrawal by physician|1
4923124|NCT00473824|16953007|P2|Overall Study|Lost to Follow-up|0
4923125|NCT00473824|16953008|P1|Overall Study|Lost to Follow-up|1
4923126|NCT00473824|16953007|P2|Overall Study|Death|0
4923127|NCT00473824|16953008|P1|Overall Study|Death|1
4923128|NCT00473824|16953007|P2|Overall Study|Adverse Event|0
4923129|NCT00473824|16953008|P1|Overall Study|Adverse Event|1
4923130|NCT00473824|16953007|P2|Overall Study|Virologic Breakthrough|0
4923131|NCT00473824|16953008|P1|Overall Study|Virologic Breakthrough|1
4923132|NCT00473746|16953019|P5|Period 2 (Phase 2)|Reason not specified|3
4923133|NCT00473746|16953020|P4|Period 2 (Phase 2)|Reason not specified|0
4923134|NCT00473746|16953021|P3|Period 2 (Phase 2)|Reason not specified|0
4923135|NCT00473746|16953022|P2|Period 2 (Phase 2)|Reason not specified|0
4923136|NCT00473746|16953023|P1|Period 2 (Phase 2)|Reason not specified|0
4923137|NCT00473746|16953019|P5|Period 2 (Phase 2)|Progressive Disease|20
4923138|NCT00473746|16953020|P4|Period 2 (Phase 2)|Progressive Disease|0
4923139|NCT00473746|16953021|P3|Period 2 (Phase 2)|Progressive Disease|0
4923140|NCT00473746|16953022|P2|Period 2 (Phase 2)|Progressive Disease|0
4923141|NCT00473746|16953023|P1|Period 2 (Phase 2)|Progressive Disease|0
4923142|NCT00473746|16953019|P5|Period 2 (Phase 2)|Death|1
4923143|NCT00473746|16953020|P4|Period 2 (Phase 2)|Death|0
4923144|NCT00473746|16953021|P3|Period 2 (Phase 2)|Death|0
4923145|NCT00473746|16953022|P2|Period 2 (Phase 2)|Death|0
4923146|NCT00473746|16953023|P1|Period 2 (Phase 2)|Death|0
4923147|NCT00473746|16953019|P5|Period 2 (Phase 2)|Adverse Event|3
4923148|NCT00473746|16953020|P4|Period 2 (Phase 2)|Adverse Event|0
4923149|NCT00473746|16953021|P3|Period 2 (Phase 2)|Adverse Event|0
4923150|NCT00473746|16953022|P2|Period 2 (Phase 2)|Adverse Event|0
4923151|NCT00473746|16953023|P1|Period 2 (Phase 2)|Adverse Event|0
4923152|NCT00473746|16953019|P5|Period 1 (Phase 1)|Reason not specified|0
4923153|NCT00473746|16953020|P4|Period 1 (Phase 1)|Reason not specified|0
4923154|NCT00473746|16953021|P3|Period 1 (Phase 1)|Reason not specified|0
4923155|NCT00473746|16953022|P2|Period 1 (Phase 1)|Reason not specified|1
4923156|NCT00473746|16953023|P1|Period 1 (Phase 1)|Reason not specified|0
4923157|NCT00473746|16953019|P5|Period 1 (Phase 1)|Symptomatic Deterioration|0
4923158|NCT00473746|16953020|P4|Period 1 (Phase 1)|Symptomatic Deterioration|0
4923159|NCT00473746|16953021|P3|Period 1 (Phase 1)|Symptomatic Deterioration|0
4923160|NCT00473746|16953022|P2|Period 1 (Phase 1)|Symptomatic Deterioration|1
4923161|NCT00473746|16953023|P1|Period 1 (Phase 1)|Symptomatic Deterioration|0
4923162|NCT00473746|16953019|P5|Period 1 (Phase 1)|Progressive Disease|0
4923163|NCT00473746|16953020|P4|Period 1 (Phase 1)|Progressive Disease|10
4923164|NCT00473746|16953021|P3|Period 1 (Phase 1)|Progressive Disease|6
4923165|NCT00473746|16953022|P2|Period 1 (Phase 1)|Progressive Disease|6
4923166|NCT00473746|16953023|P1|Period 1 (Phase 1)|Progressive Disease|5
4923167|NCT00473746|16953019|P5|Period 1 (Phase 1)|Withdrawal by Subject|0
4923168|NCT00473746|16953020|P4|Period 1 (Phase 1)|Withdrawal by Subject|0
4923169|NCT00473746|16953021|P3|Period 1 (Phase 1)|Withdrawal by Subject|0
4923170|NCT00473746|16953022|P2|Period 1 (Phase 1)|Withdrawal by Subject|1
4923171|NCT00473746|16953023|P1|Period 1 (Phase 1)|Withdrawal by Subject|0
4923172|NCT00473746|16953019|P5|Period 1 (Phase 1)|Adverse Event|0
4923173|NCT00473746|16953020|P4|Period 1 (Phase 1)|Adverse Event|0
4923174|NCT00473746|16953021|P3|Period 1 (Phase 1)|Adverse Event|0
4923175|NCT00473746|16953022|P2|Period 1 (Phase 1)|Adverse Event|0
4923176|NCT00473746|16953023|P1|Period 1 (Phase 1)|Adverse Event|1
4923177|NCT00473694|16953072|P4|Overall Study|Lost to Follow-up|1
4923178|NCT00473694|16953073|P3|Overall Study|Lost to Follow-up|0
4923179|NCT00473694|16953074|P2|Overall Study|Lost to Follow-up|0
4923180|NCT00473694|16953075|P1|Overall Study|Lost to Follow-up|0
4923181|NCT00473694|16953072|P4|Overall Study|Participants did not receive treatment|6
4923182|NCT00473694|16953073|P3|Overall Study|Participants did not receive treatment|5
4923183|NCT00473694|16953074|P2|Overall Study|Participants did not receive treatment|3
4923184|NCT00473694|16953075|P1|Overall Study|Participants did not receive treatment|11
4923185|NCT00473694|16953072|P4|Overall Study|Adverse Event|0
4923186|NCT00473694|16953073|P3|Overall Study|Adverse Event|0
4923187|NCT00473694|16953074|P2|Overall Study|Adverse Event|1
4923188|NCT00473694|16953075|P1|Overall Study|Adverse Event|0
4923189|NCT00473668|16953116|P3|Overall Study|Other|4
4923190|NCT00473668|16953117|P2|Overall Study|Other|3
4923191|NCT00473668|16953118|P1|Overall Study|Other|2
4923192|NCT00473668|16953116|P3|Overall Study|Lost to Follow-up|6
4923193|NCT00473668|16953117|P2|Overall Study|Lost to Follow-up|4
4923194|NCT00473668|16953118|P1|Overall Study|Lost to Follow-up|0
4923195|NCT00473668|16953116|P3|Overall Study|Migrated/moved from study area|0
4923196|NCT00473668|16953117|P2|Overall Study|Migrated/moved from study area|2
4923197|NCT00473668|16953118|P1|Overall Study|Migrated/moved from study area|3
4923198|NCT00473668|16953116|P3|Overall Study|Withdrawal by Subject|0
4923199|NCT00473668|16953117|P2|Overall Study|Withdrawal by Subject|2
4923200|NCT00473668|16953118|P1|Overall Study|Withdrawal by Subject|0
4923201|NCT00473655|16953171|P3|Overall Study|Lost to Follow-up|8
4923202|NCT00473655|16953172|P2|Overall Study|Lost to Follow-up|5
4923203|NCT00473655|16953173|P1|Overall Study|Lost to Follow-up|9
4923204|NCT00473590|16953220|P2|Overall Study|Other|1
4923205|NCT00473590|16953221|P1|Overall Study|Other|0
4923206|NCT00473590|16953220|P2|Overall Study|Withdrawal by Subject|3
4923207|NCT00473590|16953221|P1|Overall Study|Withdrawal by Subject|5
4923208|NCT00473590|16953220|P2|Overall Study|Physician Decision|4
4923209|NCT00473590|16953221|P1|Overall Study|Physician Decision|2
4923210|NCT00473590|16953220|P2|Overall Study|Non-protocol-specified therapy|5
4923211|NCT00473590|16953221|P1|Overall Study|Non-protocol-specified therapy|7
4923212|NCT00473590|16953220|P2|Overall Study|Progression not resulting in death|20
4923213|NCT00473590|16953221|P1|Overall Study|Progression not resulting in death|24
4923214|NCT00473590|16953220|P2|Overall Study|Death|2
4923215|NCT00473590|16953221|P1|Overall Study|Death|4
4923216|NCT00473590|16953220|P2|Overall Study|Adverse Event|3
4923217|NCT00473590|16953221|P1|Overall Study|Adverse Event|3
4923218|NCT00473564|16953237|P1|Overall Study|robot surgery aborted in OR|23
4923219|NCT00473512|16953247|P5|Period 2 (Phase 2)|Other|0
4923220|NCT00473512|16953248|P4|Period 2 (Phase 2)|Other|3
4923221|NCT00473512|16953249|P3|Period 2 (Phase 2)|Other|0
4923222|NCT00473512|16953250|P2|Period 2 (Phase 2)|Other|0
4923223|NCT00473512|16953251|P1|Period 2 (Phase 2)|Other|1
4923224|NCT00473512|16953247|P5|Period 2 (Phase 2)|Symptomatic Deterioration|0
4923225|NCT00473512|16953248|P4|Period 2 (Phase 2)|Symptomatic Deterioration|1
4923226|NCT00473512|16953249|P3|Period 2 (Phase 2)|Symptomatic Deterioration|0
4923227|NCT00473512|16953250|P2|Period 2 (Phase 2)|Symptomatic Deterioration|0
4923228|NCT00473512|16953251|P1|Period 2 (Phase 2)|Symptomatic Deterioration|0
4923229|NCT00473512|16953247|P5|Period 2 (Phase 2)|Disease Progression|1
4923230|NCT00473512|16953248|P4|Period 2 (Phase 2)|Disease Progression|17
4923231|NCT00473512|16953249|P3|Period 2 (Phase 2)|Disease Progression|2
4923232|NCT00473512|16953250|P2|Period 2 (Phase 2)|Disease Progression|2
4923233|NCT00473512|16953251|P1|Period 2 (Phase 2)|Disease Progression|0
4923234|NCT00473512|16953247|P5|Period 2 (Phase 2)|Death|1
4923235|NCT00473512|16953248|P4|Period 2 (Phase 2)|Death|1
4923236|NCT00473512|16953249|P3|Period 2 (Phase 2)|Death|0
4923237|NCT00473512|16953250|P2|Period 2 (Phase 2)|Death|0
4923238|NCT00473512|16953251|P1|Period 2 (Phase 2)|Death|0
4923239|NCT00473512|16953247|P5|Period 2 (Phase 2)|Adverse Event|0
4923240|NCT00473512|16953248|P4|Period 2 (Phase 2)|Adverse Event|1
4923241|NCT00473512|16953249|P3|Period 2 (Phase 2)|Adverse Event|0
4923242|NCT00473512|16953250|P2|Period 2 (Phase 2)|Adverse Event|0
4923243|NCT00473512|16953251|P1|Period 2 (Phase 2)|Adverse Event|0
4923244|NCT00473512|16953247|P5|Period 1 (Phase 1)|Other|0
4923245|NCT00473512|16953248|P4|Period 1 (Phase 1)|Other|1
4923246|NCT00473512|16953249|P3|Period 1 (Phase 1)|Other|0
4923247|NCT00473512|16953250|P2|Period 1 (Phase 1)|Other|0
4923248|NCT00473512|16953251|P1|Period 1 (Phase 1)|Other|0
4923249|NCT00473512|16953247|P5|Period 1 (Phase 1)|Disease Progression|1
4923250|NCT00473512|16953248|P4|Period 1 (Phase 1)|Disease Progression|10
4923251|NCT00473512|16953249|P3|Period 1 (Phase 1)|Disease Progression|0
4923252|NCT00473512|16953250|P2|Period 1 (Phase 1)|Disease Progression|1
4923253|NCT00473512|16953251|P1|Period 1 (Phase 1)|Disease Progression|1
4923254|NCT00473512|16953247|P5|Period 1 (Phase 1)|Death|0
4923255|NCT00473512|16953248|P4|Period 1 (Phase 1)|Death|1
4923256|NCT00473512|16953249|P3|Period 1 (Phase 1)|Death|0
4923257|NCT00473512|16953250|P2|Period 1 (Phase 1)|Death|0
4923258|NCT00473512|16953251|P1|Period 1 (Phase 1)|Death|0
4923259|NCT00473512|16953247|P5|Period 1 (Phase 1)|Adverse Event|0
4923260|NCT00473512|16953248|P4|Period 1 (Phase 1)|Adverse Event|5
4923261|NCT00473512|16953249|P3|Period 1 (Phase 1)|Adverse Event|0
4923262|NCT00473512|16953250|P2|Period 1 (Phase 1)|Adverse Event|0
4923263|NCT00473512|16953251|P1|Period 1 (Phase 1)|Adverse Event|0
4923264|NCT00473434|16953309|P1|Overall Study|No longer required|1
4923265|NCT00473434|16953309|P1|Overall Study|Switching to trial medication|1
4923266|NCT00473434|16953309|P1|Overall Study|Ceased in favor of Paliperidone|1
4923267|NCT00473434|16953309|P1|Overall Study|Reason not specified|6
4923268|NCT00473434|16953309|P1|Overall Study|Safety evaluation|1
4923269|NCT00473434|16953309|P1|Overall Study|Patient was selling medication to others|1
4923270|NCT00473434|16953309|P1|Overall Study|Adverse Event|3
4923271|NCT00473434|16953309|P1|Overall Study|Lack of Efficacy|3
4923272|NCT00473434|16953309|P1|Overall Study|Compliance|3
4923273|NCT00473434|16953309|P1|Overall Study|Withdrawal by Subject|9
4923274|NCT00473434|16953309|P1|Overall Study|Physician Decision|3
4923275|NCT00473382|16953374|P3|Open-label Extension Through Month 60|Subject Required Other Intervention|0
4923276|NCT00473382|16953375|P2|Open-label Extension Through Month 60|Subject Required Other Intervention|1
4923277|NCT00473382|16953376|P1|Open-label Extension Through Month 60|Subject Required Other Intervention|2
4923278|NCT00473382|16953374|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69
4923279|NCT00473382|16953375|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70
4923280|NCT00473382|16953376|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75
4923281|NCT00473382|16953374|P3|Open-label Extension Through Month 60|Subject's Decision|6
4923282|NCT00473382|16953375|P2|Open-label Extension Through Month 60|Subject's Decision|1
4923283|NCT00473382|16953376|P1|Open-label Extension Through Month 60|Subject's Decision|7
4923284|NCT00473382|16953374|P3|Open-label Extension Through Month 60|Lost to Follow-up|1
4923285|NCT00473382|16953375|P2|Open-label Extension Through Month 60|Lost to Follow-up|3
4923286|NCT00473382|16953376|P1|Open-label Extension Through Month 60|Lost to Follow-up|1
4923287|NCT00473382|16953374|P3|Open-label Extension Through Month 60|Death|4
4923288|NCT00473382|16953375|P2|Open-label Extension Through Month 60|Death|7
4923289|NCT00473382|16953376|P1|Open-label Extension Through Month 60|Death|1
4923290|NCT00473382|16953374|P3|Open-label Extension Through Month 60|Adverse Event|2
4923291|NCT00473382|16953375|P2|Open-label Extension Through Month 60|Adverse Event|0
4923292|NCT00473382|16953376|P1|Open-label Extension Through Month 60|Adverse Event|0
4923293|NCT00473382|16953374|P3|Open-label Extension Through Month 48|Subject Required Other Intervention|0
4923294|NCT00473382|16953375|P2|Open-label Extension Through Month 48|Subject Required Other Intervention|1
4923295|NCT00473382|16953376|P1|Open-label Extension Through Month 48|Subject Required Other Intervention|2
4923296|NCT00473382|16953374|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36
4923297|NCT00473382|16953375|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34
4923298|NCT00473382|16953376|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41
4923299|NCT00473382|16953374|P3|Open-label Extension Through Month 48|Subject's Decision|6
4923300|NCT00473382|16953375|P2|Open-label Extension Through Month 48|Subject's Decision|1
4923301|NCT00473382|16953376|P1|Open-label Extension Through Month 48|Subject's Decision|5
4923302|NCT00473382|16953374|P3|Open-label Extension Through Month 48|Lost to Follow-up|1
4923303|NCT00473382|16953375|P2|Open-label Extension Through Month 48|Lost to Follow-up|2
4923304|NCT00473382|16953376|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
4923305|NCT00473382|16953374|P3|Open-label Extension Through Month 48|Death|3
4923306|NCT00473382|16953375|P2|Open-label Extension Through Month 48|Death|3
4923307|NCT00473382|16953376|P1|Open-label Extension Through Month 48|Death|1
4923308|NCT00473382|16953374|P3|Open-label Extension Through Month 48|Adverse Event|1
4923309|NCT00473382|16953375|P2|Open-label Extension Through Month 48|Adverse Event|0
4923310|NCT00473382|16953376|P1|Open-label Extension Through Month 48|Adverse Event|0
4923311|NCT00473382|16953374|P3|Core Study|Subject's decision|10
4923312|NCT00473382|16953375|P2|Core Study|Subject's decision|11
4923313|NCT00473382|16953376|P1|Core Study|Subject's decision|12
4923314|NCT00473382|16953374|P3|Core Study|Subject needed other treatment|2
4923315|NCT00473382|16953375|P2|Core Study|Subject needed other treatment|3
4923316|NCT00473382|16953376|P1|Core Study|Subject needed other treatment|1
4923317|NCT00473382|16953374|P3|Core Study|Subject non-compliance|1
4923318|NCT00473382|16953375|P2|Core Study|Subject non-compliance|2
4923319|NCT00473382|16953376|P1|Core Study|Subject non-compliance|5
4923320|NCT00473382|16953374|P3|Core Study|Physician Decision|2
4923321|NCT00473382|16953375|P2|Core Study|Physician Decision|2
4923322|NCT00473382|16953376|P1|Core Study|Physician Decision|1
4923323|NCT00473382|16953374|P3|Core Study|Lost to Follow-up|3
4923324|NCT00473382|16953375|P2|Core Study|Lost to Follow-up|3
4923325|NCT00473382|16953376|P1|Core Study|Lost to Follow-up|3
4923326|NCT00473382|16953374|P3|Core Study|Death|10
4923327|NCT00473382|16953375|P2|Core Study|Death|5
4923328|NCT00473382|16953376|P1|Core Study|Death|3
4923329|NCT00473382|16953374|P3|Core Study|Adverse Event|1
4923330|NCT00473382|16953375|P2|Core Study|Adverse Event|1
4923331|NCT00473382|16953376|P1|Core Study|Adverse Event|3
4923332|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Subject Required Other Therapy|1
4923410|NCT00472446|16953601|P3|Overall Study|Questionnaires not returned|6
4923333|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Subject Required Other Therapy|0
4923334|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Subject Required Other Therapy|1
4923335|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Subject Non-compliance|0
4923336|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Subject Non-compliance|1
4923337|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Subject Non-compliance|2
4923338|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62
4923339|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71
4923340|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77
4923341|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Subject's Decision|4
4923342|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Subject's Decision|3
4923343|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Subject's Decision|1
4923344|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Physician's Decision|3
4923345|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Physician's Decision|1
4923346|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Physician's Decision|2
4923347|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Lost to Follow-up|4
4923348|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Lost to Follow-up|0
4923349|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Lost to Follow-up|3
4923350|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Death|1
4923351|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Death|2
4923352|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Death|2
4923353|NCT00473330|16953434|P3|Open-label Extension Through Month 60|Adverse Event|2
4923354|NCT00473330|16953435|P2|Open-label Extension Through Month 60|Adverse Event|0
4923355|NCT00473330|16953436|P1|Open-label Extension Through Month 60|Adverse Event|0
4923356|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Subject Required Other Therapy|1
4923357|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Subject Required Other Therapy|0
4923358|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Subject Required Other Therapy|0
4923359|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Subject Non-compliance|0
4923360|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Subject Non-compliance|1
4923361|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Subject Non-compliance|2
4923362|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16
4923363|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15
4923364|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18
4923365|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Subject's Decision|3
4923366|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Subject's Decision|3
4923367|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Subject's Decision|1
4923368|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Physician's Decision|3
4923369|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Physician's Decision|1
4923370|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Physician's Decision|2
4923371|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Lost to Follow-up|2
4923372|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Lost to Follow-up|0
4923373|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Lost to Follow-up|1
4923374|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Death|0
4923375|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Death|0
4923376|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Death|2
4923377|NCT00473330|16953434|P3|Open-label Extension Through Month 48|Adverse Event|2
4923378|NCT00473330|16953435|P2|Open-label Extension Through Month 48|Adverse Event|0
4923379|NCT00473330|16953436|P1|Open-label Extension Through Month 48|Adverse Event|0
4923380|NCT00473330|16953434|P3|Core Study|Subject's Decision|19
4923381|NCT00473330|16953435|P2|Core Study|Subject's Decision|8
4923382|NCT00473330|16953436|P1|Core Study|Subject's Decision|9
4923383|NCT00473330|16953434|P3|Core Study|Subject Required Other Therapy|3
4923384|NCT00473330|16953435|P2|Core Study|Subject Required Other Therapy|1
4923385|NCT00473330|16953436|P1|Core Study|Subject Required Other Therapy|0
4923386|NCT00473330|16953434|P3|Core Study|Subject Non-compliance|1
4923387|NCT00473330|16953435|P2|Core Study|Subject Non-compliance|2
4923388|NCT00473330|16953436|P1|Core Study|Subject Non-compliance|1
4923389|NCT00473330|16953434|P3|Core Study|Physician Decision|3
4923390|NCT00473330|16953435|P2|Core Study|Physician Decision|1
4923391|NCT00473330|16953436|P1|Core Study|Physician Decision|2
4923392|NCT00473330|16953434|P3|Core Study|Lost to Follow-up|10
4923393|NCT00473330|16953435|P2|Core Study|Lost to Follow-up|5
4923394|NCT00473330|16953436|P1|Core Study|Lost to Follow-up|5
4923395|NCT00473330|16953434|P3|Core Study|Death|4
4923396|NCT00473330|16953435|P2|Core Study|Death|4
4923397|NCT00473330|16953436|P1|Core Study|Death|6
4923398|NCT00473330|16953434|P3|Core Study|Adverse Event|1
4923399|NCT00473330|16953435|P2|Core Study|Adverse Event|4
4923400|NCT00473330|16953436|P1|Core Study|Adverse Event|4
4923401|NCT00473265|16953491|P1|Overall Study|Off treatment early|15
4923402|NCT00473265|16953491|P1|Overall Study|Unrelated adverse event|5
4923403|NCT00473083|16953503|P3|Overall Study|Adverse Event|0
4923404|NCT00473083|16953504|P2|Overall Study|Adverse Event|0
4923405|NCT00473083|16953505|P1|Overall Study|Adverse Event|1
4923406|NCT00472641|16953580|P1|Overall Study|Lost to Follow-up|1
4923407|NCT00472641|16953580|P1|Overall Study|Adverse Event|3
4923408|NCT00472641|16953580|P1|Overall Study|Lack of Efficacy|3
4923409|NCT00472446|16953600|P4|Overall Study|Questionnaires not returned|4
4923411|NCT00472446|16953602|P2|Overall Study|Questionnaires not returned|6
4923412|NCT00472446|16953603|P1|Overall Study|Questionnaires not returned|5
4923413|NCT00472446|16953600|P4|Overall Study|Reintervention|1
4923414|NCT00472446|16953601|P3|Overall Study|Reintervention|1
4923415|NCT00472446|16953602|P2|Overall Study|Reintervention|0
4923416|NCT00472446|16953603|P1|Overall Study|Reintervention|0
4923417|NCT00472446|16953600|P4|Overall Study|Protocol Violation|1
4923418|NCT00472446|16953601|P3|Overall Study|Protocol Violation|0
4923419|NCT00472446|16953602|P2|Overall Study|Protocol Violation|0
4923420|NCT00472446|16953603|P1|Overall Study|Protocol Violation|0
4923421|NCT00472420|16953633|P1|Follow-up Period|Protocol Violation|1
4923422|NCT00472420|16953633|P1|Follow-up Period|Lost to Follow-up|2
4923423|NCT00472420|16953633|P1|Follow-up Period|Physician Decision|9
4923424|NCT00472420|16953633|P1|Follow-up Period|Death|5
4923425|NCT00472420|16953633|P1|Induction Treatment Period|Death|3
4923426|NCT00472420|16953633|P1|Induction Treatment Period|Non-compliance|1
4923427|NCT00472420|16953633|P1|Induction Treatment Period|Adverse Event|3
4923428|NCT00472420|16953633|P1|Induction Treatment Period|Physician Decision|9
4923429|NCT00472303|16953641|P3|Maintenance Phase|Other|0
4923430|NCT00472303|16953642|P2|Maintenance Phase|Other|1
4923431|NCT00472303|16953643|P1|Maintenance Phase|Other|1
4923432|NCT00472303|16953641|P3|Maintenance Phase|Resolution of pain|1
4923433|NCT00472303|16953642|P2|Maintenance Phase|Resolution of pain|0
4923434|NCT00472303|16953643|P1|Maintenance Phase|Resolution of pain|0
4923435|NCT00472303|16953641|P3|Maintenance Phase|Trial medication non-compliant|1
4923436|NCT00472303|16953642|P2|Maintenance Phase|Trial medication non-compliant|0
4923437|NCT00472303|16953643|P1|Maintenance Phase|Trial medication non-compliant|0
4923438|NCT00472303|16953641|P3|Maintenance Phase|Withdrawal by Subject|3
4923439|NCT00472303|16953642|P2|Maintenance Phase|Withdrawal by Subject|7
4923440|NCT00472303|16953643|P1|Maintenance Phase|Withdrawal by Subject|6
4923441|NCT00472303|16953641|P3|Maintenance Phase|Lack of Efficacy|4
4923442|NCT00472303|16953642|P2|Maintenance Phase|Lack of Efficacy|2
4923443|NCT00472303|16953643|P1|Maintenance Phase|Lack of Efficacy|2
4923444|NCT00472303|16953641|P3|Maintenance Phase|Death|2
4923445|NCT00472303|16953642|P2|Maintenance Phase|Death|0
4923446|NCT00472303|16953643|P1|Maintenance Phase|Death|3
4923447|NCT00472303|16953641|P3|Maintenance Phase|Adverse Event|6
4923448|NCT00472303|16953642|P2|Maintenance Phase|Adverse Event|6
4923449|NCT00472303|16953643|P1|Maintenance Phase|Adverse Event|5
4923450|NCT00472303|16953641|P3|Discontinuations After Titration Phase|Other|0
4923451|NCT00472303|16953642|P2|Discontinuations After Titration Phase|Other|0
4923452|NCT00472303|16953643|P1|Discontinuations After Titration Phase|Other|5
4923453|NCT00472303|16953641|P3|Discontinuations After Titration Phase|Trial Medication non-compliant|0
4923454|NCT00472303|16953642|P2|Discontinuations After Titration Phase|Trial Medication non-compliant|1
4923455|NCT00472303|16953643|P1|Discontinuations After Titration Phase|Trial Medication non-compliant|0
4923456|NCT00472303|16953641|P3|Discontinuations After Titration Phase|Withdrawal by Subject|0
4923457|NCT00472303|16953642|P2|Discontinuations After Titration Phase|Withdrawal by Subject|2
4923458|NCT00472303|16953643|P1|Discontinuations After Titration Phase|Withdrawal by Subject|2
4923459|NCT00472303|16953641|P3|Discontinuations After Titration Phase|Lack of Efficacy|0
4923460|NCT00472303|16953642|P2|Discontinuations After Titration Phase|Lack of Efficacy|17
4923461|NCT00472303|16953643|P1|Discontinuations After Titration Phase|Lack of Efficacy|48
4923462|NCT00472303|16953641|P3|Discontinuations After Titration Phase|Adverse Event|0
4923463|NCT00472303|16953642|P2|Discontinuations After Titration Phase|Adverse Event|0
4923464|NCT00472303|16953643|P1|Discontinuations After Titration Phase|Adverse Event|6
4923465|NCT00472303|16953641|P3|Titration Phase|Other|0
4923466|NCT00472303|16953642|P2|Titration Phase|Other|1
4923467|NCT00472303|16953643|P1|Titration Phase|Other|3
4923468|NCT00472303|16953641|P3|Titration Phase|Trial Medication non-compliant|0
4923469|NCT00472303|16953642|P2|Titration Phase|Trial Medication non-compliant|1
4923470|NCT00472303|16953643|P1|Titration Phase|Trial Medication non-compliant|4
4923471|NCT00472303|16953641|P3|Titration Phase|Withdrawal by Subject|0
4923472|NCT00472303|16953642|P2|Titration Phase|Withdrawal by Subject|13
4923473|NCT00472303|16953643|P1|Titration Phase|Withdrawal by Subject|16
4923474|NCT00472303|16953641|P3|Titration Phase|Lack of Efficacy|0
4923475|NCT00472303|16953642|P2|Titration Phase|Lack of Efficacy|0
4923476|NCT00472303|16953643|P1|Titration Phase|Lack of Efficacy|10
4923477|NCT00472303|16953641|P3|Titration Phase|Death|0
4923478|NCT00472303|16953642|P2|Titration Phase|Death|2
4923479|NCT00472303|16953643|P1|Titration Phase|Death|4
4923480|NCT00472303|16953641|P3|Titration Phase|Adverse Event|0
4923481|NCT00472303|16953642|P2|Titration Phase|Adverse Event|12
4923482|NCT00472303|16953643|P1|Titration Phase|Adverse Event|22
4923483|NCT00472290|16953706|P1|Overall Study|Requirement for alternative therapy|7
4923484|NCT00472290|16953706|P1|Overall Study|Adverse Event|6
4923485|NCT00472290|16953706|P1|Overall Study|Withdrawal by Subject|5
4923486|NCT00472290|16953706|P1|Overall Study|Disease Progression|4
4923487|NCT00472290|16953706|P1|Overall Study|Lack of Efficacy|1
4923488|NCT00472290|16953706|P1|Overall Study|Lost to Follow-up|1
4923489|NCT00472290|16953706|P1|Overall Study|Death|3
4923490|NCT00472290|16953706|P1|Overall Study|Administrative Decision|37
4923491|NCT00472290|16953706|P1|Overall Study|Protocol Specified Criteria|7
4923492|NCT00472290|16953706|P1|Overall Study|Progression of Therapy-Related MDS|1
4923493|NCT00472199|16953718|P2|Overall Study|patient was asymptomatic|0
4923494|NCT00472199|16953719|P1|Overall Study|patient was asymptomatic|1
4923495|NCT00472199|16953718|P2|Overall Study|personal reason|1
4923496|NCT00472199|16953719|P1|Overall Study|personal reason|0
4923497|NCT00472199|16953718|P2|Overall Study|Withdrawal by Subject|5
4923498|NCT00472199|16953719|P1|Overall Study|Withdrawal by Subject|6
4923499|NCT00472199|16953718|P2|Overall Study|Protocol Violation|2
4923500|NCT00472199|16953719|P1|Overall Study|Protocol Violation|3
4923501|NCT00472199|16953718|P2|Overall Study|Lost to Follow-up|4
4923502|NCT00472199|16953719|P1|Overall Study|Lost to Follow-up|2
4923503|NCT00472199|16953718|P2|Overall Study|Lack of Efficacy|25
4923504|NCT00472199|16953719|P1|Overall Study|Lack of Efficacy|4
4923505|NCT00472199|16953718|P2|Overall Study|Adverse Event|23
4923506|NCT00472199|16953719|P1|Overall Study|Adverse Event|19
4923507|NCT00472082|16953785|P1|Overall Study|Study prematurely terminated|5
4923508|NCT00472030|16953807|P2|Overall Study|Physician Decision|0
4923509|NCT00472030|16953808|P1|Overall Study|Physician Decision|1
4923510|NCT00471887|16953824|P1|Overall Study|Adverse Event|9
4923511|NCT00471822|16953833|P1|Overall Study|Protocol Violation|2
4923512|NCT00471718|16953841|P1|Overall Study|Withdrawal by Subject|1
4923513|NCT00471718|16953841|P1|Overall Study|disease progression|22
4923514|NCT00471718|16953841|P1|Overall Study|other complicating disease|1
4923515|NCT00471718|16953841|P1|Overall Study|Adverse Event|3
4923516|NCT00471536|16953869|P1|Overall Study|Withdrawal by Subject|1
4923517|NCT00471497|16953881|P3|Overall Study|Sub optimal response or treat. failure|0
4923518|NCT00471497|16953882|P2|Overall Study|Sub optimal response or treat. failure|3
4923519|NCT00471497|16953883|P1|Overall Study|Sub optimal response or treat. failure|8
4923520|NCT00471497|16953881|P3|Overall Study|Protocol Violation|5
4923521|NCT00471497|16953882|P2|Overall Study|Protocol Violation|3
4923522|NCT00471497|16953883|P1|Overall Study|Protocol Violation|3
4923523|NCT00471497|16953881|P3|Overall Study|Disease Progression|2
4923524|NCT00471497|16953882|P2|Overall Study|Disease Progression|2
4923525|NCT00471497|16953883|P1|Overall Study|Disease Progression|8
4923526|NCT00471497|16953881|P3|Overall Study|Death|0
4923527|NCT00471497|16953882|P2|Overall Study|Death|2
4923528|NCT00471497|16953883|P1|Overall Study|Death|0
4923529|NCT00471497|16953881|P3|Overall Study|Lost to Follow-up|1
4923530|NCT00471497|16953882|P2|Overall Study|Lost to Follow-up|2
4923531|NCT00471497|16953883|P1|Overall Study|Lost to Follow-up|1
4923532|NCT00471497|16953881|P3|Overall Study|Withdrawal by Subject|5
4923533|NCT00471497|16953882|P2|Overall Study|Withdrawal by Subject|5
4923534|NCT00471497|16953883|P1|Overall Study|Withdrawal by Subject|3
4923535|NCT00471497|16953881|P3|Overall Study|Condition no longer requires study drug|0
4923536|NCT00471497|16953882|P2|Overall Study|Condition no longer requires study drug|1
4923537|NCT00471497|16953883|P1|Overall Study|Condition no longer requires study drug|0
4923538|NCT00471497|16953881|P3|Overall Study|Abnormal Test Procedure|1
4923539|NCT00471497|16953882|P2|Overall Study|Abnormal Test Procedure|0
4923540|NCT00471497|16953883|P1|Overall Study|Abnormal Test Procedure|1
4923541|NCT00471497|16953881|P3|Overall Study|Abnormal Laboratory Value|4
4923542|NCT00471497|16953882|P2|Overall Study|Abnormal Laboratory Value|6
4923543|NCT00471497|16953883|P1|Overall Study|Abnormal Laboratory Value|3
4923544|NCT00471497|16953881|P3|Overall Study|Adverse Event|22
4923545|NCT00471497|16953882|P2|Overall Study|Adverse Event|11
4923546|NCT00471497|16953883|P1|Overall Study|Adverse Event|19
4923547|NCT00471445|16953893|P2|Overall Study|Protocol Violation|1
4923548|NCT00471445|16953894|P1|Overall Study|Protocol Violation|0
4923549|NCT00471445|16953893|P2|Overall Study|Ineligible|0
4923550|NCT00471445|16953894|P1|Overall Study|Ineligible|1
4923551|NCT00471445|16953893|P2|Overall Study|Withdrawal by Subject|1
4923552|NCT00471445|16953894|P1|Overall Study|Withdrawal by Subject|1
4923553|NCT00471354|16953907|P1|Overall Study|Patient/Caregiver Decision|12
4923554|NCT00471354|16953907|P1|Overall Study|Lack of Efficacy|5
4923555|NCT00471354|16953907|P1|Overall Study|Lost to Follow-up|3
4923556|NCT00471354|16953907|P1|Overall Study|Sponsor Decision|1
4923557|NCT00471354|16953907|P1|Overall Study|Physician Decision|4
4923558|NCT00471354|16953907|P1|Overall Study|Withdrawal by Subject|1
4923559|NCT00471354|16953907|P1|Overall Study|Protocol Violation|12
4923560|NCT00471354|16953907|P1|Overall Study|Adverse Event|13
4923561|NCT00471354|16953907|P1|Overall Study|Protocol Entry Criteria Not Met|1
4923562|NCT00471328|16953919|P2|Extension Phase|Administrative Problem|0
4923563|NCT00471328|16953920|P1|Extension Phase|Administrative Problem|1
4923564|NCT00471328|16953919|P2|Extension Phase|New cancer Therapy|0
4923565|NCT00471328|16953920|P1|Extension Phase|New cancer Therapy|1
4923566|NCT00471328|16953919|P2|Extension Phase|Disease Progression|44
4923567|NCT00471328|16953920|P1|Extension Phase|Disease Progression|32
4923568|NCT00471328|16953919|P2|Extension Phase|Treatment duration as per protocol|1
4923569|NCT00471328|16953920|P1|Extension Phase|Treatment duration as per protocol|0
4923570|NCT00471328|16953919|P2|Extension Phase|Protocol Deviation|1
4923571|NCT00471328|16953920|P1|Extension Phase|Protocol Deviation|3
4923572|NCT00471328|16953919|P2|Extension Phase|Death|7
4923573|NCT00471328|16953920|P1|Extension Phase|Death|1
4923574|NCT00471328|16953919|P2|Extension Phase|Withdrawal by Subject|2
4923575|NCT00471328|16953920|P1|Extension Phase|Withdrawal by Subject|0
4923576|NCT00471328|16953919|P2|Extension Phase|Adverse Event|12
4923577|NCT00471328|16953920|P1|Extension Phase|Adverse Event|3
4923578|NCT00471328|16953919|P2|Core Phase|Protocol Deviation|1
4923579|NCT00471328|16953920|P1|Core Phase|Protocol Deviation|0
4923580|NCT00471328|16953919|P2|Core Phase|Administrative Problem|1
4923581|NCT00471328|16953920|P1|Core Phase|Administrative Problem|0
4923582|NCT00471328|16953919|P2|Core Phase|Disease Progression|53
4923583|NCT00471328|16953920|P1|Core Phase|Disease Progression|78
4923584|NCT00471328|16953919|P2|Core Phase|Abnormal laboratory value|0
4923585|NCT00471328|16953920|P1|Core Phase|Abnormal laboratory value|1
4923586|NCT00471328|16953919|P2|Core Phase|Withdrawal by Subject|2
4923587|NCT00471328|16953920|P1|Core Phase|Withdrawal by Subject|2
4923588|NCT00471328|16953919|P2|Core Phase|Death|4
4923589|NCT00471328|16953920|P1|Core Phase|Death|8
4923590|NCT00471328|16953919|P2|Core Phase|Adverse Event|6
4923591|NCT00471328|16953920|P1|Core Phase|Adverse Event|18
4923592|NCT00471315|16953939|P1|Overall Study|Withdrawal by Subject|1
4923593|NCT00471315|16953939|P1|Overall Study|Adverse Event|7
4923594|NCT00471276|16953944|P1|Overall Study|Refused treatment|6
4923595|NCT00471276|16953944|P1|Overall Study|Other|3
4923596|NCT00471276|16953944|P1|Overall Study|Global deterioration of health status|1
4923597|NCT00471276|16953944|P1|Overall Study|Objective progression or relapse|54
4923598|NCT00471276|16953944|P1|Overall Study|Protocol Violation|1
4923599|NCT00471276|16953944|P1|Overall Study|Adverse Event|16
4923600|NCT00471276|16953944|P1|Overall Study|Death|2
4923601|NCT00471237|16953974|P7|Overall Study|Participant's decision|0
4923602|NCT00471237|16953975|P6|Overall Study|Participant's decision|1
4923603|NCT00471237|16953976|P5|Overall Study|Participant's decision|0
4923604|NCT00471237|16953977|P4|Overall Study|Participant's decision|0
4923605|NCT00471237|16953978|P3|Overall Study|Participant's decision|0
4923606|NCT00471237|16953979|P2|Overall Study|Participant's decision|0
4923607|NCT00471237|16953980|P1|Overall Study|Participant's decision|0
4923608|NCT00471237|16953974|P7|Overall Study|Participant shifted residence|0
4923609|NCT00471237|16953975|P6|Overall Study|Participant shifted residence|0
4923610|NCT00471237|16953976|P5|Overall Study|Participant shifted residence|1
4923611|NCT00471237|16953977|P4|Overall Study|Participant shifted residence|0
4923612|NCT00471237|16953978|P3|Overall Study|Participant shifted residence|0
4923613|NCT00471237|16953979|P2|Overall Study|Participant shifted residence|0
4923614|NCT00471237|16953980|P1|Overall Study|Participant shifted residence|0
4923615|NCT00471237|16953974|P7|Overall Study|Administration of prohibited medicine|0
4923616|NCT00471237|16953975|P6|Overall Study|Administration of prohibited medicine|0
4923617|NCT00471237|16953976|P5|Overall Study|Administration of prohibited medicine|1
4923618|NCT00471237|16953977|P4|Overall Study|Administration of prohibited medicine|0
4923619|NCT00471237|16953978|P3|Overall Study|Administration of prohibited medicine|0
4923620|NCT00471237|16953979|P2|Overall Study|Administration of prohibited medicine|0
4923621|NCT00471237|16953980|P1|Overall Study|Administration of prohibited medicine|0
4923622|NCT00471237|16953974|P7|Overall Study|Participant lost medication|0
4923623|NCT00471237|16953975|P6|Overall Study|Participant lost medication|0
4923624|NCT00471237|16953976|P5|Overall Study|Participant lost medication|1
4923625|NCT00471237|16953977|P4|Overall Study|Participant lost medication|0
4923626|NCT00471237|16953978|P3|Overall Study|Participant lost medication|0
4923627|NCT00471237|16953979|P2|Overall Study|Participant lost medication|0
4923628|NCT00471237|16953980|P1|Overall Study|Participant lost medication|0
4923629|NCT00471237|16953974|P7|Overall Study|High parathyroid hormone|0
4923630|NCT00471237|16953975|P6|Overall Study|High parathyroid hormone|0
4923631|NCT00471237|16953976|P5|Overall Study|High parathyroid hormone|0
4923632|NCT00471237|16953977|P4|Overall Study|High parathyroid hormone|0
4923633|NCT00471237|16953978|P3|Overall Study|High parathyroid hormone|1
4923634|NCT00471237|16953979|P2|Overall Study|High parathyroid hormone|0
4923635|NCT00471237|16953980|P1|Overall Study|High parathyroid hormone|0
4923636|NCT00471237|16953974|P7|Overall Study|Participant planned to travel to abraod|0
4923637|NCT00471237|16953975|P6|Overall Study|Participant planned to travel to abraod|1
4923638|NCT00471237|16953976|P5|Overall Study|Participant planned to travel to abraod|0
4923639|NCT00471237|16953977|P4|Overall Study|Participant planned to travel to abraod|0
4923640|NCT00471237|16953978|P3|Overall Study|Participant planned to travel to abraod|0
4923641|NCT00471237|16953979|P2|Overall Study|Participant planned to travel to abraod|0
4923642|NCT00471237|16953980|P1|Overall Study|Participant planned to travel to abraod|1
4923643|NCT00471237|16953974|P7|Overall Study|Early stopping due to non-efficacy|0
4923644|NCT00471237|16953975|P6|Overall Study|Early stopping due to non-efficacy|0
4923645|NCT00471237|16953976|P5|Overall Study|Early stopping due to non-efficacy|1
4923646|NCT00471237|16953977|P4|Overall Study|Early stopping due to non-efficacy|0
4923647|NCT00471237|16953978|P3|Overall Study|Early stopping due to non-efficacy|0
4923648|NCT00471237|16953979|P2|Overall Study|Early stopping due to non-efficacy|0
4923649|NCT00471237|16953980|P1|Overall Study|Early stopping due to non-efficacy|1
4923650|NCT00471237|16953974|P7|Overall Study|Met serum creatinine withdrawal criteria|0
4923651|NCT00471237|16953975|P6|Overall Study|Met serum creatinine withdrawal criteria|0
4923652|NCT00471237|16953976|P5|Overall Study|Met serum creatinine withdrawal criteria|0
4923653|NCT00471237|16953977|P4|Overall Study|Met serum creatinine withdrawal criteria|2
4923654|NCT00471237|16953978|P3|Overall Study|Met serum creatinine withdrawal criteria|2
4923655|NCT00471237|16953979|P2|Overall Study|Met serum creatinine withdrawal criteria|0
4923656|NCT00471237|16953980|P1|Overall Study|Met serum creatinine withdrawal criteria|1
4923657|NCT00471237|16953974|P7|Overall Study|Non-compliance|0
4923658|NCT00471237|16953975|P6|Overall Study|Non-compliance|0
4923659|NCT00471237|16953976|P5|Overall Study|Non-compliance|0
4923660|NCT00471237|16953977|P4|Overall Study|Non-compliance|1
4923661|NCT00471237|16953978|P3|Overall Study|Non-compliance|0
4923662|NCT00471237|16953979|P2|Overall Study|Non-compliance|1
4923663|NCT00471237|16953980|P1|Overall Study|Non-compliance|0
4923664|NCT00471237|16953974|P7|Overall Study|Sponsor terminated study|0
4923665|NCT00471237|16953975|P6|Overall Study|Sponsor terminated study|24
4923666|NCT00471237|16953976|P5|Overall Study|Sponsor terminated study|18
4923667|NCT00471237|16953977|P4|Overall Study|Sponsor terminated study|22
4923668|NCT00471237|16953978|P3|Overall Study|Sponsor terminated study|19
4923669|NCT00471237|16953979|P2|Overall Study|Sponsor terminated study|23
4923670|NCT00471237|16953980|P1|Overall Study|Sponsor terminated study|20
4923671|NCT00471237|16953974|P7|Overall Study|Withdrawal by Subject|2
4923672|NCT00471237|16953975|P6|Overall Study|Withdrawal by Subject|4
4923673|NCT00471237|16953976|P5|Overall Study|Withdrawal by Subject|7
4923674|NCT00471237|16953977|P4|Overall Study|Withdrawal by Subject|8
4923675|NCT00471237|16953978|P3|Overall Study|Withdrawal by Subject|5
4923676|NCT00471237|16953979|P2|Overall Study|Withdrawal by Subject|6
4923677|NCT00471237|16953980|P1|Overall Study|Withdrawal by Subject|8
4923678|NCT00471237|16953974|P7|Overall Study|Protocol Violation|1
4923679|NCT00471237|16953975|P6|Overall Study|Protocol Violation|4
4923680|NCT00471237|16953976|P5|Overall Study|Protocol Violation|2
4923681|NCT00471237|16953977|P4|Overall Study|Protocol Violation|2
4923682|NCT00471237|16953978|P3|Overall Study|Protocol Violation|3
4923683|NCT00471237|16953979|P2|Overall Study|Protocol Violation|6
4923684|NCT00471237|16953980|P1|Overall Study|Protocol Violation|3
4923685|NCT00471237|16953974|P7|Overall Study|Lost to Follow-up|0
4923686|NCT00471237|16953975|P6|Overall Study|Lost to Follow-up|0
4923687|NCT00471237|16953976|P5|Overall Study|Lost to Follow-up|3
4923688|NCT00471237|16953977|P4|Overall Study|Lost to Follow-up|2
4923689|NCT00471237|16953978|P3|Overall Study|Lost to Follow-up|0
4923690|NCT00471237|16953979|P2|Overall Study|Lost to Follow-up|1
4923691|NCT00471237|16953980|P1|Overall Study|Lost to Follow-up|1
4923692|NCT00471237|16953974|P7|Overall Study|Adverse Event|0
4923693|NCT00471237|16953975|P6|Overall Study|Adverse Event|5
4923694|NCT00471237|16953976|P5|Overall Study|Adverse Event|7
4923695|NCT00471237|16953977|P4|Overall Study|Adverse Event|8
4923696|NCT00471237|16953978|P3|Overall Study|Adverse Event|4
4923697|NCT00471237|16953979|P2|Overall Study|Adverse Event|5
4923698|NCT00471237|16953980|P1|Overall Study|Adverse Event|6
4923699|NCT00471146|16954130|P2|Overall Study|Other|5
4923700|NCT00471146|16954131|P1|Overall Study|Other|4
4923701|NCT00471146|16954130|P2|Overall Study|Randomized but not treated|8
4923702|NCT00471146|16954131|P1|Overall Study|Randomized but not treated|9
4923703|NCT00471146|16954130|P2|Overall Study|Global deterioration of health status|14
4923704|NCT00471146|16954131|P1|Overall Study|Global deterioration of health status|12
4923705|NCT00471146|16954130|P2|Overall Study|Objective progression or relapse|87
4923706|NCT00471146|16954131|P1|Overall Study|Objective progression or relapse|84
4923707|NCT00471146|16954130|P2|Overall Study|Protocol Violation|2
4923708|NCT00471146|16954131|P1|Overall Study|Protocol Violation|2
4923709|NCT00471146|16954130|P2|Overall Study|Lost to Follow-up|2
4923710|NCT00471146|16954131|P1|Overall Study|Lost to Follow-up|4
4923711|NCT00471146|16954130|P2|Overall Study|Death|12
4923712|NCT00471146|16954131|P1|Overall Study|Death|11
4923713|NCT00471146|16954130|P2|Overall Study|Withdrawal by Subject|11
4923714|NCT00471146|16954131|P1|Overall Study|Withdrawal by Subject|14
4923715|NCT00471146|16954130|P2|Overall Study|Adverse Event|33
4923716|NCT00471146|16954131|P1|Overall Study|Adverse Event|32
4923717|NCT00471107|16954156|P3|Overall Study|Technical problems/data loss|3
4923718|NCT00471107|16954157|P2|Overall Study|Technical problems/data loss|1
4923719|NCT00471107|16954158|P1|Overall Study|Technical problems/data loss|3
4923720|NCT00471081|16954168|P2|Extended Safety Follow-Up|Missing confirmed|1
4923721|NCT00471081|16954169|P1|Extended Safety Follow-Up|Missing confirmed|0
4923722|NCT00471081|16954168|P2|Extended Safety Follow-Up|Lost to Follow-up|8
4923723|NCT00471081|16954169|P1|Extended Safety Follow-Up|Lost to Follow-up|1
4923724|NCT00471081|16954168|P2|Extended Safety Follow-Up|Withdrawal by Subject|4
4923725|NCT00471081|16954169|P1|Extended Safety Follow-Up|Withdrawal by Subject|1
4923726|NCT00471081|16954168|P2|Active Phase|Lost health plan/insurance|8
4923727|NCT00471081|16954169|P1|Active Phase|Lost health plan/insurance|1
4923728|NCT00471081|16954168|P2|Active Phase|Lost to Follow-up|1
4923729|NCT00471081|16954169|P1|Active Phase|Lost to Follow-up|0
4923730|NCT00471081|16954168|P2|Active Phase|Withdrawal by Subject|3
4923731|NCT00471081|16954169|P1|Active Phase|Withdrawal by Subject|0
4923732|NCT00471081|16954168|P2|Active Phase|Protocol Violation|1
4923733|NCT00471081|16954169|P1|Active Phase|Protocol Violation|1
4923734|NCT00470847|16954215|P1|Overall Study|Pt still receiving treatment|1
4923735|NCT00470834|16954228|P2|Extension Period (24 Months)|Disease Progression|1
4923736|NCT00470834|16954229|P1|Extension Period (24 Months)|Disease Progression|0
4923737|NCT00470834|16954228|P2|Extension Period (24 Months)|Non-compliance|1
4923738|NCT00470834|16954229|P1|Extension Period (24 Months)|Non-compliance|0
4923739|NCT00470834|16954228|P2|Extension Period (24 Months)|Lost to Follow-up|1
4923740|NCT00470834|16954229|P1|Extension Period (24 Months)|Lost to Follow-up|0
4923741|NCT00470834|16954228|P2|Extension Period (24 Months)|Sponsor Terminated Study|1
4923742|NCT00470834|16954229|P1|Extension Period (24 Months)|Sponsor Terminated Study|0
4923743|NCT00470834|16954228|P2|Extension Period (24 Months)|Physician Decision|3
4923744|NCT00470834|16954229|P1|Extension Period (24 Months)|Physician Decision|4
4923745|NCT00470834|16954228|P2|Extension Period (24 Months)|Withdrawal by Subject|5
4923746|NCT00470834|16954229|P1|Extension Period (24 Months)|Withdrawal by Subject|2
4923747|NCT00470834|16954228|P2|Extension Period (24 Months)|Adverse Event|4
4923748|NCT00470834|16954229|P1|Extension Period (24 Months)|Adverse Event|3
4923749|NCT00470834|16954228|P2|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7
4923750|NCT00470834|16954229|P1|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6
4923751|NCT00470834|16954228|P2|Treatment Period (18 Months)|Lack of Efficacy|0
4923752|NCT00470834|16954229|P1|Treatment Period (18 Months)|Lack of Efficacy|1
4923753|NCT00470834|16954228|P2|Treatment Period (18 Months)|Non-compliance|0
4923754|NCT00470834|16954229|P1|Treatment Period (18 Months)|Non-compliance|1
4923755|NCT00470834|16954228|P2|Treatment Period (18 Months)|Lost to Follow-up|0
4923756|NCT00470834|16954229|P1|Treatment Period (18 Months)|Lost to Follow-up|1
4923757|NCT00470834|16954228|P2|Treatment Period (18 Months)|Sponsor Terminated Study|1
4923758|NCT00470834|16954229|P1|Treatment Period (18 Months)|Sponsor Terminated Study|1
4923759|NCT00470834|16954228|P2|Treatment Period (18 Months)|Protocol Violation|1
4923760|NCT00470834|16954229|P1|Treatment Period (18 Months)|Protocol Violation|3
4923761|NCT00470834|16954228|P2|Treatment Period (18 Months)|Physician Decision|4
4923762|NCT00470834|16954229|P1|Treatment Period (18 Months)|Physician Decision|4
4923763|NCT00470834|16954228|P2|Treatment Period (18 Months)|Withdrawal by Subject|5
4923764|NCT00470834|16954229|P1|Treatment Period (18 Months)|Withdrawal by Subject|4
4923765|NCT00470834|16954228|P2|Treatment Period (18 Months)|Adverse Event|6
4923766|NCT00470834|16954229|P1|Treatment Period (18 Months)|Adverse Event|7
4923767|NCT00470834|16954228|P2|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14
4923768|NCT00470834|16954229|P1|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16
4923769|NCT00470626|16954243|P1|Overall Study|Withdrawal by Subject|7
4923770|NCT00470626|16954243|P1|Overall Study|Lost to Follow-up|10
4923771|NCT00470535|16954285|P1|Overall Study|Other|2
4923772|NCT00470535|16954285|P1|Overall Study|Death|1
4923773|NCT00470535|16954285|P1|Overall Study|Adverse Event|1
4923774|NCT00470535|16954285|P1|Overall Study|Withdrawal by Subject|1
4923775|NCT00470535|16954285|P1|Overall Study|Disease Progression|13
4923776|NCT00470470|16954294|P1|Overall Study|Not treated|1
4923777|NCT00470470|16954294|P1|Overall Study|Death|2
4923778|NCT00470470|16954294|P1|Overall Study|Adverse Event|2
4923779|NCT00470418|16954301|P2|Overall Study|Withdrawal by Subject|0
4923780|NCT00470418|16954302|P1|Overall Study|Withdrawal by Subject|1
4923781|NCT00470366|16954323|P1|Overall Study|Poor compliance|1
4923782|NCT00470366|16954323|P1|Overall Study|Adverse Event|3
4923783|NCT00470275|16954334|P1|Overall Study|Withdrawal by Subject|2
4923784|NCT00470275|16954334|P1|Overall Study|Lack of Efficacy|7
4923785|NCT00470275|16954334|P1|Overall Study|Death|1
4923786|NCT00470262|16954340|P2|Overall Study|Withdrawal by Subject|0
4923787|NCT00470262|16954341|P1|Overall Study|Withdrawal by Subject|2
4923788|NCT00470184|16954349|P1|Overall Study|recurrence|1
4923789|NCT00470184|16954349|P1|Overall Study|other|5
4923790|NCT00470184|16954349|P1|Overall Study|Withdrawal by Subject|4
4923791|NCT00470184|16954349|P1|Overall Study|Adverse Event|3
4923792|NCT00470184|16954349|P1|Overall Study|disease Progression|4
4923793|NCT00470184|16954349|P1|Overall Study|Not treated (other)|1
4923794|NCT00470184|16954349|P1|Overall Study|Not Treated(became ineligible)|4
4923795|NCT00470158|16954361|P5|Overall Study|Protocol Violation|0
4923796|NCT00470158|16954362|P4|Overall Study|Protocol Violation|0
4923797|NCT00470158|16954363|P3|Overall Study|Protocol Violation|0
4923798|NCT00470158|16954364|P2|Overall Study|Protocol Violation|0
4923799|NCT00470158|16954365|P1|Overall Study|Protocol Violation|1
4923800|NCT00470158|16954361|P5|Overall Study|Lost to Follow-up|4
4923801|NCT00470158|16954362|P4|Overall Study|Lost to Follow-up|5
4923802|NCT00470158|16954363|P3|Overall Study|Lost to Follow-up|8
4923803|NCT00470158|16954364|P2|Overall Study|Lost to Follow-up|8
4923804|NCT00470158|16954365|P1|Overall Study|Lost to Follow-up|7
4923805|NCT00470158|16954361|P5|Overall Study|Death|2
4923806|NCT00470158|16954362|P4|Overall Study|Death|0
4923807|NCT00470158|16954363|P3|Overall Study|Death|0
4923808|NCT00470158|16954364|P2|Overall Study|Death|0
4923809|NCT00470158|16954365|P1|Overall Study|Death|0
4923810|NCT00470093|16954398|P1|Overall Study|Adverse Event|2
4923811|NCT00470067|16954405|P1|Overall Study|Disease Progression|6
4923812|NCT00470067|16954405|P1|Overall Study|Death|1
4923813|NCT00470054|16954409|P1|Overall Study|Ineligible|1
4923814|NCT00469898|16954425|P1|Overall Study|Decreased performance status|1
4923815|NCT00469898|16954425|P1|Overall Study|Disease progression|9
4923816|NCT00469898|16954425|P1|Overall Study|Death|4
4923817|NCT00469898|16954425|P1|Overall Study|Withdrawal by Subject|4
4923818|NCT00469898|16954425|P1|Overall Study|Adverse Event|7
4923819|NCT00469859|16954434|P2|Overall Study|Inevaluable|2
4923820|NCT00469859|16954435|P1|Overall Study|Inevaluable|0
4923821|NCT00469833|16954443|P1|Overall Study|No IV access|2
4923822|NCT00469612|16954455|P2|Overall Study|Study terminated before data collected|0
4923823|NCT00469612|16954456|P1|Overall Study|Study terminated before data collected|2
4923824|NCT00469456|16954483|P2|Overall Study|Withdrawal by Subject|1
4923825|NCT00469456|16954484|P1|Overall Study|Withdrawal by Subject|4
4923826|NCT00469456|16954483|P2|Overall Study|Protocol Violation|0
4923827|NCT00469456|16954484|P1|Overall Study|Protocol Violation|1
4923828|NCT00469456|16954483|P2|Overall Study|Adverse Event|3
4923829|NCT00469456|16954484|P1|Overall Study|Adverse Event|4
4923830|NCT00469209|16954513|P3|Overall Study|Adverse Event|1
4923831|NCT00469209|16954514|P2|Overall Study|Adverse Event|0
4923832|NCT00469209|16954515|P1|Overall Study|Adverse Event|1
4923833|NCT00469092|16954525|P2|Overall Study|Use of Corticosteroid|0
4923834|NCT00469092|16954526|P1|Overall Study|Use of Corticosteroid|1
4923835|NCT00469092|16954525|P2|Overall Study|Abnormal lab value|0
4923836|NCT00469092|16954526|P1|Overall Study|Abnormal lab value|1
4923837|NCT00469092|16954525|P2|Overall Study|Hypoglycaemic Episodes|1
4923838|NCT00469092|16954526|P1|Overall Study|Hypoglycaemic Episodes|1
4923839|NCT00469092|16954525|P2|Overall Study|Use of lipid lowering drug|0
4923840|NCT00469092|16954526|P1|Overall Study|Use of lipid lowering drug|1
4923841|NCT00469092|16954525|P2|Overall Study|Contraindication metformin/glimepiride|0
4923842|NCT00469092|16954526|P1|Overall Study|Contraindication metformin/glimepiride|1
4923843|NCT00469092|16954525|P2|Overall Study|Incorrectly Randomised|3
4923844|NCT00469092|16954526|P1|Overall Study|Incorrectly Randomised|4
4923845|NCT00469092|16954525|P2|Overall Study|Withdrawal Criteria|4
4923846|NCT00469092|16954526|P1|Overall Study|Withdrawal Criteria|3
4923847|NCT00469092|16954525|P2|Overall Study|Withdrawal by Subject|4
4923848|NCT00469092|16954526|P1|Overall Study|Withdrawal by Subject|4
4923849|NCT00469092|16954525|P2|Overall Study|Protocol Violation|3
4923850|NCT00469092|16954526|P1|Overall Study|Protocol Violation|3
4923851|NCT00469092|16954525|P2|Overall Study|Lost to Follow-up|2
4923852|NCT00469092|16954526|P1|Overall Study|Lost to Follow-up|1
4923853|NCT00469092|16954525|P2|Overall Study|Lack of Efficacy|0
4923854|NCT00469092|16954526|P1|Overall Study|Lack of Efficacy|1
4923855|NCT00469092|16954525|P2|Overall Study|Adverse Event|4
4923856|NCT00469092|16954526|P1|Overall Study|Adverse Event|5
4923857|NCT00469079|16954545|P3|Overall Study|Ineligible|0
4923858|NCT00469079|16954546|P2|Overall Study|Ineligible|1
4923859|NCT00469079|16954547|P1|Overall Study|Ineligible|0
4923860|NCT00469079|16954545|P3|Overall Study|Withdrawal by Subject|2
4923861|NCT00469079|16954546|P2|Overall Study|Withdrawal by Subject|2
4923862|NCT00469079|16954547|P1|Overall Study|Withdrawal by Subject|1
4923863|NCT00469079|16954545|P3|Overall Study|Lost to Follow-up|10
4923864|NCT00469079|16954546|P2|Overall Study|Lost to Follow-up|8
4923865|NCT00469079|16954547|P1|Overall Study|Lost to Follow-up|4
4923866|NCT00469079|16954545|P3|Overall Study|Adverse Event|2
4923867|NCT00469079|16954546|P2|Overall Study|Adverse Event|3
4923868|NCT00469079|16954547|P1|Overall Study|Adverse Event|1
4923869|NCT00469079|16954545|P3|Overall Study|Lack of Efficacy|5
4923870|NCT00469079|16954546|P2|Overall Study|Lack of Efficacy|8
4923871|NCT00469079|16954547|P1|Overall Study|Lack of Efficacy|3
4923872|NCT00468910|16954566|P2|Overall Study|Medical Contraindication|1
4923873|NCT00468910|16954567|P1|Overall Study|Medical Contraindication|0
4923874|NCT00468910|16954566|P2|Overall Study|Withdrawal by Subject|1
4923875|NCT00468910|16954567|P1|Overall Study|Withdrawal by Subject|2
4923876|NCT00468910|16954566|P2|Overall Study|Lost to Follow-up|1
4923877|NCT00468910|16954567|P1|Overall Study|Lost to Follow-up|2
4923878|NCT00468858|16954586|P3|Overall Study|Other|1
4923879|NCT00468858|16954587|P2|Overall Study|Other|0
4923880|NCT00468858|16954588|P1|Overall Study|Other|0
4923881|NCT00468858|16954586|P3|Overall Study|Lost to Follow-up|5
4923882|NCT00468858|16954587|P2|Overall Study|Lost to Follow-up|2
4923883|NCT00468858|16954588|P1|Overall Study|Lost to Follow-up|1
4923884|NCT00468858|16954586|P3|Overall Study|Relocation|3
4923885|NCT00468858|16954587|P2|Overall Study|Relocation|3
4923886|NCT00468858|16954588|P1|Overall Study|Relocation|1
4923887|NCT00468858|16954586|P3|Overall Study|Withdrawal by Subject|5
4923888|NCT00468858|16954587|P2|Overall Study|Withdrawal by Subject|4
4923889|NCT00468858|16954588|P1|Overall Study|Withdrawal by Subject|7
4923890|NCT00468858|16954586|P3|Overall Study|Adverse Event|0
4923891|NCT00468858|16954587|P2|Overall Study|Adverse Event|1
4923892|NCT00468858|16954588|P1|Overall Study|Adverse Event|0
4923893|NCT00468845|16954709|P3|Overall Study|Randomized, not treated|2
4923894|NCT00468845|16954710|P2|Overall Study|Randomized, not treated|4
4923895|NCT00468845|16954711|P1|Overall Study|Randomized, not treated|1
4923896|NCT00468845|16954709|P3|Overall Study|No longer willing to participate|10
4923897|NCT00468845|16954710|P2|Overall Study|No longer willing to participate|6
4923898|NCT00468845|16954711|P1|Overall Study|No longer willing to participate|5
4923899|NCT00468845|16954709|P3|Overall Study|Other|5
4923900|NCT00468845|16954710|P2|Overall Study|Other|9
4923901|NCT00468845|16954711|P1|Overall Study|Other|4
4923902|NCT00468845|16954709|P3|Overall Study|Lost to Follow-up|2
4923903|NCT00468845|16954710|P2|Overall Study|Lost to Follow-up|1
4923904|NCT00468845|16954711|P1|Overall Study|Lost to Follow-up|2
4923905|NCT00468845|16954709|P3|Overall Study|Adverse Event|11
4923906|NCT00468845|16954710|P2|Overall Study|Adverse Event|14
4923907|NCT00468845|16954711|P1|Overall Study|Adverse Event|9
4923908|NCT00468819|16954848|P3|Overall Study|Drop-outs (Treatment never received)|0
4923909|NCT00468819|16954849|P2|Overall Study|Drop-outs (Treatment never received)|0
4923910|NCT00468819|16954850|P1|Overall Study|Drop-outs (Treatment never received)|2
4923911|NCT00468819|16954848|P3|Overall Study|Lost to Follow-up|1
4923912|NCT00468819|16954849|P2|Overall Study|Lost to Follow-up|0
4923913|NCT00468819|16954850|P1|Overall Study|Lost to Follow-up|0
4923914|NCT00468819|16954848|P3|Overall Study|Withdrawal by Subject|1
4923915|NCT00468819|16954849|P2|Overall Study|Withdrawal by Subject|0
4923916|NCT00468819|16954850|P1|Overall Study|Withdrawal by Subject|4
4923917|NCT00468728|16954930|P2|Follow-up|mITT failure|31
4923918|NCT00468728|16954931|P1|Follow-up|mITT failure|34
4923919|NCT00468728|16954930|P2|Treatment|criteria for mITT population|11
4923920|NCT00468728|16954931|P1|Treatment|criteria for mITT population|4
4923921|NCT00468676|16954943|P2|Overall Study|Death|1
4923922|NCT00468676|16954944|P1|Overall Study|Death|2
4923923|NCT00468676|16954943|P2|Overall Study|Lost to Follow-up|11
4923924|NCT00468676|16954944|P1|Overall Study|Lost to Follow-up|14
4923925|NCT00468650|16954961|P1|Overall Study|Protocol Violation|1
4923926|NCT00468650|16954961|P1|Overall Study|Withdrawal by Subject|2
4923927|NCT00468650|16954961|P1|Overall Study|Lost to Follow-up|4
4923928|NCT00468585|16955009|P4|Overall Study|Withdrawal by Subject|1
4923929|NCT00468585|16955010|P3|Overall Study|Withdrawal by Subject|2
4923930|NCT00468585|16955011|P2|Overall Study|Withdrawal by Subject|0
4923931|NCT00468585|16955012|P1|Overall Study|Withdrawal by Subject|0
4923932|NCT00468585|16955009|P4|Overall Study|Adverse Event|0
4923933|NCT00468585|16955010|P3|Overall Study|Adverse Event|1
4923934|NCT00468585|16955011|P2|Overall Study|Adverse Event|0
4923935|NCT00468585|16955012|P1|Overall Study|Adverse Event|0
4923936|NCT00468585|16955009|P4|Overall Study|Patient found to be ineligible|0
4923937|NCT00468585|16955010|P3|Overall Study|Patient found to be ineligible|1
4923938|NCT00468585|16955011|P2|Overall Study|Patient found to be ineligible|0
4923939|NCT00468585|16955012|P1|Overall Study|Patient found to be ineligible|0
4923940|NCT00468585|16955009|P4|Overall Study|Patient not treated|0
4923941|NCT00468585|16955010|P3|Overall Study|Patient not treated|1
4923942|NCT00468585|16955011|P2|Overall Study|Patient not treated|0
4923943|NCT00468585|16955012|P1|Overall Study|Patient not treated|1
4923944|NCT00468559|16955024|P3|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
4923945|NCT00468559|16955025|P2|Double-blind, Treatment-withdrawal Phase|Adverse Event|2
4923946|NCT00468559|16955026|P1|Double-blind, Treatment-withdrawal Phase|Adverse Event|0
4923947|NCT00468559|16955024|P3|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17
4923948|NCT00468559|16955025|P2|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8
4923949|NCT00468559|16955026|P1|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0
4923950|NCT00468559|16955024|P3|Open-label Treatment Phase|Withdrawal by Subject|0
4923951|NCT00468559|16955025|P2|Open-label Treatment Phase|Withdrawal by Subject|0
4923952|NCT00468559|16955026|P1|Open-label Treatment Phase|Withdrawal by Subject|4
4923953|NCT00468559|16955024|P3|Open-label Treatment Phase|Lack of Efficacy|0
4923954|NCT00468559|16955025|P2|Open-label Treatment Phase|Lack of Efficacy|0
4923955|NCT00468559|16955026|P1|Open-label Treatment Phase|Lack of Efficacy|9
4923956|NCT00468559|16955024|P3|Open-label Treatment Phase|Adverse Event|0
4923957|NCT00468559|16955025|P2|Open-label Treatment Phase|Adverse Event|0
4923958|NCT00468559|16955026|P1|Open-label Treatment Phase|Adverse Event|5
4923959|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Other|14
4923960|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Other|17
4923961|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Movement into re-treatment study|183
4923962|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Movement into re-treatment study|77
4923963|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Failure to return|2
4923964|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Failure to return|1
4923965|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Refused treatment|7
4923966|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Refused treatment|4
4923967|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Protocol Violation|2
4923968|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Protocol Violation|0
4923969|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Lack of Efficacy|12
4923970|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Lack of Efficacy|3
4923971|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Death|0
4923972|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Death|1
4923973|NCT00468546|16955054|P2|Week 24 to Week 104 Analysis|Adverse Event|5
4923974|NCT00468546|16955055|P1|Week 24 to Week 104 Analysis|Adverse Event|2
4923975|NCT00468546|16955054|P2|Week 24 Analysis|Participant unblinded (clinical hold)|0
4923976|NCT00468546|16955055|P1|Week 24 Analysis|Participant unblinded (clinical hold)|1
4923977|NCT00468546|16955054|P2|Week 24 Analysis|Went onto rescue therapy|0
4923978|NCT00468546|16955055|P1|Week 24 Analysis|Went onto rescue therapy|1
4923979|NCT00468546|16955054|P2|Week 24 Analysis|Due to clinical hold|0
4923980|NCT00468546|16955055|P1|Week 24 Analysis|Due to clinical hold|1
4923981|NCT00468546|16955054|P2|Week 24 Analysis|Incorrect diagnosis and treatment|1
4923982|NCT00468546|16955055|P1|Week 24 Analysis|Incorrect diagnosis and treatment|0
4923983|NCT00468546|16955054|P2|Week 24 Analysis|Rescue therapy|0
4923984|NCT00468546|16955055|P1|Week 24 Analysis|Rescue therapy|2
4923985|NCT00468546|16955054|P2|Week 24 Analysis|Failure to return|4
4923986|NCT00468546|16955055|P1|Week 24 Analysis|Failure to return|3
4923987|NCT00468546|16955054|P2|Week 24 Analysis|Adverse Event|8
4923988|NCT00468546|16955055|P1|Week 24 Analysis|Adverse Event|1
4923989|NCT00468546|16955054|P2|Week 24 Analysis|Refused treatment|5
4923990|NCT00468546|16955055|P1|Week 24 Analysis|Refused treatment|5
4923991|NCT00468546|16955054|P2|Week 24 Analysis|Lack of Efficacy|37
4923992|NCT00468546|16955055|P1|Week 24 Analysis|Lack of Efficacy|83
4923993|NCT00468481|16955085|P2|Overall Study|Other|0
4923994|NCT00468481|16955086|P1|Overall Study|Other|6
4923995|NCT00468481|16955085|P2|Overall Study|Non-Compliance|0
4923996|NCT00468481|16955086|P1|Overall Study|Non-Compliance|5
4923997|NCT00468481|16955085|P2|Overall Study|Moved out of area|1
4923998|NCT00468481|16955086|P1|Overall Study|Moved out of area|4
4923999|NCT00468481|16955085|P2|Overall Study|Egg Donor|0
4924000|NCT00468481|16955086|P1|Overall Study|Egg Donor|1
4924001|NCT00468481|16955085|P2|Overall Study|Prohibited Medication|1
4924002|NCT00468481|16955086|P1|Overall Study|Prohibited Medication|1
4924003|NCT00468481|16955085|P2|Overall Study|susp/diag malignant/premalignant disease|0
4924004|NCT00468481|16955086|P1|Overall Study|susp/diag malignant/premalignant disease|1
4924005|NCT00468481|16955085|P2|Overall Study|Withdrawal by Subject|3
4924006|NCT00468481|16955086|P1|Overall Study|Withdrawal by Subject|12
4924007|NCT00468481|16955085|P2|Overall Study|Protocol Violation|8
4924008|NCT00468481|16955086|P1|Overall Study|Protocol Violation|18
4924009|NCT00468481|16955085|P2|Overall Study|Pregnancy|0
4924010|NCT00468481|16955086|P1|Overall Study|Pregnancy|2
4924011|NCT00468481|16955085|P2|Overall Study|Lost to Follow-up|8
4924012|NCT00468481|16955086|P1|Overall Study|Lost to Follow-up|25
4924013|NCT00468481|16955085|P2|Overall Study|Adverse Event|3
4924014|NCT00468481|16955086|P1|Overall Study|Adverse Event|13
4924015|NCT00468312|16955186|P2|Overall Study|Did not meet protocol eligibility|1
4924016|NCT00468312|16955187|P1|Overall Study|Did not meet protocol eligibility|0
4924017|NCT00468312|16955186|P2|Overall Study|Protocol Violation|1
4924018|NCT00468312|16955187|P1|Overall Study|Protocol Violation|2
4924019|NCT00468312|16955186|P2|Overall Study|Withdrawal by Subject|1
4924020|NCT00468312|16955187|P1|Overall Study|Withdrawal by Subject|0
4924021|NCT00468312|16955186|P2|Overall Study|Lack of Efficacy|1
4924022|NCT00468312|16955187|P1|Overall Study|Lack of Efficacy|0
4924023|NCT00468312|16955186|P2|Overall Study|Adverse Event|1
4924024|NCT00468312|16955187|P1|Overall Study|Adverse Event|2
4924025|NCT00468299|16955203|P2|Overall Study|Withdrawal by Subject|1
4924026|NCT00468299|16955204|P1|Overall Study|Withdrawal by Subject|0
4924027|NCT00468286|16955214|P2|Overall Study|Physician Decision|1
4924028|NCT00468286|16955215|P1|Overall Study|Physician Decision|0
4924029|NCT00468286|16955214|P2|Overall Study|Withdrawal by Subject|3
4924030|NCT00468286|16955215|P1|Overall Study|Withdrawal by Subject|4
4924031|NCT00468286|16955214|P2|Overall Study|Protocol Violation|2
4924032|NCT00468286|16955215|P1|Overall Study|Protocol Violation|2
4924033|NCT00468286|16955214|P2|Overall Study|Adverse Event|6
4924034|NCT00468286|16955215|P1|Overall Study|Adverse Event|1
4924035|NCT00468169|16955247|P2|Overall Study|Withdrawal by Subject|0
4924036|NCT00468169|16955248|P1|Overall Study|Withdrawal by Subject|1
4924037|NCT00468143|16955264|P2|Second Intervention (3 Weeks)|Withdrawal by Subject|3
4924038|NCT00468143|16955265|P1|Second Intervention (3 Weeks)|Withdrawal by Subject|3
4924039|NCT00468143|16955264|P2|First Intervention (3 Weeks)|Withdrawal by Subject|4
4924040|NCT00468143|16955265|P1|First Intervention (3 Weeks)|Withdrawal by Subject|3
4924041|NCT00468104|16955279|P2|Second Intervention|discarded for malposition of chest tube|2
4924042|NCT00468104|16955280|P1|Second Intervention|discarded for malposition of chest tube|0
4924043|NCT00468104|16955279|P2|Second Intervention|Withdrawal by Subject|2
4924044|NCT00468104|16955280|P1|Second Intervention|Withdrawal by Subject|5
4924045|NCT00468104|16955279|P2|First Intervention|trapped lung|0
4924046|NCT00468104|16955280|P1|First Intervention|trapped lung|1
4924047|NCT00468104|16955279|P2|First Intervention|associated prolonged pneumothorax|0
4924048|NCT00468104|16955280|P1|First Intervention|associated prolonged pneumothorax|1
4924049|NCT00468104|16955279|P2|First Intervention|large lung mass with minimal effusion|0
4924050|NCT00468104|16955280|P1|First Intervention|large lung mass with minimal effusion|1
4924051|NCT00468104|16955279|P2|First Intervention|malposition/blocked chest tube tube|0
4924052|NCT00468104|16955280|P1|First Intervention|malposition/blocked chest tube tube|2
4924053|NCT00468104|16955279|P2|First Intervention|died within 3 weeks|0
4924054|NCT00468104|16955280|P1|First Intervention|died within 3 weeks|1
4924055|NCT00468104|16955279|P2|First Intervention|bleeding at chest tube site--first dose|0
4924056|NCT00468104|16955280|P1|First Intervention|bleeding at chest tube site--first dose|1
4924057|NCT00468104|16955279|P2|First Intervention|Protocol Violation|1
4924058|NCT00468104|16955280|P1|First Intervention|Protocol Violation|2
4924059|NCT00468052|16955297|P2|Overall Study|Protocol Violation|8
4924060|NCT00468052|16955298|P1|Overall Study|Protocol Violation|7
4924061|NCT00467961|16955316|P1|Overall Study|Disease Progression|2
4924062|NCT00467961|16955316|P1|Overall Study|Technical Failures|5
4924063|NCT00467896|16955320|P1|Overall Study|Patient had no improvement|1
4924064|NCT00467896|16955320|P1|Overall Study|Started inhaled Remodulin|1
4924065|NCT00467896|16955320|P1|Overall Study|Started intravenous prostacyclin|1
4924066|NCT00467896|16955320|P1|Overall Study|Mainly used Prodose not I-neb® device|1
4924067|NCT00467896|16955320|P1|Overall Study|Patient weaned off iloprost|1
4924068|NCT00467896|16955320|P1|Overall Study|Patient had atrial septostomy|1
4924069|NCT00467896|16955320|P1|Overall Study|Patient received transplant|2
4924070|NCT00467896|16955320|P1|Overall Study|Changed therapy|2
4924071|NCT00467896|16955320|P1|Overall Study|Non-compliance|3
4924072|NCT00467896|16955320|P1|Overall Study|Serious Adverse Event|13
4924073|NCT00467896|16955320|P1|Overall Study|Adverse Event|7
4924074|NCT00467896|16955320|P1|Overall Study|Consent Withdrawal|18
4924075|NCT00467870|16955346|P6|Overall Study|Other/Unknown|0
4924076|NCT00467870|16955347|P5|Overall Study|Other/Unknown|4
4924077|NCT00467870|16955348|P4|Overall Study|Other/Unknown|5
4924078|NCT00467870|16955349|P3|Overall Study|Other/Unknown|1
4924079|NCT00467870|16955350|P2|Overall Study|Other/Unknown|5
4924080|NCT00467870|16955351|P1|Overall Study|Other/Unknown|8
4924081|NCT00467870|16955346|P6|Overall Study|Subject Non-compliance|0
4924082|NCT00467870|16955347|P5|Overall Study|Subject Non-compliance|5
4924083|NCT00467870|16955348|P4|Overall Study|Subject Non-compliance|1
4924084|NCT00467870|16955349|P3|Overall Study|Subject Non-compliance|0
4924085|NCT00467870|16955350|P2|Overall Study|Subject Non-compliance|4
4924086|NCT00467870|16955351|P1|Overall Study|Subject Non-compliance|3
4924087|NCT00467870|16955346|P6|Overall Study|Lost to Follow-up|0
4924088|NCT00467870|16955347|P5|Overall Study|Lost to Follow-up|3
4924089|NCT00467870|16955348|P4|Overall Study|Lost to Follow-up|1
4924090|NCT00467870|16955349|P3|Overall Study|Lost to Follow-up|1
4924091|NCT00467870|16955350|P2|Overall Study|Lost to Follow-up|3
4924092|NCT00467870|16955351|P1|Overall Study|Lost to Follow-up|5
4924093|NCT00467870|16955346|P6|Overall Study|Withdrawal by Subject|1
4924094|NCT00467870|16955347|P5|Overall Study|Withdrawal by Subject|10
4924095|NCT00467870|16955348|P4|Overall Study|Withdrawal by Subject|9
4924096|NCT00467870|16955349|P3|Overall Study|Withdrawal by Subject|0
4924097|NCT00467870|16955350|P2|Overall Study|Withdrawal by Subject|21
4924098|NCT00467870|16955351|P1|Overall Study|Withdrawal by Subject|14
4924099|NCT00467870|16955346|P6|Overall Study|Protocol Violation|0
4924100|NCT00467870|16955347|P5|Overall Study|Protocol Violation|0
4924101|NCT00467870|16955348|P4|Overall Study|Protocol Violation|2
4924102|NCT00467870|16955349|P3|Overall Study|Protocol Violation|1
4924103|NCT00467870|16955350|P2|Overall Study|Protocol Violation|1
4924104|NCT00467870|16955351|P1|Overall Study|Protocol Violation|2
4924105|NCT00467870|16955346|P6|Overall Study|Adverse Event|1
4924106|NCT00467870|16955347|P5|Overall Study|Adverse Event|15
4924107|NCT00467870|16955348|P4|Overall Study|Adverse Event|15
4924108|NCT00467870|16955349|P3|Overall Study|Adverse Event|1
4924109|NCT00467870|16955350|P2|Overall Study|Adverse Event|9
4924110|NCT00467870|16955351|P1|Overall Study|Adverse Event|13
4924111|NCT00467857|16955394|P2|Overall Study|Discontinuation reason missing|3
4924112|NCT00467857|16955395|P1|Overall Study|Discontinuation reason missing|0
4924113|NCT00467857|16955394|P2|Overall Study|Did not meet inclusion/exclusion criteri|2
4924114|NCT00467857|16955395|P1|Overall Study|Did not meet inclusion/exclusion criteri|0
4924115|NCT00467857|16955394|P2|Overall Study|Emergency care required|1
4924116|NCT00467857|16955395|P1|Overall Study|Emergency care required|0
4924117|NCT00467857|16955394|P2|Overall Study|Discharged from court service|1
4924118|NCT00467857|16955395|P1|Overall Study|Discharged from court service|0
4924119|NCT00467857|16955394|P2|Overall Study|Death|1
4924120|NCT00467857|16955395|P1|Overall Study|Death|0
4924121|NCT00467857|16955394|P2|Overall Study|Withdrew consent|0
4924122|NCT00467857|16955395|P1|Overall Study|Withdrew consent|2
4924123|NCT00467857|16955394|P2|Overall Study|Adverse Event|0
4924124|NCT00467857|16955395|P1|Overall Study|Adverse Event|1
4924125|NCT00467831|16955443|P1|Overall Study|Withdrawal by Subject|1
4924126|NCT00467831|16955443|P1|Overall Study|Death|2
4924127|NCT00467779|16955462|P15|Stage 3|Unspecified Reason|5
4924128|NCT00467779|16955463|P14|Stage 3|Unspecified Reason|0
4924129|NCT00467779|16955464|P13|Stage 3|Unspecified Reason|0
4924130|NCT00467779|16955465|P12|Stage 3|Unspecified Reason|0
4924131|NCT00467779|16955466|P11|Stage 3|Unspecified Reason|0
4924132|NCT00467779|16955467|P10|Stage 3|Unspecified Reason|0
4924133|NCT00467779|16955468|P9|Stage 3|Unspecified Reason|0
4924134|NCT00467779|16955469|P8|Stage 3|Unspecified Reason|0
4924135|NCT00467779|16955470|P7|Stage 3|Unspecified Reason|0
4924136|NCT00467779|16955471|P6|Stage 3|Unspecified Reason|0
4924137|NCT00467779|16955472|P5|Stage 3|Unspecified Reason|0
4924138|NCT00467779|16955473|P4|Stage 3|Unspecified Reason|0
4924139|NCT00467779|16955474|P3|Stage 3|Unspecified Reason|0
4924140|NCT00467779|16955475|P2|Stage 3|Unspecified Reason|0
4924141|NCT00467779|16955476|P1|Stage 3|Unspecified Reason|0
4924142|NCT00467779|16955462|P15|Stage 3|Disease Progression|9
4924143|NCT00467779|16955463|P14|Stage 3|Disease Progression|0
4924144|NCT00467779|16955464|P13|Stage 3|Disease Progression|0
4924145|NCT00467779|16955465|P12|Stage 3|Disease Progression|0
4924146|NCT00467779|16955466|P11|Stage 3|Disease Progression|0
4924147|NCT00467779|16955467|P10|Stage 3|Disease Progression|0
4924148|NCT00467779|16955468|P9|Stage 3|Disease Progression|0
4924149|NCT00467779|16955469|P8|Stage 3|Disease Progression|0
4924150|NCT00467779|16955470|P7|Stage 3|Disease Progression|0
4924151|NCT00467779|16955471|P6|Stage 3|Disease Progression|0
4924152|NCT00467779|16955472|P5|Stage 3|Disease Progression|0
4924153|NCT00467779|16955473|P4|Stage 3|Disease Progression|0
4924154|NCT00467779|16955474|P3|Stage 3|Disease Progression|0
4924155|NCT00467779|16955475|P2|Stage 3|Disease Progression|0
4924156|NCT00467779|16955476|P1|Stage 3|Disease Progression|0
4924157|NCT00467779|16955462|P15|Stage 3|Death|1
4924158|NCT00467779|16955463|P14|Stage 3|Death|0
4924159|NCT00467779|16955464|P13|Stage 3|Death|0
4924160|NCT00467779|16955465|P12|Stage 3|Death|0
4924161|NCT00467779|16955466|P11|Stage 3|Death|0
4924162|NCT00467779|16955467|P10|Stage 3|Death|0
4924163|NCT00467779|16955468|P9|Stage 3|Death|0
4924164|NCT00467779|16955469|P8|Stage 3|Death|0
4924165|NCT00467779|16955470|P7|Stage 3|Death|0
4924166|NCT00467779|16955471|P6|Stage 3|Death|0
4924167|NCT00467779|16955472|P5|Stage 3|Death|0
4924168|NCT00467779|16955473|P4|Stage 3|Death|0
4924169|NCT00467779|16955474|P3|Stage 3|Death|0
4924170|NCT00467779|16955475|P2|Stage 3|Death|0
4924171|NCT00467779|16955476|P1|Stage 3|Death|0
4924172|NCT00467779|16955462|P15|Stage 3|Adverse Event|2
4924173|NCT00467779|16955463|P14|Stage 3|Adverse Event|0
4924174|NCT00467779|16955464|P13|Stage 3|Adverse Event|0
4924175|NCT00467779|16955465|P12|Stage 3|Adverse Event|0
4924176|NCT00467779|16955466|P11|Stage 3|Adverse Event|0
4924177|NCT00467779|16955467|P10|Stage 3|Adverse Event|0
4924178|NCT00467779|16955468|P9|Stage 3|Adverse Event|0
4924179|NCT00467779|16955469|P8|Stage 3|Adverse Event|0
4924180|NCT00467779|16955470|P7|Stage 3|Adverse Event|0
4924181|NCT00467779|16955471|P6|Stage 3|Adverse Event|0
4924182|NCT00467779|16955472|P5|Stage 3|Adverse Event|0
4924183|NCT00467779|16955473|P4|Stage 3|Adverse Event|0
4924184|NCT00467779|16955474|P3|Stage 3|Adverse Event|0
4924185|NCT00467779|16955475|P2|Stage 3|Adverse Event|0
4924186|NCT00467779|16955476|P1|Stage 3|Adverse Event|0
4924187|NCT00467779|16955462|P15|Stage 2A|Withdrawal by Subject|0
4924188|NCT00467779|16955463|P14|Stage 2A|Withdrawal by Subject|1
4924189|NCT00467779|16955464|P13|Stage 2A|Withdrawal by Subject|0
4924190|NCT00467779|16955465|P12|Stage 2A|Withdrawal by Subject|0
4924191|NCT00467779|16955466|P11|Stage 2A|Withdrawal by Subject|0
4924192|NCT00467779|16955467|P10|Stage 2A|Withdrawal by Subject|0
4924193|NCT00467779|16955468|P9|Stage 2A|Withdrawal by Subject|0
4924194|NCT00467779|16955469|P8|Stage 2A|Withdrawal by Subject|0
4924195|NCT00467779|16955470|P7|Stage 2A|Withdrawal by Subject|0
4924196|NCT00467779|16955471|P6|Stage 2A|Withdrawal by Subject|0
4924197|NCT00467779|16955472|P5|Stage 2A|Withdrawal by Subject|0
4924198|NCT00467779|16955473|P4|Stage 2A|Withdrawal by Subject|0
4924199|NCT00467779|16955474|P3|Stage 2A|Withdrawal by Subject|0
4924200|NCT00467779|16955475|P2|Stage 2A|Withdrawal by Subject|0
4924201|NCT00467779|16955476|P1|Stage 2A|Withdrawal by Subject|0
4924202|NCT00467779|16955462|P15|Stage 2A|Unspecified Reason|0
4924203|NCT00467779|16955463|P14|Stage 2A|Unspecified Reason|7
4924204|NCT00467779|16955464|P13|Stage 2A|Unspecified Reason|0
4924205|NCT00467779|16955465|P12|Stage 2A|Unspecified Reason|0
4924206|NCT00467779|16955466|P11|Stage 2A|Unspecified Reason|0
4924207|NCT00467779|16955467|P10|Stage 2A|Unspecified Reason|0
4924208|NCT00467779|16955468|P9|Stage 2A|Unspecified Reason|0
4924209|NCT00467779|16955469|P8|Stage 2A|Unspecified Reason|0
4924210|NCT00467779|16955470|P7|Stage 2A|Unspecified Reason|0
4924211|NCT00467779|16955471|P6|Stage 2A|Unspecified Reason|0
4924212|NCT00467779|16955472|P5|Stage 2A|Unspecified Reason|0
4924213|NCT00467779|16955473|P4|Stage 2A|Unspecified Reason|0
4924214|NCT00467779|16955474|P3|Stage 2A|Unspecified Reason|0
4924215|NCT00467779|16955475|P2|Stage 2A|Unspecified Reason|0
4924216|NCT00467779|16955476|P1|Stage 2A|Unspecified Reason|0
4924217|NCT00467779|16955462|P15|Stage 2A|Disease Progression|0
4924218|NCT00467779|16955463|P14|Stage 2A|Disease Progression|10
4924219|NCT00467779|16955464|P13|Stage 2A|Disease Progression|0
4924220|NCT00467779|16955465|P12|Stage 2A|Disease Progression|0
4924221|NCT00467779|16955466|P11|Stage 2A|Disease Progression|0
4924222|NCT00467779|16955467|P10|Stage 2A|Disease Progression|0
4924223|NCT00467779|16955468|P9|Stage 2A|Disease Progression|0
4924224|NCT00467779|16955469|P8|Stage 2A|Disease Progression|0
4924225|NCT00467779|16955470|P7|Stage 2A|Disease Progression|0
4924226|NCT00467779|16955471|P6|Stage 2A|Disease Progression|0
4924227|NCT00467779|16955472|P5|Stage 2A|Disease Progression|0
4924228|NCT00467779|16955473|P4|Stage 2A|Disease Progression|0
4924229|NCT00467779|16955474|P3|Stage 2A|Disease Progression|0
4924230|NCT00467779|16955475|P2|Stage 2A|Disease Progression|0
4924231|NCT00467779|16955476|P1|Stage 2A|Disease Progression|0
4924232|NCT00467779|16955462|P15|Stage 2A|Death|0
4924233|NCT00467779|16955463|P14|Stage 2A|Death|1
4924234|NCT00467779|16955464|P13|Stage 2A|Death|0
4924235|NCT00467779|16955465|P12|Stage 2A|Death|0
4924236|NCT00467779|16955466|P11|Stage 2A|Death|0
4924237|NCT00467779|16955467|P10|Stage 2A|Death|0
4924238|NCT00467779|16955468|P9|Stage 2A|Death|0
4924239|NCT00467779|16955469|P8|Stage 2A|Death|0
4924240|NCT00467779|16955470|P7|Stage 2A|Death|0
4924241|NCT00467779|16955471|P6|Stage 2A|Death|0
4924242|NCT00467779|16955472|P5|Stage 2A|Death|0
4924243|NCT00467779|16955473|P4|Stage 2A|Death|0
4924244|NCT00467779|16955474|P3|Stage 2A|Death|0
4924245|NCT00467779|16955475|P2|Stage 2A|Death|0
4924246|NCT00467779|16955476|P1|Stage 2A|Death|0
4924247|NCT00467779|16955462|P15|Stage 2A|Adverse Event|0
4924248|NCT00467779|16955463|P14|Stage 2A|Adverse Event|2
4924249|NCT00467779|16955464|P13|Stage 2A|Adverse Event|0
4924250|NCT00467779|16955465|P12|Stage 2A|Adverse Event|0
4924251|NCT00467779|16955466|P11|Stage 2A|Adverse Event|0
4924252|NCT00467779|16955467|P10|Stage 2A|Adverse Event|0
4924253|NCT00467779|16955468|P9|Stage 2A|Adverse Event|0
4924254|NCT00467779|16955469|P8|Stage 2A|Adverse Event|0
4924255|NCT00467779|16955470|P7|Stage 2A|Adverse Event|0
4924256|NCT00467779|16955471|P6|Stage 2A|Adverse Event|0
4924257|NCT00467779|16955472|P5|Stage 2A|Adverse Event|0
4924258|NCT00467779|16955473|P4|Stage 2A|Adverse Event|0
4924259|NCT00467779|16955474|P3|Stage 2A|Adverse Event|0
4924260|NCT00467779|16955475|P2|Stage 2A|Adverse Event|0
4924261|NCT00467779|16955476|P1|Stage 2A|Adverse Event|0
4924262|NCT00467779|16955462|P15|Stage 2|Unspecified Reason|0
4924263|NCT00467779|16955463|P14|Stage 2|Unspecified Reason|0
4924264|NCT00467779|16955464|P13|Stage 2|Unspecified Reason|0
4924265|NCT00467779|16955465|P12|Stage 2|Unspecified Reason|0
4924266|NCT00467779|16955466|P11|Stage 2|Unspecified Reason|0
4924267|NCT00467779|16955467|P10|Stage 2|Unspecified Reason|0
4924268|NCT00467779|16955468|P9|Stage 2|Unspecified Reason|3
4924269|NCT00467779|16955469|P8|Stage 2|Unspecified Reason|0
4924270|NCT00467779|16955470|P7|Stage 2|Unspecified Reason|0
4924271|NCT00467779|16955471|P6|Stage 2|Unspecified Reason|0
4924272|NCT00467779|16955472|P5|Stage 2|Unspecified Reason|0
4924273|NCT00467779|16955473|P4|Stage 2|Unspecified Reason|0
4924274|NCT00467779|16955474|P3|Stage 2|Unspecified Reason|0
4924275|NCT00467779|16955475|P2|Stage 2|Unspecified Reason|0
4924276|NCT00467779|16955476|P1|Stage 2|Unspecified Reason|0
4924277|NCT00467779|16955462|P15|Stage 2|Disease Progression|0
4924278|NCT00467779|16955463|P14|Stage 2|Disease Progression|0
4924279|NCT00467779|16955464|P13|Stage 2|Disease Progression|0
4924280|NCT00467779|16955465|P12|Stage 2|Disease Progression|0
4924281|NCT00467779|16955466|P11|Stage 2|Disease Progression|0
4924282|NCT00467779|16955467|P10|Stage 2|Disease Progression|0
4924283|NCT00467779|16955468|P9|Stage 2|Disease Progression|16
4924284|NCT00467779|16955469|P8|Stage 2|Disease Progression|0
4924285|NCT00467779|16955470|P7|Stage 2|Disease Progression|0
4924286|NCT00467779|16955471|P6|Stage 2|Disease Progression|0
4924287|NCT00467779|16955472|P5|Stage 2|Disease Progression|0
4924288|NCT00467779|16955473|P4|Stage 2|Disease Progression|0
4924289|NCT00467779|16955474|P3|Stage 2|Disease Progression|0
4924290|NCT00467779|16955475|P2|Stage 2|Disease Progression|0
4924291|NCT00467779|16955476|P1|Stage 2|Disease Progression|0
4924292|NCT00467779|16955462|P15|Stage 2|Death|0
4924293|NCT00467779|16955463|P14|Stage 2|Death|0
4924294|NCT00467779|16955464|P13|Stage 2|Death|0
4924295|NCT00467779|16955465|P12|Stage 2|Death|0
4924296|NCT00467779|16955466|P11|Stage 2|Death|0
4924297|NCT00467779|16955467|P10|Stage 2|Death|0
4924298|NCT00467779|16955468|P9|Stage 2|Death|1
4924299|NCT00467779|16955469|P8|Stage 2|Death|0
4924300|NCT00467779|16955470|P7|Stage 2|Death|0
4924301|NCT00467779|16955471|P6|Stage 2|Death|0
4924302|NCT00467779|16955472|P5|Stage 2|Death|0
4924303|NCT00467779|16955473|P4|Stage 2|Death|0
4924304|NCT00467779|16955474|P3|Stage 2|Death|0
4924305|NCT00467779|16955475|P2|Stage 2|Death|0
4924306|NCT00467779|16955476|P1|Stage 2|Death|0
4924307|NCT00467779|16955462|P15|Stage 2|Adverse Event|0
4924308|NCT00467779|16955463|P14|Stage 2|Adverse Event|0
4924309|NCT00467779|16955464|P13|Stage 2|Adverse Event|0
4924310|NCT00467779|16955465|P12|Stage 2|Adverse Event|0
4924311|NCT00467779|16955466|P11|Stage 2|Adverse Event|0
4924312|NCT00467779|16955467|P10|Stage 2|Adverse Event|0
4924313|NCT00467779|16955468|P9|Stage 2|Adverse Event|1
4924314|NCT00467779|16955469|P8|Stage 2|Adverse Event|0
4924315|NCT00467779|16955470|P7|Stage 2|Adverse Event|0
4924316|NCT00467779|16955471|P6|Stage 2|Adverse Event|0
4924317|NCT00467779|16955472|P5|Stage 2|Adverse Event|0
4924318|NCT00467779|16955473|P4|Stage 2|Adverse Event|0
4924319|NCT00467779|16955474|P3|Stage 2|Adverse Event|0
4924320|NCT00467779|16955475|P2|Stage 2|Adverse Event|0
4924321|NCT00467779|16955476|P1|Stage 2|Adverse Event|0
4924322|NCT00467779|16955462|P15|Stage 1A|Unspecified Reason|0
4924323|NCT00467779|16955463|P14|Stage 1A|Unspecified Reason|0
4924324|NCT00467779|16955464|P13|Stage 1A|Unspecified Reason|1
4924325|NCT00467779|16955465|P12|Stage 1A|Unspecified Reason|1
4924326|NCT00467779|16955466|P11|Stage 1A|Unspecified Reason|0
4924327|NCT00467779|16955467|P10|Stage 1A|Unspecified Reason|0
4924328|NCT00467779|16955468|P9|Stage 1A|Unspecified Reason|0
4924329|NCT00467779|16955469|P8|Stage 1A|Unspecified Reason|0
4924330|NCT00467779|16955470|P7|Stage 1A|Unspecified Reason|0
4924331|NCT00467779|16955471|P6|Stage 1A|Unspecified Reason|0
4924332|NCT00467779|16955472|P5|Stage 1A|Unspecified Reason|0
4924333|NCT00467779|16955473|P4|Stage 1A|Unspecified Reason|0
4924334|NCT00467779|16955474|P3|Stage 1A|Unspecified Reason|0
4924335|NCT00467779|16955475|P2|Stage 1A|Unspecified Reason|0
4924336|NCT00467779|16955476|P1|Stage 1A|Unspecified Reason|0
4924337|NCT00467779|16955462|P15|Stage 1A|Withdrawal by Subject|0
4924338|NCT00467779|16955463|P14|Stage 1A|Withdrawal by Subject|0
4924339|NCT00467779|16955464|P13|Stage 1A|Withdrawal by Subject|1
4924340|NCT00467779|16955465|P12|Stage 1A|Withdrawal by Subject|1
4924341|NCT00467779|16955466|P11|Stage 1A|Withdrawal by Subject|1
4924342|NCT00467779|16955467|P10|Stage 1A|Withdrawal by Subject|0
4924343|NCT00467779|16955468|P9|Stage 1A|Withdrawal by Subject|0
4924344|NCT00467779|16955469|P8|Stage 1A|Withdrawal by Subject|0
4924345|NCT00467779|16955470|P7|Stage 1A|Withdrawal by Subject|0
4924346|NCT00467779|16955471|P6|Stage 1A|Withdrawal by Subject|0
4924347|NCT00467779|16955472|P5|Stage 1A|Withdrawal by Subject|0
4924348|NCT00467779|16955473|P4|Stage 1A|Withdrawal by Subject|0
4924349|NCT00467779|16955474|P3|Stage 1A|Withdrawal by Subject|0
4924350|NCT00467779|16955475|P2|Stage 1A|Withdrawal by Subject|0
4924351|NCT00467779|16955476|P1|Stage 1A|Withdrawal by Subject|0
4924352|NCT00467779|16955462|P15|Stage 1A|Physician Decision|0
4924353|NCT00467779|16955463|P14|Stage 1A|Physician Decision|0
4924354|NCT00467779|16955464|P13|Stage 1A|Physician Decision|0
4924355|NCT00467779|16955465|P12|Stage 1A|Physician Decision|0
4924356|NCT00467779|16955466|P11|Stage 1A|Physician Decision|0
4924357|NCT00467779|16955467|P10|Stage 1A|Physician Decision|1
4924358|NCT00467779|16955468|P9|Stage 1A|Physician Decision|0
4924359|NCT00467779|16955469|P8|Stage 1A|Physician Decision|0
4924360|NCT00467779|16955470|P7|Stage 1A|Physician Decision|0
4924361|NCT00467779|16955471|P6|Stage 1A|Physician Decision|0
4924362|NCT00467779|16955472|P5|Stage 1A|Physician Decision|0
4924363|NCT00467779|16955473|P4|Stage 1A|Physician Decision|0
4924364|NCT00467779|16955474|P3|Stage 1A|Physician Decision|0
4924365|NCT00467779|16955475|P2|Stage 1A|Physician Decision|0
4924366|NCT00467779|16955476|P1|Stage 1A|Physician Decision|0
4924367|NCT00467779|16955462|P15|Stage 1A|Disease Progression|0
4924368|NCT00467779|16955463|P14|Stage 1A|Disease Progression|0
4924369|NCT00467779|16955464|P13|Stage 1A|Disease Progression|2
4924370|NCT00467779|16955465|P12|Stage 1A|Disease Progression|5
4924371|NCT00467779|16955466|P11|Stage 1A|Disease Progression|2
4924372|NCT00467779|16955467|P10|Stage 1A|Disease Progression|2
4924373|NCT00467779|16955468|P9|Stage 1A|Disease Progression|0
4924374|NCT00467779|16955469|P8|Stage 1A|Disease Progression|0
4924375|NCT00467779|16955470|P7|Stage 1A|Disease Progression|0
4924376|NCT00467779|16955471|P6|Stage 1A|Disease Progression|0
4924377|NCT00467779|16955472|P5|Stage 1A|Disease Progression|0
4924378|NCT00467779|16955473|P4|Stage 1A|Disease Progression|0
4924379|NCT00467779|16955474|P3|Stage 1A|Disease Progression|0
4924380|NCT00467779|16955475|P2|Stage 1A|Disease Progression|0
4924381|NCT00467779|16955476|P1|Stage 1A|Disease Progression|0
4924382|NCT00467779|16955462|P15|Stage 1A|Death|0
4924383|NCT00467779|16955463|P14|Stage 1A|Death|0
4924384|NCT00467779|16955464|P13|Stage 1A|Death|1
4924385|NCT00467779|16955465|P12|Stage 1A|Death|1
4924386|NCT00467779|16955466|P11|Stage 1A|Death|0
4924387|NCT00467779|16955467|P10|Stage 1A|Death|0
4924388|NCT00467779|16955468|P9|Stage 1A|Death|0
4924389|NCT00467779|16955469|P8|Stage 1A|Death|0
4924390|NCT00467779|16955470|P7|Stage 1A|Death|0
4924391|NCT00467779|16955471|P6|Stage 1A|Death|0
4924392|NCT00467779|16955472|P5|Stage 1A|Death|0
4924393|NCT00467779|16955473|P4|Stage 1A|Death|0
4924394|NCT00467779|16955474|P3|Stage 1A|Death|0
4924395|NCT00467779|16955475|P2|Stage 1A|Death|0
4924396|NCT00467779|16955476|P1|Stage 1A|Death|0
4924397|NCT00467779|16955462|P15|Stage 1A|Adverse Event|0
4924398|NCT00467779|16955463|P14|Stage 1A|Adverse Event|0
4924399|NCT00467779|16955464|P13|Stage 1A|Adverse Event|1
4924400|NCT00467779|16955465|P12|Stage 1A|Adverse Event|0
4924401|NCT00467779|16955466|P11|Stage 1A|Adverse Event|0
4924402|NCT00467779|16955467|P10|Stage 1A|Adverse Event|0
4924403|NCT00467779|16955468|P9|Stage 1A|Adverse Event|0
4924404|NCT00467779|16955469|P8|Stage 1A|Adverse Event|0
4924405|NCT00467779|16955470|P7|Stage 1A|Adverse Event|0
4924406|NCT00467779|16955471|P6|Stage 1A|Adverse Event|0
4924407|NCT00467779|16955472|P5|Stage 1A|Adverse Event|0
4924408|NCT00467779|16955473|P4|Stage 1A|Adverse Event|0
4924409|NCT00467779|16955474|P3|Stage 1A|Adverse Event|0
4924410|NCT00467779|16955475|P2|Stage 1A|Adverse Event|0
4924411|NCT00467779|16955476|P1|Stage 1A|Adverse Event|0
4924412|NCT00467779|16955462|P15|Stage 1|Withdrawal by Subject|0
4924413|NCT00467779|16955463|P14|Stage 1|Withdrawal by Subject|0
4924414|NCT00467779|16955464|P13|Stage 1|Withdrawal by Subject|0
4924415|NCT00467779|16955465|P12|Stage 1|Withdrawal by Subject|0
4924416|NCT00467779|16955466|P11|Stage 1|Withdrawal by Subject|0
4924417|NCT00467779|16955467|P10|Stage 1|Withdrawal by Subject|0
4924418|NCT00467779|16955468|P9|Stage 1|Withdrawal by Subject|0
4924419|NCT00467779|16955469|P8|Stage 1|Withdrawal by Subject|1
4924420|NCT00467779|16955470|P7|Stage 1|Withdrawal by Subject|1
4924421|NCT00467779|16955471|P6|Stage 1|Withdrawal by Subject|0
4924422|NCT00467779|16955472|P5|Stage 1|Withdrawal by Subject|0
4924423|NCT00467779|16955473|P4|Stage 1|Withdrawal by Subject|0
4924424|NCT00467779|16955474|P3|Stage 1|Withdrawal by Subject|0
4924425|NCT00467779|16955475|P2|Stage 1|Withdrawal by Subject|0
4924426|NCT00467779|16955476|P1|Stage 1|Withdrawal by Subject|0
4924427|NCT00467779|16955462|P15|Stage 1|Physician Decision|0
4924428|NCT00467779|16955463|P14|Stage 1|Physician Decision|0
4924429|NCT00467779|16955464|P13|Stage 1|Physician Decision|0
4924430|NCT00467779|16955465|P12|Stage 1|Physician Decision|0
4924431|NCT00467779|16955466|P11|Stage 1|Physician Decision|0
4924432|NCT00467779|16955467|P10|Stage 1|Physician Decision|0
4924433|NCT00467779|16955468|P9|Stage 1|Physician Decision|0
4924434|NCT00467779|16955469|P8|Stage 1|Physician Decision|0
4924435|NCT00467779|16955470|P7|Stage 1|Physician Decision|0
4924436|NCT00467779|16955471|P6|Stage 1|Physician Decision|0
4924437|NCT00467779|16955472|P5|Stage 1|Physician Decision|0
4924438|NCT00467779|16955473|P4|Stage 1|Physician Decision|0
4924439|NCT00467779|16955474|P3|Stage 1|Physician Decision|0
4924440|NCT00467779|16955475|P2|Stage 1|Physician Decision|1
4924441|NCT00467779|16955476|P1|Stage 1|Physician Decision|0
4924442|NCT00467779|16955462|P15|Stage 1|Unspecified Reason|0
4924443|NCT00467779|16955463|P14|Stage 1|Unspecified Reason|0
4924444|NCT00467779|16955464|P13|Stage 1|Unspecified Reason|0
4924445|NCT00467779|16955465|P12|Stage 1|Unspecified Reason|0
4924446|NCT00467779|16955466|P11|Stage 1|Unspecified Reason|0
4924447|NCT00467779|16955467|P10|Stage 1|Unspecified Reason|0
4924448|NCT00467779|16955468|P9|Stage 1|Unspecified Reason|0
4924449|NCT00467779|16955469|P8|Stage 1|Unspecified Reason|0
4924450|NCT00467779|16955470|P7|Stage 1|Unspecified Reason|0
4924451|NCT00467779|16955471|P6|Stage 1|Unspecified Reason|2
4924452|NCT00467779|16955472|P5|Stage 1|Unspecified Reason|1
4924453|NCT00467779|16955473|P4|Stage 1|Unspecified Reason|0
4924454|NCT00467779|16955474|P3|Stage 1|Unspecified Reason|1
4924455|NCT00467779|16955475|P2|Stage 1|Unspecified Reason|0
4924456|NCT00467779|16955476|P1|Stage 1|Unspecified Reason|1
4924457|NCT00467779|16955462|P15|Stage 1|Disease Progression|0
4924458|NCT00467779|16955463|P14|Stage 1|Disease Progression|0
4924459|NCT00467779|16955464|P13|Stage 1|Disease Progression|0
4924460|NCT00467779|16955465|P12|Stage 1|Disease Progression|0
4924461|NCT00467779|16955466|P11|Stage 1|Disease Progression|0
4924462|NCT00467779|16955467|P10|Stage 1|Disease Progression|0
4924463|NCT00467779|16955468|P9|Stage 1|Disease Progression|0
4924464|NCT00467779|16955469|P8|Stage 1|Disease Progression|5
4924465|NCT00467779|16955470|P7|Stage 1|Disease Progression|4
4924466|NCT00467779|16955471|P6|Stage 1|Disease Progression|2
4924467|NCT00467779|16955472|P5|Stage 1|Disease Progression|2
4924468|NCT00467779|16955473|P4|Stage 1|Disease Progression|3
4924469|NCT00467779|16955474|P3|Stage 1|Disease Progression|2
4924470|NCT00467779|16955475|P2|Stage 1|Disease Progression|2
4924471|NCT00467779|16955476|P1|Stage 1|Disease Progression|2
4924472|NCT00467779|16955462|P15|Stage 1|Adverse Event|0
4924473|NCT00467779|16955463|P14|Stage 1|Adverse Event|0
4924474|NCT00467779|16955464|P13|Stage 1|Adverse Event|0
4924475|NCT00467779|16955465|P12|Stage 1|Adverse Event|0
4924476|NCT00467779|16955466|P11|Stage 1|Adverse Event|0
4924477|NCT00467779|16955467|P10|Stage 1|Adverse Event|0
4924478|NCT00467779|16955468|P9|Stage 1|Adverse Event|0
4924479|NCT00467779|16955469|P8|Stage 1|Adverse Event|1
4924480|NCT00467779|16955470|P7|Stage 1|Adverse Event|2
4924481|NCT00467779|16955471|P6|Stage 1|Adverse Event|1
4924482|NCT00467779|16955472|P5|Stage 1|Adverse Event|0
4924483|NCT00467779|16955473|P4|Stage 1|Adverse Event|0
4924484|NCT00467779|16955474|P3|Stage 1|Adverse Event|0
4924485|NCT00467779|16955475|P2|Stage 1|Adverse Event|0
4924486|NCT00467779|16955476|P1|Stage 1|Adverse Event|1
4924487|NCT00467753|16955650|P2|Overall Study|Adverse Event|0
4924488|NCT00467753|16955651|P1|Overall Study|Adverse Event|2
4924489|NCT00467753|16955650|P2|Overall Study|Lost to Follow-up|2
4924490|NCT00467753|16955651|P1|Overall Study|Lost to Follow-up|1
4924491|NCT00467740|16955662|P5|Overall Study|Lack of Efficacy|0
4924492|NCT00467740|16955663|P4|Overall Study|Lack of Efficacy|0
4924493|NCT00467740|16955664|P3|Overall Study|Lack of Efficacy|0
4924494|NCT00467740|16955665|P2|Overall Study|Lack of Efficacy|1
4924495|NCT00467740|16955666|P1|Overall Study|Lack of Efficacy|0
4924496|NCT00467740|16955662|P5|Overall Study|Withdrawal by Subject|0
4924497|NCT00467740|16955663|P4|Overall Study|Withdrawal by Subject|1
4924498|NCT00467740|16955664|P3|Overall Study|Withdrawal by Subject|0
4924499|NCT00467740|16955665|P2|Overall Study|Withdrawal by Subject|1
4924500|NCT00467740|16955666|P1|Overall Study|Withdrawal by Subject|1
4924501|NCT00467740|16955662|P5|Overall Study|Lost to Follow-up|0
4924502|NCT00467740|16955663|P4|Overall Study|Lost to Follow-up|0
4924503|NCT00467740|16955664|P3|Overall Study|Lost to Follow-up|0
4924504|NCT00467740|16955665|P2|Overall Study|Lost to Follow-up|1
4924505|NCT00467740|16955666|P1|Overall Study|Lost to Follow-up|0
4924506|NCT00467740|16955662|P5|Overall Study|Protocol Violation|0
4924507|NCT00467740|16955663|P4|Overall Study|Protocol Violation|0
4924508|NCT00467740|16955664|P3|Overall Study|Protocol Violation|1
4924509|NCT00467740|16955665|P2|Overall Study|Protocol Violation|0
4924510|NCT00467740|16955666|P1|Overall Study|Protocol Violation|0
4924511|NCT00467740|16955662|P5|Overall Study|Adverse Event|0
4924512|NCT00467740|16955663|P4|Overall Study|Adverse Event|0
4924513|NCT00467740|16955664|P3|Overall Study|Adverse Event|1
4924514|NCT00467740|16955665|P2|Overall Study|Adverse Event|0
4924515|NCT00467740|16955666|P1|Overall Study|Adverse Event|0
4924516|NCT00467649|16955855|P6|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1
4924517|NCT00467649|16955856|P5|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4924518|NCT00467649|16955857|P4|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4924519|NCT00467649|16955858|P3|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4924520|NCT00467649|16955859|P2|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4924521|NCT00467649|16955860|P1|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0
4924522|NCT00467649|16955855|P6|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4924523|NCT00467649|16955856|P5|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4924524|NCT00467649|16955857|P4|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1
4924525|NCT00467649|16955858|P3|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4924526|NCT00467649|16955859|P2|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4924527|NCT00467649|16955860|P1|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0
4924528|NCT00467649|16955855|P6|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4924529|NCT00467649|16955856|P5|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4924530|NCT00467649|16955857|P4|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1
4924531|NCT00467649|16955858|P3|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4924532|NCT00467649|16955859|P2|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4924533|NCT00467649|16955860|P1|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0
4924534|NCT00467649|16955855|P6|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4924535|NCT00467649|16955856|P5|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4924536|NCT00467649|16955857|P4|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4924537|NCT00467649|16955858|P3|Phase 1 (Randomized Population)|Withdrawal of Consent|0
4924538|NCT00467649|16955859|P2|Phase 1 (Randomized Population)|Withdrawal of Consent|2
4924539|NCT00467649|16955860|P1|Phase 1 (Randomized Population)|Withdrawal of Consent|4
4924540|NCT00467649|16955855|P6|Phase 1 (Randomized Population)|Lost to Follow-up|0
4924541|NCT00467649|16955856|P5|Phase 1 (Randomized Population)|Lost to Follow-up|0
4924542|NCT00467649|16955857|P4|Phase 1 (Randomized Population)|Lost to Follow-up|0
4924543|NCT00467649|16955858|P3|Phase 1 (Randomized Population)|Lost to Follow-up|0
4924544|NCT00467649|16955859|P2|Phase 1 (Randomized Population)|Lost to Follow-up|4
4924545|NCT00467649|16955860|P1|Phase 1 (Randomized Population)|Lost to Follow-up|2
4924546|NCT00467649|16955855|P6|Phase 1 (Randomized Population)|Investigator Decision|0
4924547|NCT00467649|16955856|P5|Phase 1 (Randomized Population)|Investigator Decision|0
4924548|NCT00467649|16955857|P4|Phase 1 (Randomized Population)|Investigator Decision|0
4924549|NCT00467649|16955858|P3|Phase 1 (Randomized Population)|Investigator Decision|0
4924550|NCT00467649|16955859|P2|Phase 1 (Randomized Population)|Investigator Decision|0
4924551|NCT00467649|16955860|P1|Phase 1 (Randomized Population)|Investigator Decision|1
4924552|NCT00467649|16955855|P6|Phase 1 (Randomized Population)|Adverse Event|0
4924553|NCT00467649|16955856|P5|Phase 1 (Randomized Population)|Adverse Event|0
4924554|NCT00467649|16955857|P4|Phase 1 (Randomized Population)|Adverse Event|0
4924555|NCT00467649|16955858|P3|Phase 1 (Randomized Population)|Adverse Event|0
4924556|NCT00467649|16955859|P2|Phase 1 (Randomized Population)|Adverse Event|0
4924557|NCT00467649|16955860|P1|Phase 1 (Randomized Population)|Adverse Event|2
4924558|NCT00467610|16955900|P1|Overall Study|Withdrawal by Subject|1
4924559|NCT00467597|16955911|P2|Overall Study|Withdrawal by Subject|0
4924560|NCT00467597|16955912|P1|Overall Study|Withdrawal by Subject|2
4924561|NCT00467584|16955925|P3|Overall Study|Withdrawal by Subject|1
4924562|NCT00467584|16955926|P2|Overall Study|Withdrawal by Subject|5
4924563|NCT00467584|16955927|P1|Overall Study|Withdrawal by Subject|4
4924564|NCT00467558|16955937|P2|Overall Study|Lost to Follow-up|0
4924565|NCT00467558|16955938|P1|Overall Study|Lost to Follow-up|2
4924566|NCT00467519|16955948|P2|Overall Study|Withdrawal by Subject|10
4924567|NCT00467519|16955949|P1|Overall Study|Withdrawal by Subject|4
4924568|NCT00467519|16955948|P2|Overall Study|Lost to Follow-up|9
4924569|NCT00467519|16955949|P1|Overall Study|Lost to Follow-up|2
4924570|NCT00467519|16955948|P2|Overall Study|Protocol Violation|4
4924571|NCT00467519|16955949|P1|Overall Study|Protocol Violation|8
4924572|NCT00467363|16955978|P2|Overall Study|Lost to Follow-up|70
4924573|NCT00467363|16955979|P1|Overall Study|Lost to Follow-up|80
4924574|NCT00467285|16956026|P2|Overall Study|Lost to Follow-up|4
4924575|NCT00467285|16956027|P1|Overall Study|Lost to Follow-up|4
4924576|NCT00467259|16956047|P2|Overall Study|Site Closed|1
4924577|NCT00467259|16956048|P1|Overall Study|Site Closed|2
4924578|NCT00467259|16956047|P2|Overall Study|Lost to Follow-up|34
4924579|NCT00467259|16956048|P1|Overall Study|Lost to Follow-up|14
4924580|NCT00467259|16956047|P2|Overall Study|Physician Decision|2
4924581|NCT00467259|16956048|P1|Overall Study|Physician Decision|0
4924582|NCT00467259|16956047|P2|Overall Study|Withdrawal by Subject|108
4924583|NCT00467259|16956048|P1|Overall Study|Withdrawal by Subject|34
4924584|NCT00467259|16956047|P2|Overall Study|Protocol Violation|7
4924585|NCT00467259|16956048|P1|Overall Study|Protocol Violation|1
4924586|NCT00467259|16956047|P2|Overall Study|Adverse Event|90
4924587|NCT00467259|16956048|P1|Overall Study|Adverse Event|24
4924588|NCT00467051|16956065|P1|Overall Study|Adverse Event|2
4924589|NCT00466947|16956092|P2|Study End Analysis Period|Other - Unconformity in team's treatment|1
4924590|NCT00466947|16956093|P1|Study End Analysis Period|Other - Unconformity in team's treatment|0
4924591|NCT00466947|16956092|P2|Study End Analysis Period|Other - Subject without a legal guardian|0
4924592|NCT00466947|16956093|P1|Study End Analysis Period|Other - Subject without a legal guardian|1
4924593|NCT00466947|16956092|P2|Study End Analysis Period|Other - Forbidden vaccination|10
4924594|NCT00466947|16956093|P1|Study End Analysis Period|Other - Forbidden vaccination|21
4924595|NCT00466947|16956092|P2|Study End Analysis Period|Withdrawal by Subject|1267
4924596|NCT00466947|16956093|P1|Study End Analysis Period|Withdrawal by Subject|1264
4924597|NCT00466947|16956092|P2|Study End Analysis Period|Protocol Violation|17
4924598|NCT00466947|16956093|P1|Study End Analysis Period|Protocol Violation|9
4924599|NCT00466947|16956092|P2|Study End Analysis Period|Physician Decision|29
4924600|NCT00466947|16956093|P1|Study End Analysis Period|Physician Decision|29
4924601|NCT00466947|16956092|P2|Study End Analysis Period|Lost to Follow-up|1167
4924602|NCT00466947|16956093|P1|Study End Analysis Period|Lost to Follow-up|1137
4924603|NCT00466947|16956092|P2|Study End Analysis Period|Adverse Event|43
4924604|NCT00466947|16956093|P1|Study End Analysis Period|Adverse Event|35
4924605|NCT00466947|16956092|P2|Primary Outcome Analysis Period|Other: study still ongoing|11863
4924606|NCT00466947|16956093|P1|Primary Outcome Analysis Period|Other: study still ongoing|11875
4924607|NCT00466726|16956284|P1|Overall Study|Not evaluable for response|14
4924608|NCT00466687|16956290|P1|Overall Study|Disease progression|29
4924609|NCT00466687|16956290|P1|Overall Study|Withdrawal by Subject|1
4924610|NCT00466687|16956290|P1|Overall Study|Other complicating illness|3
4924611|NCT00466687|16956290|P1|Overall Study|Adverse Event|1
4924612|NCT00466505|16956322|P1|Overall Study|Adverse Event|4
4924613|NCT00466505|16956322|P1|Overall Study|disease progression|13
4924614|NCT00466193|16956372|P2|Overall Study|Patient refused Visit 4 procedures|0
4924615|NCT00466193|16956373|P1|Overall Study|Patient refused Visit 4 procedures|1
4924616|NCT00466193|16956372|P2|Overall Study|Withdrawal by Subject|2
4924617|NCT00466193|16956373|P1|Overall Study|Withdrawal by Subject|7
4924618|NCT00466193|16956372|P2|Overall Study|Protocol Violation|1
4924619|NCT00466193|16956373|P1|Overall Study|Protocol Violation|1
4924620|NCT00466193|16956372|P2|Overall Study|Physician Decision|0
4924621|NCT00466193|16956373|P1|Overall Study|Physician Decision|1
4924622|NCT00466193|16956372|P2|Overall Study|Lost to Follow-up|4
4924623|NCT00466193|16956373|P1|Overall Study|Lost to Follow-up|2
4924624|NCT00466193|16956372|P2|Overall Study|Adverse Event|1
4924625|NCT00466193|16956373|P1|Overall Study|Adverse Event|0
4924626|NCT00466167|16956400|P3|Overall Study|Not treated|0
4924627|NCT00466167|16956401|P2|Overall Study|Not treated|0
4924628|NCT00466167|16956402|P1|Overall Study|Not treated|1
4924629|NCT00466167|16956400|P3|Overall Study|patient did not meet inclusion criteria|1
4924630|NCT00466167|16956401|P2|Overall Study|patient did not meet inclusion criteria|0
4924631|NCT00466167|16956402|P1|Overall Study|patient did not meet inclusion criteria|1
4924632|NCT00466167|16956400|P3|Overall Study|Withdrawal by Subject|6
4924633|NCT00466167|16956401|P2|Overall Study|Withdrawal by Subject|1
4924634|NCT00466167|16956402|P1|Overall Study|Withdrawal by Subject|4
4924635|NCT00466167|16956400|P3|Overall Study|Lost to Follow-up|2
4924636|NCT00466167|16956401|P2|Overall Study|Lost to Follow-up|2
4924637|NCT00466167|16956402|P1|Overall Study|Lost to Follow-up|3
4924638|NCT00466167|16956400|P3|Overall Study|Protocol Violation|2
4924639|NCT00466167|16956401|P2|Overall Study|Protocol Violation|1
4924640|NCT00466167|16956402|P1|Overall Study|Protocol Violation|1
4924641|NCT00466167|16956400|P3|Overall Study|Lack of Efficacy|3
4924642|NCT00466167|16956401|P2|Overall Study|Lack of Efficacy|0
4924643|NCT00466167|16956402|P1|Overall Study|Lack of Efficacy|2
4924644|NCT00466167|16956400|P3|Overall Study|Adverse Event|7
4924645|NCT00466167|16956401|P2|Overall Study|Adverse Event|8
4924646|NCT00466167|16956402|P1|Overall Study|Adverse Event|8
4924647|NCT00465985|16956463|P2|Part III - Open-label Treatment Period|Adverse Event|0
4924648|NCT00465985|16956464|P1|Part III - Open-label Treatment Period|Adverse Event|1
4924649|NCT00465985|16956463|P2|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
4924650|NCT00465985|16956464|P1|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1
4924651|NCT00465985|16956463|P2|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12
4924652|NCT00465985|16956464|P1|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0
4924653|NCT00465985|16956463|P2|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0
4924654|NCT00465985|16956464|P1|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4
4924655|NCT00465972|16956487|P2|Overall Study|Withdrawal by Subject|1
4924656|NCT00465972|16956488|P1|Overall Study|Withdrawal by Subject|2
4924657|NCT00465894|16956498|P2|Treatment For 12 Weeks|Withdrawal by Subject|1
4924658|NCT00465894|16956499|P1|Treatment For 12 Weeks|Withdrawal by Subject|0
4924659|NCT00465894|16956498|P2|Treatment For 12 Weeks|Family Issues|1
4924660|NCT00465894|16956499|P1|Treatment For 12 Weeks|Family Issues|1
4924661|NCT00465894|16956498|P2|Treatment For 12 Weeks|Lost to Follow-up|1
4924662|NCT00465894|16956499|P1|Treatment For 12 Weeks|Lost to Follow-up|4
4924663|NCT00465816|16956532|P3|Overall Study|Lost to Follow-up|2
4924664|NCT00465816|16956533|P2|Overall Study|Lost to Follow-up|0
4924665|NCT00465816|16956534|P1|Overall Study|Lost to Follow-up|0
4924666|NCT00465738|16956597|P2|Overall Study|Other|5
4924667|NCT00465738|16956598|P1|Overall Study|Other|2
4924668|NCT00465738|16956597|P2|Overall Study|Withdrawal by Subject|0
4924669|NCT00465738|16956598|P1|Overall Study|Withdrawal by Subject|2
4924670|NCT00465738|16956597|P2|Overall Study|Adverse Event|1
4924671|NCT00465738|16956598|P1|Overall Study|Adverse Event|0
4924672|NCT00465738|16956597|P2|Overall Study|Lost to Follow-up|0
4924673|NCT00465738|16956598|P1|Overall Study|Lost to Follow-up|2
4924674|NCT00465647|16956692|P4|Overall Study|"The other reasons included loss of IV"|2
4924675|NCT00465647|16956693|P3|Overall Study|"The other reasons included loss of IV"|3
4924676|NCT00465647|16956694|P2|Overall Study|"The other reasons included loss of IV"|4
4924677|NCT00465647|16956695|P1|Overall Study|"The other reasons included loss of IV"|8
4924678|NCT00465647|16956692|P4|Overall Study|Withdrawal by Subject|7
4924679|NCT00465647|16956693|P3|Overall Study|Withdrawal by Subject|2
4924680|NCT00465647|16956694|P2|Overall Study|Withdrawal by Subject|2
4924681|NCT00465647|16956695|P1|Overall Study|Withdrawal by Subject|1
4924682|NCT00465647|16956692|P4|Overall Study|Adverse Event|2
4924683|NCT00465647|16956693|P3|Overall Study|Adverse Event|3
4924684|NCT00465647|16956694|P2|Overall Study|Adverse Event|0
4924685|NCT00465647|16956695|P1|Overall Study|Adverse Event|2
4924686|NCT00465647|16956692|P4|Overall Study|Administrative|2
4924687|NCT00465647|16956693|P3|Overall Study|Administrative|3
4924688|NCT00465647|16956694|P2|Overall Study|Administrative|2
4924689|NCT00465647|16956695|P1|Overall Study|Administrative|2
4924690|NCT00465569|16956743|P2|Overall Study|persistent eczema during dose escalation|0
4924691|NCT00465569|16956744|P1|Overall Study|persistent eczema during dose escalation|1
4924692|NCT00465361|16956767|P1|Baseline Assessment|Personal Issues/Scheduling|4
4924693|NCT00465270|16956773|P2|Overall Study|Investigator request|4
4924694|NCT00465270|16956774|P1|Overall Study|Investigator request|3
4924695|NCT00465270|16956773|P2|Overall Study|Lost to Follow-up|67
4924696|NCT00465270|16956774|P1|Overall Study|Lost to Follow-up|60
4924697|NCT00465270|16956773|P2|Overall Study|Withdrawal by Subject|78
4924698|NCT00465270|16956774|P1|Overall Study|Withdrawal by Subject|34
4924699|NCT00465270|16956773|P2|Overall Study|Death|11
4924700|NCT00465270|16956774|P1|Overall Study|Death|7
4924701|NCT00465179|16956783|P1|Overall Study|Progression of Disease|47
4924702|NCT00465179|16956783|P1|Overall Study|Withdrawal by Subject|2
4924703|NCT00465179|16956783|P1|Overall Study|Adverse Event|4
4924704|NCT00465101|16956789|P1|Overall Study|Withdrew consent prior to procedure|3
4924705|NCT00465101|16956789|P1|Overall Study|Physician Decision|1
4924706|NCT00465101|16956789|P1|Overall Study|Withdrawal by Subject|25
4924707|NCT00465101|16956789|P1|Overall Study|Death|3
4924708|NCT00465101|16956789|P1|Overall Study|Unable to obtain IRB approval|1
4924709|NCT00465101|16956789|P1|Overall Study|Site closed due to IRB expiration|1
4924710|NCT00465101|16956789|P1|Overall Study|Patient postponed procedure|1
4924711|NCT00465101|16956789|P1|Overall Study|Pt. Insurance not accepted at center|2
4924712|NCT00465101|16956789|P1|Overall Study|Other|6
4924713|NCT00465101|16956789|P1|Overall Study|Lost to Follow-up|5
4924714|NCT00465101|16956789|P1|Overall Study|Did not meet study criteria|4
4924715|NCT00465101|16956789|P1|Overall Study|Change in health precluded follow up|4
4924716|NCT00465101|16956789|P1|Overall Study|Aborted Proc./Treatment Not Attempted|3
4924717|NCT00464945|16956859|P2|Toddler Dose|Lost to Follow-up|1
4924718|NCT00464945|16956860|P1|Toddler Dose|Lost to Follow-up|0
4924719|NCT00464945|16956859|P2|After Infant Series|Withdrawal by Subject|2
4924720|NCT00464945|16956860|P1|After Infant Series|Withdrawal by Subject|0
4924721|NCT00464945|16956859|P2|Infant Series|Lost to Follow-up|0
4924722|NCT00464945|16956860|P1|Infant Series|Lost to Follow-up|1
4924723|NCT00464945|16956859|P2|Infant Series|Protocol Violation|0
4924724|NCT00464945|16956860|P1|Infant Series|Protocol Violation|1
4924725|NCT00464945|16956859|P2|Infant Series|Withdrawal by parent/guardian request|1
4924726|NCT00464945|16956860|P1|Infant Series|Withdrawal by parent/guardian request|2
4924727|NCT00464815|16956890|P2|Overall Study|Withdrawal by Subject|3
4924728|NCT00464815|16956891|P1|Overall Study|Withdrawal by Subject|6
4924729|NCT00464737|16956924|P3|Overall Study|Other: Subject's disability per sponsor|1
4924730|NCT00464737|16956925|P2|Overall Study|Other: Subject's disability per sponsor|0
4924731|NCT00464737|16956926|P1|Overall Study|Other: Subject's disability per sponsor|0
4924732|NCT00464737|16956924|P3|Overall Study|Other: Personal family reasons|1
4924733|NCT00464737|16956925|P2|Overall Study|Other: Personal family reasons|0
4924734|NCT00464737|16956926|P1|Overall Study|Other: Personal family reasons|0
4924735|NCT00464737|16956924|P3|Overall Study|Other: Study demands too great|0
4924736|NCT00464737|16956925|P2|Overall Study|Other: Study demands too great|1
4924737|NCT00464737|16956926|P1|Overall Study|Other: Study demands too great|0
4924738|NCT00464737|16956924|P3|Overall Study|Other: Subject left town; family illness|0
4924739|NCT00464737|16956925|P2|Overall Study|Other: Subject left town; family illness|0
4924740|NCT00464737|16956926|P1|Overall Study|Other: Subject left town; family illness|1
4924741|NCT00464737|16956924|P3|Overall Study|Other: Subject's schedule doesn't permit|0
4924742|NCT00464737|16956925|P2|Overall Study|Other: Subject's schedule doesn't permit|0
4924743|NCT00464737|16956926|P1|Overall Study|Other: Subject's schedule doesn't permit|1
4924744|NCT00464737|16956924|P3|Overall Study|Lost to Follow-up|5
4924745|NCT00464737|16956925|P2|Overall Study|Lost to Follow-up|2
4924746|NCT00464737|16956926|P1|Overall Study|Lost to Follow-up|5
4924747|NCT00464737|16956924|P3|Overall Study|Non-compliance|1
4924748|NCT00464737|16956925|P2|Overall Study|Non-compliance|1
4924749|NCT00464737|16956926|P1|Overall Study|Non-compliance|0
4924750|NCT00464737|16956924|P3|Overall Study|Protocol Violation|5
4924751|NCT00464737|16956925|P2|Overall Study|Protocol Violation|1
4924752|NCT00464737|16956926|P1|Overall Study|Protocol Violation|1
4924753|NCT00464737|16956924|P3|Overall Study|Withdrawal by Subject|5
4924754|NCT00464737|16956925|P2|Overall Study|Withdrawal by Subject|3
4924755|NCT00464737|16956926|P1|Overall Study|Withdrawal by Subject|5
4924756|NCT00464737|16956924|P3|Overall Study|Lack of Efficacy|4
4924757|NCT00464737|16956925|P2|Overall Study|Lack of Efficacy|7
4924758|NCT00464737|16956926|P1|Overall Study|Lack of Efficacy|7
4924759|NCT00464737|16956924|P3|Overall Study|Adverse Event|33
4924760|NCT00464737|16956925|P2|Overall Study|Adverse Event|17
4924761|NCT00464737|16956926|P1|Overall Study|Adverse Event|12
4924762|NCT00464672|16957006|P6|Overall Study|Lost to Follow-up|0
4924763|NCT00464672|16957007|P5|Overall Study|Lost to Follow-up|1
4924764|NCT00464672|16957008|P4|Overall Study|Lost to Follow-up|0
4924765|NCT00464672|16957009|P3|Overall Study|Lost to Follow-up|0
4924766|NCT00464672|16957010|P2|Overall Study|Lost to Follow-up|10
4924767|NCT00464672|16957011|P1|Overall Study|Lost to Follow-up|25
4924768|NCT00464672|16957006|P6|Overall Study|withdrawal of consent|4
4924769|NCT00464672|16957007|P5|Overall Study|withdrawal of consent|9
4924770|NCT00464672|16957008|P4|Overall Study|withdrawal of consent|1
4924771|NCT00464672|16957009|P3|Overall Study|withdrawal of consent|0
4924772|NCT00464672|16957010|P2|Overall Study|withdrawal of consent|0
4924773|NCT00464672|16957011|P1|Overall Study|withdrawal of consent|0
4924774|NCT00464620|16957090|P3|Overall Study|Use of prohibited concomitant medication|2
4924775|NCT00464620|16957091|P2|Overall Study|Use of prohibited concomitant medication|0
4924776|NCT00464620|16957092|P1|Overall Study|Use of prohibited concomitant medication|0
4924777|NCT00464620|16957090|P3|Overall Study|Ineligible sarcoma subtype|2
4924778|NCT00464620|16957091|P2|Overall Study|Ineligible sarcoma subtype|2
4924779|NCT00464620|16957092|P1|Overall Study|Ineligible sarcoma subtype|0
4924780|NCT00464620|16957090|P3|Overall Study|Withdrawal by Subject|3
4924781|NCT00464620|16957091|P2|Overall Study|Withdrawal by Subject|0
4924782|NCT00464620|16957092|P1|Overall Study|Withdrawal by Subject|1
4924783|NCT00464620|16957090|P3|Overall Study|Physician Decision|0
4924784|NCT00464620|16957091|P2|Overall Study|Physician Decision|0
4924785|NCT00464620|16957092|P1|Overall Study|Physician Decision|1
4924786|NCT00464568|16957119|P1|Overall Study|Adverse Event|2
4924787|NCT00464542|16957192|P1|Pre-treatment|Withdrawal by Subject|2
4924788|NCT00464490|16957199|P2|Overall Study|Physician Decision|11
4924789|NCT00464490|16957200|P1|Overall Study|Physician Decision|11
4924790|NCT00464334|16957247|P11|Overall Study|Withdrawal by Subject|0
4924791|NCT00464334|16957248|P10|Overall Study|Withdrawal by Subject|0
4924792|NCT00464334|16957249|P9|Overall Study|Withdrawal by Subject|3
4924793|NCT00464334|16957250|P8|Overall Study|Withdrawal by Subject|1
4924794|NCT00464334|16957251|P7|Overall Study|Withdrawal by Subject|2
4924795|NCT00464334|16957252|P6|Overall Study|Withdrawal by Subject|2
4924796|NCT00464334|16957253|P5|Overall Study|Withdrawal by Subject|2
4924797|NCT00464334|16957254|P4|Overall Study|Withdrawal by Subject|2
4924798|NCT00464334|16957255|P3|Overall Study|Withdrawal by Subject|4
4924799|NCT00464334|16957256|P2|Overall Study|Withdrawal by Subject|7
4924800|NCT00464334|16957257|P1|Overall Study|Withdrawal by Subject|1
4924801|NCT00464334|16957247|P11|Overall Study|Study Terminated by Sponsor|0
4924802|NCT00464334|16957248|P10|Overall Study|Study Terminated by Sponsor|0
4924803|NCT00464334|16957249|P9|Overall Study|Study Terminated by Sponsor|0
4924804|NCT00464334|16957250|P8|Overall Study|Study Terminated by Sponsor|0
4924805|NCT00464334|16957251|P7|Overall Study|Study Terminated by Sponsor|0
4924806|NCT00464334|16957252|P6|Overall Study|Study Terminated by Sponsor|0
4924807|NCT00464334|16957253|P5|Overall Study|Study Terminated by Sponsor|0
4924808|NCT00464334|16957254|P4|Overall Study|Study Terminated by Sponsor|1
4924809|NCT00464334|16957255|P3|Overall Study|Study Terminated by Sponsor|0
4924810|NCT00464334|16957256|P2|Overall Study|Study Terminated by Sponsor|0
4924811|NCT00464334|16957257|P1|Overall Study|Study Terminated by Sponsor|0
4924812|NCT00464334|16957247|P11|Overall Study|Progressive Disease|0
4924813|NCT00464334|16957248|P10|Overall Study|Progressive Disease|0
4924814|NCT00464334|16957249|P9|Overall Study|Progressive Disease|1
4924815|NCT00464334|16957250|P8|Overall Study|Progressive Disease|0
4924816|NCT00464334|16957251|P7|Overall Study|Progressive Disease|0
4924817|NCT00464334|16957252|P6|Overall Study|Progressive Disease|1
4924818|NCT00464334|16957253|P5|Overall Study|Progressive Disease|0
4924819|NCT00464334|16957254|P4|Overall Study|Progressive Disease|0
4924820|NCT00464334|16957255|P3|Overall Study|Progressive Disease|0
4924821|NCT00464334|16957256|P2|Overall Study|Progressive Disease|0
4924822|NCT00464334|16957257|P1|Overall Study|Progressive Disease|0
4924823|NCT00464334|16957247|P11|Overall Study|Lost to Follow-up|2
4924824|NCT00464334|16957248|P10|Overall Study|Lost to Follow-up|0
4924825|NCT00464334|16957249|P9|Overall Study|Lost to Follow-up|0
4924826|NCT00464334|16957250|P8|Overall Study|Lost to Follow-up|0
4924827|NCT00464334|16957251|P7|Overall Study|Lost to Follow-up|1
4924828|NCT00464334|16957252|P6|Overall Study|Lost to Follow-up|0
4924829|NCT00464334|16957253|P5|Overall Study|Lost to Follow-up|1
4924830|NCT00464334|16957254|P4|Overall Study|Lost to Follow-up|0
4924831|NCT00464334|16957255|P3|Overall Study|Lost to Follow-up|1
4924832|NCT00464334|16957256|P2|Overall Study|Lost to Follow-up|0
4924833|NCT00464334|16957257|P1|Overall Study|Lost to Follow-up|0
4924834|NCT00464334|16957247|P11|Overall Study|Lack of Efficacy|0
4924835|NCT00464334|16957248|P10|Overall Study|Lack of Efficacy|0
4924836|NCT00464334|16957249|P9|Overall Study|Lack of Efficacy|0
4924837|NCT00464334|16957250|P8|Overall Study|Lack of Efficacy|0
4924838|NCT00464334|16957251|P7|Overall Study|Lack of Efficacy|0
4924839|NCT00464334|16957252|P6|Overall Study|Lack of Efficacy|0
4924840|NCT00464334|16957253|P5|Overall Study|Lack of Efficacy|0
4924841|NCT00464334|16957254|P4|Overall Study|Lack of Efficacy|0
4924842|NCT00464334|16957255|P3|Overall Study|Lack of Efficacy|0
4924843|NCT00464334|16957256|P2|Overall Study|Lack of Efficacy|1
4924844|NCT00464334|16957257|P1|Overall Study|Lack of Efficacy|0
4924845|NCT00464334|16957247|P11|Overall Study|Adverse Event|2
4924846|NCT00464334|16957248|P10|Overall Study|Adverse Event|1
4924847|NCT00464334|16957249|P9|Overall Study|Adverse Event|2
4924848|NCT00464334|16957250|P8|Overall Study|Adverse Event|0
4924849|NCT00464334|16957251|P7|Overall Study|Adverse Event|0
4924850|NCT00464334|16957252|P6|Overall Study|Adverse Event|1
4924851|NCT00464334|16957253|P5|Overall Study|Adverse Event|1
4924852|NCT00464334|16957254|P4|Overall Study|Adverse Event|1
4924853|NCT00464334|16957255|P3|Overall Study|Adverse Event|0
4924854|NCT00464334|16957256|P2|Overall Study|Adverse Event|0
4924855|NCT00464334|16957257|P1|Overall Study|Adverse Event|0
4924856|NCT00464308|16957317|P3|Overall Study|Physician Decision|0
4924857|NCT00464308|16957318|P2|Overall Study|Physician Decision|0
4924858|NCT00464308|16957319|P1|Overall Study|Physician Decision|1
4924859|NCT00464308|16957317|P3|Overall Study|Patient discontinued and other reasons|23
4924860|NCT00464308|16957318|P2|Overall Study|Patient discontinued and other reasons|17
4924861|NCT00464308|16957319|P1|Overall Study|Patient discontinued and other reasons|17
4924862|NCT00464308|16957317|P3|Overall Study|Lost to Follow-up|20
4924863|NCT00464308|16957318|P2|Overall Study|Lost to Follow-up|19
4924864|NCT00464308|16957319|P1|Overall Study|Lost to Follow-up|29
4924865|NCT00464308|16957317|P3|Overall Study|Adverse Event|16
4924866|NCT00464308|16957318|P2|Overall Study|Adverse Event|27
4924867|NCT00464308|16957319|P1|Overall Study|Adverse Event|22
4924868|NCT00464269|16957349|P4|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4924869|NCT00464269|16957350|P3|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1
4924870|NCT00464269|16957351|P2|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4924871|NCT00464269|16957352|P1|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0
4924872|NCT00464269|16957349|P4|Overall Study|AE, non-serious non-fatal|4
4924873|NCT00464269|16957350|P3|Overall Study|AE, non-serious non-fatal|3
4924874|NCT00464269|16957351|P2|Overall Study|AE, non-serious non-fatal|8
4924875|NCT00464269|16957352|P1|Overall Study|AE, non-serious non-fatal|2
4924876|NCT00464269|16957349|P4|Overall Study|SAE, non-fatal|1
4924877|NCT00464269|16957350|P3|Overall Study|SAE, non-fatal|0
4924878|NCT00464269|16957351|P2|Overall Study|SAE, non-fatal|0
4924879|NCT00464269|16957352|P1|Overall Study|SAE, non-fatal|0
4924880|NCT00464269|16957349|P4|Overall Study|AE, serious fatal|1
4924881|NCT00464269|16957350|P3|Overall Study|AE, serious fatal|1
4924882|NCT00464269|16957351|P2|Overall Study|AE, serious fatal|0
4924883|NCT00464269|16957352|P1|Overall Study|AE, serious fatal|0
4924884|NCT00464269|16957349|P4|Overall Study|Other reason|1
4924885|NCT00464269|16957350|P3|Overall Study|Other reason|1
4924886|NCT00464269|16957351|P2|Overall Study|Other reason|3
4924887|NCT00464269|16957352|P1|Overall Study|Other reason|3
4924888|NCT00464269|16957349|P4|Overall Study|Withdrawal by Subject|1
4924889|NCT00464269|16957350|P3|Overall Study|Withdrawal by Subject|1
4924890|NCT00464269|16957351|P2|Overall Study|Withdrawal by Subject|2
4924891|NCT00464269|16957352|P1|Overall Study|Withdrawal by Subject|0
4924892|NCT00464269|16957349|P4|Overall Study|Lost to Follow-up|1
4924893|NCT00464269|16957350|P3|Overall Study|Lost to Follow-up|0
4924894|NCT00464269|16957351|P2|Overall Study|Lost to Follow-up|4
4924895|NCT00464269|16957352|P1|Overall Study|Lost to Follow-up|0
4924896|NCT00464269|16957349|P4|Overall Study|Lack of Efficacy|0
4924897|NCT00464269|16957350|P3|Overall Study|Lack of Efficacy|0
4924898|NCT00464269|16957351|P2|Overall Study|Lack of Efficacy|0
4924899|NCT00464269|16957352|P1|Overall Study|Lack of Efficacy|1
4924900|NCT00464087|16957490|P3|Overall Study|No PCI per inclusion criteria|29
4924901|NCT00464087|16957491|P2|Overall Study|No PCI per inclusion criteria|0
4924902|NCT00464087|16957492|P1|Overall Study|No PCI per inclusion criteria|0
4924903|NCT00463866|16957510|P2|Overall Study|Other|22
4924904|NCT00463866|16957511|P1|Overall Study|Other|22
4924905|NCT00463866|16957510|P2|Overall Study|Mis-Randomization of subject|1
4924906|NCT00463866|16957511|P1|Overall Study|Mis-Randomization of subject|0
4924907|NCT00463866|16957510|P2|Overall Study|Safety Reason|3
4924908|NCT00463866|16957511|P1|Overall Study|Safety Reason|1
4924909|NCT00463866|16957510|P2|Overall Study|Severe Non-Compliance to Protocol|21
4924910|NCT00463866|16957511|P1|Overall Study|Severe Non-Compliance to Protocol|25
4924911|NCT00463866|16957510|P2|Overall Study|Incorrect Enrolment|66
4924912|NCT00463866|16957511|P1|Overall Study|Incorrect Enrolment|64
4924913|NCT00463866|16957510|P2|Overall Study|Lost to Follow-up|55
4924914|NCT00463866|16957511|P1|Overall Study|Lost to Follow-up|46
4924915|NCT00463866|16957510|P2|Overall Study|Withdrawal by Subject|79
4924916|NCT00463866|16957511|P1|Overall Study|Withdrawal by Subject|81
4924917|NCT00463866|16957510|P2|Overall Study|Adverse Event|93
4924918|NCT00463866|16957511|P1|Overall Study|Adverse Event|70
4924919|NCT00463840|16957531|P1|Overall Study|Adverse Event|3
4924920|NCT00463840|16957531|P1|Overall Study|Withdrawal by Subject|2
4924921|NCT00463840|16957531|P1|Overall Study|Disease progression|7
4924922|NCT00463801|16957536|P1|Overall Study|No longer require therapy|1
4924923|NCT00463801|16957536|P1|Overall Study|Lost to Follow-up|5
4924924|NCT00463801|16957536|P1|Overall Study|Adverse Event|4
4924925|NCT00463801|16957536|P1|Overall Study|Lack of Efficacy|2
4924926|NCT00463801|16957536|P1|Overall Study|Protocol Violation|1
4924927|NCT00463788|16957542|P2|Overall Study|Randomized but not treated|1
4924928|NCT00463788|16957543|P1|Overall Study|Randomized but not treated|1
4924929|NCT00463788|16957542|P2|Overall Study|Other|0
4924930|NCT00463788|16957543|P1|Overall Study|Other|3
4924931|NCT00463788|16957542|P2|Overall Study|Protocol Violation|1
4924932|NCT00463788|16957543|P1|Overall Study|Protocol Violation|0
4924933|NCT00463788|16957542|P2|Overall Study|Lost to Follow-up|0
4924934|NCT00463788|16957543|P1|Overall Study|Lost to Follow-up|1
4924935|NCT00463788|16957542|P2|Overall Study|Symptomatic Deterioration|3
4924936|NCT00463788|16957543|P1|Overall Study|Symptomatic Deterioration|2
4924937|NCT00463788|16957542|P2|Overall Study|Death|3
4924938|NCT00463788|16957543|P1|Overall Study|Death|4
4924939|NCT00463788|16957542|P2|Overall Study|Withdrawal by Subject|2
4924940|NCT00463788|16957543|P1|Overall Study|Withdrawal by Subject|6
4924941|NCT00463788|16957542|P2|Overall Study|Adverse Event|2
4924942|NCT00463788|16957543|P1|Overall Study|Adverse Event|6
4924943|NCT00463788|16957542|P2|Overall Study|Progressive Disease|42
4924944|NCT00463788|16957543|P1|Overall Study|Progressive Disease|86
4924945|NCT00463684|16957558|P1|Overall Study|Lost to Follow-up|3
4924946|NCT00463684|16957558|P1|Overall Study|Withdrawal by Subject|1
4924947|NCT00463606|16957576|P3|Overall Study|Protocol Violation|1
4924948|NCT00463606|16957577|P2|Overall Study|Protocol Violation|0
4924949|NCT00463606|16957578|P1|Overall Study|Protocol Violation|0
4924950|NCT00463606|16957576|P3|Overall Study|Participation in another ABT-335 trial|0
4924951|NCT00463606|16957577|P2|Overall Study|Participation in another ABT-335 trial|0
4924952|NCT00463606|16957578|P1|Overall Study|Participation in another ABT-335 trial|1
4924953|NCT00463606|16957576|P3|Overall Study|Patient randomized in error|0
4924954|NCT00463606|16957577|P2|Overall Study|Patient randomized in error|0
4924955|NCT00463606|16957578|P1|Overall Study|Patient randomized in error|1
4924956|NCT00463606|16957576|P3|Overall Study|Coordinator error|0
4924957|NCT00463606|16957577|P2|Overall Study|Coordinator error|0
4924958|NCT00463606|16957578|P1|Overall Study|Coordinator error|1
4924959|NCT00463606|16957576|P3|Overall Study|Exclusion criteria violation|0
4924960|NCT00463606|16957577|P2|Overall Study|Exclusion criteria violation|0
4924961|NCT00463606|16957578|P1|Overall Study|Exclusion criteria violation|2
4924962|NCT00463606|16957576|P3|Overall Study|Sponsor request|0
4924963|NCT00463606|16957577|P2|Overall Study|Sponsor request|1
4924964|NCT00463606|16957578|P1|Overall Study|Sponsor request|0
4924965|NCT00463606|16957576|P3|Overall Study|Physician Decision|0
4924966|NCT00463606|16957577|P2|Overall Study|Physician Decision|1
4924967|NCT00463606|16957578|P1|Overall Study|Physician Decision|0
4924968|NCT00463606|16957576|P3|Overall Study|Subject moved out of town|0
4924969|NCT00463606|16957577|P2|Overall Study|Subject moved out of town|0
4924970|NCT00463606|16957578|P1|Overall Study|Subject moved out of town|1
4924971|NCT00463606|16957576|P3|Overall Study|Subject noncompliance|0
4924972|NCT00463606|16957577|P2|Overall Study|Subject noncompliance|1
4924973|NCT00463606|16957578|P1|Overall Study|Subject noncompliance|1
4924974|NCT00463606|16957576|P3|Overall Study|Lost to Follow-up|3
4924975|NCT00463606|16957577|P2|Overall Study|Lost to Follow-up|2
4924976|NCT00463606|16957578|P1|Overall Study|Lost to Follow-up|2
4924977|NCT00463606|16957576|P3|Overall Study|Withdrawal by Subject|5
4924978|NCT00463606|16957577|P2|Overall Study|Withdrawal by Subject|11
4924979|NCT00463606|16957578|P1|Overall Study|Withdrawal by Subject|11
4924980|NCT00463606|16957576|P3|Overall Study|Adverse Event|11
4924981|NCT00463606|16957577|P2|Overall Study|Adverse Event|18
4924982|NCT00463606|16957578|P1|Overall Study|Adverse Event|21
4924983|NCT00463580|16957603|P2|Overall Study|Medical/psychiatric complications|2
4924984|NCT00463580|16957604|P1|Overall Study|Medical/psychiatric complications|0
4924985|NCT00463580|16957603|P2|Overall Study|Schedule conflict|0
4924986|NCT00463580|16957604|P1|Overall Study|Schedule conflict|2
4924987|NCT00463580|16957603|P2|Overall Study|Lost to Follow-up|0
4924988|NCT00463580|16957604|P1|Overall Study|Lost to Follow-up|1
4924989|NCT00463567|16957637|P7|Overall Study|Death|0
4924990|NCT00463567|16957638|P6|Overall Study|Death|0
4924991|NCT00463567|16957639|P5|Overall Study|Death|0
4924992|NCT00463567|16957640|P4|Overall Study|Death|0
4924993|NCT00463567|16957641|P3|Overall Study|Death|2
4924994|NCT00463567|16957642|P2|Overall Study|Death|0
4924995|NCT00463567|16957643|P1|Overall Study|Death|1
4924996|NCT00463567|16957637|P7|Overall Study|Abnormal test procedure result(s)|0
4924997|NCT00463567|16957638|P6|Overall Study|Abnormal test procedure result(s)|2
4924998|NCT00463567|16957639|P5|Overall Study|Abnormal test procedure result(s)|0
4924999|NCT00463567|16957640|P4|Overall Study|Abnormal test procedure result(s)|2
4925000|NCT00463567|16957641|P3|Overall Study|Abnormal test procedure result(s)|6
4925001|NCT00463567|16957642|P2|Overall Study|Abnormal test procedure result(s)|1
4925002|NCT00463567|16957643|P1|Overall Study|Abnormal test procedure result(s)|1
4925003|NCT00463567|16957637|P7|Overall Study|Abnormal lab value(s)|0
4925004|NCT00463567|16957638|P6|Overall Study|Abnormal lab value(s)|0
4925005|NCT00463567|16957639|P5|Overall Study|Abnormal lab value(s)|1
4925006|NCT00463567|16957640|P4|Overall Study|Abnormal lab value(s)|1
4925007|NCT00463567|16957641|P3|Overall Study|Abnormal lab value(s)|2
4925008|NCT00463567|16957642|P2|Overall Study|Abnormal lab value(s)|1
4925009|NCT00463567|16957643|P1|Overall Study|Abnormal lab value(s)|1
4925010|NCT00463567|16957637|P7|Overall Study|Lack of Efficacy|1
4925011|NCT00463567|16957638|P6|Overall Study|Lack of Efficacy|0
4925012|NCT00463567|16957639|P5|Overall Study|Lack of Efficacy|1
4925013|NCT00463567|16957640|P4|Overall Study|Lack of Efficacy|17
4925014|NCT00463567|16957641|P3|Overall Study|Lack of Efficacy|9
4925015|NCT00463567|16957642|P2|Overall Study|Lack of Efficacy|9
4925016|NCT00463567|16957643|P1|Overall Study|Lack of Efficacy|4
4925017|NCT00463567|16957637|P7|Overall Study|Administrative problems|2
4925018|NCT00463567|16957638|P6|Overall Study|Administrative problems|2
4925019|NCT00463567|16957639|P5|Overall Study|Administrative problems|3
4925020|NCT00463567|16957640|P4|Overall Study|Administrative problems|9
4925021|NCT00463567|16957641|P3|Overall Study|Administrative problems|6
4925022|NCT00463567|16957642|P2|Overall Study|Administrative problems|3
4925023|NCT00463567|16957643|P1|Overall Study|Administrative problems|5
4925024|NCT00463567|16957637|P7|Overall Study|Lost to Follow-up|1
4925025|NCT00463567|16957638|P6|Overall Study|Lost to Follow-up|1
4925026|NCT00463567|16957639|P5|Overall Study|Lost to Follow-up|1
4925027|NCT00463567|16957640|P4|Overall Study|Lost to Follow-up|8
4925028|NCT00463567|16957641|P3|Overall Study|Lost to Follow-up|13
4925029|NCT00463567|16957642|P2|Overall Study|Lost to Follow-up|6
4925030|NCT00463567|16957643|P1|Overall Study|Lost to Follow-up|12
4925031|NCT00463567|16957637|P7|Overall Study|Protocol Deviation|2
4925032|NCT00463567|16957638|P6|Overall Study|Protocol Deviation|1
4925033|NCT00463567|16957639|P5|Overall Study|Protocol Deviation|1
4925034|NCT00463567|16957640|P4|Overall Study|Protocol Deviation|11
4925035|NCT00463567|16957641|P3|Overall Study|Protocol Deviation|14
4925036|NCT00463567|16957642|P2|Overall Study|Protocol Deviation|9
4925037|NCT00463567|16957643|P1|Overall Study|Protocol Deviation|13
4925038|NCT00463567|16957637|P7|Overall Study|Withdrawal by Subject|1
4925039|NCT00463567|16957638|P6|Overall Study|Withdrawal by Subject|5
4925040|NCT00463567|16957639|P5|Overall Study|Withdrawal by Subject|6
4925041|NCT00463567|16957640|P4|Overall Study|Withdrawal by Subject|37
4925042|NCT00463567|16957641|P3|Overall Study|Withdrawal by Subject|20
4925043|NCT00463567|16957642|P2|Overall Study|Withdrawal by Subject|22
4925044|NCT00463567|16957643|P1|Overall Study|Withdrawal by Subject|29
4925045|NCT00463567|16957637|P7|Overall Study|Adverse Event|4
4925046|NCT00463567|16957638|P6|Overall Study|Adverse Event|10
4925047|NCT00463567|16957639|P5|Overall Study|Adverse Event|10
4925048|NCT00463567|16957640|P4|Overall Study|Adverse Event|46
4925049|NCT00463567|16957641|P3|Overall Study|Adverse Event|17
4925050|NCT00463567|16957642|P2|Overall Study|Adverse Event|26
4925051|NCT00463567|16957643|P1|Overall Study|Adverse Event|29
4925052|NCT00463476|16957676|P2|Overall Study|Lost to Follow-up|1
4925053|NCT00463476|16957677|P1|Overall Study|Lost to Follow-up|1
4925054|NCT00463476|16957676|P2|Overall Study|Withdrawal by Subject|2
4925055|NCT00463476|16957677|P1|Overall Study|Withdrawal by Subject|1
4925056|NCT00463385|16957766|P4|Overall Study|1 participant received commercial drug|0
4925057|NCT00463385|16957767|P3|Overall Study|1 participant received commercial drug|0
4925058|NCT00463385|16957768|P2|Overall Study|1 participant received commercial drug|1
4925059|NCT00463385|16957769|P1|Overall Study|1 participant received commercial drug|0
4925060|NCT00463385|16957766|P4|Overall Study|Missing|2
4925061|NCT00463385|16957767|P3|Overall Study|Missing|0
4925062|NCT00463385|16957768|P2|Overall Study|Missing|0
4925063|NCT00463385|16957769|P1|Overall Study|Missing|2
4925064|NCT00463385|16957766|P4|Overall Study|Death|0
4925065|NCT00463385|16957767|P3|Overall Study|Death|2
4925066|NCT00463385|16957768|P2|Overall Study|Death|1
4925067|NCT00463385|16957769|P1|Overall Study|Death|2
4925068|NCT00463385|16957766|P4|Overall Study|Lost to Follow-up|1
4925069|NCT00463385|16957767|P3|Overall Study|Lost to Follow-up|0
4925070|NCT00463385|16957768|P2|Overall Study|Lost to Follow-up|0
4925071|NCT00463385|16957769|P1|Overall Study|Lost to Follow-up|0
4925072|NCT00463385|16957766|P4|Overall Study|Withdrawal by Subject|4
4925073|NCT00463385|16957767|P3|Overall Study|Withdrawal by Subject|3
4925074|NCT00463385|16957768|P2|Overall Study|Withdrawal by Subject|3
4925075|NCT00463385|16957769|P1|Overall Study|Withdrawal by Subject|3
4925076|NCT00463385|16957766|P4|Overall Study|Lack of Efficacy|9
4925077|NCT00463385|16957767|P3|Overall Study|Lack of Efficacy|7
4925078|NCT00463385|16957768|P2|Overall Study|Lack of Efficacy|6
4925079|NCT00463385|16957769|P1|Overall Study|Lack of Efficacy|6
4925080|NCT00463385|16957766|P4|Overall Study|Adverse Event|2
4925081|NCT00463385|16957767|P3|Overall Study|Adverse Event|4
4925082|NCT00463385|16957768|P2|Overall Study|Adverse Event|8
4925083|NCT00463385|16957769|P1|Overall Study|Adverse Event|5
4925084|NCT00463385|16957766|P4|Overall Study|Other|4
4925085|NCT00463385|16957767|P3|Overall Study|Other|6
4925086|NCT00463385|16957768|P2|Overall Study|Other|3
4925087|NCT00463385|16957769|P1|Overall Study|Other|4
4925088|NCT00463346|16957821|P2|Overall Study|Withdrawal by Subject|3
4925089|NCT00463346|16957822|P1|Overall Study|Withdrawal by Subject|3
4925090|NCT00463229|16957832|P2|Overall Study|Death|3
4925091|NCT00463229|16957833|P1|Overall Study|Death|4
4925092|NCT00463229|16957832|P2|Overall Study|Lost to Follow-up|7
4925093|NCT00463229|16957833|P1|Overall Study|Lost to Follow-up|5
4925094|NCT00463060|16957853|P1|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1
4925095|NCT00463060|16957853|P1|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5
4925096|NCT00463047|16957867|P2|Double-Blind Treatment Period 2|Non-compliance with procedures|0
4925097|NCT00463047|16957868|P1|Double-Blind Treatment Period 2|Non-compliance with procedures|1
4925098|NCT00463047|16957867|P2|Double-Blind Treatment Period 2|Withdrawal by Subject|1
4925099|NCT00463047|16957868|P1|Double-Blind Treatment Period 2|Withdrawal by Subject|0
4925100|NCT00463047|16957867|P2|Double-Blind Treatment Period 2|Adverse Event|1
4925101|NCT00463047|16957868|P1|Double-Blind Treatment Period 2|Adverse Event|0
4925102|NCT00463047|16957867|P2|Double-Blind Treatment Period 1|Other|0
4925103|NCT00463047|16957868|P1|Double-Blind Treatment Period 1|Other|1
4925104|NCT00463047|16957867|P2|Double-Blind Treatment Period 1|Non-compliance with procedures|0
4925105|NCT00463047|16957868|P1|Double-Blind Treatment Period 1|Non-compliance with procedures|1
4925106|NCT00463047|16957867|P2|Double-Blind Treatment Period 1|Protocol Violation|2
4925107|NCT00463047|16957868|P1|Double-Blind Treatment Period 1|Protocol Violation|1
4925108|NCT00463047|16957867|P2|Double-Blind Treatment Period 1|Adverse Event|2
4925109|NCT00463047|16957868|P1|Double-Blind Treatment Period 1|Adverse Event|0
4925110|NCT00463047|16957867|P2|Titration Period 2|Other|2
4925111|NCT00463047|16957868|P1|Titration Period 2|Other|3
4925112|NCT00463047|16957867|P2|Titration Period 2|Non-compliance procedures|1
4925113|NCT00463047|16957868|P1|Titration Period 2|Non-compliance procedures|4
4925114|NCT00463047|16957867|P2|Titration Period 2|Non-compliance study medication|2
4925115|NCT00463047|16957868|P1|Titration Period 2|Non-compliance study medication|4
4925116|NCT00463047|16957867|P2|Titration Period 2|Lost to Follow-up|2
4925117|NCT00463047|16957868|P1|Titration Period 2|Lost to Follow-up|1
4925118|NCT00463047|16957867|P2|Titration Period 2|Protocol Violation|3
4925119|NCT00463047|16957868|P1|Titration Period 2|Protocol Violation|2
4925120|NCT00463047|16957867|P2|Titration Period 2|Withdrawal by Subject|0
4925121|NCT00463047|16957868|P1|Titration Period 2|Withdrawal by Subject|1
4925122|NCT00463047|16957867|P2|Titration Period 2|Lack of Efficacy|4
4925123|NCT00463047|16957868|P1|Titration Period 2|Lack of Efficacy|6
4925124|NCT00463047|16957867|P2|Titration Period 2|Adverse Event|9
4925125|NCT00463047|16957868|P1|Titration Period 2|Adverse Event|9
4925126|NCT00463047|16957867|P2|Titration Period 1|Other|2
4925127|NCT00463047|16957868|P1|Titration Period 1|Other|0
4925128|NCT00463047|16957867|P2|Titration Period 1|Non-compliance procedures|10
4925129|NCT00463047|16957868|P1|Titration Period 1|Non-compliance procedures|4
4925130|NCT00463047|16957867|P2|Titration Period 1|Withdrawal by Subject|5
4925131|NCT00463047|16957868|P1|Titration Period 1|Withdrawal by Subject|3
4925132|NCT00463047|16957867|P2|Titration Period 1|Protocol Violation|5
4925133|NCT00463047|16957868|P1|Titration Period 1|Protocol Violation|5
4925134|NCT00463047|16957867|P2|Titration Period 1|Non-compliance with study medication|5
4925135|NCT00463047|16957868|P1|Titration Period 1|Non-compliance with study medication|3
4925136|NCT00463047|16957867|P2|Titration Period 1|Lost to Follow-up|0
4925137|NCT00463047|16957868|P1|Titration Period 1|Lost to Follow-up|2
4925138|NCT00463047|16957867|P2|Titration Period 1|Lack of Efficacy|4
4925139|NCT00463047|16957868|P1|Titration Period 1|Lack of Efficacy|10
4925140|NCT00463047|16957867|P2|Titration Period 1|Adverse Event|8
4925141|NCT00463047|16957868|P1|Titration Period 1|Adverse Event|10
4925142|NCT00462982|16957953|P1|Overall Study|Patient Not Treated|2
4925143|NCT00462982|16957953|P1|Overall Study|Adverse Event|1
4925144|NCT00462943|16957960|P3|Overall Study|Withdrawal by Subject|0
4925145|NCT00462943|16957961|P2|Overall Study|Withdrawal by Subject|1
4925146|NCT00462943|16957962|P1|Overall Study|Withdrawal by Subject|0
4925147|NCT00462943|16957960|P3|Overall Study|Physician Decision|0
4925148|NCT00462943|16957961|P2|Overall Study|Physician Decision|0
4925149|NCT00462943|16957962|P1|Overall Study|Physician Decision|1
4925150|NCT00462943|16957960|P3|Overall Study|Transplant - not specified|1
4925151|NCT00462943|16957961|P2|Overall Study|Transplant - not specified|0
4925152|NCT00462943|16957962|P1|Overall Study|Transplant - not specified|1
4925153|NCT00462943|16957960|P3|Overall Study|Required Lymphocyte Infusion|0
4925154|NCT00462943|16957961|P2|Overall Study|Required Lymphocyte Infusion|0
4925155|NCT00462943|16957962|P1|Overall Study|Required Lymphocyte Infusion|1
4925156|NCT00462943|16957960|P3|Overall Study|Bone Marrow Transplant|0
4925157|NCT00462943|16957961|P2|Overall Study|Bone Marrow Transplant|0
4925158|NCT00462943|16957962|P1|Overall Study|Bone Marrow Transplant|1
4925159|NCT00462943|16957960|P3|Overall Study|Stem Cell Transplant|0
4925160|NCT00462943|16957961|P2|Overall Study|Stem Cell Transplant|1
4925161|NCT00462943|16957962|P1|Overall Study|Stem Cell Transplant|1
4925162|NCT00462943|16957960|P3|Overall Study|Death|7
4925163|NCT00462943|16957961|P2|Overall Study|Death|2
4925164|NCT00462943|16957962|P1|Overall Study|Death|5
4925165|NCT00462943|16957960|P3|Overall Study|Disease Progression|9
4925166|NCT00462943|16957961|P2|Overall Study|Disease Progression|15
4925167|NCT00462943|16957962|P1|Overall Study|Disease Progression|15
4925168|NCT00462943|16957960|P3|Overall Study|Request of Patient, PI, Sponsor or RA|4
4925169|NCT00462943|16957961|P2|Overall Study|Request of Patient, PI, Sponsor or RA|2
4925170|NCT00462943|16957962|P1|Overall Study|Request of Patient, PI, Sponsor or RA|8
4925171|NCT00462943|16957960|P3|Overall Study|Protocol Violation|0
4925172|NCT00462943|16957961|P2|Overall Study|Protocol Violation|0
4925173|NCT00462943|16957962|P1|Overall Study|Protocol Violation|1
4925174|NCT00462943|16957960|P3|Overall Study|Adverse Event|1
4925175|NCT00462943|16957961|P2|Overall Study|Adverse Event|4
4925176|NCT00462943|16957962|P1|Overall Study|Adverse Event|6
4925177|NCT00462943|16957960|P3|Overall Study|Failure to achieve a response|1
4925178|NCT00462943|16957961|P2|Overall Study|Failure to achieve a response|5
4925179|NCT00462943|16957962|P1|Overall Study|Failure to achieve a response|5
4925180|NCT00462904|16958054|P1|Overall Study|Lost to Follow-up|1
4925181|NCT00462865|16958059|P1|Overall Study|Adverse Event|1
4925182|NCT00462826|16958079|P1|Overall Study|Never treated|1
4925183|NCT00462826|16958079|P1|Overall Study|Ineligible - wrong primary|2
4925184|NCT00462826|16958079|P1|Overall Study|Ineligible - wrong cell type|1
4925185|NCT00462826|16958079|P1|Overall Study|Ineligible - second primary|1
4925186|NCT00462761|16958092|P1|Overall Study|Other|1
4925187|NCT00462761|16958092|P1|Overall Study|Death|12
4925188|NCT00462761|16958092|P1|Overall Study|Disease progression|43
4925189|NCT00462761|16958092|P1|Overall Study|Physician Decision|5
4925190|NCT00462761|16958092|P1|Overall Study|Withdrawal by Subject|9
4925191|NCT00462761|16958092|P1|Overall Study|Adverse Event|6
4925192|NCT00462748|16958167|P3|Overall Study|Discontinued after 41 days Rx|0
4925193|NCT00462748|16958168|P2|Overall Study|Discontinued after 41 days Rx|0
4925194|NCT00462748|16958169|P1|Overall Study|Discontinued after 41 days Rx|1
4925195|NCT00462748|16958167|P3|Overall Study|Lost to Follow-up|1
4925196|NCT00462748|16958168|P2|Overall Study|Lost to Follow-up|1
4925197|NCT00462748|16958169|P1|Overall Study|Lost to Follow-up|1
4925198|NCT00462748|16958167|P3|Overall Study|Withdrew consent|0
4925199|NCT00462748|16958168|P2|Overall Study|Withdrew consent|3
4925200|NCT00462748|16958169|P1|Overall Study|Withdrew consent|3
4925201|NCT00462748|16958167|P3|Overall Study|Protocol Violation|1
4925202|NCT00462748|16958168|P2|Overall Study|Protocol Violation|2
4925203|NCT00462748|16958169|P1|Overall Study|Protocol Violation|0
4925204|NCT00462748|16958167|P3|Overall Study|Adverse Event|9
4925205|NCT00462748|16958168|P2|Overall Study|Adverse Event|5
4925206|NCT00462748|16958169|P1|Overall Study|Adverse Event|7
4925207|NCT00462709|16958222|P1|Overall Study|Withdrew to start treatment with Cetor|1
4925208|NCT00462709|16958222|P1|Overall Study|Physician Decision|1
4925209|NCT00462709|16958222|P1|Overall Study|Logistical reasons|2
4925210|NCT00462709|16958222|P1|Overall Study|Death|2
4925211|NCT00462709|16958222|P1|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3
4925212|NCT00462709|16958222|P1|Overall Study|Withdrawal by Subject|8
4925213|NCT00462709|16958222|P1|Overall Study|Lost to Follow-up|10
4925214|NCT00462709|16958222|P1|Overall Study|Transitioned to commercial C1INH-nf|40
4925215|NCT00462670|16958231|P2|Overall Study|Resolution of signs and symptoms|2
4925216|NCT00462670|16958232|P1|Overall Study|Resolution of signs and symptoms|0
4925217|NCT00462670|16958231|P2|Overall Study|Protocol Violation|0
4925218|NCT00462670|16958232|P1|Overall Study|Protocol Violation|1
4925219|NCT00462670|16958231|P2|Overall Study|Lack of Efficacy|0
4925220|NCT00462670|16958232|P1|Overall Study|Lack of Efficacy|1
4925221|NCT00462670|16958231|P2|Overall Study|Adverse Event|5
4925222|NCT00462670|16958232|P1|Overall Study|Adverse Event|3
4925223|NCT00462501|16958269|P1|Overall Study|Adverse Event|2
4925224|NCT00462501|16958269|P1|Overall Study|Not treated|3
4925225|NCT00462488|16958275|P2|Overall Study|Lack of Efficacy|17
4925226|NCT00462488|16958276|P1|Overall Study|Lack of Efficacy|19
4925227|NCT00462488|16958275|P2|Overall Study|Protocol Violation|0
4925228|NCT00462488|16958276|P1|Overall Study|Protocol Violation|1
4925229|NCT00462462|16958284|P2|Overall Study|Physician Decision|1
4925230|NCT00462462|16958285|P1|Overall Study|Physician Decision|0
4925231|NCT00462384|16958313|P1|Overall Study|Other|4
4925232|NCT00462384|16958313|P1|Overall Study|Withdrawal by Subject|1
4925233|NCT00462384|16958313|P1|Overall Study|Death|2
4925234|NCT00462384|16958313|P1|Overall Study|Adverse Event|2
4925235|NCT00462345|16958321|P1|Overall Study|Did not complete second course|1
4925236|NCT00462345|16958321|P1|Overall Study|Withdrawal by Subject|2
4925237|NCT00462306|16958356|P2|Overall Study|insufficient data|13
4925238|NCT00462306|16958357|P1|Overall Study|insufficient data|0
4925239|NCT00461981|16958488|P2|Overall Study|Withdrawal by Subject|3
4925240|NCT00461981|16958489|P1|Overall Study|Withdrawal by Subject|2
4925241|NCT00461981|16958488|P2|Overall Study|Lost to Follow-up|6
4925242|NCT00461981|16958489|P1|Overall Study|Lost to Follow-up|9
4925243|NCT00461812|16958605|P1|Overall Study|study terminated|10
4925244|NCT00461786|16958610|P1|Overall Study|Inevaluable (Never Treated)|1
4925245|NCT00461786|16958610|P1|Overall Study|Entry Criteria Not Met|2
4925246|NCT00461708|16958655|P2|Overall Study|Death|1
4925247|NCT00461708|16958656|P1|Overall Study|Death|8
4925248|NCT00461708|16958655|P2|Overall Study|Other|4
4925249|NCT00461708|16958656|P1|Overall Study|Other|4
4925250|NCT00461708|16958655|P2|Overall Study|Withdrawal by Subject|2
4925251|NCT00461708|16958656|P1|Overall Study|Withdrawal by Subject|8
4925252|NCT00461708|16958655|P2|Overall Study|Physician Decision|4
4925253|NCT00461708|16958656|P1|Overall Study|Physician Decision|10
4925254|NCT00461708|16958655|P2|Overall Study|Lack of Efficacy|20
4925255|NCT00461708|16958656|P1|Overall Study|Lack of Efficacy|68
4925256|NCT00461708|16958655|P2|Overall Study|Adverse Event|7
4925257|NCT00461708|16958656|P1|Overall Study|Adverse Event|17
4925258|NCT00461682|16958682|P1|Overall Study|Protocol Violation|1
4925259|NCT00461630|16958710|P2|Overall Study|Lost to Follow-up|95
4925260|NCT00461630|16958711|P1|Overall Study|Lost to Follow-up|108
4925261|NCT00461630|16958710|P2|Overall Study|Death|732
4925262|NCT00461630|16958711|P1|Overall Study|Death|798
4925263|NCT00461552|16958750|P2|Overall Study|Drug Dispensing error|2
4925264|NCT00461552|16958751|P1|Overall Study|Drug Dispensing error|0
4925265|NCT00461500|16958774|P2|Overall Study|Lost to Follow-up|2
4925266|NCT00461500|16958775|P1|Overall Study|Lost to Follow-up|2
4925267|NCT00461500|16958774|P2|Overall Study|No Longer Willing to Take Part in Study|0
4925268|NCT00461500|16958775|P1|Overall Study|No Longer Willing to Take Part in Study|1
4925269|NCT00461500|16958774|P2|Overall Study|Drug Treatment Misuse|0
4925270|NCT00461500|16958775|P1|Overall Study|Drug Treatment Misuse|1
4925271|NCT00461500|16958774|P2|Overall Study|Study Stopped|2
4925272|NCT00461500|16958775|P1|Overall Study|Study Stopped|1
4925273|NCT00461500|16958774|P2|Overall Study|Expired Drug Treatment|1
4925274|NCT00461500|16958775|P1|Overall Study|Expired Drug Treatment|1
4925275|NCT00461500|16958774|P2|Overall Study|Lack of Efficacy|1
4925276|NCT00461500|16958775|P1|Overall Study|Lack of Efficacy|0
4925277|NCT00461500|16958774|P2|Overall Study|Adverse Event|0
4925278|NCT00461500|16958775|P1|Overall Study|Adverse Event|1
4925279|NCT00461305|16958818|P2|Continued Treatment|Other (missing drug etc)|0
4925280|NCT00461305|16958819|P1|Continued Treatment|Other (missing drug etc)|2
4925281|NCT00461305|16958818|P2|Continued Treatment|Partially missing diary|0
4925282|NCT00461305|16958819|P1|Continued Treatment|Partially missing diary|2
4925283|NCT00461305|16958818|P2|Continued Treatment|Withdrawal by Subject|0
4925284|NCT00461305|16958819|P1|Continued Treatment|Withdrawal by Subject|48
4925285|NCT00461305|16958818|P2|Continued Treatment|Protocol Violation|0
4925286|NCT00461305|16958819|P1|Continued Treatment|Protocol Violation|13
4925287|NCT00461305|16958818|P2|Continued Treatment|Lost to Follow-up|0
4925288|NCT00461305|16958819|P1|Continued Treatment|Lost to Follow-up|4
4925289|NCT00461305|16958818|P2|Continued Treatment|Adverse Event|0
4925290|NCT00461305|16958819|P1|Continued Treatment|Adverse Event|26
4925291|NCT00461305|16958818|P2|Treatment|Other (missing drug etc)|0
4925292|NCT00461305|16958819|P1|Treatment|Other (missing drug etc)|2
4925293|NCT00461305|16958818|P2|Treatment|Partially missing diary|0
4925294|NCT00461305|16958819|P1|Treatment|Partially missing diary|2
4925295|NCT00461305|16958818|P2|Treatment|Study drug not taken|0
4925296|NCT00461305|16958819|P1|Treatment|Study drug not taken|1
4925297|NCT00461305|16958818|P2|Treatment|Never dispensed|0
4925298|NCT00461305|16958819|P1|Treatment|Never dispensed|5
4925299|NCT00461305|16958818|P2|Treatment|Withdrawal by Subject|2
4925300|NCT00461305|16958819|P1|Treatment|Withdrawal by Subject|48
4925301|NCT00461305|16958818|P2|Treatment|Protocol Violation|2
4925302|NCT00461305|16958819|P1|Treatment|Protocol Violation|13
4925303|NCT00461305|16958818|P2|Treatment|Lost to Follow-up|2
4925304|NCT00461305|16958819|P1|Treatment|Lost to Follow-up|4
4925305|NCT00461305|16958818|P2|Treatment|Adverse Event|3
4925306|NCT00461305|16958819|P1|Treatment|Adverse Event|26
4925307|NCT00461253|16958903|P2|Overall Study|administrative|7773
4925308|NCT00461253|16958904|P1|Overall Study|administrative|773
4925309|NCT00461253|16958903|P2|Overall Study|no response|11789
4925310|NCT00461253|16958904|P1|Overall Study|no response|2609
4925311|NCT00461253|16958903|P2|Overall Study|Protocol Violation|236
4925312|NCT00461253|16958904|P1|Overall Study|Protocol Violation|613
4925313|NCT00461253|16958903|P2|Overall Study|Death|0
4925314|NCT00461253|16958904|P1|Overall Study|Death|985
4925315|NCT00461175|16958912|P2|Overall Study|Protocol Violation|365
4925316|NCT00461175|16958913|P1|Overall Study|Protocol Violation|522
4925317|NCT00461123|16958923|P2|Overall Study|Withdrawal by Subject|3
4925318|NCT00461123|16958924|P1|Overall Study|Withdrawal by Subject|1
4925319|NCT00461123|16958923|P2|Overall Study|Protocol Violation|2
4925320|NCT00461123|16958924|P1|Overall Study|Protocol Violation|3
4925321|NCT00461123|16958923|P2|Overall Study|Lost to Follow-up|1
4925322|NCT00461123|16958924|P1|Overall Study|Lost to Follow-up|1
4925323|NCT00461123|16958923|P2|Overall Study|Adverse Event|0
4925324|NCT00461123|16958924|P1|Overall Study|Adverse Event|1
4925325|NCT00461032|16958969|P2|Overall Study|Other|5
4925326|NCT00461032|16958970|P1|Overall Study|Other|7
4925327|NCT00461032|16958969|P2|Overall Study|Patient Moved or Relocated|1
4925328|NCT00461032|16958970|P1|Overall Study|Patient Moved or Relocated|2
4925329|NCT00461032|16958969|P2|Overall Study|Withdrawal by Subject|15
4925330|NCT00461032|16958970|P1|Overall Study|Withdrawal by Subject|7
4925331|NCT00461032|16958969|P2|Overall Study|Protocol Violation|4
4925332|NCT00461032|16958970|P1|Overall Study|Protocol Violation|4
4925333|NCT00461032|16958969|P2|Overall Study|Lost to Follow-up|12
4925334|NCT00461032|16958970|P1|Overall Study|Lost to Follow-up|7
4925335|NCT00461032|16958969|P2|Overall Study|Lack of Efficacy|1
4925336|NCT00461032|16958970|P1|Overall Study|Lack of Efficacy|5
4925337|NCT00461032|16958969|P2|Overall Study|Adverse Event|6
4925338|NCT00461032|16958970|P1|Overall Study|Adverse Event|5
4925339|NCT00460811|16958996|P5|Overall Study|Lost to Follow-up|6
4925340|NCT00460811|16958997|P4|Overall Study|Lost to Follow-up|3
4925341|NCT00460811|16958998|P3|Overall Study|Lost to Follow-up|5
4925342|NCT00460811|16958999|P2|Overall Study|Lost to Follow-up|2
4925343|NCT00460811|16959000|P1|Overall Study|Lost to Follow-up|3
4925344|NCT00460811|16958996|P5|Overall Study|Physician Decision|0
4925345|NCT00460811|16958997|P4|Overall Study|Physician Decision|0
4925346|NCT00460811|16958998|P3|Overall Study|Physician Decision|0
4925347|NCT00460811|16958999|P2|Overall Study|Physician Decision|0
4925348|NCT00460811|16959000|P1|Overall Study|Physician Decision|1
4925349|NCT00460811|16958996|P5|Overall Study|Withdrawal by Subject|11
4925350|NCT00460811|16958997|P4|Overall Study|Withdrawal by Subject|3
4925351|NCT00460811|16958998|P3|Overall Study|Withdrawal by Subject|6
4925352|NCT00460811|16958999|P2|Overall Study|Withdrawal by Subject|7
4925353|NCT00460811|16959000|P1|Overall Study|Withdrawal by Subject|7
4925354|NCT00460811|16958996|P5|Overall Study|Noncompliance|1
4925355|NCT00460811|16958997|P4|Overall Study|Noncompliance|2
4925356|NCT00460811|16958998|P3|Overall Study|Noncompliance|0
4925357|NCT00460811|16958999|P2|Overall Study|Noncompliance|0
4925358|NCT00460811|16959000|P1|Overall Study|Noncompliance|1
4925359|NCT00460811|16958996|P5|Overall Study|Adverse Event|2
4925360|NCT00460811|16958997|P4|Overall Study|Adverse Event|10
4925361|NCT00460811|16958998|P3|Overall Study|Adverse Event|3
4925362|NCT00460811|16958999|P2|Overall Study|Adverse Event|6
4925363|NCT00460811|16959000|P1|Overall Study|Adverse Event|4
4925364|NCT00460798|16959042|P1|Overall Study|Missing/Incomplete Dosing Information|27
4925365|NCT00460798|16959042|P1|Overall Study|Ongoing at Date of Cut-Off|82
4925366|NCT00460798|16959042|P1|Overall Study|Other|27
4925367|NCT00460798|16959042|P1|Overall Study|Progressive Disease|99
4925368|NCT00460798|16959042|P1|Overall Study|Lost to Follow-up|19
4925369|NCT00460798|16959042|P1|Overall Study|Adverse Event|27
4925370|NCT00460798|16959042|P1|Overall Study|Death|59
4925371|NCT00460746|16959050|P1|Overall Study|Lost to Follow-up|1
4925372|NCT00460746|16959050|P1|Overall Study|Adverse Event|1
4925373|NCT00460655|16959065|P4|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1
4925374|NCT00460655|16959066|P3|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
4925375|NCT00460655|16959067|P2|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
4925376|NCT00460655|16959068|P1|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0
4925377|NCT00460655|16959065|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2
4925378|NCT00460655|16959066|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6
4925379|NCT00460655|16959067|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925380|NCT00460655|16959068|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925381|NCT00460655|16959065|P4|Open-Label Phase (36 Weeks)|Adverse Event|6
4925382|NCT00460655|16959066|P3|Open-Label Phase (36 Weeks)|Adverse Event|1
4925383|NCT00460655|16959067|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
4925384|NCT00460655|16959068|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
4925385|NCT00460655|16959065|P4|Double-Blind Phase (12 Weeks)|Protocol Violation|0
4925386|NCT00460655|16959066|P3|Double-Blind Phase (12 Weeks)|Protocol Violation|0
4925387|NCT00460655|16959067|P2|Double-Blind Phase (12 Weeks)|Protocol Violation|1
4925388|NCT00460655|16959068|P1|Double-Blind Phase (12 Weeks)|Protocol Violation|0
4925389|NCT00460655|16959065|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925390|NCT00460655|16959066|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925391|NCT00460655|16959067|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925392|NCT00460655|16959068|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3
4925393|NCT00460655|16959065|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925394|NCT00460655|16959066|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925395|NCT00460655|16959067|P2|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925396|NCT00460655|16959068|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
4925397|NCT00460603|16959112|P12|Phase 2|Randomized, but not treated|0
4925398|NCT00460603|16959113|P11|Phase 2|Randomized, but not treated|0
4925399|NCT00460603|16959114|P10|Phase 2|Randomized, but not treated|3
4925400|NCT00460603|16959115|P9|Phase 2|Randomized, but not treated|0
4925401|NCT00460603|16959116|P8|Phase 2|Randomized, but not treated|0
4925402|NCT00460603|16959117|P7|Phase 2|Randomized, but not treated|0
4925403|NCT00460603|16959118|P6|Phase 2|Randomized, but not treated|0
4925404|NCT00460603|16959119|P5|Phase 2|Randomized, but not treated|0
4925405|NCT00460603|16959120|P4|Phase 2|Randomized, but not treated|0
4925406|NCT00460603|16959121|P3|Phase 2|Randomized, but not treated|0
4925407|NCT00460603|16959122|P2|Phase 2|Randomized, but not treated|0
4925408|NCT00460603|16959123|P1|Phase 2|Randomized, but not treated|0
4925409|NCT00460603|16959112|P12|Phase 2|Withdrawal by Subject|5
4925410|NCT00460603|16959113|P11|Phase 2|Withdrawal by Subject|4
4925411|NCT00460603|16959114|P10|Phase 2|Withdrawal by Subject|5
4925412|NCT00460603|16959115|P9|Phase 2|Withdrawal by Subject|0
4925413|NCT00460603|16959116|P8|Phase 2|Withdrawal by Subject|0
4925414|NCT00460603|16959117|P7|Phase 2|Withdrawal by Subject|0
4925415|NCT00460603|16959118|P6|Phase 2|Withdrawal by Subject|0
4925416|NCT00460603|16959119|P5|Phase 2|Withdrawal by Subject|0
4925417|NCT00460603|16959120|P4|Phase 2|Withdrawal by Subject|0
4925418|NCT00460603|16959121|P3|Phase 2|Withdrawal by Subject|0
4925419|NCT00460603|16959122|P2|Phase 2|Withdrawal by Subject|0
4925420|NCT00460603|16959123|P1|Phase 2|Withdrawal by Subject|0
4925421|NCT00460603|16959112|P12|Phase 2|Global Deterioration of Health Status|0
4925422|NCT00460603|16959113|P11|Phase 2|Global Deterioration of Health Status|1
4925423|NCT00460603|16959114|P10|Phase 2|Global Deterioration of Health Status|0
4925424|NCT00460603|16959115|P9|Phase 2|Global Deterioration of Health Status|0
4925425|NCT00460603|16959116|P8|Phase 2|Global Deterioration of Health Status|0
4925426|NCT00460603|16959117|P7|Phase 2|Global Deterioration of Health Status|0
4925427|NCT00460603|16959118|P6|Phase 2|Global Deterioration of Health Status|0
4925428|NCT00460603|16959119|P5|Phase 2|Global Deterioration of Health Status|0
4925429|NCT00460603|16959120|P4|Phase 2|Global Deterioration of Health Status|0
4925430|NCT00460603|16959121|P3|Phase 2|Global Deterioration of Health Status|0
4925431|NCT00460603|16959122|P2|Phase 2|Global Deterioration of Health Status|0
4925432|NCT00460603|16959123|P1|Phase 2|Global Deterioration of Health Status|0
4925433|NCT00460603|16959112|P12|Phase 2|Objective Progression or Relapse|17
4925434|NCT00460603|16959113|P11|Phase 2|Objective Progression or Relapse|10
4925435|NCT00460603|16959114|P10|Phase 2|Objective Progression or Relapse|9
4925436|NCT00460603|16959115|P9|Phase 2|Objective Progression or Relapse|0
4925437|NCT00460603|16959116|P8|Phase 2|Objective Progression or Relapse|0
4925438|NCT00460603|16959117|P7|Phase 2|Objective Progression or Relapse|0
4925439|NCT00460603|16959118|P6|Phase 2|Objective Progression or Relapse|0
4925440|NCT00460603|16959119|P5|Phase 2|Objective Progression or Relapse|0
4925441|NCT00460603|16959120|P4|Phase 2|Objective Progression or Relapse|0
4925442|NCT00460603|16959121|P3|Phase 2|Objective Progression or Relapse|0
4925443|NCT00460603|16959122|P2|Phase 2|Objective Progression or Relapse|0
4925444|NCT00460603|16959123|P1|Phase 2|Objective Progression or Relapse|0
4925445|NCT00460603|16959112|P12|Phase 2|Other|7
4925446|NCT00460603|16959113|P11|Phase 2|Other|16
4925447|NCT00460603|16959114|P10|Phase 2|Other|6
4925448|NCT00460603|16959115|P9|Phase 2|Other|0
4925449|NCT00460603|16959116|P8|Phase 2|Other|0
4925450|NCT00460603|16959117|P7|Phase 2|Other|0
4925451|NCT00460603|16959118|P6|Phase 2|Other|0
4925452|NCT00460603|16959119|P5|Phase 2|Other|0
4925453|NCT00460603|16959120|P4|Phase 2|Other|0
4925454|NCT00460603|16959121|P3|Phase 2|Other|0
4925455|NCT00460603|16959122|P2|Phase 2|Other|0
4925456|NCT00460603|16959123|P1|Phase 2|Other|0
4925457|NCT00460603|16959112|P12|Phase 2|Lost to Follow-up|0
4925458|NCT00460603|16959113|P11|Phase 2|Lost to Follow-up|0
4925459|NCT00460603|16959114|P10|Phase 2|Lost to Follow-up|1
4925460|NCT00460603|16959115|P9|Phase 2|Lost to Follow-up|0
4925461|NCT00460603|16959116|P8|Phase 2|Lost to Follow-up|0
4925462|NCT00460603|16959117|P7|Phase 2|Lost to Follow-up|0
4925463|NCT00460603|16959118|P6|Phase 2|Lost to Follow-up|0
4925464|NCT00460603|16959119|P5|Phase 2|Lost to Follow-up|0
4925465|NCT00460603|16959120|P4|Phase 2|Lost to Follow-up|0
4925466|NCT00460603|16959121|P3|Phase 2|Lost to Follow-up|0
4925467|NCT00460603|16959122|P2|Phase 2|Lost to Follow-up|0
4925468|NCT00460603|16959123|P1|Phase 2|Lost to Follow-up|0
4925469|NCT00460603|16959112|P12|Phase 2|Protocol Violation|0
4925470|NCT00460603|16959113|P11|Phase 2|Protocol Violation|1
4925471|NCT00460603|16959114|P10|Phase 2|Protocol Violation|1
4925472|NCT00460603|16959115|P9|Phase 2|Protocol Violation|0
4925473|NCT00460603|16959116|P8|Phase 2|Protocol Violation|0
4925474|NCT00460603|16959117|P7|Phase 2|Protocol Violation|0
4925475|NCT00460603|16959118|P6|Phase 2|Protocol Violation|0
4925476|NCT00460603|16959119|P5|Phase 2|Protocol Violation|0
4925477|NCT00460603|16959120|P4|Phase 2|Protocol Violation|0
4925478|NCT00460603|16959121|P3|Phase 2|Protocol Violation|0
4925479|NCT00460603|16959122|P2|Phase 2|Protocol Violation|0
4925480|NCT00460603|16959123|P1|Phase 2|Protocol Violation|0
4925481|NCT00460603|16959112|P12|Phase 2|Death|2
4925482|NCT00460603|16959113|P11|Phase 2|Death|2
4925483|NCT00460603|16959114|P10|Phase 2|Death|4
4925484|NCT00460603|16959115|P9|Phase 2|Death|0
4925485|NCT00460603|16959116|P8|Phase 2|Death|0
4925486|NCT00460603|16959117|P7|Phase 2|Death|0
4925487|NCT00460603|16959118|P6|Phase 2|Death|0
4925488|NCT00460603|16959119|P5|Phase 2|Death|0
4925489|NCT00460603|16959120|P4|Phase 2|Death|0
4925490|NCT00460603|16959121|P3|Phase 2|Death|0
4925491|NCT00460603|16959122|P2|Phase 2|Death|0
4925492|NCT00460603|16959123|P1|Phase 2|Death|0
4925493|NCT00460603|16959112|P12|Phase 2|Adverse Event|10
4925494|NCT00460603|16959113|P11|Phase 2|Adverse Event|9
4925495|NCT00460603|16959114|P10|Phase 2|Adverse Event|12
4925496|NCT00460603|16959115|P9|Phase 2|Adverse Event|0
4925497|NCT00460603|16959116|P8|Phase 2|Adverse Event|0
4925498|NCT00460603|16959117|P7|Phase 2|Adverse Event|0
4925499|NCT00460603|16959118|P6|Phase 2|Adverse Event|0
4925500|NCT00460603|16959119|P5|Phase 2|Adverse Event|0
4925501|NCT00460603|16959120|P4|Phase 2|Adverse Event|0
4925502|NCT00460603|16959121|P3|Phase 2|Adverse Event|0
4925503|NCT00460603|16959122|P2|Phase 2|Adverse Event|0
4925504|NCT00460603|16959123|P1|Phase 2|Adverse Event|0
4925505|NCT00460603|16959112|P12|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925506|NCT00460603|16959113|P11|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925507|NCT00460603|16959114|P10|Phase 2|Ongoing in study A4061008 (NCT00828919)|1
4925508|NCT00460603|16959115|P9|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925509|NCT00460603|16959116|P8|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925510|NCT00460603|16959117|P7|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925511|NCT00460603|16959118|P6|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925512|NCT00460603|16959119|P5|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925513|NCT00460603|16959120|P4|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925514|NCT00460603|16959121|P3|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925515|NCT00460603|16959122|P2|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925516|NCT00460603|16959123|P1|Phase 2|Ongoing in study A4061008 (NCT00828919)|0
4925517|NCT00460603|16959112|P12|Phase 1|Other|0
4925518|NCT00460603|16959113|P11|Phase 1|Other|0
4925519|NCT00460603|16959114|P10|Phase 1|Other|0
4925520|NCT00460603|16959115|P9|Phase 1|Other|0
4925521|NCT00460603|16959116|P8|Phase 1|Other|1
4925522|NCT00460603|16959117|P7|Phase 1|Other|0
4925523|NCT00460603|16959118|P6|Phase 1|Other|2
4925524|NCT00460603|16959119|P5|Phase 1|Other|1
4925525|NCT00460603|16959120|P4|Phase 1|Other|1
4925526|NCT00460603|16959121|P3|Phase 1|Other|1
4925527|NCT00460603|16959122|P2|Phase 1|Other|3
4925528|NCT00460603|16959123|P1|Phase 1|Other|0
4925529|NCT00460603|16959112|P12|Phase 1|Withdrawal by Subject|0
4925530|NCT00460603|16959113|P11|Phase 1|Withdrawal by Subject|0
4925531|NCT00460603|16959114|P10|Phase 1|Withdrawal by Subject|0
4925532|NCT00460603|16959115|P9|Phase 1|Withdrawal by Subject|2
4925533|NCT00460603|16959116|P8|Phase 1|Withdrawal by Subject|0
4925534|NCT00460603|16959117|P7|Phase 1|Withdrawal by Subject|1
4925535|NCT00460603|16959118|P6|Phase 1|Withdrawal by Subject|0
4925536|NCT00460603|16959119|P5|Phase 1|Withdrawal by Subject|3
4925537|NCT00460603|16959120|P4|Phase 1|Withdrawal by Subject|1
4925538|NCT00460603|16959121|P3|Phase 1|Withdrawal by Subject|1
4925539|NCT00460603|16959122|P2|Phase 1|Withdrawal by Subject|2
4925540|NCT00460603|16959123|P1|Phase 1|Withdrawal by Subject|1
4925541|NCT00460603|16959112|P12|Phase 1|Lack of Efficacy|0
4925542|NCT00460603|16959113|P11|Phase 1|Lack of Efficacy|0
4925543|NCT00460603|16959114|P10|Phase 1|Lack of Efficacy|0
4925544|NCT00460603|16959115|P9|Phase 1|Lack of Efficacy|11
4925545|NCT00460603|16959116|P8|Phase 1|Lack of Efficacy|2
4925546|NCT00460603|16959117|P7|Phase 1|Lack of Efficacy|2
4925547|NCT00460603|16959118|P6|Phase 1|Lack of Efficacy|2
4925548|NCT00460603|16959119|P5|Phase 1|Lack of Efficacy|2
4925549|NCT00460603|16959120|P4|Phase 1|Lack of Efficacy|2
4925550|NCT00460603|16959121|P3|Phase 1|Lack of Efficacy|1
4925551|NCT00460603|16959122|P2|Phase 1|Lack of Efficacy|0
4925552|NCT00460603|16959123|P1|Phase 1|Lack of Efficacy|1
4925553|NCT00460603|16959112|P12|Phase 1|Adverse Event|0
4925554|NCT00460603|16959113|P11|Phase 1|Adverse Event|0
4925555|NCT00460603|16959114|P10|Phase 1|Adverse Event|0
4925556|NCT00460603|16959115|P9|Phase 1|Adverse Event|4
4925557|NCT00460603|16959116|P8|Phase 1|Adverse Event|0
4925558|NCT00460603|16959117|P7|Phase 1|Adverse Event|3
4925559|NCT00460603|16959118|P6|Phase 1|Adverse Event|0
4925560|NCT00460603|16959119|P5|Phase 1|Adverse Event|0
4925561|NCT00460603|16959120|P4|Phase 1|Adverse Event|2
4925562|NCT00460603|16959121|P3|Phase 1|Adverse Event|1
4925563|NCT00460603|16959122|P2|Phase 1|Adverse Event|1
4925564|NCT00460603|16959123|P1|Phase 1|Adverse Event|3
4925565|NCT00460603|16959112|P12|Phase 1|Death|0
4925566|NCT00460603|16959113|P11|Phase 1|Death|0
4925567|NCT00460603|16959114|P10|Phase 1|Death|0
4925568|NCT00460603|16959115|P9|Phase 1|Death|1
4925569|NCT00460603|16959116|P8|Phase 1|Death|0
4925570|NCT00460603|16959117|P7|Phase 1|Death|0
4925571|NCT00460603|16959118|P6|Phase 1|Death|0
4925572|NCT00460603|16959119|P5|Phase 1|Death|0
4925573|NCT00460603|16959120|P4|Phase 1|Death|2
4925574|NCT00460603|16959121|P3|Phase 1|Death|0
4925575|NCT00460603|16959122|P2|Phase 1|Death|0
4925576|NCT00460603|16959123|P1|Phase 1|Death|1
4925577|NCT00460577|16959217|P2|Overall Study|Protocol Violation|6
4925578|NCT00460577|16959218|P1|Overall Study|Protocol Violation|2
4925579|NCT00460564|16959236|P8|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925580|NCT00460564|16959237|P7|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925581|NCT00460564|16959238|P6|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925582|NCT00460564|16959239|P5|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1
4925583|NCT00460564|16959240|P4|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925584|NCT00460564|16959241|P3|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925585|NCT00460564|16959242|P2|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925586|NCT00460564|16959243|P1|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0
4925587|NCT00460564|16959236|P8|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925588|NCT00460564|16959237|P7|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925589|NCT00460564|16959238|P6|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1
4925590|NCT00460564|16959239|P5|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5
4925591|NCT00460564|16959240|P4|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925592|NCT00460564|16959241|P3|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925593|NCT00460564|16959242|P2|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925594|NCT00460564|16959243|P1|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0
4925595|NCT00460564|16959236|P8|Open-Label Phase (36 Weeks)|Adverse Event|0
4925596|NCT00460564|16959237|P7|Open-Label Phase (36 Weeks)|Adverse Event|2
4925597|NCT00460564|16959238|P6|Open-Label Phase (36 Weeks)|Adverse Event|5
4925598|NCT00460564|16959239|P5|Open-Label Phase (36 Weeks)|Adverse Event|3
4925599|NCT00460564|16959240|P4|Open-Label Phase (36 Weeks)|Adverse Event|0
4925600|NCT00460564|16959241|P3|Open-Label Phase (36 Weeks)|Adverse Event|0
4925601|NCT00460564|16959242|P2|Open-Label Phase (36 Weeks)|Adverse Event|0
4925602|NCT00460564|16959243|P1|Open-Label Phase (36 Weeks)|Adverse Event|0
4925603|NCT00460564|16959236|P8|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925604|NCT00460564|16959237|P7|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925605|NCT00460564|16959238|P6|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925606|NCT00460564|16959239|P5|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925607|NCT00460564|16959240|P4|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925608|NCT00460564|16959241|P3|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925609|NCT00460564|16959242|P2|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0
4925610|NCT00460564|16959243|P1|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1
4925611|NCT00460564|16959236|P8|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925612|NCT00460564|16959237|P7|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925613|NCT00460564|16959238|P6|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925614|NCT00460564|16959239|P5|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925615|NCT00460564|16959240|P4|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925616|NCT00460564|16959241|P3|Double-Blind Phase (12 Weeks)|Adverse Event|0
4925617|NCT00460564|16959242|P2|Double-Blind Phase (12 Weeks)|Adverse Event|1
4925618|NCT00460564|16959243|P1|Double-Blind Phase (12 Weeks)|Adverse Event|3
4925619|NCT00460434|16959387|P2|Overall Study|Lost to Follow-up|7
4925620|NCT00460434|16959388|P1|Overall Study|Lost to Follow-up|3
4925621|NCT00460408|16959467|P4|Overall Study|Other|0
4925622|NCT00460408|16959468|P3|Overall Study|Other|0
4925623|NCT00460408|16959469|P2|Overall Study|Other|2
4925624|NCT00460408|16959470|P1|Overall Study|Other|12
4925625|NCT00460408|16959467|P4|Overall Study|Insufficient clinical response|0
4925626|NCT00460408|16959468|P3|Overall Study|Insufficient clinical response|5
4925627|NCT00460408|16959469|P2|Overall Study|Insufficient clinical response|1
4925628|NCT00460408|16959470|P1|Overall Study|Insufficient clinical response|5
4925629|NCT00460408|16959467|P4|Overall Study|Withdrawal by Subject|0
4925630|NCT00460408|16959468|P3|Overall Study|Withdrawal by Subject|0
4925631|NCT00460408|16959469|P2|Overall Study|Withdrawal by Subject|0
4925632|NCT00460408|16959470|P1|Overall Study|Withdrawal by Subject|31
4925633|NCT00460408|16959467|P4|Overall Study|Lost to Follow-up|0
4925634|NCT00460408|16959468|P3|Overall Study|Lost to Follow-up|1
4925635|NCT00460408|16959469|P2|Overall Study|Lost to Follow-up|0
4925636|NCT00460408|16959470|P1|Overall Study|Lost to Follow-up|11
4925637|NCT00460408|16959467|P4|Overall Study|Death|0
4925638|NCT00460408|16959468|P3|Overall Study|Death|0
4925639|NCT00460408|16959469|P2|Overall Study|Death|0
4925640|NCT00460408|16959470|P1|Overall Study|Death|7
4925641|NCT00460408|16959467|P4|Overall Study|Adverse Event|0
4925642|NCT00460408|16959468|P3|Overall Study|Adverse Event|0
4925643|NCT00460408|16959469|P2|Overall Study|Adverse Event|0
4925644|NCT00460408|16959470|P1|Overall Study|Adverse Event|1
4925645|NCT00460265|16959507|P2|Overall Study|Ongoing|47
4925646|NCT00460265|16959508|P1|Overall Study|Ongoing|60
4925647|NCT00460265|16959507|P2|Overall Study|Withdrawal by Subject|25
4925648|NCT00460265|16959508|P1|Overall Study|Withdrawal by Subject|10
4925649|NCT00460265|16959507|P2|Overall Study|Physician Decision|2
4925650|NCT00460265|16959508|P1|Overall Study|Physician Decision|1
4925651|NCT00460265|16959507|P2|Overall Study|Lost to Follow-up|15
4925652|NCT00460265|16959508|P1|Overall Study|Lost to Follow-up|14
4925653|NCT00460239|16959524|P9|Overall Study|Withdrawal by Subject|0
4925654|NCT00460239|16959525|P8|Overall Study|Withdrawal by Subject|0
4925655|NCT00460239|16959526|P7|Overall Study|Withdrawal by Subject|0
4925656|NCT00460239|16959527|P6|Overall Study|Withdrawal by Subject|1
4925657|NCT00460239|16959528|P5|Overall Study|Withdrawal by Subject|0
4925658|NCT00460239|16959529|P4|Overall Study|Withdrawal by Subject|0
4925659|NCT00460239|16959530|P3|Overall Study|Withdrawal by Subject|0
4925660|NCT00460239|16959531|P2|Overall Study|Withdrawal by Subject|0
4925661|NCT00460239|16959532|P1|Overall Study|Withdrawal by Subject|0
4925662|NCT00460239|16959524|P9|Overall Study|Physician Decision|0
4925663|NCT00460239|16959525|P8|Overall Study|Physician Decision|0
4925664|NCT00460239|16959526|P7|Overall Study|Physician Decision|0
4925665|NCT00460239|16959527|P6|Overall Study|Physician Decision|2
4925666|NCT00460239|16959528|P5|Overall Study|Physician Decision|0
4925667|NCT00460239|16959529|P4|Overall Study|Physician Decision|0
4925668|NCT00460239|16959530|P3|Overall Study|Physician Decision|0
4925669|NCT00460239|16959531|P2|Overall Study|Physician Decision|1
4925670|NCT00460239|16959532|P1|Overall Study|Physician Decision|0
4925671|NCT00460109|16959601|P1|Overall Study|Death|1
4925672|NCT00460031|16959609|P1|Overall Study|Death|1
4925673|NCT00460031|16959609|P1|Overall Study|Withdrawal by Subject|5
4925674|NCT00460031|16959609|P1|Overall Study|Adverse Event|5
4925675|NCT00459979|16959617|P1|Overall Study|Protocol Violation|1
4925676|NCT00459979|16959617|P1|Overall Study|Withdrawal by Subject|1
4925677|NCT00459953|16959629|P2|Overall Study|not analyzed-household member in study|1
4925678|NCT00459953|16959630|P1|Overall Study|not analyzed-household member in study|1
4925679|NCT00459875|16959636|P1|Overall Study|Adverse Event|2
4925680|NCT00459875|16959636|P1|Overall Study|Ineligible participant|1
4925681|NCT00459706|16959672|P2|Overall Study|Other|1
4925682|NCT00459706|16959673|P1|Overall Study|Other|0
4925683|NCT00459706|16959672|P2|Overall Study|Failed to Return|0
4925684|NCT00459706|16959673|P1|Overall Study|Failed to Return|1
4925685|NCT00459706|16959672|P2|Overall Study|Protocol Violation|1
4925686|NCT00459706|16959673|P1|Overall Study|Protocol Violation|2
4925687|NCT00459706|16959672|P2|Overall Study|Discontinuation of Study by Sponsor|0
4925688|NCT00459706|16959673|P1|Overall Study|Discontinuation of Study by Sponsor|1
4925689|NCT00459706|16959672|P2|Overall Study|Physician Decision|0
4925690|NCT00459706|16959673|P1|Overall Study|Physician Decision|2
4925691|NCT00459706|16959672|P2|Overall Study|Withdrawal by Subject|6
4925692|NCT00459706|16959673|P1|Overall Study|Withdrawal by Subject|1
4925693|NCT00459706|16959672|P2|Overall Study|Adverse Event|13
4925694|NCT00459706|16959673|P1|Overall Study|Adverse Event|19
4925695|NCT00459667|16959816|P3|Overall Study|No treatment administered|1
4925696|NCT00459667|16959817|P2|Overall Study|No treatment administered|3
4925697|NCT00459667|16959818|P1|Overall Study|No treatment administered|6
4925698|NCT00459667|16959816|P3|Overall Study|Other reason (incl. 2 missing subjects)|1
4925699|NCT00459667|16959817|P2|Overall Study|Other reason (incl. 2 missing subjects)|15
4925700|NCT00459667|16959818|P1|Overall Study|Other reason (incl. 2 missing subjects)|12
4925701|NCT00459667|16959816|P3|Overall Study|Other disease modifying treatment|1
4925702|NCT00459667|16959817|P2|Overall Study|Other disease modifying treatment|2
4925703|NCT00459667|16959818|P1|Overall Study|Other disease modifying treatment|1
4925704|NCT00459667|16959816|P3|Overall Study|Withdrawal by Subject|5
4925705|NCT00459667|16959817|P2|Overall Study|Withdrawal by Subject|5
4925706|NCT00459667|16959818|P1|Overall Study|Withdrawal by Subject|3
4925707|NCT00459667|16959816|P3|Overall Study|Protocol Violation|0
4925708|NCT00459667|16959817|P2|Overall Study|Protocol Violation|0
4925709|NCT00459667|16959818|P1|Overall Study|Protocol Violation|1
4925710|NCT00459667|16959816|P3|Overall Study|Pregnancy|1
4925711|NCT00459667|16959817|P2|Overall Study|Pregnancy|1
4925712|NCT00459667|16959818|P1|Overall Study|Pregnancy|1
4925713|NCT00459667|16959816|P3|Overall Study|Lost to Follow-up|3
4925714|NCT00459667|16959817|P2|Overall Study|Lost to Follow-up|9
4925715|NCT00459667|16959818|P1|Overall Study|Lost to Follow-up|5
4925716|NCT00459667|16959816|P3|Overall Study|Adverse Event|8
4925717|NCT00459667|16959817|P2|Overall Study|Adverse Event|12
4925718|NCT00459667|16959818|P1|Overall Study|Adverse Event|9
4925719|NCT00459537|16959840|P2|Overall Study|Missing|0
4925720|NCT00459537|16959841|P1|Overall Study|Missing|1
4925721|NCT00459537|16959840|P2|Overall Study|Protocol Violation|3
4925722|NCT00459537|16959841|P1|Overall Study|Protocol Violation|4
4925723|NCT00459537|16959840|P2|Overall Study|Administrative problems|0
4925724|NCT00459537|16959841|P1|Overall Study|Administrative problems|3
4925725|NCT00459537|16959840|P2|Overall Study|Lost to Follow-up|30
4925726|NCT00459537|16959841|P1|Overall Study|Lost to Follow-up|27
4925727|NCT00459537|16959840|P2|Overall Study|Withdrawal by Subject|26
4925728|NCT00459537|16959841|P1|Overall Study|Withdrawal by Subject|20
4925729|NCT00459537|16959840|P2|Overall Study|Lack of Efficacy|11
4925730|NCT00459537|16959841|P1|Overall Study|Lack of Efficacy|10
4925731|NCT00459537|16959840|P2|Overall Study|Adverse Event|6
4925732|NCT00459537|16959841|P1|Overall Study|Adverse Event|1
4925733|NCT00459355|16959876|P2|Overall Study|Subject no longer met inc criteria|18
4925734|NCT00459355|16959877|P1|Overall Study|Subject no longer met inc criteria|20
4925735|NCT00459342|16959889|P1|Overall Study|Not eligible|1
4925736|NCT00459316|16959902|P3|Step 3|Withdrawal by Subject|1
4925737|NCT00459316|16959903|P2|Step 3|Withdrawal by Subject|0
4925738|NCT00459316|16959904|P1|Step 3|Withdrawal by Subject|3
4925739|NCT00459316|16959902|P3|Steps 1 & 2|Lost to Follow-up|2
4925740|NCT00459316|16959903|P2|Steps 1 & 2|Lost to Follow-up|0
4925741|NCT00459316|16959904|P1|Steps 1 & 2|Lost to Follow-up|5
4925742|NCT00459316|16959902|P3|Steps 1 & 2|Not willing to adhere to regulations|0
4925743|NCT00459316|16959903|P2|Steps 1 & 2|Not willing to adhere to regulations|0
4925744|NCT00459316|16959904|P1|Steps 1 & 2|Not willing to adhere to regulations|1
4925745|NCT00459316|16959902|P3|Steps 1 & 2|Withdrawal by Subject|0
4925746|NCT00459316|16959903|P2|Steps 1 & 2|Withdrawal by Subject|1
4925747|NCT00459316|16959904|P1|Steps 1 & 2|Withdrawal by Subject|6
4925748|NCT00459316|16959902|P3|Steps 1 & 2|Not able to get to clinic|0
4925749|NCT00459316|16959903|P2|Steps 1 & 2|Not able to get to clinic|4
4925750|NCT00459316|16959904|P1|Steps 1 & 2|Not able to get to clinic|7
4925751|NCT00459316|16959902|P3|Steps 1 & 2|Death|0
4925752|NCT00459316|16959903|P2|Steps 1 & 2|Death|1
4925753|NCT00459316|16959904|P1|Steps 1 & 2|Death|1
4925754|NCT00459316|16959902|P3|Steps 1 & 2|Other eligibility failure|0
4925755|NCT00459316|16959903|P2|Steps 1 & 2|Other eligibility failure|1
4925756|NCT00459316|16959904|P1|Steps 1 & 2|Other eligibility failure|1
4925757|NCT00459290|16959969|P1|Overall Study|Ineligible|2
4925758|NCT00459290|16959969|P1|Overall Study|Adverse Event|3
4925759|NCT00459186|16959984|P1|PET Imaging and Assessment|Adverse Event|3
4925760|NCT00459186|16959984|P1|Single Agent RAD001|Withdrawal by Subject|1
4925761|NCT00459134|16959991|P2|Overall Study|Multiple Reasons|3
4925762|NCT00459134|16959992|P1|Overall Study|Multiple Reasons|2
4925763|NCT00459134|16959991|P2|Overall Study|Progression|0
4925764|NCT00459134|16959992|P1|Overall Study|Progression|1
4925765|NCT00459134|16959991|P2|Overall Study|Toxicity|5
4925766|NCT00459134|16959992|P1|Overall Study|Toxicity|4
4925767|NCT00459134|16959991|P2|Overall Study|Surgery|2
4925768|NCT00459134|16959992|P1|Overall Study|Surgery|1
4925769|NCT00459134|16959991|P2|Overall Study|Lost to Follow-up|7
4925770|NCT00459134|16959992|P1|Overall Study|Lost to Follow-up|6
4925771|NCT00459134|16959991|P2|Overall Study|Withdrawal by Subject|7
4925772|NCT00459134|16959992|P1|Overall Study|Withdrawal by Subject|8
4925773|NCT00459134|16959991|P2|Overall Study|Physician Decision|1
4925774|NCT00459134|16959992|P1|Overall Study|Physician Decision|1
4925775|NCT00459108|16960008|P1|Overall Study|Progression|1
4925776|NCT00459108|16960008|P1|Overall Study|Death|2
4925777|NCT00459108|16960008|P1|Overall Study|Adverse Event|3
4925778|NCT00459108|16960008|P1|Overall Study|Withdrawal by Subject|5
4925779|NCT00459056|16960018|P2|First Intervention (First Three Months)|Lost to Follow-up|1
4925780|NCT00459056|16960019|P1|First Intervention (First Three Months)|Lost to Follow-up|1
4925781|NCT00459043|16960027|P2|Overall Study|Withdrawal by Subject|0
4925782|NCT00459043|16960028|P1|Overall Study|Withdrawal by Subject|1
4925783|NCT00458705|16960055|P1|Overall Study|Not Treated|1
4925784|NCT00458705|16960055|P1|Overall Study|Adverse Event|4
4925785|NCT00458536|16960059|P1|Overall Study|Progressive disease during treatment|2
4925786|NCT00458536|16960059|P1|Overall Study|Withdrawal by Subject|1
4925787|NCT00458536|16960059|P1|Overall Study|Ineligible due to toxicity|1
4925788|NCT00458536|16960059|P1|Overall Study|Patient did not have surgery|1
4925789|NCT00458536|16960059|P1|Overall Study|Did not have renal cell carcinoma|2
4925790|NCT00458536|16960059|P1|Overall Study|No measurable disease after surgery|2
4925791|NCT00458536|16960059|P1|Overall Study|Unable to make vaccine|3
4925792|NCT00458536|16960059|P1|Overall Study|Disease progression prior to treatment|7
4925793|NCT00458484|16960070|P7|Overall Study|Not eligible b/c prior radiation history|0
4925794|NCT00458484|16960071|P6|Overall Study|Not eligible b/c prior radiation history|1
4925795|NCT00458484|16960072|P5|Overall Study|Not eligible b/c prior radiation history|0
4925796|NCT00458484|16960073|P4|Overall Study|Not eligible b/c prior radiation history|0
4925797|NCT00458484|16960074|P3|Overall Study|Not eligible b/c prior radiation history|0
4925798|NCT00458484|16960075|P2|Overall Study|Not eligible b/c prior radiation history|0
4925799|NCT00458484|16960076|P1|Overall Study|Not eligible b/c prior radiation history|0
4925800|NCT00458393|16960142|P2|Overall Study|Sites marked other on the form.|20
4925801|NCT00458393|16960143|P1|Overall Study|Sites marked other on the form.|19
4925802|NCT00458393|16960142|P2|Overall Study|Lost to Follow-up|92
4925803|NCT00458393|16960143|P1|Overall Study|Lost to Follow-up|115
4925804|NCT00458393|16960142|P2|Overall Study|Relocated|81
4925805|NCT00458393|16960143|P1|Overall Study|Relocated|77
4925806|NCT00458393|16960142|P2|Overall Study|Physician Decision|22
4925807|NCT00458393|16960143|P1|Overall Study|Physician Decision|31
4925808|NCT00458393|16960142|P2|Overall Study|Withdrawal by Subject|80
4925809|NCT00458393|16960143|P1|Overall Study|Withdrawal by Subject|67
4925810|NCT00458341|16960191|P2|Cycle 1|Adverse Event|0
4925811|NCT00458341|16960192|P1|Cycle 1|Adverse Event|1
4925812|NCT00458302|16960232|P2|Overall Study|Other|2
4925813|NCT00458302|16960233|P1|Overall Study|Other|4
4925814|NCT00458302|16960232|P2|Overall Study|Lost to Follow-up|0
4925815|NCT00458302|16960233|P1|Overall Study|Lost to Follow-up|2
4925816|NCT00458302|16960232|P2|Overall Study|Study Termination By Sponsor|0
4925817|NCT00458302|16960233|P1|Overall Study|Study Termination By Sponsor|1
4925818|NCT00458302|16960232|P2|Overall Study|Inc/Exc Criteria Not Met|1
4925819|NCT00458302|16960233|P1|Overall Study|Inc/Exc Criteria Not Met|1
4925820|NCT00458302|16960232|P2|Overall Study|Withdrawal by Subject|4
4925821|NCT00458302|16960233|P1|Overall Study|Withdrawal by Subject|6
4925822|NCT00458302|16960232|P2|Overall Study|Protocol Violation|2
4925823|NCT00458302|16960233|P1|Overall Study|Protocol Violation|0
4925824|NCT00458302|16960232|P2|Overall Study|Pregnancy|1
4925825|NCT00458302|16960233|P1|Overall Study|Pregnancy|2
4925826|NCT00458302|16960232|P2|Overall Study|Adverse Event|14
4925827|NCT00458302|16960233|P1|Overall Study|Adverse Event|4
4925828|NCT00458211|16960278|P1|Overall Study|Protocol Violation|2
4925829|NCT00458211|16960278|P1|Overall Study|Withdrawal by Subject|2
4925830|NCT00458211|16960278|P1|Overall Study|Lack of Efficacy|12
4925831|NCT00457821|16960328|P8|Part 2|Withdrawal by Subject|1
4925832|NCT00457821|16960329|P7|Part 2|Withdrawal by Subject|0
4925833|NCT00457821|16960330|P6|Part 2|Withdrawal by Subject|0
4925834|NCT00457821|16960331|P5|Part 2|Withdrawal by Subject|0
4925835|NCT00457821|16960332|P4|Part 2|Withdrawal by Subject|0
4925836|NCT00457821|16960333|P3|Part 2|Withdrawal by Subject|0
4925837|NCT00457821|16960334|P2|Part 2|Withdrawal by Subject|0
4925838|NCT00457821|16960335|P1|Part 2|Withdrawal by Subject|0
4925839|NCT00457743|16960374|P3|Overall Study|Lack of Efficacy|3
4925840|NCT00457743|16960375|P2|Overall Study|Lack of Efficacy|23
4925841|NCT00457743|16960376|P1|Overall Study|Lack of Efficacy|3
4925842|NCT00457743|16960374|P3|Overall Study|Adverse Event|0
4925843|NCT00457743|16960375|P2|Overall Study|Adverse Event|4
4925844|NCT00457743|16960376|P1|Overall Study|Adverse Event|0
4925845|NCT00457691|16960433|P2|Overall Study|Disease progression, study terminated|196
4925846|NCT00457691|16960434|P1|Overall Study|Disease progression, study terminated|180
4925847|NCT00457691|16960433|P2|Overall Study|Subject refused (reason other than AE)|19
4925848|NCT00457691|16960434|P1|Overall Study|Subject refused (reason other than AE)|14
4925849|NCT00457691|16960433|P2|Overall Study|Study terminated by Sponsor|1
4925850|NCT00457691|16960434|P1|Overall Study|Study terminated by Sponsor|1
4925851|NCT00457691|16960433|P2|Overall Study|Lost to Follow-up|14
4925852|NCT00457691|16960434|P1|Overall Study|Lost to Follow-up|23
4925853|NCT00457691|16960433|P2|Overall Study|Protocol Violation|3
4925854|NCT00457691|16960434|P1|Overall Study|Protocol Violation|1
4925855|NCT00457691|16960433|P2|Overall Study|Death|148
4925856|NCT00457691|16960434|P1|Overall Study|Death|163
4925857|NCT00457691|16960433|P2|Overall Study|Adverse Event|1
4925858|NCT00457691|16960434|P1|Overall Study|Adverse Event|4
4925859|NCT00457665|16960456|P2|24 Months|Abnormal liver function tests|5
4925860|NCT00457665|16960457|P1|24 Months|Abnormal liver function tests|1
4925861|NCT00457665|16960456|P2|24 Months|Lipodystrophy|1
4925862|NCT00457665|16960457|P1|24 Months|Lipodystrophy|1
4925863|NCT00457665|16960456|P2|24 Months|Withdrawal by Subject|2
4925864|NCT00457665|16960457|P1|24 Months|Withdrawal by Subject|3
4925865|NCT00457665|16960456|P2|12 Months|Abnormal Liver function tests|5
4925866|NCT00457665|16960457|P1|12 Months|Abnormal Liver function tests|0
4925867|NCT00457665|16960456|P2|12 Months|Withdrawal by Subject|2
4925868|NCT00457665|16960457|P1|12 Months|Withdrawal by Subject|0
4925869|NCT00457665|16960456|P2|12 Months|Lipodystrophy|0
4925870|NCT00457665|16960457|P1|12 Months|Lipodystrophy|2
4925871|NCT00457665|16960456|P2|12 Months|High HIV viral load|1
4925872|NCT00457665|16960457|P1|12 Months|High HIV viral load|5
4925873|NCT00457665|16960456|P2|12 Months|Drug allergy|1
4925874|NCT00457665|16960457|P1|12 Months|Drug allergy|1
4925875|NCT00457639|16960463|P2|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1
4925876|NCT00457639|16960464|P1|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0
4925877|NCT00457639|16960463|P2|Intervention 1 (6 Months)|unrelated illness|2
4925878|NCT00457639|16960464|P1|Intervention 1 (6 Months)|unrelated illness|0
4925879|NCT00457639|16960463|P2|Intervention 1 (6 Months)|Lost to Follow-up|0
4925880|NCT00457639|16960464|P1|Intervention 1 (6 Months)|Lost to Follow-up|3
4925881|NCT00457418|16960472|P1|Post PK Maintenance|Lost to Follow-up|1
4925882|NCT00457418|16960472|P1|Post PK Maintenance|Withdrawal by Subject|11
4925883|NCT00457418|16960472|P1|Post PK Maintenance|Progression of Disease|6
4925884|NCT00457418|16960472|P1|Post PK Maintenance|Adverse Event|10
4925885|NCT00457418|16960472|P1|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2
4925886|NCT00457418|16960472|P1|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1
4925887|NCT00457418|16960472|P1|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2
4925888|NCT00457392|16960484|P2|Overall Study|Randomized, Not Treated|3
4925889|NCT00457392|16960485|P1|Overall Study|Randomized, Not Treated|7
4925890|NCT00457392|16960484|P2|Overall Study|Study Terminated by Sponsor|4
4925891|NCT00457392|16960485|P1|Overall Study|Study Terminated by Sponsor|1
4925892|NCT00457392|16960484|P2|Overall Study|Other|4
4925893|NCT00457392|16960485|P1|Overall Study|Other|7
4925894|NCT00457392|16960484|P2|Overall Study|Protocol Violation|3
4925895|NCT00457392|16960485|P1|Overall Study|Protocol Violation|4
4925896|NCT00457392|16960484|P2|Overall Study|Lost to Follow-up|7
4925897|NCT00457392|16960485|P1|Overall Study|Lost to Follow-up|6
4925898|NCT00457392|16960484|P2|Overall Study|Withdrawal by Subject|8
4925899|NCT00457392|16960485|P1|Overall Study|Withdrawal by Subject|14
4925900|NCT00457392|16960484|P2|Overall Study|Global Deterioration of Health Status|8
4925901|NCT00457392|16960485|P1|Overall Study|Global Deterioration of Health Status|22
4925902|NCT00457392|16960484|P2|Overall Study|Adverse Event|41
4925903|NCT00457392|16960485|P1|Overall Study|Adverse Event|84
4925904|NCT00457392|16960484|P2|Overall Study|Death|106
4925905|NCT00457392|16960485|P1|Overall Study|Death|106
4925906|NCT00457392|16960484|P2|Overall Study|Objective Progression or Relapse|296
4925907|NCT00457392|16960485|P1|Overall Study|Objective Progression or Relapse|229
4925908|NCT00457301|16960512|P2|Overall Study|Death|7
4925909|NCT00457301|16960513|P1|Overall Study|Death|5
4925910|NCT00457301|16960512|P2|Overall Study|Censored out of the study|14
4925911|NCT00457301|16960513|P1|Overall Study|Censored out of the study|15
4925912|NCT00457301|16960512|P2|Overall Study|Withdrawal by Subject|3
4925913|NCT00457301|16960513|P1|Overall Study|Withdrawal by Subject|3
4925914|NCT00457249|16960527|P2|Overall Study|Serious Adverse Events|0
4925915|NCT00457249|16960528|P1|Overall Study|Serious Adverse Events|2
4925916|NCT00457249|16960527|P2|Overall Study|Withdrawal by Subject|1
4925917|NCT00457249|16960528|P1|Overall Study|Withdrawal by Subject|3
4925918|NCT00457249|16960527|P2|Overall Study|Protocol Violation|1
4925919|NCT00457249|16960528|P1|Overall Study|Protocol Violation|4
4925920|NCT00457249|16960527|P2|Overall Study|Lost to Follow-up|0
4925921|NCT00457249|16960528|P1|Overall Study|Lost to Follow-up|3
4925922|NCT00457015|16960567|P2|Overall Study|Left study site against medical advice|1
4925923|NCT00457015|16960568|P1|Overall Study|Left study site against medical advice|0
4925924|NCT00457002|16960584|P2|Overall Study|treated for 1 day; missing status/reason|0
4925925|NCT00457002|16960585|P1|Overall Study|treated for 1 day; missing status/reason|1
4925926|NCT00457002|16960584|P2|Overall Study|non-specified|38
4925927|NCT00457002|16960585|P1|Overall Study|non-specified|29
4925928|NCT00457002|16960584|P2|Overall Study|Administrative reason by Sponsor|0
4925929|NCT00457002|16960585|P1|Overall Study|Administrative reason by Sponsor|1
4925930|NCT00457002|16960584|P2|Overall Study|No longer met criteria|37
4925931|NCT00457002|16960585|P1|Overall Study|No longer met criteria|41
4925932|NCT00457002|16960584|P2|Overall Study|Poor/Non-compliance|33
4925933|NCT00457002|16960585|P1|Overall Study|Poor/Non-compliance|46
4925934|NCT00457002|16960584|P2|Overall Study|Lost to Follow-up|71
4925935|NCT00457002|16960585|P1|Overall Study|Lost to Follow-up|72
4925936|NCT00457002|16960584|P2|Overall Study|Withdrawal by Subject|271
4925937|NCT00457002|16960585|P1|Overall Study|Withdrawal by Subject|299
4925938|NCT00457002|16960584|P2|Overall Study|Adverse Event|260
4925939|NCT00457002|16960585|P1|Overall Study|Adverse Event|284
4925940|NCT00457002|16960584|P2|Overall Study|Death|47
4925941|NCT00457002|16960585|P1|Overall Study|Death|40
4925942|NCT00456846|16960690|P2|Overall Study|Other|2
4925943|NCT00456846|16960691|P1|Overall Study|Other|0
4925944|NCT00456846|16960690|P2|Overall Study|Participant Discretion|5
4925945|NCT00456846|16960691|P1|Overall Study|Participant Discretion|1
4925946|NCT00456846|16960690|P2|Overall Study|Protocol Deviation|0
4925947|NCT00456846|16960691|P1|Overall Study|Protocol Deviation|2
4925948|NCT00456846|16960690|P2|Overall Study|Physician Decision|6
4925949|NCT00456846|16960691|P1|Overall Study|Physician Decision|11
4925950|NCT00456846|16960690|P2|Overall Study|Adverse Event|15
4925951|NCT00456846|16960691|P1|Overall Study|Adverse Event|2
4925952|NCT00456755|16960732|P2|Overall Study|Lost to Follow-up|1
4925953|NCT00456755|16960733|P1|Overall Study|Lost to Follow-up|2
4925954|NCT00456612|16960747|P1|Overall Study|Withdrawal by Subject|3
4925955|NCT00456599|16960752|P1|Overall Study|Withdrawal by Subject|2
4925956|NCT00456599|16960752|P1|Overall Study|Non-compliance|1
4925957|NCT00456521|16960775|P2|Overall Study|Drug non-compliance, moved, other|11
4925958|NCT00456521|16960776|P1|Overall Study|Drug non-compliance, moved, other|26
4925959|NCT00456521|16960775|P2|Overall Study|Pregnancy|1
4925960|NCT00456521|16960776|P1|Overall Study|Pregnancy|1
4925961|NCT00456521|16960775|P2|Overall Study|Protocol Violation|0
4925962|NCT00456521|16960776|P1|Overall Study|Protocol Violation|4
4925963|NCT00456521|16960775|P2|Overall Study|Lack of Efficacy|6
4925964|NCT00456521|16960776|P1|Overall Study|Lack of Efficacy|3
4925965|NCT00456521|16960775|P2|Overall Study|Lost to Follow-up|17
4925966|NCT00456521|16960776|P1|Overall Study|Lost to Follow-up|22
4925967|NCT00456521|16960775|P2|Overall Study|Withdrawal by Subject|24
4925968|NCT00456521|16960776|P1|Overall Study|Withdrawal by Subject|43
4925969|NCT00456521|16960775|P2|Overall Study|Adverse Event|25
4925970|NCT00456521|16960776|P1|Overall Study|Adverse Event|150
4925971|NCT00456495|16960822|P1|Overall Study|Physician Decision|2
4925972|NCT00456365|16960829|P2|Overall Study|oncologic diagnosis|1
4925973|NCT00456365|16960830|P1|Overall Study|oncologic diagnosis|1
4925974|NCT00456365|16960829|P2|Overall Study|Pregnancy|1
4925975|NCT00456365|16960830|P1|Overall Study|Pregnancy|1
4925976|NCT00456365|16960829|P2|Overall Study|Withdrawal by Subject|7
4925977|NCT00456365|16960830|P1|Overall Study|Withdrawal by Subject|4
4925978|NCT00456365|16960829|P2|Overall Study|Lost to Follow-up|3
4925979|NCT00456365|16960830|P1|Overall Study|Lost to Follow-up|1
4925980|NCT00456300|16960842|P2|Overall Study|Adverse Event|0
4925981|NCT00456300|16960843|P1|Overall Study|Adverse Event|1
4925982|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Other|0
4925983|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Other|0
4925984|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Other|1
4925985|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Other|0
4925986|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Other|1
4925987|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Lost to Follow-up|0
4925988|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Lost to Follow-up|0
4925989|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Lost to Follow-up|1
4925990|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Lost to Follow-up|1
4925991|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Lost to Follow-up|0
4925992|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Withdrew Consent|0
4925993|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Withdrew Consent|0
4925994|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Withdrew Consent|2
4925995|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Withdrew Consent|1
4925996|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Withdrew Consent|0
4925997|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
4925998|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
4925999|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7
4926000|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2
4926001|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0
4926002|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
4926003|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
4926004|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
4926005|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3
4926006|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0
4926007|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
4926008|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
4926009|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Flare of Psoriasis|2
4926010|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Flare of Psoriasis|1
4926011|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Flare of Psoriasis|0
4926012|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4926013|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4926014|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4926015|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0
4926016|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2
4926017|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
4926018|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
4926019|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0
4926020|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2
4926021|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1
4926022|NCT00456092|16960867|P5|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
4926023|NCT00456092|16960868|P4|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0
4926024|NCT00456092|16960869|P3|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2
4926025|NCT00456092|16960870|P2|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4
4926026|NCT00456092|16960871|P1|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3
4926027|NCT00456092|16960867|P5|Extension Phase|Other|1
4926028|NCT00456092|16960868|P4|Extension Phase|Other|1
4926029|NCT00456092|16960869|P3|Extension Phase|Other|0
4926030|NCT00456092|16960870|P2|Extension Phase|Other|0
4926031|NCT00456092|16960871|P1|Extension Phase|Other|2
4926032|NCT00456092|16960867|P5|Extension Phase|Lost to Follow-up|1
4926033|NCT00456092|16960868|P4|Extension Phase|Lost to Follow-up|0
4926034|NCT00456092|16960869|P3|Extension Phase|Lost to Follow-up|0
4926035|NCT00456092|16960870|P2|Extension Phase|Lost to Follow-up|1
4926036|NCT00456092|16960871|P1|Extension Phase|Lost to Follow-up|1
4926037|NCT00456092|16960867|P5|Extension Phase|Withdrew Consent|0
4926038|NCT00456092|16960868|P4|Extension Phase|Withdrew Consent|0
4926039|NCT00456092|16960869|P3|Extension Phase|Withdrew Consent|0
4926040|NCT00456092|16960870|P2|Extension Phase|Withdrew Consent|0
4926041|NCT00456092|16960871|P1|Extension Phase|Withdrew Consent|2
4926042|NCT00456092|16960867|P5|Extension Phase|Worsening / Not Responding to Study Drug|2
4926043|NCT00456092|16960868|P4|Extension Phase|Worsening / Not Responding to Study Drug|0
4926044|NCT00456092|16960869|P3|Extension Phase|Worsening / Not Responding to Study Drug|0
4926045|NCT00456092|16960870|P2|Extension Phase|Worsening / Not Responding to Study Drug|1
4926046|NCT00456092|16960871|P1|Extension Phase|Worsening / Not Responding to Study Drug|3
4926047|NCT00456092|16960867|P5|Extension Phase|Flare of Psoriatic Arthritis|1
4926048|NCT00456092|16960868|P4|Extension Phase|Flare of Psoriatic Arthritis|0
4926049|NCT00456092|16960869|P3|Extension Phase|Flare of Psoriatic Arthritis|0
4926050|NCT00456092|16960870|P2|Extension Phase|Flare of Psoriatic Arthritis|0
4926051|NCT00456092|16960871|P1|Extension Phase|Flare of Psoriatic Arthritis|1
4926052|NCT00456092|16960867|P5|Extension Phase|Grade 2 or Greater AE|2
4926053|NCT00456092|16960868|P4|Extension Phase|Grade 2 or Greater AE|0
4926054|NCT00456092|16960869|P3|Extension Phase|Grade 2 or Greater AE|0
4926055|NCT00456092|16960870|P2|Extension Phase|Grade 2 or Greater AE|2
4926056|NCT00456092|16960871|P1|Extension Phase|Grade 2 or Greater AE|2
4926057|NCT00455923|16961053|P2|Overall Study|Other|1
4926058|NCT00455923|16961054|P1|Overall Study|Other|3
4926059|NCT00455923|16961053|P2|Overall Study|Pregnancy|2
4926060|NCT00455923|16961054|P1|Overall Study|Pregnancy|0
4926061|NCT00455858|16961070|P1|Overall Study|Withdrawal|1
4926062|NCT00455858|16961070|P1|Overall Study|Well controlled FPG without insulin|1
4926063|NCT00455858|16961070|P1|Overall Study|Lack of Efficacy|1
4926064|NCT00455858|16961070|P1|Overall Study|Protocol Violation|1
4926065|NCT00455858|16961070|P1|Overall Study|Lost to Follow-up|2
4926066|NCT00455741|16961080|P2|Overall Study|Physician Decision|1
4926067|NCT00455741|16961081|P1|Overall Study|Physician Decision|0
4926068|NCT00455533|16961177|P3|Period Two: Randomized Period|Subject Withdrew Consent|1
4926069|NCT00455533|16961178|P2|Period Two: Randomized Period|Subject Withdrew Consent|2
4926070|NCT00455533|16961179|P1|Period Two: Randomized Period|Subject Withdrew Consent|0
4926071|NCT00455533|16961177|P3|Period Two: Randomized Period|Study Drug Toxicity|0
4926072|NCT00455533|16961178|P2|Period Two: Randomized Period|Study Drug Toxicity|2
4926073|NCT00455533|16961179|P1|Period Two: Randomized Period|Study Drug Toxicity|0
4926074|NCT00455533|16961177|P3|Period Two: Randomized Period|Other - need reasons|0
4926075|NCT00455533|16961178|P2|Period Two: Randomized Period|Other - need reasons|1
4926076|NCT00455533|16961179|P1|Period Two: Randomized Period|Other - need reasons|0
4926077|NCT00455533|16961177|P3|Period Two: Randomized Period|Lost to Follow-up|1
4926078|NCT00455533|16961178|P2|Period Two: Randomized Period|Lost to Follow-up|0
4926079|NCT00455533|16961179|P1|Period Two: Randomized Period|Lost to Follow-up|0
4926080|NCT00455533|16961177|P3|Period Two: Randomized Period|Disease Progression|1
4926081|NCT00455533|16961178|P2|Period Two: Randomized Period|Disease Progression|1
4926082|NCT00455533|16961179|P1|Period Two: Randomized Period|Disease Progression|0
4926083|NCT00455533|16961177|P3|Period Two: Randomized Period|Death|3
4926084|NCT00455533|16961178|P2|Period Two: Randomized Period|Death|0
4926085|NCT00455533|16961179|P1|Period Two: Randomized Period|Death|0
4926086|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
4926087|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Subject Withdrew Consent|0
4926088|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Subject Withdrew Consent|2
4926089|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
4926090|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0
4926091|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2
4926092|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
4926093|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0
4926094|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1
4926095|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Study Drug Toxicity|0
4926096|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Study Drug Toxicity|0
4926097|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Study Drug Toxicity|2
4926098|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Other--Need Reasons|0
4926099|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Other--Need Reasons|0
4926100|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Other--Need Reasons|2
4926101|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Not Reported|0
4926102|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Not Reported|0
4926103|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Not Reported|1
4926104|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Lost to Follow-up|0
4926105|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Lost to Follow-up|0
4926106|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Lost to Follow-up|2
4926107|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Disease Progression|0
4926108|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Disease Progression|0
4926109|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Disease Progression|5
4926110|NCT00455533|16961177|P3|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
4926111|NCT00455533|16961178|P2|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0
4926112|NCT00455533|16961179|P1|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1
4926113|NCT00455520|16961228|P2|Double Blind Tapentadol ER vs Placebo|All other|6
4926114|NCT00455520|16961229|P1|Double Blind Tapentadol ER vs Placebo|All other|4
4926115|NCT00455520|16961228|P2|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2
4926116|NCT00455520|16961229|P1|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4
4926117|NCT00455520|16961228|P2|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
4926118|NCT00455520|16961229|P1|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3
4926119|NCT00455520|16961228|P2|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7
4926120|NCT00455520|16961229|P1|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15
4926121|NCT00455520|16961228|P2|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29
4926122|NCT00455520|16961229|P1|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8
4926123|NCT00455520|16961228|P2|Double Blind Tapentadol ER vs Placebo|Adverse Event|15
4926124|NCT00455520|16961229|P1|Double Blind Tapentadol ER vs Placebo|Adverse Event|29
4926125|NCT00455520|16961228|P2|Open Label Tapentadol Extended Release|All other|0
4926126|NCT00455520|16961229|P1|Open Label Tapentadol Extended Release|All other|33
4926127|NCT00455520|16961228|P2|Open Label Tapentadol Extended Release|Study drug non-compliant|0
4926128|NCT00455520|16961229|P1|Open Label Tapentadol Extended Release|Study drug non-compliant|13
4926129|NCT00455520|16961228|P2|Open Label Tapentadol Extended Release|Lack of Efficacy|0
4926130|NCT00455520|16961229|P1|Open Label Tapentadol Extended Release|Lack of Efficacy|23
4926131|NCT00455520|16961228|P2|Open Label Tapentadol Extended Release|Adverse Event|0
4926132|NCT00455520|16961229|P1|Open Label Tapentadol Extended Release|Adverse Event|100
4926133|NCT00455520|16961228|P2|Open Label Tapentadol Extended Release|Lost to Follow-up|0
4926134|NCT00455520|16961229|P1|Open Label Tapentadol Extended Release|Lost to Follow-up|3
4926135|NCT00455520|16961228|P2|Open Label Tapentadol Extended Release|Withdrawal by Subject|0
4926136|NCT00455520|16961229|P1|Open Label Tapentadol Extended Release|Withdrawal by Subject|24
4926137|NCT00455455|16961245|P2|Washout|Withdrawal by Subject|0
4926138|NCT00455455|16961246|P1|Washout|Withdrawal by Subject|1
4926139|NCT00455455|16961245|P2|Washout|Withdrawal by Subject|1
4926140|NCT00455455|16961246|P1|Washout|Withdrawal by Subject|0
4926141|NCT00455429|16961266|P4|Overall Study|Other|1
4926142|NCT00455429|16961267|P3|Overall Study|Other|0
4926143|NCT00455429|16961268|P2|Overall Study|Other|2
4926144|NCT00455429|16961269|P1|Overall Study|Other|0
4926145|NCT00455429|16961266|P4|Overall Study|Non-compliance|1
4926146|NCT00455429|16961267|P3|Overall Study|Non-compliance|0
4926147|NCT00455429|16961268|P2|Overall Study|Non-compliance|0
4926148|NCT00455429|16961269|P1|Overall Study|Non-compliance|0
4926149|NCT00455429|16961266|P4|Overall Study|Personal Reason|0
4926150|NCT00455429|16961267|P3|Overall Study|Personal Reason|0
4926151|NCT00455429|16961268|P2|Overall Study|Personal Reason|0
4926152|NCT00455429|16961269|P1|Overall Study|Personal Reason|1
4926153|NCT00455429|16961266|P4|Overall Study|Randomly assigned but not treated|2
4926154|NCT00455429|16961267|P3|Overall Study|Randomly assigned but not treated|0
4926155|NCT00455429|16961268|P2|Overall Study|Randomly assigned but not treated|0
4926156|NCT00455429|16961269|P1|Overall Study|Randomly assigned but not treated|0
4926157|NCT00455429|16961266|P4|Overall Study|Adverse Event|3
4926158|NCT00455429|16961267|P3|Overall Study|Adverse Event|0
4926159|NCT00455429|16961268|P2|Overall Study|Adverse Event|1
4926160|NCT00455429|16961269|P1|Overall Study|Adverse Event|0
4926161|NCT00455429|16961266|P4|Overall Study|Lack of Efficacy|1
4926162|NCT00455429|16961267|P3|Overall Study|Lack of Efficacy|0
4926163|NCT00455429|16961268|P2|Overall Study|Lack of Efficacy|1
4926164|NCT00455429|16961269|P1|Overall Study|Lack of Efficacy|0
4926165|NCT00455429|16961266|P4|Overall Study|Withdrawal by Subject|0
4926166|NCT00455429|16961267|P3|Overall Study|Withdrawal by Subject|1
4926167|NCT00455429|16961268|P2|Overall Study|Withdrawal by Subject|1
4926168|NCT00455429|16961269|P1|Overall Study|Withdrawal by Subject|0
4926169|NCT00455429|16961266|P4|Overall Study|Lost to Follow-up|3
4926170|NCT00455429|16961267|P3|Overall Study|Lost to Follow-up|0
4926171|NCT00455429|16961268|P2|Overall Study|Lost to Follow-up|0
4926172|NCT00455429|16961269|P1|Overall Study|Lost to Follow-up|1
4926173|NCT00455429|16961266|P4|Overall Study|Study Terminated by Sponsor|3
4926174|NCT00455429|16961267|P3|Overall Study|Study Terminated by Sponsor|0
4926175|NCT00455429|16961268|P2|Overall Study|Study Terminated by Sponsor|0
4926176|NCT00455429|16961269|P1|Overall Study|Study Terminated by Sponsor|0
4926177|NCT00455312|16961328|P2|Overall Study|Death|1
4926178|NCT00455312|16961329|P1|Overall Study|Death|0
4926179|NCT00455195|16961355|P2|Double-blind Study AGLU02704|Unable to commit time to study|1
4926180|NCT00455195|16961356|P1|Double-blind Study AGLU02704|Unable to commit time to study|0
4926181|NCT00455195|16961355|P2|Double-blind Study AGLU02704|Withdrawal by Subject|2
4926182|NCT00455195|16961356|P1|Double-blind Study AGLU02704|Withdrawal by Subject|2
4926183|NCT00455195|16961355|P2|Double-blind Study AGLU02704|Death|0
4926184|NCT00455195|16961356|P1|Double-blind Study AGLU02704|Death|1
4926185|NCT00455195|16961355|P2|Double-blind Study AGLU02704|Adverse Event|1
4926186|NCT00455195|16961356|P1|Double-blind Study AGLU02704|Adverse Event|2
4926187|NCT00455143|16961370|P1|Overall Study|Surgical time, staff not available|1
4926188|NCT00455143|16961370|P1|Overall Study|No longer met Inclusion Criteria|1
4926189|NCT00455143|16961370|P1|Overall Study|Staff was not avail to follow patient|2
4926190|NCT00455143|16961370|P1|Overall Study|Withdrawal by Subject|1
4926191|NCT00455143|16961370|P1|Overall Study|Physician Decision|1
4926192|NCT00455013|16961394|P3|Long Term Extension (LTE)|non-specified|1
4926193|NCT00455013|16961395|P2|Long Term Extension (LTE)|non-specified|0
4926194|NCT00455013|16961396|P1|Long Term Extension (LTE)|non-specified|0
4926195|NCT00455013|16961394|P3|Long Term Extension (LTE)|Poor non-compliance|0
4926196|NCT00455013|16961395|P2|Long Term Extension (LTE)|Poor non-compliance|1
4926197|NCT00455013|16961396|P1|Long Term Extension (LTE)|Poor non-compliance|0
4926198|NCT00455013|16961394|P3|Long Term Extension (LTE)|Subject Request or refused|3
4926199|NCT00455013|16961395|P2|Long Term Extension (LTE)|Subject Request or refused|0
4926200|NCT00455013|16961396|P1|Long Term Extension (LTE)|Subject Request or refused|0
4926201|NCT00455013|16961394|P3|Long Term Extension (LTE)|No longer met criteria|1
4926202|NCT00455013|16961395|P2|Long Term Extension (LTE)|No longer met criteria|0
4926203|NCT00455013|16961396|P1|Long Term Extension (LTE)|No longer met criteria|0
4926204|NCT00455013|16961394|P3|Long Term Extension (LTE)|Death|0
4926205|NCT00455013|16961395|P2|Long Term Extension (LTE)|Death|1
4926206|NCT00455013|16961396|P1|Long Term Extension (LTE)|Death|1
4926207|NCT00455013|16961394|P3|Long Term Extension (LTE)|Withdrawal by Subject|1
4926208|NCT00455013|16961395|P2|Long Term Extension (LTE)|Withdrawal by Subject|0
4926209|NCT00455013|16961396|P1|Long Term Extension (LTE)|Withdrawal by Subject|1
4926210|NCT00455013|16961394|P3|Long Term Extension (LTE)|Adverse Event|1
4926211|NCT00455013|16961395|P2|Long Term Extension (LTE)|Adverse Event|1
4926212|NCT00455013|16961396|P1|Long Term Extension (LTE)|Adverse Event|0
4926213|NCT00455013|16961394|P3|Short Term Period|Other|1
4926214|NCT00455013|16961395|P2|Short Term Period|Other|0
4926215|NCT00455013|16961396|P1|Short Term Period|Other|0
4926216|NCT00455013|16961394|P3|Short Term Period|Lack of Efficacy|0
4926217|NCT00455013|16961395|P2|Short Term Period|Lack of Efficacy|0
4926218|NCT00455013|16961396|P1|Short Term Period|Lack of Efficacy|4
4926219|NCT00455013|16961394|P3|Short Term Period|Withdrawal by Subject|1
4926220|NCT00455013|16961395|P2|Short Term Period|Withdrawal by Subject|0
4926221|NCT00455013|16961396|P1|Short Term Period|Withdrawal by Subject|0
4926222|NCT00455013|16961394|P3|Short Term Period|Adverse Event|0
4926223|NCT00455013|16961395|P2|Short Term Period|Adverse Event|5
4926224|NCT00455013|16961396|P1|Short Term Period|Adverse Event|2
4926225|NCT00454987|16961464|P3|Booster Period (NCT00258700)|Lost to Follow-up|0
4926226|NCT00454987|16961465|P2|Booster Period (NCT00258700)|Lost to Follow-up|0
4926227|NCT00454987|16961466|P1|Booster Period (NCT00258700)|Lost to Follow-up|1
4926228|NCT00454987|16961464|P3|Booster Period (NCT00258700)|Withdrawal by Subject|0
4926229|NCT00454987|16961465|P2|Booster Period (NCT00258700)|Withdrawal by Subject|1
4926230|NCT00454987|16961466|P1|Booster Period (NCT00258700)|Withdrawal by Subject|0
4926231|NCT00454987|16961464|P3|Booster Period (NCT00258700)|Adverse Event|0
4926232|NCT00454987|16961465|P2|Booster Period (NCT00258700)|Adverse Event|0
4926233|NCT00454987|16961466|P1|Booster Period (NCT00258700)|Adverse Event|1
4926234|NCT00454909|16961540|P3|Overall Study|Others|0
4926235|NCT00454909|16961541|P2|Overall Study|Others|0
4926236|NCT00454909|16961542|P1|Overall Study|Others|1
4926237|NCT00454909|16961540|P3|Overall Study|Lost to follow-up (complete vaccination)|1
4926238|NCT00454909|16961541|P2|Overall Study|Lost to follow-up (complete vaccination)|3
4926239|NCT00454909|16961542|P1|Overall Study|Lost to follow-up (complete vaccination)|5
4926240|NCT00454909|16961540|P3|Overall Study|Migrated/moved from study area|1
4926241|NCT00454909|16961541|P2|Overall Study|Migrated/moved from study area|0
4926242|NCT00454909|16961542|P1|Overall Study|Migrated/moved from study area|0
4926243|NCT00454909|16961540|P3|Overall Study|Withdrawal by Subject|0
4926244|NCT00454909|16961541|P2|Overall Study|Withdrawal by Subject|0
4926245|NCT00454909|16961542|P1|Overall Study|Withdrawal by Subject|1
4926246|NCT00454857|16961580|P1|Overall Study|Reason unknown|1
4926247|NCT00454857|16961580|P1|Overall Study|Other|11
4926248|NCT00454857|16961580|P1|Overall Study|Death|5
4926249|NCT00454857|16961580|P1|Overall Study|Noncompliance|6
4926250|NCT00454857|16961580|P1|Overall Study|Lost to Follow-up|16
4926251|NCT00454857|16961580|P1|Overall Study|Withdrawal by Subject|15
4926252|NCT00454818|16961605|P5|Phase 2: Randomized Double-blind|Received left ventricular assist device|2
4926253|NCT00454818|16961606|P4|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
4926254|NCT00454818|16961607|P3|Phase 2: Randomized Double-blind|Received left ventricular assist device|1
4926255|NCT00454818|16961608|P2|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
4926256|NCT00454818|16961609|P1|Phase 2: Randomized Double-blind|Received left ventricular assist device|0
4926257|NCT00454818|16961605|P5|Phase 2: Randomized Double-blind|Received a heart transplant|1
4926258|NCT00454818|16961606|P4|Phase 2: Randomized Double-blind|Received a heart transplant|0
4926259|NCT00454818|16961607|P3|Phase 2: Randomized Double-blind|Received a heart transplant|2
4926260|NCT00454818|16961608|P2|Phase 2: Randomized Double-blind|Received a heart transplant|0
4926261|NCT00454818|16961609|P1|Phase 2: Randomized Double-blind|Received a heart transplant|0
4926262|NCT00454818|16961605|P5|Phase 2: Randomized Double-blind|Death|1
4926263|NCT00454818|16961606|P4|Phase 2: Randomized Double-blind|Death|0
4926264|NCT00454818|16961607|P3|Phase 2: Randomized Double-blind|Death|0
4926265|NCT00454818|16961608|P2|Phase 2: Randomized Double-blind|Death|1
4926266|NCT00454818|16961609|P1|Phase 2: Randomized Double-blind|Death|0
4926267|NCT00454818|16961605|P5|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
4926268|NCT00454818|16961606|P4|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
4926269|NCT00454818|16961607|P3|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
4926270|NCT00454818|16961608|P2|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1
4926271|NCT00454818|16961609|P1|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0
4926272|NCT00454818|16961605|P5|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
4926273|NCT00454818|16961606|P4|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
4926274|NCT00454818|16961607|P3|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1
4926275|NCT00454818|16961608|P2|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
4926276|NCT00454818|16961609|P1|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0
4926277|NCT00454818|16961605|P5|Phase I: Open-label Dose-escalation|Death|0
4926278|NCT00454818|16961606|P4|Phase I: Open-label Dose-escalation|Death|0
4926279|NCT00454818|16961607|P3|Phase I: Open-label Dose-escalation|Death|0
4926280|NCT00454818|16961608|P2|Phase I: Open-label Dose-escalation|Death|1
4926281|NCT00454818|16961609|P1|Phase I: Open-label Dose-escalation|Death|0
4926282|NCT00454818|16961605|P5|Phase I: Open-label Dose-escalation|Received heart transplant|0
4926283|NCT00454818|16961606|P4|Phase I: Open-label Dose-escalation|Received heart transplant|0
4926284|NCT00454818|16961607|P3|Phase I: Open-label Dose-escalation|Received heart transplant|0
4926285|NCT00454818|16961608|P2|Phase I: Open-label Dose-escalation|Received heart transplant|0
4926286|NCT00454818|16961609|P1|Phase I: Open-label Dose-escalation|Received heart transplant|1
4926287|NCT00454805|16961688|P2|Overall Study|In order to begin radiotherapy|0
4926288|NCT00454805|16961689|P1|Overall Study|In order to begin radiotherapy|1
4926289|NCT00454805|16961688|P2|Overall Study|Disease progression|19
4926290|NCT00454805|16961689|P1|Overall Study|Disease progression|16
4926291|NCT00454805|16961688|P2|Overall Study|Death|2
4926292|NCT00454805|16961689|P1|Overall Study|Death|0
4926293|NCT00454805|16961688|P2|Overall Study|Withdrawal by Subject|2
4926294|NCT00454805|16961689|P1|Overall Study|Withdrawal by Subject|9
4926295|NCT00454779|16961705|P2|Second-line Treatment Phase|Ongoing|1
4926296|NCT00454779|16961706|P1|Second-line Treatment Phase|Ongoing|0
4926297|NCT00454779|16961705|P2|Second-line Treatment Phase|Ended follow-up prior to analysis|1
4926298|NCT00454779|16961706|P1|Second-line Treatment Phase|Ended follow-up prior to analysis|0
4926299|NCT00454779|16961705|P2|Second-line Treatment Phase|Withdrawal by Subject|1
4926300|NCT00454779|16961706|P1|Second-line Treatment Phase|Withdrawal by Subject|0
4926301|NCT00454779|16961705|P2|First-line Treatment Phase|Ongoing|0
4926302|NCT00454779|16961706|P1|First-line Treatment Phase|Ongoing|1
4926303|NCT00454779|16961705|P2|First-line Treatment Phase|Ended follow-up prior to analysis|1
4926304|NCT00454779|16961706|P1|First-line Treatment Phase|Ended follow-up prior to analysis|1
4926305|NCT00454779|16961705|P2|First-line Treatment Phase|Protocol Violation|1
4926306|NCT00454779|16961706|P1|First-line Treatment Phase|Protocol Violation|0
4926307|NCT00454779|16961705|P2|First-line Treatment Phase|Lost to Follow-up|0
4926308|NCT00454779|16961706|P1|First-line Treatment Phase|Lost to Follow-up|1
4926309|NCT00454779|16961705|P2|First-line Treatment Phase|Withdrawal by Subject|4
4926310|NCT00454779|16961706|P1|First-line Treatment Phase|Withdrawal by Subject|2
4926311|NCT00454779|16961705|P2|First-line Treatment Phase|Lack of Efficacy|2
4926312|NCT00454779|16961706|P1|First-line Treatment Phase|Lack of Efficacy|0
4926313|NCT00454649|16961744|P10|Overall Study|Withdrawal by Subject|0
4926314|NCT00454649|16961745|P9|Overall Study|Withdrawal by Subject|1
4926315|NCT00454649|16961746|P8|Overall Study|Withdrawal by Subject|2
4926316|NCT00454649|16961747|P7|Overall Study|Withdrawal by Subject|0
4926317|NCT00454649|16961748|P6|Overall Study|Withdrawal by Subject|1
4926318|NCT00454649|16961749|P5|Overall Study|Withdrawal by Subject|0
4926319|NCT00454649|16961750|P4|Overall Study|Withdrawal by Subject|0
4926320|NCT00454649|16961751|P3|Overall Study|Withdrawal by Subject|0
4926321|NCT00454649|16961752|P2|Overall Study|Withdrawal by Subject|0
4926322|NCT00454649|16961753|P1|Overall Study|Withdrawal by Subject|0
4926323|NCT00454649|16961744|P10|Overall Study|Other|1
4926324|NCT00454649|16961745|P9|Overall Study|Other|3
4926325|NCT00454649|16961746|P8|Overall Study|Other|0
4926326|NCT00454649|16961747|P7|Overall Study|Other|0
4926327|NCT00454649|16961748|P6|Overall Study|Other|0
4926328|NCT00454649|16961749|P5|Overall Study|Other|0
4926329|NCT00454649|16961750|P4|Overall Study|Other|3
4926330|NCT00454649|16961751|P3|Overall Study|Other|5
4926331|NCT00454649|16961752|P2|Overall Study|Other|1
4926332|NCT00454649|16961753|P1|Overall Study|Other|1
4926333|NCT00454649|16961744|P10|Overall Study|Lost to Follow-up|0
4926334|NCT00454649|16961745|P9|Overall Study|Lost to Follow-up|0
4926335|NCT00454649|16961746|P8|Overall Study|Lost to Follow-up|0
4926336|NCT00454649|16961747|P7|Overall Study|Lost to Follow-up|1
4926337|NCT00454649|16961748|P6|Overall Study|Lost to Follow-up|0
4926338|NCT00454649|16961749|P5|Overall Study|Lost to Follow-up|0
4926339|NCT00454649|16961750|P4|Overall Study|Lost to Follow-up|0
4926340|NCT00454649|16961751|P3|Overall Study|Lost to Follow-up|1
4926341|NCT00454649|16961752|P2|Overall Study|Lost to Follow-up|0
4926342|NCT00454649|16961753|P1|Overall Study|Lost to Follow-up|0
4926343|NCT00454649|16961744|P10|Overall Study|Adverse Event|2
4926344|NCT00454649|16961745|P9|Overall Study|Adverse Event|6
4926345|NCT00454649|16961746|P8|Overall Study|Adverse Event|4
4926346|NCT00454649|16961747|P7|Overall Study|Adverse Event|3
4926347|NCT00454649|16961748|P6|Overall Study|Adverse Event|2
4926348|NCT00454649|16961749|P5|Overall Study|Adverse Event|1
4926349|NCT00454649|16961750|P4|Overall Study|Adverse Event|0
4926350|NCT00454649|16961751|P3|Overall Study|Adverse Event|3
4926351|NCT00454649|16961752|P2|Overall Study|Adverse Event|1
4926352|NCT00454649|16961753|P1|Overall Study|Adverse Event|0
4926353|NCT00454649|16961744|P10|Overall Study|Lack of Efficacy|2
4926354|NCT00454649|16961745|P9|Overall Study|Lack of Efficacy|10
4926355|NCT00454649|16961746|P8|Overall Study|Lack of Efficacy|13
4926356|NCT00454649|16961747|P7|Overall Study|Lack of Efficacy|5
4926357|NCT00454649|16961748|P6|Overall Study|Lack of Efficacy|4
4926358|NCT00454649|16961749|P5|Overall Study|Lack of Efficacy|0
4926359|NCT00454649|16961750|P4|Overall Study|Lack of Efficacy|3
4926360|NCT00454649|16961751|P3|Overall Study|Lack of Efficacy|10
4926361|NCT00454649|16961752|P2|Overall Study|Lack of Efficacy|2
4926362|NCT00454649|16961753|P1|Overall Study|Lack of Efficacy|2
4926363|NCT00454636|16961882|P4|Overall Study|Lost to Follow-up|0
4926364|NCT00454636|16961883|P3|Overall Study|Lost to Follow-up|0
4926365|NCT00454636|16961884|P2|Overall Study|Lost to Follow-up|1
4926366|NCT00454636|16961885|P1|Overall Study|Lost to Follow-up|0
4926367|NCT00454636|16961882|P4|Overall Study|Patient refusal|2
4926368|NCT00454636|16961883|P3|Overall Study|Patient refusal|3
4926369|NCT00454636|16961884|P2|Overall Study|Patient refusal|1
4926370|NCT00454636|16961885|P1|Overall Study|Patient refusal|1
4926371|NCT00454636|16961882|P4|Overall Study|Death|1
4926372|NCT00454636|16961883|P3|Overall Study|Death|1
4926373|NCT00454636|16961884|P2|Overall Study|Death|1
4926374|NCT00454636|16961885|P1|Overall Study|Death|6
4926375|NCT00454636|16961882|P4|Overall Study|Protocol Violation|3
4926376|NCT00454636|16961883|P3|Overall Study|Protocol Violation|3
4926377|NCT00454636|16961884|P2|Overall Study|Protocol Violation|2
4926378|NCT00454636|16961885|P1|Overall Study|Protocol Violation|3
4926379|NCT00454636|16961882|P4|Overall Study|Disease Progression|11
4926380|NCT00454636|16961883|P3|Overall Study|Disease Progression|4
4926381|NCT00454636|16961884|P2|Overall Study|Disease Progression|12
4926382|NCT00454636|16961885|P1|Overall Study|Disease Progression|11
4926383|NCT00454636|16961882|P4|Overall Study|Adverse Event|15
4926384|NCT00454636|16961883|P3|Overall Study|Adverse Event|9
4926385|NCT00454636|16961884|P2|Overall Study|Adverse Event|6
4926386|NCT00454636|16961885|P1|Overall Study|Adverse Event|10
4926387|NCT00454584|16961918|P6|After Controlled Period|Other|17
4926388|NCT00454584|16961919|P5|After Controlled Period|Other|5
4926389|NCT00454584|16961920|P4|After Controlled Period|Other|13
4926390|NCT00454584|16961921|P3|After Controlled Period|Other|0
4926391|NCT00454584|16961922|P2|After Controlled Period|Other|0
4926392|NCT00454584|16961923|P1|After Controlled Period|Other|0
4926393|NCT00454584|16961918|P6|After Controlled Period|Other|0
4926394|NCT00454584|16961919|P5|After Controlled Period|Other|0
4926395|NCT00454584|16961920|P4|After Controlled Period|Other|1
4926396|NCT00454584|16961921|P3|After Controlled Period|Other|0
4926397|NCT00454584|16961922|P2|After Controlled Period|Other|0
4926398|NCT00454584|16961923|P1|After Controlled Period|Other|0
4926399|NCT00454584|16961918|P6|After Controlled Period|Lost to Follow-up|6
4926400|NCT00454584|16961919|P5|After Controlled Period|Lost to Follow-up|4
4926401|NCT00454584|16961920|P4|After Controlled Period|Lost to Follow-up|2
4926402|NCT00454584|16961921|P3|After Controlled Period|Lost to Follow-up|0
4926403|NCT00454584|16961922|P2|After Controlled Period|Lost to Follow-up|0
4926404|NCT00454584|16961923|P1|After Controlled Period|Lost to Follow-up|0
4926405|NCT00454584|16961918|P6|After Controlled Period|Lack of Efficacy|0
4926406|NCT00454584|16961919|P5|After Controlled Period|Lack of Efficacy|0
4926407|NCT00454584|16961920|P4|After Controlled Period|Lack of Efficacy|1
4926408|NCT00454584|16961921|P3|After Controlled Period|Lack of Efficacy|0
4926409|NCT00454584|16961922|P2|After Controlled Period|Lack of Efficacy|0
4926410|NCT00454584|16961923|P1|After Controlled Period|Lack of Efficacy|0
4926411|NCT00454584|16961918|P6|After Controlled Period|Adverse Event|9
4926412|NCT00454584|16961919|P5|After Controlled Period|Adverse Event|3
4926413|NCT00454584|16961920|P4|After Controlled Period|Adverse Event|9
4926414|NCT00454584|16961921|P3|After Controlled Period|Adverse Event|0
4926415|NCT00454584|16961922|P2|After Controlled Period|Adverse Event|0
4926416|NCT00454584|16961923|P1|After Controlled Period|Adverse Event|0
4926417|NCT00454584|16961918|P6|Controlled Period|Other|0
4926418|NCT00454584|16961919|P5|Controlled Period|Other|0
4926419|NCT00454584|16961920|P4|Controlled Period|Other|0
4926420|NCT00454584|16961921|P3|Controlled Period|Other|2
4926421|NCT00454584|16961922|P2|Controlled Period|Other|4
4926422|NCT00454584|16961923|P1|Controlled Period|Other|5
4926423|NCT00454584|16961918|P6|Controlled Period|Lost to Follow-up|0
4926424|NCT00454584|16961919|P5|Controlled Period|Lost to Follow-up|0
4926425|NCT00454584|16961920|P4|Controlled Period|Lost to Follow-up|0
4926426|NCT00454584|16961921|P3|Controlled Period|Lost to Follow-up|2
4926427|NCT00454584|16961922|P2|Controlled Period|Lost to Follow-up|2
4926428|NCT00454584|16961923|P1|Controlled Period|Lost to Follow-up|1
4926429|NCT00454584|16961918|P6|Controlled Period|Adverse Event|0
4926430|NCT00454584|16961919|P5|Controlled Period|Adverse Event|0
4926431|NCT00454584|16961920|P4|Controlled Period|Adverse Event|0
4926432|NCT00454584|16961921|P3|Controlled Period|Adverse Event|1
4926433|NCT00454584|16961922|P2|Controlled Period|Adverse Event|2
4926434|NCT00454584|16961923|P1|Controlled Period|Adverse Event|5
4926435|NCT00454571|16961945|P2|Overall Study|Withdrawal by Subject|5
4926436|NCT00454571|16961946|P1|Overall Study|Withdrawal by Subject|10
4926437|NCT00454571|16961945|P2|Overall Study|Protocol Violation|0
4926438|NCT00454571|16961946|P1|Overall Study|Protocol Violation|1
4926439|NCT00454571|16961945|P2|Overall Study|Physician Decision|1
4926440|NCT00454571|16961946|P1|Overall Study|Physician Decision|0
4926441|NCT00454571|16961945|P2|Overall Study|Adverse Event|0
4926442|NCT00454571|16961946|P1|Overall Study|Adverse Event|2
4926443|NCT00454363|16961981|P2|Overall Study|Withdrawal prior to 12 weeks treatment|0
4926444|NCT00454363|16961982|P1|Overall Study|Withdrawal prior to 12 weeks treatment|4
4926445|NCT00454363|16961981|P2|Overall Study|Adverse Event|2
4926446|NCT00454363|16961982|P1|Overall Study|Adverse Event|1
4926447|NCT00454246|16962011|P3|Overall Study|Early termination of study|9
4926448|NCT00454246|16962012|P2|Overall Study|Early termination of study|26
4926449|NCT00454246|16962013|P1|Overall Study|Early termination of study|62
4926450|NCT00454246|16962011|P3|Overall Study|Failure to return|0
4926451|NCT00454246|16962012|P2|Overall Study|Failure to return|0
4926452|NCT00454246|16962013|P1|Overall Study|Failure to return|1
4926453|NCT00454246|16962011|P3|Overall Study|Refused Treatment|0
4926454|NCT00454246|16962012|P2|Overall Study|Refused Treatment|1
4926455|NCT00454246|16962013|P1|Overall Study|Refused Treatment|1
4926456|NCT00454246|16962011|P3|Overall Study|Protocol Violation|0
4926457|NCT00454246|16962012|P2|Overall Study|Protocol Violation|0
4926458|NCT00454246|16962013|P1|Overall Study|Protocol Violation|1
4926459|NCT00454246|16962011|P3|Overall Study|Violation of selection criteria at entry|0
4926460|NCT00454246|16962012|P2|Overall Study|Violation of selection criteria at entry|0
4926461|NCT00454246|16962013|P1|Overall Study|Violation of selection criteria at entry|6
4926462|NCT00454246|16962011|P3|Overall Study|Adverse Event|0
4926463|NCT00454246|16962012|P2|Overall Study|Adverse Event|2
4926464|NCT00454246|16962013|P1|Overall Study|Adverse Event|2
4926465|NCT00454207|16962029|P2|Overall Study|Protocol Violation|1
4926466|NCT00454207|16962030|P1|Overall Study|Protocol Violation|0
4926467|NCT00454207|16962029|P2|Overall Study|Lack of Efficacy|0
4926468|NCT00454207|16962030|P1|Overall Study|Lack of Efficacy|1
4926469|NCT00454207|16962029|P2|Overall Study|Adverse Event|1
4926470|NCT00454207|16962030|P1|Overall Study|Adverse Event|3
4926471|NCT00454194|16962075|P2|Overall Study|Other Unspecified Reason|2
4926472|NCT00454194|16962076|P1|Overall Study|Other Unspecified Reason|2
4926473|NCT00454194|16962075|P2|Overall Study|Other Medical Problems|2
4926474|NCT00454194|16962076|P1|Overall Study|Other Medical Problems|1
4926475|NCT00454194|16962075|P2|Overall Study|Withdrawal by Subject|8
4926476|NCT00454194|16962076|P1|Overall Study|Withdrawal by Subject|12
4926477|NCT00454194|16962075|P2|Overall Study|Adverse Event|2
4926478|NCT00454194|16962076|P1|Overall Study|Adverse Event|7
4926479|NCT00454181|16962094|P2|Overall Study|Withdrawal by Subject|0
4926480|NCT00454181|16962095|P1|Overall Study|Withdrawal by Subject|2
4926481|NCT00454181|16962094|P2|Overall Study|Protocol Violation|1
4926482|NCT00454181|16962095|P1|Overall Study|Protocol Violation|1
4926483|NCT00454181|16962094|P2|Overall Study|Lost to Follow-up|1
4926484|NCT00454181|16962095|P1|Overall Study|Lost to Follow-up|11
4926485|NCT00454181|16962094|P2|Overall Study|Adverse Event|1
4926486|NCT00454181|16962095|P1|Overall Study|Adverse Event|1
4926487|NCT00454142|16962111|P1|Overall Study|Withdrawal by Subject|1
4926488|NCT00454116|16962129|P3|Overall Study|Other|0
4926489|NCT00454116|16962130|P2|Overall Study|Other|2
4926490|NCT00454116|16962131|P1|Overall Study|Other|2
4926491|NCT00454116|16962129|P3|Overall Study|Withdrawal by Subject|1
4926492|NCT00454116|16962130|P2|Overall Study|Withdrawal by Subject|3
4926493|NCT00454116|16962131|P1|Overall Study|Withdrawal by Subject|3
4926494|NCT00454116|16962129|P3|Overall Study|Condition under investigation worsened|18
4926495|NCT00454116|16962130|P2|Overall Study|Condition under investigation worsened|13
4926496|NCT00454116|16962131|P1|Overall Study|Condition under investigation worsened|17
4926497|NCT00454116|16962129|P3|Overall Study|Adverse Event|9
4926498|NCT00454116|16962130|P2|Overall Study|Adverse Event|11
4926499|NCT00454116|16962131|P1|Overall Study|Adverse Event|5
4926500|NCT00454051|16962141|P2|Overall Study|Protocol Violation|1
4926501|NCT00454051|16962142|P1|Overall Study|Protocol Violation|1
4926502|NCT00454051|16962141|P2|Overall Study|Withdrawal by Subject|0
4926503|NCT00454051|16962142|P1|Overall Study|Withdrawal by Subject|1
4926504|NCT00454051|16962141|P2|Overall Study|Adverse Event|2
4926505|NCT00454051|16962142|P1|Overall Study|Adverse Event|1
4926506|NCT00453999|16962175|P3|Overall Study|Subject Request|0
4926507|NCT00453999|16962176|P2|Overall Study|Subject Request|1
4926508|NCT00453999|16962177|P1|Overall Study|Subject Request|2
4926509|NCT00453999|16962175|P3|Overall Study|Withdrawal by Subject|1
4926510|NCT00453999|16962176|P2|Overall Study|Withdrawal by Subject|1
4926511|NCT00453999|16962177|P1|Overall Study|Withdrawal by Subject|2
4926512|NCT00453999|16962175|P3|Overall Study|Lost to Follow-up|1
4926513|NCT00453999|16962176|P2|Overall Study|Lost to Follow-up|1
4926514|NCT00453999|16962177|P1|Overall Study|Lost to Follow-up|0
4926515|NCT00453999|16962175|P3|Overall Study|Adverse Event|1
4926516|NCT00453999|16962176|P2|Overall Study|Adverse Event|2
4926517|NCT00453999|16962177|P1|Overall Study|Adverse Event|1
4926518|NCT00453986|16962205|P5|Overall Study|Lost to Follow-up|0
4926519|NCT00453986|16962206|P4|Overall Study|Lost to Follow-up|2
4926520|NCT00453986|16962207|P3|Overall Study|Lost to Follow-up|6
4926521|NCT00453986|16962208|P2|Overall Study|Lost to Follow-up|5
4926522|NCT00453986|16962209|P1|Overall Study|Lost to Follow-up|6
4926523|NCT00453973|16962302|P2|Overall Study|Sponsor Decision to Terminate Study|30
4926524|NCT00453973|16962303|P1|Overall Study|Sponsor Decision to Terminate Study|35
4926525|NCT00453973|16962302|P2|Overall Study|Site closed by sponsor|0
4926526|NCT00453973|16962303|P1|Overall Study|Site closed by sponsor|3
4926527|NCT00453973|16962302|P2|Overall Study|Renal transplant|1
4926528|NCT00453973|16962303|P1|Overall Study|Renal transplant|1
4926529|NCT00453973|16962302|P2|Overall Study|Relocation|0
4926530|NCT00453973|16962303|P1|Overall Study|Relocation|1
4926531|NCT00453973|16962302|P2|Overall Study|PI Decision|2
4926532|NCT00453973|16962303|P1|Overall Study|PI Decision|0
4926533|NCT00453973|16962302|P2|Overall Study|Withdrawal by Subject|6
4926534|NCT00453973|16962303|P1|Overall Study|Withdrawal by Subject|7
4926535|NCT00453973|16962302|P2|Overall Study|Adverse Event|9
4926536|NCT00453973|16962303|P1|Overall Study|Adverse Event|4
4926537|NCT00453921|16962313|P4|Overall Study|Lost to Follow-up|0
4926538|NCT00453921|16962314|P3|Overall Study|Lost to Follow-up|1
4926539|NCT00453921|16962315|P2|Overall Study|Lost to Follow-up|0
4926540|NCT00453921|16962316|P1|Overall Study|Lost to Follow-up|0
4926541|NCT00453921|16962313|P4|Overall Study|Withdrawal by Subject|1
4926542|NCT00453921|16962314|P3|Overall Study|Withdrawal by Subject|1
4926543|NCT00453921|16962315|P2|Overall Study|Withdrawal by Subject|1
4926544|NCT00453921|16962316|P1|Overall Study|Withdrawal by Subject|1
4926545|NCT00453362|16962463|P1|Overall Study|Screening Failure|14
4926546|NCT00453362|16962463|P1|Overall Study|Progression of disease|56
4926547|NCT00453362|16962463|P1|Overall Study|Withdrawal by Subject|3
4926548|NCT00453362|16962463|P1|Overall Study|Physician Decision|2
4926549|NCT00453362|16962463|P1|Overall Study|Death|7
4926550|NCT00453362|16962463|P1|Overall Study|Adverse Event|5
4926551|NCT00453349|16962489|P2|Completed Study|Lost to follow up after study treatment|11
4926552|NCT00453349|16962490|P1|Completed Study|Lost to follow up after study treatment|2
4926553|NCT00453349|16962489|P2|Completed Study|Withdrawal by Subject|5
4926554|NCT00453349|16962490|P1|Completed Study|Withdrawal by Subject|3
4926555|NCT00453349|16962489|P2|Completed Study|Protocol Violation|1
4926556|NCT00453349|16962490|P1|Completed Study|Protocol Violation|1
4926557|NCT00453349|16962489|P2|Completed Study|Lost to Follow-up|5
4926558|NCT00453349|16962490|P1|Completed Study|Lost to Follow-up|7
4926559|NCT00453349|16962489|P2|Completed Study|Lack of Efficacy|1
4926560|NCT00453349|16962490|P1|Completed Study|Lack of Efficacy|2
4926561|NCT00453349|16962489|P2|Completed Study|Adverse Event|11
4926562|NCT00453349|16962490|P1|Completed Study|Adverse Event|12
4926563|NCT00453349|16962489|P2|Reaching of Primary Endpoint (TOC)|Missing information|11
4926564|NCT00453349|16962490|P1|Reaching of Primary Endpoint (TOC)|Missing information|10
4926565|NCT00453349|16962489|P2|Randomized|Withdrawal by Subject|5
4926566|NCT00453349|16962490|P1|Randomized|Withdrawal by Subject|3
4926567|NCT00453349|16962489|P2|Randomized|Protocol Violation|1
4926568|NCT00453349|16962490|P1|Randomized|Protocol Violation|1
4926569|NCT00453349|16962489|P2|Randomized|Lost to Follow-up|5
4926570|NCT00453349|16962490|P1|Randomized|Lost to Follow-up|7
4926571|NCT00453349|16962489|P2|Randomized|Lack of Efficacy|1
4926572|NCT00453349|16962490|P1|Randomized|Lack of Efficacy|2
4926573|NCT00453349|16962489|P2|Randomized|Adverse Event|11
4926574|NCT00453349|16962490|P1|Randomized|Adverse Event|12
4926575|NCT00453310|16962521|P1|Overall Study|Progression of Disease|10
4926576|NCT00453206|16962525|P1|Overall Study|Death|1
4926577|NCT00453180|16962535|P2|Overall Study|Adverse Event|2
4926578|NCT00453180|16962536|P1|Overall Study|Adverse Event|1
4926579|NCT00453180|16962535|P2|Overall Study|Lost to Follow-up|1
4926580|NCT00453180|16962536|P1|Overall Study|Lost to Follow-up|2
4926581|NCT00453154|16962555|P4|Double BIind Maintenance|Randomized, did not receive therapy|5
4926582|NCT00453154|16962556|P3|Double BIind Maintenance|Randomized, did not receive therapy|5
4926583|NCT00453154|16962557|P2|Double BIind Maintenance|Randomized, did not receive therapy|0
4926584|NCT00453154|16962558|P1|Double BIind Maintenance|Randomized, did not receive therapy|0
4926585|NCT00453154|16962555|P4|Double BIind Maintenance|Medical Issues|1
4926586|NCT00453154|16962556|P3|Double BIind Maintenance|Medical Issues|3
4926587|NCT00453154|16962557|P2|Double BIind Maintenance|Medical Issues|0
4926588|NCT00453154|16962558|P1|Double BIind Maintenance|Medical Issues|0
4926589|NCT00453154|16962555|P4|Double BIind Maintenance|Progression|26
4926590|NCT00453154|16962556|P3|Double BIind Maintenance|Progression|29
4926591|NCT00453154|16962557|P2|Double BIind Maintenance|Progression|0
4926592|NCT00453154|16962558|P1|Double BIind Maintenance|Progression|0
4926593|NCT00453154|16962555|P4|Double BIind Maintenance|Withdrawal by Subject|4
4926594|NCT00453154|16962556|P3|Double BIind Maintenance|Withdrawal by Subject|4
4926595|NCT00453154|16962557|P2|Double BIind Maintenance|Withdrawal by Subject|0
4926596|NCT00453154|16962558|P1|Double BIind Maintenance|Withdrawal by Subject|0
4926597|NCT00453154|16962555|P4|Double BIind Maintenance|Death|1
4926598|NCT00453154|16962556|P3|Double BIind Maintenance|Death|2
4926599|NCT00453154|16962557|P2|Double BIind Maintenance|Death|0
4926600|NCT00453154|16962558|P1|Double BIind Maintenance|Death|0
4926601|NCT00453154|16962555|P4|Double BIind Maintenance|Adverse Event|12
4926602|NCT00453154|16962556|P3|Double BIind Maintenance|Adverse Event|3
4926603|NCT00453154|16962557|P2|Double BIind Maintenance|Adverse Event|0
4926604|NCT00453154|16962558|P1|Double BIind Maintenance|Adverse Event|0
4926605|NCT00453102|16962571|P1|Overall Study|Withdrawal by Subject|2
4926606|NCT00453063|16962582|P2|Overall Study|Protocol Violation|0
4926607|NCT00453063|16962583|P1|Overall Study|Protocol Violation|1
4926608|NCT00453063|16962582|P2|Overall Study|Withdrawal by Subject|1
4926609|NCT00453063|16962583|P1|Overall Study|Withdrawal by Subject|1
4926610|NCT00453063|16962582|P2|Overall Study|Adverse Event|2
4926611|NCT00453063|16962583|P1|Overall Study|Adverse Event|1
4926612|NCT00452790|16962603|P2|Toddler Dose|Parent/legal guardian request|1
4926613|NCT00452790|16962604|P1|Toddler Dose|Parent/legal guardian request|0
4926614|NCT00452790|16962603|P2|Toddler Dose|Failed to return|1
4926615|NCT00452790|16962604|P1|Toddler Dose|Failed to return|0
4926616|NCT00452790|16962603|P2|After Infant Series|Other reasons|0
4926617|NCT00452790|16962604|P1|After Infant Series|Other reasons|1
4926618|NCT00452790|16962603|P2|After Infant Series|Failed to return|0
4926619|NCT00452790|16962604|P1|After Infant Series|Failed to return|1
4926620|NCT00452790|16962603|P2|After Infant Series|Lost to Follow-up|0
4926621|NCT00452790|16962604|P1|After Infant Series|Lost to Follow-up|4
4926622|NCT00452790|16962603|P2|After Infant Series|Parent/legal guardian request|3
4926623|NCT00452790|16962604|P1|After Infant Series|Parent/legal guardian request|1
4926624|NCT00452790|16962603|P2|After Infant Series|Adverse Event|1
4926625|NCT00452790|16962604|P1|After Infant Series|Adverse Event|4
4926626|NCT00452790|16962603|P2|After Infant Series|Investigator request|10
4926627|NCT00452790|16962604|P1|After Infant Series|Investigator request|10
4926628|NCT00452790|16962603|P2|Infant Series|Death|1
4926629|NCT00452790|16962604|P1|Infant Series|Death|0
4926630|NCT00452790|16962603|P2|Infant Series|Investigator request|1
4926631|NCT00452790|16962604|P1|Infant Series|Investigator request|0
4926632|NCT00452790|16962603|P2|Infant Series|Other reasons|2
4926633|NCT00452790|16962604|P1|Infant Series|Other reasons|1
4926634|NCT00452790|16962603|P2|Infant Series|Adverse Event|2
4926635|NCT00452790|16962604|P1|Infant Series|Adverse Event|1
4926636|NCT00452790|16962603|P2|Infant Series|Lost to Follow-up|2
4926637|NCT00452790|16962604|P1|Infant Series|Lost to Follow-up|2
4926638|NCT00452790|16962603|P2|Infant Series|Protocol Violation|3
4926639|NCT00452790|16962604|P1|Infant Series|Protocol Violation|1
4926640|NCT00452790|16962603|P2|Infant Series|Failed to return|1
4926641|NCT00452790|16962604|P1|Infant Series|Failed to return|4
4926642|NCT00452790|16962603|P2|Infant Series|Parent/legal guardian request|6
4926643|NCT00452790|16962604|P1|Infant Series|Parent/legal guardian request|8
4926644|NCT00452790|16962603|P2|Infant Series|Clinical hold - consent withdrawn|123
4926645|NCT00452790|16962604|P1|Infant Series|Clinical hold - consent withdrawn|118
4926646|NCT00452699|16962640|P2|Overall Study|Other|7
4926647|NCT00452699|16962641|P1|Overall Study|Other|12
4926648|NCT00452699|16962640|P2|Overall Study|Withdrawal by Subject|25
4926649|NCT00452699|16962641|P1|Overall Study|Withdrawal by Subject|26
4926650|NCT00452699|16962640|P2|Overall Study|Protocol Violation|25
4926651|NCT00452699|16962641|P1|Overall Study|Protocol Violation|21
4926652|NCT00452699|16962640|P2|Overall Study|Lost to Follow-up|9
4926653|NCT00452699|16962641|P1|Overall Study|Lost to Follow-up|6
4926654|NCT00452699|16962640|P2|Overall Study|Lack of Efficacy|4
4926655|NCT00452699|16962641|P1|Overall Study|Lack of Efficacy|6
4926656|NCT00452699|16962640|P2|Overall Study|Adverse Event|3
4926657|NCT00452699|16962641|P1|Overall Study|Adverse Event|10
4926658|NCT00452673|16962657|P5|Dose Expansion Period|Other|2
4926659|NCT00452673|16962658|P4|Dose Expansion Period|Other|0
4926660|NCT00452673|16962659|P3|Dose Expansion Period|Other|0
4926661|NCT00452673|16962660|P2|Dose Expansion Period|Other|0
4926662|NCT00452673|16962661|P1|Dose Expansion Period|Other|0
4926663|NCT00452673|16962657|P5|Dose Expansion Period|Disease Progression|19
4926664|NCT00452673|16962658|P4|Dose Expansion Period|Disease Progression|0
4926665|NCT00452673|16962659|P3|Dose Expansion Period|Disease Progression|0
4926666|NCT00452673|16962660|P2|Dose Expansion Period|Disease Progression|0
4926667|NCT00452673|16962661|P1|Dose Expansion Period|Disease Progression|0
4926668|NCT00452673|16962657|P5|Dose Escalation Period|Withdrawal by Subject|0
4926669|NCT00452673|16962658|P4|Dose Escalation Period|Withdrawal by Subject|1
4926670|NCT00452673|16962659|P3|Dose Escalation Period|Withdrawal by Subject|0
4926671|NCT00452673|16962660|P2|Dose Escalation Period|Withdrawal by Subject|0
4926672|NCT00452673|16962661|P1|Dose Escalation Period|Withdrawal by Subject|0
4926673|NCT00452673|16962657|P5|Dose Escalation Period|Adverse Event|0
4926674|NCT00452673|16962658|P4|Dose Escalation Period|Adverse Event|1
4926675|NCT00452673|16962659|P3|Dose Escalation Period|Adverse Event|0
4926676|NCT00452673|16962660|P2|Dose Escalation Period|Adverse Event|0
4926677|NCT00452673|16962661|P1|Dose Escalation Period|Adverse Event|0
4926678|NCT00452673|16962657|P5|Dose Escalation Period|Other|0
4926679|NCT00452673|16962658|P4|Dose Escalation Period|Other|0
4926680|NCT00452673|16962659|P3|Dose Escalation Period|Other|1
4926681|NCT00452673|16962660|P2|Dose Escalation Period|Other|0
4926682|NCT00452673|16962661|P1|Dose Escalation Period|Other|0
4926683|NCT00452673|16962657|P5|Dose Escalation Period|study drug toxicity|0
4926684|NCT00452673|16962658|P4|Dose Escalation Period|study drug toxicity|1
4926685|NCT00452673|16962659|P3|Dose Escalation Period|study drug toxicity|3
4926686|NCT00452673|16962660|P2|Dose Escalation Period|study drug toxicity|3
4926687|NCT00452673|16962661|P1|Dose Escalation Period|study drug toxicity|1
4926688|NCT00452673|16962657|P5|Dose Escalation Period|Disease Progression|0
4926689|NCT00452673|16962658|P4|Dose Escalation Period|Disease Progression|6
4926690|NCT00452673|16962659|P3|Dose Escalation Period|Disease Progression|2
4926691|NCT00452673|16962660|P2|Dose Escalation Period|Disease Progression|6
4926692|NCT00452673|16962661|P1|Dose Escalation Period|Disease Progression|6
4926693|NCT00452530|16962708|P2|Overall Study|Other|11
4926694|NCT00452530|16962709|P1|Overall Study|Other|7
4926695|NCT00452530|16962708|P2|Overall Study|No longer met study criteria|22
4926696|NCT00452530|16962709|P1|Overall Study|No longer met study criteria|18
4926697|NCT00452530|16962708|P2|Overall Study|Poor compliance/noncompliance|2
4926698|NCT00452530|16962709|P1|Overall Study|Poor compliance/noncompliance|1
4926699|NCT00452530|16962708|P2|Overall Study|Lost to Follow-up|0
4926700|NCT00452530|16962709|P1|Overall Study|Lost to Follow-up|1
4926701|NCT00452530|16962708|P2|Overall Study|Withdrawal by Subject|57
4926702|NCT00452530|16962709|P1|Overall Study|Withdrawal by Subject|68
4926703|NCT00452530|16962708|P2|Overall Study|Adverse Event|44
4926704|NCT00452530|16962709|P1|Overall Study|Adverse Event|40
4926705|NCT00452530|16962708|P2|Overall Study|Death|0
4926706|NCT00452530|16962709|P1|Overall Study|Death|1
4926707|NCT00452452|16962730|P3|Overall Study|Lost to Follow-up|0
4926708|NCT00452452|16962731|P2|Overall Study|Lost to Follow-up|0
4926709|NCT00452452|16962732|P1|Overall Study|Lost to Follow-up|1
4926710|NCT00452452|16962730|P3|Overall Study|Withdrawal by Subject|0
4926711|NCT00452452|16962731|P2|Overall Study|Withdrawal by Subject|0
4926712|NCT00452452|16962732|P1|Overall Study|Withdrawal by Subject|1
4926713|NCT00452452|16962730|P3|Overall Study|Protocol Violation|1
4926714|NCT00452452|16962731|P2|Overall Study|Protocol Violation|0
4926715|NCT00452452|16962732|P1|Overall Study|Protocol Violation|0
4926716|NCT00452400|16962777|P5|Overall Study|Other reasons not listed above|1
4926717|NCT00452400|16962778|P4|Overall Study|Other reasons not listed above|1
4926718|NCT00452400|16962779|P3|Overall Study|Other reasons not listed above|0
4926719|NCT00452400|16962780|P2|Overall Study|Other reasons not listed above|0
4926720|NCT00452400|16962781|P1|Overall Study|Other reasons not listed above|0
4926721|NCT00452400|16962777|P5|Overall Study|Lack of Efficacy|0
4926722|NCT00452400|16962778|P4|Overall Study|Lack of Efficacy|0
4926723|NCT00452400|16962779|P3|Overall Study|Lack of Efficacy|0
4926724|NCT00452400|16962780|P2|Overall Study|Lack of Efficacy|0
4926725|NCT00452400|16962781|P1|Overall Study|Lack of Efficacy|2
4926726|NCT00452400|16962777|P5|Overall Study|Withdrawal by Subject|0
4926727|NCT00452400|16962778|P4|Overall Study|Withdrawal by Subject|0
4926728|NCT00452400|16962779|P3|Overall Study|Withdrawal by Subject|1
4926729|NCT00452400|16962780|P2|Overall Study|Withdrawal by Subject|0
4926730|NCT00452400|16962781|P1|Overall Study|Withdrawal by Subject|1
4926731|NCT00452400|16962777|P5|Overall Study|Lost to Follow-up|0
4926732|NCT00452400|16962778|P4|Overall Study|Lost to Follow-up|0
4926733|NCT00452400|16962779|P3|Overall Study|Lost to Follow-up|0
4926734|NCT00452400|16962780|P2|Overall Study|Lost to Follow-up|0
4926735|NCT00452400|16962781|P1|Overall Study|Lost to Follow-up|1
4926736|NCT00452400|16962777|P5|Overall Study|Protocol Violation|0
4926737|NCT00452400|16962778|P4|Overall Study|Protocol Violation|0
4926738|NCT00452400|16962779|P3|Overall Study|Protocol Violation|1
4926739|NCT00452400|16962780|P2|Overall Study|Protocol Violation|0
4926740|NCT00452400|16962781|P1|Overall Study|Protocol Violation|0
4926741|NCT00452400|16962777|P5|Overall Study|Adverse Event|2
4926742|NCT00452400|16962778|P4|Overall Study|Adverse Event|0
4926743|NCT00452400|16962779|P3|Overall Study|Adverse Event|5
4926744|NCT00452400|16962780|P2|Overall Study|Adverse Event|1
4926745|NCT00452400|16962781|P1|Overall Study|Adverse Event|1
4926746|NCT00452361|16962968|P2|Overall Study|Premature termination|9
4926747|NCT00452361|16962969|P1|Overall Study|Premature termination|13
4926748|NCT00452361|16962968|P2|Overall Study|Withdrawal by Subject|1
4926749|NCT00452361|16962969|P1|Overall Study|Withdrawal by Subject|0
4926750|NCT00452361|16962968|P2|Overall Study|Adverse Event|0
4926751|NCT00452361|16962969|P1|Overall Study|Adverse Event|8
4926752|NCT00452348|16963013|P2|Overall Study|Other|9
4926753|NCT00452348|16963014|P1|Overall Study|Other|9
4926754|NCT00452348|16963013|P2|Overall Study|Withdrawal by Subject|21
4926755|NCT00452348|16963014|P1|Overall Study|Withdrawal by Subject|18
4926756|NCT00452348|16963013|P2|Overall Study|Protocol Violation|28
4926757|NCT00452348|16963014|P1|Overall Study|Protocol Violation|22
4926758|NCT00452348|16963013|P2|Overall Study|Lost to Follow-up|8
4926759|NCT00452348|16963014|P1|Overall Study|Lost to Follow-up|14
4926760|NCT00452348|16963013|P2|Overall Study|Lack of Efficacy|9
4926761|NCT00452348|16963014|P1|Overall Study|Lack of Efficacy|10
4926762|NCT00452348|16963013|P2|Overall Study|Adverse Event|9
4926763|NCT00452348|16963014|P1|Overall Study|Adverse Event|6
4926764|NCT00452114|16963068|P2|Overall Study|Physician Decision|3
4926765|NCT00452114|16963069|P1|Overall Study|Physician Decision|3
4926766|NCT00451958|16963085|P5|CS21A (NCT00451958)|Miscellaneous reasons|0
4926767|NCT00451958|16963086|P4|CS21A (NCT00451958)|Miscellaneous reasons|14
4926768|NCT00451958|16963087|P3|CS21A (NCT00451958)|Miscellaneous reasons|17
4926769|NCT00451958|16963088|P2|CS21A (NCT00451958)|Miscellaneous reasons|27
4926770|NCT00451958|16963089|P1|CS21A (NCT00451958)|Miscellaneous reasons|28
4926771|NCT00451958|16963085|P5|CS21A (NCT00451958)|Withdrawal by Subject|0
4926772|NCT00451958|16963086|P4|CS21A (NCT00451958)|Withdrawal by Subject|3
4926773|NCT00451958|16963087|P3|CS21A (NCT00451958)|Withdrawal by Subject|4
4926774|NCT00451958|16963088|P2|CS21A (NCT00451958)|Withdrawal by Subject|4
4926775|NCT00451958|16963089|P1|CS21A (NCT00451958)|Withdrawal by Subject|7
4926776|NCT00451958|16963085|P5|CS21A (NCT00451958)|Physician Decision|0
4926777|NCT00451958|16963086|P4|CS21A (NCT00451958)|Physician Decision|4
4926778|NCT00451958|16963087|P3|CS21A (NCT00451958)|Physician Decision|4
4926779|NCT00451958|16963088|P2|CS21A (NCT00451958)|Physician Decision|4
4926780|NCT00451958|16963089|P1|CS21A (NCT00451958)|Physician Decision|2
4926781|NCT00451958|16963085|P5|CS21A (NCT00451958)|Protocol Violation|0
4926782|NCT00451958|16963086|P4|CS21A (NCT00451958)|Protocol Violation|0
4926783|NCT00451958|16963087|P3|CS21A (NCT00451958)|Protocol Violation|2
4926784|NCT00451958|16963088|P2|CS21A (NCT00451958)|Protocol Violation|3
4926785|NCT00451958|16963089|P1|CS21A (NCT00451958)|Protocol Violation|1
4926786|NCT00451958|16963085|P5|CS21A (NCT00451958)|Lost to Follow-up|0
4926787|NCT00451958|16963086|P4|CS21A (NCT00451958)|Lost to Follow-up|1
4926788|NCT00451958|16963087|P3|CS21A (NCT00451958)|Lost to Follow-up|1
4926789|NCT00451958|16963088|P2|CS21A (NCT00451958)|Lost to Follow-up|5
4926790|NCT00451958|16963089|P1|CS21A (NCT00451958)|Lost to Follow-up|6
4926791|NCT00451958|16963085|P5|CS21A (NCT00451958)|Adverse Event|0
4926792|NCT00451958|16963086|P4|CS21A (NCT00451958)|Adverse Event|17
4926793|NCT00451958|16963087|P3|CS21A (NCT00451958)|Adverse Event|14
4926794|NCT00451958|16963088|P2|CS21A (NCT00451958)|Adverse Event|34
4926795|NCT00451958|16963089|P1|CS21A (NCT00451958)|Adverse Event|21
4926796|NCT00451906|16963119|P1|Overall Study|Did not complete final visit|4
4926797|NCT00451906|16963119|P1|Overall Study|Other Reasons|121
4926798|NCT00451906|16963119|P1|Overall Study|Termination of the study|108
4926799|NCT00451906|16963119|P1|Overall Study|Progressive disease|1328
4926800|NCT00451906|16963119|P1|Overall Study|Protocol Violation|21
4926801|NCT00451906|16963119|P1|Overall Study|Withdrawal by Subject|111
4926802|NCT00451906|16963119|P1|Overall Study|Lost to Follow-up|31
4926803|NCT00451906|16963119|P1|Overall Study|Adverse Event|515
4926804|NCT00451555|16963147|P2|Overall Study|Physician Decision|1
4926805|NCT00451555|16963148|P1|Overall Study|Physician Decision|2
4926806|NCT00451555|16963147|P2|Overall Study|Withdrawal by Subject|0
4926807|NCT00451555|16963148|P1|Overall Study|Withdrawal by Subject|6
4926808|NCT00451555|16963147|P2|Overall Study|Adverse Event|1
4926809|NCT00451555|16963148|P1|Overall Study|Adverse Event|3
4926810|NCT00451555|16963147|P2|Overall Study|Protocol Violation|2
4926811|NCT00451555|16963148|P1|Overall Study|Protocol Violation|2
4926812|NCT00451451|16963182|P4|Overall Study|Other Reasons for Not Completing Study|14
4926813|NCT00451451|16963183|P3|Overall Study|Other Reasons for Not Completing Study|17
4926814|NCT00451451|16963184|P2|Overall Study|Other Reasons for Not Completing Study|30
4926815|NCT00451451|16963185|P1|Overall Study|Other Reasons for Not Completing Study|34
4926816|NCT00451451|16963182|P4|Overall Study|Death|1
4926817|NCT00451451|16963183|P3|Overall Study|Death|0
4926818|NCT00451451|16963184|P2|Overall Study|Death|0
4926819|NCT00451451|16963185|P1|Overall Study|Death|1
4926820|NCT00451451|16963182|P4|Overall Study|Subject Non-Compliance|3
4926821|NCT00451451|16963183|P3|Overall Study|Subject Non-Compliance|3
4926822|NCT00451451|16963184|P2|Overall Study|Subject Non-Compliance|4
4926823|NCT00451451|16963185|P1|Overall Study|Subject Non-Compliance|8
4926824|NCT00451451|16963182|P4|Overall Study|Investigator Decision|2
4926825|NCT00451451|16963183|P3|Overall Study|Investigator Decision|1
4926826|NCT00451451|16963184|P2|Overall Study|Investigator Decision|2
4926827|NCT00451451|16963185|P1|Overall Study|Investigator Decision|6
4926828|NCT00451451|16963182|P4|Overall Study|Consent Withdrawn|17
4926829|NCT00451451|16963183|P3|Overall Study|Consent Withdrawn|17
4926830|NCT00451451|16963184|P2|Overall Study|Consent Withdrawn|9
4926831|NCT00451451|16963185|P1|Overall Study|Consent Withdrawn|14
4926832|NCT00451451|16963182|P4|Overall Study|Lost to Follow-up|11
4926833|NCT00451451|16963183|P3|Overall Study|Lost to Follow-up|8
4926834|NCT00451451|16963184|P2|Overall Study|Lost to Follow-up|9
4926835|NCT00451451|16963185|P1|Overall Study|Lost to Follow-up|11
4926836|NCT00451451|16963182|P4|Overall Study|Adverse Event|10
4926837|NCT00451451|16963183|P3|Overall Study|Adverse Event|26
4926838|NCT00451451|16963184|P2|Overall Study|Adverse Event|21
4926839|NCT00451451|16963185|P1|Overall Study|Adverse Event|11
4926840|NCT00451321|16963220|P8|Overall Study|Sponsor decision to amend protocol|3
4926841|NCT00451321|16963221|P7|Overall Study|Sponsor decision to amend protocol|1
4926842|NCT00451321|16963222|P6|Overall Study|Sponsor decision to amend protocol|1
4926843|NCT00451321|16963223|P5|Overall Study|Sponsor decision to amend protocol|0
4926844|NCT00451321|16963224|P4|Overall Study|Sponsor decision to amend protocol|0
4926845|NCT00451321|16963225|P3|Overall Study|Sponsor decision to amend protocol|0
4926846|NCT00451321|16963226|P2|Overall Study|Sponsor decision to amend protocol|0
4926847|NCT00451321|16963227|P1|Overall Study|Sponsor decision to amend protocol|0
4926848|NCT00451321|16963220|P8|Overall Study|Study closed/terminated|3
4926849|NCT00451321|16963221|P7|Overall Study|Study closed/terminated|5
4926850|NCT00451321|16963222|P6|Overall Study|Study closed/terminated|7
4926851|NCT00451321|16963223|P5|Overall Study|Study closed/terminated|7
4926852|NCT00451321|16963224|P4|Overall Study|Study closed/terminated|5
4926853|NCT00451321|16963225|P3|Overall Study|Study closed/terminated|17
4926854|NCT00451321|16963226|P2|Overall Study|Study closed/terminated|1
4926855|NCT00451321|16963227|P1|Overall Study|Study closed/terminated|1
4926856|NCT00451321|16963220|P8|Overall Study|Withdrawal by Subject|0
4926857|NCT00451321|16963221|P7|Overall Study|Withdrawal by Subject|0
4926858|NCT00451321|16963222|P6|Overall Study|Withdrawal by Subject|0
4926859|NCT00451321|16963223|P5|Overall Study|Withdrawal by Subject|0
4926860|NCT00451321|16963224|P4|Overall Study|Withdrawal by Subject|4
4926861|NCT00451321|16963225|P3|Overall Study|Withdrawal by Subject|0
4926862|NCT00451321|16963226|P2|Overall Study|Withdrawal by Subject|1
4926863|NCT00451321|16963227|P1|Overall Study|Withdrawal by Subject|3
4926864|NCT00451321|16963220|P8|Overall Study|Lost to Follow-up|0
4926865|NCT00451321|16963221|P7|Overall Study|Lost to Follow-up|0
4926866|NCT00451321|16963222|P6|Overall Study|Lost to Follow-up|1
4926867|NCT00451321|16963223|P5|Overall Study|Lost to Follow-up|0
4926868|NCT00451321|16963224|P4|Overall Study|Lost to Follow-up|3
4926869|NCT00451321|16963225|P3|Overall Study|Lost to Follow-up|1
4926870|NCT00451321|16963226|P2|Overall Study|Lost to Follow-up|3
4926871|NCT00451321|16963227|P1|Overall Study|Lost to Follow-up|3
4926872|NCT00451282|16963399|P2|Overall Study|Lost to Follow-up|5
4926873|NCT00451282|16963400|P1|Overall Study|Lost to Follow-up|6
4926874|NCT00451217|16963416|P4|Overall Study|Not Treated|4
4926875|NCT00451217|16963417|P3|Overall Study|Not Treated|3
4926876|NCT00451217|16963418|P2|Overall Study|Not Treated|1
4926877|NCT00451217|16963419|P1|Overall Study|Not Treated|1
4926878|NCT00451217|16963416|P4|Overall Study|Withdrawal by Subject|0
4926879|NCT00451217|16963417|P3|Overall Study|Withdrawal by Subject|0
4926880|NCT00451217|16963418|P2|Overall Study|Withdrawal by Subject|0
4926881|NCT00451217|16963419|P1|Overall Study|Withdrawal by Subject|1
4926882|NCT00451217|16963416|P4|Overall Study|Lost to Follow-up|1
4926883|NCT00451217|16963417|P3|Overall Study|Lost to Follow-up|1
4926884|NCT00451217|16963418|P2|Overall Study|Lost to Follow-up|1
4926885|NCT00451217|16963419|P1|Overall Study|Lost to Follow-up|0
4926886|NCT00451204|16963447|P2|Overall Study|Other|2
4926887|NCT00451204|16963448|P1|Overall Study|Other|1
4926888|NCT00451204|16963447|P2|Overall Study|Patient refusal|4
4926889|NCT00451204|16963448|P1|Overall Study|Patient refusal|8
4926890|NCT00451204|16963447|P2|Overall Study|Protocol Violation|0
4926891|NCT00451204|16963448|P1|Overall Study|Protocol Violation|1
4926892|NCT00451204|16963447|P2|Overall Study|Lost to Follow-up|4
4926893|NCT00451204|16963448|P1|Overall Study|Lost to Follow-up|4
4926894|NCT00451204|16963447|P2|Overall Study|Lack of Efficacy|4
4926895|NCT00451204|16963448|P1|Overall Study|Lack of Efficacy|4
4926896|NCT00451204|16963447|P2|Overall Study|Adverse Event|6
4926897|NCT00451204|16963448|P1|Overall Study|Adverse Event|4
4926898|NCT00451191|16963466|P2|Overall Study|withdrawal or received alternate tx|11
4926899|NCT00451191|16963467|P1|Overall Study|withdrawal or received alternate tx|15
4926900|NCT00451178|16963475|P2|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26
4926901|NCT00451178|16963476|P1|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6
4926902|NCT00451178|16963475|P2|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0
4926903|NCT00451178|16963476|P1|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9
4926904|NCT00451178|16963475|P2|Maintenance Therapy (up to 3 Years)|PD|0
4926905|NCT00451178|16963476|P1|Maintenance Therapy (up to 3 Years)|PD|10
4926906|NCT00451178|16963475|P2|Maintenance Therapy (up to 3 Years)|Death|0
4926907|NCT00451178|16963476|P1|Maintenance Therapy (up to 3 Years)|Death|1
4926908|NCT00451178|16963475|P2|Maintenance Therapy (up to 3 Years)|Physician Decision|0
4926909|NCT00451178|16963476|P1|Maintenance Therapy (up to 3 Years)|Physician Decision|1
4926910|NCT00451178|16963475|P2|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0
4926911|NCT00451178|16963476|P1|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5
4926912|NCT00451178|16963475|P2|Maintenance Therapy (up to 3 Years)|Adverse Event|0
4926913|NCT00451178|16963476|P1|Maintenance Therapy (up to 3 Years)|Adverse Event|4
4926914|NCT00451178|16963475|P2|Prior to Maintenance Therapy|PD|0
4926915|NCT00451178|16963476|P1|Prior to Maintenance Therapy|PD|2
4926916|NCT00451178|16963475|P2|Prior to Maintenance Therapy|Physician Decision|0
4926917|NCT00451178|16963476|P1|Prior to Maintenance Therapy|Physician Decision|2
4926918|NCT00451178|16963475|P2|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2
4926919|NCT00451178|16963476|P1|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1
4926920|NCT00451178|16963475|P2|Chemotherapy (Up To Six 21-Day Cycles)|Death|3
4926921|NCT00451178|16963476|P1|Chemotherapy (Up To Six 21-Day Cycles)|Death|4
4926922|NCT00451178|16963475|P2|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2
4926923|NCT00451178|16963476|P1|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1
4926924|NCT00451178|16963475|P2|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1
4926925|NCT00451178|16963476|P1|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2
4926926|NCT00451178|16963475|P2|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3
4926927|NCT00451178|16963476|P1|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4
4926928|NCT00451178|16963475|P2|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
4926929|NCT00451178|16963476|P1|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6
4926930|NCT00450866|16963523|P2|Overall Study|Physician Decision|0
4926931|NCT00450866|16963524|P1|Overall Study|Physician Decision|1
4926932|NCT00450866|16963523|P2|Overall Study|Death|0
4926933|NCT00450866|16963524|P1|Overall Study|Death|1
4926934|NCT00450866|16963523|P2|Overall Study|Withdrawal by Subject|2
4926935|NCT00450866|16963524|P1|Overall Study|Withdrawal by Subject|5
4926936|NCT00450866|16963523|P2|Overall Study|Adverse Event|1
4926937|NCT00450866|16963524|P1|Overall Study|Adverse Event|0
4926938|NCT00450814|16963544|P11|Overall Study|Patient withdrawal prior to treatment|0
4926939|NCT00450814|16963545|P10|Overall Study|Patient withdrawal prior to treatment|1
4926940|NCT00450814|16963546|P9|Overall Study|Patient withdrawal prior to treatment|0
4926941|NCT00450814|16963547|P8|Overall Study|Patient withdrawal prior to treatment|0
4926942|NCT00450814|16963548|P7|Overall Study|Patient withdrawal prior to treatment|0
4926943|NCT00450814|16963549|P6|Overall Study|Patient withdrawal prior to treatment|0
4926944|NCT00450814|16963550|P5|Overall Study|Patient withdrawal prior to treatment|0
4926945|NCT00450814|16963551|P4|Overall Study|Patient withdrawal prior to treatment|0
4926946|NCT00450814|16963552|P3|Overall Study|Patient withdrawal prior to treatment|0
4926947|NCT00450814|16963553|P2|Overall Study|Patient withdrawal prior to treatment|0
4926948|NCT00450814|16963554|P1|Overall Study|Patient withdrawal prior to treatment|0
4926949|NCT00450814|16963544|P11|Overall Study|Failed to complete the initial therapy|0
4926950|NCT00450814|16963545|P10|Overall Study|Failed to complete the initial therapy|0
4926951|NCT00450814|16963546|P9|Overall Study|Failed to complete the initial therapy|0
4926952|NCT00450814|16963547|P8|Overall Study|Failed to complete the initial therapy|0
4926953|NCT00450814|16963548|P7|Overall Study|Failed to complete the initial therapy|0
4926954|NCT00450814|16963549|P6|Overall Study|Failed to complete the initial therapy|1
4926955|NCT00450814|16963550|P5|Overall Study|Failed to complete the initial therapy|1
4926956|NCT00450814|16963551|P4|Overall Study|Failed to complete the initial therapy|1
4926957|NCT00450814|16963552|P3|Overall Study|Failed to complete the initial therapy|0
4926958|NCT00450814|16963553|P2|Overall Study|Failed to complete the initial therapy|0
4926959|NCT00450814|16963554|P1|Overall Study|Failed to complete the initial therapy|0
4926960|NCT00450801|16963588|P1|Overall Study|Death|1
4926961|NCT00450749|16963602|P3|Overall Study|Noncompliant|0
4926962|NCT00450749|16963603|P2|Overall Study|Noncompliant|1
4926963|NCT00450749|16963604|P1|Overall Study|Noncompliant|0
4926964|NCT00450749|16963602|P3|Overall Study|Withdrawal by Subject|2
4926965|NCT00450749|16963603|P2|Overall Study|Withdrawal by Subject|0
4926966|NCT00450749|16963604|P1|Overall Study|Withdrawal by Subject|0
4926967|NCT00450723|16963642|P1|Overall Study|Physician Decision|5
4926968|NCT00450658|16963650|P2|Overall Study|misc|10
4926969|NCT00450658|16963651|P1|Overall Study|misc|21
4926970|NCT00450658|16963650|P2|Overall Study|UGI ulcer|34
4926971|NCT00450658|16963651|P1|Overall Study|UGI ulcer|33
4926972|NCT00450658|16963650|P2|Overall Study|Lost to Follow-up|5
4926973|NCT00450658|16963651|P1|Overall Study|Lost to Follow-up|22
4926974|NCT00450658|16963650|P2|Overall Study|Withdrawal by Subject|26
4926975|NCT00450658|16963651|P1|Overall Study|Withdrawal by Subject|43
4926976|NCT00450658|16963650|P2|Overall Study|Adverse Event|15
4926977|NCT00450658|16963651|P1|Overall Study|Adverse Event|24
4926978|NCT00450619|16963665|P2|Overall Study|Adverse Event|0
4926979|NCT00450619|16963666|P1|Overall Study|Adverse Event|1
4926980|NCT00450619|16963665|P2|Overall Study|did not progress; refused further trmt|1
4926981|NCT00450619|16963666|P1|Overall Study|did not progress; refused further trmt|1
4926982|NCT00450619|16963665|P2|Overall Study|refused treatment after randomization|0
4926983|NCT00450619|16963666|P1|Overall Study|refused treatment after randomization|2
4926984|NCT00450580|16963692|P2|Overall Study|Withdrawal due to pregnancy|1
4926985|NCT00450580|16963693|P1|Overall Study|Withdrawal due to pregnancy|0
4926986|NCT00450580|16963692|P2|Overall Study|Patient could not swallow Norvir|0
4926987|NCT00450580|16963693|P1|Overall Study|Patient could not swallow Norvir|1
4926988|NCT00450580|16963692|P2|Overall Study|Patient went to Brazil|0
4926989|NCT00450580|16963693|P1|Overall Study|Patient went to Brazil|1
4926990|NCT00450580|16963692|P2|Overall Study|Could not comply with scheduled visits|0
4926991|NCT00450580|16963693|P1|Overall Study|Could not comply with scheduled visits|1
4926992|NCT00450580|16963692|P2|Overall Study|Protocol-defined virologic failure|0
4926993|NCT00450580|16963693|P1|Overall Study|Protocol-defined virologic failure|1
4926994|NCT00450580|16963692|P2|Overall Study|Protocol Violation|1
4926995|NCT00450580|16963693|P1|Overall Study|Protocol Violation|1
4926996|NCT00450580|16963692|P2|Overall Study|Withdrawal by Subject|2
4926997|NCT00450580|16963693|P1|Overall Study|Withdrawal by Subject|2
4926998|NCT00450580|16963692|P2|Overall Study|Lost to Follow-up|5
4926999|NCT00450580|16963693|P1|Overall Study|Lost to Follow-up|4
4927000|NCT00450580|16963692|P2|Overall Study|Adverse Event|7
4927001|NCT00450580|16963693|P1|Overall Study|Adverse Event|5
4927002|NCT00450450|16963730|P2|Overall Study|Missing Data|0
4927003|NCT00450450|16963731|P1|Overall Study|Missing Data|2
4927004|NCT00450450|16963730|P2|Overall Study|Relapse|0
4927005|NCT00450450|16963731|P1|Overall Study|Relapse|2
4927006|NCT00450450|16963730|P2|Overall Study|Death|3
4927007|NCT00450450|16963731|P1|Overall Study|Death|1
4927008|NCT00450437|16963755|P4|Overall Study|Unable to Classify|0
4927009|NCT00450437|16963756|P3|Overall Study|Unable to Classify|1
4927010|NCT00450437|16963757|P2|Overall Study|Unable to Classify|0
4927011|NCT00450437|16963758|P1|Overall Study|Unable to Classify|1
4927012|NCT00450437|16963755|P4|Overall Study|Administrative reason|0
4927013|NCT00450437|16963756|P3|Overall Study|Administrative reason|1
4927014|NCT00450437|16963757|P2|Overall Study|Administrative reason|0
4927015|NCT00450437|16963758|P1|Overall Study|Administrative reason|0
4927016|NCT00450437|16963755|P4|Overall Study|Inappropriate enrollment|0
4927017|NCT00450437|16963756|P3|Overall Study|Inappropriate enrollment|3
4927018|NCT00450437|16963757|P2|Overall Study|Inappropriate enrollment|1
4927019|NCT00450437|16963758|P1|Overall Study|Inappropriate enrollment|4
4927020|NCT00450437|16963755|P4|Overall Study|Protocol Violation|1
4927021|NCT00450437|16963756|P3|Overall Study|Protocol Violation|0
4927022|NCT00450437|16963757|P2|Overall Study|Protocol Violation|1
4927023|NCT00450437|16963758|P1|Overall Study|Protocol Violation|0
4927024|NCT00450437|16963755|P4|Overall Study|Lost to Follow-up|9
4927025|NCT00450437|16963756|P3|Overall Study|Lost to Follow-up|19
4927026|NCT00450437|16963757|P2|Overall Study|Lost to Follow-up|12
4927027|NCT00450437|16963758|P1|Overall Study|Lost to Follow-up|31
4927028|NCT00450437|16963755|P4|Overall Study|Withdrawal by Subject|1
4927029|NCT00450437|16963756|P3|Overall Study|Withdrawal by Subject|0
4927030|NCT00450437|16963757|P2|Overall Study|Withdrawal by Subject|2
4927031|NCT00450437|16963758|P1|Overall Study|Withdrawal by Subject|10
4927032|NCT00450411|16963789|P1|Overall Study|No protocol treatment|2
4927033|NCT00450411|16963789|P1|Overall Study|Protocol Violation|6
4927034|NCT00450385|16963794|P1|Overall Study|Other|3
4927035|NCT00450385|16963794|P1|Overall Study|Physician Decision|1
4927036|NCT00450385|16963794|P1|Overall Study|Adverse Event|1
4927037|NCT00450385|16963794|P1|Overall Study|Lack of Efficacy|2
4927038|NCT00450385|16963794|P1|Overall Study|Withdrawal by Subject|2
4927039|NCT00450385|16963794|P1|Overall Study|Protocol Violation|1
4927040|NCT00450385|16963794|P1|Overall Study|Death|3
4927041|NCT00450372|16963803|P1|Overall Study|Physician Decision|1
4927042|NCT00450333|16963816|P4|Overall Study|Death|2
4927043|NCT00450333|16963817|P3|Overall Study|Death|2
4927044|NCT00450333|16963818|P2|Overall Study|Death|2
4927045|NCT00450333|16963819|P1|Overall Study|Death|3
4927046|NCT00450333|16963816|P4|Overall Study|Kidney transplant|3
4927047|NCT00450333|16963817|P3|Overall Study|Kidney transplant|1
4927048|NCT00450333|16963818|P2|Overall Study|Kidney transplant|0
4927049|NCT00450333|16963819|P1|Overall Study|Kidney transplant|1
4927050|NCT00450333|16963816|P4|Overall Study|Withdrawal by Subject|0
4927051|NCT00450333|16963817|P3|Overall Study|Withdrawal by Subject|3
4927052|NCT00450333|16963818|P2|Overall Study|Withdrawal by Subject|0
4927053|NCT00450333|16963819|P1|Overall Study|Withdrawal by Subject|1
4927054|NCT00450333|16963816|P4|Overall Study|Protocol Violation|0
4927055|NCT00450333|16963817|P3|Overall Study|Protocol Violation|1
4927056|NCT00450333|16963818|P2|Overall Study|Protocol Violation|0
4927057|NCT00450333|16963819|P1|Overall Study|Protocol Violation|1
4927058|NCT00450333|16963816|P4|Overall Study|Adverse Event|2
4927059|NCT00450333|16963817|P3|Overall Study|Adverse Event|2
4927060|NCT00450333|16963818|P2|Overall Study|Adverse Event|7
4927061|NCT00450333|16963819|P1|Overall Study|Adverse Event|1
4927062|NCT00450333|16963816|P4|Overall Study|Study terminated|21
4927063|NCT00450333|16963817|P3|Overall Study|Study terminated|16
4927064|NCT00450333|16963818|P2|Overall Study|Study terminated|54
4927065|NCT00450333|16963819|P1|Overall Study|Study terminated|47
4927066|NCT00450255|16963842|P1|Overall Study|Prior RFA ablation of liver|1
4927067|NCT00450216|16963867|P2|Overall Study|misc|20
4927068|NCT00450216|16963868|P1|Overall Study|misc|21
4927069|NCT00450216|16963867|P2|Overall Study|upper gastrointestinal (UGI) ulcer|51
4927070|NCT00450216|16963868|P1|Overall Study|upper gastrointestinal (UGI) ulcer|51
4927071|NCT00450216|16963867|P2|Overall Study|Lost to Follow-up|9
4927072|NCT00450216|16963868|P1|Overall Study|Lost to Follow-up|16
4927073|NCT00450216|16963867|P2|Overall Study|Withdrawal by Subject|26
4927074|NCT00450216|16963868|P1|Overall Study|Withdrawal by Subject|48
4927075|NCT00450216|16963867|P2|Overall Study|Adverse Event|23
4927076|NCT00450216|16963868|P1|Overall Study|Adverse Event|38
4927077|NCT00450190|16963880|P1|Overall Study|Withdrawal by Subject|2
4927078|NCT00450177|16963890|P2|Overall Study|Withdrawal by Primary Team|1
4927079|NCT00450177|16963891|P1|Overall Study|Withdrawal by Primary Team|1
4927080|NCT00450177|16963890|P2|Overall Study|Withdrawal by Subject|6
4927081|NCT00450177|16963891|P1|Overall Study|Withdrawal by Subject|1
4927082|NCT00450177|16963890|P2|Overall Study|Adverse Event|4
4927083|NCT00450177|16963891|P1|Overall Study|Adverse Event|7
4927084|NCT00450112|16963917|P2|Overall Study|Others|3
4927085|NCT00450112|16963918|P1|Overall Study|Others|2
4927086|NCT00450112|16963917|P2|Overall Study|Lost to Follow-up|1
4927087|NCT00450112|16963918|P1|Overall Study|Lost to Follow-up|2
4927088|NCT00450112|16963917|P2|Overall Study|Withdrawal by Subject|1
4927089|NCT00450112|16963918|P1|Overall Study|Withdrawal by Subject|4
4927090|NCT00450112|16963917|P2|Overall Study|Other Treatment Required|1
4927091|NCT00450112|16963918|P1|Overall Study|Other Treatment Required|5
4927092|NCT00449956|16963956|P3|Overall Study|Physician Decision|1
4927093|NCT00449956|16963957|P2|Overall Study|Physician Decision|1
4927094|NCT00449956|16963958|P1|Overall Study|Physician Decision|2
4927095|NCT00449956|16963956|P3|Overall Study|Withdrawal by Subject|0
4927096|NCT00449956|16963957|P2|Overall Study|Withdrawal by Subject|1
4927097|NCT00449956|16963958|P1|Overall Study|Withdrawal by Subject|0
4927098|NCT00449956|16963956|P3|Overall Study|Protocol Violation|1
4927099|NCT00449956|16963957|P2|Overall Study|Protocol Violation|1
4927100|NCT00449956|16963958|P1|Overall Study|Protocol Violation|1
4927101|NCT00449956|16963956|P3|Overall Study|Lack of Efficacy|1
4927102|NCT00449956|16963957|P2|Overall Study|Lack of Efficacy|0
4927103|NCT00449956|16963958|P1|Overall Study|Lack of Efficacy|0
4927104|NCT00449956|16963956|P3|Overall Study|Adverse Event|6
4927105|NCT00449956|16963957|P2|Overall Study|Adverse Event|1
4927106|NCT00449956|16963958|P1|Overall Study|Adverse Event|7
4927107|NCT00449930|16963974|P2|Overall Study|Glycemic discontinuation criteria|1
4927108|NCT00449930|16963975|P1|Overall Study|Glycemic discontinuation criteria|1
4927109|NCT00449930|16963974|P2|Overall Study|Withdrawal by Subject|23
4927110|NCT00449930|16963975|P1|Overall Study|Withdrawal by Subject|16
4927111|NCT00449930|16963974|P2|Overall Study|Protocol Violation|15
4927112|NCT00449930|16963975|P1|Overall Study|Protocol Violation|14
4927113|NCT00449930|16963974|P2|Overall Study|Physician Decision|2
4927114|NCT00449930|16963975|P1|Overall Study|Physician Decision|1
4927115|NCT00449930|16963974|P2|Overall Study|Lost to Follow-up|14
4927116|NCT00449930|16963975|P1|Overall Study|Lost to Follow-up|9
4927117|NCT00449930|16963974|P2|Overall Study|Lack of Efficacy|1
4927118|NCT00449930|16963975|P1|Overall Study|Lack of Efficacy|10
4927119|NCT00449930|16963974|P2|Overall Study|Trial Terminated ( Site Closed)|0
4927120|NCT00449930|16963975|P1|Overall Study|Trial Terminated ( Site Closed)|1
4927121|NCT00449930|16963974|P2|Overall Study|Adverse Event|19
4927122|NCT00449930|16963975|P1|Overall Study|Adverse Event|9
4927123|NCT00449865|16963991|P2|Overall Study|Study was stopped|328
4927124|NCT00449865|16963992|P1|Overall Study|Study was stopped|324
4927125|NCT00449865|16963991|P2|Overall Study|Protocol Violation|7
4927126|NCT00449865|16963992|P1|Overall Study|Protocol Violation|8
4927127|NCT00449865|16963991|P2|Overall Study|Death|40
4927128|NCT00449865|16963992|P1|Overall Study|Death|31
4927129|NCT00449865|16963991|P2|Overall Study|Physician Decision|12
4927130|NCT00449865|16963992|P1|Overall Study|Physician Decision|13
4927131|NCT00449865|16963991|P2|Overall Study|Lost to Follow-up|37
4927132|NCT00449865|16963992|P1|Overall Study|Lost to Follow-up|36
4927133|NCT00449865|16963991|P2|Overall Study|Withdrawal by Subject|110
4927134|NCT00449865|16963992|P1|Overall Study|Withdrawal by Subject|110
4927135|NCT00449787|16964000|P2|Overall Study|Did not require medication|92
4927136|NCT00449787|16964001|P1|Overall Study|Did not require medication|95
4927137|NCT00449787|16964000|P2|Overall Study|Lost to Follow-up|8
4927138|NCT00449787|16964001|P1|Overall Study|Lost to Follow-up|10
4927139|NCT00449696|16964017|P2|Overall Study|Others|0
4927140|NCT00449696|16964018|P1|Overall Study|Others|7
4927141|NCT00449696|16964017|P2|Overall Study|Lost to Follow-up|3
4927142|NCT00449696|16964018|P1|Overall Study|Lost to Follow-up|2
4927143|NCT00449696|16964017|P2|Overall Study|Withdrawal by Subject|5
4927144|NCT00449696|16964018|P1|Overall Study|Withdrawal by Subject|5
4927145|NCT00449696|16964017|P2|Overall Study|Other Treatment Required|1
4927146|NCT00449696|16964018|P1|Overall Study|Other Treatment Required|6
4927147|NCT00449670|16964042|P2|Booster Phase (Study no.109873)|Other|2
4927148|NCT00449670|16964043|P1|Booster Phase (Study no.109873)|Other|0
4927149|NCT00449670|16964042|P2|Booster Phase (Study no.109873)|Migrated/moved from study area|1
4927150|NCT00449670|16964043|P1|Booster Phase (Study no.109873)|Migrated/moved from study area|0
4927151|NCT00449670|16964042|P2|Primary Phase (Study no.109630)|Lost to Follow-up|1
4927152|NCT00449670|16964043|P1|Primary Phase (Study no.109630)|Lost to Follow-up|5
4927153|NCT00449670|16964042|P2|Primary Phase (Study no.109630)|Withdrawal by Subject|1
4927154|NCT00449670|16964043|P1|Primary Phase (Study no.109630)|Withdrawal by Subject|4
4927155|NCT00449670|16964042|P2|Primary Phase (Study no.109630)|Non-serious adverse event|0
4927156|NCT00449670|16964043|P1|Primary Phase (Study no.109630)|Non-serious adverse event|4
4927157|NCT00449670|16964042|P2|Primary Phase (Study no.109630)|Serious Adverse Event|0
4927158|NCT00449670|16964043|P1|Primary Phase (Study no.109630)|Serious Adverse Event|1
4927159|NCT00449644|16964156|P4|Overall Study|Rolled-over to treatment with TMC207|1
4927160|NCT00449644|16964157|P3|Overall Study|Rolled-over to treatment with TMC207|0
4927161|NCT00449644|16964158|P2|Overall Study|Rolled-over to treatment with TMC207|0
4927162|NCT00449644|16964159|P1|Overall Study|Rolled-over to treatment with TMC207|0
4927163|NCT00449644|16964156|P4|Overall Study|Other|0
4927164|NCT00449644|16964157|P3|Overall Study|Other|1
4927165|NCT00449644|16964158|P2|Overall Study|Other|4
4927166|NCT00449644|16964159|P1|Overall Study|Other|1
4927167|NCT00449644|16964156|P4|Overall Study|Inclusion/exclusion criteria not met|6
4927168|NCT00449644|16964157|P3|Overall Study|Inclusion/exclusion criteria not met|2
4927169|NCT00449644|16964158|P2|Overall Study|Inclusion/exclusion criteria not met|0
4927170|NCT00449644|16964159|P1|Overall Study|Inclusion/exclusion criteria not met|0
4927171|NCT00449644|16964156|P4|Overall Study|Withdrawal by Subject|7
4927172|NCT00449644|16964157|P3|Overall Study|Withdrawal by Subject|6
4927173|NCT00449644|16964158|P2|Overall Study|Withdrawal by Subject|4
4927174|NCT00449644|16964159|P1|Overall Study|Withdrawal by Subject|3
4927175|NCT00449644|16964156|P4|Overall Study|Protocol Violation|7
4927176|NCT00449644|16964157|P3|Overall Study|Protocol Violation|3
4927177|NCT00449644|16964158|P2|Overall Study|Protocol Violation|4
4927178|NCT00449644|16964159|P1|Overall Study|Protocol Violation|4
4927179|NCT00449644|16964156|P4|Overall Study|Pregnancy|2
4927180|NCT00449644|16964157|P3|Overall Study|Pregnancy|3
4927181|NCT00449644|16964158|P2|Overall Study|Pregnancy|0
4927182|NCT00449644|16964159|P1|Overall Study|Pregnancy|0
4927183|NCT00449644|16964156|P4|Overall Study|Lost to Follow-up|3
4927184|NCT00449644|16964157|P3|Overall Study|Lost to Follow-up|5
4927185|NCT00449644|16964158|P2|Overall Study|Lost to Follow-up|1
4927186|NCT00449644|16964159|P1|Overall Study|Lost to Follow-up|1
4927187|NCT00449644|16964156|P4|Overall Study|Death|1
4927188|NCT00449644|16964157|P3|Overall Study|Death|6
4927189|NCT00449644|16964158|P2|Overall Study|Death|0
4927190|NCT00449644|16964159|P1|Overall Study|Death|1
4927191|NCT00449644|16964156|P4|Overall Study|Adverse Event|5
4927192|NCT00449644|16964157|P3|Overall Study|Adverse Event|3
4927193|NCT00449644|16964158|P2|Overall Study|Adverse Event|0
4927194|NCT00449644|16964159|P1|Overall Study|Adverse Event|0
4927195|NCT00449540|16964179|P3|Treatment Phase|did not experience or treat migraine|17
4927196|NCT00449540|16964180|P2|Treatment Phase|did not experience or treat migraine|20
4927197|NCT00449540|16964181|P1|Treatment Phase|did not experience or treat migraine|0
4927198|NCT00449540|16964179|P3|Pretreatment Phase|No migraine experienced|0
4927199|NCT00449540|16964180|P2|Pretreatment Phase|No migraine experienced|0
4927200|NCT00449540|16964181|P1|Pretreatment Phase|No migraine experienced|66
4927201|NCT00449176|16964198|P3|Overall Study|all other|20
4927202|NCT00449176|16964199|P2|Overall Study|all other|19
4927203|NCT00449176|16964200|P1|Overall Study|all other|22
4927204|NCT00449176|16964198|P3|Overall Study|Study drug non-compliant|11
4927205|NCT00449176|16964199|P2|Overall Study|Study drug non-compliant|11
4927206|NCT00449176|16964200|P1|Overall Study|Study drug non-compliant|14
4927207|NCT00449176|16964198|P3|Overall Study|Lack of Efficacy|50
4927208|NCT00449176|16964199|P2|Overall Study|Lack of Efficacy|7
4927209|NCT00449176|16964200|P1|Overall Study|Lack of Efficacy|13
4927210|NCT00449176|16964198|P3|Overall Study|Adverse Event|15
4927211|NCT00449176|16964199|P2|Overall Study|Adverse Event|107
4927212|NCT00449176|16964200|P1|Overall Study|Adverse Event|51
4927213|NCT00449176|16964198|P3|Overall Study|Lost to Follow-up|12
4927214|NCT00449176|16964199|P2|Overall Study|Lost to Follow-up|8
4927215|NCT00449176|16964200|P1|Overall Study|Lost to Follow-up|13
4927216|NCT00449176|16964198|P3|Overall Study|Withdrawal by Subject|59
4927217|NCT00449176|16964199|P2|Overall Study|Withdrawal by Subject|43
4927218|NCT00449176|16964200|P1|Overall Study|Withdrawal by Subject|39
4927219|NCT00449163|16964226|P1|Overall Study|Physician Decision|3
4927220|NCT00449150|16964236|P3|Overall Study|Protocol Violation|1
4927221|NCT00449150|16964237|P2|Overall Study|Protocol Violation|2
4927222|NCT00449150|16964238|P1|Overall Study|Protocol Violation|1
4927223|NCT00449150|16964236|P3|Overall Study|Withdrawal by Subject|21
4927224|NCT00449150|16964237|P2|Overall Study|Withdrawal by Subject|18
4927225|NCT00449150|16964238|P1|Overall Study|Withdrawal by Subject|17
4927226|NCT00449150|16964236|P3|Overall Study|Other|14
4927227|NCT00449150|16964237|P2|Overall Study|Other|13
4927228|NCT00449150|16964238|P1|Overall Study|Other|16
4927229|NCT00449150|16964236|P3|Overall Study|Lack of Efficacy|2
4927230|NCT00449150|16964237|P2|Overall Study|Lack of Efficacy|2
4927231|NCT00449150|16964238|P1|Overall Study|Lack of Efficacy|1
4927232|NCT00449150|16964236|P3|Overall Study|Adverse Event|9
4927233|NCT00449150|16964237|P2|Overall Study|Adverse Event|18
4927234|NCT00449150|16964238|P1|Overall Study|Adverse Event|11
4927235|NCT00449072|16964251|P2|Overall Study|Relocation|2
4927236|NCT00449072|16964252|P1|Overall Study|Relocation|3
4927237|NCT00449072|16964251|P2|Overall Study|Sponsor decision|3
4927238|NCT00449072|16964252|P1|Overall Study|Sponsor decision|1
4927239|NCT00449072|16964251|P2|Overall Study|Non-compliance|5
4927240|NCT00449072|16964252|P1|Overall Study|Non-compliance|2
4927241|NCT00449072|16964251|P2|Overall Study|Excluded medication|2
4927242|NCT00449072|16964252|P1|Overall Study|Excluded medication|0
4927243|NCT00449072|16964251|P2|Overall Study|Not treated|1
4927244|NCT00449072|16964252|P1|Overall Study|Not treated|0
4927245|NCT00449072|16964251|P2|Overall Study|Physician Decision|0
4927246|NCT00449072|16964252|P1|Overall Study|Physician Decision|1
4927247|NCT00449072|16964251|P2|Overall Study|Lack of Efficacy|1
4927248|NCT00449072|16964252|P1|Overall Study|Lack of Efficacy|1
4927249|NCT00449072|16964251|P2|Overall Study|Withdrawal by Subject|8
4927250|NCT00449072|16964252|P1|Overall Study|Withdrawal by Subject|11
4927251|NCT00449072|16964251|P2|Overall Study|Lost to Follow-up|7
4927252|NCT00449072|16964252|P1|Overall Study|Lost to Follow-up|5
4927253|NCT00449072|16964251|P2|Overall Study|Protocol Violation|12
4927254|NCT00449072|16964252|P1|Overall Study|Protocol Violation|14
4927255|NCT00449072|16964251|P2|Overall Study|Adverse Event|1
4927256|NCT00449072|16964252|P1|Overall Study|Adverse Event|3
4927257|NCT00449033|16964289|P2|Follow-up Period|Reason Missing|113
4927258|NCT00449033|16964290|P1|Follow-up Period|Reason Missing|120
4927259|NCT00449033|16964289|P2|Follow-up Period|Lost to Follow-up|10
4927260|NCT00449033|16964290|P1|Follow-up Period|Lost to Follow-up|6
4927261|NCT00449033|16964289|P2|Follow-up Period|Death|311
4927262|NCT00449033|16964290|P1|Follow-up Period|Death|299
4927263|NCT00449033|16964289|P2|Treatment Period|Treatment Ongoing|4
4927264|NCT00449033|16964290|P1|Treatment Period|Treatment Ongoing|6
4927265|NCT00449033|16964289|P2|Treatment Period|Reason Missing|4
4927266|NCT00449033|16964290|P1|Treatment Period|Reason Missing|0
4927267|NCT00449033|16964289|P2|Treatment Period|Second Malignancy|1
4927268|NCT00449033|16964290|P1|Treatment Period|Second Malignancy|0
4927269|NCT00449033|16964289|P2|Treatment Period|Non-compliance|8
4927270|NCT00449033|16964290|P1|Treatment Period|Non-compliance|7
4927271|NCT00449033|16964289|P2|Treatment Period|Amended Protocol Criteria|18
4927272|NCT00449033|16964290|P1|Treatment Period|Amended Protocol Criteria|22
4927273|NCT00449033|16964289|P2|Treatment Period|Consent Withdrawn|20
4927274|NCT00449033|16964290|P1|Treatment Period|Consent Withdrawn|36
4927275|NCT00449033|16964289|P2|Treatment Period|Disease Progression|288
4927276|NCT00449033|16964290|P1|Treatment Period|Disease Progression|231
4927277|NCT00449033|16964289|P2|Treatment Period|Protocol Violation|7
4927278|NCT00449033|16964290|P1|Treatment Period|Protocol Violation|8
4927279|NCT00449033|16964289|P2|Treatment Period|Physician Decision|5
4927280|NCT00449033|16964290|P1|Treatment Period|Physician Decision|4
4927281|NCT00449033|16964289|P2|Treatment Period|Lost to Follow-up|2
4927282|NCT00449033|16964290|P1|Treatment Period|Lost to Follow-up|0
4927283|NCT00449033|16964289|P2|Treatment Period|Death|12
4927284|NCT00449033|16964290|P1|Treatment Period|Death|21
4927285|NCT00449033|16964289|P2|Treatment Period|Adverse Event|83
4927286|NCT00449033|16964290|P1|Treatment Period|Adverse Event|117
4927287|NCT00448916|16964328|P4|Overall Study|Protocol Violation|1
4927288|NCT00448916|16964329|P3|Overall Study|Protocol Violation|0
4927289|NCT00448916|16964330|P2|Overall Study|Protocol Violation|0
4927290|NCT00448916|16964331|P1|Overall Study|Protocol Violation|0
4927291|NCT00448916|16964328|P4|Overall Study|Lost to Follow-up|1
4927292|NCT00448916|16964329|P3|Overall Study|Lost to Follow-up|0
4927293|NCT00448916|16964330|P2|Overall Study|Lost to Follow-up|1
4927294|NCT00448916|16964331|P1|Overall Study|Lost to Follow-up|0
4927295|NCT00448916|16964328|P4|Overall Study|Other|0
4927296|NCT00448916|16964329|P3|Overall Study|Other|0
4927297|NCT00448916|16964330|P2|Overall Study|Other|0
4927298|NCT00448916|16964331|P1|Overall Study|Other|1
4927299|NCT00448916|16964328|P4|Overall Study|Withdrawal by Subject|1
4927300|NCT00448916|16964329|P3|Overall Study|Withdrawal by Subject|1
4927301|NCT00448916|16964330|P2|Overall Study|Withdrawal by Subject|3
4927302|NCT00448916|16964331|P1|Overall Study|Withdrawal by Subject|3
4927303|NCT00448916|16964328|P4|Overall Study|Lack of Efficacy|1
4927304|NCT00448916|16964329|P3|Overall Study|Lack of Efficacy|2
4927305|NCT00448916|16964330|P2|Overall Study|Lack of Efficacy|0
4927306|NCT00448916|16964331|P1|Overall Study|Lack of Efficacy|1
4927307|NCT00448916|16964328|P4|Overall Study|Adverse Event|2
4927308|NCT00448916|16964329|P3|Overall Study|Adverse Event|3
4927309|NCT00448916|16964330|P2|Overall Study|Adverse Event|2
4927310|NCT00448916|16964331|P1|Overall Study|Adverse Event|2
4927311|NCT00448864|16964405|P3|Overall Study|Protocol Violation|0
4927312|NCT00448864|16964406|P2|Overall Study|Protocol Violation|2
4927313|NCT00448864|16964407|P1|Overall Study|Protocol Violation|0
4927314|NCT00448864|16964405|P3|Overall Study|Withdrawal by Subject|0
4927315|NCT00448864|16964406|P2|Overall Study|Withdrawal by Subject|2
4927316|NCT00448864|16964407|P1|Overall Study|Withdrawal by Subject|0
4927317|NCT00448864|16964405|P3|Overall Study|Physician Decision|1
4927318|NCT00448864|16964406|P2|Overall Study|Physician Decision|0
4927319|NCT00448864|16964407|P1|Overall Study|Physician Decision|1
4927320|NCT00448864|16964405|P3|Overall Study|Lost to Follow-up|0
4927321|NCT00448864|16964406|P2|Overall Study|Lost to Follow-up|1
4927322|NCT00448864|16964407|P1|Overall Study|Lost to Follow-up|3
4927323|NCT00448864|16964405|P3|Overall Study|Death|0
4927324|NCT00448864|16964406|P2|Overall Study|Death|0
4927325|NCT00448864|16964407|P1|Overall Study|Death|1
4927326|NCT00448760|16964423|P1|Overall Study|Death|3
4927327|NCT00448747|16964432|P2|Overall Study|collapsed veins|0
4927328|NCT00448747|16964433|P1|Overall Study|collapsed veins|1
4927329|NCT00448708|16964451|P2|Overall Study|not listed|2
4927330|NCT00448708|16964452|P1|Overall Study|not listed|0
4927331|NCT00448708|16964451|P2|Overall Study|Lost to Follow-up|8
4927332|NCT00448708|16964452|P1|Overall Study|Lost to Follow-up|6
4927333|NCT00448708|16964451|P2|Overall Study|Withdrawal by Subject|4
4927334|NCT00448708|16964452|P1|Overall Study|Withdrawal by Subject|8
4927335|NCT00448708|16964451|P2|Overall Study|Death|17
4927336|NCT00448708|16964452|P1|Overall Study|Death|21
4927337|NCT00448669|16964468|P2|Overall Study|Never started drug|7
4927338|NCT00448669|16964469|P1|Overall Study|Never started drug|9
4927339|NCT00448669|16964468|P2|Overall Study|HIV-infected at enrollment|2
4927340|NCT00448669|16964469|P1|Overall Study|HIV-infected at enrollment|1
4927341|NCT00448669|16964468|P2|Overall Study|Had other reasons|6
4927342|NCT00448669|16964469|P1|Overall Study|Had other reasons|5
4927343|NCT00448669|16964468|P2|Overall Study|Death|4
4927344|NCT00448669|16964469|P1|Overall Study|Death|2
4927345|NCT00448669|16964468|P2|Overall Study|Were withdrawn by investigator|6
4927346|NCT00448669|16964469|P1|Overall Study|Were withdrawn by investigator|10
4927347|NCT00448669|16964468|P2|Overall Study|Relocated|36
4927348|NCT00448669|16964469|P1|Overall Study|Relocated|49
4927349|NCT00448669|16964468|P2|Overall Study|Withdrawal by Subject|74
4927350|NCT00448669|16964469|P1|Overall Study|Withdrawal by Subject|90
4927351|NCT00448669|16964468|P2|Overall Study|Lost to Follow-up|63
4927352|NCT00448669|16964469|P1|Overall Study|Lost to Follow-up|52
4927353|NCT00448591|16964530|P1|Overall Study|Termination of Study|70
4927354|NCT00448591|16964530|P1|Overall Study|Other|154
4927355|NCT00448591|16964530|P1|Overall Study|Treatment Regimen Completed|70
4927356|NCT00448591|16964530|P1|Overall Study|Lost to Follow-up|19
4927357|NCT00448591|16964530|P1|Overall Study|Protocol Violation|41
4927358|NCT00448591|16964530|P1|Overall Study|Adverse Event|382
4927359|NCT00448591|16964530|P1|Overall Study|Progressive Disease|1382
4927360|NCT00448591|16964530|P1|Overall Study|Withdrawal by Subject|178
4927361|NCT00448539|16964541|P2|Overall Study|Lost to Follow-up|3
4927362|NCT00448539|16964542|P1|Overall Study|Lost to Follow-up|1
4927363|NCT00448539|16964541|P2|Overall Study|Change of meds|3
4927364|NCT00448539|16964542|P1|Overall Study|Change of meds|2
4927365|NCT00448539|16964541|P2|Overall Study|Miscellaneous|1
4927366|NCT00448539|16964542|P1|Overall Study|Miscellaneous|2
4927367|NCT00448539|16964541|P2|Overall Study|Lack of Efficacy|40
4927368|NCT00448539|16964542|P1|Overall Study|Lack of Efficacy|27
4927369|NCT00448539|16964541|P2|Overall Study|Adverse Event|26
4927370|NCT00448539|16964542|P1|Overall Study|Adverse Event|9
4927371|NCT00448539|16964541|P2|Overall Study|Diary non-compliance|0
4927372|NCT00448539|16964542|P1|Overall Study|Diary non-compliance|1
4927373|NCT00448539|16964541|P2|Overall Study|Withdrawal by Subject|24
4927374|NCT00448539|16964542|P1|Overall Study|Withdrawal by Subject|20
4927375|NCT00448539|16964541|P2|Overall Study|Request of the investigator or sponsor|54
4927376|NCT00448539|16964542|P1|Overall Study|Request of the investigator or sponsor|67
4927377|NCT00448539|16964541|P2|Overall Study|Protocol Violation|0
4927378|NCT00448539|16964542|P1|Overall Study|Protocol Violation|1
4927379|NCT00448539|16964541|P2|Overall Study|Medication non-compliance|1
4927380|NCT00448539|16964542|P1|Overall Study|Medication non-compliance|4
4927381|NCT00448448|16964550|P2|Overall Study|Signed consent lost|1
4927382|NCT00448448|16964551|P1|Overall Study|Signed consent lost|0
4927383|NCT00448448|16964550|P2|Overall Study|Wrong diagnosis (n=3) or other|1
4927384|NCT00448448|16964551|P1|Overall Study|Wrong diagnosis (n=3) or other|2
4927385|NCT00448448|16964550|P2|Overall Study|Lost to Follow-up|1
4927386|NCT00448448|16964551|P1|Overall Study|Lost to Follow-up|2
4927387|NCT00448448|16964550|P2|Overall Study|On protocol when study ended|36
4927388|NCT00448448|16964551|P1|Overall Study|On protocol when study ended|83
4927389|NCT00448448|16964550|P2|Overall Study|Withdrawal by Subject|2
4927390|NCT00448448|16964551|P1|Overall Study|Withdrawal by Subject|13
4927391|NCT00448435|16964557|P2|Washout Period - 2 Weeks|Withdrawal by Subject|0
4927392|NCT00448435|16964558|P1|Washout Period - 2 Weeks|Withdrawal by Subject|1
4927393|NCT00448344|16964609|P2|Overall Study|Physician Decision|2
4927394|NCT00448344|16964610|P1|Overall Study|Physician Decision|1
4927395|NCT00448344|16964609|P2|Overall Study|Death|4
4927396|NCT00448344|16964610|P1|Overall Study|Death|3
4927397|NCT00448344|16964609|P2|Overall Study|Withdrawal by Subject|8
4927398|NCT00448344|16964610|P1|Overall Study|Withdrawal by Subject|6
4927399|NCT00448344|16964609|P2|Overall Study|Lost to Follow-up|22
4927400|NCT00448344|16964610|P1|Overall Study|Lost to Follow-up|20
4927401|NCT00448279|16964620|P2|Overall Study|Protocol Violation|1
4927402|NCT00448279|16964621|P1|Overall Study|Protocol Violation|0
4927403|NCT00448279|16964620|P2|Overall Study|Other|4
4927404|NCT00448279|16964621|P1|Overall Study|Other|6
4927405|NCT00448279|16964620|P2|Overall Study|Withdrawal by Subject|3
4927406|NCT00448279|16964621|P1|Overall Study|Withdrawal by Subject|4
4927407|NCT00448279|16964620|P2|Overall Study|Disease progression|18
4927408|NCT00448279|16964621|P1|Overall Study|Disease progression|16
4927409|NCT00448279|16964620|P2|Overall Study|Adverse Event|1
4927410|NCT00448279|16964621|P1|Overall Study|Adverse Event|1
4927411|NCT00448279|16964620|P2|Overall Study|Lost to Follow-up|2
4927412|NCT00448279|16964621|P1|Overall Study|Lost to Follow-up|2
4927413|NCT00448136|16964684|P2|Overall Study|Investigator's decision (progression)|0
4927414|NCT00448136|16964685|P1|Overall Study|Investigator's decision (progression)|1
4927415|NCT00448136|16964684|P2|Overall Study|Death|8
4927416|NCT00448136|16964685|P1|Overall Study|Death|3
4927417|NCT00448123|16964723|P2|Overall Study|Physician Decision|6
4927418|NCT00448123|16964724|P1|Overall Study|Physician Decision|6
4927419|NCT00448123|16964723|P2|Overall Study|Lost to Follow-up|6
4927420|NCT00448123|16964724|P1|Overall Study|Lost to Follow-up|9
4927421|NCT00448019|16964734|P1|Overall Study|Insurance Issues|1
4927422|NCT00448019|16964734|P1|Overall Study|Death|2
4927423|NCT00448019|16964734|P1|Overall Study|Disease progression|1
4927424|NCT00448019|16964734|P1|Overall Study|Withdrawal by Subject|3
4927425|NCT00447902|16964742|P2|Overall Study|Lack of Efficacy|1
4927426|NCT00447902|16964743|P1|Overall Study|Lack of Efficacy|2
4927427|NCT00447902|16964742|P2|Overall Study|included patients who discontinued|1
4927428|NCT00447902|16964743|P1|Overall Study|included patients who discontinued|1
4927429|NCT00447902|16964742|P2|Overall Study|Withdrawal by Subject|1
4927430|NCT00447902|16964743|P1|Overall Study|Withdrawal by Subject|0
4927431|NCT00447902|16964742|P2|Overall Study|Protocol Violation|0
4927432|NCT00447902|16964743|P1|Overall Study|Protocol Violation|1
4927433|NCT00447902|16964742|P2|Overall Study|Adverse Event|3
4927434|NCT00447902|16964743|P1|Overall Study|Adverse Event|0
4927435|NCT00447876|16964785|P2|Overall Study|Deterioration of symptomology|0
4927436|NCT00447876|16964786|P1|Overall Study|Deterioration of symptomology|1
4927437|NCT00447876|16964785|P2|Overall Study|Lost to Follow-up|0
4927438|NCT00447876|16964786|P1|Overall Study|Lost to Follow-up|1
4927439|NCT00447876|16964785|P2|Overall Study|Withdrawal by Subject|4
4927440|NCT00447876|16964786|P1|Overall Study|Withdrawal by Subject|1
4927441|NCT00447772|16964816|P1|Overall Study|Premature re-injection required|1
4927442|NCT00447772|16964816|P1|Overall Study|Chemotherapy for lung cancer|1
4927443|NCT00447772|16964816|P1|Overall Study|Incomplete documentation at visit 1|1
4927444|NCT00447772|16964816|P1|Overall Study|Patient relocated|1
4927445|NCT00447772|16964816|P1|Overall Study|Adverse Event|1
4927446|NCT00447772|16964816|P1|Overall Study|Unable to attend all study visits|2
4927447|NCT00447772|16964816|P1|Overall Study|Withdrawal by Subject|1
4927448|NCT00447772|16964816|P1|Overall Study|Lost to Follow-up|9
4927449|NCT00447772|16964816|P1|Overall Study|Discontinuation of drug therapy|1
4927450|NCT00447772|16964816|P1|Overall Study|Insufficient compliance|6
4927451|NCT00447772|16964816|P1|Overall Study|Lack of Efficacy|3
4927452|NCT00447603|16964836|P3|Filter Period|Study terminated by Sponsor|10
4927453|NCT00447603|16964837|P2|Filter Period|Study terminated by Sponsor|1
4927454|NCT00447603|16964838|P1|Filter Period|Study terminated by Sponsor|0
4927455|NCT00447603|16964836|P3|Filter Period|Screen Failure|4
4927456|NCT00447603|16964837|P2|Filter Period|Screen Failure|3
4927457|NCT00447603|16964838|P1|Filter Period|Screen Failure|0
4927458|NCT00447603|16964836|P3|Filter Period|Adverse Event|1
4927459|NCT00447603|16964837|P2|Filter Period|Adverse Event|0
4927460|NCT00447603|16964838|P1|Filter Period|Adverse Event|0
4927461|NCT00447603|16964836|P3|Screening|Study Terminated by Sponsor|0
4927462|NCT00447603|16964837|P2|Screening|Study Terminated by Sponsor|0
4927463|NCT00447603|16964838|P1|Screening|Study Terminated by Sponsor|15
4927464|NCT00447603|16964836|P3|Screening|Screen Failure|0
4927465|NCT00447603|16964837|P2|Screening|Screen Failure|0
4927466|NCT00447603|16964838|P1|Screening|Screen Failure|4
4927467|NCT00447603|16964836|P3|Screening|Protocol Violation|0
4927468|NCT00447603|16964837|P2|Screening|Protocol Violation|0
4927469|NCT00447603|16964838|P1|Screening|Protocol Violation|1
4927470|NCT00447603|16964836|P3|Screening|Withdrawal by Subject|0
4927471|NCT00447603|16964837|P2|Screening|Withdrawal by Subject|0
4927472|NCT00447603|16964838|P1|Screening|Withdrawal by Subject|1
4927473|NCT00447590|16964858|P1|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10
4927474|NCT00447590|16964858|P1|Overall Study|Lost to Follow-up|24
4927475|NCT00447590|16964858|P1|Overall Study|Withdrawal by Subject|26
4927476|NCT00447499|16964867|P1|Overall Study|Physician Decision|1
4927477|NCT00447499|16964867|P1|Overall Study|Sponsor Decision|1
4927478|NCT00447499|16964867|P1|Overall Study|Patient Decision|4
4927479|NCT00447499|16964867|P1|Overall Study|Adverse Event|1
4927480|NCT00447421|16964877|P1|Overall Study|Sponsor Decision|2
4927481|NCT00447421|16964877|P1|Overall Study|Adverse Event|3
4927482|NCT00447421|16964877|P1|Overall Study|Lack of Efficacy|1
4927483|NCT00447382|16964889|P2|Overall Study|Unclassified|5
4927484|NCT00447382|16964890|P1|Overall Study|Unclassified|2
4927485|NCT00447382|16964889|P2|Overall Study|Protocol Violation|0
4927486|NCT00447382|16964890|P1|Overall Study|Protocol Violation|2
4927487|NCT00447382|16964889|P2|Overall Study|Lack of Efficacy|0
4927488|NCT00447382|16964890|P1|Overall Study|Lack of Efficacy|1
4927489|NCT00447382|16964889|P2|Overall Study|Adverse Event|1
4927490|NCT00447382|16964890|P1|Overall Study|Adverse Event|1
4927491|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8
4927492|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11
4927493|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Lack of Efficacy|0
4927494|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Lack of Efficacy|4
4927495|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Physician Decision|1
4927496|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Physician Decision|1
4927497|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1
4927498|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4
4927499|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Protocol Violation|1
4927500|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Protocol Violation|6
4927501|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
4927502|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Lost to Follow-up|2
4927503|NCT00447278|16964951|P2|Period III (Optional 6 Month Extension)|Adverse Event|2
4927504|NCT00447278|16964952|P1|Period III (Optional 6 Month Extension)|Adverse Event|2
4927505|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Parent/Guardian Decision|10
4927506|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Parent/Guardian Decision|9
4927507|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Lack of Efficacy|1
4927508|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Lack of Efficacy|11
4927509|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Physician Decision|1
4927510|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Physician Decision|4
4927511|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Withdrawal by Subject|3
4927512|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Withdrawal by Subject|1
4927513|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Protocol Violation|7
4927514|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Protocol Violation|10
4927515|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Lost to Follow-up|4
4927516|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Lost to Follow-up|0
4927517|NCT00447278|16964951|P2|Period II (6 Month Open-Label)|Adverse Event|3
4927518|NCT00447278|16964952|P1|Period II (6 Month Open-Label)|Adverse Event|7
4927519|NCT00447265|16964973|P2|Overall Study|Physician Decision|0
4927520|NCT00447265|16964974|P1|Overall Study|Physician Decision|1
4927521|NCT00447226|16964987|P2|Double-blind Phase|Disease Progression|3
4927522|NCT00447226|16964988|P1|Double-blind Phase|Disease Progression|4
4927523|NCT00447226|16964987|P2|12-Week Open-label Phase|Physician Decision|1
4927524|NCT00447226|16964988|P1|12-Week Open-label Phase|Physician Decision|0
4927525|NCT00447226|16964987|P2|12-Week Open-label Phase|Disease Progression|20
4927526|NCT00447226|16964988|P1|12-Week Open-label Phase|Disease Progression|0
4927527|NCT00447226|16964987|P2|12-Week Open-label Phase|Protocol Violation|1
4927528|NCT00447226|16964988|P1|12-Week Open-label Phase|Protocol Violation|0
4927529|NCT00447226|16964987|P2|12-Week Open-label Phase|Adverse Event|3
4927530|NCT00447226|16964988|P1|12-Week Open-label Phase|Adverse Event|0
4927531|NCT00447057|16965031|P4|Overall Study|Death, study drug related|0
4927532|NCT00447057|16965032|P3|Overall Study|Death, study drug related|0
4927533|NCT00447057|16965033|P2|Overall Study|Death, study drug related|1
4927534|NCT00447057|16965034|P1|Overall Study|Death, study drug related|0
4927535|NCT00447057|16965031|P4|Overall Study|Death due to adverse event|2
4927536|NCT00447057|16965032|P3|Overall Study|Death due to adverse event|1
4927537|NCT00447057|16965033|P2|Overall Study|Death due to adverse event|0
4927538|NCT00447057|16965034|P1|Overall Study|Death due to adverse event|0
4927539|NCT00447057|16965031|P4|Overall Study|Progressive disease|18
4927540|NCT00447057|16965032|P3|Overall Study|Progressive disease|13
4927541|NCT00447057|16965033|P2|Overall Study|Progressive disease|43
4927542|NCT00447057|16965034|P1|Overall Study|Progressive disease|58
4927543|NCT00447057|16965031|P4|Overall Study|Sponsor decision|0
4927544|NCT00447057|16965032|P3|Overall Study|Sponsor decision|0
4927545|NCT00447057|16965033|P2|Overall Study|Sponsor decision|1
4927546|NCT00447057|16965034|P1|Overall Study|Sponsor decision|1
4927547|NCT00447057|16965031|P4|Overall Study|Physician Decision|1
4927548|NCT00447057|16965032|P3|Overall Study|Physician Decision|3
4927549|NCT00447057|16965033|P2|Overall Study|Physician Decision|6
4927550|NCT00447057|16965034|P1|Overall Study|Physician Decision|9
4927551|NCT00447057|16965031|P4|Overall Study|Withdrawal by Subject|1
4927552|NCT00447057|16965032|P3|Overall Study|Withdrawal by Subject|1
4927553|NCT00447057|16965033|P2|Overall Study|Withdrawal by Subject|5
4927554|NCT00447057|16965034|P1|Overall Study|Withdrawal by Subject|4
4927555|NCT00447057|16965031|P4|Overall Study|Protocol Violation|0
4927556|NCT00447057|16965032|P3|Overall Study|Protocol Violation|0
4927557|NCT00447057|16965033|P2|Overall Study|Protocol Violation|1
4927558|NCT00447057|16965034|P1|Overall Study|Protocol Violation|0
4927559|NCT00447057|16965031|P4|Overall Study|Entry criteria not met|0
4927560|NCT00447057|16965032|P3|Overall Study|Entry criteria not met|0
4927561|NCT00447057|16965033|P2|Overall Study|Entry criteria not met|1
4927562|NCT00447057|16965034|P1|Overall Study|Entry criteria not met|1
4927563|NCT00447057|16965031|P4|Overall Study|Lost to Follow-up|0
4927564|NCT00447057|16965032|P3|Overall Study|Lost to Follow-up|0
4927565|NCT00447057|16965033|P2|Overall Study|Lost to Follow-up|1
4927566|NCT00447057|16965034|P1|Overall Study|Lost to Follow-up|0
4927567|NCT00447057|16965031|P4|Overall Study|Death due to study disease|1
4927568|NCT00447057|16965032|P3|Overall Study|Death due to study disease|1
4927569|NCT00447057|16965033|P2|Overall Study|Death due to study disease|4
4927570|NCT00447057|16965034|P1|Overall Study|Death due to study disease|6
4927571|NCT00447057|16965031|P4|Overall Study|Adverse Event|3
4927572|NCT00447057|16965032|P3|Overall Study|Adverse Event|0
4927573|NCT00447057|16965033|P2|Overall Study|Adverse Event|10
4927574|NCT00447057|16965034|P1|Overall Study|Adverse Event|4
4927575|NCT00447005|16965052|P1|Overall Study|Lack of Efficacy|11
4927576|NCT00447005|16965052|P1|Overall Study|Adverse Event|1
4927577|NCT00446992|16965066|P1|Overall Study|Lost to Follow-up|5
4927578|NCT00446992|16965066|P1|Overall Study|Adverse Event|11
4927579|NCT00446966|16965080|P2|Overall Study|Lost to Follow-up|7
4927580|NCT00446966|16965081|P1|Overall Study|Lost to Follow-up|10
4927581|NCT00446849|16965087|P1|Maintenance Phase|concomitant medication use|1
4927582|NCT00446849|16965087|P1|Maintenance Phase|hydrocodone use|1
4927583|NCT00446849|16965087|P1|Maintenance Phase|study closure|1
4927584|NCT00446849|16965087|P1|Maintenance Phase|antibiotic use|1
4927585|NCT00446849|16965087|P1|Maintenance Phase|prohibited medication use|2
4927586|NCT00446849|16965087|P1|Maintenance Phase|noncompliance|2
4927587|NCT00446849|16965087|P1|Maintenance Phase|Pregnancy|1
4927588|NCT00446849|16965087|P1|Maintenance Phase|Lost to Follow-up|3
4927589|NCT00446849|16965087|P1|Maintenance Phase|Consent withdrawn|5
4927590|NCT00446849|16965087|P1|Maintenance Phase|Adverse Event|6
4927591|NCT00446849|16965087|P1|Maintenance Phase|Protocol Violation|7
4927592|NCT00446849|16965087|P1|Maintenance Phase|Lack of Efficacy|40
4927593|NCT00446849|16965087|P1|Acute Phase|noncompliance|1
4927594|NCT00446849|16965087|P1|Acute Phase|Physician Decision|1
4927595|NCT00446849|16965087|P1|Acute Phase|Lost to Follow-up|2
4927596|NCT00446849|16965087|P1|Acute Phase|Consent withdrawn|4
4927597|NCT00446849|16965087|P1|Acute Phase|Protocol Violation|10
4927598|NCT00446849|16965087|P1|Acute Phase|Lack of Efficacy|64
4927599|NCT00446797|16965099|P2|Overall Study|did not meet entrance criteria|1
4927600|NCT00446797|16965100|P1|Overall Study|did not meet entrance criteria|0
4927601|NCT00446797|16965099|P2|Overall Study|subject entered at another site|1
4927602|NCT00446797|16965100|P1|Overall Study|subject entered at another site|0
4927603|NCT00446797|16965099|P2|Overall Study|Protocol Violation|3
4927604|NCT00446797|16965100|P1|Overall Study|Protocol Violation|1
4927605|NCT00446797|16965099|P2|Overall Study|Withdrawal by Subject|2
4927606|NCT00446797|16965100|P1|Overall Study|Withdrawal by Subject|2
4927607|NCT00446797|16965099|P2|Overall Study|Lost to Follow-up|3
4927608|NCT00446797|16965100|P1|Overall Study|Lost to Follow-up|5
4927609|NCT00446797|16965099|P2|Overall Study|Lack of Efficacy|2
4927610|NCT00446797|16965100|P1|Overall Study|Lack of Efficacy|0
4927611|NCT00446654|16965146|P2|Overall Study|Adverse Event|0
4927612|NCT00446654|16965147|P1|Overall Study|Adverse Event|1
4927613|NCT00446654|16965146|P2|Overall Study|Withdrawal by Subject|0
4927614|NCT00446654|16965147|P1|Overall Study|Withdrawal by Subject|1
4927615|NCT00446641|16965155|P2|Overall Study|Lost to Follow-up|1
4927616|NCT00446641|16965156|P1|Overall Study|Lost to Follow-up|1
4927617|NCT00446641|16965155|P2|Overall Study|poor compliance|6
4927618|NCT00446641|16965156|P1|Overall Study|poor compliance|8
4927619|NCT00446641|16965155|P2|Overall Study|Withdrawal by Subject|3
4927620|NCT00446641|16965156|P1|Overall Study|Withdrawal by Subject|8
4927621|NCT00446563|16965176|P2|Overall Study|Administrative problems|1
4927622|NCT00446563|16965177|P1|Overall Study|Administrative problems|0
4927623|NCT00446563|16965176|P2|Overall Study|Withdrawal by Subject|1
4927624|NCT00446563|16965177|P1|Overall Study|Withdrawal by Subject|2
4927625|NCT00446563|16965176|P2|Overall Study|Unsatisfactory therapeutic effect|3
4927626|NCT00446563|16965177|P1|Overall Study|Unsatisfactory therapeutic effect|0
4927627|NCT00446563|16965176|P2|Overall Study|Abnormal test procedure result(s)|0
4927628|NCT00446563|16965177|P1|Overall Study|Abnormal test procedure result(s)|1
4927629|NCT00446563|16965176|P2|Overall Study|Abnormal laboratory value(s)|1
4927630|NCT00446563|16965177|P1|Overall Study|Abnormal laboratory value(s)|0
4927631|NCT00446563|16965176|P2|Overall Study|Adverse Event|3
4927632|NCT00446563|16965177|P1|Overall Study|Adverse Event|4
4927633|NCT00446550|16965213|P2|Overall Study|Adverse Event|0
4927634|NCT00446550|16965214|P1|Overall Study|Adverse Event|1
4927635|NCT00446511|16965226|P4|Overall Study|Administrative Problems|1
4927636|NCT00446511|16965227|P3|Overall Study|Administrative Problems|4
4927637|NCT00446511|16965228|P2|Overall Study|Administrative Problems|0
4927638|NCT00446511|16965229|P1|Overall Study|Administrative Problems|3
4927639|NCT00446511|16965226|P4|Overall Study|Withdrawal by Subject|3
4927640|NCT00446511|16965227|P3|Overall Study|Withdrawal by Subject|0
4927641|NCT00446511|16965228|P2|Overall Study|Withdrawal by Subject|0
4927642|NCT00446511|16965229|P1|Overall Study|Withdrawal by Subject|0
4927643|NCT00446511|16965226|P4|Overall Study|Protocol Violation|1
4927644|NCT00446511|16965227|P3|Overall Study|Protocol Violation|0
4927645|NCT00446511|16965228|P2|Overall Study|Protocol Violation|0
4927646|NCT00446511|16965229|P1|Overall Study|Protocol Violation|0
4927647|NCT00446511|16965226|P4|Overall Study|Adverse Event|1
4927648|NCT00446511|16965227|P3|Overall Study|Adverse Event|3
4927649|NCT00446511|16965228|P2|Overall Study|Adverse Event|2
4927650|NCT00446511|16965229|P1|Overall Study|Adverse Event|7
4927651|NCT00446459|16965253|P1|12 Months|14 subjects to MMF + Rituximab Study|14
4927652|NCT00446459|16965253|P1|12 Months|Protocol Violation|4
4927653|NCT00446459|16965253|P1|8 Months|Protocol Violation|12
4927654|NCT00446446|16965261|P1|Overall Study|On Treatment at Time of Data Cut-off|1
4927655|NCT00446446|16965261|P1|Overall Study|Adverse Event|1
4927656|NCT00446446|16965261|P1|Overall Study|Disease Progession|2
4927657|NCT00446446|16965261|P1|Overall Study|Other|4
4927658|NCT00446446|16965261|P1|Overall Study|Withdrawal by Subject|6
4927659|NCT00446446|16965261|P1|Overall Study|Death|10
4927660|NCT00446251|16965285|P1|Overall Study|Lost to Follow-up|1
4927661|NCT00446251|16965285|P1|Overall Study|Rituximab Infusion Reaction|2
4927662|NCT00446251|16965285|P1|Overall Study|On-study Transplants|2
4927663|NCT00446199|16965295|P4|Overall Study|Move|0
4927664|NCT00446199|16965296|P3|Overall Study|Move|0
4927665|NCT00446199|16965297|P2|Overall Study|Move|1
4927666|NCT00446199|16965298|P1|Overall Study|Move|0
4927667|NCT00446199|16965295|P4|Overall Study|In-/Exclusion criterion violated|1
4927668|NCT00446199|16965296|P3|Overall Study|In-/Exclusion criterion violated|2
4927669|NCT00446199|16965297|P2|Overall Study|In-/Exclusion criterion violated|1
4927670|NCT00446199|16965298|P1|Overall Study|In-/Exclusion criterion violated|2
4927671|NCT00446199|16965295|P4|Overall Study|Lost interest in study participation|0
4927672|NCT00446199|16965296|P3|Overall Study|Lost interest in study participation|0
4927673|NCT00446199|16965297|P2|Overall Study|Lost interest in study participation|1
4927674|NCT00446199|16965298|P1|Overall Study|Lost interest in study participation|0
4927675|NCT00446199|16965295|P4|Overall Study|Hormone fear|1
4927676|NCT00446199|16965296|P3|Overall Study|Hormone fear|0
4927677|NCT00446199|16965297|P2|Overall Study|Hormone fear|0
4927678|NCT00446199|16965298|P1|Overall Study|Hormone fear|0
4927679|NCT00446199|16965295|P4|Overall Study|Non-compliant with visit schedule|2
4927680|NCT00446199|16965296|P3|Overall Study|Non-compliant with visit schedule|1
4927681|NCT00446199|16965297|P2|Overall Study|Non-compliant with visit schedule|1
4927682|NCT00446199|16965298|P1|Overall Study|Non-compliant with visit schedule|1
4927683|NCT00446199|16965295|P4|Overall Study|Non-compliant with study drug|0
4927684|NCT00446199|16965296|P3|Overall Study|Non-compliant with study drug|5
4927685|NCT00446199|16965297|P2|Overall Study|Non-compliant with study drug|0
4927686|NCT00446199|16965298|P1|Overall Study|Non-compliant with study drug|1
4927687|NCT00446199|16965295|P4|Overall Study|Lack of Efficacy|1
4927688|NCT00446199|16965296|P3|Overall Study|Lack of Efficacy|0
4927689|NCT00446199|16965297|P2|Overall Study|Lack of Efficacy|0
4927690|NCT00446199|16965298|P1|Overall Study|Lack of Efficacy|1
4927691|NCT00446199|16965295|P4|Overall Study|Randomization in Error|1
4927692|NCT00446199|16965296|P3|Overall Study|Randomization in Error|1
4927693|NCT00446199|16965297|P2|Overall Study|Randomization in Error|0
4927694|NCT00446199|16965298|P1|Overall Study|Randomization in Error|2
4927695|NCT00446199|16965295|P4|Overall Study|Site termination|1
4927696|NCT00446199|16965296|P3|Overall Study|Site termination|0
4927697|NCT00446199|16965297|P2|Overall Study|Site termination|0
4927698|NCT00446199|16965298|P1|Overall Study|Site termination|2
4927699|NCT00446199|16965295|P4|Overall Study|Withdrawal by Subject|10
4927700|NCT00446199|16965296|P3|Overall Study|Withdrawal by Subject|9
4927701|NCT00446199|16965297|P2|Overall Study|Withdrawal by Subject|5
4927702|NCT00446199|16965298|P1|Overall Study|Withdrawal by Subject|2
4927703|NCT00446199|16965295|P4|Overall Study|Protocol Violation|3
4927704|NCT00446199|16965296|P3|Overall Study|Protocol Violation|1
4927705|NCT00446199|16965297|P2|Overall Study|Protocol Violation|2
4927706|NCT00446199|16965298|P1|Overall Study|Protocol Violation|1
4927707|NCT00446199|16965295|P4|Overall Study|Lost to Follow-up|6
4927708|NCT00446199|16965296|P3|Overall Study|Lost to Follow-up|2
4927709|NCT00446199|16965297|P2|Overall Study|Lost to Follow-up|5
4927710|NCT00446199|16965298|P1|Overall Study|Lost to Follow-up|4
4927711|NCT00446199|16965295|P4|Overall Study|Adverse Event|4
4927712|NCT00446199|16965296|P3|Overall Study|Adverse Event|6
4927713|NCT00446199|16965297|P2|Overall Study|Adverse Event|4
4927714|NCT00446199|16965298|P1|Overall Study|Adverse Event|7
4927715|NCT00446134|16965391|P4|Overall Study|Reason Not Completed|2
4927716|NCT00446134|16965392|P3|Overall Study|Reason Not Completed|1
4927717|NCT00446134|16965393|P2|Overall Study|Reason Not Completed|0
4927718|NCT00446134|16965394|P1|Overall Study|Reason Not Completed|3
4927719|NCT00446134|16965391|P4|Overall Study|Adverse Event-Diarrhea|0
4927720|NCT00446134|16965392|P3|Overall Study|Adverse Event-Diarrhea|2
4927721|NCT00446134|16965393|P2|Overall Study|Adverse Event-Diarrhea|1
4927722|NCT00446134|16965394|P1|Overall Study|Adverse Event-Diarrhea|1
4927723|NCT00446134|16965391|P4|Overall Study|Physician Decision|2
4927724|NCT00446134|16965392|P3|Overall Study|Physician Decision|0
4927725|NCT00446134|16965393|P2|Overall Study|Physician Decision|0
4927726|NCT00446134|16965394|P1|Overall Study|Physician Decision|0
4927727|NCT00446134|16965391|P4|Overall Study|Withdrawal by Subject|3
4927728|NCT00446134|16965392|P3|Overall Study|Withdrawal by Subject|1
4927729|NCT00446134|16965393|P2|Overall Study|Withdrawal by Subject|3
4927730|NCT00446134|16965394|P1|Overall Study|Withdrawal by Subject|3
4927731|NCT00446134|16965391|P4|Overall Study|Lost to Follow-up|1
4927732|NCT00446134|16965392|P3|Overall Study|Lost to Follow-up|1
4927733|NCT00446134|16965393|P2|Overall Study|Lost to Follow-up|3
4927734|NCT00446134|16965394|P1|Overall Study|Lost to Follow-up|1
4927735|NCT00446134|16965391|P4|Overall Study|Protocol Violation|0
4927736|NCT00446134|16965392|P3|Overall Study|Protocol Violation|1
4927737|NCT00446134|16965393|P2|Overall Study|Protocol Violation|2
4927738|NCT00446134|16965394|P1|Overall Study|Protocol Violation|0
4927739|NCT00446134|16965391|P4|Overall Study|Lack of Efficacy|19
4927740|NCT00446134|16965392|P3|Overall Study|Lack of Efficacy|24
4927741|NCT00446134|16965393|P2|Overall Study|Lack of Efficacy|19
4927742|NCT00446134|16965394|P1|Overall Study|Lack of Efficacy|19
4927743|NCT00446134|16965391|P4|Overall Study|Adverse Event|18
4927744|NCT00446134|16965392|P3|Overall Study|Adverse Event|13
4927745|NCT00446134|16965393|P2|Overall Study|Adverse Event|17
4927746|NCT00446134|16965394|P1|Overall Study|Adverse Event|7
4927747|NCT00446095|16965421|P5|Phase I (28 Days)|Lack of Efficacy|3
4927748|NCT00446095|16965422|P4|Phase I (28 Days)|Lack of Efficacy|0
4927749|NCT00446095|16965423|P3|Phase I (28 Days)|Lack of Efficacy|0
4927750|NCT00446095|16965424|P2|Phase I (28 Days)|Lack of Efficacy|0
4927751|NCT00446095|16965425|P1|Phase I (28 Days)|Lack of Efficacy|0
4927752|NCT00446095|16965421|P5|Phase I (28 Days)|Adverse Event|0
4927753|NCT00446095|16965422|P4|Phase I (28 Days)|Adverse Event|1
4927754|NCT00446095|16965423|P3|Phase I (28 Days)|Adverse Event|0
4927755|NCT00446095|16965424|P2|Phase I (28 Days)|Adverse Event|0
4927756|NCT00446095|16965425|P1|Phase I (28 Days)|Adverse Event|0
4927757|NCT00446095|16965421|P5|Phase II (8 Weeks)|Ongoing|0
4927758|NCT00446095|16965422|P4|Phase II (8 Weeks)|Ongoing|0
4927759|NCT00446095|16965423|P3|Phase II (8 Weeks)|Ongoing|1
4927760|NCT00446095|16965424|P2|Phase II (8 Weeks)|Ongoing|0
4927761|NCT00446095|16965425|P1|Phase II (8 Weeks)|Ongoing|0
4927762|NCT00446095|16965421|P5|Phase II (8 Weeks)|Lack of Efficacy|0
4927763|NCT00446095|16965422|P4|Phase II (8 Weeks)|Lack of Efficacy|0
4927764|NCT00446095|16965423|P3|Phase II (8 Weeks)|Lack of Efficacy|1
4927765|NCT00446095|16965424|P2|Phase II (8 Weeks)|Lack of Efficacy|2
4927766|NCT00446095|16965425|P1|Phase II (8 Weeks)|Lack of Efficacy|9
4927767|NCT00446095|16965421|P5|Phase II (8 Weeks)|Physician Decision|0
4927768|NCT00446095|16965422|P4|Phase II (8 Weeks)|Physician Decision|0
4927769|NCT00446095|16965423|P3|Phase II (8 Weeks)|Physician Decision|0
4927770|NCT00446095|16965424|P2|Phase II (8 Weeks)|Physician Decision|0
4927771|NCT00446095|16965425|P1|Phase II (8 Weeks)|Physician Decision|1
4927772|NCT00446095|16965421|P5|Phase II (8 Weeks)|Withdrawal by Subject|0
4927773|NCT00446095|16965422|P4|Phase II (8 Weeks)|Withdrawal by Subject|0
4927774|NCT00446095|16965423|P3|Phase II (8 Weeks)|Withdrawal by Subject|0
4927775|NCT00446095|16965424|P2|Phase II (8 Weeks)|Withdrawal by Subject|0
4927776|NCT00446095|16965425|P1|Phase II (8 Weeks)|Withdrawal by Subject|1
4927777|NCT00446095|16965421|P5|Phase II (8 Weeks)|Adverse Event|0
4927778|NCT00446095|16965422|P4|Phase II (8 Weeks)|Adverse Event|0
4927779|NCT00446095|16965423|P3|Phase II (8 Weeks)|Adverse Event|1
4927780|NCT00446095|16965424|P2|Phase II (8 Weeks)|Adverse Event|1
4927781|NCT00446095|16965425|P1|Phase II (8 Weeks)|Adverse Event|0
4927782|NCT00446095|16965421|P5|Phase II (8 Weeks)|Lost to Follow-up|0
4927783|NCT00446095|16965422|P4|Phase II (8 Weeks)|Lost to Follow-up|0
4927784|NCT00446095|16965423|P3|Phase II (8 Weeks)|Lost to Follow-up|0
4927785|NCT00446095|16965424|P2|Phase II (8 Weeks)|Lost to Follow-up|0
4927786|NCT00446095|16965425|P1|Phase II (8 Weeks)|Lost to Follow-up|1
4927787|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1
4927788|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0
4927789|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Right axilla wound|0
4927790|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Right axilla wound|1
4927791|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Patient concern|0
4927792|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Patient concern|1
4927793|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Protocol Violation|0
4927794|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Protocol Violation|1
4927795|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Per physician discretion|0
4927796|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Per physician discretion|2
4927797|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0
4927798|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2
4927799|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2
4927800|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3
4927801|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Death|2
4927802|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Death|2
4927803|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0
4927804|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4
4927805|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0
4927806|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5
4927807|NCT00446030|16965448|P2|FOLLOW-UP (up to 2-years)|Subject's request|4
4927808|NCT00446030|16965449|P1|FOLLOW-UP (up to 2-years)|Subject's request|9
4927809|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0
4927810|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1
4927811|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Patient concern|0
4927812|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Patient concern|1
4927813|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Physician Decision|0
4927814|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Physician Decision|1
4927815|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Protocol Violation|0
4927816|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Protocol Violation|1
4927817|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0
4927818|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1
4927819|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Poor compliance|0
4927820|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Poor compliance|1
4927821|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Subject Request|1
4927822|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Subject Request|9
4927823|NCT00446030|16965448|P2|TREATMENT (up to 52 Weeks)|Adverse Event|8
4927824|NCT00446030|16965449|P1|TREATMENT (up to 52 Weeks)|Adverse Event|29
4927825|NCT00445939|16965460|P4|Period B - Week 4 - Week 8|Adverse Event|1
4927826|NCT00445939|16965461|P3|Period B - Week 4 - Week 8|Adverse Event|0
4927827|NCT00445939|16965462|P2|Period B - Week 4 - Week 8|Adverse Event|0
4927828|NCT00445939|16965463|P1|Period B - Week 4 - Week 8|Adverse Event|2
4927829|NCT00445939|16965460|P4|Period A - Week 0 - Week 4|Adverse Event|0
4927830|NCT00445939|16965461|P3|Period A - Week 0 - Week 4|Adverse Event|0
4927831|NCT00445939|16965462|P2|Period A - Week 0 - Week 4|Adverse Event|2
4927832|NCT00445939|16965463|P1|Period A - Week 0 - Week 4|Adverse Event|1
4927833|NCT00445848|16965511|P1|Overall Study|Other-Not protocol specified|5
4927834|NCT00445848|16965511|P1|Overall Study|Progression|62
4927835|NCT00445848|16965511|P1|Overall Study|Withdrawal by Subject|4
4927836|NCT00445848|16965511|P1|Overall Study|Adverse Event|14
4927837|NCT00445770|16965521|P3|Overall Study|Other|6
4927838|NCT00445770|16965522|P2|Overall Study|Other|5
4927839|NCT00445770|16965523|P1|Overall Study|Other|6
4927840|NCT00445770|16965521|P3|Overall Study|Lost to Follow-up|0
4927841|NCT00445770|16965522|P2|Overall Study|Lost to Follow-up|2
4927842|NCT00445770|16965523|P1|Overall Study|Lost to Follow-up|0
4927843|NCT00445770|16965521|P3|Overall Study|Lack of Efficacy|6
4927844|NCT00445770|16965522|P2|Overall Study|Lack of Efficacy|13
4927845|NCT00445770|16965523|P1|Overall Study|Lack of Efficacy|38
4927846|NCT00445770|16965521|P3|Overall Study|Adverse Event|19
4927847|NCT00445770|16965522|P2|Overall Study|Adverse Event|15
4927848|NCT00445770|16965523|P1|Overall Study|Adverse Event|9
4927849|NCT00445692|16965624|P1|Overall Study|Lack of Efficacy|5
4927850|NCT00445692|16965624|P1|Overall Study|Adverse Event|11
4927851|NCT00445679|16965634|P4|Overall Study|Lack of Efficacy|0
4927852|NCT00445679|16965635|P3|Overall Study|Lack of Efficacy|2
4927853|NCT00445679|16965636|P2|Overall Study|Lack of Efficacy|6
4927854|NCT00445679|16965637|P1|Overall Study|Lack of Efficacy|2
4927855|NCT00445679|16965634|P4|Overall Study|Withdrawal by Subject|18
4927856|NCT00445679|16965635|P3|Overall Study|Withdrawal by Subject|20
4927857|NCT00445679|16965636|P2|Overall Study|Withdrawal by Subject|14
4927858|NCT00445679|16965637|P1|Overall Study|Withdrawal by Subject|8
4927859|NCT00445679|16965634|P4|Overall Study|Protocol Violation|1
4927860|NCT00445679|16965635|P3|Overall Study|Protocol Violation|3
4927861|NCT00445679|16965636|P2|Overall Study|Protocol Violation|3
4927862|NCT00445679|16965637|P1|Overall Study|Protocol Violation|2
4927863|NCT00445679|16965634|P4|Overall Study|Withdrawal of Informed Consent|0
4927864|NCT00445679|16965635|P3|Overall Study|Withdrawal of Informed Consent|1
4927865|NCT00445679|16965636|P2|Overall Study|Withdrawal of Informed Consent|0
4927866|NCT00445679|16965637|P1|Overall Study|Withdrawal of Informed Consent|0
4927867|NCT00445679|16965634|P4|Overall Study|Compliance|2
4927868|NCT00445679|16965635|P3|Overall Study|Compliance|1
4927869|NCT00445679|16965636|P2|Overall Study|Compliance|2
4927870|NCT00445679|16965637|P1|Overall Study|Compliance|3
4927871|NCT00445679|16965634|P4|Overall Study|Lost to Follow-up|5
4927872|NCT00445679|16965635|P3|Overall Study|Lost to Follow-up|6
4927873|NCT00445679|16965636|P2|Overall Study|Lost to Follow-up|6
4927874|NCT00445679|16965637|P1|Overall Study|Lost to Follow-up|10
4927875|NCT00445679|16965634|P4|Overall Study|Physician Decision|0
4927876|NCT00445679|16965635|P3|Overall Study|Physician Decision|1
4927877|NCT00445679|16965636|P2|Overall Study|Physician Decision|0
4927878|NCT00445679|16965637|P1|Overall Study|Physician Decision|0
4927879|NCT00445679|16965634|P4|Overall Study|Failed to return|2
4927880|NCT00445679|16965635|P3|Overall Study|Failed to return|2
4927881|NCT00445679|16965636|P2|Overall Study|Failed to return|3
4927882|NCT00445679|16965637|P1|Overall Study|Failed to return|1
4927883|NCT00445679|16965634|P4|Overall Study|Adverse Event|19
4927884|NCT00445679|16965635|P3|Overall Study|Adverse Event|30
4927885|NCT00445679|16965636|P2|Overall Study|Adverse Event|12
4927886|NCT00445679|16965637|P1|Overall Study|Adverse Event|22
4927887|NCT00445601|16965673|P2|Overall Study|Death prior to TURBT|1
4927888|NCT00445601|16965674|P1|Overall Study|Death prior to TURBT|0
4927889|NCT00445601|16965673|P2|Overall Study|Adverse Event|0
4927890|NCT00445601|16965674|P1|Overall Study|Adverse Event|2
4927891|NCT00445601|16965673|P2|Overall Study|Drug Delivery Issue|2
4927892|NCT00445601|16965674|P1|Overall Study|Drug Delivery Issue|2
4927893|NCT00445601|16965673|P2|Overall Study|Incorrect Disease Status|6
4927894|NCT00445601|16965674|P1|Overall Study|Incorrect Disease Status|6
4927895|NCT00445601|16965673|P2|Overall Study|TURBT Complication|8
4927896|NCT00445601|16965674|P1|Overall Study|TURBT Complication|12
4927897|NCT00445601|16965673|P2|Overall Study|Withdrawal by Subject|11
4927898|NCT00445601|16965674|P1|Overall Study|Withdrawal by Subject|11
4927899|NCT00445549|16965691|P1|Overall Study|progressive disease|12
4927900|NCT00445458|16965715|P4|Overall Study|Surgery|0
4927901|NCT00445458|16965716|P3|Overall Study|Surgery|1
4927902|NCT00445458|16965717|P2|Overall Study|Surgery|0
4927903|NCT00445458|16965718|P1|Overall Study|Surgery|0
4927904|NCT00445458|16965715|P4|Overall Study|Physician Decision|1
4927905|NCT00445458|16965716|P3|Overall Study|Physician Decision|1
4927906|NCT00445458|16965717|P2|Overall Study|Physician Decision|0
4927907|NCT00445458|16965718|P1|Overall Study|Physician Decision|0
4927908|NCT00445458|16965715|P4|Overall Study|Death|0
4927909|NCT00445458|16965716|P3|Overall Study|Death|2
4927910|NCT00445458|16965717|P2|Overall Study|Death|1
4927911|NCT00445458|16965718|P1|Overall Study|Death|0
4927912|NCT00445458|16965715|P4|Overall Study|Adverse Event|0
4927913|NCT00445458|16965716|P3|Overall Study|Adverse Event|3
4927914|NCT00445458|16965717|P2|Overall Study|Adverse Event|0
4927915|NCT00445458|16965718|P1|Overall Study|Adverse Event|0
4927916|NCT00445458|16965715|P4|Overall Study|Withdrawal by Subject|0
4927917|NCT00445458|16965716|P3|Overall Study|Withdrawal by Subject|7
4927918|NCT00445458|16965717|P2|Overall Study|Withdrawal by Subject|0
4927919|NCT00445458|16965718|P1|Overall Study|Withdrawal by Subject|0
4927920|NCT00445458|16965715|P4|Overall Study|Disease Progression|27
4927921|NCT00445458|16965716|P3|Overall Study|Disease Progression|54
4927922|NCT00445458|16965717|P2|Overall Study|Disease Progression|4
4927923|NCT00445458|16965718|P1|Overall Study|Disease Progression|3
4927924|NCT00445432|16965736|P4|148 Weeks of Adalimumab Treatment|Other|9
4927925|NCT00445432|16965737|P3|148 Weeks of Adalimumab Treatment|Other|0
4927926|NCT00445432|16965738|P2|148 Weeks of Adalimumab Treatment|Other|0
4927927|NCT00445432|16965739|P1|148 Weeks of Adalimumab Treatment|Other|0
4927928|NCT00445432|16965736|P4|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3
4927929|NCT00445432|16965737|P3|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
4927930|NCT00445432|16965738|P2|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
4927931|NCT00445432|16965739|P1|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0
4927932|NCT00445432|16965736|P4|148 Weeks of Adalimumab Treatment|Adverse Event|32
4927933|NCT00445432|16965737|P3|148 Weeks of Adalimumab Treatment|Adverse Event|0
4927934|NCT00445432|16965738|P2|148 Weeks of Adalimumab Treatment|Adverse Event|0
4927935|NCT00445432|16965739|P1|148 Weeks of Adalimumab Treatment|Adverse Event|0
4927936|NCT00445432|16965736|P4|Through Week 52 of NCT00445432 (M06-837)|Other|0
4927937|NCT00445432|16965737|P3|Through Week 52 of NCT00445432 (M06-837)|Other|2
4927938|NCT00445432|16965738|P2|Through Week 52 of NCT00445432 (M06-837)|Other|1
4927939|NCT00445432|16965739|P1|Through Week 52 of NCT00445432 (M06-837)|Other|0
4927940|NCT00445432|16965736|P4|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
4927941|NCT00445432|16965737|P3|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0
4927942|NCT00445432|16965738|P2|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20
4927943|NCT00445432|16965739|P1|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14
4927944|NCT00445432|16965736|P4|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
4927945|NCT00445432|16965737|P3|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2
4927946|NCT00445432|16965738|P2|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
4927947|NCT00445432|16965739|P1|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0
4927948|NCT00445432|16965736|P4|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0
4927949|NCT00445432|16965737|P3|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7
4927950|NCT00445432|16965738|P2|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2
4927951|NCT00445432|16965739|P1|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1
4927952|NCT00445341|16965772|P1|Overall Study|taken off treatment too early|1
4927953|NCT00445341|16965772|P1|Overall Study|refused further treatment|1
4927954|NCT00445328|16965779|P2|Overall Study|Protocol Violation|0
4927955|NCT00445328|16965780|P1|Overall Study|Protocol Violation|1
4927956|NCT00445328|16965779|P2|Overall Study|Withdrawal by Subject|0
4927957|NCT00445328|16965780|P1|Overall Study|Withdrawal by Subject|2
4927958|NCT00445328|16965779|P2|Overall Study|Other|2
4927959|NCT00445328|16965780|P1|Overall Study|Other|0
4927960|NCT00445328|16965779|P2|Overall Study|Adverse Event|3
4927961|NCT00445328|16965780|P1|Overall Study|Adverse Event|0
4927962|NCT00445328|16965779|P2|Overall Study|Death|1
4927963|NCT00445328|16965780|P1|Overall Study|Death|0
4927964|NCT00445224|16965941|P2|Specific Exercises|Withdrawal by Subject|0
4927965|NCT00445224|16965942|P1|Specific Exercises|Withdrawal by Subject|1
4927966|NCT00445224|16965941|P2|Specific Exercises|Withdrawal by Subject|3
4927967|NCT00445224|16965942|P1|Specific Exercises|Withdrawal by Subject|3
4927968|NCT00445146|16965969|P1|Overall Study|Pregnancy|1
4927969|NCT00445146|16965969|P1|Overall Study|Protocol Violation|4
4927970|NCT00445146|16965969|P1|Overall Study|Death|9
4927971|NCT00445146|16965969|P1|Overall Study|Lost to Follow-up|13
4927972|NCT00445146|16965969|P1|Overall Study|Adverse Event|13
4927973|NCT00445146|16965969|P1|Overall Study|Investigator's Discretion|22
4927974|NCT00445146|16965969|P1|Overall Study|Lack of Efficacy|28
4927975|NCT00445146|16965969|P1|Overall Study|Withdrew Consent|29
4927976|NCT00445003|16965991|P3|Overall Study|Dropped|2
4927977|NCT00445003|16965992|P2|Overall Study|Dropped|3
4927978|NCT00445003|16965993|P1|Overall Study|Dropped|1
4927979|NCT00445003|16965991|P3|Overall Study|Missed Visit|1
4927980|NCT00445003|16965992|P2|Overall Study|Missed Visit|5
4927981|NCT00445003|16965993|P1|Overall Study|Missed Visit|3
4927982|NCT00445003|16965991|P3|Overall Study|Death|1
4927983|NCT00445003|16965992|P2|Overall Study|Death|2
4927984|NCT00445003|16965993|P1|Overall Study|Death|1
4927985|NCT00444951|16966025|P3|Overall Study|Withdrawal by Subject|3
4927986|NCT00444951|16966026|P2|Overall Study|Withdrawal by Subject|5
4927987|NCT00444951|16966027|P1|Overall Study|Withdrawal by Subject|4
4927988|NCT00444951|16966025|P3|Overall Study|Lost to Follow-up|0
4927989|NCT00444951|16966026|P2|Overall Study|Lost to Follow-up|1
4927990|NCT00444951|16966027|P1|Overall Study|Lost to Follow-up|1
4927991|NCT00444925|16966044|P3|Double-blind Treatment Period|Other|12
4927992|NCT00444925|16966045|P2|Double-blind Treatment Period|Other|7
4927993|NCT00444925|16966046|P1|Double-blind Treatment Period|Other|7
4927994|NCT00444925|16966044|P3|Double-blind Treatment Period|Withdrawal by Subject|7
4927995|NCT00444925|16966045|P2|Double-blind Treatment Period|Withdrawal by Subject|8
4927996|NCT00444925|16966046|P1|Double-blind Treatment Period|Withdrawal by Subject|6
4927997|NCT00444925|16966044|P3|Double-blind Treatment Period|Lost to Follow-up|5
4927998|NCT00444925|16966045|P2|Double-blind Treatment Period|Lost to Follow-up|8
4927999|NCT00444925|16966046|P1|Double-blind Treatment Period|Lost to Follow-up|4
4928000|NCT00444925|16966044|P3|Double-blind Treatment Period|Lack of Efficacy|13
4928001|NCT00444925|16966045|P2|Double-blind Treatment Period|Lack of Efficacy|5
4928002|NCT00444925|16966046|P1|Double-blind Treatment Period|Lack of Efficacy|5
4928003|NCT00444925|16966044|P3|Double-blind Treatment Period|Adverse Event|44
4928004|NCT00444925|16966045|P2|Double-blind Treatment Period|Adverse Event|28
4928005|NCT00444925|16966046|P1|Double-blind Treatment Period|Adverse Event|6
4928006|NCT00444925|16966044|P3|Double-blind Treatment Period|Death|0
4928007|NCT00444925|16966045|P2|Double-blind Treatment Period|Death|0
4928008|NCT00444925|16966046|P1|Double-blind Treatment Period|Death|2
4928009|NCT00444925|16966044|P3|Randomized to Double-blind Treatment|Never returned after randomization|6
4928010|NCT00444925|16966045|P2|Randomized to Double-blind Treatment|Never returned after randomization|6
4928011|NCT00444925|16966046|P1|Randomized to Double-blind Treatment|Never returned after randomization|3
4928012|NCT00444912|16966110|P2|Overall Study|Participant Failed Mobilization|0
4928013|NCT00444912|16966111|P1|Overall Study|Participant Failed Mobilization|1
4928014|NCT00444912|16966110|P2|Overall Study|Lost to Follow-up|0
4928015|NCT00444912|16966111|P1|Overall Study|Lost to Follow-up|1
4928016|NCT00444912|16966110|P2|Overall Study|Death|2
4928017|NCT00444912|16966111|P1|Overall Study|Death|1
4928018|NCT00444795|16966152|P1|Overall Study|Treated Prior to the Contract Date|2
4928019|NCT00444795|16966152|P1|Overall Study|Not Treated|1
4928020|NCT00444678|16966157|P1|Overall Study|Withdrawal by Subject|2
4928021|NCT00444678|16966157|P1|Overall Study|Physician Decision|3
4928022|NCT00444678|16966157|P1|Overall Study|Death|3
4928023|NCT00444678|16966157|P1|Overall Study|Disease Progression|12
4928024|NCT00444678|16966157|P1|Overall Study|Toxicity|11
4928025|NCT00444626|16966164|P1|Initial Treatment Period|Lost to Follow-up|9
4928026|NCT00444626|16966164|P1|Initial Treatment Period|Adverse Event|1
4928027|NCT00444626|16966164|P1|Initial Treatment Period|Withdrawal by Subject|2
4928028|NCT00444600|16966194|P4|Overall Study|Missed visit|1
4928029|NCT00444600|16966195|P3|Overall Study|Missed visit|0
4928030|NCT00444600|16966196|P2|Overall Study|Missed visit|0
4928031|NCT00444600|16966197|P1|Overall Study|Missed visit|1
4928032|NCT00444600|16966194|P4|Overall Study|Dropped|7
4928033|NCT00444600|16966195|P3|Overall Study|Dropped|7
4928034|NCT00444600|16966196|P2|Overall Study|Dropped|11
4928035|NCT00444600|16966197|P1|Overall Study|Dropped|11
4928036|NCT00444600|16966194|P4|Overall Study|Death|2
4928037|NCT00444600|16966195|P3|Overall Study|Death|3
4928038|NCT00444600|16966196|P2|Overall Study|Death|5
4928039|NCT00444600|16966197|P1|Overall Study|Death|7
4928040|NCT00444587|16966289|P2|Overall Study|Missing|5
4928041|NCT00444587|16966290|P1|Overall Study|Missing|0
4928042|NCT00444587|16966289|P2|Overall Study|Protocol Violation|0
4928043|NCT00444587|16966290|P1|Overall Study|Protocol Violation|1
4928044|NCT00444587|16966289|P2|Overall Study|Investigator decision|0
4928045|NCT00444587|16966290|P1|Overall Study|Investigator decision|3
4928046|NCT00444587|16966289|P2|Overall Study|Refused treatment/did not cooperate|1
4928047|NCT00444587|16966290|P1|Overall Study|Refused treatment/did not cooperate|4
4928048|NCT00444587|16966289|P2|Overall Study|Progression of the disease|8
4928049|NCT00444587|16966290|P1|Overall Study|Progression of the disease|73
4928050|NCT00444587|16966289|P2|Overall Study|Death|1
4928051|NCT00444587|16966290|P1|Overall Study|Death|2
4928052|NCT00444535|16966311|P1|Overall Study|Adverse Event|3
4928053|NCT00444535|16966311|P1|Overall Study|Investigator decision|2
4928054|NCT00444535|16966311|P1|Overall Study|Withdrawal by Subject|3
4928055|NCT00444535|16966311|P1|Overall Study|Treatment is ongoing|16
4928056|NCT00444457|16966322|P4|Toddler Dose|Protocol Violation|1
4928057|NCT00444457|16966323|P3|Toddler Dose|Protocol Violation|0
4928058|NCT00444457|16966324|P2|Toddler Dose|Protocol Violation|0
4928059|NCT00444457|16966325|P1|Toddler Dose|Protocol Violation|1
4928060|NCT00444457|16966322|P4|Toddler Dose|Parent or legal guardian request|1
4928061|NCT00444457|16966323|P3|Toddler Dose|Parent or legal guardian request|2
4928062|NCT00444457|16966324|P2|Toddler Dose|Parent or legal guardian request|3
4928063|NCT00444457|16966325|P1|Toddler Dose|Parent or legal guardian request|0
4928064|NCT00444457|16966322|P4|Toddler Dose|Failed to return|3
4928065|NCT00444457|16966323|P3|Toddler Dose|Failed to return|1
4928066|NCT00444457|16966324|P2|Toddler Dose|Failed to return|2
4928067|NCT00444457|16966325|P1|Toddler Dose|Failed to return|2
4928068|NCT00444457|16966322|P4|Toddler Dose|Lost to Follow-up|3
4928069|NCT00444457|16966323|P3|Toddler Dose|Lost to Follow-up|1
4928070|NCT00444457|16966324|P2|Toddler Dose|Lost to Follow-up|1
4928071|NCT00444457|16966325|P1|Toddler Dose|Lost to Follow-up|4
4928072|NCT00444457|16966322|P4|After Infant Series|Other|0
4928073|NCT00444457|16966323|P3|After Infant Series|Other|0
4928074|NCT00444457|16966324|P2|After Infant Series|Other|1
4928075|NCT00444457|16966325|P1|After Infant Series|Other|0
4928076|NCT00444457|16966322|P4|After Infant Series|Investigator request|1
4928077|NCT00444457|16966323|P3|After Infant Series|Investigator request|0
4928078|NCT00444457|16966324|P2|After Infant Series|Investigator request|0
4928079|NCT00444457|16966325|P1|After Infant Series|Investigator request|0
4928080|NCT00444457|16966322|P4|After Infant Series|Adverse Event|0
4928081|NCT00444457|16966323|P3|After Infant Series|Adverse Event|0
4928082|NCT00444457|16966324|P2|After Infant Series|Adverse Event|2
4928083|NCT00444457|16966325|P1|After Infant Series|Adverse Event|2
4928084|NCT00444457|16966322|P4|After Infant Series|Protocol Violation|2
4928085|NCT00444457|16966323|P3|After Infant Series|Protocol Violation|2
4928086|NCT00444457|16966324|P2|After Infant Series|Protocol Violation|4
4928087|NCT00444457|16966325|P1|After Infant Series|Protocol Violation|2
4928088|NCT00444457|16966322|P4|After Infant Series|Lost to Follow-up|2
4928089|NCT00444457|16966323|P3|After Infant Series|Lost to Follow-up|5
4928090|NCT00444457|16966324|P2|After Infant Series|Lost to Follow-up|5
4928091|NCT00444457|16966325|P1|After Infant Series|Lost to Follow-up|5
4928092|NCT00444457|16966322|P4|After Infant Series|Failed to return|1
4928093|NCT00444457|16966323|P3|After Infant Series|Failed to return|5
4928094|NCT00444457|16966324|P2|After Infant Series|Failed to return|6
4928095|NCT00444457|16966325|P1|After Infant Series|Failed to return|7
4928096|NCT00444457|16966322|P4|After Infant Series|Parent or legal guardian request|3
4928097|NCT00444457|16966323|P3|After Infant Series|Parent or legal guardian request|6
4928098|NCT00444457|16966324|P2|After Infant Series|Parent or legal guardian request|11
4928099|NCT00444457|16966325|P1|After Infant Series|Parent or legal guardian request|4
4928100|NCT00444457|16966322|P4|After Infant Series|Other|1
4928101|NCT00444457|16966323|P3|After Infant Series|Other|1
4928102|NCT00444457|16966324|P2|After Infant Series|Other|1
4928103|NCT00444457|16966325|P1|After Infant Series|Other|0
4928104|NCT00444457|16966322|P4|Infant Series|Death|1
4928105|NCT00444457|16966323|P3|Infant Series|Death|1
4928106|NCT00444457|16966324|P2|Infant Series|Death|1
4928107|NCT00444457|16966325|P1|Infant Series|Death|0
4928108|NCT00444457|16966322|P4|Infant Series|Adverse Event|0
4928109|NCT00444457|16966323|P3|Infant Series|Adverse Event|2
4928110|NCT00444457|16966324|P2|Infant Series|Adverse Event|2
4928111|NCT00444457|16966325|P1|Infant Series|Adverse Event|1
4928112|NCT00444457|16966322|P4|Infant Series|Other|0
4928113|NCT00444457|16966323|P3|Infant Series|Other|4
4928114|NCT00444457|16966324|P2|Infant Series|Other|2
4928115|NCT00444457|16966325|P1|Infant Series|Other|0
4928116|NCT00444457|16966322|P4|Infant Series|Investigator request|2
4928117|NCT00444457|16966323|P3|Infant Series|Investigator request|3
4928118|NCT00444457|16966324|P2|Infant Series|Investigator request|3
4928119|NCT00444457|16966325|P1|Infant Series|Investigator request|4
4928120|NCT00444457|16966322|P4|Infant Series|Failed to return|2
4928121|NCT00444457|16966323|P3|Infant Series|Failed to return|4
4928122|NCT00444457|16966324|P2|Infant Series|Failed to return|4
4928123|NCT00444457|16966325|P1|Infant Series|Failed to return|5
4928124|NCT00444457|16966322|P4|Infant Series|Protocol Violation|3
4928125|NCT00444457|16966323|P3|Infant Series|Protocol Violation|6
4928126|NCT00444457|16966324|P2|Infant Series|Protocol Violation|8
4928127|NCT00444457|16966325|P1|Infant Series|Protocol Violation|16
4928128|NCT00444457|16966322|P4|Infant Series|Lost to Follow-up|6
4928129|NCT00444457|16966323|P3|Infant Series|Lost to Follow-up|7
4928130|NCT00444457|16966324|P2|Infant Series|Lost to Follow-up|11
4928131|NCT00444457|16966325|P1|Infant Series|Lost to Follow-up|10
4928132|NCT00444457|16966322|P4|Infant Series|Parent or legal guardian request|14
4928133|NCT00444457|16966323|P3|Infant Series|Parent or legal guardian request|34
4928134|NCT00444457|16966324|P2|Infant Series|Parent or legal guardian request|29
4928135|NCT00444457|16966325|P1|Infant Series|Parent or legal guardian request|18
4928136|NCT00444457|16966322|P4|Infant Series|Other|0
4928137|NCT00444457|16966323|P3|Infant Series|Other|0
4928138|NCT00444457|16966324|P2|Infant Series|Other|1
4928139|NCT00444457|16966325|P1|Infant Series|Other|0
4928140|NCT00444275|16966390|P5|Maintenance Treatment Phase|Ineffectiveness|14
4928141|NCT00444275|16966391|P4|Maintenance Treatment Phase|Ineffectiveness|3
4928142|NCT00444275|16966392|P3|Maintenance Treatment Phase|Ineffectiveness|5
4928143|NCT00444275|16966393|P2|Maintenance Treatment Phase|Ineffectiveness|0
4928144|NCT00444275|16966394|P1|Maintenance Treatment Phase|Ineffectiveness|0
4928145|NCT00444275|16966390|P5|Maintenance Treatment Phase|Protocol Violation|87
4928146|NCT00444275|16966391|P4|Maintenance Treatment Phase|Protocol Violation|88
4928147|NCT00444275|16966392|P3|Maintenance Treatment Phase|Protocol Violation|103
4928148|NCT00444275|16966393|P2|Maintenance Treatment Phase|Protocol Violation|0
4928149|NCT00444275|16966394|P1|Maintenance Treatment Phase|Protocol Violation|0
4928150|NCT00444275|16966390|P5|Maintenance Treatment Phase|Patient's wish|20
4928151|NCT00444275|16966391|P4|Maintenance Treatment Phase|Patient's wish|9
4928152|NCT00444275|16966392|P3|Maintenance Treatment Phase|Patient's wish|19
4928153|NCT00444275|16966393|P2|Maintenance Treatment Phase|Patient's wish|0
4928154|NCT00444275|16966394|P1|Maintenance Treatment Phase|Patient's wish|0
4928155|NCT00444275|16966390|P5|Maintenance Treatment Phase|Protocol specific criteria's development|6
4928156|NCT00444275|16966391|P4|Maintenance Treatment Phase|Protocol specific criteria's development|0
4928157|NCT00444275|16966392|P3|Maintenance Treatment Phase|Protocol specific criteria's development|1
4928158|NCT00444275|16966393|P2|Maintenance Treatment Phase|Protocol specific criteria's development|0
4928159|NCT00444275|16966394|P1|Maintenance Treatment Phase|Protocol specific criteria's development|0
4928160|NCT00444275|16966390|P5|Maintenance Treatment Phase|Adverse Event|13
4928161|NCT00444275|16966391|P4|Maintenance Treatment Phase|Adverse Event|2
4928162|NCT00444275|16966392|P3|Maintenance Treatment Phase|Adverse Event|3
4928163|NCT00444275|16966393|P2|Maintenance Treatment Phase|Adverse Event|0
4928164|NCT00444275|16966394|P1|Maintenance Treatment Phase|Adverse Event|0
4928165|NCT00444275|16966390|P5|Maintenance Treatment Phase|Lost to Follow-up|10
4928166|NCT00444275|16966391|P4|Maintenance Treatment Phase|Lost to Follow-up|14
4928167|NCT00444275|16966392|P3|Maintenance Treatment Phase|Lost to Follow-up|8
4928168|NCT00444275|16966393|P2|Maintenance Treatment Phase|Lost to Follow-up|0
4928169|NCT00444275|16966394|P1|Maintenance Treatment Phase|Lost to Follow-up|0
4928170|NCT00444275|16966390|P5|Maintenance Treatment Phase|Didn'r receive the treatment|29
4928171|NCT00444275|16966391|P4|Maintenance Treatment Phase|Didn'r receive the treatment|17
4928172|NCT00444275|16966392|P3|Maintenance Treatment Phase|Didn'r receive the treatment|22
4928173|NCT00444275|16966393|P2|Maintenance Treatment Phase|Didn'r receive the treatment|0
4928174|NCT00444275|16966394|P1|Maintenance Treatment Phase|Didn'r receive the treatment|0
4928175|NCT00444145|16966444|P1|Overall Study|Screen Failures|5
4928176|NCT00444145|16966444|P1|Overall Study|non-compliant|11
4928177|NCT00444145|16966444|P1|Overall Study|Lost to Follow-up|1
4928178|NCT00444145|16966444|P1|Overall Study|Withdrawal by Subject|2
4928179|NCT00444106|16966451|P3|Overall Study|Abnormal Test Procedure Results|1
4928180|NCT00444106|16966452|P2|Overall Study|Abnormal Test Procedure Results|0
4928181|NCT00444106|16966453|P1|Overall Study|Abnormal Test Procedure Results|0
4928182|NCT00444106|16966451|P3|Overall Study|Lost to Follow-up|0
4928183|NCT00444106|16966452|P2|Overall Study|Lost to Follow-up|1
4928184|NCT00444106|16966453|P1|Overall Study|Lost to Follow-up|2
4928185|NCT00444067|16966485|P2|Overall Study|Lost to Follow-up|1
4928186|NCT00444067|16966486|P1|Overall Study|Lost to Follow-up|0
4928187|NCT00443898|16966549|P4|Overall Study|Death|0
4928188|NCT00443898|16966550|P3|Overall Study|Death|0
4928189|NCT00443898|16966551|P2|Overall Study|Death|1
4928190|NCT00443898|16966552|P1|Overall Study|Death|0
4928191|NCT00443898|16966549|P4|Overall Study|Lost to Follow-up|10
4928192|NCT00443898|16966550|P3|Overall Study|Lost to Follow-up|14
4928193|NCT00443898|16966551|P2|Overall Study|Lost to Follow-up|10
4928194|NCT00443898|16966552|P1|Overall Study|Lost to Follow-up|10
4928195|NCT00443898|16966549|P4|Overall Study|Withdrawal by Subject|6
4928196|NCT00443898|16966550|P3|Overall Study|Withdrawal by Subject|10
4928197|NCT00443898|16966551|P2|Overall Study|Withdrawal by Subject|10
4928198|NCT00443898|16966552|P1|Overall Study|Withdrawal by Subject|11
4928199|NCT00443898|16966549|P4|Overall Study|Protocol Violation|0
4928200|NCT00443898|16966550|P3|Overall Study|Protocol Violation|1
4928201|NCT00443898|16966551|P2|Overall Study|Protocol Violation|1
4928202|NCT00443898|16966552|P1|Overall Study|Protocol Violation|1
4928203|NCT00443898|16966549|P4|Overall Study|Lack of Efficacy|1
4928204|NCT00443898|16966550|P3|Overall Study|Lack of Efficacy|3
4928205|NCT00443898|16966551|P2|Overall Study|Lack of Efficacy|3
4928206|NCT00443898|16966552|P1|Overall Study|Lack of Efficacy|2
4928207|NCT00443898|16966549|P4|Overall Study|Adverse Event|1
4928208|NCT00443898|16966550|P3|Overall Study|Adverse Event|1
4928209|NCT00443898|16966551|P2|Overall Study|Adverse Event|0
4928210|NCT00443898|16966552|P1|Overall Study|Adverse Event|0
4928211|NCT00443872|16966574|P1|Overall Study|Adverse Event|8
4928212|NCT00443872|16966574|P1|Overall Study|Lost to Follow-up|2
4928213|NCT00443872|16966574|P1|Overall Study|Protocol Violation|7
4928214|NCT00443846|16966589|P2|Overall Study|Lost to Follow-up|2
4928215|NCT00443846|16966590|P1|Overall Study|Lost to Follow-up|1
4928216|NCT00443846|16966589|P2|Overall Study|Personal reason|3
4928217|NCT00443846|16966590|P1|Overall Study|Personal reason|8
4928218|NCT00443846|16966589|P2|Overall Study|Adverse Event|1
4928219|NCT00443846|16966590|P1|Overall Study|Adverse Event|0
4928220|NCT00443846|16966589|P2|Overall Study|Not vaccinated, no blood sample drawn|0
4928221|NCT00443846|16966590|P1|Overall Study|Not vaccinated, no blood sample drawn|1
4928222|NCT00443846|16966589|P2|Overall Study|Withdrawn due to intercurrent disease|0
4928223|NCT00443846|16966590|P1|Overall Study|Withdrawn due to intercurrent disease|1
4928224|NCT00443820|16966600|P4|Overall Study|Death|0
4928225|NCT00443820|16966601|P3|Overall Study|Death|1
4928226|NCT00443820|16966602|P2|Overall Study|Death|0
4928227|NCT00443820|16966603|P1|Overall Study|Death|0
4928228|NCT00443820|16966600|P4|Overall Study|Administrative problems|1
4928229|NCT00443820|16966601|P3|Overall Study|Administrative problems|0
4928230|NCT00443820|16966602|P2|Overall Study|Administrative problems|0
4928231|NCT00443820|16966603|P1|Overall Study|Administrative problems|0
4928232|NCT00443820|16966600|P4|Overall Study|Lost to Follow-up|5
4928233|NCT00443820|16966601|P3|Overall Study|Lost to Follow-up|6
4928234|NCT00443820|16966602|P2|Overall Study|Lost to Follow-up|8
4928235|NCT00443820|16966603|P1|Overall Study|Lost to Follow-up|9
4928236|NCT00443820|16966600|P4|Overall Study|Withdrawal by Subject|9
4928237|NCT00443820|16966601|P3|Overall Study|Withdrawal by Subject|8
4928238|NCT00443820|16966602|P2|Overall Study|Withdrawal by Subject|7
4928239|NCT00443820|16966603|P1|Overall Study|Withdrawal by Subject|6
4928240|NCT00443820|16966600|P4|Overall Study|Protocol Violation|1
4928241|NCT00443820|16966601|P3|Overall Study|Protocol Violation|2
4928242|NCT00443820|16966602|P2|Overall Study|Protocol Violation|1
4928243|NCT00443820|16966603|P1|Overall Study|Protocol Violation|2
4928244|NCT00443820|16966600|P4|Overall Study|Lack of Efficacy|1
4928245|NCT00443820|16966601|P3|Overall Study|Lack of Efficacy|1
4928246|NCT00443820|16966602|P2|Overall Study|Lack of Efficacy|2
4928247|NCT00443820|16966603|P1|Overall Study|Lack of Efficacy|3
4928248|NCT00443820|16966600|P4|Overall Study|Adverse Event|0
4928249|NCT00443820|16966601|P3|Overall Study|Adverse Event|0
4928250|NCT00443820|16966602|P2|Overall Study|Adverse Event|1
4928251|NCT00443820|16966603|P1|Overall Study|Adverse Event|1
4928252|NCT00443781|16966625|P1|Overall Study|PD/FAD not done|1
4928253|NCT00443781|16966625|P1|Overall Study|Insurance not covered|2
4928254|NCT00443781|16966625|P1|Overall Study|Investigator terminated participation|1
4928255|NCT00443781|16966625|P1|Overall Study|Unable to comply with study follow up|2
4928256|NCT00443781|16966625|P1|Overall Study|Withdrawal by Subject|6
4928257|NCT00443781|16966625|P1|Overall Study|Protocol Violation|1
4928258|NCT00443781|16966625|P1|Overall Study|Physician Decision|2
4928259|NCT00443781|16966625|P1|Overall Study|Lost to Follow-up|10
4928260|NCT00443755|16966631|P2|Overall Study|Withdrawal by Subject|1
4928261|NCT00443755|16966632|P1|Overall Study|Withdrawal by Subject|2
4928262|NCT00443729|16966666|P2|Overall Study|Withdrawal by Subject|1
4928263|NCT00443729|16966667|P1|Overall Study|Withdrawal by Subject|3
4928264|NCT00443729|16966666|P2|Overall Study|Protocol Violation|1
4928265|NCT00443729|16966667|P1|Overall Study|Protocol Violation|1
4928266|NCT00443729|16966666|P2|Overall Study|Physician Decision|1
4928267|NCT00443729|16966667|P1|Overall Study|Physician Decision|2
4928268|NCT00443729|16966666|P2|Overall Study|Lost to Follow-up|1
4928269|NCT00443729|16966667|P1|Overall Study|Lost to Follow-up|0
4928270|NCT00443729|16966666|P2|Overall Study|Lack of Efficacy|2
4928271|NCT00443729|16966667|P1|Overall Study|Lack of Efficacy|4
4928272|NCT00443729|16966666|P2|Overall Study|Never Treated|1
4928273|NCT00443729|16966667|P1|Overall Study|Never Treated|0
4928274|NCT00443703|16966715|P2|Overall Study|Progressive Disease|0
4928275|NCT00443703|16966716|P1|Overall Study|Progressive Disease|1
4928276|NCT00443703|16966715|P2|Overall Study|Withdrawal by Subject|6
4928277|NCT00443703|16966716|P1|Overall Study|Withdrawal by Subject|9
4928278|NCT00443703|16966715|P2|Overall Study|Protocol Violation|1
4928279|NCT00443703|16966716|P1|Overall Study|Protocol Violation|1
4928280|NCT00443703|16966715|P2|Overall Study|Physician Decision|2
4928281|NCT00443703|16966716|P1|Overall Study|Physician Decision|4
4928282|NCT00443703|16966715|P2|Overall Study|Lost to Follow-up|4
4928283|NCT00443703|16966716|P1|Overall Study|Lost to Follow-up|0
4928284|NCT00443703|16966715|P2|Overall Study|Lack of Efficacy|1
4928285|NCT00443703|16966716|P1|Overall Study|Lack of Efficacy|3
4928286|NCT00443703|16966715|P2|Overall Study|Adverse Event|3
4928287|NCT00443703|16966716|P1|Overall Study|Adverse Event|7
4928288|NCT00443703|16966715|P2|Overall Study|Never Treated|1
4928289|NCT00443703|16966716|P1|Overall Study|Never Treated|3
4928290|NCT00443651|16966768|P2|Overall Study|Pregnancy|1
4928291|NCT00443651|16966769|P1|Overall Study|Pregnancy|0
4928292|NCT00443651|16966768|P2|Overall Study|Physician Decision|4
4928293|NCT00443651|16966769|P1|Overall Study|Physician Decision|13
4928294|NCT00443651|16966768|P2|Overall Study|Patient's/Guardian's Decision|30
4928295|NCT00443651|16966769|P1|Overall Study|Patient's/Guardian's Decision|58
4928296|NCT00443651|16966768|P2|Overall Study|Lost to Follow-up|12
4928297|NCT00443651|16966769|P1|Overall Study|Lost to Follow-up|18
4928298|NCT00443651|16966768|P2|Overall Study|Adverse Event|6
4928299|NCT00443651|16966769|P1|Overall Study|Adverse Event|5
4928300|NCT00443651|16966768|P2|Overall Study|Death|5
4928301|NCT00443651|16966769|P1|Overall Study|Death|1
4928302|NCT00443599|16966789|P2|Overall Study|Cardiopulmonary bypass canceled|1
4928303|NCT00443599|16966790|P1|Overall Study|Cardiopulmonary bypass canceled|3
4928304|NCT00443599|16966789|P2|Overall Study|Death|1
4928305|NCT00443599|16966790|P1|Overall Study|Death|1
4928306|NCT00443599|16966789|P2|Overall Study|Physician Decision|1
4928307|NCT00443599|16966790|P1|Overall Study|Physician Decision|2
4928308|NCT00443560|16966824|P2|Overall Study|Multiple pregnancies or fetal demise|4
4928309|NCT00443560|16966825|P1|Overall Study|Multiple pregnancies or fetal demise|2
4928310|NCT00443560|16966824|P2|Overall Study|No intrathecal dose|26
4928311|NCT00443560|16966825|P1|Overall Study|No intrathecal dose|58
4928312|NCT00443534|16966860|P1|Overall Study|Enrolled, Not Treated|1
4928313|NCT00443534|16966860|P1|Overall Study|Other|10
4928314|NCT00443534|16966860|P1|Overall Study|Study Terminated by Sponsor|12
4928315|NCT00443534|16966860|P1|Overall Study|Withdrawal by Subject|8
4928316|NCT00443534|16966860|P1|Overall Study|Death|9
4928317|NCT00443534|16966860|P1|Overall Study|Adverse Event|16
4928318|NCT00443534|16966860|P1|Overall Study|Lack of Efficacy|67
4928319|NCT00443456|16966867|P1|Overall Study|Withdrawal by Subject|1
4928320|NCT00443456|16966867|P1|Overall Study|Move|1
4928321|NCT00443456|16966867|P1|Overall Study|Adverse Event|16
4928322|NCT00443430|16966902|P2|Overall Study|Adverse Event|1
4928323|NCT00443430|16966903|P1|Overall Study|Adverse Event|1
4928324|NCT00443430|16966902|P2|Overall Study|Lack of Efficacy|3
4928325|NCT00443430|16966903|P1|Overall Study|Lack of Efficacy|3
4928326|NCT00443261|16966917|P1|Overall Study|Death|1
4928327|NCT00443209|16966923|P2|Months 13 to 18 Treatment Period|Withdrawal by Subject|2
4928328|NCT00443209|16966924|P1|Months 13 to 18 Treatment Period|Withdrawal by Subject|7
4928329|NCT00443209|16966923|P2|Months 13 to 18 Treatment Period|Trial Terminated|43
4928330|NCT00443209|16966924|P1|Months 13 to 18 Treatment Period|Trial Terminated|87
4928331|NCT00443209|16966923|P2|Months 13 to 18 Treatment Period|Lost to Follow-up|2
4928332|NCT00443209|16966924|P1|Months 13 to 18 Treatment Period|Lost to Follow-up|2
4928333|NCT00443209|16966923|P2|Months 13 to 18 Treatment Period|Lack of Efficacy|0
4928334|NCT00443209|16966924|P1|Months 13 to 18 Treatment Period|Lack of Efficacy|1
4928335|NCT00443209|16966923|P2|Months 13 to 18 Treatment Period|Protocol Violation|0
4928336|NCT00443209|16966924|P1|Months 13 to 18 Treatment Period|Protocol Violation|1
4928337|NCT00443209|16966923|P2|Months 13 to 18 Treatment Period|Adverse Event|0
4928338|NCT00443209|16966924|P1|Months 13 to 18 Treatment Period|Adverse Event|1
4928339|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Not Treated|43
4928340|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Not Treated|71
4928341|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Missing|1
4928342|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Missing|2
4928343|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Withdrawal by Subject|34
4928344|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Withdrawal by Subject|95
4928345|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Trial Terminated|23
4928346|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Trial Terminated|43
4928347|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Pregnancy|4
4928348|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Pregnancy|3
4928349|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Physician Decision|4
4928350|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Physician Decision|8
4928351|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Lost to Follow-up|15
4928352|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Lost to Follow-up|36
4928353|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
4928354|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1
4928355|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Lack of Efficacy|11
4928356|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Lack of Efficacy|50
4928357|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Protocol Violation|7
4928358|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Protocol Violation|14
4928359|NCT00443209|16966923|P2|Months 1 to 12 Treatment Period|Adverse Event|11
4928360|NCT00443209|16966924|P1|Months 1 to 12 Treatment Period|Adverse Event|22
4928361|NCT00443118|16966941|P3|Overall Study|Withdrawal by Subject|0
4928362|NCT00443118|16966942|P2|Overall Study|Withdrawal by Subject|0
4928363|NCT00443118|16966943|P1|Overall Study|Withdrawal by Subject|1
4928364|NCT00443118|16966941|P3|Overall Study|unknown primary outcome|0
4928365|NCT00443118|16966942|P2|Overall Study|unknown primary outcome|1
4928366|NCT00443118|16966943|P1|Overall Study|unknown primary outcome|3
4928367|NCT00443053|16966992|P2|Overall Study|Physician Decision|4
4928368|NCT00443053|16966993|P1|Overall Study|Physician Decision|0
4928369|NCT00443053|16966992|P2|Overall Study|Other|4
4928370|NCT00443053|16966993|P1|Overall Study|Other|3
4928371|NCT00443053|16966992|P2|Overall Study|Noncompliance|1
4928372|NCT00443053|16966993|P1|Overall Study|Noncompliance|2
4928373|NCT00443053|16966992|P2|Overall Study|Did Not Meet Eligibility Criteria|0
4928374|NCT00443053|16966993|P1|Overall Study|Did Not Meet Eligibility Criteria|1
4928375|NCT00443053|16966992|P2|Overall Study|Lost to Follow-up|5
4928376|NCT00443053|16966993|P1|Overall Study|Lost to Follow-up|4
4928377|NCT00443053|16966992|P2|Overall Study|Withdrawal by Subject|18
4928378|NCT00443053|16966993|P1|Overall Study|Withdrawal by Subject|9
4928379|NCT00443053|16966992|P2|Overall Study|Adverse Event|1
4928380|NCT00443053|16966993|P1|Overall Study|Adverse Event|2
4928381|NCT00443040|16967014|P3|Overall Study|Converted to an open laparotomy|1
4928382|NCT00443040|16967015|P2|Overall Study|Converted to an open laparotomy|0
4928383|NCT00443040|16967016|P1|Overall Study|Converted to an open laparotomy|3
4928384|NCT00443040|16967014|P3|Overall Study|Withdrawal by Subject|0
4928385|NCT00443040|16967015|P2|Overall Study|Withdrawal by Subject|0
4928386|NCT00443040|16967016|P1|Overall Study|Withdrawal by Subject|1
4928387|NCT00442962|16967024|P1|Overall Study|Lost to Follow-up|7
4928388|NCT00442962|16967024|P1|Overall Study|Pregnancy|1
4928389|NCT00442936|16967042|P4|Overall Study|Protocol Violation|1
4928390|NCT00442936|16967043|P3|Overall Study|Protocol Violation|1
4928391|NCT00442936|16967044|P2|Overall Study|Protocol Violation|0
4928392|NCT00442936|16967045|P1|Overall Study|Protocol Violation|1
4928393|NCT00442897|16967093|P2|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3
4928394|NCT00442897|16967094|P1|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1
4928395|NCT00442897|16967093|P2|24 Weeks Follow-up (3 Centers)|Protocol Violation|1
4928396|NCT00442897|16967094|P1|24 Weeks Follow-up (3 Centers)|Protocol Violation|2
4928397|NCT00442897|16967093|P2|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
4928398|NCT00442897|16967094|P1|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2
4928399|NCT00442897|16967093|P2|24 Weeks Follow-up (3 Centers)|Adverse Event|0
4928400|NCT00442897|16967094|P1|24 Weeks Follow-up (3 Centers)|Adverse Event|1
4928401|NCT00442897|16967093|P2|Base Study (12 Week Follow-up)|Withdrawal by Subject|8
4928402|NCT00442897|16967094|P1|Base Study (12 Week Follow-up)|Withdrawal by Subject|9
4928403|NCT00442897|16967093|P2|Base Study (12 Week Follow-up)|Protocol Violation|3
4928404|NCT00442897|16967094|P1|Base Study (12 Week Follow-up)|Protocol Violation|7
4928405|NCT00442897|16967093|P2|Base Study (12 Week Follow-up)|Death|1
4928406|NCT00442897|16967094|P1|Base Study (12 Week Follow-up)|Death|0
4928407|NCT00442897|16967093|P2|Base Study (12 Week Follow-up)|Adverse Event|0
4928408|NCT00442897|16967094|P1|Base Study (12 Week Follow-up)|Adverse Event|1
4928409|NCT00442702|16967112|P2|Evaluation Period|Site closure|1
4928410|NCT00442702|16967113|P1|Evaluation Period|Site closure|0
4928411|NCT00442702|16967112|P2|Evaluation Period|Failure to return|0
4928412|NCT00442702|16967113|P1|Evaluation Period|Failure to return|1
4928413|NCT00442702|16967112|P2|Evaluation Period|Renal transplant|1
4928414|NCT00442702|16967113|P1|Evaluation Period|Renal transplant|0
4928415|NCT00442702|16967112|P2|Evaluation Period|Refused treatment|1
4928416|NCT00442702|16967113|P1|Evaluation Period|Refused treatment|1
4928417|NCT00442702|16967112|P2|Evaluation Period|Insufficient Therapeutic Response|0
4928418|NCT00442702|16967113|P1|Evaluation Period|Insufficient Therapeutic Response|1
4928419|NCT00442702|16967112|P2|Evaluation Period|Death|1
4928420|NCT00442702|16967113|P1|Evaluation Period|Death|1
4928421|NCT00442702|16967112|P2|Evaluation Period|Adverse Event|0
4928422|NCT00442702|16967113|P1|Evaluation Period|Adverse Event|1
4928423|NCT00442702|16967112|P2|Titration Period|Hospitalized in another hospital|0
4928424|NCT00442702|16967113|P1|Titration Period|Hospitalized in another hospital|1
4928425|NCT00442702|16967112|P2|Titration Period|Failure to return|0
4928426|NCT00442702|16967113|P1|Titration Period|Failure to return|1
4928427|NCT00442702|16967112|P2|Titration Period|Refused Treatment|1
4928428|NCT00442702|16967113|P1|Titration Period|Refused Treatment|4
4928429|NCT00442702|16967112|P2|Titration Period|Insufficient Therapeutic Response|0
4928430|NCT00442702|16967113|P1|Titration Period|Insufficient Therapeutic Response|1
4928431|NCT00442702|16967112|P2|Titration Period|Death|2
4928432|NCT00442702|16967113|P1|Titration Period|Death|3
4928433|NCT00442702|16967112|P2|Titration Period|Adverse Event|0
4928434|NCT00442702|16967113|P1|Titration Period|Adverse Event|2
4928435|NCT00442598|16967178|P3|Overall Study|Death|0
4928436|NCT00442598|16967179|P2|Overall Study|Death|1
4928437|NCT00442598|16967180|P1|Overall Study|Death|0
4928438|NCT00442598|16967178|P3|Overall Study|Reduced creatinine clearance|0
4928439|NCT00442598|16967179|P2|Overall Study|Reduced creatinine clearance|0
4928440|NCT00442598|16967180|P1|Overall Study|Reduced creatinine clearance|1
4928441|NCT00442598|16967178|P3|Overall Study|CA125 progression|0
4928442|NCT00442598|16967179|P2|Overall Study|CA125 progression|1
4928443|NCT00442598|16967180|P1|Overall Study|CA125 progression|0
4928444|NCT00442598|16967178|P3|Overall Study|Clinical deterioration|0
4928445|NCT00442598|16967179|P2|Overall Study|Clinical deterioration|2
4928446|NCT00442598|16967180|P1|Overall Study|Clinical deterioration|1
4928447|NCT00442598|16967178|P3|Overall Study|Tumor progression|0
4928448|NCT00442598|16967179|P2|Overall Study|Tumor progression|4
4928449|NCT00442598|16967180|P1|Overall Study|Tumor progression|3
4928450|NCT00442598|16967178|P3|Overall Study|Adverse Event|0
4928451|NCT00442598|16967179|P2|Overall Study|Adverse Event|0
4928452|NCT00442598|16967180|P1|Overall Study|Adverse Event|1
4928453|NCT00442572|16967198|P2|Overall Study|Withdrawal by Subject|1
4928454|NCT00442572|16967199|P1|Overall Study|Withdrawal by Subject|0
4928455|NCT00442572|16967198|P2|Overall Study|Lost to Follow-up|1
4928456|NCT00442572|16967199|P1|Overall Study|Lost to Follow-up|0
4928457|NCT00442572|16967198|P2|Overall Study|Relapse|1
4928458|NCT00442572|16967199|P1|Overall Study|Relapse|8
4928459|NCT00442559|16967239|P2|Overall Study|Withdrawal by Subject|0
4928460|NCT00442559|16967240|P1|Overall Study|Withdrawal by Subject|1
4928461|NCT00442559|16967239|P2|Overall Study|Protocol Violation|1
4928462|NCT00442559|16967240|P1|Overall Study|Protocol Violation|1
4928463|NCT00442559|16967239|P2|Overall Study|Lost to Follow-up|34
4928464|NCT00442559|16967240|P1|Overall Study|Lost to Follow-up|32
4928465|NCT00442546|16967255|P3|Overall Study|Randomized But Not Treated|6
4928466|NCT00442546|16967256|P2|Overall Study|Randomized But Not Treated|4
4928467|NCT00442546|16967257|P1|Overall Study|Randomized But Not Treated|5
4928468|NCT00442546|16967255|P3|Overall Study|Withdrawal by Subject|7
4928469|NCT00442546|16967256|P2|Overall Study|Withdrawal by Subject|5
4928470|NCT00442546|16967257|P1|Overall Study|Withdrawal by Subject|5
4928471|NCT00442546|16967255|P3|Overall Study|Other|6
4928472|NCT00442546|16967256|P2|Overall Study|Other|9
4928473|NCT00442546|16967257|P1|Overall Study|Other|4
4928474|NCT00442546|16967255|P3|Overall Study|Lost to Follow-up|1
4928475|NCT00442546|16967256|P2|Overall Study|Lost to Follow-up|2
4928476|NCT00442546|16967257|P1|Overall Study|Lost to Follow-up|1
4928477|NCT00442546|16967255|P3|Overall Study|Adverse Event|13
4928478|NCT00442546|16967256|P2|Overall Study|Adverse Event|17
4928479|NCT00442546|16967257|P1|Overall Study|Adverse Event|11
4928480|NCT00442468|16967386|P1|Overall Study|Did not complete all study procedures|88
4928481|NCT00442468|16967386|P1|Overall Study|Withdrawal by Subject|91
4928482|NCT00442468|16967386|P1|Overall Study|Adverse Event|4
4928483|NCT00442416|16967416|P2|Overall Study|Administrative/Other|33
4928484|NCT00442416|16967417|P1|Overall Study|Administrative/Other|27
4928485|NCT00442416|16967416|P2|Overall Study|Withdrew consent|2
4928486|NCT00442416|16967417|P1|Overall Study|Withdrew consent|1
4928487|NCT00442416|16967416|P2|Overall Study|Protocol Violation|3
4928488|NCT00442416|16967417|P1|Overall Study|Protocol Violation|2
4928489|NCT00442416|16967416|P2|Overall Study|Lack of Efficacy|0
4928490|NCT00442416|16967417|P1|Overall Study|Lack of Efficacy|2
4928491|NCT00442416|16967416|P2|Overall Study|Death|0
4928492|NCT00442416|16967417|P1|Overall Study|Death|1
4928493|NCT00442416|16967416|P2|Overall Study|Adverse Event|1
4928494|NCT00442416|16967417|P1|Overall Study|Adverse Event|4
4928495|NCT00442351|16967456|P2|Overall Study|Other|1
4928496|NCT00442351|16967457|P1|Overall Study|Other|0
4928497|NCT00442351|16967456|P2|Overall Study|Did not meet protocol eligibility|0
4928498|NCT00442351|16967457|P1|Overall Study|Did not meet protocol eligibility|1
4928499|NCT00442351|16967456|P2|Overall Study|Administrative|5
4928500|NCT00442351|16967457|P1|Overall Study|Administrative|6
4928501|NCT00442286|16967479|P2|Overall Study|Patient Injury|0
4928502|NCT00442286|16967480|P1|Overall Study|Patient Injury|1
4928503|NCT00442286|16967479|P2|Overall Study|System explanted|0
4928504|NCT00442286|16967480|P1|Overall Study|System explanted|1
4928505|NCT00442286|16967479|P2|Overall Study|Withdrawal by Subject|0
4928506|NCT00442286|16967480|P1|Overall Study|Withdrawal by Subject|2
4928507|NCT00442286|16967479|P2|Overall Study|Lost to Follow-up|0
4928508|NCT00442286|16967480|P1|Overall Study|Lost to Follow-up|1
4928509|NCT00442286|16967479|P2|Overall Study|Death|2
4928510|NCT00442286|16967480|P1|Overall Study|Death|2
4928511|NCT00442117|16967542|P2|Overall Study|Met Withdrawal Criteria|1
4928512|NCT00442117|16967543|P1|Overall Study|Met Withdrawal Criteria|2
4928513|NCT00442117|16967542|P2|Overall Study|Non compliance with protocol|5
4928514|NCT00442117|16967543|P1|Overall Study|Non compliance with protocol|3
4928515|NCT00442117|16967542|P2|Overall Study|Major Deviation|20
4928516|NCT00442117|16967543|P1|Overall Study|Major Deviation|25
4928517|NCT00442117|16967542|P2|Overall Study|Withdrawal by Subject|2
4928518|NCT00442117|16967543|P1|Overall Study|Withdrawal by Subject|2
4928519|NCT00442117|16967542|P2|Overall Study|Lost to Follow-up|2
4928520|NCT00442117|16967543|P1|Overall Study|Lost to Follow-up|1
4928521|NCT00442117|16967542|P2|Overall Study|Lack of Efficacy|6
4928522|NCT00442117|16967543|P1|Overall Study|Lack of Efficacy|2
4928523|NCT00442117|16967542|P2|Overall Study|Adverse Event|2
4928524|NCT00442117|16967543|P1|Overall Study|Adverse Event|3
4928525|NCT00441974|16967574|P1|Overall Study|Protocol Violation|7
4928526|NCT00441974|16967574|P1|Overall Study|Lost to Follow-up|80
4928527|NCT00441974|16967574|P1|Overall Study|Consent Withdrawn|35
4928528|NCT00441974|16967574|P1|Overall Study|Adverse Event|6
4928529|NCT00441792|16967621|P2|Overall Study|Lost to Follow-up|2
4928530|NCT00441792|16967622|P1|Overall Study|Lost to Follow-up|0
4928531|NCT00441727|16967662|P3|Overall Study|Various reason specified|5
4928532|NCT00441727|16967663|P2|Overall Study|Various reason specified|8
4928533|NCT00441727|16967664|P1|Overall Study|Various reason specified|6
4928534|NCT00441727|16967662|P3|Overall Study|Safety Reasons|3
4928535|NCT00441727|16967663|P2|Overall Study|Safety Reasons|1
4928536|NCT00441727|16967664|P1|Overall Study|Safety Reasons|3
4928537|NCT00441727|16967662|P3|Overall Study|Lost to Follow-up|5
4928538|NCT00441727|16967663|P2|Overall Study|Lost to Follow-up|6
4928539|NCT00441727|16967664|P1|Overall Study|Lost to Follow-up|5
4928540|NCT00441727|16967662|P3|Overall Study|Withdrawal by Subject|47
4928541|NCT00441727|16967663|P2|Overall Study|Withdrawal by Subject|34
4928542|NCT00441727|16967664|P1|Overall Study|Withdrawal by Subject|40
4928543|NCT00441727|16967662|P3|Overall Study|Lack of Efficacy|48
4928544|NCT00441727|16967663|P2|Overall Study|Lack of Efficacy|8
4928545|NCT00441727|16967664|P1|Overall Study|Lack of Efficacy|7
4928546|NCT00441727|16967662|P3|Overall Study|Adverse Event|28
4928547|NCT00441727|16967663|P2|Overall Study|Adverse Event|33
4928548|NCT00441727|16967664|P1|Overall Study|Adverse Event|26
4928549|NCT00441727|16967662|P3|Overall Study|Protocol Violation|32
4928550|NCT00441727|16967663|P2|Overall Study|Protocol Violation|28
4928551|NCT00441727|16967664|P1|Overall Study|Protocol Violation|19
4928552|NCT00441701|16967697|P10|Overall Study|Withdrawal by Subject|0
4928553|NCT00441701|16967698|P9|Overall Study|Withdrawal by Subject|0
4928554|NCT00441701|16967699|P8|Overall Study|Withdrawal by Subject|0
4928555|NCT00441701|16967700|P7|Overall Study|Withdrawal by Subject|0
4928556|NCT00441701|16967701|P6|Overall Study|Withdrawal by Subject|0
4928557|NCT00441701|16967702|P5|Overall Study|Withdrawal by Subject|0
4928558|NCT00441701|16967703|P4|Overall Study|Withdrawal by Subject|1
4928559|NCT00441701|16967704|P3|Overall Study|Withdrawal by Subject|1
4928560|NCT00441701|16967705|P2|Overall Study|Withdrawal by Subject|2
4928561|NCT00441701|16967706|P1|Overall Study|Withdrawal by Subject|0
4928562|NCT00441701|16967697|P10|Overall Study|Lack of Efficacy|0
4928563|NCT00441701|16967698|P9|Overall Study|Lack of Efficacy|0
4928564|NCT00441701|16967699|P8|Overall Study|Lack of Efficacy|0
4928565|NCT00441701|16967700|P7|Overall Study|Lack of Efficacy|0
4928566|NCT00441701|16967701|P6|Overall Study|Lack of Efficacy|1
4928567|NCT00441701|16967702|P5|Overall Study|Lack of Efficacy|0
4928568|NCT00441701|16967703|P4|Overall Study|Lack of Efficacy|2
4928569|NCT00441701|16967704|P3|Overall Study|Lack of Efficacy|2
4928570|NCT00441701|16967705|P2|Overall Study|Lack of Efficacy|0
4928571|NCT00441701|16967706|P1|Overall Study|Lack of Efficacy|2
4928572|NCT00441701|16967697|P10|Overall Study|Adverse Event|0
4928573|NCT00441701|16967698|P9|Overall Study|Adverse Event|0
4928574|NCT00441701|16967699|P8|Overall Study|Adverse Event|0
4928575|NCT00441701|16967700|P7|Overall Study|Adverse Event|0
4928576|NCT00441701|16967701|P6|Overall Study|Adverse Event|2
4928577|NCT00441701|16967702|P5|Overall Study|Adverse Event|2
4928578|NCT00441701|16967703|P4|Overall Study|Adverse Event|0
4928579|NCT00441701|16967704|P3|Overall Study|Adverse Event|1
4928580|NCT00441701|16967705|P2|Overall Study|Adverse Event|2
4928581|NCT00441701|16967706|P1|Overall Study|Adverse Event|3
4928582|NCT00441584|16967788|P1|Overall Study|Failure to meet eligibility criteria|3
4928583|NCT00441584|16967788|P1|Overall Study|Lost to Follow-up|4
4928584|NCT00441584|16967788|P1|Overall Study|Protocol Violation|5
4928585|NCT00441584|16967788|P1|Overall Study|Adverse Event|6
4928586|NCT00441584|16967788|P1|Overall Study|Withdrawal by Subject|8
4928587|NCT00441584|16967788|P1|Overall Study|Lack of Efficacy|79
4928588|NCT00441545|16967796|P2|Second Intervention|Subject moved|1
4928589|NCT00441545|16967797|P1|Second Intervention|Subject moved|0
4928590|NCT00441545|16967796|P2|Second Intervention|Subject exceeded safety criteria|0
4928591|NCT00441545|16967797|P1|Second Intervention|Subject exceeded safety criteria|1
4928592|NCT00441545|16967796|P2|Second Intervention|Lack of Efficacy|1
4928593|NCT00441545|16967797|P1|Second Intervention|Lack of Efficacy|0
4928594|NCT00441545|16967796|P2|Second Intervention|Kidney Transplant|1
4928595|NCT00441545|16967797|P1|Second Intervention|Kidney Transplant|1
4928596|NCT00441545|16967796|P2|Second Intervention|Withdrawal by Subject|1
4928597|NCT00441545|16967797|P1|Second Intervention|Withdrawal by Subject|1
4928598|NCT00441545|16967796|P2|Second Intervention|Protocol Violation|1
4928599|NCT00441545|16967797|P1|Second Intervention|Protocol Violation|4
4928600|NCT00441545|16967796|P2|Second Intervention|Adverse Event|2
4928601|NCT00441545|16967797|P1|Second Intervention|Adverse Event|5
4928602|NCT00441545|16967796|P2|First Intervention|Sponsor's request|0
4928603|NCT00441545|16967797|P1|First Intervention|Sponsor's request|1
4928604|NCT00441545|16967796|P2|First Intervention|Site error|0
4928605|NCT00441545|16967797|P1|First Intervention|Site error|1
4928606|NCT00441545|16967796|P2|First Intervention|Extended hospitalization|0
4928607|NCT00441545|16967797|P1|First Intervention|Extended hospitalization|1
4928608|NCT00441545|16967796|P2|First Intervention|Subject met an exclusionary criteria|0
4928609|NCT00441545|16967797|P1|First Intervention|Subject met an exclusionary criteria|1
4928610|NCT00441545|16967796|P2|First Intervention|Subject exceeded safety criteria|1
4928611|NCT00441545|16967797|P1|First Intervention|Subject exceeded safety criteria|0
4928612|NCT00441545|16967796|P2|First Intervention|Lack of Efficacy|0
4928613|NCT00441545|16967797|P1|First Intervention|Lack of Efficacy|2
4928614|NCT00441545|16967796|P2|First Intervention|Kidney transplant|1
4928615|NCT00441545|16967797|P1|First Intervention|Kidney transplant|1
4928616|NCT00441545|16967796|P2|First Intervention|Withdrawal by Subject|3
4928617|NCT00441545|16967797|P1|First Intervention|Withdrawal by Subject|3
4928618|NCT00441545|16967796|P2|First Intervention|Protocol Violation|2
4928619|NCT00441545|16967797|P1|First Intervention|Protocol Violation|2
4928620|NCT00441545|16967796|P2|First Intervention|Adverse Event|5
4928621|NCT00441545|16967797|P1|First Intervention|Adverse Event|6
4928622|NCT00441480|16967811|P2|Overall Study|Withdrawal by Subject|3
4928623|NCT00441480|16967812|P1|Overall Study|Withdrawal by Subject|2
4928624|NCT00441480|16967811|P2|Overall Study|Protocol Violation|1
4928625|NCT00441480|16967812|P1|Overall Study|Protocol Violation|1
4928626|NCT00441467|16967844|P1|Overall Study|Progressive disease|9
4928627|NCT00441467|16967844|P1|Overall Study|Withdrawal by Subject|3
4928628|NCT00441467|16967844|P1|Overall Study|Adverse Event|6
4928629|NCT00441441|16967852|P2|Overall Study|Other|3
4928630|NCT00441441|16967853|P1|Overall Study|Other|3
4928631|NCT00441441|16967852|P2|Overall Study|Withdrawal by Subject|2
4928632|NCT00441441|16967853|P1|Overall Study|Withdrawal by Subject|1
4928633|NCT00441441|16967852|P2|Overall Study|Exacerbation of asthma|2
4928634|NCT00441441|16967853|P1|Overall Study|Exacerbation of asthma|1
4928635|NCT00441441|16967852|P2|Overall Study|Protocol Violation|6
4928636|NCT00441441|16967853|P1|Overall Study|Protocol Violation|4
4928637|NCT00441441|16967852|P2|Overall Study|Adverse Event|1
4928638|NCT00441441|16967853|P1|Overall Study|Adverse Event|2
4928639|NCT00441363|16967913|P2|Overall Study|Other|0
4928640|NCT00441363|16967914|P1|Overall Study|Other|2
4928641|NCT00441363|16967913|P2|Overall Study|Lost to Follow-up|2
4928642|NCT00441363|16967914|P1|Overall Study|Lost to Follow-up|2
4928643|NCT00441363|16967913|P2|Overall Study|Physician Decision|7
4928644|NCT00441363|16967914|P1|Overall Study|Physician Decision|6
4928645|NCT00441363|16967913|P2|Overall Study|Withdrawal by Subject|4
4928646|NCT00441363|16967914|P1|Overall Study|Withdrawal by Subject|3
4928647|NCT00441363|16967913|P2|Overall Study|Adverse Event|2
4928648|NCT00441363|16967914|P1|Overall Study|Adverse Event|4
4928649|NCT00441337|16967926|P4|Overall Study|Did not meet inclusion criteria|0
4928650|NCT00441337|16967927|P3|Overall Study|Did not meet inclusion criteria|1
4928651|NCT00441337|16967928|P2|Overall Study|Did not meet inclusion criteria|0
4928652|NCT00441337|16967929|P1|Overall Study|Did not meet inclusion criteria|0
4928653|NCT00441337|16967926|P4|Overall Study|Sponsor Decision|2
4928654|NCT00441337|16967927|P3|Overall Study|Sponsor Decision|1
4928655|NCT00441337|16967928|P2|Overall Study|Sponsor Decision|0
4928656|NCT00441337|16967929|P1|Overall Study|Sponsor Decision|0
4928657|NCT00441337|16967926|P4|Overall Study|Lost to Follow-up|1
4928658|NCT00441337|16967927|P3|Overall Study|Lost to Follow-up|0
4928659|NCT00441337|16967928|P2|Overall Study|Lost to Follow-up|0
4928660|NCT00441337|16967929|P1|Overall Study|Lost to Follow-up|0
4928661|NCT00441337|16967926|P4|Overall Study|Disease Progression|18
4928662|NCT00441337|16967927|P3|Overall Study|Disease Progression|4
4928663|NCT00441337|16967928|P2|Overall Study|Disease Progression|6
4928664|NCT00441337|16967929|P1|Overall Study|Disease Progression|6
4928665|NCT00441272|16968042|P2|Overall Study|Study terminated prior to enrollment|25
4928666|NCT00441272|16968043|P1|Overall Study|Study terminated prior to enrollment|25
4928667|NCT00441168|16968070|P2|Follow-up Period|Other|3
4928668|NCT00441168|16968071|P1|Follow-up Period|Other|1
4928669|NCT00441168|16968070|P2|Follow-up Period|Withdrawal by Subject|0
4928670|NCT00441168|16968071|P1|Follow-up Period|Withdrawal by Subject|3
4928671|NCT00441168|16968070|P2|Follow-up Period|Lost to Follow-up|6
4928672|NCT00441168|16968071|P1|Follow-up Period|Lost to Follow-up|5
4928673|NCT00441168|16968070|P2|Follow-up Period|Death|0
4928674|NCT00441168|16968071|P1|Follow-up Period|Death|3
4928675|NCT00441168|16968070|P2|Treatment Period|refractory disease|0
4928676|NCT00441168|16968071|P1|Treatment Period|refractory disease|1
4928677|NCT00441168|16968070|P2|Treatment Period|qualified for stem-cell transplantation|0
4928678|NCT00441168|16968071|P1|Treatment Period|qualified for stem-cell transplantation|3
4928679|NCT00441168|16968070|P2|Treatment Period|Withdrawal by Subject|0
4928680|NCT00441168|16968071|P1|Treatment Period|Withdrawal by Subject|3
4928681|NCT00441168|16968070|P2|Treatment Period|Lost to Follow-up|1
4928682|NCT00441168|16968071|P1|Treatment Period|Lost to Follow-up|0
4928683|NCT00441168|16968070|P2|Treatment Period|Protocol Violation|1
4928684|NCT00441168|16968071|P1|Treatment Period|Protocol Violation|0
4928685|NCT00441168|16968070|P2|Treatment Period|Progressive Disease|2
4928686|NCT00441168|16968071|P1|Treatment Period|Progressive Disease|0
4928687|NCT00441168|16968070|P2|Treatment Period|Adverse Event|2
4928688|NCT00441168|16968071|P1|Treatment Period|Adverse Event|1
4928689|NCT00441168|16968070|P2|Treatment Period|Death|0
4928690|NCT00441168|16968071|P1|Treatment Period|Death|3
4928691|NCT00441142|16968085|P4|Overall Study|Death|1
4928692|NCT00441142|16968086|P3|Overall Study|Death|0
4928693|NCT00441142|16968087|P2|Overall Study|Death|0
4928694|NCT00441142|16968088|P1|Overall Study|Death|0
4928695|NCT00441142|16968085|P4|Overall Study|Physician Decision|1
4928696|NCT00441142|16968086|P3|Overall Study|Physician Decision|0
4928697|NCT00441142|16968087|P2|Overall Study|Physician Decision|1
4928698|NCT00441142|16968088|P1|Overall Study|Physician Decision|0
4928699|NCT00441142|16968085|P4|Overall Study|Patient still receiving active study tx|2
4928700|NCT00441142|16968086|P3|Overall Study|Patient still receiving active study tx|0
4928701|NCT00441142|16968087|P2|Overall Study|Patient still receiving active study tx|0
4928702|NCT00441142|16968088|P1|Overall Study|Patient still receiving active study tx|1
4928703|NCT00441142|16968085|P4|Overall Study|Withdrawal by Subject|10
4928704|NCT00441142|16968086|P3|Overall Study|Withdrawal by Subject|2
4928705|NCT00441142|16968087|P2|Overall Study|Withdrawal by Subject|0
4928706|NCT00441142|16968088|P1|Overall Study|Withdrawal by Subject|0
4928707|NCT00441142|16968085|P4|Overall Study|Lack of Efficacy|32
4928708|NCT00441142|16968086|P3|Overall Study|Lack of Efficacy|17
4928709|NCT00441142|16968087|P2|Overall Study|Lack of Efficacy|3
4928710|NCT00441142|16968088|P1|Overall Study|Lack of Efficacy|3
4928711|NCT00441142|16968085|P4|Overall Study|Adverse Event|22
4928712|NCT00441142|16968086|P3|Overall Study|Adverse Event|3
4928713|NCT00441142|16968087|P2|Overall Study|Adverse Event|3
4928714|NCT00441142|16968088|P1|Overall Study|Adverse Event|2
4928715|NCT00441129|16968110|P2|Overall Study|Withdrawal by Subject|14
4928716|NCT00441129|16968111|P1|Overall Study|Withdrawal by Subject|6
4928717|NCT00441116|16968123|P2|Overall Study|Did not meet Eligibility Criteria|1
4928718|NCT00441116|16968124|P1|Overall Study|Did not meet Eligibility Criteria|1
4928719|NCT00441116|16968123|P2|Overall Study|Withdrawal by Subject|0
4928720|NCT00441116|16968124|P1|Overall Study|Withdrawal by Subject|1
4928721|NCT00441116|16968123|P2|Overall Study|Adverse Event|1
4928722|NCT00441116|16968124|P1|Overall Study|Adverse Event|1
4928723|NCT00441103|16968192|P2|Overall Study|Participant decided to stop|1
4928724|NCT00441103|16968193|P1|Overall Study|Participant decided to stop|0
4928725|NCT00441103|16968192|P2|Overall Study|Participant's reason|1
4928726|NCT00441103|16968193|P1|Overall Study|Participant's reason|0
4928727|NCT00441103|16968192|P2|Overall Study|Participant decided to withdraw|0
4928728|NCT00441103|16968193|P1|Overall Study|Participant decided to withdraw|1
4928729|NCT00441103|16968192|P2|Overall Study|Non-compliant|1
4928730|NCT00441103|16968193|P1|Overall Study|Non-compliant|0
4928731|NCT00441103|16968192|P2|Overall Study|Inclusion criteria absent|0
4928732|NCT00441103|16968193|P1|Overall Study|Inclusion criteria absent|1
4928733|NCT00441103|16968192|P2|Overall Study|Participant refused MRI|0
4928734|NCT00441103|16968193|P1|Overall Study|Participant refused MRI|1
4928735|NCT00441103|16968192|P2|Overall Study|Participant unable to use Rebiject II|0
4928736|NCT00441103|16968193|P1|Overall Study|Participant unable to use Rebiject II|1
4928737|NCT00441103|16968192|P2|Overall Study|Protocol Violation|0
4928738|NCT00441103|16968193|P1|Overall Study|Protocol Violation|1
4928739|NCT00441103|16968192|P2|Overall Study|Lost to Follow-up|0
4928740|NCT00441103|16968193|P1|Overall Study|Lost to Follow-up|1
4928741|NCT00441103|16968192|P2|Overall Study|Disease Progression|0
4928742|NCT00441103|16968193|P1|Overall Study|Disease Progression|2
4928743|NCT00441103|16968192|P2|Overall Study|Death|0
4928744|NCT00441103|16968193|P1|Overall Study|Death|1
4928745|NCT00441103|16968192|P2|Overall Study|Adverse Event|1
4928746|NCT00441103|16968193|P1|Overall Study|Adverse Event|2
4928747|NCT00441090|16968209|P5|Overall Study|Lack of Efficacy|0
4928748|NCT00441090|16968210|P4|Overall Study|Lack of Efficacy|0
4928749|NCT00441090|16968211|P3|Overall Study|Lack of Efficacy|0
4928750|NCT00441090|16968212|P2|Overall Study|Lack of Efficacy|0
4928751|NCT00441090|16968213|P1|Overall Study|Lack of Efficacy|1
4928752|NCT00441090|16968209|P5|Overall Study|Withdrawal by Subject|0
4928753|NCT00441090|16968210|P4|Overall Study|Withdrawal by Subject|0
4928754|NCT00441090|16968211|P3|Overall Study|Withdrawal by Subject|1
4928755|NCT00441090|16968212|P2|Overall Study|Withdrawal by Subject|0
4928756|NCT00441090|16968213|P1|Overall Study|Withdrawal by Subject|1
4928757|NCT00441090|16968209|P5|Overall Study|Platelet increase;more than 500,000 mm^3|0
4928758|NCT00441090|16968210|P4|Overall Study|Platelet increase;more than 500,000 mm^3|2
4928759|NCT00441090|16968211|P3|Overall Study|Platelet increase;more than 500,000 mm^3|0
4928760|NCT00441090|16968212|P2|Overall Study|Platelet increase;more than 500,000 mm^3|0
4928761|NCT00441090|16968213|P1|Overall Study|Platelet increase;more than 500,000 mm^3|0
4928762|NCT00441090|16968209|P5|Overall Study|Adverse Event|0
4928763|NCT00441090|16968210|P4|Overall Study|Adverse Event|0
4928764|NCT00441090|16968211|P3|Overall Study|Adverse Event|1
4928765|NCT00441090|16968212|P2|Overall Study|Adverse Event|1
4928766|NCT00441090|16968213|P1|Overall Study|Adverse Event|0
4928767|NCT00441064|16968257|P2|Overall Study|Patient withdrew consent|2
4928768|NCT00441064|16968258|P1|Overall Study|Patient withdrew consent|5
4928769|NCT00441064|16968257|P2|Overall Study|Protocol Deviation|2
4928770|NCT00441064|16968258|P1|Overall Study|Protocol Deviation|3
4928771|NCT00441064|16968257|P2|Overall Study|Unsatisfactory therapeutic effect|0
4928772|NCT00441064|16968258|P1|Overall Study|Unsatisfactory therapeutic effect|1
4928773|NCT00441064|16968257|P2|Overall Study|Abnormal test procedure results|1
4928774|NCT00441064|16968258|P1|Overall Study|Abnormal test procedure results|0
4928775|NCT00441064|16968257|P2|Overall Study|Abnormal laboratory values|2
4928776|NCT00441064|16968258|P1|Overall Study|Abnormal laboratory values|0
4928777|NCT00441064|16968257|P2|Overall Study|Adverse Event|0
4928778|NCT00441064|16968258|P1|Overall Study|Adverse Event|1
4928779|NCT00441012|16968270|P2|Overall Study|Subject Randomized but Not Vaccinated|0
4928780|NCT00441012|16968271|P1|Overall Study|Subject Randomized but Not Vaccinated|1
4928781|NCT00441012|16968270|P2|Overall Study|Withdrawal by Subject|0
4928782|NCT00441012|16968271|P1|Overall Study|Withdrawal by Subject|4
4928783|NCT00441012|16968270|P2|Overall Study|Protocol Violation|9
4928784|NCT00441012|16968271|P1|Overall Study|Protocol Violation|10
4928785|NCT00441012|16968270|P2|Overall Study|Lost to Follow-up|3
4928786|NCT00441012|16968271|P1|Overall Study|Lost to Follow-up|3
4928787|NCT00441012|16968270|P2|Overall Study|Adverse Event|1
4928788|NCT00441012|16968271|P1|Overall Study|Adverse Event|0
4928789|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Participant Remained in Cuba|1
4928790|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4928791|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4928792|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4928793|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Participant Remained in Cuba|0
4928794|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Physician Decision|1
4928795|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Physician Decision|0
4928796|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Physician Decision|0
4928797|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Physician Decision|0
4928798|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Physician Decision|0
4928799|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Other|0
4928800|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Other|1
4928801|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Other|0
4928802|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Other|0
4928803|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Other|0
4928804|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
4928805|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Sponsor Terminated Site|3
4928806|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
4928807|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
4928808|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Sponsor Terminated Site|0
4928809|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Sponsor Request|1
4928810|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Sponsor Request|1
4928811|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Sponsor Request|0
4928812|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Sponsor Request|0
4928813|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Sponsor Request|0
4928814|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Participant Moved|1
4928815|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Participant Moved|1
4928816|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Participant Moved|0
4928817|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Participant Moved|0
4928818|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Participant Moved|0
4928819|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Pregnancy|0
4928820|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Pregnancy|3
4928821|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Pregnancy|0
4928822|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Pregnancy|0
4928823|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Pregnancy|0
4928824|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Withdrawal by Subject|3
4928825|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Withdrawal by Subject|4
4928826|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Withdrawal by Subject|0
4928827|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Withdrawal by Subject|0
4928828|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Withdrawal by Subject|0
4928829|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Protocol Violation|0
4928830|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Protocol Violation|1
4928831|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Protocol Violation|0
4928832|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Protocol Violation|0
4928833|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Protocol Violation|0
4928834|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Lost to Follow-up|9
4928835|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Lost to Follow-up|9
4928836|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Lost to Follow-up|0
4928837|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Lost to Follow-up|0
4928838|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Lost to Follow-up|0
4928839|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Non-compliance|1
4928840|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Non-compliance|1
4928841|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Non-compliance|0
4928842|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Non-compliance|0
4928843|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Non-compliance|0
4928844|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2
4928845|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3
4928846|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
4928847|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
4928848|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0
4929005|NCT00440557|16968405|P3|Overall Study|Adverse Event|5
4928849|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
4928850|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1
4928851|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
4928852|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
4928853|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0
4928854|NCT00440947|16968285|P5|Optional 60-Week Extension Phase|Adverse Event|3
4928855|NCT00440947|16968286|P4|Optional 60-Week Extension Phase|Adverse Event|1
4928856|NCT00440947|16968287|P3|Optional 60-Week Extension Phase|Adverse Event|0
4928857|NCT00440947|16968288|P2|Optional 60-Week Extension Phase|Adverse Event|0
4928858|NCT00440947|16968289|P1|Optional 60-Week Extension Phase|Adverse Event|0
4928859|NCT00440947|16968285|P5|48-Week Randomization Phase|Physician Decision|0
4928860|NCT00440947|16968286|P4|48-Week Randomization Phase|Physician Decision|0
4928861|NCT00440947|16968287|P3|48-Week Randomization Phase|Physician Decision|0
4928862|NCT00440947|16968288|P2|48-Week Randomization Phase|Physician Decision|2
4928863|NCT00440947|16968289|P1|48-Week Randomization Phase|Physician Decision|0
4928864|NCT00440947|16968285|P5|48-Week Randomization Phase|Trying to Get Pregnant|0
4928865|NCT00440947|16968286|P4|48-Week Randomization Phase|Trying to Get Pregnant|0
4928866|NCT00440947|16968287|P3|48-Week Randomization Phase|Trying to Get Pregnant|0
4928867|NCT00440947|16968288|P2|48-Week Randomization Phase|Trying to Get Pregnant|1
4928868|NCT00440947|16968289|P1|48-Week Randomization Phase|Trying to Get Pregnant|0
4928869|NCT00440947|16968285|P5|48-Week Randomization Phase|Incarceration|0
4928870|NCT00440947|16968286|P4|48-Week Randomization Phase|Incarceration|0
4928871|NCT00440947|16968287|P3|48-Week Randomization Phase|Incarceration|0
4928872|NCT00440947|16968288|P2|48-Week Randomization Phase|Incarceration|3
4928873|NCT00440947|16968289|P1|48-Week Randomization Phase|Incarceration|0
4928874|NCT00440947|16968285|P5|48-Week Randomization Phase|Pregnancy|0
4928875|NCT00440947|16968286|P4|48-Week Randomization Phase|Pregnancy|0
4928876|NCT00440947|16968287|P3|48-Week Randomization Phase|Pregnancy|1
4928877|NCT00440947|16968288|P2|48-Week Randomization Phase|Pregnancy|0
4928878|NCT00440947|16968289|P1|48-Week Randomization Phase|Pregnancy|0
4928879|NCT00440947|16968285|P5|48-Week Randomization Phase|Withdrawal by Subject|0
4928880|NCT00440947|16968286|P4|48-Week Randomization Phase|Withdrawal by Subject|0
4928881|NCT00440947|16968287|P3|48-Week Randomization Phase|Withdrawal by Subject|4
4928882|NCT00440947|16968288|P2|48-Week Randomization Phase|Withdrawal by Subject|2
4928883|NCT00440947|16968289|P1|48-Week Randomization Phase|Withdrawal by Subject|0
4928884|NCT00440947|16968285|P5|48-Week Randomization Phase|Protocol Violation|0
4928885|NCT00440947|16968286|P4|48-Week Randomization Phase|Protocol Violation|0
4928886|NCT00440947|16968287|P3|48-Week Randomization Phase|Protocol Violation|1
4928887|NCT00440947|16968288|P2|48-Week Randomization Phase|Protocol Violation|0
4928888|NCT00440947|16968289|P1|48-Week Randomization Phase|Protocol Violation|0
4928889|NCT00440947|16968285|P5|48-Week Randomization Phase|Lost to Follow-up|0
4928890|NCT00440947|16968286|P4|48-Week Randomization Phase|Lost to Follow-up|0
4928891|NCT00440947|16968287|P3|48-Week Randomization Phase|Lost to Follow-up|8
4928892|NCT00440947|16968288|P2|48-Week Randomization Phase|Lost to Follow-up|2
4928893|NCT00440947|16968289|P1|48-Week Randomization Phase|Lost to Follow-up|0
4928894|NCT00440947|16968285|P5|48-Week Randomization Phase|Non-compliance|0
4928895|NCT00440947|16968286|P4|48-Week Randomization Phase|Non-compliance|0
4928896|NCT00440947|16968287|P3|48-Week Randomization Phase|Non-compliance|4
4928897|NCT00440947|16968288|P2|48-Week Randomization Phase|Non-compliance|3
4928898|NCT00440947|16968289|P1|48-Week Randomization Phase|Non-compliance|0
4928899|NCT00440947|16968285|P5|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
4928900|NCT00440947|16968286|P4|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
4928901|NCT00440947|16968287|P3|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
4928902|NCT00440947|16968288|P2|48-Week Randomization Phase|Protocol-defined Virologic Failure|1
4928903|NCT00440947|16968289|P1|48-Week Randomization Phase|Protocol-defined Virologic Failure|0
4928904|NCT00440947|16968285|P5|48-Week Randomization Phase|Adverse Event|0
4928905|NCT00440947|16968286|P4|48-Week Randomization Phase|Adverse Event|0
4928906|NCT00440947|16968287|P3|48-Week Randomization Phase|Adverse Event|5
4928907|NCT00440947|16968288|P2|48-Week Randomization Phase|Adverse Event|2
4928908|NCT00440947|16968289|P1|48-Week Randomization Phase|Adverse Event|0
4928909|NCT00440947|16968285|P5|36-Week Induction Phase|Pregnancy|0
4928910|NCT00440947|16968286|P4|36-Week Induction Phase|Pregnancy|0
4928911|NCT00440947|16968287|P3|36-Week Induction Phase|Pregnancy|0
4928912|NCT00440947|16968288|P2|36-Week Induction Phase|Pregnancy|0
4928913|NCT00440947|16968289|P1|36-Week Induction Phase|Pregnancy|1
4928914|NCT00440947|16968285|P5|36-Week Induction Phase|Incarceration|0
4928915|NCT00440947|16968286|P4|36-Week Induction Phase|Incarceration|0
4928916|NCT00440947|16968287|P3|36-Week Induction Phase|Incarceration|0
4928917|NCT00440947|16968288|P2|36-Week Induction Phase|Incarceration|0
4928918|NCT00440947|16968289|P1|36-Week Induction Phase|Incarceration|3
4928919|NCT00440947|16968285|P5|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4928920|NCT00440947|16968286|P4|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4928921|NCT00440947|16968287|P3|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4928922|NCT00440947|16968288|P2|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0
4928923|NCT00440947|16968289|P1|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1
4928924|NCT00440947|16968285|P5|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4928925|NCT00440947|16968286|P4|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4928926|NCT00440947|16968287|P3|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4928927|NCT00440947|16968288|P2|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0
4928928|NCT00440947|16968289|P1|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1
4928929|NCT00440947|16968285|P5|36-Week Induction Phase|Took Exclusionary Medications|0
4928930|NCT00440947|16968286|P4|36-Week Induction Phase|Took Exclusionary Medications|0
4928931|NCT00440947|16968287|P3|36-Week Induction Phase|Took Exclusionary Medications|0
4928932|NCT00440947|16968288|P2|36-Week Induction Phase|Took Exclusionary Medications|0
4928933|NCT00440947|16968289|P1|36-Week Induction Phase|Took Exclusionary Medications|1
4928934|NCT00440947|16968285|P5|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4928935|NCT00440947|16968286|P4|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4928936|NCT00440947|16968287|P3|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4928937|NCT00440947|16968288|P2|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0
4928938|NCT00440947|16968289|P1|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1
4928939|NCT00440947|16968285|P5|36-Week Induction Phase|Withdrawal by Subject|0
4928940|NCT00440947|16968286|P4|36-Week Induction Phase|Withdrawal by Subject|0
4928941|NCT00440947|16968287|P3|36-Week Induction Phase|Withdrawal by Subject|0
4928942|NCT00440947|16968288|P2|36-Week Induction Phase|Withdrawal by Subject|0
4928943|NCT00440947|16968289|P1|36-Week Induction Phase|Withdrawal by Subject|7
4928944|NCT00440947|16968285|P5|36-Week Induction Phase|Lost to Follow-up|0
4928945|NCT00440947|16968286|P4|36-Week Induction Phase|Lost to Follow-up|0
4928946|NCT00440947|16968287|P3|36-Week Induction Phase|Lost to Follow-up|0
4928947|NCT00440947|16968288|P2|36-Week Induction Phase|Lost to Follow-up|0
4928948|NCT00440947|16968289|P1|36-Week Induction Phase|Lost to Follow-up|16
4928949|NCT00440947|16968285|P5|36-Week Induction Phase|Non-compliance|0
4928950|NCT00440947|16968286|P4|36-Week Induction Phase|Non-compliance|0
4928951|NCT00440947|16968287|P3|36-Week Induction Phase|Non-compliance|0
4928952|NCT00440947|16968288|P2|36-Week Induction Phase|Non-compliance|0
4928953|NCT00440947|16968289|P1|36-Week Induction Phase|Non-compliance|10
4928954|NCT00440947|16968285|P5|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4928955|NCT00440947|16968286|P4|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4928956|NCT00440947|16968287|P3|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4928957|NCT00440947|16968288|P2|36-Week Induction Phase|Protocol-defined Virologic Failure|0
4928958|NCT00440947|16968289|P1|36-Week Induction Phase|Protocol-defined Virologic Failure|5
4928959|NCT00440947|16968285|P5|36-Week Induction Phase|Insufficient Viral Load Response|0
4928960|NCT00440947|16968286|P4|36-Week Induction Phase|Insufficient Viral Load Response|0
4928961|NCT00440947|16968287|P3|36-Week Induction Phase|Insufficient Viral Load Response|0
4928962|NCT00440947|16968288|P2|36-Week Induction Phase|Insufficient Viral Load Response|0
4928963|NCT00440947|16968289|P1|36-Week Induction Phase|Insufficient Viral Load Response|11
4928964|NCT00440947|16968285|P5|36-Week Induction Phase|Adverse Event|0
4928965|NCT00440947|16968286|P4|36-Week Induction Phase|Adverse Event|0
4928966|NCT00440947|16968287|P3|36-Week Induction Phase|Adverse Event|0
4928967|NCT00440947|16968288|P2|36-Week Induction Phase|Adverse Event|0
4928968|NCT00440947|16968289|P1|36-Week Induction Phase|Adverse Event|16
4928969|NCT00440726|16968364|P3|Phase 2|Adverse Event|1
4928970|NCT00440726|16968365|P2|Phase 2|Adverse Event|0
4928971|NCT00440726|16968366|P1|Phase 2|Adverse Event|0
4928972|NCT00440726|16968364|P3|Phase 2|Death|1
4928973|NCT00440726|16968365|P2|Phase 2|Death|0
4928974|NCT00440726|16968366|P1|Phase 2|Death|0
4928975|NCT00440726|16968364|P3|Phase 1|Physician Decision|0
4928976|NCT00440726|16968365|P2|Phase 1|Physician Decision|0
4928977|NCT00440726|16968366|P1|Phase 1|Physician Decision|1
4928978|NCT00440726|16968364|P3|Phase 1|Dose-Limiting Toxicity|0
4928979|NCT00440726|16968365|P2|Phase 1|Dose-Limiting Toxicity|1
4928980|NCT00440726|16968366|P1|Phase 1|Dose-Limiting Toxicity|0
4928981|NCT00440700|16968380|P3|Overall Study|Withdrawal by Subject|4
4928982|NCT00440700|16968381|P2|Overall Study|Withdrawal by Subject|8
4928983|NCT00440700|16968382|P1|Overall Study|Withdrawal by Subject|8
4928984|NCT00440557|16968405|P3|Overall Study|Patient had surgery|0
4928985|NCT00440557|16968406|P2|Overall Study|Patient had surgery|0
4928986|NCT00440557|16968407|P1|Overall Study|Patient had surgery|1
4928987|NCT00440557|16968405|P3|Overall Study|Patient transferred to nursing home|0
4928988|NCT00440557|16968406|P2|Overall Study|Patient transferred to nursing home|1
4928989|NCT00440557|16968407|P1|Overall Study|Patient transferred to nursing home|0
4928990|NCT00440557|16968405|P3|Overall Study|Principal Investigator's office closed|4
4928991|NCT00440557|16968406|P2|Overall Study|Principal Investigator's office closed|6
4928992|NCT00440557|16968407|P1|Overall Study|Principal Investigator's office closed|3
4928993|NCT00440557|16968405|P3|Overall Study|Patient moved|1
4928994|NCT00440557|16968406|P2|Overall Study|Patient moved|2
4928995|NCT00440557|16968407|P1|Overall Study|Patient moved|1
4928996|NCT00440557|16968405|P3|Overall Study|Principal Investigator decision|1
4928997|NCT00440557|16968406|P2|Overall Study|Principal Investigator decision|3
4928998|NCT00440557|16968407|P1|Overall Study|Principal Investigator decision|0
4928999|NCT00440557|16968405|P3|Overall Study|Began Dialysis|4
4929000|NCT00440557|16968406|P2|Overall Study|Began Dialysis|1
4929001|NCT00440557|16968407|P1|Overall Study|Began Dialysis|4
4929002|NCT00440557|16968405|P3|Overall Study|Death|3
4929003|NCT00440557|16968406|P2|Overall Study|Death|6
4929004|NCT00440557|16968407|P1|Overall Study|Death|2
4929006|NCT00440557|16968406|P2|Overall Study|Adverse Event|3
4929007|NCT00440557|16968407|P1|Overall Study|Adverse Event|3
4929008|NCT00440557|16968405|P3|Overall Study|Lost to Follow-up|6
4929009|NCT00440557|16968406|P2|Overall Study|Lost to Follow-up|2
4929010|NCT00440557|16968407|P1|Overall Study|Lost to Follow-up|1
4929011|NCT00440557|16968405|P3|Overall Study|Withdrawal by Subject|11
4929012|NCT00440557|16968406|P2|Overall Study|Withdrawal by Subject|5
4929013|NCT00440557|16968407|P1|Overall Study|Withdrawal by Subject|10
4929014|NCT00440531|16968439|P3|Overall Study|see pre-assignment details|0
4929015|NCT00440531|16968440|P2|Overall Study|see pre-assignment details|0
4929016|NCT00440531|16968441|P1|Overall Study|see pre-assignment details|2
4929017|NCT00440531|16968439|P3|Overall Study|Lost to Follow-up|5
4929018|NCT00440531|16968440|P2|Overall Study|Lost to Follow-up|3
4929019|NCT00440531|16968441|P1|Overall Study|Lost to Follow-up|4
4929020|NCT00440531|16968439|P3|Overall Study|Protocol Violation|0
4929021|NCT00440531|16968440|P2|Overall Study|Protocol Violation|2
4929022|NCT00440531|16968441|P1|Overall Study|Protocol Violation|1
4929023|NCT00440531|16968439|P3|Overall Study|Withdrawal by Subject|0
4929024|NCT00440531|16968440|P2|Overall Study|Withdrawal by Subject|0
4929025|NCT00440531|16968441|P1|Overall Study|Withdrawal by Subject|2
4929026|NCT00440531|16968439|P3|Overall Study|Adverse Event|2
4929027|NCT00440531|16968440|P2|Overall Study|Adverse Event|0
4929028|NCT00440531|16968441|P1|Overall Study|Adverse Event|1
4929029|NCT00440518|16968458|P3|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0
4929030|NCT00440518|16968459|P2|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2
4929031|NCT00440518|16968460|P1|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1
4929032|NCT00440518|16968458|P3|Maintenance and Safety Follow-up Periods|Other|2
4929033|NCT00440518|16968459|P2|Maintenance and Safety Follow-up Periods|Other|0
4929034|NCT00440518|16968460|P1|Maintenance and Safety Follow-up Periods|Other|0
4929035|NCT00440518|16968458|P3|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6
4929036|NCT00440518|16968459|P2|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3
4929037|NCT00440518|16968460|P1|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0
4929038|NCT00440518|16968458|P3|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4
4929039|NCT00440518|16968459|P2|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2
4929040|NCT00440518|16968460|P1|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3
4929041|NCT00440518|16968458|P3|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
4929042|NCT00440518|16968459|P2|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1
4929043|NCT00440518|16968460|P1|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0
4929044|NCT00440518|16968458|P3|Maintenance and Safety Follow-up Periods|Adverse Event|2
4929045|NCT00440518|16968459|P2|Maintenance and Safety Follow-up Periods|Adverse Event|4
4929046|NCT00440518|16968460|P1|Maintenance and Safety Follow-up Periods|Adverse Event|3
4929047|NCT00440518|16968458|P3|Randomized /Titration Period|Adverse Event|0
4929048|NCT00440518|16968459|P2|Randomized /Titration Period|Adverse Event|3
4929049|NCT00440518|16968460|P1|Randomized /Titration Period|Adverse Event|2
4929050|NCT00440518|16968458|P3|Randomized /Titration Period|Lost to Follow-up|1
4929051|NCT00440518|16968459|P2|Randomized /Titration Period|Lost to Follow-up|2
4929052|NCT00440518|16968460|P1|Randomized /Titration Period|Lost to Follow-up|2
4929053|NCT00440518|16968458|P3|Randomized /Titration Period|Other|0
4929054|NCT00440518|16968459|P2|Randomized /Titration Period|Other|0
4929055|NCT00440518|16968460|P1|Randomized /Titration Period|Other|1
4929056|NCT00440518|16968458|P3|Randomized /Titration Period|Unsatisfactory Compliance|2
4929057|NCT00440518|16968459|P2|Randomized /Titration Period|Unsatisfactory Compliance|3
4929058|NCT00440518|16968460|P1|Randomized /Titration Period|Unsatisfactory Compliance|2
4929059|NCT00440518|16968458|P3|Randomized /Titration Period|Protocol Deviation|0
4929060|NCT00440518|16968459|P2|Randomized /Titration Period|Protocol Deviation|0
4929061|NCT00440518|16968460|P1|Randomized /Titration Period|Protocol Deviation|1
4929062|NCT00440518|16968458|P3|Randomized /Titration Period|Subject Withdrew Consent|0
4929063|NCT00440518|16968459|P2|Randomized /Titration Period|Subject Withdrew Consent|1
4929064|NCT00440518|16968460|P1|Randomized /Titration Period|Subject Withdrew Consent|4
4929065|NCT00440518|16968458|P3|Randomized /Titration Period|Lack of Efficacy|1
4929066|NCT00440518|16968459|P2|Randomized /Titration Period|Lack of Efficacy|0
4929067|NCT00440518|16968460|P1|Randomized /Titration Period|Lack of Efficacy|1
4929068|NCT00440466|16968505|P3|Overall Study|Met Hemoglobin Withdrawal Criteria|4
4929069|NCT00440466|16968506|P2|Overall Study|Met Hemoglobin Withdrawal Criteria|4
4929070|NCT00440466|16968507|P1|Overall Study|Met Hemoglobin Withdrawal Criteria|0
4929071|NCT00440466|16968505|P3|Overall Study|Began Dialysis|1
4929072|NCT00440466|16968506|P2|Overall Study|Began Dialysis|0
4929073|NCT00440466|16968507|P1|Overall Study|Began Dialysis|0
4929074|NCT00440466|16968505|P3|Overall Study|Withdrawal by Subject|9
4929075|NCT00440466|16968506|P2|Overall Study|Withdrawal by Subject|5
4929076|NCT00440466|16968507|P1|Overall Study|Withdrawal by Subject|2
4929077|NCT00440466|16968505|P3|Overall Study|Protocol Violation|4
4929078|NCT00440466|16968506|P2|Overall Study|Protocol Violation|0
4929079|NCT00440466|16968507|P1|Overall Study|Protocol Violation|2
4929080|NCT00440466|16968505|P3|Overall Study|Physician Decision|1
4929081|NCT00440466|16968506|P2|Overall Study|Physician Decision|0
4929082|NCT00440466|16968507|P1|Overall Study|Physician Decision|2
4929083|NCT00440466|16968505|P3|Overall Study|Lost to Follow-up|2
4929084|NCT00440466|16968506|P2|Overall Study|Lost to Follow-up|0
4929085|NCT00440466|16968507|P1|Overall Study|Lost to Follow-up|1
4929086|NCT00440466|16968505|P3|Overall Study|Adverse Event|11
4929087|NCT00440466|16968506|P2|Overall Study|Adverse Event|4
4929088|NCT00440466|16968507|P1|Overall Study|Adverse Event|3
4929089|NCT00440466|16968505|P3|Overall Study|Death|9
4929090|NCT00440466|16968506|P2|Overall Study|Death|2
4929091|NCT00440466|16968507|P1|Overall Study|Death|3
4929092|NCT00440401|16968541|P2|Overall Study|Other|5
4929093|NCT00440401|16968542|P1|Overall Study|Other|2
4929094|NCT00440401|16968541|P2|Overall Study|Adverse Event|1
4929095|NCT00440401|16968542|P1|Overall Study|Adverse Event|2
4929096|NCT00440310|16968552|P2|Overall Study|Status Unknown|3
4929097|NCT00440310|16968553|P1|Overall Study|Status Unknown|1
4929098|NCT00440310|16968552|P2|Overall Study|Other|0
4929099|NCT00440310|16968553|P1|Overall Study|Other|1
4929100|NCT00440310|16968552|P2|Overall Study|No Reply at EOS|7
4929101|NCT00440310|16968553|P1|Overall Study|No Reply at EOS|7
4929102|NCT00440310|16968552|P2|Overall Study|Withdrawal by Subject|14
4929103|NCT00440310|16968553|P1|Overall Study|Withdrawal by Subject|15
4929104|NCT00440310|16968552|P2|Overall Study|Protocol Violation|1
4929105|NCT00440310|16968553|P1|Overall Study|Protocol Violation|0
4929106|NCT00440310|16968552|P2|Overall Study|Lost to Follow-up|5
4929107|NCT00440310|16968553|P1|Overall Study|Lost to Follow-up|4
4929108|NCT00440297|16968561|P2|Overall Study|Randomized by mistake|0
4929109|NCT00440297|16968562|P1|Overall Study|Randomized by mistake|1
4929110|NCT00440297|16968561|P2|Overall Study|Withdrawal by Subject|6
4929111|NCT00440297|16968562|P1|Overall Study|Withdrawal by Subject|1
4929112|NCT00440297|16968561|P2|Overall Study|Protocol Violation|7
4929113|NCT00440297|16968562|P1|Overall Study|Protocol Violation|11
4929114|NCT00440297|16968561|P2|Overall Study|Physician Decision|0
4929115|NCT00440297|16968562|P1|Overall Study|Physician Decision|1
4929116|NCT00440297|16968561|P2|Overall Study|Lost to Follow-up|0
4929117|NCT00440297|16968562|P1|Overall Study|Lost to Follow-up|1
4929118|NCT00440297|16968561|P2|Overall Study|Adverse Event|5
4929119|NCT00440297|16968562|P1|Overall Study|Adverse Event|8
4929120|NCT00440271|16968578|P2|Overall Study|Other|0
4929121|NCT00440271|16968579|P1|Overall Study|Other|2
4929122|NCT00440271|16968578|P2|Overall Study|Due to closure of trial|10
4929123|NCT00440271|16968579|P1|Overall Study|Due to closure of trial|8
4929124|NCT00440271|16968578|P2|Overall Study|Lack of Efficacy|1
4929125|NCT00440271|16968579|P1|Overall Study|Lack of Efficacy|0
4929126|NCT00440271|16968578|P2|Overall Study|Withdrawal by Subject|2
4929127|NCT00440271|16968579|P1|Overall Study|Withdrawal by Subject|0
4929128|NCT00440271|16968578|P2|Overall Study|Lost to Follow-up|0
4929129|NCT00440271|16968579|P1|Overall Study|Lost to Follow-up|1
4929130|NCT00440271|16968578|P2|Overall Study|Adverse Event|1
4929131|NCT00440271|16968579|P1|Overall Study|Adverse Event|0
4929132|NCT00440271|16968578|P2|Overall Study|Protocol Violation|1
4929133|NCT00440271|16968579|P1|Overall Study|Protocol Violation|1
4929134|NCT00440232|16968613|P2|Overall Study|Onset of headache within 4 hours of fast|2
4929135|NCT00440232|16968614|P1|Overall Study|Onset of headache within 4 hours of fast|2
4929136|NCT00440232|16968613|P2|Overall Study|Unable to treat within allowed time|1
4929137|NCT00440232|16968614|P1|Overall Study|Unable to treat within allowed time|0
4929138|NCT00440232|16968613|P2|Overall Study|Lost to Follow-up|1
4929139|NCT00440232|16968614|P1|Overall Study|Lost to Follow-up|1
4929140|NCT00440193|16968624|P2|Observational Period|Participant convenience|0
4929141|NCT00440193|16968625|P1|Observational Period|Participant convenience|2
4929142|NCT00440193|16968624|P2|Observational Period|Clinical endpoint reached|0
4929143|NCT00440193|16968625|P1|Observational Period|Clinical endpoint reached|1
4929144|NCT00440193|16968624|P2|Observational Period|Physician Decision|0
4929145|NCT00440193|16968625|P1|Observational Period|Physician Decision|1
4929146|NCT00440193|16968624|P2|Observational Period|Withdrawal by Subject|8
4929147|NCT00440193|16968625|P1|Observational Period|Withdrawal by Subject|11
4929148|NCT00440193|16968624|P2|Observational Period|Protocol Violation|0
4929149|NCT00440193|16968625|P1|Observational Period|Protocol Violation|1
4929150|NCT00440193|16968624|P2|Observational Period|Lost to Follow-up|8
4929151|NCT00440193|16968625|P1|Observational Period|Lost to Follow-up|12
4929152|NCT00440193|16968624|P2|Observational Period|Death|20
4929153|NCT00440193|16968625|P1|Observational Period|Death|15
4929154|NCT00440193|16968624|P2|Observational Period|Adverse Event|2
4929155|NCT00440193|16968625|P1|Observational Period|Adverse Event|2
4929156|NCT00440193|16968624|P2|Treatment Period|Site closed by investigator|2
4929157|NCT00440193|16968625|P1|Treatment Period|Site closed by investigator|0
4929158|NCT00440193|16968624|P2|Treatment Period|Participant did not receive treatment|13
4929159|NCT00440193|16968625|P1|Treatment Period|Participant did not receive treatment|7
4929160|NCT00440193|16968624|P2|Treatment Period|Participant convenience|2
4929161|NCT00440193|16968625|P1|Treatment Period|Participant convenience|5
4929162|NCT00440193|16968624|P2|Treatment Period|Technical problems|1
4929163|NCT00440193|16968625|P1|Treatment Period|Technical problems|1
4929164|NCT00440193|16968624|P2|Treatment Period|Switch to commercial drug|2
4929165|NCT00440193|16968625|P1|Treatment Period|Switch to commercial drug|0
4929166|NCT00440193|16968624|P2|Treatment Period|Protocol driven decision point|2
4929167|NCT00440193|16968625|P1|Treatment Period|Protocol driven decision point|2
4929168|NCT00440193|16968624|P2|Treatment Period|Study terminated by sponsor|94
4929169|NCT00440193|16968625|P1|Treatment Period|Study terminated by sponsor|102
4929170|NCT00440193|16968624|P2|Treatment Period|Clinical endpoint reached|25
4929171|NCT00440193|16968625|P1|Treatment Period|Clinical endpoint reached|28
4929172|NCT00440193|16968624|P2|Treatment Period|Withdrawal by Subject|77
4929173|NCT00440193|16968625|P1|Treatment Period|Withdrawal by Subject|36
4929174|NCT00440193|16968624|P2|Treatment Period|Protocol Violation|19
4929175|NCT00440193|16968625|P1|Treatment Period|Protocol Violation|16
4929176|NCT00440193|16968624|P2|Treatment Period|Physician Decision|6
4929177|NCT00440193|16968625|P1|Treatment Period|Physician Decision|3
4929178|NCT00440193|16968624|P2|Treatment Period|Lost to Follow-up|18
4929179|NCT00440193|16968625|P1|Treatment Period|Lost to Follow-up|12
4929180|NCT00440193|16968624|P2|Treatment Period|Lack of Efficacy|1
4929181|NCT00440193|16968625|P1|Treatment Period|Lack of Efficacy|0
4929182|NCT00440193|16968624|P2|Treatment Period|Death|22
4929183|NCT00440193|16968625|P1|Treatment Period|Death|19
4929184|NCT00440193|16968624|P2|Treatment Period|Adverse Event|67
4929185|NCT00440193|16968625|P1|Treatment Period|Adverse Event|74
4929186|NCT00440115|16968671|P3|Overall Study|Incarceration|1
4929187|NCT00440115|16968672|P2|Overall Study|Incarceration|2
4929188|NCT00440115|16968673|P1|Overall Study|Incarceration|0
4929189|NCT00440115|16968671|P3|Overall Study|Death|5
4929190|NCT00440115|16968672|P2|Overall Study|Death|9
4929191|NCT00440115|16968673|P1|Overall Study|Death|7
4929192|NCT00440037|16968702|P1|Overall Study|Administrative decision|3
4929193|NCT00440037|16968702|P1|Overall Study|Withdrawal by Subject|6
4929194|NCT00440011|16968712|P2|Overall Study|Withdrawal by Subject|0
4929195|NCT00440011|16968713|P1|Overall Study|Withdrawal by Subject|1
4929196|NCT00440011|16968712|P2|Overall Study|Protocol Violation|1
4929197|NCT00440011|16968713|P1|Overall Study|Protocol Violation|1
4929198|NCT00440011|16968712|P2|Overall Study|Lost to Follow-up|2
4929199|NCT00440011|16968713|P1|Overall Study|Lost to Follow-up|0
4929200|NCT00440011|16968712|P2|Overall Study|Adverse Event|0
4929201|NCT00440011|16968713|P1|Overall Study|Adverse Event|2
4929202|NCT00439777|16968740|P2|Observational Period|Technical problems|1
4929203|NCT00439777|16968741|P1|Observational Period|Technical problems|0
4929204|NCT00439777|16968740|P2|Observational Period|Lack of Efficacy|0
4929205|NCT00439777|16968741|P1|Observational Period|Lack of Efficacy|1
4929206|NCT00439777|16968740|P2|Observational Period|Protocol driven decision point|1
4929207|NCT00439777|16968741|P1|Observational Period|Protocol driven decision point|0
4929208|NCT00439777|16968740|P2|Observational Period|Study terminated by sponsor|1
4929209|NCT00439777|16968741|P1|Observational Period|Study terminated by sponsor|3
4929210|NCT00439777|16968740|P2|Observational Period|Death|20
4929211|NCT00439777|16968741|P1|Observational Period|Death|27
4929212|NCT00439777|16968740|P2|Observational Period|Lost to Follow-up|11
4929213|NCT00439777|16968741|P1|Observational Period|Lost to Follow-up|1
4929214|NCT00439777|16968740|P2|Observational Period|Withdrawal by Subject|5
4929215|NCT00439777|16968741|P1|Observational Period|Withdrawal by Subject|9
4929216|NCT00439777|16968740|P2|Observational Period|Protocol Violation|2
4929217|NCT00439777|16968741|P1|Observational Period|Protocol Violation|0
4929218|NCT00439777|16968740|P2|Treatment Period|Participant convenience|8
4929219|NCT00439777|16968741|P1|Treatment Period|Participant convenience|12
4929220|NCT00439777|16968740|P2|Treatment Period|Technical problems|1
4929221|NCT00439777|16968741|P1|Treatment Period|Technical problems|3
4929222|NCT00439777|16968740|P2|Treatment Period|Clinical endpoint reached|13
4929223|NCT00439777|16968741|P1|Treatment Period|Clinical endpoint reached|26
4929224|NCT00439777|16968740|P2|Treatment Period|Physician Decision|18
4929225|NCT00439777|16968741|P1|Treatment Period|Physician Decision|7
4929226|NCT00439777|16968740|P2|Treatment Period|Protocol driven decision point|3
4929227|NCT00439777|16968741|P1|Treatment Period|Protocol driven decision point|1
4929228|NCT00439777|16968740|P2|Treatment Period|Lost to Follow-up|10
4929229|NCT00439777|16968741|P1|Treatment Period|Lost to Follow-up|8
4929230|NCT00439777|16968740|P2|Treatment Period|Lack of Efficacy|4
4929231|NCT00439777|16968741|P1|Treatment Period|Lack of Efficacy|1
4929232|NCT00439777|16968740|P2|Treatment Period|Withdrawal by Subject|118
4929233|NCT00439777|16968741|P1|Treatment Period|Withdrawal by Subject|66
4929234|NCT00439777|16968740|P2|Treatment Period|Protocol Violation|30
4929235|NCT00439777|16968741|P1|Treatment Period|Protocol Violation|23
4929236|NCT00439777|16968740|P2|Treatment Period|Adverse Event|92
4929237|NCT00439777|16968741|P1|Treatment Period|Adverse Event|111
4929238|NCT00439777|16968740|P2|Treatment Period|Did not take study treatment|8
4929239|NCT00439777|16968741|P1|Treatment Period|Did not take study treatment|7
4929240|NCT00439777|16968740|P2|Treatment Period|Site closed by investigator|1
4929241|NCT00439777|16968741|P1|Treatment Period|Site closed by investigator|0
4929242|NCT00439777|16968740|P2|Treatment Period|Study terminated by sponsor|132
4929243|NCT00439777|16968741|P1|Treatment Period|Study terminated by sponsor|125
4929244|NCT00439777|16968740|P2|Treatment Period|Death|21
4929245|NCT00439777|16968741|P1|Treatment Period|Death|29
4929246|NCT00439738|16968779|P2|Overall Study|Abnormal Lab Values|0
4929247|NCT00439738|16968780|P1|Overall Study|Abnormal Lab Values|1
4929248|NCT00439738|16968779|P2|Overall Study|Lack of Efficacy|2
4929249|NCT00439738|16968780|P1|Overall Study|Lack of Efficacy|2
4929250|NCT00439738|16968779|P2|Overall Study|Protocol Violation|3
4929251|NCT00439738|16968780|P1|Overall Study|Protocol Violation|6
4929252|NCT00439738|16968779|P2|Overall Study|Lost to Follow-up|6
4929253|NCT00439738|16968780|P1|Overall Study|Lost to Follow-up|5
4929254|NCT00439738|16968779|P2|Overall Study|Adverse Event|4
4929255|NCT00439738|16968780|P1|Overall Study|Adverse Event|6
4929256|NCT00439738|16968779|P2|Overall Study|Withdrawal by Subject|13
4929257|NCT00439738|16968780|P1|Overall Study|Withdrawal by Subject|16
4929258|NCT00439725|16968798|P2|Observational Period|Participant convenience|0
4929259|NCT00439725|16968799|P1|Observational Period|Participant convenience|1
4929260|NCT00439725|16968798|P2|Observational Period|Technical problems|0
4929261|NCT00439725|16968799|P1|Observational Period|Technical problems|1
4929262|NCT00439725|16968798|P2|Observational Period|Clinical endpoint reached|1
4929263|NCT00439725|16968799|P1|Observational Period|Clinical endpoint reached|3
4929264|NCT00439725|16968798|P2|Observational Period|Study termination by sponsor|1
4929265|NCT00439725|16968799|P1|Observational Period|Study termination by sponsor|1
4929266|NCT00439725|16968798|P2|Observational Period|Death|2
4929267|NCT00439725|16968799|P1|Observational Period|Death|0
4929268|NCT00439725|16968798|P2|Observational Period|Lost to Follow-up|1
4929269|NCT00439725|16968799|P1|Observational Period|Lost to Follow-up|0
4929270|NCT00439725|16968798|P2|Observational Period|Withdrawal by Subject|2
4929271|NCT00439725|16968799|P1|Observational Period|Withdrawal by Subject|2
4929272|NCT00439725|16968798|P2|Treatment Period|Participant did not receive treatment|4
4929273|NCT00439725|16968799|P1|Treatment Period|Participant did not receive treatment|4
4929274|NCT00439725|16968798|P2|Treatment Period|Death|1
4929275|NCT00439725|16968799|P1|Treatment Period|Death|1
4929276|NCT00439725|16968798|P2|Treatment Period|Protocol driven decision point|1
4929277|NCT00439725|16968799|P1|Treatment Period|Protocol driven decision point|1
4929278|NCT00439725|16968798|P2|Treatment Period|Participant convenience|0
4929279|NCT00439725|16968799|P1|Treatment Period|Participant convenience|1
4929280|NCT00439725|16968798|P2|Treatment Period|Lost to Follow-up|1
4929281|NCT00439725|16968799|P1|Treatment Period|Lost to Follow-up|1
4929282|NCT00439725|16968798|P2|Treatment Period|Technical problems|0
4929283|NCT00439725|16968799|P1|Treatment Period|Technical problems|1
4929284|NCT00439725|16968798|P2|Treatment Period|Clinical endpoint reached|50
4929285|NCT00439725|16968799|P1|Treatment Period|Clinical endpoint reached|6
4929286|NCT00439725|16968798|P2|Treatment Period|Protocol Violation|1
4929287|NCT00439725|16968799|P1|Treatment Period|Protocol Violation|2
4929288|NCT00439725|16968798|P2|Treatment Period|Physician Decision|1
4929289|NCT00439725|16968799|P1|Treatment Period|Physician Decision|1
4929290|NCT00439725|16968798|P2|Treatment Period|Adverse Event|18
4929291|NCT00439725|16968799|P1|Treatment Period|Adverse Event|39
4929292|NCT00439725|16968798|P2|Treatment Period|Site closed by investigator|2
4929293|NCT00439725|16968799|P1|Treatment Period|Site closed by investigator|1
4929294|NCT00439725|16968798|P2|Treatment Period|Study terminated by sponsor|148
4929295|NCT00439725|16968799|P1|Treatment Period|Study terminated by sponsor|156
4929296|NCT00439725|16968798|P2|Treatment Period|Withdrawal by Subject|19
4929297|NCT00439725|16968799|P1|Treatment Period|Withdrawal by Subject|22
4929298|NCT00439647|16968850|P2|Overall Study|Lack of Efficacy|4
4929299|NCT00439647|16968851|P1|Overall Study|Lack of Efficacy|0
4929300|NCT00439647|16968850|P2|Overall Study|Protocol Violation|4
4929301|NCT00439647|16968851|P1|Overall Study|Protocol Violation|3
4929302|NCT00439647|16968850|P2|Overall Study|Lost to Follow-up|12
4929303|NCT00439647|16968851|P1|Overall Study|Lost to Follow-up|4
4929304|NCT00439647|16968850|P2|Overall Study|Adverse Event|11
4929305|NCT00439647|16968851|P1|Overall Study|Adverse Event|11
4929306|NCT00439647|16968850|P2|Overall Study|Death|18
4929307|NCT00439647|16968851|P1|Overall Study|Death|15
4929308|NCT00439647|16968850|P2|Overall Study|Withdrawal by Subject|22
4929309|NCT00439647|16968851|P1|Overall Study|Withdrawal by Subject|25
4929310|NCT00439569|16968888|P1|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1
4929311|NCT00439569|16968888|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3
4929312|NCT00439569|16968888|P1|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1
4929313|NCT00439556|16968902|P3|Overall Study|Patient was taken off study for non-comp|0
4929314|NCT00439556|16968903|P2|Overall Study|Patient was taken off study for non-comp|1
4929315|NCT00439556|16968904|P1|Overall Study|Patient was taken off study for non-comp|0
4929316|NCT00439517|16968917|P2|Overall Study|Subject in survival follow-up|0
4929317|NCT00439517|16968918|P1|Overall Study|Subject in survival follow-up|1
4929318|NCT00439517|16968917|P2|Overall Study|Subject on treatment|0
4929319|NCT00439517|16968918|P1|Overall Study|Subject on treatment|1
4929320|NCT00439309|16969057|P2|Follow-Up|Late response by subject|1
4929321|NCT00439309|16969058|P1|Follow-Up|Late response by subject|0
4929322|NCT00439309|16969057|P2|Follow-Up|Withdrawal by Subject|1
4929323|NCT00439309|16969058|P1|Follow-Up|Withdrawal by Subject|0
4929324|NCT00439309|16969057|P2|Follow-Up|Lost to Follow-up|0
4929325|NCT00439309|16969058|P1|Follow-Up|Lost to Follow-up|2
4929326|NCT00439309|16969057|P2|Follow-Up|Death|0
4929327|NCT00439309|16969058|P1|Follow-Up|Death|1
4929328|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4929329|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1
4929330|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4929331|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4929332|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0
4929333|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4929334|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2
4929335|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4929336|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4929337|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0
4929338|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4929339|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Withdrawal by Subject|2
4929340|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4929341|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4929342|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Withdrawal by Subject|0
4929343|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|No longer meets study criteria|0
4929344|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|No longer meets study criteria|1
4929345|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|No longer meets study criteria|0
4929346|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|No longer meets study criteria|0
4929347|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|No longer meets study criteria|0
4929348|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4929349|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Maximum clinical benefit|3
4929350|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4929351|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4929352|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Maximum clinical benefit|0
4929353|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Study drug toxicity|0
4929354|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Study drug toxicity|6
4929355|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Study drug toxicity|0
4929356|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Study drug toxicity|0
4929357|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Study drug toxicity|0
4929358|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4929359|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1
4929360|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4929361|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4929362|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0
4929363|NCT00439270|16969090|P5|Phase 2 (51.6 Months)|Disease progression|0
4929364|NCT00439270|16969091|P4|Phase 2 (51.6 Months)|Disease progression|18
4929365|NCT00439270|16969092|P3|Phase 2 (51.6 Months)|Disease progression|0
4929366|NCT00439270|16969093|P2|Phase 2 (51.6 Months)|Disease progression|0
4929367|NCT00439270|16969094|P1|Phase 2 (51.6 Months)|Disease progression|0
4929368|NCT00439270|16969090|P5|Phase 1 (18.1 Months)|Study drug toxicity|0
4929369|NCT00439270|16969091|P4|Phase 1 (18.1 Months)|Study drug toxicity|0
4929370|NCT00439270|16969092|P3|Phase 1 (18.1 Months)|Study drug toxicity|0
4929371|NCT00439270|16969093|P2|Phase 1 (18.1 Months)|Study drug toxicity|1
4929372|NCT00439270|16969094|P1|Phase 1 (18.1 Months)|Study drug toxicity|0
4929373|NCT00439270|16969090|P5|Phase 1 (18.1 Months)|Disease progression|3
4929374|NCT00439270|16969091|P4|Phase 1 (18.1 Months)|Disease progression|0
4929375|NCT00439270|16969092|P3|Phase 1 (18.1 Months)|Disease progression|3
4929376|NCT00439270|16969093|P2|Phase 1 (18.1 Months)|Disease progression|2
4929377|NCT00439270|16969094|P1|Phase 1 (18.1 Months)|Disease progression|3
4929378|NCT00439244|16969136|P3|Overall Study|Administrative problems|0
4929379|NCT00439244|16969137|P2|Overall Study|Administrative problems|0
4929380|NCT00439244|16969138|P1|Overall Study|Administrative problems|1
4929381|NCT00439244|16969136|P3|Overall Study|Protocol Violation|0
4929382|NCT00439244|16969137|P2|Overall Study|Protocol Violation|1
4929383|NCT00439244|16969138|P1|Overall Study|Protocol Violation|0
4929384|NCT00439244|16969136|P3|Overall Study|Death|0
4929385|NCT00439244|16969137|P2|Overall Study|Death|1
4929386|NCT00439244|16969138|P1|Overall Study|Death|0
4929387|NCT00439244|16969136|P3|Overall Study|Lost to Follow-up|2
4929388|NCT00439244|16969137|P2|Overall Study|Lost to Follow-up|1
4929389|NCT00439244|16969138|P1|Overall Study|Lost to Follow-up|2
4929390|NCT00439244|16969136|P3|Overall Study|Withdrawal by Subject|2
4929391|NCT00439244|16969137|P2|Overall Study|Withdrawal by Subject|1
4929392|NCT00439244|16969138|P1|Overall Study|Withdrawal by Subject|3
4929393|NCT00439244|16969136|P3|Overall Study|Adverse Event|3
4929394|NCT00439244|16969137|P2|Overall Study|Adverse Event|2
4929395|NCT00439244|16969138|P1|Overall Study|Adverse Event|5
4929396|NCT00439231|16969158|P1|Overall Study|Lack of Efficacy|28
4929397|NCT00439218|16969162|P1|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1
4929398|NCT00439179|16969177|P4|Overall Study|* 1 pt inelig, 1 pt numb not used|0
4929399|NCT00439179|16969178|P3|Overall Study|* 1 pt inelig, 1 pt numb not used|0
4929400|NCT00439179|16969179|P2|Overall Study|* 1 pt inelig, 1 pt numb not used|2
4929401|NCT00439179|16969180|P1|Overall Study|* 1 pt inelig, 1 pt numb not used|0
4929402|NCT00439140|16969197|P3|Treatment Cycle 2|Lost to Follow-up|0
4929403|NCT00439140|16969198|P2|Treatment Cycle 2|Lost to Follow-up|1
4929404|NCT00439140|16969199|P1|Treatment Cycle 2|Lost to Follow-up|1
4929405|NCT00439140|16969197|P3|Treatment Cycle 2|Withdrawal by Subject|0
4929406|NCT00439140|16969198|P2|Treatment Cycle 2|Withdrawal by Subject|0
4929407|NCT00439140|16969199|P1|Treatment Cycle 2|Withdrawal by Subject|1
4929408|NCT00439140|16969197|P3|Treatment Cycle 1|Withdrawal by Subject|0
4929409|NCT00439140|16969198|P2|Treatment Cycle 1|Withdrawal by Subject|1
4929410|NCT00439140|16969199|P1|Treatment Cycle 1|Withdrawal by Subject|0
4929411|NCT00439140|16969197|P3|Treatment Cycle 1|Personal reasons|0
4929412|NCT00439140|16969198|P2|Treatment Cycle 1|Personal reasons|2
4929413|NCT00439140|16969199|P1|Treatment Cycle 1|Personal reasons|0
4929414|NCT00439140|16969197|P3|Treatment Cycle 1|Lost to Follow-up|1
4929415|NCT00439140|16969198|P2|Treatment Cycle 1|Lost to Follow-up|1
4929416|NCT00439140|16969199|P1|Treatment Cycle 1|Lost to Follow-up|1
4929417|NCT00438815|16969282|P1|Overall Study|Death|1
4929418|NCT00438815|16969282|P1|Overall Study|Withdrawal by Subject|6
4929419|NCT00438815|16969282|P1|Overall Study|Lost to Follow-up|6
4929420|NCT00438815|16969282|P1|Overall Study|Transitioned to commercial C1INH-nf|6
4929421|NCT00438815|16969282|P1|Overall Study|Noncompliance with protocol requirements|9
4929422|NCT00438815|16969282|P1|Overall Study|3-month follow-up no longer required|12
4929423|NCT00438815|16969282|P1|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30
4929424|NCT00438672|16969332|P2|Overall Study|Lost to Follow-up|9
4929425|NCT00438672|16969333|P1|Overall Study|Lost to Follow-up|7
4929426|NCT00438659|16969343|P2|Overall Study|Cancel|2
4929427|NCT00438659|16969344|P1|Overall Study|Cancel|5
4929428|NCT00438659|16969343|P2|Overall Study|Discontinued Mometasone/Placebo|2
4929429|NCT00438659|16969344|P1|Overall Study|Discontinued Mometasone/Placebo|1
4929430|NCT00438633|16969368|P2|Overall Study|Lost to Follow-up|17
4929431|NCT00438633|16969369|P1|Overall Study|Lost to Follow-up|15
4929432|NCT00438633|16969368|P2|Overall Study|Withdrawal by Subject|0
4929433|NCT00438633|16969369|P1|Overall Study|Withdrawal by Subject|1
4929434|NCT00438464|16969400|P2|Overall Study|Incomplete data submission|2
4929435|NCT00438464|16969401|P1|Overall Study|Incomplete data submission|0
4929436|NCT00438464|16969400|P2|Overall Study|Terminated Early|5
4929437|NCT00438464|16969401|P1|Overall Study|Terminated Early|14
4929438|NCT00438399|16969502|P6|Overall Study|Patien stopped study at visit 4 by error|0
4929439|NCT00438399|16969503|P5|Overall Study|Patien stopped study at visit 4 by error|0
4929440|NCT00438399|16969504|P4|Overall Study|Patien stopped study at visit 4 by error|0
4929441|NCT00438399|16969505|P3|Overall Study|Patien stopped study at visit 4 by error|0
4929442|NCT00438399|16969506|P2|Overall Study|Patien stopped study at visit 4 by error|0
4929443|NCT00438399|16969507|P1|Overall Study|Patien stopped study at visit 4 by error|1
4929444|NCT00438399|16969502|P6|Overall Study|Pregnancy|1
4929445|NCT00438399|16969503|P5|Overall Study|Pregnancy|0
4929446|NCT00438399|16969504|P4|Overall Study|Pregnancy|0
4929447|NCT00438399|16969505|P3|Overall Study|Pregnancy|0
4929448|NCT00438399|16969506|P2|Overall Study|Pregnancy|0
4929449|NCT00438399|16969507|P1|Overall Study|Pregnancy|0
4929450|NCT00438399|16969502|P6|Overall Study|Subje stopped study|0
4929451|NCT00438399|16969503|P5|Overall Study|Subje stopped study|0
4929452|NCT00438399|16969504|P4|Overall Study|Subje stopped study|0
4929453|NCT00438399|16969505|P3|Overall Study|Subje stopped study|1
4929454|NCT00438399|16969506|P2|Overall Study|Subje stopped study|0
4929455|NCT00438399|16969507|P1|Overall Study|Subje stopped study|0
4929456|NCT00438399|16969502|P6|Overall Study|Protocol Violation|1
4929457|NCT00438399|16969503|P5|Overall Study|Protocol Violation|0
4929458|NCT00438399|16969504|P4|Overall Study|Protocol Violation|0
4929459|NCT00438399|16969505|P3|Overall Study|Protocol Violation|1
4929460|NCT00438399|16969506|P2|Overall Study|Protocol Violation|0
4929461|NCT00438399|16969507|P1|Overall Study|Protocol Violation|0
4929462|NCT00438399|16969502|P6|Overall Study|Withdrawal by Subject|2
4929463|NCT00438399|16969503|P5|Overall Study|Withdrawal by Subject|2
4929464|NCT00438399|16969504|P4|Overall Study|Withdrawal by Subject|2
4929465|NCT00438399|16969505|P3|Overall Study|Withdrawal by Subject|3
4929466|NCT00438399|16969506|P2|Overall Study|Withdrawal by Subject|6
4929467|NCT00438399|16969507|P1|Overall Study|Withdrawal by Subject|5
4929468|NCT00438399|16969502|P6|Overall Study|Adverse Event|1
4929469|NCT00438399|16969503|P5|Overall Study|Adverse Event|0
4929470|NCT00438399|16969504|P4|Overall Study|Adverse Event|1
4929471|NCT00438399|16969505|P3|Overall Study|Adverse Event|1
4929472|NCT00438399|16969506|P2|Overall Study|Adverse Event|0
4929473|NCT00438399|16969507|P1|Overall Study|Adverse Event|0
4929474|NCT00438399|16969502|P6|Overall Study|Lost to Follow-up|1
4929475|NCT00438399|16969503|P5|Overall Study|Lost to Follow-up|1
4929476|NCT00438399|16969504|P4|Overall Study|Lost to Follow-up|1
4929477|NCT00438399|16969505|P3|Overall Study|Lost to Follow-up|1
4929478|NCT00438399|16969506|P2|Overall Study|Lost to Follow-up|2
4929479|NCT00438399|16969507|P1|Overall Study|Lost to Follow-up|2
4929480|NCT00438360|16969518|P2|Overall Study|Other|15
4929481|NCT00438360|16969519|P1|Overall Study|Other|24
4929482|NCT00438360|16969518|P2|Overall Study|Lack of Efficacy|27
4929483|NCT00438360|16969519|P1|Overall Study|Lack of Efficacy|42
4929484|NCT00438360|16969518|P2|Overall Study|Adverse Event|1
4929485|NCT00438360|16969519|P1|Overall Study|Adverse Event|6
4929486|NCT00438256|16969533|P4|Overall Study|Excluded final Diagnosis|2
4929487|NCT00438256|16969534|P3|Overall Study|Excluded final Diagnosis|0
4929488|NCT00438256|16969535|P2|Overall Study|Excluded final Diagnosis|0
4929489|NCT00438256|16969536|P1|Overall Study|Excluded final Diagnosis|0
4929490|NCT00438256|16969533|P4|Overall Study|Ineligible for Resection|7
4929491|NCT00438256|16969534|P3|Overall Study|Ineligible for Resection|1
4929492|NCT00438256|16969535|P2|Overall Study|Ineligible for Resection|1
4929493|NCT00438256|16969536|P1|Overall Study|Ineligible for Resection|2
4929494|NCT00437983|16969586|P2|Overall Study|Withdrawal by Subject|6
4929495|NCT00437983|16969587|P1|Overall Study|Withdrawal by Subject|5
4929496|NCT00437983|16969586|P2|Overall Study|Protocol Violation|1
4929497|NCT00437983|16969587|P1|Overall Study|Protocol Violation|2
4929498|NCT00437983|16969586|P2|Overall Study|Adverse Event|6
4929499|NCT00437983|16969587|P1|Overall Study|Adverse Event|6
4929500|NCT00437658|16969600|P3|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
4929501|NCT00437658|16969601|P2|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
4929502|NCT00437658|16969602|P1|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3
4929503|NCT00437658|16969600|P3|Post-treatment Period (24 Weeks)|Lost to Follow-up|1
4929504|NCT00437658|16969601|P2|Post-treatment Period (24 Weeks)|Lost to Follow-up|0
4929505|NCT00437658|16969602|P1|Post-treatment Period (24 Weeks)|Lost to Follow-up|5
4929506|NCT00437658|16969600|P3|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
4929507|NCT00437658|16969601|P2|Post-treatment Period (24 Weeks)|Lack of Efficacy|2
4929508|NCT00437658|16969602|P1|Post-treatment Period (24 Weeks)|Lack of Efficacy|0
4929509|NCT00437658|16969600|P3|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8
4929510|NCT00437658|16969601|P2|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6
4929511|NCT00437658|16969602|P1|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12
4929512|NCT00437658|16969600|P3|Post-treatment Period (24 Weeks)|Non-compliance|1
4929513|NCT00437658|16969601|P2|Post-treatment Period (24 Weeks)|Non-compliance|0
4929514|NCT00437658|16969602|P1|Post-treatment Period (24 Weeks)|Non-compliance|3
4929515|NCT00437658|16969600|P3|Post-treatment Period (24 Weeks)|Adverse Event|1
4929516|NCT00437658|16969601|P2|Post-treatment Period (24 Weeks)|Adverse Event|0
4929517|NCT00437658|16969602|P1|Post-treatment Period (24 Weeks)|Adverse Event|1
4929518|NCT00437658|16969600|P3|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0
4929519|NCT00437658|16969601|P2|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1
4929520|NCT00437658|16969602|P1|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5
4929521|NCT00437658|16969600|P3|Treatment Period (24 Weeks)|Lost to Follow-up|5
4929522|NCT00437658|16969601|P2|Treatment Period (24 Weeks)|Lost to Follow-up|4
4929523|NCT00437658|16969602|P1|Treatment Period (24 Weeks)|Lost to Follow-up|5
4929524|NCT00437658|16969600|P3|Treatment Period (24 Weeks)|Lack of Efficacy|3
4929525|NCT00437658|16969601|P2|Treatment Period (24 Weeks)|Lack of Efficacy|2
4929526|NCT00437658|16969602|P1|Treatment Period (24 Weeks)|Lack of Efficacy|4
4929527|NCT00437658|16969600|P3|Treatment Period (24 Weeks)|Withdrawal by Subject|7
4929528|NCT00437658|16969601|P2|Treatment Period (24 Weeks)|Withdrawal by Subject|7
4929529|NCT00437658|16969602|P1|Treatment Period (24 Weeks)|Withdrawal by Subject|9
4929530|NCT00437658|16969600|P3|Treatment Period (24 Weeks)|Non-compliance|4
4929531|NCT00437658|16969601|P2|Treatment Period (24 Weeks)|Non-compliance|1
4929532|NCT00437658|16969602|P1|Treatment Period (24 Weeks)|Non-compliance|1
4929533|NCT00437658|16969600|P3|Treatment Period (24 Weeks)|Adverse Event|14
4929534|NCT00437658|16969601|P2|Treatment Period (24 Weeks)|Adverse Event|7
4929535|NCT00437658|16969602|P1|Treatment Period (24 Weeks)|Adverse Event|4
4929536|NCT00437645|16969696|P2|Overall Study|Condition no longer requires study drug|1
4929537|NCT00437645|16969697|P1|Overall Study|Condition no longer requires study drug|1
4929538|NCT00437645|16969696|P2|Overall Study|Lack of Efficacy|1
4929539|NCT00437645|16969697|P1|Overall Study|Lack of Efficacy|2
4929540|NCT00437645|16969696|P2|Overall Study|Administrative problems|1
4929541|NCT00437645|16969697|P1|Overall Study|Administrative problems|2
4929542|NCT00437645|16969696|P2|Overall Study|Lost to Follow-up|3
4929543|NCT00437645|16969697|P1|Overall Study|Lost to Follow-up|2
4929544|NCT00437645|16969696|P2|Overall Study|Protocol Violation|3
4929545|NCT00437645|16969697|P1|Overall Study|Protocol Violation|3
4929546|NCT00437645|16969696|P2|Overall Study|Withdrawal by Subject|22
4929547|NCT00437645|16969697|P1|Overall Study|Withdrawal by Subject|10
4929548|NCT00437645|16969696|P2|Overall Study|Adverse Event|84
4929549|NCT00437645|16969697|P1|Overall Study|Adverse Event|15
4929550|NCT00437489|16969713|P2|Overall Study|Lost to Follow-up|1
4929551|NCT00437489|16969714|P1|Overall Study|Lost to Follow-up|0
4929552|NCT00437489|16969713|P2|Overall Study|Study terminated by sponsor|21
4929553|NCT00437489|16969714|P1|Overall Study|Study terminated by sponsor|23
4929554|NCT00437294|16969733|P2|Overall Study|Entry criteria not met|1
4929555|NCT00437294|16969734|P1|Overall Study|Entry criteria not met|1
4929556|NCT00437294|16969733|P2|Overall Study|Protocol Violation|1
4929557|NCT00437294|16969734|P1|Overall Study|Protocol Violation|0
4929558|NCT00437294|16969733|P2|Overall Study|Sponsor Decision|9
4929559|NCT00437294|16969734|P1|Overall Study|Sponsor Decision|8
4929560|NCT00437294|16969733|P2|Overall Study|Progressive Disease|23
4929561|NCT00437294|16969734|P1|Overall Study|Progressive Disease|19
4929562|NCT00437294|16969733|P2|Overall Study|Withdrawal by Subject|0
4929563|NCT00437294|16969734|P1|Overall Study|Withdrawal by Subject|5
4929564|NCT00437294|16969733|P2|Overall Study|Physician Decision|3
4929565|NCT00437294|16969734|P1|Overall Study|Physician Decision|0
4929566|NCT00437294|16969733|P2|Overall Study|Death|2
4929567|NCT00437294|16969734|P1|Overall Study|Death|5
4929568|NCT00437294|16969733|P2|Overall Study|Adverse Event|4
4929569|NCT00437294|16969734|P1|Overall Study|Adverse Event|5
4929570|NCT00437281|16969775|P20|Overall Study|Lost to Follow-up|1
4929571|NCT00437281|16969776|P19|Overall Study|Lost to Follow-up|0
4929572|NCT00437281|16969777|P18|Overall Study|Lost to Follow-up|0
4929573|NCT00437281|16969778|P17|Overall Study|Lost to Follow-up|0
4929574|NCT00437281|16969779|P16|Overall Study|Lost to Follow-up|0
4929575|NCT00437281|16969780|P15|Overall Study|Lost to Follow-up|0
4929576|NCT00437281|16969781|P14|Overall Study|Lost to Follow-up|0
4929577|NCT00437281|16969782|P13|Overall Study|Lost to Follow-up|0
4929578|NCT00437281|16969783|P12|Overall Study|Lost to Follow-up|0
4929579|NCT00437281|16969784|P11|Overall Study|Lost to Follow-up|0
4929580|NCT00437281|16969785|P10|Overall Study|Lost to Follow-up|0
4929581|NCT00437281|16969786|P9|Overall Study|Lost to Follow-up|0
4929582|NCT00437281|16969787|P8|Overall Study|Lost to Follow-up|0
4929583|NCT00437281|16969788|P7|Overall Study|Lost to Follow-up|0
4929584|NCT00437281|16969789|P6|Overall Study|Lost to Follow-up|0
4929585|NCT00437281|16969790|P5|Overall Study|Lost to Follow-up|0
4929586|NCT00437281|16969791|P4|Overall Study|Lost to Follow-up|0
4929587|NCT00437281|16969792|P3|Overall Study|Lost to Follow-up|0
4929588|NCT00437281|16969793|P2|Overall Study|Lost to Follow-up|0
4929589|NCT00437281|16969794|P1|Overall Study|Lost to Follow-up|0
4929590|NCT00437281|16969775|P20|Overall Study|Adverse Event|0
4929591|NCT00437281|16969776|P19|Overall Study|Adverse Event|1
4929592|NCT00437281|16969777|P18|Overall Study|Adverse Event|0
4929593|NCT00437281|16969778|P17|Overall Study|Adverse Event|0
4929594|NCT00437281|16969779|P16|Overall Study|Adverse Event|0
4929595|NCT00437281|16969780|P15|Overall Study|Adverse Event|1
4929596|NCT00437281|16969781|P14|Overall Study|Adverse Event|1
4929597|NCT00437281|16969782|P13|Overall Study|Adverse Event|0
4929598|NCT00437281|16969783|P12|Overall Study|Adverse Event|0
4929599|NCT00437281|16969784|P11|Overall Study|Adverse Event|0
4929600|NCT00437281|16969785|P10|Overall Study|Adverse Event|1
4929601|NCT00437281|16969786|P9|Overall Study|Adverse Event|0
4929602|NCT00437281|16969787|P8|Overall Study|Adverse Event|0
4929603|NCT00437281|16969788|P7|Overall Study|Adverse Event|0
4929604|NCT00437281|16969789|P6|Overall Study|Adverse Event|1
4929605|NCT00437281|16969790|P5|Overall Study|Adverse Event|0
4929606|NCT00437281|16969791|P4|Overall Study|Adverse Event|1
4929607|NCT00437281|16969792|P3|Overall Study|Adverse Event|0
4929608|NCT00437281|16969793|P2|Overall Study|Adverse Event|0
4929609|NCT00437281|16969794|P1|Overall Study|Adverse Event|0
4929610|NCT00437268|16970090|P2|Overall Study|Death|1
4929611|NCT00437268|16970091|P1|Overall Study|Death|0
4929612|NCT00437268|16970090|P2|Overall Study|Physician Decision|0
4929613|NCT00437268|16970091|P1|Overall Study|Physician Decision|1
4929614|NCT00437268|16970090|P2|Overall Study|Progressive disease|9
4929615|NCT00437268|16970091|P1|Overall Study|Progressive disease|9
4929616|NCT00437268|16970090|P2|Overall Study|Withdrawal by Subject|2
4929617|NCT00437268|16970091|P1|Overall Study|Withdrawal by Subject|2
4929618|NCT00437268|16970090|P2|Overall Study|Adverse Event|1
4929619|NCT00437268|16970091|P1|Overall Study|Adverse Event|1
4929620|NCT00437203|16970117|P10|Overall Study|Other|0
4929621|NCT00437203|16970118|P9|Overall Study|Other|0
4929622|NCT00437203|16970119|P8|Overall Study|Other|0
4929623|NCT00437203|16970120|P7|Overall Study|Other|1
4929624|NCT00437203|16970121|P6|Overall Study|Other|0
4929625|NCT00437203|16970122|P5|Overall Study|Other|0
4929626|NCT00437203|16970123|P4|Overall Study|Other|0
4929627|NCT00437203|16970124|P3|Overall Study|Other|0
4929628|NCT00437203|16970125|P2|Overall Study|Other|1
4929629|NCT00437203|16970126|P1|Overall Study|Other|0
4929630|NCT00437203|16970117|P10|Overall Study|Objective progression or relapse|2
4929631|NCT00437203|16970118|P9|Overall Study|Objective progression or relapse|2
4929632|NCT00437203|16970119|P8|Overall Study|Objective progression or relapse|1
4929633|NCT00437203|16970120|P7|Overall Study|Objective progression or relapse|6
4929634|NCT00437203|16970121|P6|Overall Study|Objective progression or relapse|3
4929635|NCT00437203|16970122|P5|Overall Study|Objective progression or relapse|3
4929636|NCT00437203|16970123|P4|Overall Study|Objective progression or relapse|3
4929637|NCT00437203|16970124|P3|Overall Study|Objective progression or relapse|2
4929638|NCT00437203|16970125|P2|Overall Study|Objective progression or relapse|6
4929639|NCT00437203|16970126|P1|Overall Study|Objective progression or relapse|5
4929640|NCT00437203|16970117|P10|Overall Study|Study terminated by sponsor|0
4929641|NCT00437203|16970118|P9|Overall Study|Study terminated by sponsor|1
4929642|NCT00437203|16970119|P8|Overall Study|Study terminated by sponsor|0
4929643|NCT00437203|16970120|P7|Overall Study|Study terminated by sponsor|0
4929644|NCT00437203|16970121|P6|Overall Study|Study terminated by sponsor|0
4929645|NCT00437203|16970122|P5|Overall Study|Study terminated by sponsor|0
4929646|NCT00437203|16970123|P4|Overall Study|Study terminated by sponsor|0
4929647|NCT00437203|16970124|P3|Overall Study|Study terminated by sponsor|0
4929648|NCT00437203|16970125|P2|Overall Study|Study terminated by sponsor|0
4929649|NCT00437203|16970126|P1|Overall Study|Study terminated by sponsor|0
4929650|NCT00437203|16970117|P10|Overall Study|Adverse Event|1
4929651|NCT00437203|16970118|P9|Overall Study|Adverse Event|0
4929652|NCT00437203|16970119|P8|Overall Study|Adverse Event|1
4929653|NCT00437203|16970120|P7|Overall Study|Adverse Event|0
4929654|NCT00437203|16970121|P6|Overall Study|Adverse Event|0
4929655|NCT00437203|16970122|P5|Overall Study|Adverse Event|0
4929656|NCT00437203|16970123|P4|Overall Study|Adverse Event|0
4929657|NCT00437203|16970124|P3|Overall Study|Adverse Event|0
4929658|NCT00437203|16970125|P2|Overall Study|Adverse Event|1
4929659|NCT00437203|16970126|P1|Overall Study|Adverse Event|1
4929660|NCT00437203|16970117|P10|Overall Study|Death|1
4929661|NCT00437203|16970118|P9|Overall Study|Death|0
4929662|NCT00437203|16970119|P8|Overall Study|Death|1
4929663|NCT00437203|16970120|P7|Overall Study|Death|0
4929664|NCT00437203|16970121|P6|Overall Study|Death|0
4929665|NCT00437203|16970122|P5|Overall Study|Death|0
4929666|NCT00437203|16970123|P4|Overall Study|Death|0
4929667|NCT00437203|16970124|P3|Overall Study|Death|1
4929668|NCT00437203|16970125|P2|Overall Study|Death|0
4929669|NCT00437203|16970126|P1|Overall Study|Death|0
4929670|NCT00437125|16970230|P1|Overall Study|Physician Decision|1
4929671|NCT00437125|16970230|P1|Overall Study|Withdrawal by Caregiver|2
4929672|NCT00437125|16970230|P1|Overall Study|Withdrawal by Subject|13
4929673|NCT00437125|16970230|P1|Overall Study|Lost to Follow-up|1
4929674|NCT00437125|16970230|P1|Overall Study|Lack of Efficacy|1
4929675|NCT00437125|16970230|P1|Overall Study|Clinical Relapse|1
4929676|NCT00437125|16970230|P1|Overall Study|Death|1
4929677|NCT00437125|16970230|P1|Overall Study|Adverse Event|12
4929678|NCT00437073|16970251|P2|Overall Study|Physician Decision|1
4929679|NCT00437073|16970252|P1|Overall Study|Physician Decision|0
4929680|NCT00437073|16970251|P2|Overall Study|Sponsor Terminated Study|0
4929681|NCT00437073|16970252|P1|Overall Study|Sponsor Terminated Study|1
4929682|NCT00437034|16970280|P1|Overall Study|Disease progression during treatment|5
4929683|NCT00437034|16970280|P1|Overall Study|Adverse Event|1
4929684|NCT00436982|16970286|P2|Overall Study|no RSA data|2
4929685|NCT00436982|16970287|P1|Overall Study|no RSA data|1
4929686|NCT00436982|16970286|P2|Overall Study|Did not receive allocated intervention|1
4929687|NCT00436982|16970287|P1|Overall Study|Did not receive allocated intervention|0
4929688|NCT00436982|16970286|P2|Overall Study|Withdrawal by Subject|1
4929689|NCT00436982|16970287|P1|Overall Study|Withdrawal by Subject|3
4929690|NCT00436956|16970358|P2|Overall Study|Not evaluable|0
4929691|NCT00436956|16970359|P1|Overall Study|Not evaluable|1
4929692|NCT00436917|16970373|P1|Overall Study|Personal conflicts of patient|1
4929693|NCT00436917|16970373|P1|Overall Study|Increased creatinine|1
4929694|NCT00436917|16970373|P1|Overall Study|Treatment for polymyalgia rheumatic|1
4929695|NCT00436917|16970373|P1|Overall Study|Lost to Follow-up|1
4929696|NCT00436917|16970373|P1|Overall Study|Death|1
4929697|NCT00436917|16970373|P1|Overall Study|Physician Decision|1
4929698|NCT00436917|16970373|P1|Overall Study|Adverse Event|2
4929699|NCT00436917|16970373|P1|Overall Study|Withdrawal by Subject|13
4929700|NCT00436852|16970399|P2|Overall Study|Ineligible|0
4929701|NCT00436852|16970400|P1|Overall Study|Ineligible|1
4929702|NCT00436852|16970399|P2|Overall Study|Withdrawal by Subject|4
4929703|NCT00436852|16970400|P1|Overall Study|Withdrawal by Subject|2
4929704|NCT00436852|16970399|P2|Overall Study|Lack of Efficacy|7
4929705|NCT00436852|16970400|P1|Overall Study|Lack of Efficacy|9
4929706|NCT00436852|16970399|P2|Overall Study|Death|34
4929707|NCT00436852|16970400|P1|Overall Study|Death|23
4929708|NCT00436826|16970419|P6|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7
4929709|NCT00436826|16970420|P5|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51
4929710|NCT00436826|16970421|P4|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4929711|NCT00436826|16970422|P3|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4929712|NCT00436826|16970423|P2|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4929713|NCT00436826|16970424|P1|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0
4929714|NCT00436826|16970419|P6|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4929715|NCT00436826|16970420|P5|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4929716|NCT00436826|16970421|P4|Ext. Period (With Cladribine Treatment)|Other un-specified|25
4929717|NCT00436826|16970422|P3|Ext. Period (With Cladribine Treatment)|Other un-specified|46
4929718|NCT00436826|16970423|P2|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4929719|NCT00436826|16970424|P1|Ext. Period (With Cladribine Treatment)|Other un-specified|0
4929720|NCT00436826|16970419|P6|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4929721|NCT00436826|16970420|P5|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4929722|NCT00436826|16970421|P4|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1
4929723|NCT00436826|16970422|P3|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4929724|NCT00436826|16970423|P2|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4929725|NCT00436826|16970424|P1|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0
4929726|NCT00436826|16970419|P6|Double Blind Period (DBP)|Other|0
4929727|NCT00436826|16970420|P5|Double Blind Period (DBP)|Other|0
4929728|NCT00436826|16970421|P4|Double Blind Period (DBP)|Other|0
4929729|NCT00436826|16970422|P3|Double Blind Period (DBP)|Other|0
4929730|NCT00436826|16970423|P2|Double Blind Period (DBP)|Other|11
4929731|NCT00436826|16970424|P1|Double Blind Period (DBP)|Other|10
4929732|NCT00436826|16970419|P6|Double Blind Period (DBP)|Protocol Violation|0
4929733|NCT00436826|16970420|P5|Double Blind Period (DBP)|Protocol Violation|0
4929734|NCT00436826|16970421|P4|Double Blind Period (DBP)|Protocol Violation|0
4929735|NCT00436826|16970422|P3|Double Blind Period (DBP)|Protocol Violation|0
4929736|NCT00436826|16970423|P2|Double Blind Period (DBP)|Protocol Violation|0
4929737|NCT00436826|16970424|P1|Double Blind Period (DBP)|Protocol Violation|1
4929738|NCT00436826|16970419|P6|Double Blind Period (DBP)|Adverse Event|0
4929739|NCT00436826|16970420|P5|Double Blind Period (DBP)|Adverse Event|0
4929740|NCT00436826|16970421|P4|Double Blind Period (DBP)|Adverse Event|0
4929741|NCT00436826|16970422|P3|Double Blind Period (DBP)|Adverse Event|0
4929742|NCT00436826|16970423|P2|Double Blind Period (DBP)|Adverse Event|0
4929743|NCT00436826|16970424|P1|Double Blind Period (DBP)|Adverse Event|2
4929744|NCT00436748|16970522|P2|Overall Study|Other|0
4929745|NCT00436748|16970523|P1|Overall Study|Other|3
4929746|NCT00436748|16970522|P2|Overall Study|Protocol-specified Criteria|4
4929747|NCT00436748|16970523|P1|Overall Study|Protocol-specified Criteria|5
4929748|NCT00436748|16970522|P2|Overall Study|Lost to Follow-up|1
4929749|NCT00436748|16970523|P1|Overall Study|Lost to Follow-up|0
4929750|NCT00436748|16970522|P2|Overall Study|Administrative Decision|0
4929751|NCT00436748|16970523|P1|Overall Study|Administrative Decision|1
4929752|NCT00436748|16970522|P2|Overall Study|Consent Withdrawn|4
4929753|NCT00436748|16970523|P1|Overall Study|Consent Withdrawn|1
4929754|NCT00436748|16970522|P2|Overall Study|Adverse Event|2
4929755|NCT00436748|16970523|P1|Overall Study|Adverse Event|0
4929756|NCT00436748|16970522|P2|Overall Study|Ineligibility Determined|1
4929757|NCT00436748|16970523|P1|Overall Study|Ineligibility Determined|1
4929758|NCT00436644|16970557|P1|Overall Study|Death|1
4929759|NCT00436644|16970557|P1|Overall Study|Adverse Event|2
4929760|NCT00436618|16970567|P3|Overall Study|Still on treatment|7
4929761|NCT00436618|16970568|P2|Overall Study|Still on treatment|2
4929762|NCT00436618|16970569|P1|Overall Study|Still on treatment|1
4929763|NCT00436618|16970567|P3|Overall Study|New Primary or Other Reasons|12
4929764|NCT00436618|16970568|P2|Overall Study|New Primary or Other Reasons|2
4929765|NCT00436618|16970569|P1|Overall Study|New Primary or Other Reasons|6
4929766|NCT00436618|16970567|P3|Overall Study|Death|3
4929767|NCT00436618|16970568|P2|Overall Study|Death|2
4929768|NCT00436618|16970569|P1|Overall Study|Death|4
4929769|NCT00436618|16970567|P3|Overall Study|Other Medical Problems|7
4929770|NCT00436618|16970568|P2|Overall Study|Other Medical Problems|1
4929771|NCT00436618|16970569|P1|Overall Study|Other Medical Problems|3
4929772|NCT00436618|16970567|P3|Overall Study|Alternate Treatment|12
4929773|NCT00436618|16970568|P2|Overall Study|Alternate Treatment|4
4929774|NCT00436618|16970569|P1|Overall Study|Alternate Treatment|3
4929775|NCT00436618|16970567|P3|Overall Study|Adverse Event|9
4929776|NCT00436618|16970568|P2|Overall Study|Adverse Event|8
4929777|NCT00436618|16970569|P1|Overall Study|Adverse Event|8
4929778|NCT00436618|16970567|P3|Overall Study|Withdrawal by Subject|11
4929779|NCT00436618|16970568|P2|Overall Study|Withdrawal by Subject|8
4929780|NCT00436618|16970569|P1|Overall Study|Withdrawal by Subject|5
4929781|NCT00436605|16970586|P1|Overall Study|Protocol Violation|3
4929782|NCT00436566|16970591|P1|Overall Study|Protocol Violation|1
4929783|NCT00436566|16970591|P1|Overall Study|Withdrawal by Subject|2
4929784|NCT00436553|16970598|P3|Overall Study|Withdrawal by Subject|3
4929785|NCT00436553|16970599|P2|Overall Study|Withdrawal by Subject|6
4929786|NCT00436553|16970600|P1|Overall Study|Withdrawal by Subject|5
4929787|NCT00436553|16970598|P3|Overall Study|Protocol Violation|0
4929788|NCT00436553|16970599|P2|Overall Study|Protocol Violation|0
4929789|NCT00436553|16970600|P1|Overall Study|Protocol Violation|1
4929790|NCT00436553|16970598|P3|Overall Study|Lost to Follow-up|0
4929791|NCT00436553|16970599|P2|Overall Study|Lost to Follow-up|2
4929792|NCT00436553|16970600|P1|Overall Study|Lost to Follow-up|0
4929793|NCT00436553|16970598|P3|Overall Study|Death|3
4929794|NCT00436553|16970599|P2|Overall Study|Death|1
4929795|NCT00436553|16970600|P1|Overall Study|Death|3
4929796|NCT00436553|16970598|P3|Overall Study|Adverse Event|4
4929797|NCT00436553|16970599|P2|Overall Study|Adverse Event|3
4929798|NCT00436553|16970600|P1|Overall Study|Adverse Event|4
4929799|NCT00436501|16970621|P2|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1
4929800|NCT00436501|16970622|P1|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0
4929801|NCT00436501|16970621|P2|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2
4929802|NCT00436501|16970622|P1|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0
4929803|NCT00436436|16970658|P1|Overall Study|Death|6
4929804|NCT00436436|16970658|P1|Overall Study|Adverse Event|2
4929805|NCT00436436|16970658|P1|Overall Study|Progression|4
4929806|NCT00436345|16970669|P2|Overall Study|ICU resident beyond follow-up period|0
4929807|NCT00436345|16970670|P1|Overall Study|ICU resident beyond follow-up period|3
4929808|NCT00436332|16970723|P1|Overall Study|Never Received Treatment|3
4929809|NCT00436332|16970723|P1|Overall Study|Ineligible|2
4929810|NCT00436332|16970723|P1|Overall Study|Not Protocol Specified|6
4929811|NCT00436332|16970723|P1|Overall Study|Death|2
4929812|NCT00436332|16970723|P1|Overall Study|Progression|59
4929813|NCT00436332|16970723|P1|Overall Study|Withdrawal by Subject|2
4929814|NCT00436332|16970723|P1|Overall Study|Adverse Event|9
4929815|NCT00436280|16970730|P1|Period 3: Maintenance|Progressive Disease|12
4929816|NCT00436280|16970730|P1|Period 3: Maintenance|Adverse Event|6
4929817|NCT00436280|16970730|P1|Period 2: Consolidation|Death|1
4929818|NCT00436280|16970730|P1|Period 2: Consolidation|Withdrawal by Subject|2
4929819|NCT00436280|16970730|P1|Period 2: Consolidation|Physician Decision|2
4929820|NCT00436280|16970730|P1|Period 2: Consolidation|Stable Disease|1
4929821|NCT00436280|16970730|P1|Period 2: Consolidation|Progressive Disease|10
4929822|NCT00436280|16970730|P1|Period 2: Consolidation|Adverse Event|1
4929823|NCT00436280|16970730|P1|Period 1: Induction|Death|1
4929824|NCT00436280|16970730|P1|Period 1: Induction|Withdrawal by Subject|1
4929825|NCT00436280|16970730|P1|Period 1: Induction|Stable Disease|6
4929826|NCT00436280|16970730|P1|Period 1: Induction|Progressive Disease|12
4929827|NCT00436280|16970730|P1|Period 1: Induction|Adverse Event|8
4929828|NCT00436215|16970744|P1|Overall Study|Small bowel obstruction|1
4929829|NCT00436215|16970744|P1|Overall Study|Refused further treatment|3
4929830|NCT00436163|16970750|P1|Overall Study|Adverse Event|1
4929831|NCT00436163|16970750|P1|Overall Study|Lost to Follow-up|2
4929832|NCT00436007|16970798|P3|Overall Study|Other|1
4929833|NCT00436007|16970799|P2|Overall Study|Other|0
4929834|NCT00436007|16970800|P1|Overall Study|Other|0
4929835|NCT00436007|16970798|P3|Overall Study|Death|3
4929836|NCT00436007|16970799|P2|Overall Study|Death|1
4929837|NCT00436007|16970800|P1|Overall Study|Death|0
4929838|NCT00436007|16970798|P3|Overall Study|Physician Decision|2
4929839|NCT00436007|16970799|P2|Overall Study|Physician Decision|0
4929840|NCT00436007|16970800|P1|Overall Study|Physician Decision|0
4929841|NCT00436007|16970798|P3|Overall Study|Lost to Follow-up|13
4929842|NCT00436007|16970799|P2|Overall Study|Lost to Follow-up|10
4929843|NCT00436007|16970800|P1|Overall Study|Lost to Follow-up|14
4929844|NCT00436007|16970798|P3|Overall Study|Withdrawal by Subject|4
4929845|NCT00436007|16970799|P2|Overall Study|Withdrawal by Subject|3
4929846|NCT00436007|16970800|P1|Overall Study|Withdrawal by Subject|5
4929847|NCT00435994|16970848|P3|Overall Study|Lost to Follow-up|0
4929848|NCT00435994|16970849|P2|Overall Study|Lost to Follow-up|0
4929849|NCT00435994|16970850|P1|Overall Study|Lost to Follow-up|7
4929850|NCT00435942|16970861|P2|Overall Study|Other|1
4929851|NCT00435942|16970862|P1|Overall Study|Other|0
4929852|NCT00435942|16970861|P2|Overall Study|Technical Failure|0
4929853|NCT00435942|16970862|P1|Overall Study|Technical Failure|3
4929854|NCT00435942|16970861|P2|Overall Study|Conversion to Open Repair|0
4929855|NCT00435942|16970862|P1|Overall Study|Conversion to Open Repair|1
4929856|NCT00435942|16970861|P2|Overall Study|Lost to Follow-up|16
4929857|NCT00435942|16970862|P1|Overall Study|Lost to Follow-up|0
4929858|NCT00435942|16970861|P2|Overall Study|Withdrawal by Subject|0
4929859|NCT00435942|16970862|P1|Overall Study|Withdrawal by Subject|2
4929860|NCT00435942|16970861|P2|Overall Study|Death|10
4929861|NCT00435942|16970862|P1|Overall Study|Death|17
4929862|NCT00435825|16970902|P4|Overall Study|Did not complete full follow-up period|5
4929863|NCT00435825|16970903|P3|Overall Study|Did not complete full follow-up period|4
4929864|NCT00435825|16970904|P2|Overall Study|Did not complete full follow-up period|6
4929865|NCT00435825|16970905|P1|Overall Study|Did not complete full follow-up period|6
4929866|NCT00435825|16970902|P4|Overall Study|Did not enter follow-up|3
4929867|NCT00435825|16970903|P3|Overall Study|Did not enter follow-up|1
4929868|NCT00435825|16970904|P2|Overall Study|Did not enter follow-up|4
4929869|NCT00435825|16970905|P1|Overall Study|Did not enter follow-up|0
4929870|NCT00435825|16970902|P4|Overall Study|Did not receive study drug|0
4929871|NCT00435825|16970903|P3|Overall Study|Did not receive study drug|2
4929872|NCT00435825|16970904|P2|Overall Study|Did not receive study drug|0
4929873|NCT00435825|16970905|P1|Overall Study|Did not receive study drug|1
4929874|NCT00435825|16970902|P4|Overall Study|Failure to return|0
4929875|NCT00435825|16970903|P3|Overall Study|Failure to return|4
4929876|NCT00435825|16970904|P2|Overall Study|Failure to return|0
4929877|NCT00435825|16970905|P1|Overall Study|Failure to return|5
4929878|NCT00435825|16970902|P4|Overall Study|Refused treatment|5
4929879|NCT00435825|16970903|P3|Overall Study|Refused treatment|0
4929880|NCT00435825|16970904|P2|Overall Study|Refused treatment|0
4929881|NCT00435825|16970905|P1|Overall Study|Refused treatment|2
4929882|NCT00435825|16970902|P4|Overall Study|Other Protocol Violation|0
4929883|NCT00435825|16970903|P3|Overall Study|Other Protocol Violation|0
4929884|NCT00435825|16970904|P2|Overall Study|Other Protocol Violation|0
4929885|NCT00435825|16970905|P1|Overall Study|Other Protocol Violation|1
4929886|NCT00435825|16970902|P4|Overall Study|Insufficient Therapeutic Response|3
4929887|NCT00435825|16970903|P3|Overall Study|Insufficient Therapeutic Response|0
4929888|NCT00435825|16970904|P2|Overall Study|Insufficient Therapeutic Response|1
4929889|NCT00435825|16970905|P1|Overall Study|Insufficient Therapeutic Response|3
4929890|NCT00435825|16970902|P4|Overall Study|Abnormality of Laboratory Test|0
4929891|NCT00435825|16970903|P3|Overall Study|Abnormality of Laboratory Test|0
4929892|NCT00435825|16970904|P2|Overall Study|Abnormality of Laboratory Test|1
4929893|NCT00435825|16970905|P1|Overall Study|Abnormality of Laboratory Test|0
4929894|NCT00435487|16971028|P2|Overall Study|Received Drug in Other Treatment Group|1
4929895|NCT00435487|16971029|P1|Overall Study|Received Drug in Other Treatment Group|0
4929896|NCT00435487|16971028|P2|Overall Study|Withdrawal by Subject Prior to Treatment|2
4929897|NCT00435487|16971029|P1|Overall Study|Withdrawal by Subject Prior to Treatment|0
4929898|NCT00435487|16971028|P2|Overall Study|Withdrawal by Subject|1
4929899|NCT00435487|16971029|P1|Overall Study|Withdrawal by Subject|2
4929900|NCT00435487|16971028|P2|Overall Study|Other|2
4929901|NCT00435487|16971029|P1|Overall Study|Other|5
4929902|NCT00435487|16971028|P2|Overall Study|Lost to Follow-up|2
4929903|NCT00435487|16971029|P1|Overall Study|Lost to Follow-up|2
4929904|NCT00435487|16971028|P2|Overall Study|Adverse Event|3
4929905|NCT00435487|16971029|P1|Overall Study|Adverse Event|0
4929906|NCT00435487|16971028|P2|Overall Study|Death|4
4929907|NCT00435487|16971029|P1|Overall Study|Death|3
4929908|NCT00435461|16971048|P3|Overall Study|Lost to Follow-up|2
4929909|NCT00435461|16971049|P2|Overall Study|Lost to Follow-up|1
4929910|NCT00435461|16971050|P1|Overall Study|Lost to Follow-up|1
4929911|NCT00435461|16971048|P3|Overall Study|Non-Compliance of diary|1
4929912|NCT00435461|16971049|P2|Overall Study|Non-Compliance of diary|0
4929913|NCT00435461|16971050|P1|Overall Study|Non-Compliance of diary|2
4929914|NCT00435461|16971048|P3|Overall Study|Adverse Event|6
4929915|NCT00435461|16971049|P2|Overall Study|Adverse Event|2
4929916|NCT00435461|16971050|P1|Overall Study|Adverse Event|1
4929917|NCT00435461|16971048|P3|Overall Study|Noncompliance with study requirements|1
4929918|NCT00435461|16971049|P2|Overall Study|Noncompliance with study requirements|1
4929919|NCT00435461|16971050|P1|Overall Study|Noncompliance with study requirements|1
4929920|NCT00435461|16971048|P3|Overall Study|Participant ended study one day early|0
4929921|NCT00435461|16971049|P2|Overall Study|Participant ended study one day early|0
4929922|NCT00435461|16971050|P1|Overall Study|Participant ended study one day early|1
4929923|NCT00435461|16971048|P3|Overall Study|Participant moved eDiary,studymedication|0
4929924|NCT00435461|16971049|P2|Overall Study|Participant moved eDiary,studymedication|0
4929925|NCT00435461|16971050|P1|Overall Study|Participant moved eDiary,studymedication|1
4929926|NCT00435461|16971048|P3|Overall Study|Pregnancy|0
4929927|NCT00435461|16971049|P2|Overall Study|Pregnancy|0
4929928|NCT00435461|16971050|P1|Overall Study|Pregnancy|2
4929929|NCT00435461|16971048|P3|Overall Study|Participant could not swallow capsule|1
4929930|NCT00435461|16971049|P2|Overall Study|Participant could not swallow capsule|0
4929931|NCT00435461|16971050|P1|Overall Study|Participant could not swallow capsule|0
4929932|NCT00435461|16971048|P3|Overall Study|Participant could not tolerate symptoms|1
4929933|NCT00435461|16971049|P2|Overall Study|Participant could not tolerate symptoms|0
4929934|NCT00435461|16971050|P1|Overall Study|Participant could not tolerate symptoms|0
4929935|NCT00435461|16971048|P3|Overall Study|Randomized in error|0
4929936|NCT00435461|16971049|P2|Overall Study|Randomized in error|0
4929937|NCT00435461|16971050|P1|Overall Study|Randomized in error|1
4929938|NCT00435461|16971048|P3|Overall Study|Withdrawal by Subject|2
4929939|NCT00435461|16971049|P2|Overall Study|Withdrawal by Subject|0
4929940|NCT00435461|16971050|P1|Overall Study|Withdrawal by Subject|1
4929941|NCT00435461|16971048|P3|Overall Study|Lack of Efficacy|0
4929942|NCT00435461|16971049|P2|Overall Study|Lack of Efficacy|1
4929943|NCT00435461|16971050|P1|Overall Study|Lack of Efficacy|2
4929944|NCT00435461|16971048|P3|Overall Study|In error, two study medications switched|0
4929945|NCT00435461|16971049|P2|Overall Study|In error, two study medications switched|0
4929946|NCT00435461|16971050|P1|Overall Study|In error, two study medications switched|1
4929947|NCT00435461|16971048|P3|Overall Study|Compliance less than 80 percent|0
4929948|NCT00435461|16971049|P2|Overall Study|Compliance less than 80 percent|0
4929949|NCT00435461|16971050|P1|Overall Study|Compliance less than 80 percent|1
4929950|NCT00435461|16971048|P3|Overall Study|Participant randomized(inadequate score)|0
4929951|NCT00435461|16971049|P2|Overall Study|Participant randomized(inadequate score)|0
4929952|NCT00435461|16971050|P1|Overall Study|Participant randomized(inadequate score)|1
4929953|NCT00435461|16971048|P3|Overall Study|Protocol Violation|10
4929954|NCT00435461|16971049|P2|Overall Study|Protocol Violation|9
4929955|NCT00435461|16971050|P1|Overall Study|Protocol Violation|6
4929956|NCT00435461|16971048|P3|Overall Study|Visit changed to EarlyWithdrawn Visit|0
4929957|NCT00435461|16971049|P2|Overall Study|Visit changed to EarlyWithdrawn Visit|0
4929958|NCT00435461|16971050|P1|Overall Study|Visit changed to EarlyWithdrawn Visit|1
4929959|NCT00435409|16971087|P3|Overall Study|Sponsor decision|0
4929960|NCT00435409|16971088|P2|Overall Study|Sponsor decision|3
4929961|NCT00435409|16971089|P1|Overall Study|Sponsor decision|0
4929962|NCT00435409|16971087|P3|Overall Study|Adverse Event|8
4929963|NCT00435409|16971088|P2|Overall Study|Adverse Event|0
4929964|NCT00435409|16971089|P1|Overall Study|Adverse Event|0
4929965|NCT00435409|16971087|P3|Overall Study|Other|1
4929966|NCT00435409|16971088|P2|Overall Study|Other|30
4929967|NCT00435409|16971089|P1|Overall Study|Other|45
4929968|NCT00435409|16971087|P3|Overall Study|Withdrawal by Subject|1
4929969|NCT00435409|16971088|P2|Overall Study|Withdrawal by Subject|7
4929970|NCT00435409|16971089|P1|Overall Study|Withdrawal by Subject|8
4929971|NCT00435409|16971087|P3|Overall Study|Global deterioration of health status|4
4929972|NCT00435409|16971088|P2|Overall Study|Global deterioration of health status|0
4929973|NCT00435409|16971089|P1|Overall Study|Global deterioration of health status|0
4929974|NCT00435409|16971087|P3|Overall Study|Objective progression or relapse|58
4929975|NCT00435409|16971088|P2|Overall Study|Objective progression or relapse|93
4929976|NCT00435409|16971089|P1|Overall Study|Objective progression or relapse|158
4929977|NCT00435409|16971087|P3|Overall Study|Death|6
4929978|NCT00435409|16971088|P2|Overall Study|Death|6
4929979|NCT00435409|16971089|P1|Overall Study|Death|8
4929980|NCT00435409|16971087|P3|Overall Study|Lost to Follow-up|0
4929981|NCT00435409|16971088|P2|Overall Study|Lost to Follow-up|2
4929982|NCT00435409|16971089|P1|Overall Study|Lost to Follow-up|1
4929983|NCT00435409|16971087|P3|Overall Study|Protocol Violation|0
4929984|NCT00435409|16971088|P2|Overall Study|Protocol Violation|2
4929985|NCT00435409|16971089|P1|Overall Study|Protocol Violation|1
4929986|NCT00435370|16971111|P2|Overall Study|Antipsychotic medication changed|2
4929987|NCT00435370|16971112|P1|Overall Study|Antipsychotic medication changed|4
4929988|NCT00435370|16971111|P2|Overall Study|Withdrawal by Subject|10
4929989|NCT00435370|16971112|P1|Overall Study|Withdrawal by Subject|10
4929990|NCT00435370|16971111|P2|Overall Study|Adverse Event|8
4929991|NCT00435370|16971112|P1|Overall Study|Adverse Event|8
4929992|NCT00435188|16971120|P2|Overall Study|Lost to Follow-up|6
4929993|NCT00435188|16971121|P1|Overall Study|Lost to Follow-up|5
4929994|NCT00435188|16971120|P2|Overall Study|Withdrawal by Subject|11
4929995|NCT00435188|16971121|P1|Overall Study|Withdrawal by Subject|16
4929996|NCT00435188|16971120|P2|Overall Study|Death|6
4929997|NCT00435188|16971121|P1|Overall Study|Death|1
4929998|NCT00435162|16971164|P6|Period 2 (2 Weeks)|Adverse Event|0
4929999|NCT00435162|16971165|P5|Period 2 (2 Weeks)|Adverse Event|0
4930000|NCT00435162|16971166|P4|Period 2 (2 Weeks)|Adverse Event|0
4930001|NCT00435162|16971167|P3|Period 2 (2 Weeks)|Adverse Event|0
4930002|NCT00435162|16971168|P2|Period 2 (2 Weeks)|Adverse Event|1
4930003|NCT00435162|16971169|P1|Period 2 (2 Weeks)|Adverse Event|0
4930004|NCT00435045|16971189|P2|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0
4930005|NCT00435045|16971190|P1|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1
4930006|NCT00435045|16971189|P2|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0
4930007|NCT00435045|16971190|P1|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1
4930008|NCT00435045|16971189|P2|Weeks 13-16 / 40mg Dose Level|Adverse Event|2
4930009|NCT00435045|16971190|P1|Weeks 13-16 / 40mg Dose Level|Adverse Event|3
4930010|NCT00435045|16971189|P2|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1
4930011|NCT00435045|16971190|P1|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0
4930012|NCT00435045|16971189|P2|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
4930013|NCT00435045|16971190|P1|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1
4930014|NCT00435045|16971189|P2|Weeks 9-12 / 20mg Dose Level|Adverse Event|3
4930015|NCT00435045|16971190|P1|Weeks 9-12 / 20mg Dose Level|Adverse Event|4
4930016|NCT00435045|16971189|P2|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1
4930017|NCT00435045|16971190|P1|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0
4930018|NCT00435045|16971189|P2|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0
4930019|NCT00435045|16971190|P1|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1
4930020|NCT00435045|16971189|P2|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1
4930021|NCT00435045|16971190|P1|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2
4930022|NCT00435045|16971189|P2|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
4930023|NCT00435045|16971190|P1|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1
4930024|NCT00435045|16971189|P2|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
4930025|NCT00435045|16971190|P1|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1
4930026|NCT00435019|16971246|P2|Overall Study|Personal reasons for withdrawal|7
4930027|NCT00435019|16971247|P1|Overall Study|Personal reasons for withdrawal|8
4930028|NCT00435019|16971246|P2|Overall Study|Protocol Violation|1
4930029|NCT00435019|16971247|P1|Overall Study|Protocol Violation|3
4930030|NCT00435019|16971246|P2|Overall Study|Lack of Efficacy|2
4930031|NCT00435019|16971247|P1|Overall Study|Lack of Efficacy|1
4930032|NCT00435019|16971246|P2|Overall Study|Adverse Event|0
4930033|NCT00435019|16971247|P1|Overall Study|Adverse Event|1
4930034|NCT00434967|16971288|P4|Overall Study|Patient Disposition Challenges|3
4930035|NCT00434967|16971289|P3|Overall Study|Patient Disposition Challenges|0
4930036|NCT00434967|16971290|P2|Overall Study|Patient Disposition Challenges|0
4930037|NCT00434967|16971291|P1|Overall Study|Patient Disposition Challenges|2
4930038|NCT00434967|16971288|P4|Overall Study|Physician Decision|0
4930039|NCT00434967|16971289|P3|Overall Study|Physician Decision|1
4930040|NCT00434967|16971290|P2|Overall Study|Physician Decision|1
4930041|NCT00434967|16971291|P1|Overall Study|Physician Decision|1
4930042|NCT00434967|16971288|P4|Overall Study|Protocol Violation|1
4930043|NCT00434967|16971289|P3|Overall Study|Protocol Violation|0
4930044|NCT00434967|16971290|P2|Overall Study|Protocol Violation|1
4930045|NCT00434967|16971291|P1|Overall Study|Protocol Violation|0
4930046|NCT00434967|16971288|P4|Overall Study|Randomized in error|1
4930047|NCT00434967|16971289|P3|Overall Study|Randomized in error|0
4930048|NCT00434967|16971290|P2|Overall Study|Randomized in error|0
4930049|NCT00434967|16971291|P1|Overall Study|Randomized in error|0
4930050|NCT00434967|16971288|P4|Overall Study|Withdrawal by Subject|6
4930051|NCT00434967|16971289|P3|Overall Study|Withdrawal by Subject|4
4930052|NCT00434967|16971290|P2|Overall Study|Withdrawal by Subject|2
4930053|NCT00434967|16971291|P1|Overall Study|Withdrawal by Subject|2
4930054|NCT00434967|16971288|P4|Overall Study|Lost to Follow-up|0
4930055|NCT00434967|16971289|P3|Overall Study|Lost to Follow-up|1
4930056|NCT00434967|16971290|P2|Overall Study|Lost to Follow-up|0
4930057|NCT00434967|16971291|P1|Overall Study|Lost to Follow-up|0
4930058|NCT00434967|16971288|P4|Overall Study|Adverse Event|3
4930059|NCT00434967|16971289|P3|Overall Study|Adverse Event|3
4930060|NCT00434967|16971290|P2|Overall Study|Adverse Event|4
4930061|NCT00434967|16971291|P1|Overall Study|Adverse Event|2
4930062|NCT00434954|16971311|P2|Overall Study|Subject decision|22
4930063|NCT00434954|16971312|P1|Overall Study|Subject decision|8
4930064|NCT00434954|16971311|P2|Overall Study|Sponsor decision|0
4930065|NCT00434954|16971312|P1|Overall Study|Sponsor decision|1
4930066|NCT00434954|16971311|P2|Overall Study|Protocol Violation|27
4930067|NCT00434954|16971312|P1|Overall Study|Protocol Violation|36
4930068|NCT00434954|16971311|P2|Overall Study|Physician Decision|3
4930069|NCT00434954|16971312|P1|Overall Study|Physician Decision|6
4930070|NCT00434954|16971311|P2|Overall Study|Lost to Follow-up|1
4930071|NCT00434954|16971312|P1|Overall Study|Lost to Follow-up|0
4930072|NCT00434954|16971311|P2|Overall Study|Entry criteria not met|16
4930073|NCT00434954|16971312|P1|Overall Study|Entry criteria not met|14
4930074|NCT00434954|16971311|P2|Overall Study|Adverse Event|2
4930075|NCT00434954|16971312|P1|Overall Study|Adverse Event|17
4930076|NCT00434876|16971342|P2|Overall Study|Lost to Follow-up|1
4930077|NCT00434876|16971343|P1|Overall Study|Lost to Follow-up|1
4930078|NCT00434759|16971357|P2|Overall Study|family affairs|0
4930079|NCT00434759|16971358|P1|Overall Study|family affairs|2
4930080|NCT00434759|16971357|P2|Overall Study|Withdrawal by Subject|1
4930081|NCT00434759|16971358|P1|Overall Study|Withdrawal by Subject|17
4930082|NCT00434759|16971357|P2|Overall Study|Lack of Efficacy|4
4930083|NCT00434759|16971358|P1|Overall Study|Lack of Efficacy|5
4930084|NCT00434642|16971374|P2|Open-label Treatment Phase|Disease Progression Per RECIST|6
4930085|NCT00434642|16971375|P1|Open-label Treatment Phase|Disease Progression Per RECIST|0
4930086|NCT00434642|16971374|P2|Open-label Treatment Phase|Adverse Event|5
4930087|NCT00434642|16971375|P1|Open-label Treatment Phase|Adverse Event|0
4930088|NCT00434642|16971374|P2|Blinded Treatment Phase|Did not Receive Treatment|1
4930089|NCT00434642|16971375|P1|Blinded Treatment Phase|Did not Receive Treatment|4
4930090|NCT00434642|16971374|P2|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29
4930091|NCT00434642|16971375|P1|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32
4930092|NCT00434642|16971374|P2|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0
4930093|NCT00434642|16971375|P1|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3
4930094|NCT00434642|16971374|P2|Blinded Treatment Phase|Physician Decision|27
4930095|NCT00434642|16971375|P1|Blinded Treatment Phase|Physician Decision|19
4930096|NCT00434642|16971374|P2|Blinded Treatment Phase|Disease Progression Per RECIST|109
4930097|NCT00434642|16971375|P1|Blinded Treatment Phase|Disease Progression Per RECIST|168
4930098|NCT00434642|16971374|P2|Blinded Treatment Phase|Clinical Disease Progression|5
4930099|NCT00434642|16971375|P1|Blinded Treatment Phase|Clinical Disease Progression|4
4930100|NCT00434642|16971374|P2|Blinded Treatment Phase|Adverse Event|58
4930101|NCT00434642|16971375|P1|Blinded Treatment Phase|Adverse Event|12
4930102|NCT00434590|16971393|P2|Overall Study|Administrative problems|5
4930103|NCT00434590|16971394|P1|Overall Study|Administrative problems|5
4930104|NCT00434577|16971405|P5|Months 0-3|Withdrawal by Subject|1
4930105|NCT00434577|16971406|P4|Months 0-3|Withdrawal by Subject|1
4930106|NCT00434577|16971407|P3|Months 0-3|Withdrawal by Subject|1
4930107|NCT00434577|16971408|P2|Months 0-3|Withdrawal by Subject|1
4930108|NCT00434577|16971409|P1|Months 0-3|Withdrawal by Subject|2
4930109|NCT00434577|16971405|P5|Months 0-3|Protocol Violation|0
4930110|NCT00434577|16971406|P4|Months 0-3|Protocol Violation|0
4930111|NCT00434577|16971407|P3|Months 0-3|Protocol Violation|1
4930112|NCT00434577|16971408|P2|Months 0-3|Protocol Violation|0
4930113|NCT00434577|16971409|P1|Months 0-3|Protocol Violation|1
4930114|NCT00434577|16971405|P5|Months 0-3|Lost to Follow-up|2
4930115|NCT00434577|16971406|P4|Months 0-3|Lost to Follow-up|0
4930116|NCT00434577|16971407|P3|Months 0-3|Lost to Follow-up|0
4930117|NCT00434577|16971408|P2|Months 0-3|Lost to Follow-up|0
4930118|NCT00434577|16971409|P1|Months 0-3|Lost to Follow-up|0
4930119|NCT00434577|16971405|P5|Months 0-3|Adverse Event|0
4930120|NCT00434577|16971406|P4|Months 0-3|Adverse Event|0
4930121|NCT00434577|16971407|P3|Months 0-3|Adverse Event|1
4930122|NCT00434577|16971408|P2|Months 0-3|Adverse Event|1
4930123|NCT00434577|16971409|P1|Months 0-3|Adverse Event|0
4930124|NCT00434577|16971405|P5|Months 0-3|Serious Adverse Event|0
4930125|NCT00434577|16971406|P4|Months 0-3|Serious Adverse Event|0
4930126|NCT00434577|16971407|P3|Months 0-3|Serious Adverse Event|1
4930127|NCT00434577|16971408|P2|Months 0-3|Serious Adverse Event|0
4930128|NCT00434577|16971409|P1|Months 0-3|Serious Adverse Event|0
4930129|NCT00434512|16971587|P6|Overall Study|Other|0
4930130|NCT00434512|16971588|P5|Overall Study|Other|0
4930131|NCT00434512|16971589|P4|Overall Study|Other|0
4930132|NCT00434512|16971590|P3|Overall Study|Other|0
4930133|NCT00434512|16971591|P2|Overall Study|Other|1
4930134|NCT00434512|16971592|P1|Overall Study|Other|0
4930135|NCT00434512|16971587|P6|Overall Study|Migrated/moved from study area|1
4930136|NCT00434512|16971588|P5|Overall Study|Migrated/moved from study area|1
4930137|NCT00434512|16971589|P4|Overall Study|Migrated/moved from study area|1
4930138|NCT00434512|16971590|P3|Overall Study|Migrated/moved from study area|0
4930139|NCT00434512|16971591|P2|Overall Study|Migrated/moved from study area|0
4930140|NCT00434512|16971592|P1|Overall Study|Migrated/moved from study area|0
4930141|NCT00434421|16971706|P1|Overall Study|Non-compliance with study treatment|1
4930142|NCT00434421|16971706|P1|Overall Study|Withdrawal by Subject|1
4930143|NCT00434330|16971734|P6|Overall Study|Subject Not Compliant With Study|0
4930144|NCT00434330|16971735|P5|Overall Study|Subject Not Compliant With Study|0
4930145|NCT00434330|16971736|P4|Overall Study|Subject Not Compliant With Study|0
4930146|NCT00434330|16971737|P3|Overall Study|Subject Not Compliant With Study|1
4930147|NCT00434330|16971738|P2|Overall Study|Subject Not Compliant With Study|0
4930148|NCT00434330|16971739|P1|Overall Study|Subject Not Compliant With Study|0
4930149|NCT00434330|16971734|P6|Overall Study|Renal transplant|0
4930150|NCT00434330|16971735|P5|Overall Study|Renal transplant|0
4930151|NCT00434330|16971736|P4|Overall Study|Renal transplant|1
4930152|NCT00434330|16971737|P3|Overall Study|Renal transplant|0
4930153|NCT00434330|16971738|P2|Overall Study|Renal transplant|0
4930154|NCT00434330|16971739|P1|Overall Study|Renal transplant|0
4930155|NCT00434330|16971734|P6|Overall Study|Withdrawal by Subject|0
4930156|NCT00434330|16971735|P5|Overall Study|Withdrawal by Subject|0
4930157|NCT00434330|16971736|P4|Overall Study|Withdrawal by Subject|1
4930158|NCT00434330|16971737|P3|Overall Study|Withdrawal by Subject|1
4930159|NCT00434330|16971738|P2|Overall Study|Withdrawal by Subject|0
4930160|NCT00434330|16971739|P1|Overall Study|Withdrawal by Subject|0
4930161|NCT00434330|16971734|P6|Overall Study|Death|1
4930162|NCT00434330|16971735|P5|Overall Study|Death|1
4930163|NCT00434330|16971736|P4|Overall Study|Death|0
4930164|NCT00434330|16971737|P3|Overall Study|Death|0
4930165|NCT00434330|16971738|P2|Overall Study|Death|0
4930166|NCT00434330|16971739|P1|Overall Study|Death|1
4930167|NCT00434330|16971734|P6|Overall Study|Adverse Event|0
4930168|NCT00434330|16971735|P5|Overall Study|Adverse Event|0
4930169|NCT00434330|16971736|P4|Overall Study|Adverse Event|0
4930170|NCT00434330|16971737|P3|Overall Study|Adverse Event|1
4930171|NCT00434330|16971738|P2|Overall Study|Adverse Event|0
4930172|NCT00434330|16971739|P1|Overall Study|Adverse Event|0
4930173|NCT00434304|16971771|P1|Overall Study|Withdrawal by Subject|4
4930174|NCT00434304|16971771|P1|Overall Study|Lack of Efficacy|2
4930175|NCT00434304|16971771|P1|Overall Study|Adverse Event|14
4930176|NCT00434252|16971820|P2|Overall Study|Withdrawal by Subject|7
4930177|NCT00434252|16971821|P1|Overall Study|Withdrawal by Subject|3
4930178|NCT00434252|16971820|P2|Overall Study|Physician Decision|8
4930179|NCT00434252|16971821|P1|Overall Study|Physician Decision|4
4930180|NCT00434252|16971820|P2|Overall Study|Lost to Follow-up|1
4930181|NCT00434252|16971821|P1|Overall Study|Lost to Follow-up|0
4930182|NCT00434252|16971820|P2|Overall Study|Death|2
4930183|NCT00434252|16971821|P1|Overall Study|Death|1
4930184|NCT00434252|16971820|P2|Overall Study|Adverse Event|13
4930185|NCT00434252|16971821|P1|Overall Study|Adverse Event|6
4930186|NCT00434252|16971820|P2|Overall Study|Lack of Efficacy|100
4930187|NCT00434252|16971821|P1|Overall Study|Lack of Efficacy|50
4930188|NCT00434213|16971855|P1|Overall Study|Non-compliant to study schedule|1
4930189|NCT00434213|16971855|P1|Overall Study|Application site reaction|1
4930190|NCT00434213|16971855|P1|Overall Study|Unable to comply with study visit window|2
4930191|NCT00434213|16971855|P1|Overall Study|Protocol Violation|3
4930192|NCT00434213|16971855|P1|Overall Study|Withdrawal by Subject|7
4930193|NCT00434213|16971855|P1|Overall Study|Lost to Follow-up|14
4930194|NCT00434213|16971855|P1|Overall Study|Lack of Efficacy|9
4930195|NCT00434213|16971855|P1|Overall Study|Adverse Event|12
4930196|NCT00434161|16971863|P3|Overall Study|Logistical error study assessments|3
4930197|NCT00434161|16971864|P2|Overall Study|Logistical error study assessments|0
4930198|NCT00434161|16971865|P1|Overall Study|Logistical error study assessments|1
4930199|NCT00434161|16971863|P3|Overall Study|Withdrawal by Subject|3
4930200|NCT00434161|16971864|P2|Overall Study|Withdrawal by Subject|0
4930201|NCT00434161|16971865|P1|Overall Study|Withdrawal by Subject|2
4930202|NCT00434161|16971863|P3|Overall Study|Non-Compliance|0
4930203|NCT00434161|16971864|P2|Overall Study|Non-Compliance|1
4930204|NCT00434161|16971865|P1|Overall Study|Non-Compliance|1
4930205|NCT00434161|16971863|P3|Overall Study|Death|1
4930206|NCT00434161|16971864|P2|Overall Study|Death|0
4930207|NCT00434161|16971865|P1|Overall Study|Death|1
4930208|NCT00434161|16971863|P3|Overall Study|Lost to Follow-up|0
4930209|NCT00434161|16971864|P2|Overall Study|Lost to Follow-up|1
4930210|NCT00434161|16971865|P1|Overall Study|Lost to Follow-up|0
4930211|NCT00434161|16971863|P3|Overall Study|Adverse Event|4
4930212|NCT00434161|16971864|P2|Overall Study|Adverse Event|1
4930213|NCT00434161|16971865|P1|Overall Study|Adverse Event|5
4930214|NCT00434148|16971909|P2|Overall Study|Abnormal test procedure result|1
4930215|NCT00434148|16971910|P1|Overall Study|Abnormal test procedure result|0
4930216|NCT00434148|16971909|P2|Overall Study|Condition no longer requires study drug|0
4930217|NCT00434148|16971910|P1|Overall Study|Condition no longer requires study drug|1
4930218|NCT00434148|16971909|P2|Overall Study|Lost to Follow-up|1
4930219|NCT00434148|16971910|P1|Overall Study|Lost to Follow-up|0
4930220|NCT00434148|16971909|P2|Overall Study|Administrative problems|10
4930221|NCT00434148|16971910|P1|Overall Study|Administrative problems|6
4930222|NCT00434148|16971909|P2|Overall Study|Protocol Violation|0
4930223|NCT00434148|16971910|P1|Overall Study|Protocol Violation|4
4930224|NCT00434148|16971909|P2|Overall Study|Withdrawal by Subject|15
4930225|NCT00434148|16971910|P1|Overall Study|Withdrawal by Subject|15
4930226|NCT00434148|16971909|P2|Overall Study|Lack of Efficacy|28
4930227|NCT00434148|16971910|P1|Overall Study|Lack of Efficacy|25
4930228|NCT00434148|16971909|P2|Overall Study|Adverse Event|18
4930229|NCT00434148|16971910|P1|Overall Study|Adverse Event|18
4930230|NCT00434122|16971946|P2|Overall Study|Travelling of subject.|0
4930231|NCT00434122|16971947|P1|Overall Study|Travelling of subject.|1
4930232|NCT00434122|16971946|P2|Overall Study|Low follicular response.|2
4930233|NCT00434122|16971947|P1|Overall Study|Low follicular response.|1
4930234|NCT00434122|16971946|P2|Overall Study|Large follicle size|2
4930235|NCT00434122|16971947|P1|Overall Study|Large follicle size|2
4930236|NCT00434122|16971946|P2|Overall Study|Personal reasons|1
4930237|NCT00434122|16971947|P1|Overall Study|Personal reasons|1
4930238|NCT00434122|16971946|P2|Overall Study|loss of subject contact|1
4930239|NCT00434122|16971947|P1|Overall Study|loss of subject contact|1
4930240|NCT00434122|16971946|P2|Overall Study|Non-compliance with protocol|1
4930241|NCT00434122|16971947|P1|Overall Study|Non-compliance with protocol|0
4930242|NCT00434109|16971956|P1|Overall Study|had embolism, did not receive sunitinib|3
4930243|NCT00434109|16971956|P1|Overall Study|Protocol Violation|1
4930244|NCT00434109|16971956|P1|Overall Study|Adverse Event|5
4930245|NCT00434109|16971956|P1|Overall Study|Physician Decision|9
4930246|NCT00434057|16971965|P1|Overall Study|Withdrawal by Subject|1
4930247|NCT00433966|16972003|P4|Stent Intervention/Randomization|Lost to Follow-up|47
4930248|NCT00433966|16972004|P3|Stent Intervention/Randomization|Lost to Follow-up|113
4930249|NCT00433966|16972005|P2|Stent Intervention/Randomization|Lost to Follow-up|0
4930250|NCT00433966|16972006|P1|Stent Intervention/Randomization|Lost to Follow-up|0
4930251|NCT00433966|16972003|P4|Stent Intervention/Randomization|Withdrawal by Subject|15
4930252|NCT00433966|16972004|P3|Stent Intervention/Randomization|Withdrawal by Subject|41
4930253|NCT00433966|16972005|P2|Stent Intervention/Randomization|Withdrawal by Subject|0
4930254|NCT00433966|16972006|P1|Stent Intervention/Randomization|Withdrawal by Subject|0
4930255|NCT00433966|16972003|P4|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
4930256|NCT00433966|16972004|P3|Pharmacology Intervention/Randomization|Not true myocardial infarction|0
4930257|NCT00433966|16972005|P2|Pharmacology Intervention/Randomization|Not true myocardial infarction|28
4930258|NCT00433966|16972006|P1|Pharmacology Intervention/Randomization|Not true myocardial infarction|29
4930259|NCT00433966|16972003|P4|Pharmacology Intervention/Randomization|Lost to Follow-up|0
4930260|NCT00433966|16972004|P3|Pharmacology Intervention/Randomization|Lost to Follow-up|0
4930261|NCT00433966|16972005|P2|Pharmacology Intervention/Randomization|Lost to Follow-up|103
4930262|NCT00433966|16972006|P1|Pharmacology Intervention/Randomization|Lost to Follow-up|97
4930263|NCT00433966|16972003|P4|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
4930264|NCT00433966|16972004|P3|Pharmacology Intervention/Randomization|Withdrawal by Subject|0
4930265|NCT00433966|16972005|P2|Pharmacology Intervention/Randomization|Withdrawal by Subject|43
4930266|NCT00433966|16972006|P1|Pharmacology Intervention/Randomization|Withdrawal by Subject|40
4930267|NCT00433914|16972028|P2|Overall Study|Lost to Follow-up|1
4930268|NCT00433914|16972029|P1|Overall Study|Lost to Follow-up|0
4930269|NCT00433914|16972028|P2|Overall Study|Withdrawal by Subject|2
4930270|NCT00433914|16972029|P1|Overall Study|Withdrawal by Subject|0
4930271|NCT00433836|16972049|P2|Overall Study|Abnormal laboratory values|1
4930272|NCT00433836|16972050|P1|Overall Study|Abnormal laboratory values|0
4930273|NCT00433836|16972049|P2|Overall Study|Condition no longer requires study drug|1
4930274|NCT00433836|16972050|P1|Overall Study|Condition no longer requires study drug|0
4930275|NCT00433836|16972049|P2|Overall Study|Protocol Violation|2
4930276|NCT00433836|16972050|P1|Overall Study|Protocol Violation|0
4930277|NCT00433836|16972049|P2|Overall Study|Unsatisfactory therapeutic effect|1
4930278|NCT00433836|16972050|P1|Overall Study|Unsatisfactory therapeutic effect|1
4930279|NCT00433836|16972049|P2|Overall Study|Withdrawal by Subject|1
4930280|NCT00433836|16972050|P1|Overall Study|Withdrawal by Subject|2
4930281|NCT00433836|16972049|P2|Overall Study|Lost to Follow-up|0
4930282|NCT00433836|16972050|P1|Overall Study|Lost to Follow-up|3
4930283|NCT00433836|16972049|P2|Overall Study|Adverse Event|0
4930284|NCT00433836|16972050|P1|Overall Study|Adverse Event|7
4930285|NCT00433771|16972062|P1|Overall Study|Failure to deploy stent|1
4930286|NCT00433771|16972062|P1|Overall Study|Death|2
4930287|NCT00433771|16972062|P1|Overall Study|Treated and later found to be ineligible|2
4930288|NCT00433771|16972062|P1|Overall Study|screen fail|14
4930289|NCT00433654|16972085|P2|Overall Study|Withdrawal by Subject|2
4930290|NCT00433654|16972086|P1|Overall Study|Withdrawal by Subject|1
4930291|NCT00433654|16972085|P2|Overall Study|Subject not yet due for visit|0
4930292|NCT00433654|16972086|P1|Overall Study|Subject not yet due for visit|4
4930293|NCT00433654|16972085|P2|Overall Study|Missed visit|3
4930294|NCT00433654|16972086|P1|Overall Study|Missed visit|6
4930295|NCT00433654|16972085|P2|Overall Study|Death|0
4930296|NCT00433654|16972086|P1|Overall Study|Death|4
4930297|NCT00433537|16972132|P3|Step 2 - Maintenance Rituximab or ASCT|Other|0
4930298|NCT00433537|16972133|P2|Step 2 - Maintenance Rituximab or ASCT|Other|0
4930299|NCT00433537|16972134|P1|Step 2 - Maintenance Rituximab or ASCT|Other|1
4930300|NCT00433537|16972132|P3|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
4930301|NCT00433537|16972133|P2|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0
4930302|NCT00433537|16972134|P1|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4
4930303|NCT00433537|16972132|P3|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
4930304|NCT00433537|16972133|P2|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0
4930305|NCT00433537|16972134|P1|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2
4930306|NCT00433537|16972132|P3|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
4930307|NCT00433537|16972133|P2|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0
4930308|NCT00433537|16972134|P1|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8
4930309|NCT00433537|16972132|P3|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
4930310|NCT00433537|16972133|P2|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0
4930311|NCT00433537|16972134|P1|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1
4930312|NCT00433537|16972132|P3|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2
4930313|NCT00433537|16972133|P2|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
4930314|NCT00433537|16972134|P1|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0
4930315|NCT00433537|16972132|P3|Step 1 - VcR-CVAD Induction|Adverse Event|4
4930316|NCT00433537|16972133|P2|Step 1 - VcR-CVAD Induction|Adverse Event|0
4930317|NCT00433537|16972134|P1|Step 1 - VcR-CVAD Induction|Adverse Event|0
4930318|NCT00433537|16972132|P3|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2
4930319|NCT00433537|16972133|P2|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
4930320|NCT00433537|16972134|P1|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0
4930321|NCT00433537|16972132|P3|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
4930322|NCT00433537|16972133|P2|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0
4930323|NCT00433537|16972134|P1|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1
4930324|NCT00433511|16972146|P3|Step 2 (Arm D)|Unknown (Missing off treatment form)|1
4930325|NCT00433511|16972147|P2|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
4930326|NCT00433511|16972148|P1|Step 2 (Arm D)|Unknown (Missing off treatment form)|0
4930327|NCT00433511|16972146|P3|Step 2 (Arm D)|Insurance/drug distribution issues|4
4930328|NCT00433511|16972147|P2|Step 2 (Arm D)|Insurance/drug distribution issues|0
4930329|NCT00433511|16972148|P1|Step 2 (Arm D)|Insurance/drug distribution issues|0
4930330|NCT00433511|16972146|P3|Step 2 (Arm D)|Suspected recurrence|1
4930331|NCT00433511|16972147|P2|Step 2 (Arm D)|Suspected recurrence|0
4930332|NCT00433511|16972148|P1|Step 2 (Arm D)|Suspected recurrence|0
4930333|NCT00433511|16972146|P3|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2
4930334|NCT00433511|16972147|P2|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
4930335|NCT00433511|16972148|P1|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0
4930336|NCT00433511|16972146|P3|Step 2 (Arm D)|Other complicating disease|3
4930337|NCT00433511|16972147|P2|Step 2 (Arm D)|Other complicating disease|0
4930338|NCT00433511|16972148|P1|Step 2 (Arm D)|Other complicating disease|0
4930339|NCT00433511|16972146|P3|Step 2 (Arm D)|Disease progression, relapse|7
4930340|NCT00433511|16972147|P2|Step 2 (Arm D)|Disease progression, relapse|0
4930341|NCT00433511|16972148|P1|Step 2 (Arm D)|Disease progression, relapse|0
4930342|NCT00433511|16972146|P3|Step 2 (Arm D)|Physician Decision|9
4930343|NCT00433511|16972147|P2|Step 2 (Arm D)|Physician Decision|0
4930344|NCT00433511|16972148|P1|Step 2 (Arm D)|Physician Decision|0
4930345|NCT00433511|16972146|P3|Step 2 (Arm D)|Never started protocol therapy|148
4930346|NCT00433511|16972147|P2|Step 2 (Arm D)|Never started protocol therapy|0
4930347|NCT00433511|16972148|P1|Step 2 (Arm D)|Never started protocol therapy|0
4930348|NCT00433511|16972146|P3|Step 2 (Arm D)|Withdrawal by Subject|181
4930349|NCT00433511|16972147|P2|Step 2 (Arm D)|Withdrawal by Subject|0
4930350|NCT00433511|16972148|P1|Step 2 (Arm D)|Withdrawal by Subject|0
4930351|NCT00433511|16972146|P3|Step 2 (Arm D)|Adverse Event|135
4930352|NCT00433511|16972147|P2|Step 2 (Arm D)|Adverse Event|0
4930353|NCT00433511|16972148|P1|Step 2 (Arm D)|Adverse Event|0
4930354|NCT00433511|16972146|P3|Step 1|Patient moved|1
4930355|NCT00433511|16972147|P2|Step 1|Patient moved|0
4930356|NCT00433511|16972148|P1|Step 1|Patient moved|0
4930357|NCT00433511|16972146|P3|Step 1|Insurance/drug distribution issues|2
4930358|NCT00433511|16972147|P2|Step 1|Insurance/drug distribution issues|1
4930359|NCT00433511|16972148|P1|Step 1|Insurance/drug distribution issues|0
4930360|NCT00433511|16972146|P3|Step 1|Suspected recurrence|0
4930361|NCT00433511|16972147|P2|Step 1|Suspected recurrence|1
4930362|NCT00433511|16972148|P1|Step 1|Suspected recurrence|0
4930363|NCT00433511|16972146|P3|Step 1|Non-breast cancer surgery/wound issues|1
4930364|NCT00433511|16972147|P2|Step 1|Non-breast cancer surgery/wound issues|4
4930365|NCT00433511|16972148|P1|Step 1|Non-breast cancer surgery/wound issues|0
4930366|NCT00433511|16972146|P3|Step 1|Other complicating disease|3
4930367|NCT00433511|16972147|P2|Step 1|Other complicating disease|6
4930368|NCT00433511|16972148|P1|Step 1|Other complicating disease|2
4930369|NCT00433511|16972146|P3|Step 1|Disease progression, relapse|3
4930370|NCT00433511|16972147|P2|Step 1|Disease progression, relapse|3
4930371|NCT00433511|16972148|P1|Step 1|Disease progression, relapse|5
4930372|NCT00433511|16972146|P3|Step 1|Alternative therapy|3
4930373|NCT00433511|16972147|P2|Step 1|Alternative therapy|1
4930374|NCT00433511|16972148|P1|Step 1|Alternative therapy|2
4930375|NCT00433511|16972146|P3|Step 1|Never started protocol therapy|66
4930376|NCT00433511|16972147|P2|Step 1|Never started protocol therapy|64
4930377|NCT00433511|16972148|P1|Step 1|Never started protocol therapy|28
4930378|NCT00433511|16972146|P3|Step 1|Physician Decision|3
4930379|NCT00433511|16972147|P2|Step 1|Physician Decision|4
4930380|NCT00433511|16972148|P1|Step 1|Physician Decision|1
4930381|NCT00433511|16972146|P3|Step 1|Death|1
4930382|NCT00433511|16972147|P2|Step 1|Death|1
4930383|NCT00433511|16972148|P1|Step 1|Death|3
4930384|NCT00433511|16972146|P3|Step 1|Withdrawal by Subject|154
4930385|NCT00433511|16972147|P2|Step 1|Withdrawal by Subject|143
4930386|NCT00433511|16972148|P1|Step 1|Withdrawal by Subject|45
4930387|NCT00433511|16972146|P3|Step 1|Adverse Event|153
4930388|NCT00433511|16972147|P2|Step 1|Adverse Event|157
4930389|NCT00433511|16972148|P1|Step 1|Adverse Event|50
4930390|NCT00433446|16972162|P1|Overall Study|Ineligible|9
4930391|NCT00433446|16972162|P1|Overall Study|Other - Not Protocol specified|3
4930392|NCT00433446|16972162|P1|Overall Study|Progression|44
4930393|NCT00433446|16972162|P1|Overall Study|Refusal Unrelated to Adverse Event|1
4930394|NCT00433446|16972162|P1|Overall Study|Adverse Event|4
4930395|NCT00433381|16972172|P2|Overall Study|Ineligible / no protocol treatment|3
4930396|NCT00433381|16972173|P1|Overall Study|Ineligible / no protocol treatment|3
4930397|NCT00433329|16972192|P1|Overall Study|Physician Decision|1
4930398|NCT00433329|16972192|P1|Overall Study|Lost to Follow-up|1
4930399|NCT00433329|16972192|P1|Overall Study|Moved out of state|1
4930400|NCT00433329|16972192|P1|Overall Study|Discontinued sildenafil|2
4930401|NCT00433329|16972192|P1|Overall Study|Withdrew consent|3
4930402|NCT00433329|16972192|P1|Overall Study|Death|4
4930403|NCT00433329|16972192|P1|Overall Study|Adverse Event|9
4930404|NCT00433290|16972198|P2|Overall Study|Lost to Follow-up|0
4930405|NCT00433290|16972199|P1|Overall Study|Lost to Follow-up|1
4930406|NCT00433290|16972198|P2|Overall Study|Entry Criteria Not Met|1
4930407|NCT00433290|16972199|P1|Overall Study|Entry Criteria Not Met|0
4930408|NCT00433290|16972198|P2|Overall Study|Physician Decision|0
4930409|NCT00433290|16972199|P1|Overall Study|Physician Decision|2
4930410|NCT00433290|16972198|P2|Overall Study|Protocol Violation|2
4930411|NCT00433290|16972199|P1|Overall Study|Protocol Violation|3
4930412|NCT00433290|16972198|P2|Overall Study|Withdrawal by Subject|2
4930413|NCT00433290|16972199|P1|Overall Study|Withdrawal by Subject|4
4930414|NCT00433290|16972198|P2|Overall Study|Lack of Efficacy|5
4930415|NCT00433290|16972199|P1|Overall Study|Lack of Efficacy|1
4930416|NCT00433290|16972198|P2|Overall Study|Adverse Event|7
4930417|NCT00433290|16972199|P1|Overall Study|Adverse Event|24
4930418|NCT00433199|16972268|P2|Open-Label Period|Administrative|1
4930419|NCT00433199|16972269|P1|Open-Label Period|Administrative|0
4930420|NCT00433199|16972268|P2|Open-Label Period|Protocol Violation|2
4930421|NCT00433199|16972269|P1|Open-Label Period|Protocol Violation|0
4930422|NCT00433199|16972268|P2|Open-Label Period|Withdrawal by Subject|7
4930423|NCT00433199|16972269|P1|Open-Label Period|Withdrawal by Subject|0
4930424|NCT00433199|16972268|P2|Open-Label Period|Lost to Follow-up|3
4930425|NCT00433199|16972269|P1|Open-Label Period|Lost to Follow-up|0
4930426|NCT00433199|16972268|P2|Open-Label Period|Lack of Efficacy|2
4930427|NCT00433199|16972269|P1|Open-Label Period|Lack of Efficacy|0
4930428|NCT00433199|16972268|P2|Open-Label Period|Adverse Event|19
4930429|NCT00433199|16972269|P1|Open-Label Period|Adverse Event|0
4930430|NCT00433199|16972268|P2|Double-Blind Period|Administrative|5
4930431|NCT00433199|16972269|P1|Double-Blind Period|Administrative|1
4930432|NCT00433199|16972268|P2|Double-Blind Period|Protocol Violation|10
4930433|NCT00433199|16972269|P1|Double-Blind Period|Protocol Violation|1
4930434|NCT00433199|16972268|P2|Double-Blind Period|Withdrawal by Subject|19
4930435|NCT00433199|16972269|P1|Double-Blind Period|Withdrawal by Subject|8
4930436|NCT00433199|16972268|P2|Double-Blind Period|Lost to Follow-up|5
4930437|NCT00433199|16972269|P1|Double-Blind Period|Lost to Follow-up|2
4930438|NCT00433199|16972268|P2|Double-Blind Period|Lack of Efficacy|2
4930439|NCT00433199|16972269|P1|Double-Blind Period|Lack of Efficacy|0
4930440|NCT00433199|16972268|P2|Double-Blind Period|Adverse Event|25
4930441|NCT00433199|16972269|P1|Double-Blind Period|Adverse Event|0
4930442|NCT00433160|16972289|P2|104 Weeks, 28-Week OL Period|Physician Decision|1
4930443|NCT00433160|16972290|P1|104 Weeks, 28-Week OL Period|Physician Decision|0
4930444|NCT00433160|16972289|P2|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2
4930445|NCT00433160|16972290|P1|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8
4930446|NCT00433160|16972289|P2|104 Weeks, 28-Week OL Period|Adverse Event|0
4930447|NCT00433160|16972290|P1|104 Weeks, 28-Week OL Period|Adverse Event|2
4930448|NCT00433160|16972289|P2|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1
4930449|NCT00433160|16972290|P1|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0
4930450|NCT00433160|16972289|P2|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0
4930451|NCT00433160|16972290|P1|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2
4930452|NCT00433160|16972289|P2|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2
4930453|NCT00433160|16972290|P1|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1
4930454|NCT00433160|16972289|P2|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1
4930455|NCT00433160|16972290|P1|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3
4930456|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Lack of Efficacy|2
4930457|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Lack of Efficacy|1
4930458|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Sponsor Decision|0
4930459|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Sponsor Decision|0
4930460|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Physician Decision|2
4930461|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Physician Decision|4
4930462|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1
4930463|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6
4930464|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Protocol Violation|2
4930465|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Protocol Violation|0
4930466|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1
4930467|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0
4930468|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
4930469|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Lost to Follow-up|0
4930470|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Death|0
4930471|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Death|0
4930472|NCT00433160|16972289|P2|52-Week Double-Blind (DB) Period|Adverse Event|2
4930473|NCT00433160|16972290|P1|52-Week Double-Blind (DB) Period|Adverse Event|6
4930474|NCT00433147|16972342|P4|Overall Study|Adverse Event|0
4930475|NCT00433147|16972343|P3|Overall Study|Adverse Event|0
4930476|NCT00433147|16972344|P2|Overall Study|Adverse Event|1
4930477|NCT00433147|16972345|P1|Overall Study|Adverse Event|0
4930478|NCT00433017|16972361|P2|Overall Study|Subject no longer requires study drug|1
4930479|NCT00433017|16972362|P1|Overall Study|Subject no longer requires study drug|1
4930480|NCT00433017|16972361|P2|Overall Study|Death|2
4930481|NCT00433017|16972362|P1|Overall Study|Death|2
4930482|NCT00433017|16972361|P2|Overall Study|Protocol Violation|0
4930483|NCT00433017|16972362|P1|Overall Study|Protocol Violation|1
4930484|NCT00433017|16972361|P2|Overall Study|Administrative problems|86
4930485|NCT00433017|16972362|P1|Overall Study|Administrative problems|80
4930486|NCT00433017|16972361|P2|Overall Study|Lost to Follow-up|4
4930487|NCT00433017|16972362|P1|Overall Study|Lost to Follow-up|3
4930488|NCT00433017|16972361|P2|Overall Study|Withdrawal by Subject|5
4930489|NCT00433017|16972362|P1|Overall Study|Withdrawal by Subject|4
4930490|NCT00433017|16972361|P2|Overall Study|Adverse Event|3
4930491|NCT00433017|16972362|P1|Overall Study|Adverse Event|5
4930492|NCT00433004|16972378|P2|Overall Study|Lost to Follow-up|7
4930493|NCT00433004|16972379|P1|Overall Study|Lost to Follow-up|5
4930494|NCT00432991|16972391|P2|Overall Study|Protocol Violation|12
4930495|NCT00432991|16972392|P1|Overall Study|Protocol Violation|7
4930496|NCT00432965|16972404|P2|Overall Study|Incomplete Data|3
4930497|NCT00432965|16972405|P1|Overall Study|Incomplete Data|4
4930498|NCT00432965|16972404|P2|Overall Study|Exclusionary Methods|2
4930499|NCT00432965|16972405|P1|Overall Study|Exclusionary Methods|1
4930500|NCT00432965|16972404|P2|Overall Study|Death|4
4930501|NCT00432965|16972405|P1|Overall Study|Death|3
4930502|NCT00432965|16972404|P2|Overall Study|Adverse Event|19
4930503|NCT00432965|16972405|P1|Overall Study|Adverse Event|22
4930504|NCT00432965|16972404|P2|Overall Study|Non-compliance|0
4930505|NCT00432965|16972405|P1|Overall Study|Non-compliance|7
4930506|NCT00432965|16972404|P2|Overall Study|Lack of Efficacy|13
4930507|NCT00432965|16972405|P1|Overall Study|Lack of Efficacy|8
4930508|NCT00432965|16972404|P2|Overall Study|Physician Decision|13
4930509|NCT00432965|16972405|P1|Overall Study|Physician Decision|14
4930510|NCT00432965|16972404|P2|Overall Study|Withdrawal by Subject|13
4930511|NCT00432965|16972405|P1|Overall Study|Withdrawal by Subject|13
4930512|NCT00432965|16972404|P2|Overall Study|Lost to Follow-up|19
4930513|NCT00432965|16972405|P1|Overall Study|Lost to Follow-up|22
4930514|NCT00432835|16972413|P2|Overall Study|Adverse event: lead dislodgement.|7
4930515|NCT00432835|16972414|P1|Overall Study|Adverse event: lead dislodgement.|6
4930516|NCT00432809|16972427|P3|1 Year Follow-up|Withdrawal by Subject|1
4930517|NCT00432809|16972428|P2|1 Year Follow-up|Withdrawal by Subject|0
4930518|NCT00432809|16972429|P1|1 Year Follow-up|Withdrawal by Subject|7
4930519|NCT00432809|16972427|P3|1 Year Follow-up|Misses 9 and 12 month visit|0
4930520|NCT00432809|16972428|P2|1 Year Follow-up|Misses 9 and 12 month visit|0
4930521|NCT00432809|16972429|P1|1 Year Follow-up|Misses 9 and 12 month visit|2
4930522|NCT00432744|16972502|P2|Months 7 - 12|Too disabled to score|1
4930523|NCT00432744|16972503|P1|Months 7 - 12|Too disabled to score|0
4930524|NCT00432744|16972502|P2|Months 7 - 12|Withdrawal by Subject|0
4930525|NCT00432744|16972503|P1|Months 7 - 12|Withdrawal by Subject|1
4930526|NCT00432744|16972502|P2|Months 0-6|Too disabled to score|0
4930527|NCT00432744|16972503|P1|Months 0-6|Too disabled to score|1
4930528|NCT00432744|16972502|P2|Months 0-6|Withdrawal by Subject|4
4930529|NCT00432744|16972503|P1|Months 0-6|Withdrawal by Subject|4
4930530|NCT00432679|16972515|P2|Overall Study|Withdrawal by Subject|2
4930531|NCT00432679|16972516|P1|Overall Study|Withdrawal by Subject|3
4930532|NCT00432679|16972515|P2|Overall Study|Adverse Event|1
4930533|NCT00432679|16972516|P1|Overall Study|Adverse Event|2
4930534|NCT00432666|16972540|P2|Open-Label Extension Period|Physician Decision|0
4930535|NCT00432666|16972541|P1|Open-Label Extension Period|Physician Decision|3
4930536|NCT00432666|16972540|P2|Open-Label Extension Period|Consent withdrawn|0
4930537|NCT00432666|16972541|P1|Open-Label Extension Period|Consent withdrawn|10
4930538|NCT00432666|16972540|P2|Open-Label Extension Period|Adverse Event|0
4930539|NCT00432666|16972541|P1|Open-Label Extension Period|Adverse Event|5
4930540|NCT00432666|16972540|P2|Open-Label Extension Period|Lack of Efficacy|0
4930541|NCT00432666|16972541|P1|Open-Label Extension Period|Lack of Efficacy|6
4930542|NCT00432666|16972540|P2|Open-Label Extension Period|Withdrawal Criteria Occurred|0
4930543|NCT00432666|16972541|P1|Open-Label Extension Period|Withdrawal Criteria Occurred|1
4930544|NCT00432666|16972540|P2|Main Period|Consent Withdrawn|0
4930545|NCT00432666|16972541|P1|Main Period|Consent Withdrawn|1
4930546|NCT00432666|16972540|P2|Main Period|Adverse Event|1
4930547|NCT00432666|16972541|P1|Main Period|Adverse Event|1
4930548|NCT00432562|16972714|P2|Overall Study|Death|0
4930549|NCT00432562|16972715|P1|Overall Study|Death|3
4930550|NCT00432380|16972767|P3|Overall Study|Adverse Event|0
4930551|NCT00432380|16972768|P2|Overall Study|Adverse Event|0
4930552|NCT00432380|16972769|P1|Overall Study|Adverse Event|1
4930553|NCT00432380|16972767|P3|Overall Study|Migrated/moved from study area|1
4930554|NCT00432380|16972768|P2|Overall Study|Migrated/moved from study area|4
4930555|NCT00432380|16972769|P1|Overall Study|Migrated/moved from study area|3
4930556|NCT00432276|16972822|P2|Overall Study|Other|3
4930557|NCT00432276|16972823|P1|Overall Study|Other|2
4930558|NCT00432276|16972822|P2|Overall Study|Physician Decision|8
4930559|NCT00432276|16972823|P1|Overall Study|Physician Decision|6
4930560|NCT00432276|16972822|P2|Overall Study|Withdrawal by Subject|20
4930561|NCT00432276|16972823|P1|Overall Study|Withdrawal by Subject|25
4930562|NCT00432276|16972822|P2|Overall Study|Lost to Follow-up|2
4930563|NCT00432276|16972823|P1|Overall Study|Lost to Follow-up|6
4930564|NCT00432276|16972822|P2|Overall Study|Protocol Violation|20
4930565|NCT00432276|16972823|P1|Overall Study|Protocol Violation|25
4930566|NCT00432276|16972822|P2|Overall Study|Adverse Event|16
4930567|NCT00432276|16972823|P1|Overall Study|Adverse Event|13
4930568|NCT00432276|16972822|P2|Overall Study|Hyperglycemic Rescue|87
4930569|NCT00432276|16972823|P1|Overall Study|Hyperglycemic Rescue|44
4930570|NCT00432237|16972913|P4|Overall Study|Lack of Qualifying Event|84
4930571|NCT00432237|16972914|P3|Overall Study|Lack of Qualifying Event|69
4930572|NCT00432237|16972915|P2|Overall Study|Lack of Qualifying Event|71
4930573|NCT00432237|16972916|P1|Overall Study|Lack of Qualifying Event|38
4930574|NCT00432237|16972913|P4|Overall Study|Withdrawal by Subject|11
4930575|NCT00432237|16972914|P3|Overall Study|Withdrawal by Subject|9
4930576|NCT00432237|16972915|P2|Overall Study|Withdrawal by Subject|6
4930577|NCT00432237|16972916|P1|Overall Study|Withdrawal by Subject|5
4930578|NCT00432237|16972913|P4|Overall Study|Protocol Violation|8
4930579|NCT00432237|16972914|P3|Overall Study|Protocol Violation|11
4930580|NCT00432237|16972915|P2|Overall Study|Protocol Violation|10
4930581|NCT00432237|16972916|P1|Overall Study|Protocol Violation|13
4930582|NCT00432237|16972913|P4|Overall Study|Pregnancy|0
4930583|NCT00432237|16972914|P3|Overall Study|Pregnancy|0
4930584|NCT00432237|16972915|P2|Overall Study|Pregnancy|1
4930585|NCT00432237|16972916|P1|Overall Study|Pregnancy|0
4930586|NCT00432237|16972913|P4|Overall Study|Physician Decision|1
4930587|NCT00432237|16972914|P3|Overall Study|Physician Decision|2
4930588|NCT00432237|16972915|P2|Overall Study|Physician Decision|3
4930589|NCT00432237|16972916|P1|Overall Study|Physician Decision|1
4930590|NCT00432237|16972913|P4|Overall Study|Lost to Follow-up|18
4930591|NCT00432237|16972914|P3|Overall Study|Lost to Follow-up|18
4930592|NCT00432237|16972915|P2|Overall Study|Lost to Follow-up|10
4930593|NCT00432237|16972916|P1|Overall Study|Lost to Follow-up|10
4930594|NCT00432237|16972913|P4|Overall Study|Lack of Efficacy|1
4930595|NCT00432237|16972914|P3|Overall Study|Lack of Efficacy|0
4930596|NCT00432237|16972915|P2|Overall Study|Lack of Efficacy|0
4930597|NCT00432237|16972916|P1|Overall Study|Lack of Efficacy|0
4930598|NCT00432237|16972913|P4|Overall Study|Adverse Event|1
4930599|NCT00432237|16972914|P3|Overall Study|Adverse Event|0
4930600|NCT00432237|16972915|P2|Overall Study|Adverse Event|0
4930601|NCT00432237|16972916|P1|Overall Study|Adverse Event|0
4930602|NCT00432172|16972958|P4|Overall Study|No treatment received|1
4930603|NCT00432172|16972959|P3|Overall Study|No treatment received|0
4930604|NCT00432172|16972960|P2|Overall Study|No treatment received|2
4930605|NCT00432172|16972961|P1|Overall Study|No treatment received|2
4930606|NCT00432172|16972958|P4|Overall Study|Withdrawal by Subject|2
4930607|NCT00432172|16972959|P3|Overall Study|Withdrawal by Subject|0
4930608|NCT00432172|16972960|P2|Overall Study|Withdrawal by Subject|1
4930609|NCT00432172|16972961|P1|Overall Study|Withdrawal by Subject|0
4930610|NCT00432172|16972958|P4|Overall Study|Disease progression|1
4930611|NCT00432172|16972959|P3|Overall Study|Disease progression|5
4930612|NCT00432172|16972960|P2|Overall Study|Disease progression|2
4930613|NCT00432172|16972961|P1|Overall Study|Disease progression|0
4930614|NCT00432172|16972958|P4|Overall Study|Adverse Event|3
4930615|NCT00432172|16972959|P3|Overall Study|Adverse Event|4
4930616|NCT00432172|16972960|P2|Overall Study|Adverse Event|2
4930617|NCT00432172|16972961|P1|Overall Study|Adverse Event|4
4930618|NCT00432172|16972958|P4|Overall Study|Physician Decision|0
4930619|NCT00432172|16972959|P3|Overall Study|Physician Decision|2
4930620|NCT00432172|16972960|P2|Overall Study|Physician Decision|0
4930621|NCT00432172|16972961|P1|Overall Study|Physician Decision|0
4930622|NCT00432159|16972986|P5|Overall Study|Missing NDI and/or neuro. assessment|7
4930623|NCT00432159|16972987|P4|Overall Study|Missing NDI and/or neuro. assessment|3
4930624|NCT00432159|16972988|P3|Overall Study|Missing NDI and/or neuro. assessment|1
4930625|NCT00432159|16972989|P2|Overall Study|Missing NDI and/or neuro. assessment|24
4930626|NCT00432159|16972990|P1|Overall Study|Missing NDI and/or neuro. assessment|13
4930627|NCT00432159|16972986|P5|Overall Study|Failure|3
4930628|NCT00432159|16972987|P4|Overall Study|Failure|2
4930629|NCT00432159|16972988|P3|Overall Study|Failure|3
4930630|NCT00432159|16972989|P2|Overall Study|Failure|5
4930631|NCT00432159|16972990|P1|Overall Study|Failure|9
4930632|NCT00432159|16972986|P5|Overall Study|Death|0
4930633|NCT00432159|16972987|P4|Overall Study|Death|0
4930634|NCT00432159|16972988|P3|Overall Study|Death|0
4930635|NCT00432159|16972989|P2|Overall Study|Death|1
4930636|NCT00432159|16972990|P1|Overall Study|Death|0
4930637|NCT00432042|16973097|P3|Overall Study|Lost to Follow-up|0
4930638|NCT00432042|16973098|P2|Overall Study|Lost to Follow-up|1
4930639|NCT00432042|16973099|P1|Overall Study|Lost to Follow-up|5
4930640|NCT00432042|16973097|P3|Overall Study|Withdrawal by Subject|2
4930641|NCT00432042|16973098|P2|Overall Study|Withdrawal by Subject|0
4930642|NCT00432042|16973099|P1|Overall Study|Withdrawal by Subject|0
4930643|NCT00432042|16973097|P3|Overall Study|Protocol Violation|0
4930644|NCT00432042|16973098|P2|Overall Study|Protocol Violation|0
4930645|NCT00432042|16973099|P1|Overall Study|Protocol Violation|2
4930646|NCT00431964|16973112|P2|Overall Study|Due to Unstable Health|1
4930647|NCT00431964|16973113|P1|Overall Study|Due to Unstable Health|0
4930648|NCT00431964|16973112|P2|Overall Study|Parental Consent Withdrawn|2
4930649|NCT00431964|16973113|P1|Overall Study|Parental Consent Withdrawn|0
4930650|NCT00431964|16973112|P2|Overall Study|Withdrawal by Subject|1
4930651|NCT00431964|16973113|P1|Overall Study|Withdrawal by Subject|2
4930652|NCT00431964|16973112|P2|Overall Study|Physician Decision|2
4930653|NCT00431964|16973113|P1|Overall Study|Physician Decision|2
4930654|NCT00431964|16973112|P2|Overall Study|Lost to Follow-up|2
4930655|NCT00431964|16973113|P1|Overall Study|Lost to Follow-up|1
4930656|NCT00431964|16973112|P2|Overall Study|Adverse Event|0
4930657|NCT00431964|16973113|P1|Overall Study|Adverse Event|1
4930658|NCT00431951|16973123|P4|Overall Study|Adverse Event|0
4930659|NCT00431951|16973124|P3|Overall Study|Adverse Event|1
4930660|NCT00431951|16973125|P2|Overall Study|Adverse Event|0
4930661|NCT00431951|16973126|P1|Overall Study|Adverse Event|0
4930662|NCT00431951|16973123|P4|Overall Study|Withdrawal by Subject|0
4930663|NCT00431951|16973124|P3|Overall Study|Withdrawal by Subject|0
4930664|NCT00431951|16973125|P2|Overall Study|Withdrawal by Subject|1
4930665|NCT00431951|16973126|P1|Overall Study|Withdrawal by Subject|0
4930666|NCT00431951|16973123|P4|Overall Study|Lost to Follow-up|0
4930667|NCT00431951|16973124|P3|Overall Study|Lost to Follow-up|0
4930668|NCT00431951|16973125|P2|Overall Study|Lost to Follow-up|1
4930669|NCT00431951|16973126|P1|Overall Study|Lost to Follow-up|0
4930670|NCT00431951|16973123|P4|Overall Study|Inability to follow study procedures|2
4930671|NCT00431951|16973124|P3|Overall Study|Inability to follow study procedures|1
4930672|NCT00431951|16973125|P2|Overall Study|Inability to follow study procedures|0
4930673|NCT00431951|16973126|P1|Overall Study|Inability to follow study procedures|1
4930674|NCT00431847|16973188|P5|Overall Study|Protocol Violation|1
4930675|NCT00431847|16973189|P4|Overall Study|Protocol Violation|0
4930676|NCT00431847|16973190|P3|Overall Study|Protocol Violation|0
4930677|NCT00431847|16973191|P2|Overall Study|Protocol Violation|0
4930678|NCT00431847|16973192|P1|Overall Study|Protocol Violation|0
4930679|NCT00431847|16973188|P5|Overall Study|completion of less than two study visits|0
4930680|NCT00431847|16973189|P4|Overall Study|completion of less than two study visits|14
4930681|NCT00431847|16973190|P3|Overall Study|completion of less than two study visits|4
4930682|NCT00431847|16973191|P2|Overall Study|completion of less than two study visits|3
4930683|NCT00431847|16973192|P1|Overall Study|completion of less than two study visits|6
4930684|NCT00431834|16973266|P1|Overall Study|Lost to Follow-up|1
4930685|NCT00431834|16973266|P1|Overall Study|Missed Endpoint Visit|2
4930686|NCT00431834|16973266|P1|Overall Study|Death|3
4930687|NCT00431834|16973266|P1|Overall Study|Withdrawal by Subject|7
4930688|NCT00431496|16973282|P1|Overall Study|Protocol-specified criteria|5
4930689|NCT00431496|16973282|P1|Overall Study|Withdrawal by Subject|2
4930690|NCT00431496|16973282|P1|Overall Study|Lost to Follow-up|1
4930691|NCT00431496|16973282|P1|Overall Study|Adverse Event|3
4930692|NCT00431444|16973293|P2|Overall Study|Administrative Problems|1
4930693|NCT00431444|16973294|P1|Overall Study|Administrative Problems|0
4930694|NCT00431444|16973293|P2|Overall Study|Lost to Follow-up|0
4930695|NCT00431444|16973294|P1|Overall Study|Lost to Follow-up|1
4930696|NCT00431444|16973293|P2|Overall Study|Withdrawal by Subject|1
4930697|NCT00431444|16973294|P1|Overall Study|Withdrawal by Subject|1
4930698|NCT00431444|16973293|P2|Overall Study|Adverse Event|1
4930699|NCT00431444|16973294|P1|Overall Study|Adverse Event|2
4930700|NCT00431444|16973293|P2|Overall Study|Protocol Violation|4
4930701|NCT00431444|16973294|P1|Overall Study|Protocol Violation|1
4930702|NCT00431067|16973334|P1|Overall Study|Non-compliance,lost to follow-up|2
4930703|NCT00431067|16973334|P1|Overall Study|Progressive disease|30
4930704|NCT00431067|16973334|P1|Overall Study|Other Adverse Event|9
4930705|NCT00430989|16973359|P2|Overall Study|Not eligible|6
4930706|NCT00430989|16973360|P1|Overall Study|Not eligible|13
4930707|NCT00430989|16973359|P2|Overall Study|Protocol Violation|37
4930708|NCT00430989|16973360|P1|Overall Study|Protocol Violation|30
4930709|NCT00430989|16973359|P2|Overall Study|Withdrawal by Subject|14
4930710|NCT00430989|16973360|P1|Overall Study|Withdrawal by Subject|15
4930711|NCT00430989|16973359|P2|Overall Study|Lost to Follow-up|3
4930712|NCT00430989|16973360|P1|Overall Study|Lost to Follow-up|2
4930713|NCT00430950|16973380|P2|Overall Study|concomitant medication,etc.|7
4930714|NCT00430950|16973381|P1|Overall Study|concomitant medication,etc.|5
4930715|NCT00430950|16973380|P2|Overall Study|Withdrawal by Subject|0
4930716|NCT00430950|16973381|P1|Overall Study|Withdrawal by Subject|1
4930717|NCT00430950|16973380|P2|Overall Study|Adverse Event|6
4930718|NCT00430950|16973381|P1|Overall Study|Adverse Event|7
4930719|NCT00430937|16973395|P2|Overall Study|Unable to classify|1
4930720|NCT00430937|16973396|P1|Overall Study|Unable to classify|0
4930721|NCT00430937|16973395|P2|Overall Study|Protocol discontinuation criteria met|2
4930722|NCT00430937|16973396|P1|Overall Study|Protocol discontinuation criteria met|1
4930723|NCT00430937|16973395|P2|Overall Study|Administrative reasons|0
4930724|NCT00430937|16973396|P1|Overall Study|Administrative reasons|1
4930725|NCT00430937|16973395|P2|Overall Study|Inappropriate enrollment|1
4930726|NCT00430937|16973396|P1|Overall Study|Inappropriate enrollment|2
4930727|NCT00430937|16973395|P2|Overall Study|Lack of Efficacy|5
4930728|NCT00430937|16973396|P1|Overall Study|Lack of Efficacy|6
4930729|NCT00430937|16973395|P2|Overall Study|Protocol Violation|2
4930730|NCT00430937|16973396|P1|Overall Study|Protocol Violation|3
4930731|NCT00430937|16973395|P2|Overall Study|Withdrawal by Subject|2
4930732|NCT00430937|16973396|P1|Overall Study|Withdrawal by Subject|5
4930733|NCT00430937|16973395|P2|Overall Study|Lost to Follow-up|6
4930734|NCT00430937|16973396|P1|Overall Study|Lost to Follow-up|6
4930735|NCT00430937|16973395|P2|Overall Study|Death|1
4930736|NCT00430937|16973396|P1|Overall Study|Death|0
4930737|NCT00430937|16973395|P2|Overall Study|Adverse Event|8
4930738|NCT00430937|16973396|P1|Overall Study|Adverse Event|3
4930739|NCT00430781|16973407|P3|End-of-Study Analysis; 28 July 2011|Other|0
4930740|NCT00430781|16973408|P2|End-of-Study Analysis; 28 July 2011|Other|1
4930741|NCT00430781|16973409|P1|End-of-Study Analysis; 28 July 2011|Other|4
4930742|NCT00430781|16973407|P3|End-of-Study Analysis; 28 July 2011|Physician Decision|6
4930743|NCT00430781|16973408|P2|End-of-Study Analysis; 28 July 2011|Physician Decision|6
4930744|NCT00430781|16973409|P1|End-of-Study Analysis; 28 July 2011|Physician Decision|4
4930745|NCT00430781|16973407|P3|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
4930746|NCT00430781|16973408|P2|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5
4930747|NCT00430781|16973409|P1|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4
4930748|NCT00430781|16973407|P3|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
4930749|NCT00430781|16973408|P2|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2
4930750|NCT00430781|16973409|P1|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7
4930751|NCT00430781|16973407|P3|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
4930752|NCT00430781|16973408|P2|End-of-Study Analysis; 28 July 2011|Protocol Violation|1
4930753|NCT00430781|16973409|P1|End-of-Study Analysis; 28 July 2011|Protocol Violation|0
4930754|NCT00430781|16973407|P3|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
4930755|NCT00430781|16973408|P2|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3
4930756|NCT00430781|16973409|P1|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5
4930757|NCT00430781|16973407|P3|Final Analysis; 31 July 2008|Ongoing|32
4930758|NCT00430781|16973408|P2|Final Analysis; 31 July 2008|Ongoing|29
4930759|NCT00430781|16973409|P1|Final Analysis; 31 July 2008|Ongoing|0
4930760|NCT00430781|16973407|P3|Final Analysis; 31 July 2008|Other|0
4930761|NCT00430781|16973408|P2|Final Analysis; 31 July 2008|Other|1
4930762|NCT00430781|16973409|P1|Final Analysis; 31 July 2008|Other|0
4930763|NCT00430781|16973407|P3|Final Analysis; 31 July 2008|Physician Decision|6
4930764|NCT00430781|16973408|P2|Final Analysis; 31 July 2008|Physician Decision|6
4930765|NCT00430781|16973409|P1|Final Analysis; 31 July 2008|Physician Decision|0
4930766|NCT00430781|16973407|P3|Final Analysis; 31 July 2008|Withdrawal by Subject|7
4930767|NCT00430781|16973408|P2|Final Analysis; 31 July 2008|Withdrawal by Subject|2
4930768|NCT00430781|16973409|P1|Final Analysis; 31 July 2008|Withdrawal by Subject|0
4930769|NCT00430781|16973407|P3|Final Analysis; 31 July 2008|Protocol Violation|0
4930770|NCT00430781|16973408|P2|Final Analysis; 31 July 2008|Protocol Violation|1
4930771|NCT00430781|16973409|P1|Final Analysis; 31 July 2008|Protocol Violation|0
4930772|NCT00430781|16973407|P3|Final Analysis; 31 July 2008|Lost to Follow-up|3
4930773|NCT00430781|16973408|P2|Final Analysis; 31 July 2008|Lost to Follow-up|0
4930774|NCT00430781|16973409|P1|Final Analysis; 31 July 2008|Lost to Follow-up|0
4930775|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Ongoing|25
4930776|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Ongoing|20
4930777|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Ongoing|23
4930778|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Physician Decision|3
4930779|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Physician Decision|3
4930780|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Physician Decision|2
4930781|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
4930782|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0
4930783|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2
4930784|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Death|0
4930785|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Death|1
4930786|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Death|0
4930787|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Disease Progression|22
4930788|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Disease Progression|30
4930789|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Disease Progression|16
4930790|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
4930791|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0
4930792|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1
4930793|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Withdrawal by Subject|2
4930794|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Withdrawal by Subject|0
4930795|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Withdrawal by Subject|4
4930796|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Protocol Violation|0
4930797|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Protocol Violation|1
4930798|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Protocol Violation|0
4930799|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Lost to Follow-up|1
4930800|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Lost to Follow-up|0
4930801|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Lost to Follow-up|1
4930802|NCT00430781|16973407|P3|Interim Analysis; 11 February 2008|Adverse Event|7
4930803|NCT00430781|16973408|P2|Interim Analysis; 11 February 2008|Adverse Event|3
4930804|NCT00430781|16973409|P1|Interim Analysis; 11 February 2008|Adverse Event|10
4930805|NCT00430755|16973451|P1|Overall Study|Withdrawal by Subject|53
4930806|NCT00430677|16973458|P3|Long-term Extension Period|Poor compliance/noncompliance|0
4930807|NCT00430677|16973459|P2|Long-term Extension Period|Poor compliance/noncompliance|0
4930808|NCT00430677|16973460|P1|Long-term Extension Period|Poor compliance/noncompliance|1
4930809|NCT00430677|16973458|P3|Long-term Extension Period|Other|1
4930810|NCT00430677|16973459|P2|Long-term Extension Period|Other|1
4930811|NCT00430677|16973460|P1|Long-term Extension Period|Other|2
4930812|NCT00430677|16973458|P3|Long-term Extension Period|Administrative reason by sponsor|46
4930813|NCT00430677|16973459|P2|Long-term Extension Period|Administrative reason by sponsor|49
4930814|NCT00430677|16973460|P1|Long-term Extension Period|Administrative reason by sponsor|41
4930815|NCT00430677|16973458|P3|Long-term Extension Period|Pregnancy|0
4930816|NCT00430677|16973459|P2|Long-term Extension Period|Pregnancy|1
4930817|NCT00430677|16973460|P1|Long-term Extension Period|Pregnancy|1
4930818|NCT00430677|16973458|P3|Long-term Extension Period|Withdrawal by Subject|2
4930819|NCT00430677|16973459|P2|Long-term Extension Period|Withdrawal by Subject|1
4930820|NCT00430677|16973460|P1|Long-term Extension Period|Withdrawal by Subject|5
4930821|NCT00430677|16973458|P3|Long-term Extension Period|Lost to Follow-up|1
4930822|NCT00430677|16973459|P2|Long-term Extension Period|Lost to Follow-up|1
4930823|NCT00430677|16973460|P1|Long-term Extension Period|Lost to Follow-up|1
4930824|NCT00430677|16973458|P3|Long-term Extension Period|Lack of Efficacy|8
4930825|NCT00430677|16973459|P2|Long-term Extension Period|Lack of Efficacy|3
4930826|NCT00430677|16973460|P1|Long-term Extension Period|Lack of Efficacy|5
4930827|NCT00430677|16973458|P3|Long-term Extension Period|Adverse Event|5
4930828|NCT00430677|16973459|P2|Long-term Extension Period|Adverse Event|2
4930829|NCT00430677|16973460|P1|Long-term Extension Period|Adverse Event|3
4930830|NCT00430677|16973458|P3|Long-term Extension Period|Death|0
4930831|NCT00430677|16973459|P2|Long-term Extension Period|Death|0
4930832|NCT00430677|16973460|P1|Long-term Extension Period|Death|1
4930833|NCT00430677|16973458|P3|Short-term Period|Pregnancy|0
4930834|NCT00430677|16973459|P2|Short-term Period|Pregnancy|2
4930835|NCT00430677|16973460|P1|Short-term Period|Pregnancy|0
4930836|NCT00430677|16973458|P3|Short-term Period|Poor compliance/ noncompliance|0
4930837|NCT00430677|16973459|P2|Short-term Period|Poor compliance/ noncompliance|1
4930838|NCT00430677|16973460|P1|Short-term Period|Poor compliance/ noncompliance|0
4930839|NCT00430677|16973458|P3|Short-term Period|Participant no longer met study criteria|2
4930840|NCT00430677|16973459|P2|Short-term Period|Participant no longer met study criteria|1
4930841|NCT00430677|16973460|P1|Short-term Period|Participant no longer met study criteria|1
4930842|NCT00430677|16973458|P3|Short-term Period|Withdrawal by Subject|2
4930843|NCT00430677|16973459|P2|Short-term Period|Withdrawal by Subject|1
4930844|NCT00430677|16973460|P1|Short-term Period|Withdrawal by Subject|1
4930845|NCT00430677|16973458|P3|Short-term Period|Lack of Efficacy|4
4930846|NCT00430677|16973459|P2|Short-term Period|Lack of Efficacy|6
4930847|NCT00430677|16973460|P1|Short-term Period|Lack of Efficacy|5
4930848|NCT00430677|16973458|P3|Short-term Period|Adverse Event|9
4930849|NCT00430677|16973459|P2|Short-term Period|Adverse Event|13
4930850|NCT00430677|16973460|P1|Short-term Period|Adverse Event|15
4930851|NCT00430677|16973458|P3|Short-term Period|Death|5
4930852|NCT00430677|16973459|P2|Short-term Period|Death|1
4930853|NCT00430677|16973460|P1|Short-term Period|Death|1
4930854|NCT00430638|16973583|P2|Overall Study|Other|2
4930855|NCT00430638|16973584|P1|Overall Study|Other|2
4930856|NCT00430638|16973583|P2|Overall Study|Non-compliant|1
4930857|NCT00430638|16973584|P1|Overall Study|Non-compliant|2
4930858|NCT00430638|16973583|P2|Overall Study|Withdrawal by Subject|6
4930859|NCT00430638|16973584|P1|Overall Study|Withdrawal by Subject|4
4930860|NCT00430638|16973583|P2|Overall Study|Protocol Violation|4
4930861|NCT00430638|16973584|P1|Overall Study|Protocol Violation|6
4930862|NCT00430638|16973583|P2|Overall Study|Lost to Follow-up|7
4930863|NCT00430638|16973584|P1|Overall Study|Lost to Follow-up|1
4930864|NCT00430638|16973583|P2|Overall Study|Uncontrolled blood pressure|13
4930865|NCT00430638|16973584|P1|Overall Study|Uncontrolled blood pressure|48
4930866|NCT00430638|16973583|P2|Overall Study|Adverse Event|15
4930867|NCT00430638|16973584|P1|Overall Study|Adverse Event|15
4930868|NCT00430573|16973619|P1|Overall Study|Withdrawal by Subject|5
4930869|NCT00430521|16973632|P8|Overall Study|Withdrawal by Subject|2
4930870|NCT00430521|16973633|P7|Overall Study|Withdrawal by Subject|0
4930871|NCT00430521|16973634|P6|Overall Study|Withdrawal by Subject|0
4930872|NCT00430521|16973635|P5|Overall Study|Withdrawal by Subject|0
4930873|NCT00430521|16973636|P4|Overall Study|Withdrawal by Subject|3
4930874|NCT00430521|16973637|P3|Overall Study|Withdrawal by Subject|0
4930875|NCT00430521|16973638|P2|Overall Study|Withdrawal by Subject|1
4930876|NCT00430521|16973639|P1|Overall Study|Withdrawal by Subject|3
4930877|NCT00430521|16973632|P8|Overall Study|Protocol Violation|0
4930878|NCT00430521|16973633|P7|Overall Study|Protocol Violation|0
4930879|NCT00430521|16973634|P6|Overall Study|Protocol Violation|0
4930880|NCT00430521|16973635|P5|Overall Study|Protocol Violation|0
4930881|NCT00430521|16973636|P4|Overall Study|Protocol Violation|0
4930882|NCT00430521|16973637|P3|Overall Study|Protocol Violation|0
4930883|NCT00430521|16973638|P2|Overall Study|Protocol Violation|0
4930884|NCT00430521|16973639|P1|Overall Study|Protocol Violation|1
4930885|NCT00430521|16973632|P8|Overall Study|Vaccine Expired|0
4930886|NCT00430521|16973633|P7|Overall Study|Vaccine Expired|0
4930887|NCT00430521|16973634|P6|Overall Study|Vaccine Expired|1
4930888|NCT00430521|16973635|P5|Overall Study|Vaccine Expired|0
4930889|NCT00430521|16973636|P4|Overall Study|Vaccine Expired|0
4930890|NCT00430521|16973637|P3|Overall Study|Vaccine Expired|0
4930891|NCT00430521|16973638|P2|Overall Study|Vaccine Expired|0
4930892|NCT00430521|16973639|P1|Overall Study|Vaccine Expired|0
4930893|NCT00430521|16973632|P8|Overall Study|Pregnancy|0
4930894|NCT00430521|16973633|P7|Overall Study|Pregnancy|1
4930895|NCT00430521|16973634|P6|Overall Study|Pregnancy|0
4930896|NCT00430521|16973635|P5|Overall Study|Pregnancy|0
4930897|NCT00430521|16973636|P4|Overall Study|Pregnancy|0
4930898|NCT00430521|16973637|P3|Overall Study|Pregnancy|0
4930899|NCT00430521|16973638|P2|Overall Study|Pregnancy|0
4930900|NCT00430521|16973639|P1|Overall Study|Pregnancy|0
4930901|NCT00430521|16973632|P8|Overall Study|Lost to Follow-up|10
4930902|NCT00430521|16973633|P7|Overall Study|Lost to Follow-up|8
4930903|NCT00430521|16973634|P6|Overall Study|Lost to Follow-up|2
4930904|NCT00430521|16973635|P5|Overall Study|Lost to Follow-up|5
4930905|NCT00430521|16973636|P4|Overall Study|Lost to Follow-up|5
4930906|NCT00430521|16973637|P3|Overall Study|Lost to Follow-up|3
4930907|NCT00430521|16973638|P2|Overall Study|Lost to Follow-up|8
4930908|NCT00430521|16973639|P1|Overall Study|Lost to Follow-up|7
4930909|NCT00430521|16973632|P8|Overall Study|Adverse Event|0
4930910|NCT00430521|16973633|P7|Overall Study|Adverse Event|1
4930911|NCT00430521|16973634|P6|Overall Study|Adverse Event|2
4930912|NCT00430521|16973635|P5|Overall Study|Adverse Event|0
4930913|NCT00430521|16973636|P4|Overall Study|Adverse Event|0
4930914|NCT00430521|16973637|P3|Overall Study|Adverse Event|0
4930915|NCT00430521|16973638|P2|Overall Study|Adverse Event|0
4930916|NCT00430521|16973639|P1|Overall Study|Adverse Event|0
4930917|NCT00430508|16973881|P4|Overall Study|Other|0
4930918|NCT00430508|16973882|P3|Overall Study|Other|3
4930919|NCT00430508|16973883|P2|Overall Study|Other|1
4930920|NCT00430508|16973884|P1|Overall Study|Other|1
4930921|NCT00430508|16973881|P4|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
4930922|NCT00430508|16973882|P3|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2
4930923|NCT00430508|16973883|P2|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1
4930924|NCT00430508|16973884|P1|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0
4930925|NCT00430508|16973881|P4|Overall Study|responder at visit 4|0
4930926|NCT00430508|16973882|P3|Overall Study|responder at visit 4|2
4930927|NCT00430508|16973883|P2|Overall Study|responder at visit 4|0
4930928|NCT00430508|16973884|P1|Overall Study|responder at visit 4|0
4930929|NCT00430508|16973881|P4|Overall Study|Withdrawal by Subject|1
4930930|NCT00430508|16973882|P3|Overall Study|Withdrawal by Subject|1
4930931|NCT00430508|16973883|P2|Overall Study|Withdrawal by Subject|1
4930932|NCT00430508|16973884|P1|Overall Study|Withdrawal by Subject|0
4930933|NCT00430508|16973881|P4|Overall Study|Adverse Event|3
4930934|NCT00430508|16973882|P3|Overall Study|Adverse Event|5
4930935|NCT00430508|16973883|P2|Overall Study|Adverse Event|3
4930936|NCT00430508|16973884|P1|Overall Study|Adverse Event|2
4930937|NCT00430495|16973922|P4|Overall Study|Randomized but not Treated|0
4930938|NCT00430495|16973923|P3|Overall Study|Randomized but not Treated|0
4930939|NCT00430495|16973924|P2|Overall Study|Randomized but not Treated|0
4930940|NCT00430495|16973925|P1|Overall Study|Randomized but not Treated|2
4930941|NCT00430495|16973922|P4|Overall Study|Other|4
4930942|NCT00430495|16973923|P3|Overall Study|Other|5
4930943|NCT00430495|16973924|P2|Overall Study|Other|2
4930944|NCT00430495|16973925|P1|Overall Study|Other|8
4930945|NCT00430495|16973922|P4|Overall Study|Disease Progression|0
4930946|NCT00430495|16973923|P3|Overall Study|Disease Progression|0
4930947|NCT00430495|16973924|P2|Overall Study|Disease Progression|1
4930948|NCT00430495|16973925|P1|Overall Study|Disease Progression|1
4930949|NCT00430495|16973922|P4|Overall Study|Protocol Violation|0
4930950|NCT00430495|16973923|P3|Overall Study|Protocol Violation|1
4930951|NCT00430495|16973924|P2|Overall Study|Protocol Violation|0
4930952|NCT00430495|16973925|P1|Overall Study|Protocol Violation|1
4930953|NCT00430495|16973922|P4|Overall Study|Lost to Follow-up|0
4930954|NCT00430495|16973923|P3|Overall Study|Lost to Follow-up|4
4930955|NCT00430495|16973924|P2|Overall Study|Lost to Follow-up|1
4930956|NCT00430495|16973925|P1|Overall Study|Lost to Follow-up|0
4930957|NCT00430495|16973922|P4|Overall Study|Death|0
4930958|NCT00430495|16973923|P3|Overall Study|Death|1
4930959|NCT00430495|16973924|P2|Overall Study|Death|0
4930960|NCT00430495|16973925|P1|Overall Study|Death|0
4930961|NCT00430495|16973922|P4|Overall Study|Adverse Event|0
4930962|NCT00430495|16973923|P3|Overall Study|Adverse Event|2
4930963|NCT00430495|16973924|P2|Overall Study|Adverse Event|3
4930964|NCT00430495|16973925|P1|Overall Study|Adverse Event|2
4930965|NCT00430482|16973965|P2|Completed Treatment|Insufficient Treatment|11
4930966|NCT00430482|16973966|P1|Completed Treatment|Insufficient Treatment|7
4930967|NCT00430352|16973974|P1|Overall Study|Other|48
4930968|NCT00430352|16973974|P1|Overall Study|Death|5
4930969|NCT00430352|16973974|P1|Overall Study|Adverse Event|16
4930970|NCT00430352|16973974|P1|Overall Study|Withdrawal by Subject|11
4930971|NCT00430352|16973974|P1|Overall Study|Disease progression|58
4930972|NCT00430300|16973992|P4|Overall Study|Other|1
4930973|NCT00430300|16973993|P3|Overall Study|Other|0
4930974|NCT00430300|16973994|P2|Overall Study|Other|0
4930975|NCT00430300|16973995|P1|Overall Study|Other|0
4930976|NCT00430300|16973992|P4|Overall Study|Laboratory abnormality|0
4930977|NCT00430300|16973993|P3|Overall Study|Laboratory abnormality|0
4930978|NCT00430300|16973994|P2|Overall Study|Laboratory abnormality|0
4930979|NCT00430300|16973995|P1|Overall Study|Laboratory abnormality|1
4930980|NCT00430300|16973992|P4|Overall Study|Withdrawal by Subject|0
4930981|NCT00430300|16973993|P3|Overall Study|Withdrawal by Subject|5
4930982|NCT00430300|16973994|P2|Overall Study|Withdrawal by Subject|0
4930983|NCT00430300|16973995|P1|Overall Study|Withdrawal by Subject|1
4930984|NCT00430300|16973992|P4|Overall Study|Adverse Event|1
4930985|NCT00430300|16973993|P3|Overall Study|Adverse Event|1
4930986|NCT00430300|16973994|P2|Overall Study|Adverse Event|2
4930987|NCT00430300|16973995|P1|Overall Study|Adverse Event|0
4930988|NCT00430248|16974100|P3|Overall Study|Reason Not Specified|11
4930989|NCT00430248|16974101|P2|Overall Study|Reason Not Specified|8
4930990|NCT00430248|16974102|P1|Overall Study|Reason Not Specified|8
4930991|NCT00430248|16974100|P3|Overall Study|Gout Flare|2
4930992|NCT00430248|16974101|P2|Overall Study|Gout Flare|7
4930993|NCT00430248|16974102|P1|Overall Study|Gout Flare|3
4930994|NCT00430248|16974100|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4930995|NCT00430248|16974101|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|2
4930996|NCT00430248|16974102|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4930997|NCT00430248|16974100|P3|Overall Study|Withdrawal by Subject|16
4930998|NCT00430248|16974101|P2|Overall Study|Withdrawal by Subject|20
4930999|NCT00430248|16974102|P1|Overall Study|Withdrawal by Subject|14
4931000|NCT00430248|16974100|P3|Overall Study|Therapeutic Failure|1
4931001|NCT00430248|16974101|P2|Overall Study|Therapeutic Failure|1
4931002|NCT00430248|16974102|P1|Overall Study|Therapeutic Failure|1
4931003|NCT00430248|16974100|P3|Overall Study|Lost to Follow-up|28
4931004|NCT00430248|16974101|P2|Overall Study|Lost to Follow-up|33
4931005|NCT00430248|16974102|P1|Overall Study|Lost to Follow-up|28
4931006|NCT00430248|16974100|P3|Overall Study|Personal Reasons|9
4931007|NCT00430248|16974101|P2|Overall Study|Personal Reasons|24
4931008|NCT00430248|16974102|P1|Overall Study|Personal Reasons|12
4931009|NCT00430248|16974100|P3|Overall Study|Protocol Violation|4
4931010|NCT00430248|16974101|P2|Overall Study|Protocol Violation|2
4931011|NCT00430248|16974102|P1|Overall Study|Protocol Violation|10
4931012|NCT00430248|16974100|P3|Overall Study|Adverse Event|64
4931013|NCT00430248|16974101|P2|Overall Study|Adverse Event|61
4931014|NCT00430248|16974102|P1|Overall Study|Adverse Event|49
4931015|NCT00430092|16974170|P3|Overall Study|Withdrawal by Subject|1
4931016|NCT00430092|16974171|P2|Overall Study|Withdrawal by Subject|1
4931017|NCT00430092|16974172|P1|Overall Study|Withdrawal by Subject|0
4931018|NCT00430092|16974170|P3|Overall Study|Protocol Violation|1
4931019|NCT00430092|16974171|P2|Overall Study|Protocol Violation|1
4931020|NCT00430092|16974172|P1|Overall Study|Protocol Violation|0
4931021|NCT00430092|16974170|P3|Overall Study|Lost to Follow-up|0
4931022|NCT00430092|16974171|P2|Overall Study|Lost to Follow-up|0
4931023|NCT00430092|16974172|P1|Overall Study|Lost to Follow-up|1
4931024|NCT00430092|16974170|P3|Overall Study|Lack of Efficacy|54
4931025|NCT00430092|16974171|P2|Overall Study|Lack of Efficacy|2
4931026|NCT00430092|16974172|P1|Overall Study|Lack of Efficacy|5
4931027|NCT00430092|16974170|P3|Overall Study|Adverse Event|1
4931028|NCT00430092|16974171|P2|Overall Study|Adverse Event|0
4931029|NCT00430092|16974172|P1|Overall Study|Adverse Event|0
4931030|NCT00430027|16974177|P1|Overall Study|Study terminated|8
4931031|NCT00429923|16974194|P3|Overall Study|Early Termination|0
4931032|NCT00429923|16974195|P2|Overall Study|Early Termination|1
4931033|NCT00429923|16974196|P1|Overall Study|Early Termination|0
4931034|NCT00429923|16974194|P3|Overall Study|Withdrew Consent|1
4931035|NCT00429923|16974195|P2|Overall Study|Withdrew Consent|0
4931036|NCT00429923|16974196|P1|Overall Study|Withdrew Consent|1
4931037|NCT00429923|16974194|P3|Overall Study|Lost to Follow-up|2
4931038|NCT00429923|16974195|P2|Overall Study|Lost to Follow-up|0
4931039|NCT00429923|16974196|P1|Overall Study|Lost to Follow-up|0
4931040|NCT00429923|16974194|P3|Overall Study|Lack of Efficacy|33
4931041|NCT00429923|16974195|P2|Overall Study|Lack of Efficacy|1
4931042|NCT00429923|16974196|P1|Overall Study|Lack of Efficacy|4
4931043|NCT00429923|16974194|P3|Overall Study|Adverse Event|3
4931044|NCT00429923|16974195|P2|Overall Study|Adverse Event|2
4931045|NCT00429923|16974196|P1|Overall Study|Adverse Event|0
4931046|NCT00429858|16974201|P1|Overall Study|Study Termination|1
4931047|NCT00429858|16974201|P1|Overall Study|Withdrawal by Subject|1
4931048|NCT00429793|16974212|P1|Overall Study|Non-measurable|1
4931049|NCT00429793|16974212|P1|Overall Study|Never treated|1
4931050|NCT00429793|16974212|P1|Overall Study|Required test not done|1
4931051|NCT00429793|16974212|P1|Overall Study|Improper pre-protocol treatment|3
4931052|NCT00429663|16974239|P2|Overall Study|Death|0
4931053|NCT00429663|16974240|P1|Overall Study|Death|4
4931054|NCT00429663|16974239|P2|Overall Study|Withdrawal by Subject|5
4931055|NCT00429663|16974240|P1|Overall Study|Withdrawal by Subject|2
4931056|NCT00429663|16974239|P2|Overall Study|Physician Decision|3
4931057|NCT00429663|16974240|P1|Overall Study|Physician Decision|6
4931058|NCT00429663|16974239|P2|Overall Study|Lost to Follow-up|31
4931059|NCT00429663|16974240|P1|Overall Study|Lost to Follow-up|24
4931060|NCT00429572|16974254|P1|Overall Study|Disease progression|1
4931061|NCT00429494|16974266|P1|Overall Study|Death|6
4931062|NCT00429494|16974266|P1|Overall Study|Withdrawal by Subject|9
4931063|NCT00429416|16974270|P1|Overall Study|Death|1
4931064|NCT00429364|16974289|P2|Overall Study|Pregnancy|1
4931065|NCT00429364|16974290|P1|Overall Study|Pregnancy|0
4931066|NCT00429364|16974289|P2|Overall Study|Underwent aortic root surgery|18
4931067|NCT00429364|16974290|P1|Overall Study|Underwent aortic root surgery|10
4931068|NCT00429364|16974289|P2|Overall Study|Death|1
4931069|NCT00429364|16974290|P1|Overall Study|Death|0
4931070|NCT00429364|16974289|P2|Overall Study|Lost to Follow-up|6
4931071|NCT00429364|16974290|P1|Overall Study|Lost to Follow-up|7
4931072|NCT00429364|16974289|P2|Overall Study|Physician Decision|2
4931073|NCT00429364|16974290|P1|Overall Study|Physician Decision|4
4931074|NCT00429364|16974289|P2|Overall Study|Withdrawal by Subject|5
4931075|NCT00429364|16974290|P1|Overall Study|Withdrawal by Subject|11
4931076|NCT00429299|16974349|P3|Overall Study|Withdrawal by Subject|3
4931077|NCT00429299|16974350|P2|Overall Study|Withdrawal by Subject|1
4931078|NCT00429299|16974351|P1|Overall Study|Withdrawal by Subject|0
4931079|NCT00429299|16974349|P3|Overall Study|Protocol Violation|0
4931080|NCT00429299|16974350|P2|Overall Study|Protocol Violation|0
4931081|NCT00429299|16974351|P1|Overall Study|Protocol Violation|1
4931082|NCT00429299|16974349|P3|Overall Study|Adverse Event|1
4931083|NCT00429299|16974350|P2|Overall Study|Adverse Event|5
4931084|NCT00429299|16974351|P1|Overall Study|Adverse Event|2
4931085|NCT00429299|16974349|P3|Overall Study|Disease Progression|0
4931086|NCT00429299|16974350|P2|Overall Study|Disease Progression|1
4931087|NCT00429299|16974351|P1|Overall Study|Disease Progression|1
4931088|NCT00429273|16974383|P3|Overall Study|Adverse Event|2
4931089|NCT00429273|16974384|P2|Overall Study|Adverse Event|1
4931090|NCT00429273|16974385|P1|Overall Study|Adverse Event|1
4931091|NCT00429273|16974383|P3|Overall Study|Physician Decision|5
4931092|NCT00429273|16974384|P2|Overall Study|Physician Decision|5
4931093|NCT00429273|16974385|P1|Overall Study|Physician Decision|6
4931094|NCT00429273|16974383|P3|Overall Study|Lost to Follow-up|2
4931095|NCT00429273|16974384|P2|Overall Study|Lost to Follow-up|2
4931096|NCT00429273|16974385|P1|Overall Study|Lost to Follow-up|1
4931097|NCT00429182|16974393|P1|Overall Study|Not eligible|5
4931098|NCT00429182|16974393|P1|Overall Study|Not evaluable, Disease Progression|2
4931099|NCT00429169|16974400|P2|Overall Study|Ineligibility discovered after entry|1
4931100|NCT00429169|16974401|P1|Overall Study|Ineligibility discovered after entry|2
4931101|NCT00429169|16974400|P2|Overall Study|Lost to Follow-up|1
4931102|NCT00429169|16974401|P1|Overall Study|Lost to Follow-up|0
4931103|NCT00429104|16974421|P1|Overall Study|Protocol Violation|1
4931104|NCT00429026|16974426|P1|Overall Study|Inevaluable for response.|40
4931105|NCT00428948|16974453|P2|Overall Study|Protocol Deviation|1
4931106|NCT00428948|16974454|P1|Overall Study|Protocol Deviation|1
4931107|NCT00428948|16974453|P2|Overall Study|Subject Withdrew Consent|30
4931108|NCT00428948|16974454|P1|Overall Study|Subject Withdrew Consent|50
4931109|NCT00428948|16974453|P2|Overall Study|Investigator Withdrew Subject|4
4931110|NCT00428948|16974454|P1|Overall Study|Investigator Withdrew Subject|3
4931111|NCT00428948|16974453|P2|Overall Study|Subject Met Withdrawal Criteria|0
4931112|NCT00428948|16974454|P1|Overall Study|Subject Met Withdrawal Criteria|4
4931113|NCT00428948|16974453|P2|Overall Study|Adverse Event|24
4931114|NCT00428948|16974454|P1|Overall Study|Adverse Event|148
4931115|NCT00428948|16974453|P2|Overall Study|Lost to Follow-up|8
4931116|NCT00428948|16974454|P1|Overall Study|Lost to Follow-up|15
4931117|NCT00428844|16974482|P3|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
4931118|NCT00428844|16974483|P2|Completed Test of Cure (TOC) Visit|Microbiologic failure|1
4931119|NCT00428844|16974484|P1|Completed Test of Cure (TOC) Visit|Microbiologic failure|0
4931120|NCT00428844|16974482|P3|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
4931121|NCT00428844|16974483|P2|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0
4931122|NCT00428844|16974484|P1|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2
4931123|NCT00428844|16974482|P3|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
4931124|NCT00428844|16974483|P2|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0
4931125|NCT00428844|16974484|P1|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1
4931126|NCT00428844|16974482|P3|Completed Test of Cure (TOC) Visit|Protocol Violation|1
4931127|NCT00428844|16974483|P2|Completed Test of Cure (TOC) Visit|Protocol Violation|0
4931128|NCT00428844|16974484|P1|Completed Test of Cure (TOC) Visit|Protocol Violation|0
4931129|NCT00428844|16974482|P3|Completed Test of Cure (TOC) Visit|Adverse Event|1
4931130|NCT00428844|16974483|P2|Completed Test of Cure (TOC) Visit|Adverse Event|1
4931217|NCT00428246|16974681|P2|Overall Study|Withdrawal by Subject|0
4931131|NCT00428844|16974484|P1|Completed Test of Cure (TOC) Visit|Adverse Event|0
4931132|NCT00428844|16974482|P3|Completed Study Drug Treatment|Randomized Not Treated|1
4931133|NCT00428844|16974483|P2|Completed Study Drug Treatment|Randomized Not Treated|0
4931134|NCT00428844|16974484|P1|Completed Study Drug Treatment|Randomized Not Treated|0
4931135|NCT00428844|16974482|P3|Completed Study Drug Treatment|Withdrawal by Subject|1
4931136|NCT00428844|16974483|P2|Completed Study Drug Treatment|Withdrawal by Subject|1
4931137|NCT00428844|16974484|P1|Completed Study Drug Treatment|Withdrawal by Subject|0
4931138|NCT00428844|16974482|P3|Completed Study Drug Treatment|Protocol Violation|1
4931139|NCT00428844|16974483|P2|Completed Study Drug Treatment|Protocol Violation|1
4931140|NCT00428844|16974484|P1|Completed Study Drug Treatment|Protocol Violation|0
4931141|NCT00428844|16974482|P3|Completed Study Drug Treatment|Adverse Event|4
4931142|NCT00428844|16974483|P2|Completed Study Drug Treatment|Adverse Event|4
4931143|NCT00428844|16974484|P1|Completed Study Drug Treatment|Adverse Event|2
4931144|NCT00428792|16974507|P2|Overall Study|Lost to Follow-up|1
4931145|NCT00428792|16974508|P1|Overall Study|Lost to Follow-up|0
4931146|NCT00428792|16974507|P2|Overall Study|Lack of Efficacy|3
4931147|NCT00428792|16974508|P1|Overall Study|Lack of Efficacy|1
4931148|NCT00428610|16974535|P3|Overall Study|Withdrawal by Subject|0
4931149|NCT00428610|16974536|P2|Overall Study|Withdrawal by Subject|0
4931150|NCT00428610|16974537|P1|Overall Study|Withdrawal by Subject|4
4931151|NCT00428610|16974535|P3|Overall Study|Progressive Disease|22
4931152|NCT00428610|16974536|P2|Overall Study|Progressive Disease|14
4931153|NCT00428610|16974537|P1|Overall Study|Progressive Disease|42
4931154|NCT00428610|16974535|P3|Overall Study|Investigator Decision|1
4931155|NCT00428610|16974536|P2|Overall Study|Investigator Decision|1
4931156|NCT00428610|16974537|P1|Overall Study|Investigator Decision|2
4931157|NCT00428610|16974535|P3|Overall Study|Adverse Event|2
4931158|NCT00428610|16974536|P2|Overall Study|Adverse Event|3
4931159|NCT00428610|16974537|P1|Overall Study|Adverse Event|2
4931160|NCT00428610|16974535|P3|Overall Study|Death Due to Progressive Disease|2
4931161|NCT00428610|16974536|P2|Overall Study|Death Due to Progressive Disease|0
4931162|NCT00428610|16974537|P1|Overall Study|Death Due to Progressive Disease|0
4931163|NCT00428610|16974535|P3|Overall Study|Death Due to Adverse Event|5
4931164|NCT00428610|16974536|P2|Overall Study|Death Due to Adverse Event|0
4931165|NCT00428610|16974537|P1|Overall Study|Death Due to Adverse Event|3
4931166|NCT00428597|16974571|P2|Overall Study|Death|3
4931167|NCT00428597|16974572|P1|Overall Study|Death|1
4931168|NCT00428597|16974571|P2|Overall Study|Pregnancy|0
4931169|NCT00428597|16974572|P1|Overall Study|Pregnancy|1
4931170|NCT00428597|16974571|P2|Overall Study|Lost to Follow-up|1
4931171|NCT00428597|16974572|P1|Overall Study|Lost to Follow-up|0
4931172|NCT00428597|16974571|P2|Overall Study|Other|1
4931173|NCT00428597|16974572|P1|Overall Study|Other|1
4931174|NCT00428597|16974571|P2|Overall Study|Withdrawal by Subject|1
4931175|NCT00428597|16974572|P1|Overall Study|Withdrawal by Subject|2
4931176|NCT00428597|16974571|P2|Overall Study|Protocol Violation|1
4931177|NCT00428597|16974572|P1|Overall Study|Protocol Violation|2
4931178|NCT00428597|16974571|P2|Overall Study|Global Deterioration of Health Status|5
4931179|NCT00428597|16974572|P1|Overall Study|Global Deterioration of Health Status|1
4931180|NCT00428597|16974571|P2|Overall Study|Adverse Event|7
4931181|NCT00428597|16974572|P1|Overall Study|Adverse Event|15
4931182|NCT00428597|16974571|P2|Overall Study|Study Terminated by Sponsor|16
4931183|NCT00428597|16974572|P1|Overall Study|Study Terminated by Sponsor|41
4931184|NCT00428597|16974571|P2|Overall Study|Objective Progression or Relapse|47
4931185|NCT00428597|16974572|P1|Overall Study|Objective Progression or Relapse|19
4931186|NCT00428597|16974571|P2|Overall Study|Randomized but not treated|3
4931187|NCT00428597|16974572|P1|Overall Study|Randomized but not treated|3
4931188|NCT00428441|16974639|P1|Overall Study|Lost to Follow-up|1
4931189|NCT00428389|16974645|P2|Extension Phase|Administrative problems|1
4931190|NCT00428389|16974646|P1|Extension Phase|Administrative problems|1
4931191|NCT00428389|16974645|P2|Extension Phase|Protocol Violation|2
4931192|NCT00428389|16974646|P1|Extension Phase|Protocol Violation|3
4931193|NCT00428389|16974645|P2|Extension Phase|Death|0
4931194|NCT00428389|16974646|P1|Extension Phase|Death|1
4931195|NCT00428389|16974645|P2|Extension Phase|Lost to Follow-up|3
4931196|NCT00428389|16974646|P1|Extension Phase|Lost to Follow-up|0
4931197|NCT00428389|16974645|P2|Extension Phase|Withdrawal by Subject|6
4931198|NCT00428389|16974646|P1|Extension Phase|Withdrawal by Subject|6
4931199|NCT00428389|16974645|P2|Extension Phase|Lack of Efficacy|3
4931200|NCT00428389|16974646|P1|Extension Phase|Lack of Efficacy|4
4931201|NCT00428389|16974645|P2|Extension Phase|Adverse Event|11
4931202|NCT00428389|16974646|P1|Extension Phase|Adverse Event|17
4931203|NCT00428389|16974645|P2|Core Phase|Protocol deviation|2
4931204|NCT00428389|16974646|P1|Core Phase|Protocol deviation|0
4931205|NCT00428389|16974645|P2|Core Phase|Withdrawal by Subject|4
4931206|NCT00428389|16974646|P1|Core Phase|Withdrawal by Subject|3
4931207|NCT00428389|16974645|P2|Core Phase|Abnormal test procedure result(s)|1
4931208|NCT00428389|16974646|P1|Core Phase|Abnormal test procedure result(s)|0
4931209|NCT00428389|16974645|P2|Core Phase|Lack of Efficacy|0
4931210|NCT00428389|16974646|P1|Core Phase|Lack of Efficacy|2
4931211|NCT00428389|16974645|P2|Core Phase|Adverse Event|4
4931212|NCT00428389|16974646|P1|Core Phase|Adverse Event|6
4931213|NCT00428246|16974680|P3|Overall Study|Adverse Event|0
4931214|NCT00428246|16974681|P2|Overall Study|Adverse Event|0
4931215|NCT00428246|16974682|P1|Overall Study|Adverse Event|1
4931216|NCT00428246|16974680|P3|Overall Study|Withdrawal by Subject|1
4931218|NCT00428246|16974682|P1|Overall Study|Withdrawal by Subject|0
4931219|NCT00428220|16974690|P1|Overall Study|Other|23
4931220|NCT00428220|16974690|P1|Overall Study|Adverse Event|51
4931221|NCT00428220|16974690|P1|Overall Study|Participant refused continued treatment|7
4931222|NCT00428220|16974690|P1|Overall Study|Objective progression or relapse|123
4931223|NCT00428220|16974690|P1|Overall Study|Lost to Follow-up|4
4931224|NCT00428220|16974690|P1|Overall Study|Global deterioration of health status|7
4931225|NCT00428220|16974690|P1|Overall Study|Participant died|8
4931226|NCT00428116|16974715|P2|Overall Study|Lost to Follow-up|0
4931227|NCT00428116|16974716|P1|Overall Study|Lost to Follow-up|1
4931228|NCT00428116|16974715|P2|Overall Study|Withdrawal by Subject|0
4931229|NCT00428116|16974716|P1|Overall Study|Withdrawal by Subject|1
4931230|NCT00428116|16974715|P2|Overall Study|Death|0
4931231|NCT00428116|16974716|P1|Overall Study|Death|1
4931232|NCT00428090|16974728|P4|Overall Study|Raised Creatinine Value|1
4931233|NCT00428090|16974729|P3|Overall Study|Raised Creatinine Value|0
4931234|NCT00428090|16974730|P2|Overall Study|Raised Creatinine Value|0
4931235|NCT00428090|16974731|P1|Overall Study|Raised Creatinine Value|0
4931236|NCT00428090|16974728|P4|Overall Study|Excluded for heart insufficiency|0
4931237|NCT00428090|16974729|P3|Overall Study|Excluded for heart insufficiency|1
4931238|NCT00428090|16974730|P2|Overall Study|Excluded for heart insufficiency|0
4931239|NCT00428090|16974731|P1|Overall Study|Excluded for heart insufficiency|0
4931240|NCT00428090|16974728|P4|Overall Study|Serious adverse event|0
4931241|NCT00428090|16974729|P3|Overall Study|Serious adverse event|1
4931242|NCT00428090|16974730|P2|Overall Study|Serious adverse event|0
4931243|NCT00428090|16974731|P1|Overall Study|Serious adverse event|0
4931244|NCT00428090|16974728|P4|Overall Study|Deterioration of cognitive status|0
4931245|NCT00428090|16974729|P3|Overall Study|Deterioration of cognitive status|1
4931246|NCT00428090|16974730|P2|Overall Study|Deterioration of cognitive status|0
4931247|NCT00428090|16974731|P1|Overall Study|Deterioration of cognitive status|0
4931248|NCT00428090|16974728|P4|Overall Study|High MMSE scores|0
4931249|NCT00428090|16974729|P3|Overall Study|High MMSE scores|1
4931250|NCT00428090|16974730|P2|Overall Study|High MMSE scores|0
4931251|NCT00428090|16974731|P1|Overall Study|High MMSE scores|0
4931252|NCT00428090|16974728|P4|Overall Study|Insufficient AD documentation|0
4931253|NCT00428090|16974729|P3|Overall Study|Insufficient AD documentation|1
4931254|NCT00428090|16974730|P2|Overall Study|Insufficient AD documentation|0
4931255|NCT00428090|16974731|P1|Overall Study|Insufficient AD documentation|0
4931256|NCT00428090|16974728|P4|Overall Study|Excluded for concerning QTc value|0
4931257|NCT00428090|16974729|P3|Overall Study|Excluded for concerning QTc value|1
4931258|NCT00428090|16974730|P2|Overall Study|Excluded for concerning QTc value|0
4931259|NCT00428090|16974731|P1|Overall Study|Excluded for concerning QTc value|0
4931260|NCT00428090|16974728|P4|Overall Study|Worsening of AD|0
4931261|NCT00428090|16974729|P3|Overall Study|Worsening of AD|1
4931262|NCT00428090|16974730|P2|Overall Study|Worsening of AD|0
4931263|NCT00428090|16974731|P1|Overall Study|Worsening of AD|0
4931264|NCT00428090|16974728|P4|Overall Study|Mental status of par. was|0
4931265|NCT00428090|16974729|P3|Overall Study|Mental status of par. was|0
4931266|NCT00428090|16974730|P2|Overall Study|Mental status of par. was|1
4931267|NCT00428090|16974731|P1|Overall Study|Mental status of par. was|0
4931268|NCT00428090|16974728|P4|Overall Study|Medical monitor terminated par.|0
4931269|NCT00428090|16974729|P3|Overall Study|Medical monitor terminated par.|0
4931270|NCT00428090|16974730|P2|Overall Study|Medical monitor terminated par.|1
4931271|NCT00428090|16974731|P1|Overall Study|Medical monitor terminated par.|0
4931272|NCT00428090|16974728|P4|Overall Study|Visit 7 exceed the visit window|0
4931273|NCT00428090|16974729|P3|Overall Study|Visit 7 exceed the visit window|0
4931274|NCT00428090|16974730|P2|Overall Study|Visit 7 exceed the visit window|1
4931275|NCT00428090|16974731|P1|Overall Study|Visit 7 exceed the visit window|0
4931276|NCT00428090|16974728|P4|Overall Study|Death of par.|0
4931277|NCT00428090|16974729|P3|Overall Study|Death of par.|1
4931278|NCT00428090|16974730|P2|Overall Study|Death of par.|0
4931279|NCT00428090|16974731|P1|Overall Study|Death of par.|1
4931280|NCT00428090|16974728|P4|Overall Study|Prohibited medication used for SAE|0
4931281|NCT00428090|16974729|P3|Overall Study|Prohibited medication used for SAE|0
4931282|NCT00428090|16974730|P2|Overall Study|Prohibited medication used for SAE|0
4931283|NCT00428090|16974731|P1|Overall Study|Prohibited medication used for SAE|1
4931284|NCT00428090|16974728|P4|Overall Study|Follow-Up visit not possible|0
4931285|NCT00428090|16974729|P3|Overall Study|Follow-Up visit not possible|0
4931286|NCT00428090|16974730|P2|Overall Study|Follow-Up visit not possible|0
4931287|NCT00428090|16974731|P1|Overall Study|Follow-Up visit not possible|1
4931288|NCT00428090|16974728|P4|Overall Study|Par. did not returned to visit|1
4931289|NCT00428090|16974729|P3|Overall Study|Par. did not returned to visit|0
4931290|NCT00428090|16974730|P2|Overall Study|Par. did not returned to visit|0
4931291|NCT00428090|16974731|P1|Overall Study|Par. did not returned to visit|1
4931292|NCT00428090|16974728|P4|Overall Study|Non-compliance|3
4931293|NCT00428090|16974729|P3|Overall Study|Non-compliance|1
4931294|NCT00428090|16974730|P2|Overall Study|Non-compliance|0
4931295|NCT00428090|16974731|P1|Overall Study|Non-compliance|4
4931296|NCT00428090|16974728|P4|Overall Study|Sponsor terminated study|0
4931297|NCT00428090|16974729|P3|Overall Study|Sponsor terminated study|0
4931298|NCT00428090|16974730|P2|Overall Study|Sponsor terminated study|1
4931299|NCT00428090|16974731|P1|Overall Study|Sponsor terminated study|0
4931300|NCT00428090|16974728|P4|Overall Study|Withdrawal by Subject|5
4931301|NCT00428090|16974729|P3|Overall Study|Withdrawal by Subject|15
4931302|NCT00428090|16974730|P2|Overall Study|Withdrawal by Subject|12
4931303|NCT00428090|16974731|P1|Overall Study|Withdrawal by Subject|10
4931304|NCT00428090|16974728|P4|Overall Study|Protocol Violation|3
4931305|NCT00428090|16974729|P3|Overall Study|Protocol Violation|3
4931306|NCT00428090|16974730|P2|Overall Study|Protocol Violation|1
4931307|NCT00428090|16974731|P1|Overall Study|Protocol Violation|3
4931308|NCT00428090|16974728|P4|Overall Study|Lost to Follow-up|4
4931309|NCT00428090|16974729|P3|Overall Study|Lost to Follow-up|1
4931310|NCT00428090|16974730|P2|Overall Study|Lost to Follow-up|6
4931311|NCT00428090|16974731|P1|Overall Study|Lost to Follow-up|3
4931312|NCT00428090|16974728|P4|Overall Study|Adverse Event|11
4931313|NCT00428090|16974729|P3|Overall Study|Adverse Event|10
4931314|NCT00428090|16974730|P2|Overall Study|Adverse Event|8
4931315|NCT00428090|16974731|P1|Overall Study|Adverse Event|10
4931316|NCT00427999|16974849|P1|Overall Study|Death|1
4931317|NCT00427999|16974849|P1|Overall Study|Withdrawal by Subject|9
4931318|NCT00427999|16974849|P1|Overall Study|Protocol Violation|2
4931319|NCT00427999|16974849|P1|Overall Study|Unsatisfactory therapeutic effect|13
4931320|NCT00427999|16974849|P1|Overall Study|Abnormal laboratory values|1
4931321|NCT00427999|16974849|P1|Overall Study|Adverse Event|6
4931322|NCT00427960|16974867|P2|Overall Study|Other|1
4931323|NCT00427960|16974868|P1|Overall Study|Other|0
4931324|NCT00427960|16974867|P2|Overall Study|Withdrawal by Subject|3
4931325|NCT00427960|16974868|P1|Overall Study|Withdrawal by Subject|0
4931326|NCT00427960|16974867|P2|Overall Study|Adverse Event|0
4931327|NCT00427960|16974868|P1|Overall Study|Adverse Event|2
4931328|NCT00427934|16974906|P4|Overall Study|Withdrawal by Subject|3
4931329|NCT00427934|16974907|P3|Overall Study|Withdrawal by Subject|1
4931330|NCT00427934|16974908|P2|Overall Study|Withdrawal by Subject|0
4931331|NCT00427934|16974909|P1|Overall Study|Withdrawal by Subject|0
4931332|NCT00427934|16974906|P4|Overall Study|Other|5
4931333|NCT00427934|16974907|P3|Overall Study|Other|11
4931334|NCT00427934|16974908|P2|Overall Study|Other|0
4931335|NCT00427934|16974909|P1|Overall Study|Other|0
4931336|NCT00427934|16974906|P4|Overall Study|Randomized But Did Not Receive Treatment|1
4931337|NCT00427934|16974907|P3|Overall Study|Randomized But Did Not Receive Treatment|1
4931338|NCT00427934|16974908|P2|Overall Study|Randomized But Did Not Receive Treatment|0
4931339|NCT00427934|16974909|P1|Overall Study|Randomized But Did Not Receive Treatment|0
4931340|NCT00427934|16974906|P4|Overall Study|Lack of Efficacy|2
4931341|NCT00427934|16974907|P3|Overall Study|Lack of Efficacy|5
4931342|NCT00427934|16974908|P2|Overall Study|Lack of Efficacy|0
4931343|NCT00427934|16974909|P1|Overall Study|Lack of Efficacy|0
4931344|NCT00427934|16974906|P4|Overall Study|Adverse Event|4
4931345|NCT00427934|16974907|P3|Overall Study|Adverse Event|5
4931346|NCT00427934|16974908|P2|Overall Study|Adverse Event|0
4931347|NCT00427934|16974909|P1|Overall Study|Adverse Event|1
4931348|NCT00427921|16974977|P1|Overall Study|Withdrew Consent + Lack of Efficacy|1
4931349|NCT00427921|16974977|P1|Overall Study|Adverse Event + Withdrawn from Study|1
4931350|NCT00427921|16974977|P1|Overall Study|Adverse Event + Lost Response|1
4931351|NCT00427921|16974977|P1|Overall Study|Adverse Event + No Therapeutic Benefit|1
4931352|NCT00427921|16974977|P1|Overall Study|Adverse Event + Worsening of CD|1
4931353|NCT00427921|16974977|P1|Overall Study|Adverse Event + No Response|1
4931354|NCT00427921|16974977|P1|Overall Study|Adverse Event + Withdrew Consent|1
4931355|NCT00427921|16974977|P1|Overall Study|Adverse Event + Hospitalization|1
4931356|NCT00427921|16974977|P1|Overall Study|Other reason not specified|10
4931357|NCT00427921|16974977|P1|Overall Study|Lost to Follow-up|2
4931358|NCT00427921|16974977|P1|Overall Study|Withdrawal by Subject|4
4931359|NCT00427921|16974977|P1|Overall Study|Adverse Event|26
4931360|NCT00427908|16975000|P4|Primary Phase|Adverse Event|0
4931361|NCT00427908|16975001|P3|Primary Phase|Adverse Event|0
4931362|NCT00427908|16975002|P2|Primary Phase|Adverse Event|1
4931363|NCT00427908|16975003|P1|Primary Phase|Adverse Event|0
4931364|NCT00427908|16975000|P4|Primary Phase|Withdrawal by Subject|0
4931365|NCT00427908|16975001|P3|Primary Phase|Withdrawal by Subject|1
4931366|NCT00427908|16975002|P2|Primary Phase|Withdrawal by Subject|2
4931367|NCT00427908|16975003|P1|Primary Phase|Withdrawal by Subject|1
4931368|NCT00427908|16975000|P4|Primary Phase|Lost to Follow-up|0
4931369|NCT00427908|16975001|P3|Primary Phase|Lost to Follow-up|2
4931370|NCT00427908|16975002|P2|Primary Phase|Lost to Follow-up|0
4931371|NCT00427908|16975003|P1|Primary Phase|Lost to Follow-up|4
4931372|NCT00427895|16975203|P8|Vax 2/Year 3 to 4|Failed to Return|0
4931373|NCT00427895|16975204|P7|Vax 2/Year 3 to 4|Failed to Return|0
4931374|NCT00427895|16975205|P6|Vax 2/Year 3 to 4|Failed to Return|0
4931375|NCT00427895|16975206|P5|Vax 2/Year 3 to 4|Failed to Return|1
4931376|NCT00427895|16975207|P4|Vax 2/Year 3 to 4|Failed to Return|0
4931377|NCT00427895|16975208|P3|Vax 2/Year 3 to 4|Failed to Return|0
4931378|NCT00427895|16975209|P2|Vax 2/Year 3 to 4|Failed to Return|0
4931379|NCT00427895|16975210|P1|Vax 2/Year 3 to 4|Failed to Return|0
4931380|NCT00427895|16975203|P8|Vax 2/Year 3 to 4|Protocol Violation|1
4931381|NCT00427895|16975204|P7|Vax 2/Year 3 to 4|Protocol Violation|0
4931382|NCT00427895|16975205|P6|Vax 2/Year 3 to 4|Protocol Violation|0
4931383|NCT00427895|16975206|P5|Vax 2/Year 3 to 4|Protocol Violation|0
4931384|NCT00427895|16975207|P4|Vax 2/Year 3 to 4|Protocol Violation|0
4931385|NCT00427895|16975208|P3|Vax 2/Year 3 to 4|Protocol Violation|0
4931386|NCT00427895|16975209|P2|Vax 2/Year 3 to 4|Protocol Violation|0
4931387|NCT00427895|16975210|P1|Vax 2/Year 3 to 4|Protocol Violation|0
4931388|NCT00427895|16975203|P8|Vax 2/Year 3 to 4|Lost to Follow-up|1
4931389|NCT00427895|16975204|P7|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931390|NCT00427895|16975205|P6|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931391|NCT00427895|16975206|P5|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931392|NCT00427895|16975207|P4|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931393|NCT00427895|16975208|P3|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931394|NCT00427895|16975209|P2|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931395|NCT00427895|16975210|P1|Vax 2/Year 3 to 4|Lost to Follow-up|0
4931396|NCT00427895|16975203|P8|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4931397|NCT00427895|16975204|P7|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4931398|NCT00427895|16975205|P6|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4931399|NCT00427895|16975206|P5|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0
4931400|NCT00427895|16975207|P4|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469
4931401|NCT00427895|16975208|P3|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159
4931402|NCT00427895|16975209|P2|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207
4931403|NCT00427895|16975210|P1|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188
4931404|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Other|0
4931405|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Other|0
4931406|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Other|0
4931407|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Other|0
4931408|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Other|2
4931409|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Other|0
4931410|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Other|0
4931411|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Other|0
4931412|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Failed to Return|0
4931413|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Failed to Return|0
4931414|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Failed to Return|0
4931415|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Failed to Return|0
4931416|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Failed to Return|5
4931417|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Failed to Return|12
4931418|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Failed to Return|0
4931419|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Failed to Return|0
4931420|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Death|0
4931421|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Death|0
4931422|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Death|0
4931423|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Death|0
4931424|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Death|0
4931425|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Death|0
4931426|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Death|0
4931427|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Death|1
4931428|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Adverse Event|0
4931429|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Adverse Event|0
4931430|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Adverse Event|0
4931431|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Adverse Event|0
4931432|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Adverse Event|0
4931433|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Adverse Event|0
4931434|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Adverse Event|1
4931435|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Adverse Event|0
4931436|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4931437|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4931438|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4931439|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0
4931440|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4
4931441|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5
4931442|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6
4931443|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3
4931444|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Protocol Violation|0
4931445|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Protocol Violation|0
4931446|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Protocol Violation|0
4931447|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Protocol Violation|0
4931448|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Protocol Violation|1
4931449|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Protocol Violation|0
4931450|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Protocol Violation|3
4931451|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Protocol Violation|3
4931452|NCT00427895|16975203|P8|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4931453|NCT00427895|16975204|P7|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4931454|NCT00427895|16975205|P6|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4931455|NCT00427895|16975206|P5|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4931456|NCT00427895|16975207|P4|Vax 1/Year 1 Follow-up|Lost to Follow-up|21
4931457|NCT00427895|16975208|P3|Vax 1/Year 1 Follow-up|Lost to Follow-up|2
4931458|NCT00427895|16975209|P2|Vax 1/Year 1 Follow-up|Lost to Follow-up|5
4931459|NCT00427895|16975210|P1|Vax 1/Year 1 Follow-up|Lost to Follow-up|0
4931460|NCT00427895|16975203|P8|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931461|NCT00427895|16975204|P7|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931462|NCT00427895|16975205|P6|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931463|NCT00427895|16975206|P5|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931464|NCT00427895|16975207|P4|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352
4931465|NCT00427895|16975208|P3|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931466|NCT00427895|16975209|P2|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931467|NCT00427895|16975210|P1|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0
4931468|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Other|0
4931469|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Other|0
4931470|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Other|0
4931471|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Other|0
4931472|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Other|2
4931473|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Other|1
4931474|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Other|0
4931475|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Other|0
4931476|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4931477|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4931478|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4931479|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0
4931480|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
4931481|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2
4931482|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3
4931483|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1
4931484|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931485|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931486|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931487|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931488|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2
4931489|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931490|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931491|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0
4931492|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4931493|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4931494|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4931495|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0
4931496|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7
4931497|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4
4931498|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
4931499|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1
4931500|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4931501|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4931502|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4931503|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4931504|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4931505|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0
4931506|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
4931507|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1
4931508|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4931509|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4931510|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4931511|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4931512|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2
4931513|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3
4931514|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0
4931515|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4
4931516|NCT00427895|16975203|P8|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4931517|NCT00427895|16975204|P7|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4931518|NCT00427895|16975205|P6|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4931519|NCT00427895|16975206|P5|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4931520|NCT00427895|16975207|P4|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32
4931521|NCT00427895|16975208|P3|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4
4931522|NCT00427895|16975209|P2|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1
4931523|NCT00427895|16975210|P1|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0
4931524|NCT00427778|16975285|P2|First Intervention (4 Weeks)|anxious about using ring|0
4931525|NCT00427778|16975286|P1|First Intervention (4 Weeks)|anxious about using ring|1
4931526|NCT00427778|16975285|P2|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1
4931527|NCT00427778|16975286|P1|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0
4931528|NCT00427778|16975285|P2|First Intervention (4 Weeks)|Not successfully fitted with ring|0
4931529|NCT00427778|16975286|P1|First Intervention (4 Weeks)|Not successfully fitted with ring|2
4931530|NCT00427778|16975285|P2|First Intervention (4 Weeks)|no longer interested|0
4931531|NCT00427778|16975286|P1|First Intervention (4 Weeks)|no longer interested|1
4931532|NCT00427700|16975311|P2|Overall Study|Pregnancy|2
4931533|NCT00427700|16975312|P1|Overall Study|Pregnancy|0
4931534|NCT00427700|16975311|P2|Overall Study|no induction of menses|4
4931535|NCT00427700|16975312|P1|Overall Study|no induction of menses|1
4931536|NCT00427700|16975311|P2|Overall Study|Lost to Follow-up|5
4931537|NCT00427700|16975312|P1|Overall Study|Lost to Follow-up|2
4931538|NCT00427648|16975328|P2|Overall Study|Adverse Event|1
4931539|NCT00427648|16975329|P1|Overall Study|Adverse Event|0
4931540|NCT00427648|16975328|P2|Overall Study|Protocol Violation|2
4931541|NCT00427648|16975329|P1|Overall Study|Protocol Violation|1
4931542|NCT00427635|16975349|P2|Study Completion to Safety Follow-up|Lost to Follow-up|1
4931543|NCT00427635|16975350|P1|Study Completion to Safety Follow-up|Lost to Follow-up|0
4931544|NCT00427635|16975349|P2|Treatment Phase|Withdrawal by Subject|0
4931545|NCT00427635|16975350|P1|Treatment Phase|Withdrawal by Subject|1
4931546|NCT00427349|16975382|P1|Overall Study|Never started therapy|1
4931547|NCT00427349|16975382|P1|Overall Study|Ineligible|1
4931548|NCT00427349|16975382|P1|Overall Study|Other|2
4931549|NCT00427349|16975382|P1|Overall Study|Alternative therapy|1
4931550|NCT00427349|16975382|P1|Overall Study|Withdrawal by Subject|3
4931551|NCT00427349|16975382|P1|Overall Study|Death|1
4931552|NCT00427349|16975382|P1|Overall Study|Adverse Event|14
4931553|NCT00427349|16975382|P1|Overall Study|Lack of Efficacy|23
4931554|NCT00427011|16975439|P1|Overall Study|Other|12
4931555|NCT00427011|16975439|P1|Overall Study|Lack of Efficacy|2
4931556|NCT00427011|16975439|P1|Overall Study|Withdrawal by Subject|1
4931557|NCT00427011|16975439|P1|Overall Study|Adverse Event|10
4931558|NCT00426842|16975454|P1|Overall Study|Lost to Follow-up|1
4931559|NCT00426764|16975460|P1|Overall Study|Other Reasons (Miscellaneous)|10
4931560|NCT00426764|16975460|P1|Overall Study|Death|1
4931561|NCT00426764|16975460|P1|Overall Study|Other|1
4931562|NCT00426764|16975460|P1|Overall Study|Adverse Event|24
4931563|NCT00426764|16975460|P1|Overall Study|Progressive Disease|83
4931564|NCT00426764|16975460|P1|Overall Study|Compassionate Use|1
4931565|NCT00426764|16975460|P1|Overall Study|Physician Decision|6
4931566|NCT00426764|16975460|P1|Overall Study|Withdrawal by Subject|4
4931567|NCT00426764|16975460|P1|Overall Study|Protocol Violation|1
4931568|NCT00426751|16975477|P2|Overall Study|Other Reasons|12
4931569|NCT00426751|16975478|P1|Overall Study|Other Reasons|7
4931570|NCT00426751|16975477|P2|Overall Study|Consent Withdrawn|1
4931571|NCT00426751|16975478|P1|Overall Study|Consent Withdrawn|0
4931572|NCT00426751|16975477|P2|Overall Study|Lost to Follow-up|6
4931573|NCT00426751|16975478|P1|Overall Study|Lost to Follow-up|7
4931574|NCT00426751|16975477|P2|Overall Study|Adverse Event|1
4931575|NCT00426751|16975478|P1|Overall Study|Adverse Event|8
4931576|NCT00426660|16975522|P1|Overall Study|Enrolled Not Treated|15
4931577|NCT00426660|16975522|P1|Overall Study|Protocol Violation|1
4931578|NCT00426660|16975522|P1|Overall Study|Withdrawal by Subject|18
4931579|NCT00426660|16975522|P1|Overall Study|Other|23
4931580|NCT00426660|16975522|P1|Overall Study|Lost to Follow-up|15
4931581|NCT00426660|16975522|P1|Overall Study|Insufficient Clinical Response|22
4931582|NCT00426660|16975522|P1|Overall Study|Adverse Event|23
4931583|NCT00426660|16975522|P1|Overall Study|Death|14
4931584|NCT00426556|16975553|P4|Phase II - Extension Phase|Adverse Event|2
4931585|NCT00426556|16975554|P3|Phase II - Extension Phase|Adverse Event|0
4931586|NCT00426556|16975555|P2|Phase II - Extension Phase|Adverse Event|0
4931587|NCT00426556|16975556|P1|Phase II - Extension Phase|Adverse Event|0
4931588|NCT00426556|16975553|P4|Phase II - Extension Phase|Disease Progression|21
4931589|NCT00426556|16975554|P3|Phase II - Extension Phase|Disease Progression|0
4931590|NCT00426556|16975555|P2|Phase II - Extension Phase|Disease Progression|0
4931591|NCT00426556|16975556|P1|Phase II - Extension Phase|Disease Progression|0
4931592|NCT00426556|16975553|P4|Phase II - Core Phase|Adverse Event|8
4931593|NCT00426556|16975554|P3|Phase II - Core Phase|Adverse Event|0
4931594|NCT00426556|16975555|P2|Phase II - Core Phase|Adverse Event|0
4931595|NCT00426556|16975556|P1|Phase II - Core Phase|Adverse Event|0
4931596|NCT00426556|16975553|P4|Phase II - Core Phase|Disease Progression|16
4931597|NCT00426556|16975554|P3|Phase II - Core Phase|Disease Progression|0
4931598|NCT00426556|16975555|P2|Phase II - Core Phase|Disease Progression|0
4931599|NCT00426556|16975556|P1|Phase II - Core Phase|Disease Progression|0
4931600|NCT00426556|16975553|P4|Phase II - Core Phase|Withdrawal by Subject|3
4931601|NCT00426556|16975554|P3|Phase II - Core Phase|Withdrawal by Subject|0
4931602|NCT00426556|16975555|P2|Phase II - Core Phase|Withdrawal by Subject|0
4931603|NCT00426556|16975556|P1|Phase II - Core Phase|Withdrawal by Subject|0
4931604|NCT00426556|16975553|P4|Phase I - Extension Phase|Disease Progression|0
4931605|NCT00426556|16975554|P3|Phase I - Extension Phase|Disease Progression|6
4931606|NCT00426556|16975555|P2|Phase I - Extension Phase|Disease Progression|5
4931607|NCT00426556|16975556|P1|Phase I - Extension Phase|Disease Progression|5
4931608|NCT00426556|16975553|P4|Phase I - Extension Phase|Adverse Event|0
4931609|NCT00426556|16975554|P3|Phase I - Extension Phase|Adverse Event|1
4931610|NCT00426556|16975555|P2|Phase I - Extension Phase|Adverse Event|1
4931611|NCT00426556|16975556|P1|Phase I - Extension Phase|Adverse Event|0
4931612|NCT00426556|16975553|P4|Phase I - Core Phase|Death|0
4931613|NCT00426556|16975554|P3|Phase I - Core Phase|Death|0
4931614|NCT00426556|16975555|P2|Phase I - Core Phase|Death|1
4931615|NCT00426556|16975556|P1|Phase I - Core Phase|Death|0
4931616|NCT00426556|16975553|P4|Phase I - Core Phase|Adverse Event|0
4931617|NCT00426556|16975554|P3|Phase I - Core Phase|Adverse Event|1
4931618|NCT00426556|16975555|P2|Phase I - Core Phase|Adverse Event|3
4931619|NCT00426556|16975556|P1|Phase I - Core Phase|Adverse Event|1
4931620|NCT00426556|16975553|P4|Phase I - Core Phase|Disease Progression|0
4931621|NCT00426556|16975554|P3|Phase I - Core Phase|Disease Progression|2
4931622|NCT00426556|16975555|P2|Phase I - Core Phase|Disease Progression|6
4931623|NCT00426556|16975556|P1|Phase I - Core Phase|Disease Progression|0
4931624|NCT00426361|16975581|P3|Overall Study|Withdrawal by Subject|0
4931625|NCT00426361|16975582|P2|Overall Study|Withdrawal by Subject|3
4931626|NCT00426361|16975583|P1|Overall Study|Withdrawal by Subject|1
4931627|NCT00426361|16975581|P3|Overall Study|Lost to Follow-up|5
4931628|NCT00426361|16975582|P2|Overall Study|Lost to Follow-up|2
4931629|NCT00426361|16975583|P1|Overall Study|Lost to Follow-up|3
4931630|NCT00426270|16975650|P1|Overall Study|Adverse Event|5
4931631|NCT00426270|16975650|P1|Overall Study|Incorrectly Enrolled in the Study|1
4931632|NCT00426231|16975660|P2|Overall Study|Withdrawal by Subject|12
4931633|NCT00426231|16975661|P1|Overall Study|Withdrawal by Subject|9
4931634|NCT00426127|16975684|P1|Overall Study|Removed due to disease progression|1
4931635|NCT00426127|16975684|P1|Overall Study|Adverse Event|1
4931636|NCT00425945|16975692|P2|Overall Study|Moved from area|1
4931637|NCT00425945|16975693|P1|Overall Study|Moved from area|0
4931638|NCT00425945|16975692|P2|Overall Study|Began cancer treatments|0
4931639|NCT00425945|16975693|P1|Overall Study|Began cancer treatments|1
4931640|NCT00425945|16975692|P2|Overall Study|Began hypertension medication|0
4931641|NCT00425945|16975693|P1|Overall Study|Began hypertension medication|1
4931642|NCT00425945|16975692|P2|Overall Study|Lost to Follow-up|2
4931643|NCT00425945|16975693|P1|Overall Study|Lost to Follow-up|0
4931644|NCT00425945|16975692|P2|Overall Study|Inconvenience|2
4931645|NCT00425945|16975693|P1|Overall Study|Inconvenience|0
4931646|NCT00425945|16975692|P2|Overall Study|Concern about Supplement|0
4931647|NCT00425945|16975693|P1|Overall Study|Concern about Supplement|2
4931648|NCT00425854|16975731|P2|Overall Study|Other Adverse Event|2
4931649|NCT00425854|16975732|P1|Overall Study|Other Adverse Event|2
4931650|NCT00425854|16975731|P2|Overall Study|Dose reduction toxicity AE|7
4931651|NCT00425854|16975732|P1|Overall Study|Dose reduction toxicity AE|8
4931652|NCT00425854|16975731|P2|Overall Study|Progressive Disease|12
4931653|NCT00425854|16975732|P1|Overall Study|Progressive Disease|19
4931654|NCT00425750|16975765|P1|Overall Study|Progression of disease|18
4931655|NCT00425750|16975765|P1|Overall Study|Adverse Event|3
4931656|NCT00425750|16975765|P1|Overall Study|Withdrawal by Subject|3
4931657|NCT00425750|16975765|P1|Overall Study|Death|1
4931658|NCT00425698|16975773|P2|Overall Study|Withdrawal by Subject|1
4931659|NCT00425698|16975774|P1|Overall Study|Withdrawal by Subject|0
4931660|NCT00425698|16975773|P2|Overall Study|Adverse Event|1
4931661|NCT00425698|16975774|P1|Overall Study|Adverse Event|3
4931662|NCT00425607|16975789|P1|Overall Study|Withdrawal by Subject|1
4931663|NCT00425607|16975789|P1|Overall Study|Death|1
4931664|NCT00425503|16975793|P1|Overall Study|Protocol Violation|1
4931665|NCT00425503|16975793|P1|Overall Study|Adverse Event|2
4931666|NCT00425438|16975805|P2|Overall Study|Termination by Sponsor|27
4931667|NCT00425438|16975806|P1|Overall Study|Termination by Sponsor|25
4931668|NCT00425373|16975840|P9|Overall Study|Lack of Efficacy|5
4931669|NCT00425373|16975841|P8|Overall Study|Lack of Efficacy|0
4931670|NCT00425373|16975842|P7|Overall Study|Lack of Efficacy|3
4931671|NCT00425373|16975843|P6|Overall Study|Lack of Efficacy|3
4931672|NCT00425373|16975844|P5|Overall Study|Lack of Efficacy|1
4931673|NCT00425373|16975845|P4|Overall Study|Lack of Efficacy|0
4931674|NCT00425373|16975846|P3|Overall Study|Lack of Efficacy|0
4931675|NCT00425373|16975847|P2|Overall Study|Lack of Efficacy|0
4931676|NCT00425373|16975848|P1|Overall Study|Lack of Efficacy|0
4931677|NCT00425373|16975840|P9|Overall Study|Withdrawal by Subject|2
4931678|NCT00425373|16975841|P8|Overall Study|Withdrawal by Subject|2
4931679|NCT00425373|16975842|P7|Overall Study|Withdrawal by Subject|2
4931680|NCT00425373|16975843|P6|Overall Study|Withdrawal by Subject|0
4931681|NCT00425373|16975844|P5|Overall Study|Withdrawal by Subject|4
4931682|NCT00425373|16975845|P4|Overall Study|Withdrawal by Subject|1
4931683|NCT00425373|16975846|P3|Overall Study|Withdrawal by Subject|2
4931684|NCT00425373|16975847|P2|Overall Study|Withdrawal by Subject|0
4931685|NCT00425373|16975848|P1|Overall Study|Withdrawal by Subject|2
4931686|NCT00425373|16975840|P9|Overall Study|Protocol Violation|3
4931687|NCT00425373|16975841|P8|Overall Study|Protocol Violation|5
4931688|NCT00425373|16975842|P7|Overall Study|Protocol Violation|0
4931689|NCT00425373|16975843|P6|Overall Study|Protocol Violation|0
4931690|NCT00425373|16975844|P5|Overall Study|Protocol Violation|0
4931691|NCT00425373|16975845|P4|Overall Study|Protocol Violation|0
4931692|NCT00425373|16975846|P3|Overall Study|Protocol Violation|1
4931693|NCT00425373|16975847|P2|Overall Study|Protocol Violation|0
4931694|NCT00425373|16975848|P1|Overall Study|Protocol Violation|1
4931695|NCT00425373|16975840|P9|Overall Study|Lost to Follow-up|0
4931696|NCT00425373|16975841|P8|Overall Study|Lost to Follow-up|0
4931697|NCT00425373|16975842|P7|Overall Study|Lost to Follow-up|0
4931698|NCT00425373|16975843|P6|Overall Study|Lost to Follow-up|0
4931699|NCT00425373|16975844|P5|Overall Study|Lost to Follow-up|1
4931700|NCT00425373|16975845|P4|Overall Study|Lost to Follow-up|0
4931701|NCT00425373|16975846|P3|Overall Study|Lost to Follow-up|0
4931702|NCT00425373|16975847|P2|Overall Study|Lost to Follow-up|1
4931703|NCT00425373|16975848|P1|Overall Study|Lost to Follow-up|0
4931704|NCT00425373|16975840|P9|Overall Study|Adverse Event|8
4931705|NCT00425373|16975841|P8|Overall Study|Adverse Event|3
4931706|NCT00425373|16975842|P7|Overall Study|Adverse Event|2
4931707|NCT00425373|16975843|P6|Overall Study|Adverse Event|6
4931708|NCT00425373|16975844|P5|Overall Study|Adverse Event|4
4931709|NCT00425373|16975845|P4|Overall Study|Adverse Event|1
4931710|NCT00425373|16975846|P3|Overall Study|Adverse Event|0
4931711|NCT00425373|16975847|P2|Overall Study|Adverse Event|2
4931712|NCT00425373|16975848|P1|Overall Study|Adverse Event|2
4931713|NCT00425308|16975906|P2|Overall Study|Death|0
4931714|NCT00425308|16975907|P1|Overall Study|Death|1
4931715|NCT00425308|16975906|P2|Overall Study|Withdrawal by Subject|0
4931716|NCT00425308|16975907|P1|Overall Study|Withdrawal by Subject|1
4931717|NCT00425308|16975906|P2|Overall Study|Adverse Event|1
4931718|NCT00425308|16975907|P1|Overall Study|Adverse Event|2
4931719|NCT00425269|16975937|P2|Overall Study|moved or medical reason|4
4931720|NCT00425269|16975938|P1|Overall Study|moved or medical reason|5
4931721|NCT00425269|16975937|P2|Overall Study|Lost to Follow-up|9
4931722|NCT00425269|16975938|P1|Overall Study|Lost to Follow-up|9
4931723|NCT00425269|16975937|P2|Overall Study|Pregnancy|7
4931724|NCT00425269|16975938|P1|Overall Study|Pregnancy|5
4931725|NCT00425113|16976016|P2|Overall Study|Withdrawal by Subject|0
4931726|NCT00425113|16976017|P1|Overall Study|Withdrawal by Subject|1
4931727|NCT00425113|16976016|P2|Overall Study|missing study drug more than 14 days|1
4931728|NCT00425113|16976017|P1|Overall Study|missing study drug more than 14 days|0
4931729|NCT00425113|16976016|P2|Overall Study|diagnosis of abdominal TB|1
4931730|NCT00425113|16976017|P1|Overall Study|diagnosis of abdominal TB|0
4931731|NCT00425113|16976016|P2|Overall Study|uncontrolled diabetes mellitus|0
4931732|NCT00425113|16976017|P1|Overall Study|uncontrolled diabetes mellitus|1
4931733|NCT00425100|16976025|P1|Overall Study|Withdrawal by Subject|7
4931734|NCT00425100|16976025|P1|Overall Study|Protocol Violation|4
4931735|NCT00425100|16976025|P1|Overall Study|Lost to Follow-up|2
4931736|NCT00425100|16976025|P1|Overall Study|Lack of Efficacy|4
4931737|NCT00425100|16976025|P1|Overall Study|Adverse Event|36
4931738|NCT00425061|16976069|P7|Overall Study|Other|1
4931739|NCT00425061|16976070|P6|Overall Study|Other|0
4931740|NCT00425061|16976071|P5|Overall Study|Other|3
4931741|NCT00425061|16976072|P4|Overall Study|Other|0
4931742|NCT00425061|16976073|P3|Overall Study|Other|0
4931743|NCT00425061|16976074|P2|Overall Study|Other|0
4931744|NCT00425061|16976075|P1|Overall Study|Other|0
4931745|NCT00425061|16976069|P7|Overall Study|Physician Decision|0
4931746|NCT00425061|16976070|P6|Overall Study|Physician Decision|0
4931747|NCT00425061|16976071|P5|Overall Study|Physician Decision|1
4931748|NCT00425061|16976072|P4|Overall Study|Physician Decision|0
4931749|NCT00425061|16976073|P3|Overall Study|Physician Decision|0
4931750|NCT00425061|16976074|P2|Overall Study|Physician Decision|0
4931751|NCT00425061|16976075|P1|Overall Study|Physician Decision|0
4931752|NCT00425061|16976069|P7|Overall Study|Sponsor's request|15
4931753|NCT00425061|16976070|P6|Overall Study|Sponsor's request|4
4931754|NCT00425061|16976071|P5|Overall Study|Sponsor's request|19
4931755|NCT00425061|16976072|P4|Overall Study|Sponsor's request|0
4931756|NCT00425061|16976073|P3|Overall Study|Sponsor's request|0
4931757|NCT00425061|16976074|P2|Overall Study|Sponsor's request|0
4931758|NCT00425061|16976075|P1|Overall Study|Sponsor's request|0
4931759|NCT00425061|16976069|P7|Overall Study|Withdrawal by Subject|3
4931760|NCT00425061|16976070|P6|Overall Study|Withdrawal by Subject|0
4931761|NCT00425061|16976071|P5|Overall Study|Withdrawal by Subject|1
4931762|NCT00425061|16976072|P4|Overall Study|Withdrawal by Subject|0
4931763|NCT00425061|16976073|P3|Overall Study|Withdrawal by Subject|0
4931764|NCT00425061|16976074|P2|Overall Study|Withdrawal by Subject|1
4931765|NCT00425061|16976075|P1|Overall Study|Withdrawal by Subject|0
4931766|NCT00425061|16976069|P7|Overall Study|Protocol Violation|0
4931767|NCT00425061|16976070|P6|Overall Study|Protocol Violation|0
4931768|NCT00425061|16976071|P5|Overall Study|Protocol Violation|0
4931769|NCT00425061|16976072|P4|Overall Study|Protocol Violation|0
4931770|NCT00425061|16976073|P3|Overall Study|Protocol Violation|0
4931771|NCT00425061|16976074|P2|Overall Study|Protocol Violation|0
4931772|NCT00425061|16976075|P1|Overall Study|Protocol Violation|1
4931773|NCT00425061|16976069|P7|Overall Study|Lost to Follow-up|0
4931774|NCT00425061|16976070|P6|Overall Study|Lost to Follow-up|0
4931775|NCT00425061|16976071|P5|Overall Study|Lost to Follow-up|0
4931776|NCT00425061|16976072|P4|Overall Study|Lost to Follow-up|0
4931777|NCT00425061|16976073|P3|Overall Study|Lost to Follow-up|0
4931778|NCT00425061|16976074|P2|Overall Study|Lost to Follow-up|1
4931779|NCT00425061|16976075|P1|Overall Study|Lost to Follow-up|0
4931780|NCT00425061|16976069|P7|Overall Study|Adverse Event|0
4931781|NCT00425061|16976070|P6|Overall Study|Adverse Event|0
4931782|NCT00425061|16976071|P5|Overall Study|Adverse Event|2
4931783|NCT00425061|16976072|P4|Overall Study|Adverse Event|2
4931784|NCT00425061|16976073|P3|Overall Study|Adverse Event|0
4931785|NCT00425061|16976074|P2|Overall Study|Adverse Event|0
4931786|NCT00425061|16976075|P1|Overall Study|Adverse Event|1
4931787|NCT00424827|16976199|P1|Overall Study|Adverse Event|1
4931788|NCT00424775|16976207|P2|Overall Study|Lack of Efficacy|0
4931789|NCT00424775|16976208|P1|Overall Study|Lack of Efficacy|1
4931790|NCT00424775|16976207|P2|Overall Study|Adverse Event|0
4931791|NCT00424775|16976208|P1|Overall Study|Adverse Event|2
4931792|NCT00424762|16976218|P2|Overall Study|Lost to Follow-up|3
4931793|NCT00424762|16976219|P1|Overall Study|Lost to Follow-up|2
4931794|NCT00424762|16976218|P2|Overall Study|Withdrawal by Subject|19
4931795|NCT00424762|16976219|P1|Overall Study|Withdrawal by Subject|18
4931796|NCT00424749|16976229|P1|Overall Study|Withdrawal by Subject|1
4931797|NCT00424645|16976236|P2|Overall Study|Death|0
4931798|NCT00424645|16976237|P1|Overall Study|Death|1
4931799|NCT00424632|16976245|P10|Overall Study|Other|0
4931800|NCT00424632|16976246|P9|Overall Study|Other|1
4931801|NCT00424632|16976247|P8|Overall Study|Other|0
4931802|NCT00424632|16976248|P7|Overall Study|Other|0
4931803|NCT00424632|16976249|P6|Overall Study|Other|0
4931804|NCT00424632|16976250|P5|Overall Study|Other|0
4931805|NCT00424632|16976251|P4|Overall Study|Other|1
4931806|NCT00424632|16976252|P3|Overall Study|Other|0
4931807|NCT00424632|16976253|P2|Overall Study|Other|0
4931808|NCT00424632|16976254|P1|Overall Study|Other|0
4931809|NCT00424632|16976245|P10|Overall Study|Objective progression or relapse|4
4931810|NCT00424632|16976246|P9|Overall Study|Objective progression or relapse|12
4931811|NCT00424632|16976247|P8|Overall Study|Objective progression or relapse|3
4931812|NCT00424632|16976248|P7|Overall Study|Objective progression or relapse|7
4931813|NCT00424632|16976249|P6|Overall Study|Objective progression or relapse|13
4931814|NCT00424632|16976250|P5|Overall Study|Objective progression or relapse|2
4931815|NCT00424632|16976251|P4|Overall Study|Objective progression or relapse|2
4931816|NCT00424632|16976252|P3|Overall Study|Objective progression or relapse|1
4931817|NCT00424632|16976253|P2|Overall Study|Objective progression or relapse|1
4931818|NCT00424632|16976254|P1|Overall Study|Objective progression or relapse|1
4931819|NCT00424632|16976245|P10|Overall Study|Global deterioration of health status|0
4931820|NCT00424632|16976246|P9|Overall Study|Global deterioration of health status|0
4931821|NCT00424632|16976247|P8|Overall Study|Global deterioration of health status|0
4931822|NCT00424632|16976248|P7|Overall Study|Global deterioration of health status|0
4931823|NCT00424632|16976249|P6|Overall Study|Global deterioration of health status|0
4931824|NCT00424632|16976250|P5|Overall Study|Global deterioration of health status|1
4931825|NCT00424632|16976251|P4|Overall Study|Global deterioration of health status|1
4931826|NCT00424632|16976252|P3|Overall Study|Global deterioration of health status|0
4931827|NCT00424632|16976253|P2|Overall Study|Global deterioration of health status|0
4931828|NCT00424632|16976254|P1|Overall Study|Global deterioration of health status|0
4931829|NCT00424632|16976245|P10|Overall Study|Adverse Event|2
4931830|NCT00424632|16976246|P9|Overall Study|Adverse Event|3
4931831|NCT00424632|16976247|P8|Overall Study|Adverse Event|0
4931832|NCT00424632|16976248|P7|Overall Study|Adverse Event|0
4931833|NCT00424632|16976249|P6|Overall Study|Adverse Event|0
4931834|NCT00424632|16976250|P5|Overall Study|Adverse Event|0
4931835|NCT00424632|16976251|P4|Overall Study|Adverse Event|0
4931836|NCT00424632|16976252|P3|Overall Study|Adverse Event|0
4931837|NCT00424632|16976253|P2|Overall Study|Adverse Event|0
4931838|NCT00424632|16976254|P1|Overall Study|Adverse Event|0
4931839|NCT00424632|16976245|P10|Overall Study|Death|0
4931840|NCT00424632|16976246|P9|Overall Study|Death|0
4931841|NCT00424632|16976247|P8|Overall Study|Death|0
4931842|NCT00424632|16976248|P7|Overall Study|Death|0
4931843|NCT00424632|16976249|P6|Overall Study|Death|2
4931844|NCT00424632|16976250|P5|Overall Study|Death|0
4931845|NCT00424632|16976251|P4|Overall Study|Death|0
4931846|NCT00424632|16976252|P3|Overall Study|Death|0
4931847|NCT00424632|16976253|P2|Overall Study|Death|0
4931848|NCT00424632|16976254|P1|Overall Study|Death|0
4931849|NCT00424593|16976424|P2|Dose-Blind Extension Period|Physician Decision|0
4931850|NCT00424593|16976425|P1|Dose-Blind Extension Period|Physician Decision|3
4931851|NCT00424593|16976424|P2|Dose-Blind Extension Period|Lost to Follow-up|0
4931852|NCT00424593|16976425|P1|Dose-Blind Extension Period|Lost to Follow-up|6
4931853|NCT00424593|16976424|P2|Dose-Blind Extension Period|Protocol Violation|0
4931854|NCT00424593|16976425|P1|Dose-Blind Extension Period|Protocol Violation|9
4931855|NCT00424593|16976424|P2|Dose-Blind Extension Period|Lack of Efficacy|0
4931856|NCT00424593|16976425|P1|Dose-Blind Extension Period|Lack of Efficacy|9
4931857|NCT00424593|16976424|P2|Dose-Blind Extension Period|Adverse Event|0
4931858|NCT00424593|16976425|P1|Dose-Blind Extension Period|Adverse Event|18
4931859|NCT00424593|16976424|P2|Dose-Blind Extension Period|Withdrawal by Subject|0
4931860|NCT00424593|16976425|P1|Dose-Blind Extension Period|Withdrawal by Subject|19
4931861|NCT00424593|16976424|P2|Acute Double-Blind Period|Lack of Efficacy|1
4931862|NCT00424593|16976425|P1|Acute Double-Blind Period|Lack of Efficacy|0
4931863|NCT00424593|16976424|P2|Acute Double-Blind Period|Lost to Follow-up|1
4931864|NCT00424593|16976425|P1|Acute Double-Blind Period|Lost to Follow-up|1
4931865|NCT00424593|16976424|P2|Acute Double-Blind Period|Physician Decision|2
4931866|NCT00424593|16976425|P1|Acute Double-Blind Period|Physician Decision|1
4931867|NCT00424593|16976424|P2|Acute Double-Blind Period|Protocol Violation|2
4931868|NCT00424593|16976425|P1|Acute Double-Blind Period|Protocol Violation|2
4931869|NCT00424593|16976424|P2|Acute Double-Blind Period|Withdrawal by Subject|10
4931870|NCT00424593|16976425|P1|Acute Double-Blind Period|Withdrawal by Subject|11
4931871|NCT00424593|16976424|P2|Acute Double-Blind Period|Adverse Event|7
4931872|NCT00424593|16976425|P1|Acute Double-Blind Period|Adverse Event|16
4931873|NCT00424528|16976489|P3|Overall Study|noncompliance with study requirements|2
4931874|NCT00424528|16976490|P2|Overall Study|noncompliance with study requirements|1
4931875|NCT00424528|16976491|P1|Overall Study|noncompliance with study requirements|2
4931876|NCT00424528|16976489|P3|Overall Study|Lost to Follow-up|0
4931877|NCT00424528|16976490|P2|Overall Study|Lost to Follow-up|1
4931878|NCT00424528|16976491|P1|Overall Study|Lost to Follow-up|0
4931879|NCT00424528|16976489|P3|Overall Study|Protocol Violation|0
4931880|NCT00424528|16976490|P2|Overall Study|Protocol Violation|1
4931881|NCT00424528|16976491|P1|Overall Study|Protocol Violation|1
4931882|NCT00424528|16976489|P3|Overall Study|Adverse Event|2
4931883|NCT00424528|16976490|P2|Overall Study|Adverse Event|1
4931884|NCT00424528|16976491|P1|Overall Study|Adverse Event|2
4931885|NCT00424515|16976546|P2|Overall Study|Withdrawal by Subject|0
4931886|NCT00424515|16976547|P1|Overall Study|Withdrawal by Subject|1
4931887|NCT00424515|16976546|P2|Overall Study|Intercurrent Illness|1
4931888|NCT00424515|16976547|P1|Overall Study|Intercurrent Illness|0
4931889|NCT00424515|16976546|P2|Overall Study|Adverse Event|1
4931890|NCT00424515|16976547|P1|Overall Study|Adverse Event|0
4931891|NCT00424515|16976546|P2|Overall Study|Progressive Disease|11
4931892|NCT00424515|16976547|P1|Overall Study|Progressive Disease|10
4931893|NCT00424489|16976566|P1|Overall Study|Death|3
4931894|NCT00424476|16976573|P3|Overall Study|Other|9
4931895|NCT00424476|16976574|P2|Overall Study|Other|3
4931896|NCT00424476|16976575|P1|Overall Study|Other|4
4931897|NCT00424476|16976573|P3|Overall Study|Physician Decision|3
4931898|NCT00424476|16976574|P2|Overall Study|Physician Decision|2
4931899|NCT00424476|16976575|P1|Overall Study|Physician Decision|3
4931900|NCT00424476|16976573|P3|Overall Study|Protocol Violation|3
4931901|NCT00424476|16976574|P2|Overall Study|Protocol Violation|2
4931902|NCT00424476|16976575|P1|Overall Study|Protocol Violation|7
4931903|NCT00424476|16976573|P3|Overall Study|Lost to Follow-up|3
4931904|NCT00424476|16976574|P2|Overall Study|Lost to Follow-up|6
4931905|NCT00424476|16976575|P1|Overall Study|Lost to Follow-up|4
4931906|NCT00424476|16976573|P3|Overall Study|Lack of Compliance|1
4931907|NCT00424476|16976574|P2|Overall Study|Lack of Compliance|1
4931908|NCT00424476|16976575|P1|Overall Study|Lack of Compliance|1
4931909|NCT00424476|16976573|P3|Overall Study|Lack of Efficacy|12
4931910|NCT00424476|16976574|P2|Overall Study|Lack of Efficacy|12
4931911|NCT00424476|16976575|P1|Overall Study|Lack of Efficacy|16
4931912|NCT00424476|16976573|P3|Overall Study|Adverse Event|15
4931913|NCT00424476|16976574|P2|Overall Study|Adverse Event|16
4931914|NCT00424476|16976575|P1|Overall Study|Adverse Event|19
4931915|NCT00424476|16976573|P3|Overall Study|Withdrawal by Subject|3
4931916|NCT00424476|16976574|P2|Overall Study|Withdrawal by Subject|6
4931917|NCT00424476|16976575|P1|Overall Study|Withdrawal by Subject|7
4931918|NCT00424463|16976601|P3|Overall Study|Patient's convenience|1
4931919|NCT00424463|16976602|P2|Overall Study|Patient's convenience|0
4931920|NCT00424463|16976603|P1|Overall Study|Patient's convenience|0
4931921|NCT00424463|16976601|P3|Overall Study|Tracheotomy due to worsening of ALS|6
4931922|NCT00424463|16976602|P2|Overall Study|Tracheotomy due to worsening of ALS|7
4931923|NCT00424463|16976603|P1|Overall Study|Tracheotomy due to worsening of ALS|1
4931924|NCT00424463|16976601|P3|Overall Study|Withdrawal by Subject|5
4931925|NCT00424463|16976602|P2|Overall Study|Withdrawal by Subject|2
4931926|NCT00424463|16976603|P1|Overall Study|Withdrawal by Subject|4
4931927|NCT00424463|16976601|P3|Overall Study|Physician Decision|2
4931928|NCT00424463|16976602|P2|Overall Study|Physician Decision|2
4931929|NCT00424463|16976603|P1|Overall Study|Physician Decision|0
4931930|NCT00424463|16976601|P3|Overall Study|Adverse Event|2
4931931|NCT00424463|16976602|P2|Overall Study|Adverse Event|3
4931932|NCT00424463|16976603|P1|Overall Study|Adverse Event|2
4931933|NCT00424398|16976632|P3|Overall Study|Subject met exclusion criteria|0
4931934|NCT00424398|16976633|P2|Overall Study|Subject met exclusion criteria|0
4931935|NCT00424398|16976634|P1|Overall Study|Subject met exclusion criteria|1
4931936|NCT00424398|16976632|P3|Overall Study|Withdrawal by Subject|0
4931937|NCT00424398|16976633|P2|Overall Study|Withdrawal by Subject|1
4931938|NCT00424398|16976634|P1|Overall Study|Withdrawal by Subject|2
4931939|NCT00424385|16976678|P1|Cohort 1|Withdrawal by Subject|1
4931940|NCT00424385|16976678|P1|Cohort 0|Physician Decision|1
4931941|NCT00424385|16976678|P1|Cohort 0|Withdrawal by Subject|5
4931942|NCT00424372|16976685|P1|Overall Study|Lack of Efficacy|6
4931943|NCT00424372|16976685|P1|Overall Study|Protocol Violation|1
4931944|NCT00424372|16976685|P1|Overall Study|Withdrawal by Subject|4
4931945|NCT00424372|16976685|P1|Overall Study|Health deterioration|1
4931946|NCT00424372|16976685|P1|Overall Study|Adverse Event|18
4931947|NCT00424372|16976685|P1|Overall Study|Death|1
4931948|NCT00424346|16976697|P4|Extension Phase|Protocol Violation|0
4931949|NCT00424346|16976698|P3|Extension Phase|Protocol Violation|1
4931950|NCT00424346|16976699|P2|Extension Phase|Protocol Violation|1
4931951|NCT00424346|16976700|P1|Extension Phase|Protocol Violation|0
4931952|NCT00424346|16976697|P4|Extension Phase|Death|1
4931953|NCT00424346|16976698|P3|Extension Phase|Death|0
4931954|NCT00424346|16976699|P2|Extension Phase|Death|0
4931955|NCT00424346|16976700|P1|Extension Phase|Death|0
4931956|NCT00424346|16976697|P4|Extension Phase|Administrative Problems|35
4931957|NCT00424346|16976698|P3|Extension Phase|Administrative Problems|32
4931958|NCT00424346|16976699|P2|Extension Phase|Administrative Problems|69
4931959|NCT00424346|16976700|P1|Extension Phase|Administrative Problems|0
4931960|NCT00424346|16976697|P4|Extension Phase|Lost to Follow-up|0
4931961|NCT00424346|16976698|P3|Extension Phase|Lost to Follow-up|0
4931962|NCT00424346|16976699|P2|Extension Phase|Lost to Follow-up|2
4931963|NCT00424346|16976700|P1|Extension Phase|Lost to Follow-up|0
4931964|NCT00424346|16976697|P4|Extension Phase|Withdrawal by Subject|4
4931965|NCT00424346|16976698|P3|Extension Phase|Withdrawal by Subject|3
4931966|NCT00424346|16976699|P2|Extension Phase|Withdrawal by Subject|5
4931967|NCT00424346|16976700|P1|Extension Phase|Withdrawal by Subject|0
4931968|NCT00424346|16976697|P4|Extension Phase|Lack of Efficacy|11
4931969|NCT00424346|16976698|P3|Extension Phase|Lack of Efficacy|14
4931970|NCT00424346|16976699|P2|Extension Phase|Lack of Efficacy|16
4931971|NCT00424346|16976700|P1|Extension Phase|Lack of Efficacy|0
4931972|NCT00424346|16976697|P4|Extension Phase|Adverse Event|4
4931973|NCT00424346|16976698|P3|Extension Phase|Adverse Event|5
4931974|NCT00424346|16976699|P2|Extension Phase|Adverse Event|9
4931975|NCT00424346|16976700|P1|Extension Phase|Adverse Event|0
4931976|NCT00424346|16976697|P4|Core Study|Protocol Violation|0
4931977|NCT00424346|16976698|P3|Core Study|Protocol Violation|2
4931978|NCT00424346|16976699|P2|Core Study|Protocol Violation|0
4931979|NCT00424346|16976700|P1|Core Study|Protocol Violation|0
4931980|NCT00424346|16976697|P4|Core Study|Administrative Problems|0
4931981|NCT00424346|16976698|P3|Core Study|Administrative Problems|1
4931982|NCT00424346|16976699|P2|Core Study|Administrative Problems|0
4931983|NCT00424346|16976700|P1|Core Study|Administrative Problems|1
4931984|NCT00424346|16976697|P4|Core Study|Lost to Follow-up|0
4931985|NCT00424346|16976698|P3|Core Study|Lost to Follow-up|0
4931986|NCT00424346|16976699|P2|Core Study|Lost to Follow-up|1
4931987|NCT00424346|16976700|P1|Core Study|Lost to Follow-up|1
4931988|NCT00424346|16976697|P4|Core Study|Withdrawal by Subject|2
4931989|NCT00424346|16976698|P3|Core Study|Withdrawal by Subject|0
4931990|NCT00424346|16976699|P2|Core Study|Withdrawal by Subject|0
4931991|NCT00424346|16976700|P1|Core Study|Withdrawal by Subject|1
4931992|NCT00424346|16976697|P4|Core Study|Lack of Efficacy|4
4931993|NCT00424346|16976698|P3|Core Study|Lack of Efficacy|0
4931994|NCT00424346|16976699|P2|Core Study|Lack of Efficacy|3
4931995|NCT00424346|16976700|P1|Core Study|Lack of Efficacy|1
4931996|NCT00424346|16976697|P4|Core Study|Abnormal Laboratory Values|0
4931997|NCT00424346|16976698|P3|Core Study|Abnormal Laboratory Values|0
4931998|NCT00424346|16976699|P2|Core Study|Abnormal Laboratory Values|1
4931999|NCT00424346|16976700|P1|Core Study|Abnormal Laboratory Values|0
4932000|NCT00424346|16976697|P4|Core Study|Adverse Event|1
4932001|NCT00424346|16976698|P3|Core Study|Adverse Event|1
4932002|NCT00424346|16976699|P2|Core Study|Adverse Event|3
4932003|NCT00424346|16976700|P1|Core Study|Adverse Event|5
4932004|NCT00424294|16976815|P2|Overall Study|Randomized but not Treated|0
4932005|NCT00424294|16976816|P1|Overall Study|Randomized but not Treated|1
4932006|NCT00424294|16976815|P2|Overall Study|Other|2
4932007|NCT00424294|16976816|P1|Overall Study|Other|0
4932008|NCT00424294|16976815|P2|Overall Study|Withdrawal by Subject|2
4932009|NCT00424294|16976816|P1|Overall Study|Withdrawal by Subject|1
4932010|NCT00424294|16976815|P2|Overall Study|Lack of Efficacy|1
4932011|NCT00424294|16976816|P1|Overall Study|Lack of Efficacy|2
4932012|NCT00424294|16976815|P2|Overall Study|Adverse Event|10
4932013|NCT00424294|16976816|P1|Overall Study|Adverse Event|4
4932014|NCT00424255|16976883|P2|Overall Study|Sponsor Terminated Study|167
4932015|NCT00424255|16976884|P1|Overall Study|Sponsor Terminated Study|161
4932016|NCT00424255|16976883|P2|Overall Study|Disease Progression|2
4932017|NCT00424255|16976884|P1|Overall Study|Disease Progression|0
4932018|NCT00424255|16976883|P2|Overall Study|Fatigue|0
4932019|NCT00424255|16976884|P1|Overall Study|Fatigue|1
4932020|NCT00424255|16976883|P2|Overall Study|Non-compliance by Participants|0
4932021|NCT00424255|16976884|P1|Overall Study|Non-compliance by Participants|1
4932022|NCT00424255|16976883|P2|Overall Study|Cognitive Disturbance|0
4932023|NCT00424255|16976884|P1|Overall Study|Cognitive Disturbance|1
4932024|NCT00424255|16976883|P2|Overall Study|Physician Decision|7
4932025|NCT00424255|16976884|P1|Overall Study|Physician Decision|3
4932026|NCT00424255|16976883|P2|Overall Study|Withdrawal by Subject|38
4932027|NCT00424255|16976884|P1|Overall Study|Withdrawal by Subject|34
4932028|NCT00424255|16976883|P2|Overall Study|Protocol Violation|1
4932029|NCT00424255|16976884|P1|Overall Study|Protocol Violation|0
4932030|NCT00424255|16976883|P2|Overall Study|Lost to Follow-up|20
4932031|NCT00424255|16976884|P1|Overall Study|Lost to Follow-up|26
4932032|NCT00424255|16976883|P2|Overall Study|Death|111
4932033|NCT00424255|16976884|P1|Overall Study|Death|115
4932034|NCT00424190|16976932|P2|Overall Study|Other|21
4932035|NCT00424190|16976933|P1|Overall Study|Other|15
4932036|NCT00424190|16976932|P2|Overall Study|Diagnosis of osteomyelitis|1
4932037|NCT00424190|16976933|P1|Overall Study|Diagnosis of osteomyelitis|0
4932038|NCT00424190|16976932|P2|Overall Study|Request of sponsor or investigator|2
4932039|NCT00424190|16976933|P1|Overall Study|Request of sponsor or investigator|0
4932040|NCT00424190|16976932|P2|Overall Study|Noncompliance|2
4932041|NCT00424190|16976933|P1|Overall Study|Noncompliance|1
4932042|NCT00424190|16976932|P2|Overall Study|Death|0
4932043|NCT00424190|16976933|P1|Overall Study|Death|3
4932044|NCT00424190|16976932|P2|Overall Study|Withdrew consent|4
4932045|NCT00424190|16976933|P1|Overall Study|Withdrew consent|3
4932046|NCT00424177|16976939|P1|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1
4932047|NCT00424177|16976939|P1|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
4932048|NCT00424177|16976939|P1|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1
4932049|NCT00424177|16976939|P1|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1
4932050|NCT00424177|16976939|P1|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1
4932051|NCT00424177|16976939|P1|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2
4932052|NCT00424177|16976939|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1
4932053|NCT00424177|16976939|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1
4932054|NCT00424177|16976939|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1
4932055|NCT00424177|16976939|P1|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8
4932056|NCT00424047|16976968|P2|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0
4932057|NCT00424047|16976969|P1|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1
4932058|NCT00424047|16976968|P2|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3
4932059|NCT00424047|16976969|P1|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7
4932060|NCT00424047|16976968|P2|Long Term Extension (Up to 25 Jun 2013)|Other|4
4932061|NCT00424047|16976969|P1|Long Term Extension (Up to 25 Jun 2013)|Other|12
4932062|NCT00424047|16976968|P2|Long Term Extension (Up to 25 Jun 2013)|Death|1
4932063|NCT00424047|16976969|P1|Long Term Extension (Up to 25 Jun 2013)|Death|0
4932064|NCT00424047|16976968|P2|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0
4932065|NCT00424047|16976969|P1|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1
4932066|NCT00424047|16976968|P2|On Study at Time of Unblinding|Other|4
4932067|NCT00424047|16976969|P1|On Study at Time of Unblinding|Other|5
4932068|NCT00424047|16976968|P2|On Study at Time of Unblinding|Death|11
4932069|NCT00424047|16976969|P1|On Study at Time of Unblinding|Death|11
4932070|NCT00424047|16976968|P2|On Study at Time of Unblinding|Withdrawal by Subject|9
4932153|NCT00423891|16977096|P3|Enrolled|No longer met criteria|1
4932071|NCT00424047|16976969|P1|On Study at Time of Unblinding|Withdrawal by Subject|24
4932072|NCT00424047|16976968|P2|On Study at Time of Unblinding|Lack of Efficacy|3
4932073|NCT00424047|16976969|P1|On Study at Time of Unblinding|Lack of Efficacy|1
4932074|NCT00424047|16976968|P2|On Study at Time of Unblinding|Progression of disease|128
4932075|NCT00424047|16976969|P1|On Study at Time of Unblinding|Progression of disease|92
4932076|NCT00424047|16976968|P2|On Study at Time of Unblinding|Adverse Event|12
4932077|NCT00424047|16976969|P1|On Study at Time of Unblinding|Adverse Event|22
4932078|NCT00424047|16976968|P2|Blinded Treatment (Up to 03 Aug 2005)|Other|1
4932079|NCT00424047|16976969|P1|Blinded Treatment (Up to 03 Aug 2005)|Other|2
4932080|NCT00424047|16976968|P2|Blinded Treatment (Up to 03 Aug 2005)|Death|10
4932081|NCT00424047|16976969|P1|Blinded Treatment (Up to 03 Aug 2005)|Death|11
4932082|NCT00424047|16976968|P2|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8
4932083|NCT00424047|16976969|P1|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23
4932084|NCT00424047|16976968|P2|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3
4932085|NCT00424047|16976969|P1|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1
4932086|NCT00424047|16976968|P2|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122
4932087|NCT00424047|16976969|P1|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67
4932088|NCT00424047|16976968|P2|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12
4932089|NCT00424047|16976969|P1|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18
4932090|NCT00424021|16977001|P4|AMB-220-E Study Period|Physician Decision|1
4932091|NCT00424021|16977002|P3|AMB-220-E Study Period|Physician Decision|0
4932092|NCT00424021|16977003|P2|AMB-220-E Study Period|Physician Decision|0
4932093|NCT00424021|16977004|P1|AMB-220-E Study Period|Physician Decision|0
4932094|NCT00424021|16977001|P4|AMB-220-E Study Period|Lost to Follow-up|1
4932095|NCT00424021|16977002|P3|AMB-220-E Study Period|Lost to Follow-up|1
4932096|NCT00424021|16977003|P2|AMB-220-E Study Period|Lost to Follow-up|1
4932097|NCT00424021|16977004|P1|AMB-220-E Study Period|Lost to Follow-up|0
4932098|NCT00424021|16977001|P4|AMB-220-E Study Period|Death|1
4932099|NCT00424021|16977002|P3|AMB-220-E Study Period|Death|1
4932100|NCT00424021|16977003|P2|AMB-220-E Study Period|Death|0
4932101|NCT00424021|16977004|P1|AMB-220-E Study Period|Death|0
4932102|NCT00424021|16977001|P4|AMB-220-E Study Period|Adverse Event|7
4932103|NCT00424021|16977002|P3|AMB-220-E Study Period|Adverse Event|3
4932104|NCT00424021|16977003|P2|AMB-220-E Study Period|Adverse Event|1
4932105|NCT00424021|16977004|P1|AMB-220-E Study Period|Adverse Event|1
4932106|NCT00424021|16977001|P4|NCT00046319 Study Period|Lost to Follow-up|0
4932107|NCT00424021|16977002|P3|NCT00046319 Study Period|Lost to Follow-up|0
4932108|NCT00424021|16977003|P2|NCT00046319 Study Period|Lost to Follow-up|1
4932109|NCT00424021|16977004|P1|NCT00046319 Study Period|Lost to Follow-up|0
4932110|NCT00424021|16977001|P4|NCT00046319 Study Period|Sponsor discretion|0
4932111|NCT00424021|16977002|P3|NCT00046319 Study Period|Sponsor discretion|0
4932112|NCT00424021|16977003|P2|NCT00046319 Study Period|Sponsor discretion|1
4932113|NCT00424021|16977004|P1|NCT00046319 Study Period|Sponsor discretion|0
4932114|NCT00424021|16977001|P4|NCT00046319 Study Period|Withdrawal by Subject|0
4932115|NCT00424021|16977002|P3|NCT00046319 Study Period|Withdrawal by Subject|0
4932116|NCT00424021|16977003|P2|NCT00046319 Study Period|Withdrawal by Subject|1
4932117|NCT00424021|16977004|P1|NCT00046319 Study Period|Withdrawal by Subject|0
4932118|NCT00424021|16977001|P4|NCT00046319 Study Period|Adverse Event|1
4932119|NCT00424021|16977002|P3|NCT00046319 Study Period|Adverse Event|1
4932120|NCT00424021|16977003|P2|NCT00046319 Study Period|Adverse Event|0
4932121|NCT00424021|16977004|P1|NCT00046319 Study Period|Adverse Event|1
4932122|NCT00424008|16977047|P2|Overall Study|Administrative|257
4932123|NCT00424008|16977048|P1|Overall Study|Administrative|266
4932124|NCT00424008|16977047|P2|Overall Study|Did not meet protocol eligibility|21
4932125|NCT00424008|16977048|P1|Overall Study|Did not meet protocol eligibility|16
4932126|NCT00424008|16977047|P2|Overall Study|Noncompliance with protocol|7
4932127|NCT00424008|16977048|P1|Overall Study|Noncompliance with protocol|13
4932128|NCT00424008|16977047|P2|Overall Study|Withdrawal by Subject|8
4932129|NCT00424008|16977048|P1|Overall Study|Withdrawal by Subject|5
4932130|NCT00424008|16977047|P2|Overall Study|Lost to Follow-up|2
4932131|NCT00424008|16977048|P1|Overall Study|Lost to Follow-up|1
4932132|NCT00424008|16977047|P2|Overall Study|Lack of Efficacy|34
4932133|NCT00424008|16977048|P1|Overall Study|Lack of Efficacy|40
4932134|NCT00424008|16977047|P2|Overall Study|Adverse Event|6
4932135|NCT00424008|16977048|P1|Overall Study|Adverse Event|8
4932136|NCT00423943|16977063|P2|Overall Study|Withdrawal by Subject|1
4932137|NCT00423943|16977064|P1|Overall Study|Withdrawal by Subject|3
4932138|NCT00423930|16977078|P1|Overall Study|Withdrawal by Subject|2
4932139|NCT00423917|16977083|P1|Overall Study|Ineligible|1
4932140|NCT00423917|16977083|P1|Overall Study|Cancel|2
4932141|NCT00423891|16977096|P3|Post-Dosing Follow Up|Lost to Follow-up|0
4932142|NCT00423891|16977097|P2|Post-Dosing Follow Up|Lost to Follow-up|0
4932143|NCT00423891|16977098|P1|Post-Dosing Follow Up|Lost to Follow-up|2
4932144|NCT00423891|16977096|P3|Post-Dosing Follow Up|Withdrawal by Subject|2
4932145|NCT00423891|16977097|P2|Post-Dosing Follow Up|Withdrawal by Subject|3
4932146|NCT00423891|16977098|P1|Post-Dosing Follow Up|Withdrawal by Subject|0
4932147|NCT00423891|16977096|P3|Treatment|Lost to Follow-up|0
4932148|NCT00423891|16977097|P2|Treatment|Lost to Follow-up|0
4932149|NCT00423891|16977098|P1|Treatment|Lost to Follow-up|1
4932150|NCT00423891|16977096|P3|Treatment|Withdrawal by Subject|0
4932151|NCT00423891|16977097|P2|Treatment|Withdrawal by Subject|0
4932152|NCT00423891|16977098|P1|Treatment|Withdrawal by Subject|1
4932154|NCT00423891|16977097|P2|Enrolled|No longer met criteria|2
4932155|NCT00423891|16977098|P1|Enrolled|No longer met criteria|11
4932156|NCT00423891|16977096|P3|Enrolled|Lost to Follow-up|1
4932157|NCT00423891|16977097|P2|Enrolled|Lost to Follow-up|0
4932158|NCT00423891|16977098|P1|Enrolled|Lost to Follow-up|0
4932159|NCT00423891|16977096|P3|Enrolled|Withdrawal by Subject|1
4932160|NCT00423891|16977097|P2|Enrolled|Withdrawal by Subject|0
4932161|NCT00423891|16977098|P1|Enrolled|Withdrawal by Subject|0
4932162|NCT00423852|16977176|P1|Overall Study|Removed pior to the high-dose portion|3
4932163|NCT00423813|16977184|P3|Overall Study|Undergoing tests for Cushings Syndrome|1
4932164|NCT00423813|16977185|P2|Overall Study|Undergoing tests for Cushings Syndrome|0
4932165|NCT00423813|16977186|P1|Overall Study|Undergoing tests for Cushings Syndrome|0
4932166|NCT00423813|16977184|P3|Overall Study|Will start exclusionary medications|0
4932167|NCT00423813|16977185|P2|Overall Study|Will start exclusionary medications|1
4932168|NCT00423813|16977186|P1|Overall Study|Will start exclusionary medications|0
4932169|NCT00423813|16977184|P3|Overall Study|Subject started night shift work|0
4932170|NCT00423813|16977185|P2|Overall Study|Subject started night shift work|0
4932171|NCT00423813|16977186|P1|Overall Study|Subject started night shift work|1
4932172|NCT00423813|16977184|P3|Overall Study|Pregnancy|1
4932173|NCT00423813|16977185|P2|Overall Study|Pregnancy|0
4932174|NCT00423813|16977186|P1|Overall Study|Pregnancy|0
4932175|NCT00423813|16977184|P3|Overall Study|Protocol Violation|4
4932176|NCT00423813|16977185|P2|Overall Study|Protocol Violation|4
4932177|NCT00423813|16977186|P1|Overall Study|Protocol Violation|9
4932178|NCT00423813|16977184|P3|Overall Study|Sponsor Decision|0
4932179|NCT00423813|16977185|P2|Overall Study|Sponsor Decision|1
4932180|NCT00423813|16977186|P1|Overall Study|Sponsor Decision|0
4932181|NCT00423813|16977184|P3|Overall Study|Physician Decision|0
4932182|NCT00423813|16977185|P2|Overall Study|Physician Decision|0
4932183|NCT00423813|16977186|P1|Overall Study|Physician Decision|2
4932184|NCT00423813|16977184|P3|Overall Study|Lack of Efficacy|19
4932185|NCT00423813|16977185|P2|Overall Study|Lack of Efficacy|18
4932186|NCT00423813|16977186|P1|Overall Study|Lack of Efficacy|23
4932187|NCT00423813|16977184|P3|Overall Study|Lost to Follow-up|4
4932188|NCT00423813|16977185|P2|Overall Study|Lost to Follow-up|4
4932189|NCT00423813|16977186|P1|Overall Study|Lost to Follow-up|5
4932190|NCT00423813|16977184|P3|Overall Study|Withdrawal by Subject|5
4932191|NCT00423813|16977185|P2|Overall Study|Withdrawal by Subject|8
4932192|NCT00423813|16977186|P1|Overall Study|Withdrawal by Subject|6
4932193|NCT00423813|16977184|P3|Overall Study|Adverse Event|40
4932194|NCT00423813|16977185|P2|Overall Study|Adverse Event|30
4932195|NCT00423813|16977186|P1|Overall Study|Adverse Event|11
4932196|NCT00423800|16977196|P2|Overall Study|Protocol Violation|1
4932197|NCT00423800|16977197|P1|Overall Study|Protocol Violation|0
4932198|NCT00423735|16977209|P3|Overall Study|Ineligible / No protocol treatment|0
4932199|NCT00423735|16977210|P2|Overall Study|Ineligible / No protocol treatment|6
4932200|NCT00423735|16977211|P1|Overall Study|Ineligible / No protocol treatment|8
4932201|NCT00423722|16977234|P2|Overall Study|Withdrawal by Subject|2
4932202|NCT00423722|16977235|P1|Overall Study|Withdrawal by Subject|4
4932203|NCT00423722|16977234|P2|Overall Study|Unable to complete questionnaires|4
4932204|NCT00423722|16977235|P1|Overall Study|Unable to complete questionnaires|4
4932205|NCT00423722|16977234|P2|Overall Study|Declined to participate|3
4932206|NCT00423722|16977235|P1|Overall Study|Declined to participate|2
4932207|NCT00423722|16977234|P2|Overall Study|Death|4
4932208|NCT00423722|16977235|P1|Overall Study|Death|4
4932209|NCT00423670|16977277|P8|Follow-up Period|Non-compliance with protocol|2
4932210|NCT00423670|16977278|P7|Follow-up Period|Non-compliance with protocol|3
4932211|NCT00423670|16977279|P6|Follow-up Period|Non-compliance with protocol|0
4932212|NCT00423670|16977280|P5|Follow-up Period|Non-compliance with protocol|0
4932213|NCT00423670|16977281|P4|Follow-up Period|Non-compliance with protocol|1
4932214|NCT00423670|16977282|P3|Follow-up Period|Non-compliance with protocol|1
4932215|NCT00423670|16977283|P2|Follow-up Period|Non-compliance with protocol|0
4932216|NCT00423670|16977284|P1|Follow-up Period|Non-compliance with protocol|2
4932217|NCT00423670|16977277|P8|Follow-up Period|Subject withdrew (not treatment related)|1
4932218|NCT00423670|16977278|P7|Follow-up Period|Subject withdrew (not treatment related)|1
4932219|NCT00423670|16977279|P6|Follow-up Period|Subject withdrew (not treatment related)|0
4932220|NCT00423670|16977280|P5|Follow-up Period|Subject withdrew (not treatment related)|1
4932221|NCT00423670|16977281|P4|Follow-up Period|Subject withdrew (not treatment related)|1
4932222|NCT00423670|16977282|P3|Follow-up Period|Subject withdrew (not treatment related)|2
4932223|NCT00423670|16977283|P2|Follow-up Period|Subject withdrew (not treatment related)|4
4932224|NCT00423670|16977284|P1|Follow-up Period|Subject withdrew (not treatment related)|1
4932225|NCT00423670|16977277|P8|Follow-up Period|Lost to Follow-up|0
4932226|NCT00423670|16977278|P7|Follow-up Period|Lost to Follow-up|5
4932227|NCT00423670|16977279|P6|Follow-up Period|Lost to Follow-up|0
4932228|NCT00423670|16977280|P5|Follow-up Period|Lost to Follow-up|1
4932229|NCT00423670|16977281|P4|Follow-up Period|Lost to Follow-up|3
4932230|NCT00423670|16977282|P3|Follow-up Period|Lost to Follow-up|8
4932231|NCT00423670|16977283|P2|Follow-up Period|Lost to Follow-up|12
4932232|NCT00423670|16977284|P1|Follow-up Period|Lost to Follow-up|0
4932233|NCT00423670|16977277|P8|Treatment Period|Non-compliance with protocol|2
4932234|NCT00423670|16977278|P7|Treatment Period|Non-compliance with protocol|2
4932235|NCT00423670|16977279|P6|Treatment Period|Non-compliance with protocol|0
4932318|NCT00423449|16977391|P4|Overall Study|Protocol Violation|1
4932236|NCT00423670|16977280|P5|Treatment Period|Non-compliance with protocol|2
4932237|NCT00423670|16977281|P4|Treatment Period|Non-compliance with protocol|3
4932238|NCT00423670|16977282|P3|Treatment Period|Non-compliance with protocol|1
4932239|NCT00423670|16977283|P2|Treatment Period|Non-compliance with protocol|1
4932240|NCT00423670|16977284|P1|Treatment Period|Non-compliance with protocol|3
4932241|NCT00423670|16977277|P8|Treatment Period|Investigator decision|1
4932242|NCT00423670|16977278|P7|Treatment Period|Investigator decision|0
4932243|NCT00423670|16977279|P6|Treatment Period|Investigator decision|0
4932244|NCT00423670|16977280|P5|Treatment Period|Investigator decision|0
4932245|NCT00423670|16977281|P4|Treatment Period|Investigator decision|0
4932246|NCT00423670|16977282|P3|Treatment Period|Investigator decision|0
4932247|NCT00423670|16977283|P2|Treatment Period|Investigator decision|0
4932248|NCT00423670|16977284|P1|Treatment Period|Investigator decision|0
4932249|NCT00423670|16977277|P8|Treatment Period|Subject withdrew (not treatment related)|0
4932250|NCT00423670|16977278|P7|Treatment Period|Subject withdrew (not treatment related)|3
4932251|NCT00423670|16977279|P6|Treatment Period|Subject withdrew (not treatment related)|0
4932252|NCT00423670|16977280|P5|Treatment Period|Subject withdrew (not treatment related)|5
4932253|NCT00423670|16977281|P4|Treatment Period|Subject withdrew (not treatment related)|4
4932254|NCT00423670|16977282|P3|Treatment Period|Subject withdrew (not treatment related)|4
4932255|NCT00423670|16977283|P2|Treatment Period|Subject withdrew (not treatment related)|9
4932256|NCT00423670|16977284|P1|Treatment Period|Subject withdrew (not treatment related)|3
4932257|NCT00423670|16977277|P8|Treatment Period|Lost to Follow-up|1
4932258|NCT00423670|16977278|P7|Treatment Period|Lost to Follow-up|3
4932259|NCT00423670|16977279|P6|Treatment Period|Lost to Follow-up|0
4932260|NCT00423670|16977280|P5|Treatment Period|Lost to Follow-up|6
4932261|NCT00423670|16977281|P4|Treatment Period|Lost to Follow-up|1
4932262|NCT00423670|16977282|P3|Treatment Period|Lost to Follow-up|3
4932263|NCT00423670|16977283|P2|Treatment Period|Lost to Follow-up|1
4932264|NCT00423670|16977284|P1|Treatment Period|Lost to Follow-up|2
4932265|NCT00423670|16977277|P8|Treatment Period|Protocol-defined clinical event|15
4932266|NCT00423670|16977278|P7|Treatment Period|Protocol-defined clinical event|16
4932267|NCT00423670|16977279|P6|Treatment Period|Protocol-defined clinical event|4
4932268|NCT00423670|16977280|P5|Treatment Period|Protocol-defined clinical event|5
4932269|NCT00423670|16977281|P4|Treatment Period|Protocol-defined clinical event|12
4932270|NCT00423670|16977282|P3|Treatment Period|Protocol-defined clinical event|4
4932271|NCT00423670|16977283|P2|Treatment Period|Protocol-defined clinical event|7
4932272|NCT00423670|16977284|P1|Treatment Period|Protocol-defined clinical event|0
4932273|NCT00423670|16977277|P8|Treatment Period|Adverse Event|2
4932274|NCT00423670|16977278|P7|Treatment Period|Adverse Event|7
4932275|NCT00423670|16977279|P6|Treatment Period|Adverse Event|4
4932276|NCT00423670|16977280|P5|Treatment Period|Adverse Event|9
4932277|NCT00423670|16977281|P4|Treatment Period|Adverse Event|20
4932278|NCT00423670|16977282|P3|Treatment Period|Adverse Event|15
4932279|NCT00423670|16977283|P2|Treatment Period|Adverse Event|12
4932280|NCT00423670|16977284|P1|Treatment Period|Adverse Event|8
4932281|NCT00423670|16977277|P8|Treatment Period|Switched to Arm 8 at TW 24|0
4932282|NCT00423670|16977278|P7|Treatment Period|Switched to Arm 8 at TW 24|0
4932283|NCT00423670|16977279|P6|Treatment Period|Switched to Arm 8 at TW 24|0
4932284|NCT00423670|16977280|P5|Treatment Period|Switched to Arm 8 at TW 24|0
4932285|NCT00423670|16977281|P4|Treatment Period|Switched to Arm 8 at TW 24|0
4932286|NCT00423670|16977282|P3|Treatment Period|Switched to Arm 8 at TW 24|0
4932287|NCT00423670|16977283|P2|Treatment Period|Switched to Arm 8 at TW 24|0
4932288|NCT00423670|16977284|P1|Treatment Period|Switched to Arm 8 at TW 24|36
4932289|NCT00423657|16977342|P2|Overall Study|Request of sponsor/investigator|0
4932290|NCT00423657|16977343|P1|Overall Study|Request of sponsor/investigator|1
4932291|NCT00423657|16977342|P2|Overall Study|Other|16
4932292|NCT00423657|16977343|P1|Overall Study|Other|15
4932293|NCT00423657|16977342|P2|Overall Study|Non-compliance|1
4932294|NCT00423657|16977343|P1|Overall Study|Non-compliance|0
4932295|NCT00423657|16977342|P2|Overall Study|Withdrew consent|8
4932296|NCT00423657|16977343|P1|Overall Study|Withdrew consent|10
4932297|NCT00423605|16977349|P1|Overall Study|Not one of the pre-specified options|5
4932298|NCT00423605|16977349|P1|Overall Study|Protocol Violation|7
4932299|NCT00423605|16977349|P1|Overall Study|Physician Decision|8
4932300|NCT00423605|16977349|P1|Overall Study|Sponsor Decision|3
4932301|NCT00423605|16977349|P1|Overall Study|Lack of Efficacy|38
4932302|NCT00423605|16977349|P1|Overall Study|Lost to Follow-up|15
4932303|NCT00423605|16977349|P1|Overall Study|Withdrawal by Subject|36
4932304|NCT00423605|16977349|P1|Overall Study|Adverse Event|129
4932305|NCT00423592|16977353|P1|Overall Study|Adverse Event (post Week 12)|5
4932306|NCT00423592|16977353|P1|Overall Study|Adverse Event (through Week 12)|2
4932307|NCT00423579|16977374|P2|Overall Study|Diagnosis of diabetes|1
4932308|NCT00423579|16977375|P1|Overall Study|Diagnosis of diabetes|0
4932309|NCT00423579|16977374|P2|Overall Study|Protocol Violation|3
4932310|NCT00423579|16977375|P1|Overall Study|Protocol Violation|1
4932311|NCT00423579|16977374|P2|Overall Study|Lost to Follow-up|0
4932312|NCT00423579|16977375|P1|Overall Study|Lost to Follow-up|3
4932313|NCT00423488|16977383|P2|Overall Study|No post baseline data|0
4932314|NCT00423488|16977384|P1|Overall Study|No post baseline data|3
4932315|NCT00423488|16977383|P2|Overall Study|No evidence of study drug intake|1
4932316|NCT00423488|16977384|P1|Overall Study|No evidence of study drug intake|2
4932317|NCT00423449|16977390|P5|Overall Study|Protocol Violation|0
4932319|NCT00423449|16977392|P3|Overall Study|Protocol Violation|2
4932320|NCT00423449|16977393|P2|Overall Study|Protocol Violation|0
4932321|NCT00423449|16977394|P1|Overall Study|Protocol Violation|0
4932322|NCT00423449|16977390|P5|Overall Study|Other|0
4932323|NCT00423449|16977391|P4|Overall Study|Other|1
4932324|NCT00423449|16977392|P3|Overall Study|Other|0
4932325|NCT00423449|16977393|P2|Overall Study|Other|0
4932326|NCT00423449|16977394|P1|Overall Study|Other|0
4932327|NCT00423449|16977390|P5|Overall Study|Laboratory Adverse Event|0
4932328|NCT00423449|16977391|P4|Overall Study|Laboratory Adverse Event|0
4932329|NCT00423449|16977392|P3|Overall Study|Laboratory Adverse Event|2
4932330|NCT00423449|16977393|P2|Overall Study|Laboratory Adverse Event|1
4932331|NCT00423449|16977394|P1|Overall Study|Laboratory Adverse Event|0
4932332|NCT00423449|16977390|P5|Overall Study|Progressive Disease|4
4932333|NCT00423449|16977391|P4|Overall Study|Progressive Disease|11
4932334|NCT00423449|16977392|P3|Overall Study|Progressive Disease|8
4932335|NCT00423449|16977393|P2|Overall Study|Progressive Disease|3
4932336|NCT00423449|16977394|P1|Overall Study|Progressive Disease|1
4932337|NCT00423449|16977390|P5|Overall Study|Death|1
4932338|NCT00423449|16977391|P4|Overall Study|Death|1
4932339|NCT00423449|16977392|P3|Overall Study|Death|2
4932340|NCT00423449|16977393|P2|Overall Study|Death|0
4932341|NCT00423449|16977394|P1|Overall Study|Death|1
4932342|NCT00423449|16977390|P5|Overall Study|Clinical Adverse Event|2
4932343|NCT00423449|16977391|P4|Overall Study|Clinical Adverse Event|8
4932344|NCT00423449|16977392|P3|Overall Study|Clinical Adverse Event|1
4932345|NCT00423449|16977393|P2|Overall Study|Clinical Adverse Event|0
4932346|NCT00423449|16977394|P1|Overall Study|Clinical Adverse Event|1
4932347|NCT00423332|16977441|P2|Overall Study|Unblinded before 12 weeks|3
4932348|NCT00423332|16977442|P1|Overall Study|Unblinded before 12 weeks|1
4932349|NCT00423332|16977441|P2|Overall Study|Progressive at Week 6|1
4932350|NCT00423332|16977442|P1|Overall Study|Progressive at Week 6|0
4932351|NCT00423332|16977441|P2|Overall Study|Condition under investigation worsened|1
4932352|NCT00423332|16977442|P1|Overall Study|Condition under investigation worsened|1
4932353|NCT00423332|16977441|P2|Overall Study|Withdrawal by Subject|0
4932354|NCT00423332|16977442|P1|Overall Study|Withdrawal by Subject|1
4932355|NCT00423332|16977441|P2|Overall Study|Adverse Event|2
4932356|NCT00423332|16977442|P1|Overall Study|Adverse Event|6
4932357|NCT00423319|16977461|P2|Overall Study|Other|22
4932358|NCT00423319|16977462|P1|Overall Study|Other|23
4932359|NCT00423319|16977461|P2|Overall Study|No longer meets study criteria|15
4932360|NCT00423319|16977462|P1|Overall Study|No longer meets study criteria|15
4932361|NCT00423319|16977461|P2|Overall Study|Poor compliance or noncompliance|1
4932362|NCT00423319|16977462|P1|Overall Study|Poor compliance or noncompliance|1
4932363|NCT00423319|16977461|P2|Overall Study|Lost to Follow-up|3
4932364|NCT00423319|16977462|P1|Overall Study|Lost to Follow-up|4
4932365|NCT00423319|16977461|P2|Overall Study|Withdrawal by Subject|99
4932366|NCT00423319|16977462|P1|Overall Study|Withdrawal by Subject|86
4932367|NCT00423319|16977461|P2|Overall Study|Adverse Event|112
4932368|NCT00423319|16977462|P1|Overall Study|Adverse Event|93
4932369|NCT00423319|16977461|P2|Overall Study|Death|0
4932370|NCT00423319|16977462|P1|Overall Study|Death|2
4932371|NCT00423293|16977494|P1|Overall Study|Ineligible / No protocol treatment|11
4932372|NCT00423267|16977511|P2|Period A|Administrative|0
4932373|NCT00423267|16977512|P1|Period A|Administrative|1
4932374|NCT00423267|16977511|P2|Period A|Non-compliance with protocol|0
4932375|NCT00423267|16977512|P1|Period A|Non-compliance with protocol|1
4932376|NCT00423267|16977511|P2|Period A|Withdrawal by Subject|1
4932377|NCT00423267|16977512|P1|Period A|Withdrawal by Subject|0
4932378|NCT00423189|16977532|P3|Overall Study|Death|0
4932379|NCT00423189|16977533|P2|Overall Study|Death|1
4932380|NCT00423189|16977534|P1|Overall Study|Death|0
4932381|NCT00423176|16977556|P2|Overall Study|Did not meet protocol eligibility|4
4932382|NCT00423176|16977557|P1|Overall Study|Did not meet protocol eligibility|2
4932383|NCT00423176|16977556|P2|Overall Study|Protocol Violation|3
4932384|NCT00423176|16977557|P1|Overall Study|Protocol Violation|1
4932385|NCT00423176|16977556|P2|Overall Study|Withdrawal by Subject|3
4932386|NCT00423176|16977557|P1|Overall Study|Withdrawal by Subject|4
4932387|NCT00423176|16977556|P2|Overall Study|Lost to Follow-up|7
4932388|NCT00423176|16977557|P1|Overall Study|Lost to Follow-up|4
4932389|NCT00423176|16977556|P2|Overall Study|Treatment Failure|6
4932390|NCT00423176|16977557|P1|Overall Study|Treatment Failure|1
4932391|NCT00423176|16977556|P2|Overall Study|Adverse Event|6
4932392|NCT00423176|16977557|P1|Overall Study|Adverse Event|4
4932393|NCT00423150|16977565|P1|Overall Study|Administrative|4
4932394|NCT00423150|16977565|P1|Overall Study|Non-compliance with protocol|1
4932395|NCT00423150|16977565|P1|Overall Study|Withdrawal by Subject|1
4932396|NCT00423150|16977565|P1|Overall Study|Progression of disease being studied|69
4932397|NCT00423150|16977565|P1|Overall Study|Adverse Event|11
4932398|NCT00423098|16977571|P2|Overall Study|Death|0
4932399|NCT00423098|16977572|P1|Overall Study|Death|2
4932400|NCT00423098|16977571|P2|Overall Study|Administrative problems|1
4932401|NCT00423098|16977572|P1|Overall Study|Administrative problems|0
4932402|NCT00423098|16977571|P2|Overall Study|Unsatisfactory therapeutic effect|1
4932403|NCT00423098|16977572|P1|Overall Study|Unsatisfactory therapeutic effect|0
4932404|NCT00423098|16977571|P2|Overall Study|Adverse Event|2
4932405|NCT00423098|16977572|P1|Overall Study|Adverse Event|1
4932406|NCT00423085|16977599|P4|52-Week Open-Label Extension Phase|Death|2
4932407|NCT00423085|16977600|P3|52-Week Open-Label Extension Phase|Death|0
4932408|NCT00423085|16977601|P2|52-Week Open-Label Extension Phase|Death|0
4932409|NCT00423085|16977602|P1|52-Week Open-Label Extension Phase|Death|0
4932410|NCT00423085|16977599|P4|52-Week Open-Label Extension Phase|Protocol deviation|9
4932411|NCT00423085|16977600|P3|52-Week Open-Label Extension Phase|Protocol deviation|0
4932412|NCT00423085|16977601|P2|52-Week Open-Label Extension Phase|Protocol deviation|0
4932413|NCT00423085|16977602|P1|52-Week Open-Label Extension Phase|Protocol deviation|0
4932414|NCT00423085|16977599|P4|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18
4932415|NCT00423085|16977600|P3|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
4932416|NCT00423085|16977601|P2|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
4932417|NCT00423085|16977602|P1|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0
4932418|NCT00423085|16977599|P4|52-Week Open-Label Extension Phase|Withdrawal by Subject|37
4932419|NCT00423085|16977600|P3|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
4932420|NCT00423085|16977601|P2|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
4932421|NCT00423085|16977602|P1|52-Week Open-Label Extension Phase|Withdrawal by Subject|0
4932422|NCT00423085|16977599|P4|52-Week Open-Label Extension Phase|Adverse Event|97
4932423|NCT00423085|16977600|P3|52-Week Open-Label Extension Phase|Adverse Event|0
4932424|NCT00423085|16977601|P2|52-Week Open-Label Extension Phase|Adverse Event|0
4932425|NCT00423085|16977602|P1|52-Week Open-Label Extension Phase|Adverse Event|0
4932426|NCT00423085|16977599|P4|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
4932427|NCT00423085|16977600|P3|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
4932428|NCT00423085|16977601|P2|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0
4932429|NCT00423085|16977602|P1|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1
4932430|NCT00423085|16977599|P4|24-Week Double-Blind Treatment Phase|Death|0
4932431|NCT00423085|16977600|P3|24-Week Double-Blind Treatment Phase|Death|0
4932432|NCT00423085|16977601|P2|24-Week Double-Blind Treatment Phase|Death|1
4932433|NCT00423085|16977602|P1|24-Week Double-Blind Treatment Phase|Death|1
4932434|NCT00423085|16977599|P4|24-Week Double-Blind Treatment Phase|Protocol Violation|0
4932435|NCT00423085|16977600|P3|24-Week Double-Blind Treatment Phase|Protocol Violation|7
4932436|NCT00423085|16977601|P2|24-Week Double-Blind Treatment Phase|Protocol Violation|3
4932437|NCT00423085|16977602|P1|24-Week Double-Blind Treatment Phase|Protocol Violation|8
4932438|NCT00423085|16977599|P4|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0
4932439|NCT00423085|16977600|P3|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
4932440|NCT00423085|16977601|P2|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6
4932441|NCT00423085|16977602|P1|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7
4932442|NCT00423085|16977599|P4|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0
4932443|NCT00423085|16977600|P3|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11
4932444|NCT00423085|16977601|P2|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16
4932445|NCT00423085|16977602|P1|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8
4932446|NCT00423085|16977599|P4|24-Week Double-Blind Treatment Phase|Adverse Event|0
4932447|NCT00423085|16977600|P3|24-Week Double-Blind Treatment Phase|Adverse Event|34
4932448|NCT00423085|16977601|P2|24-Week Double-Blind Treatment Phase|Adverse Event|38
4932449|NCT00423085|16977602|P1|24-Week Double-Blind Treatment Phase|Adverse Event|21
4932450|NCT00423046|16977631|P2|Overall Study|Other|345
4932451|NCT00423046|16977632|P1|Overall Study|Other|340
4932452|NCT00422942|16977698|P1|Overall Study|Study terminated by Sponsor|3
4932453|NCT00422903|16977717|P2|Overall Study|Informed Consent Withdrawn|2
4932454|NCT00422903|16977718|P1|Overall Study|Informed Consent Withdrawn|1
4932455|NCT00422903|16977717|P2|Overall Study|Adverse Event|2
4932456|NCT00422903|16977718|P1|Overall Study|Adverse Event|0
4932457|NCT00422903|16977717|P2|Overall Study|Disease Progression|1
4932458|NCT00422903|16977718|P1|Overall Study|Disease Progression|3
4932459|NCT00422799|16977767|P1|Overall Study|Adverse Event|7
4932460|NCT00422799|16977767|P1|Overall Study|Withdrawal by Subject|6
4932461|NCT00422734|16977776|P2|Overall Study|Partner Decision|3
4932462|NCT00422734|16977777|P1|Overall Study|Partner Decision|0
4932463|NCT00422734|16977776|P2|Overall Study|Adverse Event|3
4932464|NCT00422734|16977777|P1|Overall Study|Adverse Event|0
4932465|NCT00422734|16977776|P2|Overall Study|Withdrawal by Subject|8
4932466|NCT00422734|16977777|P1|Overall Study|Withdrawal by Subject|12
4932467|NCT00422734|16977776|P2|Overall Study|Protocol Violation|6
4932468|NCT00422734|16977777|P1|Overall Study|Protocol Violation|1
4932469|NCT00422734|16977776|P2|Overall Study|Physician Decision|1
4932470|NCT00422734|16977777|P1|Overall Study|Physician Decision|1
4932471|NCT00422669|16977823|P3|Overall Study|The study was terminated early.|7
4932472|NCT00422669|16977824|P2|Overall Study|The study was terminated early.|100
4932473|NCT00422669|16977825|P1|Overall Study|The study was terminated early.|98
4932474|NCT00422591|16977853|P1|Overall Study|Withdrawal by Subject|2
4932475|NCT00422591|16977853|P1|Overall Study|Physician Decision|4
4932476|NCT00422513|16977861|P2|Overall Study|Death|7
4932477|NCT00422513|16977862|P1|Overall Study|Death|3
4932478|NCT00422513|16977861|P2|Overall Study|Adverse Event|4
4932479|NCT00422513|16977862|P1|Overall Study|Adverse Event|4
4932480|NCT00422513|16977861|P2|Overall Study|early termination of the study|80
4932481|NCT00422513|16977862|P1|Overall Study|early termination of the study|67
4932482|NCT00422513|16977861|P2|Overall Study|Withdrawal by Subject|1
4932483|NCT00422513|16977862|P1|Overall Study|Withdrawal by Subject|2
4932484|NCT00422513|16977861|P2|Overall Study|Refused Treatment|2
4932485|NCT00422513|16977862|P1|Overall Study|Refused Treatment|4
4932486|NCT00422513|16977861|P2|Overall Study|Protocol Violation|7
4932487|NCT00422513|16977862|P1|Overall Study|Protocol Violation|23
4932488|NCT00422513|16977861|P2|Overall Study|Lack of Efficacy|5
4932489|NCT00422513|16977862|P1|Overall Study|Lack of Efficacy|4
4932490|NCT00422422|16977879|P1|Overall Study|AE, non-serious non-fatal|5
4932491|NCT00422422|16977879|P1|Overall Study|SAE, non-fatal|1
4932492|NCT00422422|16977879|P1|Overall Study|Withdrawal by Subject|2
4932493|NCT00422422|16977879|P1|Overall Study|Protocol Violation|1
4932494|NCT00422422|16977879|P1|Overall Study|Lack of Efficacy|1
4932495|NCT00422383|16977896|P5|Overall Study|Withdrawal by Subject|1
4932496|NCT00422383|16977897|P4|Overall Study|Withdrawal by Subject|0
4932497|NCT00422383|16977898|P3|Overall Study|Withdrawal by Subject|0
4932498|NCT00422383|16977899|P2|Overall Study|Withdrawal by Subject|5
4932499|NCT00422383|16977900|P1|Overall Study|Withdrawal by Subject|5
4932500|NCT00422383|16977896|P5|Overall Study|Protocol Violation|0
4932501|NCT00422383|16977897|P4|Overall Study|Protocol Violation|0
4932502|NCT00422383|16977898|P3|Overall Study|Protocol Violation|1
4932503|NCT00422383|16977899|P2|Overall Study|Protocol Violation|1
4932504|NCT00422383|16977900|P1|Overall Study|Protocol Violation|1
4932505|NCT00422383|16977896|P5|Overall Study|Lost to Follow-up|1
4932506|NCT00422383|16977897|P4|Overall Study|Lost to Follow-up|0
4932507|NCT00422383|16977898|P3|Overall Study|Lost to Follow-up|0
4932508|NCT00422383|16977899|P2|Overall Study|Lost to Follow-up|1
4932509|NCT00422383|16977900|P1|Overall Study|Lost to Follow-up|0
4932510|NCT00422383|16977896|P5|Overall Study|Lack of Efficacy|1
4932511|NCT00422383|16977897|P4|Overall Study|Lack of Efficacy|1
4932512|NCT00422383|16977898|P3|Overall Study|Lack of Efficacy|2
4932513|NCT00422383|16977899|P2|Overall Study|Lack of Efficacy|4
4932514|NCT00422383|16977900|P1|Overall Study|Lack of Efficacy|4
4932515|NCT00422383|16977896|P5|Overall Study|Adverse Event|0
4932516|NCT00422383|16977897|P4|Overall Study|Adverse Event|1
4932517|NCT00422383|16977898|P3|Overall Study|Adverse Event|1
4932518|NCT00422383|16977899|P2|Overall Study|Adverse Event|3
4932519|NCT00422383|16977900|P1|Overall Study|Adverse Event|5
4932520|NCT00422292|16978043|P4|Overall Study|Withdrawal by Subject|13
4932521|NCT00422292|16978044|P3|Overall Study|Withdrawal by Subject|7
4932522|NCT00422292|16978045|P2|Overall Study|Withdrawal by Subject|25
4932523|NCT00422292|16978046|P1|Overall Study|Withdrawal by Subject|6
4932524|NCT00422292|16978043|P4|Overall Study|Lost to Follow-up|6
4932525|NCT00422292|16978044|P3|Overall Study|Lost to Follow-up|6
4932526|NCT00422292|16978045|P2|Overall Study|Lost to Follow-up|12
4932527|NCT00422292|16978046|P1|Overall Study|Lost to Follow-up|6
4932528|NCT00422292|16978043|P4|Overall Study|Protocol Violation|5
4932529|NCT00422292|16978044|P3|Overall Study|Protocol Violation|8
4932530|NCT00422292|16978045|P2|Overall Study|Protocol Violation|25
4932531|NCT00422292|16978046|P1|Overall Study|Protocol Violation|4
4932532|NCT00422292|16978043|P4|Overall Study|Adverse Event|0
4932533|NCT00422292|16978044|P3|Overall Study|Adverse Event|1
4932534|NCT00422292|16978045|P2|Overall Study|Adverse Event|0
4932535|NCT00422292|16978046|P1|Overall Study|Adverse Event|1
4932536|NCT00422292|16978043|P4|Overall Study|Serious adverse events|0
4932537|NCT00422292|16978044|P3|Overall Study|Serious adverse events|0
4932538|NCT00422292|16978045|P2|Overall Study|Serious adverse events|4
4932539|NCT00422292|16978046|P1|Overall Study|Serious adverse events|1
4932540|NCT00422227|16978085|P2|Overall Study|Withdrawal by Subject|4
4932541|NCT00422227|16978086|P1|Overall Study|Withdrawal by Subject|0
4932542|NCT00422227|16978085|P2|Overall Study|Lost to Follow-up|3
4932543|NCT00422227|16978086|P1|Overall Study|Lost to Follow-up|1
4932544|NCT00422227|16978085|P2|Overall Study|Adverse Event|8
4932545|NCT00422227|16978086|P1|Overall Study|Adverse Event|3
4932546|NCT00422162|16978117|P2|Overall Study|Didn't Receive Treatment|1
4932547|NCT00422162|16978118|P1|Overall Study|Didn't Receive Treatment|0
4932548|NCT00422162|16978117|P2|Overall Study|Other|1
4932549|NCT00422162|16978118|P1|Overall Study|Other|0
4932550|NCT00422162|16978117|P2|Overall Study|Non-Compliant with Protocol|1
4932551|NCT00422162|16978118|P1|Overall Study|Non-Compliant with Protocol|1
4932552|NCT00422162|16978117|P2|Overall Study|Lost to Follow-up|2
4932553|NCT00422162|16978118|P1|Overall Study|Lost to Follow-up|1
4932554|NCT00422162|16978117|P2|Overall Study|Withdrawal by Subject|6
4932555|NCT00422162|16978118|P1|Overall Study|Withdrawal by Subject|7
4932556|NCT00422162|16978117|P2|Overall Study|Lack of Efficacy|10
4932557|NCT00422162|16978118|P1|Overall Study|Lack of Efficacy|4
4932558|NCT00422162|16978117|P2|Overall Study|Adverse Event|9
4932559|NCT00422162|16978118|P1|Overall Study|Adverse Event|11
4932560|NCT00422097|16978178|P8|Dose Level 2|Still on treatment|0
4932561|NCT00422097|16978179|P7|Dose Level 2|Still on treatment|0
4932562|NCT00422097|16978180|P6|Dose Level 2|Still on treatment|0
4932563|NCT00422097|16978181|P5|Dose Level 2|Still on treatment|0
4932564|NCT00422097|16978182|P4|Dose Level 2|Still on treatment|0
4932565|NCT00422097|16978183|P3|Dose Level 2|Still on treatment|0
4932566|NCT00422097|16978184|P2|Dose Level 2|Still on treatment|1
4932567|NCT00422097|16978185|P1|Dose Level 2|Still on treatment|0
4932568|NCT00422058|16978250|P6|Open-Label Extension, Week 20-104|Other|18
4932569|NCT00422058|16978251|P5|Open-Label Extension, Week 20-104|Other|16
4932570|NCT00422058|16978252|P4|Open-Label Extension, Week 20-104|Other|13
4932571|NCT00422058|16978253|P3|Open-Label Extension, Week 20-104|Other|6
4932572|NCT00422058|16978254|P2|Open-Label Extension, Week 20-104|Other|14
4932573|NCT00422058|16978255|P1|Open-Label Extension, Week 20-104|Other|13
4932574|NCT00422058|16978250|P6|Open-Label Extension, Week 20-104|Lack of Efficacy|1
4932575|NCT00422058|16978251|P5|Open-Label Extension, Week 20-104|Lack of Efficacy|0
4932576|NCT00422058|16978252|P4|Open-Label Extension, Week 20-104|Lack of Efficacy|2
4932577|NCT00422058|16978253|P3|Open-Label Extension, Week 20-104|Lack of Efficacy|5
4932578|NCT00422058|16978254|P2|Open-Label Extension, Week 20-104|Lack of Efficacy|2
4932579|NCT00422058|16978255|P1|Open-Label Extension, Week 20-104|Lack of Efficacy|3
4932580|NCT00422058|16978250|P6|Open-Label Extension, Week 20-104|Protocol Violation|3
4932581|NCT00422058|16978251|P5|Open-Label Extension, Week 20-104|Protocol Violation|5
4932582|NCT00422058|16978252|P4|Open-Label Extension, Week 20-104|Protocol Violation|1
4932583|NCT00422058|16978253|P3|Open-Label Extension, Week 20-104|Protocol Violation|3
4932584|NCT00422058|16978254|P2|Open-Label Extension, Week 20-104|Protocol Violation|2
4932585|NCT00422058|16978255|P1|Open-Label Extension, Week 20-104|Protocol Violation|1
4932586|NCT00422058|16978250|P6|Open-Label Extension, Week 20-104|Adverse Event|0
4932587|NCT00422058|16978251|P5|Open-Label Extension, Week 20-104|Adverse Event|4
4932588|NCT00422058|16978252|P4|Open-Label Extension, Week 20-104|Adverse Event|4
4932589|NCT00422058|16978253|P3|Open-Label Extension, Week 20-104|Adverse Event|7
4932590|NCT00422058|16978254|P2|Open-Label Extension, Week 20-104|Adverse Event|4
4932591|NCT00422058|16978255|P1|Open-Label Extension, Week 20-104|Adverse Event|3
4932592|NCT00422058|16978250|P6|Open-Label Extension, Week 20-104|Not giving consent for extension|12
4932593|NCT00422058|16978251|P5|Open-Label Extension, Week 20-104|Not giving consent for extension|10
4932594|NCT00422058|16978252|P4|Open-Label Extension, Week 20-104|Not giving consent for extension|8
4932595|NCT00422058|16978253|P3|Open-Label Extension, Week 20-104|Not giving consent for extension|15
4932596|NCT00422058|16978254|P2|Open-Label Extension, Week 20-104|Not giving consent for extension|17
4932597|NCT00422058|16978255|P1|Open-Label Extension, Week 20-104|Not giving consent for extension|12
4932598|NCT00422058|16978250|P6|Double-Blind, Week 0-20|Other|10
4932599|NCT00422058|16978251|P5|Double-Blind, Week 0-20|Other|4
4932600|NCT00422058|16978252|P4|Double-Blind, Week 0-20|Other|8
4932601|NCT00422058|16978253|P3|Double-Blind, Week 0-20|Other|8
4932602|NCT00422058|16978254|P2|Double-Blind, Week 0-20|Other|3
4932603|NCT00422058|16978255|P1|Double-Blind, Week 0-20|Other|11
4932604|NCT00422058|16978250|P6|Double-Blind, Week 0-20|Lack of Efficacy|1
4932605|NCT00422058|16978251|P5|Double-Blind, Week 0-20|Lack of Efficacy|0
4932606|NCT00422058|16978252|P4|Double-Blind, Week 0-20|Lack of Efficacy|0
4932607|NCT00422058|16978253|P3|Double-Blind, Week 0-20|Lack of Efficacy|1
4932608|NCT00422058|16978254|P2|Double-Blind, Week 0-20|Lack of Efficacy|1
4932609|NCT00422058|16978255|P1|Double-Blind, Week 0-20|Lack of Efficacy|2
4932610|NCT00422058|16978250|P6|Double-Blind, Week 0-20|Protocol Violation|2
4932611|NCT00422058|16978251|P5|Double-Blind, Week 0-20|Protocol Violation|2
4932612|NCT00422058|16978252|P4|Double-Blind, Week 0-20|Protocol Violation|3
4932613|NCT00422058|16978253|P3|Double-Blind, Week 0-20|Protocol Violation|2
4932614|NCT00422058|16978254|P2|Double-Blind, Week 0-20|Protocol Violation|2
4932615|NCT00422058|16978255|P1|Double-Blind, Week 0-20|Protocol Violation|3
4932616|NCT00422058|16978250|P6|Double-Blind, Week 0-20|Adverse Event|3
4932617|NCT00422058|16978251|P5|Double-Blind, Week 0-20|Adverse Event|5
4932618|NCT00422058|16978252|P4|Double-Blind, Week 0-20|Adverse Event|9
4932619|NCT00422058|16978253|P3|Double-Blind, Week 0-20|Adverse Event|5
4932620|NCT00422058|16978254|P2|Double-Blind, Week 0-20|Adverse Event|4
4932621|NCT00422058|16978255|P1|Double-Blind, Week 0-20|Adverse Event|3
4932622|NCT00421993|16978396|P4|Overall Study|Subject transportation issues|1
4932623|NCT00421993|16978397|P3|Overall Study|Subject transportation issues|0
4932624|NCT00421993|16978398|P2|Overall Study|Subject transportation issues|0
4932625|NCT00421993|16978399|P1|Overall Study|Subject transportation issues|0
4932626|NCT00421993|16978396|P4|Overall Study|Pregnancy|2
4932627|NCT00421993|16978397|P3|Overall Study|Pregnancy|1
4932628|NCT00421993|16978398|P2|Overall Study|Pregnancy|1
4932629|NCT00421993|16978399|P1|Overall Study|Pregnancy|0
4932630|NCT00421993|16978396|P4|Overall Study|Lack of Efficacy|5
4932631|NCT00421993|16978397|P3|Overall Study|Lack of Efficacy|0
4932632|NCT00421993|16978398|P2|Overall Study|Lack of Efficacy|3
4932633|NCT00421993|16978399|P1|Overall Study|Lack of Efficacy|0
4932634|NCT00421993|16978396|P4|Overall Study|Protocol Violation|1
4932635|NCT00421993|16978397|P3|Overall Study|Protocol Violation|0
4932636|NCT00421993|16978398|P2|Overall Study|Protocol Violation|2
4932637|NCT00421993|16978399|P1|Overall Study|Protocol Violation|2
4932638|NCT00421993|16978396|P4|Overall Study|Adverse Event|4
4932639|NCT00421993|16978397|P3|Overall Study|Adverse Event|6
4932640|NCT00421993|16978398|P2|Overall Study|Adverse Event|1
4932641|NCT00421993|16978399|P1|Overall Study|Adverse Event|11
4932642|NCT00421993|16978396|P4|Overall Study|Lost to Follow-up|20
4932643|NCT00421993|16978397|P3|Overall Study|Lost to Follow-up|22
4932644|NCT00421993|16978398|P2|Overall Study|Lost to Follow-up|19
4932645|NCT00421993|16978399|P1|Overall Study|Lost to Follow-up|18
4932646|NCT00421993|16978396|P4|Overall Study|Withdrawal by Subject|24
4932647|NCT00421993|16978397|P3|Overall Study|Withdrawal by Subject|23
4932648|NCT00421993|16978398|P2|Overall Study|Withdrawal by Subject|23
4932649|NCT00421993|16978399|P1|Overall Study|Withdrawal by Subject|22
4932650|NCT00421928|16978436|P3|Overall Study|Death|0
4932651|NCT00421928|16978437|P2|Overall Study|Death|1
4932652|NCT00421928|16978438|P1|Overall Study|Death|0
4932653|NCT00421928|16978436|P3|Overall Study|All other|27
4932654|NCT00421928|16978437|P2|Overall Study|All other|21
4932655|NCT00421928|16978438|P1|Overall Study|All other|26
4932656|NCT00421928|16978436|P3|Overall Study|Study drug non-compliant|4
4932657|NCT00421928|16978437|P2|Overall Study|Study drug non-compliant|7
4932658|NCT00421928|16978438|P1|Overall Study|Study drug non-compliant|6
4932659|NCT00421928|16978436|P3|Overall Study|Lack of Efficacy|35
4932660|NCT00421928|16978437|P2|Overall Study|Lack of Efficacy|7
4932661|NCT00421928|16978438|P1|Overall Study|Lack of Efficacy|15
4932662|NCT00421928|16978436|P3|Overall Study|Withdrawal by Subject|43
4932663|NCT00421928|16978437|P2|Overall Study|Withdrawal by Subject|48
4932664|NCT00421928|16978438|P1|Overall Study|Withdrawal by Subject|50
4932665|NCT00421928|16978436|P3|Overall Study|Lost to Follow-up|3
4932666|NCT00421928|16978437|P2|Overall Study|Lost to Follow-up|0
4932667|NCT00421928|16978438|P1|Overall Study|Lost to Follow-up|5
4932668|NCT00421928|16978436|P3|Overall Study|Adverse Event|22
4932669|NCT00421928|16978437|P2|Overall Study|Adverse Event|140
4932670|NCT00421928|16978438|P1|Overall Study|Adverse Event|61
4932671|NCT00421889|16978473|P9|Overall Study|Lost to Follow-up|1
4932672|NCT00421889|16978474|P8|Overall Study|Lost to Follow-up|0
4932673|NCT00421889|16978475|P7|Overall Study|Lost to Follow-up|0
4932674|NCT00421889|16978476|P6|Overall Study|Lost to Follow-up|0
4932675|NCT00421889|16978477|P5|Overall Study|Lost to Follow-up|0
4932676|NCT00421889|16978478|P4|Overall Study|Lost to Follow-up|0
4932677|NCT00421889|16978479|P3|Overall Study|Lost to Follow-up|0
4932678|NCT00421889|16978480|P2|Overall Study|Lost to Follow-up|0
4932679|NCT00421889|16978481|P1|Overall Study|Lost to Follow-up|0
4932680|NCT00421889|16978473|P9|Overall Study|Patient/Investigator request|3
4932681|NCT00421889|16978474|P8|Overall Study|Patient/Investigator request|1
4932682|NCT00421889|16978475|P7|Overall Study|Patient/Investigator request|0
4932683|NCT00421889|16978476|P6|Overall Study|Patient/Investigator request|9
4932684|NCT00421889|16978477|P5|Overall Study|Patient/Investigator request|0
4932685|NCT00421889|16978478|P4|Overall Study|Patient/Investigator request|0
4932686|NCT00421889|16978479|P3|Overall Study|Patient/Investigator request|0
4932687|NCT00421889|16978480|P2|Overall Study|Patient/Investigator request|0
4932688|NCT00421889|16978481|P1|Overall Study|Patient/Investigator request|0
4932689|NCT00421889|16978473|P9|Overall Study|Progressive disease|5
4932690|NCT00421889|16978474|P8|Overall Study|Progressive disease|1
4932691|NCT00421889|16978475|P7|Overall Study|Progressive disease|3
4932692|NCT00421889|16978476|P6|Overall Study|Progressive disease|21
4932693|NCT00421889|16978477|P5|Overall Study|Progressive disease|2
4932694|NCT00421889|16978478|P4|Overall Study|Progressive disease|3
4932695|NCT00421889|16978479|P3|Overall Study|Progressive disease|2
4932696|NCT00421889|16978480|P2|Overall Study|Progressive disease|2
4932697|NCT00421889|16978481|P1|Overall Study|Progressive disease|3
4932698|NCT00421889|16978473|P9|Overall Study|Death|0
4932699|NCT00421889|16978474|P8|Overall Study|Death|0
4932700|NCT00421889|16978475|P7|Overall Study|Death|0
4932701|NCT00421889|16978476|P6|Overall Study|Death|1
4932702|NCT00421889|16978477|P5|Overall Study|Death|1
4932703|NCT00421889|16978478|P4|Overall Study|Death|0
4932704|NCT00421889|16978479|P3|Overall Study|Death|0
4932705|NCT00421889|16978480|P2|Overall Study|Death|0
4932706|NCT00421889|16978481|P1|Overall Study|Death|0
4932707|NCT00421889|16978473|P9|Overall Study|Withdrawal by Subject|0
4932708|NCT00421889|16978474|P8|Overall Study|Withdrawal by Subject|0
4932709|NCT00421889|16978475|P7|Overall Study|Withdrawal by Subject|0
4932710|NCT00421889|16978476|P6|Overall Study|Withdrawal by Subject|0
4932711|NCT00421889|16978477|P5|Overall Study|Withdrawal by Subject|2
4932712|NCT00421889|16978478|P4|Overall Study|Withdrawal by Subject|0
4932713|NCT00421889|16978479|P3|Overall Study|Withdrawal by Subject|0
4932714|NCT00421889|16978480|P2|Overall Study|Withdrawal by Subject|3
4932715|NCT00421889|16978481|P1|Overall Study|Withdrawal by Subject|1
4932716|NCT00421889|16978473|P9|Overall Study|Adverse Event|2
4932717|NCT00421889|16978474|P8|Overall Study|Adverse Event|0
4932718|NCT00421889|16978475|P7|Overall Study|Adverse Event|1
4932719|NCT00421889|16978476|P6|Overall Study|Adverse Event|4
4932720|NCT00421889|16978477|P5|Overall Study|Adverse Event|1
4932721|NCT00421889|16978478|P4|Overall Study|Adverse Event|1
4932722|NCT00421889|16978479|P3|Overall Study|Adverse Event|1
4932723|NCT00421889|16978480|P2|Overall Study|Adverse Event|0
4932724|NCT00421889|16978481|P1|Overall Study|Adverse Event|1
4932725|NCT00421733|16978526|P3|Overall Study|Protocol deviation|2
4932726|NCT00421733|16978527|P2|Overall Study|Protocol deviation|7
4932727|NCT00421733|16978528|P1|Overall Study|Protocol deviation|4
4932728|NCT00421733|16978526|P3|Overall Study|Sponsor request|3
4932729|NCT00421733|16978527|P2|Overall Study|Sponsor request|0
4932730|NCT00421733|16978528|P1|Overall Study|Sponsor request|1
4932731|NCT00421733|16978526|P3|Overall Study|Did not satisfy entry criteria|2
4932732|NCT00421733|16978527|P2|Overall Study|Did not satisfy entry criteria|3
4932733|NCT00421733|16978528|P1|Overall Study|Did not satisfy entry criteria|1
4932734|NCT00421733|16978526|P3|Overall Study|Administrative|0
4932735|NCT00421733|16978527|P2|Overall Study|Administrative|0
4932736|NCT00421733|16978528|P1|Overall Study|Administrative|2
4932737|NCT00421733|16978526|P3|Overall Study|Required dialysis|0
4932738|NCT00421733|16978527|P2|Overall Study|Required dialysis|0
4932739|NCT00421733|16978528|P1|Overall Study|Required dialysis|1
4932740|NCT00421733|16978526|P3|Overall Study|Death|0
4932741|NCT00421733|16978527|P2|Overall Study|Death|3
4932742|NCT00421733|16978528|P1|Overall Study|Death|0
4932743|NCT00421733|16978526|P3|Overall Study|Withdrawal by Subject|7
4932744|NCT00421733|16978527|P2|Overall Study|Withdrawal by Subject|2
4932745|NCT00421733|16978528|P1|Overall Study|Withdrawal by Subject|1
4932746|NCT00421733|16978526|P3|Overall Study|Lost to Follow-up|4
4932747|NCT00421733|16978527|P2|Overall Study|Lost to Follow-up|2
4932748|NCT00421733|16978528|P1|Overall Study|Lost to Follow-up|1
4932749|NCT00421733|16978526|P3|Overall Study|Adverse Event|2
4932750|NCT00421733|16978527|P2|Overall Study|Adverse Event|9
4932751|NCT00421733|16978528|P1|Overall Study|Adverse Event|4
4932752|NCT00421707|16978548|P2|Period 3:Treatment Period 2|Adverse Event|2
4932753|NCT00421707|16978549|P1|Period 3:Treatment Period 2|Adverse Event|0
4932754|NCT00421707|16978548|P2|Period 3:Treatment Period 2|Protocol Violation|0
4932755|NCT00421707|16978549|P1|Period 3:Treatment Period 2|Protocol Violation|1
4932756|NCT00421707|16978548|P2|Period 3:Treatment Period 2|Withdrawal by Subject|1
4932757|NCT00421707|16978549|P1|Period 3:Treatment Period 2|Withdrawal by Subject|1
4932758|NCT00421707|16978548|P2|Period 2: Washout|Other: Pregnancy|1
4932759|NCT00421707|16978549|P1|Period 2: Washout|Other: Pregnancy|0
4932760|NCT00421707|16978548|P2|Period 2: Washout|Lost to Follow-up|1
4932761|NCT00421707|16978549|P1|Period 2: Washout|Lost to Follow-up|0
4932762|NCT00421707|16978548|P2|Period 2: Washout|Withdrawal by Subject|1
4932763|NCT00421707|16978549|P1|Period 2: Washout|Withdrawal by Subject|0
4932764|NCT00421707|16978548|P2|Period 2: Washout|Adverse Event|1
4932765|NCT00421707|16978549|P1|Period 2: Washout|Adverse Event|1
4932766|NCT00421707|16978548|P2|Period 1: Treatment Period 1|Protocol Violation|0
4932767|NCT00421707|16978549|P1|Period 1: Treatment Period 1|Protocol Violation|1
4932768|NCT00421707|16978548|P2|Period 1: Treatment Period 1|Lost to Follow-up|2
4932769|NCT00421707|16978549|P1|Period 1: Treatment Period 1|Lost to Follow-up|2
4932770|NCT00421707|16978548|P2|Period 1: Treatment Period 1|Adverse Event|2
4932771|NCT00421707|16978549|P1|Period 1: Treatment Period 1|Adverse Event|7
4932772|NCT00421707|16978548|P2|Period 1: Treatment Period 1|Withdrawal by Subject|5
4932773|NCT00421707|16978549|P1|Period 1: Treatment Period 1|Withdrawal by Subject|1
4932774|NCT00421408|16978600|P2|Overall Study|Discountinued from treatment/ f/u cont.|25
4932775|NCT00421408|16978601|P1|Overall Study|Discountinued from treatment/ f/u cont.|12
4932776|NCT00421408|16978600|P2|Overall Study|Lost to Follow-up|20
4932777|NCT00421408|16978601|P1|Overall Study|Lost to Follow-up|30
4932778|NCT00421343|16978619|P1|Overall Study|Lost to Follow-up|3
4932779|NCT00421343|16978619|P1|Overall Study|Withdrawal by Subject|2
4932780|NCT00421343|16978619|P1|Overall Study|Death|1
4932781|NCT00421174|16978625|P2|Overall Study|Ineligible due to infection|0
4932782|NCT00421174|16978626|P1|Overall Study|Ineligible due to infection|2
4932783|NCT00421174|16978625|P2|Overall Study|Withdrawal by Subject|1
4932784|NCT00421174|16978626|P1|Overall Study|Withdrawal by Subject|0
4932785|NCT00421148|16978674|P20|Overall Study|Protocol Violation|0
4932786|NCT00421148|16978675|P19|Overall Study|Protocol Violation|1
4932787|NCT00421148|16978676|P18|Overall Study|Protocol Violation|0
4932788|NCT00421148|16978677|P17|Overall Study|Protocol Violation|0
4932789|NCT00421148|16978678|P16|Overall Study|Protocol Violation|0
4932790|NCT00421148|16978679|P15|Overall Study|Protocol Violation|0
4932791|NCT00421148|16978680|P14|Overall Study|Protocol Violation|0
4932792|NCT00421148|16978681|P13|Overall Study|Protocol Violation|0
4932793|NCT00421148|16978682|P12|Overall Study|Protocol Violation|0
4932794|NCT00421148|16978683|P11|Overall Study|Protocol Violation|0
4932795|NCT00421148|16978684|P10|Overall Study|Protocol Violation|0
4932796|NCT00421148|16978685|P9|Overall Study|Protocol Violation|0
4932797|NCT00421148|16978686|P8|Overall Study|Protocol Violation|0
4932798|NCT00421148|16978687|P7|Overall Study|Protocol Violation|0
4932799|NCT00421148|16978688|P6|Overall Study|Protocol Violation|1
4932800|NCT00421148|16978689|P5|Overall Study|Protocol Violation|0
4932801|NCT00421148|16978690|P4|Overall Study|Protocol Violation|0
4932802|NCT00421148|16978691|P3|Overall Study|Protocol Violation|0
4932803|NCT00421148|16978692|P2|Overall Study|Protocol Violation|0
4932804|NCT00421148|16978693|P1|Overall Study|Protocol Violation|0
4932805|NCT00421148|16978674|P20|Overall Study|Withdrawal by Subject|0
4932806|NCT00421148|16978675|P19|Overall Study|Withdrawal by Subject|0
4932807|NCT00421148|16978676|P18|Overall Study|Withdrawal by Subject|1
4932808|NCT00421148|16978677|P17|Overall Study|Withdrawal by Subject|0
4932809|NCT00421148|16978678|P16|Overall Study|Withdrawal by Subject|0
4932810|NCT00421148|16978679|P15|Overall Study|Withdrawal by Subject|0
4932811|NCT00421148|16978680|P14|Overall Study|Withdrawal by Subject|0
4932812|NCT00421148|16978681|P13|Overall Study|Withdrawal by Subject|0
4932813|NCT00421148|16978682|P12|Overall Study|Withdrawal by Subject|0
4932814|NCT00421148|16978683|P11|Overall Study|Withdrawal by Subject|0
4932815|NCT00421148|16978684|P10|Overall Study|Withdrawal by Subject|0
4932816|NCT00421148|16978685|P9|Overall Study|Withdrawal by Subject|0
4932817|NCT00421148|16978686|P8|Overall Study|Withdrawal by Subject|0
4932818|NCT00421148|16978687|P7|Overall Study|Withdrawal by Subject|0
4932819|NCT00421148|16978688|P6|Overall Study|Withdrawal by Subject|0
4932820|NCT00421148|16978689|P5|Overall Study|Withdrawal by Subject|0
4932821|NCT00421148|16978690|P4|Overall Study|Withdrawal by Subject|0
4932822|NCT00421148|16978691|P3|Overall Study|Withdrawal by Subject|0
4932823|NCT00421148|16978692|P2|Overall Study|Withdrawal by Subject|0
4932824|NCT00421148|16978693|P1|Overall Study|Withdrawal by Subject|0
4932825|NCT00421148|16978674|P20|Overall Study|Lost to Follow-up|0
4932826|NCT00421148|16978675|P19|Overall Study|Lost to Follow-up|0
4932827|NCT00421148|16978676|P18|Overall Study|Lost to Follow-up|1
4932828|NCT00421148|16978677|P17|Overall Study|Lost to Follow-up|0
4932829|NCT00421148|16978678|P16|Overall Study|Lost to Follow-up|0
4932830|NCT00421148|16978679|P15|Overall Study|Lost to Follow-up|0
4932831|NCT00421148|16978680|P14|Overall Study|Lost to Follow-up|0
4932832|NCT00421148|16978681|P13|Overall Study|Lost to Follow-up|0
4932833|NCT00421148|16978682|P12|Overall Study|Lost to Follow-up|0
4932834|NCT00421148|16978683|P11|Overall Study|Lost to Follow-up|0
4932835|NCT00421148|16978684|P10|Overall Study|Lost to Follow-up|0
4932836|NCT00421148|16978685|P9|Overall Study|Lost to Follow-up|0
4932837|NCT00421148|16978686|P8|Overall Study|Lost to Follow-up|0
4932838|NCT00421148|16978687|P7|Overall Study|Lost to Follow-up|0
4932839|NCT00421148|16978688|P6|Overall Study|Lost to Follow-up|0
4932840|NCT00421148|16978689|P5|Overall Study|Lost to Follow-up|0
4932841|NCT00421148|16978690|P4|Overall Study|Lost to Follow-up|0
4932842|NCT00421148|16978691|P3|Overall Study|Lost to Follow-up|0
4932843|NCT00421148|16978692|P2|Overall Study|Lost to Follow-up|0
4932844|NCT00421148|16978693|P1|Overall Study|Lost to Follow-up|0
4932845|NCT00420927|16978792|P7|Period 2|Took prohibited medication|0
4932846|NCT00420927|16978793|P6|Period 2|Took prohibited medication|0
4932847|NCT00420927|16978794|P5|Period 2|Took prohibited medication|1
4932848|NCT00420927|16978795|P4|Period 2|Took prohibited medication|0
4932849|NCT00420927|16978796|P3|Period 2|Took prohibited medication|0
4932850|NCT00420927|16978797|P2|Period 2|Took prohibited medication|0
4932851|NCT00420927|16978798|P1|Period 2|Took prohibited medication|0
4932852|NCT00420927|16978792|P7|Period 2|Methotrexate intolerance|1
4932853|NCT00420927|16978793|P6|Period 2|Methotrexate intolerance|0
4932854|NCT00420927|16978794|P5|Period 2|Methotrexate intolerance|0
4932855|NCT00420927|16978795|P4|Period 2|Methotrexate intolerance|0
4932856|NCT00420927|16978796|P3|Period 2|Methotrexate intolerance|0
4932857|NCT00420927|16978797|P2|Period 2|Methotrexate intolerance|0
4932858|NCT00420927|16978798|P1|Period 2|Methotrexate intolerance|0
4932859|NCT00420927|16978792|P7|Period 2|Noncompliant with study drug|2
4932860|NCT00420927|16978793|P6|Period 2|Noncompliant with study drug|0
4932861|NCT00420927|16978794|P5|Period 2|Noncompliant with study drug|0
4932862|NCT00420927|16978795|P4|Period 2|Noncompliant with study drug|1
4932863|NCT00420927|16978796|P3|Period 2|Noncompliant with study drug|0
4932864|NCT00420927|16978797|P2|Period 2|Noncompliant with study drug|0
4932865|NCT00420927|16978798|P1|Period 2|Noncompliant with study drug|0
4932866|NCT00420927|16978792|P7|Period 2|Randomization error|0
4932867|NCT00420927|16978793|P6|Period 2|Randomization error|1
4932868|NCT00420927|16978794|P5|Period 2|Randomization error|1
4932869|NCT00420927|16978795|P4|Period 2|Randomization error|0
4932870|NCT00420927|16978796|P3|Period 2|Randomization error|0
4932871|NCT00420927|16978797|P2|Period 2|Randomization error|0
4932872|NCT00420927|16978798|P1|Period 2|Randomization error|0
4932873|NCT00420927|16978792|P7|Period 2|Sponsor decision|1
4932874|NCT00420927|16978793|P6|Period 2|Sponsor decision|0
4932875|NCT00420927|16978794|P5|Period 2|Sponsor decision|0
4932876|NCT00420927|16978795|P4|Period 2|Sponsor decision|0
4932877|NCT00420927|16978796|P3|Period 2|Sponsor decision|1
4932878|NCT00420927|16978797|P2|Period 2|Sponsor decision|0
4932879|NCT00420927|16978798|P1|Period 2|Sponsor decision|0
4932880|NCT00420927|16978792|P7|Period 2|Physician Decision|0
4932881|NCT00420927|16978793|P6|Period 2|Physician Decision|1
4932882|NCT00420927|16978794|P5|Period 2|Physician Decision|1
4932883|NCT00420927|16978795|P4|Period 2|Physician Decision|0
4932884|NCT00420927|16978796|P3|Period 2|Physician Decision|0
4932885|NCT00420927|16978797|P2|Period 2|Physician Decision|0
4932886|NCT00420927|16978798|P1|Period 2|Physician Decision|0
4932887|NCT00420927|16978792|P7|Period 2|Subject unable to find transportation|1
4932888|NCT00420927|16978793|P6|Period 2|Subject unable to find transportation|0
4932889|NCT00420927|16978794|P5|Period 2|Subject unable to find transportation|0
4932890|NCT00420927|16978795|P4|Period 2|Subject unable to find transportation|0
4932891|NCT00420927|16978796|P3|Period 2|Subject unable to find transportation|0
4932892|NCT00420927|16978797|P2|Period 2|Subject unable to find transportation|0
4932893|NCT00420927|16978798|P1|Period 2|Subject unable to find transportation|0
4932894|NCT00420927|16978792|P7|Period 2|Received wrong treatment/incorrect dose|1
4932895|NCT00420927|16978793|P6|Period 2|Received wrong treatment/incorrect dose|0
4932896|NCT00420927|16978794|P5|Period 2|Received wrong treatment/incorrect dose|0
4932897|NCT00420927|16978795|P4|Period 2|Received wrong treatment/incorrect dose|0
4932898|NCT00420927|16978796|P3|Period 2|Received wrong treatment/incorrect dose|0
4932899|NCT00420927|16978797|P2|Period 2|Received wrong treatment/incorrect dose|0
4932900|NCT00420927|16978798|P1|Period 2|Received wrong treatment/incorrect dose|0
4932901|NCT00420927|16978792|P7|Period 2|Lack of efficacy/Loss of efficacy|6
4932902|NCT00420927|16978793|P6|Period 2|Lack of efficacy/Loss of efficacy|2
4932903|NCT00420927|16978794|P5|Period 2|Lack of efficacy/Loss of efficacy|6
4932904|NCT00420927|16978795|P4|Period 2|Lack of efficacy/Loss of efficacy|1
4932905|NCT00420927|16978796|P3|Period 2|Lack of efficacy/Loss of efficacy|2
4932906|NCT00420927|16978797|P2|Period 2|Lack of efficacy/Loss of efficacy|0
4932907|NCT00420927|16978798|P1|Period 2|Lack of efficacy/Loss of efficacy|0
4932908|NCT00420927|16978792|P7|Period 2|Lost to Follow-up|9
4932909|NCT00420927|16978793|P6|Period 2|Lost to Follow-up|3
4932910|NCT00420927|16978794|P5|Period 2|Lost to Follow-up|6
4932911|NCT00420927|16978795|P4|Period 2|Lost to Follow-up|2
4932912|NCT00420927|16978796|P3|Period 2|Lost to Follow-up|2
4932913|NCT00420927|16978797|P2|Period 2|Lost to Follow-up|0
4932914|NCT00420927|16978798|P1|Period 2|Lost to Follow-up|0
4932915|NCT00420927|16978792|P7|Period 2|Withdrawal by Subject|12
4932916|NCT00420927|16978793|P6|Period 2|Withdrawal by Subject|2
4932917|NCT00420927|16978794|P5|Period 2|Withdrawal by Subject|11
4932918|NCT00420927|16978795|P4|Period 2|Withdrawal by Subject|3
4932919|NCT00420927|16978796|P3|Period 2|Withdrawal by Subject|1
4932920|NCT00420927|16978797|P2|Period 2|Withdrawal by Subject|0
4932921|NCT00420927|16978798|P1|Period 2|Withdrawal by Subject|0
4932922|NCT00420927|16978792|P7|Period 2|Adverse Event|20
4932923|NCT00420927|16978793|P6|Period 2|Adverse Event|6
4932924|NCT00420927|16978794|P5|Period 2|Adverse Event|17
4932925|NCT00420927|16978795|P4|Period 2|Adverse Event|3
4932926|NCT00420927|16978796|P3|Period 2|Adverse Event|7
4932927|NCT00420927|16978797|P2|Period 2|Adverse Event|0
4932928|NCT00420927|16978798|P1|Period 2|Adverse Event|0
4932929|NCT00420927|16978792|P7|Period 1|Took prohibited medication|0
4932930|NCT00420927|16978793|P6|Period 1|Took prohibited medication|0
4932931|NCT00420927|16978794|P5|Period 1|Took prohibited medication|0
4932932|NCT00420927|16978795|P4|Period 1|Took prohibited medication|0
4932933|NCT00420927|16978796|P3|Period 1|Took prohibited medication|0
4932934|NCT00420927|16978797|P2|Period 1|Took prohibited medication|3
4932935|NCT00420927|16978798|P1|Period 1|Took prohibited medication|1
4932936|NCT00420927|16978792|P7|Period 1|Failed to meet entry criteria|0
4932937|NCT00420927|16978793|P6|Period 1|Failed to meet entry criteria|0
4932938|NCT00420927|16978794|P5|Period 1|Failed to meet entry criteria|0
4932939|NCT00420927|16978795|P4|Period 1|Failed to meet entry criteria|0
4932940|NCT00420927|16978796|P3|Period 1|Failed to meet entry criteria|0
4932941|NCT00420927|16978797|P2|Period 1|Failed to meet entry criteria|7
4932942|NCT00420927|16978798|P1|Period 1|Failed to meet entry criteria|8
4932943|NCT00420927|16978792|P7|Period 1|Received wrong treatment/incorrect dose|0
4932944|NCT00420927|16978793|P6|Period 1|Received wrong treatment/incorrect dose|0
4932945|NCT00420927|16978794|P5|Period 1|Received wrong treatment/incorrect dose|0
4932946|NCT00420927|16978795|P4|Period 1|Received wrong treatment/incorrect dose|0
4932947|NCT00420927|16978796|P3|Period 1|Received wrong treatment/incorrect dose|0
4932948|NCT00420927|16978797|P2|Period 1|Received wrong treatment/incorrect dose|1
4932949|NCT00420927|16978798|P1|Period 1|Received wrong treatment/incorrect dose|0
4932950|NCT00420927|16978792|P7|Period 1|Subject received new diagnosis|0
4932951|NCT00420927|16978793|P6|Period 1|Subject received new diagnosis|0
4932952|NCT00420927|16978794|P5|Period 1|Subject received new diagnosis|0
4932953|NCT00420927|16978795|P4|Period 1|Subject received new diagnosis|0
4932954|NCT00420927|16978796|P3|Period 1|Subject received new diagnosis|0
4932955|NCT00420927|16978797|P2|Period 1|Subject received new diagnosis|2
4932956|NCT00420927|16978798|P1|Period 1|Subject received new diagnosis|0
4932957|NCT00420927|16978792|P7|Period 1|Study site closure|0
4932958|NCT00420927|16978793|P6|Period 1|Study site closure|0
4932959|NCT00420927|16978794|P5|Period 1|Study site closure|0
4932960|NCT00420927|16978795|P4|Period 1|Study site closure|0
4932961|NCT00420927|16978796|P3|Period 1|Study site closure|0
4932962|NCT00420927|16978797|P2|Period 1|Study site closure|1
4932963|NCT00420927|16978798|P1|Period 1|Study site closure|0
4932964|NCT00420927|16978792|P7|Period 1|Suspected tuberculosis/positive test|0
4932965|NCT00420927|16978793|P6|Period 1|Suspected tuberculosis/positive test|0
4932966|NCT00420927|16978794|P5|Period 1|Suspected tuberculosis/positive test|0
4932967|NCT00420927|16978795|P4|Period 1|Suspected tuberculosis/positive test|0
4932968|NCT00420927|16978796|P3|Period 1|Suspected tuberculosis/positive test|0
4932969|NCT00420927|16978797|P2|Period 1|Suspected tuberculosis/positive test|1
4932970|NCT00420927|16978798|P1|Period 1|Suspected tuberculosis/positive test|1
4932971|NCT00420927|16978792|P7|Period 1|Randomization error|0
4932972|NCT00420927|16978793|P6|Period 1|Randomization error|0
4932973|NCT00420927|16978794|P5|Period 1|Randomization error|0
4932974|NCT00420927|16978795|P4|Period 1|Randomization error|0
4932975|NCT00420927|16978796|P3|Period 1|Randomization error|0
4932976|NCT00420927|16978797|P2|Period 1|Randomization error|0
4932977|NCT00420927|16978798|P1|Period 1|Randomization error|1
4932978|NCT00420927|16978792|P7|Period 1|Noncompliant with study drug|0
4932979|NCT00420927|16978793|P6|Period 1|Noncompliant with study drug|0
4932980|NCT00420927|16978794|P5|Period 1|Noncompliant with study drug|0
4932981|NCT00420927|16978795|P4|Period 1|Noncompliant with study drug|0
4932982|NCT00420927|16978796|P3|Period 1|Noncompliant with study drug|0
4932983|NCT00420927|16978797|P2|Period 1|Noncompliant with study drug|1
4932984|NCT00420927|16978798|P1|Period 1|Noncompliant with study drug|1
4932985|NCT00420927|16978792|P7|Period 1|Subject moved/relocated|0
4932986|NCT00420927|16978793|P6|Period 1|Subject moved/relocated|0
4932987|NCT00420927|16978794|P5|Period 1|Subject moved/relocated|0
4932988|NCT00420927|16978795|P4|Period 1|Subject moved/relocated|0
4932989|NCT00420927|16978796|P3|Period 1|Subject moved/relocated|0
4932990|NCT00420927|16978797|P2|Period 1|Subject moved/relocated|2
4932991|NCT00420927|16978798|P1|Period 1|Subject moved/relocated|0
4932992|NCT00420927|16978792|P7|Period 1|Death|0
4932993|NCT00420927|16978793|P6|Period 1|Death|0
4932994|NCT00420927|16978794|P5|Period 1|Death|0
4932995|NCT00420927|16978795|P4|Period 1|Death|0
4932996|NCT00420927|16978796|P3|Period 1|Death|0
4932997|NCT00420927|16978797|P2|Period 1|Death|0
4932998|NCT00420927|16978798|P1|Period 1|Death|2
4932999|NCT00420927|16978792|P7|Period 1|Lack of efficacy/Loss of efficacy|0
4933000|NCT00420927|16978793|P6|Period 1|Lack of efficacy/Loss of efficacy|0
4933001|NCT00420927|16978794|P5|Period 1|Lack of efficacy/Loss of efficacy|0
4933002|NCT00420927|16978795|P4|Period 1|Lack of efficacy/Loss of efficacy|0
4933003|NCT00420927|16978796|P3|Period 1|Lack of efficacy/Loss of efficacy|0
4933004|NCT00420927|16978797|P2|Period 1|Lack of efficacy/Loss of efficacy|6
4933005|NCT00420927|16978798|P1|Period 1|Lack of efficacy/Loss of efficacy|1
4933006|NCT00420927|16978792|P7|Period 1|Lost to Follow-up|0
4933007|NCT00420927|16978793|P6|Period 1|Lost to Follow-up|0
4933008|NCT00420927|16978794|P5|Period 1|Lost to Follow-up|0
4933009|NCT00420927|16978795|P4|Period 1|Lost to Follow-up|0
4933010|NCT00420927|16978796|P3|Period 1|Lost to Follow-up|0
4933011|NCT00420927|16978797|P2|Period 1|Lost to Follow-up|6
4933012|NCT00420927|16978798|P1|Period 1|Lost to Follow-up|8
4933013|NCT00420927|16978792|P7|Period 1|Withdrawal by Subject|0
4933014|NCT00420927|16978793|P6|Period 1|Withdrawal by Subject|0
4933015|NCT00420927|16978794|P5|Period 1|Withdrawal by Subject|0
4933016|NCT00420927|16978795|P4|Period 1|Withdrawal by Subject|0
4933017|NCT00420927|16978796|P3|Period 1|Withdrawal by Subject|0
4933018|NCT00420927|16978797|P2|Period 1|Withdrawal by Subject|12
4933019|NCT00420927|16978798|P1|Period 1|Withdrawal by Subject|7
4933020|NCT00420927|16978792|P7|Period 1|Adverse Event|0
4933021|NCT00420927|16978793|P6|Period 1|Adverse Event|0
4933022|NCT00420927|16978794|P5|Period 1|Adverse Event|0
4933023|NCT00420927|16978795|P4|Period 1|Adverse Event|0
4933024|NCT00420927|16978796|P3|Period 1|Adverse Event|0
4933025|NCT00420927|16978797|P2|Period 1|Adverse Event|15
4933026|NCT00420927|16978798|P1|Period 1|Adverse Event|19
4933027|NCT00420849|16978902|P1|Overall Study|Lost to Follow-up|1
4933028|NCT00420849|16978902|P1|Overall Study|Protocol Violation|1
4933029|NCT00420849|16978902|P1|Overall Study|Transplant|8
4933030|NCT00420849|16978902|P1|Overall Study|Other|14
4933031|NCT00420849|16978902|P1|Overall Study|Death|18
4933032|NCT00420849|16978902|P1|Overall Study|Withdrawal by Subject|28
4933033|NCT00420849|16978902|P1|Overall Study|Adverse Event|107
4933034|NCT00420849|16978902|P1|Overall Study|Lack of Efficacy|154
4933035|NCT00420784|16978971|P4|Overall Study|Other|5
4933036|NCT00420784|16978972|P3|Overall Study|Other|0
4933037|NCT00420784|16978973|P2|Overall Study|Other|2
4933038|NCT00420784|16978974|P1|Overall Study|Other|1
4933039|NCT00420784|16978971|P4|Overall Study|Virologic Stopping Rule|67
4933040|NCT00420784|16978972|P3|Overall Study|Virologic Stopping Rule|41
4933041|NCT00420784|16978973|P2|Overall Study|Virologic Stopping Rule|26
4933042|NCT00420784|16978974|P1|Overall Study|Virologic Stopping Rule|17
4933043|NCT00420784|16978971|P4|Overall Study|Lost to Follow-up|1
4933044|NCT00420784|16978972|P3|Overall Study|Lost to Follow-up|2
4933045|NCT00420784|16978973|P2|Overall Study|Lost to Follow-up|0
4933046|NCT00420784|16978974|P1|Overall Study|Lost to Follow-up|0
4933047|NCT00420784|16978971|P4|Overall Study|Withdrawal by Subject|0
4933048|NCT00420784|16978972|P3|Overall Study|Withdrawal by Subject|0
4933049|NCT00420784|16978973|P2|Overall Study|Withdrawal by Subject|1
4933050|NCT00420784|16978974|P1|Overall Study|Withdrawal by Subject|0
4933051|NCT00420784|16978971|P4|Overall Study|Adverse Event|5
4933052|NCT00420784|16978972|P3|Overall Study|Adverse Event|10
4933053|NCT00420784|16978973|P2|Overall Study|Adverse Event|29
4933054|NCT00420784|16978974|P1|Overall Study|Adverse Event|11
4933055|NCT00420745|16979012|P2|Overall Study|Age limit exceeded for Dose 2|0
4933056|NCT00420745|16979013|P1|Overall Study|Age limit exceeded for Dose 2|1
4933057|NCT00420745|16979012|P2|Overall Study|Recurrent pneumonia & bronchitis|1
4933058|NCT00420745|16979013|P1|Overall Study|Recurrent pneumonia & bronchitis|0
4933059|NCT00420745|16979012|P2|Overall Study|Physician Decision|1
4933060|NCT00420745|16979013|P1|Overall Study|Physician Decision|1
4933061|NCT00420745|16979012|P2|Overall Study|Protocol Violation|0
4933062|NCT00420745|16979013|P1|Overall Study|Protocol Violation|1
4933063|NCT00420745|16979012|P2|Overall Study|Lost to Follow-up|2
4933064|NCT00420745|16979013|P1|Overall Study|Lost to Follow-up|10
4933065|NCT00420745|16979012|P2|Overall Study|Adverse Event|2
4933066|NCT00420745|16979013|P1|Overall Study|Adverse Event|2
4933067|NCT00420641|16979032|P3|Overall Study|Other|3
4933068|NCT00420641|16979033|P2|Overall Study|Other|4
4933069|NCT00420641|16979034|P1|Overall Study|Other|4
4933070|NCT00420641|16979032|P3|Overall Study|Non-compliance|4
4933071|NCT00420641|16979033|P2|Overall Study|Non-compliance|5
4933072|NCT00420641|16979034|P1|Overall Study|Non-compliance|7
4933073|NCT00420641|16979032|P3|Overall Study|Lack of Efficacy|4
4933074|NCT00420641|16979033|P2|Overall Study|Lack of Efficacy|5
4933075|NCT00420641|16979034|P1|Overall Study|Lack of Efficacy|6
4933076|NCT00420641|16979032|P3|Overall Study|Withdrawal by Subject|14
4933077|NCT00420641|16979033|P2|Overall Study|Withdrawal by Subject|21
4933078|NCT00420641|16979034|P1|Overall Study|Withdrawal by Subject|15
4933079|NCT00420641|16979032|P3|Overall Study|Protocol Violation|7
4933080|NCT00420641|16979033|P2|Overall Study|Protocol Violation|8
4933081|NCT00420641|16979034|P1|Overall Study|Protocol Violation|8
4933082|NCT00420641|16979032|P3|Overall Study|Lost to Follow-up|2
4933083|NCT00420641|16979033|P2|Overall Study|Lost to Follow-up|4
4933084|NCT00420641|16979034|P1|Overall Study|Lost to Follow-up|2
4933085|NCT00420641|16979032|P3|Overall Study|Adverse Event|10
4933086|NCT00420641|16979033|P2|Overall Study|Adverse Event|25
4933087|NCT00420641|16979034|P1|Overall Study|Adverse Event|3
4933088|NCT00420628|16979110|P2|Overall Study|Adverse Event|0
4933089|NCT00420628|16979111|P1|Overall Study|Adverse Event|1
4933090|NCT00420628|16979110|P2|Overall Study|Lost to Follow-up|2
4933091|NCT00420628|16979111|P1|Overall Study|Lost to Follow-up|3
4933092|NCT00420628|16979110|P2|Overall Study|Withdrawn by parent or gaurdian|2
4933093|NCT00420628|16979111|P1|Overall Study|Withdrawn by parent or gaurdian|5
4933094|NCT00420511|16979127|P2|Overall Study|Lost to Follow-up|0
4933095|NCT00420511|16979128|P1|Overall Study|Lost to Follow-up|1
4933096|NCT00420511|16979127|P2|Overall Study|Adverse Event|1
4933097|NCT00420511|16979128|P1|Overall Study|Adverse Event|1
4933098|NCT00420420|16979149|P2|Overall Study|sponsor decision (abnormal ECG @ screen)|0
4933099|NCT00420420|16979150|P1|Overall Study|sponsor decision (abnormal ECG @ screen)|1
4933100|NCT00420420|16979149|P2|Overall Study|Withdrawal by Subject|0
4933101|NCT00420420|16979150|P1|Overall Study|Withdrawal by Subject|1
4933102|NCT00420420|16979149|P2|Overall Study|Protocol Violation|1
4933103|NCT00420420|16979150|P1|Overall Study|Protocol Violation|1
4933104|NCT00420420|16979149|P2|Overall Study|Adverse Event|3
4933105|NCT00420420|16979150|P1|Overall Study|Adverse Event|5
4933106|NCT00420407|16979168|P2|Overall Study|Withdrawal by Subject|2
4933107|NCT00420407|16979169|P1|Overall Study|Withdrawal by Subject|0
4933108|NCT00420407|16979168|P2|Overall Study|subject identified as Jehovah's witness|0
4933109|NCT00420407|16979169|P1|Overall Study|subject identified as Jehovah's witness|1
4933110|NCT00420407|16979168|P2|Overall Study|subject identified as detainee|0
4933111|NCT00420407|16979169|P1|Overall Study|subject identified as detainee|1
4933112|NCT00420407|16979168|P2|Overall Study|Physician Decision|1
4933113|NCT00420407|16979169|P1|Overall Study|Physician Decision|2
4933114|NCT00420407|16979168|P2|Overall Study|Lost to Follow-up|3
4933115|NCT00420407|16979169|P1|Overall Study|Lost to Follow-up|0
4933116|NCT00420342|16979179|P3|Overall Study|Withdrawal by Subject|0
4933117|NCT00420342|16979180|P2|Overall Study|Withdrawal by Subject|2
4933118|NCT00420342|16979181|P1|Overall Study|Withdrawal by Subject|0
4933119|NCT00420342|16979179|P3|Overall Study|Lost to Follow-up|1
4933120|NCT00420342|16979180|P2|Overall Study|Lost to Follow-up|0
4933121|NCT00420342|16979181|P1|Overall Study|Lost to Follow-up|1
4933122|NCT00420316|16979224|P2|Overall Study|Lost to Follow-up|8
4933123|NCT00420316|16979225|P1|Overall Study|Lost to Follow-up|12
4933124|NCT00420316|16979224|P2|Overall Study|Withdrawal by Subject|1
4933125|NCT00420316|16979225|P1|Overall Study|Withdrawal by Subject|0
4933126|NCT00420303|16979249|P2|Overall Study|Physician Decision|1
4933127|NCT00420303|16979250|P1|Overall Study|Physician Decision|0
4933128|NCT00420303|16979249|P2|Overall Study|Lack of Efficacy|3
4933129|NCT00420303|16979250|P1|Overall Study|Lack of Efficacy|0
4933130|NCT00420303|16979249|P2|Overall Study|Serious Adverse Event|0
4933131|NCT00420303|16979250|P1|Overall Study|Serious Adverse Event|1
4933132|NCT00420290|16979262|P2|Overall Study|did not meet inclusion/exclusion|1
4933133|NCT00420290|16979263|P1|Overall Study|did not meet inclusion/exclusion|1
4933134|NCT00420290|16979262|P2|Overall Study|Withdrawal by Subject|2
4933135|NCT00420290|16979263|P1|Overall Study|Withdrawal by Subject|0
4933136|NCT00420290|16979262|P2|Overall Study|Adverse Event|1
4933137|NCT00420290|16979263|P1|Overall Study|Adverse Event|3
4933138|NCT00420238|16979279|P2|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
4933139|NCT00420238|16979280|P1|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1
4933140|NCT00420238|16979279|P2|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0
4933141|NCT00420238|16979280|P1|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1
4933142|NCT00420238|16979279|P2|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1
4933143|NCT00420238|16979280|P1|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0
4933144|NCT00420238|16979279|P2|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1
4933145|NCT00420238|16979280|P1|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0
4933146|NCT00420238|16979279|P2|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2
4933147|NCT00420238|16979280|P1|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0
4933148|NCT00420238|16979279|P2|12 Week Double-Blind Treatment Period 1|Adverse Event|0
4933149|NCT00420238|16979280|P1|12 Week Double-Blind Treatment Period 1|Adverse Event|1
4933150|NCT00420212|16979419|P3|Overall Study|Other-Unspecified|18
4933151|NCT00420212|16979420|P2|Overall Study|Other-Unspecified|14
4933152|NCT00420212|16979421|P1|Overall Study|Other-Unspecified|21
4933153|NCT00420212|16979419|P3|Overall Study|Death|1
4933154|NCT00420212|16979420|P2|Overall Study|Death|0
4933155|NCT00420212|16979421|P1|Overall Study|Death|0
4933156|NCT00420212|16979419|P3|Overall Study|Protocol Violation|8
4933157|NCT00420212|16979420|P2|Overall Study|Protocol Violation|4
4933158|NCT00420212|16979421|P1|Overall Study|Protocol Violation|4
4933159|NCT00420212|16979419|P3|Overall Study|Physician Decision|3
4933160|NCT00420212|16979420|P2|Overall Study|Physician Decision|4
4933161|NCT00420212|16979421|P1|Overall Study|Physician Decision|4
4933162|NCT00420212|16979419|P3|Overall Study|Withdrawal by Subject|19
4933163|NCT00420212|16979420|P2|Overall Study|Withdrawal by Subject|22
4933164|NCT00420212|16979421|P1|Overall Study|Withdrawal by Subject|31
4933165|NCT00420212|16979419|P3|Overall Study|Lost to Follow-up|11
4933166|NCT00420212|16979420|P2|Overall Study|Lost to Follow-up|11
4933167|NCT00420212|16979421|P1|Overall Study|Lost to Follow-up|9
4933168|NCT00420212|16979419|P3|Overall Study|Adverse Event|36
4933169|NCT00420212|16979420|P2|Overall Study|Adverse Event|40
4933170|NCT00420212|16979421|P1|Overall Study|Adverse Event|22
4933171|NCT00420199|16979447|P2|Overall Study|Participant no longer met study criteria|0
4933172|NCT00420199|16979448|P1|Overall Study|Participant no longer met study criteria|1
4933173|NCT00420095|16979514|P2|Overall Study|Lost to Follow-up|0
4933174|NCT00420095|16979515|P1|Overall Study|Lost to Follow-up|1
4933175|NCT00420095|16979514|P2|Overall Study|Protocol Violation|1
4933176|NCT00420095|16979515|P1|Overall Study|Protocol Violation|1
4933177|NCT00420095|16979514|P2|Overall Study|Adverse Event|0
4933178|NCT00420095|16979515|P1|Overall Study|Adverse Event|1
4933179|NCT00420056|16979533|P1|Overall Study|Objective progression or relapse|17
4933180|NCT00420004|16979573|P3|Overall Study|Sponsor Decision|1
4933181|NCT00420004|16979574|P2|Overall Study|Sponsor Decision|3
4933182|NCT00420004|16979575|P1|Overall Study|Sponsor Decision|3
4933183|NCT00420004|16979573|P3|Overall Study|Withdrawal by Subject|14
4933184|NCT00420004|16979574|P2|Overall Study|Withdrawal by Subject|42
4933185|NCT00420004|16979575|P1|Overall Study|Withdrawal by Subject|67
4933186|NCT00420004|16979573|P3|Overall Study|Protocol Violation|3
4933187|NCT00420004|16979574|P2|Overall Study|Protocol Violation|4
4933188|NCT00420004|16979575|P1|Overall Study|Protocol Violation|5
4933189|NCT00420004|16979573|P3|Overall Study|Physician Decision|2
4933190|NCT00420004|16979574|P2|Overall Study|Physician Decision|4
4933191|NCT00420004|16979575|P1|Overall Study|Physician Decision|14
4933192|NCT00420004|16979573|P3|Overall Study|Entry Criteria Not Met|0
4933193|NCT00420004|16979574|P2|Overall Study|Entry Criteria Not Met|1
4933194|NCT00420004|16979575|P1|Overall Study|Entry Criteria Not Met|0
4933195|NCT00420004|16979573|P3|Overall Study|Lost to Follow-up|10
4933196|NCT00420004|16979574|P2|Overall Study|Lost to Follow-up|12
4933197|NCT00420004|16979575|P1|Overall Study|Lost to Follow-up|31
4933198|NCT00420004|16979573|P3|Overall Study|Lack of Efficacy|1
4933199|NCT00420004|16979574|P2|Overall Study|Lack of Efficacy|4
4933200|NCT00420004|16979575|P1|Overall Study|Lack of Efficacy|5
4933201|NCT00420004|16979573|P3|Overall Study|Adverse Event|1
4933202|NCT00420004|16979574|P2|Overall Study|Adverse Event|1
4933203|NCT00420004|16979575|P1|Overall Study|Adverse Event|4
4933204|NCT00419952|16979640|P2|Overall Study|Abnormal ECG|0
4933205|NCT00419952|16979641|P1|Overall Study|Abnormal ECG|1
4933206|NCT00419952|16979640|P2|Overall Study|Diary or medication non-compliance|4
4933207|NCT00419952|16979641|P1|Overall Study|Diary or medication non-compliance|2
4933208|NCT00419952|16979640|P2|Overall Study|Occurence of 2 or more exacerbations|0
4933209|NCT00419952|16979641|P1|Overall Study|Occurence of 2 or more exacerbations|2
4933210|NCT00419952|16979640|P2|Overall Study|Intake of prohibited medication|2
4933211|NCT00419952|16979641|P1|Overall Study|Intake of prohibited medication|2
4933212|NCT00419952|16979640|P2|Overall Study|Incorrectly enrolled|3
4933213|NCT00419952|16979641|P1|Overall Study|Incorrectly enrolled|10
4933214|NCT00419952|16979640|P2|Overall Study|Physician Decision|3
4933215|NCT00419952|16979641|P1|Overall Study|Physician Decision|1
4933216|NCT00419952|16979640|P2|Overall Study|Pregnancy|2
4933217|NCT00419952|16979641|P1|Overall Study|Pregnancy|4
4933218|NCT00419952|16979640|P2|Overall Study|Protocol Violation|24
4933219|NCT00419952|16979641|P1|Overall Study|Protocol Violation|32
4933220|NCT00419952|16979640|P2|Overall Study|Lost to Follow-up|34
4933221|NCT00419952|16979641|P1|Overall Study|Lost to Follow-up|43
4933222|NCT00419952|16979640|P2|Overall Study|Withdrawal by Subject|43
4933223|NCT00419952|16979641|P1|Overall Study|Withdrawal by Subject|44
4933224|NCT00419952|16979640|P2|Overall Study|Adverse Event|10
4933225|NCT00419952|16979641|P1|Overall Study|Adverse Event|8
4933226|NCT00419926|16979675|P2|Overall Study|Death|1
4933227|NCT00419926|16979676|P1|Overall Study|Death|2
4933228|NCT00419926|16979675|P2|Overall Study|Lost to Follow-up|2
4933229|NCT00419926|16979676|P1|Overall Study|Lost to Follow-up|1
4933230|NCT00419926|16979675|P2|Overall Study|Administrative Problem|4
4933231|NCT00419926|16979676|P1|Overall Study|Administrative Problem|4
4933232|NCT00419926|16979675|P2|Overall Study|Withdrawal by Subject|3
4933233|NCT00419926|16979676|P1|Overall Study|Withdrawal by Subject|7
4933234|NCT00419770|16979692|P2|Overall Study|Withdrawal by Subject|1
4933235|NCT00419770|16979693|P1|Overall Study|Withdrawal by Subject|5
4933236|NCT00419757|16979701|P2|Overall Study|Multiple reasons|1
4933237|NCT00419757|16979702|P1|Overall Study|Multiple reasons|3
4933238|NCT00419757|16979701|P2|Overall Study|Study specific discontinuation criteria|8
4933239|NCT00419757|16979702|P1|Overall Study|Study specific discontinuation criteria|4
4933240|NCT00419757|16979701|P2|Overall Study|Protocol Violation|3
4933241|NCT00419757|16979702|P1|Overall Study|Protocol Violation|2
4933242|NCT00419757|16979701|P2|Overall Study|Withdrawal by Subject|1
4933243|NCT00419757|16979702|P1|Overall Study|Withdrawal by Subject|7
4933244|NCT00419757|16979701|P2|Overall Study|Lost to Follow-up|4
4933245|NCT00419757|16979702|P1|Overall Study|Lost to Follow-up|1
4933246|NCT00419757|16979701|P2|Overall Study|Adverse Event|4
4933247|NCT00419757|16979702|P1|Overall Study|Adverse Event|1
4933248|NCT00419744|16979741|P3|Overall Study|Incorrect medication kit dispensed|1
4933249|NCT00419744|16979742|P2|Overall Study|Incorrect medication kit dispensed|0
4933250|NCT00419744|16979743|P1|Overall Study|Incorrect medication kit dispensed|0
4933251|NCT00419744|16979741|P3|Overall Study|Spirometry mouthpiece issues|2
4933252|NCT00419744|16979742|P2|Overall Study|Spirometry mouthpiece issues|1
4933253|NCT00419744|16979743|P1|Overall Study|Spirometry mouthpiece issues|0
4933254|NCT00419744|16979741|P3|Overall Study|Physician Decision|6
4933255|NCT00419744|16979742|P2|Overall Study|Physician Decision|5
4933256|NCT00419744|16979743|P1|Overall Study|Physician Decision|10
4933257|NCT00419744|16979741|P3|Overall Study|Moving out of state|1
4933258|NCT00419744|16979742|P2|Overall Study|Moving out of state|0
4933259|NCT00419744|16979743|P1|Overall Study|Moving out of state|2
4933260|NCT00419744|16979741|P3|Overall Study|Randomized in error|7
4933261|NCT00419744|16979742|P2|Overall Study|Randomized in error|6
4933262|NCT00419744|16979743|P1|Overall Study|Randomized in error|9
4933263|NCT00419744|16979741|P3|Overall Study|Protocol Violation|8
4933264|NCT00419744|16979742|P2|Overall Study|Protocol Violation|7
4933265|NCT00419744|16979743|P1|Overall Study|Protocol Violation|4
4933266|NCT00419744|16979741|P3|Overall Study|Lost to Follow-up|6
4933267|NCT00419744|16979742|P2|Overall Study|Lost to Follow-up|10
4933268|NCT00419744|16979743|P1|Overall Study|Lost to Follow-up|8
4933269|NCT00419744|16979741|P3|Overall Study|Withdrawal by Subject|52
4933270|NCT00419744|16979742|P2|Overall Study|Withdrawal by Subject|49
4933271|NCT00419744|16979743|P1|Overall Study|Withdrawal by Subject|45
4933272|NCT00419744|16979741|P3|Overall Study|Adverse Event|50
4933273|NCT00419744|16979742|P2|Overall Study|Adverse Event|40
4933274|NCT00419744|16979743|P1|Overall Study|Adverse Event|39
4933275|NCT00419562|16979786|P2|Overall Study|Participant Institutionalized|0
4933276|NCT00419562|16979787|P1|Overall Study|Participant Institutionalized|1
4933277|NCT00419562|16979786|P2|Overall Study|Withdrawal by Subject|18
4933278|NCT00419562|16979787|P1|Overall Study|Withdrawal by Subject|20
4933279|NCT00419562|16979786|P2|Overall Study|Lost to Follow-up|13
4933280|NCT00419562|16979787|P1|Overall Study|Lost to Follow-up|12
4933281|NCT00419393|16979810|P1|Overall Study|Other: Investigator decision|1
4933282|NCT00419393|16979810|P1|Overall Study|Other: Other health problems|1
4933283|NCT00419393|16979810|P1|Overall Study|Other: Site closure|1
4933284|NCT00419393|16979810|P1|Overall Study|Other: Subject had temporal lobectomy|1
4933285|NCT00419393|16979810|P1|Overall Study|Other: Sponsor request|3
4933286|NCT00419393|16979810|P1|Overall Study|Withdrawal by Subject|7
4933287|NCT00419393|16979810|P1|Overall Study|Protocol Violation|5
4933288|NCT00419393|16979810|P1|Overall Study|Adverse Event|5
4933289|NCT00419380|16979820|P2|Overall Study|Withdrawal by Subject|1
4933290|NCT00419380|16979821|P1|Overall Study|Withdrawal by Subject|0
4933291|NCT00419380|16979820|P2|Overall Study|Lost to Follow-up|1
4933292|NCT00419380|16979821|P1|Overall Study|Lost to Follow-up|0
4933293|NCT00419380|16979820|P2|Overall Study|Physician Decision|1
4933294|NCT00419380|16979821|P1|Overall Study|Physician Decision|0
4933295|NCT00419380|16979820|P2|Overall Study|Lack of Efficacy|7
4933296|NCT00419380|16979821|P1|Overall Study|Lack of Efficacy|1
4933297|NCT00419341|16979829|P1|Efficacy Period|Termination of study site|1
4933298|NCT00419341|16979829|P1|Efficacy Period|Non-compliance|1
4933299|NCT00419341|16979829|P1|Efficacy Period|Lost to Follow-up|1
4933300|NCT00419341|16979829|P1|Efficacy Period|Protocol Violation|1
4933301|NCT00419341|16979829|P1|Efficacy Period|Withdrawal by Subject|6
4933302|NCT00419341|16979829|P1|Wash in/Wash Out Period|Disqualifying laboratory results|1
4933303|NCT00419341|16979829|P1|Wash in/Wash Out Period|Adverse Event|2
4933304|NCT00419341|16979829|P1|Wash in/Wash Out Period|Withdrawal by Subject|8
4933305|NCT00419263|16979864|P3|Overall Study|Withdrawal by Subject|1
4933306|NCT00419263|16979865|P2|Overall Study|Withdrawal by Subject|0
4933307|NCT00419263|16979866|P1|Overall Study|Withdrawal by Subject|0
4933308|NCT00419263|16979864|P3|Overall Study|Adverse Event|1
4933309|NCT00419263|16979865|P2|Overall Study|Adverse Event|0
4933310|NCT00419263|16979866|P1|Overall Study|Adverse Event|0
4933311|NCT00419263|16979864|P3|Overall Study|Randomized in Error, Not Treated|0
4933312|NCT00419263|16979865|P2|Overall Study|Randomized in Error, Not Treated|1
4933313|NCT00419263|16979866|P1|Overall Study|Randomized in Error, Not Treated|1
4933314|NCT00419263|16979864|P3|Overall Study|Lost to Follow-up|1
4933315|NCT00419263|16979865|P2|Overall Study|Lost to Follow-up|1
4933316|NCT00419263|16979866|P1|Overall Study|Lost to Follow-up|2
4933317|NCT00419159|16979895|P2|Overall Study|Disease progression|76
4933318|NCT00419159|16979896|P1|Overall Study|Disease progression|79
4933319|NCT00419159|16979895|P2|Overall Study|Death|2
4933320|NCT00419159|16979896|P1|Overall Study|Death|2
4933321|NCT00419159|16979895|P2|Overall Study|Lost to Follow-up|1
4933322|NCT00419159|16979896|P1|Overall Study|Lost to Follow-up|0
4933323|NCT00419159|16979895|P2|Overall Study|Withdrawal by Subject|3
4933324|NCT00419159|16979896|P1|Overall Study|Withdrawal by Subject|10
4933325|NCT00419159|16979895|P2|Overall Study|Protocol Violation|0
4933326|NCT00419159|16979896|P1|Overall Study|Protocol Violation|1
4933327|NCT00419159|16979895|P2|Overall Study|Subject's no longer requires study drug|1
4933328|NCT00419159|16979896|P1|Overall Study|Subject's no longer requires study drug|0
4933329|NCT00419159|16979895|P2|Overall Study|Abnormal laboratory value(s)|2
4933330|NCT00419159|16979896|P1|Overall Study|Abnormal laboratory value(s)|0
4933331|NCT00419159|16979895|P2|Overall Study|Adverse Event|15
4933332|NCT00419159|16979896|P1|Overall Study|Adverse Event|7
4933333|NCT00419120|16979926|P1|Long Term Follow up Period|study ongoing|10
4933334|NCT00419094|16979933|P2|Overall Study|Other: No contact for extended period|1
4933335|NCT00419094|16979934|P1|Overall Study|Other: No contact for extended period|0
4933336|NCT00419094|16979933|P2|Overall Study|Other: Patient non-compliant|1
4933337|NCT00419094|16979934|P1|Overall Study|Other: Patient non-compliant|0
4933338|NCT00419094|16979933|P2|Overall Study|Other: Error determining exit criteria|0
4933339|NCT00419094|16979934|P1|Overall Study|Other: Error determining exit criteria|1
4933340|NCT00419094|16979933|P2|Overall Study|Withdrawal of consent|5
4933341|NCT00419094|16979934|P1|Overall Study|Withdrawal of consent|1
4933342|NCT00419094|16979933|P2|Overall Study|Protocol Violation|14
4933343|NCT00419094|16979934|P1|Overall Study|Protocol Violation|1
4933344|NCT00419094|16979933|P2|Overall Study|Lost to Follow-up|2
4933345|NCT00419094|16979934|P1|Overall Study|Lost to Follow-up|0
4933346|NCT00419094|16979933|P2|Overall Study|Lack of Efficacy|0
4933347|NCT00419094|16979934|P1|Overall Study|Lack of Efficacy|1
4933348|NCT00419094|16979933|P2|Overall Study|Adverse Event|7
4933349|NCT00419094|16979934|P1|Overall Study|Adverse Event|3
4933350|NCT00419003|16979948|P2|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0
4933351|NCT00419003|16979949|P1|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1
4933352|NCT00419003|16979948|P2|Phase I, Ketamine Infusion|Lack of Efficacy|6
4933353|NCT00419003|16979949|P1|Phase I, Ketamine Infusion|Lack of Efficacy|6
4933354|NCT00418938|16980003|P2|Overall Study|Ineligibility Determined|0
4933355|NCT00418938|16980004|P1|Overall Study|Ineligibility Determined|1
4933356|NCT00418938|16980003|P2|Overall Study|On-going|1
4933357|NCT00418938|16980004|P1|Overall Study|On-going|1
4933358|NCT00418938|16980003|P2|Overall Study|Adverse Event|1
4933359|NCT00418938|16980004|P1|Overall Study|Adverse Event|1
4933360|NCT00418938|16980003|P2|Overall Study|Lost to Follow-up|3
4933361|NCT00418938|16980004|P1|Overall Study|Lost to Follow-up|1
4933362|NCT00418938|16980003|P2|Overall Study|Withdrawal by Subject|15
4933363|NCT00418938|16980004|P1|Overall Study|Withdrawal by Subject|16
4933364|NCT00418938|16980003|P2|Overall Study|Administrative decision|3
4933365|NCT00418938|16980004|P1|Overall Study|Administrative decision|3
4933366|NCT00418938|16980003|P2|Overall Study|Reimbursement|0
4933367|NCT00418938|16980004|P1|Overall Study|Reimbursement|1
4933368|NCT00418886|16980024|P2|Overall Study|randomised but no treatment received|1
4933369|NCT00418886|16980025|P1|Overall Study|randomised but no treatment received|0
4933370|NCT00418886|16980024|P2|Overall Study|withdrawn due to other reason|0
4933371|NCT00418886|16980025|P1|Overall Study|withdrawn due to other reason|1
4933372|NCT00418886|16980024|P2|Overall Study|Lost to Follow-up|6
4933373|NCT00418886|16980025|P1|Overall Study|Lost to Follow-up|4
4933374|NCT00418886|16980024|P2|Overall Study|Withdrawal by Subject|10
4933375|NCT00418886|16980025|P1|Overall Study|Withdrawal by Subject|9
4933376|NCT00418886|16980024|P2|Overall Study|Death|147
4933377|NCT00418886|16980025|P1|Overall Study|Death|122
4933378|NCT00418886|16980024|P2|Overall Study|discontinue treatment survival follow up|91
4933379|NCT00418886|16980025|P1|Overall Study|discontinue treatment survival follow up|90
4933380|NCT00418834|16980051|P2|Overall Study|Withdrawal by Subject|7
4933381|NCT00418834|16980052|P1|Overall Study|Withdrawal by Subject|3
4933382|NCT00418834|16980051|P2|Overall Study|Protocol Violation|3
4933383|NCT00418834|16980052|P1|Overall Study|Protocol Violation|4
4933384|NCT00418834|16980051|P2|Overall Study|Lost to Follow-up|1
4933385|NCT00418834|16980052|P1|Overall Study|Lost to Follow-up|0
4933386|NCT00418834|16980051|P2|Overall Study|Adverse Event|9
4933387|NCT00418834|16980052|P1|Overall Study|Adverse Event|16
4933388|NCT00418717|16980112|P1|Treatment Period B - Weeks 5-12|Adverse Event|2
4933389|NCT00418717|16980112|P1|Treatment Period A - Weeks 1-4|Protocol Violation|1
4933390|NCT00418691|16980120|P3|Overall Study|Progressive Disease|1
4933391|NCT00418691|16980121|P2|Overall Study|Progressive Disease|0
4933392|NCT00418691|16980122|P1|Overall Study|Progressive Disease|1
4933393|NCT00418691|16980120|P3|Overall Study|Started new medication voiding entry|1
4933394|NCT00418691|16980121|P2|Overall Study|Started new medication voiding entry|0
4933395|NCT00418691|16980122|P1|Overall Study|Started new medication voiding entry|0
4933396|NCT00418691|16980120|P3|Overall Study|Lost to Follow-up|3
4933397|NCT00418691|16980121|P2|Overall Study|Lost to Follow-up|2
4933398|NCT00418691|16980122|P1|Overall Study|Lost to Follow-up|1
4933399|NCT00418665|16980133|P3|Treatment Extension|Death|1
4933400|NCT00418665|16980134|P2|Treatment Extension|Death|0
4933401|NCT00418665|16980135|P1|Treatment Extension|Death|0
4933402|NCT00418665|16980133|P3|Treatment Extension|Physician Decision|1
4933403|NCT00418665|16980134|P2|Treatment Extension|Physician Decision|2
4933404|NCT00418665|16980135|P1|Treatment Extension|Physician Decision|2
4933405|NCT00418665|16980133|P3|Treatment Extension|Requirement for alternative therapy|0
4933406|NCT00418665|16980134|P2|Treatment Extension|Requirement for alternative therapy|2
4933407|NCT00418665|16980135|P1|Treatment Extension|Requirement for alternative therapy|2
4933408|NCT00418665|16980133|P3|Treatment Extension|Withdrawal by Subject|0
4933409|NCT00418665|16980134|P2|Treatment Extension|Withdrawal by Subject|0
4933410|NCT00418665|16980135|P1|Treatment Extension|Withdrawal by Subject|1
4933411|NCT00418665|16980133|P3|Treatment Extension|Adverse Event|0
4933412|NCT00418665|16980134|P2|Treatment Extension|Adverse Event|0
4933413|NCT00418665|16980135|P1|Treatment Extension|Adverse Event|1
4933414|NCT00418665|16980133|P3|Treatment Period|Physician Decision|3
4933415|NCT00418665|16980134|P2|Treatment Period|Physician Decision|0
4933416|NCT00418665|16980135|P1|Treatment Period|Physician Decision|1
4933417|NCT00418665|16980133|P3|Treatment Period|Requirement for alternative therapy|0
4933418|NCT00418665|16980134|P2|Treatment Period|Requirement for alternative therapy|0
4933419|NCT00418665|16980135|P1|Treatment Period|Requirement for alternative therapy|1
4933420|NCT00418665|16980133|P3|Treatment Period|Withdrawal by Subject|1
4933421|NCT00418665|16980134|P2|Treatment Period|Withdrawal by Subject|3
4933422|NCT00418665|16980135|P1|Treatment Period|Withdrawal by Subject|0
4933423|NCT00418665|16980133|P3|Treatment Period|Adverse Event|0
4933424|NCT00418665|16980134|P2|Treatment Period|Adverse Event|2
4933425|NCT00418665|16980135|P1|Treatment Period|Adverse Event|2
4933426|NCT00418665|16980133|P3|Treatment Period|Ineligibility determined|0
4933427|NCT00418665|16980134|P2|Treatment Period|Ineligibility determined|1
4933428|NCT00418665|16980135|P1|Treatment Period|Ineligibility determined|1
4933429|NCT00418561|16980169|P3|Overall Study|Participant's (guardian's) decision|0
4933430|NCT00418561|16980170|P2|Overall Study|Participant's (guardian's) decision|1
4933431|NCT00418561|16980171|P1|Overall Study|Participant's (guardian's) decision|0
4933432|NCT00418522|16980241|P2|Overall Study|Randomized but did not receive treatment|4
4933433|NCT00418522|16980242|P1|Overall Study|Randomized but did not receive treatment|7
4933434|NCT00418522|16980241|P2|Overall Study|Other|23
4933435|NCT00418522|16980242|P1|Overall Study|Other|27
4933436|NCT00418522|16980241|P2|Overall Study|Withdrawal by Subject|7
4933437|NCT00418522|16980242|P1|Overall Study|Withdrawal by Subject|31
4933438|NCT00418522|16980241|P2|Overall Study|Lost to Follow-up|4
4933439|NCT00418522|16980242|P1|Overall Study|Lost to Follow-up|10
4933440|NCT00418522|16980241|P2|Overall Study|Lack of Efficacy|3
4933441|NCT00418522|16980242|P1|Overall Study|Lack of Efficacy|1
4933442|NCT00418522|16980241|P2|Overall Study|Adverse Event|1
4933443|NCT00418522|16980242|P1|Overall Study|Adverse Event|7
4933444|NCT00418379|16980306|P3|Year 5|Any other reason not above-mentioned|3
4933445|NCT00418379|16980307|P2|Year 5|Any other reason not above-mentioned|4
4933446|NCT00418379|16980308|P1|Year 5|Any other reason not above-mentioned|2
4933447|NCT00418379|16980306|P3|Year 5|Adverse Event|0
4933448|NCT00418379|16980307|P2|Year 5|Adverse Event|1
4933449|NCT00418379|16980308|P1|Year 5|Adverse Event|0
4933450|NCT00418379|16980306|P3|Year 4|Any other reason not above-mentioned|0
4933451|NCT00418379|16980307|P2|Year 4|Any other reason not above-mentioned|1
4933452|NCT00418379|16980308|P1|Year 4|Any other reason not above-mentioned|1
4933453|NCT00418379|16980306|P3|Year 4|Withdrawal by Subject|2
4933454|NCT00418379|16980307|P2|Year 4|Withdrawal by Subject|3
4933455|NCT00418379|16980308|P1|Year 4|Withdrawal by Subject|2
4933456|NCT00418379|16980306|P3|Year 4|Adverse Event|0
4933457|NCT00418379|16980307|P2|Year 4|Adverse Event|1
4933458|NCT00418379|16980308|P1|Year 4|Adverse Event|0
4933459|NCT00418379|16980306|P3|Year 3|Any other reason not above-mentioned|1
4933460|NCT00418379|16980307|P2|Year 3|Any other reason not above-mentioned|1
4933461|NCT00418379|16980308|P1|Year 3|Any other reason not above-mentioned|2
4933462|NCT00418379|16980306|P3|Year 3|Withdrawal by Subject|2
4933463|NCT00418379|16980307|P2|Year 3|Withdrawal by Subject|1
4933464|NCT00418379|16980308|P1|Year 3|Withdrawal by Subject|1
4933465|NCT00418379|16980306|P3|Year 2|Any other reason not above-mentioned|6
4933466|NCT00418379|16980307|P2|Year 2|Any other reason not above-mentioned|1
4933467|NCT00418379|16980308|P1|Year 2|Any other reason not above-mentioned|2
4933468|NCT00418379|16980306|P3|Year 2|Withdrawal by Subject|3
4933469|NCT00418379|16980307|P2|Year 2|Withdrawal by Subject|1
4933470|NCT00418379|16980308|P1|Year 2|Withdrawal by Subject|1
4933471|NCT00418379|16980306|P3|Year 2|Adverse Event|1
4933472|NCT00418379|16980307|P2|Year 2|Adverse Event|2
4933473|NCT00418379|16980308|P1|Year 2|Adverse Event|5
4933474|NCT00418379|16980306|P3|Year 1|Any other reason not above-mentioned|7
4933475|NCT00418379|16980307|P2|Year 1|Any other reason not above-mentioned|5
4933476|NCT00418379|16980308|P1|Year 1|Any other reason not above-mentioned|2
4933477|NCT00418379|16980306|P3|Year 1|Withdrawal by Subject|5
4933478|NCT00418379|16980307|P2|Year 1|Withdrawal by Subject|8
4933479|NCT00418379|16980308|P1|Year 1|Withdrawal by Subject|7
4933480|NCT00418379|16980306|P3|Year 1|Adverse Event|3
4933481|NCT00418379|16980307|P2|Year 1|Adverse Event|15
4933482|NCT00418379|16980308|P1|Year 1|Adverse Event|9
4933483|NCT00418314|16980318|P2|Overall Study|Withdrawal by Subject|2
4933484|NCT00418314|16980319|P1|Overall Study|Withdrawal by Subject|1
4933485|NCT00418184|16980349|P2|Double-blind Phase|Poor compliance|1
4933486|NCT00418184|16980350|P1|Double-blind Phase|Poor compliance|3
4933487|NCT00418184|16980349|P2|Double-blind Phase|Adverse Event|1
4933488|NCT00418184|16980350|P1|Double-blind Phase|Adverse Event|2
4933489|NCT00418184|16980349|P2|Double-blind Phase|Withdrawal by Subject|9
4933490|NCT00418184|16980350|P1|Double-blind Phase|Withdrawal by Subject|22
4933491|NCT00418145|16980358|P1|Overall Study|study terminated|6
4933492|NCT00417989|16980433|P2|Overall Study|Physician Decision|2
4933493|NCT00417989|16980434|P1|Overall Study|Physician Decision|5
4933494|NCT00417989|16980433|P2|Overall Study|Death|1
4933495|NCT00417989|16980434|P1|Overall Study|Death|0
4933496|NCT00417989|16980433|P2|Overall Study|Protocol Violation|0
4933497|NCT00417989|16980434|P1|Overall Study|Protocol Violation|1
4933498|NCT00417989|16980433|P2|Overall Study|Lost to Follow-up|6
4933499|NCT00417989|16980434|P1|Overall Study|Lost to Follow-up|1
4933500|NCT00417989|16980433|P2|Overall Study|Withdrawal by Subject|13
4933501|NCT00417989|16980434|P1|Overall Study|Withdrawal by Subject|13
4933502|NCT00417976|16980456|P1|Overall Study|Treatment -related toxicity|2
4933503|NCT00417976|16980456|P1|Overall Study|Non compliance unrelated to toxicity|1
4933504|NCT00417963|16980461|P1|Overall Study|Study device could not be deployed|3
4933505|NCT00417963|16980461|P1|Overall Study|Death|17
4933506|NCT00417963|16980461|P1|Overall Study|Withdrawal by Subject|18
4933507|NCT00417963|16980461|P1|Overall Study|Lost to Follow-up|3
4933508|NCT00417885|16980478|P1|Overall Study|Transferred to Another Sunitinib Study|2
4933509|NCT00417885|16980478|P1|Overall Study|Objective Progression or Relapse|3
4933510|NCT00417885|16980478|P1|Overall Study|Adverse Event|1
4933511|NCT00417612|16980504|P2|Overall Study|Lost to Follow-up|0
4933512|NCT00417612|16980505|P1|Overall Study|Lost to Follow-up|1
4933513|NCT00417612|16980504|P2|Overall Study|Protocol Violation|2
4933514|NCT00417612|16980505|P1|Overall Study|Protocol Violation|0
4933515|NCT00417612|16980504|P2|Overall Study|Adverse Event|0
4933516|NCT00417612|16980505|P1|Overall Study|Adverse Event|2
4933517|NCT00417612|16980504|P2|Overall Study|Errant diagnosis|1
4933518|NCT00417612|16980505|P1|Overall Study|Errant diagnosis|0
4933519|NCT00417482|16980531|P3|Phase B 2nd 16 Weeks|Death|0
4933520|NCT00417482|16980532|P2|Phase B 2nd 16 Weeks|Death|1
4933521|NCT00417482|16980533|P1|Phase B 2nd 16 Weeks|Death|1
4933522|NCT00417482|16980531|P3|Phase B 2nd 16 Weeks|Moved; unclear reason|0
4933523|NCT00417482|16980532|P2|Phase B 2nd 16 Weeks|Moved; unclear reason|0
4933524|NCT00417482|16980533|P1|Phase B 2nd 16 Weeks|Moved; unclear reason|1
4933525|NCT00417482|16980531|P3|Phase B 2nd 16 Weeks|Adverse Event|1
4933526|NCT00417482|16980532|P2|Phase B 2nd 16 Weeks|Adverse Event|0
4933527|NCT00417482|16980533|P1|Phase B 2nd 16 Weeks|Adverse Event|0
4933528|NCT00417482|16980531|P3|Phase B 2nd 16 Weeks|Lack of Efficacy|2
4933529|NCT00417482|16980532|P2|Phase B 2nd 16 Weeks|Lack of Efficacy|12
4933530|NCT00417482|16980533|P1|Phase B 2nd 16 Weeks|Lack of Efficacy|1
4933531|NCT00417482|16980531|P3|Phase B 1st 16 Weeks|Death|0
4933532|NCT00417482|16980532|P2|Phase B 1st 16 Weeks|Death|0
4933533|NCT00417482|16980533|P1|Phase B 1st 16 Weeks|Death|1
4933534|NCT00417482|16980531|P3|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
4933535|NCT00417482|16980532|P2|Phase B 1st 16 Weeks|Moved, Unclear reasons|3
4933536|NCT00417482|16980533|P1|Phase B 1st 16 Weeks|Moved, Unclear reasons|2
4933537|NCT00417482|16980531|P3|Phase B 1st 16 Weeks|Adverse Event|1
4933538|NCT00417482|16980532|P2|Phase B 1st 16 Weeks|Adverse Event|0
4933539|NCT00417482|16980533|P1|Phase B 1st 16 Weeks|Adverse Event|2
4933540|NCT00417482|16980531|P3|Phase B 1st 16 Weeks|Lack of Efficacy|24
4933541|NCT00417482|16980532|P2|Phase B 1st 16 Weeks|Lack of Efficacy|8
4933542|NCT00417482|16980533|P1|Phase B 1st 16 Weeks|Lack of Efficacy|14
4933543|NCT00417248|16980572|P1|Overall Study|Lack of Efficacy|1
4933544|NCT00417248|16980572|P1|Overall Study|Death|1
4933545|NCT00417248|16980572|P1|Overall Study|Study Terminated|6
4933546|NCT00417170|16980579|P2|Overall Study|Lost to Follow-up|1
4933547|NCT00417170|16980580|P1|Overall Study|Lost to Follow-up|0
4933548|NCT00417170|16980579|P2|Overall Study|Withdrawal by Subject|1
4933549|NCT00417170|16980580|P1|Overall Study|Withdrawal by Subject|1
4933550|NCT00417170|16980579|P2|Overall Study|Adverse Event|1
4933551|NCT00417170|16980580|P1|Overall Study|Adverse Event|1
4933552|NCT00417079|16980596|P2|Overall Study|abnormal liver function tests|1
4933553|NCT00417079|16980597|P1|Overall Study|abnormal liver function tests|0
4933554|NCT00417079|16980596|P2|Overall Study|Patient unable to come to the clinic|1
4933555|NCT00417079|16980597|P1|Overall Study|Patient unable to come to the clinic|0
4933556|NCT00417079|16980596|P2|Overall Study|Withdrawal by subject's family|1
4933557|NCT00417079|16980597|P1|Overall Study|Withdrawal by subject's family|0
4933558|NCT00417079|16980596|P2|Overall Study|Screening error|1
4933559|NCT00417079|16980597|P1|Overall Study|Screening error|2
4933560|NCT00417079|16980596|P2|Overall Study|Clinical deterioration|0
4933561|NCT00417079|16980597|P1|Overall Study|Clinical deterioration|1
4933562|NCT00417079|16980596|P2|Overall Study|Non-confirmed Disease progression|1
4933563|NCT00417079|16980597|P1|Overall Study|Non-confirmed Disease progression|1
4933564|NCT00417079|16980596|P2|Overall Study|Investigator's decision|4
4933565|NCT00417079|16980597|P1|Overall Study|Investigator's decision|1
4933566|NCT00417079|16980596|P2|Overall Study|Screened failure|1
4933567|NCT00417079|16980597|P1|Overall Study|Screened failure|2
4933568|NCT00417079|16980596|P2|Overall Study|Not treated|7
4933569|NCT00417079|16980597|P1|Overall Study|Not treated|6
4933570|NCT00417079|16980596|P2|Overall Study|Withdrawal by Subject|8
4933571|NCT00417079|16980597|P1|Overall Study|Withdrawal by Subject|17
4933572|NCT00417079|16980596|P2|Overall Study|Lost to Follow-up|0
4933573|NCT00417079|16980597|P1|Overall Study|Lost to Follow-up|2
4933574|NCT00417079|16980596|P2|Overall Study|Non-compliance to protocol|1
4933575|NCT00417079|16980597|P1|Overall Study|Non-compliance to protocol|0
4933576|NCT00417079|16980596|P2|Overall Study|Adverse Event|67
4933577|NCT00417079|16980597|P1|Overall Study|Adverse Event|32
4933578|NCT00417079|16980596|P2|Overall Study|Disease progression|180
4933579|NCT00417079|16980597|P1|Overall Study|Disease progression|267
4933580|NCT00417027|16980620|P3|Overall Study|Protocol Violation|5
4933581|NCT00417027|16980621|P2|Overall Study|Protocol Violation|5
4933582|NCT00417027|16980622|P1|Overall Study|Protocol Violation|0
4933583|NCT00416949|16980648|P1|Overall Study|Patients refused to participate|5
4933584|NCT00416884|16980652|P1|Overall Study|Study terminated due to low accrual|1
4933585|NCT00416715|16980661|P1|Overall Study|Vitamin D levels not evaluable|8
4933586|NCT00416715|16980661|P1|Overall Study|Not evaluable for joint aches|7
4933587|NCT00416624|16980672|P4|Overall Study|Cancel|0
4933588|NCT00416624|16980673|P3|Overall Study|Cancel|0
4933589|NCT00416624|16980674|P2|Overall Study|Cancel|0
4933590|NCT00416624|16980675|P1|Overall Study|Cancel|1
4933591|NCT00416624|16980672|P4|Overall Study|Other|5
4933592|NCT00416624|16980673|P3|Overall Study|Other|5
4933593|NCT00416624|16980674|P2|Overall Study|Other|11
4933594|NCT00416624|16980675|P1|Overall Study|Other|8
4933595|NCT00416624|16980672|P4|Overall Study|Adverse Event|2
4933596|NCT00416624|16980673|P3|Overall Study|Adverse Event|2
4933597|NCT00416624|16980674|P2|Overall Study|Adverse Event|3
4933598|NCT00416624|16980675|P1|Overall Study|Adverse Event|8
4933599|NCT00416624|16980672|P4|Overall Study|Death|1
4933600|NCT00416624|16980673|P3|Overall Study|Death|7
4933601|NCT00416624|16980674|P2|Overall Study|Death|7
4933602|NCT00416624|16980675|P1|Overall Study|Death|4
4933603|NCT00416624|16980672|P4|Overall Study|Withdrawal by Subject|9
4933604|NCT00416624|16980673|P3|Overall Study|Withdrawal by Subject|4
4933605|NCT00416624|16980674|P2|Overall Study|Withdrawal by Subject|6
4933606|NCT00416624|16980675|P1|Overall Study|Withdrawal by Subject|1
4933607|NCT00416598|16980729|P1|Decitabine Maintenance|Physician discretion/other medical issue|9
4933608|NCT00416598|16980729|P1|Decitabine Maintenance|Alternative treatment|2
4933609|NCT00416598|16980729|P1|Decitabine Maintenance|Progression/relapse|38
4933610|NCT00416598|16980729|P1|Decitabine Maintenance|Withdrawal by Subject|18
4933611|NCT00416598|16980729|P1|Decitabine Maintenance|Adverse Event|5
4933612|NCT00416598|16980729|P1|Induction & Intensification|Failed induction|87
4933613|NCT00416598|16980729|P1|Induction & Intensification|Relapse/progression|29
4933614|NCT00416598|16980729|P1|Induction & Intensification|Physician discretion/other medical issue|45
4933615|NCT00416598|16980729|P1|Induction & Intensification|Alternative Treatment|135
4933616|NCT00416598|16980729|P1|Induction & Intensification|Withdrawal by Subject|46
4933617|NCT00416598|16980729|P1|Induction & Intensification|Death|32
4933618|NCT00416598|16980729|P1|Induction & Intensification|Adverse Event|38
4933619|NCT00416520|16980755|P4|Placebo-controlled Withdrawal Period|Protocol Violation|1
4933620|NCT00416520|16980756|P3|Placebo-controlled Withdrawal Period|Protocol Violation|1
4933621|NCT00416520|16980757|P2|Placebo-controlled Withdrawal Period|Protocol Violation|0
4933622|NCT00416520|16980758|P1|Placebo-controlled Withdrawal Period|Protocol Violation|0
4933623|NCT00416520|16980755|P4|Placebo-controlled Withdrawal Period|Lack of Efficacy|3
4933624|NCT00416520|16980756|P3|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
4933625|NCT00416520|16980757|P2|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
4933626|NCT00416520|16980758|P1|Placebo-controlled Withdrawal Period|Lack of Efficacy|0
4933627|NCT00416520|16980755|P4|Placebo-controlled Withdrawal Period|Adverse Event|1
4933628|NCT00416520|16980756|P3|Placebo-controlled Withdrawal Period|Adverse Event|0
4933629|NCT00416520|16980757|P2|Placebo-controlled Withdrawal Period|Adverse Event|0
4933630|NCT00416520|16980758|P1|Placebo-controlled Withdrawal Period|Adverse Event|0
4933631|NCT00416520|16980755|P4|Open-label Period|Other Reasons|0
4933632|NCT00416520|16980756|P3|Open-label Period|Other Reasons|0
4933633|NCT00416520|16980757|P2|Open-label Period|Other Reasons|12
4933634|NCT00416520|16980758|P1|Open-label Period|Other Reasons|3
4933635|NCT00416520|16980755|P4|Open-label Period|Withdrawal by Subject|0
4933636|NCT00416520|16980756|P3|Open-label Period|Withdrawal by Subject|0
4933637|NCT00416520|16980757|P2|Open-label Period|Withdrawal by Subject|5
4933638|NCT00416520|16980758|P1|Open-label Period|Withdrawal by Subject|16
4933639|NCT00416520|16980755|P4|Open-label Period|Protocol Violation|0
4933640|NCT00416520|16980756|P3|Open-label Period|Protocol Violation|0
4933641|NCT00416520|16980757|P2|Open-label Period|Protocol Violation|3
4933642|NCT00416520|16980758|P1|Open-label Period|Protocol Violation|3
4933643|NCT00416520|16980755|P4|Open-label Period|Lack of Efficacy|0
4933644|NCT00416520|16980756|P3|Open-label Period|Lack of Efficacy|0
4933645|NCT00416520|16980757|P2|Open-label Period|Lack of Efficacy|1
4933646|NCT00416520|16980758|P1|Open-label Period|Lack of Efficacy|8
4933647|NCT00416520|16980755|P4|Open-label Period|Death|0
4933648|NCT00416520|16980756|P3|Open-label Period|Death|0
4933649|NCT00416520|16980757|P2|Open-label Period|Death|1
4933650|NCT00416520|16980758|P1|Open-label Period|Death|2
4933651|NCT00416520|16980755|P4|Open-label Period|Adverse Event|0
4933652|NCT00416520|16980756|P3|Open-label Period|Adverse Event|0
4933653|NCT00416520|16980757|P2|Open-label Period|Adverse Event|10
4933654|NCT00416520|16980758|P1|Open-label Period|Adverse Event|28
4933655|NCT00416455|16980787|P2|Overall Study|Inadequate pathology|2
4933656|NCT00416455|16980788|P1|Overall Study|Inadequate pathology|11
4933657|NCT00416455|16980787|P2|Overall Study|PET / CT poor quality|1
4933658|NCT00416455|16980788|P1|Overall Study|PET / CT poor quality|2
4933659|NCT00416455|16980787|P2|Overall Study|PET / CT not done|5
4933660|NCT00416455|16980788|P1|Overall Study|PET / CT not done|3
4933661|NCT00416312|16980823|P1|Overall Study|tumors not visible on imaging|2
4933662|NCT00416195|16980829|P2|Overall Study|Other|1
4933663|NCT00416195|16980830|P1|Overall Study|Other|0
4933664|NCT00416195|16980829|P2|Overall Study|Protocol Violation|1
4933665|NCT00416195|16980830|P1|Overall Study|Protocol Violation|1
4933666|NCT00416195|16980829|P2|Overall Study|Adverse Event|2
4933667|NCT00416195|16980830|P1|Overall Study|Adverse Event|1
4933668|NCT00416078|16980855|P2|Overall Study|Lost to Follow-up|2
4933669|NCT00416078|16980856|P1|Overall Study|Lost to Follow-up|4
4933670|NCT00416078|16980855|P2|Overall Study|Physician Decision|0
4933671|NCT00416078|16980856|P1|Overall Study|Physician Decision|1
4933672|NCT00416078|16980855|P2|Overall Study|Withdrawal by Subject|2
4933673|NCT00416078|16980856|P1|Overall Study|Withdrawal by Subject|3
4933674|NCT00416078|16980855|P2|Overall Study|Death|4
4933675|NCT00416078|16980856|P1|Overall Study|Death|3
4933676|NCT00415909|16980872|P1|Overall Study|Death|1
4933677|NCT00415909|16980872|P1|Overall Study|Withdrawal by Subject|2
4933678|NCT00415636|16980906|P6|Overall Study|Disease progression|1
4933679|NCT00415636|16980907|P5|Overall Study|Disease progression|0
4933680|NCT00415636|16980908|P4|Overall Study|Disease progression|3
4933681|NCT00415636|16980909|P3|Overall Study|Disease progression|0
4933682|NCT00415636|16980910|P2|Overall Study|Disease progression|0
4933683|NCT00415636|16980911|P1|Overall Study|Disease progression|0
4933684|NCT00415636|16980906|P6|Overall Study|Withdrawal by Subject|0
4933685|NCT00415636|16980907|P5|Overall Study|Withdrawal by Subject|1
4933686|NCT00415636|16980908|P4|Overall Study|Withdrawal by Subject|0
4933687|NCT00415636|16980909|P3|Overall Study|Withdrawal by Subject|0
4933688|NCT00415636|16980910|P2|Overall Study|Withdrawal by Subject|0
4933689|NCT00415636|16980911|P1|Overall Study|Withdrawal by Subject|0
4933690|NCT00415636|16980906|P6|Overall Study|Adverse Event|0
4933691|NCT00415636|16980907|P5|Overall Study|Adverse Event|1
4933692|NCT00415636|16980908|P4|Overall Study|Adverse Event|1
4933693|NCT00415636|16980909|P3|Overall Study|Adverse Event|0
4933694|NCT00415636|16980910|P2|Overall Study|Adverse Event|0
4933695|NCT00415636|16980911|P1|Overall Study|Adverse Event|0
4933696|NCT00415636|16980906|P6|Overall Study|Symptomatic deterioration|1
4933697|NCT00415636|16980907|P5|Overall Study|Symptomatic deterioration|0
4933698|NCT00415636|16980908|P4|Overall Study|Symptomatic deterioration|2
4933699|NCT00415636|16980909|P3|Overall Study|Symptomatic deterioration|1
4933700|NCT00415636|16980910|P2|Overall Study|Symptomatic deterioration|0
4933701|NCT00415636|16980911|P1|Overall Study|Symptomatic deterioration|1
4933702|NCT00415623|16980945|P2|Overall Study|Withdrawal by Subject|1
4933703|NCT00415623|16980946|P1|Overall Study|Withdrawal by Subject|1
4933704|NCT00415623|16980945|P2|Overall Study|Death|0
4933705|NCT00415623|16980946|P1|Overall Study|Death|1
4933706|NCT00415623|16980945|P2|Overall Study|Adverse Event|4
4933707|NCT00415623|16980946|P1|Overall Study|Adverse Event|3
4933708|NCT00415610|16980973|P3|Overall Study|Death|5
4933709|NCT00415610|16980974|P2|Overall Study|Death|2
4933710|NCT00415610|16980975|P1|Overall Study|Death|3
4933711|NCT00415597|16980995|P1|Treatment|Multiple Reasons|1
4933712|NCT00415597|16980995|P1|Treatment|Sponsor Decision|1
4933713|NCT00415597|16980995|P1|Treatment|Administrative|3
4933714|NCT00415597|16980995|P1|Treatment|Drug Screen|2
4933715|NCT00415597|16980995|P1|Treatment|Lost to Follow-up|28
4933716|NCT00415597|16980995|P1|Treatment|Withdrawal by Subject|51
4933717|NCT00415597|16980995|P1|Treatment|Physician Decision|3
4933718|NCT00415597|16980995|P1|Treatment|Protocol Violation|67
4933719|NCT00415597|16980995|P1|Treatment|Lack of Efficacy|39
4933720|NCT00415597|16980995|P1|Treatment|Adverse Event|110
4933721|NCT00415597|16980995|P1|Enrollment|Protocol Violation|1
4933722|NCT00415597|16980995|P1|Enrollment|Withdrawal by Subject|1
4933723|NCT00415532|16981003|P2|Safety Follow Up Period|Requirement for alternative therapy|1
4933724|NCT00415532|16981004|P1|Safety Follow Up Period|Requirement for alternative therapy|0
4933725|NCT00415532|16981003|P2|Safety Follow Up Period|Noncompliance|0
4933726|NCT00415532|16981004|P1|Safety Follow Up Period|Noncompliance|1
4933727|NCT00415532|16981003|P2|Safety Follow Up Period|Ineligibility determined|1
4933728|NCT00415532|16981004|P1|Safety Follow Up Period|Ineligibility determined|1
4933729|NCT00415532|16981003|P2|Safety Follow Up Period|Other|4
4933730|NCT00415532|16981004|P1|Safety Follow Up Period|Other|1
4933731|NCT00415532|16981003|P2|Safety Follow Up Period|Withdrawal by Subject|3
4933732|NCT00415532|16981004|P1|Safety Follow Up Period|Withdrawal by Subject|2
4933733|NCT00415532|16981003|P2|Safety Follow Up Period|Death|0
4933734|NCT00415532|16981004|P1|Safety Follow Up Period|Death|3
4933735|NCT00415532|16981003|P2|Safety Follow Up Period|Adverse Event|3
4933736|NCT00415532|16981004|P1|Safety Follow Up Period|Adverse Event|1
4933737|NCT00415532|16981003|P2|Treatment Period|Requirement for alternative therapy|0
4933738|NCT00415532|16981004|P1|Treatment Period|Requirement for alternative therapy|1
4933739|NCT00415532|16981003|P2|Treatment Period|Noncompliance|1
4933740|NCT00415532|16981004|P1|Treatment Period|Noncompliance|1
4933741|NCT00415532|16981003|P2|Treatment Period|Ineligibility determined|1
4933742|NCT00415532|16981004|P1|Treatment Period|Ineligibility determined|1
4933743|NCT00415532|16981003|P2|Treatment Period|Other|2
4933744|NCT00415532|16981004|P1|Treatment Period|Other|2
4933745|NCT00415532|16981003|P2|Treatment Period|Withdrawal by Subject|6
4933746|NCT00415532|16981004|P1|Treatment Period|Withdrawal by Subject|6
4933747|NCT00415532|16981003|P2|Treatment Period|Protocol Violation|0
4933748|NCT00415532|16981004|P1|Treatment Period|Protocol Violation|1
4933749|NCT00415532|16981003|P2|Treatment Period|Lost to Follow-up|1
4933750|NCT00415532|16981004|P1|Treatment Period|Lost to Follow-up|1
4933751|NCT00415532|16981003|P2|Treatment Period|Death|1
4933752|NCT00415532|16981004|P1|Treatment Period|Death|2
4933753|NCT00415532|16981003|P2|Treatment Period|Adverse Event|3
4933754|NCT00415532|16981004|P1|Treatment Period|Adverse Event|2
4933755|NCT00415519|16981026|P2|Overall Study|Patient's convenience|0
4933756|NCT00415519|16981027|P1|Overall Study|Patient's convenience|1
4933757|NCT00415519|16981026|P2|Overall Study|Withdrawal by Subject|0
4933758|NCT00415519|16981027|P1|Overall Study|Withdrawal by Subject|2
4933759|NCT00415519|16981026|P2|Overall Study|Adverse Event|0
4933760|NCT00415519|16981027|P1|Overall Study|Adverse Event|1
4933761|NCT00415194|16981067|P2|Overall Study|Death Due to AE (Other Causes)|15
4933762|NCT00415194|16981068|P1|Overall Study|Death Due to AE (Other Causes)|27
4933763|NCT00415194|16981067|P2|Overall Study|Death Due to Procedural Related AE|1
4933764|NCT00415194|16981068|P1|Overall Study|Death Due to Procedural Related AE|0
4933765|NCT00415194|16981067|P2|Overall Study|Death Due to Study Drug Related AE|1
4933766|NCT00415194|16981068|P1|Overall Study|Death Due to Study Drug Related AE|11
4933767|NCT00415194|16981067|P2|Overall Study|Death Due to Study Disease|29
4933768|NCT00415194|16981068|P1|Overall Study|Death Due to Study Disease|26
4933769|NCT00415194|16981067|P2|Overall Study|Withdrawal by Subject|21
4933770|NCT00415194|16981068|P1|Overall Study|Withdrawal by Subject|28
4933771|NCT00415194|16981067|P2|Overall Study|Protocol Violation|2
4933772|NCT00415194|16981068|P1|Overall Study|Protocol Violation|4
4933773|NCT00415194|16981067|P2|Overall Study|Progressive Disease|217
4933774|NCT00415194|16981068|P1|Overall Study|Progressive Disease|180
4933775|NCT00415194|16981067|P2|Overall Study|Physician Decision|16
4933776|NCT00415194|16981068|P1|Overall Study|Physician Decision|10
4933777|NCT00415194|16981067|P2|Overall Study|Lost to Follow-up|0
4933778|NCT00415194|16981068|P1|Overall Study|Lost to Follow-up|1
4933779|NCT00415194|16981067|P2|Overall Study|Entry Criteria Not Met|8
4933780|NCT00415194|16981068|P1|Overall Study|Entry Criteria Not Met|4
4933781|NCT00415194|16981067|P2|Overall Study|Adverse Event|32
4933782|NCT00415194|16981068|P1|Overall Study|Adverse Event|37
4933783|NCT00415168|16981084|P1|Overall Study|Withdrawal by Subject|6
4933784|NCT00415168|16981084|P1|Overall Study|Sponsor Decision|4
4933785|NCT00415168|16981084|P1|Overall Study|Physician Decision|13
4933786|NCT00415168|16981084|P1|Overall Study|Lost to Follow-up|3
4933787|NCT00415168|16981084|P1|Overall Study|Death|26
4933788|NCT00415051|16981094|P1|Overall Study|Protocol Violation|1
4933789|NCT00414973|16981105|P4|Overall Study|Death|0
4933790|NCT00414973|16981106|P3|Overall Study|Death|1
4933791|NCT00414973|16981107|P2|Overall Study|Death|0
4933792|NCT00414973|16981108|P1|Overall Study|Death|0
4933793|NCT00414973|16981105|P4|Overall Study|Sponsor Decision|0
4933794|NCT00414973|16981106|P3|Overall Study|Sponsor Decision|0
4933795|NCT00414973|16981107|P2|Overall Study|Sponsor Decision|0
4933796|NCT00414973|16981108|P1|Overall Study|Sponsor Decision|1
4933797|NCT00414973|16981105|P4|Overall Study|Lost to Follow-up|0
4933798|NCT00414973|16981106|P3|Overall Study|Lost to Follow-up|0
4933799|NCT00414973|16981107|P2|Overall Study|Lost to Follow-up|2
4933800|NCT00414973|16981108|P1|Overall Study|Lost to Follow-up|0
4933801|NCT00414973|16981105|P4|Overall Study|Protocol Violation|0
4933802|NCT00414973|16981106|P3|Overall Study|Protocol Violation|0
4933803|NCT00414973|16981107|P2|Overall Study|Protocol Violation|4
4933804|NCT00414973|16981108|P1|Overall Study|Protocol Violation|3
4933805|NCT00414973|16981105|P4|Overall Study|Adverse Event|0
4933806|NCT00414973|16981106|P3|Overall Study|Adverse Event|1
4933807|NCT00414973|16981107|P2|Overall Study|Adverse Event|0
4933808|NCT00414973|16981108|P1|Overall Study|Adverse Event|10
4933809|NCT00414973|16981105|P4|Overall Study|Withdrawal by Subject|0
4933810|NCT00414973|16981106|P3|Overall Study|Withdrawal by Subject|1
4933811|NCT00414973|16981107|P2|Overall Study|Withdrawal by Subject|4
4933812|NCT00414973|16981108|P1|Overall Study|Withdrawal by Subject|14
4933813|NCT00414960|16981128|P2|Overall Study|Physician Decision|1
4933814|NCT00414960|16981129|P1|Overall Study|Physician Decision|0
4933815|NCT00414960|16981128|P2|Overall Study|Withdrawal by Subject|0
4933816|NCT00414960|16981129|P1|Overall Study|Withdrawal by Subject|3
4933817|NCT00414960|16981128|P2|Overall Study|Adverse Event|0
4933818|NCT00414960|16981129|P1|Overall Study|Adverse Event|4
4933819|NCT00414908|16981139|P2|Overall Study|Protocol Violation|1
4933820|NCT00414908|16981140|P1|Overall Study|Protocol Violation|1
4933821|NCT00414726|16981177|P2|Overall Study|Withdrawal by Subject|1
4933822|NCT00414726|16981178|P1|Overall Study|Withdrawal by Subject|0
4933823|NCT00414661|16981213|P4|Overall Study|Other|0
4933824|NCT00414661|16981214|P3|Overall Study|Other|0
4933825|NCT00414661|16981215|P2|Overall Study|Other|3
4933826|NCT00414661|16981216|P1|Overall Study|Other|6
4933827|NCT00414661|16981213|P4|Overall Study|Withdrawal by Subject|2
4933828|NCT00414661|16981214|P3|Overall Study|Withdrawal by Subject|2
4933829|NCT00414661|16981215|P2|Overall Study|Withdrawal by Subject|2
4933830|NCT00414661|16981216|P1|Overall Study|Withdrawal by Subject|5
4933831|NCT00414661|16981213|P4|Overall Study|Lost to Follow-up|1
4933832|NCT00414661|16981214|P3|Overall Study|Lost to Follow-up|0
4933833|NCT00414661|16981215|P2|Overall Study|Lost to Follow-up|4
4933834|NCT00414661|16981216|P1|Overall Study|Lost to Follow-up|1
4933835|NCT00414661|16981213|P4|Overall Study|Death|0
4933836|NCT00414661|16981214|P3|Overall Study|Death|0
4933837|NCT00414661|16981215|P2|Overall Study|Death|5
4933838|NCT00414661|16981216|P1|Overall Study|Death|2
4933839|NCT00414609|16981261|P3|Extension Study|Death|17
4933840|NCT00414609|16981262|P2|Extension Study|Death|0
4933841|NCT00414609|16981263|P1|Extension Study|Death|0
4933842|NCT00414609|16981261|P3|Extension Study|Administrative problems|1
4933843|NCT00414609|16981262|P2|Extension Study|Administrative problems|0
4933844|NCT00414609|16981263|P1|Extension Study|Administrative problems|0
4933845|NCT00414609|16981261|P3|Extension Study|Lost to Follow-up|10
4933846|NCT00414609|16981262|P2|Extension Study|Lost to Follow-up|0
4933847|NCT00414609|16981263|P1|Extension Study|Lost to Follow-up|0
4933848|NCT00414609|16981261|P3|Extension Study|Withdrawal by Subject|13
4933849|NCT00414609|16981262|P2|Extension Study|Withdrawal by Subject|0
4933850|NCT00414609|16981263|P1|Extension Study|Withdrawal by Subject|0
4933851|NCT00414609|16981261|P3|Extension Study|Unsatisfactory therapeutic effect|2
4933852|NCT00414609|16981262|P2|Extension Study|Unsatisfactory therapeutic effect|0
4933853|NCT00414609|16981263|P1|Extension Study|Unsatisfactory therapeutic effect|0
4933854|NCT00414609|16981261|P3|Extension Study|Adverse Event|14
4933855|NCT00414609|16981262|P2|Extension Study|Adverse Event|0
4933856|NCT00414609|16981263|P1|Extension Study|Adverse Event|0
4933857|NCT00414609|16981261|P3|Core Study|Death|0
4933858|NCT00414609|16981262|P2|Core Study|Death|14
4933859|NCT00414609|16981263|P1|Core Study|Death|7
4933860|NCT00414609|16981261|P3|Core Study|Administrative problems|0
4933861|NCT00414609|16981262|P2|Core Study|Administrative problems|2
4933862|NCT00414609|16981263|P1|Core Study|Administrative problems|0
4933863|NCT00414609|16981261|P3|Core Study|Lost to Follow-up|0
4933864|NCT00414609|16981262|P2|Core Study|Lost to Follow-up|4
4933865|NCT00414609|16981263|P1|Core Study|Lost to Follow-up|7
4933866|NCT00414609|16981261|P3|Core Study|Patient withdrew consent|0
4933867|NCT00414609|16981262|P2|Core Study|Patient withdrew consent|11
4933868|NCT00414609|16981263|P1|Core Study|Patient withdrew consent|10
4933869|NCT00414609|16981261|P3|Core Study|Protocol deviation|0
4933870|NCT00414609|16981262|P2|Core Study|Protocol deviation|1
4933871|NCT00414609|16981263|P1|Core Study|Protocol deviation|0
4933872|NCT00414609|16981261|P3|Core Study|Abnormal test procedure results|0
4933873|NCT00414609|16981262|P2|Core Study|Abnormal test procedure results|1
4933874|NCT00414609|16981263|P1|Core Study|Abnormal test procedure results|1
4933875|NCT00414609|16981261|P3|Core Study|Abnormal laboratory values|0
4933876|NCT00414609|16981262|P2|Core Study|Abnormal laboratory values|1
4933877|NCT00414609|16981263|P1|Core Study|Abnormal laboratory values|0
4933878|NCT00414609|16981261|P3|Core Study|Adverse Event|0
4933879|NCT00414609|16981262|P2|Core Study|Adverse Event|11
4933880|NCT00414609|16981263|P1|Core Study|Adverse Event|9
4933881|NCT00414596|16981286|P1|Overall Study|Protocol Violation|2
4933882|NCT00414544|16981295|P1|Overall Study|Lost to Follow-up|14
4933883|NCT00414466|16981318|P4|Overall Study|Withdrawn by Sponsor|0
4933884|NCT00414466|16981319|P3|Overall Study|Withdrawn by Sponsor|0
4933885|NCT00414466|16981320|P2|Overall Study|Withdrawn by Sponsor|0
4933886|NCT00414466|16981321|P1|Overall Study|Withdrawn by Sponsor|1
4933887|NCT00414466|16981318|P4|Overall Study|Lack of Efficacy|0
4933888|NCT00414466|16981319|P3|Overall Study|Lack of Efficacy|0
4933889|NCT00414466|16981320|P2|Overall Study|Lack of Efficacy|0
4933890|NCT00414466|16981321|P1|Overall Study|Lack of Efficacy|1
4933891|NCT00414466|16981318|P4|Overall Study|Adverse Event|1
4933892|NCT00414466|16981319|P3|Overall Study|Adverse Event|1
4933893|NCT00414466|16981320|P2|Overall Study|Adverse Event|0
4933894|NCT00414466|16981321|P1|Overall Study|Adverse Event|0
4933895|NCT00414453|16981339|P1|Overall Study|Abnormal lab work|16
4933896|NCT00414440|16981387|P2|Extension Period|Not included in follow up period|8
4933897|NCT00414440|16981388|P1|Extension Period|Not included in follow up period|18
4933898|NCT00414440|16981387|P2|Extension Period|Withdrawal by Subject|7
4933899|NCT00414440|16981388|P1|Extension Period|Withdrawal by Subject|9
4933900|NCT00414440|16981387|P2|Extension Period|Death|2
4933901|NCT00414440|16981388|P1|Extension Period|Death|1
4933902|NCT00414440|16981387|P2|Extension Period|Administrative|16
4933903|NCT00414440|16981388|P1|Extension Period|Administrative|16
4933904|NCT00414440|16981387|P2|Extension Period|Other|1
4933905|NCT00414440|16981388|P1|Extension Period|Other|1
4933906|NCT00414440|16981387|P2|Extension Period|Did not consent to continue follow up|54
4933907|NCT00414440|16981388|P1|Extension Period|Did not consent to continue follow up|61
4933908|NCT00414440|16981387|P2|Extension Period|Lost to Follow-up|52
4933909|NCT00414440|16981388|P1|Extension Period|Lost to Follow-up|44
4933910|NCT00414440|16981387|P2|Core Period|Withdrawal by Subject|32
4933911|NCT00414440|16981388|P1|Core Period|Withdrawal by Subject|70
4933912|NCT00414388|16981402|P1|Overall Study|Adverse Event|1
4933913|NCT00414310|16981410|P2|Overall Study|Not treated|0
4933914|NCT00414310|16981411|P1|Overall Study|Not treated|1
4933915|NCT00414076|16981455|P2|Overall Study|Adverse Event|0
4933916|NCT00414076|16981456|P1|Overall Study|Adverse Event|1
4933917|NCT00414076|16981455|P2|Overall Study|Withdrawal by Subject|3
4933918|NCT00414076|16981456|P1|Overall Study|Withdrawal by Subject|1
4933919|NCT00414076|16981455|P2|Overall Study|Progression|2
4933920|NCT00414076|16981456|P1|Overall Study|Progression|1
4933921|NCT00414050|16981466|P4|Overall Study|Subject Moved|1
4933922|NCT00414050|16981467|P3|Overall Study|Subject Moved|0
4933923|NCT00414050|16981468|P2|Overall Study|Subject Moved|0
4933924|NCT00414050|16981469|P1|Overall Study|Subject Moved|0
4933925|NCT00414050|16981466|P4|Overall Study|Subject discontinued for other reason|1
4933926|NCT00414050|16981467|P3|Overall Study|Subject discontinued for other reason|2
4933927|NCT00414050|16981468|P2|Overall Study|Subject discontinued for other reason|2
4933928|NCT00414050|16981469|P1|Overall Study|Subject discontinued for other reason|1
4933929|NCT00414050|16981466|P4|Overall Study|Withdrawal by Subject|4
4933930|NCT00414050|16981467|P3|Overall Study|Withdrawal by Subject|2
4933931|NCT00414050|16981468|P2|Overall Study|Withdrawal by Subject|3
4933932|NCT00414050|16981469|P1|Overall Study|Withdrawal by Subject|5
4933933|NCT00414050|16981466|P4|Overall Study|Lost to Follow-up|1
4933934|NCT00414050|16981467|P3|Overall Study|Lost to Follow-up|1
4933935|NCT00414050|16981468|P2|Overall Study|Lost to Follow-up|2
4933936|NCT00414050|16981469|P1|Overall Study|Lost to Follow-up|2
4933937|NCT00414050|16981466|P4|Overall Study|Adverse Event|1
4933938|NCT00414050|16981467|P3|Overall Study|Adverse Event|1
4933939|NCT00414050|16981468|P2|Overall Study|Adverse Event|1
4933940|NCT00414050|16981469|P1|Overall Study|Adverse Event|1
4933941|NCT00414011|16981483|P1|Overall Study|Withdrawal by Subject|2
4933942|NCT00414011|16981483|P1|Overall Study|Physician Decision|3
4933943|NCT00413972|16981492|P4|Overall Study|Other|1
4933944|NCT00413972|16981493|P3|Overall Study|Other|0
4933945|NCT00413972|16981494|P2|Overall Study|Other|0
4933946|NCT00413972|16981495|P1|Overall Study|Other|0
4933947|NCT00413972|16981492|P4|Overall Study|Protocol Violation|0
4933948|NCT00413972|16981493|P3|Overall Study|Protocol Violation|2
4933949|NCT00413972|16981494|P2|Overall Study|Protocol Violation|0
4933950|NCT00413972|16981495|P1|Overall Study|Protocol Violation|0
4933951|NCT00413972|16981492|P4|Overall Study|Withdrawal by Subject|2
4933952|NCT00413972|16981493|P3|Overall Study|Withdrawal by Subject|7
4933953|NCT00413972|16981494|P2|Overall Study|Withdrawal by Subject|5
4933954|NCT00413972|16981495|P1|Overall Study|Withdrawal by Subject|4
4933955|NCT00413972|16981492|P4|Overall Study|Lost to Follow-up|0
4933956|NCT00413972|16981493|P3|Overall Study|Lost to Follow-up|1
4933957|NCT00413972|16981494|P2|Overall Study|Lost to Follow-up|2
4933958|NCT00413972|16981495|P1|Overall Study|Lost to Follow-up|1
4933959|NCT00413972|16981492|P4|Overall Study|Adverse Event|0
4933960|NCT00413972|16981493|P3|Overall Study|Adverse Event|0
4933961|NCT00413972|16981494|P2|Overall Study|Adverse Event|1
4933962|NCT00413972|16981495|P1|Overall Study|Adverse Event|2
4933963|NCT00413959|16981505|P1|Overall Study|Pt had only one cycle.|1
4933964|NCT00413920|16981512|P2|Overall Study|Graft Loss|3
4933965|NCT00413920|16981513|P1|Overall Study|Graft Loss|5
4933966|NCT00413920|16981512|P2|Overall Study|Death|5
4933967|NCT00413920|16981513|P1|Overall Study|Death|3
4933968|NCT00413920|16981512|P2|Overall Study|Lack of Efficacy|9
4933969|NCT00413920|16981513|P1|Overall Study|Lack of Efficacy|11
4933970|NCT00413920|16981512|P2|Overall Study|Adverse Event|11
4933971|NCT00413920|16981513|P1|Overall Study|Adverse Event|9
4933972|NCT00413894|16981528|P1|Overall Study|Other|18
4933973|NCT00413894|16981528|P1|Overall Study|Protocol Violation|11
4933974|NCT00413894|16981528|P1|Overall Study|Adverse Event|28
4933975|NCT00413894|16981528|P1|Overall Study|Hb <10 grams/deciliter|12
4933976|NCT00413894|16981528|P1|Overall Study|Administrative Reasons|1
4933977|NCT00413894|16981528|P1|Overall Study|Withdrawal by Subject|10
4933978|NCT00413777|16981545|P2|Fixed-dose Period|Withdrew Consent|1
4933979|NCT00413777|16981546|P1|Fixed-dose Period|Withdrew Consent|0
4933980|NCT00413777|16981545|P2|Fixed-dose Period|Met Withdrawal Criteria|0
4933981|NCT00413777|16981546|P1|Fixed-dose Period|Met Withdrawal Criteria|1
4933982|NCT00413777|16981545|P2|Fixed-dose Period|Adverse Event|1
4933983|NCT00413777|16981546|P1|Fixed-dose Period|Adverse Event|2
4933984|NCT00413777|16981545|P2|Fixed-dose Period|Lost to Follow-up|1
4933985|NCT00413777|16981546|P1|Fixed-dose Period|Lost to Follow-up|1
4933986|NCT00413699|16981594|P3|Extension Period|Adverse Event|2
4933987|NCT00413699|16981595|P2|Extension Period|Adverse Event|0
4933988|NCT00413699|16981596|P1|Extension Period|Adverse Event|0
4933989|NCT00413699|16981594|P3|Extension Period|Protocol Violation|1
4933990|NCT00413699|16981595|P2|Extension Period|Protocol Violation|0
4933991|NCT00413699|16981596|P1|Extension Period|Protocol Violation|0
4933992|NCT00413699|16981594|P3|Extension Period|No Longer Willing to Participate|2
4933993|NCT00413699|16981595|P2|Extension Period|No Longer Willing to Participate|0
4933994|NCT00413699|16981596|P1|Extension Period|No Longer Willing to Participate|0
4933995|NCT00413699|16981594|P3|Initial Period|No longer willing to participate|0
4933996|NCT00413699|16981595|P2|Initial Period|No longer willing to participate|368
4933997|NCT00413699|16981596|P1|Initial Period|No longer willing to participate|116
4933998|NCT00413699|16981594|P3|Initial Period|Missing end of study page|0
4933999|NCT00413699|16981595|P2|Initial Period|Missing end of study page|4
4934000|NCT00413699|16981596|P1|Initial Period|Missing end of study page|0
4934001|NCT00413699|16981594|P3|Initial Period|Adverse event not related to study drug|0
4934002|NCT00413699|16981595|P2|Initial Period|Adverse event not related to study drug|248
4934003|NCT00413699|16981596|P1|Initial Period|Adverse event not related to study drug|113
4934004|NCT00413699|16981594|P3|Initial Period|Adverse event related to study drug|0
4934005|NCT00413699|16981595|P2|Initial Period|Adverse event related to study drug|527
4934006|NCT00413699|16981596|P1|Initial Period|Adverse event related to study drug|178
4934007|NCT00413699|16981594|P3|Initial Period|Other|0
4934008|NCT00413699|16981595|P2|Initial Period|Other|211
4934009|NCT00413699|16981596|P1|Initial Period|Other|67
4934010|NCT00413699|16981594|P3|Initial Period|Study terminated by Sponsor|0
4934011|NCT00413699|16981595|P2|Initial Period|Study terminated by Sponsor|1
4934012|NCT00413699|16981596|P1|Initial Period|Study terminated by Sponsor|0
4934013|NCT00413699|16981594|P3|Initial Period|Medication error without adverse event|0
4934014|NCT00413699|16981595|P2|Initial Period|Medication error without adverse event|1
4934015|NCT00413699|16981596|P1|Initial Period|Medication error without adverse event|0
4934016|NCT00413699|16981594|P3|Initial Period|Did not meet entrance criteria|0
4934017|NCT00413699|16981595|P2|Initial Period|Did not meet entrance criteria|2
4934018|NCT00413699|16981596|P1|Initial Period|Did not meet entrance criteria|2
4934019|NCT00413699|16981594|P3|Initial Period|Pregnancy|0
4934020|NCT00413699|16981595|P2|Initial Period|Pregnancy|8
4934021|NCT00413699|16981596|P1|Initial Period|Pregnancy|10
4934022|NCT00413699|16981594|P3|Initial Period|Protocol Violation|0
4934023|NCT00413699|16981595|P2|Initial Period|Protocol Violation|89
4934024|NCT00413699|16981596|P1|Initial Period|Protocol Violation|38
4934025|NCT00413699|16981594|P3|Initial Period|Lost to Follow-up|0
4934026|NCT00413699|16981595|P2|Initial Period|Lost to Follow-up|101
4934027|NCT00413699|16981596|P1|Initial Period|Lost to Follow-up|31
4934028|NCT00413699|16981594|P3|Initial Period|Lack of Efficacy|0
4934029|NCT00413699|16981595|P2|Initial Period|Lack of Efficacy|115
4934030|NCT00413699|16981596|P1|Initial Period|Lack of Efficacy|59
4934031|NCT00413699|16981594|P3|Initial Period|Death|0
4934032|NCT00413699|16981595|P2|Initial Period|Death|30
4934033|NCT00413699|16981596|P1|Initial Period|Death|25
4934034|NCT00413660|16981678|P11|Post Week 12|Other|0
4934035|NCT00413660|16981679|P10|Post Week 12|Other|0
4934036|NCT00413660|16981680|P9|Post Week 12|Other|0
4934037|NCT00413660|16981681|P8|Post Week 12|Other|0
4934038|NCT00413660|16981682|P7|Post Week 12|Other|1
4934039|NCT00413660|16981683|P6|Post Week 12|Other|1
4934040|NCT00413660|16981684|P5|Post Week 12|Other|1
4934041|NCT00413660|16981685|P4|Post Week 12|Other|0
4934042|NCT00413660|16981686|P3|Post Week 12|Other|3
4934043|NCT00413660|16981687|P2|Post Week 12|Other|2
4934044|NCT00413660|16981688|P1|Post Week 12|Other|1
4934045|NCT00413660|16981678|P11|Post Week 12|Withdrawal by Subject|1
4934046|NCT00413660|16981679|P10|Post Week 12|Withdrawal by Subject|0
4934047|NCT00413660|16981680|P9|Post Week 12|Withdrawal by Subject|0
4934048|NCT00413660|16981681|P8|Post Week 12|Withdrawal by Subject|0
4934049|NCT00413660|16981682|P7|Post Week 12|Withdrawal by Subject|0
4934050|NCT00413660|16981683|P6|Post Week 12|Withdrawal by Subject|0
4934051|NCT00413660|16981684|P5|Post Week 12|Withdrawal by Subject|1
4934052|NCT00413660|16981685|P4|Post Week 12|Withdrawal by Subject|0
4934053|NCT00413660|16981686|P3|Post Week 12|Withdrawal by Subject|1
4934054|NCT00413660|16981687|P2|Post Week 12|Withdrawal by Subject|1
4934055|NCT00413660|16981688|P1|Post Week 12|Withdrawal by Subject|0
4934056|NCT00413660|16981678|P11|Post Week 12|Lost to Follow-up|0
4934057|NCT00413660|16981679|P10|Post Week 12|Lost to Follow-up|0
4934058|NCT00413660|16981680|P9|Post Week 12|Lost to Follow-up|0
4934059|NCT00413660|16981681|P8|Post Week 12|Lost to Follow-up|0
4934060|NCT00413660|16981682|P7|Post Week 12|Lost to Follow-up|0
4934061|NCT00413660|16981683|P6|Post Week 12|Lost to Follow-up|0
4934062|NCT00413660|16981684|P5|Post Week 12|Lost to Follow-up|0
4934063|NCT00413660|16981685|P4|Post Week 12|Lost to Follow-up|0
4934064|NCT00413660|16981686|P3|Post Week 12|Lost to Follow-up|1
4934065|NCT00413660|16981687|P2|Post Week 12|Lost to Follow-up|1
4934066|NCT00413660|16981688|P1|Post Week 12|Lost to Follow-up|0
4934067|NCT00413660|16981678|P11|Post Week 12|Lack of Efficacy|0
4934068|NCT00413660|16981679|P10|Post Week 12|Lack of Efficacy|1
4934069|NCT00413660|16981680|P9|Post Week 12|Lack of Efficacy|0
4934070|NCT00413660|16981681|P8|Post Week 12|Lack of Efficacy|0
4934071|NCT00413660|16981682|P7|Post Week 12|Lack of Efficacy|0
4934072|NCT00413660|16981683|P6|Post Week 12|Lack of Efficacy|0
4934073|NCT00413660|16981684|P5|Post Week 12|Lack of Efficacy|0
4934074|NCT00413660|16981685|P4|Post Week 12|Lack of Efficacy|0
4934075|NCT00413660|16981686|P3|Post Week 12|Lack of Efficacy|1
4934076|NCT00413660|16981687|P2|Post Week 12|Lack of Efficacy|0
4934077|NCT00413660|16981688|P1|Post Week 12|Lack of Efficacy|0
4934078|NCT00413660|16981678|P11|Post Week 12|Adverse Event|0
4934079|NCT00413660|16981679|P10|Post Week 12|Adverse Event|0
4934080|NCT00413660|16981680|P9|Post Week 12|Adverse Event|0
4934081|NCT00413660|16981681|P8|Post Week 12|Adverse Event|0
4934082|NCT00413660|16981682|P7|Post Week 12|Adverse Event|2
4934083|NCT00413660|16981683|P6|Post Week 12|Adverse Event|2
4934084|NCT00413660|16981684|P5|Post Week 12|Adverse Event|4
4934085|NCT00413660|16981685|P4|Post Week 12|Adverse Event|1
4934086|NCT00413660|16981686|P3|Post Week 12|Adverse Event|2
4934087|NCT00413660|16981687|P2|Post Week 12|Adverse Event|0
4934088|NCT00413660|16981688|P1|Post Week 12|Adverse Event|2
4934089|NCT00413660|16981678|P11|Up To Week 12|Other|0
4934090|NCT00413660|16981679|P10|Up To Week 12|Other|0
4934091|NCT00413660|16981680|P9|Up To Week 12|Other|0
4934092|NCT00413660|16981681|P8|Up To Week 12|Other|0
4934093|NCT00413660|16981682|P7|Up To Week 12|Other|3
4934094|NCT00413660|16981683|P6|Up To Week 12|Other|4
4934095|NCT00413660|16981684|P5|Up To Week 12|Other|2
4934096|NCT00413660|16981685|P4|Up To Week 12|Other|1
4934097|NCT00413660|16981686|P3|Up To Week 12|Other|6
4934098|NCT00413660|16981687|P2|Up To Week 12|Other|1
4934099|NCT00413660|16981688|P1|Up To Week 12|Other|3
4934100|NCT00413660|16981678|P11|Up To Week 12|Randomized, Not Treated|0
4934101|NCT00413660|16981679|P10|Up To Week 12|Randomized, Not Treated|0
4934102|NCT00413660|16981680|P9|Up To Week 12|Randomized, Not Treated|0
4934103|NCT00413660|16981681|P8|Up To Week 12|Randomized, Not Treated|0
4934104|NCT00413660|16981682|P7|Up To Week 12|Randomized, Not Treated|0
4934105|NCT00413660|16981683|P6|Up To Week 12|Randomized, Not Treated|0
4934106|NCT00413660|16981684|P5|Up To Week 12|Randomized, Not Treated|0
4934107|NCT00413660|16981685|P4|Up To Week 12|Randomized, Not Treated|1
4934108|NCT00413660|16981686|P3|Up To Week 12|Randomized, Not Treated|0
4934109|NCT00413660|16981687|P2|Up To Week 12|Randomized, Not Treated|0
4934110|NCT00413660|16981688|P1|Up To Week 12|Randomized, Not Treated|1
4934111|NCT00413660|16981678|P11|Up To Week 12|Withdrawal by Subject|0
4934112|NCT00413660|16981679|P10|Up To Week 12|Withdrawal by Subject|0
4934113|NCT00413660|16981680|P9|Up To Week 12|Withdrawal by Subject|0
4934114|NCT00413660|16981681|P8|Up To Week 12|Withdrawal by Subject|0
4934115|NCT00413660|16981682|P7|Up To Week 12|Withdrawal by Subject|2
4934116|NCT00413660|16981683|P6|Up To Week 12|Withdrawal by Subject|2
4934117|NCT00413660|16981684|P5|Up To Week 12|Withdrawal by Subject|0
4934118|NCT00413660|16981685|P4|Up To Week 12|Withdrawal by Subject|2
4934119|NCT00413660|16981686|P3|Up To Week 12|Withdrawal by Subject|0
4934120|NCT00413660|16981687|P2|Up To Week 12|Withdrawal by Subject|2
4934121|NCT00413660|16981688|P1|Up To Week 12|Withdrawal by Subject|0
4934122|NCT00413660|16981678|P11|Up To Week 12|Lost to Follow-up|0
4934123|NCT00413660|16981679|P10|Up To Week 12|Lost to Follow-up|0
4934124|NCT00413660|16981680|P9|Up To Week 12|Lost to Follow-up|0
4934125|NCT00413660|16981681|P8|Up To Week 12|Lost to Follow-up|0
4934126|NCT00413660|16981682|P7|Up To Week 12|Lost to Follow-up|0
4934127|NCT00413660|16981683|P6|Up To Week 12|Lost to Follow-up|0
4934128|NCT00413660|16981684|P5|Up To Week 12|Lost to Follow-up|1
4934129|NCT00413660|16981685|P4|Up To Week 12|Lost to Follow-up|0
4934130|NCT00413660|16981686|P3|Up To Week 12|Lost to Follow-up|0
4934131|NCT00413660|16981687|P2|Up To Week 12|Lost to Follow-up|1
4934132|NCT00413660|16981688|P1|Up To Week 12|Lost to Follow-up|0
4934133|NCT00413660|16981678|P11|Up To Week 12|Lack of Efficacy|0
4934134|NCT00413660|16981679|P10|Up To Week 12|Lack of Efficacy|0
4934135|NCT00413660|16981680|P9|Up To Week 12|Lack of Efficacy|0
4934136|NCT00413660|16981681|P8|Up To Week 12|Lack of Efficacy|0
4934137|NCT00413660|16981682|P7|Up To Week 12|Lack of Efficacy|5
4934138|NCT00413660|16981683|P6|Up To Week 12|Lack of Efficacy|0
4934139|NCT00413660|16981684|P5|Up To Week 12|Lack of Efficacy|0
4934140|NCT00413660|16981685|P4|Up To Week 12|Lack of Efficacy|0
4934141|NCT00413660|16981686|P3|Up To Week 12|Lack of Efficacy|0
4934142|NCT00413660|16981687|P2|Up To Week 12|Lack of Efficacy|0
4934143|NCT00413660|16981688|P1|Up To Week 12|Lack of Efficacy|2
4934144|NCT00413660|16981678|P11|Up To Week 12|Adverse Event|0
4934145|NCT00413660|16981679|P10|Up To Week 12|Adverse Event|0
4934146|NCT00413660|16981680|P9|Up To Week 12|Adverse Event|0
4934147|NCT00413660|16981681|P8|Up To Week 12|Adverse Event|0
4934148|NCT00413660|16981682|P7|Up To Week 12|Adverse Event|1
4934149|NCT00413660|16981683|P6|Up To Week 12|Adverse Event|4
4934150|NCT00413660|16981684|P5|Up To Week 12|Adverse Event|6
4934151|NCT00413660|16981685|P4|Up To Week 12|Adverse Event|4
4934152|NCT00413660|16981686|P3|Up To Week 12|Adverse Event|1
4934153|NCT00413660|16981687|P2|Up To Week 12|Adverse Event|3
4934154|NCT00413660|16981688|P1|Up To Week 12|Adverse Event|1
4934155|NCT00413413|16982091|P3|Double-Blind|Lost to Follow-up|2
4934156|NCT00413413|16982092|P2|Double-Blind|Lost to Follow-up|4
4934157|NCT00413413|16982093|P1|Double-Blind|Lost to Follow-up|3
4934158|NCT00413413|16982091|P3|Double-Blind|Subject withdrew consent|9
4934159|NCT00413413|16982092|P2|Double-Blind|Subject withdrew consent|6
4934160|NCT00413413|16982093|P1|Double-Blind|Subject withdrew consent|4
4934161|NCT00413413|16982091|P3|Double-Blind|Protocol deviation|1
4934162|NCT00413413|16982092|P2|Double-Blind|Protocol deviation|2
4934163|NCT00413413|16982093|P1|Double-Blind|Protocol deviation|1
4934164|NCT00413413|16982091|P3|Double-Blind|Unsatisfactory therapeutic effect|1
4934165|NCT00413413|16982092|P2|Double-Blind|Unsatisfactory therapeutic effect|2
4934166|NCT00413413|16982093|P1|Double-Blind|Unsatisfactory therapeutic effect|1
4934167|NCT00413413|16982091|P3|Double-Blind|Adverse Event|5
4934168|NCT00413413|16982092|P2|Double-Blind|Adverse Event|0
4934169|NCT00413413|16982093|P1|Double-Blind|Adverse Event|6
4934170|NCT00413413|16982091|P3|Single-Blind|Lost to Follow-up|0
4934171|NCT00413413|16982092|P2|Single-Blind|Lost to Follow-up|8
4934172|NCT00413413|16982093|P1|Single-Blind|Lost to Follow-up|0
4934173|NCT00413413|16982091|P3|Single-Blind|Withdrawal by Subject|0
4934174|NCT00413413|16982092|P2|Single-Blind|Withdrawal by Subject|27
4934175|NCT00413413|16982093|P1|Single-Blind|Withdrawal by Subject|0
4934176|NCT00413413|16982091|P3|Single-Blind|Protocol Violation|0
4934177|NCT00413413|16982092|P2|Single-Blind|Protocol Violation|16
4934178|NCT00413413|16982093|P1|Single-Blind|Protocol Violation|0
4934179|NCT00413413|16982091|P3|Single-Blind|Subject no longer requires study drug|0
4934180|NCT00413413|16982092|P2|Single-Blind|Subject no longer requires study drug|151
4934181|NCT00413413|16982093|P1|Single-Blind|Subject no longer requires study drug|0
4934182|NCT00413413|16982091|P3|Single-Blind|Lack of Efficacy|0
4934183|NCT00413413|16982092|P2|Single-Blind|Lack of Efficacy|5
4934184|NCT00413413|16982093|P1|Single-Blind|Lack of Efficacy|0
4934185|NCT00413413|16982091|P3|Single-Blind|Adverse Event|0
4934186|NCT00413413|16982092|P2|Single-Blind|Adverse Event|9
4934187|NCT00413413|16982093|P1|Single-Blind|Adverse Event|0
4934188|NCT00413374|16982146|P2|Overall Study|Surgery|0
4934189|NCT00413374|16982147|P1|Overall Study|Surgery|1
4934190|NCT00413374|16982146|P2|Overall Study|Lost to Follow-up|0
4934191|NCT00413374|16982147|P1|Overall Study|Lost to Follow-up|1
4934192|NCT00413374|16982146|P2|Overall Study|Adverse Event|0
4934193|NCT00413374|16982147|P1|Overall Study|Adverse Event|1
4934194|NCT00413374|16982146|P2|Overall Study|Ineligible due to screening criteria.|0
4934195|NCT00413374|16982147|P1|Overall Study|Ineligible due to screening criteria.|3
4934196|NCT00413283|16982178|P4|Overall Study|Other|0
4934197|NCT00413283|16982179|P3|Overall Study|Other|1
4934198|NCT00413283|16982180|P2|Overall Study|Other|0
4934199|NCT00413283|16982181|P1|Overall Study|Other|0
4934200|NCT00413283|16982178|P4|Overall Study|Requirement for alternative therapy|0
4934201|NCT00413283|16982179|P3|Overall Study|Requirement for alternative therapy|0
4934202|NCT00413283|16982180|P2|Overall Study|Requirement for alternative therapy|2
4934203|NCT00413283|16982181|P1|Overall Study|Requirement for alternative therapy|0
4934204|NCT00413283|16982178|P4|Overall Study|Protocol deviation|0
4934205|NCT00413283|16982179|P3|Overall Study|Protocol deviation|0
4934206|NCT00413283|16982180|P2|Overall Study|Protocol deviation|1
4934207|NCT00413283|16982181|P1|Overall Study|Protocol deviation|0
4934208|NCT00413283|16982178|P4|Overall Study|Ineligibility determined|1
4934209|NCT00413283|16982179|P3|Overall Study|Ineligibility determined|0
4934210|NCT00413283|16982180|P2|Overall Study|Ineligibility determined|0
4934211|NCT00413283|16982181|P1|Overall Study|Ineligibility determined|0
4934212|NCT00413283|16982178|P4|Overall Study|Adverse Event|1
4934213|NCT00413283|16982179|P3|Overall Study|Adverse Event|0
4934214|NCT00413283|16982180|P2|Overall Study|Adverse Event|0
4934215|NCT00413283|16982181|P1|Overall Study|Adverse Event|0
4934216|NCT00413283|16982178|P4|Overall Study|Death|1
4934217|NCT00413283|16982179|P3|Overall Study|Death|1
4934218|NCT00413283|16982180|P2|Overall Study|Death|0
4934219|NCT00413283|16982181|P1|Overall Study|Death|0
4934220|NCT00413283|16982178|P4|Overall Study|Withdrawal by Subject|1
4934221|NCT00413283|16982179|P3|Overall Study|Withdrawal by Subject|0
4934222|NCT00413283|16982180|P2|Overall Study|Withdrawal by Subject|0
4934223|NCT00413283|16982181|P1|Overall Study|Withdrawal by Subject|1
4934224|NCT00413244|16982213|P2|Overall Study|Withdrawal by Subject|1
4934225|NCT00413244|16982214|P1|Overall Study|Withdrawal by Subject|10
4934226|NCT00413231|16982242|P1|365-day to 60-month Post Treatment|Exited after surgical conversion|1
4934227|NCT00413231|16982242|P1|365-day to 60-month Post Treatment|Lost to Follow-up|4
4934228|NCT00413231|16982242|P1|365-day to 60-month Post Treatment|Withdrawal by Subject|5
4934229|NCT00413231|16982242|P1|365-day to 60-month Post Treatment|Death|36
4934230|NCT00413231|16982242|P1|30-day to 365-day Post Treatment|Death|13
4934231|NCT00413231|16982242|P1|0 to 30-day Post Treatment|Intend to treat, but not implanted|3
4934232|NCT00413231|16982242|P1|0 to 30-day Post Treatment|Death|5
4934233|NCT00413218|16982274|P2|Overall Study|Withdrawal by Subject|1
4934234|NCT00413218|16982275|P1|Overall Study|Withdrawal by Subject|9
4934235|NCT00413218|16982274|P2|Overall Study|Missing|0
4934236|NCT00413218|16982275|P1|Overall Study|Missing|1
4934237|NCT00413218|16982274|P2|Overall Study|Admin|14
4934238|NCT00413218|16982275|P1|Overall Study|Admin|20
4934239|NCT00413218|16982274|P2|Overall Study|Lost to Follow-up|17
4934240|NCT00413218|16982275|P1|Overall Study|Lost to Follow-up|14
4934241|NCT00413218|16982274|P2|Overall Study|Death|56
4934242|NCT00413218|16982275|P1|Overall Study|Death|57
4934243|NCT00413218|16982274|P2|Overall Study|Randomized but didn't receive study drug|8
4934244|NCT00413218|16982275|P1|Overall Study|Randomized but didn't receive study drug|2
4934245|NCT00413192|16982301|P4|Overall Study|Not treated|1
4934246|NCT00413192|16982302|P3|Overall Study|Not treated|0
4934247|NCT00413192|16982303|P2|Overall Study|Not treated|0
4934248|NCT00413192|16982304|P1|Overall Study|Not treated|0
4934249|NCT00413192|16982301|P4|Overall Study|Other|2
4934250|NCT00413192|16982302|P3|Overall Study|Other|1
4934251|NCT00413192|16982303|P2|Overall Study|Other|1
4934252|NCT00413192|16982304|P1|Overall Study|Other|5
4934253|NCT00413192|16982301|P4|Overall Study|Intercurrent death|0
4934254|NCT00413192|16982302|P3|Overall Study|Intercurrent death|0
4934255|NCT00413192|16982303|P2|Overall Study|Intercurrent death|1
4934256|NCT00413192|16982304|P1|Overall Study|Intercurrent death|0
4934257|NCT00413192|16982301|P4|Overall Study|Intercurrent illness|1
4934258|NCT00413192|16982302|P3|Overall Study|Intercurrent illness|0
4934259|NCT00413192|16982303|P2|Overall Study|Intercurrent illness|0
4934260|NCT00413192|16982304|P1|Overall Study|Intercurrent illness|0
4934261|NCT00413192|16982301|P4|Overall Study|Withdrawal by Subject|1
4934262|NCT00413192|16982302|P3|Overall Study|Withdrawal by Subject|0
4934263|NCT00413192|16982303|P2|Overall Study|Withdrawal by Subject|5
4934264|NCT00413192|16982304|P1|Overall Study|Withdrawal by Subject|3
4934265|NCT00413192|16982301|P4|Overall Study|Toxicity|2
4934266|NCT00413192|16982302|P3|Overall Study|Toxicity|2
4934267|NCT00413192|16982303|P2|Overall Study|Toxicity|2
4934268|NCT00413192|16982304|P1|Overall Study|Toxicity|3
4934269|NCT00413192|16982301|P4|Overall Study|Disease progression|25
4934270|NCT00413192|16982302|P3|Overall Study|Disease progression|16
4934271|NCT00413192|16982303|P2|Overall Study|Disease progression|31
4934272|NCT00413192|16982304|P1|Overall Study|Disease progression|26
4934273|NCT00413153|16982357|P2|Overall Study|Adverse Event|0
4934274|NCT00413153|16982358|P1|Overall Study|Adverse Event|1
4934275|NCT00413153|16982357|P2|Overall Study|Withdrawal by Subject|1
4934276|NCT00413153|16982358|P1|Overall Study|Withdrawal by Subject|1
4934277|NCT00413062|16982382|P2|Overall Study|Other reason|34
4934278|NCT00413062|16982383|P1|Overall Study|Other reason|70
4934279|NCT00413062|16982382|P2|Overall Study|Lost to Follow-up|73
4934280|NCT00413062|16982383|P1|Overall Study|Lost to Follow-up|175
4934281|NCT00413062|16982382|P2|Overall Study|Pregnancy wish|6
4934282|NCT00413062|16982383|P1|Overall Study|Pregnancy wish|17
4934283|NCT00413062|16982382|P2|Overall Study|Pregnancy|5
4934284|NCT00413062|16982383|P1|Overall Study|Pregnancy|15
4934285|NCT00413062|16982382|P2|Overall Study|Withdrawal of informed consent|36
4934286|NCT00413062|16982383|P1|Overall Study|Withdrawal of informed consent|111
4934287|NCT00413062|16982382|P2|Overall Study|Pre-treatment (serious) adverse event|0
4934288|NCT00413062|16982383|P1|Overall Study|Pre-treatment (serious) adverse event|1
4934289|NCT00413062|16982382|P2|Overall Study|Adverse event/serious adverse event|56
4934290|NCT00413062|16982383|P1|Overall Study|Adverse event/serious adverse event|289
4934291|NCT00413049|16982409|P2|Overall Study|Lack of Efficacy|0
4934292|NCT00413049|16982410|P1|Overall Study|Lack of Efficacy|1
4934293|NCT00413049|16982409|P2|Overall Study|Abnormal laboratory value(s)|0
4934294|NCT00413049|16982410|P1|Overall Study|Abnormal laboratory value(s)|1
4934295|NCT00413049|16982409|P2|Overall Study|Subject no longer requires study drug|1
4934296|NCT00413049|16982410|P1|Overall Study|Subject no longer requires study drug|0
4934297|NCT00413049|16982409|P2|Overall Study|Protocol Violation|1
4934298|NCT00413049|16982410|P1|Overall Study|Protocol Violation|3
4934299|NCT00413049|16982409|P2|Overall Study|Lost to Follow-up|3
4934300|NCT00413049|16982410|P1|Overall Study|Lost to Follow-up|2
4934301|NCT00413049|16982409|P2|Overall Study|Withdrawal by Subject|5
4934302|NCT00413049|16982410|P1|Overall Study|Withdrawal by Subject|7
4934303|NCT00413049|16982409|P2|Overall Study|Adverse Event|8
4934304|NCT00413049|16982410|P1|Overall Study|Adverse Event|10
4934305|NCT00413036|16982426|P1|Overall Study|Missing|2
4934306|NCT00413036|16982426|P1|Overall Study|Other|26
4934307|NCT00413036|16982426|P1|Overall Study|Death|9
4934308|NCT00413036|16982426|P1|Overall Study|Withdrawal by Subject|7
4934309|NCT00413036|16982426|P1|Overall Study|Lack of Efficacy|129
4934310|NCT00413036|16982426|P1|Overall Study|Adverse Event|44
4934311|NCT00413010|16982436|P2|Overall Study|Due to termination of the study|52
4934312|NCT00413010|16982437|P1|Overall Study|Due to termination of the study|54
4934313|NCT00413010|16982436|P2|Overall Study|Withdrawal by Subject|2
4934314|NCT00413010|16982437|P1|Overall Study|Withdrawal by Subject|7
4934315|NCT00413010|16982436|P2|Overall Study|Lost to Follow-up|0
4934316|NCT00413010|16982437|P1|Overall Study|Lost to Follow-up|3
4934317|NCT00413010|16982436|P2|Overall Study|Lack of Efficacy|3
4934318|NCT00413010|16982437|P1|Overall Study|Lack of Efficacy|0
4934319|NCT00413010|16982436|P2|Overall Study|Laboratory abnormality|2
4934320|NCT00413010|16982437|P1|Overall Study|Laboratory abnormality|0
4934321|NCT00413010|16982436|P2|Overall Study|Adverse Event|4
4934322|NCT00413010|16982437|P1|Overall Study|Adverse Event|8
4934323|NCT00412984|16982459|P2|Overall Study|Not Reported|12
4934324|NCT00412984|16982460|P1|Overall Study|Not Reported|11
4934325|NCT00412984|16982459|P2|Overall Study|Other Reason|92
4934326|NCT00412984|16982460|P1|Overall Study|Other Reason|80
4934327|NCT00412984|16982459|P2|Overall Study|Physician Refused to Continue Treatment|89
4934328|NCT00412984|16982460|P1|Overall Study|Physician Refused to Continue Treatment|81
4934329|NCT00412984|16982459|P2|Overall Study|Administrative Reason by Sponsor|8
4934330|NCT00412984|16982460|P1|Overall Study|Administrative Reason by Sponsor|11
4934331|NCT00412984|16982459|P2|Overall Study|Subject No Longer Meets Study Criteria|100
4934332|NCT00412984|16982460|P1|Overall Study|Subject No Longer Meets Study Criteria|87
4934333|NCT00412984|16982459|P2|Overall Study|Pregnancy|0
4934334|NCT00412984|16982460|P1|Overall Study|Pregnancy|1
4934335|NCT00412984|16982459|P2|Overall Study|Poor/Noncompliance|77
4934336|NCT00412984|16982460|P1|Overall Study|Poor/Noncompliance|57
4934337|NCT00412984|16982459|P2|Overall Study|Lost to Follow-up|39
4934338|NCT00412984|16982460|P1|Overall Study|Lost to Follow-up|51
4934339|NCT00412984|16982459|P2|Overall Study|Withdrawal by Subject|989
4934340|NCT00412984|16982460|P1|Overall Study|Withdrawal by Subject|921
4934341|NCT00412984|16982459|P2|Overall Study|Adverse Event|738
4934342|NCT00412984|16982460|P1|Overall Study|Adverse Event|679
4934343|NCT00412984|16982459|P2|Overall Study|Death|349
4934344|NCT00412984|16982460|P1|Overall Study|Death|331
4934345|NCT00412971|16982504|P2|Overall Study|Protocol Violation|1
4934346|NCT00412971|16982505|P1|Overall Study|Protocol Violation|13
4934347|NCT00412971|16982504|P2|Overall Study|Lost to Follow-up|9
4934348|NCT00412971|16982505|P1|Overall Study|Lost to Follow-up|17
4934349|NCT00412958|16982518|P4|Overall Study|Transport issue|0
4934350|NCT00412958|16982519|P3|Overall Study|Transport issue|0
4934351|NCT00412958|16982520|P2|Overall Study|Transport issue|1
4934352|NCT00412958|16982521|P1|Overall Study|Transport issue|0
4934353|NCT00412958|16982518|P4|Overall Study|Death|0
4934354|NCT00412958|16982519|P3|Overall Study|Death|0
4934355|NCT00412958|16982520|P2|Overall Study|Death|1
4934356|NCT00412958|16982521|P1|Overall Study|Death|0
4934357|NCT00412958|16982518|P4|Overall Study|Lost to Follow-up|0
4934358|NCT00412958|16982519|P3|Overall Study|Lost to Follow-up|0
4934359|NCT00412958|16982520|P2|Overall Study|Lost to Follow-up|1
4934360|NCT00412958|16982521|P1|Overall Study|Lost to Follow-up|0
4934361|NCT00412958|16982518|P4|Overall Study|Adverse Event|0
4934362|NCT00412958|16982519|P3|Overall Study|Adverse Event|0
4934363|NCT00412958|16982520|P2|Overall Study|Adverse Event|1
4934364|NCT00412958|16982521|P1|Overall Study|Adverse Event|0
4934365|NCT00412958|16982518|P4|Overall Study|Withdrawal by Subject|1
4934366|NCT00412958|16982519|P3|Overall Study|Withdrawal by Subject|0
4934367|NCT00412958|16982520|P2|Overall Study|Withdrawal by Subject|0
4934368|NCT00412958|16982521|P1|Overall Study|Withdrawal by Subject|3
4934369|NCT00412932|16982531|P1|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1
4934370|NCT00412932|16982531|P1|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1
4934371|NCT00412932|16982531|P1|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3
4934372|NCT00412932|16982531|P1|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3
4934373|NCT00412932|16982531|P1|Olmesartan 40 mg|Withdrawal by Subject|1
4934374|NCT00412932|16982531|P1|Olmesartan 40 mg|Lack of Efficacy|3
4934375|NCT00412932|16982531|P1|Olmesartan 40 mg|Adverse Event|4
4934376|NCT00412932|16982531|P1|Olmesartan (Olm) 20 mg|Other|1
4934377|NCT00412932|16982531|P1|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2
4934378|NCT00412932|16982531|P1|Olmesartan (Olm) 20 mg|Protocol Violation|1
4934379|NCT00412932|16982531|P1|Olmesartan (Olm) 20 mg|Lack of Efficacy|2
4934380|NCT00412932|16982531|P1|Olmesartan (Olm) 20 mg|Adverse Event|1
4934381|NCT00412893|16982542|P2|Overall Study|Randomized but Never Received Study Drug|6
4934382|NCT00412893|16982543|P1|Overall Study|Randomized but Never Received Study Drug|5
4934383|NCT00412893|16982542|P2|Overall Study|Administrative Reason|15
4934384|NCT00412893|16982543|P1|Overall Study|Administrative Reason|12
4934385|NCT00412893|16982542|P2|Overall Study|Did Not Cooperate|9
4934386|NCT00412893|16982543|P1|Overall Study|Did Not Cooperate|12
4934387|NCT00412893|16982542|P2|Overall Study|Other Protocol Violation|6
4934388|NCT00412893|16982543|P1|Overall Study|Other Protocol Violation|10
4934389|NCT00412893|16982542|P2|Overall Study|Violation of Selection at Entry|10
4934390|NCT00412893|16982543|P1|Overall Study|Violation of Selection at Entry|17
4934391|NCT00412893|16982542|P2|Overall Study|Lost to Follow-up|1
4934392|NCT00412893|16982543|P1|Overall Study|Lost to Follow-up|2
4934393|NCT00412893|16982542|P2|Overall Study|Insufficient Therapeutic Response|23
4934394|NCT00412893|16982543|P1|Overall Study|Insufficient Therapeutic Response|39
4934395|NCT00412893|16982542|P2|Overall Study|Death|21
4934396|NCT00412893|16982543|P1|Overall Study|Death|17
4934397|NCT00412893|16982542|P2|Overall Study|Adverse Event|53
4934398|NCT00412893|16982543|P1|Overall Study|Adverse Event|31
4934399|NCT00412854|16982581|P2|Overall Study|Withdrawn for other reasons|11
4934400|NCT00412854|16982582|P1|Overall Study|Withdrawn for other reasons|13
4934401|NCT00412854|16982581|P2|Overall Study|Withdrawn due to adverse events|5
4934402|NCT00412854|16982582|P1|Overall Study|Withdrawn due to adverse events|1
4934403|NCT00412750|16982626|P3|Overall Study|Lack of Efficacy|3
4934404|NCT00412750|16982627|P2|Overall Study|Lack of Efficacy|0
4934405|NCT00412750|16982628|P1|Overall Study|Lack of Efficacy|0
4934406|NCT00412750|16982626|P3|Overall Study|Withdrawal by Subject|2
4934407|NCT00412750|16982627|P2|Overall Study|Withdrawal by Subject|1
4934408|NCT00412750|16982628|P1|Overall Study|Withdrawal by Subject|0
4934409|NCT00412750|16982626|P3|Overall Study|Lost to Follow-up|1
4934410|NCT00412750|16982627|P2|Overall Study|Lost to Follow-up|0
4934411|NCT00412750|16982628|P1|Overall Study|Lost to Follow-up|1
4934412|NCT00412750|16982626|P3|Overall Study|Adverse Event|3
4934413|NCT00412750|16982627|P2|Overall Study|Adverse Event|3
4934414|NCT00412750|16982628|P1|Overall Study|Adverse Event|8
4934415|NCT00412750|16982626|P3|Overall Study|Administrative problems|14
4934416|NCT00412750|16982627|P2|Overall Study|Administrative problems|17
4934417|NCT00412750|16982628|P1|Overall Study|Administrative problems|21
4934418|NCT00412750|16982626|P3|Overall Study|Abnormal laboratory value(s)|0
4934419|NCT00412750|16982627|P2|Overall Study|Abnormal laboratory value(s)|0
4934420|NCT00412750|16982628|P1|Overall Study|Abnormal laboratory value(s)|1
4934421|NCT00412737|16982653|P2|Overall Study|Failure to Return|2
4934422|NCT00412737|16982654|P1|Overall Study|Failure to Return|6
4934423|NCT00412737|16982653|P2|Overall Study|Refused Treatment|2
4934424|NCT00412737|16982654|P1|Overall Study|Refused Treatment|6
4934425|NCT00412737|16982653|P2|Overall Study|Adverse Event|2
4934426|NCT00412737|16982654|P1|Overall Study|Adverse Event|3
4934427|NCT00412737|16982653|P2|Overall Study|Death|0
4934428|NCT00412737|16982654|P1|Overall Study|Death|1
4934429|NCT00412607|16982672|P1|Overall Study|Not meet inclusion/exclusion Criteria|15
4934430|NCT00412607|16982672|P1|Overall Study|Death|61
4934431|NCT00412607|16982672|P1|Overall Study|Lost to Follow-up|19
4934432|NCT00412607|16982672|P1|Overall Study|Withdrawal by Subject|9
4934433|NCT00412542|16982685|P2|Overall Study|Not Eligible|1
4934434|NCT00412542|16982686|P1|Overall Study|Not Eligible|0
4934435|NCT00412542|16982685|P2|Overall Study|Withdrawal by Subject|2
4934436|NCT00412542|16982686|P1|Overall Study|Withdrawal by Subject|0
4934437|NCT00412373|16982771|P2|Overall Study|Other|2
4934438|NCT00412373|16982772|P1|Overall Study|Other|2
4934439|NCT00412373|16982771|P2|Overall Study|Withdrawal by Subject|27
4934440|NCT00412373|16982772|P1|Overall Study|Withdrawal by Subject|8
4934441|NCT00412373|16982771|P2|Overall Study|Lost to Follow-up|13
4934442|NCT00412373|16982772|P1|Overall Study|Lost to Follow-up|7
4934443|NCT00412373|16982771|P2|Overall Study|Lack of Efficacy|22
4934444|NCT00412373|16982772|P1|Overall Study|Lack of Efficacy|16
4934445|NCT00412373|16982771|P2|Overall Study|Adverse Event|13
4934446|NCT00412373|16982772|P1|Overall Study|Adverse Event|8
4934447|NCT00412360|16982814|P2|Overall Study|Not Transplanted|2
4934448|NCT00412360|16982815|P1|Overall Study|Not Transplanted|1
4934449|NCT00412360|16982814|P2|Overall Study|Lost to Follow-up|1
4934450|NCT00412360|16982815|P1|Overall Study|Lost to Follow-up|0
4934451|NCT00412217|16982845|P2|Overall Study|Other|1
4934452|NCT00412217|16982846|P1|Overall Study|Other|1
4934453|NCT00412217|16982845|P2|Overall Study|Study Terminated by Sponsor|33
4934454|NCT00412217|16982846|P1|Overall Study|Study Terminated by Sponsor|26
4934455|NCT00412217|16982845|P2|Overall Study|Lost to Follow-up|4
4934456|NCT00412217|16982846|P1|Overall Study|Lost to Follow-up|1
4934457|NCT00412217|16982845|P2|Overall Study|Withdrawal by Subject|0
4934458|NCT00412217|16982846|P1|Overall Study|Withdrawal by Subject|2
4934459|NCT00412217|16982845|P2|Overall Study|Investigator Decision|0
4934460|NCT00412217|16982846|P1|Overall Study|Investigator Decision|1
4934461|NCT00412217|16982845|P2|Overall Study|Disease Progression|3
4934462|NCT00412217|16982846|P1|Overall Study|Disease Progression|2
4934463|NCT00412217|16982845|P2|Overall Study|Death|4
4934464|NCT00412217|16982846|P1|Overall Study|Death|5
4934465|NCT00412217|16982845|P2|Overall Study|Insufficient Data Available|3
4934466|NCT00412217|16982846|P1|Overall Study|Insufficient Data Available|8
4934467|NCT00412113|16982860|P2|Overall Study|did not receive treatment|0
4934468|NCT00412113|16982861|P1|Overall Study|did not receive treatment|1
4934469|NCT00412113|16982860|P2|Overall Study|Adverse Event|15
4934470|NCT00412113|16982861|P1|Overall Study|Adverse Event|11
4934471|NCT00412061|16982945|P2|Open Label Phase|New Cancer Therapy|1
4934472|NCT00412061|16982946|P1|Open Label Phase|New Cancer Therapy|0
4934473|NCT00412061|16982945|P2|Open Label Phase|Lost to Follow-up|2
4934474|NCT00412061|16982946|P1|Open Label Phase|Lost to Follow-up|0
4934475|NCT00412061|16982945|P2|Open Label Phase|Death|7
4934476|NCT00412061|16982946|P1|Open Label Phase|Death|0
4934477|NCT00412061|16982945|P2|Open Label Phase|Administrative Problems|13
4934478|NCT00412061|16982946|P1|Open Label Phase|Administrative Problems|0
4934479|NCT00412061|16982945|P2|Open Label Phase|Withdrawal by Subject|15
4934480|NCT00412061|16982946|P1|Open Label Phase|Withdrawal by Subject|0
4934481|NCT00412061|16982945|P2|Open Label Phase|Adverse Event|46
4934482|NCT00412061|16982946|P1|Open Label Phase|Adverse Event|0
4934483|NCT00412061|16982945|P2|Open Label Phase|Disease Progression|86
4934484|NCT00412061|16982946|P1|Open Label Phase|Disease Progression|0
4934485|NCT00412061|16982945|P2|Double Blind Phase|Lost to Follow-up|1
4934486|NCT00412061|16982946|P1|Double Blind Phase|Lost to Follow-up|0
4934487|NCT00412061|16982945|P2|Double Blind Phase|New Cander Therapy|1
4934488|NCT00412061|16982946|P1|Double Blind Phase|New Cander Therapy|1
4934489|NCT00412061|16982945|P2|Double Blind Phase|Protocol Violation|4
4934490|NCT00412061|16982946|P1|Double Blind Phase|Protocol Violation|3
4934491|NCT00412061|16982945|P2|Double Blind Phase|Death|3
4934492|NCT00412061|16982946|P1|Double Blind Phase|Death|6
4934493|NCT00412061|16982945|P2|Double Blind Phase|Withdrawal by Subject|20
4934494|NCT00412061|16982946|P1|Double Blind Phase|Withdrawal by Subject|18
4934495|NCT00412061|16982945|P2|Double Blind Phase|Final Primary Analysis|14
4934496|NCT00412061|16982946|P1|Double Blind Phase|Final Primary Analysis|26
4934497|NCT00412061|16982945|P2|Double Blind Phase|Adverse Event|16
4934498|NCT00412061|16982946|P1|Double Blind Phase|Adverse Event|61
4934499|NCT00412061|16982945|P2|Double Blind Phase|Disease Progression|154
4934500|NCT00412061|16982946|P1|Double Blind Phase|Disease Progression|101
4934501|NCT00411788|16982964|P1|Overall Study|Adverse Event|1
4934502|NCT00411788|16982964|P1|Overall Study|Protocol Violation|1
4934503|NCT00411762|16982973|P1|Overall Study|Withdrawal by Subject|5
4934504|NCT00411671|16982997|P1|Overall Study|Lost to Follow-up|3
4934505|NCT00411671|16982997|P1|Overall Study|Death|2
4934506|NCT00411671|16982997|P1|Overall Study|Adverse Event|15
4934507|NCT00411645|16983005|P2|Overall Study|Lost to Follow-up|0
4934508|NCT00411645|16983006|P1|Overall Study|Lost to Follow-up|2
4934509|NCT00411645|16983005|P2|Overall Study|Investigator/Sponsor Decision|7
4934510|NCT00411645|16983006|P1|Overall Study|Investigator/Sponsor Decision|10
4934511|NCT00411645|16983005|P2|Overall Study|Death|135
4934512|NCT00411645|16983006|P1|Overall Study|Death|56
4934513|NCT00411645|16983005|P2|Overall Study|Consent Withdrawn|22
4934514|NCT00411645|16983006|P1|Overall Study|Consent Withdrawn|13
4934515|NCT00411632|16983030|P1|Overall Study|Death|1
4934516|NCT00411554|16983041|P2|Overall Study|Patient Moved|0
4934517|NCT00411554|16983042|P1|Overall Study|Patient Moved|1
4934518|NCT00411554|16983041|P2|Overall Study|Withdrawal by Subject|0
4934519|NCT00411554|16983042|P1|Overall Study|Withdrawal by Subject|3
4934520|NCT00411554|16983041|P2|Overall Study|Lack of Efficacy|5
4934521|NCT00411554|16983042|P1|Overall Study|Lack of Efficacy|2
4934522|NCT00411554|16983041|P2|Overall Study|Adverse Event|4
4934523|NCT00411554|16983042|P1|Overall Study|Adverse Event|2
4934524|NCT00411450|16983068|P1|Overall Study|Ongoing at time of data cut-off.|3
4934525|NCT00411216|16983111|P2|Overall Study|Ten participants were entered into the c|2
4934526|NCT00411216|16983112|P1|Overall Study|Ten participants were entered into the c|0
4934527|NCT00411151|16983118|P1|Overall Study|Trial prematurely closed|4
4934528|NCT00411151|16983118|P1|Overall Study|Protocol Violation|1
4934529|NCT00411151|16983118|P1|Overall Study|Lost to Follow-up|2
4934530|NCT00411151|16983118|P1|Overall Study|Withdrawal by Subject|2
4934531|NCT00411151|16983118|P1|Overall Study|Death|38
4934532|NCT00410813|16983162|P2|Overall Study|Death|2
4934533|NCT00410813|16983163|P1|Overall Study|Death|0
4934534|NCT00410813|16983162|P2|Overall Study|Ineligible|4
4934535|NCT00410813|16983163|P1|Overall Study|Ineligible|2
4934536|NCT00410813|16983162|P2|Overall Study|Not protocol specified|4
4934537|NCT00410813|16983163|P1|Overall Study|Not protocol specified|3
4934538|NCT00410813|16983162|P2|Overall Study|Progression|21
4934539|NCT00410813|16983163|P1|Overall Study|Progression|32
4934540|NCT00410813|16983162|P2|Overall Study|Adverse Event|11
4934541|NCT00410813|16983163|P1|Overall Study|Adverse Event|6
4934542|NCT00410761|16983200|P2|Overall Study|Never received randomised treatment|1
4934543|NCT00410761|16983201|P1|Overall Study|Never received randomised treatment|0
4934544|NCT00410761|16983200|P2|Overall Study|Other|9
4934545|NCT00410761|16983201|P1|Overall Study|Other|12
4934546|NCT00410761|16983200|P2|Overall Study|Withdrawal by Subject|4
4934547|NCT00410761|16983201|P1|Overall Study|Withdrawal by Subject|8
4934548|NCT00410761|16983200|P2|Overall Study|objective disease progression|55
4934549|NCT00410761|16983201|P1|Overall Study|objective disease progression|71
4934550|NCT00410761|16983200|P2|Overall Study|Adverse Event|3
4934551|NCT00410761|16983201|P1|Overall Study|Adverse Event|29
4934552|NCT00410605|16983221|P1|Overall Study|Transferred to another Institution|1
4934553|NCT00410605|16983221|P1|Overall Study|Stopped treatmen to collect stem cells|1
4934554|NCT00410605|16983221|P1|Overall Study|Started Non-Protocol Therapy|3
4934555|NCT00410605|16983221|P1|Overall Study|Withdrawal by Subject|5
4934556|NCT00410605|16983221|P1|Overall Study|Physician Decision|3
4934557|NCT00410605|16983221|P1|Overall Study|Adverse Event|12
4934558|NCT00410514|16983233|P3|Overall Study|Non-compliant with study procedures|2
4934559|NCT00410514|16983234|P2|Overall Study|Non-compliant with study procedures|0
4934560|NCT00410514|16983235|P1|Overall Study|Non-compliant with study procedures|0
4934561|NCT00410514|16983233|P3|Overall Study|Lost to Follow-up|2
4934562|NCT00410514|16983234|P2|Overall Study|Lost to Follow-up|0
4934563|NCT00410514|16983235|P1|Overall Study|Lost to Follow-up|0
4934564|NCT00410514|16983233|P3|Overall Study|Protocol Violation|1
4934565|NCT00410514|16983234|P2|Overall Study|Protocol Violation|1
4934566|NCT00410514|16983235|P1|Overall Study|Protocol Violation|0
4934567|NCT00410514|16983233|P3|Overall Study|Adverse Event|2
4934568|NCT00410514|16983234|P2|Overall Study|Adverse Event|2
4934569|NCT00410514|16983235|P1|Overall Study|Adverse Event|2
4934570|NCT00410410|16983318|P9|Open-Label Period (OL)|Other|7
4934571|NCT00410410|16983319|P8|Open-Label Period (OL)|Other|0
4934572|NCT00410410|16983320|P7|Open-Label Period (OL)|Other|0
4934573|NCT00410410|16983321|P6|Open-Label Period (OL)|Other|0
4934574|NCT00410410|16983322|P5|Open-Label Period (OL)|Other|0
4934575|NCT00410410|16983323|P4|Open-Label Period (OL)|Other|0
4934576|NCT00410410|16983324|P3|Open-Label Period (OL)|Other|0
4934577|NCT00410410|16983325|P2|Open-Label Period (OL)|Other|0
4934578|NCT00410410|16983326|P1|Open-Label Period (OL)|Other|0
4934579|NCT00410410|16983318|P9|Open-Label Period (OL)|Administrative Reason By Sponsor|145
4934580|NCT00410410|16983319|P8|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934581|NCT00410410|16983320|P7|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934582|NCT00410410|16983321|P6|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934583|NCT00410410|16983322|P5|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934584|NCT00410410|16983323|P4|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934585|NCT00410410|16983324|P3|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934586|NCT00410410|16983325|P2|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934587|NCT00410410|16983326|P1|Open-Label Period (OL)|Administrative Reason By Sponsor|0
4934588|NCT00410410|16983318|P9|Open-Label Period (OL)|Pregnancy|1
4934589|NCT00410410|16983319|P8|Open-Label Period (OL)|Pregnancy|0
4934590|NCT00410410|16983320|P7|Open-Label Period (OL)|Pregnancy|0
4934591|NCT00410410|16983321|P6|Open-Label Period (OL)|Pregnancy|0
4934592|NCT00410410|16983322|P5|Open-Label Period (OL)|Pregnancy|0
4934593|NCT00410410|16983323|P4|Open-Label Period (OL)|Pregnancy|0
4934594|NCT00410410|16983324|P3|Open-Label Period (OL)|Pregnancy|0
4934595|NCT00410410|16983325|P2|Open-Label Period (OL)|Pregnancy|0
4934596|NCT00410410|16983326|P1|Open-Label Period (OL)|Pregnancy|0
4934597|NCT00410410|16983318|P9|Open-Label Period (OL)|Withdrawal by Subject|20
4934598|NCT00410410|16983319|P8|Open-Label Period (OL)|Withdrawal by Subject|0
4934599|NCT00410410|16983320|P7|Open-Label Period (OL)|Withdrawal by Subject|0
4934600|NCT00410410|16983321|P6|Open-Label Period (OL)|Withdrawal by Subject|0
4934601|NCT00410410|16983322|P5|Open-Label Period (OL)|Withdrawal by Subject|0
4934602|NCT00410410|16983323|P4|Open-Label Period (OL)|Withdrawal by Subject|0
4934603|NCT00410410|16983324|P3|Open-Label Period (OL)|Withdrawal by Subject|0
4934604|NCT00410410|16983325|P2|Open-Label Period (OL)|Withdrawal by Subject|0
4934605|NCT00410410|16983326|P1|Open-Label Period (OL)|Withdrawal by Subject|0
4934606|NCT00410410|16983318|P9|Open-Label Period (OL)|Lost to Follow-up|4
4934607|NCT00410410|16983319|P8|Open-Label Period (OL)|Lost to Follow-up|0
4934608|NCT00410410|16983320|P7|Open-Label Period (OL)|Lost to Follow-up|0
4934609|NCT00410410|16983321|P6|Open-Label Period (OL)|Lost to Follow-up|0
4934610|NCT00410410|16983322|P5|Open-Label Period (OL)|Lost to Follow-up|0
4934611|NCT00410410|16983323|P4|Open-Label Period (OL)|Lost to Follow-up|0
4934612|NCT00410410|16983324|P3|Open-Label Period (OL)|Lost to Follow-up|0
4934613|NCT00410410|16983325|P2|Open-Label Period (OL)|Lost to Follow-up|0
4934614|NCT00410410|16983326|P1|Open-Label Period (OL)|Lost to Follow-up|0
4934615|NCT00410410|16983318|P9|Open-Label Period (OL)|Lack of Efficacy|161
4934616|NCT00410410|16983319|P8|Open-Label Period (OL)|Lack of Efficacy|0
4934617|NCT00410410|16983320|P7|Open-Label Period (OL)|Lack of Efficacy|0
4934618|NCT00410410|16983321|P6|Open-Label Period (OL)|Lack of Efficacy|0
4934619|NCT00410410|16983322|P5|Open-Label Period (OL)|Lack of Efficacy|0
4934620|NCT00410410|16983323|P4|Open-Label Period (OL)|Lack of Efficacy|0
4934621|NCT00410410|16983324|P3|Open-Label Period (OL)|Lack of Efficacy|0
4934622|NCT00410410|16983325|P2|Open-Label Period (OL)|Lack of Efficacy|0
4934623|NCT00410410|16983326|P1|Open-Label Period (OL)|Lack of Efficacy|0
4934624|NCT00410410|16983318|P9|Open-Label Period (OL)|Adverse Event|10
4934625|NCT00410410|16983319|P8|Open-Label Period (OL)|Adverse Event|0
4934626|NCT00410410|16983320|P7|Open-Label Period (OL)|Adverse Event|0
4934627|NCT00410410|16983321|P6|Open-Label Period (OL)|Adverse Event|0
4934628|NCT00410410|16983322|P5|Open-Label Period (OL)|Adverse Event|0
4934629|NCT00410410|16983323|P4|Open-Label Period (OL)|Adverse Event|0
4934630|NCT00410410|16983324|P3|Open-Label Period (OL)|Adverse Event|0
4934631|NCT00410410|16983325|P2|Open-Label Period (OL)|Adverse Event|0
4934632|NCT00410410|16983326|P1|Open-Label Period (OL)|Adverse Event|0
4934633|NCT00410410|16983318|P9|Open-Label Period (OL)|Death|1
4934634|NCT00410410|16983319|P8|Open-Label Period (OL)|Death|0
4934635|NCT00410410|16983320|P7|Open-Label Period (OL)|Death|0
4934636|NCT00410410|16983321|P6|Open-Label Period (OL)|Death|0
4934637|NCT00410410|16983322|P5|Open-Label Period (OL)|Death|0
4934638|NCT00410410|16983323|P4|Open-Label Period (OL)|Death|0
4934639|NCT00410410|16983324|P3|Open-Label Period (OL)|Death|0
4934640|NCT00410410|16983325|P2|Open-Label Period (OL)|Death|0
4934641|NCT00410410|16983326|P1|Open-Label Period (OL)|Death|0
4934642|NCT00410410|16983318|P9|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934643|NCT00410410|16983319|P8|Maintenance Period (MP)|Administrative Reason By Sponsor|25
4934644|NCT00410410|16983320|P7|Maintenance Period (MP)|Administrative Reason By Sponsor|21
4934645|NCT00410410|16983321|P6|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934646|NCT00410410|16983322|P5|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934647|NCT00410410|16983323|P4|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934648|NCT00410410|16983324|P3|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934649|NCT00410410|16983325|P2|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934650|NCT00410410|16983326|P1|Maintenance Period (MP)|Administrative Reason By Sponsor|0
4934651|NCT00410410|16983318|P9|Maintenance Period (MP)|Withdrawal by Subject|0
4934652|NCT00410410|16983319|P8|Maintenance Period (MP)|Withdrawal by Subject|1
4934653|NCT00410410|16983320|P7|Maintenance Period (MP)|Withdrawal by Subject|1
4934654|NCT00410410|16983321|P6|Maintenance Period (MP)|Withdrawal by Subject|0
4934655|NCT00410410|16983322|P5|Maintenance Period (MP)|Withdrawal by Subject|0
4934656|NCT00410410|16983323|P4|Maintenance Period (MP)|Withdrawal by Subject|0
4934657|NCT00410410|16983324|P3|Maintenance Period (MP)|Withdrawal by Subject|0
4934658|NCT00410410|16983325|P2|Maintenance Period (MP)|Withdrawal by Subject|0
4934659|NCT00410410|16983326|P1|Maintenance Period (MP)|Withdrawal by Subject|0
4934660|NCT00410410|16983318|P9|Maintenance Period (MP)|Lost to Follow-up|0
4934661|NCT00410410|16983319|P8|Maintenance Period (MP)|Lost to Follow-up|2
4934662|NCT00410410|16983320|P7|Maintenance Period (MP)|Lost to Follow-up|1
4934663|NCT00410410|16983321|P6|Maintenance Period (MP)|Lost to Follow-up|0
4934664|NCT00410410|16983322|P5|Maintenance Period (MP)|Lost to Follow-up|0
4934665|NCT00410410|16983323|P4|Maintenance Period (MP)|Lost to Follow-up|0
4934666|NCT00410410|16983324|P3|Maintenance Period (MP)|Lost to Follow-up|0
4934667|NCT00410410|16983325|P2|Maintenance Period (MP)|Lost to Follow-up|0
4934668|NCT00410410|16983326|P1|Maintenance Period (MP)|Lost to Follow-up|0
4934669|NCT00410410|16983318|P9|Maintenance Period (MP)|Lack of Efficacy|0
4934670|NCT00410410|16983319|P8|Maintenance Period (MP)|Lack of Efficacy|24
4934671|NCT00410410|16983320|P7|Maintenance Period (MP)|Lack of Efficacy|25
4934672|NCT00410410|16983321|P6|Maintenance Period (MP)|Lack of Efficacy|0
4934673|NCT00410410|16983322|P5|Maintenance Period (MP)|Lack of Efficacy|0
4934674|NCT00410410|16983323|P4|Maintenance Period (MP)|Lack of Efficacy|0
4934675|NCT00410410|16983324|P3|Maintenance Period (MP)|Lack of Efficacy|0
4934676|NCT00410410|16983325|P2|Maintenance Period (MP)|Lack of Efficacy|0
4934677|NCT00410410|16983326|P1|Maintenance Period (MP)|Lack of Efficacy|0
4934678|NCT00410410|16983318|P9|Maintenance Period (MP)|Adverse Event|0
4934679|NCT00410410|16983319|P8|Maintenance Period (MP)|Adverse Event|3
4934680|NCT00410410|16983320|P7|Maintenance Period (MP)|Adverse Event|1
4934681|NCT00410410|16983321|P6|Maintenance Period (MP)|Adverse Event|0
4934682|NCT00410410|16983322|P5|Maintenance Period (MP)|Adverse Event|0
4934683|NCT00410410|16983323|P4|Maintenance Period (MP)|Adverse Event|0
4934684|NCT00410410|16983324|P3|Maintenance Period (MP)|Adverse Event|0
4934685|NCT00410410|16983325|P2|Maintenance Period (MP)|Adverse Event|0
4934686|NCT00410410|16983326|P1|Maintenance Period (MP)|Adverse Event|0
4934687|NCT00410410|16983318|P9|Maintenance Period (MP)|Death|0
4934688|NCT00410410|16983319|P8|Maintenance Period (MP)|Death|0
4934689|NCT00410410|16983320|P7|Maintenance Period (MP)|Death|1
4934690|NCT00410410|16983321|P6|Maintenance Period (MP)|Death|0
4934691|NCT00410410|16983322|P5|Maintenance Period (MP)|Death|0
4934692|NCT00410410|16983323|P4|Maintenance Period (MP)|Death|0
4934693|NCT00410410|16983324|P3|Maintenance Period (MP)|Death|0
4934694|NCT00410410|16983325|P2|Maintenance Period (MP)|Death|0
4934695|NCT00410410|16983326|P1|Maintenance Period (MP)|Death|0
4934696|NCT00410410|16983318|P9|Induction Period (IP)|Other|0
4934697|NCT00410410|16983319|P8|Induction Period (IP)|Other|0
4934698|NCT00410410|16983320|P7|Induction Period (IP)|Other|0
4934699|NCT00410410|16983321|P6|Induction Period (IP)|Other|0
4934700|NCT00410410|16983322|P5|Induction Period (IP)|Other|0
4934701|NCT00410410|16983323|P4|Induction Period (IP)|Other|0
4934702|NCT00410410|16983324|P3|Induction Period (IP)|Other|1
4934703|NCT00410410|16983325|P2|Induction Period (IP)|Other|0
4934704|NCT00410410|16983326|P1|Induction Period (IP)|Other|0
4934705|NCT00410410|16983318|P9|Induction Period (IP)|Administrative Reason By Sponsor|0
4934706|NCT00410410|16983319|P8|Induction Period (IP)|Administrative Reason By Sponsor|0
4934707|NCT00410410|16983320|P7|Induction Period (IP)|Administrative Reason By Sponsor|0
4934708|NCT00410410|16983321|P6|Induction Period (IP)|Administrative Reason By Sponsor|21
4934709|NCT00410410|16983322|P5|Induction Period (IP)|Administrative Reason By Sponsor|22
4934710|NCT00410410|16983323|P4|Induction Period (IP)|Administrative Reason By Sponsor|0
4934711|NCT00410410|16983324|P3|Induction Period (IP)|Administrative Reason By Sponsor|0
4934712|NCT00410410|16983325|P2|Induction Period (IP)|Administrative Reason By Sponsor|0
4934713|NCT00410410|16983326|P1|Induction Period (IP)|Administrative Reason By Sponsor|0
4934714|NCT00410410|16983318|P9|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934715|NCT00410410|16983319|P8|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934716|NCT00410410|16983320|P7|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934717|NCT00410410|16983321|P6|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934718|NCT00410410|16983322|P5|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934719|NCT00410410|16983323|P4|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934720|NCT00410410|16983324|P3|Induction Period (IP)|Subject No Longer Meets Study Criteria|1
4934721|NCT00410410|16983325|P2|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934722|NCT00410410|16983326|P1|Induction Period (IP)|Subject No Longer Meets Study Criteria|0
4934723|NCT00410410|16983318|P9|Induction Period (IP)|Withdrawal by Subject|0
4934724|NCT00410410|16983319|P8|Induction Period (IP)|Withdrawal by Subject|0
4934725|NCT00410410|16983320|P7|Induction Period (IP)|Withdrawal by Subject|0
4934726|NCT00410410|16983321|P6|Induction Period (IP)|Withdrawal by Subject|0
4934727|NCT00410410|16983322|P5|Induction Period (IP)|Withdrawal by Subject|2
4934728|NCT00410410|16983323|P4|Induction Period (IP)|Withdrawal by Subject|5
4934729|NCT00410410|16983324|P3|Induction Period (IP)|Withdrawal by Subject|3
4934730|NCT00410410|16983325|P2|Induction Period (IP)|Withdrawal by Subject|5
4934731|NCT00410410|16983326|P1|Induction Period (IP)|Withdrawal by Subject|3
4934732|NCT00410410|16983318|P9|Induction Period (IP)|Lost to Follow-up|0
4934733|NCT00410410|16983319|P8|Induction Period (IP)|Lost to Follow-up|0
4934734|NCT00410410|16983320|P7|Induction Period (IP)|Lost to Follow-up|0
4934735|NCT00410410|16983321|P6|Induction Period (IP)|Lost to Follow-up|1
4934736|NCT00410410|16983322|P5|Induction Period (IP)|Lost to Follow-up|0
4934737|NCT00410410|16983323|P4|Induction Period (IP)|Lost to Follow-up|3
4934738|NCT00410410|16983324|P3|Induction Period (IP)|Lost to Follow-up|2
4934739|NCT00410410|16983325|P2|Induction Period (IP)|Lost to Follow-up|2
4934740|NCT00410410|16983326|P1|Induction Period (IP)|Lost to Follow-up|2
4934741|NCT00410410|16983318|P9|Induction Period (IP)|Lack of Efficacy|0
4934742|NCT00410410|16983319|P8|Induction Period (IP)|Lack of Efficacy|0
4934743|NCT00410410|16983320|P7|Induction Period (IP)|Lack of Efficacy|0
4934744|NCT00410410|16983321|P6|Induction Period (IP)|Lack of Efficacy|7
4934745|NCT00410410|16983322|P5|Induction Period (IP)|Lack of Efficacy|7
4934746|NCT00410410|16983323|P4|Induction Period (IP)|Lack of Efficacy|8
4934747|NCT00410410|16983324|P3|Induction Period (IP)|Lack of Efficacy|8
4934748|NCT00410410|16983325|P2|Induction Period (IP)|Lack of Efficacy|24
4934749|NCT00410410|16983326|P1|Induction Period (IP)|Lack of Efficacy|26
4934750|NCT00410410|16983318|P9|Induction Period (IP)|Adverse Event|0
4934751|NCT00410410|16983319|P8|Induction Period (IP)|Adverse Event|0
4934752|NCT00410410|16983320|P7|Induction Period (IP)|Adverse Event|0
4934753|NCT00410410|16983321|P6|Induction Period (IP)|Adverse Event|0
4934754|NCT00410410|16983322|P5|Induction Period (IP)|Adverse Event|1
4934755|NCT00410410|16983323|P4|Induction Period (IP)|Adverse Event|4
4934756|NCT00410410|16983324|P3|Induction Period (IP)|Adverse Event|2
4934757|NCT00410410|16983325|P2|Induction Period (IP)|Adverse Event|4
4934758|NCT00410410|16983326|P1|Induction Period (IP)|Adverse Event|3
4934759|NCT00410410|16983318|P9|Induction Period (IP)|Death|0
4934760|NCT00410410|16983319|P8|Induction Period (IP)|Death|0
4934761|NCT00410410|16983320|P7|Induction Period (IP)|Death|0
4934762|NCT00410410|16983321|P6|Induction Period (IP)|Death|0
4934763|NCT00410410|16983322|P5|Induction Period (IP)|Death|0
4934764|NCT00410410|16983323|P4|Induction Period (IP)|Death|0
4934765|NCT00410410|16983324|P3|Induction Period (IP)|Death|0
4934766|NCT00410410|16983325|P2|Induction Period (IP)|Death|0
4934767|NCT00410410|16983326|P1|Induction Period (IP)|Death|1
4934768|NCT00410384|16983487|P3|Overall Study|Other|4
4934769|NCT00410384|16983488|P2|Overall Study|Other|8
4934770|NCT00410384|16983489|P1|Overall Study|Other|3
4934771|NCT00410384|16983487|P3|Overall Study|Physician Decision|4
4934772|NCT00410384|16983488|P2|Overall Study|Physician Decision|3
4934773|NCT00410384|16983489|P1|Overall Study|Physician Decision|3
4934774|NCT00410384|16983487|P3|Overall Study|Protocol Violation|6
4934775|NCT00410384|16983488|P2|Overall Study|Protocol Violation|6
4934776|NCT00410384|16983489|P1|Overall Study|Protocol Violation|6
4934777|NCT00410384|16983487|P3|Overall Study|Lost to Follow-up|6
4934778|NCT00410384|16983488|P2|Overall Study|Lost to Follow-up|6
4934779|NCT00410384|16983489|P1|Overall Study|Lost to Follow-up|4
4934780|NCT00410384|16983487|P3|Overall Study|Lack of Compliance|2
4934781|NCT00410384|16983488|P2|Overall Study|Lack of Compliance|2
4934782|NCT00410384|16983489|P1|Overall Study|Lack of Compliance|2
4934783|NCT00410384|16983487|P3|Overall Study|Lack of Efficacy|17
4934784|NCT00410384|16983488|P2|Overall Study|Lack of Efficacy|12
4934785|NCT00410384|16983489|P1|Overall Study|Lack of Efficacy|20
4934786|NCT00410384|16983487|P3|Overall Study|Adverse Event|23
4934787|NCT00410384|16983488|P2|Overall Study|Adverse Event|18
4934788|NCT00410384|16983489|P1|Overall Study|Adverse Event|23
4934789|NCT00410384|16983487|P3|Overall Study|Withdrawal by Subject|20
4934790|NCT00410384|16983488|P2|Overall Study|Withdrawal by Subject|17
4934791|NCT00410384|16983489|P1|Overall Study|Withdrawal by Subject|28
4934792|NCT00410202|16983562|P3|Off-treatment Follow up|Lost to Follow-up|0
4934793|NCT00410202|16983563|P2|Off-treatment Follow up|Lost to Follow-up|0
4934794|NCT00410202|16983564|P1|Off-treatment Follow up|Lost to Follow-up|1
4934795|NCT00410202|16983562|P3|Off-treatment Follow up|Follow up not required per protocol|1
4934796|NCT00410202|16983563|P2|Off-treatment Follow up|Follow up not required per protocol|0
4934797|NCT00410202|16983564|P1|Off-treatment Follow up|Follow up not required per protocol|3
4934798|NCT00410202|16983562|P3|Off-treatment Follow up|Continuing off-treatment follow up|11
4934799|NCT00410202|16983563|P2|Off-treatment Follow up|Continuing off-treatment follow up|8
4934800|NCT00410202|16983564|P1|Off-treatment Follow up|Continuing off-treatment follow up|10
4934801|NCT00410202|16983562|P3|On-Treatment|Other Reason|1
4934802|NCT00410202|16983563|P2|On-Treatment|Other Reason|0
4934803|NCT00410202|16983564|P1|On-Treatment|Other Reason|0
4934804|NCT00410202|16983562|P3|On-Treatment|Withdrawal by Subject|1
4934805|NCT00410202|16983563|P2|On-Treatment|Withdrawal by Subject|1
4934806|NCT00410202|16983564|P1|On-Treatment|Withdrawal by Subject|2
4934807|NCT00410202|16983562|P3|On-Treatment|Lack of Efficacy|0
4934808|NCT00410202|16983563|P2|On-Treatment|Lack of Efficacy|4
4934809|NCT00410202|16983564|P1|On-Treatment|Lack of Efficacy|1
4934810|NCT00410202|16983562|P3|On-Treatment|Lost to Follow-up|1
4934811|NCT00410202|16983563|P2|On-Treatment|Lost to Follow-up|0
4934812|NCT00410202|16983564|P1|On-Treatment|Lost to Follow-up|1
4934813|NCT00410202|16983562|P3|On-Treatment|Death|0
4934814|NCT00410202|16983563|P2|On-Treatment|Death|0
4934815|NCT00410202|16983564|P1|On-Treatment|Death|1
4934816|NCT00410202|16983562|P3|On-Treatment|Adverse Event|2
4934817|NCT00410202|16983563|P2|On-Treatment|Adverse Event|3
4934818|NCT00410202|16983564|P1|On-Treatment|Adverse Event|1
4934819|NCT00410202|16983562|P3|On-Treatment|Continuing treatment|66
4934820|NCT00410202|16983563|P2|On-Treatment|Continuing treatment|71
4934821|NCT00410202|16983564|P1|On-Treatment|Continuing treatment|69
4934822|NCT00410163|16983651|P2|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0
4934823|NCT00410163|16983652|P1|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1
4934824|NCT00410163|16983651|P2|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8
4934825|NCT00410163|16983652|P1|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4
4934826|NCT00410163|16983651|P2|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0
4934827|NCT00410163|16983652|P1|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1
4934828|NCT00410163|16983651|P2|Extended Follow-up (FU) Phase (2-5 Years|Death|1
4934829|NCT00410163|16983652|P1|Extended Follow-up (FU) Phase (2-5 Years|Death|1
4934830|NCT00410163|16983651|P2|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1
4934831|NCT00410163|16983652|P1|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3
4934832|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1
4934833|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0
4934834|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0
4934835|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1
4934836|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
4934837|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1
4934838|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0
4934839|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1
4934840|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1
4934841|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2
4934842|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4
4934843|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0
4934844|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1
4934845|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2
4934846|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Death|1
4934847|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Death|1
4934848|NCT00410163|16983651|P2|Treatment and Follow-up Phase (2 Years)|Adverse Event|2
4934849|NCT00410163|16983652|P1|Treatment and Follow-up Phase (2 Years)|Adverse Event|4
4934850|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1
4934851|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0
4934852|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0
4934853|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1
4934854|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Disease Progression|78
4934855|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Disease Progression|56
4934856|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Death|10
4934857|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Death|2
4934858|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
4934859|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1
4934860|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1
4934861|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0
4934862|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1
4934863|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0
4934864|NCT00410124|16983705|P2|Extension Phase - Open Label (45 Months)|Adverse Event|19
4934865|NCT00410124|16983706|P1|Extension Phase - Open Label (45 Months)|Adverse Event|7
4934866|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Disease Progression|124
4934867|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Disease Progression|137
4934868|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Death|4
4934869|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Death|7
4934870|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Administrative Problems|0
4934871|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Administrative Problems|2
4934872|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Lost to Follow-up|0
4934873|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Lost to Follow-up|4
4934874|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2
4934875|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13
4934876|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Protocol Violation|1
4934877|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Protocol Violation|2
4934878|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0
4934879|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1
4934880|NCT00410124|16983705|P2|Core Phase Double Blind (15 Months)|Adverse Event|2
4934881|NCT00410124|16983706|P1|Core Phase Double Blind (15 Months)|Adverse Event|36
4934882|NCT00410072|16983737|P2|After Week 48 to Week 96|Withdrawal by Subject|1
4934883|NCT00410072|16983738|P1|After Week 48 to Week 96|Withdrawal by Subject|0
4934884|NCT00410072|16983737|P2|After Week 48 to Week 96|Pregnancy|2
4934885|NCT00410072|16983738|P1|After Week 48 to Week 96|Pregnancy|0
4934886|NCT00410072|16983737|P2|After Week 48 to Week 96|Poor compliance/noncompliance|1
4934887|NCT00410072|16983738|P1|After Week 48 to Week 96|Poor compliance/noncompliance|0
4934888|NCT00410072|16983737|P2|After Week 48 to Week 96|Other|0
4934889|NCT00410072|16983738|P1|After Week 48 to Week 96|Other|2
4934890|NCT00410072|16983737|P2|After Week 48 to Week 96|Lost to Follow-up|4
4934891|NCT00410072|16983738|P1|After Week 48 to Week 96|Lost to Follow-up|2
4934892|NCT00410072|16983737|P2|After Week 48 to Week 96|Lack of Efficacy|0
4934893|NCT00410072|16983738|P1|After Week 48 to Week 96|Lack of Efficacy|1
4934894|NCT00410072|16983737|P2|After Week 48 to Week 96|Death|1
4934895|NCT00410072|16983738|P1|After Week 48 to Week 96|Death|0
4934896|NCT00410072|16983737|P2|After Week 48 to Week 96|Adverse Event|2
4934897|NCT00410072|16983738|P1|After Week 48 to Week 96|Adverse Event|1
4934898|NCT00410072|16983737|P2|Day 1 to Week 48|Withdrawal by Subject|2
4934899|NCT00410072|16983738|P1|Day 1 to Week 48|Withdrawal by Subject|0
4934900|NCT00410072|16983737|P2|Day 1 to Week 48|Pregnancy|2
4934901|NCT00410072|16983738|P1|Day 1 to Week 48|Pregnancy|0
4934902|NCT00410072|16983737|P2|Day 1 to Week 48|poor compliance/noncompliance|3
4934903|NCT00410072|16983738|P1|Day 1 to Week 48|poor compliance/noncompliance|0
4934904|NCT00410072|16983737|P2|Day 1 to Week 48|Other|1
4934905|NCT00410072|16983738|P1|Day 1 to Week 48|Other|0
4934906|NCT00410072|16983737|P2|Day 1 to Week 48|Lost to Follow-up|2
4934907|NCT00410072|16983738|P1|Day 1 to Week 48|Lost to Follow-up|5
4934908|NCT00410072|16983737|P2|Day 1 to Week 48|Adverse Event|2
4934909|NCT00410072|16983738|P1|Day 1 to Week 48|Adverse Event|1
4934910|NCT00410046|16983778|P1|Overall Study|Lost to Follow-up|1
4934911|NCT00410046|16983778|P1|Overall Study|Withdrawal by Subject|1
4934912|NCT00410046|16983778|P1|Overall Study|Adverse Event|3
4934913|NCT00409838|16983809|P2|Long-term Extension Period|Pregnancy|0
4934914|NCT00409838|16983810|P1|Long-term Extension Period|Pregnancy|1
4934915|NCT00409838|16983809|P2|Long-term Extension Period|Poor compliance/noncompliance|0
4934916|NCT00409838|16983810|P1|Long-term Extension Period|Poor compliance/noncompliance|1
4934917|NCT00409838|16983809|P2|Long-term Extension Period|Withdrawal by Subject|0
4934918|NCT00409838|16983810|P1|Long-term Extension Period|Withdrawal by Subject|3
4934919|NCT00409838|16983809|P2|Long-term Extension Period|Lack of Efficacy|0
4934920|NCT00409838|16983810|P1|Long-term Extension Period|Lack of Efficacy|2
4934921|NCT00409838|16983809|P2|Long-term Extension Period|Death|0
4934922|NCT00409838|16983810|P1|Long-term Extension Period|Death|1
4934923|NCT00409838|16983809|P2|Long-term Extension Period|Adverse Event|0
4934924|NCT00409838|16983810|P1|Long-term Extension Period|Adverse Event|10
4934925|NCT00409838|16983809|P2|Short-term Period|Never Treated|0
4934926|NCT00409838|16983810|P1|Short-term Period|Never Treated|1
4934927|NCT00409838|16983809|P2|Short-term Period|Withdrawal by Subject|3
4934928|NCT00409838|16983810|P1|Short-term Period|Withdrawal by Subject|2
4934929|NCT00409838|16983809|P2|Short-term Period|Lost to Follow-up|1
4934930|NCT00409838|16983810|P1|Short-term Period|Lost to Follow-up|0
4934931|NCT00409838|16983809|P2|Short-term Period|Adverse Event|1
4934932|NCT00409838|16983810|P1|Short-term Period|Adverse Event|0
4934933|NCT00409786|16983875|P1|Overall Study|Withdrawal by Subject|3
4934934|NCT00409773|16983884|P5|Overall Study|Lack of Eligibility|1
4934935|NCT00409773|16983885|P4|Overall Study|Lack of Eligibility|0
4934936|NCT00409773|16983886|P3|Overall Study|Lack of Eligibility|0
4934937|NCT00409773|16983887|P2|Overall Study|Lack of Eligibility|0
4934938|NCT00409773|16983888|P1|Overall Study|Lack of Eligibility|0
4934939|NCT00409773|16983884|P5|Overall Study|Withdrawal by Subject|1
4934940|NCT00409773|16983885|P4|Overall Study|Withdrawal by Subject|2
4934941|NCT00409773|16983886|P3|Overall Study|Withdrawal by Subject|0
4934942|NCT00409773|16983887|P2|Overall Study|Withdrawal by Subject|0
4934943|NCT00409773|16983888|P1|Overall Study|Withdrawal by Subject|0
4934944|NCT00409773|16983884|P5|Overall Study|Protocol Violation|1
4934945|NCT00409773|16983885|P4|Overall Study|Protocol Violation|3
4934946|NCT00409773|16983886|P3|Overall Study|Protocol Violation|3
4934947|NCT00409773|16983887|P2|Overall Study|Protocol Violation|2
4934948|NCT00409773|16983888|P1|Overall Study|Protocol Violation|0
4934949|NCT00409773|16983884|P5|Overall Study|Physician Decision|0
4934950|NCT00409773|16983885|P4|Overall Study|Physician Decision|2
4934951|NCT00409773|16983886|P3|Overall Study|Physician Decision|0
4934952|NCT00409773|16983887|P2|Overall Study|Physician Decision|0
4934953|NCT00409773|16983888|P1|Overall Study|Physician Decision|0
4934954|NCT00409773|16983884|P5|Overall Study|Lost to Follow-up|1
4934955|NCT00409773|16983885|P4|Overall Study|Lost to Follow-up|3
4934956|NCT00409773|16983886|P3|Overall Study|Lost to Follow-up|2
4934957|NCT00409773|16983887|P2|Overall Study|Lost to Follow-up|1
4934958|NCT00409773|16983888|P1|Overall Study|Lost to Follow-up|6
4934959|NCT00409773|16983884|P5|Overall Study|Adverse Event|6
4934960|NCT00409773|16983885|P4|Overall Study|Adverse Event|2
4934961|NCT00409773|16983886|P3|Overall Study|Adverse Event|4
4934962|NCT00409773|16983887|P2|Overall Study|Adverse Event|4
4934963|NCT00409773|16983888|P1|Overall Study|Adverse Event|3
4934964|NCT00409747|16983970|P1|Overall Study|Withdrawal by Subject|1
4934965|NCT00409708|16983977|P2|Washout|Lost to Follow-up|3
4934966|NCT00409708|16983978|P1|Washout|Lost to Follow-up|1
4934967|NCT00409708|16983977|P2|Washout|Withdrawal by Subject|5
4934968|NCT00409708|16983978|P1|Washout|Withdrawal by Subject|11
4934969|NCT00409708|16983977|P2|Washout|Protocol Violation|1
4934970|NCT00409708|16983978|P1|Washout|Protocol Violation|0
4934971|NCT00409708|16983977|P2|Washout|Lack of Efficacy|1
4934972|NCT00409708|16983978|P1|Washout|Lack of Efficacy|9
4934973|NCT00409708|16983977|P2|Treatment|Administrative problems|0
4934974|NCT00409708|16983978|P1|Treatment|Administrative problems|5
4934975|NCT00409708|16983977|P2|Treatment|Lost to Follow-up|6
4934976|NCT00409708|16983978|P1|Treatment|Lost to Follow-up|0
4934977|NCT00409708|16983977|P2|Treatment|Withdrawal by Subject|8
4934978|NCT00409708|16983978|P1|Treatment|Withdrawal by Subject|3
4934979|NCT00409708|16983977|P2|Treatment|Protocol Violation|2
4934980|NCT00409708|16983978|P1|Treatment|Protocol Violation|6
4934981|NCT00409708|16983977|P2|Treatment|Lack of Efficacy|1
4934982|NCT00409708|16983978|P1|Treatment|Lack of Efficacy|0
4934983|NCT00409708|16983977|P2|Treatment|Abnormal test procedure result(s)|0
4934984|NCT00409708|16983978|P1|Treatment|Abnormal test procedure result(s)|1
4934985|NCT00409682|16983999|P3|EOW Double-blind Maintenance Period|Non-compliance|1
4934986|NCT00409682|16984000|P2|EOW Double-blind Maintenance Period|Non-compliance|0
4934987|NCT00409682|16984001|P1|EOW Double-blind Maintenance Period|Non-compliance|0
4934988|NCT00409682|16983999|P3|EOW Double-blind Maintenance Period|Protocol Violation|1
4934989|NCT00409682|16984000|P2|EOW Double-blind Maintenance Period|Protocol Violation|4
4934990|NCT00409682|16984001|P1|EOW Double-blind Maintenance Period|Protocol Violation|0
4934991|NCT00409682|16983999|P3|EOW Double-blind Maintenance Period|Withdrawal by Subject|2
4934992|NCT00409682|16984000|P2|EOW Double-blind Maintenance Period|Withdrawal by Subject|4
4934993|NCT00409682|16984001|P1|EOW Double-blind Maintenance Period|Withdrawal by Subject|0
4934994|NCT00409682|16983999|P3|EOW Double-blind Maintenance Period|Lost to Follow-up|0
4934995|NCT00409682|16984000|P2|EOW Double-blind Maintenance Period|Lost to Follow-up|1
4934996|NCT00409682|16984001|P1|EOW Double-blind Maintenance Period|Lost to Follow-up|0
4934997|NCT00409682|16983999|P3|EOW Double-blind Maintenance Period|Lack of Efficacy|11
4934998|NCT00409682|16984000|P2|EOW Double-blind Maintenance Period|Lack of Efficacy|18
4934999|NCT00409682|16984001|P1|EOW Double-blind Maintenance Period|Lack of Efficacy|0
4935000|NCT00409682|16983999|P3|EOW Double-blind Maintenance Period|Adverse Event|12
4935001|NCT00409682|16984000|P2|EOW Double-blind Maintenance Period|Adverse Event|10
4935002|NCT00409682|16984001|P1|EOW Double-blind Maintenance Period|Adverse Event|0
4935003|NCT00409682|16983999|P3|Open-label Induction Period|Subject did not satisfy entry criteria|0
4935004|NCT00409682|16984000|P2|Open-label Induction Period|Subject did not satisfy entry criteria|0
4935005|NCT00409682|16984001|P1|Open-label Induction Period|Subject did not satisfy entry criteria|1
4935006|NCT00409682|16983999|P3|Open-label Induction Period|Protocol Violation|0
4935007|NCT00409682|16984000|P2|Open-label Induction Period|Protocol Violation|0
4935008|NCT00409682|16984001|P1|Open-label Induction Period|Protocol Violation|1
4935009|NCT00409682|16983999|P3|Open-label Induction Period|Lack of Efficacy|0
4935010|NCT00409682|16984000|P2|Open-label Induction Period|Lack of Efficacy|0
4935011|NCT00409682|16984001|P1|Open-label Induction Period|Lack of Efficacy|1
4935012|NCT00409682|16983999|P3|Open-label Induction Period|Adverse Event|0
4935013|NCT00409682|16984000|P2|Open-label Induction Period|Adverse Event|0
4935014|NCT00409682|16984001|P1|Open-label Induction Period|Adverse Event|1
4935015|NCT00409617|16984018|P1|Overall Study|Not described|14
4935016|NCT00409617|16984018|P1|Overall Study|Administrative reasons|1
4935017|NCT00409617|16984018|P1|Overall Study|Withdrawal by Subject|8
4935018|NCT00409617|16984018|P1|Overall Study|Protocol Violation|24
4935019|NCT00409617|16984018|P1|Overall Study|Lost to Follow-up|2
4935020|NCT00409617|16984018|P1|Overall Study|Lack of Efficacy|54
4935021|NCT00409617|16984018|P1|Overall Study|Adverse Event|57
4935022|NCT00409578|16984034|P4|Overall Study|Missing|1
4935023|NCT00409578|16984035|P3|Overall Study|Missing|0
4935024|NCT00409578|16984036|P2|Overall Study|Missing|1
4935025|NCT00409578|16984037|P1|Overall Study|Missing|0
4935026|NCT00409578|16984034|P4|Overall Study|Protocol Violation|1
4935027|NCT00409578|16984035|P3|Overall Study|Protocol Violation|3
4935028|NCT00409578|16984036|P2|Overall Study|Protocol Violation|2
4935029|NCT00409578|16984037|P1|Overall Study|Protocol Violation|3
4935030|NCT00409578|16984034|P4|Overall Study|Death|2
4935031|NCT00409578|16984035|P3|Overall Study|Death|4
4935032|NCT00409578|16984036|P2|Overall Study|Death|4
4935033|NCT00409578|16984037|P1|Overall Study|Death|2
4935034|NCT00409578|16984034|P4|Overall Study|Administrative problems|4
4935035|NCT00409578|16984035|P3|Overall Study|Administrative problems|2
4935036|NCT00409578|16984036|P2|Overall Study|Administrative problems|9
4935037|NCT00409578|16984037|P1|Overall Study|Administrative problems|8
4935038|NCT00409578|16984034|P4|Overall Study|Lost to Follow-up|2
4935039|NCT00409578|16984035|P3|Overall Study|Lost to Follow-up|2
4935040|NCT00409578|16984036|P2|Overall Study|Lost to Follow-up|0
4935041|NCT00409578|16984037|P1|Overall Study|Lost to Follow-up|2
4935042|NCT00409578|16984034|P4|Overall Study|Withdrawal by Subject|17
4935043|NCT00409578|16984035|P3|Overall Study|Withdrawal by Subject|16
4935044|NCT00409578|16984036|P2|Overall Study|Withdrawal by Subject|15
4935045|NCT00409578|16984037|P1|Overall Study|Withdrawal by Subject|8
4935046|NCT00409578|16984034|P4|Overall Study|Subject no longer requires study drug|1
4935047|NCT00409578|16984035|P3|Overall Study|Subject no longer requires study drug|0
4935048|NCT00409578|16984036|P2|Overall Study|Subject no longer requires study drug|0
4935049|NCT00409578|16984037|P1|Overall Study|Subject no longer requires study drug|0
4935050|NCT00409578|16984034|P4|Overall Study|Lack of Efficacy|2
4935051|NCT00409578|16984035|P3|Overall Study|Lack of Efficacy|0
4935052|NCT00409578|16984036|P2|Overall Study|Lack of Efficacy|0
4935053|NCT00409578|16984037|P1|Overall Study|Lack of Efficacy|0
4935054|NCT00409578|16984034|P4|Overall Study|Abnormal laboratory value(s)|4
4935055|NCT00409578|16984035|P3|Overall Study|Abnormal laboratory value(s)|2
4935056|NCT00409578|16984036|P2|Overall Study|Abnormal laboratory value(s)|2
4935057|NCT00409578|16984037|P1|Overall Study|Abnormal laboratory value(s)|2
4935058|NCT00409578|16984034|P4|Overall Study|Adverse Event|33
4935059|NCT00409578|16984035|P3|Overall Study|Adverse Event|25
4935060|NCT00409578|16984036|P2|Overall Study|Adverse Event|37
4935061|NCT00409578|16984037|P1|Overall Study|Adverse Event|27
4935062|NCT00409409|16984095|P2|Overall Study|Any other reason not above-mentioned|1
4935063|NCT00409409|16984096|P1|Overall Study|Any other reason not above-mentioned|0
4935064|NCT00409409|16984095|P2|Overall Study|Withdrawal by Subject|1
4935065|NCT00409409|16984096|P1|Overall Study|Withdrawal by Subject|1
4935066|NCT00409409|16984095|P2|Overall Study|Adverse Event|2
4935067|NCT00409409|16984096|P1|Overall Study|Adverse Event|7
4935068|NCT00409344|16984104|P2|Overall Study|no enrollment|0
4935069|NCT00409344|16984105|P1|Overall Study|no enrollment|0
4935070|NCT00409331|16984123|P1|Overall Study|Physician Decision|1
4935071|NCT00409188|16984145|P2|Overall Study|Ongoing at data cut-off|175
4935072|NCT00409188|16984146|P1|Overall Study|Ongoing at data cut-off|383
4935073|NCT00409175|16984162|P2|Overall Study|Liver transplantation|13
4935074|NCT00409175|16984163|P1|Overall Study|Liver transplantation|13
4935075|NCT00409175|16984162|P2|Overall Study|Negative genotype|1
4935076|NCT00409175|16984163|P1|Overall Study|Negative genotype|0
4935077|NCT00409175|16984162|P2|Overall Study|Withdrawal by Subject|2
4935078|NCT00409175|16984163|P1|Overall Study|Withdrawal by Subject|1
4935079|NCT00409175|16984162|P2|Overall Study|Adverse Event|3
4935080|NCT00409175|16984163|P1|Overall Study|Adverse Event|4
4935081|NCT00409006|16984189|P2|Overall Study|Physician Decision|2
4935082|NCT00409006|16984190|P1|Overall Study|Physician Decision|1
4935083|NCT00409006|16984189|P2|Overall Study|Withdrawal by Subject|2
4935084|NCT00409006|16984190|P1|Overall Study|Withdrawal by Subject|3
4935085|NCT00409006|16984189|P2|Overall Study|Lost to Follow-up|2
4935086|NCT00409006|16984190|P1|Overall Study|Lost to Follow-up|1
4935087|NCT00409006|16984189|P2|Overall Study|Death|6
4935088|NCT00409006|16984190|P1|Overall Study|Death|15
4935089|NCT00408993|16984206|P2|Overall Study|Withdrawal by Subject|3
4935090|NCT00408993|16984207|P1|Overall Study|Withdrawal by Subject|2
4935091|NCT00408993|16984206|P2|Overall Study|Lack of Efficacy|4
4935092|NCT00408993|16984207|P1|Overall Study|Lack of Efficacy|1
4935093|NCT00408993|16984206|P2|Overall Study|Protocol Violation|6
4935094|NCT00408993|16984207|P1|Overall Study|Protocol Violation|1
4935095|NCT00408993|16984206|P2|Overall Study|Adverse Event|4
4935096|NCT00408993|16984207|P1|Overall Study|Adverse Event|15
4935097|NCT00408928|16984239|P1|Overall Study|Infection indistinguishable from GVHD|1
4935098|NCT00408928|16984239|P1|Overall Study|Death|1
4935099|NCT00408928|16984239|P1|Overall Study|Withdrawal by Subject|1
4935100|NCT00408902|16984244|P1|Overall Study|Adverse Event|3
4935101|NCT00408902|16984244|P1|Overall Study|Lack of Efficacy|7
4935102|NCT00408876|16984254|P4|Overall Study|Physician Decision|0
4935103|NCT00408876|16984255|P3|Overall Study|Physician Decision|3
4935104|NCT00408876|16984256|P2|Overall Study|Physician Decision|0
4935105|NCT00408876|16984257|P1|Overall Study|Physician Decision|1
4935106|NCT00408876|16984254|P4|Overall Study|Protocol Violation|3
4935107|NCT00408876|16984255|P3|Overall Study|Protocol Violation|4
4935108|NCT00408876|16984256|P2|Overall Study|Protocol Violation|3
4935109|NCT00408876|16984257|P1|Overall Study|Protocol Violation|0
4935110|NCT00408876|16984254|P4|Overall Study|Lost to Follow-up|2
4935111|NCT00408876|16984255|P3|Overall Study|Lost to Follow-up|5
4935112|NCT00408876|16984256|P2|Overall Study|Lost to Follow-up|6
4935113|NCT00408876|16984257|P1|Overall Study|Lost to Follow-up|1
4935114|NCT00408876|16984254|P4|Overall Study|Lack of Efficacy|6
4935115|NCT00408876|16984255|P3|Overall Study|Lack of Efficacy|5
4935116|NCT00408876|16984256|P2|Overall Study|Lack of Efficacy|4
4935117|NCT00408876|16984257|P1|Overall Study|Lack of Efficacy|2
4935118|NCT00408876|16984254|P4|Overall Study|Withdrawal by Subject|14
4935119|NCT00408876|16984255|P3|Overall Study|Withdrawal by Subject|6
4935120|NCT00408876|16984256|P2|Overall Study|Withdrawal by Subject|6
4935121|NCT00408876|16984257|P1|Overall Study|Withdrawal by Subject|3
4935122|NCT00408876|16984254|P4|Overall Study|Adverse Event|10
4935123|NCT00408876|16984255|P3|Overall Study|Adverse Event|27
4935124|NCT00408876|16984256|P2|Overall Study|Adverse Event|17
4935125|NCT00408876|16984257|P1|Overall Study|Adverse Event|9
4935126|NCT00408694|16984507|P1|Overall Study|No protocol treatment|1
4935127|NCT00408694|16984507|P1|Overall Study|Ineligible|1
4935128|NCT00408681|16984519|P1|Overall Study|Adverse Event|7
4935129|NCT00408681|16984519|P1|Overall Study|Lack of Efficacy|2
4935130|NCT00408629|16984538|P2|Overall Study|Miscellaneous|15
4935131|NCT00408629|16984539|P1|Overall Study|Miscellaneous|11
4935132|NCT00408629|16984538|P2|Overall Study|Protocol Violation|5
4935133|NCT00408629|16984539|P1|Overall Study|Protocol Violation|1
4935134|NCT00408629|16984538|P2|Overall Study|Lack of Efficacy|73
4935135|NCT00408629|16984539|P1|Overall Study|Lack of Efficacy|63
4935136|NCT00408629|16984538|P2|Overall Study|Lost to Follow-up|1
4935137|NCT00408629|16984539|P1|Overall Study|Lost to Follow-up|1
4935138|NCT00408629|16984538|P2|Overall Study|Withdrawal by Subject|4
4935139|NCT00408629|16984539|P1|Overall Study|Withdrawal by Subject|8
4935140|NCT00408629|16984538|P2|Overall Study|Adverse Event|27
4935141|NCT00408629|16984539|P1|Overall Study|Adverse Event|13
4935142|NCT00408499|16984635|P5|Phase II- MTD Expansion|treatment delay|3
4935143|NCT00408499|16984636|P4|Phase II- MTD Expansion|treatment delay|0
4935144|NCT00408499|16984637|P3|Phase II- MTD Expansion|treatment delay|0
4935145|NCT00408499|16984638|P2|Phase II- MTD Expansion|treatment delay|0
4935146|NCT00408499|16984639|P1|Phase II- MTD Expansion|treatment delay|0
4935147|NCT00408499|16984635|P5|Phase II- MTD Expansion|Withdrawal by Subject|5
4935148|NCT00408499|16984636|P4|Phase II- MTD Expansion|Withdrawal by Subject|0
4935149|NCT00408499|16984637|P3|Phase II- MTD Expansion|Withdrawal by Subject|0
4935150|NCT00408499|16984638|P2|Phase II- MTD Expansion|Withdrawal by Subject|0
4935151|NCT00408499|16984639|P1|Phase II- MTD Expansion|Withdrawal by Subject|0
4935152|NCT00408499|16984635|P5|Phase II- MTD Expansion|Physician Decision|1
4935153|NCT00408499|16984636|P4|Phase II- MTD Expansion|Physician Decision|0
4935154|NCT00408499|16984637|P3|Phase II- MTD Expansion|Physician Decision|0
4935155|NCT00408499|16984638|P2|Phase II- MTD Expansion|Physician Decision|0
4935156|NCT00408499|16984639|P1|Phase II- MTD Expansion|Physician Decision|0
4935157|NCT00408499|16984635|P5|Phase II- MTD Expansion|Death|2
4935158|NCT00408499|16984636|P4|Phase II- MTD Expansion|Death|0
4935159|NCT00408499|16984637|P3|Phase II- MTD Expansion|Death|0
4935160|NCT00408499|16984638|P2|Phase II- MTD Expansion|Death|0
4935161|NCT00408499|16984639|P1|Phase II- MTD Expansion|Death|0
4935162|NCT00408499|16984635|P5|Phase II- MTD Expansion|Adverse Event|9
4935163|NCT00408499|16984636|P4|Phase II- MTD Expansion|Adverse Event|0
4935164|NCT00408499|16984637|P3|Phase II- MTD Expansion|Adverse Event|0
4935165|NCT00408499|16984638|P2|Phase II- MTD Expansion|Adverse Event|0
4935166|NCT00408499|16984639|P1|Phase II- MTD Expansion|Adverse Event|0
4935167|NCT00408499|16984635|P5|Phase 1: Dose Levels 1-4|Physician Decision|0
4935168|NCT00408499|16984636|P4|Phase 1: Dose Levels 1-4|Physician Decision|0
4935169|NCT00408499|16984637|P3|Phase 1: Dose Levels 1-4|Physician Decision|0
4935170|NCT00408499|16984638|P2|Phase 1: Dose Levels 1-4|Physician Decision|1
4935171|NCT00408499|16984639|P1|Phase 1: Dose Levels 1-4|Physician Decision|1
4935172|NCT00408499|16984635|P5|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
4935173|NCT00408499|16984636|P4|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
4935174|NCT00408499|16984637|P3|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0
4935175|NCT00408499|16984638|P2|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
4935176|NCT00408499|16984639|P1|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1
4935177|NCT00408499|16984635|P5|Phase 1: Dose Levels 1-4|Adverse Event|0
4935178|NCT00408499|16984636|P4|Phase 1: Dose Levels 1-4|Adverse Event|0
4935179|NCT00408499|16984637|P3|Phase 1: Dose Levels 1-4|Adverse Event|1
4935180|NCT00408499|16984638|P2|Phase 1: Dose Levels 1-4|Adverse Event|0
4935181|NCT00408499|16984639|P1|Phase 1: Dose Levels 1-4|Adverse Event|0
4935182|NCT00408434|16984661|P7|Overall Study|Terminated by Investigator|0
4935183|NCT00408434|16984662|P6|Overall Study|Terminated by Investigator|1
4935184|NCT00408434|16984663|P5|Overall Study|Terminated by Investigator|1
4935185|NCT00408434|16984664|P4|Overall Study|Terminated by Investigator|0
4935186|NCT00408434|16984665|P3|Overall Study|Terminated by Investigator|0
4935187|NCT00408434|16984666|P2|Overall Study|Terminated by Investigator|0
4935188|NCT00408434|16984667|P1|Overall Study|Terminated by Investigator|0
4935189|NCT00408434|16984661|P7|Overall Study|Other|0
4935190|NCT00408434|16984662|P6|Overall Study|Other|1
4935191|NCT00408434|16984663|P5|Overall Study|Other|2
4935192|NCT00408434|16984664|P4|Overall Study|Other|0
4935193|NCT00408434|16984665|P3|Overall Study|Other|1
4935194|NCT00408434|16984666|P2|Overall Study|Other|0
4935195|NCT00408434|16984667|P1|Overall Study|Other|0
4935196|NCT00408434|16984661|P7|Overall Study|Progressive disease|4
4935197|NCT00408434|16984662|P6|Overall Study|Progressive disease|1
4935198|NCT00408434|16984663|P5|Overall Study|Progressive disease|3
4935199|NCT00408434|16984664|P4|Overall Study|Progressive disease|3
4935200|NCT00408434|16984665|P3|Overall Study|Progressive disease|4
4935201|NCT00408434|16984666|P2|Overall Study|Progressive disease|3
4935202|NCT00408434|16984667|P1|Overall Study|Progressive disease|6
4935203|NCT00408434|16984661|P7|Overall Study|Adverse Event|0
4935204|NCT00408434|16984662|P6|Overall Study|Adverse Event|0
4935205|NCT00408434|16984663|P5|Overall Study|Adverse Event|0
4935206|NCT00408434|16984664|P4|Overall Study|Adverse Event|0
4935207|NCT00408434|16984665|P3|Overall Study|Adverse Event|1
4935208|NCT00408434|16984666|P2|Overall Study|Adverse Event|0
4935209|NCT00408434|16984667|P1|Overall Study|Adverse Event|0
4935210|NCT00408421|16984714|P3|Treatment Re-Randomization|Withdrawal by Subject|0
4935211|NCT00408421|16984715|P2|Treatment Re-Randomization|Withdrawal by Subject|1
4935212|NCT00408421|16984716|P1|Treatment Re-Randomization|Withdrawal by Subject|2
4935213|NCT00408421|16984714|P3|Treatment Re-Randomization|Protocol Violation|0
4935214|NCT00408421|16984715|P2|Treatment Re-Randomization|Protocol Violation|1
4935215|NCT00408421|16984716|P1|Treatment Re-Randomization|Protocol Violation|1
4935216|NCT00408421|16984714|P3|Treatment Re-Randomization|Physician Decision|0
4935217|NCT00408421|16984715|P2|Treatment Re-Randomization|Physician Decision|3
4935218|NCT00408421|16984716|P1|Treatment Re-Randomization|Physician Decision|1
4935219|NCT00408421|16984714|P3|Treatment Re-Randomization|Lost to Follow-up|1
4935220|NCT00408421|16984715|P2|Treatment Re-Randomization|Lost to Follow-up|0
4935221|NCT00408421|16984716|P1|Treatment Re-Randomization|Lost to Follow-up|0
4935222|NCT00408421|16984714|P3|Treatment Re-Randomization|Lack of Efficacy|0
4935223|NCT00408421|16984715|P2|Treatment Re-Randomization|Lack of Efficacy|0
4935224|NCT00408421|16984716|P1|Treatment Re-Randomization|Lack of Efficacy|1
4935225|NCT00408421|16984714|P3|Treatment Re-Randomization|Adverse Event|4
4935226|NCT00408421|16984715|P2|Treatment Re-Randomization|Adverse Event|2
4935227|NCT00408421|16984716|P1|Treatment Re-Randomization|Adverse Event|2
4935228|NCT00408421|16984714|P3|Treatment Initial Randomization|Sponsor Decision|0
4935229|NCT00408421|16984715|P2|Treatment Initial Randomization|Sponsor Decision|0
4935230|NCT00408421|16984716|P1|Treatment Initial Randomization|Sponsor Decision|1
4935231|NCT00408421|16984714|P3|Treatment Initial Randomization|Entry Criteria Not Met|0
4935232|NCT00408421|16984715|P2|Treatment Initial Randomization|Entry Criteria Not Met|0
4935233|NCT00408421|16984716|P1|Treatment Initial Randomization|Entry Criteria Not Met|1
4935234|NCT00408421|16984714|P3|Treatment Initial Randomization|Withdrawal by Subject|0
4935235|NCT00408421|16984715|P2|Treatment Initial Randomization|Withdrawal by Subject|7
4935236|NCT00408421|16984716|P1|Treatment Initial Randomization|Withdrawal by Subject|7
4935237|NCT00408421|16984714|P3|Treatment Initial Randomization|Protocol Violation|0
4935238|NCT00408421|16984715|P2|Treatment Initial Randomization|Protocol Violation|1
4935239|NCT00408421|16984716|P1|Treatment Initial Randomization|Protocol Violation|0
4935240|NCT00408421|16984714|P3|Treatment Initial Randomization|Physician Decision|0
4935241|NCT00408421|16984715|P2|Treatment Initial Randomization|Physician Decision|0
4935242|NCT00408421|16984716|P1|Treatment Initial Randomization|Physician Decision|1
4935243|NCT00408421|16984714|P3|Treatment Initial Randomization|Lost to Follow-up|0
4935244|NCT00408421|16984715|P2|Treatment Initial Randomization|Lost to Follow-up|3
4935245|NCT00408421|16984716|P1|Treatment Initial Randomization|Lost to Follow-up|0
4935246|NCT00408421|16984714|P3|Treatment Initial Randomization|Lack of Efficacy|0
4935247|NCT00408421|16984715|P2|Treatment Initial Randomization|Lack of Efficacy|2
4935248|NCT00408421|16984716|P1|Treatment Initial Randomization|Lack of Efficacy|2
4935249|NCT00408421|16984714|P3|Treatment Initial Randomization|Adverse Event|0
4935250|NCT00408421|16984715|P2|Treatment Initial Randomization|Adverse Event|9
4935251|NCT00408421|16984716|P1|Treatment Initial Randomization|Adverse Event|5
4935252|NCT00408408|16984796|P6|Overall Study|No follow up data|3
4935253|NCT00408408|16984797|P5|Overall Study|No follow up data|5
4935254|NCT00408408|16984798|P4|Overall Study|No follow up data|7
4935255|NCT00408408|16984799|P3|Overall Study|No follow up data|0
4935256|NCT00408408|16984800|P2|Overall Study|No follow up data|3
4935257|NCT00408408|16984801|P1|Overall Study|No follow up data|2
4935258|NCT00408317|16984863|P2|Second Intervention Period|Withdrawal of consent|1
4935259|NCT00408317|16984864|P1|Second Intervention Period|Withdrawal of consent|0
4935260|NCT00408317|16984863|P2|Second Intervention Period|Protocol Violation|1
4935261|NCT00408317|16984864|P1|Second Intervention Period|Protocol Violation|0
4935262|NCT00408317|16984863|P2|Second Intervention Period|Adverse Event|0
4935263|NCT00408317|16984864|P1|Second Intervention Period|Adverse Event|2
4935264|NCT00408317|16984863|P2|First Intervention Period|Adverse Event|1
4935265|NCT00408317|16984864|P1|First Intervention Period|Adverse Event|0
4935266|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Development of SMN|0
4935267|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Development of SMN|0
4935268|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Development of SMN|1
4935269|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Development of SMN|1
4935270|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Development of SMN|1
4935271|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Development of SMN|3
4935272|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Development of SMN|0
4935273|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Development of SMN|0
4935274|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
4935275|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1
4935276|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15
4935277|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49
4935278|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7
4935279|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13
4935280|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
4935281|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0
4935282|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4935283|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4935284|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2
4935285|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1
4935286|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4935287|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4935288|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4935289|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0
4935290|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4935291|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4935292|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
4935293|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
4935294|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Protocol Deviation|1
4935295|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Protocol Deviation|2
4935296|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4935297|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Protocol Deviation|0
4935298|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935299|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935300|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Inevaluable|1
4935301|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935302|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935303|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935304|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935305|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Inevaluable|0
4935306|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Progressive Disease|7
4935307|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Progressive Disease|7
4935308|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4935309|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Progressive Disease|1
4935310|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4935311|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4935312|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4935313|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Progressive Disease|0
4935314|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4935315|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
4935316|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4935317|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
4935318|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1
4935319|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3
4935320|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4935321|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0
4935322|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935323|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935324|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935325|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1
4935326|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935327|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935328|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935329|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0
4935330|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2
4935331|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4
4935332|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16
4935333|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36
4935334|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10
4935335|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27
4935336|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
4935337|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0
4935338|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4935339|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4935340|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2
4935341|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4935342|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
4935343|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1
4935344|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4935345|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0
4935346|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Physician Decision|4
4935347|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Physician Decision|10
4935348|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Physician Decision|45
4935349|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Physician Decision|27
4935350|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Physician Decision|19
4935351|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Physician Decision|24
4935352|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Physician Decision|0
4935353|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Physician Decision|0
4935354|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4935355|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4935356|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4935357|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1
4935358|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4935359|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2
4935360|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4935361|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0
4935362|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Death|1
4935363|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Death|3
4935364|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Death|5
4935365|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Death|5
4935366|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Death|0
4935367|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Death|3
4935368|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Death|0
4935369|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Death|0
4935370|NCT00408005|16984897|P8|Post Induction Therapy by Tx Assignment|Adverse Event|0
4935371|NCT00408005|16984898|P7|Post Induction Therapy by Tx Assignment|Adverse Event|2
4935372|NCT00408005|16984899|P6|Post Induction Therapy by Tx Assignment|Adverse Event|12
4935373|NCT00408005|16984900|P5|Post Induction Therapy by Tx Assignment|Adverse Event|8
4935374|NCT00408005|16984901|P4|Post Induction Therapy by Tx Assignment|Adverse Event|4
4935375|NCT00408005|16984902|P3|Post Induction Therapy by Tx Assignment|Adverse Event|7
4935376|NCT00408005|16984903|P2|Post Induction Therapy by Tx Assignment|Adverse Event|0
4935377|NCT00408005|16984904|P1|Post Induction Therapy by Tx Assignment|Adverse Event|0
4935378|NCT00408005|16984897|P8|Induction|Recurrent leukemia|0
4935379|NCT00408005|16984898|P7|Induction|Recurrent leukemia|0
4935380|NCT00408005|16984899|P6|Induction|Recurrent leukemia|0
4935381|NCT00408005|16984900|P5|Induction|Recurrent leukemia|0
4935382|NCT00408005|16984901|P4|Induction|Recurrent leukemia|0
4935383|NCT00408005|16984902|P3|Induction|Recurrent leukemia|0
4935384|NCT00408005|16984903|P2|Induction|Recurrent leukemia|0
4935385|NCT00408005|16984904|P1|Induction|Recurrent leukemia|1
4935386|NCT00408005|16984897|P8|Induction|Hematopoietic Stem Cell Transplantation|0
4935387|NCT00408005|16984898|P7|Induction|Hematopoietic Stem Cell Transplantation|0
4935388|NCT00408005|16984899|P6|Induction|Hematopoietic Stem Cell Transplantation|0
4935389|NCT00408005|16984900|P5|Induction|Hematopoietic Stem Cell Transplantation|0
4935390|NCT00408005|16984901|P4|Induction|Hematopoietic Stem Cell Transplantation|0
4935391|NCT00408005|16984902|P3|Induction|Hematopoietic Stem Cell Transplantation|0
4935392|NCT00408005|16984903|P2|Induction|Hematopoietic Stem Cell Transplantation|0
4935393|NCT00408005|16984904|P1|Induction|Hematopoietic Stem Cell Transplantation|1
4935394|NCT00408005|16984897|P8|Induction|Protocol Deviation|0
4935395|NCT00408005|16984898|P7|Induction|Protocol Deviation|0
4935396|NCT00408005|16984899|P6|Induction|Protocol Deviation|0
4935397|NCT00408005|16984900|P5|Induction|Protocol Deviation|0
4935398|NCT00408005|16984901|P4|Induction|Protocol Deviation|0
4935399|NCT00408005|16984902|P3|Induction|Protocol Deviation|0
4935400|NCT00408005|16984903|P2|Induction|Protocol Deviation|1
4935401|NCT00408005|16984904|P1|Induction|Protocol Deviation|3
4935402|NCT00408005|16984897|P8|Induction|Failed to Complete Randomization|0
4935403|NCT00408005|16984898|P7|Induction|Failed to Complete Randomization|0
4935404|NCT00408005|16984899|P6|Induction|Failed to Complete Randomization|0
4935405|NCT00408005|16984900|P5|Induction|Failed to Complete Randomization|0
4935406|NCT00408005|16984901|P4|Induction|Failed to Complete Randomization|0
4935407|NCT00408005|16984902|P3|Induction|Failed to Complete Randomization|0
4935408|NCT00408005|16984903|P2|Induction|Failed to Complete Randomization|2
4935409|NCT00408005|16984904|P1|Induction|Failed to Complete Randomization|3
4935410|NCT00408005|16984897|P8|Induction|Inevaluable|0
4935411|NCT00408005|16984898|P7|Induction|Inevaluable|0
4935412|NCT00408005|16984899|P6|Induction|Inevaluable|0
4935413|NCT00408005|16984900|P5|Induction|Inevaluable|0
4935414|NCT00408005|16984901|P4|Induction|Inevaluable|0
4935415|NCT00408005|16984902|P3|Induction|Inevaluable|0
4935416|NCT00408005|16984903|P2|Induction|Inevaluable|14
4935417|NCT00408005|16984904|P1|Induction|Inevaluable|18
4935418|NCT00408005|16984897|P8|Induction|Progressive Disease|0
4935419|NCT00408005|16984898|P7|Induction|Progressive Disease|0
4935420|NCT00408005|16984899|P6|Induction|Progressive Disease|0
4935421|NCT00408005|16984900|P5|Induction|Progressive Disease|0
4935422|NCT00408005|16984901|P4|Induction|Progressive Disease|0
4935423|NCT00408005|16984902|P3|Induction|Progressive Disease|0
4935424|NCT00408005|16984903|P2|Induction|Progressive Disease|1
4935425|NCT00408005|16984904|P1|Induction|Progressive Disease|0
4935426|NCT00408005|16984897|P8|Induction|Identified as Philadelphia Chr. Positive|0
4935427|NCT00408005|16984898|P7|Induction|Identified as Philadelphia Chr. Positive|0
4935428|NCT00408005|16984899|P6|Induction|Identified as Philadelphia Chr. Positive|0
4935429|NCT00408005|16984900|P5|Induction|Identified as Philadelphia Chr. Positive|0
4935430|NCT00408005|16984901|P4|Induction|Identified as Philadelphia Chr. Positive|0
4935431|NCT00408005|16984902|P3|Induction|Identified as Philadelphia Chr. Positive|0
4935432|NCT00408005|16984903|P2|Induction|Identified as Philadelphia Chr. Positive|0
4935433|NCT00408005|16984904|P1|Induction|Identified as Philadelphia Chr. Positive|6
4935434|NCT00408005|16984897|P8|Induction|Patient transferred Tx to Non-COG Site|0
4935435|NCT00408005|16984898|P7|Induction|Patient transferred Tx to Non-COG Site|0
4935436|NCT00408005|16984899|P6|Induction|Patient transferred Tx to Non-COG Site|0
4935437|NCT00408005|16984900|P5|Induction|Patient transferred Tx to Non-COG Site|0
4935438|NCT00408005|16984901|P4|Induction|Patient transferred Tx to Non-COG Site|0
4935439|NCT00408005|16984902|P3|Induction|Patient transferred Tx to Non-COG Site|0
4935440|NCT00408005|16984903|P2|Induction|Patient transferred Tx to Non-COG Site|2
4935441|NCT00408005|16984904|P1|Induction|Patient transferred Tx to Non-COG Site|3
4935442|NCT00408005|16984897|P8|Induction|Entered another COG therapeutic protocol|0
4935443|NCT00408005|16984898|P7|Induction|Entered another COG therapeutic protocol|0
4935444|NCT00408005|16984899|P6|Induction|Entered another COG therapeutic protocol|0
4935445|NCT00408005|16984900|P5|Induction|Entered another COG therapeutic protocol|0
4935446|NCT00408005|16984901|P4|Induction|Entered another COG therapeutic protocol|0
4935447|NCT00408005|16984902|P3|Induction|Entered another COG therapeutic protocol|0
4935448|NCT00408005|16984903|P2|Induction|Entered another COG therapeutic protocol|0
4935449|NCT00408005|16984904|P1|Induction|Entered another COG therapeutic protocol|4
4935450|NCT00408005|16984897|P8|Induction|Refusal of Further Protocol Therapy|0
4935451|NCT00408005|16984898|P7|Induction|Refusal of Further Protocol Therapy|0
4935452|NCT00408005|16984899|P6|Induction|Refusal of Further Protocol Therapy|0
4935453|NCT00408005|16984900|P5|Induction|Refusal of Further Protocol Therapy|0
4935454|NCT00408005|16984901|P4|Induction|Refusal of Further Protocol Therapy|0
4935455|NCT00408005|16984902|P3|Induction|Refusal of Further Protocol Therapy|0
4935456|NCT00408005|16984903|P2|Induction|Refusal of Further Protocol Therapy|44
4935457|NCT00408005|16984904|P1|Induction|Refusal of Further Protocol Therapy|225
4935458|NCT00408005|16984897|P8|Induction|Ineligible|0
4935459|NCT00408005|16984898|P7|Induction|Ineligible|0
4935460|NCT00408005|16984899|P6|Induction|Ineligible|0
4935461|NCT00408005|16984900|P5|Induction|Ineligible|0
4935462|NCT00408005|16984901|P4|Induction|Ineligible|0
4935463|NCT00408005|16984902|P3|Induction|Ineligible|0
4935464|NCT00408005|16984903|P2|Induction|Ineligible|14
4935465|NCT00408005|16984904|P1|Induction|Ineligible|33
4935466|NCT00408005|16984897|P8|Induction|Withdrawal by Subject|0
4935467|NCT00408005|16984898|P7|Induction|Withdrawal by Subject|0
4935468|NCT00408005|16984899|P6|Induction|Withdrawal by Subject|0
4935469|NCT00408005|16984900|P5|Induction|Withdrawal by Subject|0
4935470|NCT00408005|16984901|P4|Induction|Withdrawal by Subject|0
4935471|NCT00408005|16984902|P3|Induction|Withdrawal by Subject|0
4935472|NCT00408005|16984903|P2|Induction|Withdrawal by Subject|4
4935473|NCT00408005|16984904|P1|Induction|Withdrawal by Subject|2
4935474|NCT00408005|16984897|P8|Induction|Physician Decision|0
4935475|NCT00408005|16984898|P7|Induction|Physician Decision|0
4935476|NCT00408005|16984899|P6|Induction|Physician Decision|0
4935477|NCT00408005|16984900|P5|Induction|Physician Decision|0
4935478|NCT00408005|16984901|P4|Induction|Physician Decision|0
4935479|NCT00408005|16984902|P3|Induction|Physician Decision|0
4935480|NCT00408005|16984903|P2|Induction|Physician Decision|9
4935481|NCT00408005|16984904|P1|Induction|Physician Decision|83
4935482|NCT00408005|16984897|P8|Induction|Death|0
4935483|NCT00408005|16984898|P7|Induction|Death|0
4935484|NCT00408005|16984899|P6|Induction|Death|0
4935485|NCT00408005|16984900|P5|Induction|Death|0
4935486|NCT00408005|16984901|P4|Induction|Death|0
4935487|NCT00408005|16984902|P3|Induction|Death|0
4935488|NCT00408005|16984903|P2|Induction|Death|0
4935489|NCT00408005|16984904|P1|Induction|Death|6
4935490|NCT00408005|16984897|P8|Induction|Adverse Event|0
4935491|NCT00408005|16984898|P7|Induction|Adverse Event|0
4935492|NCT00408005|16984899|P6|Induction|Adverse Event|0
4935493|NCT00408005|16984900|P5|Induction|Adverse Event|0
4935494|NCT00408005|16984901|P4|Induction|Adverse Event|0
4935495|NCT00408005|16984902|P3|Induction|Adverse Event|0
4935496|NCT00408005|16984903|P2|Induction|Adverse Event|3
4935497|NCT00408005|16984904|P1|Induction|Adverse Event|19
4935498|NCT00407797|16984946|P1|Overall Study|Withdrawal by Subject|3
4935499|NCT00407797|16984946|P1|Overall Study|Other|7
4935500|NCT00407797|16984946|P1|Overall Study|Adverse Event|6
4935501|NCT00407797|16984946|P1|Overall Study|Lost to Follow-up|2
4935502|NCT00407758|16984961|P1|Overall Study|ineligible -improper prior treatment|1
4935503|NCT00407745|16984974|P2|Overall Study|Randomized, unknown if treated|1
4935504|NCT00407745|16984975|P1|Overall Study|Randomized, unknown if treated|0
4935505|NCT00407745|16984974|P2|Overall Study|Other|0
4935506|NCT00407745|16984975|P1|Overall Study|Other|2
4935507|NCT00407745|16984974|P2|Overall Study|Adverse Event|8
4935508|NCT00407745|16984975|P1|Overall Study|Adverse Event|8
4935509|NCT00407745|16984974|P2|Overall Study|Protocol Violation|3
4935510|NCT00407745|16984975|P1|Overall Study|Protocol Violation|5
4935511|NCT00407745|16984974|P2|Overall Study|Withdrawal by Subject|3
4935512|NCT00407745|16984975|P1|Overall Study|Withdrawal by Subject|3
4935513|NCT00407745|16984974|P2|Overall Study|Lack of Efficacy|2
4935514|NCT00407745|16984975|P1|Overall Study|Lack of Efficacy|1
4935515|NCT00407563|16985061|P1|Overall Study|Patient continues on treatment|1
4935516|NCT00407550|16985071|P2|Overall Study|Insurance or Other medical condition|1
4935517|NCT00407550|16985072|P1|Overall Study|Insurance or Other medical condition|2
4935518|NCT00407550|16985071|P2|Overall Study|Death|0
4935519|NCT00407550|16985072|P1|Overall Study|Death|1
4935520|NCT00407550|16985071|P2|Overall Study|Withdrawal by Subject|2
4935521|NCT00407550|16985072|P1|Overall Study|Withdrawal by Subject|0
4935522|NCT00407550|16985071|P2|Overall Study|Adverse Event|1
4935523|NCT00407550|16985072|P1|Overall Study|Adverse Event|0
4935524|NCT00407537|16985086|P2|Overall Study|Withdrawal by Subject|16
4935525|NCT00407537|16985087|P1|Overall Study|Withdrawal by Subject|34
4935526|NCT00407537|16985086|P2|Overall Study|Other|7
4935527|NCT00407537|16985087|P1|Overall Study|Other|6
4935528|NCT00407537|16985086|P2|Overall Study|Lost to Follow-up|19
4935529|NCT00407537|16985087|P1|Overall Study|Lost to Follow-up|12
4935530|NCT00407537|16985086|P2|Overall Study|Adverse Event|0
4935531|NCT00407537|16985087|P1|Overall Study|Adverse Event|36
4935532|NCT00407537|16985086|P2|Overall Study|Death|2
4935533|NCT00407537|16985087|P1|Overall Study|Death|5
4935534|NCT00407511|16985135|P1|Overall Study|Withdrawal by Subject|4
4935535|NCT00407511|16985135|P1|Overall Study|Other|5
4935536|NCT00407511|16985135|P1|Overall Study|Lost to Follow-up|4
4935537|NCT00407511|16985135|P1|Overall Study|Adverse Event|9
4935538|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Physician Decision|0
4935539|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Physician Decision|2
4935540|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Physician Decision|1
4935541|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Patient Decision|0
4935542|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Patient Decision|2
4935543|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Patient Decision|1
4935544|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Lost to Follow-up|0
4935545|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Lost to Follow-up|5
4935546|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Lost to Follow-up|5
4935547|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Consent Withdrawn|0
4935548|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Consent Withdrawn|4
4935549|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Consent Withdrawn|4
4935550|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Adverse Event|0
4935551|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Adverse Event|0
4935552|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Adverse Event|1
4935553|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Lack of Efficacy|0
4935554|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Lack of Efficacy|11
4935555|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Lack of Efficacy|11
4935556|NCT00407030|16985196|P3|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
4935557|NCT00407030|16985197|P2|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5
4935558|NCT00407030|16985198|P1|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
4935559|NCT00407030|16985196|P3|Main Period - 8 to 20 Weeks|Patient Decision|0
4935560|NCT00407030|16985197|P2|Main Period - 8 to 20 Weeks|Patient Decision|0
4935561|NCT00407030|16985198|P1|Main Period - 8 to 20 Weeks|Patient Decision|1
4935562|NCT00407030|16985196|P3|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1
4935563|NCT00407030|16985197|P2|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
4935564|NCT00407030|16985198|P1|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0
4935565|NCT00407030|16985196|P3|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
4935566|NCT00407030|16985197|P2|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
4935567|NCT00407030|16985198|P1|Main Period - 8 to 20 Weeks|Consent Withdrawn|1
4935568|NCT00407030|16985196|P3|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
4935569|NCT00407030|16985197|P2|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
4935570|NCT00407030|16985198|P1|Main Period - 8 to 20 Weeks|Lost to Follow-up|1
4935571|NCT00407030|16985196|P3|Main Period - 8 to 20 Weeks|Lack of Efficacy|3
4935572|NCT00407030|16985197|P2|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
4935573|NCT00407030|16985198|P1|Main Period - 8 to 20 Weeks|Lack of Efficacy|0
4935574|NCT00407030|16985196|P3|Main Period - 8 to 20 Weeks|Adverse Event|0
4935575|NCT00407030|16985197|P2|Main Period - 8 to 20 Weeks|Adverse Event|1
4935576|NCT00407030|16985198|P1|Main Period - 8 to 20 Weeks|Adverse Event|2
4935577|NCT00406848|16985226|P2|Overall Study|Sponsor Decision|1
4935578|NCT00406848|16985227|P1|Overall Study|Sponsor Decision|1
4935579|NCT00406848|16985226|P2|Overall Study|Physician Decision|2
4935580|NCT00406848|16985227|P1|Overall Study|Physician Decision|2
4935581|NCT00406848|16985226|P2|Overall Study|Lost to Follow-up|2
4935582|NCT00406848|16985227|P1|Overall Study|Lost to Follow-up|6
4935583|NCT00406848|16985226|P2|Overall Study|Protocol Violation|6
4935584|NCT00406848|16985227|P1|Overall Study|Protocol Violation|10
4935585|NCT00406848|16985226|P2|Overall Study|Lack of Efficacy|14
4935586|NCT00406848|16985227|P1|Overall Study|Lack of Efficacy|9
4935587|NCT00406848|16985226|P2|Overall Study|Adverse Event|7
4935588|NCT00406848|16985227|P1|Overall Study|Adverse Event|38
4935589|NCT00406848|16985226|P2|Overall Study|Withdrawal by Subject|22
4935590|NCT00406848|16985227|P1|Overall Study|Withdrawal by Subject|27
4935591|NCT00406783|16985291|P2|Overall Study|Protocol Violation|4
4935592|NCT00406783|16985292|P1|Overall Study|Protocol Violation|4
4935593|NCT00406783|16985291|P2|Overall Study|Withdrawal by Subject|4
4935594|NCT00406783|16985292|P1|Overall Study|Withdrawal by Subject|1
4935595|NCT00406783|16985291|P2|Overall Study|Lost to Follow-up|0
4935596|NCT00406783|16985292|P1|Overall Study|Lost to Follow-up|3
4935597|NCT00406783|16985291|P2|Overall Study|Treatment Failure|3
4935598|NCT00406783|16985292|P1|Overall Study|Treatment Failure|2
4935599|NCT00406783|16985291|P2|Overall Study|Adverse Event|4
4935600|NCT00406783|16985292|P1|Overall Study|Adverse Event|4
4935601|NCT00406718|16985307|P3|Overall Study|Lost to Follow-up|4
4935602|NCT00406718|16985308|P2|Overall Study|Lost to Follow-up|5
4935603|NCT00406718|16985309|P1|Overall Study|Lost to Follow-up|2
4935604|NCT00406718|16985307|P3|Overall Study|Withdrawal by Subject|4
4935605|NCT00406718|16985308|P2|Overall Study|Withdrawal by Subject|9
4935606|NCT00406718|16985309|P1|Overall Study|Withdrawal by Subject|2
4935607|NCT00406692|16985323|P1|Overall Study|Lack of Efficacy|1
4935608|NCT00406692|16985323|P1|Overall Study|Adverse Event|1
4935609|NCT00406692|16985323|P1|Overall Study|Physician Decision|1
4935610|NCT00406692|16985323|P1|Overall Study|Withdrawal by Subject|4
4935611|NCT00406653|16985333|P7|Open-Label Period|Refused followup|1
4935612|NCT00406653|16985334|P6|Open-Label Period|Refused followup|0
4935613|NCT00406653|16985335|P5|Open-Label Period|Refused followup|0
4935614|NCT00406653|16985336|P4|Open-Label Period|Refused followup|0
4935615|NCT00406653|16985337|P3|Open-Label Period|Refused followup|0
4935616|NCT00406653|16985338|P2|Open-Label Period|Refused followup|0
4935617|NCT00406653|16985339|P1|Open-Label Period|Refused followup|0
4935618|NCT00406653|16985333|P7|Open-Label Period|Discontinued by Sponsor|1
4935619|NCT00406653|16985334|P6|Open-Label Period|Discontinued by Sponsor|0
4935620|NCT00406653|16985335|P5|Open-Label Period|Discontinued by Sponsor|0
4935621|NCT00406653|16985336|P4|Open-Label Period|Discontinued by Sponsor|0
4935622|NCT00406653|16985337|P3|Open-Label Period|Discontinued by Sponsor|0
4935623|NCT00406653|16985338|P2|Open-Label Period|Discontinued by Sponsor|0
4935624|NCT00406653|16985339|P1|Open-Label Period|Discontinued by Sponsor|0
4935625|NCT00406653|16985333|P7|Open-Label Period|Declined participation but followup done|8
4935626|NCT00406653|16985334|P6|Open-Label Period|Declined participation but followup done|0
4935627|NCT00406653|16985335|P5|Open-Label Period|Declined participation but followup done|0
4935628|NCT00406653|16985336|P4|Open-Label Period|Declined participation but followup done|0
4935629|NCT00406653|16985337|P3|Open-Label Period|Declined participation but followup done|0
4935630|NCT00406653|16985338|P2|Open-Label Period|Declined participation but followup done|0
4935631|NCT00406653|16985339|P1|Open-Label Period|Declined participation but followup done|0
4935632|NCT00406653|16985333|P7|Open-Label Period|Administrative Reason By Sponsor|115
4935633|NCT00406653|16985334|P6|Open-Label Period|Administrative Reason By Sponsor|0
4935634|NCT00406653|16985335|P5|Open-Label Period|Administrative Reason By Sponsor|0
4935635|NCT00406653|16985336|P4|Open-Label Period|Administrative Reason By Sponsor|0
4935636|NCT00406653|16985337|P3|Open-Label Period|Administrative Reason By Sponsor|0
4935637|NCT00406653|16985338|P2|Open-Label Period|Administrative Reason By Sponsor|0
4935638|NCT00406653|16985339|P1|Open-Label Period|Administrative Reason By Sponsor|0
4935639|NCT00406653|16985333|P7|Open-Label Period|Pregnancy|2
4935640|NCT00406653|16985334|P6|Open-Label Period|Pregnancy|0
4935641|NCT00406653|16985335|P5|Open-Label Period|Pregnancy|0
4935642|NCT00406653|16985336|P4|Open-Label Period|Pregnancy|0
4935643|NCT00406653|16985337|P3|Open-Label Period|Pregnancy|0
4935644|NCT00406653|16985338|P2|Open-Label Period|Pregnancy|0
4935645|NCT00406653|16985339|P1|Open-Label Period|Pregnancy|0
4935730|NCT00406653|16985333|P7|Maintenance Period|Adverse Event|0
4935646|NCT00406653|16985333|P7|Open-Label Period|Subject No Longer Meets Study Criteria|1
4935647|NCT00406653|16985334|P6|Open-Label Period|Subject No Longer Meets Study Criteria|0
4935648|NCT00406653|16985335|P5|Open-Label Period|Subject No Longer Meets Study Criteria|0
4935649|NCT00406653|16985336|P4|Open-Label Period|Subject No Longer Meets Study Criteria|0
4935650|NCT00406653|16985337|P3|Open-Label Period|Subject No Longer Meets Study Criteria|0
4935651|NCT00406653|16985338|P2|Open-Label Period|Subject No Longer Meets Study Criteria|0
4935652|NCT00406653|16985339|P1|Open-Label Period|Subject No Longer Meets Study Criteria|0
4935653|NCT00406653|16985333|P7|Open-Label Period|Withdrawal of Consent|11
4935654|NCT00406653|16985334|P6|Open-Label Period|Withdrawal of Consent|0
4935655|NCT00406653|16985335|P5|Open-Label Period|Withdrawal of Consent|0
4935656|NCT00406653|16985336|P4|Open-Label Period|Withdrawal of Consent|0
4935657|NCT00406653|16985337|P3|Open-Label Period|Withdrawal of Consent|0
4935658|NCT00406653|16985338|P2|Open-Label Period|Withdrawal of Consent|0
4935659|NCT00406653|16985339|P1|Open-Label Period|Withdrawal of Consent|0
4935660|NCT00406653|16985333|P7|Open-Label Period|Lost to Follow-up|6
4935661|NCT00406653|16985334|P6|Open-Label Period|Lost to Follow-up|0
4935662|NCT00406653|16985335|P5|Open-Label Period|Lost to Follow-up|0
4935663|NCT00406653|16985336|P4|Open-Label Period|Lost to Follow-up|0
4935664|NCT00406653|16985337|P3|Open-Label Period|Lost to Follow-up|0
4935665|NCT00406653|16985338|P2|Open-Label Period|Lost to Follow-up|0
4935666|NCT00406653|16985339|P1|Open-Label Period|Lost to Follow-up|0
4935667|NCT00406653|16985333|P7|Open-Label Period|Lack of Efficacy|160
4935668|NCT00406653|16985334|P6|Open-Label Period|Lack of Efficacy|0
4935669|NCT00406653|16985335|P5|Open-Label Period|Lack of Efficacy|0
4935670|NCT00406653|16985336|P4|Open-Label Period|Lack of Efficacy|0
4935671|NCT00406653|16985337|P3|Open-Label Period|Lack of Efficacy|0
4935672|NCT00406653|16985338|P2|Open-Label Period|Lack of Efficacy|0
4935673|NCT00406653|16985339|P1|Open-Label Period|Lack of Efficacy|0
4935674|NCT00406653|16985333|P7|Open-Label Period|Adverse Event|18
4935675|NCT00406653|16985334|P6|Open-Label Period|Adverse Event|0
4935676|NCT00406653|16985335|P5|Open-Label Period|Adverse Event|0
4935677|NCT00406653|16985336|P4|Open-Label Period|Adverse Event|0
4935678|NCT00406653|16985337|P3|Open-Label Period|Adverse Event|0
4935679|NCT00406653|16985338|P2|Open-Label Period|Adverse Event|0
4935680|NCT00406653|16985339|P1|Open-Label Period|Adverse Event|0
4935681|NCT00406653|16985333|P7|Open-Label Period|Death|1
4935682|NCT00406653|16985334|P6|Open-Label Period|Death|0
4935683|NCT00406653|16985335|P5|Open-Label Period|Death|0
4935684|NCT00406653|16985336|P4|Open-Label Period|Death|0
4935685|NCT00406653|16985337|P3|Open-Label Period|Death|0
4935686|NCT00406653|16985338|P2|Open-Label Period|Death|0
4935687|NCT00406653|16985339|P1|Open-Label Period|Death|0
4935688|NCT00406653|16985333|P7|Maintenance Period|Error in disease score evaluation|0
4935689|NCT00406653|16985334|P6|Maintenance Period|Error in disease score evaluation|0
4935690|NCT00406653|16985335|P5|Maintenance Period|Error in disease score evaluation|1
4935691|NCT00406653|16985336|P4|Maintenance Period|Error in disease score evaluation|0
4935692|NCT00406653|16985337|P3|Maintenance Period|Error in disease score evaluation|0
4935693|NCT00406653|16985338|P2|Maintenance Period|Error in disease score evaluation|0
4935694|NCT00406653|16985339|P1|Maintenance Period|Error in disease score evaluation|0
4935695|NCT00406653|16985333|P7|Maintenance Period|Administrative Reason By Sponsor|0
4935696|NCT00406653|16985334|P6|Maintenance Period|Administrative Reason By Sponsor|7
4935697|NCT00406653|16985335|P5|Maintenance Period|Administrative Reason By Sponsor|4
4935698|NCT00406653|16985336|P4|Maintenance Period|Administrative Reason By Sponsor|0
4935699|NCT00406653|16985337|P3|Maintenance Period|Administrative Reason By Sponsor|0
4935700|NCT00406653|16985338|P2|Maintenance Period|Administrative Reason By Sponsor|0
4935701|NCT00406653|16985339|P1|Maintenance Period|Administrative Reason By Sponsor|0
4935702|NCT00406653|16985333|P7|Maintenance Period|Pregnancy|0
4935703|NCT00406653|16985334|P6|Maintenance Period|Pregnancy|1
4935704|NCT00406653|16985335|P5|Maintenance Period|Pregnancy|0
4935705|NCT00406653|16985336|P4|Maintenance Period|Pregnancy|0
4935706|NCT00406653|16985337|P3|Maintenance Period|Pregnancy|0
4935707|NCT00406653|16985338|P2|Maintenance Period|Pregnancy|0
4935708|NCT00406653|16985339|P1|Maintenance Period|Pregnancy|0
4935709|NCT00406653|16985333|P7|Maintenance Period|Withdrawal of Consent|0
4935710|NCT00406653|16985334|P6|Maintenance Period|Withdrawal of Consent|0
4935711|NCT00406653|16985335|P5|Maintenance Period|Withdrawal of Consent|2
4935712|NCT00406653|16985336|P4|Maintenance Period|Withdrawal of Consent|0
4935713|NCT00406653|16985337|P3|Maintenance Period|Withdrawal of Consent|0
4935714|NCT00406653|16985338|P2|Maintenance Period|Withdrawal of Consent|0
4935715|NCT00406653|16985339|P1|Maintenance Period|Withdrawal of Consent|0
4935716|NCT00406653|16985333|P7|Maintenance Period|Lost to Follow-up|0
4935717|NCT00406653|16985334|P6|Maintenance Period|Lost to Follow-up|1
4935718|NCT00406653|16985335|P5|Maintenance Period|Lost to Follow-up|2
4935719|NCT00406653|16985336|P4|Maintenance Period|Lost to Follow-up|0
4935720|NCT00406653|16985337|P3|Maintenance Period|Lost to Follow-up|0
4935721|NCT00406653|16985338|P2|Maintenance Period|Lost to Follow-up|0
4935722|NCT00406653|16985339|P1|Maintenance Period|Lost to Follow-up|0
4935723|NCT00406653|16985333|P7|Maintenance Period|Lack of Efficacy|0
4935724|NCT00406653|16985334|P6|Maintenance Period|Lack of Efficacy|26
4935725|NCT00406653|16985335|P5|Maintenance Period|Lack of Efficacy|20
4935726|NCT00406653|16985336|P4|Maintenance Period|Lack of Efficacy|0
4935727|NCT00406653|16985337|P3|Maintenance Period|Lack of Efficacy|0
4935728|NCT00406653|16985338|P2|Maintenance Period|Lack of Efficacy|0
4935729|NCT00406653|16985339|P1|Maintenance Period|Lack of Efficacy|0
4935731|NCT00406653|16985334|P6|Maintenance Period|Adverse Event|1
4935732|NCT00406653|16985335|P5|Maintenance Period|Adverse Event|1
4935733|NCT00406653|16985336|P4|Maintenance Period|Adverse Event|0
4935734|NCT00406653|16985337|P3|Maintenance Period|Adverse Event|0
4935735|NCT00406653|16985338|P2|Maintenance Period|Adverse Event|0
4935736|NCT00406653|16985339|P1|Maintenance Period|Adverse Event|0
4935737|NCT00406653|16985333|P7|Induction Period|Patient relocated|0
4935738|NCT00406653|16985334|P6|Induction Period|Patient relocated|0
4935739|NCT00406653|16985335|P5|Induction Period|Patient relocated|0
4935740|NCT00406653|16985336|P4|Induction Period|Patient relocated|0
4935741|NCT00406653|16985337|P3|Induction Period|Patient relocated|1
4935742|NCT00406653|16985338|P2|Induction Period|Patient relocated|0
4935743|NCT00406653|16985339|P1|Induction Period|Patient relocated|0
4935744|NCT00406653|16985333|P7|Induction Period|Incarcerated|0
4935745|NCT00406653|16985334|P6|Induction Period|Incarcerated|0
4935746|NCT00406653|16985335|P5|Induction Period|Incarcerated|0
4935747|NCT00406653|16985336|P4|Induction Period|Incarcerated|0
4935748|NCT00406653|16985337|P3|Induction Period|Incarcerated|1
4935749|NCT00406653|16985338|P2|Induction Period|Incarcerated|0
4935750|NCT00406653|16985339|P1|Induction Period|Incarcerated|0
4935751|NCT00406653|16985333|P7|Induction Period|Given prohibited drug|0
4935752|NCT00406653|16985334|P6|Induction Period|Given prohibited drug|0
4935753|NCT00406653|16985335|P5|Induction Period|Given prohibited drug|0
4935754|NCT00406653|16985336|P4|Induction Period|Given prohibited drug|0
4935755|NCT00406653|16985337|P3|Induction Period|Given prohibited drug|2
4935756|NCT00406653|16985338|P2|Induction Period|Given prohibited drug|1
4935757|NCT00406653|16985339|P1|Induction Period|Given prohibited drug|0
4935758|NCT00406653|16985333|P7|Induction Period|Declined participation but followup done|0
4935759|NCT00406653|16985334|P6|Induction Period|Declined participation but followup done|0
4935760|NCT00406653|16985335|P5|Induction Period|Declined participation but followup done|0
4935761|NCT00406653|16985336|P4|Induction Period|Declined participation but followup done|1
4935762|NCT00406653|16985337|P3|Induction Period|Declined participation but followup done|1
4935763|NCT00406653|16985338|P2|Induction Period|Declined participation but followup done|2
4935764|NCT00406653|16985339|P1|Induction Period|Declined participation but followup done|0
4935765|NCT00406653|16985333|P7|Induction Period|Pregnancy|0
4935766|NCT00406653|16985334|P6|Induction Period|Pregnancy|0
4935767|NCT00406653|16985335|P5|Induction Period|Pregnancy|0
4935768|NCT00406653|16985336|P4|Induction Period|Pregnancy|0
4935769|NCT00406653|16985337|P3|Induction Period|Pregnancy|0
4935770|NCT00406653|16985338|P2|Induction Period|Pregnancy|0
4935771|NCT00406653|16985339|P1|Induction Period|Pregnancy|1
4935772|NCT00406653|16985333|P7|Induction Period|Subject No Longer Meets Study Criteria|0
4935773|NCT00406653|16985334|P6|Induction Period|Subject No Longer Meets Study Criteria|0
4935774|NCT00406653|16985335|P5|Induction Period|Subject No Longer Meets Study Criteria|0
4935775|NCT00406653|16985336|P4|Induction Period|Subject No Longer Meets Study Criteria|2
4935776|NCT00406653|16985337|P3|Induction Period|Subject No Longer Meets Study Criteria|0
4935777|NCT00406653|16985338|P2|Induction Period|Subject No Longer Meets Study Criteria|0
4935778|NCT00406653|16985339|P1|Induction Period|Subject No Longer Meets Study Criteria|0
4935779|NCT00406653|16985333|P7|Induction Period|Withdrawal of Consent|0
4935780|NCT00406653|16985334|P6|Induction Period|Withdrawal of Consent|0
4935781|NCT00406653|16985335|P5|Induction Period|Withdrawal of Consent|0
4935782|NCT00406653|16985336|P4|Induction Period|Withdrawal of Consent|2
4935783|NCT00406653|16985337|P3|Induction Period|Withdrawal of Consent|1
4935784|NCT00406653|16985338|P2|Induction Period|Withdrawal of Consent|5
4935785|NCT00406653|16985339|P1|Induction Period|Withdrawal of Consent|2
4935786|NCT00406653|16985333|P7|Induction Period|Lost to Follow-up|0
4935787|NCT00406653|16985334|P6|Induction Period|Lost to Follow-up|0
4935788|NCT00406653|16985335|P5|Induction Period|Lost to Follow-up|0
4935789|NCT00406653|16985336|P4|Induction Period|Lost to Follow-up|0
4935790|NCT00406653|16985337|P3|Induction Period|Lost to Follow-up|0
4935791|NCT00406653|16985338|P2|Induction Period|Lost to Follow-up|2
4935792|NCT00406653|16985339|P1|Induction Period|Lost to Follow-up|0
4935793|NCT00406653|16985333|P7|Induction Period|Lack of Efficacy|0
4935794|NCT00406653|16985334|P6|Induction Period|Lack of Efficacy|0
4935795|NCT00406653|16985335|P5|Induction Period|Lack of Efficacy|0
4935796|NCT00406653|16985336|P4|Induction Period|Lack of Efficacy|10
4935797|NCT00406653|16985337|P3|Induction Period|Lack of Efficacy|8
4935798|NCT00406653|16985338|P2|Induction Period|Lack of Efficacy|14
4935799|NCT00406653|16985339|P1|Induction Period|Lack of Efficacy|11
4935800|NCT00406653|16985333|P7|Induction Period|Adverse Event|0
4935801|NCT00406653|16985334|P6|Induction Period|Adverse Event|0
4935802|NCT00406653|16985335|P5|Induction Period|Adverse Event|0
4935803|NCT00406653|16985336|P4|Induction Period|Adverse Event|11
4935804|NCT00406653|16985337|P3|Induction Period|Adverse Event|4
4935805|NCT00406653|16985338|P2|Induction Period|Adverse Event|10
4935806|NCT00406653|16985339|P1|Induction Period|Adverse Event|1
4935807|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|Lack of Efficacy|7
4935808|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|Lack of Efficacy|6
4935809|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|Withdrawal by Subject|6
4935810|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|Withdrawal by Subject|3
4935811|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|non-compliance|2
4935812|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|non-compliance|3
4935974|NCT00405756|16985844|P2|Open-label Extension|Disease Progression|23
4935813|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|Lost to Follow-up|3
4935814|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|Lost to Follow-up|2
4935815|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|Physician Decision|0
4935816|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|Physician Decision|1
4935817|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|Failed to Return|0
4935818|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|Failed to Return|1
4935819|NCT00406640|16985420|P2|OL Extension Phase for Non-Responders|Adverse Event|6
4935820|NCT00406640|16985421|P1|OL Extension Phase for Non-Responders|Adverse Event|6
4935821|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Lack of Efficacy|1
4935822|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Lack of Efficacy|1
4935823|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Withdrawal by Subject|6
4935824|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Withdrawal by Subject|8
4935825|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Protocol Violation|2
4935826|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Protocol Violation|2
4935827|NCT00406640|16985420|P2|DB Continuation Phase for Responders|non-compliance|5
4935828|NCT00406640|16985421|P1|DB Continuation Phase for Responders|non-compliance|7
4935829|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Lost to Follow-up|7
4935830|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Lost to Follow-up|1
4935831|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Physician Decision|3
4935832|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Physician Decision|2
4935833|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Failed to Return|2
4935834|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Failed to Return|0
4935835|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Death|0
4935836|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Death|1
4935837|NCT00406640|16985420|P2|DB Continuation Phase for Responders|Adverse Event|11
4935838|NCT00406640|16985421|P1|DB Continuation Phase for Responders|Adverse Event|11
4935839|NCT00406640|16985420|P2|Acute Phase|Lack of Efficacy|3
4935840|NCT00406640|16985421|P1|Acute Phase|Lack of Efficacy|3
4935841|NCT00406640|16985420|P2|Acute Phase|Withdrawal by Subject|9
4935842|NCT00406640|16985421|P1|Acute Phase|Withdrawal by Subject|11
4935843|NCT00406640|16985420|P2|Acute Phase|Protocol Violation|2
4935844|NCT00406640|16985421|P1|Acute Phase|Protocol Violation|3
4935845|NCT00406640|16985420|P2|Acute Phase|Protocol deviation|10
4935846|NCT00406640|16985421|P1|Acute Phase|Protocol deviation|4
4935847|NCT00406640|16985420|P2|Acute Phase|Lost to Follow-up|4
4935848|NCT00406640|16985421|P1|Acute Phase|Lost to Follow-up|7
4935849|NCT00406640|16985420|P2|Acute Phase|Physician Decision|1
4935850|NCT00406640|16985421|P1|Acute Phase|Physician Decision|0
4935851|NCT00406640|16985420|P2|Acute Phase|Failed to Return|1
4935852|NCT00406640|16985421|P1|Acute Phase|Failed to Return|5
4935853|NCT00406640|16985420|P2|Acute Phase|Adverse Event|13
4935854|NCT00406640|16985421|P1|Acute Phase|Adverse Event|18
4935855|NCT00406393|16985453|P2|Overall Study|Did not undergo transplantation|1
4935856|NCT00406393|16985454|P1|Overall Study|Did not undergo transplantation|2
4935857|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0
4935858|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1
4935859|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0
4935860|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1
4935861|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0
4935862|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1
4935863|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0
4935864|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1
4935865|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0
4935866|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4
4935867|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0
4935868|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4
4935869|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0
4935870|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6
4935871|NCT00406367|16985484|P2|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0
4935872|NCT00406367|16985485|P1|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2
4935873|NCT00406367|16985484|P2|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1
4935874|NCT00406367|16985485|P1|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0
4935875|NCT00406367|16985484|P2|Main Period - 6 to 20 Weeks|Lost to Follow-up|1
4935876|NCT00406367|16985485|P1|Main Period - 6 to 20 Weeks|Lost to Follow-up|0
4935877|NCT00406367|16985484|P2|Main Period - 6 to 20 Weeks|Consent Withdrawn|0
4935878|NCT00406367|16985485|P1|Main Period - 6 to 20 Weeks|Consent Withdrawn|1
4935879|NCT00406367|16985484|P2|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0
4935880|NCT00406367|16985485|P1|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4
4935881|NCT00406354|16985500|P3|All Randomized and Treated Patients|Physician Decision|1
4935882|NCT00406354|16985501|P2|All Randomized and Treated Patients|Physician Decision|0
4935883|NCT00406354|16985502|P1|All Randomized and Treated Patients|Physician Decision|0
4935884|NCT00406354|16985500|P3|All Randomized and Treated Patients|Withdrawal by Subject|2
4935885|NCT00406354|16985501|P2|All Randomized and Treated Patients|Withdrawal by Subject|1
4935886|NCT00406354|16985502|P1|All Randomized and Treated Patients|Withdrawal by Subject|1
4935887|NCT00406354|16985500|P3|All Randomized and Treated Patients|Parent/Caregiver Decision|1
4935888|NCT00406354|16985501|P2|All Randomized and Treated Patients|Parent/Caregiver Decision|6
4935889|NCT00406354|16985502|P1|All Randomized and Treated Patients|Parent/Caregiver Decision|2
4935890|NCT00406354|16985500|P3|All Randomized and Treated Patients|Adverse Event|1
4935891|NCT00406354|16985501|P2|All Randomized and Treated Patients|Adverse Event|2
4935892|NCT00406354|16985502|P1|All Randomized and Treated Patients|Adverse Event|6
4935893|NCT00406354|16985500|P3|All Randomized and Treated Patients|Lack of Efficacy|17
4935894|NCT00406354|16985501|P2|All Randomized and Treated Patients|Lack of Efficacy|4
4935895|NCT00406354|16985502|P1|All Randomized and Treated Patients|Lack of Efficacy|7
4935896|NCT00406354|16985500|P3|All Randomized Patients|Protocol Violation|1
4935897|NCT00406354|16985501|P2|All Randomized Patients|Protocol Violation|0
4935898|NCT00406354|16985502|P1|All Randomized Patients|Protocol Violation|0
4935899|NCT00406315|16985573|P1|Overall Study|Withdrawal by Subject|30
4935900|NCT00406315|16985573|P1|Overall Study|Lost to Follow-up|21
4935901|NCT00406315|16985573|P1|Overall Study|Other|33
4935902|NCT00406315|16985573|P1|Overall Study|Lack of Efficacy|13
4935903|NCT00406315|16985573|P1|Overall Study|Laboratory Abnormality|4
4935904|NCT00406315|16985573|P1|Overall Study|Adverse Event|39
4935905|NCT00406315|16985573|P1|Overall Study|Death|1
4935906|NCT00406029|16985683|P5|Overall Study|Randomized in Error|1
4935907|NCT00406029|16985684|P4|Overall Study|Randomized in Error|3
4935908|NCT00406029|16985685|P3|Overall Study|Randomized in Error|2
4935909|NCT00406029|16985686|P2|Overall Study|Randomized in Error|0
4935910|NCT00406029|16985687|P1|Overall Study|Randomized in Error|0
4935911|NCT00406029|16985683|P5|Overall Study|Did Not Meet Eligibility Criteria|0
4935912|NCT00406029|16985684|P4|Overall Study|Did Not Meet Eligibility Criteria|0
4935913|NCT00406029|16985685|P3|Overall Study|Did Not Meet Eligibility Criteria|1
4935914|NCT00406029|16985686|P2|Overall Study|Did Not Meet Eligibility Criteria|0
4935915|NCT00406029|16985687|P1|Overall Study|Did Not Meet Eligibility Criteria|0
4935916|NCT00406029|16985683|P5|Overall Study|Protocol Violation|0
4935917|NCT00406029|16985684|P4|Overall Study|Protocol Violation|2
4935918|NCT00406029|16985685|P3|Overall Study|Protocol Violation|0
4935919|NCT00406029|16985686|P2|Overall Study|Protocol Violation|2
4935920|NCT00406029|16985687|P1|Overall Study|Protocol Violation|1
4935921|NCT00406029|16985683|P5|Overall Study|Withdrawal by Subject|0
4935922|NCT00406029|16985684|P4|Overall Study|Withdrawal by Subject|2
4935923|NCT00406029|16985685|P3|Overall Study|Withdrawal by Subject|2
4935924|NCT00406029|16985686|P2|Overall Study|Withdrawal by Subject|4
4935925|NCT00406029|16985687|P1|Overall Study|Withdrawal by Subject|3
4935926|NCT00406029|16985683|P5|Overall Study|Adverse Event|7
4935927|NCT00406029|16985684|P4|Overall Study|Adverse Event|10
4935928|NCT00406029|16985685|P3|Overall Study|Adverse Event|5
4935929|NCT00406029|16985686|P2|Overall Study|Adverse Event|2
4935930|NCT00406029|16985687|P1|Overall Study|Adverse Event|12
4935931|NCT00405964|16985791|P2|Overall Study|Protocol Violation|6
4935932|NCT00405964|16985792|P1|Overall Study|Protocol Violation|11
4935933|NCT00405964|16985791|P2|Overall Study|Withdrawal by Subject|23
4935934|NCT00405964|16985792|P1|Overall Study|Withdrawal by Subject|19
4935935|NCT00405964|16985791|P2|Overall Study|Lost to Follow-up|5
4935936|NCT00405964|16985792|P1|Overall Study|Lost to Follow-up|5
4935937|NCT00405964|16985791|P2|Overall Study|Adverse Event|16
4935938|NCT00405964|16985792|P1|Overall Study|Adverse Event|7
4935939|NCT00405964|16985791|P2|Overall Study|Treatment Failure|45
4935940|NCT00405964|16985792|P1|Overall Study|Treatment Failure|17
4935941|NCT00405912|16985814|P3|Overall Study|Lost to Follow-up|4
4935942|NCT00405912|16985815|P2|Overall Study|Lost to Follow-up|8
4935943|NCT00405912|16985816|P1|Overall Study|Lost to Follow-up|4
4935944|NCT00405912|16985814|P3|Overall Study|Withdrawal by Subject|12
4935945|NCT00405912|16985815|P2|Overall Study|Withdrawal by Subject|11
4935946|NCT00405912|16985816|P1|Overall Study|Withdrawal by Subject|12
4935947|NCT00405821|16985829|P2|Overall Study|initiated ART|8
4935948|NCT00405821|16985830|P1|Overall Study|initiated ART|9
4935949|NCT00405821|16985829|P2|Overall Study|Protocol Violation|0
4935950|NCT00405821|16985830|P1|Overall Study|Protocol Violation|1
4935951|NCT00405821|16985829|P2|Overall Study|Lost to Follow-up|7
4935952|NCT00405821|16985830|P1|Overall Study|Lost to Follow-up|7
4935953|NCT00405821|16985829|P2|Overall Study|Death|7
4935954|NCT00405821|16985830|P1|Overall Study|Death|5
4935955|NCT00405756|16985843|P3|Follow-up|Lost to Follow-up|4
4935956|NCT00405756|16985844|P2|Follow-up|Lost to Follow-up|8
4935957|NCT00405756|16985845|P1|Follow-up|Lost to Follow-up|2
4935958|NCT00405756|16985843|P3|Follow-up|Death|24
4935959|NCT00405756|16985844|P2|Follow-up|Death|31
4935960|NCT00405756|16985845|P1|Follow-up|Death|21
4935961|NCT00405756|16985843|P3|Follow-up|Ongoing in Follow-up Period|60
4935962|NCT00405756|16985844|P2|Follow-up|Ongoing in Follow-up Period|51
4935963|NCT00405756|16985845|P1|Follow-up|Ongoing in Follow-up Period|52
4935964|NCT00405756|16985843|P3|Open-label Extension|Other|7
4935965|NCT00405756|16985844|P2|Open-label Extension|Other|1
4935966|NCT00405756|16985845|P1|Open-label Extension|Other|0
4935967|NCT00405756|16985843|P3|Open-label Extension|Death|4
4935968|NCT00405756|16985844|P2|Open-label Extension|Death|2
4935969|NCT00405756|16985845|P1|Open-label Extension|Death|1
4935970|NCT00405756|16985843|P3|Open-label Extension|Withdrawal by Subject|3
4935971|NCT00405756|16985844|P2|Open-label Extension|Withdrawal by Subject|3
4935972|NCT00405756|16985845|P1|Open-label Extension|Withdrawal by Subject|2
4935973|NCT00405756|16985843|P3|Open-label Extension|Disease Progression|26
4935975|NCT00405756|16985845|P1|Open-label Extension|Disease Progression|8
4935976|NCT00405756|16985843|P3|Open-label Extension|Adverse Event|7
4935977|NCT00405756|16985844|P2|Open-label Extension|Adverse Event|3
4935978|NCT00405756|16985845|P1|Open-label Extension|Adverse Event|1
4935979|NCT00405756|16985843|P3|Open-label Extension|Ongoing in Open Label Period|25
4935980|NCT00405756|16985844|P2|Open-label Extension|Ongoing in Open Label Period|15
4935981|NCT00405756|16985845|P1|Open-label Extension|Ongoing in Open Label Period|7
4935982|NCT00405756|16985843|P3|Double-blind Treatment|Other|4
4935983|NCT00405756|16985844|P2|Double-blind Treatment|Other|4
4935984|NCT00405756|16985845|P1|Double-blind Treatment|Other|7
4935985|NCT00405756|16985843|P3|Double-blind Treatment|Protocol Violation|2
4935986|NCT00405756|16985844|P2|Double-blind Treatment|Protocol Violation|0
4935987|NCT00405756|16985845|P1|Double-blind Treatment|Protocol Violation|1
4935988|NCT00405756|16985843|P3|Double-blind Treatment|Death|4
4935989|NCT00405756|16985844|P2|Double-blind Treatment|Death|4
4935990|NCT00405756|16985845|P1|Double-blind Treatment|Death|4
4935991|NCT00405756|16985843|P3|Double-blind Treatment|Lost to Follow-up|0
4935992|NCT00405756|16985844|P2|Double-blind Treatment|Lost to Follow-up|0
4935993|NCT00405756|16985845|P1|Double-blind Treatment|Lost to Follow-up|1
4935994|NCT00405756|16985843|P3|Double-blind Treatment|Withdrawal by Subject|10
4935995|NCT00405756|16985844|P2|Double-blind Treatment|Withdrawal by Subject|9
4935996|NCT00405756|16985845|P1|Double-blind Treatment|Withdrawal by Subject|15
4935997|NCT00405756|16985843|P3|Double-blind Treatment|Lack of Efficacy|2
4935998|NCT00405756|16985844|P2|Double-blind Treatment|Lack of Efficacy|4
4935999|NCT00405756|16985845|P1|Double-blind Treatment|Lack of Efficacy|1
4936000|NCT00405756|16985843|P3|Double-blind Treatment|Disease Progression|102
4936001|NCT00405756|16985844|P2|Double-blind Treatment|Disease Progression|81
4936002|NCT00405756|16985845|P1|Double-blind Treatment|Disease Progression|47
4936003|NCT00405756|16985843|P3|Double-blind Treatment|Adverse Event|12
4936004|NCT00405756|16985844|P2|Double-blind Treatment|Adverse Event|27
4936005|NCT00405756|16985845|P1|Double-blind Treatment|Adverse Event|31
4936006|NCT00405756|16985843|P3|Double-blind Treatment|Ongoing in Double-blind Treatment|18
4936007|NCT00405756|16985844|P2|Double-blind Treatment|Ongoing in Double-blind Treatment|24
4936008|NCT00405756|16985845|P1|Double-blind Treatment|Ongoing in Double-blind Treatment|45
4936009|NCT00405652|16985956|P1|Overall Study|Adverse Event|4
4936010|NCT00405639|16985963|P2|Overall Study|Seizure prior to receiving BNP|0
4936011|NCT00405639|16985964|P1|Overall Study|Seizure prior to receiving BNP|1
4936012|NCT00405639|16985963|P2|Overall Study|Adverse Event|0
4936013|NCT00405639|16985964|P1|Overall Study|Adverse Event|1
4936014|NCT00405639|16985963|P2|Overall Study|Withdrawal by Subject|0
4936015|NCT00405639|16985964|P1|Overall Study|Withdrawal by Subject|1
4936016|NCT00405587|16985980|P4|Overall Study|Participant not dosed|0
4936017|NCT00405587|16985981|P3|Overall Study|Participant not dosed|0
4936018|NCT00405587|16985982|P2|Overall Study|Participant not dosed|1
4936019|NCT00405587|16985983|P1|Overall Study|Participant not dosed|0
4936020|NCT00405587|16985980|P4|Overall Study|Withdrawal by Subject|2
4936021|NCT00405587|16985981|P3|Overall Study|Withdrawal by Subject|0
4936022|NCT00405587|16985982|P2|Overall Study|Withdrawal by Subject|0
4936023|NCT00405587|16985983|P1|Overall Study|Withdrawal by Subject|0
4936024|NCT00405587|16985980|P4|Overall Study|Radiation induced necrosis|0
4936025|NCT00405587|16985981|P3|Overall Study|Radiation induced necrosis|0
4936026|NCT00405587|16985982|P2|Overall Study|Radiation induced necrosis|1
4936027|NCT00405587|16985983|P1|Overall Study|Radiation induced necrosis|0
4936028|NCT00405587|16985980|P4|Overall Study|Lost to Follow-up|0
4936029|NCT00405587|16985981|P3|Overall Study|Lost to Follow-up|1
4936030|NCT00405587|16985982|P2|Overall Study|Lost to Follow-up|1
4936031|NCT00405587|16985983|P1|Overall Study|Lost to Follow-up|0
4936032|NCT00405587|16985980|P4|Overall Study|Adverse Event|0
4936033|NCT00405587|16985981|P3|Overall Study|Adverse Event|0
4936034|NCT00405587|16985982|P2|Overall Study|Adverse Event|0
4936035|NCT00405587|16985983|P1|Overall Study|Adverse Event|1
4936036|NCT00405587|16985980|P4|Overall Study|Physician Decision|0
4936037|NCT00405587|16985981|P3|Overall Study|Physician Decision|0
4936038|NCT00405587|16985982|P2|Overall Study|Physician Decision|2
4936039|NCT00405587|16985983|P1|Overall Study|Physician Decision|3
4936040|NCT00405587|16985980|P4|Overall Study|Disease Progression|17
4936041|NCT00405587|16985981|P3|Overall Study|Disease Progression|21
4936042|NCT00405587|16985982|P2|Overall Study|Disease Progression|23
4936043|NCT00405587|16985983|P1|Overall Study|Disease Progression|22
4936044|NCT00405587|16985980|P4|Overall Study|Death|1
4936045|NCT00405587|16985981|P3|Overall Study|Death|0
4936046|NCT00405587|16985982|P2|Overall Study|Death|0
4936047|NCT00405587|16985983|P1|Overall Study|Death|0
4936048|NCT00405548|16986101|P2|Overall Study|Withdrawal by Subject|0
4936049|NCT00405548|16986102|P1|Overall Study|Withdrawal by Subject|1
4936050|NCT00405548|16986101|P2|Overall Study|Venous access failed during study day|0
4936051|NCT00405548|16986102|P1|Overall Study|Venous access failed during study day|1
4936052|NCT00405548|16986101|P2|Overall Study|Unable to self-administer shots|0
4936053|NCT00405548|16986102|P1|Overall Study|Unable to self-administer shots|1
4936054|NCT00405548|16986101|P2|Overall Study|Amyloidosis on study echo-exclusionary|1
4936055|NCT00405548|16986102|P1|Overall Study|Amyloidosis on study echo-exclusionary|0
4936056|NCT00405548|16986101|P2|Overall Study|Cognitive Memory problems on study day|0
4936057|NCT00405548|16986102|P1|Overall Study|Cognitive Memory problems on study day|1
4936058|NCT00405392|16986146|P2|Overall Study|Other|5
4936059|NCT00405392|16986147|P1|Overall Study|Other|1
4936060|NCT00405392|16986146|P2|Overall Study|Non-compliance|1
4936061|NCT00405392|16986147|P1|Overall Study|Non-compliance|0
4936062|NCT00405392|16986146|P2|Overall Study|Data missing|0
4936063|NCT00405392|16986147|P1|Overall Study|Data missing|2
4936064|NCT00405392|16986146|P2|Overall Study|Lost to Follow-up|2
4936065|NCT00405392|16986147|P1|Overall Study|Lost to Follow-up|1
4936066|NCT00405392|16986146|P2|Overall Study|Withdrawal by Subject|3
4936067|NCT00405392|16986147|P1|Overall Study|Withdrawal by Subject|4
4936068|NCT00405392|16986146|P2|Overall Study|Did not meet Eligibility criteria|2
4936069|NCT00405392|16986147|P1|Overall Study|Did not meet Eligibility criteria|7
4936070|NCT00405392|16986146|P2|Overall Study|Adverse Event|14
4936071|NCT00405392|16986147|P1|Overall Study|Adverse Event|15
4936072|NCT00405275|16986194|P2|Overall Study|Unwilling to continue|9
4936073|NCT00405275|16986195|P1|Overall Study|Unwilling to continue|10
4936074|NCT00405275|16986194|P2|Overall Study|Withdrawal by Subject|9
4936075|NCT00405275|16986195|P1|Overall Study|Withdrawal by Subject|7
4936076|NCT00405275|16986194|P2|Overall Study|Lost to Follow-up|1
4936077|NCT00405275|16986195|P1|Overall Study|Lost to Follow-up|5
4936078|NCT00405275|16986194|P2|Overall Study|Death|0
4936079|NCT00405275|16986195|P1|Overall Study|Death|1
4936080|NCT00405067|16986204|P3|Overall Study|Lost to Follow-up|1
4936081|NCT00405067|16986205|P2|Overall Study|Lost to Follow-up|0
4936082|NCT00405067|16986206|P1|Overall Study|Lost to Follow-up|0
4936083|NCT00405067|16986204|P3|Overall Study|Adverse Event|4
4936084|NCT00405067|16986205|P2|Overall Study|Adverse Event|9
4936085|NCT00405067|16986206|P1|Overall Study|Adverse Event|4
4936086|NCT00404924|16986243|P2|Overall Study|Randomised but not received treatment|1
4936087|NCT00404924|16986244|P1|Overall Study|Randomised but not received treatment|1
4936088|NCT00404924|16986243|P2|Overall Study|Other|11
4936089|NCT00404924|16986244|P1|Overall Study|Other|25
4936090|NCT00404924|16986243|P2|Overall Study|Withdrawal by Subject|13
4936091|NCT00404924|16986244|P1|Overall Study|Withdrawal by Subject|26
4936092|NCT00404924|16986243|P2|Overall Study|Lost to Follow-up|1
4936093|NCT00404924|16986244|P1|Overall Study|Lost to Follow-up|1
4936094|NCT00404924|16986243|P2|Overall Study|Condition under investigation worsened|264
4936095|NCT00404924|16986244|P1|Overall Study|Condition under investigation worsened|475
4936096|NCT00404924|16986243|P2|Overall Study|Adverse Event|16
4936097|NCT00404924|16986244|P1|Overall Study|Adverse Event|75
4936098|NCT00404820|16986262|P2|Overall Study|Other|2
4936099|NCT00404820|16986263|P1|Overall Study|Other|0
4936100|NCT00404820|16986262|P2|Overall Study|Death|0
4936101|NCT00404820|16986263|P1|Overall Study|Death|1
4936102|NCT00404820|16986262|P2|Overall Study|Administrative problems|0
4936103|NCT00404820|16986263|P1|Overall Study|Administrative problems|2
4936104|NCT00404820|16986262|P2|Overall Study|Lost to Follow-up|3
4936105|NCT00404820|16986263|P1|Overall Study|Lost to Follow-up|7
4936106|NCT00404820|16986262|P2|Overall Study|Withdrawal by Subject|3
4936107|NCT00404820|16986263|P1|Overall Study|Withdrawal by Subject|5
4936108|NCT00404820|16986262|P2|Overall Study|Adverse Event|16
4936109|NCT00404820|16986263|P1|Overall Study|Adverse Event|4
4936110|NCT00404768|16986285|P4|Part C|Researcher suspended study medication|1
4936111|NCT00404768|16986286|P3|Part C|Researcher suspended study medication|0
4936112|NCT00404768|16986287|P2|Part C|Researcher suspended study medication|0
4936113|NCT00404768|16986288|P1|Part C|Researcher suspended study medication|0
4936114|NCT00404768|16986285|P4|Part C|Investigator discretion|1
4936115|NCT00404768|16986286|P3|Part C|Investigator discretion|0
4936116|NCT00404768|16986287|P2|Part C|Investigator discretion|0
4936117|NCT00404768|16986288|P1|Part C|Investigator discretion|0
4936118|NCT00404768|16986285|P4|Part C|Treatment failure|1
4936119|NCT00404768|16986286|P3|Part C|Treatment failure|0
4936120|NCT00404768|16986287|P2|Part C|Treatment failure|0
4936121|NCT00404768|16986288|P1|Part C|Treatment failure|0
4936122|NCT00404768|16986285|P4|Part C|Lack of Efficacy|2
4936123|NCT00404768|16986286|P3|Part C|Lack of Efficacy|0
4936124|NCT00404768|16986287|P2|Part C|Lack of Efficacy|0
4936125|NCT00404768|16986288|P1|Part C|Lack of Efficacy|0
4936126|NCT00404768|16986285|P4|Part C|Active labor|1
4936127|NCT00404768|16986286|P3|Part C|Active labor|0
4936128|NCT00404768|16986287|P2|Part C|Active labor|0
4936129|NCT00404768|16986288|P1|Part C|Active labor|0
4936130|NCT00404768|16986285|P4|Part C|Unsatisfactory uterine response to IP|1
4936131|NCT00404768|16986286|P3|Part C|Unsatisfactory uterine response to IP|0
4936132|NCT00404768|16986287|P2|Part C|Unsatisfactory uterine response to IP|0
4936133|NCT00404768|16986288|P1|Part C|Unsatisfactory uterine response to IP|0
4936134|NCT00404768|16986285|P4|Part C|Participant delivered baby|1
4936135|NCT00404768|16986286|P3|Part C|Participant delivered baby|0
4936136|NCT00404768|16986287|P2|Part C|Participant delivered baby|0
4936137|NCT00404768|16986288|P1|Part C|Participant delivered baby|0
4936138|NCT00404768|16986285|P4|Part C|Physician withdrew the study medication|0
4936139|NCT00404768|16986286|P3|Part C|Physician withdrew the study medication|1
4936140|NCT00404768|16986287|P2|Part C|Physician withdrew the study medication|0
4936141|NCT00404768|16986288|P1|Part C|Physician withdrew the study medication|0
4936142|NCT00404768|16986285|P4|Part C|Participant did not respond to therapy|1
4936143|NCT00404768|16986286|P3|Part C|Participant did not respond to therapy|1
4936144|NCT00404768|16986287|P2|Part C|Participant did not respond to therapy|0
4936145|NCT00404768|16986288|P1|Part C|Participant did not respond to therapy|0
4936146|NCT00404768|16986285|P4|Part C|Early withdrawal from study medication|0
4936147|NCT00404768|16986286|P3|Part C|Early withdrawal from study medication|1
4936148|NCT00404768|16986287|P2|Part C|Early withdrawal from study medication|0
4936149|NCT00404768|16986288|P1|Part C|Early withdrawal from study medication|0
4936150|NCT00404768|16986285|P4|Part C|Withdrawal by Subject|1
4936151|NCT00404768|16986286|P3|Part C|Withdrawal by Subject|2
4936152|NCT00404768|16986287|P2|Part C|Withdrawal by Subject|0
4936153|NCT00404768|16986288|P1|Part C|Withdrawal by Subject|0
4936154|NCT00404768|16986285|P4|Part C|Lost to Follow-up|1
4936155|NCT00404768|16986286|P3|Part C|Lost to Follow-up|3
4936156|NCT00404768|16986287|P2|Part C|Lost to Follow-up|0
4936157|NCT00404768|16986288|P1|Part C|Lost to Follow-up|0
4936158|NCT00404768|16986285|P4|Part C|Adverse Event|3
4936159|NCT00404768|16986286|P3|Part C|Adverse Event|0
4936160|NCT00404768|16986287|P2|Part C|Adverse Event|0
4936161|NCT00404768|16986288|P1|Part C|Adverse Event|0
4936162|NCT00404768|16986285|P4|Part A and B|Withdrawn as delivery imminemnt|0
4936163|NCT00404768|16986286|P3|Part A and B|Withdrawn as delivery imminemnt|0
4936164|NCT00404768|16986287|P2|Part A and B|Withdrawn as delivery imminemnt|1
4936165|NCT00404768|16986288|P1|Part A and B|Withdrawn as delivery imminemnt|0
4936166|NCT00404768|16986285|P4|Part A and B|Withdrawn due to labor progression|0
4936167|NCT00404768|16986286|P3|Part A and B|Withdrawn due to labor progression|0
4936168|NCT00404768|16986287|P2|Part A and B|Withdrawn due to labor progression|0
4936169|NCT00404768|16986288|P1|Part A and B|Withdrawn due to labor progression|1
4936170|NCT00404755|16986349|P1|Phase II (Escitalopram)|Lost to Follow-up|2
4936171|NCT00404755|16986349|P1|Phase I (Bupropion)|Other|1
4936172|NCT00404755|16986349|P1|Phase I (Bupropion)|Adverse Event|3
4936173|NCT00404651|16986364|P4|Overall Study|Withdrawal by Subject|6
4936174|NCT00404651|16986365|P3|Overall Study|Withdrawal by Subject|16
4936175|NCT00404651|16986366|P2|Overall Study|Withdrawal by Subject|12
4936176|NCT00404651|16986367|P1|Overall Study|Withdrawal by Subject|14
4936177|NCT00404651|16986364|P4|Overall Study|Lost to Follow-up|10
4936178|NCT00404651|16986365|P3|Overall Study|Lost to Follow-up|13
4936179|NCT00404651|16986366|P2|Overall Study|Lost to Follow-up|11
4936180|NCT00404651|16986367|P1|Overall Study|Lost to Follow-up|15
4936181|NCT00404651|16986364|P4|Overall Study|Protocol Violation|5
4936182|NCT00404651|16986365|P3|Overall Study|Protocol Violation|14
4936183|NCT00404651|16986366|P2|Overall Study|Protocol Violation|5
4936184|NCT00404651|16986367|P1|Overall Study|Protocol Violation|10
4936185|NCT00404651|16986364|P4|Overall Study|Serious Adverse Event|0
4936186|NCT00404651|16986365|P3|Overall Study|Serious Adverse Event|2
4936187|NCT00404651|16986366|P2|Overall Study|Serious Adverse Event|0
4936188|NCT00404651|16986367|P1|Overall Study|Serious Adverse Event|0
4936189|NCT00404547|16986395|P2|Overall Study|Reason not stated|6
4936190|NCT00404547|16986396|P1|Overall Study|Reason not stated|3
4936191|NCT00404547|16986395|P2|Overall Study|Other|0
4936192|NCT00404547|16986396|P1|Overall Study|Other|4
4936193|NCT00404547|16986395|P2|Overall Study|Lack of compliance|1
4936194|NCT00404547|16986396|P1|Overall Study|Lack of compliance|5
4936195|NCT00404547|16986395|P2|Overall Study|Lost to Follow-up|9
4936196|NCT00404547|16986396|P1|Overall Study|Lost to Follow-up|20
4936197|NCT00404547|16986395|P2|Overall Study|Protocol Violation|1
4936198|NCT00404547|16986396|P1|Overall Study|Protocol Violation|0
4936199|NCT00404547|16986395|P2|Overall Study|Withdrawal by Subject|2
4936200|NCT00404547|16986396|P1|Overall Study|Withdrawal by Subject|19
4936201|NCT00404547|16986395|P2|Overall Study|Adverse Event|6
4936202|NCT00404547|16986396|P1|Overall Study|Adverse Event|39
4936203|NCT00404495|16986406|P2|Overall Study|Withdrawal by Subject|0
4936204|NCT00404495|16986407|P1|Overall Study|Withdrawal by Subject|1
4936205|NCT00404495|16986406|P2|Overall Study|Other|0
4936206|NCT00404495|16986407|P1|Overall Study|Other|1
4936207|NCT00404495|16986406|P2|Overall Study|Lost to Follow-up|0
4936208|NCT00404495|16986407|P1|Overall Study|Lost to Follow-up|5
4936209|NCT00404495|16986406|P2|Overall Study|Death|11
4936210|NCT00404495|16986407|P1|Overall Study|Death|37
4936211|NCT00404352|16986426|P9|Open Label Extension (up to 36 Months)|Other|2
4936212|NCT00404352|16986427|P8|Open Label Extension (up to 36 Months)|Other|0
4936213|NCT00404352|16986428|P7|Open Label Extension (up to 36 Months)|Other|0
4936214|NCT00404352|16986429|P6|Open Label Extension (up to 36 Months)|Other|0
4936215|NCT00404352|16986430|P5|Open Label Extension (up to 36 Months)|Other|0
4936216|NCT00404352|16986431|P4|Open Label Extension (up to 36 Months)|Other|0
4936217|NCT00404352|16986432|P3|Open Label Extension (up to 36 Months)|Other|0
4936218|NCT00404352|16986433|P2|Open Label Extension (up to 36 Months)|Other|0
4936219|NCT00404352|16986434|P1|Open Label Extension (up to 36 Months)|Other|0
4936220|NCT00404352|16986426|P9|Open Label Extension (up to 36 Months)|Adverse Event|0
4936221|NCT00404352|16986427|P8|Open Label Extension (up to 36 Months)|Adverse Event|1
4936222|NCT00404352|16986428|P7|Open Label Extension (up to 36 Months)|Adverse Event|1
4936223|NCT00404352|16986429|P6|Open Label Extension (up to 36 Months)|Adverse Event|0
4936224|NCT00404352|16986430|P5|Open Label Extension (up to 36 Months)|Adverse Event|0
4936225|NCT00404352|16986431|P4|Open Label Extension (up to 36 Months)|Adverse Event|0
4936226|NCT00404352|16986432|P3|Open Label Extension (up to 36 Months)|Adverse Event|0
4936227|NCT00404352|16986433|P2|Open Label Extension (up to 36 Months)|Adverse Event|0
4936228|NCT00404352|16986434|P1|Open Label Extension (up to 36 Months)|Adverse Event|0
4936229|NCT00404352|16986426|P9|Open Label (up to 24 Month)|Disease progression|0
4936230|NCT00404352|16986427|P8|Open Label (up to 24 Month)|Disease progression|0
4936231|NCT00404352|16986428|P7|Open Label (up to 24 Month)|Disease progression|0
4936232|NCT00404352|16986429|P6|Open Label (up to 24 Month)|Disease progression|0
4936233|NCT00404352|16986430|P5|Open Label (up to 24 Month)|Disease progression|0
4936234|NCT00404352|16986431|P4|Open Label (up to 24 Month)|Disease progression|1
4936235|NCT00404352|16986432|P3|Open Label (up to 24 Month)|Disease progression|0
4936236|NCT00404352|16986433|P2|Open Label (up to 24 Month)|Disease progression|0
4936237|NCT00404352|16986434|P1|Open Label (up to 24 Month)|Disease progression|0
4936238|NCT00404352|16986426|P9|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936239|NCT00404352|16986427|P8|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936240|NCT00404352|16986428|P7|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936241|NCT00404352|16986429|P6|Open Label (up to 24 Month)|Withdrawal by Subject|5
4936242|NCT00404352|16986430|P5|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936243|NCT00404352|16986431|P4|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936244|NCT00404352|16986432|P3|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936245|NCT00404352|16986433|P2|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936246|NCT00404352|16986434|P1|Open Label (up to 24 Month)|Withdrawal by Subject|0
4936247|NCT00404352|16986426|P9|Open Label (up to 24 Month)|Lost to Follow-up|0
4936248|NCT00404352|16986427|P8|Open Label (up to 24 Month)|Lost to Follow-up|0
4936249|NCT00404352|16986428|P7|Open Label (up to 24 Month)|Lost to Follow-up|0
4936250|NCT00404352|16986429|P6|Open Label (up to 24 Month)|Lost to Follow-up|0
4936251|NCT00404352|16986430|P5|Open Label (up to 24 Month)|Lost to Follow-up|1
4936252|NCT00404352|16986431|P4|Open Label (up to 24 Month)|Lost to Follow-up|0
4936253|NCT00404352|16986432|P3|Open Label (up to 24 Month)|Lost to Follow-up|0
4936254|NCT00404352|16986433|P2|Open Label (up to 24 Month)|Lost to Follow-up|0
4936255|NCT00404352|16986434|P1|Open Label (up to 24 Month)|Lost to Follow-up|0
4936256|NCT00404352|16986426|P9|Open Label (up to 24 Month)|Pregnancy|0
4936257|NCT00404352|16986427|P8|Open Label (up to 24 Month)|Pregnancy|0
4936258|NCT00404352|16986428|P7|Open Label (up to 24 Month)|Pregnancy|0
4936259|NCT00404352|16986429|P6|Open Label (up to 24 Month)|Pregnancy|1
4936260|NCT00404352|16986430|P5|Open Label (up to 24 Month)|Pregnancy|0
4936261|NCT00404352|16986431|P4|Open Label (up to 24 Month)|Pregnancy|0
4936262|NCT00404352|16986432|P3|Open Label (up to 24 Month)|Pregnancy|0
4936263|NCT00404352|16986433|P2|Open Label (up to 24 Month)|Pregnancy|0
4936264|NCT00404352|16986434|P1|Open Label (up to 24 Month)|Pregnancy|0
4936265|NCT00404352|16986426|P9|Open Label (up to 24 Month)|Adverse Event|0
4936266|NCT00404352|16986427|P8|Open Label (up to 24 Month)|Adverse Event|0
4936267|NCT00404352|16986428|P7|Open Label (up to 24 Month)|Adverse Event|0
4936268|NCT00404352|16986429|P6|Open Label (up to 24 Month)|Adverse Event|1
4936269|NCT00404352|16986430|P5|Open Label (up to 24 Month)|Adverse Event|1
4936270|NCT00404352|16986431|P4|Open Label (up to 24 Month)|Adverse Event|2
4936271|NCT00404352|16986432|P3|Open Label (up to 24 Month)|Adverse Event|0
4936272|NCT00404352|16986433|P2|Open Label (up to 24 Month)|Adverse Event|0
4936273|NCT00404352|16986434|P1|Open Label (up to 24 Month)|Adverse Event|0
4936274|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Other|0
4936275|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Other|0
4936276|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Other|0
4936277|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Other|0
4936278|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Other|0
4936279|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Other|0
4936280|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Other|0
4936281|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Other|1
4936282|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Other|0
4936283|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Physician Decision|0
4936284|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Physician Decision|0
4936285|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Physician Decision|0
4936286|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Physician Decision|0
4936287|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Physician Decision|0
4936288|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Physician Decision|0
4936289|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Physician Decision|1
4936290|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Physician Decision|0
4936291|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Physician Decision|0
4936292|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Randomized but not treated|0
4936293|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Randomized but not treated|0
4936294|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Randomized but not treated|0
4936295|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Randomized but not treated|0
4936296|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Randomized but not treated|0
4936297|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Randomized but not treated|0
4936298|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Randomized but not treated|0
4936299|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Randomized but not treated|2
4936300|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Randomized but not treated|0
4936301|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Switched to open label phase|0
4936302|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Switched to open label phase|0
4936303|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Switched to open label phase|0
4936304|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Switched to open label phase|0
4936305|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Switched to open label phase|0
4936306|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Switched to open label phase|0
4936307|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Switched to open label phase|59
4936308|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Switched to open label phase|30
4936309|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Switched to open label phase|31
4936310|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Poor compliance|0
4936557|NCT00402688|16987124|P2|Overall Study|Lack of Efficacy|4
4936311|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Poor compliance|0
4936312|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Poor compliance|0
4936313|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Poor compliance|0
4936314|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Poor compliance|0
4936315|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Poor compliance|0
4936316|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Poor compliance|0
4936317|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Poor compliance|0
4936318|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Poor compliance|1
4936319|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Disease progression|0
4936320|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Disease progression|0
4936321|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Disease progression|0
4936322|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Disease progression|0
4936323|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Disease progression|0
4936324|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Disease progression|0
4936325|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Disease progression|2
4936326|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Disease progression|0
4936327|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Disease progression|3
4936328|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4936329|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4936330|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4936331|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4936332|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4936333|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Withdrawal by Subject|0
4936334|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Withdrawal by Subject|7
4936335|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Withdrawal by Subject|8
4936336|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Withdrawal by Subject|11
4936337|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Lost to Follow-up|0
4936338|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Lost to Follow-up|0
4936339|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Lost to Follow-up|0
4936340|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Lost to Follow-up|0
4936341|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Lost to Follow-up|0
4936342|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Lost to Follow-up|0
4936343|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Lost to Follow-up|1
4936344|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Lost to Follow-up|2
4936345|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Lost to Follow-up|1
4936346|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Death|0
4936347|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Death|0
4936348|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Death|0
4936349|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Death|0
4936350|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Death|0
4936351|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Death|0
4936352|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Death|1
4936353|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Death|0
4936354|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Death|0
4936355|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Pregnancy|0
4936356|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Pregnancy|0
4936357|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Pregnancy|0
4936358|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Pregnancy|0
4936359|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Pregnancy|0
4936360|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Pregnancy|0
4936361|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Pregnancy|2
4936362|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Pregnancy|0
4936363|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Pregnancy|0
4936364|NCT00404352|16986426|P9|Double Blind (up to 24 Month)|Adverse Event|0
4936365|NCT00404352|16986427|P8|Double Blind (up to 24 Month)|Adverse Event|0
4936366|NCT00404352|16986428|P7|Double Blind (up to 24 Month)|Adverse Event|0
4936367|NCT00404352|16986429|P6|Double Blind (up to 24 Month)|Adverse Event|0
4936368|NCT00404352|16986430|P5|Double Blind (up to 24 Month)|Adverse Event|0
4936369|NCT00404352|16986431|P4|Double Blind (up to 24 Month)|Adverse Event|0
4936370|NCT00404352|16986432|P3|Double Blind (up to 24 Month)|Adverse Event|6
4936371|NCT00404352|16986433|P2|Double Blind (up to 24 Month)|Adverse Event|4
4936372|NCT00404352|16986434|P1|Double Blind (up to 24 Month)|Adverse Event|5
4936373|NCT00404248|16986469|P9|Overall Study|pts declining status|0
4936374|NCT00404248|16986470|P8|Overall Study|pts declining status|0
4936375|NCT00404248|16986471|P7|Overall Study|pts declining status|0
4936376|NCT00404248|16986472|P6|Overall Study|pts declining status|0
4936377|NCT00404248|16986473|P5|Overall Study|pts declining status|0
4936378|NCT00404248|16986474|P4|Overall Study|pts declining status|0
4936379|NCT00404248|16986475|P3|Overall Study|pts declining status|0
4936380|NCT00404248|16986476|P2|Overall Study|pts declining status|1
4936381|NCT00404248|16986477|P1|Overall Study|pts declining status|0
4936382|NCT00404235|16986510|P2|Overall Study|Withdrawal by Subject|2
4936383|NCT00404235|16986511|P1|Overall Study|Withdrawal by Subject|1
4936384|NCT00404092|16986529|P4|Overall Study|Adverse Event|0
4936385|NCT00404092|16986530|P3|Overall Study|Adverse Event|1
4936386|NCT00404092|16986531|P2|Overall Study|Adverse Event|0
4936387|NCT00404092|16986532|P1|Overall Study|Adverse Event|0
4936388|NCT00404092|16986529|P4|Overall Study|Death|0
4936389|NCT00404092|16986530|P3|Overall Study|Death|0
4936390|NCT00404092|16986531|P2|Overall Study|Death|0
4936391|NCT00404092|16986532|P1|Overall Study|Death|1
4936392|NCT00404079|16986548|P2|Overall Study|Lost to follow up, adverse event etc|20
4936393|NCT00404079|16986549|P1|Overall Study|Lost to follow up, adverse event etc|22
4936394|NCT00404066|16986555|P1|Overall Study|Withdrawal by Subject - Adverse event|2
4936395|NCT00404066|16986555|P1|Overall Study|Withdrawal by Subject - Pre-treatment|1
4936396|NCT00403845|16986560|P4|Treatment Period 3|Adverse Event|1
4936397|NCT00403845|16986561|P3|Treatment Period 3|Adverse Event|0
4936398|NCT00403845|16986562|P2|Treatment Period 3|Adverse Event|0
4936399|NCT00403845|16986563|P1|Treatment Period 3|Adverse Event|0
4936400|NCT00403845|16986560|P4|Treatment Period 3|Subject withdrew consent|1
4936401|NCT00403845|16986561|P3|Treatment Period 3|Subject withdrew consent|0
4936402|NCT00403845|16986562|P2|Treatment Period 3|Subject withdrew consent|0
4936403|NCT00403845|16986563|P1|Treatment Period 3|Subject withdrew consent|0
4936404|NCT00403845|16986560|P4|Treatment Period 2|Subject withdrew consent|0
4936405|NCT00403845|16986561|P3|Treatment Period 2|Subject withdrew consent|0
4936406|NCT00403845|16986562|P2|Treatment Period 2|Subject withdrew consent|0
4936407|NCT00403845|16986563|P1|Treatment Period 2|Subject withdrew consent|1
4936408|NCT00403845|16986560|P4|Treatment Period 1|Subject no longer needs study drug|1
4936409|NCT00403845|16986561|P3|Treatment Period 1|Subject no longer needs study drug|0
4936410|NCT00403845|16986562|P2|Treatment Period 1|Subject no longer needs study drug|0
4936411|NCT00403845|16986563|P1|Treatment Period 1|Subject no longer needs study drug|0
4936412|NCT00403845|16986560|P4|Treatment Period 1|Subject withdrew consent|0
4936413|NCT00403845|16986561|P3|Treatment Period 1|Subject withdrew consent|0
4936414|NCT00403845|16986562|P2|Treatment Period 1|Subject withdrew consent|0
4936415|NCT00403845|16986563|P1|Treatment Period 1|Subject withdrew consent|1
4936416|NCT00403767|16986587|P2|Overall Study|Missing/incomplete data|1
4936417|NCT00403767|16986588|P1|Overall Study|Missing/incomplete data|1
4936418|NCT00403767|16986587|P2|Overall Study|Study terminated by sponsor|69
4936419|NCT00403767|16986588|P1|Overall Study|Study terminated by sponsor|82
4936420|NCT00403767|16986587|P2|Overall Study|Clinical efficacy endpoint reached|332
4936421|NCT00403767|16986588|P1|Overall Study|Clinical efficacy endpoint reached|300
4936422|NCT00403767|16986587|P2|Overall Study|Protocol Violation|124
4936423|NCT00403767|16986588|P1|Overall Study|Protocol Violation|142
4936424|NCT00403767|16986587|P2|Overall Study|Lost to Follow-up|8
4936425|NCT00403767|16986588|P1|Overall Study|Lost to Follow-up|6
4936426|NCT00403767|16986587|P2|Overall Study|Investigator dec./not protocol-related|178
4936427|NCT00403767|16986588|P1|Overall Study|Investigator dec./not protocol-related|191
4936428|NCT00403767|16986587|P2|Overall Study|Consent withdrawn|673
4936429|NCT00403767|16986588|P1|Overall Study|Consent withdrawn|671
4936430|NCT00403767|16986587|P2|Overall Study|Non-compliant with study medication|164
4936431|NCT00403767|16986588|P1|Overall Study|Non-compliant with study medication|134
4936432|NCT00403767|16986587|P2|Overall Study|Adverse Event|919
4936433|NCT00403767|16986588|P1|Overall Study|Adverse Event|993
4936434|NCT00403754|16986612|P4|Core Treatment Period 2|Lack of Efficacy|0
4936435|NCT00403754|16986613|P3|Core Treatment Period 2|Lack of Efficacy|1
4936436|NCT00403754|16986614|P2|Core Treatment Period 2|Lack of Efficacy|0
4936437|NCT00403754|16986615|P1|Core Treatment Period 2|Lack of Efficacy|0
4936438|NCT00403754|16986612|P4|Core Treatment Period 1|Withdrawal by Subject|0
4936439|NCT00403754|16986613|P3|Core Treatment Period 1|Withdrawal by Subject|0
4936440|NCT00403754|16986614|P2|Core Treatment Period 1|Withdrawal by Subject|1
4936441|NCT00403754|16986615|P1|Core Treatment Period 1|Withdrawal by Subject|0
4936442|NCT00403585|16986642|P1|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4
4936443|NCT00403585|16986642|P1|Open-Label Phase; Extension Study|Withdrawal by Subject|2
4936444|NCT00403585|16986642|P1|Initial Treatment Phase|Lost to Follow-up|2
4936445|NCT00403546|16986653|P3|Randomized Trial|Early Terminations|16
4936446|NCT00403546|16986654|P2|Randomized Trial|Early Terminations|17
4936447|NCT00403546|16986655|P1|Randomized Trial|Early Terminations|0
4936448|NCT00403546|16986653|P3|Screening Phase|Terminated Prior to Randomization|0
4936449|NCT00403546|16986654|P2|Screening Phase|Terminated Prior to Randomization|0
4936450|NCT00403546|16986655|P1|Screening Phase|Terminated Prior to Randomization|5
4936451|NCT00403546|16986653|P3|Screening Phase|Adverse Event|0
4936452|NCT00403546|16986654|P2|Screening Phase|Adverse Event|0
4936453|NCT00403546|16986655|P1|Screening Phase|Adverse Event|1
4936454|NCT00403546|16986653|P3|Screening Phase|Screening Failure|0
4936455|NCT00403546|16986654|P2|Screening Phase|Screening Failure|0
4936456|NCT00403546|16986655|P1|Screening Phase|Screening Failure|22
4936457|NCT00403546|16986653|P3|Signed Informed Consent/Open-Label|Adverse Event|0
4936458|NCT00403546|16986654|P2|Signed Informed Consent/Open-Label|Adverse Event|0
4936459|NCT00403546|16986655|P1|Signed Informed Consent/Open-Label|Adverse Event|5
4936460|NCT00403546|16986653|P3|Signed Informed Consent/Open-Label|Terminated by Investigator|0
4936461|NCT00403546|16986654|P2|Signed Informed Consent/Open-Label|Terminated by Investigator|0
4936462|NCT00403546|16986655|P1|Signed Informed Consent/Open-Label|Terminated by Investigator|9
4936463|NCT00403546|16986653|P3|Signed Informed Consent/Open-Label|Early Termination|0
4936464|NCT00403546|16986654|P2|Signed Informed Consent/Open-Label|Early Termination|0
4936465|NCT00403546|16986655|P1|Signed Informed Consent/Open-Label|Early Termination|8
4936466|NCT00403546|16986653|P3|Signed Informed Consent/Open-Label|Withdrew Consent|0
4936467|NCT00403546|16986654|P2|Signed Informed Consent/Open-Label|Withdrew Consent|0
4936468|NCT00403546|16986655|P1|Signed Informed Consent/Open-Label|Withdrew Consent|6
4936469|NCT00403481|16986695|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1
4936470|NCT00403481|16986695|P1|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1
4936471|NCT00403481|16986695|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1
4936472|NCT00403481|16986695|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1
4936473|NCT00403481|16986695|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1
4936474|NCT00403481|16986695|P1|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2
4936475|NCT00403481|16986695|P1|Olm 40 mg|Other|1
4936476|NCT00403481|16986695|P1|Olm 40 mg|Withdrawal by Subject|1
4936477|NCT00403481|16986695|P1|Olm 40 mg|Protocol Violation|1
4936478|NCT00403481|16986695|P1|Olm 40 mg|Adverse Event|2
4936479|NCT00403481|16986695|P1|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1
4936480|NCT00403481|16986695|P1|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3
4936481|NCT00403481|16986695|P1|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1
4936482|NCT00403481|16986695|P1|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1
4936483|NCT00403455|16986710|P1|Overall Study|Withdrawal by Subject|1
4936484|NCT00403390|16986733|P2|Overall Study|non-compliant|0
4936485|NCT00403390|16986734|P1|Overall Study|non-compliant|1
4936486|NCT00403390|16986733|P2|Overall Study|samples lost|0
4936487|NCT00403390|16986734|P1|Overall Study|samples lost|1
4936488|NCT00403390|16986733|P2|Overall Study|Withdrawal by Subject|0
4936489|NCT00403390|16986734|P1|Overall Study|Withdrawal by Subject|1
4936490|NCT00403273|16986742|P2|Overall Study|pt. wanted to have a surgical procedure|1
4936491|NCT00403273|16986743|P1|Overall Study|pt. wanted to have a surgical procedure|0
4936492|NCT00403273|16986742|P2|Overall Study|Physician Decision|1
4936493|NCT00403273|16986743|P1|Overall Study|Physician Decision|0
4936494|NCT00403273|16986742|P2|Overall Study|Lost to Follow-up|2
4936495|NCT00403273|16986743|P1|Overall Study|Lost to Follow-up|3
4936496|NCT00403234|16986785|P4|Overall Study|Adverse Event|0
4936497|NCT00403234|16986786|P3|Overall Study|Adverse Event|1
4936498|NCT00403234|16986787|P2|Overall Study|Adverse Event|0
4936499|NCT00403234|16986788|P1|Overall Study|Adverse Event|1
4936500|NCT00403234|16986785|P4|Overall Study|Withdrawal by Subject|0
4936501|NCT00403234|16986786|P3|Overall Study|Withdrawal by Subject|0
4936502|NCT00403234|16986787|P2|Overall Study|Withdrawal by Subject|1
4936503|NCT00403234|16986788|P1|Overall Study|Withdrawal by Subject|0
4936504|NCT00403130|16986798|P1|Survival Follow-up up to 6 Years|Lost to Follow-up|10
4936505|NCT00403130|16986798|P1|2 Years From Start of Treatment|Withdrawal by Subject|1
4936506|NCT00403130|16986798|P1|2 Years From Start of Treatment|Lost to Follow up|1
4936507|NCT00403130|16986798|P1|2 Years From Start of Treatment|Not Eligible|3
4936508|NCT00402987|16986851|P4|Overall Study|Lack of Efficacy|0
4936509|NCT00402987|16986852|P3|Overall Study|Lack of Efficacy|1
4936510|NCT00402987|16986853|P2|Overall Study|Lack of Efficacy|0
4936511|NCT00402987|16986854|P1|Overall Study|Lack of Efficacy|0
4936512|NCT00402831|16987026|P2|Overall Study|Non-compliance with protocol|1
4936513|NCT00402831|16987027|P1|Overall Study|Non-compliance with protocol|0
4936514|NCT00402831|16987026|P2|Overall Study|Lost to Follow-up|2
4936515|NCT00402831|16987027|P1|Overall Study|Lost to Follow-up|1
4936516|NCT00402779|16987061|P2|Overall Study|Screen Failure|76
4936517|NCT00402779|16987062|P1|Overall Study|Screen Failure|77
4936518|NCT00402740|16987068|P1|Overall Study|Subject disposition unknown.|1
4936519|NCT00402740|16987068|P1|Overall Study|No stent. Completed FU at 30 days.|5
4936520|NCT00402740|16987068|P1|Overall Study|Lost to Follow-up|6
4936521|NCT00402740|16987068|P1|Overall Study|Death|50
4936522|NCT00402740|16987068|P1|Overall Study|Withdrawal by Subject|18
4936523|NCT00402727|16987080|P2|Overall Study|non-compliance|1
4936524|NCT00402727|16987081|P1|Overall Study|non-compliance|0
4936525|NCT00402727|16987080|P2|Overall Study|supply problems|1
4936526|NCT00402727|16987081|P1|Overall Study|supply problems|2
4936527|NCT00402727|16987080|P2|Overall Study|Withdrawal by Subject|7
4936528|NCT00402727|16987081|P1|Overall Study|Withdrawal by Subject|3
4936529|NCT00402727|16987080|P2|Overall Study|Protocol Violation|4
4936530|NCT00402727|16987081|P1|Overall Study|Protocol Violation|0
4936531|NCT00402727|16987080|P2|Overall Study|Physician Decision|1
4936532|NCT00402727|16987081|P1|Overall Study|Physician Decision|1
4936533|NCT00402727|16987080|P2|Overall Study|Lost to Follow-up|11
4936534|NCT00402727|16987081|P1|Overall Study|Lost to Follow-up|24
4936535|NCT00402727|16987080|P2|Overall Study|Lack of Efficacy|3
4936536|NCT00402727|16987081|P1|Overall Study|Lack of Efficacy|1
4936537|NCT00402727|16987080|P2|Overall Study|Death|0
4936538|NCT00402727|16987081|P1|Overall Study|Death|1
4936539|NCT00402727|16987080|P2|Overall Study|Adverse Event|6
4936540|NCT00402727|16987081|P1|Overall Study|Adverse Event|10
4936541|NCT00402688|16987123|P3|Overall Study|Patient Left Town and Forgot Medication|1
4936542|NCT00402688|16987124|P2|Overall Study|Patient Left Town and Forgot Medication|0
4936543|NCT00402688|16987125|P1|Overall Study|Patient Left Town and Forgot Medication|0
4936544|NCT00402688|16987123|P3|Overall Study|Urine Cult. Yield Resistant to Levaquin|1
4936545|NCT00402688|16987124|P2|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
4936546|NCT00402688|16987125|P1|Overall Study|Urine Cult. Yield Resistant to Levaquin|0
4936547|NCT00402688|16987123|P3|Overall Study|Culture Show Fluoroquinolone Resistance|0
4936548|NCT00402688|16987124|P2|Overall Study|Culture Show Fluoroquinolone Resistance|1
4936549|NCT00402688|16987125|P1|Overall Study|Culture Show Fluoroquinolone Resistance|0
4936550|NCT00402688|16987123|P3|Overall Study|Lost to Follow-up|2
4936551|NCT00402688|16987124|P2|Overall Study|Lost to Follow-up|0
4936552|NCT00402688|16987125|P1|Overall Study|Lost to Follow-up|1
4936553|NCT00402688|16987123|P3|Overall Study|Protocol Violation|1
4936554|NCT00402688|16987124|P2|Overall Study|Protocol Violation|1
4936555|NCT00402688|16987125|P1|Overall Study|Protocol Violation|1
4936556|NCT00402688|16987123|P3|Overall Study|Lack of Efficacy|5
4936558|NCT00402688|16987125|P1|Overall Study|Lack of Efficacy|4
4936559|NCT00402688|16987123|P3|Overall Study|Physician Decision|1
4936560|NCT00402688|16987124|P2|Overall Study|Physician Decision|0
4936561|NCT00402688|16987125|P1|Overall Study|Physician Decision|0
4936562|NCT00402688|16987123|P3|Overall Study|Withdrawal by Subject|1
4936563|NCT00402688|16987124|P2|Overall Study|Withdrawal by Subject|1
4936564|NCT00402688|16987125|P1|Overall Study|Withdrawal by Subject|3
4936565|NCT00402688|16987123|P3|Overall Study|Adverse Event|3
4936566|NCT00402688|16987124|P2|Overall Study|Adverse Event|9
4936567|NCT00402688|16987125|P1|Overall Study|Adverse Event|12
4936568|NCT00402649|16987148|P1|Overall Study|Withdrawal by Subject|1
4936569|NCT00402649|16987148|P1|Overall Study|Lost to Follow-up|1
4936570|NCT00402597|16987163|P5|Overall Study|reason not specified|20
4936571|NCT00402597|16987164|P4|Overall Study|reason not specified|14
4936572|NCT00402597|16987165|P3|Overall Study|reason not specified|27
4936573|NCT00402597|16987166|P2|Overall Study|reason not specified|4
4936574|NCT00402597|16987167|P1|Overall Study|reason not specified|30
4936575|NCT00402597|16987163|P5|Overall Study|Withdrawal by Subject|24
4936576|NCT00402597|16987164|P4|Overall Study|Withdrawal by Subject|15
4936577|NCT00402597|16987165|P3|Overall Study|Withdrawal by Subject|65
4936578|NCT00402597|16987166|P2|Overall Study|Withdrawal by Subject|16
4936579|NCT00402597|16987167|P1|Overall Study|Withdrawal by Subject|57
4936580|NCT00402597|16987163|P5|Overall Study|Lost to Follow-up|3
4936581|NCT00402597|16987164|P4|Overall Study|Lost to Follow-up|2
4936582|NCT00402597|16987165|P3|Overall Study|Lost to Follow-up|8
4936583|NCT00402597|16987166|P2|Overall Study|Lost to Follow-up|1
4936584|NCT00402597|16987167|P1|Overall Study|Lost to Follow-up|8
4936585|NCT00402597|16987163|P5|Overall Study|Adverse Event|71
4936586|NCT00402597|16987164|P4|Overall Study|Adverse Event|39
4936587|NCT00402597|16987165|P3|Overall Study|Adverse Event|106
4936588|NCT00402597|16987166|P2|Overall Study|Adverse Event|18
4936589|NCT00402597|16987167|P1|Overall Study|Adverse Event|81
4936590|NCT00402597|16987163|P5|Overall Study|Death|6
4936591|NCT00402597|16987164|P4|Overall Study|Death|4
4936592|NCT00402597|16987165|P3|Overall Study|Death|6
4936593|NCT00402597|16987166|P2|Overall Study|Death|7
4936594|NCT00402597|16987167|P1|Overall Study|Death|15
4936595|NCT00402363|16987208|P4|Overall Study|"Captured as Other"|2
4936596|NCT00402363|16987209|P3|Overall Study|"Captured as Other"|2
4936597|NCT00402363|16987210|P2|Overall Study|"Captured as Other"|2
4936598|NCT00402363|16987211|P1|Overall Study|"Captured as Other"|6
4936599|NCT00402363|16987208|P4|Overall Study|Lost to Follow-up|2
4936600|NCT00402363|16987209|P3|Overall Study|Lost to Follow-up|0
4936601|NCT00402363|16987210|P2|Overall Study|Lost to Follow-up|4
4936602|NCT00402363|16987211|P1|Overall Study|Lost to Follow-up|5
4936603|NCT00402363|16987208|P4|Overall Study|Protocol Violation|3
4936604|NCT00402363|16987209|P3|Overall Study|Protocol Violation|0
4936605|NCT00402363|16987210|P2|Overall Study|Protocol Violation|5
4936606|NCT00402363|16987211|P1|Overall Study|Protocol Violation|3
4936607|NCT00402363|16987208|P4|Overall Study|Withdrew Consent|1
4936608|NCT00402363|16987209|P3|Overall Study|Withdrew Consent|2
4936609|NCT00402363|16987210|P2|Overall Study|Withdrew Consent|5
4936610|NCT00402363|16987211|P1|Overall Study|Withdrew Consent|10
4936611|NCT00402363|16987208|P4|Overall Study|Adverse Event|2
4936612|NCT00402363|16987209|P3|Overall Study|Adverse Event|2
4936613|NCT00402363|16987210|P2|Overall Study|Adverse Event|14
4936614|NCT00402363|16987211|P1|Overall Study|Adverse Event|9
4936615|NCT00402337|16987274|P5|Overall Study|Other Reason|0
4936616|NCT00402337|16987275|P4|Overall Study|Other Reason|0
4936617|NCT00402337|16987276|P3|Overall Study|Other Reason|0
4936618|NCT00402337|16987277|P2|Overall Study|Other Reason|1
4936619|NCT00402337|16987278|P1|Overall Study|Other Reason|0
4936620|NCT00402337|16987274|P5|Overall Study|Physician Decision|0
4936621|NCT00402337|16987275|P4|Overall Study|Physician Decision|1
4936622|NCT00402337|16987276|P3|Overall Study|Physician Decision|0
4936623|NCT00402337|16987277|P2|Overall Study|Physician Decision|0
4936624|NCT00402337|16987278|P1|Overall Study|Physician Decision|0
4936625|NCT00402337|16987274|P5|Overall Study|Lost to Follow-up|0
4936626|NCT00402337|16987275|P4|Overall Study|Lost to Follow-up|2
4936627|NCT00402337|16987276|P3|Overall Study|Lost to Follow-up|1
4936628|NCT00402337|16987277|P2|Overall Study|Lost to Follow-up|0
4936629|NCT00402337|16987278|P1|Overall Study|Lost to Follow-up|0
4936630|NCT00402337|16987274|P5|Overall Study|Withdrawal by Subject|4
4936631|NCT00402337|16987275|P4|Overall Study|Withdrawal by Subject|6
4936632|NCT00402337|16987276|P3|Overall Study|Withdrawal by Subject|1
4936633|NCT00402337|16987277|P2|Overall Study|Withdrawal by Subject|3
4936634|NCT00402337|16987278|P1|Overall Study|Withdrawal by Subject|5
4936635|NCT00402337|16987274|P5|Overall Study|Noncompliance|2
4936636|NCT00402337|16987275|P4|Overall Study|Noncompliance|0
4936637|NCT00402337|16987276|P3|Overall Study|Noncompliance|0
4936638|NCT00402337|16987277|P2|Overall Study|Noncompliance|0
4936639|NCT00402337|16987278|P1|Overall Study|Noncompliance|0
4936640|NCT00402337|16987274|P5|Overall Study|Adverse Event|2
4936641|NCT00402337|16987275|P4|Overall Study|Adverse Event|3
4936642|NCT00402337|16987276|P3|Overall Study|Adverse Event|2
4936643|NCT00402337|16987277|P2|Overall Study|Adverse Event|2
4936644|NCT00402337|16987278|P1|Overall Study|Adverse Event|0
4936645|NCT00402324|16987317|P2|Overall Study|Death|0
4936646|NCT00402324|16987318|P1|Overall Study|Death|1
4936647|NCT00402324|16987317|P2|Overall Study|Adverse Event|4
4936648|NCT00402324|16987318|P1|Overall Study|Adverse Event|6
4936649|NCT00402324|16987317|P2|Overall Study|Lack of Efficacy|4
4936650|NCT00402324|16987318|P1|Overall Study|Lack of Efficacy|1
4936651|NCT00402324|16987317|P2|Overall Study|Sponsor Decision|5
4936652|NCT00402324|16987318|P1|Overall Study|Sponsor Decision|4
4936653|NCT00402324|16987317|P2|Overall Study|Physician Decision|4
4936654|NCT00402324|16987318|P1|Overall Study|Physician Decision|2
4936655|NCT00402324|16987317|P2|Overall Study|Withdrawal by Subject|2
4936656|NCT00402324|16987318|P1|Overall Study|Withdrawal by Subject|5
4936657|NCT00402324|16987317|P2|Overall Study|Protocol Violation|7
4936658|NCT00402324|16987318|P1|Overall Study|Protocol Violation|8
4936659|NCT00402324|16987317|P2|Overall Study|Protocol Entry Criteria Not Met|4
4936660|NCT00402324|16987318|P1|Overall Study|Protocol Entry Criteria Not Met|5
4936661|NCT00402324|16987317|P2|Overall Study|Lost to Follow-up|11
4936662|NCT00402324|16987318|P1|Overall Study|Lost to Follow-up|11
4936663|NCT00402285|16987351|P3|Overall Study|insufficient RNA quality|2
4936664|NCT00402285|16987352|P2|Overall Study|insufficient RNA quality|6
4936665|NCT00402285|16987353|P1|Overall Study|insufficient RNA quality|7
4936666|NCT00402246|16987361|P2|Overall Study|Deterioriating Condition|2
4936667|NCT00402246|16987362|P1|Overall Study|Deterioriating Condition|3
4936668|NCT00402246|16987361|P2|Overall Study|Center Closure|3
4936669|NCT00402246|16987362|P1|Overall Study|Center Closure|5
4936670|NCT00402246|16987361|P2|Overall Study|Patient's device explanted|2
4936671|NCT00402246|16987362|P1|Overall Study|Patient's device explanted|6
4936672|NCT00402246|16987361|P2|Overall Study|Heart Transplant|1
4936673|NCT00402246|16987362|P1|Overall Study|Heart Transplant|0
4936674|NCT00402246|16987361|P2|Overall Study|Insurance Issues|1
4936675|NCT00402246|16987362|P1|Overall Study|Insurance Issues|2
4936676|NCT00402246|16987361|P2|Overall Study|Missed Final Visit|2
4936677|NCT00402246|16987362|P1|Overall Study|Missed Final Visit|1
4936678|NCT00402246|16987361|P2|Overall Study|Protocol Violation|24
4936679|NCT00402246|16987362|P1|Overall Study|Protocol Violation|25
4936680|NCT00402246|16987361|P2|Overall Study|Physician Decision|26
4936681|NCT00402246|16987362|P1|Overall Study|Physician Decision|24
4936682|NCT00402246|16987361|P2|Overall Study|Withdrawal by Subject|87
4936683|NCT00402246|16987362|P1|Overall Study|Withdrawal by Subject|72
4936684|NCT00402246|16987361|P2|Overall Study|Lost to Follow-up|28
4936685|NCT00402246|16987362|P1|Overall Study|Lost to Follow-up|20
4936686|NCT00402246|16987361|P2|Overall Study|Death|58
4936687|NCT00402246|16987362|P1|Overall Study|Death|62
4936688|NCT00402233|16987396|P4|Overall Study|Worsening of other pre-existing disease|0
4936689|NCT00402233|16987397|P3|Overall Study|Worsening of other pre-existing disease|0
4936690|NCT00402233|16987398|P2|Overall Study|Worsening of other pre-existing disease|1
4936691|NCT00402233|16987399|P1|Overall Study|Worsening of other pre-existing disease|0
4936692|NCT00402233|16987396|P4|Overall Study|Worsening of disease under study|0
4936693|NCT00402233|16987397|P3|Overall Study|Worsening of disease under study|0
4936694|NCT00402233|16987398|P2|Overall Study|Worsening of disease under study|0
4936695|NCT00402233|16987399|P1|Overall Study|Worsening of disease under study|2
4936696|NCT00402233|16987396|P4|Overall Study|Withdrawal by Subject|2
4936697|NCT00402233|16987397|P3|Overall Study|Withdrawal by Subject|2
4936698|NCT00402233|16987398|P2|Overall Study|Withdrawal by Subject|1
4936699|NCT00402233|16987399|P1|Overall Study|Withdrawal by Subject|2
4936700|NCT00402233|16987396|P4|Overall Study|Protocol Violation|0
4936701|NCT00402233|16987397|P3|Overall Study|Protocol Violation|0
4936702|NCT00402233|16987398|P2|Overall Study|Protocol Violation|1
4936703|NCT00402233|16987399|P1|Overall Study|Protocol Violation|0
4936704|NCT00402233|16987396|P4|Overall Study|Adverse Event|9
4936705|NCT00402233|16987397|P3|Overall Study|Adverse Event|9
4936706|NCT00402233|16987398|P2|Overall Study|Adverse Event|7
4936707|NCT00402233|16987399|P1|Overall Study|Adverse Event|1
4936708|NCT00402168|16987434|P2|Switched From CNI to Belatacept in LT|Adverse Event|0
4936709|NCT00402168|16987435|P1|Switched From CNI to Belatacept in LT|Adverse Event|4
4936710|NCT00402168|16987434|P2|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0
4936711|NCT00402168|16987435|P1|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2
4936712|NCT00402168|16987434|P2|Long Term (LT)|non-specified|2
4936713|NCT00402168|16987435|P1|Long Term (LT)|non-specified|1
4936714|NCT00402168|16987434|P2|Long Term (LT)|Lack of Efficacy|2
4936715|NCT00402168|16987435|P1|Long Term (LT)|Lack of Efficacy|0
4936716|NCT00402168|16987434|P2|Long Term (LT)|Death|0
4936717|NCT00402168|16987435|P1|Long Term (LT)|Death|4
4936718|NCT00402168|16987434|P2|Long Term (LT)|Lost to Follow-up|0
4936719|NCT00402168|16987435|P1|Long Term (LT)|Lost to Follow-up|1
4936720|NCT00402168|16987434|P2|Long Term (LT)|Pregnancy|1
4936721|NCT00402168|16987435|P1|Long Term (LT)|Pregnancy|0
4936722|NCT00402168|16987434|P2|Long Term (LT)|Withdrawal by Subject|7
4936723|NCT00402168|16987435|P1|Long Term (LT)|Withdrawal by Subject|4
4936724|NCT00402168|16987434|P2|Long Term (LT)|Adverse Event|5
4936725|NCT00402168|16987435|P1|Long Term (LT)|Adverse Event|1
4936726|NCT00402168|16987434|P2|Treatment (up to 12 Months)|non-specified|1
4936727|NCT00402168|16987435|P1|Treatment (up to 12 Months)|non-specified|0
4936728|NCT00402168|16987434|P2|Treatment (up to 12 Months)|Lack of Efficacy|0
4936729|NCT00402168|16987435|P1|Treatment (up to 12 Months)|Lack of Efficacy|2
4936730|NCT00402168|16987434|P2|Treatment (up to 12 Months)|Death|1
4936731|NCT00402168|16987435|P1|Treatment (up to 12 Months)|Death|0
4936732|NCT00402168|16987434|P2|Randomized|Withdrawal by Subject|1
4936733|NCT00402168|16987435|P1|Randomized|Withdrawal by Subject|0
4936734|NCT00402168|16987434|P2|Randomized|Lost to Follow-up|0
4936735|NCT00402168|16987435|P1|Randomized|Lost to Follow-up|1
4936736|NCT00402116|16987493|P3|Overall Study|Adverse Event|6
4936737|NCT00402116|16987494|P2|Overall Study|Adverse Event|1
4936738|NCT00402116|16987495|P1|Overall Study|Adverse Event|0
4936739|NCT00402116|16987493|P3|Overall Study|decline related hyponatremia/tumor|1
4936740|NCT00402116|16987494|P2|Overall Study|decline related hyponatremia/tumor|0
4936741|NCT00402116|16987495|P1|Overall Study|decline related hyponatremia/tumor|0
4936742|NCT00402116|16987493|P3|Overall Study|mistaken thrombocytopenia|1
4936743|NCT00402116|16987494|P2|Overall Study|mistaken thrombocytopenia|0
4936744|NCT00402116|16987495|P1|Overall Study|mistaken thrombocytopenia|0
4936745|NCT00402116|16987493|P3|Overall Study|Disease Progression|38
4936746|NCT00402116|16987494|P2|Overall Study|Disease Progression|4
4936747|NCT00402116|16987495|P1|Overall Study|Disease Progression|0
4936748|NCT00402116|16987493|P3|Overall Study|other complicating disease|2
4936749|NCT00402116|16987494|P2|Overall Study|other complicating disease|0
4936750|NCT00402116|16987495|P1|Overall Study|other complicating disease|0
4936751|NCT00402116|16987493|P3|Overall Study|Treatment completed per protocol|2
4936752|NCT00402116|16987494|P2|Overall Study|Treatment completed per protocol|1
4936753|NCT00402116|16987495|P1|Overall Study|Treatment completed per protocol|1
4936754|NCT00402116|16987493|P3|Overall Study|Withdrawal by Subject|5
4936755|NCT00402116|16987494|P2|Overall Study|Withdrawal by Subject|0
4936756|NCT00402116|16987495|P1|Overall Study|Withdrawal by Subject|1
4936757|NCT00402116|16987493|P3|Overall Study|Jaw infection after surgery-other|0
4936758|NCT00402116|16987494|P2|Overall Study|Jaw infection after surgery-other|0
4936759|NCT00402116|16987495|P1|Overall Study|Jaw infection after surgery-other|1
4936760|NCT00402103|16987525|P2|Overall Study|Administrative problems|0
4936761|NCT00402103|16987526|P1|Overall Study|Administrative problems|2
4936762|NCT00402103|16987525|P2|Overall Study|Lost to Follow-up|3
4936763|NCT00402103|16987526|P1|Overall Study|Lost to Follow-up|6
4936764|NCT00402103|16987525|P2|Overall Study|Patient withdrew consent|1
4936765|NCT00402103|16987526|P1|Overall Study|Patient withdrew consent|12
4936766|NCT00402103|16987525|P2|Overall Study|Protocol Deviation|0
4936767|NCT00402103|16987526|P1|Overall Study|Protocol Deviation|8
4936768|NCT00402103|16987525|P2|Overall Study|Condition no longer requires study drug|0
4936769|NCT00402103|16987526|P1|Overall Study|Condition no longer requires study drug|2
4936770|NCT00402103|16987525|P2|Overall Study|Unsatisfactory therapeutic effect|2
4936771|NCT00402103|16987526|P1|Overall Study|Unsatisfactory therapeutic effect|1
4936772|NCT00402103|16987525|P2|Overall Study|Adverse Event|7
4936773|NCT00402103|16987526|P1|Overall Study|Adverse Event|60
4936774|NCT00402051|16987542|P2|Overall Study|Lost to Follow-up|0
4936775|NCT00402051|16987543|P1|Overall Study|Lost to Follow-up|1
4936776|NCT00402051|16987542|P2|Overall Study|Death Due to Adverse Event|2
4936777|NCT00402051|16987543|P1|Overall Study|Death Due to Adverse Event|0
4936778|NCT00402051|16987542|P2|Overall Study|Death Due to Study Disease|1
4936779|NCT00402051|16987543|P1|Overall Study|Death Due to Study Disease|2
4936780|NCT00402051|16987542|P2|Overall Study|Death - Related to Study Drug|2
4936781|NCT00402051|16987543|P1|Overall Study|Death - Related to Study Drug|1
4936782|NCT00402051|16987542|P2|Overall Study|Withdrawal by Subject|3
4936783|NCT00402051|16987543|P1|Overall Study|Withdrawal by Subject|3
4936784|NCT00402051|16987542|P2|Overall Study|Physician Decision|3
4936785|NCT00402051|16987543|P1|Overall Study|Physician Decision|7
4936786|NCT00402051|16987542|P2|Overall Study|Adverse Event|4
4936787|NCT00402051|16987543|P1|Overall Study|Adverse Event|11
4936788|NCT00402051|16987542|P2|Overall Study|Progressive Disease|20
4936789|NCT00402051|16987543|P1|Overall Study|Progressive Disease|13
4936790|NCT00402025|16987560|P3|Overall Study|Participant Decision|1
4936791|NCT00402025|16987561|P2|Overall Study|Participant Decision|0
4936792|NCT00402025|16987562|P1|Overall Study|Participant Decision|0
4936793|NCT00402025|16987560|P3|Overall Study|Physician Decision|0
4936794|NCT00402025|16987561|P2|Overall Study|Physician Decision|1
4936795|NCT00402025|16987562|P1|Overall Study|Physician Decision|1
4936796|NCT00402025|16987560|P3|Overall Study|Disease Progression|2
4936797|NCT00402025|16987561|P2|Overall Study|Disease Progression|1
4936798|NCT00402025|16987562|P1|Overall Study|Disease Progression|1
4936799|NCT00402025|16987560|P3|Overall Study|Death|5
4936800|NCT00402025|16987561|P2|Overall Study|Death|1
4936801|NCT00402025|16987562|P1|Overall Study|Death|0
4936802|NCT00402025|16987560|P3|Overall Study|Adverse Event|2
4936803|NCT00402025|16987561|P2|Overall Study|Adverse Event|0
4936804|NCT00402025|16987562|P1|Overall Study|Adverse Event|0
4936805|NCT00401973|16987588|P3|Overall Study|Withdrawal by Subject|9
4936806|NCT00401973|16987589|P2|Overall Study|Withdrawal by Subject|12
4936807|NCT00401973|16987590|P1|Overall Study|Withdrawal by Subject|4
4936808|NCT00401973|16987588|P3|Overall Study|Sponsor Decision|0
4936809|NCT00401973|16987589|P2|Overall Study|Sponsor Decision|1
4936810|NCT00401973|16987590|P1|Overall Study|Sponsor Decision|0
4936811|NCT00401973|16987588|P3|Overall Study|Protocol Violation|3
4936812|NCT00401973|16987589|P2|Overall Study|Protocol Violation|2
4936813|NCT00401973|16987590|P1|Overall Study|Protocol Violation|1
4936814|NCT00401973|16987588|P3|Overall Study|Physician Decision|1
4936815|NCT00401973|16987589|P2|Overall Study|Physician Decision|0
4936816|NCT00401973|16987590|P1|Overall Study|Physician Decision|2
4936817|NCT00401973|16987588|P3|Overall Study|Lost to Follow-up|2
4936818|NCT00401973|16987589|P2|Overall Study|Lost to Follow-up|2
4936819|NCT00401973|16987590|P1|Overall Study|Lost to Follow-up|2
4936820|NCT00401973|16987588|P3|Overall Study|Lack of Efficacy|3
4936821|NCT00401973|16987589|P2|Overall Study|Lack of Efficacy|0
4936822|NCT00401973|16987590|P1|Overall Study|Lack of Efficacy|0
4936823|NCT00401973|16987588|P3|Overall Study|Clinical Relapse|1
4936824|NCT00401973|16987589|P2|Overall Study|Clinical Relapse|1
4936825|NCT00401973|16987590|P1|Overall Study|Clinical Relapse|0
4936826|NCT00401973|16987588|P3|Overall Study|Adverse Event|4
4936827|NCT00401973|16987589|P2|Overall Study|Adverse Event|8
4936828|NCT00401973|16987590|P1|Overall Study|Adverse Event|2
4936829|NCT00401960|16987629|P2|Overall Study|Death|0
4936830|NCT00401960|16987630|P1|Overall Study|Death|2
4936831|NCT00401960|16987629|P2|Overall Study|Lost to Follow-up|0
4936832|NCT00401960|16987630|P1|Overall Study|Lost to Follow-up|3
4936833|NCT00401843|16987660|P3|Overall Study|Received incorrect treatment|0
4936834|NCT00401843|16987661|P2|Overall Study|Received incorrect treatment|3
4936835|NCT00401843|16987662|P1|Overall Study|Received incorrect treatment|0
4936836|NCT00401843|16987660|P3|Overall Study|Randomized but not Treated|3
4936837|NCT00401843|16987661|P2|Overall Study|Randomized but not Treated|2
4936838|NCT00401843|16987662|P1|Overall Study|Randomized but not Treated|0
4936839|NCT00401843|16987660|P3|Overall Study|Withdrawal of consent to study agent|17
4936840|NCT00401843|16987661|P2|Overall Study|Withdrawal of consent to study agent|15
4936841|NCT00401843|16987662|P1|Overall Study|Withdrawal of consent to study agent|1
4936842|NCT00401843|16987660|P3|Overall Study|Withdrawal by Subject|5
4936843|NCT00401843|16987661|P2|Overall Study|Withdrawal by Subject|5
4936844|NCT00401843|16987662|P1|Overall Study|Withdrawal by Subject|1
4936845|NCT00401843|16987660|P3|Overall Study|Protocol Violation|1
4936846|NCT00401843|16987661|P2|Overall Study|Protocol Violation|0
4936847|NCT00401843|16987662|P1|Overall Study|Protocol Violation|0
4936848|NCT00401843|16987660|P3|Overall Study|Physician Decision|10
4936849|NCT00401843|16987661|P2|Overall Study|Physician Decision|16
4936850|NCT00401843|16987662|P1|Overall Study|Physician Decision|0
4936851|NCT00401843|16987660|P3|Overall Study|Other Unspecified|5
4936852|NCT00401843|16987661|P2|Overall Study|Other Unspecified|3
4936853|NCT00401843|16987662|P1|Overall Study|Other Unspecified|0
4936854|NCT00401843|16987660|P3|Overall Study|Lost to Follow-up|2
4936855|NCT00401843|16987661|P2|Overall Study|Lost to Follow-up|0
4936856|NCT00401843|16987662|P1|Overall Study|Lost to Follow-up|0
4936857|NCT00401843|16987660|P3|Overall Study|End of Study|2
4936858|NCT00401843|16987661|P2|Overall Study|End of Study|1
4936859|NCT00401843|16987662|P1|Overall Study|End of Study|1
4936860|NCT00401843|16987660|P3|Overall Study|Disease progression|49
4936861|NCT00401843|16987661|P2|Overall Study|Disease progression|60
4936862|NCT00401843|16987662|P1|Overall Study|Disease progression|10
4936863|NCT00401843|16987660|P3|Overall Study|Death|10
4936864|NCT00401843|16987661|P2|Overall Study|Death|8
4936865|NCT00401843|16987662|P1|Overall Study|Death|0
4936866|NCT00401843|16987660|P3|Overall Study|Adverse Event|27
4936867|NCT00401843|16987661|P2|Overall Study|Adverse Event|26
4936868|NCT00401843|16987662|P1|Overall Study|Adverse Event|7
4936869|NCT00401843|16987660|P3|Overall Study|Achieved Complete Response|11
4936870|NCT00401843|16987661|P2|Overall Study|Achieved Complete Response|5
4936871|NCT00401843|16987662|P1|Overall Study|Achieved Complete Response|1
4936872|NCT00401830|16987680|P2|Overall Study|Other: Personal / Family problems|0
4936873|NCT00401830|16987681|P1|Overall Study|Other: Personal / Family problems|1
4936874|NCT00401830|16987680|P2|Overall Study|Lost to Follow-up|3
4936875|NCT00401830|16987681|P1|Overall Study|Lost to Follow-up|1
4936876|NCT00401830|16987680|P2|Overall Study|Non-compliance with drug study|0
4936877|NCT00401830|16987681|P1|Overall Study|Non-compliance with drug study|1
4936878|NCT00401830|16987680|P2|Overall Study|Protocol Violation|3
4936879|NCT00401830|16987681|P1|Overall Study|Protocol Violation|3
4936880|NCT00401830|16987680|P2|Overall Study|Withdrawal by Subject|3
4936881|NCT00401830|16987681|P1|Overall Study|Withdrawal by Subject|4
4936882|NCT00401830|16987680|P2|Overall Study|Lack of Efficacy|5
4936883|NCT00401830|16987681|P1|Overall Study|Lack of Efficacy|11
4936884|NCT00401830|16987680|P2|Overall Study|Adverse Event|18
4936885|NCT00401830|16987681|P1|Overall Study|Adverse Event|10
4936886|NCT00401752|16987739|P2|Overall Study|Physician Decision|1
4936887|NCT00401752|16987740|P1|Overall Study|Physician Decision|1
4936888|NCT00401752|16987739|P2|Overall Study|Development of any exclusion criteria|2
4936889|NCT00401752|16987740|P1|Overall Study|Development of any exclusion criteria|4
4936890|NCT00401752|16987739|P2|Overall Study|Lost to Follow-up|4
4936891|NCT00401752|16987740|P1|Overall Study|Lost to Follow-up|1
4936892|NCT00401752|16987739|P2|Overall Study|Withdrawal by Subject|6
4936893|NCT00401752|16987740|P1|Overall Study|Withdrawal by Subject|2
4936894|NCT00401752|16987739|P2|Overall Study|Adverse Event|5
4936895|NCT00401752|16987740|P1|Overall Study|Adverse Event|2
4936896|NCT00401726|16987758|P2|Overall Study|Protocol Deviation|4
4936897|NCT00401726|16987759|P1|Overall Study|Protocol Deviation|9
4936898|NCT00401726|16987758|P2|Overall Study|Lack of Efficacy|6
4936899|NCT00401726|16987759|P1|Overall Study|Lack of Efficacy|4
4936900|NCT00401726|16987758|P2|Overall Study|Withdrawal by Subject|24
4936901|NCT00401726|16987759|P1|Overall Study|Withdrawal by Subject|18
4936902|NCT00401726|16987758|P2|Overall Study|Protocol Violation|3
4936903|NCT00401726|16987759|P1|Overall Study|Protocol Violation|6
4936904|NCT00401726|16987758|P2|Overall Study|Lost to Follow-up|20
4936905|NCT00401726|16987759|P1|Overall Study|Lost to Follow-up|23
4936906|NCT00401726|16987758|P2|Overall Study|Physician Decision|6
4936907|NCT00401726|16987759|P1|Overall Study|Physician Decision|3
4936908|NCT00401726|16987758|P2|Overall Study|Sponsor Request|1
4936909|NCT00401726|16987759|P1|Overall Study|Sponsor Request|0
4936910|NCT00401726|16987758|P2|Overall Study|Death|3
4936911|NCT00401726|16987759|P1|Overall Study|Death|0
4936912|NCT00401726|16987758|P2|Overall Study|Adverse Event|45
4936913|NCT00401726|16987759|P1|Overall Study|Adverse Event|34
4936914|NCT00401544|16987794|P4|Overall Study|Other|2
4936915|NCT00401544|16987795|P3|Overall Study|Other|2
4936916|NCT00401544|16987796|P2|Overall Study|Other|0
4936917|NCT00401544|16987797|P1|Overall Study|Other|0
4936918|NCT00401544|16987794|P4|Overall Study|Disease progression|0
4936919|NCT00401544|16987795|P3|Overall Study|Disease progression|0
4936920|NCT00401544|16987796|P2|Overall Study|Disease progression|1
4936921|NCT00401544|16987797|P1|Overall Study|Disease progression|0
4936922|NCT00401544|16987794|P4|Overall Study|Ineligibility determined|2
4936923|NCT00401544|16987795|P3|Overall Study|Ineligibility determined|0
4936924|NCT00401544|16987796|P2|Overall Study|Ineligibility determined|1
4936925|NCT00401544|16987797|P1|Overall Study|Ineligibility determined|0
4936926|NCT00401544|16987794|P4|Overall Study|Physician Decision|0
4936927|NCT00401544|16987795|P3|Overall Study|Physician Decision|0
4936928|NCT00401544|16987796|P2|Overall Study|Physician Decision|3
4936929|NCT00401544|16987797|P1|Overall Study|Physician Decision|1
4936930|NCT00401544|16987794|P4|Overall Study|Withdrawal by Subject|5
4936931|NCT00401544|16987795|P3|Overall Study|Withdrawal by Subject|6
4936932|NCT00401544|16987796|P2|Overall Study|Withdrawal by Subject|6
4936933|NCT00401544|16987797|P1|Overall Study|Withdrawal by Subject|7
4936934|NCT00401544|16987794|P4|Overall Study|Lost to Follow-up|1
4936935|NCT00401544|16987795|P3|Overall Study|Lost to Follow-up|1
4936936|NCT00401544|16987796|P2|Overall Study|Lost to Follow-up|0
4936937|NCT00401544|16987797|P1|Overall Study|Lost to Follow-up|2
4936938|NCT00401544|16987794|P4|Overall Study|Death|5
4936939|NCT00401544|16987795|P3|Overall Study|Death|2
4936940|NCT00401544|16987796|P2|Overall Study|Death|6
4936941|NCT00401544|16987797|P1|Overall Study|Death|3
4936942|NCT00401544|16987794|P4|Overall Study|Adverse Event|1
4936943|NCT00401544|16987795|P3|Overall Study|Adverse Event|1
4936944|NCT00401544|16987796|P2|Overall Study|Adverse Event|1
4936945|NCT00401544|16987797|P1|Overall Study|Adverse Event|5
4936946|NCT00401531|16987837|P2|Overall Study|Withdrawal by Subject|2
4936947|NCT00401531|16987838|P1|Overall Study|Withdrawal by Subject|3
4936948|NCT00401531|16987837|P2|Overall Study|Lost to Follow-up|1
4936949|NCT00401531|16987838|P1|Overall Study|Lost to Follow-up|1
4936950|NCT00401531|16987837|P2|Overall Study|Protocol Violation|7
4936951|NCT00401531|16987838|P1|Overall Study|Protocol Violation|3
4936952|NCT00401531|16987837|P2|Overall Study|Adverse Event|0
4936953|NCT00401531|16987838|P1|Overall Study|Adverse Event|2
4936954|NCT00401375|16987942|P3|Overall Study|Randomized but not treated|3
4936955|NCT00401375|16987943|P2|Overall Study|Randomized but not treated|3
4936956|NCT00401375|16987944|P1|Overall Study|Randomized but not treated|3
4936957|NCT00401375|16987942|P3|Overall Study|Other than specified|3
4936958|NCT00401375|16987943|P2|Overall Study|Other than specified|1
4936959|NCT00401375|16987944|P1|Overall Study|Other than specified|2
4936960|NCT00401375|16987942|P3|Overall Study|Lost to Follow-up|1
4936961|NCT00401375|16987943|P2|Overall Study|Lost to Follow-up|1
4936962|NCT00401375|16987944|P1|Overall Study|Lost to Follow-up|0
4936963|NCT00401375|16987942|P3|Overall Study|Withdrawal by Subject|7
4936964|NCT00401375|16987943|P2|Overall Study|Withdrawal by Subject|7
4936965|NCT00401375|16987944|P1|Overall Study|Withdrawal by Subject|9
4936966|NCT00401375|16987942|P3|Overall Study|Adverse Event|10
4936967|NCT00401375|16987943|P2|Overall Study|Adverse Event|11
4936968|NCT00401375|16987944|P1|Overall Study|Adverse Event|6
4936969|NCT00401375|16987942|P3|Overall Study|Protocol Violation|1
4936970|NCT00401375|16987943|P2|Overall Study|Protocol Violation|2
4936971|NCT00401375|16987944|P1|Overall Study|Protocol Violation|2
4936972|NCT00401258|16987961|P1|Overall Study|Adverse Event|7
4936973|NCT00401245|16987976|P8|Double Blind Tapering Phase|Lack of Efficacy|0
4936974|NCT00401245|16987977|P7|Double Blind Tapering Phase|Lack of Efficacy|0
4936975|NCT00401245|16987978|P6|Double Blind Tapering Phase|Lack of Efficacy|1
4936976|NCT00401245|16987979|P5|Double Blind Tapering Phase|Lack of Efficacy|0
4936977|NCT00401245|16987980|P4|Double Blind Tapering Phase|Lack of Efficacy|0
4936978|NCT00401245|16987981|P3|Double Blind Tapering Phase|Lack of Efficacy|0
4936979|NCT00401245|16987982|P2|Double Blind Tapering Phase|Lack of Efficacy|0
4936980|NCT00401245|16987983|P1|Double Blind Tapering Phase|Lack of Efficacy|0
4936981|NCT00401245|16987976|P8|Double Blind Tapering Phase|Withdrawal by Subject|0
4936982|NCT00401245|16987977|P7|Double Blind Tapering Phase|Withdrawal by Subject|3
4936983|NCT00401245|16987978|P6|Double Blind Tapering Phase|Withdrawal by Subject|2
4936984|NCT00401245|16987979|P5|Double Blind Tapering Phase|Withdrawal by Subject|2
4936985|NCT00401245|16987980|P4|Double Blind Tapering Phase|Withdrawal by Subject|0
4936986|NCT00401245|16987981|P3|Double Blind Tapering Phase|Withdrawal by Subject|0
4936987|NCT00401245|16987982|P2|Double Blind Tapering Phase|Withdrawal by Subject|0
4936988|NCT00401245|16987983|P1|Double Blind Tapering Phase|Withdrawal by Subject|0
4936989|NCT00401245|16987976|P8|Double Blind Tapering Phase|Other|2
4936990|NCT00401245|16987977|P7|Double Blind Tapering Phase|Other|2
4936991|NCT00401245|16987978|P6|Double Blind Tapering Phase|Other|0
4936992|NCT00401245|16987979|P5|Double Blind Tapering Phase|Other|1
4936993|NCT00401245|16987980|P4|Double Blind Tapering Phase|Other|0
4936994|NCT00401245|16987981|P3|Double Blind Tapering Phase|Other|0
4936995|NCT00401245|16987982|P2|Double Blind Tapering Phase|Other|0
4936996|NCT00401245|16987983|P1|Double Blind Tapering Phase|Other|0
4936997|NCT00401245|16987976|P8|Double Blind Tapering Phase|Investigator request|1
4936998|NCT00401245|16987977|P7|Double Blind Tapering Phase|Investigator request|0
4936999|NCT00401245|16987978|P6|Double Blind Tapering Phase|Investigator request|0
4937000|NCT00401245|16987979|P5|Double Blind Tapering Phase|Investigator request|0
4937001|NCT00401245|16987980|P4|Double Blind Tapering Phase|Investigator request|0
4937002|NCT00401245|16987981|P3|Double Blind Tapering Phase|Investigator request|0
4937003|NCT00401245|16987982|P2|Double Blind Tapering Phase|Investigator request|0
4937004|NCT00401245|16987983|P1|Double Blind Tapering Phase|Investigator request|0
4937005|NCT00401245|16987976|P8|Double Blind Tapering Phase|Adverse Event|4
4937006|NCT00401245|16987977|P7|Double Blind Tapering Phase|Adverse Event|2
4937007|NCT00401245|16987978|P6|Double Blind Tapering Phase|Adverse Event|1
4937008|NCT00401245|16987979|P5|Double Blind Tapering Phase|Adverse Event|1
4937009|NCT00401245|16987980|P4|Double Blind Tapering Phase|Adverse Event|0
4937010|NCT00401245|16987981|P3|Double Blind Tapering Phase|Adverse Event|0
4937011|NCT00401245|16987982|P2|Double Blind Tapering Phase|Adverse Event|0
4937012|NCT00401245|16987983|P1|Double Blind Tapering Phase|Adverse Event|0
4937013|NCT00401245|16987976|P8|Open Label Phase|Lack of Efficacy|0
4937014|NCT00401245|16987977|P7|Open Label Phase|Lack of Efficacy|0
4937015|NCT00401245|16987978|P6|Open Label Phase|Lack of Efficacy|0
4937016|NCT00401245|16987979|P5|Open Label Phase|Lack of Efficacy|0
4937017|NCT00401245|16987980|P4|Open Label Phase|Lack of Efficacy|0
4937018|NCT00401245|16987981|P3|Open Label Phase|Lack of Efficacy|3
4937019|NCT00401245|16987982|P2|Open Label Phase|Lack of Efficacy|2
4937020|NCT00401245|16987983|P1|Open Label Phase|Lack of Efficacy|4
4937021|NCT00401245|16987976|P8|Open Label Phase|Withdrawal by Subject|0
4937022|NCT00401245|16987977|P7|Open Label Phase|Withdrawal by Subject|0
4937023|NCT00401245|16987978|P6|Open Label Phase|Withdrawal by Subject|0
4937024|NCT00401245|16987979|P5|Open Label Phase|Withdrawal by Subject|0
4937025|NCT00401245|16987980|P4|Open Label Phase|Withdrawal by Subject|1
4937026|NCT00401245|16987981|P3|Open Label Phase|Withdrawal by Subject|2
4937027|NCT00401245|16987982|P2|Open Label Phase|Withdrawal by Subject|3
4937028|NCT00401245|16987983|P1|Open Label Phase|Withdrawal by Subject|3
4937029|NCT00401245|16987976|P8|Open Label Phase|Protocol Violation|0
4937030|NCT00401245|16987977|P7|Open Label Phase|Protocol Violation|0
4937031|NCT00401245|16987978|P6|Open Label Phase|Protocol Violation|0
4937032|NCT00401245|16987979|P5|Open Label Phase|Protocol Violation|0
4937033|NCT00401245|16987980|P4|Open Label Phase|Protocol Violation|1
4937034|NCT00401245|16987981|P3|Open Label Phase|Protocol Violation|0
4937035|NCT00401245|16987982|P2|Open Label Phase|Protocol Violation|1
4937036|NCT00401245|16987983|P1|Open Label Phase|Protocol Violation|0
4937037|NCT00401245|16987976|P8|Open Label Phase|Other|0
4937038|NCT00401245|16987977|P7|Open Label Phase|Other|0
4937039|NCT00401245|16987978|P6|Open Label Phase|Other|0
4937040|NCT00401245|16987979|P5|Open Label Phase|Other|0
4937041|NCT00401245|16987980|P4|Open Label Phase|Other|8
4937042|NCT00401245|16987981|P3|Open Label Phase|Other|7
4937043|NCT00401245|16987982|P2|Open Label Phase|Other|8
4937044|NCT00401245|16987983|P1|Open Label Phase|Other|4
4937045|NCT00401245|16987976|P8|Open Label Phase|Lost to Follow-up|0
4937046|NCT00401245|16987977|P7|Open Label Phase|Lost to Follow-up|0
4937047|NCT00401245|16987978|P6|Open Label Phase|Lost to Follow-up|0
4937048|NCT00401245|16987979|P5|Open Label Phase|Lost to Follow-up|0
4937049|NCT00401245|16987980|P4|Open Label Phase|Lost to Follow-up|4
4937050|NCT00401245|16987981|P3|Open Label Phase|Lost to Follow-up|5
4937051|NCT00401245|16987982|P2|Open Label Phase|Lost to Follow-up|7
4937052|NCT00401245|16987983|P1|Open Label Phase|Lost to Follow-up|5
4937053|NCT00401245|16987976|P8|Open Label Phase|Adverse Event|0
4937054|NCT00401245|16987977|P7|Open Label Phase|Adverse Event|0
4937055|NCT00401245|16987978|P6|Open Label Phase|Adverse Event|0
4937056|NCT00401245|16987979|P5|Open Label Phase|Adverse Event|0
4937057|NCT00401245|16987980|P4|Open Label Phase|Adverse Event|7
4937058|NCT00401245|16987981|P3|Open Label Phase|Adverse Event|6
4937059|NCT00401245|16987982|P2|Open Label Phase|Adverse Event|14
4937060|NCT00401245|16987983|P1|Open Label Phase|Adverse Event|5
4937061|NCT00401245|16987976|P8|Between Titration and Open Label Phase|Did not enter the open label phase|0
4937062|NCT00401245|16987977|P7|Between Titration and Open Label Phase|Did not enter the open label phase|0
4937063|NCT00401245|16987978|P6|Between Titration and Open Label Phase|Did not enter the open label phase|0
4937064|NCT00401245|16987979|P5|Between Titration and Open Label Phase|Did not enter the open label phase|0
4937065|NCT00401245|16987980|P4|Between Titration and Open Label Phase|Did not enter the open label phase|2
4937066|NCT00401245|16987981|P3|Between Titration and Open Label Phase|Did not enter the open label phase|0
4937067|NCT00401245|16987982|P2|Between Titration and Open Label Phase|Did not enter the open label phase|2
4937068|NCT00401245|16987983|P1|Between Titration and Open Label Phase|Did not enter the open label phase|0
4937069|NCT00401245|16987976|P8|Double Blind Titration Phase|Withdrawal by Subject|0
4937070|NCT00401245|16987977|P7|Double Blind Titration Phase|Withdrawal by Subject|0
4937071|NCT00401245|16987978|P6|Double Blind Titration Phase|Withdrawal by Subject|0
4937072|NCT00401245|16987979|P5|Double Blind Titration Phase|Withdrawal by Subject|0
4937073|NCT00401245|16987980|P4|Double Blind Titration Phase|Withdrawal by Subject|2
4937074|NCT00401245|16987981|P3|Double Blind Titration Phase|Withdrawal by Subject|0
4937075|NCT00401245|16987982|P2|Double Blind Titration Phase|Withdrawal by Subject|1
4937076|NCT00401245|16987983|P1|Double Blind Titration Phase|Withdrawal by Subject|1
4937077|NCT00401245|16987976|P8|Double Blind Titration Phase|Protocol Violation|0
4937078|NCT00401245|16987977|P7|Double Blind Titration Phase|Protocol Violation|0
4937079|NCT00401245|16987978|P6|Double Blind Titration Phase|Protocol Violation|0
4937080|NCT00401245|16987979|P5|Double Blind Titration Phase|Protocol Violation|0
4937081|NCT00401245|16987980|P4|Double Blind Titration Phase|Protocol Violation|1
4937082|NCT00401245|16987981|P3|Double Blind Titration Phase|Protocol Violation|0
4937083|NCT00401245|16987982|P2|Double Blind Titration Phase|Protocol Violation|0
4937084|NCT00401245|16987983|P1|Double Blind Titration Phase|Protocol Violation|0
4937085|NCT00401245|16987976|P8|Double Blind Titration Phase|Other|0
4937086|NCT00401245|16987977|P7|Double Blind Titration Phase|Other|0
4937087|NCT00401245|16987978|P6|Double Blind Titration Phase|Other|0
4937088|NCT00401245|16987979|P5|Double Blind Titration Phase|Other|0
4937089|NCT00401245|16987980|P4|Double Blind Titration Phase|Other|0
4937090|NCT00401245|16987981|P3|Double Blind Titration Phase|Other|1
4937091|NCT00401245|16987982|P2|Double Blind Titration Phase|Other|0
4937092|NCT00401245|16987983|P1|Double Blind Titration Phase|Other|0
4937093|NCT00401245|16987976|P8|Double Blind Titration Phase|Adverse Event|0
4937094|NCT00401245|16987977|P7|Double Blind Titration Phase|Adverse Event|0
4937095|NCT00401245|16987978|P6|Double Blind Titration Phase|Adverse Event|0
4937096|NCT00401245|16987979|P5|Double Blind Titration Phase|Adverse Event|0
4937097|NCT00401245|16987980|P4|Double Blind Titration Phase|Adverse Event|12
4937098|NCT00401245|16987981|P3|Double Blind Titration Phase|Adverse Event|5
4937099|NCT00401245|16987982|P2|Double Blind Titration Phase|Adverse Event|2
4937100|NCT00401245|16987983|P1|Double Blind Titration Phase|Adverse Event|3
4937101|NCT00401193|16988051|P3|Overall Study|Other Event|2
4937102|NCT00401193|16988052|P2|Overall Study|Other Event|2
4937103|NCT00401193|16988053|P1|Overall Study|Other Event|3
4937104|NCT00401193|16988051|P3|Overall Study|Withdrawal by Subject|1
4937105|NCT00401193|16988052|P2|Overall Study|Withdrawal by Subject|0
4937106|NCT00401193|16988053|P1|Overall Study|Withdrawal by Subject|2
4937107|NCT00401193|16988051|P3|Overall Study|Lost to Follow-up|1
4937108|NCT00401193|16988052|P2|Overall Study|Lost to Follow-up|5
4937109|NCT00401193|16988053|P1|Overall Study|Lost to Follow-up|6
4937110|NCT00401193|16988051|P3|Overall Study|Protocol Violation|1
4937111|NCT00401193|16988052|P2|Overall Study|Protocol Violation|1
4937112|NCT00401193|16988053|P1|Overall Study|Protocol Violation|3
4937113|NCT00401193|16988051|P3|Overall Study|Adverse Event|1
4937114|NCT00401193|16988052|P2|Overall Study|Adverse Event|3
4937115|NCT00401193|16988053|P1|Overall Study|Adverse Event|1
4937116|NCT00400985|16988071|P1|Overall Study|Lost to Follow-up|9
4937117|NCT00400985|16988071|P1|Overall Study|Death|30
4937118|NCT00400985|16988071|P1|Overall Study|system modification|8
4937119|NCT00400985|16988071|P1|Overall Study|Withdrawal by Subject|5
4937120|NCT00400946|16988080|P5|Overall Study|Other|1
4937121|NCT00400946|16988081|P4|Overall Study|Other|0
4937122|NCT00400946|16988082|P3|Overall Study|Other|0
4937123|NCT00400946|16988083|P2|Overall Study|Other|0
4937124|NCT00400946|16988084|P1|Overall Study|Other|0
4937125|NCT00400946|16988080|P5|Overall Study|Clinical|9
4937126|NCT00400946|16988081|P4|Overall Study|Clinical|2
4937127|NCT00400946|16988082|P3|Overall Study|Clinical|0
4937128|NCT00400946|16988083|P2|Overall Study|Clinical|2
4937129|NCT00400946|16988084|P1|Overall Study|Clinical|1
4937130|NCT00400946|16988080|P5|Overall Study|Withdrawal by Subject|8
4937131|NCT00400946|16988081|P4|Overall Study|Withdrawal by Subject|5
4937132|NCT00400946|16988082|P3|Overall Study|Withdrawal by Subject|1
4937133|NCT00400946|16988083|P2|Overall Study|Withdrawal by Subject|5
4937134|NCT00400946|16988084|P1|Overall Study|Withdrawal by Subject|2
4937135|NCT00400946|16988080|P5|Overall Study|Transplant in CR1|1
4937136|NCT00400946|16988081|P4|Overall Study|Transplant in CR1|10
4937137|NCT00400946|16988082|P3|Overall Study|Transplant in CR1|0
4937138|NCT00400946|16988083|P2|Overall Study|Transplant in CR1|0
4937139|NCT00400946|16988084|P1|Overall Study|Transplant in CR1|0
4937140|NCT00400946|16988080|P5|Overall Study|Relapse|5
4937141|NCT00400946|16988081|P4|Overall Study|Relapse|1
4937142|NCT00400946|16988082|P3|Overall Study|Relapse|1
4937143|NCT00400946|16988083|P2|Overall Study|Relapse|2
4937144|NCT00400946|16988084|P1|Overall Study|Relapse|9
4937145|NCT00400946|16988080|P5|Overall Study|Remission Death|1
4937146|NCT00400946|16988081|P4|Overall Study|Remission Death|0
4937147|NCT00400946|16988082|P3|Overall Study|Remission Death|0
4937148|NCT00400946|16988083|P2|Overall Study|Remission Death|1
4937149|NCT00400946|16988084|P1|Overall Study|Remission Death|1
4937150|NCT00400946|16988080|P5|Overall Study|Lost to Follow-up|1
4937151|NCT00400946|16988081|P4|Overall Study|Lost to Follow-up|0
4937152|NCT00400946|16988082|P3|Overall Study|Lost to Follow-up|0
4937153|NCT00400946|16988083|P2|Overall Study|Lost to Follow-up|1
4937154|NCT00400946|16988084|P1|Overall Study|Lost to Follow-up|1
4937155|NCT00400946|16988080|P5|Overall Study|Induction Death|3
4937156|NCT00400946|16988081|P4|Overall Study|Induction Death|13
4937157|NCT00400946|16988082|P3|Overall Study|Induction Death|0
4937158|NCT00400946|16988083|P2|Overall Study|Induction Death|0
4937159|NCT00400946|16988084|P1|Overall Study|Induction Death|0
4937160|NCT00400946|16988080|P5|Overall Study|Induction Failure|8
4937161|NCT00400946|16988081|P4|Overall Study|Induction Failure|11
4937162|NCT00400946|16988082|P3|Overall Study|Induction Failure|0
4937163|NCT00400946|16988083|P2|Overall Study|Induction Failure|0
4937164|NCT00400946|16988084|P1|Overall Study|Induction Failure|0
4937165|NCT00400946|16988080|P5|Overall Study|Ineligible|1
4937166|NCT00400946|16988081|P4|Overall Study|Ineligible|5
4937167|NCT00400946|16988082|P3|Overall Study|Ineligible|0
4937168|NCT00400946|16988083|P2|Overall Study|Ineligible|0
4937169|NCT00400946|16988084|P1|Overall Study|Ineligible|0
4937170|NCT00400764|16988143|P5|Phase II|Withdrawal by Subject|0
4937171|NCT00400764|16988144|P4|Phase II|Withdrawal by Subject|1
4937172|NCT00400764|16988145|P3|Phase II|Withdrawal by Subject|1
4937173|NCT00400764|16988146|P2|Phase II|Withdrawal by Subject|0
4937174|NCT00400764|16988147|P1|Phase II|Withdrawal by Subject|0
4937175|NCT00400764|16988143|P5|Phase II|Patient began new, non-protocol, therapy|0
4937176|NCT00400764|16988144|P4|Phase II|Patient began new, non-protocol, therapy|0
4937177|NCT00400764|16988145|P3|Phase II|Patient began new, non-protocol, therapy|1
4937178|NCT00400764|16988146|P2|Phase II|Patient began new, non-protocol, therapy|0
4937179|NCT00400764|16988147|P1|Phase II|Patient began new, non-protocol, therapy|0
4937180|NCT00400764|16988143|P5|Phase II|Sponsor's decision to terminate|11
4937181|NCT00400764|16988144|P4|Phase II|Sponsor's decision to terminate|22
4937182|NCT00400764|16988145|P3|Phase II|Sponsor's decision to terminate|18
4937183|NCT00400764|16988146|P2|Phase II|Sponsor's decision to terminate|0
4937184|NCT00400764|16988147|P1|Phase II|Sponsor's decision to terminate|0
4937185|NCT00400764|16988143|P5|Phase II|Physician Decision|0
4937186|NCT00400764|16988144|P4|Phase II|Physician Decision|1
4937187|NCT00400764|16988145|P3|Phase II|Physician Decision|1
4937188|NCT00400764|16988146|P2|Phase II|Physician Decision|0
4937189|NCT00400764|16988147|P1|Phase II|Physician Decision|0
4937190|NCT00400764|16988143|P5|Phase II|Lost to Follow-up|0
4937191|NCT00400764|16988144|P4|Phase II|Lost to Follow-up|0
4937192|NCT00400764|16988145|P3|Phase II|Lost to Follow-up|1
4937193|NCT00400764|16988146|P2|Phase II|Lost to Follow-up|0
4937194|NCT00400764|16988147|P1|Phase II|Lost to Follow-up|0
4937195|NCT00400764|16988143|P5|Phase II|Death|0
4937196|NCT00400764|16988144|P4|Phase II|Death|2
4937197|NCT00400764|16988145|P3|Phase II|Death|1
4937198|NCT00400764|16988146|P2|Phase II|Death|0
4937199|NCT00400764|16988147|P1|Phase II|Death|0
4937200|NCT00400764|16988143|P5|Phase Ib|Disease Progression|0
4937201|NCT00400764|16988144|P4|Phase Ib|Disease Progression|0
4937202|NCT00400764|16988145|P3|Phase Ib|Disease Progression|0
4937203|NCT00400764|16988146|P2|Phase Ib|Disease Progression|4
4937204|NCT00400764|16988147|P1|Phase Ib|Disease Progression|4
4937205|NCT00400764|16988143|P5|Phase Ib|Death|0
4937206|NCT00400764|16988144|P4|Phase Ib|Death|0
4937207|NCT00400764|16988145|P3|Phase Ib|Death|0
4937208|NCT00400764|16988146|P2|Phase Ib|Death|0
4937209|NCT00400764|16988147|P1|Phase Ib|Death|1
4937210|NCT00400764|16988143|P5|Phase Ib|Adverse Event|0
4937211|NCT00400764|16988144|P4|Phase Ib|Adverse Event|0
4937212|NCT00400764|16988145|P3|Phase Ib|Adverse Event|0
4937213|NCT00400764|16988146|P2|Phase Ib|Adverse Event|0
4937214|NCT00400764|16988147|P1|Phase Ib|Adverse Event|1
4937215|NCT00400712|16988200|P2|Overall Study|Physician Decision|4
4937216|NCT00400712|16988201|P1|Overall Study|Physician Decision|5
4937217|NCT00400712|16988200|P2|Overall Study|Withdrawal by Subject|12
4937218|NCT00400712|16988201|P1|Overall Study|Withdrawal by Subject|11
4937219|NCT00400712|16988200|P2|Overall Study|Death|0
4937220|NCT00400712|16988201|P1|Overall Study|Death|1
4937221|NCT00400569|16988236|P1|Overall Study|Death|1
4937222|NCT00400517|16988247|P1|Overall Study|Physician Decision|1
4937223|NCT00400517|16988247|P1|Overall Study|Withdrawal by Subject|1
4937224|NCT00400400|16988267|P2|Overall Study|Did not receive study drug|3
4937225|NCT00400400|16988268|P1|Overall Study|Did not receive study drug|1
4937226|NCT00400400|16988267|P2|Overall Study|Lost to Follow-up|1
4937227|NCT00400400|16988268|P1|Overall Study|Lost to Follow-up|0
4937228|NCT00400400|16988267|P2|Overall Study|Administrative Problem|0
4937229|NCT00400400|16988268|P1|Overall Study|Administrative Problem|1
4937230|NCT00400400|16988267|P2|Overall Study|Withdrawal by Subject|3
4937231|NCT00400400|16988268|P1|Overall Study|Withdrawal by Subject|1
4937232|NCT00400400|16988267|P2|Overall Study|Protocol Violation|0
4937233|NCT00400400|16988268|P1|Overall Study|Protocol Violation|2
4937234|NCT00400400|16988267|P2|Overall Study|Adverse Event|8
4937235|NCT00400400|16988268|P1|Overall Study|Adverse Event|9
4937236|NCT00400179|16988293|P2|Overall Study|Randomization error/patient ineligible|6
4937237|NCT00400179|16988294|P1|Overall Study|Randomization error/patient ineligible|1
4937238|NCT00400179|16988293|P2|Overall Study|Investigator judgment|1
4937239|NCT00400179|16988294|P1|Overall Study|Investigator judgment|0
4937240|NCT00400179|16988293|P2|Overall Study|Intercurrent illness|1
4937241|NCT00400179|16988294|P1|Overall Study|Intercurrent illness|0
4937242|NCT00400179|16988293|P2|Overall Study|Disease progression|1
4937243|NCT00400179|16988294|P1|Overall Study|Disease progression|1
4937244|NCT00400179|16988293|P2|Overall Study|Withdrew Consent|5
4937245|NCT00400179|16988294|P1|Overall Study|Withdrew Consent|1
4937246|NCT00400179|16988293|P2|Overall Study|Death|2
4937247|NCT00400179|16988294|P1|Overall Study|Death|1
4937248|NCT00400179|16988293|P2|Overall Study|Adverse Event|2
4937249|NCT00400179|16988294|P1|Overall Study|Adverse Event|2
4937250|NCT00400153|16988311|P3|Overall Study|Other reasons - not mentioned above|3
4937251|NCT00400153|16988312|P2|Overall Study|Other reasons - not mentioned above|5
4937252|NCT00400153|16988313|P1|Overall Study|Other reasons - not mentioned above|8
4937253|NCT00400153|16988311|P3|Overall Study|Withdrawal by Subject|10
4937254|NCT00400153|16988312|P2|Overall Study|Withdrawal by Subject|11
4937255|NCT00400153|16988313|P1|Overall Study|Withdrawal by Subject|12
4937256|NCT00400153|16988311|P3|Overall Study|Lost to Follow-up|4
4937257|NCT00400153|16988312|P2|Overall Study|Lost to Follow-up|1
4937258|NCT00400153|16988313|P1|Overall Study|Lost to Follow-up|2
4937259|NCT00400153|16988311|P3|Overall Study|Protocol Violation|9
4937260|NCT00400153|16988312|P2|Overall Study|Protocol Violation|4
4937261|NCT00400153|16988313|P1|Overall Study|Protocol Violation|7
4937262|NCT00400153|16988311|P3|Overall Study|AE due to other condition|15
4937263|NCT00400153|16988312|P2|Overall Study|AE due to other condition|14
4937264|NCT00400153|16988313|P1|Overall Study|AE due to other condition|3
4937265|NCT00400153|16988311|P3|Overall Study|AE due to other disease worsening|0
4937266|NCT00400153|16988312|P2|Overall Study|AE due to other disease worsening|1
4937267|NCT00400153|16988313|P1|Overall Study|AE due to other disease worsening|2
4937268|NCT00400153|16988311|P3|Overall Study|AE due to study disease worsening|20
4937269|NCT00400153|16988312|P2|Overall Study|AE due to study disease worsening|19
4937270|NCT00400153|16988313|P1|Overall Study|AE due to study disease worsening|14
4937271|NCT00399893|16988560|P2|Overall Study|Withdrawal by Subject|0
4937272|NCT00399893|16988561|P1|Overall Study|Withdrawal by Subject|1
4937273|NCT00399802|16988600|P2|Overall Study|Participant discontinued by mistake|1
4937274|NCT00399802|16988601|P1|Overall Study|Participant discontinued by mistake|0
4937275|NCT00399802|16988600|P2|Overall Study|Adverse Event|2
4937276|NCT00399802|16988601|P1|Overall Study|Adverse Event|0
4937277|NCT00399763|16988615|P2|Overall Study|Lost to Follow-up|3
4937278|NCT00399763|16988616|P1|Overall Study|Lost to Follow-up|2
4937279|NCT00399568|16988628|P2|Overall Study|Lost to Follow-up|2
4937280|NCT00399568|16988629|P1|Overall Study|Lost to Follow-up|2
4937281|NCT00399568|16988628|P2|Overall Study|Protocol non-compliance|2
4937282|NCT00399568|16988629|P1|Overall Study|Protocol non-compliance|2
4937283|NCT00399568|16988628|P2|Overall Study|Withdrawal by Subject|3
4937284|NCT00399568|16988629|P1|Overall Study|Withdrawal by Subject|7
4937285|NCT00399568|16988628|P2|Overall Study|Adverse Event|2
4937286|NCT00399568|16988629|P1|Overall Study|Adverse Event|1
4937287|NCT00399542|16988643|P2|Overall Study|Physician Decision|1
4937288|NCT00399542|16988644|P1|Overall Study|Physician Decision|0
4937289|NCT00399542|16988643|P2|Overall Study|Other|0
4937290|NCT00399542|16988644|P1|Overall Study|Other|1
4937291|NCT00399542|16988643|P2|Overall Study|Lost to Follow-up|6
4937292|NCT00399542|16988644|P1|Overall Study|Lost to Follow-up|6
4937293|NCT00399542|16988643|P2|Overall Study|Lack of Efficacy|8
4937294|NCT00399542|16988644|P1|Overall Study|Lack of Efficacy|18
4937295|NCT00399542|16988643|P2|Overall Study|Withdrawal by Subject|10
4937296|NCT00399542|16988644|P1|Overall Study|Withdrawal by Subject|28
4937297|NCT00399542|16988643|P2|Overall Study|Protocol Violation|3
4937298|NCT00399542|16988644|P1|Overall Study|Protocol Violation|13
4937299|NCT00399542|16988643|P2|Overall Study|Adverse Event|15
4937300|NCT00399542|16988644|P1|Overall Study|Adverse Event|18
4937301|NCT00399529|16988706|P1|Overall Study|Off Study Prior to Treatment|2
4937302|NCT00399516|16988712|P1|Overall Study|Lost to Follow-up|2
4937303|NCT00399360|16988720|P4|Overall Study|Withdrawal by Subject|2
4937304|NCT00399360|16988721|P3|Overall Study|Withdrawal by Subject|0
4937305|NCT00399360|16988722|P2|Overall Study|Withdrawal by Subject|2
4937306|NCT00399360|16988723|P1|Overall Study|Withdrawal by Subject|0
4937307|NCT00399360|16988720|P4|Overall Study|Adverse Event|0
4937308|NCT00399360|16988721|P3|Overall Study|Adverse Event|1
4937309|NCT00399360|16988722|P2|Overall Study|Adverse Event|0
4937310|NCT00399360|16988723|P1|Overall Study|Adverse Event|0
4937311|NCT00399360|16988720|P4|Overall Study|Lost to Follow-up|4
4937312|NCT00399360|16988721|P3|Overall Study|Lost to Follow-up|2
4937313|NCT00399360|16988722|P2|Overall Study|Lost to Follow-up|1
4937314|NCT00399360|16988723|P1|Overall Study|Lost to Follow-up|2
4937315|NCT00399035|16988794|P3|Overall Study|Severe non-compliance with protocol|0
4937316|NCT00399035|16988795|P2|Overall Study|Severe non-compliance with protocol|1
4937317|NCT00399035|16988796|P1|Overall Study|Severe non-compliance with protocol|2
4937318|NCT00399035|16988794|P3|Overall Study|Incorrect enrolment/eligib not fulfilled|1
4937319|NCT00399035|16988795|P2|Overall Study|Incorrect enrolment/eligib not fulfilled|0
4937320|NCT00399035|16988796|P1|Overall Study|Incorrect enrolment/eligib not fulfilled|1
4937321|NCT00399035|16988794|P3|Overall Study|Withdrawal by Subject|12
4937322|NCT00399035|16988795|P2|Overall Study|Withdrawal by Subject|15
4937323|NCT00399035|16988796|P1|Overall Study|Withdrawal by Subject|19
4937324|NCT00399035|16988794|P3|Overall Study|Lost to Follow-up|5
4937325|NCT00399035|16988795|P2|Overall Study|Lost to Follow-up|1
4937326|NCT00399035|16988796|P1|Overall Study|Lost to Follow-up|2
4937327|NCT00399035|16988794|P3|Overall Study|Death|234
4937328|NCT00399035|16988795|P2|Overall Study|Death|141
4937329|NCT00399035|16988796|P1|Overall Study|Death|289
4937330|NCT00398866|16988832|P3|Overall Study|Unable to complete requirements of study|1
4937331|NCT00398866|16988833|P2|Overall Study|Unable to complete requirements of study|1
4937332|NCT00398866|16988834|P1|Overall Study|Unable to complete requirements of study|1
4937333|NCT00398866|16988832|P3|Overall Study|Withdrawal by Subject|2
4937334|NCT00398866|16988833|P2|Overall Study|Withdrawal by Subject|1
4937335|NCT00398866|16988834|P1|Overall Study|Withdrawal by Subject|5
4937336|NCT00398866|16988832|P3|Overall Study|Lost to Follow-up|4
4937337|NCT00398866|16988833|P2|Overall Study|Lost to Follow-up|6
4937338|NCT00398866|16988834|P1|Overall Study|Lost to Follow-up|7
4937339|NCT00398866|16988832|P3|Overall Study|Lack of Efficacy|1
4937340|NCT00398866|16988833|P2|Overall Study|Lack of Efficacy|0
4937341|NCT00398866|16988834|P1|Overall Study|Lack of Efficacy|0
4937342|NCT00398866|16988832|P3|Overall Study|Adverse Event|0
4937343|NCT00398866|16988833|P2|Overall Study|Adverse Event|0
4937344|NCT00398866|16988834|P1|Overall Study|Adverse Event|1
4937345|NCT00398632|16988845|P1|Overall Study|Lack of Efficacy|1
4937346|NCT00398632|16988845|P1|Overall Study|Withdrawal by Subject|1
4937347|NCT00398567|16988853|P3|Overall Study|Protocol Violation|1
4937348|NCT00398567|16988854|P2|Overall Study|Protocol Violation|0
4937349|NCT00398567|16988855|P1|Overall Study|Protocol Violation|0
4937350|NCT00398567|16988853|P3|Overall Study|Adverse Event|2
4937351|NCT00398567|16988854|P2|Overall Study|Adverse Event|0
4937352|NCT00398567|16988855|P1|Overall Study|Adverse Event|0
4937353|NCT00398567|16988853|P3|Overall Study|Withdrawal by Subject|4
4937354|NCT00398567|16988854|P2|Overall Study|Withdrawal by Subject|0
4937355|NCT00398567|16988855|P1|Overall Study|Withdrawal by Subject|1
4937356|NCT00398567|16988853|P3|Overall Study|Disease Progression|27
4937357|NCT00398567|16988854|P2|Overall Study|Disease Progression|4
4937358|NCT00398567|16988855|P1|Overall Study|Disease Progression|3
4937359|NCT00398411|16988909|P2|Overall Study|Death|1
4937360|NCT00398411|16988910|P1|Overall Study|Death|0
4937361|NCT00398320|16988933|P1|Overall Study|Physician Decision|1
4937362|NCT00398320|16988933|P1|Overall Study|Adverse Event|4
4937363|NCT00398320|16988933|P1|Overall Study|Death|1
4937364|NCT00398216|16988946|P5|Overall Study|entrance criteria|2
4937365|NCT00398216|16988947|P4|Overall Study|entrance criteria|0
4937366|NCT00398216|16988948|P3|Overall Study|entrance criteria|0
4937367|NCT00398216|16988949|P2|Overall Study|entrance criteria|0
4937368|NCT00398216|16988950|P1|Overall Study|entrance criteria|0
4937369|NCT00398216|16988946|P5|Overall Study|administrative reasons|3
4937370|NCT00398216|16988947|P4|Overall Study|administrative reasons|3
4937371|NCT00398216|16988948|P3|Overall Study|administrative reasons|4
4937372|NCT00398216|16988949|P2|Overall Study|administrative reasons|4
4937373|NCT00398216|16988950|P1|Overall Study|administrative reasons|3
4937374|NCT00398216|16988946|P5|Overall Study|Withdrawal by Subject|2
4937375|NCT00398216|16988947|P4|Overall Study|Withdrawal by Subject|1
4937376|NCT00398216|16988948|P3|Overall Study|Withdrawal by Subject|3
4937377|NCT00398216|16988949|P2|Overall Study|Withdrawal by Subject|0
4937378|NCT00398216|16988950|P1|Overall Study|Withdrawal by Subject|1
4937379|NCT00398216|16988946|P5|Overall Study|Death|0
4937380|NCT00398216|16988947|P4|Overall Study|Death|0
4937381|NCT00398216|16988948|P3|Overall Study|Death|0
4937382|NCT00398216|16988949|P2|Overall Study|Death|3
4937383|NCT00398216|16988950|P1|Overall Study|Death|0
4937384|NCT00398216|16988946|P5|Overall Study|Lost to Follow-up|1
4937385|NCT00398216|16988947|P4|Overall Study|Lost to Follow-up|4
4937386|NCT00398216|16988948|P3|Overall Study|Lost to Follow-up|4
4937387|NCT00398216|16988949|P2|Overall Study|Lost to Follow-up|6
4937388|NCT00398216|16988950|P1|Overall Study|Lost to Follow-up|1
4937389|NCT00398216|16988946|P5|Overall Study|Protocol Violation|5
4937390|NCT00398216|16988947|P4|Overall Study|Protocol Violation|7
4937391|NCT00398216|16988948|P3|Overall Study|Protocol Violation|5
4937392|NCT00398216|16988949|P2|Overall Study|Protocol Violation|4
4937393|NCT00398216|16988950|P1|Overall Study|Protocol Violation|2
4937394|NCT00398216|16988946|P5|Overall Study|Adverse Event|2
4937395|NCT00398216|16988947|P4|Overall Study|Adverse Event|7
4937396|NCT00398216|16988948|P3|Overall Study|Adverse Event|5
4937397|NCT00398216|16988949|P2|Overall Study|Adverse Event|2
4937398|NCT00398216|16988950|P1|Overall Study|Adverse Event|4
4937399|NCT00398138|16988977|P1|Overall Study|Adverse Event|2
4937400|NCT00398112|16988982|P1|Overall Study|Death|1
4937401|NCT00398112|16988982|P1|Overall Study|Withdrawal by Subject|3
4937402|NCT00398112|16988982|P1|Overall Study|Alternative treatment|1
4937403|NCT00398112|16988982|P1|Overall Study|Disease progression|9
4937404|NCT00398112|16988982|P1|Overall Study|Adverse Event|4
4937405|NCT00398086|16988993|P3|Overall Study|Withdrawal by Subject|0
4937406|NCT00398086|16988994|P2|Overall Study|Withdrawal by Subject|7
4937407|NCT00398086|16988995|P1|Overall Study|Withdrawal by Subject|5
4937408|NCT00398086|16988993|P3|Overall Study|Physician Decision|0
4937409|NCT00398086|16988994|P2|Overall Study|Physician Decision|4
4937410|NCT00398086|16988995|P1|Overall Study|Physician Decision|1
4937411|NCT00398086|16988993|P3|Overall Study|Adverse Event|0
4937412|NCT00398086|16988994|P2|Overall Study|Adverse Event|4
4937413|NCT00398086|16988995|P1|Overall Study|Adverse Event|1
4937414|NCT00398086|16988993|P3|Overall Study|Unacceptable Toxicity|2
4937415|NCT00398086|16988994|P2|Overall Study|Unacceptable Toxicity|8
4937416|NCT00398086|16988995|P1|Overall Study|Unacceptable Toxicity|2
4937417|NCT00398073|16989029|P2|Overall Study|Withdrawal by Subject|0
4937418|NCT00398073|16989030|P1|Overall Study|Withdrawal by Subject|1
4937419|NCT00398047|16989040|P1|Overall Study|all patient progressed before completion|3
4937420|NCT00397982|16989050|P1|Overall Study|Unrelated health issues|1
4937421|NCT00397982|16989050|P1|Overall Study|noncompliance|1
4937422|NCT00397982|16989050|P1|Overall Study|Adverse Event|1
4937423|NCT00397982|16989050|P1|Overall Study|Withdrawal by Subject|1
4937424|NCT00397943|16989064|P5|Overall Study|Unspecified reasons|0
4937425|NCT00397943|16989065|P4|Overall Study|Unspecified reasons|0
4937426|NCT00397943|16989066|P3|Overall Study|Unspecified reasons|0
4937427|NCT00397943|16989067|P2|Overall Study|Unspecified reasons|9
4937428|NCT00397943|16989068|P1|Overall Study|Unspecified reasons|12
4937429|NCT00397930|16989224|P2|Overall Study|Missing data|4
4937430|NCT00397930|16989225|P1|Overall Study|Missing data|0
4937431|NCT00397930|16989224|P2|Overall Study|Withdrawal by Subject|8
4937432|NCT00397930|16989225|P1|Overall Study|Withdrawal by Subject|0
4937433|NCT00397930|16989224|P2|Overall Study|Did not want to be in control group|1
4937434|NCT00397930|16989225|P1|Overall Study|Did not want to be in control group|0
4937435|NCT00397930|16989224|P2|Overall Study|Started own yoga program|1
4937436|NCT00397930|16989225|P1|Overall Study|Started own yoga program|1
4937437|NCT00397930|16989224|P2|Overall Study|Too time-consuming|9
4937438|NCT00397930|16989225|P1|Overall Study|Too time-consuming|2
4937439|NCT00397930|16989224|P2|Overall Study|Noncompliant|2
4937440|NCT00397930|16989225|P1|Overall Study|Noncompliant|3
4937441|NCT00397930|16989224|P2|Overall Study|Unknown reasons|14
4937442|NCT00397930|16989225|P1|Overall Study|Unknown reasons|9
4937443|NCT00397930|16989224|P2|Overall Study|Other medical|4
4937444|NCT00397930|16989225|P1|Overall Study|Other medical|9
4937445|NCT00397930|16989224|P2|Overall Study|Personal reasons|8
4937446|NCT00397930|16989225|P1|Overall Study|Personal reasons|14
4937447|NCT00397891|16989240|P5|Overall Study|Withdrawal by Subject|1
4937448|NCT00397891|16989241|P4|Overall Study|Withdrawal by Subject|0
4937449|NCT00397891|16989242|P3|Overall Study|Withdrawal by Subject|0
4937450|NCT00397891|16989243|P2|Overall Study|Withdrawal by Subject|0
4937451|NCT00397891|16989244|P1|Overall Study|Withdrawal by Subject|1
4937452|NCT00397631|16989417|P2|Overall Study|protocol discontinuation criteria|4
4937453|NCT00397631|16989418|P1|Overall Study|protocol discontinuation criteria|1
4937454|NCT00397631|16989417|P2|Overall Study|Withdrawal by Subject|14
4937455|NCT00397631|16989418|P1|Overall Study|Withdrawal by Subject|7
4937456|NCT00397631|16989417|P2|Overall Study|Protocol Violation|1
4937457|NCT00397631|16989418|P1|Overall Study|Protocol Violation|0
4937458|NCT00397631|16989417|P2|Overall Study|Physician Decision|0
4937459|NCT00397631|16989418|P1|Overall Study|Physician Decision|2
4937460|NCT00397631|16989417|P2|Overall Study|Lost to Follow-up|9
4937461|NCT00397631|16989418|P1|Overall Study|Lost to Follow-up|8
4937462|NCT00397631|16989417|P2|Overall Study|Lack of Efficacy|10
4937463|NCT00397631|16989418|P1|Overall Study|Lack of Efficacy|7
4937464|NCT00397631|16989417|P2|Overall Study|Adverse Event|6
4937465|NCT00397631|16989418|P1|Overall Study|Adverse Event|5
4937466|NCT00397540|16989434|P2|Overall Study|short follow-up duration < 12 months|0
4937467|NCT00397540|16989435|P1|Overall Study|short follow-up duration < 12 months|1
4937468|NCT00397514|16989443|P1|Overall Study|poor echocardiographic windows|1
4937469|NCT00397514|16989443|P1|Overall Study|early extubation|2
4937470|NCT00397514|16989443|P1|Overall Study|Not able to capture & pace LV intraoper.|4
4937471|NCT00397514|16989443|P1|Overall Study|Pacing wire malfunction|1
4937472|NCT00397514|16989443|P1|Overall Study|Withdrawal by Subject|1
4937473|NCT00397488|16989453|P1|Overall Study|Death|1
4937474|NCT00397488|16989453|P1|Overall Study|Adverse Event|3
4937475|NCT00397488|16989453|P1|Overall Study|Withdrawal by Subject|3
4937476|NCT00397254|16989473|P2|Overall Study|Lost to Follow-up|2
4937477|NCT00397254|16989474|P1|Overall Study|Lost to Follow-up|2
4937478|NCT00397215|16989496|P4|Month 6 (Day 180)|Other|0
4937479|NCT00397215|16989497|P3|Month 6 (Day 180)|Other|3
4937480|NCT00397215|16989498|P2|Month 6 (Day 180)|Other|0
4937481|NCT00397215|16989499|P1|Month 6 (Day 180)|Other|2
4937482|NCT00397215|16989496|P4|Month 6 (Day 180)|Adverse Event|0
4937483|NCT00397215|16989497|P3|Month 6 (Day 180)|Adverse Event|2
4937484|NCT00397215|16989498|P2|Month 6 (Day 180)|Adverse Event|3
4937485|NCT00397215|16989499|P1|Month 6 (Day 180)|Adverse Event|0
4937486|NCT00397215|16989496|P4|Month 0 (Day 0)|Other|3
4937487|NCT00397215|16989497|P3|Month 0 (Day 0)|Other|3
4937488|NCT00397215|16989498|P2|Month 0 (Day 0)|Other|1
4937489|NCT00397215|16989499|P1|Month 0 (Day 0)|Other|4
4937490|NCT00397215|16989496|P4|Month 0 (Day 0)|Withdrawal by Subject|1
4937491|NCT00397215|16989497|P3|Month 0 (Day 0)|Withdrawal by Subject|3
4937492|NCT00397215|16989498|P2|Month 0 (Day 0)|Withdrawal by Subject|3
4937493|NCT00397215|16989499|P1|Month 0 (Day 0)|Withdrawal by Subject|3
4937494|NCT00397215|16989496|P4|Month 0 (Day 0)|Adverse Event|0
4937495|NCT00397215|16989497|P3|Month 0 (Day 0)|Adverse Event|0
4937496|NCT00397215|16989498|P2|Month 0 (Day 0)|Adverse Event|1
4937497|NCT00397215|16989499|P1|Month 0 (Day 0)|Adverse Event|0
4937498|NCT00397189|16989635|P2|3 Weeks Period|Other|2
4937499|NCT00397189|16989636|P1|3 Weeks Period|Other|0
4937500|NCT00397189|16989635|P2|3 Weeks Period|Protocol Violation|3
4937501|NCT00397189|16989636|P1|3 Weeks Period|Protocol Violation|0
4937502|NCT00397189|16989635|P2|3 Weeks Period|Physician Decision|2
4937503|NCT00397189|16989636|P1|3 Weeks Period|Physician Decision|0
4937504|NCT00397189|16989635|P2|3 Weeks Period|Withdrawal by Subject|9
4937505|NCT00397189|16989636|P1|3 Weeks Period|Withdrawal by Subject|13
4937506|NCT00397189|16989635|P2|3 Weeks Period|Adverse Event|2
4937507|NCT00397189|16989636|P1|3 Weeks Period|Adverse Event|3
4937508|NCT00397189|16989635|P2|3 Weeks Period|Lost to Follow-up|4
4937509|NCT00397189|16989636|P1|3 Weeks Period|Lost to Follow-up|5
4937510|NCT00397046|16989663|P4|Overall Study|Disease Progression|5
4937511|NCT00397046|16989664|P3|Overall Study|Disease Progression|10
4937512|NCT00397046|16989665|P2|Overall Study|Disease Progression|3
4937513|NCT00397046|16989666|P1|Overall Study|Disease Progression|3
4937514|NCT00397033|16989688|P3|Overall Study|Other|2
4937515|NCT00397033|16989689|P2|Overall Study|Other|5
4937516|NCT00397033|16989690|P1|Overall Study|Other|0
4937517|NCT00397033|16989688|P3|Overall Study|Withdrawal by Subject|5
4937518|NCT00397033|16989689|P2|Overall Study|Withdrawal by Subject|7
4937519|NCT00397033|16989690|P1|Overall Study|Withdrawal by Subject|12
4937520|NCT00397033|16989688|P3|Overall Study|Lost to Follow-up|3
4937521|NCT00397033|16989689|P2|Overall Study|Lost to Follow-up|3
4937522|NCT00397033|16989690|P1|Overall Study|Lost to Follow-up|3
4937523|NCT00397033|16989688|P3|Overall Study|Lack of Efficacy|9
4937524|NCT00397033|16989689|P2|Overall Study|Lack of Efficacy|12
4937525|NCT00397033|16989690|P1|Overall Study|Lack of Efficacy|22
4937526|NCT00397033|16989688|P3|Overall Study|Adverse Event|4
4937527|NCT00397033|16989689|P2|Overall Study|Adverse Event|10
4937528|NCT00397033|16989690|P1|Overall Study|Adverse Event|7
4937529|NCT00396877|16989781|P2|Overall Study|Parent(s)/guardian(s)'s request|7
4937530|NCT00396877|16989782|P1|Overall Study|Parent(s)/guardian(s)'s request|4
4937531|NCT00396877|16989781|P2|Overall Study|Lost to Follow-up|1
4937532|NCT00396877|16989782|P1|Overall Study|Lost to Follow-up|2
4937533|NCT00396812|16989792|P1|Overall Study|Physician Decision|1
4937534|NCT00396656|16989804|P2|Second Treatment Period|Adverse Event|1
4937535|NCT00396656|16989805|P1|Second Treatment Period|Adverse Event|0
4937536|NCT00396656|16989804|P2|First Treatment Period|Withdrawal by Subject|2
4937537|NCT00396656|16989805|P1|First Treatment Period|Withdrawal by Subject|0
4937538|NCT00396630|16989823|P2|Overall Study|Not vaccinated at Visit 3|3
4937539|NCT00396630|16989824|P1|Overall Study|Not vaccinated at Visit 3|3
4937540|NCT00396630|16989823|P2|Overall Study|Withdrawal by Subject|1
4937541|NCT00396630|16989824|P1|Overall Study|Withdrawal by Subject|1
4937542|NCT00396630|16989823|P2|Overall Study|Lost to Follow-up|1
4937543|NCT00396630|16989824|P1|Overall Study|Lost to Follow-up|1
4937544|NCT00396591|16989844|P1|Overall Study|Participant request|1
4937545|NCT00396591|16989844|P1|Overall Study|Adverse Event|2
4937546|NCT00396591|16989844|P1|Overall Study|Disease Progression|13
4937547|NCT00396565|16989857|P3|Overall Study|Lack of Efficacy|11
4937548|NCT00396565|16989858|P2|Overall Study|Lack of Efficacy|64
4937549|NCT00396565|16989859|P1|Overall Study|Lack of Efficacy|32
4937550|NCT00396565|16989857|P3|Overall Study|Withdrawal by Subject|1
4937551|NCT00396565|16989858|P2|Overall Study|Withdrawal by Subject|13
4937552|NCT00396565|16989859|P1|Overall Study|Withdrawal by Subject|8
4937553|NCT00396565|16989857|P3|Overall Study|Adverse Event|3
4937554|NCT00396565|16989858|P2|Overall Study|Adverse Event|13
4937555|NCT00396565|16989859|P1|Overall Study|Adverse Event|5
4937556|NCT00396565|16989857|P3|Overall Study|Physician Decision|2
4937557|NCT00396565|16989858|P2|Overall Study|Physician Decision|1
4937558|NCT00396565|16989859|P1|Overall Study|Physician Decision|3
4937559|NCT00396409|16989884|P2|Period 2 - 2008|Lost to Follow-up|1
4937560|NCT00396409|16989885|P1|Period 2 - 2008|Lost to Follow-up|3
4937561|NCT00396409|16989884|P2|Period 2 - 2008|Withdrawal by Subject|1
4937562|NCT00396409|16989885|P1|Period 2 - 2008|Withdrawal by Subject|3
4937563|NCT00396409|16989884|P2|Period 2 - 2008|Protocol Violation|0
4937564|NCT00396409|16989885|P1|Period 2 - 2008|Protocol Violation|1
4937565|NCT00396409|16989884|P2|Between Period 1 and Period 2|Withdrawal by Subject|2
4937566|NCT00396409|16989885|P1|Between Period 1 and Period 2|Withdrawal by Subject|3
4937567|NCT00396409|16989884|P2|Period 1 - 2007|Lost to Follow-up|3
4937568|NCT00396409|16989885|P1|Period 1 - 2007|Lost to Follow-up|2
4937569|NCT00396409|16989884|P2|Period 1 - 2007|Withdrawal by Subject|1
4937570|NCT00396409|16989885|P1|Period 1 - 2007|Withdrawal by Subject|1
4937571|NCT00396409|16989884|P2|Period 1 - 2007|Lack of Efficacy|1
4937572|NCT00396409|16989885|P1|Period 1 - 2007|Lack of Efficacy|0
4937573|NCT00396409|16989884|P2|Period 1 - 2007|Adverse Event|1
4937574|NCT00396409|16989885|P1|Period 1 - 2007|Adverse Event|0
4937575|NCT00396383|16989915|P1|Overall Study|Lost to Follow-up|1
4937576|NCT00396383|16989915|P1|Overall Study|Death|2
4937577|NCT00396331|16989928|P1|Overall Study|Death|16
4937578|NCT00396331|16989928|P1|Overall Study|Lost to Follow-up|3
4937579|NCT00396331|16989928|P1|Overall Study|Did not go on to transplant|5
4937580|NCT00396331|16989928|P1|Overall Study|Failed to mobilize - no transplant|8
4937581|NCT00396318|16989981|P1|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5
4937582|NCT00396279|16990001|P1|Overall Study|Physician Decision|1
4937583|NCT00396279|16990001|P1|Overall Study|Withdrawal by Subject|1
4937584|NCT00396279|16990001|P1|Overall Study|Disease progression|2
4937585|NCT00396279|16990001|P1|Overall Study|Ongoing in study|26
4937586|NCT00396253|16990034|P1|Overall Study|Change in eligibility status|1
4937587|NCT00396253|16990034|P1|Overall Study|Physician Decision|1
4937588|NCT00396253|16990034|P1|Overall Study|Death|3
4937589|NCT00396253|16990034|P1|Overall Study|Withdrawal by Subject|7
4937590|NCT00396253|16990034|P1|Overall Study|Protocol Violation|1
4937591|NCT00396162|16990065|P2|Overall Study|Withdrawal by Subject|3
4937592|NCT00396162|16990066|P1|Overall Study|Withdrawal by Subject|2
4937593|NCT00396136|16990078|P1|Overall Study|Study device explanted|8
4937594|NCT00396136|16990078|P1|Overall Study|Lost to Follow-up|15
4937595|NCT00396136|16990078|P1|Overall Study|Withdrawal by Subject|59
4937596|NCT00396136|16990078|P1|Overall Study|Death|43
4937597|NCT00396097|16990085|P2|Overall Study|Insufficient Clinical Response|4
4937598|NCT00396097|16990086|P1|Overall Study|Insufficient Clinical Response|1
4937599|NCT00396097|16990085|P2|Overall Study|Adverse Event|5
4937600|NCT00396097|16990086|P1|Overall Study|Adverse Event|1
4937601|NCT00396097|16990085|P2|Overall Study|Protocol Violation|6
4937602|NCT00396097|16990086|P1|Overall Study|Protocol Violation|0
4937603|NCT00396097|16990085|P2|Overall Study|Other|5
4937604|NCT00396097|16990086|P1|Overall Study|Other|3
4937605|NCT00396097|16990085|P2|Overall Study|Lost to Follow-up|9
4937606|NCT00396097|16990086|P1|Overall Study|Lost to Follow-up|4
4937607|NCT00396097|16990085|P2|Overall Study|Withdrawal by Subject|17
4937608|NCT00396097|16990086|P1|Overall Study|Withdrawal by Subject|17
4937609|NCT00396084|16990114|P6|Overall Study|Withdrawal by Subject|0
4937610|NCT00396084|16990115|P5|Overall Study|Withdrawal by Subject|0
4937611|NCT00396084|16990116|P4|Overall Study|Withdrawal by Subject|1
4937612|NCT00396084|16990117|P3|Overall Study|Withdrawal by Subject|0
4937613|NCT00396084|16990118|P2|Overall Study|Withdrawal by Subject|0
4937614|NCT00396084|16990119|P1|Overall Study|Withdrawal by Subject|0
4937615|NCT00396084|16990114|P6|Overall Study|Adverse Event|2
4937616|NCT00396084|16990115|P5|Overall Study|Adverse Event|1
4937617|NCT00396084|16990116|P4|Overall Study|Adverse Event|0
4937618|NCT00396084|16990117|P3|Overall Study|Adverse Event|0
4937619|NCT00396084|16990118|P2|Overall Study|Adverse Event|0
4937620|NCT00396084|16990119|P1|Overall Study|Adverse Event|0
4937621|NCT00395967|16990248|P1|Follow-up Period|Lost to Follow-up|1
4937622|NCT00395967|16990248|P1|Follow-up Period|Death|1
4937623|NCT00395967|16990248|P1|Treatment Period|Failed Mobilization|1
4937624|NCT00395863|16990288|P2|Overall Study|Patients did not complete both exams|3
4937625|NCT00395863|16990289|P1|Overall Study|Patients did not complete both exams|2
4937626|NCT00395850|16990324|P4|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
4937627|NCT00395850|16990325|P3|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
4937628|NCT00395850|16990326|P2|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0
4937629|NCT00395850|16990327|P1|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1
4937630|NCT00395850|16990324|P4|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
4937631|NCT00395850|16990325|P3|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
4937632|NCT00395850|16990326|P2|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0
4937633|NCT00395850|16990327|P1|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1
4937634|NCT00395850|16990324|P4|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
4937635|NCT00395850|16990325|P3|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
4937636|NCT00395850|16990326|P2|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0
4937637|NCT00395850|16990327|P1|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1
4937638|NCT00395850|16990324|P4|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4
4937639|NCT00395850|16990325|P3|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6
4937640|NCT00395850|16990326|P2|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
4937641|NCT00395850|16990327|P1|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2
4937642|NCT00395850|16990324|P4|Pre-randomization Baseline/Induction|Inconsistent attendance|0
4937643|NCT00395850|16990325|P3|Pre-randomization Baseline/Induction|Inconsistent attendance|0
4937644|NCT00395850|16990326|P2|Pre-randomization Baseline/Induction|Inconsistent attendance|0
4937645|NCT00395850|16990327|P1|Pre-randomization Baseline/Induction|Inconsistent attendance|1
4937646|NCT00395850|16990324|P4|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
4937647|NCT00395850|16990325|P3|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
4937648|NCT00395850|16990326|P2|Pre-randomization Baseline/Induction|Withdrawal by Subject|0
4937649|NCT00395850|16990327|P1|Pre-randomization Baseline/Induction|Withdrawal by Subject|4
4937650|NCT00395850|16990324|P4|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
4937651|NCT00395850|16990325|P3|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
4937652|NCT00395850|16990326|P2|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0
4937653|NCT00395850|16990327|P1|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6
4937654|NCT00395746|16990344|P3|Overall Study|Unable to visit site on schedule|0
4937655|NCT00395746|16990345|P2|Overall Study|Unable to visit site on schedule|0
4937656|NCT00395746|16990346|P1|Overall Study|Unable to visit site on schedule|1
4937657|NCT00395746|16990344|P3|Overall Study|Difficultulty in use of device|1
4937658|NCT00395746|16990345|P2|Overall Study|Difficultulty in use of device|0
4937659|NCT00395746|16990346|P1|Overall Study|Difficultulty in use of device|0
4937660|NCT00395746|16990344|P3|Overall Study|Withdrawal of consent|1
4937661|NCT00395746|16990345|P2|Overall Study|Withdrawal of consent|0
4937662|NCT00395746|16990346|P1|Overall Study|Withdrawal of consent|0
4937663|NCT00395746|16990344|P3|Overall Study|Subject decision|1
4937664|NCT00395746|16990345|P2|Overall Study|Subject decision|0
4937665|NCT00395746|16990346|P1|Overall Study|Subject decision|0
4937666|NCT00395746|16990344|P3|Overall Study|Hypoglycaemia|0
4937667|NCT00395746|16990345|P2|Overall Study|Hypoglycaemia|1
4937668|NCT00395746|16990346|P1|Overall Study|Hypoglycaemia|2
4937669|NCT00395746|16990344|P3|Overall Study|Lack of Efficacy|17
4937670|NCT00395746|16990345|P2|Overall Study|Lack of Efficacy|0
4937671|NCT00395746|16990346|P1|Overall Study|Lack of Efficacy|2
4937672|NCT00395746|16990344|P3|Overall Study|Protocol Violation|0
4937673|NCT00395746|16990345|P2|Overall Study|Protocol Violation|1
4937674|NCT00395746|16990346|P1|Overall Study|Protocol Violation|0
4937675|NCT00395746|16990344|P3|Overall Study|Adverse Event|2
4937676|NCT00395746|16990345|P2|Overall Study|Adverse Event|2
4937677|NCT00395746|16990346|P1|Overall Study|Adverse Event|5
4937678|NCT00395733|16990392|P2|Period 2|Technical problems|0
4937679|NCT00395733|16990393|P1|Period 2|Technical problems|1
4937680|NCT00395733|16990392|P2|Period 2|Adverse Event|2
4937681|NCT00395733|16990393|P1|Period 2|Adverse Event|0
4937682|NCT00395733|16990392|P2|Period 2|Protocol Violation|1
4937683|NCT00395733|16990393|P1|Period 2|Protocol Violation|0
4937684|NCT00395733|16990392|P2|Period 2|Withdrawal by Subject|2
4937685|NCT00395733|16990393|P1|Period 2|Withdrawal by Subject|1
4937686|NCT00395694|16990417|P2|Continuation Phase|Withdrawal by Subject|2
4937687|NCT00395694|16990418|P1|Continuation Phase|Withdrawal by Subject|0
4937688|NCT00395694|16990417|P2|Continuation Phase|Poor Compliance|0
4937689|NCT00395694|16990418|P1|Continuation Phase|Poor Compliance|1
4937690|NCT00395694|16990417|P2|Continuation Phase|Withdrawal Due to Wishes of Family|0
4937777|NCT00395512|16990551|P3|Overall Study|Protocol Violation|6
4937691|NCT00395694|16990418|P1|Continuation Phase|Withdrawal Due to Wishes of Family|1
4937692|NCT00395694|16990417|P2|Continuation Phase|Lack of Efficacy|11
4937693|NCT00395694|16990418|P1|Continuation Phase|Lack of Efficacy|12
4937694|NCT00395694|16990417|P2|Continuation Phase|Adverse Event|0
4937695|NCT00395694|16990418|P1|Continuation Phase|Adverse Event|1
4937696|NCT00395694|16990417|P2|Escalation Phase + Maintenance Phase|Adverse Event|2
4937697|NCT00395694|16990418|P1|Escalation Phase + Maintenance Phase|Adverse Event|1
4937698|NCT00395642|16990449|P1|Overall Study|Withdrawal by Subject|1
4937699|NCT00395642|16990449|P1|Overall Study|Physician Decision|7
4937700|NCT00395642|16990449|P1|Overall Study|Lost to Follow-up|1
4937701|NCT00395642|16990449|P1|Overall Study|Death|4
4937702|NCT00395629|16990456|P3|Extension Study|Administrative problems|1
4937703|NCT00395629|16990457|P2|Extension Study|Administrative problems|0
4937704|NCT00395629|16990458|P1|Extension Study|Administrative problems|0
4937705|NCT00395629|16990456|P3|Extension Study|Adverse Event|2
4937706|NCT00395629|16990457|P2|Extension Study|Adverse Event|0
4937707|NCT00395629|16990458|P1|Extension Study|Adverse Event|0
4937708|NCT00395629|16990456|P3|Core Study|Lost to Follow-up|1
4937709|NCT00395629|16990457|P2|Core Study|Lost to Follow-up|0
4937710|NCT00395629|16990458|P1|Core Study|Lost to Follow-up|0
4937711|NCT00395629|16990456|P3|Core Study|Withdrawal by Subject|1
4937712|NCT00395629|16990457|P2|Core Study|Withdrawal by Subject|1
4937713|NCT00395629|16990458|P1|Core Study|Withdrawal by Subject|0
4937714|NCT00395629|16990456|P3|Core Study|Protocol Violation|0
4937715|NCT00395629|16990457|P2|Core Study|Protocol Violation|0
4937716|NCT00395629|16990458|P1|Core Study|Protocol Violation|1
4937717|NCT00395629|16990456|P3|Core Study|Abnormal laboratory value(s)|1
4937718|NCT00395629|16990457|P2|Core Study|Abnormal laboratory value(s)|0
4937719|NCT00395629|16990458|P1|Core Study|Abnormal laboratory value(s)|0
4937720|NCT00395629|16990456|P3|Core Study|Adverse Event|4
4937721|NCT00395629|16990457|P2|Core Study|Adverse Event|3
4937722|NCT00395629|16990458|P1|Core Study|Adverse Event|0
4937723|NCT00395538|16990475|P3|Overall Study|Participant elected to discontinue|1
4937724|NCT00395538|16990476|P2|Overall Study|Participant elected to discontinue|0
4937725|NCT00395538|16990477|P1|Overall Study|Participant elected to discontinue|0
4937726|NCT00395538|16990475|P3|Overall Study|Partial recovery of parathyroid function|1
4937727|NCT00395538|16990476|P2|Overall Study|Partial recovery of parathyroid function|0
4937728|NCT00395538|16990477|P1|Overall Study|Partial recovery of parathyroid function|0
4937729|NCT00395538|16990475|P3|Overall Study|Pregnancy|0
4937730|NCT00395538|16990476|P2|Overall Study|Pregnancy|0
4937731|NCT00395538|16990477|P1|Overall Study|Pregnancy|1
4937732|NCT00395538|16990475|P3|Overall Study|PTH resistance|1
4937733|NCT00395538|16990476|P2|Overall Study|PTH resistance|0
4937734|NCT00395538|16990477|P1|Overall Study|PTH resistance|0
4937735|NCT00395538|16990475|P3|Overall Study|Non-compliance with study protocol|0
4937736|NCT00395538|16990476|P2|Overall Study|Non-compliance with study protocol|1
4937737|NCT00395538|16990477|P1|Overall Study|Non-compliance with study protocol|0
4937738|NCT00395538|16990475|P3|Overall Study|DXA or QCT z-score or t-score<-2|0
4937739|NCT00395538|16990476|P2|Overall Study|DXA or QCT z-score or t-score<-2|2
4937740|NCT00395538|16990477|P1|Overall Study|DXA or QCT z-score or t-score<-2|0
4937741|NCT00395538|16990475|P3|Overall Study|Adverse Event|2
4937742|NCT00395538|16990476|P2|Overall Study|Adverse Event|0
4937743|NCT00395538|16990477|P1|Overall Study|Adverse Event|1
4937744|NCT00395538|16990475|P3|Overall Study|Switch to Natpara|3
4937745|NCT00395538|16990476|P2|Overall Study|Switch to Natpara|0
4937746|NCT00395538|16990477|P1|Overall Study|Switch to Natpara|0
4937747|NCT00395538|16990475|P3|Overall Study|Failed screening|4
4937748|NCT00395538|16990476|P2|Overall Study|Failed screening|0
4937749|NCT00395538|16990477|P1|Overall Study|Failed screening|0
4937750|NCT00395538|16990475|P3|Overall Study|FDA partial hold on PTH|11
4937751|NCT00395538|16990476|P2|Overall Study|FDA partial hold on PTH|0
4937752|NCT00395538|16990477|P1|Overall Study|FDA partial hold on PTH|0
4937753|NCT00395538|16990475|P3|Overall Study|Did not re-consent to revised protocol|0
4937754|NCT00395538|16990476|P2|Overall Study|Did not re-consent to revised protocol|10
4937755|NCT00395538|16990477|P1|Overall Study|Did not re-consent to revised protocol|1
4937756|NCT00395512|16990550|P4|Overall Study|Hyperglycemic Rescue|6
4937757|NCT00395512|16990551|P3|Overall Study|Hyperglycemic Rescue|4
4937758|NCT00395512|16990552|P2|Overall Study|Hyperglycemic Rescue|10
4937759|NCT00395512|16990553|P1|Overall Study|Hyperglycemic Rescue|18
4937760|NCT00395512|16990550|P4|Overall Study|Other|0
4937761|NCT00395512|16990551|P3|Overall Study|Other|0
4937762|NCT00395512|16990552|P2|Overall Study|Other|1
4937763|NCT00395512|16990553|P1|Overall Study|Other|1
4937764|NCT00395512|16990550|P4|Overall Study|Physician Decision|2
4937765|NCT00395512|16990551|P3|Overall Study|Physician Decision|2
4937766|NCT00395512|16990552|P2|Overall Study|Physician Decision|4
4937767|NCT00395512|16990553|P1|Overall Study|Physician Decision|6
4937768|NCT00395512|16990550|P4|Overall Study|Withdrawal by Subject|12
4937769|NCT00395512|16990551|P3|Overall Study|Withdrawal by Subject|5
4937770|NCT00395512|16990552|P2|Overall Study|Withdrawal by Subject|5
4937771|NCT00395512|16990553|P1|Overall Study|Withdrawal by Subject|6
4937772|NCT00395512|16990550|P4|Overall Study|Lost to Follow-up|5
4937773|NCT00395512|16990551|P3|Overall Study|Lost to Follow-up|5
4937774|NCT00395512|16990552|P2|Overall Study|Lost to Follow-up|6
4937775|NCT00395512|16990553|P1|Overall Study|Lost to Follow-up|2
4937776|NCT00395512|16990550|P4|Overall Study|Protocol Violation|7
4937778|NCT00395512|16990552|P2|Overall Study|Protocol Violation|3
4937779|NCT00395512|16990553|P1|Overall Study|Protocol Violation|2
4937780|NCT00395512|16990550|P4|Overall Study|Adverse Event|6
4937781|NCT00395512|16990551|P3|Overall Study|Adverse Event|6
4937782|NCT00395512|16990552|P2|Overall Study|Adverse Event|8
4937783|NCT00395512|16990553|P1|Overall Study|Adverse Event|3
4937784|NCT00395486|16990725|P2|Overall Study|Lost to Follow-up|1
4937785|NCT00395486|16990726|P1|Overall Study|Lost to Follow-up|0
4937786|NCT00395486|16990725|P2|Overall Study|Withdrawal by Subject|2
4937787|NCT00395486|16990726|P1|Overall Study|Withdrawal by Subject|5
4937788|NCT00395486|16990725|P2|Overall Study|Adverse Event|2
4937789|NCT00395486|16990726|P1|Overall Study|Adverse Event|1
4937790|NCT00395460|16990756|P2|Overall Study|Withdrawal by Subject|0
4937791|NCT00395460|16990757|P1|Overall Study|Withdrawal by Subject|1
4937792|NCT00395447|16990781|P2|Overall Study|Withdrawl - Other (not subject)|17
4937793|NCT00395447|16990782|P1|Overall Study|Withdrawl - Other (not subject)|8
4937794|NCT00395447|16990781|P2|Overall Study|Withdrawal by Subject|19
4937795|NCT00395447|16990782|P1|Overall Study|Withdrawal by Subject|24
4937796|NCT00395447|16990781|P2|Overall Study|Lost to Follow-up|43
4937797|NCT00395447|16990782|P1|Overall Study|Lost to Follow-up|52
4937798|NCT00395447|16990781|P2|Overall Study|Death|32
4937799|NCT00395447|16990782|P1|Overall Study|Death|37
4937800|NCT00395343|16990790|P2|Overall Study|Other|2
4937801|NCT00395343|16990791|P1|Overall Study|Other|5
4937802|NCT00395343|16990790|P2|Overall Study|Withdrawal by Subject|12
4937803|NCT00395343|16990791|P1|Overall Study|Withdrawal by Subject|11
4937804|NCT00395343|16990790|P2|Overall Study|Protocol Violation|8
4937805|NCT00395343|16990791|P1|Overall Study|Protocol Violation|6
4937806|NCT00395343|16990790|P2|Overall Study|Physician Decision|4
4937807|NCT00395343|16990791|P1|Overall Study|Physician Decision|2
4937808|NCT00395343|16990790|P2|Overall Study|Lost to Follow-up|4
4937809|NCT00395343|16990791|P1|Overall Study|Lost to Follow-up|4
4937810|NCT00395343|16990790|P2|Overall Study|Lack of Efficacy|1
4937811|NCT00395343|16990791|P1|Overall Study|Lack of Efficacy|0
4937812|NCT00395343|16990790|P2|Overall Study|Adverse Event|5
4937813|NCT00395343|16990791|P1|Overall Study|Adverse Event|13
4937814|NCT00395304|16990809|P6|Treatment Period 3|Other|0
4937815|NCT00395304|16990810|P5|Treatment Period 3|Other|0
4937816|NCT00395304|16990811|P4|Treatment Period 3|Other|1
4937817|NCT00395304|16990812|P3|Treatment Period 3|Other|0
4937818|NCT00395304|16990813|P2|Treatment Period 3|Other|0
4937819|NCT00395304|16990814|P1|Treatment Period 3|Other|0
4937820|NCT00395304|16990809|P6|Treatment Period 3|Physician Decision|0
4937821|NCT00395304|16990810|P5|Treatment Period 3|Physician Decision|0
4937822|NCT00395304|16990811|P4|Treatment Period 3|Physician Decision|0
4937823|NCT00395304|16990812|P3|Treatment Period 3|Physician Decision|0
4937824|NCT00395304|16990813|P2|Treatment Period 3|Physician Decision|1
4937825|NCT00395304|16990814|P1|Treatment Period 3|Physician Decision|0
4937826|NCT00395304|16990809|P6|Treatment Period 3|Lost to Follow-up|0
4937827|NCT00395304|16990810|P5|Treatment Period 3|Lost to Follow-up|0
4937828|NCT00395304|16990811|P4|Treatment Period 3|Lost to Follow-up|0
4937829|NCT00395304|16990812|P3|Treatment Period 3|Lost to Follow-up|0
4937830|NCT00395304|16990813|P2|Treatment Period 3|Lost to Follow-up|1
4937831|NCT00395304|16990814|P1|Treatment Period 3|Lost to Follow-up|1
4937832|NCT00395304|16990809|P6|Treatment Period 3|Withdrawal by Subject|1
4937833|NCT00395304|16990810|P5|Treatment Period 3|Withdrawal by Subject|0
4937834|NCT00395304|16990811|P4|Treatment Period 3|Withdrawal by Subject|1
4937835|NCT00395304|16990812|P3|Treatment Period 3|Withdrawal by Subject|0
4937836|NCT00395304|16990813|P2|Treatment Period 3|Withdrawal by Subject|0
4937837|NCT00395304|16990814|P1|Treatment Period 3|Withdrawal by Subject|0
4937838|NCT00395304|16990809|P6|Treatment Period 2|Other|0
4937839|NCT00395304|16990810|P5|Treatment Period 2|Other|0
4937840|NCT00395304|16990811|P4|Treatment Period 2|Other|0
4937841|NCT00395304|16990812|P3|Treatment Period 2|Other|0
4937842|NCT00395304|16990813|P2|Treatment Period 2|Other|1
4937843|NCT00395304|16990814|P1|Treatment Period 2|Other|0
4937844|NCT00395304|16990809|P6|Treatment Period 2|Physician Decision|0
4937845|NCT00395304|16990810|P5|Treatment Period 2|Physician Decision|0
4937846|NCT00395304|16990811|P4|Treatment Period 2|Physician Decision|0
4937847|NCT00395304|16990812|P3|Treatment Period 2|Physician Decision|1
4937848|NCT00395304|16990813|P2|Treatment Period 2|Physician Decision|0
4937849|NCT00395304|16990814|P1|Treatment Period 2|Physician Decision|0
4937850|NCT00395304|16990809|P6|Treatment Period 2|Lost to Follow-up|0
4937851|NCT00395304|16990810|P5|Treatment Period 2|Lost to Follow-up|0
4937852|NCT00395304|16990811|P4|Treatment Period 2|Lost to Follow-up|0
4937853|NCT00395304|16990812|P3|Treatment Period 2|Lost to Follow-up|0
4937854|NCT00395304|16990813|P2|Treatment Period 2|Lost to Follow-up|3
4937855|NCT00395304|16990814|P1|Treatment Period 2|Lost to Follow-up|0
4937856|NCT00395304|16990809|P6|Treatment Period 2|Withdrawal by Subject|2
4937857|NCT00395304|16990810|P5|Treatment Period 2|Withdrawal by Subject|0
4937858|NCT00395304|16990811|P4|Treatment Period 2|Withdrawal by Subject|1
4937859|NCT00395304|16990812|P3|Treatment Period 2|Withdrawal by Subject|0
4937860|NCT00395304|16990813|P2|Treatment Period 2|Withdrawal by Subject|0
4937861|NCT00395304|16990814|P1|Treatment Period 2|Withdrawal by Subject|0
4937862|NCT00395304|16990809|P6|Treatment Period 1|Physician Decision|0
4937863|NCT00395304|16990810|P5|Treatment Period 1|Physician Decision|0
4937864|NCT00395304|16990811|P4|Treatment Period 1|Physician Decision|0
4937865|NCT00395304|16990812|P3|Treatment Period 1|Physician Decision|0
4937866|NCT00395304|16990813|P2|Treatment Period 1|Physician Decision|1
4937867|NCT00395304|16990814|P1|Treatment Period 1|Physician Decision|0
4937868|NCT00395304|16990809|P6|Treatment Period 1|Lost to Follow-up|1
4937869|NCT00395304|16990810|P5|Treatment Period 1|Lost to Follow-up|0
4937870|NCT00395304|16990811|P4|Treatment Period 1|Lost to Follow-up|1
4937871|NCT00395304|16990812|P3|Treatment Period 1|Lost to Follow-up|0
4937872|NCT00395304|16990813|P2|Treatment Period 1|Lost to Follow-up|0
4937873|NCT00395304|16990814|P1|Treatment Period 1|Lost to Follow-up|1
4937874|NCT00395304|16990809|P6|Treatment Period 1|Withdrawal by Subject|1
4937875|NCT00395304|16990810|P5|Treatment Period 1|Withdrawal by Subject|1
4937876|NCT00395304|16990811|P4|Treatment Period 1|Withdrawal by Subject|2
4937877|NCT00395304|16990812|P3|Treatment Period 1|Withdrawal by Subject|0
4937878|NCT00395304|16990813|P2|Treatment Period 1|Withdrawal by Subject|3
4937879|NCT00395304|16990814|P1|Treatment Period 1|Withdrawal by Subject|0
4937880|NCT00395226|16990890|P2|Overall Study|Lost to Follow-up|1
4937881|NCT00395226|16990891|P1|Overall Study|Lost to Follow-up|0
4937882|NCT00395226|16990890|P2|Overall Study|Withdrawal by Subject|1
4937883|NCT00395226|16990891|P1|Overall Study|Withdrawal by Subject|0
4937884|NCT00395226|16990890|P2|Overall Study|Adverse Event|3
4937885|NCT00395226|16990891|P1|Overall Study|Adverse Event|4
4937886|NCT00395083|16990938|P2|Overall Study|Developed another disease|3
4937887|NCT00395083|16990939|P1|Overall Study|Developed another disease|4
4937888|NCT00395083|16990938|P2|Overall Study|Withdrawal by Subject|5
4937889|NCT00395083|16990939|P1|Overall Study|Withdrawal by Subject|6
4937890|NCT00395018|16991005|P1|Off-Treatment Follow-up|Poor/non-compliance|1
4937891|NCT00395018|16991005|P1|Off-Treatment Follow-up|Lost to Follow-up|2
4937892|NCT00395018|16991005|P1|Off-Treatment Follow-up|Followup no longer required per protocol|1
4937893|NCT00395018|16991005|P1|On-Treatment|Subject no longer meets study criteria|2
4937894|NCT00395018|16991005|P1|On-Treatment|Poor/non-compliance|2
4937895|NCT00395018|16991005|P1|On-Treatment|Other Reason|2
4937896|NCT00395018|16991005|P1|On-Treatment|Death|4
4937897|NCT00394953|16991026|P2|Second Treatment Period|Not defined|8
4937898|NCT00394953|16991027|P1|Second Treatment Period|Not defined|3
4937899|NCT00394953|16991026|P2|Second Treatment Period|Renal transplant|6
4937900|NCT00394953|16991027|P1|Second Treatment Period|Renal transplant|4
4937901|NCT00394953|16991026|P2|Second Treatment Period|Lost to Follow-up|1
4937902|NCT00394953|16991027|P1|Second Treatment Period|Lost to Follow-up|0
4937903|NCT00394953|16991026|P2|Second Treatment Period|Withdrawal by Subject|3
4937904|NCT00394953|16991027|P1|Second Treatment Period|Withdrawal by Subject|3
4937905|NCT00394953|16991026|P2|Second Treatment Period|Lack of Efficacy|47
4937906|NCT00394953|16991027|P1|Second Treatment Period|Lack of Efficacy|9
4937907|NCT00394953|16991026|P2|Second Treatment Period|Death|4
4937908|NCT00394953|16991027|P1|Second Treatment Period|Death|8
4937909|NCT00394953|16991026|P2|Second Treatment Period|Adverse Event|5
4937910|NCT00394953|16991027|P1|Second Treatment Period|Adverse Event|2
4937911|NCT00394953|16991026|P2|First Treatment Period|Not defined|1
4937912|NCT00394953|16991027|P1|First Treatment Period|Not defined|4
4937913|NCT00394953|16991026|P2|First Treatment Period|Renal transplant|7
4937914|NCT00394953|16991027|P1|First Treatment Period|Renal transplant|11
4937915|NCT00394953|16991026|P2|First Treatment Period|Lost to Follow-up|1
4937916|NCT00394953|16991027|P1|First Treatment Period|Lost to Follow-up|0
4937917|NCT00394953|16991026|P2|First Treatment Period|Withdrawal by Subject|3
4937918|NCT00394953|16991027|P1|First Treatment Period|Withdrawal by Subject|6
4937919|NCT00394953|16991026|P2|First Treatment Period|Lack of Efficacy|1
4937920|NCT00394953|16991027|P1|First Treatment Period|Lack of Efficacy|1
4937921|NCT00394953|16991026|P2|First Treatment Period|Death|7
4937922|NCT00394953|16991027|P1|First Treatment Period|Death|6
4937923|NCT00394953|16991026|P2|First Treatment Period|Adverse Event|2
4937924|NCT00394953|16991027|P1|First Treatment Period|Adverse Event|1
4937925|NCT00394914|16991045|P3|Treatment Period|Did not meet protocol eligibility|1
4937926|NCT00394914|16991046|P2|Treatment Period|Did not meet protocol eligibility|1
4937927|NCT00394914|16991047|P1|Treatment Period|Did not meet protocol eligibility|0
4937928|NCT00394914|16991045|P3|Treatment Period|Noncompliance with protocol|2
4937929|NCT00394914|16991046|P2|Treatment Period|Noncompliance with protocol|3
4937930|NCT00394914|16991047|P1|Treatment Period|Noncompliance with protocol|0
4937931|NCT00394914|16991045|P3|Treatment Period|Withdrawal by Subject|2
4937932|NCT00394914|16991046|P2|Treatment Period|Withdrawal by Subject|2
4937933|NCT00394914|16991047|P1|Treatment Period|Withdrawal by Subject|0
4937934|NCT00394914|16991045|P3|Treatment Period|Lost to Follow-up|0
4937935|NCT00394914|16991046|P2|Treatment Period|Lost to Follow-up|1
4937936|NCT00394914|16991047|P1|Treatment Period|Lost to Follow-up|0
4937937|NCT00394914|16991045|P3|Treatment Period|Adverse Event|1
4937938|NCT00394914|16991046|P2|Treatment Period|Adverse Event|3
4937939|NCT00394914|16991047|P1|Treatment Period|Adverse Event|0
4937940|NCT00394901|16991075|P4|Double-blind Phase|Found not to meet entrance criteria|1
4937941|NCT00394901|16991076|P3|Double-blind Phase|Found not to meet entrance criteria|0
4937942|NCT00394901|16991077|P2|Double-blind Phase|Found not to meet entrance criteria|0
4937943|NCT00394901|16991078|P1|Double-blind Phase|Found not to meet entrance criteria|0
4937944|NCT00394901|16991075|P4|Double-blind Phase|Entry into another study was found|0
4937945|NCT00394901|16991076|P3|Double-blind Phase|Entry into another study was found|1
4937946|NCT00394901|16991077|P2|Double-blind Phase|Entry into another study was found|0
4937947|NCT00394901|16991078|P1|Double-blind Phase|Entry into another study was found|0
4939319|NCT00385827|16995229|P3|Part 2|Other|21
4937948|NCT00394901|16991075|P4|Double-blind Phase|Lack of Compliance|0
4937949|NCT00394901|16991076|P3|Double-blind Phase|Lack of Compliance|0
4937950|NCT00394901|16991077|P2|Double-blind Phase|Lack of Compliance|3
4937951|NCT00394901|16991078|P1|Double-blind Phase|Lack of Compliance|0
4937952|NCT00394901|16991075|P4|Double-blind Phase|Subject's Personal Reason|1
4937953|NCT00394901|16991076|P3|Double-blind Phase|Subject's Personal Reason|0
4937954|NCT00394901|16991077|P2|Double-blind Phase|Subject's Personal Reason|0
4937955|NCT00394901|16991078|P1|Double-blind Phase|Subject's Personal Reason|1
4937956|NCT00394901|16991075|P4|Double-blind Phase|Death|0
4937957|NCT00394901|16991076|P3|Double-blind Phase|Death|0
4937958|NCT00394901|16991077|P2|Double-blind Phase|Death|0
4937959|NCT00394901|16991078|P1|Double-blind Phase|Death|1
4937960|NCT00394901|16991075|P4|Double-blind Phase|Protocol Violation|1
4937961|NCT00394901|16991076|P3|Double-blind Phase|Protocol Violation|0
4937962|NCT00394901|16991077|P2|Double-blind Phase|Protocol Violation|0
4937963|NCT00394901|16991078|P1|Double-blind Phase|Protocol Violation|0
4937964|NCT00394901|16991075|P4|Double-blind Phase|Lost to Follow-up|1
4937965|NCT00394901|16991076|P3|Double-blind Phase|Lost to Follow-up|0
4937966|NCT00394901|16991077|P2|Double-blind Phase|Lost to Follow-up|0
4937967|NCT00394901|16991078|P1|Double-blind Phase|Lost to Follow-up|0
4937968|NCT00394901|16991075|P4|Double-blind Phase|Withdrawal by Subject|0
4937969|NCT00394901|16991076|P3|Double-blind Phase|Withdrawal by Subject|0
4937970|NCT00394901|16991077|P2|Double-blind Phase|Withdrawal by Subject|0
4937971|NCT00394901|16991078|P1|Double-blind Phase|Withdrawal by Subject|2
4937972|NCT00394901|16991075|P4|Double-blind Phase|Lack of Efficacy|3
4937973|NCT00394901|16991076|P3|Double-blind Phase|Lack of Efficacy|1
4937974|NCT00394901|16991077|P2|Double-blind Phase|Lack of Efficacy|4
4937975|NCT00394901|16991078|P1|Double-blind Phase|Lack of Efficacy|6
4937976|NCT00394901|16991075|P4|Double-blind Phase|Adverse Event|20
4937977|NCT00394901|16991076|P3|Double-blind Phase|Adverse Event|16
4937978|NCT00394901|16991077|P2|Double-blind Phase|Adverse Event|7
4937979|NCT00394901|16991078|P1|Double-blind Phase|Adverse Event|5
4937980|NCT00394901|16991075|P4|Baseline Phase|Protocol Violation|0
4937981|NCT00394901|16991076|P3|Baseline Phase|Protocol Violation|1
4937982|NCT00394901|16991077|P2|Baseline Phase|Protocol Violation|0
4937983|NCT00394901|16991078|P1|Baseline Phase|Protocol Violation|0
4937984|NCT00394836|16991321|P2|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10
4937985|NCT00394836|16991322|P1|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7
4937986|NCT00394836|16991321|P2|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41
4937987|NCT00394836|16991322|P1|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13
4937988|NCT00394836|16991321|P2|Extended Follow-up Phase (2-5 Years)|Death|1
4937989|NCT00394836|16991322|P1|Extended Follow-up Phase (2-5 Years)|Death|0
4937990|NCT00394836|16991321|P2|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1
4937991|NCT00394836|16991322|P1|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0
4937992|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Non compliance|1
4937993|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Non compliance|0
4937994|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1
4937995|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0
4937996|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Physician Decision|1
4937997|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Physician Decision|0
4937998|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1
4937999|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0
4938000|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Started alternative treatment|6
4938001|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Started alternative treatment|0
4938002|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1
4938003|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0
4938004|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Death|1
4938005|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Death|0
4938006|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Patient Refusal|2
4938007|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Patient Refusal|1
4938008|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Disease Progression|60
4938009|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Disease Progression|27
4938010|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Protocol Violation|2
4938011|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Protocol Violation|0
4938012|NCT00394836|16991321|P2|Teatment or Follow-up Phase|Adverse Event|2
4938013|NCT00394836|16991322|P1|Teatment or Follow-up Phase|Adverse Event|0
4938014|NCT00394771|16991368|P4|Overall Study|Other|0
4938015|NCT00394771|16991369|P3|Overall Study|Other|1
4938016|NCT00394771|16991370|P2|Overall Study|Other|3
4938017|NCT00394771|16991371|P1|Overall Study|Other|3
4938018|NCT00394771|16991368|P4|Overall Study|Lost to Follow-up|10
4938019|NCT00394771|16991369|P3|Overall Study|Lost to Follow-up|13
4938020|NCT00394771|16991370|P2|Overall Study|Lost to Follow-up|15
4938021|NCT00394771|16991371|P1|Overall Study|Lost to Follow-up|15
4938022|NCT00394771|16991368|P4|Overall Study|Participant pregnant|2
4938023|NCT00394771|16991369|P3|Overall Study|Participant pregnant|2
4938024|NCT00394771|16991370|P2|Overall Study|Participant pregnant|1
4938025|NCT00394771|16991371|P1|Overall Study|Participant pregnant|0
4938026|NCT00394771|16991368|P4|Overall Study|Adverse Event|8
4938027|NCT00394771|16991369|P3|Overall Study|Adverse Event|12
4938028|NCT00394771|16991370|P2|Overall Study|Adverse Event|5
4938029|NCT00394771|16991371|P1|Overall Study|Adverse Event|10
4938030|NCT00394771|16991368|P4|Overall Study|Withdrawal by Subject|12
4938031|NCT00394771|16991369|P3|Overall Study|Withdrawal by Subject|8
4938032|NCT00394771|16991370|P2|Overall Study|Withdrawal by Subject|6
4938033|NCT00394771|16991371|P1|Overall Study|Withdrawal by Subject|10
4938034|NCT00394771|16991368|P4|Overall Study|Protocol Violation|7
4938035|NCT00394771|16991369|P3|Overall Study|Protocol Violation|9
4938036|NCT00394771|16991370|P2|Overall Study|Protocol Violation|4
4938037|NCT00394771|16991371|P1|Overall Study|Protocol Violation|2
4938038|NCT00394771|16991368|P4|Overall Study|Did not meet protocol requirements|0
4938039|NCT00394771|16991369|P3|Overall Study|Did not meet protocol requirements|2
4938040|NCT00394771|16991370|P2|Overall Study|Did not meet protocol requirements|0
4938041|NCT00394771|16991371|P1|Overall Study|Did not meet protocol requirements|1
4938042|NCT00394706|16991441|P8|Overall Study|Lost to Follow-up|0
4938043|NCT00394706|16991442|P7|Overall Study|Lost to Follow-up|2
4938044|NCT00394706|16991443|P6|Overall Study|Lost to Follow-up|5
4938045|NCT00394706|16991444|P5|Overall Study|Lost to Follow-up|2
4938046|NCT00394706|16991445|P4|Overall Study|Lost to Follow-up|1
4938047|NCT00394706|16991446|P3|Overall Study|Lost to Follow-up|8
4938048|NCT00394706|16991447|P2|Overall Study|Lost to Follow-up|2
4938049|NCT00394706|16991448|P1|Overall Study|Lost to Follow-up|2
4938050|NCT00394706|16991441|P8|Overall Study|Withdrawal by Subject|0
4938051|NCT00394706|16991442|P7|Overall Study|Withdrawal by Subject|1
4938052|NCT00394706|16991443|P6|Overall Study|Withdrawal by Subject|2
4938053|NCT00394706|16991444|P5|Overall Study|Withdrawal by Subject|0
4938054|NCT00394706|16991445|P4|Overall Study|Withdrawal by Subject|0
4938055|NCT00394706|16991446|P3|Overall Study|Withdrawal by Subject|1
4938056|NCT00394706|16991447|P2|Overall Study|Withdrawal by Subject|0
4938057|NCT00394706|16991448|P1|Overall Study|Withdrawal by Subject|2
4938058|NCT00394654|16991480|P2|Overall Study|PARTICIPANT LEFT STDUY REGION|0
4938059|NCT00394654|16991481|P1|Overall Study|PARTICIPANT LEFT STDUY REGION|1
4938060|NCT00394654|16991480|P2|Overall Study|Lost to Follow-up|0
4938061|NCT00394654|16991481|P1|Overall Study|Lost to Follow-up|1
4938062|NCT00394589|16991546|P3|Overall Study|Protocol Violation|2
4938063|NCT00394589|16991547|P2|Overall Study|Protocol Violation|0
4938064|NCT00394589|16991548|P1|Overall Study|Protocol Violation|4
4938065|NCT00394589|16991546|P3|Overall Study|Lack of Efficacy|3
4938066|NCT00394589|16991547|P2|Overall Study|Lack of Efficacy|2
4938067|NCT00394589|16991548|P1|Overall Study|Lack of Efficacy|2
4938068|NCT00394589|16991546|P3|Overall Study|Adverse Event|2
4938069|NCT00394589|16991547|P2|Overall Study|Adverse Event|1
4938070|NCT00394589|16991548|P1|Overall Study|Adverse Event|2
4938071|NCT00394524|16991558|P2|Overall Study|Withdrawal by Subject|1
4938072|NCT00394524|16991559|P1|Overall Study|Withdrawal by Subject|0
4938073|NCT00394524|16991558|P2|Overall Study|Death|0
4938074|NCT00394524|16991559|P1|Overall Study|Death|1
4938075|NCT00394524|16991558|P2|Overall Study|Protocol Violation|3
4938076|NCT00394524|16991559|P1|Overall Study|Protocol Violation|2
4938077|NCT00394472|16991573|P2|Overall Study|Lost to Follow-up|1
4938078|NCT00394472|16991574|P1|Overall Study|Lost to Follow-up|0
4938079|NCT00394472|16991573|P2|Overall Study|Physician Decision|1
4938080|NCT00394472|16991574|P1|Overall Study|Physician Decision|0
4938081|NCT00394472|16991573|P2|Overall Study|Withdrawal by Subject|2
4938082|NCT00394472|16991574|P1|Overall Study|Withdrawal by Subject|0
4938083|NCT00394472|16991573|P2|Overall Study|Adverse Event|2
4938084|NCT00394472|16991574|P1|Overall Study|Adverse Event|4
4938085|NCT00394472|16991573|P2|Overall Study|incorrect enrolment|2
4938086|NCT00394472|16991574|P1|Overall Study|incorrect enrolment|4
4938087|NCT00394472|16991573|P2|Overall Study|Protocol Violation|3
4938088|NCT00394472|16991574|P1|Overall Study|Protocol Violation|1
4938089|NCT00394433|16991582|P1|Overall Study|Alternative Therapy|1
4938090|NCT00394433|16991582|P1|Overall Study|Adverse Event|2
4938091|NCT00394355|16991593|P4|Overall Study|Lack of Efficacy|3
4938092|NCT00394355|16991594|P3|Overall Study|Lack of Efficacy|2
4938093|NCT00394355|16991595|P2|Overall Study|Lack of Efficacy|0
4938094|NCT00394355|16991596|P1|Overall Study|Lack of Efficacy|0
4938095|NCT00394355|16991593|P4|Overall Study|Administrative|1
4938096|NCT00394355|16991594|P3|Overall Study|Administrative|1
4938097|NCT00394355|16991595|P2|Overall Study|Administrative|1
4938098|NCT00394355|16991596|P1|Overall Study|Administrative|0
4938099|NCT00394355|16991593|P4|Overall Study|Noncompliance with protocol|8
4938100|NCT00394355|16991594|P3|Overall Study|Noncompliance with protocol|10
4938101|NCT00394355|16991595|P2|Overall Study|Noncompliance with protocol|3
4938102|NCT00394355|16991596|P1|Overall Study|Noncompliance with protocol|4
4938103|NCT00394355|16991593|P4|Overall Study|Lost to Follow-up|3
4938104|NCT00394355|16991594|P3|Overall Study|Lost to Follow-up|4
4938105|NCT00394355|16991595|P2|Overall Study|Lost to Follow-up|5
4938106|NCT00394355|16991596|P1|Overall Study|Lost to Follow-up|7
4938107|NCT00394355|16991593|P4|Overall Study|Subject withdrawal - related to drug|0
4938108|NCT00394355|16991594|P3|Overall Study|Subject withdrawal - related to drug|0
4938109|NCT00394355|16991595|P2|Overall Study|Subject withdrawal - related to drug|0
4938110|NCT00394355|16991596|P1|Overall Study|Subject withdrawal - related to drug|1
4938111|NCT00394355|16991593|P4|Overall Study|Subject withdrawal - unrelated to drug|6
4938112|NCT00394355|16991594|P3|Overall Study|Subject withdrawal - unrelated to drug|10
4938113|NCT00394355|16991595|P2|Overall Study|Subject withdrawal - unrelated to drug|14
4938114|NCT00394355|16991596|P1|Overall Study|Subject withdrawal - unrelated to drug|12
4938115|NCT00394355|16991593|P4|Overall Study|Did not meet protocol eligibility|2
4938116|NCT00394355|16991594|P3|Overall Study|Did not meet protocol eligibility|4
4939320|NCT00385827|16995230|P2|Part 2|Other|11
4938117|NCT00394355|16991595|P2|Overall Study|Did not meet protocol eligibility|5
4938118|NCT00394355|16991596|P1|Overall Study|Did not meet protocol eligibility|1
4938119|NCT00394355|16991593|P4|Overall Study|Adverse Event|8
4938120|NCT00394355|16991594|P3|Overall Study|Adverse Event|7
4938121|NCT00394355|16991595|P2|Overall Study|Adverse Event|6
4938122|NCT00394355|16991596|P1|Overall Study|Adverse Event|10
4938123|NCT00394251|16991702|P2|Overall Study|Non-compliance, pt moved, pt/inv agree|2
4938124|NCT00394251|16991703|P1|Overall Study|Non-compliance, pt moved, pt/inv agree|2
4938125|NCT00394251|16991702|P2|Overall Study|Withdrawal by Subject|11
4938126|NCT00394251|16991703|P1|Overall Study|Withdrawal by Subject|7
4938127|NCT00394251|16991702|P2|Overall Study|Protocol Violation|1
4938128|NCT00394251|16991703|P1|Overall Study|Protocol Violation|0
4938129|NCT00394251|16991702|P2|Overall Study|Physician Decision|1
4938130|NCT00394251|16991703|P1|Overall Study|Physician Decision|1
4938131|NCT00394251|16991702|P2|Overall Study|Unacceptable Toxicity|18
4938132|NCT00394251|16991703|P1|Overall Study|Unacceptable Toxicity|20
4938133|NCT00394251|16991702|P2|Overall Study|Adverse Event|5
4938134|NCT00394251|16991703|P1|Overall Study|Adverse Event|7
4938135|NCT00394212|16991731|P2|Overall Study|Withdrawal by Subject|1
4938136|NCT00394212|16991732|P1|Overall Study|Withdrawal by Subject|4
4938137|NCT00394212|16991731|P2|Overall Study|Lost to Follow-up|0
4938138|NCT00394212|16991732|P1|Overall Study|Lost to Follow-up|3
4938139|NCT00394095|16991746|P2|Overall Study|Adverse Event|0
4938140|NCT00394095|16991747|P1|Overall Study|Adverse Event|1
4938141|NCT00394082|16991755|P1|Overall Study|Other|1
4938142|NCT00394082|16991755|P1|Overall Study|Withdrawal by Subject|2
4938143|NCT00394082|16991755|P1|Overall Study|Physician Decision|4
4938144|NCT00394082|16991755|P1|Overall Study|Adverse Event|4
4938145|NCT00394082|16991755|P1|Overall Study|Unacceptable toxicity|15
4938146|NCT00393939|16991777|P2|Overall Study|Other|45
4938147|NCT00393939|16991778|P1|Overall Study|Other|37
4938148|NCT00393939|16991777|P2|Overall Study|Withdrawal by Subject|7
4938149|NCT00393939|16991778|P1|Overall Study|Withdrawal by Subject|2
4938150|NCT00393939|16991777|P2|Overall Study|Objective progression or relapse|223
4938151|NCT00393939|16991778|P1|Overall Study|Objective progression or relapse|239
4938152|NCT00393939|16991777|P2|Overall Study|Sponsor|13
4938153|NCT00393939|16991778|P1|Overall Study|Sponsor|5
4938154|NCT00393939|16991777|P2|Overall Study|Death|4
4938155|NCT00393939|16991778|P1|Overall Study|Death|10
4938156|NCT00393939|16991777|P2|Overall Study|Lost to Follow-up|4
4938157|NCT00393939|16991778|P1|Overall Study|Lost to Follow-up|2
4938158|NCT00393939|16991777|P2|Overall Study|Protocol Violation|1
4938159|NCT00393939|16991778|P1|Overall Study|Protocol Violation|1
4938160|NCT00393913|16991796|P1|CPAP|TEchnical problem with CPAP|3
4938161|NCT00393913|16991796|P1|CPAP|Physician Decision|1
4938162|NCT00393913|16991796|P1|CPAP|Withdrawal by Subject|3
4938163|NCT00393913|16991796|P1|Initial Assessment|Withdrawal by Subject|16
4938164|NCT00393913|16991796|P1|Initial Assessment|diagnosed with other sleep disorder|21
4938165|NCT00393887|16991804|P2|Overall Study|Lost to Follow-up|9
4938166|NCT00393887|16991805|P1|Overall Study|Lost to Follow-up|11
4938167|NCT00393887|16991804|P2|Overall Study|Physician Decision|0
4938168|NCT00393887|16991805|P1|Overall Study|Physician Decision|5
4938169|NCT00393861|16991833|P1|Overall Study|Disease Progression|24
4938170|NCT00393861|16991833|P1|Overall Study|Adverse Event|2
4938171|NCT00393848|16991844|P4|Overall Study|Personal reasons|0
4938172|NCT00393848|16991845|P3|Overall Study|Personal reasons|2
4938173|NCT00393848|16991846|P2|Overall Study|Personal reasons|0
4938174|NCT00393848|16991847|P1|Overall Study|Personal reasons|0
4938175|NCT00393848|16991844|P4|Overall Study|Surgical schedule|1
4938176|NCT00393848|16991845|P3|Overall Study|Surgical schedule|0
4938177|NCT00393848|16991846|P2|Overall Study|Surgical schedule|0
4938178|NCT00393848|16991847|P1|Overall Study|Surgical schedule|0
4938179|NCT00393718|16991870|P2|Overall Study|Move|0
4938180|NCT00393718|16991871|P1|Overall Study|Move|1
4938181|NCT00393718|16991870|P2|Overall Study|Missed measurement|0
4938182|NCT00393718|16991871|P1|Overall Study|Missed measurement|1
4938183|NCT00393718|16991870|P2|Overall Study|Withdrawal of consent|1
4938184|NCT00393718|16991871|P1|Overall Study|Withdrawal of consent|2
4938185|NCT00393718|16991870|P2|Overall Study|Subject decision|0
4938186|NCT00393718|16991871|P1|Overall Study|Subject decision|5
4938187|NCT00393718|16991870|P2|Overall Study|Hypoglycaemia|2
4938188|NCT00393718|16991871|P1|Overall Study|Hypoglycaemia|3
4938189|NCT00393718|16991870|P2|Overall Study|Lack of Efficacy|9
4938190|NCT00393718|16991871|P1|Overall Study|Lack of Efficacy|10
4938191|NCT00393718|16991870|P2|Overall Study|Protocol Violation|2
4938192|NCT00393718|16991871|P1|Overall Study|Protocol Violation|1
4938193|NCT00393718|16991870|P2|Overall Study|Adverse Event|8
4938194|NCT00393718|16991871|P1|Overall Study|Adverse Event|20
4938195|NCT00393705|16991903|P2|Overall Study|Physician Decision|2
4938196|NCT00393705|16991904|P1|Overall Study|Physician Decision|2
4938197|NCT00393705|16991903|P2|Overall Study|Withdrawal by Subject|3
4938198|NCT00393705|16991904|P1|Overall Study|Withdrawal by Subject|5
4938199|NCT00393705|16991903|P2|Overall Study|Protocol Violation|3
4938200|NCT00393705|16991904|P1|Overall Study|Protocol Violation|4
4938201|NCT00393705|16991903|P2|Overall Study|Entry Criteria Not Met|10
4938202|NCT00393705|16991904|P1|Overall Study|Entry Criteria Not Met|10
4938203|NCT00393705|16991903|P2|Overall Study|Lost to Follow-up|2
4938204|NCT00393705|16991904|P1|Overall Study|Lost to Follow-up|2
4938205|NCT00393705|16991903|P2|Overall Study|Death|1
4938206|NCT00393705|16991904|P1|Overall Study|Death|0
4938207|NCT00393705|16991903|P2|Overall Study|Adverse Event|2
4938208|NCT00393705|16991904|P1|Overall Study|Adverse Event|0
4938209|NCT00393523|16991933|P5|Overall Study|Vaccine supply issue|0
4938210|NCT00393523|16991934|P4|Overall Study|Vaccine supply issue|0
4938211|NCT00393523|16991935|P3|Overall Study|Vaccine supply issue|1
4938212|NCT00393523|16991936|P2|Overall Study|Vaccine supply issue|0
4938213|NCT00393523|16991937|P1|Overall Study|Vaccine supply issue|0
4938214|NCT00393523|16991933|P5|Overall Study|Difficulties in specimen collection|0
4938215|NCT00393523|16991934|P4|Overall Study|Difficulties in specimen collection|0
4938216|NCT00393523|16991935|P3|Overall Study|Difficulties in specimen collection|1
4938217|NCT00393523|16991936|P2|Overall Study|Difficulties in specimen collection|0
4938218|NCT00393523|16991937|P1|Overall Study|Difficulties in specimen collection|0
4938219|NCT00393523|16991933|P5|Overall Study|Withdrawal by Subject|0
4938220|NCT00393523|16991934|P4|Overall Study|Withdrawal by Subject|3
4938221|NCT00393523|16991935|P3|Overall Study|Withdrawal by Subject|2
4938222|NCT00393523|16991936|P2|Overall Study|Withdrawal by Subject|7
4938223|NCT00393523|16991937|P1|Overall Study|Withdrawal by Subject|6
4938224|NCT00393523|16991933|P5|Overall Study|Protocol Violation|0
4938225|NCT00393523|16991934|P4|Overall Study|Protocol Violation|1
4938226|NCT00393523|16991935|P3|Overall Study|Protocol Violation|0
4938227|NCT00393523|16991936|P2|Overall Study|Protocol Violation|2
4938228|NCT00393523|16991937|P1|Overall Study|Protocol Violation|6
4938229|NCT00393523|16991933|P5|Overall Study|Lost to Follow-up|1
4938230|NCT00393523|16991934|P4|Overall Study|Lost to Follow-up|2
4938231|NCT00393523|16991935|P3|Overall Study|Lost to Follow-up|0
4938232|NCT00393523|16991936|P2|Overall Study|Lost to Follow-up|0
4938233|NCT00393523|16991937|P1|Overall Study|Lost to Follow-up|0
4938234|NCT00393510|16991954|P2|Overall Study|Physician Decision|9
4938235|NCT00393510|16991955|P1|Overall Study|Physician Decision|3
4938236|NCT00393484|16991967|P2|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18
4938237|NCT00393484|16991968|P1|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0
4938238|NCT00393484|16991967|P2|Open-label Period (Weeks 96 to 240)|Noncompliance|2
4938239|NCT00393484|16991968|P1|Open-label Period (Weeks 96 to 240)|Noncompliance|2
4938240|NCT00393484|16991967|P2|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2
4938241|NCT00393484|16991968|P1|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1
4938242|NCT00393484|16991967|P2|Open-label Period (Weeks 96 to 240)|Death|0
4938243|NCT00393484|16991968|P1|Open-label Period (Weeks 96 to 240)|Death|1
4938244|NCT00393484|16991967|P2|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1
4938245|NCT00393484|16991968|P1|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4
4938246|NCT00393484|16991967|P2|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2
4938247|NCT00393484|16991968|P1|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0
4938248|NCT00393484|16991967|P2|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6
4938249|NCT00393484|16991968|P1|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0
4938250|NCT00393484|16991967|P2|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3
4938251|NCT00393484|16991968|P1|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0
4938252|NCT00393484|16991967|P2|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0
4938253|NCT00393484|16991968|P1|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2
4938254|NCT00393484|16991967|P2|Double-blind Period (Day 1 to Week 96)|Adverse Event|1
4938255|NCT00393484|16991968|P1|Double-blind Period (Day 1 to Week 96)|Adverse Event|0
4938256|NCT00393458|16992004|P4|Overall Study|Subject no longer requires study drug|0
4938257|NCT00393458|16992005|P3|Overall Study|Subject no longer requires study drug|0
4938258|NCT00393458|16992006|P2|Overall Study|Subject no longer requires study drug|1
4938259|NCT00393458|16992007|P1|Overall Study|Subject no longer requires study drug|0
4938260|NCT00393458|16992004|P4|Overall Study|Abnormal test procedure result(s)|2
4938261|NCT00393458|16992005|P3|Overall Study|Abnormal test procedure result(s)|1
4938262|NCT00393458|16992006|P2|Overall Study|Abnormal test procedure result(s)|1
4938263|NCT00393458|16992007|P1|Overall Study|Abnormal test procedure result(s)|0
4938264|NCT00393458|16992004|P4|Overall Study|Death|5
4938265|NCT00393458|16992005|P3|Overall Study|Death|5
4938266|NCT00393458|16992006|P2|Overall Study|Death|1
4938267|NCT00393458|16992007|P1|Overall Study|Death|1
4938268|NCT00393458|16992004|P4|Overall Study|Abnormal laboratory value(s)|0
4938269|NCT00393458|16992005|P3|Overall Study|Abnormal laboratory value(s)|0
4938270|NCT00393458|16992006|P2|Overall Study|Abnormal laboratory value(s)|1
4938271|NCT00393458|16992007|P1|Overall Study|Abnormal laboratory value(s)|1
4938272|NCT00393458|16992004|P4|Overall Study|Lost to Follow-up|3
4938273|NCT00393458|16992005|P3|Overall Study|Lost to Follow-up|5
4938274|NCT00393458|16992006|P2|Overall Study|Lost to Follow-up|6
4938275|NCT00393458|16992007|P1|Overall Study|Lost to Follow-up|5
4938276|NCT00393458|16992004|P4|Overall Study|Administrative problems|2
4938277|NCT00393458|16992005|P3|Overall Study|Administrative problems|5
4938278|NCT00393458|16992006|P2|Overall Study|Administrative problems|8
4938279|NCT00393458|16992007|P1|Overall Study|Administrative problems|7
4938280|NCT00393458|16992004|P4|Overall Study|Protocol deviation|10
4938281|NCT00393458|16992005|P3|Overall Study|Protocol deviation|11
4938282|NCT00393458|16992006|P2|Overall Study|Protocol deviation|11
4938283|NCT00393458|16992007|P1|Overall Study|Protocol deviation|11
4938284|NCT00393458|16992004|P4|Overall Study|Unsatisfactory therapeutic effect|30
4938285|NCT00393458|16992005|P3|Overall Study|Unsatisfactory therapeutic effect|12
4938286|NCT00393458|16992006|P2|Overall Study|Unsatisfactory therapeutic effect|9
4938287|NCT00393458|16992007|P1|Overall Study|Unsatisfactory therapeutic effect|12
4938288|NCT00393458|16992004|P4|Overall Study|Subject withdrew consent|50
4938289|NCT00393458|16992005|P3|Overall Study|Subject withdrew consent|33
4938290|NCT00393458|16992006|P2|Overall Study|Subject withdrew consent|40
4938291|NCT00393458|16992007|P1|Overall Study|Subject withdrew consent|27
4938292|NCT00393458|16992004|P4|Overall Study|Adverse Event|35
4938293|NCT00393458|16992005|P3|Overall Study|Adverse Event|40
4938294|NCT00393458|16992006|P2|Overall Study|Adverse Event|24
4938295|NCT00393458|16992007|P1|Overall Study|Adverse Event|35
4938296|NCT00393367|16992034|P2|Overall Study|Withdrawal by Subject|2
4938297|NCT00393367|16992035|P1|Overall Study|Withdrawal by Subject|0
4938298|NCT00393367|16992034|P2|Overall Study|Protocol Violation|5
4938299|NCT00393367|16992035|P1|Overall Study|Protocol Violation|2
4938300|NCT00393094|16992063|P1|Disease Progression After Trtmt: Onstudy|Refused further treatment|1
4938301|NCT00393094|16992063|P1|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1
4938302|NCT00393042|16992074|P2|Second Intervetion|Protocol Violation|1
4938303|NCT00393042|16992075|P1|Second Intervetion|Protocol Violation|1
4938304|NCT00393042|16992074|P2|Second Intervetion|Lost to Follow-up|2
4938305|NCT00393042|16992075|P1|Second Intervetion|Lost to Follow-up|0
4938306|NCT00393042|16992074|P2|Second Intervetion|Lack of Efficacy|0
4938307|NCT00393042|16992075|P1|Second Intervetion|Lack of Efficacy|1
4938308|NCT00393042|16992074|P2|Second Intervetion|Withdrawal by Subject|2
4938309|NCT00393042|16992075|P1|Second Intervetion|Withdrawal by Subject|0
4938310|NCT00393042|16992074|P2|Second Intervetion|Adverse Event|3
4938311|NCT00393042|16992075|P1|Second Intervetion|Adverse Event|0
4938312|NCT00393042|16992074|P2|First Intervention|Adverse Event|1
4938313|NCT00393042|16992075|P1|First Intervention|Adverse Event|0
4938314|NCT00393042|16992074|P2|First Intervention|Protocol Violation|0
4938315|NCT00393042|16992075|P1|First Intervention|Protocol Violation|1
4938316|NCT00393042|16992074|P2|First Intervention|Lost to Follow-up|3
4938317|NCT00393042|16992075|P1|First Intervention|Lost to Follow-up|3
4938318|NCT00393042|16992074|P2|First Intervention|Withdrawal by Subject|2
4938319|NCT00393042|16992075|P1|First Intervention|Withdrawal by Subject|1
4938320|NCT00393029|16992147|P2|Overall Study|Not treated|1
4938321|NCT00393029|16992148|P1|Overall Study|Not treated|0
4938322|NCT00392990|16992159|P2|Follow up for 2 Years|Death|0
4938323|NCT00392990|16992160|P1|Follow up for 2 Years|Death|4
4938324|NCT00392990|16992159|P2|Treatment on Study|Adverse Event|1
4938325|NCT00392990|16992160|P1|Treatment on Study|Adverse Event|3
4938326|NCT00392925|16992184|P4|Randomization to Treatment Group Period|Lost to Follow-up|4
4938327|NCT00392925|16992185|P3|Randomization to Treatment Group Period|Lost to Follow-up|8
4938328|NCT00392925|16992186|P2|Randomization to Treatment Group Period|Lost to Follow-up|3
4938329|NCT00392925|16992187|P1|Randomization to Treatment Group Period|Lost to Follow-up|0
4938330|NCT00392925|16992184|P4|Randomization to Treatment Group Period|Protocol Violation|1
4938331|NCT00392925|16992185|P3|Randomization to Treatment Group Period|Protocol Violation|2
4938332|NCT00392925|16992186|P2|Randomization to Treatment Group Period|Protocol Violation|0
4938333|NCT00392925|16992187|P1|Randomization to Treatment Group Period|Protocol Violation|0
4938334|NCT00392925|16992184|P4|Randomization to Treatment Group Period|Adverse Event|5
4938335|NCT00392925|16992185|P3|Randomization to Treatment Group Period|Adverse Event|3
4938336|NCT00392925|16992186|P2|Randomization to Treatment Group Period|Adverse Event|3
4938337|NCT00392925|16992187|P1|Randomization to Treatment Group Period|Adverse Event|0
4938338|NCT00392925|16992184|P4|Randomization to Treatment Group Period|Withdrawal by Subject|8
4938339|NCT00392925|16992185|P3|Randomization to Treatment Group Period|Withdrawal by Subject|6
4938340|NCT00392925|16992186|P2|Randomization to Treatment Group Period|Withdrawal by Subject|2
4938341|NCT00392925|16992187|P1|Randomization to Treatment Group Period|Withdrawal by Subject|0
4938342|NCT00392925|16992184|P4|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
4938343|NCT00392925|16992185|P3|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
4938344|NCT00392925|16992186|P2|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0
4938345|NCT00392925|16992187|P1|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16
4938346|NCT00392925|16992184|P4|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
4938347|NCT00392925|16992185|P3|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
4938348|NCT00392925|16992186|P2|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0
4938349|NCT00392925|16992187|P1|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5
4938350|NCT00392925|16992184|P4|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
4938351|NCT00392925|16992185|P3|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
4938352|NCT00392925|16992186|P2|4 Week Lead-In Period - Non-Randomized|Physician Decision|0
4938353|NCT00392925|16992187|P1|4 Week Lead-In Period - Non-Randomized|Physician Decision|1
4938354|NCT00392925|16992184|P4|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
4938355|NCT00392925|16992185|P3|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
4938356|NCT00392925|16992186|P2|4 Week Lead-In Period - Non-Randomized|Adverse Event|0
4938357|NCT00392925|16992187|P1|4 Week Lead-In Period - Non-Randomized|Adverse Event|5
4938358|NCT00392925|16992184|P4|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
4938359|NCT00392925|16992185|P3|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
4938360|NCT00392925|16992186|P2|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0
4938361|NCT00392925|16992187|P1|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11
4938362|NCT00392808|16992301|P4|Overall Study|Unable to withdraw blood|2
4938363|NCT00392808|16992302|P3|Overall Study|Unable to withdraw blood|1
4938364|NCT00392808|16992303|P2|Overall Study|Unable to withdraw blood|1
4938365|NCT00392808|16992304|P1|Overall Study|Unable to withdraw blood|3
4938366|NCT00392808|16992301|P4|Overall Study|Lost to Follow-up|2
4938367|NCT00392808|16992302|P3|Overall Study|Lost to Follow-up|1
4938368|NCT00392808|16992303|P2|Overall Study|Lost to Follow-up|2
4938369|NCT00392808|16992304|P1|Overall Study|Lost to Follow-up|3
4938370|NCT00392769|16992328|P1|Overall Study|Adverse Event|1
4938371|NCT00392769|16992328|P1|Overall Study|Clinical Deterioration|9
4938372|NCT00392665|16992380|P2|Overall Study|Lost to Follow-up|1
4938373|NCT00392665|16992381|P1|Overall Study|Lost to Follow-up|1
4938374|NCT00392665|16992380|P2|Overall Study|Death|14
4938375|NCT00392665|16992381|P1|Overall Study|Death|16
4938376|NCT00392379|16992407|P2|Overall Study|Adverse Event|1
4938377|NCT00392379|16992408|P1|Overall Study|Adverse Event|1
4938378|NCT00392379|16992407|P2|Overall Study|Lost to Follow-up|9
4938379|NCT00392379|16992408|P1|Overall Study|Lost to Follow-up|4
4938380|NCT00392379|16992407|P2|Overall Study|Withdrawal by Subject|28
4938381|NCT00392379|16992408|P1|Overall Study|Withdrawal by Subject|17
4938382|NCT00392327|16992426|P8|Overall Study|Ineligible|0
4938383|NCT00392327|16992427|P7|Overall Study|Ineligible|0
4938384|NCT00392327|16992428|P6|Overall Study|Ineligible|0
4938385|NCT00392327|16992429|P5|Overall Study|Ineligible|0
4938386|NCT00392327|16992430|P4|Overall Study|Ineligible|2
4938387|NCT00392327|16992431|P3|Overall Study|Ineligible|3
4938388|NCT00392327|16992432|P2|Overall Study|Ineligible|4
4938389|NCT00392327|16992433|P1|Overall Study|Ineligible|0
4938390|NCT00392327|16992426|P8|Overall Study|Withdrawal by Subject|5
4938391|NCT00392327|16992427|P7|Overall Study|Withdrawal by Subject|1
4938392|NCT00392327|16992428|P6|Overall Study|Withdrawal by Subject|1
4938393|NCT00392327|16992429|P5|Overall Study|Withdrawal by Subject|0
4938394|NCT00392327|16992430|P4|Overall Study|Withdrawal by Subject|6
4938395|NCT00392327|16992431|P3|Overall Study|Withdrawal by Subject|4
4938396|NCT00392327|16992432|P2|Overall Study|Withdrawal by Subject|2
4938397|NCT00392327|16992433|P1|Overall Study|Withdrawal by Subject|3
4938398|NCT00392327|16992426|P8|Overall Study|Protocol Violation|0
4938399|NCT00392327|16992427|P7|Overall Study|Protocol Violation|0
4938400|NCT00392327|16992428|P6|Overall Study|Protocol Violation|0
4938401|NCT00392327|16992429|P5|Overall Study|Protocol Violation|0
4938402|NCT00392327|16992430|P4|Overall Study|Protocol Violation|0
4938403|NCT00392327|16992431|P3|Overall Study|Protocol Violation|1
4938404|NCT00392327|16992432|P2|Overall Study|Protocol Violation|0
4938405|NCT00392327|16992433|P1|Overall Study|Protocol Violation|0
4938406|NCT00392327|16992426|P8|Overall Study|Physician Decision|3
4938407|NCT00392327|16992427|P7|Overall Study|Physician Decision|5
4938408|NCT00392327|16992428|P6|Overall Study|Physician Decision|1
4938409|NCT00392327|16992429|P5|Overall Study|Physician Decision|0
4938410|NCT00392327|16992430|P4|Overall Study|Physician Decision|2
4938411|NCT00392327|16992431|P3|Overall Study|Physician Decision|2
4938412|NCT00392327|16992432|P2|Overall Study|Physician Decision|5
4938413|NCT00392327|16992433|P1|Overall Study|Physician Decision|3
4938414|NCT00392327|16992426|P8|Overall Study|Lack of Efficacy|3
4938415|NCT00392327|16992427|P7|Overall Study|Lack of Efficacy|3
4938416|NCT00392327|16992428|P6|Overall Study|Lack of Efficacy|3
4938417|NCT00392327|16992429|P5|Overall Study|Lack of Efficacy|3
4938418|NCT00392327|16992430|P4|Overall Study|Lack of Efficacy|6
4938419|NCT00392327|16992431|P3|Overall Study|Lack of Efficacy|9
4938420|NCT00392327|16992432|P2|Overall Study|Lack of Efficacy|8
4938421|NCT00392327|16992433|P1|Overall Study|Lack of Efficacy|8
4938422|NCT00392327|16992426|P8|Overall Study|Death|0
4938423|NCT00392327|16992427|P7|Overall Study|Death|0
4938424|NCT00392327|16992428|P6|Overall Study|Death|0
4938425|NCT00392327|16992429|P5|Overall Study|Death|0
4938426|NCT00392327|16992430|P4|Overall Study|Death|0
4938427|NCT00392327|16992431|P3|Overall Study|Death|1
4938428|NCT00392327|16992432|P2|Overall Study|Death|0
4938429|NCT00392327|16992433|P1|Overall Study|Death|1
4938430|NCT00392288|16992502|P3|Overall Study|Other|1
4938431|NCT00392288|16992503|P2|Overall Study|Other|4
4938432|NCT00392288|16992504|P1|Overall Study|Other|3
4938433|NCT00392288|16992502|P3|Overall Study|Parent/legal guardian withdrawal|1
4938434|NCT00392288|16992503|P2|Overall Study|Parent/legal guardian withdrawal|2
4938435|NCT00392288|16992504|P1|Overall Study|Parent/legal guardian withdrawal|1
4938436|NCT00392288|16992502|P3|Overall Study|Withdrawal by Subject|2
4938437|NCT00392288|16992503|P2|Overall Study|Withdrawal by Subject|0
4938438|NCT00392288|16992504|P1|Overall Study|Withdrawal by Subject|1
4938439|NCT00392288|16992502|P3|Overall Study|Lost to Follow-up|1
4938440|NCT00392288|16992503|P2|Overall Study|Lost to Follow-up|1
4938441|NCT00392288|16992504|P1|Overall Study|Lost to Follow-up|1
4938442|NCT00392288|16992502|P3|Overall Study|Protocol Violation|1
4938443|NCT00392288|16992503|P2|Overall Study|Protocol Violation|3
4938444|NCT00392288|16992504|P1|Overall Study|Protocol Violation|1
4938445|NCT00392288|16992502|P3|Overall Study|Lack of Efficacy|3
4938446|NCT00392288|16992503|P2|Overall Study|Lack of Efficacy|5
4938447|NCT00392288|16992504|P1|Overall Study|Lack of Efficacy|8
4938448|NCT00392288|16992502|P3|Overall Study|Adverse Event|8
4938449|NCT00392288|16992503|P2|Overall Study|Adverse Event|7
4938450|NCT00392288|16992504|P1|Overall Study|Adverse Event|17
4938451|NCT00392223|16992529|P2|Overall Study|Withdrawal by Subject|2
4938452|NCT00392223|16992530|P1|Overall Study|Withdrawal by Subject|3
4938453|NCT00392223|16992529|P2|Overall Study|Protocol Violation|3
4938454|NCT00392223|16992530|P1|Overall Study|Protocol Violation|0
4938455|NCT00392223|16992529|P2|Overall Study|Lost to Follow-up|4
4938456|NCT00392223|16992530|P1|Overall Study|Lost to Follow-up|1
4938457|NCT00392223|16992529|P2|Overall Study|Adverse Event|4
4938458|NCT00392223|16992530|P1|Overall Study|Adverse Event|5
4938459|NCT00392210|16992548|P2|First Voiding Trial|Physician Decision|2
4938460|NCT00392210|16992549|P1|First Voiding Trial|Physician Decision|2
4938461|NCT00392197|16992557|P2|Overall Study|Withdrawal by Subject|6
4938462|NCT00392197|16992558|P1|Overall Study|Withdrawal by Subject|4
4938463|NCT00392197|16992557|P2|Overall Study|Protocol Violation|5
4938464|NCT00392197|16992558|P1|Overall Study|Protocol Violation|7
4938465|NCT00392197|16992557|P2|Overall Study|Physician Decision|2
4938466|NCT00392197|16992558|P1|Overall Study|Physician Decision|3
4938467|NCT00392197|16992557|P2|Overall Study|Lost to Follow-up|1
4938468|NCT00392197|16992558|P1|Overall Study|Lost to Follow-up|0
4938469|NCT00392197|16992557|P2|Overall Study|Lack of Efficacy|4
4938470|NCT00392197|16992558|P1|Overall Study|Lack of Efficacy|3
4938471|NCT00392197|16992557|P2|Overall Study|Adverse Event|12
4938472|NCT00392197|16992558|P1|Overall Study|Adverse Event|4
4938473|NCT00392171|16992566|P1|Overall Study|Disease progression|101
4938474|NCT00392171|16992566|P1|Overall Study|Did not meet inclusion criteria|4
4938475|NCT00391976|16992600|P3|Overall Study|Positive P. aeruginosa antibody test|31
4938476|NCT00391976|16992601|P2|Overall Study|Positive P. aeruginosa antibody test|0
4938477|NCT00391976|16992602|P1|Overall Study|Positive P. aeruginosa antibody test|0
4938478|NCT00391976|16992600|P3|Overall Study|Unable to classify|1
4938479|NCT00391976|16992601|P2|Overall Study|Unable to classify|0
4938480|NCT00391976|16992602|P1|Overall Study|Unable to classify|0
4938481|NCT00391976|16992600|P3|Overall Study|Recurrence/no eradication of infection|0
4938482|NCT00391976|16992601|P2|Overall Study|Recurrence/no eradication of infection|19
4938483|NCT00391976|16992602|P1|Overall Study|Recurrence/no eradication of infection|21
4938484|NCT00391976|16992600|P3|Overall Study|Protocol deviation/violation|1
4938485|NCT00391976|16992601|P2|Overall Study|Protocol deviation/violation|2
4938486|NCT00391976|16992602|P1|Overall Study|Protocol deviation/violation|4
4938487|NCT00391976|16992600|P3|Overall Study|Inappropriate enrollment|0
4938488|NCT00391976|16992601|P2|Overall Study|Inappropriate enrollment|1
4938489|NCT00391976|16992602|P1|Overall Study|Inappropriate enrollment|1
4938490|NCT00391976|16992600|P3|Overall Study|Lost to Follow-up|0
4938491|NCT00391976|16992601|P2|Overall Study|Lost to Follow-up|2
4938492|NCT00391976|16992602|P1|Overall Study|Lost to Follow-up|1
4938493|NCT00391976|16992600|P3|Overall Study|Withdrawal of consent|1
4938494|NCT00391976|16992601|P2|Overall Study|Withdrawal of consent|1
4938495|NCT00391976|16992602|P1|Overall Study|Withdrawal of consent|0
4938496|NCT00391976|16992600|P3|Overall Study|Adverse Event|1
4938497|NCT00391976|16992601|P2|Overall Study|Adverse Event|0
4938498|NCT00391976|16992602|P1|Overall Study|Adverse Event|0
4938499|NCT00391898|16992626|P2|Overall Study|Other|10
4938500|NCT00391898|16992627|P1|Overall Study|Other|8
4938501|NCT00391898|16992626|P2|Overall Study|Adverse Event|0
4938502|NCT00391898|16992627|P1|Overall Study|Adverse Event|3
4938503|NCT00391872|16992647|P2|Overall Study|Lost to Follow-up|0
4938504|NCT00391872|16992648|P1|Overall Study|Lost to Follow-up|2
4938505|NCT00391872|16992647|P2|Overall Study|Reason unknown|4
4938506|NCT00391872|16992648|P1|Overall Study|Reason unknown|2
4938507|NCT00391872|16992647|P2|Overall Study|Withdrawal by Subject|249
4938508|NCT00391872|16992648|P1|Overall Study|Withdrawal by Subject|296
4938509|NCT00391872|16992647|P2|Overall Study|Protocol Violation|2
4938510|NCT00391872|16992648|P1|Overall Study|Protocol Violation|7
4938511|NCT00391846|16992686|P2|Overall Study|Developed study specific DC criteria|1
4938512|NCT00391846|16992687|P1|Overall Study|Developed study specific DC criteria|0
4938513|NCT00391846|16992686|P2|Overall Study|Withdrawal by Subject|3
4938514|NCT00391846|16992687|P1|Overall Study|Withdrawal by Subject|2
4938515|NCT00391846|16992686|P2|Overall Study|Did not meet the required elig. crit|2
4938516|NCT00391846|16992687|P1|Overall Study|Did not meet the required elig. crit|2
4938517|NCT00391846|16992686|P2|Overall Study|Adverse Event|1
4938518|NCT00391846|16992687|P1|Overall Study|Adverse Event|4
4938519|NCT00391807|16992707|P1|Overall Study|Various|96
4938520|NCT00391807|16992707|P1|Overall Study|Protocol Violation|20
4938521|NCT00391807|16992707|P1|Overall Study|Withdrawal by Subject|147
4938522|NCT00391807|16992707|P1|Overall Study|Lost to Follow-up|227
4938523|NCT00391807|16992707|P1|Overall Study|Pregnancy|25
4938524|NCT00391807|16992707|P1|Overall Study|Adverse Event|177
4938525|NCT00391807|16992707|P1|Overall Study|Did not receive study medication|23
4938526|NCT00391768|16992734|P7|Overall Study|Lost to Follow-up|3
4938527|NCT00391768|16992735|P6|Overall Study|Lost to Follow-up|2
4938528|NCT00391768|16992736|P5|Overall Study|Lost to Follow-up|2
4938529|NCT00391768|16992737|P4|Overall Study|Lost to Follow-up|1
4938530|NCT00391768|16992738|P3|Overall Study|Lost to Follow-up|0
4938531|NCT00391768|16992739|P2|Overall Study|Lost to Follow-up|0
4938532|NCT00391768|16992740|P1|Overall Study|Lost to Follow-up|0
4938533|NCT00391768|16992734|P7|Overall Study|Withdrawal by Subject|1
4938534|NCT00391768|16992735|P6|Overall Study|Withdrawal by Subject|1
4938535|NCT00391768|16992736|P5|Overall Study|Withdrawal by Subject|0
4938536|NCT00391768|16992737|P4|Overall Study|Withdrawal by Subject|0
4938537|NCT00391768|16992738|P3|Overall Study|Withdrawal by Subject|1
4938538|NCT00391768|16992739|P2|Overall Study|Withdrawal by Subject|0
4938539|NCT00391768|16992740|P1|Overall Study|Withdrawal by Subject|0
4938540|NCT00391625|16992827|P1|Month 50|Physician Decision|1
4938541|NCT00391625|16992827|P1|Month 14|Withdrawal by Subject|1
4938542|NCT00391586|16992880|P1|Overall Study|Death|4
4938543|NCT00391586|16992880|P1|Overall Study|Physician Decision|2
4938544|NCT00391586|16992880|P1|Overall Study|Adverse Event|5
4938545|NCT00391586|16992880|P1|Overall Study|Progressive disease|13
4938546|NCT00391391|16992917|P4|Overall Study|Withdrawal by Subject|7
4938547|NCT00391391|16992918|P3|Overall Study|Withdrawal by Subject|10
4938548|NCT00391391|16992919|P2|Overall Study|Withdrawal by Subject|4
4938549|NCT00391391|16992920|P1|Overall Study|Withdrawal by Subject|6
4938550|NCT00391391|16992917|P4|Overall Study|Protocol Violation|7
4938551|NCT00391391|16992918|P3|Overall Study|Protocol Violation|6
4938552|NCT00391391|16992919|P2|Overall Study|Protocol Violation|3
4938553|NCT00391391|16992920|P1|Overall Study|Protocol Violation|2
4938554|NCT00391391|16992917|P4|Overall Study|Lost to Follow-up|4
4938555|NCT00391391|16992918|P3|Overall Study|Lost to Follow-up|7
4938556|NCT00391391|16992919|P2|Overall Study|Lost to Follow-up|3
4938557|NCT00391391|16992920|P1|Overall Study|Lost to Follow-up|1
4938558|NCT00391391|16992917|P4|Overall Study|Adverse Event|1
4938559|NCT00391391|16992918|P3|Overall Study|Adverse Event|0
4938560|NCT00391391|16992919|P2|Overall Study|Adverse Event|0
4938561|NCT00391391|16992920|P1|Overall Study|Adverse Event|0
4938562|NCT00391274|16992965|P2|Overall Study|Death Not Study Related|1
4938563|NCT00391274|16992966|P1|Overall Study|Death Not Study Related|0
4938564|NCT00391274|16992965|P2|Overall Study|Death Due to Indeterminate Cause|0
4938565|NCT00391274|16992966|P1|Overall Study|Death Due to Indeterminate Cause|1
4938566|NCT00391274|16992965|P2|Overall Study|Death Due to Adverse Event|3
4938567|NCT00391274|16992966|P1|Overall Study|Death Due to Adverse Event|1
4938568|NCT00391274|16992965|P2|Overall Study|Withdrawal by Subject|3
4938569|NCT00391274|16992966|P1|Overall Study|Withdrawal by Subject|0
4938570|NCT00391274|16992965|P2|Overall Study|Physician Decision|2
4938571|NCT00391274|16992966|P1|Overall Study|Physician Decision|4
4938572|NCT00391274|16992965|P2|Overall Study|Lost to Follow-up|3
4938573|NCT00391274|16992966|P1|Overall Study|Lost to Follow-up|0
4938574|NCT00391274|16992965|P2|Overall Study|Death Due to Study Disease|45
4938575|NCT00391274|16992966|P1|Overall Study|Death Due to Study Disease|55
4938576|NCT00391222|16992985|P4|Period III (Double-Blind Treatment)|Other|0
4938577|NCT00391222|16992986|P3|Period III (Double-Blind Treatment)|Other|6
4938578|NCT00391222|16992987|P2|Period III (Double-Blind Treatment)|Other|1
4938579|NCT00391222|16992988|P1|Period III (Double-Blind Treatment)|Other|6
4938580|NCT00391222|16992985|P4|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
4938581|NCT00391222|16992986|P3|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3
4938582|NCT00391222|16992987|P2|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1
4938583|NCT00391222|16992988|P1|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0
4938584|NCT00391222|16992985|P4|Period III (Double-Blind Treatment)|Pregnancy|0
4938585|NCT00391222|16992986|P3|Period III (Double-Blind Treatment)|Pregnancy|0
4938586|NCT00391222|16992987|P2|Period III (Double-Blind Treatment)|Pregnancy|2
4938587|NCT00391222|16992988|P1|Period III (Double-Blind Treatment)|Pregnancy|0
4938588|NCT00391222|16992985|P4|Period III (Double-Blind Treatment)|Adverse Event|0
4938589|NCT00391222|16992986|P3|Period III (Double-Blind Treatment)|Adverse Event|4
4938590|NCT00391222|16992987|P2|Period III (Double-Blind Treatment)|Adverse Event|2
4938591|NCT00391222|16992988|P1|Period III (Double-Blind Treatment)|Adverse Event|5
4938592|NCT00391222|16992985|P4|Period III (Double-Blind Treatment)|Lost to Follow-up|0
4938593|NCT00391222|16992986|P3|Period III (Double-Blind Treatment)|Lost to Follow-up|4
4938594|NCT00391222|16992987|P2|Period III (Double-Blind Treatment)|Lost to Follow-up|4
4938595|NCT00391222|16992988|P1|Period III (Double-Blind Treatment)|Lost to Follow-up|2
4938596|NCT00391222|16992985|P4|Period III (Double-Blind Treatment)|Withdrawal by Subject|0
4938597|NCT00391222|16992986|P3|Period III (Double-Blind Treatment)|Withdrawal by Subject|6
4938598|NCT00391222|16992987|P2|Period III (Double-Blind Treatment)|Withdrawal by Subject|12
4938599|NCT00391222|16992988|P1|Period III (Double-Blind Treatment)|Withdrawal by Subject|15
4938600|NCT00391222|16992985|P4|Period II (Open-label Risperidone LAI)|Other|24
4938601|NCT00391222|16992986|P3|Period II (Open-label Risperidone LAI)|Other|0
4938602|NCT00391222|16992987|P2|Period II (Open-label Risperidone LAI)|Other|0
4938603|NCT00391222|16992988|P1|Period II (Open-label Risperidone LAI)|Other|0
4938604|NCT00391222|16992985|P4|Period II (Open-label Risperidone LAI)|Non-responder|97
4938605|NCT00391222|16992986|P3|Period II (Open-label Risperidone LAI)|Non-responder|0
4938606|NCT00391222|16992987|P2|Period II (Open-label Risperidone LAI)|Non-responder|0
4938607|NCT00391222|16992988|P1|Period II (Open-label Risperidone LAI)|Non-responder|0
4938608|NCT00391222|16992985|P4|Period II (Open-label Risperidone LAI)|Adverse Event|10
4938609|NCT00391222|16992986|P3|Period II (Open-label Risperidone LAI)|Adverse Event|0
4938610|NCT00391222|16992987|P2|Period II (Open-label Risperidone LAI)|Adverse Event|0
4938611|NCT00391222|16992988|P1|Period II (Open-label Risperidone LAI)|Adverse Event|0
4938612|NCT00391222|16992985|P4|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5
4938613|NCT00391222|16992986|P3|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
4938614|NCT00391222|16992987|P2|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
4938615|NCT00391222|16992988|P1|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0
4938616|NCT00391222|16992985|P4|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26
4938617|NCT00391222|16992986|P3|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
4938618|NCT00391222|16992987|P2|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
4938619|NCT00391222|16992988|P1|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0
4938620|NCT00391118|16993015|P3|Overall Study|Protocol Violation|0
4938621|NCT00391118|16993016|P2|Overall Study|Protocol Violation|0
4938622|NCT00391118|16993017|P1|Overall Study|Protocol Violation|1
4938623|NCT00391118|16993015|P3|Overall Study|Sponsor Decision|3
4938624|NCT00391118|16993016|P2|Overall Study|Sponsor Decision|1
4938625|NCT00391118|16993017|P1|Overall Study|Sponsor Decision|0
4938626|NCT00391118|16993015|P3|Overall Study|Progressive Disease|43
4938627|NCT00391118|16993016|P2|Overall Study|Progressive Disease|26
4938628|NCT00391118|16993017|P1|Overall Study|Progressive Disease|7
4938629|NCT00391118|16993015|P3|Overall Study|Protocol Entry Criteria Not Met|1
4938630|NCT00391118|16993016|P2|Overall Study|Protocol Entry Criteria Not Met|3
4938631|NCT00391118|16993017|P1|Overall Study|Protocol Entry Criteria Not Met|0
4938632|NCT00391118|16993015|P3|Overall Study|Physician Decision|0
4938633|NCT00391118|16993016|P2|Overall Study|Physician Decision|3
4938634|NCT00391118|16993017|P1|Overall Study|Physician Decision|0
4938635|NCT00391118|16993015|P3|Overall Study|Death|0
4938636|NCT00391118|16993016|P2|Overall Study|Death|1
4938637|NCT00391118|16993017|P1|Overall Study|Death|0
4938638|NCT00391118|16993015|P3|Overall Study|Withdrawal by Subject|1
4938639|NCT00391118|16993016|P2|Overall Study|Withdrawal by Subject|9
4938640|NCT00391118|16993017|P1|Overall Study|Withdrawal by Subject|0
4938641|NCT00391118|16993015|P3|Overall Study|Lost to Follow-up|3
4938642|NCT00391118|16993016|P2|Overall Study|Lost to Follow-up|2
4938643|NCT00391118|16993017|P1|Overall Study|Lost to Follow-up|0
4938644|NCT00391118|16993015|P3|Overall Study|Adverse Event|7
4938645|NCT00391118|16993016|P2|Overall Study|Adverse Event|10
4938646|NCT00391118|16993017|P1|Overall Study|Adverse Event|3
4938647|NCT00391092|16993043|P2|Overall Study|Alive in follow-up|84
4938648|NCT00391092|16993044|P1|Overall Study|Alive in follow-up|88
4938649|NCT00391092|16993043|P2|Overall Study|Alive on treatment|33
4938650|NCT00391092|16993044|P1|Overall Study|Alive on treatment|29
4938651|NCT00391092|16993043|P2|Overall Study|Lost to Follow-up|18
4938652|NCT00391092|16993044|P1|Overall Study|Lost to Follow-up|13
4938653|NCT00391092|16993043|P2|Overall Study|Death|81
4938654|NCT00391092|16993044|P1|Overall Study|Death|78
4938655|NCT00391053|16993087|P4|Overall Study|Withdrawal by Subject|1
4938656|NCT00391053|16993088|P3|Overall Study|Withdrawal by Subject|1
4938657|NCT00391053|16993089|P2|Overall Study|Withdrawal by Subject|1
4938658|NCT00391053|16993090|P1|Overall Study|Withdrawal by Subject|5
4938659|NCT00391053|16993087|P4|Overall Study|Lost to Follow-up|5
4938660|NCT00391053|16993088|P3|Overall Study|Lost to Follow-up|0
4938661|NCT00391053|16993089|P2|Overall Study|Lost to Follow-up|0
4938662|NCT00391053|16993090|P1|Overall Study|Lost to Follow-up|1
4938663|NCT00391053|16993087|P4|Overall Study|Protocol Violation|0
4938664|NCT00391053|16993088|P3|Overall Study|Protocol Violation|0
4938665|NCT00391053|16993089|P2|Overall Study|Protocol Violation|0
4938666|NCT00391053|16993090|P1|Overall Study|Protocol Violation|2
4938667|NCT00391053|16993087|P4|Overall Study|Serious Adverse Events|4
4938668|NCT00391053|16993088|P3|Overall Study|Serious Adverse Events|1
4938669|NCT00391053|16993089|P2|Overall Study|Serious Adverse Events|0
4938670|NCT00391053|16993090|P1|Overall Study|Serious Adverse Events|1
4938671|NCT00391027|16993114|P2|Overall Study|Other|3
4938672|NCT00391027|16993115|P1|Overall Study|Other|4
4938673|NCT00391027|16993114|P2|Overall Study|Withdrawal by Subject|1
4938674|NCT00391027|16993115|P1|Overall Study|Withdrawal by Subject|10
4938675|NCT00391027|16993114|P2|Overall Study|Lack of Efficacy|0
4938676|NCT00391027|16993115|P1|Overall Study|Lack of Efficacy|3
4938677|NCT00391027|16993114|P2|Overall Study|Adverse Event|8
4938678|NCT00391027|16993115|P1|Overall Study|Adverse Event|8
4938679|NCT00390910|16993165|P3|Overall Study|Migrated/moved from study area|3
4938680|NCT00390910|16993166|P2|Overall Study|Migrated/moved from study area|0
4938681|NCT00390910|16993167|P1|Overall Study|Migrated/moved from study area|0
4938682|NCT00390910|16993165|P3|Overall Study|Withdrawal by Subject|2
4938683|NCT00390910|16993166|P2|Overall Study|Withdrawal by Subject|3
4938684|NCT00390910|16993167|P1|Overall Study|Withdrawal by Subject|1
4938685|NCT00390910|16993165|P3|Overall Study|Lost to Follow-up|5
4938686|NCT00390910|16993166|P2|Overall Study|Lost to Follow-up|1
4938687|NCT00390910|16993167|P1|Overall Study|Lost to Follow-up|0
4938688|NCT00390910|16993165|P3|Overall Study|Adverse Event|0
4938689|NCT00390910|16993166|P2|Overall Study|Adverse Event|0
4938690|NCT00390910|16993167|P1|Overall Study|Adverse Event|1
4938691|NCT00390884|16993255|P2|Overall Study|Withdrawal by Subject|2
4938692|NCT00390884|16993256|P1|Overall Study|Withdrawal by Subject|2
4938693|NCT00390858|16993268|P2|Overall Study|Withdrawal by Subject|4
4938694|NCT00390858|16993269|P1|Overall Study|Withdrawal by Subject|3
4938695|NCT00390858|16993268|P2|Overall Study|Lack of Efficacy|1
4938696|NCT00390858|16993269|P1|Overall Study|Lack of Efficacy|0
4938697|NCT00390858|16993268|P2|Overall Study|Adverse Event|2
4938698|NCT00390858|16993269|P1|Overall Study|Adverse Event|6
4938699|NCT00390806|16993283|P2|Overall Study|Ongoing|2
4938700|NCT00390806|16993284|P1|Overall Study|Ongoing|4
4938701|NCT00390806|16993283|P2|Overall Study|Physician Decision|1
4938702|NCT00390806|16993284|P1|Overall Study|Physician Decision|0
4938703|NCT00390806|16993283|P2|Overall Study|Death|0
4938704|NCT00390806|16993284|P1|Overall Study|Death|1
4938705|NCT00390806|16993283|P2|Overall Study|Investigator Decision|6
4938706|NCT00390806|16993284|P1|Overall Study|Investigator Decision|4
4938707|NCT00390806|16993283|P2|Overall Study|Withdrawal by Subject|15
4938708|NCT00390806|16993284|P1|Overall Study|Withdrawal by Subject|12
4938709|NCT00390806|16993283|P2|Overall Study|Protocol Violation|2
4938710|NCT00390806|16993284|P1|Overall Study|Protocol Violation|2
4938711|NCT00390806|16993283|P2|Overall Study|Lost to Follow-up|6
4938712|NCT00390806|16993284|P1|Overall Study|Lost to Follow-up|7
4938713|NCT00390780|16993352|P2|Overall Study|SAE, death|1
4938714|NCT00390780|16993353|P1|Overall Study|SAE, death|0
4938715|NCT00390780|16993352|P2|Overall Study|Investigator decision, SAE, other reason|1
4938716|NCT00390780|16993353|P1|Overall Study|Investigator decision, SAE, other reason|0
4938717|NCT00390780|16993352|P2|Overall Study|Lost to follow up and other reasons|1
4938718|NCT00390780|16993353|P1|Overall Study|Lost to follow up and other reasons|0
4938719|NCT00390780|16993352|P2|Overall Study|Inclusion criteria not satisfied|2
4938720|NCT00390780|16993353|P1|Overall Study|Inclusion criteria not satisfied|0
4938721|NCT00390780|16993352|P2|Overall Study|Withdrawal by Subject|2
4938722|NCT00390780|16993353|P1|Overall Study|Withdrawal by Subject|1
4938723|NCT00390780|16993352|P2|Overall Study|Death|3
4938724|NCT00390780|16993353|P1|Overall Study|Death|1
4938725|NCT00390780|16993352|P2|Overall Study|Adverse Event|3
4938726|NCT00390780|16993353|P1|Overall Study|Adverse Event|2
4938727|NCT00390780|16993352|P2|Overall Study|Lost to Follow-up|6
4938728|NCT00390780|16993353|P1|Overall Study|Lost to Follow-up|3
4938729|NCT00390780|16993352|P2|Overall Study|Protocol Violation|4
4938730|NCT00390780|16993353|P1|Overall Study|Protocol Violation|6
4938731|NCT00390780|16993352|P2|Overall Study|Not completed|4
4938732|NCT00390780|16993353|P1|Overall Study|Not completed|10
4938733|NCT00390689|16993386|P3|Overall Study|Investigator's judgement|0
4938734|NCT00390689|16993387|P2|Overall Study|Investigator's judgement|0
4938735|NCT00390689|16993388|P1|Overall Study|Investigator's judgement|2
4938736|NCT00390689|16993386|P3|Overall Study|Protocol Violation|0
4938737|NCT00390689|16993387|P2|Overall Study|Protocol Violation|0
4938738|NCT00390689|16993388|P1|Overall Study|Protocol Violation|1
4938739|NCT00390689|16993386|P3|Overall Study|Lack of Efficacy|1
4938740|NCT00390689|16993387|P2|Overall Study|Lack of Efficacy|0
4938741|NCT00390689|16993388|P1|Overall Study|Lack of Efficacy|0
4938742|NCT00390689|16993386|P3|Overall Study|Adverse Event|2
4938743|NCT00390689|16993387|P2|Overall Study|Adverse Event|5
4938744|NCT00390689|16993388|P1|Overall Study|Adverse Event|2
4938745|NCT00390572|16993463|P2|Overall Study|health condition|1
4938746|NCT00390572|16993464|P1|Overall Study|health condition|0
4938747|NCT00390572|16993463|P2|Overall Study|Lost to Follow-up|4
4938748|NCT00390572|16993464|P1|Overall Study|Lost to Follow-up|8
4938749|NCT00390546|16993490|P2|Overall Study|Physician Decision|5
4938750|NCT00390546|16993491|P1|Overall Study|Physician Decision|5
4938751|NCT00390546|16993490|P2|Overall Study|Renal impairment|0
4938752|NCT00390546|16993491|P1|Overall Study|Renal impairment|1
4938753|NCT00390468|16993501|P1|Overall Study|Lack of Efficacy|1
4938754|NCT00390468|16993501|P1|Overall Study|Protocol Violation|2
4938755|NCT00390455|16993507|P2|Overall Study|Other Medical Reasons|11
4938756|NCT00390455|16993508|P1|Overall Study|Other Medical Reasons|7
4938757|NCT00390455|16993507|P2|Overall Study|Alternate Treatment|1
4938758|NCT00390455|16993508|P1|Overall Study|Alternate Treatment|0
4938759|NCT00390455|16993507|P2|Overall Study|Withdrawal by Subject|8
4938760|NCT00390455|16993508|P1|Overall Study|Withdrawal by Subject|8
4938761|NCT00390455|16993507|P2|Overall Study|Adverse Event|3
4938762|NCT00390455|16993508|P1|Overall Study|Adverse Event|17
4938763|NCT00390416|16993553|P1|Overall Study|Not treated|3
4938764|NCT00390416|16993553|P1|Overall Study|Withdrawal by Subject|1
4938765|NCT00390299|16993591|P5|Overall Study|Cancellation|0
4938766|NCT00390299|16993592|P4|Overall Study|Cancellation|0
4938767|NCT00390299|16993593|P3|Overall Study|Cancellation|0
4938768|NCT00390299|16993594|P2|Overall Study|Cancellation|0
4938769|NCT00390299|16993595|P1|Overall Study|Cancellation|1
4938770|NCT00390221|16993626|P3|Overall Study|Other|2
4938771|NCT00390221|16993627|P2|Overall Study|Other|4
4938772|NCT00390221|16993628|P1|Overall Study|Other|3
4938773|NCT00390221|16993626|P3|Overall Study|Subject Non-compliance|2
4938774|NCT00390221|16993627|P2|Overall Study|Subject Non-compliance|0
4938775|NCT00390221|16993628|P1|Overall Study|Subject Non-compliance|1
4938776|NCT00390221|16993626|P3|Overall Study|Withdrawal by Subject|7
4938777|NCT00390221|16993627|P2|Overall Study|Withdrawal by Subject|9
4938778|NCT00390221|16993628|P1|Overall Study|Withdrawal by Subject|13
4938779|NCT00390221|16993626|P3|Overall Study|Investigator Decision|1
4938780|NCT00390221|16993627|P2|Overall Study|Investigator Decision|0
4938781|NCT00390221|16993628|P1|Overall Study|Investigator Decision|0
4938782|NCT00390221|16993626|P3|Overall Study|Adverse Event|3
4938783|NCT00390221|16993627|P2|Overall Study|Adverse Event|4
4938784|NCT00390221|16993628|P1|Overall Study|Adverse Event|1
4938785|NCT00390221|16993626|P3|Overall Study|Lost to Follow-up|0
4938786|NCT00390221|16993627|P2|Overall Study|Lost to Follow-up|3
4938787|NCT00390221|16993628|P1|Overall Study|Lost to Follow-up|0
4938788|NCT00390013|16993658|P4|Phase 2 First Treatment|Withdrawal by Subject|0
4938789|NCT00390013|16993659|P3|Phase 2 First Treatment|Withdrawal by Subject|0
4938790|NCT00390013|16993660|P2|Phase 2 First Treatment|Withdrawal by Subject|1
4938791|NCT00390013|16993661|P1|Phase 2 First Treatment|Withdrawal by Subject|0
4938792|NCT00390013|16993658|P4|Phase 2 First Treatment|tired|0
4938793|NCT00390013|16993659|P3|Phase 2 First Treatment|tired|0
4938794|NCT00390013|16993660|P2|Phase 2 First Treatment|tired|0
4938795|NCT00390013|16993661|P1|Phase 2 First Treatment|tired|1
4938796|NCT00390013|16993658|P4|Phase 1|tired|1
4938797|NCT00390013|16993659|P3|Phase 1|tired|0
4938798|NCT00390013|16993660|P2|Phase 1|tired|0
4938799|NCT00390013|16993661|P1|Phase 1|tired|0
4938800|NCT00389831|16993686|P2|Overall Study|Lost to Follow-up|1
4938801|NCT00389831|16993687|P1|Overall Study|Lost to Follow-up|0
4938802|NCT00389831|16993686|P2|Overall Study|Other reasons|2
4938803|NCT00389831|16993687|P1|Overall Study|Other reasons|0
4938804|NCT00389831|16993686|P2|Overall Study|Did not receive treatment.|2
4938805|NCT00389831|16993687|P1|Overall Study|Did not receive treatment.|0
4938806|NCT00389831|16993686|P2|Overall Study|Lack of Efficacy|2
4938807|NCT00389831|16993687|P1|Overall Study|Lack of Efficacy|0
4938808|NCT00389597|16993750|P4|Overall Study|Lost to Follow-up|6
4938809|NCT00389597|16993751|P3|Overall Study|Lost to Follow-up|4
4938810|NCT00389597|16993752|P2|Overall Study|Lost to Follow-up|6
4938811|NCT00389597|16993753|P1|Overall Study|Lost to Follow-up|8
4938812|NCT00389519|16993778|P4|Treated|Reason not specified|2
4938813|NCT00389519|16993779|P3|Treated|Reason not specified|0
4938814|NCT00389519|16993780|P2|Treated|Reason not specified|1
4938815|NCT00389519|16993781|P1|Treated|Reason not specified|1
4938816|NCT00389519|16993778|P4|Treated|Adverse Event|2
4938817|NCT00389519|16993779|P3|Treated|Adverse Event|0
4938818|NCT00389519|16993780|P2|Treated|Adverse Event|0
4938819|NCT00389519|16993781|P1|Treated|Adverse Event|1
4938820|NCT00389519|16993778|P4|Randomized|Did not receive study drug|0
4938821|NCT00389519|16993779|P3|Randomized|Did not receive study drug|0
4938822|NCT00389519|16993780|P2|Randomized|Did not receive study drug|0
4938823|NCT00389519|16993781|P1|Randomized|Did not receive study drug|2
4938824|NCT00389519|16993778|P4|Placebo Run-In|Reason not specified|0
4938825|NCT00389519|16993779|P3|Placebo Run-In|Reason not specified|0
4938826|NCT00389519|16993780|P2|Placebo Run-In|Reason not specified|0
4938827|NCT00389519|16993781|P1|Placebo Run-In|Reason not specified|40
4938828|NCT00389519|16993778|P4|Placebo Run-In|Withdrawal by Subject|0
4938829|NCT00389519|16993779|P3|Placebo Run-In|Withdrawal by Subject|0
4938830|NCT00389519|16993780|P2|Placebo Run-In|Withdrawal by Subject|0
4938831|NCT00389519|16993781|P1|Placebo Run-In|Withdrawal by Subject|19
4938832|NCT00389519|16993778|P4|Placebo Run-In|Did not meet blood pressure criteria|0
4938833|NCT00389519|16993779|P3|Placebo Run-In|Did not meet blood pressure criteria|0
4938834|NCT00389519|16993780|P2|Placebo Run-In|Did not meet blood pressure criteria|0
4938835|NCT00389519|16993781|P1|Placebo Run-In|Did not meet blood pressure criteria|119
4938836|NCT00389441|16993858|P1|Overall Study|Clinical progression|1
4938837|NCT00389441|16993858|P1|Overall Study|Ongoing in study A4061008 (NCT00828919)|2
4938838|NCT00389441|16993858|P1|Overall Study|Objective progression or relapse|26
4938839|NCT00389441|16993858|P1|Overall Study|Global deterioration of health status|4
4938840|NCT00389441|16993858|P1|Overall Study|Protocol Violation|1
4938841|NCT00389441|16993858|P1|Overall Study|Physician Decision|1
4938842|NCT00389441|16993858|P1|Overall Study|Withdrawal by Subject|4
4938843|NCT00389441|16993858|P1|Overall Study|Lost to Follow-up|2
4938844|NCT00389441|16993858|P1|Overall Study|Death|4
4938845|NCT00389441|16993858|P1|Overall Study|Adverse Event|7
4938846|NCT00389324|16993867|P1|Subcutaneous Phase|Lost to Follow-up|1
4938847|NCT00389324|16993867|P1|Subcutaneous Phase|Withdrawal by Subject|2
4938848|NCT00389324|16993867|P1|Subcutaneous Phase|Non-compliance with study medication|2
4938849|NCT00389324|16993867|P1|Subcutaneous Phase|Adverse Event|2
4938850|NCT00389324|16993867|P1|Run-In Phase|Withdrawal by Subject|1
4938851|NCT00389324|16993867|P1|Run-In Phase|Lost to Follow-up|1
4938852|NCT00389324|16993867|P1|Run-In Phase|Adverse Event|1
4938853|NCT00389207|16993877|P3|Overall Study|Other|9
4938854|NCT00389207|16993878|P2|Overall Study|Other|23
4938855|NCT00389207|16993879|P1|Overall Study|Other|17
4938856|NCT00389207|16993877|P3|Overall Study|Withdrawal by Subject|11
4938857|NCT00389207|16993878|P2|Overall Study|Withdrawal by Subject|7
4938858|NCT00389207|16993879|P1|Overall Study|Withdrawal by Subject|5
4938859|NCT00389207|16993877|P3|Overall Study|Lost to Follow-up|7
4938860|NCT00389207|16993878|P2|Overall Study|Lost to Follow-up|9
4938861|NCT00389207|16993879|P1|Overall Study|Lost to Follow-up|12
4938862|NCT00389207|16993877|P3|Overall Study|Protocol Violation|4
4938863|NCT00389207|16993878|P2|Overall Study|Protocol Violation|1
4938864|NCT00389207|16993879|P1|Overall Study|Protocol Violation|3
4938865|NCT00389207|16993877|P3|Overall Study|Adverse Event|10
4938866|NCT00389207|16993878|P2|Overall Study|Adverse Event|32
4938867|NCT00389207|16993879|P1|Overall Study|Adverse Event|26
4938868|NCT00389064|16994002|P2|Overall Study|Multiple Reasons|11
4938869|NCT00389064|16994003|P1|Overall Study|Multiple Reasons|9
4938870|NCT00389064|16994002|P2|Overall Study|Protocol Violation|0
4938871|NCT00389064|16994003|P1|Overall Study|Protocol Violation|2
4938872|NCT00389064|16994002|P2|Overall Study|Lost to Follow-up|2
4938873|NCT00389064|16994003|P1|Overall Study|Lost to Follow-up|1
4938874|NCT00389064|16994002|P2|Overall Study|Physician Decision|2
4938875|NCT00389064|16994003|P1|Overall Study|Physician Decision|2
4938876|NCT00389064|16994002|P2|Overall Study|Withdrawal by Subject|27
4938877|NCT00389064|16994003|P1|Overall Study|Withdrawal by Subject|17
4938878|NCT00389064|16994002|P2|Overall Study|Lack of Efficacy|14
4938879|NCT00389064|16994003|P1|Overall Study|Lack of Efficacy|3
4938880|NCT00389064|16994002|P2|Overall Study|Adverse Event|3
4938881|NCT00389064|16994003|P1|Overall Study|Adverse Event|11
4938882|NCT00388973|16994031|P2|Overall Study|Did not complete 2-week follow-up visit|17
4938883|NCT00388973|16994032|P1|Overall Study|Did not complete 2-week follow-up visit|17
4938884|NCT00388973|16994031|P2|Overall Study|Left region|1
4938885|NCT00388973|16994032|P1|Overall Study|Left region|0
4938886|NCT00388973|16994031|P2|Overall Study|Did not complete 61 days of treatment|4
4938887|NCT00388973|16994032|P1|Overall Study|Did not complete 61 days of treatment|5
4938888|NCT00388973|16994031|P2|Overall Study|Study specific Discontinuation Criteria|1
4938889|NCT00388973|16994032|P1|Overall Study|Study specific Discontinuation Criteria|0
4938890|NCT00388973|16994031|P2|Overall Study|Withdrawal by Subject|17
4938891|NCT00388973|16994032|P1|Overall Study|Withdrawal by Subject|14
4938892|NCT00388973|16994031|P2|Overall Study|Protocol Violation|0
4938893|NCT00388973|16994032|P1|Overall Study|Protocol Violation|3
4938894|NCT00388973|16994031|P2|Overall Study|Lack of Efficacy|12
4938895|NCT00388973|16994032|P1|Overall Study|Lack of Efficacy|1
4938896|NCT00388973|16994031|P2|Overall Study|Adverse Event|6
4938897|NCT00388973|16994032|P1|Overall Study|Adverse Event|16
4938898|NCT00388947|16994052|P1|Overall Study|Protocol Violation|47
4938899|NCT00388726|16994068|P2|Overall Study|Death|2
4938900|NCT00388726|16994069|P1|Overall Study|Death|3
4938901|NCT00388726|16994068|P2|Overall Study|Physician Decision|13
4938902|NCT00388726|16994069|P1|Overall Study|Physician Decision|18
4938903|NCT00388726|16994068|P2|Overall Study|Administrative|9
4938904|NCT00388726|16994069|P1|Overall Study|Administrative|6
4938905|NCT00388726|16994068|P2|Overall Study|Withdrawal by Subject|7
4938906|NCT00388726|16994069|P1|Overall Study|Withdrawal by Subject|10
4938907|NCT00388726|16994068|P2|Overall Study|Clinical Progression|36
4938908|NCT00388726|16994069|P1|Overall Study|Clinical Progression|61
4938909|NCT00388726|16994068|P2|Overall Study|Progressive Disease|153
4938910|NCT00388726|16994069|P1|Overall Study|Progressive Disease|336
4938911|NCT00388726|16994068|P2|Overall Study|Adverse Event|24
4938912|NCT00388726|16994069|P1|Overall Study|Adverse Event|50
4938913|NCT00388674|16994085|P2|End of Study|Not Reported|1
4938914|NCT00388674|16994086|P1|End of Study|Not Reported|0
4938915|NCT00388674|16994085|P2|End of Study|No Off-Treatment Status Data|30
4938916|NCT00388674|16994086|P1|End of Study|No Off-Treatment Status Data|22
4938917|NCT00388674|16994085|P2|End of Study|Participant Withdrew Consent|673
4938918|NCT00388674|16994086|P1|End of Study|Participant Withdrew Consent|437
4938919|NCT00388674|16994085|P2|End of Study|Not Defined|214
4938920|NCT00388674|16994086|P1|End of Study|Not Defined|135
4938921|NCT00388674|16994085|P2|End of Study|Non-Study Related Comorbidities|4
4938922|NCT00388674|16994086|P1|End of Study|Non-Study Related Comorbidities|3
4938923|NCT00388674|16994085|P2|End of Study|Malignancy (Non-HCC)|1
4938924|NCT00388674|16994086|P1|End of Study|Malignancy (Non-HCC)|1
4938925|NCT00388674|16994085|P2|End of Study|Lost to Follow-up|715
4938926|NCT00388674|16994086|P1|End of Study|Lost to Follow-up|587
4938927|NCT00388674|16994085|P2|End of Study|HCC|7
4938928|NCT00388674|16994086|P1|End of Study|HCC|8
4938929|NCT00388674|16994085|P2|End of Study|HBV Disease Progression (Non-HCC)|9
4938930|NCT00388674|16994086|P1|End of Study|HBV Disease Progression (Non-HCC)|3
4938931|NCT00388674|16994085|P2|End of Study|Death|262
4938932|NCT00388674|16994086|P1|End of Study|Death|239
4938933|NCT00388674|16994085|P2|End of Study|Administrative Reason By Sponsor|253
4938934|NCT00388674|16994086|P1|End of Study|Administrative Reason By Sponsor|299
4938935|NCT00388674|16994085|P2|Initial Treatment|Not Reported|12
4938936|NCT00388674|16994086|P1|Initial Treatment|Not Reported|10
4938937|NCT00388674|16994085|P2|Initial Treatment|No Off-Treatment Status Data|13
4938938|NCT00388674|16994086|P1|Initial Treatment|No Off-Treatment Status Data|11
4938939|NCT00388674|16994085|P2|Initial Treatment|Participant Request|673
4938940|NCT00388674|16994086|P1|Initial Treatment|Participant Request|501
4938941|NCT00388674|16994085|P2|Initial Treatment|Study Drug Toxicity|92
4938942|NCT00388674|16994086|P1|Initial Treatment|Study Drug Toxicity|5
4938943|NCT00388674|16994085|P2|Initial Treatment|Pregnancy|16
4938944|NCT00388674|16994086|P1|Initial Treatment|Pregnancy|26
4938945|NCT00388674|16994085|P2|Initial Treatment|Partial or inadequate Treatment|472
4938946|NCT00388674|16994086|P1|Initial Treatment|Partial or inadequate Treatment|112
4938947|NCT00388674|16994085|P2|Initial Treatment|Not Defined|172
4938948|NCT00388674|16994086|P1|Initial Treatment|Not Defined|125
4938949|NCT00388674|16994085|P2|Initial Treatment|Non-Study related Comorbidities|4
4938950|NCT00388674|16994086|P1|Initial Treatment|Non-Study related Comorbidities|3
4938951|NCT00388674|16994085|P2|Initial Treatment|Never Treated with Study Medication|7
4938952|NCT00388674|16994086|P1|Initial Treatment|Never Treated with Study Medication|1
4938953|NCT00388674|16994085|P2|Initial Treatment|Malignancy (Non-HCC)|3
4938954|NCT00388674|16994086|P1|Initial Treatment|Malignancy (Non-HCC)|7
4938955|NCT00388674|16994085|P2|Initial Treatment|Lost to Follow-up|624
4938956|NCT00388674|16994086|P1|Initial Treatment|Lost to Follow-up|526
4938957|NCT00388674|16994085|P2|Initial Treatment|HCC|20
4938958|NCT00388674|16994086|P1|Initial Treatment|HCC|12
4938959|NCT00388674|16994085|P2|Initial Treatment|Non-HCC HBV Disease Progression|17
4938960|NCT00388674|16994086|P1|Initial Treatment|Non-HCC HBV Disease Progression|11
4938961|NCT00388674|16994085|P2|Initial Treatment|Death|216
4938962|NCT00388674|16994086|P1|Initial Treatment|Death|215
4938963|NCT00388674|16994085|P2|Initial Treatment|Adverse Event|87
4938964|NCT00388674|16994086|P1|Initial Treatment|Adverse Event|22
4938965|NCT00388674|16994085|P2|Initial Treatment|Administrative Reason by Sponsor|158
4938966|NCT00388674|16994086|P1|Initial Treatment|Administrative Reason by Sponsor|241
4938967|NCT00388583|16994104|P2|Overall Study|Did not receive vaccine|1
4938968|NCT00388583|16994105|P1|Overall Study|Did not receive vaccine|0
4938969|NCT00388583|16994104|P2|Overall Study|Serious Adverse Event|0
4938970|NCT00388583|16994105|P1|Overall Study|Serious Adverse Event|2
4938971|NCT00388583|16994104|P2|Overall Study|Withdrawal by Subject|3
4938972|NCT00388583|16994105|P1|Overall Study|Withdrawal by Subject|3
4938973|NCT00388583|16994104|P2|Overall Study|Protocol Violation|0
4938974|NCT00388583|16994105|P1|Overall Study|Protocol Violation|1
4938975|NCT00388505|16994119|P2|Overall Study|Unable to classify|3
4938976|NCT00388505|16994120|P1|Overall Study|Unable to classify|4
4938977|NCT00388505|16994119|P2|Overall Study|Protocol Violation|5
4938978|NCT00388505|16994120|P1|Overall Study|Protocol Violation|6
4938979|NCT00388505|16994119|P2|Overall Study|Administrative Reason|0
4938980|NCT00388505|16994120|P1|Overall Study|Administrative Reason|1
4938981|NCT00388505|16994119|P2|Overall Study|Inappropriate Enrollment|1
4938982|NCT00388505|16994120|P1|Overall Study|Inappropriate Enrollment|0
4938983|NCT00388505|16994119|P2|Overall Study|Lost to Follow-up|3
4938984|NCT00388505|16994120|P1|Overall Study|Lost to Follow-up|5
4938985|NCT00388505|16994119|P2|Overall Study|Withdrawal by Subject|9
4938986|NCT00388505|16994120|P1|Overall Study|Withdrawal by Subject|24
4938987|NCT00388505|16994119|P2|Overall Study|Adverse Event or Death|17
4938988|NCT00388505|16994120|P1|Overall Study|Adverse Event or Death|43
4938989|NCT00388362|16994175|P1|Remained on Study Median of 514 Days|Death|2
4938990|NCT00388362|16994175|P1|Enrolled|Withdrawal by Subject|1
4938991|NCT00388362|16994175|P1|Enrolled|Loss insurance|1
4938992|NCT00388362|16994175|P1|Enrolled|Death|1
4938993|NCT00388362|16994175|P1|Enrolled|Adverse Event|9
4938994|NCT00388362|16994175|P1|Enrolled|Ineligible|1
4938995|NCT00388349|16994180|P2|Phase I Dose Escalation|Dose reduction due to DLT|3
4938996|NCT00388349|16994181|P1|Phase I Dose Escalation|Dose reduction due to DLT|0
4938997|NCT00388297|16994194|P4|Overall Study|Lost to Follow-up|8
4938998|NCT00388297|16994195|P3|Overall Study|Lost to Follow-up|11
4938999|NCT00388297|16994196|P2|Overall Study|Lost to Follow-up|12
4939000|NCT00388297|16994197|P1|Overall Study|Lost to Follow-up|16
4939001|NCT00388154|16994307|P1|Overall Study|Withdrawal by Subject|1
4939002|NCT00388037|16994312|P1|Overall Study|Protocol Violation|1
4939003|NCT00387894|16994320|P1|Overall Study|Withdrawal by Subject|1
4939004|NCT00387881|16994327|P2|Overall Study|Not otherwise specified|7
4939005|NCT00387881|16994328|P1|Overall Study|Not otherwise specified|11
4939006|NCT00387881|16994327|P2|Overall Study|No opportunity to treat headache|34
4939007|NCT00387881|16994328|P1|Overall Study|No opportunity to treat headache|32
4939008|NCT00387881|16994327|P2|Overall Study|Not eligible|7
4939009|NCT00387881|16994328|P1|Overall Study|Not eligible|6
4939010|NCT00387881|16994327|P2|Overall Study|Sponsor terminated Study|1
4939011|NCT00387881|16994328|P1|Overall Study|Sponsor terminated Study|0
4939012|NCT00387881|16994327|P2|Overall Study|Withdrawal by Subject|18
4939013|NCT00387881|16994328|P1|Overall Study|Withdrawal by Subject|15
4939014|NCT00387881|16994327|P2|Overall Study|Protocol Violation|12
4939015|NCT00387881|16994328|P1|Overall Study|Protocol Violation|2
4939016|NCT00387881|16994327|P2|Overall Study|Lost to Follow-up|23
4939017|NCT00387881|16994328|P1|Overall Study|Lost to Follow-up|23
4939018|NCT00387790|16994361|P1|Overall Study|Ineligible for study|2
4939019|NCT00387790|16994361|P1|Overall Study|Withdrawal by Subject|3
4939020|NCT00387790|16994361|P1|Overall Study|Physician Decision|2
4939021|NCT00387790|16994361|P1|Overall Study|Lack of Efficacy|2
4939022|NCT00387790|16994361|P1|Overall Study|Adverse Event|5
4939023|NCT00387764|16994367|P1|Overall Study|Death|7
4939024|NCT00387764|16994367|P1|Overall Study|Other|2
4939025|NCT00387764|16994367|P1|Overall Study|Physician Decision|1
4939026|NCT00387764|16994367|P1|Overall Study|Sponsor Terminated Study|1
4939027|NCT00387764|16994367|P1|Overall Study|Withdrawal by Subject|8
4939028|NCT00387764|16994367|P1|Overall Study|Adverse Event|12
4939029|NCT00387725|16994395|P4|Overall Study|Parent/legal guardian request|1
4939030|NCT00387725|16994396|P3|Overall Study|Parent/legal guardian request|1
4939031|NCT00387725|16994397|P2|Overall Study|Parent/legal guardian request|0
4939032|NCT00387725|16994398|P1|Overall Study|Parent/legal guardian request|0
4939033|NCT00387725|16994395|P4|Overall Study|Withdrawal by Subject|0
4939034|NCT00387725|16994396|P3|Overall Study|Withdrawal by Subject|1
4939035|NCT00387725|16994397|P2|Overall Study|Withdrawal by Subject|0
4939036|NCT00387725|16994398|P1|Overall Study|Withdrawal by Subject|1
4939037|NCT00387725|16994395|P4|Overall Study|Protocol Violation|0
4939038|NCT00387725|16994396|P3|Overall Study|Protocol Violation|0
4939039|NCT00387725|16994397|P2|Overall Study|Protocol Violation|1
4939040|NCT00387725|16994398|P1|Overall Study|Protocol Violation|0
4939041|NCT00387725|16994395|P4|Overall Study|Adverse Event|1
4939042|NCT00387725|16994396|P3|Overall Study|Adverse Event|0
4939043|NCT00387725|16994397|P2|Overall Study|Adverse Event|0
4939044|NCT00387725|16994398|P1|Overall Study|Adverse Event|0
4939045|NCT00387712|16994418|P2|Overall Study|Withdrawal by Subject|12
4939046|NCT00387712|16994419|P1|Overall Study|Withdrawal by Subject|6
4939047|NCT00387712|16994418|P2|Overall Study|Lost to Follow-up|20
4939048|NCT00387712|16994419|P1|Overall Study|Lost to Follow-up|17
4939049|NCT00387712|16994418|P2|Overall Study|Physician Decision|4
4939050|NCT00387712|16994419|P1|Overall Study|Physician Decision|6
4939051|NCT00387647|16994450|P1|Overall Study|Death|18
4939052|NCT00387465|16994493|P3|Overall Study|Withdrawal by Subject|0
4939053|NCT00387465|16994494|P2|Overall Study|Withdrawal by Subject|1
4939054|NCT00387465|16994495|P1|Overall Study|Withdrawal by Subject|0
4939055|NCT00387426|16994512|P1|Overall Study|Disease Progression|3
4939056|NCT00387426|16994512|P1|Overall Study|Toxicities|4
4939057|NCT00387426|16994512|P1|Overall Study|Lack of Response|7
4939058|NCT00387348|16994519|P3|Overall Study|Adverse Event|1
4939059|NCT00387348|16994520|P2|Overall Study|Adverse Event|0
4939060|NCT00387348|16994521|P1|Overall Study|Adverse Event|1
4939061|NCT00387348|16994519|P3|Overall Study|Withdrawal by Subject|2
4939062|NCT00387348|16994520|P2|Overall Study|Withdrawal by Subject|2
4939063|NCT00387348|16994521|P1|Overall Study|Withdrawal by Subject|0
4939064|NCT00387348|16994519|P3|Overall Study|Physician Decision|1
4939065|NCT00387348|16994520|P2|Overall Study|Physician Decision|0
4939066|NCT00387348|16994521|P1|Overall Study|Physician Decision|1
4939067|NCT00387348|16994519|P3|Overall Study|Death|0
4939068|NCT00387348|16994520|P2|Overall Study|Death|1
4939069|NCT00387348|16994521|P1|Overall Study|Death|1
4939070|NCT00387153|16994550|P1|Overall Study|Lack of Response|4
4939071|NCT00387153|16994550|P1|Overall Study|Disease Progression|3
4939072|NCT00387153|16994550|P1|Overall Study|Adverse Event|1
4939073|NCT00387127|16994556|P2|Overall Study|Sponsor Unblinded|0
4939074|NCT00387127|16994557|P1|Overall Study|Sponsor Unblinded|1
4939075|NCT00387127|16994556|P2|Overall Study|Serious Adverse Event|1
4939076|NCT00387127|16994557|P1|Overall Study|Serious Adverse Event|1
4939077|NCT00387127|16994556|P2|Overall Study|Required by Protocol Amendment #4|10
4939078|NCT00387127|16994557|P1|Overall Study|Required by Protocol Amendment #4|12
4939079|NCT00387127|16994556|P2|Overall Study|Withdrawal by Subject|2
4939080|NCT00387127|16994557|P1|Overall Study|Withdrawal by Subject|3
4939081|NCT00387127|16994556|P2|Overall Study|Physician Decision|1
4939082|NCT00387127|16994557|P1|Overall Study|Physician Decision|0
4939083|NCT00387127|16994556|P2|Overall Study|Death|16
4939084|NCT00387127|16994557|P1|Overall Study|Death|16
4939085|NCT00387127|16994556|P2|Overall Study|Lost to Follow-up|4
4939086|NCT00387127|16994557|P1|Overall Study|Lost to Follow-up|0
4939087|NCT00387088|16994599|P2|Overall Study|Other|52
4939088|NCT00387088|16994600|P1|Overall Study|Other|58
4939089|NCT00387088|16994599|P2|Overall Study|Lost to Follow-up|28
4939090|NCT00387088|16994600|P1|Overall Study|Lost to Follow-up|22
4939091|NCT00387088|16994599|P2|Overall Study|Lack of Efficacy|67
4939092|NCT00387088|16994600|P1|Overall Study|Lack of Efficacy|28
4939093|NCT00387088|16994599|P2|Overall Study|Withdrawal by Subject|35
4939094|NCT00387088|16994600|P1|Overall Study|Withdrawal by Subject|20
4939095|NCT00387088|16994599|P2|Overall Study|Protocol Violation|35
4939096|NCT00387088|16994600|P1|Overall Study|Protocol Violation|47
4939097|NCT00387088|16994599|P2|Overall Study|Adverse Event|156
4939098|NCT00387088|16994600|P1|Overall Study|Adverse Event|143
4939099|NCT00387010|16994657|P1|Treatment Period|Participant reported study drug stolen|1
4939100|NCT00387010|16994657|P1|Treatment Period|Noncompliance with study procedures|3
4939101|NCT00387010|16994657|P1|Treatment Period|Noncompliance with study medication|2
4939102|NCT00387010|16994657|P1|Treatment Period|Withdrawal by Subject|1
4939103|NCT00387010|16994657|P1|Treatment Period|Adverse Event|4
4939104|NCT00387010|16994657|P1|Dose Titration Period|Noncompliance with study procedures|7
4939105|NCT00387010|16994657|P1|Dose Titration Period|Noncompliance with study medication|8
4939106|NCT00387010|16994657|P1|Dose Titration Period|Lost to Follow-up|2
4939107|NCT00387010|16994657|P1|Dose Titration Period|Protocol Violation|1
4939108|NCT00387010|16994657|P1|Dose Titration Period|Withdrawal by Subject|3
4939109|NCT00387010|16994657|P1|Dose Titration Period|Lack of Efficacy|5
4939110|NCT00387010|16994657|P1|Dose Titration Period|Adverse Event|12
4939111|NCT00386776|16994684|P1|Overall Study|Withdrawal by Subject|8
4939112|NCT00386607|16994694|P2|Extension|Unsatisfactory therapeutic effect|1
4939113|NCT00386607|16994695|P1|Extension|Unsatisfactory therapeutic effect|0
4939114|NCT00386607|16994694|P2|Extension|Patient withdrew consent|5
4939115|NCT00386607|16994695|P1|Extension|Patient withdrew consent|0
4939116|NCT00386607|16994694|P2|Extension|Lost to Follow-up|3
4939117|NCT00386607|16994695|P1|Extension|Lost to Follow-up|0
4939118|NCT00386607|16994694|P2|Extension|Administrative problems|1
4939119|NCT00386607|16994695|P1|Extension|Administrative problems|0
4939120|NCT00386607|16994694|P2|Extension|Abnormal laboratory value(s)|1
4939121|NCT00386607|16994695|P1|Extension|Abnormal laboratory value(s)|0
4939122|NCT00386607|16994694|P2|Extension|Adverse Event|6
4939123|NCT00386607|16994695|P1|Extension|Adverse Event|0
4939124|NCT00386607|16994694|P2|Core|Protocol Deviation|0
4939125|NCT00386607|16994695|P1|Core|Protocol Deviation|6
4939126|NCT00386607|16994694|P2|Core|Administrative problems|0
4939127|NCT00386607|16994695|P1|Core|Administrative problems|1
4939128|NCT00386607|16994694|P2|Core|Lost to Follow-up|0
4939129|NCT00386607|16994695|P1|Core|Lost to Follow-up|23
4939130|NCT00386607|16994694|P2|Core|Patient withdrew consent|0
4939131|NCT00386607|16994695|P1|Core|Patient withdrew consent|15
4939132|NCT00386607|16994694|P2|Core|Condition no longer requires study drug|0
4939133|NCT00386607|16994695|P1|Core|Condition no longer requires study drug|4
4939134|NCT00386607|16994694|P2|Core|Unsatisfactory therapeutic effect|0
4939135|NCT00386607|16994695|P1|Core|Unsatisfactory therapeutic effect|23
4939136|NCT00386607|16994694|P2|Core|Abnormal laboratory value(s)|0
4939137|NCT00386607|16994695|P1|Core|Abnormal laboratory value(s)|3
4939138|NCT00386607|16994694|P2|Core|Adverse Event|0
4939139|NCT00386607|16994695|P1|Core|Adverse Event|40
4939140|NCT00386425|16994723|P3|Overall Study|Withdrawal by Subject|0
4939141|NCT00386425|16994724|P2|Overall Study|Withdrawal by Subject|1
4939142|NCT00386425|16994725|P1|Overall Study|Withdrawal by Subject|0
4939143|NCT00386425|16994723|P3|Overall Study|Physician Decision|0
4939144|NCT00386425|16994724|P2|Overall Study|Physician Decision|0
4939145|NCT00386425|16994725|P1|Overall Study|Physician Decision|3
4939146|NCT00386360|16994751|P2|Overall Study|Did not take any study medication|2
4939147|NCT00386360|16994752|P1|Overall Study|Did not take any study medication|0
4939148|NCT00386360|16994751|P2|Overall Study|Withdrawal by Subject|6
4939149|NCT00386360|16994752|P1|Overall Study|Withdrawal by Subject|3
4939150|NCT00386360|16994751|P2|Overall Study|Protocol Violation|3
4939151|NCT00386360|16994752|P1|Overall Study|Protocol Violation|0
4939152|NCT00386360|16994751|P2|Overall Study|Lost to Follow-up|2
4939153|NCT00386360|16994752|P1|Overall Study|Lost to Follow-up|0
4939154|NCT00386360|16994751|P2|Overall Study|Physician Decision|2
4939155|NCT00386360|16994752|P1|Overall Study|Physician Decision|2
4939156|NCT00386360|16994751|P2|Overall Study|Adverse Event|2
4939157|NCT00386360|16994752|P1|Overall Study|Adverse Event|4
4939158|NCT00386334|16994786|P2|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1
4939159|NCT00386334|16994787|P1|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3
4939160|NCT00386334|16994786|P2|Double Blind Period|Other|3
4939161|NCT00386334|16994787|P1|Double Blind Period|Other|3
4939162|NCT00386334|16994786|P2|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5
4939163|NCT00386334|16994787|P1|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4
4939164|NCT00386334|16994786|P2|Double Blind Period|Lack of Efficacy|11
4939165|NCT00386334|16994787|P1|Double Blind Period|Lack of Efficacy|20
4939166|NCT00386334|16994786|P2|Double Blind Period|Withdrawal by Subject|13
4939167|NCT00386334|16994787|P1|Double Blind Period|Withdrawal by Subject|9
4939168|NCT00386334|16994786|P2|Double Blind Period|Protocol Violation|1
4939169|NCT00386334|16994787|P1|Double Blind Period|Protocol Violation|1
4939170|NCT00386334|16994786|P2|Double Blind Period|Adverse Event|14
4939171|NCT00386334|16994787|P1|Double Blind Period|Adverse Event|9
4939172|NCT00386308|16994931|P2|Overall Study|Other Event|1
4939173|NCT00386308|16994932|P1|Overall Study|Other Event|8
4939174|NCT00386308|16994931|P2|Overall Study|Withdrawal by Subject|2
4939175|NCT00386308|16994932|P1|Overall Study|Withdrawal by Subject|6
4939176|NCT00386308|16994931|P2|Overall Study|Lost to Follow-up|6
4939177|NCT00386308|16994932|P1|Overall Study|Lost to Follow-up|10
4939178|NCT00386308|16994931|P2|Overall Study|Lack of Efficacy|2
4939179|NCT00386308|16994932|P1|Overall Study|Lack of Efficacy|0
4939180|NCT00386308|16994931|P2|Overall Study|Protocol Violation|5
4939181|NCT00386308|16994932|P1|Overall Study|Protocol Violation|2
4939182|NCT00386308|16994931|P2|Overall Study|Adverse Event|3
4939183|NCT00386308|16994932|P1|Overall Study|Adverse Event|3
4939184|NCT00386152|16994989|P3|Overall Study|Withdrawal by Subject|10
4939185|NCT00386152|16994990|P2|Overall Study|Withdrawal by Subject|6
4939186|NCT00386152|16994991|P1|Overall Study|Withdrawal by Subject|3
4939187|NCT00386152|16994989|P3|Overall Study|Protocol Violation|2
4939188|NCT00386152|16994990|P2|Overall Study|Protocol Violation|5
4939189|NCT00386152|16994991|P1|Overall Study|Protocol Violation|3
4939190|NCT00386152|16994989|P3|Overall Study|Completed chemotherapy|1
4939191|NCT00386152|16994990|P2|Overall Study|Completed chemotherapy|5
4939192|NCT00386152|16994991|P1|Overall Study|Completed chemotherapy|4
4939193|NCT00386152|16994989|P3|Overall Study|Lost to Follow-up|0
4939194|NCT00386152|16994990|P2|Overall Study|Lost to Follow-up|0
4939195|NCT00386152|16994991|P1|Overall Study|Lost to Follow-up|1
4939196|NCT00386152|16994989|P3|Overall Study|Physician Decision|4
4939197|NCT00386152|16994990|P2|Overall Study|Physician Decision|10
4939198|NCT00386152|16994991|P1|Overall Study|Physician Decision|13
4939199|NCT00386152|16994989|P3|Overall Study|Disease progression|5
4939200|NCT00386152|16994990|P2|Overall Study|Disease progression|4
4939201|NCT00386152|16994991|P1|Overall Study|Disease progression|7
4939202|NCT00386152|16994989|P3|Overall Study|Death|1
4939203|NCT00386152|16994990|P2|Overall Study|Death|0
4939204|NCT00386152|16994991|P1|Overall Study|Death|3
4939205|NCT00386152|16994989|P3|Overall Study|Chang from original chemo stratification|6
4939206|NCT00386152|16994990|P2|Overall Study|Chang from original chemo stratification|5
4939207|NCT00386152|16994991|P1|Overall Study|Chang from original chemo stratification|4
4939208|NCT00386152|16994989|P3|Overall Study|Adverse Event|4
4939209|NCT00386152|16994990|P2|Overall Study|Adverse Event|5
4939210|NCT00386152|16994991|P1|Overall Study|Adverse Event|6
4939211|NCT00386100|16995010|P2|Overall Study|Participant randomized in error|0
4939212|NCT00386100|16995011|P1|Overall Study|Participant randomized in error|1
4939213|NCT00386100|16995010|P2|Overall Study|Hb1Ac >8%|1
4939214|NCT00386100|16995011|P1|Overall Study|Hb1Ac >8%|0
4939215|NCT00386100|16995010|P2|Overall Study|Out of country for 5 months|0
4939216|NCT00386100|16995011|P1|Overall Study|Out of country for 5 months|1
4939217|NCT00386100|16995010|P2|Overall Study|Positive pregnancy test|3
4939218|NCT00386100|16995011|P1|Overall Study|Positive pregnancy test|1
4939219|NCT00386100|16995010|P2|Overall Study|Osteoporosis|1
4939220|NCT00386100|16995011|P1|Overall Study|Osteoporosis|0
4939221|NCT00386100|16995010|P2|Overall Study|7.6% bone loss|0
4939222|NCT00386100|16995011|P1|Overall Study|7.6% bone loss|1
4939223|NCT00386100|16995010|P2|Overall Study|DBP 93 mmHg at randomization|0
4939224|NCT00386100|16995011|P1|Overall Study|DBP 93 mmHg at randomization|1
4939225|NCT00386100|16995010|P2|Overall Study|Bone loss by DXA bone scan|0
4939226|NCT00386100|16995011|P1|Overall Study|Bone loss by DXA bone scan|1
4939227|NCT00386100|16995010|P2|Overall Study|Bad metabolic control & patient security|0
4939228|NCT00386100|16995011|P1|Overall Study|Bad metabolic control & patient security|1
4939229|NCT00386100|16995010|P2|Overall Study|Osteoporosis findings on Visit 2 DXA|1
4939230|NCT00386100|16995011|P1|Overall Study|Osteoporosis findings on Visit 2 DXA|0
4939231|NCT00386100|16995010|P2|Overall Study|Participant's PCP wanted to stop drug|0
4939232|NCT00386100|16995011|P1|Overall Study|Participant's PCP wanted to stop drug|1
4939233|NCT00386100|16995010|P2|Overall Study|Didn't meet entry criteria|1
4939234|NCT00386100|16995011|P1|Overall Study|Didn't meet entry criteria|1
4939235|NCT00386100|16995010|P2|Overall Study|Excessive bone loss vs. baseline value|1
4939236|NCT00386100|16995011|P1|Overall Study|Excessive bone loss vs. baseline value|0
4939237|NCT00386100|16995010|P2|Overall Study|Participant moving out of state|0
4939238|NCT00386100|16995011|P1|Overall Study|Participant moving out of state|2
4939239|NCT00386100|16995010|P2|Overall Study|Participant's concern due to CPK levels|0
4939240|NCT00386100|16995011|P1|Overall Study|Participant's concern due to CPK levels|1
4939241|NCT00386100|16995010|P2|Overall Study|Laboratory findings|0
4939242|NCT00386100|16995011|P1|Overall Study|Laboratory findings|1
4939243|NCT00386100|16995010|P2|Overall Study|Visit 11 DXA showed excessive bone loss|1
4939244|NCT00386100|16995011|P1|Overall Study|Visit 11 DXA showed excessive bone loss|0
4939245|NCT00386100|16995010|P2|Overall Study|Consecutive elevated Hba1C|0
4939246|NCT00386100|16995011|P1|Overall Study|Consecutive elevated Hba1C|1
4939247|NCT00386100|16995010|P2|Overall Study|BMD <2.5|0
4939248|NCT00386100|16995011|P1|Overall Study|BMD <2.5|1
4939249|NCT00386100|16995010|P2|Overall Study|Bone mass density (BMD) loss >6%|4
4939250|NCT00386100|16995011|P1|Overall Study|Bone mass density (BMD) loss >6%|4
4939251|NCT00386100|16995010|P2|Overall Study|Withdrawal by Subject|31
4939252|NCT00386100|16995011|P1|Overall Study|Withdrawal by Subject|32
4939253|NCT00386100|16995010|P2|Overall Study|Protocol Violation|3
4939254|NCT00386100|16995011|P1|Overall Study|Protocol Violation|5
4939255|NCT00386100|16995010|P2|Overall Study|Non-compliance|19
4939256|NCT00386100|16995011|P1|Overall Study|Non-compliance|18
4939257|NCT00386100|16995010|P2|Overall Study|Lost to Follow-up|29
4939258|NCT00386100|16995011|P1|Overall Study|Lost to Follow-up|29
4939259|NCT00386100|16995010|P2|Overall Study|Insufficient therapeutic effect|6
4939260|NCT00386100|16995011|P1|Overall Study|Insufficient therapeutic effect|30
4939261|NCT00386100|16995010|P2|Overall Study|Death|1
4939262|NCT00386100|16995011|P1|Overall Study|Death|0
4939263|NCT00386100|16995010|P2|Overall Study|Adverse Event|25
4939264|NCT00386100|16995011|P1|Overall Study|Adverse Event|15
4939265|NCT00386100|16995010|P2|Overall Study|Did not receive study medication|4
4939266|NCT00386100|16995011|P1|Overall Study|Did not receive study medication|6
4939267|NCT00386022|16995075|P2|Plus Estrogen|Adverse Event|1
4939268|NCT00386022|16995076|P1|Plus Estrogen|Adverse Event|0
4939269|NCT00386022|16995075|P2|Plus Estrogen|Lost to Follow-up|0
4939270|NCT00386022|16995076|P1|Plus Estrogen|Lost to Follow-up|2
4939271|NCT00386009|16995086|P2|Overall Study|Withdrawal by Subject|4
4939272|NCT00386009|16995087|P1|Overall Study|Withdrawal by Subject|5
4939273|NCT00386009|16995086|P2|Overall Study|Sponsor Decision|1
4939274|NCT00386009|16995087|P1|Overall Study|Sponsor Decision|1
4939275|NCT00386009|16995086|P2|Overall Study|Protocol Violation|0
4939276|NCT00386009|16995087|P1|Overall Study|Protocol Violation|1
4939277|NCT00386009|16995086|P2|Overall Study|Lost to Follow-up|1
4939278|NCT00386009|16995087|P1|Overall Study|Lost to Follow-up|1
4939279|NCT00386009|16995086|P2|Overall Study|Entry Criteria Not Met|2
4939280|NCT00386009|16995087|P1|Overall Study|Entry Criteria Not Met|0
4939281|NCT00386009|16995086|P2|Overall Study|Death|0
4939282|NCT00386009|16995087|P1|Overall Study|Death|1
4939283|NCT00386009|16995086|P2|Overall Study|Adverse Event|2
4939284|NCT00386009|16995087|P1|Overall Study|Adverse Event|0
4939285|NCT00385944|16995134|P3|2nd Maintenance Dose Period|Invalid PD Data|0
4939286|NCT00385944|16995135|P2|2nd Maintenance Dose Period|Invalid PD Data|3
4939287|NCT00385944|16995136|P1|2nd Maintenance Dose Period|Invalid PD Data|2
4939288|NCT00385944|16995134|P3|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
4939289|NCT00385944|16995135|P2|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0
4939290|NCT00385944|16995136|P1|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3
4939291|NCT00385944|16995134|P3|1st Maintenance Dose Period|Entry Criteria Exclusion|0
4939292|NCT00385944|16995135|P2|1st Maintenance Dose Period|Entry Criteria Exclusion|1
4939293|NCT00385944|16995136|P1|1st Maintenance Dose Period|Entry Criteria Exclusion|0
4939294|NCT00385944|16995134|P3|1st Maintenance Dose Period|Physician Decision|0
4939295|NCT00385944|16995135|P2|1st Maintenance Dose Period|Physician Decision|0
4939296|NCT00385944|16995136|P1|1st Maintenance Dose Period|Physician Decision|1
4939297|NCT00385918|16995179|P3|Intervention Phase After Randomization|Lost to Follow-up|0
4939298|NCT00385918|16995180|P2|Intervention Phase After Randomization|Lost to Follow-up|0
4939299|NCT00385918|16995181|P1|Intervention Phase After Randomization|Lost to Follow-up|1
4939300|NCT00385918|16995179|P3|Intervention Phase After Randomization|Physician Decision|0
4939301|NCT00385918|16995180|P2|Intervention Phase After Randomization|Physician Decision|0
4939302|NCT00385918|16995181|P1|Intervention Phase After Randomization|Physician Decision|1
4939303|NCT00385918|16995179|P3|Intervention Phase After Randomization|Withdrawal by Subject|0
4939304|NCT00385918|16995180|P2|Intervention Phase After Randomization|Withdrawal by Subject|0
4939305|NCT00385918|16995181|P1|Intervention Phase After Randomization|Withdrawal by Subject|1
4939306|NCT00385918|16995179|P3|Feasibility & Baseline Measurement Phase|Physician Decision|1
4939307|NCT00385918|16995180|P2|Feasibility & Baseline Measurement Phase|Physician Decision|0
4939308|NCT00385918|16995181|P1|Feasibility & Baseline Measurement Phase|Physician Decision|0
4939309|NCT00385918|16995179|P3|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5
4939310|NCT00385918|16995180|P2|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
4939311|NCT00385918|16995181|P1|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0
4939312|NCT00385918|16995179|P3|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8
4939313|NCT00385918|16995180|P2|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
4939314|NCT00385918|16995181|P1|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0
4939315|NCT00385840|16995205|P2|Overall Study|Lost to Follow-up|13
4939316|NCT00385840|16995206|P1|Overall Study|Lost to Follow-up|3
4939317|NCT00385840|16995205|P2|Overall Study|Adverse Event|1
4939318|NCT00385840|16995206|P1|Overall Study|Adverse Event|1
4939322|NCT00385827|16995229|P3|Part 2|Randomized but not treated|2
4939323|NCT00385827|16995230|P2|Part 2|Randomized but not treated|2
4939324|NCT00385827|16995231|P1|Part 2|Randomized but not treated|0
4939325|NCT00385827|16995229|P3|Part 2|Lack of Efficacy|13
4939326|NCT00385827|16995230|P2|Part 2|Lack of Efficacy|14
4939327|NCT00385827|16995231|P1|Part 2|Lack of Efficacy|0
4939328|NCT00385827|16995229|P3|Part 2|Death|2
4939329|NCT00385827|16995230|P2|Part 2|Death|0
4939330|NCT00385827|16995231|P1|Part 2|Death|0
4939331|NCT00385827|16995229|P3|Part 2|Adverse Event|10
4939332|NCT00385827|16995230|P2|Part 2|Adverse Event|6
4939333|NCT00385827|16995231|P1|Part 2|Adverse Event|0
4939334|NCT00385827|16995229|P3|Part 1|Other|0
4939335|NCT00385827|16995230|P2|Part 1|Other|0
4939336|NCT00385827|16995231|P1|Part 1|Other|1
4939337|NCT00385827|16995229|P3|Part 1|Lack of Efficacy|0
4939338|NCT00385827|16995230|P2|Part 1|Lack of Efficacy|0
4939339|NCT00385827|16995231|P1|Part 1|Lack of Efficacy|5
4939340|NCT00385827|16995229|P3|Part 1|Death|0
4939341|NCT00385827|16995230|P2|Part 1|Death|0
4939342|NCT00385827|16995231|P1|Part 1|Death|2
4939343|NCT00385827|16995229|P3|Part 1|Adverse Event|0
4939344|NCT00385827|16995230|P2|Part 1|Adverse Event|0
4939345|NCT00385827|16995231|P1|Part 1|Adverse Event|1
4939346|NCT00385762|16995275|P1|Overall Study|Lost to Follow-up|1
4939347|NCT00385762|16995275|P1|Overall Study|Adverse Event|1
4939348|NCT00385736|16995285|P3|Safety Analysis Set|Other|4
4939349|NCT00385736|16995286|P2|Safety Analysis Set|Other|4
4939350|NCT00385736|16995287|P1|Safety Analysis Set|Other|1
4939351|NCT00385736|16995285|P3|Safety Analysis Set|Protocol Violation|6
4939352|NCT00385736|16995286|P2|Safety Analysis Set|Protocol Violation|1
4939353|NCT00385736|16995287|P1|Safety Analysis Set|Protocol Violation|2
4939354|NCT00385736|16995285|P3|Safety Analysis Set|Lack of Efficacy|31
4939355|NCT00385736|16995286|P2|Safety Analysis Set|Lack of Efficacy|16
4939356|NCT00385736|16995287|P1|Safety Analysis Set|Lack of Efficacy|38
4939357|NCT00385736|16995285|P3|Safety Analysis Set|Lost to Follow-up|2
4939358|NCT00385736|16995286|P2|Safety Analysis Set|Lost to Follow-up|2
4939359|NCT00385736|16995287|P1|Safety Analysis Set|Lost to Follow-up|0
4939360|NCT00385736|16995285|P3|Safety Analysis Set|Withdrawal by Subject|14
4939361|NCT00385736|16995286|P2|Safety Analysis Set|Withdrawal by Subject|6
4939362|NCT00385736|16995287|P1|Safety Analysis Set|Withdrawal by Subject|6
4939363|NCT00385736|16995285|P3|Safety Analysis Set|Adverse Event|23
4939364|NCT00385736|16995286|P2|Safety Analysis Set|Adverse Event|15
4939365|NCT00385736|16995287|P1|Safety Analysis Set|Adverse Event|23
4939366|NCT00385736|16995285|P3|Efficacy Analysis Set - Maintenance|Other|4
4939367|NCT00385736|16995286|P2|Efficacy Analysis Set - Maintenance|Other|4
4939368|NCT00385736|16995287|P1|Efficacy Analysis Set - Maintenance|Other|0
4939369|NCT00385736|16995285|P3|Efficacy Analysis Set - Maintenance|Protocol Violation|6
4939370|NCT00385736|16995286|P2|Efficacy Analysis Set - Maintenance|Protocol Violation|1
4939371|NCT00385736|16995287|P1|Efficacy Analysis Set - Maintenance|Protocol Violation|2
4939372|NCT00385736|16995285|P3|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31
4939373|NCT00385736|16995286|P2|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16
4939374|NCT00385736|16995287|P1|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38
4939375|NCT00385736|16995285|P3|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
4939376|NCT00385736|16995286|P2|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2
4939377|NCT00385736|16995287|P1|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0
4939378|NCT00385736|16995285|P3|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14
4939379|NCT00385736|16995286|P2|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
4939380|NCT00385736|16995287|P1|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6
4939381|NCT00385736|16995285|P3|Efficacy Analysis Set - Maintenance|Adverse Event|23
4939382|NCT00385736|16995286|P2|Efficacy Analysis Set - Maintenance|Adverse Event|15
4939383|NCT00385736|16995287|P1|Efficacy Analysis Set - Maintenance|Adverse Event|23
4939384|NCT00385736|16995285|P3|Efficacy Analysis Set - Induction|Other|1
4939385|NCT00385736|16995286|P2|Efficacy Analysis Set - Induction|Other|0
4939386|NCT00385736|16995287|P1|Efficacy Analysis Set - Induction|Other|0
4939387|NCT00385736|16995285|P3|Efficacy Analysis Set - Induction|Protocol Violation|2
4939388|NCT00385736|16995286|P2|Efficacy Analysis Set - Induction|Protocol Violation|0
4939389|NCT00385736|16995287|P1|Efficacy Analysis Set - Induction|Protocol Violation|0
4939390|NCT00385736|16995285|P3|Efficacy Analysis Set - Induction|Lack of Efficacy|1
4939391|NCT00385736|16995286|P2|Efficacy Analysis Set - Induction|Lack of Efficacy|2
4939392|NCT00385736|16995287|P1|Efficacy Analysis Set - Induction|Lack of Efficacy|4
4939393|NCT00385736|16995285|P3|Efficacy Analysis Set - Induction|Lost to Follow-up|0
4939394|NCT00385736|16995286|P2|Efficacy Analysis Set - Induction|Lost to Follow-up|2
4939395|NCT00385736|16995287|P1|Efficacy Analysis Set - Induction|Lost to Follow-up|0
4939396|NCT00385736|16995285|P3|Efficacy Analysis Set - Induction|Withdrawal by Subject|1
4939397|NCT00385736|16995286|P2|Efficacy Analysis Set - Induction|Withdrawal by Subject|2
4939398|NCT00385736|16995287|P1|Efficacy Analysis Set - Induction|Withdrawal by Subject|0
4939399|NCT00385736|16995285|P3|Efficacy Analysis Set - Induction|Adverse Event|4
4939400|NCT00385736|16995286|P2|Efficacy Analysis Set - Induction|Adverse Event|6
4939401|NCT00385736|16995287|P1|Efficacy Analysis Set - Induction|Adverse Event|5
4939402|NCT00385723|16995332|P3|Overall Study|Withdrawal by Subject|2
4939403|NCT00385723|16995333|P2|Overall Study|Withdrawal by Subject|0
4939404|NCT00385723|16995334|P1|Overall Study|Withdrawal by Subject|1
4939405|NCT00385723|16995332|P3|Overall Study|Lost to Follow-up|0
4939406|NCT00385723|16995333|P2|Overall Study|Lost to Follow-up|1
4939407|NCT00385723|16995334|P1|Overall Study|Lost to Follow-up|1
4939408|NCT00385684|16995348|P2|SECOND INTERVENTION OF PHASE A|study drug recall|1
4939409|NCT00385684|16995349|P1|SECOND INTERVENTION OF PHASE A|study drug recall|0
4939410|NCT00385684|16995348|P2|SECOND INTERVENTION OF PHASE A|Adverse Event|1
4939411|NCT00385684|16995349|P1|SECOND INTERVENTION OF PHASE A|Adverse Event|0
4939412|NCT00385684|16995348|P2|FIRST INTERVENTION OF PHASE A|Death|0
4939413|NCT00385684|16995349|P1|FIRST INTERVENTION OF PHASE A|Death|1
4939414|NCT00385671|16995358|P3|Overall Study|Withdrawal by Subject|4
4939415|NCT00385671|16995359|P2|Overall Study|Withdrawal by Subject|4
4939416|NCT00385671|16995360|P1|Overall Study|Withdrawal by Subject|4
4939417|NCT00385671|16995358|P3|Overall Study|Sponsor Decision|1
4939418|NCT00385671|16995359|P2|Overall Study|Sponsor Decision|2
4939419|NCT00385671|16995360|P1|Overall Study|Sponsor Decision|2
4939420|NCT00385671|16995358|P3|Overall Study|Protocol Violation|1
4939421|NCT00385671|16995359|P2|Overall Study|Protocol Violation|2
4939422|NCT00385671|16995360|P1|Overall Study|Protocol Violation|5
4939423|NCT00385671|16995358|P3|Overall Study|Physician Decision|2
4939424|NCT00385671|16995359|P2|Overall Study|Physician Decision|1
4939425|NCT00385671|16995360|P1|Overall Study|Physician Decision|2
4939426|NCT00385671|16995358|P3|Overall Study|Lost to Follow-up|5
4939427|NCT00385671|16995359|P2|Overall Study|Lost to Follow-up|6
4939428|NCT00385671|16995360|P1|Overall Study|Lost to Follow-up|6
4939429|NCT00385671|16995358|P3|Overall Study|Lack of Efficacy|5
4939430|NCT00385671|16995359|P2|Overall Study|Lack of Efficacy|9
4939431|NCT00385671|16995360|P1|Overall Study|Lack of Efficacy|5
4939432|NCT00385671|16995358|P3|Overall Study|Adverse Event|18
4939433|NCT00385671|16995359|P2|Overall Study|Adverse Event|27
4939434|NCT00385671|16995360|P1|Overall Study|Adverse Event|14
4939435|NCT00385593|16995516|P2|Overall Study|Incorrect randomization|1
4939436|NCT00385593|16995517|P1|Overall Study|Incorrect randomization|0
4939437|NCT00385593|16995516|P2|Overall Study|Incorrect inclusion|0
4939438|NCT00385593|16995517|P1|Overall Study|Incorrect inclusion|2
4939439|NCT00385593|16995516|P2|Overall Study|Several reasons|15
4939440|NCT00385593|16995517|P1|Overall Study|Several reasons|17
4939441|NCT00385593|16995516|P2|Overall Study|Protocol Violation|4
4939442|NCT00385593|16995517|P1|Overall Study|Protocol Violation|7
4939443|NCT00385593|16995516|P2|Overall Study|Lost to Follow-up|8
4939444|NCT00385593|16995517|P1|Overall Study|Lost to Follow-up|12
4939445|NCT00385593|16995516|P2|Overall Study|Withdrawal by Subject|7
4939446|NCT00385593|16995517|P1|Overall Study|Withdrawal by Subject|17
4939447|NCT00385593|16995516|P2|Overall Study|Adverse Event|2
4939448|NCT00385593|16995517|P1|Overall Study|Adverse Event|3
4939449|NCT00385541|16995627|P2|Overall Study|severe pain, clinician requested unblind|1
4939450|NCT00385541|16995628|P1|Overall Study|severe pain, clinician requested unblind|0
4939451|NCT00385255|16995662|P2|Overall Study|Lost to Follow-up|58
4939452|NCT00385255|16995663|P1|Overall Study|Lost to Follow-up|20
4939453|NCT00385255|16995662|P2|Overall Study|Migrated/moved from study area|1
4939454|NCT00385255|16995663|P1|Overall Study|Migrated/moved from study area|0
4939455|NCT00385255|16995662|P2|Overall Study|Withdrawal by Subject|8
4939456|NCT00385255|16995663|P1|Overall Study|Withdrawal by Subject|0
4939457|NCT00385255|16995662|P2|Overall Study|Protocol Violation|4
4939458|NCT00385255|16995663|P1|Overall Study|Protocol Violation|0
4939459|NCT00385255|16995662|P2|Overall Study|Serious Adverse Event|2
4939460|NCT00385255|16995663|P1|Overall Study|Serious Adverse Event|1
4939461|NCT00385203|16995742|P2|Overall Study|Incorrect enrollment|0
4939462|NCT00385203|16995743|P1|Overall Study|Incorrect enrollment|2
4939463|NCT00385203|16995742|P2|Overall Study|Condition under investigation worsened|3
4939464|NCT00385203|16995743|P1|Overall Study|Condition under investigation worsened|18
4939465|NCT00385203|16995742|P2|Overall Study|Death|0
4939466|NCT00385203|16995743|P1|Overall Study|Death|1
4939467|NCT00385203|16995742|P2|Overall Study|Adverse Event|4
4939468|NCT00385203|16995743|P1|Overall Study|Adverse Event|5
4939469|NCT00384956|16995831|P1|Overall Study|Ineligible (acute myeloid leukemia)|3
4939470|NCT00384930|16995848|P5|Overall Study|Didn't Receive Double-Blind Study Drug|0
4939471|NCT00384930|16995849|P4|Overall Study|Didn't Receive Double-Blind Study Drug|0
4939472|NCT00384930|16995850|P3|Overall Study|Didn't Receive Double-Blind Study Drug|0
4939473|NCT00384930|16995851|P2|Overall Study|Didn't Receive Double-Blind Study Drug|1
4939474|NCT00384930|16995852|P1|Overall Study|Didn't Receive Double-Blind Study Drug|1
4939475|NCT00384930|16995848|P5|Overall Study|Withdrawal by Subject|16
4939476|NCT00384930|16995849|P4|Overall Study|Withdrawal by Subject|6
4939477|NCT00384930|16995850|P3|Overall Study|Withdrawal by Subject|7
4939478|NCT00384930|16995851|P2|Overall Study|Withdrawal by Subject|7
4939479|NCT00384930|16995852|P1|Overall Study|Withdrawal by Subject|9
4939480|NCT00384930|16995848|P5|Overall Study|Sponsor Decision|0
4939481|NCT00384930|16995849|P4|Overall Study|Sponsor Decision|5
4939482|NCT00384930|16995850|P3|Overall Study|Sponsor Decision|0
4939483|NCT00384930|16995851|P2|Overall Study|Sponsor Decision|4
4939484|NCT00384930|16995852|P1|Overall Study|Sponsor Decision|3
4939485|NCT00384930|16995848|P5|Overall Study|Protocol Violation|4
4939486|NCT00384930|16995849|P4|Overall Study|Protocol Violation|6
4939487|NCT00384930|16995850|P3|Overall Study|Protocol Violation|1
4939488|NCT00384930|16995851|P2|Overall Study|Protocol Violation|0
4939489|NCT00384930|16995852|P1|Overall Study|Protocol Violation|1
4939490|NCT00384930|16995848|P5|Overall Study|Physician Decision|1
4939491|NCT00384930|16995849|P4|Overall Study|Physician Decision|0
4939492|NCT00384930|16995850|P3|Overall Study|Physician Decision|1
4939493|NCT00384930|16995851|P2|Overall Study|Physician Decision|1
4939494|NCT00384930|16995852|P1|Overall Study|Physician Decision|0
4939495|NCT00384930|16995848|P5|Overall Study|Lost to Follow-up|6
4939496|NCT00384930|16995849|P4|Overall Study|Lost to Follow-up|4
4939497|NCT00384930|16995850|P3|Overall Study|Lost to Follow-up|0
4939498|NCT00384930|16995851|P2|Overall Study|Lost to Follow-up|3
4939499|NCT00384930|16995852|P1|Overall Study|Lost to Follow-up|5
4939500|NCT00384930|16995848|P5|Overall Study|Lack of Efficacy|2
4939501|NCT00384930|16995849|P4|Overall Study|Lack of Efficacy|1
4939502|NCT00384930|16995850|P3|Overall Study|Lack of Efficacy|2
4939503|NCT00384930|16995851|P2|Overall Study|Lack of Efficacy|1
4939504|NCT00384930|16995852|P1|Overall Study|Lack of Efficacy|1
4939505|NCT00384930|16995848|P5|Overall Study|Entry Criteria Not Met|4
4939506|NCT00384930|16995849|P4|Overall Study|Entry Criteria Not Met|8
4939507|NCT00384930|16995850|P3|Overall Study|Entry Criteria Not Met|7
4939508|NCT00384930|16995851|P2|Overall Study|Entry Criteria Not Met|6
4939509|NCT00384930|16995852|P1|Overall Study|Entry Criteria Not Met|2
4939510|NCT00384930|16995848|P5|Overall Study|Adverse Event|14
4939511|NCT00384930|16995849|P4|Overall Study|Adverse Event|11
4939512|NCT00384930|16995850|P3|Overall Study|Adverse Event|12
4939513|NCT00384930|16995851|P2|Overall Study|Adverse Event|4
4939514|NCT00384930|16995852|P1|Overall Study|Adverse Event|5
4939515|NCT00384839|16995931|P1|Overall Study|Ineligible|2
4939516|NCT00384839|16995931|P1|Overall Study|Patient Request|1
4939517|NCT00384839|16995931|P1|Overall Study|Investigator Request|1
4939518|NCT00384839|16995931|P1|Overall Study|Adverse Event|4
4939519|NCT00384397|16996064|P3|Overall Study|Withdrawal by Subject|15
4939520|NCT00384397|16996065|P2|Overall Study|Withdrawal by Subject|17
4939521|NCT00384397|16996066|P1|Overall Study|Withdrawal by Subject|14
4939522|NCT00384397|16996064|P3|Overall Study|Lost to Follow-up|3
4939523|NCT00384397|16996065|P2|Overall Study|Lost to Follow-up|13
4939524|NCT00384397|16996066|P1|Overall Study|Lost to Follow-up|11
4939525|NCT00384397|16996064|P3|Overall Study|Protocol Violation|13
4939526|NCT00384397|16996065|P2|Overall Study|Protocol Violation|15
4939527|NCT00384397|16996066|P1|Overall Study|Protocol Violation|7
4939528|NCT00384397|16996064|P3|Overall Study|Adverse Event|2
4939529|NCT00384397|16996065|P2|Overall Study|Adverse Event|1
4939530|NCT00384397|16996066|P1|Overall Study|Adverse Event|0
4939531|NCT00384332|16996085|P2|Overall Study|Lost to Follow-up|0
4939532|NCT00384332|16996086|P1|Overall Study|Lost to Follow-up|4
4939533|NCT00384293|16996096|P3|Post-randomization Period|Patient Randomized in Error|1
4939534|NCT00384293|16996097|P2|Post-randomization Period|Patient Randomized in Error|0
4939535|NCT00384293|16996098|P1|Post-randomization Period|Patient Randomized in Error|0
4939536|NCT00384293|16996096|P3|Post-randomization Period|Trial Termination|204
4939537|NCT00384293|16996097|P2|Post-randomization Period|Trial Termination|180
4939538|NCT00384293|16996098|P1|Post-randomization Period|Trial Termination|0
4939539|NCT00384293|16996096|P3|Post-randomization Period|Withdrawal by Subject|6
4939540|NCT00384293|16996097|P2|Post-randomization Period|Withdrawal by Subject|8
4939541|NCT00384293|16996098|P1|Post-randomization Period|Withdrawal by Subject|0
4939542|NCT00384293|16996096|P3|Post-randomization Period|Protocol Violation|0
4939543|NCT00384293|16996097|P2|Post-randomization Period|Protocol Violation|1
4939544|NCT00384293|16996098|P1|Post-randomization Period|Protocol Violation|0
4939545|NCT00384293|16996096|P3|Post-randomization Period|Lost to Follow-up|1
4939546|NCT00384293|16996097|P2|Post-randomization Period|Lost to Follow-up|2
4939547|NCT00384293|16996098|P1|Post-randomization Period|Lost to Follow-up|0
4939548|NCT00384293|16996096|P3|Post-randomization Period|Adverse Event|7
4939549|NCT00384293|16996097|P2|Post-randomization Period|Adverse Event|23
4939550|NCT00384293|16996098|P1|Post-randomization Period|Adverse Event|0
4939551|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
4939552|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0
4939553|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1
4939554|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
4939555|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0
4939556|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2
4939557|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
4939558|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Trial Termination|0
4939559|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Trial Termination|16
4939560|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
4939561|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0
4939562|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340
4939563|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
4939564|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0
4939565|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24
4939566|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
4939567|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0
4939568|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1
4939569|NCT00384293|16996096|P3|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
4939570|NCT00384293|16996097|P2|MK0524A Active Run-In, Pre-randomization|Adverse Event|0
4939571|NCT00384293|16996098|P1|MK0524A Active Run-In, Pre-randomization|Adverse Event|120
4939572|NCT00384189|16996122|P4|Overall Study|Reason Not Specified|40
4939573|NCT00384189|16996123|P3|Overall Study|Reason Not Specified|58
4939574|NCT00384189|16996124|P2|Overall Study|Reason Not Specified|57
4939575|NCT00384189|16996125|P1|Overall Study|Reason Not Specified|50
4939576|NCT00384176|16996186|P3|Overall Study|Liver metastases, colon resec. planned|0
4939577|NCT00384176|16996187|P2|Overall Study|Liver metastases, colon resec. planned|0
4939578|NCT00384176|16996188|P1|Overall Study|Liver metastases, colon resec. planned|1
4939579|NCT00384176|16996186|P3|Overall Study|Physician Decision|0
4939580|NCT00384176|16996187|P2|Overall Study|Physician Decision|2
4939581|NCT00384176|16996188|P1|Overall Study|Physician Decision|0
4939582|NCT00384176|16996186|P3|Overall Study|Did not receive study treatment|1
4939583|NCT00384176|16996187|P2|Overall Study|Did not receive study treatment|1
4939584|NCT00384176|16996188|P1|Overall Study|Did not receive study treatment|0
4939585|NCT00384176|16996186|P3|Overall Study|Toxicity of treatment|0
4939586|NCT00384176|16996187|P2|Overall Study|Toxicity of treatment|0
4939587|NCT00384176|16996188|P1|Overall Study|Toxicity of treatment|1
4939588|NCT00384176|16996186|P3|Overall Study|Longer QTC as Visit 1|0
4939589|NCT00384176|16996187|P2|Overall Study|Longer QTC as Visit 1|0
4939590|NCT00384176|16996188|P1|Overall Study|Longer QTC as Visit 1|1
4939591|NCT00384176|16996186|P3|Overall Study|Incorrect enrol/elig crit not fulfilled|0
4939592|NCT00384176|16996187|P2|Overall Study|Incorrect enrol/elig crit not fulfilled|3
4939593|NCT00384176|16996188|P1|Overall Study|Incorrect enrol/elig crit not fulfilled|2
4939594|NCT00384176|16996186|P3|Overall Study|Lost to Follow-up|4
4939595|NCT00384176|16996187|P2|Overall Study|Lost to Follow-up|18
4939596|NCT00384176|16996188|P1|Overall Study|Lost to Follow-up|16
4939597|NCT00384176|16996186|P3|Overall Study|Withdrawal by Subject|22
4939598|NCT00384176|16996187|P2|Overall Study|Withdrawal by Subject|48
4939599|NCT00384176|16996188|P1|Overall Study|Withdrawal by Subject|52
4939600|NCT00384176|16996186|P3|Overall Study|Death|105
4939601|NCT00384176|16996187|P2|Overall Study|Death|247
4939602|NCT00384176|16996188|P1|Overall Study|Death|239
4939603|NCT00384085|16996214|P3|Overall Study|Patient required surgery|0
4939604|NCT00384085|16996215|P2|Overall Study|Patient required surgery|1
4939605|NCT00384085|16996216|P1|Overall Study|Patient required surgery|0
4939606|NCT00384085|16996214|P3|Overall Study|Patient moved|1
4939607|NCT00384085|16996215|P2|Overall Study|Patient moved|0
4939608|NCT00384085|16996216|P1|Overall Study|Patient moved|1
4939609|NCT00384085|16996214|P3|Overall Study|Sponsor decision|1
4939610|NCT00384085|16996215|P2|Overall Study|Sponsor decision|2
4939611|NCT00384085|16996216|P1|Overall Study|Sponsor decision|1
4939612|NCT00384085|16996214|P3|Overall Study|Loss of site personnel|1
4939613|NCT00384085|16996215|P2|Overall Study|Loss of site personnel|0
4939614|NCT00384085|16996216|P1|Overall Study|Loss of site personnel|1
4939615|NCT00384085|16996214|P3|Overall Study|Physician Decision|0
4939616|NCT00384085|16996215|P2|Overall Study|Physician Decision|0
4939617|NCT00384085|16996216|P1|Overall Study|Physician Decision|1
4939618|NCT00384085|16996214|P3|Overall Study|Patient non-compliant|5
4939619|NCT00384085|16996215|P2|Overall Study|Patient non-compliant|4
4939620|NCT00384085|16996216|P1|Overall Study|Patient non-compliant|4
4939621|NCT00384085|16996214|P3|Overall Study|Withdrawal by Subject|29
4939622|NCT00384085|16996215|P2|Overall Study|Withdrawal by Subject|19
4939623|NCT00384085|16996216|P1|Overall Study|Withdrawal by Subject|14
4939624|NCT00384085|16996214|P3|Overall Study|Progressive Disease|0
4939625|NCT00384085|16996215|P2|Overall Study|Progressive Disease|1
4939626|NCT00384085|16996216|P1|Overall Study|Progressive Disease|0
4939627|NCT00384085|16996214|P3|Overall Study|Lost to Follow-up|10
4939628|NCT00384085|16996215|P2|Overall Study|Lost to Follow-up|9
4939629|NCT00384085|16996216|P1|Overall Study|Lost to Follow-up|9
4939630|NCT00384085|16996214|P3|Overall Study|Protocol Violation|2
4939631|NCT00384085|16996215|P2|Overall Study|Protocol Violation|2
4939632|NCT00384085|16996216|P1|Overall Study|Protocol Violation|2
4939633|NCT00384085|16996214|P3|Overall Study|No longer Requires Study Treatment|1
4939634|NCT00384085|16996215|P2|Overall Study|No longer Requires Study Treatment|0
4939635|NCT00384085|16996216|P1|Overall Study|No longer Requires Study Treatment|1
4939636|NCT00384085|16996214|P3|Overall Study|Lack of Efficacy|2
4939637|NCT00384085|16996215|P2|Overall Study|Lack of Efficacy|3
4939638|NCT00384085|16996216|P1|Overall Study|Lack of Efficacy|0
4939639|NCT00384085|16996214|P3|Overall Study|Adverse Event|4
4939640|NCT00384085|16996215|P2|Overall Study|Adverse Event|5
4939641|NCT00384085|16996216|P1|Overall Study|Adverse Event|5
4939642|NCT00384059|16996242|P2|Toddler Dose|Failed to return|1
4939643|NCT00384059|16996243|P1|Toddler Dose|Failed to return|0
4939644|NCT00384059|16996242|P2|Toddler Dose|Lost to Follow-up|1
4939645|NCT00384059|16996243|P1|Toddler Dose|Lost to Follow-up|1
4939646|NCT00384059|16996242|P2|After Infant Series|Lost to Follow-up|1
4939647|NCT00384059|16996243|P1|After Infant Series|Lost to Follow-up|0
4939648|NCT00384059|16996242|P2|After Infant Series|Physician Decision|1
4939649|NCT00384059|16996243|P1|After Infant Series|Physician Decision|0
4939650|NCT00384059|16996242|P2|After Infant Series|Adverse Event|1
4939651|NCT00384059|16996243|P1|After Infant Series|Adverse Event|0
4939652|NCT00384059|16996242|P2|After Infant Series|Failed to Return|2
4939653|NCT00384059|16996243|P1|After Infant Series|Failed to Return|0
4939654|NCT00384059|16996242|P2|After Infant Series|Withdrawal by Subject|2
4939655|NCT00384059|16996243|P1|After Infant Series|Withdrawal by Subject|2
4939656|NCT00384059|16996242|P2|After Infant Series|Protocol Violation|3
4939657|NCT00384059|16996243|P1|After Infant Series|Protocol Violation|2
4939658|NCT00384059|16996242|P2|Infant Series|Lost to Follow-up|1
4939659|NCT00384059|16996243|P1|Infant Series|Lost to Follow-up|0
4939660|NCT00384059|16996242|P2|Infant Series|Protocol Violation|2
4939661|NCT00384059|16996243|P1|Infant Series|Protocol Violation|1
4939662|NCT00384059|16996242|P2|Infant Series|Adverse Event|2
4939663|NCT00384059|16996243|P1|Infant Series|Adverse Event|1
4939664|NCT00384059|16996242|P2|Infant Series|Withdrawal by Subject|2
4939665|NCT00384059|16996243|P1|Infant Series|Withdrawal by Subject|2
4939666|NCT00384059|16996242|P2|Infant Series|Not consented|6
4939667|NCT00384059|16996243|P1|Infant Series|Not consented|2
4939668|NCT00384033|16996293|P4|Overall Study|Randomized but not treated|2
4939669|NCT00384033|16996294|P3|Overall Study|Randomized but not treated|10
4939670|NCT00384033|16996295|P2|Overall Study|Randomized but not treated|7
4939671|NCT00384033|16996296|P1|Overall Study|Randomized but not treated|3
4939672|NCT00384033|16996293|P4|Overall Study|Lack of Efficacy|1
4939673|NCT00384033|16996294|P3|Overall Study|Lack of Efficacy|3
4939674|NCT00384033|16996295|P2|Overall Study|Lack of Efficacy|3
4939675|NCT00384033|16996296|P1|Overall Study|Lack of Efficacy|7
4939676|NCT00384033|16996293|P4|Overall Study|Withdrawal by Subject|2
4939677|NCT00384033|16996294|P3|Overall Study|Withdrawal by Subject|5
4939678|NCT00384033|16996295|P2|Overall Study|Withdrawal by Subject|2
4939679|NCT00384033|16996296|P1|Overall Study|Withdrawal by Subject|6
4939680|NCT00384033|16996293|P4|Overall Study|Protocol Violation|6
4939681|NCT00384033|16996294|P3|Overall Study|Protocol Violation|5
4939682|NCT00384033|16996295|P2|Overall Study|Protocol Violation|0
4939683|NCT00384033|16996296|P1|Overall Study|Protocol Violation|5
4939684|NCT00384033|16996293|P4|Overall Study|Other|0
4939685|NCT00384033|16996294|P3|Overall Study|Other|0
4939686|NCT00384033|16996295|P2|Overall Study|Other|0
4939687|NCT00384033|16996296|P1|Overall Study|Other|2
4939688|NCT00384033|16996293|P4|Overall Study|Lost to Follow-up|7
4939689|NCT00384033|16996294|P3|Overall Study|Lost to Follow-up|7
4939690|NCT00384033|16996295|P2|Overall Study|Lost to Follow-up|12
4939691|NCT00384033|16996296|P1|Overall Study|Lost to Follow-up|6
4939692|NCT00384033|16996293|P4|Overall Study|Physician Decision|0
4939693|NCT00384033|16996294|P3|Overall Study|Physician Decision|0
4939694|NCT00384033|16996295|P2|Overall Study|Physician Decision|0
4939695|NCT00384033|16996296|P1|Overall Study|Physician Decision|1
4939696|NCT00384033|16996293|P4|Overall Study|Failed to return|2
4939697|NCT00384033|16996294|P3|Overall Study|Failed to return|2
4939698|NCT00384033|16996295|P2|Overall Study|Failed to return|3
4939699|NCT00384033|16996296|P1|Overall Study|Failed to return|1
4939700|NCT00384033|16996293|P4|Overall Study|Adverse Event|20
4939701|NCT00384033|16996294|P3|Overall Study|Adverse Event|11
4939702|NCT00384033|16996295|P2|Overall Study|Adverse Event|8
4939703|NCT00384033|16996296|P1|Overall Study|Adverse Event|10
4939704|NCT00383786|16996349|P2|Overall Study|Physician Decision|1
4939705|NCT00383786|16996350|P1|Overall Study|Physician Decision|0
4939706|NCT00383786|16996349|P2|Overall Study|Withdrawal by Subject|5
4939707|NCT00383786|16996350|P1|Overall Study|Withdrawal by Subject|2
4939708|NCT00383786|16996349|P2|Overall Study|Protocol Violation|6
4939709|NCT00383786|16996350|P1|Overall Study|Protocol Violation|2
4939710|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Administrative|0
4939711|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Administrative|1
4939712|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Administrative|3
4939713|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Administrative|2
4939714|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Administrative|1
4939715|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4939716|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4939717|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4939718|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4939719|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4939720|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
4939721|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|4
4939722|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4939723|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4939724|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|2
4939725|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Participant withdrawal related|0
4939726|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Participant withdrawal related|1
4939727|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Participant withdrawal related|1
4939728|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Participant withdrawal related|1
4939729|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
4939730|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
4939731|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7
4939732|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
4939733|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4
4939734|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
4939735|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Lost to Follow-up|0
4939736|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Lost to Follow-up|1
4939737|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
4939738|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Lost to Follow-up|0
4939739|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Lost to Follow-up|2
4939740|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
4939741|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
4939742|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Lack of Efficacy|4
4939743|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Lack of Efficacy|2
4939744|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Lack of Efficacy|0
4939745|NCT00383721|16996400|P5|26-Week Treatment Safety Extension|Adverse Event|0
4939746|NCT00383721|16996401|P4|26-Week Treatment Safety Extension|Adverse Event|1
4939747|NCT00383721|16996402|P3|26-Week Treatment Safety Extension|Adverse Event|10
4939748|NCT00383721|16996403|P2|26-Week Treatment Safety Extension|Adverse Event|7
4939749|NCT00383721|16996404|P1|26-Week Treatment Safety Extension|Adverse Event|6
4939750|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Ongoing|0
4939751|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Ongoing|0
4939752|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Ongoing|0
4939753|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Ongoing|0
4939754|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Ongoing|1
4939755|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Administrative|3
4939756|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Administrative|3
4939757|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Administrative|3
4939758|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Administrative|3
4939759|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Administrative|1
4939760|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13
4939761|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4
4939762|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11
4939763|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
4939764|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
4939765|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
4939766|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6
4939767|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
4939768|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
4939769|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7
4939770|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|9
4939771|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|8
4939772|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|6
4939773|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
4939774|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|5
4939775|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11
4939776|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
4939777|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15
4939778|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
4939779|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4
4939780|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|4
4939781|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
4939782|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
4939783|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
4939784|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|0
4939785|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
4939786|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|4
4939787|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4939788|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4939789|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|1
4939790|NCT00383721|16996400|P5|26-Week Double-Blind Treatment Period|Adverse Event|13
4939791|NCT00383721|16996401|P4|26-Week Double-Blind Treatment Period|Adverse Event|14
4939792|NCT00383721|16996402|P3|26-Week Double-Blind Treatment Period|Adverse Event|7
4939793|NCT00383721|16996403|P2|26-Week Double-Blind Treatment Period|Adverse Event|5
4939794|NCT00383721|16996404|P1|26-Week Double-Blind Treatment Period|Adverse Event|11
4939795|NCT00383708|16996441|P1|Co-administration Period|Adverse Event|5
4939796|NCT00383708|16996441|P1|Run-in Period|Claustrophobia|1
4939797|NCT00383708|16996441|P1|Run-in Period|Adverse Event|2
4939798|NCT00383708|16996441|P1|Run-in Period|Protocol Violation|4
4939799|NCT00383708|16996441|P1|Enrolment Through Start Treatment|Did not meet entry criteria|32
4939800|NCT00383708|16996441|P1|Enrolment Through Start Treatment|Withdrawal by Subject|1
4939801|NCT00383552|16996516|P4|Overall Study|Administrative|1
4939802|NCT00383552|16996517|P3|Overall Study|Administrative|1
4939803|NCT00383552|16996518|P2|Overall Study|Administrative|0
4939804|NCT00383552|16996519|P1|Overall Study|Administrative|1
4939805|NCT00383552|16996516|P4|Overall Study|Did not meet protocol eligibility|3
4939806|NCT00383552|16996517|P3|Overall Study|Did not meet protocol eligibility|2
4939807|NCT00383552|16996518|P2|Overall Study|Did not meet protocol eligibility|6
4939808|NCT00383552|16996519|P1|Overall Study|Did not meet protocol eligibility|8
4939809|NCT00383552|16996516|P4|Overall Study|Noncompliance with the protocol|10
4939810|NCT00383552|16996517|P3|Overall Study|Noncompliance with the protocol|8
4939811|NCT00383552|16996518|P2|Overall Study|Noncompliance with the protocol|6
4939812|NCT00383552|16996519|P1|Overall Study|Noncompliance with the protocol|11
4939813|NCT00383552|16996516|P4|Overall Study|Did not wish to continue (related)|3
4939814|NCT00383552|16996517|P3|Overall Study|Did not wish to continue (related)|2
4939815|NCT00383552|16996518|P2|Overall Study|Did not wish to continue (related)|0
4939816|NCT00383552|16996519|P1|Overall Study|Did not wish to continue (related)|1
4939817|NCT00383552|16996516|P4|Overall Study|Did not wish to continue (unrelated)|6
4939818|NCT00383552|16996517|P3|Overall Study|Did not wish to continue (unrelated)|5
4939819|NCT00383552|16996518|P2|Overall Study|Did not wish to continue (unrelated)|9
4939820|NCT00383552|16996519|P1|Overall Study|Did not wish to continue (unrelated)|4
4939821|NCT00383552|16996516|P4|Overall Study|Lost to Follow-up|1
4939822|NCT00383552|16996517|P3|Overall Study|Lost to Follow-up|5
4939823|NCT00383552|16996518|P2|Overall Study|Lost to Follow-up|1
4939824|NCT00383552|16996519|P1|Overall Study|Lost to Follow-up|0
4939825|NCT00383552|16996516|P4|Overall Study|Lack of Efficacy|42
4939826|NCT00383552|16996517|P3|Overall Study|Lack of Efficacy|29
4939827|NCT00383552|16996518|P2|Overall Study|Lack of Efficacy|13
4939828|NCT00383552|16996519|P1|Overall Study|Lack of Efficacy|4
4939829|NCT00383552|16996516|P4|Overall Study|Adverse Event|6
4939830|NCT00383552|16996517|P3|Overall Study|Adverse Event|9
4939831|NCT00383552|16996518|P2|Overall Study|Adverse Event|6
4939832|NCT00383552|16996519|P1|Overall Study|Adverse Event|7
4939833|NCT00383500|16996561|P3|Overall Study|Lost to Follow-up|2
4939834|NCT00383500|16996562|P2|Overall Study|Lost to Follow-up|0
4939835|NCT00383500|16996563|P1|Overall Study|Lost to Follow-up|0
4939836|NCT00383500|16996561|P3|Overall Study|Withdrawal by Subject|0
4939837|NCT00383500|16996562|P2|Overall Study|Withdrawal by Subject|3
4939838|NCT00383500|16996563|P1|Overall Study|Withdrawal by Subject|8
4939839|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Administrative|0
4939840|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Administrative|1
4939841|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Administrative|0
4939842|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Administrative|1
4939843|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Administrative|1
4939844|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4939845|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4939846|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4939847|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0
4939848|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1
4939849|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Non-compliance with protocol|0
4939850|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4939851|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4939852|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Non-compliance with protocol|1
4939853|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Non-compliance with protocol|4
4939854|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Participant withdrawal related|1
4939855|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Participant withdrawal related|0
4939856|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Participant withdrawal related|2
4939857|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Participant withdrawal related|0
4939858|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Participant withdrawal related|1
4939859|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0
4939860|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
4939861|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6
4939862|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
4939863|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2
4939864|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Lost to Follow-up|1
4939865|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Lost to Follow-up|0
4939866|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Lost to Follow-up|1
4939867|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Lost to Follow-up|2
4939868|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Lost to Follow-up|0
4939869|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Lack of Efficacy|0
4939870|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Lack of Efficacy|1
4939871|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Lack of Efficacy|1
4939872|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Lack of Efficacy|1
4939873|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Lack of Efficacy|1
4939874|NCT00383435|16996587|P5|26-Week Treatment Safety Extension|Adverse Event|1
4939875|NCT00383435|16996588|P4|26-Week Treatment Safety Extension|Adverse Event|5
4939876|NCT00383435|16996589|P3|26-Week Treatment Safety Extension|Adverse Event|5
4939877|NCT00383435|16996590|P2|26-Week Treatment Safety Extension|Adverse Event|2
4939878|NCT00383435|16996591|P1|26-Week Treatment Safety Extension|Adverse Event|4
4939879|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Administrative|1
4939880|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Administrative|1
4939881|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Administrative|1
4939882|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Administrative|3
4939883|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Administrative|5
4939884|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6
4939885|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5
4939886|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9
4939887|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8
4939888|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10
4939889|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4
4939890|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
4939891|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3
4939892|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5
4939893|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1
4939894|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
4939895|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
4939896|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Participant withdrawal related|7
4939897|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Participant withdrawal related|3
4939898|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Participant withdrawal related|2
4939899|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17
4939900|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10
4939901|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14
4939902|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12
4939903|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7
4939904|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
4939905|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Lost to Follow-up|2
4939906|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Lost to Follow-up|1
4939907|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
4939908|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Lost to Follow-up|3
4939909|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Lack of Efficacy|8
4939910|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Lack of Efficacy|5
4939911|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4939912|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Lack of Efficacy|2
4939913|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Lack of Efficacy|3
4939914|NCT00383435|16996587|P5|26-Week Double-Blind Treatment Period|Adverse Event|8
4939915|NCT00383435|16996588|P4|26-Week Double-Blind Treatment Period|Adverse Event|6
4939916|NCT00383435|16996589|P3|26-Week Double-Blind Treatment Period|Adverse Event|8
4939917|NCT00383435|16996590|P2|26-Week Double-Blind Treatment Period|Adverse Event|2
4939918|NCT00383435|16996591|P1|26-Week Double-Blind Treatment Period|Adverse Event|10
4939919|NCT00383331|16996630|P2|Overall Study|Protocol Violation|1
4939920|NCT00383331|16996631|P1|Overall Study|Protocol Violation|0
4939921|NCT00383292|16996650|P3|Overall Study|Other|0
4939922|NCT00383292|16996651|P2|Overall Study|Other|0
4939923|NCT00383292|16996652|P1|Overall Study|Other|1
4939924|NCT00383292|16996650|P3|Overall Study|Withdrawal by Subject|2
4939925|NCT00383292|16996651|P2|Overall Study|Withdrawal by Subject|2
4939926|NCT00383292|16996652|P1|Overall Study|Withdrawal by Subject|3
4939927|NCT00383292|16996650|P3|Overall Study|Physician Decision|1
4939928|NCT00383292|16996651|P2|Overall Study|Physician Decision|0
4939929|NCT00383292|16996652|P1|Overall Study|Physician Decision|4
4939930|NCT00383292|16996650|P3|Overall Study|Death|3
4939931|NCT00383292|16996651|P2|Overall Study|Death|3
4939932|NCT00383292|16996652|P1|Overall Study|Death|3
4939933|NCT00383292|16996650|P3|Overall Study|Adverse Event|2
4939934|NCT00383292|16996651|P2|Overall Study|Adverse Event|1
4939935|NCT00383292|16996652|P1|Overall Study|Adverse Event|4
4939936|NCT00383240|16996693|P4|Overall Study|Administrative|0
4939937|NCT00383240|16996694|P3|Overall Study|Administrative|0
4939938|NCT00383240|16996695|P2|Overall Study|Administrative|1
4939939|NCT00383240|16996696|P1|Overall Study|Administrative|1
4939940|NCT00383240|16996693|P4|Overall Study|Did not meet protocol eligibility|3
4939941|NCT00383240|16996694|P3|Overall Study|Did not meet protocol eligibility|9
4939942|NCT00383240|16996695|P2|Overall Study|Did not meet protocol eligibility|4
4939943|NCT00383240|16996696|P1|Overall Study|Did not meet protocol eligibility|9
4939944|NCT00383240|16996693|P4|Overall Study|Protocol Violation|6
4939945|NCT00383240|16996694|P3|Overall Study|Protocol Violation|9
4939946|NCT00383240|16996695|P2|Overall Study|Protocol Violation|5
4939947|NCT00383240|16996696|P1|Overall Study|Protocol Violation|4
4939948|NCT00383240|16996693|P4|Overall Study|Withdrawal by subjects, reasons related|5
4939949|NCT00383240|16996694|P3|Overall Study|Withdrawal by subjects, reasons related|3
4939950|NCT00383240|16996695|P2|Overall Study|Withdrawal by subjects, reasons related|1
4939951|NCT00383240|16996696|P1|Overall Study|Withdrawal by subjects, reasons related|0
4939952|NCT00383240|16996693|P4|Overall Study|Withdrawal by subject, reasons unrelated|8
4939953|NCT00383240|16996694|P3|Overall Study|Withdrawal by subject, reasons unrelated|8
4939954|NCT00383240|16996695|P2|Overall Study|Withdrawal by subject, reasons unrelated|3
4939955|NCT00383240|16996696|P1|Overall Study|Withdrawal by subject, reasons unrelated|6
4939956|NCT00383240|16996693|P4|Overall Study|Lost to Follow-up|2
4939957|NCT00383240|16996694|P3|Overall Study|Lost to Follow-up|0
4939958|NCT00383240|16996695|P2|Overall Study|Lost to Follow-up|0
4939959|NCT00383240|16996696|P1|Overall Study|Lost to Follow-up|3
4939960|NCT00383240|16996693|P4|Overall Study|Treatment Failure|46
4939961|NCT00383240|16996694|P3|Overall Study|Treatment Failure|47
4939962|NCT00383240|16996695|P2|Overall Study|Treatment Failure|13
4939963|NCT00383240|16996696|P1|Overall Study|Treatment Failure|8
4939964|NCT00383240|16996693|P4|Overall Study|Adverse Event|7
4939965|NCT00383240|16996694|P3|Overall Study|Adverse Event|9
4939966|NCT00383240|16996695|P2|Overall Study|Adverse Event|6
4939967|NCT00383240|16996696|P1|Overall Study|Adverse Event|4
4939968|NCT00383162|16996727|P2|Migraine Attack 2 (Period 2)|Unknown reason|3
4939969|NCT00383162|16996728|P1|Migraine Attack 2 (Period 2)|Unknown reason|0
4939970|NCT00383162|16996727|P2|Migraine Attack 2 (Period 2)|Adverse Event|0
4939971|NCT00383162|16996728|P1|Migraine Attack 2 (Period 2)|Adverse Event|1
4939972|NCT00383162|16996727|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
4939973|NCT00383162|16996728|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
4939974|NCT00383162|16996727|P2|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3
4939975|NCT00383162|16996728|P1|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1
4939976|NCT00383162|16996727|P2|Migraine Attack 1 (Period 1)|Non-compliant|0
4939977|NCT00383162|16996728|P1|Migraine Attack 1 (Period 1)|Non-compliant|3
4939978|NCT00383162|16996727|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0
4939979|NCT00383162|16996728|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2
4939980|NCT00383162|16996727|P2|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2
4939981|NCT00383162|16996728|P1|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4
4939982|NCT00383162|16996727|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
4939983|NCT00383162|16996728|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|8
4939984|NCT00383162|16996727|P2|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4
4939985|NCT00383162|16996728|P1|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3
4939986|NCT00383149|16996770|P1|Overall Study|Participant Withdrew Consent|1
4939987|NCT00383149|16996770|P1|Overall Study|Request to Discontinue Treatment|4
4939988|NCT00383149|16996770|P1|Overall Study|Study Drug Toxicity|4
4939989|NCT00383149|16996770|P1|Overall Study|Other|1
4939990|NCT00383149|16996770|P1|Overall Study|Lost to Follow-up|1
4939991|NCT00383149|16996770|P1|Overall Study|Disease Progression|38
4939992|NCT00383149|16996770|P1|Overall Study|Death|2
4939993|NCT00383149|16996770|P1|Overall Study|Adverse Event not Related to Study Drug|3
4939994|NCT00383123|16996789|P2|Overall Study|Other reason|6
4939995|NCT00383123|16996790|P1|Overall Study|Other reason|10
4939996|NCT00383123|16996789|P2|Overall Study|Withdrawal by Subject|18
4939997|NCT00383123|16996790|P1|Overall Study|Withdrawal by Subject|27
4939998|NCT00383123|16996789|P2|Overall Study|Protocol Violation|1
4939999|NCT00383123|16996790|P1|Overall Study|Protocol Violation|5
4940000|NCT00383123|16996789|P2|Overall Study|Lost to Follow-up|61
4940001|NCT00383123|16996790|P1|Overall Study|Lost to Follow-up|68
4940002|NCT00383123|16996789|P2|Overall Study|Adverse Event|0
4940003|NCT00383123|16996790|P1|Overall Study|Adverse Event|1
4940004|NCT00383084|16996831|P2|Overall Study|Withdrawal by Subject|10
4940005|NCT00383084|16996832|P1|Overall Study|Withdrawal by Subject|12
4940006|NCT00383019|16996863|P2|Overall Study|Withdrawal by Subject|1
4940007|NCT00383019|16996864|P1|Overall Study|Withdrawal by Subject|0
4940008|NCT00383019|16996863|P2|Overall Study|Adverse Event|1
4940009|NCT00383019|16996864|P1|Overall Study|Adverse Event|5
4940010|NCT00382993|16996886|P2|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
4940011|NCT00382993|16996887|P1|Migraine Attack 2 (Period 2)|Other (no additional data present)|1
4940012|NCT00382993|16996886|P2|Migraine Attack 2 (Period 2)|Protocol Violation|1
4940013|NCT00382993|16996887|P1|Migraine Attack 2 (Period 2)|Protocol Violation|0
4940014|NCT00382993|16996886|P2|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1
4940015|NCT00382993|16996887|P1|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0
4940016|NCT00382993|16996886|P2|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1
4940017|NCT00382993|16996887|P1|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0
4940018|NCT00382993|16996886|P2|Migraine Attack 2 (Period 2)|Lost to Follow-up|0
4940019|NCT00382993|16996887|P1|Migraine Attack 2 (Period 2)|Lost to Follow-up|1
4940020|NCT00382993|16996886|P2|Migraine Attack 1 (Period 1)|Other (no additional data present)|5
4940021|NCT00382993|16996887|P1|Migraine Attack 1 (Period 1)|Other (no additional data present)|3
4940022|NCT00382993|16996886|P2|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
4940023|NCT00382993|16996887|P1|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3
4940024|NCT00382993|16996886|P2|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5
4940025|NCT00382993|16996887|P1|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0
4940026|NCT00382993|16996886|P2|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3
4940027|NCT00382993|16996887|P1|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1
4940028|NCT00382993|16996886|P2|Migraine Attack 1 (Period 1)|Lost to Follow-up|2
4940029|NCT00382993|16996887|P1|Migraine Attack 1 (Period 1)|Lost to Follow-up|7
4940030|NCT00382967|16996931|P2|Overall Study|Protocol Violation|1
4940031|NCT00382967|16996932|P1|Overall Study|Protocol Violation|1
4940032|NCT00382863|16996957|P2|Overall Study|Withdrawal by Subject|25
4940033|NCT00382863|16996958|P1|Overall Study|Withdrawal by Subject|5
4940034|NCT00382863|16996957|P2|Overall Study|Lost to Follow-up|2
4940035|NCT00382863|16996958|P1|Overall Study|Lost to Follow-up|1
4940036|NCT00382863|16996957|P2|Overall Study|Death|9
4940037|NCT00382863|16996958|P1|Overall Study|Death|9
4940038|NCT00382733|16997042|P5|Overall Study|Withdrawal by Subject|0
4940039|NCT00382733|16997043|P4|Overall Study|Withdrawal by Subject|0
4940040|NCT00382733|16997044|P3|Overall Study|Withdrawal by Subject|0
4940041|NCT00382733|16997045|P2|Overall Study|Withdrawal by Subject|1
4940042|NCT00382733|16997046|P1|Overall Study|Withdrawal by Subject|0
4940043|NCT00382720|16997067|P3|Overall Study|Discontinued at end of study|2
4940044|NCT00382720|16997068|P2|Overall Study|Discontinued at end of study|1
4940045|NCT00382720|16997069|P1|Overall Study|Discontinued at end of study|0
4940046|NCT00382720|16997067|P3|Overall Study|Investigator/Clinical decision|6
4940047|NCT00382720|16997068|P2|Overall Study|Investigator/Clinical decision|6
4940048|NCT00382720|16997069|P1|Overall Study|Investigator/Clinical decision|5
4940049|NCT00382720|16997067|P3|Overall Study|Good prognosis|0
4940050|NCT00382720|16997068|P2|Overall Study|Good prognosis|1
4940051|NCT00382720|16997069|P1|Overall Study|Good prognosis|0
4940052|NCT00382720|16997067|P3|Overall Study|Clinically progressive disease|0
4940053|NCT00382720|16997068|P2|Overall Study|Clinically progressive disease|1
4940054|NCT00382720|16997069|P1|Overall Study|Clinically progressive disease|0
4940055|NCT00382720|16997067|P3|Overall Study|Patient did not receive study medication|4
4940056|NCT00382720|16997068|P2|Overall Study|Patient did not receive study medication|1
4940057|NCT00382720|16997069|P1|Overall Study|Patient did not receive study medication|1
4940058|NCT00382720|16997067|P3|Overall Study|Surgery|4
4940059|NCT00382720|16997068|P2|Overall Study|Surgery|1
4940060|NCT00382720|16997069|P1|Overall Study|Surgery|1
4940061|NCT00382720|16997067|P3|Overall Study|Withdrawal by Subject|12
4940062|NCT00382720|16997068|P2|Overall Study|Withdrawal by Subject|20
4940063|NCT00382720|16997069|P1|Overall Study|Withdrawal by Subject|11
4940064|NCT00382720|16997067|P3|Overall Study|Withdrew consent|2
4940065|NCT00382720|16997068|P2|Overall Study|Withdrew consent|1
4940066|NCT00382720|16997069|P1|Overall Study|Withdrew consent|1
4940067|NCT00382720|16997067|P3|Overall Study|Progressive disease|38
4940068|NCT00382720|16997068|P2|Overall Study|Progressive disease|28
4940069|NCT00382720|16997069|P1|Overall Study|Progressive disease|37
4940070|NCT00382720|16997067|P3|Overall Study|Death|2
4940071|NCT00382720|16997068|P2|Overall Study|Death|1
4940072|NCT00382720|16997069|P1|Overall Study|Death|0
4940073|NCT00382720|16997067|P3|Overall Study|Protocol Violation|1
4940074|NCT00382720|16997068|P2|Overall Study|Protocol Violation|5
4940075|NCT00382720|16997069|P1|Overall Study|Protocol Violation|2
4940076|NCT00382720|16997067|P3|Overall Study|Adverse Event|15
4940077|NCT00382720|16997068|P2|Overall Study|Adverse Event|23
4940078|NCT00382720|16997069|P1|Overall Study|Adverse Event|21
4940079|NCT00382408|16997094|P2|Overall Study|Other|35
4940080|NCT00382408|16997095|P1|Overall Study|Other|100
4940081|NCT00382408|16997094|P2|Overall Study|Lost to Follow-up|8
4940082|NCT00382408|16997095|P1|Overall Study|Lost to Follow-up|19
4940083|NCT00382408|16997094|P2|Overall Study|Pregnancy|0
4940084|NCT00382408|16997095|P1|Overall Study|Pregnancy|2
4940085|NCT00382408|16997094|P2|Overall Study|Withdrawal by Subject|6
4940086|NCT00382408|16997095|P1|Overall Study|Withdrawal by Subject|17
4940087|NCT00382408|16997094|P2|Overall Study|Physician Decision|0
4940088|NCT00382408|16997095|P1|Overall Study|Physician Decision|1
4940089|NCT00382408|16997094|P2|Overall Study|Protocol Violation|2
4940090|NCT00382408|16997095|P1|Overall Study|Protocol Violation|2
4940091|NCT00382408|16997094|P2|Overall Study|Did not meet protocol requirement|3
4940092|NCT00382408|16997095|P1|Overall Study|Did not meet protocol requirement|3
4940093|NCT00382291|16997122|P3|Overall Study|Lack of Efficacy|1
4940094|NCT00382291|16997123|P2|Overall Study|Lack of Efficacy|0
4940095|NCT00382291|16997124|P1|Overall Study|Lack of Efficacy|0
4940096|NCT00382291|16997122|P3|Overall Study|Physician Decision|0
4940097|NCT00382291|16997123|P2|Overall Study|Physician Decision|1
4940098|NCT00382291|16997124|P1|Overall Study|Physician Decision|0
4940099|NCT00382291|16997122|P3|Overall Study|Withdrawal by Subject|0
4940100|NCT00382291|16997123|P2|Overall Study|Withdrawal by Subject|2
4940101|NCT00382291|16997124|P1|Overall Study|Withdrawal by Subject|0
4940102|NCT00382291|16997122|P3|Overall Study|Temporary study suspension|5
4940103|NCT00382291|16997123|P2|Overall Study|Temporary study suspension|2
4940104|NCT00382291|16997124|P1|Overall Study|Temporary study suspension|2
4940105|NCT00382291|16997122|P3|Overall Study|Protocol Violation|0
4940106|NCT00382291|16997123|P2|Overall Study|Protocol Violation|0
4940107|NCT00382291|16997124|P1|Overall Study|Protocol Violation|1
4940108|NCT00382291|16997122|P3|Overall Study|Adverse Event|2
4940109|NCT00382291|16997123|P2|Overall Study|Adverse Event|2
4940110|NCT00382291|16997124|P1|Overall Study|Adverse Event|1
4940111|NCT00382174|16997156|P3|Overall Study|Wounds merged|2
4940112|NCT00382174|16997157|P2|Overall Study|Wounds merged|2
4940113|NCT00382174|16997158|P1|Overall Study|Wounds merged|0
4940114|NCT00382174|16997156|P3|Overall Study|Failed to meet criteria|1
4940115|NCT00382174|16997157|P2|Overall Study|Failed to meet criteria|1
4940116|NCT00382174|16997158|P1|Overall Study|Failed to meet criteria|0
4940117|NCT00382174|16997156|P3|Overall Study|Physician Decision|2
4940118|NCT00382174|16997157|P2|Overall Study|Physician Decision|2
4940119|NCT00382174|16997158|P1|Overall Study|Physician Decision|0
4940120|NCT00382174|16997156|P3|Overall Study|Non compliance|1
4940121|NCT00382174|16997157|P2|Overall Study|Non compliance|0
4940122|NCT00382174|16997158|P1|Overall Study|Non compliance|1
4940123|NCT00382174|16997156|P3|Overall Study|Withdrawal by Subject|5
4940124|NCT00382174|16997157|P2|Overall Study|Withdrawal by Subject|4
4940125|NCT00382174|16997158|P1|Overall Study|Withdrawal by Subject|1
4940126|NCT00382174|16997156|P3|Overall Study|Adverse Event|5
4940127|NCT00382174|16997157|P2|Overall Study|Adverse Event|4
4940128|NCT00382174|16997158|P1|Overall Study|Adverse Event|1
4940129|NCT00382174|16997156|P3|Overall Study|Lost to Follow-up|5
4940130|NCT00382174|16997157|P2|Overall Study|Lost to Follow-up|4
4940131|NCT00382174|16997158|P1|Overall Study|Lost to Follow-up|1
4940132|NCT00382109|16997186|P2|Overall Study|consent withdrawal|1
4940133|NCT00382109|16997187|P1|Overall Study|consent withdrawal|0
4940134|NCT00382109|16997186|P2|Overall Study|Other|2
4940135|NCT00382109|16997187|P1|Overall Study|Other|0
4940136|NCT00382109|16997186|P2|Overall Study|ineligible|0
4940137|NCT00382109|16997187|P1|Overall Study|ineligible|2
4940138|NCT00382109|16997186|P2|Overall Study|Withdrawal by Subject|0
4940139|NCT00382109|16997187|P1|Overall Study|Withdrawal by Subject|1
4940140|NCT00382109|16997186|P2|Overall Study|Physician Decision|1
4940141|NCT00382109|16997187|P1|Overall Study|Physician Decision|6
4940142|NCT00382109|16997186|P2|Overall Study|Adverse Event|0
4940143|NCT00382109|16997187|P1|Overall Study|Adverse Event|3
4940144|NCT00382018|16997226|P4|Overall Study|Other, not protocol specified|1
4940145|NCT00382018|16997227|P3|Overall Study|Other, not protocol specified|3
4940146|NCT00382018|16997228|P2|Overall Study|Other, not protocol specified|16
4940147|NCT00382018|16997229|P1|Overall Study|Other, not protocol specified|0
4940148|NCT00382018|16997226|P4|Overall Study|Withdrawal by Subject|4
4940149|NCT00382018|16997227|P3|Overall Study|Withdrawal by Subject|3
4940150|NCT00382018|16997228|P2|Overall Study|Withdrawal by Subject|4
4940151|NCT00382018|16997229|P1|Overall Study|Withdrawal by Subject|0
4940152|NCT00382018|16997226|P4|Overall Study|Death|11
4940153|NCT00382018|16997227|P3|Overall Study|Death|7
4940154|NCT00382018|16997228|P2|Overall Study|Death|9
4940155|NCT00382018|16997229|P1|Overall Study|Death|0
4940156|NCT00382018|16997226|P4|Overall Study|Progression|43
4940157|NCT00382018|16997227|P3|Overall Study|Progression|51
4940158|NCT00382018|16997228|P2|Overall Study|Progression|136
4940159|NCT00382018|16997229|P1|Overall Study|Progression|0
4940160|NCT00381940|16997252|P1|Overall Study|Ineligible|1
4940161|NCT00381940|16997252|P1|Overall Study|Protocol Violation|1
4940162|NCT00381940|16997252|P1|Overall Study|Lack of Efficacy|3
4940163|NCT00381888|16997256|P1|Overall Study|Adverse Event|1
4940164|NCT00381888|16997256|P1|Overall Study|Surgery was cancelled|2
4940165|NCT00381888|16997256|P1|Overall Study|Had laparoscopic surgery|2
4940166|NCT00381888|16997256|P1|Overall Study|Protocol Violation|9
4940167|NCT00381888|16997256|P1|Overall Study|Physician Decision|1
4940168|NCT00381888|16997256|P1|Overall Study|Withdrawal by Subject|1
4940169|NCT00381888|16997256|P1|Overall Study|Death|1
4940170|NCT00381849|16997267|P2|Wash Out|Withdrawal by Subject|1
4940171|NCT00381849|16997268|P1|Wash Out|Withdrawal by Subject|0
4940172|NCT00381797|16997295|P5|Overall Study|Ineligible|0
4940173|NCT00381797|16997296|P4|Overall Study|Ineligible|1
4940174|NCT00381797|16997297|P3|Overall Study|Ineligible|0
4940175|NCT00381797|16997298|P2|Overall Study|Ineligible|0
4940176|NCT00381797|16997299|P1|Overall Study|Ineligible|0
4940177|NCT00381797|16997295|P5|Overall Study|Withdrawal by Subject|2
4940178|NCT00381797|16997296|P4|Overall Study|Withdrawal by Subject|0
4940179|NCT00381797|16997297|P3|Overall Study|Withdrawal by Subject|0
4940180|NCT00381797|16997298|P2|Overall Study|Withdrawal by Subject|1
4940181|NCT00381797|16997299|P1|Overall Study|Withdrawal by Subject|1
4940182|NCT00381706|16997374|P3|Overall Study|Never treated|1
4940183|NCT00381706|16997375|P2|Overall Study|Never treated|2
4940184|NCT00381706|16997376|P1|Overall Study|Never treated|7
4940185|NCT00381693|16997399|P1|Overall Study|Progression|2
4940186|NCT00381693|16997399|P1|Overall Study|Patient Choice|1
4940187|NCT00381693|16997399|P1|Overall Study|Adverse Event|4
4940188|NCT00381693|16997399|P1|Overall Study|Death|1
4940189|NCT00381680|16997408|P2|Overall Study|Ineligible|1
4940190|NCT00381680|16997409|P1|Overall Study|Ineligible|3
4940191|NCT00381680|16997408|P2|Overall Study|Other not otherwise specified|2
4940192|NCT00381680|16997409|P1|Overall Study|Other not otherwise specified|7
4940193|NCT00381680|16997408|P2|Overall Study|Progression|1
4940194|NCT00381680|16997409|P1|Overall Study|Progression|1
4940195|NCT00381680|16997408|P2|Overall Study|Induction Failure|1
4940196|NCT00381680|16997409|P1|Overall Study|Induction Failure|4
4940197|NCT00381680|16997408|P2|Overall Study|Relapse|9
4940198|NCT00381680|16997409|P1|Overall Study|Relapse|18
4940199|NCT00381680|16997408|P2|Overall Study|Stem Cell Transplant|10
4940200|NCT00381680|16997409|P1|Overall Study|Stem Cell Transplant|26
4940201|NCT00381680|16997408|P2|Overall Study|Delay initiation|0
4940202|NCT00381680|16997409|P1|Overall Study|Delay initiation|1
4940203|NCT00381680|16997408|P2|Overall Study|Secondary Malignancy|0
4940204|NCT00381680|16997409|P1|Overall Study|Secondary Malignancy|3
4940205|NCT00381680|16997408|P2|Overall Study|Alternative Therapy|5
4940206|NCT00381680|16997409|P1|Overall Study|Alternative Therapy|11
4940207|NCT00381680|16997408|P2|Overall Study|Entry onto another COG Trial|2
4940208|NCT00381680|16997409|P1|Overall Study|Entry onto another COG Trial|1
4940209|NCT00381680|16997408|P2|Overall Study|Withdrawal by Subject|1
4940210|NCT00381680|16997409|P1|Overall Study|Withdrawal by Subject|3
4940211|NCT00381680|16997408|P2|Overall Study|Physician Decision|6
4940212|NCT00381680|16997409|P1|Overall Study|Physician Decision|25
4940213|NCT00381680|16997408|P2|Overall Study|Lost to Follow-up|2
4940214|NCT00381680|16997409|P1|Overall Study|Lost to Follow-up|3
4940215|NCT00381680|16997408|P2|Overall Study|Death|7
4940216|NCT00381680|16997409|P1|Overall Study|Death|10
4940217|NCT00381680|16997408|P2|Overall Study|Adverse Event|3
4940218|NCT00381680|16997409|P1|Overall Study|Adverse Event|9
4940219|NCT00381641|16997426|P2|Overall Study|Withdrawal by Subject|2
4940220|NCT00381641|16997427|P1|Overall Study|Withdrawal by Subject|0
4940221|NCT00381615|16997460|P4|Overall Study|Protocol Violation|0
4940222|NCT00381615|16997461|P3|Overall Study|Protocol Violation|1
4940223|NCT00381615|16997462|P2|Overall Study|Protocol Violation|0
4940224|NCT00381615|16997463|P1|Overall Study|Protocol Violation|0
4940225|NCT00381615|16997460|P4|Overall Study|Lost to Follow-up|1
4940226|NCT00381615|16997461|P3|Overall Study|Lost to Follow-up|0
4940227|NCT00381615|16997462|P2|Overall Study|Lost to Follow-up|2
4940228|NCT00381615|16997463|P1|Overall Study|Lost to Follow-up|3
4940229|NCT00381615|16997460|P4|Overall Study|Withdrawal by Subject|1
4940230|NCT00381615|16997461|P3|Overall Study|Withdrawal by Subject|0
4940231|NCT00381615|16997462|P2|Overall Study|Withdrawal by Subject|3
4940232|NCT00381615|16997463|P1|Overall Study|Withdrawal by Subject|1
4940233|NCT00381563|16997515|P2|Overall Study|Protocol Violation|1
4940234|NCT00381563|16997516|P1|Overall Study|Protocol Violation|0
4940235|NCT00381563|16997515|P2|Overall Study|Lost to Follow-up|0
4940236|NCT00381563|16997516|P1|Overall Study|Lost to Follow-up|2
4940237|NCT00381563|16997515|P2|Overall Study|Withdrawal by Subject|5
4940238|NCT00381563|16997516|P1|Overall Study|Withdrawal by Subject|5
4940239|NCT00381485|16997531|P4|Double-Blind Treatment Period|Administrative|1
4940240|NCT00381485|16997532|P3|Double-Blind Treatment Period|Administrative|0
4940241|NCT00381485|16997533|P2|Double-Blind Treatment Period|Administrative|1
4940242|NCT00381485|16997534|P1|Double-Blind Treatment Period|Administrative|0
4940243|NCT00381485|16997531|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1
4940244|NCT00381485|16997532|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
4940245|NCT00381485|16997533|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
4940246|NCT00381485|16997534|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0
4940247|NCT00381485|16997531|P4|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4
4940248|NCT00381485|16997532|P3|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1
4940249|NCT00381485|16997533|P2|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2
4940250|NCT00381485|16997534|P1|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0
4940251|NCT00381485|16997531|P4|Double-Blind Treatment Period|Did not meet protocol eligibility|5
4940252|NCT00381485|16997532|P3|Double-Blind Treatment Period|Did not meet protocol eligibility|7
4940253|NCT00381485|16997533|P2|Double-Blind Treatment Period|Did not meet protocol eligibility|5
4940254|NCT00381485|16997534|P1|Double-Blind Treatment Period|Did not meet protocol eligibility|0
4940255|NCT00381485|16997531|P4|Double-Blind Treatment Period|Noncompliance with protocol|3
4940256|NCT00381485|16997532|P3|Double-Blind Treatment Period|Noncompliance with protocol|3
4940257|NCT00381485|16997533|P2|Double-Blind Treatment Period|Noncompliance with protocol|9
4940258|NCT00381485|16997534|P1|Double-Blind Treatment Period|Noncompliance with protocol|0
4940259|NCT00381485|16997531|P4|Double-Blind Treatment Period|Lost to Follow-up|1
4940260|NCT00381485|16997532|P3|Double-Blind Treatment Period|Lost to Follow-up|1
4940261|NCT00381485|16997533|P2|Double-Blind Treatment Period|Lost to Follow-up|0
4940262|NCT00381485|16997534|P1|Double-Blind Treatment Period|Lost to Follow-up|0
4940263|NCT00381485|16997531|P4|Double-Blind Treatment Period|Lack of Efficacy|13
4940264|NCT00381485|16997532|P3|Double-Blind Treatment Period|Lack of Efficacy|11
4940265|NCT00381485|16997533|P2|Double-Blind Treatment Period|Lack of Efficacy|8
4940266|NCT00381485|16997534|P1|Double-Blind Treatment Period|Lack of Efficacy|0
4940267|NCT00381485|16997531|P4|Double-Blind Treatment Period|Adverse Event|5
4940268|NCT00381485|16997532|P3|Double-Blind Treatment Period|Adverse Event|2
4940269|NCT00381485|16997533|P2|Double-Blind Treatment Period|Adverse Event|2
4940270|NCT00381485|16997534|P1|Double-Blind Treatment Period|Adverse Event|0
4940271|NCT00381485|16997531|P4|Open-Label Run-In Period|Treatment failure|0
4940272|NCT00381485|16997532|P3|Open-Label Run-In Period|Treatment failure|0
4940273|NCT00381485|16997533|P2|Open-Label Run-In Period|Treatment failure|0
4940274|NCT00381485|16997534|P1|Open-Label Run-In Period|Treatment failure|1
4940275|NCT00381485|16997531|P4|Open-Label Run-In Period|Lost to Follow-up|0
4940276|NCT00381485|16997532|P3|Open-Label Run-In Period|Lost to Follow-up|0
4940277|NCT00381485|16997533|P2|Open-Label Run-In Period|Lost to Follow-up|0
4940278|NCT00381485|16997534|P1|Open-Label Run-In Period|Lost to Follow-up|3
4940279|NCT00381485|16997531|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
4940280|NCT00381485|16997532|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
4940281|NCT00381485|16997533|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0
4940282|NCT00381485|16997534|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1
4940283|NCT00381485|16997531|P4|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
4940284|NCT00381485|16997532|P3|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
4940285|NCT00381485|16997533|P2|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0
4940286|NCT00381485|16997534|P1|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16
4940287|NCT00381485|16997531|P4|Open-Label Run-In Period|Did not meet protocol eligibility|0
4940288|NCT00381485|16997532|P3|Open-Label Run-In Period|Did not meet protocol eligibility|0
4940289|NCT00381485|16997533|P2|Open-Label Run-In Period|Did not meet protocol eligibility|0
4940290|NCT00381485|16997534|P1|Open-Label Run-In Period|Did not meet protocol eligibility|76
4940291|NCT00381485|16997531|P4|Open-Label Run-In Period|Adverse Event|0
4940292|NCT00381485|16997532|P3|Open-Label Run-In Period|Adverse Event|0
4940293|NCT00381485|16997533|P2|Open-Label Run-In Period|Adverse Event|0
4940294|NCT00381485|16997534|P1|Open-Label Run-In Period|Adverse Event|9
4940295|NCT00381381|16997552|P1|Overall Study|Withdrawal by Subject|9
4940296|NCT00381381|16997552|P1|Overall Study|Lost to Follow-up|52
4940297|NCT00381381|16997552|P1|Overall Study|Adverse Event|3
4940298|NCT00381303|16997561|P2|Overall Study|Subject primary physician's decision|0
4940299|NCT00381303|16997562|P1|Overall Study|Subject primary physician's decision|1
4940300|NCT00381303|16997561|P2|Overall Study|Subject did not continue visits|0
4940301|NCT00381303|16997562|P1|Overall Study|Subject did not continue visits|1
4940302|NCT00381303|16997561|P2|Overall Study|Subject was too busy for appointments|0
4940303|NCT00381303|16997562|P1|Overall Study|Subject was too busy for appointments|1
4940304|NCT00381303|16997561|P2|Overall Study|No virologic response by week 12|0
4940305|NCT00381303|16997562|P1|Overall Study|No virologic response by week 12|1
4940306|NCT00381303|16997561|P2|Overall Study|Subject taking too many different meds|0
4940307|NCT00381303|16997562|P1|Overall Study|Subject taking too many different meds|1
4940308|NCT00381303|16997561|P2|Overall Study|Subject moved out of state|0
4940309|NCT00381303|16997562|P1|Overall Study|Subject moved out of state|2
4940310|NCT00381303|16997561|P2|Overall Study|Physician's decision to close the site|1
4940311|NCT00381303|16997562|P1|Overall Study|Physician's decision to close the site|3
4940312|NCT00381303|16997561|P2|Overall Study|Physician Decision|0
4940313|NCT00381303|16997562|P1|Overall Study|Physician Decision|1
4940314|NCT00381303|16997561|P2|Overall Study|Pregnancy|0
4940315|NCT00381303|16997562|P1|Overall Study|Pregnancy|2
4940316|NCT00381303|16997561|P2|Overall Study|Ineligible to continue the trial|1
4940317|NCT00381303|16997562|P1|Overall Study|Ineligible to continue the trial|2
4940318|NCT00381303|16997561|P2|Overall Study|Virologic failure|4
4940319|NCT00381303|16997562|P1|Overall Study|Virologic failure|6
4940320|NCT00381303|16997561|P2|Overall Study|Withdrawal by Subject|6
4940321|NCT00381303|16997562|P1|Overall Study|Withdrawal by Subject|13
4940322|NCT00381303|16997561|P2|Overall Study|Non-Adherence|6
4940323|NCT00381303|16997562|P1|Overall Study|Non-Adherence|13
4940324|NCT00381303|16997561|P2|Overall Study|AE/HIV-related event|6
4940325|NCT00381303|16997562|P1|Overall Study|AE/HIV-related event|22
4940326|NCT00381303|16997561|P2|Overall Study|Lost to Follow-up|9
4940327|NCT00381303|16997562|P1|Overall Study|Lost to Follow-up|25
4940328|NCT00381238|16997622|P1|Overall Study|Disease progression|1
4940329|NCT00381238|16997622|P1|Overall Study|Withdrew by physician|1
4940330|NCT00381238|16997622|P1|Overall Study|Lack of Efficacy|2
4940331|NCT00381238|16997622|P1|Overall Study|Withdrawal by Subject|4
4940332|NCT00381238|16997622|P1|Overall Study|Protocol Violation|1
4940333|NCT00381238|16997622|P1|Overall Study|Adverse Event|3
4940334|NCT00381095|16997638|P2|Overall Study|Adverse Event|7
4940335|NCT00381095|16997639|P1|Overall Study|Adverse Event|2
4940336|NCT00381095|16997638|P2|Overall Study|Withdrawal by Subject|3
4940337|NCT00381095|16997639|P1|Overall Study|Withdrawal by Subject|3
4940338|NCT00381095|16997638|P2|Overall Study|Protocol Violation|1
4940339|NCT00381095|16997639|P1|Overall Study|Protocol Violation|1
4940340|NCT00381095|16997638|P2|Overall Study|Other|2
4940341|NCT00381095|16997639|P1|Overall Study|Other|2
4940342|NCT00381095|16997638|P2|Overall Study|Lack of Efficacy|4
4940343|NCT00381095|16997639|P1|Overall Study|Lack of Efficacy|2
4940344|NCT00381095|16997638|P2|Overall Study|Death|4
4940345|NCT00381095|16997639|P1|Overall Study|Death|3
4940346|NCT00381043|16997671|P2|Overall Study|incarcerated|0
4940347|NCT00381043|16997672|P1|Overall Study|incarcerated|1
4940348|NCT00381043|16997671|P2|Overall Study|wanted more care|1
4940349|NCT00381043|16997672|P1|Overall Study|wanted more care|0
4940350|NCT00381043|16997671|P2|Overall Study|Withdrawal by Subject|1
4940351|NCT00381043|16997672|P1|Overall Study|Withdrawal by Subject|3
4940352|NCT00381043|16997671|P2|Overall Study|Lost to Follow-up|6
4940353|NCT00381043|16997672|P1|Overall Study|Lost to Follow-up|8
4940354|NCT00380978|16997698|P2|Overall Study|Parous patient|0
4940355|NCT00380978|16997699|P1|Overall Study|Parous patient|1
4940356|NCT00380978|16997698|P2|Overall Study|Allocation prior to analgesia request|2
4940357|NCT00380978|16997699|P1|Overall Study|Allocation prior to analgesia request|1
4940358|NCT00380978|16997698|P2|Overall Study|Wrong study envelope|2
4940359|NCT00380978|16997699|P1|Overall Study|Wrong study envelope|0
4940360|NCT00380978|16997698|P2|Overall Study|Refused allocated intervention|6
4940361|NCT00380978|16997699|P1|Overall Study|Refused allocated intervention|0
4940362|NCT00380874|16997721|P2|Overall Study|Not related to study drug|2
4940363|NCT00380874|16997722|P1|Overall Study|Not related to study drug|3
4940364|NCT00380874|16997721|P2|Overall Study|Withdrawal by Subject|1
4940365|NCT00380874|16997722|P1|Overall Study|Withdrawal by Subject|2
4940366|NCT00380874|16997721|P2|Overall Study|Death|0
4940367|NCT00380874|16997722|P1|Overall Study|Death|1
4940368|NCT00380874|16997721|P2|Overall Study|Adverse Event|7
4940369|NCT00380874|16997722|P1|Overall Study|Adverse Event|7
4940370|NCT00380744|16997754|P7|Overall Study|Withdrawal by Subject|0
4940371|NCT00380744|16997755|P6|Overall Study|Withdrawal by Subject|0
4940372|NCT00380744|16997756|P5|Overall Study|Withdrawal by Subject|0
4940373|NCT00380744|16997757|P4|Overall Study|Withdrawal by Subject|0
4940374|NCT00380744|16997758|P3|Overall Study|Withdrawal by Subject|0
4940375|NCT00380744|16997759|P2|Overall Study|Withdrawal by Subject|0
4940376|NCT00380744|16997760|P1|Overall Study|Withdrawal by Subject|1
4940377|NCT00380744|16997754|P7|Overall Study|Death|1
4940378|NCT00380744|16997755|P6|Overall Study|Death|0
4940379|NCT00380744|16997756|P5|Overall Study|Death|0
4940380|NCT00380744|16997757|P4|Overall Study|Death|0
4940381|NCT00380744|16997758|P3|Overall Study|Death|0
4940382|NCT00380744|16997759|P2|Overall Study|Death|0
4940383|NCT00380744|16997760|P1|Overall Study|Death|0
4940384|NCT00380718|16997810|P1|Overall Study|Death after 30-day post-therapy followup|17
4940385|NCT00380718|16997810|P1|Overall Study|Adverse Event|1
4940386|NCT00380692|16997822|P2|Study Period III - Open Label|Parent/Caregiver Decision|1
4940387|NCT00380692|16997823|P1|Study Period III - Open Label|Parent/Caregiver Decision|1
4940388|NCT00380692|16997822|P2|Study Period III - Open Label|Lack of Efficacy|4
4940389|NCT00380692|16997823|P1|Study Period III - Open Label|Lack of Efficacy|0
4940390|NCT00380692|16997822|P2|Study Period III - Open Label|Physician Decision|3
4940391|NCT00380692|16997823|P1|Study Period III - Open Label|Physician Decision|0
4940392|NCT00380692|16997822|P2|Study Period III - Open Label|Withdrawal by Subject|1
4940393|NCT00380692|16997823|P1|Study Period III - Open Label|Withdrawal by Subject|0
4940394|NCT00380692|16997822|P2|Study Period III - Open Label|Protocol Violation|0
4940395|NCT00380692|16997823|P1|Study Period III - Open Label|Protocol Violation|0
4940396|NCT00380692|16997822|P2|Study Period III - Open Label|Adverse Event|3
4940397|NCT00380692|16997823|P1|Study Period III - Open Label|Adverse Event|5
4940398|NCT00380692|16997822|P2|Study Period II - Double Blind|Parent/Caregiver Decision|0
4940399|NCT00380692|16997823|P1|Study Period II - Double Blind|Parent/Caregiver Decision|1
4940400|NCT00380692|16997822|P2|Study Period II - Double Blind|Lack of Efficacy|0
4940401|NCT00380692|16997823|P1|Study Period II - Double Blind|Lack of Efficacy|1
4940402|NCT00380692|16997822|P2|Study Period II - Double Blind|Physician Decision|1
4940403|NCT00380692|16997823|P1|Study Period II - Double Blind|Physician Decision|0
4940404|NCT00380692|16997822|P2|Study Period II - Double Blind|Withdrawal by Subject|0
4940405|NCT00380692|16997823|P1|Study Period II - Double Blind|Withdrawal by Subject|0
4940406|NCT00380692|16997822|P2|Study Period II - Double Blind|Protocol Violation|2
4940407|NCT00380692|16997823|P1|Study Period II - Double Blind|Protocol Violation|2
4940408|NCT00380692|16997822|P2|Study Period II - Double Blind|Adverse Event|0
4940409|NCT00380692|16997823|P1|Study Period II - Double Blind|Adverse Event|1
4940410|NCT00380588|16997871|P2|Overall Study|Physician Decision|0
4940411|NCT00380588|16997872|P1|Overall Study|Physician Decision|2
4940412|NCT00380588|16997871|P2|Overall Study|Withdrawal by Subject|3
4940413|NCT00380588|16997872|P1|Overall Study|Withdrawal by Subject|1
4940414|NCT00380588|16997871|P2|Overall Study|Adverse Event|3
4940415|NCT00380588|16997872|P1|Overall Study|Adverse Event|7
4940416|NCT00380588|16997871|P2|Overall Study|Next Cycle Not Started|0
4940417|NCT00380588|16997872|P1|Overall Study|Next Cycle Not Started|4
4940418|NCT00380588|16997871|P2|Overall Study|Unequivocal Disease Progression|34
4940419|NCT00380588|16997872|P1|Overall Study|Unequivocal Disease Progression|25
4940420|NCT00380393|16997886|P2|Month 14|Others|6
4940421|NCT00380393|16997887|P1|Month 14|Others|6
4940422|NCT00380393|16997886|P2|Month 14|Protocol Violation|0
4940423|NCT00380393|16997887|P1|Month 14|Protocol Violation|2
4940424|NCT00380393|16997886|P2|Month 14|Migrated/moved from study area|42
4940425|NCT00380393|16997887|P1|Month 14|Migrated/moved from study area|39
4940426|NCT00380393|16997886|P2|Month 14|Lost to Follow-up|1
4940427|NCT00380393|16997887|P1|Month 14|Lost to Follow-up|0
4940428|NCT00380393|16997886|P2|Month 14|Death|0
4940429|NCT00380393|16997887|P1|Month 14|Death|1
4940430|NCT00380393|16997886|P2|Month 14|Withdrawal by Subject|7
4940431|NCT00380393|16997887|P1|Month 14|Withdrawal by Subject|9
4940432|NCT00380393|16997886|P2|Month 8 (Cross-sectional Visit)|Others|4
4940433|NCT00380393|16997887|P1|Month 8 (Cross-sectional Visit)|Others|5
4940434|NCT00380393|16997886|P2|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
4940435|NCT00380393|16997887|P1|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1
4940436|NCT00380393|16997886|P2|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29
4940437|NCT00380393|16997887|P1|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37
4940438|NCT00380393|16997886|P2|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1
4940439|NCT00380393|16997887|P1|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0
4940440|NCT00380393|16997886|P2|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5
4940441|NCT00380393|16997887|P1|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6
4940442|NCT00380367|16997935|P1|Overall Study|Withdrawal by Subject|1
4940443|NCT00380367|16997935|P1|Overall Study|Lost to Follow-up|1
4940444|NCT00380250|16997942|P2|Overall Study|Physician Decision|0
4940445|NCT00380250|16997943|P1|Overall Study|Physician Decision|1
4940446|NCT00380250|16997942|P2|Overall Study|Lost to Follow-up|5
4940447|NCT00380250|16997943|P1|Overall Study|Lost to Follow-up|14
4940448|NCT00380250|16997942|P2|Overall Study|Protocol Violation|5
4940449|NCT00380250|16997943|P1|Overall Study|Protocol Violation|15
4940450|NCT00380250|16997942|P2|Overall Study|Lack of Efficacy|8
4940451|NCT00380250|16997943|P1|Overall Study|Lack of Efficacy|10
4940452|NCT00380250|16997942|P2|Overall Study|Adverse Event|9
4940453|NCT00380250|16997943|P1|Overall Study|Adverse Event|20
4940454|NCT00380250|16997942|P2|Overall Study|Withdrawal by Subject|28
4940455|NCT00380250|16997943|P1|Overall Study|Withdrawal by Subject|39
4940456|NCT00380081|16998011|P6|Overall Study|Family Emergency|1
4940457|NCT00380081|16998012|P5|Overall Study|Family Emergency|0
4940458|NCT00380081|16998013|P4|Overall Study|Family Emergency|0
4940459|NCT00380081|16998014|P3|Overall Study|Family Emergency|0
4940460|NCT00380081|16998015|P2|Overall Study|Family Emergency|0
4940461|NCT00380081|16998016|P1|Overall Study|Family Emergency|0
4940462|NCT00380081|16998011|P6|Overall Study|Withdrawal by Subject|0
4940463|NCT00380081|16998012|P5|Overall Study|Withdrawal by Subject|1
4940464|NCT00380081|16998013|P4|Overall Study|Withdrawal by Subject|0
4940465|NCT00380081|16998014|P3|Overall Study|Withdrawal by Subject|0
4940466|NCT00380081|16998015|P2|Overall Study|Withdrawal by Subject|0
4940467|NCT00380081|16998016|P1|Overall Study|Withdrawal by Subject|0
4940468|NCT00380068|16998066|P1|Overall Study|Lack of Efficacy|5
4940469|NCT00380068|16998066|P1|Overall Study|Partipant moved away|1
4940470|NCT00380068|16998066|P1|Overall Study|Physician Decision|2
4940471|NCT00380068|16998066|P1|Overall Study|Lung transplant|3
4940472|NCT00380068|16998066|P1|Overall Study|Addition of other PAH therapeutic agent|1
4940473|NCT00380068|16998066|P1|Overall Study|Lost to Follow-up|1
4940474|NCT00380068|16998066|P1|Overall Study|Not compliant|6
4940475|NCT00380068|16998066|P1|Overall Study|Withdrawal by Subject|10
4940476|NCT00380068|16998066|P1|Overall Study|Adverse Event|40
4940477|NCT00379912|16998098|P2|Overall Study|Lack of Efficacy|0
4940478|NCT00379912|16998099|P1|Overall Study|Lack of Efficacy|1
4940479|NCT00379899|16998121|P2|Overall Study|Other|1
4940480|NCT00379899|16998122|P1|Overall Study|Other|3
4940481|NCT00379899|16998121|P2|Overall Study|Other protocol-specified criteria|4
4940482|NCT00379899|16998122|P1|Overall Study|Other protocol-specified criteria|3
4940483|NCT00379899|16998121|P2|Overall Study|Coronary artery bypass graft|1
4940484|NCT00379899|16998122|P1|Overall Study|Coronary artery bypass graft|1
4940485|NCT00379899|16998121|P2|Overall Study|Renal transplantation|4
4940486|NCT00379899|16998122|P1|Overall Study|Renal transplantation|5
4940487|NCT00379899|16998121|P2|Overall Study|Parathyroidectomy|2
4940488|NCT00379899|16998122|P1|Overall Study|Parathyroidectomy|0
4940489|NCT00379899|16998121|P2|Overall Study|Noncompliance|1
4940490|NCT00379899|16998122|P1|Overall Study|Noncompliance|1
4940491|NCT00379899|16998121|P2|Overall Study|Ineligibility determined|1
4940492|NCT00379899|16998122|P1|Overall Study|Ineligibility determined|0
4940493|NCT00379899|16998121|P2|Overall Study|Withdrawal by Subject|5
4940494|NCT00379899|16998122|P1|Overall Study|Withdrawal by Subject|5
4940495|NCT00379899|16998121|P2|Overall Study|Physician Decision|4
4940496|NCT00379899|16998122|P1|Overall Study|Physician Decision|3
4940497|NCT00379899|16998121|P2|Overall Study|Lost to Follow-up|4
4940498|NCT00379899|16998122|P1|Overall Study|Lost to Follow-up|2
4940499|NCT00379899|16998121|P2|Overall Study|Death|10
4940500|NCT00379899|16998122|P1|Overall Study|Death|10
4940501|NCT00379899|16998121|P2|Overall Study|Adverse Event|3
4940502|NCT00379899|16998122|P1|Overall Study|Adverse Event|7
4940503|NCT00379834|16998150|P1|Overall Study|Time constraints|2
4940504|NCT00379808|16998302|P2|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1
4940505|NCT00379808|16998303|P1|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0
4940506|NCT00379795|16998324|P5|Overall Study|Sponsor's decision|10
4940507|NCT00379795|16998325|P4|Overall Study|Sponsor's decision|47
4940508|NCT00379795|16998326|P3|Overall Study|Sponsor's decision|54
4940509|NCT00379795|16998327|P2|Overall Study|Sponsor's decision|17
4940510|NCT00379795|16998328|P1|Overall Study|Sponsor's decision|257
4940511|NCT00379795|16998324|P5|Overall Study|Subjects condition mandated intervention|7
4940512|NCT00379795|16998325|P4|Overall Study|Subjects condition mandated intervention|5
4940513|NCT00379795|16998326|P3|Overall Study|Subjects condition mandated intervention|7
4940514|NCT00379795|16998327|P2|Overall Study|Subjects condition mandated intervention|9
4940515|NCT00379795|16998328|P1|Overall Study|Subjects condition mandated intervention|34
4940516|NCT00379795|16998324|P5|Overall Study|Verteporfin photodynamic therapy in eye|0
4940517|NCT00379795|16998325|P4|Overall Study|Verteporfin photodynamic therapy in eye|1
4940518|NCT00379795|16998326|P3|Overall Study|Verteporfin photodynamic therapy in eye|0
4940519|NCT00379795|16998327|P2|Overall Study|Verteporfin photodynamic therapy in eye|0
4940520|NCT00379795|16998328|P1|Overall Study|Verteporfin photodynamic therapy in eye|3
4940521|NCT00379795|16998324|P5|Overall Study|Subject non-compliance|1
4940522|NCT00379795|16998325|P4|Overall Study|Subject non-compliance|0
4940523|NCT00379795|16998326|P3|Overall Study|Subject non-compliance|0
4940524|NCT00379795|16998327|P2|Overall Study|Subject non-compliance|2
4940525|NCT00379795|16998328|P1|Overall Study|Subject non-compliance|7
4940526|NCT00379795|16998324|P5|Overall Study|Withdrawal by Subject|14
4940527|NCT00379795|16998325|P4|Overall Study|Withdrawal by Subject|7
4940528|NCT00379795|16998326|P3|Overall Study|Withdrawal by Subject|19
4940529|NCT00379795|16998327|P2|Overall Study|Withdrawal by Subject|11
4940530|NCT00379795|16998328|P1|Overall Study|Withdrawal by Subject|94
4940531|NCT00379795|16998324|P5|Overall Study|Physician Decision|2
4940532|NCT00379795|16998325|P4|Overall Study|Physician Decision|2
4940533|NCT00379795|16998326|P3|Overall Study|Physician Decision|2
4940534|NCT00379795|16998327|P2|Overall Study|Physician Decision|0
4940535|NCT00379795|16998328|P1|Overall Study|Physician Decision|25
4940536|NCT00379795|16998324|P5|Overall Study|Lost to Follow-up|4
4940537|NCT00379795|16998325|P4|Overall Study|Lost to Follow-up|1
4940538|NCT00379795|16998326|P3|Overall Study|Lost to Follow-up|2
4940539|NCT00379795|16998327|P2|Overall Study|Lost to Follow-up|1
4940540|NCT00379795|16998328|P1|Overall Study|Lost to Follow-up|8
4940541|NCT00379795|16998324|P5|Overall Study|Adverse Event|4
4940542|NCT00379795|16998325|P4|Overall Study|Adverse Event|1
4940543|NCT00379795|16998326|P3|Overall Study|Adverse Event|3
4940544|NCT00379795|16998327|P2|Overall Study|Adverse Event|3
4940545|NCT00379795|16998328|P1|Overall Study|Adverse Event|17
4940546|NCT00379795|16998324|P5|Overall Study|Death|7
4940547|NCT00379795|16998325|P4|Overall Study|Death|4
4940548|NCT00379795|16998326|P3|Overall Study|Death|6
4940549|NCT00379795|16998327|P2|Overall Study|Death|8
4940550|NCT00379795|16998328|P1|Overall Study|Death|31
4940551|NCT00379769|16998358|P6|Observational Follow-up|Unknown; Reason Not Provided|1
4940552|NCT00379769|16998359|P5|Observational Follow-up|Unknown; Reason Not Provided|1
4940553|NCT00379769|16998360|P4|Observational Follow-up|Unknown; Reason Not Provided|0
4940554|NCT00379769|16998361|P3|Observational Follow-up|Unknown; Reason Not Provided|0
4940555|NCT00379769|16998362|P2|Observational Follow-up|Unknown; Reason Not Provided|0
4940556|NCT00379769|16998363|P1|Observational Follow-up|Unknown; Reason Not Provided|0
4940557|NCT00379769|16998358|P6|Observational Follow-up|Participant Moved|1
4940558|NCT00379769|16998359|P5|Observational Follow-up|Participant Moved|0
4940559|NCT00379769|16998360|P4|Observational Follow-up|Participant Moved|0
4940560|NCT00379769|16998361|P3|Observational Follow-up|Participant Moved|0
4940561|NCT00379769|16998362|P2|Observational Follow-up|Participant Moved|0
4940562|NCT00379769|16998363|P1|Observational Follow-up|Participant Moved|0
4940563|NCT00379769|16998358|P6|Observational Follow-up|Site Closed Early|7
4940564|NCT00379769|16998359|P5|Observational Follow-up|Site Closed Early|6
4940565|NCT00379769|16998360|P4|Observational Follow-up|Site Closed Early|0
4940566|NCT00379769|16998361|P3|Observational Follow-up|Site Closed Early|0
4940567|NCT00379769|16998362|P2|Observational Follow-up|Site Closed Early|0
4940568|NCT00379769|16998363|P1|Observational Follow-up|Site Closed Early|0
4940569|NCT00379769|16998358|P6|Observational Follow-up|Physician Decision|8
4940570|NCT00379769|16998359|P5|Observational Follow-up|Physician Decision|8
4940571|NCT00379769|16998360|P4|Observational Follow-up|Physician Decision|0
4940572|NCT00379769|16998361|P3|Observational Follow-up|Physician Decision|0
4940573|NCT00379769|16998362|P2|Observational Follow-up|Physician Decision|0
4940574|NCT00379769|16998363|P1|Observational Follow-up|Physician Decision|0
4940575|NCT00379769|16998358|P6|Observational Follow-up|Entered into Another Clinical Trial|22
4940576|NCT00379769|16998359|P5|Observational Follow-up|Entered into Another Clinical Trial|18
4940577|NCT00379769|16998360|P4|Observational Follow-up|Entered into Another Clinical Trial|0
4940578|NCT00379769|16998361|P3|Observational Follow-up|Entered into Another Clinical Trial|0
4940579|NCT00379769|16998362|P2|Observational Follow-up|Entered into Another Clinical Trial|0
4940580|NCT00379769|16998363|P1|Observational Follow-up|Entered into Another Clinical Trial|0
4940581|NCT00379769|16998358|P6|Observational Follow-up|Withdrawal by Subject|12
4940582|NCT00379769|16998359|P5|Observational Follow-up|Withdrawal by Subject|12
4940583|NCT00379769|16998360|P4|Observational Follow-up|Withdrawal by Subject|0
4940584|NCT00379769|16998361|P3|Observational Follow-up|Withdrawal by Subject|0
4940585|NCT00379769|16998362|P2|Observational Follow-up|Withdrawal by Subject|0
4940586|NCT00379769|16998363|P1|Observational Follow-up|Withdrawal by Subject|0
4940587|NCT00379769|16998358|P6|Observational Follow-up|Lost to Follow-up|27
4940588|NCT00379769|16998359|P5|Observational Follow-up|Lost to Follow-up|25
4940589|NCT00379769|16998360|P4|Observational Follow-up|Lost to Follow-up|0
4940590|NCT00379769|16998361|P3|Observational Follow-up|Lost to Follow-up|0
4940591|NCT00379769|16998362|P2|Observational Follow-up|Lost to Follow-up|0
4940592|NCT00379769|16998363|P1|Observational Follow-up|Lost to Follow-up|0
4940593|NCT00379769|16998358|P6|Observational Follow-up|Adverse Event|0
4940594|NCT00379769|16998359|P5|Observational Follow-up|Adverse Event|1
4940595|NCT00379769|16998360|P4|Observational Follow-up|Adverse Event|0
4940596|NCT00379769|16998361|P3|Observational Follow-up|Adverse Event|0
4940597|NCT00379769|16998362|P2|Observational Follow-up|Adverse Event|0
4940598|NCT00379769|16998363|P1|Observational Follow-up|Adverse Event|0
4940599|NCT00379769|16998358|P6|Observational Follow-up|Death|70
4940600|NCT00379769|16998359|P5|Observational Follow-up|Death|78
4940601|NCT00379769|16998360|P4|Observational Follow-up|Death|0
4940602|NCT00379769|16998361|P3|Observational Follow-up|Death|0
4940603|NCT00379769|16998362|P2|Observational Follow-up|Death|0
4940604|NCT00379769|16998363|P1|Observational Follow-up|Death|0
4940605|NCT00379769|16998358|P6|Main Study|Reason unspecified|0
4940606|NCT00379769|16998359|P5|Main Study|Reason unspecified|0
4940607|NCT00379769|16998360|P4|Main Study|Reason unspecified|0
4940608|NCT00379769|16998361|P3|Main Study|Reason unspecified|1
4940609|NCT00379769|16998362|P2|Main Study|Reason unspecified|0
4940610|NCT00379769|16998363|P1|Main Study|Reason unspecified|0
4940611|NCT00379769|16998358|P6|Main Study|Investigator refused to log temperature|0
4940612|NCT00379769|16998359|P5|Main Study|Investigator refused to log temperature|0
4940613|NCT00379769|16998360|P4|Main Study|Investigator refused to log temperature|0
4940614|NCT00379769|16998361|P3|Main Study|Investigator refused to log temperature|1
4940615|NCT00379769|16998362|P2|Main Study|Investigator refused to log temperature|0
4940616|NCT00379769|16998363|P1|Main Study|Investigator refused to log temperature|0
4940617|NCT00379769|16998358|P6|Main Study|Risk of heart failure|0
4940618|NCT00379769|16998359|P5|Main Study|Risk of heart failure|0
4940619|NCT00379769|16998360|P4|Main Study|Risk of heart failure|0
4940620|NCT00379769|16998361|P3|Main Study|Risk of heart failure|0
4940621|NCT00379769|16998362|P2|Main Study|Risk of heart failure|1
4940622|NCT00379769|16998363|P1|Main Study|Risk of heart failure|0
4940623|NCT00379769|16998358|P6|Main Study|Personal reasons|0
4940624|NCT00379769|16998359|P5|Main Study|Personal reasons|0
4940625|NCT00379769|16998360|P4|Main Study|Personal reasons|0
4940626|NCT00379769|16998361|P3|Main Study|Personal reasons|0
4940627|NCT00379769|16998362|P2|Main Study|Personal reasons|0
4940628|NCT00379769|16998363|P1|Main Study|Personal reasons|1
4940629|NCT00379769|16998358|P6|Main Study|Participant completed study at visit 27|0
4940630|NCT00379769|16998359|P5|Main Study|Participant completed study at visit 27|0
4940631|NCT00379769|16998360|P4|Main Study|Participant completed study at visit 27|0
4940632|NCT00379769|16998361|P3|Main Study|Participant completed study at visit 27|0
4940633|NCT00379769|16998362|P2|Main Study|Participant completed study at visit 27|0
4940634|NCT00379769|16998363|P1|Main Study|Participant completed study at visit 27|1
4940635|NCT00379769|16998358|P6|Main Study|Physician Decision|0
4940636|NCT00379769|16998359|P5|Main Study|Physician Decision|0
4940637|NCT00379769|16998360|P4|Main Study|Physician Decision|1
4940638|NCT00379769|16998361|P3|Main Study|Physician Decision|1
4940639|NCT00379769|16998362|P2|Main Study|Physician Decision|2
4940640|NCT00379769|16998363|P1|Main Study|Physician Decision|2
4940641|NCT00379769|16998358|P6|Main Study|Participant did not take study drug|0
4940642|NCT00379769|16998359|P5|Main Study|Participant did not take study drug|0
4940643|NCT00379769|16998360|P4|Main Study|Participant did not take study drug|0
4940644|NCT00379769|16998361|P3|Main Study|Participant did not take study drug|1
4940645|NCT00379769|16998362|P2|Main Study|Participant did not take study drug|0
4940646|NCT00379769|16998363|P1|Main Study|Participant did not take study drug|0
4940647|NCT00379769|16998358|P6|Main Study|Entry criteria violation|0
4940648|NCT00379769|16998359|P5|Main Study|Entry criteria violation|0
4940649|NCT00379769|16998360|P4|Main Study|Entry criteria violation|1
4940650|NCT00379769|16998361|P3|Main Study|Entry criteria violation|1
4940651|NCT00379769|16998362|P2|Main Study|Entry criteria violation|0
4940652|NCT00379769|16998363|P1|Main Study|Entry criteria violation|0
4940653|NCT00379769|16998358|P6|Main Study|Site closed|0
4940654|NCT00379769|16998359|P5|Main Study|Site closed|0
4940655|NCT00379769|16998360|P4|Main Study|Site closed|8
4940656|NCT00379769|16998361|P3|Main Study|Site closed|4
4940657|NCT00379769|16998362|P2|Main Study|Site closed|4
4940658|NCT00379769|16998363|P1|Main Study|Site closed|4
4940659|NCT00379769|16998358|P6|Main Study|Prohibited glucose lowering medication|0
4940660|NCT00379769|16998359|P5|Main Study|Prohibited glucose lowering medication|0
4940661|NCT00379769|16998360|P4|Main Study|Prohibited glucose lowering medication|1
4940662|NCT00379769|16998361|P3|Main Study|Prohibited glucose lowering medication|0
4940663|NCT00379769|16998362|P2|Main Study|Prohibited glucose lowering medication|3
4940664|NCT00379769|16998363|P1|Main Study|Prohibited glucose lowering medication|0
4940665|NCT00379769|16998358|P6|Main Study|Poor compliance|0
4940666|NCT00379769|16998359|P5|Main Study|Poor compliance|0
4940667|NCT00379769|16998360|P4|Main Study|Poor compliance|1
4940668|NCT00379769|16998361|P3|Main Study|Poor compliance|2
4940669|NCT00379769|16998362|P2|Main Study|Poor compliance|2
4940670|NCT00379769|16998363|P1|Main Study|Poor compliance|3
4940671|NCT00379769|16998358|P6|Main Study|Participant moved|0
4940672|NCT00379769|16998359|P5|Main Study|Participant moved|0
4940673|NCT00379769|16998360|P4|Main Study|Participant moved|3
4940674|NCT00379769|16998361|P3|Main Study|Participant moved|3
4940675|NCT00379769|16998362|P2|Main Study|Participant moved|2
4940676|NCT00379769|16998363|P1|Main Study|Participant moved|3
4940677|NCT00379769|16998358|P6|Main Study|Moved to survival status follow-up only|0
4940678|NCT00379769|16998359|P5|Main Study|Moved to survival status follow-up only|0
4940679|NCT00379769|16998360|P4|Main Study|Moved to survival status follow-up only|36
4940680|NCT00379769|16998361|P3|Main Study|Moved to survival status follow-up only|32
4940681|NCT00379769|16998362|P2|Main Study|Moved to survival status follow-up only|25
4940682|NCT00379769|16998363|P1|Main Study|Moved to survival status follow-up only|27
4940683|NCT00379769|16998358|P6|Main Study|Withdrawal by Subject|0
4940684|NCT00379769|16998359|P5|Main Study|Withdrawal by Subject|0
4940685|NCT00379769|16998360|P4|Main Study|Withdrawal by Subject|70
4940686|NCT00379769|16998361|P3|Main Study|Withdrawal by Subject|72
4940687|NCT00379769|16998362|P2|Main Study|Withdrawal by Subject|56
4940688|NCT00379769|16998363|P1|Main Study|Withdrawal by Subject|46
4940689|NCT00379769|16998358|P6|Main Study|Lost to Follow-up|0
4940690|NCT00379769|16998359|P5|Main Study|Lost to Follow-up|0
4940691|NCT00379769|16998360|P4|Main Study|Lost to Follow-up|26
4940692|NCT00379769|16998361|P3|Main Study|Lost to Follow-up|25
4940693|NCT00379769|16998362|P2|Main Study|Lost to Follow-up|29
4940694|NCT00379769|16998363|P1|Main Study|Lost to Follow-up|29
4940695|NCT00379769|16998358|P6|Main Study|Adverse Event|0
4940696|NCT00379769|16998359|P5|Main Study|Adverse Event|0
4940697|NCT00379769|16998360|P4|Main Study|Adverse Event|11
4940698|NCT00379769|16998361|P3|Main Study|Adverse Event|10
4940699|NCT00379769|16998362|P2|Main Study|Adverse Event|8
4940700|NCT00379769|16998363|P1|Main Study|Adverse Event|5
4940701|NCT00379769|16998358|P6|Main Study|Death|0
4940702|NCT00379769|16998359|P5|Main Study|Death|0
4940703|NCT00379769|16998360|P4|Main Study|Death|72
4940704|NCT00379769|16998361|P3|Main Study|Death|54
4940705|NCT00379769|16998362|P2|Main Study|Death|67
4940706|NCT00379769|16998363|P1|Main Study|Death|57
4940707|NCT00379639|16998522|P5|Overall Study|Other|0
4940708|NCT00379639|16998523|P4|Overall Study|Other|0
4940709|NCT00379639|16998524|P3|Overall Study|Other|3
4940710|NCT00379639|16998525|P2|Overall Study|Other|0
4940711|NCT00379639|16998526|P1|Overall Study|Other|0
4940712|NCT00379639|16998522|P5|Overall Study|Lost to Follow-up|0
4940713|NCT00379639|16998523|P4|Overall Study|Lost to Follow-up|1
4940714|NCT00379639|16998524|P3|Overall Study|Lost to Follow-up|0
4940715|NCT00379639|16998525|P2|Overall Study|Lost to Follow-up|0
4940716|NCT00379639|16998526|P1|Overall Study|Lost to Follow-up|0
4940717|NCT00379639|16998522|P5|Overall Study|Adverse Event|1
4940718|NCT00379639|16998523|P4|Overall Study|Adverse Event|0
4940719|NCT00379639|16998524|P3|Overall Study|Adverse Event|1
4940720|NCT00379639|16998525|P2|Overall Study|Adverse Event|0
4940721|NCT00379639|16998526|P1|Overall Study|Adverse Event|0
4940722|NCT00379639|16998522|P5|Overall Study|Symptomatic Deterioration|1
4940723|NCT00379639|16998523|P4|Overall Study|Symptomatic Deterioration|0
4940724|NCT00379639|16998524|P3|Overall Study|Symptomatic Deterioration|1
4940725|NCT00379639|16998525|P2|Overall Study|Symptomatic Deterioration|0
4940726|NCT00379639|16998526|P1|Overall Study|Symptomatic Deterioration|0
4940727|NCT00379639|16998522|P5|Overall Study|Physician Decision|0
4940728|NCT00379639|16998523|P4|Overall Study|Physician Decision|1
4940729|NCT00379639|16998524|P3|Overall Study|Physician Decision|1
4940730|NCT00379639|16998525|P2|Overall Study|Physician Decision|2
4940731|NCT00379639|16998526|P1|Overall Study|Physician Decision|0
4940732|NCT00379639|16998522|P5|Overall Study|Disease Progression|4
4940733|NCT00379639|16998523|P4|Overall Study|Disease Progression|4
4940734|NCT00379639|16998524|P3|Overall Study|Disease Progression|3
4940735|NCT00379639|16998525|P2|Overall Study|Disease Progression|3
4940736|NCT00379639|16998526|P1|Overall Study|Disease Progression|3
4940737|NCT00379587|16998548|P1|Overall Study|Lost to Follow-up|2
4940738|NCT00379353|16998562|P2|Overall Study|Conflicting drug treatment|1
4940739|NCT00379353|16998563|P1|Overall Study|Conflicting drug treatment|0
4940740|NCT00379353|16998562|P2|Overall Study|Non-compliance|0
4940741|NCT00379353|16998563|P1|Overall Study|Non-compliance|1
4940742|NCT00379353|16998562|P2|Overall Study|Cardiac Tamponade|0
4940743|NCT00379353|16998563|P1|Overall Study|Cardiac Tamponade|1
4940744|NCT00379353|16998562|P2|Overall Study|Death|0
4940745|NCT00379353|16998563|P1|Overall Study|Death|1
4940746|NCT00379353|16998562|P2|Overall Study|Withdrawal by Subject|2
4940747|NCT00379353|16998563|P1|Overall Study|Withdrawal by Subject|5
4940748|NCT00379353|16998562|P2|Overall Study|Hospitalization|3
4940749|NCT00379353|16998563|P1|Overall Study|Hospitalization|3
4940750|NCT00379340|16998598|P5|Overall Study|Delayed nephrectomy and anaplasia|1
4940751|NCT00379340|16998599|P4|Overall Study|Delayed nephrectomy and anaplasia|1
4940752|NCT00379340|16998600|P3|Overall Study|Delayed nephrectomy and anaplasia|0
4940753|NCT00379340|16998601|P2|Overall Study|Delayed nephrectomy and anaplasia|0
4940754|NCT00379340|16998602|P1|Overall Study|Delayed nephrectomy and anaplasia|0
4940755|NCT00379340|16998598|P5|Overall Study|On more than 1 tumor therapeutic study|0
4940756|NCT00379340|16998599|P4|Overall Study|On more than 1 tumor therapeutic study|2
4940757|NCT00379340|16998600|P3|Overall Study|On more than 1 tumor therapeutic study|0
4940758|NCT00379340|16998601|P2|Overall Study|On more than 1 tumor therapeutic study|0
4940759|NCT00379340|16998602|P1|Overall Study|On more than 1 tumor therapeutic study|0
4940760|NCT00379340|16998598|P5|Overall Study|Refusal of further protocol therapy|7
4940761|NCT00379340|16998599|P4|Overall Study|Refusal of further protocol therapy|1
4940762|NCT00379340|16998600|P3|Overall Study|Refusal of further protocol therapy|1
4940763|NCT00379340|16998601|P2|Overall Study|Refusal of further protocol therapy|0
4940764|NCT00379340|16998602|P1|Overall Study|Refusal of further protocol therapy|1
4940765|NCT00379340|16998598|P5|Overall Study|Withdrawal by Subject|0
4940766|NCT00379340|16998599|P4|Overall Study|Withdrawal by Subject|1
4940767|NCT00379340|16998600|P3|Overall Study|Withdrawal by Subject|0
4940768|NCT00379340|16998601|P2|Overall Study|Withdrawal by Subject|0
4940769|NCT00379340|16998602|P1|Overall Study|Withdrawal by Subject|0
4940770|NCT00379340|16998598|P5|Overall Study|Physician Decision|3
4940771|NCT00379340|16998599|P4|Overall Study|Physician Decision|2
4940772|NCT00379340|16998600|P3|Overall Study|Physician Decision|1
4940773|NCT00379340|16998601|P2|Overall Study|Physician Decision|2
4940774|NCT00379340|16998602|P1|Overall Study|Physician Decision|6
4940775|NCT00379340|16998598|P5|Overall Study|Lack of Efficacy|3
4940776|NCT00379340|16998599|P4|Overall Study|Lack of Efficacy|4
4940777|NCT00379340|16998600|P3|Overall Study|Lack of Efficacy|0
4940778|NCT00379340|16998601|P2|Overall Study|Lack of Efficacy|1
4940779|NCT00379340|16998602|P1|Overall Study|Lack of Efficacy|6
4940780|NCT00379340|16998598|P5|Overall Study|Death|0
4940781|NCT00379340|16998599|P4|Overall Study|Death|2
4940782|NCT00379340|16998600|P3|Overall Study|Death|0
4940783|NCT00379340|16998601|P2|Overall Study|Death|0
4940784|NCT00379340|16998602|P1|Overall Study|Death|0
4940785|NCT00379288|16998619|P4|Overall Study|Administrative|1
4940786|NCT00379288|16998620|P3|Overall Study|Administrative|0
4940787|NCT00379288|16998621|P2|Overall Study|Administrative|2
4940788|NCT00379288|16998622|P1|Overall Study|Administrative|2
4940789|NCT00379288|16998619|P4|Overall Study|Did not meet protocol eligibility|2
4940790|NCT00379288|16998620|P3|Overall Study|Did not meet protocol eligibility|0
4940791|NCT00379288|16998621|P2|Overall Study|Did not meet protocol eligibility|1
4940792|NCT00379288|16998622|P1|Overall Study|Did not meet protocol eligibility|0
4940793|NCT00379288|16998619|P4|Overall Study|Noncompliance with protocol|1
4940794|NCT00379288|16998620|P3|Overall Study|Noncompliance with protocol|2
4940795|NCT00379288|16998621|P2|Overall Study|Noncompliance with protocol|6
4940796|NCT00379288|16998622|P1|Overall Study|Noncompliance with protocol|8
4940797|NCT00379288|16998619|P4|Overall Study|Subject withdrew-related to study drug|1
4940798|NCT00379288|16998620|P3|Overall Study|Subject withdrew-related to study drug|0
4940799|NCT00379288|16998621|P2|Overall Study|Subject withdrew-related to study drug|0
4940800|NCT00379288|16998622|P1|Overall Study|Subject withdrew-related to study drug|1
4940801|NCT00379288|16998619|P4|Overall Study|Subject withdrew-unrelated to study drug|2
4940802|NCT00379288|16998620|P3|Overall Study|Subject withdrew-unrelated to study drug|4
4940803|NCT00379288|16998621|P2|Overall Study|Subject withdrew-unrelated to study drug|3
4940804|NCT00379288|16998622|P1|Overall Study|Subject withdrew-unrelated to study drug|0
4940805|NCT00379288|16998619|P4|Overall Study|Lost to Follow-up|0
4940806|NCT00379288|16998620|P3|Overall Study|Lost to Follow-up|2
4940807|NCT00379288|16998621|P2|Overall Study|Lost to Follow-up|3
4940808|NCT00379288|16998622|P1|Overall Study|Lost to Follow-up|3
4940809|NCT00379288|16998619|P4|Overall Study|Treatment Failure|1
4940810|NCT00379288|16998620|P3|Overall Study|Treatment Failure|0
4940811|NCT00379288|16998621|P2|Overall Study|Treatment Failure|1
4940812|NCT00379288|16998622|P1|Overall Study|Treatment Failure|0
4940813|NCT00379288|16998619|P4|Overall Study|Adverse Event|0
4940814|NCT00379288|16998620|P3|Overall Study|Adverse Event|2
4940815|NCT00379288|16998621|P2|Overall Study|Adverse Event|6
4940816|NCT00379288|16998622|P1|Overall Study|Adverse Event|5
4940817|NCT00379236|16998634|P3|Open-label Extension|Other|7
4940818|NCT00379236|16998635|P2|Open-label Extension|Other|0
4940819|NCT00379236|16998636|P1|Open-label Extension|Other|0
4940820|NCT00379236|16998634|P3|Open-label Extension|Use of exclusionary medication|3
4940821|NCT00379236|16998635|P2|Open-label Extension|Use of exclusionary medication|0
4940822|NCT00379236|16998636|P1|Open-label Extension|Use of exclusionary medication|0
4940823|NCT00379236|16998634|P3|Open-label Extension|Lost to Follow-up|12
4940824|NCT00379236|16998635|P2|Open-label Extension|Lost to Follow-up|0
4940825|NCT00379236|16998636|P1|Open-label Extension|Lost to Follow-up|0
4940826|NCT00379236|16998634|P3|Open-label Extension|Withdrawal by Subject|13
4940827|NCT00379236|16998635|P2|Open-label Extension|Withdrawal by Subject|0
4940828|NCT00379236|16998636|P1|Open-label Extension|Withdrawal by Subject|0
4940829|NCT00379236|16998634|P3|Open-label Extension|Protocol Violation|7
4940830|NCT00379236|16998635|P2|Open-label Extension|Protocol Violation|0
4940831|NCT00379236|16998636|P1|Open-label Extension|Protocol Violation|0
4940832|NCT00379236|16998634|P3|Open-label Extension|Adverse Event|13
4940833|NCT00379236|16998635|P2|Open-label Extension|Adverse Event|0
4940834|NCT00379236|16998636|P1|Open-label Extension|Adverse Event|0
4940835|NCT00379236|16998634|P3|Double-blind|Data could not be retrieved|0
4940836|NCT00379236|16998635|P2|Double-blind|Data could not be retrieved|2
4940837|NCT00379236|16998636|P1|Double-blind|Data could not be retrieved|2
4940838|NCT00379236|16998634|P3|Double-blind|Other|0
4940839|NCT00379236|16998635|P2|Double-blind|Other|7
4940840|NCT00379236|16998636|P1|Double-blind|Other|3
4940841|NCT00379236|16998634|P3|Double-blind|Use of exclusionary medication|0
4940842|NCT00379236|16998635|P2|Double-blind|Use of exclusionary medication|2
4940843|NCT00379236|16998636|P1|Double-blind|Use of exclusionary medication|1
4940844|NCT00379236|16998634|P3|Double-blind|Lost to Follow-up|0
4940845|NCT00379236|16998635|P2|Double-blind|Lost to Follow-up|3
4940846|NCT00379236|16998636|P1|Double-blind|Lost to Follow-up|4
4940847|NCT00379236|16998634|P3|Double-blind|Withdrawal by Subject|0
4940848|NCT00379236|16998635|P2|Double-blind|Withdrawal by Subject|13
4940849|NCT00379236|16998636|P1|Double-blind|Withdrawal by Subject|12
4940850|NCT00379236|16998634|P3|Double-blind|Protocol Violation|0
4940851|NCT00379236|16998635|P2|Double-blind|Protocol Violation|3
4940852|NCT00379236|16998636|P1|Double-blind|Protocol Violation|3
4940853|NCT00379236|16998634|P3|Double-blind|Adverse Event|0
4940854|NCT00379236|16998635|P2|Double-blind|Adverse Event|6
4940855|NCT00379236|16998636|P1|Double-blind|Adverse Event|11
4940856|NCT00379210|16998681|P2|Overall Study|Withdrawal by Subject|7
4940857|NCT00379210|16998682|P1|Overall Study|Withdrawal by Subject|10
4940858|NCT00379080|16998705|P3|Overall Study|Withdrawal by Subject|0
4940859|NCT00379080|16998706|P2|Overall Study|Withdrawal by Subject|4
4940860|NCT00379080|16998707|P1|Overall Study|Withdrawal by Subject|0
4940861|NCT00378898|16998752|P2|Overall Study|Protocol Violation|1
4940862|NCT00378898|16998753|P1|Overall Study|Protocol Violation|1
4940863|NCT00378898|16998752|P2|Overall Study|Withdrawal by Subject|5
4940864|NCT00378898|16998753|P1|Overall Study|Withdrawal by Subject|10
4940865|NCT00378703|16998765|P4|Overall Study|Other|3
4940866|NCT00378703|16998766|P3|Overall Study|Other|2
4940867|NCT00378703|16998767|P2|Overall Study|Other|1
4940868|NCT00378703|16998768|P1|Overall Study|Other|1
4940869|NCT00378703|16998765|P4|Overall Study|Never started treatment|0
4940870|NCT00378703|16998766|P3|Overall Study|Never started treatment|0
4940871|NCT00378703|16998767|P2|Overall Study|Never started treatment|4
4940872|NCT00378703|16998768|P1|Overall Study|Never started treatment|1
4940873|NCT00378703|16998765|P4|Overall Study|Ineligible|7
4940874|NCT00378703|16998766|P3|Overall Study|Ineligible|7
4940875|NCT00378703|16998767|P2|Overall Study|Ineligible|7
4940876|NCT00378703|16998768|P1|Overall Study|Ineligible|4
4940877|NCT00378703|16998765|P4|Overall Study|Relocation|0
4940878|NCT00378703|16998766|P3|Overall Study|Relocation|1
4940879|NCT00378703|16998767|P2|Overall Study|Relocation|0
4940880|NCT00378703|16998768|P1|Overall Study|Relocation|0
4940881|NCT00378703|16998765|P4|Overall Study|Adverse events and progressive disease|1
4940882|NCT00378703|16998766|P3|Overall Study|Adverse events and progressive disease|0
4940883|NCT00378703|16998767|P2|Overall Study|Adverse events and progressive disease|0
4940884|NCT00378703|16998768|P1|Overall Study|Adverse events and progressive disease|0
4940885|NCT00378703|16998765|P4|Overall Study|Joint decision of physician and patient|0
4940886|NCT00378703|16998766|P3|Overall Study|Joint decision of physician and patient|0
4940887|NCT00378703|16998767|P2|Overall Study|Joint decision of physician and patient|0
4940888|NCT00378703|16998768|P1|Overall Study|Joint decision of physician and patient|1
4940889|NCT00378703|16998765|P4|Overall Study|Surgery|1
4940890|NCT00378703|16998766|P3|Overall Study|Surgery|0
4940891|NCT00378703|16998767|P2|Overall Study|Surgery|0
4940892|NCT00378703|16998768|P1|Overall Study|Surgery|1
4940893|NCT00378703|16998765|P4|Overall Study|Symptomatic deterioration|2
4940894|NCT00378703|16998766|P3|Overall Study|Symptomatic deterioration|0
4940895|NCT00378703|16998767|P2|Overall Study|Symptomatic deterioration|1
4940896|NCT00378703|16998768|P1|Overall Study|Symptomatic deterioration|0
4940897|NCT00378703|16998765|P4|Overall Study|Other complicated disease|0
4940898|NCT00378703|16998766|P3|Overall Study|Other complicated disease|2
4940899|NCT00378703|16998767|P2|Overall Study|Other complicated disease|2
4940900|NCT00378703|16998768|P1|Overall Study|Other complicated disease|0
4940901|NCT00378703|16998765|P4|Overall Study|Alternative therapy|0
4940902|NCT00378703|16998766|P3|Overall Study|Alternative therapy|0
4940903|NCT00378703|16998767|P2|Overall Study|Alternative therapy|2
4940904|NCT00378703|16998768|P1|Overall Study|Alternative therapy|4
4940905|NCT00378703|16998765|P4|Overall Study|Physician Decision|0
4940906|NCT00378703|16998766|P3|Overall Study|Physician Decision|1
4940907|NCT00378703|16998767|P2|Overall Study|Physician Decision|4
4940908|NCT00378703|16998768|P1|Overall Study|Physician Decision|1
4940909|NCT00378703|16998765|P4|Overall Study|Withdrawal by Subject|7
4940910|NCT00378703|16998766|P3|Overall Study|Withdrawal by Subject|5
4940911|NCT00378703|16998767|P2|Overall Study|Withdrawal by Subject|8
4940912|NCT00378703|16998768|P1|Overall Study|Withdrawal by Subject|4
4940913|NCT00378703|16998765|P4|Overall Study|Death|3
4940914|NCT00378703|16998766|P3|Overall Study|Death|4
4940915|NCT00378703|16998767|P2|Overall Study|Death|2
4940916|NCT00378703|16998768|P1|Overall Study|Death|2
4940917|NCT00378703|16998765|P4|Overall Study|Adverse Event|18
4940918|NCT00378703|16998766|P3|Overall Study|Adverse Event|20
4940919|NCT00378703|16998767|P2|Overall Study|Adverse Event|17
4940920|NCT00378703|16998768|P1|Overall Study|Adverse Event|11
4940921|NCT00378703|16998765|P4|Overall Study|Disease progression|49
4940922|NCT00378703|16998766|P3|Overall Study|Disease progression|48
4940923|NCT00378703|16998767|P2|Overall Study|Disease progression|43
4940924|NCT00378703|16998768|P1|Overall Study|Disease progression|59
4940925|NCT00378599|16998790|P1|Overall Study|Withdrawal by Subject|5
4940926|NCT00378599|16998790|P1|Overall Study|Treatment failure|7
4940927|NCT00378599|16998790|P1|Overall Study|Protocol Violation|2
4940928|NCT00378599|16998790|P1|Overall Study|Adverse Event|38
4940929|NCT00378573|16998794|P1|Follow-up|Withdrawal by Subject|1
4940930|NCT00378573|16998794|P1|Follow-up|Lost to Follow-up|1
4940931|NCT00378573|16998794|P1|Follow-up|Death|12
4940932|NCT00378573|16998794|P1|Treatment Period|Sponsor decision to close study|1
4940933|NCT00378573|16998794|P1|Treatment Period|Disease Progression|4
4940934|NCT00378573|16998794|P1|Treatment Period|Withdrawal by Subject|2
4940935|NCT00378573|16998794|P1|Treatment Period|Physician Decision|1
4940936|NCT00378573|16998794|P1|Treatment Period|Adverse Event|9
4940937|NCT00378560|16998802|P2|Overall Study|Laboratory test values abnormal|0
4940938|NCT00378560|16998803|P1|Overall Study|Laboratory test values abnormal|1
4940939|NCT00378560|16998802|P2|Overall Study|Pregnancy|5
4940940|NCT00378560|16998803|P1|Overall Study|Pregnancy|7
4940941|NCT00378560|16998802|P2|Overall Study|Moved|3
4940942|NCT00378560|16998803|P1|Overall Study|Moved|4
4940943|NCT00378560|16998802|P2|Overall Study|Withdrawal by Subject|21
4940944|NCT00378560|16998803|P1|Overall Study|Withdrawal by Subject|17
4940945|NCT00378560|16998802|P2|Overall Study|Protocol Violation|0
4940946|NCT00378560|16998803|P1|Overall Study|Protocol Violation|2
4940947|NCT00378560|16998802|P2|Overall Study|Lost to Follow-up|29
4940948|NCT00378560|16998803|P1|Overall Study|Lost to Follow-up|24
4940949|NCT00378560|16998802|P2|Overall Study|Adverse Event|0
4940950|NCT00378560|16998803|P1|Overall Study|Adverse Event|1
4940951|NCT00378534|16998817|P1|Overall Study|Subjects did not receive a transplant|3
4940952|NCT00378534|16998817|P1|Overall Study|Donors|57
4940953|NCT00378508|16998823|P2|Overall Study|Lost to Follow-up|0
4940954|NCT00378508|16998824|P1|Overall Study|Lost to Follow-up|1
4940955|NCT00378508|16998823|P2|Overall Study|Withdrawal by Subject|3
4940956|NCT00378508|16998824|P1|Overall Study|Withdrawal by Subject|1
4940957|NCT00378378|16998843|P3|Overall Study|Non-compliance with protocol|1
4940958|NCT00378378|16998844|P2|Overall Study|Non-compliance with protocol|0
4940959|NCT00378378|16998845|P1|Overall Study|Non-compliance with protocol|0
4940960|NCT00378378|16998843|P3|Overall Study|Treatment Failure|1
4940961|NCT00378378|16998844|P2|Overall Study|Treatment Failure|0
4940962|NCT00378378|16998845|P1|Overall Study|Treatment Failure|0
4940963|NCT00378378|16998843|P3|Overall Study|Withdrawal by Subject|0
4940964|NCT00378378|16998844|P2|Overall Study|Withdrawal by Subject|1
4940965|NCT00378378|16998845|P1|Overall Study|Withdrawal by Subject|0
4940966|NCT00378209|16998891|P1|Overall Study|Treatment delay|1
4940967|NCT00378209|16998891|P1|Overall Study|Death|1
4940968|NCT00378209|16998891|P1|Overall Study|Physician Decision|3
4940969|NCT00378209|16998891|P1|Overall Study|Initiation of non-protocol therapy|3
4940970|NCT00378209|16998891|P1|Overall Study|Adverse Event|3
4940971|NCT00378209|16998891|P1|Overall Study|Progressive disease|11
4940972|NCT00378105|16998901|P2|Overall Study|necessity to increase lenalidomide dose|1
4940973|NCT00378105|16998902|P1|Overall Study|necessity to increase lenalidomide dose|0
4940974|NCT00378105|16998901|P2|Overall Study|Going non-protocol therapy|1
4940975|NCT00378105|16998902|P1|Overall Study|Going non-protocol therapy|0
4940976|NCT00378105|16998901|P2|Overall Study|Physician Decision|2
4940977|NCT00378105|16998902|P1|Overall Study|Physician Decision|0
4940978|NCT00378105|16998901|P2|Overall Study|remain on study|11
4940979|NCT00378105|16998902|P1|Overall Study|remain on study|3
4940980|NCT00378105|16998901|P2|Overall Study|Progressive disease|3
4940981|NCT00378105|16998902|P1|Overall Study|Progressive disease|3
4940982|NCT00378105|16998901|P2|Overall Study|Going to transplant|8
4940983|NCT00378105|16998902|P1|Overall Study|Going to transplant|7
4940984|NCT00378105|16998901|P2|Overall Study|Death|0
4940985|NCT00378105|16998902|P1|Overall Study|Death|1
4940986|NCT00378105|16998901|P2|Overall Study|Withdrawal by Subject|3
4940987|NCT00378105|16998902|P1|Overall Study|Withdrawal by Subject|3
4940988|NCT00378105|16998901|P2|Overall Study|Adverse Event|1
4940989|NCT00378105|16998902|P1|Overall Study|Adverse Event|3
4940990|NCT00378079|16998914|P3|Overall Study|Lost to Follow-up|0
4940991|NCT00378079|16998915|P2|Overall Study|Lost to Follow-up|1
4940992|NCT00378079|16998916|P1|Overall Study|Lost to Follow-up|6
4940993|NCT00378014|16998938|P2|Extension (Month 12 to Month 59)|Lack of Efficacy|1
4940994|NCT00378014|16998939|P1|Extension (Month 12 to Month 59)|Lack of Efficacy|3
4940995|NCT00378014|16998938|P2|Extension (Month 12 to Month 59)|Withdrawal by Subject|3
4940996|NCT00378014|16998939|P1|Extension (Month 12 to Month 59)|Withdrawal by Subject|0
4940997|NCT00378014|16998938|P2|Extension (Month 12 to Month 59)|Lost to Follow-up|1
4940998|NCT00378014|16998939|P1|Extension (Month 12 to Month 59)|Lost to Follow-up|1
4940999|NCT00378014|16998938|P2|Extension (Month 12 to Month 59)|Administrative problems|0
4941000|NCT00378014|16998939|P1|Extension (Month 12 to Month 59)|Administrative problems|1
4941001|NCT00378014|16998938|P2|Extension (Month 12 to Month 59)|Death|2
4941002|NCT00378014|16998939|P1|Extension (Month 12 to Month 59)|Death|1
4941003|NCT00378014|16998938|P2|Extension (Month 12 to Month 59)|Adverse Event|7
4941004|NCT00378014|16998939|P1|Extension (Month 12 to Month 59)|Adverse Event|8
4941005|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Lack of Efficacy|1
4941006|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Lack of Efficacy|0
4941007|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Protocol deviation|1
4941008|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Protocol deviation|0
4941009|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Withdrawal by Subject|2
4941010|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Withdrawal by Subject|5
4941011|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Lost to Follow-up|1
4941012|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Lost to Follow-up|0
4941013|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Administrative Problems|2
4941014|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Administrative Problems|2
4941015|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Death|3
4941016|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Death|5
4941017|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Graft loss|2
4941018|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Graft loss|1
4941019|NCT00378014|16998938|P2|Core (Randomization to Month 11)|Adverse Event|0
4941020|NCT00378014|16998939|P1|Core (Randomization to Month 11)|Adverse Event|1
4941021|NCT00377962|16998965|P2|Extension Study: 12-24 Months|Unspecified reason|3
4941022|NCT00377962|16998966|P1|Extension Study: 12-24 Months|Unspecified reason|0
4941023|NCT00377962|16998965|P2|Extension Study: 12-24 Months|Abnormal laboratory value|0
4941024|NCT00377962|16998966|P1|Extension Study: 12-24 Months|Abnormal laboratory value|1
4941025|NCT00377962|16998965|P2|Extension Study: 12-24 Months|Adverse Event|0
4941026|NCT00377962|16998966|P1|Extension Study: 12-24 Months|Adverse Event|8
4941027|NCT00377962|16998965|P2|Extension Study: 12-24 Months|Death|1
4941028|NCT00377962|16998966|P1|Extension Study: 12-24 Months|Death|1
4941029|NCT00377962|16998965|P2|Core Study: 0-12 Months|Unspecified reasons|4
4941030|NCT00377962|16998966|P1|Core Study: 0-12 Months|Unspecified reasons|1
4941031|NCT00377962|16998965|P2|Core Study: 0-12 Months|Administrative Reason|1
4941032|NCT00377962|16998966|P1|Core Study: 0-12 Months|Administrative Reason|1
4941033|NCT00377962|16998965|P2|Core Study: 0-12 Months|Withdrew Consent|2
4941034|NCT00377962|16998966|P1|Core Study: 0-12 Months|Withdrew Consent|5
4941035|NCT00377962|16998965|P2|Core Study: 0-12 Months|Death|0
4941036|NCT00377962|16998966|P1|Core Study: 0-12 Months|Death|3
4941037|NCT00377962|16998965|P2|Core Study: 0-12 Months|Adverse Event|2
4941038|NCT00377962|16998966|P1|Core Study: 0-12 Months|Adverse Event|18
4941039|NCT00377858|16999002|P2|Overall Study|Death|3
4941040|NCT00377858|16999003|P1|Overall Study|Death|0
4941041|NCT00377858|16999002|P2|Overall Study|Sponsor Decision|2
4941042|NCT00377858|16999003|P1|Overall Study|Sponsor Decision|1
4941043|NCT00377858|16999002|P2|Overall Study|Entry Criteria Not Met|0
4941044|NCT00377858|16999003|P1|Overall Study|Entry Criteria Not Met|2
4941045|NCT00377858|16999002|P2|Overall Study|Adverse Event|1
4941046|NCT00377858|16999003|P1|Overall Study|Adverse Event|2
4941047|NCT00377858|16999002|P2|Overall Study|Protocol Violation|4
4941048|NCT00377858|16999003|P1|Overall Study|Protocol Violation|3
4941049|NCT00377858|16999002|P2|Overall Study|Physician Decision|5
4941050|NCT00377858|16999003|P1|Overall Study|Physician Decision|5
4941051|NCT00377858|16999002|P2|Overall Study|Lost to Follow-up|1
4941052|NCT00377858|16999003|P1|Overall Study|Lost to Follow-up|6
4941053|NCT00377858|16999002|P2|Overall Study|Withdrawal by Subject|11
4941054|NCT00377858|16999003|P1|Overall Study|Withdrawal by Subject|12
4941055|NCT00377819|16999056|P2|Overall Study|Protocol Violation|1
4941056|NCT00377819|16999057|P1|Overall Study|Protocol Violation|1
4941057|NCT00377819|16999056|P2|Overall Study|Lost to Follow-up|1
4941058|NCT00377819|16999057|P1|Overall Study|Lost to Follow-up|0
4941059|NCT00377819|16999056|P2|Overall Study|Death|1
4941060|NCT00377819|16999057|P1|Overall Study|Death|0
4941061|NCT00377819|16999056|P2|Overall Study|Withdrawal by Subject|4
4941062|NCT00377819|16999057|P1|Overall Study|Withdrawal by Subject|10
4941063|NCT00377819|16999056|P2|Overall Study|Adverse Event|3
4941064|NCT00377819|16999057|P1|Overall Study|Adverse Event|2
4941065|NCT00377676|16999086|P2|Overall Study|Other|58
4941066|NCT00377676|16999087|P1|Overall Study|Other|118
4941067|NCT00377676|16999086|P2|Overall Study|Lost to Follow-up|56
4941068|NCT00377676|16999087|P1|Overall Study|Lost to Follow-up|120
4941069|NCT00377676|16999086|P2|Overall Study|Withdrawal by Subject|72
4941070|NCT00377676|16999087|P1|Overall Study|Withdrawal by Subject|187
4941071|NCT00377676|16999086|P2|Overall Study|Death|2
4941072|NCT00377676|16999087|P1|Overall Study|Death|5
4941073|NCT00377676|16999086|P2|Overall Study|Protocol Violation|27
4941074|NCT00377676|16999087|P1|Overall Study|Protocol Violation|33
4941075|NCT00377676|16999086|P2|Overall Study|Adverse Event|107
4941076|NCT00377676|16999087|P1|Overall Study|Adverse Event|498
4941077|NCT00377637|16999103|P4|Maintenance Phase|Death|1
4941078|NCT00377637|16999104|P3|Maintenance Phase|Death|0
4941079|NCT00377637|16999105|P2|Maintenance Phase|Death|0
4941080|NCT00377637|16999106|P1|Maintenance Phase|Death|0
4941081|NCT00377637|16999103|P4|Maintenance Phase|Study medication stopped > 14 days|1
4941082|NCT00377637|16999104|P3|Maintenance Phase|Study medication stopped > 14 days|0
4941083|NCT00377637|16999105|P2|Maintenance Phase|Study medication stopped > 14 days|0
4941084|NCT00377637|16999106|P1|Maintenance Phase|Study medication stopped > 14 days|0
4941085|NCT00377637|16999103|P4|Maintenance Phase|Non-compliance|1
4941086|NCT00377637|16999104|P3|Maintenance Phase|Non-compliance|1
4941087|NCT00377637|16999105|P2|Maintenance Phase|Non-compliance|0
4941088|NCT00377637|16999106|P1|Maintenance Phase|Non-compliance|0
4941089|NCT00377637|16999103|P4|Maintenance Phase|Sponsor decision|3
4941090|NCT00377637|16999104|P3|Maintenance Phase|Sponsor decision|2
4941091|NCT00377637|16999105|P2|Maintenance Phase|Sponsor decision|0
4941092|NCT00377637|16999106|P1|Maintenance Phase|Sponsor decision|0
4941093|NCT00377637|16999103|P4|Maintenance Phase|Withdrawal by Subject|3
4941094|NCT00377637|16999104|P3|Maintenance Phase|Withdrawal by Subject|3
4941095|NCT00377637|16999105|P2|Maintenance Phase|Withdrawal by Subject|0
4941096|NCT00377637|16999106|P1|Maintenance Phase|Withdrawal by Subject|0
4941097|NCT00377637|16999103|P4|Maintenance Phase|Lost to Follow-up|1
4941098|NCT00377637|16999104|P3|Maintenance Phase|Lost to Follow-up|3
4941099|NCT00377637|16999105|P2|Maintenance Phase|Lost to Follow-up|0
4941100|NCT00377637|16999106|P1|Maintenance Phase|Lost to Follow-up|0
4941101|NCT00377637|16999103|P4|Maintenance Phase|Physician Decision|4
4941102|NCT00377637|16999104|P3|Maintenance Phase|Physician Decision|5
4941103|NCT00377637|16999105|P2|Maintenance Phase|Physician Decision|0
4941104|NCT00377637|16999106|P1|Maintenance Phase|Physician Decision|0
4941105|NCT00377637|16999103|P4|Maintenance Phase|Adverse Event|43
4941106|NCT00377637|16999104|P3|Maintenance Phase|Adverse Event|29
4941107|NCT00377637|16999105|P2|Maintenance Phase|Adverse Event|0
4941108|NCT00377637|16999106|P1|Maintenance Phase|Adverse Event|0
4941109|NCT00377637|16999103|P4|Induction Phase|Reason for withdrawal is not noted|0
4941110|NCT00377637|16999104|P3|Induction Phase|Reason for withdrawal is not noted|0
4941111|NCT00377637|16999105|P2|Induction Phase|Reason for withdrawal is not noted|0
4941112|NCT00377637|16999106|P1|Induction Phase|Reason for withdrawal is not noted|2
4941113|NCT00377637|16999103|P4|Induction Phase|Non-Compliance|0
4941114|NCT00377637|16999104|P3|Induction Phase|Non-Compliance|0
4941115|NCT00377637|16999105|P2|Induction Phase|Non-Compliance|0
4941116|NCT00377637|16999106|P1|Induction Phase|Non-Compliance|1
4941117|NCT00377637|16999103|P4|Induction Phase|Sponsor decision|0
4941118|NCT00377637|16999104|P3|Induction Phase|Sponsor decision|0
4941119|NCT00377637|16999105|P2|Induction Phase|Sponsor decision|2
4941120|NCT00377637|16999106|P1|Induction Phase|Sponsor decision|1
4941121|NCT00377637|16999103|P4|Induction Phase|Physician Decision|0
4941122|NCT00377637|16999104|P3|Induction Phase|Physician Decision|0
4941123|NCT00377637|16999105|P2|Induction Phase|Physician Decision|1
4941124|NCT00377637|16999106|P1|Induction Phase|Physician Decision|3
4941125|NCT00377637|16999103|P4|Induction Phase|Withdrawal by Subject|0
4941126|NCT00377637|16999104|P3|Induction Phase|Withdrawal by Subject|0
4941127|NCT00377637|16999105|P2|Induction Phase|Withdrawal by Subject|6
4941128|NCT00377637|16999106|P1|Induction Phase|Withdrawal by Subject|5
4941129|NCT00377637|16999103|P4|Induction Phase|Death|0
4941130|NCT00377637|16999104|P3|Induction Phase|Death|0
4941131|NCT00377637|16999105|P2|Induction Phase|Death|3
4941132|NCT00377637|16999106|P1|Induction Phase|Death|1
4941133|NCT00377637|16999103|P4|Induction Phase|Lost to Follow-up|0
4941134|NCT00377637|16999104|P3|Induction Phase|Lost to Follow-up|0
4941135|NCT00377637|16999105|P2|Induction Phase|Lost to Follow-up|1
4941136|NCT00377637|16999106|P1|Induction Phase|Lost to Follow-up|2
4941137|NCT00377637|16999103|P4|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
4941138|NCT00377637|16999104|P3|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
4941139|NCT00377637|16999105|P2|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1
4941140|NCT00377637|16999106|P1|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0
4941141|NCT00377637|16999103|P4|Induction Phase|Deterioration/serum creatinine|0
4941142|NCT00377637|16999104|P3|Induction Phase|Deterioration/serum creatinine|0
4941143|NCT00377637|16999105|P2|Induction Phase|Deterioration/serum creatinine|0
4941144|NCT00377637|16999106|P1|Induction Phase|Deterioration/serum creatinine|2
4941145|NCT00377637|16999103|P4|Induction Phase|Adverse Event|0
4941146|NCT00377637|16999104|P3|Induction Phase|Adverse Event|0
4941147|NCT00377637|16999105|P2|Induction Phase|Adverse Event|21
4941148|NCT00377637|16999106|P1|Induction Phase|Adverse Event|12
4941149|NCT00377611|16999142|P2|Overall Study|Other|3
4941150|NCT00377611|16999143|P1|Overall Study|Other|0
4941151|NCT00377611|16999142|P2|Overall Study|Lost to Follow-up|16
4941152|NCT00377611|16999143|P1|Overall Study|Lost to Follow-up|18
4941153|NCT00377611|16999142|P2|Overall Study|Withdrawal by Subject|5
4941154|NCT00377611|16999143|P1|Overall Study|Withdrawal by Subject|0
4941155|NCT00377611|16999142|P2|Overall Study|Protocol Violation|0
4941156|NCT00377611|16999143|P1|Overall Study|Protocol Violation|2
4941157|NCT00377611|16999142|P2|Overall Study|Adverse Event|9
4941158|NCT00377611|16999143|P1|Overall Study|Adverse Event|2
4941159|NCT00377520|16999245|P1|Overall Study|Ineligible (Prior radiation)|1
4941160|NCT00377455|16999250|P1|Overall Study|Withdrawal by Subject|1
4941161|NCT00377429|16999258|P1|Overall Study|Patient non-compliance|1
4941162|NCT00377429|16999258|P1|Overall Study|Physician Decision|1
4941163|NCT00377429|16999258|P1|Overall Study|Adverse Event|8
4941164|NCT00377429|16999258|P1|Overall Study|Withdrawal by Subject|5
4941165|NCT00377403|16999269|P2|Overall Study|Unable to contact for telephone intervie|7
4941166|NCT00377403|16999270|P1|Overall Study|Unable to contact for telephone intervie|4
4941167|NCT00377364|16999278|P2|Overall Study|Withdrawal by Subject|0
4941168|NCT00377364|16999279|P1|Overall Study|Withdrawal by Subject|1
4941169|NCT00377364|16999278|P2|Overall Study|Lost to Follow-up|0
4941170|NCT00377364|16999279|P1|Overall Study|Lost to Follow-up|1
4941171|NCT00377312|16999305|P2|Overall Study|Adverse Event|1
4941172|NCT00377312|16999306|P1|Overall Study|Adverse Event|1
4941173|NCT00377299|16999338|P2|Overall Study|Withdrawal by Subject|4
4941174|NCT00377299|16999339|P1|Overall Study|Withdrawal by Subject|5
4941175|NCT00377299|16999338|P2|Overall Study|Adverse Event|1
4941176|NCT00377299|16999339|P1|Overall Study|Adverse Event|0
4941177|NCT00377299|16999338|P2|Overall Study|Lost to Follow-up|19
4941178|NCT00377299|16999339|P1|Overall Study|Lost to Follow-up|14
4941179|NCT00377260|16999355|P2|Overall Study|Withdrawal by Subject|4
4941180|NCT00377260|16999356|P1|Overall Study|Withdrawal by Subject|2
4941181|NCT00377260|16999355|P2|Overall Study|Lost to Follow-up|1
4941182|NCT00377260|16999356|P1|Overall Study|Lost to Follow-up|0
4941183|NCT00377234|16999410|P2|Overall Study|Not assigned|2
4941184|NCT00377234|16999411|P1|Overall Study|Not assigned|3
4941185|NCT00377234|16999410|P2|Overall Study|Administrative|1
4941186|NCT00377234|16999411|P1|Overall Study|Administrative|2
4941187|NCT00377234|16999410|P2|Overall Study|Lost to Follow-up|2
4941188|NCT00377234|16999411|P1|Overall Study|Lost to Follow-up|4
4941189|NCT00377234|16999410|P2|Overall Study|Withdrawal by Subject|9
4941190|NCT00377234|16999411|P1|Overall Study|Withdrawal by Subject|11
4941191|NCT00377234|16999410|P2|Overall Study|Adverse Event|17
4941192|NCT00377234|16999411|P1|Overall Study|Adverse Event|14
4941193|NCT00377156|16999429|P2|Overall Study|Other|2
4941194|NCT00377156|16999430|P1|Overall Study|Other|5
4941195|NCT00377156|16999429|P2|Overall Study|Disability or language problem|1
4941196|NCT00377156|16999430|P1|Overall Study|Disability or language problem|0
4941197|NCT00377156|16999429|P2|Overall Study|Ineligible|1
4941198|NCT00377156|16999430|P1|Overall Study|Ineligible|0
4941199|NCT00377156|16999429|P2|Overall Study|Refused testing|1
4941200|NCT00377156|16999430|P1|Overall Study|Refused testing|0
4941201|NCT00377156|16999429|P2|Overall Study|Cancellation|0
4941202|NCT00377156|16999430|P1|Overall Study|Cancellation|1
4941203|NCT00377156|16999429|P2|Overall Study|Had follow-up <90 d|6
4941204|NCT00377156|16999430|P1|Overall Study|Had follow-up <90 d|3
4941205|NCT00377156|16999429|P2|Overall Study|Withdrawal by Subject|24
4941206|NCT00377156|16999430|P1|Overall Study|Withdrawal by Subject|16
4941207|NCT00377156|16999429|P2|Overall Study|Death|19
4941208|NCT00377156|16999430|P1|Overall Study|Death|23
4941209|NCT00376961|16999444|P2|Maintenance|Ineligible|3
4941210|NCT00376961|16999445|P1|Maintenance|Ineligible|0
4941211|NCT00376961|16999444|P2|Maintenance|Progression/relapse|18
4941212|NCT00376961|16999445|P1|Maintenance|Progression/relapse|0
4941213|NCT00376961|16999444|P2|Maintenance|Refusal Unrelated to Adverse Event|1
4941214|NCT00376961|16999445|P1|Maintenance|Refusal Unrelated to Adverse Event|0
4941215|NCT00376961|16999444|P2|Maintenance|Adverse Event|1
4941216|NCT00376961|16999445|P1|Maintenance|Adverse Event|0
4941217|NCT00376961|16999444|P2|Initial Registration|Ineligible|0
4941218|NCT00376961|16999445|P1|Initial Registration|Ineligible|3
4941219|NCT00376961|16999444|P2|Initial Registration|Progression/relapse|0
4941220|NCT00376961|16999445|P1|Initial Registration|Progression/relapse|1
4941221|NCT00376961|16999444|P2|Initial Registration|Refusal Unrelated to Adverse Event|0
4941222|NCT00376961|16999445|P1|Initial Registration|Refusal Unrelated to Adverse Event|2
4941223|NCT00376961|16999444|P2|Initial Registration|Adverse Event|0
4941224|NCT00376961|16999445|P1|Initial Registration|Adverse Event|1
4941225|NCT00376688|16999511|P1|Overall Study|Death|1
4941226|NCT00376688|16999511|P1|Overall Study|Adverse Event|3
4941227|NCT00376675|16999517|P2|Overall Study|Other Reason|7
4941228|NCT00376675|16999518|P1|Overall Study|Other Reason|1
4941229|NCT00376675|16999517|P2|Overall Study|Adverse Event|5
4941230|NCT00376675|16999518|P1|Overall Study|Adverse Event|10
4941231|NCT00376675|16999517|P2|Overall Study|Withdrawal by Subject|2
4941232|NCT00376675|16999518|P1|Overall Study|Withdrawal by Subject|9
4941233|NCT00376532|16999567|P2|Overall Study|Lack sufficient blood sample|6
4941234|NCT00376532|16999568|P1|Overall Study|Lack sufficient blood sample|6
4941235|NCT00376506|16999578|P2|Overall Study|Death|2
4941236|NCT00376506|16999579|P1|Overall Study|Death|0
4941237|NCT00376259|16999610|P2|Overall Study|Patient request|0
4941238|NCT00376259|16999611|P1|Overall Study|Patient request|1
4941239|NCT00376259|16999610|P2|Overall Study|Sponsor request - study termination|21
4941240|NCT00376259|16999611|P1|Overall Study|Sponsor request - study termination|21
4941241|NCT00376246|16999623|P2|First Intervention (2 Weeks)|Lost to Follow-up|0
4941242|NCT00376246|16999624|P1|First Intervention (2 Weeks)|Lost to Follow-up|1
4941243|NCT00376246|16999623|P2|First Intervention (2 Weeks)|Withdrawal by Subject|2
4941244|NCT00376246|16999624|P1|First Intervention (2 Weeks)|Withdrawal by Subject|1
4941245|NCT00376246|16999623|P2|First Intervention (2 Weeks)|Adverse Event|0
4941246|NCT00376246|16999624|P1|First Intervention (2 Weeks)|Adverse Event|2
4941247|NCT00376220|16999634|P2|Overall Study|Withdrawal by Subject|2
4941248|NCT00376220|16999635|P1|Overall Study|Withdrawal by Subject|3
4941249|NCT00376220|16999634|P2|Overall Study|Lost to Follow-up|10
4941250|NCT00376220|16999635|P1|Overall Study|Lost to Follow-up|7
4941251|NCT00376168|16999643|P2|Overall Study|Pregnancy|0
4941252|NCT00376168|16999644|P1|Overall Study|Pregnancy|1
4941253|NCT00376168|16999643|P2|Overall Study|Adverse Event|1
4941254|NCT00376168|16999644|P1|Overall Study|Adverse Event|1
4941255|NCT00375934|16999685|P2|Overall Study|Physician Decision|1
4941256|NCT00375934|16999686|P1|Overall Study|Physician Decision|0
4941257|NCT00375934|16999685|P2|Overall Study|Lack of Efficacy|2
4941258|NCT00375934|16999686|P1|Overall Study|Lack of Efficacy|0
4941259|NCT00375934|16999685|P2|Overall Study|Withdrawal by Subject|2
4941260|NCT00375934|16999686|P1|Overall Study|Withdrawal by Subject|2
4941261|NCT00375934|16999685|P2|Overall Study|Adverse Event|1
4941262|NCT00375934|16999686|P1|Overall Study|Adverse Event|1
4941263|NCT00375752|16999744|P2|Overall Study|Administrative Problems|1
4941264|NCT00375752|16999745|P1|Overall Study|Administrative Problems|0
4941265|NCT00375752|16999744|P2|Overall Study|Protocol Violation|2
4941266|NCT00375752|16999745|P1|Overall Study|Protocol Violation|0
4941267|NCT00375752|16999744|P2|Overall Study|Abnormal Laboratory Value(s)|1
4941268|NCT00375752|16999745|P1|Overall Study|Abnormal Laboratory Value(s)|1
4941269|NCT00375752|16999744|P2|Overall Study|Withdrawal by Subject|1
4941270|NCT00375752|16999745|P1|Overall Study|Withdrawal by Subject|6
4941271|NCT00375752|16999744|P2|Overall Study|Adverse Event|6
4941272|NCT00375752|16999745|P1|Overall Study|Adverse Event|1
4941273|NCT00375752|16999744|P2|Overall Study|Lack of Efficacy|4
4941274|NCT00375752|16999745|P1|Overall Study|Lack of Efficacy|4
4941275|NCT00375674|16999776|P2|Overall Study|Enrolled but not treated|2
4941276|NCT00375674|16999777|P1|Overall Study|Enrolled but not treated|3
4941277|NCT00375674|16999776|P2|Overall Study|Lost to Follow-up|15
4941278|NCT00375674|16999777|P1|Overall Study|Lost to Follow-up|17
4941279|NCT00375674|16999776|P2|Overall Study|Participants refused further follow-up|30
4941280|NCT00375674|16999777|P1|Overall Study|Participants refused further follow-up|31
4941281|NCT00375674|16999776|P2|Overall Study|Death|76
4941282|NCT00375674|16999777|P1|Overall Study|Death|67
4941283|NCT00375674|16999776|P2|Overall Study|Other|18
4941284|NCT00375674|16999777|P1|Overall Study|Other|26
4941285|NCT00375609|16999806|P3|Overall Study|Neurologist Wanted Pt to start Plavix|0
4941286|NCT00375609|16999807|P2|Overall Study|Neurologist Wanted Pt to start Plavix|0
4941287|NCT00375609|16999808|P1|Overall Study|Neurologist Wanted Pt to start Plavix|1
4941288|NCT00375609|16999806|P3|Overall Study|Withdrawal by Subject|0
4941289|NCT00375609|16999807|P2|Overall Study|Withdrawal by Subject|4
4941290|NCT00375609|16999808|P1|Overall Study|Withdrawal by Subject|1
4941291|NCT00375609|16999806|P3|Overall Study|Physician Decision|1
4941292|NCT00375609|16999807|P2|Overall Study|Physician Decision|0
4941293|NCT00375609|16999808|P1|Overall Study|Physician Decision|0
4941294|NCT00375609|16999806|P3|Overall Study|Lost to Follow-up|0
4941295|NCT00375609|16999807|P2|Overall Study|Lost to Follow-up|0
4941296|NCT00375609|16999808|P1|Overall Study|Lost to Follow-up|1
4941297|NCT00375609|16999806|P3|Overall Study|Adverse Event|0
4941298|NCT00375609|16999807|P2|Overall Study|Adverse Event|3
4941299|NCT00375609|16999808|P1|Overall Study|Adverse Event|0
4941300|NCT00375609|16999806|P3|Overall Study|Did not receive treatment|0
4941301|NCT00375609|16999807|P2|Overall Study|Did not receive treatment|0
4941302|NCT00375609|16999808|P1|Overall Study|Did not receive treatment|1
4941303|NCT00375518|16999824|P2|Overall Study|Death|1
4941304|NCT00375518|16999825|P1|Overall Study|Death|0
4941305|NCT00375518|16999824|P2|Overall Study|Patient Not Treated|6
4941306|NCT00375518|16999825|P1|Overall Study|Patient Not Treated|6
4941307|NCT00375518|16999824|P2|Overall Study|Withdrawal by Subject|10
4941308|NCT00375518|16999825|P1|Overall Study|Withdrawal by Subject|2
4941309|NCT00375505|16999833|P2|Overall Study|Adverse Event|2
4941310|NCT00375505|16999834|P1|Overall Study|Adverse Event|1
4941311|NCT00375492|16999878|P2|Overall Study|Withdrawal by Subject|6
4941312|NCT00375492|16999879|P1|Overall Study|Withdrawal by Subject|6
4941313|NCT00375492|16999878|P2|Overall Study|Sponsor Decision|1
4941314|NCT00375492|16999879|P1|Overall Study|Sponsor Decision|0
4941315|NCT00375492|16999878|P2|Overall Study|Protocol Violation|3
4941316|NCT00375492|16999879|P1|Overall Study|Protocol Violation|6
4941317|NCT00375492|16999878|P2|Overall Study|Physician Decision|4
4941318|NCT00375492|16999879|P1|Overall Study|Physician Decision|0
4941319|NCT00375492|16999878|P2|Overall Study|Lost to Follow-up|5
4941320|NCT00375492|16999879|P1|Overall Study|Lost to Follow-up|10
4941321|NCT00375492|16999878|P2|Overall Study|Loss of Glucose Control|1
4941322|NCT00375492|16999879|P1|Overall Study|Loss of Glucose Control|0
4941323|NCT00375492|16999878|P2|Overall Study|Entry Criteria Not Met|1
4941324|NCT00375492|16999879|P1|Overall Study|Entry Criteria Not Met|0
4941325|NCT00375492|16999878|P2|Overall Study|Adverse Event|5
4941326|NCT00375492|16999879|P1|Overall Study|Adverse Event|4
4941327|NCT00375427|16999909|P2|Overall Study|Death|10
4941328|NCT00375427|16999910|P1|Overall Study|Death|11
4941329|NCT00375427|16999909|P2|Overall Study|Administrative reasons|1
4941330|NCT00375427|16999910|P1|Overall Study|Administrative reasons|0
4941331|NCT00375427|16999909|P2|Overall Study|Lost to Follow-up|1
4941332|NCT00375427|16999910|P1|Overall Study|Lost to Follow-up|1
4941333|NCT00375427|16999909|P2|Overall Study|Withdrawal by Subject|13
4941334|NCT00375427|16999910|P1|Overall Study|Withdrawal by Subject|9
4941335|NCT00375427|16999909|P2|Overall Study|Protocol Violation|8
4941336|NCT00375427|16999910|P1|Overall Study|Protocol Violation|10
4941337|NCT00375427|16999909|P2|Overall Study|Patient no longer requires study drug|7
4941338|NCT00375427|16999910|P1|Overall Study|Patient no longer requires study drug|3
4941339|NCT00375427|16999909|P2|Overall Study|Unsatisfactory therapeutic effect|4
4941340|NCT00375427|16999910|P1|Overall Study|Unsatisfactory therapeutic effect|4
4941341|NCT00375427|16999909|P2|Overall Study|Abnormal laboratory value(s)|2
4941342|NCT00375427|16999910|P1|Overall Study|Abnormal laboratory value(s)|1
4941343|NCT00375427|16999909|P2|Overall Study|Abnormal test procedure result(s)|1
4941344|NCT00375427|16999910|P1|Overall Study|Abnormal test procedure result(s)|0
4941345|NCT00375427|16999909|P2|Overall Study|Adverse Event|27
4941346|NCT00375427|16999910|P1|Overall Study|Adverse Event|21
4941347|NCT00375219|16999935|P3|Overall Study|Withdrawal by Subject|0
4941348|NCT00375219|16999936|P2|Overall Study|Withdrawal by Subject|0
4941349|NCT00375219|16999937|P1|Overall Study|Withdrawal by Subject|1
4941350|NCT00375219|16999935|P3|Overall Study|Cord blood transplantation|0
4941351|NCT00375219|16999936|P2|Overall Study|Cord blood transplantation|0
4941352|NCT00375219|16999937|P1|Overall Study|Cord blood transplantation|1
4941353|NCT00375219|16999935|P3|Overall Study|Allograft|0
4941354|NCT00375219|16999936|P2|Overall Study|Allograft|0
4941355|NCT00375219|16999937|P1|Overall Study|Allograft|2
4941356|NCT00375219|16999935|P3|Overall Study|Specific tyrosine kinase inhibitor avail|0
4941357|NCT00375219|16999936|P2|Overall Study|Specific tyrosine kinase inhibitor avail|0
4941358|NCT00375219|16999937|P1|Overall Study|Specific tyrosine kinase inhibitor avail|1
4941359|NCT00375219|16999935|P3|Overall Study|Hematologic resistance|0
4941360|NCT00375219|16999936|P2|Overall Study|Hematologic resistance|0
4941361|NCT00375219|16999937|P1|Overall Study|Hematologic resistance|1
4941362|NCT00375219|16999935|P3|Overall Study|Death|7
4941363|NCT00375219|16999936|P2|Overall Study|Death|3
4941364|NCT00375219|16999937|P1|Overall Study|Death|4
4941365|NCT00375219|16999935|P3|Overall Study|Disease progression|12
4941366|NCT00375219|16999936|P2|Overall Study|Disease progression|9
4941367|NCT00375219|16999937|P1|Overall Study|Disease progression|18
4941368|NCT00375219|16999935|P3|Overall Study|Lost to Follow-up|0
4941369|NCT00375219|16999936|P2|Overall Study|Lost to Follow-up|1
4941370|NCT00375219|16999937|P1|Overall Study|Lost to Follow-up|1
4941371|NCT00375219|16999935|P3|Overall Study|Request of Patient, PI, Sponsor or RA|0
4941372|NCT00375219|16999936|P2|Overall Study|Request of Patient, PI, Sponsor or RA|3
4941373|NCT00375219|16999937|P1|Overall Study|Request of Patient, PI, Sponsor or RA|5
4941374|NCT00375219|16999935|P3|Overall Study|Protocol Violation|1
4941375|NCT00375219|16999936|P2|Overall Study|Protocol Violation|0
4941376|NCT00375219|16999937|P1|Overall Study|Protocol Violation|1
4941377|NCT00375219|16999935|P3|Overall Study|Adverse Event|1
4941378|NCT00375219|16999936|P2|Overall Study|Adverse Event|2
4941379|NCT00375219|16999937|P1|Overall Study|Adverse Event|8
4941380|NCT00375219|16999935|P3|Overall Study|Failure to achieve a response|0
4941381|NCT00375219|16999936|P2|Overall Study|Failure to achieve a response|2
4941382|NCT00375219|16999937|P1|Overall Study|Failure to achieve a response|16
4941383|NCT00374907|17000020|P2|116-Week Short-term + Long-term Period|Lost to Follow-up|1
4941384|NCT00374907|17000021|P1|116-Week Short-term + Long-term Period|Lost to Follow-up|1
4941385|NCT00374907|17000020|P2|116-Week Short-term + Long-term Period|Adverse Event|2
4941386|NCT00374907|17000021|P1|116-Week Short-term + Long-term Period|Adverse Event|0
4941387|NCT00374907|17000020|P2|116-Week Short-term + Long-term Period|Lack of Efficacy|2
4941388|NCT00374907|17000021|P1|116-Week Short-term + Long-term Period|Lack of Efficacy|4
4941389|NCT00374907|17000020|P2|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9
4941390|NCT00374907|17000021|P1|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8
4941391|NCT00374907|17000020|P2|12-Week Short-term Period|Subject Withdrew Consent|1
4941392|NCT00374907|17000021|P1|12-Week Short-term Period|Subject Withdrew Consent|3
4941393|NCT00374868|17000033|P1|Overall Study|Other - Not Specified|1
4941394|NCT00374868|17000033|P1|Overall Study|Death|2
4941395|NCT00374868|17000033|P1|Overall Study|Lost to Follow-up|1
4941396|NCT00374868|17000033|P1|Overall Study|Physician Decision|13
4941397|NCT00374868|17000033|P1|Overall Study|Progressive Disease|7
4941398|NCT00374868|17000033|P1|Overall Study|Adverse Event|12
4941399|NCT00374556|17000097|P2|Overall Study|Removed at baseline due to medical cond|1
4941400|NCT00374556|17000098|P1|Overall Study|Removed at baseline due to medical cond|0
4941401|NCT00374556|17000097|P2|Overall Study|Lost to Follow-up|0
4941402|NCT00374556|17000098|P1|Overall Study|Lost to Follow-up|1
4941403|NCT00374452|17000159|P2|Overall Study|Withdrawal by Subject|2
4941404|NCT00374452|17000160|P1|Overall Study|Withdrawal by Subject|0
4941405|NCT00374452|17000159|P2|Overall Study|Left clinic after intervention started|1
4941406|NCT00374452|17000160|P1|Overall Study|Left clinic after intervention started|1
4941407|NCT00374452|17000159|P2|Overall Study|Change in job role before intervention|1
4941408|NCT00374452|17000160|P1|Overall Study|Change in job role before intervention|0
4941409|NCT00374452|17000159|P2|Overall Study|Left clinic before intervention started|1
4941410|NCT00374452|17000160|P1|Overall Study|Left clinic before intervention started|4
4941411|NCT00374322|17000173|P2|Overall Study|Did Not Receive Study Medication|6
4941412|NCT00374322|17000174|P1|Overall Study|Did Not Receive Study Medication|8
4941413|NCT00374322|17000173|P2|Overall Study|Withdrew Consent During Follow-up|5
4941414|NCT00374322|17000174|P1|Overall Study|Withdrew Consent During Follow-up|0
4941415|NCT00374322|17000173|P2|Overall Study|Noncompliance with Study Requirements|1
4941416|NCT00374322|17000174|P1|Overall Study|Noncompliance with Study Requirements|0
4941417|NCT00374322|17000173|P2|Overall Study|Started Another Chemotherapy Regimen|1
4941418|NCT00374322|17000174|P1|Overall Study|Started Another Chemotherapy Regimen|0
4941419|NCT00374322|17000173|P2|Overall Study|Participant Changed Physician|0
4941420|NCT00374322|17000174|P1|Overall Study|Participant Changed Physician|1
4941421|NCT00374322|17000173|P2|Overall Study|Site Closed|2
4941422|NCT00374322|17000174|P1|Overall Study|Site Closed|2
4941423|NCT00374322|17000173|P2|Overall Study|Severe Toxicity|0
4941424|NCT00374322|17000174|P1|Overall Study|Severe Toxicity|1
4941425|NCT00374322|17000173|P2|Overall Study|Seen in FU by a Non-Primary Investigator|0
4941426|NCT00374322|17000174|P1|Overall Study|Seen in FU by a Non-Primary Investigator|1
4941427|NCT00374322|17000173|P2|Overall Study|FU by a Non-Principal Investigator (PI)|3
4941428|NCT00374322|17000174|P1|Overall Study|FU by a Non-Principal Investigator (PI)|2
4941429|NCT00374322|17000173|P2|Overall Study|Sponsor Decision|3
4941430|NCT00374322|17000174|P1|Overall Study|Sponsor Decision|2
4941431|NCT00374322|17000173|P2|Overall Study|Par. Consented to Survival FU Only|1
4941432|NCT00374322|17000174|P1|Overall Study|Par. Consented to Survival FU Only|3
4941433|NCT00374322|17000173|P2|Overall Study|Physician Decision|32
4941434|NCT00374322|17000174|P1|Overall Study|Physician Decision|36
4941435|NCT00374322|17000173|P2|Overall Study|Sponsor Terminated Study|990
4941436|NCT00374322|17000174|P1|Overall Study|Sponsor Terminated Study|866
4941437|NCT00374322|17000173|P2|Overall Study|Withdrawal by Subject|167
4941438|NCT00374322|17000174|P1|Overall Study|Withdrawal by Subject|235
4941439|NCT00374322|17000173|P2|Overall Study|Protocol Violation|3
4941440|NCT00374322|17000174|P1|Overall Study|Protocol Violation|8
4941441|NCT00374322|17000173|P2|Overall Study|Lost to Follow-up|90
4941442|NCT00374322|17000174|P1|Overall Study|Lost to Follow-up|92
4941443|NCT00374140|17000265|P1|Overall Study|Protocol Violation|1
4941444|NCT00374140|17000265|P1|Overall Study|Lost to Follow-up|1
4941445|NCT00374127|17000272|P1|Overall Study|Pregnancy|1
4941446|NCT00374127|17000272|P1|Overall Study|Protocol Violation|5
4941447|NCT00374127|17000272|P1|Overall Study|Blood could not be drawn.|2
4941448|NCT00374127|17000272|P1|Overall Study|Did not inhale during smoking procedure.|3
4941449|NCT00373958|17000321|P2|Toddler Dose|Withdrawn after infant series|25
4941450|NCT00373958|17000322|P1|Toddler Dose|Withdrawn after infant series|22
4941451|NCT00373958|17000321|P2|Toddler Dose|Protocol Violation|1
4941452|NCT00373958|17000322|P1|Toddler Dose|Protocol Violation|0
4941453|NCT00373958|17000321|P2|Toddler Dose|Failed to return|2
4941454|NCT00373958|17000322|P1|Toddler Dose|Failed to return|1
4941455|NCT00373958|17000321|P2|Toddler Dose|Withdrawal by Subject|2
4941456|NCT00373958|17000322|P1|Toddler Dose|Withdrawal by Subject|2
4941457|NCT00373958|17000321|P2|Toddler Dose|Lost to Follow-up|8
4941458|NCT00373958|17000322|P1|Toddler Dose|Lost to Follow-up|5
4941459|NCT00373958|17000321|P2|Infant Series|Physician Decision|1
4941460|NCT00373958|17000322|P1|Infant Series|Physician Decision|1
4941461|NCT00373958|17000321|P2|Infant Series|Adverse Event|1
4941462|NCT00373958|17000322|P1|Infant Series|Adverse Event|3
4941463|NCT00373958|17000321|P2|Infant Series|Consent was not received|0
4941464|NCT00373958|17000322|P1|Infant Series|Consent was not received|1
4941465|NCT00373958|17000321|P2|Infant Series|Child relocated|0
4941466|NCT00373958|17000322|P1|Infant Series|Child relocated|1
4941467|NCT00373958|17000321|P2|Infant Series|Lost Kaiser coverage|0
4941468|NCT00373958|17000322|P1|Infant Series|Lost Kaiser coverage|4
4941469|NCT00373958|17000321|P2|Infant Series|Protocol Violation|7
4941470|NCT00373958|17000322|P1|Infant Series|Protocol Violation|3
4941471|NCT00373958|17000321|P2|Infant Series|Lost to Follow-up|5
4941472|NCT00373958|17000322|P1|Infant Series|Lost to Follow-up|6
4941473|NCT00373958|17000321|P2|Infant Series|Failed to return|13
4941474|NCT00373958|17000322|P1|Infant Series|Failed to return|8
4941475|NCT00373958|17000321|P2|Infant Series|Withdrawal by Subject|15
4941476|NCT00373958|17000322|P1|Infant Series|Withdrawal by Subject|13
4941477|NCT00373880|17000370|P1|Overall Study|Protocol Violation|14
4941478|NCT00373880|17000370|P1|Overall Study|Arrested|1
4941479|NCT00373880|17000370|P1|Overall Study|Physician Decision|3
4941480|NCT00373685|17000415|P2|Overall Study|Randomized, not treated|77
4941481|NCT00373685|17000416|P1|Overall Study|Randomized, not treated|51
4941482|NCT00373685|17000415|P2|Overall Study|Final Status Unknown|4
4941483|NCT00373685|17000416|P1|Overall Study|Final Status Unknown|12
4941484|NCT00373685|17000415|P2|Overall Study|Protocol Violation|182
4941485|NCT00373685|17000416|P1|Overall Study|Protocol Violation|191
4941486|NCT00373685|17000415|P2|Overall Study|Other|146
4941487|NCT00373685|17000416|P1|Overall Study|Other|149
4941488|NCT00373685|17000415|P2|Overall Study|No longer willing to participate|352
4941489|NCT00373685|17000416|P1|Overall Study|No longer willing to participate|337
4941490|NCT00373685|17000415|P2|Overall Study|Lost to follow up|103
4941491|NCT00373685|17000416|P1|Overall Study|Lost to follow up|83
4941492|NCT00373685|17000415|P2|Overall Study|Did not meet entrance criteria|184
4941493|NCT00373685|17000416|P1|Overall Study|Did not meet entrance criteria|167
4941494|NCT00373685|17000415|P2|Overall Study|Insufficient clinical response|119
4941495|NCT00373685|17000416|P1|Overall Study|Insufficient clinical response|169
4941496|NCT00373685|17000415|P2|Overall Study|Adverse Event|253
4941497|NCT00373685|17000416|P1|Overall Study|Adverse Event|278
4941498|NCT00373685|17000415|P2|Overall Study|Death|1
4941499|NCT00373685|17000416|P1|Overall Study|Death|2
4941500|NCT00373529|17000450|P1|Overall Study|Consent violation|1
4941501|NCT00373529|17000450|P1|Overall Study|Failed independent confirmation of AML|3
4941502|NCT00373529|17000450|P1|Overall Study|Other|8
4941503|NCT00373529|17000450|P1|Overall Study|Need for treatment prohibited by study|1
4941504|NCT00373529|17000450|P1|Overall Study|Death|16
4941505|NCT00373529|17000450|P1|Overall Study|Disease recurrence|10
4941506|NCT00373529|17000450|P1|Overall Study|Treatment failure|36
4941507|NCT00373529|17000450|P1|Overall Study|Adverse Event|7
4941508|NCT00373529|17000450|P1|Overall Study|Withdrawal by Subject|7
4941509|NCT00373529|17000450|P1|Overall Study|Physician Decision|19
4941510|NCT00373490|17000462|P2|Overall Study|Withdrawal by Subject|1
4941511|NCT00373490|17000463|P1|Overall Study|Withdrawal by Subject|0
4941512|NCT00373490|17000462|P2|Overall Study|Lack of Efficacy|4
4941513|NCT00373490|17000463|P1|Overall Study|Lack of Efficacy|9
4941514|NCT00373490|17000462|P2|Overall Study|Adverse Event|1
4941515|NCT00373490|17000463|P1|Overall Study|Adverse Event|0
4941516|NCT00373425|17000486|P5|Overall Study|Death|0
4941517|NCT00373425|17000487|P4|Overall Study|Death|1
4941518|NCT00373425|17000488|P3|Overall Study|Death|3
4941519|NCT00373425|17000489|P2|Overall Study|Death|0
4941520|NCT00373425|17000490|P1|Overall Study|Death|7
4941521|NCT00373425|17000486|P5|Overall Study|Medical/ethical/noncompliance reason|5
4941522|NCT00373425|17000487|P4|Overall Study|Medical/ethical/noncompliance reason|2
4941523|NCT00373425|17000488|P3|Overall Study|Medical/ethical/noncompliance reason|10
4941524|NCT00373425|17000489|P2|Overall Study|Medical/ethical/noncompliance reason|9
4941525|NCT00373425|17000490|P1|Overall Study|Medical/ethical/noncompliance reason|21
4941526|NCT00373425|17000486|P5|Overall Study|Patient request|7
4941527|NCT00373425|17000487|P4|Overall Study|Patient request|6
4941528|NCT00373425|17000488|P3|Overall Study|Patient request|43
4941529|NCT00373425|17000489|P2|Overall Study|Patient request|18
4941530|NCT00373425|17000490|P1|Overall Study|Patient request|35
4941531|NCT00373425|17000486|P5|Overall Study|Adverse Event|34
4941532|NCT00373425|17000487|P4|Overall Study|Adverse Event|0
4941533|NCT00373425|17000488|P3|Overall Study|Adverse Event|59
4941534|NCT00373425|17000489|P2|Overall Study|Adverse Event|22
4941535|NCT00373425|17000490|P1|Overall Study|Adverse Event|191
4941536|NCT00373425|17000486|P5|Overall Study|Relapse of NSCLC|26
4941537|NCT00373425|17000487|P4|Overall Study|Relapse of NSCLC|2
4941538|NCT00373425|17000488|P3|Overall Study|Relapse of NSCLC|19
4941539|NCT00373425|17000489|P2|Overall Study|Relapse of NSCLC|104
4941540|NCT00373425|17000490|P1|Overall Study|Relapse of NSCLC|116
4941541|NCT00373295|17000585|P6|Intervention 1 (8 Days)|Withdrawal by Subject|0
4941542|NCT00373295|17000586|P5|Intervention 1 (8 Days)|Withdrawal by Subject|1
4941543|NCT00373295|17000587|P4|Intervention 1 (8 Days)|Withdrawal by Subject|0
4941544|NCT00373295|17000588|P3|Intervention 1 (8 Days)|Withdrawal by Subject|0
4941545|NCT00373295|17000589|P2|Intervention 1 (8 Days)|Withdrawal by Subject|2
4941546|NCT00373295|17000590|P1|Intervention 1 (8 Days)|Withdrawal by Subject|0
4941547|NCT00373256|17000611|P2|Overall Study|Study Terminated by Sponsor|13
4941548|NCT00373256|17000612|P1|Overall Study|Study Terminated by Sponsor|41
4941549|NCT00373256|17000611|P2|Overall Study|Protocol Violation|2
4941550|NCT00373256|17000612|P1|Overall Study|Protocol Violation|0
4941551|NCT00373256|17000611|P2|Overall Study|Other|107
4941552|NCT00373256|17000612|P1|Overall Study|Other|73
4941553|NCT00373256|17000611|P2|Overall Study|Refused Treatment-Reason Other Than AE|7
4941554|NCT00373256|17000612|P1|Overall Study|Refused Treatment-Reason Other Than AE|4
4941555|NCT00373256|17000611|P2|Overall Study|Objective Progression or Relapse|104
4941556|NCT00373256|17000612|P1|Overall Study|Objective Progression or Relapse|111
4941557|NCT00373256|17000611|P2|Overall Study|Death|8
4941558|NCT00373256|17000612|P1|Overall Study|Death|9
4941559|NCT00373256|17000611|P2|Overall Study|Lost to Follow-up|1
4941560|NCT00373256|17000612|P1|Overall Study|Lost to Follow-up|2
4941561|NCT00373256|17000611|P2|Overall Study|Adverse Event (AE)|5
4941562|NCT00373256|17000612|P1|Overall Study|Adverse Event (AE)|1
4941563|NCT00373113|17000638|P2|Overall Study|Withdrawal by Subject|15
4941564|NCT00373113|17000639|P1|Overall Study|Withdrawal by Subject|10
4941565|NCT00373113|17000638|P2|Overall Study|Protocol Violation|1
4941566|NCT00373113|17000639|P1|Overall Study|Protocol Violation|5
4941567|NCT00373113|17000638|P2|Overall Study|Other|17
4941568|NCT00373113|17000639|P1|Overall Study|Other|14
4941569|NCT00373113|17000638|P2|Overall Study|Objective progression or relapse|169
4941570|NCT00373113|17000639|P1|Overall Study|Objective progression or relapse|150
4941571|NCT00373113|17000638|P2|Overall Study|Lost to Follow-up|3
4941572|NCT00373113|17000639|P1|Overall Study|Lost to Follow-up|1
4941573|NCT00373113|17000638|P2|Overall Study|Global deterioration of health status|7
4941574|NCT00373113|17000639|P1|Overall Study|Global deterioration of health status|10
4941575|NCT00373113|17000638|P2|Overall Study|Study terminated by sponsor|1
4941576|NCT00373113|17000639|P1|Overall Study|Study terminated by sponsor|9
4941577|NCT00373113|17000638|P2|Overall Study|Adverse Event|24
4941578|NCT00373113|17000639|P1|Overall Study|Adverse Event|38
4941579|NCT00373113|17000638|P2|Overall Study|Death|7
4941580|NCT00373113|17000639|P1|Overall Study|Death|1
4941581|NCT00372996|17000661|P4|Overall Study|Other|7
4941582|NCT00372996|17000662|P3|Overall Study|Other|7
4941583|NCT00372996|17000663|P2|Overall Study|Other|2
4941584|NCT00372996|17000664|P1|Overall Study|Other|10
4941585|NCT00372996|17000661|P4|Overall Study|Study Terminated by Sponsor|0
4941586|NCT00372996|17000662|P3|Overall Study|Study Terminated by Sponsor|4
4941587|NCT00372996|17000663|P2|Overall Study|Study Terminated by Sponsor|0
4941588|NCT00372996|17000664|P1|Overall Study|Study Terminated by Sponsor|4
4941589|NCT00372996|17000661|P4|Overall Study|Withdrawal by Subject|5
4941590|NCT00372996|17000662|P3|Overall Study|Withdrawal by Subject|9
4941591|NCT00372996|17000663|P2|Overall Study|Withdrawal by Subject|6
4941592|NCT00372996|17000664|P1|Overall Study|Withdrawal by Subject|12
4941593|NCT00372996|17000661|P4|Overall Study|Lost to Follow-up|1
4941594|NCT00372996|17000662|P3|Overall Study|Lost to Follow-up|0
4941595|NCT00372996|17000663|P2|Overall Study|Lost to Follow-up|2
4941596|NCT00372996|17000664|P1|Overall Study|Lost to Follow-up|0
4941597|NCT00372996|17000661|P4|Overall Study|Death|7
4941598|NCT00372996|17000662|P3|Overall Study|Death|8
4941599|NCT00372996|17000663|P2|Overall Study|Death|4
4941600|NCT00372996|17000664|P1|Overall Study|Death|11
4941601|NCT00372905|17000749|P4|Follow up Until Relapse or Progression|Other|0
4941602|NCT00372905|17000750|P3|Follow up Until Relapse or Progression|Other|0
4941603|NCT00372905|17000751|P2|Follow up Until Relapse or Progression|Other|1
4941604|NCT00372905|17000752|P1|Follow up Until Relapse or Progression|Other|0
4941605|NCT00372905|17000749|P4|Follow up Until Relapse or Progression|Study closed|3
4941606|NCT00372905|17000750|P3|Follow up Until Relapse or Progression|Study closed|0
4941607|NCT00372905|17000751|P2|Follow up Until Relapse or Progression|Study closed|0
4941608|NCT00372905|17000752|P1|Follow up Until Relapse or Progression|Study closed|0
4941609|NCT00372905|17000749|P4|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2
4941610|NCT00372905|17000750|P3|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
4941611|NCT00372905|17000751|P2|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
4941612|NCT00372905|17000752|P1|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0
4941613|NCT00372905|17000749|P4|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
4941614|NCT00372905|17000750|P3|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1
4941615|NCT00372905|17000751|P2|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
4941616|NCT00372905|17000752|P1|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0
4941617|NCT00372905|17000749|P4|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
4941618|NCT00372905|17000750|P3|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2
4941619|NCT00372905|17000751|P2|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
4941620|NCT00372905|17000752|P1|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0
4941621|NCT00372905|17000749|P4|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
4941622|NCT00372905|17000750|P3|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
4941623|NCT00372905|17000751|P2|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0
4941624|NCT00372905|17000752|P1|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2
4941625|NCT00372775|17000764|P1|Overall Study|Not Treated|2
4941626|NCT00372775|17000764|P1|Overall Study|Other|1
4941627|NCT00372775|17000764|P1|Overall Study|Withdrawal by Subject|1
4941628|NCT00372775|17000764|P1|Overall Study|Global deterioration of health status|6
4941629|NCT00372775|17000764|P1|Overall Study|Objective progression or relapse|30
4941630|NCT00372775|17000764|P1|Overall Study|Death|15
4941631|NCT00372775|17000764|P1|Overall Study|Adverse Event|8
4941632|NCT00372697|17000786|P2|Overall Study|Protocol Violation|1
4941633|NCT00372697|17000787|P1|Overall Study|Protocol Violation|1
4941634|NCT00372619|17000812|P7|Overall Study|Inevaluable|0
4941635|NCT00372619|17000813|P6|Overall Study|Inevaluable|1
4941636|NCT00372619|17000814|P5|Overall Study|Inevaluable|0
4941637|NCT00372619|17000815|P4|Overall Study|Inevaluable|0
4941638|NCT00372619|17000816|P3|Overall Study|Inevaluable|0
4941639|NCT00372619|17000817|P2|Overall Study|Inevaluable|0
4941640|NCT00372619|17000818|P1|Overall Study|Inevaluable|0
4941641|NCT00372619|17000812|P7|Overall Study|Ineligible|0
4941642|NCT00372619|17000813|P6|Overall Study|Ineligible|2
4941643|NCT00372619|17000814|P5|Overall Study|Ineligible|0
4941644|NCT00372619|17000815|P4|Overall Study|Ineligible|0
4941645|NCT00372619|17000816|P3|Overall Study|Ineligible|0
4941646|NCT00372619|17000817|P2|Overall Study|Ineligible|0
4941647|NCT00372619|17000818|P1|Overall Study|Ineligible|0
4941648|NCT00372593|17000851|P3|Overall Study|Ineligible|1
4941649|NCT00372593|17000852|P2|Overall Study|Ineligible|21
4941650|NCT00372593|17000853|P1|Overall Study|Ineligible|20
4941651|NCT00372593|17000851|P3|Overall Study|Physician Decision|0
4941652|NCT00372593|17000852|P2|Overall Study|Physician Decision|41
4941653|NCT00372593|17000853|P1|Overall Study|Physician Decision|42
4941654|NCT00372593|17000851|P3|Overall Study|Lost to Follow-up|0
4941655|NCT00372593|17000852|P2|Overall Study|Lost to Follow-up|0
4941656|NCT00372593|17000853|P1|Overall Study|Lost to Follow-up|1
4941657|NCT00372593|17000851|P3|Overall Study|Lack of Efficacy|2
4941658|NCT00372593|17000852|P2|Overall Study|Lack of Efficacy|71
4941659|NCT00372593|17000853|P1|Overall Study|Lack of Efficacy|82
4941660|NCT00372593|17000851|P3|Overall Study|Death|1
4941661|NCT00372593|17000852|P2|Overall Study|Death|20
4941662|NCT00372593|17000853|P1|Overall Study|Death|16
4941663|NCT00372593|17000851|P3|Overall Study|Adverse Event|0
4941664|NCT00372593|17000852|P2|Overall Study|Adverse Event|45
4941665|NCT00372593|17000853|P1|Overall Study|Adverse Event|43
4941666|NCT00372567|17000882|P3|Phase 3 Study|study terminated by sponsor|5
4941667|NCT00372567|17000883|P2|Phase 3 Study|study terminated by sponsor|8
4941668|NCT00372567|17000884|P1|Phase 3 Study|study terminated by sponsor|13
4941669|NCT00372567|17000882|P3|Phase 3 Study|Other|1
4941670|NCT00372567|17000883|P2|Phase 3 Study|Other|2
4941671|NCT00372567|17000884|P1|Phase 3 Study|Other|2
4941672|NCT00372567|17000882|P3|Phase 3 Study|Global deterioration of health status|0
4941673|NCT00372567|17000883|P2|Phase 3 Study|Global deterioration of health status|1
4941674|NCT00372567|17000884|P1|Phase 3 Study|Global deterioration of health status|0
4941675|NCT00372567|17000882|P3|Phase 3 Study|Objective progression or relapse|4
4941676|NCT00372567|17000883|P2|Phase 3 Study|Objective progression or relapse|13
4941677|NCT00372567|17000884|P1|Phase 3 Study|Objective progression or relapse|10
4941678|NCT00372567|17000882|P3|Phase 3 Study|Protocol Violation|1
4941679|NCT00372567|17000883|P2|Phase 3 Study|Protocol Violation|0
4941680|NCT00372567|17000884|P1|Phase 3 Study|Protocol Violation|0
4941681|NCT00372567|17000882|P3|Phase 3 Study|Death|0
4941682|NCT00372567|17000883|P2|Phase 3 Study|Death|1
4941683|NCT00372567|17000884|P1|Phase 3 Study|Death|1
4941684|NCT00372567|17000882|P3|Phase 3 Study|Adverse Event|1
4941685|NCT00372567|17000883|P2|Phase 3 Study|Adverse Event|1
4941686|NCT00372567|17000884|P1|Phase 3 Study|Adverse Event|5
4941687|NCT00372528|17000912|P1|Overall Study|Other|1
4941688|NCT00372528|17000912|P1|Overall Study|Study Terminated by Sponsor|18
4941689|NCT00372528|17000912|P1|Overall Study|Adverse Event|1
4941690|NCT00372528|17000912|P1|Overall Study|Lack of Efficacy|1
4941691|NCT00372489|17000917|P1|Overall Study|Sponsor Decision to Terminate Study|41
4941692|NCT00372489|17000917|P1|Overall Study|Renal transplant|6
4941693|NCT00372489|17000917|P1|Overall Study|Patient Relocation|2
4941694|NCT00372489|17000917|P1|Overall Study|Withdrawal by Subject|5
4941695|NCT00372489|17000917|P1|Overall Study|Physician Decision|3
4941696|NCT00372489|17000917|P1|Overall Study|Lost to Follow-up|3
4941697|NCT00372489|17000917|P1|Overall Study|Lack of Efficacy|1
4941698|NCT00372489|17000917|P1|Overall Study|Adverse Event|18
4941699|NCT00372424|17000921|P1|Overall Study|Enrolled, Not Treated|1
4941700|NCT00372424|17000921|P1|Overall Study|Other|7
4941701|NCT00372424|17000921|P1|Overall Study|Objective Progression or Relapse|14
4941702|NCT00372424|17000921|P1|Overall Study|Death|1
4941703|NCT00372424|17000921|P1|Overall Study|Withdrawal by Subject|1
4941704|NCT00372424|17000921|P1|Overall Study|Adverse Event|2
4941705|NCT00372411|17000935|P3|Overall Study|Adverse Event|0
4941706|NCT00372411|17000936|P2|Overall Study|Adverse Event|1
4941707|NCT00372411|17000937|P1|Overall Study|Adverse Event|1
4941708|NCT00372411|17000935|P3|Overall Study|Lost to Follow-up|1
4941709|NCT00372411|17000936|P2|Overall Study|Lost to Follow-up|1
4941710|NCT00372411|17000937|P1|Overall Study|Lost to Follow-up|1
4941711|NCT00372411|17000935|P3|Overall Study|Death|1
4941712|NCT00372411|17000936|P2|Overall Study|Death|2
4941713|NCT00372411|17000937|P1|Overall Study|Death|0
4941714|NCT00372411|17000935|P3|Overall Study|Withdrawal by Subject|1
4941715|NCT00372411|17000936|P2|Overall Study|Withdrawal by Subject|4
4941716|NCT00372411|17000937|P1|Overall Study|Withdrawal by Subject|3
4941717|NCT00372385|17000961|P4|Overall Study|Virologic Stopping Rule|0
4941718|NCT00372385|17000962|P3|Overall Study|Virologic Stopping Rule|0
4941719|NCT00372385|17000963|P2|Overall Study|Virologic Stopping Rule|0
4941720|NCT00372385|17000964|P1|Overall Study|Virologic Stopping Rule|17
4941721|NCT00372385|17000961|P4|Overall Study|Ineligibility due to Exclusion Criterion|0
4941722|NCT00372385|17000962|P3|Overall Study|Ineligibility due to Exclusion Criterion|0
4941723|NCT00372385|17000963|P2|Overall Study|Ineligibility due to Exclusion Criterion|0
4941724|NCT00372385|17000964|P1|Overall Study|Ineligibility due to Exclusion Criterion|1
4941725|NCT00372385|17000961|P4|Overall Study|No Response|0
4941726|NCT00372385|17000962|P3|Overall Study|No Response|0
4941727|NCT00372385|17000963|P2|Overall Study|No Response|1
4941728|NCT00372385|17000964|P1|Overall Study|No Response|1
4941729|NCT00372385|17000961|P4|Overall Study|Refusal of Treatment|0
4941730|NCT00372385|17000962|P3|Overall Study|Refusal of Treatment|0
4941731|NCT00372385|17000963|P2|Overall Study|Refusal of Treatment|6
4941732|NCT00372385|17000964|P1|Overall Study|Refusal of Treatment|3
4941733|NCT00372385|17000961|P4|Overall Study|Withdrawal by Subject|0
4941734|NCT00372385|17000962|P3|Overall Study|Withdrawal by Subject|0
4941735|NCT00372385|17000963|P2|Overall Study|Withdrawal by Subject|1
4941736|NCT00372385|17000964|P1|Overall Study|Withdrawal by Subject|2
4941737|NCT00372385|17000961|P4|Overall Study|Lost to Follow-up|0
4941738|NCT00372385|17000962|P3|Overall Study|Lost to Follow-up|0
4941739|NCT00372385|17000963|P2|Overall Study|Lost to Follow-up|0
4941740|NCT00372385|17000964|P1|Overall Study|Lost to Follow-up|2
4941741|NCT00372385|17000961|P4|Overall Study|Physician Decision|0
4941742|NCT00372385|17000962|P3|Overall Study|Physician Decision|0
4941743|NCT00372385|17000963|P2|Overall Study|Physician Decision|0
4941744|NCT00372385|17000964|P1|Overall Study|Physician Decision|1
4941745|NCT00372385|17000961|P4|Overall Study|Noncompliance|1
4941746|NCT00372385|17000962|P3|Overall Study|Noncompliance|1
4941747|NCT00372385|17000963|P2|Overall Study|Noncompliance|1
4941748|NCT00372385|17000964|P1|Overall Study|Noncompliance|0
4941749|NCT00372385|17000961|P4|Overall Study|Adverse Event|7
4941750|NCT00372385|17000962|P3|Overall Study|Adverse Event|9
4941751|NCT00372385|17000963|P2|Overall Study|Adverse Event|11
4941752|NCT00372385|17000964|P1|Overall Study|Adverse Event|6
4941753|NCT00372255|17000993|P2|Overall Study|Withdrawn for other reasons|1
4941754|NCT00372255|17000994|P1|Overall Study|Withdrawn for other reasons|2
4941755|NCT00372229|17001016|P2|Follow-Up Phase|Lost to Follow-up|10
4941756|NCT00372229|17001017|P1|Follow-Up Phase|Lost to Follow-up|12
4941757|NCT00372229|17001016|P2|Follow-Up Phase|Reason not specified|3
4941758|NCT00372229|17001017|P1|Follow-Up Phase|Reason not specified|2
4941759|NCT00372229|17001016|P2|Follow-Up Phase|Administrative|0
4941760|NCT00372229|17001017|P1|Follow-Up Phase|Administrative|1
4941761|NCT00372229|17001016|P2|Follow-Up Phase|Death|12
4941762|NCT00372229|17001017|P1|Follow-Up Phase|Death|9
4941763|NCT00372229|17001016|P2|Follow-Up Phase|Adverse event/intercurrent illness|0
4941764|NCT00372229|17001017|P1|Follow-Up Phase|Adverse event/intercurrent illness|1
4941765|NCT00372229|17001016|P2|Follow-Up Phase|Refused treatment/did not cooperate|1
4941766|NCT00372229|17001017|P1|Follow-Up Phase|Refused treatment/did not cooperate|0
4941767|NCT00372229|17001016|P2|Follow-Up Phase|Consent withdrawn|19
4941768|NCT00372229|17001017|P1|Follow-Up Phase|Consent withdrawn|13
4941769|NCT00372229|17001016|P2|Follow-Up Phase|Graft loss|7
4941770|NCT00372229|17001017|P1|Follow-Up Phase|Graft loss|8
4941771|NCT00372229|17001016|P2|Study Phase|Lost to Follow-up|3
4941772|NCT00372229|17001017|P1|Study Phase|Lost to Follow-up|3
4941773|NCT00372229|17001016|P2|Study Phase|Reason not specified|2
4941774|NCT00372229|17001017|P1|Study Phase|Reason not specified|3
4941775|NCT00372229|17001016|P2|Study Phase|Death|2
4941776|NCT00372229|17001017|P1|Study Phase|Death|3
4941777|NCT00372229|17001016|P2|Study Phase|Refused treatment/did not cooperate|1
4941778|NCT00372229|17001017|P1|Study Phase|Refused treatment/did not cooperate|3
4941779|NCT00372229|17001016|P2|Study Phase|Consent withdrawn|14
4941780|NCT00372229|17001017|P1|Study Phase|Consent withdrawn|16
4941781|NCT00372229|17001016|P2|Study Phase|Protocol Violation|4
4941782|NCT00372229|17001017|P1|Study Phase|Protocol Violation|3
4941783|NCT00372229|17001016|P2|Study Phase|Graft loss|3
4941784|NCT00372229|17001017|P1|Study Phase|Graft loss|0
4941785|NCT00372190|17001107|P2|Overall Study|Lost to Follow-up|1
4941786|NCT00372190|17001108|P1|Overall Study|Lost to Follow-up|3
4941787|NCT00372112|17001124|P4|Overall Study|Other-protocol violation|0
4941788|NCT00372112|17001125|P3|Overall Study|Other-protocol violation|1
4941789|NCT00372112|17001126|P2|Overall Study|Other-protocol violation|0
4941790|NCT00372112|17001127|P1|Overall Study|Other-protocol violation|0
4941791|NCT00372112|17001124|P4|Overall Study|Hepatitis B|0
4941792|NCT00372112|17001125|P3|Overall Study|Hepatitis B|0
4941793|NCT00372112|17001126|P2|Overall Study|Hepatitis B|0
4941794|NCT00372112|17001127|P1|Overall Study|Hepatitis B|1
4941795|NCT00372112|17001124|P4|Overall Study|PR >240 at Visit 3|1
4941796|NCT00372112|17001125|P3|Overall Study|PR >240 at Visit 3|0
4941797|NCT00372112|17001126|P2|Overall Study|PR >240 at Visit 3|0
4941798|NCT00372112|17001127|P1|Overall Study|PR >240 at Visit 3|0
4941799|NCT00372112|17001124|P4|Overall Study|Exacerbation|1
4941800|NCT00372112|17001125|P3|Overall Study|Exacerbation|0
4941801|NCT00372112|17001126|P2|Overall Study|Exacerbation|0
4941802|NCT00372112|17001127|P1|Overall Study|Exacerbation|0
4941803|NCT00372112|17001124|P4|Overall Study|Withdrawal by Subject|1
4941804|NCT00372112|17001125|P3|Overall Study|Withdrawal by Subject|2
4941805|NCT00372112|17001126|P2|Overall Study|Withdrawal by Subject|0
4941806|NCT00372112|17001127|P1|Overall Study|Withdrawal by Subject|0
4941807|NCT00372112|17001124|P4|Overall Study|Adverse Event|1
4941808|NCT00372112|17001125|P3|Overall Study|Adverse Event|1
4941809|NCT00372112|17001126|P2|Overall Study|Adverse Event|1
4941810|NCT00372112|17001127|P1|Overall Study|Adverse Event|0
4941811|NCT00372060|17001258|P2|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0
4941812|NCT00372060|17001259|P1|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2
4941813|NCT00372060|17001258|P2|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8
4941814|NCT00372060|17001259|P1|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9
4941815|NCT00372060|17001258|P2|Period II - Open-label (Weeks 12-52)|Adverse Event|0
4941816|NCT00372060|17001259|P1|Period II - Open-label (Weeks 12-52)|Adverse Event|3
4941817|NCT00372060|17001258|P2|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0
4941818|NCT00372060|17001259|P1|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1
4941819|NCT00372060|17001258|P2|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1
4941820|NCT00372060|17001259|P1|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0
4941821|NCT00372060|17001258|P2|Period I - Double-blind (Weeks 0-12)|Adverse Event|0
4941822|NCT00372060|17001259|P1|Period I - Double-blind (Weeks 0-12)|Adverse Event|2
4941823|NCT00371865|17001274|P2|Overall Study|Withdrawal by Subject|10
4941824|NCT00371865|17001275|P1|Overall Study|Withdrawal by Subject|12
4941825|NCT00371865|17001274|P2|Overall Study|Protocol Violation|2
4941826|NCT00371865|17001275|P1|Overall Study|Protocol Violation|3
4941827|NCT00371865|17001274|P2|Overall Study|Lack of Efficacy|2
4941828|NCT00371865|17001275|P1|Overall Study|Lack of Efficacy|0
4941829|NCT00371839|17001292|P3|Overall Study|Lost to Follow-up|2
4941830|NCT00371839|17001293|P2|Overall Study|Lost to Follow-up|3
4941831|NCT00371839|17001294|P1|Overall Study|Lost to Follow-up|6
4941832|NCT00371839|17001292|P3|Overall Study|Withdrawal by Subject|0
4941833|NCT00371839|17001293|P2|Overall Study|Withdrawal by Subject|4
4941834|NCT00371839|17001294|P1|Overall Study|Withdrawal by Subject|7
4941835|NCT00371839|17001292|P3|Overall Study|Death|0
4941836|NCT00371839|17001293|P2|Overall Study|Death|0
4941837|NCT00371839|17001294|P1|Overall Study|Death|4
4941838|NCT00371826|17001303|P3|Extension Phase (24 Months)|Administrative problems|2
4941839|NCT00371826|17001304|P2|Extension Phase (24 Months)|Administrative problems|0
4941840|NCT00371826|17001305|P1|Extension Phase (24 Months)|Administrative problems|0
4941841|NCT00371826|17001303|P3|Extension Phase (24 Months)|Subject withdrew consent|0
4941842|NCT00371826|17001304|P2|Extension Phase (24 Months)|Subject withdrew consent|2
4941843|NCT00371826|17001305|P1|Extension Phase (24 Months)|Subject withdrew consent|1
4941844|NCT00371826|17001303|P3|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
4941845|NCT00371826|17001304|P2|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2
4941846|NCT00371826|17001305|P1|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0
4941847|NCT00371826|17001303|P3|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
4941848|NCT00371826|17001304|P2|Extension Phase (24 Months)|Abnormal test procedure result(s)|1
4941849|NCT00371826|17001305|P1|Extension Phase (24 Months)|Abnormal test procedure result(s)|0
4941850|NCT00371826|17001303|P3|Extension Phase (24 Months)|Adverse Event|0
4941851|NCT00371826|17001304|P2|Extension Phase (24 Months)|Adverse Event|5
4941852|NCT00371826|17001305|P1|Extension Phase (24 Months)|Adverse Event|4
4941853|NCT00371826|17001303|P3|Core Phase (12 Months)|Graft Loss|0
4941854|NCT00371826|17001304|P2|Core Phase (12 Months)|Graft Loss|1
4941855|NCT00371826|17001305|P1|Core Phase (12 Months)|Graft Loss|0
4941856|NCT00371826|17001303|P3|Core Phase (12 Months)|Administrative problems|8
4941857|NCT00371826|17001304|P2|Core Phase (12 Months)|Administrative problems|0
4941858|NCT00371826|17001305|P1|Core Phase (12 Months)|Administrative problems|1
4941859|NCT00371826|17001303|P3|Core Phase (12 Months)|Subject withdrew consent|3
4941860|NCT00371826|17001304|P2|Core Phase (12 Months)|Subject withdrew consent|0
4941861|NCT00371826|17001305|P1|Core Phase (12 Months)|Subject withdrew consent|0
4941862|NCT00371826|17001303|P3|Core Phase (12 Months)|Protocol Violation|1
4941863|NCT00371826|17001304|P2|Core Phase (12 Months)|Protocol Violation|0
4941864|NCT00371826|17001305|P1|Core Phase (12 Months)|Protocol Violation|1
4941865|NCT00371826|17001303|P3|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2
4941866|NCT00371826|17001304|P2|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3
4941867|NCT00371826|17001305|P1|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6
4941868|NCT00371826|17001303|P3|Core Phase (12 Months)|Abnormal test procedure result(s)|1
4941869|NCT00371826|17001304|P2|Core Phase (12 Months)|Abnormal test procedure result(s)|0
4941870|NCT00371826|17001305|P1|Core Phase (12 Months)|Abnormal test procedure result(s)|1
4941871|NCT00371826|17001303|P3|Core Phase (12 Months)|Adverse Event|9
4941872|NCT00371826|17001304|P2|Core Phase (12 Months)|Adverse Event|4
4941873|NCT00371826|17001305|P1|Core Phase (12 Months)|Adverse Event|15
4941874|NCT00371787|17001429|P2|Overall Study|Withdrawal by Subject|1
4941875|NCT00371787|17001430|P1|Overall Study|Withdrawal by Subject|3
4941876|NCT00371761|17001444|P2|Overall Study|Study termination|3
4941877|NCT00371761|17001445|P1|Overall Study|Study termination|4
4941878|NCT00371761|17001444|P2|Overall Study|Investigator Judgment|3
4941879|NCT00371761|17001445|P1|Overall Study|Investigator Judgment|2
4941880|NCT00371761|17001444|P2|Overall Study|Withdrawal by Subject|3
4941881|NCT00371761|17001445|P1|Overall Study|Withdrawal by Subject|1
4941882|NCT00371761|17001444|P2|Overall Study|Adverse Event|1
4941883|NCT00371761|17001445|P1|Overall Study|Adverse Event|1
4941884|NCT00371683|17001453|P2|Follow-Up Period - Randomized Patients|non-specified|12
4941885|NCT00371683|17001454|P1|Follow-Up Period - Randomized Patients|non-specified|6
4941886|NCT00371683|17001453|P2|Follow-Up Period - Randomized Patients|Lost to Follow-up|39
4941887|NCT00371683|17001454|P1|Follow-Up Period - Randomized Patients|Lost to Follow-up|38
4941888|NCT00371683|17001453|P2|Follow-Up Period - Randomized Patients|Death|2
4941889|NCT00371683|17001454|P1|Follow-Up Period - Randomized Patients|Death|0
4941890|NCT00371683|17001453|P2|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19
4941891|NCT00371683|17001454|P1|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17
4941892|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|non-specified|8
4941893|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|non-specified|9
4941894|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0
4941895|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1
4941896|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|No longer meets study criteria|2
4941897|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|No longer meets study criteria|1
4941898|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|Lost to Follow-up|1
4941899|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|Lost to Follow-up|0
4941900|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37
4941901|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18
4941902|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|Adverse Event|58
4941903|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|Adverse Event|60
4941904|NCT00371683|17001453|P2|DB Treatment Period-Randomized Patients|Death|1
4941905|NCT00371683|17001454|P1|DB Treatment Period-Randomized Patients|Death|1
4941906|NCT00371566|17001522|P2|Follow Up Phase|Lost to Follow-up|0
4941907|NCT00371566|17001523|P1|Follow Up Phase|Lost to Follow-up|1
4941908|NCT00371566|17001522|P2|Follow Up Phase|Physician Decision|1
4941909|NCT00371566|17001523|P1|Follow Up Phase|Physician Decision|1
4941910|NCT00371566|17001522|P2|Follow Up Phase|Withdrawal by Subject|1
4941911|NCT00371566|17001523|P1|Follow Up Phase|Withdrawal by Subject|0
4941912|NCT00371566|17001522|P2|Follow Up Phase|Disease progression|0
4941913|NCT00371566|17001523|P1|Follow Up Phase|Disease progression|1
4941914|NCT00371566|17001522|P2|Follow Up Phase|Death|5
4941915|NCT00371566|17001523|P1|Follow Up Phase|Death|0
4941916|NCT00371566|17001522|P2|Chemoradiation Phase|Death|0
4941917|NCT00371566|17001523|P1|Chemoradiation Phase|Death|2
4941918|NCT00371566|17001522|P2|Chemoradiation Phase|Progressive Disease|1
4941919|NCT00371566|17001523|P1|Chemoradiation Phase|Progressive Disease|1
4941920|NCT00371566|17001522|P2|Chemoradiation Phase|Non compliant|1
4941921|NCT00371566|17001523|P1|Chemoradiation Phase|Non compliant|0
4941922|NCT00371566|17001522|P2|Chemoradiation Phase|Withdrawal by Subject|1
4941923|NCT00371566|17001523|P1|Chemoradiation Phase|Withdrawal by Subject|0
4941924|NCT00371566|17001522|P2|Chemoradiation Phase|Physician Decision|0
4941925|NCT00371566|17001523|P1|Chemoradiation Phase|Physician Decision|2
4941926|NCT00371566|17001522|P2|Treatment Phase|Protocol Violation|1
4941927|NCT00371566|17001523|P1|Treatment Phase|Protocol Violation|0
4941928|NCT00371566|17001522|P2|Treatment Phase|Adverse Event|1
4941929|NCT00371566|17001523|P1|Treatment Phase|Adverse Event|0
4941930|NCT00371566|17001522|P2|Treatment Phase|Withdrawal by Subject|1
4941931|NCT00371566|17001523|P1|Treatment Phase|Withdrawal by Subject|0
4941932|NCT00371462|17001608|P2|Overall Study|Other|8
4941933|NCT00371462|17001609|P1|Overall Study|Other|7
4941934|NCT00371462|17001608|P2|Overall Study|Withdrawal by Subject|0
4941935|NCT00371462|17001609|P1|Overall Study|Withdrawal by Subject|1
4941936|NCT00371397|17001633|P12|Session 1|Withdrawal by Subject|0
4941937|NCT00371397|17001634|P11|Session 1|Withdrawal by Subject|0
4941938|NCT00371397|17001635|P10|Session 1|Withdrawal by Subject|0
4941939|NCT00371397|17001636|P9|Session 1|Withdrawal by Subject|0
4941940|NCT00371397|17001637|P8|Session 1|Withdrawal by Subject|1
4941941|NCT00371397|17001638|P7|Session 1|Withdrawal by Subject|0
4941942|NCT00371397|17001639|P6|Session 1|Withdrawal by Subject|0
4941943|NCT00371397|17001640|P5|Session 1|Withdrawal by Subject|0
4941944|NCT00371397|17001641|P4|Session 1|Withdrawal by Subject|0
4941945|NCT00371397|17001642|P3|Session 1|Withdrawal by Subject|0
4941946|NCT00371397|17001643|P2|Session 1|Withdrawal by Subject|0
4941947|NCT00371397|17001644|P1|Session 1|Withdrawal by Subject|1
4941948|NCT00371345|17001652|P2|Overall Study|Participant Withdrew Consent|1
4941949|NCT00371345|17001653|P1|Overall Study|Participant Withdrew Consent|0
4941950|NCT00371345|17001652|P2|Overall Study|Participant Request|1
4941951|NCT00371345|17001653|P1|Overall Study|Participant Request|1
4941952|NCT00371345|17001652|P2|Overall Study|Adverse event(AE Unrelated to Study Drug|2
4941953|NCT00371345|17001653|P1|Overall Study|Adverse event(AE Unrelated to Study Drug|1
4941954|NCT00371345|17001652|P2|Overall Study|Study Drug Toxicity|7
4941955|NCT00371345|17001653|P1|Overall Study|Study Drug Toxicity|1
4941956|NCT00371345|17001652|P2|Overall Study|Disease Progression|35
4941957|NCT00371345|17001653|P1|Overall Study|Disease Progression|21
4941958|NCT00371254|17001754|P2|Overall Study|Withdrawal by Subject|1
4941959|NCT00371254|17001755|P1|Overall Study|Withdrawal by Subject|0
4941960|NCT00371254|17001754|P2|Overall Study|Lost to Follow-up|1
4941961|NCT00371254|17001755|P1|Overall Study|Lost to Follow-up|0
4941962|NCT00371254|17001754|P2|Overall Study|Adverse event unrelated to study drug|1
4941963|NCT00371254|17001755|P1|Overall Study|Adverse event unrelated to study drug|0
4941964|NCT00371254|17001754|P2|Overall Study|Investigator Decision|0
4941965|NCT00371254|17001755|P1|Overall Study|Investigator Decision|2
4941966|NCT00371254|17001754|P2|Overall Study|Subject request|0
4941967|NCT00371254|17001755|P1|Overall Study|Subject request|5
4941968|NCT00371254|17001754|P2|Overall Study|Study drug toxicity|5
4941969|NCT00371254|17001755|P1|Overall Study|Study drug toxicity|3
4941970|NCT00371254|17001754|P2|Overall Study|Disease progression|13
4941971|NCT00371254|17001755|P1|Overall Study|Disease progression|13
4941972|NCT00371150|17001838|P2|Overall Study|Lost to Follow-up|2
4941973|NCT00371150|17001839|P1|Overall Study|Lost to Follow-up|3
4941974|NCT00371137|17001874|P3|Overall Study|Protocol Violation|1
4941975|NCT00371137|17001875|P2|Overall Study|Protocol Violation|1
4941976|NCT00371137|17001876|P1|Overall Study|Protocol Violation|2
4941977|NCT00371137|17001874|P3|Overall Study|Physician Decision|1
4941978|NCT00371137|17001875|P2|Overall Study|Physician Decision|1
4941979|NCT00371137|17001876|P1|Overall Study|Physician Decision|1
4941980|NCT00371137|17001874|P3|Overall Study|Sponsor Decision|2
4941981|NCT00371137|17001875|P2|Overall Study|Sponsor Decision|1
4941982|NCT00371137|17001876|P1|Overall Study|Sponsor Decision|2
4941983|NCT00371137|17001874|P3|Overall Study|Lack of Efficacy|13
4941984|NCT00371137|17001875|P2|Overall Study|Lack of Efficacy|12
4941985|NCT00371137|17001876|P1|Overall Study|Lack of Efficacy|30
4941986|NCT00371137|17001874|P3|Overall Study|Lost to Follow-up|5
4941987|NCT00371137|17001875|P2|Overall Study|Lost to Follow-up|3
4941988|NCT00371137|17001876|P1|Overall Study|Lost to Follow-up|6
4941989|NCT00371137|17001874|P3|Overall Study|Withdrawal by Subject|15
4941990|NCT00371137|17001875|P2|Overall Study|Withdrawal by Subject|10
4941991|NCT00371137|17001876|P1|Overall Study|Withdrawal by Subject|11
4941992|NCT00371137|17001874|P3|Overall Study|Adverse Event|42
4941993|NCT00371137|17001875|P2|Overall Study|Adverse Event|35
4941994|NCT00371137|17001876|P1|Overall Study|Adverse Event|20
4941995|NCT00370682|17001919|P3|Overall Study|Lost to Follow-up|1
4941996|NCT00370682|17001920|P2|Overall Study|Lost to Follow-up|1
4941997|NCT00370682|17001921|P1|Overall Study|Lost to Follow-up|0
4941998|NCT00370682|17001919|P3|Overall Study|Moved from area|0
4941999|NCT00370682|17001920|P2|Overall Study|Moved from area|2
4942000|NCT00370682|17001921|P1|Overall Study|Moved from area|0
4942001|NCT00370552|17001963|P3|Overall Study|Planned radiation for palliation|0
4942002|NCT00370552|17001964|P2|Overall Study|Planned radiation for palliation|1
4942003|NCT00370552|17001965|P1|Overall Study|Planned radiation for palliation|0
4942004|NCT00370552|17001963|P3|Overall Study|High risk of allergic reaction|0
4942005|NCT00370552|17001964|P2|Overall Study|High risk of allergic reaction|1
4942006|NCT00370552|17001965|P1|Overall Study|High risk of allergic reaction|0
4942007|NCT00370552|17001963|P3|Overall Study|Investigator decision|0
4942008|NCT00370552|17001964|P2|Overall Study|Investigator decision|1
4942009|NCT00370552|17001965|P1|Overall Study|Investigator decision|2
4942010|NCT00370552|17001963|P3|Overall Study|Physician Decision|0
4942011|NCT00370552|17001964|P2|Overall Study|Physician Decision|1
4942012|NCT00370552|17001965|P1|Overall Study|Physician Decision|1
4942013|NCT00370552|17001963|P3|Overall Study|Never treated|0
4942014|NCT00370552|17001964|P2|Overall Study|Never treated|0
4942015|NCT00370552|17001965|P1|Overall Study|Never treated|1
4942016|NCT00370552|17001963|P3|Overall Study|Still on treatment|2
4942017|NCT00370552|17001964|P2|Overall Study|Still on treatment|3
4942018|NCT00370552|17001965|P1|Overall Study|Still on treatment|1
4942019|NCT00370552|17001963|P3|Overall Study|Withdrawal by Subject|1
4942020|NCT00370552|17001964|P2|Overall Study|Withdrawal by Subject|0
4942021|NCT00370552|17001965|P1|Overall Study|Withdrawal by Subject|2
4942022|NCT00370552|17001963|P3|Overall Study|Study drug toxicity|6
4942023|NCT00370552|17001964|P2|Overall Study|Study drug toxicity|8
4942024|NCT00370552|17001965|P1|Overall Study|Study drug toxicity|11
4942025|NCT00370552|17001963|P3|Overall Study|Poor or noncompliance|1
4942026|NCT00370552|17001964|P2|Overall Study|Poor or noncompliance|0
4942027|NCT00370552|17001965|P1|Overall Study|Poor or noncompliance|0
4942028|NCT00370552|17001963|P3|Overall Study|Maximum clinical benefit|5
4942029|NCT00370552|17001964|P2|Overall Study|Maximum clinical benefit|5
4942030|NCT00370552|17001965|P1|Overall Study|Maximum clinical benefit|3
4942031|NCT00370552|17001963|P3|Overall Study|Disease progression|15
4942032|NCT00370552|17001964|P2|Overall Study|Disease progression|23
4942033|NCT00370552|17001965|P1|Overall Study|Disease progression|23
4942034|NCT00370552|17001963|P3|Overall Study|Adverse Event|2
4942035|NCT00370552|17001964|P2|Overall Study|Adverse Event|2
4942036|NCT00370552|17001965|P1|Overall Study|Adverse Event|2
4942037|NCT00370396|17002006|P3|Overall Study|Lost to Follow-up|0
4942038|NCT00370396|17002007|P2|Overall Study|Lost to Follow-up|1
4942039|NCT00370396|17002008|P1|Overall Study|Lost to Follow-up|11
4942040|NCT00370396|17002006|P3|Overall Study|Withdrawal by Subject|1
4942041|NCT00370396|17002007|P2|Overall Study|Withdrawal by Subject|0
4942042|NCT00370396|17002008|P1|Overall Study|Withdrawal by Subject|0
4942043|NCT00370331|17002062|P2|Overall Study|Protocol Violation|1
4942044|NCT00370331|17002063|P1|Overall Study|Protocol Violation|1
4942045|NCT00370331|17002062|P2|Overall Study|Non-compliance|1
4942046|NCT00370331|17002063|P1|Overall Study|Non-compliance|0
4942047|NCT00370331|17002062|P2|Overall Study|Lack of Efficacy|1
4942048|NCT00370331|17002063|P1|Overall Study|Lack of Efficacy|0
4942049|NCT00370331|17002062|P2|Overall Study|Lost to Follow-up|3
4942050|NCT00370331|17002063|P1|Overall Study|Lost to Follow-up|0
4942051|NCT00370331|17002062|P2|Overall Study|Withdrawal by Subject|4
4942052|NCT00370331|17002063|P1|Overall Study|Withdrawal by Subject|2
4942053|NCT00370331|17002062|P2|Overall Study|Adverse Event|13
4942054|NCT00370331|17002063|P1|Overall Study|Adverse Event|4
4942055|NCT00370292|17002089|P1|Overall Study|Physician Decision|2
4942056|NCT00370292|17002089|P1|Overall Study|Adverse Event|7
4942057|NCT00370292|17002089|P1|Overall Study|Disease Progression|4
4942058|NCT00370149|17002102|P2|Overall Study|Antibiotic coated dressing placed|1
4942059|NCT00370149|17002103|P1|Overall Study|Antibiotic coated dressing placed|0
4942060|NCT00370149|17002102|P2|Overall Study|Pre-existing infection|1
4942061|NCT00370149|17002103|P1|Overall Study|Pre-existing infection|0
4942062|NCT00370149|17002102|P2|Overall Study|Catheter inserted in wrong vessel-|1
4942063|NCT00370149|17002103|P1|Overall Study|Catheter inserted in wrong vessel-|2
4942064|NCT00370149|17002102|P2|Overall Study|Protocol Violation|0
4942065|NCT00370149|17002103|P1|Overall Study|Protocol Violation|1
4942066|NCT00370149|17002102|P2|Overall Study|Physician Decision|16
4942067|NCT00370149|17002103|P1|Overall Study|Physician Decision|16
4942068|NCT00370071|17002113|P1|Overall Study|Withdrawal by Subject|2
4942069|NCT00370032|17002130|P2|Follow-up Period|Withdrawal by Subject|0
4942070|NCT00370032|17002131|P1|Follow-up Period|Withdrawal by Subject|1
4942071|NCT00370032|17002130|P2|Washout Period|Adverse Event|0
4942072|NCT00370032|17002131|P1|Washout Period|Adverse Event|1
4942073|NCT00370032|17002130|P2|Washout Period|Lost to Follow-up|1
4942074|NCT00370032|17002131|P1|Washout Period|Lost to Follow-up|0
4942075|NCT00370032|17002130|P2|Washout Period|Withdrawal by Subject|1
4942076|NCT00370032|17002131|P1|Washout Period|Withdrawal by Subject|0
4942077|NCT00370032|17002130|P2|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1
4942078|NCT00370032|17002131|P1|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0
4942079|NCT00369967|17002151|P2|Overall Study|Lost to Follow-up|12
4942080|NCT00369967|17002152|P1|Overall Study|Lost to Follow-up|23
4942081|NCT00369941|17002170|P2|Overall Study|Miscellaneous|3
4942082|NCT00369941|17002171|P1|Overall Study|Miscellaneous|3
4942083|NCT00369941|17002170|P2|Overall Study|Study Site Terminated|0
4942084|NCT00369941|17002171|P1|Overall Study|Study Site Terminated|2
4942085|NCT00369941|17002170|P2|Overall Study|Employment Interfered with Study Visits|0
4942086|NCT00369941|17002171|P1|Overall Study|Employment Interfered with Study Visits|1
4942087|NCT00369941|17002170|P2|Overall Study|Treatment with Prohibited Medication|1
4942088|NCT00369941|17002171|P1|Overall Study|Treatment with Prohibited Medication|3
4942089|NCT00369941|17002170|P2|Overall Study|Moved|5
4942090|NCT00369941|17002171|P1|Overall Study|Moved|11
4942091|NCT00369941|17002170|P2|Overall Study|Completed, Did Not Enter Extension|6
4942092|NCT00369941|17002171|P1|Overall Study|Completed, Did Not Enter Extension|5
4942093|NCT00369941|17002170|P2|Overall Study|Pregnancy|2
4942094|NCT00369941|17002171|P1|Overall Study|Pregnancy|4
4942095|NCT00369941|17002170|P2|Overall Study|Withdrawal by Subject|18
4942096|NCT00369941|17002171|P1|Overall Study|Withdrawal by Subject|5
4942097|NCT00369941|17002170|P2|Overall Study|Protocol Violation|3
4942098|NCT00369941|17002171|P1|Overall Study|Protocol Violation|5
4942099|NCT00369941|17002170|P2|Overall Study|Lost to Follow-up|22
4942100|NCT00369941|17002171|P1|Overall Study|Lost to Follow-up|12
4942101|NCT00369941|17002170|P2|Overall Study|Lack of Efficacy|10
4942102|NCT00369941|17002171|P1|Overall Study|Lack of Efficacy|6
4942103|NCT00369941|17002170|P2|Overall Study|Adverse Event|28
4942104|NCT00369941|17002171|P1|Overall Study|Adverse Event|14
4942105|NCT00369941|17002170|P2|Overall Study|Never Treated|2
4942106|NCT00369941|17002171|P1|Overall Study|Never Treated|1
4942107|NCT00369915|17002336|P2|Overall Study|W/drawl by investigators|1
4942108|NCT00369915|17002337|P1|Overall Study|W/drawl by investigators|0
4942109|NCT00369915|17002336|P2|Overall Study|Withdrawal by Subject|1
4942110|NCT00369915|17002337|P1|Overall Study|Withdrawal by Subject|4
4942111|NCT00369915|17002336|P2|Overall Study|expected side effects|1
4942112|NCT00369915|17002337|P1|Overall Study|expected side effects|2
4942113|NCT00369824|17002351|P6|Overall Study|Other|3
4942114|NCT00369824|17002352|P5|Overall Study|Other|1
4942115|NCT00369824|17002353|P4|Overall Study|Other|2
4942116|NCT00369824|17002354|P3|Overall Study|Other|0
4942117|NCT00369824|17002355|P2|Overall Study|Other|0
4942118|NCT00369824|17002356|P1|Overall Study|Other|0
4942119|NCT00369824|17002351|P6|Overall Study|Lost to Follow-up|6
4942120|NCT00369824|17002352|P5|Overall Study|Lost to Follow-up|9
4942121|NCT00369824|17002353|P4|Overall Study|Lost to Follow-up|8
4942122|NCT00369824|17002354|P3|Overall Study|Lost to Follow-up|7
4942123|NCT00369824|17002355|P2|Overall Study|Lost to Follow-up|11
4942124|NCT00369824|17002356|P1|Overall Study|Lost to Follow-up|6
4942125|NCT00369824|17002351|P6|Overall Study|Withdrawal by Subject|2
4942126|NCT00369824|17002352|P5|Overall Study|Withdrawal by Subject|6
4942127|NCT00369824|17002353|P4|Overall Study|Withdrawal by Subject|4
4942128|NCT00369824|17002354|P3|Overall Study|Withdrawal by Subject|5
4942129|NCT00369824|17002355|P2|Overall Study|Withdrawal by Subject|5
4942130|NCT00369824|17002356|P1|Overall Study|Withdrawal by Subject|9
4942131|NCT00369824|17002351|P6|Overall Study|Protocol Violation|0
4942132|NCT00369824|17002352|P5|Overall Study|Protocol Violation|1
4942133|NCT00369824|17002353|P4|Overall Study|Protocol Violation|1
4942134|NCT00369824|17002354|P3|Overall Study|Protocol Violation|0
4942135|NCT00369824|17002355|P2|Overall Study|Protocol Violation|1
4942136|NCT00369824|17002356|P1|Overall Study|Protocol Violation|0
4942137|NCT00369824|17002351|P6|Overall Study|Adverse Event|0
4942138|NCT00369824|17002352|P5|Overall Study|Adverse Event|1
4942139|NCT00369824|17002353|P4|Overall Study|Adverse Event|0
4942140|NCT00369824|17002354|P3|Overall Study|Adverse Event|0
4942141|NCT00369824|17002355|P2|Overall Study|Adverse Event|2
4942142|NCT00369824|17002356|P1|Overall Study|Adverse Event|0
4942143|NCT00369785|17002456|P2|Overall Study|Multiple reasons|5
4942144|NCT00369785|17002457|P1|Overall Study|Multiple reasons|6
4942145|NCT00369785|17002456|P2|Overall Study|Progression|4
4942146|NCT00369785|17002457|P1|Overall Study|Progression|4
4942147|NCT00369785|17002456|P2|Overall Study|Never started|2
4942148|NCT00369785|17002457|P1|Overall Study|Never started|0
4942149|NCT00369785|17002456|P2|Overall Study|Toxicity|4
4942150|NCT00369785|17002457|P1|Overall Study|Toxicity|6
4942151|NCT00369785|17002456|P2|Overall Study|Withdrawal by Subject|6
4942152|NCT00369785|17002457|P1|Overall Study|Withdrawal by Subject|7
4942153|NCT00369785|17002456|P2|Overall Study|Death|2
4942154|NCT00369785|17002457|P1|Overall Study|Death|1
4942155|NCT00369785|17002456|P2|Overall Study|Physician Decision|2
4942156|NCT00369785|17002457|P1|Overall Study|Physician Decision|3
4942157|NCT00369707|17002478|P1|Follow up for 2 Years After Treatment|Other|2
4942158|NCT00369707|17002478|P1|Follow up for 2 Years After Treatment|Death|1
4942159|NCT00369707|17002478|P1|Maintenance Period (up to 4 Cycles)|Progressive disease|4
4942160|NCT00369707|17002478|P1|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2
4942161|NCT00369707|17002478|P1|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2
4942162|NCT00369707|17002478|P1|Induction Part B (2 Cycles)|Progressive disease|1
4942163|NCT00369707|17002478|P1|Induction Part B (2 Cycles)|Inadequate response/MD decision|1
4942164|NCT00369707|17002478|P1|Induction Part B (2 Cycles)|Withdrawal by Subject|2
4942165|NCT00369707|17002478|P1|Induction Part B (2 Cycles)|Adverse Event|3
4942166|NCT00369681|17002491|P1|Overall Study|Death|1
4942167|NCT00369668|17002501|P3|Overall Study|Lack of Efficacy|7
4942168|NCT00369668|17002502|P2|Overall Study|Lack of Efficacy|5
4942169|NCT00369668|17002503|P1|Overall Study|Lack of Efficacy|4
4942170|NCT00369655|17002517|P1|Overall Study|Refusal of further treatment|2
4942171|NCT00369629|17002526|P4|Follow up for 1 Year|stopped being followed as study closed|0
4942172|NCT00369629|17002527|P3|Follow up for 1 Year|stopped being followed as study closed|2
4942173|NCT00369629|17002528|P2|Follow up for 1 Year|stopped being followed as study closed|0
4942174|NCT00369629|17002529|P1|Follow up for 1 Year|stopped being followed as study closed|0
4942175|NCT00369629|17002526|P4|Follow up for 1 Year|Lost to Follow-up|0
4942176|NCT00369629|17002527|P3|Follow up for 1 Year|Lost to Follow-up|0
4942177|NCT00369629|17002528|P2|Follow up for 1 Year|Lost to Follow-up|1
4942178|NCT00369629|17002529|P1|Follow up for 1 Year|Lost to Follow-up|0
4942179|NCT00369629|17002526|P4|Follow up for 1 Year|Death|0
4942180|NCT00369629|17002527|P3|Follow up for 1 Year|Death|1
4942181|NCT00369629|17002528|P2|Follow up for 1 Year|Death|1
4942182|NCT00369629|17002529|P1|Follow up for 1 Year|Death|2
4942183|NCT00369629|17002526|P4|Completed 4 More Cycles|Progressive disease|0
4942184|NCT00369629|17002527|P3|Completed 4 More Cycles|Progressive disease|2
4942185|NCT00369629|17002528|P2|Completed 4 More Cycles|Progressive disease|1
4942186|NCT00369629|17002529|P1|Completed 4 More Cycles|Progressive disease|2
4942187|NCT00369629|17002526|P4|Completed 4 More Cycles|Withdrawal by Subject|0
4942188|NCT00369629|17002527|P3|Completed 4 More Cycles|Withdrawal by Subject|0
4942189|NCT00369629|17002528|P2|Completed 4 More Cycles|Withdrawal by Subject|1
4942190|NCT00369629|17002529|P1|Completed 4 More Cycles|Withdrawal by Subject|2
4942191|NCT00369629|17002526|P4|Moved on to 4 More Cycles|Progressive Disease|0
4942192|NCT00369629|17002527|P3|Moved on to 4 More Cycles|Progressive Disease|1
4942193|NCT00369629|17002528|P2|Moved on to 4 More Cycles|Progressive Disease|0
4942194|NCT00369629|17002529|P1|Moved on to 4 More Cycles|Progressive Disease|0
4942195|NCT00369629|17002526|P4|Treated 2 Cycles/Reached First Response|Progressive disease|0
4942196|NCT00369629|17002527|P3|Treated 2 Cycles/Reached First Response|Progressive disease|0
4942197|NCT00369629|17002528|P2|Treated 2 Cycles/Reached First Response|Progressive disease|0
4942198|NCT00369629|17002529|P1|Treated 2 Cycles/Reached First Response|Progressive disease|2
4942199|NCT00369629|17002526|P4|Treated 2 Cycles/Reached First Response|Adverse Event|0
4942200|NCT00369629|17002527|P3|Treated 2 Cycles/Reached First Response|Adverse Event|1
4942201|NCT00369629|17002528|P2|Treated 2 Cycles/Reached First Response|Adverse Event|0
4942202|NCT00369629|17002529|P1|Treated 2 Cycles/Reached First Response|Adverse Event|0
4942203|NCT00369629|17002526|P4|Treated 2 Cycles/Reached First Response|Physician Decision|0
4942204|NCT00369629|17002527|P3|Treated 2 Cycles/Reached First Response|Physician Decision|1
4942205|NCT00369629|17002528|P2|Treated 2 Cycles/Reached First Response|Physician Decision|1
4942206|NCT00369629|17002529|P1|Treated 2 Cycles/Reached First Response|Physician Decision|0
4942207|NCT00369577|17002560|P3|Overall Study|Withdrawal by Subject|1
4942208|NCT00369577|17002561|P2|Overall Study|Withdrawal by Subject|0
4942209|NCT00369577|17002562|P1|Overall Study|Withdrawal by Subject|0
4942210|NCT00369486|17002599|P5|34-Week Visit|Dropped|3
4942211|NCT00369486|17002600|P4|34-Week Visit|Dropped|3
4942212|NCT00369486|17002601|P3|34-Week Visit|Dropped|1
4942213|NCT00369486|17002602|P2|34-Week Visit|Dropped|1
4942214|NCT00369486|17002603|P1|34-Week Visit|Dropped|0
4942215|NCT00369486|17002599|P5|17-Week Visit|Missed visit|1
4942216|NCT00369486|17002600|P4|17-Week Visit|Missed visit|1
4942217|NCT00369486|17002601|P3|17-Week Visit|Missed visit|1
4942218|NCT00369486|17002602|P2|17-Week Visit|Missed visit|0
4942219|NCT00369486|17002603|P1|17-Week Visit|Missed visit|0
4942220|NCT00369486|17002599|P5|8-Week Visit|Dropped|0
4942221|NCT00369486|17002600|P4|8-Week Visit|Dropped|1
4942222|NCT00369486|17002601|P3|8-Week Visit|Dropped|0
4942223|NCT00369486|17002602|P2|8-Week Visit|Dropped|0
4942224|NCT00369486|17002603|P1|8-Week Visit|Dropped|0
4942225|NCT00369486|17002599|P5|8-Week Visit|Missed visit|1
4942226|NCT00369486|17002600|P4|8-Week Visit|Missed visit|0
4942227|NCT00369486|17002601|P3|8-Week Visit|Missed visit|0
4942228|NCT00369486|17002602|P2|8-Week Visit|Missed visit|1
4942229|NCT00369486|17002603|P1|8-Week Visit|Missed visit|0
4942230|NCT00369486|17002599|P5|4-Week Visit|Dropped|0
4942231|NCT00369486|17002600|P4|4-Week Visit|Dropped|0
4942232|NCT00369486|17002601|P3|4-Week Visit|Dropped|1
4942233|NCT00369486|17002602|P2|4-Week Visit|Dropped|0
4942234|NCT00369486|17002603|P1|4-Week Visit|Dropped|0
4942235|NCT00369486|17002599|P5|4-Week Visit|Missed visit|1
4942236|NCT00369486|17002600|P4|4-Week Visit|Missed visit|2
4942237|NCT00369486|17002601|P3|4-Week Visit|Missed visit|0
4942238|NCT00369486|17002602|P2|4-Week Visit|Missed visit|2
4942239|NCT00369486|17002603|P1|4-Week Visit|Missed visit|2
4942240|NCT00369382|17002642|P2|Overall Study|Other|0
4942241|NCT00369382|17002643|P1|Overall Study|Other|1
4942242|NCT00369382|17002642|P2|Overall Study|Randomized, not treated|0
4942243|NCT00369382|17002643|P1|Overall Study|Randomized, not treated|2
4942244|NCT00369382|17002642|P2|Overall Study|Withdrawal by Subject|0
4942245|NCT00369382|17002643|P1|Overall Study|Withdrawal by Subject|5
4942246|NCT00369382|17002642|P2|Overall Study|Physician Decision|1
4942247|NCT00369382|17002643|P1|Overall Study|Physician Decision|2
4942248|NCT00369382|17002642|P2|Overall Study|Death|2
4942249|NCT00369382|17002643|P1|Overall Study|Death|0
4942250|NCT00369343|17002676|P2|Open-label Phase|did not take study drug|2
4942251|NCT00369343|17002677|P1|Open-label Phase|did not take study drug|1
4942252|NCT00369343|17002676|P2|Open-label Phase|Lack of continuance tolerability|4
4942253|NCT00369343|17002677|P1|Open-label Phase|Lack of continuance tolerability|3
4942254|NCT00369343|17002676|P2|Open-label Phase|Lack of Efficacy|3
4942255|NCT00369343|17002677|P1|Open-label Phase|Lack of Efficacy|4
4942256|NCT00369343|17002676|P2|Open-label Phase|Withdrawal by Subject|6
4942257|NCT00369343|17002677|P1|Open-label Phase|Withdrawal by Subject|15
4942258|NCT00369343|17002676|P2|Open-label Phase|Protocol Violation|3
4942259|NCT00369343|17002677|P1|Open-label Phase|Protocol Violation|1
4942260|NCT00369343|17002676|P2|Open-label Phase|inadvertently reported study completers|2
4942261|NCT00369343|17002677|P1|Open-label Phase|inadvertently reported study completers|3
4942262|NCT00369343|17002676|P2|Open-label Phase|Lost to Follow-up|3
4942263|NCT00369343|17002677|P1|Open-label Phase|Lost to Follow-up|5
4942264|NCT00369343|17002676|P2|Open-label Phase|Physician Decision|0
4942265|NCT00369343|17002677|P1|Open-label Phase|Physician Decision|2
4942266|NCT00369343|17002676|P2|Open-label Phase|Failed to return|0
4942267|NCT00369343|17002677|P1|Open-label Phase|Failed to return|4
4942268|NCT00369343|17002676|P2|Open-label Phase|Adverse Event|7
4942269|NCT00369343|17002677|P1|Open-label Phase|Adverse Event|19
4942270|NCT00369343|17002676|P2|Double-blind Phase|Protocol deviation|0
4942271|NCT00369343|17002677|P1|Double-blind Phase|Protocol deviation|4
4942272|NCT00369343|17002676|P2|Double-blind Phase|Lack of Efficacy|4
4942273|NCT00369343|17002677|P1|Double-blind Phase|Lack of Efficacy|0
4942274|NCT00369343|17002676|P2|Double-blind Phase|Withdrawal by Subject|6
4942275|NCT00369343|17002677|P1|Double-blind Phase|Withdrawal by Subject|8
4942276|NCT00369343|17002676|P2|Double-blind Phase|Protocol Violation|0
4942277|NCT00369343|17002677|P1|Double-blind Phase|Protocol Violation|2
4942278|NCT00369343|17002676|P2|Double-blind Phase|Lost to Follow-up|2
4942279|NCT00369343|17002677|P1|Double-blind Phase|Lost to Follow-up|9
4942280|NCT00369343|17002676|P2|Double-blind Phase|Failed to return|0
4942281|NCT00369343|17002677|P1|Double-blind Phase|Failed to return|2
4942282|NCT00369343|17002676|P2|Double-blind Phase|Adverse Event|4
4942283|NCT00369343|17002677|P1|Double-blind Phase|Adverse Event|19
4942284|NCT00369317|17002710|P1|Overall Study|Ineligible|1
4942285|NCT00369317|17002710|P1|Overall Study|Withdrawal by Subject|8
4942286|NCT00369317|17002710|P1|Overall Study|Physician Decision|2
4942287|NCT00369317|17002710|P1|Overall Study|Lack of Efficacy|5
4942288|NCT00369317|17002710|P1|Overall Study|Death|1
4942289|NCT00369317|17002710|P1|Overall Study|Adverse Event|3
4942290|NCT00369278|17002726|P2|Overall Study|Graft loss|2
4942291|NCT00369278|17002727|P1|Overall Study|Graft loss|1
4942292|NCT00369278|17002726|P2|Overall Study|Lost to Follow-up|0
4942293|NCT00369278|17002727|P1|Overall Study|Lost to Follow-up|1
4942294|NCT00369278|17002726|P2|Overall Study|Withdrawal by Subject|2
4942295|NCT00369278|17002727|P1|Overall Study|Withdrawal by Subject|2
4942296|NCT00369278|17002726|P2|Overall Study|Protocol Violation|1
4942297|NCT00369278|17002727|P1|Overall Study|Protocol Violation|2
4942298|NCT00369278|17002726|P2|Overall Study|Unsatisfactory therapeutic effect|5
4942299|NCT00369278|17002727|P1|Overall Study|Unsatisfactory therapeutic effect|4
4942300|NCT00369278|17002726|P2|Overall Study|Adverse Event|11
4942301|NCT00369278|17002727|P1|Overall Study|Adverse Event|14
4942302|NCT00369265|17002743|P2|Overall Study|Study terminated|7
4942303|NCT00369265|17002744|P1|Overall Study|Study terminated|4
4942304|NCT00369161|17002765|P2|Overall Study|Administrative Problem|2
4942305|NCT00369161|17002766|P1|Overall Study|Administrative Problem|2
4942306|NCT00369161|17002765|P2|Overall Study|Graft loss|0
4942307|NCT00369161|17002766|P1|Overall Study|Graft loss|4
4942308|NCT00369161|17002765|P2|Overall Study|Death|2
4942309|NCT00369161|17002766|P1|Overall Study|Death|1
4942310|NCT00369161|17002765|P2|Overall Study|Withdrawal by Subject|3
4942311|NCT00369161|17002766|P1|Overall Study|Withdrawal by Subject|2
4942312|NCT00369161|17002765|P2|Overall Study|Protocol Violation|2
4942313|NCT00369161|17002766|P1|Overall Study|Protocol Violation|0
4942314|NCT00369161|17002765|P2|Overall Study|Lack of Efficacy|1
4942315|NCT00369161|17002766|P1|Overall Study|Lack of Efficacy|3
4942316|NCT00369161|17002765|P2|Overall Study|Abnormal laboratory value|1
4942317|NCT00369161|17002766|P1|Overall Study|Abnormal laboratory value|0
4942318|NCT00369161|17002765|P2|Overall Study|Adverse Event|13
4942319|NCT00369161|17002766|P1|Overall Study|Adverse Event|15
4942320|NCT00369122|17002776|P1|Overall Study|No protocol treatment|1
4942321|NCT00369122|17002776|P1|Overall Study|Ineligible|10
4942322|NCT00368992|17002783|P1|Overall Study|Other|9
4942323|NCT00368992|17002783|P1|Overall Study|Death|4
4942324|NCT00368992|17002783|P1|Overall Study|Adverse Event|26
4942325|NCT00368992|17002783|P1|Overall Study|Lack of Efficacy|63
4942326|NCT00368992|17002783|P1|Overall Study|Refused treatment|3
4942327|NCT00368992|17002783|P1|Overall Study|Ineligible|5
4942328|NCT00368979|17002792|P2|Overall Study|Withdrawal by Subject|9
4942329|NCT00368979|17002793|P1|Overall Study|Withdrawal by Subject|5
4942330|NCT00368979|17002792|P2|Overall Study|Protocol Violation|1
4942331|NCT00368979|17002793|P1|Overall Study|Protocol Violation|2
4942332|NCT00368979|17002792|P2|Overall Study|Lost to Follow-up|0
4942333|NCT00368979|17002793|P1|Overall Study|Lost to Follow-up|1
4942334|NCT00368979|17002792|P2|Overall Study|Other|1
4942335|NCT00368979|17002793|P1|Overall Study|Other|3
4942336|NCT00368979|17002792|P2|Overall Study|Lack of Efficacy|3
4942337|NCT00368979|17002793|P1|Overall Study|Lack of Efficacy|5
4942338|NCT00368979|17002792|P2|Overall Study|Adverse Event|16
4942339|NCT00368979|17002793|P1|Overall Study|Adverse Event|9
4942340|NCT00368966|17002809|P2|Toddler Dose|Lost to Follow-up|2
4942341|NCT00368966|17002810|P1|Toddler Dose|Lost to Follow-up|0
4942342|NCT00368966|17002809|P2|Toddler Dose|Withdrawal by Subject|1
4942343|NCT00368966|17002810|P1|Toddler Dose|Withdrawal by Subject|1
4942344|NCT00368966|17002809|P2|After Infant|Lost to Follow-up|1
4942345|NCT00368966|17002810|P1|After Infant|Lost to Follow-up|0
4942346|NCT00368966|17002809|P2|After Infant|Death|0
4942347|NCT00368966|17002810|P1|After Infant|Death|1
4942348|NCT00368966|17002809|P2|After Infant|Withdrawal by Subject|1
4942349|NCT00368966|17002810|P1|After Infant|Withdrawal by Subject|1
4942350|NCT00368966|17002809|P2|After Infant|Adverse Event|2
4942351|NCT00368966|17002810|P1|After Infant|Adverse Event|1
4942352|NCT00368966|17002809|P2|After Infant|Failed to return|1
4942353|NCT00368966|17002810|P1|After Infant|Failed to return|3
4942354|NCT00368966|17002809|P2|Infant Series|Failed to return|0
4942355|NCT00368966|17002810|P1|Infant Series|Failed to return|1
4942356|NCT00368966|17002809|P2|Infant Series|Adverse Event|1
4942357|NCT00368966|17002810|P1|Infant Series|Adverse Event|0
4942358|NCT00368966|17002809|P2|Infant Series|Failed to meet eligibility criteria|1
4942359|NCT00368966|17002810|P1|Infant Series|Failed to meet eligibility criteria|0
4942360|NCT00368966|17002809|P2|Infant Series|Randomization error|1
4942361|NCT00368966|17002810|P1|Infant Series|Randomization error|0
4942362|NCT00368966|17002809|P2|Infant Series|Lost to Follow-up|0
4942363|NCT00368966|17002810|P1|Infant Series|Lost to Follow-up|2
4942364|NCT00368966|17002809|P2|Infant Series|Protocol Violation|1
4942365|NCT00368966|17002810|P1|Infant Series|Protocol Violation|2
4942366|NCT00368966|17002809|P2|Infant Series|Withdrawal by Subject|6
4942367|NCT00368966|17002810|P1|Infant Series|Withdrawal by Subject|11
4942368|NCT00368927|17002881|P2|Overall Study|Physician Decision|0
4942369|NCT00368927|17002882|P1|Overall Study|Physician Decision|1
4942370|NCT00368927|17002881|P2|Overall Study|Withdrawal by Subject|2
4942371|NCT00368927|17002882|P1|Overall Study|Withdrawal by Subject|1
4942372|NCT00368927|17002881|P2|Overall Study|Adverse Event|1
4942373|NCT00368927|17002882|P1|Overall Study|Adverse Event|1
4942374|NCT00368927|17002881|P2|Overall Study|Lost to Follow-up|0
4942375|NCT00368927|17002882|P1|Overall Study|Lost to Follow-up|2
4942376|NCT00368875|17002890|P2|Overall Study|Alternative Therapy|1
4942377|NCT00368875|17002891|P1|Overall Study|Alternative Therapy|1
4942378|NCT00368875|17002890|P2|Overall Study|Other Reason|2
4942379|NCT00368875|17002891|P1|Overall Study|Other Reason|0
4942380|NCT00368875|17002890|P2|Overall Study|Withdrawal by Subject|6
4942381|NCT00368875|17002891|P1|Overall Study|Withdrawal by Subject|2
4942382|NCT00368875|17002890|P2|Overall Study|Progressive disease|27
4942383|NCT00368875|17002891|P1|Overall Study|Progressive disease|3
4942384|NCT00368875|17002890|P2|Overall Study|Adverse Event|12
4942385|NCT00368875|17002891|P1|Overall Study|Adverse Event|0
4942386|NCT00368849|17002899|P2|Overall Study|Physician Decision|1
4942387|NCT00368849|17002900|P1|Overall Study|Physician Decision|0
4942388|NCT00368849|17002899|P2|Overall Study|Withdrawal by Subject|1
4942389|NCT00368849|17002900|P1|Overall Study|Withdrawal by Subject|0
4942390|NCT00368745|17002916|P2|Double-blind Treatment Period|Other|6
4942391|NCT00368745|17002917|P1|Double-blind Treatment Period|Other|7
4942392|NCT00368745|17002916|P2|Double-blind Treatment Period|Withdrawal by Subject|3
4942393|NCT00368745|17002917|P1|Double-blind Treatment Period|Withdrawal by Subject|5
4942394|NCT00368745|17002916|P2|Double-blind Treatment Period|Lost to Follow-up|0
4942395|NCT00368745|17002917|P1|Double-blind Treatment Period|Lost to Follow-up|1
4942396|NCT00368745|17002916|P2|Double-blind Treatment Period|Lack of Efficacy|16
4942397|NCT00368745|17002917|P1|Double-blind Treatment Period|Lack of Efficacy|7
4942398|NCT00368745|17002916|P2|Double-blind Treatment Period|Adverse Event|6
4942399|NCT00368745|17002917|P1|Double-blind Treatment Period|Adverse Event|6
4942400|NCT00368641|17002970|P2|Overall Study|Sponsor decision to terminate study|5
4942401|NCT00368641|17002971|P1|Overall Study|Sponsor decision to terminate study|2
4942402|NCT00368641|17002970|P2|Overall Study|Withdrawal by Subject|0
4942403|NCT00368641|17002971|P1|Overall Study|Withdrawal by Subject|1
4942404|NCT00368641|17002970|P2|Overall Study|Death|0
4942405|NCT00368641|17002971|P1|Overall Study|Death|1
4942406|NCT00368641|17002970|P2|Overall Study|Adverse Event|1
4942407|NCT00368641|17002971|P1|Overall Study|Adverse Event|2
4942408|NCT00368550|17002979|P2|Overall Study|Withdrawal by Subject|10
4942409|NCT00368550|17002980|P1|Overall Study|Withdrawal by Subject|17
4942410|NCT00368550|17002979|P2|Overall Study|Lack of Efficacy|9
4942411|NCT00368550|17002980|P1|Overall Study|Lack of Efficacy|4
4942412|NCT00368550|17002979|P2|Overall Study|Adverse Event|4
4942413|NCT00368550|17002980|P1|Overall Study|Adverse Event|7
4942414|NCT00368537|17002992|P2|Baseline Participants|Patient uncompliant|1
4942415|NCT00368537|17002993|P1|Baseline Participants|Patient uncompliant|0
4942416|NCT00368537|17002992|P2|Baseline Participants|No susceptibility|0
4942417|NCT00368537|17002993|P1|Baseline Participants|No susceptibility|1
4942418|NCT00368537|17002992|P2|Baseline Participants|Death|2
4942419|NCT00368537|17002993|P1|Baseline Participants|Death|1
4942420|NCT00368537|17002992|P2|Baseline Participants|Withdrawal by Subject|4
4942421|NCT00368537|17002993|P1|Baseline Participants|Withdrawal by Subject|6
4942422|NCT00368537|17002992|P2|Baseline Participants|Lost to Follow-up|17
4942423|NCT00368537|17002993|P1|Baseline Participants|Lost to Follow-up|16
4942424|NCT00368537|17002992|P2|Randomization|No study drug dosed|6
4942425|NCT00368537|17002993|P1|Randomization|No study drug dosed|13
4942426|NCT00368472|17003007|P1|Overall Study|Missing Final Disposition Date|1
4942427|NCT00368472|17003007|P1|Overall Study|Other|32
4942428|NCT00368472|17003007|P1|Overall Study|Diary non-compliance|1
4942429|NCT00368472|17003007|P1|Overall Study|Withdrawal by Subject|40
4942430|NCT00368472|17003007|P1|Overall Study|Request of Investigator or Sponsor|3
4942431|NCT00368472|17003007|P1|Overall Study|Protocol Violation|2
4942432|NCT00368472|17003007|P1|Overall Study|Medication non-compliance|4
4942433|NCT00368472|17003007|P1|Overall Study|Adverse Event|22
4942434|NCT00368355|17003042|P2|Overall Study|Treatment - hematopoietic cell product|0
4942435|NCT00368355|17003043|P1|Overall Study|Treatment - hematopoietic cell product|2
4942436|NCT00368355|17003042|P2|Overall Study|Subsequent transplant|3
4942437|NCT00368355|17003043|P1|Overall Study|Subsequent transplant|0
4942438|NCT00368355|17003042|P2|Overall Study|Relapse|10
4942439|NCT00368355|17003043|P1|Overall Study|Relapse|6
4942440|NCT00368355|17003042|P2|Overall Study|Death|4
4942441|NCT00368355|17003043|P1|Overall Study|Death|2
4942442|NCT00368355|17003042|P2|Overall Study|Adverse Event|0
4942443|NCT00368355|17003043|P1|Overall Study|Adverse Event|1
4942444|NCT00368277|17003083|P2|Overall Study|Lost to Follow-up|6
4942445|NCT00368277|17003084|P1|Overall Study|Lost to Follow-up|8
4942446|NCT00368277|17003083|P2|Overall Study|Patient withdrew consent|28
4942447|NCT00368277|17003084|P1|Overall Study|Patient withdrew consent|32
4942448|NCT00368277|17003083|P2|Overall Study|Protocol deviation|0
4942449|NCT00368277|17003084|P1|Overall Study|Protocol deviation|7
4942450|NCT00368277|17003083|P2|Overall Study|Unsatisfactory therapeutic effect|24
4942451|NCT00368277|17003084|P1|Overall Study|Unsatisfactory therapeutic effect|31
4942452|NCT00368277|17003083|P2|Overall Study|Death|1
4942453|NCT00368277|17003084|P1|Overall Study|Death|2
4942454|NCT00368277|17003083|P2|Overall Study|Adverse Event|49
4942455|NCT00368277|17003084|P1|Overall Study|Adverse Event|33
4942456|NCT00368251|17003099|P3|Overall Study|AE, non-serious non-fatal|1
4942457|NCT00368251|17003100|P2|Overall Study|AE, non-serious non-fatal|0
4942458|NCT00368251|17003101|P1|Overall Study|AE, non-serious non-fatal|0
4942459|NCT00368251|17003099|P3|Overall Study|SAE, non-fatal|0
4942460|NCT00368251|17003100|P2|Overall Study|SAE, non-fatal|0
4942461|NCT00368251|17003101|P1|Overall Study|SAE, non-fatal|1
4942462|NCT00368108|17003124|P3|Overall Study|Other|1
4942463|NCT00368108|17003125|P2|Overall Study|Other|7
4942464|NCT00368108|17003126|P1|Overall Study|Other|3
4942465|NCT00368108|17003124|P3|Overall Study|Physician Decision|1
4942466|NCT00368108|17003125|P2|Overall Study|Physician Decision|0
4942467|NCT00368108|17003126|P1|Overall Study|Physician Decision|2
4942468|NCT00368108|17003124|P3|Overall Study|Lack of Efficacy|5
4942469|NCT00368108|17003125|P2|Overall Study|Lack of Efficacy|8
4942470|NCT00368108|17003126|P1|Overall Study|Lack of Efficacy|7
4942471|NCT00368108|17003124|P3|Overall Study|Withdrawal by Subject|5
4942472|NCT00368108|17003125|P2|Overall Study|Withdrawal by Subject|3
4942473|NCT00368108|17003126|P1|Overall Study|Withdrawal by Subject|9
4942474|NCT00368108|17003124|P3|Overall Study|Protocol Violation|9
4942475|NCT00368108|17003125|P2|Overall Study|Protocol Violation|9
4942476|NCT00368108|17003126|P1|Overall Study|Protocol Violation|5
4942477|NCT00368108|17003124|P3|Overall Study|Abnormal Laboratory Value|3
4942478|NCT00368108|17003125|P2|Overall Study|Abnormal Laboratory Value|0
4942479|NCT00368108|17003126|P1|Overall Study|Abnormal Laboratory Value|0
4942480|NCT00368108|17003124|P3|Overall Study|Adverse Event|44
4942481|NCT00368108|17003125|P2|Overall Study|Adverse Event|26
4942482|NCT00368108|17003126|P1|Overall Study|Adverse Event|38
4942483|NCT00368069|17003145|P2|Overall Study|no blood sampling possible|1
4942484|NCT00368069|17003146|P1|Overall Study|no blood sampling possible|0
4942485|NCT00368069|17003145|P2|Overall Study|Withdrawal of Consent|1
4942486|NCT00368069|17003146|P1|Overall Study|Withdrawal of Consent|2
4942487|NCT00368069|17003145|P2|Overall Study|Protocol Violation|2
4942488|NCT00368069|17003146|P1|Overall Study|Protocol Violation|0
4942489|NCT00368069|17003145|P2|Overall Study|Lost to Follow-up|0
4942490|NCT00368069|17003146|P1|Overall Study|Lost to Follow-up|1
4942491|NCT00368069|17003145|P2|Overall Study|Lack of Efficacy|1
4942492|NCT00368069|17003146|P1|Overall Study|Lack of Efficacy|0
4942493|NCT00368069|17003145|P2|Overall Study|Adverse Event|2
4942494|NCT00368069|17003146|P1|Overall Study|Adverse Event|5
4942495|NCT00367991|17003164|P2|Overall Study|Adverse Event|1
4942496|NCT00367991|17003165|P1|Overall Study|Adverse Event|1
4942497|NCT00367991|17003164|P2|Overall Study|Withdrawal by Subject|1
4942498|NCT00367991|17003165|P1|Overall Study|Withdrawal by Subject|1
4942499|NCT00367835|17003183|P2|Overall Study|History of lead poisoning|1
4942500|NCT00367835|17003184|P1|Overall Study|History of lead poisoning|0
4942501|NCT00367835|17003183|P2|Overall Study|Did not respond to calls|0
4942502|NCT00367835|17003184|P1|Overall Study|Did not respond to calls|1
4942503|NCT00367835|17003183|P2|Overall Study|refused blood collection|0
4942504|NCT00367835|17003184|P1|Overall Study|refused blood collection|1
4942505|NCT00367835|17003183|P2|Overall Study|Subject in juvenile detention center|0
4942506|NCT00367835|17003184|P1|Overall Study|Subject in juvenile detention center|1
4942507|NCT00367835|17003183|P2|Overall Study|Lack of Efficacy|12
4942508|NCT00367835|17003184|P1|Overall Study|Lack of Efficacy|3
4942509|NCT00367835|17003183|P2|Overall Study|Lost to Follow-up|4
4942510|NCT00367835|17003184|P1|Overall Study|Lost to Follow-up|1
4942511|NCT00367835|17003183|P2|Overall Study|Withdrawal by Subject|6
4942512|NCT00367835|17003184|P1|Overall Study|Withdrawal by Subject|7
4942513|NCT00367835|17003183|P2|Overall Study|Protocol Violation|7
4942514|NCT00367835|17003184|P1|Overall Study|Protocol Violation|1
4942515|NCT00367835|17003183|P2|Overall Study|Adverse Event|1
4942516|NCT00367835|17003184|P1|Overall Study|Adverse Event|14
4942517|NCT00367770|17003210|P1|Overall Study|Withdrawal by Subject|1
4942518|NCT00367770|17003210|P1|Overall Study|Adverse Event|1
4942519|NCT00367744|17003218|P2|Overall Study|Lost to Follow-up|5
4942520|NCT00367744|17003219|P1|Overall Study|Lost to Follow-up|4
4942521|NCT00367640|17003248|P4|Overall Study|Any other reason not above-mentioned|4
4942522|NCT00367640|17003249|P3|Overall Study|Any other reason not above-mentioned|3
4942523|NCT00367640|17003250|P2|Overall Study|Any other reason not above-mentioned|5
4942524|NCT00367640|17003251|P1|Overall Study|Any other reason not above-mentioned|7
4942525|NCT00367640|17003248|P4|Overall Study|Withdrawal by Subject|6
4942526|NCT00367640|17003249|P3|Overall Study|Withdrawal by Subject|8
4942527|NCT00367640|17003250|P2|Overall Study|Withdrawal by Subject|11
4942528|NCT00367640|17003251|P1|Overall Study|Withdrawal by Subject|8
4942529|NCT00367640|17003248|P4|Overall Study|Adverse Event|0
4942530|NCT00367640|17003249|P3|Overall Study|Adverse Event|8
4942531|NCT00367640|17003250|P2|Overall Study|Adverse Event|6
4942532|NCT00367640|17003251|P1|Overall Study|Adverse Event|3
4942533|NCT00367484|17003267|P1|Overall Study|Lack of Efficacy|1
4942534|NCT00367484|17003267|P1|Overall Study|The choice of the patient|1
4942535|NCT00367484|17003267|P1|Overall Study|Protocol Violation|1
4942536|NCT00367484|17003267|P1|Overall Study|Lost to Follow-up|1
4942537|NCT00367484|17003267|P1|Overall Study|Travel to USA|1
4942538|NCT00367484|17003267|P1|Overall Study|Withdrew informed consent|5
4942539|NCT00367484|17003267|P1|Overall Study|Adverse Event|7
4942540|NCT00367458|17003273|P2|First Intervention - 8 Weeks|Adverse Event|0
4942541|NCT00367458|17003274|P1|First Intervention - 8 Weeks|Adverse Event|2
4942542|NCT00367432|17003288|P2|Second Period (up to 54 Months)|Other Reason|2
4942543|NCT00367432|17003289|P1|Second Period (up to 54 Months)|Other Reason|6
4942544|NCT00367432|17003288|P2|Second Period (up to 54 Months)|Withdrawal by Subject|5
4942545|NCT00367432|17003289|P1|Second Period (up to 54 Months)|Withdrawal by Subject|8
4942546|NCT00367432|17003288|P2|Second Period (up to 54 Months)|Lost to Follow-up|1
4942547|NCT00367432|17003289|P1|Second Period (up to 54 Months)|Lost to Follow-up|0
4942548|NCT00367432|17003288|P2|Second Period (up to 54 Months)|Lack of Efficacy|5
4942549|NCT00367432|17003289|P1|Second Period (up to 54 Months)|Lack of Efficacy|59
4942550|NCT00367432|17003288|P2|Second Period (up to 54 Months)|Adverse Event|3
4942551|NCT00367432|17003289|P1|Second Period (up to 54 Months)|Adverse Event|14
4942552|NCT00367432|17003288|P2|First Period (16 Weeks)|Other Reason|0
4942553|NCT00367432|17003289|P1|First Period (16 Weeks)|Other Reason|2
4942554|NCT00367432|17003288|P2|First Period (16 Weeks)|Withdrawal by Subject|0
4942555|NCT00367432|17003289|P1|First Period (16 Weeks)|Withdrawal by Subject|6
4942556|NCT00367432|17003288|P2|First Period (16 Weeks)|Lack of Efficacy|0
4942557|NCT00367432|17003289|P1|First Period (16 Weeks)|Lack of Efficacy|24
4942558|NCT00367432|17003288|P2|First Period (16 Weeks)|Adverse Event|0
4942559|NCT00367432|17003289|P1|First Period (16 Weeks)|Adverse Event|6
4942560|NCT00367341|17003316|P2|Overall Study|Protocol Violation|0
4942561|NCT00367341|17003317|P1|Overall Study|Protocol Violation|1
4942562|NCT00367341|17003316|P2|Overall Study|Physician Decision|0
4942563|NCT00367341|17003317|P1|Overall Study|Physician Decision|1
4942564|NCT00367237|17003327|P2|Overall Study|Protocol Violation|5
4942565|NCT00367237|17003328|P1|Overall Study|Protocol Violation|2
4942566|NCT00367237|17003327|P2|Overall Study|Withdrawal by Subject|4
4942567|NCT00367237|17003328|P1|Overall Study|Withdrawal by Subject|0
4942568|NCT00367237|17003327|P2|Overall Study|Lost to Follow-up|0
4942569|NCT00367237|17003328|P1|Overall Study|Lost to Follow-up|1
4942570|NCT00367237|17003327|P2|Overall Study|Adverse Event|2
4942571|NCT00367237|17003328|P1|Overall Study|Adverse Event|7
4942572|NCT00367133|17003337|P3|2 Years|Missed visit|4
4942573|NCT00367133|17003338|P2|2 Years|Missed visit|5
4942574|NCT00367133|17003339|P1|2 Years|Missed visit|4
4942575|NCT00367133|17003337|P3|2 Years|Dropped|33
4942576|NCT00367133|17003338|P2|2 Years|Dropped|19
4942577|NCT00367133|17003339|P1|2 Years|Dropped|34
4942578|NCT00367133|17003337|P3|2 Years|Death|12
4942579|NCT00367133|17003338|P2|2 Years|Death|12
4942580|NCT00367133|17003339|P1|2 Years|Death|20
4942581|NCT00367055|17003391|P2|Overall Study|Participant Living too Far from Hospital|1
4942582|NCT00367055|17003392|P1|Overall Study|Participant Living too Far from Hospital|0
4942583|NCT00367055|17003391|P2|Overall Study|Stopping Criterion Met|1
4942584|NCT00367055|17003392|P1|Overall Study|Stopping Criterion Met|0
4942585|NCT00367055|17003391|P2|Overall Study|Protocol Violation|1
4942586|NCT00367055|17003392|P1|Overall Study|Protocol Violation|0
4942587|NCT00367055|17003391|P2|Overall Study|Lost to Follow-up|1
4942588|NCT00367055|17003392|P1|Overall Study|Lost to Follow-up|1
4942589|NCT00367055|17003391|P2|Overall Study|Lack of Efficacy|2
4942590|NCT00367055|17003392|P1|Overall Study|Lack of Efficacy|1
4942591|NCT00367055|17003391|P2|Overall Study|Patient's Willing|2
4942592|NCT00367055|17003392|P1|Overall Study|Patient's Willing|3
4942593|NCT00367055|17003391|P2|Overall Study|Adverse Event|3
4942594|NCT00367055|17003392|P1|Overall Study|Adverse Event|6
4942595|NCT00366899|17003412|P2|Toddler Dose|Protocol Violation|0
4942596|NCT00366899|17003413|P1|Toddler Dose|Protocol Violation|1
4942597|NCT00366899|17003412|P2|Toddler Dose|Withdrawal by Subject|1
4942598|NCT00366899|17003413|P1|Toddler Dose|Withdrawal by Subject|1
4942599|NCT00366899|17003412|P2|After Infant Series|Protocol Violation|0
4942600|NCT00366899|17003413|P1|After Infant Series|Protocol Violation|1
4942601|NCT00366899|17003412|P2|After Infant Series|Adverse Event|2
4942602|NCT00366899|17003413|P1|After Infant Series|Adverse Event|1
4942603|NCT00366899|17003412|P2|After Infant Series|Withdrawal by Subject|4
4942604|NCT00366899|17003413|P1|After Infant Series|Withdrawal by Subject|1
4942605|NCT00366899|17003412|P2|After Infant Series|Lost to Follow-up|3
4942606|NCT00366899|17003413|P1|After Infant Series|Lost to Follow-up|4
4942607|NCT00366899|17003412|P2|Infant Series|Randomized but not consented|0
4942608|NCT00366899|17003413|P1|Infant Series|Randomized but not consented|1
4942609|NCT00366899|17003412|P2|Infant Series|Physician Decision|0
4942610|NCT00366899|17003413|P1|Infant Series|Physician Decision|1
4942611|NCT00366899|17003412|P2|Infant Series|Adverse Event|1
4942612|NCT00366899|17003413|P1|Infant Series|Adverse Event|0
4942613|NCT00366899|17003412|P2|Infant Series|Lost to Follow-up|2
4942614|NCT00366899|17003413|P1|Infant Series|Lost to Follow-up|0
4942615|NCT00366899|17003412|P2|Infant Series|Failed to return|1
4942616|NCT00366899|17003413|P1|Infant Series|Failed to return|1
4942617|NCT00366899|17003412|P2|Infant Series|Protocol Violation|1
4942618|NCT00366899|17003413|P1|Infant Series|Protocol Violation|2
4942619|NCT00366899|17003412|P2|Infant Series|Withdrawal by Subject|7
4942620|NCT00366899|17003413|P1|Infant Series|Withdrawal by Subject|4
4942621|NCT00366678|17003473|P3|Toddler Dose|protocol deviation|0
4942622|NCT00366678|17003474|P2|Toddler Dose|protocol deviation|0
4942623|NCT00366678|17003475|P1|Toddler Dose|protocol deviation|1
4942624|NCT00366678|17003473|P3|Toddler Dose|Withdrawal by Subject|0
4942625|NCT00366678|17003474|P2|Toddler Dose|Withdrawal by Subject|0
4942626|NCT00366678|17003475|P1|Toddler Dose|Withdrawal by Subject|1
4942627|NCT00366678|17003473|P3|Toddler Dose|Failed to return|0
4942628|NCT00366678|17003474|P2|Toddler Dose|Failed to return|0
4942629|NCT00366678|17003475|P1|Toddler Dose|Failed to return|1
4942630|NCT00366678|17003473|P3|Toddler Dose|Protocol Violation|0
4942631|NCT00366678|17003474|P2|Toddler Dose|Protocol Violation|1
4942632|NCT00366678|17003475|P1|Toddler Dose|Protocol Violation|2
4942633|NCT00366678|17003473|P3|After Infant|Protocol Violation|0
4942634|NCT00366678|17003474|P2|After Infant|Protocol Violation|0
4942635|NCT00366678|17003475|P1|After Infant|Protocol Violation|1
4942636|NCT00366678|17003473|P3|After Infant|Adverse Event|0
4942637|NCT00366678|17003474|P2|After Infant|Adverse Event|0
4942638|NCT00366678|17003475|P1|After Infant|Adverse Event|1
4942639|NCT00366678|17003473|P3|After Infant|Failed to return|0
4942640|NCT00366678|17003474|P2|After Infant|Failed to return|5
4942641|NCT00366678|17003475|P1|After Infant|Failed to return|5
4942642|NCT00366678|17003473|P3|After Infant|Lost to Follow-up|0
4942643|NCT00366678|17003474|P2|After Infant|Lost to Follow-up|1
4942644|NCT00366678|17003475|P1|After Infant|Lost to Follow-up|2
4942645|NCT00366678|17003473|P3|After Infant|Withdrawal by Subject|0
4942646|NCT00366678|17003474|P2|After Infant|Withdrawal by Subject|4
4942647|NCT00366678|17003475|P1|After Infant|Withdrawal by Subject|8
4942648|NCT00366678|17003473|P3|Infant Series|Adverse Event|0
4942649|NCT00366678|17003474|P2|Infant Series|Adverse Event|0
4942650|NCT00366678|17003475|P1|Infant Series|Adverse Event|1
4942651|NCT00366678|17003473|P3|Infant Series|Failed to return|0
4942652|NCT00366678|17003474|P2|Infant Series|Failed to return|1
4942653|NCT00366678|17003475|P1|Infant Series|Failed to return|1
4942654|NCT00366678|17003473|P3|Infant Series|Protocol Violation|0
4942655|NCT00366678|17003474|P2|Infant Series|Protocol Violation|3
4942656|NCT00366678|17003475|P1|Infant Series|Protocol Violation|4
4942657|NCT00366678|17003473|P3|Infant Series|Withdrawal by Subject|0
4942658|NCT00366678|17003474|P2|Infant Series|Withdrawal by Subject|6
4942659|NCT00366678|17003475|P1|Infant Series|Withdrawal by Subject|8
4942660|NCT00366548|17003557|P2|After Infant Series|Lost to Follow-up|0
4942661|NCT00366548|17003558|P1|After Infant Series|Lost to Follow-up|1
4942662|NCT00366548|17003557|P2|After Infant Series|Adverse Event|0
4942663|NCT00366548|17003558|P1|After Infant Series|Adverse Event|2
4942664|NCT00366548|17003557|P2|After Infant Series|Withdrawal by Subject|1
4942665|NCT00366548|17003558|P1|After Infant Series|Withdrawal by Subject|3
4942666|NCT00366548|17003557|P2|Infant Series|Withdrawal by Subject|1
4942667|NCT00366548|17003558|P1|Infant Series|Withdrawal by Subject|3
4942668|NCT00366548|17003557|P2|Infant Series|Protocol Violation|1
4942669|NCT00366548|17003558|P1|Infant Series|Protocol Violation|0
4942670|NCT00366548|17003557|P2|Infant Series|Adverse Event|3
4942671|NCT00366548|17003558|P1|Infant Series|Adverse Event|1
4942672|NCT00366535|17003594|P2|Second Phase: 12 Weeks|Withdrawal by Subject|2
4942673|NCT00366535|17003595|P1|Second Phase: 12 Weeks|Withdrawal by Subject|2
4942674|NCT00366535|17003594|P2|Second Phase: 12 Weeks|Adverse Event|1
4942675|NCT00366535|17003595|P1|Second Phase: 12 Weeks|Adverse Event|1
4942676|NCT00366535|17003594|P2|First Phase: 12 Weeks|Withdrawal by Subject|5
4942677|NCT00366535|17003595|P1|First Phase: 12 Weeks|Withdrawal by Subject|2
4942678|NCT00366535|17003594|P2|First Phase: 12 Weeks|Adverse Event|3
4942679|NCT00366535|17003595|P1|First Phase: 12 Weeks|Adverse Event|1
4942680|NCT00366457|17003609|P1|Overall Study|never began study therapy|2
4942681|NCT00366444|17003618|P2|Overall Study|Lack of Efficacy|1
4942682|NCT00366444|17003619|P1|Overall Study|Lack of Efficacy|0
4942683|NCT00366444|17003618|P2|Overall Study|Withdrawal by Subject|1
4942684|NCT00366444|17003619|P1|Overall Study|Withdrawal by Subject|1
4942685|NCT00366340|17003647|P2|Toddler Dose|Parent/legal guardian request|1
4942686|NCT00366340|17003648|P1|Toddler Dose|Parent/legal guardian request|0
4942687|NCT00366340|17003647|P2|Toddler Dose|Failed to return|0
4942688|NCT00366340|17003648|P1|Toddler Dose|Failed to return|1
4942689|NCT00366340|17003647|P2|After the Infant Series|Lost to Follow-up|1
4942690|NCT00366340|17003648|P1|After the Infant Series|Lost to Follow-up|0
4942691|NCT00366340|17003647|P2|After the Infant Series|Adverse Event|1
4942692|NCT00366340|17003648|P1|After the Infant Series|Adverse Event|0
4942693|NCT00366340|17003647|P2|After the Infant Series|Protocol Violation|2
4942694|NCT00366340|17003648|P1|After the Infant Series|Protocol Violation|2
4942695|NCT00366340|17003647|P2|After the Infant Series|Failed to return|1
4942696|NCT00366340|17003648|P1|After the Infant Series|Failed to return|0
4942697|NCT00366340|17003647|P2|After the Infant Series|Parent/legal guardian request|1
4942698|NCT00366340|17003648|P1|After the Infant Series|Parent/legal guardian request|1
4942699|NCT00366340|17003647|P2|Infant Series|Failure to return|0
4942700|NCT00366340|17003648|P1|Infant Series|Failure to return|1
4942701|NCT00366340|17003647|P2|Infant Series|Lost to Follow-up|1
4942702|NCT00366340|17003648|P1|Infant Series|Lost to Follow-up|1
4942703|NCT00366340|17003647|P2|Infant Series|Adverse Event|2
4942704|NCT00366340|17003648|P1|Infant Series|Adverse Event|0
4942705|NCT00366340|17003647|P2|Infant Series|Withdrawal by Subject|3
4942706|NCT00366340|17003648|P1|Infant Series|Withdrawal by Subject|3
4942707|NCT00366340|17003647|P2|Infant Series|Protocol Violation|4
4942708|NCT00366340|17003648|P1|Infant Series|Protocol Violation|3
4942709|NCT00366301|17003706|P4|Overall Study|Withdrawal by Subject|1
4942710|NCT00366301|17003707|P3|Overall Study|Withdrawal by Subject|1
4942711|NCT00366301|17003708|P2|Overall Study|Withdrawal by Subject|2
4942712|NCT00366301|17003709|P1|Overall Study|Withdrawal by Subject|4
4942713|NCT00366301|17003706|P4|Overall Study|Lost to Follow-up|7
4942714|NCT00366301|17003707|P3|Overall Study|Lost to Follow-up|3
4942715|NCT00366301|17003708|P2|Overall Study|Lost to Follow-up|4
4942716|NCT00366301|17003709|P1|Overall Study|Lost to Follow-up|4
4942717|NCT00366249|17003725|P2|Overall Study|Most due to osteomylitis status|20
4942718|NCT00366249|17003726|P1|Overall Study|Most due to osteomylitis status|31
4942719|NCT00366249|17003725|P2|Overall Study|Lack of Efficacy|21
4942720|NCT00366249|17003726|P1|Overall Study|Lack of Efficacy|21
4942721|NCT00366249|17003725|P2|Overall Study|Withdrawal by Subject|4
4942722|NCT00366249|17003726|P1|Overall Study|Withdrawal by Subject|18
4942723|NCT00366249|17003725|P2|Overall Study|Protocol Violation|2
4942724|NCT00366249|17003726|P1|Overall Study|Protocol Violation|1
4942725|NCT00366249|17003725|P2|Overall Study|Lost to Follow-up|0
4942726|NCT00366249|17003726|P1|Overall Study|Lost to Follow-up|2
4942727|NCT00366249|17003725|P2|Overall Study|Physician Decision|2
4942728|NCT00366249|17003726|P1|Overall Study|Physician Decision|5
4942729|NCT00366249|17003725|P2|Overall Study|Death|1
4942730|NCT00366249|17003726|P1|Overall Study|Death|0
4942731|NCT00366249|17003725|P2|Overall Study|Adverse Event|28
4942732|NCT00366249|17003726|P1|Overall Study|Adverse Event|53
4942733|NCT00365989|17003758|P1|Overall Study|Non-compliance|1
4942734|NCT00365989|17003758|P1|Overall Study|Withdrawal by Subject|1
4942735|NCT00365976|17003766|P2|Overall Study|Withdrawal by Subject|5
4942736|NCT00365976|17003767|P1|Overall Study|Withdrawal by Subject|1
4942737|NCT00365846|17003905|P1|Overall Study|Lost to Follow-up|1
4942738|NCT00365794|17003914|P1|Overall Study|Withdrawal by Subject|2
4942739|NCT00365716|17003943|P7|Extension 2|Withdrawal by Subject|5
4942740|NCT00365716|17003944|P6|Extension 2|Withdrawal by Subject|0
4942741|NCT00365716|17003945|P5|Extension 2|Withdrawal by Subject|0
4942742|NCT00365716|17003946|P4|Extension 2|Withdrawal by Subject|0
4942743|NCT00365716|17003947|P3|Extension 2|Withdrawal by Subject|0
4942744|NCT00365716|17003948|P2|Extension 2|Withdrawal by Subject|0
4942745|NCT00365716|17003949|P1|Extension 2|Withdrawal by Subject|0
4942746|NCT00365716|17003943|P7|Extension 2|Other|3
4942747|NCT00365716|17003944|P6|Extension 2|Other|0
4942748|NCT00365716|17003945|P5|Extension 2|Other|0
4942749|NCT00365716|17003946|P4|Extension 2|Other|0
4942750|NCT00365716|17003947|P3|Extension 2|Other|0
4942751|NCT00365716|17003948|P2|Extension 2|Other|0
4942752|NCT00365716|17003949|P1|Extension 2|Other|0
4942753|NCT00365716|17003943|P7|Extension 2|Lost to Follow-up|2
4942754|NCT00365716|17003944|P6|Extension 2|Lost to Follow-up|0
4942755|NCT00365716|17003945|P5|Extension 2|Lost to Follow-up|0
4942756|NCT00365716|17003946|P4|Extension 2|Lost to Follow-up|0
4942757|NCT00365716|17003947|P3|Extension 2|Lost to Follow-up|0
4942758|NCT00365716|17003948|P2|Extension 2|Lost to Follow-up|0
4942759|NCT00365716|17003949|P1|Extension 2|Lost to Follow-up|0
4942760|NCT00365716|17003943|P7|Extension 1|Protocol Violation|0
4942761|NCT00365716|17003944|P6|Extension 1|Protocol Violation|1
4942762|NCT00365716|17003945|P5|Extension 1|Protocol Violation|0
4942763|NCT00365716|17003946|P4|Extension 1|Protocol Violation|0
4942764|NCT00365716|17003947|P3|Extension 1|Protocol Violation|0
4942765|NCT00365716|17003948|P2|Extension 1|Protocol Violation|0
4942766|NCT00365716|17003949|P1|Extension 1|Protocol Violation|0
4942767|NCT00365716|17003943|P7|Extension 1|Pregnancy|0
4942768|NCT00365716|17003944|P6|Extension 1|Pregnancy|4
4942769|NCT00365716|17003945|P5|Extension 1|Pregnancy|0
4942770|NCT00365716|17003946|P4|Extension 1|Pregnancy|0
4942771|NCT00365716|17003947|P3|Extension 1|Pregnancy|0
4942772|NCT00365716|17003948|P2|Extension 1|Pregnancy|0
4942773|NCT00365716|17003949|P1|Extension 1|Pregnancy|0
4942774|NCT00365716|17003943|P7|Extension 1|Withdrawal by Subject|0
4942775|NCT00365716|17003944|P6|Extension 1|Withdrawal by Subject|3
4942776|NCT00365716|17003945|P5|Extension 1|Withdrawal by Subject|0
4942777|NCT00365716|17003946|P4|Extension 1|Withdrawal by Subject|0
4942778|NCT00365716|17003947|P3|Extension 1|Withdrawal by Subject|0
4942779|NCT00365716|17003948|P2|Extension 1|Withdrawal by Subject|0
4942780|NCT00365716|17003949|P1|Extension 1|Withdrawal by Subject|0
4942781|NCT00365716|17003943|P7|Extension 1|Moved|0
4942782|NCT00365716|17003944|P6|Extension 1|Moved|4
4942783|NCT00365716|17003945|P5|Extension 1|Moved|0
4942784|NCT00365716|17003946|P4|Extension 1|Moved|0
4942785|NCT00365716|17003947|P3|Extension 1|Moved|0
4942786|NCT00365716|17003948|P2|Extension 1|Moved|0
4942787|NCT00365716|17003949|P1|Extension 1|Moved|0
4942788|NCT00365716|17003943|P7|Extension 1|Other|0
4942789|NCT00365716|17003944|P6|Extension 1|Other|9
4942790|NCT00365716|17003945|P5|Extension 1|Other|0
4942791|NCT00365716|17003946|P4|Extension 1|Other|0
4942792|NCT00365716|17003947|P3|Extension 1|Other|0
4942793|NCT00365716|17003948|P2|Extension 1|Other|0
4942794|NCT00365716|17003949|P1|Extension 1|Other|0
4942795|NCT00365716|17003943|P7|Extension 1|Lost to Follow-up|0
4942796|NCT00365716|17003944|P6|Extension 1|Lost to Follow-up|1
4942797|NCT00365716|17003945|P5|Extension 1|Lost to Follow-up|0
4942798|NCT00365716|17003946|P4|Extension 1|Lost to Follow-up|0
4942799|NCT00365716|17003947|P3|Extension 1|Lost to Follow-up|0
4942800|NCT00365716|17003948|P2|Extension 1|Lost to Follow-up|0
4942801|NCT00365716|17003949|P1|Extension 1|Lost to Follow-up|0
4942802|NCT00365716|17003943|P7|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
4942803|NCT00365716|17003944|P6|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0
4942804|NCT00365716|17003945|P5|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3
4942805|NCT00365716|17003946|P4|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
4942806|NCT00365716|17003947|P3|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13
4942807|NCT00365716|17003948|P2|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4
4942808|NCT00365716|17003949|P1|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7
4942884|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Adverse Event|2
4942809|NCT00365716|17003943|P7|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4942810|NCT00365716|17003944|P6|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4942811|NCT00365716|17003945|P5|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4942812|NCT00365716|17003946|P4|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4942813|NCT00365716|17003947|P3|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
4942814|NCT00365716|17003948|P2|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1
4942815|NCT00365716|17003949|P1|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0
4942816|NCT00365716|17003943|P7|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4942817|NCT00365716|17003944|P6|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4942818|NCT00365716|17003945|P5|Long Term Follow-up (Month 7 toMonth 36)|Other|1
4942819|NCT00365716|17003946|P4|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4942820|NCT00365716|17003947|P3|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4942821|NCT00365716|17003948|P2|Long Term Follow-up (Month 7 toMonth 36)|Other|0
4942822|NCT00365716|17003949|P1|Long Term Follow-up (Month 7 toMonth 36)|Other|2
4942823|NCT00365716|17003943|P7|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
4942824|NCT00365716|17003944|P6|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
4942825|NCT00365716|17003945|P5|Long Term Follow-up (Month 7 toMonth 36)|Moved|0
4942826|NCT00365716|17003946|P4|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
4942827|NCT00365716|17003947|P3|Long Term Follow-up (Month 7 toMonth 36)|Moved|1
4942828|NCT00365716|17003948|P2|Long Term Follow-up (Month 7 toMonth 36)|Moved|2
4942829|NCT00365716|17003949|P1|Long Term Follow-up (Month 7 toMonth 36)|Moved|3
4942830|NCT00365716|17003943|P7|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
4942831|NCT00365716|17003944|P6|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0
4942832|NCT00365716|17003945|P5|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3
4942833|NCT00365716|17003946|P4|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4
4942834|NCT00365716|17003947|P3|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5
4942835|NCT00365716|17003948|P2|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8
4942836|NCT00365716|17003949|P1|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6
4942837|NCT00365716|17003943|P7|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4942838|NCT00365716|17003944|P6|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4942839|NCT00365716|17003945|P5|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75
4942840|NCT00365716|17003946|P4|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69
4942841|NCT00365716|17003947|P3|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4942842|NCT00365716|17003948|P2|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0
4942843|NCT00365716|17003949|P1|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114
4942844|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
4942845|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0
4942846|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3
4942847|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4
4942848|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
4942849|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9
4942850|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12
4942851|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Protocol Violation|0
4942852|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Protocol Violation|0
4942853|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Protocol Violation|2
4942854|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Protocol Violation|1
4942855|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Protocol Violation|0
4942856|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Protocol Violation|2
4942857|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Protocol Violation|1
4942858|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Pregnancy|0
4942859|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Pregnancy|0
4942860|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Pregnancy|1
4942861|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Pregnancy|1
4942862|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Pregnancy|3
4942863|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Pregnancy|2
4942864|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Pregnancy|3
4942865|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Other|0
4942866|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Other|0
4942867|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Other|0
4942868|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Other|0
4942869|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Other|0
4942870|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Other|1
4942871|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Other|0
4942872|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
4942873|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
4942874|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Lost to Follow-up|0
4942875|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
4942876|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
4942877|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Lost to Follow-up|6
4942878|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Lost to Follow-up|4
4942879|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Adverse Event|0
4942880|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Adverse Event|0
4942881|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Adverse Event|1
4942882|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Adverse Event|0
4942883|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Adverse Event|0
4942885|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Adverse Event|0
4942886|NCT00365716|17003943|P7|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4942887|NCT00365716|17003944|P6|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4942888|NCT00365716|17003945|P5|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4942889|NCT00365716|17003946|P4|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4942890|NCT00365716|17003947|P3|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0
4942891|NCT00365716|17003948|P2|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2
4942892|NCT00365716|17003949|P1|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1
4942893|NCT00365547|17003970|P1|Overall Study|Withdrawal by Subject|1
4942894|NCT00365547|17003970|P1|Overall Study|Screen failure|1
4942895|NCT00365547|17003970|P1|Overall Study|Insurance did not cover Avastin|1
4942896|NCT00365508|17003980|P2|Overall Study|Lost to Follow-up|154
4942897|NCT00365508|17003981|P1|Overall Study|Lost to Follow-up|139
4942898|NCT00365456|17003989|P2|Trial Period III (12 Months)|Other|1
4942899|NCT00365456|17003990|P1|Trial Period III (12 Months)|Other|1
4942900|NCT00365456|17003989|P2|Trial Period III (12 Months)|Withdrawal by Subject|1
4942901|NCT00365456|17003990|P1|Trial Period III (12 Months)|Withdrawal by Subject|4
4942902|NCT00365456|17003989|P2|Trial Period III (12 Months)|Adverse Event|3
4942903|NCT00365456|17003990|P1|Trial Period III (12 Months)|Adverse Event|13
4942904|NCT00365456|17003989|P2|Trial Period II (12 Months)|Other|1
4942905|NCT00365456|17003990|P1|Trial Period II (12 Months)|Other|0
4942906|NCT00365456|17003989|P2|Trial Period II (12 Months)|Withdrawal by Subject|5
4942907|NCT00365456|17003990|P1|Trial Period II (12 Months)|Withdrawal by Subject|0
4942908|NCT00365456|17003989|P2|Trial Period II (12 Months)|Non-compliance|2
4942909|NCT00365456|17003990|P1|Trial Period II (12 Months)|Non-compliance|0
4942910|NCT00365456|17003989|P2|Trial Period II (12 Months)|Adverse Event|6
4942911|NCT00365456|17003990|P1|Trial Period II (12 Months)|Adverse Event|0
4942912|NCT00365456|17003989|P2|Trial Period I (12 Months)|Other|0
4942913|NCT00365456|17003990|P1|Trial Period I (12 Months)|Other|11
4942914|NCT00365456|17003989|P2|Trial Period I (12 Months)|Withdrawal by Subject|0
4942915|NCT00365456|17003990|P1|Trial Period I (12 Months)|Withdrawal by Subject|27
4942916|NCT00365456|17003989|P2|Trial Period I (12 Months)|Non-compliance|0
4942917|NCT00365456|17003990|P1|Trial Period I (12 Months)|Non-compliance|3
4942918|NCT00365456|17003989|P2|Trial Period I (12 Months)|Adverse Event|0
4942919|NCT00365456|17003990|P1|Trial Period I (12 Months)|Adverse Event|84
4942920|NCT00365378|17004017|P3|Extension|Other|31
4942921|NCT00365378|17004018|P2|Extension|Other|0
4942922|NCT00365378|17004019|P1|Extension|Other|0
4942923|NCT00365378|17004017|P3|Extension|Withdrawal by Subject|98
4942924|NCT00365378|17004018|P2|Extension|Withdrawal by Subject|0
4942925|NCT00365378|17004019|P1|Extension|Withdrawal by Subject|0
4942926|NCT00365378|17004017|P3|Extension|Protocol Violation|2
4942927|NCT00365378|17004018|P2|Extension|Protocol Violation|0
4942928|NCT00365378|17004019|P1|Extension|Protocol Violation|0
4942929|NCT00365378|17004017|P3|Extension|Lost to Follow-up|57
4942930|NCT00365378|17004018|P2|Extension|Lost to Follow-up|0
4942931|NCT00365378|17004019|P1|Extension|Lost to Follow-up|0
4942932|NCT00365378|17004017|P3|Extension|Moved|8
4942933|NCT00365378|17004018|P2|Extension|Moved|0
4942934|NCT00365378|17004019|P1|Extension|Moved|0
4942935|NCT00365378|17004017|P3|Extension|Adverse Event|1
4942936|NCT00365378|17004018|P2|Extension|Adverse Event|0
4942937|NCT00365378|17004019|P1|Extension|Adverse Event|0
4942938|NCT00365378|17004017|P3|Follow-up (Month 7 Though Month 48)|Other|0
4942939|NCT00365378|17004018|P2|Follow-up (Month 7 Though Month 48)|Other|21
4942940|NCT00365378|17004019|P1|Follow-up (Month 7 Though Month 48)|Other|11
4942941|NCT00365378|17004017|P3|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0
4942942|NCT00365378|17004018|P2|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104
4942943|NCT00365378|17004019|P1|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73
4942944|NCT00365378|17004017|P3|Follow-up (Month 7 Though Month 48)|Protocol Violation|0
4942945|NCT00365378|17004018|P2|Follow-up (Month 7 Though Month 48)|Protocol Violation|2
4942946|NCT00365378|17004019|P1|Follow-up (Month 7 Though Month 48)|Protocol Violation|1
4942947|NCT00365378|17004017|P3|Follow-up (Month 7 Though Month 48)|Pregnancy|0
4942948|NCT00365378|17004018|P2|Follow-up (Month 7 Though Month 48)|Pregnancy|1
4942949|NCT00365378|17004019|P1|Follow-up (Month 7 Though Month 48)|Pregnancy|0
4942950|NCT00365378|17004017|P3|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0
4942951|NCT00365378|17004018|P2|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69
4942952|NCT00365378|17004019|P1|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67
4942953|NCT00365378|17004017|P3|Follow-up (Month 7 Though Month 48)|Moved|0
4942954|NCT00365378|17004018|P2|Follow-up (Month 7 Though Month 48)|Moved|5
4942955|NCT00365378|17004019|P1|Follow-up (Month 7 Though Month 48)|Moved|6
4942956|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Other|0
4942957|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Other|9
4942958|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Other|17
4942959|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0
4942960|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44
4942961|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50
4942962|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Protocol Violation|0
4942963|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Protocol Violation|13
4942964|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Protocol Violation|22
4942965|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Pregnancy|0
4942966|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Pregnancy|14
4942967|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Pregnancy|19
4942968|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0
4942969|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75
4942970|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88
4942971|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Adverse Event|0
4942972|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Adverse Event|5
4942973|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Adverse Event|4
4942974|NCT00365378|17004017|P3|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0
4942975|NCT00365378|17004018|P2|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7
4942976|NCT00365378|17004019|P1|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11
4942977|NCT00365365|17004033|P3|Overall Study|Patient/physician decision|1
4942978|NCT00365365|17004034|P2|Overall Study|Patient/physician decision|0
4942979|NCT00365365|17004035|P1|Overall Study|Patient/physician decision|0
4942980|NCT00365365|17004033|P3|Overall Study|Second malignancy|0
4942981|NCT00365365|17004034|P2|Overall Study|Second malignancy|1
4942982|NCT00365365|17004035|P1|Overall Study|Second malignancy|0
4942983|NCT00365365|17004033|P3|Overall Study|Withdrew consent|0
4942984|NCT00365365|17004034|P2|Overall Study|Withdrew consent|1
4942985|NCT00365365|17004035|P1|Overall Study|Withdrew consent|1
4942986|NCT00365365|17004033|P3|Overall Study|New cancer|0
4942987|NCT00365365|17004034|P2|Overall Study|New cancer|0
4942988|NCT00365365|17004035|P1|Overall Study|New cancer|1
4942989|NCT00365365|17004033|P3|Overall Study|Moved|0
4942990|NCT00365365|17004034|P2|Overall Study|Moved|0
4942991|NCT00365365|17004035|P1|Overall Study|Moved|2
4942992|NCT00365365|17004033|P3|Overall Study|Adverse Event|3
4942993|NCT00365365|17004034|P2|Overall Study|Adverse Event|6
4942994|NCT00365365|17004035|P1|Overall Study|Adverse Event|6
4942995|NCT00365365|17004033|P3|Overall Study|Disease progression/relapse|7
4942996|NCT00365365|17004034|P2|Overall Study|Disease progression/relapse|6
4942997|NCT00365365|17004035|P1|Overall Study|Disease progression/relapse|9
4942998|NCT00365365|17004033|P3|Overall Study|Subject's request|1
4942999|NCT00365365|17004034|P2|Overall Study|Subject's request|13
4943000|NCT00365365|17004035|P1|Overall Study|Subject's request|11
4943001|NCT00365365|17004033|P3|Overall Study|Death|0
4943002|NCT00365365|17004034|P2|Overall Study|Death|3
4943003|NCT00365365|17004035|P1|Overall Study|Death|1
4943004|NCT00365365|17004033|P3|Overall Study|Lost to Follow-up|3
4943005|NCT00365365|17004034|P2|Overall Study|Lost to Follow-up|3
4943006|NCT00365365|17004035|P1|Overall Study|Lost to Follow-up|3
4943007|NCT00365365|17004033|P3|Overall Study|Poor compliance to protocol|0
4943008|NCT00365365|17004034|P2|Overall Study|Poor compliance to protocol|1
4943009|NCT00365365|17004035|P1|Overall Study|Poor compliance to protocol|0
4943010|NCT00365365|17004033|P3|Overall Study|Randomized but not treated|0
4943011|NCT00365365|17004034|P2|Overall Study|Randomized but not treated|2
4943012|NCT00365365|17004035|P1|Overall Study|Randomized but not treated|0
4943013|NCT00365352|17004052|P3|Overall Study|Withdrawal of Participant by Sponsor|0
4943014|NCT00365352|17004053|P2|Overall Study|Withdrawal of Participant by Sponsor|0
4943015|NCT00365352|17004054|P1|Overall Study|Withdrawal of Participant by Sponsor|1
4943016|NCT00365352|17004052|P3|Overall Study|Lost to Follow-up|0
4943017|NCT00365352|17004053|P2|Overall Study|Lost to Follow-up|1
4943018|NCT00365352|17004054|P1|Overall Study|Lost to Follow-up|1
4943019|NCT00365352|17004052|P3|Overall Study|Non-Compliance (after Randomization)|1
4943020|NCT00365352|17004053|P2|Overall Study|Non-Compliance (after Randomization)|0
4943021|NCT00365352|17004054|P1|Overall Study|Non-Compliance (after Randomization)|1
4943022|NCT00365352|17004052|P3|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2
4943023|NCT00365352|17004053|P2|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
4943024|NCT00365352|17004054|P1|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0
4943025|NCT00365352|17004052|P3|Overall Study|Lack of Efficacy|0
4943026|NCT00365352|17004053|P2|Overall Study|Lack of Efficacy|0
4943027|NCT00365352|17004054|P1|Overall Study|Lack of Efficacy|3
4943028|NCT00365352|17004052|P3|Overall Study|Participant Withdrew Consent|4
4943029|NCT00365352|17004053|P2|Overall Study|Participant Withdrew Consent|3
4943030|NCT00365352|17004054|P1|Overall Study|Participant Withdrew Consent|8
4943031|NCT00365352|17004052|P3|Overall Study|Adverse Event|8
4943032|NCT00365352|17004053|P2|Overall Study|Adverse Event|7
4943033|NCT00365352|17004054|P1|Overall Study|Adverse Event|6
4943034|NCT00365300|17004138|P2|Double-blind Phase|Lack of Efficacy|6
4943035|NCT00365300|17004139|P1|Double-blind Phase|Lack of Efficacy|6
4943036|NCT00365300|17004138|P2|Double-blind Phase|Protocol Violation|1
4943037|NCT00365300|17004139|P1|Double-blind Phase|Protocol Violation|3
4943038|NCT00365300|17004138|P2|Double-blind Phase|Withdrawal by Subject|1
4943039|NCT00365300|17004139|P1|Double-blind Phase|Withdrawal by Subject|0
4943040|NCT00365300|17004138|P2|Double-blind Phase|Noncompliance|1
4943041|NCT00365300|17004139|P1|Double-blind Phase|Noncompliance|1
4943042|NCT00365300|17004138|P2|Double-blind Phase|Failed to return|0
4943043|NCT00365300|17004139|P1|Double-blind Phase|Failed to return|1
4943044|NCT00365300|17004138|P2|Open-label Phase|Patient skipped open label phase|0
4943045|NCT00365300|17004139|P1|Open-label Phase|Patient skipped open label phase|1
4943046|NCT00365300|17004138|P2|Open-label Phase|Lack of Efficacy|0
4943047|NCT00365300|17004139|P1|Open-label Phase|Lack of Efficacy|1
4943048|NCT00365300|17004138|P2|Open-label Phase|Protocol Violation|0
4943049|NCT00365300|17004139|P1|Open-label Phase|Protocol Violation|1
4943050|NCT00365300|17004138|P2|Open-label Phase|Parent/Legal Guardian Request|0
4943051|NCT00365300|17004139|P1|Open-label Phase|Parent/Legal Guardian Request|4
4943052|NCT00365300|17004138|P2|Open-label Phase|Noncompliance|0
4943053|NCT00365300|17004139|P1|Open-label Phase|Noncompliance|9
4943054|NCT00365300|17004138|P2|Open-label Phase|Physician Decision|0
4943055|NCT00365300|17004139|P1|Open-label Phase|Physician Decision|1
4943056|NCT00365300|17004138|P2|Open-label Phase|Failed to Return|0
4943057|NCT00365300|17004139|P1|Open-label Phase|Failed to Return|1
4943058|NCT00365300|17004138|P2|Open-label Phase|Adverse Event|0
4943059|NCT00365300|17004139|P1|Open-label Phase|Adverse Event|4
4943060|NCT00365105|17004204|P2|Overall Study|Protocol Violation|8
4943061|NCT00365105|17004205|P1|Overall Study|Protocol Violation|5
4943062|NCT00364923|17004251|P1|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24
4943063|NCT00364923|17004251|P1|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4
4943064|NCT00364858|17004260|P2|Overall Study|Clinical baseline issue|1
4943065|NCT00364858|17004261|P1|Overall Study|Clinical baseline issue|0
4943066|NCT00364858|17004260|P2|Overall Study|Return to Q2 regimen|1
4943067|NCT00364858|17004261|P1|Overall Study|Return to Q2 regimen|0
4943068|NCT00364858|17004260|P2|Overall Study|Non-compliant|0
4943069|NCT00364858|17004261|P1|Overall Study|Non-compliant|1
4943070|NCT00364858|17004260|P2|Overall Study|Discontinuation at baseline|0
4943071|NCT00364858|17004261|P1|Overall Study|Discontinuation at baseline|1
4943072|NCT00364858|17004260|P2|Overall Study|Clinical failure|13
4943073|NCT00364858|17004261|P1|Overall Study|Clinical failure|2
4943074|NCT00364858|17004260|P2|Overall Study|Pregnancy|1
4943075|NCT00364858|17004261|P1|Overall Study|Pregnancy|1
4943076|NCT00364858|17004260|P2|Overall Study|Withdrawal by Subject|1
4943077|NCT00364858|17004261|P1|Overall Study|Withdrawal by Subject|1
4943078|NCT00364858|17004260|P2|Overall Study|Adverse Event|5
4943079|NCT00364858|17004261|P1|Overall Study|Adverse Event|1
4943080|NCT00364845|17004276|P2|Overall Study|Death|1
4943081|NCT00364845|17004277|P1|Overall Study|Death|0
4943082|NCT00364845|17004276|P2|Overall Study|Lost to Follow-up|1
4943083|NCT00364845|17004277|P1|Overall Study|Lost to Follow-up|0
4943084|NCT00364845|17004276|P2|Overall Study|Physician Decision|8
4943085|NCT00364845|17004277|P1|Overall Study|Physician Decision|8
4943086|NCT00364845|17004276|P2|Overall Study|Withdrawal by Subject|1
4943087|NCT00364845|17004277|P1|Overall Study|Withdrawal by Subject|2
4943088|NCT00364845|17004276|P2|Overall Study|Adverse Event|0
4943089|NCT00364845|17004277|P1|Overall Study|Adverse Event|1
4943090|NCT00364832|17004298|P12|Extension Year 2|Early Withdrawals|3
4943091|NCT00364832|17004299|P11|Extension Year 2|Early Withdrawals|5
4943092|NCT00364832|17004300|P10|Extension Year 2|Early Withdrawals|5
4943093|NCT00364832|17004301|P9|Extension Year 2|Early Withdrawals|0
4943094|NCT00364832|17004302|P8|Extension Year 2|Early Withdrawals|0
4943095|NCT00364832|17004303|P7|Extension Year 2|Early Withdrawals|0
4943096|NCT00364832|17004304|P6|Extension Year 2|Early Withdrawals|0
4943097|NCT00364832|17004305|P5|Extension Year 2|Early Withdrawals|0
4943098|NCT00364832|17004306|P4|Extension Year 2|Early Withdrawals|0
4943099|NCT00364832|17004307|P3|Extension Year 2|Early Withdrawals|0
4943100|NCT00364832|17004308|P2|Extension Year 2|Early Withdrawals|0
4943101|NCT00364832|17004309|P1|Extension Year 2|Early Withdrawals|0
4943102|NCT00364832|17004298|P12|Extension Year 1|Early Withdrawals|10
4943103|NCT00364832|17004299|P11|Extension Year 1|Early Withdrawals|2
4943104|NCT00364832|17004300|P10|Extension Year 1|Early Withdrawals|4
4943105|NCT00364832|17004301|P9|Extension Year 1|Early Withdrawals|0
4943106|NCT00364832|17004302|P8|Extension Year 1|Early Withdrawals|0
4943107|NCT00364832|17004303|P7|Extension Year 1|Early Withdrawals|0
4943108|NCT00364832|17004304|P6|Extension Year 1|Early Withdrawals|0
4943109|NCT00364832|17004305|P5|Extension Year 1|Early Withdrawals|0
4943110|NCT00364832|17004306|P4|Extension Year 1|Early Withdrawals|0
4943111|NCT00364832|17004307|P3|Extension Year 1|Early Withdrawals|0
4943112|NCT00364832|17004308|P2|Extension Year 1|Early Withdrawals|0
4943113|NCT00364832|17004309|P1|Extension Year 1|Early Withdrawals|0
4943114|NCT00364832|17004298|P12|Core Period|Early Withdrawals|0
4943115|NCT00364832|17004299|P11|Core Period|Early Withdrawals|0
4943116|NCT00364832|17004300|P10|Core Period|Early Withdrawals|0
4943117|NCT00364832|17004301|P9|Core Period|Early Withdrawals|0
4943118|NCT00364832|17004302|P8|Core Period|Early Withdrawals|1
4943119|NCT00364832|17004303|P7|Core Period|Early Withdrawals|4
4943120|NCT00364832|17004304|P6|Core Period|Early Withdrawals|0
4943121|NCT00364832|17004305|P5|Core Period|Early Withdrawals|0
4943122|NCT00364832|17004306|P4|Core Period|Early Withdrawals|1
4943123|NCT00364832|17004307|P3|Core Period|Early Withdrawals|1
4943124|NCT00364832|17004308|P2|Core Period|Early Withdrawals|2
4943125|NCT00364832|17004309|P1|Core Period|Early Withdrawals|2
4943126|NCT00364793|17004374|P4|Overall Study|Withdrawal by Subject|0
4943127|NCT00364793|17004375|P3|Overall Study|Withdrawal by Subject|0
4943128|NCT00364793|17004376|P2|Overall Study|Withdrawal by Subject|1
4943129|NCT00364793|17004377|P1|Overall Study|Withdrawal by Subject|0
4943130|NCT00364793|17004374|P4|Overall Study|No longer meets criteria|1
4943131|NCT00364793|17004375|P3|Overall Study|No longer meets criteria|0
4943132|NCT00364793|17004376|P2|Overall Study|No longer meets criteria|0
4943133|NCT00364793|17004377|P1|Overall Study|No longer meets criteria|0
4943134|NCT00364793|17004374|P4|Overall Study|Poor or non-compliance|1
4943135|NCT00364793|17004375|P3|Overall Study|Poor or non-compliance|0
4943136|NCT00364793|17004376|P2|Overall Study|Poor or non-compliance|1
4943137|NCT00364793|17004377|P1|Overall Study|Poor or non-compliance|1
4943138|NCT00364793|17004374|P4|Overall Study|Lost to Follow-up|0
4943139|NCT00364793|17004375|P3|Overall Study|Lost to Follow-up|2
4943140|NCT00364793|17004376|P2|Overall Study|Lost to Follow-up|0
4943141|NCT00364793|17004377|P1|Overall Study|Lost to Follow-up|1
4943142|NCT00364793|17004374|P4|Overall Study|Lack of Efficacy|1
4943143|NCT00364793|17004375|P3|Overall Study|Lack of Efficacy|1
4943144|NCT00364793|17004376|P2|Overall Study|Lack of Efficacy|3
4943145|NCT00364793|17004377|P1|Overall Study|Lack of Efficacy|3
4943146|NCT00364793|17004374|P4|Overall Study|Death|0
4943147|NCT00364793|17004375|P3|Overall Study|Death|1
4943148|NCT00364793|17004376|P2|Overall Study|Death|0
4943149|NCT00364793|17004377|P1|Overall Study|Death|1
4943150|NCT00364793|17004374|P4|Overall Study|Adverse Event|0
4943151|NCT00364793|17004375|P3|Overall Study|Adverse Event|0
4943152|NCT00364793|17004376|P2|Overall Study|Adverse Event|0
4943153|NCT00364793|17004377|P1|Overall Study|Adverse Event|2
4943154|NCT00364689|17004514|P1|Overall Study|Lost to Follow-up|1
4943155|NCT00364611|17004534|P2|Overall Study|Receiving Liver Ablation|1
4943156|NCT00364611|17004535|P1|Overall Study|Receiving Liver Ablation|0
4943157|NCT00364611|17004534|P2|Overall Study|Presumed CR on Study|1
4943158|NCT00364611|17004535|P1|Overall Study|Presumed CR on Study|0
4943159|NCT00364611|17004534|P2|Overall Study|Found Ineligible|0
4943160|NCT00364611|17004535|P1|Overall Study|Found Ineligible|1
4943161|NCT00364611|17004534|P2|Overall Study|Investigator decision|2
4943162|NCT00364611|17004535|P1|Overall Study|Investigator decision|2
4943163|NCT00364611|17004534|P2|Overall Study|Disease Progression|8
4943164|NCT00364611|17004535|P1|Overall Study|Disease Progression|38
4943165|NCT00364611|17004534|P2|Overall Study|Participant's Request|4
4943166|NCT00364611|17004535|P1|Overall Study|Participant's Request|3
4943167|NCT00364611|17004534|P2|Overall Study|Adverse Event|4
4943168|NCT00364611|17004535|P1|Overall Study|Adverse Event|7
4943169|NCT00364611|17004534|P2|Overall Study|Did not receive study medication|1
4943170|NCT00364611|17004535|P1|Overall Study|Did not receive study medication|0
4943171|NCT00364533|17004558|P5|Overall Study|Protocol Violation|0
4943172|NCT00364533|17004559|P4|Overall Study|Protocol Violation|0
4943173|NCT00364533|17004560|P3|Overall Study|Protocol Violation|0
4943174|NCT00364533|17004561|P2|Overall Study|Protocol Violation|1
4943175|NCT00364533|17004562|P1|Overall Study|Protocol Violation|1
4943176|NCT00364533|17004558|P5|Overall Study|Non-compliance|0
4943177|NCT00364533|17004559|P4|Overall Study|Non-compliance|0
4943178|NCT00364533|17004560|P3|Overall Study|Non-compliance|0
4943179|NCT00364533|17004561|P2|Overall Study|Non-compliance|0
4943180|NCT00364533|17004562|P1|Overall Study|Non-compliance|1
4943181|NCT00364533|17004558|P5|Overall Study|Variations in drug compliance|0
4943182|NCT00364533|17004559|P4|Overall Study|Variations in drug compliance|0
4943183|NCT00364533|17004560|P3|Overall Study|Variations in drug compliance|1
4943184|NCT00364533|17004561|P2|Overall Study|Variations in drug compliance|1
4943185|NCT00364533|17004562|P1|Overall Study|Variations in drug compliance|2
4943186|NCT00364533|17004558|P5|Overall Study|Subject discharged from hospital|1
4943187|NCT00364533|17004559|P4|Overall Study|Subject discharged from hospital|3
4943188|NCT00364533|17004560|P3|Overall Study|Subject discharged from hospital|2
4943189|NCT00364533|17004561|P2|Overall Study|Subject discharged from hospital|1
4943190|NCT00364533|17004562|P1|Overall Study|Subject discharged from hospital|4
4943191|NCT00364533|17004558|P5|Overall Study|Lack of Efficacy|42
4943192|NCT00364533|17004559|P4|Overall Study|Lack of Efficacy|17
4943193|NCT00364533|17004560|P3|Overall Study|Lack of Efficacy|21
4943194|NCT00364533|17004561|P2|Overall Study|Lack of Efficacy|22
4943195|NCT00364533|17004562|P1|Overall Study|Lack of Efficacy|22
4943196|NCT00364533|17004558|P5|Overall Study|Withdrawal by Subject|6
4943197|NCT00364533|17004559|P4|Overall Study|Withdrawal by Subject|6
4943198|NCT00364533|17004560|P3|Overall Study|Withdrawal by Subject|6
4943199|NCT00364533|17004561|P2|Overall Study|Withdrawal by Subject|8
4943200|NCT00364533|17004562|P1|Overall Study|Withdrawal by Subject|4
4943201|NCT00364533|17004558|P5|Overall Study|Adverse Event|2
4943202|NCT00364533|17004559|P4|Overall Study|Adverse Event|5
4943203|NCT00364533|17004560|P3|Overall Study|Adverse Event|15
4943204|NCT00364533|17004561|P2|Overall Study|Adverse Event|7
4943205|NCT00364533|17004562|P1|Overall Study|Adverse Event|8
4943206|NCT00364351|17004595|P2|Overall Study|Randomised treatment not started|3
4943207|NCT00364351|17004596|P1|Overall Study|Randomised treatment not started|0
4943208|NCT00364351|17004595|P2|Overall Study|Patient could not travel to site|1
4943209|NCT00364351|17004596|P1|Overall Study|Patient could not travel to site|0
4943210|NCT00364351|17004595|P2|Overall Study|Investigator error|2
4943211|NCT00364351|17004596|P1|Overall Study|Investigator error|0
4943212|NCT00364351|17004595|P2|Overall Study|Poor treatment compliance|3
4943213|NCT00364351|17004596|P1|Overall Study|Poor treatment compliance|0
4943214|NCT00364351|17004595|P2|Overall Study|Sponsor decision|0
4943215|NCT00364351|17004596|P1|Overall Study|Sponsor decision|1
4943216|NCT00364351|17004595|P2|Overall Study|Incorrect enrollment|1
4943217|NCT00364351|17004596|P1|Overall Study|Incorrect enrollment|1
4943218|NCT00364351|17004595|P2|Overall Study|Withdrawal by Subject|29
4943219|NCT00364351|17004596|P1|Overall Study|Withdrawal by Subject|30
4943220|NCT00364351|17004595|P2|Overall Study|Lost to Follow-up|1
4943221|NCT00364351|17004596|P1|Overall Study|Lost to Follow-up|1
4943222|NCT00364351|17004595|P2|Overall Study|Prohibited concomitant medication|2
4943223|NCT00364351|17004596|P1|Overall Study|Prohibited concomitant medication|0
4943224|NCT00364351|17004595|P2|Overall Study|Condition under investigation worsened|497
4943225|NCT00364351|17004596|P1|Overall Study|Condition under investigation worsened|469
4943226|NCT00364351|17004595|P2|Overall Study|Adverse Event|44
4943227|NCT00364351|17004596|P1|Overall Study|Adverse Event|90
4943228|NCT00364286|17004614|P1|Overall Study|Adverse Event|2
4943229|NCT00364286|17004614|P1|Overall Study|Withdrawal by Subject|1
4943230|NCT00364182|17004621|P3|Third Intervention|Lost to Follow-up|1
4943231|NCT00364182|17004622|P2|Third Intervention|Lost to Follow-up|0
4943232|NCT00364182|17004623|P1|Third Intervention|Lost to Follow-up|0
4943233|NCT00364182|17004621|P3|Third Intervention|non-compliance|0
4943234|NCT00364182|17004622|P2|Third Intervention|non-compliance|1
4943235|NCT00364182|17004623|P1|Third Intervention|non-compliance|0
4943236|NCT00364182|17004621|P3|Second Intervention|Adverse Event|1
4943237|NCT00364182|17004622|P2|Second Intervention|Adverse Event|0
4943238|NCT00364182|17004623|P1|Second Intervention|Adverse Event|0
4943239|NCT00364182|17004621|P3|Second Intervention|Protocol Violation|0
4943240|NCT00364182|17004622|P2|Second Intervention|Protocol Violation|1
4943241|NCT00364182|17004623|P1|Second Intervention|Protocol Violation|0
4943242|NCT00364182|17004621|P3|Second Intervention|non-compliance|1
4943243|NCT00364182|17004622|P2|Second Intervention|non-compliance|1
4943244|NCT00364182|17004623|P1|Second Intervention|non-compliance|0
4943245|NCT00364182|17004621|P3|First Intervention|Withdrawal by Subject|0
4943246|NCT00364182|17004622|P2|First Intervention|Withdrawal by Subject|0
4943247|NCT00364182|17004623|P1|First Intervention|Withdrawal by Subject|2
4943248|NCT00364182|17004621|P3|First Intervention|Secondary prophylaxis|0
4943249|NCT00364182|17004622|P2|First Intervention|Secondary prophylaxis|0
4943250|NCT00364182|17004623|P1|First Intervention|Secondary prophylaxis|1
4943251|NCT00364156|17004657|P2|Overall Study|Protocol Violation|1
4943252|NCT00364156|17004658|P1|Overall Study|Protocol Violation|6
4943253|NCT00364156|17004657|P2|Overall Study|Withdrawal by Subject|80
4943254|NCT00364156|17004658|P1|Overall Study|Withdrawal by Subject|73
4943255|NCT00364130|17004666|P2|Post Intervention Follow-up Period|Lost to Follow-up|11
4943256|NCT00364130|17004667|P1|Post Intervention Follow-up Period|Lost to Follow-up|5
4943257|NCT00364130|17004666|P2|Intervention Period|Withdrawal by Subject|5
4943258|NCT00364130|17004667|P1|Intervention Period|Withdrawal by Subject|4
4943259|NCT00364130|17004666|P2|Intervention Period|Pregnancy|0
4943260|NCT00364130|17004667|P1|Intervention Period|Pregnancy|1
4943261|NCT00364130|17004666|P2|Intervention Period|Lost to Follow-up|3
4943262|NCT00364130|17004667|P1|Intervention Period|Lost to Follow-up|4
4943263|NCT00364013|17004689|P2|Overall Study|Ongoing|13
4943264|NCT00364013|17004690|P1|Overall Study|Ongoing|20
4943265|NCT00364013|17004689|P2|Overall Study|Other|47
4943266|NCT00364013|17004690|P1|Overall Study|Other|41
4943267|NCT00364013|17004689|P2|Overall Study|Protocol-specified criteria|6
4943268|NCT00364013|17004690|P1|Overall Study|Protocol-specified criteria|6
4943269|NCT00364013|17004689|P2|Overall Study|Lost to Follow-up|3
4943270|NCT00364013|17004690|P1|Overall Study|Lost to Follow-up|10
4943271|NCT00364013|17004689|P2|Overall Study|Physician Decision|3
4943272|NCT00364013|17004690|P1|Overall Study|Physician Decision|3
4943273|NCT00364013|17004689|P2|Overall Study|Withdrawal by Subject|18
4943274|NCT00364013|17004690|P1|Overall Study|Withdrawal by Subject|13
4943275|NCT00364013|17004689|P2|Overall Study|Adverse Event|3
4943276|NCT00364013|17004690|P1|Overall Study|Adverse Event|4
4943277|NCT00364013|17004689|P2|Overall Study|Ineligibility determined|2
4943278|NCT00364013|17004690|P1|Overall Study|Ineligibility determined|4
4943279|NCT00363896|17004718|P2|Overall Study|Other|2
4943280|NCT00363896|17004719|P1|Overall Study|Other|1
4943281|NCT00363896|17004718|P2|Overall Study|Non-fulfilment of entry criteria|0
4943282|NCT00363896|17004719|P1|Overall Study|Non-fulfilment of entry criteria|1
4943283|NCT00363896|17004718|P2|Overall Study|Lost to Follow-up|0
4943284|NCT00363896|17004719|P1|Overall Study|Lost to Follow-up|3
4943285|NCT00363896|17004718|P2|Overall Study|Protocol Violation|1
4943286|NCT00363896|17004719|P1|Overall Study|Protocol Violation|6
4943287|NCT00363896|17004718|P2|Overall Study|Lack of Efficacy|8
4943288|NCT00363896|17004719|P1|Overall Study|Lack of Efficacy|12
4943289|NCT00363896|17004718|P2|Overall Study|COPD exacerbation|7
4943290|NCT00363896|17004719|P1|Overall Study|COPD exacerbation|13
4943291|NCT00363896|17004718|P2|Overall Study|Adverse Event|13
4943292|NCT00363896|17004719|P1|Overall Study|Adverse Event|24
4943293|NCT00363896|17004718|P2|Overall Study|Withdrawal by Subject|16
4943294|NCT00363896|17004719|P1|Overall Study|Withdrawal by Subject|29
4943295|NCT00363766|17004760|P2|Overall Study|Physician Decision|2
4943296|NCT00363766|17004761|P1|Overall Study|Physician Decision|1
4943297|NCT00363766|17004760|P2|Overall Study|Withdrawal by Subject|0
4943298|NCT00363766|17004761|P1|Overall Study|Withdrawal by Subject|2
4943299|NCT00363766|17004760|P2|Overall Study|Not Disease Related Death|4
4943300|NCT00363766|17004761|P1|Overall Study|Not Disease Related Death|3
4943301|NCT00363766|17004760|P2|Overall Study|Disease Related Death|3
4943302|NCT00363766|17004761|P1|Overall Study|Disease Related Death|1
4943303|NCT00363766|17004760|P2|Overall Study|Adverse Event|2
4943304|NCT00363766|17004761|P1|Overall Study|Adverse Event|10
4943305|NCT00363766|17004760|P2|Overall Study|Progressive Disease|9
4943306|NCT00363766|17004761|P1|Overall Study|Progressive Disease|15
4943307|NCT00363649|17004790|P2|Overall Study|Adverse Event|0
4943308|NCT00363649|17004791|P1|Overall Study|Adverse Event|6
4943309|NCT00363649|17004790|P2|Overall Study|Withdrawal by Subject|1
4943310|NCT00363649|17004791|P1|Overall Study|Withdrawal by Subject|1
4943311|NCT00363545|17004807|P2|Overall Study|Others|0
4943312|NCT00363545|17004808|P1|Overall Study|Others|1
4943313|NCT00363545|17004807|P2|Overall Study|Lost to follow-up (complete vaccination)|17
4943314|NCT00363545|17004808|P1|Overall Study|Lost to follow-up (complete vaccination)|14
4943315|NCT00363545|17004807|P2|Overall Study|Lost to follow-up (incompl. vaccination)|18
4943316|NCT00363545|17004808|P1|Overall Study|Lost to follow-up (incompl. vaccination)|14
4943317|NCT00363545|17004807|P2|Overall Study|Migrated/moved from study area|6
4943318|NCT00363545|17004808|P1|Overall Study|Migrated/moved from study area|3
4943319|NCT00363545|17004807|P2|Overall Study|Withdrawal by Subject|15
4943320|NCT00363545|17004808|P1|Overall Study|Withdrawal by Subject|12
4943321|NCT00363545|17004807|P2|Overall Study|Serious Adverse Event|1
4943322|NCT00363545|17004808|P1|Overall Study|Serious Adverse Event|0
4943323|NCT00363480|17004826|P1|Overall Study|Participant discontinued on its own|1
4943324|NCT00363480|17004826|P1|Overall Study|Non-compliance of subject|1
4943325|NCT00363480|17004826|P1|Overall Study|Withdrawal by Subject|5
4943326|NCT00363480|17004826|P1|Overall Study|Lost to Follow-up|5
4943327|NCT00363480|17004826|P1|Overall Study|Adverse Event|4
4943328|NCT00363480|17004826|P1|Overall Study|Criteria for treatment period not fulfil|1
4943329|NCT00363467|17004846|P1|Overall Study|Physician Decision|1
4943330|NCT00363415|17004856|P2|Overall Study|Protocol Violation|4
4943331|NCT00363415|17004857|P1|Overall Study|Protocol Violation|1
4943332|NCT00363415|17004856|P2|Overall Study|Lost to Follow-up|3
4943333|NCT00363415|17004857|P1|Overall Study|Lost to Follow-up|3
4943334|NCT00363415|17004856|P2|Overall Study|Withdrawal by Subject|15
4943335|NCT00363415|17004857|P1|Overall Study|Withdrawal by Subject|9
4943336|NCT00363415|17004856|P2|Overall Study|Entry Criteria Not Met|10
4943337|NCT00363415|17004857|P1|Overall Study|Entry Criteria Not Met|11
4943338|NCT00363415|17004856|P2|Overall Study|Physician Decision|35
4943339|NCT00363415|17004857|P1|Overall Study|Physician Decision|18
4943340|NCT00363415|17004856|P2|Overall Study|Adverse Event|15
4943341|NCT00363415|17004857|P1|Overall Study|Adverse Event|24
4943342|NCT00363415|17004856|P2|Overall Study|Death|29
4943343|NCT00363415|17004857|P1|Overall Study|Death|32
4943344|NCT00363415|17004856|P2|Overall Study|Sponsor Decision|31
4943345|NCT00363415|17004857|P1|Overall Study|Sponsor Decision|67
4943346|NCT00363415|17004856|P2|Overall Study|Progressive Disease|107
4943347|NCT00363415|17004857|P1|Overall Study|Progressive Disease|196
4943348|NCT00363311|17004875|P2|Overall Study|Participant Moved to Louisiana|1
4943349|NCT00363311|17004876|P1|Overall Study|Participant Moved to Louisiana|0
4943350|NCT00363311|17004875|P2|Overall Study|Withdrawn per Instructions of Monitor|1
4943351|NCT00363311|17004876|P1|Overall Study|Withdrawn per Instructions of Monitor|0
4943352|NCT00363311|17004875|P2|Overall Study|Participant Withdrew Waiting for Surgery|1
4943353|NCT00363311|17004876|P1|Overall Study|Participant Withdrew Waiting for Surgery|0
4943354|NCT00363311|17004875|P2|Overall Study|Participant Moved to Another Country|0
4943355|NCT00363311|17004876|P1|Overall Study|Participant Moved to Another Country|1
4943356|NCT00363311|17004875|P2|Overall Study|Participant Opted for Treatment|0
4943357|NCT00363311|17004876|P1|Overall Study|Participant Opted for Treatment|1
4943358|NCT00363311|17004875|P2|Overall Study|Prostate Volume/PSA Doubled|0
4943359|NCT00363311|17004876|P1|Overall Study|Prostate Volume/PSA Doubled|1
4943360|NCT00363311|17004875|P2|Overall Study|Participant Refused Biopsy|0
4943361|NCT00363311|17004876|P1|Overall Study|Participant Refused Biopsy|1
4943362|NCT00363311|17004875|P2|Overall Study|Non-Compliance|1
4943363|NCT00363311|17004876|P1|Overall Study|Non-Compliance|1
4943364|NCT00363311|17004875|P2|Overall Study|Disease Progression|26
4943365|NCT00363311|17004876|P1|Overall Study|Disease Progression|46
4943366|NCT00363311|17004875|P2|Overall Study|Sponsor Terminated Study|2
4943367|NCT00363311|17004876|P1|Overall Study|Sponsor Terminated Study|2
4943368|NCT00363311|17004875|P2|Overall Study|Physician Decision|1
4943369|NCT00363311|17004876|P1|Overall Study|Physician Decision|1
4943370|NCT00363311|17004875|P2|Overall Study|Withdrawal by Subject|6
4943371|NCT00363311|17004876|P1|Overall Study|Withdrawal by Subject|12
4943372|NCT00363311|17004875|P2|Overall Study|Protocol Violation|2
4943373|NCT00363311|17004876|P1|Overall Study|Protocol Violation|1
4943374|NCT00363311|17004875|P2|Overall Study|Lost to Follow-up|0
4943375|NCT00363311|17004876|P1|Overall Study|Lost to Follow-up|3
4943376|NCT00363311|17004875|P2|Overall Study|Adverse Event|4
4943377|NCT00363311|17004876|P1|Overall Study|Adverse Event|6
4943378|NCT00363298|17004942|P2|4-week Study Continuation Phase|Lack of Efficacy|0
4943379|NCT00363298|17004943|P1|4-week Study Continuation Phase|Lack of Efficacy|1
4943380|NCT00363298|17004942|P2|First Study Week|Lack of Efficacy|5
4943381|NCT00363298|17004943|P1|First Study Week|Lack of Efficacy|6
4943382|NCT00363246|17004951|P1|Overall Study|Eligibility changed due to Hospice move|5
4943383|NCT00363246|17004951|P1|Overall Study|Subject expressed security concerns|2
4943384|NCT00363246|17004951|P1|Overall Study|Stopped using wheelchair|11
4943385|NCT00363246|17004951|P1|Overall Study|Bad health|6
4943386|NCT00363246|17004951|P1|Overall Study|Lost to Follow-up|14
4943387|NCT00363246|17004951|P1|Overall Study|Withdrawal by Subject|19
4943388|NCT00363246|17004951|P1|Overall Study|Death|40
4943389|NCT00363142|17004969|P2|Overall Study|Withdrawal by Subject|1
4943390|NCT00363142|17004970|P1|Overall Study|Withdrawal by Subject|3
4943391|NCT00363142|17004969|P2|Overall Study|Non-compliance|1
4943392|NCT00363142|17004970|P1|Overall Study|Non-compliance|1
4943393|NCT00363142|17004969|P2|Overall Study|Lost to Follow-up|0
4943394|NCT00363142|17004970|P1|Overall Study|Lost to Follow-up|1
4943395|NCT00363142|17004969|P2|Overall Study|Lack of Efficacy|1
4943396|NCT00363142|17004970|P1|Overall Study|Lack of Efficacy|0
4943397|NCT00363142|17004969|P2|Overall Study|Adverse Event|0
4943398|NCT00363142|17004970|P1|Overall Study|Adverse Event|2
4943399|NCT00363129|17004999|P2|Overall Study|Other Reasons|3
4943400|NCT00363129|17005000|P1|Overall Study|Other Reasons|6
4943401|NCT00363129|17004999|P2|Overall Study|Death|1
4943402|NCT00363129|17005000|P1|Overall Study|Death|0
4943403|NCT00363129|17004999|P2|Overall Study|Other Medical Problems|4
4943404|NCT00363129|17005000|P1|Overall Study|Other Medical Problems|2
4943405|NCT00363129|17004999|P2|Overall Study|Alternate Treatment|4
4943406|NCT00363129|17005000|P1|Overall Study|Alternate Treatment|2
4943407|NCT00363129|17004999|P2|Overall Study|Adverse Event|3
4943408|NCT00363129|17005000|P1|Overall Study|Adverse Event|8
4943409|NCT00363129|17004999|P2|Overall Study|Withdrawal by Subject|18
4943410|NCT00363129|17005000|P1|Overall Study|Withdrawal by Subject|11
4943411|NCT00363051|17005043|P2|Overall Study|Death|2
4943412|NCT00363051|17005044|P1|Overall Study|Death|3
4943413|NCT00363051|17005043|P2|Overall Study|Protocol Violation|2
4943414|NCT00363051|17005044|P1|Overall Study|Protocol Violation|0
4943415|NCT00363051|17005043|P2|Overall Study|Lost to Follow-up|1
4943416|NCT00363051|17005044|P1|Overall Study|Lost to Follow-up|0
4943417|NCT00363051|17005043|P2|Overall Study|Withdrawal by Subject|3
4943418|NCT00363051|17005044|P1|Overall Study|Withdrawal by Subject|11
4943419|NCT00363051|17005043|P2|Overall Study|New Cancer Therapy|1
4943420|NCT00363051|17005044|P1|Overall Study|New Cancer Therapy|2
4943421|NCT00363051|17005043|P2|Overall Study|Adverse Event|12
4943422|NCT00363051|17005044|P1|Overall Study|Adverse Event|21
4943423|NCT00363051|17005043|P2|Overall Study|Adminstrative problems|1
4943424|NCT00363051|17005044|P1|Overall Study|Adminstrative problems|1
4943425|NCT00362648|17005093|P4|Overall Study|Withdrawal by Subject|6
4943426|NCT00362648|17005094|P3|Overall Study|Withdrawal by Subject|2
4943427|NCT00362648|17005095|P2|Overall Study|Withdrawal by Subject|42
4943428|NCT00362648|17005096|P1|Overall Study|Withdrawal by Subject|48
4943429|NCT00362648|17005093|P4|Overall Study|Protocol Violation|2
4943430|NCT00362648|17005094|P3|Overall Study|Protocol Violation|2
4943431|NCT00362648|17005095|P2|Overall Study|Protocol Violation|2
4943432|NCT00362648|17005096|P1|Overall Study|Protocol Violation|4
4943433|NCT00362648|17005093|P4|Overall Study|Lost to Follow-up|3
4943434|NCT00362648|17005094|P3|Overall Study|Lost to Follow-up|4
4943435|NCT00362648|17005095|P2|Overall Study|Lost to Follow-up|69
4943436|NCT00362648|17005096|P1|Overall Study|Lost to Follow-up|62
4943437|NCT00362648|17005093|P4|Overall Study|Adverse Event|0
4943438|NCT00362648|17005094|P3|Overall Study|Adverse Event|1
4943439|NCT00362648|17005095|P2|Overall Study|Adverse Event|21
4943440|NCT00362648|17005096|P1|Overall Study|Adverse Event|12
4943441|NCT00362609|17005114|P2|Overall Study|Protocol Violation|1
4943442|NCT00362609|17005115|P1|Overall Study|Protocol Violation|0
4943443|NCT00362609|17005114|P2|Overall Study|Withdrawal by Subject|1
4943444|NCT00362609|17005115|P1|Overall Study|Withdrawal by Subject|0
4943445|NCT00362414|17005196|P1|Overall Study|Adverse Event|1
4943446|NCT00362414|17005196|P1|Overall Study|Death|2
4943447|NCT00362375|17005225|P2|Overall Study|Lost to Follow-up|35
4943448|NCT00362375|17005226|P1|Overall Study|Lost to Follow-up|40
4943449|NCT00362336|17005243|P3|Overall Study|Withdrawal by Subject|1
4943450|NCT00362336|17005244|P2|Overall Study|Withdrawal by Subject|3
4943451|NCT00362336|17005245|P1|Overall Study|Withdrawal by Subject|3
4943452|NCT00362336|17005243|P3|Overall Study|Lost to Follow-up|0
4943453|NCT00362336|17005244|P2|Overall Study|Lost to Follow-up|4
4943454|NCT00362336|17005245|P1|Overall Study|Lost to Follow-up|6
4943455|NCT00362336|17005243|P3|Overall Study|Protocol Violation|1
4943456|NCT00362336|17005244|P2|Overall Study|Protocol Violation|0
4943457|NCT00362336|17005245|P1|Overall Study|Protocol Violation|0
4943458|NCT00362336|17005243|P3|Overall Study|Serious Adverse Event|1
4943459|NCT00362336|17005244|P2|Overall Study|Serious Adverse Event|0
4943460|NCT00362336|17005245|P1|Overall Study|Serious Adverse Event|1
4943461|NCT00362297|17005273|P2|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4
4943462|NCT00362297|17005274|P1|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0
4943463|NCT00362232|17005282|P2|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7
4943464|NCT00362232|17005283|P1|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8
4943465|NCT00362232|17005282|P2|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28
4943466|NCT00362232|17005283|P1|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27
4943467|NCT00362232|17005282|P2|Follow-up (30 (+ 5) Days)|Death|1
4943468|NCT00362232|17005283|P1|Follow-up (30 (+ 5) Days)|Death|1
4943469|NCT00362232|17005282|P2|Follow-up (30 (+ 5) Days)|Adverse Event|3
4943470|NCT00362232|17005283|P1|Follow-up (30 (+ 5) Days)|Adverse Event|2
4943471|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18
4943472|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10
4943473|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Technical Problems|0
4943474|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Technical Problems|1
4943475|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0
4943476|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9
4943477|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47
4943478|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49
4943479|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Protocol Violation|21
4943480|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Protocol Violation|22
4943481|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Physician Decision|5
4943482|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Physician Decision|2
4943483|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Lost to Follow-up|1
4943484|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Lost to Follow-up|3
4943485|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Death|3
4943486|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Death|1
4943487|NCT00362232|17005282|P2|Treatment (12 +/- 2 Days)|Adverse Event|56
4943488|NCT00362232|17005283|P1|Treatment (12 +/- 2 Days)|Adverse Event|62
4943489|NCT00362180|17005328|P9|Treated Period|Adverse Event|0
4943490|NCT00362180|17005329|P8|Treated Period|Adverse Event|1
4943491|NCT00362180|17005330|P7|Treated Period|Adverse Event|0
4943492|NCT00362180|17005331|P6|Treated Period|Adverse Event|1
4943493|NCT00362180|17005332|P5|Treated Period|Adverse Event|0
4943494|NCT00362180|17005333|P4|Treated Period|Adverse Event|0
4943495|NCT00362180|17005334|P3|Treated Period|Adverse Event|0
4943496|NCT00362180|17005335|P2|Treated Period|Adverse Event|0
4943497|NCT00362180|17005336|P1|Treated Period|Adverse Event|0
4943498|NCT00362180|17005328|P9|Treated Period|Withdrawal by Subject|0
4943499|NCT00362180|17005329|P8|Treated Period|Withdrawal by Subject|0
4943500|NCT00362180|17005330|P7|Treated Period|Withdrawal by Subject|0
4943501|NCT00362180|17005331|P6|Treated Period|Withdrawal by Subject|0
4943502|NCT00362180|17005332|P5|Treated Period|Withdrawal by Subject|0
4943503|NCT00362180|17005333|P4|Treated Period|Withdrawal by Subject|0
4943504|NCT00362180|17005334|P3|Treated Period|Withdrawal by Subject|0
4943505|NCT00362180|17005335|P2|Treated Period|Withdrawal by Subject|0
4943506|NCT00362180|17005336|P1|Treated Period|Withdrawal by Subject|1
4943507|NCT00362115|17005408|P7|Overall Study|Other|0
4943508|NCT00362115|17005409|P6|Overall Study|Other|1
4943509|NCT00362115|17005410|P5|Overall Study|Other|0
4943510|NCT00362115|17005411|P4|Overall Study|Other|1
4943511|NCT00362115|17005412|P3|Overall Study|Other|0
4943512|NCT00362115|17005413|P2|Overall Study|Other|1
4943513|NCT00362115|17005414|P1|Overall Study|Other|0
4943514|NCT00362115|17005408|P7|Overall Study|Physician Decision|3
4943515|NCT00362115|17005409|P6|Overall Study|Physician Decision|0
4943516|NCT00362115|17005410|P5|Overall Study|Physician Decision|0
4943517|NCT00362115|17005411|P4|Overall Study|Physician Decision|0
4943518|NCT00362115|17005412|P3|Overall Study|Physician Decision|0
4943519|NCT00362115|17005413|P2|Overall Study|Physician Decision|0
4943520|NCT00362115|17005414|P1|Overall Study|Physician Decision|0
4943521|NCT00362115|17005408|P7|Overall Study|Lack of Efficacy|3
4943522|NCT00362115|17005409|P6|Overall Study|Lack of Efficacy|0
4943523|NCT00362115|17005410|P5|Overall Study|Lack of Efficacy|2
4943524|NCT00362115|17005411|P4|Overall Study|Lack of Efficacy|2
4943525|NCT00362115|17005412|P3|Overall Study|Lack of Efficacy|5
4943526|NCT00362115|17005413|P2|Overall Study|Lack of Efficacy|0
4943527|NCT00362115|17005414|P1|Overall Study|Lack of Efficacy|1
4943528|NCT00362115|17005408|P7|Overall Study|Withdrawal by Subject|4
4943529|NCT00362115|17005409|P6|Overall Study|Withdrawal by Subject|3
4943530|NCT00362115|17005410|P5|Overall Study|Withdrawal by Subject|1
4943531|NCT00362115|17005411|P4|Overall Study|Withdrawal by Subject|0
4943532|NCT00362115|17005412|P3|Overall Study|Withdrawal by Subject|1
4943533|NCT00362115|17005413|P2|Overall Study|Withdrawal by Subject|3
4943534|NCT00362115|17005414|P1|Overall Study|Withdrawal by Subject|1
4943535|NCT00362115|17005408|P7|Overall Study|Lost to Follow-up|1
4943536|NCT00362115|17005409|P6|Overall Study|Lost to Follow-up|0
4943537|NCT00362115|17005410|P5|Overall Study|Lost to Follow-up|2
4943538|NCT00362115|17005411|P4|Overall Study|Lost to Follow-up|0
4943539|NCT00362115|17005412|P3|Overall Study|Lost to Follow-up|0
4943540|NCT00362115|17005413|P2|Overall Study|Lost to Follow-up|1
4943541|NCT00362115|17005414|P1|Overall Study|Lost to Follow-up|0
4943542|NCT00362115|17005408|P7|Overall Study|Protocol Violation|0
4943543|NCT00362115|17005409|P6|Overall Study|Protocol Violation|1
4943544|NCT00362115|17005410|P5|Overall Study|Protocol Violation|0
4943545|NCT00362115|17005411|P4|Overall Study|Protocol Violation|0
4943546|NCT00362115|17005412|P3|Overall Study|Protocol Violation|0
4943547|NCT00362115|17005413|P2|Overall Study|Protocol Violation|0
4943548|NCT00362115|17005414|P1|Overall Study|Protocol Violation|0
4943549|NCT00362115|17005408|P7|Overall Study|Adverse Event|1
4943550|NCT00362115|17005409|P6|Overall Study|Adverse Event|2
4943551|NCT00362115|17005410|P5|Overall Study|Adverse Event|2
4943552|NCT00362115|17005411|P4|Overall Study|Adverse Event|1
4943553|NCT00362115|17005412|P3|Overall Study|Adverse Event|1
4943554|NCT00362115|17005413|P2|Overall Study|Adverse Event|1
4943555|NCT00362115|17005414|P1|Overall Study|Adverse Event|0
4943556|NCT00361634|17005587|P1|Overall Study|Withdrawal by Subject|1
4943557|NCT00361634|17005587|P1|Overall Study|Lost to Follow-up|1
4943558|NCT00361569|17005616|P4|Overall Study|Not specified by investigator|1
4943559|NCT00361569|17005617|P3|Overall Study|Not specified by investigator|0
4943560|NCT00361569|17005618|P2|Overall Study|Not specified by investigator|0
4943561|NCT00361569|17005619|P1|Overall Study|Not specified by investigator|2
4943562|NCT00361569|17005616|P4|Overall Study|Lost to Follow-up|2
4943563|NCT00361569|17005617|P3|Overall Study|Lost to Follow-up|3
4943564|NCT00361569|17005618|P2|Overall Study|Lost to Follow-up|3
4943565|NCT00361569|17005619|P1|Overall Study|Lost to Follow-up|2
4943566|NCT00361569|17005616|P4|Overall Study|Adverse Event|2
4943567|NCT00361569|17005617|P3|Overall Study|Adverse Event|2
4943568|NCT00361569|17005618|P2|Overall Study|Adverse Event|5
4943569|NCT00361569|17005619|P1|Overall Study|Adverse Event|3
4943570|NCT00361569|17005616|P4|Overall Study|Withdrawal by Subject|14
4943571|NCT00361569|17005617|P3|Overall Study|Withdrawal by Subject|9
4943572|NCT00361569|17005618|P2|Overall Study|Withdrawal by Subject|1
4943573|NCT00361569|17005619|P1|Overall Study|Withdrawal by Subject|2
4943574|NCT00361569|17005616|P4|Overall Study|Protocol Violation|2
4943575|NCT00361569|17005617|P3|Overall Study|Protocol Violation|4
4943576|NCT00361569|17005618|P2|Overall Study|Protocol Violation|2
4943577|NCT00361569|17005619|P1|Overall Study|Protocol Violation|3
4943578|NCT00361504|17005643|P2|Overall Study|All other|3
4943579|NCT00361504|17005644|P1|Overall Study|All other|28
4943580|NCT00361504|17005643|P2|Overall Study|Study medication non compliant|15
4943581|NCT00361504|17005644|P1|Overall Study|Study medication non compliant|42
4943582|NCT00361504|17005643|P2|Overall Study|Resolution of Pain|0
4943583|NCT00361504|17005644|P1|Overall Study|Resolution of Pain|2
4943584|NCT00361504|17005643|P2|Overall Study|Lack of Efficacy|7
4943585|NCT00361504|17005644|P1|Overall Study|Lack of Efficacy|72
4943586|NCT00361504|17005643|P2|Overall Study|Adverse Event|82
4943587|NCT00361504|17005644|P1|Overall Study|Adverse Event|203
4943588|NCT00361504|17005643|P2|Overall Study|Lost to Follow-up|7
4943589|NCT00361504|17005644|P1|Overall Study|Lost to Follow-up|40
4943590|NCT00361504|17005643|P2|Overall Study|Withdrawal by Subject|31
4943591|NCT00361504|17005644|P1|Overall Study|Withdrawal by Subject|94
4943592|NCT00361335|17005685|P7|SC Period: Week E0 to Week E24|Lack of Efficacy|3
4943593|NCT00361335|17005686|P6|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4943594|NCT00361335|17005687|P5|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4943595|NCT00361335|17005688|P4|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4943596|NCT00361335|17005689|P3|SC Period: Week E0 to Week E24|Lack of Efficacy|2
4943597|NCT00361335|17005690|P2|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4943598|NCT00361335|17005691|P1|SC Period: Week E0 to Week E24|Lack of Efficacy|0
4943599|NCT00361335|17005685|P7|SC Period: Week E0 to Week E24|Other|2
4943600|NCT00361335|17005686|P6|SC Period: Week E0 to Week E24|Other|1
4943601|NCT00361335|17005687|P5|SC Period: Week E0 to Week E24|Other|0
4943602|NCT00361335|17005688|P4|SC Period: Week E0 to Week E24|Other|1
4943603|NCT00361335|17005689|P3|SC Period: Week E0 to Week E24|Other|0
4943604|NCT00361335|17005690|P2|SC Period: Week E0 to Week E24|Other|0
4943605|NCT00361335|17005691|P1|SC Period: Week E0 to Week E24|Other|1
4943606|NCT00361335|17005685|P7|SC Period: Week E0 to Week E24|Worsening of RA|0
4943607|NCT00361335|17005686|P6|SC Period: Week E0 to Week E24|Worsening of RA|0
4943608|NCT00361335|17005687|P5|SC Period: Week E0 to Week E24|Worsening of RA|0
4943609|NCT00361335|17005688|P4|SC Period: Week E0 to Week E24|Worsening of RA|1
4943610|NCT00361335|17005689|P3|SC Period: Week E0 to Week E24|Worsening of RA|1
4943611|NCT00361335|17005690|P2|SC Period: Week E0 to Week E24|Worsening of RA|1
4943612|NCT00361335|17005691|P1|SC Period: Week E0 to Week E24|Worsening of RA|0
4943613|NCT00361335|17005685|P7|SC Period: Week E0 to Week E24|Death|1
4943614|NCT00361335|17005686|P6|SC Period: Week E0 to Week E24|Death|0
4943615|NCT00361335|17005687|P5|SC Period: Week E0 to Week E24|Death|0
4943616|NCT00361335|17005688|P4|SC Period: Week E0 to Week E24|Death|0
4943617|NCT00361335|17005689|P3|SC Period: Week E0 to Week E24|Death|0
4943618|NCT00361335|17005690|P2|SC Period: Week E0 to Week E24|Death|0
4943619|NCT00361335|17005691|P1|SC Period: Week E0 to Week E24|Death|0
4943620|NCT00361335|17005685|P7|SC Period: Week E0 to Week E24|Lost to Follow-up|1
4943621|NCT00361335|17005686|P6|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4943622|NCT00361335|17005687|P5|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4943623|NCT00361335|17005688|P4|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4943624|NCT00361335|17005689|P3|SC Period: Week E0 to Week E24|Lost to Follow-up|1
4943625|NCT00361335|17005690|P2|SC Period: Week E0 to Week E24|Lost to Follow-up|0
4943626|NCT00361335|17005691|P1|SC Period: Week E0 to Week E24|Lost to Follow-up|1
4943627|NCT00361335|17005685|P7|SC Period: Week E0 to Week E24|Adverse Event|2
4943628|NCT00361335|17005686|P6|SC Period: Week E0 to Week E24|Adverse Event|0
4943629|NCT00361335|17005687|P5|SC Period: Week E0 to Week E24|Adverse Event|0
4943630|NCT00361335|17005688|P4|SC Period: Week E0 to Week E24|Adverse Event|2
4943631|NCT00361335|17005689|P3|SC Period: Week E0 to Week E24|Adverse Event|1
4943632|NCT00361335|17005690|P2|SC Period: Week E0 to Week E24|Adverse Event|2
4943633|NCT00361335|17005691|P1|SC Period: Week E0 to Week E24|Adverse Event|0
4943634|NCT00361335|17005685|P7|IV Period: Baseline to E0|Lack of Efficacy|0
4943635|NCT00361335|17005686|P6|IV Period: Baseline to E0|Lack of Efficacy|0
4943636|NCT00361335|17005687|P5|IV Period: Baseline to E0|Lack of Efficacy|8
4943637|NCT00361335|17005688|P4|IV Period: Baseline to E0|Lack of Efficacy|7
4943638|NCT00361335|17005689|P3|IV Period: Baseline to E0|Lack of Efficacy|3
4943639|NCT00361335|17005690|P2|IV Period: Baseline to E0|Lack of Efficacy|9
4943640|NCT00361335|17005691|P1|IV Period: Baseline to E0|Lack of Efficacy|5
4943641|NCT00361335|17005685|P7|IV Period: Baseline to E0|Other|0
4943642|NCT00361335|17005686|P6|IV Period: Baseline to E0|Other|0
4943643|NCT00361335|17005687|P5|IV Period: Baseline to E0|Other|2
4943644|NCT00361335|17005688|P4|IV Period: Baseline to E0|Other|3
4943645|NCT00361335|17005689|P3|IV Period: Baseline to E0|Other|9
4943646|NCT00361335|17005690|P2|IV Period: Baseline to E0|Other|9
4943647|NCT00361335|17005691|P1|IV Period: Baseline to E0|Other|2
4943648|NCT00361335|17005685|P7|IV Period: Baseline to E0|Worsening of RA|0
4943649|NCT00361335|17005686|P6|IV Period: Baseline to E0|Worsening of RA|0
4943650|NCT00361335|17005687|P5|IV Period: Baseline to E0|Worsening of RA|2
4943651|NCT00361335|17005688|P4|IV Period: Baseline to E0|Worsening of RA|4
4943652|NCT00361335|17005689|P3|IV Period: Baseline to E0|Worsening of RA|1
4943653|NCT00361335|17005690|P2|IV Period: Baseline to E0|Worsening of RA|5
4943654|NCT00361335|17005691|P1|IV Period: Baseline to E0|Worsening of RA|0
4943655|NCT00361335|17005685|P7|IV Period: Baseline to E0|Protocol-prohibited medications|0
4943656|NCT00361335|17005686|P6|IV Period: Baseline to E0|Protocol-prohibited medications|0
4943657|NCT00361335|17005687|P5|IV Period: Baseline to E0|Protocol-prohibited medications|0
4943658|NCT00361335|17005688|P4|IV Period: Baseline to E0|Protocol-prohibited medications|0
4943659|NCT00361335|17005689|P3|IV Period: Baseline to E0|Protocol-prohibited medications|1
4943660|NCT00361335|17005690|P2|IV Period: Baseline to E0|Protocol-prohibited medications|0
4943661|NCT00361335|17005691|P1|IV Period: Baseline to E0|Protocol-prohibited medications|0
4943662|NCT00361335|17005685|P7|IV Period: Baseline to E0|Discontinued oral study agent|0
4943663|NCT00361335|17005686|P6|IV Period: Baseline to E0|Discontinued oral study agent|0
4943664|NCT00361335|17005687|P5|IV Period: Baseline to E0|Discontinued oral study agent|2
4943665|NCT00361335|17005688|P4|IV Period: Baseline to E0|Discontinued oral study agent|1
4943666|NCT00361335|17005689|P3|IV Period: Baseline to E0|Discontinued oral study agent|1
4943667|NCT00361335|17005690|P2|IV Period: Baseline to E0|Discontinued oral study agent|1
4943668|NCT00361335|17005691|P1|IV Period: Baseline to E0|Discontinued oral study agent|2
4943669|NCT00361335|17005685|P7|IV Period: Baseline to E0|Death|0
4943670|NCT00361335|17005686|P6|IV Period: Baseline to E0|Death|0
4943671|NCT00361335|17005687|P5|IV Period: Baseline to E0|Death|0
4943672|NCT00361335|17005688|P4|IV Period: Baseline to E0|Death|1
4943673|NCT00361335|17005689|P3|IV Period: Baseline to E0|Death|1
4943674|NCT00361335|17005690|P2|IV Period: Baseline to E0|Death|1
4943675|NCT00361335|17005691|P1|IV Period: Baseline to E0|Death|1
4943676|NCT00361335|17005685|P7|IV Period: Baseline to E0|Lost to Follow-up|0
4943677|NCT00361335|17005686|P6|IV Period: Baseline to E0|Lost to Follow-up|0
4943678|NCT00361335|17005687|P5|IV Period: Baseline to E0|Lost to Follow-up|2
4943679|NCT00361335|17005688|P4|IV Period: Baseline to E0|Lost to Follow-up|2
4943680|NCT00361335|17005689|P3|IV Period: Baseline to E0|Lost to Follow-up|0
4943681|NCT00361335|17005690|P2|IV Period: Baseline to E0|Lost to Follow-up|0
4943682|NCT00361335|17005691|P1|IV Period: Baseline to E0|Lost to Follow-up|1
4943683|NCT00361335|17005685|P7|IV Period: Baseline to E0|Adverse Event|0
4943684|NCT00361335|17005686|P6|IV Period: Baseline to E0|Adverse Event|0
4943685|NCT00361335|17005687|P5|IV Period: Baseline to E0|Adverse Event|8
4943686|NCT00361335|17005688|P4|IV Period: Baseline to E0|Adverse Event|9
4943687|NCT00361335|17005689|P3|IV Period: Baseline to E0|Adverse Event|5
4943688|NCT00361335|17005690|P2|IV Period: Baseline to E0|Adverse Event|4
4943689|NCT00361335|17005691|P1|IV Period: Baseline to E0|Adverse Event|9
4943690|NCT00361296|17005735|P1|Overall Study|Lack of Efficacy|2
4943691|NCT00361296|17005735|P1|Overall Study|Physician Decision|1
4943692|NCT00361283|17005742|P1|Overall Study|Lost to Follow-up|27
4943693|NCT00361270|17005750|P4|Overall Study|Adverse Event|0
4943694|NCT00361270|17005751|P3|Overall Study|Adverse Event|1
4943695|NCT00361270|17005752|P2|Overall Study|Adverse Event|1
4943696|NCT00361270|17005753|P1|Overall Study|Adverse Event|0
4943697|NCT00361270|17005750|P4|Overall Study|Problems with Transportation|0
4943698|NCT00361270|17005751|P3|Overall Study|Problems with Transportation|0
4943699|NCT00361270|17005752|P2|Overall Study|Problems with Transportation|0
4943700|NCT00361270|17005753|P1|Overall Study|Problems with Transportation|4
4943701|NCT00361270|17005750|P4|Overall Study|Afraid of Hypnosis|0
4943702|NCT00361270|17005751|P3|Overall Study|Afraid of Hypnosis|0
4943703|NCT00361270|17005752|P2|Overall Study|Afraid of Hypnosis|2
4943704|NCT00361270|17005753|P1|Overall Study|Afraid of Hypnosis|1
4943705|NCT00361270|17005750|P4|Overall Study|Withdrawal by Subject|7
4943706|NCT00361270|17005751|P3|Overall Study|Withdrawal by Subject|3
4943707|NCT00361270|17005752|P2|Overall Study|Withdrawal by Subject|6
4943708|NCT00361270|17005753|P1|Overall Study|Withdrawal by Subject|6
4943709|NCT00361270|17005750|P4|Overall Study|Protocol Violation|4
4943710|NCT00361270|17005751|P3|Overall Study|Protocol Violation|5
4943711|NCT00361270|17005752|P2|Overall Study|Protocol Violation|4
4943712|NCT00361270|17005753|P1|Overall Study|Protocol Violation|9
4943713|NCT00361270|17005750|P4|Overall Study|Physician Decision|0
4943714|NCT00361270|17005751|P3|Overall Study|Physician Decision|1
4943715|NCT00361270|17005752|P2|Overall Study|Physician Decision|0
4943716|NCT00361270|17005753|P1|Overall Study|Physician Decision|0
4943717|NCT00361270|17005750|P4|Overall Study|Lost to Follow-up|0
4943718|NCT00361270|17005751|P3|Overall Study|Lost to Follow-up|0
4943719|NCT00361270|17005752|P2|Overall Study|Lost to Follow-up|1
4943720|NCT00361270|17005753|P1|Overall Study|Lost to Follow-up|4
4943721|NCT00361270|17005750|P4|Overall Study|Death|2
4943722|NCT00361270|17005751|P3|Overall Study|Death|0
4943723|NCT00361270|17005752|P2|Overall Study|Death|0
4943724|NCT00361270|17005753|P1|Overall Study|Death|0
4943725|NCT00361231|17005826|P1|Overall Study|Adverse Event|6
4943726|NCT00361231|17005826|P1|Overall Study|Withdrawal by Subject|4
4943727|NCT00361231|17005826|P1|Overall Study|Radiographic disease progression|16
4943728|NCT00361231|17005826|P1|Overall Study|Symptomatic deterioration|5
4943729|NCT00361231|17005826|P1|Overall Study|Physician Decision|3
4943730|NCT00361218|17005831|P1|Overall Study|terminated / withdrawn due to toxicity /|5
4943731|NCT00361218|17005831|P1|Overall Study|Personal Reasons|7
4943732|NCT00361218|17005831|P1|Overall Study|Lost to Follow-up|11
4943733|NCT00360698|17005910|P2|Treatment Period|Early termination by error|1
4943734|NCT00360698|17005911|P1|Treatment Period|Early termination by error|0
4943735|NCT00360698|17005910|P2|Treatment Period|Non compliance with treatment procedure|0
4943736|NCT00360698|17005911|P1|Treatment Period|Non compliance with treatment procedure|1
4943737|NCT00360698|17005910|P2|Run-In|Need of insulin with meals|1
4943738|NCT00360698|17005911|P1|Run-In|Need of insulin with meals|0
4943739|NCT00360698|17005910|P2|Run-In|Patient personal reasons|2
4943740|NCT00360698|17005911|P1|Run-In|Patient personal reasons|0
4943741|NCT00360698|17005910|P2|Run-In|Patient did not meet inclusion criteria|1
4943742|NCT00360698|17005911|P1|Run-In|Patient did not meet inclusion criteria|0
4943743|NCT00360698|17005910|P2|Run-In|Sponsor request|2
4943744|NCT00360698|17005911|P1|Run-In|Sponsor request|0
4943745|NCT00360698|17005910|P2|Run-In|Non compliance with treatment procedure|1
4943746|NCT00360698|17005911|P1|Run-In|Non compliance with treatment procedure|0
4943747|NCT00360698|17005910|P2|Run-In|Withdrawal by Subject|2
4943748|NCT00360698|17005911|P1|Run-In|Withdrawal by Subject|0
4943749|NCT00360698|17005910|P2|Run-In|Physician Decision|1
4943750|NCT00360698|17005911|P1|Run-In|Physician Decision|0
4943751|NCT00360568|17005956|P2|Overall Study|Withdrawal by Subject|3
4943752|NCT00360568|17005957|P1|Overall Study|Withdrawal by Subject|0
4943753|NCT00360568|17005956|P2|Overall Study|Lack of Efficacy|0
4943754|NCT00360568|17005957|P1|Overall Study|Lack of Efficacy|1
4943755|NCT00360568|17005956|P2|Overall Study|Adverse Event|2
4943756|NCT00360568|17005957|P1|Overall Study|Adverse Event|1
4943757|NCT00360529|17006088|P3|Overall Study|Reason discontinued not explained above|11
4943758|NCT00360529|17006089|P2|Overall Study|Reason discontinued not explained above|9
4943759|NCT00360529|17006090|P1|Overall Study|Reason discontinued not explained above|4
4943760|NCT00360529|17006088|P3|Overall Study|Lack of Efficacy|5
4943761|NCT00360529|17006089|P2|Overall Study|Lack of Efficacy|6
4943762|NCT00360529|17006090|P1|Overall Study|Lack of Efficacy|8
4943763|NCT00360529|17006088|P3|Overall Study|Withdrawal by Subject|18
4943764|NCT00360529|17006089|P2|Overall Study|Withdrawal by Subject|14
4943765|NCT00360529|17006090|P1|Overall Study|Withdrawal by Subject|22
4943766|NCT00360529|17006088|P3|Overall Study|Lost to Follow-up|13
4943767|NCT00360529|17006089|P2|Overall Study|Lost to Follow-up|10
4943768|NCT00360529|17006090|P1|Overall Study|Lost to Follow-up|14
4943769|NCT00360529|17006088|P3|Overall Study|Protocol Violation|11
4943770|NCT00360529|17006089|P2|Overall Study|Protocol Violation|3
4943771|NCT00360529|17006090|P1|Overall Study|Protocol Violation|3
4943772|NCT00360529|17006088|P3|Overall Study|Adverse Event|33
4943773|NCT00360529|17006089|P2|Overall Study|Adverse Event|23
4943774|NCT00360529|17006090|P1|Overall Study|Adverse Event|10
4943775|NCT00360490|17006118|P2|Overall Study|Withdrawal by Subject|3
4943776|NCT00360490|17006119|P1|Overall Study|Withdrawal by Subject|1
4943777|NCT00360490|17006118|P2|Overall Study|Protocol Violation|4
4943778|NCT00360490|17006119|P1|Overall Study|Protocol Violation|0
4943779|NCT00360490|17006118|P2|Overall Study|Physician Decision|1
4943780|NCT00360490|17006119|P1|Overall Study|Physician Decision|2
4943781|NCT00360490|17006118|P2|Overall Study|Lost to Follow-up|1
4943782|NCT00360490|17006119|P1|Overall Study|Lost to Follow-up|2
4943783|NCT00360490|17006118|P2|Overall Study|Adverse Event|2
4943784|NCT00360490|17006119|P1|Overall Study|Adverse Event|4
4943785|NCT00360412|17006154|P2|Overall Study|Study termination by Sponsor|469
4943786|NCT00360412|17006155|P1|Overall Study|Study termination by Sponsor|214
4943787|NCT00360412|17006154|P2|Overall Study|Other|6
4943788|NCT00360412|17006155|P1|Overall Study|Other|5
4943789|NCT00360412|17006154|P2|Overall Study|Physician Decision|4
4943790|NCT00360412|17006155|P1|Overall Study|Physician Decision|2
4943791|NCT00360412|17006154|P2|Overall Study|Lack of therapeutic efficacy|61
4943792|NCT00360412|17006155|P1|Overall Study|Lack of therapeutic efficacy|46
4943793|NCT00360412|17006154|P2|Overall Study|Patient withdrew consent|52
4943794|NCT00360412|17006155|P1|Overall Study|Patient withdrew consent|27
4943795|NCT00360412|17006154|P2|Overall Study|Protocol Violation|5
4943796|NCT00360412|17006155|P1|Overall Study|Protocol Violation|2
4943797|NCT00360412|17006154|P2|Overall Study|Adverse Event|65
4943798|NCT00360412|17006155|P1|Overall Study|Adverse Event|37
4943799|NCT00360334|17006202|P2|Overall Study|Subject decision|2
4943800|NCT00360334|17006203|P1|Overall Study|Subject decision|8
4943801|NCT00360334|17006202|P2|Overall Study|Entry criterion not met|2
4943802|NCT00360334|17006203|P1|Overall Study|Entry criterion not met|1
4943803|NCT00360334|17006202|P2|Overall Study|Lack of Efficacy|1
4943804|NCT00360334|17006203|P1|Overall Study|Lack of Efficacy|0
4943805|NCT00360334|17006202|P2|Overall Study|Physician Decision|3
4943806|NCT00360334|17006203|P1|Overall Study|Physician Decision|2
4943807|NCT00360334|17006202|P2|Overall Study|Protocol Violation|1
4943808|NCT00360334|17006203|P1|Overall Study|Protocol Violation|1
4943809|NCT00360334|17006202|P2|Overall Study|Adverse Event|4
4943810|NCT00360334|17006203|P1|Overall Study|Adverse Event|7
4943811|NCT00360308|17006266|P3|Overall Study|Study termination by sponsor|44
4943812|NCT00360308|17006267|P2|Overall Study|Study termination by sponsor|55
4943813|NCT00360308|17006268|P1|Overall Study|Study termination by sponsor|43
4943814|NCT00360308|17006266|P3|Overall Study|Other|1
4943815|NCT00360308|17006267|P2|Overall Study|Other|1
4943816|NCT00360308|17006268|P1|Overall Study|Other|2
4943817|NCT00360308|17006266|P3|Overall Study|Lack of Efficacy|2
4943818|NCT00360308|17006267|P2|Overall Study|Lack of Efficacy|0
4943819|NCT00360308|17006268|P1|Overall Study|Lack of Efficacy|3
4943820|NCT00360308|17006266|P3|Overall Study|Withdrawal by Subject|14
4943821|NCT00360308|17006267|P2|Overall Study|Withdrawal by Subject|7
4943822|NCT00360308|17006268|P1|Overall Study|Withdrawal by Subject|11
4943823|NCT00360308|17006266|P3|Overall Study|Protocol Violation|2
4943824|NCT00360308|17006267|P2|Overall Study|Protocol Violation|1
4943825|NCT00360308|17006268|P1|Overall Study|Protocol Violation|2
4943826|NCT00360308|17006266|P3|Overall Study|Abnormal Laboratory Value(s)|0
4943827|NCT00360308|17006267|P2|Overall Study|Abnormal Laboratory Value(s)|1
4943828|NCT00360308|17006268|P1|Overall Study|Abnormal Laboratory Value(s)|0
4943829|NCT00360308|17006266|P3|Overall Study|Adverse Event|25
4943830|NCT00360308|17006267|P2|Overall Study|Adverse Event|14
4943831|NCT00360308|17006268|P1|Overall Study|Adverse Event|15
4943832|NCT00360282|17006285|P4|Second Intervention|Adverse Event|0
4943833|NCT00360282|17006286|P3|Second Intervention|Adverse Event|0
4943834|NCT00360282|17006287|P2|Second Intervention|Adverse Event|1
4943835|NCT00360282|17006288|P1|Second Intervention|Adverse Event|0
4943836|NCT00360282|17006285|P4|Washout 1-3 Weeks|Lost to Follow-up|0
4943837|NCT00360282|17006286|P3|Washout 1-3 Weeks|Lost to Follow-up|1
4943838|NCT00360282|17006287|P2|Washout 1-3 Weeks|Lost to Follow-up|0
4943839|NCT00360282|17006288|P1|Washout 1-3 Weeks|Lost to Follow-up|0
4943840|NCT00360269|17006300|P2|Overall Study|Withdrawal by Subject|1
4943841|NCT00360269|17006301|P1|Overall Study|Withdrawal by Subject|1
4943842|NCT00360269|17006300|P2|Overall Study|Adverse Event|0
4943843|NCT00360269|17006301|P1|Overall Study|Adverse Event|1
4943844|NCT00360269|17006300|P2|Overall Study|Physician Decision|2
4943845|NCT00360269|17006301|P1|Overall Study|Physician Decision|1
4943846|NCT00360269|17006300|P2|Overall Study|Lost to Follow-up|9
4943847|NCT00360269|17006301|P1|Overall Study|Lost to Follow-up|7
4943848|NCT00360230|17006343|P7|Overall Study|Death|1
4943849|NCT00360230|17006344|P6|Overall Study|Death|1
4943850|NCT00360230|17006345|P5|Overall Study|Death|0
4943851|NCT00360230|17006346|P4|Overall Study|Death|0
4943852|NCT00360230|17006347|P3|Overall Study|Death|0
4943853|NCT00360230|17006348|P2|Overall Study|Death|1
4943854|NCT00360230|17006349|P1|Overall Study|Death|0
4943855|NCT00360230|17006343|P7|Overall Study|Protocol Violation|0
4943856|NCT00360230|17006344|P6|Overall Study|Protocol Violation|1
4943857|NCT00360230|17006345|P5|Overall Study|Protocol Violation|0
4943858|NCT00360230|17006346|P4|Overall Study|Protocol Violation|0
4943859|NCT00360230|17006347|P3|Overall Study|Protocol Violation|0
4943860|NCT00360230|17006348|P2|Overall Study|Protocol Violation|0
4943861|NCT00360230|17006349|P1|Overall Study|Protocol Violation|0
4943862|NCT00360230|17006343|P7|Overall Study|Other|0
4943863|NCT00360230|17006344|P6|Overall Study|Other|0
4943864|NCT00360230|17006345|P5|Overall Study|Other|0
4943865|NCT00360230|17006346|P4|Overall Study|Other|0
4943866|NCT00360230|17006347|P3|Overall Study|Other|0
4943867|NCT00360230|17006348|P2|Overall Study|Other|0
4943868|NCT00360230|17006349|P1|Overall Study|Other|1
4943869|NCT00360230|17006343|P7|Overall Study|Migrated|1
4943870|NCT00360230|17006344|P6|Overall Study|Migrated|1
4943871|NCT00360230|17006345|P5|Overall Study|Migrated|4
4943872|NCT00360230|17006346|P4|Overall Study|Migrated|1
4943873|NCT00360230|17006347|P3|Overall Study|Migrated|3
4943874|NCT00360230|17006348|P2|Overall Study|Migrated|1
4943875|NCT00360230|17006349|P1|Overall Study|Migrated|4
4943876|NCT00360230|17006343|P7|Overall Study|Withdrawal by Subject|0
4943877|NCT00360230|17006344|P6|Overall Study|Withdrawal by Subject|1
4943878|NCT00360230|17006345|P5|Overall Study|Withdrawal by Subject|1
4943879|NCT00360230|17006346|P4|Overall Study|Withdrawal by Subject|1
4943880|NCT00360230|17006347|P3|Overall Study|Withdrawal by Subject|0
4943881|NCT00360230|17006348|P2|Overall Study|Withdrawal by Subject|1
4943882|NCT00360230|17006349|P1|Overall Study|Withdrawal by Subject|1
4943883|NCT00359801|17006505|P2|Overall Study|Sponsor Decision|16
4943884|NCT00359801|17006506|P1|Overall Study|Sponsor Decision|17
4943885|NCT00359801|17006505|P2|Overall Study|Final Status Unknown: missing data|4
4943886|NCT00359801|17006506|P1|Overall Study|Final Status Unknown: missing data|7
4943887|NCT00359801|17006505|P2|Overall Study|Other|46
4943888|NCT00359801|17006506|P1|Overall Study|Other|66
4943889|NCT00359801|17006505|P2|Overall Study|Withdrawal by Subject|96
4943890|NCT00359801|17006506|P1|Overall Study|Withdrawal by Subject|143
4943891|NCT00359801|17006505|P2|Overall Study|Lost to Follow-up|58
4943892|NCT00359801|17006506|P1|Overall Study|Lost to Follow-up|72
4943893|NCT00359788|17006540|P2|Overall Study|Protocol Violation|2
4943894|NCT00359788|17006541|P1|Overall Study|Protocol Violation|4
4943895|NCT00359788|17006540|P2|Overall Study|Withdrawal by Subject|1
4943896|NCT00359788|17006541|P1|Overall Study|Withdrawal by Subject|4
4943897|NCT00359788|17006540|P2|Overall Study|Lost to Follow-up|2
4943898|NCT00359788|17006541|P1|Overall Study|Lost to Follow-up|3
4943899|NCT00359788|17006540|P2|Overall Study|Lack of Efficacy|2
4943900|NCT00359788|17006541|P1|Overall Study|Lack of Efficacy|1
4943901|NCT00359788|17006540|P2|Overall Study|Adverse Event|10
4943902|NCT00359788|17006541|P1|Overall Study|Adverse Event|11
4943903|NCT00359762|17006775|P5|Period III|Subject Decision|0
4943904|NCT00359762|17006776|P4|Period III|Subject Decision|20
4943905|NCT00359762|17006777|P3|Period III|Subject Decision|8
4943906|NCT00359762|17006778|P2|Period III|Subject Decision|7
4943907|NCT00359762|17006779|P1|Period III|Subject Decision|0
4943908|NCT00359762|17006775|P5|Period III|Entry Criteria Not Met|0
4943909|NCT00359762|17006776|P4|Period III|Entry Criteria Not Met|1
4943910|NCT00359762|17006777|P3|Period III|Entry Criteria Not Met|0
4943911|NCT00359762|17006778|P2|Period III|Entry Criteria Not Met|1
4943912|NCT00359762|17006779|P1|Period III|Entry Criteria Not Met|0
4943913|NCT00359762|17006775|P5|Period III|Lost to follow up|0
4943914|NCT00359762|17006776|P4|Period III|Lost to follow up|2
4943915|NCT00359762|17006777|P3|Period III|Lost to follow up|1
4943916|NCT00359762|17006778|P2|Period III|Lost to follow up|1
4943917|NCT00359762|17006779|P1|Period III|Lost to follow up|0
4943918|NCT00359762|17006775|P5|Period III|Lack of Efficacy|0
4943919|NCT00359762|17006776|P4|Period III|Lack of Efficacy|9
4943920|NCT00359762|17006777|P3|Period III|Lack of Efficacy|5
4943921|NCT00359762|17006778|P2|Period III|Lack of Efficacy|7
4943922|NCT00359762|17006779|P1|Period III|Lack of Efficacy|0
4943923|NCT00359762|17006775|P5|Period III|Physician Decision|0
4943924|NCT00359762|17006776|P4|Period III|Physician Decision|15
4943925|NCT00359762|17006777|P3|Period III|Physician Decision|9
4943926|NCT00359762|17006778|P2|Period III|Physician Decision|5
4943927|NCT00359762|17006779|P1|Period III|Physician Decision|0
4943928|NCT00359762|17006775|P5|Period III|Adverse Event|0
4943929|NCT00359762|17006776|P4|Period III|Adverse Event|10
4943930|NCT00359762|17006777|P3|Period III|Adverse Event|4
4943931|NCT00359762|17006778|P2|Period III|Adverse Event|3
4943932|NCT00359762|17006779|P1|Period III|Adverse Event|0
4943933|NCT00359762|17006775|P5|Period III|Protocol Violation|0
4943934|NCT00359762|17006776|P4|Period III|Protocol Violation|8
4943935|NCT00359762|17006777|P3|Period III|Protocol Violation|3
4943936|NCT00359762|17006778|P2|Period III|Protocol Violation|5
4943937|NCT00359762|17006779|P1|Period III|Protocol Violation|0
4943938|NCT00359762|17006775|P5|Period II|Subject Decision|70
4943939|NCT00359762|17006776|P4|Period II|Subject Decision|0
4943940|NCT00359762|17006777|P3|Period II|Subject Decision|0
4943941|NCT00359762|17006778|P2|Period II|Subject Decision|0
4943942|NCT00359762|17006779|P1|Period II|Subject Decision|50
4943943|NCT00359762|17006775|P5|Period II|Entry Criteria Not Met|4
4943944|NCT00359762|17006776|P4|Period II|Entry Criteria Not Met|0
4943945|NCT00359762|17006777|P3|Period II|Entry Criteria Not Met|0
4943946|NCT00359762|17006778|P2|Period II|Entry Criteria Not Met|0
4943947|NCT00359762|17006779|P1|Period II|Entry Criteria Not Met|8
4943948|NCT00359762|17006775|P5|Period II|Lost to follow up|5
4943949|NCT00359762|17006776|P4|Period II|Lost to follow up|0
4943950|NCT00359762|17006777|P3|Period II|Lost to follow up|0
4943951|NCT00359762|17006778|P2|Period II|Lost to follow up|0
4943952|NCT00359762|17006779|P1|Period II|Lost to follow up|5
4943953|NCT00359762|17006775|P5|Period II|Lack of Efficacy|8
4943954|NCT00359762|17006776|P4|Period II|Lack of Efficacy|0
4943955|NCT00359762|17006777|P3|Period II|Lack of Efficacy|0
4943956|NCT00359762|17006778|P2|Period II|Lack of Efficacy|0
4943957|NCT00359762|17006779|P1|Period II|Lack of Efficacy|11
4943958|NCT00359762|17006775|P5|Period II|Death|4
4943959|NCT00359762|17006776|P4|Period II|Death|0
4943960|NCT00359762|17006777|P3|Period II|Death|0
4943961|NCT00359762|17006778|P2|Period II|Death|0
4943962|NCT00359762|17006779|P1|Period II|Death|2
4943963|NCT00359762|17006775|P5|Period II|Physician Decision|23
4943964|NCT00359762|17006776|P4|Period II|Physician Decision|0
4943965|NCT00359762|17006777|P3|Period II|Physician Decision|0
4943966|NCT00359762|17006778|P2|Period II|Physician Decision|0
4943967|NCT00359762|17006779|P1|Period II|Physician Decision|17
4943968|NCT00359762|17006775|P5|Period II|Protocol Violation|11
4943969|NCT00359762|17006776|P4|Period II|Protocol Violation|0
4943970|NCT00359762|17006777|P3|Period II|Protocol Violation|0
4943971|NCT00359762|17006778|P2|Period II|Protocol Violation|0
4943972|NCT00359762|17006779|P1|Period II|Protocol Violation|18
4943973|NCT00359762|17006775|P5|Period II|Adverse Event|49
4943974|NCT00359762|17006776|P4|Period II|Adverse Event|0
4943975|NCT00359762|17006777|P3|Period II|Adverse Event|0
4943976|NCT00359762|17006778|P2|Period II|Adverse Event|0
4943977|NCT00359762|17006779|P1|Period II|Adverse Event|17
4943978|NCT00359632|17006853|P2|Overall Study|Non-compliance with visit schedule|0
4943979|NCT00359632|17006854|P1|Overall Study|Non-compliance with visit schedule|1
4943980|NCT00359632|17006853|P2|Overall Study|Adverse Event|0
4943981|NCT00359632|17006854|P1|Overall Study|Adverse Event|1
4943982|NCT00359632|17006853|P2|Overall Study|Death|0
4943983|NCT00359632|17006854|P1|Overall Study|Death|2
4943984|NCT00359619|17006868|P7|Overall Study|Lost to Follow-up|0
4943985|NCT00359619|17006869|P6|Overall Study|Lost to Follow-up|5
4943986|NCT00359619|17006870|P5|Overall Study|Lost to Follow-up|1
4943987|NCT00359619|17006871|P4|Overall Study|Lost to Follow-up|1
4943988|NCT00359619|17006872|P3|Overall Study|Lost to Follow-up|2
4943989|NCT00359619|17006873|P2|Overall Study|Lost to Follow-up|4
4943990|NCT00359619|17006874|P1|Overall Study|Lost to Follow-up|4
4943991|NCT00359619|17006868|P7|Overall Study|Other|0
4943992|NCT00359619|17006869|P6|Overall Study|Other|0
4943993|NCT00359619|17006870|P5|Overall Study|Other|0
4943994|NCT00359619|17006871|P4|Overall Study|Other|0
4943995|NCT00359619|17006872|P3|Overall Study|Other|0
4943996|NCT00359619|17006873|P2|Overall Study|Other|0
4943997|NCT00359619|17006874|P1|Overall Study|Other|1
4943998|NCT00359619|17006868|P7|Overall Study|Withdrawal by Subject|3
4943999|NCT00359619|17006869|P6|Overall Study|Withdrawal by Subject|0
4944000|NCT00359619|17006870|P5|Overall Study|Withdrawal by Subject|2
4944001|NCT00359619|17006871|P4|Overall Study|Withdrawal by Subject|2
4944002|NCT00359619|17006872|P3|Overall Study|Withdrawal by Subject|4
4944003|NCT00359619|17006873|P2|Overall Study|Withdrawal by Subject|1
4944004|NCT00359619|17006874|P1|Overall Study|Withdrawal by Subject|3
4944005|NCT00359619|17006868|P7|Overall Study|Adverse Event|1
4944006|NCT00359619|17006869|P6|Overall Study|Adverse Event|0
4944007|NCT00359619|17006870|P5|Overall Study|Adverse Event|0
4944008|NCT00359619|17006871|P4|Overall Study|Adverse Event|0
4944009|NCT00359619|17006872|P3|Overall Study|Adverse Event|1
4944010|NCT00359619|17006873|P2|Overall Study|Adverse Event|0
4944011|NCT00359619|17006874|P1|Overall Study|Adverse Event|0
4944012|NCT00359424|17007004|P2|Overall Study|follow up not conducted|0
4944013|NCT00359424|17007005|P1|Overall Study|follow up not conducted|2
4944014|NCT00359424|17007004|P2|Overall Study|Withdrawal by Subject|2
4944015|NCT00359424|17007005|P1|Overall Study|Withdrawal by Subject|10
4944016|NCT00359424|17007004|P2|Overall Study|Lost to Follow-up|7
4944017|NCT00359424|17007005|P1|Overall Study|Lost to Follow-up|19
4944018|NCT00359424|17007004|P2|Overall Study|Death|58
4944019|NCT00359424|17007005|P1|Overall Study|Death|99
4944020|NCT00359281|17007044|P9|Overall Study|Withdrawal by Subject|0
4944021|NCT00359281|17007045|P8|Overall Study|Withdrawal by Subject|0
4944022|NCT00359281|17007046|P7|Overall Study|Withdrawal by Subject|1
4944023|NCT00359281|17007047|P6|Overall Study|Withdrawal by Subject|0
4944024|NCT00359281|17007048|P5|Overall Study|Withdrawal by Subject|0
4944025|NCT00359281|17007049|P4|Overall Study|Withdrawal by Subject|0
4944026|NCT00359281|17007050|P3|Overall Study|Withdrawal by Subject|0
4944027|NCT00359281|17007051|P2|Overall Study|Withdrawal by Subject|0
4944028|NCT00359281|17007052|P1|Overall Study|Withdrawal by Subject|0
4944029|NCT00359281|17007044|P9|Overall Study|Adverse Event|0
4944030|NCT00359281|17007045|P8|Overall Study|Adverse Event|0
4944031|NCT00359281|17007046|P7|Overall Study|Adverse Event|1
4944032|NCT00359281|17007047|P6|Overall Study|Adverse Event|0
4944033|NCT00359281|17007048|P5|Overall Study|Adverse Event|0
4944034|NCT00359281|17007049|P4|Overall Study|Adverse Event|0
4944035|NCT00359281|17007050|P3|Overall Study|Adverse Event|0
4944036|NCT00359281|17007051|P2|Overall Study|Adverse Event|0
4944037|NCT00359281|17007052|P1|Overall Study|Adverse Event|1
4944038|NCT00359073|17007115|P2|Overall Study|developed RV16 antibody|1
4944039|NCT00359073|17007116|P1|Overall Study|developed RV16 antibody|0
4944040|NCT00359073|17007115|P2|Overall Study|Eligibility criteria no longer met|0
4944041|NCT00359073|17007116|P1|Overall Study|Eligibility criteria no longer met|3
4944042|NCT00359073|17007115|P2|Overall Study|Withdrawal by Subject|1
4944043|NCT00359073|17007116|P1|Overall Study|Withdrawal by Subject|1
4944044|NCT00359021|17007128|P2|Overall Study|Pregnancy|0
4944045|NCT00359021|17007129|P1|Overall Study|Pregnancy|1
4944046|NCT00359021|17007128|P2|Overall Study|Other|1
4944047|NCT00359021|17007129|P1|Overall Study|Other|4
4944048|NCT00359021|17007128|P2|Overall Study|Lost to Follow-up|0
4944049|NCT00359021|17007129|P1|Overall Study|Lost to Follow-up|1
4944050|NCT00359021|17007128|P2|Overall Study|Withdrawal by Subject|9
4944051|NCT00359021|17007129|P1|Overall Study|Withdrawal by Subject|2
4944052|NCT00359021|17007128|P2|Overall Study|Subject Reached A Virologic Endpoint|32
4944053|NCT00359021|17007129|P1|Overall Study|Subject Reached A Virologic Endpoint|45
4944054|NCT00359021|17007128|P2|Overall Study|Subject Ineligible To Continue The Trial|0
4944055|NCT00359021|17007129|P1|Overall Study|Subject Ineligible To Continue The Trial|1
4944056|NCT00359021|17007128|P2|Overall Study|Subject Non-Compliant|2
4944057|NCT00359021|17007129|P1|Overall Study|Subject Non-Compliant|1
4944058|NCT00359021|17007128|P2|Overall Study|Adverse Event|8
4944059|NCT00359021|17007129|P1|Overall Study|Adverse Event|26
4944060|NCT00358956|17007141|P1|Overall Study|Withdrawal by Subject|1
4944061|NCT00358956|17007141|P1|Overall Study|condition under investigation worsened|4
4944062|NCT00358956|17007141|P1|Overall Study|Adverse Event|3
4944063|NCT00358917|17007153|P2|Overall Study|Unable to Continue Participation|2
4944064|NCT00358917|17007154|P1|Overall Study|Unable to Continue Participation|2
4944065|NCT00358917|17007153|P2|Overall Study|Virologic failure|8
4944066|NCT00358917|17007154|P1|Overall Study|Virologic failure|11
4944067|NCT00358917|17007153|P2|Overall Study|Death|3
4944068|NCT00358917|17007154|P1|Overall Study|Death|2
4944069|NCT00358917|17007153|P2|Overall Study|Noncompliance|11
4944070|NCT00358917|17007154|P1|Overall Study|Noncompliance|12
4944071|NCT00358917|17007153|P2|Overall Study|Lost to Follow-up|17
4944072|NCT00358917|17007154|P1|Overall Study|Lost to Follow-up|20
4944073|NCT00358917|17007153|P2|Overall Study|Withdrawal by Subject|7
4944074|NCT00358917|17007154|P1|Overall Study|Withdrawal by Subject|5
4944075|NCT00358917|17007153|P2|Overall Study|Adverse Event|21
4944076|NCT00358917|17007154|P1|Overall Study|Adverse Event|14
4944077|NCT00358826|17007172|P8|MDCT Substudy|Withdrawal by Subject|0
4944078|NCT00358826|17007173|P7|MDCT Substudy|Withdrawal by Subject|0
4944079|NCT00358826|17007174|P6|MDCT Substudy|Withdrawal by Subject|1
4944080|NCT00358826|17007175|P5|MDCT Substudy|Withdrawal by Subject|0
4944081|NCT00358826|17007176|P4|MDCT Substudy|Withdrawal by Subject|0
4944082|NCT00358826|17007177|P3|MDCT Substudy|Withdrawal by Subject|0
4944083|NCT00358826|17007178|P2|MDCT Substudy|Withdrawal by Subject|0
4944084|NCT00358826|17007179|P1|MDCT Substudy|Withdrawal by Subject|0
4944085|NCT00358826|17007172|P8|MDCT Substudy|Lost to Follow-up|0
4944086|NCT00358826|17007173|P7|MDCT Substudy|Lost to Follow-up|0
4944087|NCT00358826|17007174|P6|MDCT Substudy|Lost to Follow-up|1
4944088|NCT00358826|17007175|P5|MDCT Substudy|Lost to Follow-up|0
4944089|NCT00358826|17007176|P4|MDCT Substudy|Lost to Follow-up|0
4944090|NCT00358826|17007177|P3|MDCT Substudy|Lost to Follow-up|0
4944091|NCT00358826|17007178|P2|MDCT Substudy|Lost to Follow-up|0
4944092|NCT00358826|17007179|P1|MDCT Substudy|Lost to Follow-up|0
4944093|NCT00358826|17007172|P8|MDCT Substudy|Adverse Event|0
4944094|NCT00358826|17007173|P7|MDCT Substudy|Adverse Event|0
4944095|NCT00358826|17007174|P6|MDCT Substudy|Adverse Event|0
4944096|NCT00358826|17007175|P5|MDCT Substudy|Adverse Event|1
4944097|NCT00358826|17007176|P4|MDCT Substudy|Adverse Event|0
4944098|NCT00358826|17007177|P3|MDCT Substudy|Adverse Event|0
4944099|NCT00358826|17007178|P2|MDCT Substudy|Adverse Event|0
4944100|NCT00358826|17007179|P1|MDCT Substudy|Adverse Event|0
4944101|NCT00358826|17007172|P8|Core Study|Physician Decision|0
4944102|NCT00358826|17007173|P7|Core Study|Physician Decision|0
4944103|NCT00358826|17007174|P6|Core Study|Physician Decision|0
4944104|NCT00358826|17007175|P5|Core Study|Physician Decision|0
4944105|NCT00358826|17007176|P4|Core Study|Physician Decision|0
4944106|NCT00358826|17007177|P3|Core Study|Physician Decision|1
4944107|NCT00358826|17007178|P2|Core Study|Physician Decision|0
4944108|NCT00358826|17007179|P1|Core Study|Physician Decision|0
4944109|NCT00358826|17007172|P8|Core Study|Lost to Follow-up|0
4944110|NCT00358826|17007173|P7|Core Study|Lost to Follow-up|0
4944111|NCT00358826|17007174|P6|Core Study|Lost to Follow-up|0
4944112|NCT00358826|17007175|P5|Core Study|Lost to Follow-up|0
4944113|NCT00358826|17007176|P4|Core Study|Lost to Follow-up|1
4944114|NCT00358826|17007177|P3|Core Study|Lost to Follow-up|0
4944115|NCT00358826|17007178|P2|Core Study|Lost to Follow-up|0
4944116|NCT00358826|17007179|P1|Core Study|Lost to Follow-up|0
4944117|NCT00358826|17007172|P8|Core Study|Withdrawal by Subject|0
4944118|NCT00358826|17007173|P7|Core Study|Withdrawal by Subject|0
4944119|NCT00358826|17007174|P6|Core Study|Withdrawal by Subject|0
4944120|NCT00358826|17007175|P5|Core Study|Withdrawal by Subject|0
4944121|NCT00358826|17007176|P4|Core Study|Withdrawal by Subject|0
4944122|NCT00358826|17007177|P3|Core Study|Withdrawal by Subject|0
4944123|NCT00358826|17007178|P2|Core Study|Withdrawal by Subject|2
4944124|NCT00358826|17007179|P1|Core Study|Withdrawal by Subject|2
4944125|NCT00358826|17007172|P8|Core Study|Adverse Event|0
4944126|NCT00358826|17007173|P7|Core Study|Adverse Event|0
4944127|NCT00358826|17007174|P6|Core Study|Adverse Event|0
4944128|NCT00358826|17007175|P5|Core Study|Adverse Event|0
4944129|NCT00358826|17007176|P4|Core Study|Adverse Event|1
4944130|NCT00358826|17007177|P3|Core Study|Adverse Event|1
4944131|NCT00358826|17007178|P2|Core Study|Adverse Event|3
4944132|NCT00358826|17007179|P1|Core Study|Adverse Event|1
4944133|NCT00358670|17007246|P2|Overall Study|Administrative|125
4944134|NCT00358670|17007247|P1|Overall Study|Administrative|153
4944135|NCT00358670|17007246|P2|Overall Study|Did Not Meet Protocol Eligibility|3
4944136|NCT00358670|17007247|P1|Overall Study|Did Not Meet Protocol Eligibility|0
4944137|NCT00358670|17007246|P2|Overall Study|Protocol Defined Clinical Event|1
4944138|NCT00358670|17007247|P1|Overall Study|Protocol Defined Clinical Event|0
4944139|NCT00358670|17007246|P2|Overall Study|Withdrawal by Subject|24
4944140|NCT00358670|17007247|P1|Overall Study|Withdrawal by Subject|13
4944141|NCT00358670|17007246|P2|Overall Study|Lost to Follow-up|5
4944142|NCT00358670|17007247|P1|Overall Study|Lost to Follow-up|4
4944143|NCT00358670|17007246|P2|Overall Study|Protocol Violation|9
4944144|NCT00358670|17007247|P1|Overall Study|Protocol Violation|6
4944145|NCT00358670|17007246|P2|Overall Study|Lack of Efficacy|23
4944146|NCT00358670|17007247|P1|Overall Study|Lack of Efficacy|20
4944147|NCT00358670|17007246|P2|Overall Study|Adverse Event|29
4944148|NCT00358670|17007247|P1|Overall Study|Adverse Event|26
4944149|NCT00358644|17007261|P1|Overall Study|Patient not eligible for study|1
4944150|NCT00358644|17007261|P1|Overall Study|Physician Decision|6
4944151|NCT00358644|17007261|P1|Overall Study|Withdrawal by Subject|4
4944152|NCT00358644|17007261|P1|Overall Study|Death|11
4944153|NCT00358644|17007261|P1|Overall Study|Adverse Event|7
4944154|NCT00358644|17007261|P1|Overall Study|Progressive Disease|21
4944155|NCT00358527|17007284|P2|Overall Study|Administrative|1
4944156|NCT00358527|17007285|P1|Overall Study|Administrative|2
4944157|NCT00358527|17007284|P2|Overall Study|Non-compliance with protocol|1
4944158|NCT00358527|17007285|P1|Overall Study|Non-compliance with protocol|6
4944159|NCT00358527|17007284|P2|Overall Study|Withdrawal by Subject|1
4944160|NCT00358527|17007285|P1|Overall Study|Withdrawal by Subject|1
4944161|NCT00358527|17007284|P2|Overall Study|Adverse Event|0
4944162|NCT00358527|17007285|P1|Overall Study|Adverse Event|4
4944163|NCT00358449|17007335|P3|Overall Study|Steriod Inhaler was Increased|1
4944164|NCT00358449|17007336|P2|Overall Study|Steriod Inhaler was Increased|0
4944165|NCT00358449|17007337|P1|Overall Study|Steriod Inhaler was Increased|0
4944166|NCT00358449|17007335|P3|Overall Study|Lack of Efficacy|0
4944167|NCT00358449|17007336|P2|Overall Study|Lack of Efficacy|1
4944168|NCT00358449|17007337|P1|Overall Study|Lack of Efficacy|0
4944169|NCT00358449|17007335|P3|Overall Study|Withdrawal by Subject|0
4944170|NCT00358449|17007336|P2|Overall Study|Withdrawal by Subject|0
4944171|NCT00358449|17007337|P1|Overall Study|Withdrawal by Subject|2
4944172|NCT00358449|17007335|P3|Overall Study|Lost to Follow-up|0
4944173|NCT00358449|17007336|P2|Overall Study|Lost to Follow-up|0
4944174|NCT00358449|17007337|P1|Overall Study|Lost to Follow-up|1
4944175|NCT00358449|17007335|P3|Overall Study|Adverse Event|1
4944176|NCT00358449|17007336|P2|Overall Study|Adverse Event|0
4944177|NCT00358449|17007337|P1|Overall Study|Adverse Event|1
4944178|NCT00358436|17007440|P2|Overall Study|Other|1
4944179|NCT00358436|17007441|P1|Overall Study|Other|6
4944180|NCT00358436|17007440|P2|Overall Study|COPD exacerbation|10
4944181|NCT00358436|17007441|P1|Overall Study|COPD exacerbation|22
4944182|NCT00358436|17007440|P2|Overall Study|Non-fulfilment of inclusion/exclusion|0
4944183|NCT00358436|17007441|P1|Overall Study|Non-fulfilment of inclusion/exclusion|4
4944184|NCT00358436|17007440|P2|Overall Study|Withdrawal by Subject|17
4944185|NCT00358436|17007441|P1|Overall Study|Withdrawal by Subject|40
4944186|NCT00358436|17007440|P2|Overall Study|Protocol Violation|3
4944187|NCT00358436|17007441|P1|Overall Study|Protocol Violation|8
4944188|NCT00358436|17007440|P2|Overall Study|Lost to Follow-up|6
4944189|NCT00358436|17007441|P1|Overall Study|Lost to Follow-up|11
4944190|NCT00358436|17007440|P2|Overall Study|Lack of Efficacy|36
4944191|NCT00358436|17007441|P1|Overall Study|Lack of Efficacy|34
4944192|NCT00358436|17007440|P2|Overall Study|Adverse Event|13
4944193|NCT00358436|17007441|P1|Overall Study|Adverse Event|29
4944194|NCT00358215|17007512|P2|Overall Study|Did not receive investigational product|3
4944195|NCT00358215|17007513|P1|Overall Study|Did not receive investigational product|2
4944196|NCT00358215|17007512|P2|Overall Study|Other|14
4944197|NCT00358215|17007513|P1|Overall Study|Other|21
4944198|NCT00358215|17007512|P2|Overall Study|Pregnancy|0
4944199|NCT00358215|17007513|P1|Overall Study|Pregnancy|1
4944200|NCT00358215|17007512|P2|Overall Study|Protocol Violation|59
4944201|NCT00358215|17007513|P1|Overall Study|Protocol Violation|64
4944202|NCT00358215|17007512|P2|Overall Study|Death|281
4944203|NCT00358215|17007513|P1|Overall Study|Death|265
4944204|NCT00358215|17007512|P2|Overall Study|Lost to Follow-up|22
4944205|NCT00358215|17007513|P1|Overall Study|Lost to Follow-up|16
4944206|NCT00358215|17007512|P2|Overall Study|Physician Decision|39
4944207|NCT00358215|17007513|P1|Overall Study|Physician Decision|47
4944208|NCT00358215|17007512|P2|Overall Study|Participant request|64
4944209|NCT00358215|17007513|P1|Overall Study|Participant request|65
4944210|NCT00358215|17007512|P2|Overall Study|Withdrawal by Subject|102
4944211|NCT00358215|17007513|P1|Overall Study|Withdrawal by Subject|111
4944212|NCT00358215|17007512|P2|Overall Study|Adverse Event|65
4944213|NCT00358215|17007513|P1|Overall Study|Adverse Event|83
4944214|NCT00358215|17007512|P2|Overall Study|Ineligibility determined|3
4944215|NCT00358215|17007513|P1|Overall Study|Ineligibility determined|4
4944216|NCT00358150|17007527|P1|Overall Study|Undefined|3
4944217|NCT00358150|17007527|P1|Overall Study|Withdrawal by Subject|1
4944218|NCT00358150|17007527|P1|Overall Study|Adverse Event|3
4944219|NCT00357994|17007556|P2|Overall Study|Protocol Violation|0
4944220|NCT00357994|17007557|P1|Overall Study|Protocol Violation|1
4944221|NCT00357994|17007556|P2|Overall Study|Lack of Efficacy|1
4944222|NCT00357994|17007557|P1|Overall Study|Lack of Efficacy|0
4944223|NCT00357994|17007556|P2|Overall Study|Adverse Event|2
4944224|NCT00357994|17007557|P1|Overall Study|Adverse Event|1
4944225|NCT00357968|17007611|P2|First Maintenance Dose Phase|Withdrawal by Subject|2
4944226|NCT00357968|17007612|P1|First Maintenance Dose Phase|Withdrawal by Subject|1
4944227|NCT00357968|17007611|P2|First Maintenance Dose Phase|Not a PCI patient|42
4944228|NCT00357968|17007612|P1|First Maintenance Dose Phase|Not a PCI patient|47
4944229|NCT00357903|17007665|P2|Overall Study|Other|10
4944230|NCT00357903|17007666|P1|Overall Study|Other|49
4944231|NCT00357903|17007665|P2|Overall Study|Response status|9
4944232|NCT00357903|17007666|P1|Overall Study|Response status|61
4944233|NCT00357903|17007665|P2|Overall Study|Protocol issues|3
4944234|NCT00357903|17007666|P1|Overall Study|Protocol issues|14
4944235|NCT00357903|17007665|P2|Overall Study|Completed month 12 only|1
4944236|NCT00357903|17007666|P1|Overall Study|Completed month 12 only|0
4944237|NCT00357903|17007665|P2|Overall Study|Withdrawal by Subject|7
4944238|NCT00357903|17007666|P1|Overall Study|Withdrawal by Subject|57
4944239|NCT00357903|17007665|P2|Overall Study|Physician Decision|5
4944240|NCT00357903|17007666|P1|Overall Study|Physician Decision|39
4944241|NCT00357903|17007665|P2|Overall Study|Lost to Follow-up|4
4944242|NCT00357903|17007666|P1|Overall Study|Lost to Follow-up|23
4944243|NCT00357903|17007665|P2|Overall Study|Death|0
4944244|NCT00357903|17007666|P1|Overall Study|Death|33
4944245|NCT00357903|17007665|P2|Overall Study|Adverse Event|4
4944246|NCT00357903|17007666|P1|Overall Study|Adverse Event|87
4944247|NCT00357877|17007706|P2|Overall Study|Other|2
4944248|NCT00357877|17007707|P1|Overall Study|Other|0
4944249|NCT00357877|17007706|P2|Overall Study|Administrative withdrawal|1
4944250|NCT00357877|17007707|P1|Overall Study|Administrative withdrawal|1
4944251|NCT00357877|17007706|P2|Overall Study|Withdrawal by Subject|3
4944252|NCT00357877|17007707|P1|Overall Study|Withdrawal by Subject|3
4944253|NCT00357877|17007706|P2|Overall Study|Lost to Follow-up|23
4944254|NCT00357877|17007707|P1|Overall Study|Lost to Follow-up|20
4944255|NCT00357877|17007706|P2|Overall Study|Death|1
4944256|NCT00357877|17007707|P1|Overall Study|Death|2
4944257|NCT00357760|17007721|P2|Overall Study|To receive hospice care|1
4944258|NCT00357760|17007722|P1|Overall Study|To receive hospice care|0
4944259|NCT00357760|17007721|P2|Overall Study|Protocol Violation|1
4944260|NCT00357760|17007722|P1|Overall Study|Protocol Violation|0
4944261|NCT00357760|17007721|P2|Overall Study|Physician Decision|1
4944262|NCT00357760|17007722|P1|Overall Study|Physician Decision|2
4944263|NCT00357760|17007721|P2|Overall Study|Ineligible|2
4944264|NCT00357760|17007722|P1|Overall Study|Ineligible|0
4944265|NCT00357760|17007721|P2|Overall Study|Never started treatment|1
4944266|NCT00357760|17007722|P1|Overall Study|Never started treatment|2
4944267|NCT00357760|17007721|P2|Overall Study|Withdrawal by Subject|2
4944268|NCT00357760|17007722|P1|Overall Study|Withdrawal by Subject|0
4944269|NCT00357760|17007721|P2|Overall Study|Alternative therapy|0
4944270|NCT00357760|17007722|P1|Overall Study|Alternative therapy|1
4944271|NCT00357760|17007721|P2|Overall Study|Death|3
4944272|NCT00357760|17007722|P1|Overall Study|Death|0
4944273|NCT00357760|17007721|P2|Overall Study|Adverse Event|7
4944274|NCT00357760|17007722|P1|Overall Study|Adverse Event|10
4944275|NCT00357760|17007721|P2|Overall Study|Disease progression|17
4944276|NCT00357760|17007722|P1|Overall Study|Disease progression|44
4944277|NCT00357656|17007743|P2|Overall Study|Other, No surgery performed|3
4944278|NCT00357656|17007744|P1|Overall Study|Other, No surgery performed|0
4944279|NCT00357552|17007795|P1|Weeks 24 to 104|Not able to get to clinic|2
4944280|NCT00357552|17007795|P1|Weeks 24 to 104|Death|3
4944281|NCT00357552|17007795|P1|Weeks 0 to 24|Death|1
4944282|NCT00357552|17007795|P1|Screening|Did not meet eligibility criteria|84
4944283|NCT00357500|17007810|P1|Overall Study|Not Started Protocol Therapy|4
4944284|NCT00357500|17007810|P1|Overall Study|Progressive Disease|65
4944285|NCT00357500|17007810|P1|Overall Study|Withdrawal by Subject|5
4944286|NCT00357500|17007810|P1|Overall Study|Adverse Event|3
4944287|NCT00357396|17007819|P2|Overall Study|Adverse Event|0
4944288|NCT00357396|17007820|P1|Overall Study|Adverse Event|1
4944289|NCT00357370|17007828|P3|Cohort 2|Withdrawal by Subject|0
4944290|NCT00357370|17007829|P2|Cohort 2|Withdrawal by Subject|2
4944291|NCT00357370|17007830|P1|Cohort 2|Withdrawal by Subject|0
4944292|NCT00357370|17007828|P3|Cohort 2|non-compliance, not met criteria, etc|0
4944293|NCT00357370|17007829|P2|Cohort 2|non-compliance, not met criteria, etc|1
4944294|NCT00357370|17007830|P1|Cohort 2|non-compliance, not met criteria, etc|1
4944295|NCT00357370|17007828|P3|Cohort 2|Lost to Follow-up|0
4944296|NCT00357370|17007829|P2|Cohort 2|Lost to Follow-up|1
4944297|NCT00357370|17007830|P1|Cohort 2|Lost to Follow-up|0
4944298|NCT00357370|17007828|P3|Cohort 2|Adverse Event|1
4944299|NCT00357370|17007829|P2|Cohort 2|Adverse Event|1
4944300|NCT00357370|17007830|P1|Cohort 2|Adverse Event|1
4944301|NCT00357370|17007828|P3|Cohort 2|Lack of Efficacy|1
4944302|NCT00357370|17007829|P2|Cohort 2|Lack of Efficacy|2
4944303|NCT00357370|17007830|P1|Cohort 2|Lack of Efficacy|0
4944304|NCT00357110|17007893|P2|Overall Study|Early study termination|5
4944305|NCT00357110|17007894|P1|Overall Study|Early study termination|5
4944306|NCT00357097|17007902|P2|Overall Study|Increase of RLS Symptoms|1
4944307|NCT00357097|17007903|P1|Overall Study|Increase of RLS Symptoms|0
4944308|NCT00357097|17007902|P2|Overall Study|Other|1
4944309|NCT00357097|17007903|P1|Overall Study|Other|1
4944310|NCT00357097|17007902|P2|Overall Study|Met Exclusion Criteria|1
4944311|NCT00357097|17007903|P1|Overall Study|Met Exclusion Criteria|3
4944312|NCT00357097|17007902|P2|Overall Study|Lack of Efficacy|8
4944313|NCT00357097|17007903|P1|Overall Study|Lack of Efficacy|2
4944314|NCT00357097|17007902|P2|Overall Study|Non-compliance|2
4944315|NCT00357097|17007903|P1|Overall Study|Non-compliance|1
4944316|NCT00357097|17007902|P2|Overall Study|Withdrawal by Subject|7
4944317|NCT00357097|17007903|P1|Overall Study|Withdrawal by Subject|8
4944318|NCT00357097|17007902|P2|Overall Study|Adverse Event|6
4944319|NCT00357097|17007903|P1|Overall Study|Adverse Event|34
4944320|NCT00357097|17007902|P2|Overall Study|Did not meet inclusion criteria|3
4944321|NCT00357097|17007903|P1|Overall Study|Did not meet inclusion criteria|5
4944322|NCT00357006|17007957|P3|Overall Study|Withdrawal by Subject|2
4944323|NCT00357006|17007958|P2|Overall Study|Withdrawal by Subject|3
4944324|NCT00357006|17007959|P1|Overall Study|Withdrawal by Subject|1
4944325|NCT00357006|17007957|P3|Overall Study|Lost to Follow-up|1
4944326|NCT00357006|17007958|P2|Overall Study|Lost to Follow-up|2
4944327|NCT00357006|17007959|P1|Overall Study|Lost to Follow-up|1
4944328|NCT00356915|17007974|P3|Overall Study|Miscellaneous reasons|3
4944329|NCT00356915|17007975|P2|Overall Study|Miscellaneous reasons|8
4944330|NCT00356915|17007976|P1|Overall Study|Miscellaneous reasons|11
4944331|NCT00356915|17007974|P3|Overall Study|Adverse Event|8
4944332|NCT00356915|17007975|P2|Overall Study|Adverse Event|31
4944333|NCT00356915|17007976|P1|Overall Study|Adverse Event|21
4944334|NCT00356915|17007974|P3|Overall Study|Physician Decision|0
4944335|NCT00356915|17007975|P2|Overall Study|Physician Decision|2
4944336|NCT00356915|17007976|P1|Overall Study|Physician Decision|0
4944337|NCT00356915|17007974|P3|Overall Study|Administrative Decision|1
4944338|NCT00356915|17007975|P2|Overall Study|Administrative Decision|0
4944339|NCT00356915|17007976|P1|Overall Study|Administrative Decision|0
4944340|NCT00356915|17007974|P3|Overall Study|Lost to Follow-up|14
4944341|NCT00356915|17007975|P2|Overall Study|Lost to Follow-up|34
4944342|NCT00356915|17007976|P1|Overall Study|Lost to Follow-up|27
4944343|NCT00356915|17007974|P3|Overall Study|Lack of Efficacy|3
4944344|NCT00356915|17007975|P2|Overall Study|Lack of Efficacy|0
4944345|NCT00356915|17007976|P1|Overall Study|Lack of Efficacy|0
4944346|NCT00356915|17007974|P3|Overall Study|Withdrawal by Subject|10
4944347|NCT00356915|17007975|P2|Overall Study|Withdrawal by Subject|14
4944348|NCT00356915|17007976|P1|Overall Study|Withdrawal by Subject|14
4944349|NCT00356915|17007974|P3|Overall Study|Protocol Violation|2
4944350|NCT00356915|17007975|P2|Overall Study|Protocol Violation|3
4944351|NCT00356915|17007976|P1|Overall Study|Protocol Violation|2
4944352|NCT00356915|17007974|P3|Overall Study|Non compliance|1
4944353|NCT00356915|17007975|P2|Overall Study|Non compliance|2
4944354|NCT00356915|17007976|P1|Overall Study|Non compliance|1
4944355|NCT00356889|17007993|P1|Overall Study|Adverse Event|1
4944356|NCT00356889|17007993|P1|Overall Study|Protocol Violation|2
4944357|NCT00356863|17008002|P2|Overall Study|Lost to Follow-up|43
4944358|NCT00356863|17008003|P1|Overall Study|Lost to Follow-up|76
4944359|NCT00356863|17008002|P2|Overall Study|Death|32
4944360|NCT00356863|17008003|P1|Overall Study|Death|16
4944361|NCT00356811|17008029|P1|Overall Study|Site Closed during Follow-up|2
4944362|NCT00356811|17008029|P1|Overall Study|Study Is Terminating|3
4944363|NCT00356811|17008029|P1|Overall Study|Participant Could Not Make a Checkup|1
4944364|NCT00356811|17008029|P1|Overall Study|Withdrawal by Subject|6
4944365|NCT00356811|17008029|P1|Overall Study|Lost to Follow-up|2
4944366|NCT00356811|17008029|P1|Overall Study|Death|35
4944367|NCT00356759|17008044|P2|Overall Study|Intercurrent disease or persistent extre|2
4944368|NCT00356759|17008045|P1|Overall Study|Intercurrent disease or persistent extre|5
4944369|NCT00356759|17008044|P2|Overall Study|Lost to Follow-up|1
4944370|NCT00356759|17008045|P1|Overall Study|Lost to Follow-up|1
4944371|NCT00356759|17008044|P2|Overall Study|Adverse Event|3
4944372|NCT00356759|17008045|P1|Overall Study|Adverse Event|1
4944373|NCT00356759|17008044|P2|Overall Study|Withdrawal by Subject|2
4944374|NCT00356759|17008045|P1|Overall Study|Withdrawal by Subject|2
4944375|NCT00356759|17008044|P2|Overall Study|Death|2
4944376|NCT00356759|17008045|P1|Overall Study|Death|5
4944377|NCT00356603|17008063|P2|Overall Study|Other|3
4944378|NCT00356603|17008064|P1|Overall Study|Other|6
4944379|NCT00356590|17008078|P1|Overall Study|Other|52
4944380|NCT00356590|17008078|P1|Overall Study|Response status|28
4944381|NCT00356590|17008078|P1|Overall Study|Protocol issues|6
4944382|NCT00356590|17008078|P1|Overall Study|Completed month 12 only|2
4944383|NCT00356590|17008078|P1|Overall Study|Withdrawal by Subject|41
4944384|NCT00356590|17008078|P1|Overall Study|Physician Decision|46
4944385|NCT00356590|17008078|P1|Overall Study|Lost to Follow-up|35
4944386|NCT00356590|17008078|P1|Overall Study|Death|10
4944387|NCT00356590|17008078|P1|Overall Study|Adverse Event|54
4944388|NCT00356525|17008114|P4|Overall Study|Sponsor Decision|1
4944389|NCT00356525|17008115|P3|Overall Study|Sponsor Decision|0
4944390|NCT00356525|17008116|P2|Overall Study|Sponsor Decision|0
4944391|NCT00356525|17008117|P1|Overall Study|Sponsor Decision|0
4944392|NCT00356525|17008114|P4|Overall Study|Death|1
4944393|NCT00356525|17008115|P3|Overall Study|Death|0
4944394|NCT00356525|17008116|P2|Overall Study|Death|0
4944395|NCT00356525|17008117|P1|Overall Study|Death|0
4944396|NCT00356525|17008114|P4|Overall Study|Withdrawal by Subject|3
4944397|NCT00356525|17008115|P3|Overall Study|Withdrawal by Subject|0
4944398|NCT00356525|17008116|P2|Overall Study|Withdrawal by Subject|1
4944399|NCT00356525|17008117|P1|Overall Study|Withdrawal by Subject|1
4944400|NCT00356525|17008114|P4|Overall Study|Protocol Entry Criteria Not Met|0
4944401|NCT00356525|17008115|P3|Overall Study|Protocol Entry Criteria Not Met|0
4944402|NCT00356525|17008116|P2|Overall Study|Protocol Entry Criteria Not Met|0
4944403|NCT00356525|17008117|P1|Overall Study|Protocol Entry Criteria Not Met|1
4944404|NCT00356525|17008114|P4|Overall Study|Physician Decision|1
4944405|NCT00356525|17008115|P3|Overall Study|Physician Decision|2
4944406|NCT00356525|17008116|P2|Overall Study|Physician Decision|2
4944407|NCT00356525|17008117|P1|Overall Study|Physician Decision|2
4944408|NCT00356525|17008114|P4|Overall Study|Lost to Follow-up|0
4944409|NCT00356525|17008115|P3|Overall Study|Lost to Follow-up|0
4944410|NCT00356525|17008116|P2|Overall Study|Lost to Follow-up|0
4944411|NCT00356525|17008117|P1|Overall Study|Lost to Follow-up|1
4944412|NCT00356525|17008114|P4|Overall Study|Adverse Event|1
4944413|NCT00356525|17008115|P3|Overall Study|Adverse Event|1
4944414|NCT00356525|17008116|P2|Overall Study|Adverse Event|3
4944415|NCT00356525|17008117|P1|Overall Study|Adverse Event|1
4944416|NCT00356525|17008114|P4|Overall Study|Progressive Disease|2
4944417|NCT00356525|17008115|P3|Overall Study|Progressive Disease|4
4944418|NCT00356525|17008116|P2|Overall Study|Progressive Disease|5
4944419|NCT00356525|17008117|P1|Overall Study|Progressive Disease|8
4944420|NCT00356421|17008158|P2|Overall Study|Not related to study drug|3
4944421|NCT00356421|17008159|P1|Overall Study|Not related to study drug|5
4944422|NCT00356421|17008158|P2|Overall Study|Related to study drug|12
4944423|NCT00356421|17008159|P1|Overall Study|Related to study drug|15
4944424|NCT00356421|17008158|P2|Overall Study|Withdrawal by Subject|2
4944425|NCT00356421|17008159|P1|Overall Study|Withdrawal by Subject|9
4944426|NCT00356421|17008158|P2|Overall Study|Lack of Efficacy|0
4944427|NCT00356421|17008159|P1|Overall Study|Lack of Efficacy|3
4944428|NCT00356408|17008199|P1|Overall Study|Other: Subject chose commerical dosing|1
4944429|NCT00356408|17008199|P1|Overall Study|Other: Failed to meet Inc/Exc criteria|1
4944430|NCT00356408|17008199|P1|Overall Study|Other: Azathioprine stopped|1
4944431|NCT00356408|17008199|P1|Overall Study|Other: Sponsor request|1
4944432|NCT00356408|17008199|P1|Overall Study|Other: Principal investigator discretion|3
4944433|NCT00356408|17008199|P1|Overall Study|Withdrawal by Subject|6
4944434|NCT00356408|17008199|P1|Overall Study|Lost to Follow-up|2
4944435|NCT00356408|17008199|P1|Overall Study|Lack of Efficacy|36
4944436|NCT00356408|17008199|P1|Overall Study|Adverse Event|9
4944437|NCT00356369|17008216|P2|Active Phase|Withdrawal by Subject|1
4944438|NCT00356369|17008217|P1|Active Phase|Withdrawal by Subject|2
4944439|NCT00356278|17008299|P3|Overall Study|Withdrawal by Subject|19
4944440|NCT00356278|17008300|P2|Overall Study|Withdrawal by Subject|15
4944441|NCT00356278|17008301|P1|Overall Study|Withdrawal by Subject|25
4944442|NCT00356265|17008339|P3|Overall Study|Withdrawal by Subject|1
4944443|NCT00356265|17008340|P2|Overall Study|Withdrawal by Subject|0
4944444|NCT00356265|17008341|P1|Overall Study|Withdrawal by Subject|0
4944445|NCT00356200|17008353|P2|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2
4944446|NCT00356200|17008354|P1|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0
4944447|NCT00356200|17008353|P2|Cohort 1: 10 ug/ml|Lack of Efficacy|0
4944448|NCT00356200|17008354|P1|Cohort 1: 10 ug/ml|Lack of Efficacy|1
4944449|NCT00356148|17008383|P2|Overall Study|Reoperation within 30 days|1
4944450|NCT00356148|17008384|P1|Overall Study|Reoperation within 30 days|2
4944451|NCT00356135|17008395|P3|Overall Study|Subject non-compliance|3
4944452|NCT00356135|17008396|P2|Overall Study|Subject non-compliance|1
4944453|NCT00356135|17008397|P1|Overall Study|Subject non-compliance|1
4944454|NCT00356135|17008395|P3|Overall Study|Physician Decision|1
4944455|NCT00356135|17008396|P2|Overall Study|Physician Decision|1
4944456|NCT00356135|17008397|P1|Overall Study|Physician Decision|1
4944457|NCT00356135|17008395|P3|Overall Study|Lost to Follow-up|1
4944458|NCT00356135|17008396|P2|Overall Study|Lost to Follow-up|0
4944459|NCT00356135|17008397|P1|Overall Study|Lost to Follow-up|0
4944460|NCT00356135|17008395|P3|Overall Study|Adverse Event|0
4944461|NCT00356135|17008396|P2|Overall Study|Adverse Event|0
4944462|NCT00356135|17008397|P1|Overall Study|Adverse Event|1
4944463|NCT00356135|17008395|P3|Overall Study|Protocol Violation|0
4944464|NCT00356135|17008396|P2|Overall Study|Protocol Violation|0
4944465|NCT00356135|17008397|P1|Overall Study|Protocol Violation|1
4944466|NCT00356122|17008419|P1|FOLLOW-UP|Other|2
4944467|NCT00356122|17008419|P1|FOLLOW-UP|Lost to Follow-up|2
4944468|NCT00356122|17008419|P1|FOLLOW-UP|Death|37
4944469|NCT00356122|17008419|P1|TREATMENT|Did not receive study medication|1
4944470|NCT00356122|17008419|P1|TREATMENT|Other|4
4944471|NCT00356122|17008419|P1|TREATMENT|Subject's request|4
4944472|NCT00356122|17008419|P1|TREATMENT|Adverse Event|10
4944473|NCT00356122|17008419|P1|TREATMENT|Lack of Efficacy|26
4944474|NCT00355784|17008527|P3|Overall Study|Withdrawal by Subject|2
4944475|NCT00355784|17008528|P2|Overall Study|Withdrawal by Subject|0
4944476|NCT00355784|17008529|P1|Overall Study|Withdrawal by Subject|0
4944477|NCT00355615|17008578|P5|40-week Rosuvastatin Open Label Period|investigational site closed|1
4944478|NCT00355615|17008579|P4|40-week Rosuvastatin Open Label Period|investigational site closed|0
4944479|NCT00355615|17008580|P3|40-week Rosuvastatin Open Label Period|investigational site closed|0
4944480|NCT00355615|17008581|P2|40-week Rosuvastatin Open Label Period|investigational site closed|0
4944481|NCT00355615|17008582|P1|40-week Rosuvastatin Open Label Period|investigational site closed|0
4944482|NCT00355615|17008578|P5|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3
4944483|NCT00355615|17008579|P4|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4944484|NCT00355615|17008580|P3|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4944485|NCT00355615|17008581|P2|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4944486|NCT00355615|17008582|P1|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0
4944487|NCT00355615|17008578|P5|40-week Rosuvastatin Open Label Period|Protocol Violation|1
4944488|NCT00355615|17008579|P4|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4944489|NCT00355615|17008580|P3|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4944490|NCT00355615|17008581|P2|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4944491|NCT00355615|17008582|P1|40-week Rosuvastatin Open Label Period|Protocol Violation|0
4944492|NCT00355615|17008578|P5|40-week Rosuvastatin Open Label Period|Adverse Event|4
4944493|NCT00355615|17008579|P4|40-week Rosuvastatin Open Label Period|Adverse Event|0
4944494|NCT00355615|17008580|P3|40-week Rosuvastatin Open Label Period|Adverse Event|0
4944495|NCT00355615|17008581|P2|40-week Rosuvastatin Open Label Period|Adverse Event|0
4944496|NCT00355615|17008582|P1|40-week Rosuvastatin Open Label Period|Adverse Event|0
4944497|NCT00355615|17008578|P5|Randomized Double Blind Period|Protocol Violation|0
4944498|NCT00355615|17008579|P4|Randomized Double Blind Period|Protocol Violation|1
4944499|NCT00355615|17008580|P3|Randomized Double Blind Period|Protocol Violation|1
4944500|NCT00355615|17008581|P2|Randomized Double Blind Period|Protocol Violation|0
4944501|NCT00355615|17008582|P1|Randomized Double Blind Period|Protocol Violation|0
4944502|NCT00355615|17008578|P5|Randomized Double Blind Period|Adverse Event|0
4944503|NCT00355615|17008579|P4|Randomized Double Blind Period|Adverse Event|0
4944504|NCT00355615|17008580|P3|Randomized Double Blind Period|Adverse Event|0
4944505|NCT00355615|17008581|P2|Randomized Double Blind Period|Adverse Event|0
4944506|NCT00355615|17008582|P1|Randomized Double Blind Period|Adverse Event|1
4944507|NCT00355472|17008641|P1|Overall Study|Physician Decision|1
4944508|NCT00355368|17008687|P2|Overall Study|cardiac arrest prior to intubation|2
4944509|NCT00355368|17008688|P1|Overall Study|cardiac arrest prior to intubation|2
4944510|NCT00355368|17008687|P2|Overall Study|Protocol Violation|7
4944511|NCT00355368|17008688|P1|Overall Study|Protocol Violation|8
4944512|NCT00355342|17008702|P2|Overall Study|Use of protocol excluded medication|1
4944513|NCT00355342|17008703|P1|Overall Study|Use of protocol excluded medication|0
4944514|NCT00355342|17008702|P2|Overall Study|Protocol Violation|1
4944515|NCT00355342|17008703|P1|Overall Study|Protocol Violation|0
4944516|NCT00355342|17008702|P2|Overall Study|Study management|1
4944517|NCT00355342|17008703|P1|Overall Study|Study management|0
4944518|NCT00355342|17008702|P2|Overall Study|Participant discontinued study drug|1
4944519|NCT00355342|17008703|P1|Overall Study|Participant discontinued study drug|0
4944520|NCT00355342|17008702|P2|Overall Study|Participant relocated|1
4944521|NCT00355342|17008703|P1|Overall Study|Participant relocated|0
4944522|NCT00355342|17008702|P2|Overall Study|Withdrawal by participant and physician|0
4944523|NCT00355342|17008703|P1|Overall Study|Withdrawal by participant and physician|1
4944524|NCT00355342|17008702|P2|Overall Study|Non-compliance with Dexa scans|0
4944525|NCT00355342|17008703|P1|Overall Study|Non-compliance with Dexa scans|1
4944526|NCT00355342|17008702|P2|Overall Study|Dispensed wrong study drug kit|0
4944527|NCT00355342|17008703|P1|Overall Study|Dispensed wrong study drug kit|1
4944528|NCT00355342|17008702|P2|Overall Study|COPD exacerbation|1
4944529|NCT00355342|17008703|P1|Overall Study|COPD exacerbation|1
4944530|NCT00355342|17008702|P2|Overall Study|Use of prohibited medication|0
4944531|NCT00355342|17008703|P1|Overall Study|Use of prohibited medication|1
4944532|NCT00355342|17008702|P2|Overall Study|Overcompliant-PI discretion|0
4944533|NCT00355342|17008703|P1|Overall Study|Overcompliant-PI discretion|1
4944534|NCT00355342|17008702|P2|Overall Study|Sponsor terminated study|2
4944535|NCT00355342|17008703|P1|Overall Study|Sponsor terminated study|2
4944536|NCT00355342|17008702|P2|Overall Study|Withdrawal by Subject|11
4944537|NCT00355342|17008703|P1|Overall Study|Withdrawal by Subject|14
4944538|NCT00355342|17008702|P2|Overall Study|Lost to Follow-up|2
4944539|NCT00355342|17008703|P1|Overall Study|Lost to Follow-up|4
4944540|NCT00355342|17008702|P2|Overall Study|Adverse Event|15
4944541|NCT00355342|17008703|P1|Overall Study|Adverse Event|13
4944542|NCT00355264|17008711|P1|Extension (Variable Duration)|Withdrew Consent|1
4944543|NCT00355264|17008711|P1|Extension (Variable Duration)|Adverse Event|1
4944544|NCT00355147|17008739|P2|Overall Study|Withdrawal by Subject|12
4944545|NCT00355147|17008740|P1|Overall Study|Withdrawal by Subject|8
4944546|NCT00355147|17008739|P2|Overall Study|Lost to Follow-up|8
4944547|NCT00355147|17008740|P1|Overall Study|Lost to Follow-up|10
4944548|NCT00355134|17008759|P5|Extension Phase|Protocol Violation|0
4944549|NCT00355134|17008760|P4|Extension Phase|Protocol Violation|1
4944550|NCT00355134|17008761|P3|Extension Phase|Protocol Violation|0
4944551|NCT00355134|17008762|P2|Extension Phase|Protocol Violation|0
4944552|NCT00355134|17008763|P1|Extension Phase|Protocol Violation|0
4944553|NCT00355134|17008759|P5|Extension Phase|Abnormal test procedure result(s)|1
4944554|NCT00355134|17008760|P4|Extension Phase|Abnormal test procedure result(s)|0
4944555|NCT00355134|17008761|P3|Extension Phase|Abnormal test procedure result(s)|0
4944556|NCT00355134|17008762|P2|Extension Phase|Abnormal test procedure result(s)|1
4944557|NCT00355134|17008763|P1|Extension Phase|Abnormal test procedure result(s)|0
4944558|NCT00355134|17008759|P5|Extension Phase|Unsatisfactory therapeutic effect|1
4944559|NCT00355134|17008760|P4|Extension Phase|Unsatisfactory therapeutic effect|0
4944560|NCT00355134|17008761|P3|Extension Phase|Unsatisfactory therapeutic effect|0
4944561|NCT00355134|17008762|P2|Extension Phase|Unsatisfactory therapeutic effect|4
4944562|NCT00355134|17008763|P1|Extension Phase|Unsatisfactory therapeutic effect|3
4944563|NCT00355134|17008759|P5|Extension Phase|Administrative problems|1
4944564|NCT00355134|17008760|P4|Extension Phase|Administrative problems|1
4944565|NCT00355134|17008761|P3|Extension Phase|Administrative problems|0
4944566|NCT00355134|17008762|P2|Extension Phase|Administrative problems|4
4944567|NCT00355134|17008763|P1|Extension Phase|Administrative problems|2
4944568|NCT00355134|17008759|P5|Extension Phase|Abnormal laboratory value(s)|2
4944569|NCT00355134|17008760|P4|Extension Phase|Abnormal laboratory value(s)|2
4944570|NCT00355134|17008761|P3|Extension Phase|Abnormal laboratory value(s)|0
4944571|NCT00355134|17008762|P2|Extension Phase|Abnormal laboratory value(s)|2
4944572|NCT00355134|17008763|P1|Extension Phase|Abnormal laboratory value(s)|4
4944573|NCT00355134|17008759|P5|Extension Phase|Lost to Follow-up|4
4944574|NCT00355134|17008760|P4|Extension Phase|Lost to Follow-up|2
4944575|NCT00355134|17008761|P3|Extension Phase|Lost to Follow-up|0
4944576|NCT00355134|17008762|P2|Extension Phase|Lost to Follow-up|6
4944577|NCT00355134|17008763|P1|Extension Phase|Lost to Follow-up|2
4944578|NCT00355134|17008759|P5|Extension Phase|Adverse Event|5
4944579|NCT00355134|17008760|P4|Extension Phase|Adverse Event|3
4944580|NCT00355134|17008761|P3|Extension Phase|Adverse Event|0
4944581|NCT00355134|17008762|P2|Extension Phase|Adverse Event|9
4944582|NCT00355134|17008763|P1|Extension Phase|Adverse Event|13
4944583|NCT00355134|17008759|P5|Extension Phase|Withdrawal by Subject|5
4944584|NCT00355134|17008760|P4|Extension Phase|Withdrawal by Subject|7
4944585|NCT00355134|17008761|P3|Extension Phase|Withdrawal by Subject|0
4944586|NCT00355134|17008762|P2|Extension Phase|Withdrawal by Subject|11
4944587|NCT00355134|17008763|P1|Extension Phase|Withdrawal by Subject|7
4944588|NCT00355134|17008759|P5|Core Phase|Condition no longer requires study drug|0
4944589|NCT00355134|17008760|P4|Core Phase|Condition no longer requires study drug|0
4944590|NCT00355134|17008761|P3|Core Phase|Condition no longer requires study drug|1
4944591|NCT00355134|17008762|P2|Core Phase|Condition no longer requires study drug|0
4944592|NCT00355134|17008763|P1|Core Phase|Condition no longer requires study drug|1
4944593|NCT00355134|17008759|P5|Core Phase|Abnormal test procedure result(s)|0
4944594|NCT00355134|17008760|P4|Core Phase|Abnormal test procedure result(s)|0
4944595|NCT00355134|17008761|P3|Core Phase|Abnormal test procedure result(s)|1
4944596|NCT00355134|17008762|P2|Core Phase|Abnormal test procedure result(s)|2
4944597|NCT00355134|17008763|P1|Core Phase|Abnormal test procedure result(s)|1
4944598|NCT00355134|17008759|P5|Core Phase|Protocol Violation|0
4944599|NCT00355134|17008760|P4|Core Phase|Protocol Violation|0
4944600|NCT00355134|17008761|P3|Core Phase|Protocol Violation|2
4944601|NCT00355134|17008762|P2|Core Phase|Protocol Violation|2
4944602|NCT00355134|17008763|P1|Core Phase|Protocol Violation|3
4944603|NCT00355134|17008759|P5|Core Phase|Administrative problems|0
4944604|NCT00355134|17008760|P4|Core Phase|Administrative problems|0
4944605|NCT00355134|17008761|P3|Core Phase|Administrative problems|5
4944606|NCT00355134|17008762|P2|Core Phase|Administrative problems|3
4944607|NCT00355134|17008763|P1|Core Phase|Administrative problems|5
4944608|NCT00355134|17008759|P5|Core Phase|Unsatisfactory therapeutic effect|0
4944609|NCT00355134|17008760|P4|Core Phase|Unsatisfactory therapeutic effect|0
4944610|NCT00355134|17008761|P3|Core Phase|Unsatisfactory therapeutic effect|17
4944611|NCT00355134|17008762|P2|Core Phase|Unsatisfactory therapeutic effect|6
4944612|NCT00355134|17008763|P1|Core Phase|Unsatisfactory therapeutic effect|10
4944613|NCT00355134|17008759|P5|Core Phase|Abnormal laboratory value(s)|0
4944614|NCT00355134|17008760|P4|Core Phase|Abnormal laboratory value(s)|0
4944615|NCT00355134|17008761|P3|Core Phase|Abnormal laboratory value(s)|2
4944616|NCT00355134|17008762|P2|Core Phase|Abnormal laboratory value(s)|14
4944617|NCT00355134|17008763|P1|Core Phase|Abnormal laboratory value(s)|19
4944618|NCT00355134|17008759|P5|Core Phase|Lost to Follow-up|0
4944619|NCT00355134|17008760|P4|Core Phase|Lost to Follow-up|0
4944620|NCT00355134|17008761|P3|Core Phase|Lost to Follow-up|21
4944621|NCT00355134|17008762|P2|Core Phase|Lost to Follow-up|13
4944622|NCT00355134|17008763|P1|Core Phase|Lost to Follow-up|17
4944623|NCT00355134|17008759|P5|Core Phase|Adverse Event|0
4944624|NCT00355134|17008760|P4|Core Phase|Adverse Event|0
4944625|NCT00355134|17008761|P3|Core Phase|Adverse Event|16
4944626|NCT00355134|17008762|P2|Core Phase|Adverse Event|22
4944627|NCT00355134|17008763|P1|Core Phase|Adverse Event|28
4944628|NCT00355134|17008759|P5|Core Phase|Withdrawal by Subject|0
4944629|NCT00355134|17008760|P4|Core Phase|Withdrawal by Subject|0
4944630|NCT00355134|17008761|P3|Core Phase|Withdrawal by Subject|35
4944631|NCT00355134|17008762|P2|Core Phase|Withdrawal by Subject|24
4944632|NCT00355134|17008763|P1|Core Phase|Withdrawal by Subject|35
4944633|NCT00355121|17008806|P3|Overall Study|Serious adverse events|0
4944634|NCT00355121|17008807|P2|Overall Study|Serious adverse events|2
4944635|NCT00355121|17008808|P1|Overall Study|Serious adverse events|0
4944636|NCT00355121|17008806|P3|Overall Study|Withdrawal by Subject|2
4944637|NCT00355121|17008807|P2|Overall Study|Withdrawal by Subject|10
4944638|NCT00355121|17008808|P1|Overall Study|Withdrawal by Subject|9
4944639|NCT00355121|17008806|P3|Overall Study|Lost to Follow-up|1
4944640|NCT00355121|17008807|P2|Overall Study|Lost to Follow-up|7
4944641|NCT00355121|17008808|P1|Overall Study|Lost to Follow-up|4
4944642|NCT00355121|17008806|P3|Overall Study|Protocol Violation|1
4944643|NCT00355121|17008807|P2|Overall Study|Protocol Violation|9
4944644|NCT00355121|17008808|P1|Overall Study|Protocol Violation|7
4944645|NCT00355121|17008806|P3|Overall Study|Adverse Event|0
4944646|NCT00355121|17008807|P2|Overall Study|Adverse Event|1
4944647|NCT00355121|17008808|P1|Overall Study|Adverse Event|0
4944648|NCT00355121|17008806|P3|Overall Study|Did not receive study vaccine|1
4944649|NCT00355121|17008807|P2|Overall Study|Did not receive study vaccine|0
4944650|NCT00355121|17008808|P1|Overall Study|Did not receive study vaccine|1
4944651|NCT00355082|17008839|P3|Continuation Phase|Ran Out of Drug Due to Travel|0
4944652|NCT00355082|17008840|P2|Continuation Phase|Ran Out of Drug Due to Travel|0
4944653|NCT00355082|17008841|P1|Continuation Phase|Ran Out of Drug Due to Travel|1
4944654|NCT00355082|17008839|P3|Continuation Phase|Scheduling Error|0
4944655|NCT00355082|17008840|P2|Continuation Phase|Scheduling Error|0
4944656|NCT00355082|17008841|P1|Continuation Phase|Scheduling Error|1
4944657|NCT00355082|17008839|P3|Continuation Phase|Site Closed by Sponsor|0
4944658|NCT00355082|17008840|P2|Continuation Phase|Site Closed by Sponsor|0
4944659|NCT00355082|17008841|P1|Continuation Phase|Site Closed by Sponsor|8
4944660|NCT00355082|17008839|P3|Continuation Phase|Lack of Efficacy|0
4944661|NCT00355082|17008840|P2|Continuation Phase|Lack of Efficacy|0
4944662|NCT00355082|17008841|P1|Continuation Phase|Lack of Efficacy|5
4944663|NCT00355082|17008839|P3|Continuation Phase|Withdrawal by Subject|0
4944664|NCT00355082|17008840|P2|Continuation Phase|Withdrawal by Subject|0
4944665|NCT00355082|17008841|P1|Continuation Phase|Withdrawal by Subject|4
4944666|NCT00355082|17008839|P3|Continuation Phase|Protocol Violation|1
4944667|NCT00355082|17008840|P2|Continuation Phase|Protocol Violation|0
4944668|NCT00355082|17008841|P1|Continuation Phase|Protocol Violation|1
4944669|NCT00355082|17008839|P3|Continuation Phase|Lost to Follow-up|1
4944670|NCT00355082|17008840|P2|Continuation Phase|Lost to Follow-up|0
4944671|NCT00355082|17008841|P1|Continuation Phase|Lost to Follow-up|2
4944672|NCT00355082|17008839|P3|Continuation Phase|Adverse Event|1
4944673|NCT00355082|17008840|P2|Continuation Phase|Adverse Event|0
4944674|NCT00355082|17008841|P1|Continuation Phase|Adverse Event|2
4944675|NCT00355082|17008839|P3|Double-Blind (DB) Treatment Phase|Pregnancy|0
4944676|NCT00355082|17008840|P2|Double-Blind (DB) Treatment Phase|Pregnancy|1
4944677|NCT00355082|17008841|P1|Double-Blind (DB) Treatment Phase|Pregnancy|0
4944678|NCT00355082|17008839|P3|Double-Blind (DB) Treatment Phase|Protocol Violation|0
4944679|NCT00355082|17008840|P2|Double-Blind (DB) Treatment Phase|Protocol Violation|4
4944680|NCT00355082|17008841|P1|Double-Blind (DB) Treatment Phase|Protocol Violation|0
4944681|NCT00355082|17008839|P3|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
4944682|NCT00355082|17008840|P2|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4
4944683|NCT00355082|17008841|P1|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0
4944684|NCT00355082|17008839|P3|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0
4944685|NCT00355082|17008840|P2|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7
4944686|NCT00355082|17008841|P1|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6
4944687|NCT00355082|17008839|P3|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0
4944688|NCT00355082|17008840|P2|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8
4944689|NCT00355082|17008841|P1|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9
4944690|NCT00355082|17008839|P3|Double-Blind (DB) Treatment Phase|Adverse Event|0
4944691|NCT00355082|17008840|P2|Double-Blind (DB) Treatment Phase|Adverse Event|10
4944692|NCT00355082|17008841|P1|Double-Blind (DB) Treatment Phase|Adverse Event|4
4944693|NCT00355056|17008863|P2|Randomization Period|Early Termination|6
4944694|NCT00355056|17008864|P1|Randomization Period|Early Termination|4
4944695|NCT00355030|17008894|P2|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
4944696|NCT00355030|17008895|P1|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1
4944697|NCT00355030|17008894|P2|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1
4944698|NCT00355030|17008895|P1|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0
4944699|NCT00355030|17008894|P2|Study Period 1 Treatment|Other|6
4944700|NCT00355030|17008895|P1|Study Period 1 Treatment|Other|2
4944701|NCT00355030|17008894|P2|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1
4944702|NCT00355030|17008895|P1|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0
4944703|NCT00355030|17008894|P2|Study Period 1 Treatment|Sponsor Decision|32
4944704|NCT00355030|17008895|P1|Study Period 1 Treatment|Sponsor Decision|34
4944705|NCT00355030|17008894|P2|Study Period 1 Treatment|Physician Decision|1
4944706|NCT00355030|17008895|P1|Study Period 1 Treatment|Physician Decision|0
4944707|NCT00355030|17008894|P2|Study Period 1 Treatment|Parent/Caregiver Decision|2
4944708|NCT00355030|17008895|P1|Study Period 1 Treatment|Parent/Caregiver Decision|1
4944709|NCT00355030|17008894|P2|Study Period 1 Treatment|Withdrawal by Subject|1
4944710|NCT00355030|17008895|P1|Study Period 1 Treatment|Withdrawal by Subject|4
4944711|NCT00355030|17008894|P2|Study Period 1 Treatment|Lost to Follow-up|0
4944712|NCT00355030|17008895|P1|Study Period 1 Treatment|Lost to Follow-up|3
4944713|NCT00355030|17008894|P2|Study Period 1 Treatment|Adverse Event|1
4944714|NCT00355030|17008895|P1|Study Period 1 Treatment|Adverse Event|1
4944715|NCT00354835|17008934|P2|Overall Study|Refusal of further therapy|8
4944716|NCT00354835|17008935|P1|Overall Study|Refusal of further therapy|3
4944717|NCT00354835|17008934|P2|Overall Study|Adverse Event|0
4944718|NCT00354835|17008935|P1|Overall Study|Adverse Event|6
4944719|NCT00354835|17008934|P2|Overall Study|Disease progression or relapse|22
4944720|NCT00354835|17008935|P1|Overall Study|Disease progression or relapse|15
4944721|NCT00354835|17008934|P2|Overall Study|Ineligible|16
4944722|NCT00354835|17008935|P1|Overall Study|Ineligible|17
4944723|NCT00354835|17008934|P2|Overall Study|Withdrawal by Subject|1
4944724|NCT00354835|17008935|P1|Overall Study|Withdrawal by Subject|2
4944725|NCT00354835|17008934|P2|Overall Study|Physician Decision|13
4944726|NCT00354835|17008935|P1|Overall Study|Physician Decision|8
4944727|NCT00354835|17008934|P2|Overall Study|Death|1
4944728|NCT00354835|17008935|P1|Overall Study|Death|1
4944729|NCT00354744|17008974|P1|Overall Study|Withdrawal by Subject|14
4944730|NCT00354744|17008974|P1|Overall Study|Physician Decision|11
4944731|NCT00354744|17008974|P1|Overall Study|Lost to Follow-up|2
4944732|NCT00354744|17008974|P1|Overall Study|Lack of Efficacy|11
4944733|NCT00354744|17008974|P1|Overall Study|Death|2
4944734|NCT00354744|17008974|P1|Overall Study|Adverse Event|2
4944735|NCT00354679|17008980|P1|Overall Study|Patient Not Treated|1
4944736|NCT00354614|17008989|P1|Overall Study|Lack of Efficacy|28
4944737|NCT00354601|17008993|P1|Overall Study|progression|1
4944738|NCT00354601|17008993|P1|Overall Study|Protocol Violation|1
4944739|NCT00354432|17009013|P4|Overall Study|Off/Toxicity|5
4944740|NCT00354432|17009014|P3|Overall Study|Off/Toxicity|5
4944741|NCT00354432|17009015|P2|Overall Study|Off/Toxicity|7
4944742|NCT00354432|17009016|P1|Overall Study|Off/Toxicity|3
4944743|NCT00354432|17009013|P4|Overall Study|Adverse Event|5
4944744|NCT00354432|17009014|P3|Overall Study|Adverse Event|5
4944745|NCT00354432|17009015|P2|Overall Study|Adverse Event|1
4944746|NCT00354432|17009016|P1|Overall Study|Adverse Event|3
4944747|NCT00354341|17009032|P2|Overall Study|Other|2
4944748|NCT00354341|17009033|P1|Overall Study|Other|1
4944749|NCT00354341|17009032|P2|Overall Study|Failure to return|1
4944750|NCT00354341|17009033|P1|Overall Study|Failure to return|0
4944751|NCT00354341|17009032|P2|Overall Study|Refused treatment|2
4944752|NCT00354341|17009033|P1|Overall Study|Refused treatment|1
4944753|NCT00354341|17009032|P2|Overall Study|Death|2
4944754|NCT00354341|17009033|P1|Overall Study|Death|0
4944755|NCT00354341|17009032|P2|Overall Study|Adverse Event|0
4944756|NCT00354341|17009033|P1|Overall Study|Adverse Event|1
4944757|NCT00354172|17009055|P1|Overall Study|Did not receive transplant|1
4944758|NCT00354159|17009075|P2|Long-term Follow-up|Study Closed|34
4944759|NCT00354159|17009076|P1|Long-term Follow-up|Study Closed|29
4944760|NCT00354159|17009075|P2|Long-term Follow-up|Death|11
4944761|NCT00354159|17009076|P1|Long-term Follow-up|Death|14
4944762|NCT00354159|17009075|P2|Long-term Follow-up|Lost to Follow-up|0
4944763|NCT00354159|17009076|P1|Long-term Follow-up|Lost to Follow-up|1
4944764|NCT00354159|17009075|P2|Long-term Follow-up|Physician Decision|122
4944765|NCT00354159|17009076|P1|Long-term Follow-up|Physician Decision|127
4944766|NCT00354159|17009075|P2|Long-term Follow-up|Withdrawal by Subject|9
4944767|NCT00354159|17009076|P1|Long-term Follow-up|Withdrawal by Subject|9
4944768|NCT00354159|17009075|P2|Randomized Study Period|Death|9
4944769|NCT00354159|17009076|P1|Randomized Study Period|Death|7
4944770|NCT00354159|17009075|P2|Randomized Study Period|Lost to Follow-up|0
4944771|NCT00354159|17009076|P1|Randomized Study Period|Lost to Follow-up|4
4944772|NCT00354159|17009075|P2|Randomized Study Period|Physician Decision|10
4944773|NCT00354159|17009076|P1|Randomized Study Period|Physician Decision|6
4944774|NCT00354159|17009075|P2|Randomized Study Period|Withdrawal by Subject|3
4944775|NCT00354159|17009076|P1|Randomized Study Period|Withdrawal by Subject|5
4944776|NCT00354107|17009119|P1|Overall Study|Withdrawal by Subject|1
4944777|NCT00354107|17009119|P1|Overall Study|Physician Decision|2
4944778|NCT00354107|17009119|P1|Overall Study|Adverse Event|2
4944779|NCT00354029|17009129|P2|Overall Study|Protocol Violation|2
4944780|NCT00354029|17009130|P1|Overall Study|Protocol Violation|4
4944781|NCT00353873|17009142|P2|Overall Study|Withdrawal by Subject|1
4944782|NCT00353873|17009143|P1|Overall Study|Withdrawal by Subject|1
4944783|NCT00353873|17009142|P2|Overall Study|Physician Decision|0
4944784|NCT00353873|17009143|P1|Overall Study|Physician Decision|2
4944785|NCT00353873|17009142|P2|Overall Study|Adverse Event|0
4944786|NCT00353873|17009143|P1|Overall Study|Adverse Event|1
4944787|NCT00353873|17009142|P2|Overall Study|Exacerbation|0
4944788|NCT00353873|17009143|P1|Overall Study|Exacerbation|1
4944789|NCT00353873|17009142|P2|Overall Study|Protocol Violation|2
4944790|NCT00353873|17009143|P1|Overall Study|Protocol Violation|1
4944791|NCT00353704|17009172|P2|Overall Study|Protocol Violation|1
4944792|NCT00353704|17009173|P1|Overall Study|Protocol Violation|3
4944793|NCT00353496|17009243|P2|Overall Study|Not otherwise specified|2
4944794|NCT00353496|17009244|P1|Overall Study|Not otherwise specified|4
4944795|NCT00353496|17009243|P2|Overall Study|Physician Decision|9
4944796|NCT00353496|17009244|P1|Overall Study|Physician Decision|6
4944797|NCT00353496|17009243|P2|Overall Study|Withdrawal by Subject|4
4944798|NCT00353496|17009244|P1|Overall Study|Withdrawal by Subject|3
4944799|NCT00353496|17009243|P2|Overall Study|Protocol Violation|2
4944800|NCT00353496|17009244|P1|Overall Study|Protocol Violation|2
4944801|NCT00353496|17009243|P2|Overall Study|Adverse Event|0
4944802|NCT00353496|17009244|P1|Overall Study|Adverse Event|1
4944803|NCT00353366|17009297|P1|Overall Study|Other|135
4944804|NCT00353366|17009297|P1|Overall Study|Adverse Event|8
4944805|NCT00353262|17009324|P1|Overall Study|Break from Chemotherapy|1
4944806|NCT00353262|17009324|P1|Overall Study|Surgery|4
4944807|NCT00353262|17009324|P1|Overall Study|Progression|1
4944808|NCT00353262|17009324|P1|Overall Study|Insufficient Therapeutic Response|13
4944809|NCT00353262|17009324|P1|Overall Study|Withdrawal by Subject|2
4944810|NCT00353262|17009324|P1|Overall Study|Adverse Event|8
4944811|NCT00352885|17009365|P2|Overall Study|Side effects of IL-2 administration|0
4944812|NCT00352885|17009366|P1|Overall Study|Side effects of IL-2 administration|1
4944813|NCT00352885|17009365|P2|Overall Study|Progression of metastatic melanoma|3
4944814|NCT00352885|17009366|P1|Overall Study|Progression of metastatic melanoma|5
4944815|NCT00352885|17009365|P2|Overall Study|Development of major depression|1
4944816|NCT00352885|17009366|P1|Overall Study|Development of major depression|0
4944817|NCT00352885|17009365|P2|Overall Study|Withdrawal by Subject|3
4944818|NCT00352885|17009366|P1|Overall Study|Withdrawal by Subject|0
4944819|NCT00352846|17009384|P2|Overall Study|Death|1
4944820|NCT00352846|17009385|P1|Overall Study|Death|0
4944821|NCT00352846|17009384|P2|Overall Study|Non-compliance|0
4944822|NCT00352846|17009385|P1|Overall Study|Non-compliance|2
4944823|NCT00352846|17009384|P2|Overall Study|Ineligible|2
4944824|NCT00352846|17009385|P1|Overall Study|Ineligible|3
4944825|NCT00352846|17009384|P2|Overall Study|Withdrawal by Subject|8
4944826|NCT00352846|17009385|P1|Overall Study|Withdrawal by Subject|3
4944827|NCT00352846|17009384|P2|Overall Study|Disease progression|2
4944828|NCT00352846|17009385|P1|Overall Study|Disease progression|0
4944829|NCT00352755|17009400|P1|Overall Study|Adverse Event|1
4944830|NCT00352755|17009400|P1|Overall Study|Physician Decision|1
4944831|NCT00352690|17009410|P2|Overall Study|Determined to be ineligible|0
4944832|NCT00352690|17009411|P1|Overall Study|Determined to be ineligible|2
4944833|NCT00352664|17009431|P2|Overall Study|Withdrawal by Subject|0
4944834|NCT00352664|17009432|P1|Overall Study|Withdrawal by Subject|7
4944835|NCT00352534|17009449|P7|Final Risk Group Assignment|Death|0
4944836|NCT00352534|17009450|P6|Final Risk Group Assignment|Death|2
4944837|NCT00352534|17009451|P5|Final Risk Group Assignment|Death|0
4944838|NCT00352534|17009452|P4|Final Risk Group Assignment|Death|0
4944839|NCT00352534|17009453|P3|Final Risk Group Assignment|Death|0
4944840|NCT00352534|17009454|P2|Final Risk Group Assignment|Death|0
4944841|NCT00352534|17009455|P1|Final Risk Group Assignment|Death|0
4944842|NCT00352534|17009449|P7|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11
4944843|NCT00352534|17009450|P6|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4944844|NCT00352534|17009451|P5|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4944845|NCT00352534|17009452|P4|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4944846|NCT00352534|17009453|P3|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4944847|NCT00352534|17009454|P2|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4944848|NCT00352534|17009455|P1|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0
4944849|NCT00352534|17009449|P7|Final Risk Group Assignment|Enrollment onto another COG study|28
4944850|NCT00352534|17009450|P6|Final Risk Group Assignment|Enrollment onto another COG study|0
4944851|NCT00352534|17009451|P5|Final Risk Group Assignment|Enrollment onto another COG study|0
4944852|NCT00352534|17009452|P4|Final Risk Group Assignment|Enrollment onto another COG study|0
4944853|NCT00352534|17009453|P3|Final Risk Group Assignment|Enrollment onto another COG study|0
4944854|NCT00352534|17009454|P2|Final Risk Group Assignment|Enrollment onto another COG study|0
4944855|NCT00352534|17009455|P1|Final Risk Group Assignment|Enrollment onto another COG study|0
4944856|NCT00352534|17009449|P7|Final Risk Group Assignment|Ineligible|0
4944857|NCT00352534|17009450|P6|Final Risk Group Assignment|Ineligible|13
4944858|NCT00352534|17009451|P5|Final Risk Group Assignment|Ineligible|0
4944859|NCT00352534|17009452|P4|Final Risk Group Assignment|Ineligible|1
4944860|NCT00352534|17009453|P3|Final Risk Group Assignment|Ineligible|3
4944861|NCT00352534|17009454|P2|Final Risk Group Assignment|Ineligible|0
4944862|NCT00352534|17009455|P1|Final Risk Group Assignment|Ineligible|0
4944863|NCT00352534|17009449|P7|Final Risk Group Assignment|Withdrawal by Subject|0
4944864|NCT00352534|17009450|P6|Final Risk Group Assignment|Withdrawal by Subject|3
4944865|NCT00352534|17009451|P5|Final Risk Group Assignment|Withdrawal by Subject|0
4944866|NCT00352534|17009452|P4|Final Risk Group Assignment|Withdrawal by Subject|0
4944867|NCT00352534|17009453|P3|Final Risk Group Assignment|Withdrawal by Subject|0
4944868|NCT00352534|17009454|P2|Final Risk Group Assignment|Withdrawal by Subject|0
4944869|NCT00352534|17009455|P1|Final Risk Group Assignment|Withdrawal by Subject|0
4944870|NCT00352534|17009449|P7|Final Risk Group Assignment|Physician Decision|0
4944871|NCT00352534|17009450|P6|Final Risk Group Assignment|Physician Decision|8
4944872|NCT00352534|17009451|P5|Final Risk Group Assignment|Physician Decision|0
4944873|NCT00352534|17009452|P4|Final Risk Group Assignment|Physician Decision|0
4944874|NCT00352534|17009453|P3|Final Risk Group Assignment|Physician Decision|0
4944875|NCT00352534|17009454|P2|Final Risk Group Assignment|Physician Decision|0
4944876|NCT00352534|17009455|P1|Final Risk Group Assignment|Physician Decision|0
4944877|NCT00352534|17009449|P7|Final Risk Group Assignment|Lack of Efficacy|0
4944878|NCT00352534|17009450|P6|Final Risk Group Assignment|Lack of Efficacy|19
4944879|NCT00352534|17009451|P5|Final Risk Group Assignment|Lack of Efficacy|1
4944880|NCT00352534|17009452|P4|Final Risk Group Assignment|Lack of Efficacy|2
4944881|NCT00352534|17009453|P3|Final Risk Group Assignment|Lack of Efficacy|0
4944882|NCT00352534|17009454|P2|Final Risk Group Assignment|Lack of Efficacy|0
4944883|NCT00352534|17009455|P1|Final Risk Group Assignment|Lack of Efficacy|0
4944884|NCT00352534|17009449|P7|Initial Staging|Ineligible|0
4944885|NCT00352534|17009450|P6|Initial Staging|Ineligible|0
4944886|NCT00352534|17009451|P5|Initial Staging|Ineligible|0
4944887|NCT00352534|17009452|P4|Initial Staging|Ineligible|0
4944888|NCT00352534|17009453|P3|Initial Staging|Ineligible|0
4944889|NCT00352534|17009454|P2|Initial Staging|Ineligible|9
4944890|NCT00352534|17009455|P1|Initial Staging|Ineligible|8
4944891|NCT00352417|17009472|P2|Overall Study|Schedule Change|1
4944892|NCT00352417|17009473|P1|Overall Study|Schedule Change|2
4944893|NCT00352417|17009472|P2|Overall Study|Lost to Follow-up|0
4944894|NCT00352417|17009473|P1|Overall Study|Lost to Follow-up|1
4944895|NCT00352417|17009472|P2|Overall Study|Withdrawal by Subject|2
4944896|NCT00352417|17009473|P1|Overall Study|Withdrawal by Subject|1
4944897|NCT00352417|17009472|P2|Overall Study|Protocol Violation|2
4944898|NCT00352417|17009473|P1|Overall Study|Protocol Violation|0
4944899|NCT00352417|17009472|P2|Overall Study|Adverse Event|0
4944900|NCT00352417|17009473|P1|Overall Study|Adverse Event|1
4944901|NCT00352365|17009487|P1|Maintenance Therapy|Not eligible|4
4944902|NCT00352365|17009487|P1|Maintenance Therapy|Not protocol specified|3
4944903|NCT00352365|17009487|P1|Maintenance Therapy|Death|2
4944904|NCT00352365|17009487|P1|Maintenance Therapy|Progression/Relapse|3
4944905|NCT00352365|17009487|P1|Induction Therapy|Death before starting protocol therapy|1
4944906|NCT00352365|17009487|P1|Induction Therapy|Not eligible|3
4944907|NCT00352365|17009487|P1|Induction Therapy|Not protocol specified|1
4944908|NCT00352365|17009487|P1|Induction Therapy|Death|7
4944909|NCT00352365|17009487|P1|Induction Therapy|Progression/Relapse|8
4944910|NCT00352365|17009487|P1|Induction Therapy|Adverse Event|7
4944911|NCT00352118|17009497|P1|Overall Study|Physician Decision|4
4944912|NCT00352105|17009507|P1|Overall Study|Protocol Violation|2
4944913|NCT00352105|17009507|P1|Overall Study|Adverse Event|19
4944914|NCT00352105|17009507|P1|Overall Study|Lack of Efficacy|9
4944915|NCT00352105|17009507|P1|Overall Study|Withdrawal by Subject|5
4944916|NCT00352105|17009507|P1|Overall Study|Death|5
4944917|NCT00352053|17009518|P2|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1
4944918|NCT00352053|17009519|P1|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0
4944919|NCT00352053|17009518|P2|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
4944920|NCT00352053|17009519|P1|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1
4944921|NCT00352053|17009518|P2|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
4944922|NCT00352053|17009519|P1|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1
4944923|NCT00352053|17009518|P2|Second Extension Phase (Weeks 144-240)|Physician Decision|4
4944924|NCT00352053|17009519|P1|Second Extension Phase (Weeks 144-240)|Physician Decision|4
4944925|NCT00352053|17009518|P2|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0
4944926|NCT00352053|17009519|P1|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1
4944927|NCT00352053|17009518|P2|First Extension Phase (Weeks 48-144)|Pregnancy|0
4944928|NCT00352053|17009519|P1|First Extension Phase (Weeks 48-144)|Pregnancy|1
4944929|NCT00352053|17009518|P2|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4
4944930|NCT00352053|17009519|P1|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1
4944931|NCT00352053|17009518|P2|First Extension Phase (Weeks 48-144)|Physician Decision|13
4944932|NCT00352053|17009519|P1|First Extension Phase (Weeks 48-144)|Physician Decision|9
4944933|NCT00352053|17009518|P2|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0
4944934|NCT00352053|17009519|P1|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1
4944935|NCT00352053|17009518|P2|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1
4944936|NCT00352053|17009519|P1|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0
4944937|NCT00352053|17009518|P2|Double-Blind Phase (Through Week 48)|Adverse Event|0
4944938|NCT00352053|17009519|P1|Double-Blind Phase (Through Week 48)|Adverse Event|1
4944939|NCT00352053|17009518|P2|Double-Blind Phase (Through Week 48)|Physician Decision|2
4944940|NCT00352053|17009519|P1|Double-Blind Phase (Through Week 48)|Physician Decision|2
4944941|NCT00352053|17009518|P2|Double-Blind Phase (Through Week 48)|Virologic Failure|10
4944942|NCT00352053|17009519|P1|Double-Blind Phase (Through Week 48)|Virologic Failure|14
4944943|NCT00352027|17009686|P1|Overall Study|Progressive disease|3
4944944|NCT00351819|17009985|P2|Overall Study|Enrolled in another trial|1
4944945|NCT00351819|17009986|P1|Overall Study|Enrolled in another trial|0
4944946|NCT00351819|17009985|P2|Overall Study|Incarcerated|1
4944947|NCT00351819|17009986|P1|Overall Study|Incarcerated|0
4944948|NCT00351819|17009985|P2|Overall Study|Non-compliance|1
4944949|NCT00351819|17009986|P1|Overall Study|Non-compliance|0
4944950|NCT00351819|17009985|P2|Overall Study|Unprofessional behavior|0
4944951|NCT00351819|17009986|P1|Overall Study|Unprofessional behavior|1
4944952|NCT00351819|17009985|P2|Overall Study|Traumatic ankle fracture|0
4944953|NCT00351819|17009986|P1|Overall Study|Traumatic ankle fracture|1
4944954|NCT00351819|17009985|P2|Overall Study|Elevated PSA|1
4944955|NCT00351819|17009986|P1|Overall Study|Elevated PSA|1
4944956|NCT00351819|17009985|P2|Overall Study|Withdrawal by Subject|4
4944957|NCT00351819|17009986|P1|Overall Study|Withdrawal by Subject|0
4944958|NCT00351819|17009985|P2|Overall Study|Lost to Follow-up|4
4944959|NCT00351819|17009986|P1|Overall Study|Lost to Follow-up|4
4944960|NCT00351533|17010057|P2|Overall Study|Withdrawal by Subject|1
4944961|NCT00351533|17010058|P1|Overall Study|Withdrawal by Subject|0
4944962|NCT00351533|17010057|P2|Overall Study|Physician Decision|1
4944963|NCT00351533|17010058|P1|Overall Study|Physician Decision|0
4944964|NCT00351533|17010057|P2|Overall Study|Lost to Follow-up|3
4944965|NCT00351533|17010058|P1|Overall Study|Lost to Follow-up|1
4944966|NCT00351533|17010057|P2|Overall Study|Extubated before first BAL|0
4944967|NCT00351533|17010058|P1|Overall Study|Extubated before first BAL|1
4944968|NCT00351468|17010118|P1|Overall Study|Protocol Violation|3
4944969|NCT00351468|17010118|P1|Overall Study|Lost to Follow-up|4
4944970|NCT00351468|17010118|P1|Overall Study|Non-compliance|8
4944971|NCT00351468|17010118|P1|Overall Study|Lack of Efficacy|32
4944972|NCT00351468|17010118|P1|Overall Study|Various -follow up w clinical team|39
4944973|NCT00351468|17010118|P1|Overall Study|Withdrawal by Subject|39
4944974|NCT00351468|17010118|P1|Overall Study|Adverse Event|42
4944975|NCT00351377|17010142|P1|Overall Study|Unsatisfactory therapeutic effect|1
4944976|NCT00351377|17010142|P1|Overall Study|Death|1
4944977|NCT00351377|17010142|P1|Overall Study|Adverse Event|5
4944978|NCT00351351|17010156|P2|Overall Study|surgical access pbs; device issues|4
4944979|NCT00351351|17010157|P1|Overall Study|surgical access pbs; device issues|9
4944980|NCT00351273|17010183|P3|Overall Study|Lost to Follow-up|5
4944981|NCT00351273|17010184|P2|Overall Study|Lost to Follow-up|2
4944982|NCT00351273|17010185|P1|Overall Study|Lost to Follow-up|1
4944983|NCT00350870|17010228|P4|Overall Study|Physician Decision|1
4944984|NCT00350870|17010229|P3|Overall Study|Physician Decision|1
4944985|NCT00350870|17010230|P2|Overall Study|Physician Decision|0
4944986|NCT00350870|17010231|P1|Overall Study|Physician Decision|1
4944987|NCT00350870|17010228|P4|Overall Study|Withdrawal by Subject|14
4944988|NCT00350870|17010229|P3|Overall Study|Withdrawal by Subject|15
4944989|NCT00350870|17010230|P2|Overall Study|Withdrawal by Subject|17
4944990|NCT00350870|17010231|P1|Overall Study|Withdrawal by Subject|21
4944991|NCT00350844|17010245|P1|Overall Study|Lost to Follow-up|1
4944992|NCT00350792|17010249|P1|Overall Study|Lack of Efficacy|11
4944993|NCT00350792|17010249|P1|Overall Study|Physician Decision|2
4944994|NCT00350792|17010249|P1|Overall Study|Withdrawal by Subject|4
4944995|NCT00350792|17010249|P1|Overall Study|Protocol Violation|1
4944996|NCT00350792|17010249|P1|Overall Study|Death Not Study Drug Related|2
4944997|NCT00350792|17010249|P1|Overall Study|Death from Study Drug Toxicity|1
4944998|NCT00350792|17010249|P1|Overall Study|Death from Study Disease|1
4944999|NCT00350792|17010249|P1|Overall Study|Adverse Event|11
4945000|NCT00350779|17010259|P2|Overall Study|Non-compliance with study procedures|1
4945001|NCT00350779|17010260|P1|Overall Study|Non-compliance with study procedures|0
4945002|NCT00350779|17010259|P2|Overall Study|Patient Moved|1
4945003|NCT00350779|17010260|P1|Overall Study|Patient Moved|2
4945004|NCT00350779|17010259|P2|Overall Study|Withdrawal by Subject|8
4945005|NCT00350779|17010260|P1|Overall Study|Withdrawal by Subject|9
4945006|NCT00350779|17010259|P2|Overall Study|Protocol Violation|1
4945007|NCT00350779|17010260|P1|Overall Study|Protocol Violation|3
4945008|NCT00350779|17010259|P2|Overall Study|Physician Decision|4
4945009|NCT00350779|17010260|P1|Overall Study|Physician Decision|2
4945010|NCT00350779|17010259|P2|Overall Study|Lost to Follow-up|0
4945011|NCT00350779|17010260|P1|Overall Study|Lost to Follow-up|2
4945012|NCT00350779|17010259|P2|Overall Study|Lack of Efficacy|4
4945013|NCT00350779|17010260|P1|Overall Study|Lack of Efficacy|0
4945014|NCT00350779|17010259|P2|Overall Study|Adverse Event|2
4945015|NCT00350779|17010260|P1|Overall Study|Adverse Event|4
4945016|NCT00350727|17010281|P3|Phase II|Enrolled in Rollover Study|1
4945017|NCT00350727|17010282|P2|Phase II|Enrolled in Rollover Study|0
4945018|NCT00350727|17010283|P1|Phase II|Enrolled in Rollover Study|0
4945019|NCT00350727|17010281|P3|Phase II|Sponsor Terminated Study|1
4945020|NCT00350727|17010282|P2|Phase II|Sponsor Terminated Study|0
4945021|NCT00350727|17010283|P1|Phase II|Sponsor Terminated Study|0
4945022|NCT00350727|17010281|P3|Phase II|Death|2
4945023|NCT00350727|17010282|P2|Phase II|Death|0
4945024|NCT00350727|17010283|P1|Phase II|Death|0
4945025|NCT00350727|17010281|P3|Phase II|Adverse Event|1
4945026|NCT00350727|17010282|P2|Phase II|Adverse Event|1
4945027|NCT00350727|17010283|P1|Phase II|Adverse Event|0
4945028|NCT00350727|17010281|P3|Phase II|Withdrawal by Subject|1
4945029|NCT00350727|17010282|P2|Phase II|Withdrawal by Subject|2
4945030|NCT00350727|17010283|P1|Phase II|Withdrawal by Subject|0
4945031|NCT00350727|17010281|P3|Phase II|Clinical Deterioration|0
4945032|NCT00350727|17010282|P2|Phase II|Clinical Deterioration|1
4945033|NCT00350727|17010283|P1|Phase II|Clinical Deterioration|0
4945034|NCT00350727|17010281|P3|Phase II|Disease Progression|16
4945035|NCT00350727|17010282|P2|Phase II|Disease Progression|15
4945036|NCT00350727|17010283|P1|Phase II|Disease Progression|0
4945037|NCT00350727|17010281|P3|Phase I: Dose Escalation|Transition to Extension Phase|0
4945038|NCT00350727|17010282|P2|Phase I: Dose Escalation|Transition to Extension Phase|0
4945039|NCT00350727|17010283|P1|Phase I: Dose Escalation|Transition to Extension Phase|3
4945040|NCT00350727|17010281|P3|Phase I: Dose Escalation|Physician Decision|0
4945041|NCT00350727|17010282|P2|Phase I: Dose Escalation|Physician Decision|0
4945042|NCT00350727|17010283|P1|Phase I: Dose Escalation|Physician Decision|1
4945043|NCT00350727|17010281|P3|Phase I: Dose Escalation|Death|0
4945044|NCT00350727|17010282|P2|Phase I: Dose Escalation|Death|0
4945045|NCT00350727|17010283|P1|Phase I: Dose Escalation|Death|1
4945046|NCT00350727|17010281|P3|Phase I: Dose Escalation|Lack of Efficacy|0
4945047|NCT00350727|17010282|P2|Phase I: Dose Escalation|Lack of Efficacy|0
4945048|NCT00350727|17010283|P1|Phase I: Dose Escalation|Lack of Efficacy|25
4945049|NCT00350727|17010281|P3|Phase I: Dose Escalation|Adverse Event|0
4945050|NCT00350727|17010282|P2|Phase I: Dose Escalation|Adverse Event|0
4945051|NCT00350727|17010283|P1|Phase I: Dose Escalation|Adverse Event|4
4945052|NCT00350636|17010427|P2|Overall Study|Other|2
4945053|NCT00350636|17010428|P1|Overall Study|Other|1
4945054|NCT00350636|17010427|P2|Overall Study|Physician Decision|2
4945055|NCT00350636|17010428|P1|Overall Study|Physician Decision|0
4945056|NCT00350636|17010427|P2|Overall Study|Lost to Follow-up|8
4945057|NCT00350636|17010428|P1|Overall Study|Lost to Follow-up|9
4945058|NCT00350636|17010427|P2|Overall Study|Withdrawal by Subject|17
4945059|NCT00350636|17010428|P1|Overall Study|Withdrawal by Subject|13
4945060|NCT00350636|17010427|P2|Overall Study|Protocol Violation|3
4945061|NCT00350636|17010428|P1|Overall Study|Protocol Violation|1
4945062|NCT00350636|17010427|P2|Overall Study|Adverse Event|13
4945063|NCT00350636|17010428|P1|Overall Study|Adverse Event|19
4945064|NCT00350623|17010447|P3|Overall Study|patient traveling outside the country|1
4945065|NCT00350623|17010448|P2|Overall Study|patient traveling outside the country|0
4945066|NCT00350623|17010449|P1|Overall Study|patient traveling outside the country|0
4945067|NCT00350623|17010447|P3|Overall Study|Withdrawal by Subject|1
4945068|NCT00350623|17010448|P2|Overall Study|Withdrawal by Subject|1
4945069|NCT00350623|17010449|P1|Overall Study|Withdrawal by Subject|0
4945070|NCT00350623|17010447|P3|Overall Study|Lost to Follow-up|4
4945071|NCT00350623|17010448|P2|Overall Study|Lost to Follow-up|3
4945072|NCT00350623|17010449|P1|Overall Study|Lost to Follow-up|8
4945073|NCT00350545|17010457|P1|Overall Study|Withdrawal by Subject|2
4945074|NCT00350519|17010476|P2|Overall Study|Withdrawal by Subject|2
4945075|NCT00350519|17010477|P1|Overall Study|Withdrawal by Subject|3
4945076|NCT00350519|17010476|P2|Overall Study|Protocol Violation|2
4945077|NCT00350519|17010477|P1|Overall Study|Protocol Violation|1
4945078|NCT00350519|17010476|P2|Overall Study|Physician Decision|1
4945079|NCT00350519|17010477|P1|Overall Study|Physician Decision|0
4945080|NCT00350519|17010476|P2|Overall Study|Death|1
4945081|NCT00350519|17010477|P1|Overall Study|Death|0
4945082|NCT00350402|17010491|P2|Overall Study|Lost to Follow-up|1
4945083|NCT00350402|17010492|P1|Overall Study|Lost to Follow-up|1
4945084|NCT00350272|17010565|P2|Open-Label 84 Week Treatment|Sponsor decision|1
4945085|NCT00350272|17010566|P1|Open-Label 84 Week Treatment|Sponsor decision|2
4945086|NCT00350272|17010565|P2|Open-Label 84 Week Treatment|Physician Decision|2
4945087|NCT00350272|17010566|P1|Open-Label 84 Week Treatment|Physician Decision|1
4945088|NCT00350272|17010565|P2|Open-Label 84 Week Treatment|Withdrawal by Subject|2
4945089|NCT00350272|17010566|P1|Open-Label 84 Week Treatment|Withdrawal by Subject|1
4945090|NCT00350272|17010565|P2|Open-Label 84 Week Treatment|Lost to Follow-up|2
4945091|NCT00350272|17010566|P1|Open-Label 84 Week Treatment|Lost to Follow-up|3
4945092|NCT00350272|17010565|P2|Open-Label 84 Week Treatment|Adverse Event|1
4945093|NCT00350272|17010566|P1|Open-Label 84 Week Treatment|Adverse Event|2
4945094|NCT00350272|17010565|P2|Blinded 12 Week Treatment|Sponsor decision|1
4945095|NCT00350272|17010566|P1|Blinded 12 Week Treatment|Sponsor decision|0
4945096|NCT00350272|17010565|P2|Blinded 12 Week Treatment|Physician Decision|1
4945097|NCT00350272|17010566|P1|Blinded 12 Week Treatment|Physician Decision|2
4945098|NCT00350272|17010565|P2|Blinded 12 Week Treatment|Withdrawal by Subject|0
4945099|NCT00350272|17010566|P1|Blinded 12 Week Treatment|Withdrawal by Subject|3
4945100|NCT00350272|17010565|P2|Blinded 12 Week Treatment|Lost to Follow-up|0
4945101|NCT00350272|17010566|P1|Blinded 12 Week Treatment|Lost to Follow-up|2
4945102|NCT00350272|17010565|P2|Blinded 12 Week Treatment|Death|0
4945103|NCT00350272|17010566|P1|Blinded 12 Week Treatment|Death|1
4945104|NCT00350272|17010565|P2|Blinded 12 Week Treatment|Adverse Event|0
4945105|NCT00350272|17010566|P1|Blinded 12 Week Treatment|Adverse Event|1
4945106|NCT00350207|17010588|P3|Overall Study|Other|1
4945107|NCT00350207|17010589|P2|Overall Study|Other|3
4945108|NCT00350207|17010590|P1|Overall Study|Other|1
4945109|NCT00350207|17010588|P3|Overall Study|Withdrawal by Subject|1
4945110|NCT00350207|17010589|P2|Overall Study|Withdrawal by Subject|1
4945111|NCT00350207|17010590|P1|Overall Study|Withdrawal by Subject|0
4945112|NCT00350207|17010588|P3|Overall Study|Lost to Follow-up|1
4945113|NCT00350207|17010589|P2|Overall Study|Lost to Follow-up|0
4945114|NCT00350207|17010590|P1|Overall Study|Lost to Follow-up|1
4945115|NCT00350207|17010588|P3|Overall Study|Lack of Efficacy|2
4945116|NCT00350207|17010589|P2|Overall Study|Lack of Efficacy|0
4945117|NCT00350207|17010590|P1|Overall Study|Lack of Efficacy|1
4945118|NCT00350207|17010588|P3|Overall Study|Adverse Event|2
4945119|NCT00350207|17010589|P2|Overall Study|Adverse Event|2
4945120|NCT00350207|17010590|P1|Overall Study|Adverse Event|5
4945121|NCT00349973|17010802|P2|Overall Study|Withdrawal by Subject|0
4945122|NCT00349973|17010803|P1|Overall Study|Withdrawal by Subject|1
4945123|NCT00349973|17010802|P2|Overall Study|Adverse Event|3
4945124|NCT00349973|17010803|P1|Overall Study|Adverse Event|3
4945125|NCT00349921|17010817|P4|First Spinal Injection|Adverse Event|0
4945126|NCT00349921|17010818|P3|First Spinal Injection|Adverse Event|1
4945127|NCT00349921|17010819|P2|First Spinal Injection|Adverse Event|0
4945128|NCT00349921|17010820|P1|First Spinal Injection|Adverse Event|0
4945129|NCT00349921|17010817|P4|First Spinal Injection|Physician Decision|0
4945130|NCT00349921|17010818|P3|First Spinal Injection|Physician Decision|0
4945131|NCT00349921|17010819|P2|First Spinal Injection|Physician Decision|0
4945132|NCT00349921|17010820|P1|First Spinal Injection|Physician Decision|1
4945133|NCT00349908|17010831|P2|Overall Study|Withdrawal by Subject|4
4945134|NCT00349908|17010832|P1|Overall Study|Withdrawal by Subject|0
4945135|NCT00349752|17010858|P2|Overall Study|Other:History of squamous cell carcinoma|0
4945136|NCT00349752|17010859|P1|Overall Study|Other:History of squamous cell carcinoma|1
4945137|NCT00349752|17010858|P2|Overall Study|Other: Inadvertently unblinded|0
4945138|NCT00349752|17010859|P1|Overall Study|Other: Inadvertently unblinded|1
4945139|NCT00349752|17010858|P2|Overall Study|Other: Ineligible|0
4945140|NCT00349752|17010859|P1|Overall Study|Other: Ineligible|1
4945141|NCT00349752|17010858|P2|Overall Study|Other: Patient's steroid use|0
4945142|NCT00349752|17010859|P1|Overall Study|Other: Patient's steroid use|1
4945143|NCT00349752|17010858|P2|Overall Study|Other: Patient stopped steroids|1
4945144|NCT00349752|17010859|P1|Overall Study|Other: Patient stopped steroids|0
4945145|NCT00349752|17010858|P2|Overall Study|Other: Non compliance|1
4945146|NCT00349752|17010859|P1|Overall Study|Other: Non compliance|0
4945147|NCT00349752|17010858|P2|Overall Study|Other: Required exclusionary medication|1
4945148|NCT00349752|17010859|P1|Overall Study|Other: Required exclusionary medication|0
4945149|NCT00349752|17010858|P2|Overall Study|Personal reasons|5
4945150|NCT00349752|17010859|P1|Overall Study|Personal reasons|6
4945151|NCT00349752|17010858|P2|Overall Study|Lost to Follow-up|2
4945152|NCT00349752|17010859|P1|Overall Study|Lost to Follow-up|4
4945153|NCT00349752|17010858|P2|Overall Study|Lack of Efficacy|42
4945154|NCT00349752|17010859|P1|Overall Study|Lack of Efficacy|37
4945155|NCT00349752|17010858|P2|Overall Study|Adverse Event|12
4945156|NCT00349752|17010859|P1|Overall Study|Adverse Event|8
4945157|NCT00349622|17010912|P2|Overall Study|Withdrawal by Subject|9
4945158|NCT00349622|17010913|P1|Overall Study|Withdrawal by Subject|5
4945159|NCT00349622|17010912|P2|Overall Study|Lost to Follow-up|1
4945160|NCT00349622|17010913|P1|Overall Study|Lost to Follow-up|5
4945161|NCT00349622|17010912|P2|Overall Study|Death|86
4945162|NCT00349622|17010913|P1|Overall Study|Death|168
4945163|NCT00349349|17010952|P3|Overall Study|New Malignancy (Bladder Cancer)|0
4945164|NCT00349349|17010953|P2|Overall Study|New Malignancy (Bladder Cancer)|1
4945165|NCT00349349|17010954|P1|Overall Study|New Malignancy (Bladder Cancer)|0
4945166|NCT00349349|17010952|P3|Overall Study|No Response|0
4945167|NCT00349349|17010953|P2|Overall Study|No Response|3
4945168|NCT00349349|17010954|P1|Overall Study|No Response|0
4945169|NCT00349349|17010952|P3|Overall Study|Physician Decision|1
4945170|NCT00349349|17010953|P2|Overall Study|Physician Decision|2
4945171|NCT00349349|17010954|P1|Overall Study|Physician Decision|1
4945172|NCT00349349|17010952|P3|Overall Study|Participant Reduced General Condition|0
4945173|NCT00349349|17010953|P2|Overall Study|Participant Reduced General Condition|1
4945174|NCT00349349|17010954|P1|Overall Study|Participant Reduced General Condition|0
4945175|NCT00349349|17010952|P3|Overall Study|Other Treatment Selected|0
4945176|NCT00349349|17010953|P2|Overall Study|Other Treatment Selected|0
4945177|NCT00349349|17010954|P1|Overall Study|Other Treatment Selected|2
4945178|NCT00349349|17010952|P3|Overall Study|Death|1
4945179|NCT00349349|17010953|P2|Overall Study|Death|10
4945180|NCT00349349|17010954|P1|Overall Study|Death|13
4945181|NCT00349349|17010952|P3|Overall Study|Withdrawn due to Disease Progression|1
4945182|NCT00349349|17010953|P2|Overall Study|Withdrawn due to Disease Progression|37
4945183|NCT00349349|17010954|P1|Overall Study|Withdrawn due to Disease Progression|27
4945184|NCT00349349|17010952|P3|Overall Study|Withdrawal by Subject|1
4945185|NCT00349349|17010953|P2|Overall Study|Withdrawal by Subject|2
4945186|NCT00349349|17010954|P1|Overall Study|Withdrawal by Subject|5
4945187|NCT00349349|17010952|P3|Overall Study|Adverse Event|2
4945188|NCT00349349|17010953|P2|Overall Study|Adverse Event|6
4945189|NCT00349349|17010954|P1|Overall Study|Adverse Event|5
4945190|NCT00348933|17011043|P1|Overall Study|Adverse Event|7
4945191|NCT00348933|17011043|P1|Overall Study|Protocol Violation|2
4945192|NCT00348933|17011043|P1|Overall Study|Lost to Follow-up|6
4945193|NCT00348933|17011043|P1|Overall Study|Withdrawal by Subject|10
4945194|NCT00348881|17011051|P2|Overall Study|Serious Adverse Event|2
4945195|NCT00348881|17011052|P1|Overall Study|Serious Adverse Event|0
4945196|NCT00348881|17011051|P2|Overall Study|Adverse Event|0
4945197|NCT00348881|17011052|P1|Overall Study|Adverse Event|2
4945198|NCT00348881|17011051|P2|Overall Study|Withdrawal by Subject|4
4945199|NCT00348881|17011052|P1|Overall Study|Withdrawal by Subject|3
4945200|NCT00348881|17011051|P2|Overall Study|Lost to Follow-up|6
4945201|NCT00348881|17011052|P1|Overall Study|Lost to Follow-up|12
4945202|NCT00348816|17011064|P1|Overall Study|Noncompliance with radiation treatment|1
4945203|NCT00348790|17011071|P1|Completed Treatment|Unable to travel to study site|1
4945204|NCT00348790|17011071|P1|Completed Treatment|Required surgery|2
4945205|NCT00348790|17011071|P1|Completed Treatment|Adverse Event|4
4945206|NCT00348790|17011071|P1|Completed Treatment|Disease progression|14
4945207|NCT00348790|17011071|P1|Completed Treatment|Withdrawal by Subject|4
4945208|NCT00348686|17011083|P1|Overall Study|Multiple Reasons|8
4945209|NCT00348686|17011083|P1|Overall Study|Lost to Follow-up|2
4945210|NCT00348686|17011083|P1|Overall Study|Protocol Violation|6
4945211|NCT00348686|17011083|P1|Overall Study|Adverse Event|5
4945212|NCT00348686|17011083|P1|Overall Study|Withdrawal by Subject|45
4945213|NCT00348673|17011100|P9|Stage 1|Randomized but not Treated|0
4945214|NCT00348673|17011101|P8|Stage 1|Randomized but not Treated|0
4945215|NCT00348673|17011102|P7|Stage 1|Randomized but not Treated|0
4945216|NCT00348673|17011103|P6|Stage 1|Randomized but not Treated|0
4945217|NCT00348673|17011104|P5|Stage 1|Randomized but not Treated|0
4945218|NCT00348673|17011105|P4|Stage 1|Randomized but not Treated|0
4945219|NCT00348673|17011106|P3|Stage 1|Randomized but not Treated|1
4945220|NCT00348673|17011107|P2|Stage 1|Randomized but not Treated|0
4945221|NCT00348673|17011108|P1|Stage 1|Randomized but not Treated|0
4945222|NCT00348595|17011157|P2|Overall Study|Adverse Event|8
4945223|NCT00348595|17011158|P1|Overall Study|Adverse Event|5
4945224|NCT00348556|17011170|P1|Overall Study|Adverse Event|1
4945225|NCT00348374|17011177|P2|Overall Study|randomized but did not receive treatment|7
4945226|NCT00348374|17011178|P1|Overall Study|randomized but did not receive treatment|0
4945227|NCT00348374|17011177|P2|Overall Study|ongoing at date of cutoff|1
4945228|NCT00348374|17011178|P1|Overall Study|ongoing at date of cutoff|1
4945229|NCT00348374|17011177|P2|Overall Study|Other|12
4945230|NCT00348374|17011178|P1|Overall Study|Other|11
4945231|NCT00348374|17011177|P2|Overall Study|Withdrawal by Subject|5
4945232|NCT00348374|17011178|P1|Overall Study|Withdrawal by Subject|5
4945233|NCT00348374|17011177|P2|Overall Study|Lost to Follow-up|3
4945234|NCT00348374|17011178|P1|Overall Study|Lost to Follow-up|1
4945235|NCT00348374|17011177|P2|Overall Study|Adverse Event|4
4945236|NCT00348374|17011178|P1|Overall Study|Adverse Event|1
4945237|NCT00348348|17011225|P2|Overall Study|Adverse event probably related to study|0
4945238|NCT00348348|17011226|P1|Overall Study|Adverse event probably related to study|1
4945239|NCT00348348|17011225|P2|Overall Study|Worsening of BC - Unlikely related|2
4945240|NCT00348348|17011226|P1|Overall Study|Worsening of BC - Unlikely related|1
4945241|NCT00348348|17011225|P2|Overall Study|Worsening of BC - Unrelated to study|3
4945242|NCT00348348|17011226|P1|Overall Study|Worsening of BC - Unrelated to study|0
4945243|NCT00348348|17011225|P2|Overall Study|Dissallowed Meds - possibly releated|1
4945244|NCT00348348|17011226|P1|Overall Study|Dissallowed Meds - possibly releated|1
4945245|NCT00348348|17011225|P2|Overall Study|Dissallowed Meds - unlikley related|1
4945246|NCT00348348|17011226|P1|Overall Study|Dissallowed Meds - unlikley related|1
4945247|NCT00348348|17011225|P2|Overall Study|Dissallowed Meds - unrelated to study|3
4945248|NCT00348348|17011226|P1|Overall Study|Dissallowed Meds - unrelated to study|1
4945249|NCT00348348|17011225|P2|Overall Study|Other|4
4945250|NCT00348348|17011226|P1|Overall Study|Other|7
4945251|NCT00348348|17011225|P2|Overall Study|Withdrawal by Subject|1
4945252|NCT00348348|17011226|P1|Overall Study|Withdrawal by Subject|4
4945253|NCT00348348|17011225|P2|Overall Study|Lost to Follow-up|10
4945254|NCT00348348|17011226|P1|Overall Study|Lost to Follow-up|8
4945255|NCT00348348|17011225|P2|Overall Study|Lack of Efficacy|1
4945256|NCT00348348|17011226|P1|Overall Study|Lack of Efficacy|1
4945257|NCT00348348|17011225|P2|Overall Study|Adverse event - unrelated to study drug|1
4945258|NCT00348348|17011226|P1|Overall Study|Adverse event - unrelated to study drug|0
4945259|NCT00348309|17011241|P3|Overall Study|HCV career|1
4945260|NCT00348309|17011242|P2|Overall Study|HCV career|0
4945261|NCT00348309|17011243|P1|Overall Study|HCV career|0
4945262|NCT00348309|17011241|P3|Overall Study|Cardiologist recommendations|1
4945263|NCT00348309|17011242|P2|Overall Study|Cardiologist recommendations|0
4945264|NCT00348309|17011243|P1|Overall Study|Cardiologist recommendations|0
4945265|NCT00348309|17011241|P3|Overall Study|ECG abnormal|2
4945266|NCT00348309|17011242|P2|Overall Study|ECG abnormal|0
4945267|NCT00348309|17011243|P1|Overall Study|ECG abnormal|0
4945268|NCT00348309|17011241|P3|Overall Study|Adverse event not attended|1
4945269|NCT00348309|17011242|P2|Overall Study|Adverse event not attended|0
4945270|NCT00348309|17011243|P1|Overall Study|Adverse event not attended|0
4945271|NCT00348309|17011241|P3|Overall Study|Site closure|1
4945272|NCT00348309|17011242|P2|Overall Study|Site closure|0
4945273|NCT00348309|17011243|P1|Overall Study|Site closure|0
4945274|NCT00348309|17011241|P3|Overall Study|Increased dose of Aricept|1
4945275|NCT00348309|17011242|P2|Overall Study|Increased dose of Aricept|0
4945276|NCT00348309|17011243|P1|Overall Study|Increased dose of Aricept|0
4945277|NCT00348309|17011241|P3|Overall Study|Medical Monitor decision|1
4945278|NCT00348309|17011242|P2|Overall Study|Medical Monitor decision|0
4945279|NCT00348309|17011243|P1|Overall Study|Medical Monitor decision|0
4945280|NCT00348309|17011241|P3|Overall Study|Forgot often medication|0
4945281|NCT00348309|17011242|P2|Overall Study|Forgot often medication|1
4945282|NCT00348309|17011243|P1|Overall Study|Forgot often medication|0
4945283|NCT00348309|17011241|P3|Overall Study|Sponsor refuseal|1
4945284|NCT00348309|17011242|P2|Overall Study|Sponsor refuseal|1
4945285|NCT00348309|17011243|P1|Overall Study|Sponsor refuseal|0
4945286|NCT00348309|17011241|P3|Overall Study|Participant was hospitalized|0
4945287|NCT00348309|17011242|P2|Overall Study|Participant was hospitalized|1
4945288|NCT00348309|17011243|P1|Overall Study|Participant was hospitalized|0
4945289|NCT00348309|17011241|P3|Overall Study|A foul of exclusion criteria|0
4945290|NCT00348309|17011242|P2|Overall Study|A foul of exclusion criteria|1
4945291|NCT00348309|17011243|P1|Overall Study|A foul of exclusion criteria|0
4945292|NCT00348309|17011241|P3|Overall Study|Ineffectiveness of treatment|0
4945293|NCT00348309|17011242|P2|Overall Study|Ineffectiveness of treatment|1
4945294|NCT00348309|17011243|P1|Overall Study|Ineffectiveness of treatment|0
4945295|NCT00348309|17011241|P3|Overall Study|Decision of sponsor|0
4945296|NCT00348309|17011242|P2|Overall Study|Decision of sponsor|0
4945297|NCT00348309|17011243|P1|Overall Study|Decision of sponsor|1
4945298|NCT00348309|17011241|P3|Overall Study|Participant died|1
4945299|NCT00348309|17011242|P2|Overall Study|Participant died|1
4945300|NCT00348309|17011243|P1|Overall Study|Participant died|2
4945301|NCT00348309|17011241|P3|Overall Study|Did not appear in time for Visit 3|0
4945302|NCT00348309|17011242|P2|Overall Study|Did not appear in time for Visit 3|0
4945303|NCT00348309|17011243|P1|Overall Study|Did not appear in time for Visit 3|1
4945304|NCT00348309|17011241|P3|Overall Study|Worsening of alzheimer|1
4945305|NCT00348309|17011242|P2|Overall Study|Worsening of alzheimer|0
4945306|NCT00348309|17011243|P1|Overall Study|Worsening of alzheimer|1
4945307|NCT00348309|17011241|P3|Overall Study|Cognitive and behaviour worsening|0
4945308|NCT00348309|17011242|P2|Overall Study|Cognitive and behaviour worsening|0
4945309|NCT00348309|17011243|P1|Overall Study|Cognitive and behaviour worsening|2
4945310|NCT00348309|17011241|P3|Overall Study|Worsened neurodegenerative disease|0
4945311|NCT00348309|17011242|P2|Overall Study|Worsened neurodegenerative disease|0
4945312|NCT00348309|17011243|P1|Overall Study|Worsened neurodegenerative disease|1
4945313|NCT00348309|17011241|P3|Overall Study|No disponibility of medication|0
4945314|NCT00348309|17011242|P2|Overall Study|No disponibility of medication|0
4945315|NCT00348309|17011243|P1|Overall Study|No disponibility of medication|1
4945316|NCT00348309|17011241|P3|Overall Study|Principal investigator's decision|0
4945317|NCT00348309|17011242|P2|Overall Study|Principal investigator's decision|0
4945318|NCT00348309|17011243|P1|Overall Study|Principal investigator's decision|1
4945319|NCT00348309|17011241|P3|Overall Study|PI closing medical practice|0
4945320|NCT00348309|17011242|P2|Overall Study|PI closing medical practice|0
4945321|NCT00348309|17011243|P1|Overall Study|PI closing medical practice|1
4945322|NCT00348309|17011241|P3|Overall Study|Unable to complete ET visit|0
4945323|NCT00348309|17011242|P2|Overall Study|Unable to complete ET visit|0
4945324|NCT00348309|17011243|P1|Overall Study|Unable to complete ET visit|1
4945325|NCT00348309|17011241|P3|Overall Study|Caregiver withdrawal|7
4945326|NCT00348309|17011242|P2|Overall Study|Caregiver withdrawal|0
4945327|NCT00348309|17011243|P1|Overall Study|Caregiver withdrawal|3
4945328|NCT00348309|17011241|P3|Overall Study|Use of prohibited medication|2
4945329|NCT00348309|17011242|P2|Overall Study|Use of prohibited medication|2
4945330|NCT00348309|17011243|P1|Overall Study|Use of prohibited medication|5
4945331|NCT00348309|17011241|P3|Overall Study|Caregiver sick|0
4945332|NCT00348309|17011242|P2|Overall Study|Caregiver sick|0
4945333|NCT00348309|17011243|P1|Overall Study|Caregiver sick|1
4945334|NCT00348309|17011241|P3|Overall Study|Wrong bottle allocated|0
4945335|NCT00348309|17011242|P2|Overall Study|Wrong bottle allocated|0
4945336|NCT00348309|17011243|P1|Overall Study|Wrong bottle allocated|1
4945337|NCT00348309|17011241|P3|Overall Study|Lack of insight, dementia|0
4945338|NCT00348309|17011242|P2|Overall Study|Lack of insight, dementia|0
4945339|NCT00348309|17011243|P1|Overall Study|Lack of insight, dementia|1
4945340|NCT00348309|17011241|P3|Overall Study|Death of caregiver|1
4945341|NCT00348309|17011242|P2|Overall Study|Death of caregiver|0
4945342|NCT00348309|17011243|P1|Overall Study|Death of caregiver|1
4945343|NCT00348309|17011241|P3|Overall Study|Non-compliance|8
4945344|NCT00348309|17011242|P2|Overall Study|Non-compliance|6
4945345|NCT00348309|17011243|P1|Overall Study|Non-compliance|8
4945346|NCT00348309|17011241|P3|Overall Study|Withdrawal by Subject|40
4945347|NCT00348309|17011242|P2|Overall Study|Withdrawal by Subject|37
4945348|NCT00348309|17011243|P1|Overall Study|Withdrawal by Subject|33
4945349|NCT00348309|17011241|P3|Overall Study|Protocol Violation|7
4945350|NCT00348309|17011242|P2|Overall Study|Protocol Violation|12
4945351|NCT00348309|17011243|P1|Overall Study|Protocol Violation|7
4945352|NCT00348309|17011241|P3|Overall Study|Lost to Follow-up|4
4945353|NCT00348309|17011242|P2|Overall Study|Lost to Follow-up|7
4945354|NCT00348309|17011243|P1|Overall Study|Lost to Follow-up|6
4945355|NCT00348309|17011241|P3|Overall Study|Adverse Event|63
4945356|NCT00348309|17011242|P2|Overall Study|Adverse Event|28
4945357|NCT00348309|17011243|P1|Overall Study|Adverse Event|56
4945358|NCT00348283|17011316|P2|Open Label|Sponsor decision|1
4945359|NCT00348283|17011317|P1|Open Label|Sponsor decision|0
4945360|NCT00348283|17011316|P2|Open Label|Pregnancy|1
4945361|NCT00348283|17011317|P1|Open Label|Pregnancy|0
4945362|NCT00348283|17011316|P2|Open Label|Subject moved to the United States|1
4945363|NCT00348283|17011317|P1|Open Label|Subject moved to the United States|0
4945364|NCT00348283|17011316|P2|Open Label|Administrative reasons|5
4945365|NCT00348283|17011317|P1|Open Label|Administrative reasons|0
4945366|NCT00348283|17011316|P2|Open Label|Lack of Efficacy|13
4945367|NCT00348283|17011317|P1|Open Label|Lack of Efficacy|0
4945368|NCT00348283|17011316|P2|Open Label|Lost to Follow-up|1
4945369|NCT00348283|17011317|P1|Open Label|Lost to Follow-up|0
4945370|NCT00348283|17011316|P2|Open Label|Withdrawal by Subject|4
4945371|NCT00348283|17011317|P1|Open Label|Withdrawal by Subject|0
4945372|NCT00348283|17011316|P2|Open Label|Adverse Event|8
4945373|NCT00348283|17011317|P1|Open Label|Adverse Event|0
4945374|NCT00348283|17011316|P2|Double Blind|Pregnancy|1
4945375|NCT00348283|17011317|P1|Double Blind|Pregnancy|0
4945376|NCT00348283|17011316|P2|Double Blind|Lack of Efficacy|2
4945377|NCT00348283|17011317|P1|Double Blind|Lack of Efficacy|2
4945378|NCT00348283|17011316|P2|Double Blind|Protocol Violation|1
4945379|NCT00348283|17011317|P1|Double Blind|Protocol Violation|0
4945380|NCT00348283|17011316|P2|Double Blind|Withdrawal by Subject|1
4945381|NCT00348283|17011317|P1|Double Blind|Withdrawal by Subject|1
4945382|NCT00348283|17011316|P2|Double Blind|Adverse Event|5
4945383|NCT00348283|17011317|P1|Double Blind|Adverse Event|2
4945384|NCT00348283|17011316|P2|Induction|Protocol Violation|4
4945385|NCT00348283|17011317|P1|Induction|Protocol Violation|0
4945386|NCT00348283|17011316|P2|Induction|Adverse Event|2
4945387|NCT00348283|17011317|P1|Induction|Adverse Event|0
4945388|NCT00348140|17011346|P3|Overall Study|Memory declined|1
4945389|NCT00348140|17011347|P2|Overall Study|Memory declined|0
4945390|NCT00348140|17011348|P1|Overall Study|Memory declined|0
4945391|NCT00348140|17011346|P3|Overall Study|Exclusion criteria met|1
4945392|NCT00348140|17011347|P2|Overall Study|Exclusion criteria met|0
4945393|NCT00348140|17011348|P1|Overall Study|Exclusion criteria met|0
4945394|NCT00348140|17011346|P3|Overall Study|Participant died|0
4945395|NCT00348140|17011347|P2|Overall Study|Participant died|1
4945396|NCT00348140|17011348|P1|Overall Study|Participant died|0
4945397|NCT00348140|17011346|P3|Overall Study|Abnormal ECG|3
4945398|NCT00348140|17011347|P2|Overall Study|Abnormal ECG|1
4945399|NCT00348140|17011348|P1|Overall Study|Abnormal ECG|0
4945400|NCT00348140|17011346|P3|Overall Study|Serious adverse event|0
4945401|NCT00348140|17011347|P2|Overall Study|Serious adverse event|1
4945402|NCT00348140|17011348|P1|Overall Study|Serious adverse event|0
4945403|NCT00348140|17011346|P3|Overall Study|Increased risk of cardiac infarction|0
4945404|NCT00348140|17011347|P2|Overall Study|Increased risk of cardiac infarction|1
4945405|NCT00348140|17011348|P1|Overall Study|Increased risk of cardiac infarction|0
4945406|NCT00348140|17011346|P3|Overall Study|Disease progression|5
4945407|NCT00348140|17011347|P2|Overall Study|Disease progression|2
4945408|NCT00348140|17011348|P1|Overall Study|Disease progression|1
4945409|NCT00348140|17011346|P3|Overall Study|Use of prohibited drug|2
4945410|NCT00348140|17011347|P2|Overall Study|Use of prohibited drug|0
4945411|NCT00348140|17011348|P1|Overall Study|Use of prohibited drug|1
4945412|NCT00348140|17011346|P3|Overall Study|Decided to discontinue on their own|1
4945413|NCT00348140|17011347|P2|Overall Study|Decided to discontinue on their own|4
4945414|NCT00348140|17011348|P1|Overall Study|Decided to discontinue on their own|1
4945415|NCT00348140|17011346|P3|Overall Study|Investigator decided to discontinue|4
4945416|NCT00348140|17011347|P2|Overall Study|Investigator decided to discontinue|1
4945417|NCT00348140|17011348|P1|Overall Study|Investigator decided to discontinue|4
4945418|NCT00348140|17011346|P3|Overall Study|Screen failure|0
4945419|NCT00348140|17011347|P2|Overall Study|Screen failure|0
4945420|NCT00348140|17011348|P1|Overall Study|Screen failure|1
4945421|NCT00348140|17011346|P3|Overall Study|Participant unwell|0
4945422|NCT00348140|17011347|P2|Overall Study|Participant unwell|0
4945423|NCT00348140|17011348|P1|Overall Study|Participant unwell|1
4945424|NCT00348140|17011346|P3|Overall Study|Unmet inclusion-exclusion criteria|1
4945425|NCT00348140|17011347|P2|Overall Study|Unmet inclusion-exclusion criteria|0
4945426|NCT00348140|17011348|P1|Overall Study|Unmet inclusion-exclusion criteria|1
4945427|NCT00348140|17011346|P3|Overall Study|Administration related|1
4945428|NCT00348140|17011347|P2|Overall Study|Administration related|1
4945429|NCT00348140|17011348|P1|Overall Study|Administration related|3
4945430|NCT00348140|17011346|P3|Overall Study|Efficacy related|0
4945431|NCT00348140|17011347|P2|Overall Study|Efficacy related|1
4945432|NCT00348140|17011348|P1|Overall Study|Efficacy related|1
4945433|NCT00348140|17011346|P3|Overall Study|Participant hospitalised|0
4945434|NCT00348140|17011347|P2|Overall Study|Participant hospitalised|0
4945435|NCT00348140|17011348|P1|Overall Study|Participant hospitalised|3
4945436|NCT00348140|17011346|P3|Overall Study|Caregiver related|3
4945437|NCT00348140|17011347|P2|Overall Study|Caregiver related|7
4945438|NCT00348140|17011348|P1|Overall Study|Caregiver related|4
4945439|NCT00348140|17011346|P3|Overall Study|Conditional medication increased dose|0
4945440|NCT00348140|17011347|P2|Overall Study|Conditional medication increased dose|0
4945441|NCT00348140|17011348|P1|Overall Study|Conditional medication increased dose|1
4945442|NCT00348140|17011346|P3|Overall Study|Participant at risk due to study drug|0
4945443|NCT00348140|17011347|P2|Overall Study|Participant at risk due to study drug|0
4945444|NCT00348140|17011348|P1|Overall Study|Participant at risk due to study drug|2
4945445|NCT00348140|17011346|P3|Overall Study|Non-compliance|5
4945446|NCT00348140|17011347|P2|Overall Study|Non-compliance|13
4945447|NCT00348140|17011348|P1|Overall Study|Non-compliance|8
4945448|NCT00348140|17011346|P3|Overall Study|Withdrawal by Subject|40
4945449|NCT00348140|17011347|P2|Overall Study|Withdrawal by Subject|40
4945450|NCT00348140|17011348|P1|Overall Study|Withdrawal by Subject|32
4945451|NCT00348140|17011346|P3|Overall Study|Protocol Violation|14
4945452|NCT00348140|17011347|P2|Overall Study|Protocol Violation|13
4945453|NCT00348140|17011348|P1|Overall Study|Protocol Violation|12
4945454|NCT00348140|17011346|P3|Overall Study|Lost to Follow-up|4
4945455|NCT00348140|17011347|P2|Overall Study|Lost to Follow-up|4
4945456|NCT00348140|17011348|P1|Overall Study|Lost to Follow-up|4
4945457|NCT00348140|17011346|P3|Overall Study|Adverse Event|78
4945458|NCT00348140|17011347|P2|Overall Study|Adverse Event|49
4945459|NCT00348140|17011348|P1|Overall Study|Adverse Event|46
4945460|NCT00347958|17011446|P1|Overall Study|Withdrawal by Subject|1
4945461|NCT00347958|17011446|P1|Overall Study|Protocol Violation|2
4945462|NCT00347958|17011446|P1|Overall Study|Adverse Event|1
4945463|NCT00347932|17011455|P2|Overall Study|Did not meet inclusion criteria|8
4945464|NCT00347932|17011456|P1|Overall Study|Did not meet inclusion criteria|4
4945465|NCT00347932|17011455|P2|Overall Study|Withdrawal by Subject|16
4945466|NCT00347932|17011456|P1|Overall Study|Withdrawal by Subject|10
4945467|NCT00347932|17011455|P2|Overall Study|Lost to Follow-up|9
4945468|NCT00347932|17011456|P1|Overall Study|Lost to Follow-up|10
4945469|NCT00347932|17011455|P2|Overall Study|Lack of Efficacy|14
4945470|NCT00347932|17011456|P1|Overall Study|Lack of Efficacy|3
4945471|NCT00347932|17011455|P2|Overall Study|Adverse Event|5
4945472|NCT00347932|17011456|P1|Overall Study|Adverse Event|4
4945473|NCT00347919|17011471|P3|Overall Study|Missing|2
4945474|NCT00347919|17011472|P2|Overall Study|Missing|1
4945475|NCT00347919|17011473|P1|Overall Study|Missing|2
4945476|NCT00347919|17011471|P3|Overall Study|Par. Started Other Treatment|1
4945477|NCT00347919|17011472|P2|Overall Study|Par. Started Other Treatment|1
4945478|NCT00347919|17011473|P1|Overall Study|Par. Started Other Treatment|1
4945479|NCT00347919|17011471|P3|Overall Study|Death|19
4945480|NCT00347919|17011472|P2|Overall Study|Death|42
4945481|NCT00347919|17011473|P1|Overall Study|Death|35
4945482|NCT00347919|17011471|P3|Overall Study|Sponsor terminated study|16
4945483|NCT00347919|17011472|P2|Overall Study|Sponsor terminated study|10
4945484|NCT00347919|17011473|P1|Overall Study|Sponsor terminated study|15
4945485|NCT00347919|17011471|P3|Overall Study|Physician Decision|0
4945486|NCT00347919|17011472|P2|Overall Study|Physician Decision|1
4945487|NCT00347919|17011473|P1|Overall Study|Physician Decision|1
4945488|NCT00347919|17011471|P3|Overall Study|Withdrawal by Subject|0
4945489|NCT00347919|17011472|P2|Overall Study|Withdrawal by Subject|8
4945490|NCT00347919|17011473|P1|Overall Study|Withdrawal by Subject|6
4945491|NCT00347919|17011471|P3|Overall Study|Lost to Follow-up|0
4945492|NCT00347919|17011472|P2|Overall Study|Lost to Follow-up|13
4945493|NCT00347919|17011473|P1|Overall Study|Lost to Follow-up|11
4945494|NCT00347776|17011496|P3|12 Month Follow-up|Reached endpoint|9
4945495|NCT00347776|17011497|P2|12 Month Follow-up|Reached endpoint|6
4945496|NCT00347776|17011498|P1|12 Month Follow-up|Reached endpoint|13
4945497|NCT00347776|17011496|P3|12 Month Follow-up|Death|4
4945498|NCT00347776|17011497|P2|12 Month Follow-up|Death|4
4945499|NCT00347776|17011498|P1|12 Month Follow-up|Death|3
4945500|NCT00347776|17011496|P3|12 Month Follow-up|Lost to Follow-up|6
4945501|NCT00347776|17011497|P2|12 Month Follow-up|Lost to Follow-up|6
4945502|NCT00347776|17011498|P1|12 Month Follow-up|Lost to Follow-up|7
4945503|NCT00347776|17011496|P3|6 Month Follow-up|reached endpont|15
4945504|NCT00347776|17011497|P2|6 Month Follow-up|reached endpont|12
4945505|NCT00347776|17011498|P1|6 Month Follow-up|reached endpont|20
4945506|NCT00347776|17011496|P3|6 Month Follow-up|Death|3
4945507|NCT00347776|17011497|P2|6 Month Follow-up|Death|1
4945508|NCT00347776|17011498|P1|6 Month Follow-up|Death|2
4945509|NCT00347776|17011496|P3|1.5 Month Follow-up|reached the endpoint|12
4945510|NCT00347776|17011497|P2|1.5 Month Follow-up|reached the endpoint|8
4945511|NCT00347776|17011498|P1|1.5 Month Follow-up|reached the endpoint|12
4945512|NCT00347776|17011496|P3|1.5 Month Follow-up|Death|0
4945513|NCT00347776|17011497|P2|1.5 Month Follow-up|Death|0
4945514|NCT00347776|17011498|P1|1.5 Month Follow-up|Death|2
4945515|NCT00347438|17011510|P1|Overall Study|Physician Decision|1
4945516|NCT00347438|17011510|P1|Overall Study|Withdrawal by Subject|1
4945517|NCT00347360|17011532|P15|Overall Study|Visits conflicted with new job|0
4945518|NCT00347360|17011533|P14|Overall Study|Visits conflicted with new job|0
4945519|NCT00347360|17011534|P13|Overall Study|Visits conflicted with new job|0
4945520|NCT00347360|17011535|P12|Overall Study|Visits conflicted with new job|0
4945521|NCT00347360|17011536|P11|Overall Study|Visits conflicted with new job|0
4945522|NCT00347360|17011537|P10|Overall Study|Visits conflicted with new job|0
4945523|NCT00347360|17011538|P9|Overall Study|Visits conflicted with new job|0
4945524|NCT00347360|17011539|P8|Overall Study|Visits conflicted with new job|0
4945525|NCT00347360|17011540|P7|Overall Study|Visits conflicted with new job|1
4945526|NCT00347360|17011541|P6|Overall Study|Visits conflicted with new job|0
4945527|NCT00347360|17011542|P5|Overall Study|Visits conflicted with new job|0
4945528|NCT00347360|17011543|P4|Overall Study|Visits conflicted with new job|0
4945529|NCT00347360|17011544|P3|Overall Study|Visits conflicted with new job|0
4945530|NCT00347360|17011545|P2|Overall Study|Visits conflicted with new job|0
4945531|NCT00347360|17011546|P1|Overall Study|Visits conflicted with new job|0
4945532|NCT00347360|17011532|P15|Overall Study|Subject refuse to sign updated consent|1
4945533|NCT00347360|17011533|P14|Overall Study|Subject refuse to sign updated consent|0
4945534|NCT00347360|17011534|P13|Overall Study|Subject refuse to sign updated consent|0
4945535|NCT00347360|17011535|P12|Overall Study|Subject refuse to sign updated consent|0
4945536|NCT00347360|17011536|P11|Overall Study|Subject refuse to sign updated consent|0
4945537|NCT00347360|17011537|P10|Overall Study|Subject refuse to sign updated consent|0
4945538|NCT00347360|17011538|P9|Overall Study|Subject refuse to sign updated consent|0
4945539|NCT00347360|17011539|P8|Overall Study|Subject refuse to sign updated consent|0
4945540|NCT00347360|17011540|P7|Overall Study|Subject refuse to sign updated consent|0
4945541|NCT00347360|17011541|P6|Overall Study|Subject refuse to sign updated consent|0
4945542|NCT00347360|17011542|P5|Overall Study|Subject refuse to sign updated consent|0
4945543|NCT00347360|17011543|P4|Overall Study|Subject refuse to sign updated consent|0
4945544|NCT00347360|17011544|P3|Overall Study|Subject refuse to sign updated consent|0
4945545|NCT00347360|17011545|P2|Overall Study|Subject refuse to sign updated consent|0
4945546|NCT00347360|17011546|P1|Overall Study|Subject refuse to sign updated consent|0
4945547|NCT00347360|17011532|P15|Overall Study|Subject left town, ran out of study drug|0
4945548|NCT00347360|17011533|P14|Overall Study|Subject left town, ran out of study drug|1
4945549|NCT00347360|17011534|P13|Overall Study|Subject left town, ran out of study drug|0
4945550|NCT00347360|17011535|P12|Overall Study|Subject left town, ran out of study drug|0
4945551|NCT00347360|17011536|P11|Overall Study|Subject left town, ran out of study drug|0
4945552|NCT00347360|17011537|P10|Overall Study|Subject left town, ran out of study drug|0
4945553|NCT00347360|17011538|P9|Overall Study|Subject left town, ran out of study drug|0
4945554|NCT00347360|17011539|P8|Overall Study|Subject left town, ran out of study drug|0
4945555|NCT00347360|17011540|P7|Overall Study|Subject left town, ran out of study drug|0
4945556|NCT00347360|17011541|P6|Overall Study|Subject left town, ran out of study drug|0
4945557|NCT00347360|17011542|P5|Overall Study|Subject left town, ran out of study drug|0
4945558|NCT00347360|17011543|P4|Overall Study|Subject left town, ran out of study drug|0
4945559|NCT00347360|17011544|P3|Overall Study|Subject left town, ran out of study drug|0
4945560|NCT00347360|17011545|P2|Overall Study|Subject left town, ran out of study drug|0
4945561|NCT00347360|17011546|P1|Overall Study|Subject left town, ran out of study drug|0
4945562|NCT00347360|17011532|P15|Overall Study|Prolonged duration between visits|0
4945563|NCT00347360|17011533|P14|Overall Study|Prolonged duration between visits|0
4945564|NCT00347360|17011534|P13|Overall Study|Prolonged duration between visits|1
4945565|NCT00347360|17011535|P12|Overall Study|Prolonged duration between visits|0
4945566|NCT00347360|17011536|P11|Overall Study|Prolonged duration between visits|0
4945567|NCT00347360|17011537|P10|Overall Study|Prolonged duration between visits|0
4945568|NCT00347360|17011538|P9|Overall Study|Prolonged duration between visits|0
4945569|NCT00347360|17011539|P8|Overall Study|Prolonged duration between visits|0
4945570|NCT00347360|17011540|P7|Overall Study|Prolonged duration between visits|0
4945571|NCT00347360|17011541|P6|Overall Study|Prolonged duration between visits|0
4945572|NCT00347360|17011542|P5|Overall Study|Prolonged duration between visits|0
4945573|NCT00347360|17011543|P4|Overall Study|Prolonged duration between visits|0
4945574|NCT00347360|17011544|P3|Overall Study|Prolonged duration between visits|0
4945575|NCT00347360|17011545|P2|Overall Study|Prolonged duration between visits|0
4945576|NCT00347360|17011546|P1|Overall Study|Prolonged duration between visits|0
4945577|NCT00347360|17011532|P15|Overall Study|Failed inclusion criteria #4|0
4945578|NCT00347360|17011533|P14|Overall Study|Failed inclusion criteria #4|0
4945579|NCT00347360|17011534|P13|Overall Study|Failed inclusion criteria #4|0
4945580|NCT00347360|17011535|P12|Overall Study|Failed inclusion criteria #4|1
4945581|NCT00347360|17011536|P11|Overall Study|Failed inclusion criteria #4|0
4945582|NCT00347360|17011537|P10|Overall Study|Failed inclusion criteria #4|0
4945583|NCT00347360|17011538|P9|Overall Study|Failed inclusion criteria #4|0
4945584|NCT00347360|17011539|P8|Overall Study|Failed inclusion criteria #4|0
4945585|NCT00347360|17011540|P7|Overall Study|Failed inclusion criteria #4|0
4945586|NCT00347360|17011541|P6|Overall Study|Failed inclusion criteria #4|0
4945587|NCT00347360|17011542|P5|Overall Study|Failed inclusion criteria #4|0
4945588|NCT00347360|17011543|P4|Overall Study|Failed inclusion criteria #4|0
4945589|NCT00347360|17011544|P3|Overall Study|Failed inclusion criteria #4|0
4945590|NCT00347360|17011545|P2|Overall Study|Failed inclusion criteria #4|0
4945591|NCT00347360|17011546|P1|Overall Study|Failed inclusion criteria #4|0
4945592|NCT00347360|17011532|P15|Overall Study|Randomized in error|0
4945593|NCT00347360|17011533|P14|Overall Study|Randomized in error|0
4945594|NCT00347360|17011534|P13|Overall Study|Randomized in error|0
4945595|NCT00347360|17011535|P12|Overall Study|Randomized in error|1
4945596|NCT00347360|17011536|P11|Overall Study|Randomized in error|0
4945597|NCT00347360|17011537|P10|Overall Study|Randomized in error|0
4945598|NCT00347360|17011538|P9|Overall Study|Randomized in error|0
4945599|NCT00347360|17011539|P8|Overall Study|Randomized in error|0
4945600|NCT00347360|17011540|P7|Overall Study|Randomized in error|0
4945601|NCT00347360|17011541|P6|Overall Study|Randomized in error|0
4945602|NCT00347360|17011542|P5|Overall Study|Randomized in error|0
4945603|NCT00347360|17011543|P4|Overall Study|Randomized in error|0
4945604|NCT00347360|17011544|P3|Overall Study|Randomized in error|0
4945605|NCT00347360|17011545|P2|Overall Study|Randomized in error|0
4945606|NCT00347360|17011546|P1|Overall Study|Randomized in error|0
4945607|NCT00347360|17011532|P15|Overall Study|Did not meet criteria before ABPM|0
4945608|NCT00347360|17011533|P14|Overall Study|Did not meet criteria before ABPM|0
4945609|NCT00347360|17011534|P13|Overall Study|Did not meet criteria before ABPM|0
4945610|NCT00347360|17011535|P12|Overall Study|Did not meet criteria before ABPM|0
4945611|NCT00347360|17011536|P11|Overall Study|Did not meet criteria before ABPM|1
4945612|NCT00347360|17011537|P10|Overall Study|Did not meet criteria before ABPM|0
4945613|NCT00347360|17011538|P9|Overall Study|Did not meet criteria before ABPM|0
4945614|NCT00347360|17011539|P8|Overall Study|Did not meet criteria before ABPM|0
4945615|NCT00347360|17011540|P7|Overall Study|Did not meet criteria before ABPM|0
4945616|NCT00347360|17011541|P6|Overall Study|Did not meet criteria before ABPM|0
4945617|NCT00347360|17011542|P5|Overall Study|Did not meet criteria before ABPM|0
4945618|NCT00347360|17011543|P4|Overall Study|Did not meet criteria before ABPM|0
4945619|NCT00347360|17011544|P3|Overall Study|Did not meet criteria before ABPM|0
4945620|NCT00347360|17011545|P2|Overall Study|Did not meet criteria before ABPM|0
4945621|NCT00347360|17011546|P1|Overall Study|Did not meet criteria before ABPM|0
4945622|NCT00347360|17011532|P15|Overall Study|PI recommended early withdrawal|0
4945623|NCT00347360|17011533|P14|Overall Study|PI recommended early withdrawal|0
4945624|NCT00347360|17011534|P13|Overall Study|PI recommended early withdrawal|0
4945625|NCT00347360|17011535|P12|Overall Study|PI recommended early withdrawal|0
4945626|NCT00347360|17011536|P11|Overall Study|PI recommended early withdrawal|0
4945627|NCT00347360|17011537|P10|Overall Study|PI recommended early withdrawal|1
4945628|NCT00347360|17011538|P9|Overall Study|PI recommended early withdrawal|0
4945629|NCT00347360|17011539|P8|Overall Study|PI recommended early withdrawal|0
4945630|NCT00347360|17011540|P7|Overall Study|PI recommended early withdrawal|0
4945631|NCT00347360|17011541|P6|Overall Study|PI recommended early withdrawal|0
4945632|NCT00347360|17011542|P5|Overall Study|PI recommended early withdrawal|0
4945633|NCT00347360|17011543|P4|Overall Study|PI recommended early withdrawal|0
4945634|NCT00347360|17011544|P3|Overall Study|PI recommended early withdrawal|0
4945635|NCT00347360|17011545|P2|Overall Study|PI recommended early withdrawal|0
4945636|NCT00347360|17011546|P1|Overall Study|PI recommended early withdrawal|0
4945637|NCT00347360|17011532|P15|Overall Study|Abnormal lab values|0
4945638|NCT00347360|17011533|P14|Overall Study|Abnormal lab values|0
4945639|NCT00347360|17011534|P13|Overall Study|Abnormal lab values|0
4945640|NCT00347360|17011535|P12|Overall Study|Abnormal lab values|0
4945641|NCT00347360|17011536|P11|Overall Study|Abnormal lab values|0
4945642|NCT00347360|17011537|P10|Overall Study|Abnormal lab values|0
4945643|NCT00347360|17011538|P9|Overall Study|Abnormal lab values|0
4945644|NCT00347360|17011539|P8|Overall Study|Abnormal lab values|0
4945645|NCT00347360|17011540|P7|Overall Study|Abnormal lab values|1
4945646|NCT00347360|17011541|P6|Overall Study|Abnormal lab values|0
4945647|NCT00347360|17011542|P5|Overall Study|Abnormal lab values|0
4945648|NCT00347360|17011543|P4|Overall Study|Abnormal lab values|0
4945649|NCT00347360|17011544|P3|Overall Study|Abnormal lab values|0
4945650|NCT00347360|17011545|P2|Overall Study|Abnormal lab values|0
4945651|NCT00347360|17011546|P1|Overall Study|Abnormal lab values|0
4945652|NCT00347360|17011532|P15|Overall Study|Subject did not meet end of study ABPM|0
4945653|NCT00347360|17011533|P14|Overall Study|Subject did not meet end of study ABPM|1
4945654|NCT00347360|17011534|P13|Overall Study|Subject did not meet end of study ABPM|1
4945655|NCT00347360|17011535|P12|Overall Study|Subject did not meet end of study ABPM|0
4945656|NCT00347360|17011536|P11|Overall Study|Subject did not meet end of study ABPM|1
4945657|NCT00347360|17011537|P10|Overall Study|Subject did not meet end of study ABPM|0
4945658|NCT00347360|17011538|P9|Overall Study|Subject did not meet end of study ABPM|0
4945659|NCT00347360|17011539|P8|Overall Study|Subject did not meet end of study ABPM|0
4945660|NCT00347360|17011540|P7|Overall Study|Subject did not meet end of study ABPM|1
4945661|NCT00347360|17011541|P6|Overall Study|Subject did not meet end of study ABPM|0
4945662|NCT00347360|17011542|P5|Overall Study|Subject did not meet end of study ABPM|0
4945663|NCT00347360|17011543|P4|Overall Study|Subject did not meet end of study ABPM|0
4945664|NCT00347360|17011544|P3|Overall Study|Subject did not meet end of study ABPM|0
4945665|NCT00347360|17011545|P2|Overall Study|Subject did not meet end of study ABPM|0
4945666|NCT00347360|17011546|P1|Overall Study|Subject did not meet end of study ABPM|0
4945667|NCT00347360|17011532|P15|Overall Study|P.I. recommended due to blood pressure|0
4945668|NCT00347360|17011533|P14|Overall Study|P.I. recommended due to blood pressure|0
4945669|NCT00347360|17011534|P13|Overall Study|P.I. recommended due to blood pressure|0
4945670|NCT00347360|17011535|P12|Overall Study|P.I. recommended due to blood pressure|0
4945671|NCT00347360|17011536|P11|Overall Study|P.I. recommended due to blood pressure|0
4945672|NCT00347360|17011537|P10|Overall Study|P.I. recommended due to blood pressure|0
4945673|NCT00347360|17011538|P9|Overall Study|P.I. recommended due to blood pressure|0
4945674|NCT00347360|17011539|P8|Overall Study|P.I. recommended due to blood pressure|0
4945675|NCT00347360|17011540|P7|Overall Study|P.I. recommended due to blood pressure|0
4945676|NCT00347360|17011541|P6|Overall Study|P.I. recommended due to blood pressure|0
4945677|NCT00347360|17011542|P5|Overall Study|P.I. recommended due to blood pressure|1
4945678|NCT00347360|17011543|P4|Overall Study|P.I. recommended due to blood pressure|0
4945679|NCT00347360|17011544|P3|Overall Study|P.I. recommended due to blood pressure|0
4945680|NCT00347360|17011545|P2|Overall Study|P.I. recommended due to blood pressure|0
4945681|NCT00347360|17011546|P1|Overall Study|P.I. recommended due to blood pressure|0
4945682|NCT00347360|17011532|P15|Overall Study|Per sponsors instruction|0
4945683|NCT00347360|17011533|P14|Overall Study|Per sponsors instruction|0
4945684|NCT00347360|17011534|P13|Overall Study|Per sponsors instruction|0
4945685|NCT00347360|17011535|P12|Overall Study|Per sponsors instruction|0
4945686|NCT00347360|17011536|P11|Overall Study|Per sponsors instruction|0
4945687|NCT00347360|17011537|P10|Overall Study|Per sponsors instruction|0
4945688|NCT00347360|17011538|P9|Overall Study|Per sponsors instruction|0
4945689|NCT00347360|17011539|P8|Overall Study|Per sponsors instruction|0
4945690|NCT00347360|17011540|P7|Overall Study|Per sponsors instruction|0
4945691|NCT00347360|17011541|P6|Overall Study|Per sponsors instruction|0
4945692|NCT00347360|17011542|P5|Overall Study|Per sponsors instruction|0
4945693|NCT00347360|17011543|P4|Overall Study|Per sponsors instruction|0
4945694|NCT00347360|17011544|P3|Overall Study|Per sponsors instruction|0
4945695|NCT00347360|17011545|P2|Overall Study|Per sponsors instruction|1
4945696|NCT00347360|17011546|P1|Overall Study|Per sponsors instruction|0
4945697|NCT00347360|17011532|P15|Overall Study|Reason not listed/blank|0
4945698|NCT00347360|17011533|P14|Overall Study|Reason not listed/blank|1
4945699|NCT00347360|17011534|P13|Overall Study|Reason not listed/blank|0
4945700|NCT00347360|17011535|P12|Overall Study|Reason not listed/blank|0
4945701|NCT00347360|17011536|P11|Overall Study|Reason not listed/blank|0
4945702|NCT00347360|17011537|P10|Overall Study|Reason not listed/blank|0
4945703|NCT00347360|17011538|P9|Overall Study|Reason not listed/blank|0
4945704|NCT00347360|17011539|P8|Overall Study|Reason not listed/blank|0
4945705|NCT00347360|17011540|P7|Overall Study|Reason not listed/blank|1
4945706|NCT00347360|17011541|P6|Overall Study|Reason not listed/blank|0
4945707|NCT00347360|17011542|P5|Overall Study|Reason not listed/blank|0
4945708|NCT00347360|17011543|P4|Overall Study|Reason not listed/blank|0
4945709|NCT00347360|17011544|P3|Overall Study|Reason not listed/blank|0
4945710|NCT00347360|17011545|P2|Overall Study|Reason not listed/blank|0
4945711|NCT00347360|17011546|P1|Overall Study|Reason not listed/blank|1
4945712|NCT00347360|17011532|P15|Overall Study|Lack of Efficacy|0
4945713|NCT00347360|17011533|P14|Overall Study|Lack of Efficacy|0
4945714|NCT00347360|17011534|P13|Overall Study|Lack of Efficacy|0
4945715|NCT00347360|17011535|P12|Overall Study|Lack of Efficacy|0
4945716|NCT00347360|17011536|P11|Overall Study|Lack of Efficacy|0
4945717|NCT00347360|17011537|P10|Overall Study|Lack of Efficacy|0
4945718|NCT00347360|17011538|P9|Overall Study|Lack of Efficacy|1
4945719|NCT00347360|17011539|P8|Overall Study|Lack of Efficacy|1
4945720|NCT00347360|17011540|P7|Overall Study|Lack of Efficacy|0
4945721|NCT00347360|17011541|P6|Overall Study|Lack of Efficacy|1
4945722|NCT00347360|17011542|P5|Overall Study|Lack of Efficacy|0
4945723|NCT00347360|17011543|P4|Overall Study|Lack of Efficacy|1
4945724|NCT00347360|17011544|P3|Overall Study|Lack of Efficacy|3
4945725|NCT00347360|17011545|P2|Overall Study|Lack of Efficacy|1
4945726|NCT00347360|17011546|P1|Overall Study|Lack of Efficacy|1
4945727|NCT00347360|17011532|P15|Overall Study|Withdrawal by Subject|1
4945728|NCT00347360|17011533|P14|Overall Study|Withdrawal by Subject|2
4945729|NCT00347360|17011534|P13|Overall Study|Withdrawal by Subject|4
4945730|NCT00347360|17011535|P12|Overall Study|Withdrawal by Subject|3
4945731|NCT00347360|17011536|P11|Overall Study|Withdrawal by Subject|0
4945732|NCT00347360|17011537|P10|Overall Study|Withdrawal by Subject|1
4945733|NCT00347360|17011538|P9|Overall Study|Withdrawal by Subject|1
4945734|NCT00347360|17011539|P8|Overall Study|Withdrawal by Subject|1
4945735|NCT00347360|17011540|P7|Overall Study|Withdrawal by Subject|1
4945736|NCT00347360|17011541|P6|Overall Study|Withdrawal by Subject|2
4945737|NCT00347360|17011542|P5|Overall Study|Withdrawal by Subject|1
4945738|NCT00347360|17011543|P4|Overall Study|Withdrawal by Subject|4
4945739|NCT00347360|17011544|P3|Overall Study|Withdrawal by Subject|2
4945740|NCT00347360|17011545|P2|Overall Study|Withdrawal by Subject|1
4945741|NCT00347360|17011546|P1|Overall Study|Withdrawal by Subject|0
4945742|NCT00347360|17011532|P15|Overall Study|Protocol Violation|0
4945743|NCT00347360|17011533|P14|Overall Study|Protocol Violation|1
4945744|NCT00347360|17011534|P13|Overall Study|Protocol Violation|0
4945745|NCT00347360|17011535|P12|Overall Study|Protocol Violation|0
4945746|NCT00347360|17011536|P11|Overall Study|Protocol Violation|0
4945747|NCT00347360|17011537|P10|Overall Study|Protocol Violation|2
4945748|NCT00347360|17011538|P9|Overall Study|Protocol Violation|1
4945749|NCT00347360|17011539|P8|Overall Study|Protocol Violation|0
4945750|NCT00347360|17011540|P7|Overall Study|Protocol Violation|0
4945751|NCT00347360|17011541|P6|Overall Study|Protocol Violation|2
4945752|NCT00347360|17011542|P5|Overall Study|Protocol Violation|1
4945753|NCT00347360|17011543|P4|Overall Study|Protocol Violation|2
4945754|NCT00347360|17011544|P3|Overall Study|Protocol Violation|1
4945755|NCT00347360|17011545|P2|Overall Study|Protocol Violation|3
4945756|NCT00347360|17011546|P1|Overall Study|Protocol Violation|2
4945757|NCT00347360|17011532|P15|Overall Study|Lost to Follow-up|0
4945758|NCT00347360|17011533|P14|Overall Study|Lost to Follow-up|0
4945759|NCT00347360|17011534|P13|Overall Study|Lost to Follow-up|1
4945760|NCT00347360|17011535|P12|Overall Study|Lost to Follow-up|0
4945761|NCT00347360|17011536|P11|Overall Study|Lost to Follow-up|0
4945762|NCT00347360|17011537|P10|Overall Study|Lost to Follow-up|2
4945763|NCT00347360|17011538|P9|Overall Study|Lost to Follow-up|1
4945764|NCT00347360|17011539|P8|Overall Study|Lost to Follow-up|1
4945765|NCT00347360|17011540|P7|Overall Study|Lost to Follow-up|0
4945766|NCT00347360|17011541|P6|Overall Study|Lost to Follow-up|1
4945767|NCT00347360|17011542|P5|Overall Study|Lost to Follow-up|1
4945768|NCT00347360|17011543|P4|Overall Study|Lost to Follow-up|2
4945769|NCT00347360|17011544|P3|Overall Study|Lost to Follow-up|0
4945770|NCT00347360|17011545|P2|Overall Study|Lost to Follow-up|0
4945771|NCT00347360|17011546|P1|Overall Study|Lost to Follow-up|0
4945772|NCT00347360|17011532|P15|Overall Study|Adverse Event|2
4945773|NCT00347360|17011533|P14|Overall Study|Adverse Event|2
4945774|NCT00347360|17011534|P13|Overall Study|Adverse Event|3
4945775|NCT00347360|17011535|P12|Overall Study|Adverse Event|1
4945776|NCT00347360|17011536|P11|Overall Study|Adverse Event|3
4945777|NCT00347360|17011537|P10|Overall Study|Adverse Event|3
4945778|NCT00347360|17011538|P9|Overall Study|Adverse Event|2
4945779|NCT00347360|17011539|P8|Overall Study|Adverse Event|0
4945780|NCT00347360|17011540|P7|Overall Study|Adverse Event|2
4945781|NCT00347360|17011541|P6|Overall Study|Adverse Event|2
4945782|NCT00347360|17011542|P5|Overall Study|Adverse Event|1
4945783|NCT00347360|17011543|P4|Overall Study|Adverse Event|4
4945784|NCT00347360|17011544|P3|Overall Study|Adverse Event|0
4945785|NCT00347360|17011545|P2|Overall Study|Adverse Event|2
4945786|NCT00347360|17011546|P1|Overall Study|Adverse Event|1
4945787|NCT00347269|17011734|P2|Overall Study|Death|3
4945788|NCT00347269|17011735|P1|Overall Study|Death|2
4945789|NCT00347269|17011734|P2|Overall Study|Withdrawal by Subject|38
4945790|NCT00347269|17011735|P1|Overall Study|Withdrawal by Subject|18
4945791|NCT00347269|17011734|P2|Overall Study|Lost to Follow-up|65
4945792|NCT00347269|17011735|P1|Overall Study|Lost to Follow-up|74
4945793|NCT00347009|17011750|P1|Overall Study|Serious Adverse Event|1
4945794|NCT00347009|17011750|P1|Overall Study|Increased ALT/HBV DNA|1
4945795|NCT00347009|17011750|P1|Overall Study|Insufficient Viral Suppression|3
4945796|NCT00347009|17011750|P1|Overall Study|Adverse Laboratory Experience|1
4945797|NCT00347009|17011750|P1|Overall Study|Protocol Violation|2
4945798|NCT00347009|17011750|P1|Overall Study|Lost to Follow-up|4
4945799|NCT00347009|17011750|P1|Overall Study|Physician Decision|5
4945800|NCT00347009|17011750|P1|Overall Study|Withdrawal by Subject|3
4945801|NCT00347009|17011750|P1|Overall Study|Adverse Event|6
4945802|NCT00347009|17011750|P1|Overall Study|Death|1
4945803|NCT00346775|17011771|P2|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0
4945804|NCT00346775|17011772|P1|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1
4945805|NCT00346775|17011771|P2|Period 1: Intervention Period 1|Protocol Violation|2
4945806|NCT00346775|17011772|P1|Period 1: Intervention Period 1|Protocol Violation|3
4945807|NCT00346775|17011771|P2|Period 1: Intervention Period 1|Lost to Follow-up|1
4945898|NCT00346216|17012046|P3|Overall Study|Study terminated by sponsor|8
4945808|NCT00346775|17011772|P1|Period 1: Intervention Period 1|Lost to Follow-up|1
4945809|NCT00346697|17011784|P2|Overall Study|Lost to Follow-up|1
4945810|NCT00346697|17011785|P1|Overall Study|Lost to Follow-up|0
4945811|NCT00346632|17011821|P10|Overall Study|Not Stated|1
4945812|NCT00346632|17011822|P9|Overall Study|Not Stated|2
4945813|NCT00346632|17011823|P8|Overall Study|Not Stated|2
4945814|NCT00346632|17011824|P7|Overall Study|Not Stated|0
4945815|NCT00346632|17011825|P6|Overall Study|Not Stated|0
4945816|NCT00346632|17011826|P5|Overall Study|Not Stated|0
4945817|NCT00346632|17011827|P4|Overall Study|Not Stated|0
4945818|NCT00346632|17011828|P3|Overall Study|Not Stated|0
4945819|NCT00346632|17011829|P2|Overall Study|Not Stated|1
4945820|NCT00346632|17011830|P1|Overall Study|Not Stated|1
4945821|NCT00346632|17011821|P10|Overall Study|Switched to alternative treatment|0
4945822|NCT00346632|17011822|P9|Overall Study|Switched to alternative treatment|0
4945823|NCT00346632|17011823|P8|Overall Study|Switched to alternative treatment|0
4945824|NCT00346632|17011824|P7|Overall Study|Switched to alternative treatment|0
4945825|NCT00346632|17011825|P6|Overall Study|Switched to alternative treatment|0
4945826|NCT00346632|17011826|P5|Overall Study|Switched to alternative treatment|0
4945827|NCT00346632|17011827|P4|Overall Study|Switched to alternative treatment|0
4945828|NCT00346632|17011828|P3|Overall Study|Switched to alternative treatment|1
4945829|NCT00346632|17011829|P2|Overall Study|Switched to alternative treatment|0
4945830|NCT00346632|17011830|P1|Overall Study|Switched to alternative treatment|0
4945831|NCT00346632|17011821|P10|Overall Study|Withdrawal by Subject|0
4945832|NCT00346632|17011822|P9|Overall Study|Withdrawal by Subject|0
4945833|NCT00346632|17011823|P8|Overall Study|Withdrawal by Subject|0
4945834|NCT00346632|17011824|P7|Overall Study|Withdrawal by Subject|1
4945835|NCT00346632|17011825|P6|Overall Study|Withdrawal by Subject|0
4945836|NCT00346632|17011826|P5|Overall Study|Withdrawal by Subject|0
4945837|NCT00346632|17011827|P4|Overall Study|Withdrawal by Subject|0
4945838|NCT00346632|17011828|P3|Overall Study|Withdrawal by Subject|0
4945839|NCT00346632|17011829|P2|Overall Study|Withdrawal by Subject|0
4945840|NCT00346632|17011830|P1|Overall Study|Withdrawal by Subject|0
4945841|NCT00346632|17011821|P10|Overall Study|Protocol Violation|0
4945842|NCT00346632|17011822|P9|Overall Study|Protocol Violation|0
4945843|NCT00346632|17011823|P8|Overall Study|Protocol Violation|0
4945844|NCT00346632|17011824|P7|Overall Study|Protocol Violation|1
4945845|NCT00346632|17011825|P6|Overall Study|Protocol Violation|0
4945846|NCT00346632|17011826|P5|Overall Study|Protocol Violation|0
4945847|NCT00346632|17011827|P4|Overall Study|Protocol Violation|0
4945848|NCT00346632|17011828|P3|Overall Study|Protocol Violation|0
4945849|NCT00346632|17011829|P2|Overall Study|Protocol Violation|0
4945850|NCT00346632|17011830|P1|Overall Study|Protocol Violation|0
4945851|NCT00346632|17011821|P10|Overall Study|Death|0
4945852|NCT00346632|17011822|P9|Overall Study|Death|0
4945853|NCT00346632|17011823|P8|Overall Study|Death|0
4945854|NCT00346632|17011824|P7|Overall Study|Death|0
4945855|NCT00346632|17011825|P6|Overall Study|Death|0
4945856|NCT00346632|17011826|P5|Overall Study|Death|0
4945857|NCT00346632|17011827|P4|Overall Study|Death|0
4945858|NCT00346632|17011828|P3|Overall Study|Death|1
4945859|NCT00346632|17011829|P2|Overall Study|Death|0
4945860|NCT00346632|17011830|P1|Overall Study|Death|0
4945861|NCT00346632|17011821|P10|Overall Study|Adverse Event|0
4945862|NCT00346632|17011822|P9|Overall Study|Adverse Event|0
4945863|NCT00346632|17011823|P8|Overall Study|Adverse Event|0
4945864|NCT00346632|17011824|P7|Overall Study|Adverse Event|1
4945865|NCT00346632|17011825|P6|Overall Study|Adverse Event|1
4945866|NCT00346632|17011826|P5|Overall Study|Adverse Event|1
4945867|NCT00346632|17011827|P4|Overall Study|Adverse Event|0
4945868|NCT00346632|17011828|P3|Overall Study|Adverse Event|0
4945869|NCT00346632|17011829|P2|Overall Study|Adverse Event|0
4945870|NCT00346632|17011830|P1|Overall Study|Adverse Event|0
4945871|NCT00346632|17011821|P10|Overall Study|Progressive Disease|2
4945872|NCT00346632|17011822|P9|Overall Study|Progressive Disease|2
4945873|NCT00346632|17011823|P8|Overall Study|Progressive Disease|2
4945874|NCT00346632|17011824|P7|Overall Study|Progressive Disease|2
4945875|NCT00346632|17011825|P6|Overall Study|Progressive Disease|1
4945876|NCT00346632|17011826|P5|Overall Study|Progressive Disease|3
4945877|NCT00346632|17011827|P4|Overall Study|Progressive Disease|3
4945878|NCT00346632|17011828|P3|Overall Study|Progressive Disease|4
4945879|NCT00346632|17011829|P2|Overall Study|Progressive Disease|2
4945880|NCT00346632|17011830|P1|Overall Study|Progressive Disease|2
4945881|NCT00346398|17011980|P2|Overall Study|Withdrawal by Subject|2
4945882|NCT00346398|17011981|P1|Overall Study|Withdrawal by Subject|0
4945883|NCT00346398|17011980|P2|Overall Study|Lost to Follow-up|0
4945884|NCT00346398|17011981|P1|Overall Study|Lost to Follow-up|3
4945885|NCT00346333|17011993|P2|Overall Study|unwilling or unable to continue|8
4945886|NCT00346333|17011994|P1|Overall Study|unwilling or unable to continue|4
4945887|NCT00346333|17011993|P2|Overall Study|Death|0
4945888|NCT00346333|17011994|P1|Overall Study|Death|1
4945889|NCT00346268|17012010|P2|Overall Study|Participant refused|3
4945890|NCT00346268|17012011|P1|Overall Study|Participant refused|0
4945891|NCT00346268|17012010|P2|Overall Study|Protocol Violation|0
4945892|NCT00346268|17012011|P1|Overall Study|Protocol Violation|1
4945893|NCT00346268|17012010|P2|Overall Study|Adverse Event|0
4945894|NCT00346268|17012011|P1|Overall Study|Adverse Event|1
4945895|NCT00346216|17012046|P3|Overall Study|Missing Subject Summary Status|62
4945896|NCT00346216|17012047|P2|Overall Study|Missing Subject Summary Status|61
4945897|NCT00346216|17012048|P1|Overall Study|Missing Subject Summary Status|62
4945899|NCT00346216|17012047|P2|Overall Study|Study terminated by sponsor|4
4945900|NCT00346216|17012048|P1|Overall Study|Study terminated by sponsor|11
4945901|NCT00346216|17012046|P3|Overall Study|Death|228
4945902|NCT00346216|17012047|P2|Overall Study|Death|192
4945903|NCT00346216|17012048|P1|Overall Study|Death|189
4945904|NCT00346216|17012046|P3|Overall Study|Does not meet entrance criteria|8
4945905|NCT00346216|17012047|P2|Overall Study|Does not meet entrance criteria|10
4945906|NCT00346216|17012048|P1|Overall Study|Does not meet entrance criteria|13
4945907|NCT00346216|17012046|P3|Overall Study|Physician Decision|59
4945908|NCT00346216|17012047|P2|Overall Study|Physician Decision|76
4945909|NCT00346216|17012048|P1|Overall Study|Physician Decision|80
4945910|NCT00346216|17012046|P3|Overall Study|Lost to Follow-up|542
4945911|NCT00346216|17012047|P2|Overall Study|Lost to Follow-up|588
4945912|NCT00346216|17012048|P1|Overall Study|Lost to Follow-up|611
4945913|NCT00346216|17012046|P3|Overall Study|Withdrawal by Subject|651
4945914|NCT00346216|17012047|P2|Overall Study|Withdrawal by Subject|692
4945915|NCT00346216|17012048|P1|Overall Study|Withdrawal by Subject|661
4945916|NCT00346216|17012046|P3|Overall Study|No longer willing to participate|585
4945917|NCT00346216|17012047|P2|Overall Study|No longer willing to participate|606
4945918|NCT00346216|17012048|P1|Overall Study|No longer willing to participate|600
4945919|NCT00346216|17012046|P3|Overall Study|Other|205
4945920|NCT00346216|17012047|P2|Overall Study|Other|231
4945921|NCT00346216|17012048|P1|Overall Study|Other|181
4945922|NCT00346164|17012069|P4|Overall Study|Inability to start week 16 tx on time|11
4945923|NCT00346164|17012070|P3|Overall Study|Inability to start week 16 tx on time|0
4945924|NCT00346164|17012071|P2|Overall Study|Inability to start week 16 tx on time|0
4945925|NCT00346164|17012072|P1|Overall Study|Inability to start week 16 tx on time|0
4945926|NCT00346164|17012069|P4|Overall Study|Refusal of further protocol therapy|15
4945927|NCT00346164|17012070|P3|Overall Study|Refusal of further protocol therapy|3
4945928|NCT00346164|17012071|P2|Overall Study|Refusal of further protocol therapy|1
4945929|NCT00346164|17012072|P1|Overall Study|Refusal of further protocol therapy|0
4945930|NCT00346164|17012069|P4|Overall Study|Ineligible|23
4945931|NCT00346164|17012070|P3|Overall Study|Ineligible|2
4945932|NCT00346164|17012071|P2|Overall Study|Ineligible|2
4945933|NCT00346164|17012072|P1|Overall Study|Ineligible|11
4945934|NCT00346164|17012069|P4|Overall Study|Withdrawal by Subject|0
4945935|NCT00346164|17012070|P3|Overall Study|Withdrawal by Subject|2
4945936|NCT00346164|17012071|P2|Overall Study|Withdrawal by Subject|0
4945937|NCT00346164|17012072|P1|Overall Study|Withdrawal by Subject|0
4945938|NCT00346164|17012069|P4|Overall Study|Protocol Violation|4
4945939|NCT00346164|17012070|P3|Overall Study|Protocol Violation|10
4945940|NCT00346164|17012071|P2|Overall Study|Protocol Violation|2
4945941|NCT00346164|17012072|P1|Overall Study|Protocol Violation|6
4945942|NCT00346164|17012069|P4|Overall Study|Physician Decision|27
4945943|NCT00346164|17012070|P3|Overall Study|Physician Decision|2
4945944|NCT00346164|17012071|P2|Overall Study|Physician Decision|1
4945945|NCT00346164|17012072|P1|Overall Study|Physician Decision|0
4945946|NCT00346164|17012069|P4|Overall Study|Lack of Efficacy|25
4945947|NCT00346164|17012070|P3|Overall Study|Lack of Efficacy|7
4945948|NCT00346164|17012071|P2|Overall Study|Lack of Efficacy|1
4945949|NCT00346164|17012072|P1|Overall Study|Lack of Efficacy|0
4945950|NCT00346164|17012069|P4|Overall Study|Adverse Event|1
4945951|NCT00346164|17012070|P3|Overall Study|Adverse Event|0
4945952|NCT00346164|17012071|P2|Overall Study|Adverse Event|0
4945953|NCT00346164|17012072|P1|Overall Study|Adverse Event|0
4945954|NCT00346151|17012107|P1|Overall Study|Withdrawal by Subject|3
4945955|NCT00346073|17012127|P2|Overall Study|Lost to Follow-up|24
4945956|NCT00346073|17012128|P1|Overall Study|Lost to Follow-up|39
4945957|NCT00346073|17012127|P2|Overall Study|Serious Adverse Event|0
4945958|NCT00346073|17012128|P1|Overall Study|Serious Adverse Event|2
4945959|NCT00346034|17012162|P1|Overall Study|Not Willing to Follow Dosing Regimen|1
4945960|NCT00346034|17012162|P1|Overall Study|Patient Stopped Taking Study Drug|1
4945961|NCT00346034|17012162|P1|Overall Study|Withdrawal by Subject|13
4945962|NCT00346034|17012162|P1|Overall Study|Lack of Efficacy|8
4945963|NCT00346034|17012162|P1|Overall Study|Adverse Event|34
4945964|NCT00345878|17012202|P2|Overall Study|Other|0
4945965|NCT00345878|17012203|P1|Overall Study|Other|1
4945966|NCT00345878|17012202|P2|Overall Study|Lost to Follow-up|1
4945967|NCT00345878|17012203|P1|Overall Study|Lost to Follow-up|2
4945968|NCT00345878|17012202|P2|Overall Study|Adverse Event|0
4945969|NCT00345878|17012203|P1|Overall Study|Adverse Event|1
4945970|NCT00345839|17012262|P2|Overall Study|Lost to Follow-up|61
4945971|NCT00345839|17012263|P1|Overall Study|Lost to Follow-up|58
4945972|NCT00345839|17012262|P2|Overall Study|Withdrawal by Subject|98
4945973|NCT00345839|17012263|P1|Overall Study|Withdrawal by Subject|91
4945974|NCT00345683|17012289|P2|Overall Study|Other|2
4945975|NCT00345683|17012290|P1|Overall Study|Other|6
4945976|NCT00345683|17012289|P2|Overall Study|Lost to Follow-up|7
4945977|NCT00345683|17012290|P1|Overall Study|Lost to Follow-up|19
4945978|NCT00345631|17012313|P3|Overall Study|Other reasons|1
4945979|NCT00345631|17012314|P2|Overall Study|Other reasons|0
4945980|NCT00345631|17012315|P1|Overall Study|Other reasons|0
4945981|NCT00345631|17012313|P3|Overall Study|Lost to Follow-up|4
4945982|NCT00345631|17012314|P2|Overall Study|Lost to Follow-up|7
4945983|NCT00345631|17012315|P1|Overall Study|Lost to Follow-up|3
4945984|NCT00345631|17012313|P3|Overall Study|Adverse Event|0
4945985|NCT00345631|17012314|P2|Overall Study|Adverse Event|1
4945986|NCT00345631|17012315|P1|Overall Study|Adverse Event|0
4945987|NCT00345631|17012313|P3|Overall Study|Withdrawal by Subject|1
4945988|NCT00345631|17012314|P2|Overall Study|Withdrawal by Subject|0
4945989|NCT00345631|17012315|P1|Overall Study|Withdrawal by Subject|1
4945990|NCT00345605|17012347|P2|Arm 2, Opposite Treatment|Adverse Event|0
4945991|NCT00345605|17012348|P1|Arm 2, Opposite Treatment|Adverse Event|1
4945992|NCT00345605|17012347|P2|Arm 1|Adverse Event|1
4945993|NCT00345605|17012348|P1|Arm 1|Adverse Event|0
4945994|NCT00345592|17012368|P2|Overall Study|Withdrawal by Subject|8
4945995|NCT00345592|17012369|P1|Overall Study|Withdrawal by Subject|11
4945996|NCT00345592|17012368|P2|Overall Study|Death|16
4945997|NCT00345592|17012369|P1|Overall Study|Death|14
4945998|NCT00345579|17012377|P2|Overall Study|Other|1
4945999|NCT00345579|17012378|P1|Overall Study|Other|9
4946000|NCT00345579|17012377|P2|Overall Study|Lost to Follow-up|36
4946001|NCT00345579|17012378|P1|Overall Study|Lost to Follow-up|82
4946002|NCT00345579|17012377|P2|Overall Study|Withdrawal by Subject|17
4946003|NCT00345579|17012378|P1|Overall Study|Withdrawal by Subject|50
4946004|NCT00345579|17012377|P2|Overall Study|Protocol Violation|5
4946005|NCT00345579|17012378|P1|Overall Study|Protocol Violation|14
4946006|NCT00345579|17012377|P2|Overall Study|Adverse Event|6
4946007|NCT00345579|17012378|P1|Overall Study|Adverse Event|9
4946008|NCT00345540|17012398|P1|Overall Study|Withdrawal by Subject|1
4946009|NCT00345397|17012404|P1|Overall Study|Death|1
4946010|NCT00345358|17012435|P4|Booster Vaccination Phase|Lost to Follow-up|0
4946011|NCT00345358|17012436|P3|Booster Vaccination Phase|Lost to Follow-up|0
4946012|NCT00345358|17012437|P2|Booster Vaccination Phase|Lost to Follow-up|0
4946013|NCT00345358|17012438|P1|Booster Vaccination Phase|Lost to Follow-up|3
4946014|NCT00345358|17012435|P4|Booster Vaccination Phase|Withdrawal by Subject|0
4946015|NCT00345358|17012436|P3|Booster Vaccination Phase|Withdrawal by Subject|0
4946016|NCT00345358|17012437|P2|Booster Vaccination Phase|Withdrawal by Subject|0
4946017|NCT00345358|17012438|P1|Booster Vaccination Phase|Withdrawal by Subject|1
4946018|NCT00345358|17012435|P4|Primary Vaccination Phase|Lost to Follow-up|2
4946019|NCT00345358|17012436|P3|Primary Vaccination Phase|Lost to Follow-up|2
4946020|NCT00345358|17012437|P2|Primary Vaccination Phase|Lost to Follow-up|0
4946021|NCT00345358|17012438|P1|Primary Vaccination Phase|Lost to Follow-up|1
4946022|NCT00345358|17012435|P4|Primary Vaccination Phase|Withdrawal by Subject|0
4946023|NCT00345358|17012436|P3|Primary Vaccination Phase|Withdrawal by Subject|4
4946024|NCT00345358|17012437|P2|Primary Vaccination Phase|Withdrawal by Subject|2
4946025|NCT00345358|17012438|P1|Primary Vaccination Phase|Withdrawal by Subject|1
4946026|NCT00345358|17012435|P4|Primary Vaccination Phase|Adverse event, non-fatal|0
4946027|NCT00345358|17012436|P3|Primary Vaccination Phase|Adverse event, non-fatal|1
4946028|NCT00345358|17012437|P2|Primary Vaccination Phase|Adverse event, non-fatal|1
4946029|NCT00345358|17012438|P1|Primary Vaccination Phase|Adverse event, non-fatal|3
4946030|NCT00345358|17012435|P4|Primary Vaccination Phase|Other|0
4946031|NCT00345358|17012436|P3|Primary Vaccination Phase|Other|1
4946032|NCT00345358|17012437|P2|Primary Vaccination Phase|Other|1
4946033|NCT00345358|17012438|P1|Primary Vaccination Phase|Other|0
4946034|NCT00345293|17012528|P2|Overall Study|Withdrawal by Subject|0
4946035|NCT00345293|17012529|P1|Overall Study|Withdrawal by Subject|1
4946036|NCT00345293|17012528|P2|Overall Study|Unable to access line for sample|0
4946037|NCT00345293|17012529|P1|Overall Study|Unable to access line for sample|1
4946038|NCT00345046|17012575|P3|Overall Study|Protocol Violation|2
4946039|NCT00345046|17012576|P2|Overall Study|Protocol Violation|1
4946040|NCT00345046|17012577|P1|Overall Study|Protocol Violation|1
4946041|NCT00344968|17012607|P3|Overall Study|Other|0
4946042|NCT00344968|17012608|P2|Overall Study|Other|1
4946043|NCT00344968|17012609|P1|Overall Study|Other|0
4946044|NCT00344968|17012607|P3|Overall Study|Death|31
4946045|NCT00344968|17012608|P2|Overall Study|Death|27
4946046|NCT00344968|17012609|P1|Overall Study|Death|11
4946047|NCT00344968|17012607|P3|Overall Study|Lost to Follow-up|37
4946048|NCT00344968|17012608|P2|Overall Study|Lost to Follow-up|37
4946049|NCT00344968|17012609|P1|Overall Study|Lost to Follow-up|24
4946050|NCT00344968|17012607|P3|Overall Study|Withdrawal by Subject|27
4946051|NCT00344968|17012608|P2|Overall Study|Withdrawal by Subject|31
4946052|NCT00344968|17012609|P1|Overall Study|Withdrawal by Subject|14
4946053|NCT00344968|17012607|P3|Overall Study|Protocol Violation|5
4946054|NCT00344968|17012608|P2|Overall Study|Protocol Violation|2
4946055|NCT00344968|17012609|P1|Overall Study|Protocol Violation|2
4946056|NCT00344968|17012607|P3|Overall Study|Unsatisfactory Therapeutic Effect|1
4946057|NCT00344968|17012608|P2|Overall Study|Unsatisfactory Therapeutic Effect|0
4946058|NCT00344968|17012609|P1|Overall Study|Unsatisfactory Therapeutic Effect|3
4946059|NCT00344968|17012607|P3|Overall Study|Adverse Event|15
4946060|NCT00344968|17012608|P2|Overall Study|Adverse Event|4
4946061|NCT00344968|17012609|P1|Overall Study|Adverse Event|5
4946062|NCT00344773|17012620|P1|Overall Study|Not Eligible for the study|2
4946063|NCT00344773|17012620|P1|Overall Study|Withdrawal by Subject|1
4946064|NCT00344773|17012620|P1|Overall Study|Objective Disease Progression|16
4946065|NCT00344773|17012620|P1|Overall Study|Adverse Event|2
4946066|NCT00344500|17012643|P3|Overall Study|Not Noted|0
4946067|NCT00344500|17012644|P2|Overall Study|Not Noted|3
4946068|NCT00344500|17012645|P1|Overall Study|Not Noted|1
4946069|NCT00344500|17012643|P3|Overall Study|Protocol Violation|1
4946070|NCT00344500|17012644|P2|Overall Study|Protocol Violation|7
4946071|NCT00344500|17012645|P1|Overall Study|Protocol Violation|4
4946072|NCT00344500|17012643|P3|Overall Study|Withdrawal by Subject|0
4946073|NCT00344500|17012644|P2|Overall Study|Withdrawal by Subject|10
4946074|NCT00344500|17012645|P1|Overall Study|Withdrawal by Subject|7
4946075|NCT00344500|17012643|P3|Overall Study|Lost to Follow-up|1
4946076|NCT00344500|17012644|P2|Overall Study|Lost to Follow-up|13
4946077|NCT00344500|17012645|P1|Overall Study|Lost to Follow-up|5
4946078|NCT00344500|17012643|P3|Overall Study|Adverse Event|0
4946079|NCT00344500|17012644|P2|Overall Study|Adverse Event|2
4946080|NCT00344500|17012645|P1|Overall Study|Adverse Event|6
4946081|NCT00344487|17012656|P1|Overall Study|immunologic failure|1
4946082|NCT00344461|17012660|P1|Overall Study|Withdrawal by Subject|2
4946083|NCT00344461|17012660|P1|Overall Study|Protocol Violation|6
4946084|NCT00344461|17012660|P1|Overall Study|Physician Decision|2
4946085|NCT00344461|17012660|P1|Overall Study|Lost to Follow-up|2
4946086|NCT00344461|17012660|P1|Overall Study|Lack of Efficacy|2
4946087|NCT00344461|17012660|P1|Overall Study|Death|1
4946088|NCT00344461|17012660|P1|Overall Study|Adverse Event|6
4946089|NCT00344448|17012671|P2|Open Label|Study terminated|0
4946090|NCT00344448|17012672|P1|Open Label|Study terminated|1
4946091|NCT00344448|17012671|P2|Open Label|Withdrawal by Subject|1
4946092|NCT00344448|17012672|P1|Open Label|Withdrawal by Subject|1
4946093|NCT00344448|17012671|P2|Double Blind, Placebo Controlled|Study terminated|0
4946094|NCT00344448|17012672|P1|Double Blind, Placebo Controlled|Study terminated|1
4946095|NCT00344448|17012671|P2|Double Blind, Placebo Controlled|Withdrawal by Subject|0
4946096|NCT00344448|17012672|P1|Double Blind, Placebo Controlled|Withdrawal by Subject|1
4946097|NCT00344448|17012671|P2|Screening|Withdrawal by Subject|1
4946098|NCT00344448|17012672|P1|Screening|Withdrawal by Subject|0
4946099|NCT00344318|17012693|P4|Overall Study|Lost to Follow-up|0
4946100|NCT00344318|17012694|P3|Overall Study|Lost to Follow-up|1
4946101|NCT00344318|17012695|P2|Overall Study|Lost to Follow-up|0
4946102|NCT00344318|17012696|P1|Overall Study|Lost to Follow-up|2
4946103|NCT00344318|17012693|P4|Overall Study|Withdrawal by Subject|2
4946104|NCT00344318|17012694|P3|Overall Study|Withdrawal by Subject|0
4946105|NCT00344318|17012695|P2|Overall Study|Withdrawal by Subject|2
4946106|NCT00344318|17012696|P1|Overall Study|Withdrawal by Subject|2
4946107|NCT00344318|17012693|P4|Overall Study|Adverse Event|1
4946108|NCT00344318|17012694|P3|Overall Study|Adverse Event|0
4946109|NCT00344318|17012695|P2|Overall Study|Adverse Event|3
4946110|NCT00344318|17012696|P1|Overall Study|Adverse Event|0
4946111|NCT00344305|17012818|P2|Overall Study|Participant was not contacted in window|1
4946112|NCT00344305|17012819|P1|Overall Study|Participant was not contacted in window|0
4946113|NCT00344305|17012818|P2|Overall Study|Lost to Follow-up|0
4946114|NCT00344305|17012819|P1|Overall Study|Lost to Follow-up|2
4946115|NCT00344032|17012869|P2|Overall Study|Physician Decision|1
4946116|NCT00344032|17012870|P1|Overall Study|Physician Decision|4
4946117|NCT00344032|17012869|P2|Overall Study|Lost to Follow-up|6
4946118|NCT00344032|17012870|P1|Overall Study|Lost to Follow-up|4
4946119|NCT00344032|17012869|P2|Overall Study|Withdrawal by Subject|2
4946120|NCT00344032|17012870|P1|Overall Study|Withdrawal by Subject|6
4946121|NCT00344032|17012869|P2|Overall Study|Adverse Event|1
4946122|NCT00344032|17012870|P1|Overall Study|Adverse Event|0
4946123|NCT00344019|17012889|P3|Overall Study|did not meet final inclusion criteria|74
4946124|NCT00344019|17012890|P2|Overall Study|did not meet final inclusion criteria|0
4946125|NCT00344019|17012891|P1|Overall Study|did not meet final inclusion criteria|0
4946126|NCT00343915|17012909|P2|Primary Study|Other|0
4946127|NCT00343915|17012910|P1|Primary Study|Other|1
4946128|NCT00343915|17012909|P2|Primary Study|Lost to Follow-up|3
4946129|NCT00343915|17012910|P1|Primary Study|Lost to Follow-up|2
4946130|NCT00343915|17012909|P2|Primary Study|Withdrawal by Subject|0
4946131|NCT00343915|17012910|P1|Primary Study|Withdrawal by Subject|1
4946132|NCT00343889|17012936|P2|Overall Study|Protocol Violation|0
4946133|NCT00343889|17012937|P1|Overall Study|Protocol Violation|1
4946134|NCT00343889|17012936|P2|Overall Study|Withdrawal by Subject|1
4946135|NCT00343889|17012937|P1|Overall Study|Withdrawal by Subject|0
4946136|NCT00343889|17012936|P2|Overall Study|Lost to Follow-up|0
4946137|NCT00343889|17012937|P1|Overall Study|Lost to Follow-up|2
4946138|NCT00343512|17013101|P1|Overall Study|Withdrawal by Subject|2
4946139|NCT00343382|17013189|P3|Overall Study|Other Reason Not Specified|4
4946140|NCT00343382|17013190|P2|Overall Study|Other Reason Not Specified|2
4946141|NCT00343382|17013191|P1|Overall Study|Other Reason Not Specified|1
4946142|NCT00343382|17013189|P3|Overall Study|Withdrawal by Subject|6
4946143|NCT00343382|17013190|P2|Overall Study|Withdrawal by Subject|2
4946144|NCT00343382|17013191|P1|Overall Study|Withdrawal by Subject|1
4946145|NCT00343382|17013189|P3|Overall Study|Adverse Event|7
4946146|NCT00343382|17013190|P2|Overall Study|Adverse Event|10
4946147|NCT00343382|17013191|P1|Overall Study|Adverse Event|2
4946148|NCT00343291|17013210|P2|Overall Study|Other|5
4946149|NCT00343291|17013211|P1|Overall Study|Other|8
4946150|NCT00343291|17013210|P2|Overall Study|Withdrawal by Subject|2
4946151|NCT00343291|17013211|P1|Overall Study|Withdrawal by Subject|0
4946152|NCT00343291|17013210|P2|Overall Study|Progressive disease|34
4946153|NCT00343291|17013211|P1|Overall Study|Progressive disease|33
4946154|NCT00343291|17013210|P2|Overall Study|Death|2
4946155|NCT00343291|17013211|P1|Overall Study|Death|3
4946156|NCT00343291|17013210|P2|Overall Study|Adverse Event|13
4946157|NCT00343291|17013211|P1|Overall Study|Adverse Event|13
4946158|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Withdrawal by Subject|20
4946159|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Withdrawal by Subject|36
4946160|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Sponsor Decision|5
4946161|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Sponsor Decision|8
4946162|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Protocol Violation|3
4946163|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Protocol Violation|3
4946164|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Physician Decision|7
4946165|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Physician Decision|4
4946166|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Lost to Follow-up|7
4946167|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Lost to Follow-up|3
4946168|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Lack of Efficacy|1
4946169|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Lack of Efficacy|1
4946170|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Entry Criteria Not Met|10
4946171|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Entry Criteria Not Met|11
4946172|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Death|5
4946173|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Death|4
4946174|NCT00343252|17013227|P2|18 Months (All Treated Participants)|Adverse Event|23
4946175|NCT00343252|17013228|P1|18 Months (All Treated Participants)|Adverse Event|31
4946176|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Withdrawal by Subject|17
4946177|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Withdrawal by Subject|33
4946178|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Sponsor Decision|6
4946179|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Sponsor Decision|9
4946180|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Protocol Violation|2
4946181|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Protocol Violation|3
4946182|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Physician Decision|5
4946183|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Physician Decision|4
4946184|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Lost to Follow-up|5
4946185|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Lost to Follow-up|1
4946186|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Lack of Efficacy|1
4946187|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Lack of Efficacy|1
4946188|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Entry Criteria Not Met|10
4946189|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Entry Criteria Not Met|10
4946190|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Death|3
4946191|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Death|3
4946192|NCT00343252|17013227|P2|12 Months (All Treated Participants)|Adverse Event|20
4946193|NCT00343252|17013228|P1|12 Months (All Treated Participants)|Adverse Event|22
4946194|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Withdrawal by Subject|9
4946195|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Withdrawal by Subject|19
4946196|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Sponsor Decision|4
4946197|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Sponsor Decision|7
4946198|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Protocol Violation|2
4946199|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Protocol Violation|2
4946200|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Physician Decision|3
4946201|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Physician Decision|1
4946202|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Lost to Follow-up|4
4946203|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Lost to Follow-up|0
4946204|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Lack of Efficacy|1
4946205|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Lack of Efficacy|0
4946206|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Entry Criteria Not Met|8
4946207|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Entry Criteria Not Met|10
4946208|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Death|2
4946209|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Death|0
4946210|NCT00343252|17013227|P2|6 Months (All Treated Participants)|Adverse Event|11
4946211|NCT00343252|17013228|P1|6 Months (All Treated Participants)|Adverse Event|17
4946212|NCT00342628|17013293|P3|Overall Study|moved residence|1
4946213|NCT00342628|17013294|P2|Overall Study|moved residence|1
4946214|NCT00342628|17013295|P1|Overall Study|moved residence|0
4946215|NCT00342628|17013293|P3|Overall Study|Death|0
4946216|NCT00342628|17013294|P2|Overall Study|Death|1
4946217|NCT00342628|17013295|P1|Overall Study|Death|1
4946218|NCT00342628|17013293|P3|Overall Study|Withdrawal by Subject|18
4946219|NCT00342628|17013294|P2|Overall Study|Withdrawal by Subject|19
4946220|NCT00342628|17013295|P1|Overall Study|Withdrawal by Subject|19
4946221|NCT00340834|17013361|P5|Extension Phase of Study|Death|1
4946222|NCT00340834|17013362|P4|Extension Phase of Study|Death|0
4946223|NCT00340834|17013363|P3|Extension Phase of Study|Death|0
4946224|NCT00340834|17013364|P2|Extension Phase of Study|Death|0
4946225|NCT00340834|17013365|P1|Extension Phase of Study|Death|0
4946226|NCT00340834|17013361|P5|Extension Phase of Study|Protocol Violation|0
4946227|NCT00340834|17013362|P4|Extension Phase of Study|Protocol Violation|0
4946228|NCT00340834|17013363|P3|Extension Phase of Study|Protocol Violation|0
4946229|NCT00340834|17013364|P2|Extension Phase of Study|Protocol Violation|0
4946230|NCT00340834|17013365|P1|Extension Phase of Study|Protocol Violation|3
4946231|NCT00340834|17013361|P5|Extension Phase of Study|Abnormal test procedure result(s)|2
4946232|NCT00340834|17013362|P4|Extension Phase of Study|Abnormal test procedure result(s)|0
4946233|NCT00340834|17013363|P3|Extension Phase of Study|Abnormal test procedure result(s)|0
4946234|NCT00340834|17013364|P2|Extension Phase of Study|Abnormal test procedure result(s)|1
4946235|NCT00340834|17013365|P1|Extension Phase of Study|Abnormal test procedure result(s)|0
4946236|NCT00340834|17013361|P5|Extension Phase of Study|Administrative problems|1
4946237|NCT00340834|17013362|P4|Extension Phase of Study|Administrative problems|1
4946238|NCT00340834|17013363|P3|Extension Phase of Study|Administrative problems|0
4946239|NCT00340834|17013364|P2|Extension Phase of Study|Administrative problems|0
4946240|NCT00340834|17013365|P1|Extension Phase of Study|Administrative problems|3
4946241|NCT00340834|17013361|P5|Extension Phase of Study|Subject no longer requires study drug|2
4946242|NCT00340834|17013362|P4|Extension Phase of Study|Subject no longer requires study drug|0
4946243|NCT00340834|17013363|P3|Extension Phase of Study|Subject no longer requires study drug|0
4946244|NCT00340834|17013364|P2|Extension Phase of Study|Subject no longer requires study drug|0
4946245|NCT00340834|17013365|P1|Extension Phase of Study|Subject no longer requires study drug|4
4946246|NCT00340834|17013361|P5|Extension Phase of Study|Lost to Follow-up|3
4946247|NCT00340834|17013362|P4|Extension Phase of Study|Lost to Follow-up|2
4946248|NCT00340834|17013363|P3|Extension Phase of Study|Lost to Follow-up|0
4946249|NCT00340834|17013364|P2|Extension Phase of Study|Lost to Follow-up|1
4946250|NCT00340834|17013365|P1|Extension Phase of Study|Lost to Follow-up|1
4946251|NCT00340834|17013361|P5|Extension Phase of Study|Unsatisfactory therapeutic effect|9
4946252|NCT00340834|17013362|P4|Extension Phase of Study|Unsatisfactory therapeutic effect|4
4946253|NCT00340834|17013363|P3|Extension Phase of Study|Unsatisfactory therapeutic effect|0
4946254|NCT00340834|17013364|P2|Extension Phase of Study|Unsatisfactory therapeutic effect|7
4946255|NCT00340834|17013365|P1|Extension Phase of Study|Unsatisfactory therapeutic effect|13
4946256|NCT00340834|17013361|P5|Extension Phase of Study|Abnormal laboratory value(s)|4
4946257|NCT00340834|17013362|P4|Extension Phase of Study|Abnormal laboratory value(s)|13
4946258|NCT00340834|17013363|P3|Extension Phase of Study|Abnormal laboratory value(s)|0
4946259|NCT00340834|17013364|P2|Extension Phase of Study|Abnormal laboratory value(s)|13
4946260|NCT00340834|17013365|P1|Extension Phase of Study|Abnormal laboratory value(s)|14
4946261|NCT00340834|17013361|P5|Extension Phase of Study|Adverse Event|7
4946262|NCT00340834|17013362|P4|Extension Phase of Study|Adverse Event|19
4946263|NCT00340834|17013363|P3|Extension Phase of Study|Adverse Event|0
4946264|NCT00340834|17013364|P2|Extension Phase of Study|Adverse Event|22
4946265|NCT00340834|17013365|P1|Extension Phase of Study|Adverse Event|21
4946266|NCT00340834|17013361|P5|Extension Phase of Study|Subject withdrew consent|15
4946267|NCT00340834|17013362|P4|Extension Phase of Study|Subject withdrew consent|12
4946268|NCT00340834|17013363|P3|Extension Phase of Study|Subject withdrew consent|0
4946269|NCT00340834|17013364|P2|Extension Phase of Study|Subject withdrew consent|31
4946270|NCT00340834|17013365|P1|Extension Phase of Study|Subject withdrew consent|26
4946271|NCT00340834|17013361|P5|Extension Phase of Study|Subject did not receive study drug|0
4946272|NCT00340834|17013362|P4|Extension Phase of Study|Subject did not receive study drug|2
4946273|NCT00340834|17013363|P3|Extension Phase of Study|Subject did not receive study drug|0
4946274|NCT00340834|17013364|P2|Extension Phase of Study|Subject did not receive study drug|1
4946275|NCT00340834|17013365|P1|Extension Phase of Study|Subject did not receive study drug|0
4946276|NCT00340834|17013361|P5|Core Phase of Study|Protocol Violation|0
4946277|NCT00340834|17013362|P4|Core Phase of Study|Protocol Violation|0
4946278|NCT00340834|17013363|P3|Core Phase of Study|Protocol Violation|2
4946279|NCT00340834|17013364|P2|Core Phase of Study|Protocol Violation|0
4946280|NCT00340834|17013365|P1|Core Phase of Study|Protocol Violation|0
4946281|NCT00340834|17013361|P5|Core Phase of Study|Death|0
4946282|NCT00340834|17013362|P4|Core Phase of Study|Death|0
4946283|NCT00340834|17013363|P3|Core Phase of Study|Death|0
4946284|NCT00340834|17013364|P2|Core Phase of Study|Death|0
4946285|NCT00340834|17013365|P1|Core Phase of Study|Death|2
4946286|NCT00340834|17013361|P5|Core Phase of Study|Lost to Follow-up|0
4946287|NCT00340834|17013362|P4|Core Phase of Study|Lost to Follow-up|0
4946288|NCT00340834|17013363|P3|Core Phase of Study|Lost to Follow-up|4
4946289|NCT00340834|17013364|P2|Core Phase of Study|Lost to Follow-up|1
4946290|NCT00340834|17013365|P1|Core Phase of Study|Lost to Follow-up|1
4946291|NCT00340834|17013361|P5|Core Phase of Study|Abnormal test procedure result(s)|0
4946292|NCT00340834|17013362|P4|Core Phase of Study|Abnormal test procedure result(s)|0
4946293|NCT00340834|17013363|P3|Core Phase of Study|Abnormal test procedure result(s)|3
4946294|NCT00340834|17013364|P2|Core Phase of Study|Abnormal test procedure result(s)|3
4946295|NCT00340834|17013365|P1|Core Phase of Study|Abnormal test procedure result(s)|4
4946296|NCT00340834|17013361|P5|Core Phase of Study|Abnormal laboratory value(s)|0
4946297|NCT00340834|17013362|P4|Core Phase of Study|Abnormal laboratory value(s)|0
4946298|NCT00340834|17013363|P3|Core Phase of Study|Abnormal laboratory value(s)|1
4946299|NCT00340834|17013364|P2|Core Phase of Study|Abnormal laboratory value(s)|6
4946300|NCT00340834|17013365|P1|Core Phase of Study|Abnormal laboratory value(s)|4
4946301|NCT00340834|17013361|P5|Core Phase of Study|Lack of Efficacy|0
4946302|NCT00340834|17013362|P4|Core Phase of Study|Lack of Efficacy|0
4946303|NCT00340834|17013363|P3|Core Phase of Study|Lack of Efficacy|7
4946304|NCT00340834|17013364|P2|Core Phase of Study|Lack of Efficacy|3
4946305|NCT00340834|17013365|P1|Core Phase of Study|Lack of Efficacy|3
4946306|NCT00340834|17013361|P5|Core Phase of Study|Administrative Problems|0
4946307|NCT00340834|17013362|P4|Core Phase of Study|Administrative Problems|0
4946308|NCT00340834|17013363|P3|Core Phase of Study|Administrative Problems|7
4946309|NCT00340834|17013364|P2|Core Phase of Study|Administrative Problems|2
4946310|NCT00340834|17013365|P1|Core Phase of Study|Administrative Problems|6
4946311|NCT00340834|17013361|P5|Core Phase of Study|Withdrawal by Subject|0
4946312|NCT00340834|17013362|P4|Core Phase of Study|Withdrawal by Subject|0
4946313|NCT00340834|17013363|P3|Core Phase of Study|Withdrawal by Subject|16
4946314|NCT00340834|17013364|P2|Core Phase of Study|Withdrawal by Subject|9
4946315|NCT00340834|17013365|P1|Core Phase of Study|Withdrawal by Subject|11
4946316|NCT00340834|17013361|P5|Core Phase of Study|Adverse Event|0
4946317|NCT00340834|17013362|P4|Core Phase of Study|Adverse Event|0
4946318|NCT00340834|17013363|P3|Core Phase of Study|Adverse Event|9
4946319|NCT00340834|17013364|P2|Core Phase of Study|Adverse Event|9
4946320|NCT00340834|17013365|P1|Core Phase of Study|Adverse Event|26
4946321|NCT00340704|17013399|P9|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28
4946322|NCT00340704|17013400|P8|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11
4946323|NCT00340704|17013401|P7|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53
4946324|NCT00340704|17013402|P6|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3
4946325|NCT00340704|17013403|P5|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4946326|NCT00340704|17013404|P4|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4946327|NCT00340704|17013405|P3|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4946328|NCT00340704|17013406|P2|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4946329|NCT00340704|17013407|P1|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0
4946330|NCT00340704|17013399|P9|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946331|NCT00340704|17013400|P8|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946332|NCT00340704|17013401|P7|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946333|NCT00340704|17013402|P6|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3
4946334|NCT00340704|17013403|P5|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1
4946335|NCT00340704|17013404|P4|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946336|NCT00340704|17013405|P3|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946337|NCT00340704|17013406|P2|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946338|NCT00340704|17013407|P1|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0
4946339|NCT00340704|17013399|P9|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946340|NCT00340704|17013400|P8|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946341|NCT00340704|17013401|P7|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946342|NCT00340704|17013402|P6|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1
4946343|NCT00340704|17013403|P5|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946344|NCT00340704|17013404|P4|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946345|NCT00340704|17013405|P3|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946346|NCT00340704|17013406|P2|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946347|NCT00340704|17013407|P1|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0
4946348|NCT00340704|17013399|P9|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
4946349|NCT00340704|17013400|P8|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1
4946350|NCT00340704|17013401|P7|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4946351|NCT00340704|17013402|P6|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4946352|NCT00340704|17013403|P5|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4
4946353|NCT00340704|17013404|P4|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2
4946354|NCT00340704|17013405|P3|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4946355|NCT00340704|17013406|P2|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4946356|NCT00340704|17013407|P1|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0
4946357|NCT00340704|17013399|P9|PK Study|Not treated|0
4946358|NCT00340704|17013400|P8|PK Study|Not treated|0
4946359|NCT00340704|17013401|P7|PK Study|Not treated|0
4946360|NCT00340704|17013402|P6|PK Study|Not treated|0
4946361|NCT00340704|17013403|P5|PK Study|Not treated|0
4946362|NCT00340704|17013404|P4|PK Study|Not treated|0
4946363|NCT00340704|17013405|P3|PK Study|Not treated|1
4946364|NCT00340704|17013406|P2|PK Study|Not treated|0
4946365|NCT00340704|17013407|P1|PK Study|Not treated|0
4946366|NCT00340704|17013399|P9|PK Study|Adverse Event|0
4946367|NCT00340704|17013400|P8|PK Study|Adverse Event|0
4946368|NCT00340704|17013401|P7|PK Study|Adverse Event|0
4946369|NCT00340704|17013402|P6|PK Study|Adverse Event|0
4946370|NCT00340704|17013403|P5|PK Study|Adverse Event|0
4946371|NCT00340704|17013404|P4|PK Study|Adverse Event|0
4946372|NCT00340704|17013405|P3|PK Study|Adverse Event|0
4946373|NCT00340704|17013406|P2|PK Study|Adverse Event|1
4946374|NCT00340704|17013407|P1|PK Study|Adverse Event|0
4946375|NCT00340678|17013513|P4|Overall Study|Lost to Follow-up|0
4946376|NCT00340678|17013514|P3|Overall Study|Lost to Follow-up|0
4946377|NCT00340678|17013515|P2|Overall Study|Lost to Follow-up|0
4946378|NCT00340678|17013516|P1|Overall Study|Lost to Follow-up|1
4946379|NCT00339833|17013543|P2|Overall Study|Error in data records|0
4946380|NCT00339833|17013544|P1|Overall Study|Error in data records|1
4946381|NCT00339833|17013543|P2|Overall Study|anaemia or excess drop in glycaemia|0
4946382|NCT00339833|17013544|P1|Overall Study|anaemia or excess drop in glycaemia|2
4946383|NCT00339833|17013543|P2|Overall Study|Poor venous access|2
4946384|NCT00339833|17013544|P1|Overall Study|Poor venous access|2
4946385|NCT00339833|17013543|P2|Overall Study|minor infection|1
4946386|NCT00339833|17013544|P1|Overall Study|minor infection|0
4946387|NCT00339833|17013543|P2|Overall Study|Chest pain|1
4946388|NCT00339833|17013544|P1|Overall Study|Chest pain|0
4946389|NCT00339833|17013543|P2|Overall Study|indigestion|1
4946390|NCT00339833|17013544|P1|Overall Study|indigestion|0
4946391|NCT00339833|17013543|P2|Overall Study|toothache|1
4946392|NCT00339833|17013544|P1|Overall Study|toothache|0
4946393|NCT00339833|17013543|P2|Overall Study|Withdrawal by Subject|2
4946394|NCT00339833|17013544|P1|Overall Study|Withdrawal by Subject|1
4946395|NCT00339183|17013554|P2|Overall Study|Ongoing|13
4946396|NCT00339183|17013555|P1|Overall Study|Ongoing|20
4946397|NCT00339183|17013554|P2|Overall Study|Other|40
4946398|NCT00339183|17013555|P1|Overall Study|Other|46
4946399|NCT00339183|17013554|P2|Overall Study|Missing reason|1
4946400|NCT00339183|17013555|P1|Overall Study|Missing reason|3
4946401|NCT00339183|17013554|P2|Overall Study|Protocol-specified criteria|8
4946402|NCT00339183|17013555|P1|Overall Study|Protocol-specified criteria|12
4946403|NCT00339183|17013554|P2|Overall Study|Lost to Follow-up|17
4946404|NCT00339183|17013555|P1|Overall Study|Lost to Follow-up|17
4946405|NCT00339183|17013554|P2|Overall Study|Physician Decision|4
4946406|NCT00339183|17013555|P1|Overall Study|Physician Decision|2
4946407|NCT00339183|17013554|P2|Overall Study|Withdrawal by Subject|19
4946408|NCT00339183|17013555|P1|Overall Study|Withdrawal by Subject|16
4946409|NCT00339183|17013554|P2|Overall Study|Adverse Event|3
4946410|NCT00339183|17013555|P1|Overall Study|Adverse Event|5
4946411|NCT00339144|17013584|P3|Overall Study|Participant's request to discontinuation|1
4946412|NCT00339144|17013585|P2|Overall Study|Participant's request to discontinuation|0
4946413|NCT00339144|17013586|P1|Overall Study|Participant's request to discontinuation|1
4946414|NCT00339144|17013584|P3|Overall Study|Study drug toxicity|1
4946415|NCT00339144|17013585|P2|Overall Study|Study drug toxicity|1
4946416|NCT00339144|17013586|P1|Overall Study|Study drug toxicity|3
4946417|NCT00339144|17013584|P3|Overall Study|Disease progression|2
4946418|NCT00339144|17013585|P2|Overall Study|Disease progression|2
4946419|NCT00339144|17013586|P1|Overall Study|Disease progression|5
4946420|NCT00339040|17013691|P2|Stage II|Site closing|0
4946421|NCT00339040|17013692|P1|Stage II|Site closing|2
4946422|NCT00339040|17013691|P2|Stage II|Not able to attend clinic|0
4946423|NCT00339040|17013692|P1|Stage II|Not able to attend clinic|1
4946424|NCT00339040|17013691|P2|Stage II|Protocol Violation|0
4946425|NCT00339040|17013692|P1|Stage II|Protocol Violation|3
4946426|NCT00339040|17013691|P2|Stage II|Withdrawal by Subject|2
4946427|NCT00339040|17013692|P1|Stage II|Withdrawal by Subject|1
4946428|NCT00339040|17013691|P2|Stage II|Lost to Follow-up|0
4946429|NCT00339040|17013692|P1|Stage II|Lost to Follow-up|3
4946430|NCT00339040|17013691|P2|Stage I|Protocol Violation|1
4946431|NCT00339040|17013692|P1|Stage I|Protocol Violation|1
4946432|NCT00339040|17013691|P2|Stage I|Not able to attend clinic|0
4946433|NCT00339040|17013692|P1|Stage I|Not able to attend clinic|1
4946434|NCT00338962|17013719|P4|Overall Study|Poor Compliance|0
4946435|NCT00338962|17013720|P3|Overall Study|Poor Compliance|2
4946436|NCT00338962|17013721|P2|Overall Study|Poor Compliance|0
4946437|NCT00338962|17013722|P1|Overall Study|Poor Compliance|0
4946438|NCT00338962|17013719|P4|Overall Study|Adverse Event|0
4946439|NCT00338962|17013720|P3|Overall Study|Adverse Event|2
4946440|NCT00338962|17013721|P2|Overall Study|Adverse Event|0
4946441|NCT00338962|17013722|P1|Overall Study|Adverse Event|0
4946442|NCT00338962|17013719|P4|Overall Study|Moved|0
4946443|NCT00338962|17013720|P3|Overall Study|Moved|0
4946444|NCT00338962|17013721|P2|Overall Study|Moved|1
4946445|NCT00338962|17013722|P1|Overall Study|Moved|0
4946446|NCT00338962|17013719|P4|Overall Study|Time Constraint|0
4946447|NCT00338962|17013720|P3|Overall Study|Time Constraint|0
4946448|NCT00338962|17013721|P2|Overall Study|Time Constraint|0
4946449|NCT00338962|17013722|P1|Overall Study|Time Constraint|2
4946450|NCT00338962|17013719|P4|Overall Study|No Transportation|0
4946451|NCT00338962|17013720|P3|Overall Study|No Transportation|0
4946452|NCT00338962|17013721|P2|Overall Study|No Transportation|0
4946453|NCT00338962|17013722|P1|Overall Study|No Transportation|2
4946454|NCT00338962|17013719|P4|Overall Study|Withdrawal by Subject|0
4946455|NCT00338962|17013720|P3|Overall Study|Withdrawal by Subject|0
4946456|NCT00338962|17013721|P2|Overall Study|Withdrawal by Subject|0
4946457|NCT00338962|17013722|P1|Overall Study|Withdrawal by Subject|1
4946458|NCT00338962|17013719|P4|Overall Study|Lost to Follow-up|3
4946459|NCT00338962|17013720|P3|Overall Study|Lost to Follow-up|2
4946460|NCT00338962|17013721|P2|Overall Study|Lost to Follow-up|3
4946461|NCT00338962|17013722|P1|Overall Study|Lost to Follow-up|3
4946462|NCT00338884|17013744|P1|Overall Study|Randomized But Did Not Receive Treatment|1
4946463|NCT00338884|17013744|P1|Overall Study|Lost to Follow-up|1
4946464|NCT00338884|17013744|P1|Overall Study|Withdrawal by Subject|3
4946465|NCT00338884|17013744|P1|Overall Study|Global Deterioration of Health Status|3
4946466|NCT00338884|17013744|P1|Overall Study|Other|4
4946467|NCT00338884|17013744|P1|Overall Study|Death|8
4946468|NCT00338884|17013744|P1|Overall Study|Adverse Event|14
4946469|NCT00338884|17013744|P1|Overall Study|Objective Disease Progression or Relapse|44
4946470|NCT00338806|17013778|P2|Follow-up|Lost to Follow-up|3
4946471|NCT00338806|17013779|P1|Follow-up|Lost to Follow-up|1
4946472|NCT00338806|17013778|P2|Acute Phase|Withdrawal by Subject|1
4946473|NCT00338806|17013779|P1|Acute Phase|Withdrawal by Subject|0
4946474|NCT00338741|17013841|P2|Overall Study|Lost to Follow-up|0
4946475|NCT00338741|17013842|P1|Overall Study|Lost to Follow-up|2
4946476|NCT00338728|17013850|P1|Overall Study|Screen Failure|14
4946477|NCT00338455|17013878|P2|Overall Study|Physician Decision|0
4946478|NCT00338455|17013879|P1|Overall Study|Physician Decision|1
4946479|NCT00338455|17013878|P2|Overall Study|Death|1
4946480|NCT00338455|17013879|P1|Overall Study|Death|2
4946481|NCT00338286|17013893|P2|Overall Study|Other|93
4946482|NCT00338286|17013894|P1|Overall Study|Other|103
4946483|NCT00338286|17013893|P2|Overall Study|Lost to Follow-up|66
4946484|NCT00338286|17013894|P1|Overall Study|Lost to Follow-up|80
4946485|NCT00338286|17013893|P2|Overall Study|Withdrawal by Subject|54
4946486|NCT00338286|17013894|P1|Overall Study|Withdrawal by Subject|50
4946487|NCT00338104|17013911|P3|Overall Study|Protocol Violation|3
4946488|NCT00338104|17013912|P2|Overall Study|Protocol Violation|1
4946489|NCT00338104|17013913|P1|Overall Study|Protocol Violation|2
4946490|NCT00337935|17013936|P2|Overall Study|Lack of Efficacy|1
4946491|NCT00337935|17013937|P1|Overall Study|Lack of Efficacy|0
4946492|NCT00337935|17013936|P2|Overall Study|Other|1
4946493|NCT00337935|17013937|P1|Overall Study|Other|0
4946494|NCT00337935|17013936|P2|Overall Study|Withdrawal by Subject|7
4946495|NCT00337935|17013937|P1|Overall Study|Withdrawal by Subject|1
4946496|NCT00337935|17013936|P2|Overall Study|Protocol Violation|3
4946497|NCT00337935|17013937|P1|Overall Study|Protocol Violation|4
4946498|NCT00337935|17013936|P2|Overall Study|Lost to Follow-up|1
4946499|NCT00337935|17013937|P1|Overall Study|Lost to Follow-up|0
4946500|NCT00337935|17013936|P2|Overall Study|Physician Decision|1
4946501|NCT00337935|17013937|P1|Overall Study|Physician Decision|1
4946502|NCT00337935|17013936|P2|Overall Study|Death|8
4946503|NCT00337935|17013937|P1|Overall Study|Death|2
4946504|NCT00337935|17013936|P2|Overall Study|Adverse Event|5
4946505|NCT00337935|17013937|P1|Overall Study|Adverse Event|2
4946506|NCT00337818|17013950|P3|Overall Study|Lost to Follow-up|107
4946507|NCT00337818|17013951|P2|Overall Study|Lost to Follow-up|91
4946508|NCT00337818|17013952|P1|Overall Study|Lost to Follow-up|289
4946509|NCT00337779|17013974|P2|Overall Study|Death|1
4946510|NCT00337779|17013975|P1|Overall Study|Death|0
4946511|NCT00337779|17013974|P2|Overall Study|Pregnancy|2
4946512|NCT00337779|17013975|P1|Overall Study|Pregnancy|3
4946513|NCT00337779|17013974|P2|Overall Study|Adverse Event|51
4946514|NCT00337779|17013975|P1|Overall Study|Adverse Event|28
4946515|NCT00337779|17013974|P2|Overall Study|Lost to Follow-up|5
4946516|NCT00337779|17013975|P1|Overall Study|Lost to Follow-up|6
4946517|NCT00337779|17013974|P2|Overall Study|Protocol Violation|1
4946518|NCT00337779|17013975|P1|Overall Study|Protocol Violation|1
4946519|NCT00337779|17013974|P2|Overall Study|Physician Decision|6
4946520|NCT00337779|17013975|P1|Overall Study|Physician Decision|3
4946521|NCT00337779|17013974|P2|Overall Study|Sponsor decision|1
4946522|NCT00337779|17013975|P1|Overall Study|Sponsor decision|1
4946523|NCT00337779|17013974|P2|Overall Study|Withdrawal by Subject|12
4946524|NCT00337779|17013975|P1|Overall Study|Withdrawal by Subject|10
4946525|NCT00337727|17013987|P2|Overall Study|Withdrawal by Subject|5
4946526|NCT00337727|17013988|P1|Overall Study|Withdrawal by Subject|3
4946527|NCT00337727|17013987|P2|Overall Study|Protocol Violation|0
4946528|NCT00337727|17013988|P1|Overall Study|Protocol Violation|4
4946529|NCT00337727|17013987|P2|Overall Study|Physician Decision|0
4946530|NCT00337727|17013988|P1|Overall Study|Physician Decision|1
4946531|NCT00337727|17013987|P2|Overall Study|Lost to Follow-up|4
4946532|NCT00337727|17013988|P1|Overall Study|Lost to Follow-up|5
4946533|NCT00337727|17013987|P2|Overall Study|Adverse Event|3
4946534|NCT00337727|17013988|P1|Overall Study|Adverse Event|5
4946535|NCT00337675|17013999|P3|Overall Study|Trial Terminated|2
4946536|NCT00337675|17014000|P2|Overall Study|Trial Terminated|0
4946537|NCT00337675|17014001|P1|Overall Study|Trial Terminated|0
4946538|NCT00337675|17013999|P3|Overall Study|Progressive Disease|0
4946539|NCT00337675|17014000|P2|Overall Study|Progressive Disease|2
4946540|NCT00337675|17014001|P1|Overall Study|Progressive Disease|0
4946541|NCT00337675|17013999|P3|Overall Study|Withdrawal by Subject|19
4946542|NCT00337675|17014000|P2|Overall Study|Withdrawal by Subject|25
4946543|NCT00337675|17014001|P1|Overall Study|Withdrawal by Subject|25
4946544|NCT00337675|17013999|P3|Overall Study|Protocol Violation|19
4946545|NCT00337675|17014000|P2|Overall Study|Protocol Violation|24
4946546|NCT00337675|17014001|P1|Overall Study|Protocol Violation|21
4946547|NCT00337675|17013999|P3|Overall Study|Physician Decision|14
4946548|NCT00337675|17014000|P2|Overall Study|Physician Decision|17
4946549|NCT00337675|17014001|P1|Overall Study|Physician Decision|9
4946550|NCT00337675|17013999|P3|Overall Study|Lost to Follow-up|17
4946551|NCT00337675|17014000|P2|Overall Study|Lost to Follow-up|19
4946552|NCT00337675|17014001|P1|Overall Study|Lost to Follow-up|22
4946553|NCT00337675|17013999|P3|Overall Study|Lack of Efficacy|9
4946554|NCT00337675|17014000|P2|Overall Study|Lack of Efficacy|7
4946555|NCT00337675|17014001|P1|Overall Study|Lack of Efficacy|10
4946556|NCT00337675|17013999|P3|Overall Study|Adverse Event|19
4946557|NCT00337675|17014000|P2|Overall Study|Adverse Event|9
4946558|NCT00337675|17014001|P1|Overall Study|Adverse Event|10
4946559|NCT00337662|17014018|P4|Study Period III|Clinical Relapse|0
4946560|NCT00337662|17014019|P3|Study Period III|Clinical Relapse|0
4946561|NCT00337662|17014020|P2|Study Period III|Clinical Relapse|0
4946562|NCT00337662|17014021|P1|Study Period III|Clinical Relapse|1
4946563|NCT00337662|17014018|P4|Study Period III|Sponsor Decision|0
4946564|NCT00337662|17014019|P3|Study Period III|Sponsor Decision|1
4946565|NCT00337662|17014020|P2|Study Period III|Sponsor Decision|0
4946566|NCT00337662|17014021|P1|Study Period III|Sponsor Decision|1
4946567|NCT00337662|17014018|P4|Study Period III|Parent/Caregiver Decision|0
4946568|NCT00337662|17014019|P3|Study Period III|Parent/Caregiver Decision|2
4946569|NCT00337662|17014020|P2|Study Period III|Parent/Caregiver Decision|0
4946570|NCT00337662|17014021|P1|Study Period III|Parent/Caregiver Decision|0
4946571|NCT00337662|17014018|P4|Study Period III|Lack of Efficacy|0
4946572|NCT00337662|17014019|P3|Study Period III|Lack of Efficacy|2
4946573|NCT00337662|17014020|P2|Study Period III|Lack of Efficacy|4
4946574|NCT00337662|17014021|P1|Study Period III|Lack of Efficacy|4
4946575|NCT00337662|17014018|P4|Study Period III|Entry Criteria Not Met|0
4946576|NCT00337662|17014019|P3|Study Period III|Entry Criteria Not Met|3
4946577|NCT00337662|17014020|P2|Study Period III|Entry Criteria Not Met|1
4946578|NCT00337662|17014021|P1|Study Period III|Entry Criteria Not Met|4
4946579|NCT00337662|17014018|P4|Study Period III|Physician Decision|0
4946580|NCT00337662|17014019|P3|Study Period III|Physician Decision|0
4946581|NCT00337662|17014020|P2|Study Period III|Physician Decision|5
4946582|NCT00337662|17014021|P1|Study Period III|Physician Decision|6
4946583|NCT00337662|17014018|P4|Study Period III|Protocol Violation|0
4946584|NCT00337662|17014019|P3|Study Period III|Protocol Violation|2
4946585|NCT00337662|17014020|P2|Study Period III|Protocol Violation|8
4946586|NCT00337662|17014021|P1|Study Period III|Protocol Violation|3
4946587|NCT00337662|17014018|P4|Study Period III|Adverse Event|0
4946588|NCT00337662|17014019|P3|Study Period III|Adverse Event|8
4946589|NCT00337662|17014020|P2|Study Period III|Adverse Event|10
4946590|NCT00337662|17014021|P1|Study Period III|Adverse Event|9
4946591|NCT00337662|17014018|P4|Study Period III|Withdrawal by Subject|0
4946592|NCT00337662|17014019|P3|Study Period III|Withdrawal by Subject|12
4946593|NCT00337662|17014020|P2|Study Period III|Withdrawal by Subject|14
4946594|NCT00337662|17014021|P1|Study Period III|Withdrawal by Subject|18
4946595|NCT00337662|17014018|P4|Study Period III|Lost to Follow-up|0
4946596|NCT00337662|17014019|P3|Study Period III|Lost to Follow-up|14
4946597|NCT00337662|17014020|P2|Study Period III|Lost to Follow-up|16
4946598|NCT00337662|17014021|P1|Study Period III|Lost to Follow-up|14
4946599|NCT00337662|17014018|P4|Study Period II|Parent/Caregiver Decision|1
4946600|NCT00337662|17014019|P3|Study Period II|Parent/Caregiver Decision|0
4946601|NCT00337662|17014020|P2|Study Period II|Parent/Caregiver Decision|0
4946602|NCT00337662|17014021|P1|Study Period II|Parent/Caregiver Decision|0
4946603|NCT00337662|17014018|P4|Study Period II|Sponsor Decision|2
4946604|NCT00337662|17014019|P3|Study Period II|Sponsor Decision|0
4946605|NCT00337662|17014020|P2|Study Period II|Sponsor Decision|0
4946606|NCT00337662|17014021|P1|Study Period II|Sponsor Decision|0
4946607|NCT00337662|17014018|P4|Study Period II|Lack of Efficacy|7
4946608|NCT00337662|17014019|P3|Study Period II|Lack of Efficacy|0
4946609|NCT00337662|17014020|P2|Study Period II|Lack of Efficacy|0
4946610|NCT00337662|17014021|P1|Study Period II|Lack of Efficacy|0
4946611|NCT00337662|17014018|P4|Study Period II|Protocol Violation|6
4946612|NCT00337662|17014019|P3|Study Period II|Protocol Violation|0
4946613|NCT00337662|17014020|P2|Study Period II|Protocol Violation|0
4946614|NCT00337662|17014021|P1|Study Period II|Protocol Violation|0
4946615|NCT00337662|17014018|P4|Study Period II|Entry Criteria Not Met|6
4946616|NCT00337662|17014019|P3|Study Period II|Entry Criteria Not Met|0
4946617|NCT00337662|17014020|P2|Study Period II|Entry Criteria Not Met|0
4946618|NCT00337662|17014021|P1|Study Period II|Entry Criteria Not Met|0
4946619|NCT00337662|17014018|P4|Study Period II|Physician Decision|13
4946620|NCT00337662|17014019|P3|Study Period II|Physician Decision|0
4946621|NCT00337662|17014020|P2|Study Period II|Physician Decision|0
4946622|NCT00337662|17014021|P1|Study Period II|Physician Decision|0
4946623|NCT00337662|17014018|P4|Study Period II|Adverse Event|16
4946624|NCT00337662|17014019|P3|Study Period II|Adverse Event|0
4946625|NCT00337662|17014020|P2|Study Period II|Adverse Event|0
4946626|NCT00337662|17014021|P1|Study Period II|Adverse Event|0
4946627|NCT00337662|17014018|P4|Study Period II|Withdrawal by Subject|20
4946628|NCT00337662|17014019|P3|Study Period II|Withdrawal by Subject|0
4946629|NCT00337662|17014020|P2|Study Period II|Withdrawal by Subject|0
4946630|NCT00337662|17014021|P1|Study Period II|Withdrawal by Subject|0
4946631|NCT00337662|17014018|P4|Study Period II|Lost to Follow-up|35
4946632|NCT00337662|17014019|P3|Study Period II|Lost to Follow-up|0
4946633|NCT00337662|17014020|P2|Study Period II|Lost to Follow-up|0
4946634|NCT00337662|17014021|P1|Study Period II|Lost to Follow-up|0
4946635|NCT00337610|17014075|P2|Overall Study|Withdrawal by Subject|5
4946636|NCT00337610|17014076|P1|Overall Study|Withdrawal by Subject|6
4946637|NCT00337610|17014075|P2|Overall Study|Lost to Follow-up|3
4946638|NCT00337610|17014076|P1|Overall Study|Lost to Follow-up|3
4946639|NCT00337610|17014075|P2|Overall Study|Lack of Efficacy|3
4946640|NCT00337610|17014076|P1|Overall Study|Lack of Efficacy|6
4946641|NCT00337610|17014075|P2|Overall Study|Death|1
4946642|NCT00337610|17014076|P1|Overall Study|Death|0
4946643|NCT00337610|17014075|P2|Overall Study|Adverse Event|2
4946644|NCT00337610|17014076|P1|Overall Study|Adverse Event|2
4946645|NCT00337571|17014092|P4|Overall Study|High Potassium level|1
4946646|NCT00337571|17014093|P3|Overall Study|High Potassium level|0
4946647|NCT00337571|17014094|P2|Overall Study|High Potassium level|0
4946648|NCT00337571|17014095|P1|Overall Study|High Potassium level|0
4946649|NCT00337571|17014092|P4|Overall Study|No longer met study criteria|0
4946650|NCT00337571|17014093|P3|Overall Study|No longer met study criteria|0
4946651|NCT00337571|17014094|P2|Overall Study|No longer met study criteria|0
4946652|NCT00337571|17014095|P1|Overall Study|No longer met study criteria|1
4946653|NCT00337571|17014092|P4|Overall Study|Poor/noncompliance|1
4946654|NCT00337571|17014093|P3|Overall Study|Poor/noncompliance|1
4946655|NCT00337571|17014094|P2|Overall Study|Poor/noncompliance|1
4946656|NCT00337571|17014095|P1|Overall Study|Poor/noncompliance|1
4946657|NCT00337571|17014092|P4|Overall Study|Lost to Follow-up|1
4946658|NCT00337571|17014093|P3|Overall Study|Lost to Follow-up|0
4946659|NCT00337571|17014094|P2|Overall Study|Lost to Follow-up|1
4946660|NCT00337571|17014095|P1|Overall Study|Lost to Follow-up|3
4946661|NCT00337571|17014092|P4|Overall Study|Withdrawal by Subject|0
4946662|NCT00337571|17014093|P3|Overall Study|Withdrawal by Subject|1
4946663|NCT00337571|17014094|P2|Overall Study|Withdrawal by Subject|2
4946664|NCT00337571|17014095|P1|Overall Study|Withdrawal by Subject|2
4946665|NCT00337571|17014092|P4|Overall Study|Adverse Event|4
4946666|NCT00337571|17014093|P3|Overall Study|Adverse Event|8
4946667|NCT00337571|17014094|P2|Overall Study|Adverse Event|5
4946668|NCT00337571|17014095|P1|Overall Study|Adverse Event|4
4946669|NCT00337571|17014092|P4|Overall Study|Lack of Efficacy|0
4946670|NCT00337571|17014093|P3|Overall Study|Lack of Efficacy|0
4946671|NCT00337571|17014094|P2|Overall Study|Lack of Efficacy|0
4946672|NCT00337571|17014095|P1|Overall Study|Lack of Efficacy|3
4946673|NCT00337467|17014133|P1|Overall Study|Subject No Longer Met Study Criteria|2
4946674|NCT00337467|17014133|P1|Overall Study|Lost to Follow-up|2
4946675|NCT00337467|17014133|P1|Overall Study|Pregnancy|1
4946676|NCT00337467|17014133|P1|Overall Study|Subject Withdrew Consent|2
4946677|NCT00337467|17014133|P1|Overall Study|Adverse Event|3
4946678|NCT00337428|17014152|P2|Overall Study|Anorexia|0
4946679|NCT00337428|17014153|P1|Overall Study|Anorexia|1
4946680|NCT00337428|17014152|P2|Overall Study|Unwilling to Continue|0
4946681|NCT00337428|17014153|P1|Overall Study|Unwilling to Continue|1
4946682|NCT00337428|17014152|P2|Overall Study|Lack of Time|1
4946683|NCT00337428|17014153|P1|Overall Study|Lack of Time|1
4946684|NCT00337428|17014152|P2|Overall Study|Withdrawal by Subject|2
4946685|NCT00337428|17014153|P1|Overall Study|Withdrawal by Subject|1
4946686|NCT00337285|17014204|P1|Overall Study|Lack of protocol compliance|7
4946687|NCT00337285|17014204|P1|Overall Study|Physician Decision|1
4946688|NCT00337285|17014204|P1|Overall Study|Death|1
4946689|NCT00337285|17014204|P1|Overall Study|Lack of Efficacy|11
4946690|NCT00337285|17014204|P1|Overall Study|Protocol Violation|27
4946691|NCT00337285|17014204|P1|Overall Study|Adverse Event|28
4946692|NCT00337285|17014204|P1|Overall Study|Lost to Follow-up|41
4946693|NCT00337285|17014204|P1|Overall Study|Withdrawal by Subject|42
4946694|NCT00337272|17014212|P2|Withdrawal Period|Non-compliance|1
4946695|NCT00337272|17014213|P1|Withdrawal Period|Non-compliance|0
4946696|NCT00337272|17014212|P2|Treatment Period|Withdrawal by Subject|1
4946697|NCT00337272|17014213|P1|Treatment Period|Withdrawal by Subject|0
4946698|NCT00337272|17014212|P2|Treatment Period|Non-compliance|1
4946699|NCT00337272|17014213|P1|Treatment Period|Non-compliance|1
4946700|NCT00337272|17014212|P2|Screening Period (Pre-randomization)|Screen failure|0
4946701|NCT00337272|17014213|P1|Screening Period (Pre-randomization)|Screen failure|3
4946702|NCT00337272|17014212|P2|Screening Period (Pre-randomization)|Non-compliance|0
4946703|NCT00337272|17014213|P1|Screening Period (Pre-randomization)|Non-compliance|1
4946704|NCT00337272|17014212|P2|Screening Period (Pre-randomization)|Withdrawal by Subject|0
4946705|NCT00337272|17014213|P1|Screening Period (Pre-randomization)|Withdrawal by Subject|2
4946706|NCT00337207|17014233|P1|Overall Study|Withdrawal by Subject|3
4946707|NCT00337194|17014241|P2|Overall Study|Subsequent non-protocol therapy|1
4946708|NCT00337194|17014242|P1|Overall Study|Subsequent non-protocol therapy|3
4946709|NCT00337194|17014241|P2|Overall Study|Disease progression|2
4946710|NCT00337194|17014242|P1|Overall Study|Disease progression|1
4946711|NCT00337194|17014241|P2|Overall Study|Withdrawal by Subject|0
4946712|NCT00337194|17014242|P1|Overall Study|Withdrawal by Subject|1
4946713|NCT00337194|17014241|P2|Overall Study|Death|0
4946714|NCT00337194|17014242|P1|Overall Study|Death|2
4946715|NCT00337194|17014241|P2|Overall Study|Adverse Event|1
4946716|NCT00337194|17014242|P1|Overall Study|Adverse Event|5
4946717|NCT00337168|17014266|P1|Overall Study|Did not start therapy|1
4946718|NCT00337168|17014266|P1|Overall Study|Not protocol specified|2
4946719|NCT00337168|17014266|P1|Overall Study|Death|5
4946720|NCT00337129|17014273|P1|Overall Study|not protocol specified|1
4946721|NCT00337129|17014273|P1|Overall Study|Death|2
4946722|NCT00337129|17014273|P1|Overall Study|Lack of Efficacy|32
4946723|NCT00337129|17014273|P1|Overall Study|Withdrawal by Subject|1
4946724|NCT00337129|17014273|P1|Overall Study|Adverse Event|4
4946725|NCT00337103|17014282|P2|Overall Study|Death|0
4946726|NCT00337103|17014283|P1|Overall Study|Death|1
4946727|NCT00337103|17014282|P2|Overall Study|Lost to Follow-up|2
4946728|NCT00337103|17014283|P1|Overall Study|Lost to Follow-up|1
4946729|NCT00337103|17014282|P2|Overall Study|Entry Criteria Not Met|1
4946730|NCT00337103|17014283|P1|Overall Study|Entry Criteria Not Met|4
4946731|NCT00337103|17014282|P2|Overall Study|Other|6
4946732|NCT00337103|17014283|P1|Overall Study|Other|5
4946733|NCT00337103|17014282|P2|Overall Study|Withdrawal by Subject|5
4946734|NCT00337103|17014283|P1|Overall Study|Withdrawal by Subject|8
4946735|NCT00337103|17014282|P2|Overall Study|Physician Decision|14
4946736|NCT00337103|17014283|P1|Overall Study|Physician Decision|15
4946737|NCT00337103|17014282|P2|Overall Study|Clinical Progression|24
4946738|NCT00337103|17014283|P1|Overall Study|Clinical Progression|27
4946739|NCT00337103|17014282|P2|Overall Study|Subject Choice|27
4946740|NCT00337103|17014283|P1|Overall Study|Subject Choice|34
4946741|NCT00337103|17014282|P2|Overall Study|Adverse Event|59
4946742|NCT00337103|17014283|P1|Overall Study|Adverse Event|45
4946743|NCT00337103|17014282|P2|Overall Study|Progressive Disease|410
4946744|NCT00337103|17014283|P1|Overall Study|Progressive Disease|414
4946745|NCT00337077|17014317|P3|Overall Study|Ineligible|1
4946746|NCT00337077|17014318|P2|Overall Study|Ineligible|1
4946747|NCT00337077|17014319|P1|Overall Study|Ineligible|1
4946748|NCT00337077|17014317|P3|Overall Study|Never started treatment|0
4946749|NCT00337077|17014318|P2|Overall Study|Never started treatment|1
4946750|NCT00337077|17014319|P1|Overall Study|Never started treatment|1
4946751|NCT00337077|17014317|P3|Overall Study|Physician Decision|2
4946752|NCT00337077|17014318|P2|Overall Study|Physician Decision|4
4946753|NCT00337077|17014319|P1|Overall Study|Physician Decision|1
4946754|NCT00337077|17014317|P3|Overall Study|Alternative therapy|0
4946755|NCT00337077|17014318|P2|Overall Study|Alternative therapy|0
4946756|NCT00337077|17014319|P1|Overall Study|Alternative therapy|1
4946757|NCT00337077|17014317|P3|Overall Study|Withdrawal by Subject|2
4946758|NCT00337077|17014318|P2|Overall Study|Withdrawal by Subject|2
4946759|NCT00337077|17014319|P1|Overall Study|Withdrawal by Subject|7
4946760|NCT00337077|17014317|P3|Overall Study|Death|0
4946761|NCT00337077|17014318|P2|Overall Study|Death|1
4946762|NCT00337077|17014319|P1|Overall Study|Death|0
4946763|NCT00337077|17014317|P3|Overall Study|Adverse Event|1
4946764|NCT00337077|17014318|P2|Overall Study|Adverse Event|7
4946765|NCT00337077|17014319|P1|Overall Study|Adverse Event|7
4946766|NCT00337077|17014317|P3|Overall Study|Progressive disease|19
4946767|NCT00337077|17014318|P2|Overall Study|Progressive disease|37
4946768|NCT00337077|17014319|P1|Overall Study|Progressive disease|25
4946769|NCT00336895|17014334|P1|Overall Study|screen failed|1
4946770|NCT00336895|17014334|P1|Overall Study|Physician Decision|1
4946771|NCT00336895|17014334|P1|Overall Study|nausea and upset stomach|1
4946772|NCT00336895|17014334|P1|Overall Study|diarrhea|1
4946773|NCT00336856|17014340|P1|Overall Study|Found ineligible at time of analysis|1
4946774|NCT00336856|17014340|P1|Overall Study|Withdrawal by Subject|3
4946775|NCT00336583|17014388|P1|Overall Study|Death|1
4946776|NCT00336583|17014388|P1|Overall Study|Lost to Follow-up|1
4946777|NCT00336544|17014395|P2|Overall Study|Other|5
4946778|NCT00336544|17014396|P1|Overall Study|Other|3
4946779|NCT00336544|17014395|P2|Overall Study|Withdrawal by Subject|3
4946780|NCT00336544|17014396|P1|Overall Study|Withdrawal by Subject|4
4946781|NCT00336544|17014395|P2|Overall Study|Adverse Event|9
4946782|NCT00336544|17014396|P1|Overall Study|Adverse Event|4
4946783|NCT00336544|17014395|P2|Overall Study|Lack of Efficacy|5
4946784|NCT00336544|17014396|P1|Overall Study|Lack of Efficacy|8
4946785|NCT00336505|17014410|P2|Overall Study|Other|7
4946786|NCT00336505|17014411|P1|Overall Study|Other|7
4946787|NCT00336505|17014410|P2|Overall Study|Withdrawal by Subject|3
4946788|NCT00336505|17014411|P1|Overall Study|Withdrawal by Subject|5
4946789|NCT00336505|17014410|P2|Overall Study|Lost to Follow-up|4
4946790|NCT00336505|17014411|P1|Overall Study|Lost to Follow-up|7
4946791|NCT00336505|17014410|P2|Overall Study|Lack of Efficacy|4
4946792|NCT00336505|17014411|P1|Overall Study|Lack of Efficacy|8
4946793|NCT00336505|17014410|P2|Overall Study|Adverse Event|9
4946794|NCT00336505|17014411|P1|Overall Study|Adverse Event|10
4946795|NCT00336492|17014426|P3|Overall Study|Other|1
4946796|NCT00336492|17014427|P2|Overall Study|Other|0
4946797|NCT00336492|17014428|P1|Overall Study|Other|5
4946798|NCT00336492|17014426|P3|Overall Study|Lack of Efficacy|4
4946799|NCT00336492|17014427|P2|Overall Study|Lack of Efficacy|1
4946800|NCT00336492|17014428|P1|Overall Study|Lack of Efficacy|6
4946801|NCT00336492|17014426|P3|Overall Study|Adverse Event|6
4946802|NCT00336492|17014427|P2|Overall Study|Adverse Event|3
4946803|NCT00336492|17014428|P1|Overall Study|Adverse Event|4
4946804|NCT00336479|17014440|P4|Overall Study|Virologic Stopping Rule|0
4946805|NCT00336479|17014441|P3|Overall Study|Virologic Stopping Rule|0
4946806|NCT00336479|17014442|P2|Overall Study|Virologic Stopping Rule|0
4946807|NCT00336479|17014443|P1|Overall Study|Virologic Stopping Rule|20
4946808|NCT00336479|17014440|P4|Overall Study|Other|0
4946809|NCT00336479|17014441|P3|Overall Study|Other|1
4946810|NCT00336479|17014442|P2|Overall Study|Other|0
4946811|NCT00336479|17014443|P1|Overall Study|Other|0
4946812|NCT00336479|17014440|P4|Overall Study|Withdrawal by Subject|0
4946813|NCT00336479|17014441|P3|Overall Study|Withdrawal by Subject|3
4946814|NCT00336479|17014442|P2|Overall Study|Withdrawal by Subject|2
4946815|NCT00336479|17014443|P1|Overall Study|Withdrawal by Subject|3
4946816|NCT00336479|17014440|P4|Overall Study|Lost to Follow-up|0
4946817|NCT00336479|17014441|P3|Overall Study|Lost to Follow-up|0
4946818|NCT00336479|17014442|P2|Overall Study|Lost to Follow-up|2
4946819|NCT00336479|17014443|P1|Overall Study|Lost to Follow-up|3
4946820|NCT00336479|17014440|P4|Overall Study|Physician Decision|0
4946821|NCT00336479|17014441|P3|Overall Study|Physician Decision|1
4946822|NCT00336479|17014442|P2|Overall Study|Physician Decision|3
4946823|NCT00336479|17014443|P1|Overall Study|Physician Decision|2
4946824|NCT00336479|17014440|P4|Overall Study|Noncompliant|0
4946825|NCT00336479|17014441|P3|Overall Study|Noncompliant|3
4946826|NCT00336479|17014442|P2|Overall Study|Noncompliant|7
4946827|NCT00336479|17014443|P1|Overall Study|Noncompliant|1
4946828|NCT00336479|17014440|P4|Overall Study|Adverse Event|4
4946829|NCT00336479|17014441|P3|Overall Study|Adverse Event|18
4946830|NCT00336479|17014442|P2|Overall Study|Adverse Event|11
4946831|NCT00336479|17014443|P1|Overall Study|Adverse Event|8
4946832|NCT00336284|17014532|P2|Overall Study|Withdrawal by Physician or Subject|64
4946833|NCT00336284|17014533|P1|Overall Study|Withdrawal by Physician or Subject|102
4946834|NCT00336284|17014532|P2|Overall Study|Lost to Follow-up|61
4946835|NCT00336284|17014533|P1|Overall Study|Lost to Follow-up|82
4946836|NCT00336284|17014532|P2|Overall Study|Death|26
4946837|NCT00336284|17014533|P1|Overall Study|Death|52
4946838|NCT00336024|17014551|P2|Overall Study|Ineligible|7
4946839|NCT00336024|17014552|P1|Overall Study|Ineligible|7
4946840|NCT00336024|17014551|P2|Overall Study|Progressive Disease|7
4946841|NCT00336024|17014552|P1|Overall Study|Progressive Disease|4
4946842|NCT00336024|17014551|P2|Overall Study|Failure to fulfill consolidation|1
4946843|NCT00336024|17014552|P1|Overall Study|Failure to fulfill consolidation|1
4946844|NCT00336024|17014551|P2|Overall Study|Withdrawal by Subject|2
4946845|NCT00336024|17014552|P1|Overall Study|Withdrawal by Subject|1
4946846|NCT00336024|17014551|P2|Overall Study|Protocol Violation|0
4946847|NCT00336024|17014552|P1|Overall Study|Protocol Violation|1
4946848|NCT00336024|17014551|P2|Overall Study|Physician Decision|1
4946849|NCT00336024|17014552|P1|Overall Study|Physician Decision|4
4946850|NCT00336024|17014551|P2|Overall Study|Death|1
4946851|NCT00336024|17014552|P1|Overall Study|Death|2
4946852|NCT00335972|17014588|P2|Overall Study|not given treatments|3
4946853|NCT00335972|17014589|P1|Overall Study|not given treatments|0
4946854|NCT00335959|17014599|P1|Overall Study|Ineligible|1
4946855|NCT00335959|17014599|P1|Overall Study|Adverse Event|2
4946856|NCT00335829|17014604|P1|Overall Study|Adverse Event|1
4946857|NCT00335829|17014604|P1|Overall Study|Lost to Follow-up|1
4946858|NCT00335829|17014604|P1|Overall Study|Withdrawal by Subject|1
4946859|NCT00335777|17014618|P1|Treated 2 Headaches Per Protocol|Treated 1 early and 1 late out of protoc|12
4946860|NCT00335777|17014618|P1|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1
4946861|NCT00335777|17014618|P1|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18
4946862|NCT00335777|17014618|P1|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6
4946863|NCT00335777|17014618|P1|Enrolled and Dispensed Study Medication|Lost to Follow-up|5
4946864|NCT00335764|17014628|P5|Overall Study|wrong histology|1
4946865|NCT00335764|17014629|P4|Overall Study|wrong histology|0
4946866|NCT00335764|17014630|P3|Overall Study|wrong histology|0
4946867|NCT00335764|17014631|P2|Overall Study|wrong histology|0
4946868|NCT00335764|17014632|P1|Overall Study|wrong histology|1
4946869|NCT00335738|17014681|P2|Overall Study|Ineligible|4
4946870|NCT00335738|17014682|P1|Overall Study|Ineligible|3
4946871|NCT00335738|17014681|P2|Overall Study|Withdrawal by Subject|0
4946872|NCT00335738|17014682|P1|Overall Study|Withdrawal by Subject|2
4946873|NCT00335738|17014681|P2|Overall Study|Physician Decision|0
4946874|NCT00335738|17014682|P1|Overall Study|Physician Decision|6
4946875|NCT00335556|17014714|P6|Overall Study|Refusal of further protocol therapy|0
4946876|NCT00335556|17014715|P5|Overall Study|Refusal of further protocol therapy|0
4946877|NCT00335556|17014716|P4|Overall Study|Refusal of further protocol therapy|1
4946878|NCT00335556|17014717|P3|Overall Study|Refusal of further protocol therapy|0
4946879|NCT00335556|17014718|P2|Overall Study|Refusal of further protocol therapy|4
4946880|NCT00335556|17014719|P1|Overall Study|Refusal of further protocol therapy|0
4946881|NCT00335556|17014714|P6|Overall Study|Ineligible|0
4946882|NCT00335556|17014715|P5|Overall Study|Ineligible|0
4946883|NCT00335556|17014716|P4|Overall Study|Ineligible|0
4946884|NCT00335556|17014717|P3|Overall Study|Ineligible|0
4946885|NCT00335556|17014718|P2|Overall Study|Ineligible|0
4946886|NCT00335556|17014719|P1|Overall Study|Ineligible|2
4946887|NCT00335556|17014714|P6|Overall Study|Physician Decision|0
4946888|NCT00335556|17014715|P5|Overall Study|Physician Decision|0
4946889|NCT00335556|17014716|P4|Overall Study|Physician Decision|1
4946890|NCT00335556|17014717|P3|Overall Study|Physician Decision|2
4946891|NCT00335556|17014718|P2|Overall Study|Physician Decision|6
4946892|NCT00335556|17014719|P1|Overall Study|Physician Decision|0
4946893|NCT00335556|17014714|P6|Overall Study|Lack of Efficacy|1
4946894|NCT00335556|17014715|P5|Overall Study|Lack of Efficacy|0
4946895|NCT00335556|17014716|P4|Overall Study|Lack of Efficacy|3
4946896|NCT00335556|17014717|P3|Overall Study|Lack of Efficacy|3
4946897|NCT00335556|17014718|P2|Overall Study|Lack of Efficacy|19
4946898|NCT00335556|17014719|P1|Overall Study|Lack of Efficacy|0
4946899|NCT00335556|17014714|P6|Overall Study|Death|0
4946900|NCT00335556|17014715|P5|Overall Study|Death|1
4946901|NCT00335556|17014716|P4|Overall Study|Death|0
4946902|NCT00335556|17014717|P3|Overall Study|Death|0
4946903|NCT00335556|17014718|P2|Overall Study|Death|5
4946904|NCT00335556|17014719|P1|Overall Study|Death|0
4946905|NCT00335452|17014781|P4|Overall Study|Lost to Follow-up|2
4946906|NCT00335452|17014782|P3|Overall Study|Lost to Follow-up|1
4946907|NCT00335452|17014783|P2|Overall Study|Lost to Follow-up|3
4946908|NCT00335452|17014784|P1|Overall Study|Lost to Follow-up|2
4946909|NCT00335452|17014781|P4|Overall Study|Death|129
4946910|NCT00335452|17014782|P3|Overall Study|Death|158
4946911|NCT00335452|17014783|P2|Overall Study|Death|144
4946912|NCT00335452|17014784|P1|Overall Study|Death|156
4946913|NCT00335322|17014809|P3|Overall Study|Randomised but withdrew prior to ART sta|2
4946914|NCT00335322|17014810|P2|Overall Study|Randomised but withdrew prior to ART sta|2
4946915|NCT00335322|17014811|P1|Overall Study|Randomised but withdrew prior to ART sta|1
4946916|NCT00335153|17014859|P1|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2
4946917|NCT00335153|17014859|P1|Post-PEG-J Long-Term Treatment Period|Administrative|13
4946918|NCT00335153|17014859|P1|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13
4946919|NCT00335153|17014859|P1|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2
4946920|NCT00335153|17014859|P1|Post-PEG-J Long-Term Treatment Period|Adverse Event|22
4946921|NCT00335153|17014859|P1|Nasojejunal (NJ) Test Period|Protocol Violation|7
4946922|NCT00335153|17014859|P1|Nasojejunal (NJ) Test Period|Administrative|1
4946923|NCT00335153|17014859|P1|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12
4946924|NCT00335153|17014859|P1|Nasojejunal (NJ) Test Period|Lack of Efficacy|5
4946925|NCT00335153|17014859|P1|Nasojejunal (NJ) Test Period|Adverse Event|5
4946926|NCT00335140|17014896|P1|Overall Study|Ineligible|1
4946927|NCT00334958|17014902|P2|Overall Study|Other|2
4946928|NCT00334958|17014903|P1|Overall Study|Other|1
4946929|NCT00334958|17014902|P2|Overall Study|Adverse Event|12
4946930|NCT00334958|17014903|P1|Overall Study|Adverse Event|27
4946931|NCT00334958|17014902|P2|Overall Study|Withdrawal by Subject|4
4946932|NCT00334958|17014903|P1|Overall Study|Withdrawal by Subject|7
4946933|NCT00334958|17014902|P2|Overall Study|Request of the investigator or sponsor|1
4946934|NCT00334958|17014903|P1|Overall Study|Request of the investigator or sponsor|0
4946935|NCT00334958|17014902|P2|Overall Study|Protocol Violation|2
4946936|NCT00334958|17014903|P1|Overall Study|Protocol Violation|2
4946937|NCT00334958|17014902|P2|Overall Study|Medication Noncompliance|3
4946938|NCT00334958|17014903|P1|Overall Study|Medication Noncompliance|0
4946939|NCT00334893|17014917|P2|Overall Study|Not Treated|0
4946940|NCT00334893|17014918|P1|Overall Study|Not Treated|1
4946941|NCT00334815|17014928|P2|Overall Study|Physician Decision|4
4946942|NCT00334815|17014929|P1|Overall Study|Physician Decision|2
4946943|NCT00334815|17014928|P2|Overall Study|patient refused treatment|1
4946944|NCT00334815|17014929|P1|Overall Study|patient refused treatment|0
4946945|NCT00334815|17014928|P2|Overall Study|ineligible|1
4946946|NCT00334815|17014929|P1|Overall Study|ineligible|1
4946947|NCT00334815|17014928|P2|Overall Study|Progression|0
4946948|NCT00334815|17014929|P1|Overall Study|Progression|1
4946949|NCT00334815|17014928|P2|Overall Study|Death|2
4946950|NCT00334815|17014929|P1|Overall Study|Death|0
4946951|NCT00334815|17014928|P2|Overall Study|Adverse Event|2
4946952|NCT00334815|17014929|P1|Overall Study|Adverse Event|3
4946953|NCT00334802|17014943|P2|Overall Study|Criteria for Starting Next Cycle Not Met|1
4946954|NCT00334802|17014944|P1|Overall Study|Criteria for Starting Next Cycle Not Met|0
4946955|NCT00334802|17014943|P2|Overall Study|Adverse Event|3
4946956|NCT00334802|17014944|P1|Overall Study|Adverse Event|0
4946957|NCT00334802|17014943|P2|Overall Study|Withdrawal by Subject|4
4946958|NCT00334802|17014944|P1|Overall Study|Withdrawal by Subject|0
4946959|NCT00334802|17014943|P2|Overall Study|Physician Decision|0
4946960|NCT00334802|17014944|P1|Overall Study|Physician Decision|1
4946961|NCT00334802|17014943|P2|Overall Study|Patient Condition Aggrevated|0
4946962|NCT00334802|17014944|P1|Overall Study|Patient Condition Aggrevated|1
4946963|NCT00334802|17014943|P2|Overall Study|Lack of Efficacy|3
4946964|NCT00334802|17014944|P1|Overall Study|Lack of Efficacy|1
4946965|NCT00334802|17014943|P2|Overall Study|Toxicity|5
4946966|NCT00334802|17014944|P1|Overall Study|Toxicity|1
4946967|NCT00334802|17014943|P2|Overall Study|Progressive Disease|24
4946968|NCT00334802|17014944|P1|Overall Study|Progressive Disease|2
4946969|NCT00334737|17014964|P3|Follow up Phase|Lost to Follow-up|6
4946970|NCT00334737|17014965|P2|Follow up Phase|Lost to Follow-up|3
4946971|NCT00334737|17014966|P1|Follow up Phase|Lost to Follow-up|5
4946972|NCT00334737|17014964|P3|Hospital Phase|Did not receive study drug|0
4946973|NCT00334737|17014965|P2|Hospital Phase|Did not receive study drug|0
4946974|NCT00334737|17014966|P1|Hospital Phase|Did not receive study drug|1
4946975|NCT00334737|17014964|P3|Hospital Phase|Withdrawal by Subject|1
4946976|NCT00334737|17014965|P2|Hospital Phase|Withdrawal by Subject|0
4946977|NCT00334737|17014966|P1|Hospital Phase|Withdrawal by Subject|0
4946978|NCT00334737|17014964|P3|Hospital Phase|Death|3
4946979|NCT00334737|17014965|P2|Hospital Phase|Death|2
4946980|NCT00334737|17014966|P1|Hospital Phase|Death|1
4946981|NCT00334542|17015014|P1|Overall Study|New cancer diagnosis|1
4946982|NCT00334542|17015014|P1|Overall Study|Withdrawal by Subject|1
4946983|NCT00334542|17015014|P1|Overall Study|Adverse Event|3
4946984|NCT00334295|17015021|P1|Overall Study|Patients received fewer than 3 injection|5
4946985|NCT00334282|17015031|P2|Overall Study|Death|100
4946986|NCT00334282|17015032|P1|Overall Study|Death|194
4946987|NCT00334282|17015031|P2|Overall Study|Withdrawal by Subject|3
4946988|NCT00334282|17015032|P1|Overall Study|Withdrawal by Subject|17
4946989|NCT00334282|17015031|P2|Overall Study|Lost to Follow-up|5
4946990|NCT00334282|17015032|P1|Overall Study|Lost to Follow-up|11
4946991|NCT00334113|17015063|P2|Overall Study|Withdrawal by Subject|1
4946992|NCT00334113|17015064|P1|Overall Study|Withdrawal by Subject|0
4946993|NCT00334113|17015063|P2|Overall Study|Lost to Follow-up|2
4946994|NCT00334113|17015064|P1|Overall Study|Lost to Follow-up|2
4946995|NCT00333983|17015087|P3|Overall Study|Withdrawal by Subject|1
4946996|NCT00333983|17015088|P2|Overall Study|Withdrawal by Subject|3
4946997|NCT00333983|17015089|P1|Overall Study|Withdrawal by Subject|0
4946998|NCT00333983|17015087|P3|Overall Study|Adverse Event|1
4946999|NCT00333983|17015088|P2|Overall Study|Adverse Event|1
4947000|NCT00333983|17015089|P1|Overall Study|Adverse Event|1
4947001|NCT00333983|17015087|P3|Overall Study|Lost to Follow-up|0
4947002|NCT00333983|17015088|P2|Overall Study|Lost to Follow-up|1
4947003|NCT00333983|17015089|P1|Overall Study|Lost to Follow-up|2
4947004|NCT00333970|17015099|P2|Overall Study|Withdrawal by Subject|7
4947005|NCT00333970|17015100|P1|Overall Study|Withdrawal by Subject|13
4947006|NCT00333866|17015115|P4|Overall Study|Randomized but not Treated|1
4947007|NCT00333866|17015116|P3|Overall Study|Randomized but not Treated|2
4947008|NCT00333866|17015117|P2|Overall Study|Randomized but not Treated|3
4947009|NCT00333866|17015118|P1|Overall Study|Randomized but not Treated|5
4947010|NCT00333866|17015115|P4|Overall Study|Withdrawal by Subject|9
4947011|NCT00333866|17015116|P3|Overall Study|Withdrawal by Subject|4
4947012|NCT00333866|17015117|P2|Overall Study|Withdrawal by Subject|14
4947013|NCT00333866|17015118|P1|Overall Study|Withdrawal by Subject|8
4947014|NCT00333866|17015115|P4|Overall Study|Lost to Follow-up|2
4947015|NCT00333866|17015116|P3|Overall Study|Lost to Follow-up|2
4947016|NCT00333866|17015117|P2|Overall Study|Lost to Follow-up|2
4947017|NCT00333866|17015118|P1|Overall Study|Lost to Follow-up|1
4947018|NCT00333866|17015115|P4|Overall Study|Lack of Efficacy|5
4947019|NCT00333866|17015116|P3|Overall Study|Lack of Efficacy|3
4947020|NCT00333866|17015117|P2|Overall Study|Lack of Efficacy|6
4947021|NCT00333866|17015118|P1|Overall Study|Lack of Efficacy|8
4947022|NCT00333866|17015115|P4|Overall Study|Other|2
4947023|NCT00333866|17015116|P3|Overall Study|Other|2
4947024|NCT00333866|17015117|P2|Overall Study|Other|2
4947025|NCT00333866|17015118|P1|Overall Study|Other|3
4947026|NCT00333866|17015115|P4|Overall Study|Adverse Event|47
4947027|NCT00333866|17015116|P3|Overall Study|Adverse Event|38
4947028|NCT00333866|17015117|P2|Overall Study|Adverse Event|37
4947029|NCT00333866|17015118|P1|Overall Study|Adverse Event|23
4947030|NCT00333840|17015178|P4|Second-line Treatment Period|Death|9
4947031|NCT00333840|17015179|P3|Second-line Treatment Period|Death|0
4947032|NCT00333840|17015180|P2|Second-line Treatment Period|Death|0
4947033|NCT00333840|17015181|P1|Second-line Treatment Period|Death|0
4947034|NCT00333840|17015178|P4|Second-line Treatment Period|Administrative problems|7
4947035|NCT00333840|17015179|P3|Second-line Treatment Period|Administrative problems|0
4947036|NCT00333840|17015180|P2|Second-line Treatment Period|Administrative problems|0
4947037|NCT00333840|17015181|P1|Second-line Treatment Period|Administrative problems|0
4947038|NCT00333840|17015178|P4|Second-line Treatment Period|Lost to Follow-up|6
4947039|NCT00333840|17015179|P3|Second-line Treatment Period|Lost to Follow-up|0
4947040|NCT00333840|17015180|P2|Second-line Treatment Period|Lost to Follow-up|0
4947041|NCT00333840|17015181|P1|Second-line Treatment Period|Lost to Follow-up|0
4947042|NCT00333840|17015178|P4|Second-line Treatment Period|Subject withdrew consent|34
4947043|NCT00333840|17015179|P3|Second-line Treatment Period|Subject withdrew consent|0
4947044|NCT00333840|17015180|P2|Second-line Treatment Period|Subject withdrew consent|0
4947045|NCT00333840|17015181|P1|Second-line Treatment Period|Subject withdrew consent|0
4947046|NCT00333840|17015178|P4|Second-line Treatment Period|Protocol Violation|10
4947047|NCT00333840|17015179|P3|Second-line Treatment Period|Protocol Violation|1
4947048|NCT00333840|17015180|P2|Second-line Treatment Period|Protocol Violation|0
4947049|NCT00333840|17015181|P1|Second-line Treatment Period|Protocol Violation|0
4947050|NCT00333840|17015178|P4|Second-line Treatment Period|No longer required study drug|14
4947051|NCT00333840|17015179|P3|Second-line Treatment Period|No longer required study drug|1
4947052|NCT00333840|17015180|P2|Second-line Treatment Period|No longer required study drug|0
4947053|NCT00333840|17015181|P1|Second-line Treatment Period|No longer required study drug|0
4947054|NCT00333840|17015178|P4|Second-line Treatment Period|Unsatisfactory therapeutic effect|70
4947055|NCT00333840|17015179|P3|Second-line Treatment Period|Unsatisfactory therapeutic effect|9
4947056|NCT00333840|17015180|P2|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
4947057|NCT00333840|17015181|P1|Second-line Treatment Period|Unsatisfactory therapeutic effect|0
4947058|NCT00333840|17015178|P4|Second-line Treatment Period|Abnormal procedure|1
4947059|NCT00333840|17015179|P3|Second-line Treatment Period|Abnormal procedure|0
4947060|NCT00333840|17015180|P2|Second-line Treatment Period|Abnormal procedure|0
4947061|NCT00333840|17015181|P1|Second-line Treatment Period|Abnormal procedure|0
4947062|NCT00333840|17015178|P4|Second-line Treatment Period|Abnormal Laboratory Values|3
4947063|NCT00333840|17015179|P3|Second-line Treatment Period|Abnormal Laboratory Values|0
4947064|NCT00333840|17015180|P2|Second-line Treatment Period|Abnormal Laboratory Values|0
4947065|NCT00333840|17015181|P1|Second-line Treatment Period|Abnormal Laboratory Values|0
4947066|NCT00333840|17015178|P4|Second-line Treatment Period|Adverse Event|34
4947067|NCT00333840|17015179|P3|Second-line Treatment Period|Adverse Event|3
4947068|NCT00333840|17015180|P2|Second-line Treatment Period|Adverse Event|0
4947069|NCT00333840|17015181|P1|Second-line Treatment Period|Adverse Event|0
4947070|NCT00333840|17015178|P4|First-line Treatment Period|Crossed over to other treatment arm|0
4947071|NCT00333840|17015179|P3|First-line Treatment Period|Crossed over to other treatment arm|0
4947072|NCT00333840|17015180|P2|First-line Treatment Period|Crossed over to other treatment arm|363
4947073|NCT00333840|17015181|P1|First-line Treatment Period|Crossed over to other treatment arm|14
4947074|NCT00333840|17015178|P4|First-line Treatment Period|Death|0
4947075|NCT00333840|17015179|P3|First-line Treatment Period|Death|0
4947076|NCT00333840|17015180|P2|First-line Treatment Period|Death|2
4947077|NCT00333840|17015181|P1|First-line Treatment Period|Death|19
4947078|NCT00333840|17015178|P4|First-line Treatment Period|Administrative problems|0
4947079|NCT00333840|17015179|P3|First-line Treatment Period|Administrative problems|0
4947080|NCT00333840|17015180|P2|First-line Treatment Period|Administrative problems|6
4947081|NCT00333840|17015181|P1|First-line Treatment Period|Administrative problems|12
4947082|NCT00333840|17015178|P4|First-line Treatment Period|Lost to Follow-up|0
4947083|NCT00333840|17015179|P3|First-line Treatment Period|Lost to Follow-up|0
4947084|NCT00333840|17015180|P2|First-line Treatment Period|Lost to Follow-up|6
4947085|NCT00333840|17015181|P1|First-line Treatment Period|Lost to Follow-up|15
4947086|NCT00333840|17015178|P4|First-line Treatment Period|Subject withdrew consent|0
4947087|NCT00333840|17015179|P3|First-line Treatment Period|Subject withdrew consent|0
4947088|NCT00333840|17015180|P2|First-line Treatment Period|Subject withdrew consent|77
4947089|NCT00333840|17015181|P1|First-line Treatment Period|Subject withdrew consent|57
4947090|NCT00333840|17015178|P4|First-line Treatment Period|Protocol Violation|0
4947091|NCT00333840|17015179|P3|First-line Treatment Period|Protocol Violation|0
4947092|NCT00333840|17015180|P2|First-line Treatment Period|Protocol Violation|17
4947093|NCT00333840|17015181|P1|First-line Treatment Period|Protocol Violation|17
4947094|NCT00333840|17015178|P4|First-line Treatment Period|No longer required study drug|0
4947095|NCT00333840|17015179|P3|First-line Treatment Period|No longer required study drug|0
4947096|NCT00333840|17015180|P2|First-line Treatment Period|No longer required study drug|8
4947097|NCT00333840|17015181|P1|First-line Treatment Period|No longer required study drug|21
4947098|NCT00333840|17015178|P4|First-line Treatment Period|Unsatisfactory therapeutic effect|0
4947099|NCT00333840|17015179|P3|First-line Treatment Period|Unsatisfactory therapeutic effect|0
4947100|NCT00333840|17015180|P2|First-line Treatment Period|Unsatisfactory therapeutic effect|29
4947101|NCT00333840|17015181|P1|First-line Treatment Period|Unsatisfactory therapeutic effect|88
4947102|NCT00333840|17015178|P4|First-line Treatment Period|Abnormal procedure|0
4947103|NCT00333840|17015179|P3|First-line Treatment Period|Abnormal procedure|0
4947104|NCT00333840|17015180|P2|First-line Treatment Period|Abnormal procedure|0
4947105|NCT00333840|17015181|P1|First-line Treatment Period|Abnormal procedure|2
4947106|NCT00333840|17015178|P4|First-line Treatment Period|Abnormal laboratory values|0
4947107|NCT00333840|17015179|P3|First-line Treatment Period|Abnormal laboratory values|0
4947108|NCT00333840|17015180|P2|First-line Treatment Period|Abnormal laboratory values|1
4947109|NCT00333840|17015181|P1|First-line Treatment Period|Abnormal laboratory values|3
4947110|NCT00333840|17015178|P4|First-line Treatment Period|Adverse Event|0
4947111|NCT00333840|17015179|P3|First-line Treatment Period|Adverse Event|0
4947112|NCT00333840|17015180|P2|First-line Treatment Period|Adverse Event|37
4947113|NCT00333840|17015181|P1|First-line Treatment Period|Adverse Event|38
4947114|NCT00333801|17015227|P2|Overall Study|Withdrawal by Subject|1
4947115|NCT00333801|17015228|P1|Overall Study|Withdrawal by Subject|0
4947116|NCT00333801|17015227|P2|Overall Study|Incarcerated|2
4947117|NCT00333801|17015228|P1|Overall Study|Incarcerated|1
4947118|NCT00333801|17015227|P2|Overall Study|Lost to Follow-up|0
4947119|NCT00333801|17015228|P1|Overall Study|Lost to Follow-up|2
4947120|NCT00333801|17015227|P2|Overall Study|Moved to another state|3
4947121|NCT00333801|17015228|P1|Overall Study|Moved to another state|5
4947122|NCT00333788|17015246|P1|Overall Study|Other: Signed consent for another study|1
4947123|NCT00333788|17015246|P1|Overall Study|Other: Physician decision|1
4947124|NCT00333788|17015246|P1|Overall Study|Other: Medical monitor decision|1
4947125|NCT00333788|17015246|P1|Overall Study|Other: Subject in need of an Entocort|1
4947126|NCT00333788|17015246|P1|Overall Study|Other: Sponsor decision|1
4947127|NCT00333788|17015246|P1|Overall Study|Other: Quality of life concern|1
4947128|NCT00333788|17015246|P1|Overall Study|Other: Investigator decision|1
4947129|NCT00333788|17015246|P1|Overall Study|Other: Recurrent squamaous cell cancer|1
4947130|NCT00333788|17015246|P1|Overall Study|Other: Moved|2
4947131|NCT00333788|17015246|P1|Overall Study|Other: Non-compliance|2
4947132|NCT00333788|17015246|P1|Overall Study|Withdrawal by Subject|24
4947133|NCT00333788|17015246|P1|Overall Study|Lost to Follow-up|2
4947134|NCT00333788|17015246|P1|Overall Study|Lack of Efficacy|80
4947135|NCT00333788|17015246|P1|Overall Study|Adverse Event|44
4947136|NCT00333775|17015276|P3|Overall Study|Lost to Follow-up|8
4947137|NCT00333775|17015277|P2|Overall Study|Lost to Follow-up|7
4947138|NCT00333775|17015278|P1|Overall Study|Lost to Follow-up|10
4947139|NCT00333775|17015276|P3|Overall Study|In Follow-up When Study Stopped|96
4947140|NCT00333775|17015277|P2|Overall Study|In Follow-up When Study Stopped|92
4947141|NCT00333775|17015278|P1|Overall Study|In Follow-up When Study Stopped|87
4947142|NCT00333775|17015276|P3|Overall Study|Death|143
4947143|NCT00333775|17015277|P2|Overall Study|Death|149
4947144|NCT00333775|17015278|P1|Overall Study|Death|144
4947145|NCT00333619|17015317|P2|Overall Study|Lost to Follow-up|3
4947146|NCT00333619|17015318|P1|Overall Study|Lost to Follow-up|3
4947147|NCT00333619|17015317|P2|Overall Study|Withdrawal by Subject|1
4947148|NCT00333619|17015318|P1|Overall Study|Withdrawal by Subject|6
4947149|NCT00333619|17015317|P2|Overall Study|Death|6
4947150|NCT00333619|17015318|P1|Overall Study|Death|12
4947151|NCT00333359|17015347|P2|Overall Study|Withdrew before Receiving One Dose|6
4947152|NCT00333359|17015348|P1|Overall Study|Withdrew before Receiving One Dose|2
4947153|NCT00333359|17015347|P2|Overall Study|Treatment Failure|8
4947154|NCT00333359|17015348|P1|Overall Study|Treatment Failure|3
4947155|NCT00333359|17015347|P2|Overall Study|Termination or Withdrawal by Sponsor|1
4947156|NCT00333359|17015348|P1|Overall Study|Termination or Withdrawal by Sponsor|1
4947157|NCT00333359|17015347|P2|Overall Study|Lost to Follow-up|25
4947158|NCT00333359|17015348|P1|Overall Study|Lost to Follow-up|15
4947159|NCT00333359|17015347|P2|Overall Study|Protocol Non-compliance|8
4947160|NCT00333359|17015348|P1|Overall Study|Protocol Non-compliance|2
4947161|NCT00333359|17015347|P2|Overall Study|Physician Decision|2
4947162|NCT00333359|17015348|P1|Overall Study|Physician Decision|2
4947163|NCT00333359|17015347|P2|Overall Study|Withdrawal by Subject|37
4947164|NCT00333359|17015348|P1|Overall Study|Withdrawal by Subject|19
4947165|NCT00333359|17015347|P2|Overall Study|Adverse Event|35
4947166|NCT00333359|17015348|P1|Overall Study|Adverse Event|29
4947167|NCT00333229|17015391|P2|Overall Study|Lack of Efficacy|1
4947168|NCT00333229|17015392|P1|Overall Study|Lack of Efficacy|0
4947169|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Death|0
4947170|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Death|1
4947171|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Death|0
4947172|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Lost to Follow-up|0
4947173|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
4947174|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Lost to Follow-up|1
4947175|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0
4947176|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1
4947177|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2
4947178|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
4947179|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Lack of Efficacy|4
4947180|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Lack of Efficacy|7
4947181|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
4947182|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13
4947183|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14
4947184|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Protocol Violation|3
4947185|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Protocol Violation|0
4947186|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Protocol Violation|0
4947187|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Adverse Event|15
4947188|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Adverse Event|19
4947189|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Adverse Event|15
4947190|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Administrative problems|2
4947191|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Administrative problems|1
4947192|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Administrative problems|1
4947193|NCT00333138|17015462|P3|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
4947194|NCT00333138|17015463|P2|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2
4947195|NCT00333138|17015464|P1|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3
4947196|NCT00333138|17015462|P3|Core Study (6 Months)|Laboratory abnormality|1
4947197|NCT00333138|17015463|P2|Core Study (6 Months)|Laboratory abnormality|0
4947198|NCT00333138|17015464|P1|Core Study (6 Months)|Laboratory abnormality|0
4947199|NCT00333138|17015462|P3|Core Study (6 Months)|Protocol Violation|1
4947200|NCT00333138|17015463|P2|Core Study (6 Months)|Protocol Violation|0
4947201|NCT00333138|17015464|P1|Core Study (6 Months)|Protocol Violation|1
4947202|NCT00333138|17015462|P3|Core Study (6 Months)|Lack of Efficacy|0
4947203|NCT00333138|17015463|P2|Core Study (6 Months)|Lack of Efficacy|0
4947204|NCT00333138|17015464|P1|Core Study (6 Months)|Lack of Efficacy|1
4947205|NCT00333138|17015462|P3|Core Study (6 Months)|Withdrawal by Subject|2
4947206|NCT00333138|17015463|P2|Core Study (6 Months)|Withdrawal by Subject|1
4947207|NCT00333138|17015464|P1|Core Study (6 Months)|Withdrawal by Subject|1
4947208|NCT00333138|17015462|P3|Core Study (6 Months)|Adverse Event|8
4947209|NCT00333138|17015463|P2|Core Study (6 Months)|Adverse Event|5
4947210|NCT00333138|17015464|P1|Core Study (6 Months)|Adverse Event|4
4947211|NCT00332839|17015503|P2|Follow-up (Months 12 - 60)|Death|1
4947212|NCT00332839|17015504|P1|Follow-up (Months 12 - 60)|Death|1
4947213|NCT00332839|17015503|P2|Follow-up (Months 12 - 60)|Lost to Follow-up|1
4947214|NCT00332839|17015504|P1|Follow-up (Months 12 - 60)|Lost to Follow-up|2
4947215|NCT00332839|17015503|P2|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
4947216|NCT00332839|17015504|P1|Follow-up (Months 12 - 60)|Withdrawal by Subject|1
4947217|NCT00332839|17015503|P2|Core (Months 0 - 12)|Adverse Event|15
4947218|NCT00332839|17015504|P1|Core (Months 0 - 12)|Adverse Event|5
4947219|NCT00332839|17015503|P2|Core (Months 0 - 12)|Protocol deviation|1
4947220|NCT00332839|17015504|P1|Core (Months 0 - 12)|Protocol deviation|1
4947221|NCT00332839|17015503|P2|Core (Months 0 - 12)|Withdrawal by Subject|1
4947222|NCT00332839|17015504|P1|Core (Months 0 - 12)|Withdrawal by Subject|3
4947223|NCT00332839|17015503|P2|Core (Months 0 - 12)|Administrative problems|1
4947224|NCT00332839|17015504|P1|Core (Months 0 - 12)|Administrative problems|1
4947225|NCT00332709|17015535|P2|Overall Study|Abnormal test procedure result|0
4947226|NCT00332709|17015536|P1|Overall Study|Abnormal test procedure result|1
4947227|NCT00332709|17015535|P2|Overall Study|Administrative Problems|3
4947228|NCT00332709|17015536|P1|Overall Study|Administrative Problems|0
4947229|NCT00332709|17015535|P2|Overall Study|Lost to Follow-up|0
4947230|NCT00332709|17015536|P1|Overall Study|Lost to Follow-up|2
4947231|NCT00332709|17015535|P2|Overall Study|Withdrawal by Subject|3
4947232|NCT00332709|17015536|P1|Overall Study|Withdrawal by Subject|2
4947233|NCT00332709|17015535|P2|Overall Study|Adverse Event|14
4947234|NCT00332709|17015536|P1|Overall Study|Adverse Event|11
4947235|NCT00332696|17015560|P2|Overall Study|Withdrawal by Subject|0
4947236|NCT00332696|17015561|P1|Overall Study|Withdrawal by Subject|1
4947237|NCT00332696|17015560|P2|Overall Study|Lost to Follow-up|1
4947238|NCT00332696|17015561|P1|Overall Study|Lost to Follow-up|0
4947239|NCT00332696|17015560|P2|Overall Study|Condition does not justify treatment|2
4947240|NCT00332696|17015561|P1|Overall Study|Condition does not justify treatment|0
4947241|NCT00332696|17015560|P2|Overall Study|Adverse Event|2
4947242|NCT00332696|17015561|P1|Overall Study|Adverse Event|1
4947243|NCT00332696|17015560|P2|Overall Study|Insufficient therapeutic effect|11
4947244|NCT00332696|17015561|P1|Overall Study|Insufficient therapeutic effect|4
4947245|NCT00332696|17015560|P2|Overall Study|Death|14
4947246|NCT00332696|17015561|P1|Overall Study|Death|24
4947247|NCT00332488|17015637|P3|Transfer Treatment Phase (Weeks 12 - 24)|Various|5
4947248|NCT00332488|17015638|P2|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
4947249|NCT00332488|17015639|P1|Transfer Treatment Phase (Weeks 12 - 24)|Various|0
4947250|NCT00332488|17015637|P3|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8
4947251|NCT00332488|17015638|P2|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
4947252|NCT00332488|17015639|P1|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2
4947253|NCT00332488|17015637|P3|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1
4947254|NCT00332488|17015638|P2|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
4947255|NCT00332488|17015639|P1|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0
4947256|NCT00332488|17015637|P3|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3
4947257|NCT00332488|17015638|P2|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
4947258|NCT00332488|17015639|P1|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0
4947259|NCT00332488|17015637|P3|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1
4947260|NCT00332488|17015638|P2|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
4947261|NCT00332488|17015639|P1|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0
4947262|NCT00332488|17015637|P3|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3
4947263|NCT00332488|17015638|P2|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
4947264|NCT00332488|17015639|P1|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0
4947265|NCT00332488|17015637|P3|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0
4947266|NCT00332488|17015638|P2|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1
4947267|NCT00332488|17015639|P1|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3
4947268|NCT00332488|17015637|P3|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0
4947269|NCT00332488|17015638|P2|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3
4947270|NCT00332488|17015639|P1|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1
4947271|NCT00332488|17015637|P3|Initial Treatment Phase (Weeks 0 - 12)|Various|20
4947272|NCT00332488|17015638|P2|Initial Treatment Phase (Weeks 0 - 12)|Various|0
4947273|NCT00332488|17015639|P1|Initial Treatment Phase (Weeks 0 - 12)|Various|4
4947274|NCT00332488|17015637|P3|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20
4947275|NCT00332488|17015638|P2|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10
4947276|NCT00332488|17015639|P1|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21
4947277|NCT00332488|17015637|P3|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10
4947278|NCT00332488|17015638|P2|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2
4947279|NCT00332488|17015639|P1|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13
4947280|NCT00332488|17015637|P3|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6
4947281|NCT00332488|17015638|P2|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2
4947282|NCT00332488|17015639|P1|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8
4947283|NCT00332462|17015651|P1|Overall Study|Graft Loss|2
4947284|NCT00332462|17015651|P1|Overall Study|Death|3
4947285|NCT00332462|17015651|P1|Overall Study|no longer requires study drug|1
4947286|NCT00332462|17015651|P1|Overall Study|Unsatisfactory therapeutic effect|4
4947287|NCT00332462|17015651|P1|Overall Study|Abnormal Lab Value|1
4947288|NCT00332462|17015651|P1|Overall Study|Adverse Event|5
4947289|NCT00332332|17015658|P1|Overall Study|Did not receive study treatment|16
4947290|NCT00332332|17015658|P1|Overall Study|Other|18
4947291|NCT00332332|17015658|P1|Overall Study|Disease progression|2
4947292|NCT00332332|17015658|P1|Overall Study|Noncompliance|2
4947293|NCT00332332|17015658|P1|Overall Study|Protocol deviation|4
4947294|NCT00332332|17015658|P1|Overall Study|Lost to Follow-up|3
4947295|NCT00332332|17015658|P1|Overall Study|Physician Decision|1
4947296|NCT00332332|17015658|P1|Overall Study|Withdrawal by Subject|8
4947297|NCT00332332|17015658|P1|Overall Study|Death|1
4947298|NCT00332332|17015658|P1|Overall Study|Adverse Event|13
4947299|NCT00332241|17015667|P2|Overall Study|Lost to Follow-up|1
4947300|NCT00332241|17015668|P1|Overall Study|Lost to Follow-up|4
4947301|NCT00332241|17015667|P2|Overall Study|Withdrawal by Subject|1
4947302|NCT00332241|17015668|P1|Overall Study|Withdrawal by Subject|2
4947303|NCT00332241|17015667|P2|Overall Study|Adverse Event|5
4947304|NCT00332241|17015668|P1|Overall Study|Adverse Event|3
4947305|NCT00332241|17015667|P2|Overall Study|Lack of Efficacy|1
4947306|NCT00332241|17015668|P1|Overall Study|Lack of Efficacy|6
4947307|NCT00332202|17015690|P2|Overall Study|Death|2
4947308|NCT00332202|17015691|P1|Overall Study|Death|5
4947309|NCT00332202|17015690|P2|Overall Study|Progressive Disease|60
4947310|NCT00332202|17015691|P1|Overall Study|Progressive Disease|106
4947311|NCT00332202|17015690|P2|Overall Study|Withdrawal by Subject|17
4947312|NCT00332202|17015691|P1|Overall Study|Withdrawal by Subject|36
4947313|NCT00332202|17015690|P2|Overall Study|Sponsor Decision|2
4947314|NCT00332202|17015691|P1|Overall Study|Sponsor Decision|1
4947315|NCT00332202|17015690|P2|Overall Study|Protocol Violation|2
4947316|NCT00332202|17015691|P1|Overall Study|Protocol Violation|7
4947317|NCT00332202|17015690|P2|Overall Study|Protocol Entry Criteria Not Met|5
4947318|NCT00332202|17015691|P1|Overall Study|Protocol Entry Criteria Not Met|6
4947319|NCT00332202|17015690|P2|Overall Study|Physician Decision|8
4947320|NCT00332202|17015691|P1|Overall Study|Physician Decision|6
4947321|NCT00332202|17015690|P2|Overall Study|Lost to Follow-up|1
4947322|NCT00332202|17015691|P1|Overall Study|Lost to Follow-up|2
4947323|NCT00332202|17015690|P2|Overall Study|Adverse Event|28
4947324|NCT00332202|17015691|P1|Overall Study|Adverse Event|72
4947325|NCT00332189|17015720|P1|Overall Study|Moved out of country|2
4947326|NCT00332189|17015720|P1|Overall Study|Lack of Efficacy|4
4947327|NCT00332189|17015720|P1|Overall Study|Withdrawal by Subject|9
4947328|NCT00332189|17015720|P1|Overall Study|Uncooperative/Noncompliant|3
4947329|NCT00332189|17015720|P1|Overall Study|Adverse Event|3
4947330|NCT00331864|17015762|P2|Overall Study|Death|0
4947331|NCT00331864|17015763|P1|Overall Study|Death|6
4947332|NCT00331864|17015762|P2|Overall Study|Administrative Problems|0
4947333|NCT00331864|17015763|P1|Overall Study|Administrative Problems|1
4947334|NCT00331864|17015762|P2|Overall Study|Lost to Follow-up|3
4947335|NCT00331864|17015763|P1|Overall Study|Lost to Follow-up|4
4947336|NCT00331864|17015762|P2|Overall Study|Withdrawal by Subject|0
4947337|NCT00331864|17015763|P1|Overall Study|Withdrawal by Subject|10
4947338|NCT00331864|17015762|P2|Overall Study|Protocol Violation|0
4947339|NCT00331864|17015763|P1|Overall Study|Protocol Violation|3
4947340|NCT00331864|17015762|P2|Overall Study|Lack of Efficacy|0
4947341|NCT00331864|17015763|P1|Overall Study|Lack of Efficacy|4
4947342|NCT00331864|17015762|P2|Overall Study|Adverse Event|1
4947343|NCT00331864|17015763|P1|Overall Study|Adverse Event|30
4947344|NCT00331799|17015782|P1|Overall Study|Sedation|1
4947345|NCT00331799|17015782|P1|Overall Study|Withdrawal by Subject|2
4947346|NCT00331773|17015788|P2|Overall Study|Protocol Violation|3
4947347|NCT00331773|17015789|P1|Overall Study|Protocol Violation|10
4947348|NCT00331773|17015788|P2|Overall Study|Withdrawal by Subject|4
4947349|NCT00331773|17015789|P1|Overall Study|Withdrawal by Subject|6
4947350|NCT00331760|17015819|P2|Overall Study|Ineligible / no protocol treatment|8
4947351|NCT00331760|17015820|P1|Overall Study|Ineligible / no protocol treatment|15
4947352|NCT00331682|17015841|P1|Overall Study|Adverse Event|1
4947353|NCT00331630|17015847|P1|Follow up for 5 Years|Data collection was stopped|24
4947354|NCT00331630|17015847|P1|Follow up for 5 Years|Death|5
4947355|NCT00331630|17015847|P1|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1
4947356|NCT00331630|17015847|P1|Evaluated for and Completed SOC Surgery|Progressive Disease|1
4947357|NCT00331552|17015859|P2|Period 3: Phase II|Severe Nausea|0
4947358|NCT00331552|17015860|P1|Period 3: Phase II|Severe Nausea|1
4947359|NCT00331552|17015859|P2|Period 3: Phase II|Neurological Symptoms|0
4947360|NCT00331552|17015860|P1|Period 3: Phase II|Neurological Symptoms|1
4947361|NCT00331422|17015874|P1|Overall Study|Did not receive entire study regimen|5
4947362|NCT00331409|17015883|P1|Overall Study|Lack of Efficacy|4
4947363|NCT00331344|17015891|P9|Phase II|Death|4
4947364|NCT00331344|17015892|P8|Phase II|Death|0
4947365|NCT00331344|17015893|P7|Phase II|Death|0
4947366|NCT00331344|17015894|P6|Phase II|Death|0
4947367|NCT00331344|17015895|P5|Phase II|Death|0
4947368|NCT00331344|17015896|P4|Phase II|Death|0
4947369|NCT00331344|17015897|P3|Phase II|Death|0
4947370|NCT00331344|17015898|P2|Phase II|Death|0
4947371|NCT00331344|17015899|P1|Phase II|Death|0
4947372|NCT00331344|17015891|P9|Phase I|Adverse Event|0
4947373|NCT00331344|17015892|P8|Phase I|Adverse Event|1
4947374|NCT00331344|17015893|P7|Phase I|Adverse Event|0
4947375|NCT00331344|17015894|P6|Phase I|Adverse Event|2
4947376|NCT00331344|17015895|P5|Phase I|Adverse Event|2
4947377|NCT00331344|17015896|P4|Phase I|Adverse Event|1
4947378|NCT00331344|17015897|P3|Phase I|Adverse Event|0
4947379|NCT00331344|17015898|P2|Phase I|Adverse Event|0
4947380|NCT00331344|17015899|P1|Phase I|Adverse Event|0
4947381|NCT00331006|17015936|P1|Follow-Up Phase II|Lost to Follow-up|3
4947382|NCT00331006|17015936|P1|Follow-Up Phase I|Lost to Follow-up|1
4947383|NCT00331006|17015936|P1|Treatment Phase|Withdrawal by Subject|1
4947384|NCT00331006|17015936|P1|Screening Phase|Ineligible for treatment phase|4
4947385|NCT00331006|17015936|P1|Screening Phase|Lost to Follow-up|1
4947386|NCT00331006|17015936|P1|Screening Phase|enrollment halted|1
4947387|NCT00331006|17015936|P1|Screening Phase|Withdrawal by Subject|1
4947388|NCT00330967|17015949|P2|Overall Study|Physician Decision|9
4947389|NCT00330967|17015950|P1|Overall Study|Physician Decision|0
4947390|NCT00330967|17015949|P2|Overall Study|Withdrawal by Subject|5
4947391|NCT00330967|17015950|P1|Overall Study|Withdrawal by Subject|0
4947392|NCT00330928|17015961|P1|Overall Study|IVUS could not be performed.|1
4947393|NCT00330928|17015961|P1|Overall Study|Death|1
4947394|NCT00330928|17015961|P1|Overall Study|Physician Decision|9
4947395|NCT00330928|17015961|P1|Overall Study|Lost to Follow-up|6
4947396|NCT00330759|17016003|P2|Overall Study|Other|44
4947397|NCT00330759|17016004|P1|Overall Study|Other|36
4947398|NCT00330759|17016003|P2|Overall Study|Ineligibility determined|1
4947399|NCT00330759|17016004|P1|Overall Study|Ineligibility determined|2
4947400|NCT00330759|17016003|P2|Overall Study|Protocol deviation|2
4947401|NCT00330759|17016004|P1|Overall Study|Protocol deviation|0
4947402|NCT00330759|17016003|P2|Overall Study|Physician Decision|2
4947403|NCT00330759|17016004|P1|Overall Study|Physician Decision|1
4947404|NCT00330759|17016003|P2|Overall Study|Noncompliance|17
4947405|NCT00330759|17016004|P1|Overall Study|Noncompliance|15
4947406|NCT00330759|17016003|P2|Overall Study|Lost to Follow-up|22
4947407|NCT00330759|17016004|P1|Overall Study|Lost to Follow-up|16
4947408|NCT00330759|17016003|P2|Overall Study|Participant request|22
4947409|NCT00330759|17016004|P1|Overall Study|Participant request|31
4947410|NCT00330759|17016003|P2|Overall Study|Adverse Event|36
4947411|NCT00330759|17016004|P1|Overall Study|Adverse Event|48
4947412|NCT00330759|17016003|P2|Overall Study|Withdrawal by Subject|124
4947413|NCT00330759|17016004|P1|Overall Study|Withdrawal by Subject|143
4947414|NCT00330759|17016003|P2|Overall Study|Disease progression|126
4947415|NCT00330759|17016004|P1|Overall Study|Disease progression|104
4947416|NCT00330759|17016003|P2|Overall Study|Death|310
4947417|NCT00330759|17016004|P1|Overall Study|Death|316
4947418|NCT00330681|17016037|P2|Overall Study|Tracheotomy due to worsening of ALS|2
4947419|NCT00330681|17016038|P1|Overall Study|Tracheotomy due to worsening of ALS|1
4947420|NCT00330681|17016037|P2|Overall Study|Withdrawal by Subject|5
4947421|NCT00330681|17016038|P1|Overall Study|Withdrawal by Subject|5
4947422|NCT00330681|17016037|P2|Overall Study|Protocol Violation|1
4947423|NCT00330681|17016038|P1|Overall Study|Protocol Violation|0
4947424|NCT00330681|17016037|P2|Overall Study|Adverse Event|6
4947425|NCT00330681|17016038|P1|Overall Study|Adverse Event|3
4947426|NCT00330668|17016060|P1|QD Dosing Period|Lost to Follow-up|2
4947427|NCT00330668|17016060|P1|QD Dosing Period|Withdrawal by Subject|1
4947428|NCT00330668|17016060|P1|QD Dosing Period|Other|1
4947429|NCT00330668|17016060|P1|QD Dosing Period|Sponsor decision to terminate study|74
4947430|NCT00330668|17016060|P1|BID Dosing Period|Other|3
4947431|NCT00330668|17016060|P1|BID Dosing Period|Sponsor's decision|1
4947432|NCT00330668|17016060|P1|BID Dosing Period|Withdrawal by Subject|19
4947433|NCT00330668|17016060|P1|BID Dosing Period|Non-Compliance|5
4947434|NCT00330668|17016060|P1|BID Dosing Period|Lost to Follow-up|7
4947435|NCT00330668|17016060|P1|BID Dosing Period|Adverse Event|1
4947436|NCT00330616|17016068|P1|Overall Study|Other|1
4947437|NCT00330616|17016068|P1|Overall Study|Withdrawal by Subject|4
4947438|NCT00330616|17016068|P1|Overall Study|Lost to Follow-up|2
4947439|NCT00330616|17016068|P1|Overall Study|Lack of Efficacy|1
4947440|NCT00330616|17016068|P1|Overall Study|Adverse Event|13
4947441|NCT00330460|17016119|P2|Overall Study|Other|0
4947442|NCT00330460|17016120|P1|Overall Study|Other|1
4947443|NCT00330460|17016119|P2|Overall Study|Noncompliance|1
4947444|NCT00330460|17016120|P1|Overall Study|Noncompliance|2
4947445|NCT00330460|17016119|P2|Overall Study|Lost to Follow-up|3
4947446|NCT00330460|17016120|P1|Overall Study|Lost to Follow-up|8
4947447|NCT00330460|17016119|P2|Overall Study|Ineligibility determined|3
4947448|NCT00330460|17016120|P1|Overall Study|Ineligibility determined|1
4947449|NCT00330460|17016119|P2|Overall Study|Death|1
4947450|NCT00330460|17016120|P1|Overall Study|Death|1
4947451|NCT00330460|17016119|P2|Overall Study|Withdrawal by Subject|17
4947452|NCT00330460|17016120|P1|Overall Study|Withdrawal by Subject|18
4947453|NCT00330460|17016119|P2|Overall Study|Adverse Event|8
4947454|NCT00330460|17016120|P1|Overall Study|Adverse Event|10
4947455|NCT00330460|17016119|P2|Overall Study|Physician Decision|0
4947456|NCT00330460|17016120|P1|Overall Study|Physician Decision|1
4947457|NCT00330343|17016163|P1|Overall Study|Lost to Follow-up|5
4947458|NCT00330187|17016171|P4|Overall Study|Withdrawal by Subject|4
4947459|NCT00330187|17016172|P3|Overall Study|Withdrawal by Subject|4
4947460|NCT00330187|17016173|P2|Overall Study|Withdrawal by Subject|5
4947461|NCT00330187|17016174|P1|Overall Study|Withdrawal by Subject|8
4947462|NCT00330187|17016171|P4|Overall Study|Lost to Follow-up|10
4947463|NCT00330187|17016172|P3|Overall Study|Lost to Follow-up|14
4947464|NCT00330187|17016173|P2|Overall Study|Lost to Follow-up|13
4947465|NCT00330187|17016174|P1|Overall Study|Lost to Follow-up|12
4947466|NCT00330174|17016186|P2|Overall Study|Miscellaneous reasons|1
4947467|NCT00330174|17016187|P1|Overall Study|Miscellaneous reasons|7
4947468|NCT00330174|17016186|P2|Overall Study|Excessive missed visits|8
4947469|NCT00330174|17016187|P1|Overall Study|Excessive missed visits|3
4947470|NCT00330174|17016186|P2|Overall Study|Clinical deterioration|2
4947471|NCT00330174|17016187|P1|Overall Study|Clinical deterioration|1
4947472|NCT00330174|17016186|P2|Overall Study|Lost to Follow-up|1
4947473|NCT00330174|17016187|P1|Overall Study|Lost to Follow-up|4
4947474|NCT00330174|17016186|P2|Overall Study|Withdrawal by Subject|7
4947475|NCT00330174|17016187|P1|Overall Study|Withdrawal by Subject|7
4947476|NCT00329901|17016211|P3|Overall Study|Unable to classify|0
4947477|NCT00329901|17016212|P2|Overall Study|Unable to classify|2
4947478|NCT00329901|17016213|P1|Overall Study|Unable to classify|2
4947479|NCT00329901|17016211|P3|Overall Study|Protocol Violation|1
4947480|NCT00329901|17016212|P2|Overall Study|Protocol Violation|0
4947481|NCT00329901|17016213|P1|Overall Study|Protocol Violation|1
4947482|NCT00329901|17016211|P3|Overall Study|Lost to Follow-up|1
4947483|NCT00329901|17016212|P2|Overall Study|Lost to Follow-up|0
4947484|NCT00329901|17016213|P1|Overall Study|Lost to Follow-up|2
4947485|NCT00329901|17016211|P3|Overall Study|Withdrawal by Subject|2
4947486|NCT00329901|17016212|P2|Overall Study|Withdrawal by Subject|3
4947487|NCT00329901|17016213|P1|Overall Study|Withdrawal by Subject|4
4947488|NCT00329849|17016243|P2|Overall Study|Withdrawal by Subject|4
4947489|NCT00329849|17016244|P1|Overall Study|Withdrawal by Subject|6
4947490|NCT00329797|17016270|P2|Overall Study|Withdrawal by Subject|6
4947491|NCT00329797|17016271|P1|Overall Study|Withdrawal by Subject|6
4947492|NCT00329797|17016270|P2|Overall Study|Protocol Violation|0
4947493|NCT00329797|17016271|P1|Overall Study|Protocol Violation|1
4947494|NCT00329784|17016287|P4|Overall Study|Other|0
4947495|NCT00329784|17016288|P3|Overall Study|Other|0
4947496|NCT00329784|17016289|P2|Overall Study|Other|2
4947497|NCT00329784|17016290|P1|Overall Study|Other|1
4947498|NCT00329784|17016287|P4|Overall Study|Withdrawal by Subject|0
4947499|NCT00329784|17016288|P3|Overall Study|Withdrawal by Subject|0
4947500|NCT00329784|17016289|P2|Overall Study|Withdrawal by Subject|2
4947501|NCT00329784|17016290|P1|Overall Study|Withdrawal by Subject|4
4947502|NCT00329784|17016287|P4|Overall Study|Lost to Follow-up|0
4947503|NCT00329784|17016288|P3|Overall Study|Lost to Follow-up|0
4947504|NCT00329784|17016289|P2|Overall Study|Lost to Follow-up|1
4947505|NCT00329784|17016290|P1|Overall Study|Lost to Follow-up|0
4947506|NCT00329745|17016318|P2|Overall Study|Lost to Follow-up|101
4947507|NCT00329745|17016319|P1|Overall Study|Lost to Follow-up|86
4947508|NCT00329745|17016318|P2|Overall Study|Withdrawal by Subject|1
4947509|NCT00329745|17016319|P1|Overall Study|Withdrawal by Subject|0
4947510|NCT00329745|17016318|P2|Overall Study|Protocol Violation|0
4947511|NCT00329745|17016319|P1|Overall Study|Protocol Violation|1
4947512|NCT00329719|17016339|P4|Overall Study|Lost to Follow-up|1
4947513|NCT00329719|17016340|P3|Overall Study|Lost to Follow-up|0
4947514|NCT00329719|17016341|P2|Overall Study|Lost to Follow-up|0
4947515|NCT00329719|17016342|P1|Overall Study|Lost to Follow-up|0
4947516|NCT00329641|17016364|P1|Overall Study|Other reason, not protocol specified|1
4947517|NCT00329641|17016364|P1|Overall Study|Adverse Event|3
4947518|NCT00329641|17016364|P1|Overall Study|Not eligible|1
4947519|NCT00329641|17016364|P1|Overall Study|Did not start treatment|1
4947520|NCT00329602|17016373|P3|40-Week Open-Label Treatment Phase|Captured as Other|4
4947521|NCT00329602|17016374|P2|40-Week Open-Label Treatment Phase|Captured as Other|0
4947522|NCT00329602|17016375|P1|40-Week Open-Label Treatment Phase|Captured as Other|0
4947523|NCT00329602|17016373|P3|40-Week Open-Label Treatment Phase|Lack of Efficacy|9
4947524|NCT00329602|17016374|P2|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
4947525|NCT00329602|17016375|P1|40-Week Open-Label Treatment Phase|Lack of Efficacy|0
4947526|NCT00329602|17016373|P3|40-Week Open-Label Treatment Phase|Protocol Violation|2
4947527|NCT00329602|17016374|P2|40-Week Open-Label Treatment Phase|Protocol Violation|0
4947528|NCT00329602|17016375|P1|40-Week Open-Label Treatment Phase|Protocol Violation|0
4947529|NCT00329602|17016373|P3|40-Week Open-Label Treatment Phase|Lost to Follow-up|1
4947530|NCT00329602|17016374|P2|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
4947531|NCT00329602|17016375|P1|40-Week Open-Label Treatment Phase|Lost to Follow-up|0
4947532|NCT00329602|17016373|P3|40-Week Open-Label Treatment Phase|Adverse Event|20
4947533|NCT00329602|17016374|P2|40-Week Open-Label Treatment Phase|Adverse Event|0
4947534|NCT00329602|17016375|P1|40-Week Open-Label Treatment Phase|Adverse Event|0
4947535|NCT00329602|17016373|P3|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0
4947536|NCT00329602|17016374|P2|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99
4947537|NCT00329602|17016375|P1|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119
4947538|NCT00329550|17016413|P3|Overall Study|Due to Relocation|1
4947539|NCT00329550|17016414|P2|Overall Study|Due to Relocation|0
4947540|NCT00329550|17016415|P1|Overall Study|Due to Relocation|0
4947541|NCT00329550|17016413|P3|Overall Study|Withdrawal of Consent|1
4947542|NCT00329550|17016414|P2|Overall Study|Withdrawal of Consent|0
4947543|NCT00329550|17016415|P1|Overall Study|Withdrawal of Consent|1
4947544|NCT00329550|17016413|P3|Overall Study|Adverse Event|2
4947545|NCT00329550|17016414|P2|Overall Study|Adverse Event|4
4947546|NCT00329550|17016415|P1|Overall Study|Adverse Event|3
4947547|NCT00329420|17016684|P3|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
4947548|NCT00329420|17016685|P2|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0
4947549|NCT00329420|17016686|P1|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1
4947550|NCT00329420|17016684|P3|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0
4947551|NCT00329420|17016685|P2|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
4947552|NCT00329420|17016686|P1|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1
4947553|NCT00329420|17016684|P3|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
4947554|NCT00329420|17016685|P2|4-weekly Dosing Phase (Responders Only)|Adverse Event|1
4947555|NCT00329420|17016686|P1|4-weekly Dosing Phase (Responders Only)|Adverse Event|2
4947556|NCT00329420|17016684|P3|Re-induction Phase|Did not respond to re-induction|7
4947557|NCT00329420|17016685|P2|Re-induction Phase|Did not respond to re-induction|5
4947558|NCT00329420|17016686|P1|Re-induction Phase|Did not respond to re-induction|6
4947559|NCT00329420|17016684|P3|Re-induction Phase|Withdrawal of Consent|1
4947560|NCT00329420|17016685|P2|Re-induction Phase|Withdrawal of Consent|0
4947561|NCT00329420|17016686|P1|Re-induction Phase|Withdrawal of Consent|0
4947562|NCT00329420|17016684|P3|Re-induction Phase|Lack of Efficacy|0
4947563|NCT00329420|17016685|P2|Re-induction Phase|Lack of Efficacy|1
4947564|NCT00329420|17016686|P1|Re-induction Phase|Lack of Efficacy|0
4947565|NCT00329407|17017065|P1|Overall Study|Withdrawal by Subject|1
4947566|NCT00329303|17017072|P2|Overall Study|Patient relocated|1
4947567|NCT00329303|17017073|P1|Overall Study|Patient relocated|0
4947568|NCT00329303|17017072|P2|Overall Study|Patient no longer available|0
4947569|NCT00329303|17017073|P1|Overall Study|Patient no longer available|1
4947570|NCT00329303|17017072|P2|Overall Study|Decision of the sponsor|1
4947571|NCT00329303|17017073|P1|Overall Study|Decision of the sponsor|0
4947572|NCT00329303|17017072|P2|Overall Study|Lack of Efficacy|0
4947573|NCT00329303|17017073|P1|Overall Study|Lack of Efficacy|1
4947574|NCT00329238|17017235|P2|Overall Study|Other reason (not specified)|54
4947575|NCT00329238|17017236|P1|Overall Study|Other reason (not specified)|40
4947576|NCT00329238|17017235|P2|Overall Study|Withdrawal by Subject|58
4947577|NCT00329238|17017236|P1|Overall Study|Withdrawal by Subject|64
4947578|NCT00329238|17017235|P2|Overall Study|Lost to Follow-up|6
4947579|NCT00329238|17017236|P1|Overall Study|Lost to Follow-up|2
4947580|NCT00329238|17017235|P2|Overall Study|Protocol Violation|34
4947581|NCT00329238|17017236|P1|Overall Study|Protocol Violation|23
4947582|NCT00329238|17017235|P2|Overall Study|Adverse Event|129
4947583|NCT00329238|17017236|P1|Overall Study|Adverse Event|147
4947584|NCT00329160|17017272|P1|Overall Study|Incomplete IVUS|45
4947585|NCT00329160|17017272|P1|Overall Study|Did not Receive Study Drug|1
4947586|NCT00329160|17017272|P1|Overall Study|Protocol Violation|2
4947587|NCT00329160|17017272|P1|Overall Study|Withdrawal by Subject|13
4947588|NCT00329160|17017272|P1|Overall Study|Adverse Event|27
4947589|NCT00329108|17017281|P2|Overall Study|Protocol Violation|2
4947590|NCT00329108|17017282|P1|Overall Study|Protocol Violation|0
4947591|NCT00329108|17017281|P2|Overall Study|withdrew patient after SAE resolved|0
4947592|NCT00329108|17017282|P1|Overall Study|withdrew patient after SAE resolved|1
4947593|NCT00329108|17017281|P2|Overall Study|study terminated by sponsor|0
4947594|NCT00329108|17017282|P1|Overall Study|study terminated by sponsor|1
4947595|NCT00329108|17017281|P2|Overall Study|Subject no longer willing to participate|2
4947596|NCT00329108|17017282|P1|Overall Study|Subject no longer willing to participate|2
4947597|NCT00329108|17017281|P2|Overall Study|symptomatic deterioration|1
4947598|NCT00329108|17017282|P1|Overall Study|symptomatic deterioration|1
4947599|NCT00329108|17017281|P2|Overall Study|Withdrawal by Subject|2
4947600|NCT00329108|17017282|P1|Overall Study|Withdrawal by Subject|0
4947601|NCT00329108|17017281|P2|Overall Study|Lack of Efficacy|3
4947602|NCT00329108|17017282|P1|Overall Study|Lack of Efficacy|3
4947603|NCT00329108|17017281|P2|Overall Study|Adverse Event|2
4947604|NCT00329108|17017282|P1|Overall Study|Adverse Event|2
4947605|NCT00329030|17017290|P2|Overall Study|Ineligible Pathology|1
4947606|NCT00329030|17017291|P1|Overall Study|Ineligible Pathology|1
4947607|NCT00329030|17017290|P2|Overall Study|Progressive Disease|2
4947608|NCT00329030|17017291|P1|Overall Study|Progressive Disease|6
4947609|NCT00329030|17017290|P2|Overall Study|Withdrawal by Subject|3
4947610|NCT00329030|17017291|P1|Overall Study|Withdrawal by Subject|1
4947611|NCT00328926|17017322|P3|Overall Study|Lack of ovarian response|0
4947612|NCT00328926|17017323|P2|Overall Study|Lack of ovarian response|1
4947613|NCT00328926|17017324|P1|Overall Study|Lack of ovarian response|0
4947614|NCT00328926|17017322|P3|Overall Study|In vitro fertilization treatment|1
4947615|NCT00328926|17017323|P2|Overall Study|In vitro fertilization treatment|0
4947616|NCT00328926|17017324|P1|Overall Study|In vitro fertilization treatment|0
4947617|NCT00328926|17017322|P3|Overall Study|Death|1
4947618|NCT00328926|17017323|P2|Overall Study|Death|0
4947619|NCT00328926|17017324|P1|Overall Study|Death|0
4947620|NCT00328926|17017322|P3|Overall Study|Lost to Follow-up|0
4947621|NCT00328926|17017323|P2|Overall Study|Lost to Follow-up|1
4947622|NCT00328926|17017324|P1|Overall Study|Lost to Follow-up|0
4947623|NCT00328926|17017322|P3|Overall Study|Pregnancy|0
4947624|NCT00328926|17017323|P2|Overall Study|Pregnancy|1
4947625|NCT00328926|17017324|P1|Overall Study|Pregnancy|2
4947626|NCT00328783|17017349|P1|Overall Study|Withdrawal by Subject|1
4947627|NCT00328783|17017349|P1|Overall Study|No heart in RT field|4
4947628|NCT00328783|17017349|P1|Overall Study|Could not tolerate ABC|21
4947629|NCT00328627|17017375|P12|Overall Study|Other|0
4947630|NCT00328627|17017376|P11|Overall Study|Other|1
4947631|NCT00328627|17017377|P10|Overall Study|Other|1
4947632|NCT00328627|17017378|P9|Overall Study|Other|0
4947633|NCT00328627|17017379|P8|Overall Study|Other|0
4947634|NCT00328627|17017380|P7|Overall Study|Other|1
4947635|NCT00328627|17017381|P6|Overall Study|Other|0
4947636|NCT00328627|17017382|P5|Overall Study|Other|0
4947637|NCT00328627|17017383|P4|Overall Study|Other|1
4947638|NCT00328627|17017384|P3|Overall Study|Other|0
4947639|NCT00328627|17017385|P2|Overall Study|Other|0
4947640|NCT00328627|17017386|P1|Overall Study|Other|0
4947641|NCT00328627|17017375|P12|Overall Study|Physician Decision|0
4947642|NCT00328627|17017376|P11|Overall Study|Physician Decision|1
4947643|NCT00328627|17017377|P10|Overall Study|Physician Decision|2
4947644|NCT00328627|17017378|P9|Overall Study|Physician Decision|3
4947645|NCT00328627|17017379|P8|Overall Study|Physician Decision|0
4947646|NCT00328627|17017380|P7|Overall Study|Physician Decision|1
4947647|NCT00328627|17017381|P6|Overall Study|Physician Decision|1
4947648|NCT00328627|17017382|P5|Overall Study|Physician Decision|1
4947649|NCT00328627|17017383|P4|Overall Study|Physician Decision|2
4947650|NCT00328627|17017384|P3|Overall Study|Physician Decision|1
4947651|NCT00328627|17017385|P2|Overall Study|Physician Decision|3
4947652|NCT00328627|17017386|P1|Overall Study|Physician Decision|4
4947653|NCT00328627|17017375|P12|Overall Study|Pregnancy|0
4947654|NCT00328627|17017376|P11|Overall Study|Pregnancy|0
4947655|NCT00328627|17017377|P10|Overall Study|Pregnancy|0
4947656|NCT00328627|17017378|P9|Overall Study|Pregnancy|0
4947657|NCT00328627|17017379|P8|Overall Study|Pregnancy|0
4947658|NCT00328627|17017380|P7|Overall Study|Pregnancy|0
4947659|NCT00328627|17017381|P6|Overall Study|Pregnancy|0
4947660|NCT00328627|17017382|P5|Overall Study|Pregnancy|0
4947661|NCT00328627|17017383|P4|Overall Study|Pregnancy|0
4947662|NCT00328627|17017384|P3|Overall Study|Pregnancy|0
4947663|NCT00328627|17017385|P2|Overall Study|Pregnancy|1
4947664|NCT00328627|17017386|P1|Overall Study|Pregnancy|0
4947665|NCT00328627|17017375|P12|Overall Study|Withdrawal by Subject|7
4947666|NCT00328627|17017376|P11|Overall Study|Withdrawal by Subject|2
4947667|NCT00328627|17017377|P10|Overall Study|Withdrawal by Subject|5
4947668|NCT00328627|17017378|P9|Overall Study|Withdrawal by Subject|4
4947669|NCT00328627|17017379|P8|Overall Study|Withdrawal by Subject|4
4947670|NCT00328627|17017380|P7|Overall Study|Withdrawal by Subject|4
4947671|NCT00328627|17017381|P6|Overall Study|Withdrawal by Subject|5
4947672|NCT00328627|17017382|P5|Overall Study|Withdrawal by Subject|2
4947673|NCT00328627|17017383|P4|Overall Study|Withdrawal by Subject|6
4947674|NCT00328627|17017384|P3|Overall Study|Withdrawal by Subject|5
4947675|NCT00328627|17017385|P2|Overall Study|Withdrawal by Subject|4
4947676|NCT00328627|17017386|P1|Overall Study|Withdrawal by Subject|5
4947677|NCT00328627|17017375|P12|Overall Study|Lost to Follow-up|1
4947678|NCT00328627|17017376|P11|Overall Study|Lost to Follow-up|0
4947679|NCT00328627|17017377|P10|Overall Study|Lost to Follow-up|2
4947680|NCT00328627|17017378|P9|Overall Study|Lost to Follow-up|3
4947681|NCT00328627|17017379|P8|Overall Study|Lost to Follow-up|0
4947682|NCT00328627|17017380|P7|Overall Study|Lost to Follow-up|3
4947683|NCT00328627|17017381|P6|Overall Study|Lost to Follow-up|2
4947684|NCT00328627|17017382|P5|Overall Study|Lost to Follow-up|0
4947685|NCT00328627|17017383|P4|Overall Study|Lost to Follow-up|4
4947686|NCT00328627|17017384|P3|Overall Study|Lost to Follow-up|2
4947687|NCT00328627|17017385|P2|Overall Study|Lost to Follow-up|2
4947688|NCT00328627|17017386|P1|Overall Study|Lost to Follow-up|4
4947689|NCT00328627|17017375|P12|Overall Study|Protocol Violation|2
4947690|NCT00328627|17017376|P11|Overall Study|Protocol Violation|6
4947691|NCT00328627|17017377|P10|Overall Study|Protocol Violation|4
4947692|NCT00328627|17017378|P9|Overall Study|Protocol Violation|1
4947693|NCT00328627|17017379|P8|Overall Study|Protocol Violation|2
4947694|NCT00328627|17017380|P7|Overall Study|Protocol Violation|6
4947695|NCT00328627|17017381|P6|Overall Study|Protocol Violation|5
4947696|NCT00328627|17017382|P5|Overall Study|Protocol Violation|5
4947697|NCT00328627|17017383|P4|Overall Study|Protocol Violation|8
4947698|NCT00328627|17017384|P3|Overall Study|Protocol Violation|2
4947699|NCT00328627|17017385|P2|Overall Study|Protocol Violation|2
4947700|NCT00328627|17017386|P1|Overall Study|Protocol Violation|2
4947701|NCT00328627|17017375|P12|Overall Study|Adverse Event|4
4947702|NCT00328627|17017376|P11|Overall Study|Adverse Event|5
4947703|NCT00328627|17017377|P10|Overall Study|Adverse Event|7
4947704|NCT00328627|17017378|P9|Overall Study|Adverse Event|0
4947705|NCT00328627|17017379|P8|Overall Study|Adverse Event|2
4947706|NCT00328627|17017380|P7|Overall Study|Adverse Event|1
4947707|NCT00328627|17017381|P6|Overall Study|Adverse Event|2
4947708|NCT00328627|17017382|P5|Overall Study|Adverse Event|1
4947709|NCT00328627|17017383|P4|Overall Study|Adverse Event|3
4947710|NCT00328627|17017384|P3|Overall Study|Adverse Event|2
4947711|NCT00328627|17017385|P2|Overall Study|Adverse Event|1
4947712|NCT00328627|17017386|P1|Overall Study|Adverse Event|3
4947713|NCT00328627|17017375|P12|Overall Study|Hyperglycemic Rescue|2
4947714|NCT00328627|17017376|P11|Overall Study|Hyperglycemic Rescue|3
4947715|NCT00328627|17017377|P10|Overall Study|Hyperglycemic Rescue|11
4947716|NCT00328627|17017378|P9|Overall Study|Hyperglycemic Rescue|6
4947717|NCT00328627|17017379|P8|Overall Study|Hyperglycemic Rescue|6
4947718|NCT00328627|17017380|P7|Overall Study|Hyperglycemic Rescue|19
4947719|NCT00328627|17017381|P6|Overall Study|Hyperglycemic Rescue|5
4947720|NCT00328627|17017382|P5|Overall Study|Hyperglycemic Rescue|6
4947721|NCT00328627|17017383|P4|Overall Study|Hyperglycemic Rescue|13
4947722|NCT00328627|17017384|P3|Overall Study|Hyperglycemic Rescue|16
4947723|NCT00328627|17017385|P2|Overall Study|Hyperglycemic Rescue|18
4947724|NCT00328627|17017386|P1|Overall Study|Hyperglycemic Rescue|41
4947725|NCT00328562|17018923|P1|Overall Study|Disease progression|1
4947726|NCT00328510|17018932|P2|Overall Study|Treatment changed to a single fraction|1
4947727|NCT00328510|17018933|P1|Overall Study|Treatment changed to a single fraction|1
4947728|NCT00328510|17018932|P2|Overall Study|Severe kyphosis, could not use mask|1
4947729|NCT00328510|17018933|P1|Overall Study|Severe kyphosis, could not use mask|0
4947730|NCT00328510|17018932|P2|Overall Study|Withdrawal by Subject|2
4947731|NCT00328510|17018933|P1|Overall Study|Withdrawal by Subject|4
4947732|NCT00328510|17018932|P2|Overall Study|Dentition problems, could not use frame|0
4947733|NCT00328510|17018933|P1|Overall Study|Dentition problems, could not use frame|1
4947734|NCT00328510|17018932|P2|Overall Study|Gag disorder, could not use frame|0
4947735|NCT00328510|17018933|P1|Overall Study|Gag disorder, could not use frame|4
4947736|NCT00328198|17018948|P1|Follow-up|Death|31
4947737|NCT00328198|17018948|P1|Follow-up|Lost to Follow-up|4
4947738|NCT00328198|17018948|P1|Treatment|Confirmed complete response, MRD -|3
4947739|NCT00328198|17018948|P1|Treatment|Non-compliance|1
4947740|NCT00328198|17018948|P1|Treatment|Evidence of disease progression|2
4947741|NCT00328198|17018948|P1|Treatment|Withdrawal by Subject|5
4947742|NCT00328198|17018948|P1|Treatment|Physician Decision|5
4947743|NCT00328198|17018948|P1|Treatment|Death|1
4947744|NCT00328198|17018948|P1|Treatment|Adverse Event|21
4947745|NCT00328172|17018963|P5|Overall Study|Other reason (not specified)|0
4947746|NCT00328172|17018964|P4|Overall Study|Other reason (not specified)|0
4947747|NCT00328172|17018965|P3|Overall Study|Other reason (not specified)|1
4947748|NCT00328172|17018966|P2|Overall Study|Other reason (not specified)|0
4947749|NCT00328172|17018967|P1|Overall Study|Other reason (not specified)|3
4947750|NCT00328172|17018963|P5|Overall Study|Lack of Efficacy|3
4947751|NCT00328172|17018964|P4|Overall Study|Lack of Efficacy|4
4947752|NCT00328172|17018965|P3|Overall Study|Lack of Efficacy|4
4947753|NCT00328172|17018966|P2|Overall Study|Lack of Efficacy|9
4947754|NCT00328172|17018967|P1|Overall Study|Lack of Efficacy|14
4947755|NCT00328172|17018963|P5|Overall Study|Withdrawal by Subject|0
4947756|NCT00328172|17018964|P4|Overall Study|Withdrawal by Subject|6
4947757|NCT00328172|17018965|P3|Overall Study|Withdrawal by Subject|1
4947758|NCT00328172|17018966|P2|Overall Study|Withdrawal by Subject|1
4947759|NCT00328172|17018967|P1|Overall Study|Withdrawal by Subject|1
4947760|NCT00328172|17018963|P5|Overall Study|Lost to Follow-up|1
4947761|NCT00328172|17018964|P4|Overall Study|Lost to Follow-up|1
4947762|NCT00328172|17018965|P3|Overall Study|Lost to Follow-up|2
4947763|NCT00328172|17018966|P2|Overall Study|Lost to Follow-up|1
4947764|NCT00328172|17018967|P1|Overall Study|Lost to Follow-up|1
4947765|NCT00328172|17018963|P5|Overall Study|Protocol Violation|0
4947766|NCT00328172|17018964|P4|Overall Study|Protocol Violation|0
4947767|NCT00328172|17018965|P3|Overall Study|Protocol Violation|1
4947768|NCT00328172|17018966|P2|Overall Study|Protocol Violation|1
4947769|NCT00328172|17018967|P1|Overall Study|Protocol Violation|0
4947770|NCT00328172|17018963|P5|Overall Study|Adverse Event|1
4947771|NCT00328172|17018964|P4|Overall Study|Adverse Event|2
4947772|NCT00328172|17018965|P3|Overall Study|Adverse Event|1
4947773|NCT00328172|17018966|P2|Overall Study|Adverse Event|2
4947774|NCT00328172|17018967|P1|Overall Study|Adverse Event|3
4947775|NCT00328094|17018991|P2|Overall Study|Physician Decision|3
4947776|NCT00328094|17018992|P1|Overall Study|Physician Decision|3
4947777|NCT00327717|17019026|P2|Overall Study|Withdrawal by Subject|7
4947778|NCT00327717|17019027|P1|Overall Study|Withdrawal by Subject|3
4947779|NCT00327717|17019026|P2|Overall Study|Lack of Efficacy|1
4947780|NCT00327717|17019027|P1|Overall Study|Lack of Efficacy|0
4947781|NCT00327717|17019026|P2|Overall Study|Adverse Event|6
4947782|NCT00327717|17019027|P1|Overall Study|Adverse Event|6
4947783|NCT00327470|17019053|P2|Overall Study|Death|4
4947784|NCT00327470|17019054|P1|Overall Study|Death|1
4947785|NCT00327470|17019053|P2|Overall Study|Withdrawal by Subject|12
4947786|NCT00327470|17019054|P1|Overall Study|Withdrawal by Subject|6
4947787|NCT00327470|17019053|P2|Overall Study|Lost to Follow-up|3
4947788|NCT00327470|17019054|P1|Overall Study|Lost to Follow-up|1
4947789|NCT00327470|17019053|P2|Overall Study|Other|9
4947790|NCT00327470|17019054|P1|Overall Study|Other|5
4947791|NCT00327470|17019053|P2|Overall Study|Lack of Efficacy|19
4947792|NCT00327470|17019054|P1|Overall Study|Lack of Efficacy|7
4947793|NCT00327470|17019053|P2|Overall Study|Adverse Event|14
4947794|NCT00327470|17019054|P1|Overall Study|Adverse Event|9
4947795|NCT00327470|17019053|P2|Overall Study|Randomized, but not treated|2
4947796|NCT00327470|17019054|P1|Overall Study|Randomized, but not treated|0
4947797|NCT00327444|17019074|P2|Open Label Treatment (OL) Period|Ongoing Treatment|0
4947798|NCT00327444|17019075|P1|Open Label Treatment (OL) Period|Ongoing Treatment|1
4947799|NCT00327444|17019074|P2|Open Label Treatment (OL) Period|Worsening dyspnea|1
4947800|NCT00327444|17019075|P1|Open Label Treatment (OL) Period|Worsening dyspnea|0
4947801|NCT00327444|17019074|P2|Open Label Treatment (OL) Period|Adverse Event|2
4947802|NCT00327444|17019075|P1|Open Label Treatment (OL) Period|Adverse Event|2
4947803|NCT00327444|17019074|P2|Open Label Treatment (OL) Period|Disease progression|7
4947804|NCT00327444|17019075|P1|Open Label Treatment (OL) Period|Disease progression|8
4947805|NCT00327444|17019074|P2|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10
4947806|NCT00327444|17019075|P1|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11
4947807|NCT00327444|17019074|P2|Double Blind Treatment (DB) Period|Subject request|1
4947808|NCT00327444|17019075|P1|Double Blind Treatment (DB) Period|Subject request|0
4947809|NCT00327444|17019074|P2|Double Blind Treatment (DB) Period|Adverse Event|5
4947810|NCT00327444|17019075|P1|Double Blind Treatment (DB) Period|Adverse Event|5
4947811|NCT00327444|17019074|P2|Double Blind Treatment (DB) Period|Disease progression|13
4947812|NCT00327444|17019075|P1|Double Blind Treatment (DB) Period|Disease progression|10
4947813|NCT00327340|17019093|P2|Overall Study|Adverse Event|3
4947814|NCT00327340|17019094|P1|Overall Study|Adverse Event|3
4947815|NCT00327340|17019093|P2|Overall Study|Symptomatic Disease|2
4947816|NCT00327340|17019094|P1|Overall Study|Symptomatic Disease|0
4947817|NCT00327340|17019093|P2|Overall Study|Disease Progression|19
4947818|NCT00327340|17019094|P1|Overall Study|Disease Progression|10
4947819|NCT00327340|17019093|P2|Overall Study|Physician Decision|1
4947820|NCT00327340|17019094|P1|Overall Study|Physician Decision|1
4947821|NCT00327340|17019093|P2|Overall Study|Withdrawal by Subject|5
4947822|NCT00327340|17019094|P1|Overall Study|Withdrawal by Subject|1
4947823|NCT00327171|17019108|P2|Overall Study|Other|0
4947824|NCT00327171|17019109|P1|Overall Study|Other|1
4947825|NCT00327171|17019108|P2|Overall Study|Undisclosed history of ischemia|1
4947826|NCT00327171|17019109|P1|Overall Study|Undisclosed history of ischemia|0
4947827|NCT00327171|17019108|P2|Overall Study|Clinical progression|8
4947828|NCT00327171|17019109|P1|Overall Study|Clinical progression|12
4947829|NCT00327171|17019108|P2|Overall Study|Investigator/participant request|8
4947830|NCT00327171|17019109|P1|Overall Study|Investigator/participant request|1
4947831|NCT00327171|17019108|P2|Overall Study|Disease progression/lack of efficacy|69
4947832|NCT00327171|17019109|P1|Overall Study|Disease progression/lack of efficacy|68
4947833|NCT00327171|17019108|P2|Overall Study|Adverse Event|23
4947834|NCT00327171|17019109|P1|Overall Study|Adverse Event|23
4947835|NCT00327171|17019108|P2|Overall Study|Did not receive study medication|0
4947836|NCT00327171|17019109|P1|Overall Study|Did not receive study medication|3
4947837|NCT00327015|17019141|P4|Overall Study|Administrative Reason by Sponsor|1
4947838|NCT00327015|17019142|P3|Overall Study|Administrative Reason by Sponsor|2
4947839|NCT00327015|17019143|P2|Overall Study|Administrative Reason by Sponsor|2
4947840|NCT00327015|17019144|P1|Overall Study|Administrative Reason by Sponsor|1
4947841|NCT00327015|17019141|P4|Overall Study|Pregnancy|1
4947842|NCT00327015|17019142|P3|Overall Study|Pregnancy|1
4947843|NCT00327015|17019143|P2|Overall Study|Pregnancy|2
4947844|NCT00327015|17019144|P1|Overall Study|Pregnancy|0
4947845|NCT00327015|17019141|P4|Overall Study|Death|3
4947846|NCT00327015|17019142|P3|Overall Study|Death|2
4947847|NCT00327015|17019143|P2|Overall Study|Death|2
4947848|NCT00327015|17019144|P1|Overall Study|Death|1
4947849|NCT00327015|17019141|P4|Overall Study|Physician Decision|2
4947850|NCT00327015|17019142|P3|Overall Study|Physician Decision|3
4947851|NCT00327015|17019143|P2|Overall Study|Physician Decision|1
4947852|NCT00327015|17019144|P1|Overall Study|Physician Decision|0
4947853|NCT00327015|17019141|P4|Overall Study|Poor/Noncompliance|5
4947854|NCT00327015|17019142|P3|Overall Study|Poor/Noncompliance|4
4947855|NCT00327015|17019143|P2|Overall Study|Poor/Noncompliance|8
4947856|NCT00327015|17019144|P1|Overall Study|Poor/Noncompliance|11
4947857|NCT00327015|17019141|P4|Overall Study|Subject no longer meets study criteria|7
4947858|NCT00327015|17019142|P3|Overall Study|Subject no longer meets study criteria|8
4947859|NCT00327015|17019143|P2|Overall Study|Subject no longer meets study criteria|2
4947860|NCT00327015|17019144|P1|Overall Study|Subject no longer meets study criteria|4
4947861|NCT00327015|17019141|P4|Overall Study|Adverse Event|14
4947862|NCT00327015|17019142|P3|Overall Study|Adverse Event|14
4947863|NCT00327015|17019143|P2|Overall Study|Adverse Event|10
4947864|NCT00327015|17019144|P1|Overall Study|Adverse Event|14
4947865|NCT00327015|17019141|P4|Overall Study|Lost to Follow-up|22
4947866|NCT00327015|17019142|P3|Overall Study|Lost to Follow-up|29
4947867|NCT00327015|17019143|P2|Overall Study|Lost to Follow-up|23
4947868|NCT00327015|17019144|P1|Overall Study|Lost to Follow-up|22
4947869|NCT00327015|17019141|P4|Overall Study|Withdrawal of Consent by Subject|25
4947870|NCT00327015|17019142|P3|Overall Study|Withdrawal of Consent by Subject|28
4947871|NCT00327015|17019143|P2|Overall Study|Withdrawal of Consent by Subject|24
4947872|NCT00327015|17019144|P1|Overall Study|Withdrawal of Consent by Subject|20
4947873|NCT00327015|17019141|P4|Overall Study|Lack of Efficacy|29
4947874|NCT00327015|17019142|P3|Overall Study|Lack of Efficacy|35
4947875|NCT00327015|17019143|P2|Overall Study|Lack of Efficacy|18
4947876|NCT00327015|17019144|P1|Overall Study|Lack of Efficacy|18
4947877|NCT00326963|17019186|P1|Overall Study|Administrative / other|1
4947878|NCT00326963|17019186|P1|Overall Study|Other protocol violation|1
4947879|NCT00326963|17019186|P1|Overall Study|Violation of selection criteria at entry|2
4947880|NCT00326963|17019186|P1|Overall Study|Refused treatment / did not cooperate|5
4947881|NCT00326963|17019186|P1|Overall Study|Withdrawal by Subject|10
4947882|NCT00326963|17019186|P1|Overall Study|Failure to return|10
4947883|NCT00326963|17019186|P1|Overall Study|Death|1
4947884|NCT00326963|17019186|P1|Overall Study|Injection site reaction|1
4947885|NCT00326963|17019186|P1|Overall Study|Adverse Event|2
4947886|NCT00326950|17019206|P1|Overall Study|Progressive Disease|1
4947887|NCT00326911|17019228|P2|Overall Study|Withdrawal by subject prior to treatment|1
4947888|NCT00326911|17019229|P1|Overall Study|Withdrawal by subject prior to treatment|0
4947889|NCT00326911|17019228|P2|Overall Study|Physician decision prior to treatment|0
4947890|NCT00326911|17019229|P1|Overall Study|Physician decision prior to treatment|1
4947891|NCT00326911|17019228|P2|Overall Study|Hospitalization prior to treatment|1
4947892|NCT00326911|17019229|P1|Overall Study|Hospitalization prior to treatment|0
4947893|NCT00326898|17019282|P3|Overall Study|Other/Missing/Unknown|32
4947894|NCT00326898|17019283|P2|Overall Study|Other/Missing/Unknown|28
4947895|NCT00326898|17019284|P1|Overall Study|Other/Missing/Unknown|33
4947896|NCT00326898|17019282|P3|Overall Study|Other complicating disease|4
4947897|NCT00326898|17019283|P2|Overall Study|Other complicating disease|5
4947898|NCT00326898|17019284|P1|Overall Study|Other complicating disease|5
4947899|NCT00326898|17019282|P3|Overall Study|Alternative therapy|0
4947900|NCT00326898|17019283|P2|Overall Study|Alternative therapy|0
4947901|NCT00326898|17019284|P1|Overall Study|Alternative therapy|1
4947902|NCT00326898|17019282|P3|Overall Study|Withdrawal by Subject|32
4947903|NCT00326898|17019283|P2|Overall Study|Withdrawal by Subject|128
4947904|NCT00326898|17019284|P1|Overall Study|Withdrawal by Subject|134
4947905|NCT00326898|17019282|P3|Overall Study|Death|0
4947906|NCT00326898|17019283|P2|Overall Study|Death|0
4947907|NCT00326898|17019284|P1|Overall Study|Death|2
4947908|NCT00326898|17019282|P3|Overall Study|Adverse Event|33
4947909|NCT00326898|17019283|P2|Overall Study|Adverse Event|128
4947910|NCT00326898|17019284|P1|Overall Study|Adverse Event|124
4947911|NCT00326898|17019282|P3|Overall Study|Disease progression|102
4947912|NCT00326898|17019283|P2|Overall Study|Disease progression|54
4947913|NCT00326898|17019284|P1|Overall Study|Disease progression|52
4947914|NCT00326885|17019301|P1|Overall Study|Hospice withdrew consent|2
4947915|NCT00326885|17019301|P1|Overall Study|Physician Decision|1
4947916|NCT00326885|17019301|P1|Overall Study|Withdrawal by Subject|3
4947917|NCT00326885|17019301|P1|Overall Study|Adverse Event|1
4947918|NCT00326716|17019332|P4|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
4947919|NCT00326716|17019333|P3|Pre-Natal Mothers|Discontinued ATV Before Delivery|0
4947920|NCT00326716|17019334|P2|Pre-Natal Mothers|Discontinued ATV Before Delivery|2
4947921|NCT00326716|17019335|P1|Pre-Natal Mothers|Discontinued ATV Before Delivery|1
4947922|NCT00326612|17019407|P2|Overall Study|They did not have a seizure requiring tx|137
4947923|NCT00326612|17019408|P1|Overall Study|They did not have a seizure requiring tx|129
4947924|NCT00326599|17019430|P4|Overall Study|Other Unspecified Reason|1
4947925|NCT00326599|17019431|P3|Overall Study|Other Unspecified Reason|2
4947926|NCT00326599|17019432|P2|Overall Study|Other Unspecified Reason|0
4947927|NCT00326599|17019433|P1|Overall Study|Other Unspecified Reason|0
4947928|NCT00326599|17019430|P4|Overall Study|Death|2
4947929|NCT00326599|17019431|P3|Overall Study|Death|1
4947930|NCT00326599|17019432|P2|Overall Study|Death|0
4947931|NCT00326599|17019433|P1|Overall Study|Death|0
4947932|NCT00326599|17019430|P4|Overall Study|Alternate Treatment|0
4947933|NCT00326599|17019431|P3|Overall Study|Alternate Treatment|0
4947934|NCT00326599|17019432|P2|Overall Study|Alternate Treatment|0
4947935|NCT00326599|17019433|P1|Overall Study|Alternate Treatment|1
4947936|NCT00326599|17019430|P4|Overall Study|Disease Progression|11
4947937|NCT00326599|17019431|P3|Overall Study|Disease Progression|13
4947938|NCT00326599|17019432|P2|Overall Study|Disease Progression|1
4947939|NCT00326599|17019433|P1|Overall Study|Disease Progression|3
4947940|NCT00326599|17019430|P4|Overall Study|Adverse Event|3
4947941|NCT00326599|17019431|P3|Overall Study|Adverse Event|32
4947942|NCT00326599|17019432|P2|Overall Study|Adverse Event|0
4947943|NCT00326599|17019433|P1|Overall Study|Adverse Event|1
4947944|NCT00326599|17019430|P4|Overall Study|Withdrawal by Subject|2
4947945|NCT00326599|17019431|P3|Overall Study|Withdrawal by Subject|5
4947946|NCT00326599|17019432|P2|Overall Study|Withdrawal by Subject|0
4947947|NCT00326599|17019433|P1|Overall Study|Withdrawal by Subject|1
4947948|NCT00326495|17019452|P1|Overall Study|Subject off study before assessment|1
4947949|NCT00326495|17019452|P1|Overall Study|Refused further treatment|2
4947950|NCT00326495|17019452|P1|Overall Study|Disease progression before treatment|1
4947951|NCT00326495|17019452|P1|Overall Study|Switched to alternative treatment|1
4947952|NCT00326417|17019459|P4|Overall Study|Death|0
4947953|NCT00326417|17019460|P3|Overall Study|Death|0
4947954|NCT00326417|17019461|P2|Overall Study|Death|0
4947955|NCT00326417|17019462|P1|Overall Study|Death|7
4947956|NCT00326417|17019459|P4|Overall Study|Arm Closed|3
4947957|NCT00326417|17019460|P3|Overall Study|Arm Closed|0
4947958|NCT00326417|17019461|P2|Overall Study|Arm Closed|0
4947959|NCT00326417|17019462|P1|Overall Study|Arm Closed|7
4947960|NCT00326417|17019459|P4|Overall Study|Withdrawal by Subject|0
4947961|NCT00326417|17019460|P3|Overall Study|Withdrawal by Subject|1
4947962|NCT00326417|17019461|P2|Overall Study|Withdrawal by Subject|0
4947963|NCT00326417|17019462|P1|Overall Study|Withdrawal by Subject|0
4947964|NCT00326209|17019478|P1|Overall Study|Pregnancy|1
4947965|NCT00326209|17019478|P1|Overall Study|Withdrawn in error|1
4947966|NCT00326209|17019478|P1|Overall Study|Violation of entry criteria|1
4947967|NCT00326209|17019478|P1|Overall Study|Prohibited medication use|1
4947968|NCT00326209|17019478|P1|Overall Study|Sponsor closed study|173
4947969|NCT00326209|17019478|P1|Overall Study|Participant non-compliant|6
4947970|NCT00326209|17019478|P1|Overall Study|Lost to Follow-up|18
4947971|NCT00326209|17019478|P1|Overall Study|Lack of Efficacy|31
4947972|NCT00326209|17019478|P1|Overall Study|Withdrawal by Subject|22
4947973|NCT00326209|17019478|P1|Overall Study|Adverse Event|28
4947974|NCT00326183|17019496|P2|Overall Study|Adverse Event|0
4947975|NCT00326183|17019497|P1|Overall Study|Adverse Event|1
4947976|NCT00326183|17019496|P2|Overall Study|Other|13
4947977|NCT00326183|17019497|P1|Overall Study|Other|47
4947978|NCT00326183|17019496|P2|Overall Study|Subject Moved|4
4947979|NCT00326183|17019497|P1|Overall Study|Subject Moved|7
4947980|NCT00326183|17019496|P2|Overall Study|Withdrawal by Subject|7
4947981|NCT00326183|17019497|P1|Overall Study|Withdrawal by Subject|35
4947982|NCT00326183|17019496|P2|Overall Study|Protocol Violation|3
4947983|NCT00326183|17019497|P1|Overall Study|Protocol Violation|6
4947984|NCT00326183|17019496|P2|Overall Study|Lost to Follow-up|56
4947985|NCT00326183|17019497|P1|Overall Study|Lost to Follow-up|104
4947986|NCT00326118|17019529|P2|Active Phase|Withdrawal by Subject|1
4947987|NCT00326118|17019530|P1|Active Phase|Withdrawal by Subject|4
4947988|NCT00326001|17019566|P2|Overall Study|Physician Decision|3
4947989|NCT00326001|17019567|P1|Overall Study|Physician Decision|3
4947990|NCT00326001|17019566|P2|Overall Study|Adverse Event|5
4947991|NCT00326001|17019567|P1|Overall Study|Adverse Event|4
4947992|NCT00325897|17019581|P2|Overall Study|Lost to Follow-up|13
4947993|NCT00325897|17019582|P1|Overall Study|Lost to Follow-up|12
4947994|NCT00325819|17019602|P2|Overall Study|Lost to Follow-up|3
4947995|NCT00325819|17019603|P1|Overall Study|Lost to Follow-up|3
4947996|NCT00325819|17019602|P2|Overall Study|Did not take a dose of study product|9
4947997|NCT00325819|17019603|P1|Overall Study|Did not take a dose of study product|4
4947998|NCT00325819|17019602|P2|Overall Study|Study product lost in mail|1
4947999|NCT00325819|17019603|P1|Overall Study|Study product lost in mail|2
4948000|NCT00325754|17019630|P2|Overall Study|Adverse Event|1
4948001|NCT00325754|17019631|P1|Overall Study|Adverse Event|4
4948002|NCT00325468|17019686|P5|Overall Study|site closure etc|1
4948003|NCT00325468|17019687|P4|Overall Study|site closure etc|8
4948004|NCT00325468|17019688|P3|Overall Study|site closure etc|1
4948005|NCT00325468|17019689|P2|Overall Study|site closure etc|2
4948006|NCT00325468|17019690|P1|Overall Study|site closure etc|4
4948007|NCT00325468|17019686|P5|Overall Study|Withdrawal by Subject|4
4948008|NCT00325468|17019687|P4|Overall Study|Withdrawal by Subject|14
4948009|NCT00325468|17019688|P3|Overall Study|Withdrawal by Subject|0
4948010|NCT00325468|17019689|P2|Overall Study|Withdrawal by Subject|1
4948011|NCT00325468|17019690|P1|Overall Study|Withdrawal by Subject|3
4948012|NCT00325468|17019686|P5|Overall Study|Physician Decision|0
4948013|NCT00325468|17019687|P4|Overall Study|Physician Decision|1
4948014|NCT00325468|17019688|P3|Overall Study|Physician Decision|0
4948015|NCT00325468|17019689|P2|Overall Study|Physician Decision|1
4948016|NCT00325468|17019690|P1|Overall Study|Physician Decision|1
4948017|NCT00325468|17019686|P5|Overall Study|Lost to Follow-up|2
4948018|NCT00325468|17019687|P4|Overall Study|Lost to Follow-up|2
4948019|NCT00325468|17019688|P3|Overall Study|Lost to Follow-up|1
4948020|NCT00325468|17019689|P2|Overall Study|Lost to Follow-up|0
4948021|NCT00325468|17019690|P1|Overall Study|Lost to Follow-up|0
4948022|NCT00325468|17019686|P5|Overall Study|Death|0
4948023|NCT00325468|17019687|P4|Overall Study|Death|4
4948024|NCT00325468|17019688|P3|Overall Study|Death|2
4948025|NCT00325468|17019689|P2|Overall Study|Death|0
4948026|NCT00325468|17019690|P1|Overall Study|Death|2
4948027|NCT00325468|17019686|P5|Overall Study|Adverse Event|1
4948028|NCT00325468|17019687|P4|Overall Study|Adverse Event|5
4948029|NCT00325468|17019688|P3|Overall Study|Adverse Event|0
4948030|NCT00325468|17019689|P2|Overall Study|Adverse Event|1
4948031|NCT00325468|17019690|P1|Overall Study|Adverse Event|1
4948032|NCT00325416|17019773|P2|Phase II: Treatment at MTD|Withdrawal by Subject|1
4948033|NCT00325416|17019774|P1|Phase II: Treatment at MTD|Withdrawal by Subject|0
4948034|NCT00325416|17019773|P2|Phase II: Treatment at MTD|denial of insurance coverage|1
4948035|NCT00325416|17019774|P1|Phase II: Treatment at MTD|denial of insurance coverage|0
4948119|NCT00324805|17020031|P1|Overall Study|Alternative therapy|4
4948036|NCT00325416|17019773|P2|Phase I: Dose Escalation|Inability to collect adequate stem cells|1
4948037|NCT00325416|17019774|P1|Phase I: Dose Escalation|Inability to collect adequate stem cells|0
4948038|NCT00325416|17019773|P2|Phase I: Dose Escalation|Withdrawal by Subject|2
4948039|NCT00325416|17019774|P1|Phase I: Dose Escalation|Withdrawal by Subject|7
4948040|NCT00325416|17019773|P2|Phase I: Dose Escalation|Denial of insurance coverage|4
4948041|NCT00325416|17019774|P1|Phase I: Dose Escalation|Denial of insurance coverage|7
4948042|NCT00325416|17019773|P2|Phase I: Dose Escalation|Pre-transplant screen failure|9
4948043|NCT00325416|17019774|P1|Phase I: Dose Escalation|Pre-transplant screen failure|8
4948044|NCT00325234|17019827|P2|Overall Study|Progressive Disease|37
4948045|NCT00325234|17019828|P1|Overall Study|Progressive Disease|34
4948046|NCT00325234|17019827|P2|Overall Study|Physician Decision|12
4948047|NCT00325234|17019828|P1|Overall Study|Physician Decision|17
4948048|NCT00325234|17019827|P2|Overall Study|Subject Decision|8
4948049|NCT00325234|17019828|P1|Overall Study|Subject Decision|6
4948050|NCT00325234|17019827|P2|Overall Study|Entry Criteria Not Met|2
4948051|NCT00325234|17019828|P1|Overall Study|Entry Criteria Not Met|1
4948052|NCT00325234|17019827|P2|Overall Study|Death due to Study Disease|0
4948053|NCT00325234|17019828|P1|Overall Study|Death due to Study Disease|1
4948054|NCT00325234|17019827|P2|Overall Study|Adverse Event|7
4948055|NCT00325234|17019828|P1|Overall Study|Adverse Event|10
4948056|NCT00325195|17019847|P3|Received Intervention: ITT Population|Protocol violation/non-compliance|0
4948057|NCT00325195|17019848|P2|Received Intervention: ITT Population|Protocol violation/non-compliance|1
4948058|NCT00325195|17019849|P1|Received Intervention: ITT Population|Protocol violation/non-compliance|1
4948059|NCT00325195|17019847|P3|Received Intervention: ITT Population|Lost to Follow-up|2
4948060|NCT00325195|17019848|P2|Received Intervention: ITT Population|Lost to Follow-up|0
4948061|NCT00325195|17019849|P1|Received Intervention: ITT Population|Lost to Follow-up|0
4948062|NCT00325195|17019847|P3|Received Intervention: ITT Population|Withdrawal by Subject|1
4948063|NCT00325195|17019848|P2|Received Intervention: ITT Population|Withdrawal by Subject|6
4948064|NCT00325195|17019849|P1|Received Intervention: ITT Population|Withdrawal by Subject|7
4948065|NCT00325195|17019847|P3|Received Intervention: ITT Population|Death|0
4948066|NCT00325195|17019848|P2|Received Intervention: ITT Population|Death|1
4948067|NCT00325195|17019849|P1|Received Intervention: ITT Population|Death|3
4948068|NCT00325195|17019847|P3|Received Intervention: ITT Population|Adverse Event|1
4948069|NCT00325195|17019848|P2|Received Intervention: ITT Population|Adverse Event|17
4948070|NCT00325195|17019849|P1|Received Intervention: ITT Population|Adverse Event|15
4948071|NCT00325195|17019847|P3|Randomized|Not dosed|3
4948072|NCT00325195|17019848|P2|Randomized|Not dosed|5
4948073|NCT00325195|17019849|P1|Randomized|Not dosed|5
4948074|NCT00325156|17019872|P1|Overall Study|Withdrawal by Subject|31
4948075|NCT00325156|17019872|P1|Overall Study|Other|1
4948076|NCT00325156|17019872|P1|Overall Study|Lost to follow-up (incompl. vaccination)|16
4948077|NCT00325156|17019872|P1|Overall Study|Adverse event, non-fatal|3
4948078|NCT00325156|17019872|P1|Overall Study|Migrated/moved from study area|12
4948079|NCT00325156|17019872|P1|Overall Study|Lost to follow-up (complete vaccination)|41
4948080|NCT00325156|17019872|P1|Overall Study|Protocol Violation|8
4948081|NCT00325143|17019879|P1|Overall Study|Withdrawal by Subject|8
4948082|NCT00325143|17019879|P1|Overall Study|Lost to follow-up(incompl. vacc. course)|4
4948083|NCT00325143|17019879|P1|Overall Study|Migrated/moved from study area|1
4948084|NCT00325143|17019879|P1|Overall Study|Lost to follow-up(complete vacc. course)|13
4948085|NCT00325130|17019889|P2|Overall Study|Patient Discontinued for Other|0
4948086|NCT00325130|17019890|P1|Overall Study|Patient Discontinued for Other|1
4948087|NCT00325130|17019889|P2|Overall Study|Moved|1
4948088|NCT00325130|17019890|P1|Overall Study|Moved|0
4948089|NCT00325130|17019889|P2|Overall Study|Protocol Deviation|1
4948090|NCT00325130|17019890|P1|Overall Study|Protocol Deviation|0
4948091|NCT00325130|17019889|P2|Overall Study|Withdrawal by Subject|14
4948092|NCT00325130|17019890|P1|Overall Study|Withdrawal by Subject|12
4948093|NCT00325130|17019889|P2|Overall Study|Lost to Follow-up|14
4948094|NCT00325130|17019890|P1|Overall Study|Lost to Follow-up|6
4948095|NCT00325039|17019947|P2|Overall Study|Lost to Follow-up|14
4948096|NCT00325039|17019948|P1|Overall Study|Lost to Follow-up|18
4948097|NCT00324987|17019964|P2|Overall Study|symptomatic deterioration, toxicity, etc|3
4948098|NCT00324987|17019965|P1|Overall Study|symptomatic deterioration, toxicity, etc|2
4948099|NCT00324987|17019964|P2|Overall Study|Progression|1
4948100|NCT00324987|17019965|P1|Overall Study|Progression|1
4948101|NCT00324987|17019964|P2|Overall Study|Withdrawal by Subject|1
4948102|NCT00324987|17019965|P1|Overall Study|Withdrawal by Subject|1
4948103|NCT00324987|17019964|P2|Overall Study|Adverse Event|1
4948104|NCT00324987|17019965|P1|Overall Study|Adverse Event|2
4948105|NCT00324961|17019979|P1|Overall Study|Other|2
4948106|NCT00324961|17019979|P1|Overall Study|Protocol Violation|3
4948107|NCT00324961|17019979|P1|Overall Study|Lost to Follow-up|22
4948108|NCT00324961|17019979|P1|Overall Study|Consent Withdrawn|11
4948109|NCT00324961|17019979|P1|Overall Study|Adverse Event|5
4948110|NCT00324805|17020030|P2|Overall Study|Did not start therapy|17
4948111|NCT00324805|17020031|P1|Overall Study|Did not start therapy|12
4948112|NCT00324805|17020030|P2|Overall Study|Other|2
4948113|NCT00324805|17020031|P1|Overall Study|Other|0
4948114|NCT00324805|17020030|P2|Overall Study|Other reasons|26
4948115|NCT00324805|17020031|P1|Overall Study|Other reasons|7
4948116|NCT00324805|17020030|P2|Overall Study|Other complicating disease|9
4948117|NCT00324805|17020031|P1|Overall Study|Other complicating disease|1
4948118|NCT00324805|17020030|P2|Overall Study|Alternative therapy|8
4948120|NCT00324805|17020030|P2|Overall Study|Death|9
4948121|NCT00324805|17020031|P1|Overall Study|Death|6
4948122|NCT00324805|17020030|P2|Overall Study|Withdrawal by Subject|174
4948123|NCT00324805|17020031|P1|Overall Study|Withdrawal by Subject|51
4948124|NCT00324805|17020030|P2|Overall Study|Progression|35
4948125|NCT00324805|17020031|P1|Overall Study|Progression|7
4948126|NCT00324805|17020030|P2|Overall Study|Adverse Event|203
4948127|NCT00324805|17020031|P1|Overall Study|Adverse Event|62
4948128|NCT00324740|17020056|P3|Overall Study|Withdrawal by Subject|1
4948129|NCT00324740|17020057|P2|Overall Study|Withdrawal by Subject|0
4948130|NCT00324740|17020058|P1|Overall Study|Withdrawal by Subject|1
4948131|NCT00324675|17020078|P2|Overall Study|Adverse Event|0
4948132|NCT00324675|17020079|P1|Overall Study|Adverse Event|1
4948133|NCT00324649|17020087|P2|Overall Study|Noncompliance|0
4948134|NCT00324649|17020088|P1|Overall Study|Noncompliance|1
4948135|NCT00324649|17020087|P2|Overall Study|Withdrawal by Subject|1
4948136|NCT00324649|17020088|P1|Overall Study|Withdrawal by Subject|0
4948137|NCT00324649|17020087|P2|Overall Study|Adverse Event|4
4948138|NCT00324649|17020088|P1|Overall Study|Adverse Event|1
4948139|NCT00324233|17020219|P2|Second Period|Protocol Violation|6
4948140|NCT00324233|17020220|P1|Second Period|Protocol Violation|4
4948141|NCT00324233|17020219|P2|Second Period|unable to insert catheter|1
4948142|NCT00324233|17020220|P1|Second Period|unable to insert catheter|1
4948143|NCT00324233|17020219|P2|First Period|unable to insert catheter|0
4948144|NCT00324233|17020220|P1|First Period|unable to insert catheter|1
4948145|NCT00324168|17020228|P2|Overall Study|Patient did not visit in f/u window|9
4948146|NCT00324168|17020229|P1|Overall Study|Patient did not visit in f/u window|6
4948147|NCT00324168|17020228|P2|Overall Study|Death|3
4948148|NCT00324168|17020229|P1|Overall Study|Death|3
4948149|NCT00324168|17020228|P2|Overall Study|Lost to Follow-up|18
4948150|NCT00324168|17020229|P1|Overall Study|Lost to Follow-up|19
4948151|NCT00324155|17020257|P2|Follow-up Phase|On-going participants still on drug|6
4948152|NCT00324155|17020258|P1|Follow-up Phase|On-going participants still on drug|11
4948153|NCT00324155|17020257|P2|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0
4948154|NCT00324155|17020258|P1|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1
4948155|NCT00324155|17020257|P2|Received Treatment in Maintenance Phase|Adverse Event|3
4948156|NCT00324155|17020258|P1|Received Treatment in Maintenance Phase|Adverse Event|0
4948157|NCT00324155|17020257|P2|Received Treatment in Maintenance Phase|Withdrawal by Subject|3
4948158|NCT00324155|17020258|P1|Received Treatment in Maintenance Phase|Withdrawal by Subject|1
4948159|NCT00324155|17020257|P2|Received Treatment in Maintenance Phase|Study Drug Toxicity|0
4948160|NCT00324155|17020258|P1|Received Treatment in Maintenance Phase|Study Drug Toxicity|4
4948161|NCT00324155|17020257|P2|Received Treatment in Maintenance Phase|Disease Progression|41
4948162|NCT00324155|17020258|P1|Received Treatment in Maintenance Phase|Disease Progression|26
4948163|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Physician Decision|0
4948164|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Physician Decision|2
4948165|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Withdrawal by Subject|5
4948166|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Withdrawal by Subject|6
4948167|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Adverse Event|7
4948168|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Adverse Event|6
4948169|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8
4948170|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9
4948171|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Death|15
4948172|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Death|8
4948173|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Study Drug Toxicity|10
4948174|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Study Drug Toxicity|83
4948175|NCT00324155|17020257|P2|Received Treatment in Induction Phase|Disease Progression|152
4948176|NCT00324155|17020258|P1|Received Treatment in Induction Phase|Disease Progression|88
4948177|NCT00324155|17020257|P2|Enrolled and Randomized|Lost to Follow-up|1
4948178|NCT00324155|17020258|P1|Enrolled and Randomized|Lost to Follow-up|0
4948179|NCT00324155|17020257|P2|Enrolled and Randomized|No longer met study criteria|0
4948180|NCT00324155|17020258|P1|Enrolled and Randomized|No longer met study criteria|3
4948181|NCT00324116|17020288|P1|Overall Study|Other|5
4948182|NCT00324116|17020288|P1|Overall Study|Withdrawal by Subject|5
4948183|NCT00324116|17020288|P1|Overall Study|Lack of Efficacy|17
4948184|NCT00324116|17020288|P1|Overall Study|Adverse Event|5
4948185|NCT00324038|17020300|P2|Overall Study|Other|13
4948186|NCT00324038|17020301|P1|Overall Study|Other|6
4948187|NCT00324038|17020300|P2|Overall Study|Lost to Follow-up|2
4948188|NCT00324038|17020301|P1|Overall Study|Lost to Follow-up|0
4948189|NCT00324038|17020300|P2|Overall Study|Lack of Efficacy|13
4948190|NCT00324038|17020301|P1|Overall Study|Lack of Efficacy|5
4948191|NCT00324038|17020300|P2|Overall Study|Adverse Event|23
4948192|NCT00324038|17020301|P1|Overall Study|Adverse Event|38
4948193|NCT00323882|17020312|P5|Overall Study|Other|1
4948194|NCT00323882|17020313|P4|Overall Study|Other|1
4948195|NCT00323882|17020314|P3|Overall Study|Other|0
4948196|NCT00323882|17020315|P2|Overall Study|Other|0
4948197|NCT00323882|17020316|P1|Overall Study|Other|0
4948198|NCT00323882|17020312|P5|Overall Study|Lost to Follow-up|1
4948199|NCT00323882|17020313|P4|Overall Study|Lost to Follow-up|0
4948200|NCT00323882|17020314|P3|Overall Study|Lost to Follow-up|1
4948201|NCT00323882|17020315|P2|Overall Study|Lost to Follow-up|0
4948202|NCT00323882|17020316|P1|Overall Study|Lost to Follow-up|0
4948203|NCT00323882|17020312|P5|Overall Study|Death|5
4948204|NCT00323882|17020313|P4|Overall Study|Death|0
4948205|NCT00323882|17020314|P3|Overall Study|Death|1
4948206|NCT00323882|17020315|P2|Overall Study|Death|1
4948207|NCT00323882|17020316|P1|Overall Study|Death|0
4948208|NCT00323882|17020312|P5|Overall Study|Disease Progression|22
4948209|NCT00323882|17020313|P4|Overall Study|Disease Progression|5
4948210|NCT00323882|17020314|P3|Overall Study|Disease Progression|10
4948211|NCT00323882|17020315|P2|Overall Study|Disease Progression|4
4948212|NCT00323882|17020316|P1|Overall Study|Disease Progression|6
4948213|NCT00323882|17020312|P5|Overall Study|Adverse Event|3
4948214|NCT00323882|17020313|P4|Overall Study|Adverse Event|1
4948215|NCT00323882|17020314|P3|Overall Study|Adverse Event|1
4948216|NCT00323882|17020315|P2|Overall Study|Adverse Event|1
4948217|NCT00323882|17020316|P1|Overall Study|Adverse Event|2
4948218|NCT00323869|17020387|P1|Overall Study|Death|1
4948219|NCT00323622|17020443|P8|Overall Study|Death|2
4948220|NCT00323622|17020444|P7|Overall Study|Death|0
4948221|NCT00323622|17020445|P6|Overall Study|Death|0
4948222|NCT00323622|17020446|P5|Overall Study|Death|7
4948223|NCT00323622|17020447|P4|Overall Study|Death|0
4948224|NCT00323622|17020448|P3|Overall Study|Death|0
4948225|NCT00323622|17020449|P2|Overall Study|Death|1
4948226|NCT00323622|17020450|P1|Overall Study|Death|1
4948227|NCT00323622|17020443|P8|Overall Study|Other|13
4948228|NCT00323622|17020444|P7|Overall Study|Other|5
4948229|NCT00323622|17020445|P6|Overall Study|Other|74
4948230|NCT00323622|17020446|P5|Overall Study|Other|32
4948231|NCT00323622|17020447|P4|Overall Study|Other|12
4948232|NCT00323622|17020448|P3|Overall Study|Other|4
4948233|NCT00323622|17020449|P2|Overall Study|Other|91
4948234|NCT00323622|17020450|P1|Overall Study|Other|30
4948235|NCT00323609|17020492|P4|Overall Study|Other reason|9
4948236|NCT00323609|17020493|P3|Overall Study|Other reason|4
4948237|NCT00323609|17020494|P2|Overall Study|Other reason|8
4948238|NCT00323609|17020495|P1|Overall Study|Other reason|11
4948239|NCT00323609|17020492|P4|Overall Study|Logistical withdrawal|1
4948240|NCT00323609|17020493|P3|Overall Study|Logistical withdrawal|0
4948241|NCT00323609|17020494|P2|Overall Study|Logistical withdrawal|5
4948242|NCT00323609|17020495|P1|Overall Study|Logistical withdrawal|9
4948243|NCT00323609|17020492|P4|Overall Study|Unrelenting or severe back pain|0
4948244|NCT00323609|17020493|P3|Overall Study|Unrelenting or severe back pain|0
4948245|NCT00323609|17020494|P2|Overall Study|Unrelenting or severe back pain|1
4948246|NCT00323609|17020495|P1|Overall Study|Unrelenting or severe back pain|1
4948247|NCT00323609|17020492|P4|Overall Study|Sponsor discontinued trial|0
4948248|NCT00323609|17020493|P3|Overall Study|Sponsor discontinued trial|0
4948249|NCT00323609|17020494|P2|Overall Study|Sponsor discontinued trial|29
4948250|NCT00323609|17020495|P1|Overall Study|Sponsor discontinued trial|29
4948251|NCT00323609|17020492|P4|Overall Study|Other non-VCF-related medical condition|0
4948252|NCT00323609|17020493|P3|Overall Study|Other non-VCF-related medical condition|0
4948253|NCT00323609|17020494|P2|Overall Study|Other non-VCF-related medical condition|2
4948254|NCT00323609|17020495|P1|Overall Study|Other non-VCF-related medical condition|3
4948255|NCT00323609|17020492|P4|Overall Study|Withdrawal by Subject|4
4948256|NCT00323609|17020493|P3|Overall Study|Withdrawal by Subject|4
4948257|NCT00323609|17020494|P2|Overall Study|Withdrawal by Subject|23
4948258|NCT00323609|17020495|P1|Overall Study|Withdrawal by Subject|11
4948259|NCT00323609|17020492|P4|Overall Study|Physician Decision|1
4948260|NCT00323609|17020493|P3|Overall Study|Physician Decision|0
4948261|NCT00323609|17020494|P2|Overall Study|Physician Decision|0
4948262|NCT00323609|17020495|P1|Overall Study|Physician Decision|2
4948263|NCT00323609|17020492|P4|Overall Study|Lost to Follow-up|0
4948264|NCT00323609|17020493|P3|Overall Study|Lost to Follow-up|0
4948265|NCT00323609|17020494|P2|Overall Study|Lost to Follow-up|10
4948266|NCT00323609|17020495|P1|Overall Study|Lost to Follow-up|9
4948267|NCT00323609|17020492|P4|Overall Study|Death|0
4948268|NCT00323609|17020493|P3|Overall Study|Death|0
4948269|NCT00323609|17020494|P2|Overall Study|Death|21
4948270|NCT00323609|17020495|P1|Overall Study|Death|16
4948271|NCT00323557|17020531|P2|Overall Study|Physician Decision|0
4948272|NCT00323557|17020532|P1|Overall Study|Physician Decision|1
4948273|NCT00323492|17020541|P3|Study Phase 2|Protocol Violation|0
4948274|NCT00323492|17020542|P2|Study Phase 2|Protocol Violation|0
4948275|NCT00323492|17020543|P1|Study Phase 2|Protocol Violation|1
4948276|NCT00323492|17020541|P3|Study Phase 2|Noncompliance with study schedule|1
4948277|NCT00323492|17020542|P2|Study Phase 2|Noncompliance with study schedule|0
4948278|NCT00323492|17020543|P1|Study Phase 2|Noncompliance with study schedule|0
4948279|NCT00323492|17020541|P3|Study Phase 2|Withdrawal by Subject|0
4948280|NCT00323492|17020542|P2|Study Phase 2|Withdrawal by Subject|1
4948281|NCT00323492|17020543|P1|Study Phase 2|Withdrawal by Subject|0
4948282|NCT00323492|17020541|P3|Study Phase 2|Lost to Follow-up|0
4948283|NCT00323492|17020542|P2|Study Phase 2|Lost to Follow-up|0
4948284|NCT00323492|17020543|P1|Study Phase 2|Lost to Follow-up|1
4948285|NCT00323492|17020541|P3|Study Phase 2|Physician Decision|0
4948286|NCT00323492|17020542|P2|Study Phase 2|Physician Decision|0
4948287|NCT00323492|17020543|P1|Study Phase 2|Physician Decision|1
4948288|NCT00323492|17020541|P3|Study Phase 2|Adverse Event|0
4948289|NCT00323492|17020542|P2|Study Phase 2|Adverse Event|0
4948290|NCT00323492|17020543|P1|Study Phase 2|Adverse Event|1
4948291|NCT00323492|17020541|P3|Study Phase 1|Adverse Event|0
4948292|NCT00323492|17020542|P2|Study Phase 1|Adverse Event|0
4948293|NCT00323492|17020543|P1|Study Phase 1|Adverse Event|2
4948294|NCT00323479|17020574|P1|Overall Study|house moving|1
4948295|NCT00323479|17020574|P1|Overall Study|Protocol Violation|3
4948296|NCT00323479|17020574|P1|Overall Study|Withdrawal by Subject|2
4948297|NCT00323479|17020574|P1|Overall Study|Adverse Event|2
4948298|NCT00323414|17020607|P2|Overall Study|Withdrawal by Subject|1
4948299|NCT00323414|17020608|P1|Overall Study|Withdrawal by Subject|0
4948300|NCT00323310|17020630|P1|Overall Study|did not complete the 24-hr f-up visit|1
4948301|NCT00323310|17020630|P1|Overall Study|a parent refused blood draw|1
4948302|NCT00323310|17020630|P1|Overall Study|Withdrawal by Subject|1
4948303|NCT00323297|17020645|P2|Part B (Open-label)|Protocol Violation|1
4948304|NCT00323297|17020646|P1|Part B (Open-label)|Protocol Violation|0
4948305|NCT00323297|17020645|P2|Part B (Open-label)|Adverse Event|5
4948306|NCT00323297|17020646|P1|Part B (Open-label)|Adverse Event|5
4948307|NCT00323297|17020645|P2|Part B (Open-label)|Lack of Efficacy|1
4948308|NCT00323297|17020646|P1|Part B (Open-label)|Lack of Efficacy|3
4948309|NCT00323297|17020645|P2|Part B (Open-label)|Withdrawal by Subject|3
4948310|NCT00323297|17020646|P1|Part B (Open-label)|Withdrawal by Subject|1
4948311|NCT00323297|17020645|P2|Part B (Open-label)|Reason unspecified|1
4948312|NCT00323297|17020646|P1|Part B (Open-label)|Reason unspecified|0
4948313|NCT00323297|17020645|P2|Part B (Open-label)|Death|1
4948314|NCT00323297|17020646|P1|Part B (Open-label)|Death|0
4948315|NCT00323297|17020645|P2|Part A (Double Blind Randomized)|Related adverse event|2
4948316|NCT00323297|17020646|P1|Part A (Double Blind Randomized)|Related adverse event|2
4948317|NCT00323297|17020645|P2|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0
4948318|NCT00323297|17020646|P1|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1
4948319|NCT00323297|17020645|P2|Part A (Double Blind Randomized)|Unrelated adverse event|0
4948320|NCT00323297|17020646|P1|Part A (Double Blind Randomized)|Unrelated adverse event|1
4948321|NCT00323297|17020645|P2|Part A (Double Blind Randomized)|Protocol Violation|3
4948322|NCT00323297|17020646|P1|Part A (Double Blind Randomized)|Protocol Violation|1
4948323|NCT00323297|17020645|P2|Part A (Double Blind Randomized)|Death|1
4948324|NCT00323297|17020646|P1|Part A (Double Blind Randomized)|Death|0
4948325|NCT00323297|17020645|P2|Part A (Double Blind Randomized)|Reason unspecified|1
4948326|NCT00323297|17020646|P1|Part A (Double Blind Randomized)|Reason unspecified|0
4948327|NCT00323258|17020686|P2|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2
4948328|NCT00323258|17020687|P1|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1
4948329|NCT00323258|17020686|P2|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10
4948330|NCT00323258|17020687|P1|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12
4948331|NCT00323258|17020686|P2|Secondary Outcome (6 Mon Refill Records)|Death|2
4948332|NCT00323258|17020687|P1|Secondary Outcome (6 Mon Refill Records)|Death|1
4948333|NCT00323258|17020686|P2|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1
4948334|NCT00323258|17020687|P1|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2
4948335|NCT00323258|17020686|P2|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5
4948336|NCT00323258|17020687|P1|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1
4948337|NCT00323258|17020686|P2|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11
4948338|NCT00323258|17020687|P1|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12
4948339|NCT00323258|17020686|P2|Primary Outcome (Phone Call at 6 Months)|Death|2
4948340|NCT00323258|17020687|P1|Primary Outcome (Phone Call at 6 Months)|Death|1
4948341|NCT00323115|17020712|P1|Adjuvant Therapy & Survival Follow-Up|Death|8
4948342|NCT00323115|17020712|P1|Vaccine Administration|Adverse Event|1
4948343|NCT00323063|17020739|P2|Overall Study|brain mets discovered prior to treatment|0
4948344|NCT00323063|17020740|P1|Overall Study|brain mets discovered prior to treatment|1
4948345|NCT00323063|17020739|P2|Overall Study|Adverse Event|0
4948346|NCT00323063|17020740|P1|Overall Study|Adverse Event|1
4948347|NCT00322881|17020757|P1|Overall Study|Disease Progression|2
4948348|NCT00322881|17020757|P1|Overall Study|Adverse Event|1
4948349|NCT00322881|17020757|P1|Overall Study|Death|2
4948350|NCT00322868|17020761|P1|Overall Study|disease progression|1
4948351|NCT00322842|17020786|P2|Overall Study|Death|0
4948352|NCT00322842|17020787|P1|Overall Study|Death|1
4948353|NCT00322842|17020786|P2|Overall Study|Refused transplant|0
4948354|NCT00322842|17020787|P1|Overall Study|Refused transplant|1
4948355|NCT00322842|17020786|P2|Overall Study|Lost to Follow-up|1
4948356|NCT00322842|17020787|P1|Overall Study|Lost to Follow-up|0
4948357|NCT00322842|17020786|P2|Overall Study|Withdrawal by Subject|1
4948358|NCT00322842|17020787|P1|Overall Study|Withdrawal by Subject|0
4948359|NCT00322712|17020825|P1|Overall Study|treated with bevacizumab not cetuximab|1
4948360|NCT00322621|17020829|P3|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
4948361|NCT00322621|17020830|P2|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1
4948362|NCT00322621|17020831|P1|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0
4948363|NCT00322621|17020829|P3|Period III - Maintenance / Rescue Phase|Death|0
4948364|NCT00322621|17020830|P2|Period III - Maintenance / Rescue Phase|Death|1
4948365|NCT00322621|17020831|P1|Period III - Maintenance / Rescue Phase|Death|0
4948366|NCT00322621|17020829|P3|Period III - Maintenance / Rescue Phase|Protocol Violation|5
4948367|NCT00322621|17020830|P2|Period III - Maintenance / Rescue Phase|Protocol Violation|2
4948368|NCT00322621|17020831|P1|Period III - Maintenance / Rescue Phase|Protocol Violation|0
4948369|NCT00322621|17020829|P3|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1
4948370|NCT00322621|17020830|P2|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7
4948371|NCT00322621|17020831|P1|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0
4948372|NCT00322621|17020829|P3|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24
4948373|NCT00322621|17020830|P2|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4
4948374|NCT00322621|17020831|P1|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0
4948375|NCT00322621|17020829|P3|Period III - Maintenance / Rescue Phase|Adverse Event|5
4948376|NCT00322621|17020830|P2|Period III - Maintenance / Rescue Phase|Adverse Event|14
4948377|NCT00322621|17020831|P1|Period III - Maintenance / Rescue Phase|Adverse Event|0
4948378|NCT00322621|17020829|P3|Period II - Acute Therapy Phase|Physician Decision|0
4948379|NCT00322621|17020830|P2|Period II - Acute Therapy Phase|Physician Decision|0
4948380|NCT00322621|17020831|P1|Period II - Acute Therapy Phase|Physician Decision|1
4948381|NCT00322621|17020829|P3|Period II - Acute Therapy Phase|Protocol Violation|0
4948382|NCT00322621|17020830|P2|Period II - Acute Therapy Phase|Protocol Violation|0
4948383|NCT00322621|17020831|P1|Period II - Acute Therapy Phase|Protocol Violation|2
4948384|NCT00322621|17020829|P3|Period II - Acute Therapy Phase|Withdrawal by Subject|0
4948385|NCT00322621|17020830|P2|Period II - Acute Therapy Phase|Withdrawal by Subject|0
4948386|NCT00322621|17020831|P1|Period II - Acute Therapy Phase|Withdrawal by Subject|8
4948387|NCT00322621|17020829|P3|Period II - Acute Therapy Phase|Lack of Efficacy|0
4948388|NCT00322621|17020830|P2|Period II - Acute Therapy Phase|Lack of Efficacy|0
4948389|NCT00322621|17020831|P1|Period II - Acute Therapy Phase|Lack of Efficacy|1
4948390|NCT00322621|17020829|P3|Period II - Acute Therapy Phase|Adverse Event|0
4948391|NCT00322621|17020830|P2|Period II - Acute Therapy Phase|Adverse Event|0
4948392|NCT00322621|17020831|P1|Period II - Acute Therapy Phase|Adverse Event|20
4948393|NCT00322556|17020883|P1|Overall Study|Other Reason|7
4948394|NCT00322556|17020883|P1|Overall Study|Lost to Follow-up|3
4948395|NCT00322556|17020883|P1|Overall Study|Withdrawal by Subject|1
4948396|NCT00322556|17020883|P1|Overall Study|Adverse Event|1
4948397|NCT00322491|17020899|P2|Overall Study|Death|2
4948398|NCT00322491|17020900|P1|Overall Study|Death|1
4948399|NCT00322491|17020899|P2|Overall Study|Adverse Event|0
4948400|NCT00322491|17020900|P1|Overall Study|Adverse Event|1
4948401|NCT00322452|17020990|P2|Overall Study|Death|227
4948402|NCT00322452|17020991|P1|Overall Study|Death|223
4948403|NCT00322452|17020990|P2|Overall Study|Withdrawal by Subject|46
4948404|NCT00322452|17020991|P1|Overall Study|Withdrawal by Subject|19
4948405|NCT00322452|17020990|P2|Overall Study|Lost to Follow-up|2
4948406|NCT00322452|17020991|P1|Overall Study|Lost to Follow-up|5
4948407|NCT00322452|17020990|P2|Overall Study|Eligibility criteria not fulfilled|1
4948408|NCT00322452|17020991|P1|Overall Study|Eligibility criteria not fulfilled|0
4948409|NCT00322387|17021042|P2|Follow-up Period|Death|0
4948410|NCT00322387|17021043|P1|Follow-up Period|Death|1
4948411|NCT00322387|17021042|P2|Follow-up Period|Final assessment not done|3
4948412|NCT00322387|17021043|P1|Follow-up Period|Final assessment not done|1
4948413|NCT00322387|17021042|P2|Treatment Period|Adverse Event|1
4948414|NCT00322387|17021043|P1|Treatment Period|Adverse Event|0
4948415|NCT00322374|17021077|P4|Second Escalation|Study Drug Toxicity|0
4948416|NCT00322374|17021078|P3|Second Escalation|Study Drug Toxicity|1
4948417|NCT00322374|17021079|P2|Second Escalation|Study Drug Toxicity|0
4948418|NCT00322374|17021080|P1|Second Escalation|Study Drug Toxicity|0
4948419|NCT00322374|17021077|P4|Second Escalation|Physician Decision|0
4948420|NCT00322374|17021078|P3|Second Escalation|Physician Decision|5
4948421|NCT00322374|17021079|P2|Second Escalation|Physician Decision|0
4948422|NCT00322374|17021080|P1|Second Escalation|Physician Decision|0
4948423|NCT00322374|17021077|P4|First Escalation|Participant Request|0
4948424|NCT00322374|17021078|P3|First Escalation|Participant Request|0
4948425|NCT00322374|17021079|P2|First Escalation|Participant Request|1
4948426|NCT00322374|17021080|P1|First Escalation|Participant Request|0
4948427|NCT00322374|17021077|P4|First Escalation|Study Drug Toxicity|0
4948428|NCT00322374|17021078|P3|First Escalation|Study Drug Toxicity|0
4948429|NCT00322374|17021079|P2|First Escalation|Study Drug Toxicity|11
4948430|NCT00322374|17021080|P1|First Escalation|Study Drug Toxicity|0
4948431|NCT00322374|17021077|P4|First Escalation|Physician Decision|0
4948432|NCT00322374|17021078|P3|First Escalation|Physician Decision|0
4948433|NCT00322374|17021079|P2|First Escalation|Physician Decision|12
4948434|NCT00322374|17021080|P1|First Escalation|Physician Decision|0
4948435|NCT00322374|17021077|P4|First Escalation|Documented Disease Progression|0
4948436|NCT00322374|17021078|P3|First Escalation|Documented Disease Progression|0
4948437|NCT00322374|17021079|P2|First Escalation|Documented Disease Progression|6
4948438|NCT00322374|17021080|P1|First Escalation|Documented Disease Progression|0
4948439|NCT00322374|17021077|P4|Starting Dose|Study Drug Toxicity|0
4948440|NCT00322374|17021078|P3|Starting Dose|Study Drug Toxicity|0
4948441|NCT00322374|17021079|P2|Starting Dose|Study Drug Toxicity|0
4948442|NCT00322374|17021080|P1|Starting Dose|Study Drug Toxicity|4
4948443|NCT00322374|17021077|P4|Starting Dose|Physician Decision|0
4948444|NCT00322374|17021078|P3|Starting Dose|Physician Decision|0
4948445|NCT00322374|17021079|P2|Starting Dose|Physician Decision|0
4948446|NCT00322374|17021080|P1|Starting Dose|Physician Decision|2
4948447|NCT00322348|17021130|P2|Overall Study|Reasons not specified|1
4948448|NCT00322348|17021131|P1|Overall Study|Reasons not specified|5
4948449|NCT00322348|17021130|P2|Overall Study|Disease Progression|25
4948450|NCT00322348|17021131|P1|Overall Study|Disease Progression|30
4948451|NCT00322348|17021130|P2|Overall Study|Death|2
4948452|NCT00322348|17021131|P1|Overall Study|Death|0
4948453|NCT00322348|17021130|P2|Overall Study|Lost to Follow-up|0
4948454|NCT00322348|17021131|P1|Overall Study|Lost to Follow-up|1
4948455|NCT00322348|17021130|P2|Overall Study|Withdrawal by Subject|4
4948456|NCT00322348|17021131|P1|Overall Study|Withdrawal by Subject|1
4948457|NCT00322348|17021130|P2|Overall Study|Adverse Event|1
4948458|NCT00322348|17021131|P1|Overall Study|Adverse Event|0
4948459|NCT00322153|17021222|P2|Overall Study|Withdrawn for other reasons|4
4948460|NCT00322153|17021223|P1|Overall Study|Withdrawn for other reasons|5
4948461|NCT00322153|17021222|P2|Overall Study|Lost to Follow-up|4
4948462|NCT00322153|17021223|P1|Overall Study|Lost to Follow-up|5
4948463|NCT00322153|17021222|P2|Overall Study|Lack of Efficacy|3
4948464|NCT00322153|17021223|P1|Overall Study|Lack of Efficacy|8
4948465|NCT00322153|17021222|P2|Overall Study|Withdrawal by Subject|10
4948466|NCT00322153|17021223|P1|Overall Study|Withdrawal by Subject|18
4948467|NCT00322153|17021222|P2|Overall Study|Protocol Violation|14
4948468|NCT00322153|17021223|P1|Overall Study|Protocol Violation|6
4948469|NCT00322153|17021222|P2|Overall Study|Adverse Event|34
4948470|NCT00322153|17021223|P1|Overall Study|Adverse Event|21
4948471|NCT00322049|17021256|P4|Overall Study|Infected with Dengue during study|0
4948472|NCT00322049|17021257|P3|Overall Study|Infected with Dengue during study|0
4948473|NCT00322049|17021258|P2|Overall Study|Infected with Dengue during study|1
4948474|NCT00322049|17021259|P1|Overall Study|Infected with Dengue during study|0
4948475|NCT00322049|17021256|P4|Overall Study|Moved out of area|1
4948476|NCT00322049|17021257|P3|Overall Study|Moved out of area|0
4948477|NCT00322049|17021258|P2|Overall Study|Moved out of area|0
4948478|NCT00322049|17021259|P1|Overall Study|Moved out of area|0
4948479|NCT00322023|17021292|P3|Overall Study|various|6
4948480|NCT00322023|17021293|P2|Overall Study|various|2
4948481|NCT00322023|17021294|P1|Overall Study|various|0
4948482|NCT00321984|17021311|P3|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
4948483|NCT00321984|17021312|P2|Overall Study|Per Sponsor Due to High Baseline Gastrin|1
4948484|NCT00321984|17021313|P1|Overall Study|Per Sponsor Due to High Baseline Gastrin|0
4948485|NCT00321984|17021311|P3|Overall Study|Per Investigator Request|0
4948486|NCT00321984|17021312|P2|Overall Study|Per Investigator Request|0
4948487|NCT00321984|17021313|P1|Overall Study|Per Investigator Request|1
4948488|NCT00321984|17021311|P3|Overall Study|Per Subject Request|0
4948489|NCT00321984|17021312|P2|Overall Study|Per Subject Request|0
4948490|NCT00321984|17021313|P1|Overall Study|Per Subject Request|1
4948491|NCT00321984|17021311|P3|Overall Study|Pregnancy|0
4948492|NCT00321984|17021312|P2|Overall Study|Pregnancy|1
4948493|NCT00321984|17021313|P1|Overall Study|Pregnancy|0
4948494|NCT00321984|17021311|P3|Overall Study|Noncompliant|2
4948495|NCT00321984|17021312|P2|Overall Study|Noncompliant|0
4948496|NCT00321984|17021313|P1|Overall Study|Noncompliant|0
4948497|NCT00321984|17021311|P3|Overall Study|Lack of Efficacy|3
4948498|NCT00321984|17021312|P2|Overall Study|Lack of Efficacy|1
4948499|NCT00321984|17021313|P1|Overall Study|Lack of Efficacy|3
4948500|NCT00321984|17021311|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
4948501|NCT00321984|17021312|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|1
4948502|NCT00321984|17021313|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|3
4948503|NCT00321984|17021311|P3|Overall Study|Withdrawal by Subject|5
4948504|NCT00321984|17021312|P2|Overall Study|Withdrawal by Subject|6
4948505|NCT00321984|17021313|P1|Overall Study|Withdrawal by Subject|8
4948506|NCT00321984|17021311|P3|Overall Study|Lost to Follow-up|2
4948507|NCT00321984|17021312|P2|Overall Study|Lost to Follow-up|4
4948508|NCT00321984|17021313|P1|Overall Study|Lost to Follow-up|2
4948509|NCT00321984|17021311|P3|Overall Study|Protocol Violation|1
4948510|NCT00321984|17021312|P2|Overall Study|Protocol Violation|1
4948511|NCT00321984|17021313|P1|Overall Study|Protocol Violation|0
4948512|NCT00321984|17021311|P3|Overall Study|Adverse Event|8
4948513|NCT00321984|17021312|P2|Overall Study|Adverse Event|6
4948514|NCT00321984|17021313|P1|Overall Study|Adverse Event|9
4948515|NCT00321932|17021341|P2|Overall Study|Missing data|1
4948516|NCT00321932|17021342|P1|Overall Study|Missing data|2
4948517|NCT00321932|17021341|P2|Overall Study|Early relapse|8
4948518|NCT00321932|17021342|P1|Overall Study|Early relapse|2
4948519|NCT00321932|17021341|P2|Overall Study|Withdrawal by Subject|6
4948520|NCT00321932|17021342|P1|Overall Study|Withdrawal by Subject|3
4948521|NCT00321932|17021341|P2|Overall Study|Death|6
4948522|NCT00321932|17021342|P1|Overall Study|Death|3
4948523|NCT00321919|17021366|P2|Overall Study|Other withdrawal reason|6
4948524|NCT00321919|17021367|P1|Overall Study|Other withdrawal reason|7
4948525|NCT00321919|17021366|P2|Overall Study|Failure to Return|1
4948526|NCT00321919|17021367|P1|Overall Study|Failure to Return|3
4948527|NCT00321919|17021366|P2|Overall Study|Other Protocol Violation|3
4948528|NCT00321919|17021367|P1|Overall Study|Other Protocol Violation|2
4948529|NCT00321919|17021366|P2|Overall Study|Refused Treatment|14
4948530|NCT00321919|17021367|P1|Overall Study|Refused Treatment|23
4948531|NCT00321919|17021366|P2|Overall Study|Violation of Selection Criteria at Entry|1
4948532|NCT00321919|17021367|P1|Overall Study|Violation of Selection Criteria at Entry|1
4948533|NCT00321919|17021366|P2|Overall Study|Insufficient Therapeutic Response|0
4948534|NCT00321919|17021367|P1|Overall Study|Insufficient Therapeutic Response|1
4948535|NCT00321919|17021366|P2|Overall Study|Death|17
4948536|NCT00321919|17021367|P1|Overall Study|Death|21
4948537|NCT00321919|17021366|P2|Overall Study|Adverse Event|10
4948538|NCT00321919|17021367|P1|Overall Study|Adverse Event|17
4948539|NCT00321906|17021409|P2|Overall Study|Withdrawal by Subject|4
4948540|NCT00321906|17021410|P1|Overall Study|Withdrawal by Subject|0
4948541|NCT00321906|17021409|P2|Overall Study|Lost to Follow-up|2
4948542|NCT00321906|17021410|P1|Overall Study|Lost to Follow-up|1
4948543|NCT00321906|17021409|P2|Overall Study|Death|6
4948544|NCT00321906|17021410|P1|Overall Study|Death|9
4948545|NCT00321906|17021409|P2|Overall Study|Adverse Event|44
4948546|NCT00321906|17021410|P1|Overall Study|Adverse Event|36
4948547|NCT00321893|17021432|P2|Overall Study|Adverse Event|3
4948548|NCT00321893|17021433|P1|Overall Study|Adverse Event|6
4948549|NCT00321893|17021432|P2|Overall Study|Lost to Follow-up|1
4948550|NCT00321893|17021433|P1|Overall Study|Lost to Follow-up|2
4948551|NCT00321893|17021432|P2|Overall Study|Non-Compliance/Refusal|10
4948552|NCT00321893|17021433|P1|Overall Study|Non-Compliance/Refusal|16
4948553|NCT00321854|17021447|P2|Overall Study|Other|1
4948554|NCT00321854|17021448|P1|Overall Study|Other|1
4948555|NCT00321854|17021447|P2|Overall Study|Withdrawal by Subject|17
4948556|NCT00321854|17021448|P1|Overall Study|Withdrawal by Subject|6
4948557|NCT00321854|17021447|P2|Overall Study|Lost to Follow-up|2
4948558|NCT00321854|17021448|P1|Overall Study|Lost to Follow-up|0
4948559|NCT00321854|17021447|P2|Overall Study|Protocol Violation|5
4948560|NCT00321854|17021448|P1|Overall Study|Protocol Violation|6
4948561|NCT00321854|17021447|P2|Overall Study|Lack of Efficacy|14
4948562|NCT00321854|17021448|P1|Overall Study|Lack of Efficacy|9
4948563|NCT00321854|17021447|P2|Overall Study|Adverse Event|43
4948564|NCT00321854|17021448|P1|Overall Study|Adverse Event|41
4948565|NCT00321828|17021566|P1|Overall Study|No follow up data|1
4948566|NCT00321828|17021566|P1|Overall Study|Ineligible|3
4948567|NCT00321789|17021572|P2|Overall Study|Protocol Violation|3
4948568|NCT00321789|17021573|P1|Overall Study|Protocol Violation|5
4948569|NCT00321789|17021572|P2|Overall Study|Withdrawal by Subject|6
4948570|NCT00321789|17021573|P1|Overall Study|Withdrawal by Subject|6
4948571|NCT00321789|17021572|P2|Overall Study|Lost to Follow-up|7
4948572|NCT00321789|17021573|P1|Overall Study|Lost to Follow-up|4
4948573|NCT00321763|17021605|P4|Overall Study|Lost to Follow-up|4
4948574|NCT00321763|17021606|P3|Overall Study|Lost to Follow-up|5
4948575|NCT00321763|17021607|P2|Overall Study|Lost to Follow-up|1
4948576|NCT00321763|17021608|P1|Overall Study|Lost to Follow-up|3
4948577|NCT00321763|17021605|P4|Overall Study|Withdrawal by Subject|0
4948578|NCT00321763|17021606|P3|Overall Study|Withdrawal by Subject|1
4948579|NCT00321763|17021607|P2|Overall Study|Withdrawal by Subject|0
4948580|NCT00321763|17021608|P1|Overall Study|Withdrawal by Subject|2
4948581|NCT00321763|17021605|P4|Overall Study|Adverse Event|1
4948582|NCT00321763|17021606|P3|Overall Study|Adverse Event|0
4948583|NCT00321763|17021607|P2|Overall Study|Adverse Event|1
4948584|NCT00321763|17021608|P1|Overall Study|Adverse Event|1
4948585|NCT00321737|17021668|P3|Overall Study|Subject Request/ Subject Unavailable|2
4948586|NCT00321737|17021669|P2|Overall Study|Subject Request/ Subject Unavailable|0
4948587|NCT00321737|17021670|P1|Overall Study|Subject Request/ Subject Unavailable|0
4948588|NCT00321737|17021668|P3|Overall Study|Noncompliance|0
4948589|NCT00321737|17021669|P2|Overall Study|Noncompliance|0
4948590|NCT00321737|17021670|P1|Overall Study|Noncompliance|2
4948591|NCT00321737|17021668|P3|Overall Study|Pregnancy|0
4948592|NCT00321737|17021669|P2|Overall Study|Pregnancy|2
4948593|NCT00321737|17021670|P1|Overall Study|Pregnancy|0
4948594|NCT00321737|17021668|P3|Overall Study|Therapeutic Failure|2
4948595|NCT00321737|17021669|P2|Overall Study|Therapeutic Failure|0
4948596|NCT00321737|17021670|P1|Overall Study|Therapeutic Failure|6
4948597|NCT00321737|17021668|P3|Overall Study|Possible Barrett's Esophagus|1
4948598|NCT00321737|17021669|P2|Overall Study|Possible Barrett's Esophagus|1
4948599|NCT00321737|17021670|P1|Overall Study|Possible Barrett's Esophagus|2
4948600|NCT00321737|17021668|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4948601|NCT00321737|17021669|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4948602|NCT00321737|17021670|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|1
4948603|NCT00321737|17021668|P3|Overall Study|Protocol Violation|1
4948604|NCT00321737|17021669|P2|Overall Study|Protocol Violation|0
4948605|NCT00321737|17021670|P1|Overall Study|Protocol Violation|0
4948606|NCT00321737|17021668|P3|Overall Study|Withdrawal by Subject|17
4948607|NCT00321737|17021669|P2|Overall Study|Withdrawal by Subject|12
4948608|NCT00321737|17021670|P1|Overall Study|Withdrawal by Subject|19
4948609|NCT00321737|17021668|P3|Overall Study|Lost to Follow-up|6
4948610|NCT00321737|17021669|P2|Overall Study|Lost to Follow-up|5
4948611|NCT00321737|17021670|P1|Overall Study|Lost to Follow-up|5
4948612|NCT00321737|17021668|P3|Overall Study|Adverse Event|6
4948613|NCT00321737|17021669|P2|Overall Study|Adverse Event|3
4948614|NCT00321737|17021670|P1|Overall Study|Adverse Event|11
4948615|NCT00321737|17021668|P3|Overall Study|Relapse of Erosive Esophagitis|19
4948616|NCT00321737|17021669|P2|Overall Study|Relapse of Erosive Esophagitis|25
4948617|NCT00321737|17021670|P1|Overall Study|Relapse of Erosive Esophagitis|76
4948618|NCT00321711|17021698|P5|Part B|Death|1
4948619|NCT00321711|17021699|P4|Part B|Death|2
4948620|NCT00321711|17021700|P3|Part B|Death|0
4948621|NCT00321711|17021701|P2|Part B|Death|0
4948622|NCT00321711|17021702|P1|Part B|Death|0
4948623|NCT00321711|17021698|P5|Part B|Physician Decision|2
4948624|NCT00321711|17021699|P4|Part B|Physician Decision|1
4948625|NCT00321711|17021700|P3|Part B|Physician Decision|0
4948626|NCT00321711|17021701|P2|Part B|Physician Decision|0
4948627|NCT00321711|17021702|P1|Part B|Physician Decision|0
4948628|NCT00321711|17021698|P5|Part B|Disease progression|0
4948629|NCT00321711|17021699|P4|Part B|Disease progression|1
4948630|NCT00321711|17021700|P3|Part B|Disease progression|0
4948631|NCT00321711|17021701|P2|Part B|Disease progression|0
4948632|NCT00321711|17021702|P1|Part B|Disease progression|0
4948633|NCT00321711|17021698|P5|Part B|Adverse Event|1
4948634|NCT00321711|17021699|P4|Part B|Adverse Event|2
4948635|NCT00321711|17021700|P3|Part B|Adverse Event|0
4948636|NCT00321711|17021701|P2|Part B|Adverse Event|0
4948637|NCT00321711|17021702|P1|Part B|Adverse Event|0
4948638|NCT00321711|17021698|P5|Part B|Noncompliance|1
4948639|NCT00321711|17021699|P4|Part B|Noncompliance|0
4948640|NCT00321711|17021700|P3|Part B|Noncompliance|0
4948641|NCT00321711|17021701|P2|Part B|Noncompliance|0
4948642|NCT00321711|17021702|P1|Part B|Noncompliance|0
4948643|NCT00321711|17021698|P5|Part A|Protocol deviation|0
4948644|NCT00321711|17021699|P4|Part A|Protocol deviation|0
4948645|NCT00321711|17021700|P3|Part A|Protocol deviation|1
4948646|NCT00321711|17021701|P2|Part A|Protocol deviation|0
4948647|NCT00321711|17021702|P1|Part A|Protocol deviation|0
4948648|NCT00321711|17021698|P5|Part A|Other|0
4948649|NCT00321711|17021699|P4|Part A|Other|0
4948650|NCT00321711|17021700|P3|Part A|Other|3
4948651|NCT00321711|17021701|P2|Part A|Other|2
4948652|NCT00321711|17021702|P1|Part A|Other|1
4948653|NCT00321711|17021698|P5|Part A|Physician Decision|0
4948654|NCT00321711|17021699|P4|Part A|Physician Decision|0
4948655|NCT00321711|17021700|P3|Part A|Physician Decision|3
4948656|NCT00321711|17021701|P2|Part A|Physician Decision|1
4948657|NCT00321711|17021702|P1|Part A|Physician Decision|0
4948658|NCT00321711|17021698|P5|Part A|Requirement for alternative therapy|0
4948659|NCT00321711|17021699|P4|Part A|Requirement for alternative therapy|0
4948660|NCT00321711|17021700|P3|Part A|Requirement for alternative therapy|1
4948661|NCT00321711|17021701|P2|Part A|Requirement for alternative therapy|2
4948662|NCT00321711|17021702|P1|Part A|Requirement for alternative therapy|0
4948663|NCT00321711|17021698|P5|Part A|Disease progression|0
4948664|NCT00321711|17021699|P4|Part A|Disease progression|0
4948665|NCT00321711|17021700|P3|Part A|Disease progression|0
4948666|NCT00321711|17021701|P2|Part A|Disease progression|1
4948667|NCT00321711|17021702|P1|Part A|Disease progression|0
4948668|NCT00321711|17021698|P5|Part A|Withdrawal by Subject|0
4948669|NCT00321711|17021699|P4|Part A|Withdrawal by Subject|0
4948670|NCT00321711|17021700|P3|Part A|Withdrawal by Subject|1
4948671|NCT00321711|17021701|P2|Part A|Withdrawal by Subject|1
4948672|NCT00321711|17021702|P1|Part A|Withdrawal by Subject|1
4948673|NCT00321711|17021698|P5|Part A|Adverse Event|0
4948674|NCT00321711|17021699|P4|Part A|Adverse Event|0
4948675|NCT00321711|17021700|P3|Part A|Adverse Event|2
4948676|NCT00321711|17021701|P2|Part A|Adverse Event|3
4948677|NCT00321711|17021702|P1|Part A|Adverse Event|3
4948678|NCT00321685|17021752|P1|Overall Study|Ineligible|2
4948679|NCT00321685|17021752|P1|Overall Study|Not start protocol therapy|2
4948680|NCT00321685|17021752|P1|Overall Study|Other|5
4948681|NCT00321685|17021752|P1|Overall Study|Complicating disese|1
4948682|NCT00321685|17021752|P1|Overall Study|Alternative therapy|1
4948683|NCT00321685|17021752|P1|Overall Study|Withdrawal by Subject|8
4948684|NCT00321685|17021752|P1|Overall Study|Death|2
4948685|NCT00321685|17021752|P1|Overall Study|Adverse Event|18
4948686|NCT00321672|17021764|P4|Overall Study|Extensive travel required for new job|0
4948687|NCT00321672|17021765|P3|Overall Study|Extensive travel required for new job|0
4948688|NCT00321672|17021766|P2|Overall Study|Extensive travel required for new job|1
4948689|NCT00321672|17021767|P1|Overall Study|Extensive travel required for new job|0
4948690|NCT00321672|17021764|P4|Overall Study|Diagnosis of testicular cancer|0
4948691|NCT00321672|17021765|P3|Overall Study|Diagnosis of testicular cancer|0
4948692|NCT00321672|17021766|P2|Overall Study|Diagnosis of testicular cancer|1
4948693|NCT00321672|17021767|P1|Overall Study|Diagnosis of testicular cancer|0
4948694|NCT00321672|17021764|P4|Overall Study|Protocol Violation|0
4948695|NCT00321672|17021765|P3|Overall Study|Protocol Violation|1
4948696|NCT00321672|17021766|P2|Overall Study|Protocol Violation|0
4948697|NCT00321672|17021767|P1|Overall Study|Protocol Violation|0
4948698|NCT00321672|17021764|P4|Overall Study|Moved out of state|0
4948699|NCT00321672|17021765|P3|Overall Study|Moved out of state|1
4948700|NCT00321672|17021766|P2|Overall Study|Moved out of state|1
4948701|NCT00321672|17021767|P1|Overall Study|Moved out of state|0
4948702|NCT00321672|17021764|P4|Overall Study|Incarcerated|0
4948703|NCT00321672|17021765|P3|Overall Study|Incarcerated|2
4948704|NCT00321672|17021766|P2|Overall Study|Incarcerated|0
4948705|NCT00321672|17021767|P1|Overall Study|Incarcerated|0
4948706|NCT00321672|17021764|P4|Overall Study|Too far to travel for visits|0
4948707|NCT00321672|17021765|P3|Overall Study|Too far to travel for visits|0
4948708|NCT00321672|17021766|P2|Overall Study|Too far to travel for visits|0
4948709|NCT00321672|17021767|P1|Overall Study|Too far to travel for visits|1
4948710|NCT00321672|17021764|P4|Overall Study|Death|0
4948711|NCT00321672|17021765|P3|Overall Study|Death|0
4948712|NCT00321672|17021766|P2|Overall Study|Death|0
4948713|NCT00321672|17021767|P1|Overall Study|Death|1
4948714|NCT00321672|17021764|P4|Overall Study|Lost to Follow-up|2
4948715|NCT00321672|17021765|P3|Overall Study|Lost to Follow-up|4
4948716|NCT00321672|17021766|P2|Overall Study|Lost to Follow-up|0
4948717|NCT00321672|17021767|P1|Overall Study|Lost to Follow-up|2
4948718|NCT00321672|17021764|P4|Overall Study|Lack of Efficacy|0
4948719|NCT00321672|17021765|P3|Overall Study|Lack of Efficacy|0
4948720|NCT00321672|17021766|P2|Overall Study|Lack of Efficacy|1
4948721|NCT00321672|17021767|P1|Overall Study|Lack of Efficacy|1
4948722|NCT00321672|17021764|P4|Overall Study|Adverse Event|0
4948723|NCT00321672|17021765|P3|Overall Study|Adverse Event|0
4948724|NCT00321672|17021766|P2|Overall Study|Adverse Event|1
4948725|NCT00321672|17021767|P1|Overall Study|Adverse Event|1
4948726|NCT00321672|17021764|P4|Overall Study|Noncompliance|0
4948727|NCT00321672|17021765|P3|Overall Study|Noncompliance|1
4948728|NCT00321672|17021766|P2|Overall Study|Noncompliance|2
4948729|NCT00321672|17021767|P1|Overall Study|Noncompliance|1
4948730|NCT00321672|17021764|P4|Overall Study|Withdrawal by Subject|0
4948731|NCT00321672|17021765|P3|Overall Study|Withdrawal by Subject|2
4948732|NCT00321672|17021766|P2|Overall Study|Withdrawal by Subject|1
4948733|NCT00321672|17021767|P1|Overall Study|Withdrawal by Subject|5
4948734|NCT00321646|17021793|P1|Neoadjuvant Chemotherapy|Disease progression|1
4948735|NCT00321646|17021793|P1|Neoadjuvant Chemotherapy|Adverse Event|2
4948736|NCT00321646|17021793|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
4948737|NCT00321620|17021800|P2|Overall Study|Other|33
4948738|NCT00321620|17021801|P1|Overall Study|Other|42
4948739|NCT00321620|17021800|P2|Overall Study|Participant request|52
4948740|NCT00321620|17021801|P1|Overall Study|Participant request|75
4948741|NCT00321620|17021800|P2|Overall Study|Ineligibility determined|3
4948742|NCT00321620|17021801|P1|Overall Study|Ineligibility determined|2
4948743|NCT00321620|17021800|P2|Overall Study|Protocol deviation|3
4948744|NCT00321620|17021801|P1|Overall Study|Protocol deviation|4
4948745|NCT00321620|17021800|P2|Overall Study|Noncompliance|7
4948746|NCT00321620|17021801|P1|Overall Study|Noncompliance|14
4948747|NCT00321620|17021800|P2|Overall Study|Physician Decision|1
4948748|NCT00321620|17021801|P1|Overall Study|Physician Decision|4
4948749|NCT00321620|17021800|P2|Overall Study|Lost to Follow-up|9
4948750|NCT00321620|17021801|P1|Overall Study|Lost to Follow-up|13
4948751|NCT00321620|17021800|P2|Overall Study|Adverse Event|56
4948752|NCT00321620|17021801|P1|Overall Study|Adverse Event|43
4948753|NCT00321620|17021800|P2|Overall Study|Disease progression|117
4948754|NCT00321620|17021801|P1|Overall Study|Disease progression|113
4948755|NCT00321620|17021800|P2|Overall Study|Withdrawal by Subject|147
4948756|NCT00321620|17021801|P1|Overall Study|Withdrawal by Subject|164
4948757|NCT00321620|17021800|P2|Overall Study|Death|294
4948758|NCT00321620|17021801|P1|Overall Study|Death|269
4948759|NCT00321555|17021829|P1|Overall Study|Disease progression on study|1
4948760|NCT00321555|17021829|P1|Overall Study|Physician Decision|1
4948761|NCT00321555|17021829|P1|Overall Study|Switched to alternative treatment|3
4948762|NCT00321555|17021829|P1|Overall Study|Developed antibodies|1
4948763|NCT00321464|17021837|P2|Overall Study|Other|18
4948764|NCT00321464|17021838|P1|Overall Study|Other|21
4948765|NCT00321464|17021837|P2|Overall Study|Ineligibility determined|1
4948766|NCT00321464|17021838|P1|Overall Study|Ineligibility determined|2
4948767|NCT00321464|17021837|P2|Overall Study|Protocol deviation|2
4948768|NCT00321464|17021838|P1|Overall Study|Protocol deviation|0
4948769|NCT00321464|17021837|P2|Overall Study|Lost to Follow-up|8
4948770|NCT00321464|17021838|P1|Overall Study|Lost to Follow-up|7
4948771|NCT00321464|17021837|P2|Overall Study|Noncompliance|10
4948772|NCT00321464|17021838|P1|Overall Study|Noncompliance|4
4948773|NCT00321464|17021837|P2|Overall Study|Physician Decision|14
4948774|NCT00321464|17021838|P1|Overall Study|Physician Decision|15
4948775|NCT00321464|17021837|P2|Overall Study|Adverse Event|28
4948776|NCT00321464|17021838|P1|Overall Study|Adverse Event|43
4948777|NCT00321464|17021837|P2|Overall Study|Participant request|61
4948778|NCT00321464|17021838|P1|Overall Study|Participant request|57
4948779|NCT00321464|17021837|P2|Overall Study|Withdrawal by Subject|118
4948780|NCT00321464|17021838|P1|Overall Study|Withdrawal by Subject|117
4948781|NCT00321464|17021837|P2|Overall Study|Disease progression|124
4948782|NCT00321464|17021838|P1|Overall Study|Disease progression|124
4948783|NCT00321464|17021837|P2|Overall Study|Death|174
4948784|NCT00321464|17021838|P1|Overall Study|Death|169
4948785|NCT00321373|17021851|P3|Overall Study|Other|1
4948786|NCT00321373|17021852|P2|Overall Study|Other|0
4948787|NCT00321373|17021853|P1|Overall Study|Other|0
4948788|NCT00321373|17021851|P3|Overall Study|Withdrawal by Subject|0
4948789|NCT00321373|17021852|P2|Overall Study|Withdrawal by Subject|0
4948790|NCT00321373|17021853|P1|Overall Study|Withdrawal by Subject|1
4948791|NCT00321373|17021851|P3|Overall Study|Lost to Follow-up|1
4948792|NCT00321373|17021852|P2|Overall Study|Lost to Follow-up|0
4948793|NCT00321373|17021853|P1|Overall Study|Lost to Follow-up|1
4948794|NCT00321373|17021851|P3|Overall Study|Adverse Event|1
4948795|NCT00321373|17021852|P2|Overall Study|Adverse Event|0
4948796|NCT00321373|17021853|P1|Overall Study|Adverse Event|0
4948797|NCT00321048|17021893|P2|Overall Study|Withdrawal by Subject|8
4948798|NCT00321048|17021894|P1|Overall Study|Withdrawal by Subject|6
4948799|NCT00320801|17021902|P4|Extension Phase|Lost to Follow-up|3
4948800|NCT00320801|17021903|P3|Extension Phase|Lost to Follow-up|0
4948801|NCT00320801|17021904|P2|Extension Phase|Lost to Follow-up|0
4948802|NCT00320801|17021905|P1|Extension Phase|Lost to Follow-up|0
4948803|NCT00320801|17021902|P4|Extension Phase|Lack of Efficacy|2
4948804|NCT00320801|17021903|P3|Extension Phase|Lack of Efficacy|0
4948805|NCT00320801|17021904|P2|Extension Phase|Lack of Efficacy|0
4948806|NCT00320801|17021905|P1|Extension Phase|Lack of Efficacy|0
4948807|NCT00320801|17021902|P4|Extension Phase|Administrative|29
4948808|NCT00320801|17021903|P3|Extension Phase|Administrative|0
4948809|NCT00320801|17021904|P2|Extension Phase|Administrative|0
4948810|NCT00320801|17021905|P1|Extension Phase|Administrative|0
4948811|NCT00320801|17021902|P4|Extension Phase|Adverse Event|8
4948812|NCT00320801|17021903|P3|Extension Phase|Adverse Event|0
4948813|NCT00320801|17021904|P2|Extension Phase|Adverse Event|0
4948814|NCT00320801|17021905|P1|Extension Phase|Adverse Event|0
4948815|NCT00320801|17021902|P4|Extension Phase|Withdrawal by Subject|6
4948816|NCT00320801|17021903|P3|Extension Phase|Withdrawal by Subject|0
4948817|NCT00320801|17021904|P2|Extension Phase|Withdrawal by Subject|0
4948818|NCT00320801|17021905|P1|Extension Phase|Withdrawal by Subject|0
4948819|NCT00320801|17021902|P4|Double-blind Phase|Lack of Efficacy|0
4948820|NCT00320801|17021903|P3|Double-blind Phase|Lack of Efficacy|1
4948821|NCT00320801|17021904|P2|Double-blind Phase|Lack of Efficacy|9
4948822|NCT00320801|17021905|P1|Double-blind Phase|Lack of Efficacy|0
4948823|NCT00320801|17021902|P4|Double-blind Phase|Administrative|0
4948824|NCT00320801|17021903|P3|Double-blind Phase|Administrative|4
4948825|NCT00320801|17021904|P2|Double-blind Phase|Administrative|0
4948826|NCT00320801|17021905|P1|Double-blind Phase|Administrative|0
4948827|NCT00320801|17021902|P4|Double-blind Phase|Adverse Event|0
4948828|NCT00320801|17021903|P3|Double-blind Phase|Adverse Event|8
4948829|NCT00320801|17021904|P2|Double-blind Phase|Adverse Event|2
4948830|NCT00320801|17021905|P1|Double-blind Phase|Adverse Event|0
4948831|NCT00320801|17021902|P4|Double-blind Phase|Withdrawal by Subject|0
4948832|NCT00320801|17021903|P3|Double-blind Phase|Withdrawal by Subject|1
4948833|NCT00320801|17021904|P2|Double-blind Phase|Withdrawal by Subject|0
4948834|NCT00320801|17021905|P1|Double-blind Phase|Withdrawal by Subject|0
4948835|NCT00320801|17021902|P4|Open-label Run-in Period|Did not qualify|0
4948836|NCT00320801|17021903|P3|Open-label Run-in Period|Did not qualify|0
4948837|NCT00320801|17021904|P2|Open-label Run-in Period|Did not qualify|0
4948838|NCT00320801|17021905|P1|Open-label Run-in Period|Did not qualify|1
4948839|NCT00320801|17021902|P4|Open-label Run-in Period|Lost to Follow-up|0
4948840|NCT00320801|17021903|P3|Open-label Run-in Period|Lost to Follow-up|0
4948841|NCT00320801|17021904|P2|Open-label Run-in Period|Lost to Follow-up|0
4948842|NCT00320801|17021905|P1|Open-label Run-in Period|Lost to Follow-up|2
4948843|NCT00320801|17021902|P4|Open-label Run-in Period|Lack of Efficacy|0
4948844|NCT00320801|17021903|P3|Open-label Run-in Period|Lack of Efficacy|0
4948845|NCT00320801|17021904|P2|Open-label Run-in Period|Lack of Efficacy|0
4948846|NCT00320801|17021905|P1|Open-label Run-in Period|Lack of Efficacy|44
4948847|NCT00320801|17021902|P4|Open-label Run-in Period|Administrative|0
4948848|NCT00320801|17021903|P3|Open-label Run-in Period|Administrative|0
4948849|NCT00320801|17021904|P2|Open-label Run-in Period|Administrative|0
4948850|NCT00320801|17021905|P1|Open-label Run-in Period|Administrative|10
4948851|NCT00320801|17021902|P4|Open-label Run-in Period|Adverse Event|0
4948852|NCT00320801|17021903|P3|Open-label Run-in Period|Adverse Event|0
4948853|NCT00320801|17021904|P2|Open-label Run-in Period|Adverse Event|0
4948854|NCT00320801|17021905|P1|Open-label Run-in Period|Adverse Event|33
4948855|NCT00320801|17021902|P4|Open-label Run-in Period|Withdrawal by Subject|0
4948856|NCT00320801|17021903|P3|Open-label Run-in Period|Withdrawal by Subject|0
4948857|NCT00320801|17021904|P2|Open-label Run-in Period|Withdrawal by Subject|0
4948858|NCT00320801|17021905|P1|Open-label Run-in Period|Withdrawal by Subject|2
4948859|NCT00320788|17021920|P5|Overall Study|Withdrawal by Subject|1
4948860|NCT00320788|17021921|P4|Overall Study|Withdrawal by Subject|3
4948861|NCT00320788|17021922|P3|Overall Study|Withdrawal by Subject|0
4948862|NCT00320788|17021923|P2|Overall Study|Withdrawal by Subject|0
4948863|NCT00320788|17021924|P1|Overall Study|Withdrawal by Subject|3
4948864|NCT00320788|17021920|P5|Overall Study|Protocol Violation|1
4948865|NCT00320788|17021921|P4|Overall Study|Protocol Violation|0
4948866|NCT00320788|17021922|P3|Overall Study|Protocol Violation|0
4948867|NCT00320788|17021923|P2|Overall Study|Protocol Violation|0
4948868|NCT00320788|17021924|P1|Overall Study|Protocol Violation|0
4948869|NCT00320788|17021920|P5|Overall Study|Physician Decision|0
4948870|NCT00320788|17021921|P4|Overall Study|Physician Decision|0
4948871|NCT00320788|17021922|P3|Overall Study|Physician Decision|0
4948872|NCT00320788|17021923|P2|Overall Study|Physician Decision|1
4948873|NCT00320788|17021924|P1|Overall Study|Physician Decision|1
4948874|NCT00320788|17021920|P5|Overall Study|Other|1
4948875|NCT00320788|17021921|P4|Overall Study|Other|1
4948876|NCT00320788|17021922|P3|Overall Study|Other|1
4948877|NCT00320788|17021923|P2|Overall Study|Other|2
4948878|NCT00320788|17021924|P1|Overall Study|Other|1
4948879|NCT00320788|17021920|P5|Overall Study|Decision by the Sponsor|1
4948880|NCT00320788|17021921|P4|Overall Study|Decision by the Sponsor|0
4948881|NCT00320788|17021922|P3|Overall Study|Decision by the Sponsor|0
4948882|NCT00320788|17021923|P2|Overall Study|Decision by the Sponsor|1
4948883|NCT00320788|17021924|P1|Overall Study|Decision by the Sponsor|1
4948884|NCT00320788|17021920|P5|Overall Study|Lost to Follow-up|0
4948885|NCT00320788|17021921|P4|Overall Study|Lost to Follow-up|0
4948886|NCT00320788|17021922|P3|Overall Study|Lost to Follow-up|1
4948887|NCT00320788|17021923|P2|Overall Study|Lost to Follow-up|2
4948888|NCT00320788|17021924|P1|Overall Study|Lost to Follow-up|0
4948889|NCT00320788|17021920|P5|Overall Study|Death|1
4948890|NCT00320788|17021921|P4|Overall Study|Death|0
4948891|NCT00320788|17021922|P3|Overall Study|Death|1
4948892|NCT00320788|17021923|P2|Overall Study|Death|0
4948893|NCT00320788|17021924|P1|Overall Study|Death|0
4948894|NCT00320788|17021920|P5|Overall Study|Adverse Event|0
4948895|NCT00320788|17021921|P4|Overall Study|Adverse Event|1
4948896|NCT00320788|17021922|P3|Overall Study|Adverse Event|0
4948897|NCT00320788|17021923|P2|Overall Study|Adverse Event|0
4948898|NCT00320788|17021924|P1|Overall Study|Adverse Event|0
4948899|NCT00320710|17021978|P3|Overall Study|Lost to Follow-up|0
4948900|NCT00320710|17021979|P2|Overall Study|Lost to Follow-up|0
4948901|NCT00320710|17021980|P1|Overall Study|Lost to Follow-up|1
4948902|NCT00320710|17021978|P3|Overall Study|Adverse Event|1
4948903|NCT00320710|17021979|P2|Overall Study|Adverse Event|14
4948904|NCT00320710|17021980|P1|Overall Study|Adverse Event|18
4948905|NCT00320710|17021978|P3|Overall Study|Abnormal laboratory value(s)|0
4948906|NCT00320710|17021979|P2|Overall Study|Abnormal laboratory value(s)|3
4948907|NCT00320710|17021980|P1|Overall Study|Abnormal laboratory value(s)|12
4948908|NCT00320710|17021978|P3|Overall Study|Abnormal test procedure result(s)|0
4948909|NCT00320710|17021979|P2|Overall Study|Abnormal test procedure result(s)|0
4948910|NCT00320710|17021980|P1|Overall Study|Abnormal test procedure result(s)|2
4948911|NCT00320710|17021978|P3|Overall Study|Protocol Violation|0
4948912|NCT00320710|17021979|P2|Overall Study|Protocol Violation|5
4948913|NCT00320710|17021980|P1|Overall Study|Protocol Violation|6
4948914|NCT00320710|17021978|P3|Overall Study|Withdrawal by Subject|1
4948915|NCT00320710|17021979|P2|Overall Study|Withdrawal by Subject|26
4948916|NCT00320710|17021980|P1|Overall Study|Withdrawal by Subject|20
4948917|NCT00320710|17021978|P3|Overall Study|Administrative problems|0
4948918|NCT00320710|17021979|P2|Overall Study|Administrative problems|2
4948919|NCT00320710|17021980|P1|Overall Study|Administrative problems|1
4948920|NCT00320710|17021978|P3|Overall Study|Death|1
4948921|NCT00320710|17021979|P2|Overall Study|Death|7
4948922|NCT00320710|17021980|P1|Overall Study|Death|10
4948923|NCT00320710|17021978|P3|Overall Study|Disease progression|2
4948924|NCT00320710|17021979|P2|Overall Study|Disease progression|19
4948925|NCT00320710|17021980|P1|Overall Study|Disease progression|24
4948926|NCT00320606|17022010|P1|Overall Study|Withdrawal by Subject|1
4948927|NCT00320606|17022010|P1|Overall Study|Protocol Violation|1
4948928|NCT00320606|17022010|P1|Overall Study|Adverse Event|1
4948929|NCT00320593|17022026|P2|Overall Study|Withdrawal by clinical center|0
4948930|NCT00320593|17022027|P1|Overall Study|Withdrawal by clinical center|1
4948931|NCT00320593|17022026|P2|Overall Study|Withdrawal by Subject|1
4948932|NCT00320593|17022027|P1|Overall Study|Withdrawal by Subject|2
4948933|NCT00320593|17022026|P2|Overall Study|Moved to another state|0
4948934|NCT00320593|17022027|P1|Overall Study|Moved to another state|1
4948935|NCT00320593|17022026|P2|Overall Study|Lost to Follow-up|0
4948936|NCT00320593|17022027|P1|Overall Study|Lost to Follow-up|3
4948937|NCT00320541|17022051|P2|Overall Study|Protocol Entry Criterion Not Met|0
4948938|NCT00320541|17022052|P1|Overall Study|Protocol Entry Criterion Not Met|1
4948939|NCT00320541|17022051|P2|Overall Study|Death due to Adverse Event(s)|0
4948940|NCT00320541|17022052|P1|Overall Study|Death due to Adverse Event(s)|1
4948941|NCT00320541|17022051|P2|Overall Study|Death due to Study Disease|3
4948942|NCT00320541|17022052|P1|Overall Study|Death due to Study Disease|1
4948943|NCT00320541|17022051|P2|Overall Study|Sponsor Decision|1
4948944|NCT00320541|17022052|P1|Overall Study|Sponsor Decision|2
4948945|NCT00320541|17022051|P2|Overall Study|Other|4
4948946|NCT00320541|17022052|P1|Overall Study|Other|3
4948947|NCT00320541|17022051|P2|Overall Study|Physician Decision|13
4948948|NCT00320541|17022052|P1|Overall Study|Physician Decision|9
4948949|NCT00320541|17022051|P2|Overall Study|Withdrawal by Subject|16
4948950|NCT00320541|17022052|P1|Overall Study|Withdrawal by Subject|12
4948951|NCT00320541|17022051|P2|Overall Study|Protocol Violation|1
4948952|NCT00320541|17022052|P1|Overall Study|Protocol Violation|0
4948953|NCT00320541|17022051|P2|Overall Study|Adverse Event|19
4948954|NCT00320541|17022052|P1|Overall Study|Adverse Event|21
4948955|NCT00320528|17022079|P3|Study Period III|Atomoxetine Commercially Available|90
4948956|NCT00320528|17022080|P2|Study Period III|Atomoxetine Commercially Available|25
4948957|NCT00320528|17022081|P1|Study Period III|Atomoxetine Commercially Available|68
4948958|NCT00320528|17022079|P3|Study Period III|Sponsor Decision|1
4948959|NCT00320528|17022080|P2|Study Period III|Sponsor Decision|0
4948960|NCT00320528|17022081|P1|Study Period III|Sponsor Decision|0
4948961|NCT00320528|17022079|P3|Study Period III|Physician Decision|2
4948962|NCT00320528|17022080|P2|Study Period III|Physician Decision|1
4948963|NCT00320528|17022081|P1|Study Period III|Physician Decision|0
4948964|NCT00320528|17022079|P3|Study Period III|Protocol Violation|0
4948965|NCT00320528|17022080|P2|Study Period III|Protocol Violation|1
4948966|NCT00320528|17022081|P1|Study Period III|Protocol Violation|0
4948967|NCT00320528|17022079|P3|Study Period III|Parent/Caregiver Decision|11
4948968|NCT00320528|17022080|P2|Study Period III|Parent/Caregiver Decision|3
4948969|NCT00320528|17022081|P1|Study Period III|Parent/Caregiver Decision|14
4948970|NCT00320528|17022079|P3|Study Period III|Lack of Efficacy|0
4948971|NCT00320528|17022080|P2|Study Period III|Lack of Efficacy|0
4948972|NCT00320528|17022081|P1|Study Period III|Lack of Efficacy|2
4948973|NCT00320528|17022079|P3|Study Period III|Withdrawal by Subject|2
4948974|NCT00320528|17022080|P2|Study Period III|Withdrawal by Subject|1
4948975|NCT00320528|17022081|P1|Study Period III|Withdrawal by Subject|1
4948976|NCT00320528|17022079|P3|Study Period III|Lost to Follow-up|0
4948977|NCT00320528|17022080|P2|Study Period III|Lost to Follow-up|0
4948978|NCT00320528|17022081|P1|Study Period III|Lost to Follow-up|1
4948979|NCT00320528|17022079|P3|Study Period III|Adverse Event|0
4948980|NCT00320528|17022080|P2|Study Period III|Adverse Event|0
4948981|NCT00320528|17022081|P1|Study Period III|Adverse Event|1
4948982|NCT00320528|17022079|P3|Study Period II|Entry Criteria Exclusion|2
4948983|NCT00320528|17022080|P2|Study Period II|Entry Criteria Exclusion|2
4948984|NCT00320528|17022081|P1|Study Period II|Entry Criteria Exclusion|0
4948985|NCT00320528|17022079|P3|Study Period II|Withdrawal by Subject|1
4948986|NCT00320528|17022080|P2|Study Period II|Withdrawal by Subject|1
4948987|NCT00320528|17022081|P1|Study Period II|Withdrawal by Subject|0
4948988|NCT00320528|17022079|P3|Study Period II|Parent/Caregiver Decision|11
4948989|NCT00320528|17022080|P2|Study Period II|Parent/Caregiver Decision|3
4948990|NCT00320528|17022081|P1|Study Period II|Parent/Caregiver Decision|8
4948991|NCT00320528|17022079|P3|Study Period II|Adverse Event|8
4948992|NCT00320528|17022080|P2|Study Period II|Adverse Event|4
4948993|NCT00320528|17022081|P1|Study Period II|Adverse Event|3
4948994|NCT00320515|17022116|P1|Overall Study|Withdrawal by Subject|8
4948995|NCT00320515|17022116|P1|Overall Study|Physician Decision|2
4948996|NCT00320515|17022116|P1|Overall Study|Lost to Follow-up|6
4948997|NCT00320515|17022116|P1|Overall Study|Death|33
4948998|NCT00320489|17022125|P2|Overall Study|Withdrawal by Subject|41
4948999|NCT00320489|17022126|P1|Overall Study|Withdrawal by Subject|39
4949000|NCT00320489|17022125|P2|Overall Study|Sponsor Decision|3
4949001|NCT00320489|17022126|P1|Overall Study|Sponsor Decision|3
4949002|NCT00320489|17022125|P2|Overall Study|Protocol Violation|4
4949003|NCT00320489|17022126|P1|Overall Study|Protocol Violation|4
4949004|NCT00320489|17022125|P2|Overall Study|Physician Decision|8
4949005|NCT00320489|17022126|P1|Overall Study|Physician Decision|8
4949006|NCT00320489|17022125|P2|Overall Study|Lost to Follow-up|22
4949007|NCT00320489|17022126|P1|Overall Study|Lost to Follow-up|21
4949008|NCT00320489|17022125|P2|Overall Study|Lack of Efficacy|7
4949009|NCT00320489|17022126|P1|Overall Study|Lack of Efficacy|16
4949010|NCT00320489|17022125|P2|Overall Study|Entry Criteria Exclusion|4
4949011|NCT00320489|17022126|P1|Overall Study|Entry Criteria Exclusion|2
4949012|NCT00320489|17022125|P2|Overall Study|Death|2
4949013|NCT00320489|17022126|P1|Overall Study|Death|0
4949014|NCT00320489|17022125|P2|Overall Study|Clinical Relapse|20
4949015|NCT00320489|17022126|P1|Overall Study|Clinical Relapse|26
4949016|NCT00320489|17022125|P2|Overall Study|Adverse Event|25
4949017|NCT00320489|17022126|P1|Overall Study|Adverse Event|26
4949018|NCT00320424|17022182|P1|Overall Study|Other|3
4949019|NCT00320424|17022182|P1|Overall Study|Adverse Event|3
4949020|NCT00320411|17022196|P1|Overall Study|No investigational product admin.|4
4949021|NCT00320398|17022219|P2|Overall Study|Other|0
4949022|NCT00320398|17022220|P1|Overall Study|Other|1
4949023|NCT00320398|17022219|P2|Overall Study|Adverse Event|4
4949024|NCT00320398|17022220|P1|Overall Study|Adverse Event|1
4949025|NCT00320385|17022248|P2|Overall Study|Adverse Event|1
4949026|NCT00320385|17022249|P1|Overall Study|Adverse Event|0
4949027|NCT00320385|17022248|P2|Overall Study|Withdrew Consent|0
4949028|NCT00320385|17022249|P1|Overall Study|Withdrew Consent|1
4949029|NCT00320385|17022248|P2|Overall Study|Serious Adverse Event|0
4949030|NCT00320385|17022249|P1|Overall Study|Serious Adverse Event|1
4949031|NCT00320385|17022248|P2|Overall Study|Death|2
4949032|NCT00320385|17022249|P1|Overall Study|Death|1
4949033|NCT00320385|17022248|P2|Overall Study|Investigator Decision|1
4949034|NCT00320385|17022249|P1|Overall Study|Investigator Decision|0
4949035|NCT00320385|17022248|P2|Overall Study|Sponsor Terminated Study|1
4949036|NCT00320385|17022249|P1|Overall Study|Sponsor Terminated Study|2
4949037|NCT00320385|17022248|P2|Overall Study|Withdrawal by Subject|7
4949038|NCT00320385|17022249|P1|Overall Study|Withdrawal by Subject|6
4949039|NCT00320385|17022248|P2|Overall Study|Lost to Follow-up|10
4949040|NCT00320385|17022249|P1|Overall Study|Lost to Follow-up|7
4949041|NCT00320372|17022272|P2|Overall Study|Other (i.e. lost to f/u, site closure)|71
4949042|NCT00320372|17022273|P1|Overall Study|Other (i.e. lost to f/u, site closure)|86
4949043|NCT00320372|17022272|P2|Overall Study|Did not Meet (I/E)|1
4949044|NCT00320372|17022273|P1|Overall Study|Did not Meet (I/E)|3
4949045|NCT00320372|17022272|P2|Overall Study|Non-Compliance|39
4949046|NCT00320372|17022273|P1|Overall Study|Non-Compliance|40
4949047|NCT00320372|17022272|P2|Overall Study|Withdrawal by Subject|37
4949048|NCT00320372|17022273|P1|Overall Study|Withdrawal by Subject|55
4949049|NCT00320372|17022272|P2|Overall Study|Death|8
4949050|NCT00320372|17022273|P1|Overall Study|Death|7
4949051|NCT00320372|17022272|P2|Overall Study|Physician Decision|7
4949052|NCT00320372|17022273|P1|Overall Study|Physician Decision|4
4949053|NCT00320255|17022315|P6|Overall Study|Other|0
4949054|NCT00320255|17022316|P5|Overall Study|Other|0
4949055|NCT00320255|17022317|P4|Overall Study|Other|0
4949056|NCT00320255|17022318|P3|Overall Study|Other|1
4949057|NCT00320255|17022319|P2|Overall Study|Other|2
4949058|NCT00320255|17022320|P1|Overall Study|Other|3
4949059|NCT00320255|17022315|P6|Overall Study|No longer meets study criteria|0
4949060|NCT00320255|17022316|P5|Overall Study|No longer meets study criteria|0
4949061|NCT00320255|17022317|P4|Overall Study|No longer meets study criteria|1
4949062|NCT00320255|17022318|P3|Overall Study|No longer meets study criteria|0
4949063|NCT00320255|17022319|P2|Overall Study|No longer meets study criteria|0
4949064|NCT00320255|17022320|P1|Overall Study|No longer meets study criteria|0
4949065|NCT00320255|17022315|P6|Overall Study|Poor compliance/noncompliance|0
4949066|NCT00320255|17022316|P5|Overall Study|Poor compliance/noncompliance|0
4949067|NCT00320255|17022317|P4|Overall Study|Poor compliance/noncompliance|1
4949068|NCT00320255|17022318|P3|Overall Study|Poor compliance/noncompliance|0
4949069|NCT00320255|17022319|P2|Overall Study|Poor compliance/noncompliance|1
4949070|NCT00320255|17022320|P1|Overall Study|Poor compliance/noncompliance|1
4949071|NCT00320255|17022315|P6|Overall Study|Withdrawal by Subject|0
4949072|NCT00320255|17022316|P5|Overall Study|Withdrawal by Subject|0
4949073|NCT00320255|17022317|P4|Overall Study|Withdrawal by Subject|4
4949074|NCT00320255|17022318|P3|Overall Study|Withdrawal by Subject|2
4949075|NCT00320255|17022319|P2|Overall Study|Withdrawal by Subject|2
4949076|NCT00320255|17022320|P1|Overall Study|Withdrawal by Subject|1
4949077|NCT00320255|17022315|P6|Overall Study|Adverse Event|0
4949078|NCT00320255|17022316|P5|Overall Study|Adverse Event|0
4949079|NCT00320255|17022317|P4|Overall Study|Adverse Event|2
4949080|NCT00320255|17022318|P3|Overall Study|Adverse Event|3
4949081|NCT00320255|17022319|P2|Overall Study|Adverse Event|2
4949082|NCT00320255|17022320|P1|Overall Study|Adverse Event|5
4949083|NCT00320255|17022315|P6|Overall Study|Lack of Efficacy|0
4949084|NCT00320255|17022316|P5|Overall Study|Lack of Efficacy|0
4949085|NCT00320255|17022317|P4|Overall Study|Lack of Efficacy|0
4949086|NCT00320255|17022318|P3|Overall Study|Lack of Efficacy|0
4949087|NCT00320255|17022319|P2|Overall Study|Lack of Efficacy|0
4949088|NCT00320255|17022320|P1|Overall Study|Lack of Efficacy|1
4949089|NCT00320216|17022413|P5|Overall Study|Other|3
4949090|NCT00320216|17022414|P4|Overall Study|Other|1
4949091|NCT00320216|17022415|P3|Overall Study|Other|5
4949092|NCT00320216|17022416|P2|Overall Study|Other|2
4949093|NCT00320216|17022417|P1|Overall Study|Other|7
4949094|NCT00320216|17022413|P5|Overall Study|Lost to Follow-up|0
4949095|NCT00320216|17022414|P4|Overall Study|Lost to Follow-up|0
4949096|NCT00320216|17022415|P3|Overall Study|Lost to Follow-up|0
4949097|NCT00320216|17022416|P2|Overall Study|Lost to Follow-up|0
4949098|NCT00320216|17022417|P1|Overall Study|Lost to Follow-up|3
4949099|NCT00320216|17022413|P5|Overall Study|Lack of Efficacy|1
4949100|NCT00320216|17022414|P4|Overall Study|Lack of Efficacy|0
4949101|NCT00320216|17022415|P3|Overall Study|Lack of Efficacy|1
4949102|NCT00320216|17022416|P2|Overall Study|Lack of Efficacy|2
4949103|NCT00320216|17022417|P1|Overall Study|Lack of Efficacy|6
4949104|NCT00320216|17022413|P5|Overall Study|Adverse Event|2
4949105|NCT00320216|17022414|P4|Overall Study|Adverse Event|2
4949106|NCT00320216|17022415|P3|Overall Study|Adverse Event|0
4949107|NCT00320216|17022416|P2|Overall Study|Adverse Event|6
4949108|NCT00320216|17022417|P1|Overall Study|Adverse Event|0
4949109|NCT00320190|17022451|P2|Long-term (12-month) Extension|Withdrawal by Subject|0
4949110|NCT00320190|17022452|P1|Long-term (12-month) Extension|Withdrawal by Subject|1
4949111|NCT00320190|17022451|P2|Long-term (12-month) Extension|Lack of major molecular response|2
4949112|NCT00320190|17022452|P1|Long-term (12-month) Extension|Lack of major molecular response|1
4949113|NCT00320190|17022451|P2|Long-term (12-month) Extension|Sponsor terminated study|0
4949114|NCT00320190|17022452|P1|Long-term (12-month) Extension|Sponsor terminated study|7
4949115|NCT00320190|17022451|P2|First 12 Months|Withdrawal by Subject|1
4949116|NCT00320190|17022452|P1|First 12 Months|Withdrawal by Subject|0
4949117|NCT00320190|17022451|P2|First 12 Months|Study drug toxicity|1
4949118|NCT00320190|17022452|P1|First 12 Months|Study drug toxicity|0
4949119|NCT00320190|17022451|P2|First 12 Months|Investigator request|1
4949120|NCT00320190|17022452|P1|First 12 Months|Investigator request|0
4949121|NCT00320190|17022451|P2|First 12 Months|Adverse event unrelated to study drug|0
4949122|NCT00320190|17022452|P1|First 12 Months|Adverse event unrelated to study drug|1
4949123|NCT00320190|17022451|P2|First 12 Months|Enrollment failure|1
4949124|NCT00320190|17022452|P1|First 12 Months|Enrollment failure|0
4949125|NCT00320190|17022451|P2|First 12 Months|Lost to Follow-up|1
4949126|NCT00320190|17022452|P1|First 12 Months|Lost to Follow-up|0
4949127|NCT00320190|17022451|P2|First 12 Months|Sponsor terminated study|2
4949128|NCT00320190|17022452|P1|First 12 Months|Sponsor terminated study|2
4949129|NCT00320190|17022451|P2|First 12 Months|Completed but did not enter extension|3
4949130|NCT00320190|17022452|P1|First 12 Months|Completed but did not enter extension|5
4949131|NCT00320112|17022472|P2|Overall Study|Death|1
4949132|NCT00320112|17022473|P1|Overall Study|Death|2
4949133|NCT00320112|17022472|P2|Overall Study|Withdrawal by Subject|0
4949134|NCT00320112|17022473|P1|Overall Study|Withdrawal by Subject|3
4949135|NCT00320112|17022472|P2|Overall Study|Lost to Follow-up|4
4949136|NCT00320112|17022473|P1|Overall Study|Lost to Follow-up|3
4949137|NCT00319982|17022487|P2|Overall Study|Withdrawal by Subject|0
4949138|NCT00319982|17022488|P1|Overall Study|Withdrawal by Subject|1
4949139|NCT00319956|17022508|P2|Overall Study|Death|24
4949140|NCT00319956|17022509|P1|Overall Study|Death|20
4949141|NCT00319839|17022521|P1|Overall Study|Withdrawal by Subject|1
4949142|NCT00319839|17022521|P1|Overall Study|Adverse Event|5
4949143|NCT00319735|17022537|P1|Overall Study|Death|2
4949144|NCT00319696|17022550|P1|Overall Study|Lost to Follow-up|3
4949145|NCT00319696|17022550|P1|Overall Study|administrative|7
4949146|NCT00319696|17022550|P1|Overall Study|withdrawal of consent|14
4949147|NCT00319696|17022550|P1|Overall Study|Adverse Event|36
4949148|NCT00319592|17022587|P2|Overall Study|Physician Decision|1
4949149|NCT00319592|17022588|P1|Overall Study|Physician Decision|0
4949150|NCT00319592|17022587|P2|Overall Study|Protocol Violation|0
4949151|NCT00319592|17022588|P1|Overall Study|Protocol Violation|1
4949152|NCT00319553|17022604|P2|Overall Study|Withdrawal by Subject|1
4949153|NCT00319553|17022605|P1|Overall Study|Withdrawal by Subject|1
4949154|NCT00319553|17022604|P2|Overall Study|Lost to Follow-up|1
4949155|NCT00319553|17022605|P1|Overall Study|Lost to Follow-up|2
4949156|NCT00319553|17022604|P2|Overall Study|Protocol Violation|2
4949157|NCT00319553|17022605|P1|Overall Study|Protocol Violation|1
4949158|NCT00319501|17022619|P2|Open-label Extension Period|Withdrawal by Subject|0
4949159|NCT00319501|17022620|P1|Open-label Extension Period|Withdrawal by Subject|2
4949160|NCT00319501|17022619|P2|Open-label Extension Period|Sponsor request|0
4949161|NCT00319501|17022620|P1|Open-label Extension Period|Sponsor request|26
4949162|NCT00319501|17022619|P2|Open-label Extension Period|Principal investigator decision|0
4949163|NCT00319501|17022620|P1|Open-label Extension Period|Principal investigator decision|2
4949164|NCT00319501|17022619|P2|Open-label Extension Period|Other|0
4949165|NCT00319501|17022620|P1|Open-label Extension Period|Other|1
4949166|NCT00319501|17022619|P2|Open-label Extension Period|Did not receive treatment|0
4949167|NCT00319501|17022620|P1|Open-label Extension Period|Did not receive treatment|18
4949168|NCT00319501|17022619|P2|Open-label Extension Period|Adverse Event|0
4949169|NCT00319501|17022620|P1|Open-label Extension Period|Adverse Event|2
4949170|NCT00319501|17022619|P2|Open-label Period|Other|0
4949171|NCT00319501|17022620|P1|Open-label Period|Other|11
4949172|NCT00319501|17022619|P2|Open-label Period|Did not receive treatment|0
4949173|NCT00319501|17022620|P1|Open-label Period|Did not receive treatment|33
4949174|NCT00319501|17022619|P2|Open-label Period|Lost to Follow-up|0
4949175|NCT00319501|17022620|P1|Open-label Period|Lost to Follow-up|5
4949176|NCT00319501|17022619|P2|Open-label Period|Sponsor request|0
4949177|NCT00319501|17022620|P1|Open-label Period|Sponsor request|12
4949178|NCT00319501|17022619|P2|Open-label Period|Principal Investigator decision|0
4949179|NCT00319501|17022620|P1|Open-label Period|Principal Investigator decision|6
4949180|NCT00319501|17022619|P2|Open-label Period|Withdrawal by Subject|0
4949181|NCT00319501|17022620|P1|Open-label Period|Withdrawal by Subject|38
4949182|NCT00319501|17022619|P2|Open-label Period|Protocol Violation|0
4949183|NCT00319501|17022620|P1|Open-label Period|Protocol Violation|6
4949184|NCT00319501|17022619|P2|Open-label Period|Adverse Event|0
4949185|NCT00319501|17022620|P1|Open-label Period|Adverse Event|5
4949186|NCT00319501|17022619|P2|Double-blind Period|Did not receive treatment|29
4949187|NCT00319501|17022620|P1|Double-blind Period|Did not receive treatment|42
4949188|NCT00319501|17022619|P2|Double-blind Period|Sponsor Request|0
4949189|NCT00319501|17022620|P1|Double-blind Period|Sponsor Request|1
4949190|NCT00319501|17022619|P2|Double-blind Period|Withdrawal by Subject|3
4949191|NCT00319501|17022620|P1|Double-blind Period|Withdrawal by Subject|0
4949192|NCT00319449|17022646|P2|Overall Study|Noncompliance with the protocol|0
4949193|NCT00319449|17022647|P1|Overall Study|Noncompliance with the protocol|1
4949194|NCT00319449|17022646|P2|Overall Study|Subject did not wish to continue|0
4949195|NCT00319449|17022647|P1|Overall Study|Subject did not wish to continue|1
4949196|NCT00319436|17022659|P2|Overall Study|Withdrawal by Subject|7
4949197|NCT00319436|17022660|P1|Overall Study|Withdrawal by Subject|6
4949198|NCT00319254|17022678|P1|Overall Study|Enrolled, Not Treated|2
4949199|NCT00319254|17022678|P1|Overall Study|Lost to Follow-up|2
4949200|NCT00319254|17022678|P1|Overall Study|Death|46
4949201|NCT00319254|17022678|P1|Overall Study|Withdrawal by Subject|4
4949202|NCT00319111|17022691|P1|Overall Study|Treatment failure|1
4949203|NCT00319111|17022691|P1|Overall Study|Administrative|2
4949204|NCT00319111|17022691|P1|Overall Study|Lack of clinical improvement|4
4949205|NCT00319111|17022691|P1|Overall Study|Death|9
4949206|NCT00319111|17022691|P1|Overall Study|Withdrawal of consent|11
4949207|NCT00319111|17022691|P1|Overall Study|Adverse Event|20
4949208|NCT00319098|17022705|P2|Overall Study|Protocol Violation|1
4949209|NCT00319098|17022706|P1|Overall Study|Protocol Violation|3
4949210|NCT00319098|17022705|P2|Overall Study|Others|8
4949211|NCT00319098|17022706|P1|Overall Study|Others|33
4949212|NCT00319098|17022705|P2|Overall Study|Lost to Follow-up|13
4949213|NCT00319098|17022706|P1|Overall Study|Lost to Follow-up|37
4949214|NCT00319098|17022705|P2|Overall Study|Migrated/moved from study area|1
4949215|NCT00319098|17022706|P1|Overall Study|Migrated/moved from study area|2
4949216|NCT00319098|17022705|P2|Overall Study|Withdrawal by Subject|8
4949217|NCT00319098|17022706|P1|Overall Study|Withdrawal by Subject|37
4949218|NCT00319098|17022705|P2|Overall Study|Adverse Event|1
4949219|NCT00319098|17022706|P1|Overall Study|Adverse Event|20
4949220|NCT00319098|17022705|P2|Overall Study|Serious adverse event|0
4949221|NCT00319098|17022706|P1|Overall Study|Serious adverse event|3
4949222|NCT00319046|17022764|P1|Overall Study|administrative reason|1
4949223|NCT00319046|17022764|P1|Overall Study|withdrawal of subject's consent|7
4949224|NCT00319020|17022773|P2|Overall Study|Adverse Event|1
4949225|NCT00319020|17022774|P1|Overall Study|Adverse Event|0
4949226|NCT00319020|17022773|P2|Overall Study|Treatment failure|1
4949227|NCT00319020|17022774|P1|Overall Study|Treatment failure|0
4949228|NCT00319020|17022773|P2|Overall Study|Transplant|1
4949229|NCT00319020|17022774|P1|Overall Study|Transplant|0
4949230|NCT00319020|17022773|P2|Overall Study|Disease progression|2
4949231|NCT00319020|17022774|P1|Overall Study|Disease progression|0
4949232|NCT00319020|17022773|P2|Overall Study|Administrative reason|5
4949233|NCT00319020|17022774|P1|Overall Study|Administrative reason|0
4949234|NCT00319020|17022773|P2|Overall Study|F-1 completed but not enrolled in F-2|0
4949235|NCT00319020|17022774|P1|Overall Study|F-1 completed but not enrolled in F-2|1
4949236|NCT00319020|17022773|P2|Overall Study|Withdrawal by Subject|1
4949237|NCT00319020|17022774|P1|Overall Study|Withdrawal by Subject|4
4949238|NCT00319020|17022773|P2|Overall Study|Death|2
4949239|NCT00319020|17022774|P1|Overall Study|Death|2
4949240|NCT00318656|17022846|P2|Overall Study|Did not receive any treatment|1
4949241|NCT00318656|17022847|P1|Overall Study|Did not receive any treatment|0
4949242|NCT00318656|17022846|P2|Overall Study|Took Avandamet instead of Glim/Met|1
4949243|NCT00318656|17022847|P1|Overall Study|Took Avandamet instead of Glim/Met|0
4949244|NCT00318565|17022904|P1|Overall Study|Excluded per protocol|24
4949245|NCT00318474|17022911|P2|Overall Study|Trial terminated|7
4949246|NCT00318474|17022912|P1|Overall Study|Trial terminated|10
4949247|NCT00318474|17022911|P2|Overall Study|Post-therapy hyperflycemia|1
4949248|NCT00318474|17022912|P1|Overall Study|Post-therapy hyperflycemia|0
4949249|NCT00318474|17022911|P2|Overall Study|Fall in GFR|3
4949250|NCT00318474|17022912|P1|Overall Study|Fall in GFR|3
4949251|NCT00318474|17022911|P2|Overall Study|Withdrawal by Subject|2
4949252|NCT00318474|17022912|P1|Overall Study|Withdrawal by Subject|3
4949253|NCT00318474|17022911|P2|Overall Study|Protocol Violation|0
4949254|NCT00318474|17022912|P1|Overall Study|Protocol Violation|1
4949255|NCT00318474|17022911|P2|Overall Study|Pregnancy|2
4949256|NCT00318474|17022912|P1|Overall Study|Pregnancy|0
4949257|NCT00318474|17022911|P2|Overall Study|Lost to Follow-up|1
4949258|NCT00318474|17022912|P1|Overall Study|Lost to Follow-up|0
4949259|NCT00318474|17022911|P2|Overall Study|Adverse Event|1
4949260|NCT00318474|17022912|P1|Overall Study|Adverse Event|1
4949261|NCT00318461|17022923|P5|Open-Label Extension, 18 Months|Protocol Violation|6
4949262|NCT00318461|17022924|P4|Open-Label Extension, 18 Months|Protocol Violation|4
4949263|NCT00318461|17022925|P3|Open-Label Extension, 18 Months|Protocol Violation|3
4949264|NCT00318461|17022926|P2|Open-Label Extension, 18 Months|Protocol Violation|5
4949265|NCT00318461|17022927|P1|Open-Label Extension, 18 Months|Protocol Violation|7
4949266|NCT00318461|17022923|P5|Open-Label Extension, 18 Months|Lack of Efficacy|63
4949267|NCT00318461|17022924|P4|Open-Label Extension, 18 Months|Lack of Efficacy|27
4949268|NCT00318461|17022925|P3|Open-Label Extension, 18 Months|Lack of Efficacy|37
4949269|NCT00318461|17022926|P2|Open-Label Extension, 18 Months|Lack of Efficacy|33
4949270|NCT00318461|17022927|P1|Open-Label Extension, 18 Months|Lack of Efficacy|41
4949271|NCT00318461|17022923|P5|Open-Label Extension, 18 Months|Adverse Event|6
4949272|NCT00318461|17022924|P4|Open-Label Extension, 18 Months|Adverse Event|1
4949273|NCT00318461|17022925|P3|Open-Label Extension, 18 Months|Adverse Event|6
4949274|NCT00318461|17022926|P2|Open-Label Extension, 18 Months|Adverse Event|8
4949275|NCT00318461|17022927|P1|Open-Label Extension, 18 Months|Adverse Event|11
4949276|NCT00318461|17022923|P5|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22
4949277|NCT00318461|17022924|P4|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11
4949278|NCT00318461|17022925|P3|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27
4949279|NCT00318461|17022926|P2|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14
4949280|NCT00318461|17022927|P1|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19
4949281|NCT00318461|17022923|P5|Double-Blind, 6 Months|Fear of experiencing AE again|0
4949282|NCT00318461|17022924|P4|Double-Blind, 6 Months|Fear of experiencing AE again|0
4949283|NCT00318461|17022925|P3|Double-Blind, 6 Months|Fear of experiencing AE again|0
4949284|NCT00318461|17022926|P2|Double-Blind, 6 Months|Fear of experiencing AE again|1
4949285|NCT00318461|17022927|P1|Double-Blind, 6 Months|Fear of experiencing AE again|0
4949286|NCT00318461|17022923|P5|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1
4949287|NCT00318461|17022924|P4|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4949288|NCT00318461|17022925|P3|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4949289|NCT00318461|17022926|P2|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4949290|NCT00318461|17022927|P1|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0
4949291|NCT00318461|17022923|P5|Double-Blind, 6 Months|Hyperglicaemia|0
4949292|NCT00318461|17022924|P4|Double-Blind, 6 Months|Hyperglicaemia|1
4949293|NCT00318461|17022925|P3|Double-Blind, 6 Months|Hyperglicaemia|0
4949294|NCT00318461|17022926|P2|Double-Blind, 6 Months|Hyperglicaemia|0
4949295|NCT00318461|17022927|P1|Double-Blind, 6 Months|Hyperglicaemia|0
4949296|NCT00318461|17022923|P5|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2
4949297|NCT00318461|17022924|P4|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4949298|NCT00318461|17022925|P3|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4949299|NCT00318461|17022926|P2|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4949300|NCT00318461|17022927|P1|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0
4949301|NCT00318461|17022923|P5|Double-Blind, 6 Months|Lack of time|0
4949302|NCT00318461|17022924|P4|Double-Blind, 6 Months|Lack of time|0
4949303|NCT00318461|17022925|P3|Double-Blind, 6 Months|Lack of time|0
4949304|NCT00318461|17022926|P2|Double-Blind, 6 Months|Lack of time|0
4949305|NCT00318461|17022927|P1|Double-Blind, 6 Months|Lack of time|1
4949306|NCT00318461|17022923|P5|Double-Blind, 6 Months|Investigator decision|1
4949307|NCT00318461|17022924|P4|Double-Blind, 6 Months|Investigator decision|0
4949308|NCT00318461|17022925|P3|Double-Blind, 6 Months|Investigator decision|0
4949309|NCT00318461|17022926|P2|Double-Blind, 6 Months|Investigator decision|0
4949310|NCT00318461|17022927|P1|Double-Blind, 6 Months|Investigator decision|0
4949311|NCT00318461|17022923|P5|Double-Blind, 6 Months|Work commitment|1
4949312|NCT00318461|17022924|P4|Double-Blind, 6 Months|Work commitment|0
4949313|NCT00318461|17022925|P3|Double-Blind, 6 Months|Work commitment|0
4949314|NCT00318461|17022926|P2|Double-Blind, 6 Months|Work commitment|0
4949315|NCT00318461|17022927|P1|Double-Blind, 6 Months|Work commitment|0
4949316|NCT00318461|17022923|P5|Double-Blind, 6 Months|FPG exceeds limits/too high|0
4949317|NCT00318461|17022924|P4|Double-Blind, 6 Months|FPG exceeds limits/too high|2
4949318|NCT00318461|17022925|P3|Double-Blind, 6 Months|FPG exceeds limits/too high|0
4949319|NCT00318461|17022926|P2|Double-Blind, 6 Months|FPG exceeds limits/too high|0
4949320|NCT00318461|17022927|P1|Double-Blind, 6 Months|FPG exceeds limits/too high|1
4949321|NCT00318461|17022923|P5|Double-Blind, 6 Months|Tendency to low blood glucose levels|1
4949322|NCT00318461|17022924|P4|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4949323|NCT00318461|17022925|P3|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4949324|NCT00318461|17022926|P2|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4949325|NCT00318461|17022927|P1|Double-Blind, 6 Months|Tendency to low blood glucose levels|0
4949326|NCT00318461|17022923|P5|Double-Blind, 6 Months|Move|0
4949327|NCT00318461|17022924|P4|Double-Blind, 6 Months|Move|0
4949328|NCT00318461|17022925|P3|Double-Blind, 6 Months|Move|0
4949329|NCT00318461|17022926|P2|Double-Blind, 6 Months|Move|1
4949330|NCT00318461|17022927|P1|Double-Blind, 6 Months|Move|0
4949331|NCT00318461|17022923|P5|Double-Blind, 6 Months|Subject decision/No wish to continue|2
4949332|NCT00318461|17022924|P4|Double-Blind, 6 Months|Subject decision/No wish to continue|0
4949333|NCT00318461|17022925|P3|Double-Blind, 6 Months|Subject decision/No wish to continue|1
4949334|NCT00318461|17022926|P2|Double-Blind, 6 Months|Subject decision/No wish to continue|2
4949335|NCT00318461|17022927|P1|Double-Blind, 6 Months|Subject decision/No wish to continue|0
4949336|NCT00318461|17022923|P5|Double-Blind, 6 Months|Consent withdrawn|4
4949337|NCT00318461|17022924|P4|Double-Blind, 6 Months|Consent withdrawn|10
4949338|NCT00318461|17022925|P3|Double-Blind, 6 Months|Consent withdrawn|4
4949339|NCT00318461|17022926|P2|Double-Blind, 6 Months|Consent withdrawn|3
4949340|NCT00318461|17022927|P1|Double-Blind, 6 Months|Consent withdrawn|0
4949341|NCT00318461|17022923|P5|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4949342|NCT00318461|17022924|P4|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4949343|NCT00318461|17022925|P3|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4949344|NCT00318461|17022926|P2|Double-Blind, 6 Months|Poor compliance/Non-compliance|1
4949345|NCT00318461|17022927|P1|Double-Blind, 6 Months|Poor compliance/Non-compliance|0
4949346|NCT00318461|17022923|P5|Double-Blind, 6 Months|Lost to follow up|0
4949347|NCT00318461|17022924|P4|Double-Blind, 6 Months|Lost to follow up|0
4949348|NCT00318461|17022925|P3|Double-Blind, 6 Months|Lost to follow up|0
4949349|NCT00318461|17022926|P2|Double-Blind, 6 Months|Lost to follow up|1
4949350|NCT00318461|17022927|P1|Double-Blind, 6 Months|Lost to follow up|0
4949351|NCT00318461|17022923|P5|Double-Blind, 6 Months|Protocol Violation|5
4949352|NCT00318461|17022924|P4|Double-Blind, 6 Months|Protocol Violation|4
4949353|NCT00318461|17022925|P3|Double-Blind, 6 Months|Protocol Violation|4
4949354|NCT00318461|17022926|P2|Double-Blind, 6 Months|Protocol Violation|4
4949355|NCT00318461|17022927|P1|Double-Blind, 6 Months|Protocol Violation|2
4949356|NCT00318461|17022923|P5|Double-Blind, 6 Months|Lack of Efficacy|9
4949357|NCT00318461|17022924|P4|Double-Blind, 6 Months|Lack of Efficacy|29
4949358|NCT00318461|17022925|P3|Double-Blind, 6 Months|Lack of Efficacy|13
4949359|NCT00318461|17022926|P2|Double-Blind, 6 Months|Lack of Efficacy|8
4949360|NCT00318461|17022927|P1|Double-Blind, 6 Months|Lack of Efficacy|19
4949361|NCT00318461|17022923|P5|Double-Blind, 6 Months|Adverse Event|8
4949362|NCT00318461|17022924|P4|Double-Blind, 6 Months|Adverse Event|2
4949363|NCT00318461|17022925|P3|Double-Blind, 6 Months|Adverse Event|29
4949364|NCT00318461|17022926|P2|Double-Blind, 6 Months|Adverse Event|23
4949365|NCT00318461|17022927|P1|Double-Blind, 6 Months|Adverse Event|11
4949366|NCT00318370|17023026|P3|Period 3|Other|3
4949367|NCT00318370|17023027|P2|Period 3|Other|0
4949368|NCT00318370|17023028|P1|Period 3|Other|0
4949369|NCT00318370|17023026|P3|Period 3|Withdrawal by Subject|3
4949370|NCT00318370|17023027|P2|Period 3|Withdrawal by Subject|0
4949371|NCT00318370|17023028|P1|Period 3|Withdrawal by Subject|0
4949372|NCT00318370|17023026|P3|Period 3|Physician Decision|1
4949373|NCT00318370|17023027|P2|Period 3|Physician Decision|0
4949374|NCT00318370|17023028|P1|Period 3|Physician Decision|0
4949375|NCT00318370|17023026|P3|Period 3|Death|1
4949376|NCT00318370|17023027|P2|Period 3|Death|0
4949377|NCT00318370|17023028|P1|Period 3|Death|0
4949378|NCT00318370|17023026|P3|Period 3|Lack of Efficacy|24
4949379|NCT00318370|17023027|P2|Period 3|Lack of Efficacy|0
4949380|NCT00318370|17023028|P1|Period 3|Lack of Efficacy|0
4949381|NCT00318370|17023026|P3|Period 3|Adverse Event|1
4949382|NCT00318370|17023027|P2|Period 3|Adverse Event|0
4949383|NCT00318370|17023028|P1|Period 3|Adverse Event|0
4949384|NCT00318370|17023026|P3|Period 2|Other|0
4949385|NCT00318370|17023027|P2|Period 2|Other|1
4949386|NCT00318370|17023028|P1|Period 2|Other|0
4949387|NCT00318370|17023026|P3|Period 2|Withdrawal by Subject|0
4949388|NCT00318370|17023027|P2|Period 2|Withdrawal by Subject|1
4949389|NCT00318370|17023028|P1|Period 2|Withdrawal by Subject|0
4949390|NCT00318370|17023026|P3|Period 2|Physician Decision|0
4949391|NCT00318370|17023027|P2|Period 2|Physician Decision|1
4949392|NCT00318370|17023028|P1|Period 2|Physician Decision|0
4949393|NCT00318370|17023026|P3|Period 2|Lack of Efficacy|0
4949394|NCT00318370|17023027|P2|Period 2|Lack of Efficacy|5
4949395|NCT00318370|17023028|P1|Period 2|Lack of Efficacy|0
4949396|NCT00318370|17023026|P3|Period 2|Adverse Event|0
4949397|NCT00318370|17023027|P2|Period 2|Adverse Event|3
4949398|NCT00318370|17023028|P1|Period 2|Adverse Event|0
4949399|NCT00318370|17023026|P3|Period 1|Withdrawal by Subject|0
4949400|NCT00318370|17023027|P2|Period 1|Withdrawal by Subject|0
4949401|NCT00318370|17023028|P1|Period 1|Withdrawal by Subject|1
4949402|NCT00318370|17023026|P3|Period 1|Physician Decision|0
4949403|NCT00318370|17023027|P2|Period 1|Physician Decision|0
4949404|NCT00318370|17023028|P1|Period 1|Physician Decision|1
4949405|NCT00318370|17023026|P3|Period 1|Lack of Efficacy|0
4949406|NCT00318370|17023027|P2|Period 1|Lack of Efficacy|0
4949407|NCT00318370|17023028|P1|Period 1|Lack of Efficacy|5
4949408|NCT00318149|17023062|P6|Overall Study|Adverse Event|2
4949409|NCT00318149|17023063|P5|Overall Study|Adverse Event|0
4949410|NCT00318149|17023064|P4|Overall Study|Adverse Event|0
4949411|NCT00318149|17023065|P3|Overall Study|Adverse Event|0
4949412|NCT00318149|17023066|P2|Overall Study|Adverse Event|0
4949413|NCT00318149|17023067|P1|Overall Study|Adverse Event|0
4949414|NCT00317642|17023213|P2|Overall Study|AML Not Centrally Confirmed|5
4949415|NCT00317642|17023214|P1|Overall Study|AML Not Centrally Confirmed|1
4949416|NCT00317642|17023213|P2|Overall Study|Referred For Transplantation|0
4949417|NCT00317642|17023214|P1|Overall Study|Referred For Transplantation|1
4949418|NCT00317642|17023213|P2|Overall Study|Withdrawal by Subject|1
4949419|NCT00317642|17023214|P1|Overall Study|Withdrawal by Subject|0
4949420|NCT00317642|17023213|P2|Overall Study|Not Continue to Consolidation|0
4949421|NCT00317642|17023214|P1|Overall Study|Not Continue to Consolidation|2
4949422|NCT00317642|17023213|P2|Overall Study|Death|7
4949423|NCT00317642|17023214|P1|Overall Study|Death|14
4949424|NCT00317642|17023213|P2|Overall Study|Disease Recurrence|2
4949425|NCT00317642|17023214|P1|Overall Study|Disease Recurrence|1
4949426|NCT00317642|17023213|P2|Overall Study|Treatment Failure|102
4949427|NCT00317642|17023214|P1|Overall Study|Treatment Failure|56
4949428|NCT00317642|17023213|P2|Overall Study|Adverse Event|5
4949429|NCT00317642|17023214|P1|Overall Study|Adverse Event|17
4949430|NCT00317642|17023213|P2|Overall Study|Participant declined treatment|3
4949431|NCT00317642|17023214|P1|Overall Study|Participant declined treatment|14
4949432|NCT00317642|17023213|P2|Overall Study|Physician Decision|7
4949433|NCT00317642|17023214|P1|Overall Study|Physician Decision|15
4949434|NCT00317642|17023213|P2|Overall Study|Not Received Either Study Drug|3
4949435|NCT00317642|17023214|P1|Overall Study|Not Received Either Study Drug|1
4949436|NCT00317473|17023293|P6|Overall Study|Other|0
4949437|NCT00317473|17023294|P5|Overall Study|Other|0
4949438|NCT00317473|17023295|P4|Overall Study|Other|0
4949439|NCT00317473|17023296|P3|Overall Study|Other|0
4949440|NCT00317473|17023297|P2|Overall Study|Other|2
4949441|NCT00317473|17023298|P1|Overall Study|Other|0
4949442|NCT00317473|17023293|P6|Overall Study|Death|0
4949443|NCT00317473|17023294|P5|Overall Study|Death|0
4949444|NCT00317473|17023295|P4|Overall Study|Death|0
4949445|NCT00317473|17023296|P3|Overall Study|Death|0
4949446|NCT00317473|17023297|P2|Overall Study|Death|0
4949447|NCT00317473|17023298|P1|Overall Study|Death|1
4949448|NCT00317473|17023293|P6|Overall Study|Relocation|2
4949449|NCT00317473|17023294|P5|Overall Study|Relocation|5
4949450|NCT00317473|17023295|P4|Overall Study|Relocation|1
4949451|NCT00317473|17023296|P3|Overall Study|Relocation|1
4949452|NCT00317473|17023297|P2|Overall Study|Relocation|0
4949453|NCT00317473|17023298|P1|Overall Study|Relocation|1
4949454|NCT00317473|17023293|P6|Overall Study|Withdrawal by Subject|1
4949455|NCT00317473|17023294|P5|Overall Study|Withdrawal by Subject|3
4949456|NCT00317473|17023295|P4|Overall Study|Withdrawal by Subject|1
4949457|NCT00317473|17023296|P3|Overall Study|Withdrawal by Subject|2
4949458|NCT00317473|17023297|P2|Overall Study|Withdrawal by Subject|1
4949459|NCT00317473|17023298|P1|Overall Study|Withdrawal by Subject|2
4949460|NCT00317109|17023337|P2|Overall Study|Migated/moved from study area|0
4949461|NCT00317109|17023338|P1|Overall Study|Migated/moved from study area|1
4949462|NCT00317109|17023337|P2|Overall Study|Withdrawal by Subject|0
4949463|NCT00317109|17023338|P1|Overall Study|Withdrawal by Subject|2
4949464|NCT00317044|17023375|P3|Overall Study|Multiple Reasons|6
4949465|NCT00317044|17023376|P2|Overall Study|Multiple Reasons|2
4949466|NCT00317044|17023377|P1|Overall Study|Multiple Reasons|6
4949467|NCT00317044|17023375|P3|Overall Study|Lost to Follow-up|3
4949468|NCT00317044|17023376|P2|Overall Study|Lost to Follow-up|2
4949469|NCT00317044|17023377|P1|Overall Study|Lost to Follow-up|0
4949470|NCT00317044|17023375|P3|Overall Study|Withdrawal by Subject|12
4949471|NCT00317044|17023376|P2|Overall Study|Withdrawal by Subject|7
4949472|NCT00317044|17023377|P1|Overall Study|Withdrawal by Subject|10
4949473|NCT00317044|17023375|P3|Overall Study|Adverse Event|4
4949474|NCT00317044|17023376|P2|Overall Study|Adverse Event|7
4949475|NCT00317044|17023377|P1|Overall Study|Adverse Event|4
4949476|NCT00317044|17023375|P3|Overall Study|Protocol Violation|20
4949477|NCT00317044|17023376|P2|Overall Study|Protocol Violation|22
4949478|NCT00317044|17023377|P1|Overall Study|Protocol Violation|28
4949479|NCT00316914|17023423|P2|Overall Study|Missing end of treatment documentation|15
4949480|NCT00316914|17023424|P1|Overall Study|Missing end of treatment documentation|14
4949481|NCT00316914|17023423|P2|Overall Study|Other Problems|11
4949482|NCT00316914|17023424|P1|Overall Study|Other Problems|6
4949483|NCT00316914|17023423|P2|Overall Study|Adverse Event|7
4949484|NCT00316914|17023424|P1|Overall Study|Adverse Event|8
4949485|NCT00316914|17023423|P2|Overall Study|Withdrawal by Subject|3
4949486|NCT00316914|17023424|P1|Overall Study|Withdrawal by Subject|5
4949487|NCT00316888|17023454|P2|Overall Study|Not start protocol therapy|1
4949488|NCT00316888|17023455|P1|Overall Study|Not start protocol therapy|0
4949489|NCT00316888|17023454|P2|Overall Study|Withdrawal by Subject|2
4949490|NCT00316888|17023455|P1|Overall Study|Withdrawal by Subject|2
4949491|NCT00316888|17023454|P2|Overall Study|Adverse Event|5
4949492|NCT00316888|17023455|P1|Overall Study|Adverse Event|4
4949493|NCT00316719|17023477|P2|Overall Study|Consent withdrawn|0
4949494|NCT00316719|17023478|P1|Overall Study|Consent withdrawn|2
4949495|NCT00316719|17023477|P2|Overall Study|Adverse Event|6
4949496|NCT00316719|17023478|P1|Overall Study|Adverse Event|0
4949497|NCT00316706|17023504|P2|Overall Study|Lost to Follow-up|48
4949498|NCT00316706|17023505|P1|Overall Study|Lost to Follow-up|38
4949499|NCT00316693|17023521|P2|Overall Study|Other|44
4949500|NCT00316693|17023522|P1|Overall Study|Other|38
4949501|NCT00316693|17023521|P2|Overall Study|Lost to Follow-up|34
4949502|NCT00316693|17023522|P1|Overall Study|Lost to Follow-up|26
4949503|NCT00316693|17023521|P2|Overall Study|Withdrawal by Subject|6
4949504|NCT00316693|17023522|P1|Overall Study|Withdrawal by Subject|6
4949505|NCT00316693|17023521|P2|Overall Study|Protocol Violation|0
4949506|NCT00316693|17023522|P1|Overall Study|Protocol Violation|1
4949507|NCT00316693|17023521|P2|Overall Study|Adverse Event|1
4949508|NCT00316693|17023522|P1|Overall Study|Adverse Event|6
4949509|NCT00316602|17023564|P2|Overall Study|Other|6
4949510|NCT00316602|17023565|P1|Overall Study|Other|3
4949511|NCT00316602|17023564|P2|Overall Study|Adverse Event|0
4949512|NCT00316602|17023565|P1|Overall Study|Adverse Event|1
4949513|NCT00316602|17023564|P2|Overall Study|Subject unwilling/unable to comply with|17
4949514|NCT00316602|17023565|P1|Overall Study|Subject unwilling/unable to comply with|3
4949515|NCT00316602|17023564|P2|Overall Study|Withdrawal by Subject|2
4949516|NCT00316602|17023565|P1|Overall Study|Withdrawal by Subject|3
4949517|NCT00316589|17023597|P4|Overall Study|Other reason|1
4949518|NCT00316589|17023598|P3|Overall Study|Other reason|1
4949519|NCT00316589|17023599|P2|Overall Study|Other reason|12
4949520|NCT00316589|17023600|P1|Overall Study|Other reason|0
4949521|NCT00316589|17023597|P4|Overall Study|Physician Decision|0
4949522|NCT00316589|17023598|P3|Overall Study|Physician Decision|0
4949523|NCT00316589|17023599|P2|Overall Study|Physician Decision|1
4949524|NCT00316589|17023600|P1|Overall Study|Physician Decision|0
4949525|NCT00316589|17023597|P4|Overall Study|Adverse Event|1
4949526|NCT00316589|17023598|P3|Overall Study|Adverse Event|0
4949527|NCT00316589|17023599|P2|Overall Study|Adverse Event|0
4949528|NCT00316589|17023600|P1|Overall Study|Adverse Event|1
4949529|NCT00316589|17023597|P4|Overall Study|Subject unwilling/unable to comply|2
4949530|NCT00316589|17023598|P3|Overall Study|Subject unwilling/unable to comply|0
4949531|NCT00316589|17023599|P2|Overall Study|Subject unwilling/unable to comply|6
4949532|NCT00316589|17023600|P1|Overall Study|Subject unwilling/unable to comply|0
4949533|NCT00316589|17023597|P4|Overall Study|Withdrawal by Subject|1
4949534|NCT00316589|17023598|P3|Overall Study|Withdrawal by Subject|0
4949535|NCT00316589|17023599|P2|Overall Study|Withdrawal by Subject|5
4949536|NCT00316589|17023600|P1|Overall Study|Withdrawal by Subject|0
4949537|NCT00316303|17023734|P2|Overall Study|Lost to Follow-up|16
4949538|NCT00316303|17023735|P1|Overall Study|Lost to Follow-up|11
4949539|NCT00316277|17023751|P2|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1
4949540|NCT00316277|17023752|P1|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0
4949541|NCT00316277|17023751|P2|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18
4949542|NCT00316277|17023752|P1|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19
4949543|NCT00316277|17023751|P2|Phase 1 (12 Weeks)|Eligible for Phase 2|225
4949544|NCT00316277|17023752|P1|Phase 1 (12 Weeks)|Eligible for Phase 2|220
4949545|NCT00316277|17023751|P2|Phase 1 (12 Weeks)|Investigator-initiated termination|0
4949546|NCT00316277|17023752|P1|Phase 1 (12 Weeks)|Investigator-initiated termination|2
4949547|NCT00316277|17023751|P2|Phase 1 (12 Weeks)|Lost to Follow-up|75
4949548|NCT00316277|17023752|P1|Phase 1 (12 Weeks)|Lost to Follow-up|88
4949549|NCT00316264|17023773|P3|Overall Study|Other|0
4949550|NCT00316264|17023774|P2|Overall Study|Other|1
4949551|NCT00316264|17023775|P1|Overall Study|Other|1
4949552|NCT00316264|17023773|P3|Overall Study|Death|0
4949553|NCT00316264|17023774|P2|Overall Study|Death|0
4949554|NCT00316264|17023775|P1|Overall Study|Death|2
4949555|NCT00316264|17023773|P3|Overall Study|Withdrawal of Consent|6
4949556|NCT00316264|17023774|P2|Overall Study|Withdrawal of Consent|5
4949557|NCT00316264|17023775|P1|Overall Study|Withdrawal of Consent|3
4949558|NCT00316264|17023773|P3|Overall Study|Lost to Follow-up|0
4949559|NCT00316264|17023774|P2|Overall Study|Lost to Follow-up|1
4949560|NCT00316264|17023775|P1|Overall Study|Lost to Follow-up|0
4949561|NCT00316225|17023843|P1|Overall Study|Death|2
4949562|NCT00316225|17023843|P1|Overall Study|Withdrawal by Subject|3
4949563|NCT00316225|17023843|P1|Overall Study|Progressive Disease|15
4949564|NCT00316225|17023843|P1|Overall Study|Physician Decision|3
4949565|NCT00316225|17023843|P1|Overall Study|Adverse Event|2
4949566|NCT00316199|17023852|P1|Overall Study|Lost to Follow-up|2
4949567|NCT00316199|17023852|P1|Overall Study|Death|8
4949568|NCT00316199|17023852|P1|Overall Study|Adverse Event|2
4949569|NCT00316186|17023860|P1|Overall Study|Other|1
4949570|NCT00316186|17023860|P1|Overall Study|Lost to Follow-up|1
4949571|NCT00316186|17023860|P1|Overall Study|Disease Progression|4
4949572|NCT00316186|17023860|P1|Overall Study|Adverse Event|6
4949573|NCT00316173|17023874|P2|Treatment Phase|Study Follow-up Stopped|34
4949574|NCT00316173|17023875|P1|Treatment Phase|Study Follow-up Stopped|0
4949575|NCT00316173|17023874|P2|Treatment Phase|Withdrawal by Subject|1
4949576|NCT00316173|17023875|P1|Treatment Phase|Withdrawal by Subject|0
4949577|NCT00316173|17023874|P2|Treatment Phase|Lost to Follow-up|3
4949578|NCT00316173|17023875|P1|Treatment Phase|Lost to Follow-up|0
4949579|NCT00316173|17023874|P2|Treatment Phase|Lack of Efficacy|3
4949580|NCT00316173|17023875|P1|Treatment Phase|Lack of Efficacy|0
4949581|NCT00316173|17023874|P2|Treatment Phase|Adverse Event|1
4949582|NCT00316173|17023875|P1|Treatment Phase|Adverse Event|0
4949583|NCT00316173|17023874|P2|Run-in Phase|Study Follow-up Stopped|0
4949584|NCT00316173|17023875|P1|Run-in Phase|Study Follow-up Stopped|5
4949585|NCT00316173|17023874|P2|Run-in Phase|Protocol Violation|0
4949586|NCT00316173|17023875|P1|Run-in Phase|Protocol Violation|1
4949587|NCT00316173|17023874|P2|Run-in Phase|Adverse Event|0
4949588|NCT00316173|17023875|P1|Run-in Phase|Adverse Event|1
4949589|NCT00316121|17023888|P2|Overall Study|Subject did not have 24 month visit|0
4949590|NCT00316121|17023889|P1|Overall Study|Subject did not have 24 month visit|1
4949591|NCT00316121|17023888|P2|Overall Study|Subject no show for visit x 3|0
4949592|NCT00316121|17023889|P1|Overall Study|Subject no show for visit x 3|1
4949593|NCT00316121|17023888|P2|Overall Study|Subject refused to return|0
4949594|NCT00316121|17023889|P1|Overall Study|Subject refused to return|1
4949595|NCT00316121|17023888|P2|Overall Study|Subject relocated|1
4949596|NCT00316121|17023889|P1|Overall Study|Subject relocated|1
4949597|NCT00316121|17023888|P2|Overall Study|Reason is missing|0
4949598|NCT00316121|17023889|P1|Overall Study|Reason is missing|1
4949599|NCT00316121|17023888|P2|Overall Study|Withdrawal by Subject|0
4949600|NCT00316121|17023889|P1|Overall Study|Withdrawal by Subject|2
4949601|NCT00316121|17023888|P2|Overall Study|Lost to Follow-up|8
4949602|NCT00316121|17023889|P1|Overall Study|Lost to Follow-up|14
4949603|NCT00316121|17023888|P2|Overall Study|Death|0
4949604|NCT00316121|17023889|P1|Overall Study|Death|1
4949605|NCT00316082|17023900|P5|Overall Study|Administrative reason by sponsor|0
4949606|NCT00316082|17023901|P4|Overall Study|Administrative reason by sponsor|0
4949607|NCT00316082|17023902|P3|Overall Study|Administrative reason by sponsor|1
4949608|NCT00316082|17023903|P2|Overall Study|Administrative reason by sponsor|0
4949609|NCT00316082|17023904|P1|Overall Study|Administrative reason by sponsor|0
4949610|NCT00316082|17023900|P5|Overall Study|Death|0
4949611|NCT00316082|17023901|P4|Overall Study|Death|0
4949612|NCT00316082|17023902|P3|Overall Study|Death|1
4949613|NCT00316082|17023903|P2|Overall Study|Death|0
4949614|NCT00316082|17023904|P1|Overall Study|Death|0
4949615|NCT00316082|17023900|P5|Overall Study|Physician Decision|1
4949616|NCT00316082|17023901|P4|Overall Study|Physician Decision|1
4949617|NCT00316082|17023902|P3|Overall Study|Physician Decision|2
4949618|NCT00316082|17023903|P2|Overall Study|Physician Decision|1
4949619|NCT00316082|17023904|P1|Overall Study|Physician Decision|1
4949620|NCT00316082|17023900|P5|Overall Study|Subject no longer meets study criteria|1
4949621|NCT00316082|17023901|P4|Overall Study|Subject no longer meets study criteria|2
4949622|NCT00316082|17023902|P3|Overall Study|Subject no longer meets study criteria|2
4949623|NCT00316082|17023903|P2|Overall Study|Subject no longer meets study criteria|1
4949624|NCT00316082|17023904|P1|Overall Study|Subject no longer meets study criteria|3
4949625|NCT00316082|17023900|P5|Overall Study|Adverse Event|3
4949626|NCT00316082|17023901|P4|Overall Study|Adverse Event|1
4949627|NCT00316082|17023902|P3|Overall Study|Adverse Event|5
4949628|NCT00316082|17023903|P2|Overall Study|Adverse Event|2
4949629|NCT00316082|17023904|P1|Overall Study|Adverse Event|4
4949630|NCT00316082|17023900|P5|Overall Study|Poor/noncompliance|4
4949631|NCT00316082|17023901|P4|Overall Study|Poor/noncompliance|1
4949632|NCT00316082|17023902|P3|Overall Study|Poor/noncompliance|4
4949633|NCT00316082|17023903|P2|Overall Study|Poor/noncompliance|1
4949634|NCT00316082|17023904|P1|Overall Study|Poor/noncompliance|6
4949635|NCT00316082|17023900|P5|Overall Study|Lost to Follow-up|6
4949636|NCT00316082|17023901|P4|Overall Study|Lost to Follow-up|8
4949637|NCT00316082|17023902|P3|Overall Study|Lost to Follow-up|7
4949638|NCT00316082|17023903|P2|Overall Study|Lost to Follow-up|6
4949639|NCT00316082|17023904|P1|Overall Study|Lost to Follow-up|7
4949640|NCT00316082|17023900|P5|Overall Study|Withdrawal of Consent by Subject|5
4949641|NCT00316082|17023901|P4|Overall Study|Withdrawal of Consent by Subject|9
4949642|NCT00316082|17023902|P3|Overall Study|Withdrawal of Consent by Subject|2
4949643|NCT00316082|17023903|P2|Overall Study|Withdrawal of Consent by Subject|8
4949644|NCT00316082|17023904|P1|Overall Study|Withdrawal of Consent by Subject|10
4949645|NCT00316082|17023900|P5|Overall Study|Lack of Efficacy|6
4949646|NCT00316082|17023901|P4|Overall Study|Lack of Efficacy|4
4949647|NCT00316082|17023902|P3|Overall Study|Lack of Efficacy|3
4949648|NCT00316082|17023903|P2|Overall Study|Lack of Efficacy|3
4949649|NCT00316082|17023904|P1|Overall Study|Lack of Efficacy|2
4949650|NCT00316017|17023935|P3|Overall Study|Protocol Violation|19
4949651|NCT00316017|17023936|P2|Overall Study|Protocol Violation|13
4949652|NCT00316017|17023937|P1|Overall Study|Protocol Violation|11
4949653|NCT00316004|17024011|P3|Overall Study|Subject was not given study fluid.|21
4949654|NCT00316004|17024012|P2|Overall Study|Subject was not given study fluid.|14
4949655|NCT00316004|17024013|P1|Overall Study|Subject was not given study fluid.|14
4949656|NCT00315731|17024084|P1|Overall Study|Death|5
4949657|NCT00315731|17024084|P1|Overall Study|Lost to Follow-up|1
4949658|NCT00315705|17024112|P1|Phase 2|Death|7
4949659|NCT00315705|17024112|P1|Phase 2|Other|1
4949660|NCT00315705|17024112|P1|Phase 2|Scheduled for transplant|8
4949661|NCT00315705|17024112|P1|Phase 2|Disease relapse|1
4949662|NCT00315705|17024112|P1|Phase 2|Failure to achieve response|3
4949663|NCT00315705|17024112|P1|Phase 2|Adverse Event|1
4949664|NCT00315705|17024112|P1|Phase 2|Physician Decision|4
4949665|NCT00315705|17024112|P1|Phase 1|Death|3
4949666|NCT00315705|17024112|P1|Phase 1|Scheduled for transplant|9
4949667|NCT00315705|17024112|P1|Phase 1|Disease relapse|4
4949668|NCT00315705|17024112|P1|Phase 1|Failure to achieve response|8
4949669|NCT00315705|17024112|P1|Phase 1|Refused further treatment|1
4949670|NCT00315458|17024173|P4|Overall Study|Did not qualify|0
4949671|NCT00315458|17024174|P3|Overall Study|Did not qualify|1
4949672|NCT00315458|17024175|P2|Overall Study|Did not qualify|0
4949673|NCT00315458|17024176|P1|Overall Study|Did not qualify|0
4949674|NCT00315458|17024173|P4|Overall Study|Lack of Efficacy|1
4949675|NCT00315458|17024174|P3|Overall Study|Lack of Efficacy|20
4949676|NCT00315458|17024175|P2|Overall Study|Lack of Efficacy|0
4949677|NCT00315458|17024176|P1|Overall Study|Lack of Efficacy|0
4949678|NCT00315458|17024173|P4|Overall Study|Withdrawal by Subject|2
4949679|NCT00315458|17024174|P3|Overall Study|Withdrawal by Subject|0
4949680|NCT00315458|17024175|P2|Overall Study|Withdrawal by Subject|3
4949681|NCT00315458|17024176|P1|Overall Study|Withdrawal by Subject|0
4949682|NCT00315458|17024173|P4|Overall Study|Lost to Follow-up|2
4949683|NCT00315458|17024174|P3|Overall Study|Lost to Follow-up|0
4949684|NCT00315458|17024175|P2|Overall Study|Lost to Follow-up|2
4949685|NCT00315458|17024176|P1|Overall Study|Lost to Follow-up|1
4949686|NCT00315458|17024173|P4|Overall Study|Adverse Event|3
4949687|NCT00315458|17024174|P3|Overall Study|Adverse Event|23
4949688|NCT00315458|17024175|P2|Overall Study|Adverse Event|4
4949689|NCT00315458|17024176|P1|Overall Study|Adverse Event|2
4949690|NCT00315458|17024173|P4|Overall Study|Administrative|21
4949691|NCT00315458|17024174|P3|Overall Study|Administrative|8
4949692|NCT00315458|17024175|P2|Overall Study|Administrative|3
4949693|NCT00315458|17024176|P1|Overall Study|Administrative|0
4949694|NCT00315445|17024189|P3|Overall Study|Other|0
4949695|NCT00315445|17024190|P2|Overall Study|Other|3
4949696|NCT00315445|17024191|P1|Overall Study|Other|1
4949697|NCT00315445|17024189|P3|Overall Study|Protocol Violation|1
4949698|NCT00315445|17024190|P2|Overall Study|Protocol Violation|0
4949699|NCT00315445|17024191|P1|Overall Study|Protocol Violation|2
4949700|NCT00315445|17024189|P3|Overall Study|Lost to Follow-up|1
4949701|NCT00315445|17024190|P2|Overall Study|Lost to Follow-up|0
4949702|NCT00315445|17024191|P1|Overall Study|Lost to Follow-up|1
4949703|NCT00315445|17024189|P3|Overall Study|Lack of Efficacy|7
4949704|NCT00315445|17024190|P2|Overall Study|Lack of Efficacy|1
4949705|NCT00315445|17024191|P1|Overall Study|Lack of Efficacy|16
4949706|NCT00315445|17024189|P3|Overall Study|Adverse Event|15
4949707|NCT00315445|17024190|P2|Overall Study|Adverse Event|12
4949708|NCT00315445|17024191|P1|Overall Study|Adverse Event|7
4949709|NCT00315055|17024481|P2|Overall Study|Lost to Follow-up|1
4949710|NCT00315055|17024482|P1|Overall Study|Lost to Follow-up|1
4949711|NCT00315055|17024481|P2|Overall Study|Protocol Violation|4
4949712|NCT00315055|17024482|P1|Overall Study|Protocol Violation|2
4949713|NCT00314951|17024500|P2|Follow-up|mITT failure|34
4949714|NCT00314951|17024501|P1|Follow-up|mITT failure|44
4949715|NCT00314951|17024500|P2|Treatment|Didn't meet criteria for mITT population|11
4949716|NCT00314951|17024501|P1|Treatment|Didn't meet criteria for mITT population|16
4949717|NCT00314808|17024511|P1|Overall Study|Withdrawal by Subject/PI without AE|4
4949718|NCT00314808|17024511|P1|Overall Study|Disease Progression without AE|4
4949719|NCT00314795|17024519|P1|Overall Study|Participants Withdrew Consent|2
4949720|NCT00314795|17024519|P1|Overall Study|Renal Transplant|3
4949721|NCT00314795|17024519|P1|Overall Study|Reason not Specified|3
4949722|NCT00314795|17024519|P1|Overall Study|Death|4
4949723|NCT00314795|17024519|P1|Overall Study|Adverse Event|8
4949724|NCT00314574|17024529|P2|Overall Study|Data unknown at database lock|1
4949725|NCT00314574|17024530|P1|Overall Study|Data unknown at database lock|0
4949726|NCT00314574|17024529|P2|Overall Study|Pregnancy|4
4949727|NCT00314574|17024530|P1|Overall Study|Pregnancy|6
4949728|NCT00314574|17024529|P2|Overall Study|Physician Decision|15
4949729|NCT00314574|17024530|P1|Overall Study|Physician Decision|22
4949730|NCT00314574|17024529|P2|Overall Study|Withdrawal by Subject|22
4949731|NCT00314574|17024530|P1|Overall Study|Withdrawal by Subject|33
4949732|NCT00314574|17024529|P2|Overall Study|Lost to Follow-up|25
4949733|NCT00314574|17024530|P1|Overall Study|Lost to Follow-up|19
4949734|NCT00314574|17024529|P2|Overall Study|Adverse Event|16
4949735|NCT00314574|17024530|P1|Overall Study|Adverse Event|11
4949736|NCT00314574|17024529|P2|Overall Study|Death|0
4949737|NCT00314574|17024530|P1|Overall Study|Death|3
4949738|NCT00314366|17024546|P2|Overall Study|not treated due to patient medical condi|0
4949739|NCT00314366|17024547|P1|Overall Study|not treated due to patient medical condi|1
4949740|NCT00314340|17024592|P1|Overall Study|lost interest|1
4949741|NCT00314327|17024598|P1|Overall Study|Withdrawal by Subject|1
4949742|NCT00314262|17024603|P1|Overall Study|Physician Decision|1
4949743|NCT00314262|17024603|P1|Overall Study|Withdrawal by Subject|2
4949744|NCT00314262|17024603|P1|Overall Study|Adverse Event|2
4949745|NCT00314249|17024611|P2|Overall Study|Non-Compliant|6
4949746|NCT00314249|17024612|P1|Overall Study|Non-Compliant|5
4949747|NCT00314249|17024611|P2|Overall Study|Withdrawn for other reasons|1
4949748|NCT00314249|17024612|P1|Overall Study|Withdrawn for other reasons|4
4949749|NCT00314249|17024611|P2|Overall Study|Physician Decision|1
4949750|NCT00314249|17024612|P1|Overall Study|Physician Decision|1
4949751|NCT00314249|17024611|P2|Overall Study|Lost to Follow-up|9
4949752|NCT00314249|17024612|P1|Overall Study|Lost to Follow-up|15
4949753|NCT00314249|17024611|P2|Overall Study|Withdrawal by Subject|28
4949754|NCT00314249|17024612|P1|Overall Study|Withdrawal by Subject|21
4949755|NCT00314249|17024611|P2|Overall Study|Lack of Efficacy|24
4949756|NCT00314249|17024612|P1|Overall Study|Lack of Efficacy|33
4949757|NCT00314249|17024611|P2|Overall Study|Adverse Event|94
4949758|NCT00314249|17024612|P1|Overall Study|Adverse Event|73
4949759|NCT00314145|17024645|P2|Overall Study|Sponsor Decision|0
4949760|NCT00314145|17024646|P1|Overall Study|Sponsor Decision|2
4949761|NCT00314145|17024645|P2|Overall Study|Protocol Violation|0
4949762|NCT00314145|17024646|P1|Overall Study|Protocol Violation|3
4949763|NCT00314145|17024645|P2|Overall Study|Adverse Event|3
4949764|NCT00314145|17024646|P1|Overall Study|Adverse Event|0
4949765|NCT00314145|17024645|P2|Overall Study|Physician Decision|4
4949766|NCT00314145|17024646|P1|Overall Study|Physician Decision|3
4949767|NCT00314145|17024645|P2|Overall Study|Lost to Follow-up|12
4949768|NCT00314145|17024646|P1|Overall Study|Lost to Follow-up|5
4949769|NCT00314145|17024645|P2|Overall Study|Withdrawal by Subject|10
4949770|NCT00314145|17024646|P1|Overall Study|Withdrawal by Subject|8
4949771|NCT00314132|17024660|P2|Overall Study|Physician Decision|0
4949772|NCT00314132|17024661|P1|Overall Study|Physician Decision|1
4949773|NCT00314132|17024660|P2|Overall Study|Adverse Event|0
4949774|NCT00314132|17024661|P1|Overall Study|Adverse Event|1
4949775|NCT00314132|17024660|P2|Overall Study|Withdrawal by Subject|5
4949776|NCT00314132|17024661|P1|Overall Study|Withdrawal by Subject|3
4949777|NCT00314132|17024660|P2|Overall Study|Lost to Follow-up|13
4949778|NCT00314132|17024661|P1|Overall Study|Lost to Follow-up|3
4949779|NCT00313911|17024688|P2|Overall Study|Did not meet age criteria|1
4949780|NCT00313911|17024689|P1|Overall Study|Did not meet age criteria|1
4949781|NCT00313911|17024688|P2|Overall Study|Withdrawal by Subject|12
4949782|NCT00313911|17024689|P1|Overall Study|Withdrawal by Subject|39
4949783|NCT00313911|17024688|P2|Overall Study|Lost to Follow-up|14
4949784|NCT00313911|17024689|P1|Overall Study|Lost to Follow-up|27
4949785|NCT00313911|17024688|P2|Overall Study|Protocol Violation|10
4949786|NCT00313911|17024689|P1|Overall Study|Protocol Violation|19
4949787|NCT00313911|17024688|P2|Overall Study|Adverse Event|3
4949788|NCT00313911|17024689|P1|Overall Study|Adverse Event|2
4949789|NCT00313911|17024688|P2|Overall Study|Serious adverse event|1
4949790|NCT00313911|17024689|P1|Overall Study|Serious adverse event|6
4949791|NCT00313846|17024703|P2|Overall Study|Administrative|3
4949792|NCT00313846|17024704|P1|Overall Study|Administrative|2
4949793|NCT00313846|17024703|P2|Overall Study|Adverse Event|8
4949794|NCT00313846|17024704|P1|Overall Study|Adverse Event|1
4949795|NCT00313846|17024703|P2|Overall Study|Withdrawal by Subject|0
4949796|NCT00313846|17024704|P1|Overall Study|Withdrawal by Subject|2
4949797|NCT00313820|17024715|P2|Pregabalin or Placebo Treatment Period|Other|3
4949798|NCT00313820|17024716|P1|Pregabalin or Placebo Treatment Period|Other|2
4949799|NCT00313820|17024715|P2|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4
4949800|NCT00313820|17024716|P1|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6
4949801|NCT00313820|17024715|P2|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7
4949802|NCT00313820|17024716|P1|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0
4949803|NCT00313820|17024715|P2|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1
4949804|NCT00313820|17024716|P1|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0
4949805|NCT00313820|17024715|P2|Pregabalin or Placebo Treatment Period|Adverse Event|4
4949806|NCT00313820|17024716|P1|Pregabalin or Placebo Treatment Period|Adverse Event|9
4949807|NCT00313820|17024715|P2|Assigned to Treatment|Other|0
4949808|NCT00313820|17024716|P1|Assigned to Treatment|Other|1
4949809|NCT00313781|17024754|P3|After Crossover|Other|18
4949810|NCT00313781|17024755|P2|After Crossover|Other|0
4949811|NCT00313781|17024756|P1|After Crossover|Other|0
4949812|NCT00313781|17024754|P3|After Crossover|Withdrawal by Subject|3
4949813|NCT00313781|17024755|P2|After Crossover|Withdrawal by Subject|0
4949814|NCT00313781|17024756|P1|After Crossover|Withdrawal by Subject|0
4949815|NCT00313781|17024754|P3|After Crossover|Death|6
4949816|NCT00313781|17024755|P2|After Crossover|Death|0
4949817|NCT00313781|17024756|P1|After Crossover|Death|0
4949818|NCT00313781|17024754|P3|Before Crossover|Randomized, not treated|0
4949819|NCT00313781|17024755|P2|Before Crossover|Randomized, not treated|0
4949820|NCT00313781|17024756|P1|Before Crossover|Randomized, not treated|5
4949821|NCT00313781|17024754|P3|Before Crossover|Crossover|0
4949822|NCT00313781|17024755|P2|Before Crossover|Crossover|37
4949823|NCT00313781|17024756|P1|Before Crossover|Crossover|0
4949824|NCT00313781|17024754|P3|Before Crossover|Other|0
4949825|NCT00313781|17024755|P2|Before Crossover|Other|30
4949826|NCT00313781|17024756|P1|Before Crossover|Other|45
4949827|NCT00313781|17024754|P3|Before Crossover|Withdrawal by Subject|0
4949828|NCT00313781|17024755|P2|Before Crossover|Withdrawal by Subject|1
4949829|NCT00313781|17024756|P1|Before Crossover|Withdrawal by Subject|3
4949830|NCT00313781|17024754|P3|Before Crossover|Lost to Follow-up|0
4949831|NCT00313781|17024755|P2|Before Crossover|Lost to Follow-up|3
4949832|NCT00313781|17024756|P1|Before Crossover|Lost to Follow-up|0
4949833|NCT00313781|17024754|P3|Before Crossover|Death|0
4949834|NCT00313781|17024755|P2|Before Crossover|Death|8
4949835|NCT00313781|17024756|P1|Before Crossover|Death|22
4949836|NCT00313716|17024802|P6|Overall Study|Withdrawal by Subject|0
4949837|NCT00313716|17024803|P5|Overall Study|Withdrawal by Subject|1
4949838|NCT00313716|17024804|P4|Overall Study|Withdrawal by Subject|0
4949839|NCT00313716|17024805|P3|Overall Study|Withdrawal by Subject|1
4949840|NCT00313716|17024806|P2|Overall Study|Withdrawal by Subject|1
4949841|NCT00313716|17024807|P1|Overall Study|Withdrawal by Subject|0
4949842|NCT00313716|17024802|P6|Overall Study|Lost to Follow-up|4
4949843|NCT00313716|17024803|P5|Overall Study|Lost to Follow-up|0
4949844|NCT00313716|17024804|P4|Overall Study|Lost to Follow-up|1
4949845|NCT00313716|17024805|P3|Overall Study|Lost to Follow-up|2
4949846|NCT00313716|17024806|P2|Overall Study|Lost to Follow-up|5
4949847|NCT00313716|17024807|P1|Overall Study|Lost to Follow-up|2
4949848|NCT00313716|17024802|P6|Overall Study|Death|9
4949849|NCT00313716|17024803|P5|Overall Study|Death|5
4949850|NCT00313716|17024804|P4|Overall Study|Death|3
4949851|NCT00313716|17024805|P3|Overall Study|Death|9
4949852|NCT00313716|17024806|P2|Overall Study|Death|2
4949853|NCT00313716|17024807|P1|Overall Study|Death|3
4949854|NCT00313703|17024834|P4|Overall Study|Lost to Follow-up|12
4949855|NCT00313703|17024835|P3|Overall Study|Lost to Follow-up|5
4949856|NCT00313703|17024836|P2|Overall Study|Lost to Follow-up|2
4949857|NCT00313703|17024837|P1|Overall Study|Lost to Follow-up|11
4949858|NCT00313612|17024853|P2|Overall Study|Patient never received treatment|1
4949859|NCT00313612|17024854|P1|Overall Study|Patient never received treatment|0
4949860|NCT00313586|17024866|P4|Overall Study|Death before starting treatment|0
4949861|NCT00313586|17024867|P3|Overall Study|Death before starting treatment|0
4949862|NCT00313586|17024868|P2|Overall Study|Death before starting treatment|0
4949863|NCT00313586|17024869|P1|Overall Study|Death before starting treatment|1
4949864|NCT00313586|17024866|P4|Overall Study|Moved|0
4949865|NCT00313586|17024867|P3|Overall Study|Moved|0
4949866|NCT00313586|17024868|P2|Overall Study|Moved|1
4949867|NCT00313586|17024869|P1|Overall Study|Moved|0
4949868|NCT00313586|17024866|P4|Overall Study|Lost insurance|0
4949869|NCT00313586|17024867|P3|Overall Study|Lost insurance|0
4949870|NCT00313586|17024868|P2|Overall Study|Lost insurance|1
4949871|NCT00313586|17024869|P1|Overall Study|Lost insurance|0
4949872|NCT00313586|17024866|P4|Overall Study|Absolute neutrophil count not recovered|0
4949873|NCT00313586|17024867|P3|Overall Study|Absolute neutrophil count not recovered|0
4949874|NCT00313586|17024868|P2|Overall Study|Absolute neutrophil count not recovered|1
4949875|NCT00313586|17024869|P1|Overall Study|Absolute neutrophil count not recovered|2
4949876|NCT00313586|17024866|P4|Overall Study|Physician Decision|0
4949877|NCT00313586|17024867|P3|Overall Study|Physician Decision|0
4949878|NCT00313586|17024868|P2|Overall Study|Physician Decision|1
4949879|NCT00313586|17024869|P1|Overall Study|Physician Decision|2
4949880|NCT00313586|17024866|P4|Overall Study|Did not achieve HI-major/better response|1
4949881|NCT00313586|17024867|P3|Overall Study|Did not achieve HI-major/better response|2
4949882|NCT00313586|17024868|P2|Overall Study|Did not achieve HI-major/better response|7
4949883|NCT00313586|17024869|P1|Overall Study|Did not achieve HI-major/better response|10
4949884|NCT00313586|17024866|P4|Overall Study|Other complicating disease|0
4949885|NCT00313586|17024867|P3|Overall Study|Other complicating disease|0
4949886|NCT00313586|17024868|P2|Overall Study|Other complicating disease|2
4949887|NCT00313586|17024869|P1|Overall Study|Other complicating disease|2
4949888|NCT00313586|17024866|P4|Overall Study|Alternative therapy|0
4949889|NCT00313586|17024867|P3|Overall Study|Alternative therapy|2
4949890|NCT00313586|17024868|P2|Overall Study|Alternative therapy|6
4949891|NCT00313586|17024869|P1|Overall Study|Alternative therapy|3
4949892|NCT00313586|17024866|P4|Overall Study|Withdrawal by Subject|2
4949893|NCT00313586|17024867|P3|Overall Study|Withdrawal by Subject|6
4949894|NCT00313586|17024868|P2|Overall Study|Withdrawal by Subject|6
4949895|NCT00313586|17024869|P1|Overall Study|Withdrawal by Subject|13
4949896|NCT00313586|17024866|P4|Overall Study|Death|7
4949897|NCT00313586|17024867|P3|Overall Study|Death|1
4949898|NCT00313586|17024868|P2|Overall Study|Death|8
4949899|NCT00313586|17024869|P1|Overall Study|Death|11
4949900|NCT00313586|17024866|P4|Overall Study|Adverse Event|10
4949901|NCT00313586|17024867|P3|Overall Study|Adverse Event|3
4949902|NCT00313586|17024868|P2|Overall Study|Adverse Event|18
4949903|NCT00313586|17024869|P1|Overall Study|Adverse Event|12
4949904|NCT00313586|17024866|P4|Overall Study|Disease progression|3
4949905|NCT00313586|17024867|P3|Overall Study|Disease progression|10
4949906|NCT00313586|17024868|P2|Overall Study|Disease progression|19
4949907|NCT00313586|17024869|P1|Overall Study|Disease progression|14
4949908|NCT00313313|17024897|P3|Overall Study|Subject No Longer Meets Study Criteria|2
4949909|NCT00313313|17024898|P2|Overall Study|Subject No Longer Meets Study Criteria|3
4949910|NCT00313313|17024899|P1|Overall Study|Subject No Longer Meets Study Criteria|0
4949911|NCT00313313|17024897|P3|Overall Study|Death|2
4949912|NCT00313313|17024898|P2|Overall Study|Death|0
4949913|NCT00313313|17024899|P1|Overall Study|Death|0
4949914|NCT00313313|17024897|P3|Overall Study|Pregnancy|0
4949915|NCT00313313|17024898|P2|Overall Study|Pregnancy|2
4949916|NCT00313313|17024899|P1|Overall Study|Pregnancy|1
4949917|NCT00313313|17024897|P3|Overall Study|Poor/Noncompliance|2
4949918|NCT00313313|17024898|P2|Overall Study|Poor/Noncompliance|6
4949919|NCT00313313|17024899|P1|Overall Study|Poor/Noncompliance|3
4949920|NCT00313313|17024897|P3|Overall Study|Physician Decision|4
4949921|NCT00313313|17024898|P2|Overall Study|Physician Decision|6
4949922|NCT00313313|17024899|P1|Overall Study|Physician Decision|2
4949923|NCT00313313|17024897|P3|Overall Study|Adverse Event|12
4949924|NCT00313313|17024898|P2|Overall Study|Adverse Event|16
4949925|NCT00313313|17024899|P1|Overall Study|Adverse Event|15
4949926|NCT00313313|17024897|P3|Overall Study|Lost to Follow-up|9
4949927|NCT00313313|17024898|P2|Overall Study|Lost to Follow-up|7
4949928|NCT00313313|17024899|P1|Overall Study|Lost to Follow-up|10
4949929|NCT00313313|17024897|P3|Overall Study|Withdrawal of consent by subject|31
4949930|NCT00313313|17024898|P2|Overall Study|Withdrawal of consent by subject|17
4949931|NCT00313313|17024899|P1|Overall Study|Withdrawal of consent by subject|18
4949932|NCT00313313|17024897|P3|Overall Study|Lack of Efficacy|20
4949933|NCT00313313|17024898|P2|Overall Study|Lack of Efficacy|9
4949934|NCT00313313|17024899|P1|Overall Study|Lack of Efficacy|14
4949935|NCT00313300|17024921|P5|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
4949936|NCT00313300|17024922|P4|Follow-Up(30days)-Randomized Phase B|missing end of study status|2
4949937|NCT00313300|17024923|P3|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
4949938|NCT00313300|17024924|P2|Follow-Up(30days)-Randomized Phase B|missing end of study status|0
4949939|NCT00313300|17024925|P1|Follow-Up(30days)-Randomized Phase B|missing end of study status|1
4949940|NCT00313300|17024921|P5|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1
4949941|NCT00313300|17024922|P4|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2
4949942|NCT00313300|17024923|P3|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
4949943|NCT00313300|17024924|P2|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
4949944|NCT00313300|17024925|P1|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0
4949945|NCT00313300|17024921|P5|Follow-Up(30days)-Randomized Phase B|Death|0
4949946|NCT00313300|17024922|P4|Follow-Up(30days)-Randomized Phase B|Death|0
4949947|NCT00313300|17024923|P3|Follow-Up(30days)-Randomized Phase B|Death|0
4949948|NCT00313300|17024924|P2|Follow-Up(30days)-Randomized Phase B|Death|0
4949949|NCT00313300|17024925|P1|Follow-Up(30days)-Randomized Phase B|Death|1
4949950|NCT00313300|17024921|P5|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
4949951|NCT00313300|17024922|P4|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
4949952|NCT00313300|17024923|P3|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2
4949953|NCT00313300|17024924|P2|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0
4949954|NCT00313300|17024925|P1|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1
4949955|NCT00313300|17024921|P5|Follow-Up(30days)-Randomized Phase A|Death|0
4949956|NCT00313300|17024922|P4|Follow-Up(30days)-Randomized Phase A|Death|0
4949957|NCT00313300|17024923|P3|Follow-Up(30days)-Randomized Phase A|Death|0
4949958|NCT00313300|17024924|P2|Follow-Up(30days)-Randomized Phase A|Death|1
4949959|NCT00313300|17024925|P1|Follow-Up(30days)-Randomized Phase A|Death|0
4949960|NCT00313300|17024921|P5|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
4949961|NCT00313300|17024922|P4|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0
4949962|NCT00313300|17024923|P3|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2
4949963|NCT00313300|17024924|P2|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
4949964|NCT00313300|17024925|P1|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5
4949965|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|non-specified|0
4949966|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|non-specified|0
4949967|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|non-specified|0
4949968|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|non-specified|0
4949969|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|non-specified|1
4949970|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164
4949971|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193
4949972|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0
4949973|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1
4949974|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2
4949975|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
4949976|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|no longer meets criteria|0
4949977|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|no longer meets criteria|2
4949978|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|no longer meets criteria|3
4949979|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|no longer meets criteria|9
4949980|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
4949981|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|poor/non-compliance|0
4949982|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
4949983|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|poor/non-compliance|1
4949984|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|poor/non-compliance|3
4949985|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
4949986|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
4949987|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3
4949988|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2
4949989|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5
4949990|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|Death|1
4949991|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|Death|0
4949992|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|Death|1
4949993|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|Death|3
4949994|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|Death|5
4949995|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
4949996|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15
4949997|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19
4949998|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14
4949999|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35
4950000|NCT00313300|17024921|P5|Randomized in Phase B (26 Weeks)|Adverse Event|19
4950001|NCT00313300|17024922|P4|Randomized in Phase B (26 Weeks)|Adverse Event|23
4950002|NCT00313300|17024923|P3|Randomized in Phase B (26 Weeks)|Adverse Event|12
4950003|NCT00313300|17024924|P2|Randomized in Phase B (26 Weeks)|Adverse Event|9
4950004|NCT00313300|17024925|P1|Randomized in Phase B (26 Weeks)|Adverse Event|34
4950005|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4950006|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4950007|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4950008|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0
4950009|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1
4950010|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
4950011|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|no longer meets criteria|0
4950012|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|no longer meets criteria|2
4950013|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|no longer meets criteria|3
4950014|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|no longer meets criteria|4
4950015|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
4950016|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0
4950017|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1
4950018|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2
4950019|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3
4950020|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
4950021|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0
4950022|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2
4950023|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
4950024|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4
4950025|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|Death|0
4950026|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|Death|0
4950027|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|Death|0
4950028|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|Death|4
4950029|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|Death|3
4950030|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
4950031|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0
4950032|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13
4950033|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12
4950034|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20
4950035|NCT00313300|17024921|P5|Randomized in Phase A (26 Weeks)|Adverse Event|0
4950036|NCT00313300|17024922|P4|Randomized in Phase A (26 Weeks)|Adverse Event|0
4950037|NCT00313300|17024923|P3|Randomized in Phase A (26 Weeks)|Adverse Event|17
4950038|NCT00313300|17024924|P2|Randomized in Phase A (26 Weeks)|Adverse Event|14
4950039|NCT00313300|17024925|P1|Randomized in Phase A (26 Weeks)|Adverse Event|19
4950040|NCT00313170|17024995|P3|Overall Study|Progression (investigators opinion)|0
4950041|NCT00313170|17024996|P2|Overall Study|Progression (investigators opinion)|0
4950042|NCT00313170|17024997|P1|Overall Study|Progression (investigators opinion)|1
4950043|NCT00313170|17024995|P3|Overall Study|Lost to Follow-up|1
4950044|NCT00313170|17024996|P2|Overall Study|Lost to Follow-up|0
4950045|NCT00313170|17024997|P1|Overall Study|Lost to Follow-up|0
4950046|NCT00313170|17024995|P3|Overall Study|Incorrect enrollment|1
4950047|NCT00313170|17024996|P2|Overall Study|Incorrect enrollment|2
4950048|NCT00313170|17024997|P1|Overall Study|Incorrect enrollment|0
4950049|NCT00313170|17024995|P3|Overall Study|Withdrawal by Subject|1
4950050|NCT00313170|17024996|P2|Overall Study|Withdrawal by Subject|0
4950051|NCT00313170|17024997|P1|Overall Study|Withdrawal by Subject|1
4950052|NCT00313170|17024995|P3|Overall Study|Disease progression|27
4950053|NCT00313170|17024996|P2|Overall Study|Disease progression|26
4950054|NCT00313170|17024997|P1|Overall Study|Disease progression|31
4950055|NCT00313170|17024995|P3|Overall Study|Adverse Event|0
4950056|NCT00313170|17024996|P2|Overall Study|Adverse Event|2
4950057|NCT00313170|17024997|P1|Overall Study|Adverse Event|1
4950058|NCT00313170|17024995|P3|Overall Study|Death|2
4950059|NCT00313170|17024996|P2|Overall Study|Death|4
4950060|NCT00313170|17024997|P1|Overall Study|Death|2
4950061|NCT00313144|17025016|P1|Overall Study|Due to termination of the study|66
4950062|NCT00313144|17025016|P1|Overall Study|Change to different product|1
4950063|NCT00313144|17025016|P1|Overall Study|Insurance (homecare provider) change|1
4950064|NCT00313144|17025016|P1|Overall Study|Liver transplant|1
4950065|NCT00313144|17025016|P1|Overall Study|Adverse event - transient|5
4950066|NCT00313144|17025016|P1|Overall Study|Physician Decision|4
4950067|NCT00313144|17025016|P1|Overall Study|Terminated by sponsor/ homecare provider|4
4950068|NCT00313144|17025016|P1|Overall Study|Withdrawal by Subject|4
4950069|NCT00313144|17025016|P1|Overall Study|Lost to Follow-up|5
4950070|NCT00313144|17025016|P1|Overall Study|Death|7
4950071|NCT00313144|17025016|P1|Overall Study|Discontinue Aralast ≥4 consecutive doses|12
4950072|NCT00313014|17025103|P3|Overall Study|Lack of Efficacy|16
4950073|NCT00313014|17025104|P2|Overall Study|Lack of Efficacy|25
4950074|NCT00313014|17025105|P1|Overall Study|Lack of Efficacy|52
4950075|NCT00313014|17025103|P3|Overall Study|Administrative|14
4950076|NCT00313014|17025104|P2|Overall Study|Administrative|6
4950077|NCT00313014|17025105|P1|Overall Study|Administrative|9
4950078|NCT00313014|17025103|P3|Overall Study|Lost to Follow-up|10
4950079|NCT00313014|17025104|P2|Overall Study|Lost to Follow-up|6
4950080|NCT00313014|17025105|P1|Overall Study|Lost to Follow-up|7
4950081|NCT00313014|17025103|P3|Overall Study|Adverse Event|16
4950082|NCT00313014|17025104|P2|Overall Study|Adverse Event|29
4950083|NCT00313014|17025105|P1|Overall Study|Adverse Event|14
4950084|NCT00313014|17025103|P3|Overall Study|Withdrawal by Subject|5
4950085|NCT00313014|17025104|P2|Overall Study|Withdrawal by Subject|7
4950086|NCT00313014|17025105|P1|Overall Study|Withdrawal by Subject|11
4950087|NCT00312897|17025136|P2|Overall Study|discontinued prior to getting treatment|3
4950088|NCT00312897|17025137|P1|Overall Study|discontinued prior to getting treatment|0
4950089|NCT00312897|17025136|P2|Overall Study|Pregnancy|0
4950090|NCT00312897|17025137|P1|Overall Study|Pregnancy|1
4950091|NCT00312897|17025136|P2|Overall Study|Withdrawal by Subject|3
4950092|NCT00312897|17025137|P1|Overall Study|Withdrawal by Subject|1
4950093|NCT00312897|17025136|P2|Overall Study|Physician Decision|0
4950094|NCT00312897|17025137|P1|Overall Study|Physician Decision|1
4950095|NCT00312897|17025136|P2|Overall Study|Lost to Follow-up|0
4950096|NCT00312897|17025137|P1|Overall Study|Lost to Follow-up|2
4950097|NCT00312897|17025136|P2|Overall Study|Adverse Event|0
4950098|NCT00312897|17025137|P1|Overall Study|Adverse Event|1
4950099|NCT00312858|17025162|P2|Overall Study|Other|12
4950100|NCT00312858|17025163|P1|Overall Study|Other|9
4950101|NCT00312858|17025162|P2|Overall Study|Participant Moved|10
4950102|NCT00312858|17025163|P1|Overall Study|Participant Moved|11
4950103|NCT00312858|17025162|P2|Overall Study|Withdraw by Participant|20
4950104|NCT00312858|17025163|P1|Overall Study|Withdraw by Participant|20
4950105|NCT00312858|17025162|P2|Overall Study|Protocol Violation|8
4950106|NCT00312858|17025163|P1|Overall Study|Protocol Violation|3
4950107|NCT00312858|17025162|P2|Overall Study|Lost to Follow-up|42
4950108|NCT00312858|17025163|P1|Overall Study|Lost to Follow-up|25
4950109|NCT00312858|17025162|P2|Overall Study|Adverse Event|1
4950110|NCT00312858|17025163|P1|Overall Study|Adverse Event|0
4950111|NCT00312845|17025217|P2|Overall Study|Other|5
4950112|NCT00312845|17025218|P1|Overall Study|Other|6
4950113|NCT00312845|17025217|P2|Overall Study|Lost to Follow-up|0
4950114|NCT00312845|17025218|P1|Overall Study|Lost to Follow-up|2
4950115|NCT00312845|17025217|P2|Overall Study|Disease Progression|77
4950116|NCT00312845|17025218|P1|Overall Study|Disease Progression|56
4950117|NCT00312845|17025217|P2|Overall Study|Withdrawal by Subject|6
4950118|NCT00312845|17025218|P1|Overall Study|Withdrawal by Subject|14
4950119|NCT00312845|17025217|P2|Overall Study|Death|2
4950120|NCT00312845|17025218|P1|Overall Study|Death|2
4950121|NCT00312845|17025217|P2|Overall Study|Adverse Event|5
4950122|NCT00312845|17025218|P1|Overall Study|Adverse Event|19
4950123|NCT00312728|17025226|P1|Overall Study|Other|1
4950124|NCT00312728|17025226|P1|Overall Study|Other|10
4950125|NCT00312728|17025226|P1|Overall Study|Protocol Violation|2
4950126|NCT00312728|17025226|P1|Overall Study|Required non-protocol cancer treatment|2
4950127|NCT00312728|17025226|P1|Overall Study|Withdrawal by Subject|10
4950128|NCT00312728|17025226|P1|Overall Study|Adverse Event|32
4950129|NCT00312728|17025226|P1|Overall Study|Progressive disease|53
4950130|NCT00312702|17025238|P3|Immunization Phase|Lost to Follow-up|0
4950131|NCT00312702|17025239|P2|Immunization Phase|Lost to Follow-up|1
4950132|NCT00312702|17025240|P1|Immunization Phase|Lost to Follow-up|0
4950133|NCT00312663|17025253|P3|Immunization Phase|Adverse Event|0
4950134|NCT00312663|17025254|P2|Immunization Phase|Adverse Event|1
4950135|NCT00312663|17025255|P1|Immunization Phase|Adverse Event|0
4950136|NCT00312572|17025268|P2|Overall Study|Lack of Efficacy|2
4950137|NCT00312572|17025269|P1|Overall Study|Lack of Efficacy|1
4950138|NCT00312572|17025268|P2|Overall Study|Administrative|2
4950139|NCT00312572|17025269|P1|Overall Study|Administrative|4
4950140|NCT00312572|17025268|P2|Overall Study|Lost to Follow-up|1
4950141|NCT00312572|17025269|P1|Overall Study|Lost to Follow-up|1
4950142|NCT00312572|17025268|P2|Overall Study|Adverse Event|16
4950143|NCT00312572|17025269|P1|Overall Study|Adverse Event|10
4950144|NCT00312494|17025280|P3|Overall Study|Other|1
4950145|NCT00312494|17025281|P2|Overall Study|Other|10
4950146|NCT00312494|17025282|P1|Overall Study|Other|10
4950147|NCT00312494|17025280|P3|Overall Study|Withdrawal by Subject|10
4950148|NCT00312494|17025281|P2|Overall Study|Withdrawal by Subject|9
4950149|NCT00312494|17025282|P1|Overall Study|Withdrawal by Subject|6
4950150|NCT00312494|17025280|P3|Overall Study|Lost to Follow-up|8
4950151|NCT00312494|17025281|P2|Overall Study|Lost to Follow-up|8
4950152|NCT00312494|17025282|P1|Overall Study|Lost to Follow-up|8
4950153|NCT00312494|17025280|P3|Overall Study|Laboratory abnormality|0
4950154|NCT00312494|17025281|P2|Overall Study|Laboratory abnormality|0
4950155|NCT00312494|17025282|P1|Overall Study|Laboratory abnormality|1
4950156|NCT00312494|17025280|P3|Overall Study|Lack of Efficacy|8
4950157|NCT00312494|17025281|P2|Overall Study|Lack of Efficacy|6
4950158|NCT00312494|17025282|P1|Overall Study|Lack of Efficacy|4
4950159|NCT00312494|17025280|P3|Overall Study|Adverse Event|11
4950160|NCT00312494|17025281|P2|Overall Study|Adverse Event|15
4950161|NCT00312494|17025282|P1|Overall Study|Adverse Event|33
4950162|NCT00312494|17025280|P3|Overall Study|Randomized; not treated with study drug|5
4950163|NCT00312494|17025281|P2|Overall Study|Randomized; not treated with study drug|10
4950164|NCT00312494|17025282|P1|Overall Study|Randomized; not treated with study drug|9
4950165|NCT00312377|17025316|P2|Overall Study|Site ended participation in study|0
4950166|NCT00312377|17025317|P1|Overall Study|Site ended participation in study|1
4950167|NCT00312377|17025316|P2|Overall Study|Discontinue treatment survival follow up|200
4950168|NCT00312377|17025317|P1|Overall Study|Discontinue treatment survival follow up|202
4950169|NCT00312377|17025316|P2|Overall Study|Randomised but never received treatment|6
4950170|NCT00312377|17025317|P1|Overall Study|Randomised but never received treatment|6
4950171|NCT00312377|17025316|P2|Overall Study|Non-compliance|2
4950172|NCT00312377|17025317|P1|Overall Study|Non-compliance|0
4950173|NCT00312377|17025316|P2|Overall Study|Lost to Follow-up|12
4950174|NCT00312377|17025317|P1|Overall Study|Lost to Follow-up|9
4950175|NCT00312377|17025316|P2|Overall Study|Withdrawal by Subject|30
4950176|NCT00312377|17025317|P1|Overall Study|Withdrawal by Subject|23
4950177|NCT00312377|17025316|P2|Overall Study|Death|418
4950178|NCT00312377|17025317|P1|Overall Study|Death|403
4950179|NCT00312338|17025341|P2|Overall Study|Subsequent infection|0
4950180|NCT00312338|17025342|P1|Overall Study|Subsequent infection|2
4950181|NCT00312338|17025341|P2|Overall Study|Withdrawal by Subject|0
4950182|NCT00312338|17025342|P1|Overall Study|Withdrawal by Subject|4
4950183|NCT00312338|17025341|P2|Overall Study|Lost to Follow-up|1
4950184|NCT00312338|17025342|P1|Overall Study|Lost to Follow-up|9
4950185|NCT00312338|17025341|P2|Overall Study|Adverse Event|2
4950186|NCT00312338|17025342|P1|Overall Study|Adverse Event|7
4950187|NCT00312221|17025355|P4|Double-blind Phase|Lack of Efficacy|10
4950188|NCT00312221|17025356|P3|Double-blind Phase|Lack of Efficacy|6
4950189|NCT00312221|17025357|P2|Double-blind Phase|Lack of Efficacy|17
4950190|NCT00312221|17025358|P1|Double-blind Phase|Lack of Efficacy|0
4950191|NCT00312221|17025355|P4|Double-blind Phase|Administrative|33
4950192|NCT00312221|17025356|P3|Double-blind Phase|Administrative|37
4950193|NCT00312221|17025357|P2|Double-blind Phase|Administrative|26
4950194|NCT00312221|17025358|P1|Double-blind Phase|Administrative|0
4950195|NCT00312221|17025355|P4|Double-blind Phase|Lost to Follow-up|2
4950196|NCT00312221|17025356|P3|Double-blind Phase|Lost to Follow-up|2
4950197|NCT00312221|17025357|P2|Double-blind Phase|Lost to Follow-up|0
4950198|NCT00312221|17025358|P1|Double-blind Phase|Lost to Follow-up|0
4950199|NCT00312221|17025355|P4|Double-blind Phase|Adverse Event|18
4950200|NCT00312221|17025356|P3|Double-blind Phase|Adverse Event|19
4950201|NCT00312221|17025357|P2|Double-blind Phase|Adverse Event|10
4950202|NCT00312221|17025358|P1|Double-blind Phase|Adverse Event|0
4950203|NCT00312221|17025355|P4|Double-blind Phase|Withdrawal by Subject|7
4950204|NCT00312221|17025356|P3|Double-blind Phase|Withdrawal by Subject|8
4950205|NCT00312221|17025357|P2|Double-blind Phase|Withdrawal by Subject|6
4950206|NCT00312221|17025358|P1|Double-blind Phase|Withdrawal by Subject|0
4950207|NCT00312221|17025355|P4|Open-label Run-in Period|Did not qualify|0
4950208|NCT00312221|17025356|P3|Open-label Run-in Period|Did not qualify|0
4950209|NCT00312221|17025357|P2|Open-label Run-in Period|Did not qualify|0
4950210|NCT00312221|17025358|P1|Open-label Run-in Period|Did not qualify|5
4950211|NCT00312221|17025355|P4|Open-label Run-in Period|Lack of Efficacy|0
4950212|NCT00312221|17025356|P3|Open-label Run-in Period|Lack of Efficacy|0
4950213|NCT00312221|17025357|P2|Open-label Run-in Period|Lack of Efficacy|0
4950214|NCT00312221|17025358|P1|Open-label Run-in Period|Lack of Efficacy|102
4950215|NCT00312221|17025355|P4|Open-label Run-in Period|Administrative|0
4950216|NCT00312221|17025356|P3|Open-label Run-in Period|Administrative|0
4950217|NCT00312221|17025357|P2|Open-label Run-in Period|Administrative|0
4950218|NCT00312221|17025358|P1|Open-label Run-in Period|Administrative|42
4950219|NCT00312221|17025355|P4|Open-label Run-in Period|Lost to Follow-up|0
4950220|NCT00312221|17025356|P3|Open-label Run-in Period|Lost to Follow-up|0
4950221|NCT00312221|17025357|P2|Open-label Run-in Period|Lost to Follow-up|0
4950222|NCT00312221|17025358|P1|Open-label Run-in Period|Lost to Follow-up|5
4950223|NCT00312221|17025355|P4|Open-label Run-in Period|Adverse Event|0
4950224|NCT00312221|17025356|P3|Open-label Run-in Period|Adverse Event|0
4950225|NCT00312221|17025357|P2|Open-label Run-in Period|Adverse Event|0
4950226|NCT00312221|17025358|P1|Open-label Run-in Period|Adverse Event|74
4950227|NCT00312221|17025355|P4|Open-label Run-in Period|Withdrawal by Subject|0
4950228|NCT00312221|17025356|P3|Open-label Run-in Period|Withdrawal by Subject|0
4950229|NCT00312221|17025357|P2|Open-label Run-in Period|Withdrawal by Subject|0
4950230|NCT00312221|17025358|P1|Open-label Run-in Period|Withdrawal by Subject|6
4950231|NCT00312208|17025378|P2|Overall Study|Other|7
4950232|NCT00312208|17025379|P1|Overall Study|Other|5
4950233|NCT00312208|17025378|P2|Overall Study|Withdrawal by Subject|42
4950234|NCT00312208|17025379|P1|Overall Study|Withdrawal by Subject|53
4950235|NCT00312208|17025378|P2|Overall Study|Lost to Follow-up|5
4950236|NCT00312208|17025379|P1|Overall Study|Lost to Follow-up|3
4950237|NCT00312208|17025378|P2|Overall Study|Lack of Efficacy|4
4950238|NCT00312208|17025379|P1|Overall Study|Lack of Efficacy|7
4950239|NCT00312208|17025378|P2|Overall Study|Death|1
4950240|NCT00312208|17025379|P1|Overall Study|Death|2
4950241|NCT00312208|17025378|P2|Overall Study|Protocol Violation|3
4950242|NCT00312208|17025379|P1|Overall Study|Protocol Violation|5
4950243|NCT00312208|17025378|P2|Overall Study|Adverse Event|61
4950244|NCT00312208|17025379|P1|Overall Study|Adverse Event|97
4950245|NCT00312195|17025389|P2|Overall Study|Protocol Violation|0
4950246|NCT00312195|17025390|P1|Overall Study|Protocol Violation|1
4950247|NCT00312195|17025389|P2|Overall Study|Lost to Follow-up|0
4950248|NCT00312195|17025390|P1|Overall Study|Lost to Follow-up|1
4950249|NCT00312195|17025389|P2|Overall Study|Adverse Event|6
4950250|NCT00312195|17025390|P1|Overall Study|Adverse Event|4
4950251|NCT00311623|17025418|P3|Overall Study|Physician Decision|2
4950252|NCT00311623|17025419|P2|Overall Study|Physician Decision|0
4950253|NCT00311623|17025420|P1|Overall Study|Physician Decision|0
4950254|NCT00311584|17025462|P2|Overall Study|ineligible|2
4950255|NCT00311584|17025463|P1|Overall Study|ineligible|2
4950256|NCT00311584|17025462|P2|Overall Study|Withdrawal by Subject|1
4950257|NCT00311584|17025463|P1|Overall Study|Withdrawal by Subject|1
4950258|NCT00311584|17025462|P2|Overall Study|Physician Decision|5
4950259|NCT00311584|17025463|P1|Overall Study|Physician Decision|4
4950260|NCT00311584|17025462|P2|Overall Study|Lack of Efficacy|15
4950261|NCT00311584|17025463|P1|Overall Study|Lack of Efficacy|12
4950262|NCT00311584|17025462|P2|Overall Study|Death|0
4950263|NCT00311584|17025463|P1|Overall Study|Death|1
4950264|NCT00311402|17025471|P2|Overall Study|IRB's rejection etc.|3
4950265|NCT00311402|17025472|P1|Overall Study|IRB's rejection etc.|10
4950266|NCT00311402|17025471|P2|Overall Study|Protocol Violation|6
4950267|NCT00311402|17025472|P1|Overall Study|Protocol Violation|7
4950268|NCT00311402|17025471|P2|Overall Study|Lack of Efficacy|42
4950269|NCT00311402|17025472|P1|Overall Study|Lack of Efficacy|58
4950270|NCT00311402|17025471|P2|Overall Study|Withdrawal by Subject|18
4950271|NCT00311402|17025472|P1|Overall Study|Withdrawal by Subject|17
4950272|NCT00311402|17025471|P2|Overall Study|Lost to Follow-up|3
4950273|NCT00311402|17025472|P1|Overall Study|Lost to Follow-up|0
4950274|NCT00311402|17025471|P2|Overall Study|Adverse Event|105
4950275|NCT00311402|17025472|P1|Overall Study|Adverse Event|118
4950276|NCT00311363|17025521|P3|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
4950277|NCT00311363|17025522|P2|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1
4950278|NCT00311363|17025523|P1|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0
4950279|NCT00311363|17025521|P3|12-Week Double-Blind Treatment Period|Protocol Violation|2
4950280|NCT00311363|17025522|P2|12-Week Double-Blind Treatment Period|Protocol Violation|1
4950281|NCT00311363|17025523|P1|12-Week Double-Blind Treatment Period|Protocol Violation|0
4950282|NCT00311363|17025521|P3|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4
4950283|NCT00311363|17025522|P2|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2
4950284|NCT00311363|17025523|P1|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0
4950285|NCT00311363|17025521|P3|12-Week Double-Blind Treatment Period|Lack of Efficacy|4
4950286|NCT00311363|17025522|P2|12-Week Double-Blind Treatment Period|Lack of Efficacy|6
4950287|NCT00311363|17025523|P1|12-Week Double-Blind Treatment Period|Lack of Efficacy|0
4950288|NCT00311363|17025521|P3|12-Week Double-Blind Treatment Period|Lost to Follow-up|2
4950289|NCT00311363|17025522|P2|12-Week Double-Blind Treatment Period|Lost to Follow-up|1
4950290|NCT00311363|17025523|P1|12-Week Double-Blind Treatment Period|Lost to Follow-up|0
4950291|NCT00311363|17025521|P3|12-Week Double-Blind Treatment Period|Adverse Event|0
4950292|NCT00311363|17025522|P2|12-Week Double-Blind Treatment Period|Adverse Event|3
4950293|NCT00311363|17025523|P1|12-Week Double-Blind Treatment Period|Adverse Event|0
4950294|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Death|0
4950295|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Death|0
4950296|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Death|1
4950297|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Pregnancy|0
4950298|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Pregnancy|0
4950299|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Pregnancy|1
4950300|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
4950301|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0
4950302|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1
4950303|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Elective Surgery|0
4950304|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Elective Surgery|0
4950305|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Elective Surgery|1
4950306|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Protocol Violation|0
4950307|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Protocol Violation|0
4950308|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Protocol Violation|8
4950309|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
4950310|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Lost to Follow-up|0
4950311|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Lost to Follow-up|12
4950312|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
4950313|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0
4950314|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27
4950315|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
4950316|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Lack of Efficacy|0
4950317|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Lack of Efficacy|13
4950318|NCT00311363|17025521|P3|24-Week Single-Blind Treatment Period|Adverse Event|0
4950319|NCT00311363|17025522|P2|24-Week Single-Blind Treatment Period|Adverse Event|0
4950320|NCT00311363|17025523|P1|24-Week Single-Blind Treatment Period|Adverse Event|42
4950321|NCT00311311|17025583|P2|Overall Study|Lack of ancillary assistance|1
4950322|NCT00311311|17025584|P1|Overall Study|Lack of ancillary assistance|0
4950323|NCT00311311|17025583|P2|Overall Study|Death|0
4950324|NCT00311311|17025584|P1|Overall Study|Death|1
4950325|NCT00311311|17025583|P2|Overall Study|Study Termination by Sponsor|4
4950326|NCT00311311|17025584|P1|Overall Study|Study Termination by Sponsor|3
4950327|NCT00311311|17025583|P2|Overall Study|Noncompliance|1
4950328|NCT00311311|17025584|P1|Overall Study|Noncompliance|0
4950329|NCT00311311|17025583|P2|Overall Study|Withdrawal by Subject|1
4950330|NCT00311311|17025584|P1|Overall Study|Withdrawal by Subject|1
4950331|NCT00311311|17025583|P2|Overall Study|Adverse Event|2
4950332|NCT00311311|17025584|P1|Overall Study|Adverse Event|3
4950333|NCT00311181|17025642|P1|Overall Study|Final DFTs were not obtained|96
4950334|NCT00311155|17025648|P1|Overall Study|Did not meet entry criteria|55
4950335|NCT00311155|17025648|P1|Overall Study|Withdrawal by Subject|17
4950336|NCT00311155|17025648|P1|Overall Study|Adverse Event|21
4950337|NCT00310856|17025660|P3|Overall Study|Unable to classify|0
4950338|NCT00310856|17025661|P2|Overall Study|Unable to classify|0
4950339|NCT00310856|17025662|P1|Overall Study|Unable to classify|1
4950340|NCT00310856|17025660|P3|Overall Study|Inappropriate enrollment|0
4950341|NCT00310856|17025661|P2|Overall Study|Inappropriate enrollment|1
4950342|NCT00310856|17025662|P1|Overall Study|Inappropriate enrollment|1
4950343|NCT00310856|17025660|P3|Overall Study|Lost to Follow-up|6
4950344|NCT00310856|17025661|P2|Overall Study|Lost to Follow-up|2
4950345|NCT00310856|17025662|P1|Overall Study|Lost to Follow-up|1
4950346|NCT00310856|17025660|P3|Overall Study|Withdrawal by Subject|2
4950347|NCT00310856|17025661|P2|Overall Study|Withdrawal by Subject|2
4950348|NCT00310856|17025662|P1|Overall Study|Withdrawal by Subject|2
4950349|NCT00310817|17025686|P4|Overall Study|Unable to classify|0
4950350|NCT00310817|17025687|P3|Overall Study|Unable to classify|0
4950351|NCT00310817|17025688|P2|Overall Study|Unable to classify|1
4950352|NCT00310817|17025689|P1|Overall Study|Unable to classify|3
4950353|NCT00310817|17025686|P4|Overall Study|Protocol Violation|1
4950354|NCT00310817|17025687|P3|Overall Study|Protocol Violation|1
4950355|NCT00310817|17025688|P2|Overall Study|Protocol Violation|1
4950356|NCT00310817|17025689|P1|Overall Study|Protocol Violation|1
4950357|NCT00310817|17025686|P4|Overall Study|Inappropriate Enrollment|0
4950358|NCT00310817|17025687|P3|Overall Study|Inappropriate Enrollment|1
4950359|NCT00310817|17025688|P2|Overall Study|Inappropriate Enrollment|0
4950360|NCT00310817|17025689|P1|Overall Study|Inappropriate Enrollment|1
4950361|NCT00310817|17025686|P4|Overall Study|Lost to Follow-up|0
4950362|NCT00310817|17025687|P3|Overall Study|Lost to Follow-up|0
4950363|NCT00310817|17025688|P2|Overall Study|Lost to Follow-up|1
4950364|NCT00310817|17025689|P1|Overall Study|Lost to Follow-up|2
4950365|NCT00310817|17025686|P4|Overall Study|Withdrawal by Subject|7
4950366|NCT00310817|17025687|P3|Overall Study|Withdrawal by Subject|6
4950367|NCT00310817|17025688|P2|Overall Study|Withdrawal by Subject|4
4950368|NCT00310817|17025689|P1|Overall Study|Withdrawal by Subject|1
4950369|NCT00310817|17025686|P4|Overall Study|AE or Death|0
4950370|NCT00310817|17025687|P3|Overall Study|AE or Death|0
4950371|NCT00310817|17025688|P2|Overall Study|AE or Death|1
4950372|NCT00310817|17025689|P1|Overall Study|AE or Death|3
4950373|NCT00310804|17025777|P2|Overall Study|Withdrawal by Subject|0
4950374|NCT00310804|17025778|P1|Overall Study|Withdrawal by Subject|3
4950375|NCT00310804|17025777|P2|Overall Study|Lost to Follow-up|0
4950376|NCT00310804|17025778|P1|Overall Study|Lost to Follow-up|2
4950377|NCT00310440|17025837|P2|Overall Study|Missed 12 Month Visit|4
4950378|NCT00310440|17025838|P1|Overall Study|Missed 12 Month Visit|7
4950379|NCT00310440|17025837|P2|Overall Study|Withdrawal by Subject|1
4950380|NCT00310440|17025838|P1|Overall Study|Withdrawal by Subject|2
4950381|NCT00310440|17025837|P2|Overall Study|Lost to Follow-up|8
4950382|NCT00310440|17025838|P1|Overall Study|Lost to Follow-up|17
4950383|NCT00310388|17025902|P2|Safety Follow-up Continuation Phase|Study Closed/Terminated|2
4950384|NCT00310388|17025903|P1|Safety Follow-up Continuation Phase|Study Closed/Terminated|0
4950385|NCT00310388|17025902|P2|Safety Follow-up Continuation Phase|Withdrawal by Subject|5
4950386|NCT00310388|17025903|P1|Safety Follow-up Continuation Phase|Withdrawal by Subject|0
4950387|NCT00310388|17025902|P2|Safety Follow-up Continuation Phase|Adverse Event|1
4950388|NCT00310388|17025903|P1|Safety Follow-up Continuation Phase|Adverse Event|0
4950389|NCT00310388|17025902|P2|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5
4950390|NCT00310388|17025903|P1|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0
4950391|NCT00310388|17025902|P2|Primary Reporting Phase|Other|0
4950392|NCT00310388|17025903|P1|Primary Reporting Phase|Other|1
4950393|NCT00310388|17025902|P2|Primary Reporting Phase|Missing|0
4950394|NCT00310388|17025903|P1|Primary Reporting Phase|Missing|1
4950395|NCT00310388|17025902|P2|Primary Reporting Phase|Participant retired the informed consent|0
4950396|NCT00310388|17025903|P1|Primary Reporting Phase|Participant retired the informed consent|1
4950397|NCT00310388|17025902|P2|Primary Reporting Phase|Participant passed away|0
4950398|NCT00310388|17025903|P1|Primary Reporting Phase|Participant passed away|1
4950399|NCT00310388|17025902|P2|Primary Reporting Phase|Due to pigmentation risk concerns|0
4950400|NCT00310388|17025903|P1|Primary Reporting Phase|Due to pigmentation risk concerns|2
4950401|NCT00310388|17025902|P2|Primary Reporting Phase|Ongoing SAE from parent study|0
4950402|NCT00310388|17025903|P1|Primary Reporting Phase|Ongoing SAE from parent study|1
4950403|NCT00310388|17025902|P2|Primary Reporting Phase|Termination of study at sponsor request|0
4950404|NCT00310388|17025903|P1|Primary Reporting Phase|Termination of study at sponsor request|3
4950405|NCT00310388|17025902|P2|Primary Reporting Phase|Participant Immigrated to New Zealand|0
4950406|NCT00310388|17025903|P1|Primary Reporting Phase|Participant Immigrated to New Zealand|1
4950407|NCT00310388|17025902|P2|Primary Reporting Phase|Discontinuation of study|0
4950408|NCT00310388|17025903|P1|Primary Reporting Phase|Discontinuation of study|1
4950409|NCT00310388|17025902|P2|Primary Reporting Phase|Ministry of Health decision|0
4950410|NCT00310388|17025903|P1|Primary Reporting Phase|Ministry of Health decision|25
4950411|NCT00310388|17025902|P2|Primary Reporting Phase|Participant request|0
4950412|NCT00310388|17025903|P1|Primary Reporting Phase|Participant request|2
4950413|NCT00310388|17025902|P2|Primary Reporting Phase|Participant request unrelated to study|0
4950414|NCT00310388|17025903|P1|Primary Reporting Phase|Participant request unrelated to study|2
4950415|NCT00310388|17025902|P2|Primary Reporting Phase|Failed to return|0
4950416|NCT00310388|17025903|P1|Primary Reporting Phase|Failed to return|8
4950417|NCT00310388|17025902|P2|Primary Reporting Phase|Request of the sponsor|0
4950418|NCT00310388|17025903|P1|Primary Reporting Phase|Request of the sponsor|19
4950419|NCT00310388|17025902|P2|Primary Reporting Phase|Physician Decision|0
4950420|NCT00310388|17025903|P1|Primary Reporting Phase|Physician Decision|2
4950421|NCT00310388|17025902|P2|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0
4950422|NCT00310388|17025903|P1|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3
4950423|NCT00310388|17025902|P2|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0
4950424|NCT00310388|17025903|P1|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3
4950425|NCT00310388|17025902|P2|Primary Reporting Phase|Change in participant medical condition|0
4950426|NCT00310388|17025903|P1|Primary Reporting Phase|Change in participant medical condition|3
4950427|NCT00310388|17025902|P2|Primary Reporting Phase|Pregnancy|0
4950428|NCT00310388|17025903|P1|Primary Reporting Phase|Pregnancy|3
4950429|NCT00310388|17025902|P2|Primary Reporting Phase|Protocol Violation|0
4950430|NCT00310388|17025903|P1|Primary Reporting Phase|Protocol Violation|10
4950431|NCT00310388|17025902|P2|Primary Reporting Phase|Withdrawal by Subject|0
4950432|NCT00310388|17025903|P1|Primary Reporting Phase|Withdrawal by Subject|97
4950433|NCT00310388|17025902|P2|Primary Reporting Phase|Lack of Efficacy|0
4950434|NCT00310388|17025903|P1|Primary Reporting Phase|Lack of Efficacy|56
4950435|NCT00310388|17025902|P2|Primary Reporting Phase|Adverse Event|0
4950436|NCT00310388|17025903|P1|Primary Reporting Phase|Adverse Event|101
4950437|NCT00310375|17025945|P3|Safety Follow-up Continuation Phase|Lost to Follow-up|1
4950438|NCT00310375|17025946|P2|Safety Follow-up Continuation Phase|Lost to Follow-up|0
4950439|NCT00310375|17025947|P1|Safety Follow-up Continuation Phase|Lost to Follow-up|0
4950440|NCT00310375|17025945|P3|Primary Reporting Phase|Request of Ethics Committee|0
4950441|NCT00310375|17025946|P2|Primary Reporting Phase|Request of Ethics Committee|1
4950442|NCT00310375|17025947|P1|Primary Reporting Phase|Request of Ethics Committee|0
4950443|NCT00310375|17025945|P3|Primary Reporting Phase|Par. switched to commercial product|0
4950444|NCT00310375|17025946|P2|Primary Reporting Phase|Par. switched to commercial product|1
4950445|NCT00310375|17025947|P1|Primary Reporting Phase|Par. switched to commercial product|0
4950446|NCT00310375|17025945|P3|Primary Reporting Phase|Missed study drug for 2 months|0
4950447|NCT00310375|17025946|P2|Primary Reporting Phase|Missed study drug for 2 months|0
4950448|NCT00310375|17025947|P1|Primary Reporting Phase|Missed study drug for 2 months|1
4950449|NCT00310375|17025945|P3|Primary Reporting Phase|Site closure|0
4950450|NCT00310375|17025946|P2|Primary Reporting Phase|Site closure|0
4950451|NCT00310375|17025947|P1|Primary Reporting Phase|Site closure|3
4950452|NCT00310375|17025945|P3|Primary Reporting Phase|Missed study drug >5 days|0
4950453|NCT00310375|17025946|P2|Primary Reporting Phase|Missed study drug >5 days|0
4950454|NCT00310375|17025947|P1|Primary Reporting Phase|Missed study drug >5 days|1
4950455|NCT00310375|17025945|P3|Primary Reporting Phase|Going for temporal lobectomy|0
4950456|NCT00310375|17025946|P2|Primary Reporting Phase|Going for temporal lobectomy|0
4950457|NCT00310375|17025947|P1|Primary Reporting Phase|Going for temporal lobectomy|1
4950458|NCT00310375|17025945|P3|Primary Reporting Phase|Participant request unrelated to study|0
4950459|NCT00310375|17025946|P2|Primary Reporting Phase|Participant request unrelated to study|2
4950460|NCT00310375|17025947|P1|Primary Reporting Phase|Participant request unrelated to study|1
4950461|NCT00310375|17025945|P3|Primary Reporting Phase|Failed to return|0
4950462|NCT00310375|17025946|P2|Primary Reporting Phase|Failed to return|3
4950463|NCT00310375|17025947|P1|Primary Reporting Phase|Failed to return|1
4950464|NCT00310375|17025945|P3|Primary Reporting Phase|Request of the sponsor|0
4950465|NCT00310375|17025946|P2|Primary Reporting Phase|Request of the sponsor|2
4950466|NCT00310375|17025947|P1|Primary Reporting Phase|Request of the sponsor|2
4950467|NCT00310375|17025945|P3|Primary Reporting Phase|Physician Decision|0
4950468|NCT00310375|17025946|P2|Primary Reporting Phase|Physician Decision|3
4950469|NCT00310375|17025947|P1|Primary Reporting Phase|Physician Decision|5
4950470|NCT00310375|17025945|P3|Primary Reporting Phase|Transaminase >5 upper limit of normal|0
4950471|NCT00310375|17025946|P2|Primary Reporting Phase|Transaminase >5 upper limit of normal|1
4950472|NCT00310375|17025947|P1|Primary Reporting Phase|Transaminase >5 upper limit of normal|2
4950473|NCT00310375|17025945|P3|Primary Reporting Phase|Change in Par medical condition|0
4950474|NCT00310375|17025946|P2|Primary Reporting Phase|Change in Par medical condition|0
4950475|NCT00310375|17025947|P1|Primary Reporting Phase|Change in Par medical condition|2
4950476|NCT00310375|17025945|P3|Primary Reporting Phase|Protocol Violation|0
4950477|NCT00310375|17025946|P2|Primary Reporting Phase|Protocol Violation|5
4950478|NCT00310375|17025947|P1|Primary Reporting Phase|Protocol Violation|8
4950479|NCT00310375|17025945|P3|Primary Reporting Phase|Withdrawal by Subject|0
4950480|NCT00310375|17025946|P2|Primary Reporting Phase|Withdrawal by Subject|7
4950481|NCT00310375|17025947|P1|Primary Reporting Phase|Withdrawal by Subject|10
4950482|NCT00310375|17025945|P3|Primary Reporting Phase|Pregnancy|0
4950483|NCT00310375|17025946|P2|Primary Reporting Phase|Pregnancy|2
4950484|NCT00310375|17025947|P1|Primary Reporting Phase|Pregnancy|2
4950485|NCT00310375|17025945|P3|Primary Reporting Phase|Lack of Efficacy|0
4950486|NCT00310375|17025946|P2|Primary Reporting Phase|Lack of Efficacy|19
4950487|NCT00310375|17025947|P1|Primary Reporting Phase|Lack of Efficacy|24
4950488|NCT00310375|17025945|P3|Primary Reporting Phase|Adverse Event|0
4950489|NCT00310375|17025946|P2|Primary Reporting Phase|Adverse Event|22
4950490|NCT00310375|17025947|P1|Primary Reporting Phase|Adverse Event|28
4950491|NCT00310037|17026092|P2|Overall Study|Non-protocol treatment|0
4950492|NCT00310037|17026093|P1|Overall Study|Non-protocol treatment|1
4950493|NCT00310037|17026092|P2|Overall Study|Progression|0
4950494|NCT00310037|17026093|P1|Overall Study|Progression|6
4950495|NCT00310037|17026092|P2|Overall Study|Withdrawal by Subject|3
4950496|NCT00310037|17026093|P1|Overall Study|Withdrawal by Subject|4
4950497|NCT00310037|17026092|P2|Overall Study|Adverse Event|14
4950498|NCT00310037|17026093|P1|Overall Study|Adverse Event|7
4950499|NCT00309985|17026107|P2|Overall Study|Chemotherapy discontinued only|0
4950500|NCT00309985|17026108|P1|Overall Study|Chemotherapy discontinued only|1
4950501|NCT00309985|17026107|P2|Overall Study|Non-compliance|0
4950502|NCT00309985|17026108|P1|Overall Study|Non-compliance|1
4950503|NCT00309985|17026107|P2|Overall Study|Complicating disease|0
4950504|NCT00309985|17026108|P1|Overall Study|Complicating disease|1
4950505|NCT00309985|17026107|P2|Overall Study|Never started treatment|0
4950506|NCT00309985|17026108|P1|Overall Study|Never started treatment|7
4950507|NCT00309985|17026107|P2|Overall Study|Physician Decision|0
4950508|NCT00309985|17026108|P1|Overall Study|Physician Decision|3
4950509|NCT00309985|17026107|P2|Overall Study|Withdrawal by Subject|1
4950510|NCT00309985|17026108|P1|Overall Study|Withdrawal by Subject|5
4950511|NCT00309985|17026107|P2|Overall Study|Death|0
4950512|NCT00309985|17026108|P1|Overall Study|Death|2
4950513|NCT00309985|17026107|P2|Overall Study|Adverse Event|0
4950514|NCT00309985|17026108|P1|Overall Study|Adverse Event|30
4950515|NCT00309985|17026107|P2|Overall Study|Disease progression|0
4950516|NCT00309985|17026108|P1|Overall Study|Disease progression|12
4950517|NCT00309959|17026124|P1|Overall Study|Ineligible - no prior chemotherapy|2
4950518|NCT00309946|17026133|P1|Overall Study|Withdrawal by Subject|1
4950519|NCT00309907|17026139|P1|Overall Study|Major infectious event|4
4950520|NCT00309907|17026139|P1|Overall Study|Ineligible|11
4950521|NCT00309907|17026139|P1|Overall Study|Physician Decision|1
4950522|NCT00309907|17026139|P1|Overall Study|Death|4
4950523|NCT00309842|17026148|P1|Overall Study|Lost to Follow-up|1
4950524|NCT00309777|17026166|P4|Overall Study|Death|0
4950525|NCT00309777|17026167|P3|Overall Study|Death|0
4950526|NCT00309777|17026168|P2|Overall Study|Death|1
4950527|NCT00309777|17026169|P1|Overall Study|Death|0
4950528|NCT00309777|17026166|P4|Overall Study|Lost to Follow-up|0
4950529|NCT00309777|17026167|P3|Overall Study|Lost to Follow-up|1
4950530|NCT00309777|17026168|P2|Overall Study|Lost to Follow-up|0
4950531|NCT00309777|17026169|P1|Overall Study|Lost to Follow-up|0
4950532|NCT00309777|17026166|P4|Overall Study|Withdrawal by Subject|2
4950533|NCT00309777|17026167|P3|Overall Study|Withdrawal by Subject|7
4950534|NCT00309777|17026168|P2|Overall Study|Withdrawal by Subject|5
4950535|NCT00309777|17026169|P1|Overall Study|Withdrawal by Subject|6
4950536|NCT00309777|17026166|P4|Overall Study|Protocol Violation|1
4950537|NCT00309777|17026167|P3|Overall Study|Protocol Violation|3
4950538|NCT00309777|17026168|P2|Overall Study|Protocol Violation|1
4950539|NCT00309777|17026169|P1|Overall Study|Protocol Violation|4
4950540|NCT00309777|17026166|P4|Overall Study|Adverse Event|1
4950541|NCT00309777|17026167|P3|Overall Study|Adverse Event|8
4950542|NCT00309777|17026168|P2|Overall Study|Adverse Event|2
4950543|NCT00309777|17026169|P1|Overall Study|Adverse Event|13
4950544|NCT00309608|17026210|P5|Overall Study|Other incl. Lack of efficacy|0
4950545|NCT00309608|17026211|P4|Overall Study|Other incl. Lack of efficacy|4
4950546|NCT00309608|17026212|P3|Overall Study|Other incl. Lack of efficacy|3
4950547|NCT00309608|17026213|P2|Overall Study|Other incl. Lack of efficacy|4
4950548|NCT00309608|17026214|P1|Overall Study|Other incl. Lack of efficacy|10
4950549|NCT00309608|17026210|P5|Overall Study|Withdrawal by Subject|0
4950550|NCT00309608|17026211|P4|Overall Study|Withdrawal by Subject|0
4950551|NCT00309608|17026212|P3|Overall Study|Withdrawal by Subject|2
4950552|NCT00309608|17026213|P2|Overall Study|Withdrawal by Subject|4
4950553|NCT00309608|17026214|P1|Overall Study|Withdrawal by Subject|1
4950554|NCT00309608|17026210|P5|Overall Study|Lost to Follow-up|1
4950555|NCT00309608|17026211|P4|Overall Study|Lost to Follow-up|0
4950556|NCT00309608|17026212|P3|Overall Study|Lost to Follow-up|2
4950557|NCT00309608|17026213|P2|Overall Study|Lost to Follow-up|0
4950558|NCT00309608|17026214|P1|Overall Study|Lost to Follow-up|0
4950559|NCT00309608|17026210|P5|Overall Study|Protocol Violation|0
4950560|NCT00309608|17026211|P4|Overall Study|Protocol Violation|0
4950561|NCT00309608|17026212|P3|Overall Study|Protocol Violation|0
4950562|NCT00309608|17026213|P2|Overall Study|Protocol Violation|0
4950563|NCT00309608|17026214|P1|Overall Study|Protocol Violation|2
4950564|NCT00309608|17026210|P5|Overall Study|Adverse Event|3
4950565|NCT00309608|17026211|P4|Overall Study|Adverse Event|2
4950566|NCT00309608|17026212|P3|Overall Study|Adverse Event|3
4950567|NCT00309608|17026213|P2|Overall Study|Adverse Event|5
4950568|NCT00309608|17026214|P1|Overall Study|Adverse Event|1
4950569|NCT00309452|17026262|P2|Overall Study|Withdrawal by Subject|0
4950570|NCT00309452|17026263|P1|Overall Study|Withdrawal by Subject|3
4950571|NCT00309387|17026291|P2|Overall Study|Lost to Follow-up|86
4950572|NCT00309387|17026292|P1|Overall Study|Lost to Follow-up|70
4950573|NCT00309387|17026291|P2|Overall Study|Death|73
4950574|NCT00309387|17026292|P1|Overall Study|Death|72
4950575|NCT00309244|17026310|P2|Overall Study|Death|1
4950576|NCT00309244|17026311|P1|Overall Study|Death|4
4950577|NCT00309244|17026310|P2|Overall Study|Randomized but not dosed|12
4950578|NCT00309244|17026311|P1|Overall Study|Randomized but not dosed|11
4950579|NCT00309244|17026310|P2|Overall Study|Various|7
4950580|NCT00309244|17026311|P1|Overall Study|Various|7
4950581|NCT00309244|17026310|P2|Overall Study|Withdrawal by Subject|32
4950582|NCT00309244|17026311|P1|Overall Study|Withdrawal by Subject|50
4950583|NCT00309244|17026310|P2|Overall Study|Protocol Violation|3
4950584|NCT00309244|17026311|P1|Overall Study|Protocol Violation|6
4950585|NCT00309244|17026310|P2|Overall Study|Physician Decision|8
4950586|NCT00309244|17026311|P1|Overall Study|Physician Decision|5
4950587|NCT00309244|17026310|P2|Overall Study|Lost to Follow-up|22
4950588|NCT00309244|17026311|P1|Overall Study|Lost to Follow-up|6
4950589|NCT00309244|17026310|P2|Overall Study|Adverse Event|12
4950590|NCT00309244|17026311|P1|Overall Study|Adverse Event|29
4950591|NCT00309166|17026333|P2|Overall Study|Withdrawal by Subject|3
4950592|NCT00309166|17026334|P1|Overall Study|Withdrawal by Subject|4
4950593|NCT00309166|17026333|P2|Overall Study|Adverse event, non-fatal|0
4950594|NCT00309166|17026334|P1|Overall Study|Adverse event, non-fatal|1
4950595|NCT00308997|17026368|P2|Overall Study|Unable to tolerate intervention|0
4950596|NCT00308997|17026369|P1|Overall Study|Unable to tolerate intervention|1
4950597|NCT00308997|17026368|P2|Overall Study|Subject feigned clinical data|1
4950598|NCT00308997|17026369|P1|Overall Study|Subject feigned clinical data|0
4950599|NCT00308737|17026388|P3|Overall Study|Various|8
4950600|NCT00308737|17026389|P2|Overall Study|Various|20
4950601|NCT00308737|17026390|P1|Overall Study|Various|32
4950602|NCT00308737|17026388|P3|Overall Study|Withdrawal by Subject|18
4950603|NCT00308737|17026389|P2|Overall Study|Withdrawal by Subject|166
4950604|NCT00308737|17026390|P1|Overall Study|Withdrawal by Subject|218
4950605|NCT00308737|17026388|P3|Overall Study|Protocol Violation|5
4950606|NCT00308737|17026389|P2|Overall Study|Protocol Violation|9
4950607|NCT00308737|17026390|P1|Overall Study|Protocol Violation|34
4950608|NCT00308737|17026388|P3|Overall Study|Physician Decision|1
4950609|NCT00308737|17026389|P2|Overall Study|Physician Decision|2
4950610|NCT00308737|17026390|P1|Overall Study|Physician Decision|15
4950611|NCT00308737|17026388|P3|Overall Study|Lost to Follow-up|5
4950612|NCT00308737|17026389|P2|Overall Study|Lost to Follow-up|80
4950613|NCT00308737|17026390|P1|Overall Study|Lost to Follow-up|56
4950614|NCT00308737|17026388|P3|Overall Study|Death|0
4950615|NCT00308737|17026389|P2|Overall Study|Death|3
4950616|NCT00308737|17026390|P1|Overall Study|Death|4
4950617|NCT00308737|17026388|P3|Overall Study|Adverse Event|0
4950618|NCT00308737|17026389|P2|Overall Study|Adverse Event|9
4950619|NCT00308737|17026390|P1|Overall Study|Adverse Event|104
4950620|NCT00308711|17026430|P3|Overall Study|Subject incarcerated, data not allowed|1
4950621|NCT00308711|17026431|P2|Overall Study|Subject incarcerated, data not allowed|0
4950622|NCT00308711|17026432|P1|Overall Study|Subject incarcerated, data not allowed|0
4950623|NCT00308711|17026430|P3|Overall Study|Baby not born within 7 days of treatment|2
4950624|NCT00308711|17026431|P2|Overall Study|Baby not born within 7 days of treatment|2
4950625|NCT00308711|17026432|P1|Overall Study|Baby not born within 7 days of treatment|1
4950626|NCT00308711|17026430|P3|Overall Study|Lost to Follow-up|0
4950627|NCT00308711|17026431|P2|Overall Study|Lost to Follow-up|1
4950628|NCT00308711|17026432|P1|Overall Study|Lost to Follow-up|0
4950629|NCT00308711|17026430|P3|Overall Study|Protocol Violation|1
4950630|NCT00308711|17026431|P2|Overall Study|Protocol Violation|1
4950631|NCT00308711|17026432|P1|Overall Study|Protocol Violation|0
4950632|NCT00308711|17026430|P3|Overall Study|Withdrawal by Subject|1
4950633|NCT00308711|17026431|P2|Overall Study|Withdrawal by Subject|0
4950634|NCT00308711|17026432|P1|Overall Study|Withdrawal by Subject|1
4950635|NCT00308620|17026467|P3|Overall Study|Lost to Follow-up|1
4950636|NCT00308620|17026468|P2|Overall Study|Lost to Follow-up|0
4950637|NCT00308620|17026469|P1|Overall Study|Lost to Follow-up|0
4950638|NCT00308620|17026467|P3|Overall Study|Death|0
4950639|NCT00308620|17026468|P2|Overall Study|Death|1
4950640|NCT00308620|17026469|P1|Overall Study|Death|1
4950641|NCT00308581|17026478|P3|Randomized Maintenance Phase|Unknown reason|0
4950642|NCT00308581|17026479|P2|Randomized Maintenance Phase|Unknown reason|0
4950643|NCT00308581|17026480|P1|Randomized Maintenance Phase|Unknown reason|3
4950644|NCT00308581|17026478|P3|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0
4950645|NCT00308581|17026479|P2|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59
4950646|NCT00308581|17026480|P1|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82
4950647|NCT00308581|17026478|P3|Randomized Maintenance Phase|Withdrawal by Subject|0
4950648|NCT00308581|17026479|P2|Randomized Maintenance Phase|Withdrawal by Subject|4
4950649|NCT00308581|17026480|P1|Randomized Maintenance Phase|Withdrawal by Subject|1
4950650|NCT00308581|17026478|P3|Randomized Maintenance Phase|Lost to Follow-up|0
4950651|NCT00308581|17026479|P2|Randomized Maintenance Phase|Lost to Follow-up|2
4950652|NCT00308581|17026480|P1|Randomized Maintenance Phase|Lost to Follow-up|0
4950653|NCT00308581|17026478|P3|Randomized Maintenance Phase|Lack of Efficacy|0
4950654|NCT00308581|17026479|P2|Randomized Maintenance Phase|Lack of Efficacy|21
4950655|NCT00308581|17026480|P1|Randomized Maintenance Phase|Lack of Efficacy|9
4950656|NCT00308581|17026478|P3|Randomized Maintenance Phase|Adverse Event|0
4950657|NCT00308581|17026479|P2|Randomized Maintenance Phase|Adverse Event|17
4950658|NCT00308581|17026480|P1|Randomized Maintenance Phase|Adverse Event|10
4950659|NCT00308581|17026478|P3|Induction Phase|Unknown reason|3
4950660|NCT00308581|17026479|P2|Induction Phase|Unknown reason|0
4950661|NCT00308581|17026480|P1|Induction Phase|Unknown reason|0
4950662|NCT00308581|17026478|P3|Induction Phase|Withdrawal by Subject|5
4950663|NCT00308581|17026479|P2|Induction Phase|Withdrawal by Subject|0
4950664|NCT00308581|17026480|P1|Induction Phase|Withdrawal by Subject|0
4950665|NCT00308581|17026478|P3|Induction Phase|Lack of Efficacy|121
4950666|NCT00308581|17026479|P2|Induction Phase|Lack of Efficacy|0
4950667|NCT00308581|17026480|P1|Induction Phase|Lack of Efficacy|0
4950668|NCT00308581|17026478|P3|Induction Phase|Adverse Event|37
4950669|NCT00308581|17026479|P2|Induction Phase|Adverse Event|0
4950670|NCT00308581|17026480|P1|Induction Phase|Adverse Event|0
4950671|NCT00308555|17026606|P2|Overall Study|Physician Decision|0
4950672|NCT00308555|17026607|P1|Overall Study|Physician Decision|2
4950673|NCT00308555|17026606|P2|Overall Study|Withdrawal by Subject|0
4950674|NCT00308555|17026607|P1|Overall Study|Withdrawal by Subject|1
4950675|NCT00308308|17026624|P2|Overall Study|Other|0
4950676|NCT00308308|17026625|P1|Overall Study|Other|1
4950677|NCT00308308|17026624|P2|Overall Study|Randomized but not dosed|16
4950678|NCT00308308|17026625|P1|Overall Study|Randomized but not dosed|8
4950679|NCT00308308|17026624|P2|Overall Study|Various|5
4950680|NCT00308308|17026625|P1|Overall Study|Various|7
4950681|NCT00308308|17026624|P2|Overall Study|Withdrawal by Subject|19
4950682|NCT00308308|17026625|P1|Overall Study|Withdrawal by Subject|47
4950683|NCT00308308|17026624|P2|Overall Study|Protocol Violation|14
4950684|NCT00308308|17026625|P1|Overall Study|Protocol Violation|3
4950685|NCT00308308|17026624|P2|Overall Study|Physician Decision|7
4950686|NCT00308308|17026625|P1|Overall Study|Physician Decision|15
4950687|NCT00308308|17026624|P2|Overall Study|Lost to Follow-up|5
4950688|NCT00308308|17026625|P1|Overall Study|Lost to Follow-up|5
4950689|NCT00308308|17026624|P2|Overall Study|Adverse Event|2
4950690|NCT00308308|17026625|P1|Overall Study|Adverse Event|17
4950691|NCT00308139|17026704|P2|Overall Study|Other|0
4950692|NCT00308139|17026705|P1|Overall Study|Other|1
4950693|NCT00308139|17026704|P2|Overall Study|Administrative|4
4950694|NCT00308139|17026705|P1|Overall Study|Administrative|1
4950695|NCT00308139|17026704|P2|Overall Study|Loss of Glucose Control|7
4950696|NCT00308139|17026705|P1|Overall Study|Loss of Glucose Control|5
4950697|NCT00308139|17026704|P2|Overall Study|Investigator Decision|10
4950698|NCT00308139|17026705|P1|Overall Study|Investigator Decision|11
4950699|NCT00308139|17026704|P2|Overall Study|Withdrawal of Consent|42
4950700|NCT00308139|17026705|P1|Overall Study|Withdrawal of Consent|40
4950701|NCT00308139|17026704|P2|Overall Study|Protocol Violation|2
4950702|NCT00308139|17026705|P1|Overall Study|Protocol Violation|3
4950703|NCT00308139|17026704|P2|Overall Study|Lost to Follow-up|8
4950704|NCT00308139|17026705|P1|Overall Study|Lost to Follow-up|13
4950705|NCT00308139|17026704|P2|Overall Study|Adverse Event|14
4950706|NCT00308139|17026705|P1|Overall Study|Adverse Event|20
4950707|NCT00308113|17026779|P4|Overall Study|Protocol closure|1
4950708|NCT00308113|17026780|P3|Overall Study|Protocol closure|0
4950709|NCT00308113|17026781|P2|Overall Study|Protocol closure|0
4950710|NCT00308113|17026782|P1|Overall Study|Protocol closure|0
4950711|NCT00308087|17026802|P2|Overall Study|Other|3
4950712|NCT00308087|17026803|P1|Overall Study|Other|4
4950713|NCT00308087|17026802|P2|Overall Study|Withdrawal by Subject|1
4950714|NCT00308087|17026803|P1|Overall Study|Withdrawal by Subject|2
4950715|NCT00308087|17026802|P2|Overall Study|Study Closure|12
4950716|NCT00308087|17026803|P1|Overall Study|Study Closure|11
4950717|NCT00308087|17026802|P2|Overall Study|Progressive Disease|21
4950718|NCT00308087|17026803|P1|Overall Study|Progressive Disease|19
4950719|NCT00308074|17026819|P1|Overall Study|Withdrawal by Subject|1
4950720|NCT00307931|17026836|P1|Overall Study|Adverse Event|1
4950721|NCT00307801|17026853|P2|Overall Study|Pregnancy|1
4950722|NCT00307801|17026854|P1|Overall Study|Pregnancy|0
4950723|NCT00307801|17026853|P2|Overall Study|No reason specified|0
4950724|NCT00307801|17026854|P1|Overall Study|No reason specified|2
4950725|NCT00307801|17026853|P2|Overall Study|Protocol Violation|2
4950726|NCT00307801|17026854|P1|Overall Study|Protocol Violation|3
4950727|NCT00307801|17026853|P2|Overall Study|Frustration with e-diary|0
4950728|NCT00307801|17026854|P1|Overall Study|Frustration with e-diary|1
4950729|NCT00307801|17026853|P2|Overall Study|Lost to Follow-up, moved abroad|1
4950730|NCT00307801|17026854|P1|Overall Study|Lost to Follow-up, moved abroad|1
4950731|NCT00307801|17026853|P2|Overall Study|Lack of Efficacy|2
4950732|NCT00307801|17026854|P1|Overall Study|Lack of Efficacy|0
4950733|NCT00307801|17026853|P2|Overall Study|Wrong Randomization|0
4950734|NCT00307801|17026854|P1|Overall Study|Wrong Randomization|1
4950735|NCT00307801|17026853|P2|Overall Study|Decreased Libido (AE at discontinuation)|1
4950736|NCT00307801|17026854|P1|Overall Study|Decreased Libido (AE at discontinuation)|0
4950737|NCT00307801|17026853|P2|Overall Study|Adverse event (AE)/Withdrawal of consent|0
4950738|NCT00307801|17026854|P1|Overall Study|Adverse event (AE)/Withdrawal of consent|2
4950739|NCT00307801|17026853|P2|Overall Study|Non-compliance, not taken all tablets|2
4950740|NCT00307801|17026854|P1|Overall Study|Non-compliance, not taken all tablets|1
4950741|NCT00307801|17026853|P2|Overall Study|Withdrawal by Subject|4
4950742|NCT00307801|17026854|P1|Overall Study|Withdrawal by Subject|9
4950743|NCT00307801|17026853|P2|Overall Study|Adverse Event|4
4950744|NCT00307801|17026854|P1|Overall Study|Adverse Event|12
4950745|NCT00307736|17026966|P4|Overall Study|Withdrawal by Subject|0
4950746|NCT00307736|17026967|P3|Overall Study|Withdrawal by Subject|2
4950747|NCT00307736|17026968|P2|Overall Study|Withdrawal by Subject|0
4950748|NCT00307736|17026969|P1|Overall Study|Withdrawal by Subject|0
4950749|NCT00307736|17026966|P4|Overall Study|Adverse Event|3
4950750|NCT00307736|17026967|P3|Overall Study|Adverse Event|1
4950751|NCT00307736|17026968|P2|Overall Study|Adverse Event|0
4950752|NCT00307736|17026969|P1|Overall Study|Adverse Event|0
4950753|NCT00307684|17026980|P3|Double Blind Phase|Lack of Efficacy|0
4950754|NCT00307684|17026981|P2|Double Blind Phase|Lack of Efficacy|5
4950755|NCT00307684|17026982|P1|Double Blind Phase|Lack of Efficacy|2
4950756|NCT00307684|17026980|P3|Open Label Phase|other|6
4950757|NCT00307684|17026981|P2|Open Label Phase|other|0
4950758|NCT00307684|17026982|P1|Open Label Phase|other|0
4950759|NCT00307684|17026980|P3|Open Label Phase|non compliance|5
4950760|NCT00307684|17026981|P2|Open Label Phase|non compliance|0
4950761|NCT00307684|17026982|P1|Open Label Phase|non compliance|0
4950762|NCT00307684|17026980|P3|Open Label Phase|Lost to Follow-up|11
4950763|NCT00307684|17026981|P2|Open Label Phase|Lost to Follow-up|0
4950764|NCT00307684|17026982|P1|Open Label Phase|Lost to Follow-up|0
4950765|NCT00307684|17026980|P3|Open Label Phase|Withdrawal by Subject|15
4950766|NCT00307684|17026981|P2|Open Label Phase|Withdrawal by Subject|0
4950767|NCT00307684|17026982|P1|Open Label Phase|Withdrawal by Subject|0
4950768|NCT00307684|17026980|P3|Open Label Phase|Adverse Event|16
4950769|NCT00307684|17026981|P2|Open Label Phase|Adverse Event|0
4950770|NCT00307684|17026982|P1|Open Label Phase|Adverse Event|0
4950771|NCT00307684|17026980|P3|Open Label Phase|Lack of Efficacy|3
4950772|NCT00307684|17026981|P2|Open Label Phase|Lack of Efficacy|0
4950773|NCT00307684|17026982|P1|Open Label Phase|Lack of Efficacy|0
4950774|NCT00307489|17027010|P2|Week 48 Through Week 168|Seroconversion|0
4950775|NCT00307489|17027011|P1|Week 48 Through Week 168|Seroconversion|1
4950776|NCT00307489|17027010|P2|Week 48 Through Week 168|Lost to Follow-up|1
4950777|NCT00307489|17027011|P1|Week 48 Through Week 168|Lost to Follow-up|0
4950778|NCT00307489|17027010|P2|Week 48 Through Week 168|Death|1
4950779|NCT00307489|17027011|P1|Week 48 Through Week 168|Death|0
4950780|NCT00307489|17027010|P2|Week 48 Through Week 168|Lack of Efficacy|2
4950781|NCT00307489|17027011|P1|Week 48 Through Week 168|Lack of Efficacy|2
4950782|NCT00307489|17027010|P2|Week 48 Through Week 168|Withdrawal by Subject|2
4950783|NCT00307489|17027011|P1|Week 48 Through Week 168|Withdrawal by Subject|1
4950784|NCT00307489|17027010|P2|Week 48 Through Week 168|Physician Decision|0
4950785|NCT00307489|17027011|P1|Week 48 Through Week 168|Physician Decision|1
4950786|NCT00307489|17027010|P2|Week 48 Through Week 168|Adverse Event|0
4950787|NCT00307489|17027011|P1|Week 48 Through Week 168|Adverse Event|1
4950788|NCT00307489|17027010|P2|Baseline Through Week 48|Withdrawal by Subject|1
4950789|NCT00307489|17027011|P1|Baseline Through Week 48|Withdrawal by Subject|0
4950790|NCT00307489|17027010|P2|Baseline Through Week 48|Physician Decision|0
4950791|NCT00307489|17027011|P1|Baseline Through Week 48|Physician Decision|1
4950792|NCT00307489|17027010|P2|Baseline Through Week 48|Lost to Follow-up|1
4950793|NCT00307489|17027011|P1|Baseline Through Week 48|Lost to Follow-up|0
4950794|NCT00307437|17027056|P7|After Controlled Period|Other|28
4950795|NCT00307437|17027057|P6|After Controlled Period|Other|40
4950796|NCT00307437|17027058|P5|After Controlled Period|Other|9
4950797|NCT00307437|17027059|P4|After Controlled Period|Other|15
4950798|NCT00307437|17027060|P3|After Controlled Period|Other|0
4950799|NCT00307437|17027061|P2|After Controlled Period|Other|0
4950800|NCT00307437|17027062|P1|After Controlled Period|Other|0
4950801|NCT00307437|17027056|P7|After Controlled Period|Lost to Follow-up|18
4950802|NCT00307437|17027057|P6|After Controlled Period|Lost to Follow-up|13
4950803|NCT00307437|17027058|P5|After Controlled Period|Lost to Follow-up|12
4950804|NCT00307437|17027059|P4|After Controlled Period|Lost to Follow-up|7
4950805|NCT00307437|17027060|P3|After Controlled Period|Lost to Follow-up|0
4950806|NCT00307437|17027061|P2|After Controlled Period|Lost to Follow-up|0
4950807|NCT00307437|17027062|P1|After Controlled Period|Lost to Follow-up|0
4950808|NCT00307437|17027056|P7|After Controlled Period|Lack of Efficacy|24
4950809|NCT00307437|17027057|P6|After Controlled Period|Lack of Efficacy|37
4950810|NCT00307437|17027058|P5|After Controlled Period|Lack of Efficacy|17
4950811|NCT00307437|17027059|P4|After Controlled Period|Lack of Efficacy|15
4950812|NCT00307437|17027060|P3|After Controlled Period|Lack of Efficacy|0
4950813|NCT00307437|17027061|P2|After Controlled Period|Lack of Efficacy|0
4950814|NCT00307437|17027062|P1|After Controlled Period|Lack of Efficacy|0
4950815|NCT00307437|17027056|P7|After Controlled Period|Death|3
4950816|NCT00307437|17027057|P6|After Controlled Period|Death|1
4950817|NCT00307437|17027058|P5|After Controlled Period|Death|1
4950818|NCT00307437|17027059|P4|After Controlled Period|Death|3
4950819|NCT00307437|17027060|P3|After Controlled Period|Death|0
4950820|NCT00307437|17027061|P2|After Controlled Period|Death|0
4950821|NCT00307437|17027062|P1|After Controlled Period|Death|0
4950822|NCT00307437|17027056|P7|After Controlled Period|Adverse Event|40
4950823|NCT00307437|17027057|P6|After Controlled Period|Adverse Event|31
4950824|NCT00307437|17027058|P5|After Controlled Period|Adverse Event|16
4950825|NCT00307437|17027059|P4|After Controlled Period|Adverse Event|18
4950826|NCT00307437|17027060|P3|After Controlled Period|Adverse Event|0
4950827|NCT00307437|17027061|P2|After Controlled Period|Adverse Event|0
4950828|NCT00307437|17027062|P1|After Controlled Period|Adverse Event|0
4950829|NCT00307437|17027056|P7|Controlled Period|Other|0
4950830|NCT00307437|17027057|P6|Controlled Period|Other|0
4950831|NCT00307437|17027058|P5|Controlled Period|Other|0
4950832|NCT00307437|17027059|P4|Controlled Period|Other|0
4950833|NCT00307437|17027060|P3|Controlled Period|Other|3
4950834|NCT00307437|17027061|P2|Controlled Period|Other|1
4950835|NCT00307437|17027062|P1|Controlled Period|Other|5
4950836|NCT00307437|17027056|P7|Controlled Period|Lost to Follow-up|0
4950837|NCT00307437|17027057|P6|Controlled Period|Lost to Follow-up|0
4950838|NCT00307437|17027058|P5|Controlled Period|Lost to Follow-up|0
4950839|NCT00307437|17027059|P4|Controlled Period|Lost to Follow-up|0
4950840|NCT00307437|17027060|P3|Controlled Period|Lost to Follow-up|0
4950841|NCT00307437|17027061|P2|Controlled Period|Lost to Follow-up|3
4950842|NCT00307437|17027062|P1|Controlled Period|Lost to Follow-up|2
4950843|NCT00307437|17027056|P7|Controlled Period|Lack of Efficacy|0
4950844|NCT00307437|17027057|P6|Controlled Period|Lack of Efficacy|0
4950845|NCT00307437|17027058|P5|Controlled Period|Lack of Efficacy|0
4950846|NCT00307437|17027059|P4|Controlled Period|Lack of Efficacy|0
4950847|NCT00307437|17027060|P3|Controlled Period|Lack of Efficacy|0
4950848|NCT00307437|17027061|P2|Controlled Period|Lack of Efficacy|0
4950849|NCT00307437|17027062|P1|Controlled Period|Lack of Efficacy|2
4950850|NCT00307437|17027056|P7|Controlled Period|Death|0
4950851|NCT00307437|17027057|P6|Controlled Period|Death|0
4950852|NCT00307437|17027058|P5|Controlled Period|Death|0
4950853|NCT00307437|17027059|P4|Controlled Period|Death|0
4950854|NCT00307437|17027060|P3|Controlled Period|Death|1
4950855|NCT00307437|17027061|P2|Controlled Period|Death|0
4950856|NCT00307437|17027062|P1|Controlled Period|Death|0
4950857|NCT00307437|17027056|P7|Controlled Period|Adverse Event|0
4950858|NCT00307437|17027057|P6|Controlled Period|Adverse Event|0
4950859|NCT00307437|17027058|P5|Controlled Period|Adverse Event|0
4950860|NCT00307437|17027059|P4|Controlled Period|Adverse Event|0
4950861|NCT00307437|17027060|P3|Controlled Period|Adverse Event|5
4950862|NCT00307437|17027061|P2|Controlled Period|Adverse Event|2
4950863|NCT00307437|17027062|P1|Controlled Period|Adverse Event|7
4950864|NCT00307333|17027088|P2|Overall Study|Lost to Follow-up|3
4950865|NCT00307333|17027089|P1|Overall Study|Lost to Follow-up|11
4950866|NCT00307294|17027101|P1|Overall Study|Withdrawal by Subject|1
4950867|NCT00307164|17027110|P2|Overall Study|Lost to Follow-up|1
4950868|NCT00307164|17027111|P1|Overall Study|Lost to Follow-up|6
4950869|NCT00307164|17027110|P2|Overall Study|Not compliant with requirements|4
4950870|NCT00307164|17027111|P1|Overall Study|Not compliant with requirements|4
4950871|NCT00307164|17027110|P2|Overall Study|Withdrawal by Subject|8
4950872|NCT00307164|17027111|P1|Overall Study|Withdrawal by Subject|1
4950873|NCT00307164|17027110|P2|Overall Study|Subject/parent not able to get to clinic|1
4950874|NCT00307164|17027111|P1|Overall Study|Subject/parent not able to get to clinic|2
4950875|NCT00307164|17027110|P2|Overall Study|Severe debilitation, unable to continue|0
4950876|NCT00307164|17027111|P1|Overall Study|Severe debilitation, unable to continue|1
4950877|NCT00307164|17027110|P2|Overall Study|Death|0
4950878|NCT00307164|17027111|P1|Overall Study|Death|1
4950879|NCT00307151|17027151|P4|Overall Study|Clinic unable to contact subject|1
4950880|NCT00307151|17027152|P3|Overall Study|Clinic unable to contact subject|1
4950881|NCT00307151|17027153|P2|Overall Study|Clinic unable to contact subject|3
4950882|NCT00307151|17027154|P1|Overall Study|Clinic unable to contact subject|3
4950883|NCT00307151|17027151|P4|Overall Study|Not willing to adhere to study reqs|2
4950884|NCT00307151|17027152|P3|Overall Study|Not willing to adhere to study reqs|2
4950885|NCT00307151|17027153|P2|Overall Study|Not willing to adhere to study reqs|0
4950886|NCT00307151|17027154|P1|Overall Study|Not willing to adhere to study reqs|2
4950887|NCT00307151|17027151|P4|Overall Study|Withdrew consent|3
4950888|NCT00307151|17027152|P3|Overall Study|Withdrew consent|1
4950889|NCT00307151|17027153|P2|Overall Study|Withdrew consent|1
4950890|NCT00307151|17027154|P1|Overall Study|Withdrew consent|0
4950891|NCT00307151|17027151|P4|Overall Study|Subject unable to get to clinic|2
4950892|NCT00307151|17027152|P3|Overall Study|Subject unable to get to clinic|6
4950893|NCT00307151|17027153|P2|Overall Study|Subject unable to get to clinic|0
4950894|NCT00307151|17027154|P1|Overall Study|Subject unable to get to clinic|1
4950895|NCT00307151|17027151|P4|Overall Study|Severe debilitation, unable to continue|0
4950896|NCT00307151|17027152|P3|Overall Study|Severe debilitation, unable to continue|0
4950897|NCT00307151|17027153|P2|Overall Study|Severe debilitation, unable to continue|0
4950898|NCT00307151|17027154|P1|Overall Study|Severe debilitation, unable to continue|1
4950899|NCT00307151|17027151|P4|Overall Study|Death|3
4950900|NCT00307151|17027152|P3|Overall Study|Death|10
4950901|NCT00307151|17027153|P2|Overall Study|Death|3
4950902|NCT00307151|17027154|P1|Overall Study|Death|4
4950903|NCT00307125|17027198|P3|Pilot Phase|Withdrawal by Subject|1
4950904|NCT00307125|17027199|P2|Pilot Phase|Withdrawal by Subject|1
4950905|NCT00307125|17027200|P1|Pilot Phase|Withdrawal by Subject|0
4950906|NCT00307125|17027198|P3|Pilot Phase|Lost to Follow-up|0
4950907|NCT00307125|17027199|P2|Pilot Phase|Lost to Follow-up|1
4950908|NCT00307125|17027200|P1|Pilot Phase|Lost to Follow-up|0
4950909|NCT00307125|17027198|P3|Screening Phase|Coronary artery bypass|0
4950910|NCT00307125|17027199|P2|Screening Phase|Coronary artery bypass|0
4950911|NCT00307125|17027200|P1|Screening Phase|Coronary artery bypass|1
4950912|NCT00307125|17027198|P3|Screening Phase|AMR and treated with rituximab|0
4950913|NCT00307125|17027199|P2|Screening Phase|AMR and treated with rituximab|0
4950914|NCT00307125|17027200|P1|Screening Phase|AMR and treated with rituximab|1
4950915|NCT00307125|17027198|P3|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
4950916|NCT00307125|17027199|P2|Screening Phase|Sample of Anti-HLA Ab was not obtained|0
4950917|NCT00307125|17027200|P1|Screening Phase|Sample of Anti-HLA Ab was not obtained|1
4950918|NCT00307125|17027198|P3|Screening Phase|Screen Error|0
4950919|NCT00307125|17027199|P2|Screening Phase|Screen Error|0
4950920|NCT00307125|17027200|P1|Screening Phase|Screen Error|1
4950921|NCT00307125|17027198|P3|Screening Phase|Ineligible|0
4950922|NCT00307125|17027199|P2|Screening Phase|Ineligible|0
4950923|NCT00307125|17027200|P1|Screening Phase|Ineligible|1
4950924|NCT00307125|17027198|P3|Screening Phase|PAK|0
4950925|NCT00307125|17027199|P2|Screening Phase|PAK|0
4950926|NCT00307125|17027200|P1|Screening Phase|PAK|1
4950927|NCT00307125|17027198|P3|Screening Phase|Malignancy|0
4950928|NCT00307125|17027199|P2|Screening Phase|Malignancy|0
4950929|NCT00307125|17027200|P1|Screening Phase|Malignancy|1
4950930|NCT00307125|17027198|P3|Screening Phase|Metastatic colon cancer|0
4950931|NCT00307125|17027199|P2|Screening Phase|Metastatic colon cancer|0
4950932|NCT00307125|17027200|P1|Screening Phase|Metastatic colon cancer|1
4950933|NCT00307125|17027198|P3|Screening Phase|Developed acute leukemia|0
4950934|NCT00307125|17027199|P2|Screening Phase|Developed acute leukemia|0
4950935|NCT00307125|17027200|P1|Screening Phase|Developed acute leukemia|1
4950936|NCT00307125|17027198|P3|Screening Phase|Try to get pregnant|0
4950937|NCT00307125|17027199|P2|Screening Phase|Try to get pregnant|0
4950938|NCT00307125|17027200|P1|Screening Phase|Try to get pregnant|1
4950939|NCT00307125|17027198|P3|Screening Phase|Ineligible for pilot|0
4950940|NCT00307125|17027199|P2|Screening Phase|Ineligible for pilot|0
4950941|NCT00307125|17027200|P1|Screening Phase|Ineligible for pilot|4
4950942|NCT00307125|17027198|P3|Screening Phase|Received Pancreas Transplant|0
4950943|NCT00307125|17027199|P2|Screening Phase|Received Pancreas Transplant|0
4950944|NCT00307125|17027200|P1|Screening Phase|Received Pancreas Transplant|8
4950945|NCT00307125|17027198|P3|Screening Phase|Moved or transferred facilities|0
4950946|NCT00307125|17027199|P2|Screening Phase|Moved or transferred facilities|0
4950947|NCT00307125|17027200|P1|Screening Phase|Moved or transferred facilities|34
4950948|NCT00307125|17027198|P3|Screening Phase|Scheduling issues/Non-compliance|0
4950949|NCT00307125|17027199|P2|Screening Phase|Scheduling issues/Non-compliance|0
4950950|NCT00307125|17027200|P1|Screening Phase|Scheduling issues/Non-compliance|55
4950951|NCT00307125|17027198|P3|Screening Phase|Follow-up period ended on Dec 31, 2011|0
4951039|NCT00306891|17027812|P4|Part A|Suspicion of second malignancy|0
4950952|NCT00307125|17027199|P2|Screening Phase|Follow-up period ended on Dec 31, 2011|0
4950953|NCT00307125|17027200|P1|Screening Phase|Follow-up period ended on Dec 31, 2011|83
4950954|NCT00307125|17027198|P3|Screening Phase|Graft Failure|0
4950955|NCT00307125|17027199|P2|Screening Phase|Graft Failure|0
4950956|NCT00307125|17027200|P1|Screening Phase|Graft Failure|8
4950957|NCT00307125|17027198|P3|Screening Phase|Graft Loss|0
4950958|NCT00307125|17027199|P2|Screening Phase|Graft Loss|0
4950959|NCT00307125|17027200|P1|Screening Phase|Graft Loss|3
4950960|NCT00307125|17027198|P3|Screening Phase|Study Terminated|0
4950961|NCT00307125|17027199|P2|Screening Phase|Study Terminated|0
4950962|NCT00307125|17027200|P1|Screening Phase|Study Terminated|17
4950963|NCT00307125|17027198|P3|Screening Phase|Sponsor Decision|0
4950964|NCT00307125|17027199|P2|Screening Phase|Sponsor Decision|0
4950965|NCT00307125|17027200|P1|Screening Phase|Sponsor Decision|4
4950966|NCT00307125|17027198|P3|Screening Phase|Physician Decision|0
4950967|NCT00307125|17027199|P2|Screening Phase|Physician Decision|0
4950968|NCT00307125|17027200|P1|Screening Phase|Physician Decision|26
4950969|NCT00307125|17027198|P3|Screening Phase|Withdrawal by Subject|0
4950970|NCT00307125|17027199|P2|Screening Phase|Withdrawal by Subject|0
4950971|NCT00307125|17027200|P1|Screening Phase|Withdrawal by Subject|77
4950972|NCT00307125|17027198|P3|Screening Phase|Death|0
4950973|NCT00307125|17027199|P2|Screening Phase|Death|0
4950974|NCT00307125|17027200|P1|Screening Phase|Death|10
4950975|NCT00307125|17027198|P3|Screening Phase|Lost to Follow-up|0
4950976|NCT00307125|17027199|P2|Screening Phase|Lost to Follow-up|0
4950977|NCT00307125|17027200|P1|Screening Phase|Lost to Follow-up|87
4950978|NCT00307125|17027198|P3|Screening Phase|Protocol Violation|0
4950979|NCT00307125|17027199|P2|Screening Phase|Protocol Violation|0
4950980|NCT00307125|17027200|P1|Screening Phase|Protocol Violation|27
4950981|NCT00307125|17027198|P3|Screening Phase|Adverse Event|0
4950982|NCT00307125|17027199|P2|Screening Phase|Adverse Event|0
4950983|NCT00307125|17027200|P1|Screening Phase|Adverse Event|1
4950984|NCT00307086|17027222|P1|Overall Study|ineligible|5
4950985|NCT00307047|17027228|P2|Overall Study|All death, all MI, all Revascularization|16
4950986|NCT00307047|17027229|P1|Overall Study|All death, all MI, all Revascularization|27
4950987|NCT00307047|17027228|P2|Overall Study|Lost to follow-up for other reasons|1
4950988|NCT00307047|17027229|P1|Overall Study|Lost to follow-up for other reasons|0
4950989|NCT00307047|17027228|P2|Overall Study|Physician Decision|2
4950990|NCT00307047|17027229|P1|Overall Study|Physician Decision|1
4950991|NCT00307047|17027228|P2|Overall Study|Withdrawal by Subject|6
4950992|NCT00307047|17027229|P1|Overall Study|Withdrawal by Subject|6
4950993|NCT00307047|17027228|P2|Overall Study|Lost to Follow-up|24
4950994|NCT00307047|17027229|P1|Overall Study|Lost to Follow-up|35
4950995|NCT00307034|17027367|P2|Overall Study|Lost to Follow-up|3
4950996|NCT00307034|17027368|P1|Overall Study|Lost to Follow-up|0
4950997|NCT00307034|17027367|P2|Overall Study|Withdrawal by Subject|2
4950998|NCT00307034|17027368|P1|Overall Study|Withdrawal by Subject|1
4950999|NCT00307034|17027367|P2|Overall Study|Adverse Event|2
4951000|NCT00307034|17027368|P1|Overall Study|Adverse Event|1
4951001|NCT00306995|17027413|P7|Study Part II for Subset 2|Serious Adverse Event|0
4951002|NCT00306995|17027414|P6|Study Part II for Subset 2|Serious Adverse Event|0
4951003|NCT00306995|17027415|P5|Study Part II for Subset 2|Serious Adverse Event|0
4951004|NCT00306995|17027416|P4|Study Part II for Subset 2|Serious Adverse Event|0
4951005|NCT00306995|17027417|P3|Study Part II for Subset 2|Serious Adverse Event|0
4951006|NCT00306995|17027418|P2|Study Part II for Subset 2|Serious Adverse Event|1
4951007|NCT00306995|17027419|P1|Study Part II for Subset 2|Serious Adverse Event|0
4951008|NCT00306995|17027413|P7|Study Part I|Withdrawal by Subject|1
4951009|NCT00306995|17027414|P6|Study Part I|Withdrawal by Subject|0
4951010|NCT00306995|17027415|P5|Study Part I|Withdrawal by Subject|0
4951011|NCT00306995|17027416|P4|Study Part I|Withdrawal by Subject|0
4951012|NCT00306995|17027417|P3|Study Part I|Withdrawal by Subject|0
4951013|NCT00306995|17027418|P2|Study Part I|Withdrawal by Subject|0
4951014|NCT00306995|17027419|P1|Study Part I|Withdrawal by Subject|0
4951015|NCT00306891|17027812|P4|Part B|Development of study specific disc crit.|1
4951016|NCT00306891|17027813|P3|Part B|Development of study specific disc crit.|0
4951017|NCT00306891|17027814|P2|Part B|Development of study specific disc crit.|0
4951018|NCT00306891|17027815|P1|Part B|Development of study specific disc crit.|0
4951019|NCT00306891|17027812|P4|Part B|Condition under investigation worsened|8
4951020|NCT00306891|17027813|P3|Part B|Condition under investigation worsened|2
4951021|NCT00306891|17027814|P2|Part B|Condition under investigation worsened|0
4951022|NCT00306891|17027815|P1|Part B|Condition under investigation worsened|0
4951023|NCT00306891|17027812|P4|Part B|Withdrawal by Subject|1
4951024|NCT00306891|17027813|P3|Part B|Withdrawal by Subject|3
4951025|NCT00306891|17027814|P2|Part B|Withdrawal by Subject|0
4951026|NCT00306891|17027815|P1|Part B|Withdrawal by Subject|0
4951027|NCT00306891|17027812|P4|Part B|Adverse Event|5
4951028|NCT00306891|17027813|P3|Part B|Adverse Event|5
4951029|NCT00306891|17027814|P2|Part B|Adverse Event|0
4951030|NCT00306891|17027815|P1|Part B|Adverse Event|0
4951031|NCT00306891|17027812|P4|Part B|Death|2
4951032|NCT00306891|17027813|P3|Part B|Death|1
4951033|NCT00306891|17027814|P2|Part B|Death|0
4951034|NCT00306891|17027815|P1|Part B|Death|0
4951035|NCT00306891|17027812|P4|Part A|QTC interval outwith elig. criteria|0
4951036|NCT00306891|17027813|P3|Part A|QTC interval outwith elig. criteria|0
4951037|NCT00306891|17027814|P2|Part A|QTC interval outwith elig. criteria|0
4951038|NCT00306891|17027815|P1|Part A|QTC interval outwith elig. criteria|1
4951040|NCT00306891|17027813|P3|Part A|Suspicion of second malignancy|0
4951041|NCT00306891|17027814|P2|Part A|Suspicion of second malignancy|1
4951042|NCT00306891|17027815|P1|Part A|Suspicion of second malignancy|0
4951043|NCT00306891|17027812|P4|Part A|Reaccumul. of ascites following drainage|0
4951044|NCT00306891|17027813|P3|Part A|Reaccumul. of ascites following drainage|0
4951045|NCT00306891|17027814|P2|Part A|Reaccumul. of ascites following drainage|1
4951046|NCT00306891|17027815|P1|Part A|Reaccumul. of ascites following drainage|0
4951047|NCT00306891|17027812|P4|Part A|Partial bowel obstruction|0
4951048|NCT00306891|17027813|P3|Part A|Partial bowel obstruction|0
4951049|NCT00306891|17027814|P2|Part A|Partial bowel obstruction|0
4951050|NCT00306891|17027815|P1|Part A|Partial bowel obstruction|1
4951051|NCT00306891|17027812|P4|Part A|Incorrect enrol/entry crit not fulfilled|0
4951052|NCT00306891|17027813|P3|Part A|Incorrect enrol/entry crit not fulfilled|0
4951053|NCT00306891|17027814|P2|Part A|Incorrect enrol/entry crit not fulfilled|1
4951054|NCT00306891|17027815|P1|Part A|Incorrect enrol/entry crit not fulfilled|0
4951055|NCT00306891|17027812|P4|Part A|Condition under investigation worsened|0
4951056|NCT00306891|17027813|P3|Part A|Condition under investigation worsened|0
4951057|NCT00306891|17027814|P2|Part A|Condition under investigation worsened|2
4951058|NCT00306891|17027815|P1|Part A|Condition under investigation worsened|2
4951059|NCT00306891|17027812|P4|Part A|Withdrawal by Subject|0
4951060|NCT00306891|17027813|P3|Part A|Withdrawal by Subject|0
4951061|NCT00306891|17027814|P2|Part A|Withdrawal by Subject|1
4951062|NCT00306891|17027815|P1|Part A|Withdrawal by Subject|1
4951063|NCT00306852|17027838|P2|Overall Study|Lost to Follow-up|24
4951064|NCT00306852|17027839|P1|Overall Study|Lost to Follow-up|15
4951065|NCT00306852|17027838|P2|Overall Study|Death|14
4951066|NCT00306852|17027839|P1|Overall Study|Death|14
4951067|NCT00306787|17027857|P2|Overall Study|Abnormal laboratory value(s)|0
4951068|NCT00306787|17027858|P1|Overall Study|Abnormal laboratory value(s)|1
4951069|NCT00306787|17027857|P2|Overall Study|Administrative problems|0
4951070|NCT00306787|17027858|P1|Overall Study|Administrative problems|4
4951071|NCT00306787|17027857|P2|Overall Study|Lost to Follow-up|6
4951072|NCT00306787|17027858|P1|Overall Study|Lost to Follow-up|9
4951073|NCT00306787|17027857|P2|Overall Study|Withdrawal by Subject|9
4951074|NCT00306787|17027858|P1|Overall Study|Withdrawal by Subject|2
4951075|NCT00306787|17027857|P2|Overall Study|Protocol Violation|10
4951076|NCT00306787|17027858|P1|Overall Study|Protocol Violation|8
4951077|NCT00306787|17027857|P2|Overall Study|Lack of Efficacy|0
4951078|NCT00306787|17027858|P1|Overall Study|Lack of Efficacy|1
4951079|NCT00306787|17027857|P2|Overall Study|Adverse Event|1
4951080|NCT00306787|17027858|P1|Overall Study|Adverse Event|1
4951081|NCT00306787|17027857|P2|Overall Study|Discontinued without taking study drug|215
4951082|NCT00306787|17027858|P1|Overall Study|Discontinued without taking study drug|208
4951083|NCT00306670|17027876|P2|Overall Study|patients recruited; Genentech, the st|2
4951084|NCT00306670|17027877|P1|Overall Study|patients recruited; Genentech, the st|0
4951085|NCT00306592|17027883|P2|Overall Study|48-week Treatment Period Ongoing|20
4951086|NCT00306592|17027884|P1|Overall Study|48-week Treatment Period Ongoing|0
4951087|NCT00306592|17027883|P2|Overall Study|Other|2
4951088|NCT00306592|17027884|P1|Overall Study|Other|1
4951089|NCT00306592|17027883|P2|Overall Study|Other|10
4951090|NCT00306592|17027884|P1|Overall Study|Other|5
4951091|NCT00306592|17027883|P2|Overall Study|Voluntary|6
4951092|NCT00306592|17027884|P1|Overall Study|Voluntary|10
4951093|NCT00306592|17027883|P2|Overall Study|Persistent Antibodies|3
4951094|NCT00306592|17027884|P1|Overall Study|Persistent Antibodies|6
4951095|NCT00306592|17027883|P2|Overall Study|Noncompliance|2
4951096|NCT00306592|17027884|P1|Overall Study|Noncompliance|0
4951097|NCT00306592|17027883|P2|Overall Study|Lost to Follow-up|0
4951098|NCT00306592|17027884|P1|Overall Study|Lost to Follow-up|1
4951099|NCT00306592|17027883|P2|Overall Study|Adverse Event|15
4951100|NCT00306592|17027884|P1|Overall Study|Adverse Event|8
4951101|NCT00306527|17027894|P4|Overall Study|Death|2
4951102|NCT00306527|17027895|P3|Overall Study|Death|1
4951103|NCT00306527|17027896|P2|Overall Study|Death|0
4951104|NCT00306527|17027897|P1|Overall Study|Death|1
4951105|NCT00306527|17027894|P4|Overall Study|Adverse Event|1
4951106|NCT00306527|17027895|P3|Overall Study|Adverse Event|1
4951107|NCT00306527|17027896|P2|Overall Study|Adverse Event|0
4951108|NCT00306527|17027897|P1|Overall Study|Adverse Event|0
4951109|NCT00306527|17027894|P4|Overall Study|Withdrawal by Subject|3
4951110|NCT00306527|17027895|P3|Overall Study|Withdrawal by Subject|0
4951111|NCT00306527|17027896|P2|Overall Study|Withdrawal by Subject|3
4951112|NCT00306527|17027897|P1|Overall Study|Withdrawal by Subject|2
4951113|NCT00306527|17027894|P4|Overall Study|Lost to Follow-up|0
4951114|NCT00306527|17027895|P3|Overall Study|Lost to Follow-up|3
4951115|NCT00306527|17027896|P2|Overall Study|Lost to Follow-up|4
4951116|NCT00306527|17027897|P1|Overall Study|Lost to Follow-up|3
4951117|NCT00306384|17027969|P3|Overall Study|Site closure|0
4951118|NCT00306384|17027970|P2|Overall Study|Site closure|0
4951119|NCT00306384|17027971|P1|Overall Study|Site closure|2
4951120|NCT00306384|17027969|P3|Overall Study|Other|32
4951121|NCT00306384|17027970|P2|Overall Study|Other|70
4951122|NCT00306384|17027971|P1|Overall Study|Other|80
4951123|NCT00306384|17027969|P3|Overall Study|Investigator discretion|21
4951124|NCT00306384|17027970|P2|Overall Study|Investigator discretion|31
4951125|NCT00306384|17027971|P1|Overall Study|Investigator discretion|28
4951126|NCT00306384|17027969|P3|Overall Study|Lack of Efficacy|38
4951127|NCT00306384|17027970|P2|Overall Study|Lack of Efficacy|40
4951128|NCT00306384|17027971|P1|Overall Study|Lack of Efficacy|26
4951129|NCT00306384|17027969|P3|Overall Study|Pregnancy|1
4951130|NCT00306384|17027970|P2|Overall Study|Pregnancy|1
4951131|NCT00306384|17027971|P1|Overall Study|Pregnancy|3
4951132|NCT00306384|17027969|P3|Overall Study|Study termination|1
4951133|NCT00306384|17027970|P2|Overall Study|Study termination|0
4951134|NCT00306384|17027971|P1|Overall Study|Study termination|1
4951135|NCT00306384|17027969|P3|Overall Study|Voluntary withdrawal|91
4951136|NCT00306384|17027970|P2|Overall Study|Voluntary withdrawal|187
4951137|NCT00306384|17027971|P1|Overall Study|Voluntary withdrawal|199
4951138|NCT00306384|17027969|P3|Overall Study|Lost to Follow-up|35
4951139|NCT00306384|17027970|P2|Overall Study|Lost to Follow-up|41
4951140|NCT00306384|17027971|P1|Overall Study|Lost to Follow-up|57
4951141|NCT00306384|17027969|P3|Overall Study|Major protocol deviation|18
4951142|NCT00306384|17027970|P2|Overall Study|Major protocol deviation|51
4951143|NCT00306384|17027971|P1|Overall Study|Major protocol deviation|43
4951144|NCT00306384|17027969|P3|Overall Study|Adverse Event|40
4951145|NCT00306384|17027970|P2|Overall Study|Adverse Event|87
4951146|NCT00306384|17027971|P1|Overall Study|Adverse Event|103
4951147|NCT00306293|17028003|P2|Period 2 (Day 67 to Day 126 )|Pregnancy|0
4951148|NCT00306293|17028004|P1|Period 2 (Day 67 to Day 126 )|Pregnancy|1
4951149|NCT00306293|17028003|P2|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1
4951150|NCT00306293|17028004|P1|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0
4951151|NCT00306293|17028003|P2|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0
4951152|NCT00306293|17028004|P1|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1
4951153|NCT00306293|17028003|P2|Period 2 (Day 67 to Day 126 )|Adverse Event|0
4951154|NCT00306293|17028004|P1|Period 2 (Day 67 to Day 126 )|Adverse Event|1
4951155|NCT00306293|17028003|P2|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
4951156|NCT00306293|17028004|P1|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2
4951157|NCT00306293|17028003|P2|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
4951158|NCT00306293|17028004|P1|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2
4951159|NCT00306293|17028003|P2|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4
4951160|NCT00306293|17028004|P1|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3
4951161|NCT00306293|17028003|P2|Period 1 (Day 1 to Day 60)|Adverse Event|0
4951162|NCT00306293|17028004|P1|Period 1 (Day 1 to Day 60)|Adverse Event|1
4951163|NCT00306202|17028025|P3|Overall Study|Still on treatment|0
4951164|NCT00306202|17028026|P2|Overall Study|Still on treatment|1
4951165|NCT00306202|17028027|P1|Overall Study|Still on treatment|6
4951166|NCT00306189|17028187|P4|Overall Study|Other|0
4951167|NCT00306189|17028188|P3|Overall Study|Other|0
4951168|NCT00306189|17028189|P2|Overall Study|Other|0
4951169|NCT00306189|17028190|P1|Overall Study|Other|1
4951170|NCT00306189|17028187|P4|Overall Study|Ineligibility determined|1
4951171|NCT00306189|17028188|P3|Overall Study|Ineligibility determined|1
4951172|NCT00306189|17028189|P2|Overall Study|Ineligibility determined|1
4951173|NCT00306189|17028190|P1|Overall Study|Ineligibility determined|1
4951174|NCT00306189|17028187|P4|Overall Study|Withdrawal by Subject|1
4951175|NCT00306189|17028188|P3|Overall Study|Withdrawal by Subject|8
4951176|NCT00306189|17028189|P2|Overall Study|Withdrawal by Subject|2
4951177|NCT00306189|17028190|P1|Overall Study|Withdrawal by Subject|4
4951178|NCT00306189|17028187|P4|Overall Study|Adverse Event|2
4951179|NCT00306189|17028188|P3|Overall Study|Adverse Event|2
4951180|NCT00306189|17028189|P2|Overall Study|Adverse Event|3
4951181|NCT00306189|17028190|P1|Overall Study|Adverse Event|3
4951182|NCT00306189|17028187|P4|Overall Study|Physician Decision|1
4951183|NCT00306189|17028188|P3|Overall Study|Physician Decision|0
4951184|NCT00306189|17028189|P2|Overall Study|Physician Decision|0
4951185|NCT00306189|17028190|P1|Overall Study|Physician Decision|0
4951186|NCT00305877|17028217|P2|Overall Study|Transportation issue with daily RT|1
4951187|NCT00305877|17028218|P1|Overall Study|Transportation issue with daily RT|0
4951188|NCT00305877|17028217|P2|Overall Study|Ineligible|1
4951189|NCT00305877|17028218|P1|Overall Study|Ineligible|2
4951190|NCT00305877|17028217|P2|Overall Study|Never start treatment|5
4951191|NCT00305877|17028218|P1|Overall Study|Never start treatment|2
4951192|NCT00305877|17028217|P2|Overall Study|Physician Decision|1
4951193|NCT00305877|17028218|P1|Overall Study|Physician Decision|1
4951194|NCT00305877|17028217|P2|Overall Study|Withdrawal by Subject|2
4951195|NCT00305877|17028218|P1|Overall Study|Withdrawal by Subject|4
4951196|NCT00305877|17028217|P2|Overall Study|Death|1
4951197|NCT00305877|17028218|P1|Overall Study|Death|0
4951198|NCT00305877|17028217|P2|Overall Study|Adverse Event|14
4951199|NCT00305877|17028218|P1|Overall Study|Adverse Event|9
4951200|NCT00305877|17028217|P2|Overall Study|Lack of Efficacy|9
4951201|NCT00305877|17028218|P1|Overall Study|Lack of Efficacy|6
4951202|NCT00305864|17028232|P4|Overall Study|Ineligible / No protocol treatment|13
4951203|NCT00305864|17028233|P3|Overall Study|Ineligible / No protocol treatment|1
4951204|NCT00305864|17028234|P2|Overall Study|Ineligible / No protocol treatment|1
4951205|NCT00305864|17028235|P1|Overall Study|Ineligible / No protocol treatment|0
4951206|NCT00305773|17028248|P2|Overall Study|All other reasons|2
4951207|NCT00305773|17028249|P1|Overall Study|All other reasons|3
4951208|NCT00305773|17028248|P2|Overall Study|Disease Progression|3
4951209|NCT00305773|17028249|P1|Overall Study|Disease Progression|1
4951210|NCT00305773|17028248|P2|Overall Study|Withdrawal by Subject|4
4951211|NCT00305773|17028249|P1|Overall Study|Withdrawal by Subject|1
4951212|NCT00305773|17028248|P2|Overall Study|Physician Decision|1
4951213|NCT00305773|17028249|P1|Overall Study|Physician Decision|1
4951214|NCT00305773|17028248|P2|Overall Study|Alternative Treatment|4
4951215|NCT00305773|17028249|P1|Overall Study|Alternative Treatment|4
4951216|NCT00305773|17028248|P2|Overall Study|Adverse Event|2
4951217|NCT00305773|17028249|P1|Overall Study|Adverse Event|1
4951218|NCT00305773|17028248|P2|Overall Study|Death|2
4951219|NCT00305773|17028249|P1|Overall Study|Death|3
4951220|NCT00305695|17028269|P2|Overall Study|Did not have baseline scan|1
4951221|NCT00305695|17028270|P1|Overall Study|Did not have baseline scan|1
4951222|NCT00305695|17028269|P2|Overall Study|Withdrawal by subject prior to 18 month|26
4951223|NCT00305695|17028270|P1|Overall Study|Withdrawal by subject prior to 18 month|40
4951224|NCT00305604|17028295|P2|Overall Study|Patient moved|0
4951225|NCT00305604|17028296|P1|Overall Study|Patient moved|1
4951226|NCT00305604|17028295|P2|Overall Study|Withdrawal by Subject|21
4951227|NCT00305604|17028296|P1|Overall Study|Withdrawal by Subject|12
4951228|NCT00305604|17028295|P2|Overall Study|Protocol Violation|1
4951229|NCT00305604|17028296|P1|Overall Study|Protocol Violation|2
4951230|NCT00305604|17028295|P2|Overall Study|Lost to Follow-up|4
4951231|NCT00305604|17028296|P1|Overall Study|Lost to Follow-up|0
4951232|NCT00305604|17028295|P2|Overall Study|Lack of Efficacy|18
4951233|NCT00305604|17028296|P1|Overall Study|Lack of Efficacy|11
4951234|NCT00305604|17028295|P2|Overall Study|Adverse Event|3
4951235|NCT00305604|17028296|P1|Overall Study|Adverse Event|6
4951236|NCT00305448|17028440|P3|Overall Study|Tumor Marker Elevation|1
4951237|NCT00305448|17028441|P2|Overall Study|Tumor Marker Elevation|0
4951238|NCT00305448|17028442|P1|Overall Study|Tumor Marker Elevation|0
4951239|NCT00305448|17028440|P3|Overall Study|Subjective Disease Progression|2
4951240|NCT00305448|17028441|P2|Overall Study|Subjective Disease Progression|2
4951241|NCT00305448|17028442|P1|Overall Study|Subjective Disease Progression|1
4951242|NCT00305448|17028440|P3|Overall Study|Disease Progression|28
4951243|NCT00305448|17028441|P2|Overall Study|Disease Progression|31
4951244|NCT00305448|17028442|P1|Overall Study|Disease Progression|27
4951245|NCT00305448|17028440|P3|Overall Study|Adverse Event|1
4951246|NCT00305448|17028441|P2|Overall Study|Adverse Event|0
4951247|NCT00305448|17028442|P1|Overall Study|Adverse Event|1
4951248|NCT00305448|17028440|P3|Overall Study|Withdrawal by Subject|1
4951249|NCT00305448|17028441|P2|Overall Study|Withdrawal by Subject|0
4951250|NCT00305448|17028442|P1|Overall Study|Withdrawal by Subject|2
4951251|NCT00305448|17028440|P3|Overall Study|Protocol Violation|0
4951252|NCT00305448|17028441|P2|Overall Study|Protocol Violation|1
4951253|NCT00305448|17028442|P1|Overall Study|Protocol Violation|0
4951254|NCT00305253|17028464|P2|Overall Study|Withdrawal by Subject|1
4951255|NCT00305253|17028465|P1|Overall Study|Withdrawal by Subject|0
4951256|NCT00305227|17028477|P2|Overall Study|Lost to Follow-up|6
4951257|NCT00305227|17028478|P1|Overall Study|Lost to Follow-up|7
4951258|NCT00305110|17028525|P1|Overall Study|Missing data|29
4951259|NCT00305058|17028598|P2|Overall Study|Missing outcome data|2
4951260|NCT00305058|17028599|P1|Overall Study|Missing outcome data|3
4951261|NCT00305058|17028598|P2|Overall Study|Missing data collection instrument|2
4951262|NCT00305058|17028599|P1|Overall Study|Missing data collection instrument|3
4951263|NCT00305058|17028598|P2|Overall Study|Participant too young|0
4951264|NCT00305058|17028599|P1|Overall Study|Participant too young|1
4951265|NCT00304954|17028615|P4|Overall Study|Adverse Event|0
4951266|NCT00304954|17028616|P3|Overall Study|Adverse Event|0
4951267|NCT00304954|17028617|P2|Overall Study|Adverse Event|0
4951268|NCT00304954|17028618|P1|Overall Study|Adverse Event|1
4951269|NCT00304954|17028615|P4|Overall Study|Withdrawal by Subject|0
4951270|NCT00304954|17028616|P3|Overall Study|Withdrawal by Subject|1
4951271|NCT00304954|17028617|P2|Overall Study|Withdrawal by Subject|0
4951272|NCT00304954|17028618|P1|Overall Study|Withdrawal by Subject|0
4951273|NCT00304915|17028638|P2|Overall Study|Withdrawal by Subject|0
4951274|NCT00304915|17028639|P1|Overall Study|Withdrawal by Subject|3
4951275|NCT00304915|17028638|P2|Overall Study|Death|5
4951276|NCT00304915|17028639|P1|Overall Study|Death|4
4951277|NCT00304915|17028638|P2|Overall Study|Lost to Follow-up|11
4951278|NCT00304915|17028639|P1|Overall Study|Lost to Follow-up|11
4951279|NCT00304356|17028684|P1|Nitazoxanide|Physician Decision|1
4951280|NCT00304356|17028684|P1|Nitazoxanide|Physician Decision|1
4951281|NCT00304356|17028684|P1|Nitazoxanide|Physician Decision|1
4951282|NCT00304356|17028684|P1|Nitazoxanide|number is 0|1
4951283|NCT00304356|17028684|P1|Nitazoxanide|Physician Decision|1
4951284|NCT00304356|17028684|P1|Nitazoxanide|Physician Decision|5
4951285|NCT00304278|17028688|P1|Overall Study|PT had medical condition preventing TX|1
4951286|NCT00304278|17028688|P1|Overall Study|lack of insurance coverage for chemoRT|1
4951287|NCT00304083|17028737|P2|Overall Study|Other|2
4951288|NCT00304083|17028738|P1|Overall Study|Other|5
4951289|NCT00304083|17028737|P2|Overall Study|Disease Progression|1
4951290|NCT00304083|17028738|P1|Overall Study|Disease Progression|5
4951291|NCT00304083|17028737|P2|Overall Study|Physician Decision|3
4951292|NCT00304083|17028738|P1|Overall Study|Physician Decision|8
4951293|NCT00304083|17028737|P2|Overall Study|Withdrawal by Subject|2
4951294|NCT00304083|17028738|P1|Overall Study|Withdrawal by Subject|4
4951295|NCT00304070|17028757|P3|Overall Study|Progressive Disease|4
4951296|NCT00304070|17028758|P2|Overall Study|Progressive Disease|7
4951297|NCT00304070|17028759|P1|Overall Study|Progressive Disease|3
4951298|NCT00304070|17028757|P3|Overall Study|Withdrawal by Subject|1
4951299|NCT00304070|17028758|P2|Overall Study|Withdrawal by Subject|0
4951300|NCT00304070|17028759|P1|Overall Study|Withdrawal by Subject|0
4951301|NCT00304070|17028757|P3|Overall Study|Physician Decision|3
4951302|NCT00304070|17028758|P2|Overall Study|Physician Decision|0
4951303|NCT00304070|17028759|P1|Overall Study|Physician Decision|0
4951304|NCT00304070|17028757|P3|Overall Study|Lost to Follow-up|1
4951305|NCT00304070|17028758|P2|Overall Study|Lost to Follow-up|0
4951306|NCT00304070|17028759|P1|Overall Study|Lost to Follow-up|0
4951307|NCT00304070|17028757|P3|Overall Study|Death|3
4951308|NCT00304070|17028758|P2|Overall Study|Death|0
4951309|NCT00304070|17028759|P1|Overall Study|Death|0
4951310|NCT00304031|17028774|P3|Randomization to Adjuvant TMZ Arm|No follow-up collected|2
4951311|NCT00304031|17028775|P2|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
4951312|NCT00304031|17028776|P1|Randomization to Adjuvant TMZ Arm|No follow-up collected|0
4951313|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
4951314|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0
4951315|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37
4951316|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
4951317|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0
4951318|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1
4951319|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
4951320|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0
4951321|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10
4951322|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
4951323|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0
4951324|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15
4951325|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Death|0
4951326|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Death|0
4951327|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Death|18
4951328|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
4951329|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0
4951330|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19
4951331|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
4951332|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0
4951333|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48
4951334|NCT00304031|17028774|P3|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
4951335|NCT00304031|17028775|P2|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0
4951336|NCT00304031|17028776|P1|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144
4951337|NCT00303953|17028858|P1|Overall Study|Physician Decision|1
4951338|NCT00303953|17028858|P1|Overall Study|Lack of Efficacy|12
4951339|NCT00303953|17028858|P1|Overall Study|Adverse Event|4
4951340|NCT00303953|17028858|P1|Overall Study|Death|1
4951341|NCT00303953|17028858|P1|Overall Study|Ineligible|1
4951342|NCT00303719|17028894|P2|Overall Study|Lost to Follow-up|7
4951343|NCT00303719|17028895|P1|Overall Study|Lost to Follow-up|0
4951344|NCT00303719|17028894|P2|Overall Study|Not evaluable, prior therapies|30
4951345|NCT00303719|17028895|P1|Overall Study|Not evaluable, prior therapies|0
4951346|NCT00303667|17028911|P2|Overall Study|Death|4
4951347|NCT00303667|17028912|P1|Overall Study|Death|0
4951348|NCT00303628|17028936|P2|Overall Study|Other|9
4951349|NCT00303628|17028937|P1|Overall Study|Other|8
4951350|NCT00303628|17028936|P2|Overall Study|Not start protocol therapy|5
4951351|NCT00303628|17028937|P1|Overall Study|Not start protocol therapy|3
4951352|NCT00303628|17028936|P2|Overall Study|Other complicating disease|1
4951353|NCT00303628|17028937|P1|Overall Study|Other complicating disease|0
4951354|NCT00303628|17028936|P2|Overall Study|Alternative therapy|0
4951355|NCT00303628|17028937|P1|Overall Study|Alternative therapy|2
4951356|NCT00303628|17028936|P2|Overall Study|Withdrawal by Subject|20
4951357|NCT00303628|17028937|P1|Overall Study|Withdrawal by Subject|11
4951358|NCT00303628|17028936|P2|Overall Study|Death|1
4951359|NCT00303628|17028937|P1|Overall Study|Death|0
4951360|NCT00303628|17028936|P2|Overall Study|Adverse Event|36
4951361|NCT00303628|17028937|P1|Overall Study|Adverse Event|26
4951362|NCT00303628|17028936|P2|Overall Study|Disease progression|1
4951363|NCT00303628|17028937|P1|Overall Study|Disease progression|0
4951364|NCT00303602|17028955|P2|Overall Study|Protocol Violation|0
4951365|NCT00303602|17028956|P1|Overall Study|Protocol Violation|1
4951366|NCT00303602|17028955|P2|Overall Study|Noncompliance|2
4951367|NCT00303602|17028956|P1|Overall Study|Noncompliance|2
4951368|NCT00303602|17028955|P2|Overall Study|Physician Decision|1
4951369|NCT00303602|17028956|P1|Overall Study|Physician Decision|2
4951370|NCT00303602|17028955|P2|Overall Study|Protocol entry criteria not met|2
4951371|NCT00303602|17028956|P1|Overall Study|Protocol entry criteria not met|2
4951372|NCT00303602|17028955|P2|Overall Study|Lost to Follow-up|2
4951373|NCT00303602|17028956|P1|Overall Study|Lost to Follow-up|5
4951374|NCT00303602|17028955|P2|Overall Study|Withdrawal by Subject|6
4951375|NCT00303602|17028956|P1|Overall Study|Withdrawal by Subject|5
4951376|NCT00303602|17028955|P2|Overall Study|Adverse Event|2
4951377|NCT00303602|17028956|P1|Overall Study|Adverse Event|2
4951378|NCT00303485|17029002|P2|Overall Study|Withdrawal by Subject|0
4951379|NCT00303485|17029003|P1|Overall Study|Withdrawal by Subject|1
4951380|NCT00303485|17029002|P2|Overall Study|Failure to return|1
4951381|NCT00303485|17029003|P1|Overall Study|Failure to return|0
4951382|NCT00303485|17029002|P2|Overall Study|Adverse Event/Intercurrent Illness|1
4951383|NCT00303485|17029003|P1|Overall Study|Adverse Event/Intercurrent Illness|0
4951384|NCT00303472|17029034|P7|Treatment Extension (Optional)|Disease Progression (to AML)|0
4951385|NCT00303472|17029035|P6|Treatment Extension (Optional)|Disease Progression (to AML)|1
4951386|NCT00303472|17029036|P5|Treatment Extension (Optional)|Disease Progression (to AML)|0
4951387|NCT00303472|17029037|P4|Treatment Extension (Optional)|Disease Progression (to AML)|0
4951388|NCT00303472|17029038|P3|Treatment Extension (Optional)|Disease Progression (to AML)|0
4951389|NCT00303472|17029039|P2|Treatment Extension (Optional)|Disease Progression (to AML)|0
4951390|NCT00303472|17029040|P1|Treatment Extension (Optional)|Disease Progression (to AML)|1
4951391|NCT00303472|17029034|P7|Treatment Extension (Optional)|Other|0
4951392|NCT00303472|17029035|P6|Treatment Extension (Optional)|Other|0
4951393|NCT00303472|17029036|P5|Treatment Extension (Optional)|Other|1
4951394|NCT00303472|17029037|P4|Treatment Extension (Optional)|Other|2
4951395|NCT00303472|17029038|P3|Treatment Extension (Optional)|Other|4
4951396|NCT00303472|17029039|P2|Treatment Extension (Optional)|Other|2
4951397|NCT00303472|17029040|P1|Treatment Extension (Optional)|Other|0
4951398|NCT00303472|17029034|P7|Treatment Extension (Optional)|Withdrawal by Subject|0
4951399|NCT00303472|17029035|P6|Treatment Extension (Optional)|Withdrawal by Subject|0
4951400|NCT00303472|17029036|P5|Treatment Extension (Optional)|Withdrawal by Subject|1
4951401|NCT00303472|17029037|P4|Treatment Extension (Optional)|Withdrawal by Subject|2
4951402|NCT00303472|17029038|P3|Treatment Extension (Optional)|Withdrawal by Subject|1
4951403|NCT00303472|17029039|P2|Treatment Extension (Optional)|Withdrawal by Subject|0
4951404|NCT00303472|17029040|P1|Treatment Extension (Optional)|Withdrawal by Subject|1
4951405|NCT00303472|17029034|P7|Treatment Extension (Optional)|Physician Decision|0
4951406|NCT00303472|17029035|P6|Treatment Extension (Optional)|Physician Decision|0
4951407|NCT00303472|17029036|P5|Treatment Extension (Optional)|Physician Decision|2
4951408|NCT00303472|17029037|P4|Treatment Extension (Optional)|Physician Decision|3
4951409|NCT00303472|17029038|P3|Treatment Extension (Optional)|Physician Decision|2
4951410|NCT00303472|17029039|P2|Treatment Extension (Optional)|Physician Decision|4
4951411|NCT00303472|17029040|P1|Treatment Extension (Optional)|Physician Decision|0
4951412|NCT00303472|17029034|P7|Treatment Extension (Optional)|Lost to Follow-up|0
4951413|NCT00303472|17029035|P6|Treatment Extension (Optional)|Lost to Follow-up|0
4951414|NCT00303472|17029036|P5|Treatment Extension (Optional)|Lost to Follow-up|0
4951415|NCT00303472|17029037|P4|Treatment Extension (Optional)|Lost to Follow-up|1
4951416|NCT00303472|17029038|P3|Treatment Extension (Optional)|Lost to Follow-up|0
4951417|NCT00303472|17029039|P2|Treatment Extension (Optional)|Lost to Follow-up|0
4951418|NCT00303472|17029040|P1|Treatment Extension (Optional)|Lost to Follow-up|0
4951419|NCT00303472|17029034|P7|Treatment Extension (Optional)|Death|0
4951420|NCT00303472|17029035|P6|Treatment Extension (Optional)|Death|0
4951421|NCT00303472|17029036|P5|Treatment Extension (Optional)|Death|0
4951422|NCT00303472|17029037|P4|Treatment Extension (Optional)|Death|0
4951423|NCT00303472|17029038|P3|Treatment Extension (Optional)|Death|1
4951424|NCT00303472|17029039|P2|Treatment Extension (Optional)|Death|0
4951425|NCT00303472|17029040|P1|Treatment Extension (Optional)|Death|2
4951426|NCT00303472|17029034|P7|Treatment Extension (Optional)|Adverse Event|0
4951427|NCT00303472|17029035|P6|Treatment Extension (Optional)|Adverse Event|0
4951428|NCT00303472|17029036|P5|Treatment Extension (Optional)|Adverse Event|0
4951429|NCT00303472|17029037|P4|Treatment Extension (Optional)|Adverse Event|0
4951430|NCT00303472|17029038|P3|Treatment Extension (Optional)|Adverse Event|1
4951431|NCT00303472|17029039|P2|Treatment Extension (Optional)|Adverse Event|0
4951432|NCT00303472|17029040|P1|Treatment Extension (Optional)|Adverse Event|1
4951433|NCT00303472|17029034|P7|Treatment Period|Disease Progression (to AML)|0
4951434|NCT00303472|17029035|P6|Treatment Period|Disease Progression (to AML)|0
4951435|NCT00303472|17029036|P5|Treatment Period|Disease Progression (to AML)|1
4951436|NCT00303472|17029037|P4|Treatment Period|Disease Progression (to AML)|0
4951437|NCT00303472|17029038|P3|Treatment Period|Disease Progression (to AML)|0
4951438|NCT00303472|17029039|P2|Treatment Period|Disease Progression (to AML)|0
4951439|NCT00303472|17029040|P1|Treatment Period|Disease Progression (to AML)|0
4951440|NCT00303472|17029034|P7|Treatment Period|Other|1
4951441|NCT00303472|17029035|P6|Treatment Period|Other|0
4951442|NCT00303472|17029036|P5|Treatment Period|Other|1
4951443|NCT00303472|17029037|P4|Treatment Period|Other|0
4951444|NCT00303472|17029038|P3|Treatment Period|Other|0
4951445|NCT00303472|17029039|P2|Treatment Period|Other|0
4951446|NCT00303472|17029040|P1|Treatment Period|Other|0
4951447|NCT00303472|17029034|P7|Treatment Period|Withdrawal by Subject|0
4951448|NCT00303472|17029035|P6|Treatment Period|Withdrawal by Subject|1
4951449|NCT00303472|17029036|P5|Treatment Period|Withdrawal by Subject|0
4951450|NCT00303472|17029037|P4|Treatment Period|Withdrawal by Subject|1
4951451|NCT00303472|17029038|P3|Treatment Period|Withdrawal by Subject|0
4951452|NCT00303472|17029039|P2|Treatment Period|Withdrawal by Subject|0
4951453|NCT00303472|17029040|P1|Treatment Period|Withdrawal by Subject|0
4951454|NCT00303472|17029034|P7|Treatment Period|Death|1
4951455|NCT00303472|17029035|P6|Treatment Period|Death|0
4951456|NCT00303472|17029036|P5|Treatment Period|Death|0
4951457|NCT00303472|17029037|P4|Treatment Period|Death|1
4951458|NCT00303472|17029038|P3|Treatment Period|Death|0
4951459|NCT00303472|17029039|P2|Treatment Period|Death|0
4951460|NCT00303472|17029040|P1|Treatment Period|Death|0
4951461|NCT00303472|17029034|P7|Treatment Period|Adverse Event|0
4951462|NCT00303472|17029035|P6|Treatment Period|Adverse Event|0
4951463|NCT00303472|17029036|P5|Treatment Period|Adverse Event|1
4951464|NCT00303472|17029037|P4|Treatment Period|Adverse Event|0
4951465|NCT00303472|17029038|P3|Treatment Period|Adverse Event|0
4951466|NCT00303472|17029039|P2|Treatment Period|Adverse Event|0
4951467|NCT00303472|17029040|P1|Treatment Period|Adverse Event|0
4951468|NCT00303459|17029100|P2|Overall Study|Lung transplantation|1
4951469|NCT00303459|17029101|P1|Overall Study|Lung transplantation|1
4951470|NCT00303459|17029100|P2|Overall Study|Decision by the investigator|7
4951471|NCT00303459|17029101|P1|Overall Study|Decision by the investigator|5
4951472|NCT00303459|17029100|P2|Overall Study|Administrative reason|7
4951473|NCT00303459|17029101|P1|Overall Study|Administrative reason|7
4951474|NCT00303459|17029100|P2|Overall Study|Lost to Follow-up|4
4951475|NCT00303459|17029101|P1|Overall Study|Lost to Follow-up|5
4951476|NCT00303459|17029100|P2|Overall Study|Withdrawal of consent|26
4951477|NCT00303459|17029101|P1|Overall Study|Withdrawal of consent|32
4951478|NCT00303459|17029100|P2|Overall Study|Death|44
4951479|NCT00303459|17029101|P1|Overall Study|Death|33
4951480|NCT00303446|17029127|P2|Overall Study|Physician Decision|1
4951481|NCT00303446|17029128|P1|Overall Study|Physician Decision|0
4951482|NCT00303446|17029127|P2|Overall Study|Death|1
4951483|NCT00303446|17029128|P1|Overall Study|Death|0
4951484|NCT00303446|17029127|P2|Overall Study|Withdrawal by Subject|2
4951485|NCT00303446|17029128|P1|Overall Study|Withdrawal by Subject|2
4951486|NCT00303329|17029164|P2|Overall Study|Stopped at end of extension 1|0
4951487|NCT00303329|17029165|P1|Overall Study|Stopped at end of extension 1|1
4951488|NCT00303329|17029164|P2|Overall Study|Stopped at end of core|9
4951489|NCT00303329|17029165|P1|Overall Study|Stopped at end of core|3
4951490|NCT00303329|17029164|P2|Overall Study|Death|12
4951491|NCT00303329|17029165|P1|Overall Study|Death|2
4951492|NCT00303329|17029164|P2|Overall Study|Administrative problems|0
4951493|NCT00303329|17029165|P1|Overall Study|Administrative problems|1
4951494|NCT00303329|17029164|P2|Overall Study|Lost to Follow-up|1
4951495|NCT00303329|17029165|P1|Overall Study|Lost to Follow-up|0
4951496|NCT00303329|17029164|P2|Overall Study|Withdrawal by Subject|15
4951497|NCT00303329|17029165|P1|Overall Study|Withdrawal by Subject|9
4951498|NCT00303329|17029164|P2|Overall Study|Protocol Violation|0
4951499|NCT00303329|17029165|P1|Overall Study|Protocol Violation|3
4951500|NCT00303329|17029164|P2|Overall Study|Condition no longer requires study drug|8
4951501|NCT00303329|17029165|P1|Overall Study|Condition no longer requires study drug|0
4951502|NCT00303329|17029164|P2|Overall Study|Unsatisfactory therapeutic effect|2
4951503|NCT00303329|17029165|P1|Overall Study|Unsatisfactory therapeutic effect|9
4951504|NCT00303329|17029164|P2|Overall Study|Abnormal Laboratory Values|1
4951505|NCT00303329|17029165|P1|Overall Study|Abnormal Laboratory Values|0
4951506|NCT00303329|17029164|P2|Overall Study|Adverse Event|14
4951507|NCT00303329|17029165|P1|Overall Study|Adverse Event|7
4951508|NCT00303316|17029179|P2|Overall Study|Withdrawal by Subject|2
4951509|NCT00303316|17029180|P1|Overall Study|Withdrawal by Subject|1
4951510|NCT00303316|17029179|P2|Overall Study|Lost to Follow-up|1
4951511|NCT00303316|17029180|P1|Overall Study|Lost to Follow-up|0
4951512|NCT00303316|17029179|P2|Overall Study|Protocol Violation|0
4951513|NCT00303316|17029180|P1|Overall Study|Protocol Violation|1
4951514|NCT00303186|17029192|P1|Overall Study|Other|52
4951515|NCT00303108|17029226|P3|Overall Study|ineligible|0
4951516|NCT00303108|17029227|P2|Overall Study|ineligible|1
4951517|NCT00303108|17029228|P1|Overall Study|ineligible|2
4951518|NCT00303108|17029226|P3|Overall Study|Failed Entry|1
4951519|NCT00303108|17029227|P2|Overall Study|Failed Entry|0
4951520|NCT00303108|17029228|P1|Overall Study|Failed Entry|1
4951521|NCT00303108|17029226|P3|Overall Study|Patient Request|8
4951522|NCT00303108|17029227|P2|Overall Study|Patient Request|2
4951523|NCT00303108|17029228|P1|Overall Study|Patient Request|4
4951524|NCT00303108|17029226|P3|Overall Study|Adverse Event|7
4951525|NCT00303108|17029227|P2|Overall Study|Adverse Event|6
4951526|NCT00303108|17029228|P1|Overall Study|Adverse Event|5
4951527|NCT00303069|17029248|P4|Overall Study|Recruitment into Army Reserves|0
4951528|NCT00303069|17029249|P3|Overall Study|Recruitment into Army Reserves|1
4951529|NCT00303069|17029250|P2|Overall Study|Recruitment into Army Reserves|0
4951530|NCT00303069|17029251|P1|Overall Study|Recruitment into Army Reserves|0
4951531|NCT00303069|17029248|P4|Overall Study|subject moved|0
4951532|NCT00303069|17029249|P3|Overall Study|subject moved|0
4951533|NCT00303069|17029250|P2|Overall Study|subject moved|0
4951534|NCT00303069|17029251|P1|Overall Study|subject moved|1
4951535|NCT00303069|17029248|P4|Overall Study|Lost to Follow-up|2
4951536|NCT00303069|17029249|P3|Overall Study|Lost to Follow-up|0
4951537|NCT00303069|17029250|P2|Overall Study|Lost to Follow-up|0
4951538|NCT00303069|17029251|P1|Overall Study|Lost to Follow-up|1
4951539|NCT00302952|17029271|P2|Overall Study|Elevated SGOT (AST) lab value|1
4951540|NCT00302952|17029272|P1|Overall Study|Elevated SGOT (AST) lab value|0
4951541|NCT00302952|17029271|P2|Overall Study|Withdrawal by Subject|3
4951542|NCT00302952|17029272|P1|Overall Study|Withdrawal by Subject|2
4951543|NCT00302952|17029271|P2|Overall Study|Physician Decision|1
4951544|NCT00302952|17029272|P1|Overall Study|Physician Decision|1
4951545|NCT00302731|17029322|P4|Overall Study|cancer unrelated to study discovered|0
4951546|NCT00302731|17029323|P3|Overall Study|cancer unrelated to study discovered|1
4951547|NCT00302731|17029324|P2|Overall Study|cancer unrelated to study discovered|0
4951548|NCT00302731|17029325|P1|Overall Study|cancer unrelated to study discovered|1
4951549|NCT00302731|17029322|P4|Overall Study|Protocol Violation|0
4951550|NCT00302731|17029323|P3|Overall Study|Protocol Violation|0
4951551|NCT00302731|17029324|P2|Overall Study|Protocol Violation|0
4951552|NCT00302731|17029325|P1|Overall Study|Protocol Violation|1
4951553|NCT00302731|17029322|P4|Overall Study|Withdrawal by Subject|0
4951554|NCT00302731|17029323|P3|Overall Study|Withdrawal by Subject|0
4951555|NCT00302731|17029324|P2|Overall Study|Withdrawal by Subject|1
4951556|NCT00302731|17029325|P1|Overall Study|Withdrawal by Subject|1
4951557|NCT00302731|17029322|P4|Overall Study|Adverse Event|0
4951558|NCT00302731|17029323|P3|Overall Study|Adverse Event|2
4951559|NCT00302731|17029324|P2|Overall Study|Adverse Event|2
4951560|NCT00302731|17029325|P1|Overall Study|Adverse Event|0
4951561|NCT00302731|17029322|P4|Overall Study|Lost to Follow-up|0
4951562|NCT00302731|17029323|P3|Overall Study|Lost to Follow-up|0
4951563|NCT00302731|17029324|P2|Overall Study|Lost to Follow-up|2
4951564|NCT00302731|17029325|P1|Overall Study|Lost to Follow-up|1
4951565|NCT00302718|17029351|P4|Overall Study|Participant left primary care setting|1
4951566|NCT00302718|17029352|P3|Overall Study|Participant left primary care setting|2
4951567|NCT00302718|17029353|P2|Overall Study|Participant left primary care setting|0
4951568|NCT00302718|17029354|P1|Overall Study|Participant left primary care setting|0
4951569|NCT00302718|17029351|P4|Overall Study|Withdrawal by Subject|0
4951570|NCT00302718|17029352|P3|Overall Study|Withdrawal by Subject|0
4951571|NCT00302718|17029353|P2|Overall Study|Withdrawal by Subject|1
4951572|NCT00302718|17029354|P1|Overall Study|Withdrawal by Subject|0
4951573|NCT00302718|17029351|P4|Overall Study|Participant left the hospital|1
4951574|NCT00302718|17029352|P3|Overall Study|Participant left the hospital|0
4951575|NCT00302718|17029353|P2|Overall Study|Participant left the hospital|0
4951576|NCT00302718|17029354|P1|Overall Study|Participant left the hospital|1
4951577|NCT00302458|17029420|P1|Overall Study|Withdrawal by Subject|1
4951578|NCT00302458|17029420|P1|Overall Study|Ineligible after screening|1
4951579|NCT00302458|17029420|P1|Overall Study|Lost to Follow-up|1
4951580|NCT00302328|17029431|P3|Overall Study|Physician Decision|0
4951581|NCT00302328|17029432|P2|Overall Study|Physician Decision|1
4951582|NCT00302328|17029433|P1|Overall Study|Physician Decision|0
4951583|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4951584|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1
4951585|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4951586|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4951587|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0
4951588|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|PH requiring lung transplant|1
4951589|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4951590|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4951591|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4951592|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|PH requiring lung transplant|0
4951593|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Lost to Follow-up|1
4951594|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4951595|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4951596|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4951597|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Lost to Follow-up|0
4951598|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Death|1
4951599|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Death|1
4951600|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Death|0
4951601|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Death|0
4951602|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Death|0
4951603|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Disease progression|2
4951604|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Disease progression|1
4951605|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Disease progression|0
4951606|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Disease progression|0
4951607|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Disease progression|0
4951608|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Investigator's judgement|0
4951609|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Investigator's judgement|1
4951610|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Investigator's judgement|0
4951611|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Investigator's judgement|0
4951612|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Investigator's judgement|0
4951613|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Adverse Event|0
4951614|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Adverse Event|1
4951615|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Adverse Event|0
4951616|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Adverse Event|0
4951617|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Adverse Event|0
4951618|NCT00302211|17029450|P5|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
4951619|NCT00302211|17029451|P4|Open Label-Patients From Double-Blind|Withdrawal by Subject|3
4951620|NCT00302211|17029452|P3|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
4951621|NCT00302211|17029453|P2|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
4951622|NCT00302211|17029454|P1|Open Label-Patients From Double-Blind|Withdrawal by Subject|0
4951623|NCT00302211|17029450|P5|Double Blind Period (New Patients)|Disease progression|0
4951624|NCT00302211|17029451|P4|Double Blind Period (New Patients)|Disease progression|0
4951625|NCT00302211|17029452|P3|Double Blind Period (New Patients)|Disease progression|1
4951626|NCT00302211|17029453|P2|Double Blind Period (New Patients)|Disease progression|1
4951627|NCT00302211|17029454|P1|Double Blind Period (New Patients)|Disease progression|0
4951628|NCT00302211|17029450|P5|Double Blind Period (New Patients)|Investigator's judgement|0
4951801|NCT00300274|17030217|P1|Overall Study|Death|31
4951629|NCT00302211|17029451|P4|Double Blind Period (New Patients)|Investigator's judgement|0
4951630|NCT00302211|17029452|P3|Double Blind Period (New Patients)|Investigator's judgement|0
4951631|NCT00302211|17029453|P2|Double Blind Period (New Patients)|Investigator's judgement|0
4951632|NCT00302211|17029454|P1|Double Blind Period (New Patients)|Investigator's judgement|1
4951633|NCT00302211|17029450|P5|Double Blind Period (New Patients)|Adverse Event|0
4951634|NCT00302211|17029451|P4|Double Blind Period (New Patients)|Adverse Event|0
4951635|NCT00302211|17029452|P3|Double Blind Period (New Patients)|Adverse Event|3
4951636|NCT00302211|17029453|P2|Double Blind Period (New Patients)|Adverse Event|0
4951637|NCT00302211|17029454|P1|Double Blind Period (New Patients)|Adverse Event|0
4951638|NCT00302211|17029450|P5|Double Blind Period (New Patients)|Withdrawal by Subject|0
4951639|NCT00302211|17029451|P4|Double Blind Period (New Patients)|Withdrawal by Subject|0
4951640|NCT00302211|17029452|P3|Double Blind Period (New Patients)|Withdrawal by Subject|0
4951641|NCT00302211|17029453|P2|Double Blind Period (New Patients)|Withdrawal by Subject|1
4951642|NCT00302211|17029454|P1|Double Blind Period (New Patients)|Withdrawal by Subject|2
4951643|NCT00302159|17029480|P1|Overall Study|pt started Avastin|1
4951644|NCT00302159|17029480|P1|Overall Study|pt declined before treatment started|1
4951645|NCT00302107|17029502|P2|Overall Study|Adverse Event|0
4951646|NCT00302107|17029503|P1|Overall Study|Adverse Event|1
4951647|NCT00302107|17029502|P2|Overall Study|Withdrawal by Subject|3
4951648|NCT00302107|17029503|P1|Overall Study|Withdrawal by Subject|0
4951649|NCT00302107|17029502|P2|Overall Study|Relocation|1
4951650|NCT00302107|17029503|P1|Overall Study|Relocation|0
4951651|NCT00302107|17029502|P2|Overall Study|Protocol Violation|0
4951652|NCT00302107|17029503|P1|Overall Study|Protocol Violation|1
4951653|NCT00302107|17029502|P2|Overall Study|Lost to Follow-up|5
4951654|NCT00302107|17029503|P1|Overall Study|Lost to Follow-up|6
4951655|NCT00302081|17029512|P3|Overall Study|Other|5
4951656|NCT00302081|17029513|P2|Overall Study|Other|6
4951657|NCT00302081|17029514|P1|Overall Study|Other|13
4951658|NCT00302081|17029512|P3|Overall Study|Death|0
4951659|NCT00302081|17029513|P2|Overall Study|Death|1
4951660|NCT00302081|17029514|P1|Overall Study|Death|2
4951661|NCT00302081|17029512|P3|Overall Study|Lack of Efficacy|5
4951662|NCT00302081|17029513|P2|Overall Study|Lack of Efficacy|0
4951663|NCT00302081|17029514|P1|Overall Study|Lack of Efficacy|1
4951664|NCT00302081|17029512|P3|Overall Study|Protocol Violation|2
4951665|NCT00302081|17029513|P2|Overall Study|Protocol Violation|1
4951666|NCT00302081|17029514|P1|Overall Study|Protocol Violation|5
4951667|NCT00302081|17029512|P3|Overall Study|Withdrawal by Subject|8
4951668|NCT00302081|17029513|P2|Overall Study|Withdrawal by Subject|12
4951669|NCT00302081|17029514|P1|Overall Study|Withdrawal by Subject|8
4951670|NCT00302081|17029512|P3|Overall Study|Lost to Follow-up|28
4951671|NCT00302081|17029513|P2|Overall Study|Lost to Follow-up|18
4951672|NCT00302081|17029514|P1|Overall Study|Lost to Follow-up|21
4951673|NCT00302081|17029512|P3|Overall Study|Adverse Event|4
4951674|NCT00302081|17029513|P2|Overall Study|Adverse Event|5
4951675|NCT00302081|17029514|P1|Overall Study|Adverse Event|6
4951676|NCT00302003|17029571|P1|Overall Study|Protocol Violation|1
4951677|NCT00302003|17029571|P1|Overall Study|Ineligible|9
4951678|NCT00302003|17029571|P1|Overall Study|Withdrawal by Subject|5
4951679|NCT00302003|17029571|P1|Overall Study|Physician Decision|2
4951680|NCT00302003|17029571|P1|Overall Study|Lost to Follow-up|1
4951681|NCT00302003|17029571|P1|Overall Study|Lack of Efficacy|62
4951682|NCT00301964|17029578|P1|Overall Study|Inadequate pathology|1
4951683|NCT00301964|17029578|P1|Overall Study|Wrong primary|1
4951684|NCT00301964|17029578|P1|Overall Study|Second primary|2
4951685|NCT00301834|17029599|P1|Overall Study|Death|1
4951686|NCT00301821|17029608|P1|Overall Study|Cancel|1
4951687|NCT00301821|17029608|P1|Overall Study|Ineligible|25
4951688|NCT00301808|17029615|P1|Overall Study|Lack of Efficacy|4
4951689|NCT00301808|17029615|P1|Overall Study|Death|3
4951690|NCT00301808|17029615|P1|Overall Study|Adverse Event|5
4951691|NCT00301366|17029640|P1|Overall Study|Adverse Event|1
4951692|NCT00301262|17029646|P2|Open Label Phase (OL)|Other|0
4951693|NCT00301262|17029647|P1|Open Label Phase (OL)|Other|2
4951694|NCT00301262|17029646|P2|Open Label Phase (OL)|Lost to Follow-up|2
4951695|NCT00301262|17029647|P1|Open Label Phase (OL)|Lost to Follow-up|1
4951696|NCT00301262|17029646|P2|Open Label Phase (OL)|Adverse Event|0
4951697|NCT00301262|17029647|P1|Open Label Phase (OL)|Adverse Event|1
4951698|NCT00301262|17029646|P2|Double Blind Phase (DB)|Other|4
4951699|NCT00301262|17029647|P1|Double Blind Phase (DB)|Other|1
4951700|NCT00301262|17029646|P2|Double Blind Phase (DB)|Withdrawal by Subject|5
4951701|NCT00301262|17029647|P1|Double Blind Phase (DB)|Withdrawal by Subject|5
4951702|NCT00301262|17029646|P2|Double Blind Phase (DB)|Lost to Follow-up|3
4951703|NCT00301262|17029647|P1|Double Blind Phase (DB)|Lost to Follow-up|3
4951704|NCT00301262|17029646|P2|Double Blind Phase (DB)|Lack of Efficacy|1
4951705|NCT00301262|17029647|P1|Double Blind Phase (DB)|Lack of Efficacy|0
4951706|NCT00301262|17029646|P2|Double Blind Phase (DB)|Adverse Event|0
4951707|NCT00301262|17029647|P1|Double Blind Phase (DB)|Adverse Event|1
4951708|NCT00301080|17029805|P5|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4951709|NCT00301080|17029806|P4|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4951710|NCT00301080|17029807|P3|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4951711|NCT00301080|17029808|P2|Original Version (2 Arms & 4 Weeks)|Never received drug|0
4951712|NCT00301080|17029809|P1|Original Version (2 Arms & 4 Weeks)|Never received drug|1
4951713|NCT00301067|17029838|P4|Follow up Until Death|Alive at last data cut point|1
4951714|NCT00301067|17029839|P3|Follow up Until Death|Alive at last data cut point|0
4951715|NCT00301067|17029840|P2|Follow up Until Death|Alive at last data cut point|0
4951716|NCT00301067|17029841|P1|Follow up Until Death|Alive at last data cut point|1
4951717|NCT00301067|17029838|P4|Completed 12 Cycles of Treatment|Adverse Event|1
4951718|NCT00301067|17029839|P3|Completed 12 Cycles of Treatment|Adverse Event|0
4951719|NCT00301067|17029840|P2|Completed 12 Cycles of Treatment|Adverse Event|0
4951720|NCT00301067|17029841|P1|Completed 12 Cycles of Treatment|Adverse Event|0
4951721|NCT00301067|17029838|P4|Completed 12 Cycles of Treatment|Progressive Disease|1
4951722|NCT00301067|17029839|P3|Completed 12 Cycles of Treatment|Progressive Disease|0
4951723|NCT00301067|17029840|P2|Completed 12 Cycles of Treatment|Progressive Disease|1
4951724|NCT00301067|17029841|P1|Completed 12 Cycles of Treatment|Progressive Disease|0
4951725|NCT00301067|17029838|P4|Completed 4 Cycles of Treatment|Progressive disease|5
4951726|NCT00301067|17029839|P3|Completed 4 Cycles of Treatment|Progressive disease|2
4951727|NCT00301067|17029840|P2|Completed 4 Cycles of Treatment|Progressive disease|1
4951728|NCT00301067|17029841|P1|Completed 4 Cycles of Treatment|Progressive disease|1
4951729|NCT00301067|17029838|P4|Reached 1st Response/2 Cycles|Progressive Disease|2
4951730|NCT00301067|17029839|P3|Reached 1st Response/2 Cycles|Progressive Disease|1
4951731|NCT00301067|17029840|P2|Reached 1st Response/2 Cycles|Progressive Disease|1
4951732|NCT00301067|17029841|P1|Reached 1st Response/2 Cycles|Progressive Disease|2
4951733|NCT00301067|17029838|P4|Completed DLT Period/1st Cycle|Progressive Disease|1
4951734|NCT00301067|17029839|P3|Completed DLT Period/1st Cycle|Progressive Disease|0
4951735|NCT00301067|17029840|P2|Completed DLT Period/1st Cycle|Progressive Disease|0
4951736|NCT00301067|17029841|P1|Completed DLT Period/1st Cycle|Progressive Disease|1
4951737|NCT00300885|17029866|P2|Follow-up|Withdrawal by Subject|25
4951738|NCT00300885|17029867|P1|Follow-up|Withdrawal by Subject|26
4951739|NCT00300885|17029866|P2|Follow-up|Lost to Follow-up|7
4951740|NCT00300885|17029867|P1|Follow-up|Lost to Follow-up|11
4951741|NCT00300885|17029866|P2|Follow-up|Death|163
4951742|NCT00300885|17029867|P1|Follow-up|Death|141
4951743|NCT00300885|17029866|P2|Treatment|Non-compliant with study medication|4
4951744|NCT00300885|17029867|P1|Treatment|Non-compliant with study medication|3
4951745|NCT00300885|17029866|P2|Treatment|Random code broken (subject died)|1
4951746|NCT00300885|17029867|P1|Treatment|Random code broken (subject died)|0
4951747|NCT00300885|17029866|P2|Treatment|Disease progression|238
4951748|NCT00300885|17029867|P1|Treatment|Disease progression|171
4951749|NCT00300885|17029866|P2|Treatment|Withdrawal by Subject|23
4951750|NCT00300885|17029867|P1|Treatment|Withdrawal by Subject|26
4951751|NCT00300885|17029866|P2|Treatment|Protocol Violation|11
4951752|NCT00300885|17029867|P1|Treatment|Protocol Violation|11
4951753|NCT00300885|17029866|P2|Treatment|Physician Decision|5
4951754|NCT00300885|17029867|P1|Treatment|Physician Decision|4
4951755|NCT00300885|17029866|P2|Treatment|Lost to Follow-up|2
4951756|NCT00300885|17029867|P1|Treatment|Lost to Follow-up|3
4951757|NCT00300885|17029866|P2|Treatment|Lack of Efficacy|1
4951758|NCT00300885|17029867|P1|Treatment|Lack of Efficacy|1
4951759|NCT00300885|17029866|P2|Treatment|Death|7
4951760|NCT00300885|17029867|P1|Treatment|Death|20
4951761|NCT00300885|17029866|P2|Treatment|Adverse Event|82
4951762|NCT00300885|17029867|P1|Treatment|Adverse Event|134
4951763|NCT00300781|17029885|P2|Overall Study|Lost to Follow-up|1
4951764|NCT00300781|17029886|P1|Overall Study|Lost to Follow-up|0
4951765|NCT00300781|17029885|P2|Overall Study|Symptomatic Deterioration|0
4951766|NCT00300781|17029886|P1|Overall Study|Symptomatic Deterioration|1
4951767|NCT00300781|17029885|P2|Overall Study|Not Recorded|1
4951768|NCT00300781|17029886|P1|Overall Study|Not Recorded|0
4951769|NCT00300781|17029885|P2|Overall Study|Physician Decision|0
4951770|NCT00300781|17029886|P1|Overall Study|Physician Decision|1
4951771|NCT00300781|17029885|P2|Overall Study|Withdrawal by Subject|2
4951772|NCT00300781|17029886|P1|Overall Study|Withdrawal by Subject|1
4951773|NCT00300781|17029885|P2|Overall Study|Adverse Event|6
4951774|NCT00300781|17029886|P1|Overall Study|Adverse Event|5
4951775|NCT00300781|17029885|P2|Overall Study|Disease Progression|52
4951776|NCT00300781|17029886|P1|Overall Study|Disease Progression|55
4951777|NCT00300755|17029901|P3|Overall Study|Protocol Violation|1
4951778|NCT00300755|17029902|P2|Overall Study|Protocol Violation|0
4951779|NCT00300755|17029903|P1|Overall Study|Protocol Violation|0
4951780|NCT00300755|17029901|P3|Overall Study|Withdrawal by Subject|0
4951781|NCT00300755|17029902|P2|Overall Study|Withdrawal by Subject|2
4951782|NCT00300755|17029903|P1|Overall Study|Withdrawal by Subject|0
4951783|NCT00300755|17029901|P3|Overall Study|Adverse Event|1
4951784|NCT00300755|17029902|P2|Overall Study|Adverse Event|2
4951785|NCT00300755|17029903|P1|Overall Study|Adverse Event|1
4951786|NCT00300495|17029937|P2|Overall Study|Protocol Violation|1
4951787|NCT00300495|17029938|P1|Overall Study|Protocol Violation|4
4951788|NCT00300365|17030205|P2|Overall Study|Adverse Event|2
4951789|NCT00300365|17030206|P1|Overall Study|Adverse Event|0
4951790|NCT00300365|17030205|P2|Overall Study|Withdrawal by Subject|0
4951791|NCT00300365|17030206|P1|Overall Study|Withdrawal by Subject|1
4951792|NCT00300365|17030205|P2|Overall Study|Physician Decision|0
4951793|NCT00300365|17030206|P1|Overall Study|Physician Decision|2
4951794|NCT00300365|17030205|P2|Overall Study|Lost to Follow-up|0
4951795|NCT00300365|17030206|P1|Overall Study|Lost to Follow-up|1
4951796|NCT00300274|17030215|P3|Overall Study|Re-transplant|1
4951797|NCT00300274|17030216|P2|Overall Study|Re-transplant|0
4951798|NCT00300274|17030217|P1|Overall Study|Re-transplant|0
4951799|NCT00300274|17030215|P3|Overall Study|Death|25
4951800|NCT00300274|17030216|P2|Overall Study|Death|20
4951802|NCT00300274|17030215|P3|Overall Study|Lost to Follow-up|5
4951803|NCT00300274|17030216|P2|Overall Study|Lost to Follow-up|4
4951804|NCT00300274|17030217|P1|Overall Study|Lost to Follow-up|3
4951805|NCT00300274|17030215|P3|Overall Study|Withdrawal by Subject|14
4951806|NCT00300274|17030216|P2|Overall Study|Withdrawal by Subject|3
4951807|NCT00300274|17030217|P1|Overall Study|Withdrawal by Subject|12
4951808|NCT00299975|17030287|P3|Overall Study|Physician Decision|1
4951809|NCT00299975|17030288|P2|Overall Study|Physician Decision|0
4951810|NCT00299975|17030289|P1|Overall Study|Physician Decision|0
4951811|NCT00299975|17030287|P3|Overall Study|Withdrawal by Subject|3
4951812|NCT00299975|17030288|P2|Overall Study|Withdrawal by Subject|1
4951813|NCT00299975|17030289|P1|Overall Study|Withdrawal by Subject|0
4951814|NCT00299975|17030287|P3|Overall Study|Lost to Follow-up|0
4951815|NCT00299975|17030288|P2|Overall Study|Lost to Follow-up|0
4951816|NCT00299975|17030289|P1|Overall Study|Lost to Follow-up|1
4951817|NCT00299975|17030287|P3|Overall Study|Lack of Efficacy|1
4951818|NCT00299975|17030288|P2|Overall Study|Lack of Efficacy|0
4951819|NCT00299975|17030289|P1|Overall Study|Lack of Efficacy|1
4951820|NCT00299975|17030287|P3|Overall Study|Pregnancy|1
4951821|NCT00299975|17030288|P2|Overall Study|Pregnancy|0
4951822|NCT00299975|17030289|P1|Overall Study|Pregnancy|0
4951823|NCT00299975|17030287|P3|Overall Study|Adverse Event|2
4951824|NCT00299975|17030288|P2|Overall Study|Adverse Event|0
4951825|NCT00299975|17030289|P1|Overall Study|Adverse Event|1
4951826|NCT00299702|17030346|P2|Overall Study|Admin issues, sponsor decision, etc.|9
4951827|NCT00299702|17030347|P1|Overall Study|Admin issues, sponsor decision, etc.|5
4951828|NCT00299702|17030346|P2|Overall Study|Insufficient Response|3
4951829|NCT00299702|17030347|P1|Overall Study|Insufficient Response|4
4951830|NCT00299702|17030346|P2|Overall Study|Pregnancy|1
4951831|NCT00299702|17030347|P1|Overall Study|Pregnancy|0
4951832|NCT00299702|17030346|P2|Overall Study|Withdrawal by Subject|23
4951833|NCT00299702|17030347|P1|Overall Study|Withdrawal by Subject|25
4951834|NCT00299702|17030346|P2|Overall Study|Lost to Follow-up|10
4951835|NCT00299702|17030347|P1|Overall Study|Lost to Follow-up|18
4951836|NCT00299702|17030346|P2|Overall Study|Adverse Event|4
4951837|NCT00299702|17030347|P1|Overall Study|Adverse Event|0
4951838|NCT00299702|17030346|P2|Overall Study|Death|0
4951839|NCT00299702|17030347|P1|Overall Study|Death|1
4951840|NCT00299546|17030362|P3|Overall Study|Not treated|1
4951841|NCT00299546|17030363|P2|Overall Study|Not treated|1
4951842|NCT00299546|17030364|P1|Overall Study|Not treated|0
4951843|NCT00299546|17030362|P3|Overall Study|Other|19
4951844|NCT00299546|17030363|P2|Overall Study|Other|26
4951845|NCT00299546|17030364|P1|Overall Study|Other|24
4951846|NCT00299546|17030362|P3|Overall Study|Unsatisfactory therapeutic effect|34
4951847|NCT00299546|17030363|P2|Overall Study|Unsatisfactory therapeutic effect|39
4951848|NCT00299546|17030364|P1|Overall Study|Unsatisfactory therapeutic effect|34
4951849|NCT00299546|17030362|P3|Overall Study|Adverse Event|27
4951850|NCT00299546|17030363|P2|Overall Study|Adverse Event|22
4951851|NCT00299546|17030364|P1|Overall Study|Adverse Event|37
4951852|NCT00299546|17030362|P3|Overall Study|Lost to Follow-up|5
4951853|NCT00299546|17030363|P2|Overall Study|Lost to Follow-up|2
4951854|NCT00299546|17030364|P1|Overall Study|Lost to Follow-up|2
4951855|NCT00299546|17030362|P3|Overall Study|Death|0
4951856|NCT00299546|17030363|P2|Overall Study|Death|2
4951857|NCT00299546|17030364|P1|Overall Study|Death|3
4951858|NCT00299494|17030395|P6|Overall Study|Other - site closure|1
4951859|NCT00299494|17030396|P5|Overall Study|Other - site closure|1
4951860|NCT00299494|17030397|P4|Overall Study|Other - site closure|1
4951861|NCT00299494|17030398|P3|Overall Study|Other - site closure|0
4951862|NCT00299494|17030399|P2|Overall Study|Other - site closure|0
4951863|NCT00299494|17030400|P1|Overall Study|Other - site closure|0
4951864|NCT00299494|17030395|P6|Overall Study|Other - Unspecified|1
4951865|NCT00299494|17030396|P5|Overall Study|Other - Unspecified|3
4951866|NCT00299494|17030397|P4|Overall Study|Other - Unspecified|0
4951867|NCT00299494|17030398|P3|Overall Study|Other - Unspecified|0
4951868|NCT00299494|17030399|P2|Overall Study|Other - Unspecified|0
4951869|NCT00299494|17030400|P1|Overall Study|Other - Unspecified|0
4951870|NCT00299494|17030395|P6|Overall Study|Lost to Follow-up|1
4951871|NCT00299494|17030396|P5|Overall Study|Lost to Follow-up|3
4951872|NCT00299494|17030397|P4|Overall Study|Lost to Follow-up|0
4951873|NCT00299494|17030398|P3|Overall Study|Lost to Follow-up|0
4951874|NCT00299494|17030399|P2|Overall Study|Lost to Follow-up|0
4951875|NCT00299494|17030400|P1|Overall Study|Lost to Follow-up|0
4951876|NCT00299494|17030395|P6|Overall Study|Death|19
4951877|NCT00299494|17030396|P5|Overall Study|Death|18
4951878|NCT00299494|17030397|P4|Overall Study|Death|6
4951879|NCT00299494|17030398|P3|Overall Study|Death|4
4951880|NCT00299494|17030399|P2|Overall Study|Death|1
4951881|NCT00299494|17030400|P1|Overall Study|Death|3
4951882|NCT00299494|17030395|P6|Overall Study|Physician Decision|0
4951883|NCT00299494|17030396|P5|Overall Study|Physician Decision|1
4951884|NCT00299494|17030397|P4|Overall Study|Physician Decision|0
4951885|NCT00299494|17030398|P3|Overall Study|Physician Decision|0
4951886|NCT00299494|17030399|P2|Overall Study|Physician Decision|0
4951887|NCT00299494|17030400|P1|Overall Study|Physician Decision|0
4951888|NCT00299494|17030395|P6|Overall Study|Withdrawal by Subject|4
4951889|NCT00299494|17030396|P5|Overall Study|Withdrawal by Subject|1
4951890|NCT00299494|17030397|P4|Overall Study|Withdrawal by Subject|3
4951891|NCT00299494|17030398|P3|Overall Study|Withdrawal by Subject|0
4951892|NCT00299494|17030399|P2|Overall Study|Withdrawal by Subject|0
4951893|NCT00299494|17030400|P1|Overall Study|Withdrawal by Subject|0
4951894|NCT00299156|17030529|P3|Period 2 (Randomized)|Screen Failure|0
4951895|NCT00299156|17030530|P2|Period 2 (Randomized)|Screen Failure|1
4951896|NCT00299156|17030531|P1|Period 2 (Randomized)|Screen Failure|0
4951897|NCT00299130|17030542|P3|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4
4951898|NCT00299130|17030543|P2|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3
4951899|NCT00299130|17030544|P1|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0
4951900|NCT00299130|17030542|P3|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
4951901|NCT00299130|17030543|P2|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2
4951902|NCT00299130|17030544|P1|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0
4951903|NCT00299130|17030542|P3|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
4951904|NCT00299130|17030543|P2|Extended SFU (ESFU) (up to 5.1 Years)|Death|3
4951905|NCT00299130|17030544|P1|Extended SFU (ESFU) (up to 5.1 Years)|Death|0
4951906|NCT00299130|17030542|P3|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21
4951907|NCT00299130|17030543|P2|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
4951908|NCT00299130|17030544|P1|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22
4951909|NCT00299130|17030542|P3|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
4951910|NCT00299130|17030543|P2|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1
4951911|NCT00299130|17030544|P1|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0
4951912|NCT00299130|17030542|P3|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15
4951913|NCT00299130|17030543|P2|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7
4951914|NCT00299130|17030544|P1|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14
4951915|NCT00299130|17030542|P3|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2
4951916|NCT00299130|17030543|P2|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
4951917|NCT00299130|17030544|P1|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1
4951918|NCT00299130|17030542|P3|Safety Follow-up (SFU) (48 Weeks)|Death|3
4951919|NCT00299130|17030543|P2|Safety Follow-up (SFU) (48 Weeks)|Death|5
4951920|NCT00299130|17030544|P1|Safety Follow-up (SFU) (48 Weeks)|Death|4
4951921|NCT00299130|17030542|P3|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
4951922|NCT00299130|17030543|P2|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9
4951923|NCT00299130|17030544|P1|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4
4951924|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
4951925|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Withdrawal by Subject|1
4951926|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Withdrawal by Subject|0
4951927|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Reason not Specified|4
4951928|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Reason not Specified|6
4951929|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Reason not Specified|4
4951930|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Failure to Return|6
4951931|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Failure to Return|6
4951932|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Failure to Return|4
4951933|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Refused Treatment|19
4951934|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Refused Treatment|12
4951935|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Refused Treatment|12
4951936|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Protocol Violation|0
4951937|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Protocol Violation|1
4951938|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Protocol Violation|0
4951939|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
4951940|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6
4951941|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19
4951942|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Death|1
4951943|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Death|3
4951944|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Death|1
4951945|NCT00299130|17030542|P3|Treatment Period (up to 5 Years)|Adverse Event|13
4951946|NCT00299130|17030543|P2|Treatment Period (up to 5 Years)|Adverse Event|8
4951947|NCT00299130|17030544|P1|Treatment Period (up to 5 Years)|Adverse Event|13
4951948|NCT00299104|17030649|P3|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
4951949|NCT00299104|17030650|P2|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2
4951950|NCT00299104|17030651|P1|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1
4951951|NCT00299104|17030649|P3|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8
4951952|NCT00299104|17030650|P2|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4
4951953|NCT00299104|17030651|P1|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2
4951954|NCT00299104|17030649|P3|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
4951955|NCT00299104|17030650|P2|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
4951956|NCT00299104|17030651|P1|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2
4951957|NCT00299104|17030649|P3|Extended Safety Follow-Up (ESFU) Period|Death|0
4951958|NCT00299104|17030650|P2|Extended Safety Follow-Up (ESFU) Period|Death|1
4951959|NCT00299104|17030651|P1|Extended Safety Follow-Up (ESFU) Period|Death|0
4951960|NCT00299104|17030649|P3|Safety Follow-Up (SFU) Period|Administrative reasons|5
4951961|NCT00299104|17030650|P2|Safety Follow-Up (SFU) Period|Administrative reasons|7
4951962|NCT00299104|17030651|P1|Safety Follow-Up (SFU) Period|Administrative reasons|27
4951963|NCT00299104|17030649|P3|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11
4951964|NCT00299104|17030650|P2|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21
4951965|NCT00299104|17030651|P1|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16
4951966|NCT00299104|17030649|P3|Safety Follow-Up (SFU) Period|Lost to Follow-up|20
4951967|NCT00299104|17030650|P2|Safety Follow-Up (SFU) Period|Lost to Follow-up|11
4951968|NCT00299104|17030651|P1|Safety Follow-Up (SFU) Period|Lost to Follow-up|9
4951969|NCT00299104|17030649|P3|Safety Follow-Up (SFU) Period|Death|1
4951970|NCT00299104|17030650|P2|Safety Follow-Up (SFU) Period|Death|2
4951971|NCT00299104|17030651|P1|Safety Follow-Up (SFU) Period|Death|3
4951972|NCT00299104|17030649|P3|Treatment Period|Administrative reasons|137
4951973|NCT00299104|17030650|P2|Treatment Period|Administrative reasons|120
4951974|NCT00299104|17030651|P1|Treatment Period|Administrative reasons|106
4951975|NCT00299104|17030649|P3|Treatment Period|Withdrew consent|9
4951976|NCT00299104|17030650|P2|Treatment Period|Withdrew consent|19
4951977|NCT00299104|17030651|P1|Treatment Period|Withdrew consent|14
4951978|NCT00299104|17030649|P3|Treatment Period|Refused treatment|2
4951979|NCT00299104|17030650|P2|Treatment Period|Refused treatment|2
4951980|NCT00299104|17030651|P1|Treatment Period|Refused treatment|9
4951981|NCT00299104|17030649|P3|Treatment Period|Protocol Violation|0
4951982|NCT00299104|17030650|P2|Treatment Period|Protocol Violation|1
4951983|NCT00299104|17030651|P1|Treatment Period|Protocol Violation|1
4951984|NCT00299104|17030649|P3|Treatment Period|Violation of selection criteria|0
4951985|NCT00299104|17030650|P2|Treatment Period|Violation of selection criteria|2
4951986|NCT00299104|17030651|P1|Treatment Period|Violation of selection criteria|1
4951987|NCT00299104|17030649|P3|Treatment Period|Failure to return|8
4951988|NCT00299104|17030650|P2|Treatment Period|Failure to return|8
4951989|NCT00299104|17030651|P1|Treatment Period|Failure to return|9
4951990|NCT00299104|17030649|P3|Treatment Period|Insufficient therapeutic response|8
4951991|NCT00299104|17030650|P2|Treatment Period|Insufficient therapeutic response|13
4951992|NCT00299104|17030651|P1|Treatment Period|Insufficient therapeutic response|34
4951993|NCT00299104|17030649|P3|Treatment Period|Death|1
4951994|NCT00299104|17030650|P2|Treatment Period|Death|1
4951995|NCT00299104|17030651|P1|Treatment Period|Death|1
4951996|NCT00299104|17030649|P3|Treatment Period|Adverse Event|7
4951997|NCT00299104|17030650|P2|Treatment Period|Adverse Event|9
4951998|NCT00299104|17030651|P1|Treatment Period|Adverse Event|14
4951999|NCT00298896|17030761|P1|Overall Study|Assigned to treatment in error|1
4952000|NCT00298896|17030761|P1|Overall Study|Withdrawal by Subject|2
4952001|NCT00298896|17030761|P1|Overall Study|Disease Progression|41
4952002|NCT00298896|17030761|P1|Overall Study|Intercurrent Illness|1
4952003|NCT00298896|17030761|P1|Overall Study|Physician Decision|2
4952004|NCT00298896|17030761|P1|Overall Study|Death|3
4952005|NCT00298831|17030766|P1|Overall Study|Participants did not receive treatment|27
4952006|NCT00298831|17030766|P1|Overall Study|Withdrawal by Subject|1
4952007|NCT00298831|17030766|P1|Overall Study|Lost to Follow-up|3
4952008|NCT00298831|17030766|P1|Overall Study|Adverse Event|1
4952009|NCT00298766|17030775|P1|Overall Study|Other|4
4952010|NCT00298766|17030775|P1|Overall Study|Subjects overall condition deterioration|4
4952011|NCT00298766|17030775|P1|Overall Study|Deterioration in KPS and organ function|1
4952012|NCT00298766|17030775|P1|Overall Study|Progression of amyloid markers|4
4952013|NCT00298766|17030775|P1|Overall Study|Treatment ongoing|4
4952014|NCT00298766|17030775|P1|Overall Study|Withdrawal by Subject|9
4952015|NCT00298766|17030775|P1|Overall Study|Death|2
4952016|NCT00298766|17030775|P1|Overall Study|Adverse Event|18
4952017|NCT00298740|17030784|P1|Overall Study|Withdrawal by Subject|3
4952018|NCT00298740|17030784|P1|Overall Study|Lack of Efficacy|6
4952019|NCT00298363|17030854|P3|Overall Study|Lack of Efficacy|0
4952020|NCT00298363|17030855|P2|Overall Study|Lack of Efficacy|3
4952021|NCT00298363|17030856|P1|Overall Study|Lack of Efficacy|2
4952022|NCT00298363|17030854|P3|Overall Study|Adverse Event|2
4952023|NCT00298363|17030855|P2|Overall Study|Adverse Event|2
4952024|NCT00298363|17030856|P1|Overall Study|Adverse Event|5
4952025|NCT00298363|17030854|P3|Overall Study|Withdrawal by Subject|3
4952026|NCT00298363|17030855|P2|Overall Study|Withdrawal by Subject|1
4952027|NCT00298363|17030856|P1|Overall Study|Withdrawal by Subject|5
4952028|NCT00298363|17030854|P3|Overall Study|Protocol Violation|0
4952029|NCT00298363|17030855|P2|Overall Study|Protocol Violation|1
4952030|NCT00298363|17030856|P1|Overall Study|Protocol Violation|1
4952031|NCT00298363|17030854|P3|Overall Study|Physician Decision|0
4952032|NCT00298363|17030855|P2|Overall Study|Physician Decision|1
4952033|NCT00298363|17030856|P1|Overall Study|Physician Decision|4
4952034|NCT00298363|17030854|P3|Overall Study|Lost to Follow-up|1
4952035|NCT00298363|17030855|P2|Overall Study|Lost to Follow-up|0
4952036|NCT00298363|17030856|P1|Overall Study|Lost to Follow-up|0
4952037|NCT00298272|17031014|P2|Safety Follow-up Phase|Administrative/Other Reason|1
4952038|NCT00298272|17031015|P1|Safety Follow-up Phase|Administrative/Other Reason|1
4952039|NCT00298272|17031014|P2|Safety Follow-up Phase|Withdrawal by Subject|2
4952040|NCT00298272|17031015|P1|Safety Follow-up Phase|Withdrawal by Subject|2
4952041|NCT00298272|17031014|P2|Safety Follow-up Phase|Failure to Return|1
4952042|NCT00298272|17031015|P1|Safety Follow-up Phase|Failure to Return|1
4952043|NCT00298272|17031014|P2|Open Label Retreatment Phase|Administrative/Other Reason|0
4952044|NCT00298272|17031015|P1|Open Label Retreatment Phase|Administrative/Other Reason|2
4952045|NCT00298272|17031014|P2|Open Label Retreatment Phase|Withdrawal by Subject|0
4952046|NCT00298272|17031015|P1|Open Label Retreatment Phase|Withdrawal by Subject|1
4952047|NCT00298272|17031014|P2|Open Label Retreatment Phase|Protocol Violation|1
4952048|NCT00298272|17031015|P1|Open Label Retreatment Phase|Protocol Violation|2
4952049|NCT00298272|17031014|P2|Open Label Retreatment Phase|Failure to Return|0
4952050|NCT00298272|17031015|P1|Open Label Retreatment Phase|Failure to Return|1
4952051|NCT00298272|17031014|P2|Open Label Retreatment Phase|Insufficient Therapeutic Response|1
4952052|NCT00298272|17031015|P1|Open Label Retreatment Phase|Insufficient Therapeutic Response|2
4952053|NCT00298272|17031014|P2|Open Label Retreatment Phase|Adverse Event|2
4952054|NCT00298272|17031015|P1|Open Label Retreatment Phase|Adverse Event|1
4952055|NCT00298272|17031014|P2|Double-blind Phase|Withdrawal by Subject|0
4952056|NCT00298272|17031015|P1|Double-blind Phase|Withdrawal by Subject|2
4952057|NCT00298272|17031014|P2|Double-blind Phase|Protocol Violation|0
4952058|NCT00298272|17031015|P1|Double-blind Phase|Protocol Violation|2
4952059|NCT00298272|17031014|P2|Double-blind Phase|Failure to Return|0
4952060|NCT00298272|17031015|P1|Double-blind Phase|Failure to Return|2
4952061|NCT00298272|17031014|P2|Double-blind Phase|Adverse Event|0
4952062|NCT00298272|17031015|P1|Double-blind Phase|Adverse Event|2
4952063|NCT00298038|17031079|P2|Overall Study|Severe Gastrointestinal Bleed|0
4952064|NCT00298038|17031080|P1|Overall Study|Severe Gastrointestinal Bleed|1
4952065|NCT00298038|17031079|P2|Overall Study|Cocaine Abuse|0
4952066|NCT00298038|17031080|P1|Overall Study|Cocaine Abuse|1
4952067|NCT00298038|17031079|P2|Overall Study|Noncompliance|0
4952068|NCT00298038|17031080|P1|Overall Study|Noncompliance|1
4952069|NCT00298038|17031079|P2|Overall Study|Breakthrough overt HE episode|69
4952070|NCT00298038|17031080|P1|Overall Study|Breakthrough overt HE episode|28
4952071|NCT00298038|17031079|P2|Overall Study|Adverse Event|7
4952072|NCT00298038|17031080|P1|Overall Study|Adverse Event|8
4952073|NCT00298038|17031079|P2|Overall Study|Withdrawal by Subject|9
4952074|NCT00298038|17031080|P1|Overall Study|Withdrawal by Subject|6
4952075|NCT00298038|17031079|P2|Overall Study|Death|3
4952076|NCT00298038|17031080|P1|Overall Study|Death|6
4952077|NCT00298038|17031079|P2|Overall Study|Protocol Violation|3
4952078|NCT00298038|17031080|P1|Overall Study|Protocol Violation|1
4952079|NCT00298038|17031079|P2|Overall Study|Liver Transplant|1
4952080|NCT00298038|17031080|P1|Overall Study|Liver Transplant|0
4952081|NCT00298038|17031079|P2|Overall Study|Lost to Follow-up|1
4952082|NCT00298038|17031080|P1|Overall Study|Lost to Follow-up|0
4952083|NCT00297830|17031099|P3|12 Month Visit|Withdrawal by Subject|0
4952084|NCT00297830|17031100|P2|12 Month Visit|Withdrawal by Subject|3
4952085|NCT00297830|17031101|P1|12 Month Visit|Withdrawal by Subject|0
4952086|NCT00297830|17031099|P3|12 Month Visit|Adverse Event|0
4952087|NCT00297830|17031100|P2|12 Month Visit|Adverse Event|3
4952088|NCT00297830|17031101|P1|12 Month Visit|Adverse Event|0
4952089|NCT00297830|17031099|P3|12 Month Visit|Lost to Follow-up|0
4952090|NCT00297830|17031100|P2|12 Month Visit|Lost to Follow-up|0
4952091|NCT00297830|17031101|P1|12 Month Visit|Lost to Follow-up|1
4952092|NCT00297830|17031099|P3|6 Month Visit|Adverse Event|0
4952093|NCT00297830|17031100|P2|6 Month Visit|Adverse Event|1
4952094|NCT00297830|17031101|P1|6 Month Visit|Adverse Event|0
4952095|NCT00297830|17031099|P3|6 Month Visit|Withdrawal by Subject|1
4952096|NCT00297830|17031100|P2|6 Month Visit|Withdrawal by Subject|1
4952097|NCT00297830|17031101|P1|6 Month Visit|Withdrawal by Subject|2
4952098|NCT00297830|17031099|P3|6 Month Visit|Death|2
4952099|NCT00297830|17031100|P2|6 Month Visit|Death|0
4952100|NCT00297830|17031101|P1|6 Month Visit|Death|1
4952101|NCT00297778|17031120|P2|Overall Study|Other|1
4952102|NCT00297778|17031121|P1|Overall Study|Other|0
4952103|NCT00297778|17031120|P2|Overall Study|Non-compliant with trial protocol|3
4952104|NCT00297778|17031121|P1|Overall Study|Non-compliant with trial protocol|0
4952105|NCT00297778|17031120|P2|Overall Study|Lack of Efficacy|1
4952106|NCT00297778|17031121|P1|Overall Study|Lack of Efficacy|2
4952107|NCT00297778|17031120|P2|Overall Study|Withdrawal by Subject|5
4952108|NCT00297778|17031121|P1|Overall Study|Withdrawal by Subject|1
4952109|NCT00297778|17031120|P2|Overall Study|Adverse Event|10
4952110|NCT00297778|17031121|P1|Overall Study|Adverse Event|16
4952111|NCT00297648|17031155|P1|Overall Study|Other: Incompliance|1
4952112|NCT00297648|17031155|P1|Overall Study|Withdrawal by Subject|3
4952113|NCT00297648|17031155|P1|Overall Study|Lost to Follow-up|1
4952114|NCT00297648|17031155|P1|Overall Study|Lack of Efficacy|18
4952115|NCT00297648|17031155|P1|Overall Study|Adverse Event|13
4952116|NCT00297492|17031201|P3|6 Month Follow-up|Lost to Follow-up|27
4952117|NCT00297492|17031202|P2|6 Month Follow-up|Lost to Follow-up|49
4952118|NCT00297492|17031203|P1|6 Month Follow-up|Lost to Follow-up|63
4952119|NCT00297492|17031201|P3|Set Quit Date|Lost to Follow-up|5
4952120|NCT00297492|17031202|P2|Set Quit Date|Lost to Follow-up|13
4952121|NCT00297492|17031203|P1|Set Quit Date|Lost to Follow-up|7
4952122|NCT00297479|17031214|P3|Overall Study|Lost to Follow-up|51
4952123|NCT00297479|17031215|P2|Overall Study|Lost to Follow-up|54
4952124|NCT00297479|17031216|P1|Overall Study|Lost to Follow-up|37
4952125|NCT00297427|17031235|P2|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0
4952126|NCT00297427|17031236|P1|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2
4952127|NCT00297427|17031235|P2|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0
4952128|NCT00297427|17031236|P1|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3
4952129|NCT00297427|17031235|P2|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0
4952130|NCT00297427|17031236|P1|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29
4952131|NCT00297427|17031235|P2|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0
4952132|NCT00297427|17031236|P1|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1
4952133|NCT00297427|17031235|P2|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0
4952134|NCT00297427|17031236|P1|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15
4952135|NCT00297427|17031235|P2|Phase 1: Initial Intervention|Death|1
4952136|NCT00297427|17031236|P1|Phase 1: Initial Intervention|Death|0
4952137|NCT00297427|17031235|P2|Phase 1: Initial Intervention|Lost to Follow-up|3
4952138|NCT00297427|17031236|P1|Phase 1: Initial Intervention|Lost to Follow-up|0
4952139|NCT00297427|17031235|P2|Phase 1: Initial Intervention|Withdrawal by Subject|5
4952140|NCT00297427|17031236|P1|Phase 1: Initial Intervention|Withdrawal by Subject|8
4952141|NCT00297258|17031277|P1|Overall Study|Interruption: Cold/Flu-like Symptoms|1
4952142|NCT00297258|17031277|P1|Overall Study|Switch to Commercial Treatment|1
4952143|NCT00297258|17031277|P1|Overall Study|Surgery Performed on Target Lesion|1
4952144|NCT00297258|17031277|P1|Overall Study|Radiotherapy to Destroy Last Lesion|1
4952145|NCT00297258|17031277|P1|Overall Study|Deteriorization of General Condition|1
4952146|NCT00297258|17031277|P1|Overall Study|Intercurrent Death|2
4952147|NCT00297258|17031277|P1|Overall Study|Intercurrent Illness|3
4952148|NCT00297258|17031277|P1|Overall Study|Patient Refusal: Not Related to Toxicity|2
4952149|NCT00297258|17031277|P1|Overall Study|Toxicity (or Toxic Death)|10
4952150|NCT00297258|17031277|P1|Overall Study|Disease Progression, Relapse, Death|120
4952151|NCT00297232|17031296|P1|Overall Study|Other|1
4952152|NCT00297232|17031296|P1|Overall Study|No data available after Week 264|161
4952153|NCT00297232|17031296|P1|Overall Study|Did Not Enroll to Week 480|17
4952154|NCT00297232|17031296|P1|Overall Study|Did Not Enroll to Week 264|34
4952155|NCT00297232|17031296|P1|Overall Study|Investigator Withdrew From Program|19
4952156|NCT00297232|17031296|P1|Overall Study|Persistently Positive Antibodies|11
4952157|NCT00297232|17031296|P1|Overall Study|Subject Withdrew Consent|37
4952158|NCT00297232|17031296|P1|Overall Study|Subject Relocated|7
4952159|NCT00297232|17031296|P1|Overall Study|Sponsor Decision|34
4952160|NCT00297232|17031296|P1|Overall Study|Miscellaneous|5
4952161|NCT00297232|17031296|P1|Overall Study|Anti-JCV Antibody Positive|13
4952162|NCT00297232|17031296|P1|Overall Study|Fear of PML|10
4952163|NCT00297232|17031296|P1|Overall Study|Disease Progression|8
4952164|NCT00297232|17031296|P1|Overall Study|Switched to Commercial Tysabri|22
4952165|NCT00297232|17031296|P1|Overall Study|Anti-natalizumab Positive|8
4952166|NCT00297232|17031296|P1|Overall Study|Death|9
4952167|NCT00297232|17031296|P1|Overall Study|Subject was Noncompliant|9
4952168|NCT00297232|17031296|P1|Overall Study|Voluntary Withdrawal|120
4952169|NCT00297232|17031296|P1|Overall Study|Adverse Event|63
4952170|NCT00297232|17031296|P1|Overall Study|Lost to Follow-up|10
4952171|NCT00297232|17031296|P1|Overall Study|Lack of Efficacy|7
4952172|NCT00297167|17031302|P3|Second Double-blind Intervention Period|Protocol Violation|0
4952173|NCT00297167|17031303|P2|Second Double-blind Intervention Period|Protocol Violation|0
4952174|NCT00297167|17031304|P1|Second Double-blind Intervention Period|Protocol Violation|1
4952175|NCT00297167|17031302|P3|Open-label Dose Normalization Period 1|Withdrawal by Subject|1
4952176|NCT00297167|17031303|P2|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
4952177|NCT00297167|17031304|P1|Open-label Dose Normalization Period 1|Withdrawal by Subject|0
4952178|NCT00297037|17031368|P2|Overall Study|Withdrawal by Subject|0
4952179|NCT00297037|17031369|P1|Overall Study|Withdrawal by Subject|2
4952180|NCT00296816|17031381|P1|Overall Study|ineligibility due to radiation treatment|1
4952181|NCT00296816|17031381|P1|Overall Study|Proteinuria|1
4952182|NCT00296816|17031381|P1|Overall Study|Neuropathy/patient preference|1
4952183|NCT00296816|17031381|P1|Overall Study|Urine protein/creatinine ratio delay|1
4952184|NCT00296816|17031381|P1|Overall Study|Noncompliance/decision to discontinue|1
4952185|NCT00296816|17031381|P1|Overall Study|Relocation to Florida|1
4952186|NCT00296816|17031381|P1|Overall Study|Poor performance status|1
4952187|NCT00296816|17031381|P1|Overall Study|Progression based on CA-125 (biomarker)|2
4952188|NCT00296816|17031381|P1|Overall Study|Missing for end of treatment|4
4952189|NCT00296816|17031381|P1|Overall Study|Non-compliance|1
4952190|NCT00296816|17031381|P1|Overall Study|Investigator/Participant request|5
4952191|NCT00296816|17031381|P1|Overall Study|Adverse Event|18
4952192|NCT00296816|17031381|P1|Overall Study|Disease Progression|37
4952193|NCT00296725|17031393|P1|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1
4952194|NCT00296725|17031393|P1|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4
4952195|NCT00296725|17031393|P1|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1
4952196|NCT00296647|17031406|P5|Overall Study|Withdrawal by Subject|19
4952197|NCT00296647|17031407|P4|Overall Study|Withdrawal by Subject|16
4952198|NCT00296647|17031408|P3|Overall Study|Withdrawal by Subject|32
4952199|NCT00296647|17031409|P2|Overall Study|Withdrawal by Subject|27
4952200|NCT00296647|17031410|P1|Overall Study|Withdrawal by Subject|28
4952201|NCT00296647|17031406|P5|Overall Study|Death|1
4952202|NCT00296647|17031407|P4|Overall Study|Death|1
4952203|NCT00296647|17031408|P3|Overall Study|Death|2
4952204|NCT00296647|17031409|P2|Overall Study|Death|1
4952205|NCT00296647|17031410|P1|Overall Study|Death|4
4952206|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Other|2
4952207|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Other|0
4952208|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Non - Compliance|0
4952209|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Non - Compliance|1
4952210|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18
4952211|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7
4952212|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Protocol Violation|0
4952213|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Protocol Violation|1
4952214|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2
4952215|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3
4952216|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6
4952217|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3
4952218|NCT00296517|17031424|P2|Dose Level 3 - Weeks 3-12|Adverse Event|34
4952219|NCT00296517|17031425|P1|Dose Level 3 - Weeks 3-12|Adverse Event|30
4952220|NCT00296517|17031424|P2|Dose Level 2 - Week 2|Withdrawal by Subject|0
4952221|NCT00296517|17031425|P1|Dose Level 2 - Week 2|Withdrawal by Subject|1
4952222|NCT00296517|17031424|P2|Dose Level 2 - Week 2|Adverse Event|5
4952223|NCT00296517|17031425|P1|Dose Level 2 - Week 2|Adverse Event|1
4952224|NCT00296504|17031461|P9|Final Analysis|Poor Adherence|1
4952225|NCT00296504|17031462|P8|Final Analysis|Poor Adherence|0
4952226|NCT00296504|17031463|P7|Final Analysis|Poor Adherence|0
4952227|NCT00296504|17031464|P6|Final Analysis|Poor Adherence|0
4952228|NCT00296504|17031465|P5|Final Analysis|Poor Adherence|0
4952229|NCT00296504|17031466|P4|Final Analysis|Poor Adherence|0
4952230|NCT00296504|17031467|P3|Final Analysis|Poor Adherence|0
4952231|NCT00296504|17031468|P2|Final Analysis|Poor Adherence|0
4952232|NCT00296504|17031469|P1|Final Analysis|Poor Adherence|0
4952233|NCT00296504|17031461|P9|Final Analysis|Participant Moved to Another Country|1
4952234|NCT00296504|17031462|P8|Final Analysis|Participant Moved to Another Country|0
4952235|NCT00296504|17031463|P7|Final Analysis|Participant Moved to Another Country|0
4952236|NCT00296504|17031464|P6|Final Analysis|Participant Moved to Another Country|0
4952237|NCT00296504|17031465|P5|Final Analysis|Participant Moved to Another Country|0
4952238|NCT00296504|17031466|P4|Final Analysis|Participant Moved to Another Country|0
4952239|NCT00296504|17031467|P3|Final Analysis|Participant Moved to Another Country|0
4952240|NCT00296504|17031468|P2|Final Analysis|Participant Moved to Another Country|0
4952241|NCT00296504|17031469|P1|Final Analysis|Participant Moved to Another Country|0
4952242|NCT00296504|17031461|P9|Final Analysis|Tuberculosis|1
4952243|NCT00296504|17031462|P8|Final Analysis|Tuberculosis|0
4952244|NCT00296504|17031463|P7|Final Analysis|Tuberculosis|0
4952245|NCT00296504|17031464|P6|Final Analysis|Tuberculosis|0
4952246|NCT00296504|17031465|P5|Final Analysis|Tuberculosis|0
4952247|NCT00296504|17031466|P4|Final Analysis|Tuberculosis|0
4952248|NCT00296504|17031467|P3|Final Analysis|Tuberculosis|0
4952249|NCT00296504|17031468|P2|Final Analysis|Tuberculosis|0
4952250|NCT00296504|17031469|P1|Final Analysis|Tuberculosis|0
4952251|NCT00296504|17031461|P9|Final Analysis|Pregnancy|4
4952252|NCT00296504|17031462|P8|Final Analysis|Pregnancy|0
4952253|NCT00296504|17031463|P7|Final Analysis|Pregnancy|0
4952254|NCT00296504|17031464|P6|Final Analysis|Pregnancy|0
4952255|NCT00296504|17031465|P5|Final Analysis|Pregnancy|0
4952256|NCT00296504|17031466|P4|Final Analysis|Pregnancy|0
4952257|NCT00296504|17031467|P3|Final Analysis|Pregnancy|0
4952258|NCT00296504|17031468|P2|Final Analysis|Pregnancy|0
4952259|NCT00296504|17031469|P1|Final Analysis|Pregnancy|0
4952260|NCT00296504|17031461|P9|Final Analysis|Adverse Event|2
4952261|NCT00296504|17031462|P8|Final Analysis|Adverse Event|0
4952262|NCT00296504|17031463|P7|Final Analysis|Adverse Event|0
4952263|NCT00296504|17031464|P6|Final Analysis|Adverse Event|0
4952264|NCT00296504|17031465|P5|Final Analysis|Adverse Event|0
4952265|NCT00296504|17031466|P4|Final Analysis|Adverse Event|0
4952266|NCT00296504|17031467|P3|Final Analysis|Adverse Event|0
4952267|NCT00296504|17031468|P2|Final Analysis|Adverse Event|0
4952268|NCT00296504|17031469|P1|Final Analysis|Adverse Event|0
4952269|NCT00296504|17031461|P9|Final Analysis|Insufficient Viral Load Response|6
4952270|NCT00296504|17031462|P8|Final Analysis|Insufficient Viral Load Response|0
4952271|NCT00296504|17031463|P7|Final Analysis|Insufficient Viral Load Response|0
4952272|NCT00296504|17031464|P6|Final Analysis|Insufficient Viral Load Response|0
4952273|NCT00296504|17031465|P5|Final Analysis|Insufficient Viral Load Response|0
4952274|NCT00296504|17031466|P4|Final Analysis|Insufficient Viral Load Response|0
4952275|NCT00296504|17031467|P3|Final Analysis|Insufficient Viral Load Response|0
4952276|NCT00296504|17031468|P2|Final Analysis|Insufficient Viral Load Response|0
4952277|NCT00296504|17031469|P1|Final Analysis|Insufficient Viral Load Response|0
4952278|NCT00296504|17031461|P9|Final Analysis|Lost to Follow-up|5
4952279|NCT00296504|17031462|P8|Final Analysis|Lost to Follow-up|0
4952280|NCT00296504|17031463|P7|Final Analysis|Lost to Follow-up|0
4952281|NCT00296504|17031464|P6|Final Analysis|Lost to Follow-up|0
4952282|NCT00296504|17031465|P5|Final Analysis|Lost to Follow-up|0
4952283|NCT00296504|17031466|P4|Final Analysis|Lost to Follow-up|0
4952284|NCT00296504|17031467|P3|Final Analysis|Lost to Follow-up|0
4952285|NCT00296504|17031468|P2|Final Analysis|Lost to Follow-up|0
4952286|NCT00296504|17031469|P1|Final Analysis|Lost to Follow-up|0
4952287|NCT00296504|17031461|P9|Final Analysis|Withdrawal by Subject|1
4952288|NCT00296504|17031462|P8|Final Analysis|Withdrawal by Subject|0
4952289|NCT00296504|17031463|P7|Final Analysis|Withdrawal by Subject|0
4952290|NCT00296504|17031464|P6|Final Analysis|Withdrawal by Subject|0
4952291|NCT00296504|17031465|P5|Final Analysis|Withdrawal by Subject|0
4952292|NCT00296504|17031466|P4|Final Analysis|Withdrawal by Subject|0
4952293|NCT00296504|17031467|P3|Final Analysis|Withdrawal by Subject|0
4952294|NCT00296504|17031468|P2|Final Analysis|Withdrawal by Subject|0
4952295|NCT00296504|17031469|P1|Final Analysis|Withdrawal by Subject|0
4952296|NCT00296504|17031461|P9|Interim Analysis|Ongoing|0
4952297|NCT00296504|17031462|P8|Interim Analysis|Ongoing|1
4952298|NCT00296504|17031463|P7|Interim Analysis|Ongoing|30
4952299|NCT00296504|17031464|P6|Interim Analysis|Ongoing|0
4952300|NCT00296504|17031465|P5|Interim Analysis|Ongoing|0
4952301|NCT00296504|17031466|P4|Interim Analysis|Ongoing|22
4952302|NCT00296504|17031467|P3|Interim Analysis|Ongoing|16
4952303|NCT00296504|17031468|P2|Interim Analysis|Ongoing|12
4952304|NCT00296504|17031469|P1|Interim Analysis|Ongoing|32
4952305|NCT00296504|17031461|P9|Interim Analysis|Participant Needed Interferon|0
4952306|NCT00296504|17031462|P8|Interim Analysis|Participant Needed Interferon|1
4952307|NCT00296504|17031463|P7|Interim Analysis|Participant Needed Interferon|0
4952308|NCT00296504|17031464|P6|Interim Analysis|Participant Needed Interferon|0
4952309|NCT00296504|17031465|P5|Interim Analysis|Participant Needed Interferon|0
4952310|NCT00296504|17031466|P4|Interim Analysis|Participant Needed Interferon|0
4952311|NCT00296504|17031467|P3|Interim Analysis|Participant Needed Interferon|0
4952312|NCT00296504|17031468|P2|Interim Analysis|Participant Needed Interferon|0
4952313|NCT00296504|17031469|P1|Interim Analysis|Participant Needed Interferon|0
4952314|NCT00296504|17031461|P9|Interim Analysis|Study Ended|0
4952315|NCT00296504|17031462|P8|Interim Analysis|Study Ended|0
4952316|NCT00296504|17031463|P7|Interim Analysis|Study Ended|1
4952317|NCT00296504|17031464|P6|Interim Analysis|Study Ended|0
4952318|NCT00296504|17031465|P5|Interim Analysis|Study Ended|0
4952319|NCT00296504|17031466|P4|Interim Analysis|Study Ended|0
4952320|NCT00296504|17031467|P3|Interim Analysis|Study Ended|0
4952321|NCT00296504|17031468|P2|Interim Analysis|Study Ended|0
4952322|NCT00296504|17031469|P1|Interim Analysis|Study Ended|0
4952323|NCT00296504|17031461|P9|Interim Analysis|Participant Stopped HIV Medications|0
4952324|NCT00296504|17031462|P8|Interim Analysis|Participant Stopped HIV Medications|0
4952325|NCT00296504|17031463|P7|Interim Analysis|Participant Stopped HIV Medications|1
4952326|NCT00296504|17031464|P6|Interim Analysis|Participant Stopped HIV Medications|0
4952327|NCT00296504|17031465|P5|Interim Analysis|Participant Stopped HIV Medications|0
4952328|NCT00296504|17031466|P4|Interim Analysis|Participant Stopped HIV Medications|0
4952329|NCT00296504|17031467|P3|Interim Analysis|Participant Stopped HIV Medications|0
4952330|NCT00296504|17031468|P2|Interim Analysis|Participant Stopped HIV Medications|0
4952331|NCT00296504|17031469|P1|Interim Analysis|Participant Stopped HIV Medications|0
4952332|NCT00296504|17031461|P9|Interim Analysis|Physician and Participant Decision|0
4952333|NCT00296504|17031462|P8|Interim Analysis|Physician and Participant Decision|0
4952334|NCT00296504|17031463|P7|Interim Analysis|Physician and Participant Decision|0
4952335|NCT00296504|17031464|P6|Interim Analysis|Physician and Participant Decision|1
4952336|NCT00296504|17031465|P5|Interim Analysis|Physician and Participant Decision|0
4952337|NCT00296504|17031466|P4|Interim Analysis|Physician and Participant Decision|0
4952338|NCT00296504|17031467|P3|Interim Analysis|Physician and Participant Decision|0
4952339|NCT00296504|17031468|P2|Interim Analysis|Physician and Participant Decision|0
4952340|NCT00296504|17031469|P1|Interim Analysis|Physician and Participant Decision|0
4952341|NCT00296504|17031461|P9|Interim Analysis|Participant Stopped|0
4952342|NCT00296504|17031462|P8|Interim Analysis|Participant Stopped|0
4952343|NCT00296504|17031463|P7|Interim Analysis|Participant Stopped|0
4952344|NCT00296504|17031464|P6|Interim Analysis|Participant Stopped|0
4952345|NCT00296504|17031465|P5|Interim Analysis|Participant Stopped|1
4952346|NCT00296504|17031466|P4|Interim Analysis|Participant Stopped|0
4952347|NCT00296504|17031467|P3|Interim Analysis|Participant Stopped|0
4952348|NCT00296504|17031468|P2|Interim Analysis|Participant Stopped|0
4952349|NCT00296504|17031469|P1|Interim Analysis|Participant Stopped|0
4952350|NCT00296504|17031461|P9|Interim Analysis|Inclusion in Other Protocol|0
4952351|NCT00296504|17031462|P8|Interim Analysis|Inclusion in Other Protocol|0
4952352|NCT00296504|17031463|P7|Interim Analysis|Inclusion in Other Protocol|0
4952353|NCT00296504|17031464|P6|Interim Analysis|Inclusion in Other Protocol|0
4952354|NCT00296504|17031465|P5|Interim Analysis|Inclusion in Other Protocol|0
4952355|NCT00296504|17031466|P4|Interim Analysis|Inclusion in Other Protocol|1
4952356|NCT00296504|17031467|P3|Interim Analysis|Inclusion in Other Protocol|0
4952357|NCT00296504|17031468|P2|Interim Analysis|Inclusion in Other Protocol|0
4952358|NCT00296504|17031469|P1|Interim Analysis|Inclusion in Other Protocol|0
4952359|NCT00296504|17031461|P9|Interim Analysis|Missed Schedule Date|0
4952360|NCT00296504|17031462|P8|Interim Analysis|Missed Schedule Date|0
4952361|NCT00296504|17031463|P7|Interim Analysis|Missed Schedule Date|0
4952362|NCT00296504|17031464|P6|Interim Analysis|Missed Schedule Date|0
4952363|NCT00296504|17031465|P5|Interim Analysis|Missed Schedule Date|0
4952364|NCT00296504|17031466|P4|Interim Analysis|Missed Schedule Date|0
4952365|NCT00296504|17031467|P3|Interim Analysis|Missed Schedule Date|0
4952366|NCT00296504|17031468|P2|Interim Analysis|Missed Schedule Date|0
4952367|NCT00296504|17031469|P1|Interim Analysis|Missed Schedule Date|1
4952368|NCT00296504|17031461|P9|Interim Analysis|Lack of Personnel at Site|0
4952369|NCT00296504|17031462|P8|Interim Analysis|Lack of Personnel at Site|0
4952370|NCT00296504|17031463|P7|Interim Analysis|Lack of Personnel at Site|0
4952371|NCT00296504|17031464|P6|Interim Analysis|Lack of Personnel at Site|0
4952372|NCT00296504|17031465|P5|Interim Analysis|Lack of Personnel at Site|0
4952373|NCT00296504|17031466|P4|Interim Analysis|Lack of Personnel at Site|0
4952374|NCT00296504|17031467|P3|Interim Analysis|Lack of Personnel at Site|0
4952375|NCT00296504|17031468|P2|Interim Analysis|Lack of Personnel at Site|0
4952376|NCT00296504|17031469|P1|Interim Analysis|Lack of Personnel at Site|1
4952377|NCT00296504|17031461|P9|Interim Analysis|Site Closing|0
4952378|NCT00296504|17031462|P8|Interim Analysis|Site Closing|0
4952379|NCT00296504|17031463|P7|Interim Analysis|Site Closing|2
4952380|NCT00296504|17031464|P6|Interim Analysis|Site Closing|1
4952381|NCT00296504|17031465|P5|Interim Analysis|Site Closing|0
4952382|NCT00296504|17031466|P4|Interim Analysis|Site Closing|0
4952383|NCT00296504|17031467|P3|Interim Analysis|Site Closing|0
4952384|NCT00296504|17031468|P2|Interim Analysis|Site Closing|0
4952385|NCT00296504|17031469|P1|Interim Analysis|Site Closing|1
4952386|NCT00296504|17031461|P9|Interim Analysis|Non-adherence|0
4952387|NCT00296504|17031462|P8|Interim Analysis|Non-adherence|1
4952388|NCT00296504|17031463|P7|Interim Analysis|Non-adherence|0
4952389|NCT00296504|17031464|P6|Interim Analysis|Non-adherence|0
4952390|NCT00296504|17031465|P5|Interim Analysis|Non-adherence|1
4952391|NCT00296504|17031466|P4|Interim Analysis|Non-adherence|0
4952392|NCT00296504|17031467|P3|Interim Analysis|Non-adherence|0
4952393|NCT00296504|17031468|P2|Interim Analysis|Non-adherence|0
4952394|NCT00296504|17031469|P1|Interim Analysis|Non-adherence|2
4952395|NCT00296504|17031461|P9|Interim Analysis|Principle Investigator Terminated Study|0
4952396|NCT00296504|17031462|P8|Interim Analysis|Principle Investigator Terminated Study|0
4952397|NCT00296504|17031463|P7|Interim Analysis|Principle Investigator Terminated Study|0
4952398|NCT00296504|17031464|P6|Interim Analysis|Principle Investigator Terminated Study|0
4952399|NCT00296504|17031465|P5|Interim Analysis|Principle Investigator Terminated Study|0
4952400|NCT00296504|17031466|P4|Interim Analysis|Principle Investigator Terminated Study|0
4952401|NCT00296504|17031467|P3|Interim Analysis|Principle Investigator Terminated Study|1
4952402|NCT00296504|17031468|P2|Interim Analysis|Principle Investigator Terminated Study|0
4952403|NCT00296504|17031469|P1|Interim Analysis|Principle Investigator Terminated Study|0
4952404|NCT00296504|17031461|P9|Interim Analysis|Principle Investigator Discretion|0
4952405|NCT00296504|17031462|P8|Interim Analysis|Principle Investigator Discretion|0
4952406|NCT00296504|17031463|P7|Interim Analysis|Principle Investigator Discretion|0
4952407|NCT00296504|17031464|P6|Interim Analysis|Principle Investigator Discretion|0
4952408|NCT00296504|17031465|P5|Interim Analysis|Principle Investigator Discretion|0
4952409|NCT00296504|17031466|P4|Interim Analysis|Principle Investigator Discretion|1
4952410|NCT00296504|17031467|P3|Interim Analysis|Principle Investigator Discretion|1
4952411|NCT00296504|17031468|P2|Interim Analysis|Principle Investigator Discretion|0
4952412|NCT00296504|17031469|P1|Interim Analysis|Principle Investigator Discretion|2
4952413|NCT00296504|17031461|P9|Interim Analysis|Physician Decision|0
4952414|NCT00296504|17031462|P8|Interim Analysis|Physician Decision|0
4952415|NCT00296504|17031463|P7|Interim Analysis|Physician Decision|0
4952416|NCT00296504|17031464|P6|Interim Analysis|Physician Decision|0
4952417|NCT00296504|17031465|P5|Interim Analysis|Physician Decision|0
4952418|NCT00296504|17031466|P4|Interim Analysis|Physician Decision|0
4952419|NCT00296504|17031467|P3|Interim Analysis|Physician Decision|1
4952420|NCT00296504|17031468|P2|Interim Analysis|Physician Decision|0
4952421|NCT00296504|17031469|P1|Interim Analysis|Physician Decision|0
4952422|NCT00296504|17031461|P9|Interim Analysis|Resistance to FPV|0
4952423|NCT00296504|17031462|P8|Interim Analysis|Resistance to FPV|0
4952424|NCT00296504|17031463|P7|Interim Analysis|Resistance to FPV|0
4952425|NCT00296504|17031464|P6|Interim Analysis|Resistance to FPV|0
4952426|NCT00296504|17031465|P5|Interim Analysis|Resistance to FPV|0
4952427|NCT00296504|17031466|P4|Interim Analysis|Resistance to FPV|0
4952428|NCT00296504|17031467|P3|Interim Analysis|Resistance to FPV|1
4952429|NCT00296504|17031468|P2|Interim Analysis|Resistance to FPV|0
4952430|NCT00296504|17031469|P1|Interim Analysis|Resistance to FPV|0
4952431|NCT00296504|17031461|P9|Interim Analysis|Participant Was Incarcerated|0
4952432|NCT00296504|17031462|P8|Interim Analysis|Participant Was Incarcerated|0
4952433|NCT00296504|17031463|P7|Interim Analysis|Participant Was Incarcerated|0
4952434|NCT00296504|17031464|P6|Interim Analysis|Participant Was Incarcerated|0
4952435|NCT00296504|17031465|P5|Interim Analysis|Participant Was Incarcerated|0
4952436|NCT00296504|17031466|P4|Interim Analysis|Participant Was Incarcerated|0
4952437|NCT00296504|17031467|P3|Interim Analysis|Participant Was Incarcerated|1
4952438|NCT00296504|17031468|P2|Interim Analysis|Participant Was Incarcerated|0
4952439|NCT00296504|17031469|P1|Interim Analysis|Participant Was Incarcerated|2
4952440|NCT00296504|17031461|P9|Interim Analysis|Participant Moved|0
4952441|NCT00296504|17031462|P8|Interim Analysis|Participant Moved|0
4952442|NCT00296504|17031463|P7|Interim Analysis|Participant Moved|1
4952443|NCT00296504|17031464|P6|Interim Analysis|Participant Moved|1
4952444|NCT00296504|17031465|P5|Interim Analysis|Participant Moved|0
4952445|NCT00296504|17031466|P4|Interim Analysis|Participant Moved|0
4952446|NCT00296504|17031467|P3|Interim Analysis|Participant Moved|1
4952447|NCT00296504|17031468|P2|Interim Analysis|Participant Moved|0
4952448|NCT00296504|17031469|P1|Interim Analysis|Participant Moved|1
4952449|NCT00296504|17031461|P9|Interim Analysis|Participant Had Problems with Alcohol|0
4952450|NCT00296504|17031462|P8|Interim Analysis|Participant Had Problems with Alcohol|0
4952451|NCT00296504|17031463|P7|Interim Analysis|Participant Had Problems with Alcohol|0
4952452|NCT00296504|17031464|P6|Interim Analysis|Participant Had Problems with Alcohol|0
4952453|NCT00296504|17031465|P5|Interim Analysis|Participant Had Problems with Alcohol|0
4952454|NCT00296504|17031466|P4|Interim Analysis|Participant Had Problems with Alcohol|0
4952455|NCT00296504|17031467|P3|Interim Analysis|Participant Had Problems with Alcohol|1
4952456|NCT00296504|17031468|P2|Interim Analysis|Participant Had Problems with Alcohol|0
4952457|NCT00296504|17031469|P1|Interim Analysis|Participant Had Problems with Alcohol|0
4952458|NCT00296504|17031461|P9|Interim Analysis|To Simplify Treatment|0
4952459|NCT00296504|17031462|P8|Interim Analysis|To Simplify Treatment|0
4952460|NCT00296504|17031463|P7|Interim Analysis|To Simplify Treatment|2
4952461|NCT00296504|17031464|P6|Interim Analysis|To Simplify Treatment|0
4952462|NCT00296504|17031465|P5|Interim Analysis|To Simplify Treatment|0
4952463|NCT00296504|17031466|P4|Interim Analysis|To Simplify Treatment|0
4952464|NCT00296504|17031467|P3|Interim Analysis|To Simplify Treatment|1
4952465|NCT00296504|17031468|P2|Interim Analysis|To Simplify Treatment|0
4952466|NCT00296504|17031469|P1|Interim Analysis|To Simplify Treatment|0
4952467|NCT00296504|17031461|P9|Interim Analysis|Participant Wanted to Become Pregnant|0
4952468|NCT00296504|17031462|P8|Interim Analysis|Participant Wanted to Become Pregnant|0
4952469|NCT00296504|17031463|P7|Interim Analysis|Participant Wanted to Become Pregnant|0
4952470|NCT00296504|17031464|P6|Interim Analysis|Participant Wanted to Become Pregnant|1
4952471|NCT00296504|17031465|P5|Interim Analysis|Participant Wanted to Become Pregnant|0
4952472|NCT00296504|17031466|P4|Interim Analysis|Participant Wanted to Become Pregnant|0
4952473|NCT00296504|17031467|P3|Interim Analysis|Participant Wanted to Become Pregnant|2
4952474|NCT00296504|17031468|P2|Interim Analysis|Participant Wanted to Become Pregnant|0
4952475|NCT00296504|17031469|P1|Interim Analysis|Participant Wanted to Become Pregnant|0
4952476|NCT00296504|17031461|P9|Interim Analysis|Participant Non-compliant|0
4952477|NCT00296504|17031462|P8|Interim Analysis|Participant Non-compliant|2
4952478|NCT00296504|17031463|P7|Interim Analysis|Participant Non-compliant|6
4952479|NCT00296504|17031464|P6|Interim Analysis|Participant Non-compliant|3
4952480|NCT00296504|17031465|P5|Interim Analysis|Participant Non-compliant|1
4952481|NCT00296504|17031466|P4|Interim Analysis|Participant Non-compliant|1
4952482|NCT00296504|17031467|P3|Interim Analysis|Participant Non-compliant|2
4952483|NCT00296504|17031468|P2|Interim Analysis|Participant Non-compliant|1
4952484|NCT00296504|17031469|P1|Interim Analysis|Participant Non-compliant|0
4952485|NCT00296504|17031461|P9|Interim Analysis|Death|0
4952486|NCT00296504|17031462|P8|Interim Analysis|Death|0
4952487|NCT00296504|17031463|P7|Interim Analysis|Death|0
4952488|NCT00296504|17031464|P6|Interim Analysis|Death|0
4952489|NCT00296504|17031465|P5|Interim Analysis|Death|0
4952490|NCT00296504|17031466|P4|Interim Analysis|Death|0
4952491|NCT00296504|17031467|P3|Interim Analysis|Death|3
4952492|NCT00296504|17031468|P2|Interim Analysis|Death|0
4952493|NCT00296504|17031469|P1|Interim Analysis|Death|1
4952494|NCT00296504|17031461|P9|Interim Analysis|Pregnancy|0
4952495|NCT00296504|17031462|P8|Interim Analysis|Pregnancy|1
4952496|NCT00296504|17031463|P7|Interim Analysis|Pregnancy|1
4952497|NCT00296504|17031464|P6|Interim Analysis|Pregnancy|1
4952498|NCT00296504|17031465|P5|Interim Analysis|Pregnancy|0
4952499|NCT00296504|17031466|P4|Interim Analysis|Pregnancy|2
4952500|NCT00296504|17031467|P3|Interim Analysis|Pregnancy|4
4952501|NCT00296504|17031468|P2|Interim Analysis|Pregnancy|1
4952502|NCT00296504|17031469|P1|Interim Analysis|Pregnancy|4
4952503|NCT00296504|17031461|P9|Interim Analysis|Switched to Commercially Available Drug|0
4952504|NCT00296504|17031462|P8|Interim Analysis|Switched to Commercially Available Drug|4
4952505|NCT00296504|17031463|P7|Interim Analysis|Switched to Commercially Available Drug|3
4952506|NCT00296504|17031464|P6|Interim Analysis|Switched to Commercially Available Drug|5
4952507|NCT00296504|17031465|P5|Interim Analysis|Switched to Commercially Available Drug|0
4952508|NCT00296504|17031466|P4|Interim Analysis|Switched to Commercially Available Drug|1
4952509|NCT00296504|17031467|P3|Interim Analysis|Switched to Commercially Available Drug|4
4952510|NCT00296504|17031468|P2|Interim Analysis|Switched to Commercially Available Drug|0
4952511|NCT00296504|17031469|P1|Interim Analysis|Switched to Commercially Available Drug|2
4952512|NCT00296504|17031461|P9|Interim Analysis|Insufficient CD4 Response|0
4952513|NCT00296504|17031462|P8|Interim Analysis|Insufficient CD4 Response|0
4952514|NCT00296504|17031463|P7|Interim Analysis|Insufficient CD4 Response|0
4952515|NCT00296504|17031464|P6|Interim Analysis|Insufficient CD4 Response|1
4952516|NCT00296504|17031465|P5|Interim Analysis|Insufficient CD4 Response|1
4952517|NCT00296504|17031466|P4|Interim Analysis|Insufficient CD4 Response|0
4952518|NCT00296504|17031467|P3|Interim Analysis|Insufficient CD4 Response|0
4952519|NCT00296504|17031468|P2|Interim Analysis|Insufficient CD4 Response|0
4952520|NCT00296504|17031469|P1|Interim Analysis|Insufficient CD4 Response|0
4952521|NCT00296504|17031461|P9|Interim Analysis|Protocol Violation|0
4952522|NCT00296504|17031462|P8|Interim Analysis|Protocol Violation|1
4952523|NCT00296504|17031463|P7|Interim Analysis|Protocol Violation|0
4952524|NCT00296504|17031464|P6|Interim Analysis|Protocol Violation|0
4952525|NCT00296504|17031465|P5|Interim Analysis|Protocol Violation|1
4952526|NCT00296504|17031466|P4|Interim Analysis|Protocol Violation|0
4952527|NCT00296504|17031467|P3|Interim Analysis|Protocol Violation|2
4952528|NCT00296504|17031468|P2|Interim Analysis|Protocol Violation|0
4952529|NCT00296504|17031469|P1|Interim Analysis|Protocol Violation|0
4952530|NCT00296504|17031461|P9|Interim Analysis|Adverse Event|0
4952531|NCT00296504|17031462|P8|Interim Analysis|Adverse Event|5
4952532|NCT00296504|17031463|P7|Interim Analysis|Adverse Event|4
4952533|NCT00296504|17031464|P6|Interim Analysis|Adverse Event|3
4952534|NCT00296504|17031465|P5|Interim Analysis|Adverse Event|6
4952535|NCT00296504|17031466|P4|Interim Analysis|Adverse Event|4
4952536|NCT00296504|17031467|P3|Interim Analysis|Adverse Event|13
4952537|NCT00296504|17031468|P2|Interim Analysis|Adverse Event|0
4952538|NCT00296504|17031469|P1|Interim Analysis|Adverse Event|0
4952539|NCT00296504|17031461|P9|Interim Analysis|Insufficient Viral Load Response|0
4952540|NCT00296504|17031462|P8|Interim Analysis|Insufficient Viral Load Response|24
4952541|NCT00296504|17031463|P7|Interim Analysis|Insufficient Viral Load Response|2
4952542|NCT00296504|17031464|P6|Interim Analysis|Insufficient Viral Load Response|9
4952543|NCT00296504|17031465|P5|Interim Analysis|Insufficient Viral Load Response|7
4952544|NCT00296504|17031466|P4|Interim Analysis|Insufficient Viral Load Response|2
4952545|NCT00296504|17031467|P3|Interim Analysis|Insufficient Viral Load Response|12
4952546|NCT00296504|17031468|P2|Interim Analysis|Insufficient Viral Load Response|1
4952547|NCT00296504|17031469|P1|Interim Analysis|Insufficient Viral Load Response|5
4952548|NCT00296504|17031461|P9|Interim Analysis|Clinical Progression|0
4952549|NCT00296504|17031462|P8|Interim Analysis|Clinical Progression|2
4952550|NCT00296504|17031463|P7|Interim Analysis|Clinical Progression|1
4952551|NCT00296504|17031464|P6|Interim Analysis|Clinical Progression|2
4952552|NCT00296504|17031465|P5|Interim Analysis|Clinical Progression|0
4952553|NCT00296504|17031466|P4|Interim Analysis|Clinical Progression|1
4952554|NCT00296504|17031467|P3|Interim Analysis|Clinical Progression|1
4952555|NCT00296504|17031468|P2|Interim Analysis|Clinical Progression|0
4952556|NCT00296504|17031469|P1|Interim Analysis|Clinical Progression|1
4952557|NCT00296504|17031461|P9|Interim Analysis|Lost to Follow-up|0
4952558|NCT00296504|17031462|P8|Interim Analysis|Lost to Follow-up|4
4952559|NCT00296504|17031463|P7|Interim Analysis|Lost to Follow-up|11
4952560|NCT00296504|17031464|P6|Interim Analysis|Lost to Follow-up|4
4952561|NCT00296504|17031465|P5|Interim Analysis|Lost to Follow-up|14
4952562|NCT00296504|17031466|P4|Interim Analysis|Lost to Follow-up|8
4952563|NCT00296504|17031467|P3|Interim Analysis|Lost to Follow-up|26
4952564|NCT00296504|17031468|P2|Interim Analysis|Lost to Follow-up|3
4952565|NCT00296504|17031469|P1|Interim Analysis|Lost to Follow-up|13
4952566|NCT00296504|17031461|P9|Interim Analysis|Withdrawal by Subject|0
4952567|NCT00296504|17031462|P8|Interim Analysis|Withdrawal by Subject|3
4952568|NCT00296504|17031463|P7|Interim Analysis|Withdrawal by Subject|9
4952569|NCT00296504|17031464|P6|Interim Analysis|Withdrawal by Subject|5
4952570|NCT00296504|17031465|P5|Interim Analysis|Withdrawal by Subject|5
4952571|NCT00296504|17031466|P4|Interim Analysis|Withdrawal by Subject|0
4952572|NCT00296504|17031467|P3|Interim Analysis|Withdrawal by Subject|12
4952573|NCT00296504|17031468|P2|Interim Analysis|Withdrawal by Subject|0
4952574|NCT00296504|17031469|P1|Interim Analysis|Withdrawal by Subject|8
4952575|NCT00296491|17031562|P4|Overall Study|Lost to Follow-up|0
4952576|NCT00296491|17031563|P3|Overall Study|Lost to Follow-up|2
4952577|NCT00296491|17031564|P2|Overall Study|Lost to Follow-up|2
4952578|NCT00296491|17031565|P1|Overall Study|Lost to Follow-up|0
4952579|NCT00296491|17031562|P4|Overall Study|Non-Compliance|14
4952580|NCT00296491|17031563|P3|Overall Study|Non-Compliance|10
4952581|NCT00296491|17031564|P2|Overall Study|Non-Compliance|13
4952582|NCT00296491|17031565|P1|Overall Study|Non-Compliance|12
4952583|NCT00296491|17031562|P4|Overall Study|Withdrawal by Subject|2
4952584|NCT00296491|17031563|P3|Overall Study|Withdrawal by Subject|3
4952585|NCT00296491|17031564|P2|Overall Study|Withdrawal by Subject|3
4952586|NCT00296491|17031565|P1|Overall Study|Withdrawal by Subject|7
4952587|NCT00296491|17031562|P4|Overall Study|Withdrawn due to Asthma|4
4952588|NCT00296491|17031563|P3|Overall Study|Withdrawn due to Asthma|0
4952589|NCT00296491|17031564|P2|Overall Study|Withdrawn due to Asthma|0
4952590|NCT00296491|17031565|P1|Overall Study|Withdrawn due to Asthma|0
4952591|NCT00296491|17031562|P4|Overall Study|Adverse Event|4
4952592|NCT00296491|17031563|P3|Overall Study|Adverse Event|1
4952593|NCT00296491|17031564|P2|Overall Study|Adverse Event|3
4952594|NCT00296491|17031565|P1|Overall Study|Adverse Event|1
4952595|NCT00296491|17031562|P4|Overall Study|Protocol Violation|3
4952596|NCT00296491|17031563|P3|Overall Study|Protocol Violation|2
4952597|NCT00296491|17031564|P2|Overall Study|Protocol Violation|6
4952598|NCT00296491|17031565|P1|Overall Study|Protocol Violation|4
4952599|NCT00296491|17031562|P4|Overall Study|Low Pollen Counts|16
4952600|NCT00296491|17031563|P3|Overall Study|Low Pollen Counts|25
4952601|NCT00296491|17031564|P2|Overall Study|Low Pollen Counts|26
4952602|NCT00296491|17031565|P1|Overall Study|Low Pollen Counts|18
4952603|NCT00296400|17031594|P3|Overall Study|Pregnancy|0
4952604|NCT00296400|17031595|P2|Overall Study|Pregnancy|2
4952605|NCT00296400|17031596|P1|Overall Study|Pregnancy|1
4952606|NCT00296400|17031594|P3|Overall Study|Visit 10 was performed earlier|0
4952607|NCT00296400|17031595|P2|Overall Study|Visit 10 was performed earlier|1
4952608|NCT00296400|17031596|P1|Overall Study|Visit 10 was performed earlier|0
4952609|NCT00296400|17031594|P3|Overall Study|Study specific discontinuation criteria|1
4952610|NCT00296400|17031595|P2|Overall Study|Study specific discontinuation criteria|0
4952611|NCT00296400|17031596|P1|Overall Study|Study specific discontinuation criteria|0
4952612|NCT00296400|17031594|P3|Overall Study|Lost to Follow-up|2
4952613|NCT00296400|17031595|P2|Overall Study|Lost to Follow-up|1
4952614|NCT00296400|17031596|P1|Overall Study|Lost to Follow-up|1
4952615|NCT00296400|17031594|P3|Overall Study|Protocol Violation|1
4952616|NCT00296400|17031595|P2|Overall Study|Protocol Violation|1
4952617|NCT00296400|17031596|P1|Overall Study|Protocol Violation|1
4952618|NCT00296400|17031594|P3|Overall Study|Incorrect enrollment|0
4952619|NCT00296400|17031595|P2|Overall Study|Incorrect enrollment|0
4952620|NCT00296400|17031596|P1|Overall Study|Incorrect enrollment|2
4952621|NCT00296400|17031594|P3|Overall Study|Withdrawal by Subject|2
4952622|NCT00296400|17031595|P2|Overall Study|Withdrawal by Subject|6
4952623|NCT00296400|17031596|P1|Overall Study|Withdrawal by Subject|5
4952624|NCT00296400|17031594|P3|Overall Study|Adverse Event|7
4952625|NCT00296400|17031595|P2|Overall Study|Adverse Event|7
4952626|NCT00296400|17031596|P1|Overall Study|Adverse Event|7
4952627|NCT00296374|17031820|P3|Overall Study|Other|1
4952628|NCT00296374|17031821|P2|Overall Study|Other|0
4952629|NCT00296374|17031822|P1|Overall Study|Other|0
4952630|NCT00296374|17031820|P3|Overall Study|Pregnancy|2
4952631|NCT00296374|17031821|P2|Overall Study|Pregnancy|0
4952632|NCT00296374|17031822|P1|Overall Study|Pregnancy|0
4952633|NCT00296374|17031820|P3|Overall Study|Nephrologist introduced ACE|0
4952634|NCT00296374|17031821|P2|Overall Study|Nephrologist introduced ACE|1
4952635|NCT00296374|17031822|P1|Overall Study|Nephrologist introduced ACE|0
4952636|NCT00296374|17031820|P3|Overall Study|Stopped drug before end of study visit|0
4952637|NCT00296374|17031821|P2|Overall Study|Stopped drug before end of study visit|1
4952638|NCT00296374|17031822|P1|Overall Study|Stopped drug before end of study visit|0
4952639|NCT00296374|17031820|P3|Overall Study|Relocated to another state|0
4952640|NCT00296374|17031821|P2|Overall Study|Relocated to another state|0
4952641|NCT00296374|17031822|P1|Overall Study|Relocated to another state|1
4952642|NCT00296374|17031820|P3|Overall Study|Lost to Follow-up|1
4952643|NCT00296374|17031821|P2|Overall Study|Lost to Follow-up|1
4952644|NCT00296374|17031822|P1|Overall Study|Lost to Follow-up|3
4952645|NCT00296374|17031820|P3|Overall Study|Protocol Violation|3
4952646|NCT00296374|17031821|P2|Overall Study|Protocol Violation|2
4952647|NCT00296374|17031822|P1|Overall Study|Protocol Violation|1
4952648|NCT00296374|17031820|P3|Overall Study|Incorrect enrollment|4
4952649|NCT00296374|17031821|P2|Overall Study|Incorrect enrollment|3
4952650|NCT00296374|17031822|P1|Overall Study|Incorrect enrollment|3
4952651|NCT00296374|17031820|P3|Overall Study|Withdrawal by Subject|11
4952652|NCT00296374|17031821|P2|Overall Study|Withdrawal by Subject|5
4952653|NCT00296374|17031822|P1|Overall Study|Withdrawal by Subject|3
4952654|NCT00296374|17031820|P3|Overall Study|Adverse Event|7
4952655|NCT00296374|17031821|P2|Overall Study|Adverse Event|10
4952656|NCT00296374|17031822|P1|Overall Study|Adverse Event|14
4952657|NCT00296335|17032045|P2|Overall Study|Physician Decision|11
4952658|NCT00296335|17032046|P1|Overall Study|Physician Decision|3
4952659|NCT00296335|17032045|P2|Overall Study|Lost to Follow-up|33
4952660|NCT00296335|17032046|P1|Overall Study|Lost to Follow-up|7
4952661|NCT00296335|17032045|P2|Overall Study|Adverse Event|27
4952662|NCT00296335|17032046|P1|Overall Study|Adverse Event|17
4952663|NCT00296335|17032045|P2|Overall Study|Recurrence|51
4952664|NCT00296335|17032046|P1|Overall Study|Recurrence|3
4952665|NCT00296244|17032086|P2|Overall Study|Underwent retransplant|1
4952666|NCT00296244|17032087|P1|Overall Study|Underwent retransplant|0
4952667|NCT00296140|17032151|P2|Overall Study|Discharge to Nursing Home|0
4952668|NCT00296140|17032152|P1|Overall Study|Discharge to Nursing Home|1
4952669|NCT00296140|17032151|P2|Overall Study|Withdrawal by Subject|0
4952670|NCT00296140|17032152|P1|Overall Study|Withdrawal by Subject|1
4952671|NCT00296140|17032151|P2|Overall Study|Lost to Follow-up|0
4952672|NCT00296140|17032152|P1|Overall Study|Lost to Follow-up|1
4952673|NCT00296036|17032164|P6|Overall Study|Protocol Violation|3
4952674|NCT00296036|17032165|P5|Overall Study|Protocol Violation|0
4952675|NCT00296036|17032166|P4|Overall Study|Protocol Violation|0
4952676|NCT00296036|17032167|P3|Overall Study|Protocol Violation|0
4952677|NCT00296036|17032168|P2|Overall Study|Protocol Violation|0
4952678|NCT00296036|17032169|P1|Overall Study|Protocol Violation|0
4952679|NCT00296036|17032164|P6|Overall Study|Withdrawal by Subject|1
4952680|NCT00296036|17032165|P5|Overall Study|Withdrawal by Subject|2
4952681|NCT00296036|17032166|P4|Overall Study|Withdrawal by Subject|1
4952682|NCT00296036|17032167|P3|Overall Study|Withdrawal by Subject|2
4952683|NCT00296036|17032168|P2|Overall Study|Withdrawal by Subject|0
4952684|NCT00296036|17032169|P1|Overall Study|Withdrawal by Subject|1
4952685|NCT00295932|17032206|P11|Overall Study|Not Treated|1
4952686|NCT00295932|17032207|P10|Overall Study|Not Treated|0
4952687|NCT00295932|17032208|P9|Overall Study|Not Treated|0
4952688|NCT00295932|17032209|P8|Overall Study|Not Treated|0
4952689|NCT00295932|17032210|P7|Overall Study|Not Treated|0
4952690|NCT00295932|17032211|P6|Overall Study|Not Treated|0
4952691|NCT00295932|17032212|P5|Overall Study|Not Treated|0
4952692|NCT00295932|17032213|P4|Overall Study|Not Treated|0
4952693|NCT00295932|17032214|P3|Overall Study|Not Treated|0
4952694|NCT00295932|17032215|P2|Overall Study|Not Treated|0
4952695|NCT00295932|17032216|P1|Overall Study|Not Treated|0
4952696|NCT00295880|17032250|P1|Overall Study|Unit randomization did not occur|1
4952697|NCT00295880|17032250|P1|Overall Study|IBMI unit could not be volume reduced|1
4952698|NCT00295854|17032270|P3|Overall Study|Other|1
4952699|NCT00295854|17032271|P2|Overall Study|Other|5
4952700|NCT00295854|17032272|P1|Overall Study|Other|3
4952701|NCT00295854|17032270|P3|Overall Study|required a prohibited medication|0
4952702|NCT00295854|17032271|P2|Overall Study|required a prohibited medication|0
4952703|NCT00295854|17032272|P1|Overall Study|required a prohibited medication|1
4952704|NCT00295854|17032270|P3|Overall Study|did not continue to meet criteria|2
4952705|NCT00295854|17032271|P2|Overall Study|did not continue to meet criteria|1
4952706|NCT00295854|17032272|P1|Overall Study|did not continue to meet criteria|1
4952707|NCT00295854|17032270|P3|Overall Study|Withdrawal by Subject|4
4952708|NCT00295854|17032271|P2|Overall Study|Withdrawal by Subject|7
4952709|NCT00295854|17032272|P1|Overall Study|Withdrawal by Subject|3
4952710|NCT00295854|17032270|P3|Overall Study|Lost to Follow-up|1
4952711|NCT00295854|17032271|P2|Overall Study|Lost to Follow-up|0
4952712|NCT00295854|17032272|P1|Overall Study|Lost to Follow-up|2
4952713|NCT00295854|17032270|P3|Overall Study|Protocol Violation|1
4952714|NCT00295854|17032271|P2|Overall Study|Protocol Violation|1
4952715|NCT00295854|17032272|P1|Overall Study|Protocol Violation|1
4952716|NCT00295854|17032270|P3|Overall Study|Adverse Event|6
4952717|NCT00295854|17032271|P2|Overall Study|Adverse Event|7
4952718|NCT00295854|17032272|P1|Overall Study|Adverse Event|7
4952719|NCT00295750|17032286|P3|Overall Study|Protocol Violation|2
4952720|NCT00295750|17032287|P2|Overall Study|Protocol Violation|4
4952721|NCT00295750|17032288|P1|Overall Study|Protocol Violation|2
4952722|NCT00295750|17032286|P3|Overall Study|Withdrawal by Subject|7
4952723|NCT00295750|17032287|P2|Overall Study|Withdrawal by Subject|4
4952724|NCT00295750|17032288|P1|Overall Study|Withdrawal by Subject|9
4952725|NCT00295750|17032286|P3|Overall Study|Randomized but never received trial drug|3
4952726|NCT00295750|17032287|P2|Overall Study|Randomized but never received trial drug|3
4952727|NCT00295750|17032288|P1|Overall Study|Randomized but never received trial drug|4
4952728|NCT00295750|17032286|P3|Overall Study|Personal reasons|0
4952729|NCT00295750|17032287|P2|Overall Study|Personal reasons|1
4952730|NCT00295750|17032288|P1|Overall Study|Personal reasons|0
4952731|NCT00295750|17032286|P3|Overall Study|Disease progression|0
4952732|NCT00295750|17032287|P2|Overall Study|Disease progression|1
4952733|NCT00295750|17032288|P1|Overall Study|Disease progression|2
4952734|NCT00295750|17032286|P3|Overall Study|Trial drug errors|0
4952735|NCT00295750|17032287|P2|Overall Study|Trial drug errors|1
4952736|NCT00295750|17032288|P1|Overall Study|Trial drug errors|1
4952737|NCT00295750|17032286|P3|Overall Study|Administrative errors|5
4952738|NCT00295750|17032287|P2|Overall Study|Administrative errors|4
4952739|NCT00295750|17032288|P1|Overall Study|Administrative errors|2
4952740|NCT00295750|17032286|P3|Overall Study|Taking prohibited therapy|2
4952741|NCT00295750|17032287|P2|Overall Study|Taking prohibited therapy|3
4952742|NCT00295750|17032288|P1|Overall Study|Taking prohibited therapy|2
4952743|NCT00295750|17032286|P3|Overall Study|Lost to Follow-up|1
4952744|NCT00295750|17032287|P2|Overall Study|Lost to Follow-up|4
4952745|NCT00295750|17032288|P1|Overall Study|Lost to Follow-up|1
4952746|NCT00295750|17032286|P3|Overall Study|Lack of Efficacy|0
4952747|NCT00295750|17032287|P2|Overall Study|Lack of Efficacy|1
4952748|NCT00295750|17032288|P1|Overall Study|Lack of Efficacy|1
4952749|NCT00295750|17032286|P3|Overall Study|Adverse Event|12
4952750|NCT00295750|17032287|P2|Overall Study|Adverse Event|15
4952751|NCT00295750|17032288|P1|Overall Study|Adverse Event|19
4952752|NCT00295633|17032323|P3|Overall Study|Administrative reason by sponsor|1
4952753|NCT00295633|17032324|P2|Overall Study|Administrative reason by sponsor|0
4952754|NCT00295633|17032325|P1|Overall Study|Administrative reason by sponsor|0
4952755|NCT00295633|17032323|P3|Overall Study|Death|0
4952756|NCT00295633|17032324|P2|Overall Study|Death|1
4952757|NCT00295633|17032325|P1|Overall Study|Death|1
4952758|NCT00295633|17032323|P3|Overall Study|Subject No Longer Meets Study Criteria|3
4952759|NCT00295633|17032324|P2|Overall Study|Subject No Longer Meets Study Criteria|3
4952760|NCT00295633|17032325|P1|Overall Study|Subject No Longer Meets Study Criteria|0
4952761|NCT00295633|17032323|P3|Overall Study|Poor/Noncompliance|6
4952762|NCT00295633|17032324|P2|Overall Study|Poor/Noncompliance|2
4952763|NCT00295633|17032325|P1|Overall Study|Poor/Noncompliance|2
4952764|NCT00295633|17032323|P3|Overall Study|Physician Decision|8
4952765|NCT00295633|17032324|P2|Overall Study|Physician Decision|10
4952766|NCT00295633|17032325|P1|Overall Study|Physician Decision|9
4952767|NCT00295633|17032323|P3|Overall Study|Lost to Follow-up|7
4952768|NCT00295633|17032324|P2|Overall Study|Lost to Follow-up|11
4952769|NCT00295633|17032325|P1|Overall Study|Lost to Follow-up|6
4952770|NCT00295633|17032323|P3|Overall Study|Adverse Event|9
4952771|NCT00295633|17032324|P2|Overall Study|Adverse Event|17
4952772|NCT00295633|17032325|P1|Overall Study|Adverse Event|9
4952773|NCT00295633|17032323|P3|Overall Study|Withdrawal of consent by subject|26
4952774|NCT00295633|17032324|P2|Overall Study|Withdrawal of consent by subject|16
4952775|NCT00295633|17032325|P1|Overall Study|Withdrawal of consent by subject|16
4952776|NCT00295633|17032323|P3|Overall Study|Lack of Efficacy|16
4952777|NCT00295633|17032324|P2|Overall Study|Lack of Efficacy|7
4952778|NCT00295633|17032325|P1|Overall Study|Lack of Efficacy|19
4952779|NCT00295620|17032344|P2|Overall Study|Protocol Violation|32
4952780|NCT00295620|17032345|P1|Overall Study|Protocol Violation|30
4952781|NCT00295620|17032344|P2|Overall Study|Discontinuation by sponsor|593
4952782|NCT00295620|17032345|P1|Overall Study|Discontinuation by sponsor|580
4952783|NCT00295620|17032344|P2|Overall Study|Other reasons|9
4952784|NCT00295620|17032345|P1|Overall Study|Other reasons|10
4952785|NCT00295620|17032344|P2|Overall Study|Death|207
4952786|NCT00295620|17032345|P1|Overall Study|Death|206
4952787|NCT00295620|17032344|P2|Overall Study|Withdrawal by Subject|50
4952788|NCT00295620|17032345|P1|Overall Study|Withdrawal by Subject|37
4952789|NCT00295620|17032344|P2|Overall Study|Lost to Follow-up|5
4952790|NCT00295620|17032345|P1|Overall Study|Lost to Follow-up|9
4952791|NCT00295490|17032369|P4|Overall Study|Other|1
4952792|NCT00295490|17032370|P3|Overall Study|Other|0
4952793|NCT00295490|17032371|P2|Overall Study|Other|2
4952794|NCT00295490|17032372|P1|Overall Study|Other|0
4952795|NCT00295490|17032369|P4|Overall Study|Adverse Event|0
4952796|NCT00295490|17032370|P3|Overall Study|Adverse Event|0
4952797|NCT00295490|17032371|P2|Overall Study|Adverse Event|0
4952798|NCT00295490|17032372|P1|Overall Study|Adverse Event|1
4952799|NCT00295490|17032369|P4|Overall Study|Lost to Follow-up|0
4952800|NCT00295490|17032370|P3|Overall Study|Lost to Follow-up|1
4952801|NCT00295490|17032371|P2|Overall Study|Lost to Follow-up|0
4952802|NCT00295490|17032372|P1|Overall Study|Lost to Follow-up|0
4952803|NCT00295490|17032369|P4|Overall Study|Withdrawal by Subject|1
4952804|NCT00295490|17032370|P3|Overall Study|Withdrawal by Subject|0
4952805|NCT00295490|17032371|P2|Overall Study|Withdrawal by Subject|2
4952806|NCT00295490|17032372|P1|Overall Study|Withdrawal by Subject|0
4952807|NCT00295490|17032369|P4|Overall Study|Protocol Violation|3
4952808|NCT00295490|17032370|P3|Overall Study|Protocol Violation|3
4952809|NCT00295490|17032371|P2|Overall Study|Protocol Violation|0
4952810|NCT00295490|17032372|P1|Overall Study|Protocol Violation|0
4952811|NCT00295022|17032422|P3|Overall Study|Withdrawal by Subject|2
4952812|NCT00295022|17032423|P2|Overall Study|Withdrawal by Subject|0
4952813|NCT00295022|17032424|P1|Overall Study|Withdrawal by Subject|0
4952814|NCT00295022|17032422|P3|Overall Study|Lost to Follow-up|1
4952815|NCT00295022|17032423|P2|Overall Study|Lost to Follow-up|0
4952816|NCT00295022|17032424|P1|Overall Study|Lost to Follow-up|0
4952817|NCT00295022|17032422|P3|Overall Study|Adverse Event|2
4952818|NCT00295022|17032423|P2|Overall Study|Adverse Event|1
4952819|NCT00295022|17032424|P1|Overall Study|Adverse Event|1
4952820|NCT00294762|17032540|P2|Overall Study|Did not receive study treatment|3
4952821|NCT00294762|17032541|P1|Overall Study|Did not receive study treatment|3
4952822|NCT00294723|17032560|P3|Additional Open-Label Extension 91 Weeks|Not specified in study report|3
4952823|NCT00294723|17032561|P2|Additional Open-Label Extension 91 Weeks|Not specified in study report|5
4952824|NCT00294723|17032562|P1|Additional Open-Label Extension 91 Weeks|Not specified in study report|2
4952825|NCT00294723|17032560|P3|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
4952826|NCT00294723|17032561|P2|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
4952827|NCT00294723|17032562|P1|Additional Open-Label Extension 91 Weeks|Protocol Violation|1
4952828|NCT00294723|17032560|P3|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16
4952829|NCT00294723|17032561|P2|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14
4952830|NCT00294723|17032562|P1|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24
4952831|NCT00294723|17032560|P3|Additional Open-Label Extension 91 Weeks|Adverse Event|0
4952832|NCT00294723|17032561|P2|Additional Open-Label Extension 91 Weeks|Adverse Event|1
4952833|NCT00294723|17032562|P1|Additional Open-Label Extension 91 Weeks|Adverse Event|1
4952834|NCT00294723|17032560|P3|Open-Label Extension 52 Weeks|Not specified in study report|14
4952835|NCT00294723|17032561|P2|Open-Label Extension 52 Weeks|Not specified in study report|16
4952836|NCT00294723|17032562|P1|Open-Label Extension 52 Weeks|Not specified in study report|19
4952837|NCT00294723|17032560|P3|Open-Label Extension 52 Weeks|Protocol Violation|3
4952838|NCT00294723|17032561|P2|Open-Label Extension 52 Weeks|Protocol Violation|3
4952839|NCT00294723|17032562|P1|Open-Label Extension 52 Weeks|Protocol Violation|4
4952840|NCT00294723|17032560|P3|Open-Label Extension 52 Weeks|Lack of Efficacy|21
4952841|NCT00294723|17032561|P2|Open-Label Extension 52 Weeks|Lack of Efficacy|15
4952842|NCT00294723|17032562|P1|Open-Label Extension 52 Weeks|Lack of Efficacy|12
4952843|NCT00294723|17032560|P3|Open-Label Extension 52 Weeks|Adverse Event|2
4952844|NCT00294723|17032561|P2|Open-Label Extension 52 Weeks|Adverse Event|5
4952845|NCT00294723|17032562|P1|Open-Label Extension 52 Weeks|Adverse Event|5
4952846|NCT00294723|17032560|P3|Double-Blind Period 52 Weeks|Not specified in study report|51
4952847|NCT00294723|17032561|P2|Double-Blind Period 52 Weeks|Not specified in study report|38
4952848|NCT00294723|17032562|P1|Double-Blind Period 52 Weeks|Not specified in study report|36
4952849|NCT00294723|17032560|P3|Double-Blind Period 52 Weeks|Protocol Violation|5
4952850|NCT00294723|17032561|P2|Double-Blind Period 52 Weeks|Protocol Violation|11
4952851|NCT00294723|17032562|P1|Double-Blind Period 52 Weeks|Protocol Violation|11
4952852|NCT00294723|17032560|P3|Double-Blind Period 52 Weeks|Lack of Efficacy|25
4952853|NCT00294723|17032561|P2|Double-Blind Period 52 Weeks|Lack of Efficacy|15
4952854|NCT00294723|17032562|P1|Double-Blind Period 52 Weeks|Lack of Efficacy|9
4952855|NCT00294723|17032560|P3|Double-Blind Period 52 Weeks|Adverse Event|15
4952856|NCT00294723|17032561|P2|Double-Blind Period 52 Weeks|Adverse Event|25
4952857|NCT00294723|17032562|P1|Double-Blind Period 52 Weeks|Adverse Event|18
4952858|NCT00294684|17032623|P2|Overall Study|Lost to Follow-up|8
4952859|NCT00294684|17032624|P1|Overall Study|Lost to Follow-up|5
4952860|NCT00294671|17032664|P2|Overall Study|Death|1
4952861|NCT00294671|17032665|P1|Overall Study|Death|0
4952862|NCT00294671|17032664|P2|Overall Study|Non-compliance|0
4952863|NCT00294671|17032665|P1|Overall Study|Non-compliance|1
4952864|NCT00294671|17032664|P2|Overall Study|Lost to Follow-up|3
4952865|NCT00294671|17032665|P1|Overall Study|Lost to Follow-up|1
4952866|NCT00294671|17032664|P2|Overall Study|Non-drug related AE|2
4952867|NCT00294671|17032665|P1|Overall Study|Non-drug related AE|3
4952868|NCT00294671|17032664|P2|Overall Study|Drug related adverse event (AE)|2
4952869|NCT00294671|17032665|P1|Overall Study|Drug related adverse event (AE)|4
4952870|NCT00294671|17032664|P2|Overall Study|Liver transplant|9
4952871|NCT00294671|17032665|P1|Overall Study|Liver transplant|7
4952872|NCT00294671|17032664|P2|Overall Study|Lack of Efficacy|23
4952873|NCT00294671|17032665|P1|Overall Study|Lack of Efficacy|11
4952874|NCT00294658|17032681|P2|Overall Study|Patient and family were not satisfied|1
4952875|NCT00294658|17032682|P1|Overall Study|Patient and family were not satisfied|0
4952876|NCT00294658|17032681|P2|Overall Study|Found to have invasive thymoma|0
4952877|NCT00294658|17032682|P1|Overall Study|Found to have invasive thymoma|1
4952878|NCT00294658|17032681|P2|Overall Study|Withdrawal by Subject|4
4952879|NCT00294658|17032682|P1|Overall Study|Withdrawal by Subject|0
4952880|NCT00294658|17032681|P2|Overall Study|Pregnancy|1
4952881|NCT00294658|17032682|P1|Overall Study|Pregnancy|0
4952882|NCT00294658|17032681|P2|Overall Study|Physician Decision|2
4952883|NCT00294658|17032682|P1|Overall Study|Physician Decision|1
4952884|NCT00294658|17032681|P2|Overall Study|Lost to Follow-up|0
4952885|NCT00294658|17032682|P1|Overall Study|Lost to Follow-up|4
4952886|NCT00294658|17032681|P2|Overall Study|Death|1
4952887|NCT00294658|17032682|P1|Overall Study|Death|0
4952888|NCT00294645|17032746|P2|Overall Study|Other|10
4952889|NCT00294645|17032747|P1|Overall Study|Other|4
4952890|NCT00294645|17032746|P2|Overall Study|Physician Decision|20
4952891|NCT00294645|17032747|P1|Overall Study|Physician Decision|15
4952892|NCT00294645|17032746|P2|Overall Study|Withdrawal by Subject|34
4952893|NCT00294645|17032747|P1|Overall Study|Withdrawal by Subject|18
4952894|NCT00294645|17032746|P2|Overall Study|Lost to Follow-up|10
4952895|NCT00294645|17032747|P1|Overall Study|Lost to Follow-up|1
4952896|NCT00294645|17032746|P2|Overall Study|Death|18
4952897|NCT00294645|17032747|P1|Overall Study|Death|10
4952898|NCT00294554|17032791|P2|Overall Study|Physician Decision|1
4952899|NCT00294554|17032792|P1|Overall Study|Physician Decision|0
4952900|NCT00294554|17032791|P2|Overall Study|Lack of Efficacy|1
4952901|NCT00294554|17032792|P1|Overall Study|Lack of Efficacy|0
4952902|NCT00294398|17032819|P2|Overall Study|Lost to Follow-up|26
4952903|NCT00294398|17032820|P1|Overall Study|Lost to Follow-up|21
4952904|NCT00294060|17032828|P1|Overall Study|Device explanted/not replaced|23
4952905|NCT00294060|17032828|P1|Overall Study|Medical condition|3
4952906|NCT00294060|17032828|P1|Overall Study|Physician Decision|797
4952907|NCT00294060|17032828|P1|Overall Study|Withdrawal by Subject|11
4952908|NCT00294060|17032828|P1|Overall Study|Lost to Follow-up|55
4952909|NCT00294060|17032828|P1|Overall Study|Other|59
4952910|NCT00294060|17032828|P1|Overall Study|Death|225
4952911|NCT00294047|17032836|P2|Month 84|No consent for Month 84 Follow-up|754
4952912|NCT00294047|17032837|P1|Month 84|No consent for Month 84 Follow-up|731
4952913|NCT00294047|17032836|P2|Month 84|Visit missed|1
4952914|NCT00294047|17032837|P1|Month 84|Visit missed|0
4952915|NCT00294047|17032836|P2|Month 84|Under investigation locally|0
4952916|NCT00294047|17032837|P1|Month 84|Under investigation locally|1
4952917|NCT00294047|17032836|P2|Month 84|Unable to reach study site|0
4952918|NCT00294047|17032837|P1|Month 84|Unable to reach study site|1
4952919|NCT00294047|17032836|P2|Month 84|Transport reimbursement delayed|1
4952920|NCT00294047|17032837|P1|Month 84|Transport reimbursement delayed|0
4952921|NCT00294047|17032836|P2|Month 84|Subject does not want male physician|0
4952922|NCT00294047|17032837|P1|Month 84|Subject does not want male physician|1
4952923|NCT00294047|17032836|P2|Month 84|Personal reason|4
4952924|NCT00294047|17032837|P1|Month 84|Personal reason|2
4952925|NCT00294047|17032836|P2|Month 84|Lack of time|1
4952926|NCT00294047|17032837|P1|Month 84|Lack of time|3
4952927|NCT00294047|17032836|P2|Month 84|Family problems|2
4952928|NCT00294047|17032837|P1|Month 84|Family problems|2
4952929|NCT00294047|17032836|P2|Month 84|Center closed, subject did not transfer|0
4952930|NCT00294047|17032837|P1|Month 84|Center closed, subject did not transfer|1
4952931|NCT00294047|17032836|P2|Month 84|Work related reasons|2
4952932|NCT00294047|17032837|P1|Month 84|Work related reasons|4
4952933|NCT00294047|17032836|P2|Month 84|Absent Cervix|0
4952934|NCT00294047|17032837|P1|Month 84|Absent Cervix|2
4952935|NCT00294047|17032836|P2|Month 84|Lost to Follow-up|190
4952936|NCT00294047|17032837|P1|Month 84|Lost to Follow-up|187
4952937|NCT00294047|17032836|P2|Month 84|Withdrawal by Subject|31
4952938|NCT00294047|17032837|P1|Month 84|Withdrawal by Subject|33
4952939|NCT00294047|17032836|P2|Month 84|Protocol Violation|1
4952940|NCT00294047|17032837|P1|Month 84|Protocol Violation|1
4952941|NCT00294047|17032836|P2|Month 84|Adverse Event|2
4952942|NCT00294047|17032837|P1|Month 84|Adverse Event|4
4952943|NCT00294047|17032836|P2|Month 48|Other|14
4952944|NCT00294047|17032837|P1|Month 48|Other|10
4952945|NCT00294047|17032836|P2|Month 48|Lost to Follow-up|287
4952946|NCT00294047|17032837|P1|Month 48|Lost to Follow-up|272
4952947|NCT00294047|17032836|P2|Month 48|Withdrawal by Subject|115
4952948|NCT00294047|17032837|P1|Month 48|Withdrawal by Subject|111
4952949|NCT00294047|17032836|P2|Month 48|Protocol Violation|4
4952950|NCT00294047|17032837|P1|Month 48|Protocol Violation|4
4952951|NCT00294047|17032836|P2|Month 48|Adverse Event|13
4952952|NCT00294047|17032837|P1|Month 48|Adverse Event|28
4952953|NCT00293813|17032942|P3|Overall Study|Noncompliance|0
4952954|NCT00293813|17032943|P2|Overall Study|Noncompliance|1
4952955|NCT00293813|17032944|P1|Overall Study|Noncompliance|0
4952956|NCT00293813|17032942|P3|Overall Study|Lost to Follow-up|3
4952957|NCT00293813|17032943|P2|Overall Study|Lost to Follow-up|2
4952958|NCT00293813|17032944|P1|Overall Study|Lost to Follow-up|3
4952959|NCT00293813|17032942|P3|Overall Study|Withdrawal by Subject|4
4952960|NCT00293813|17032943|P2|Overall Study|Withdrawal by Subject|4
4952961|NCT00293813|17032944|P1|Overall Study|Withdrawal by Subject|7
4952962|NCT00293813|17032942|P3|Overall Study|Adverse Event|1
4952963|NCT00293813|17032943|P2|Overall Study|Adverse Event|1
4952964|NCT00293813|17032944|P1|Overall Study|Adverse Event|3
4952965|NCT00293813|17032942|P3|Overall Study|Physician Decision|0
4952966|NCT00293813|17032943|P2|Overall Study|Physician Decision|1
4952967|NCT00293813|17032944|P1|Overall Study|Physician Decision|0
4952968|NCT00293722|17032955|P1|Overall Study|Other|427
4952969|NCT00293709|17032969|P1|Overall Study|Other|47
4952970|NCT00293579|17032983|P1|Overall Study|Withdrawal by Subject|1
4952971|NCT00293462|17033002|P3|Overall Study|Physician Decision|0
4952972|NCT00293462|17033003|P2|Overall Study|Physician Decision|1
4952973|NCT00293462|17033004|P1|Overall Study|Physician Decision|0
4952974|NCT00293462|17033002|P3|Overall Study|Low radiation dose in oral cavity|0
4952975|NCT00293462|17033003|P2|Overall Study|Low radiation dose in oral cavity|1
4952976|NCT00293462|17033004|P1|Overall Study|Low radiation dose in oral cavity|0
4952977|NCT00293462|17033002|P3|Overall Study|Possible Tracheostomy leakage|0
4952978|NCT00293462|17033003|P2|Overall Study|Possible Tracheostomy leakage|1
4952979|NCT00293462|17033004|P1|Overall Study|Possible Tracheostomy leakage|0
4952980|NCT00293462|17033002|P3|Overall Study|Ischemic stroke after chemotherapy|1
4952981|NCT00293462|17033003|P2|Overall Study|Ischemic stroke after chemotherapy|0
4952982|NCT00293462|17033004|P1|Overall Study|Ischemic stroke after chemotherapy|0
4952983|NCT00293462|17033002|P3|Overall Study|Blood clot after chemotherapy|1
4952984|NCT00293462|17033003|P2|Overall Study|Blood clot after chemotherapy|0
4952985|NCT00293462|17033004|P1|Overall Study|Blood clot after chemotherapy|0
4952986|NCT00293462|17033002|P3|Overall Study|Went back to his home country|1
4952987|NCT00293462|17033003|P2|Overall Study|Went back to his home country|0
4952988|NCT00293462|17033004|P1|Overall Study|Went back to his home country|0
4952989|NCT00293462|17033002|P3|Overall Study|No Show|1
4952990|NCT00293462|17033003|P2|Overall Study|No Show|0
4952991|NCT00293462|17033004|P1|Overall Study|No Show|0
4952992|NCT00293462|17033002|P3|Overall Study|Refuse Radiation Treatment|0
4952993|NCT00293462|17033003|P2|Overall Study|Refuse Radiation Treatment|0
4952994|NCT00293462|17033004|P1|Overall Study|Refuse Radiation Treatment|1
4952995|NCT00293462|17033002|P3|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
4952996|NCT00293462|17033003|P2|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1
4952997|NCT00293462|17033004|P1|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0
4952998|NCT00293462|17033002|P3|Overall Study|Change Treatment Regimen (ineligible)|0
4952999|NCT00293462|17033003|P2|Overall Study|Change Treatment Regimen (ineligible)|0
4953000|NCT00293462|17033004|P1|Overall Study|Change Treatment Regimen (ineligible)|1
4953001|NCT00293462|17033002|P3|Overall Study|Lost to Follow-up|0
4953002|NCT00293462|17033003|P2|Overall Study|Lost to Follow-up|1
4953003|NCT00293462|17033004|P1|Overall Study|Lost to Follow-up|0
4953004|NCT00293462|17033002|P3|Overall Study|Death|0
4953005|NCT00293462|17033003|P2|Overall Study|Death|0
4953006|NCT00293462|17033004|P1|Overall Study|Death|1
4953007|NCT00293462|17033002|P3|Overall Study|Withdrawal by Subject|6
4953008|NCT00293462|17033003|P2|Overall Study|Withdrawal by Subject|3
4953009|NCT00293462|17033004|P1|Overall Study|Withdrawal by Subject|4
4953010|NCT00293397|17033023|P1|Overall Study|Death|2
4953011|NCT00293384|17033033|P1|Overall Study|Ineligible|2
4953012|NCT00293384|17033033|P1|Overall Study|Missed dosage/study drug|1
4953013|NCT00293384|17033033|P1|Overall Study|Non-compliance|2
4953014|NCT00293293|17033042|P2|Overall Study|Patient discontinued chemotherapy|1
4953015|NCT00293293|17033043|P1|Overall Study|Patient discontinued chemotherapy|0
4953016|NCT00293293|17033042|P2|Overall Study|"Patient too anxious to complete trial"|0
4953017|NCT00293293|17033043|P1|Overall Study|"Patient too anxious to complete trial"|1
4953018|NCT00293293|17033042|P2|Overall Study|Withdrawal by Subject|1
4953019|NCT00293293|17033043|P1|Overall Study|Withdrawal by Subject|1
4953020|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Other Reason|5
4953021|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Other Reason|4
4953022|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2
4953023|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0
4953024|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2
4953025|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0
4953026|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
4953027|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2
4953028|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4
4953029|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2
4953030|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19
4953031|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23
4953032|NCT00293267|17033071|P2|Open-Label Post Virologic Failure Phase|Adverse Event|3
4953033|NCT00293267|17033072|P1|Open-Label Post Virologic Failure Phase|Adverse Event|2
4953034|NCT00293267|17033071|P2|Extension - Open-Label Week 157-240|Other Reason|1
4953035|NCT00293267|17033072|P1|Extension - Open-Label Week 157-240|Other Reason|3
4953036|NCT00293267|17033071|P2|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0
4953037|NCT00293267|17033072|P1|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2
4953038|NCT00293267|17033071|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
4953039|NCT00293267|17033072|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|2
4953040|NCT00293267|17033071|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
4953041|NCT00293267|17033072|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|1
4953042|NCT00293267|17033071|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
4953043|NCT00293267|17033072|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|7
4953044|NCT00293267|17033071|P2|Extension - Open-Label Week 157-240|Adverse Event|0
4953045|NCT00293267|17033072|P1|Extension - Open-Label Week 157-240|Adverse Event|5
4953046|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6
4953047|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
4953048|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Other Reason|0
4953049|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Other Reason|7
4953050|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0
4953051|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2
4953052|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Death|0
4953053|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Death|3
4953054|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4
4953055|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13
4953056|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|0
4953057|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|4
4953058|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|1
4953059|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|7
4953060|NCT00293267|17033071|P2|Extension - Double-Blind Week 49-156|Adverse Event|4
4953061|NCT00293267|17033072|P1|Extension - Double-Blind Week 49-156|Adverse Event|1
4953062|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60
4953063|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33
4953064|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
4953065|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
4953066|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
4953067|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
4953068|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
4953069|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0
4953070|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Death|3
4953071|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Death|3
4953072|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
4953073|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|1
4953074|NCT00293267|17033071|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
4953075|NCT00293267|17033072|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
4953076|NCT00293254|17033112|P2|Open-Label Post Virologic Failure Phase|Other Reason|2
4953077|NCT00293254|17033113|P1|Open-Label Post Virologic Failure Phase|Other Reason|1
4953078|NCT00293254|17033112|P2|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
4953079|NCT00293254|17033113|P1|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1
4953080|NCT00293254|17033112|P2|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0
4953081|NCT00293254|17033113|P1|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3
4953082|NCT00293254|17033112|P2|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3
4953083|NCT00293254|17033113|P1|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6
4953084|NCT00293254|17033112|P2|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14
4953085|NCT00293254|17033113|P1|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16
4953086|NCT00293254|17033112|P2|Open-Label Post Virologic Failure Phase|Adverse Event|7
4953087|NCT00293254|17033113|P1|Open-Label Post Virologic Failure Phase|Adverse Event|4
4953088|NCT00293254|17033112|P2|Extension - Open-Label Week 157-240|Other Reason|0
4953089|NCT00293254|17033113|P1|Extension - Open-Label Week 157-240|Other Reason|4
4953090|NCT00293254|17033112|P2|Extension - Open-Label Week 157-240|Lost to Follow-up|0
4953091|NCT00293254|17033113|P1|Extension - Open-Label Week 157-240|Lost to Follow-up|2
4953092|NCT00293254|17033112|P2|Extension - Open-Label Week 157-240|Withdrawal by Subject|0
4953093|NCT00293254|17033113|P1|Extension - Open-Label Week 157-240|Withdrawal by Subject|1
4953094|NCT00293254|17033112|P2|Extension - Open-Label Week 157-240|Lack of Efficacy|0
4953095|NCT00293254|17033113|P1|Extension - Open-Label Week 157-240|Lack of Efficacy|1
4953096|NCT00293254|17033112|P2|Extension - Open-Label Week 157-240|Adverse Event|1
4953097|NCT00293254|17033113|P1|Extension - Open-Label Week 157-240|Adverse Event|2
4953098|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7
4953099|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15
4953100|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Other Reason|2
4953101|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Other Reason|10
4953102|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3
4953103|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6
4953104|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8
4953105|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12
4953106|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
4953107|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Lost to Follow-up|3
4953108|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Lack of Efficacy|4
4953109|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Lack of Efficacy|3
4953110|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Death|1
4953111|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Death|4
4953112|NCT00293254|17033112|P2|Extension - Double-Blind Week 49-156|Adverse Event|1
4953113|NCT00293254|17033113|P1|Extension - Double-Blind Week 49-156|Adverse Event|4
4953114|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57
4953115|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35
4953116|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0
4953117|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1
4953118|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1
4953119|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5
4953120|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1
4953121|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3
4953122|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
4953123|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2
4953124|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Death|2
4953125|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Death|5
4953126|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Adverse Event|1
4953127|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Adverse Event|2
4953128|NCT00293254|17033112|P2|Primary Study - Double-Blind Week 0-48|Never Treated|0
4953129|NCT00293254|17033113|P1|Primary Study - Double-Blind Week 0-48|Never Treated|2
4953130|NCT00293241|17033153|P2|Overall Study|Withdrawal by Subject|8
4953131|NCT00293241|17033154|P1|Overall Study|Withdrawal by Subject|4
4953132|NCT00293241|17033153|P2|Overall Study|Physician Decision|17
4953133|NCT00293241|17033154|P1|Overall Study|Physician Decision|23
4953134|NCT00293241|17033153|P2|Overall Study|Lost to Follow-up|16
4953135|NCT00293241|17033154|P1|Overall Study|Lost to Follow-up|9
4953136|NCT00293215|17033198|P2|Overall Study|Adverse Event|2
4953137|NCT00293215|17033199|P1|Overall Study|Adverse Event|2
4953138|NCT00293215|17033198|P2|Overall Study|Progressive disease|1
4953139|NCT00293215|17033199|P1|Overall Study|Progressive disease|3
4953140|NCT00293059|17033221|P2|Overall Study|missing|5
4953141|NCT00293059|17033222|P1|Overall Study|missing|3
4953142|NCT00293059|17033221|P2|Overall Study|Noncompliant - sanitary pads collection|1
4953143|NCT00293059|17033222|P1|Overall Study|Noncompliant - sanitary pads collection|0
4953144|NCT00293059|17033221|P2|Overall Study|Participant stopped study drug|0
4953145|NCT00293059|17033222|P1|Overall Study|Participant stopped study drug|1
4953146|NCT00293059|17033221|P2|Overall Study|Participant moved out of state|0
4953147|NCT00293059|17033222|P1|Overall Study|Participant moved out of state|1
4953148|NCT00293059|17033221|P2|Overall Study|Withdrawal by Subject|5
4953149|NCT00293059|17033222|P1|Overall Study|Withdrawal by Subject|11
4953150|NCT00293059|17033221|P2|Overall Study|Protocol Violation|0
4953151|NCT00293059|17033222|P1|Overall Study|Protocol Violation|2
4953152|NCT00293059|17033221|P2|Overall Study|Pregnancy|1
4953153|NCT00293059|17033222|P1|Overall Study|Pregnancy|1
4953154|NCT00293059|17033221|P2|Overall Study|Lost to Follow-up|3
4953155|NCT00293059|17033222|P1|Overall Study|Lost to Follow-up|2
4953156|NCT00293059|17033221|P2|Overall Study|Lack of Efficacy|0
4953157|NCT00293059|17033222|P1|Overall Study|Lack of Efficacy|2
4953158|NCT00293059|17033221|P2|Overall Study|Adverse Event|4
4953159|NCT00293059|17033222|P1|Overall Study|Adverse Event|12
4953160|NCT00293033|17033334|P1|Double-blind Treatment Period|Noncompliance|4
4953161|NCT00293033|17033334|P1|Double-blind Treatment Period|Withdrawal by Subject|4
4953162|NCT00293033|17033334|P1|Double-blind Treatment Period|Lack of Efficacy|1
4953163|NCT00293033|17033334|P1|Double-blind Treatment Period|Adverse Event|3
4953164|NCT00293033|17033334|P1|Open-label Titration Period|Noncompliance and other|27
4953165|NCT00293033|17033334|P1|Open-label Titration Period|Withdrawal by Subject|22
4953166|NCT00293033|17033334|P1|Open-label Titration Period|Protocol Violation|2
4953167|NCT00293033|17033334|P1|Open-label Titration Period|Lack of Efficacy|5
4953168|NCT00293033|17033334|P1|Open-label Titration Period|Death|3
4953169|NCT00293033|17033334|P1|Open-label Titration Period|Adverse Event|10
4953170|NCT00293020|17033437|P1|Overall Study|No dose taken|1
4953171|NCT00293020|17033437|P1|Overall Study|Other Reason|22
4953172|NCT00293020|17033437|P1|Overall Study|Physician Decision|21
4953173|NCT00293020|17033437|P1|Overall Study|Protocol Violation|6
4953174|NCT00293020|17033437|P1|Overall Study|Lost to Follow-up|4
4953175|NCT00293020|17033437|P1|Overall Study|Lack of Efficacy|12
4953176|NCT00293020|17033437|P1|Overall Study|Death|32
4953177|NCT00293020|17033437|P1|Overall Study|Adverse Event|30
4953178|NCT00293020|17033437|P1|Overall Study|Withdrawal by Subject|34
4953179|NCT00292981|17033441|P1|Overall Study|Other|3
4953180|NCT00292981|17033441|P1|Overall Study|Withdrawal by Subject|22
4953181|NCT00292981|17033441|P1|Overall Study|Lost to Follow-up|13
4953182|NCT00292981|17033441|P1|Overall Study|Adverse Event|1
4953183|NCT00292942|17033452|P4|Overall Study|Adverse Event|1
4953184|NCT00292942|17033453|P3|Overall Study|Adverse Event|0
4953185|NCT00292942|17033454|P2|Overall Study|Adverse Event|0
4953186|NCT00292942|17033455|P1|Overall Study|Adverse Event|0
4953187|NCT00292942|17033452|P4|Overall Study|Withdrawal by Subject|0
4953188|NCT00292942|17033453|P3|Overall Study|Withdrawal by Subject|1
4953189|NCT00292942|17033454|P2|Overall Study|Withdrawal by Subject|0
4953190|NCT00292942|17033455|P1|Overall Study|Withdrawal by Subject|0
4953191|NCT00292461|17033501|P2|Overall Study|Lost to Follow-up|0
4953192|NCT00292461|17033502|P1|Overall Study|Lost to Follow-up|1
4953193|NCT00292461|17033501|P2|Overall Study|Protocol Violation|3
4953194|NCT00292461|17033502|P1|Overall Study|Protocol Violation|4
4953195|NCT00292461|17033501|P2|Overall Study|Withdrawal by Subject|1
4953196|NCT00292461|17033502|P1|Overall Study|Withdrawal by Subject|0
4953197|NCT00292461|17033501|P2|Overall Study|Lack of Efficacy|0
4953198|NCT00292461|17033502|P1|Overall Study|Lack of Efficacy|1
4953199|NCT00292461|17033501|P2|Overall Study|Adverse Event|2
4953200|NCT00292461|17033502|P1|Overall Study|Adverse Event|4
4953201|NCT00292370|17033517|P3|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5
4953202|NCT00292370|17033518|P2|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1
4953203|NCT00292370|17033519|P1|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0
4953204|NCT00292370|17033517|P3|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2
4953205|NCT00292370|17033518|P2|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3
4953206|NCT00292370|17033519|P1|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0
4953207|NCT00292370|17033517|P3|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
4953208|NCT00292370|17033518|P2|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0
4953209|NCT00292370|17033519|P1|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4
4953210|NCT00292370|17033517|P3|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
4953211|NCT00292370|17033518|P2|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0
4953212|NCT00292370|17033519|P1|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8
4953213|NCT00292370|17033517|P3|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
4953214|NCT00292370|17033518|P2|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0
4953215|NCT00292370|17033519|P1|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22
4953216|NCT00292370|17033517|P3|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
4953217|NCT00292370|17033518|P2|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0
4953218|NCT00292370|17033519|P1|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12
4953219|NCT00292318|17033544|P2|Overall Study|Study terminated by officials|1
4953220|NCT00292318|17033545|P1|Overall Study|Study terminated by officials|2
4953221|NCT00292227|17033555|P3|Patch Period|Withdrawal by Subject|1
4953222|NCT00292227|17033556|P2|Patch Period|Withdrawal by Subject|0
4953223|NCT00292227|17033557|P1|Patch Period|Withdrawal by Subject|0
4953224|NCT00292227|17033555|P3|Patch Period|Adverse Event|2
4953225|NCT00292227|17033556|P2|Patch Period|Adverse Event|0
4953226|NCT00292227|17033557|P1|Patch Period|Adverse Event|1
4953227|NCT00292188|17033639|P3|Double-Blind|Laboratory Abnormality|1
4953228|NCT00292188|17033640|P2|Double-Blind|Laboratory Abnormality|0
4953229|NCT00292188|17033641|P1|Double-Blind|Laboratory Abnormality|0
4953230|NCT00292188|17033639|P3|Double-Blind|Withdrawal by Subject|3
4953231|NCT00292188|17033640|P2|Double-Blind|Withdrawal by Subject|0
4953232|NCT00292188|17033641|P1|Double-Blind|Withdrawal by Subject|0
4953233|NCT00292188|17033639|P3|Double-Blind|Other|4
4953234|NCT00292188|17033640|P2|Double-Blind|Other|3
4953235|NCT00292188|17033641|P1|Double-Blind|Other|0
4953236|NCT00292188|17033639|P3|Double-Blind|Lost to Follow-up|0
4953237|NCT00292188|17033640|P2|Double-Blind|Lost to Follow-up|1
4953238|NCT00292188|17033641|P1|Double-Blind|Lost to Follow-up|0
4953239|NCT00292188|17033639|P3|Double-Blind|Lack of Efficacy|12
4953240|NCT00292188|17033640|P2|Double-Blind|Lack of Efficacy|2
4953241|NCT00292188|17033641|P1|Double-Blind|Lack of Efficacy|0
4953242|NCT00292188|17033639|P3|Double-Blind|Adverse Event|9
4953243|NCT00292188|17033640|P2|Double-Blind|Adverse Event|25
4953244|NCT00292188|17033641|P1|Double-Blind|Adverse Event|0
4953245|NCT00292188|17033639|P3|Single-Blind|Did not receive treatment|0
4953246|NCT00292188|17033640|P2|Single-Blind|Did not receive treatment|0
4953247|NCT00292188|17033641|P1|Single-Blind|Did not receive treatment|1
4953248|NCT00292188|17033639|P3|Single-Blind|Withdrawal by Subject|0
4953249|NCT00292188|17033640|P2|Single-Blind|Withdrawal by Subject|0
4953250|NCT00292188|17033641|P1|Single-Blind|Withdrawal by Subject|12
4953251|NCT00292188|17033639|P3|Single-Blind|Other|0
4953252|NCT00292188|17033640|P2|Single-Blind|Other|0
4953253|NCT00292188|17033641|P1|Single-Blind|Other|77
4953254|NCT00292188|17033639|P3|Single-Blind|Lost to Follow-up|0
4953255|NCT00292188|17033640|P2|Single-Blind|Lost to Follow-up|0
4953256|NCT00292188|17033641|P1|Single-Blind|Lost to Follow-up|3
4953257|NCT00292188|17033639|P3|Single-Blind|Laboratory Abnormality|0
4953258|NCT00292188|17033640|P2|Single-Blind|Laboratory Abnormality|0
4953259|NCT00292188|17033641|P1|Single-Blind|Laboratory Abnormality|5
4953260|NCT00292188|17033639|P3|Single-Blind|Lack of Efficacy|0
4953261|NCT00292188|17033640|P2|Single-Blind|Lack of Efficacy|0
4953262|NCT00292188|17033641|P1|Single-Blind|Lack of Efficacy|2
4953263|NCT00292188|17033639|P3|Single-Blind|Adverse Event|0
4953264|NCT00292188|17033640|P2|Single-Blind|Adverse Event|0
4953265|NCT00292188|17033641|P1|Single-Blind|Adverse Event|14
4953266|NCT00291668|17033751|P3|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4953267|NCT00291668|17033752|P2|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0
4953268|NCT00291668|17033753|P1|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1
4953269|NCT00291668|17033751|P3|Overall Study|AE, non-serious non-fatal|0
4953270|NCT00291668|17033752|P2|Overall Study|AE, non-serious non-fatal|0
4953271|NCT00291668|17033753|P1|Overall Study|AE, non-serious non-fatal|1
4953272|NCT00291668|17033751|P3|Overall Study|SAE, non-fatal|1
4953273|NCT00291668|17033752|P2|Overall Study|SAE, non-fatal|1
4953274|NCT00291668|17033753|P1|Overall Study|SAE, non-fatal|1
4953275|NCT00291668|17033751|P3|Overall Study|Lack of Efficacy|0
4953276|NCT00291668|17033752|P2|Overall Study|Lack of Efficacy|0
4953277|NCT00291668|17033753|P1|Overall Study|Lack of Efficacy|1
4953278|NCT00291642|17033849|P5|Overall Study|Intake of prohibited medication|0
4953279|NCT00291642|17033850|P4|Overall Study|Intake of prohibited medication|0
4953280|NCT00291642|17033851|P3|Overall Study|Intake of prohibited medication|0
4953281|NCT00291642|17033852|P2|Overall Study|Intake of prohibited medication|0
4953282|NCT00291642|17033853|P1|Overall Study|Intake of prohibited medication|1
4953283|NCT00291642|17033849|P5|Overall Study|Patient missed visit|0
4953284|NCT00291642|17033850|P4|Overall Study|Patient missed visit|0
4953285|NCT00291642|17033851|P3|Overall Study|Patient missed visit|1
4953286|NCT00291642|17033852|P2|Overall Study|Patient missed visit|0
4953287|NCT00291642|17033853|P1|Overall Study|Patient missed visit|0
4953288|NCT00291642|17033849|P5|Overall Study|Adverse Event|1
4953289|NCT00291642|17033850|P4|Overall Study|Adverse Event|0
4953290|NCT00291642|17033851|P3|Overall Study|Adverse Event|1
4953291|NCT00291642|17033852|P2|Overall Study|Adverse Event|0
4953292|NCT00291642|17033853|P1|Overall Study|Adverse Event|1
4953293|NCT00291577|17033905|P1|Overall Study|Lack of Efficacy|14
4953294|NCT00291577|17033905|P1|Overall Study|Withdrawal by Subject|2
4953295|NCT00291577|17033905|P1|Overall Study|Other|4
4953296|NCT00291577|17033905|P1|Overall Study|Adverse Event|1
4953297|NCT00291551|17033924|P1|Overall Study|Withdrawal by Subject|6
4953298|NCT00291551|17033924|P1|Overall Study|Death|7
4953299|NCT00291330|17033972|P2|Overall Study|Other|1
4953300|NCT00291330|17033973|P1|Overall Study|Other|3
4953301|NCT00291330|17033972|P2|Overall Study|Withdrawal by Subject|25
4953302|NCT00291330|17033973|P1|Overall Study|Withdrawal by Subject|22
4953303|NCT00291330|17033972|P2|Overall Study|Lost to Follow-up|11
4953304|NCT00291330|17033973|P1|Overall Study|Lost to Follow-up|16
4953305|NCT00291330|17033972|P2|Overall Study|Protocol Violation|20
4953306|NCT00291330|17033973|P1|Overall Study|Protocol Violation|13
4953307|NCT00291330|17033972|P2|Overall Study|Adverse Event|40
4953308|NCT00291330|17033973|P1|Overall Study|Adverse Event|47
4953309|NCT00291187|17034015|P4|Overall Study|Protocol Violation- No Drug Administered|0
4953310|NCT00291187|17034016|P3|Overall Study|Protocol Violation- No Drug Administered|1
4953311|NCT00291187|17034017|P2|Overall Study|Protocol Violation- No Drug Administered|0
4953312|NCT00291187|17034018|P1|Overall Study|Protocol Violation- No Drug Administered|0
4953313|NCT00291018|17034062|P3|Overall Study|Lost to Follow-up|18
4953314|NCT00291018|17034063|P2|Overall Study|Lost to Follow-up|4
4953315|NCT00291018|17034064|P1|Overall Study|Lost to Follow-up|3
4953316|NCT00291018|17034062|P3|Overall Study|Failures|5
4953317|NCT00291018|17034063|P2|Overall Study|Failures|12
4953318|NCT00291018|17034064|P1|Overall Study|Failures|5
4953319|NCT00291018|17034062|P3|Overall Study|Withdrawal by Subject|1
4953320|NCT00291018|17034063|P2|Overall Study|Withdrawal by Subject|8
4953321|NCT00291018|17034064|P1|Overall Study|Withdrawal by Subject|2
4953322|NCT00291018|17034062|P3|Overall Study|Death|4
4953323|NCT00291018|17034063|P2|Overall Study|Death|3
4953324|NCT00291018|17034064|P1|Overall Study|Death|3
4953325|NCT00291018|17034062|P3|Overall Study|Not Consented or Declined PAS|15
4953326|NCT00291018|17034063|P2|Overall Study|Not Consented or Declined PAS|15
4953327|NCT00291018|17034064|P1|Overall Study|Not Consented or Declined PAS|12
4953328|NCT00290888|17034104|P2|Overall Study|Physician Decision|1
4953329|NCT00290888|17034105|P1|Overall Study|Physician Decision|3
4953330|NCT00290771|17034122|P2|Overall Study|Lost to Follow-up|1
4953331|NCT00290771|17034123|P1|Overall Study|Lost to Follow-up|0
4953332|NCT00290771|17034122|P2|Overall Study|Protocol Violation|0
4953333|NCT00290771|17034123|P1|Overall Study|Protocol Violation|2
4953334|NCT00290771|17034122|P2|Overall Study|Administrative problems|1
4953335|NCT00290771|17034123|P1|Overall Study|Administrative problems|2
4953336|NCT00290771|17034122|P2|Overall Study|Withdrawal by Subject|6
4953337|NCT00290771|17034123|P1|Overall Study|Withdrawal by Subject|5
4953338|NCT00290771|17034122|P2|Overall Study|Adverse Event|6
4953339|NCT00290771|17034123|P1|Overall Study|Adverse Event|12
4953340|NCT00290771|17034122|P2|Overall Study|Death|10
4953341|NCT00290771|17034123|P1|Overall Study|Death|11
4953342|NCT00290771|17034122|P2|Overall Study|Disease progression|73
4953343|NCT00290771|17034123|P1|Overall Study|Disease progression|95
4953344|NCT00290758|17034147|P2|Post Intervention rFNA|<4000 Epithelial Cells|5
4953345|NCT00290758|17034148|P1|Post Intervention rFNA|<4000 Epithelial Cells|6
4953346|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1
4953347|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0
4953348|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0
4953349|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1
4953350|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5
4953351|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0
4953352|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
4953353|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1
4953354|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1
4953355|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3
4953356|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|ConMeds|0
4953357|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|ConMeds|1
4953358|NCT00290758|17034147|P2|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2
4953359|NCT00290758|17034148|P1|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1
4953360|NCT00290732|17034170|P5|Overall Study|Inability to instill drug intraductally.|0
4953361|NCT00290732|17034171|P4|Overall Study|Inability to instill drug intraductally.|0
4953362|NCT00290732|17034172|P3|Overall Study|Inability to instill drug intraductally.|1
4953363|NCT00290732|17034173|P2|Overall Study|Inability to instill drug intraductally.|1
4953364|NCT00290732|17034174|P1|Overall Study|Inability to instill drug intraductally.|0
4953365|NCT00290706|17034196|P4|Overall Study|Physician Decision|1
4953366|NCT00290706|17034197|P3|Overall Study|Physician Decision|0
4953367|NCT00290706|17034198|P2|Overall Study|Physician Decision|0
4953368|NCT00290706|17034199|P1|Overall Study|Physician Decision|0
4953369|NCT00290706|17034196|P4|Overall Study|Receive auto transplant or radiation|1
4953370|NCT00290706|17034197|P3|Overall Study|Receive auto transplant or radiation|0
4953371|NCT00290706|17034198|P2|Overall Study|Receive auto transplant or radiation|0
4953372|NCT00290706|17034199|P1|Overall Study|Receive auto transplant or radiation|0
4953373|NCT00290706|17034196|P4|Overall Study|Adverse Event|0
4953374|NCT00290706|17034197|P3|Overall Study|Adverse Event|2
4953375|NCT00290706|17034198|P2|Overall Study|Adverse Event|1
4953376|NCT00290706|17034199|P1|Overall Study|Adverse Event|0
4953377|NCT00290706|17034196|P4|Overall Study|Progressive Disease|10
4953378|NCT00290706|17034197|P3|Overall Study|Progressive Disease|4
4953379|NCT00290706|17034198|P2|Overall Study|Progressive Disease|5
4953380|NCT00290706|17034199|P1|Overall Study|Progressive Disease|3
4953381|NCT00290706|17034196|P4|Overall Study|Withdrawal by Subject|0
4953382|NCT00290706|17034197|P3|Overall Study|Withdrawal by Subject|0
4953383|NCT00290706|17034198|P2|Overall Study|Withdrawal by Subject|0
4953384|NCT00290706|17034199|P1|Overall Study|Withdrawal by Subject|2
4953385|NCT00290693|17034218|P1|Overall Study|Withdrawal by Subject|2
4953386|NCT00290589|17034246|P2|Overall Study|Lost to Follow-up|2
4953387|NCT00290589|17034247|P1|Overall Study|Lost to Follow-up|2
4953388|NCT00290498|17034265|P2|Overall Study|Non-Compliance|0
4953389|NCT00290498|17034266|P1|Overall Study|Non-Compliance|1
4953390|NCT00290498|17034265|P2|Overall Study|Ineligible|0
4953391|NCT00290498|17034266|P1|Overall Study|Ineligible|3
4953392|NCT00290498|17034265|P2|Overall Study|Withdrawal by Subject|0
4953393|NCT00290498|17034266|P1|Overall Study|Withdrawal by Subject|1
4953394|NCT00290498|17034265|P2|Overall Study|Physician Decision|0
4953395|NCT00290498|17034266|P1|Overall Study|Physician Decision|1
4953396|NCT00290498|17034265|P2|Overall Study|Death|0
4953397|NCT00290498|17034266|P1|Overall Study|Death|2
4953398|NCT00290433|17034291|P1|Overall Study|Unrelated Infection/Death|1
4953399|NCT00290433|17034291|P1|Overall Study|Transplant in CR|5
4953400|NCT00290433|17034291|P1|Overall Study|Congestive Heart Failure|1
4953401|NCT00290433|17034291|P1|Overall Study|Non-Compliance|1
4953402|NCT00290433|17034291|P1|Overall Study|Withdrawal by Subject|1
4953403|NCT00290433|17034291|P1|Overall Study|Adverse Event|14
4953404|NCT00290433|17034291|P1|Overall Study|Disease Progression|13
4953405|NCT00290407|17034295|P1|Overall Study|Physician Decision|2
4953406|NCT00290355|17034302|P2|Overall Study|Other|0
4953407|NCT00290355|17034303|P1|Overall Study|Other|2
4953408|NCT00290355|17034302|P2|Overall Study|Lost to Follow-up|1
4953409|NCT00290355|17034303|P1|Overall Study|Lost to Follow-up|3
4953410|NCT00290355|17034302|P2|Overall Study|Migrated / moved from the study area|0
4953411|NCT00290355|17034303|P1|Overall Study|Migrated / moved from the study area|1
4953412|NCT00290355|17034302|P2|Overall Study|Withdrawal by Subject|0
4953413|NCT00290355|17034303|P1|Overall Study|Withdrawal by Subject|2
4953414|NCT00290355|17034302|P2|Overall Study|Protocol Violation|0
4953415|NCT00290355|17034303|P1|Overall Study|Protocol Violation|1
4953416|NCT00290355|17034302|P2|Overall Study|Study product reactogenicity|0
4953417|NCT00290355|17034303|P1|Overall Study|Study product reactogenicity|1
4953418|NCT00290355|17034302|P2|Overall Study|Serious adverse event|4
4953419|NCT00290355|17034303|P1|Overall Study|Serious adverse event|7
4953420|NCT00290342|17034347|P2|Overall Study|Lost to Follow-up|0
4953421|NCT00290342|17034348|P1|Overall Study|Lost to Follow-up|1
4953422|NCT00290342|17034347|P2|Overall Study|Withdrawal by Subject|4
4953423|NCT00290342|17034348|P1|Overall Study|Withdrawal by Subject|6
4953424|NCT00290342|17034347|P2|Overall Study|Other|1
4953425|NCT00290342|17034348|P1|Overall Study|Other|0
4953426|NCT00290290|17034403|P2|Overall Study|Underwent clean surgical procedure|12
4953427|NCT00290290|17034404|P1|Overall Study|Underwent clean surgical procedure|13
4953428|NCT00290290|17034403|P2|Overall Study|Withdrawal by Subject|2
4953429|NCT00290290|17034404|P1|Overall Study|Withdrawal by Subject|2
4953430|NCT00290290|17034403|P2|Overall Study|Death|4
4953431|NCT00290290|17034404|P1|Overall Study|Death|3
4953432|NCT00290251|17034410|P3|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
4953433|NCT00290251|17034411|P2|Treatment 2 (Months 4 - 6)|Lost to Follow-up|0
4953434|NCT00290251|17034412|P1|Treatment 2 (Months 4 - 6)|Lost to Follow-up|2
4953435|NCT00290251|17034410|P3|Treatment 1 (Months 1 - 3)|Out of body experience|0
4953436|NCT00290251|17034411|P2|Treatment 1 (Months 1 - 3)|Out of body experience|0
4953437|NCT00290251|17034412|P1|Treatment 1 (Months 1 - 3)|Out of body experience|1
4953438|NCT00290251|17034410|P3|Treatment 1 (Months 1 - 3)|headache|0
4953439|NCT00290251|17034411|P2|Treatment 1 (Months 1 - 3)|headache|1
4953440|NCT00290251|17034412|P1|Treatment 1 (Months 1 - 3)|headache|0
4953441|NCT00290251|17034410|P3|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|2
4953442|NCT00290251|17034411|P2|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
4953443|NCT00290251|17034412|P1|Treatment 1 (Months 1 - 3)|Withdrawal by Subject|0
4953444|NCT00290238|17034424|P2|Overall Study|Withdrawal by Subject|13
4953445|NCT00290238|17034425|P1|Overall Study|Withdrawal by Subject|15
4953446|NCT00290238|17034424|P2|Overall Study|Lost to Follow-up|1
4953447|NCT00290238|17034425|P1|Overall Study|Lost to Follow-up|0
4953448|NCT00290238|17034424|P2|Overall Study|Study terminated|27
4953449|NCT00290238|17034425|P1|Overall Study|Study terminated|27
4953450|NCT00290186|17034450|P2|Overall Study|Withdrawal by Subject|1
4953451|NCT00290186|17034451|P1|Overall Study|Withdrawal by Subject|0
4953452|NCT00290186|17034450|P2|Overall Study|Study was terminated prior to 3-month te|1
4953453|NCT00290186|17034451|P1|Overall Study|Study was terminated prior to 3-month te|1
4953454|NCT00290186|17034450|P2|Overall Study|Lost to Follow-up|2
4953455|NCT00290186|17034451|P1|Overall Study|Lost to Follow-up|3
4953456|NCT00290186|17034450|P2|Overall Study|Adverse Event|1
4953457|NCT00290186|17034451|P1|Overall Study|Adverse Event|1
4953458|NCT00289991|17034502|P2|Overall Study|Other|14
4953459|NCT00289991|17034503|P1|Overall Study|Other|5
4953460|NCT00289991|17034502|P2|Overall Study|Withdrawal by Subject|12
4953461|NCT00289991|17034503|P1|Overall Study|Withdrawal by Subject|2
4953462|NCT00289991|17034502|P2|Overall Study|Lost to Follow-up|1
4953463|NCT00289991|17034503|P1|Overall Study|Lost to Follow-up|0
4953464|NCT00289991|17034502|P2|Overall Study|Fungal breakthrough infection|1
4953465|NCT00289991|17034503|P1|Overall Study|Fungal breakthrough infection|0
4953466|NCT00289991|17034502|P2|Overall Study|Failure of prophylaxis|1
4953467|NCT00289991|17034503|P1|Overall Study|Failure of prophylaxis|1
4953468|NCT00289991|17034502|P2|Overall Study|Adverse Event|13
4953469|NCT00289991|17034503|P1|Overall Study|Adverse Event|15
4953470|NCT00289991|17034502|P2|Overall Study|Death|38
4953471|NCT00289991|17034503|P1|Overall Study|Death|35
4953472|NCT00289978|17034528|P3|Overall Study|Death|2
4953473|NCT00289978|17034529|P2|Overall Study|Death|0
4953474|NCT00289978|17034530|P1|Overall Study|Death|1
4953475|NCT00289978|17034528|P3|Overall Study|Abnormal test procedure result(s)|1
4953476|NCT00289978|17034529|P2|Overall Study|Abnormal test procedure result(s)|1
4953477|NCT00289978|17034530|P1|Overall Study|Abnormal test procedure result(s)|2
4953478|NCT00289978|17034528|P3|Overall Study|Protocol Violation|4
4953479|NCT00289978|17034529|P2|Overall Study|Protocol Violation|5
4953480|NCT00289978|17034530|P1|Overall Study|Protocol Violation|5
4953481|NCT00289978|17034528|P3|Overall Study|Lost to Follow-up|7
4953482|NCT00289978|17034529|P2|Overall Study|Lost to Follow-up|5
4953483|NCT00289978|17034530|P1|Overall Study|Lost to Follow-up|3
4953484|NCT00289978|17034528|P3|Overall Study|Abnormal laboratory value(s)|1
4953485|NCT00289978|17034529|P2|Overall Study|Abnormal laboratory value(s)|9
4953486|NCT00289978|17034530|P1|Overall Study|Abnormal laboratory value(s)|20
4953487|NCT00289978|17034528|P3|Overall Study|Lack of Efficacy|25
4953488|NCT00289978|17034529|P2|Overall Study|Lack of Efficacy|6
4953489|NCT00289978|17034530|P1|Overall Study|Lack of Efficacy|13
4953490|NCT00289978|17034528|P3|Overall Study|Adverse Event|18
4953491|NCT00289978|17034529|P2|Overall Study|Adverse Event|13
4953492|NCT00289978|17034530|P1|Overall Study|Adverse Event|22
4953493|NCT00289978|17034528|P3|Overall Study|Withdrawal by Subject|28
4953494|NCT00289978|17034529|P2|Overall Study|Withdrawal by Subject|17
4953495|NCT00289978|17034530|P1|Overall Study|Withdrawal by Subject|31
4953496|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4953497|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4953498|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4953499|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1
4953500|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0
4953501|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1
4953502|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4953503|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4953504|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4953505|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0
4953506|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4953507|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4953508|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
4953509|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1
4953510|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4953511|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4
4953512|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
4953513|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0
4953514|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2
4953515|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1
4953516|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1
4953517|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4953518|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4953519|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4953520|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0
4953521|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953522|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1
4953523|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953524|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953525|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953526|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
4953527|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2
4953528|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1
4953529|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3
4953530|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8
4953531|NCT00289913|17034549|P5|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953532|NCT00289913|17034550|P4|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953533|NCT00289913|17034551|P3|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953534|NCT00289913|17034552|P2|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1
4953535|NCT00289913|17034553|P1|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953536|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9
4953537|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4953538|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4953539|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4953540|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0
4953541|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7
4953542|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4953543|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4953544|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4953545|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0
4953546|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6
4953547|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4953548|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4953549|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4953550|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0
4953551|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11
4953552|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4953553|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4953554|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4953555|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0
4953556|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7
4953557|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4953558|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4953559|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4953560|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0
4953561|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4953562|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4953563|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4953564|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0
4953565|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1
4953566|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
4953567|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
4953568|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2
4953569|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1
4953570|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0
4953571|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
4953572|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3
4953573|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0
4953574|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5
4953575|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2
4953576|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4953577|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
4953578|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3
4953579|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1
4953580|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4953581|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
4953582|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
4953583|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
4953584|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0
4953585|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1
4953586|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953587|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953588|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1
4953589|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4953590|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3
4953591|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4953592|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4953593|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4953594|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1
4953595|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0
4953596|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0
4953597|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
4953598|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2
4953599|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11
4953600|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8
4953601|NCT00289913|17034549|P5|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953602|NCT00289913|17034550|P4|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953603|NCT00289913|17034551|P3|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1
4953604|NCT00289913|17034552|P2|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953605|NCT00289913|17034553|P1|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953606|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
4953607|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
4953608|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2
4953609|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0
4953610|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1
4953611|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4953612|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6
4953613|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5
4953614|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8
4953615|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0
4953616|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5
4953617|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
4953618|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0
4953619|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1
4953620|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2
4953621|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4953622|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4953623|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0
4953624|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2
4953625|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1
4953626|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4953627|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1
4953628|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4953629|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4953630|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0
4953631|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1
4953632|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4953633|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4953634|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4953635|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0
4953636|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4953637|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4953638|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0
4953639|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4953640|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2
4953641|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1
4953642|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
4953643|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
4953644|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2
4953645|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3
4953646|NCT00289913|17034549|P5|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953647|NCT00289913|17034550|P4|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953648|NCT00289913|17034551|P3|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953649|NCT00289913|17034552|P2|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1
4953650|NCT00289913|17034553|P1|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0
4953651|NCT00289900|17034584|P6|Overall Study|Not treated|0
4953652|NCT00289900|17034585|P5|Overall Study|Not treated|0
4953653|NCT00289900|17034586|P4|Overall Study|Not treated|0
4953654|NCT00289900|17034587|P3|Overall Study|Not treated|0
4953655|NCT00289900|17034588|P2|Overall Study|Not treated|1
4953656|NCT00289900|17034589|P1|Overall Study|Not treated|0
4953657|NCT00289900|17034584|P6|Overall Study|site terminated|0
4953658|NCT00289900|17034585|P5|Overall Study|site terminated|0
4953659|NCT00289900|17034586|P4|Overall Study|site terminated|0
4953660|NCT00289900|17034587|P3|Overall Study|site terminated|1
4953661|NCT00289900|17034588|P2|Overall Study|site terminated|0
4953662|NCT00289900|17034589|P1|Overall Study|site terminated|1
4953663|NCT00289900|17034584|P6|Overall Study|Protocol Violation|4
4953664|NCT00289900|17034585|P5|Overall Study|Protocol Violation|7
4953665|NCT00289900|17034586|P4|Overall Study|Protocol Violation|6
4953666|NCT00289900|17034587|P3|Overall Study|Protocol Violation|2
4953667|NCT00289900|17034588|P2|Overall Study|Protocol Violation|9
4953668|NCT00289900|17034589|P1|Overall Study|Protocol Violation|3
4953669|NCT00289900|17034584|P6|Overall Study|Withdrawal by Subject|11
4953670|NCT00289900|17034585|P5|Overall Study|Withdrawal by Subject|12
4953671|NCT00289900|17034586|P4|Overall Study|Withdrawal by Subject|18
4953672|NCT00289900|17034587|P3|Overall Study|Withdrawal by Subject|8
4953673|NCT00289900|17034588|P2|Overall Study|Withdrawal by Subject|21
4953674|NCT00289900|17034589|P1|Overall Study|Withdrawal by Subject|10
4953675|NCT00289900|17034584|P6|Overall Study|Participant moved|1
4953676|NCT00289900|17034585|P5|Overall Study|Participant moved|1
4953677|NCT00289900|17034586|P4|Overall Study|Participant moved|1
4953678|NCT00289900|17034587|P3|Overall Study|Participant moved|0
4953679|NCT00289900|17034588|P2|Overall Study|Participant moved|0
4953680|NCT00289900|17034589|P1|Overall Study|Participant moved|1
4953681|NCT00289900|17034584|P6|Overall Study|Other|0
4953682|NCT00289900|17034585|P5|Overall Study|Other|1
4953683|NCT00289900|17034586|P4|Overall Study|Other|5
4953684|NCT00289900|17034587|P3|Overall Study|Other|0
4953685|NCT00289900|17034588|P2|Overall Study|Other|0
4953686|NCT00289900|17034589|P1|Overall Study|Other|0
4953687|NCT00289900|17034584|P6|Overall Study|Participant had flushing|4
4953688|NCT00289900|17034585|P5|Overall Study|Participant had flushing|0
4953689|NCT00289900|17034586|P4|Overall Study|Participant had flushing|2
4953690|NCT00289900|17034587|P3|Overall Study|Participant had flushing|1
4953691|NCT00289900|17034588|P2|Overall Study|Participant had flushing|42
4953692|NCT00289900|17034589|P1|Overall Study|Participant had flushing|18
4953693|NCT00289900|17034584|P6|Overall Study|Lost to Follow-up|8
4953694|NCT00289900|17034585|P5|Overall Study|Lost to Follow-up|4
4953695|NCT00289900|17034586|P4|Overall Study|Lost to Follow-up|8
4953696|NCT00289900|17034587|P3|Overall Study|Lost to Follow-up|8
4953697|NCT00289900|17034588|P2|Overall Study|Lost to Follow-up|7
4953698|NCT00289900|17034589|P1|Overall Study|Lost to Follow-up|7
4953699|NCT00289900|17034584|P6|Overall Study|Adverse Event|33
4953700|NCT00289900|17034585|P5|Overall Study|Adverse Event|20
4953701|NCT00289900|17034586|P4|Overall Study|Adverse Event|19
4953702|NCT00289900|17034587|P3|Overall Study|Adverse Event|13
4953703|NCT00289900|17034588|P2|Overall Study|Adverse Event|40
4953704|NCT00289900|17034589|P1|Overall Study|Adverse Event|28
4953705|NCT00289887|17034693|P2|Overall Study|Other|3
4953706|NCT00289887|17034694|P1|Overall Study|Other|7
4953707|NCT00289887|17034693|P2|Overall Study|Withdrawal by Subject|8
4953708|NCT00289887|17034694|P1|Overall Study|Withdrawal by Subject|3
4953709|NCT00289887|17034693|P2|Overall Study|Protocol Violation|1
4953710|NCT00289887|17034694|P1|Overall Study|Protocol Violation|3
4953711|NCT00289887|17034693|P2|Overall Study|Lost to Follow-up|3
4953712|NCT00289887|17034694|P1|Overall Study|Lost to Follow-up|3
4953713|NCT00289887|17034693|P2|Overall Study|Lack of Efficacy|11
4953714|NCT00289887|17034694|P1|Overall Study|Lack of Efficacy|3
4953715|NCT00289887|17034693|P2|Overall Study|Adverse Event|3
4953716|NCT00289887|17034694|P1|Overall Study|Adverse Event|3
4953717|NCT00289874|17034712|P2|Overall Study|Did not meet eligibility|0
4953718|NCT00289874|17034713|P1|Overall Study|Did not meet eligibility|1
4953719|NCT00289874|17034712|P2|Overall Study|Protocol Violation|2
4953720|NCT00289874|17034713|P1|Overall Study|Protocol Violation|3
4953721|NCT00289874|17034712|P2|Overall Study|Lost to Follow-up|1
4953722|NCT00289874|17034713|P1|Overall Study|Lost to Follow-up|1
4953723|NCT00289874|17034712|P2|Overall Study|Adverse Event|5
4953724|NCT00289874|17034713|P1|Overall Study|Adverse Event|1
4953725|NCT00289848|17034723|P2|Overall Study|Open-Label AHA Treatment Requested|1
4953726|NCT00289848|17034724|P1|Overall Study|Open-Label AHA Treatment Requested|0
4953727|NCT00289848|17034723|P2|Overall Study|Patient Moved|2
4953728|NCT00289848|17034724|P1|Overall Study|Patient Moved|6
4953729|NCT00289848|17034723|P2|Overall Study|Withdrawal by Subject|11
4953730|NCT00289848|17034724|P1|Overall Study|Withdrawal by Subject|5
4953731|NCT00289848|17034723|P2|Overall Study|Protocol Violation|2
4953732|NCT00289848|17034724|P1|Overall Study|Protocol Violation|5
4953733|NCT00289848|17034723|P2|Overall Study|Lost to Follow-up|1
4953734|NCT00289848|17034724|P1|Overall Study|Lost to Follow-up|3
4953735|NCT00289848|17034723|P2|Overall Study|Lack of Efficacy|24
4953736|NCT00289848|17034724|P1|Overall Study|Lack of Efficacy|20
4953737|NCT00289848|17034723|P2|Overall Study|Death|0
4953738|NCT00289848|17034724|P1|Overall Study|Death|1
4953739|NCT00289848|17034723|P2|Overall Study|Adverse Event|4
4953740|NCT00289848|17034724|P1|Overall Study|Adverse Event|6
4953741|NCT00289783|17034736|P2|Fourth Dose Phase|Other|10
4953742|NCT00289783|17034737|P1|Fourth Dose Phase|Other|22
4953743|NCT00289783|17034736|P2|Fourth Dose Phase|Migration from the study area|1
4953744|NCT00289783|17034737|P1|Fourth Dose Phase|Migration from the study area|1
4953745|NCT00289783|17034736|P2|Fourth Dose Phase|Lost to Follow-up|12
4953746|NCT00289783|17034737|P1|Fourth Dose Phase|Lost to Follow-up|53
4953747|NCT00289783|17034736|P2|Fourth Dose Phase|Withdrawal by Subject|1
4953748|NCT00289783|17034737|P1|Fourth Dose Phase|Withdrawal by Subject|10
4953749|NCT00289783|17034736|P2|Fourth Dose Phase|Adverse Event|0
4953750|NCT00289783|17034737|P1|Fourth Dose Phase|Adverse Event|1
4953751|NCT00289783|17034736|P2|Primary Phase|Other|12
4953752|NCT00289783|17034737|P1|Primary Phase|Other|32
4953753|NCT00289783|17034736|P2|Primary Phase|Migration from the study area|10
4953754|NCT00289783|17034737|P1|Primary Phase|Migration from the study area|26
4953755|NCT00289783|17034736|P2|Primary Phase|Lost to Follow-up|14
4953756|NCT00289783|17034737|P1|Primary Phase|Lost to Follow-up|60
4953757|NCT00289783|17034736|P2|Primary Phase|Withdrawal by Subject|40
4953758|NCT00289783|17034737|P1|Primary Phase|Withdrawal by Subject|93
4953759|NCT00289783|17034736|P2|Primary Phase|Protocol Violation|6
4953760|NCT00289783|17034737|P1|Primary Phase|Protocol Violation|27
4953761|NCT00289783|17034736|P2|Primary Phase|Adverse Event|1
4953762|NCT00289783|17034737|P1|Primary Phase|Adverse Event|10
4953763|NCT00289770|17034915|P1|Year 15|Withdrawal by Subject|1
4953764|NCT00289731|17034961|P3|Overall Study|Other|0
4953765|NCT00289731|17034962|P2|Overall Study|Other|0
4953766|NCT00289731|17034963|P1|Overall Study|Other|1
4953767|NCT00289731|17034961|P3|Overall Study|Adverse Event|2
4953768|NCT00289731|17034962|P2|Overall Study|Adverse Event|2
4953769|NCT00289731|17034963|P1|Overall Study|Adverse Event|1
4953770|NCT00289536|17035075|P3|Period 3|Lost to Follow-up|1
4953771|NCT00289536|17035076|P2|Period 3|Lost to Follow-up|0
4953772|NCT00289536|17035077|P1|Period 3|Lost to Follow-up|0
4953773|NCT00289458|17035123|P3|Overall Study|Withdrawal by Subject|4
4953774|NCT00289458|17035124|P2|Overall Study|Withdrawal by Subject|2
4953775|NCT00289458|17035125|P1|Overall Study|Withdrawal by Subject|2
4953776|NCT00289458|17035123|P3|Overall Study|Physician Decision|2
4953777|NCT00289458|17035124|P2|Overall Study|Physician Decision|4
4953778|NCT00289458|17035125|P1|Overall Study|Physician Decision|3
4953779|NCT00289458|17035123|P3|Overall Study|Death|0
4953780|NCT00289458|17035124|P2|Overall Study|Death|0
4953781|NCT00289458|17035125|P1|Overall Study|Death|1
4953782|NCT00289289|17035186|P3|Overall Study|Other Exit Reason|12
4953783|NCT00289289|17035187|P2|Overall Study|Other Exit Reason|4
4953784|NCT00289289|17035188|P1|Overall Study|Other Exit Reason|6
4953785|NCT00289289|17035186|P3|Overall Study|Did not meet inclusion/exclusion|6
4953786|NCT00289289|17035187|P2|Overall Study|Did not meet inclusion/exclusion|0
4953787|NCT00289289|17035188|P1|Overall Study|Did not meet inclusion/exclusion|0
4953788|NCT00289289|17035186|P3|Overall Study|Non-study device implanted|3
4953789|NCT00289289|17035187|P2|Overall Study|Non-study device implanted|1
4953790|NCT00289289|17035188|P1|Overall Study|Non-study device implanted|2
4953791|NCT00289289|17035186|P3|Overall Study|Physician Decision|6
4953792|NCT00289289|17035187|P2|Overall Study|Physician Decision|0
4953793|NCT00289289|17035188|P1|Overall Study|Physician Decision|1
4953794|NCT00289289|17035186|P3|Overall Study|No implant attempted|1
4953795|NCT00289289|17035187|P2|Overall Study|No implant attempted|0
4953796|NCT00289289|17035188|P1|Overall Study|No implant attempted|0
4953797|NCT00289289|17035186|P3|Overall Study|Death|5
4953798|NCT00289289|17035187|P2|Overall Study|Death|2
4953799|NCT00289289|17035188|P1|Overall Study|Death|4
4953800|NCT00289289|17035186|P3|Overall Study|Lost to Follow-up|1
4953801|NCT00289289|17035187|P2|Overall Study|Lost to Follow-up|0
4953802|NCT00289289|17035188|P1|Overall Study|Lost to Follow-up|1
4953803|NCT00289289|17035186|P3|Overall Study|Withdrawal by Subject|15
4953804|NCT00289289|17035187|P2|Overall Study|Withdrawal by Subject|3
4953805|NCT00289289|17035188|P1|Overall Study|Withdrawal by Subject|5
4953806|NCT00289276|17035203|P2|Second Part of FAST Study (Expansion)|Lost to Follow-up|1
4953807|NCT00289276|17035204|P1|Second Part of FAST Study (Expansion)|Lost to Follow-up|0
4953808|NCT00289276|17035203|P2|Second Part of FAST Study (Expansion)|Death|2
4953809|NCT00289276|17035204|P1|Second Part of FAST Study (Expansion)|Death|0
4953810|NCT00289198|17035239|P2|Overall Study|Other: Impossible to come on visit|1
4953811|NCT00289198|17035240|P1|Overall Study|Other: Impossible to come on visit|0
4953812|NCT00289198|17035239|P2|Overall Study|Other: Miscalculation of the visit date|22
4953813|NCT00289198|17035240|P1|Overall Study|Other: Miscalculation of the visit date|21
4953814|NCT00289198|17035239|P2|Overall Study|Other: Unable to attend on schedule|1
4953815|NCT00289198|17035240|P1|Overall Study|Other: Unable to attend on schedule|2
4953816|NCT00289198|17035239|P2|Overall Study|Other: Physician's decision|1
4953817|NCT00289198|17035240|P1|Overall Study|Other: Physician's decision|0
4953818|NCT00289198|17035239|P2|Overall Study|Other: Low compliance|1
4953819|NCT00289198|17035240|P1|Overall Study|Other: Low compliance|0
4953820|NCT00289198|17035239|P2|Overall Study|Lack of Efficacy|0
4953821|NCT00289198|17035240|P1|Overall Study|Lack of Efficacy|2
4953822|NCT00289198|17035239|P2|Overall Study|Withdrawal by Subject|1
4953823|NCT00289198|17035240|P1|Overall Study|Withdrawal by Subject|4
4953824|NCT00289198|17035239|P2|Overall Study|Protocol Violation|1
4953825|NCT00289198|17035240|P1|Overall Study|Protocol Violation|2
4953826|NCT00289198|17035239|P2|Overall Study|Adverse Event|2
4953827|NCT00289198|17035240|P1|Overall Study|Adverse Event|0
4953828|NCT00289133|17035290|P2|Overall Study|Lost to Follow-up|115
4953829|NCT00289133|17035291|P1|Overall Study|Lost to Follow-up|92
4953830|NCT00289133|17035290|P2|Overall Study|Revision|6
4953831|NCT00289133|17035291|P1|Overall Study|Revision|8
4953832|NCT00289133|17035290|P2|Overall Study|Physician Decision|45
4953833|NCT00289133|17035291|P1|Overall Study|Physician Decision|41
4953834|NCT00289133|17035290|P2|Overall Study|Lost to Follow-up - Hurricane Katri|74
4953835|NCT00289133|17035291|P1|Overall Study|Lost to Follow-up - Hurricane Katri|73
4953836|NCT00289133|17035290|P2|Overall Study|Death|10
4953837|NCT00289133|17035291|P1|Overall Study|Death|5
4953838|NCT00289133|17035290|P2|Overall Study|Withdrawal by Subject|10
4953839|NCT00289133|17035291|P1|Overall Study|Withdrawal by Subject|9
4953840|NCT00289133|17035290|P2|Overall Study|Protocol Violation|38
4953841|NCT00289133|17035291|P1|Overall Study|Protocol Violation|32
4953842|NCT00289133|17035290|P2|Overall Study|Non-study device implanted|0
4953843|NCT00289133|17035291|P1|Overall Study|Non-study device implanted|12
4953844|NCT00289016|17035347|P1|Overall Study|Other|1
4953845|NCT00289016|17035347|P1|Overall Study|Adverse Event|1
4953846|NCT00289016|17035347|P1|Overall Study|Withdrawal by Subject|2
4953847|NCT00289016|17035347|P1|Overall Study|Unrelated Medical Condition or Accident|2
4953848|NCT00289016|17035347|P1|Overall Study|Death|2
4953849|NCT00289016|17035347|P1|Overall Study|Disease Progression|29
4953850|NCT00288912|17035359|P3|Overall Study|Withdrawal by Subject|12
4953851|NCT00288912|17035360|P2|Overall Study|Withdrawal by Subject|5
4953852|NCT00288912|17035361|P1|Overall Study|Withdrawal by Subject|4
4953853|NCT00288912|17035359|P3|Overall Study|Lost to Follow-up|9
4953854|NCT00288912|17035360|P2|Overall Study|Lost to Follow-up|6
4953855|NCT00288912|17035361|P1|Overall Study|Lost to Follow-up|9
4953856|NCT00288912|17035359|P3|Overall Study|Developed exclusion criterion|7
4953857|NCT00288912|17035360|P2|Overall Study|Developed exclusion criterion|6
4953858|NCT00288912|17035361|P1|Overall Study|Developed exclusion criterion|4
4953859|NCT00288860|17035401|P2|Overall Study|Lost to Follow-up|71
4953860|NCT00288860|17035402|P1|Overall Study|Lost to Follow-up|74
4953861|NCT00288860|17035401|P2|Overall Study|Withdrawal by Subject|15
4953862|NCT00288860|17035402|P1|Overall Study|Withdrawal by Subject|20
4953863|NCT00288860|17035401|P2|Overall Study|Death|3
4953864|NCT00288860|17035402|P1|Overall Study|Death|4
4953865|NCT00288860|17035401|P2|Overall Study|Did not complete intake|8
4953866|NCT00288860|17035402|P1|Overall Study|Did not complete intake|4
4953867|NCT00288704|17035415|P3|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1
4953868|NCT00288704|17035416|P2|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
4953869|NCT00288704|17035417|P1|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0
4953870|NCT00288704|17035415|P3|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15
4953871|NCT00288704|17035416|P2|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
4953872|NCT00288704|17035417|P1|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0
4953873|NCT00288704|17035415|P3|Open-Label Extension (OLE) Weeks 24-117|Death|2
4953874|NCT00288704|17035416|P2|Open-Label Extension (OLE) Weeks 24-117|Death|0
4953875|NCT00288704|17035417|P1|Open-Label Extension (OLE) Weeks 24-117|Death|0
4953876|NCT00288704|17035415|P3|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1
4953877|NCT00288704|17035416|P2|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
4953878|NCT00288704|17035417|P1|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0
4953879|NCT00288704|17035415|P3|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1
4953880|NCT00288704|17035416|P2|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
4953881|NCT00288704|17035417|P1|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0
4953882|NCT00288704|17035415|P3|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
4953883|NCT00288704|17035416|P2|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1
4953884|NCT00288704|17035417|P1|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0
4953885|NCT00288704|17035415|P3|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
4953886|NCT00288704|17035416|P2|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1
4953887|NCT00288704|17035417|P1|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0
4953888|NCT00288639|17035444|P1|Overall Study|Other|1
4953889|NCT00288639|17035444|P1|Overall Study|Withdrawal by Subject|2
4953890|NCT00288639|17035444|P1|Overall Study|Lack of Efficacy|4
4953891|NCT00288639|17035444|P1|Overall Study|Adverse Event|5
4953892|NCT00288626|17035461|P1|Overall Study|Withdrawal by Subject|4
4953893|NCT00288626|17035461|P1|Overall Study|Death|3
4953894|NCT00288587|17035495|P2|Overall Study|Severe Aortic Stenosis|0
4953895|NCT00288587|17035496|P1|Overall Study|Severe Aortic Stenosis|1
4953896|NCT00288587|17035495|P2|Overall Study|Physician Decision|2
4953897|NCT00288587|17035496|P1|Overall Study|Physician Decision|0
4953898|NCT00288587|17035495|P2|Overall Study|Adverse Event|1
4953899|NCT00288587|17035496|P1|Overall Study|Adverse Event|0
4953900|NCT00288587|17035495|P2|Overall Study|Transplant|3
4953901|NCT00288587|17035496|P1|Overall Study|Transplant|0
4953902|NCT00288587|17035495|P2|Overall Study|Death|4
4953903|NCT00288587|17035496|P1|Overall Study|Death|4
4953904|NCT00288509|17035539|P1|Treatment Cycle 4|Treatment stopped according to protocol|1
4953905|NCT00288509|17035539|P1|Treatment Cycle 4|Physician Decision|4
4953906|NCT00288509|17035539|P1|Treatment Cycle 4|Withdrawal by Subject|3
4953907|NCT00288509|17035539|P1|Treatment Cycle 3|Treatment stopped according to protocol|1
4953908|NCT00288509|17035539|P1|Treatment Cycle 3|Lost to Follow-up|2
4953909|NCT00288509|17035539|P1|Treatment Cycle 3|Withdrawal by Subject|1
4953910|NCT00288509|17035539|P1|Treatment Cycle 3|Lack of Efficacy|1
4953911|NCT00288509|17035539|P1|Treatment Cycle 2|Withdrawal by Subject|2
4953912|NCT00288509|17035539|P1|Treatment Cycle 2|Lack of Efficacy|1
4953913|NCT00288509|17035539|P1|Treatment Cycle 1|Treatment stopped according to protocol|1
4953914|NCT00288509|17035539|P1|Treatment Cycle 1|Lost to Follow-up|2
4953915|NCT00288509|17035539|P1|Treatment Cycle 1|Withdrawal by Subject|1
4953916|NCT00288509|17035539|P1|Treatment Cycle 1|Lack of Efficacy|1
4953917|NCT00288509|17035539|P1|Treatment Cycle 1|Adverse Event|1
4953918|NCT00288080|17035557|P2|Overall Study|Protocol Violation|20
4953919|NCT00288080|17035558|P1|Overall Study|Protocol Violation|25
4953920|NCT00288080|17035557|P2|Overall Study|Withdrawal by Subject|3
4953921|NCT00288080|17035558|P1|Overall Study|Withdrawal by Subject|1
4953922|NCT00288054|17035580|P1|Overall Study|Not protocol specified|2
4953923|NCT00288054|17035580|P1|Overall Study|Withdrawal by Subject|1
4953924|NCT00288054|17035580|P1|Overall Study|Adverse Event|3
4953925|NCT00288054|17035580|P1|Overall Study|Lack of Efficacy|16
4953926|NCT00288054|17035580|P1|Overall Study|Protocol Violation|2
4953927|NCT00288015|17035588|P1|Follow up for Survival x 2 Years|Other|9
4953928|NCT00288015|17035588|P1|Follow up for Survival x 2 Years|Lost to Follow-up|4
4953929|NCT00288015|17035588|P1|Follow up for Survival x 2 Years|Death|13
4953930|NCT00288015|17035588|P1|Continued Bevacizumab Cycle 3+|Disease progressed|7
4953931|NCT00288015|17035588|P1|First Response Assessment|Physician Decision|2
4953932|NCT00288015|17035588|P1|First Response Assessment|Death|1
4953933|NCT00288015|17035588|P1|First Response Assessment|Withdrawal by Subject|1
4953934|NCT00288015|17035588|P1|Bevacizumab Treatment Cycles 1-2|Physician Decision|1
4953935|NCT00288015|17035588|P1|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1
4953936|NCT00287690|17035680|P2|Overall Study|Protocol Violation|26
4953937|NCT00287690|17035681|P1|Overall Study|Protocol Violation|20
4953938|NCT00287586|17035693|P2|Overall Study|Recurrent Melanoma|1
4953939|NCT00287586|17035694|P1|Overall Study|Recurrent Melanoma|0
4953940|NCT00287586|17035693|P2|Overall Study|Itchy Swollen Eyes|1
4953941|NCT00287586|17035694|P1|Overall Study|Itchy Swollen Eyes|0
4953942|NCT00287586|17035693|P2|Overall Study|Bradycardia|1
4953943|NCT00287586|17035694|P1|Overall Study|Bradycardia|0
4953944|NCT00287586|17035693|P2|Overall Study|Mood Swings and Irritability|1
4953945|NCT00287586|17035694|P1|Overall Study|Mood Swings and Irritability|0
4953946|NCT00287586|17035693|P2|Overall Study|Mastodynia and Gynecomastia|1
4953947|NCT00287586|17035694|P1|Overall Study|Mastodynia and Gynecomastia|0
4953948|NCT00287586|17035693|P2|Overall Study|Retroperitoneal Cancer|1
4953949|NCT00287586|17035694|P1|Overall Study|Retroperitoneal Cancer|0
4953950|NCT00287586|17035693|P2|Overall Study|Elevated IPSS Score|1
4953951|NCT00287586|17035694|P1|Overall Study|Elevated IPSS Score|0
4953952|NCT00287586|17035693|P2|Overall Study|Lung Cancer|2
4953953|NCT00287586|17035694|P1|Overall Study|Lung Cancer|0
4953954|NCT00287586|17035693|P2|Overall Study|Major Depression|2
4953955|NCT00287586|17035694|P1|Overall Study|Major Depression|0
4953956|NCT00287586|17035693|P2|Overall Study|Enrolled in Another Study|0
4953957|NCT00287586|17035694|P1|Overall Study|Enrolled in Another Study|1
4953958|NCT00287586|17035693|P2|Overall Study|Nonadherence|1
4953959|NCT00287586|17035694|P1|Overall Study|Nonadherence|1
4953960|NCT00287586|17035693|P2|Overall Study|Inappropriate Behaviour with Staff|0
4953961|NCT00287586|17035694|P1|Overall Study|Inappropriate Behaviour with Staff|1
4953962|NCT00287586|17035693|P2|Overall Study|Shoulder Pain|0
4953963|NCT00287586|17035694|P1|Overall Study|Shoulder Pain|1
4953964|NCT00287586|17035693|P2|Overall Study|Sleep Apnea|0
4953965|NCT00287586|17035694|P1|Overall Study|Sleep Apnea|1
4953966|NCT00287586|17035693|P2|Overall Study|Pancreatic Cancer|3
4953967|NCT00287586|17035694|P1|Overall Study|Pancreatic Cancer|1
4953968|NCT00287586|17035693|P2|Overall Study|Cognitive Impairment|0
4953969|NCT00287586|17035694|P1|Overall Study|Cognitive Impairment|1
4953970|NCT00287586|17035693|P2|Overall Study|Lower Urinary Tract Symptoms|0
4953971|NCT00287586|17035694|P1|Overall Study|Lower Urinary Tract Symptoms|1
4953972|NCT00287586|17035693|P2|Overall Study|Myocardial Infarction|0
4953973|NCT00287586|17035694|P1|Overall Study|Myocardial Infarction|1
4953974|NCT00287586|17035693|P2|Overall Study|Stroke|0
4953975|NCT00287586|17035694|P1|Overall Study|Stroke|2
4953976|NCT00287586|17035693|P2|Overall Study|Elevated Prostate Specific Antigen|0
4953977|NCT00287586|17035694|P1|Overall Study|Elevated Prostate Specific Antigen|2
4953978|NCT00287586|17035693|P2|Overall Study|Rash|0
4953979|NCT00287586|17035694|P1|Overall Study|Rash|3
4953980|NCT00287586|17035693|P2|Overall Study|Elevated Hematocrit|0
4953981|NCT00287586|17035694|P1|Overall Study|Elevated Hematocrit|3
4953982|NCT00287586|17035693|P2|Overall Study|Death|3
4953983|NCT00287586|17035694|P1|Overall Study|Death|2
4953984|NCT00287586|17035693|P2|Overall Study|Lost to Follow-up|4
4953985|NCT00287586|17035694|P1|Overall Study|Lost to Follow-up|5
4953986|NCT00287586|17035693|P2|Overall Study|Withdrew Consent|30
4953987|NCT00287586|17035694|P1|Overall Study|Withdrew Consent|19
4953988|NCT00287469|17035732|P2|Overall Study|Lost to Follow-up|69
4953989|NCT00287469|17035733|P1|Overall Study|Lost to Follow-up|74
4953990|NCT00287469|17035732|P2|Overall Study|moved from area|138
4953991|NCT00287469|17035733|P1|Overall Study|moved from area|144
4953992|NCT00287469|17035732|P2|Overall Study|Adverse Event|1
4953993|NCT00287469|17035733|P1|Overall Study|Adverse Event|1
4953994|NCT00287469|17035732|P2|Overall Study|serious adverse event|6
4953995|NCT00287469|17035733|P1|Overall Study|serious adverse event|1
4953996|NCT00287365|17035743|P1|Overall Study|sample not acquired|13
4953997|NCT00287118|17035769|P1|Overall Study|Other|7
4953998|NCT00287118|17035769|P1|Overall Study|Protocol Violation|2
4953999|NCT00287118|17035769|P1|Overall Study|Lost to Follow-up|1
4954000|NCT00287118|17035769|P1|Overall Study|Lack of Efficacy|11
4954001|NCT00287118|17035769|P1|Overall Study|Death|1
4954002|NCT00287118|17035769|P1|Overall Study|Adverse Event|30
4954003|NCT00287079|17035775|P2|Overall Study|Other|0
4954004|NCT00287079|17035776|P1|Overall Study|Other|3
4954005|NCT00287079|17035775|P2|Overall Study|Protocol Violation|0
4954006|NCT00287079|17035776|P1|Overall Study|Protocol Violation|1
4954007|NCT00287079|17035775|P2|Overall Study|Adverse Event|0
4954008|NCT00287079|17035776|P1|Overall Study|Adverse Event|5
4954009|NCT00287079|17035775|P2|Overall Study|Non-qualifying relapse|0
4954010|NCT00287079|17035776|P1|Overall Study|Non-qualifying relapse|1
4954011|NCT00287079|17035775|P2|Overall Study|Qualifying relapse|1
4954012|NCT00287079|17035776|P1|Overall Study|Qualifying relapse|12
4954013|NCT00286754|17035804|P3|Overall Study|Moved out of state|1
4954014|NCT00286754|17035805|P2|Overall Study|Moved out of state|0
4954015|NCT00286754|17035806|P1|Overall Study|Moved out of state|0
4954016|NCT00286754|17035804|P3|Overall Study|Lost to Follow-up|6
4954017|NCT00286754|17035805|P2|Overall Study|Lost to Follow-up|14
4954018|NCT00286754|17035806|P1|Overall Study|Lost to Follow-up|12
4954019|NCT00286754|17035804|P3|Overall Study|Withdrawal by Subject|0
4954020|NCT00286754|17035805|P2|Overall Study|Withdrawal by Subject|2
4954021|NCT00286754|17035806|P1|Overall Study|Withdrawal by Subject|6
4954022|NCT00286754|17035804|P3|Overall Study|Adverse Event|3
4954023|NCT00286754|17035805|P2|Overall Study|Adverse Event|2
4954024|NCT00286754|17035806|P1|Overall Study|Adverse Event|2
4954025|NCT00286494|17035865|P3|Overall Study|Protocol Violation|2
4954026|NCT00286494|17035866|P2|Overall Study|Protocol Violation|1
4954027|NCT00286494|17035867|P1|Overall Study|Protocol Violation|1
4954028|NCT00286494|17035865|P3|Overall Study|Lost to Follow-up|3
4954029|NCT00286494|17035866|P2|Overall Study|Lost to Follow-up|1
4954030|NCT00286494|17035867|P1|Overall Study|Lost to Follow-up|3
4954031|NCT00286494|17035865|P3|Overall Study|Physician Decision|1
4954032|NCT00286494|17035866|P2|Overall Study|Physician Decision|5
4954033|NCT00286494|17035867|P1|Overall Study|Physician Decision|5
4954034|NCT00286494|17035865|P3|Overall Study|Adverse Event|6
4954035|NCT00286494|17035866|P2|Overall Study|Adverse Event|8
4954036|NCT00286494|17035867|P1|Overall Study|Adverse Event|3
4954037|NCT00286494|17035865|P3|Overall Study|Withdrawal by Subject|9
4954038|NCT00286494|17035866|P2|Overall Study|Withdrawal by Subject|10
4954039|NCT00286494|17035867|P1|Overall Study|Withdrawal by Subject|2
4954040|NCT00286494|17035865|P3|Overall Study|Hyperglycemic rescue|18
4954041|NCT00286494|17035866|P2|Overall Study|Hyperglycemic rescue|19
4954042|NCT00286494|17035867|P1|Overall Study|Hyperglycemic rescue|12
4954043|NCT00286468|17036028|P3|Overall Study|Physician Decision|1
4954044|NCT00286468|17036029|P2|Overall Study|Physician Decision|2
4954045|NCT00286468|17036030|P1|Overall Study|Physician Decision|3
4954046|NCT00286468|17036028|P3|Overall Study|Withdrawal by Subject|11
4954047|NCT00286468|17036029|P2|Overall Study|Withdrawal by Subject|8
4954048|NCT00286468|17036030|P1|Overall Study|Withdrawal by Subject|3
4954049|NCT00286468|17036028|P3|Overall Study|Lost to Follow-up|2
4954050|NCT00286468|17036029|P2|Overall Study|Lost to Follow-up|1
4954051|NCT00286468|17036030|P1|Overall Study|Lost to Follow-up|1
4954052|NCT00286468|17036028|P3|Overall Study|Protocol Violation|1
4954053|NCT00286468|17036029|P2|Overall Study|Protocol Violation|3
4954054|NCT00286468|17036030|P1|Overall Study|Protocol Violation|0
4954055|NCT00286468|17036028|P3|Overall Study|Adverse Event|4
4954056|NCT00286468|17036029|P2|Overall Study|Adverse Event|6
4954057|NCT00286468|17036030|P1|Overall Study|Adverse Event|2
4954058|NCT00286468|17036028|P3|Overall Study|Hyperglycemic Rescue|31
4954059|NCT00286468|17036029|P2|Overall Study|Hyperglycemic Rescue|30
4954060|NCT00286468|17036030|P1|Overall Study|Hyperglycemic Rescue|28
4954061|NCT00286455|17036191|P3|Overall Study|Withdrawal by Subject|7
4954062|NCT00286455|17036192|P2|Overall Study|Withdrawal by Subject|8
4954063|NCT00286455|17036193|P1|Overall Study|Withdrawal by Subject|0
4954064|NCT00286455|17036191|P3|Overall Study|Participant Non-compliance|0
4954065|NCT00286455|17036192|P2|Overall Study|Participant Non-compliance|0
4954066|NCT00286455|17036193|P1|Overall Study|Participant Non-compliance|1
4954067|NCT00286455|17036191|P3|Overall Study|Protocol Violation|0
4954068|NCT00286455|17036192|P2|Overall Study|Protocol Violation|1
4954069|NCT00286455|17036193|P1|Overall Study|Protocol Violation|1
4954070|NCT00286455|17036191|P3|Overall Study|Physician Decision|2
4954071|NCT00286455|17036192|P2|Overall Study|Physician Decision|0
4954072|NCT00286455|17036193|P1|Overall Study|Physician Decision|3
4954073|NCT00286455|17036191|P3|Overall Study|Lost to Follow-up|3
4954074|NCT00286455|17036192|P2|Overall Study|Lost to Follow-up|3
4954075|NCT00286455|17036193|P1|Overall Study|Lost to Follow-up|0
4954076|NCT00286455|17036191|P3|Overall Study|Adverse Event|2
4954077|NCT00286455|17036192|P2|Overall Study|Adverse Event|3
4954078|NCT00286455|17036193|P1|Overall Study|Adverse Event|1
4954079|NCT00286455|17036191|P3|Overall Study|Hyperglycemia rescue|10
4954080|NCT00286455|17036192|P2|Overall Study|Hyperglycemia rescue|13
4954081|NCT00286455|17036193|P1|Overall Study|Hyperglycemia rescue|19
4954082|NCT00286442|17036372|P3|Overall Study|Withdrawal by Subject|2
4954083|NCT00286442|17036373|P2|Overall Study|Withdrawal by Subject|14
4954084|NCT00286442|17036374|P1|Overall Study|Withdrawal by Subject|2
4954085|NCT00286442|17036372|P3|Overall Study|Administrative Error|0
4954086|NCT00286442|17036373|P2|Overall Study|Administrative Error|1
4954087|NCT00286442|17036374|P1|Overall Study|Administrative Error|1
4954088|NCT00286442|17036372|P3|Overall Study|Physician Decision|1
4954089|NCT00286442|17036373|P2|Overall Study|Physician Decision|1
4954090|NCT00286442|17036374|P1|Overall Study|Physician Decision|1
4954091|NCT00286442|17036372|P3|Overall Study|Lost to Follow-up|1
4954092|NCT00286442|17036373|P2|Overall Study|Lost to Follow-up|2
4954093|NCT00286442|17036374|P1|Overall Study|Lost to Follow-up|5
4954094|NCT00286442|17036372|P3|Overall Study|Protocol Violation|2
4954095|NCT00286442|17036373|P2|Overall Study|Protocol Violation|4
4954096|NCT00286442|17036374|P1|Overall Study|Protocol Violation|2
4954097|NCT00286442|17036372|P3|Overall Study|Adverse Event|1
4954098|NCT00286442|17036373|P2|Overall Study|Adverse Event|6
4954099|NCT00286442|17036374|P1|Overall Study|Adverse Event|7
4954100|NCT00286442|17036372|P3|Overall Study|Hyperglycemic Rescue|25
4954101|NCT00286442|17036373|P2|Overall Study|Hyperglycemic Rescue|17
4954102|NCT00286442|17036374|P1|Overall Study|Hyperglycemic Rescue|19
4954103|NCT00286429|17036535|P3|Overall Study|Administrative Decision|0
4954104|NCT00286429|17036536|P2|Overall Study|Administrative Decision|1
4954105|NCT00286429|17036537|P1|Overall Study|Administrative Decision|0
4954106|NCT00286429|17036535|P3|Overall Study|Administrative Error|1
4954107|NCT00286429|17036536|P2|Overall Study|Administrative Error|1
4954108|NCT00286429|17036537|P1|Overall Study|Administrative Error|1
4954109|NCT00286429|17036535|P3|Overall Study|Withdrawal by Subject|6
4954110|NCT00286429|17036536|P2|Overall Study|Withdrawal by Subject|2
4954111|NCT00286429|17036537|P1|Overall Study|Withdrawal by Subject|3
4954112|NCT00286429|17036535|P3|Overall Study|Protocol Violation|4
4954113|NCT00286429|17036536|P2|Overall Study|Protocol Violation|5
4954114|NCT00286429|17036537|P1|Overall Study|Protocol Violation|3
4954115|NCT00286429|17036535|P3|Overall Study|Physician Decision|7
4954116|NCT00286429|17036536|P2|Overall Study|Physician Decision|7
4954117|NCT00286429|17036537|P1|Overall Study|Physician Decision|10
4954118|NCT00286429|17036535|P3|Overall Study|Lost to Follow-up|3
4954119|NCT00286429|17036536|P2|Overall Study|Lost to Follow-up|4
4954120|NCT00286429|17036537|P1|Overall Study|Lost to Follow-up|2
4954121|NCT00286429|17036535|P3|Overall Study|Lack of Efficacy|25
4954122|NCT00286429|17036536|P2|Overall Study|Lack of Efficacy|27
4954123|NCT00286429|17036537|P1|Overall Study|Lack of Efficacy|52
4954124|NCT00286429|17036535|P3|Overall Study|Adverse Event|6
4954125|NCT00286429|17036536|P2|Overall Study|Adverse Event|1
4954126|NCT00286429|17036537|P1|Overall Study|Adverse Event|4
4954127|NCT00286221|17036653|P4|Overall Study|Unrecognized exclusion criteria met|0
4954128|NCT00286221|17036654|P3|Overall Study|Unrecognized exclusion criteria met|0
4954129|NCT00286221|17036655|P2|Overall Study|Unrecognized exclusion criteria met|1
4954130|NCT00286221|17036656|P1|Overall Study|Unrecognized exclusion criteria met|0
4954131|NCT00286221|17036653|P4|Overall Study|Inability to trigger PCA|0
4954132|NCT00286221|17036654|P3|Overall Study|Inability to trigger PCA|0
4954133|NCT00286221|17036655|P2|Overall Study|Inability to trigger PCA|0
4954134|NCT00286221|17036656|P1|Overall Study|Inability to trigger PCA|2
4954135|NCT00286221|17036653|P4|Overall Study|Unanticipated Neurosurgical Complication|2
4954136|NCT00286221|17036654|P3|Overall Study|Unanticipated Neurosurgical Complication|3
4954137|NCT00286221|17036655|P2|Overall Study|Unanticipated Neurosurgical Complication|3
4954138|NCT00286221|17036656|P1|Overall Study|Unanticipated Neurosurgical Complication|6
4954139|NCT00286221|17036653|P4|Overall Study|Protocol Violation|4
4954140|NCT00286221|17036654|P3|Overall Study|Protocol Violation|6
4954141|NCT00286221|17036655|P2|Overall Study|Protocol Violation|1
4954142|NCT00286221|17036656|P1|Overall Study|Protocol Violation|2
4954143|NCT00286156|17036682|P3|Overall Study|AE: pneumonia|0
4954144|NCT00286156|17036683|P2|Overall Study|AE: pneumonia|0
4954145|NCT00286156|17036684|P1|Overall Study|AE: pneumonia|1
4954146|NCT00286156|17036682|P3|Overall Study|AE: nephrotic-range proteinuruia|0
4954147|NCT00286156|17036683|P2|Overall Study|AE: nephrotic-range proteinuruia|0
4954148|NCT00286156|17036684|P1|Overall Study|AE: nephrotic-range proteinuruia|1
4954149|NCT00286156|17036682|P3|Overall Study|AE: pulmonary embolus|0
4954150|NCT00286156|17036683|P2|Overall Study|AE: pulmonary embolus|1
4954151|NCT00286156|17036684|P1|Overall Study|AE: pulmonary embolus|0
4954152|NCT00286156|17036682|P3|Overall Study|Missed 12 month visit|1
4954153|NCT00286156|17036683|P2|Overall Study|Missed 12 month visit|0
4954154|NCT00286156|17036684|P1|Overall Study|Missed 12 month visit|0
4954155|NCT00286091|17036697|P2|Open-label Treatment Phase|Missing End of Study Information|1
4954156|NCT00286091|17036698|P1|Open-label Treatment Phase|Missing End of Study Information|0
4954157|NCT00286091|17036697|P2|Open-label Treatment Phase|Protocol-specified Criteria|0
4954158|NCT00286091|17036698|P1|Open-label Treatment Phase|Protocol-specified Criteria|1
4954159|NCT00286091|17036697|P2|Open-label Treatment Phase|Lost to Follow-up|1
4954160|NCT00286091|17036698|P1|Open-label Treatment Phase|Lost to Follow-up|0
4954161|NCT00286091|17036697|P2|Open-label Treatment Phase|Noncompliance|1
4954162|NCT00286091|17036698|P1|Open-label Treatment Phase|Noncompliance|3
4954163|NCT00286091|17036697|P2|Open-label Treatment Phase|Disease Progression|3
4954164|NCT00286091|17036698|P1|Open-label Treatment Phase|Disease Progression|9
4954165|NCT00286091|17036697|P2|Open-label Treatment Phase|Death|7
4954166|NCT00286091|17036698|P1|Open-label Treatment Phase|Death|10
4954167|NCT00286091|17036697|P2|Open-label Treatment Phase|Withdrawal by Subject|10
4954168|NCT00286091|17036698|P1|Open-label Treatment Phase|Withdrawal by Subject|14
4954169|NCT00286091|17036697|P2|Open-label Treatment Phase|Other|11
4954170|NCT00286091|17036698|P1|Open-label Treatment Phase|Other|11
4954171|NCT00286091|17036697|P2|Open-label Treatment Phase|Adverse Event|16
4954172|NCT00286091|17036698|P1|Open-label Treatment Phase|Adverse Event|5
4954173|NCT00286091|17036697|P2|Open-label Treatment Phase|Physician Decision|21
4954174|NCT00286091|17036698|P1|Open-label Treatment Phase|Physician Decision|24
4954175|NCT00286091|17036697|P2|Double-blind Treatment Phase|Ineligibility Determined|2
4954176|NCT00286091|17036698|P1|Double-blind Treatment Phase|Ineligibility Determined|1
4954177|NCT00286091|17036697|P2|Double-blind Treatment Phase|Protocol Deviation|3
4954178|NCT00286091|17036698|P1|Double-blind Treatment Phase|Protocol Deviation|1
4954179|NCT00286091|17036697|P2|Double-blind Treatment Phase|Lost to Follow-up|4
4954180|NCT00286091|17036698|P1|Double-blind Treatment Phase|Lost to Follow-up|11
4954181|NCT00286091|17036697|P2|Double-blind Treatment Phase|Noncompliance|8
4954182|NCT00286091|17036698|P1|Double-blind Treatment Phase|Noncompliance|8
4954183|NCT00286091|17036697|P2|Double-blind Treatment Phase|Administrative Decision|21
4954184|NCT00286091|17036698|P1|Double-blind Treatment Phase|Administrative Decision|20
4954185|NCT00286091|17036697|P2|Double-blind Treatment Phase|Other|33
4954186|NCT00286091|17036698|P1|Double-blind Treatment Phase|Other|25
4954187|NCT00286091|17036697|P2|Double-blind Treatment Phase|Disease Progression|35
4954188|NCT00286091|17036698|P1|Double-blind Treatment Phase|Disease Progression|22
4954189|NCT00286091|17036697|P2|Double-blind Treatment Phase|Adverse Event|40
4954190|NCT00286091|17036698|P1|Double-blind Treatment Phase|Adverse Event|28
4954191|NCT00286091|17036697|P2|Double-blind Treatment Phase|Death|65
4954192|NCT00286091|17036698|P1|Double-blind Treatment Phase|Death|58
4954193|NCT00286091|17036697|P2|Double-blind Treatment Phase|Protocol-Specified Criteria|269
4954194|NCT00286091|17036698|P1|Double-blind Treatment Phase|Protocol-Specified Criteria|307
4954195|NCT00286091|17036697|P2|Double-blind Treatment Phase|Withdrawal by Subject|113
4954196|NCT00286091|17036698|P1|Double-blind Treatment Phase|Withdrawal by Subject|103
4954197|NCT00285857|17036721|P1|Overall Study|Adverse Event|1
4954198|NCT00285857|17036721|P1|Overall Study|Inadequate initial breast cytology|1
4954199|NCT00285857|17036721|P1|Overall Study|Withdrawal by Subject|2
4954200|NCT00285818|17036734|P2|Overall Study|Lost to Follow-up|0
4954201|NCT00285818|17036735|P1|Overall Study|Lost to Follow-up|1
4954202|NCT00285818|17036734|P2|Overall Study|Withdrawal by Subject|2
4954203|NCT00285818|17036735|P1|Overall Study|Withdrawal by Subject|3
4954204|NCT00285649|17036780|P3|Overall Study|Withdrawal by Subject|2
4954205|NCT00285649|17036781|P2|Overall Study|Withdrawal by Subject|2
4954206|NCT00285649|17036782|P1|Overall Study|Withdrawal by Subject|3
4954207|NCT00285649|17036780|P3|Overall Study|Lost to Follow-up|4
4954208|NCT00285649|17036781|P2|Overall Study|Lost to Follow-up|4
4954209|NCT00285649|17036782|P1|Overall Study|Lost to Follow-up|6
4954210|NCT00285584|17036792|P2|Month 6|Lost to Follow-up|1
4954211|NCT00285584|17036793|P1|Month 6|Lost to Follow-up|0
4954212|NCT00285584|17036792|P2|Month 3|Withdrawal by Subject|0
4954213|NCT00285584|17036793|P1|Month 3|Withdrawal by Subject|1
4954214|NCT00285584|17036792|P2|Month 3|Lost to Follow-up|3
4954215|NCT00285584|17036793|P1|Month 3|Lost to Follow-up|3
4954216|NCT00285207|17036825|P2|Overall Study|non-compliance|1
4954217|NCT00285207|17036826|P1|Overall Study|non-compliance|0
4954218|NCT00285207|17036825|P2|Overall Study|Pregnancy|1
4954219|NCT00285207|17036826|P1|Overall Study|Pregnancy|1
4954220|NCT00285207|17036825|P2|Overall Study|Withdrawal by Subject|2
4954221|NCT00285207|17036826|P1|Overall Study|Withdrawal by Subject|5
4954222|NCT00285207|17036825|P2|Overall Study|Lost to Follow-up|2
4954223|NCT00285207|17036826|P1|Overall Study|Lost to Follow-up|3
4954224|NCT00285012|17036834|P2|Received Study Tx|Other|5
4954225|NCT00285012|17036835|P1|Received Study Tx|Other|5
4954226|NCT00285012|17036834|P2|Received Study Tx|Withdrawal by Subject|43
4954227|NCT00285012|17036835|P1|Received Study Tx|Withdrawal by Subject|31
4954228|NCT00285012|17036834|P2|Received Study Tx|Lost to Follow-up|31
4954229|NCT00285012|17036835|P1|Received Study Tx|Lost to Follow-up|29
4954230|NCT00285012|17036834|P2|Received Study Tx|Lack of Efficacy|3
4954231|NCT00285012|17036835|P1|Received Study Tx|Lack of Efficacy|0
4954232|NCT00285012|17036834|P2|Received Study Tx|Adverse Event|11
4954233|NCT00285012|17036835|P1|Received Study Tx|Adverse Event|5
4954234|NCT00285012|17036834|P2|Received Study Tx|Death|1
4954235|NCT00285012|17036835|P1|Received Study Tx|Death|2
4954236|NCT00285012|17036834|P2|Assigned to Study Treatment (Tx)|Other|3
4954237|NCT00285012|17036835|P1|Assigned to Study Treatment (Tx)|Other|2
4954238|NCT00284934|17036861|P2|Overall Study|Other reasons|1
4954239|NCT00284934|17036862|P1|Overall Study|Other reasons|3
4954240|NCT00284934|17036861|P2|Overall Study|Adverse Event|2
4954241|NCT00284934|17036862|P1|Overall Study|Adverse Event|1
4954242|NCT00284856|17036877|P3|Overall Study|Other|4
4954243|NCT00284856|17036878|P2|Overall Study|Other|5
4954244|NCT00284856|17036879|P1|Overall Study|Other|4
4954245|NCT00284856|17036877|P3|Overall Study|Withdrawal by Subject|18
4954246|NCT00284856|17036878|P2|Overall Study|Withdrawal by Subject|16
4954247|NCT00284856|17036879|P1|Overall Study|Withdrawal by Subject|12
4954248|NCT00284856|17036877|P3|Overall Study|Protocol Violation|5
4954249|NCT00284856|17036878|P2|Overall Study|Protocol Violation|4
4954250|NCT00284856|17036879|P1|Overall Study|Protocol Violation|5
4954251|NCT00284856|17036877|P3|Overall Study|Lost to Follow-up|22
4954252|NCT00284856|17036878|P2|Overall Study|Lost to Follow-up|21
4954253|NCT00284856|17036879|P1|Overall Study|Lost to Follow-up|25
4954254|NCT00284856|17036877|P3|Overall Study|Lack of Efficacy|8
4954255|NCT00284856|17036878|P2|Overall Study|Lack of Efficacy|1
4954256|NCT00284856|17036879|P1|Overall Study|Lack of Efficacy|2
4954257|NCT00284856|17036877|P3|Overall Study|Adverse Event|3
4954258|NCT00284856|17036878|P2|Overall Study|Adverse Event|3
4954259|NCT00284856|17036879|P1|Overall Study|Adverse Event|3
4954260|NCT00284141|17036978|P1|Overall Study|Ongoing treatment|2
4954261|NCT00284141|17036978|P1|Overall Study|Did not take study medication|2
4954262|NCT00284141|17036978|P1|Overall Study|Pneumonia|1
4954263|NCT00284141|17036978|P1|Overall Study|General decline|1
4954264|NCT00284141|17036978|P1|Overall Study|Clinical deterioration / death|2
4954265|NCT00284141|17036978|P1|Overall Study|Symptomatic / Clinical Progression|11
4954266|NCT00284141|17036978|P1|Overall Study|Participant's request|9
4954267|NCT00284141|17036978|P1|Overall Study|Adverse Event|19
4954268|NCT00284141|17036978|P1|Overall Study|Disease Progression / Lack of efficacy|51
4954269|NCT00284089|17037001|P4|Extension Phase|Withdrawal by Subject|3
4954270|NCT00284089|17037002|P3|Extension Phase|Withdrawal by Subject|1
4954271|NCT00284089|17037003|P2|Extension Phase|Withdrawal by Subject|0
4954272|NCT00284089|17037004|P1|Extension Phase|Withdrawal by Subject|0
4954273|NCT00284089|17037001|P4|Extension Phase|Protocol Violation|0
4954274|NCT00284089|17037002|P3|Extension Phase|Protocol Violation|1
4954275|NCT00284089|17037003|P2|Extension Phase|Protocol Violation|0
4954276|NCT00284089|17037004|P1|Extension Phase|Protocol Violation|0
4954277|NCT00284089|17037001|P4|Extension Phase|condition no longer requires study drug|7
4954278|NCT00284089|17037002|P3|Extension Phase|condition no longer requires study drug|2
4954279|NCT00284089|17037003|P2|Extension Phase|condition no longer requires study drug|0
4954280|NCT00284089|17037004|P1|Extension Phase|condition no longer requires study drug|2
4954281|NCT00284089|17037001|P4|Extension Phase|Adverse Event|2
4954282|NCT00284089|17037002|P3|Extension Phase|Adverse Event|2
4954283|NCT00284089|17037003|P2|Extension Phase|Adverse Event|0
4954284|NCT00284089|17037004|P1|Extension Phase|Adverse Event|0
4954285|NCT00284089|17037001|P4|Multiple Dose Phase|Death|1
4954286|NCT00284089|17037002|P3|Multiple Dose Phase|Death|1
4954287|NCT00284089|17037003|P2|Multiple Dose Phase|Death|0
4954288|NCT00284089|17037004|P1|Multiple Dose Phase|Death|0
4954289|NCT00284089|17037001|P4|Multiple Dose Phase|Withdrawal by Subject|2
4954290|NCT00284089|17037002|P3|Multiple Dose Phase|Withdrawal by Subject|1
4954291|NCT00284089|17037003|P2|Multiple Dose Phase|Withdrawal by Subject|0
4954292|NCT00284089|17037004|P1|Multiple Dose Phase|Withdrawal by Subject|0
4954293|NCT00284089|17037001|P4|Multiple Dose Phase|Protocol Violation|0
4954294|NCT00284089|17037002|P3|Multiple Dose Phase|Protocol Violation|1
4954295|NCT00284089|17037003|P2|Multiple Dose Phase|Protocol Violation|0
4954296|NCT00284089|17037004|P1|Multiple Dose Phase|Protocol Violation|0
4954297|NCT00284089|17037001|P4|Multiple Dose Phase|Adverse Event|1
4954298|NCT00284089|17037002|P3|Multiple Dose Phase|Adverse Event|1
4954299|NCT00284089|17037003|P2|Multiple Dose Phase|Adverse Event|0
4954300|NCT00284089|17037004|P1|Multiple Dose Phase|Adverse Event|1
4954301|NCT00284050|17037033|P3|Overall Study|Death|0
4954302|NCT00284050|17037034|P2|Overall Study|Death|0
4954303|NCT00284050|17037035|P1|Overall Study|Death|1
4954304|NCT00284050|17037033|P3|Overall Study|Lost to Follow-up|1
4954305|NCT00284050|17037034|P2|Overall Study|Lost to Follow-up|0
4954306|NCT00284050|17037035|P1|Overall Study|Lost to Follow-up|1
4954307|NCT00284050|17037033|P3|Overall Study|Withdrawal by Subject|2
4954308|NCT00284050|17037034|P2|Overall Study|Withdrawal by Subject|2
4954309|NCT00284050|17037035|P1|Overall Study|Withdrawal by Subject|2
4954310|NCT00284050|17037033|P3|Overall Study|Protocol Violation|2
4954311|NCT00284050|17037034|P2|Overall Study|Protocol Violation|1
4954312|NCT00284050|17037035|P1|Overall Study|Protocol Violation|0
4954313|NCT00284050|17037033|P3|Overall Study|Lack of Efficacy|3
4954314|NCT00284050|17037034|P2|Overall Study|Lack of Efficacy|1
4954315|NCT00284050|17037035|P1|Overall Study|Lack of Efficacy|0
4954316|NCT00284050|17037033|P3|Overall Study|Adverse Event|1
4954317|NCT00284050|17037034|P2|Overall Study|Adverse Event|1
4954318|NCT00284050|17037035|P1|Overall Study|Adverse Event|1
4954319|NCT00283959|17037049|P1|Extension Period|Low Compliance|1
4954320|NCT00283868|17037061|P2|Overall Study|Lost to Follow-up|8
4954321|NCT00283868|17037062|P1|Overall Study|Lost to Follow-up|7
4954322|NCT00283842|17037079|P5|Overall Study|Lost to Follow-up|1
4954323|NCT00283842|17037080|P4|Overall Study|Lost to Follow-up|1
4954324|NCT00283842|17037081|P3|Overall Study|Lost to Follow-up|4
4954325|NCT00283842|17037082|P2|Overall Study|Lost to Follow-up|2
4954326|NCT00283842|17037083|P1|Overall Study|Lost to Follow-up|0
4954327|NCT00283842|17037079|P5|Overall Study|Lack of Efficacy|3
4954328|NCT00283842|17037080|P4|Overall Study|Lack of Efficacy|0
4954329|NCT00283842|17037081|P3|Overall Study|Lack of Efficacy|1
4954330|NCT00283842|17037082|P2|Overall Study|Lack of Efficacy|3
4954331|NCT00283842|17037083|P1|Overall Study|Lack of Efficacy|1
4954332|NCT00283842|17037079|P5|Overall Study|Withdrawal by Subject|4
4954333|NCT00283842|17037080|P4|Overall Study|Withdrawal by Subject|5
4954334|NCT00283842|17037081|P3|Overall Study|Withdrawal by Subject|1
4954335|NCT00283842|17037082|P2|Overall Study|Withdrawal by Subject|1
4954336|NCT00283842|17037083|P1|Overall Study|Withdrawal by Subject|2
4954337|NCT00283842|17037079|P5|Overall Study|Protocol deviation|2
4954338|NCT00283842|17037080|P4|Overall Study|Protocol deviation|0
4954339|NCT00283842|17037081|P3|Overall Study|Protocol deviation|0
4954340|NCT00283842|17037082|P2|Overall Study|Protocol deviation|0
4954341|NCT00283842|17037083|P1|Overall Study|Protocol deviation|0
4954342|NCT00283842|17037079|P5|Overall Study|Protocol Violation|0
4954343|NCT00283842|17037080|P4|Overall Study|Protocol Violation|0
4954344|NCT00283842|17037081|P3|Overall Study|Protocol Violation|4
4954345|NCT00283842|17037082|P2|Overall Study|Protocol Violation|5
4954346|NCT00283842|17037083|P1|Overall Study|Protocol Violation|1
4954347|NCT00283842|17037079|P5|Overall Study|Adverse Event|5
4954348|NCT00283842|17037080|P4|Overall Study|Adverse Event|21
4954349|NCT00283842|17037081|P3|Overall Study|Adverse Event|21
4954350|NCT00283842|17037082|P2|Overall Study|Adverse Event|7
4954351|NCT00283842|17037083|P1|Overall Study|Adverse Event|8
4954352|NCT00283803|17037115|P1|Overall Study|Withdrawal by Subject|4
4954353|NCT00283803|17037115|P1|Overall Study|Physician Decision|9
4954354|NCT00283712|17037123|P2|Overall Study|Death|1
4954355|NCT00283712|17037124|P1|Overall Study|Death|0
4954356|NCT00283686|17037162|P4|Overall Study|Less than full participation|12
4954357|NCT00283686|17037163|P3|Overall Study|Less than full participation|6
4954358|NCT00283686|17037164|P2|Overall Study|Less than full participation|9
4954359|NCT00283686|17037165|P1|Overall Study|Less than full participation|7
4954360|NCT00283686|17037162|P4|Overall Study|Lost to Follow-up|20
4954361|NCT00283686|17037163|P3|Overall Study|Lost to Follow-up|26
4954362|NCT00283686|17037164|P2|Overall Study|Lost to Follow-up|31
4954363|NCT00283686|17037165|P1|Overall Study|Lost to Follow-up|21
4954364|NCT00283686|17037162|P4|Overall Study|Death|0
4954365|NCT00283686|17037163|P3|Overall Study|Death|1
4954366|NCT00283686|17037164|P2|Overall Study|Death|1
4954367|NCT00283686|17037165|P1|Overall Study|Death|1
4954368|NCT00283595|17037209|P2|Overall Study|Withdrawal by Subject|2
4954369|NCT00283595|17037210|P1|Overall Study|Withdrawal by Subject|1
4954370|NCT00283439|17037235|P4|Overall Study|Other|0
4954371|NCT00283439|17037236|P3|Overall Study|Other|0
4954372|NCT00283439|17037237|P2|Overall Study|Other|0
4954373|NCT00283439|17037238|P1|Overall Study|Other|1
4954374|NCT00283439|17037235|P4|Overall Study|Treatment discontinued|3
4954375|NCT00283439|17037236|P3|Overall Study|Treatment discontinued|1
4954376|NCT00283439|17037237|P2|Overall Study|Treatment discontinued|2
4954377|NCT00283439|17037238|P1|Overall Study|Treatment discontinued|0
4954378|NCT00283439|17037235|P4|Overall Study|Stem cell transplant|3
4954379|NCT00283439|17037236|P3|Overall Study|Stem cell transplant|4
4954380|NCT00283439|17037237|P2|Overall Study|Stem cell transplant|6
4954381|NCT00283439|17037238|P1|Overall Study|Stem cell transplant|6
4954382|NCT00283439|17037235|P4|Overall Study|Requirement for alternative therapy|2
4954383|NCT00283439|17037236|P3|Overall Study|Requirement for alternative therapy|5
4954384|NCT00283439|17037237|P2|Overall Study|Requirement for alternative therapy|2
4954385|NCT00283439|17037238|P1|Overall Study|Requirement for alternative therapy|1
4954386|NCT00283439|17037235|P4|Overall Study|Disease progression|0
4954387|NCT00283439|17037236|P3|Overall Study|Disease progression|0
4954388|NCT00283439|17037237|P2|Overall Study|Disease progression|1
4954389|NCT00283439|17037238|P1|Overall Study|Disease progression|0
4954390|NCT00283439|17037235|P4|Overall Study|Death|0
4954391|NCT00283439|17037236|P3|Overall Study|Death|1
4954392|NCT00283439|17037237|P2|Overall Study|Death|0
4954393|NCT00283439|17037238|P1|Overall Study|Death|0
4954394|NCT00283439|17037235|P4|Overall Study|Adverse Event|1
4954395|NCT00283439|17037236|P3|Overall Study|Adverse Event|0
4954396|NCT00283439|17037237|P2|Overall Study|Adverse Event|0
4954397|NCT00283439|17037238|P1|Overall Study|Adverse Event|0
4954398|NCT00283400|17037264|P4|Overall Study|Death|0
4954399|NCT00283400|17037265|P3|Overall Study|Death|1
4954400|NCT00283400|17037266|P2|Overall Study|Death|0
4954401|NCT00283400|17037267|P1|Overall Study|Death|1
4954402|NCT00283400|17037264|P4|Overall Study|Withdrawal by Subject|0
4954403|NCT00283400|17037265|P3|Overall Study|Withdrawal by Subject|0
4954404|NCT00283400|17037266|P2|Overall Study|Withdrawal by Subject|1
4954405|NCT00283400|17037267|P1|Overall Study|Withdrawal by Subject|1
4954406|NCT00283387|17037285|P2|First Intervention|Withdrawal by Subject|1
4954407|NCT00283387|17037286|P1|First Intervention|Withdrawal by Subject|0
4954408|NCT00283387|17037285|P2|First Intervention|Subject non-compliant|1
4954409|NCT00283387|17037286|P1|First Intervention|Subject non-compliant|1
4954410|NCT00283296|17037292|P1|Overall Study|in-home trial not completed|5
4954411|NCT00283244|17037323|P3|Overall Study|Clinical deterioration|3
4954412|NCT00283244|17037324|P2|Overall Study|Clinical deterioration|3
4954413|NCT00283244|17037325|P1|Overall Study|Clinical deterioration|1
4954414|NCT00283244|17037323|P3|Overall Study|Medical illness (other complicating dz)|6
4954415|NCT00283244|17037324|P2|Overall Study|Medical illness (other complicating dz)|3
4954416|NCT00283244|17037325|P1|Overall Study|Medical illness (other complicating dz)|4
4954417|NCT00283244|17037323|P3|Overall Study|Physician Decision|1
4954418|NCT00283244|17037324|P2|Overall Study|Physician Decision|0
4954419|NCT00283244|17037325|P1|Overall Study|Physician Decision|0
4954420|NCT00283244|17037323|P3|Overall Study|Withdrawal by Subject|2
4954421|NCT00283244|17037324|P2|Overall Study|Withdrawal by Subject|2
4954422|NCT00283244|17037325|P1|Overall Study|Withdrawal by Subject|1
4954423|NCT00283244|17037323|P3|Overall Study|Lack of Efficacy|26
4954424|NCT00283244|17037324|P2|Overall Study|Lack of Efficacy|32
4954425|NCT00283244|17037325|P1|Overall Study|Lack of Efficacy|8
4954426|NCT00283244|17037323|P3|Overall Study|Death|2
4954427|NCT00283244|17037324|P2|Overall Study|Death|3
4954428|NCT00283244|17037325|P1|Overall Study|Death|4
4954429|NCT00283244|17037323|P3|Overall Study|Adverse Event|11
4954430|NCT00283244|17037324|P2|Overall Study|Adverse Event|8
4954431|NCT00283244|17037325|P1|Overall Study|Adverse Event|0
4954432|NCT00283062|17037361|P4|Overall Study|chemotherapy not completed (cycle 6)|0
4954433|NCT00283062|17037362|P3|Overall Study|chemotherapy not completed (cycle 6)|0
4954434|NCT00283062|17037363|P2|Overall Study|chemotherapy not completed (cycle 6)|0
4954435|NCT00283062|17037364|P1|Overall Study|chemotherapy not completed (cycle 6)|1
4954436|NCT00283062|17037361|P4|Overall Study|Undefined|4
4954437|NCT00283062|17037362|P3|Overall Study|Undefined|1
4954438|NCT00283062|17037363|P2|Overall Study|Undefined|1
4954439|NCT00283062|17037364|P1|Overall Study|Undefined|0
4954440|NCT00283062|17037361|P4|Overall Study|Participant did not wish to continue|0
4954441|NCT00283062|17037362|P3|Overall Study|Participant did not wish to continue|1
4954442|NCT00283062|17037363|P2|Overall Study|Participant did not wish to continue|2
4954443|NCT00283062|17037364|P1|Overall Study|Participant did not wish to continue|3
4954444|NCT00283062|17037361|P4|Overall Study|Progressive disease|0
4954445|NCT00283062|17037362|P3|Overall Study|Progressive disease|1
4954446|NCT00283062|17037363|P2|Overall Study|Progressive disease|0
4954447|NCT00283062|17037364|P1|Overall Study|Progressive disease|0
4954448|NCT00283062|17037361|P4|Overall Study|Lost to Follow-up|0
4954449|NCT00283062|17037362|P3|Overall Study|Lost to Follow-up|1
4954450|NCT00283062|17037363|P2|Overall Study|Lost to Follow-up|0
4954451|NCT00283062|17037364|P1|Overall Study|Lost to Follow-up|1
4954452|NCT00283062|17037361|P4|Overall Study|Adverse Event|0
4954453|NCT00283062|17037362|P3|Overall Study|Adverse Event|1
4954454|NCT00283062|17037363|P2|Overall Study|Adverse Event|0
4954455|NCT00283062|17037364|P1|Overall Study|Adverse Event|2
4954456|NCT00283062|17037361|P4|Overall Study|Did not receive any study medication|45
4954457|NCT00283062|17037362|P3|Overall Study|Did not receive any study medication|36
4954458|NCT00283062|17037363|P2|Overall Study|Did not receive any study medication|4
4954459|NCT00283062|17037364|P1|Overall Study|Did not receive any study medication|5
4954460|NCT00283049|17037397|P3|Overall Study|No longer requires study treatment|1
4954461|NCT00283049|17037398|P2|Overall Study|No longer requires study treatment|0
4954462|NCT00283049|17037399|P1|Overall Study|No longer requires study treatment|0
4954463|NCT00283049|17037397|P3|Overall Study|Discontinuation of Study|20
4954464|NCT00283049|17037398|P2|Overall Study|Discontinuation of Study|16
4954465|NCT00283049|17037399|P1|Overall Study|Discontinuation of Study|18
4954466|NCT00283049|17037397|P3|Overall Study|Withdrawal by Subject|19
4954467|NCT00283049|17037398|P2|Overall Study|Withdrawal by Subject|24
4954468|NCT00283049|17037399|P1|Overall Study|Withdrawal by Subject|26
4954469|NCT00283049|17037397|P3|Overall Study|Lost to Follow-up|5
4954470|NCT00283049|17037398|P2|Overall Study|Lost to Follow-up|2
4954471|NCT00283049|17037399|P1|Overall Study|Lost to Follow-up|4
4954472|NCT00283049|17037397|P3|Overall Study|Lack of Efficacy|1
4954473|NCT00283049|17037398|P2|Overall Study|Lack of Efficacy|1
4954474|NCT00283049|17037399|P1|Overall Study|Lack of Efficacy|0
4954475|NCT00283049|17037397|P3|Overall Study|Death|1
4954476|NCT00283049|17037398|P2|Overall Study|Death|1
4954477|NCT00283049|17037399|P1|Overall Study|Death|1
4954478|NCT00283049|17037397|P3|Overall Study|Protocol Violation|3
4954479|NCT00283049|17037398|P2|Overall Study|Protocol Violation|0
4954480|NCT00283049|17037399|P1|Overall Study|Protocol Violation|3
4954481|NCT00283049|17037397|P3|Overall Study|Adverse Event|4
4954482|NCT00283049|17037398|P2|Overall Study|Adverse Event|1
4954483|NCT00283049|17037399|P1|Overall Study|Adverse Event|6
4954484|NCT00282984|17037427|P2|Overall Study|Protocol Violation|0
4954485|NCT00282984|17037428|P1|Overall Study|Protocol Violation|2
4954486|NCT00282984|17037427|P2|Overall Study|in prison|1
4954487|NCT00282984|17037428|P1|Overall Study|in prison|0
4954488|NCT00282984|17037427|P2|Overall Study|lack of motivation|0
4954489|NCT00282984|17037428|P1|Overall Study|lack of motivation|1
4954490|NCT00282984|17037427|P2|Overall Study|Participant used antipsychosis meds|1
4954491|NCT00282984|17037428|P1|Overall Study|Participant used antipsychosis meds|0
4954492|NCT00282984|17037427|P2|Overall Study|Participant only allowed phone follow-up|1
4954493|NCT00282984|17037428|P1|Overall Study|Participant only allowed phone follow-up|0
4954494|NCT00282984|17037427|P2|Overall Study|Participant stopped study medication|2
4954495|NCT00282984|17037428|P1|Overall Study|Participant stopped study medication|2
4954496|NCT00282984|17037427|P2|Overall Study|Withdrawal by Participant|34
4954497|NCT00282984|17037428|P1|Overall Study|Withdrawal by Participant|22
4954498|NCT00282984|17037427|P2|Overall Study|Lost to Follow-up|10
4954499|NCT00282984|17037428|P1|Overall Study|Lost to Follow-up|14
4954500|NCT00282984|17037427|P2|Overall Study|Lack of Efficacy|2
4954501|NCT00282984|17037428|P1|Overall Study|Lack of Efficacy|0
4954502|NCT00282984|17037427|P2|Overall Study|Adverse Event|5
4954503|NCT00282984|17037428|P1|Overall Study|Adverse Event|8
4954504|NCT00282984|17037427|P2|Overall Study|Death|5
4954505|NCT00282984|17037428|P1|Overall Study|Death|2
4954506|NCT00282919|17037465|P1|Overall Study|Asymptomatic Parasitemia|2
4954507|NCT00282919|17037465|P1|Overall Study|Withdrawal by Subject|1
4954508|NCT00282919|17037465|P1|Overall Study|Lack of Efficacy|4
4954509|NCT00282867|17037480|P3|Overall Study|d/c prior to prim outcome, 3 m f/u done|0
4954510|NCT00282867|17037481|P2|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
4954511|NCT00282867|17037482|P1|Overall Study|d/c prior to prim outcome, 3 m f/u done|1
4954512|NCT00282568|17037584|P1|Extended Treatment Period|Lost to Follow-up|2
4954513|NCT00282568|17037584|P1|Extended Treatment Period|Physician Decision|1
4954514|NCT00282568|17037584|P1|Extended Treatment Period|Non-compliance|4
4954515|NCT00282568|17037584|P1|Extended Treatment Period|Adverse Event|17
4954516|NCT00282568|17037584|P1|Pharmacokinetic Treatment Period|Enrolled erroneously|1
4954517|NCT00282568|17037584|P1|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2
4954518|NCT00282464|17037610|P2|Overall Study|dropped due to missed visits|1
4954519|NCT00282464|17037611|P1|Overall Study|dropped due to missed visits|0
4954520|NCT00282464|17037610|P2|Overall Study|dispensed wrong kit|1
4954521|NCT00282464|17037611|P1|Overall Study|dispensed wrong kit|0
4954522|NCT00282464|17037610|P2|Overall Study|family crisis|1
4954523|NCT00282464|17037611|P1|Overall Study|family crisis|0
4954524|NCT00282464|17037610|P2|Overall Study|patient incarcerated|1
4954525|NCT00282464|17037611|P1|Overall Study|patient incarcerated|0
4954526|NCT00282464|17037610|P2|Overall Study|patient no show|1
4954527|NCT00282464|17037611|P1|Overall Study|patient no show|0
4954528|NCT00282464|17037610|P2|Overall Study|patient non-compliant|0
4954529|NCT00282464|17037611|P1|Overall Study|patient non-compliant|3
4954530|NCT00282464|17037610|P2|Overall Study|Patient moved|0
4954531|NCT00282464|17037611|P1|Overall Study|Patient moved|1
4954532|NCT00282464|17037610|P2|Overall Study|Protocol Violation|7
4954533|NCT00282464|17037611|P1|Overall Study|Protocol Violation|0
4954534|NCT00282464|17037610|P2|Overall Study|laboratory abnormality|2
4954535|NCT00282464|17037611|P1|Overall Study|laboratory abnormality|1
4954536|NCT00282464|17037610|P2|Overall Study|Withdrawal by Subject|10
4954537|NCT00282464|17037611|P1|Overall Study|Withdrawal by Subject|24
4954538|NCT00282464|17037610|P2|Overall Study|Lost to Follow-up|10
4954539|NCT00282464|17037611|P1|Overall Study|Lost to Follow-up|10
4954540|NCT00282464|17037610|P2|Overall Study|Lack of Efficacy|8
4954541|NCT00282464|17037611|P1|Overall Study|Lack of Efficacy|8
4954542|NCT00282464|17037610|P2|Overall Study|Adverse Event|20
4954543|NCT00282464|17037611|P1|Overall Study|Adverse Event|26
4954544|NCT00282438|17037661|P2|Overall Study|Death|1
4954545|NCT00282438|17037662|P1|Overall Study|Death|0
4954546|NCT00282438|17037661|P2|Overall Study|Lack of Efficacy|0
4954547|NCT00282438|17037662|P1|Overall Study|Lack of Efficacy|1
4954548|NCT00282412|17037672|P1|Overall Study|Death|2
4954549|NCT00282347|17037678|P2|B Cell Follow-up Period|Reason Not Specified|0
4954550|NCT00282347|17037679|P1|B Cell Follow-up Period|Reason Not Specified|2
4954551|NCT00282347|17037678|P2|B Cell Follow-up Period|Physician Decision|0
4954552|NCT00282347|17037679|P1|B Cell Follow-up Period|Physician Decision|1
4954553|NCT00282347|17037678|P2|B Cell Follow-up Period|Withdrawal by Subject|0
4954554|NCT00282347|17037679|P1|B Cell Follow-up Period|Withdrawal by Subject|2
4954555|NCT00282347|17037678|P2|Safety Follow-up Period|Protocol Deviation|2
4954556|NCT00282347|17037679|P1|Safety Follow-up Period|Protocol Deviation|0
4954557|NCT00282347|17037678|P2|Safety Follow-up Period|Physician Decision|1
4954558|NCT00282347|17037679|P1|Safety Follow-up Period|Physician Decision|1
4954559|NCT00282347|17037678|P2|Safety Follow-up Period|Withdrawal by Subject|1
4954560|NCT00282347|17037679|P1|Safety Follow-up Period|Withdrawal by Subject|2
4954561|NCT00282347|17037678|P2|Safety Follow-up Period|Lost to Follow-up|2
4954562|NCT00282347|17037679|P1|Safety Follow-up Period|Lost to Follow-up|0
4954563|NCT00282347|17037678|P2|Treatment Period|Physician Decision|1
4954564|NCT00282347|17037679|P1|Treatment Period|Physician Decision|0
4954565|NCT00282347|17037678|P2|Treatment Period|Withdrawal by Subject|3
4954566|NCT00282347|17037679|P1|Treatment Period|Withdrawal by Subject|1
4954567|NCT00282347|17037678|P2|Treatment Period|Lost to Follow-up|5
4954568|NCT00282347|17037679|P1|Treatment Period|Lost to Follow-up|2
4954569|NCT00282347|17037678|P2|Treatment Period|Death|0
4954570|NCT00282347|17037679|P1|Treatment Period|Death|2
4954571|NCT00282334|17037705|P2|Overall Study|Withdrawal by Subject|5
4954572|NCT00282334|17037706|P1|Overall Study|Withdrawal by Subject|8
4954573|NCT00282308|17037714|P3|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12
4954574|NCT00282308|17037715|P2|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
4954575|NCT00282308|17037716|P1|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0
4954576|NCT00282308|17037714|P3|Safety Follow-up Period|Physician Decision to Withdraw|1
4954577|NCT00282308|17037715|P2|Safety Follow-up Period|Physician Decision to Withdraw|0
4954578|NCT00282308|17037716|P1|Safety Follow-up Period|Physician Decision to Withdraw|0
4954579|NCT00282308|17037714|P3|Safety Follow-up Period|Lost to Follow-up|5
4954580|NCT00282308|17037715|P2|Safety Follow-up Period|Lost to Follow-up|0
4954581|NCT00282308|17037716|P1|Safety Follow-up Period|Lost to Follow-up|0
4954582|NCT00282308|17037714|P3|Safety Follow-up Period|Adverse Event|1
4954583|NCT00282308|17037715|P2|Safety Follow-up Period|Adverse Event|0
4954584|NCT00282308|17037716|P1|Safety Follow-up Period|Adverse Event|0
4954585|NCT00282308|17037714|P3|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1
4954586|NCT00282308|17037715|P2|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
4954587|NCT00282308|17037716|P1|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0
4954588|NCT00282308|17037714|P3|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1
4954589|NCT00282308|17037715|P2|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
4954590|NCT00282308|17037716|P1|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0
4954591|NCT00282308|17037714|P3|Optional Extension Re-treatment Period|Adverse Event|4
4954592|NCT00282308|17037715|P2|Optional Extension Re-treatment Period|Adverse Event|0
4954593|NCT00282308|17037716|P1|Optional Extension Re-treatment Period|Adverse Event|0
4954594|NCT00282308|17037714|P3|Treatment Period|Not Treated with Study Drug|0
4954595|NCT00282308|17037715|P2|Treatment Period|Not Treated with Study Drug|0
4954596|NCT00282308|17037716|P1|Treatment Period|Not Treated with Study Drug|1
4954597|NCT00282308|17037714|P3|Treatment Period|Adverse Event|0
4954598|NCT00282308|17037715|P2|Treatment Period|Adverse Event|2
4954599|NCT00282308|17037716|P1|Treatment Period|Adverse Event|0
4954600|NCT00282308|17037714|P3|Treatment Period|Subject/Guardian Decision to Withdraw|0
4954601|NCT00282308|17037715|P2|Treatment Period|Subject/Guardian Decision to Withdraw|4
4954602|NCT00282308|17037716|P1|Treatment Period|Subject/Guardian Decision to Withdraw|2
4954603|NCT00282308|17037714|P3|Treatment Period|Lost to Follow-up|0
4954604|NCT00282308|17037715|P2|Treatment Period|Lost to Follow-up|0
4954605|NCT00282308|17037716|P1|Treatment Period|Lost to Follow-up|1
4954606|NCT00282295|17037746|P3|Overall Study|Other|0
4954607|NCT00282295|17037747|P2|Overall Study|Other|1
4954608|NCT00282295|17037748|P1|Overall Study|Other|0
4954609|NCT00282295|17037746|P3|Overall Study|Lost to Follow-up|2
4954610|NCT00282295|17037747|P2|Overall Study|Lost to Follow-up|7
4954611|NCT00282295|17037748|P1|Overall Study|Lost to Follow-up|1
4954612|NCT00282295|17037746|P3|Overall Study|Withdrawal by Subject|4
4954613|NCT00282295|17037747|P2|Overall Study|Withdrawal by Subject|6
4954614|NCT00282295|17037748|P1|Overall Study|Withdrawal by Subject|2
4954615|NCT00282295|17037746|P3|Overall Study|Protocol Violation|1
4954616|NCT00282295|17037747|P2|Overall Study|Protocol Violation|2
4954617|NCT00282295|17037748|P1|Overall Study|Protocol Violation|0
4954618|NCT00282295|17037746|P3|Overall Study|Serious Adverse Events|1
4954619|NCT00282295|17037747|P2|Overall Study|Serious Adverse Events|0
4954620|NCT00282295|17037748|P1|Overall Study|Serious Adverse Events|0
4954621|NCT00282295|17037746|P3|Overall Study|Adverse Event|0
4954622|NCT00282295|17037747|P2|Overall Study|Adverse Event|1
4954623|NCT00282295|17037748|P1|Overall Study|Adverse Event|0
4954624|NCT00282256|17037803|P1|Extension Treatment Period|Adverse Event|2
4954625|NCT00282256|17037803|P1|Pharmacokinetic Treatment Period|Poor venous access|1
4954626|NCT00282243|17037824|P1|Extension Treatment Period|Physician Decision|1
4954627|NCT00282243|17037824|P1|Extension Treatment Period|Non-compliance|2
4954628|NCT00282243|17037824|P1|Extension Treatment Period|Withdrawal by Subject|4
4954629|NCT00282243|17037824|P1|Extension Treatment Period|Adverse Event|15
4954630|NCT00282243|17037824|P1|Pharmacokinetic Treatment Period|Withdrawal by Subject|2
4954631|NCT00282243|17037824|P1|Pharmacokinetic Treatment Period|Adverse Event|3
4954632|NCT00282152|17037850|P2|Overall Study|Withdrawal by Subject|0
4954633|NCT00282152|17037851|P1|Overall Study|Withdrawal by Subject|1
4954634|NCT00282113|17037872|P3|Overall Study|Removed at parents request|0
4954635|NCT00282113|17037873|P2|Overall Study|Removed at parents request|0
4954636|NCT00282113|17037874|P1|Overall Study|Removed at parents request|1
4954637|NCT00282087|17037888|P1|Overall Study|Death|1
4954638|NCT00282048|17037901|P1|Overall Study|Ongoing|1
4954639|NCT00282048|17037901|P1|Overall Study|Other|8
4954640|NCT00282048|17037901|P1|Overall Study|Withdrawal by Subject|1
4954641|NCT00282048|17037901|P1|Overall Study|Adverse Event|22
4954642|NCT00282048|17037901|P1|Overall Study|Lack of Efficacy|30
4954643|NCT00281957|17037915|P2|Overall Study|Refusal unrelated to adverse events|1
4954644|NCT00281957|17037916|P1|Overall Study|Refusal unrelated to adverse events|0
4954645|NCT00281957|17037915|P2|Overall Study|Did not start treatment|1
4954646|NCT00281957|17037916|P1|Overall Study|Did not start treatment|3
4954647|NCT00281957|17037915|P2|Overall Study|Not eligible|2
4954648|NCT00281957|17037916|P1|Overall Study|Not eligible|1
4954649|NCT00281957|17037915|P2|Overall Study|Not protocol specified|1
4954650|NCT00281957|17037916|P1|Overall Study|Not protocol specified|8
4954651|NCT00281957|17037915|P2|Overall Study|Progression/relapse|35
4954652|NCT00281957|17037916|P1|Overall Study|Progression/relapse|47
4954653|NCT00281957|17037915|P2|Overall Study|Death|0
4954654|NCT00281957|17037916|P1|Overall Study|Death|1
4954655|NCT00281957|17037915|P2|Overall Study|Adverse Event|2
4954656|NCT00281957|17037916|P1|Overall Study|Adverse Event|7
4954657|NCT00281840|17037990|P1|Overall Study|Complicating Disease|1
4954658|NCT00281840|17037990|P1|Overall Study|exceed maximum delay in treatment|1
4954659|NCT00281840|17037990|P1|Overall Study|Disease Progression|2
4954660|NCT00281840|17037990|P1|Overall Study|Withdrawal by Subject|3
4954661|NCT00281840|17037990|P1|Overall Study|Physician Decision|6
4954662|NCT00281840|17037990|P1|Overall Study|Adverse Event|12
4954663|NCT00281697|17038006|P2|Overall Study|Did not receive study drug|2
4954664|NCT00281697|17038007|P1|Overall Study|Did not receive study drug|3
4954665|NCT00281697|17038006|P2|Overall Study|Subject/guardian's decision to withdraw|6
4954666|NCT00281697|17038007|P1|Overall Study|Subject/guardian's decision to withdraw|33
4954667|NCT00281697|17038006|P2|Overall Study|Physician's decision to withdraw|12
4954668|NCT00281697|17038007|P1|Overall Study|Physician's decision to withdraw|15
4954669|NCT00281697|17038006|P2|Overall Study|Other|6
4954670|NCT00281697|17038007|P1|Overall Study|Other|5
4954671|NCT00281697|17038006|P2|Overall Study|Disease progression|149
4954672|NCT00281697|17038007|P1|Overall Study|Disease progression|279
4954673|NCT00281697|17038006|P2|Overall Study|Death|3
4954674|NCT00281697|17038007|P1|Overall Study|Death|8
4954675|NCT00281697|17038006|P2|Overall Study|Adverse Event|15
4954676|NCT00281697|17038007|P1|Overall Study|Adverse Event|54
4954677|NCT00281697|17038006|P2|Overall Study|> 60 days since last dose of study drug|4
4954678|NCT00281697|17038007|P1|Overall Study|> 60 days since last dose of study drug|4
4954679|NCT00281684|17038027|P4|Overall Study|Withdrawal by Subject|0
4954680|NCT00281684|17038028|P3|Overall Study|Withdrawal by Subject|0
4954681|NCT00281684|17038029|P2|Overall Study|Withdrawal by Subject|0
4954682|NCT00281684|17038030|P1|Overall Study|Withdrawal by Subject|1
4954683|NCT00281684|17038027|P4|Overall Study|Lost to Follow-up|0
4954684|NCT00281684|17038028|P3|Overall Study|Lost to Follow-up|1
4954685|NCT00281684|17038029|P2|Overall Study|Lost to Follow-up|0
4954686|NCT00281684|17038030|P1|Overall Study|Lost to Follow-up|0
4954687|NCT00281658|17038117|P3|Open-label Monotherapy Extension Phase|Withdrawal by Subject|1
4954688|NCT00281658|17038118|P2|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
4954689|NCT00281658|17038119|P1|Open-label Monotherapy Extension Phase|Withdrawal by Subject|0
4954690|NCT00281658|17038117|P3|Open-label Monotherapy Extension Phase|Lost to Follow-up|3
4954691|NCT00281658|17038118|P2|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
4954692|NCT00281658|17038119|P1|Open-label Monotherapy Extension Phase|Lost to Follow-up|0
4954693|NCT00281658|17038117|P3|Open-label Monotherapy Extension Phase|Death|97
4954694|NCT00281658|17038118|P2|Open-label Monotherapy Extension Phase|Death|0
4954695|NCT00281658|17038119|P1|Open-label Monotherapy Extension Phase|Death|0
4954696|NCT00281658|17038117|P3|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
4954697|NCT00281658|17038118|P2|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|1
4954698|NCT00281658|17038119|P1|Double-blind, Randomized Phase|Screen Failure; Randomized in Error|0
4954699|NCT00281658|17038117|P3|Double-blind, Randomized Phase|Participant Entered New Protocol|0
4954700|NCT00281658|17038118|P2|Double-blind, Randomized Phase|Participant Entered New Protocol|1
4954701|NCT00281658|17038119|P1|Double-blind, Randomized Phase|Participant Entered New Protocol|1
4954702|NCT00281658|17038117|P3|Double-blind, Randomized Phase|Withdrawal by Subject|0
4954703|NCT00281658|17038118|P2|Double-blind, Randomized Phase|Withdrawal by Subject|1
4954704|NCT00281658|17038119|P1|Double-blind, Randomized Phase|Withdrawal by Subject|4
4954705|NCT00281658|17038117|P3|Double-blind, Randomized Phase|Lost to Follow-up|0
4954706|NCT00281658|17038118|P2|Double-blind, Randomized Phase|Lost to Follow-up|5
4954707|NCT00281658|17038119|P1|Double-blind, Randomized Phase|Lost to Follow-up|12
4954708|NCT00281658|17038117|P3|Double-blind, Randomized Phase|Death|0
4954709|NCT00281658|17038118|P2|Double-blind, Randomized Phase|Death|46
4954710|NCT00281658|17038119|P1|Double-blind, Randomized Phase|Death|120
4954711|NCT00281632|17038136|P1|Overall Study|Ongoing|3
4954712|NCT00281632|17038136|P1|Overall Study|Physician Decision|1
4954713|NCT00281632|17038136|P1|Overall Study|Death|1
4954714|NCT00281632|17038136|P1|Overall Study|Disease Progression|22
4954715|NCT00281632|17038136|P1|Overall Study|Withdrawal by Subject|2
4954716|NCT00281632|17038136|P1|Overall Study|Adverse Event|7
4954717|NCT00281580|17038178|P16|Overall Study|Randomised in error; pregnancy; moving|2
4954718|NCT00281580|17038179|P15|Overall Study|Randomised in error; pregnancy; moving|1
4954719|NCT00281580|17038180|P14|Overall Study|Randomised in error; pregnancy; moving|0
4954720|NCT00281580|17038181|P13|Overall Study|Randomised in error; pregnancy; moving|2
4954721|NCT00281580|17038182|P12|Overall Study|Randomised in error; pregnancy; moving|1
4954722|NCT00281580|17038183|P11|Overall Study|Randomised in error; pregnancy; moving|1
4954723|NCT00281580|17038184|P10|Overall Study|Randomised in error; pregnancy; moving|1
4954724|NCT00281580|17038185|P9|Overall Study|Randomised in error; pregnancy; moving|2
4954725|NCT00281580|17038186|P8|Overall Study|Randomised in error; pregnancy; moving|0
4954726|NCT00281580|17038187|P7|Overall Study|Randomised in error; pregnancy; moving|1
4954727|NCT00281580|17038188|P6|Overall Study|Randomised in error; pregnancy; moving|0
4954728|NCT00281580|17038189|P5|Overall Study|Randomised in error; pregnancy; moving|0
4954729|NCT00281580|17038190|P4|Overall Study|Randomised in error; pregnancy; moving|2
4954730|NCT00281580|17038191|P3|Overall Study|Randomised in error; pregnancy; moving|0
4954731|NCT00281580|17038192|P2|Overall Study|Randomised in error; pregnancy; moving|0
4954732|NCT00281580|17038193|P1|Overall Study|Randomised in error; pregnancy; moving|0
4954733|NCT00281580|17038178|P16|Overall Study|Lost to Follow-up|0
4954734|NCT00281580|17038179|P15|Overall Study|Lost to Follow-up|0
4954735|NCT00281580|17038180|P14|Overall Study|Lost to Follow-up|0
4954736|NCT00281580|17038181|P13|Overall Study|Lost to Follow-up|1
4954737|NCT00281580|17038182|P12|Overall Study|Lost to Follow-up|0
4954738|NCT00281580|17038183|P11|Overall Study|Lost to Follow-up|1
4954739|NCT00281580|17038184|P10|Overall Study|Lost to Follow-up|1
4954740|NCT00281580|17038185|P9|Overall Study|Lost to Follow-up|2
4954741|NCT00281580|17038186|P8|Overall Study|Lost to Follow-up|1
4954742|NCT00281580|17038187|P7|Overall Study|Lost to Follow-up|0
4954743|NCT00281580|17038188|P6|Overall Study|Lost to Follow-up|1
4954744|NCT00281580|17038189|P5|Overall Study|Lost to Follow-up|0
4954745|NCT00281580|17038190|P4|Overall Study|Lost to Follow-up|3
4954746|NCT00281580|17038191|P3|Overall Study|Lost to Follow-up|0
4954747|NCT00281580|17038192|P2|Overall Study|Lost to Follow-up|0
4954748|NCT00281580|17038193|P1|Overall Study|Lost to Follow-up|0
4954749|NCT00281580|17038178|P16|Overall Study|Lack of Efficacy|0
4954750|NCT00281580|17038179|P15|Overall Study|Lack of Efficacy|1
4954751|NCT00281580|17038180|P14|Overall Study|Lack of Efficacy|2
4954752|NCT00281580|17038181|P13|Overall Study|Lack of Efficacy|0
4954753|NCT00281580|17038182|P12|Overall Study|Lack of Efficacy|1
4954754|NCT00281580|17038183|P11|Overall Study|Lack of Efficacy|0
4954755|NCT00281580|17038184|P10|Overall Study|Lack of Efficacy|0
4954756|NCT00281580|17038185|P9|Overall Study|Lack of Efficacy|0
4954757|NCT00281580|17038186|P8|Overall Study|Lack of Efficacy|0
4954758|NCT00281580|17038187|P7|Overall Study|Lack of Efficacy|0
4954759|NCT00281580|17038188|P6|Overall Study|Lack of Efficacy|0
4954760|NCT00281580|17038189|P5|Overall Study|Lack of Efficacy|2
4954761|NCT00281580|17038190|P4|Overall Study|Lack of Efficacy|6
4954762|NCT00281580|17038191|P3|Overall Study|Lack of Efficacy|1
4954763|NCT00281580|17038192|P2|Overall Study|Lack of Efficacy|1
4954764|NCT00281580|17038193|P1|Overall Study|Lack of Efficacy|2
4954765|NCT00281580|17038178|P16|Overall Study|Withdrawal by Subject|5
4954766|NCT00281580|17038179|P15|Overall Study|Withdrawal by Subject|1
4954767|NCT00281580|17038180|P14|Overall Study|Withdrawal by Subject|2
4954768|NCT00281580|17038181|P13|Overall Study|Withdrawal by Subject|2
4954769|NCT00281580|17038182|P12|Overall Study|Withdrawal by Subject|1
4954770|NCT00281580|17038183|P11|Overall Study|Withdrawal by Subject|1
4954771|NCT00281580|17038184|P10|Overall Study|Withdrawal by Subject|4
4954772|NCT00281580|17038185|P9|Overall Study|Withdrawal by Subject|1
4954773|NCT00281580|17038186|P8|Overall Study|Withdrawal by Subject|0
4954774|NCT00281580|17038187|P7|Overall Study|Withdrawal by Subject|2
4954775|NCT00281580|17038188|P6|Overall Study|Withdrawal by Subject|2
4954776|NCT00281580|17038189|P5|Overall Study|Withdrawal by Subject|1
4954777|NCT00281580|17038190|P4|Overall Study|Withdrawal by Subject|1
4954778|NCT00281580|17038191|P3|Overall Study|Withdrawal by Subject|1
4954779|NCT00281580|17038192|P2|Overall Study|Withdrawal by Subject|0
4954780|NCT00281580|17038193|P1|Overall Study|Withdrawal by Subject|3
4954781|NCT00281580|17038178|P16|Overall Study|Protocol Violation|3
4954782|NCT00281580|17038179|P15|Overall Study|Protocol Violation|1
4954783|NCT00281580|17038180|P14|Overall Study|Protocol Violation|1
4954784|NCT00281580|17038181|P13|Overall Study|Protocol Violation|0
4954785|NCT00281580|17038182|P12|Overall Study|Protocol Violation|2
4954786|NCT00281580|17038183|P11|Overall Study|Protocol Violation|1
4954787|NCT00281580|17038184|P10|Overall Study|Protocol Violation|0
4954788|NCT00281580|17038185|P9|Overall Study|Protocol Violation|2
4954789|NCT00281580|17038186|P8|Overall Study|Protocol Violation|0
4954790|NCT00281580|17038187|P7|Overall Study|Protocol Violation|1
4954791|NCT00281580|17038188|P6|Overall Study|Protocol Violation|0
4954792|NCT00281580|17038189|P5|Overall Study|Protocol Violation|0
4954793|NCT00281580|17038190|P4|Overall Study|Protocol Violation|1
4954794|NCT00281580|17038191|P3|Overall Study|Protocol Violation|1
4954795|NCT00281580|17038192|P2|Overall Study|Protocol Violation|0
4954796|NCT00281580|17038193|P1|Overall Study|Protocol Violation|0
4954797|NCT00281580|17038178|P16|Overall Study|Adverse Event|3
4954798|NCT00281580|17038179|P15|Overall Study|Adverse Event|3
4954799|NCT00281580|17038180|P14|Overall Study|Adverse Event|2
4954800|NCT00281580|17038181|P13|Overall Study|Adverse Event|8
4954801|NCT00281580|17038182|P12|Overall Study|Adverse Event|5
4954802|NCT00281580|17038183|P11|Overall Study|Adverse Event|0
4954803|NCT00281580|17038184|P10|Overall Study|Adverse Event|6
4954804|NCT00281580|17038185|P9|Overall Study|Adverse Event|1
4954805|NCT00281580|17038186|P8|Overall Study|Adverse Event|0
4954806|NCT00281580|17038187|P7|Overall Study|Adverse Event|1
4954807|NCT00281580|17038188|P6|Overall Study|Adverse Event|0
4954808|NCT00281580|17038189|P5|Overall Study|Adverse Event|1
4954809|NCT00281580|17038190|P4|Overall Study|Adverse Event|4
4954810|NCT00281580|17038191|P3|Overall Study|Adverse Event|2
4954811|NCT00281580|17038192|P2|Overall Study|Adverse Event|0
4954812|NCT00281580|17038193|P1|Overall Study|Adverse Event|2
4954813|NCT00281528|17038540|P3|Overall Study|Other|5
4954814|NCT00281528|17038541|P2|Overall Study|Other|3
4954815|NCT00281528|17038542|P1|Overall Study|Other|6
4954816|NCT00281528|17038540|P3|Overall Study|Withdrawal by Subject|7
4954817|NCT00281528|17038541|P2|Overall Study|Withdrawal by Subject|5
4954818|NCT00281528|17038542|P1|Overall Study|Withdrawal by Subject|5
4954819|NCT00281528|17038540|P3|Overall Study|Protocol Violation|1
4954820|NCT00281528|17038541|P2|Overall Study|Protocol Violation|0
4954821|NCT00281528|17038542|P1|Overall Study|Protocol Violation|1
4954822|NCT00281528|17038540|P3|Overall Study|Physician Decision|5
4954823|NCT00281528|17038541|P2|Overall Study|Physician Decision|4
4954824|NCT00281528|17038542|P1|Overall Study|Physician Decision|11
4954825|NCT00281528|17038540|P3|Overall Study|Adverse Event-unrelated to treatment|2
4954826|NCT00281528|17038541|P2|Overall Study|Adverse Event-unrelated to treatment|0
4954827|NCT00281528|17038542|P1|Overall Study|Adverse Event-unrelated to treatment|3
4954828|NCT00281528|17038540|P3|Overall Study|Unacceptable Toxicity-related to trt|32
4954829|NCT00281528|17038541|P2|Overall Study|Unacceptable Toxicity-related to trt|24
4954830|NCT00281528|17038542|P1|Overall Study|Unacceptable Toxicity-related to trt|21
4954831|NCT00281528|17038540|P3|Overall Study|Progressive Disease|27
4954832|NCT00281528|17038541|P2|Overall Study|Progressive Disease|18
4954833|NCT00281528|17038542|P1|Overall Study|Progressive Disease|28
4954834|NCT00281320|17038593|P2|Overall Study|Other|1
4954835|NCT00281320|17038594|P1|Overall Study|Other|3
4954836|NCT00281320|17038593|P2|Overall Study|Lost to Follow-up|2
4954837|NCT00281320|17038594|P1|Overall Study|Lost to Follow-up|1
4954838|NCT00281320|17038593|P2|Overall Study|Withdrawal by Subject|6
4954839|NCT00281320|17038594|P1|Overall Study|Withdrawal by Subject|5
4954840|NCT00281320|17038593|P2|Overall Study|Lack of Efficacy|3
4954841|NCT00281320|17038594|P1|Overall Study|Lack of Efficacy|4
4954842|NCT00281320|17038593|P2|Overall Study|Adverse Event|9
4954843|NCT00281320|17038594|P1|Overall Study|Adverse Event|12
4954844|NCT00281099|17038616|P2|Overall Study|Heart Transplant/Device Exit/Changeout|4
4954845|NCT00281099|17038617|P1|Overall Study|Heart Transplant/Device Exit/Changeout|5
4954846|NCT00281099|17038616|P2|Overall Study|Physician Decision|72
4954847|NCT00281099|17038617|P1|Overall Study|Physician Decision|79
4954848|NCT00281099|17038616|P2|Overall Study|Withdrawal by Subject|70
4954849|NCT00281099|17038617|P1|Overall Study|Withdrawal by Subject|65
4954850|NCT00281099|17038616|P2|Overall Study|Lost to Follow-up|19
4954851|NCT00281099|17038617|P1|Overall Study|Lost to Follow-up|10
4954852|NCT00281099|17038616|P2|Overall Study|Death|57
4954853|NCT00281099|17038617|P1|Overall Study|Death|46
4954854|NCT00280917|17038666|P4|Overall Study|Noncompliance|0
4954855|NCT00280917|17038667|P3|Overall Study|Noncompliance|2
4954856|NCT00280917|17038668|P2|Overall Study|Noncompliance|1
4954857|NCT00280917|17038669|P1|Overall Study|Noncompliance|0
4954858|NCT00280917|17038666|P4|Overall Study|Withdrawal by Subject|1
4954859|NCT00280917|17038667|P3|Overall Study|Withdrawal by Subject|0
4954860|NCT00280917|17038668|P2|Overall Study|Withdrawal by Subject|2
4954861|NCT00280917|17038669|P1|Overall Study|Withdrawal by Subject|0
4954862|NCT00280917|17038666|P4|Overall Study|Change Therapy|0
4954863|NCT00280917|17038667|P3|Overall Study|Change Therapy|0
4954864|NCT00280917|17038668|P2|Overall Study|Change Therapy|2
4954865|NCT00280917|17038669|P1|Overall Study|Change Therapy|1
4954866|NCT00280917|17038666|P4|Overall Study|Adverse Event|1
4954867|NCT00280917|17038667|P3|Overall Study|Adverse Event|4
4954868|NCT00280917|17038668|P2|Overall Study|Adverse Event|1
4954869|NCT00280917|17038669|P1|Overall Study|Adverse Event|1
4954870|NCT00280748|17038692|P1|Overall Study|Extra-cranial disease progression|1
4954871|NCT00280748|17038692|P1|Overall Study|Decline in performance|3
4954872|NCT00280735|17038702|P1|Overall Study|Intercurrent Illness|2
4954873|NCT00280735|17038702|P1|Overall Study|Withdrawal by Subject|8
4954874|NCT00280735|17038702|P1|Overall Study|Lack of Efficacy|3
4954875|NCT00280735|17038702|P1|Overall Study|Adverse Event|5
4954876|NCT00280683|17038714|P2|Overall Study|Adverse Event|1
4954877|NCT00280683|17038715|P1|Overall Study|Adverse Event|1
4954878|NCT00280683|17038714|P2|Overall Study|Withdrawal by Subject|2
4954879|NCT00280683|17038715|P1|Overall Study|Withdrawal by Subject|1
4954880|NCT00280566|17038725|P3|Period 2 Double Blind|miscellaneous|5
4954881|NCT00280566|17038726|P2|Period 2 Double Blind|miscellaneous|10
4954882|NCT00280566|17038727|P1|Period 2 Double Blind|miscellaneous|0
4954883|NCT00280566|17038725|P3|Period 2 Double Blind|Withdrawal by Subject|9
4954884|NCT00280566|17038726|P2|Period 2 Double Blind|Withdrawal by Subject|9
4954885|NCT00280566|17038727|P1|Period 2 Double Blind|Withdrawal by Subject|0
4954886|NCT00280566|17038725|P3|Period 2 Double Blind|Lost to Follow-up|6
4954887|NCT00280566|17038726|P2|Period 2 Double Blind|Lost to Follow-up|3
4954888|NCT00280566|17038727|P1|Period 2 Double Blind|Lost to Follow-up|0
4954889|NCT00280566|17038725|P3|Period 2 Double Blind|Adverse Event|15
4954890|NCT00280566|17038726|P2|Period 2 Double Blind|Adverse Event|11
4954891|NCT00280566|17038727|P1|Period 2 Double Blind|Adverse Event|0
4954892|NCT00280566|17038725|P3|Period 2 Double Blind|Laboratory Abnormality|0
4954893|NCT00280566|17038726|P2|Period 2 Double Blind|Laboratory Abnormality|1
4954894|NCT00280566|17038727|P1|Period 2 Double Blind|Laboratory Abnormality|0
4954895|NCT00280566|17038725|P3|Period 2 Double Blind|Lack of Efficacy|22
4954896|NCT00280566|17038726|P2|Period 2 Double Blind|Lack of Efficacy|9
4954897|NCT00280566|17038727|P1|Period 2 Double Blind|Lack of Efficacy|0
4954898|NCT00280566|17038725|P3|Period 1 Open Label Ziprasidone|Miscellaneous|0
4954899|NCT00280566|17038726|P2|Period 1 Open Label Ziprasidone|Miscellaneous|0
4954900|NCT00280566|17038727|P1|Period 1 Open Label Ziprasidone|Miscellaneous|50
4954901|NCT00280566|17038725|P3|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
4954902|NCT00280566|17038726|P2|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0
4954903|NCT00280566|17038727|P1|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76
4954904|NCT00280566|17038725|P3|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
4954905|NCT00280566|17038726|P2|Period 1 Open Label Ziprasidone|Lost to Follow-up|0
4954906|NCT00280566|17038727|P1|Period 1 Open Label Ziprasidone|Lost to Follow-up|35
4954907|NCT00280566|17038725|P3|Period 1 Open Label Ziprasidone|Adverse Event|0
4954908|NCT00280566|17038726|P2|Period 1 Open Label Ziprasidone|Adverse Event|0
4954909|NCT00280566|17038727|P1|Period 1 Open Label Ziprasidone|Adverse Event|148
4954910|NCT00280566|17038725|P3|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
4954911|NCT00280566|17038726|P2|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0
4954912|NCT00280566|17038727|P1|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3
4954913|NCT00280566|17038725|P3|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
4954914|NCT00280566|17038726|P2|Period 1 Open Label Ziprasidone|Lack of Efficacy|0
4954915|NCT00280566|17038727|P1|Period 1 Open Label Ziprasidone|Lack of Efficacy|31
4954916|NCT00280397|17038752|P1|Overall Study|Adverse Event|1
4954917|NCT00280293|17038818|P2|Overall Study|Adverse Event|1
4954918|NCT00280293|17038819|P1|Overall Study|Adverse Event|0
4954919|NCT00280293|17038818|P2|Overall Study|Incarceration/Legal Reasons|1
4954920|NCT00280293|17038819|P1|Overall Study|Incarceration/Legal Reasons|1
4954921|NCT00280293|17038818|P2|Overall Study|Withdrawal by Subject|5
4954922|NCT00280293|17038819|P1|Overall Study|Withdrawal by Subject|3
4954923|NCT00280293|17038818|P2|Overall Study|Lost to Follow-up|12
4954924|NCT00280293|17038819|P1|Overall Study|Lost to Follow-up|14
4954925|NCT00280293|17038818|P2|Overall Study|Physician Decision|4
4954926|NCT00280293|17038819|P1|Overall Study|Physician Decision|5
4954927|NCT00280293|17038818|P2|Overall Study|Protocol Violation|0
4954928|NCT00280293|17038819|P1|Overall Study|Protocol Violation|3
4954929|NCT00280150|17038842|P4|Overall Study|Declining Performance Status|1
4954930|NCT00280150|17038843|P3|Overall Study|Declining Performance Status|0
4954931|NCT00280150|17038844|P2|Overall Study|Declining Performance Status|0
4954932|NCT00280150|17038845|P1|Overall Study|Declining Performance Status|0
4954933|NCT00280150|17038842|P4|Overall Study|Did not get consolidation therapy|0
4954934|NCT00280150|17038843|P3|Overall Study|Did not get consolidation therapy|3
4954935|NCT00280150|17038844|P2|Overall Study|Did not get consolidation therapy|0
4954936|NCT00280150|17038845|P1|Overall Study|Did not get consolidation therapy|3
4954937|NCT00280150|17038842|P4|Overall Study|Withdrawal by Subject|1
4954938|NCT00280150|17038843|P3|Overall Study|Withdrawal by Subject|0
4954939|NCT00280150|17038844|P2|Overall Study|Withdrawal by Subject|0
4954940|NCT00280150|17038845|P1|Overall Study|Withdrawal by Subject|0
4954941|NCT00280150|17038842|P4|Overall Study|Protocol Violation|1
4954942|NCT00280150|17038843|P3|Overall Study|Protocol Violation|0
4954943|NCT00280150|17038844|P2|Overall Study|Protocol Violation|0
4954944|NCT00280150|17038845|P1|Overall Study|Protocol Violation|0
4954945|NCT00280150|17038842|P4|Overall Study|Physician Decision|1
4954946|NCT00280150|17038843|P3|Overall Study|Physician Decision|0
4954947|NCT00280150|17038844|P2|Overall Study|Physician Decision|0
4954948|NCT00280150|17038845|P1|Overall Study|Physician Decision|0
4954949|NCT00280150|17038842|P4|Overall Study|Lack of Efficacy|3
4954950|NCT00280150|17038843|P3|Overall Study|Lack of Efficacy|0
4954951|NCT00280150|17038844|P2|Overall Study|Lack of Efficacy|0
4954952|NCT00280150|17038845|P1|Overall Study|Lack of Efficacy|0
4954953|NCT00280150|17038842|P4|Overall Study|Adverse Event|3
4954954|NCT00280150|17038843|P3|Overall Study|Adverse Event|2
4954955|NCT00280150|17038844|P2|Overall Study|Adverse Event|1
4954956|NCT00280150|17038845|P1|Overall Study|Adverse Event|0
4954957|NCT00280059|17038860|P2|Efficacy Assessment Phase|Withdrawal by Subject|25
4954958|NCT00280059|17038861|P1|Efficacy Assessment Phase|Withdrawal by Subject|26
4954959|NCT00280059|17038860|P2|Efficacy Assessment Phase|Other|8
4954960|NCT00280059|17038861|P1|Efficacy Assessment Phase|Other|7
4954961|NCT00280059|17038860|P2|Efficacy Assessment Phase|Lost to Follow-up|13
4954962|NCT00280059|17038861|P1|Efficacy Assessment Phase|Lost to Follow-up|6
4954963|NCT00280059|17038860|P2|Efficacy Assessment Phase|Lack of Efficacy|3
4954964|NCT00280059|17038861|P1|Efficacy Assessment Phase|Lack of Efficacy|19
4954965|NCT00280059|17038860|P2|Efficacy Assessment Phase|Laboratory abnormaility|0
4954966|NCT00280059|17038861|P1|Efficacy Assessment Phase|Laboratory abnormaility|1
4954967|NCT00280059|17038860|P2|Efficacy Assessment Phase|Adverse Event|31
4954968|NCT00280059|17038861|P1|Efficacy Assessment Phase|Adverse Event|33
4954969|NCT00280059|17038860|P2|Efficacy Assessment Phase|Death|0
4954970|NCT00280059|17038861|P1|Efficacy Assessment Phase|Death|2
4954971|NCT00279916|17038925|P2|Overall Study|Lost to Follow-up|2
4954972|NCT00279916|17038926|P1|Overall Study|Lost to Follow-up|3
4954973|NCT00279916|17038925|P2|Overall Study|Withdrawal by Subject|3
4954974|NCT00279916|17038926|P1|Overall Study|Withdrawal by Subject|4
4954975|NCT00279812|17038952|P6|Overall Study|Adverse Event|1
4954976|NCT00279812|17038953|P5|Overall Study|Adverse Event|2
4954977|NCT00279812|17038954|P4|Overall Study|Adverse Event|0
4954978|NCT00279812|17038955|P3|Overall Study|Adverse Event|1
4954979|NCT00279812|17038956|P2|Overall Study|Adverse Event|1
4954980|NCT00279812|17038957|P1|Overall Study|Adverse Event|0
4954981|NCT00279812|17038952|P6|Overall Study|Withdrawal by Subject|0
4954982|NCT00279812|17038953|P5|Overall Study|Withdrawal by Subject|0
4954983|NCT00279812|17038954|P4|Overall Study|Withdrawal by Subject|0
4954984|NCT00279812|17038955|P3|Overall Study|Withdrawal by Subject|2
4954985|NCT00279812|17038956|P2|Overall Study|Withdrawal by Subject|4
4954986|NCT00279812|17038957|P1|Overall Study|Withdrawal by Subject|0
4954987|NCT00279812|17038952|P6|Overall Study|Protocol Violation|0
4954988|NCT00279812|17038953|P5|Overall Study|Protocol Violation|1
4954989|NCT00279812|17038954|P4|Overall Study|Protocol Violation|0
4954990|NCT00279812|17038955|P3|Overall Study|Protocol Violation|0
4954991|NCT00279812|17038956|P2|Overall Study|Protocol Violation|1
4954992|NCT00279812|17038957|P1|Overall Study|Protocol Violation|1
4954993|NCT00279708|17038985|P2|Overall Study|Adverse Event|1
4954994|NCT00279708|17038986|P1|Overall Study|Adverse Event|1
4954995|NCT00279708|17038985|P2|Overall Study|Withdrawal by Subject|3
4954996|NCT00279708|17038986|P1|Overall Study|Withdrawal by Subject|2
4954997|NCT00279305|17039024|P2|Overall Study|FDA Safety Alert|1
4954998|NCT00279305|17039025|P1|Overall Study|FDA Safety Alert|4
4954999|NCT00279305|17039024|P2|Overall Study|Dificulting establishing IV|0
4955000|NCT00279305|17039025|P1|Overall Study|Dificulting establishing IV|1
4955001|NCT00279305|17039024|P2|Overall Study|Withdrawal by Subject|0
4955002|NCT00279305|17039025|P1|Overall Study|Withdrawal by Subject|2
4955003|NCT00279305|17039024|P2|Overall Study|Pregnancy|0
4955004|NCT00279305|17039025|P1|Overall Study|Pregnancy|1
4955005|NCT00279214|17039033|P2|Overall Study|Physician Decision|2
4955006|NCT00279214|17039034|P1|Overall Study|Physician Decision|3
4955007|NCT00279201|17039064|P6|Intensification Addendum|Death|0
4955008|NCT00279201|17039065|P5|Intensification Addendum|Death|1
4955009|NCT00279201|17039066|P4|Intensification Addendum|Death|0
4955010|NCT00279201|17039067|P3|Intensification Addendum|Death|0
4955011|NCT00279201|17039068|P2|Intensification Addendum|Death|0
4955012|NCT00279201|17039069|P1|Intensification Addendum|Death|0
4955013|NCT00279201|17039064|P6|Intensification Addendum|Lack of Efficacy|0
4955014|NCT00279201|17039065|P5|Intensification Addendum|Lack of Efficacy|1
4955015|NCT00279201|17039066|P4|Intensification Addendum|Lack of Efficacy|1
4955016|NCT00279201|17039067|P3|Intensification Addendum|Lack of Efficacy|0
4955017|NCT00279201|17039068|P2|Intensification Addendum|Lack of Efficacy|0
4955018|NCT00279201|17039069|P1|Intensification Addendum|Lack of Efficacy|0
4955019|NCT00279201|17039064|P6|Intensification Addendum|Entry Criteria Exclusion|0
4955020|NCT00279201|17039065|P5|Intensification Addendum|Entry Criteria Exclusion|0
4955021|NCT00279201|17039066|P4|Intensification Addendum|Entry Criteria Exclusion|0
4955022|NCT00279201|17039067|P3|Intensification Addendum|Entry Criteria Exclusion|1
4955023|NCT00279201|17039068|P2|Intensification Addendum|Entry Criteria Exclusion|0
4955024|NCT00279201|17039069|P1|Intensification Addendum|Entry Criteria Exclusion|0
4955025|NCT00279201|17039064|P6|Intensification Addendum|Sponsor Decision|1
4955026|NCT00279201|17039065|P5|Intensification Addendum|Sponsor Decision|1
4955027|NCT00279201|17039066|P4|Intensification Addendum|Sponsor Decision|0
4955028|NCT00279201|17039067|P3|Intensification Addendum|Sponsor Decision|0
4955029|NCT00279201|17039068|P2|Intensification Addendum|Sponsor Decision|0
4955030|NCT00279201|17039069|P1|Intensification Addendum|Sponsor Decision|0
4955031|NCT00279201|17039064|P6|Intensification Addendum|Physician Decision|2
4955032|NCT00279201|17039065|P5|Intensification Addendum|Physician Decision|3
4955033|NCT00279201|17039066|P4|Intensification Addendum|Physician Decision|1
4955034|NCT00279201|17039067|P3|Intensification Addendum|Physician Decision|4
4955035|NCT00279201|17039068|P2|Intensification Addendum|Physician Decision|0
4955036|NCT00279201|17039069|P1|Intensification Addendum|Physician Decision|0
4955037|NCT00279201|17039064|P6|Intensification Addendum|Adverse Event|3
4955038|NCT00279201|17039065|P5|Intensification Addendum|Adverse Event|1
4955039|NCT00279201|17039066|P4|Intensification Addendum|Adverse Event|4
4955040|NCT00279201|17039067|P3|Intensification Addendum|Adverse Event|0
4955041|NCT00279201|17039068|P2|Intensification Addendum|Adverse Event|0
4955042|NCT00279201|17039069|P1|Intensification Addendum|Adverse Event|0
4955043|NCT00279201|17039064|P6|Intensification Addendum|Protocol Violation|6
4955044|NCT00279201|17039065|P5|Intensification Addendum|Protocol Violation|6
4955045|NCT00279201|17039066|P4|Intensification Addendum|Protocol Violation|2
4955046|NCT00279201|17039067|P3|Intensification Addendum|Protocol Violation|2
4955047|NCT00279201|17039068|P2|Intensification Addendum|Protocol Violation|0
4955048|NCT00279201|17039069|P1|Intensification Addendum|Protocol Violation|0
4955049|NCT00279201|17039064|P6|Intensification Addendum|Lost to Follow-up|7
4955050|NCT00279201|17039065|P5|Intensification Addendum|Lost to Follow-up|7
4955051|NCT00279201|17039066|P4|Intensification Addendum|Lost to Follow-up|6
4955052|NCT00279201|17039067|P3|Intensification Addendum|Lost to Follow-up|4
4955053|NCT00279201|17039068|P2|Intensification Addendum|Lost to Follow-up|0
4955054|NCT00279201|17039069|P1|Intensification Addendum|Lost to Follow-up|0
4955055|NCT00279201|17039064|P6|Intensification Addendum|Withdrawal by Subject|18
4955056|NCT00279201|17039065|P5|Intensification Addendum|Withdrawal by Subject|9
4955057|NCT00279201|17039066|P4|Intensification Addendum|Withdrawal by Subject|14
4955058|NCT00279201|17039067|P3|Intensification Addendum|Withdrawal by Subject|12
4955059|NCT00279201|17039068|P2|Intensification Addendum|Withdrawal by Subject|0
4955060|NCT00279201|17039069|P1|Intensification Addendum|Withdrawal by Subject|0
4955061|NCT00279201|17039064|P6|Maintenance|HbA1c>7.5%|0
4955062|NCT00279201|17039065|P5|Maintenance|HbA1c>7.5%|0
4955063|NCT00279201|17039066|P4|Maintenance|HbA1c>7.5%|0
4955064|NCT00279201|17039067|P3|Maintenance|HbA1c>7.5%|0
4955065|NCT00279201|17039068|P2|Maintenance|HbA1c>7.5%|126
4955066|NCT00279201|17039069|P1|Maintenance|HbA1c>7.5%|123
4955067|NCT00279201|17039064|P6|Maintenance|Sponsor Decision|0
4955068|NCT00279201|17039065|P5|Maintenance|Sponsor Decision|0
4955069|NCT00279201|17039066|P4|Maintenance|Sponsor Decision|0
4955070|NCT00279201|17039067|P3|Maintenance|Sponsor Decision|0
4955071|NCT00279201|17039068|P2|Maintenance|Sponsor Decision|0
4955072|NCT00279201|17039069|P1|Maintenance|Sponsor Decision|4
4955073|NCT00279201|17039064|P6|Maintenance|Physician Decision|0
4955074|NCT00279201|17039065|P5|Maintenance|Physician Decision|0
4955075|NCT00279201|17039066|P4|Maintenance|Physician Decision|0
4955076|NCT00279201|17039067|P3|Maintenance|Physician Decision|0
4955077|NCT00279201|17039068|P2|Maintenance|Physician Decision|9
4955078|NCT00279201|17039069|P1|Maintenance|Physician Decision|9
4955079|NCT00279201|17039064|P6|Maintenance|Withdrawal by Subject|0
4955080|NCT00279201|17039065|P5|Maintenance|Withdrawal by Subject|0
4955081|NCT00279201|17039066|P4|Maintenance|Withdrawal by Subject|0
4955082|NCT00279201|17039067|P3|Maintenance|Withdrawal by Subject|0
4955083|NCT00279201|17039068|P2|Maintenance|Withdrawal by Subject|18
4955084|NCT00279201|17039069|P1|Maintenance|Withdrawal by Subject|18
4955085|NCT00279201|17039064|P6|Maintenance|Protocol Violation|0
4955086|NCT00279201|17039065|P5|Maintenance|Protocol Violation|0
4955087|NCT00279201|17039066|P4|Maintenance|Protocol Violation|0
4955088|NCT00279201|17039067|P3|Maintenance|Protocol Violation|0
4955089|NCT00279201|17039068|P2|Maintenance|Protocol Violation|24
4955090|NCT00279201|17039069|P1|Maintenance|Protocol Violation|16
4955091|NCT00279201|17039064|P6|Maintenance|Entry Criteria Exclusion|0
4955092|NCT00279201|17039065|P5|Maintenance|Entry Criteria Exclusion|0
4955093|NCT00279201|17039066|P4|Maintenance|Entry Criteria Exclusion|0
4955094|NCT00279201|17039067|P3|Maintenance|Entry Criteria Exclusion|0
4955095|NCT00279201|17039068|P2|Maintenance|Entry Criteria Exclusion|4
4955096|NCT00279201|17039069|P1|Maintenance|Entry Criteria Exclusion|1
4955097|NCT00279201|17039064|P6|Maintenance|Lost to Follow-up|0
4955098|NCT00279201|17039065|P5|Maintenance|Lost to Follow-up|0
4955099|NCT00279201|17039066|P4|Maintenance|Lost to Follow-up|0
4955100|NCT00279201|17039067|P3|Maintenance|Lost to Follow-up|0
4955101|NCT00279201|17039068|P2|Maintenance|Lost to Follow-up|13
4955102|NCT00279201|17039069|P1|Maintenance|Lost to Follow-up|17
4955103|NCT00279201|17039064|P6|Maintenance|Death|0
4955104|NCT00279201|17039065|P5|Maintenance|Death|0
4955105|NCT00279201|17039066|P4|Maintenance|Death|0
4955106|NCT00279201|17039067|P3|Maintenance|Death|0
4955107|NCT00279201|17039068|P2|Maintenance|Death|4
4955108|NCT00279201|17039069|P1|Maintenance|Death|4
4955109|NCT00279201|17039064|P6|Maintenance|Adverse Event|0
4955110|NCT00279201|17039065|P5|Maintenance|Adverse Event|0
4955111|NCT00279201|17039066|P4|Maintenance|Adverse Event|0
4955112|NCT00279201|17039067|P3|Maintenance|Adverse Event|0
4955113|NCT00279201|17039068|P2|Maintenance|Adverse Event|4
4955114|NCT00279201|17039069|P1|Maintenance|Adverse Event|4
4955115|NCT00279201|17039064|P6|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4955116|NCT00279201|17039065|P5|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4955117|NCT00279201|17039066|P4|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4955118|NCT00279201|17039067|P3|Maintenance|Discontinuation Antihyperglycemic Drugs|0
4955119|NCT00279201|17039068|P2|Maintenance|Discontinuation Antihyperglycemic Drugs|2
4955120|NCT00279201|17039069|P1|Maintenance|Discontinuation Antihyperglycemic Drugs|3
4955121|NCT00279201|17039064|P6|Maintenance|Lack of Efficacy|0
4955122|NCT00279201|17039065|P5|Maintenance|Lack of Efficacy|0
4955123|NCT00279201|17039066|P4|Maintenance|Lack of Efficacy|0
4955124|NCT00279201|17039067|P3|Maintenance|Lack of Efficacy|0
4955125|NCT00279201|17039068|P2|Maintenance|Lack of Efficacy|30
4955126|NCT00279201|17039069|P1|Maintenance|Lack of Efficacy|32
4955127|NCT00279201|17039064|P6|Initiation|Discontinuation Oral Antihyperglycemics|0
4955128|NCT00279201|17039065|P5|Initiation|Discontinuation Oral Antihyperglycemics|0
4955129|NCT00279201|17039066|P4|Initiation|Discontinuation Oral Antihyperglycemics|0
4955130|NCT00279201|17039067|P3|Initiation|Discontinuation Oral Antihyperglycemics|0
4955131|NCT00279201|17039068|P2|Initiation|Discontinuation Oral Antihyperglycemics|1
4955132|NCT00279201|17039069|P1|Initiation|Discontinuation Oral Antihyperglycemics|0
4955133|NCT00279201|17039064|P6|Initiation|Sponsor Decision|0
4955134|NCT00279201|17039065|P5|Initiation|Sponsor Decision|0
4955135|NCT00279201|17039066|P4|Initiation|Sponsor Decision|0
4955136|NCT00279201|17039067|P3|Initiation|Sponsor Decision|0
4955137|NCT00279201|17039068|P2|Initiation|Sponsor Decision|5
4955138|NCT00279201|17039069|P1|Initiation|Sponsor Decision|13
4955139|NCT00279201|17039064|P6|Initiation|Physician Decision|0
4955140|NCT00279201|17039065|P5|Initiation|Physician Decision|0
4955141|NCT00279201|17039066|P4|Initiation|Physician Decision|0
4955142|NCT00279201|17039067|P3|Initiation|Physician Decision|0
4955143|NCT00279201|17039068|P2|Initiation|Physician Decision|18
4955144|NCT00279201|17039069|P1|Initiation|Physician Decision|15
4955145|NCT00279201|17039064|P6|Initiation|Withdrawal by Subject|0
4955146|NCT00279201|17039065|P5|Initiation|Withdrawal by Subject|0
4955147|NCT00279201|17039066|P4|Initiation|Withdrawal by Subject|0
4955148|NCT00279201|17039067|P3|Initiation|Withdrawal by Subject|0
4955149|NCT00279201|17039068|P2|Initiation|Withdrawal by Subject|41
4955150|NCT00279201|17039069|P1|Initiation|Withdrawal by Subject|35
4955151|NCT00279201|17039064|P6|Initiation|Protocol Violation|0
4955152|NCT00279201|17039065|P5|Initiation|Protocol Violation|0
4955153|NCT00279201|17039066|P4|Initiation|Protocol Violation|0
4955154|NCT00279201|17039067|P3|Initiation|Protocol Violation|0
4955155|NCT00279201|17039068|P2|Initiation|Protocol Violation|10
4955156|NCT00279201|17039069|P1|Initiation|Protocol Violation|9
4955157|NCT00279201|17039064|P6|Initiation|Entry Criteria Exclusion|0
4955158|NCT00279201|17039065|P5|Initiation|Entry Criteria Exclusion|0
4955159|NCT00279201|17039066|P4|Initiation|Entry Criteria Exclusion|0
4955160|NCT00279201|17039067|P3|Initiation|Entry Criteria Exclusion|0
4955161|NCT00279201|17039068|P2|Initiation|Entry Criteria Exclusion|9
4955162|NCT00279201|17039069|P1|Initiation|Entry Criteria Exclusion|7
4955163|NCT00279201|17039064|P6|Initiation|Lost to Follow-up|0
4955164|NCT00279201|17039065|P5|Initiation|Lost to Follow-up|0
4955165|NCT00279201|17039066|P4|Initiation|Lost to Follow-up|0
4955166|NCT00279201|17039067|P3|Initiation|Lost to Follow-up|0
4955167|NCT00279201|17039068|P2|Initiation|Lost to Follow-up|41
4955168|NCT00279201|17039069|P1|Initiation|Lost to Follow-up|42
4955169|NCT00279201|17039064|P6|Initiation|Adverse Event|0
4955170|NCT00279201|17039065|P5|Initiation|Adverse Event|0
4955171|NCT00279201|17039066|P4|Initiation|Adverse Event|0
4955172|NCT00279201|17039067|P3|Initiation|Adverse Event|0
4955173|NCT00279201|17039068|P2|Initiation|Adverse Event|15
4955174|NCT00279201|17039069|P1|Initiation|Adverse Event|6
4955175|NCT00279201|17039064|P6|Initiation|Death|0
4955176|NCT00279201|17039065|P5|Initiation|Death|0
4955177|NCT00279201|17039066|P4|Initiation|Death|0
4955178|NCT00279201|17039067|P3|Initiation|Death|0
4955179|NCT00279201|17039068|P2|Initiation|Death|5
4955180|NCT00279201|17039069|P1|Initiation|Death|1
4955181|NCT00278993|17039213|P1|Overall Study|Not Otherwise Specified|4
4955182|NCT00278993|17039213|P1|Overall Study|Physician Decision|9
4955183|NCT00278993|17039213|P1|Overall Study|Progressive Disease|65
4955184|NCT00278993|17039213|P1|Overall Study|Withdrawal by Subject|5
4955185|NCT00278993|17039213|P1|Overall Study|Adverse Event|24
4955186|NCT00278954|17039221|P1|Overall Study|Withdrawal by Subject|1
4955187|NCT00278954|17039221|P1|Overall Study|Lost to Follow-up|1
4955188|NCT00278954|17039221|P1|Overall Study|Adverse Event|3
4955189|NCT00278915|17039229|P1|Overall Study|Lack of Efficacy|1
4955190|NCT00278889|17039265|P3|Overall Study|Death|17
4955191|NCT00278889|17039266|P2|Overall Study|Death|21
4955192|NCT00278889|17039267|P1|Overall Study|Death|24
4955193|NCT00278889|17039265|P3|Overall Study|Lost to Follow-up|0
4955194|NCT00278889|17039266|P2|Overall Study|Lost to Follow-up|1
4955195|NCT00278889|17039267|P1|Overall Study|Lost to Follow-up|1
4955196|NCT00278889|17039265|P3|Overall Study|Withdrawal by Subject|3
4955197|NCT00278889|17039266|P2|Overall Study|Withdrawal by Subject|5
4955198|NCT00278889|17039267|P1|Overall Study|Withdrawal by Subject|0
4955199|NCT00278629|17039315|P1|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14
4955200|NCT00278564|17039322|P1|Overall Study|Lack of Efficacy|4
4955201|NCT00278512|17039343|P2|Overall Study|Death|0
4955202|NCT00278512|17039344|P1|Overall Study|Death|1
4955203|NCT00278473|17039352|P2|Overall Study|drop out|3
4955204|NCT00278473|17039353|P1|Overall Study|drop out|4
4955205|NCT00278395|17039369|P1|Overall Study|Nonevaluable|1
4955206|NCT00278395|17039369|P1|Overall Study|Adverse Event|2
4955207|NCT00278200|17039387|P2|Overall Study|Physician Decision|1
4955208|NCT00278200|17039388|P1|Overall Study|Physician Decision|0
4955209|NCT00278200|17039387|P2|Overall Study|Death|3
4955210|NCT00278200|17039388|P1|Overall Study|Death|1
4955211|NCT00278161|17039397|P1|Overall Study|Death|11
4955212|NCT00278148|17039403|P3|Phase II - Expansion Phase|Adverse Event|2
4955213|NCT00278148|17039404|P2|Phase II - Expansion Phase|Adverse Event|0
4955214|NCT00278148|17039405|P1|Phase II - Expansion Phase|Adverse Event|0
4955215|NCT00278148|17039403|P3|Phase II - Expansion Phase|Disease progression|4
4955216|NCT00278148|17039404|P2|Phase II - Expansion Phase|Disease progression|0
4955217|NCT00278148|17039405|P1|Phase II - Expansion Phase|Disease progression|0
4955218|NCT00278109|17039417|P1|Overall Study|social circumstances|1
4955219|NCT00278109|17039417|P1|Overall Study|Adverse Event|3
4955220|NCT00277355|17039463|P2|Overall Study|Physician Decision|0
4955221|NCT00277355|17039464|P1|Overall Study|Physician Decision|1
4955222|NCT00277355|17039463|P2|Overall Study|Death|0
4955223|NCT00277355|17039464|P1|Overall Study|Death|3
4955224|NCT00277355|17039463|P2|Overall Study|Adverse Event|0
4955225|NCT00277355|17039464|P1|Overall Study|Adverse Event|5
4955226|NCT00277355|17039463|P2|Overall Study|Lost to Follow-up|2
4955227|NCT00277355|17039464|P1|Overall Study|Lost to Follow-up|2
4955228|NCT00277355|17039463|P2|Overall Study|Withdrawal by Subject|3
4955229|NCT00277355|17039464|P1|Overall Study|Withdrawal by Subject|3
4955230|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Other reasons|5
4955231|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Other reasons|7
4955232|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Other reasons|0
4955233|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3
4955234|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1
4955235|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0
4955236|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6
4955237|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4
4955238|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0
4955239|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Pregnancy|2
4955240|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Pregnancy|2
4955241|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Pregnancy|0
4955242|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8
4955243|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7
4955244|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0
4955245|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
4955246|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18
4955247|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0
4955248|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16
4955249|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17
4955250|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0
4955251|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Adverse Event|16
4955252|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Adverse Event|10
4955253|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Adverse Event|0
4955254|NCT00277212|17039472|P3|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39
4955255|NCT00277212|17039473|P2|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54
4955256|NCT00277212|17039474|P1|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0
4955257|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Other Reasons|0
4955258|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Other Reasons|0
4955259|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Other Reasons|12
4955260|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
4955261|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0
4955262|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1
4955263|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
4955264|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0
4955265|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44
4955266|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Pregnancy|0
4955267|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Pregnancy|0
4955268|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Pregnancy|6
4955269|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
4955270|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0
4955271|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35
4955272|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
4955273|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0
4955274|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87
4955275|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
4955276|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0
4955277|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96
4955278|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Adverse Event|0
4955279|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Adverse Event|0
4955280|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Adverse Event|93
4955281|NCT00277212|17039472|P3|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
4955282|NCT00277212|17039473|P2|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0
4955283|NCT00277212|17039474|P1|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61
4955284|NCT00277095|17039512|P1|Overall Study|Physician Decision|1
4955285|NCT00277095|17039512|P1|Overall Study|Missed Follow-up|9
4955286|NCT00277095|17039512|P1|Overall Study|Lost to Follow-up|2
4955287|NCT00277095|17039512|P1|Overall Study|Explanted|7
4955288|NCT00277095|17039512|P1|Overall Study|Death|2
4955289|NCT00276744|17039521|P1|PART A|Reason unknown|98
4955290|NCT00276614|17039525|P1|Overall Study|Progression of disease under study|3
4955291|NCT00276484|17039536|P2|Overall Study|Could not take time off work|1
4955292|NCT00276484|17039537|P1|Overall Study|Could not take time off work|0
4955293|NCT00276484|17039536|P2|Overall Study|Withdrawal by Subject|3
4955294|NCT00276484|17039537|P1|Overall Study|Withdrawal by Subject|4
4955295|NCT00276484|17039536|P2|Overall Study|Protocol Violation|1
4955296|NCT00276484|17039537|P1|Overall Study|Protocol Violation|0
4955297|NCT00276484|17039536|P2|Overall Study|Lost to Follow-up|1
4955298|NCT00276484|17039537|P1|Overall Study|Lost to Follow-up|1
4955299|NCT00276484|17039536|P2|Overall Study|Adverse Event|7
4955300|NCT00276484|17039537|P1|Overall Study|Adverse Event|4
4955301|NCT00276458|17039569|P2|Overall Study|Protocol Violation|3
4955302|NCT00276458|17039570|P1|Overall Study|Protocol Violation|4
4955303|NCT00276458|17039569|P2|Overall Study|Lost to Follow-up|2
4955304|NCT00276458|17039570|P1|Overall Study|Lost to Follow-up|2
4955305|NCT00276458|17039569|P2|Overall Study|Adverse Event|2
4955306|NCT00276458|17039570|P1|Overall Study|Adverse Event|0
4955307|NCT00276419|17039604|P2|First Intervention|Withdrawal by Subject|2
4955308|NCT00276419|17039605|P1|First Intervention|Withdrawal by Subject|0
4955309|NCT00276419|17039604|P2|First Intervention|Adverse Event|0
4955310|NCT00276419|17039605|P1|First Intervention|Adverse Event|1
4955311|NCT00276380|17039648|P2|Overall Study|Abnormal aPPT Levels|1
4955312|NCT00276380|17039649|P1|Overall Study|Abnormal aPPT Levels|0
4955313|NCT00276380|17039648|P2|Overall Study|Death|3
4955314|NCT00276380|17039649|P1|Overall Study|Death|5
4955315|NCT00276380|17039648|P2|Overall Study|Withdrawal by Subject|6
4955316|NCT00276380|17039649|P1|Overall Study|Withdrawal by Subject|3
4955317|NCT00276380|17039648|P2|Overall Study|Lost to Follow-up|1
4955318|NCT00276380|17039649|P1|Overall Study|Lost to Follow-up|1
4955319|NCT00276380|17039648|P2|Overall Study|Adverse Event|3
4955320|NCT00276380|17039649|P1|Overall Study|Adverse Event|5
4955321|NCT00276159|17039704|P1|Overall Study|Did not receive all 24 doses of 852A|6
4955322|NCT00276094|17039714|P3|Overall Study|Other-Study medication lost|1
4955323|NCT00276094|17039715|P2|Overall Study|Other-Study medication lost|0
4955324|NCT00276094|17039716|P1|Overall Study|Other-Study medication lost|0
4955325|NCT00276094|17039714|P3|Overall Study|Other-Relocation|0
4955326|NCT00276094|17039715|P2|Overall Study|Other-Relocation|1
4955327|NCT00276094|17039716|P1|Overall Study|Other-Relocation|0
4955328|NCT00276094|17039714|P3|Overall Study|Other-Repeat safety labs-exclusionary|0
4955329|NCT00276094|17039715|P2|Overall Study|Other-Repeat safety labs-exclusionary|1
4955330|NCT00276094|17039716|P1|Overall Study|Other-Repeat safety labs-exclusionary|0
4955331|NCT00276094|17039714|P3|Overall Study|Other-Refused follow-up visit|0
4955332|NCT00276094|17039715|P2|Overall Study|Other-Refused follow-up visit|0
4955333|NCT00276094|17039716|P1|Overall Study|Other-Refused follow-up visit|1
4955334|NCT00276094|17039714|P3|Overall Study|Other-Lack of efficacy|0
4955335|NCT00276094|17039715|P2|Overall Study|Other-Lack of efficacy|0
4955336|NCT00276094|17039716|P1|Overall Study|Other-Lack of efficacy|1
4955337|NCT00276094|17039714|P3|Overall Study|Other-Scheduled gastroplasty|0
4955338|NCT00276094|17039715|P2|Overall Study|Other-Scheduled gastroplasty|0
4955339|NCT00276094|17039716|P1|Overall Study|Other-Scheduled gastroplasty|1
4955340|NCT00276094|17039714|P3|Overall Study|Other-Subject moved out of country|0
4955341|NCT00276094|17039715|P2|Overall Study|Other-Subject moved out of country|0
4955342|NCT00276094|17039716|P1|Overall Study|Other-Subject moved out of country|1
4955343|NCT00276094|17039714|P3|Overall Study|Lost to Follow-up|4
4955344|NCT00276094|17039715|P2|Overall Study|Lost to Follow-up|6
4955345|NCT00276094|17039716|P1|Overall Study|Lost to Follow-up|8
4955346|NCT00276094|17039714|P3|Overall Study|Protocol Violation|10
4955347|NCT00276094|17039715|P2|Overall Study|Protocol Violation|7
4955348|NCT00276094|17039716|P1|Overall Study|Protocol Violation|16
4955349|NCT00276094|17039714|P3|Overall Study|Withdrawal by Subject|12
4955350|NCT00276094|17039715|P2|Overall Study|Withdrawal by Subject|14
4955351|NCT00276094|17039716|P1|Overall Study|Withdrawal by Subject|14
4955352|NCT00276094|17039714|P3|Overall Study|Adverse Event|11
4955353|NCT00276094|17039715|P2|Overall Study|Adverse Event|13
4955354|NCT00276094|17039716|P1|Overall Study|Adverse Event|15
4955355|NCT00276016|17039769|P6|Intervention 1|Withdrawal by Subject|0
4955356|NCT00276016|17039770|P5|Intervention 1|Withdrawal by Subject|0
4955357|NCT00276016|17039771|P4|Intervention 1|Withdrawal by Subject|0
4955358|NCT00276016|17039772|P3|Intervention 1|Withdrawal by Subject|0
4955359|NCT00276016|17039773|P2|Intervention 1|Withdrawal by Subject|1
4955360|NCT00276016|17039774|P1|Intervention 1|Withdrawal by Subject|0
4955361|NCT00275821|17039820|P3|Overall Study|Protocol Violation|0
4955362|NCT00275821|17039821|P2|Overall Study|Protocol Violation|1
4955363|NCT00275821|17039822|P1|Overall Study|Protocol Violation|5
4955364|NCT00275821|17039820|P3|Overall Study|Lack of Efficacy|0
4955365|NCT00275821|17039821|P2|Overall Study|Lack of Efficacy|1
4955366|NCT00275821|17039822|P1|Overall Study|Lack of Efficacy|2
4955367|NCT00275821|17039820|P3|Overall Study|Death|1
4955368|NCT00275821|17039821|P2|Overall Study|Death|2
4955369|NCT00275821|17039822|P1|Overall Study|Death|0
4955370|NCT00275821|17039820|P3|Overall Study|Lost to Follow-up|1
4955371|NCT00275821|17039821|P2|Overall Study|Lost to Follow-up|1
4955372|NCT00275821|17039822|P1|Overall Study|Lost to Follow-up|0
4955373|NCT00275821|17039820|P3|Overall Study|Withdrawal by Subject|1
4955374|NCT00275821|17039821|P2|Overall Study|Withdrawal by Subject|2
4955375|NCT00275821|17039822|P1|Overall Study|Withdrawal by Subject|0
4955376|NCT00275821|17039820|P3|Overall Study|Administrative problems|4
4955377|NCT00275821|17039821|P2|Overall Study|Administrative problems|4
4955378|NCT00275821|17039822|P1|Overall Study|Administrative problems|3
4955379|NCT00275821|17039820|P3|Overall Study|Adverse Event|5
4955380|NCT00275821|17039821|P2|Overall Study|Adverse Event|12
4955381|NCT00275821|17039822|P1|Overall Study|Adverse Event|4
4955382|NCT00275561|17039841|P2|Overall Study|Family Issues|2
4955383|NCT00275561|17039842|P1|Overall Study|Family Issues|0
4955384|NCT00275561|17039841|P2|Overall Study|Scheduling|2
4955385|NCT00275561|17039842|P1|Overall Study|Scheduling|1
4955386|NCT00275561|17039841|P2|Overall Study|Travel|1
4955387|NCT00275561|17039842|P1|Overall Study|Travel|1
4955388|NCT00275561|17039841|P2|Overall Study|Withdrawal by Subject|1
4955389|NCT00275561|17039842|P1|Overall Study|Withdrawal by Subject|0
4955390|NCT00275509|17039854|P2|Overall Study|graft thrombosis, post-operative day #8|1
4955391|NCT00275509|17039855|P1|Overall Study|graft thrombosis, post-operative day #8|0
4955392|NCT00275340|17039878|P2|Overall Study|Lost to Follow-up|4
4955393|NCT00275340|17039879|P1|Overall Study|Lost to Follow-up|2
4955394|NCT00275301|17039883|P1|Overall Study|Adverse Event|5
4955395|NCT00275262|17039902|P2|Overall Study|Started Chemotherapy|0
4955396|NCT00275262|17039903|P1|Overall Study|Started Chemotherapy|1
4955397|NCT00275262|17039902|P2|Overall Study|Death|0
4955398|NCT00275262|17039903|P1|Overall Study|Death|1
4955399|NCT00275262|17039902|P2|Overall Study|Protocol Violation|2
4955400|NCT00275262|17039903|P1|Overall Study|Protocol Violation|0
4955401|NCT00275262|17039902|P2|Overall Study|Lost to Follow-up|2
4955402|NCT00275262|17039903|P1|Overall Study|Lost to Follow-up|0
4955403|NCT00275262|17039902|P2|Overall Study|Disease progression|5
4955404|NCT00275262|17039903|P1|Overall Study|Disease progression|2
4955405|NCT00275262|17039902|P2|Overall Study|Adverse Event|0
4955406|NCT00275262|17039903|P1|Overall Study|Adverse Event|2
4955407|NCT00275028|17039917|P1|Overall Study|Physician Decision|2
4955408|NCT00275028|17039917|P1|Overall Study|Progressive Disease|30
4955409|NCT00275028|17039917|P1|Overall Study|Adverse Event|9
4955410|NCT00275028|17039917|P1|Overall Study|Withdrawal by Subject|5
4955411|NCT00275028|17039917|P1|Overall Study|Withdrew consent before treatment began|1
4955412|NCT00275002|17039924|P2|Overall Study|Adverse Event|1
4955413|NCT00275002|17039925|P1|Overall Study|Adverse Event|0
4955414|NCT00275002|17039924|P2|Overall Study|Disease progression|15
4955415|NCT00275002|17039925|P1|Overall Study|Disease progression|21
4955416|NCT00275002|17039924|P2|Overall Study|Death|0
4955417|NCT00275002|17039925|P1|Overall Study|Death|1
4955418|NCT00274937|17039933|P1|Overall Study|Progressive Disease|4
4955419|NCT00274937|17039933|P1|Overall Study|Withdrawal by Subject|6
4955420|NCT00274937|17039933|P1|Overall Study|Physician Decision|10
4955421|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
4955422|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1
4955423|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0
4955424|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
4955425|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1
4955426|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0
4955427|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Death|0
4955428|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Death|1
4955429|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Death|0
4955430|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
4955431|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0
4955432|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1
4955433|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
4955434|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0
4955435|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1
4955436|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
4955437|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0
4955438|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1
4955439|NCT00274924|17039945|P3|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0
4955440|NCT00274924|17039946|P2|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15
4955441|NCT00274924|17039947|P1|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4
4955442|NCT00274924|17039945|P3|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1
4955443|NCT00274924|17039946|P2|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
4955444|NCT00274924|17039947|P1|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0
4955445|NCT00274924|17039945|P3|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1
4955446|NCT00274924|17039946|P2|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
4955447|NCT00274924|17039947|P1|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0
4955448|NCT00274924|17039945|P3|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1
4955449|NCT00274924|17039946|P2|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
4955450|NCT00274924|17039947|P1|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0
4955451|NCT00274924|17039945|P3|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1
4955452|NCT00274924|17039946|P2|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
4955453|NCT00274924|17039947|P1|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0
4955454|NCT00274924|17039945|P3|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1
4955455|NCT00274924|17039946|P2|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
4955456|NCT00274924|17039947|P1|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0
4955457|NCT00274924|17039945|P3|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1
4955458|NCT00274924|17039946|P2|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14
4955459|NCT00274924|17039947|P1|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4
4955460|NCT00274846|17039956|P1|Overall Study|Did not receive adequate NK cells|1
4955461|NCT00274742|17039985|P6|Overall Study|Other|0
4955462|NCT00274742|17039986|P5|Overall Study|Other|2
4955463|NCT00274742|17039987|P4|Overall Study|Other|0
4955464|NCT00274742|17039988|P3|Overall Study|Other|0
4955465|NCT00274742|17039989|P2|Overall Study|Other|3
4955466|NCT00274742|17039990|P1|Overall Study|Other|0
4955467|NCT00274742|17039985|P6|Overall Study|Disease Progression|0
4955468|NCT00274742|17039986|P5|Overall Study|Disease Progression|1
4955469|NCT00274742|17039987|P4|Overall Study|Disease Progression|0
4955470|NCT00274742|17039988|P3|Overall Study|Disease Progression|1
4955471|NCT00274742|17039989|P2|Overall Study|Disease Progression|1
4955472|NCT00274742|17039990|P1|Overall Study|Disease Progression|0
4955473|NCT00274742|17039985|P6|Overall Study|End of Study|0
4955474|NCT00274742|17039986|P5|Overall Study|End of Study|0
4955475|NCT00274742|17039987|P4|Overall Study|End of Study|1
4955476|NCT00274742|17039988|P3|Overall Study|End of Study|0
4955477|NCT00274742|17039989|P2|Overall Study|End of Study|0
4955478|NCT00274742|17039990|P1|Overall Study|End of Study|0
4955479|NCT00274742|17039985|P6|Overall Study|Lost to Follow-up|0
4955480|NCT00274742|17039986|P5|Overall Study|Lost to Follow-up|1
4955481|NCT00274742|17039987|P4|Overall Study|Lost to Follow-up|0
4955482|NCT00274742|17039988|P3|Overall Study|Lost to Follow-up|0
4955483|NCT00274742|17039989|P2|Overall Study|Lost to Follow-up|0
4955484|NCT00274742|17039990|P1|Overall Study|Lost to Follow-up|0
4955485|NCT00274742|17039985|P6|Overall Study|Adverse Event|3
4955486|NCT00274742|17039986|P5|Overall Study|Adverse Event|12
4955487|NCT00274742|17039987|P4|Overall Study|Adverse Event|4
4955488|NCT00274742|17039988|P3|Overall Study|Adverse Event|1
4955489|NCT00274742|17039989|P2|Overall Study|Adverse Event|4
4955490|NCT00274742|17039990|P1|Overall Study|Adverse Event|0
4955491|NCT00274716|17040028|P6|Phase B|Lost to Follow-up|0
4955492|NCT00274716|17040029|P5|Phase B|Lost to Follow-up|0
4955493|NCT00274716|17040030|P4|Phase B|Lost to Follow-up|0
4955494|NCT00274716|17040031|P3|Phase B|Lost to Follow-up|0
4955495|NCT00274716|17040032|P2|Phase B|Lost to Follow-up|1
4955496|NCT00274716|17040033|P1|Phase B|Lost to Follow-up|0
4955497|NCT00274716|17040028|P6|Phase B|Other non-reported reason|0
4955498|NCT00274716|17040029|P5|Phase B|Other non-reported reason|0
4955499|NCT00274716|17040030|P4|Phase B|Other non-reported reason|1
4955500|NCT00274716|17040031|P3|Phase B|Other non-reported reason|1
4955501|NCT00274716|17040032|P2|Phase B|Other non-reported reason|0
4955502|NCT00274716|17040033|P1|Phase B|Other non-reported reason|0
4955503|NCT00274716|17040028|P6|Phase B|Participant moved|0
4955504|NCT00274716|17040029|P5|Phase B|Participant moved|0
4955505|NCT00274716|17040030|P4|Phase B|Participant moved|0
4955506|NCT00274716|17040031|P3|Phase B|Participant moved|0
4955507|NCT00274716|17040032|P2|Phase B|Participant moved|0
4955508|NCT00274716|17040033|P1|Phase B|Participant moved|1
4955509|NCT00274716|17040028|P6|Phase B|Withdrawal by Subject|0
4955510|NCT00274716|17040029|P5|Phase B|Withdrawal by Subject|0
4955511|NCT00274716|17040030|P4|Phase B|Withdrawal by Subject|0
4955512|NCT00274716|17040031|P3|Phase B|Withdrawal by Subject|0
4955513|NCT00274716|17040032|P2|Phase B|Withdrawal by Subject|1
4955514|NCT00274716|17040033|P1|Phase B|Withdrawal by Subject|0
4955515|NCT00274716|17040028|P6|Phase B|Protocol Violation|0
4955516|NCT00274716|17040029|P5|Phase B|Protocol Violation|0
4955517|NCT00274716|17040030|P4|Phase B|Protocol Violation|0
4955518|NCT00274716|17040031|P3|Phase B|Protocol Violation|0
4955519|NCT00274716|17040032|P2|Phase B|Protocol Violation|2
4955520|NCT00274716|17040033|P1|Phase B|Protocol Violation|0
4955521|NCT00274716|17040028|P6|Phase B|Adverse Event|1
4955522|NCT00274716|17040029|P5|Phase B|Adverse Event|0
4955523|NCT00274716|17040030|P4|Phase B|Adverse Event|0
4955524|NCT00274716|17040031|P3|Phase B|Adverse Event|2
4955525|NCT00274716|17040032|P2|Phase B|Adverse Event|0
4955526|NCT00274716|17040033|P1|Phase B|Adverse Event|0
4955527|NCT00274716|17040028|P6|Phase A|Completed but did not enter Phase B|1
4955528|NCT00274716|17040029|P5|Phase A|Completed but did not enter Phase B|1
4955529|NCT00274716|17040030|P4|Phase A|Completed but did not enter Phase B|2
4955530|NCT00274716|17040031|P3|Phase A|Completed but did not enter Phase B|2
4955531|NCT00274716|17040032|P2|Phase A|Completed but did not enter Phase B|2
4955532|NCT00274716|17040033|P1|Phase A|Completed but did not enter Phase B|1
4955533|NCT00274716|17040028|P6|Phase A|Adverse Event|0
4955534|NCT00274716|17040029|P5|Phase A|Adverse Event|2
4955535|NCT00274716|17040030|P4|Phase A|Adverse Event|0
4955536|NCT00274716|17040031|P3|Phase A|Adverse Event|3
4955537|NCT00274716|17040032|P2|Phase A|Adverse Event|3
4955538|NCT00274716|17040033|P1|Phase A|Adverse Event|2
4955539|NCT00274716|17040028|P6|Phase A|Withdrawal by Subject|1
4955540|NCT00274716|17040029|P5|Phase A|Withdrawal by Subject|0
4955541|NCT00274716|17040030|P4|Phase A|Withdrawal by Subject|3
4955542|NCT00274716|17040031|P3|Phase A|Withdrawal by Subject|1
4955543|NCT00274716|17040032|P2|Phase A|Withdrawal by Subject|2
4955544|NCT00274716|17040033|P1|Phase A|Withdrawal by Subject|2
4955545|NCT00274716|17040028|P6|Phase A|Met criteria for discontinuation|0
4955546|NCT00274716|17040029|P5|Phase A|Met criteria for discontinuation|0
4955547|NCT00274716|17040030|P4|Phase A|Met criteria for discontinuation|0
4955548|NCT00274716|17040031|P3|Phase A|Met criteria for discontinuation|0
4955549|NCT00274716|17040032|P2|Phase A|Met criteria for discontinuation|1
4955550|NCT00274716|17040033|P1|Phase A|Met criteria for discontinuation|1
4955551|NCT00274716|17040028|P6|Phase A|Protocol Violation|0
4955552|NCT00274716|17040029|P5|Phase A|Protocol Violation|0
4955553|NCT00274716|17040030|P4|Phase A|Protocol Violation|1
4955554|NCT00274716|17040031|P3|Phase A|Protocol Violation|0
4955555|NCT00274716|17040032|P2|Phase A|Protocol Violation|0
4955556|NCT00274716|17040033|P1|Phase A|Protocol Violation|1
4955557|NCT00274716|17040028|P6|Phase A|Site Terminated|0
4955558|NCT00274716|17040029|P5|Phase A|Site Terminated|0
4955559|NCT00274716|17040030|P4|Phase A|Site Terminated|1
4955560|NCT00274716|17040031|P3|Phase A|Site Terminated|0
4955561|NCT00274716|17040032|P2|Phase A|Site Terminated|0
4955562|NCT00274716|17040033|P1|Phase A|Site Terminated|0
4955563|NCT00274716|17040028|P6|Phase A|Participant moved|1
4955564|NCT00274716|17040029|P5|Phase A|Participant moved|0
4955565|NCT00274716|17040030|P4|Phase A|Participant moved|0
4955566|NCT00274716|17040031|P3|Phase A|Participant moved|1
4955567|NCT00274716|17040032|P2|Phase A|Participant moved|0
4955568|NCT00274716|17040033|P1|Phase A|Participant moved|0
4955569|NCT00274716|17040028|P6|Phase A|Other non-reported reason|1
4955570|NCT00274716|17040029|P5|Phase A|Other non-reported reason|0
4955571|NCT00274716|17040030|P4|Phase A|Other non-reported reason|2
4955572|NCT00274716|17040031|P3|Phase A|Other non-reported reason|1
4955573|NCT00274716|17040032|P2|Phase A|Other non-reported reason|2
4955574|NCT00274716|17040033|P1|Phase A|Other non-reported reason|4
4955575|NCT00274651|17040095|P2|Overall Study|Physician Decision|7
4955576|NCT00274651|17040096|P1|Overall Study|Physician Decision|8
4955577|NCT00274651|17040095|P2|Overall Study|Withdrawal by Subject|1
4955578|NCT00274651|17040096|P1|Overall Study|Withdrawal by Subject|0
4955579|NCT00274651|17040095|P2|Overall Study|Death|3
4955580|NCT00274651|17040096|P1|Overall Study|Death|1
4955581|NCT00274651|17040095|P2|Overall Study|Lack of Efficacy|6
4955582|NCT00274651|17040096|P1|Overall Study|Lack of Efficacy|13
4955583|NCT00274651|17040095|P2|Overall Study|Adverse Event|3
4955584|NCT00274651|17040096|P1|Overall Study|Adverse Event|6
4955585|NCT00274625|17040111|P2|Overall Study|Excluded from analysis|8
4955586|NCT00274625|17040112|P1|Overall Study|Excluded from analysis|14
4955587|NCT00274625|17040111|P2|Overall Study|Lost to Follow-up|54
4955588|NCT00274625|17040112|P1|Overall Study|Lost to Follow-up|46
4955589|NCT00274469|17040120|P2|Overall Study|Did not consent to OS follow-up|19
4955590|NCT00274469|17040121|P1|Overall Study|Did not consent to OS follow-up|16
4955591|NCT00274469|17040120|P2|Overall Study|Death|74
4955592|NCT00274469|17040121|P1|Overall Study|Death|63
4955593|NCT00274456|17040141|P4|Overall Study|Withdrawal by Subject|13
4955594|NCT00274456|17040142|P3|Overall Study|Withdrawal by Subject|9
4955595|NCT00274456|17040143|P2|Overall Study|Withdrawal by Subject|13
4955596|NCT00274456|17040144|P1|Overall Study|Withdrawal by Subject|18
4955597|NCT00274456|17040141|P4|Overall Study|Lost to Follow-up|0
4955598|NCT00274456|17040142|P3|Overall Study|Lost to Follow-up|1
4955599|NCT00274456|17040143|P2|Overall Study|Lost to Follow-up|0
4955600|NCT00274456|17040144|P1|Overall Study|Lost to Follow-up|0
4955601|NCT00274456|17040141|P4|Overall Study|Physician Decision|13
4955602|NCT00274456|17040142|P3|Overall Study|Physician Decision|6
4955603|NCT00274456|17040143|P2|Overall Study|Physician Decision|5
4955604|NCT00274456|17040144|P1|Overall Study|Physician Decision|7
4955605|NCT00274456|17040141|P4|Overall Study|Adverse Event|2
4955606|NCT00274456|17040142|P3|Overall Study|Adverse Event|2
4955607|NCT00274456|17040143|P2|Overall Study|Adverse Event|1
4955608|NCT00274456|17040144|P1|Overall Study|Adverse Event|0
4955609|NCT00274456|17040141|P4|Overall Study|Unacceptable toxicity|16
4955610|NCT00274456|17040142|P3|Overall Study|Unacceptable toxicity|12
4955611|NCT00274456|17040143|P2|Overall Study|Unacceptable toxicity|5
4955612|NCT00274456|17040144|P1|Overall Study|Unacceptable toxicity|10
4955613|NCT00274456|17040141|P4|Overall Study|Still on treatment|1
4955614|NCT00274456|17040142|P3|Overall Study|Still on treatment|5
4955615|NCT00274456|17040143|P2|Overall Study|Still on treatment|3
4955616|NCT00274456|17040144|P1|Overall Study|Still on treatment|2
4955617|NCT00274287|17040186|P1|Overall Study|subject non-compliance|1
4955618|NCT00274287|17040186|P1|Overall Study|Withdrawal by Subject|1
4955619|NCT00274261|17040196|P2|Overall Study|Lost to Follow-up|75
4955620|NCT00274261|17040197|P1|Overall Study|Lost to Follow-up|106
4955621|NCT00274261|17040196|P2|Overall Study|Protocol Violation|42
4955622|NCT00274261|17040197|P1|Overall Study|Protocol Violation|71
4955623|NCT00274261|17040196|P2|Overall Study|Withdrawal by Subject|126
4955624|NCT00274261|17040197|P1|Overall Study|Withdrawal by Subject|179
4955625|NCT00274261|17040196|P2|Overall Study|Pregnancy|83
4955626|NCT00274261|17040197|P1|Overall Study|Pregnancy|114
4955627|NCT00274261|17040196|P2|Overall Study|Adverse Event|11
4955628|NCT00274261|17040197|P1|Overall Study|Adverse Event|19
4955629|NCT00273858|17040236|P1|Overall Study|Adverse Event|81
4955630|NCT00273858|17040236|P1|Overall Study|Withdrawal by Subject|21
4955631|NCT00273858|17040236|P1|Overall Study|Lost to Follow-up|101
4955632|NCT00273858|17040236|P1|Overall Study|Not completed 24 month observation time|334
4955633|NCT00273182|17040304|P1|Overall Study|Site exit, system change, 36 m FU missed|36
4955634|NCT00273182|17040304|P1|Overall Study|Device/System Explant|154
4955635|NCT00273182|17040304|P1|Overall Study|Withdrawal by Subject|257
4955636|NCT00273182|17040304|P1|Overall Study|Lost to Follow-up|88
4955637|NCT00273182|17040304|P1|Overall Study|Death|450
4955638|NCT00273052|17040314|P2|Overall Study|Worsening serum lipid levels|2
4955639|NCT00273052|17040315|P1|Overall Study|Worsening serum lipid levels|0
4955640|NCT00273052|17040314|P2|Overall Study|Other|0
4955641|NCT00273052|17040315|P1|Overall Study|Other|2
4955642|NCT00273052|17040314|P2|Overall Study|Non-Compliance|1
4955643|NCT00273052|17040315|P1|Overall Study|Non-Compliance|3
4955644|NCT00273052|17040314|P2|Overall Study|Lack of Efficacy|4
4955645|NCT00273052|17040315|P1|Overall Study|Lack of Efficacy|6
4955646|NCT00273052|17040314|P2|Overall Study|Lost to Follow-up|25
4955647|NCT00273052|17040315|P1|Overall Study|Lost to Follow-up|7
4955648|NCT00273052|17040314|P2|Overall Study|Protocol Violation|18
4955649|NCT00273052|17040315|P1|Overall Study|Protocol Violation|14
4955650|NCT00273052|17040314|P2|Overall Study|Adverse Event|19
4955651|NCT00273052|17040315|P1|Overall Study|Adverse Event|21
4955652|NCT00273052|17040314|P2|Overall Study|Withdrawal by Subject|19
4955653|NCT00273052|17040315|P1|Overall Study|Withdrawal by Subject|16
4955654|NCT00272987|17040350|P3|Overall Study|Ongoing|15
4955655|NCT00272987|17040351|P2|Overall Study|Ongoing|14
4955656|NCT00272987|17040352|P1|Overall Study|Ongoing|20
4955657|NCT00272987|17040350|P3|Overall Study|Missed >3 Visits|1
4955658|NCT00272987|17040351|P2|Overall Study|Missed >3 Visits|0
4955659|NCT00272987|17040352|P1|Overall Study|Missed >3 Visits|0
4955660|NCT00272987|17040350|P3|Overall Study|Withdrawal by Subject|3
4955661|NCT00272987|17040351|P2|Overall Study|Withdrawal by Subject|0
4955662|NCT00272987|17040352|P1|Overall Study|Withdrawal by Subject|0
4955663|NCT00272987|17040350|P3|Overall Study|Adverse Event|0
4955664|NCT00272987|17040351|P2|Overall Study|Adverse Event|0
4955665|NCT00272987|17040352|P1|Overall Study|Adverse Event|1
4955666|NCT00272961|17040416|P5|Treatment Phase: Week 3 Up to Week 12|Other|2
4955667|NCT00272961|17040417|P4|Treatment Phase: Week 3 Up to Week 12|Other|2
4955668|NCT00272961|17040418|P3|Treatment Phase: Week 3 Up to Week 12|Other|3
4955669|NCT00272961|17040419|P2|Treatment Phase: Week 3 Up to Week 12|Other|3
4955670|NCT00272961|17040420|P1|Treatment Phase: Week 3 Up to Week 12|Other|1
4955671|NCT00272961|17040416|P5|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
4955672|NCT00272961|17040417|P4|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
4955673|NCT00272961|17040418|P3|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
4955674|NCT00272961|17040419|P2|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0
4955675|NCT00272961|17040420|P1|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1
4955676|NCT00272961|17040416|P5|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2
4955677|NCT00272961|17040417|P4|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
4955678|NCT00272961|17040418|P3|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
4955679|NCT00272961|17040419|P2|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1
4955680|NCT00272961|17040420|P1|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0
4955681|NCT00272961|17040416|P5|Placebo Run-in Phase: Up to Week 2|Other|0
4955682|NCT00272961|17040417|P4|Placebo Run-in Phase: Up to Week 2|Other|0
4955683|NCT00272961|17040418|P3|Placebo Run-in Phase: Up to Week 2|Other|0
4955684|NCT00272961|17040419|P2|Placebo Run-in Phase: Up to Week 2|Other|0
4955685|NCT00272961|17040420|P1|Placebo Run-in Phase: Up to Week 2|Other|2
4955686|NCT00272961|17040416|P5|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4955687|NCT00272961|17040417|P4|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4955688|NCT00272961|17040418|P3|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4955689|NCT00272961|17040419|P2|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0
4955690|NCT00272961|17040420|P1|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2
4955691|NCT00272961|17040416|P5|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4955692|NCT00272961|17040417|P4|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4955693|NCT00272961|17040418|P3|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4955694|NCT00272961|17040419|P2|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0
4955695|NCT00272961|17040420|P1|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5
4955696|NCT00272961|17040416|P5|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4955697|NCT00272961|17040417|P4|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4955698|NCT00272961|17040418|P3|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4955699|NCT00272961|17040419|P2|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0
4955700|NCT00272961|17040420|P1|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1
4955701|NCT00272961|17040416|P5|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4955702|NCT00272961|17040417|P4|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4955703|NCT00272961|17040418|P3|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4955704|NCT00272961|17040419|P2|Placebo Run-in Phase: Up to Week 2|Physician Decision|0
4955705|NCT00272961|17040420|P1|Placebo Run-in Phase: Up to Week 2|Physician Decision|1
4955706|NCT00272844|17040477|P1|Overall Study|Withdrawal by Subject|5
4955707|NCT00272792|17040485|P2|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1
4955708|NCT00272792|17040486|P1|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0
4955709|NCT00272792|17040485|P2|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0
4955710|NCT00272792|17040486|P1|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1
4955711|NCT00272792|17040485|P2|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2
4955712|NCT00272792|17040486|P1|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0
4955713|NCT00272792|17040485|P2|Part 1: Responsiveness|Lost to Follow-up|0
4955714|NCT00272792|17040486|P1|Part 1: Responsiveness|Lost to Follow-up|1
4955715|NCT00272779|17040496|P2|Baseline Through Week 96|Continuing on treatment|38
4955716|NCT00272779|17040497|P1|Baseline Through Week 96|Continuing on treatment|61
4955717|NCT00272779|17040496|P2|Baseline Through Week 96|Never treated|3
4955718|NCT00272779|17040497|P1|Baseline Through Week 96|Never treated|2
4955719|NCT00272779|17040496|P2|Baseline Through Week 96|Pregnancy at Week 96|0
4955720|NCT00272779|17040497|P1|Baseline Through Week 96|Pregnancy at Week 96|1
4955721|NCT00272779|17040496|P2|Baseline Through Week 96|Poor/non compliance at Week 96]|0
4955722|NCT00272779|17040497|P1|Baseline Through Week 96|Poor/non compliance at Week 96]|2
4955723|NCT00272779|17040496|P2|Baseline Through Week 96|Lost to follow-up at Week 96|0
4955724|NCT00272779|17040497|P1|Baseline Through Week 96|Lost to follow-up at Week 96|1
4955725|NCT00272779|17040496|P2|Baseline Through Week 96|Changed address before Week 96|1
4955726|NCT00272779|17040497|P1|Baseline Through Week 96|Changed address before Week 96|0
4955727|NCT00272779|17040496|P2|Baseline Through Week 96|Withdrew consent before Week 96|18
4955728|NCT00272779|17040497|P1|Baseline Through Week 96|Withdrew consent before Week 96|5
4955729|NCT00272779|17040496|P2|Baseline Through Week 96|No longer meets criteria before Week 96|3
4955730|NCT00272779|17040497|P1|Baseline Through Week 96|No longer meets criteria before Week 96|4
4955731|NCT00272779|17040496|P2|Baseline Through Week 96|Pregnancy before Week 96|7
4955732|NCT00272779|17040497|P1|Baseline Through Week 96|Pregnancy before Week 96|5
4955733|NCT00272779|17040496|P2|Baseline Through Week 96|Poor/non compliance before Week 96|16
4955734|NCT00272779|17040497|P1|Baseline Through Week 96|Poor/non compliance before Week 96|12
4955735|NCT00272779|17040496|P2|Baseline Through Week 96|Participant Imprisoned before Week 96|0
4955736|NCT00272779|17040497|P1|Baseline Through Week 96|Participant Imprisoned before Week 96|1
4955737|NCT00272779|17040496|P2|Baseline Through Week 96|Lost to follow up before Week 96|13
4955738|NCT00272779|17040497|P1|Baseline Through Week 96|Lost to follow up before Week 96|10
4955739|NCT00272779|17040496|P2|Baseline Through Week 96|Lack of efficacy before Week 96|10
4955740|NCT00272779|17040497|P1|Baseline Through Week 96|Lack of efficacy before Week 96|16
4955741|NCT00272779|17040496|P2|Baseline Through Week 96|Death before Week 96|5
4955742|NCT00272779|17040497|P1|Baseline Through Week 96|Death before Week 96|6
4955743|NCT00272779|17040496|P2|Baseline Through Week 96|Adverse event before Week 96|22
4955744|NCT00272779|17040497|P1|Baseline Through Week 96|Adverse event before Week 96|13
4955745|NCT00272779|17040496|P2|Baseline Through Week 48|Never treated|3
4955746|NCT00272779|17040497|P1|Baseline Through Week 48|Never treated|2
4955747|NCT00272779|17040496|P2|Baseline Through Week 48|Lost to follow-up on/after Week 48|3
4955748|NCT00272779|17040497|P1|Baseline Through Week 48|Lost to follow-up on/after Week 48|0
4955749|NCT00272779|17040496|P2|Baseline Through Week 48|Continuing treatment|368
4955750|NCT00272779|17040497|P1|Baseline Through Week 48|Continuing treatment|385
4955751|NCT00272779|17040496|P2|Baseline Through Week 48|Withdrew consent on/after Week 48|2
4955752|NCT00272779|17040497|P1|Baseline Through Week 48|Withdrew consent on/after Week 48|0
4955753|NCT00272779|17040496|P2|Baseline Through Week 48|Pregnancy on/after Week 48|2
4955754|NCT00272779|17040497|P1|Baseline Through Week 48|Pregnancy on/after Week 48|1
4955755|NCT00272779|17040496|P2|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
4955756|NCT00272779|17040497|P1|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2
4955757|NCT00272779|17040496|P2|Baseline Through Week 48|Poor/non compliance on/after Week|2
4955758|NCT00272779|17040497|P1|Baseline Through Week 48|Poor/non compliance on/after Week|2
4955759|NCT00272779|17040496|P2|Baseline Through Week 48|Lack of efficacy on/after Week 48|1
4955760|NCT00272779|17040497|P1|Baseline Through Week 48|Lack of efficacy on/after Week 48|7
4955761|NCT00272779|17040496|P2|Baseline Through Week 48|Death on/after Week 48|1
4955762|NCT00272779|17040497|P1|Baseline Through Week 48|Death on/after Week 48|1
4955763|NCT00272779|17040496|P2|Baseline Through Week 48|Adverse event on/after Week 48|1
4955764|NCT00272779|17040497|P1|Baseline Through Week 48|Adverse event on/after Week 48|1
4955765|NCT00272779|17040496|P2|Baseline Through Week 48|Chose different site before wk 48|1
4955766|NCT00272779|17040497|P1|Baseline Through Week 48|Chose different site before wk 48|0
4955767|NCT00272779|17040496|P2|Baseline Through Week 48|Participant's decision before wk 48|1
4955768|NCT00272779|17040497|P1|Baseline Through Week 48|Participant's decision before wk 48|0
4955769|NCT00272779|17040496|P2|Baseline Through Week 48|Withdrew consent before Week 48|13
4955770|NCT00272779|17040497|P1|Baseline Through Week 48|Withdrew consent before Week 48|4
4955771|NCT00272779|17040496|P2|Baseline Through Week 48|No longer meets criteria before Week 48|0
4955772|NCT00272779|17040497|P1|Baseline Through Week 48|No longer meets criteria before Week 48|1
4955773|NCT00272779|17040496|P2|Baseline Through Week 48|Pregnancy before Week 48|2
4955774|NCT00272779|17040497|P1|Baseline Through Week 48|Pregnancy before Week 48|2
4955775|NCT00272779|17040496|P2|Baseline Through Week 48|Poor/non compliance before Week 48|9
4955776|NCT00272779|17040497|P1|Baseline Through Week 48|Poor/non compliance before Week 48|6
4955777|NCT00272779|17040496|P2|Baseline Through Week 48|Viral load rebound before Week 48|0
4955778|NCT00272779|17040497|P1|Baseline Through Week 48|Viral load rebound before Week 48|1
4955779|NCT00272779|17040496|P2|Baseline Through Week 48|Lost to follow-up before Week 48|6
4955780|NCT00272779|17040497|P1|Baseline Through Week 48|Lost to follow-up before Week 48|6
4955781|NCT00272779|17040496|P2|Baseline Through Week 48|Lack of efficacy before Week 48|8
4955782|NCT00272779|17040497|P1|Baseline Through Week 48|Lack of efficacy before Week 48|5
4955783|NCT00272779|17040496|P2|Baseline Through Week 48|Death before Week 48|4
4955784|NCT00272779|17040497|P1|Baseline Through Week 48|Death before Week 48|4
4955785|NCT00272779|17040496|P2|Baseline Through Week 48|Adverse event before Week 48|14
4955786|NCT00272779|17040497|P1|Baseline Through Week 48|Adverse event before Week 48|10
4955787|NCT00272038|17040757|P1|Overall Study|withdrew before they received 2 cycles|7
4955788|NCT00271947|17040763|P1|Overall Study|Lost to Follow-up|1
4955789|NCT00271856|17040769|P2|Overall Study|Lost to Follow-up|11
4955790|NCT00271856|17040770|P1|Overall Study|Lost to Follow-up|10
4955791|NCT00271856|17040769|P2|Overall Study|Withdrawal by Subject|7
4955792|NCT00271856|17040770|P1|Overall Study|Withdrawal by Subject|1
4955793|NCT00271817|17040789|P3|Part 2|LDL < 50 mg/dL|4
4955794|NCT00271817|17040790|P2|Part 2|LDL < 50 mg/dL|3
4955795|NCT00271817|17040791|P1|Part 2|LDL < 50 mg/dL|0
4955796|NCT00271817|17040789|P3|Part 2|Withdrawal by Subject|13
4955797|NCT00271817|17040790|P2|Part 2|Withdrawal by Subject|2
4955798|NCT00271817|17040791|P1|Part 2|Withdrawal by Subject|0
4955799|NCT00271817|17040789|P3|Part 2|Patient Moved|5
4955800|NCT00271817|17040790|P2|Part 2|Patient Moved|0
4955801|NCT00271817|17040791|P1|Part 2|Patient Moved|0
4955802|NCT00271817|17040789|P3|Part 2|Protocol Violation|5
4955803|NCT00271817|17040790|P2|Part 2|Protocol Violation|3
4955804|NCT00271817|17040791|P1|Part 2|Protocol Violation|0
4955805|NCT00271817|17040789|P3|Part 2|Lost to Follow-up|18
4955806|NCT00271817|17040790|P2|Part 2|Lost to Follow-up|6
4955807|NCT00271817|17040791|P1|Part 2|Lost to Follow-up|0
4955808|NCT00271817|17040789|P3|Part 2|Lack of Efficacy|6
4955809|NCT00271817|17040790|P2|Part 2|Lack of Efficacy|1
4955810|NCT00271817|17040791|P1|Part 2|Lack of Efficacy|0
4955811|NCT00271817|17040789|P3|Part 2|Adverse Event|33
4955812|NCT00271817|17040790|P2|Part 2|Adverse Event|17
4955813|NCT00271817|17040791|P1|Part 2|Adverse Event|0
4955814|NCT00271817|17040789|P3|Part 1|LDL < 50 mg/dL|48
4955815|NCT00271817|17040790|P2|Part 1|LDL < 50 mg/dL|4
4955816|NCT00271817|17040791|P1|Part 1|LDL < 50 mg/dL|1
4955817|NCT00271817|17040789|P3|Part 1|Withdrawal by Subject|45
4955818|NCT00271817|17040790|P2|Part 1|Withdrawal by Subject|17
4955819|NCT00271817|17040791|P1|Part 1|Withdrawal by Subject|23
4955820|NCT00271817|17040789|P3|Part 1|Patient Moved|5
4955821|NCT00271817|17040790|P2|Part 1|Patient Moved|1
4955822|NCT00271817|17040791|P1|Part 1|Patient Moved|3
4955823|NCT00271817|17040789|P3|Part 1|Protocol Violation|7
4955824|NCT00271817|17040790|P2|Part 1|Protocol Violation|4
4955825|NCT00271817|17040791|P1|Part 1|Protocol Violation|5
4955826|NCT00271817|17040789|P3|Part 1|Lost to Follow-up|24
4955827|NCT00271817|17040790|P2|Part 1|Lost to Follow-up|8
4955828|NCT00271817|17040791|P1|Part 1|Lost to Follow-up|6
4955829|NCT00271817|17040789|P3|Part 1|Adverse Event|156
4955830|NCT00271817|17040790|P2|Part 1|Adverse Event|25
4955831|NCT00271817|17040791|P1|Part 1|Adverse Event|68
4955832|NCT00271609|17040833|P2|Overall Study|Withdrawal by Subject|0
4955833|NCT00271609|17040834|P1|Overall Study|Withdrawal by Subject|2
4955834|NCT00271609|17040833|P2|Overall Study|Adverse Event|3
4955835|NCT00271609|17040834|P1|Overall Study|Adverse Event|11
4955836|NCT00271596|17040844|P2|Overall Study|Withdrawal by Subject|1
4955837|NCT00271596|17040845|P1|Overall Study|Withdrawal by Subject|0
4955838|NCT00271596|17040844|P2|Overall Study|Protocol Violation|0
4955839|NCT00271596|17040845|P1|Overall Study|Protocol Violation|1
4955840|NCT00271544|17040880|P1|Overall Study|Implant not attempted|4
4955841|NCT00271544|17040880|P1|Overall Study|Model 4196 lead not attempted|9
4955842|NCT00271544|17040880|P1|Overall Study|Subjects did not receive a 4196 lead|7
4955843|NCT00271505|17040901|P1|Overall Study|Death|1
4955844|NCT00271505|17040901|P1|Overall Study|Adverse Event|1
4955845|NCT00271505|17040901|P1|Overall Study|Screen Failure|3
4955846|NCT00271024|17041000|P4|Overall Study|Time Commitment, Scheduling, or Travel|4
4955847|NCT00271024|17041001|P3|Overall Study|Time Commitment, Scheduling, or Travel|4
4955848|NCT00271024|17041002|P2|Overall Study|Time Commitment, Scheduling, or Travel|2
4955849|NCT00271024|17041003|P1|Overall Study|Time Commitment, Scheduling, or Travel|6
4955850|NCT00271024|17041000|P4|Overall Study|Unpleasant Reaction To Tablet|2
4955851|NCT00271024|17041001|P3|Overall Study|Unpleasant Reaction To Tablet|4
4955852|NCT00271024|17041002|P2|Overall Study|Unpleasant Reaction To Tablet|3
4955853|NCT00271024|17041003|P1|Overall Study|Unpleasant Reaction To Tablet|1
4955854|NCT00271024|17041000|P4|Overall Study|Protocol Violation|11
4955855|NCT00271024|17041001|P3|Overall Study|Protocol Violation|5
4955856|NCT00271024|17041002|P2|Overall Study|Protocol Violation|6
4955857|NCT00271024|17041003|P1|Overall Study|Protocol Violation|1
4955858|NCT00271024|17041000|P4|Overall Study|Unknown/Unspecified|4
4955859|NCT00271024|17041001|P3|Overall Study|Unknown/Unspecified|8
4955860|NCT00271024|17041002|P2|Overall Study|Unknown/Unspecified|11
4955861|NCT00271024|17041003|P1|Overall Study|Unknown/Unspecified|11
4955862|NCT00271024|17041000|P4|Overall Study|Lost Interest|3
4955863|NCT00271024|17041001|P3|Overall Study|Lost Interest|2
4955864|NCT00271024|17041002|P2|Overall Study|Lost Interest|4
4955865|NCT00271024|17041003|P1|Overall Study|Lost Interest|3
4955866|NCT00270998|17041053|P3|12 Month Follow-up|Received/desired alternate treatment|1
4955867|NCT00270998|17041054|P2|12 Month Follow-up|Received/desired alternate treatment|4
4955868|NCT00270998|17041055|P1|12 Month Follow-up|Received/desired alternate treatment|1
4955869|NCT00270998|17041053|P3|12 Month Follow-up|Personal/family health|1
4955870|NCT00270998|17041054|P2|12 Month Follow-up|Personal/family health|5
4955871|NCT00270998|17041055|P1|12 Month Follow-up|Personal/family health|0
4955872|NCT00270998|17041053|P3|12 Month Follow-up|Pessary did not fit|0
4955873|NCT00270998|17041054|P2|12 Month Follow-up|Pessary did not fit|0
4955874|NCT00270998|17041055|P1|12 Month Follow-up|Pessary did not fit|1
4955875|NCT00270998|17041053|P3|12 Month Follow-up|Withdrawal by Subject|16
4955876|NCT00270998|17041054|P2|12 Month Follow-up|Withdrawal by Subject|12
4955877|NCT00270998|17041055|P1|12 Month Follow-up|Withdrawal by Subject|7
4955878|NCT00270998|17041053|P3|12 Month Follow-up|Lack of Efficacy|3
4955879|NCT00270998|17041054|P2|12 Month Follow-up|Lack of Efficacy|4
4955880|NCT00270998|17041055|P1|12 Month Follow-up|Lack of Efficacy|5
4955881|NCT00270998|17041053|P3|3 Month Follow-up|Received/desired alternate treatment|2
4955882|NCT00270998|17041054|P2|3 Month Follow-up|Received/desired alternate treatment|5
4955883|NCT00270998|17041055|P1|3 Month Follow-up|Received/desired alternate treatment|13
4955884|NCT00270998|17041053|P3|3 Month Follow-up|Personal/family health|0
4955885|NCT00270998|17041054|P2|3 Month Follow-up|Personal/family health|1
4955886|NCT00270998|17041055|P1|3 Month Follow-up|Personal/family health|1
4955887|NCT00270998|17041053|P3|3 Month Follow-up|Pessary did not fit|0
4955888|NCT00270998|17041054|P2|3 Month Follow-up|Pessary did not fit|0
4955889|NCT00270998|17041055|P1|3 Month Follow-up|Pessary did not fit|12
4955890|NCT00270998|17041053|P3|3 Month Follow-up|Withdrawal by Subject|15
4955891|NCT00270998|17041054|P2|3 Month Follow-up|Withdrawal by Subject|14
4955892|NCT00270998|17041055|P1|3 Month Follow-up|Withdrawal by Subject|11
4955893|NCT00270998|17041053|P3|3 Month Follow-up|Lack of Efficacy|1
4955894|NCT00270998|17041054|P2|3 Month Follow-up|Lack of Efficacy|2
4955895|NCT00270998|17041055|P1|3 Month Follow-up|Lack of Efficacy|1
4955896|NCT00270998|17041053|P3|3 Month Follow-up|Adverse Event|0
4955897|NCT00270998|17041054|P2|3 Month Follow-up|Adverse Event|0
4955898|NCT00270998|17041055|P1|3 Month Follow-up|Adverse Event|1
4955899|NCT00270894|17041084|P1|Overall Study|Withdrawal by Subject|1
4955900|NCT00270894|17041084|P1|Overall Study|Adverse Event|1
4955901|NCT00270855|17041096|P2|Overall Study|Withdrawal by Subject|8
4955902|NCT00270855|17041097|P1|Overall Study|Withdrawal by Subject|8
4955903|NCT00270257|17041233|P2|Overall Study|Data Safety Monitoring Board (DSMB) halt|424
4955904|NCT00270257|17041234|P1|Overall Study|Data Safety Monitoring Board (DSMB) halt|412
4955905|NCT00270231|17041252|P2|Second Intervention|Lost to Follow-up|1
4955906|NCT00270231|17041253|P1|Second Intervention|Lost to Follow-up|0
4955907|NCT00270231|17041252|P2|Washout Period|Lost to Follow-up|0
4955908|NCT00270231|17041253|P1|Washout Period|Lost to Follow-up|1
4955909|NCT00270231|17041252|P2|First Intervention|Lost to Follow-up|1
4955910|NCT00270231|17041253|P1|First Intervention|Lost to Follow-up|1
4955911|NCT00270205|17041263|P4|Overall Study|Lost to Follow-up|1
4955912|NCT00270205|17041264|P3|Overall Study|Lost to Follow-up|0
4955913|NCT00270205|17041265|P2|Overall Study|Lost to Follow-up|0
4955914|NCT00270205|17041266|P1|Overall Study|Lost to Follow-up|1
4955915|NCT00269919|17041384|P1|Overall Study|Started but not treated|1
4955916|NCT00269919|17041384|P1|Overall Study|Other|26
4955917|NCT00269633|17041403|P2|Overall Study|Withdrawal by Subject|0
4955918|NCT00269633|17041404|P1|Overall Study|Withdrawal by Subject|1
4955919|NCT00269477|17041414|P4|Overall Study|Missed post-vaccination blood draw|0
4955920|NCT00269477|17041415|P3|Overall Study|Missed post-vaccination blood draw|0
4955921|NCT00269477|17041416|P2|Overall Study|Missed post-vaccination blood draw|1
4955922|NCT00269477|17041417|P1|Overall Study|Missed post-vaccination blood draw|0
4955923|NCT00269477|17041414|P4|Overall Study|Protocol Violation|0
4955924|NCT00269477|17041415|P3|Overall Study|Protocol Violation|1
4955925|NCT00269477|17041416|P2|Overall Study|Protocol Violation|5
4955926|NCT00269477|17041417|P1|Overall Study|Protocol Violation|5
4955927|NCT00269399|17041433|P2|Overall Study|Development of exclusion criteria|1
4955928|NCT00269399|17041434|P1|Overall Study|Development of exclusion criteria|0
4955929|NCT00269399|17041433|P2|Overall Study|Other|4
4955930|NCT00269399|17041434|P1|Overall Study|Other|0
4955931|NCT00269399|17041433|P2|Overall Study|Negative Lab Result for C. difficile|3
4955932|NCT00269399|17041434|P1|Overall Study|Negative Lab Result for C. difficile|2
4955933|NCT00269399|17041433|P2|Overall Study|Withdrawal by Subject|5
4955934|NCT00269399|17041434|P1|Overall Study|Withdrawal by Subject|2
4955935|NCT00269399|17041433|P2|Overall Study|Adverse Event|4
4955936|NCT00269399|17041434|P1|Overall Study|Adverse Event|10
4955937|NCT00269399|17041433|P2|Overall Study|Lack of Efficacy|10
4955938|NCT00269399|17041434|P1|Overall Study|Lack of Efficacy|27
4955939|NCT00269152|17041444|P2|Overall Study|Protocol Violation|1
4955940|NCT00269152|17041445|P1|Overall Study|Protocol Violation|0
4955941|NCT00269152|17041444|P2|Overall Study|Physician Decision|3
4955942|NCT00269152|17041445|P1|Overall Study|Physician Decision|2
4955943|NCT00269152|17041444|P2|Overall Study|Withdrawal by Subject|3
4955944|NCT00269152|17041445|P1|Overall Study|Withdrawal by Subject|7
4955945|NCT00269152|17041444|P2|Overall Study|Adverse Event|3
4955946|NCT00269152|17041445|P1|Overall Study|Adverse Event|9
4955947|NCT00269113|17041461|P2|Overall Study|Other|2
4955948|NCT00269113|17041462|P1|Overall Study|Other|0
4955949|NCT00269113|17041461|P2|Overall Study|Protocol Violation|5
4955950|NCT00269113|17041462|P1|Overall Study|Protocol Violation|15
4955951|NCT00269113|17041461|P2|Overall Study|Lost to Follow-up|1
4955952|NCT00269113|17041462|P1|Overall Study|Lost to Follow-up|2
4955953|NCT00269113|17041461|P2|Overall Study|Death|2
4955954|NCT00269113|17041462|P1|Overall Study|Death|6
4955955|NCT00269113|17041461|P2|Overall Study|Withdrawal by Subject|2
4955956|NCT00269113|17041462|P1|Overall Study|Withdrawal by Subject|0
4955957|NCT00269113|17041461|P2|Overall Study|Early Improvement|0
4955958|NCT00269113|17041462|P1|Overall Study|Early Improvement|2
4955959|NCT00269113|17041461|P2|Overall Study|Lack of Efficacy|18
4955960|NCT00269113|17041462|P1|Overall Study|Lack of Efficacy|35
4955961|NCT00269113|17041461|P2|Overall Study|Adverse Event|7
4955962|NCT00269113|17041462|P1|Overall Study|Adverse Event|14
4955963|NCT00269087|17041480|P1|Overall Study|Exacerbation of COPD|13
4955964|NCT00269087|17041480|P1|Overall Study|Withdrawal by Subject|1
4955965|NCT00269087|17041480|P1|Overall Study|Adverse Event|20
4955966|NCT00268996|17041510|P2|Overall Study|Other|1
4955967|NCT00268996|17041511|P1|Overall Study|Other|1
4955968|NCT00268996|17041510|P2|Overall Study|Non-compliance|0
4955969|NCT00268996|17041511|P1|Overall Study|Non-compliance|1
4955970|NCT00268996|17041510|P2|Overall Study|Withdrawal by Subject|11
4955971|NCT00268996|17041511|P1|Overall Study|Withdrawal by Subject|5
4955972|NCT00268996|17041510|P2|Overall Study|Lost to Follow-up|1
4955973|NCT00268996|17041511|P1|Overall Study|Lost to Follow-up|3
4955974|NCT00268996|17041510|P2|Overall Study|Adverse Event|7
4955975|NCT00268996|17041511|P1|Overall Study|Adverse Event|11
4955976|NCT00268983|17041555|P2|Overall Study|Death|0
4955977|NCT00268983|17041556|P1|Overall Study|Death|3
4955978|NCT00268905|17041599|P3|Overall Study|Clinical Progression|1
4955979|NCT00268905|17041600|P2|Overall Study|Clinical Progression|4
4955980|NCT00268905|17041601|P1|Overall Study|Clinical Progression|9
4955981|NCT00268905|17041599|P3|Overall Study|Physician Decision|1
4955982|NCT00268905|17041600|P2|Overall Study|Physician Decision|0
4955983|NCT00268905|17041601|P1|Overall Study|Physician Decision|3
4955984|NCT00268905|17041599|P3|Overall Study|Progressive Disease|3
4955985|NCT00268905|17041600|P2|Overall Study|Progressive Disease|4
4955986|NCT00268905|17041601|P1|Overall Study|Progressive Disease|28
4955987|NCT00268905|17041599|P3|Overall Study|Withdrawal by Subject|3
4955988|NCT00268905|17041600|P2|Overall Study|Withdrawal by Subject|0
4955989|NCT00268905|17041601|P1|Overall Study|Withdrawal by Subject|0
4955990|NCT00268905|17041599|P3|Overall Study|Lost to Follow-up|0
4955991|NCT00268905|17041600|P2|Overall Study|Lost to Follow-up|1
4955992|NCT00268905|17041601|P1|Overall Study|Lost to Follow-up|0
4955993|NCT00268905|17041599|P3|Overall Study|Adverse Event|4
4955994|NCT00268905|17041600|P2|Overall Study|Adverse Event|0
4955995|NCT00268905|17041601|P1|Overall Study|Adverse Event|3
4955996|NCT00268892|17041618|P3|Overall Study|Trial Site Closed|2
4955997|NCT00268892|17041619|P2|Overall Study|Trial Site Closed|2
4955998|NCT00268892|17041620|P1|Overall Study|Trial Site Closed|4
4955999|NCT00268892|17041618|P3|Overall Study|Disease Progression|0
4956000|NCT00268892|17041619|P2|Overall Study|Disease Progression|1
4956001|NCT00268892|17041620|P1|Overall Study|Disease Progression|1
4956002|NCT00268892|17041618|P3|Overall Study|Protocol Violation|0
4956003|NCT00268892|17041619|P2|Overall Study|Protocol Violation|1
4956004|NCT00268892|17041620|P1|Overall Study|Protocol Violation|0
4956005|NCT00268892|17041618|P3|Overall Study|Lost to Follow-up|4
4956006|NCT00268892|17041619|P2|Overall Study|Lost to Follow-up|2
4956007|NCT00268892|17041620|P1|Overall Study|Lost to Follow-up|5
4956008|NCT00268892|17041618|P3|Overall Study|Physician Decision|0
4956009|NCT00268892|17041619|P2|Overall Study|Physician Decision|1
4956010|NCT00268892|17041620|P1|Overall Study|Physician Decision|0
4956011|NCT00268892|17041618|P3|Overall Study|Withdrawal by Subject|13
4956012|NCT00268892|17041619|P2|Overall Study|Withdrawal by Subject|15
4956013|NCT00268892|17041620|P1|Overall Study|Withdrawal by Subject|14
4956014|NCT00268892|17041618|P3|Overall Study|Lack of Efficacy|0
4956015|NCT00268892|17041619|P2|Overall Study|Lack of Efficacy|3
4956016|NCT00268892|17041620|P1|Overall Study|Lack of Efficacy|1
4956017|NCT00268892|17041618|P3|Overall Study|Adverse Event|20
4956018|NCT00268892|17041619|P2|Overall Study|Adverse Event|17
4956019|NCT00268892|17041620|P1|Overall Study|Adverse Event|14
4956020|NCT00268463|17041639|P2|Overall Study|study terminated due to low accrual|12
4956021|NCT00268463|17041640|P1|Overall Study|study terminated due to low accrual|10
4956022|NCT00268437|17041656|P1|Overall Study|Ineligible|1
4956023|NCT00268346|17041663|P2|Overall Study|Withdrawal by Subject|1
4956024|NCT00268346|17041664|P1|Overall Study|Withdrawal by Subject|0
4956025|NCT00268346|17041663|P2|Overall Study|Death|1
4956026|NCT00268346|17041664|P1|Overall Study|Death|0
4956027|NCT00268346|17041663|P2|Overall Study|Adverse Event|1
4956028|NCT00268346|17041664|P1|Overall Study|Adverse Event|0
4956029|NCT00268242|17041670|P1|Overall Study|Death|1
4956030|NCT00268203|17041679|P1|Overall Study|Completed 2 Years of Follow-up|62
4956031|NCT00268203|17041679|P1|Overall Study|Reason Not Specified|34
4956032|NCT00268203|17041679|P1|Overall Study|Death|84
4956033|NCT00268203|17041679|P1|Overall Study|Progressive Disease|359
4956034|NCT00268203|17041679|P1|Overall Study|Received Other NHL Therapy|7
4956035|NCT00268203|17041679|P1|Overall Study|Withdrawal by Subject|9
4956036|NCT00268203|17041679|P1|Overall Study|Lost to Follow-up|92
4956037|NCT00267969|17041693|P7|After Controlled Period|Other|25
4956038|NCT00267969|17041694|P6|After Controlled Period|Other|22
4956039|NCT00267969|17041695|P5|After Controlled Period|Other|11
4956040|NCT00267969|17041696|P4|After Controlled Period|Other|13
4956041|NCT00267969|17041697|P3|After Controlled Period|Other|0
4956042|NCT00267969|17041698|P2|After Controlled Period|Other|0
4956043|NCT00267969|17041699|P1|After Controlled Period|Other|0
4956044|NCT00267969|17041693|P7|After Controlled Period|Lost to Follow-up|10
4956045|NCT00267969|17041694|P6|After Controlled Period|Lost to Follow-up|9
4956046|NCT00267969|17041695|P5|After Controlled Period|Lost to Follow-up|8
4956047|NCT00267969|17041696|P4|After Controlled Period|Lost to Follow-up|5
4956048|NCT00267969|17041697|P3|After Controlled Period|Lost to Follow-up|0
4956049|NCT00267969|17041698|P2|After Controlled Period|Lost to Follow-up|0
4956050|NCT00267969|17041699|P1|After Controlled Period|Lost to Follow-up|0
4956051|NCT00267969|17041693|P7|After Controlled Period|Lack of Efficacy|15
4956052|NCT00267969|17041694|P6|After Controlled Period|Lack of Efficacy|28
4956053|NCT00267969|17041695|P5|After Controlled Period|Lack of Efficacy|6
4956054|NCT00267969|17041696|P4|After Controlled Period|Lack of Efficacy|10
4956055|NCT00267969|17041697|P3|After Controlled Period|Lack of Efficacy|0
4956056|NCT00267969|17041698|P2|After Controlled Period|Lack of Efficacy|0
4956057|NCT00267969|17041699|P1|After Controlled Period|Lack of Efficacy|0
4956058|NCT00267969|17041693|P7|After Controlled Period|Death|1
4956059|NCT00267969|17041694|P6|After Controlled Period|Death|0
4956060|NCT00267969|17041695|P5|After Controlled Period|Death|2
4956061|NCT00267969|17041696|P4|After Controlled Period|Death|1
4956062|NCT00267969|17041697|P3|After Controlled Period|Death|0
4956063|NCT00267969|17041698|P2|After Controlled Period|Death|0
4956064|NCT00267969|17041699|P1|After Controlled Period|Death|0
4956065|NCT00267969|17041693|P7|After Controlled Period|Adverse Event|21
4956066|NCT00267969|17041694|P6|After Controlled Period|Adverse Event|23
4956067|NCT00267969|17041695|P5|After Controlled Period|Adverse Event|8
4956068|NCT00267969|17041696|P4|After Controlled Period|Adverse Event|7
4956069|NCT00267969|17041697|P3|After Controlled Period|Adverse Event|0
4956070|NCT00267969|17041698|P2|After Controlled Period|Adverse Event|0
4956071|NCT00267969|17041699|P1|After Controlled Period|Adverse Event|0
4956072|NCT00267969|17041693|P7|Controlled Period|Other|0
4956073|NCT00267969|17041694|P6|Controlled Period|Other|0
4956074|NCT00267969|17041695|P5|Controlled Period|Other|0
4956075|NCT00267969|17041696|P4|Controlled Period|Other|0
4956076|NCT00267969|17041697|P3|Controlled Period|Other|6
4956077|NCT00267969|17041698|P2|Controlled Period|Other|1
4956078|NCT00267969|17041699|P1|Controlled Period|Other|2
4956079|NCT00267969|17041693|P7|Controlled Period|Randomized but not treated|0
4956080|NCT00267969|17041694|P6|Controlled Period|Randomized but not treated|0
4956081|NCT00267969|17041695|P5|Controlled Period|Randomized but not treated|0
4956082|NCT00267969|17041696|P4|Controlled Period|Randomized but not treated|0
4956083|NCT00267969|17041697|P3|Controlled Period|Randomized but not treated|1
4956084|NCT00267969|17041698|P2|Controlled Period|Randomized but not treated|0
4956085|NCT00267969|17041699|P1|Controlled Period|Randomized but not treated|0
4956086|NCT00267969|17041693|P7|Controlled Period|Lost to Follow-up|0
4956087|NCT00267969|17041694|P6|Controlled Period|Lost to Follow-up|0
4956088|NCT00267969|17041695|P5|Controlled Period|Lost to Follow-up|0
4956089|NCT00267969|17041696|P4|Controlled Period|Lost to Follow-up|0
4956090|NCT00267969|17041697|P3|Controlled Period|Lost to Follow-up|1
4956091|NCT00267969|17041698|P2|Controlled Period|Lost to Follow-up|0
4956092|NCT00267969|17041699|P1|Controlled Period|Lost to Follow-up|1
4956093|NCT00267969|17041693|P7|Controlled Period|Lack of Efficacy|0
4956094|NCT00267969|17041694|P6|Controlled Period|Lack of Efficacy|0
4956095|NCT00267969|17041695|P5|Controlled Period|Lack of Efficacy|0
4956096|NCT00267969|17041696|P4|Controlled Period|Lack of Efficacy|0
4956097|NCT00267969|17041697|P3|Controlled Period|Lack of Efficacy|1
4956098|NCT00267969|17041698|P2|Controlled Period|Lack of Efficacy|0
4956099|NCT00267969|17041699|P1|Controlled Period|Lack of Efficacy|3
4956100|NCT00267969|17041693|P7|Controlled Period|Adverse Event|0
4956101|NCT00267969|17041694|P6|Controlled Period|Adverse Event|0
4956102|NCT00267969|17041695|P5|Controlled Period|Adverse Event|0
4956103|NCT00267969|17041696|P4|Controlled Period|Adverse Event|0
4956104|NCT00267969|17041697|P3|Controlled Period|Adverse Event|2
4956105|NCT00267969|17041698|P2|Controlled Period|Adverse Event|0
4956106|NCT00267969|17041699|P1|Controlled Period|Adverse Event|6
4956107|NCT00267956|17041725|P4|After Controlled Period|Withdrew consent|0
4956108|NCT00267956|17041726|P3|After Controlled Period|Withdrew consent|1
4956109|NCT00267956|17041727|P2|After Controlled Period|Withdrew consent|0
4956110|NCT00267956|17041728|P1|After Controlled Period|Withdrew consent|0
4956111|NCT00267956|17041725|P4|After Controlled Period|Lost to Follow-up|0
4956112|NCT00267956|17041726|P3|After Controlled Period|Lost to Follow-up|1
4956113|NCT00267956|17041727|P2|After Controlled Period|Lost to Follow-up|0
4956114|NCT00267956|17041728|P1|After Controlled Period|Lost to Follow-up|0
4956115|NCT00267956|17041725|P4|After Controlled Period|Lack of Efficacy|1
4956116|NCT00267956|17041726|P3|After Controlled Period|Lack of Efficacy|1
4956117|NCT00267956|17041727|P2|After Controlled Period|Lack of Efficacy|0
4956118|NCT00267956|17041728|P1|After Controlled Period|Lack of Efficacy|0
4956119|NCT00267956|17041725|P4|After Controlled Period|Adverse Event|1
4956120|NCT00267956|17041726|P3|After Controlled Period|Adverse Event|2
4956121|NCT00267956|17041727|P2|After Controlled Period|Adverse Event|0
4956122|NCT00267956|17041728|P1|After Controlled Period|Adverse Event|0
4956123|NCT00267956|17041725|P4|Controlled Period|Withdrew consent|0
4956124|NCT00267956|17041726|P3|Controlled Period|Withdrew consent|0
4956125|NCT00267956|17041727|P2|Controlled Period|Withdrew consent|1
4956126|NCT00267956|17041728|P1|Controlled Period|Withdrew consent|3
4956127|NCT00267956|17041725|P4|Controlled Period|Lost to Follow-up|0
4956128|NCT00267956|17041726|P3|Controlled Period|Lost to Follow-up|0
4956129|NCT00267956|17041727|P2|Controlled Period|Lost to Follow-up|0
4956130|NCT00267956|17041728|P1|Controlled Period|Lost to Follow-up|2
4956131|NCT00267956|17041725|P4|Controlled Period|Lack of Efficacy|0
4956132|NCT00267956|17041726|P3|Controlled Period|Lack of Efficacy|0
4956133|NCT00267956|17041727|P2|Controlled Period|Lack of Efficacy|2
4956134|NCT00267956|17041728|P1|Controlled Period|Lack of Efficacy|4
4956135|NCT00267956|17041725|P4|Controlled Period|Adverse Event|0
4956136|NCT00267956|17041726|P3|Controlled Period|Adverse Event|0
4956137|NCT00267956|17041727|P2|Controlled Period|Adverse Event|1
4956138|NCT00267956|17041728|P1|Controlled Period|Adverse Event|4
4956139|NCT00267865|17041746|P1|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1
4956140|NCT00267865|17041746|P1|Induction Treatment|Died before completing.|2
4956141|NCT00267748|17041769|P3|Randomized Period|randomized but not treated|3
4956142|NCT00267748|17041770|P2|Randomized Period|randomized but not treated|0
4956143|NCT00267748|17041771|P1|Randomized Period|randomized but not treated|0
4956144|NCT00267748|17041769|P3|Randomized Period|Other|6
4956145|NCT00267748|17041770|P2|Randomized Period|Other|9
4956146|NCT00267748|17041771|P1|Randomized Period|Other|0
4956147|NCT00267748|17041769|P3|Randomized Period|Withdrawal by Subject|2
4956148|NCT00267748|17041770|P2|Randomized Period|Withdrawal by Subject|9
4956149|NCT00267748|17041771|P1|Randomized Period|Withdrawal by Subject|0
4956150|NCT00267748|17041769|P3|Randomized Period|Objective progression or relapse|86
4956151|NCT00267748|17041770|P2|Randomized Period|Objective progression or relapse|77
4956152|NCT00267748|17041771|P1|Randomized Period|Objective progression or relapse|0
4956153|NCT00267748|17041769|P3|Randomized Period|Lost to Follow-up|0
4956154|NCT00267748|17041770|P2|Randomized Period|Lost to Follow-up|1
4956155|NCT00267748|17041771|P1|Randomized Period|Lost to Follow-up|0
4956156|NCT00267748|17041769|P3|Randomized Period|Global deterioration of health status|7
4956157|NCT00267748|17041770|P2|Randomized Period|Global deterioration of health status|6
4956158|NCT00267748|17041771|P1|Randomized Period|Global deterioration of health status|0
4956159|NCT00267748|17041769|P3|Randomized Period|Adverse Event|25
4956160|NCT00267748|17041770|P2|Randomized Period|Adverse Event|23
4956161|NCT00267748|17041771|P1|Randomized Period|Adverse Event|0
4956162|NCT00267748|17041769|P3|Randomized Period|Death|3
4956163|NCT00267748|17041770|P2|Randomized Period|Death|2
4956164|NCT00267748|17041771|P1|Randomized Period|Death|0
4956165|NCT00267748|17041769|P3|Non-randomized Period|Other|0
4956166|NCT00267748|17041770|P2|Non-randomized Period|Other|0
4956167|NCT00267748|17041771|P1|Non-randomized Period|Other|3
4956168|NCT00267748|17041769|P3|Non-randomized Period|Participant not willing to participate|0
4956169|NCT00267748|17041770|P2|Non-randomized Period|Participant not willing to participate|0
4956170|NCT00267748|17041771|P1|Non-randomized Period|Participant not willing to participate|1
4956171|NCT00267748|17041769|P3|Non-randomized Period|Death|0
4956172|NCT00267748|17041770|P2|Non-randomized Period|Death|0
4956173|NCT00267748|17041771|P1|Non-randomized Period|Death|1
4956174|NCT00267748|17041769|P3|Non-randomized Period|Adverse Event|0
4956175|NCT00267748|17041770|P2|Non-randomized Period|Adverse Event|0
4956176|NCT00267748|17041771|P1|Non-randomized Period|Adverse Event|8
4956177|NCT00267748|17041769|P3|Non-randomized Period|Progressive disease|0
4956178|NCT00267748|17041770|P2|Non-randomized Period|Progressive disease|0
4956179|NCT00267748|17041771|P1|Non-randomized Period|Progressive disease|10
4956180|NCT00267488|17041828|P1|Overall Study|Other (Disease Progression)|1
4956181|NCT00267488|17041828|P1|Overall Study|Protocol Violation|1
4956182|NCT00267488|17041828|P1|Overall Study|Sponsor Terminated Study|9
4956183|NCT00267202|17041852|P2|Overall Study|Lost to Follow-up|0
4956184|NCT00267202|17041853|P1|Overall Study|Lost to Follow-up|3
4956185|NCT00267202|17041852|P2|Overall Study|Administrative problems|1
4956186|NCT00267202|17041853|P1|Overall Study|Administrative problems|2
4956187|NCT00267202|17041852|P2|Overall Study|Protocol Violation|3
4956188|NCT00267202|17041853|P1|Overall Study|Protocol Violation|2
4956189|NCT00267202|17041852|P2|Overall Study|Adverse Event|7
4956190|NCT00267202|17041853|P1|Overall Study|Adverse Event|13
4956191|NCT00267202|17041852|P2|Overall Study|Withdrawal by Subject|15
4956192|NCT00267202|17041853|P1|Overall Study|Withdrawal by Subject|12
4956193|NCT00267202|17041852|P2|Overall Study|Unsatisfactory therapeutic effect|8
4956194|NCT00267202|17041853|P1|Overall Study|Unsatisfactory therapeutic effect|21
4956195|NCT00267189|17041874|P2|Overall Study|Missing|0
4956196|NCT00267189|17041875|P1|Overall Study|Missing|3
4956197|NCT00267189|17041874|P2|Overall Study|Death|0
4956198|NCT00267189|17041875|P1|Overall Study|Death|1
4956199|NCT00267189|17041874|P2|Overall Study|Patient withdrew consent|1
4956200|NCT00267189|17041875|P1|Overall Study|Patient withdrew consent|1
4956201|NCT00267150|17041885|P1|Overall Study|Adverse Event|1
4956202|NCT00267098|17041909|P8|Overall Study|Sponsor withdrew subject|0
4956203|NCT00267098|17041910|P7|Overall Study|Sponsor withdrew subject|0
4956204|NCT00267098|17041911|P6|Overall Study|Sponsor withdrew subject|0
4956205|NCT00267098|17041912|P5|Overall Study|Sponsor withdrew subject|0
4956206|NCT00267098|17041913|P4|Overall Study|Sponsor withdrew subject|1
4956207|NCT00267098|17041914|P3|Overall Study|Sponsor withdrew subject|0
4956208|NCT00267098|17041915|P2|Overall Study|Sponsor withdrew subject|0
4956209|NCT00267098|17041916|P1|Overall Study|Sponsor withdrew subject|0
4956210|NCT00267098|17041909|P8|Overall Study|Subject listed for heart transplant|0
4956211|NCT00267098|17041910|P7|Overall Study|Subject listed for heart transplant|1
4956212|NCT00267098|17041911|P6|Overall Study|Subject listed for heart transplant|0
4956213|NCT00267098|17041912|P5|Overall Study|Subject listed for heart transplant|0
4956214|NCT00267098|17041913|P4|Overall Study|Subject listed for heart transplant|0
4956215|NCT00267098|17041914|P3|Overall Study|Subject listed for heart transplant|0
4956216|NCT00267098|17041915|P2|Overall Study|Subject listed for heart transplant|0
4956217|NCT00267098|17041916|P1|Overall Study|Subject listed for heart transplant|0
4956218|NCT00267098|17041909|P8|Overall Study|Non-Medtronic LV Lead Implanted|0
4956219|NCT00267098|17041910|P7|Overall Study|Non-Medtronic LV Lead Implanted|0
4956220|NCT00267098|17041911|P6|Overall Study|Non-Medtronic LV Lead Implanted|0
4956221|NCT00267098|17041912|P5|Overall Study|Non-Medtronic LV Lead Implanted|2
4956222|NCT00267098|17041913|P4|Overall Study|Non-Medtronic LV Lead Implanted|0
4956223|NCT00267098|17041914|P3|Overall Study|Non-Medtronic LV Lead Implanted|0
4956224|NCT00267098|17041915|P2|Overall Study|Non-Medtronic LV Lead Implanted|0
4956225|NCT00267098|17041916|P1|Overall Study|Non-Medtronic LV Lead Implanted|0
4956226|NCT00267098|17041909|P8|Overall Study|Explanted Medtronic device|0
4956227|NCT00267098|17041910|P7|Overall Study|Explanted Medtronic device|0
4956228|NCT00267098|17041911|P6|Overall Study|Explanted Medtronic device|0
4956229|NCT00267098|17041912|P5|Overall Study|Explanted Medtronic device|0
4956230|NCT00267098|17041913|P4|Overall Study|Explanted Medtronic device|1
4956231|NCT00267098|17041914|P3|Overall Study|Explanted Medtronic device|0
4956232|NCT00267098|17041915|P2|Overall Study|Explanted Medtronic device|0
4956233|NCT00267098|17041916|P1|Overall Study|Explanted Medtronic device|0
4956234|NCT00267098|17041909|P8|Overall Study|Site closure|0
4956235|NCT00267098|17041910|P7|Overall Study|Site closure|1
4956236|NCT00267098|17041911|P6|Overall Study|Site closure|1
4956237|NCT00267098|17041912|P5|Overall Study|Site closure|0
4956238|NCT00267098|17041913|P4|Overall Study|Site closure|1
4956239|NCT00267098|17041914|P3|Overall Study|Site closure|0
4956240|NCT00267098|17041915|P2|Overall Study|Site closure|0
4956241|NCT00267098|17041916|P1|Overall Study|Site closure|0
4956242|NCT00267098|17041909|P8|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956243|NCT00267098|17041910|P7|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956244|NCT00267098|17041911|P6|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956245|NCT00267098|17041912|P5|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956246|NCT00267098|17041913|P4|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956247|NCT00267098|17041914|P3|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956248|NCT00267098|17041915|P2|Overall Study|Unsuccessful Implant Exit Per Protocol|51
4956249|NCT00267098|17041916|P1|Overall Study|Unsuccessful Implant Exit Per Protocol|0
4956250|NCT00267098|17041909|P8|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4956251|NCT00267098|17041910|P7|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4956252|NCT00267098|17041911|P6|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4956253|NCT00267098|17041912|P5|Overall Study|Inclusion/Exclusion Criteria Not Met|2
4956254|NCT00267098|17041913|P4|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4956255|NCT00267098|17041914|P3|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4956256|NCT00267098|17041915|P2|Overall Study|Inclusion/Exclusion Criteria Not Met|0
4956257|NCT00267098|17041916|P1|Overall Study|Inclusion/Exclusion Criteria Not Met|96
4956258|NCT00267098|17041909|P8|Overall Study|Physician Decision|0
4956259|NCT00267098|17041910|P7|Overall Study|Physician Decision|3
4956260|NCT00267098|17041911|P6|Overall Study|Physician Decision|4
4956261|NCT00267098|17041912|P5|Overall Study|Physician Decision|5
4956262|NCT00267098|17041913|P4|Overall Study|Physician Decision|11
4956263|NCT00267098|17041914|P3|Overall Study|Physician Decision|7
4956264|NCT00267098|17041915|P2|Overall Study|Physician Decision|0
4956265|NCT00267098|17041916|P1|Overall Study|Physician Decision|5
4956266|NCT00267098|17041909|P8|Overall Study|Withdrawal by Subject|5
4956267|NCT00267098|17041910|P7|Overall Study|Withdrawal by Subject|12
4956268|NCT00267098|17041911|P6|Overall Study|Withdrawal by Subject|9
4956269|NCT00267098|17041912|P5|Overall Study|Withdrawal by Subject|12
4956270|NCT00267098|17041913|P4|Overall Study|Withdrawal by Subject|21
4956271|NCT00267098|17041914|P3|Overall Study|Withdrawal by Subject|24
4956272|NCT00267098|17041915|P2|Overall Study|Withdrawal by Subject|0
4956273|NCT00267098|17041916|P1|Overall Study|Withdrawal by Subject|8
4956274|NCT00267098|17041909|P8|Overall Study|Lost to Follow-up|1
4956275|NCT00267098|17041910|P7|Overall Study|Lost to Follow-up|1
4956276|NCT00267098|17041911|P6|Overall Study|Lost to Follow-up|3
4956277|NCT00267098|17041912|P5|Overall Study|Lost to Follow-up|2
4956278|NCT00267098|17041913|P4|Overall Study|Lost to Follow-up|5
4956279|NCT00267098|17041914|P3|Overall Study|Lost to Follow-up|6
4956280|NCT00267098|17041915|P2|Overall Study|Lost to Follow-up|0
4956281|NCT00267098|17041916|P1|Overall Study|Lost to Follow-up|0
4956282|NCT00267098|17041909|P8|Overall Study|Death|9
4956283|NCT00267098|17041910|P7|Overall Study|Death|28
4956284|NCT00267098|17041911|P6|Overall Study|Death|23
4956285|NCT00267098|17041912|P5|Overall Study|Death|14
4956286|NCT00267098|17041913|P4|Overall Study|Death|66
4956287|NCT00267098|17041914|P3|Overall Study|Death|57
4956288|NCT00267098|17041915|P2|Overall Study|Death|0
4956289|NCT00267098|17041916|P1|Overall Study|Death|0
4956290|NCT00267046|17042059|P2|Overall Study|Radiation|1
4956291|NCT00267046|17042060|P1|Overall Study|Radiation|0
4956292|NCT00267046|17042059|P2|Overall Study|Withdrawal by Subject|0
4956293|NCT00267046|17042060|P1|Overall Study|Withdrawal by Subject|1
4956294|NCT00267046|17042059|P2|Overall Study|Surgery|1
4956295|NCT00267046|17042060|P1|Overall Study|Surgery|3
4956296|NCT00267046|17042059|P2|Overall Study|Open-label palifermin|7
4956297|NCT00267046|17042060|P1|Overall Study|Open-label palifermin|2
4956298|NCT00267046|17042059|P2|Overall Study|Chemotoxicity|0
4956299|NCT00267046|17042060|P1|Overall Study|Chemotoxicity|2
4956300|NCT00267046|17042059|P2|Overall Study|Disease progression|2
4956301|NCT00267046|17042060|P1|Overall Study|Disease progression|4
4956302|NCT00267020|17042070|P2|Overall Study|Other|2
4956303|NCT00267020|17042071|P1|Overall Study|Other|1
4956304|NCT00267020|17042070|P2|Overall Study|Sponsor Request|0
4956305|NCT00267020|17042071|P1|Overall Study|Sponsor Request|1
4956306|NCT00267020|17042070|P2|Overall Study|Unrelated Complication|1
4956307|NCT00267020|17042071|P1|Overall Study|Unrelated Complication|1
4956308|NCT00267020|17042070|P2|Overall Study|Disease Progression|25
4956309|NCT00267020|17042071|P1|Overall Study|Disease Progression|39
4956310|NCT00267020|17042070|P2|Overall Study|Physician Decision|2
4956311|NCT00267020|17042071|P1|Overall Study|Physician Decision|3
4956312|NCT00267020|17042070|P2|Overall Study|Withdrawal by Subject|7
4956313|NCT00267020|17042071|P1|Overall Study|Withdrawal by Subject|17
4956314|NCT00267020|17042070|P2|Overall Study|Death|1
4956315|NCT00267020|17042071|P1|Overall Study|Death|2
4956316|NCT00267020|17042070|P2|Overall Study|Adverse Event|5
4956317|NCT00267020|17042071|P1|Overall Study|Adverse Event|22
4956318|NCT00267007|17042093|P2|Overall Study|Adverse Event|0
4956319|NCT00267007|17042094|P1|Overall Study|Adverse Event|1
4956320|NCT00267007|17042093|P2|Overall Study|Non-compliance|1
4956321|NCT00267007|17042094|P1|Overall Study|Non-compliance|0
4956322|NCT00267007|17042093|P2|Overall Study|Lost to Follow-up|0
4956323|NCT00267007|17042094|P1|Overall Study|Lost to Follow-up|1
4956324|NCT00267007|17042093|P2|Overall Study|Withdrawal by Subject|0
4956325|NCT00267007|17042094|P1|Overall Study|Withdrawal by Subject|6
4956326|NCT00266877|17042105|P3|Overall Study|Concomitant Radiotherapy|0
4956327|NCT00266877|17042106|P2|Overall Study|Concomitant Radiotherapy|1
4956328|NCT00266877|17042107|P1|Overall Study|Concomitant Radiotherapy|0
4956329|NCT00266877|17042105|P3|Overall Study|Hospitalization|0
4956330|NCT00266877|17042106|P2|Overall Study|Hospitalization|0
4956331|NCT00266877|17042107|P1|Overall Study|Hospitalization|1
4956332|NCT00266877|17042105|P3|Overall Study|Symptomatic Deterioration|1
4956333|NCT00266877|17042106|P2|Overall Study|Symptomatic Deterioration|3
4956334|NCT00266877|17042107|P1|Overall Study|Symptomatic Deterioration|6
4956335|NCT00266877|17042105|P3|Overall Study|Disease Progression|23
4956336|NCT00266877|17042106|P2|Overall Study|Disease Progression|37
4956337|NCT00266877|17042107|P1|Overall Study|Disease Progression|72
4956338|NCT00266877|17042105|P3|Overall Study|Withdrawal by Subject|1
4956339|NCT00266877|17042106|P2|Overall Study|Withdrawal by Subject|1
4956340|NCT00266877|17042107|P1|Overall Study|Withdrawal by Subject|3
4956341|NCT00266877|17042105|P3|Overall Study|Physician Decision|1
4956342|NCT00266877|17042106|P2|Overall Study|Physician Decision|1
4956343|NCT00266877|17042107|P1|Overall Study|Physician Decision|2
4956344|NCT00266877|17042105|P3|Overall Study|Adverse Event|1
4956345|NCT00266877|17042106|P2|Overall Study|Adverse Event|4
4956346|NCT00266877|17042107|P1|Overall Study|Adverse Event|6
4956347|NCT00266877|17042105|P3|Overall Study|Death|1
4956348|NCT00266877|17042106|P2|Overall Study|Death|1
4956349|NCT00266877|17042107|P1|Overall Study|Death|1
4956350|NCT00266864|17042126|P2|Overall Study|Withdrawal by Subject|1
4956351|NCT00266864|17042127|P1|Overall Study|Withdrawal by Subject|1
4956352|NCT00266864|17042126|P2|Overall Study|Lost to Follow-up|1
4956353|NCT00266864|17042127|P1|Overall Study|Lost to Follow-up|4
4956354|NCT00266825|17042158|P2|Completed Follow-Up|Withdrawal by Subject|5
4956355|NCT00266825|17042159|P1|Completed Follow-Up|Withdrawal by Subject|11
4956356|NCT00266825|17042158|P2|Completed Follow-Up|Lost to Follow-up|19
4956357|NCT00266825|17042159|P1|Completed Follow-Up|Lost to Follow-up|14
4956358|NCT00266812|17042185|P2|Overall Study|Discontinued before starting study drug|0
4956359|NCT00266812|17042186|P1|Overall Study|Discontinued before starting study drug|4
4956360|NCT00266812|17042185|P2|Overall Study|Withdrawal by Subject|2
4956361|NCT00266812|17042186|P1|Overall Study|Withdrawal by Subject|0
4956362|NCT00266812|17042185|P2|Overall Study|Protocol Violation|1
4956363|NCT00266812|17042186|P1|Overall Study|Protocol Violation|0
4956364|NCT00266812|17042185|P2|Overall Study|Adverse Event|1
4956365|NCT00266812|17042186|P1|Overall Study|Adverse Event|3
4956366|NCT00266812|17042185|P2|Overall Study|Death|4
4956367|NCT00266812|17042186|P1|Overall Study|Death|5
4956368|NCT00266812|17042185|P2|Overall Study|Disease Progression|3
4956369|NCT00266812|17042186|P1|Overall Study|Disease Progression|9
4956370|NCT00266708|17042211|P2|Overall Study|Asthma|2
4956371|NCT00266708|17042212|P1|Overall Study|Asthma|0
4956372|NCT00266708|17042211|P2|Overall Study|Refused biopsy|6
4956373|NCT00266708|17042212|P1|Overall Study|Refused biopsy|3
4956374|NCT00266708|17042211|P2|Overall Study|No renal function|1
4956375|NCT00266708|17042212|P1|Overall Study|No renal function|1
4956376|NCT00266695|17042252|P1|Overall Study|Withdrawal by Subject|15
4956377|NCT00266695|17042252|P1|Overall Study|Lost to Follow-up|3
4956378|NCT00266695|17042252|P1|Overall Study|Physician Decision|1
4956379|NCT00266695|17042252|P1|Overall Study|Death|9
4956380|NCT00266695|17042252|P1|Overall Study|Adverse Event|1
4956381|NCT00266656|17042264|P2|Overall Study|Parent/Caregiver Decision|2
4956382|NCT00266656|17042265|P1|Overall Study|Parent/Caregiver Decision|1
4956383|NCT00266656|17042264|P2|Overall Study|Did Not Reach Final Height|8
4956384|NCT00266656|17042265|P1|Overall Study|Did Not Reach Final Height|4
4956385|NCT00266656|17042264|P2|Overall Study|Withdrawal by Subject|2
4956386|NCT00266656|17042265|P1|Overall Study|Withdrawal by Subject|4
4956387|NCT00266656|17042264|P2|Overall Study|Lost to Follow-up|1
4956388|NCT00266656|17042265|P1|Overall Study|Lost to Follow-up|4
4956389|NCT00266656|17042264|P2|Overall Study|Death|0
4956390|NCT00266656|17042265|P1|Overall Study|Death|1
4956391|NCT00266630|17042289|P2|Overall Study|Other|11
4956392|NCT00266630|17042290|P1|Overall Study|Other|19
4956393|NCT00266630|17042289|P2|Overall Study|Lost to Follow-up|0
4956394|NCT00266630|17042290|P1|Overall Study|Lost to Follow-up|1
4956395|NCT00266630|17042289|P2|Overall Study|Withdrawal by Subject|2
4956396|NCT00266630|17042290|P1|Overall Study|Withdrawal by Subject|10
4956397|NCT00266630|17042289|P2|Overall Study|Physician Decision|2
4956398|NCT00266630|17042290|P1|Overall Study|Physician Decision|1
4956399|NCT00266630|17042289|P2|Overall Study|Protocol Violation|3
4956400|NCT00266630|17042290|P1|Overall Study|Protocol Violation|1
4956401|NCT00266630|17042289|P2|Overall Study|Entry Criteria not met|0
4956402|NCT00266630|17042290|P1|Overall Study|Entry Criteria not met|1
4956403|NCT00266630|17042289|P2|Overall Study|Lack of Efficacy|4
4956404|NCT00266630|17042290|P1|Overall Study|Lack of Efficacy|1
4956405|NCT00266630|17042289|P2|Overall Study|Adverse Event|6
4956406|NCT00266630|17042290|P1|Overall Study|Adverse Event|8
4956407|NCT00266409|17042332|P4|Overall Study|Other|0
4956408|NCT00266409|17042333|P3|Overall Study|Other|2
4956409|NCT00266409|17042334|P2|Overall Study|Other|4
4956410|NCT00266409|17042335|P1|Overall Study|Other|7
4956411|NCT00266409|17042332|P4|Overall Study|Protocol Violation|2
4956412|NCT00266409|17042333|P3|Overall Study|Protocol Violation|4
4956413|NCT00266409|17042334|P2|Overall Study|Protocol Violation|3
4956414|NCT00266409|17042335|P1|Overall Study|Protocol Violation|5
4956415|NCT00266409|17042332|P4|Overall Study|Withdrawal by Subject|9
4956416|NCT00266409|17042333|P3|Overall Study|Withdrawal by Subject|3
4956417|NCT00266409|17042334|P2|Overall Study|Withdrawal by Subject|10
4956418|NCT00266409|17042335|P1|Overall Study|Withdrawal by Subject|6
4956419|NCT00266409|17042332|P4|Overall Study|Lost to Follow-up|8
4956420|NCT00266409|17042333|P3|Overall Study|Lost to Follow-up|6
4956421|NCT00266409|17042334|P2|Overall Study|Lost to Follow-up|21
4956422|NCT00266409|17042335|P1|Overall Study|Lost to Follow-up|18
4956423|NCT00266409|17042332|P4|Overall Study|Adverse Event|1
4956424|NCT00266409|17042333|P3|Overall Study|Adverse Event|1
4956425|NCT00266409|17042334|P2|Overall Study|Adverse Event|2
4956426|NCT00266409|17042335|P1|Overall Study|Adverse Event|7
4956427|NCT00266409|17042332|P4|Overall Study|Lack of Efficacy|2
4956428|NCT00266409|17042333|P3|Overall Study|Lack of Efficacy|1
4956429|NCT00266409|17042334|P2|Overall Study|Lack of Efficacy|6
4956430|NCT00266409|17042335|P1|Overall Study|Lack of Efficacy|2
4956431|NCT00266227|17042624|P3|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0
4956432|NCT00266227|17042625|P2|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10
4956433|NCT00266227|17042626|P1|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15
4956434|NCT00266227|17042624|P3|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0
4956435|NCT00266227|17042625|P2|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29
4956436|NCT00266227|17042626|P1|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41
4956437|NCT00266227|17042624|P3|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
4956438|NCT00266227|17042625|P2|Retreatment: Week 48 to Week 72|Lost to Follow-up|0
4956439|NCT00266227|17042626|P1|Retreatment: Week 48 to Week 72|Lost to Follow-up|1
4956440|NCT00266227|17042624|P3|Retreatment: Week 48 to Week 72|Adverse Event|0
4956441|NCT00266227|17042625|P2|Retreatment: Week 48 to Week 72|Adverse Event|2
4956442|NCT00266227|17042626|P1|Retreatment: Week 48 to Week 72|Adverse Event|6
4956443|NCT00266227|17042624|P3|Retreatment: Week 48 to Week 72|Death|0
4956444|NCT00266227|17042625|P2|Retreatment: Week 48 to Week 72|Death|1
4956445|NCT00266227|17042626|P1|Retreatment: Week 48 to Week 72|Death|1
4956446|NCT00266227|17042624|P3|Retreatment: Up to Week 48|Pregnancy|0
4956447|NCT00266227|17042625|P2|Retreatment: Up to Week 48|Pregnancy|0
4956448|NCT00266227|17042626|P1|Retreatment: Up to Week 48|Pregnancy|1
4956449|NCT00266227|17042624|P3|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0
4956450|NCT00266227|17042625|P2|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2
4956451|NCT00266227|17042626|P1|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4
4956452|NCT00266227|17042624|P3|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0
4956453|NCT00266227|17042625|P2|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14
4956454|NCT00266227|17042626|P1|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11
4956455|NCT00266227|17042624|P3|Retreatment: Up to Week 48|Lost to Follow-up|0
4956456|NCT00266227|17042625|P2|Retreatment: Up to Week 48|Lost to Follow-up|0
4956457|NCT00266227|17042626|P1|Retreatment: Up to Week 48|Lost to Follow-up|3
4956458|NCT00266227|17042624|P3|Retreatment: Up to Week 48|Adverse Event|0
4956459|NCT00266227|17042625|P2|Retreatment: Up to Week 48|Adverse Event|7
4956460|NCT00266227|17042626|P1|Retreatment: Up to Week 48|Adverse Event|7
4956461|NCT00266227|17042624|P3|Retreatment: Up to Week 48|Death|0
4956462|NCT00266227|17042625|P2|Retreatment: Up to Week 48|Death|0
4956463|NCT00266227|17042626|P1|Retreatment: Up to Week 48|Death|1
4956464|NCT00266227|17042624|P3|Initial Treatment|Pregnancy|1
4956465|NCT00266227|17042625|P2|Initial Treatment|Pregnancy|0
4956466|NCT00266227|17042626|P1|Initial Treatment|Pregnancy|0
4956467|NCT00266227|17042624|P3|Initial Treatment|Physician decision to withdraw|12
4956468|NCT00266227|17042625|P2|Initial Treatment|Physician decision to withdraw|0
4956469|NCT00266227|17042626|P1|Initial Treatment|Physician decision to withdraw|0
4956470|NCT00266227|17042624|P3|Initial Treatment|Subject/Guardian decision to withdraw|45
4956471|NCT00266227|17042625|P2|Initial Treatment|Subject/Guardian decision to withdraw|0
4956472|NCT00266227|17042626|P1|Initial Treatment|Subject/Guardian decision to withdraw|0
4956473|NCT00266227|17042624|P3|Initial Treatment|Lost to Follow-up|6
4956474|NCT00266227|17042625|P2|Initial Treatment|Lost to Follow-up|0
4956475|NCT00266227|17042626|P1|Initial Treatment|Lost to Follow-up|0
4956476|NCT00266227|17042624|P3|Initial Treatment|Adverse Event|13
4956477|NCT00266227|17042625|P2|Initial Treatment|Adverse Event|0
4956478|NCT00266227|17042626|P1|Initial Treatment|Adverse Event|0
4956479|NCT00266032|17042680|P3|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1
4956480|NCT00266032|17042681|P2|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2
4956481|NCT00266032|17042682|P1|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10
4956482|NCT00266032|17042680|P3|Open-label Safety Extension|Withdrawal by Subject|12
4956483|NCT00266032|17042681|P2|Open-label Safety Extension|Withdrawal by Subject|3
4956484|NCT00266032|17042682|P1|Open-label Safety Extension|Withdrawal by Subject|19
4956485|NCT00266032|17042680|P3|Open-label Safety Extension|Protocol Violation|2
4956486|NCT00266032|17042681|P2|Open-label Safety Extension|Protocol Violation|3
4956487|NCT00266032|17042682|P1|Open-label Safety Extension|Protocol Violation|1
4956488|NCT00266032|17042680|P3|Open-label Safety Extension|Pregnancy|2
4956489|NCT00266032|17042681|P2|Open-label Safety Extension|Pregnancy|1
4956490|NCT00266032|17042682|P1|Open-label Safety Extension|Pregnancy|4
4956491|NCT00266032|17042680|P3|Open-label Safety Extension|Lost to Follow-up|4
4956492|NCT00266032|17042681|P2|Open-label Safety Extension|Lost to Follow-up|5
4956493|NCT00266032|17042682|P1|Open-label Safety Extension|Lost to Follow-up|2
4956494|NCT00266032|17042680|P3|Open-label Safety Extension|Adverse Event|4
4956495|NCT00266032|17042681|P2|Open-label Safety Extension|Adverse Event|0
4956496|NCT00266032|17042682|P1|Open-label Safety Extension|Adverse Event|5
4956497|NCT00266032|17042680|P3|Treatment|patient moved/wish for pregnancy/no need|8
4956498|NCT00266032|17042681|P2|Treatment|patient moved/wish for pregnancy/no need|5
4956499|NCT00266032|17042682|P1|Treatment|patient moved/wish for pregnancy/no need|13
4956500|NCT00266032|17042680|P3|Treatment|Withdrawal by Subject|12
4956501|NCT00266032|17042681|P2|Treatment|Withdrawal by Subject|13
4956502|NCT00266032|17042682|P1|Treatment|Withdrawal by Subject|28
4956503|NCT00266032|17042680|P3|Treatment|Protocol Violation|13
4956504|NCT00266032|17042681|P2|Treatment|Protocol Violation|14
4956505|NCT00266032|17042682|P1|Treatment|Protocol Violation|6
4956506|NCT00266032|17042680|P3|Treatment|Pregnancy|2
4956507|NCT00266032|17042681|P2|Treatment|Pregnancy|2
4956508|NCT00266032|17042682|P1|Treatment|Pregnancy|3
4956509|NCT00266032|17042680|P3|Treatment|Lost to Follow-up|2
4956510|NCT00266032|17042681|P2|Treatment|Lost to Follow-up|4
4956511|NCT00266032|17042682|P1|Treatment|Lost to Follow-up|19
4956512|NCT00266032|17042680|P3|Treatment|Adverse Event|10
4956513|NCT00266032|17042681|P2|Treatment|Adverse Event|26
4956514|NCT00266032|17042682|P1|Treatment|Adverse Event|42
4956515|NCT00265941|17042717|P2|Overall Study|Lost to Follow-up|1
4956516|NCT00265941|17042718|P1|Overall Study|Lost to Follow-up|1
4956517|NCT00265941|17042717|P2|Overall Study|Protocol Violation|25
4956518|NCT00265941|17042718|P1|Overall Study|Protocol Violation|22
4956519|NCT00265889|17042750|P1|Overall Study|Insurance denied the request|3
4956520|NCT00265889|17042750|P1|Overall Study|Protocol Violation|1
4956521|NCT00265889|17042750|P1|Overall Study|Physician Decision|1
4956522|NCT00265785|17042777|P1|Overall Study|Did not receive protocol treatment|2
4956523|NCT00265785|17042777|P1|Overall Study|Ineligible|1
4956524|NCT00265785|17042777|P1|Overall Study|Not protocol specified|2
4956525|NCT00265785|17042777|P1|Overall Study|Progression/Relapse|15
4956526|NCT00265785|17042777|P1|Overall Study|Withdrawal by Subject|3
4956527|NCT00265785|17042777|P1|Overall Study|Adverse Event|4
4956528|NCT00265759|17042790|P4|Overall Study|Discontinued due to intolerability|1
4956529|NCT00265759|17042791|P3|Overall Study|Discontinued due to intolerability|0
4956530|NCT00265759|17042792|P2|Overall Study|Discontinued due to intolerability|0
4956531|NCT00265759|17042793|P1|Overall Study|Discontinued due to intolerability|0
4956532|NCT00265759|17042790|P4|Overall Study|Bilateral disease|2
4956533|NCT00265759|17042791|P3|Overall Study|Bilateral disease|0
4956534|NCT00265759|17042792|P2|Overall Study|Bilateral disease|0
4956535|NCT00265759|17042793|P1|Overall Study|Bilateral disease|0
4956536|NCT00265759|17042790|P4|Overall Study|Ineligible|1
4956537|NCT00265759|17042791|P3|Overall Study|Ineligible|0
4956538|NCT00265759|17042792|P2|Overall Study|Ineligible|0
4956539|NCT00265759|17042793|P1|Overall Study|Ineligible|0
4956540|NCT00265759|17042790|P4|Overall Study|Cancel|3
4956541|NCT00265759|17042791|P3|Overall Study|Cancel|0
4956542|NCT00265759|17042792|P2|Overall Study|Cancel|0
4956543|NCT00265759|17042793|P1|Overall Study|Cancel|0
4956544|NCT00265759|17042790|P4|Overall Study|Withdrawal by Subject|2
4956545|NCT00265759|17042791|P3|Overall Study|Withdrawal by Subject|2
4956546|NCT00265759|17042792|P2|Overall Study|Withdrawal by Subject|1
4956547|NCT00265759|17042793|P1|Overall Study|Withdrawal by Subject|0
4956548|NCT00265564|17042843|P2|Overall Study|met exclusion criteria|2
4956549|NCT00265564|17042844|P1|Overall Study|met exclusion criteria|5
4956550|NCT00265564|17042843|P2|Overall Study|Lost to Follow-up|7
4956551|NCT00265564|17042844|P1|Overall Study|Lost to Follow-up|5
4956552|NCT00265395|17042894|P2|Overall Study|Administrative|1
4956553|NCT00265395|17042895|P1|Overall Study|Administrative|0
4956554|NCT00265395|17042894|P2|Overall Study|Lack of Efficacy|1
4956555|NCT00265395|17042895|P1|Overall Study|Lack of Efficacy|0
4956556|NCT00265395|17042894|P2|Overall Study|Protocol Violation|2
4956557|NCT00265395|17042895|P1|Overall Study|Protocol Violation|2
4956558|NCT00265395|17042894|P2|Overall Study|Withdrawal by Subject|6
4956559|NCT00265395|17042895|P1|Overall Study|Withdrawal by Subject|1
4956560|NCT00265395|17042894|P2|Overall Study|Lost to Follow-up|1
4956561|NCT00265395|17042895|P1|Overall Study|Lost to Follow-up|2
4956562|NCT00265395|17042894|P2|Overall Study|Adverse Event|6
4956563|NCT00265395|17042895|P1|Overall Study|Adverse Event|3
4956564|NCT00265382|17042900|P1|Overall Study|Death|1
4956565|NCT00265382|17042900|P1|Overall Study|Study terminated by sponsor|94
4956566|NCT00265382|17042900|P1|Overall Study|Withdrawal by Subject|13
4956567|NCT00265382|17042900|P1|Overall Study|Miscellaneous|6
4956568|NCT00265382|17042900|P1|Overall Study|Lack of Efficacy|6
4956569|NCT00265382|17042900|P1|Overall Study|Lost to Follow-up|3
4956570|NCT00265382|17042900|P1|Overall Study|Laboratory Abnormality|1
4956571|NCT00265382|17042900|P1|Overall Study|Adverse Event|21
4956572|NCT00265343|17042920|P2|Overall Study|Other|3
4956573|NCT00265343|17042921|P1|Overall Study|Other|8
4956574|NCT00265343|17042920|P2|Overall Study|Withdrawal by Subject|9
4956575|NCT00265343|17042921|P1|Overall Study|Withdrawal by Subject|3
4956576|NCT00265343|17042920|P2|Overall Study|Adverse Event|7
4956577|NCT00265343|17042921|P1|Overall Study|Adverse Event|10
4956578|NCT00265330|17042929|P1|Overall Study|Protocol Violation|1
4956579|NCT00265330|17042929|P1|Overall Study|Withdrew Consent|1
4956580|NCT00265330|17042929|P1|Overall Study|Principal Investigators Request|1
4956581|NCT00265330|17042929|P1|Overall Study|Site Closed by Sponsor|1
4956582|NCT00265330|17042929|P1|Overall Study|Discharged from Unit for Long Term Care|1
4956583|NCT00265330|17042929|P1|Overall Study|Began Taking Formulary Geodon|1
4956584|NCT00265330|17042929|P1|Overall Study|Family Scheduling Conflicts|1
4956585|NCT00265330|17042929|P1|Overall Study|Lack of Efficacy|4
4956586|NCT00265330|17042929|P1|Overall Study|Patient Wanted to Start Psychotherapy|1
4956587|NCT00265330|17042929|P1|Overall Study|Withdrawal by Subject|34
4956588|NCT00265330|17042929|P1|Overall Study|Lost to Follow-up|8
4956589|NCT00265330|17042929|P1|Overall Study|Adverse Event|41
4956590|NCT00265317|17042955|P4|Phase 2|Other|1
4956591|NCT00265317|17042956|P3|Phase 2|Other|1
4956592|NCT00265317|17042957|P2|Phase 2|Other|0
4956593|NCT00265317|17042958|P1|Phase 2|Other|0
4956594|NCT00265317|17042955|P4|Phase 2|Study terminated by sponsor|0
4956595|NCT00265317|17042956|P3|Phase 2|Study terminated by sponsor|1
4956596|NCT00265317|17042957|P2|Phase 2|Study terminated by sponsor|0
4956597|NCT00265317|17042958|P1|Phase 2|Study terminated by sponsor|0
4956598|NCT00265317|17042955|P4|Phase 2|Withdrawal/other than adverse event|1
4956599|NCT00265317|17042956|P3|Phase 2|Withdrawal/other than adverse event|2
4956600|NCT00265317|17042957|P2|Phase 2|Withdrawal/other than adverse event|0
4956601|NCT00265317|17042958|P1|Phase 2|Withdrawal/other than adverse event|0
4956602|NCT00265317|17042955|P4|Phase 2|Lost to Follow-up|1
4956603|NCT00265317|17042956|P3|Phase 2|Lost to Follow-up|0
4956604|NCT00265317|17042957|P2|Phase 2|Lost to Follow-up|0
4956605|NCT00265317|17042958|P1|Phase 2|Lost to Follow-up|0
4956606|NCT00265317|17042955|P4|Phase 2|Protocol Violation|4
4956607|NCT00265317|17042956|P3|Phase 2|Protocol Violation|1
4956608|NCT00265317|17042957|P2|Phase 2|Protocol Violation|0
4956609|NCT00265317|17042958|P1|Phase 2|Protocol Violation|0
4956610|NCT00265317|17042955|P4|Phase 2|Death|15
4956611|NCT00265317|17042956|P3|Phase 2|Death|12
4956612|NCT00265317|17042957|P2|Phase 2|Death|0
4956613|NCT00265317|17042958|P1|Phase 2|Death|0
4956614|NCT00265317|17042955|P4|Phase 2|Adverse Event|5
4956615|NCT00265317|17042956|P3|Phase 2|Adverse Event|7
4956616|NCT00265317|17042957|P2|Phase 2|Adverse Event|0
4956617|NCT00265317|17042958|P1|Phase 2|Adverse Event|0
4956618|NCT00265317|17042955|P4|Phase 2|Global deterioration of health status|0
4956619|NCT00265317|17042956|P3|Phase 2|Global deterioration of health status|3
4956620|NCT00265317|17042957|P2|Phase 2|Global deterioration of health status|0
4956621|NCT00265317|17042958|P1|Phase 2|Global deterioration of health status|0
4956622|NCT00265317|17042955|P4|Phase 2|Objective progression or relapse|38
4956623|NCT00265317|17042956|P3|Phase 2|Objective progression or relapse|37
4956624|NCT00265317|17042957|P2|Phase 2|Objective progression or relapse|0
4956625|NCT00265317|17042958|P1|Phase 2|Objective progression or relapse|0
4956626|NCT00265317|17042955|P4|Lead-In|Withdrawal/other than adverse event|0
4956627|NCT00265317|17042956|P3|Lead-In|Withdrawal/other than adverse event|0
4956628|NCT00265317|17042957|P2|Lead-In|Withdrawal/other than adverse event|0
4956629|NCT00265317|17042958|P1|Lead-In|Withdrawal/other than adverse event|1
4956630|NCT00265317|17042955|P4|Lead-In|Death|0
4956631|NCT00265317|17042956|P3|Lead-In|Death|0
4956632|NCT00265317|17042957|P2|Lead-In|Death|5
4956633|NCT00265317|17042958|P1|Lead-In|Death|3
4956634|NCT00265317|17042955|P4|Lead-In|Adverse Event|0
4956635|NCT00265317|17042956|P3|Lead-In|Adverse Event|0
4956636|NCT00265317|17042957|P2|Lead-In|Adverse Event|1
4956637|NCT00265317|17042958|P1|Lead-In|Adverse Event|2
4956638|NCT00265317|17042955|P4|Lead-In|Objective progression or relapse|0
4956639|NCT00265317|17042956|P3|Lead-In|Objective progression or relapse|0
4956640|NCT00265317|17042957|P2|Lead-In|Objective progression or relapse|11
4956641|NCT00265317|17042958|P1|Lead-In|Objective progression or relapse|6
4956642|NCT00265239|17043073|P2|Overall Study|Adverse Event|1
4956643|NCT00265239|17043074|P1|Overall Study|Adverse Event|2
4956644|NCT00265122|17043096|P6|Intervention Period 2 (Weeks 8 to 28):|Other|0
4956645|NCT00265122|17043097|P5|Intervention Period 2 (Weeks 8 to 28):|Other|0
4956646|NCT00265122|17043098|P4|Intervention Period 2 (Weeks 8 to 28):|Other|1
4956647|NCT00265122|17043099|P3|Intervention Period 2 (Weeks 8 to 28):|Other|1
4956648|NCT00265122|17043100|P2|Intervention Period 2 (Weeks 8 to 28):|Other|0
4956649|NCT00265122|17043101|P1|Intervention Period 2 (Weeks 8 to 28):|Other|4
4956650|NCT00265122|17043096|P6|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
4956651|NCT00265122|17043097|P5|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
4956652|NCT00265122|17043098|P4|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2
4956653|NCT00265122|17043099|P3|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
4956654|NCT00265122|17043100|P2|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0
4956655|NCT00265122|17043101|P1|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1
4956656|NCT00265122|17043096|P6|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0
4956657|NCT00265122|17043097|P5|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
4956658|NCT00265122|17043098|P4|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
4956659|NCT00265122|17043099|P3|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3
4956660|NCT00265122|17043100|P2|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1
4956661|NCT00265122|17043101|P1|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2
4956662|NCT00265122|17043096|P6|Intervention Period 1 (Weeks 0 to 8):|Other|0
4956663|NCT00265122|17043097|P5|Intervention Period 1 (Weeks 0 to 8):|Other|0
4956664|NCT00265122|17043098|P4|Intervention Period 1 (Weeks 0 to 8):|Other|1
4956665|NCT00265122|17043099|P3|Intervention Period 1 (Weeks 0 to 8):|Other|2
4956666|NCT00265122|17043100|P2|Intervention Period 1 (Weeks 0 to 8):|Other|1
4956667|NCT00265122|17043101|P1|Intervention Period 1 (Weeks 0 to 8):|Other|0
4956668|NCT00265122|17043096|P6|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4956669|NCT00265122|17043097|P5|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4956670|NCT00265122|17043098|P4|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
4956671|NCT00265122|17043099|P3|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4956672|NCT00265122|17043100|P2|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0
4956673|NCT00265122|17043101|P1|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1
4956674|NCT00265122|17043096|P6|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
4956675|NCT00265122|17043097|P5|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
4956676|NCT00265122|17043098|P4|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0
4956677|NCT00265122|17043099|P3|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3
4956678|NCT00265122|17043100|P2|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
4956679|NCT00265122|17043101|P1|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1
4956680|NCT00265109|17043123|P1|Overall Study|Adverse Event|1
4956681|NCT00265109|17043123|P1|Overall Study|Withdrawal by Subject|5
4956682|NCT00265096|17043142|P3|Overall Study|Other|10
4956683|NCT00265096|17043143|P2|Overall Study|Other|19
4956684|NCT00265096|17043144|P1|Overall Study|Other|11
4956685|NCT00265096|17043142|P3|Overall Study|Unsatisfactory therapeutic effect|6
4956686|NCT00265096|17043143|P2|Overall Study|Unsatisfactory therapeutic effect|8
4956687|NCT00265096|17043144|P1|Overall Study|Unsatisfactory therapeutic effect|9
4956688|NCT00265096|17043142|P3|Overall Study|Death|2
4956689|NCT00265096|17043143|P2|Overall Study|Death|1
4956690|NCT00265096|17043144|P1|Overall Study|Death|0
4956691|NCT00265096|17043142|P3|Overall Study|Lost to Follow-up|3
4956692|NCT00265096|17043143|P2|Overall Study|Lost to Follow-up|5
4956693|NCT00265096|17043144|P1|Overall Study|Lost to Follow-up|2
4956694|NCT00265096|17043142|P3|Overall Study|Adverse Event|18
4956695|NCT00265096|17043143|P2|Overall Study|Adverse Event|18
4956696|NCT00265096|17043144|P1|Overall Study|Adverse Event|14
4956697|NCT00265083|17043176|P3|Overall Study|Other|9
4956698|NCT00265083|17043177|P2|Overall Study|Other|12
4956699|NCT00265083|17043178|P1|Overall Study|Other|1
4956700|NCT00265083|17043176|P3|Overall Study|Unsatisfactory therapeutic effect|14
4956701|NCT00265083|17043177|P2|Overall Study|Unsatisfactory therapeutic effect|13
4956702|NCT00265083|17043178|P1|Overall Study|Unsatisfactory therapeutic effect|8
4956703|NCT00265083|17043176|P3|Overall Study|Lost to Follow-up|4
4956704|NCT00265083|17043177|P2|Overall Study|Lost to Follow-up|4
4956705|NCT00265083|17043178|P1|Overall Study|Lost to Follow-up|3
4956706|NCT00265083|17043176|P3|Overall Study|Adverse Event|15
4956707|NCT00265083|17043177|P2|Overall Study|Adverse Event|13
4956708|NCT00265083|17043178|P1|Overall Study|Adverse Event|5
4956709|NCT00264875|17043199|P1|Overall Study|Withdrawal by Subject|7
4956710|NCT00264875|17043199|P1|Overall Study|Protocol Violation|11
4956711|NCT00264875|17043199|P1|Overall Study|Lost to Follow-up|6
4956712|NCT00264875|17043199|P1|Overall Study|Adverse Event|6
4956713|NCT00264849|17043205|P2|Overall Study|Administrative Problems|0
4956714|NCT00264849|17043206|P1|Overall Study|Administrative Problems|2
4956715|NCT00264849|17043205|P2|Overall Study|Death|1
4956716|NCT00264849|17043206|P1|Overall Study|Death|0
4956717|NCT00264849|17043205|P2|Overall Study|Lost to Follow-up|2
4956718|NCT00264849|17043206|P1|Overall Study|Lost to Follow-up|0
4956719|NCT00264849|17043205|P2|Overall Study|Lack of Efficacy|6
4956720|NCT00264849|17043206|P1|Overall Study|Lack of Efficacy|1
4956721|NCT00264849|17043205|P2|Overall Study|Protocol Violation|3
4956722|NCT00264849|17043206|P1|Overall Study|Protocol Violation|5
4956723|NCT00264849|17043205|P2|Overall Study|Withdrawal by Subject|11
4956724|NCT00264849|17043206|P1|Overall Study|Withdrawal by Subject|7
4956725|NCT00264849|17043205|P2|Overall Study|Adverse Event|2
4956726|NCT00264849|17043206|P1|Overall Study|Adverse Event|7
4956727|NCT00264810|17043240|P2|Open Label Evaluation Period|Pursue Other Treatment Options|3
4956728|NCT00264810|17043241|P1|Open Label Evaluation Period|Pursue Other Treatment Options|2
4956729|NCT00264810|17043240|P2|Open Label Evaluation Period|Death|2
4956730|NCT00264810|17043241|P1|Open Label Evaluation Period|Death|3
4956731|NCT00264810|17043240|P2|Open Label Evaluation Period|Explant due to infection|1
4956732|NCT00264810|17043241|P1|Open Label Evaluation Period|Explant due to infection|1
4956733|NCT00264810|17043240|P2|Blinded Evaluation Period|Explant due to infection|1
4956734|NCT00264810|17043241|P1|Blinded Evaluation Period|Explant due to infection|1
4956735|NCT00264810|17043240|P2|Stimulation Optimization Period|Death|1
4956736|NCT00264810|17043241|P1|Stimulation Optimization Period|Death|0
4956737|NCT00264810|17043240|P2|Stimulation Optimization Period|Withdrawal by Subject|0
4956738|NCT00264810|17043241|P1|Stimulation Optimization Period|Withdrawal by Subject|1
4956739|NCT00264810|17043240|P2|Baseline|Other|1
4956740|NCT00264810|17043241|P1|Baseline|Other|0
4956741|NCT00264810|17043240|P2|Baseline|Did not Meet/Maintain Study I/E Criteria|2
4956742|NCT00264810|17043241|P1|Baseline|Did not Meet/Maintain Study I/E Criteria|1
4956743|NCT00264810|17043240|P2|Baseline|Insufficient Seizure Frequency|2
4956744|NCT00264810|17043241|P1|Baseline|Insufficient Seizure Frequency|2
4956745|NCT00264810|17043240|P2|Baseline|Subject Compliance Failure|3
4956746|NCT00264810|17043241|P1|Baseline|Subject Compliance Failure|3
4956747|NCT00264810|17043240|P2|Baseline|Physician Decision|8
4956748|NCT00264810|17043241|P1|Baseline|Physician Decision|7
4956749|NCT00264810|17043240|P2|Baseline|Withdrawal by Subject|10
4956750|NCT00264810|17043241|P1|Baseline|Withdrawal by Subject|10
4956751|NCT00264797|17043251|P2|Overall Study|Other|4
4956752|NCT00264797|17043252|P1|Overall Study|Other|3
4956753|NCT00264797|17043251|P2|Overall Study|Feels treatment not necessary, not worki|1
4956754|NCT00264797|17043252|P1|Overall Study|Feels treatment not necessary, not worki|0
4956755|NCT00264797|17043251|P2|Overall Study|Pressure/advice from Outsiders|1
4956756|NCT00264797|17043252|P1|Overall Study|Pressure/advice from Outsiders|1
4956757|NCT00264797|17043251|P2|Overall Study|Incarceration|5
4956758|NCT00264797|17043252|P1|Overall Study|Incarceration|4
4956759|NCT00264797|17043251|P2|Overall Study|Practical Problems|3
4956760|NCT00264797|17043252|P1|Overall Study|Practical Problems|2
4956761|NCT00264797|17043251|P2|Overall Study|Moved from area|1
4956762|NCT00264797|17043252|P1|Overall Study|Moved from area|3
4956763|NCT00264797|17043251|P2|Overall Study|Lost to Follow-up|17
4956764|NCT00264797|17043252|P1|Overall Study|Lost to Follow-up|9
4956765|NCT00264797|17043251|P2|Overall Study|Withdrawal by Subject|11
4956766|NCT00264797|17043252|P1|Overall Study|Withdrawal by Subject|11
4956767|NCT00264576|17043274|P2|Overall Study|Lost to Follow-up|1
4956768|NCT00264576|17043275|P1|Overall Study|Lost to Follow-up|1
4956769|NCT00264550|17043299|P4|Overall Study|Other|9
4956770|NCT00264550|17043300|P3|Overall Study|Other|3
4956771|NCT00264550|17043301|P2|Overall Study|Other|7
4956772|NCT00264550|17043302|P1|Overall Study|Other|13
4956773|NCT00264550|17043299|P4|Overall Study|Discontinued oral study agent|0
4956774|NCT00264550|17043300|P3|Overall Study|Discontinued oral study agent|0
4956775|NCT00264550|17043301|P2|Overall Study|Discontinued oral study agent|1
4956776|NCT00264550|17043302|P1|Overall Study|Discontinued oral study agent|0
4956777|NCT00264550|17043299|P4|Overall Study|Unsatisfactory therapeutic effect|6
4956778|NCT00264550|17043300|P3|Overall Study|Unsatisfactory therapeutic effect|4
4956779|NCT00264550|17043301|P2|Overall Study|Unsatisfactory therapeutic effect|11
4956780|NCT00264550|17043302|P1|Overall Study|Unsatisfactory therapeutic effect|4
4956781|NCT00264550|17043299|P4|Overall Study|Adverse Event|14
4956782|NCT00264550|17043300|P3|Overall Study|Adverse Event|9
4956783|NCT00264550|17043301|P2|Overall Study|Adverse Event|18
4956784|NCT00264550|17043302|P1|Overall Study|Adverse Event|23
4956785|NCT00264550|17043299|P4|Overall Study|Lost to Follow-up|1
4956786|NCT00264550|17043300|P3|Overall Study|Lost to Follow-up|1
4956787|NCT00264550|17043301|P2|Overall Study|Lost to Follow-up|1
4956788|NCT00264550|17043302|P1|Overall Study|Lost to Follow-up|3
4956789|NCT00264550|17043299|P4|Overall Study|Death|0
4956790|NCT00264550|17043300|P3|Overall Study|Death|0
4956791|NCT00264550|17043301|P2|Overall Study|Death|3
4956792|NCT00264550|17043302|P1|Overall Study|Death|0
4956793|NCT00264537|17043341|P4|Overall Study|Not treated|0
4956794|NCT00264537|17043342|P3|Overall Study|Not treated|1
4956795|NCT00264537|17043343|P2|Overall Study|Not treated|2
4956796|NCT00264537|17043344|P1|Overall Study|Not treated|0
4956797|NCT00264537|17043341|P4|Overall Study|Other|11
4956798|NCT00264537|17043342|P3|Overall Study|Other|10
4956799|NCT00264537|17043343|P2|Overall Study|Other|11
4956800|NCT00264537|17043344|P1|Overall Study|Other|21
4956801|NCT00264537|17043341|P4|Overall Study|Unsatisfactory therapeutic effect|7
4956802|NCT00264537|17043342|P3|Overall Study|Unsatisfactory therapeutic effect|5
4956803|NCT00264537|17043343|P2|Overall Study|Unsatisfactory therapeutic effect|6
4956804|NCT00264537|17043344|P1|Overall Study|Unsatisfactory therapeutic effect|5
4956805|NCT00264537|17043341|P4|Overall Study|Adverse Event|34
4956806|NCT00264537|17043342|P3|Overall Study|Adverse Event|24
4956807|NCT00264537|17043343|P2|Overall Study|Adverse Event|32
4956808|NCT00264537|17043344|P1|Overall Study|Adverse Event|21
4956809|NCT00264537|17043341|P4|Overall Study|Lost to Follow-up|6
4956810|NCT00264537|17043342|P3|Overall Study|Lost to Follow-up|7
4956811|NCT00264537|17043343|P2|Overall Study|Lost to Follow-up|4
4956812|NCT00264537|17043344|P1|Overall Study|Lost to Follow-up|3
4956813|NCT00264537|17043341|P4|Overall Study|Death|2
4956814|NCT00264537|17043342|P3|Overall Study|Death|3
4956815|NCT00264537|17043343|P2|Overall Study|Death|3
4956816|NCT00264537|17043344|P1|Overall Study|Death|0
4956817|NCT00264498|17043376|P2|Crossover Treatment|Withdrawal by Subject|0
4956818|NCT00264498|17043377|P1|Crossover Treatment|Withdrawal by Subject|1
4956819|NCT00264498|17043376|P2|Crossover Treatment|Study closure|1
4956820|NCT00264498|17043377|P1|Crossover Treatment|Study closure|0
4956821|NCT00264498|17043376|P2|Crossover Treatment|Objective disease progression|5
4956822|NCT00264498|17043377|P1|Crossover Treatment|Objective disease progression|4
4956823|NCT00264498|17043376|P2|Crossover Treatment|Death|3
4956824|NCT00264498|17043377|P1|Crossover Treatment|Death|1
4956825|NCT00264498|17043376|P2|Randomized Treatment|Protocol Violation|0
4956826|NCT00264498|17043377|P1|Randomized Treatment|Protocol Violation|1
4956827|NCT00264498|17043376|P2|Randomized Treatment|Study Closure|0
4956828|NCT00264498|17043377|P1|Randomized Treatment|Study Closure|1
4956829|NCT00264498|17043376|P2|Randomized Treatment|Incorrectly randomized|0
4956830|NCT00264498|17043377|P1|Randomized Treatment|Incorrectly randomized|1
4956831|NCT00264498|17043376|P2|Randomized Treatment|Physician Decision|0
4956832|NCT00264498|17043377|P1|Randomized Treatment|Physician Decision|1
4956833|NCT00264498|17043376|P2|Randomized Treatment|Objective disease Progression|14
4956834|NCT00264498|17043377|P1|Randomized Treatment|Objective disease Progression|13
4956835|NCT00264498|17043376|P2|Randomized Treatment|Withdrawal by Subject|1
4956836|NCT00264498|17043377|P1|Randomized Treatment|Withdrawal by Subject|0
4956837|NCT00264498|17043376|P2|Randomized Treatment|Death|3
4956838|NCT00264498|17043377|P1|Randomized Treatment|Death|0
4956839|NCT00264303|17043400|P2|Overall Study|Various reasons listed in study report|7
4956840|NCT00264303|17043401|P1|Overall Study|Various reasons listed in study report|6
4956841|NCT00264303|17043400|P2|Overall Study|Withdrawal by Subject|3
4956842|NCT00264303|17043401|P1|Overall Study|Withdrawal by Subject|2
4956843|NCT00264303|17043400|P2|Overall Study|Lost to Follow-up|3
4956844|NCT00264303|17043401|P1|Overall Study|Lost to Follow-up|3
4956845|NCT00264303|17043400|P2|Overall Study|Lack of Efficacy|13
4956846|NCT00264303|17043401|P1|Overall Study|Lack of Efficacy|10
4956847|NCT00264303|17043400|P2|Overall Study|Adverse Event|3
4956848|NCT00264303|17043401|P1|Overall Study|Adverse Event|4
4956849|NCT00264290|17043419|P2|Intervention (8 Weeks)|Adverse Event|0
4956850|NCT00264290|17043420|P1|Intervention (8 Weeks)|Adverse Event|1
4956851|NCT00264238|17043436|P1|Overall Study|Protocol Violation|1
4956852|NCT00264147|17043448|P6|Treatment II Period|Pre-scheduled total hip replacement|1
4956853|NCT00264147|17043449|P5|Treatment II Period|Pre-scheduled total hip replacement|0
4956854|NCT00264147|17043450|P4|Treatment II Period|Pre-scheduled total hip replacement|0
4956855|NCT00264147|17043451|P3|Treatment II Period|Pre-scheduled total hip replacement|0
4956856|NCT00264147|17043452|P2|Treatment II Period|Pre-scheduled total hip replacement|0
4956857|NCT00264147|17043453|P1|Treatment II Period|Pre-scheduled total hip replacement|0
4956858|NCT00264147|17043448|P6|Treatment II Period|Withdrawal by Subject|2
4956859|NCT00264147|17043449|P5|Treatment II Period|Withdrawal by Subject|3
4956860|NCT00264147|17043450|P4|Treatment II Period|Withdrawal by Subject|0
4956861|NCT00264147|17043451|P3|Treatment II Period|Withdrawal by Subject|0
4956862|NCT00264147|17043452|P2|Treatment II Period|Withdrawal by Subject|0
4956863|NCT00264147|17043453|P1|Treatment II Period|Withdrawal by Subject|0
4956864|NCT00264147|17043448|P6|Treatment II Period|Lost to Follow-up|1
4956865|NCT00264147|17043449|P5|Treatment II Period|Lost to Follow-up|1
4956866|NCT00264147|17043450|P4|Treatment II Period|Lost to Follow-up|0
4956867|NCT00264147|17043451|P3|Treatment II Period|Lost to Follow-up|0
4956868|NCT00264147|17043452|P2|Treatment II Period|Lost to Follow-up|0
4956869|NCT00264147|17043453|P1|Treatment II Period|Lost to Follow-up|0
4956870|NCT00264147|17043448|P6|Treatment II Period|Lack of Efficacy|19
4956871|NCT00264147|17043449|P5|Treatment II Period|Lack of Efficacy|20
4956872|NCT00264147|17043450|P4|Treatment II Period|Lack of Efficacy|0
4956873|NCT00264147|17043451|P3|Treatment II Period|Lack of Efficacy|0
4956874|NCT00264147|17043452|P2|Treatment II Period|Lack of Efficacy|0
4956875|NCT00264147|17043453|P1|Treatment II Period|Lack of Efficacy|0
4956876|NCT00264147|17043448|P6|Treatment II Period|Laboratory Adverse Event|1
4956877|NCT00264147|17043449|P5|Treatment II Period|Laboratory Adverse Event|0
4956878|NCT00264147|17043450|P4|Treatment II Period|Laboratory Adverse Event|0
4956879|NCT00264147|17043451|P3|Treatment II Period|Laboratory Adverse Event|0
4956880|NCT00264147|17043452|P2|Treatment II Period|Laboratory Adverse Event|0
4956881|NCT00264147|17043453|P1|Treatment II Period|Laboratory Adverse Event|0
4956882|NCT00264147|17043448|P6|Treatment II Period|Adverse Event|9
4956883|NCT00264147|17043449|P5|Treatment II Period|Adverse Event|9
4956884|NCT00264147|17043450|P4|Treatment II Period|Adverse Event|0
4956885|NCT00264147|17043451|P3|Treatment II Period|Adverse Event|0
4956886|NCT00264147|17043452|P2|Treatment II Period|Adverse Event|0
4956887|NCT00264147|17043453|P1|Treatment II Period|Adverse Event|0
4956888|NCT00264147|17043448|P6|Treatment I Period|Reassigned to Treatment II Period|0
4956889|NCT00264147|17043449|P5|Treatment I Period|Reassigned to Treatment II Period|45
4956890|NCT00264147|17043450|P4|Treatment I Period|Reassigned to Treatment II Period|63
4956891|NCT00264147|17043451|P3|Treatment I Period|Reassigned to Treatment II Period|65
4956892|NCT00264147|17043452|P2|Treatment I Period|Reassigned to Treatment II Period|72
4956893|NCT00264147|17043453|P1|Treatment I Period|Reassigned to Treatment II Period|84
4956894|NCT00264147|17043448|P6|Treatment I Period|Unblinded due to Serious Adverse Event|0
4956895|NCT00264147|17043449|P5|Treatment I Period|Unblinded due to Serious Adverse Event|0
4956896|NCT00264147|17043450|P4|Treatment I Period|Unblinded due to Serious Adverse Event|0
4956897|NCT00264147|17043451|P3|Treatment I Period|Unblinded due to Serious Adverse Event|1
4956898|NCT00264147|17043452|P2|Treatment I Period|Unblinded due to Serious Adverse Event|0
4956899|NCT00264147|17043453|P1|Treatment I Period|Unblinded due to Serious Adverse Event|0
4956900|NCT00264147|17043448|P6|Treatment I Period|Patient out of town for an extended time|0
4956901|NCT00264147|17043449|P5|Treatment I Period|Patient out of town for an extended time|0
4956902|NCT00264147|17043450|P4|Treatment I Period|Patient out of town for an extended time|0
4956903|NCT00264147|17043451|P3|Treatment I Period|Patient out of town for an extended time|0
4956904|NCT00264147|17043452|P2|Treatment I Period|Patient out of town for an extended time|1
4956905|NCT00264147|17043453|P1|Treatment I Period|Patient out of town for an extended time|0
4956906|NCT00264147|17043448|P6|Treatment I Period|Withdrawal by Subject|0
4956907|NCT00264147|17043449|P5|Treatment I Period|Withdrawal by Subject|2
4956908|NCT00264147|17043450|P4|Treatment I Period|Withdrawal by Subject|2
4956909|NCT00264147|17043451|P3|Treatment I Period|Withdrawal by Subject|0
4956910|NCT00264147|17043452|P2|Treatment I Period|Withdrawal by Subject|0
4956911|NCT00264147|17043453|P1|Treatment I Period|Withdrawal by Subject|2
4956912|NCT00264147|17043448|P6|Treatment I Period|Protocol Violation|0
4956913|NCT00264147|17043449|P5|Treatment I Period|Protocol Violation|0
4956914|NCT00264147|17043450|P4|Treatment I Period|Protocol Violation|0
4956915|NCT00264147|17043451|P3|Treatment I Period|Protocol Violation|0
4956916|NCT00264147|17043452|P2|Treatment I Period|Protocol Violation|2
4956917|NCT00264147|17043453|P1|Treatment I Period|Protocol Violation|2
4956918|NCT00264147|17043448|P6|Treatment I Period|Lost to Follow-up|0
4956919|NCT00264147|17043449|P5|Treatment I Period|Lost to Follow-up|1
4956920|NCT00264147|17043450|P4|Treatment I Period|Lost to Follow-up|1
4956921|NCT00264147|17043451|P3|Treatment I Period|Lost to Follow-up|0
4956922|NCT00264147|17043452|P2|Treatment I Period|Lost to Follow-up|0
4956923|NCT00264147|17043453|P1|Treatment I Period|Lost to Follow-up|1
4956924|NCT00264147|17043448|P6|Treatment I Period|Lack of Efficacy|0
4956925|NCT00264147|17043449|P5|Treatment I Period|Lack of Efficacy|1
4956926|NCT00264147|17043450|P4|Treatment I Period|Lack of Efficacy|0
4956927|NCT00264147|17043451|P3|Treatment I Period|Lack of Efficacy|8
4956928|NCT00264147|17043452|P2|Treatment I Period|Lack of Efficacy|2
4956929|NCT00264147|17043453|P1|Treatment I Period|Lack of Efficacy|6
4956930|NCT00264147|17043448|P6|Treatment I Period|Laboratory Adverse Event|0
4956931|NCT00264147|17043449|P5|Treatment I Period|Laboratory Adverse Event|0
4956932|NCT00264147|17043450|P4|Treatment I Period|Laboratory Adverse Event|1
4956933|NCT00264147|17043451|P3|Treatment I Period|Laboratory Adverse Event|0
4956934|NCT00264147|17043452|P2|Treatment I Period|Laboratory Adverse Event|0
4956935|NCT00264147|17043453|P1|Treatment I Period|Laboratory Adverse Event|0
4956936|NCT00264147|17043448|P6|Treatment I Period|Adverse Event|0
4956937|NCT00264147|17043449|P5|Treatment I Period|Adverse Event|7
4956938|NCT00264147|17043450|P4|Treatment I Period|Adverse Event|5
4956939|NCT00264147|17043451|P3|Treatment I Period|Adverse Event|3
4956940|NCT00264147|17043452|P2|Treatment I Period|Adverse Event|6
4956941|NCT00264147|17043453|P1|Treatment I Period|Adverse Event|3
4956942|NCT00264004|17043496|P4|Overall Study|Not treated|2
4956943|NCT00264004|17043497|P3|Overall Study|Not treated|2
4956944|NCT00264004|17043498|P2|Overall Study|Not treated|0
4956945|NCT00264004|17043499|P1|Overall Study|Not treated|3
4956946|NCT00264004|17043496|P4|Overall Study|Cond. under inv. worsened|4
4956947|NCT00264004|17043497|P3|Overall Study|Cond. under inv. worsened|3
4956948|NCT00264004|17043498|P2|Overall Study|Cond. under inv. worsened|5
4956949|NCT00264004|17043499|P1|Overall Study|Cond. under inv. worsened|9
4956950|NCT00264004|17043496|P4|Overall Study|Development study specific disc. crit.|0
4956951|NCT00264004|17043497|P3|Overall Study|Development study specific disc. crit.|1
4956952|NCT00264004|17043498|P2|Overall Study|Development study specific disc. crit.|0
4956953|NCT00264004|17043499|P1|Overall Study|Development study specific disc. crit.|1
4956954|NCT00264004|17043496|P4|Overall Study|Other|3
4956955|NCT00264004|17043497|P3|Overall Study|Other|0
4956956|NCT00264004|17043498|P2|Overall Study|Other|2
4956957|NCT00264004|17043499|P1|Overall Study|Other|2
4956958|NCT00264004|17043496|P4|Overall Study|Withdrawal by Subject|2
4956959|NCT00264004|17043497|P3|Overall Study|Withdrawal by Subject|2
4956960|NCT00264004|17043498|P2|Overall Study|Withdrawal by Subject|1
4956961|NCT00264004|17043499|P1|Overall Study|Withdrawal by Subject|0
4956962|NCT00264004|17043496|P4|Overall Study|Adverse Event|4
4956963|NCT00264004|17043497|P3|Overall Study|Adverse Event|6
4956964|NCT00264004|17043498|P2|Overall Study|Adverse Event|3
4956965|NCT00264004|17043499|P1|Overall Study|Adverse Event|2
4956966|NCT00263887|17043527|P2|Overall Study|Lack of Efficacy|1
4956967|NCT00263887|17043528|P1|Overall Study|Lack of Efficacy|0
4956968|NCT00263887|17043527|P2|Overall Study|Disease progression|1
4956969|NCT00263887|17043528|P1|Overall Study|Disease progression|0
4956970|NCT00263887|17043527|P2|Overall Study|Adverse Event|2
4956971|NCT00263887|17043528|P1|Overall Study|Adverse Event|0
4956972|NCT00263887|17043527|P2|Overall Study|Too ill to attend visit|0
4956973|NCT00263887|17043528|P1|Overall Study|Too ill to attend visit|1
4956974|NCT00263887|17043527|P2|Overall Study|Lung transplantation|2
4956975|NCT00263887|17043528|P1|Overall Study|Lung transplantation|1
4956976|NCT00263887|17043527|P2|Overall Study|Withdrawal by Subject|1
4956977|NCT00263887|17043528|P1|Overall Study|Withdrawal by Subject|1
4956978|NCT00263757|17043536|P2|Overall Study|Adverse Event|3
4956979|NCT00263757|17043537|P1|Overall Study|Adverse Event|3
4956980|NCT00263757|17043536|P2|Overall Study|Screen failure|1
4956981|NCT00263757|17043537|P1|Overall Study|Screen failure|0
4956982|NCT00263757|17043536|P2|Overall Study|Withdrawal by Subject|4
4956983|NCT00263757|17043537|P1|Overall Study|Withdrawal by Subject|5
4956984|NCT00263666|17043549|P2|Overall Study|Withdrawal by Subject|1
4956985|NCT00263666|17043550|P1|Overall Study|Withdrawal by Subject|0
4956986|NCT00263666|17043549|P2|Overall Study|Lost to Follow-up|2
4956987|NCT00263666|17043550|P1|Overall Study|Lost to Follow-up|1
4956988|NCT00263666|17043549|P2|Overall Study|Adverse Event|8
4956989|NCT00263666|17043550|P1|Overall Study|Adverse Event|6
4956990|NCT00263588|17043603|P2|Overall Study|Sponsor terminated study|1
4956991|NCT00263588|17043604|P1|Overall Study|Sponsor terminated study|0
4956992|NCT00263588|17043603|P2|Overall Study|Investigator decision|15
4956993|NCT00263588|17043604|P1|Overall Study|Investigator decision|7
4956994|NCT00263588|17043603|P2|Overall Study|Protocol Violation|1
4956995|NCT00263588|17043604|P1|Overall Study|Protocol Violation|0
4956996|NCT00263588|17043603|P2|Overall Study|Withdrawal by Subject|4
4956997|NCT00263588|17043604|P1|Overall Study|Withdrawal by Subject|3
4956998|NCT00263588|17043603|P2|Overall Study|Lost to Follow-up|10
4956999|NCT00263588|17043604|P1|Overall Study|Lost to Follow-up|7
4957000|NCT00263588|17043603|P2|Overall Study|disease progression, coma, 1 unknown|11
4957001|NCT00263588|17043604|P1|Overall Study|disease progression, coma, 1 unknown|10
4957002|NCT00263588|17043603|P2|Overall Study|Death|90
4957003|NCT00263588|17043604|P1|Overall Study|Death|54
4957004|NCT00263562|17043629|P2|Overall Study|Protocol Violation|0
4957005|NCT00263562|17043630|P1|Overall Study|Protocol Violation|3
4957006|NCT00263328|17043647|P3|Overall Study|Adverse Event|4
4957007|NCT00263328|17043648|P2|Overall Study|Adverse Event|1
4957008|NCT00263328|17043649|P1|Overall Study|Adverse Event|1
4957009|NCT00263328|17043647|P3|Overall Study|Other|1
4957010|NCT00263328|17043648|P2|Overall Study|Other|0
4957011|NCT00263328|17043649|P1|Overall Study|Other|3
4957012|NCT00263328|17043647|P3|Overall Study|Withdrawal by Subject|1
4957013|NCT00263328|17043648|P2|Overall Study|Withdrawal by Subject|0
4957014|NCT00263328|17043649|P1|Overall Study|Withdrawal by Subject|3
4957015|NCT00263328|17043647|P3|Overall Study|Lost to Follow-up|0
4957016|NCT00263328|17043648|P2|Overall Study|Lost to Follow-up|1
4957017|NCT00263328|17043649|P1|Overall Study|Lost to Follow-up|1
4957018|NCT00263328|17043647|P3|Overall Study|Death|1
4957019|NCT00263328|17043648|P2|Overall Study|Death|0
4957020|NCT00263328|17043649|P1|Overall Study|Death|0
4957021|NCT00263211|17043807|P2|Overall Study|Disease Progression|1
4957022|NCT00263211|17043808|P1|Overall Study|Disease Progression|0
4957023|NCT00263211|17043807|P2|Overall Study|Protocol Violation|0
4957024|NCT00263211|17043808|P1|Overall Study|Protocol Violation|1
4957025|NCT00263211|17043807|P2|Overall Study|Withdrawal by Subject|0
4957026|NCT00263211|17043808|P1|Overall Study|Withdrawal by Subject|3
4957027|NCT00263211|17043807|P2|Overall Study|Death|0
4957028|NCT00263211|17043808|P1|Overall Study|Death|1
4957029|NCT00262951|17043859|P1|Overall Study|Off treatment for other disease|1
4957030|NCT00262951|17043859|P1|Overall Study|Alternative treatment|3
4957031|NCT00262951|17043859|P1|Overall Study|Withdrawal by Subject|1
4957032|NCT00262951|17043859|P1|Overall Study|Death|1
4957033|NCT00262951|17043859|P1|Overall Study|Adverse Event|7
4957034|NCT00262951|17043859|P1|Overall Study|Progressive disease/relapse|3
4957035|NCT00262925|17043864|P1|Overall Study|Other|1
4957036|NCT00262925|17043864|P1|Overall Study|alternative therapy|1
4957037|NCT00262925|17043864|P1|Overall Study|Death|2
4957038|NCT00262925|17043864|P1|Overall Study|Adverse Event|4
4957039|NCT00262925|17043864|P1|Overall Study|Lack of Efficacy|3
4957040|NCT00262873|17043870|P1|Overall Study|Withdrawal by Subject|5
4957041|NCT00262873|17043870|P1|Overall Study|Adverse Event|3
4957042|NCT00262860|17043881|P1|Overall Study|Adverse Event|2
4957043|NCT00262847|17043890|P3|Overall Study|Did not receive study treatment|4
4957293|NCT00262002|17044267|P2|Overall Study|Unable to classify|0
4957044|NCT00262847|17043891|P2|Overall Study|Did not receive study treatment|1
4957045|NCT00262847|17043892|P1|Overall Study|Did not receive study treatment|4
4957046|NCT00262847|17043890|P3|Overall Study|Other Reasons|27
4957047|NCT00262847|17043891|P2|Overall Study|Other Reasons|88
4957048|NCT00262847|17043892|P1|Overall Study|Other Reasons|79
4957049|NCT00262847|17043890|P3|Overall Study|Concomitant disease|4
4957050|NCT00262847|17043891|P2|Overall Study|Concomitant disease|2
4957051|NCT00262847|17043892|P1|Overall Study|Concomitant disease|3
4957052|NCT00262847|17043890|P3|Overall Study|Death|11
4957053|NCT00262847|17043891|P2|Overall Study|Death|8
4957054|NCT00262847|17043892|P1|Overall Study|Death|8
4957055|NCT00262847|17043890|P3|Overall Study|Adverse Event|108
4957056|NCT00262847|17043891|P2|Overall Study|Adverse Event|88
4957057|NCT00262847|17043892|P1|Overall Study|Adverse Event|74
4957058|NCT00262847|17043890|P3|Overall Study|Patient Refusal|47
4957059|NCT00262847|17043891|P2|Overall Study|Patient Refusal|52
4957060|NCT00262847|17043892|P1|Overall Study|Patient Refusal|41
4957061|NCT00262847|17043890|P3|Overall Study|Disease Progression|195
4957062|NCT00262847|17043891|P2|Overall Study|Disease Progression|274
4957063|NCT00262847|17043892|P1|Overall Study|Disease Progression|309
4957064|NCT00262834|17043911|P2|Overall Study|Surgery delayed/tissue not collected|4
4957065|NCT00262834|17043912|P1|Overall Study|Surgery delayed/tissue not collected|1
4957066|NCT00262821|17043925|P2|Overall Study|Inevaluable - inadequate data|4
4957067|NCT00262821|17043926|P1|Overall Study|Inevaluable - inadequate data|0
4957068|NCT00262821|17043925|P2|Overall Study|Ineligible - required test not done|4
4957069|NCT00262821|17043926|P1|Overall Study|Ineligible - required test not done|1
4957070|NCT00262821|17043925|P2|Overall Study|Ineligible - elevated creatinine|2
4957071|NCT00262821|17043926|P1|Overall Study|Ineligible - elevated creatinine|0
4957072|NCT00262821|17043925|P2|Overall Study|Ineligible - inadequate pathology|3
4957073|NCT00262821|17043926|P1|Overall Study|Ineligible - inadequate pathology|1
4957074|NCT00262821|17043925|P2|Overall Study|Ineligible - wrong primary|1
4957075|NCT00262821|17043926|P1|Overall Study|Ineligible - wrong primary|0
4957076|NCT00262821|17043925|P2|Overall Study|Ineligible - wrong cell type|2
4957077|NCT00262821|17043926|P1|Overall Study|Ineligible - wrong cell type|2
4957078|NCT00262821|17043925|P2|Overall Study|Ineligible - wrong stage|3
4957079|NCT00262821|17043926|P1|Overall Study|Ineligible - wrong stage|0
4957080|NCT00262743|17043938|P2|Overall Study|Disease progression|3
4957081|NCT00262743|17043939|P1|Overall Study|Disease progression|0
4957082|NCT00262743|17043938|P2|Overall Study|Adverse Event|9
4957083|NCT00262743|17043939|P1|Overall Study|Adverse Event|0
4957084|NCT00262600|17043974|P3|Overall Study|Other|62
4957085|NCT00262600|17043975|P2|Overall Study|Other|59
4957086|NCT00262600|17043976|P1|Overall Study|Other|58
4957087|NCT00262600|17043974|P3|Overall Study|Not Treated|24
4957088|NCT00262600|17043975|P2|Overall Study|Not Treated|17
4957089|NCT00262600|17043976|P1|Overall Study|Not Treated|32
4957090|NCT00262600|17043974|P3|Overall Study|Withdrawal by Subject|139
4957091|NCT00262600|17043975|P2|Overall Study|Withdrawal by Subject|145
4957092|NCT00262600|17043976|P1|Overall Study|Withdrawal by Subject|128
4957093|NCT00262600|17043974|P3|Overall Study|Lost to Follow-up|41
4957094|NCT00262600|17043975|P2|Overall Study|Lost to Follow-up|31
4957095|NCT00262600|17043976|P1|Overall Study|Lost to Follow-up|17
4957096|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
4957097|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9
4957098|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0
4957099|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10
4957100|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Virologic failure|0
4957101|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Virologic failure|8
4957102|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Virologic failure|0
4957103|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Virologic failure|5
4957104|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Death|0
4957105|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Death|2
4957106|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Death|0
4957107|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Death|2
4957108|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Noncompliance|0
4957109|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Noncompliance|11
4957110|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Noncompliance|0
4957111|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Noncompliance|6
4957112|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Lost to Follow-up|0
4957113|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Lost to Follow-up|18
4957114|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Lost to Follow-up|0
4957115|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Lost to Follow-up|19
4957116|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Withdrawal by Subject|0
4957117|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Withdrawal by Subject|13
4957118|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Withdrawal by Subject|0
4957119|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Withdrawal by Subject|15
4957120|NCT00262522|17044003|P4|Study Start Through 96 Weeks|Adverse Event|0
4957121|NCT00262522|17044004|P3|Study Start Through 96 Weeks|Adverse Event|16
4957122|NCT00262522|17044005|P2|Study Start Through 96 Weeks|Adverse Event|0
4957123|NCT00262522|17044006|P1|Study Start Through 96 Weeks|Adverse Event|20
4957124|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
4957125|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7
4957126|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0
4957127|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8
4957128|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Virologic failure|0
4957129|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Virologic failure|4
4957130|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Virologic failure|0
4957131|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Virologic failure|2
4957132|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Death|0
4957133|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Death|1
4957134|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Death|0
4957135|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Death|2
4957136|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Noncompliance|0
4957137|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Noncompliance|8
4957138|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Noncompliance|0
4957139|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Noncompliance|3
4957140|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Lost to Follow-up|0
4957141|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Lost to Follow-up|14
4957142|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Lost to Follow-up|0
4957143|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Lost to Follow-up|8
4957144|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Withdrawal by Subject|0
4957145|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Withdrawal by Subject|11
4957146|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Withdrawal by Subject|0
4957147|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Withdrawal by Subject|10
4957148|NCT00262522|17044003|P4|Study Start Through 48 Weeks|Adverse Event|0
4957149|NCT00262522|17044004|P3|Study Start Through 48 Weeks|Adverse Event|10
4957150|NCT00262522|17044005|P2|Study Start Through 48 Weeks|Adverse Event|0
4957151|NCT00262522|17044006|P1|Study Start Through 48 Weeks|Adverse Event|16
4957152|NCT00262522|17044003|P4|Study Start Through 8 Weeks|Death|0
4957153|NCT00262522|17044004|P3|Study Start Through 8 Weeks|Death|0
4957154|NCT00262522|17044005|P2|Study Start Through 8 Weeks|Death|0
4957155|NCT00262522|17044006|P1|Study Start Through 8 Weeks|Death|1
4957156|NCT00262522|17044003|P4|Study Start Through 8 Weeks|Noncompliance|2
4957157|NCT00262522|17044004|P3|Study Start Through 8 Weeks|Noncompliance|2
4957158|NCT00262522|17044005|P2|Study Start Through 8 Weeks|Noncompliance|0
4957159|NCT00262522|17044006|P1|Study Start Through 8 Weeks|Noncompliance|0
4957160|NCT00262522|17044003|P4|Study Start Through 8 Weeks|Lost to Follow-up|2
4957161|NCT00262522|17044004|P3|Study Start Through 8 Weeks|Lost to Follow-up|3
4957162|NCT00262522|17044005|P2|Study Start Through 8 Weeks|Lost to Follow-up|2
4957163|NCT00262522|17044006|P1|Study Start Through 8 Weeks|Lost to Follow-up|1
4957164|NCT00262522|17044003|P4|Study Start Through 8 Weeks|Withdrawal by Subject|0
4957165|NCT00262522|17044004|P3|Study Start Through 8 Weeks|Withdrawal by Subject|3
4957166|NCT00262522|17044005|P2|Study Start Through 8 Weeks|Withdrawal by Subject|1
4957167|NCT00262522|17044006|P1|Study Start Through 8 Weeks|Withdrawal by Subject|1
4957168|NCT00262522|17044003|P4|Study Start Through 8 Weeks|Adverse Event|1
4957169|NCT00262522|17044004|P3|Study Start Through 8 Weeks|Adverse Event|3
4957170|NCT00262522|17044005|P2|Study Start Through 8 Weeks|Adverse Event|2
4957171|NCT00262522|17044006|P1|Study Start Through 8 Weeks|Adverse Event|1
4957172|NCT00262314|17044035|P1|Overall Study|Administrative withdrawal|30
4957173|NCT00262314|17044035|P1|Overall Study|Lost to Follow-up|70
4957174|NCT00262314|17044035|P1|Overall Study|Other|95
4957175|NCT00262314|17044035|P1|Overall Study|Patient's decision|92
4957176|NCT00262314|17044035|P1|Overall Study|Death|12
4957177|NCT00262314|17044035|P1|Overall Study|Changing physicians|38
4957178|NCT00262301|17044053|P3|Double-blind Phase|"worsening of HAE symptoms"|0
4957179|NCT00262301|17044054|P2|Double-blind Phase|"worsening of HAE symptoms"|1
4957180|NCT00262301|17044055|P1|Double-blind Phase|"worsening of HAE symptoms"|0
4957181|NCT00262301|17044053|P3|Double-blind Phase|Lost to Follow-up|0
4957182|NCT00262301|17044054|P2|Double-blind Phase|Lost to Follow-up|0
4957183|NCT00262301|17044055|P1|Double-blind Phase|Lost to Follow-up|1
4957184|NCT00262223|17044068|P2|12-month Post-treatment Follow-up|Lost to Follow-up|7
4957185|NCT00262223|17044069|P1|12-month Post-treatment Follow-up|Lost to Follow-up|7
4957186|NCT00262223|17044068|P2|6-month Post-treatment Follow-up|Lost to Follow-up|1
4957187|NCT00262223|17044069|P1|6-month Post-treatment Follow-up|Lost to Follow-up|6
4957188|NCT00262223|17044068|P2|1-week Post-treatment Follow-up|Lost to Follow-up|4
4957189|NCT00262223|17044069|P1|1-week Post-treatment Follow-up|Lost to Follow-up|4
4957190|NCT00262223|17044068|P2|Treatment Phase|Adverse Event|2
4957191|NCT00262223|17044069|P1|Treatment Phase|Adverse Event|1
4957192|NCT00262223|17044068|P2|Treatment Phase|Withdrawal by Subject|6
4957193|NCT00262223|17044069|P1|Treatment Phase|Withdrawal by Subject|3
4957194|NCT00262119|17044080|P3|Overall Study|Death|16
4957195|NCT00262119|17044081|P2|Overall Study|Death|19
4957196|NCT00262119|17044082|P1|Overall Study|Death|20
4957197|NCT00262119|17044080|P3|Overall Study|Lost to Follow-up|42
4957198|NCT00262119|17044081|P2|Overall Study|Lost to Follow-up|51
4957199|NCT00262119|17044082|P1|Overall Study|Lost to Follow-up|38
4957200|NCT00262080|17044102|P3|Repeat Dose Treatment Period|enrolled in EDEMA4|0
4957201|NCT00262080|17044103|P2|Repeat Dose Treatment Period|enrolled in EDEMA4|0
4957202|NCT00262080|17044104|P1|Repeat Dose Treatment Period|enrolled in EDEMA4|1
4957203|NCT00262080|17044102|P3|Repeat Dose Treatment Period|Decision to discontinue the study|2
4957204|NCT00262080|17044103|P2|Repeat Dose Treatment Period|Decision to discontinue the study|0
4957205|NCT00262080|17044104|P1|Repeat Dose Treatment Period|Decision to discontinue the study|0
4957206|NCT00262080|17044102|P3|Repeat Dose Treatment Period|Lost to Follow-up|2
4957207|NCT00262080|17044103|P2|Repeat Dose Treatment Period|Lost to Follow-up|0
4957208|NCT00262080|17044104|P1|Repeat Dose Treatment Period|Lost to Follow-up|2
4957209|NCT00262080|17044102|P3|Repeat Dose Treatment Period|Withdrawal by Subject|1
4957210|NCT00262080|17044103|P2|Repeat Dose Treatment Period|Withdrawal by Subject|1
4957211|NCT00262080|17044104|P1|Repeat Dose Treatment Period|Withdrawal by Subject|0
4957212|NCT00262080|17044102|P3|Repeat Dose Treatment Period|Adverse Event|0
4957213|NCT00262080|17044103|P2|Repeat Dose Treatment Period|Adverse Event|0
4957214|NCT00262080|17044104|P1|Repeat Dose Treatment Period|Adverse Event|1
4957215|NCT00262080|17044102|P3|Double Blind Treatment Period|Lost to Follow-up|0
4957216|NCT00262080|17044103|P2|Double Blind Treatment Period|Lost to Follow-up|0
4957217|NCT00262080|17044104|P1|Double Blind Treatment Period|Lost to Follow-up|1
4957218|NCT00262067|17044124|P4|Overall Study|Patient Withdrew for Survival Follow-up|9
4957219|NCT00262067|17044125|P3|Overall Study|Patient Withdrew for Survival Follow-up|23
4957220|NCT00262067|17044126|P2|Overall Study|Patient Withdrew for Survival Follow-up|7
4957221|NCT00262067|17044127|P1|Overall Study|Patient Withdrew for Survival Follow-up|23
4957222|NCT00262067|17044124|P4|Overall Study|Sponsor's Decision to Terminate Study|0
4957223|NCT00262067|17044125|P3|Overall Study|Sponsor's Decision to Terminate Study|0
4957224|NCT00262067|17044126|P2|Overall Study|Sponsor's Decision to Terminate Study|0
4957225|NCT00262067|17044127|P1|Overall Study|Sponsor's Decision to Terminate Study|1
4957226|NCT00262067|17044124|P4|Overall Study|Lost to Follow-up|5
4957227|NCT00262067|17044125|P3|Overall Study|Lost to Follow-up|7
4957228|NCT00262067|17044126|P2|Overall Study|Lost to Follow-up|4
4957229|NCT00262067|17044127|P1|Overall Study|Lost to Follow-up|5
4957230|NCT00262067|17044124|P4|Overall Study|Death|99
4957231|NCT00262067|17044125|P3|Overall Study|Death|186
4957232|NCT00262067|17044126|P2|Overall Study|Death|89
4957233|NCT00262067|17044127|P1|Overall Study|Death|190
4957234|NCT00262041|17044161|P3|Overall Study|Unable to classify|0
4957235|NCT00262041|17044162|P2|Overall Study|Unable to classify|0
4957236|NCT00262041|17044163|P1|Overall Study|Unable to classify|1
4957237|NCT00262041|17044161|P3|Overall Study|Lost to Follow-up|5
4957238|NCT00262041|17044162|P2|Overall Study|Lost to Follow-up|1
4957239|NCT00262041|17044163|P1|Overall Study|Lost to Follow-up|1
4957240|NCT00262041|17044161|P3|Overall Study|Withdrawal by Subject|1
4957241|NCT00262041|17044162|P2|Overall Study|Withdrawal by Subject|3
4957242|NCT00262041|17044163|P1|Overall Study|Withdrawal by Subject|0
4957243|NCT00262028|17044192|P9|Overall Study|Unable to classify|1
4957244|NCT00262028|17044193|P8|Overall Study|Unable to classify|0
4957245|NCT00262028|17044194|P7|Overall Study|Unable to classify|0
4957246|NCT00262028|17044195|P6|Overall Study|Unable to classify|0
4957247|NCT00262028|17044196|P5|Overall Study|Unable to classify|0
4957248|NCT00262028|17044197|P4|Overall Study|Unable to classify|0
4957249|NCT00262028|17044198|P3|Overall Study|Unable to classify|0
4957250|NCT00262028|17044199|P2|Overall Study|Unable to classify|3
4957251|NCT00262028|17044200|P1|Overall Study|Unable to classify|0
4957252|NCT00262028|17044192|P9|Overall Study|Protocol Violation|0
4957253|NCT00262028|17044193|P8|Overall Study|Protocol Violation|0
4957254|NCT00262028|17044194|P7|Overall Study|Protocol Violation|0
4957255|NCT00262028|17044195|P6|Overall Study|Protocol Violation|0
4957256|NCT00262028|17044196|P5|Overall Study|Protocol Violation|0
4957257|NCT00262028|17044197|P4|Overall Study|Protocol Violation|1
4957258|NCT00262028|17044198|P3|Overall Study|Protocol Violation|0
4957259|NCT00262028|17044199|P2|Overall Study|Protocol Violation|0
4957260|NCT00262028|17044200|P1|Overall Study|Protocol Violation|0
4957261|NCT00262028|17044192|P9|Overall Study|Administrative Reason|10
4957262|NCT00262028|17044193|P8|Overall Study|Administrative Reason|6
4957263|NCT00262028|17044194|P7|Overall Study|Administrative Reason|4
4957264|NCT00262028|17044195|P6|Overall Study|Administrative Reason|7
4957265|NCT00262028|17044196|P5|Overall Study|Administrative Reason|6
4957266|NCT00262028|17044197|P4|Overall Study|Administrative Reason|12
4957267|NCT00262028|17044198|P3|Overall Study|Administrative Reason|9
4957268|NCT00262028|17044199|P2|Overall Study|Administrative Reason|14
4957269|NCT00262028|17044200|P1|Overall Study|Administrative Reason|11
4957270|NCT00262028|17044192|P9|Overall Study|Lost to Follow-up|6
4957271|NCT00262028|17044193|P8|Overall Study|Lost to Follow-up|5
4957272|NCT00262028|17044194|P7|Overall Study|Lost to Follow-up|3
4957273|NCT00262028|17044195|P6|Overall Study|Lost to Follow-up|3
4957274|NCT00262028|17044196|P5|Overall Study|Lost to Follow-up|4
4957275|NCT00262028|17044197|P4|Overall Study|Lost to Follow-up|5
4957276|NCT00262028|17044198|P3|Overall Study|Lost to Follow-up|5
4957277|NCT00262028|17044199|P2|Overall Study|Lost to Follow-up|7
4957278|NCT00262028|17044200|P1|Overall Study|Lost to Follow-up|7
4957279|NCT00262028|17044192|P9|Overall Study|Withdrawal by Subject|2
4957280|NCT00262028|17044193|P8|Overall Study|Withdrawal by Subject|7
4957281|NCT00262028|17044194|P7|Overall Study|Withdrawal by Subject|5
4957282|NCT00262028|17044195|P6|Overall Study|Withdrawal by Subject|3
4957283|NCT00262028|17044196|P5|Overall Study|Withdrawal by Subject|2
4957284|NCT00262028|17044197|P4|Overall Study|Withdrawal by Subject|5
4957285|NCT00262028|17044198|P3|Overall Study|Withdrawal by Subject|6
4957286|NCT00262028|17044199|P2|Overall Study|Withdrawal by Subject|3
4957287|NCT00262028|17044200|P1|Overall Study|Withdrawal by Subject|6
4957288|NCT00262002|17044262|P7|Overall Study|Unable to classify|2
4957289|NCT00262002|17044263|P6|Overall Study|Unable to classify|0
4957290|NCT00262002|17044264|P5|Overall Study|Unable to classify|0
4957291|NCT00262002|17044265|P4|Overall Study|Unable to classify|0
4957292|NCT00262002|17044266|P3|Overall Study|Unable to classify|0
4957294|NCT00262002|17044268|P1|Overall Study|Unable to classify|0
4957295|NCT00262002|17044262|P7|Overall Study|Protocol Violation|2
4957296|NCT00262002|17044263|P6|Overall Study|Protocol Violation|3
4957297|NCT00262002|17044264|P5|Overall Study|Protocol Violation|5
4957298|NCT00262002|17044265|P4|Overall Study|Protocol Violation|2
4957299|NCT00262002|17044266|P3|Overall Study|Protocol Violation|0
4957300|NCT00262002|17044267|P2|Overall Study|Protocol Violation|2
4957301|NCT00262002|17044268|P1|Overall Study|Protocol Violation|3
4957302|NCT00262002|17044262|P7|Overall Study|Inapropriate enrollment|0
4957303|NCT00262002|17044263|P6|Overall Study|Inapropriate enrollment|0
4957304|NCT00262002|17044264|P5|Overall Study|Inapropriate enrollment|0
4957305|NCT00262002|17044265|P4|Overall Study|Inapropriate enrollment|0
4957306|NCT00262002|17044266|P3|Overall Study|Inapropriate enrollment|0
4957307|NCT00262002|17044267|P2|Overall Study|Inapropriate enrollment|1
4957308|NCT00262002|17044268|P1|Overall Study|Inapropriate enrollment|0
4957309|NCT00262002|17044262|P7|Overall Study|Lost to Follow-up|0
4957310|NCT00262002|17044263|P6|Overall Study|Lost to Follow-up|1
4957311|NCT00262002|17044264|P5|Overall Study|Lost to Follow-up|0
4957312|NCT00262002|17044265|P4|Overall Study|Lost to Follow-up|2
4957313|NCT00262002|17044266|P3|Overall Study|Lost to Follow-up|0
4957314|NCT00262002|17044267|P2|Overall Study|Lost to Follow-up|0
4957315|NCT00262002|17044268|P1|Overall Study|Lost to Follow-up|2
4957316|NCT00262002|17044262|P7|Overall Study|Withdrawal by Subject|2
4957317|NCT00262002|17044263|P6|Overall Study|Withdrawal by Subject|2
4957318|NCT00262002|17044264|P5|Overall Study|Withdrawal by Subject|2
4957319|NCT00262002|17044265|P4|Overall Study|Withdrawal by Subject|1
4957320|NCT00262002|17044266|P3|Overall Study|Withdrawal by Subject|0
4957321|NCT00262002|17044267|P2|Overall Study|Withdrawal by Subject|2
4957322|NCT00262002|17044268|P1|Overall Study|Withdrawal by Subject|4
4957323|NCT00262002|17044262|P7|Overall Study|Adverse Event|0
4957324|NCT00262002|17044263|P6|Overall Study|Adverse Event|1
4957325|NCT00262002|17044264|P5|Overall Study|Adverse Event|0
4957326|NCT00262002|17044265|P4|Overall Study|Adverse Event|0
4957327|NCT00262002|17044266|P3|Overall Study|Adverse Event|0
4957328|NCT00262002|17044267|P2|Overall Study|Adverse Event|1
4957329|NCT00262002|17044268|P1|Overall Study|Adverse Event|2
4957330|NCT00261950|17044361|P1|Overall Study|Protocol specified Criteria|11
4957331|NCT00261950|17044361|P1|Overall Study|Physician Decision|1
4957332|NCT00261950|17044361|P1|Overall Study|Other|1
4957333|NCT00261950|17044361|P1|Overall Study|Withdrawal by Subject|5
4957334|NCT00261950|17044361|P1|Overall Study|Death|6
4957335|NCT00261950|17044361|P1|Overall Study|Lost to Follow-up|2
4957336|NCT00261846|17044386|P12|Period 2: Part 2 (Efficacy)|Extension study|1
4957337|NCT00261846|17044387|P11|Period 2: Part 2 (Efficacy)|Extension study|1
4957338|NCT00261846|17044388|P10|Period 2: Part 2 (Efficacy)|Extension study|9
4957339|NCT00261846|17044389|P9|Period 2: Part 2 (Efficacy)|Extension study|5
4957340|NCT00261846|17044390|P8|Period 2: Part 2 (Efficacy)|Extension study|9
4957341|NCT00261846|17044391|P7|Period 2: Part 2 (Efficacy)|Extension study|4
4957342|NCT00261846|17044392|P6|Period 2: Part 2 (Efficacy)|Extension study|0
4957343|NCT00261846|17044393|P5|Period 2: Part 2 (Efficacy)|Extension study|27
4957344|NCT00261846|17044394|P4|Period 2: Part 2 (Efficacy)|Extension study|61
4957345|NCT00261846|17044395|P3|Period 2: Part 2 (Efficacy)|Extension study|0
4957346|NCT00261846|17044396|P2|Period 2: Part 2 (Efficacy)|Extension study|0
4957347|NCT00261846|17044397|P1|Period 2: Part 2 (Efficacy)|Extension study|0
4957348|NCT00261846|17044386|P12|Period 2: Part 2 (Efficacy)|Death|22
4957349|NCT00261846|17044387|P11|Period 2: Part 2 (Efficacy)|Death|44
4957350|NCT00261846|17044388|P10|Period 2: Part 2 (Efficacy)|Death|30
4957351|NCT00261846|17044389|P9|Period 2: Part 2 (Efficacy)|Death|3
4957352|NCT00261846|17044390|P8|Period 2: Part 2 (Efficacy)|Death|12
4957353|NCT00261846|17044391|P7|Period 2: Part 2 (Efficacy)|Death|10
4957354|NCT00261846|17044392|P6|Period 2: Part 2 (Efficacy)|Death|1
4957355|NCT00261846|17044393|P5|Period 2: Part 2 (Efficacy)|Death|7
4957356|NCT00261846|17044394|P4|Period 2: Part 2 (Efficacy)|Death|37
4957357|NCT00261846|17044395|P3|Period 2: Part 2 (Efficacy)|Death|0
4957358|NCT00261846|17044396|P2|Period 2: Part 2 (Efficacy)|Death|0
4957359|NCT00261846|17044397|P1|Period 2: Part 2 (Efficacy)|Death|0
4957360|NCT00261846|17044386|P12|Period 2: Part 2 (Efficacy)|Other|0
4957361|NCT00261846|17044387|P11|Period 2: Part 2 (Efficacy)|Other|0
4957362|NCT00261846|17044388|P10|Period 2: Part 2 (Efficacy)|Other|4
4957363|NCT00261846|17044389|P9|Period 2: Part 2 (Efficacy)|Other|4
4957364|NCT00261846|17044390|P8|Period 2: Part 2 (Efficacy)|Other|5
4957365|NCT00261846|17044391|P7|Period 2: Part 2 (Efficacy)|Other|1
4957366|NCT00261846|17044392|P6|Period 2: Part 2 (Efficacy)|Other|0
4957367|NCT00261846|17044393|P5|Period 2: Part 2 (Efficacy)|Other|4
4957368|NCT00261846|17044394|P4|Period 2: Part 2 (Efficacy)|Other|15
4957369|NCT00261846|17044395|P3|Period 2: Part 2 (Efficacy)|Other|0
4957370|NCT00261846|17044396|P2|Period 2: Part 2 (Efficacy)|Other|0
4957371|NCT00261846|17044397|P1|Period 2: Part 2 (Efficacy)|Other|0
4957372|NCT00261846|17044386|P12|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4957373|NCT00261846|17044387|P11|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4957374|NCT00261846|17044388|P10|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4957375|NCT00261846|17044389|P9|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1
4957376|NCT00261846|17044390|P8|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4957377|NCT00261846|17044391|P7|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4957378|NCT00261846|17044392|P6|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4957379|NCT00261846|17044393|P5|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4
4957380|NCT00261846|17044394|P4|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12
4957381|NCT00261846|17044395|P3|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4957382|NCT00261846|17044396|P2|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4957383|NCT00261846|17044397|P1|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0
4957384|NCT00261846|17044386|P12|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4957385|NCT00261846|17044387|P11|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4957386|NCT00261846|17044388|P10|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2
4957387|NCT00261846|17044389|P9|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4957388|NCT00261846|17044390|P8|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
4957389|NCT00261846|17044391|P7|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3
4957390|NCT00261846|17044392|P6|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1
4957391|NCT00261846|17044393|P5|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8
4957392|NCT00261846|17044394|P4|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9
4957393|NCT00261846|17044395|P3|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4957394|NCT00261846|17044396|P2|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4957395|NCT00261846|17044397|P1|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0
4957396|NCT00261846|17044386|P12|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957397|NCT00261846|17044387|P11|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957398|NCT00261846|17044388|P10|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957399|NCT00261846|17044389|P9|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
4957400|NCT00261846|17044390|P8|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957401|NCT00261846|17044391|P7|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957402|NCT00261846|17044392|P6|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957403|NCT00261846|17044393|P5|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957404|NCT00261846|17044394|P4|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1
4957405|NCT00261846|17044395|P3|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957406|NCT00261846|17044396|P2|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957407|NCT00261846|17044397|P1|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0
4957408|NCT00261846|17044386|P12|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957409|NCT00261846|17044387|P11|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957410|NCT00261846|17044388|P10|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957411|NCT00261846|17044389|P9|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957412|NCT00261846|17044390|P8|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957413|NCT00261846|17044391|P7|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957414|NCT00261846|17044392|P6|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957415|NCT00261846|17044393|P5|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957416|NCT00261846|17044394|P4|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0
4957417|NCT00261846|17044395|P3|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12
4957418|NCT00261846|17044396|P2|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
4957419|NCT00261846|17044397|P1|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3
4957420|NCT00261833|17044656|P2|Overall Study|Not interested in being participant|1
4957421|NCT00261833|17044657|P1|Overall Study|Not interested in being participant|0
4957422|NCT00261833|17044656|P2|Overall Study|Missing reason|0
4957423|NCT00261833|17044657|P1|Overall Study|Missing reason|1
4957424|NCT00261833|17044656|P2|Overall Study|Lung transplantation|1
4957425|NCT00261833|17044657|P1|Overall Study|Lung transplantation|1
4957426|NCT00261833|17044656|P2|Overall Study|Suspicion of pulmonary cancer|1
4957427|NCT00261833|17044657|P1|Overall Study|Suspicion of pulmonary cancer|0
4957428|NCT00261833|17044656|P2|Overall Study|Protocol Violation|1
4957429|NCT00261833|17044657|P1|Overall Study|Protocol Violation|0
4957430|NCT00261833|17044656|P2|Overall Study|Withdrawal by Subject|7
4957431|NCT00261833|17044657|P1|Overall Study|Withdrawal by Subject|5
4957432|NCT00261833|17044656|P2|Overall Study|Adverse Event|4
4957433|NCT00261833|17044657|P1|Overall Study|Adverse Event|1
4957434|NCT00261833|17044656|P2|Overall Study|Death|3
4957435|NCT00261833|17044657|P1|Overall Study|Death|1
4957436|NCT00261716|17044691|P2|Overall Study|Lost to Follow-up|2
4957437|NCT00261716|17044692|P1|Overall Study|Lost to Follow-up|0
4957438|NCT00261716|17044691|P2|Overall Study|Withdrawal by Subject|8
4957439|NCT00261716|17044692|P1|Overall Study|Withdrawal by Subject|6
4957440|NCT00261495|17044712|P2|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0
4957441|NCT00261495|17044713|P1|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1
4957442|NCT00261495|17044712|P2|Extension Phase (Weeks 24 to 52)|Non-compliance|0
4957443|NCT00261495|17044713|P1|Extension Phase (Weeks 24 to 52)|Non-compliance|1
4957444|NCT00261495|17044712|P2|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1
4957445|NCT00261495|17044713|P1|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0
4957446|NCT00261495|17044712|P2|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1
4957447|NCT00261495|17044713|P1|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0
4957448|NCT00261495|17044712|P2|Extension Phase (Weeks 24 to 52)|Adverse Event|1
4957449|NCT00261495|17044713|P1|Extension Phase (Weeks 24 to 52)|Adverse Event|4
4957450|NCT00261495|17044712|P2|Extension Phase (Weeks 24 to 52)|Other|2
4957451|NCT00261495|17044713|P1|Extension Phase (Weeks 24 to 52)|Other|4
4957452|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0
4957453|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2
4957454|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0
4957610|NCT00259740|17045282|P2|Overall Study|Other|0
4957455|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2
4957456|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
4957457|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1
4957458|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Other|5
4957459|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Other|6
4957460|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2
4957461|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5
4957462|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5
4957463|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1
4957464|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5
4957465|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6
4957466|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10
4957467|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14
4957468|NCT00261495|17044712|P2|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20
4957469|NCT00261495|17044713|P1|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29
4957470|NCT00261495|17044712|P2|Titration Phase (Weeks 0 to 4)|Protocol Violation|4
4957471|NCT00261495|17044713|P1|Titration Phase (Weeks 0 to 4)|Protocol Violation|1
4957472|NCT00261495|17044712|P2|Titration Phase (Weeks 0 to 4)|Non-compliance|5
4957473|NCT00261495|17044713|P1|Titration Phase (Weeks 0 to 4)|Non-compliance|2
4957474|NCT00261495|17044712|P2|Titration Phase (Weeks 0 to 4)|Physician Decision|1
4957475|NCT00261495|17044713|P1|Titration Phase (Weeks 0 to 4)|Physician Decision|3
4957476|NCT00261495|17044712|P2|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
4957477|NCT00261495|17044713|P1|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8
4957478|NCT00261495|17044712|P2|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11
4957479|NCT00261495|17044713|P1|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6
4957480|NCT00261495|17044712|P2|Titration Phase (Weeks 0 to 4)|Adverse Event|36
4957481|NCT00261495|17044713|P1|Titration Phase (Weeks 0 to 4)|Adverse Event|28
4957482|NCT00261443|17044877|P3|4: Extension Phase|Lost to Follow-up|0
4957483|NCT00261443|17044878|P2|4: Extension Phase|Lost to Follow-up|1
4957484|NCT00261443|17044879|P1|4: Extension Phase|Lost to Follow-up|0
4957485|NCT00261443|17044877|P3|4: Extension Phase|Withdrawal by Subject|2
4957486|NCT00261443|17044878|P2|4: Extension Phase|Withdrawal by Subject|1
4957487|NCT00261443|17044879|P1|4: Extension Phase|Withdrawal by Subject|0
4957488|NCT00261443|17044877|P3|4: Extension Phase|Adverse Event|0
4957489|NCT00261443|17044878|P2|4: Extension Phase|Adverse Event|1
4957490|NCT00261443|17044879|P1|4: Extension Phase|Adverse Event|0
4957491|NCT00261443|17044877|P3|3: Assessment of Relapse|Other Reasons|3
4957492|NCT00261443|17044878|P2|3: Assessment of Relapse|Other Reasons|4
4957493|NCT00261443|17044879|P1|3: Assessment of Relapse|Other Reasons|0
4957494|NCT00261443|17044877|P3|3: Assessment of Relapse|Administrative Reason By Sponsor|2
4957495|NCT00261443|17044878|P2|3: Assessment of Relapse|Administrative Reason By Sponsor|0
4957496|NCT00261443|17044879|P1|3: Assessment of Relapse|Administrative Reason By Sponsor|0
4957497|NCT00261443|17044877|P3|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1
4957498|NCT00261443|17044878|P2|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2
4957499|NCT00261443|17044879|P1|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0
4957500|NCT00261443|17044877|P3|3: Assessment of Relapse|Pregnancy|1
4957501|NCT00261443|17044878|P2|3: Assessment of Relapse|Pregnancy|2
4957502|NCT00261443|17044879|P1|3: Assessment of Relapse|Pregnancy|0
4957503|NCT00261443|17044877|P3|3: Assessment of Relapse|Poor/Noncompliance|3
4957504|NCT00261443|17044878|P2|3: Assessment of Relapse|Poor/Noncompliance|5
4957505|NCT00261443|17044879|P1|3: Assessment of Relapse|Poor/Noncompliance|0
4957506|NCT00261443|17044877|P3|3: Assessment of Relapse|Lost to Follow-up|6
4957507|NCT00261443|17044878|P2|3: Assessment of Relapse|Lost to Follow-up|7
4957508|NCT00261443|17044879|P1|3: Assessment of Relapse|Lost to Follow-up|0
4957509|NCT00261443|17044877|P3|3: Assessment of Relapse|Death|1
4957510|NCT00261443|17044878|P2|3: Assessment of Relapse|Death|0
4957511|NCT00261443|17044879|P1|3: Assessment of Relapse|Death|0
4957512|NCT00261443|17044877|P3|3: Assessment of Relapse|Withdrawal by Subject|15
4957513|NCT00261443|17044878|P2|3: Assessment of Relapse|Withdrawal by Subject|14
4957514|NCT00261443|17044879|P1|3: Assessment of Relapse|Withdrawal by Subject|0
4957515|NCT00261443|17044877|P3|3: Assessment of Relapse|Adverse Event|19
4957516|NCT00261443|17044878|P2|3: Assessment of Relapse|Adverse Event|15
4957517|NCT00261443|17044879|P1|3: Assessment of Relapse|Adverse Event|0
4957518|NCT00261443|17044877|P3|3: Assessment of Relapse|Lack of Efficacy|14
4957519|NCT00261443|17044878|P2|3: Assessment of Relapse|Lack of Efficacy|31
4957520|NCT00261443|17044879|P1|3: Assessment of Relapse|Lack of Efficacy|0
4957521|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Other Reasons|0
4957522|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Other Reasons|0
4957523|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Other Reasons|13
4957524|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
4957525|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0
4957526|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1
4957527|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
4957528|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0
4957529|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32
4957530|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Pregnancy|0
4957531|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Pregnancy|0
4957532|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Pregnancy|1
4957533|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
4957534|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Poor/Noncompliance|0
4957535|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Poor/Noncompliance|33
4957536|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Lost to Follow-up|0
4957537|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Lost to Follow-up|0
4957538|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Lost to Follow-up|59
4957539|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
4957540|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Withdrawal by Subject|0
4957541|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Withdrawal by Subject|65
4957542|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Adverse Event|0
4957543|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Adverse Event|0
4957544|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Adverse Event|93
4957545|NCT00261443|17044877|P3|2: Stability & Maintenance of Stability|Lack of Efficacy|0
4957546|NCT00261443|17044878|P2|2: Stability & Maintenance of Stability|Lack of Efficacy|0
4957547|NCT00261443|17044879|P1|2: Stability & Maintenance of Stability|Lack of Efficacy|43
4957548|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Other Reasons|0
4957549|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Other Reasons|0
4957550|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Other Reasons|16
4957551|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
4957552|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0
4957553|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307
4957554|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Pregnancy|0
4957555|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Pregnancy|0
4957556|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Pregnancy|1
4957557|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
4957558|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0
4957559|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23
4957560|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
4957561|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0
4957562|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111
4957563|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
4957564|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0
4957565|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93
4957566|NCT00261443|17044877|P3|1: Confirmation of Partial Nonresponse|Adverse Event|0
4957567|NCT00261443|17044878|P2|1: Confirmation of Partial Nonresponse|Adverse Event|0
4957568|NCT00261443|17044879|P1|1: Confirmation of Partial Nonresponse|Adverse Event|33
4957569|NCT00260832|17045164|P2|Overall Study|Protocol Violation|1
4957570|NCT00260832|17045165|P1|Overall Study|Protocol Violation|3
4957571|NCT00260832|17045164|P2|Overall Study|Other|7
4957572|NCT00260832|17045165|P1|Overall Study|Other|10
4957573|NCT00260832|17045164|P2|Overall Study|Death|62
4957574|NCT00260832|17045165|P1|Overall Study|Death|43
4957575|NCT00260832|17045164|P2|Overall Study|Physician Decision|9
4957576|NCT00260832|17045165|P1|Overall Study|Physician Decision|15
4957577|NCT00260832|17045164|P2|Overall Study|Withdrawal by Subject|17
4957578|NCT00260832|17045165|P1|Overall Study|Withdrawal by Subject|15
4957579|NCT00260832|17045164|P2|Overall Study|Progression|96
4957580|NCT00260832|17045165|P1|Overall Study|Progression|116
4957581|NCT00260832|17045164|P2|Overall Study|Adverse Event|19
4957582|NCT00260832|17045165|P1|Overall Study|Adverse Event|26
4957583|NCT00260533|17045194|P2|Overall Study|Other|3
4957584|NCT00260533|17045195|P1|Overall Study|Other|3
4957585|NCT00260429|17045203|P2|Overall Study|scheduled hand surgery|0
4957586|NCT00260429|17045204|P1|Overall Study|scheduled hand surgery|1
4957587|NCT00260429|17045203|P2|Overall Study|failure to follow appointments|0
4957588|NCT00260429|17045204|P1|Overall Study|failure to follow appointments|1
4957589|NCT00260208|17045212|P2|Overall Study|Missing|16
4957590|NCT00260208|17045213|P1|Overall Study|Missing|18
4957591|NCT00260208|17045212|P2|Overall Study|Death|10
4957592|NCT00260208|17045213|P1|Overall Study|Death|12
4957593|NCT00260208|17045212|P2|Overall Study|Lost to Follow-up|1
4957594|NCT00260208|17045213|P1|Overall Study|Lost to Follow-up|6
4957595|NCT00260208|17045212|P2|Overall Study|Subject withdrew consent|7
4957596|NCT00260208|17045213|P1|Overall Study|Subject withdrew consent|11
4957597|NCT00260065|17045256|P1|Overall Study|Medication Noncompliance|1
4957598|NCT00260065|17045256|P1|Overall Study|Not otherwise specified|8
4957599|NCT00260065|17045256|P1|Overall Study|Physician Decision|19
4957600|NCT00260065|17045256|P1|Overall Study|Withdrawal by Subject|13
4957601|NCT00260065|17045256|P1|Overall Study|Death|13
4957602|NCT00260065|17045256|P1|Overall Study|Adverse Event|17
4957603|NCT00260065|17045256|P1|Overall Study|Progressive Disease|22
4957604|NCT00259857|17045263|P2|24 Months Treatment|Lost to Follow-up|3
4957605|NCT00259857|17045264|P1|24 Months Treatment|Lost to Follow-up|0
4957606|NCT00259857|17045263|P2|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2
4957607|NCT00259857|17045264|P1|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1
4957608|NCT00259740|17045282|P2|Overall Study|Requirement for alternative therapy|4
4957609|NCT00259740|17045283|P1|Overall Study|Requirement for alternative therapy|0
4957611|NCT00259740|17045283|P1|Overall Study|Other|3
4957612|NCT00259740|17045282|P2|Overall Study|Ongoing|3
4957613|NCT00259740|17045283|P1|Overall Study|Ongoing|17
4957614|NCT00259740|17045282|P2|Overall Study|Disease progression|36
4957615|NCT00259740|17045283|P1|Overall Study|Disease progression|19
4957616|NCT00259740|17045282|P2|Overall Study|Death|1
4957617|NCT00259740|17045283|P1|Overall Study|Death|1
4957618|NCT00259740|17045282|P2|Overall Study|Withdrawal by Subject|6
4957619|NCT00259740|17045283|P1|Overall Study|Withdrawal by Subject|2
4957620|NCT00259740|17045282|P2|Overall Study|Adverse Event|2
4957621|NCT00259740|17045283|P1|Overall Study|Adverse Event|0
4957622|NCT00259740|17045282|P2|Overall Study|Physician Decision|1
4957623|NCT00259740|17045283|P1|Overall Study|Physician Decision|1
4957624|NCT00259649|17045293|P1|Overall Study|irregular menses|3
4957625|NCT00259649|17045293|P1|Overall Study|Lost to Follow-up|7
4957626|NCT00259610|17045301|P4|Overall Study|Serious Adverse Event|2
4957627|NCT00259610|17045302|P3|Overall Study|Serious Adverse Event|2
4957628|NCT00259610|17045303|P2|Overall Study|Serious Adverse Event|2
4957629|NCT00259610|17045304|P1|Overall Study|Serious Adverse Event|8
4957630|NCT00259610|17045301|P4|Overall Study|Adverse Event|2
4957631|NCT00259610|17045302|P3|Overall Study|Adverse Event|5
4957632|NCT00259610|17045303|P2|Overall Study|Adverse Event|4
4957633|NCT00259610|17045304|P1|Overall Study|Adverse Event|3
4957634|NCT00259610|17045301|P4|Overall Study|non medical reason|3
4957635|NCT00259610|17045302|P3|Overall Study|non medical reason|10
4957636|NCT00259610|17045303|P2|Overall Study|non medical reason|2
4957637|NCT00259610|17045304|P1|Overall Study|non medical reason|6
4957638|NCT00259610|17045301|P4|Overall Study|Death|0
4957639|NCT00259610|17045302|P3|Overall Study|Death|2
4957640|NCT00259610|17045303|P2|Overall Study|Death|1
4957641|NCT00259610|17045304|P1|Overall Study|Death|1
4957642|NCT00259610|17045301|P4|Overall Study|Physician Decision|2
4957643|NCT00259610|17045302|P3|Overall Study|Physician Decision|7
4957644|NCT00259610|17045303|P2|Overall Study|Physician Decision|4
4957645|NCT00259610|17045304|P1|Overall Study|Physician Decision|6
4957646|NCT00259610|17045301|P4|Overall Study|Lost to Follow-up|15
4957647|NCT00259610|17045302|P3|Overall Study|Lost to Follow-up|18
4957648|NCT00259610|17045303|P2|Overall Study|Lost to Follow-up|8
4957649|NCT00259610|17045304|P1|Overall Study|Lost to Follow-up|19
4957650|NCT00259610|17045301|P4|Overall Study|Withdrawal by Subject|19
4957651|NCT00259610|17045302|P3|Overall Study|Withdrawal by Subject|29
4957652|NCT00259610|17045303|P2|Overall Study|Withdrawal by Subject|25
4957653|NCT00259610|17045304|P1|Overall Study|Withdrawal by Subject|33
4957654|NCT00259298|17045318|P1|Overall Study|Physician Decision|2
4957655|NCT00259298|17045318|P1|Overall Study|Withdrawal by Subject|1
4957656|NCT00259272|17045336|P4|Overall Study|Lost to Follow-up|1
4957657|NCT00259272|17045337|P3|Overall Study|Lost to Follow-up|0
4957658|NCT00259272|17045338|P2|Overall Study|Lost to Follow-up|0
4957659|NCT00259272|17045339|P1|Overall Study|Lost to Follow-up|1
4957660|NCT00259272|17045336|P4|Overall Study|Withdrawal by Subject|7
4957661|NCT00259272|17045337|P3|Overall Study|Withdrawal by Subject|2
4957662|NCT00259272|17045338|P2|Overall Study|Withdrawal by Subject|2
4957663|NCT00259272|17045339|P1|Overall Study|Withdrawal by Subject|4
4957664|NCT00259272|17045336|P4|Overall Study|Sponsor Decision|0
4957665|NCT00259272|17045337|P3|Overall Study|Sponsor Decision|0
4957666|NCT00259272|17045338|P2|Overall Study|Sponsor Decision|1
4957667|NCT00259272|17045339|P1|Overall Study|Sponsor Decision|0
4957668|NCT00259272|17045336|P4|Overall Study|Protocol Violation|1
4957669|NCT00259272|17045337|P3|Overall Study|Protocol Violation|0
4957670|NCT00259272|17045338|P2|Overall Study|Protocol Violation|0
4957671|NCT00259272|17045339|P1|Overall Study|Protocol Violation|2
4957672|NCT00259272|17045336|P4|Overall Study|Physician Decision|3
4957673|NCT00259272|17045337|P3|Overall Study|Physician Decision|1
4957674|NCT00259272|17045338|P2|Overall Study|Physician Decision|2
4957675|NCT00259272|17045339|P1|Overall Study|Physician Decision|1
4957676|NCT00259272|17045336|P4|Overall Study|Lack of Efficacy|6
4957677|NCT00259272|17045337|P3|Overall Study|Lack of Efficacy|2
4957678|NCT00259272|17045338|P2|Overall Study|Lack of Efficacy|1
4957679|NCT00259272|17045339|P1|Overall Study|Lack of Efficacy|5
4957680|NCT00259272|17045336|P4|Overall Study|Adverse Event|3
4957681|NCT00259272|17045337|P3|Overall Study|Adverse Event|0
4957682|NCT00259272|17045338|P2|Overall Study|Adverse Event|1
4957683|NCT00259272|17045339|P1|Overall Study|Adverse Event|2
4957684|NCT00259012|17045435|P2|Overall Study|Protocol Violation|1
4957685|NCT00259012|17045436|P1|Overall Study|Protocol Violation|1
4957686|NCT00259012|17045435|P2|Overall Study|Lost to Follow-up|1
4957687|NCT00259012|17045436|P1|Overall Study|Lost to Follow-up|0
4957688|NCT00259012|17045435|P2|Overall Study|Physician Decision|1
4957689|NCT00259012|17045436|P1|Overall Study|Physician Decision|0
4957690|NCT00259012|17045435|P2|Overall Study|Withdrawal by Subject|0
4957691|NCT00259012|17045436|P1|Overall Study|Withdrawal by Subject|1
4957692|NCT00259012|17045435|P2|Overall Study|Adverse Event|1
4957693|NCT00259012|17045436|P1|Overall Study|Adverse Event|0
4957694|NCT00258960|17045468|P1|Overall Study|Mistake|2
4957695|NCT00258960|17045468|P1|Overall Study|Withdrawal by Subject|1
4957696|NCT00258960|17045468|P1|Overall Study|Physician Decision|1
4957697|NCT00258960|17045468|P1|Overall Study|Adverse Event|4
4957698|NCT00258960|17045468|P1|Overall Study|Disease Progression|7
4957699|NCT00258960|17045468|P1|Overall Study|Death|2
4957700|NCT00258895|17045484|P2|Overall Study|Withdrawal by Subject|0
4957701|NCT00258895|17045485|P1|Overall Study|Withdrawal by Subject|1
4957702|NCT00258895|17045484|P2|Overall Study|Protocol Violation|2
4957703|NCT00258895|17045485|P1|Overall Study|Protocol Violation|6
4957704|NCT00258895|17045484|P2|Overall Study|Lost to Follow-up|1
4957705|NCT00258895|17045485|P1|Overall Study|Lost to Follow-up|3
4957706|NCT00258856|17045521|P4|Overall Study|Non-compliance|1
4957707|NCT00258856|17045522|P3|Overall Study|Non-compliance|0
4957708|NCT00258856|17045523|P2|Overall Study|Non-compliance|0
4957709|NCT00258856|17045524|P1|Overall Study|Non-compliance|2
4957710|NCT00258856|17045521|P4|Overall Study|Lost to Follow-up|0
4957711|NCT00258856|17045522|P3|Overall Study|Lost to Follow-up|2
4957712|NCT00258856|17045523|P2|Overall Study|Lost to Follow-up|0
4957713|NCT00258856|17045524|P1|Overall Study|Lost to Follow-up|1
4957714|NCT00258674|17045565|P3|Overall Study|Death|34
4957715|NCT00258674|17045566|P2|Overall Study|Death|53
4957716|NCT00258674|17045567|P1|Overall Study|Death|32
4957717|NCT00258440|17045626|P3|Overall Study|Withdrawal by Subject|1
4957718|NCT00258440|17045627|P2|Overall Study|Withdrawal by Subject|0
4957719|NCT00258440|17045628|P1|Overall Study|Withdrawal by Subject|0
4957720|NCT00258154|17045666|P2|Overall Study|Patient Moved|1
4957721|NCT00258154|17045667|P1|Overall Study|Patient Moved|3
4957722|NCT00258154|17045666|P2|Overall Study|Withdrawal by Subject|4
4957723|NCT00258154|17045667|P1|Overall Study|Withdrawal by Subject|3
4957724|NCT00258154|17045666|P2|Overall Study|Protocol Violation|1
4957725|NCT00258154|17045667|P1|Overall Study|Protocol Violation|2
4957726|NCT00258154|17045666|P2|Overall Study|Lost to Follow-up|1
4957727|NCT00258154|17045667|P1|Overall Study|Lost to Follow-up|0
4957728|NCT00258154|17045666|P2|Overall Study|Adverse Event|0
4957729|NCT00258154|17045667|P1|Overall Study|Adverse Event|1
4957730|NCT00257920|17045762|P2|Period: Second Intervention|Other|1
4957731|NCT00257920|17045763|P1|Period: Second Intervention|Other|2
4957732|NCT00257920|17045762|P2|Period: Washout Period of Two Weeks|Lost to Follow-up|1
4957733|NCT00257920|17045763|P1|Period: Washout Period of Two Weeks|Lost to Follow-up|0
4957734|NCT00257725|17045786|P1|Overall Study|Adverse Event|3
4957735|NCT00257660|17045825|P2|Overall Study|No longer wanted to do blood draws|0
4957736|NCT00257660|17045826|P1|Overall Study|No longer wanted to do blood draws|1
4957737|NCT00257660|17045825|P2|Overall Study|PI & Subject Schedule Conflicts|0
4957738|NCT00257660|17045826|P1|Overall Study|PI & Subject Schedule Conflicts|1
4957739|NCT00257660|17045825|P2|Overall Study|Lost to Follow-up|0
4957740|NCT00257660|17045826|P1|Overall Study|Lost to Follow-up|1
4957741|NCT00257660|17045825|P2|Overall Study|Withdrawal by Subject|0
4957742|NCT00257660|17045826|P1|Overall Study|Withdrawal by Subject|2
4957743|NCT00257660|17045825|P2|Overall Study|Lack of Efficacy|23
4957744|NCT00257660|17045826|P1|Overall Study|Lack of Efficacy|5
4957745|NCT00257608|17045856|P3|Post Chemotherapy Phase|Not treated|7
4957746|NCT00257608|17045857|P2|Post Chemotherapy Phase|Not treated|4
4957747|NCT00257608|17045858|P1|Post Chemotherapy Phase|Not treated|0
4957748|NCT00257608|17045856|P3|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
4957749|NCT00257608|17045857|P2|Post Chemotherapy Phase|Sponsor's decision to terminate study|1
4957750|NCT00257608|17045858|P1|Post Chemotherapy Phase|Sponsor's decision to terminate study|0
4957751|NCT00257608|17045856|P3|Post Chemotherapy Phase|Physician Decision|11
4957752|NCT00257608|17045857|P2|Post Chemotherapy Phase|Physician Decision|8
4957753|NCT00257608|17045858|P1|Post Chemotherapy Phase|Physician Decision|0
4957754|NCT00257608|17045856|P3|Post Chemotherapy Phase|Lost to Follow-up|1
4957755|NCT00257608|17045857|P2|Post Chemotherapy Phase|Lost to Follow-up|0
4957756|NCT00257608|17045858|P1|Post Chemotherapy Phase|Lost to Follow-up|0
4957757|NCT00257608|17045856|P3|Post Chemotherapy Phase|Unrelated intercurrent illness|1
4957758|NCT00257608|17045857|P2|Post Chemotherapy Phase|Unrelated intercurrent illness|0
4957759|NCT00257608|17045858|P1|Post Chemotherapy Phase|Unrelated intercurrent illness|0
4957760|NCT00257608|17045856|P3|Post Chemotherapy Phase|Patient's decision to discontinue|8
4957761|NCT00257608|17045857|P2|Post Chemotherapy Phase|Patient's decision to discontinue|4
4957762|NCT00257608|17045858|P1|Post Chemotherapy Phase|Patient's decision to discontinue|0
4957763|NCT00257608|17045856|P3|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
4957764|NCT00257608|17045857|P2|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5
4957765|NCT00257608|17045858|P1|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0
4957766|NCT00257608|17045856|P3|Post Chemotherapy Phase|Unwillingness or inability to comply|5
4957767|NCT00257608|17045857|P2|Post Chemotherapy Phase|Unwillingness or inability to comply|4
4957768|NCT00257608|17045858|P1|Post Chemotherapy Phase|Unwillingness or inability to comply|0
4957769|NCT00257608|17045856|P3|Post Chemotherapy Phase|Disease progression|168
4957770|NCT00257608|17045857|P2|Post Chemotherapy Phase|Disease progression|204
4957771|NCT00257608|17045858|P1|Post Chemotherapy Phase|Disease progression|0
4957772|NCT00257608|17045856|P3|Post Chemotherapy Phase|Adverse Event|38
4957773|NCT00257608|17045857|P2|Post Chemotherapy Phase|Adverse Event|34
4957774|NCT00257608|17045858|P1|Post Chemotherapy Phase|Adverse Event|0
4957775|NCT00257608|17045856|P3|Chemotherapy Phase|Physician Decision|0
4957776|NCT00257608|17045857|P2|Chemotherapy Phase|Physician Decision|0
4957777|NCT00257608|17045858|P1|Chemotherapy Phase|Physician Decision|28
4957778|NCT00257608|17045856|P3|Chemotherapy Phase|Unrelated intercurrent illness|0
4957779|NCT00257608|17045857|P2|Chemotherapy Phase|Unrelated intercurrent illness|0
4957780|NCT00257608|17045858|P1|Chemotherapy Phase|Unrelated intercurrent illness|3
4957781|NCT00257608|17045856|P3|Chemotherapy Phase|Patient's decision to discontinue|0
4957782|NCT00257608|17045857|P2|Chemotherapy Phase|Patient's decision to discontinue|0
4957783|NCT00257608|17045858|P1|Chemotherapy Phase|Patient's decision to discontinue|35
4957784|NCT00257608|17045856|P3|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
4957785|NCT00257608|17045857|P2|Chemotherapy Phase|Need for concomitant/ancillary therapy|0
4957786|NCT00257608|17045858|P1|Chemotherapy Phase|Need for concomitant/ancillary therapy|27
4957787|NCT00257608|17045856|P3|Chemotherapy Phase|Unwillingness or inability to comply|0
4957788|NCT00257608|17045857|P2|Chemotherapy Phase|Unwillingness or inability to comply|0
4957789|NCT00257608|17045858|P1|Chemotherapy Phase|Unwillingness or inability to comply|6
4957790|NCT00257608|17045856|P3|Chemotherapy Phase|Disease progression|0
4957791|NCT00257608|17045857|P2|Chemotherapy Phase|Disease progression|0
4957792|NCT00257608|17045858|P1|Chemotherapy Phase|Disease progression|139
4957793|NCT00257608|17045856|P3|Chemotherapy Phase|Adverse Event|0
4957794|NCT00257608|17045857|P2|Chemotherapy Phase|Adverse Event|0
4957795|NCT00257608|17045858|P1|Chemotherapy Phase|Adverse Event|138
4957796|NCT00257556|17045884|P2|Overall Study|other reason|6
4957797|NCT00257556|17045885|P1|Overall Study|other reason|4
4957798|NCT00257556|17045884|P2|Overall Study|Did not meet hCG criterion|0
4957799|NCT00257556|17045885|P1|Overall Study|Did not meet hCG criterion|3
4957800|NCT00257556|17045884|P2|Overall Study|Physician Decision|0
4957801|NCT00257556|17045885|P1|Overall Study|Physician Decision|6
4957802|NCT00257556|17045884|P2|Overall Study|Adverse Event|4
4957803|NCT00257556|17045885|P1|Overall Study|Adverse Event|1
4957804|NCT00257192|17045929|P2|Overall Study|Miscellaneous|4
4957805|NCT00257192|17045930|P1|Overall Study|Miscellaneous|0
4957806|NCT00257192|17045929|P2|Overall Study|Study terminated by sponsor|0
4957807|NCT00257192|17045930|P1|Overall Study|Study terminated by sponsor|1
4957808|NCT00257192|17045929|P2|Overall Study|Randomized but not treated|1
4957809|NCT00257192|17045930|P1|Overall Study|Randomized but not treated|0
4957810|NCT00257192|17045929|P2|Overall Study|Withdrawal by Subject|2
4957811|NCT00257192|17045930|P1|Overall Study|Withdrawal by Subject|14
4957812|NCT00257192|17045929|P2|Overall Study|Insufficient clinical response|18
4957813|NCT00257192|17045930|P1|Overall Study|Insufficient clinical response|18
4957814|NCT00257192|17045929|P2|Overall Study|Lost to Follow-up|3
4957815|NCT00257192|17045930|P1|Overall Study|Lost to Follow-up|3
4957816|NCT00257192|17045929|P2|Overall Study|Laboratory abnormality|1
4957817|NCT00257192|17045930|P1|Overall Study|Laboratory abnormality|1
4957818|NCT00257192|17045929|P2|Overall Study|Adverse Event|10
4957819|NCT00257192|17045930|P1|Overall Study|Adverse Event|21
4957820|NCT00257166|17045974|P2|Overall Study|Randomized, but not treated|0
4957821|NCT00257166|17045975|P1|Overall Study|Randomized, but not treated|1
4957822|NCT00257166|17045974|P2|Overall Study|Other|21
4957823|NCT00257166|17045975|P1|Overall Study|Other|16
4957824|NCT00257166|17045974|P2|Overall Study|Withdrawal by Subject|2
4957825|NCT00257166|17045975|P1|Overall Study|Withdrawal by Subject|9
4957826|NCT00257166|17045974|P2|Overall Study|Lost to Follow-up|1
4957827|NCT00257166|17045975|P1|Overall Study|Lost to Follow-up|8
4957828|NCT00257166|17045974|P2|Overall Study|Laboratory abnormality|0
4957829|NCT00257166|17045975|P1|Overall Study|Laboratory abnormality|1
4957830|NCT00257166|17045974|P2|Overall Study|Adverse Event|13
4957831|NCT00257166|17045975|P1|Overall Study|Adverse Event|18
4957832|NCT00257010|17045987|P1|Overall Study|no headache reported|9
4957833|NCT00257010|17045987|P1|Overall Study|various|11
4957834|NCT00257010|17045987|P1|Overall Study|Adverse Event|10
4957835|NCT00257010|17045987|P1|Overall Study|Withdrawal by Subject|34
4957836|NCT00257010|17045987|P1|Overall Study|Lost to Follow-up|53
4957837|NCT00257010|17045987|P1|Overall Study|Lack of Efficacy|11
4957838|NCT00256997|17045998|P2|Overall Study|Investigator Withdrew Participant|1
4957839|NCT00256997|17045999|P1|Overall Study|Investigator Withdrew Participant|2
4957840|NCT00256997|17045998|P2|Overall Study|Participant Non-compliant|6
4957841|NCT00256997|17045999|P1|Overall Study|Participant Non-compliant|3
4957842|NCT00256997|17045998|P2|Overall Study|End of Study (As Per Sponsor)|24
4957843|NCT00256997|17045999|P1|Overall Study|End of Study (As Per Sponsor)|12
4957844|NCT00256997|17045998|P2|Overall Study|Other|8
4957845|NCT00256997|17045999|P1|Overall Study|Other|5
4957846|NCT00256997|17045998|P2|Overall Study|Started but not treated|0
4957847|NCT00256997|17045999|P1|Overall Study|Started but not treated|2
4957848|NCT00256997|17045998|P2|Overall Study|Withdrawal by Subject|3
4957849|NCT00256997|17045999|P1|Overall Study|Withdrawal by Subject|13
4957850|NCT00256997|17045998|P2|Overall Study|Lost to Follow-up|5
4957851|NCT00256997|17045999|P1|Overall Study|Lost to Follow-up|3
4957852|NCT00256997|17045998|P2|Overall Study|Adverse Event|0
4957853|NCT00256997|17045999|P1|Overall Study|Adverse Event|4
4957854|NCT00256997|17045998|P2|Overall Study|Death|0
4957855|NCT00256997|17045999|P1|Overall Study|Death|2
4957856|NCT00256997|17045998|P2|Overall Study|Lack of Efficacy|4
4957857|NCT00256997|17045999|P1|Overall Study|Lack of Efficacy|1
4957858|NCT00256997|17045998|P2|Overall Study|Protocol Violation|4
4957859|NCT00256997|17045999|P1|Overall Study|Protocol Violation|1
4957860|NCT00256867|17046041|P8|Overall Study|Withdrawal by participant|0
4957861|NCT00256867|17046042|P7|Overall Study|Withdrawal by participant|0
4957862|NCT00256867|17046043|P6|Overall Study|Withdrawal by participant|1
4957863|NCT00256867|17046044|P5|Overall Study|Withdrawal by participant|0
4957864|NCT00256867|17046045|P4|Overall Study|Withdrawal by participant|0
4957865|NCT00256867|17046046|P3|Overall Study|Withdrawal by participant|0
4957866|NCT00256867|17046047|P2|Overall Study|Withdrawal by participant|0
4957867|NCT00256867|17046048|P1|Overall Study|Withdrawal by participant|0
4957868|NCT00256867|17046041|P8|Overall Study|Participant out of assessment window|0
4957869|NCT00256867|17046042|P7|Overall Study|Participant out of assessment window|0
4957870|NCT00256867|17046043|P6|Overall Study|Participant out of assessment window|0
4957871|NCT00256867|17046044|P5|Overall Study|Participant out of assessment window|0
4957872|NCT00256867|17046045|P4|Overall Study|Participant out of assessment window|0
4957873|NCT00256867|17046046|P3|Overall Study|Participant out of assessment window|1
4957874|NCT00256867|17046047|P2|Overall Study|Participant out of assessment window|0
4957875|NCT00256867|17046048|P1|Overall Study|Participant out of assessment window|0
4957876|NCT00256867|17046041|P8|Overall Study|Participant travelled Overseas|0
4957877|NCT00256867|17046042|P7|Overall Study|Participant travelled Overseas|0
4957878|NCT00256867|17046043|P6|Overall Study|Participant travelled Overseas|0
4957879|NCT00256867|17046044|P5|Overall Study|Participant travelled Overseas|0
4957880|NCT00256867|17046045|P4|Overall Study|Participant travelled Overseas|0
4957881|NCT00256867|17046046|P3|Overall Study|Participant travelled Overseas|0
4957882|NCT00256867|17046047|P2|Overall Study|Participant travelled Overseas|1
4957883|NCT00256867|17046048|P1|Overall Study|Participant travelled Overseas|0
4957884|NCT00256867|17046041|P8|Overall Study|Non-compliance with study medication|1
4957885|NCT00256867|17046042|P7|Overall Study|Non-compliance with study medication|0
4957886|NCT00256867|17046043|P6|Overall Study|Non-compliance with study medication|0
4957887|NCT00256867|17046044|P5|Overall Study|Non-compliance with study medication|0
4957888|NCT00256867|17046045|P4|Overall Study|Non-compliance with study medication|0
4957889|NCT00256867|17046046|P3|Overall Study|Non-compliance with study medication|0
4957890|NCT00256867|17046047|P2|Overall Study|Non-compliance with study medication|0
4957891|NCT00256867|17046048|P1|Overall Study|Non-compliance with study medication|0
4957892|NCT00256867|17046041|P8|Overall Study|Investigator's Decision|0
4957893|NCT00256867|17046042|P7|Overall Study|Investigator's Decision|0
4957894|NCT00256867|17046043|P6|Overall Study|Investigator's Decision|0
4957895|NCT00256867|17046044|P5|Overall Study|Investigator's Decision|1
4957896|NCT00256867|17046045|P4|Overall Study|Investigator's Decision|0
4957897|NCT00256867|17046046|P3|Overall Study|Investigator's Decision|0
4957898|NCT00256867|17046047|P2|Overall Study|Investigator's Decision|0
4957899|NCT00256867|17046048|P1|Overall Study|Investigator's Decision|0
4957900|NCT00256867|17046041|P8|Overall Study|Glycemia over 13.3 millimole per litre|1
4957901|NCT00256867|17046042|P7|Overall Study|Glycemia over 13.3 millimole per litre|0
4957902|NCT00256867|17046043|P6|Overall Study|Glycemia over 13.3 millimole per litre|0
4957903|NCT00256867|17046044|P5|Overall Study|Glycemia over 13.3 millimole per litre|0
4957904|NCT00256867|17046045|P4|Overall Study|Glycemia over 13.3 millimole per litre|0
4957905|NCT00256867|17046046|P3|Overall Study|Glycemia over 13.3 millimole per litre|0
4957906|NCT00256867|17046047|P2|Overall Study|Glycemia over 13.3 millimole per litre|0
4957907|NCT00256867|17046048|P1|Overall Study|Glycemia over 13.3 millimole per litre|0
4957908|NCT00256867|17046041|P8|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957909|NCT00256867|17046042|P7|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957910|NCT00256867|17046043|P6|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957911|NCT00256867|17046044|P5|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957912|NCT00256867|17046045|P4|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957913|NCT00256867|17046046|P3|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957914|NCT00256867|17046047|P2|Overall Study|Fasting plasma glucose >240 mg/dL|1
4957915|NCT00256867|17046048|P1|Overall Study|Fasting plasma glucose >240 mg/dL|0
4957916|NCT00256867|17046041|P8|Overall Study|Withdrawal by Subject|2
4957917|NCT00256867|17046042|P7|Overall Study|Withdrawal by Subject|3
4957918|NCT00256867|17046043|P6|Overall Study|Withdrawal by Subject|2
4957919|NCT00256867|17046044|P5|Overall Study|Withdrawal by Subject|2
4957920|NCT00256867|17046045|P4|Overall Study|Withdrawal by Subject|1
4957921|NCT00256867|17046046|P3|Overall Study|Withdrawal by Subject|1
4957922|NCT00256867|17046047|P2|Overall Study|Withdrawal by Subject|0
4957923|NCT00256867|17046048|P1|Overall Study|Withdrawal by Subject|0
4957924|NCT00256867|17046041|P8|Overall Study|Protocol Violation|1
4957925|NCT00256867|17046042|P7|Overall Study|Protocol Violation|0
4957926|NCT00256867|17046043|P6|Overall Study|Protocol Violation|1
4957927|NCT00256867|17046044|P5|Overall Study|Protocol Violation|0
4957928|NCT00256867|17046045|P4|Overall Study|Protocol Violation|1
4957929|NCT00256867|17046046|P3|Overall Study|Protocol Violation|0
4957930|NCT00256867|17046047|P2|Overall Study|Protocol Violation|0
4957931|NCT00256867|17046048|P1|Overall Study|Protocol Violation|0
4957932|NCT00256867|17046041|P8|Overall Study|Lost to Follow-up|2
4957933|NCT00256867|17046042|P7|Overall Study|Lost to Follow-up|1
4957934|NCT00256867|17046043|P6|Overall Study|Lost to Follow-up|0
4957935|NCT00256867|17046044|P5|Overall Study|Lost to Follow-up|2
4957936|NCT00256867|17046045|P4|Overall Study|Lost to Follow-up|3
4957937|NCT00256867|17046046|P3|Overall Study|Lost to Follow-up|2
4957938|NCT00256867|17046047|P2|Overall Study|Lost to Follow-up|2
4957939|NCT00256867|17046048|P1|Overall Study|Lost to Follow-up|2
4957940|NCT00256867|17046041|P8|Overall Study|Adverse Event|4
4957941|NCT00256867|17046042|P7|Overall Study|Adverse Event|1
4957942|NCT00256867|17046043|P6|Overall Study|Adverse Event|2
4957943|NCT00256867|17046044|P5|Overall Study|Adverse Event|2
4957944|NCT00256867|17046045|P4|Overall Study|Adverse Event|1
4957945|NCT00256867|17046046|P3|Overall Study|Adverse Event|1
4957946|NCT00256867|17046047|P2|Overall Study|Adverse Event|1
4957947|NCT00256867|17046048|P1|Overall Study|Adverse Event|0
4957948|NCT00256854|17046138|P6|Overall Study|Not compliant with the study drug|0
4957949|NCT00256854|17046139|P5|Overall Study|Not compliant with the study drug|1
4957950|NCT00256854|17046140|P4|Overall Study|Not compliant with the study drug|0
4957951|NCT00256854|17046141|P3|Overall Study|Not compliant with the study drug|0
4957952|NCT00256854|17046142|P2|Overall Study|Not compliant with the study drug|0
4957953|NCT00256854|17046143|P1|Overall Study|Not compliant with the study drug|0
4957954|NCT00256854|17046138|P6|Overall Study|Adverse Event|1
4957955|NCT00256854|17046139|P5|Overall Study|Adverse Event|0
4957956|NCT00256854|17046140|P4|Overall Study|Adverse Event|2
4957957|NCT00256854|17046141|P3|Overall Study|Adverse Event|2
4957958|NCT00256854|17046142|P2|Overall Study|Adverse Event|0
4957959|NCT00256854|17046143|P1|Overall Study|Adverse Event|0
4957960|NCT00256854|17046138|P6|Overall Study|Protocol Violation|0
4957961|NCT00256854|17046139|P5|Overall Study|Protocol Violation|0
4957962|NCT00256854|17046140|P4|Overall Study|Protocol Violation|1
4957963|NCT00256854|17046141|P3|Overall Study|Protocol Violation|1
4957964|NCT00256854|17046142|P2|Overall Study|Protocol Violation|1
4957965|NCT00256854|17046143|P1|Overall Study|Protocol Violation|0
4957966|NCT00256854|17046138|P6|Overall Study|Lack of Efficacy|0
4957967|NCT00256854|17046139|P5|Overall Study|Lack of Efficacy|0
4957968|NCT00256854|17046140|P4|Overall Study|Lack of Efficacy|0
4957969|NCT00256854|17046141|P3|Overall Study|Lack of Efficacy|0
4957970|NCT00256854|17046142|P2|Overall Study|Lack of Efficacy|0
4957971|NCT00256854|17046143|P1|Overall Study|Lack of Efficacy|1
4957972|NCT00256854|17046138|P6|Overall Study|Withdrawal by Subject|0
4957973|NCT00256854|17046139|P5|Overall Study|Withdrawal by Subject|0
4957974|NCT00256854|17046140|P4|Overall Study|Withdrawal by Subject|0
4957975|NCT00256854|17046141|P3|Overall Study|Withdrawal by Subject|0
4957976|NCT00256854|17046142|P2|Overall Study|Withdrawal by Subject|3
4957977|NCT00256854|17046143|P1|Overall Study|Withdrawal by Subject|2
4957978|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Other|5
4957979|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Other|4
4957980|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Other|5
4957981|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0
4957982|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
4957983|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1
4957984|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Pregnancy|2
4957985|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Pregnancy|1
4957986|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Pregnancy|0
4957987|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
4957988|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1
4957989|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4
4957990|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0
4957991|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3
4957992|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6
4957993|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Death|4
4957994|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Death|4
4957995|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Death|9
4957996|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
4957997|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1
4957998|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4
4957999|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1
4958000|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4
4958001|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5
4958002|NCT00256750|17046202|P3|Long Term Extension (LTE; 84 Months)|Adverse Event|14
4958003|NCT00256750|17046203|P2|Long Term Extension (LTE; 84 Months)|Adverse Event|11
4958004|NCT00256750|17046204|P1|Long Term Extension (LTE; 84 Months)|Adverse Event|13
4958005|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Other|1
4958006|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Other|1
4958007|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Other|0
4958008|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Protocol Violation|0
4958009|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Protocol Violation|1
4958010|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Protocol Violation|0
4958011|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Lack of Efficacy|0
4958012|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Lack of Efficacy|1
4958013|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Lack of Efficacy|4
4958014|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1
4958015|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
4958016|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0
4958017|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Death|1
4958018|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Death|2
4958019|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Death|0
4958020|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
4958021|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0
4958022|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1
4958023|NCT00256750|17046202|P3|Post-Transplant Treated (36 Months)|Adverse Event|2
4958024|NCT00256750|17046203|P2|Post-Transplant Treated (36 Months)|Adverse Event|1
4958025|NCT00256750|17046204|P1|Post-Transplant Treated (36 Months)|Adverse Event|5
4958026|NCT00256750|17046202|P3|Post-Transplant Treated (24 Months)|Other|1
4958027|NCT00256750|17046203|P2|Post-Transplant Treated (24 Months)|Other|0
4958028|NCT00256750|17046204|P1|Post-Transplant Treated (24 Months)|Other|2
4958029|NCT00256750|17046202|P3|Post-Transplant Treated (24 Months)|Lack of Efficacy|2
4958030|NCT00256750|17046203|P2|Post-Transplant Treated (24 Months)|Lack of Efficacy|3
4958031|NCT00256750|17046204|P1|Post-Transplant Treated (24 Months)|Lack of Efficacy|4
4958032|NCT00256750|17046202|P3|Post-Transplant Treated (24 Months)|Death|0
4958033|NCT00256750|17046203|P2|Post-Transplant Treated (24 Months)|Death|0
4958034|NCT00256750|17046204|P1|Post-Transplant Treated (24 Months)|Death|3
4958035|NCT00256750|17046202|P3|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0
4958036|NCT00256750|17046203|P2|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1
4958037|NCT00256750|17046204|P1|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5
4958038|NCT00256750|17046202|P3|Post-Transplant Treated (24 Months)|Adverse Event|6
4958039|NCT00256750|17046203|P2|Post-Transplant Treated (24 Months)|Adverse Event|3
4958040|NCT00256750|17046204|P1|Post-Transplant Treated (24 Months)|Adverse Event|7
4958041|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Protocol Violation|0
4958042|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Protocol Violation|0
4958043|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Protocol Violation|2
4958044|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5
4958045|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3
4958046|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0
4958047|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Other|2
4958048|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Other|4
4958049|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Other|5
4958050|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
4958051|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Lost to Follow-up|0
4958052|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Lost to Follow-up|1
4958053|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Lack of Efficacy|27
4958054|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Lack of Efficacy|22
4958055|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Lack of Efficacy|10
4958056|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Death|4
4958057|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Death|2
4958058|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Death|3
4958059|NCT00256750|17046202|P3|Post-Transplant Treated (12 Months)|Adverse Event|8
4958060|NCT00256750|17046203|P2|Post-Transplant Treated (12 Months)|Adverse Event|12
4958061|NCT00256750|17046204|P1|Post-Transplant Treated (12 Months)|Adverse Event|20
4958062|NCT00256750|17046202|P3|Transplanted Pre-Treatment|Death|0
4958063|NCT00256750|17046203|P2|Transplanted Pre-Treatment|Death|0
4958064|NCT00256750|17046204|P1|Transplanted Pre-Treatment|Death|1
4958065|NCT00256750|17046202|P3|Transplanted Pre-Treatment|Other|0
4958066|NCT00256750|17046203|P2|Transplanted Pre-Treatment|Other|0
4958067|NCT00256750|17046204|P1|Transplanted Pre-Treatment|Other|2
4958068|NCT00256750|17046202|P3|Transplanted Pre-Treatment|Withdrawal by Subject|0
4958069|NCT00256750|17046203|P2|Transplanted Pre-Treatment|Withdrawal by Subject|0
4958070|NCT00256750|17046204|P1|Transplanted Pre-Treatment|Withdrawal by Subject|3
4958071|NCT00256724|17046340|P2|Overall Study|Protocol Violation|3
4958072|NCT00256724|17046341|P1|Overall Study|Protocol Violation|3
4958073|NCT00256724|17046340|P2|Overall Study|Physician Decision|5
4958074|NCT00256724|17046341|P1|Overall Study|Physician Decision|2
4958075|NCT00256698|17046351|P2|Overall Study|Prematurely Discontinued|0
4958076|NCT00256698|17046352|P1|Overall Study|Prematurely Discontinued|1
4958077|NCT00256698|17046351|P2|Overall Study|withdrawn due to osteoporosis|0
4958078|NCT00256698|17046352|P1|Overall Study|withdrawn due to osteoporosis|1
4958079|NCT00256698|17046351|P2|Overall Study|still ongoing at data cut-off|46
4958080|NCT00256698|17046352|P1|Overall Study|still ongoing at data cut-off|41
4958081|NCT00256698|17046351|P2|Overall Study|disease progression|105
4958082|NCT00256698|17046352|P1|Overall Study|disease progression|97
4958083|NCT00256698|17046351|P2|Overall Study|Lost to Follow-up|3
4958084|NCT00256698|17046352|P1|Overall Study|Lost to Follow-up|1
4958085|NCT00256698|17046351|P2|Overall Study|Protocol Violation|5
4958086|NCT00256698|17046352|P1|Overall Study|Protocol Violation|6
4958087|NCT00256698|17046351|P2|Overall Study|Adverse Event|6
4958088|NCT00256698|17046352|P1|Overall Study|Adverse Event|13
4958089|NCT00256698|17046351|P2|Overall Study|Withdrawal by Subject|7
4958090|NCT00256698|17046352|P1|Overall Study|Withdrawal by Subject|7
4958091|NCT00256308|17046399|P1|Overall Study|Death|2
4958092|NCT00256295|17046407|P1|Overall Study|Death|1
4958093|NCT00256295|17046407|P1|Overall Study|Withdrawal by Subject|3
4958094|NCT00256282|17046413|P1|Overall Study|Physician Decision|1
4958095|NCT00256282|17046413|P1|Overall Study|Adverse Event|3
4958096|NCT00256282|17046413|P1|Overall Study|Disease progression, relapse during acti|12
4958097|NCT00256243|17046418|P1|Overall Study|Not treated|1
4958098|NCT00256243|17046418|P1|Overall Study|Death|7
4958099|NCT00256243|17046418|P1|Overall Study|Lost to Follow-up|2
4958100|NCT00256204|17046427|P4|Overall Study|Need for additional prohibited treatment|25
4958101|NCT00256204|17046428|P3|Overall Study|Need for additional prohibited treatment|27
4958102|NCT00256204|17046429|P2|Overall Study|Need for additional prohibited treatment|28
4958103|NCT00256204|17046430|P1|Overall Study|Need for additional prohibited treatment|38
4958104|NCT00256204|17046427|P4|Overall Study|Withdrawal by Subject|5
4958105|NCT00256204|17046428|P3|Overall Study|Withdrawal by Subject|7
4958106|NCT00256204|17046429|P2|Overall Study|Withdrawal by Subject|6
4958107|NCT00256204|17046430|P1|Overall Study|Withdrawal by Subject|17
4958108|NCT00256204|17046427|P4|Overall Study|Physician Decision|2
4958109|NCT00256204|17046428|P3|Overall Study|Physician Decision|1
4958110|NCT00256204|17046429|P2|Overall Study|Physician Decision|0
4958111|NCT00256204|17046430|P1|Overall Study|Physician Decision|0
4958112|NCT00256204|17046427|P4|Overall Study|Protocol Violation|1
4958113|NCT00256204|17046428|P3|Overall Study|Protocol Violation|2
4958114|NCT00256204|17046429|P2|Overall Study|Protocol Violation|0
4958115|NCT00256204|17046430|P1|Overall Study|Protocol Violation|1
4958116|NCT00256204|17046427|P4|Overall Study|Lost to Follow-up|2
4958117|NCT00256204|17046428|P3|Overall Study|Lost to Follow-up|1
4958118|NCT00256204|17046429|P2|Overall Study|Lost to Follow-up|1
4958119|NCT00256204|17046430|P1|Overall Study|Lost to Follow-up|1
4958120|NCT00256204|17046427|P4|Overall Study|Death|0
4958121|NCT00256204|17046428|P3|Overall Study|Death|0
4958122|NCT00256204|17046429|P2|Overall Study|Death|1
4958123|NCT00256204|17046430|P1|Overall Study|Death|0
4958124|NCT00256204|17046427|P4|Overall Study|Adverse Event|14
4958125|NCT00256204|17046428|P3|Overall Study|Adverse Event|16
4958126|NCT00256204|17046429|P2|Overall Study|Adverse Event|14
4958127|NCT00256204|17046430|P1|Overall Study|Adverse Event|10
4958128|NCT00256126|17046445|P2|Overall Study|Other|2
4958129|NCT00256126|17046446|P1|Overall Study|Other|1
4958130|NCT00256126|17046445|P2|Overall Study|Adverse Event|0
4958131|NCT00256126|17046446|P1|Overall Study|Adverse Event|1
4958132|NCT00255944|17046485|P2|Overall Study|Lost to Follow-up|834
4958133|NCT00255944|17046486|P1|Overall Study|Lost to Follow-up|797
4958134|NCT00255840|17046494|P2|Overall Study|Discontinued intervention|56
4958135|NCT00255840|17046495|P1|Overall Study|Discontinued intervention|53
4958136|NCT00255840|17046494|P2|Overall Study|Lost to Follow-up|14
4958137|NCT00255840|17046495|P1|Overall Study|Lost to Follow-up|10
4958138|NCT00255723|17046508|P2|Overall Study|Response Data Not Available|0
4958139|NCT00255723|17046509|P1|Overall Study|Response Data Not Available|1
4958140|NCT00255723|17046508|P2|Overall Study|Death|1
4958141|NCT00255723|17046509|P1|Overall Study|Death|0
4958142|NCT00255723|17046508|P2|Overall Study|Adverse Event|1
4958143|NCT00255723|17046509|P1|Overall Study|Adverse Event|1
4958144|NCT00255346|17046525|P5|Overall Study|Adverse Event|0
4958145|NCT00255346|17046526|P4|Overall Study|Adverse Event|0
4958146|NCT00255346|17046527|P3|Overall Study|Adverse Event|0
4958147|NCT00255346|17046528|P2|Overall Study|Adverse Event|0
4958148|NCT00255346|17046529|P1|Overall Study|Adverse Event|1
4958149|NCT00255190|17046544|P2|Overall Study|Various|23
4958150|NCT00255190|17046545|P1|Overall Study|Various|4
4958151|NCT00255190|17046544|P2|Overall Study|Erosive esophagitis not healed|20
4958152|NCT00255190|17046545|P1|Overall Study|Erosive esophagitis not healed|0
4958153|NCT00255190|17046544|P2|Overall Study|Inclusion/Exclusion criteria not met|1
4958154|NCT00255190|17046545|P1|Overall Study|Inclusion/Exclusion criteria not met|0
4958155|NCT00255190|17046544|P2|Overall Study|Withdrew Consent|48
4958156|NCT00255190|17046545|P1|Overall Study|Withdrew Consent|17
4958157|NCT00255190|17046544|P2|Overall Study|Lost to Follow-up|27
4958158|NCT00255190|17046545|P1|Overall Study|Lost to Follow-up|10
4958159|NCT00255190|17046544|P2|Overall Study|Protocol Violation|2
4958160|NCT00255190|17046545|P1|Overall Study|Protocol Violation|2
4958161|NCT00255190|17046544|P2|Overall Study|Adverse Event|36
4958162|NCT00255190|17046545|P1|Overall Study|Adverse Event|17
4958163|NCT00255164|17046629|P3|Overall Study|Therapeutic Failure|3
4958164|NCT00255164|17046630|P2|Overall Study|Therapeutic Failure|2
4958165|NCT00255164|17046631|P1|Overall Study|Therapeutic Failure|11
4958166|NCT00255164|17046629|P3|Overall Study|Esophageal Stricture|1
4958167|NCT00255164|17046630|P2|Overall Study|Esophageal Stricture|0
4958168|NCT00255164|17046631|P1|Overall Study|Esophageal Stricture|0
4958169|NCT00255164|17046629|P3|Overall Study|Possible Barrett's Esophagus|8
4958170|NCT00255164|17046630|P2|Overall Study|Possible Barrett's Esophagus|3
4958171|NCT00255164|17046631|P1|Overall Study|Possible Barrett's Esophagus|1
4958172|NCT00255164|17046629|P3|Overall Study|Relapse of Erosive Esophagitis|12
4958173|NCT00255164|17046630|P2|Overall Study|Relapse of Erosive Esophagitis|16
4958174|NCT00255164|17046631|P1|Overall Study|Relapse of Erosive Esophagitis|78
4958175|NCT00255164|17046629|P3|Overall Study|Subject Request/Subject Unavailable|2
4958176|NCT00255164|17046630|P2|Overall Study|Subject Request/Subject Unavailable|1
4958177|NCT00255164|17046631|P1|Overall Study|Subject Request/Subject Unavailable|1
4958178|NCT00255164|17046629|P3|Overall Study|Noncompliance|2
4958179|NCT00255164|17046630|P2|Overall Study|Noncompliance|1
4958180|NCT00255164|17046631|P1|Overall Study|Noncompliance|0
4958181|NCT00255164|17046629|P3|Overall Study|Withdrawal by Subject|8
4958182|NCT00255164|17046630|P2|Overall Study|Withdrawal by Subject|17
4958183|NCT00255164|17046631|P1|Overall Study|Withdrawal by Subject|18
4958184|NCT00255164|17046629|P3|Overall Study|Lost to Follow-up|4
4958185|NCT00255164|17046630|P2|Overall Study|Lost to Follow-up|3
4958186|NCT00255164|17046631|P1|Overall Study|Lost to Follow-up|4
4958187|NCT00255164|17046629|P3|Overall Study|Adverse Event|9
4958188|NCT00255164|17046630|P2|Overall Study|Adverse Event|6
4958189|NCT00255164|17046631|P1|Overall Study|Adverse Event|10
4958190|NCT00255151|17046657|P3|Overall Study|Therapeutic Failure|3
4958191|NCT00255151|17046658|P2|Overall Study|Therapeutic Failure|2
4958192|NCT00255151|17046659|P1|Overall Study|Therapeutic Failure|11
4958193|NCT00255151|17046657|P3|Overall Study|Esophageal Stricture|1
4958194|NCT00255151|17046658|P2|Overall Study|Esophageal Stricture|0
4958195|NCT00255151|17046659|P1|Overall Study|Esophageal Stricture|0
4958196|NCT00255151|17046657|P3|Overall Study|Possible Barrett's Esophagus|8
4958197|NCT00255151|17046658|P2|Overall Study|Possible Barrett's Esophagus|3
4958198|NCT00255151|17046659|P1|Overall Study|Possible Barrett's Esophagus|1
4958199|NCT00255151|17046657|P3|Overall Study|Relapse of Erosive Esophagitis|12
4958200|NCT00255151|17046658|P2|Overall Study|Relapse of Erosive Esophagitis|16
4958201|NCT00255151|17046659|P1|Overall Study|Relapse of Erosive Esophagitis|78
4958202|NCT00255151|17046657|P3|Overall Study|Subject Request/Subject Unavailable|2
4958203|NCT00255151|17046658|P2|Overall Study|Subject Request/Subject Unavailable|1
4958204|NCT00255151|17046659|P1|Overall Study|Subject Request/Subject Unavailable|1
4958205|NCT00255151|17046657|P3|Overall Study|Noncompliance|2
4958206|NCT00255151|17046658|P2|Overall Study|Noncompliance|1
4958207|NCT00255151|17046659|P1|Overall Study|Noncompliance|0
4958208|NCT00255151|17046657|P3|Overall Study|Withdrawal by Subject|8
4958209|NCT00255151|17046658|P2|Overall Study|Withdrawal by Subject|17
4958210|NCT00255151|17046659|P1|Overall Study|Withdrawal by Subject|18
4958211|NCT00255151|17046657|P3|Overall Study|Lost to Follow-up|4
4958212|NCT00255151|17046658|P2|Overall Study|Lost to Follow-up|3
4958213|NCT00255151|17046659|P1|Overall Study|Lost to Follow-up|4
4958214|NCT00255151|17046657|P3|Overall Study|Adverse Event|9
4958215|NCT00255151|17046658|P2|Overall Study|Adverse Event|6
4958216|NCT00255151|17046659|P1|Overall Study|Adverse Event|10
4958217|NCT00255086|17046697|P2|Overall Study|Protocol Violation|1
4958218|NCT00255086|17046698|P1|Overall Study|Protocol Violation|1
4958219|NCT00255086|17046697|P2|Overall Study|Adverse Event|1
4958220|NCT00255086|17046698|P1|Overall Study|Adverse Event|1
4958221|NCT00255047|17046710|P4|Overall Study|Withdrawal by Subject|18
4958222|NCT00255047|17046711|P3|Overall Study|Withdrawal by Subject|25
4958223|NCT00255047|17046712|P2|Overall Study|Withdrawal by Subject|23
4958224|NCT00255047|17046713|P1|Overall Study|Withdrawal by Subject|24
4958225|NCT00255047|17046710|P4|Overall Study|Lost to Follow-up|6
4958226|NCT00255047|17046711|P3|Overall Study|Lost to Follow-up|5
4958227|NCT00255047|17046712|P2|Overall Study|Lost to Follow-up|8
4958228|NCT00255047|17046713|P1|Overall Study|Lost to Follow-up|9
4958229|NCT00255047|17046710|P4|Overall Study|Protocol Violation|20
4958230|NCT00255047|17046711|P3|Overall Study|Protocol Violation|16
4958231|NCT00255047|17046712|P2|Overall Study|Protocol Violation|13
4958232|NCT00255047|17046713|P1|Overall Study|Protocol Violation|13
4958233|NCT00255047|17046710|P4|Overall Study|Adverse Event|1
4958234|NCT00255047|17046711|P3|Overall Study|Adverse Event|2
4958235|NCT00255047|17046712|P2|Overall Study|Adverse Event|3
4958236|NCT00255047|17046713|P1|Overall Study|Adverse Event|0
4958237|NCT00255047|17046710|P4|Overall Study|Serious Adverse Events|1
4958238|NCT00255047|17046711|P3|Overall Study|Serious Adverse Events|2
4958239|NCT00255047|17046712|P2|Overall Study|Serious Adverse Events|1
4958240|NCT00255047|17046713|P1|Overall Study|Serious Adverse Events|2
4958241|NCT00255034|17046737|P2|Overall Study|Withdrawal by Subject|38
4958242|NCT00255034|17046738|P1|Overall Study|Withdrawal by Subject|15
4958243|NCT00255008|17046748|P4|Overall Study|Other|2
4958244|NCT00255008|17046749|P3|Overall Study|Other|3
4958245|NCT00255008|17046750|P2|Overall Study|Other|0
4958246|NCT00255008|17046751|P1|Overall Study|Other|7
4958247|NCT00255008|17046748|P4|Overall Study|Adverse lab experience|0
4958248|NCT00255008|17046749|P3|Overall Study|Adverse lab experience|0
4958249|NCT00255008|17046750|P2|Overall Study|Adverse lab experience|0
4958250|NCT00255008|17046751|P1|Overall Study|Adverse lab experience|1
4958251|NCT00255008|17046748|P4|Overall Study|Sponsor request|17
4958252|NCT00255008|17046749|P3|Overall Study|Sponsor request|8
4958253|NCT00255008|17046750|P2|Overall Study|Sponsor request|3
4958254|NCT00255008|17046751|P1|Overall Study|Sponsor request|18
4958255|NCT00255008|17046748|P4|Overall Study|Withdrew consent|0
4958256|NCT00255008|17046749|P3|Overall Study|Withdrew consent|2
4958257|NCT00255008|17046750|P2|Overall Study|Withdrew consent|0
4958258|NCT00255008|17046751|P1|Overall Study|Withdrew consent|0
4958259|NCT00255008|17046748|P4|Overall Study|Did not meet viral reduction criteria|1
4958260|NCT00255008|17046749|P3|Overall Study|Did not meet viral reduction criteria|0
4958261|NCT00255008|17046750|P2|Overall Study|Did not meet viral reduction criteria|5
4958262|NCT00255008|17046751|P1|Overall Study|Did not meet viral reduction criteria|4
4958263|NCT00255008|17046748|P4|Overall Study|Lost to Follow-up|2
4958264|NCT00255008|17046749|P3|Overall Study|Lost to Follow-up|1
4958265|NCT00255008|17046750|P2|Overall Study|Lost to Follow-up|0
4958266|NCT00255008|17046751|P1|Overall Study|Lost to Follow-up|1
4958267|NCT00255008|17046748|P4|Overall Study|Adverse Event|0
4958268|NCT00255008|17046749|P3|Overall Study|Adverse Event|2
4958269|NCT00255008|17046750|P2|Overall Study|Adverse Event|1
4958270|NCT00255008|17046751|P1|Overall Study|Adverse Event|1
4958271|NCT00254982|17046787|P2|Overall Study|Abnormal liver function tests|1
4958272|NCT00254982|17046788|P1|Overall Study|Abnormal liver function tests|2
4958273|NCT00254982|17046787|P2|Overall Study|Opportunistic infection|0
4958274|NCT00254982|17046788|P1|Overall Study|Opportunistic infection|1
4958275|NCT00254982|17046787|P2|Overall Study|Malignancy|2
4958276|NCT00254982|17046788|P1|Overall Study|Malignancy|0
4958277|NCT00254982|17046787|P2|Overall Study|Diagnosis of Tuberculosis|1
4958278|NCT00254982|17046788|P1|Overall Study|Diagnosis of Tuberculosis|1
4958279|NCT00254982|17046787|P2|Overall Study|Protocol deviation|1
4958280|NCT00254982|17046788|P1|Overall Study|Protocol deviation|1
4958281|NCT00254982|17046787|P2|Overall Study|Inclusion/exclusion criteria violation|2
4958282|NCT00254982|17046788|P1|Overall Study|Inclusion/exclusion criteria violation|0
4958283|NCT00254982|17046787|P2|Overall Study|Withdrawal by Subject|1
4958284|NCT00254982|17046788|P1|Overall Study|Withdrawal by Subject|1
4958285|NCT00254982|17046787|P2|Overall Study|Adverse Event|16
4958286|NCT00254982|17046788|P1|Overall Study|Adverse Event|18
4958287|NCT00254982|17046787|P2|Overall Study|Lost to Follow-up|3
4958288|NCT00254982|17046788|P1|Overall Study|Lost to Follow-up|5
4958289|NCT00254982|17046787|P2|Overall Study|Lack of Efficacy|3
4958290|NCT00254982|17046788|P1|Overall Study|Lack of Efficacy|5
4958291|NCT00254982|17046787|P2|Overall Study|Other|1
4958292|NCT00254982|17046788|P1|Overall Study|Other|2
4958293|NCT00254566|17046800|P2|Overall Study|Lost to Follow-up|2
4958294|NCT00254566|17046801|P1|Overall Study|Lost to Follow-up|7
4958295|NCT00254566|17046800|P2|Overall Study|Withdrawal by Subject|6
4958296|NCT00254566|17046801|P1|Overall Study|Withdrawal by Subject|5
4958297|NCT00254566|17046800|P2|Overall Study|Other|5
4958298|NCT00254566|17046801|P1|Overall Study|Other|1
4958299|NCT00254566|17046800|P2|Overall Study|Lack of Efficacy|9
4958300|NCT00254566|17046801|P1|Overall Study|Lack of Efficacy|12
4958301|NCT00254566|17046800|P2|Overall Study|Adverse Event|4
4958302|NCT00254566|17046801|P1|Overall Study|Adverse Event|5
4958303|NCT00254566|17046800|P2|Overall Study|Death|0
4958304|NCT00254566|17046801|P1|Overall Study|Death|1
4958305|NCT00254540|17046825|P2|Overall Study|Laboratory Test Abnormality|1
4958306|NCT00254540|17046826|P1|Overall Study|Laboratory Test Abnormality|0
4958307|NCT00254540|17046825|P2|Overall Study|Death|1
4958308|NCT00254540|17046826|P1|Overall Study|Death|0
4958309|NCT00254540|17046825|P2|Overall Study|Lack of Efficacy|13
4958310|NCT00254540|17046826|P1|Overall Study|Lack of Efficacy|13
4958311|NCT00254540|17046825|P2|Overall Study|Adverse Event|7
4958312|NCT00254540|17046826|P1|Overall Study|Adverse Event|6
4958313|NCT00254501|17046855|P2|Overall Study|Lost to Follow-up|1
4958314|NCT00254501|17046856|P1|Overall Study|Lost to Follow-up|1
4958315|NCT00254397|17046901|P4|Overall Study|Adverse Event|1
4958316|NCT00254397|17046902|P3|Overall Study|Adverse Event|3
4958317|NCT00254397|17046903|P2|Overall Study|Adverse Event|0
4958318|NCT00254397|17046904|P1|Overall Study|Adverse Event|2
4958319|NCT00254397|17046901|P4|Overall Study|Non-Compliant|1
4958320|NCT00254397|17046902|P3|Overall Study|Non-Compliant|0
4958321|NCT00254397|17046903|P2|Overall Study|Non-Compliant|0
4958322|NCT00254397|17046904|P1|Overall Study|Non-Compliant|0
4958323|NCT00254397|17046901|P4|Overall Study|Disease Progression|23
4958324|NCT00254397|17046902|P3|Overall Study|Disease Progression|16
4958325|NCT00254397|17046903|P2|Overall Study|Disease Progression|1
4958326|NCT00254397|17046904|P1|Overall Study|Disease Progression|4
4958327|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Other|1
4958328|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Other|0
4958329|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Other|0
4958330|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Other|0
4958331|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Other|0
4958332|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Other|0
4958333|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Other|0
4958334|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Poor or non-compliance|1
4958335|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4958336|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4958337|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4958338|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4958339|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4958340|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Poor or non-compliance|0
4958341|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Withdrawal by Subject|3
4958342|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4958343|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4958344|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4958345|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4958346|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4958347|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Withdrawal by Subject|0
4958348|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Lost to Follow-up|1
4958349|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4958350|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4958351|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4958352|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4958353|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4958354|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Lost to Follow-up|0
4958355|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Lack of Efficacy|3
4958356|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4958357|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4958358|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4958359|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4958360|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4958361|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Lack of Efficacy|0
4958362|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Adverse Event|1
4958363|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Adverse Event|0
4958364|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Adverse Event|0
4958365|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Adverse Event|0
4958366|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Adverse Event|0
4958367|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Adverse Event|0
4958368|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Adverse Event|0
4958369|NCT00254293|17046928|P7|LTE Open Label Fixed Dosing|Death|3
4958370|NCT00254293|17046929|P6|LTE Open Label Fixed Dosing|Death|0
4958371|NCT00254293|17046930|P5|LTE Open Label Fixed Dosing|Death|0
4958372|NCT00254293|17046931|P4|LTE Open Label Fixed Dosing|Death|0
4958373|NCT00254293|17046932|P3|LTE Open Label Fixed Dosing|Death|0
4958374|NCT00254293|17046933|P2|LTE Open Label Fixed Dosing|Death|0
4958375|NCT00254293|17046934|P1|LTE Open Label Fixed Dosing|Death|0
4958376|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Other|0
4958377|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Other|0
4958378|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Other|0
4958379|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Other|0
4958380|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Other|2
4958381|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Other|0
4958382|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Other|0
4958383|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4958384|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4958385|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4958386|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4958387|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Poor or non-compliance|1
4958388|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4958389|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Poor or non-compliance|0
4958390|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4958391|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4958392|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4958393|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4958394|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1
4958395|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4958396|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0
4958397|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4958398|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4958399|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4958400|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4958401|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Lost to Follow-up|1
4958402|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4958403|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Lost to Follow-up|0
4958404|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4958405|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4958406|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Lack of Efficacy|1
4958407|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4958408|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
4958409|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Lack of Efficacy|0
4958410|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Lack of Efficacy|2
4958411|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Adverse Event|0
4958412|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Adverse Event|0
4958413|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Adverse Event|1
4958414|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Adverse Event|0
4958415|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Adverse Event|2
4958416|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Adverse Event|0
4958417|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Adverse Event|1
4958418|NCT00254293|17046928|P7|LTE Open Label Variable SC Dosing|Death|0
4958419|NCT00254293|17046929|P6|LTE Open Label Variable SC Dosing|Death|0
4958420|NCT00254293|17046930|P5|LTE Open Label Variable SC Dosing|Death|0
4958421|NCT00254293|17046931|P4|LTE Open Label Variable SC Dosing|Death|0
4958422|NCT00254293|17046932|P3|LTE Open Label Variable SC Dosing|Death|1
4958423|NCT00254293|17046933|P2|LTE Open Label Variable SC Dosing|Death|0
4958424|NCT00254293|17046934|P1|LTE Open Label Variable SC Dosing|Death|0
4958425|NCT00254293|17046928|P7|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4958426|NCT00254293|17046929|P6|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4958427|NCT00254293|17046930|P5|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4958428|NCT00254293|17046931|P4|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4958429|NCT00254293|17046932|P3|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2
4958430|NCT00254293|17046933|P2|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4958431|NCT00254293|17046934|P1|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0
4958432|NCT00254293|17046928|P7|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4958433|NCT00254293|17046929|P6|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4958434|NCT00254293|17046930|P5|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4958435|NCT00254293|17046931|P4|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4958436|NCT00254293|17046932|P3|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1
4958437|NCT00254293|17046933|P2|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4958438|NCT00254293|17046934|P1|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0
4958439|NCT00254293|17046928|P7|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4958440|NCT00254293|17046929|P6|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4958441|NCT00254293|17046930|P5|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4958442|NCT00254293|17046931|P4|Short Term (12 Week) Randomized Dosing|Adverse Event|1
4958443|NCT00254293|17046932|P3|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4958444|NCT00254293|17046933|P2|Short Term (12 Week) Randomized Dosing|Adverse Event|1
4958445|NCT00254293|17046934|P1|Short Term (12 Week) Randomized Dosing|Adverse Event|0
4958446|NCT00254163|17047017|P2|Overall Study|Other|8
4958447|NCT00254163|17047018|P1|Overall Study|Other|8
4958448|NCT00254163|17047017|P2|Overall Study|Death|1
4958449|NCT00254163|17047018|P1|Overall Study|Death|0
4958450|NCT00254163|17047017|P2|Overall Study|Progressive disease|1
4958451|NCT00254163|17047018|P1|Overall Study|Progressive disease|0
4958452|NCT00254163|17047017|P2|Overall Study|Failed entry|3
4958453|NCT00254163|17047018|P1|Overall Study|Failed entry|1
4958454|NCT00254163|17047017|P2|Overall Study|Investigator request|3
4958455|NCT00254163|17047018|P1|Overall Study|Investigator request|1
4958456|NCT00254163|17047017|P2|Overall Study|Patient request/withdrew consent|4
4958457|NCT00254163|17047018|P1|Overall Study|Patient request/withdrew consent|6
4958458|NCT00254163|17047017|P2|Overall Study|Adverse Event|26
4958459|NCT00254163|17047018|P1|Overall Study|Adverse Event|29
4958460|NCT00253747|17047069|P2|Overall Study|Administrative Discharge (1), Other (2)|2
4958461|NCT00253747|17047070|P1|Overall Study|Administrative Discharge (1), Other (2)|1
4958462|NCT00253747|17047069|P2|Overall Study|Withdrawal by Subject|11
4958463|NCT00253747|17047070|P1|Overall Study|Withdrawal by Subject|10
4958464|NCT00253747|17047069|P2|Overall Study|Lost to Follow-up|14
4958465|NCT00253747|17047070|P1|Overall Study|Lost to Follow-up|13
4958466|NCT00253643|17047123|P4|Overall Study|Non-Compliance|2
4958467|NCT00253643|17047124|P3|Overall Study|Non-Compliance|0
4958468|NCT00253643|17047125|P2|Overall Study|Non-Compliance|0
4958469|NCT00253643|17047126|P1|Overall Study|Non-Compliance|0
4958470|NCT00253643|17047123|P4|Overall Study|Withdrawal by Subject|1
4958471|NCT00253643|17047124|P3|Overall Study|Withdrawal by Subject|1
4958472|NCT00253643|17047125|P2|Overall Study|Withdrawal by Subject|0
4958473|NCT00253643|17047126|P1|Overall Study|Withdrawal by Subject|0
4958474|NCT00253630|17047140|P1|Overall Study|ineligible|2
4958475|NCT00253448|17047156|P1|Overall Study|Withdrawal by Subject|1
4958476|NCT00253370|17047175|P1|Overall Study|Abdominal pain due to disease|1
4958477|NCT00253370|17047175|P1|Overall Study|Protocol Violation|1
4958478|NCT00253370|17047175|P1|Overall Study|Physician Decision|1
4958479|NCT00253370|17047175|P1|Overall Study|Non-protocol therapy|1
4958480|NCT00253370|17047175|P1|Overall Study|Withdrawal by Subject|6
4958481|NCT00253370|17047175|P1|Overall Study|Death|2
4958482|NCT00253370|17047175|P1|Overall Study|Disease progression|13
4958483|NCT00253370|17047175|P1|Overall Study|Adverse Event|18
4958484|NCT00252733|17047221|P2|Overall Study|Multiple Reasons|14
4958485|NCT00252733|17047222|P1|Overall Study|Multiple Reasons|14
4958486|NCT00252733|17047221|P2|Overall Study|Lost to Follow-up|6
4958487|NCT00252733|17047222|P1|Overall Study|Lost to Follow-up|12
4958488|NCT00252733|17047221|P2|Overall Study|Death|5
4958489|NCT00252733|17047222|P1|Overall Study|Death|7
4958490|NCT00252733|17047221|P2|Overall Study|Withdrawal by Subject|67
4958491|NCT00252733|17047222|P1|Overall Study|Withdrawal by Subject|73
4958492|NCT00252720|17047232|P2|Overall Study|Mainly patients lost to follow-up|18
4958493|NCT00252720|17047233|P1|Overall Study|Mainly patients lost to follow-up|7
4958494|NCT00252720|17047232|P2|Overall Study|Moving|42
4958495|NCT00252720|17047233|P1|Overall Study|Moving|23
4958496|NCT00252720|17047232|P2|Overall Study|Death|8
4958497|NCT00252720|17047233|P1|Overall Study|Death|7
4958498|NCT00252720|17047232|P2|Overall Study|Withdrawal by Subject|97
4958499|NCT00252720|17047233|P1|Overall Study|Withdrawal by Subject|95
4958500|NCT00252694|17047247|P2|Overall Study|Patient Moving|16
4958501|NCT00252694|17047248|P1|Overall Study|Patient Moving|17
4958502|NCT00252694|17047247|P2|Overall Study|Mostly Lost to Follow Up|13
4958503|NCT00252694|17047248|P1|Overall Study|Mostly Lost to Follow Up|8
4958504|NCT00252694|17047247|P2|Overall Study|Death|34
4958505|NCT00252694|17047248|P1|Overall Study|Death|36
4958506|NCT00252694|17047247|P2|Overall Study|Withdrawal by Subject|91
4958507|NCT00252694|17047248|P1|Overall Study|Withdrawal by Subject|83
4958508|NCT00252577|17047294|P1|Overall Study|Lost to Follow-up|20
4958509|NCT00252564|17047300|P2|Overall Study|Withdrawal by Subject|2
4958510|NCT00252564|17047301|P1|Overall Study|Withdrawal by Subject|0
4958511|NCT00252564|17047300|P2|Overall Study|Patient Request|5
4958512|NCT00252564|17047301|P1|Overall Study|Patient Request|4
4958513|NCT00252564|17047300|P2|Overall Study|Lost to Follow-up|0
4958514|NCT00252564|17047301|P1|Overall Study|Lost to Follow-up|1
4958515|NCT00252564|17047300|P2|Overall Study|Physician Decision|0
4958516|NCT00252564|17047301|P1|Overall Study|Physician Decision|1
4958517|NCT00252564|17047300|P2|Overall Study|Death|3
4958518|NCT00252564|17047301|P1|Overall Study|Death|0
4958519|NCT00252564|17047300|P2|Overall Study|Disease Progression|20
4958520|NCT00252564|17047301|P1|Overall Study|Disease Progression|14
4958521|NCT00252564|17047300|P2|Overall Study|Unrelated Complication|1
4958522|NCT00252564|17047301|P1|Overall Study|Unrelated Complication|2
4958523|NCT00252564|17047300|P2|Overall Study|Adverse Event|13
4958524|NCT00252564|17047301|P1|Overall Study|Adverse Event|17
4958525|NCT00252499|17047341|P3|Overall Study|Lost to Follow-up|0
4958526|NCT00252499|17047342|P2|Overall Study|Lost to Follow-up|0
4958527|NCT00252499|17047343|P1|Overall Study|Lost to Follow-up|1
4958528|NCT00252239|17047375|P4|Overall Study|Lost to Follow-up|0
4958529|NCT00252239|17047376|P3|Overall Study|Lost to Follow-up|2
4958530|NCT00252239|17047377|P2|Overall Study|Lost to Follow-up|0
4958531|NCT00252239|17047378|P1|Overall Study|Lost to Follow-up|0
4958532|NCT00252239|17047375|P4|Overall Study|Withdrawal by Subject|1
4958533|NCT00252239|17047376|P3|Overall Study|Withdrawal by Subject|0
4958534|NCT00252239|17047377|P2|Overall Study|Withdrawal by Subject|0
4958535|NCT00252239|17047378|P1|Overall Study|Withdrawal by Subject|1
4958536|NCT00252187|17047390|P2|Overall Study|Withdrawal by Subject|0
4958537|NCT00252187|17047391|P1|Overall Study|Withdrawal by Subject|1
4958538|NCT00252187|17047390|P2|Overall Study|Adverse Event|1
4958539|NCT00252187|17047391|P1|Overall Study|Adverse Event|3
4958540|NCT00252174|17047414|P3|Overall Study|Withdrawal by Subject|0
4958541|NCT00252174|17047415|P2|Overall Study|Withdrawal by Subject|1
4958542|NCT00252174|17047416|P1|Overall Study|Withdrawal by Subject|0
4958543|NCT00252057|17047456|P2|Overall Study|Participant previously enrolled|1
4958544|NCT00252057|17047457|P1|Overall Study|Participant previously enrolled|0
4958545|NCT00252057|17047456|P2|Overall Study|Death|2
4958546|NCT00252057|17047457|P1|Overall Study|Death|1
4958547|NCT00252057|17047456|P2|Overall Study|Withdrawal by Subject|5
4958548|NCT00252057|17047457|P1|Overall Study|Withdrawal by Subject|2
4958549|NCT00251979|17047465|P2|Overall Study|Death|5
4958550|NCT00251979|17047466|P1|Overall Study|Death|3
4958551|NCT00251979|17047465|P2|Overall Study|Lost to Follow-up|6
4958552|NCT00251979|17047466|P1|Overall Study|Lost to Follow-up|8
4958553|NCT00251979|17047465|P2|Overall Study|Withdrawal by Subject|7
4958554|NCT00251979|17047466|P1|Overall Study|Withdrawal by Subject|13
4958555|NCT00251979|17047465|P2|Overall Study|Adverse Event|17
4958556|NCT00251979|17047466|P1|Overall Study|Adverse Event|11
4958557|NCT00251979|17047465|P2|Overall Study|Protocol Violation|5
4958558|NCT00251979|17047466|P1|Overall Study|Protocol Violation|3
4958559|NCT00251927|17047498|P2|Overall Study|Study procedure non-compliance|6
4958560|NCT00251927|17047499|P1|Overall Study|Study procedure non-compliance|5
4958561|NCT00251927|17047498|P2|Overall Study|Study-specific discont. achieved|2
4958562|NCT00251927|17047499|P1|Overall Study|Study-specific discont. achieved|13
4958563|NCT00251927|17047498|P2|Overall Study|Withdrawal by Subject|25
4958564|NCT00251927|17047499|P1|Overall Study|Withdrawal by Subject|40
4958565|NCT00251927|17047498|P2|Overall Study|Pregnancy|0
4958566|NCT00251927|17047499|P1|Overall Study|Pregnancy|2
4958567|NCT00251927|17047498|P2|Overall Study|Protocol Violation|2
4958568|NCT00251927|17047499|P1|Overall Study|Protocol Violation|1
4958569|NCT00251927|17047498|P2|Overall Study|Lost to Follow-up|8
4958570|NCT00251927|17047499|P1|Overall Study|Lost to Follow-up|22
4958571|NCT00251927|17047498|P2|Overall Study|Lack of Efficacy|16
4958572|NCT00251927|17047499|P1|Overall Study|Lack of Efficacy|22
4958573|NCT00251927|17047498|P2|Overall Study|Adverse Event|15
4958574|NCT00251927|17047499|P1|Overall Study|Adverse Event|3
4958575|NCT00251758|17047551|P3|Overall Study|Per Investigator Request|0
4958576|NCT00251758|17047552|P2|Overall Study|Per Investigator Request|0
4958577|NCT00251758|17047553|P1|Overall Study|Per Investigator Request|1
4958578|NCT00251758|17047551|P3|Overall Study|Per Subject Request|1
4958579|NCT00251758|17047552|P2|Overall Study|Per Subject Request|0
4958580|NCT00251758|17047553|P1|Overall Study|Per Subject Request|0
4958581|NCT00251758|17047551|P3|Overall Study|Pregnancy|0
4958582|NCT00251758|17047552|P2|Overall Study|Pregnancy|1
4958583|NCT00251758|17047553|P1|Overall Study|Pregnancy|0
4958584|NCT00251758|17047551|P3|Overall Study|Noncompliant|2
4958585|NCT00251758|17047552|P2|Overall Study|Noncompliant|2
4958586|NCT00251758|17047553|P1|Overall Study|Noncompliant|0
4958587|NCT00251758|17047551|P3|Overall Study|Lack of Efficacy|0
4958588|NCT00251758|17047552|P2|Overall Study|Lack of Efficacy|0
4958589|NCT00251758|17047553|P1|Overall Study|Lack of Efficacy|3
4958590|NCT00251758|17047551|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
4958591|NCT00251758|17047552|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
4958592|NCT00251758|17047553|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4958593|NCT00251758|17047551|P3|Overall Study|Withdrawal by Subject|3
4958594|NCT00251758|17047552|P2|Overall Study|Withdrawal by Subject|7
4958595|NCT00251758|17047553|P1|Overall Study|Withdrawal by Subject|13
4958596|NCT00251758|17047551|P3|Overall Study|Lost to Follow-up|5
4958597|NCT00251758|17047552|P2|Overall Study|Lost to Follow-up|2
4958598|NCT00251758|17047553|P1|Overall Study|Lost to Follow-up|4
4958599|NCT00251758|17047551|P3|Overall Study|Adverse Event|11
4958600|NCT00251758|17047552|P2|Overall Study|Adverse Event|9
4958601|NCT00251758|17047553|P1|Overall Study|Adverse Event|7
4958602|NCT00251745|17047573|P3|Overall Study|Per Investigator Request|0
4958603|NCT00251745|17047574|P2|Overall Study|Per Investigator Request|0
4958604|NCT00251745|17047575|P1|Overall Study|Per Investigator Request|1
4958605|NCT00251745|17047573|P3|Overall Study|Per Subject Request|1
4958606|NCT00251745|17047574|P2|Overall Study|Per Subject Request|0
4958607|NCT00251745|17047575|P1|Overall Study|Per Subject Request|0
4958608|NCT00251745|17047573|P3|Overall Study|Pregnancy|0
4958609|NCT00251745|17047574|P2|Overall Study|Pregnancy|1
4958610|NCT00251745|17047575|P1|Overall Study|Pregnancy|0
4958611|NCT00251745|17047573|P3|Overall Study|Noncompliant|2
4958612|NCT00251745|17047574|P2|Overall Study|Noncompliant|2
4958613|NCT00251745|17047575|P1|Overall Study|Noncompliant|0
4958614|NCT00251745|17047573|P3|Overall Study|Lack of Efficacy|0
4958615|NCT00251745|17047574|P2|Overall Study|Lack of Efficacy|0
4958616|NCT00251745|17047575|P1|Overall Study|Lack of Efficacy|3
4958617|NCT00251745|17047573|P3|Overall Study|Unmet Inclusion/Exclusion Criteria|5
4958618|NCT00251745|17047574|P2|Overall Study|Unmet Inclusion/Exclusion Criteria|6
4958619|NCT00251745|17047575|P1|Overall Study|Unmet Inclusion/Exclusion Criteria|0
4958620|NCT00251745|17047573|P3|Overall Study|Withdrawal by Subject|3
4958621|NCT00251745|17047574|P2|Overall Study|Withdrawal by Subject|7
4958622|NCT00251745|17047575|P1|Overall Study|Withdrawal by Subject|13
4958623|NCT00251745|17047573|P3|Overall Study|Lost to Follow-up|5
4958624|NCT00251745|17047574|P2|Overall Study|Lost to Follow-up|2
4958625|NCT00251745|17047575|P1|Overall Study|Lost to Follow-up|4
4958626|NCT00251745|17047573|P3|Overall Study|Adverse Event|11
4958627|NCT00251745|17047574|P2|Overall Study|Adverse Event|9
4958628|NCT00251745|17047575|P1|Overall Study|Adverse Event|7
4958629|NCT00251719|17047595|P3|Overall Study|Barrett's esophagus|0
4958630|NCT00251719|17047596|P2|Overall Study|Barrett's esophagus|2
4958631|NCT00251719|17047597|P1|Overall Study|Barrett's esophagus|2
4958632|NCT00251719|17047595|P3|Overall Study|Noncompliance|1
4958633|NCT00251719|17047596|P2|Overall Study|Noncompliance|3
4958634|NCT00251719|17047597|P1|Overall Study|Noncompliance|2
4958635|NCT00251719|17047595|P3|Overall Study|Investigator decision|0
4958636|NCT00251719|17047596|P2|Overall Study|Investigator decision|1
4958637|NCT00251719|17047597|P1|Overall Study|Investigator decision|1
4958638|NCT00251719|17047595|P3|Overall Study|Inclusion/exclusion criteria not met|2
4958639|NCT00251719|17047596|P2|Overall Study|Inclusion/exclusion criteria not met|6
4958640|NCT00251719|17047597|P1|Overall Study|Inclusion/exclusion criteria not met|12
4958641|NCT00251719|17047595|P3|Overall Study|Lack of Efficacy|0
4958642|NCT00251719|17047596|P2|Overall Study|Lack of Efficacy|1
4958643|NCT00251719|17047597|P1|Overall Study|Lack of Efficacy|2
4958644|NCT00251719|17047595|P3|Overall Study|Withdrawal by Subject|11
4958645|NCT00251719|17047596|P2|Overall Study|Withdrawal by Subject|12
4958646|NCT00251719|17047597|P1|Overall Study|Withdrawal by Subject|14
4958647|NCT00251719|17047595|P3|Overall Study|Lost to Follow-up|8
4958648|NCT00251719|17047596|P2|Overall Study|Lost to Follow-up|11
4958649|NCT00251719|17047597|P1|Overall Study|Lost to Follow-up|5
4958650|NCT00251719|17047595|P3|Overall Study|Protocol Violation|1
4958651|NCT00251719|17047596|P2|Overall Study|Protocol Violation|1
4958652|NCT00251719|17047597|P1|Overall Study|Protocol Violation|1
4958653|NCT00251719|17047595|P3|Overall Study|Adverse Event|7
4958654|NCT00251719|17047596|P2|Overall Study|Adverse Event|8
4958655|NCT00251719|17047597|P1|Overall Study|Adverse Event|14
4958656|NCT00251693|17047623|P3|Overall Study|Abnormal laboratory findings|1
4958657|NCT00251693|17047624|P2|Overall Study|Abnormal laboratory findings|0
4958658|NCT00251693|17047625|P1|Overall Study|Abnormal laboratory findings|0
4958659|NCT00251693|17047623|P3|Overall Study|Subject request/subject unavailable|0
4958660|NCT00251693|17047624|P2|Overall Study|Subject request/subject unavailable|2
4958661|NCT00251693|17047625|P1|Overall Study|Subject request/subject unavailable|1
4958662|NCT00251693|17047623|P3|Overall Study|Possible Barrett's esophagus|2
4958663|NCT00251693|17047624|P2|Overall Study|Possible Barrett's esophagus|5
4958664|NCT00251693|17047625|P1|Overall Study|Possible Barrett's esophagus|3
4958665|NCT00251693|17047623|P3|Overall Study|Noncompliant|2
4958666|NCT00251693|17047624|P2|Overall Study|Noncompliant|0
4958667|NCT00251693|17047625|P1|Overall Study|Noncompliant|0
4958668|NCT00251693|17047623|P3|Overall Study|Inclusion/exclusion criteria not met|8
4958669|NCT00251693|17047624|P2|Overall Study|Inclusion/exclusion criteria not met|3
4958670|NCT00251693|17047625|P1|Overall Study|Inclusion/exclusion criteria not met|5
4958671|NCT00251693|17047623|P3|Overall Study|Lack of Efficacy|0
4958672|NCT00251693|17047624|P2|Overall Study|Lack of Efficacy|1
4958673|NCT00251693|17047625|P1|Overall Study|Lack of Efficacy|0
4958674|NCT00251693|17047623|P3|Overall Study|Withdrawal by Subject|14
4958675|NCT00251693|17047624|P2|Overall Study|Withdrawal by Subject|17
4958676|NCT00251693|17047625|P1|Overall Study|Withdrawal by Subject|11
4958677|NCT00251693|17047623|P3|Overall Study|Lost to Follow-up|8
4958678|NCT00251693|17047624|P2|Overall Study|Lost to Follow-up|7
4958679|NCT00251693|17047625|P1|Overall Study|Lost to Follow-up|12
4958680|NCT00251693|17047623|P3|Overall Study|Protocol Violation|2
4958681|NCT00251693|17047624|P2|Overall Study|Protocol Violation|0
4958682|NCT00251693|17047625|P1|Overall Study|Protocol Violation|2
4958683|NCT00251693|17047623|P3|Overall Study|Adverse Event|9
4958684|NCT00251693|17047624|P2|Overall Study|Adverse Event|9
4958685|NCT00251693|17047625|P1|Overall Study|Adverse Event|17
4958686|NCT00251641|17047650|P2|Overall Study|Switched Treatment|63
4958687|NCT00251641|17047651|P1|Overall Study|Switched Treatment|9
4958688|NCT00251641|17047650|P2|Overall Study|Did not Meet protocol Eligibility|1
4958689|NCT00251641|17047651|P1|Overall Study|Did not Meet protocol Eligibility|2
4958690|NCT00251641|17047650|P2|Overall Study|Protocol Violation|2
4958691|NCT00251641|17047651|P1|Overall Study|Protocol Violation|10
4958692|NCT00251641|17047650|P2|Overall Study|Withdrawal by Subject|8
4958693|NCT00251641|17047651|P1|Overall Study|Withdrawal by Subject|6
4958694|NCT00251641|17047650|P2|Overall Study|Lost to Follow-up|3
4958695|NCT00251641|17047651|P1|Overall Study|Lost to Follow-up|3
4958696|NCT00251641|17047650|P2|Overall Study|Progression of Disease|2
4958697|NCT00251641|17047651|P1|Overall Study|Progression of Disease|0
4958698|NCT00251641|17047650|P2|Overall Study|Lack of Efficacy|1
4958699|NCT00251641|17047651|P1|Overall Study|Lack of Efficacy|2
4958700|NCT00251641|17047650|P2|Overall Study|Adverse Event|8
4958701|NCT00251641|17047651|P1|Overall Study|Adverse Event|80
4958702|NCT00251589|17047669|P4|Overall Study|Discontinued due to progressive disease|1
4958703|NCT00251589|17047670|P3|Overall Study|Discontinued due to progressive disease|0
4958704|NCT00251589|17047671|P2|Overall Study|Discontinued due to progressive disease|1
4958705|NCT00251589|17047672|P1|Overall Study|Discontinued due to progressive disease|9
4958706|NCT00251589|17047669|P4|Overall Study|Withdrawal by Subject|0
4958707|NCT00251589|17047670|P3|Overall Study|Withdrawal by Subject|0
4958708|NCT00251589|17047671|P2|Overall Study|Withdrawal by Subject|1
4958709|NCT00251589|17047672|P1|Overall Study|Withdrawal by Subject|1
4958710|NCT00251589|17047669|P4|Overall Study|Adverse Event|1
4958711|NCT00251589|17047670|P3|Overall Study|Adverse Event|2
4958712|NCT00251589|17047671|P2|Overall Study|Adverse Event|1
4958713|NCT00251589|17047672|P1|Overall Study|Adverse Event|5
4958714|NCT00251316|17047709|P2|Overall Study|Physician Decision|3
4958715|NCT00251316|17047710|P1|Overall Study|Physician Decision|2
4958716|NCT00251004|17047749|P3|Overall Study|Graft Loss|8
4958717|NCT00251004|17047750|P2|Overall Study|Graft Loss|13
4958718|NCT00251004|17047751|P1|Overall Study|Graft Loss|12
4958719|NCT00251004|17047749|P3|Overall Study|Lost to Follow-up|1
4958720|NCT00251004|17047750|P2|Overall Study|Lost to Follow-up|2
4958721|NCT00251004|17047751|P1|Overall Study|Lost to Follow-up|1
4958722|NCT00251004|17047749|P3|Overall Study|Death|8
4958723|NCT00251004|17047750|P2|Overall Study|Death|10
4958724|NCT00251004|17047751|P1|Overall Study|Death|9
4958725|NCT00251004|17047749|P3|Overall Study|Withdrawal by Subject|14
4958726|NCT00251004|17047750|P2|Overall Study|Withdrawal by Subject|16
4958727|NCT00251004|17047751|P1|Overall Study|Withdrawal by Subject|23
4958728|NCT00250835|17047775|P1|Overall Study|Withdrawal by Subject|1
4958729|NCT00250718|17047784|P1|Overall Study|Withdrawal by Subject|1
4958730|NCT00250718|17047784|P1|Overall Study|Adverse Event|1
4958731|NCT00250718|17047784|P1|Overall Study|Death|1
4958732|NCT00250705|17047789|P1|Overall Study|Lack of Efficacy|2
4958733|NCT00250679|17047800|P3|Overall Study|various single events: hip surgery,diary|1
4958734|NCT00250679|17047801|P2|Overall Study|various single events: hip surgery,diary|1
4958735|NCT00250679|17047802|P1|Overall Study|various single events: hip surgery,diary|3
4958736|NCT00250679|17047800|P3|Overall Study|Non-compliance|0
4958737|NCT00250679|17047801|P2|Overall Study|Non-compliance|1
4958738|NCT00250679|17047802|P1|Overall Study|Non-compliance|1
4958739|NCT00250679|17047800|P3|Overall Study|Moved|0
4958740|NCT00250679|17047801|P2|Overall Study|Moved|1
4958741|NCT00250679|17047802|P1|Overall Study|Moved|1
4958742|NCT00250679|17047800|P3|Overall Study|Technical Holter issues|2
4958743|NCT00250679|17047801|P2|Overall Study|Technical Holter issues|0
4958744|NCT00250679|17047802|P1|Overall Study|Technical Holter issues|1
4958745|NCT00250679|17047800|P3|Overall Study|Lack of Efficacy|3
4958746|NCT00250679|17047801|P2|Overall Study|Lack of Efficacy|1
4958747|NCT00250679|17047802|P1|Overall Study|Lack of Efficacy|0
4958748|NCT00250679|17047800|P3|Overall Study|Does Not Meet Entry Criteria|2
4958749|NCT00250679|17047801|P2|Overall Study|Does Not Meet Entry Criteria|4
4958750|NCT00250679|17047802|P1|Overall Study|Does Not Meet Entry Criteria|1
4958751|NCT00250679|17047800|P3|Overall Study|Lost to Follow-up|2
4958752|NCT00250679|17047801|P2|Overall Study|Lost to Follow-up|4
4958753|NCT00250679|17047802|P1|Overall Study|Lost to Follow-up|3
4958754|NCT00250679|17047800|P3|Overall Study|Withdrawal by Subject|15
4958755|NCT00250679|17047801|P2|Overall Study|Withdrawal by Subject|18
4958756|NCT00250679|17047802|P1|Overall Study|Withdrawal by Subject|15
4958757|NCT00250679|17047800|P3|Overall Study|Protocol Violation|3
4958758|NCT00250679|17047801|P2|Overall Study|Protocol Violation|4
4958759|NCT00250679|17047802|P1|Overall Study|Protocol Violation|2
4958760|NCT00250679|17047800|P3|Overall Study|Adverse Event|16
4958761|NCT00250679|17047801|P2|Overall Study|Adverse Event|15
4958762|NCT00250679|17047802|P1|Overall Study|Adverse Event|12
4958763|NCT00250588|17047903|P3|Overall Study|Lost to Follow-up|13
4958764|NCT00250588|17047904|P2|Overall Study|Lost to Follow-up|13
4958765|NCT00250588|17047905|P1|Overall Study|Lost to Follow-up|6
4958766|NCT00250588|17047903|P3|Overall Study|Withdrawal by Subject|0
4958767|NCT00250588|17047904|P2|Overall Study|Withdrawal by Subject|6
4958768|NCT00250588|17047905|P1|Overall Study|Withdrawal by Subject|3
4958769|NCT00250458|17047953|P2|Overall Study|Other|0
4958770|NCT00250458|17047954|P1|Overall Study|Other|1
4958771|NCT00250458|17047953|P2|Overall Study|Qualifying migraine but did not treat|3
4958772|NCT00250458|17047954|P1|Overall Study|Qualifying migraine but did not treat|3
4958773|NCT00250458|17047953|P2|Overall Study|Lack of Migraine Attack|9
4958774|NCT00250458|17047954|P1|Overall Study|Lack of Migraine Attack|20
4958775|NCT00250458|17047953|P2|Overall Study|Withdrawal by Subject|2
4958776|NCT00250458|17047954|P1|Overall Study|Withdrawal by Subject|4
4958777|NCT00250458|17047953|P2|Overall Study|Protocol Violation|1
4958778|NCT00250458|17047954|P1|Overall Study|Protocol Violation|0
4958779|NCT00250458|17047953|P2|Overall Study|Lost to Follow-up|2
4958780|NCT00250458|17047954|P1|Overall Study|Lost to Follow-up|4
4958781|NCT00250432|17047964|P2|Overall Study|Pt was considered untreatable|1
4958782|NCT00250432|17047965|P1|Overall Study|Pt was considered untreatable|0
4958783|NCT00250432|17047964|P2|Overall Study|Pt died out of posttherapy report period|5
4958784|NCT00250432|17047965|P1|Overall Study|Pt died out of posttherapy report period|6
4958785|NCT00250432|17047964|P2|Overall Study|Withdrawal by Subject|2
4958786|NCT00250432|17047965|P1|Overall Study|Withdrawal by Subject|6
4958787|NCT00250432|17047964|P2|Overall Study|Protocol Violation|3
4958788|NCT00250432|17047965|P1|Overall Study|Protocol Violation|0
4958789|NCT00250432|17047964|P2|Overall Study|Patient Moved|1
4958790|NCT00250432|17047965|P1|Overall Study|Patient Moved|0
4958791|NCT00250432|17047964|P2|Overall Study|Lost to Follow-up|5
4958792|NCT00250432|17047965|P1|Overall Study|Lost to Follow-up|6
4958793|NCT00250432|17047964|P2|Overall Study|Lack of Efficacy|1
4958794|NCT00250432|17047965|P1|Overall Study|Lack of Efficacy|2
4958795|NCT00250432|17047964|P2|Overall Study|Adverse Event|29
4958796|NCT00250432|17047965|P1|Overall Study|Adverse Event|25
4958797|NCT00250276|17047977|P4|Overall Study|Lost to Follow-up|8
4958798|NCT00250276|17047978|P3|Overall Study|Lost to Follow-up|13
4958799|NCT00250276|17047979|P2|Overall Study|Lost to Follow-up|18
4958800|NCT00250276|17047980|P1|Overall Study|Lost to Follow-up|11
4958801|NCT00250276|17047977|P4|Overall Study|Migrated/moved from study area|7
4958802|NCT00250276|17047978|P3|Overall Study|Migrated/moved from study area|2
4958803|NCT00250276|17047979|P2|Overall Study|Migrated/moved from study area|0
4958804|NCT00250276|17047980|P1|Overall Study|Migrated/moved from study area|3
4958805|NCT00250276|17047977|P4|Overall Study|Withdrawal by Subject|2
4958806|NCT00250276|17047978|P3|Overall Study|Withdrawal by Subject|3
4958807|NCT00250276|17047979|P2|Overall Study|Withdrawal by Subject|2
4958808|NCT00250276|17047980|P1|Overall Study|Withdrawal by Subject|1
4958809|NCT00250276|17047977|P4|Overall Study|Protocol Violation|0
4958810|NCT00250276|17047978|P3|Overall Study|Protocol Violation|0
4958811|NCT00250276|17047979|P2|Overall Study|Protocol Violation|1
4958812|NCT00250276|17047980|P1|Overall Study|Protocol Violation|0
4958813|NCT00250276|17047977|P4|Overall Study|Non-serious Adverse Event|2
4958814|NCT00250276|17047978|P3|Overall Study|Non-serious Adverse Event|0
4958815|NCT00250276|17047979|P2|Overall Study|Non-serious Adverse Event|0
4958816|NCT00250276|17047980|P1|Overall Study|Non-serious Adverse Event|2
4958817|NCT00250276|17047977|P4|Overall Study|Serious Adverse Event|0
4958818|NCT00250276|17047978|P3|Overall Study|Serious Adverse Event|1
4958819|NCT00250276|17047979|P2|Overall Study|Serious Adverse Event|0
4958820|NCT00250276|17047980|P1|Overall Study|Serious Adverse Event|0
4958821|NCT00249873|17048060|P2|Overall Study|Thromboembolic/outcome event|122
4958822|NCT00249873|17048061|P1|Overall Study|Thromboembolic/outcome event|82
4958823|NCT00249873|17048060|P2|Overall Study|Event related to cardiac condition|21
4958824|NCT00249873|17048061|P1|Overall Study|Event related to cardiac condition|12
4958825|NCT00249873|17048060|P2|Overall Study|Surgery/ procedure|9
4958826|NCT00249873|17048061|P1|Overall Study|Surgery/ procedure|9
4958827|NCT00249873|17048060|P2|Overall Study|Study drug intolerance|0
4958828|NCT00249873|17048061|P1|Overall Study|Study drug intolerance|5
4958829|NCT00249873|17048060|P2|Overall Study|Oral anticoagulant required|157
4958830|NCT00249873|17048061|P1|Overall Study|Oral anticoagulant required|159
4958831|NCT00249873|17048060|P2|Overall Study|Angiotensin II receptor blocker required|0
4958832|NCT00249873|17048061|P1|Overall Study|Angiotensin II receptor blocker required|1
4958833|NCT00249873|17048060|P2|Overall Study|Open label clopidogrel required|42
4958834|NCT00249873|17048061|P1|Overall Study|Open label clopidogrel required|31
4958835|NCT00249873|17048060|P2|Overall Study|Physician withdrew consent|60
4958836|NCT00249873|17048061|P1|Overall Study|Physician withdrew consent|59
4958837|NCT00249873|17048060|P2|Overall Study|Patient not wish to continue after May08|4
4958838|NCT00249873|17048061|P1|Overall Study|Patient not wish to continue after May08|3
4958839|NCT00249873|17048060|P2|Overall Study|Other contraindicated medication|0
4958840|NCT00249873|17048061|P1|Overall Study|Other contraindicated medication|1
4958841|NCT00249873|17048060|P2|Overall Study|Other non serious Adverse Event|108
4958842|NCT00249873|17048061|P1|Overall Study|Other non serious Adverse Event|112
4958843|NCT00249873|17048060|P2|Overall Study|Non-compliance|46
4958844|NCT00249873|17048061|P1|Overall Study|Non-compliance|41
4958845|NCT00249873|17048060|P2|Overall Study|Minor bleeding|37
4958846|NCT00249873|17048061|P1|Overall Study|Minor bleeding|99
4958847|NCT00249873|17048060|P2|Overall Study|Lost to Follow-up|7
4958848|NCT00249873|17048061|P1|Overall Study|Lost to Follow-up|4
4958849|NCT00249873|17048060|P2|Overall Study|Withdrawal by Subject|466
4958850|NCT00249873|17048061|P1|Overall Study|Withdrawal by Subject|504
4958851|NCT00249873|17048060|P2|Overall Study|Contraindication to oral anticoagulant|8
4958852|NCT00249873|17048061|P1|Overall Study|Contraindication to oral anticoagulant|4
4958853|NCT00249873|17048060|P2|Overall Study|Qualifying condition not present|23
4958854|NCT00249873|17048061|P1|Overall Study|Qualifying condition not present|20
4958855|NCT00249873|17048060|P2|Overall Study|Other Serious Adverse Event|97
4958856|NCT00249873|17048061|P1|Overall Study|Other Serious Adverse Event|86
4958857|NCT00249873|17048060|P2|Overall Study|Serious haemorrhagic Adverse Event|30
4958858|NCT00249873|17048061|P1|Overall Study|Serious haemorrhagic Adverse Event|74
4958859|NCT00249873|17048060|P2|Overall Study|Severe allergic reaction|1
4958860|NCT00249873|17048061|P1|Overall Study|Severe allergic reaction|8
4958861|NCT00249873|17048060|P2|Overall Study|Significant thrombocytopenia|8
4958862|NCT00249873|17048061|P1|Overall Study|Significant thrombocytopenia|9
4958863|NCT00249873|17048060|P2|Overall Study|Not treated|8
4958864|NCT00249873|17048061|P1|Overall Study|Not treated|7
4958865|NCT00249834|17048081|P8|Overall Study|Protocol Violation|0
4958866|NCT00249834|17048082|P7|Overall Study|Protocol Violation|0
4958867|NCT00249834|17048083|P6|Overall Study|Protocol Violation|2
4958868|NCT00249834|17048084|P5|Overall Study|Protocol Violation|5
4958869|NCT00249834|17048085|P4|Overall Study|Protocol Violation|8
4958870|NCT00249834|17048086|P3|Overall Study|Protocol Violation|14
4958871|NCT00249834|17048087|P2|Overall Study|Protocol Violation|19
4958872|NCT00249834|17048088|P1|Overall Study|Protocol Violation|0
4958873|NCT00249834|17048081|P8|Overall Study|Failure of down-regulation|0
4958874|NCT00249834|17048082|P7|Overall Study|Failure of down-regulation|1
4958875|NCT00249834|17048083|P6|Overall Study|Failure of down-regulation|0
4958876|NCT00249834|17048084|P5|Overall Study|Failure of down-regulation|0
4958877|NCT00249834|17048085|P4|Overall Study|Failure of down-regulation|0
4958878|NCT00249834|17048086|P3|Overall Study|Failure of down-regulation|0
4958879|NCT00249834|17048087|P2|Overall Study|Failure of down-regulation|0
4958880|NCT00249834|17048088|P1|Overall Study|Failure of down-regulation|0
4958881|NCT00249834|17048081|P8|Overall Study|Ovarian stimulation failed|0
4958882|NCT00249834|17048082|P7|Overall Study|Ovarian stimulation failed|0
4958883|NCT00249834|17048083|P6|Overall Study|Ovarian stimulation failed|0
4958884|NCT00249834|17048084|P5|Overall Study|Ovarian stimulation failed|0
4958885|NCT00249834|17048085|P4|Overall Study|Ovarian stimulation failed|0
4958886|NCT00249834|17048086|P3|Overall Study|Ovarian stimulation failed|0
4958887|NCT00249834|17048087|P2|Overall Study|Ovarian stimulation failed|0
4958888|NCT00249834|17048088|P1|Overall Study|Ovarian stimulation failed|1
4958889|NCT00249821|17048137|P2|Overall Study|Technical problem|1
4958890|NCT00249821|17048138|P1|Overall Study|Technical problem|0
4958891|NCT00249808|17048158|P1|Overall Study|Did Not Provide Post-Baseline Data|11
4958892|NCT00249808|17048158|P1|Overall Study|Lack of Efficacy|52
4958893|NCT00249808|17048158|P1|Overall Study|Adverse Event|81
4958894|NCT00249808|17048158|P1|Overall Study|Lost to Follow-up|8
4958895|NCT00249808|17048158|P1|Overall Study|Protocol Violation|3
4958896|NCT00249808|17048158|P1|Overall Study|Other|27
4958897|NCT00249795|17048166|P2|Overall Study|Missing|1
4958898|NCT00249795|17048167|P1|Overall Study|Missing|0
4958899|NCT00249795|17048166|P2|Overall Study|Lost to Follow-up|2
4958900|NCT00249795|17048167|P1|Overall Study|Lost to Follow-up|0
4958901|NCT00249795|17048166|P2|Overall Study|Site not agree to continue after May08|1
4958902|NCT00249795|17048167|P1|Overall Study|Site not agree to continue after May08|1
4958903|NCT00249795|17048166|P2|Overall Study|Patient not wish to continue after May08|6
4958904|NCT00249795|17048167|P1|Overall Study|Patient not wish to continue after May08|4
4958905|NCT00249795|17048166|P2|Overall Study|Event related to cardiac condition|16
4958906|NCT00249795|17048167|P1|Overall Study|Event related to cardiac condition|17
4958907|NCT00249795|17048166|P2|Overall Study|Other contraindicated medication|1
4958908|NCT00249795|17048167|P1|Overall Study|Other contraindicated medication|1
4958909|NCT00249795|17048166|P2|Overall Study|Hypotension (non-symptomatic)|5
4958910|NCT00249795|17048167|P1|Overall Study|Hypotension (non-symptomatic)|5
4958911|NCT00249795|17048166|P2|Overall Study|Lightheadedness / dizziness|11
4958912|NCT00249795|17048167|P1|Overall Study|Lightheadedness / dizziness|15
4958913|NCT00249795|17048166|P2|Overall Study|Angiotensin II receptor blocker required|58
4958914|NCT00249795|17048167|P1|Overall Study|Angiotensin II receptor blocker required|35
4958915|NCT00249795|17048166|P2|Overall Study|Surgery / procedure|5
4958916|NCT00249795|17048167|P1|Overall Study|Surgery / procedure|4
4958917|NCT00249795|17048166|P2|Overall Study|Physician withdrew consent|63
4958918|NCT00249795|17048167|P1|Overall Study|Physician withdrew consent|71
4958919|NCT00249795|17048166|P2|Overall Study|Other adverse events (non-serious)|159
4958920|NCT00249795|17048167|P1|Overall Study|Other adverse events (non-serious)|188
4958921|NCT00249795|17048166|P2|Overall Study|Study drug intolerance|3
4958922|NCT00249795|17048167|P1|Overall Study|Study drug intolerance|3
4958923|NCT00249795|17048166|P2|Overall Study|Non-compliance|69
4958924|NCT00249795|17048167|P1|Overall Study|Non-compliance|71
4958925|NCT00249795|17048166|P2|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3
4958926|NCT00249795|17048167|P1|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7
4958927|NCT00249795|17048166|P2|Overall Study|Oral anticoagulant required|0
4958928|NCT00249795|17048167|P1|Overall Study|Oral anticoagulant required|2
4958929|NCT00249795|17048166|P2|Overall Study|Thromboembolic / outcome event|45
4958930|NCT00249795|17048167|P1|Overall Study|Thromboembolic / outcome event|39
4958931|NCT00249795|17048166|P2|Overall Study|Withdrawal by Subject|742
4958932|NCT00249795|17048167|P1|Overall Study|Withdrawal by Subject|678
4958933|NCT00249795|17048166|P2|Overall Study|Qualifying condition not present|29
4958934|NCT00249795|17048167|P1|Overall Study|Qualifying condition not present|26
4958935|NCT00249795|17048166|P2|Overall Study|Other Serious Adverse Event|93
4958936|NCT00249795|17048167|P1|Overall Study|Other Serious Adverse Event|84
4958937|NCT00249795|17048166|P2|Overall Study|Symptomatic hypotension|64
4958938|NCT00249795|17048167|P1|Overall Study|Symptomatic hypotension|127
4958939|NCT00249795|17048166|P2|Overall Study|Not treated|14
4958940|NCT00249795|17048167|P1|Overall Study|Not treated|16
4958941|NCT00249769|17048188|P3|Overall Study|Lost to Follow-up|3
4958942|NCT00249769|17048189|P2|Overall Study|Lost to Follow-up|0
4958943|NCT00249769|17048190|P1|Overall Study|Lost to Follow-up|0
4958944|NCT00249769|17048188|P3|Overall Study|Physician Decision|2
4958945|NCT00249769|17048189|P2|Overall Study|Physician Decision|0
4958946|NCT00249769|17048190|P1|Overall Study|Physician Decision|0
4958947|NCT00249769|17048188|P3|Overall Study|Adverse Event|1
4958948|NCT00249769|17048189|P2|Overall Study|Adverse Event|0
4958949|NCT00249769|17048190|P1|Overall Study|Adverse Event|0
4958950|NCT00249769|17048188|P3|Overall Study|Miscellaneous|2
4958951|NCT00249769|17048189|P2|Overall Study|Miscellaneous|2
4958952|NCT00249769|17048190|P1|Overall Study|Miscellaneous|0
4958953|NCT00249769|17048188|P3|Overall Study|Migration from Study Area|14
4958954|NCT00249769|17048189|P2|Overall Study|Migration from Study Area|3
4958955|NCT00249769|17048190|P1|Overall Study|Migration from Study Area|1
4958956|NCT00249769|17048188|P3|Overall Study|Withdrawal by Subject|6
4958957|NCT00249769|17048189|P2|Overall Study|Withdrawal by Subject|10
4958958|NCT00249769|17048190|P1|Overall Study|Withdrawal by Subject|1
4958959|NCT00249613|17048218|P2|12 Month Follow-up|Lost to Follow-up|8
4958960|NCT00249613|17048219|P1|12 Month Follow-up|Lost to Follow-up|10
4958961|NCT00249613|17048218|P2|12 Month Follow-up|Withdrawal by Subject|6
4958962|NCT00249613|17048219|P1|12 Month Follow-up|Withdrawal by Subject|6
4958963|NCT00249613|17048218|P2|12 Month Follow-up|Death|1
4958964|NCT00249613|17048219|P1|12 Month Follow-up|Death|1
4958965|NCT00249444|17048260|P2|Overall Study|life event|1
4958966|NCT00249444|17048261|P1|Overall Study|life event|0
4958967|NCT00249444|17048260|P2|Overall Study|Adverse Event|1
4958968|NCT00249444|17048261|P1|Overall Study|Adverse Event|1
4958969|NCT00249444|17048260|P2|Overall Study|non-compliant|11
4958970|NCT00249444|17048261|P1|Overall Study|non-compliant|9
4958971|NCT00249444|17048260|P2|Overall Study|Lost to Follow-up|2
4958972|NCT00249444|17048261|P1|Overall Study|Lost to Follow-up|2
4958973|NCT00249288|17048286|P2|Overall Study|Withdrawal by Subject|2
4958974|NCT00249288|17048287|P1|Overall Study|Withdrawal by Subject|2
4958975|NCT00249288|17048286|P2|Overall Study|Lost to Follow-up|3
4958976|NCT00249288|17048287|P1|Overall Study|Lost to Follow-up|3
4958977|NCT00249002|17048379|P1|Overall Study|Other|2
4958978|NCT00249002|17048379|P1|Overall Study|Study cancellation|3
4958979|NCT00249002|17048379|P1|Overall Study|Adverse Event|2
4958980|NCT00248833|17048398|P3|Overall Study|Other|0
4958981|NCT00248833|17048399|P2|Overall Study|Other|1
4958982|NCT00248833|17048400|P1|Overall Study|Other|0
4958983|NCT00248833|17048398|P3|Overall Study|Lost to Follow-up|1
4958984|NCT00248833|17048399|P2|Overall Study|Lost to Follow-up|1
4958985|NCT00248833|17048400|P1|Overall Study|Lost to Follow-up|1
4958986|NCT00248833|17048398|P3|Overall Study|Withdrawal by Subject|1
4958987|NCT00248833|17048399|P2|Overall Study|Withdrawal by Subject|1
4958988|NCT00248833|17048400|P1|Overall Study|Withdrawal by Subject|0
4958989|NCT00248833|17048398|P3|Overall Study|Adverse Event|0
4958990|NCT00248833|17048399|P2|Overall Study|Adverse Event|0
4958991|NCT00248833|17048400|P1|Overall Study|Adverse Event|2
4958992|NCT00248794|17048436|P3|Overall Study|Lost to Follow-up|3
4958993|NCT00248794|17048437|P2|Overall Study|Lost to Follow-up|8
4958994|NCT00248794|17048438|P1|Overall Study|Lost to Follow-up|6
4958995|NCT00248651|17048488|P3|Overall Study|Withdrawal by Subject|32
4958996|NCT00248651|17048489|P2|Overall Study|Withdrawal by Subject|40
4958997|NCT00248651|17048490|P1|Overall Study|Withdrawal by Subject|28
4958998|NCT00248625|17048526|P2|Overall Study|Withdrawal by Subject|2
4958999|NCT00248625|17048527|P1|Overall Study|Withdrawal by Subject|0
4959000|NCT00248495|17048619|P1|Overall Study|Withdrawal by Subject|1
4959001|NCT00248287|17048630|P2|Overall Study|Other|2
4959002|NCT00248287|17048631|P1|Overall Study|Other|3
4959003|NCT00248287|17048630|P2|Overall Study|Patient Request|3
4959004|NCT00248287|17048631|P1|Overall Study|Patient Request|5
4959005|NCT00248287|17048630|P2|Overall Study|Investigator Request|3
4959006|NCT00248287|17048631|P1|Overall Study|Investigator Request|4
4959007|NCT00248287|17048630|P2|Overall Study|Lost to Follow-up|1
4959008|NCT00248287|17048631|P1|Overall Study|Lost to Follow-up|0
4959009|NCT00248287|17048630|P2|Overall Study|Death|0
4959010|NCT00248287|17048631|P1|Overall Study|Death|1
4959011|NCT00248287|17048630|P2|Overall Study|Adverse Event|10
4959012|NCT00248287|17048631|P1|Overall Study|Adverse Event|11
4959013|NCT00248170|17048645|P2|Overall Study|Protocol deviation|19
4959014|NCT00248170|17048646|P1|Overall Study|Protocol deviation|17
4959015|NCT00248170|17048645|P2|Overall Study|Abnormal laboratory values|0
4959016|NCT00248170|17048646|P1|Overall Study|Abnormal laboratory values|4
4959017|NCT00248170|17048645|P2|Overall Study|Abnormal test procedure(s) result|61
4959018|NCT00248170|17048646|P1|Overall Study|Abnormal test procedure(s) result|49
4959019|NCT00248170|17048645|P2|Overall Study|Administrative problems|25
4959020|NCT00248170|17048646|P1|Overall Study|Administrative problems|22
4959021|NCT00248170|17048645|P2|Overall Study|Adverse Event|296
4959022|NCT00248170|17048646|P1|Overall Study|Adverse Event|311
4959023|NCT00248170|17048645|P2|Overall Study|Death|47
4959024|NCT00248170|17048646|P1|Overall Study|Death|28
4959025|NCT00248170|17048645|P2|Overall Study|Disease progression|216
4959026|NCT00248170|17048646|P1|Overall Study|Disease progression|196
4959027|NCT00248170|17048645|P2|Overall Study|Lost to Follow-up|35
4959028|NCT00248170|17048646|P1|Overall Study|Lost to Follow-up|28
4959029|NCT00248170|17048645|P2|Overall Study|Protocol Violation|30
4959030|NCT00248170|17048646|P1|Overall Study|Protocol Violation|35
4959031|NCT00248170|17048645|P2|Overall Study|Withdrawal by Subject|79
4959032|NCT00248170|17048646|P1|Overall Study|Withdrawal by Subject|71
4959033|NCT00248040|17048669|P3|Overall Study|Death|1
4959034|NCT00248040|17048670|P2|Overall Study|Death|0
4959035|NCT00248040|17048671|P1|Overall Study|Death|0
4959036|NCT00248040|17048669|P3|Overall Study|transplant cancelled post treat start|0
4959037|NCT00248040|17048670|P2|Overall Study|transplant cancelled post treat start|0
4959038|NCT00248040|17048671|P1|Overall Study|transplant cancelled post treat start|1
4959039|NCT00248040|17048669|P3|Overall Study|transplantectomy|3
4959040|NCT00248040|17048670|P2|Overall Study|transplantectomy|1
4959041|NCT00248040|17048671|P1|Overall Study|transplantectomy|2
4959042|NCT00247962|17048720|P2|Overall Study|Lack of Efficacy|2
4959043|NCT00247962|17048721|P1|Overall Study|Lack of Efficacy|4
4959044|NCT00247962|17048720|P2|Overall Study|Withdrawal by Subject|2
4959045|NCT00247962|17048721|P1|Overall Study|Withdrawal by Subject|3
4959046|NCT00247962|17048720|P2|Overall Study|Protocol Violation|1
4959047|NCT00247962|17048721|P1|Overall Study|Protocol Violation|1
4959048|NCT00247962|17048720|P2|Overall Study|Physician Decision|1
4959049|NCT00247962|17048721|P1|Overall Study|Physician Decision|0
4959050|NCT00247962|17048720|P2|Overall Study|Lost to Follow-up|1
4959051|NCT00247962|17048721|P1|Overall Study|Lost to Follow-up|3
4959052|NCT00247962|17048720|P2|Overall Study|Adverse Event|12
4959053|NCT00247962|17048721|P1|Overall Study|Adverse Event|15
4959054|NCT00247676|17048729|P1|Overall Study|Withdrawal by Subject|2
4959055|NCT00247676|17048729|P1|Overall Study|Other|3
4959056|NCT00247676|17048729|P1|Overall Study|Lack of Efficacy|15
4959057|NCT00247676|17048729|P1|Overall Study|Adverse Event|11
4959058|NCT00247676|17048729|P1|Overall Study|Death|5
4959059|NCT00247611|17048774|P2|Baselined|Completed baseline only|8
4959060|NCT00247611|17048775|P1|Baselined|Completed baseline only|9
4959061|NCT00247611|17048774|P2|Baselined|Completed baseline, never placed on ARVs|5
4959062|NCT00247611|17048775|P1|Baselined|Completed baseline, never placed on ARVs|8
4959063|NCT00247416|17048793|P2|Overall Study|3 patients were found to be ineligible|2
4959064|NCT00247416|17048794|P1|Overall Study|3 patients were found to be ineligible|1
4959065|NCT00247273|17048835|P2|Overall Study|Did not take any study drug|0
4959066|NCT00247273|17048836|P1|Overall Study|Did not take any study drug|2
4959067|NCT00247273|17048835|P2|Overall Study|Withdrawal by Subject|47
4959068|NCT00247273|17048836|P1|Overall Study|Withdrawal by Subject|46
4959069|NCT00247273|17048835|P2|Overall Study|Lost to Follow-up|7
4959070|NCT00247273|17048836|P1|Overall Study|Lost to Follow-up|7
4959071|NCT00247273|17048835|P2|Overall Study|Physician Decision|3
4959072|NCT00247273|17048836|P1|Overall Study|Physician Decision|6
4959073|NCT00247273|17048835|P2|Overall Study|Adverse Event|80
4959074|NCT00247273|17048836|P1|Overall Study|Adverse Event|85
4959075|NCT00246805|17048882|P2|Phase 1|Lost to Follow-up|0
4959076|NCT00246805|17048883|P1|Phase 1|Lost to Follow-up|1
4959077|NCT00246753|17048889|P1|Overall Study|Unacceptable toxicity|2
4959078|NCT00246753|17048889|P1|Overall Study|Adverse Event|2
4959079|NCT00246753|17048889|P1|Overall Study|Physician Decision|2
4959080|NCT00246753|17048889|P1|Overall Study|Withdrawal by Subject|2
4959081|NCT00246740|17048897|P2|Initial Enrollment|Other|2
4959082|NCT00246740|17048898|P1|Initial Enrollment|Other|1
4959083|NCT00246740|17048897|P2|Initial Enrollment|Surgery schedule change|4
4959084|NCT00246740|17048898|P1|Initial Enrollment|Surgery schedule change|4
4959085|NCT00246740|17048897|P2|Initial Enrollment|Additional surgery scheduled|2
4959086|NCT00246740|17048898|P1|Initial Enrollment|Additional surgery scheduled|0
4959087|NCT00246740|17048897|P2|Initial Enrollment|Death|0
4959088|NCT00246740|17048898|P1|Initial Enrollment|Death|1
4959089|NCT00246571|17048922|P2|Overall Study|Crossover participants|74
4959090|NCT00246571|17048923|P1|Overall Study|Crossover participants|0
4959091|NCT00246571|17048922|P2|Overall Study|Laboratory abnormalities|0
4959092|NCT00246571|17048923|P1|Overall Study|Laboratory abnormalities|1
4959093|NCT00246571|17048922|P2|Overall Study|Did not meet entrance criteria|1
4959094|NCT00246571|17048923|P1|Overall Study|Did not meet entrance criteria|2
4959095|NCT00246571|17048922|P2|Overall Study|Sponsor|1
4959096|NCT00246571|17048923|P1|Overall Study|Sponsor|0
4959097|NCT00246571|17048922|P2|Overall Study|Death|3
4959098|NCT00246571|17048923|P1|Overall Study|Death|17
4959099|NCT00246571|17048922|P2|Overall Study|Lack of Efficacy|21
4959100|NCT00246571|17048923|P1|Overall Study|Lack of Efficacy|84
4959101|NCT00246571|17048922|P2|Overall Study|Withdrawal by Subject|3
4959102|NCT00246571|17048923|P1|Overall Study|Withdrawal by Subject|2
4959103|NCT00246571|17048922|P2|Overall Study|Protocol Violation|1
4959104|NCT00246571|17048923|P1|Overall Study|Protocol Violation|0
4959105|NCT00246571|17048922|P2|Overall Study|Adverse Event|0
4959106|NCT00246571|17048923|P1|Overall Study|Adverse Event|7
4959107|NCT00246376|17048988|P5|Overall Study|Lost to Follow-up|13
4959108|NCT00246376|17048989|P4|Overall Study|Lost to Follow-up|16
4959109|NCT00246376|17048990|P3|Overall Study|Lost to Follow-up|11
4959110|NCT00246376|17048991|P2|Overall Study|Lost to Follow-up|11
4959111|NCT00246376|17048992|P1|Overall Study|Lost to Follow-up|2
4959112|NCT00246376|17048988|P5|Overall Study|Adverse Event|1
4959113|NCT00246376|17048989|P4|Overall Study|Adverse Event|3
4959114|NCT00246376|17048990|P3|Overall Study|Adverse Event|1
4959115|NCT00246376|17048991|P2|Overall Study|Adverse Event|3
4959116|NCT00246376|17048992|P1|Overall Study|Adverse Event|2
4959117|NCT00246376|17048988|P5|Overall Study|Dropped/withdrew during dietary run-in|3
4959118|NCT00246376|17048989|P4|Overall Study|Dropped/withdrew during dietary run-in|7
4959119|NCT00246376|17048990|P3|Overall Study|Dropped/withdrew during dietary run-in|4
4959120|NCT00246376|17048991|P2|Overall Study|Dropped/withdrew during dietary run-in|5
4959121|NCT00246376|17048992|P1|Overall Study|Dropped/withdrew during dietary run-in|11
4959122|NCT00246337|17049043|P9|Overall Study|Reported as completing trial in error|0
4959123|NCT00246337|17049044|P8|Overall Study|Reported as completing trial in error|1
4959124|NCT00246337|17049045|P7|Overall Study|Reported as completing trial in error|0
4959125|NCT00246337|17049046|P6|Overall Study|Reported as completing trial in error|0
4959126|NCT00246337|17049047|P5|Overall Study|Reported as completing trial in error|0
4959127|NCT00246337|17049048|P4|Overall Study|Reported as completing trial in error|0
4959128|NCT00246337|17049049|P3|Overall Study|Reported as completing trial in error|0
4959129|NCT00246337|17049050|P2|Overall Study|Reported as completing trial in error|0
4959130|NCT00246337|17049051|P1|Overall Study|Reported as completing trial in error|0
4959131|NCT00246337|17049043|P9|Overall Study|Protocol Violator|0
4959132|NCT00246337|17049044|P8|Overall Study|Protocol Violator|0
4959133|NCT00246337|17049045|P7|Overall Study|Protocol Violator|0
4959134|NCT00246337|17049046|P6|Overall Study|Protocol Violator|0
4959135|NCT00246337|17049047|P5|Overall Study|Protocol Violator|0
4959136|NCT00246337|17049048|P4|Overall Study|Protocol Violator|0
4959137|NCT00246337|17049049|P3|Overall Study|Protocol Violator|0
4959138|NCT00246337|17049050|P2|Overall Study|Protocol Violator|0
4959139|NCT00246337|17049051|P1|Overall Study|Protocol Violator|1
4959140|NCT00246337|17049043|P9|Overall Study|Overwhelmed|0
4959141|NCT00246337|17049044|P8|Overall Study|Overwhelmed|0
4959142|NCT00246337|17049045|P7|Overall Study|Overwhelmed|0
4959143|NCT00246337|17049046|P6|Overall Study|Overwhelmed|1
4959144|NCT00246337|17049047|P5|Overall Study|Overwhelmed|0
4959145|NCT00246337|17049048|P4|Overall Study|Overwhelmed|0
4959146|NCT00246337|17049049|P3|Overall Study|Overwhelmed|0
4959147|NCT00246337|17049050|P2|Overall Study|Overwhelmed|0
4959148|NCT00246337|17049051|P1|Overall Study|Overwhelmed|0
4959149|NCT00246337|17049043|P9|Overall Study|Abnormal baseline lab values|4
4959150|NCT00246337|17049044|P8|Overall Study|Abnormal baseline lab values|0
4959151|NCT00246337|17049045|P7|Overall Study|Abnormal baseline lab values|2
4959152|NCT00246337|17049046|P6|Overall Study|Abnormal baseline lab values|2
4959153|NCT00246337|17049047|P5|Overall Study|Abnormal baseline lab values|0
4959154|NCT00246337|17049048|P4|Overall Study|Abnormal baseline lab values|0
4959155|NCT00246337|17049049|P3|Overall Study|Abnormal baseline lab values|2
4959156|NCT00246337|17049050|P2|Overall Study|Abnormal baseline lab values|0
4959157|NCT00246337|17049051|P1|Overall Study|Abnormal baseline lab values|7
4959158|NCT00246337|17049043|P9|Overall Study|Site Terminated|2
4959159|NCT00246337|17049044|P8|Overall Study|Site Terminated|6
4959160|NCT00246337|17049045|P7|Overall Study|Site Terminated|1
4959161|NCT00246337|17049046|P6|Overall Study|Site Terminated|7
4959162|NCT00246337|17049047|P5|Overall Study|Site Terminated|0
4959163|NCT00246337|17049048|P4|Overall Study|Site Terminated|0
4959164|NCT00246337|17049049|P3|Overall Study|Site Terminated|0
4959165|NCT00246337|17049050|P2|Overall Study|Site Terminated|0
4959166|NCT00246337|17049051|P1|Overall Study|Site Terminated|10
4959167|NCT00246337|17049043|P9|Overall Study|Lack of Qualifying Event|5
4959168|NCT00246337|17049044|P8|Overall Study|Lack of Qualifying Event|2
4959169|NCT00246337|17049045|P7|Overall Study|Lack of Qualifying Event|3
4959170|NCT00246337|17049046|P6|Overall Study|Lack of Qualifying Event|3
4959171|NCT00246337|17049047|P5|Overall Study|Lack of Qualifying Event|1
4959172|NCT00246337|17049048|P4|Overall Study|Lack of Qualifying Event|1
4959173|NCT00246337|17049049|P3|Overall Study|Lack of Qualifying Event|1
4959174|NCT00246337|17049050|P2|Overall Study|Lack of Qualifying Event|2
4959175|NCT00246337|17049051|P1|Overall Study|Lack of Qualifying Event|8
4959176|NCT00246337|17049043|P9|Overall Study|Withdrawal by Subject|0
4959177|NCT00246337|17049044|P8|Overall Study|Withdrawal by Subject|1
4959178|NCT00246337|17049045|P7|Overall Study|Withdrawal by Subject|1
4959179|NCT00246337|17049046|P6|Overall Study|Withdrawal by Subject|0
4959180|NCT00246337|17049047|P5|Overall Study|Withdrawal by Subject|0
4959181|NCT00246337|17049048|P4|Overall Study|Withdrawal by Subject|0
4959182|NCT00246337|17049049|P3|Overall Study|Withdrawal by Subject|0
4959183|NCT00246337|17049050|P2|Overall Study|Withdrawal by Subject|0
4959184|NCT00246337|17049051|P1|Overall Study|Withdrawal by Subject|2
4959185|NCT00246337|17049043|P9|Overall Study|Protocol Violation|0
4959186|NCT00246337|17049044|P8|Overall Study|Protocol Violation|1
4959187|NCT00246337|17049045|P7|Overall Study|Protocol Violation|1
4959188|NCT00246337|17049046|P6|Overall Study|Protocol Violation|0
4959189|NCT00246337|17049047|P5|Overall Study|Protocol Violation|1
4959190|NCT00246337|17049048|P4|Overall Study|Protocol Violation|0
4959191|NCT00246337|17049049|P3|Overall Study|Protocol Violation|0
4959192|NCT00246337|17049050|P2|Overall Study|Protocol Violation|0
4959193|NCT00246337|17049051|P1|Overall Study|Protocol Violation|1
4959194|NCT00246337|17049043|P9|Overall Study|Lost to Follow-up|0
4959195|NCT00246337|17049044|P8|Overall Study|Lost to Follow-up|2
4959196|NCT00246337|17049045|P7|Overall Study|Lost to Follow-up|1
4959197|NCT00246337|17049046|P6|Overall Study|Lost to Follow-up|2
4959198|NCT00246337|17049047|P5|Overall Study|Lost to Follow-up|2
4959199|NCT00246337|17049048|P4|Overall Study|Lost to Follow-up|0
4959200|NCT00246337|17049049|P3|Overall Study|Lost to Follow-up|0
4959201|NCT00246337|17049050|P2|Overall Study|Lost to Follow-up|0
4959202|NCT00246337|17049051|P1|Overall Study|Lost to Follow-up|3
4959203|NCT00246324|17049098|P1|Overall Study|Withdrawal by Subject|1
4959204|NCT00246259|17049105|P2|Overall Study|randomly assigned, not eligible for ITT|6
4959205|NCT00246259|17049106|P1|Overall Study|randomly assigned, not eligible for ITT|2
4959206|NCT00246259|17049105|P2|Overall Study|Withdrawal by Subject|1
4959207|NCT00246259|17049106|P1|Overall Study|Withdrawal by Subject|5
4959208|NCT00246259|17049105|P2|Overall Study|Lost to Follow-up|4
4959209|NCT00246259|17049106|P1|Overall Study|Lost to Follow-up|3
4959210|NCT00246259|17049105|P2|Overall Study|Adverse Event|0
4959211|NCT00246259|17049106|P1|Overall Study|Adverse Event|5
4959212|NCT00246259|17049105|P2|Overall Study|Investigator withdrew participant|0
4959213|NCT00246259|17049106|P1|Overall Study|Investigator withdrew participant|2
4959214|NCT00246259|17049105|P2|Overall Study|Lack of Efficacy|2
4959215|NCT00246259|17049106|P1|Overall Study|Lack of Efficacy|2
4959216|NCT00246259|17049105|P2|Overall Study|Participant non-compliant|9
4959217|NCT00246259|17049106|P1|Overall Study|Participant non-compliant|4
4959218|NCT00246259|17049105|P2|Overall Study|Not stable by Week 18|1
4959219|NCT00246259|17049106|P1|Overall Study|Not stable by Week 18|2
4959220|NCT00246259|17049105|P2|Overall Study|Other|3
4959221|NCT00246259|17049106|P1|Overall Study|Other|3
4959222|NCT00246090|17049140|P1|Overall Study|Not Otherwise Specified|10
4959223|NCT00246090|17049140|P1|Overall Study|Physician Decision|11
4959224|NCT00246090|17049140|P1|Overall Study|Clinical Progression|30
4959225|NCT00246090|17049140|P1|Overall Study|Progressive Disease|212
4959226|NCT00246090|17049140|P1|Overall Study|Withdrawal by Subject|7
4959227|NCT00246090|17049140|P1|Overall Study|Adverse Event|25
4959228|NCT00246025|17049149|P4|Overall Study|unsuitable medical history was found|1
4959229|NCT00246025|17049150|P3|Overall Study|unsuitable medical history was found|0
4959230|NCT00246025|17049151|P2|Overall Study|unsuitable medical history was found|0
4959231|NCT00246025|17049152|P1|Overall Study|unsuitable medical history was found|0
4959232|NCT00246025|17049149|P4|Overall Study|Withdrawal by Subject|2
4959233|NCT00246025|17049150|P3|Overall Study|Withdrawal by Subject|1
4959234|NCT00246025|17049151|P2|Overall Study|Withdrawal by Subject|0
4959235|NCT00246025|17049152|P1|Overall Study|Withdrawal by Subject|3
4959236|NCT00246025|17049149|P4|Overall Study|Adverse Event|10
4959237|NCT00246025|17049150|P3|Overall Study|Adverse Event|9
4959238|NCT00246025|17049151|P2|Overall Study|Adverse Event|9
4959239|NCT00246025|17049152|P1|Overall Study|Adverse Event|7
4959240|NCT00246012|17049211|P9|Overall Study|Randomly assigned but not treated|0
4959241|NCT00246012|17049212|P8|Overall Study|Randomly assigned but not treated|0
4959242|NCT00246012|17049213|P7|Overall Study|Randomly assigned but not treated|1
4959243|NCT00246012|17049214|P6|Overall Study|Randomly assigned but not treated|1
4959244|NCT00246012|17049215|P5|Overall Study|Randomly assigned but not treated|0
4959245|NCT00246012|17049216|P4|Overall Study|Randomly assigned but not treated|0
4959246|NCT00246012|17049217|P3|Overall Study|Randomly assigned but not treated|0
4959247|NCT00246012|17049218|P2|Overall Study|Randomly assigned but not treated|0
4959248|NCT00246012|17049219|P1|Overall Study|Randomly assigned but not treated|0
4959249|NCT00246012|17049211|P9|Overall Study|Other|0
4959250|NCT00246012|17049212|P8|Overall Study|Other|1
4959251|NCT00246012|17049213|P7|Overall Study|Other|0
4959252|NCT00246012|17049214|P6|Overall Study|Other|0
4959253|NCT00246012|17049215|P5|Overall Study|Other|0
4959254|NCT00246012|17049216|P4|Overall Study|Other|0
4959255|NCT00246012|17049217|P3|Overall Study|Other|0
4959256|NCT00246012|17049218|P2|Overall Study|Other|0
4959257|NCT00246012|17049219|P1|Overall Study|Other|0
4959258|NCT00246012|17049211|P9|Overall Study|Disease progression|26
4959259|NCT00246012|17049212|P8|Overall Study|Disease progression|27
4959260|NCT00246012|17049213|P7|Overall Study|Disease progression|30
4959261|NCT00246012|17049214|P6|Overall Study|Disease progression|25
4959262|NCT00246012|17049215|P5|Overall Study|Disease progression|3
4959263|NCT00246012|17049216|P4|Overall Study|Disease progression|3
4959264|NCT00246012|17049217|P3|Overall Study|Disease progression|2
4959265|NCT00246012|17049218|P2|Overall Study|Disease progression|1
4959266|NCT00246012|17049219|P1|Overall Study|Disease progression|3
4959267|NCT00246012|17049211|P9|Overall Study|Withdrawal by Subject|0
4959268|NCT00246012|17049212|P8|Overall Study|Withdrawal by Subject|0
4959269|NCT00246012|17049213|P7|Overall Study|Withdrawal by Subject|0
4959270|NCT00246012|17049214|P6|Overall Study|Withdrawal by Subject|1
4959271|NCT00246012|17049215|P5|Overall Study|Withdrawal by Subject|0
4959272|NCT00246012|17049216|P4|Overall Study|Withdrawal by Subject|0
4959273|NCT00246012|17049217|P3|Overall Study|Withdrawal by Subject|0
4959274|NCT00246012|17049218|P2|Overall Study|Withdrawal by Subject|0
4959275|NCT00246012|17049219|P1|Overall Study|Withdrawal by Subject|0
4959276|NCT00246012|17049211|P9|Overall Study|Adverse Event|2
4959277|NCT00246012|17049212|P8|Overall Study|Adverse Event|0
4959278|NCT00246012|17049213|P7|Overall Study|Adverse Event|0
4959279|NCT00246012|17049214|P6|Overall Study|Adverse Event|1
4959280|NCT00246012|17049215|P5|Overall Study|Adverse Event|0
4959281|NCT00246012|17049216|P4|Overall Study|Adverse Event|0
4959282|NCT00246012|17049217|P3|Overall Study|Adverse Event|0
4959283|NCT00246012|17049218|P2|Overall Study|Adverse Event|0
4959284|NCT00246012|17049219|P1|Overall Study|Adverse Event|0
4959285|NCT00245960|17049314|P2|Overall Study|Lack of Efficacy|6
4959286|NCT00245960|17049315|P1|Overall Study|Lack of Efficacy|4
4959287|NCT00245960|17049314|P2|Overall Study|Withdrawal by Subject|7
4959288|NCT00245960|17049315|P1|Overall Study|Withdrawal by Subject|5
4959289|NCT00245960|17049314|P2|Overall Study|Protocol Violation|3
4959290|NCT00245960|17049315|P1|Overall Study|Protocol Violation|4
4959291|NCT00245960|17049314|P2|Overall Study|Lost to Follow-up|2
4959292|NCT00245960|17049315|P1|Overall Study|Lost to Follow-up|2
4959293|NCT00245960|17049314|P2|Overall Study|Adverse Event|10
4959294|NCT00245960|17049315|P1|Overall Study|Adverse Event|14
4959295|NCT00245856|17049323|P2|Period Two|Withdrawal by Subject|1
4959296|NCT00245856|17049324|P1|Period Two|Withdrawal by Subject|0
4959297|NCT00245765|17049334|P3|Overall Study|Other|4
4959298|NCT00245765|17049335|P2|Overall Study|Other|4
4959299|NCT00245765|17049336|P1|Overall Study|Other|13
4959300|NCT00245765|17049334|P3|Overall Study|Other reason|1
4959301|NCT00245765|17049335|P2|Overall Study|Other reason|0
4959302|NCT00245765|17049336|P1|Overall Study|Other reason|2
4959303|NCT00245765|17049334|P3|Overall Study|Withdrawal by Subject|3
4959304|NCT00245765|17049335|P2|Overall Study|Withdrawal by Subject|0
4959305|NCT00245765|17049336|P1|Overall Study|Withdrawal by Subject|1
4959306|NCT00245765|17049334|P3|Overall Study|Lost to Follow-up|0
4959307|NCT00245765|17049335|P2|Overall Study|Lost to Follow-up|2
4959308|NCT00245765|17049336|P1|Overall Study|Lost to Follow-up|1
4959309|NCT00245765|17049334|P3|Overall Study|Lack of Efficacy|0
4959310|NCT00245765|17049335|P2|Overall Study|Lack of Efficacy|7
4959311|NCT00245765|17049336|P1|Overall Study|Lack of Efficacy|14
4959312|NCT00245765|17049334|P3|Overall Study|Adverse Event|0
4959313|NCT00245765|17049335|P2|Overall Study|Adverse Event|1
4959314|NCT00245765|17049336|P1|Overall Study|Adverse Event|1
4959315|NCT00245583|17049385|P2|Overall Study|Withdrawal by Subject|3
4959316|NCT00245583|17049386|P1|Overall Study|Withdrawal by Subject|2
4959317|NCT00245583|17049385|P2|Overall Study|Lack of Efficacy|0
4959318|NCT00245583|17049386|P1|Overall Study|Lack of Efficacy|1
4959319|NCT00245583|17049385|P2|Overall Study|Adverse Event|1
4959320|NCT00245583|17049386|P1|Overall Study|Adverse Event|2
4959321|NCT00245583|17049385|P2|Overall Study|Lost to Follow-up|5
4959322|NCT00245583|17049386|P1|Overall Study|Lost to Follow-up|1
4959323|NCT00245570|17049406|P6|Washout Between Periods III and IV|Adverse Event|0
4959413|NCT00244764|17049677|P1|Overall Study|Developed Secondary Malignancy|1
4959324|NCT00245570|17049407|P5|Washout Between Periods III and IV|Adverse Event|0
4959325|NCT00245570|17049408|P4|Washout Between Periods III and IV|Adverse Event|0
4959326|NCT00245570|17049409|P3|Washout Between Periods III and IV|Adverse Event|0
4959327|NCT00245570|17049410|P2|Washout Between Periods III and IV|Adverse Event|1
4959328|NCT00245570|17049411|P1|Washout Between Periods III and IV|Adverse Event|0
4959329|NCT00245466|17049545|P3|Overall Study|Administrative reasons|0
4959330|NCT00245466|17049546|P2|Overall Study|Administrative reasons|1
4959331|NCT00245466|17049547|P1|Overall Study|Administrative reasons|0
4959332|NCT00245466|17049545|P3|Overall Study|Death|0
4959333|NCT00245466|17049546|P2|Overall Study|Death|2
4959334|NCT00245466|17049547|P1|Overall Study|Death|0
4959335|NCT00245466|17049545|P3|Overall Study|Protocol Violation|2
4959336|NCT00245466|17049546|P2|Overall Study|Protocol Violation|2
4959337|NCT00245466|17049547|P1|Overall Study|Protocol Violation|1
4959338|NCT00245466|17049545|P3|Overall Study|Disease progression|1
4959339|NCT00245466|17049546|P2|Overall Study|Disease progression|3
4959340|NCT00245466|17049547|P1|Overall Study|Disease progression|0
4959341|NCT00245466|17049545|P3|Overall Study|Lost to Follow-up|0
4959342|NCT00245466|17049546|P2|Overall Study|Lost to Follow-up|0
4959343|NCT00245466|17049547|P1|Overall Study|Lost to Follow-up|3
4959344|NCT00245466|17049545|P3|Overall Study|Withdrawal by Subject|1
4959345|NCT00245466|17049546|P2|Overall Study|Withdrawal by Subject|2
4959346|NCT00245466|17049547|P1|Overall Study|Withdrawal by Subject|2
4959347|NCT00245466|17049545|P3|Overall Study|Insufficient PSA and testosterone suppr|3
4959348|NCT00245466|17049546|P2|Overall Study|Insufficient PSA and testosterone suppr|0
4959349|NCT00245466|17049547|P1|Overall Study|Insufficient PSA and testosterone suppr|0
4959350|NCT00245466|17049545|P3|Overall Study|Insufficient testosterone suppr|21
4959351|NCT00245466|17049546|P2|Overall Study|Insufficient testosterone suppr|12
4959352|NCT00245466|17049547|P1|Overall Study|Insufficient testosterone suppr|12
4959353|NCT00245466|17049545|P3|Overall Study|Low prostate specific antigen suppr|5
4959354|NCT00245466|17049546|P2|Overall Study|Low prostate specific antigen suppr|14
4959355|NCT00245466|17049547|P1|Overall Study|Low prostate specific antigen suppr|16
4959356|NCT00245466|17049545|P3|Overall Study|Adverse Event|4
4959357|NCT00245466|17049546|P2|Overall Study|Adverse Event|8
4959358|NCT00245466|17049547|P1|Overall Study|Adverse Event|2
4959359|NCT00245102|17049590|P6|Overall Study|Clinical progression|0
4959360|NCT00245102|17049591|P5|Overall Study|Clinical progression|0
4959361|NCT00245102|17049592|P4|Overall Study|Clinical progression|0
4959362|NCT00245102|17049593|P3|Overall Study|Clinical progression|0
4959363|NCT00245102|17049594|P2|Overall Study|Clinical progression|0
4959364|NCT00245102|17049595|P1|Overall Study|Clinical progression|1
4959365|NCT00245102|17049590|P6|Overall Study|Participant needed surgery|0
4959366|NCT00245102|17049591|P5|Overall Study|Participant needed surgery|0
4959367|NCT00245102|17049592|P4|Overall Study|Participant needed surgery|0
4959368|NCT00245102|17049593|P3|Overall Study|Participant needed surgery|1
4959369|NCT00245102|17049594|P2|Overall Study|Participant needed surgery|0
4959370|NCT00245102|17049595|P1|Overall Study|Participant needed surgery|0
4959371|NCT00245102|17049590|P6|Overall Study|Decline in performance|2
4959372|NCT00245102|17049591|P5|Overall Study|Decline in performance|0
4959373|NCT00245102|17049592|P4|Overall Study|Decline in performance|1
4959374|NCT00245102|17049593|P3|Overall Study|Decline in performance|0
4959375|NCT00245102|17049594|P2|Overall Study|Decline in performance|2
4959376|NCT00245102|17049595|P1|Overall Study|Decline in performance|0
4959377|NCT00245102|17049590|P6|Overall Study|Adverse Event|2
4959378|NCT00245102|17049591|P5|Overall Study|Adverse Event|0
4959379|NCT00245102|17049592|P4|Overall Study|Adverse Event|1
4959380|NCT00245102|17049593|P3|Overall Study|Adverse Event|5
4959381|NCT00245102|17049594|P2|Overall Study|Adverse Event|2
4959382|NCT00245102|17049595|P1|Overall Study|Adverse Event|4
4959383|NCT00245102|17049590|P6|Overall Study|Death|0
4959384|NCT00245102|17049591|P5|Overall Study|Death|0
4959385|NCT00245102|17049592|P4|Overall Study|Death|1
4959386|NCT00245102|17049593|P3|Overall Study|Death|0
4959387|NCT00245102|17049594|P2|Overall Study|Death|0
4959388|NCT00245102|17049595|P1|Overall Study|Death|0
4959389|NCT00245102|17049590|P6|Overall Study|Protocol Violation|0
4959390|NCT00245102|17049591|P5|Overall Study|Protocol Violation|0
4959391|NCT00245102|17049592|P4|Overall Study|Protocol Violation|0
4959392|NCT00245102|17049593|P3|Overall Study|Protocol Violation|0
4959393|NCT00245102|17049594|P2|Overall Study|Protocol Violation|0
4959394|NCT00245102|17049595|P1|Overall Study|Protocol Violation|1
4959395|NCT00245102|17049590|P6|Overall Study|Not Treated|0
4959396|NCT00245102|17049591|P5|Overall Study|Not Treated|0
4959397|NCT00245102|17049592|P4|Overall Study|Not Treated|0
4959398|NCT00245102|17049593|P3|Overall Study|Not Treated|1
4959399|NCT00245102|17049594|P2|Overall Study|Not Treated|0
4959400|NCT00245102|17049595|P1|Overall Study|Not Treated|1
4959401|NCT00245063|17049611|P2|Overall Study|Death|0
4959402|NCT00245063|17049612|P1|Overall Study|Death|1
4959403|NCT00245063|17049611|P2|Overall Study|Adverse Event|5
4959404|NCT00245063|17049612|P1|Overall Study|Adverse Event|6
4959405|NCT00245050|17049620|P2|Overall Study|Adverse Event|2
4959406|NCT00245050|17049621|P1|Overall Study|Adverse Event|3
4959407|NCT00245037|17049629|P1|Overall Study|Death|17
4959408|NCT00245011|17049639|P1|Overall Study|Lack of Efficacy|1
4959409|NCT00244933|17049656|P1|Overall Study|Not response evaluable|2
4959410|NCT00244881|17049660|P1|Overall Study|Withdrawal by Subject|3
4959411|NCT00244855|17049668|P2|Overall Study|Withdrawal by Subject|1
4959412|NCT00244855|17049669|P1|Overall Study|Withdrawal by Subject|0
4959414|NCT00244764|17049677|P1|Overall Study|Sponsor Terminated Study|2
4959415|NCT00244764|17049677|P1|Overall Study|Primary Investigator Discretion|2
4959416|NCT00244764|17049677|P1|Overall Study|Participant was Hospitalized until Death|1
4959417|NCT00244764|17049677|P1|Overall Study|Declining Performance Status|1
4959418|NCT00244764|17049677|P1|Overall Study|Off Study Medication for >21 Days|1
4959419|NCT00244764|17049677|P1|Overall Study|Death|1
4959420|NCT00244764|17049677|P1|Overall Study|Protocol Violation|2
4959421|NCT00244764|17049677|P1|Overall Study|Disease Progression|13
4959422|NCT00244764|17049677|P1|Overall Study|Withdrawal by Subject|12
4959423|NCT00244764|17049677|P1|Overall Study|Lost to Follow-up|23
4959424|NCT00244764|17049677|P1|Overall Study|Adverse Event|37
4959425|NCT00244751|17049687|P3|Overall Study|Participant randomized by mistake|1
4959426|NCT00244751|17049688|P2|Overall Study|Participant randomized by mistake|0
4959427|NCT00244751|17049689|P1|Overall Study|Participant randomized by mistake|0
4959428|NCT00244751|17049687|P3|Overall Study|Safety reasons|0
4959429|NCT00244751|17049688|P2|Overall Study|Safety reasons|1
4959430|NCT00244751|17049689|P1|Overall Study|Safety reasons|0
4959431|NCT00244751|17049687|P3|Overall Study|Lack of compliance with protocol|0
4959432|NCT00244751|17049688|P2|Overall Study|Lack of compliance with protocol|1
4959433|NCT00244751|17049689|P1|Overall Study|Lack of compliance with protocol|0
4959434|NCT00244751|17049687|P3|Overall Study|Elevated liver enzymes|0
4959435|NCT00244751|17049688|P2|Overall Study|Elevated liver enzymes|0
4959436|NCT00244751|17049689|P1|Overall Study|Elevated liver enzymes|1
4959437|NCT00244751|17049687|P3|Overall Study|Withdrawal by Subject|3
4959438|NCT00244751|17049688|P2|Overall Study|Withdrawal by Subject|5
4959439|NCT00244751|17049689|P1|Overall Study|Withdrawal by Subject|7
4959440|NCT00244751|17049687|P3|Overall Study|Protocol Violation|1
4959441|NCT00244751|17049688|P2|Overall Study|Protocol Violation|0
4959442|NCT00244751|17049689|P1|Overall Study|Protocol Violation|1
4959443|NCT00244751|17049687|P3|Overall Study|Lost to Follow-up|0
4959444|NCT00244751|17049688|P2|Overall Study|Lost to Follow-up|1
4959445|NCT00244751|17049689|P1|Overall Study|Lost to Follow-up|0
4959446|NCT00244751|17049687|P3|Overall Study|Adverse Event|5
4959447|NCT00244751|17049688|P2|Overall Study|Adverse Event|7
4959448|NCT00244751|17049689|P1|Overall Study|Adverse Event|7
4959449|NCT00244725|17049790|P4|Overall Study|Failed to follow-up|1
4959450|NCT00244725|17049791|P3|Overall Study|Failed to follow-up|1
4959451|NCT00244725|17049792|P2|Overall Study|Failed to follow-up|0
4959452|NCT00244725|17049793|P1|Overall Study|Failed to follow-up|0
4959453|NCT00244725|17049790|P4|Overall Study|Vomit|0
4959454|NCT00244725|17049791|P3|Overall Study|Vomit|1
4959455|NCT00244725|17049792|P2|Overall Study|Vomit|0
4959456|NCT00244725|17049793|P1|Overall Study|Vomit|0
4959457|NCT00244725|17049790|P4|Overall Study|Administrative reason|0
4959458|NCT00244725|17049791|P3|Overall Study|Administrative reason|1
4959459|NCT00244725|17049792|P2|Overall Study|Administrative reason|0
4959460|NCT00244725|17049793|P1|Overall Study|Administrative reason|0
4959461|NCT00244725|17049790|P4|Overall Study|Confirmed venous thromboembolism (VTE)|0
4959462|NCT00244725|17049791|P3|Overall Study|Confirmed venous thromboembolism (VTE)|0
4959463|NCT00244725|17049792|P2|Overall Study|Confirmed venous thromboembolism (VTE)|1
4959464|NCT00244725|17049793|P1|Overall Study|Confirmed venous thromboembolism (VTE)|0
4959465|NCT00244725|17049790|P4|Overall Study|Received prohibited medication|1
4959466|NCT00244725|17049791|P3|Overall Study|Received prohibited medication|0
4959467|NCT00244725|17049792|P2|Overall Study|Received prohibited medication|1
4959468|NCT00244725|17049793|P1|Overall Study|Received prohibited medication|0
4959469|NCT00244725|17049790|P4|Overall Study|Headache|0
4959470|NCT00244725|17049791|P3|Overall Study|Headache|0
4959471|NCT00244725|17049792|P2|Overall Study|Headache|1
4959472|NCT00244725|17049793|P1|Overall Study|Headache|0
4959473|NCT00244725|17049790|P4|Overall Study|Rehab Refused to allow participantion|0
4959474|NCT00244725|17049791|P3|Overall Study|Rehab Refused to allow participantion|0
4959475|NCT00244725|17049792|P2|Overall Study|Rehab Refused to allow participantion|1
4959476|NCT00244725|17049793|P1|Overall Study|Rehab Refused to allow participantion|0
4959477|NCT00244725|17049790|P4|Overall Study|Mediciation Error|0
4959478|NCT00244725|17049791|P3|Overall Study|Mediciation Error|0
4959479|NCT00244725|17049792|P2|Overall Study|Mediciation Error|1
4959480|NCT00244725|17049793|P1|Overall Study|Mediciation Error|0
4959481|NCT00244725|17049790|P4|Overall Study|Sponsor withdrew the participant|1
4959482|NCT00244725|17049791|P3|Overall Study|Sponsor withdrew the participant|0
4959483|NCT00244725|17049792|P2|Overall Study|Sponsor withdrew the participant|0
4959484|NCT00244725|17049793|P1|Overall Study|Sponsor withdrew the participant|1
4959485|NCT00244725|17049790|P4|Overall Study|Liver function test abnormality|1
4959486|NCT00244725|17049791|P3|Overall Study|Liver function test abnormality|0
4959487|NCT00244725|17049792|P2|Overall Study|Liver function test abnormality|0
4959488|NCT00244725|17049793|P1|Overall Study|Liver function test abnormality|2
4959489|NCT00244725|17049790|P4|Overall Study|Withdrwal by participant|1
4959490|NCT00244725|17049791|P3|Overall Study|Withdrwal by participant|0
4959491|NCT00244725|17049792|P2|Overall Study|Withdrwal by participant|0
4959492|NCT00244725|17049793|P1|Overall Study|Withdrwal by participant|1
4959493|NCT00244725|17049790|P4|Overall Study|Adverse Events|4
4959494|NCT00244725|17049791|P3|Overall Study|Adverse Events|4
4959495|NCT00244725|17049792|P2|Overall Study|Adverse Events|1
4959496|NCT00244725|17049793|P1|Overall Study|Adverse Events|3
4959497|NCT00244725|17049790|P4|Overall Study|Physician Decision|2
4959498|NCT00244725|17049791|P3|Overall Study|Physician Decision|1
4959499|NCT00244725|17049792|P2|Overall Study|Physician Decision|0
4959500|NCT00244725|17049793|P1|Overall Study|Physician Decision|3
4959501|NCT00244725|17049790|P4|Overall Study|Not meet treatment eligibility criteria|0
4959502|NCT00244725|17049791|P3|Overall Study|Not meet treatment eligibility criteria|0
4959503|NCT00244725|17049792|P2|Overall Study|Not meet treatment eligibility criteria|2
4959504|NCT00244725|17049793|P1|Overall Study|Not meet treatment eligibility criteria|1
4959505|NCT00244725|17049790|P4|Overall Study|Withdrawal by Subject|8
4959506|NCT00244725|17049791|P3|Overall Study|Withdrawal by Subject|7
4959507|NCT00244725|17049792|P2|Overall Study|Withdrawal by Subject|7
4959508|NCT00244725|17049793|P1|Overall Study|Withdrawal by Subject|9
4959509|NCT00244725|17049790|P4|Overall Study|Lost to Follow-up|2
4959510|NCT00244725|17049791|P3|Overall Study|Lost to Follow-up|9
4959511|NCT00244725|17049792|P2|Overall Study|Lost to Follow-up|4
4959512|NCT00244725|17049793|P1|Overall Study|Lost to Follow-up|3
4959513|NCT00244712|17049849|P2|Overall Study|Protocol Violation, disease progression|11
4959514|NCT00244712|17049850|P1|Overall Study|Protocol Violation, disease progression|13
4959515|NCT00244712|17049849|P2|Overall Study|Withdrawal by Subject|23
4959516|NCT00244712|17049850|P1|Overall Study|Withdrawal by Subject|13
4959517|NCT00244712|17049849|P2|Overall Study|Lost to Follow-up|52
4959518|NCT00244712|17049850|P1|Overall Study|Lost to Follow-up|45
4959519|NCT00244712|17049849|P2|Overall Study|Lack of Compliance|11
4959520|NCT00244712|17049850|P1|Overall Study|Lack of Compliance|10
4959521|NCT00244712|17049849|P2|Overall Study|Protocol-Defined Virologic Failure|6
4959522|NCT00244712|17049850|P1|Overall Study|Protocol-Defined Virologic Failure|8
4959523|NCT00244712|17049849|P2|Overall Study|Adverse Event|21
4959524|NCT00244712|17049850|P1|Overall Study|Adverse Event|20
4959525|NCT00244621|17049885|P3|Open-label Treatment Period|Moved abroad|1
4959526|NCT00244621|17049886|P2|Open-label Treatment Period|Moved abroad|0
4959527|NCT00244621|17049887|P1|Open-label Treatment Period|Moved abroad|0
4959528|NCT00244621|17049885|P3|Open-label Treatment Period|Adverse Event|1
4959529|NCT00244621|17049886|P2|Open-label Treatment Period|Adverse Event|0
4959530|NCT00244621|17049887|P1|Open-label Treatment Period|Adverse Event|0
4959531|NCT00244621|17049885|P3|Open-label Treatment Period|Withdrawal by Subject|0
4959532|NCT00244621|17049886|P2|Open-label Treatment Period|Withdrawal by Subject|0
4959533|NCT00244621|17049887|P1|Open-label Treatment Period|Withdrawal by Subject|1
4959534|NCT00244621|17049885|P3|Open-label Treatment Period|Lost to Follow-up|0
4959535|NCT00244621|17049886|P2|Open-label Treatment Period|Lost to Follow-up|1
4959536|NCT00244621|17049887|P1|Open-label Treatment Period|Lost to Follow-up|0
4959537|NCT00244621|17049885|P3|Double-blind Treatment Period|Multiple Reasons|1
4959538|NCT00244621|17049886|P2|Double-blind Treatment Period|Multiple Reasons|1
4959539|NCT00244621|17049887|P1|Double-blind Treatment Period|Multiple Reasons|2
4959540|NCT00244621|17049885|P3|Double-blind Treatment Period|Lack of Efficacy|0
4959541|NCT00244621|17049886|P2|Double-blind Treatment Period|Lack of Efficacy|1
4959542|NCT00244621|17049887|P1|Double-blind Treatment Period|Lack of Efficacy|0
4959543|NCT00244621|17049885|P3|Double-blind Treatment Period|Withdrawal by Subject|0
4959544|NCT00244621|17049886|P2|Double-blind Treatment Period|Withdrawal by Subject|1
4959545|NCT00244621|17049887|P1|Double-blind Treatment Period|Withdrawal by Subject|0
4959546|NCT00244621|17049885|P3|Double-blind Treatment Period|Lost to Follow-up|1
4959547|NCT00244621|17049886|P2|Double-blind Treatment Period|Lost to Follow-up|0
4959548|NCT00244621|17049887|P1|Double-blind Treatment Period|Lost to Follow-up|0
4959549|NCT00244374|17049904|P5|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4959550|NCT00244374|17049905|P4|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4959551|NCT00244374|17049906|P3|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4959552|NCT00244374|17049907|P2|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0
4959553|NCT00244374|17049908|P1|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12
4959554|NCT00244374|17049904|P5|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4959555|NCT00244374|17049905|P4|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4959556|NCT00244374|17049906|P3|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4959557|NCT00244374|17049907|P2|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0
4959558|NCT00244374|17049908|P1|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4
4959559|NCT00244374|17049904|P5|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4959560|NCT00244374|17049905|P4|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4959561|NCT00244374|17049906|P3|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4959562|NCT00244374|17049907|P2|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0
4959563|NCT00244374|17049908|P1|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34
4959564|NCT00244374|17049904|P5|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4959565|NCT00244374|17049905|P4|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4959566|NCT00244374|17049906|P3|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4959567|NCT00244374|17049907|P2|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0
4959568|NCT00244374|17049908|P1|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51
4959569|NCT00244374|17049904|P5|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4959570|NCT00244374|17049905|P4|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4959571|NCT00244374|17049906|P3|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4959572|NCT00244374|17049907|P2|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0
4959573|NCT00244374|17049908|P1|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172
4959574|NCT00244374|17049904|P5|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4959575|NCT00244374|17049905|P4|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4959576|NCT00244374|17049906|P3|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4959577|NCT00244374|17049907|P2|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0
4959578|NCT00244374|17049908|P1|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1
4959579|NCT00244374|17049904|P5|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4959580|NCT00244374|17049905|P4|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4959581|NCT00244374|17049906|P3|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4959582|NCT00244374|17049907|P2|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0
4959583|NCT00244374|17049908|P1|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14
4959584|NCT00244374|17049904|P5|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4959585|NCT00244374|17049905|P4|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4959586|NCT00244374|17049906|P3|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4959587|NCT00244374|17049907|P2|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0
4959588|NCT00244374|17049908|P1|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17
4959589|NCT00244374|17049904|P5|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4959590|NCT00244374|17049905|P4|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4959591|NCT00244374|17049906|P3|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4959592|NCT00244374|17049907|P2|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0
4959593|NCT00244374|17049908|P1|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105
4959594|NCT00243932|17049964|P3|Stage 1: Dose Selection|Lost to Follow-up|0
4959595|NCT00243932|17049965|P2|Stage 1: Dose Selection|Lost to Follow-up|0
4959596|NCT00243932|17049966|P1|Stage 1: Dose Selection|Lost to Follow-up|2
4959597|NCT00243919|17049977|P3|Overall Study|Physician Decision|0
4959598|NCT00243919|17049978|P2|Overall Study|Physician Decision|1
4959599|NCT00243919|17049979|P1|Overall Study|Physician Decision|1
4959600|NCT00243919|17049977|P3|Overall Study|Administrative Error|0
4959601|NCT00243919|17049978|P2|Overall Study|Administrative Error|0
4959602|NCT00243919|17049979|P1|Overall Study|Administrative Error|1
4959603|NCT00243919|17049977|P3|Overall Study|Lost to Follow-up|3
4959604|NCT00243919|17049978|P2|Overall Study|Lost to Follow-up|7
4959605|NCT00243919|17049979|P1|Overall Study|Lost to Follow-up|6
4959606|NCT00243919|17049977|P3|Overall Study|Withdrawal by Subject|2
4959607|NCT00243919|17049978|P2|Overall Study|Withdrawal by Subject|6
4959608|NCT00243919|17049979|P1|Overall Study|Withdrawal by Subject|6
4959609|NCT00243919|17049977|P3|Overall Study|Death|6
4959610|NCT00243919|17049978|P2|Overall Study|Death|4
4959611|NCT00243919|17049979|P1|Overall Study|Death|3
4959612|NCT00243841|17050023|P6|Overall Study|Physician Decision|2
4959613|NCT00243841|17050024|P5|Overall Study|Physician Decision|0
4959614|NCT00243841|17050025|P4|Overall Study|Physician Decision|0
4959615|NCT00243841|17050026|P3|Overall Study|Physician Decision|1
4959616|NCT00243841|17050027|P2|Overall Study|Physician Decision|0
4959617|NCT00243841|17050028|P1|Overall Study|Physician Decision|0
4959618|NCT00243659|17050050|P2|Overall Study|Protocol Violation|2
4959619|NCT00243659|17050051|P1|Overall Study|Protocol Violation|1
4959620|NCT00243659|17050050|P2|Overall Study|Withdrawal by Subject|1
4959621|NCT00243659|17050051|P1|Overall Study|Withdrawal by Subject|1
4959622|NCT00243503|17050059|P1|Overall Study|Other|1
4959623|NCT00243503|17050059|P1|Overall Study|Death|1
4959624|NCT00243503|17050059|P1|Overall Study|Lack of Efficacy|44
4959625|NCT00243503|17050059|P1|Overall Study|Withdrawal by Subject|1
4959626|NCT00243503|17050059|P1|Overall Study|Adverse Event|11
4959627|NCT00243412|17050076|P2|Overall Study|Other|1
4959628|NCT00243412|17050077|P1|Overall Study|Other|1
4959629|NCT00243412|17050076|P2|Overall Study|Withdrawal by Subject|5
4959630|NCT00243412|17050077|P1|Overall Study|Withdrawal by Subject|4
4959631|NCT00243412|17050076|P2|Overall Study|Physician Decision|1
4959632|NCT00243412|17050077|P1|Overall Study|Physician Decision|1
4959633|NCT00243412|17050076|P2|Overall Study|Lost to Follow-up|1
4959634|NCT00243412|17050077|P1|Overall Study|Lost to Follow-up|0
4959635|NCT00243412|17050076|P2|Overall Study|Adverse Event|2
4959636|NCT00243412|17050077|P1|Overall Study|Adverse Event|4
4959637|NCT00243412|17050076|P2|Overall Study|Death|1
4959638|NCT00243412|17050077|P1|Overall Study|Death|0
4959639|NCT00243386|17050103|P3|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
4959640|NCT00243386|17050104|P2|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1
4959641|NCT00243386|17050105|P1|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0
4959642|NCT00243386|17050103|P3|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
4959643|NCT00243386|17050104|P2|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2
4959644|NCT00243386|17050105|P1|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0
4959645|NCT00243386|17050103|P3|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
4959646|NCT00243386|17050104|P2|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0
4959808|NCT00242567|17050388|P1|Overall Study|Disease Progression|17
4959647|NCT00243386|17050105|P1|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1
4959648|NCT00243386|17050103|P3|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
4959649|NCT00243386|17050104|P2|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0
4959650|NCT00243386|17050105|P1|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1
4959651|NCT00243386|17050103|P3|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
4959652|NCT00243386|17050104|P2|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0
4959653|NCT00243386|17050105|P1|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1
4959654|NCT00243386|17050103|P3|On-Demand Regimen (Study Part 1)|Screen Failures|0
4959655|NCT00243386|17050104|P2|On-Demand Regimen (Study Part 1)|Screen Failures|0
4959656|NCT00243386|17050105|P1|On-Demand Regimen (Study Part 1)|Screen Failures|2
4959657|NCT00243386|17050103|P3|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
4959658|NCT00243386|17050104|P2|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0
4959659|NCT00243386|17050105|P1|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1
4959660|NCT00243386|17050103|P3|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
4959661|NCT00243386|17050104|P2|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0
4959662|NCT00243386|17050105|P1|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1
4959663|NCT00243347|17050170|P1|Overall Study|Condition worsened|7
4959664|NCT00243347|17050170|P1|Overall Study|Withdrawal by Subject|5
4959665|NCT00243347|17050170|P1|Overall Study|Death|1
4959666|NCT00243347|17050170|P1|Overall Study|Adverse Event|2
4959667|NCT00243347|17050170|P1|Overall Study|Lack of Efficacy|4
4959668|NCT00243269|17050179|P4|Overall Study|Lost to Follow-up|3
4959669|NCT00243269|17050180|P3|Overall Study|Lost to Follow-up|1
4959670|NCT00243269|17050181|P2|Overall Study|Lost to Follow-up|0
4959671|NCT00243269|17050182|P1|Overall Study|Lost to Follow-up|1
4959672|NCT00243269|17050179|P4|Overall Study|Protocol Violation|1
4959673|NCT00243269|17050180|P3|Overall Study|Protocol Violation|0
4959674|NCT00243269|17050181|P2|Overall Study|Protocol Violation|1
4959675|NCT00243269|17050182|P1|Overall Study|Protocol Violation|2
4959676|NCT00243074|17050217|P1|Overall Study|Did not receive any treatment|1
4959677|NCT00243074|17050217|P1|Overall Study|not protocol specified|1
4959678|NCT00243074|17050217|P1|Overall Study|Death|2
4959679|NCT00243074|17050217|P1|Overall Study|Lack of Efficacy|36
4959680|NCT00243074|17050217|P1|Overall Study|Withdrawal by Subject|2
4959681|NCT00243074|17050217|P1|Overall Study|Adverse Event|6
4959682|NCT00243074|17050217|P1|Overall Study|Ineligible|6
4959683|NCT00243022|17050243|P2|Overall Study|Difficult Travel Distance|1
4959684|NCT00243022|17050244|P1|Overall Study|Difficult Travel Distance|0
4959685|NCT00243022|17050243|P2|Overall Study|Death|0
4959686|NCT00243022|17050244|P1|Overall Study|Death|1
4959687|NCT00243022|17050243|P2|Overall Study|Withdrawal by Subject|0
4959688|NCT00243022|17050244|P1|Overall Study|Withdrawal by Subject|1
4959689|NCT00242710|17050268|P4|Study Extension (up to Year 2)|Withdrawal by Subject|1
4959690|NCT00242710|17050269|P3|Study Extension (up to Year 2)|Withdrawal by Subject|4
4959691|NCT00242710|17050270|P2|Study Extension (up to Year 2)|Withdrawal by Subject|6
4959692|NCT00242710|17050271|P1|Study Extension (up to Year 2)|Withdrawal by Subject|10
4959693|NCT00242710|17050268|P4|Study Extension (up to Year 2)|Protocol Violation|1
4959694|NCT00242710|17050269|P3|Study Extension (up to Year 2)|Protocol Violation|0
4959695|NCT00242710|17050270|P2|Study Extension (up to Year 2)|Protocol Violation|2
4959696|NCT00242710|17050271|P1|Study Extension (up to Year 2)|Protocol Violation|0
4959697|NCT00242710|17050268|P4|Study Extension (up to Year 2)|Other|3
4959698|NCT00242710|17050269|P3|Study Extension (up to Year 2)|Other|4
4959699|NCT00242710|17050270|P2|Study Extension (up to Year 2)|Other|5
4959700|NCT00242710|17050271|P1|Study Extension (up to Year 2)|Other|3
4959701|NCT00242710|17050268|P4|Study Extension (up to Year 2)|Lost to Follow-up|0
4959702|NCT00242710|17050269|P3|Study Extension (up to Year 2)|Lost to Follow-up|5
4959703|NCT00242710|17050270|P2|Study Extension (up to Year 2)|Lost to Follow-up|7
4959704|NCT00242710|17050271|P1|Study Extension (up to Year 2)|Lost to Follow-up|7
4959705|NCT00242710|17050268|P4|Study Extension (up to Year 2)|Death|1
4959706|NCT00242710|17050269|P3|Study Extension (up to Year 2)|Death|0
4959707|NCT00242710|17050270|P2|Study Extension (up to Year 2)|Death|0
4959708|NCT00242710|17050271|P1|Study Extension (up to Year 2)|Death|0
4959709|NCT00242710|17050268|P4|Study Extension (up to Year 2)|Adverse Event|4
4959710|NCT00242710|17050269|P3|Study Extension (up to Year 2)|Adverse Event|2
4959711|NCT00242710|17050270|P2|Study Extension (up to Year 2)|Adverse Event|9
4959712|NCT00242710|17050271|P1|Study Extension (up to Year 2)|Adverse Event|7
4959713|NCT00242710|17050268|P4|Period Between Core Study and Extension|Withdrawal by Subject|28
4959714|NCT00242710|17050269|P3|Period Between Core Study and Extension|Withdrawal by Subject|24
4959715|NCT00242710|17050270|P2|Period Between Core Study and Extension|Withdrawal by Subject|63
4959716|NCT00242710|17050271|P1|Period Between Core Study and Extension|Withdrawal by Subject|75
4959717|NCT00242710|17050268|P4|Period Between Core Study and Extension|Protocol Violation|1
4959718|NCT00242710|17050269|P3|Period Between Core Study and Extension|Protocol Violation|2
4959719|NCT00242710|17050270|P2|Period Between Core Study and Extension|Protocol Violation|0
4959720|NCT00242710|17050271|P1|Period Between Core Study and Extension|Protocol Violation|0
4959721|NCT00242710|17050268|P4|Period Between Core Study and Extension|Extension not Available|7
4959722|NCT00242710|17050269|P3|Period Between Core Study and Extension|Extension not Available|8
4959723|NCT00242710|17050270|P2|Period Between Core Study and Extension|Extension not Available|21
4959724|NCT00242710|17050271|P1|Period Between Core Study and Extension|Extension not Available|17
4959725|NCT00242710|17050268|P4|Period Between Core Study and Extension|Other|11
4959726|NCT00242710|17050269|P3|Period Between Core Study and Extension|Other|9
4959727|NCT00242710|17050270|P2|Period Between Core Study and Extension|Other|24
4959728|NCT00242710|17050271|P1|Period Between Core Study and Extension|Other|24
4959729|NCT00242710|17050268|P4|Period Between Core Study and Extension|Physician Decision|0
4959730|NCT00242710|17050269|P3|Period Between Core Study and Extension|Physician Decision|0
4959731|NCT00242710|17050270|P2|Period Between Core Study and Extension|Physician Decision|1
4959732|NCT00242710|17050271|P1|Period Between Core Study and Extension|Physician Decision|1
4959733|NCT00242710|17050268|P4|Period Between Core Study and Extension|Adverse Event|2
4959734|NCT00242710|17050269|P3|Period Between Core Study and Extension|Adverse Event|5
4959735|NCT00242710|17050270|P2|Period Between Core Study and Extension|Adverse Event|3
4959736|NCT00242710|17050271|P1|Period Between Core Study and Extension|Adverse Event|2
4959737|NCT00242710|17050268|P4|Core Study (up to Year 1)|Randomized but not Treated|2
4959738|NCT00242710|17050269|P3|Core Study (up to Year 1)|Randomized but not Treated|4
4959739|NCT00242710|17050270|P2|Core Study (up to Year 1)|Randomized but not Treated|4
4959740|NCT00242710|17050271|P1|Core Study (up to Year 1)|Randomized but not Treated|12
4959741|NCT00242710|17050268|P4|Core Study (up to Year 1)|Lack of Efficacy|0
4959742|NCT00242710|17050269|P3|Core Study (up to Year 1)|Lack of Efficacy|0
4959743|NCT00242710|17050270|P2|Core Study (up to Year 1)|Lack of Efficacy|0
4959744|NCT00242710|17050271|P1|Core Study (up to Year 1)|Lack of Efficacy|1
4959745|NCT00242710|17050268|P4|Core Study (up to Year 1)|Withdrawal by Subject|6
4959746|NCT00242710|17050269|P3|Core Study (up to Year 1)|Withdrawal by Subject|15
4959747|NCT00242710|17050270|P2|Core Study (up to Year 1)|Withdrawal by Subject|16
4959748|NCT00242710|17050271|P1|Core Study (up to Year 1)|Withdrawal by Subject|27
4959749|NCT00242710|17050268|P4|Core Study (up to Year 1)|Protocol Violation|3
4959750|NCT00242710|17050269|P3|Core Study (up to Year 1)|Protocol Violation|1
4959751|NCT00242710|17050270|P2|Core Study (up to Year 1)|Protocol Violation|9
4959752|NCT00242710|17050271|P1|Core Study (up to Year 1)|Protocol Violation|2
4959753|NCT00242710|17050268|P4|Core Study (up to Year 1)|Other|2
4959754|NCT00242710|17050269|P3|Core Study (up to Year 1)|Other|0
4959755|NCT00242710|17050270|P2|Core Study (up to Year 1)|Other|1
4959756|NCT00242710|17050271|P1|Core Study (up to Year 1)|Other|6
4959757|NCT00242710|17050268|P4|Core Study (up to Year 1)|Lost to Follow-up|3
4959758|NCT00242710|17050269|P3|Core Study (up to Year 1)|Lost to Follow-up|7
4959759|NCT00242710|17050270|P2|Core Study (up to Year 1)|Lost to Follow-up|8
4959760|NCT00242710|17050271|P1|Core Study (up to Year 1)|Lost to Follow-up|8
4959761|NCT00242710|17050268|P4|Core Study (up to Year 1)|Physician Decision|1
4959762|NCT00242710|17050269|P3|Core Study (up to Year 1)|Physician Decision|0
4959763|NCT00242710|17050270|P2|Core Study (up to Year 1)|Physician Decision|1
4959764|NCT00242710|17050271|P1|Core Study (up to Year 1)|Physician Decision|0
4959765|NCT00242710|17050268|P4|Core Study (up to Year 1)|Death|0
4959766|NCT00242710|17050269|P3|Core Study (up to Year 1)|Death|1
4959767|NCT00242710|17050270|P2|Core Study (up to Year 1)|Death|0
4959768|NCT00242710|17050271|P1|Core Study (up to Year 1)|Death|0
4959769|NCT00242710|17050268|P4|Core Study (up to Year 1)|Adverse Event|14
4959770|NCT00242710|17050269|P3|Core Study (up to Year 1)|Adverse Event|23
4959771|NCT00242710|17050270|P2|Core Study (up to Year 1)|Adverse Event|25
4959772|NCT00242710|17050271|P1|Core Study (up to Year 1)|Adverse Event|30
4959773|NCT00242658|17050328|P2|Overall Study|Lost to Follow-up|19
4959774|NCT00242658|17050329|P1|Overall Study|Lost to Follow-up|22
4959775|NCT00242580|17050360|P3|Overall Study|Death|1
4959776|NCT00242580|17050361|P2|Overall Study|Death|2
4959777|NCT00242580|17050362|P1|Overall Study|Death|1
4959778|NCT00242580|17050360|P3|Overall Study|Lost to Follow-up|0
4959779|NCT00242580|17050361|P2|Overall Study|Lost to Follow-up|3
4959780|NCT00242580|17050362|P1|Overall Study|Lost to Follow-up|0
4959781|NCT00242580|17050360|P3|Overall Study|Subject withdrew consent|5
4959782|NCT00242580|17050361|P2|Overall Study|Subject withdrew consent|2
4959783|NCT00242580|17050362|P1|Overall Study|Subject withdrew consent|2
4959784|NCT00242580|17050360|P3|Overall Study|Protocol Violation|1
4959785|NCT00242580|17050361|P2|Overall Study|Protocol Violation|0
4959786|NCT00242580|17050362|P1|Overall Study|Protocol Violation|0
4959787|NCT00242580|17050360|P3|Overall Study|Unsatisfactory therapeutic effect|5
4959788|NCT00242580|17050361|P2|Overall Study|Unsatisfactory therapeutic effect|5
4959789|NCT00242580|17050362|P1|Overall Study|Unsatisfactory therapeutic effect|4
4959790|NCT00242580|17050360|P3|Overall Study|Adverse Event|2
4959791|NCT00242580|17050361|P2|Overall Study|Adverse Event|0
4959792|NCT00242580|17050362|P1|Overall Study|Adverse Event|3
4959793|NCT00242567|17050387|P2|Overall Study|Other|9
4959794|NCT00242567|17050388|P1|Overall Study|Other|14
4959795|NCT00242567|17050387|P2|Overall Study|Use of an inhibitor of bone resorption|2
4959796|NCT00242567|17050388|P1|Overall Study|Use of an inhibitor of bone resorption|0
4959797|NCT00242567|17050387|P2|Overall Study|Protocol Violation|12
4959798|NCT00242567|17050388|P1|Overall Study|Protocol Violation|12
4959799|NCT00242567|17050387|P2|Overall Study|Withdrawal by Subject|28
4959800|NCT00242567|17050388|P1|Overall Study|Withdrawal by Subject|33
4959801|NCT00242567|17050387|P2|Overall Study|Lost to Follow-up|19
4959802|NCT00242567|17050388|P1|Overall Study|Lost to Follow-up|9
4959803|NCT00242567|17050387|P2|Overall Study|Lack of Efficacy|2
4959804|NCT00242567|17050388|P1|Overall Study|Lack of Efficacy|2
4959805|NCT00242567|17050387|P2|Overall Study|Symptomatic deterioration|3
4959806|NCT00242567|17050388|P1|Overall Study|Symptomatic deterioration|9
4959807|NCT00242567|17050387|P2|Overall Study|Disease Progression|22
4959809|NCT00242567|17050387|P2|Overall Study|Adverse Event|43
4959810|NCT00242567|17050388|P1|Overall Study|Adverse Event|70
4959811|NCT00242216|17050435|P2|Overall Study|no medicaiton dispensed|1
4959812|NCT00242216|17050436|P1|Overall Study|no medicaiton dispensed|1
4959813|NCT00242216|17050435|P2|Overall Study|Lack of Efficacy|2
4959814|NCT00242216|17050436|P1|Overall Study|Lack of Efficacy|1
4959815|NCT00242216|17050435|P2|Overall Study|Death|2
4959816|NCT00242216|17050436|P1|Overall Study|Death|4
4959817|NCT00242216|17050435|P2|Overall Study|Lost to Follow-up|17
4959818|NCT00242216|17050436|P1|Overall Study|Lost to Follow-up|12
4959819|NCT00241839|17050474|P2|Overall Study|Adverse Event|1
4959820|NCT00241839|17050475|P1|Overall Study|Adverse Event|1
4959821|NCT00241839|17050474|P2|Overall Study|Withdrawal by Subject|17
4959822|NCT00241839|17050475|P1|Overall Study|Withdrawal by Subject|18
4959823|NCT00241644|17050491|P4|Second Efficacy Period (Year 2)|Consenting parent passed away|2
4959824|NCT00241644|17050492|P3|Second Efficacy Period (Year 2)|Consenting parent passed away|2
4959825|NCT00241644|17050493|P2|Second Efficacy Period (Year 2)|Consenting parent passed away|1
4959826|NCT00241644|17050494|P1|Second Efficacy Period (Year 2)|Consenting parent passed away|1
4959827|NCT00241644|17050491|P4|Second Efficacy Period (Year 2)|Lost to Follow-up|86
4959828|NCT00241644|17050492|P3|Second Efficacy Period (Year 2)|Lost to Follow-up|46
4959829|NCT00241644|17050493|P2|Second Efficacy Period (Year 2)|Lost to Follow-up|43
4959830|NCT00241644|17050494|P1|Second Efficacy Period (Year 2)|Lost to Follow-up|43
4959831|NCT00241644|17050491|P4|Second Efficacy Period (Year 2)|Withdrawal by Subject|7
4959832|NCT00241644|17050492|P3|Second Efficacy Period (Year 2)|Withdrawal by Subject|2
4959833|NCT00241644|17050493|P2|Second Efficacy Period (Year 2)|Withdrawal by Subject|3
4959834|NCT00241644|17050494|P1|Second Efficacy Period (Year 2)|Withdrawal by Subject|4
4959835|NCT00241644|17050491|P4|Second Efficacy Period (Year 2)|Protocol Violation|3
4959836|NCT00241644|17050492|P3|Second Efficacy Period (Year 2)|Protocol Violation|2
4959837|NCT00241644|17050493|P2|Second Efficacy Period (Year 2)|Protocol Violation|1
4959838|NCT00241644|17050494|P1|Second Efficacy Period (Year 2)|Protocol Violation|2
4959839|NCT00241644|17050491|P4|Second Efficacy Period (Year 2)|Adverse Event|20
4959840|NCT00241644|17050492|P3|Second Efficacy Period (Year 2)|Adverse Event|12
4959841|NCT00241644|17050493|P2|Second Efficacy Period (Year 2)|Adverse Event|9
4959842|NCT00241644|17050494|P1|Second Efficacy Period (Year 2)|Adverse Event|11
4959843|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Subject's parent passed away|1
4959844|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Subject's parent passed away|0
4959845|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Subject's parent passed away|1
4959846|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Subject's parent passed away|0
4959847|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
4959848|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1
4959849|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
4959850|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0
4959851|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Return dates not reliable|1
4959852|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Return dates not reliable|0
4959853|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Return dates not reliable|0
4959854|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Return dates not reliable|1
4959855|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Non-compliance|3
4959856|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Non-compliance|2
4959857|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Non-compliance|1
4959858|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Non-compliance|2
4959859|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Lost to Follow-up|258
4959860|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Lost to Follow-up|116
4959861|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Lost to Follow-up|142
4959862|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Lost to Follow-up|116
4959863|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Withdrawal by Subject|133
4959864|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Withdrawal by Subject|81
4959865|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Withdrawal by Subject|74
4959866|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Withdrawal by Subject|59
4959867|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Protocol Violation|8
4959868|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Protocol Violation|4
4959869|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Protocol Violation|5
4959870|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Protocol Violation|3
4959871|NCT00241644|17050491|P4|First Efficacy Period (Year 1)|Adverse Event|91
4959872|NCT00241644|17050492|P3|First Efficacy Period (Year 1)|Adverse Event|45
4959873|NCT00241644|17050493|P2|First Efficacy Period (Year 1)|Adverse Event|45
4959874|NCT00241644|17050494|P1|First Efficacy Period (Year 1)|Adverse Event|46
4959875|NCT00241631|17050578|P2|Phase 1 (4 Weeks)|Lack of Efficacy|1
4959876|NCT00241631|17050579|P1|Phase 1 (4 Weeks)|Lack of Efficacy|0
4959877|NCT00241631|17050578|P2|Phase 1 (4 Weeks)|Lost to Follow-up|0
4959878|NCT00241631|17050579|P1|Phase 1 (4 Weeks)|Lost to Follow-up|3
4959879|NCT00241631|17050578|P2|Phase 1 (4 Weeks)|Withdrawal by Subject|4
4959880|NCT00241631|17050579|P1|Phase 1 (4 Weeks)|Withdrawal by Subject|4
4959881|NCT00241631|17050578|P2|Phase 1 (4 Weeks)|sore throat|0
4959882|NCT00241631|17050579|P1|Phase 1 (4 Weeks)|sore throat|1
4959883|NCT00241631|17050578|P2|Run in (2 Weeks)|Physician Decision|3
4959884|NCT00241631|17050579|P1|Run in (2 Weeks)|Physician Decision|3
4959885|NCT00241358|17050592|P3|Overall Study|Determined to be not ineligible|1
4959886|NCT00241358|17050593|P2|Overall Study|Determined to be not ineligible|1
4959887|NCT00241358|17050594|P1|Overall Study|Determined to be not ineligible|0
4959888|NCT00241280|17050627|P2|Overall Study|Excessive Dryness|1
4959889|NCT00241280|17050628|P1|Overall Study|Excessive Dryness|0
4959890|NCT00241280|17050627|P2|Overall Study|Coating on Lens|0
4959891|NCT00241280|17050628|P1|Overall Study|Coating on Lens|1
4959892|NCT00241280|17050627|P2|Overall Study|History of Ocular Surgery|1
4959893|NCT00241280|17050628|P1|Overall Study|History of Ocular Surgery|0
4959894|NCT00241280|17050627|P2|Overall Study|Scheduling Conflict|2
4959895|NCT00241280|17050628|P1|Overall Study|Scheduling Conflict|0
4959896|NCT00241280|17050627|P2|Overall Study|Unacceptable Fit|1
4959897|NCT00241280|17050628|P1|Overall Study|Unacceptable Fit|0
4959898|NCT00241280|17050627|P2|Overall Study|Dispensed incorrect test article|2
4959899|NCT00241280|17050628|P1|Overall Study|Dispensed incorrect test article|1
4959900|NCT00241280|17050627|P2|Overall Study|Subject Ineligible/Dispensed|6
4959901|NCT00241280|17050628|P1|Overall Study|Subject Ineligible/Dispensed|9
4959902|NCT00241280|17050627|P2|Overall Study|Diabetic|0
4959903|NCT00241280|17050628|P1|Overall Study|Diabetic|1
4959904|NCT00241280|17050627|P2|Overall Study|Unsatisfactory Visual Response|1
4959905|NCT00241280|17050628|P1|Overall Study|Unsatisfactory Visual Response|1
4959906|NCT00241280|17050627|P2|Overall Study|Unsatisfactory Physiological Response|1
4959907|NCT00241280|17050628|P1|Overall Study|Unsatisfactory Physiological Response|1
4959908|NCT00241280|17050627|P2|Overall Study|Relocation|4
4959909|NCT00241280|17050628|P1|Overall Study|Relocation|4
4959910|NCT00241280|17050627|P2|Overall Study|Protocol Violation|10
4959911|NCT00241280|17050628|P1|Overall Study|Protocol Violation|4
4959912|NCT00241280|17050627|P2|Overall Study|Withdrawal by Subject|4
4959913|NCT00241280|17050628|P1|Overall Study|Withdrawal by Subject|7
4959914|NCT00241280|17050627|P2|Overall Study|Lost to Follow-up|8
4959915|NCT00241280|17050628|P1|Overall Study|Lost to Follow-up|5
4959916|NCT00241280|17050627|P2|Overall Study|Pregnancy|5
4959917|NCT00241280|17050628|P1|Overall Study|Pregnancy|1
4959918|NCT00241280|17050627|P2|Overall Study|Discomfort|16
4959919|NCT00241280|17050628|P1|Overall Study|Discomfort|11
4959920|NCT00241280|17050627|P2|Overall Study|Adverse Event|6
4959921|NCT00241280|17050628|P1|Overall Study|Adverse Event|2
4959922|NCT00240994|17050643|P1|Overall Study|Graft failure|1
4959923|NCT00240994|17050643|P1|Overall Study|Protocol Violation|1
4959924|NCT00240994|17050643|P1|Overall Study|Lost to Follow-up|1
4959925|NCT00240331|17050778|P2|Overall Study|Option selected by investigator|2
4959926|NCT00240331|17050779|P1|Overall Study|Option selected by investigator|1
4959927|NCT00240331|17050778|P2|Overall Study|Withdrawal by Subject|132
4959928|NCT00240331|17050779|P1|Overall Study|Withdrawal by Subject|125
4959929|NCT00240110|17050822|P2|Overall Study|Lost to Follow-up|7
4959930|NCT00240110|17050823|P1|Overall Study|Lost to Follow-up|6
4959931|NCT00240097|17050831|P1|Part II|did not continue from Part I|23
4959932|NCT00240097|17050831|P1|Part I|unevaluable|1
4959933|NCT00240097|17050831|P1|Part I|histology|1
4959934|NCT00240097|17050831|P1|Part I|Death|1
4959935|NCT00240097|17050831|P1|Part I|Adverse Event|1
4959936|NCT00240071|17050841|P1|Overall Study|Withdrawal by Subject|3
4959937|NCT00239928|17050846|P1|Overall Study|Withdrawal by Subject|2
4959938|NCT00239928|17050846|P1|Overall Study|Not need to continue study|3
4959939|NCT00239928|17050846|P1|Overall Study|Adverse Event|4
4959940|NCT00239928|17050846|P1|Overall Study|Lack of Efficacy|1
4959941|NCT00239837|17050858|P2|Overall Study|Lost to Follow-up|7
4959942|NCT00239837|17050859|P1|Overall Study|Lost to Follow-up|3
4959943|NCT00239720|17050886|P2|Overall Study|Lost to Follow-up|1
4959944|NCT00239720|17050887|P1|Overall Study|Lost to Follow-up|0
4959945|NCT00239720|17050886|P2|Overall Study|Adverse Event|0
4959946|NCT00239720|17050887|P1|Overall Study|Adverse Event|1
4959947|NCT00239681|17050895|P2|Overall Study|No information chacked on CaseReportForm|84
4959948|NCT00239681|17050896|P1|Overall Study|No information chacked on CaseReportForm|90
4959949|NCT00239681|17050895|P2|Overall Study|Physician Decision|17
4959950|NCT00239681|17050896|P1|Overall Study|Physician Decision|13
4959951|NCT00239681|17050895|P2|Overall Study|Protocol Violation|4
4959952|NCT00239681|17050896|P1|Overall Study|Protocol Violation|4
4959953|NCT00239681|17050895|P2|Overall Study|Lost to Follow-up|22
4959954|NCT00239681|17050896|P1|Overall Study|Lost to Follow-up|28
4959955|NCT00239681|17050895|P2|Overall Study|Withdrawal by Subject|489
4959956|NCT00239681|17050896|P1|Overall Study|Withdrawal by Subject|458
4959957|NCT00239681|17050895|P2|Overall Study|Adverse Event|99
4959958|NCT00239681|17050896|P1|Overall Study|Adverse Event|100
4959959|NCT00239590|17050949|P2|Completed Study Protocol|Withdrawal by Subject|1
4959960|NCT00239590|17050950|P1|Completed Study Protocol|Withdrawal by Subject|0
4959961|NCT00239590|17050949|P2|Completed Study Protocol|Adverse Event|1
4959962|NCT00239590|17050950|P1|Completed Study Protocol|Adverse Event|1
4959963|NCT00239590|17050949|P2|Randomized|Withdrawal by Subject|1
4959964|NCT00239590|17050950|P1|Randomized|Withdrawal by Subject|0
4959965|NCT00239590|17050949|P2|Randomized|Lost to Follow-up|1
4959966|NCT00239590|17050950|P1|Randomized|Lost to Follow-up|0
4959967|NCT00239577|17050962|P4|Primary Phase|Other|0
4959968|NCT00239577|17050963|P3|Primary Phase|Other|2
4959969|NCT00239577|17050964|P2|Primary Phase|Other|3
4959970|NCT00239577|17050965|P1|Primary Phase|Other|5
4959971|NCT00239577|17050962|P4|Primary Phase|Adverse Event|0
4959972|NCT00239577|17050963|P3|Primary Phase|Adverse Event|1
4959973|NCT00239577|17050964|P2|Primary Phase|Adverse Event|0
4959974|NCT00239577|17050965|P1|Primary Phase|Adverse Event|0
4959975|NCT00239356|17051069|P2|Overall Study|Drug available on market|2
4959976|NCT00239356|17051070|P1|Overall Study|Drug available on market|11
4959977|NCT00239356|17051069|P2|Overall Study|Administrative reason|1
4959978|NCT00239356|17051070|P1|Overall Study|Administrative reason|0
4959979|NCT00239356|17051069|P2|Overall Study|Pregnancy|0
4959980|NCT00239356|17051070|P1|Overall Study|Pregnancy|1
4959981|NCT00239356|17051069|P2|Overall Study|poor/non-compliance|0
4959982|NCT00239356|17051070|P1|Overall Study|poor/non-compliance|2
4959983|NCT00239356|17051069|P2|Overall Study|Lost to Follow-up|0
4959984|NCT00239356|17051070|P1|Overall Study|Lost to Follow-up|3
4959985|NCT00239356|17051069|P2|Overall Study|Withdrawal by Subject|6
4959986|NCT00239356|17051070|P1|Overall Study|Withdrawal by Subject|15
4959987|NCT00239356|17051069|P2|Overall Study|Adverse Event|0
4959988|NCT00239356|17051070|P1|Overall Study|Adverse Event|6
4959989|NCT00239356|17051069|P2|Overall Study|Lack of Efficacy|0
4959990|NCT00239356|17051070|P1|Overall Study|Lack of Efficacy|1
4959991|NCT00239226|17051092|P4|Overall Study|Lost to Follow-up|0
4959992|NCT00239226|17051093|P3|Overall Study|Lost to Follow-up|1
4959993|NCT00239226|17051094|P2|Overall Study|Lost to Follow-up|0
4959994|NCT00239226|17051095|P1|Overall Study|Lost to Follow-up|1
4959995|NCT00239226|17051092|P4|Overall Study|permAF during stabilization period|3
4959996|NCT00239226|17051093|P3|Overall Study|permAF during stabilization period|0
4959997|NCT00239226|17051094|P2|Overall Study|permAF during stabilization period|0
4959998|NCT00239226|17051095|P1|Overall Study|permAF during stabilization period|0
4959999|NCT00239005|17051107|P2|Overall Study|Lost to Follow-up|1
4960000|NCT00239005|17051108|P1|Overall Study|Lost to Follow-up|0
4960001|NCT00239005|17051107|P2|Overall Study|Subj. cond. no longer needs study drug|1
4960002|NCT00239005|17051108|P1|Overall Study|Subj. cond. no longer needs study drug|0
4960003|NCT00239005|17051107|P2|Overall Study|Protocol Violation|0
4960004|NCT00239005|17051108|P1|Overall Study|Protocol Violation|1
4960005|NCT00239005|17051107|P2|Overall Study|Unsatisfactory Therapeutic effect|0
4960006|NCT00239005|17051108|P1|Overall Study|Unsatisfactory Therapeutic effect|2
4960007|NCT00239005|17051107|P2|Overall Study|Withdrawal by Subject|4
4960008|NCT00239005|17051108|P1|Overall Study|Withdrawal by Subject|3
4960009|NCT00239005|17051107|P2|Overall Study|Adverse Event|6
4960010|NCT00239005|17051108|P1|Overall Study|Adverse Event|6
4960011|NCT00238433|17051124|P1|Overall Study|Death|1
4960012|NCT00238433|17051124|P1|Overall Study|Lost to Follow-up|1
4960013|NCT00238433|17051124|P1|Overall Study|Screen failure|1
4960014|NCT00238420|17051131|P2|Overall Study|Protocol Violation|1
4960015|NCT00238420|17051132|P1|Overall Study|Protocol Violation|1
4960016|NCT00238303|17051149|P3|Overall Study|Adverse Event|3
4960017|NCT00238303|17051150|P2|Overall Study|Adverse Event|1
4960018|NCT00238303|17051151|P1|Overall Study|Adverse Event|0
4960019|NCT00238303|17051149|P3|Overall Study|Poor tolerance of study treatment|1
4960020|NCT00238303|17051150|P2|Overall Study|Poor tolerance of study treatment|0
4960021|NCT00238303|17051151|P1|Overall Study|Poor tolerance of study treatment|1
4960022|NCT00238303|17051149|P3|Overall Study|Other Medical Problems|2
4960023|NCT00238303|17051150|P2|Overall Study|Other Medical Problems|0
4960024|NCT00238303|17051151|P1|Overall Study|Other Medical Problems|2
4960025|NCT00238303|17051149|P3|Overall Study|Death|1
4960026|NCT00238303|17051150|P2|Overall Study|Death|0
4960027|NCT00238303|17051151|P1|Overall Study|Death|1
4960028|NCT00238303|17051149|P3|Overall Study|Withdrawal by Subject|2
4960029|NCT00238303|17051150|P2|Overall Study|Withdrawal by Subject|1
4960030|NCT00238303|17051151|P1|Overall Study|Withdrawal by Subject|11
4960031|NCT00238264|17051168|P1|Overall Study|Ineligible|7
4960032|NCT00238264|17051168|P1|Overall Study|Withdrawal by Subject|4
4960033|NCT00238264|17051168|P1|Overall Study|Lost to Follow-up|18
4960034|NCT00238264|17051168|P1|Overall Study|Death|7
4960035|NCT00238238|17051181|P3|Overall Study|Withdrawal by Subject|0
4960036|NCT00238238|17051182|P2|Overall Study|Withdrawal by Subject|3
4960037|NCT00238238|17051183|P1|Overall Study|Withdrawal by Subject|0
4960038|NCT00238121|17051196|P2|Overall Study|Adverse Event|1
4960039|NCT00238121|17051197|P1|Overall Study|Adverse Event|2
4960040|NCT00238121|17051196|P2|Overall Study|Withdrawal by Subject|1
4960041|NCT00238121|17051197|P1|Overall Study|Withdrawal by Subject|1
4960042|NCT00237809|17051223|P4|Overall Study|Lost to Follow-up|9
4960043|NCT00237809|17051224|P3|Overall Study|Lost to Follow-up|9
4960044|NCT00237809|17051225|P2|Overall Study|Lost to Follow-up|10
4960045|NCT00237809|17051226|P1|Overall Study|Lost to Follow-up|11
4960046|NCT00237796|17051262|P2|Overall Study|Baseline and one other ILSS required|5
4960047|NCT00237796|17051263|P1|Overall Study|Baseline and one other ILSS required|10
4960048|NCT00237744|17051297|P3|Overall Study|Withdrawal by Subject|0
4960049|NCT00237744|17051298|P2|Overall Study|Withdrawal by Subject|1
4960050|NCT00237744|17051299|P1|Overall Study|Withdrawal by Subject|3
4960051|NCT00237692|17051325|P4|Overall Study|Withdrawal by Subject|4
4960052|NCT00237692|17051326|P3|Overall Study|Withdrawal by Subject|10
4960053|NCT00237692|17051327|P2|Overall Study|Withdrawal by Subject|6
4960054|NCT00237692|17051328|P1|Overall Study|Withdrawal by Subject|4
4960055|NCT00237692|17051325|P4|Overall Study|Excluded - did not meet criteria|9
4960056|NCT00237692|17051326|P3|Overall Study|Excluded - did not meet criteria|5
4960057|NCT00237692|17051327|P2|Overall Study|Excluded - did not meet criteria|3
4960058|NCT00237692|17051328|P1|Overall Study|Excluded - did not meet criteria|4
4960059|NCT00237692|17051325|P4|Overall Study|Death|3
4960060|NCT00237692|17051326|P3|Overall Study|Death|2
4960061|NCT00237692|17051327|P2|Overall Study|Death|2
4960062|NCT00237692|17051328|P1|Overall Study|Death|1
4960063|NCT00237692|17051325|P4|Overall Study|Lost to Follow-up|3
4960064|NCT00237692|17051326|P3|Overall Study|Lost to Follow-up|5
4960065|NCT00237692|17051327|P2|Overall Study|Lost to Follow-up|3
4960066|NCT00237692|17051328|P1|Overall Study|Lost to Follow-up|9
4960067|NCT00237458|17051368|P1|Overall Study|Withdrawal by Subject|1
4960068|NCT00237458|17051368|P1|Overall Study|Adverse Event|1
4960069|NCT00237458|17051368|P1|Overall Study|Lack of Efficacy|1
4960070|NCT00237185|17051386|P2|Extension|Death|1
4960071|NCT00237185|17051387|P1|Extension|Death|1
4960072|NCT00237185|17051386|P2|Extension|Administrative problems|0
4960073|NCT00237185|17051387|P1|Extension|Administrative problems|1
4960074|NCT00237185|17051386|P2|Extension|Lost to Follow-up|0
4960075|NCT00237185|17051387|P1|Extension|Lost to Follow-up|1
4960076|NCT00237185|17051386|P2|Extension|Withdrawal by Subject|2
4960077|NCT00237185|17051387|P1|Extension|Withdrawal by Subject|3
4960078|NCT00237185|17051386|P2|Extension|Condition no longer required study drug|1
4960079|NCT00237185|17051387|P1|Extension|Condition no longer required study drug|0
4960080|NCT00237185|17051386|P2|Extension|Lack of Efficacy|14
4960081|NCT00237185|17051387|P1|Extension|Lack of Efficacy|9
4960082|NCT00237185|17051386|P2|Extension|Abnormal laboratory value|1
4960083|NCT00237185|17051387|P1|Extension|Abnormal laboratory value|0
4960084|NCT00237185|17051386|P2|Extension|Adverse Event|0
4960085|NCT00237185|17051387|P1|Extension|Adverse Event|1
4960086|NCT00237185|17051386|P2|Core|Determined ineligible post randomization|0
4960087|NCT00237185|17051387|P1|Core|Determined ineligible post randomization|1
4960088|NCT00237185|17051386|P2|Core|Death|0
4960089|NCT00237185|17051387|P1|Core|Death|4
4960090|NCT00237185|17051386|P2|Core|Administrative problems|1
4960091|NCT00237185|17051387|P1|Core|Administrative problems|0
4960092|NCT00237185|17051386|P2|Core|Withdrawal by Subject|4
4960093|NCT00237185|17051387|P1|Core|Withdrawal by Subject|4
4960094|NCT00237185|17051386|P2|Core|Protocol Violation|1
4960095|NCT00237185|17051387|P1|Core|Protocol Violation|1
4960096|NCT00237185|17051386|P2|Core|Lack of Efficacy|23
4960097|NCT00237185|17051387|P1|Core|Lack of Efficacy|30
4960098|NCT00237185|17051386|P2|Core|Abnormal test procedure results|0
4960099|NCT00237185|17051387|P1|Core|Abnormal test procedure results|1
4960100|NCT00237185|17051386|P2|Core|Abnormal laboratory value|4
4960101|NCT00237185|17051387|P1|Core|Abnormal laboratory value|0
4960102|NCT00237185|17051386|P2|Core|Adverse Event|4
4960103|NCT00237185|17051387|P1|Core|Adverse Event|3
4960104|NCT00237042|17051418|P3|Long Term (12 Month) Follow up|Lost to Follow-up|9
4960105|NCT00237042|17051419|P2|Long Term (12 Month) Follow up|Lost to Follow-up|9
4960106|NCT00237042|17051420|P1|Long Term (12 Month) Follow up|Lost to Follow-up|11
4960107|NCT00237042|17051418|P3|Short Term (6 Month) Follow up|Lost to Follow-up|11
4960108|NCT00237042|17051419|P2|Short Term (6 Month) Follow up|Lost to Follow-up|8
4960109|NCT00237042|17051420|P1|Short Term (6 Month) Follow up|Lost to Follow-up|9
4960110|NCT00237042|17051418|P3|Treatment|Completed no treatment|21
4960111|NCT00237042|17051419|P2|Treatment|Completed no treatment|5
4960112|NCT00237042|17051420|P1|Treatment|Completed no treatment|5
4960113|NCT00237042|17051418|P3|Treatment|Moved out of state|1
4960114|NCT00237042|17051419|P2|Treatment|Moved out of state|1
4960115|NCT00237042|17051420|P1|Treatment|Moved out of state|1
4960116|NCT00237042|17051418|P3|Treatment|Became ineligible post-randomization|16
4960117|NCT00237042|17051419|P2|Treatment|Became ineligible post-randomization|1
4960118|NCT00237042|17051420|P1|Treatment|Became ineligible post-randomization|0
4960119|NCT00236899|17051494|P4|Overall Study|Lack of Efficacy|23
4960120|NCT00236899|17051495|P3|Overall Study|Lack of Efficacy|25
4960121|NCT00236899|17051496|P2|Overall Study|Lack of Efficacy|18
4960122|NCT00236899|17051497|P1|Overall Study|Lack of Efficacy|18
4960123|NCT00236899|17051494|P4|Overall Study|Satisfactory Response|1
4960124|NCT00236899|17051495|P3|Overall Study|Satisfactory Response|0
4960125|NCT00236899|17051496|P2|Overall Study|Satisfactory Response|0
4960126|NCT00236899|17051497|P1|Overall Study|Satisfactory Response|2
4960127|NCT00236899|17051494|P4|Overall Study|Physician Decision|6
4960128|NCT00236899|17051495|P3|Overall Study|Physician Decision|7
4960129|NCT00236899|17051496|P2|Overall Study|Physician Decision|8
4960130|NCT00236899|17051497|P1|Overall Study|Physician Decision|7
4960131|NCT00236899|17051494|P4|Overall Study|Withdrawal by Subject|2
4960132|NCT00236899|17051495|P3|Overall Study|Withdrawal by Subject|5
4960133|NCT00236899|17051496|P2|Overall Study|Withdrawal by Subject|4
4960134|NCT00236899|17051497|P1|Overall Study|Withdrawal by Subject|6
4960135|NCT00236899|17051494|P4|Overall Study|Protocol Violation|0
4960136|NCT00236899|17051495|P3|Overall Study|Protocol Violation|0
4960137|NCT00236899|17051496|P2|Overall Study|Protocol Violation|0
4960138|NCT00236899|17051497|P1|Overall Study|Protocol Violation|1
4960139|NCT00236899|17051494|P4|Overall Study|Entry Criteria Exclusion|0
4960140|NCT00236899|17051495|P3|Overall Study|Entry Criteria Exclusion|1
4960141|NCT00236899|17051496|P2|Overall Study|Entry Criteria Exclusion|1
4960142|NCT00236899|17051497|P1|Overall Study|Entry Criteria Exclusion|0
4960143|NCT00236899|17051494|P4|Overall Study|Lost to Follow-up|0
4960144|NCT00236899|17051495|P3|Overall Study|Lost to Follow-up|0
4960145|NCT00236899|17051496|P2|Overall Study|Lost to Follow-up|1
4960146|NCT00236899|17051497|P1|Overall Study|Lost to Follow-up|0
4960147|NCT00236899|17051494|P4|Overall Study|Death (Study Drug Toxicity)|0
4960148|NCT00236899|17051495|P3|Overall Study|Death (Study Drug Toxicity)|0
4960149|NCT00236899|17051496|P2|Overall Study|Death (Study Drug Toxicity)|0
4960150|NCT00236899|17051497|P1|Overall Study|Death (Study Drug Toxicity)|1
4960151|NCT00236899|17051494|P4|Overall Study|Death (Not Study Related)|0
4960152|NCT00236899|17051495|P3|Overall Study|Death (Not Study Related)|0
4960153|NCT00236899|17051496|P2|Overall Study|Death (Not Study Related)|0
4960154|NCT00236899|17051497|P1|Overall Study|Death (Not Study Related)|2
4960155|NCT00236899|17051494|P4|Overall Study|Death (Study Disease)|0
4960156|NCT00236899|17051495|P3|Overall Study|Death (Study Disease)|0
4960157|NCT00236899|17051496|P2|Overall Study|Death (Study Disease)|4
4960158|NCT00236899|17051497|P1|Overall Study|Death (Study Disease)|1
4960159|NCT00236899|17051494|P4|Overall Study|Adverse Event (Not Study Related)|7
4960160|NCT00236899|17051495|P3|Overall Study|Adverse Event (Not Study Related)|4
4960161|NCT00236899|17051496|P2|Overall Study|Adverse Event (Not Study Related)|3
4960162|NCT00236899|17051497|P1|Overall Study|Adverse Event (Not Study Related)|3
4960163|NCT00236899|17051494|P4|Overall Study|Adverse Event (Study Related)|1
4960164|NCT00236899|17051495|P3|Overall Study|Adverse Event (Study Related)|2
4960165|NCT00236899|17051496|P2|Overall Study|Adverse Event (Study Related)|1
4960166|NCT00236899|17051497|P1|Overall Study|Adverse Event (Study Related)|1
4960167|NCT00236197|17051529|P2|Overall Study|Other|2
4960168|NCT00236197|17051530|P1|Overall Study|Other|0
4960169|NCT00236197|17051529|P2|Overall Study|Medication non-compliance|2
4960170|NCT00236197|17051530|P1|Overall Study|Medication non-compliance|1
4960171|NCT00236197|17051529|P2|Overall Study|Protocol Violation|3
4960172|NCT00236197|17051530|P1|Overall Study|Protocol Violation|0
4960173|NCT00236197|17051529|P2|Overall Study|Lost to Follow-up|5
4960174|NCT00236197|17051530|P1|Overall Study|Lost to Follow-up|1
4960175|NCT00236197|17051529|P2|Overall Study|Withdrawal by Subject|2
4960176|NCT00236197|17051530|P1|Overall Study|Withdrawal by Subject|3
4960177|NCT00236184|17051538|P2|Overall Study|other|2
4960178|NCT00236184|17051539|P1|Overall Study|other|1
4960179|NCT00236184|17051538|P2|Overall Study|non-compliance with study drug|1
4960180|NCT00236184|17051539|P1|Overall Study|non-compliance with study drug|2
4960181|NCT00236184|17051538|P2|Overall Study|Protocol Violation|0
4960182|NCT00236184|17051539|P1|Overall Study|Protocol Violation|3
4960183|NCT00236184|17051538|P2|Overall Study|Withdrawal by Subject|0
4960184|NCT00236184|17051539|P1|Overall Study|Withdrawal by Subject|3
4960185|NCT00236184|17051538|P2|Overall Study|Physician Decision|1
4960186|NCT00236184|17051539|P1|Overall Study|Physician Decision|1
4960187|NCT00236184|17051538|P2|Overall Study|Lost to Follow-up|4
4960188|NCT00236184|17051539|P1|Overall Study|Lost to Follow-up|3
4960189|NCT00236184|17051538|P2|Overall Study|Lack of Efficacy|1
4960190|NCT00236184|17051539|P1|Overall Study|Lack of Efficacy|0
4960191|NCT00236184|17051538|P2|Overall Study|Adverse Event|2
4960192|NCT00236184|17051539|P1|Overall Study|Adverse Event|5
4960193|NCT00236080|17051550|P5|Overall Study|Miscellaneous|0
4960194|NCT00236080|17051551|P4|Overall Study|Miscellaneous|0
4960195|NCT00236080|17051552|P3|Overall Study|Miscellaneous|1
4960196|NCT00236080|17051553|P2|Overall Study|Miscellaneous|0
4960197|NCT00236080|17051554|P1|Overall Study|Miscellaneous|0
4960198|NCT00236080|17051550|P5|Overall Study|Withdrawal by Subject|0
4960199|NCT00236080|17051551|P4|Overall Study|Withdrawal by Subject|0
4960200|NCT00236080|17051552|P3|Overall Study|Withdrawal by Subject|0
4960201|NCT00236080|17051553|P2|Overall Study|Withdrawal by Subject|0
4960202|NCT00236080|17051554|P1|Overall Study|Withdrawal by Subject|1
4960203|NCT00236080|17051550|P5|Overall Study|Physician Decision|1
4960204|NCT00236080|17051551|P4|Overall Study|Physician Decision|1
4960205|NCT00236080|17051552|P3|Overall Study|Physician Decision|1
4960206|NCT00236080|17051553|P2|Overall Study|Physician Decision|0
4960207|NCT00236080|17051554|P1|Overall Study|Physician Decision|1
4960208|NCT00236080|17051550|P5|Overall Study|Lost to Follow-up|0
4960209|NCT00236080|17051551|P4|Overall Study|Lost to Follow-up|0
4960210|NCT00236080|17051552|P3|Overall Study|Lost to Follow-up|0
4960211|NCT00236080|17051553|P2|Overall Study|Lost to Follow-up|1
4960212|NCT00236080|17051554|P1|Overall Study|Lost to Follow-up|0
4960213|NCT00236080|17051550|P5|Overall Study|Adverse Event|0
4960214|NCT00236080|17051551|P4|Overall Study|Adverse Event|1
4960215|NCT00236080|17051552|P3|Overall Study|Adverse Event|3
4960216|NCT00236080|17051553|P2|Overall Study|Adverse Event|0
4960217|NCT00236080|17051554|P1|Overall Study|Adverse Event|0
4960218|NCT00235989|17051575|P6|Extension Treatment Period (ET)|´Other´ not further itemized|0
4960219|NCT00235989|17051576|P5|Extension Treatment Period (ET)|´Other´ not further itemized|0
4960220|NCT00235989|17051577|P4|Extension Treatment Period (ET)|´Other´ not further itemized|2
4960221|NCT00235989|17051578|P3|Extension Treatment Period (ET)|´Other´ not further itemized|1
4960222|NCT00235989|17051579|P2|Extension Treatment Period (ET)|´Other´ not further itemized|3
4960223|NCT00235989|17051580|P1|Extension Treatment Period (ET)|´Other´ not further itemized|2
4960224|NCT00235989|17051575|P6|Extension Treatment Period (ET)|Withdrawal by Subject|0
4960225|NCT00235989|17051576|P5|Extension Treatment Period (ET)|Withdrawal by Subject|0
4960226|NCT00235989|17051577|P4|Extension Treatment Period (ET)|Withdrawal by Subject|4
4960227|NCT00235989|17051578|P3|Extension Treatment Period (ET)|Withdrawal by Subject|1
4960228|NCT00235989|17051579|P2|Extension Treatment Period (ET)|Withdrawal by Subject|1
4960229|NCT00235989|17051580|P1|Extension Treatment Period (ET)|Withdrawal by Subject|1
4960230|NCT00235989|17051575|P6|Extension Treatment Period (ET)|Lost to Follow-up|0
4960231|NCT00235989|17051576|P5|Extension Treatment Period (ET)|Lost to Follow-up|0
4960232|NCT00235989|17051577|P4|Extension Treatment Period (ET)|Lost to Follow-up|0
4960233|NCT00235989|17051578|P3|Extension Treatment Period (ET)|Lost to Follow-up|1
4960234|NCT00235989|17051579|P2|Extension Treatment Period (ET)|Lost to Follow-up|0
4960235|NCT00235989|17051580|P1|Extension Treatment Period (ET)|Lost to Follow-up|2
4960236|NCT00235989|17051575|P6|Extension Treatment Period (ET)|Adverse Event|0
4960237|NCT00235989|17051576|P5|Extension Treatment Period (ET)|Adverse Event|0
4960238|NCT00235989|17051577|P4|Extension Treatment Period (ET)|Adverse Event|0
4960239|NCT00235989|17051578|P3|Extension Treatment Period (ET)|Adverse Event|2
4960240|NCT00235989|17051579|P2|Extension Treatment Period (ET)|Adverse Event|0
4960241|NCT00235989|17051580|P1|Extension Treatment Period (ET)|Adverse Event|3
4960242|NCT00235989|17051575|P6|Core Treatment Period (CT)|Lost to Follow-up|2
4960243|NCT00235989|17051576|P5|Core Treatment Period (CT)|Lost to Follow-up|0
4960244|NCT00235989|17051577|P4|Core Treatment Period (CT)|Lost to Follow-up|0
4960245|NCT00235989|17051578|P3|Core Treatment Period (CT)|Lost to Follow-up|0
4960246|NCT00235989|17051579|P2|Core Treatment Period (CT)|Lost to Follow-up|0
4960247|NCT00235989|17051580|P1|Core Treatment Period (CT)|Lost to Follow-up|0
4960248|NCT00235872|17051594|P1|Overall Study|Administrative reason|61
4960249|NCT00235872|17051594|P1|Overall Study|Withdrawal by Subject|50
4960250|NCT00235872|17051594|P1|Overall Study|Lost to Follow-up|1
4960251|NCT00235872|17051594|P1|Overall Study|Death|1
4960252|NCT00235872|17051594|P1|Overall Study|Adverse Event|34
4960253|NCT00235755|17051625|P3|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
4960254|NCT00235755|17051626|P2|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0
4960255|NCT00235755|17051627|P1|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1
4960256|NCT00235755|17051625|P3|12-Week Maintenance Phase|Withdrawal by Subject|3
4960257|NCT00235755|17051626|P2|12-Week Maintenance Phase|Withdrawal by Subject|8
4960258|NCT00235755|17051627|P1|12-Week Maintenance Phase|Withdrawal by Subject|0
4960259|NCT00235755|17051625|P3|12-Week Maintenance Phase|Protocol Violation|2
4960260|NCT00235755|17051626|P2|12-Week Maintenance Phase|Protocol Violation|4
4960261|NCT00235755|17051627|P1|12-Week Maintenance Phase|Protocol Violation|0
4960262|NCT00235755|17051625|P3|12-Week Maintenance Phase|Lack of Efficacy|0
4960263|NCT00235755|17051626|P2|12-Week Maintenance Phase|Lack of Efficacy|0
4960264|NCT00235755|17051627|P1|12-Week Maintenance Phase|Lack of Efficacy|5
4960265|NCT00235755|17051625|P3|12-Week Maintenance Phase|Lost to Follow-up|0
4960266|NCT00235755|17051626|P2|12-Week Maintenance Phase|Lost to Follow-up|3
4960267|NCT00235755|17051627|P1|12-Week Maintenance Phase|Lost to Follow-up|2
4960268|NCT00235755|17051625|P3|12-Week Maintenance Phase|Adverse Event|26
4960269|NCT00235755|17051626|P2|12-Week Maintenance Phase|Adverse Event|12
4960270|NCT00235755|17051627|P1|12-Week Maintenance Phase|Adverse Event|8
4960271|NCT00235755|17051625|P3|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
4960272|NCT00235755|17051626|P2|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0
4960273|NCT00235755|17051627|P1|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1
4960274|NCT00235755|17051625|P3|4-Week Titration Phase|Randomization Occurred in Error|0
4960275|NCT00235755|17051626|P2|4-Week Titration Phase|Randomization Occurred in Error|0
4960276|NCT00235755|17051627|P1|4-Week Titration Phase|Randomization Occurred in Error|1
4960277|NCT00235755|17051625|P3|4-Week Titration Phase|Participant Did Not Receive Study Drug|1
4960278|NCT00235755|17051626|P2|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
4960279|NCT00235755|17051627|P1|4-Week Titration Phase|Participant Did Not Receive Study Drug|0
4960280|NCT00235755|17051625|P3|4-Week Titration Phase|Withdrawal by Subject|3
4960281|NCT00235755|17051626|P2|4-Week Titration Phase|Withdrawal by Subject|2
4960282|NCT00235755|17051627|P1|4-Week Titration Phase|Withdrawal by Subject|1
4960283|NCT00235755|17051625|P3|4-Week Titration Phase|Protocol Violation|1
4960284|NCT00235755|17051626|P2|4-Week Titration Phase|Protocol Violation|2
4960285|NCT00235755|17051627|P1|4-Week Titration Phase|Protocol Violation|2
4960286|NCT00235755|17051625|P3|4-Week Titration Phase|Lost to Follow-up|1
4960287|NCT00235755|17051626|P2|4-Week Titration Phase|Lost to Follow-up|1
4960288|NCT00235755|17051627|P1|4-Week Titration Phase|Lost to Follow-up|0
4960289|NCT00235755|17051625|P3|4-Week Titration Phase|Adverse Event|20
4960290|NCT00235755|17051626|P2|4-Week Titration Phase|Adverse Event|14
4960291|NCT00235755|17051627|P1|4-Week Titration Phase|Adverse Event|6
4960292|NCT00235716|17051705|P4|Overall Study|Physician Decision|3
4960293|NCT00235716|17051706|P3|Overall Study|Physician Decision|1
4960294|NCT00235716|17051707|P2|Overall Study|Physician Decision|1
4960295|NCT00235716|17051708|P1|Overall Study|Physician Decision|0
4960296|NCT00235716|17051705|P4|Overall Study|Adverse Event|0
4960297|NCT00235716|17051706|P3|Overall Study|Adverse Event|1
4960298|NCT00235716|17051707|P2|Overall Study|Adverse Event|1
4960299|NCT00235716|17051708|P1|Overall Study|Adverse Event|1
4960300|NCT00235716|17051705|P4|Overall Study|Lost to Follow-up|10
4960301|NCT00235716|17051706|P3|Overall Study|Lost to Follow-up|14
4960302|NCT00235716|17051707|P2|Overall Study|Lost to Follow-up|7
4960303|NCT00235716|17051708|P1|Overall Study|Lost to Follow-up|12
4960304|NCT00235716|17051705|P4|Overall Study|Withdrawal by Subject|18
4960305|NCT00235716|17051706|P3|Overall Study|Withdrawal by Subject|17
4960306|NCT00235716|17051707|P2|Overall Study|Withdrawal by Subject|19
4960307|NCT00235716|17051708|P1|Overall Study|Withdrawal by Subject|23
4960308|NCT00235716|17051705|P4|Overall Study|Death|31
4960309|NCT00235716|17051706|P3|Overall Study|Death|32
4960310|NCT00235716|17051707|P2|Overall Study|Death|39
4960311|NCT00235716|17051708|P1|Overall Study|Death|26
4960312|NCT00235495|17051759|P2|Overall Study|Visit/assessmen outside window/missing|10
4960313|NCT00235495|17051760|P1|Overall Study|Visit/assessmen outside window/missing|0
4960314|NCT00235495|17051759|P2|Overall Study|Lost to Follow-up|13
4960315|NCT00235495|17051760|P1|Overall Study|Lost to Follow-up|11
4960316|NCT00235495|17051759|P2|Overall Study|Withdrawal by Subject|3
4960317|NCT00235495|17051760|P1|Overall Study|Withdrawal by Subject|5
4960318|NCT00235495|17051759|P2|Overall Study|Death|42
4960319|NCT00235495|17051760|P1|Overall Study|Death|52
4960320|NCT00235443|17051833|P6|Overall Study|Other reasons for premature termination|6
4960321|NCT00235443|17051834|P5|Overall Study|Other reasons for premature termination|3
4960322|NCT00235443|17051835|P4|Overall Study|Other reasons for premature termination|7
4960323|NCT00235443|17051836|P3|Overall Study|Other reasons for premature termination|6
4960324|NCT00235443|17051837|P2|Overall Study|Other reasons for premature termination|6
4960325|NCT00235443|17051838|P1|Overall Study|Other reasons for premature termination|1
4960326|NCT00235443|17051833|P6|Overall Study|Unsatisfactory compliance|0
4960327|NCT00235443|17051834|P5|Overall Study|Unsatisfactory compliance|1
4960328|NCT00235443|17051835|P4|Overall Study|Unsatisfactory compliance|4
4960329|NCT00235443|17051836|P3|Overall Study|Unsatisfactory compliance|3
4960330|NCT00235443|17051837|P2|Overall Study|Unsatisfactory compliance|2
4960331|NCT00235443|17051838|P1|Overall Study|Unsatisfactory compliance|0
4960332|NCT00235443|17051833|P6|Overall Study|Lost to Follow-up|3
4960333|NCT00235443|17051834|P5|Overall Study|Lost to Follow-up|4
4960334|NCT00235443|17051835|P4|Overall Study|Lost to Follow-up|6
4960335|NCT00235443|17051836|P3|Overall Study|Lost to Follow-up|6
4960336|NCT00235443|17051837|P2|Overall Study|Lost to Follow-up|8
4960337|NCT00235443|17051838|P1|Overall Study|Lost to Follow-up|0
4960338|NCT00235443|17051833|P6|Overall Study|Withdrawal by Subject|12
4960339|NCT00235443|17051834|P5|Overall Study|Withdrawal by Subject|10
4960340|NCT00235443|17051835|P4|Overall Study|Withdrawal by Subject|24
4960341|NCT00235443|17051836|P3|Overall Study|Withdrawal by Subject|25
4960342|NCT00235443|17051837|P2|Overall Study|Withdrawal by Subject|9
4960343|NCT00235443|17051838|P1|Overall Study|Withdrawal by Subject|3
4960344|NCT00235443|17051833|P6|Overall Study|Lack of Efficacy|9
4960345|NCT00235443|17051834|P5|Overall Study|Lack of Efficacy|2
4960346|NCT00235443|17051835|P4|Overall Study|Lack of Efficacy|12
4960347|NCT00235443|17051836|P3|Overall Study|Lack of Efficacy|5
4960348|NCT00235443|17051837|P2|Overall Study|Lack of Efficacy|1
4960349|NCT00235443|17051838|P1|Overall Study|Lack of Efficacy|0
4960350|NCT00235443|17051833|P6|Overall Study|Adverse Event|15
4960351|NCT00235443|17051834|P5|Overall Study|Adverse Event|10
4960352|NCT00235443|17051835|P4|Overall Study|Adverse Event|44
4960353|NCT00235443|17051836|P3|Overall Study|Adverse Event|17
4960354|NCT00235443|17051837|P2|Overall Study|Adverse Event|12
4960355|NCT00235443|17051838|P1|Overall Study|Adverse Event|4
4960356|NCT00235391|17051979|P6|Overall Study|Death|0
4960357|NCT00235391|17051980|P5|Overall Study|Death|0
4960358|NCT00235391|17051981|P4|Overall Study|Death|4
4960359|NCT00235391|17051982|P3|Overall Study|Death|1
4960360|NCT00235391|17051983|P2|Overall Study|Death|0
4960361|NCT00235391|17051984|P1|Overall Study|Death|0
4960362|NCT00235391|17051979|P6|Overall Study|Administrative problems|0
4960363|NCT00235391|17051980|P5|Overall Study|Administrative problems|0
4960364|NCT00235391|17051981|P4|Overall Study|Administrative problems|1
4960365|NCT00235391|17051982|P3|Overall Study|Administrative problems|0
4960366|NCT00235391|17051983|P2|Overall Study|Administrative problems|0
4960367|NCT00235391|17051984|P1|Overall Study|Administrative problems|0
4960368|NCT00235391|17051979|P6|Overall Study|Lost to Follow-up|0
4960369|NCT00235391|17051980|P5|Overall Study|Lost to Follow-up|0
4960370|NCT00235391|17051981|P4|Overall Study|Lost to Follow-up|16
4960371|NCT00235391|17051982|P3|Overall Study|Lost to Follow-up|3
4960372|NCT00235391|17051983|P2|Overall Study|Lost to Follow-up|3
4960373|NCT00235391|17051984|P1|Overall Study|Lost to Follow-up|0
4960374|NCT00235391|17051979|P6|Overall Study|Withdrawal by Subject|0
4960375|NCT00235391|17051980|P5|Overall Study|Withdrawal by Subject|5
4960376|NCT00235391|17051981|P4|Overall Study|Withdrawal by Subject|61
4960377|NCT00235391|17051982|P3|Overall Study|Withdrawal by Subject|3
4960378|NCT00235391|17051983|P2|Overall Study|Withdrawal by Subject|3
4960379|NCT00235391|17051984|P1|Overall Study|Withdrawal by Subject|2
4960380|NCT00235391|17051979|P6|Overall Study|Protocol deviation|0
4960381|NCT00235391|17051980|P5|Overall Study|Protocol deviation|0
4960382|NCT00235391|17051981|P4|Overall Study|Protocol deviation|11
4960383|NCT00235391|17051982|P3|Overall Study|Protocol deviation|1
4960384|NCT00235391|17051983|P2|Overall Study|Protocol deviation|0
4960385|NCT00235391|17051984|P1|Overall Study|Protocol deviation|0
4960386|NCT00235391|17051979|P6|Overall Study|Condition no longer requires treatment|0
4960387|NCT00235391|17051980|P5|Overall Study|Condition no longer requires treatment|1
4960388|NCT00235391|17051981|P4|Overall Study|Condition no longer requires treatment|11
4960389|NCT00235391|17051982|P3|Overall Study|Condition no longer requires treatment|0
4960390|NCT00235391|17051983|P2|Overall Study|Condition no longer requires treatment|0
4960391|NCT00235391|17051984|P1|Overall Study|Condition no longer requires treatment|3
4960392|NCT00235391|17051979|P6|Overall Study|Unsatisfactory therapeutic effect|0
4960393|NCT00235391|17051980|P5|Overall Study|Unsatisfactory therapeutic effect|0
4960394|NCT00235391|17051981|P4|Overall Study|Unsatisfactory therapeutic effect|17
4960395|NCT00235391|17051982|P3|Overall Study|Unsatisfactory therapeutic effect|2
4960396|NCT00235391|17051983|P2|Overall Study|Unsatisfactory therapeutic effect|2
4960397|NCT00235391|17051984|P1|Overall Study|Unsatisfactory therapeutic effect|0
4960398|NCT00235391|17051979|P6|Overall Study|Abnormal laboratory value(s)|2
4960399|NCT00235391|17051980|P5|Overall Study|Abnormal laboratory value(s)|1
4960400|NCT00235391|17051981|P4|Overall Study|Abnormal laboratory value(s)|27
4960401|NCT00235391|17051982|P3|Overall Study|Abnormal laboratory value(s)|4
4960402|NCT00235391|17051983|P2|Overall Study|Abnormal laboratory value(s)|5
4960403|NCT00235391|17051984|P1|Overall Study|Abnormal laboratory value(s)|3
4960404|NCT00235391|17051979|P6|Overall Study|Adverse Event|2
4960405|NCT00235391|17051980|P5|Overall Study|Adverse Event|5
4960406|NCT00235391|17051981|P4|Overall Study|Adverse Event|72
4960407|NCT00235391|17051982|P3|Overall Study|Adverse Event|10
4960408|NCT00235391|17051983|P2|Overall Study|Adverse Event|5
4960409|NCT00235391|17051984|P1|Overall Study|Adverse Event|4
4960410|NCT00235326|17052001|P2|Overall Study|Lost to Follow-up|1400
4960411|NCT00235326|17052002|P1|Overall Study|Lost to Follow-up|746
4960412|NCT00234533|17052042|P1|Overall Study|Enrolled but not treated|3
4960413|NCT00234533|17052042|P1|Overall Study|Adverse Event|2
4960414|NCT00234533|17052042|P1|Overall Study|Withdrawal by Subject|6
4960415|NCT00234494|17052061|P1|Overall Study|Protocol Violation|2
4960416|NCT00234104|17052107|P4|Overall Study|Physician Decision|2
4960417|NCT00234104|17052108|P3|Overall Study|Physician Decision|2
4960418|NCT00234104|17052109|P2|Overall Study|Physician Decision|1
4960419|NCT00234104|17052110|P1|Overall Study|Physician Decision|0
4960420|NCT00234104|17052107|P4|Overall Study|Protocol Violation|1
4960421|NCT00234104|17052108|P3|Overall Study|Protocol Violation|0
4960422|NCT00234104|17052109|P2|Overall Study|Protocol Violation|0
4960423|NCT00234104|17052110|P1|Overall Study|Protocol Violation|0
4960424|NCT00234104|17052107|P4|Overall Study|Adverse Event|5
4960425|NCT00234104|17052108|P3|Overall Study|Adverse Event|3
4960426|NCT00234104|17052109|P2|Overall Study|Adverse Event|0
4960427|NCT00234104|17052110|P1|Overall Study|Adverse Event|4
4960428|NCT00234065|17052151|P2|Overall Study|Not Classified|112
4960429|NCT00234065|17052152|P1|Overall Study|Not Classified|111
4960430|NCT00234065|17052151|P2|Overall Study|Physician Decision|22
4960431|NCT00234065|17052152|P1|Overall Study|Physician Decision|23
4960432|NCT00234065|17052151|P2|Overall Study|Withdrawal by Subject|56
4960433|NCT00234065|17052152|P1|Overall Study|Withdrawal by Subject|73
4960434|NCT00234065|17052151|P2|Overall Study|Adverse Event|166
4960435|NCT00234065|17052152|P1|Overall Study|Adverse Event|268
4960436|NCT00234052|17052168|P1|Follow-up for 5 Years|Other|7
4960437|NCT00234052|17052168|P1|Follow-up for 5 Years|Lost to Follow-up|1
4960438|NCT00234052|17052168|P1|Follow-up for 5 Years|Death|41
4960439|NCT00234052|17052168|P1|Treatment|Progressive Disease|11
4960440|NCT00234052|17052168|P1|Treatment|Death|2
4960441|NCT00234052|17052168|P1|Treatment|Adverse Event|5
4960442|NCT00234052|17052168|P1|Treatment|Withdrawal by Subject|3
4960443|NCT00234039|17052178|P1|Overall Study|No Protocol Treatment Received|2
4960444|NCT00234039|17052178|P1|Overall Study|Ineligible|9
4960445|NCT00234039|17052178|P1|Overall Study|Other - Not Protocol Specified|3
4960446|NCT00234039|17052178|P1|Overall Study|Progression/relapse|34
4960447|NCT00234039|17052178|P1|Overall Study|Adverse Event|2
4960448|NCT00233987|17052185|P1|Overall Study|Ineligible|4
4960449|NCT00233987|17052185|P1|Overall Study|Eligible but No Treatment Received|2
4960450|NCT00233987|17052185|P1|Overall Study|Other - Not Protocol Specified|5
4960451|NCT00233987|17052185|P1|Overall Study|Reason Under Review|1
4960452|NCT00233987|17052185|P1|Overall Study|Lack of Efficacy|2
4960453|NCT00233987|17052185|P1|Overall Study|Withdrawal by Subject|1
4960454|NCT00233948|17052194|P6|Overall Study|Adverse Event|0
4960455|NCT00233948|17052195|P5|Overall Study|Adverse Event|0
4960456|NCT00233948|17052196|P4|Overall Study|Adverse Event|0
4960457|NCT00233948|17052197|P3|Overall Study|Adverse Event|0
4960458|NCT00233948|17052198|P2|Overall Study|Adverse Event|0
4960459|NCT00233948|17052199|P1|Overall Study|Adverse Event|1
4960460|NCT00233480|17052225|P2|Overall Study|Underwent status II heart transplant|1
4960461|NCT00233480|17052226|P1|Overall Study|Underwent status II heart transplant|0
4960462|NCT00233454|17052242|P1|Overall Study|Death|6
4960463|NCT00233402|17052250|P2|Overall Study|Lost to follow up etc|21
4960464|NCT00233402|17052251|P1|Overall Study|Lost to follow up etc|3
4960465|NCT00233402|17052250|P2|Overall Study|No Ta/T1|94
4960466|NCT00233402|17052251|P1|Overall Study|No Ta/T1|89
4960467|NCT00233402|17052250|P2|Overall Study|No pathology data|9
4960468|NCT00233402|17052251|P1|Overall Study|No pathology data|12
4960469|NCT00233324|17052266|P4|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
4960470|NCT00233324|17052267|P3|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13
4960471|NCT00233324|17052268|P2|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7
4960472|NCT00233324|17052269|P1|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8
4960473|NCT00233324|17052266|P4|Follow up at 18-22 Months Corrected Age|Death|4
4960474|NCT00233324|17052267|P3|Follow up at 18-22 Months Corrected Age|Death|5
4960475|NCT00233324|17052268|P2|Follow up at 18-22 Months Corrected Age|Death|7
4960476|NCT00233324|17052269|P1|Follow up at 18-22 Months Corrected Age|Death|5
4960477|NCT00233324|17052266|P4|Main Study|Death|47
4960478|NCT00233324|17052267|P3|Main Study|Death|62
4960479|NCT00233324|17052268|P2|Main Study|Death|60
4960480|NCT00233324|17052269|P1|Main Study|Death|68
4960481|NCT00233064|17052391|P2|Overall Study|Moved to Dom. Republic|0
4960482|NCT00233064|17052392|P1|Overall Study|Moved to Dom. Republic|1
4960483|NCT00233064|17052391|P2|Overall Study|Protocol Violation|0
4960484|NCT00233064|17052392|P1|Overall Study|Protocol Violation|1
4960485|NCT00233064|17052391|P2|Overall Study|Relocation|1
4960486|NCT00233064|17052392|P1|Overall Study|Relocation|0
4960487|NCT00233064|17052391|P2|Overall Study|Death|1
4960488|NCT00233064|17052392|P1|Overall Study|Death|0
4960489|NCT00233064|17052391|P2|Overall Study|Withdrawal by Subject|3
4960490|NCT00233064|17052392|P1|Overall Study|Withdrawal by Subject|5
4960491|NCT00233064|17052391|P2|Overall Study|Lost to Follow-up|7
4960492|NCT00233064|17052392|P1|Overall Study|Lost to Follow-up|7
4960493|NCT00232596|17052418|P2|12-Week Maintenance Phase|Other|3
4960494|NCT00232596|17052419|P1|12-Week Maintenance Phase|Other|1
4960495|NCT00232596|17052418|P2|12-Week Maintenance Phase|Protocol Violation|1
4960496|NCT00232596|17052419|P1|12-Week Maintenance Phase|Protocol Violation|3
4960497|NCT00232596|17052418|P2|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2
4960498|NCT00232596|17052419|P1|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1
4960499|NCT00232596|17052418|P2|12-Week Maintenance Phase|Adverse Event|22
4960500|NCT00232596|17052419|P1|12-Week Maintenance Phase|Adverse Event|7
4960501|NCT00232596|17052418|P2|6-Week Titration Phase|Participant Did Not Receive Study Drug|1
4960502|NCT00232596|17052419|P1|6-Week Titration Phase|Participant Did Not Receive Study Drug|0
4960503|NCT00232596|17052418|P2|6-Week Titration Phase|Other|3
4960504|NCT00232596|17052419|P1|6-Week Titration Phase|Other|3
4960505|NCT00232596|17052418|P2|6-Week Titration Phase|Participant Request Unrelated to Study|0
4960506|NCT00232596|17052419|P1|6-Week Titration Phase|Participant Request Unrelated to Study|1
4960507|NCT00232596|17052418|P2|6-Week Titration Phase|Protocol Violation|3
4960508|NCT00232596|17052419|P1|6-Week Titration Phase|Protocol Violation|1
4960509|NCT00232596|17052418|P2|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2
4960510|NCT00232596|17052419|P1|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1
4960511|NCT00232596|17052418|P2|6-Week Titration Phase|Failed to Return|1
4960512|NCT00232596|17052419|P1|6-Week Titration Phase|Failed to Return|2
4960513|NCT00232596|17052418|P2|6-Week Titration Phase|Adverse Event|19
4960514|NCT00232596|17052419|P1|6-Week Titration Phase|Adverse Event|6
4960515|NCT00232557|17052510|P2|Overall Study|Lost to Follow-up|5
4960516|NCT00232557|17052511|P1|Overall Study|Lost to Follow-up|3
4960517|NCT00232544|17052521|P2|Overall Study|Lost to Follow-up|15
4960518|NCT00232544|17052522|P1|Overall Study|Lost to Follow-up|20
4960519|NCT00232180|17052553|P3|Open Label Phase|Randomized but not treated|1
4960520|NCT00232180|17052554|P2|Open Label Phase|Randomized but not treated|0
4960521|NCT00232180|17052555|P1|Open Label Phase|Randomized but not treated|0
4960522|NCT00232180|17052553|P3|Open Label Phase|Laboratory abnormality|10
4960523|NCT00232180|17052554|P2|Open Label Phase|Laboratory abnormality|0
4960524|NCT00232180|17052555|P1|Open Label Phase|Laboratory abnormality|0
4960525|NCT00232180|17052553|P3|Open Label Phase|Adverse Event|25
4960526|NCT00232180|17052554|P2|Open Label Phase|Adverse Event|0
4960527|NCT00232180|17052555|P1|Open Label Phase|Adverse Event|0
4960528|NCT00232180|17052553|P3|Open Label Phase|Other|16
4960529|NCT00232180|17052554|P2|Open Label Phase|Other|0
4960530|NCT00232180|17052555|P1|Open Label Phase|Other|0
4960531|NCT00232180|17052553|P3|Open Label Phase|Withdrawal by Subject|37
4960532|NCT00232180|17052554|P2|Open Label Phase|Withdrawal by Subject|0
4960533|NCT00232180|17052555|P1|Open Label Phase|Withdrawal by Subject|0
4960534|NCT00232180|17052553|P3|Open Label Phase|Study terminated by sponsor|3
4960535|NCT00232180|17052554|P2|Open Label Phase|Study terminated by sponsor|0
4960536|NCT00232180|17052555|P1|Open Label Phase|Study terminated by sponsor|0
4960537|NCT00232180|17052553|P3|Open Label Phase|Protocol Violation|3
4960538|NCT00232180|17052554|P2|Open Label Phase|Protocol Violation|0
4960539|NCT00232180|17052555|P1|Open Label Phase|Protocol Violation|0
4960540|NCT00232180|17052553|P3|Open Label Phase|Lost to Follow-up|5
4960541|NCT00232180|17052554|P2|Open Label Phase|Lost to Follow-up|0
4960542|NCT00232180|17052555|P1|Open Label Phase|Lost to Follow-up|0
4960543|NCT00232180|17052553|P3|Open Label Phase|Death|48
4960544|NCT00232180|17052554|P2|Open Label Phase|Death|0
4960545|NCT00232180|17052555|P1|Open Label Phase|Death|0
4960546|NCT00232180|17052553|P3|Double-blind (DB) Phase|Laboratory abnormality|0
4960547|NCT00232180|17052554|P2|Double-blind (DB) Phase|Laboratory abnormality|7
4960548|NCT00232180|17052555|P1|Double-blind (DB) Phase|Laboratory abnormality|6
4960549|NCT00232180|17052553|P3|Double-blind (DB) Phase|Randomized but not treated|0
4960550|NCT00232180|17052554|P2|Double-blind (DB) Phase|Randomized but not treated|4
4960551|NCT00232180|17052555|P1|Double-blind (DB) Phase|Randomized but not treated|3
4960552|NCT00232180|17052553|P3|Double-blind (DB) Phase|Other|0
4960553|NCT00232180|17052554|P2|Double-blind (DB) Phase|Other|75
4960554|NCT00232180|17052555|P1|Double-blind (DB) Phase|Other|70
4960555|NCT00232180|17052553|P3|Double-blind (DB) Phase|Adverse Event|0
4960556|NCT00232180|17052554|P2|Double-blind (DB) Phase|Adverse Event|100
4960557|NCT00232180|17052555|P1|Double-blind (DB) Phase|Adverse Event|83
4960558|NCT00232180|17052553|P3|Double-blind (DB) Phase|Protocol Violation|0
4960559|NCT00232180|17052554|P2|Double-blind (DB) Phase|Protocol Violation|21
4960560|NCT00232180|17052555|P1|Double-blind (DB) Phase|Protocol Violation|28
4960561|NCT00232180|17052553|P3|Double-blind (DB) Phase|Withdrawal by Subject|0
4960562|NCT00232180|17052554|P2|Double-blind (DB) Phase|Withdrawal by Subject|148
4960563|NCT00232180|17052555|P1|Double-blind (DB) Phase|Withdrawal by Subject|131
4960564|NCT00232180|17052553|P3|Double-blind (DB) Phase|Lost to Follow-up|0
4960565|NCT00232180|17052554|P2|Double-blind (DB) Phase|Lost to Follow-up|28
4960566|NCT00232180|17052555|P1|Double-blind (DB) Phase|Lost to Follow-up|34
4960567|NCT00232180|17052553|P3|Double-blind (DB) Phase|Death|0
4960568|NCT00232180|17052554|P2|Double-blind (DB) Phase|Death|222
4960569|NCT00232180|17052555|P1|Double-blind (DB) Phase|Death|186
4960570|NCT00232141|17052600|P2|Overall Study|Withdrawal by Subject|3
4960571|NCT00232141|17052601|P1|Overall Study|Withdrawal by Subject|5
4960572|NCT00232141|17052600|P2|Overall Study|Other|10
4960573|NCT00232141|17052601|P1|Overall Study|Other|8
4960574|NCT00232141|17052600|P2|Overall Study|Lost to Follow-up|6
4960575|NCT00232141|17052601|P1|Overall Study|Lost to Follow-up|9
4960576|NCT00232141|17052600|P2|Overall Study|Lack of Efficacy|3
4960577|NCT00232141|17052601|P1|Overall Study|Lack of Efficacy|0
4960578|NCT00232141|17052600|P2|Overall Study|Adverse Event|4
4960579|NCT00232141|17052601|P1|Overall Study|Adverse Event|9
4960580|NCT00231894|17052671|P2|Overall Study|Withdrawal by Subject|1
4960581|NCT00231894|17052672|P1|Overall Study|Withdrawal by Subject|1
4960582|NCT00231842|17052698|P1|Overall Study|Did not complete the last 3 cycle|8
4960583|NCT00231842|17052698|P1|Overall Study|Withdrawal by Subject|3
4960584|NCT00231816|17052705|P2|Overall Study|Other|1
4960585|NCT00231816|17052706|P1|Overall Study|Other|2
4960586|NCT00231816|17052705|P2|Overall Study|Withdrawal by Subject|3
4960587|NCT00231816|17052706|P1|Overall Study|Withdrawal by Subject|3
4960588|NCT00231816|17052705|P2|Overall Study|Protocol Violation|3
4960589|NCT00231816|17052706|P1|Overall Study|Protocol Violation|2
4960590|NCT00231816|17052705|P2|Overall Study|Lost to Follow-up|5
4960591|NCT00231816|17052706|P1|Overall Study|Lost to Follow-up|8
4960592|NCT00231816|17052705|P2|Overall Study|Adverse Event|0
4960593|NCT00231816|17052706|P1|Overall Study|Adverse Event|1
4960594|NCT00231777|17052721|P2|Overall Study|Other|2
4960595|NCT00231777|17052722|P1|Overall Study|Other|3
4960596|NCT00231777|17052721|P2|Overall Study|Lost to Follow-up|0
4960597|NCT00231777|17052722|P1|Overall Study|Lost to Follow-up|3
4960598|NCT00231478|17052736|P2|Overall Study|Administrative|2
4960599|NCT00231478|17052737|P1|Overall Study|Administrative|3
4960600|NCT00231478|17052736|P2|Overall Study|Adverse Event|1
4960601|NCT00231478|17052737|P1|Overall Study|Adverse Event|0
4960602|NCT00231478|17052736|P2|Overall Study|Withdrawal by Subject|0
4960603|NCT00231478|17052737|P1|Overall Study|Withdrawal by Subject|1
4960604|NCT00231478|17052736|P2|Overall Study|Refused Treatment|1
4960605|NCT00231478|17052737|P1|Overall Study|Refused Treatment|1
4960606|NCT00231478|17052736|P2|Overall Study|Protocol Violation|2
4960607|NCT00231478|17052737|P1|Overall Study|Protocol Violation|3
4960608|NCT00231465|17052749|P1|Overall Study|Did not have follow up CT scans|1
4960609|NCT00231465|17052749|P1|Overall Study|Completed only one cycle|1
4960610|NCT00231413|17052762|P7|Overall Study|Pregnancy|0
4960611|NCT00231413|17052763|P6|Overall Study|Pregnancy|0
4960612|NCT00231413|17052764|P5|Overall Study|Pregnancy|0
4960613|NCT00231413|17052765|P4|Overall Study|Pregnancy|0
4960614|NCT00231413|17052766|P3|Overall Study|Pregnancy|0
4960615|NCT00231413|17052767|P2|Overall Study|Pregnancy|0
4960616|NCT00231413|17052768|P1|Overall Study|Pregnancy|1
4960617|NCT00231413|17052762|P7|Overall Study|Lost to Follow-up|0
4960618|NCT00231413|17052763|P6|Overall Study|Lost to Follow-up|4
4960619|NCT00231413|17052764|P5|Overall Study|Lost to Follow-up|1
4960620|NCT00231413|17052765|P4|Overall Study|Lost to Follow-up|1
4960621|NCT00231413|17052766|P3|Overall Study|Lost to Follow-up|1
4960622|NCT00231413|17052767|P2|Overall Study|Lost to Follow-up|4
4960623|NCT00231413|17052768|P1|Overall Study|Lost to Follow-up|4
4960624|NCT00231413|17052762|P7|Overall Study|Migrated/moved from study area|0
4960625|NCT00231413|17052763|P6|Overall Study|Migrated/moved from study area|1
4960626|NCT00231413|17052764|P5|Overall Study|Migrated/moved from study area|0
4960627|NCT00231413|17052765|P4|Overall Study|Migrated/moved from study area|0
4960628|NCT00231413|17052766|P3|Overall Study|Migrated/moved from study area|1
4960629|NCT00231413|17052767|P2|Overall Study|Migrated/moved from study area|0
4960630|NCT00231413|17052768|P1|Overall Study|Migrated/moved from study area|0
4960631|NCT00231413|17052762|P7|Overall Study|Withdrawal by Subject|3
4960632|NCT00231413|17052763|P6|Overall Study|Withdrawal by Subject|0
4960633|NCT00231413|17052764|P5|Overall Study|Withdrawal by Subject|2
4960634|NCT00231413|17052765|P4|Overall Study|Withdrawal by Subject|2
4960635|NCT00231413|17052766|P3|Overall Study|Withdrawal by Subject|4
4960636|NCT00231413|17052767|P2|Overall Study|Withdrawal by Subject|1
4960637|NCT00231413|17052768|P1|Overall Study|Withdrawal by Subject|3
4960638|NCT00231413|17052762|P7|Overall Study|Non-serious AE|1
4960639|NCT00231413|17052763|P6|Overall Study|Non-serious AE|0
4960640|NCT00231413|17052764|P5|Overall Study|Non-serious AE|0
4960641|NCT00231413|17052765|P4|Overall Study|Non-serious AE|0
4960642|NCT00231413|17052766|P3|Overall Study|Non-serious AE|1
4960643|NCT00231413|17052767|P2|Overall Study|Non-serious AE|0
4960644|NCT00231413|17052768|P1|Overall Study|Non-serious AE|0
4960645|NCT00231179|17052938|P2|Overall Study|Withdrawal by Subject|3
4960646|NCT00231179|17052939|P1|Overall Study|Withdrawal by Subject|3
4960647|NCT00231179|17052938|P2|Overall Study|Lost to Follow-up|21
4960648|NCT00231179|17052939|P1|Overall Study|Lost to Follow-up|21
4960649|NCT00231114|17052966|P2|Post-Treatment Period|Withdrawal by Subject|0
4960650|NCT00231114|17052967|P1|Post-Treatment Period|Withdrawal by Subject|1
4960651|NCT00231114|17052966|P2|Post-Treatment Period|Physician Decision|0
4960652|NCT00231114|17052967|P1|Post-Treatment Period|Physician Decision|1
4960653|NCT00231114|17052966|P2|Post-Treatment Period|Lost to Follow-up|1
4960654|NCT00231114|17052967|P1|Post-Treatment Period|Lost to Follow-up|6
4960655|NCT00231114|17052966|P2|Treatment Period|Death: Motor Vehicle Accident|0
4960656|NCT00231114|17052967|P1|Treatment Period|Death: Motor Vehicle Accident|1
4960657|NCT00231114|17052966|P2|Randomized|Withdrawal by Subject|3
4960658|NCT00231114|17052967|P1|Randomized|Withdrawal by Subject|6
4960659|NCT00231062|17053003|P1|Overall Study|Physician Decision|6
4960660|NCT00230971|17053011|P2|Baseline Participants|Reintervention|0
4960661|NCT00230971|17053012|P1|Baseline Participants|Reintervention|1
4960662|NCT00230971|17053011|P2|Baseline Participants|Failure to return|1
4960663|NCT00230971|17053012|P1|Baseline Participants|Failure to return|1
4960664|NCT00230971|17053011|P2|Baseline Participants|No bacteria observed|0
4960665|NCT00230971|17053012|P1|Baseline Participants|No bacteria observed|1
4960666|NCT00230971|17053011|P2|Baseline Participants|Adverse Event|0
4960667|NCT00230971|17053012|P1|Baseline Participants|Adverse Event|1
4960668|NCT00230971|17053011|P2|Baseline Participants|Withdrawal by Subject|1
4960669|NCT00230971|17053012|P1|Baseline Participants|Withdrawal by Subject|7
4960670|NCT00230971|17053011|P2|Baseline Participants|Death|5
4960671|NCT00230971|17053012|P1|Baseline Participants|Death|6
4960672|NCT00230971|17053011|P2|Baseline Participants|Lost to Follow-up|12
4960673|NCT00230971|17053012|P1|Baseline Participants|Lost to Follow-up|5
4960674|NCT00230971|17053011|P2|Randomization|No study drug administered|3
4960675|NCT00230971|17053012|P1|Randomization|No study drug administered|3
4960676|NCT00230282|17053050|P1|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2
4960677|NCT00230282|17053050|P1|Fludarabine + Cyclophosphamide|Change in diagnosis|1
4960678|NCT00230282|17053050|P1|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1
4960679|NCT00230282|17053050|P1|Fludarabine + Cyclophosphamide|Lost to Follow-up|4
4960680|NCT00230178|17053058|P3|Overall Study|Various other reasons|4
4960681|NCT00230178|17053059|P2|Overall Study|Various other reasons|2
4960682|NCT00230178|17053060|P1|Overall Study|Various other reasons|3
4960683|NCT00230178|17053058|P3|Overall Study|Withdrawal by Subject|1
4960684|NCT00230178|17053059|P2|Overall Study|Withdrawal by Subject|0
4960685|NCT00230178|17053060|P1|Overall Study|Withdrawal by Subject|0
4960686|NCT00230178|17053058|P3|Overall Study|Adverse Event|2
4960687|NCT00230178|17053059|P2|Overall Study|Adverse Event|5
4960688|NCT00230178|17053060|P1|Overall Study|Adverse Event|1
4960689|NCT00230048|17053112|P2|Overall Study|Lost to Follow-up|18
4960690|NCT00230048|17053113|P1|Overall Study|Lost to Follow-up|13
4960691|NCT00229931|17053171|P2|Overall Study|Lost to Follow-up|2
4960692|NCT00229931|17053172|P1|Overall Study|Lost to Follow-up|3
4960693|NCT00229931|17053171|P2|Overall Study|Death|0
4960694|NCT00229931|17053172|P1|Overall Study|Death|1
4960695|NCT00229723|17053187|P7|Maintenance Phase|Other|1
4960696|NCT00229723|17053188|P6|Maintenance Phase|Other|3
4960697|NCT00229723|17053189|P5|Maintenance Phase|Other|3
4960698|NCT00229723|17053190|P4|Maintenance Phase|Other|2
4960699|NCT00229723|17053191|P3|Maintenance Phase|Other|1
4960700|NCT00229723|17053192|P2|Maintenance Phase|Other|4
4960701|NCT00229723|17053193|P1|Maintenance Phase|Other|5
4960702|NCT00229723|17053187|P7|Maintenance Phase|Severe non-compliance|0
4960703|NCT00229723|17053188|P6|Maintenance Phase|Severe non-compliance|0
4960704|NCT00229723|17053189|P5|Maintenance Phase|Severe non-compliance|1
4960705|NCT00229723|17053190|P4|Maintenance Phase|Severe non-compliance|0
4960706|NCT00229723|17053191|P3|Maintenance Phase|Severe non-compliance|0
4960707|NCT00229723|17053192|P2|Maintenance Phase|Severe non-compliance|1
4960708|NCT00229723|17053193|P1|Maintenance Phase|Severe non-compliance|3
4960709|NCT00229723|17053187|P7|Maintenance Phase|Informed consent withdrawn|0
4960710|NCT00229723|17053188|P6|Maintenance Phase|Informed consent withdrawn|1
4960711|NCT00229723|17053189|P5|Maintenance Phase|Informed consent withdrawn|1
4960712|NCT00229723|17053190|P4|Maintenance Phase|Informed consent withdrawn|1
4960713|NCT00229723|17053191|P3|Maintenance Phase|Informed consent withdrawn|0
4960714|NCT00229723|17053192|P2|Maintenance Phase|Informed consent withdrawn|0
4960715|NCT00229723|17053193|P1|Maintenance Phase|Informed consent withdrawn|1
4960716|NCT00229723|17053187|P7|Maintenance Phase|Lost to Follow-up|1
4960717|NCT00229723|17053188|P6|Maintenance Phase|Lost to Follow-up|0
4960718|NCT00229723|17053189|P5|Maintenance Phase|Lost to Follow-up|0
4960719|NCT00229723|17053190|P4|Maintenance Phase|Lost to Follow-up|2
4960720|NCT00229723|17053191|P3|Maintenance Phase|Lost to Follow-up|2
4960721|NCT00229723|17053192|P2|Maintenance Phase|Lost to Follow-up|1
4960722|NCT00229723|17053193|P1|Maintenance Phase|Lost to Follow-up|0
4960723|NCT00229723|17053187|P7|Maintenance Phase|Clinical progression|1
4960724|NCT00229723|17053188|P6|Maintenance Phase|Clinical progression|1
4960725|NCT00229723|17053189|P5|Maintenance Phase|Clinical progression|1
4960726|NCT00229723|17053190|P4|Maintenance Phase|Clinical progression|2
4960727|NCT00229723|17053191|P3|Maintenance Phase|Clinical progression|2
4960728|NCT00229723|17053192|P2|Maintenance Phase|Clinical progression|1
4960729|NCT00229723|17053193|P1|Maintenance Phase|Clinical progression|4
4960730|NCT00229723|17053187|P7|Maintenance Phase|Objective disease progression|5
4960731|NCT00229723|17053188|P6|Maintenance Phase|Objective disease progression|9
4960732|NCT00229723|17053189|P5|Maintenance Phase|Objective disease progression|2
4960733|NCT00229723|17053190|P4|Maintenance Phase|Objective disease progression|6
4960734|NCT00229723|17053191|P3|Maintenance Phase|Objective disease progression|3
4960735|NCT00229723|17053192|P2|Maintenance Phase|Objective disease progression|5
4960736|NCT00229723|17053193|P1|Maintenance Phase|Objective disease progression|5
4960737|NCT00229723|17053187|P7|Maintenance Phase|Adverse Event|2
4960738|NCT00229723|17053188|P6|Maintenance Phase|Adverse Event|5
4960739|NCT00229723|17053189|P5|Maintenance Phase|Adverse Event|7
4960740|NCT00229723|17053190|P4|Maintenance Phase|Adverse Event|4
4960741|NCT00229723|17053191|P3|Maintenance Phase|Adverse Event|1
4960742|NCT00229723|17053192|P2|Maintenance Phase|Adverse Event|2
4960743|NCT00229723|17053193|P1|Maintenance Phase|Adverse Event|7
4960744|NCT00229723|17053187|P7|Concomitant Phase|Other|0
4960745|NCT00229723|17053188|P6|Concomitant Phase|Other|2
4960746|NCT00229723|17053189|P5|Concomitant Phase|Other|0
4960747|NCT00229723|17053190|P4|Concomitant Phase|Other|1
4960748|NCT00229723|17053191|P3|Concomitant Phase|Other|1
4960749|NCT00229723|17053192|P2|Concomitant Phase|Other|0
4960750|NCT00229723|17053193|P1|Concomitant Phase|Other|3
4960751|NCT00229723|17053187|P7|Concomitant Phase|Severe non-compliance|0
4960752|NCT00229723|17053188|P6|Concomitant Phase|Severe non-compliance|0
4960753|NCT00229723|17053189|P5|Concomitant Phase|Severe non-compliance|1
4960754|NCT00229723|17053190|P4|Concomitant Phase|Severe non-compliance|0
4960755|NCT00229723|17053191|P3|Concomitant Phase|Severe non-compliance|0
4960756|NCT00229723|17053192|P2|Concomitant Phase|Severe non-compliance|1
4960757|NCT00229723|17053193|P1|Concomitant Phase|Severe non-compliance|0
4960758|NCT00229723|17053187|P7|Concomitant Phase|Informed consent withdrawn|0
4960759|NCT00229723|17053188|P6|Concomitant Phase|Informed consent withdrawn|0
4960760|NCT00229723|17053189|P5|Concomitant Phase|Informed consent withdrawn|0
4960761|NCT00229723|17053190|P4|Concomitant Phase|Informed consent withdrawn|2
4960762|NCT00229723|17053191|P3|Concomitant Phase|Informed consent withdrawn|0
4960763|NCT00229723|17053192|P2|Concomitant Phase|Informed consent withdrawn|2
4960764|NCT00229723|17053193|P1|Concomitant Phase|Informed consent withdrawn|3
4960765|NCT00229723|17053187|P7|Concomitant Phase|Lost to Follow-up|0
4960766|NCT00229723|17053188|P6|Concomitant Phase|Lost to Follow-up|0
4960767|NCT00229723|17053189|P5|Concomitant Phase|Lost to Follow-up|1
4960768|NCT00229723|17053190|P4|Concomitant Phase|Lost to Follow-up|0
4960769|NCT00229723|17053191|P3|Concomitant Phase|Lost to Follow-up|0
4960770|NCT00229723|17053192|P2|Concomitant Phase|Lost to Follow-up|0
4960771|NCT00229723|17053193|P1|Concomitant Phase|Lost to Follow-up|0
4960772|NCT00229723|17053187|P7|Concomitant Phase|Clinical progression|1
4960773|NCT00229723|17053188|P6|Concomitant Phase|Clinical progression|0
4960774|NCT00229723|17053189|P5|Concomitant Phase|Clinical progression|0
4960775|NCT00229723|17053190|P4|Concomitant Phase|Clinical progression|0
4960776|NCT00229723|17053191|P3|Concomitant Phase|Clinical progression|0
4960777|NCT00229723|17053192|P2|Concomitant Phase|Clinical progression|0
4960778|NCT00229723|17053193|P1|Concomitant Phase|Clinical progression|0
4960779|NCT00229723|17053187|P7|Concomitant Phase|Objective disease progression|0
4960780|NCT00229723|17053188|P6|Concomitant Phase|Objective disease progression|0
4960781|NCT00229723|17053189|P5|Concomitant Phase|Objective disease progression|0
4960782|NCT00229723|17053190|P4|Concomitant Phase|Objective disease progression|0
4960783|NCT00229723|17053191|P3|Concomitant Phase|Objective disease progression|0
4960784|NCT00229723|17053192|P2|Concomitant Phase|Objective disease progression|0
4960785|NCT00229723|17053193|P1|Concomitant Phase|Objective disease progression|0
4960786|NCT00229723|17053187|P7|Concomitant Phase|Adverse Event|2
4960787|NCT00229723|17053188|P6|Concomitant Phase|Adverse Event|1
4960788|NCT00229723|17053189|P5|Concomitant Phase|Adverse Event|0
4960789|NCT00229723|17053190|P4|Concomitant Phase|Adverse Event|2
4960790|NCT00229723|17053191|P3|Concomitant Phase|Adverse Event|5
4960791|NCT00229723|17053192|P2|Concomitant Phase|Adverse Event|2
4960792|NCT00229723|17053193|P1|Concomitant Phase|Adverse Event|4
4960793|NCT00229658|17053246|P2|Overall Study|Withdrawal of consent|39
4960794|NCT00229658|17053247|P1|Overall Study|Withdrawal of consent|46
4960795|NCT00229658|17053246|P2|Overall Study|Serious Adverse Event|2
4960796|NCT00229658|17053247|P1|Overall Study|Serious Adverse Event|2
4960797|NCT00229658|17053246|P2|Overall Study|Lost to Follow-up|55
4960798|NCT00229658|17053247|P1|Overall Study|Lost to Follow-up|82
4960799|NCT00229658|17053246|P2|Overall Study|Other|60
4960800|NCT00229658|17053247|P1|Overall Study|Other|80
4960801|NCT00229658|17053246|P2|Overall Study|Investigator decision|10
4960802|NCT00229658|17053247|P1|Overall Study|Investigator decision|13
4960803|NCT00229658|17053246|P2|Overall Study|Administrative|1
4960804|NCT00229658|17053247|P1|Overall Study|Administrative|2
4960805|NCT00229203|17053283|P2|Overall Study|Withdrawal by Subject|4
4960806|NCT00229203|17053284|P1|Overall Study|Withdrawal by Subject|1
4960807|NCT00229203|17053283|P2|Overall Study|Other|3
4960808|NCT00229203|17053284|P1|Overall Study|Other|3
4960809|NCT00229203|17053283|P2|Overall Study|Death|2
4960810|NCT00229203|17053284|P1|Overall Study|Death|4
4960811|NCT00229203|17053283|P2|Overall Study|Toxicity|1
4960812|NCT00229203|17053284|P1|Overall Study|Toxicity|6
4960813|NCT00229203|17053283|P2|Overall Study|Progressive disease|9
4960814|NCT00229203|17053284|P1|Overall Study|Progressive disease|18
4960815|NCT00228917|17053312|P8|Overall Study|Migrated/moved from study area|0
4960816|NCT00228917|17053313|P7|Overall Study|Migrated/moved from study area|0
4960817|NCT00228917|17053314|P6|Overall Study|Migrated/moved from study area|2
4960818|NCT00228917|17053315|P5|Overall Study|Migrated/moved from study area|0
4960819|NCT00228917|17053316|P4|Overall Study|Migrated/moved from study area|0
4960820|NCT00228917|17053317|P3|Overall Study|Migrated/moved from study area|0
4960821|NCT00228917|17053318|P2|Overall Study|Migrated/moved from study area|0
4960822|NCT00228917|17053319|P1|Overall Study|Migrated/moved from study area|0
4960823|NCT00228813|17053365|P1|Overall Study|Death|4
4960824|NCT00228566|17053371|P1|Overall Study|Miscellaneous|1
4960825|NCT00228566|17053371|P1|Overall Study|Withdrawal by Subject|4
4960826|NCT00228566|17053371|P1|Overall Study|Physician Decision|5
4960827|NCT00228566|17053371|P1|Overall Study|Lost to Follow-up|16
4960828|NCT00228566|17053371|P1|Overall Study|Lack of Efficacy|14
4960829|NCT00228566|17053371|P1|Overall Study|Adverse Event|31
4960830|NCT00228553|17053375|P1|Overall Study|Miscellaneous|46
4960831|NCT00228553|17053375|P1|Overall Study|Pregnancy|2
4960832|NCT00228553|17053375|P1|Overall Study|Withdrawal by Subject|115
4960833|NCT00228553|17053375|P1|Overall Study|Protocol Violation|6
4960834|NCT00228553|17053375|P1|Overall Study|Physician Decision|48
4960835|NCT00228553|17053375|P1|Overall Study|Lost to Follow-up|67
4960836|NCT00228553|17053375|P1|Overall Study|Lack of Efficacy|34
4960837|NCT00228553|17053375|P1|Overall Study|Adverse Event|112
4960838|NCT00228384|17053381|P2|Overall Study|Physician Decision|1
4960839|NCT00228384|17053382|P1|Overall Study|Physician Decision|0
4960840|NCT00228384|17053381|P2|Overall Study|Withdrawal by Subject|10
4960841|NCT00228384|17053382|P1|Overall Study|Withdrawal by Subject|9
4960842|NCT00228384|17053381|P2|Overall Study|Surgical Intervention (bypass)|5
4960843|NCT00228384|17053382|P1|Overall Study|Surgical Intervention (bypass)|5
4960844|NCT00228384|17053381|P2|Overall Study|Lost to Follow-up|10
4960845|NCT00228384|17053382|P1|Overall Study|Lost to Follow-up|6
4960846|NCT00228384|17053381|P2|Overall Study|Death|3
4960847|NCT00228384|17053382|P1|Overall Study|Death|9
4960848|NCT00227903|17053433|P2|Overall Study|Miscarriage|0
4960849|NCT00227903|17053434|P1|Overall Study|Miscarriage|1
4960850|NCT00227903|17053433|P2|Overall Study|Lost to Follow-up|3
4960851|NCT00227903|17053434|P1|Overall Study|Lost to Follow-up|1
4960852|NCT00227903|17053433|P2|Overall Study|Subject moved out of area|2
4960853|NCT00227903|17053434|P1|Overall Study|Subject moved out of area|1
4960854|NCT00227903|17053433|P2|Overall Study|Withdrawal by Subject|5
4960855|NCT00227903|17053434|P1|Overall Study|Withdrawal by Subject|2
4960856|NCT00227877|17053498|P4|12-months Follow-up|Lost to Follow-up|26
4960857|NCT00227877|17053499|P3|12-months Follow-up|Lost to Follow-up|30
4960858|NCT00227877|17053500|P2|12-months Follow-up|Lost to Follow-up|189
4960859|NCT00227877|17053501|P1|12-months Follow-up|Lost to Follow-up|232
4960860|NCT00227877|17053498|P4|12-months Follow-up|Completed late|0
4960861|NCT00227877|17053499|P3|12-months Follow-up|Completed late|1
4960862|NCT00227877|17053500|P2|12-months Follow-up|Completed late|74
4960863|NCT00227877|17053501|P1|12-months Follow-up|Completed late|78
4960864|NCT00227877|17053498|P4|3-months Follow-up|Lost to Follow-up|13
4960865|NCT00227877|17053499|P3|3-months Follow-up|Lost to Follow-up|18
4960866|NCT00227877|17053500|P2|3-months Follow-up|Lost to Follow-up|139
4960867|NCT00227877|17053501|P1|3-months Follow-up|Lost to Follow-up|178
4960868|NCT00227877|17053498|P4|3-months Follow-up|Completed late|8
4960869|NCT00227877|17053499|P3|3-months Follow-up|Completed late|34
4960870|NCT00227877|17053500|P2|3-months Follow-up|Completed late|128
4960871|NCT00227877|17053501|P1|3-months Follow-up|Completed late|135
4960872|NCT00227877|17053498|P4|Post-visit Checklist|Lost to Follow-up|0
4960873|NCT00227877|17053499|P3|Post-visit Checklist|Lost to Follow-up|1
4960874|NCT00227877|17053500|P2|Post-visit Checklist|Lost to Follow-up|13
4960875|NCT00227877|17053501|P1|Post-visit Checklist|Lost to Follow-up|24
4960876|NCT00227877|17053498|P4|Pre-visit Assessment|Technical difficulties|0
4960877|NCT00227877|17053499|P3|Pre-visit Assessment|Technical difficulties|0
4960878|NCT00227877|17053500|P2|Pre-visit Assessment|Technical difficulties|3
4960879|NCT00227877|17053501|P1|Pre-visit Assessment|Technical difficulties|7
4960880|NCT00227721|17053537|P1|Overall Study|On study, but never treated.|1
4960881|NCT00227591|17053559|P1|Overall Study|Withdrawal by Subject|1
4960882|NCT00227539|17053563|P1|Overall Study|Protocol Violation|1
4960883|NCT00227370|17053571|P2|Overall Study|Other reasons|1
4960884|NCT00227370|17053572|P1|Overall Study|Other reasons|2
4960885|NCT00227370|17053571|P2|Overall Study|Physician Decision|6
4960886|NCT00227370|17053572|P1|Overall Study|Physician Decision|9
4960887|NCT00227370|17053571|P2|Overall Study|Adverse Event|11
4960888|NCT00227370|17053572|P1|Overall Study|Adverse Event|6
4960889|NCT00227370|17053571|P2|Overall Study|Death|4
4960890|NCT00227370|17053572|P1|Overall Study|Death|3
4960891|NCT00227370|17053571|P2|Overall Study|Withdrawal by Subject|2
4960892|NCT00227370|17053572|P1|Overall Study|Withdrawal by Subject|1
4960893|NCT00227344|17053592|P2|Overall Study|study terminated early|5
4960894|NCT00227344|17053593|P1|Overall Study|study terminated early|12
4960895|NCT00227305|17053613|P1|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1
4960896|NCT00227305|17053613|P1|Overall Study|LEAVING TOWN FOR 6 WEEKS|1
4960897|NCT00227305|17053613|P1|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1
4960898|NCT00227305|17053613|P1|Overall Study|Physician Decision|3
4960899|NCT00227305|17053613|P1|Overall Study|Lack of Efficacy|7
4960900|NCT00227305|17053613|P1|Overall Study|MOVED OUT OF AREA|3
4960901|NCT00227305|17053613|P1|Overall Study|Study specific discontinuation|13
4960902|NCT00227305|17053613|P1|Overall Study|Lost to Follow-up|33
4960903|NCT00227305|17053613|P1|Overall Study|Withdrawal by Subject|42
4960904|NCT00227305|17053613|P1|Overall Study|Adverse Event|40
4960905|NCT00227266|17053630|P3|Overall Study|Excessive weight gain|2
4960906|NCT00227266|17053631|P2|Overall Study|Excessive weight gain|0
4960907|NCT00227266|17053632|P1|Overall Study|Excessive weight gain|0
4960908|NCT00227266|17053630|P3|Overall Study|Protocol Violation|1
4960909|NCT00227266|17053631|P2|Overall Study|Protocol Violation|0
4960910|NCT00227266|17053632|P1|Overall Study|Protocol Violation|1
4960911|NCT00227266|17053630|P3|Overall Study|Withdrawal by Subject|1
4960912|NCT00227266|17053631|P2|Overall Study|Withdrawal by Subject|0
4960913|NCT00227266|17053632|P1|Overall Study|Withdrawal by Subject|0
4960914|NCT00226941|17053662|P4|Overall Study|Withdrawn by investigator - unrelated AE|1
4960915|NCT00226941|17053663|P3|Overall Study|Withdrawn by investigator - unrelated AE|0
4960916|NCT00226941|17053664|P2|Overall Study|Withdrawn by investigator - unrelated AE|0
4960917|NCT00226941|17053665|P1|Overall Study|Withdrawn by investigator - unrelated AE|0
4960918|NCT00226941|17053662|P4|Overall Study|Withdrawal by subject - toxicity|1
4960919|NCT00226941|17053663|P3|Overall Study|Withdrawal by subject - toxicity|0
4960920|NCT00226941|17053664|P2|Overall Study|Withdrawal by subject - toxicity|0
4960921|NCT00226941|17053665|P1|Overall Study|Withdrawal by subject - toxicity|0
4960922|NCT00226811|17053699|P1|Overall Study|Withdrawal by Subject|2
4960923|NCT00226811|17053699|P1|Overall Study|Lack of Efficacy|55
4960924|NCT00226811|17053699|P1|Overall Study|Adverse Event|11
4960925|NCT00226811|17053699|P1|Overall Study|Death|8
4960926|NCT00226655|17053709|P1|Overall Study|Clinical deterioration|10
4960927|NCT00226655|17053709|P1|Overall Study|Physician Decision|6
4960928|NCT00226655|17053709|P1|Overall Study|Adverse Event|35
4960929|NCT00226655|17053709|P1|Overall Study|Withdrawal by Subject|15
4960930|NCT00226655|17053709|P1|Overall Study|Death|13
4960931|NCT00226499|17053731|P3|Overall Study|Others|356
4960932|NCT00226499|17053732|P2|Overall Study|Others|1066
4960933|NCT00226499|17053733|P1|Overall Study|Others|1064
4960934|NCT00226499|17053731|P3|Overall Study|Adverse Event|3
4960935|NCT00226499|17053732|P2|Overall Study|Adverse Event|6
4960936|NCT00226499|17053733|P1|Overall Study|Adverse Event|10
4960937|NCT00225758|17053868|P1|Overall Study|Adverse Event|4
4960938|NCT00225277|17053900|P2|Overall Study|Other|9
4960939|NCT00225277|17053901|P1|Overall Study|Other|7
4960940|NCT00225277|17053900|P2|Overall Study|Withdrawal by Subject|34
4960941|NCT00225277|17053901|P1|Overall Study|Withdrawal by Subject|40
4960942|NCT00225277|17053900|P2|Overall Study|Protocol Violation|3
4960943|NCT00225277|17053901|P1|Overall Study|Protocol Violation|6
4960944|NCT00225277|17053900|P2|Overall Study|Physician Decision|8
4960945|NCT00225277|17053901|P1|Overall Study|Physician Decision|6
4960946|NCT00225277|17053900|P2|Overall Study|Lost to Follow-up|6
4960947|NCT00225277|17053901|P1|Overall Study|Lost to Follow-up|4
4960948|NCT00225277|17053900|P2|Overall Study|Lack of Efficacy|1
4960949|NCT00225277|17053901|P1|Overall Study|Lack of Efficacy|4
4960950|NCT00225277|17053900|P2|Overall Study|Adverse Event|34
4960951|NCT00225277|17053901|P1|Overall Study|Adverse Event|30
4960952|NCT00225251|17053919|P2|Overall Study|Withdrawal by Subject|1
4960953|NCT00225251|17053920|P1|Overall Study|Withdrawal by Subject|1
4960954|NCT00225212|17053934|P1|Overall Study|Intercurrent illness|1
4960955|NCT00225212|17053934|P1|Overall Study|Adverse Event|2
4960956|NCT00225212|17053934|P1|Overall Study|Death|1
4960957|NCT00225212|17053934|P1|Overall Study|Disease progression|2
4960958|NCT00225147|17053943|P4|Open-label Phase|Withdrawal by Subject|6
4960959|NCT00225147|17053944|P3|Open-label Phase|Withdrawal by Subject|0
4960960|NCT00225147|17053945|P2|Open-label Phase|Withdrawal by Subject|0
4960961|NCT00225147|17053946|P1|Open-label Phase|Withdrawal by Subject|0
4960962|NCT00225147|17053943|P4|Open-label Phase|Lost to Follow-up|4
4960963|NCT00225147|17053944|P3|Open-label Phase|Lost to Follow-up|0
4960964|NCT00225147|17053945|P2|Open-label Phase|Lost to Follow-up|0
4960965|NCT00225147|17053946|P1|Open-label Phase|Lost to Follow-up|0
4960966|NCT00224874|17053993|P4|Overall Study|Withdrawal by Subject|0
4960967|NCT00224874|17053994|P3|Overall Study|Withdrawal by Subject|1
4960968|NCT00224874|17053995|P2|Overall Study|Withdrawal by Subject|0
4960969|NCT00224874|17053996|P1|Overall Study|Withdrawal by Subject|0
4960970|NCT00224770|17054041|P3|Overall Study|Lost to Follow-up|0
4960971|NCT00224770|17054042|P2|Overall Study|Lost to Follow-up|2
4960972|NCT00224770|17054043|P1|Overall Study|Lost to Follow-up|4
4960973|NCT00224484|17054078|P3|Overall Study|Reason not specified|2
4960974|NCT00224484|17054079|P2|Overall Study|Reason not specified|4
4960975|NCT00224484|17054080|P1|Overall Study|Reason not specified|5
4960976|NCT00224484|17054078|P3|Overall Study|Lost to Follow-up|36
4960977|NCT00224484|17054079|P2|Overall Study|Lost to Follow-up|28
4960978|NCT00224484|17054080|P1|Overall Study|Lost to Follow-up|66
4960979|NCT00224484|17054078|P3|Overall Study|Migrated/moved from study area|5
4960980|NCT00224484|17054079|P2|Overall Study|Migrated/moved from study area|5
4960981|NCT00224484|17054080|P1|Overall Study|Migrated/moved from study area|18
4960982|NCT00224484|17054078|P3|Overall Study|Withdrawal by Subject|16
4960983|NCT00224484|17054079|P2|Overall Study|Withdrawal by Subject|18
4960984|NCT00224484|17054080|P1|Overall Study|Withdrawal by Subject|49
4960985|NCT00224484|17054078|P3|Overall Study|Protocol Violation|0
4960986|NCT00224484|17054079|P2|Overall Study|Protocol Violation|2
4960987|NCT00224484|17054080|P1|Overall Study|Protocol Violation|2
4960988|NCT00224484|17054078|P3|Overall Study|Non-Serious Adverse Event|3
4960989|NCT00224484|17054079|P2|Overall Study|Non-Serious Adverse Event|7
4960990|NCT00224484|17054080|P1|Overall Study|Non-Serious Adverse Event|5
4960991|NCT00224484|17054078|P3|Overall Study|Serious Adverse Event|0
4960992|NCT00224484|17054079|P2|Overall Study|Serious Adverse Event|1
4960993|NCT00224484|17054080|P1|Overall Study|Serious Adverse Event|1
4960994|NCT00224133|17054144|P1|Overall Study|Other|14
4960995|NCT00224133|17054144|P1|Overall Study|Physician Decision|1
4960996|NCT00224133|17054144|P1|Overall Study|Lost to Follow-up|21
4960997|NCT00224133|17054144|P1|Overall Study|Lack of Efficacy|58
4960998|NCT00224133|17054144|P1|Overall Study|Withdrawal by Subject|33
4960999|NCT00224133|17054144|P1|Overall Study|Protocol Violation|6
4961000|NCT00224133|17054144|P1|Overall Study|Adverse Event|93
4961001|NCT00224120|17054150|P2|Overall Study|Other|5
4961002|NCT00224120|17054151|P1|Overall Study|Other|4
4961003|NCT00224120|17054150|P2|Overall Study|Lost to Follow-up|3
4961004|NCT00224120|17054151|P1|Overall Study|Lost to Follow-up|2
4961005|NCT00224120|17054150|P2|Overall Study|Lack of Efficacy|2
4961006|NCT00224120|17054151|P1|Overall Study|Lack of Efficacy|0
4961007|NCT00224120|17054150|P2|Overall Study|Withdrawal by Subject|10
4961008|NCT00224120|17054151|P1|Overall Study|Withdrawal by Subject|5
4961009|NCT00224120|17054150|P2|Overall Study|Protocol Violation|0
4961010|NCT00224120|17054151|P1|Overall Study|Protocol Violation|1
4961011|NCT00224120|17054150|P2|Overall Study|Adverse Event|4
4961012|NCT00224120|17054151|P1|Overall Study|Adverse Event|10
4961013|NCT00224107|17054161|P2|Overall Study|Other|1
4961014|NCT00224107|17054162|P1|Overall Study|Other|1
4961015|NCT00224107|17054161|P2|Overall Study|Physician Decision|0
4961016|NCT00224107|17054162|P1|Overall Study|Physician Decision|1
4961017|NCT00224107|17054161|P2|Overall Study|Lost to Follow-up|0
4961018|NCT00224107|17054162|P1|Overall Study|Lost to Follow-up|4
4961019|NCT00224107|17054161|P2|Overall Study|Lack of Efficacy|0
4961020|NCT00224107|17054162|P1|Overall Study|Lack of Efficacy|2
4961021|NCT00224107|17054161|P2|Overall Study|Withdrawal by Subject|4
4961022|NCT00224107|17054162|P1|Overall Study|Withdrawal by Subject|1
4961023|NCT00224107|17054161|P2|Overall Study|Protocol Violation|3
4961024|NCT00224107|17054162|P1|Overall Study|Protocol Violation|2
4961025|NCT00224107|17054161|P2|Overall Study|Adverse Event|6
4961026|NCT00224107|17054162|P1|Overall Study|Adverse Event|20
4961027|NCT00224055|17054172|P2|Overall Study|Other|0
4961028|NCT00224055|17054173|P1|Overall Study|Other|1
4961029|NCT00224055|17054172|P2|Overall Study|Withdrawal by Subject|2
4961030|NCT00224055|17054173|P1|Overall Study|Withdrawal by Subject|0
4961031|NCT00224055|17054172|P2|Overall Study|Inclusion Violation|6
4961032|NCT00224055|17054173|P1|Overall Study|Inclusion Violation|3
4961033|NCT00224055|17054172|P2|Overall Study|Protocol Violation|1
4961034|NCT00224055|17054173|P1|Overall Study|Protocol Violation|1
4961035|NCT00224055|17054172|P2|Overall Study|Lost to Follow-up|2
4961036|NCT00224055|17054173|P1|Overall Study|Lost to Follow-up|1
4961037|NCT00224055|17054172|P2|Overall Study|Adverse Event|3
4961038|NCT00224055|17054173|P1|Overall Study|Adverse Event|9
4961039|NCT00224042|17054183|P2|Overall Study|Other|0
4961040|NCT00224042|17054184|P1|Overall Study|Other|2
4961041|NCT00224042|17054183|P2|Overall Study|Did not meet lab incusion criteria|3
4961042|NCT00224042|17054184|P1|Overall Study|Did not meet lab incusion criteria|2
4961043|NCT00224042|17054183|P2|Overall Study|Physician Decision|1
4961044|NCT00224042|17054184|P1|Overall Study|Physician Decision|0
4961045|NCT00224042|17054183|P2|Overall Study|Protocol Violation|1
4961046|NCT00224042|17054184|P1|Overall Study|Protocol Violation|0
4961047|NCT00224042|17054183|P2|Overall Study|Adverse Event|1
4961048|NCT00224042|17054184|P1|Overall Study|Adverse Event|2
4961049|NCT00224029|17054196|P1|Overall Study|Other|1
4961050|NCT00224029|17054196|P1|Overall Study|Withdrawal by Subject|4
4961051|NCT00224029|17054196|P1|Overall Study|Lost to Follow-up|1
4961052|NCT00224016|17054202|P2|Maintenance Period|Lost to Follow-up|1
4961053|NCT00224016|17054203|P1|Maintenance Period|Lost to Follow-up|0
4961054|NCT00224016|17054202|P2|Maintenance Period|Withdrawal by Subject|0
4961055|NCT00224016|17054203|P1|Maintenance Period|Withdrawal by Subject|2
4961056|NCT00224016|17054202|P2|Titration Period|Lost to Follow-up|0
4961057|NCT00224016|17054203|P1|Titration Period|Lost to Follow-up|1
4961058|NCT00224016|17054202|P2|Titration Period|Withdrawal by Subject|1
4961059|NCT00224016|17054203|P1|Titration Period|Withdrawal by Subject|0
4961060|NCT00224003|17054211|P1|Overall Study|unk|3
4961061|NCT00224003|17054211|P1|Overall Study|Withdrawal by Subject|1
4961062|NCT00224003|17054211|P1|Overall Study|Protocol Violation|2
4961063|NCT00224003|17054211|P1|Overall Study|Adverse Event|1
4961064|NCT00223990|17054217|P2|Overall Study|Lost to Follow-up|0
4961065|NCT00223990|17054218|P1|Overall Study|Lost to Follow-up|1
4961066|NCT00223990|17054217|P2|Overall Study|Withdrawal by Subject|8
4961067|NCT00223990|17054218|P1|Overall Study|Withdrawal by Subject|4
4961068|NCT00223990|17054217|P2|Overall Study|Moved from area|1
4961069|NCT00223990|17054218|P1|Overall Study|Moved from area|2
4961070|NCT00223977|17054243|P3|Overall Study|Other|0
4961071|NCT00223977|17054244|P2|Overall Study|Other|0
4961072|NCT00223977|17054245|P1|Overall Study|Other|1
4961073|NCT00223977|17054243|P3|Overall Study|Withdrawal by Subject|2
4961074|NCT00223977|17054244|P2|Overall Study|Withdrawal by Subject|1
4961075|NCT00223977|17054245|P1|Overall Study|Withdrawal by Subject|1
4961076|NCT00223977|17054243|P3|Overall Study|Protocol Violation|1
4961077|NCT00223977|17054244|P2|Overall Study|Protocol Violation|0
4961078|NCT00223977|17054245|P1|Overall Study|Protocol Violation|0
4961079|NCT00223977|17054243|P3|Overall Study|Adverse Event|0
4961080|NCT00223977|17054244|P2|Overall Study|Adverse Event|10
4961081|NCT00223977|17054245|P1|Overall Study|Adverse Event|7
4961082|NCT00223808|17054279|P3|Overall Study|<5 hrs therapy before discharge|5
4961083|NCT00223808|17054280|P2|Overall Study|<5 hrs therapy before discharge|5
4961084|NCT00223808|17054281|P1|Overall Study|<5 hrs therapy before discharge|3
4961085|NCT00223795|17054298|P2|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
4961086|NCT00223795|17054299|P1|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1
4961087|NCT00223795|17054298|P2|First Intervention - Eight Weeks|Lost to Follow-up|9
4961088|NCT00223795|17054299|P1|First Intervention - Eight Weeks|Lost to Follow-up|7
4961089|NCT00223496|17054377|P1|Overall Study|Physician Decision|2
4961090|NCT00223496|17054377|P1|Overall Study|Withdrawal by Subject|1
4961091|NCT00223496|17054377|P1|Overall Study|Lack of Efficacy|6
4961092|NCT00223496|17054377|P1|Overall Study|Lost to Follow-up|4
4961093|NCT00223496|17054377|P1|Overall Study|screen failure|9
4961094|NCT00223080|17054407|P2|Overall Study|Adverse Event|1
4961095|NCT00223080|17054408|P1|Overall Study|Adverse Event|0
4961096|NCT00223080|17054407|P2|Overall Study|Reason not provided|140
4961097|NCT00223080|17054408|P1|Overall Study|Reason not provided|141
4961098|NCT00223080|17054407|P2|Overall Study|Other|11
4961099|NCT00223080|17054408|P1|Overall Study|Other|14
4961100|NCT00223080|17054407|P2|Overall Study|Death|74
4961101|NCT00223080|17054408|P1|Overall Study|Death|85
4961102|NCT00223080|17054407|P2|Overall Study|Lost to Follow-up|284
4961103|NCT00223080|17054408|P1|Overall Study|Lost to Follow-up|259
4961104|NCT00223080|17054407|P2|Overall Study|Moved from study area|47
4961105|NCT00223080|17054408|P1|Overall Study|Moved from study area|37
4961106|NCT00223080|17054407|P2|Overall Study|Non-compliant|7
4961107|NCT00223080|17054408|P1|Overall Study|Non-compliant|7
4961108|NCT00223080|17054407|P2|Overall Study|Required contraindicated med|1
4961109|NCT00223080|17054408|P1|Overall Study|Required contraindicated med|0
4961110|NCT00223080|17054407|P2|Overall Study|Withdrawal by Subject|232
4961111|NCT00223080|17054408|P1|Overall Study|Withdrawal by Subject|253
4961112|NCT00222729|17054426|P1|Overall Study|Adverse Event|3
4961113|NCT00222105|17054444|P1|Overall Study|Death|2
4961114|NCT00222105|17054444|P1|Overall Study|Treatment delays|2
4961115|NCT00222105|17054444|P1|Overall Study|Adverse Event|8
4961116|NCT00222105|17054444|P1|Overall Study|Withdrawal by Subject|1
4961117|NCT00222105|17054444|P1|Overall Study|Removed due to wrong diagnosis|1
4961118|NCT00221403|17054452|P3|Overall Study|Adverse Event|0
4961119|NCT00221403|17054453|P2|Overall Study|Adverse Event|1
4961120|NCT00221403|17054454|P1|Overall Study|Adverse Event|0
4961121|NCT00221403|17054452|P3|Overall Study|Lack of Efficacy|0
4961122|NCT00221403|17054453|P2|Overall Study|Lack of Efficacy|1
4961123|NCT00221403|17054454|P1|Overall Study|Lack of Efficacy|0
4961124|NCT00221403|17054452|P3|Overall Study|Withdrawal by Subject|0
4961125|NCT00221403|17054453|P2|Overall Study|Withdrawal by Subject|3
4961126|NCT00221403|17054454|P1|Overall Study|Withdrawal by Subject|0
4961127|NCT00221403|17054452|P3|Overall Study|Physician Decision|0
4961128|NCT00221403|17054453|P2|Overall Study|Physician Decision|0
4961129|NCT00221403|17054454|P1|Overall Study|Physician Decision|1
4961130|NCT00221403|17054452|P3|Overall Study|Protocol Violation|0
4961131|NCT00221403|17054453|P2|Overall Study|Protocol Violation|0
4961132|NCT00221403|17054454|P1|Overall Study|Protocol Violation|1
4961133|NCT00221195|17054497|P2|Therapy 2 (Months 10-15)|Adverse Event|0
4961134|NCT00221195|17054498|P1|Therapy 2 (Months 10-15)|Adverse Event|1
4961135|NCT00221195|17054497|P2|Therapy 2 (Months 10-15)|Death|0
4961136|NCT00221195|17054498|P1|Therapy 2 (Months 10-15)|Death|1
4961137|NCT00221195|17054497|P2|Washout Period (Months 7-9)|Death|1
4961138|NCT00221195|17054498|P1|Washout Period (Months 7-9)|Death|0
4961139|NCT00221195|17054497|P2|Therapy 1 (Months 1-6)|Lost to Follow-up|1
4961140|NCT00221195|17054498|P1|Therapy 1 (Months 1-6)|Lost to Follow-up|0
4961141|NCT00221195|17054497|P2|Therapy 1 (Months 1-6)|Withdrawal by Subject|1
4961142|NCT00221195|17054498|P1|Therapy 1 (Months 1-6)|Withdrawal by Subject|3
4961143|NCT00221104|17054520|P2|Overall Study|Others|47
4961144|NCT00221104|17054521|P1|Overall Study|Others|37
4961145|NCT00221104|17054520|P2|Overall Study|Withdrawal by Subject|29
4961146|NCT00221104|17054521|P1|Overall Study|Withdrawal by Subject|42
4961147|NCT00221104|17054520|P2|Overall Study|Protocol Violation|0
4961148|NCT00221104|17054521|P1|Overall Study|Protocol Violation|2
4961149|NCT00221104|17054520|P2|Overall Study|Physician Decision|0
4961150|NCT00221104|17054521|P1|Overall Study|Physician Decision|1
4961151|NCT00221104|17054520|P2|Overall Study|Adverse Event|0
4961152|NCT00221104|17054521|P1|Overall Study|Adverse Event|1
4961153|NCT00220805|17054554|P2|Overall Study|Develop. of choroidal neovascularization|8
4961154|NCT00220805|17054555|P1|Overall Study|Develop. of choroidal neovascularization|3
4961155|NCT00220805|17054554|P2|Overall Study|Lack of Efficacy|0
4961156|NCT00220805|17054555|P1|Overall Study|Lack of Efficacy|1
4961157|NCT00220805|17054554|P2|Overall Study|Withdrawal by Subject|0
4961158|NCT00220805|17054555|P1|Overall Study|Withdrawal by Subject|3
4961159|NCT00220805|17054554|P2|Overall Study|Adverse Event|3
4961160|NCT00220805|17054555|P1|Overall Study|Adverse Event|1
4961161|NCT00220779|17054576|P3|Overall Study|Lack of Efficacy|1
4961162|NCT00220779|17054577|P2|Overall Study|Lack of Efficacy|0
4961163|NCT00220779|17054578|P1|Overall Study|Lack of Efficacy|3
4961164|NCT00220779|17054576|P3|Overall Study|Pregnancy|2
4961165|NCT00220779|17054577|P2|Overall Study|Pregnancy|0
4961166|NCT00220779|17054578|P1|Overall Study|Pregnancy|0
4961167|NCT00220779|17054576|P3|Overall Study|Too time consuming|0
4961168|NCT00220779|17054577|P2|Overall Study|Too time consuming|0
4961169|NCT00220779|17054578|P1|Overall Study|Too time consuming|1
4961170|NCT00220779|17054576|P3|Overall Study|Non-compliance|0
4961171|NCT00220779|17054577|P2|Overall Study|Non-compliance|0
4961172|NCT00220779|17054578|P1|Overall Study|Non-compliance|1
4961173|NCT00220779|17054576|P3|Overall Study|Withdrawal by Subject|1
4961174|NCT00220779|17054577|P2|Overall Study|Withdrawal by Subject|4
4961175|NCT00220779|17054578|P1|Overall Study|Withdrawal by Subject|1
4961176|NCT00220779|17054576|P3|Overall Study|Adverse Event|0
4961177|NCT00220779|17054577|P2|Overall Study|Adverse Event|0
4961178|NCT00220779|17054578|P1|Overall Study|Adverse Event|1
4961179|NCT00220740|17054588|P2|Efficacy Period|Entered Rescue Treatment with IGIV-C|45
4961180|NCT00220740|17054589|P1|Efficacy Period|Entered Rescue Treatment with IGIV-C|0
4961181|NCT00220740|17054588|P2|Efficacy Period|Protocol Violation|0
4961182|NCT00220740|17054589|P1|Efficacy Period|Protocol Violation|1
4961183|NCT00220740|17054588|P2|Efficacy Period|Withdrawal by Subject|0
4961184|NCT00220740|17054589|P1|Efficacy Period|Withdrawal by Subject|1
4961185|NCT00220740|17054588|P2|Efficacy Period|Adverse Event|1
4961186|NCT00220740|17054589|P1|Efficacy Period|Adverse Event|1
4961187|NCT00220740|17054588|P2|Efficacy Period|Entered rescue treatment with placebo|0
4961188|NCT00220740|17054589|P1|Efficacy Period|Entered rescue treatment with placebo|23
4961189|NCT00220727|17054603|P2|Second Infusion (Week <6)|Pt did not meet study requirement|0
4961190|NCT00220727|17054604|P1|Second Infusion (Week <6)|Pt did not meet study requirement|1
4961191|NCT00220701|17054620|P2|Overall Study|Lost to Follow-up|4
4961192|NCT00220701|17054621|P1|Overall Study|Lost to Follow-up|5
4961193|NCT00220636|17054637|P1|Overall Study|Withdrawal by Subject|4
4961194|NCT00219557|17054647|P3|Phase 2|Treatment not received|3
4961195|NCT00219557|17054648|P2|Phase 2|Treatment not received|1
4961196|NCT00219557|17054649|P1|Phase 2|Treatment not received|0
4961197|NCT00219557|17054647|P3|Phase 2|Withdrawal by Subject|5
4961198|NCT00219557|17054648|P2|Phase 2|Withdrawal by Subject|9
4961199|NCT00219557|17054649|P1|Phase 2|Withdrawal by Subject|0
4961200|NCT00219557|17054647|P3|Phase 2|Other|6
4961201|NCT00219557|17054648|P2|Phase 2|Other|8
4961202|NCT00219557|17054649|P1|Phase 2|Other|0
4961203|NCT00219557|17054647|P3|Phase 2|Death|2
4961204|NCT00219557|17054648|P2|Phase 2|Death|8
4961205|NCT00219557|17054649|P1|Phase 2|Death|0
4961206|NCT00219557|17054647|P3|Phase 2|Adverse Event|2
4961207|NCT00219557|17054648|P2|Phase 2|Adverse Event|22
4961208|NCT00219557|17054649|P1|Phase 2|Adverse Event|0
4961209|NCT00219557|17054647|P3|Phase 2|Lack of Efficacy|15
4961210|NCT00219557|17054648|P2|Phase 2|Lack of Efficacy|21
4961211|NCT00219557|17054649|P1|Phase 2|Lack of Efficacy|0
4961212|NCT00219557|17054647|P3|Phase 1|Started chemotherapy at other institute|0
4961213|NCT00219557|17054648|P2|Phase 1|Started chemotherapy at other institute|0
4961214|NCT00219557|17054649|P1|Phase 1|Started chemotherapy at other institute|1
4961215|NCT00219557|17054647|P3|Phase 1|Withdrawal by Subject|0
4961216|NCT00219557|17054648|P2|Phase 1|Withdrawal by Subject|0
4961217|NCT00219557|17054649|P1|Phase 1|Withdrawal by Subject|1
4961218|NCT00219557|17054647|P3|Phase 1|Adverse Event|0
4961219|NCT00219557|17054648|P2|Phase 1|Adverse Event|0
4961220|NCT00219557|17054649|P1|Phase 1|Adverse Event|2
4961221|NCT00219557|17054647|P3|Phase 1|Lack of Efficacy|0
4961222|NCT00219557|17054648|P2|Phase 1|Lack of Efficacy|0
4961223|NCT00219557|17054649|P1|Phase 1|Lack of Efficacy|3
4961224|NCT00219544|17054677|P2|Single Blind Treatment Period|Withdrawal by Subject|0
4961225|NCT00219544|17054678|P1|Single Blind Treatment Period|Withdrawal by Subject|1
4961226|NCT00219544|17054677|P2|Single Blind Treatment Period|Investigator decision to withdraw|0
4961227|NCT00219544|17054678|P1|Single Blind Treatment Period|Investigator decision to withdraw|1
4961228|NCT00219544|17054677|P2|Single Blind Treatment Period|Lost to Follow-up|0
4961229|NCT00219544|17054678|P1|Single Blind Treatment Period|Lost to Follow-up|2
4961230|NCT00219544|17054677|P2|Single Blind Treatment Period|Protocol Violation|0
4961231|NCT00219544|17054678|P1|Single Blind Treatment Period|Protocol Violation|4
4961232|NCT00219544|17054677|P2|Single Blind Treatment Period|Adverse Event|0
4961233|NCT00219544|17054678|P1|Single Blind Treatment Period|Adverse Event|9
4961234|NCT00219544|17054677|P2|Single Blind Treatment Period|Lack of Efficacy|0
4961235|NCT00219544|17054678|P1|Single Blind Treatment Period|Lack of Efficacy|5
4961236|NCT00219349|17054716|P1|Escitalopram Phase|Withdrawal by Subject|3
4961237|NCT00219349|17054716|P1|Cognitive Behavioral Therapy Phase|Protocol Violation|2
4961238|NCT00219349|17054716|P1|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2
4961239|NCT00219349|17054716|P1|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6
4961240|NCT00219284|17054729|P2|Extension Phase - 8 Weeks|Lost to Follow-up|2
4961241|NCT00219284|17054730|P1|Extension Phase - 8 Weeks|Lost to Follow-up|0
4961242|NCT00219284|17054729|P2|Extension Phase - 8 Weeks|Withdrawal by Subject|2
4961243|NCT00219284|17054730|P1|Extension Phase - 8 Weeks|Withdrawal by Subject|0
4961244|NCT00219284|17054729|P2|Extension Phase - 8 Weeks|Adverse Event|3
4961245|NCT00219284|17054730|P1|Extension Phase - 8 Weeks|Adverse Event|2
4961246|NCT00219284|17054729|P2|Treatment Phase - 16 Weeks|Lost to Follow-up|2
4961247|NCT00219284|17054730|P1|Treatment Phase - 16 Weeks|Lost to Follow-up|1
4961248|NCT00219284|17054729|P2|Treatment Phase - 16 Weeks|Withdrawal by Subject|9
4961249|NCT00219284|17054730|P1|Treatment Phase - 16 Weeks|Withdrawal by Subject|5
4961250|NCT00219284|17054729|P2|Treatment Phase - 16 Weeks|Protocol Violation|5
4961251|NCT00219284|17054730|P1|Treatment Phase - 16 Weeks|Protocol Violation|9
4961252|NCT00219284|17054729|P2|Treatment Phase - 16 Weeks|Lack of Efficacy|10
4961253|NCT00219284|17054730|P1|Treatment Phase - 16 Weeks|Lack of Efficacy|3
4961254|NCT00219284|17054729|P2|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1
4961255|NCT00219284|17054730|P1|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0
4961256|NCT00219284|17054729|P2|Treatment Phase - 16 Weeks|Adverse Event|24
4961257|NCT00219284|17054730|P1|Treatment Phase - 16 Weeks|Adverse Event|26
4961258|NCT00219141|17054755|P3|Overall Study|Condition no longer requires study drug|0
4961259|NCT00219141|17054756|P2|Overall Study|Condition no longer requires study drug|0
4961260|NCT00219141|17054757|P1|Overall Study|Condition no longer requires study drug|1
4961261|NCT00219141|17054755|P3|Overall Study|Withdrawal by Subject|5
4961262|NCT00219141|17054756|P2|Overall Study|Withdrawal by Subject|3
4961263|NCT00219141|17054757|P1|Overall Study|Withdrawal by Subject|1
4961264|NCT00219141|17054755|P3|Overall Study|Protocol Violation|1
4961265|NCT00219141|17054756|P2|Overall Study|Protocol Violation|1
4961266|NCT00219141|17054757|P1|Overall Study|Protocol Violation|3
4961267|NCT00219141|17054755|P3|Overall Study|Lost to Follow-up|1
4961268|NCT00219141|17054756|P2|Overall Study|Lost to Follow-up|4
4961269|NCT00219141|17054757|P1|Overall Study|Lost to Follow-up|2
4961270|NCT00219141|17054755|P3|Overall Study|Administrative problems|0
4961271|NCT00219141|17054756|P2|Overall Study|Administrative problems|1
4961272|NCT00219141|17054757|P1|Overall Study|Administrative problems|0
4961273|NCT00219141|17054755|P3|Overall Study|Lack of Efficacy|0
4961274|NCT00219141|17054756|P2|Overall Study|Lack of Efficacy|2
4961275|NCT00219141|17054757|P1|Overall Study|Lack of Efficacy|3
4961276|NCT00219141|17054755|P3|Overall Study|Adverse Event|5
4961277|NCT00219141|17054756|P2|Overall Study|Adverse Event|10
4961278|NCT00219141|17054757|P1|Overall Study|Adverse Event|4
4961279|NCT00218634|17054803|P2|Overall Study|Lost to Follow-up|15
4961280|NCT00218634|17054804|P1|Overall Study|Lost to Follow-up|8
4961281|NCT00218543|17054824|P1|Overall Study|Adverse Event|2
4961282|NCT00218543|17054824|P1|Overall Study|Physician Decision|3
4961283|NCT00218543|17054824|P1|Overall Study|Withdrawal by Subject|1
4961284|NCT00218543|17054824|P1|Overall Study|relocated|1
4961285|NCT00218543|17054824|P1|Overall Study|Lost to Follow-up|8
4961286|NCT00218296|17055002|P2|Overall Study|Randomized but did not enter treatment|67
4961287|NCT00218296|17055003|P1|Overall Study|Randomized but did not enter treatment|66
4961288|NCT00218296|17055002|P2|Overall Study|Withdrawal by Subject|47
4961289|NCT00218296|17055003|P1|Overall Study|Withdrawal by Subject|36
4961290|NCT00218296|17055002|P2|Overall Study|Lost to Follow-up|7
4961291|NCT00218296|17055003|P1|Overall Study|Lost to Follow-up|9
4961292|NCT00218257|17055019|P2|Period Between Visit 1 and 2|Lost to Follow-up|3
4961293|NCT00218257|17055020|P1|Period Between Visit 1 and 2|Lost to Follow-up|4
4961294|NCT00217971|17055121|P2|Overall Study|non compliant|0
4961295|NCT00217971|17055122|P1|Overall Study|non compliant|1
4961296|NCT00217971|17055121|P2|Overall Study|Withdrawal by Subject|12
4961297|NCT00217971|17055122|P1|Overall Study|Withdrawal by Subject|7
4961298|NCT00217971|17055121|P2|Overall Study|Physician Decision|1
4961299|NCT00217971|17055122|P1|Overall Study|Physician Decision|0
4961300|NCT00217971|17055121|P2|Overall Study|Lost to Follow-up|19
4961301|NCT00217971|17055122|P1|Overall Study|Lost to Follow-up|15
4961302|NCT00217971|17055121|P2|Overall Study|Adverse Event|1
4961303|NCT00217971|17055122|P1|Overall Study|Adverse Event|1
4961304|NCT00217672|17055137|P2|Follow-up|Lost to Follow-up|0
4961305|NCT00217672|17055138|P1|Follow-up|Lost to Follow-up|1
4961306|NCT00217672|17055137|P2|Follow-up|Withdrawal by Subject|0
4961307|NCT00217672|17055138|P1|Follow-up|Withdrawal by Subject|4
4961308|NCT00217672|17055137|P2|Treatment|secondary malignancy|0
4961309|NCT00217672|17055138|P1|Treatment|secondary malignancy|1
4961310|NCT00217672|17055137|P2|Treatment|Death|0
4961311|NCT00217672|17055138|P1|Treatment|Death|2
4961312|NCT00217672|17055137|P2|Treatment|insurance issues|1
4961313|NCT00217672|17055138|P1|Treatment|insurance issues|1
4961314|NCT00217672|17055137|P2|Treatment|Physician Decision|0
4961315|NCT00217672|17055138|P1|Treatment|Physician Decision|6
4961316|NCT00217672|17055137|P2|Treatment|reqd treatment not permitted by protocol|0
4961317|NCT00217672|17055138|P1|Treatment|reqd treatment not permitted by protocol|6
4961318|NCT00217672|17055137|P2|Treatment|Adverse Event|2
4961319|NCT00217672|17055138|P1|Treatment|Adverse Event|18
4961320|NCT00217672|17055137|P2|Treatment|disease progression|4
4961321|NCT00217672|17055138|P1|Treatment|disease progression|33
4961322|NCT00217672|17055137|P2|Allocation|Ineligible|0
4961323|NCT00217672|17055138|P1|Allocation|Ineligible|2
4961324|NCT00217620|17055144|P1|Overall Study|Never received treatment|1
4961325|NCT00217620|17055144|P1|Overall Study|Ineligible|13
4961326|NCT00217620|17055144|P1|Overall Study|Not Protocol Specified|4
4961327|NCT00217620|17055144|P1|Overall Study|Progression|31
4961328|NCT00217620|17055144|P1|Overall Study|Adverse Event|2
4961329|NCT00217581|17055159|P1|Overall Study|Withdrawal by Subject|1
4961330|NCT00217464|17055188|P1|Overall Study|Other|2
4961331|NCT00217464|17055188|P1|Overall Study|Progression|15
4961332|NCT00217425|17055204|P1|Overall Study|Other|4
4961333|NCT00217425|17055204|P1|Overall Study|Other complicating disease|1
4961334|NCT00217425|17055204|P1|Overall Study|Withdrawal by Subject|4
4961335|NCT00217425|17055204|P1|Overall Study|Adverse Event|8
4961336|NCT00217425|17055204|P1|Overall Study|Lack of Efficacy|13
4961337|NCT00217425|17055204|P1|Overall Study|Patient ineligible|5
4961338|NCT00217425|17055204|P1|Overall Study|Never started treatment|2
4961339|NCT00217087|17055218|P2|Overall Study|completed less than 12 months return|18
4961340|NCT00217087|17055219|P1|Overall Study|completed less than 12 months return|10
4961341|NCT00217087|17055218|P2|Overall Study|decided to have esophagectomy|2
4961342|NCT00217087|17055219|P1|Overall Study|decided to have esophagectomy|1
4961343|NCT00217022|17055233|P2|Overall Study|Withdrawal by Subject|1
4961344|NCT00217022|17055234|P1|Overall Study|Withdrawal by Subject|1
4961345|NCT00216736|17055244|P2|Overall Study|Lost to Follow-up|1
4961346|NCT00216736|17055245|P1|Overall Study|Lost to Follow-up|1
4961347|NCT00216671|17055259|P2|Overall Study|Insufficient Response Adverse Event|1
4961348|NCT00216671|17055260|P1|Overall Study|Insufficient Response Adverse Event|2
4961349|NCT00216671|17055259|P2|Overall Study|Ineligible, no efficacy data|2
4961350|NCT00216671|17055260|P1|Overall Study|Ineligible, no efficacy data|2
4961351|NCT00216671|17055259|P2|Overall Study|Patient Moved|1
4961352|NCT00216671|17055260|P1|Overall Study|Patient Moved|0
4961353|NCT00216671|17055259|P2|Overall Study|Investigator Illness|1
4961354|NCT00216671|17055260|P1|Overall Study|Investigator Illness|0
4961355|NCT00216671|17055259|P2|Overall Study|Relapse|0
4961356|NCT00216671|17055260|P1|Overall Study|Relapse|1
4961357|NCT00216671|17055259|P2|Overall Study|Protocol Violation|5
4961358|NCT00216671|17055260|P1|Overall Study|Protocol Violation|3
4961359|NCT00216671|17055259|P2|Overall Study|Physician Decision|1
4961360|NCT00216671|17055260|P1|Overall Study|Physician Decision|1
4961361|NCT00216671|17055259|P2|Overall Study|Ineligible|2
4961362|NCT00216671|17055260|P1|Overall Study|Ineligible|0
4961363|NCT00216671|17055259|P2|Overall Study|Non compliant|2
4961364|NCT00216671|17055260|P1|Overall Study|Non compliant|2
4961365|NCT00216671|17055259|P2|Overall Study|Lost to Follow-up|5
4961366|NCT00216671|17055260|P1|Overall Study|Lost to Follow-up|3
4961367|NCT00216671|17055259|P2|Overall Study|Insufficient Response|4
4961368|NCT00216671|17055260|P1|Overall Study|Insufficient Response|9
4961369|NCT00216671|17055259|P2|Overall Study|No Need to Continue Medication|1
4961370|NCT00216671|17055260|P1|Overall Study|No Need to Continue Medication|1
4961371|NCT00216671|17055259|P2|Overall Study|Refused Injections|13
4961372|NCT00216671|17055260|P1|Overall Study|Refused Injections|3
4961373|NCT00216671|17055259|P2|Overall Study|Withdrawal by Subject|2
4961374|NCT00216671|17055260|P1|Overall Study|Withdrawal by Subject|4
4961375|NCT00216671|17055259|P2|Overall Study|Pregnancy|1
4961376|NCT00216671|17055260|P1|Overall Study|Pregnancy|0
4961377|NCT00216671|17055259|P2|Overall Study|Adverse Event|9
4961378|NCT00216671|17055260|P1|Overall Study|Adverse Event|4
4961379|NCT00216476|17055278|P3|Overall Study|Patient Moved|0
4961380|NCT00216476|17055279|P2|Overall Study|Patient Moved|2
4961381|NCT00216476|17055280|P1|Overall Study|Patient Moved|2
4961382|NCT00216476|17055278|P3|Overall Study|Protocol Deviation|0
4961383|NCT00216476|17055279|P2|Overall Study|Protocol Deviation|1
4961384|NCT00216476|17055280|P1|Overall Study|Protocol Deviation|5
4961385|NCT00216476|17055278|P3|Overall Study|Administrative Reasons|0
4961386|NCT00216476|17055279|P2|Overall Study|Administrative Reasons|1
4961387|NCT00216476|17055280|P1|Overall Study|Administrative Reasons|1
4961388|NCT00216476|17055278|P3|Overall Study|Higher dose/Extra Medication Required|2
4961389|NCT00216476|17055279|P2|Overall Study|Higher dose/Extra Medication Required|0
4961390|NCT00216476|17055280|P1|Overall Study|Higher dose/Extra Medication Required|2
4961391|NCT00216476|17055278|P3|Overall Study|Non-compliance|1
4961392|NCT00216476|17055279|P2|Overall Study|Non-compliance|4
4961393|NCT00216476|17055280|P1|Overall Study|Non-compliance|0
4961394|NCT00216476|17055278|P3|Overall Study|No Further Need for Treatment|1
4961395|NCT00216476|17055279|P2|Overall Study|No Further Need for Treatment|4
4961396|NCT00216476|17055280|P1|Overall Study|No Further Need for Treatment|3
4961397|NCT00216476|17055278|P3|Overall Study|Refuses Injection|0
4961398|NCT00216476|17055279|P2|Overall Study|Refuses Injection|0
4961399|NCT00216476|17055280|P1|Overall Study|Refuses Injection|11
4961400|NCT00216476|17055278|P3|Overall Study|Other|1
4961401|NCT00216476|17055279|P2|Overall Study|Other|0
4961402|NCT00216476|17055280|P1|Overall Study|Other|0
4961403|NCT00216476|17055278|P3|Overall Study|Pregnancy|1
4961404|NCT00216476|17055279|P2|Overall Study|Pregnancy|1
4961405|NCT00216476|17055280|P1|Overall Study|Pregnancy|0
4961406|NCT00216476|17055278|P3|Overall Study|Death|0
4961407|NCT00216476|17055279|P2|Overall Study|Death|0
4961408|NCT00216476|17055280|P1|Overall Study|Death|2
4961409|NCT00216476|17055278|P3|Overall Study|Lack of Efficacy|0
4961410|NCT00216476|17055279|P2|Overall Study|Lack of Efficacy|3
4961411|NCT00216476|17055280|P1|Overall Study|Lack of Efficacy|4
4961412|NCT00216476|17055278|P3|Overall Study|Adverse Event|1
4961413|NCT00216476|17055279|P2|Overall Study|Adverse Event|10
4961414|NCT00216476|17055280|P1|Overall Study|Adverse Event|6
4961415|NCT00216476|17055278|P3|Overall Study|Lost to Follow-up|1
4961416|NCT00216476|17055279|P2|Overall Study|Lost to Follow-up|9
4961417|NCT00216476|17055280|P1|Overall Study|Lost to Follow-up|10
4961418|NCT00216476|17055278|P3|Overall Study|Withdrawal by Subject|9
4961419|NCT00216476|17055279|P2|Overall Study|Withdrawal by Subject|72
4961420|NCT00216476|17055280|P1|Overall Study|Withdrawal by Subject|59
4961421|NCT00216203|17055317|P1|Overall Study|Withdrawal by Subject|2
4961422|NCT00216086|17055347|P1|Overall Study|Social Reasons|2
4961423|NCT00216086|17055347|P1|Overall Study|Diagnosis of Metastatic Disease|1
4961424|NCT00216086|17055347|P1|Overall Study|Protocol Violation|1
4961425|NCT00215943|17055379|P2|Overall Study|Other complications|1
4961426|NCT00215943|17055380|P1|Overall Study|Other complications|3
4961427|NCT00215943|17055379|P2|Overall Study|Other disease|1
4961428|NCT00215943|17055380|P1|Overall Study|Other disease|0
4961429|NCT00215943|17055379|P2|Overall Study|Adverse Event|6
4961430|NCT00215943|17055380|P1|Overall Study|Adverse Event|3
4961431|NCT00215943|17055379|P2|Overall Study|Alternate therapy|1
4961432|NCT00215943|17055380|P1|Overall Study|Alternate therapy|0
4961433|NCT00215943|17055379|P2|Overall Study|Disease Progression|5
4961434|NCT00215943|17055380|P1|Overall Study|Disease Progression|3
4961435|NCT00215683|17055405|P3|Overall Study|Intermittent therapy required|0
4961436|NCT00215683|17055406|P2|Overall Study|Intermittent therapy required|1
4961437|NCT00215683|17055407|P1|Overall Study|Intermittent therapy required|0
4961438|NCT00215683|17055405|P3|Overall Study|No study drug available|0
4961439|NCT00215683|17055406|P2|Overall Study|No study drug available|1
4961440|NCT00215683|17055407|P1|Overall Study|No study drug available|0
4961441|NCT00215683|17055405|P3|Overall Study|Difficult to attend visits|0
4961442|NCT00215683|17055406|P2|Overall Study|Difficult to attend visits|1
4961443|NCT00215683|17055407|P1|Overall Study|Difficult to attend visits|0
4961444|NCT00215683|17055405|P3|Overall Study|Physician Decision|1
4961445|NCT00215683|17055406|P2|Overall Study|Physician Decision|0
4961446|NCT00215683|17055407|P1|Overall Study|Physician Decision|0
4961447|NCT00215683|17055405|P3|Overall Study|Withdrawal by Subject|13
4961448|NCT00215683|17055406|P2|Overall Study|Withdrawal by Subject|4
4961449|NCT00215683|17055407|P1|Overall Study|Withdrawal by Subject|9
4961450|NCT00215683|17055405|P3|Overall Study|Lost to Follow-up|1
4961451|NCT00215683|17055406|P2|Overall Study|Lost to Follow-up|2
4961452|NCT00215683|17055407|P1|Overall Study|Lost to Follow-up|0
4961453|NCT00215683|17055405|P3|Overall Study|Lack of Efficacy|2
4961454|NCT00215683|17055406|P2|Overall Study|Lack of Efficacy|1
4961455|NCT00215683|17055407|P1|Overall Study|Lack of Efficacy|5
4961456|NCT00215683|17055405|P3|Overall Study|Adverse Event|15
4961457|NCT00215683|17055406|P2|Overall Study|Adverse Event|16
4961458|NCT00215683|17055407|P1|Overall Study|Adverse Event|15
4961459|NCT00215657|17055426|P8|Overall Study|Other|1
4961460|NCT00215657|17055427|P7|Overall Study|Other|6
4961461|NCT00215657|17055428|P6|Overall Study|Other|4
4961462|NCT00215657|17055429|P5|Overall Study|Other|5
4961463|NCT00215657|17055430|P4|Overall Study|Other|3
4961464|NCT00215657|17055431|P3|Overall Study|Other|2
4961465|NCT00215657|17055432|P2|Overall Study|Other|1
4961466|NCT00215657|17055433|P1|Overall Study|Other|3
4961467|NCT00215657|17055426|P8|Overall Study|Insufficient testosterone response|7
4961468|NCT00215657|17055427|P7|Overall Study|Insufficient testosterone response|4
4961469|NCT00215657|17055428|P6|Overall Study|Insufficient testosterone response|12
4961470|NCT00215657|17055429|P5|Overall Study|Insufficient testosterone response|8
4961471|NCT00215657|17055430|P4|Overall Study|Insufficient testosterone response|12
4961472|NCT00215657|17055431|P3|Overall Study|Insufficient testosterone response|1
4961473|NCT00215657|17055432|P2|Overall Study|Insufficient testosterone response|4
4961474|NCT00215657|17055433|P1|Overall Study|Insufficient testosterone response|5
4961475|NCT00215657|17055426|P8|Overall Study|Insuff prostate specific antigen resp|2
4961476|NCT00215657|17055427|P7|Overall Study|Insuff prostate specific antigen resp|3
4961477|NCT00215657|17055428|P6|Overall Study|Insuff prostate specific antigen resp|2
4961478|NCT00215657|17055429|P5|Overall Study|Insuff prostate specific antigen resp|1
4961479|NCT00215657|17055430|P4|Overall Study|Insuff prostate specific antigen resp|2
4961480|NCT00215657|17055431|P3|Overall Study|Insuff prostate specific antigen resp|2
4961481|NCT00215657|17055432|P2|Overall Study|Insuff prostate specific antigen resp|2
4961482|NCT00215657|17055433|P1|Overall Study|Insuff prostate specific antigen resp|3
4961483|NCT00215657|17055426|P8|Overall Study|Withdrawal by Subject|3
4961484|NCT00215657|17055427|P7|Overall Study|Withdrawal by Subject|10
4961485|NCT00215657|17055428|P6|Overall Study|Withdrawal by Subject|1
4961486|NCT00215657|17055429|P5|Overall Study|Withdrawal by Subject|6
4961487|NCT00215657|17055430|P4|Overall Study|Withdrawal by Subject|1
4961488|NCT00215657|17055431|P3|Overall Study|Withdrawal by Subject|3
4961489|NCT00215657|17055432|P2|Overall Study|Withdrawal by Subject|3
4961490|NCT00215657|17055433|P1|Overall Study|Withdrawal by Subject|6
4961491|NCT00215657|17055426|P8|Overall Study|Adverse Event|3
4961492|NCT00215657|17055427|P7|Overall Study|Adverse Event|0
4961493|NCT00215657|17055428|P6|Overall Study|Adverse Event|1
4961494|NCT00215657|17055429|P5|Overall Study|Adverse Event|3
4961495|NCT00215657|17055430|P4|Overall Study|Adverse Event|0
4961496|NCT00215657|17055431|P3|Overall Study|Adverse Event|3
4961497|NCT00215657|17055432|P2|Overall Study|Adverse Event|1
4961498|NCT00215657|17055433|P1|Overall Study|Adverse Event|5
4961499|NCT00215644|17055461|P2|Overall Study|Randomized but Not Treated|0
4961500|NCT00215644|17055462|P1|Overall Study|Randomized but Not Treated|1
4961501|NCT00215644|17055461|P2|Overall Study|Other|15
4961502|NCT00215644|17055462|P1|Overall Study|Other|3
4961503|NCT00215644|17055461|P2|Overall Study|Withdrawal by Subject|0
4961504|NCT00215644|17055462|P1|Overall Study|Withdrawal by Subject|1
4961505|NCT00215644|17055461|P2|Overall Study|Death|2
4961506|NCT00215644|17055462|P1|Overall Study|Death|1
4961507|NCT00215644|17055461|P2|Overall Study|Adverse Event|9
4961508|NCT00215644|17055462|P1|Overall Study|Adverse Event|2
4961509|NCT00215644|17055461|P2|Overall Study|Disease Progression|10
4961510|NCT00215644|17055462|P1|Overall Study|Disease Progression|28
4961511|NCT00215553|17055489|P7|Overall Study|Adverse Event|0
4961512|NCT00215553|17055490|P6|Overall Study|Adverse Event|6
4961513|NCT00215553|17055491|P5|Overall Study|Adverse Event|2
4961514|NCT00215553|17055492|P4|Overall Study|Adverse Event|1
4961515|NCT00215553|17055493|P3|Overall Study|Adverse Event|2
4961516|NCT00215553|17055494|P2|Overall Study|Adverse Event|1
4961517|NCT00215553|17055495|P1|Overall Study|Adverse Event|0
4961518|NCT00215540|17055528|P3|Overall Study|Withdrew from study medication|0
4961519|NCT00215540|17055529|P2|Overall Study|Withdrew from study medication|0
4961520|NCT00215540|17055530|P1|Overall Study|Withdrew from study medication|1
4961521|NCT00215150|17055565|P1|Randomization Phase Placebo|Withdrawal by Subject|1
4961522|NCT00215150|17055565|P1|Randomization Phase Ziprasidone|Withdrawal by Subject|1
4961523|NCT00215150|17055565|P1|Randomization Phase Ziprasidone|Lost to Follow-up|2
4961524|NCT00215150|17055565|P1|Open Label Phase|Did not meet randomization criteria|9
4961525|NCT00215150|17055565|P1|Open Label Phase|Did not complete a post base visit|13
4961526|NCT00215150|17055565|P1|Open Label Phase|Withdrawal by Subject|1
4961527|NCT00215150|17055565|P1|Open Label Phase|Lost to Follow-up|7
4961528|NCT00215137|17055573|P3|Randomization Period|Withdrawal by Subject|0
4961529|NCT00215137|17055574|P2|Randomization Period|Withdrawal by Subject|1
4961530|NCT00215137|17055575|P1|Randomization Period|Withdrawal by Subject|0
4961531|NCT00215137|17055573|P3|Randomization Period|Lost to Follow-up|0
4961532|NCT00215137|17055574|P2|Randomization Period|Lost to Follow-up|1
4961533|NCT00215137|17055575|P1|Randomization Period|Lost to Follow-up|0
4961534|NCT00215137|17055573|P3|Open Label Escitalopram|Lack of Efficacy|0
4961535|NCT00215137|17055574|P2|Open Label Escitalopram|Lack of Efficacy|0
4961536|NCT00215137|17055575|P1|Open Label Escitalopram|Lack of Efficacy|1
4961537|NCT00214500|17055673|P1|Extension Period|Withdrawal by Subject|2
4961538|NCT00214500|17055673|P1|Treatment Period|Adverse Event|1
4961539|NCT00214461|17055694|P4|Overall Study|Withdrawal by Subject|0
4961540|NCT00214461|17055695|P3|Overall Study|Withdrawal by Subject|1
4961541|NCT00214461|17055696|P2|Overall Study|Withdrawal by Subject|0
4961542|NCT00214461|17055697|P1|Overall Study|Withdrawal by Subject|0
4961543|NCT00214461|17055694|P4|Overall Study|Adverse Event|1
4961544|NCT00214461|17055695|P3|Overall Study|Adverse Event|1
4961545|NCT00214461|17055696|P2|Overall Study|Adverse Event|0
4961546|NCT00214461|17055697|P1|Overall Study|Adverse Event|0
4961547|NCT00214422|17055714|P3|Overall Study|Unable to make a radiation treatment|1
4961548|NCT00214422|17055715|P2|Overall Study|Unable to make a radiation treatment|0
4961549|NCT00214422|17055716|P1|Overall Study|Unable to make a radiation treatment|0
4961550|NCT00214422|17055714|P3|Overall Study|Disease progression on study|0
4961551|NCT00214422|17055715|P2|Overall Study|Disease progression on study|0
4961552|NCT00214422|17055716|P1|Overall Study|Disease progression on study|1
4961553|NCT00214422|17055714|P3|Overall Study|Pt taken off study|0
4961554|NCT00214422|17055715|P2|Overall Study|Pt taken off study|1
4961555|NCT00214422|17055716|P1|Overall Study|Pt taken off study|1
4961556|NCT00214422|17055714|P3|Overall Study|Developed esophageal ca|0
4961557|NCT00214422|17055715|P2|Overall Study|Developed esophageal ca|0
4961558|NCT00214422|17055716|P1|Overall Study|Developed esophageal ca|1
4961559|NCT00214422|17055714|P3|Overall Study|Physician Decision|0
4961560|NCT00214422|17055715|P2|Overall Study|Physician Decision|0
4961561|NCT00214422|17055716|P1|Overall Study|Physician Decision|2
4961562|NCT00214383|17055739|P2|Overall Study|Lost to Follow-up|26
4961563|NCT00214383|17055740|P1|Overall Study|Lost to Follow-up|16
4961564|NCT00214201|17055752|P2|Overall Study|Death|2
4961565|NCT00214201|17055753|P1|Overall Study|Death|0
4961566|NCT00214201|17055752|P2|Overall Study|Withdrawal by Subject|0
4961567|NCT00214201|17055753|P1|Overall Study|Withdrawal by Subject|2
4961568|NCT00214136|17055768|P1|Overall Study|Death|5
4961569|NCT00214019|17055813|P1|Overall Study|Screen Failed prior to randomization|17
4961570|NCT00214019|17055813|P1|Overall Study|Withdrawal by Subject|2
4961571|NCT00214019|17055813|P1|Overall Study|Lost to Follow-up|11
4961572|NCT00213980|17055822|P2|Overall Study|Failed to obtain all 3 DXAs|3
4961573|NCT00213980|17055823|P1|Overall Study|Failed to obtain all 3 DXAs|1
4961574|NCT00213980|17055822|P2|Overall Study|Developed ovarian cancer|0
4961575|NCT00213980|17055823|P1|Overall Study|Developed ovarian cancer|1
4961576|NCT00213980|17055822|P2|Overall Study|Disease progression|2
4961577|NCT00213980|17055823|P1|Overall Study|Disease progression|0
4961578|NCT00213980|17055822|P2|Overall Study|Adverse Event|1
4961579|NCT00213980|17055823|P1|Overall Study|Adverse Event|1
4961580|NCT00213980|17055822|P2|Overall Study|Withdrawal by Subject|1
4961581|NCT00213980|17055823|P1|Overall Study|Withdrawal by Subject|3
4961582|NCT00213148|17055850|P5|Cycle 3 (1 Month)|Other|0
4961583|NCT00213148|17055851|P4|Cycle 3 (1 Month)|Other|1
4961584|NCT00213148|17055852|P3|Cycle 3 (1 Month)|Other|1
4961585|NCT00213148|17055853|P2|Cycle 3 (1 Month)|Other|0
4961586|NCT00213148|17055854|P1|Cycle 3 (1 Month)|Other|0
4961587|NCT00213148|17055850|P5|Cycle 3 (1 Month)|Lost to Follow-up|1
4961588|NCT00213148|17055851|P4|Cycle 3 (1 Month)|Lost to Follow-up|0
4961589|NCT00213148|17055852|P3|Cycle 3 (1 Month)|Lost to Follow-up|0
4961590|NCT00213148|17055853|P2|Cycle 3 (1 Month)|Lost to Follow-up|2
4961591|NCT00213148|17055854|P1|Cycle 3 (1 Month)|Lost to Follow-up|0
4961592|NCT00213148|17055850|P5|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6
4961593|NCT00213148|17055851|P4|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
4961594|NCT00213148|17055852|P3|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3
4961595|NCT00213148|17055853|P2|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1
4961596|NCT00213148|17055854|P1|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10
4961597|NCT00213148|17055850|P5|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4961598|NCT00213148|17055851|P4|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4961599|NCT00213148|17055852|P3|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4961600|NCT00213148|17055853|P2|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0
4961601|NCT00213148|17055854|P1|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1
4961602|NCT00213148|17055850|P5|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4961603|NCT00213148|17055851|P4|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4961604|NCT00213148|17055852|P3|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4961605|NCT00213148|17055853|P2|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1
4961606|NCT00213148|17055854|P1|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0
4961607|NCT00213148|17055850|P5|Cycle 2 (1 Month)|Other|7
4961608|NCT00213148|17055851|P4|Cycle 2 (1 Month)|Other|8
4961609|NCT00213148|17055852|P3|Cycle 2 (1 Month)|Other|2
4961610|NCT00213148|17055853|P2|Cycle 2 (1 Month)|Other|1
4961611|NCT00213148|17055854|P1|Cycle 2 (1 Month)|Other|2
4961612|NCT00213148|17055850|P5|Cycle 2 (1 Month)|Lack of Efficacy|16
4961613|NCT00213148|17055851|P4|Cycle 2 (1 Month)|Lack of Efficacy|6
4961614|NCT00213148|17055852|P3|Cycle 2 (1 Month)|Lack of Efficacy|7
4961615|NCT00213148|17055853|P2|Cycle 2 (1 Month)|Lack of Efficacy|3
4961616|NCT00213148|17055854|P1|Cycle 2 (1 Month)|Lack of Efficacy|1
4961617|NCT00213148|17055850|P5|Cycle 2 (1 Month)|Lost to Follow-up|1
4961618|NCT00213148|17055851|P4|Cycle 2 (1 Month)|Lost to Follow-up|2
4961619|NCT00213148|17055852|P3|Cycle 2 (1 Month)|Lost to Follow-up|2
4961620|NCT00213148|17055853|P2|Cycle 2 (1 Month)|Lost to Follow-up|0
4961621|NCT00213148|17055854|P1|Cycle 2 (1 Month)|Lost to Follow-up|0
4961622|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
4961623|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8
4961624|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5
4961625|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0
4961626|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15
4961627|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1
4961628|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4961629|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4961630|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4961631|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0
4961632|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4961633|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1
4961634|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4961635|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4961636|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0
4961637|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Other|7
4961638|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Other|2
4961639|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Other|2
4961640|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Other|0
4961641|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Other|3
4961642|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Protocol Violation|0
4961643|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Protocol Violation|0
4961644|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Protocol Violation|1
4961645|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Protocol Violation|0
4961646|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Protocol Violation|1
4961647|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Lack of Efficacy|8
4961648|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Lack of Efficacy|5
4961649|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Lack of Efficacy|8
4961650|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Lack of Efficacy|0
4961651|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Lack of Efficacy|4
4961652|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Adverse Event|0
4961653|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Adverse Event|0
4961654|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Adverse Event|1
4961655|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Adverse Event|0
4961656|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Adverse Event|0
4961657|NCT00213148|17055850|P5|Cycle 1 (1 Month)|Lost to Follow-up|1
4961658|NCT00213148|17055851|P4|Cycle 1 (1 Month)|Lost to Follow-up|2
4961659|NCT00213148|17055852|P3|Cycle 1 (1 Month)|Lost to Follow-up|2
4961660|NCT00213148|17055853|P2|Cycle 1 (1 Month)|Lost to Follow-up|0
4961661|NCT00213148|17055854|P1|Cycle 1 (1 Month)|Lost to Follow-up|1
4961662|NCT00213135|17055881|P3|Overall Study|Other|15
4961663|NCT00213135|17055882|P2|Overall Study|Other|12
4961664|NCT00213135|17055883|P1|Overall Study|Other|21
4961665|NCT00213135|17055881|P3|Overall Study|Disease progression|21
4961666|NCT00213135|17055882|P2|Overall Study|Disease progression|5
4961667|NCT00213135|17055883|P1|Overall Study|Disease progression|4
4961668|NCT00213135|17055881|P3|Overall Study|Death|2
4961669|NCT00213135|17055882|P2|Overall Study|Death|1
4961670|NCT00213135|17055883|P1|Overall Study|Death|1
4961671|NCT00213135|17055881|P3|Overall Study|Protocol Violation|10
4961672|NCT00213135|17055882|P2|Overall Study|Protocol Violation|4
4961673|NCT00213135|17055883|P1|Overall Study|Protocol Violation|4
4961674|NCT00213135|17055881|P3|Overall Study|Lost to Follow-up|4
4961675|NCT00213135|17055882|P2|Overall Study|Lost to Follow-up|8
4961676|NCT00213135|17055883|P1|Overall Study|Lost to Follow-up|11
4961677|NCT00213135|17055881|P3|Overall Study|Adverse Event|5
4961678|NCT00213135|17055882|P2|Overall Study|Adverse Event|5
4961679|NCT00213135|17055883|P1|Overall Study|Adverse Event|9
4961680|NCT00212758|17055926|P2|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
4961681|NCT00212758|17055927|P1|Standard Therapy of GH (12 Months)|Lost to Follow-up|1
4961682|NCT00212758|17055926|P2|Standard Therapy of GH (12 Months)|Adverse Event|0
4961683|NCT00212758|17055927|P1|Standard Therapy of GH (12 Months)|Adverse Event|1
4961684|NCT00212355|17055943|P1|Overall Study|A change of address|1
4961685|NCT00212355|17055943|P1|Overall Study|Withdrawal by Subject|1
4961686|NCT00212355|17055943|P1|Overall Study|Adverse Event|1
4961687|NCT00212134|17055964|P2|Phase 3 (Age 10 Years)|On Going|21
4961688|NCT00212134|17055965|P1|Phase 3 (Age 10 Years)|On Going|21
4961689|NCT00211887|17055986|P3|Overall Study|Side effects|5
4961690|NCT00211887|17055987|P2|Overall Study|Side effects|13
4961691|NCT00211887|17055988|P1|Overall Study|Side effects|19
4961692|NCT00211887|17055986|P3|Overall Study|Other medical reason|7
4961693|NCT00211887|17055987|P2|Overall Study|Other medical reason|11
4961694|NCT00211887|17055988|P1|Overall Study|Other medical reason|15
4961695|NCT00211887|17055986|P3|Overall Study|Non-medical reason|8
4961696|NCT00211887|17055987|P2|Overall Study|Non-medical reason|14
4961697|NCT00211887|17055988|P1|Overall Study|Non-medical reason|31
4961698|NCT00211887|17055986|P3|Overall Study|Lost to Follow-up|9
4961699|NCT00211887|17055987|P2|Overall Study|Lost to Follow-up|13
4961700|NCT00211887|17055988|P1|Overall Study|Lost to Follow-up|28
4961701|NCT00211887|17055986|P3|Overall Study|Death|1
4961702|NCT00211887|17055987|P2|Overall Study|Death|1
4961703|NCT00211887|17055988|P1|Overall Study|Death|1
4961704|NCT00211887|17055986|P3|Overall Study|Adverse Event|6
4961705|NCT00211887|17055987|P2|Overall Study|Adverse Event|4
4961706|NCT00211887|17055988|P1|Overall Study|Adverse Event|8
4961707|NCT00211809|17056005|P1|Overall Study|side effects|2
4961708|NCT00211809|17056005|P1|Overall Study|Pregnancy|1
4961709|NCT00211809|17056005|P1|Overall Study|Lost to Follow-up|2
4961710|NCT00211809|17056005|P1|Overall Study|Lack of Efficacy|1
4961711|NCT00211757|17056021|P2|Overall Study|Lack of Efficacy|1
4961712|NCT00211757|17056022|P1|Overall Study|Lack of Efficacy|0
4961713|NCT00211757|17056021|P2|Overall Study|Withdrawal by Subject|1
4961714|NCT00211757|17056022|P1|Overall Study|Withdrawal by Subject|1
4961715|NCT00211536|17056043|P2|Overall Study|Adverse Event|0
4961716|NCT00211536|17056044|P1|Overall Study|Adverse Event|2
4961717|NCT00211536|17056043|P2|Overall Study|Physician Decision|5
4961718|NCT00211536|17056044|P1|Overall Study|Physician Decision|0
4961719|NCT00211536|17056043|P2|Overall Study|Withdrawal by Subject|2
4961720|NCT00211536|17056044|P1|Overall Study|Withdrawal by Subject|2
4961721|NCT00211510|17056060|P2|Overall Study|Withdrawal by Subject|1
4961722|NCT00211510|17056061|P1|Overall Study|Withdrawal by Subject|3
4961723|NCT00211510|17056060|P2|Overall Study|Physician Decision|1
4961724|NCT00211510|17056061|P1|Overall Study|Physician Decision|3
4961725|NCT00211237|17056079|P3|12 Months|unrelated medical problem|1
4961726|NCT00211237|17056080|P2|12 Months|unrelated medical problem|0
4961727|NCT00211237|17056081|P1|12 Months|unrelated medical problem|0
4961728|NCT00211237|17056079|P3|12 Months|Withdrew|1
4961729|NCT00211237|17056080|P2|12 Months|Withdrew|0
4961730|NCT00211237|17056081|P1|12 Months|Withdrew|0
4961731|NCT00211237|17056079|P3|12 Months|Lost to Follow-up|1
4961732|NCT00211237|17056080|P2|12 Months|Lost to Follow-up|0
4961733|NCT00211237|17056081|P1|12 Months|Lost to Follow-up|1
4961734|NCT00211237|17056079|P3|12 Months|Death|3
4961735|NCT00211237|17056080|P2|12 Months|Death|2
4961736|NCT00211237|17056081|P1|12 Months|Death|8
4961737|NCT00211237|17056079|P3|6 Months|Could not comply with protocol|0
4961738|NCT00211237|17056080|P2|6 Months|Could not comply with protocol|2
4961739|NCT00211237|17056081|P1|6 Months|Could not comply with protocol|0
4961740|NCT00211237|17056079|P3|6 Months|Lost to Follow-up|0
4961741|NCT00211237|17056080|P2|6 Months|Lost to Follow-up|0
4961742|NCT00211237|17056081|P1|6 Months|Lost to Follow-up|2
4961743|NCT00211237|17056079|P3|6 Months|Death|3
4961744|NCT00211237|17056080|P2|6 Months|Death|0
4961745|NCT00211237|17056081|P1|6 Months|Death|6
4961746|NCT00211237|17056079|P3|3 Months|Non-medical problem|1
4961747|NCT00211237|17056080|P2|3 Months|Non-medical problem|0
4961748|NCT00211237|17056081|P1|3 Months|Non-medical problem|0
4961749|NCT00211237|17056079|P3|3 Months|Withdrew|0
4961750|NCT00211237|17056080|P2|3 Months|Withdrew|1
4961751|NCT00211237|17056081|P1|3 Months|Withdrew|0
4961752|NCT00211237|17056079|P3|3 Months|Could not comply with protocol|0
4961753|NCT00211237|17056080|P2|3 Months|Could not comply with protocol|0
4961754|NCT00211237|17056081|P1|3 Months|Could not comply with protocol|1
4961755|NCT00211237|17056079|P3|3 Months|Death|0
4961756|NCT00211237|17056080|P2|3 Months|Death|3
4961757|NCT00211237|17056081|P1|3 Months|Death|7
4961758|NCT00211237|17056079|P3|1 Month|Non-medical problem|0
4961759|NCT00211237|17056080|P2|1 Month|Non-medical problem|2
4961760|NCT00211237|17056081|P1|1 Month|Non-medical problem|0
4961761|NCT00211237|17056079|P3|1 Month|Additional surgery needed|0
4961762|NCT00211237|17056080|P2|1 Month|Additional surgery needed|0
4961763|NCT00211237|17056081|P1|1 Month|Additional surgery needed|1
4961764|NCT00211237|17056079|P3|1 Month|Withdrew|0
4961765|NCT00211237|17056080|P2|1 Month|Withdrew|4
4961766|NCT00211237|17056081|P1|1 Month|Withdrew|0
4961767|NCT00211237|17056079|P3|1 Month|Lost to Follow-up|0
4961768|NCT00211237|17056080|P2|1 Month|Lost to Follow-up|2
4961769|NCT00211237|17056081|P1|1 Month|Lost to Follow-up|0
4961770|NCT00211237|17056079|P3|1 Month|Death|0
4961771|NCT00211237|17056080|P2|1 Month|Death|1
4961772|NCT00211237|17056081|P1|1 Month|Death|2
4961773|NCT00211237|17056079|P3|Baseline|Refused random assignment|0
4961774|NCT00211237|17056080|P2|Baseline|Refused random assignment|0
4961775|NCT00211237|17056081|P1|Baseline|Refused random assignment|1
4961776|NCT00211237|17056079|P3|Baseline|Withdrew|0
4961777|NCT00211237|17056080|P2|Baseline|Withdrew|3
4961778|NCT00211237|17056081|P1|Baseline|Withdrew|1
4961779|NCT00211185|17056171|P1|Overall Study|Physician Decision|5
4961780|NCT00211185|17056171|P1|Overall Study|Withdrawal by Subject|6
4961781|NCT00211185|17056171|P1|Overall Study|Disease progression|7
4961782|NCT00211185|17056171|P1|Overall Study|Death|2
4961783|NCT00211172|17056185|P2|Overall Study|Died or lost health plan eligibility|32
4961784|NCT00211172|17056186|P1|Overall Study|Died or lost health plan eligibility|39
4961785|NCT00211081|17056192|P1|Overall Study|Withdrawal by Subject|2
4961786|NCT00210639|17056204|P2|Overall Study|Other|12
4961787|NCT00210639|17056205|P1|Overall Study|Other|18
4961788|NCT00210639|17056204|P2|Overall Study|Withdrawal by Subject|1
4961789|NCT00210639|17056205|P1|Overall Study|Withdrawal by Subject|8
4961790|NCT00210639|17056204|P2|Overall Study|Lost to Follow-up|29
4961791|NCT00210639|17056205|P1|Overall Study|Lost to Follow-up|37
4961792|NCT00210626|17056213|P2|Overall Study|Other|5
4961793|NCT00210626|17056214|P1|Overall Study|Other|4
4961794|NCT00210626|17056213|P2|Overall Study|Sponser Request|0
4961795|NCT00210626|17056214|P1|Overall Study|Sponser Request|1
4961796|NCT00210626|17056213|P2|Overall Study|Physician Decision|2
4961797|NCT00210626|17056214|P1|Overall Study|Physician Decision|0
4961798|NCT00210626|17056213|P2|Overall Study|Withdrawal by Subject|20
4961799|NCT00210626|17056214|P1|Overall Study|Withdrawal by Subject|29
4961800|NCT00210626|17056213|P2|Overall Study|Death|0
4961801|NCT00210626|17056214|P1|Overall Study|Death|1
4961802|NCT00210626|17056213|P2|Overall Study|Lost to Follow-up|11
4961803|NCT00210626|17056214|P1|Overall Study|Lost to Follow-up|11
4961804|NCT00210626|17056213|P2|Overall Study|Protocol Violation|5
4961805|NCT00210626|17056214|P1|Overall Study|Protocol Violation|1
4961806|NCT00210626|17056213|P2|Overall Study|Adverse Event|2
4961807|NCT00210626|17056214|P1|Overall Study|Adverse Event|1
4961808|NCT00210470|17056222|P1|Overall Study|Subject did not continue to surgery|1
4961809|NCT00209560|17056253|P2|Overall Study|Lack of Efficacy|0
4961810|NCT00209560|17056254|P1|Overall Study|Lack of Efficacy|1
4961811|NCT00209339|17056273|P1|At 5 Years Follow-up|Death|1
4961812|NCT00209339|17056273|P1|At 5 Years Follow-up|Withdrawal because of other reasons|5
4961813|NCT00209339|17056273|P1|At 5 Years Follow-up|Withdrawal by Subject|2
4961814|NCT00209339|17056273|P1|At 4 Years Follow-up|Death|1
4961815|NCT00209339|17056273|P1|At 4 Years Follow-up|Withdrawal by Subject|4
4961816|NCT00209339|17056273|P1|At 3 Years Follow-up|Withdrawal by Subject|1
4961817|NCT00209339|17056273|P1|At 24 Months Follow-up|Death|1
4961818|NCT00209339|17056273|P1|At 24 Months Follow-up|Withdrawal because of other reasons|6
4961819|NCT00209339|17056273|P1|At 24 Months Follow-up|Withdrawal by Subject|4
4961820|NCT00209339|17056273|P1|At 12 Months Follow-up|No MitraClip Device Implanted|6
4961821|NCT00209339|17056273|P1|At 12 Months Follow-up|Death|1
4961822|NCT00209339|17056273|P1|At 12 Months Follow-up|Withdrawal by Subject|8
4961823|NCT00209274|17056357|P2|Overall Study|Randomized not treated (RNT)|15
4961824|NCT00209274|17056358|P1|Overall Study|Randomized not treated (RNT)|6
4961825|NCT00209274|17056357|P2|Overall Study|Withdrawal by Subject|15
4961826|NCT00209274|17056358|P1|Overall Study|Withdrawal by Subject|30
4961827|NCT00209274|17056357|P2|Overall Study|Death|15
4961828|NCT00209274|17056358|P1|Overall Study|Death|32
4961829|NCT00209274|17056357|P2|Overall Study|Missed visit|2
4961830|NCT00209274|17056358|P1|Overall Study|Missed visit|3
4961831|NCT00209170|17056678|P2|Overall Study|Lack of Efficacy|1
4961832|NCT00209170|17056679|P1|Overall Study|Lack of Efficacy|0
4961833|NCT00209170|17056678|P2|Overall Study|Withdrawal by Subject|1
4961834|NCT00209170|17056679|P1|Overall Study|Withdrawal by Subject|2
4961835|NCT00209170|17056678|P2|Overall Study|Adverse Event|1
4961836|NCT00209170|17056679|P1|Overall Study|Adverse Event|0
4961837|NCT00209131|17056687|P2|Overall Study|Lack of personnel due to turnovers.|11
4961838|NCT00209131|17056688|P1|Overall Study|Lack of personnel due to turnovers.|15
4961839|NCT00209092|17056698|P2|Overall Study|Withdrawal by Subject|0
4961840|NCT00209092|17056699|P1|Overall Study|Withdrawal by Subject|1
4961841|NCT00209092|17056698|P2|Overall Study|Adverse Event|1
4961842|NCT00209092|17056699|P1|Overall Study|Adverse Event|0
4961843|NCT00209092|17056698|P2|Overall Study|Progression of disease|1
4961844|NCT00209092|17056699|P1|Overall Study|Progression of disease|7
4961845|NCT00209027|17056709|P2|Overall Study|study terminated|0
4961846|NCT00209027|17056710|P1|Overall Study|study terminated|10
4961847|NCT00208767|17056734|P2|Overall Study|Lost to Follow-up|3
4961848|NCT00208767|17056735|P1|Overall Study|Lost to Follow-up|3
4961849|NCT00208767|17056734|P2|Overall Study|Death|0
4961850|NCT00208767|17056735|P1|Overall Study|Death|1
4961851|NCT00208767|17056734|P2|Overall Study|Withdrawal by Subject|3
4961852|NCT00208767|17056735|P1|Overall Study|Withdrawal by Subject|14
4961853|NCT00208767|17056734|P2|Overall Study|Adverse Event|1
4961854|NCT00208767|17056735|P1|Overall Study|Adverse Event|9
4961855|NCT00208325|17056763|P4|Overall Study|Mis-Randomized|0
4961856|NCT00208325|17056764|P3|Overall Study|Mis-Randomized|0
4961857|NCT00208325|17056765|P2|Overall Study|Mis-Randomized|20
4961858|NCT00208325|17056766|P1|Overall Study|Mis-Randomized|17
4961859|NCT00208325|17056763|P4|Overall Study|Other|0
4961860|NCT00208325|17056764|P3|Overall Study|Other|1
4961861|NCT00208325|17056765|P2|Overall Study|Other|1
4961862|NCT00208325|17056766|P1|Overall Study|Other|2
4961863|NCT00208325|17056763|P4|Overall Study|Does not wish to Continue in Study|2
4961864|NCT00208325|17056764|P3|Overall Study|Does not wish to Continue in Study|3
4961865|NCT00208325|17056765|P2|Overall Study|Does not wish to Continue in Study|8
4961866|NCT00208325|17056766|P1|Overall Study|Does not wish to Continue in Study|5
4961867|NCT00208325|17056763|P4|Overall Study|Unsurfaced to Resurfaced Patella|3
4961868|NCT00208325|17056764|P3|Overall Study|Unsurfaced to Resurfaced Patella|1
4961869|NCT00208325|17056765|P2|Overall Study|Unsurfaced to Resurfaced Patella|4
4961870|NCT00208325|17056766|P1|Overall Study|Unsurfaced to Resurfaced Patella|4
4961871|NCT00208325|17056763|P4|Overall Study|Lost to Follow-up|0
4961872|NCT00208325|17056764|P3|Overall Study|Lost to Follow-up|2
4961873|NCT00208325|17056765|P2|Overall Study|Lost to Follow-up|0
4961874|NCT00208325|17056766|P1|Overall Study|Lost to Follow-up|1
4961875|NCT00208325|17056763|P4|Overall Study|Revision|4
4961876|NCT00208325|17056764|P3|Overall Study|Revision|0
4961877|NCT00208325|17056765|P2|Overall Study|Revision|1
4961878|NCT00208325|17056766|P1|Overall Study|Revision|4
4961879|NCT00208325|17056763|P4|Overall Study|Withdrawal by Subject|0
4961880|NCT00208325|17056764|P3|Overall Study|Withdrawal by Subject|0
4961881|NCT00208325|17056765|P2|Overall Study|Withdrawal by Subject|1
4961882|NCT00208325|17056766|P1|Overall Study|Withdrawal by Subject|0
4961883|NCT00208325|17056763|P4|Overall Study|Death|5
4961884|NCT00208325|17056764|P3|Overall Study|Death|7
4961885|NCT00208325|17056765|P2|Overall Study|Death|19
4961886|NCT00208325|17056766|P1|Overall Study|Death|18
4961887|NCT00207740|17056903|P4|Overall Study|Other|5
4961888|NCT00207740|17056904|P3|Overall Study|Other|7
4961889|NCT00207740|17056905|P2|Overall Study|Other|10
4961890|NCT00207740|17056906|P1|Overall Study|Other|2
4961891|NCT00207740|17056903|P4|Overall Study|Sponsor Directive|21
4961892|NCT00207740|17056904|P3|Overall Study|Sponsor Directive|16
4961893|NCT00207740|17056905|P2|Overall Study|Sponsor Directive|15
4961894|NCT00207740|17056906|P1|Overall Study|Sponsor Directive|22
4961895|NCT00207740|17056903|P4|Overall Study|Death|1
4961896|NCT00207740|17056904|P3|Overall Study|Death|0
4961897|NCT00207740|17056905|P2|Overall Study|Death|0
4961898|NCT00207740|17056906|P1|Overall Study|Death|0
4961899|NCT00207740|17056903|P4|Overall Study|Lost to Follow-up|1
4961900|NCT00207740|17056904|P3|Overall Study|Lost to Follow-up|1
4961901|NCT00207740|17056905|P2|Overall Study|Lost to Follow-up|2
4961902|NCT00207740|17056906|P1|Overall Study|Lost to Follow-up|0
4961903|NCT00207740|17056903|P4|Overall Study|Unsatisfactory therapeutic effect|4
4961904|NCT00207740|17056904|P3|Overall Study|Unsatisfactory therapeutic effect|2
4961905|NCT00207740|17056905|P2|Overall Study|Unsatisfactory therapeutic effect|0
4961906|NCT00207740|17056906|P1|Overall Study|Unsatisfactory therapeutic effect|1
4961907|NCT00207740|17056903|P4|Overall Study|Adverse Event|11
4961908|NCT00207740|17056904|P3|Overall Study|Adverse Event|14
4961909|NCT00207740|17056905|P2|Overall Study|Adverse Event|14
4961910|NCT00207740|17056906|P1|Overall Study|Adverse Event|4
4961911|NCT00207727|17056952|P5|Overall Study|Other|33
4961912|NCT00207727|17056953|P4|Overall Study|Other|37
4961913|NCT00207727|17056954|P3|Overall Study|Other|41
4961914|NCT00207727|17056955|P2|Overall Study|Other|41
4961915|NCT00207727|17056956|P1|Overall Study|Other|38
4961916|NCT00207727|17056952|P5|Overall Study|Lost to Follow-up|0
4961917|NCT00207727|17056953|P4|Overall Study|Lost to Follow-up|0
4961918|NCT00207727|17056954|P3|Overall Study|Lost to Follow-up|0
4961919|NCT00207727|17056955|P2|Overall Study|Lost to Follow-up|1
4961920|NCT00207727|17056956|P1|Overall Study|Lost to Follow-up|0
4961921|NCT00207727|17056952|P5|Overall Study|Withdrawal by Subject|1
4961922|NCT00207727|17056953|P4|Overall Study|Withdrawal by Subject|0
4961923|NCT00207727|17056954|P3|Overall Study|Withdrawal by Subject|0
4961924|NCT00207727|17056955|P2|Overall Study|Withdrawal by Subject|0
4961925|NCT00207727|17056956|P1|Overall Study|Withdrawal by Subject|0
4961926|NCT00207714|17056983|P5|Overall Study|Other|0
4961927|NCT00207714|17056984|P4|Overall Study|Other|1
4961928|NCT00207714|17056985|P3|Overall Study|Other|5
4961929|NCT00207714|17056986|P2|Overall Study|Other|2
4961930|NCT00207714|17056987|P1|Overall Study|Other|3
4961931|NCT00207714|17056983|P5|Overall Study|Unsatisfactory therapeutic effect|4
4961932|NCT00207714|17056984|P4|Overall Study|Unsatisfactory therapeutic effect|4
4961933|NCT00207714|17056985|P3|Overall Study|Unsatisfactory therapeutic effect|1
4961934|NCT00207714|17056986|P2|Overall Study|Unsatisfactory therapeutic effect|3
4961935|NCT00207714|17056987|P1|Overall Study|Unsatisfactory therapeutic effect|5
4961936|NCT00207714|17056983|P5|Overall Study|Adverse Event|1
4961937|NCT00207714|17056984|P4|Overall Study|Adverse Event|3
4961938|NCT00207714|17056985|P3|Overall Study|Adverse Event|4
4961939|NCT00207714|17056986|P2|Overall Study|Adverse Event|2
4961940|NCT00207714|17056987|P1|Overall Study|Adverse Event|6
4961941|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Lack of Efficacy|1
4961942|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
4961943|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
4961944|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Lack of Efficacy|0
4961945|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Death|1
4961946|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Death|0
4961947|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Death|0
4961948|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Death|0
4961949|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1
4961950|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
4961951|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2
4961952|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0
4961953|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
4961954|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1
4961955|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
4961956|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0
4961957|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Pregnancy|0
4961958|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Pregnancy|2
4961959|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Pregnancy|2
4961960|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Pregnancy|0
4961961|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
4961962|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Poor/noncompliance|2
4961963|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Poor/noncompliance|3
4961964|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Poor/noncompliance|0
4961965|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|RTV intake impossible|0
4961966|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|RTV intake impossible|1
4961967|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|RTV intake impossible|0
4961968|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|RTV intake impossible|0
4961969|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Lost to Follow-up|2
4961970|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
4961971|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Lost to Follow-up|1
4961972|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Lost to Follow-up|0
4961973|NCT00207142|17057009|P4|Maintenance Phase/Rescue Phase|Adverse Event|1
4961974|NCT00207142|17057010|P3|Maintenance Phase/Rescue Phase|Adverse Event|4
4961975|NCT00207142|17057011|P2|Maintenance Phase/Rescue Phase|Adverse Event|1
4961976|NCT00207142|17057012|P1|Maintenance Phase/Rescue Phase|Adverse Event|0
4961977|NCT00207142|17057009|P4|Induction Phase|Missing lab data|0
4961978|NCT00207142|17057010|P3|Induction Phase|Missing lab data|0
4961979|NCT00207142|17057011|P2|Induction Phase|Missing lab data|0
4961980|NCT00207142|17057012|P1|Induction Phase|Missing lab data|1
4961981|NCT00207142|17057009|P4|Induction Phase|Incarceration|0
4961982|NCT00207142|17057010|P3|Induction Phase|Incarceration|0
4961983|NCT00207142|17057011|P2|Induction Phase|Incarceration|0
4961984|NCT00207142|17057012|P1|Induction Phase|Incarceration|1
4961985|NCT00207142|17057009|P4|Induction Phase|Withdrawal by Subject|0
4961986|NCT00207142|17057010|P3|Induction Phase|Withdrawal by Subject|0
4961987|NCT00207142|17057011|P2|Induction Phase|Withdrawal by Subject|0
4961988|NCT00207142|17057012|P1|Induction Phase|Withdrawal by Subject|4
4961989|NCT00207142|17057009|P4|Induction Phase|Subject no longer meets study criteria|0
4961990|NCT00207142|17057010|P3|Induction Phase|Subject no longer meets study criteria|0
4961991|NCT00207142|17057011|P2|Induction Phase|Subject no longer meets study criteria|0
4961992|NCT00207142|17057012|P1|Induction Phase|Subject no longer meets study criteria|3
4961993|NCT00207142|17057009|P4|Induction Phase|Pregnancy|0
4961994|NCT00207142|17057010|P3|Induction Phase|Pregnancy|0
4961995|NCT00207142|17057011|P2|Induction Phase|Pregnancy|0
4961996|NCT00207142|17057012|P1|Induction Phase|Pregnancy|1
4961997|NCT00207142|17057009|P4|Induction Phase|Poor/noncompliance|0
4961998|NCT00207142|17057010|P3|Induction Phase|Poor/noncompliance|0
4961999|NCT00207142|17057011|P2|Induction Phase|Poor/noncompliance|0
4962000|NCT00207142|17057012|P1|Induction Phase|Poor/noncompliance|2
4962001|NCT00207142|17057009|P4|Induction Phase|Physician Decision|0
4962002|NCT00207142|17057010|P3|Induction Phase|Physician Decision|0
4962003|NCT00207142|17057011|P2|Induction Phase|Physician Decision|0
4962004|NCT00207142|17057012|P1|Induction Phase|Physician Decision|2
4962005|NCT00207142|17057009|P4|Induction Phase|Lost to Follow-up|0
4962006|NCT00207142|17057010|P3|Induction Phase|Lost to Follow-up|0
4962007|NCT00207142|17057011|P2|Induction Phase|Lost to Follow-up|0
4962008|NCT00207142|17057012|P1|Induction Phase|Lost to Follow-up|5
4962009|NCT00207142|17057009|P4|Induction Phase|Lack of Efficacy|0
4962010|NCT00207142|17057010|P3|Induction Phase|Lack of Efficacy|0
4962011|NCT00207142|17057011|P2|Induction Phase|Lack of Efficacy|0
4962012|NCT00207142|17057012|P1|Induction Phase|Lack of Efficacy|1
4962013|NCT00207142|17057009|P4|Induction Phase|Death|0
4962014|NCT00207142|17057010|P3|Induction Phase|Death|0
4962015|NCT00207142|17057011|P2|Induction Phase|Death|0
4962016|NCT00207142|17057012|P1|Induction Phase|Death|1
4962017|NCT00207142|17057009|P4|Induction Phase|Adverse Event|0
4962018|NCT00207142|17057010|P3|Induction Phase|Adverse Event|0
4962019|NCT00207142|17057011|P2|Induction Phase|Adverse Event|0
4962020|NCT00207142|17057012|P1|Induction Phase|Adverse Event|9
4962021|NCT00207090|17057049|P1|Overall Study|Physician Decision|1
4962022|NCT00207090|17057049|P1|Overall Study|Disease progression/relapse|2
4962023|NCT00207090|17057049|P1|Overall Study|Chest wall mass larger|1
4962024|NCT00207090|17057049|P1|Overall Study|Study drug toxicity|3
4962025|NCT00206726|17057078|P1|Overall Study|Withdrawal by Subject|8
4962026|NCT00206726|17057078|P1|Overall Study|Protocol Violation|1
4962027|NCT00206726|17057078|P1|Overall Study|Death|4
4962028|NCT00206726|17057078|P1|Overall Study|Adverse Event|17
4962029|NCT00206726|17057078|P1|Overall Study|Bone marrow transplant|1
4962030|NCT00206726|17057078|P1|Overall Study|Placed on new protocol|1
4962031|NCT00206726|17057078|P1|Overall Study|Progressive disease or relapsed disease|18
4962032|NCT00206726|17057078|P1|Overall Study|Delayed recovery of blood counts|1
4962033|NCT00206518|17057089|P2|Overall Study|Protocol Violation|1
4962034|NCT00206518|17057090|P1|Overall Study|Protocol Violation|1
4962035|NCT00206518|17057089|P2|Overall Study|Physician Decision|0
4962036|NCT00206518|17057090|P1|Overall Study|Physician Decision|1
4962037|NCT00206518|17057089|P2|Overall Study|Adverse Event|1
4962038|NCT00206518|17057090|P1|Overall Study|Adverse Event|2
4962039|NCT00206518|17057089|P2|Overall Study|Lack of Efficacy|4
4962040|NCT00206518|17057090|P1|Overall Study|Lack of Efficacy|6
4962041|NCT00206440|17057102|P2|Overall Study|Adverse Event|2
4962042|NCT00206440|17057103|P1|Overall Study|Adverse Event|4
4962043|NCT00206440|17057102|P2|Overall Study|Protocol Violation|2
4962044|NCT00206440|17057103|P1|Overall Study|Protocol Violation|1
4962045|NCT00206427|17057109|P1|Overall Study|Adverse Event|2
4962046|NCT00206323|17057119|P2|Overall Study|Lost to Follow-up|1
4962047|NCT00206323|17057120|P1|Overall Study|Lost to Follow-up|1
4962048|NCT00206323|17057119|P2|Overall Study|Adverse Event|1
4962049|NCT00206323|17057120|P1|Overall Study|Adverse Event|1
4962050|NCT00206323|17057119|P2|Overall Study|Lack of Efficacy|1
4962051|NCT00206323|17057120|P1|Overall Study|Lack of Efficacy|4
4962052|NCT00206102|17057128|P2|Overall Study|None of those categories|36
4962053|NCT00206102|17057129|P1|Overall Study|None of those categories|42
4962054|NCT00206102|17057128|P2|Overall Study|Study-specific discontinuation criteria|17
4962055|NCT00206102|17057129|P1|Overall Study|Study-specific discontinuation criteria|18
4962056|NCT00206102|17057128|P2|Overall Study|Withdrawal by Subject|101
4962057|NCT00206102|17057129|P1|Overall Study|Withdrawal by Subject|118
4962058|NCT00206102|17057128|P2|Overall Study|Lost to Follow-up|66
4962059|NCT00206102|17057129|P1|Overall Study|Lost to Follow-up|95
4962060|NCT00206102|17057128|P2|Overall Study|Lack of therapeutic response|11
4962061|NCT00206102|17057129|P1|Overall Study|Lack of therapeutic response|16
4962062|NCT00206102|17057128|P2|Overall Study|Protocol Violation|2
4962063|NCT00206102|17057129|P1|Overall Study|Protocol Violation|0
4962064|NCT00206102|17057128|P2|Overall Study|Adverse Event|82
4962065|NCT00206102|17057129|P1|Overall Study|Adverse Event|119
4962066|NCT00206076|17057165|P2|Overall Study|Withdrawal by Subject|1
4962067|NCT00206076|17057166|P1|Overall Study|Withdrawal by Subject|1
4962068|NCT00206076|17057165|P2|Overall Study|Physician Decision|0
4962069|NCT00206076|17057166|P1|Overall Study|Physician Decision|2
4962070|NCT00205881|17057176|P1|Overall Study|Withdrawal by Subject|16
4962071|NCT00205855|17057181|P1|Overall Study|Withdrawal by Subject|5
4962072|NCT00205855|17057181|P1|Overall Study|Only received temporary implants|16
4962073|NCT00205803|17057187|P2|Toddler Dose|Lost to Follow-up|3
4962074|NCT00205803|17057188|P1|Toddler Dose|Lost to Follow-up|2
4962075|NCT00205803|17057187|P2|After Infant Series|Other|4
4962076|NCT00205803|17057188|P1|After Infant Series|Other|10
4962077|NCT00205803|17057187|P2|After Infant Series|Withdrawal by Subject|4
4962078|NCT00205803|17057188|P1|After Infant Series|Withdrawal by Subject|1
4962079|NCT00205803|17057187|P2|After Infant Series|Physician Decision|2
4962080|NCT00205803|17057188|P1|After Infant Series|Physician Decision|3
4962081|NCT00205803|17057187|P2|After Infant Series|Lost to Follow-up|1
4962082|NCT00205803|17057188|P1|After Infant Series|Lost to Follow-up|2
4962083|NCT00205803|17057187|P2|After Infant Series|Protocol Violation|1
4962084|NCT00205803|17057188|P1|After Infant Series|Protocol Violation|1
4962085|NCT00205803|17057187|P2|After Infant Series|Adverse Event|1
4962086|NCT00205803|17057188|P1|After Infant Series|Adverse Event|1
4962087|NCT00205803|17057187|P2|Infant Series|Sponsor request|0
4962088|NCT00205803|17057188|P1|Infant Series|Sponsor request|1
4962089|NCT00205803|17057187|P2|Infant Series|Non-compliant|0
4962090|NCT00205803|17057188|P1|Infant Series|Non-compliant|1
4962091|NCT00205803|17057187|P2|Infant Series|Lost Kaiser coverage|1
4962092|NCT00205803|17057188|P1|Infant Series|Lost Kaiser coverage|0
4962093|NCT00205803|17057187|P2|Infant Series|Protocol Violation|0
4962094|NCT00205803|17057188|P1|Infant Series|Protocol Violation|1
4962095|NCT00205803|17057187|P2|Infant Series|Physician Decision|1
4962096|NCT00205803|17057188|P1|Infant Series|Physician Decision|3
4962097|NCT00205803|17057187|P2|Infant Series|Withdrawal by Subject|5
4962098|NCT00205803|17057188|P1|Infant Series|Withdrawal by Subject|2
4962099|NCT00205803|17057187|P2|Infant Series|Lost to Follow-up|4
4962100|NCT00205803|17057188|P1|Infant Series|Lost to Follow-up|10
4962101|NCT00205777|17057244|P6|Study Extension II|Enrolled but not treated|131
4962102|NCT00205777|17057245|P5|Study Extension II|Enrolled but not treated|0
4962103|NCT00205777|17057246|P4|Study Extension II|Enrolled but not treated|71
4962104|NCT00205777|17057247|P3|Study Extension II|Enrolled but not treated|0
4962105|NCT00205777|17057248|P2|Study Extension II|Enrolled but not treated|0
4962106|NCT00205777|17057249|P1|Study Extension II|Enrolled but not treated|0
4962107|NCT00205777|17057244|P6|Study Extension II|Other Event|20
4962108|NCT00205777|17057245|P5|Study Extension II|Other Event|0
4962109|NCT00205777|17057246|P4|Study Extension II|Other Event|12
4962110|NCT00205777|17057247|P3|Study Extension II|Other Event|0
4962111|NCT00205777|17057248|P2|Study Extension II|Other Event|0
4962112|NCT00205777|17057249|P1|Study Extension II|Other Event|0
4962113|NCT00205777|17057244|P6|Study Extension II|Failed to return|26
4962114|NCT00205777|17057245|P5|Study Extension II|Failed to return|0
4962115|NCT00205777|17057246|P4|Study Extension II|Failed to return|14
4962116|NCT00205777|17057247|P3|Study Extension II|Failed to return|0
4962117|NCT00205777|17057248|P2|Study Extension II|Failed to return|0
4962118|NCT00205777|17057249|P1|Study Extension II|Failed to return|0
4962119|NCT00205777|17057244|P6|Study Extension II|Lack of Efficacy|1
4962120|NCT00205777|17057245|P5|Study Extension II|Lack of Efficacy|0
4962121|NCT00205777|17057246|P4|Study Extension II|Lack of Efficacy|0
4962122|NCT00205777|17057247|P3|Study Extension II|Lack of Efficacy|0
4962123|NCT00205777|17057248|P2|Study Extension II|Lack of Efficacy|0
4962124|NCT00205777|17057249|P1|Study Extension II|Lack of Efficacy|0
4962125|NCT00205777|17057244|P6|Study Extension II|Protocol Violation|10
4962126|NCT00205777|17057245|P5|Study Extension II|Protocol Violation|0
4962127|NCT00205777|17057246|P4|Study Extension II|Protocol Violation|1
4962128|NCT00205777|17057247|P3|Study Extension II|Protocol Violation|0
4962129|NCT00205777|17057248|P2|Study Extension II|Protocol Violation|0
4962130|NCT00205777|17057249|P1|Study Extension II|Protocol Violation|0
4962131|NCT00205777|17057244|P6|Study Extension II|Withdrawal by Subject|59
4962132|NCT00205777|17057245|P5|Study Extension II|Withdrawal by Subject|0
4962133|NCT00205777|17057246|P4|Study Extension II|Withdrawal by Subject|35
4962134|NCT00205777|17057247|P3|Study Extension II|Withdrawal by Subject|0
4962135|NCT00205777|17057248|P2|Study Extension II|Withdrawal by Subject|0
4962136|NCT00205777|17057249|P1|Study Extension II|Withdrawal by Subject|0
4962137|NCT00205777|17057244|P6|Study Extension II|Death|5
4962138|NCT00205777|17057245|P5|Study Extension II|Death|0
4962139|NCT00205777|17057246|P4|Study Extension II|Death|2
4962140|NCT00205777|17057247|P3|Study Extension II|Death|0
4962141|NCT00205777|17057248|P2|Study Extension II|Death|0
4962142|NCT00205777|17057249|P1|Study Extension II|Death|0
4962143|NCT00205777|17057244|P6|Study Extension II|Adverse Event|30
4962144|NCT00205777|17057245|P5|Study Extension II|Adverse Event|0
4962145|NCT00205777|17057246|P4|Study Extension II|Adverse Event|14
4962146|NCT00205777|17057247|P3|Study Extension II|Adverse Event|0
4962147|NCT00205777|17057248|P2|Study Extension II|Adverse Event|0
4962148|NCT00205777|17057249|P1|Study Extension II|Adverse Event|0
4962149|NCT00205777|17057244|P6|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
4962150|NCT00205777|17057245|P5|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258
4962151|NCT00205777|17057246|P4|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240
4962152|NCT00205777|17057247|P3|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
4962320|NCT00203996|17057680|P3|Overall Study|Protocol Violation|0
4962153|NCT00205777|17057248|P2|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0
4962154|NCT00205777|17057249|P1|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273
4962155|NCT00205777|17057244|P6|Study Extension I|Withdrawn as per protocol|0
4962156|NCT00205777|17057245|P5|Study Extension I|Withdrawn as per protocol|0
4962157|NCT00205777|17057246|P4|Study Extension I|Withdrawn as per protocol|0
4962158|NCT00205777|17057247|P3|Study Extension I|Withdrawn as per protocol|1070
4962159|NCT00205777|17057248|P2|Study Extension I|Withdrawn as per protocol|0
4962160|NCT00205777|17057249|P1|Study Extension I|Withdrawn as per protocol|0
4962161|NCT00205777|17057244|P6|Study Extension I|Other Event|0
4962162|NCT00205777|17057245|P5|Study Extension I|Other Event|29
4962163|NCT00205777|17057246|P4|Study Extension I|Other Event|34
4962164|NCT00205777|17057247|P3|Study Extension I|Other Event|0
4962165|NCT00205777|17057248|P2|Study Extension I|Other Event|0
4962166|NCT00205777|17057249|P1|Study Extension I|Other Event|34
4962167|NCT00205777|17057244|P6|Study Extension I|Failed to return|0
4962168|NCT00205777|17057245|P5|Study Extension I|Failed to return|13
4962169|NCT00205777|17057246|P4|Study Extension I|Failed to return|17
4962170|NCT00205777|17057247|P3|Study Extension I|Failed to return|0
4962171|NCT00205777|17057248|P2|Study Extension I|Failed to return|0
4962172|NCT00205777|17057249|P1|Study Extension I|Failed to return|15
4962173|NCT00205777|17057244|P6|Study Extension I|Lack of Efficacy|0
4962174|NCT00205777|17057245|P5|Study Extension I|Lack of Efficacy|2
4962175|NCT00205777|17057246|P4|Study Extension I|Lack of Efficacy|1
4962176|NCT00205777|17057247|P3|Study Extension I|Lack of Efficacy|0
4962177|NCT00205777|17057248|P2|Study Extension I|Lack of Efficacy|0
4962178|NCT00205777|17057249|P1|Study Extension I|Lack of Efficacy|0
4962179|NCT00205777|17057244|P6|Study Extension I|Protocol Violation|0
4962180|NCT00205777|17057245|P5|Study Extension I|Protocol Violation|8
4962181|NCT00205777|17057246|P4|Study Extension I|Protocol Violation|8
4962182|NCT00205777|17057247|P3|Study Extension I|Protocol Violation|0
4962183|NCT00205777|17057248|P2|Study Extension I|Protocol Violation|0
4962184|NCT00205777|17057249|P1|Study Extension I|Protocol Violation|4
4962185|NCT00205777|17057244|P6|Study Extension I|Withdrawal by Subject|0
4962186|NCT00205777|17057245|P5|Study Extension I|Withdrawal by Subject|89
4962187|NCT00205777|17057246|P4|Study Extension I|Withdrawal by Subject|106
4962188|NCT00205777|17057247|P3|Study Extension I|Withdrawal by Subject|0
4962189|NCT00205777|17057248|P2|Study Extension I|Withdrawal by Subject|0
4962190|NCT00205777|17057249|P1|Study Extension I|Withdrawal by Subject|99
4962191|NCT00205777|17057244|P6|Study Extension I|Death|0
4962192|NCT00205777|17057245|P5|Study Extension I|Death|2
4962193|NCT00205777|17057246|P4|Study Extension I|Death|1
4962194|NCT00205777|17057247|P3|Study Extension I|Death|0
4962195|NCT00205777|17057248|P2|Study Extension I|Death|0
4962196|NCT00205777|17057249|P1|Study Extension I|Death|5
4962197|NCT00205777|17057244|P6|Study Extension I|Adverse Event|0
4962198|NCT00205777|17057245|P5|Study Extension I|Adverse Event|58
4962199|NCT00205777|17057246|P4|Study Extension I|Adverse Event|61
4962200|NCT00205777|17057247|P3|Study Extension I|Adverse Event|0
4962201|NCT00205777|17057248|P2|Study Extension I|Adverse Event|0
4962202|NCT00205777|17057249|P1|Study Extension I|Adverse Event|57
4962203|NCT00205777|17057244|P6|Completed Core Study, Entered SE I|Other Event|0
4962204|NCT00205777|17057245|P5|Completed Core Study, Entered SE I|Other Event|0
4962205|NCT00205777|17057246|P4|Completed Core Study, Entered SE I|Other Event|50
4962206|NCT00205777|17057247|P3|Completed Core Study, Entered SE I|Other Event|47
4962207|NCT00205777|17057248|P2|Completed Core Study, Entered SE I|Other Event|46
4962208|NCT00205777|17057249|P1|Completed Core Study, Entered SE I|Other Event|52
4962209|NCT00205777|17057244|P6|Completed Core Study, Entered SE I|Withdrawal by Subject|0
4962210|NCT00205777|17057245|P5|Completed Core Study, Entered SE I|Withdrawal by Subject|0
4962211|NCT00205777|17057246|P4|Completed Core Study, Entered SE I|Withdrawal by Subject|174
4962212|NCT00205777|17057247|P3|Completed Core Study, Entered SE I|Withdrawal by Subject|160
4962213|NCT00205777|17057248|P2|Completed Core Study, Entered SE I|Withdrawal by Subject|158
4962214|NCT00205777|17057249|P1|Completed Core Study, Entered SE I|Withdrawal by Subject|180
4962215|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Randomized but not treated|0
4962216|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Randomized but not treated|0
4962217|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Randomized but not treated|29
4962218|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Randomized but not treated|35
4962219|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Randomized but not treated|32
4962220|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Randomized but not treated|21
4962221|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Lack of Efficacy|0
4962222|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Lack of Efficacy|0
4962223|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Lack of Efficacy|75
4962224|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Lack of Efficacy|39
4962225|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Lack of Efficacy|52
4962226|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Lack of Efficacy|52
4962227|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Protocol Violation|0
4962228|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Protocol Violation|0
4962229|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Protocol Violation|42
4962230|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Protocol Violation|50
4962231|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Protocol Violation|55
4962232|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Protocol Violation|53
4962233|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Withdrawal by Subject|0
4962234|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Withdrawal by Subject|0
4962235|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Withdrawal by Subject|162
4962236|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Withdrawal by Subject|149
4962237|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Withdrawal by Subject|169
4962238|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Withdrawal by Subject|144
4962239|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Other Event|0
4962240|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Other Event|0
4962241|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Other Event|58
4962242|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Other Event|41
4962243|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Other Event|52
4962244|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Other Event|49
4962245|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Failed to return|0
4962246|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Failed to return|0
4962247|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Failed to return|27
4962248|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Failed to return|27
4962249|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Failed to return|25
4962250|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Failed to return|40
4962251|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Death|0
4962252|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Death|0
4962253|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Death|7
4962254|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Death|14
4962255|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Death|7
4962256|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Death|9
4962257|NCT00205777|17057244|P6|Core Study (Up to 3 Years)|Adverse Event|0
4962258|NCT00205777|17057245|P5|Core Study (Up to 3 Years)|Adverse Event|0
4962259|NCT00205777|17057246|P4|Core Study (Up to 3 Years)|Adverse Event|232
4962260|NCT00205777|17057247|P3|Core Study (Up to 3 Years)|Adverse Event|252
4962261|NCT00205777|17057248|P2|Core Study (Up to 3 Years)|Adverse Event|267
4962262|NCT00205777|17057249|P1|Core Study (Up to 3 Years)|Adverse Event|260
4962263|NCT00205712|17057458|P2|Overall Study|Lost to Follow-up|1
4962264|NCT00205712|17057459|P1|Overall Study|Lost to Follow-up|0
4962265|NCT00205699|17057472|P3|Overall Study|Lack of Efficacy|0
4962266|NCT00205699|17057473|P2|Overall Study|Lack of Efficacy|1
4962267|NCT00205699|17057474|P1|Overall Study|Lack of Efficacy|0
4962268|NCT00205699|17057472|P3|Overall Study|Withdrawal by Subject|1
4962269|NCT00205699|17057473|P2|Overall Study|Withdrawal by Subject|2
4962270|NCT00205699|17057474|P1|Overall Study|Withdrawal by Subject|1
4962271|NCT00205699|17057472|P3|Overall Study|Adverse Event|0
4962272|NCT00205699|17057473|P2|Overall Study|Adverse Event|0
4962273|NCT00205699|17057474|P1|Overall Study|Adverse Event|1
4962274|NCT00205699|17057472|P3|Overall Study|Lost to Follow-up|5
4962275|NCT00205699|17057473|P2|Overall Study|Lost to Follow-up|3
4962276|NCT00205699|17057474|P1|Overall Study|Lost to Follow-up|1
4962277|NCT00205179|17057554|P2|Overall Study|Adverse Event|1
4962278|NCT00205179|17057555|P1|Overall Study|Adverse Event|1
4962279|NCT00205179|17057554|P2|Overall Study|Physician Decision|1
4962280|NCT00205179|17057555|P1|Overall Study|Physician Decision|1
4962281|NCT00205179|17057554|P2|Overall Study|Death|2
4962282|NCT00205179|17057555|P1|Overall Study|Death|0
4962283|NCT00203996|17057673|P10|Overall Study|Scheduling issue|0
4962284|NCT00203996|17057674|P9|Overall Study|Scheduling issue|0
4962285|NCT00203996|17057675|P8|Overall Study|Scheduling issue|2
4962286|NCT00203996|17057676|P7|Overall Study|Scheduling issue|0
4962287|NCT00203996|17057677|P6|Overall Study|Scheduling issue|0
4962288|NCT00203996|17057678|P5|Overall Study|Scheduling issue|0
4962289|NCT00203996|17057679|P4|Overall Study|Scheduling issue|0
4962290|NCT00203996|17057680|P3|Overall Study|Scheduling issue|0
4962291|NCT00203996|17057681|P2|Overall Study|Scheduling issue|0
4962292|NCT00203996|17057682|P1|Overall Study|Scheduling issue|0
4962293|NCT00203996|17057673|P10|Overall Study|CPAP machine malfunction|0
4962294|NCT00203996|17057674|P9|Overall Study|CPAP machine malfunction|0
4962295|NCT00203996|17057675|P8|Overall Study|CPAP machine malfunction|0
4962296|NCT00203996|17057676|P7|Overall Study|CPAP machine malfunction|0
4962297|NCT00203996|17057677|P6|Overall Study|CPAP machine malfunction|0
4962298|NCT00203996|17057678|P5|Overall Study|CPAP machine malfunction|0
4962299|NCT00203996|17057679|P4|Overall Study|CPAP machine malfunction|1
4962300|NCT00203996|17057680|P3|Overall Study|CPAP machine malfunction|0
4962301|NCT00203996|17057681|P2|Overall Study|CPAP machine malfunction|0
4962302|NCT00203996|17057682|P1|Overall Study|CPAP machine malfunction|0
4962303|NCT00203996|17057673|P10|Overall Study|Physician Decision|1
4962304|NCT00203996|17057674|P9|Overall Study|Physician Decision|0
4962305|NCT00203996|17057675|P8|Overall Study|Physician Decision|0
4962306|NCT00203996|17057676|P7|Overall Study|Physician Decision|0
4962307|NCT00203996|17057677|P6|Overall Study|Physician Decision|0
4962308|NCT00203996|17057678|P5|Overall Study|Physician Decision|0
4962309|NCT00203996|17057679|P4|Overall Study|Physician Decision|2
4962310|NCT00203996|17057680|P3|Overall Study|Physician Decision|0
4962311|NCT00203996|17057681|P2|Overall Study|Physician Decision|0
4962312|NCT00203996|17057682|P1|Overall Study|Physician Decision|0
4962313|NCT00203996|17057673|P10|Overall Study|Protocol Violation|0
4962314|NCT00203996|17057674|P9|Overall Study|Protocol Violation|0
4962315|NCT00203996|17057675|P8|Overall Study|Protocol Violation|0
4962316|NCT00203996|17057676|P7|Overall Study|Protocol Violation|0
4962317|NCT00203996|17057677|P6|Overall Study|Protocol Violation|0
4962318|NCT00203996|17057678|P5|Overall Study|Protocol Violation|1
4962319|NCT00203996|17057679|P4|Overall Study|Protocol Violation|6
4962321|NCT00203996|17057681|P2|Overall Study|Protocol Violation|0
4962322|NCT00203996|17057682|P1|Overall Study|Protocol Violation|0
4962323|NCT00203996|17057673|P10|Overall Study|Lost to Follow-up|0
4962324|NCT00203996|17057674|P9|Overall Study|Lost to Follow-up|0
4962325|NCT00203996|17057675|P8|Overall Study|Lost to Follow-up|0
4962326|NCT00203996|17057676|P7|Overall Study|Lost to Follow-up|0
4962327|NCT00203996|17057677|P6|Overall Study|Lost to Follow-up|0
4962328|NCT00203996|17057678|P5|Overall Study|Lost to Follow-up|0
4962329|NCT00203996|17057679|P4|Overall Study|Lost to Follow-up|1
4962330|NCT00203996|17057680|P3|Overall Study|Lost to Follow-up|0
4962331|NCT00203996|17057681|P2|Overall Study|Lost to Follow-up|0
4962332|NCT00203996|17057682|P1|Overall Study|Lost to Follow-up|0
4962333|NCT00203892|17057749|P3|Overall Study|Death|0
4962334|NCT00203892|17057750|P2|Overall Study|Death|0
4962335|NCT00203892|17057751|P1|Overall Study|Death|1
4962336|NCT00203892|17057749|P3|Overall Study|Physician Decision|0
4962337|NCT00203892|17057750|P2|Overall Study|Physician Decision|2
4962338|NCT00203892|17057751|P1|Overall Study|Physician Decision|1
4962339|NCT00203502|17057762|P1|Overall Study|Death|1
4962340|NCT00203476|17057773|P3|Overall Study|Withdrawal by Subject|0
4962341|NCT00203476|17057774|P2|Overall Study|Withdrawal by Subject|1
4962342|NCT00203476|17057775|P1|Overall Study|Withdrawal by Subject|0
4962343|NCT00203476|17057773|P3|Overall Study|Lost to Follow-up|0
4962344|NCT00203476|17057774|P2|Overall Study|Lost to Follow-up|0
4962345|NCT00203476|17057775|P1|Overall Study|Lost to Follow-up|1
4962346|NCT00203424|17057792|P1|Follow-up Period|Lost to Follow-up|1
4962347|NCT00203424|17057792|P1|Follow-up Period|progressive disease|4
4962348|NCT00203424|17057792|P1|Follow-up Period|Withdrawal by Subject|1
4962349|NCT00203424|17057792|P1|Treatment Period|progressive disease|2
4962350|NCT00203424|17057792|P1|Treatment Period|Adverse Event|5
4962351|NCT00203424|17057792|P1|Treatment Period|Withdrawal by Subject|4
4962352|NCT00203411|17057799|P1|Follow-up|Progressive Disease|4
4962353|NCT00203307|17057808|P2|First Intervention|Adverse Event|0
4962354|NCT00203307|17057809|P1|First Intervention|Adverse Event|2
4962355|NCT00203294|17057817|P2|Overall Study|Withdrawal by Subject|13
4962356|NCT00203294|17057818|P1|Overall Study|Withdrawal by Subject|8
4962357|NCT00203268|17057824|P1|Early Treatment|Withdrawal by Subject|1
4962358|NCT00203268|17057824|P1|Early Treatment|Lost to Follow-up|1
4962359|NCT00203268|17057824|P1|Early Treatment|only treated one headache|2
4962360|NCT00203242|17057830|P1|Overall Study|Lost to Follow-up|1
4962361|NCT00203047|17057882|P2|Overall Study|Other|5
4962362|NCT00203047|17057883|P1|Overall Study|Other|5
4962363|NCT00203047|17057882|P2|Overall Study|Pregnancy|0
4962364|NCT00203047|17057883|P1|Overall Study|Pregnancy|3
4962365|NCT00203047|17057882|P2|Overall Study|Death|2
4962366|NCT00203047|17057883|P1|Overall Study|Death|1
4962367|NCT00203047|17057882|P2|Overall Study|Adverse Event|18
4962368|NCT00203047|17057883|P1|Overall Study|Adverse Event|8
4962369|NCT00203047|17057882|P2|Overall Study|Lost to Follow-up|5
4962370|NCT00203047|17057883|P1|Overall Study|Lost to Follow-up|11
4962371|NCT00203047|17057882|P2|Overall Study|Protocol Violation|0
4962372|NCT00203047|17057883|P1|Overall Study|Protocol Violation|1
4962373|NCT00203047|17057882|P2|Overall Study|Non-compliance|8
4962374|NCT00203047|17057883|P1|Overall Study|Non-compliance|4
4962375|NCT00203047|17057882|P2|Overall Study|Physician Decision|7
4962376|NCT00203047|17057883|P1|Overall Study|Physician Decision|8
4962377|NCT00203047|17057882|P2|Overall Study|Teva requested participant withdrawal|1
4962378|NCT00203047|17057883|P1|Overall Study|Teva requested participant withdrawal|1
4962379|NCT00203047|17057882|P2|Overall Study|Withdrawal by Subject|47
4962380|NCT00203047|17057883|P1|Overall Study|Withdrawal by Subject|13
4962381|NCT00203047|17057882|P2|Overall Study|Ongoing: not in database - Jan 29, 2009|1
4962382|NCT00203047|17057883|P1|Overall Study|Ongoing: not in database - Jan 29, 2009|5
4962383|NCT00203047|17057882|P2|Overall Study|Ongoing: in database - January 29, 2009|109
4962384|NCT00203047|17057883|P1|Overall Study|Ongoing: in database - January 29, 2009|131
4962385|NCT00203021|17057897|P2|Overall Study|Other than specified|16
4962386|NCT00203021|17057898|P1|Overall Study|Other than specified|11
4962387|NCT00203021|17057897|P2|Overall Study|Lost to Follow-up|7
4962388|NCT00203021|17057898|P1|Overall Study|Lost to Follow-up|9
4962389|NCT00203021|17057897|P2|Overall Study|Withdrawal by Subject|48
4962390|NCT00203021|17057898|P1|Overall Study|Withdrawal by Subject|45
4962391|NCT00203021|17057897|P2|Overall Study|Adverse Event|5
4962392|NCT00203021|17057898|P1|Overall Study|Adverse Event|10
4962393|NCT00203021|17057897|P2|Overall Study|Death|1
4962394|NCT00203021|17057898|P1|Overall Study|Death|4
4962395|NCT00202878|17057908|P2|Overall Study|Withdrawal by Subject|808
4962396|NCT00202878|17057909|P1|Overall Study|Withdrawal by Subject|795
4962397|NCT00202878|17057908|P2|Overall Study|Site Closure|36
4962398|NCT00202878|17057909|P1|Overall Study|Site Closure|39
4962399|NCT00202878|17057908|P2|Overall Study|Lost to Follow-up|49
4962400|NCT00202878|17057909|P1|Overall Study|Lost to Follow-up|44
4962401|NCT00202878|17057908|P2|Overall Study|Only Vital Status Known|356
4962402|NCT00202878|17057909|P1|Overall Study|Only Vital Status Known|357
4962403|NCT00202878|17057908|P2|Overall Study|Death|968
4962404|NCT00202878|17057909|P1|Overall Study|Death|964
4962405|NCT00202839|17057923|P2|Overall Study|Lost to Follow-up|2
4962406|NCT00202839|17057924|P1|Overall Study|Lost to Follow-up|3
4962407|NCT00202839|17057923|P2|Overall Study|Protocol Violation|1
4962408|NCT00202839|17057924|P1|Overall Study|Protocol Violation|2
4962409|NCT00202839|17057923|P2|Overall Study|Withdrawal by Subject|2
4962410|NCT00202839|17057924|P1|Overall Study|Withdrawal by Subject|6
4962411|NCT00202839|17057923|P2|Overall Study|Physician Decision|0
4962412|NCT00202839|17057924|P1|Overall Study|Physician Decision|12
4962413|NCT00202839|17057923|P2|Overall Study|Adverse Event|5
4962414|NCT00202839|17057924|P1|Overall Study|Adverse Event|1
4962415|NCT00202644|17057939|P2|Overall Study|Other|1
4962416|NCT00202644|17057940|P1|Overall Study|Other|9
4962417|NCT00202644|17057939|P2|Overall Study|Lost to Follow-up|1
4962418|NCT00202644|17057940|P1|Overall Study|Lost to Follow-up|0
4962419|NCT00202644|17057939|P2|Overall Study|Lack of Efficacy|6
4962420|NCT00202644|17057940|P1|Overall Study|Lack of Efficacy|6
4962421|NCT00202644|17057939|P2|Overall Study|Withdrawal by Subject|6
4962422|NCT00202644|17057940|P1|Overall Study|Withdrawal by Subject|8
4962423|NCT00202644|17057939|P2|Overall Study|Adverse Event|13
4962424|NCT00202644|17057940|P1|Overall Study|Adverse Event|12
4962425|NCT00201851|17058001|P3|Overall Study|Ineligible post enrollment|1
4962426|NCT00201851|17058002|P2|Overall Study|Ineligible post enrollment|1
4962427|NCT00201851|17058003|P1|Overall Study|Ineligible post enrollment|6
4962428|NCT00201851|17058001|P3|Overall Study|Lost to Follow-up|0
4962429|NCT00201851|17058002|P2|Overall Study|Lost to Follow-up|1
4962430|NCT00201851|17058003|P1|Overall Study|Lost to Follow-up|2
4962431|NCT00201643|17058075|P2|Overall Study|Withdrawal by Subject|4
4962432|NCT00201643|17058076|P1|Overall Study|Withdrawal by Subject|5
4962433|NCT00201201|17058140|P2|Overall Study|Withdrawal by Subject|5
4962434|NCT00201201|17058141|P1|Overall Study|Withdrawal by Subject|5
4962435|NCT00201201|17058140|P2|Overall Study|Death|2
4962436|NCT00201201|17058141|P1|Overall Study|Death|0
4962437|NCT00201006|17058179|P3|Overall Study|Adverse Event|1
4962438|NCT00201006|17058180|P2|Overall Study|Adverse Event|0
4962439|NCT00201006|17058181|P1|Overall Study|Adverse Event|1
4962440|NCT00201006|17058179|P3|Overall Study|Withdrawal by Subject|3
4962441|NCT00201006|17058180|P2|Overall Study|Withdrawal by Subject|2
4962442|NCT00201006|17058181|P1|Overall Study|Withdrawal by Subject|7
4962443|NCT00200967|17058191|P2|Run-out Period|Lost to Follow-up|0
4962444|NCT00200967|17058192|P1|Run-out Period|Lost to Follow-up|1
4962445|NCT00200967|17058191|P2|Second Treatment Period|Withdrawal by Subject|2
4962446|NCT00200967|17058192|P1|Second Treatment Period|Withdrawal by Subject|1
4962447|NCT00200967|17058191|P2|Wash-out Period|Lost to Follow-up|1
4962448|NCT00200967|17058192|P1|Wash-out Period|Lost to Follow-up|0
4962449|NCT00200967|17058191|P2|First Treatment Period|Pregnancy|0
4962450|NCT00200967|17058192|P1|First Treatment Period|Pregnancy|1
4962451|NCT00200967|17058191|P2|First Treatment Period|Withdrawal by Subject|1
4962452|NCT00200967|17058192|P1|First Treatment Period|Withdrawal by Subject|5
4962453|NCT00200850|17058242|P3|Overall Study|Adverse Event|2
4962454|NCT00200850|17058243|P2|Overall Study|Adverse Event|1
4962455|NCT00200850|17058244|P1|Overall Study|Adverse Event|1
4962456|NCT00200850|17058242|P3|Overall Study|optic neuritis|1
4962457|NCT00200850|17058243|P2|Overall Study|optic neuritis|0
4962458|NCT00200850|17058244|P1|Overall Study|optic neuritis|0
4962459|NCT00200850|17058242|P3|Overall Study|Poor adherence|1
4962460|NCT00200850|17058243|P2|Overall Study|Poor adherence|0
4962461|NCT00200850|17058244|P1|Overall Study|Poor adherence|0
4962462|NCT00200850|17058242|P3|Overall Study|Pregnancy|1
4962463|NCT00200850|17058243|P2|Overall Study|Pregnancy|0
4962464|NCT00200850|17058244|P1|Overall Study|Pregnancy|0
4962465|NCT00200850|17058242|P3|Overall Study|too busy|0
4962466|NCT00200850|17058243|P2|Overall Study|too busy|0
4962467|NCT00200850|17058244|P1|Overall Study|too busy|1
4962468|NCT00200850|17058242|P3|Overall Study|relocation|1
4962469|NCT00200850|17058243|P2|Overall Study|relocation|0
4962470|NCT00200850|17058244|P1|Overall Study|relocation|1
4962471|NCT00200356|17058265|P2|Overall Study|Nontreatment|0
4962472|NCT00200356|17058266|P1|Overall Study|Nontreatment|1
4962473|NCT00200356|17058265|P2|Overall Study|Protocol Violation|4
4962474|NCT00200356|17058266|P1|Overall Study|Protocol Violation|4
4962475|NCT00200356|17058265|P2|Overall Study|Lack of Efficacy|3
4962476|NCT00200356|17058266|P1|Overall Study|Lack of Efficacy|3
4962477|NCT00200057|17058333|P1|Overall Study|Death|1
4962478|NCT00200057|17058333|P1|Overall Study|Infection|1
4962479|NCT00200057|17058333|P1|Overall Study|Change in medical condition|1
4962480|NCT00200057|17058333|P1|Overall Study|Withdrawal by Subject|1
4962481|NCT00200057|17058333|P1|Overall Study|Exited due to terminal illness of PI|2
4962482|NCT00200057|17058333|P1|Overall Study|Lack of Efficacy|3
4962483|NCT00199875|17058357|P5|Overall Study|Withdrawal by Subject|1
4962484|NCT00199875|17058358|P4|Overall Study|Withdrawal by Subject|0
4962485|NCT00199875|17058359|P3|Overall Study|Withdrawal by Subject|0
4962486|NCT00199875|17058360|P2|Overall Study|Withdrawal by Subject|0
4962487|NCT00199875|17058361|P1|Overall Study|Withdrawal by Subject|0
4962488|NCT00199381|17058383|P1|Overall Study|Study termination by Sponsor|323
4962489|NCT00199381|17058383|P1|Overall Study|Not including due to early termination|37
4962490|NCT00199381|17058383|P1|Overall Study|Lack of Efficacy|27
4962491|NCT00199381|17058383|P1|Overall Study|Protocol Violation|6
4962492|NCT00199381|17058383|P1|Overall Study|Adverse Event|73
4962493|NCT00199381|17058383|P1|Overall Study|Withdrawal by Subject|38
4962494|NCT00198822|17058390|P3|Overall Study|Lost to Follow-up|21
4962495|NCT00198822|17058391|P2|Overall Study|Lost to Follow-up|20
4962496|NCT00198822|17058392|P1|Overall Study|Lost to Follow-up|14
4962497|NCT00198133|17058411|P2|Overall Study|Physician Decision|0
4962498|NCT00198133|17058412|P1|Overall Study|Physician Decision|1
4962499|NCT00198133|17058411|P2|Overall Study|Withdrawal by Subject|0
4962500|NCT00198133|17058412|P1|Overall Study|Withdrawal by Subject|1
4962501|NCT00198133|17058411|P2|Overall Study|Adverse Event|3
4962502|NCT00198133|17058412|P1|Overall Study|Adverse Event|1
4962503|NCT00198133|17058411|P2|Overall Study|Disease progression|5
4962504|NCT00198133|17058412|P1|Overall Study|Disease progression|2
4962505|NCT00198107|17058424|P3|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2
4962506|NCT00198107|17058425|P2|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
4962507|NCT00198107|17058426|P1|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0
4962508|NCT00198107|17058424|P3|Double-Blind Period|Withdrawal by Subject|0
4962509|NCT00198107|17058425|P2|Double-Blind Period|Withdrawal by Subject|1
4962510|NCT00198107|17058426|P1|Double-Blind Period|Withdrawal by Subject|0
4962511|NCT00198107|17058424|P3|Double-Blind Period|Physician Decision|0
4962512|NCT00198107|17058425|P2|Double-Blind Period|Physician Decision|0
4962513|NCT00198107|17058426|P1|Double-Blind Period|Physician Decision|1
4962514|NCT00198107|17058424|P3|Double-Blind Period|Lost to Follow-up|0
4962515|NCT00198107|17058425|P2|Double-Blind Period|Lost to Follow-up|1
4962516|NCT00198107|17058426|P1|Double-Blind Period|Lost to Follow-up|2
4962517|NCT00198107|17058424|P3|Double-Blind Period|Lack of Efficacy|0
4962518|NCT00198107|17058425|P2|Double-Blind Period|Lack of Efficacy|0
4962519|NCT00198107|17058426|P1|Double-Blind Period|Lack of Efficacy|2
4962520|NCT00198107|17058424|P3|Double-Blind Period|Adverse Event|0
4962521|NCT00198107|17058425|P2|Double-Blind Period|Adverse Event|1
4962522|NCT00198107|17058426|P1|Double-Blind Period|Adverse Event|1
4962523|NCT00198029|17058494|P1|Overall Study|Withdrawal by Subject|4
4962524|NCT00197496|17058501|P2|Follow-up|Lost to Follow-up|1
4962525|NCT00197496|17058502|P1|Follow-up|Lost to Follow-up|2
4962526|NCT00197496|17058501|P2|Baseline to Discharge|Protocol Violation|1
4962527|NCT00197496|17058502|P1|Baseline to Discharge|Protocol Violation|0
4962528|NCT00197496|17058501|P2|Baseline to Discharge|Physician Decision|1
4962529|NCT00197496|17058502|P1|Baseline to Discharge|Physician Decision|0
4962530|NCT00197496|17058501|P2|Baseline to Discharge|MRSA|0
4962531|NCT00197496|17058502|P1|Baseline to Discharge|MRSA|1
4962532|NCT00197496|17058501|P2|Baseline to Discharge|not interested|0
4962533|NCT00197496|17058502|P1|Baseline to Discharge|not interested|1
4962534|NCT00197236|17058550|P3|Overall Study|Returned out of specified time window|1
4962535|NCT00197236|17058551|P2|Overall Study|Returned out of specified time window|0
4962536|NCT00197236|17058552|P1|Overall Study|Returned out of specified time window|0
4962537|NCT00197236|17058550|P3|Overall Study|Study drug/medication expiration|3
4962538|NCT00197236|17058551|P2|Overall Study|Study drug/medication expiration|0
4962539|NCT00197236|17058552|P1|Overall Study|Study drug/medication expiration|1
4962540|NCT00197236|17058550|P3|Overall Study|Withdrawal by Subject|11
4962541|NCT00197236|17058551|P2|Overall Study|Withdrawal by Subject|3
4962542|NCT00197236|17058552|P1|Overall Study|Withdrawal by Subject|7
4962543|NCT00197236|17058550|P3|Overall Study|Protocol Violation|1
4962544|NCT00197236|17058551|P2|Overall Study|Protocol Violation|0
4962545|NCT00197236|17058552|P1|Overall Study|Protocol Violation|0
4962546|NCT00197236|17058550|P3|Overall Study|Lost to Follow-up|6
4962547|NCT00197236|17058551|P2|Overall Study|Lost to Follow-up|14
4962548|NCT00197236|17058552|P1|Overall Study|Lost to Follow-up|5
4962549|NCT00197236|17058550|P3|Overall Study|Adverse Event|1
4962550|NCT00197236|17058551|P2|Overall Study|Adverse Event|0
4962551|NCT00197236|17058552|P1|Overall Study|Adverse Event|1
4962552|NCT00197145|17058626|P2|Period 2 : Open Label Phase|Other|0
4962553|NCT00197145|17058627|P1|Period 2 : Open Label Phase|Other|1
4962554|NCT00197145|17058626|P2|Period 2 : Open Label Phase|Were ongoing till data freeze|0
4962555|NCT00197145|17058627|P1|Period 2 : Open Label Phase|Were ongoing till data freeze|3
4962556|NCT00197145|17058626|P2|Period 2 : Open Label Phase|Availability of alternative ART|0
4962557|NCT00197145|17058627|P1|Period 2 : Open Label Phase|Availability of alternative ART|2
4962558|NCT00197145|17058626|P2|Period 2 : Open Label Phase|Protocol defined virological failure|0
4962559|NCT00197145|17058627|P1|Period 2 : Open Label Phase|Protocol defined virological failure|3
4962560|NCT00197145|17058626|P2|Period 2 : Open Label Phase|Insufficient viral load response|0
4962561|NCT00197145|17058627|P1|Period 2 : Open Label Phase|Insufficient viral load response|1
4962562|NCT00197145|17058626|P2|Period 1: Randomized Treatment Phase|Other|2
4962563|NCT00197145|17058627|P1|Period 1: Randomized Treatment Phase|Other|2
4962564|NCT00197145|17058626|P2|Period 1: Randomized Treatment Phase|Sponsor terminated study|8
4962565|NCT00197145|17058627|P1|Period 1: Randomized Treatment Phase|Sponsor terminated study|10
4962566|NCT00197145|17058626|P2|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
4962567|NCT00197145|17058627|P1|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1
4962568|NCT00197106|17058698|P3|Overall Treatment Period|Withdrawal by Subject|2
4962569|NCT00197106|17058699|P2|Overall Treatment Period|Withdrawal by Subject|0
4962570|NCT00197106|17058700|P1|Overall Treatment Period|Withdrawal by Subject|0
4962571|NCT00197106|17058698|P3|Overall Treatment Period|Protocol Violation|2
4962572|NCT00197106|17058699|P2|Overall Treatment Period|Protocol Violation|0
4962573|NCT00197106|17058700|P1|Overall Treatment Period|Protocol Violation|0
4962574|NCT00197106|17058698|P3|Overall Treatment Period|Lost to Follow-up|2
4962575|NCT00197106|17058699|P2|Overall Treatment Period|Lost to Follow-up|0
4962576|NCT00197106|17058700|P1|Overall Treatment Period|Lost to Follow-up|0
4962577|NCT00197106|17058698|P3|Overall Treatment Period|Lack of Efficacy|0
4962578|NCT00197106|17058699|P2|Overall Treatment Period|Lack of Efficacy|1
4962579|NCT00197106|17058700|P1|Overall Treatment Period|Lack of Efficacy|0
4962580|NCT00197106|17058698|P3|4-Week Run-In Period|Did not meet entry criteria|0
4962581|NCT00197106|17058699|P2|4-Week Run-In Period|Did not meet entry criteria|0
4962582|NCT00197106|17058700|P1|4-Week Run-In Period|Did not meet entry criteria|99
4962583|NCT00197028|17058736|P2|Overall Study|Other|6
4962584|NCT00197028|17058737|P1|Overall Study|Other|3
4962585|NCT00197028|17058736|P2|Overall Study|Lost to Follow-up|0
4962586|NCT00197028|17058737|P1|Overall Study|Lost to Follow-up|1
4962587|NCT00197028|17058736|P2|Overall Study|Withdrawal by Subject|12
4962588|NCT00197028|17058737|P1|Overall Study|Withdrawal by Subject|8
4962589|NCT00197028|17058736|P2|Overall Study|Protocol Violation|1
4962590|NCT00197028|17058737|P1|Overall Study|Protocol Violation|2
4962591|NCT00197028|17058736|P2|Overall Study|Adverse Event|2
4962592|NCT00197028|17058737|P1|Overall Study|Adverse Event|2
4962593|NCT00197015|17058780|P3|Overall Study|Other|2
4962594|NCT00197015|17058781|P2|Overall Study|Other|3
4962595|NCT00197015|17058782|P1|Overall Study|Other|2
4962596|NCT00197015|17058780|P3|Overall Study|Lost to Follow-up|37
4962597|NCT00197015|17058781|P2|Overall Study|Lost to Follow-up|46
4962598|NCT00197015|17058782|P1|Overall Study|Lost to Follow-up|28
4962599|NCT00197015|17058780|P3|Overall Study|Withdrawal by Subject|34
4962600|NCT00197015|17058781|P2|Overall Study|Withdrawal by Subject|37
4962601|NCT00197015|17058782|P1|Overall Study|Withdrawal by Subject|17
4962602|NCT00197015|17058780|P3|Overall Study|Protocol Violation|3
4962603|NCT00197015|17058781|P2|Overall Study|Protocol Violation|3
4962604|NCT00197015|17058782|P1|Overall Study|Protocol Violation|0
4962605|NCT00197015|17058780|P3|Overall Study|Adverse Event|1
4962606|NCT00197015|17058781|P2|Overall Study|Adverse Event|0
4962607|NCT00197015|17058782|P1|Overall Study|Adverse Event|3
4962608|NCT00197002|17058841|P3|Overall Study|Others|1
4962609|NCT00197002|17058842|P2|Overall Study|Others|1
4962610|NCT00197002|17058843|P1|Overall Study|Others|3
4962611|NCT00197002|17058841|P3|Overall Study|Lost to follow-up (compl. vaccination)|1
4962612|NCT00197002|17058842|P2|Overall Study|Lost to follow-up (compl. vaccination)|2
4962613|NCT00197002|17058843|P1|Overall Study|Lost to follow-up (compl. vaccination)|2
4962614|NCT00197002|17058841|P3|Overall Study|Lost to follow-up (incompl. vaccination)|5
4962615|NCT00197002|17058842|P2|Overall Study|Lost to follow-up (incompl. vaccination)|4
4962616|NCT00197002|17058843|P1|Overall Study|Lost to follow-up (incompl. vaccination)|4
4962617|NCT00197002|17058841|P3|Overall Study|Migrated/moved from study area|1
4962618|NCT00197002|17058842|P2|Overall Study|Migrated/moved from study area|5
4962619|NCT00197002|17058843|P1|Overall Study|Migrated/moved from study area|3
4962620|NCT00197002|17058841|P3|Overall Study|Withdrawal by Subject|7
4962621|NCT00197002|17058842|P2|Overall Study|Withdrawal by Subject|5
4962622|NCT00197002|17058843|P1|Overall Study|Withdrawal by Subject|9
4962623|NCT00197002|17058841|P3|Overall Study|Protocol Violation|2
4962624|NCT00197002|17058842|P2|Overall Study|Protocol Violation|0
4962625|NCT00197002|17058843|P1|Overall Study|Protocol Violation|1
4962626|NCT00197002|17058841|P3|Overall Study|Adverse Event|0
4962627|NCT00197002|17058842|P2|Overall Study|Adverse Event|1
4962628|NCT00197002|17058843|P1|Overall Study|Adverse Event|0
4962629|NCT00196976|17058894|P14|Booster Study|Lost to Follow-up|0
4962630|NCT00196976|17058895|P13|Booster Study|Lost to Follow-up|0
4962631|NCT00196976|17058896|P12|Booster Study|Lost to Follow-up|2
4962632|NCT00196976|17058897|P11|Booster Study|Lost to Follow-up|1
4962633|NCT00196976|17058898|P10|Booster Study|Lost to Follow-up|0
4962634|NCT00196976|17058899|P9|Booster Study|Lost to Follow-up|0
4962635|NCT00196976|17058900|P8|Booster Study|Lost to Follow-up|0
4962636|NCT00196976|17058901|P7|Booster Study|Lost to Follow-up|0
4962637|NCT00196976|17058902|P6|Booster Study|Lost to Follow-up|0
4962638|NCT00196976|17058903|P5|Booster Study|Lost to Follow-up|0
4962639|NCT00196976|17058904|P4|Booster Study|Lost to Follow-up|0
4962640|NCT00196976|17058905|P3|Booster Study|Lost to Follow-up|0
4962641|NCT00196976|17058906|P2|Booster Study|Lost to Follow-up|0
4962642|NCT00196976|17058907|P1|Booster Study|Lost to Follow-up|0
4962643|NCT00196976|17058894|P14|Booster Study|Withdrawal by Subject|0
4962644|NCT00196976|17058895|P13|Booster Study|Withdrawal by Subject|0
4962645|NCT00196976|17058896|P12|Booster Study|Withdrawal by Subject|0
4962646|NCT00196976|17058897|P11|Booster Study|Withdrawal by Subject|1
4962647|NCT00196976|17058898|P10|Booster Study|Withdrawal by Subject|0
4962648|NCT00196976|17058899|P9|Booster Study|Withdrawal by Subject|0
4962649|NCT00196976|17058900|P8|Booster Study|Withdrawal by Subject|0
4962650|NCT00196976|17058901|P7|Booster Study|Withdrawal by Subject|0
4962651|NCT00196976|17058902|P6|Booster Study|Withdrawal by Subject|0
4962652|NCT00196976|17058903|P5|Booster Study|Withdrawal by Subject|0
4962653|NCT00196976|17058904|P4|Booster Study|Withdrawal by Subject|0
4962654|NCT00196976|17058905|P3|Booster Study|Withdrawal by Subject|0
4962655|NCT00196976|17058906|P2|Booster Study|Withdrawal by Subject|0
4962656|NCT00196976|17058907|P1|Booster Study|Withdrawal by Subject|0
4962657|NCT00196976|17058894|P14|Primary Study|Other|0
4962658|NCT00196976|17058895|P13|Primary Study|Other|0
4962659|NCT00196976|17058896|P12|Primary Study|Other|0
4962660|NCT00196976|17058897|P11|Primary Study|Other|0
4962661|NCT00196976|17058898|P10|Primary Study|Other|0
4962662|NCT00196976|17058899|P9|Primary Study|Other|0
4962663|NCT00196976|17058900|P8|Primary Study|Other|0
4962664|NCT00196976|17058901|P7|Primary Study|Other|0
4962665|NCT00196976|17058902|P6|Primary Study|Other|0
4962666|NCT00196976|17058903|P5|Primary Study|Other|0
4962667|NCT00196976|17058904|P4|Primary Study|Other|0
4962668|NCT00196976|17058905|P3|Primary Study|Other|2
4962669|NCT00196976|17058906|P2|Primary Study|Other|0
4962670|NCT00196976|17058907|P1|Primary Study|Other|0
4962671|NCT00196976|17058894|P14|Primary Study|Lost to Follow-up|0
4962672|NCT00196976|17058895|P13|Primary Study|Lost to Follow-up|0
4962673|NCT00196976|17058896|P12|Primary Study|Lost to Follow-up|0
4962674|NCT00196976|17058897|P11|Primary Study|Lost to Follow-up|0
4962675|NCT00196976|17058898|P10|Primary Study|Lost to Follow-up|0
4962676|NCT00196976|17058899|P9|Primary Study|Lost to Follow-up|0
4962677|NCT00196976|17058900|P8|Primary Study|Lost to Follow-up|2
4962678|NCT00196976|17058901|P7|Primary Study|Lost to Follow-up|0
4962679|NCT00196976|17058902|P6|Primary Study|Lost to Follow-up|1
4962680|NCT00196976|17058903|P5|Primary Study|Lost to Follow-up|1
4962681|NCT00196976|17058904|P4|Primary Study|Lost to Follow-up|0
4962682|NCT00196976|17058905|P3|Primary Study|Lost to Follow-up|0
4962683|NCT00196976|17058906|P2|Primary Study|Lost to Follow-up|0
4962684|NCT00196976|17058907|P1|Primary Study|Lost to Follow-up|0
4962685|NCT00196976|17058894|P14|Primary Study|Withdrawal by Subject|0
4962686|NCT00196976|17058895|P13|Primary Study|Withdrawal by Subject|0
4962687|NCT00196976|17058896|P12|Primary Study|Withdrawal by Subject|0
4962688|NCT00196976|17058897|P11|Primary Study|Withdrawal by Subject|0
4962689|NCT00196976|17058898|P10|Primary Study|Withdrawal by Subject|1
4962690|NCT00196976|17058899|P9|Primary Study|Withdrawal by Subject|0
4962691|NCT00196976|17058900|P8|Primary Study|Withdrawal by Subject|0
4962692|NCT00196976|17058901|P7|Primary Study|Withdrawal by Subject|0
4962693|NCT00196976|17058902|P6|Primary Study|Withdrawal by Subject|1
4962694|NCT00196976|17058903|P5|Primary Study|Withdrawal by Subject|2
4962695|NCT00196976|17058904|P4|Primary Study|Withdrawal by Subject|1
4962696|NCT00196976|17058905|P3|Primary Study|Withdrawal by Subject|1
4962697|NCT00196976|17058906|P2|Primary Study|Withdrawal by Subject|0
4962698|NCT00196976|17058907|P1|Primary Study|Withdrawal by Subject|1
4962699|NCT00196976|17058894|P14|Primary Study|Protocol Violation|0
4962700|NCT00196976|17058895|P13|Primary Study|Protocol Violation|0
4962701|NCT00196976|17058896|P12|Primary Study|Protocol Violation|0
4962702|NCT00196976|17058897|P11|Primary Study|Protocol Violation|0
4962703|NCT00196976|17058898|P10|Primary Study|Protocol Violation|0
4962704|NCT00196976|17058899|P9|Primary Study|Protocol Violation|0
4962705|NCT00196976|17058900|P8|Primary Study|Protocol Violation|0
4962706|NCT00196976|17058901|P7|Primary Study|Protocol Violation|0
4962707|NCT00196976|17058902|P6|Primary Study|Protocol Violation|0
4962708|NCT00196976|17058903|P5|Primary Study|Protocol Violation|0
4962709|NCT00196976|17058904|P4|Primary Study|Protocol Violation|0
4962710|NCT00196976|17058905|P3|Primary Study|Protocol Violation|1
4962711|NCT00196976|17058906|P2|Primary Study|Protocol Violation|1
4962712|NCT00196976|17058907|P1|Primary Study|Protocol Violation|0
4962713|NCT00196976|17058894|P14|Primary Study|Migrated from study area|0
4962714|NCT00196976|17058895|P13|Primary Study|Migrated from study area|0
4962715|NCT00196976|17058896|P12|Primary Study|Migrated from study area|0
4962716|NCT00196976|17058897|P11|Primary Study|Migrated from study area|0
4962717|NCT00196976|17058898|P10|Primary Study|Migrated from study area|0
4962718|NCT00196976|17058899|P9|Primary Study|Migrated from study area|0
4962719|NCT00196976|17058900|P8|Primary Study|Migrated from study area|1
4962720|NCT00196976|17058901|P7|Primary Study|Migrated from study area|0
4962721|NCT00196976|17058902|P6|Primary Study|Migrated from study area|0
4962722|NCT00196976|17058903|P5|Primary Study|Migrated from study area|0
4962723|NCT00196976|17058904|P4|Primary Study|Migrated from study area|0
4962724|NCT00196976|17058905|P3|Primary Study|Migrated from study area|0
4962725|NCT00196976|17058906|P2|Primary Study|Migrated from study area|0
4962726|NCT00196976|17058907|P1|Primary Study|Migrated from study area|0
4962727|NCT00196937|17059103|P3|Overall Study|Other|1
4962728|NCT00196937|17059104|P2|Overall Study|Other|1
4962729|NCT00196937|17059105|P1|Overall Study|Other|3
4962730|NCT00196937|17059103|P3|Overall Study|Lost to Follow-up|3
4962731|NCT00196937|17059104|P2|Overall Study|Lost to Follow-up|3
4962732|NCT00196937|17059105|P1|Overall Study|Lost to Follow-up|4
4962733|NCT00196937|17059103|P3|Overall Study|Withdrawal by Subject|2
4962734|NCT00196937|17059104|P2|Overall Study|Withdrawal by Subject|0
4962735|NCT00196937|17059105|P1|Overall Study|Withdrawal by Subject|0
4962736|NCT00196937|17059103|P3|Overall Study|Non-serious adverse event|1
4962737|NCT00196937|17059104|P2|Overall Study|Non-serious adverse event|1
4962738|NCT00196937|17059105|P1|Overall Study|Non-serious adverse event|1
4962739|NCT00196937|17059103|P3|Overall Study|Serious Adverse Event|0
4962740|NCT00196937|17059104|P2|Overall Study|Serious Adverse Event|0
4962741|NCT00196937|17059105|P1|Overall Study|Serious Adverse Event|1
4962742|NCT00196326|17059159|P1|Overall Study|Other|22
4962743|NCT00196326|17059159|P1|Overall Study|Lost to Follow-up|304
4962744|NCT00196326|17059159|P1|Overall Study|Pregnancy|34
4962745|NCT00196326|17059159|P1|Overall Study|Adverse Event|253
4962746|NCT00196326|17059159|P1|Overall Study|Withdrawal by Subject|225
4962747|NCT00196326|17059159|P1|Overall Study|Physician Decision|3
4962748|NCT00196326|17059159|P1|Overall Study|Non-compliance with the protocol|81
4962749|NCT00196326|17059159|P1|Overall Study|Did not meet protocol requirements|64
4962750|NCT00196313|17059167|P2|Overall Study|Lost to Follow-up|2
4962751|NCT00196313|17059168|P1|Overall Study|Lost to Follow-up|2
4962752|NCT00196313|17059167|P2|Overall Study|Subject Pregnant|1
4962753|NCT00196313|17059168|P1|Overall Study|Subject Pregnant|1
4962754|NCT00196313|17059167|P2|Overall Study|Adverse Event|1
4962755|NCT00196313|17059168|P1|Overall Study|Adverse Event|3
4962756|NCT00196313|17059167|P2|Overall Study|Withdrawal by Subject|1
4962757|NCT00196313|17059168|P1|Overall Study|Withdrawal by Subject|3
4962758|NCT00196313|17059167|P2|Overall Study|Protocol Violation|3
4962759|NCT00196313|17059168|P1|Overall Study|Protocol Violation|2
4962760|NCT00196196|17059182|P1|Overall Study|Did not have required condition (hydroce|5
4962761|NCT00196196|17059182|P1|Overall Study|Withdrawal by Subject|2
4962762|NCT00196105|17059190|P3|Overall Study|Lost to Follow-up|7
4962763|NCT00196105|17059191|P2|Overall Study|Lost to Follow-up|5
4962764|NCT00196105|17059192|P1|Overall Study|Lost to Follow-up|4
4962765|NCT00195819|17059212|P2|Open-label|Withdrawal by Subject|5
4962766|NCT00195819|17059213|P1|Open-label|Withdrawal by Subject|0
4962767|NCT00195819|17059212|P2|Open-label|Moved|1
4962768|NCT00195819|17059213|P1|Open-label|Moved|0
4962769|NCT00195819|17059212|P2|Open-label|Protocol Violation|2
4962770|NCT00195819|17059213|P1|Open-label|Protocol Violation|0
4962771|NCT00195819|17059212|P2|Open-label|Pregnancy|1
4962772|NCT00195819|17059213|P1|Open-label|Pregnancy|0
4962773|NCT00195819|17059212|P2|Open-label|Lack of Efficacy|2
4962774|NCT00195819|17059213|P1|Open-label|Lack of Efficacy|0
4962775|NCT00195819|17059212|P2|Open-label|Adverse Event|9
4962776|NCT00195819|17059213|P1|Open-label|Adverse Event|0
4962777|NCT00195819|17059212|P2|Double-Blind|Moved|0
4962778|NCT00195819|17059213|P1|Double-Blind|Moved|1
4962779|NCT00195819|17059212|P2|Double-Blind|Withdrawal by Subject|0
4962780|NCT00195819|17059213|P1|Double-Blind|Withdrawal by Subject|1
4962781|NCT00195715|17059263|P1|Overall Study|Sponsor discretion - trial ended early|1
4962782|NCT00195715|17059263|P1|Overall Study|Sponsor discontinued trial|1
4962783|NCT00195715|17059263|P1|Overall Study|Colonic stricture|1
4962784|NCT00195715|17059263|P1|Overall Study|Ineligible|1
4962785|NCT00195715|17059263|P1|Overall Study|Increased infection rate|1
4962786|NCT00195715|17059263|P1|Overall Study|Planned surgery|2
4962787|NCT00195715|17059263|P1|Overall Study|Use of prohibited medication|2
4962788|NCT00195715|17059263|P1|Overall Study|Subject wants to get pregnant|4
4962789|NCT00195715|17059263|P1|Overall Study|Investigator's decision|2
4962790|NCT00195715|17059263|P1|Overall Study|Administrative reasons|2
4962791|NCT00195715|17059263|P1|Overall Study|Sponsor stopped study|1
4962792|NCT00195715|17059263|P1|Overall Study|Loss of response/no improvement|3
4962793|NCT00195715|17059263|P1|Overall Study|Subject choice|3
4962794|NCT00195715|17059263|P1|Overall Study|Subject started commercial Humira|5
4962795|NCT00195715|17059263|P1|Overall Study|Subject non-compliance|6
4962796|NCT00195715|17059263|P1|Overall Study|Subject moved/relocated|7
4962797|NCT00195715|17059263|P1|Overall Study|Investigative site closure|8
4962798|NCT00195715|17059263|P1|Overall Study|Pregnancy|14
4962799|NCT00195715|17059263|P1|Overall Study|Lack of Efficacy|93
4962800|NCT00195715|17059263|P1|Overall Study|Protocol Violation|13
4962801|NCT00195715|17059263|P1|Overall Study|Lost to Follow-up|27
4962802|NCT00195715|17059263|P1|Overall Study|Withdrawal by Subject|58
4962803|NCT00195715|17059263|P1|Overall Study|Adverse Event|122
4962804|NCT00195676|17059363|P1|Period R - Retreatment 16 Weeks|Other reasons|6
4962805|NCT00195676|17059363|P1|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9
4962806|NCT00195676|17059363|P1|Period R - Retreatment 16 Weeks|Lost to Follow-up|11
4962807|NCT00195676|17059363|P1|Period R - Retreatment 16 Weeks|Lack of Efficacy|5
4962808|NCT00195676|17059363|P1|Period R - Retreatment 16 Weeks|Adverse Event|4
4962809|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Other reasons|18
4962810|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Administrative reasons|1
4962811|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Period W Close-out|129
4962812|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397
4962813|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46
4962814|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11
4962815|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Death|2
4962816|NCT00195676|17059363|P1|Period W (Withdrawal) - No Treatment|Adverse Event|4
4962817|NCT00195676|17059363|P1|Period O - Open-label Treatment|Other reasons|68
4962818|NCT00195676|17059363|P1|Period O - Open-label Treatment|Administrative reasons|2
4962819|NCT00195676|17059363|P1|Period O - Open-label Treatment|Withdrawal by Subject|147
4962820|NCT00195676|17059363|P1|Period O - Open-label Treatment|Protocol Violation|12
4962821|NCT00195676|17059363|P1|Period O - Open-label Treatment|Lost to Follow-up|91
4962822|NCT00195676|17059363|P1|Period O - Open-label Treatment|Lack of Efficacy|198
4962823|NCT00195676|17059363|P1|Period O - Open-label Treatment|Death|6
4962824|NCT00195676|17059363|P1|Period O - Open-label Treatment|Adverse Event|82
4962825|NCT00195663|17059377|P3|Open-Label Extension Period|Administrative reasons|13
4962826|NCT00195663|17059378|P2|Open-Label Extension Period|Administrative reasons|11
4962827|NCT00195663|17059379|P1|Open-Label Extension Period|Administrative reasons|11
4962828|NCT00195663|17059377|P3|Open-Label Extension Period|Lack of Efficacy|12
4962829|NCT00195663|17059378|P2|Open-Label Extension Period|Lack of Efficacy|6
4962830|NCT00195663|17059379|P1|Open-Label Extension Period|Lack of Efficacy|14
4962831|NCT00195663|17059377|P3|Open-Label Extension Period|Withdrawal by Subject|22
4962832|NCT00195663|17059378|P2|Open-Label Extension Period|Withdrawal by Subject|15
4962833|NCT00195663|17059379|P1|Open-Label Extension Period|Withdrawal by Subject|16
4962834|NCT00195663|17059377|P3|Open-Label Extension Period|Death|2
4962835|NCT00195663|17059378|P2|Open-Label Extension Period|Death|2
4962836|NCT00195663|17059379|P1|Open-Label Extension Period|Death|2
4962837|NCT00195663|17059377|P3|Open-Label Extension Period|Protocol Violation|4
4962838|NCT00195663|17059378|P2|Open-Label Extension Period|Protocol Violation|4
4962839|NCT00195663|17059379|P1|Open-Label Extension Period|Protocol Violation|3
4962840|NCT00195663|17059377|P3|Open-Label Extension Period|Recovery|2
4962841|NCT00195663|17059378|P2|Open-Label Extension Period|Recovery|2
4962842|NCT00195663|17059379|P1|Open-Label Extension Period|Recovery|0
4962843|NCT00195663|17059377|P3|Open-Label Extension Period|Lost to Follow-up|6
4962844|NCT00195663|17059378|P2|Open-Label Extension Period|Lost to Follow-up|2
4962845|NCT00195663|17059379|P1|Open-Label Extension Period|Lost to Follow-up|9
4962846|NCT00195663|17059377|P3|Open-Label Extension Period|Adverse Event|36
4962847|NCT00195663|17059378|P2|Open-Label Extension Period|Adverse Event|32
4962848|NCT00195663|17059379|P1|Open-Label Extension Period|Adverse Event|21
4962849|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Administrative reasons|9
4962850|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Administrative reasons|2
4962851|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Administrative reasons|3
4962852|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Recovery|1
4962853|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Recovery|0
4962854|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Recovery|1
4962855|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Planned selection criteria|0
4962856|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Planned selection criteria|1
4962857|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Planned selection criteria|0
4962858|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Protocol Violation|4
4962859|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Protocol Violation|6
4962860|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Protocol Violation|6
4962861|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Lack of Efficacy|13
4962862|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Lack of Efficacy|52
4962863|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Lack of Efficacy|47
4962864|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Withdrawal by Subject|12
4962865|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Withdrawal by Subject|18
4962866|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Withdrawal by Subject|15
4962867|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Lost to Follow-up|1
4962868|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Lost to Follow-up|0
4962869|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Lost to Follow-up|0
4962870|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Death|0
4962871|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Death|2
4962872|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Death|0
4962873|NCT00195663|17059377|P3|2-year Double-blind Treatment Period|Adverse Event|32
4962874|NCT00195663|17059378|P2|2-year Double-blind Treatment Period|Adverse Event|27
4962875|NCT00195663|17059379|P1|2-year Double-blind Treatment Period|Adverse Event|21
4962876|NCT00195650|17059473|P1|Overall Study|Administrative reasons|83
4962877|NCT00195650|17059473|P1|Overall Study|Protocol Violation|15
4962878|NCT00195650|17059473|P1|Overall Study|Death|23
4962879|NCT00195650|17059473|P1|Overall Study|Lost to Follow-up|44
4962880|NCT00195650|17059473|P1|Overall Study|Withdrawal by Subject|67
4962881|NCT00195650|17059473|P1|Overall Study|Lack of Efficacy|99
4962882|NCT00195650|17059473|P1|Overall Study|Adverse Event|194
4962883|NCT00195507|17059498|P2|Overall Study|Protocol Deviation|3
4962884|NCT00195507|17059499|P1|Overall Study|Protocol Deviation|6
4962885|NCT00195507|17059498|P2|Overall Study|Withdrawal by Subject|23
4962886|NCT00195507|17059499|P1|Overall Study|Withdrawal by Subject|16
4962887|NCT00195507|17059498|P2|Overall Study|Lack of Efficacy|67
4962888|NCT00195507|17059499|P1|Overall Study|Lack of Efficacy|40
4962889|NCT00195507|17059498|P2|Overall Study|Protocol Violation|4
4962890|NCT00195507|17059499|P1|Overall Study|Protocol Violation|5
4962891|NCT00195507|17059498|P2|Overall Study|Lost to Follow-up|2
4962892|NCT00195507|17059499|P1|Overall Study|Lost to Follow-up|3
4962893|NCT00195507|17059498|P2|Overall Study|Physician Decision|2
4962894|NCT00195507|17059499|P1|Overall Study|Physician Decision|1
4962895|NCT00195507|17059498|P2|Overall Study|Failed to Return|3
4962896|NCT00195507|17059499|P1|Overall Study|Failed to Return|4
4962897|NCT00195507|17059498|P2|Overall Study|Death|1
4962898|NCT00195507|17059499|P1|Overall Study|Death|0
4962899|NCT00195507|17059498|P2|Overall Study|Adverse Event|13
4962900|NCT00195507|17059499|P1|Overall Study|Adverse Event|24
4962901|NCT00195494|17059513|P6|Year 2|System toxicity|0
4962902|NCT00195494|17059514|P5|Year 2|System toxicity|0
4962903|NCT00195494|17059515|P4|Year 2|System toxicity|1
4962904|NCT00195494|17059516|P3|Year 2|System toxicity|0
4962905|NCT00195494|17059517|P2|Year 2|System toxicity|0
4962906|NCT00195494|17059518|P1|Year 2|System toxicity|0
4962907|NCT00195494|17059513|P6|Year 2|Withdrawal by Subject|0
4962908|NCT00195494|17059514|P5|Year 2|Withdrawal by Subject|0
4962909|NCT00195494|17059515|P4|Year 2|Withdrawal by Subject|3
4962910|NCT00195494|17059516|P3|Year 2|Withdrawal by Subject|4
4962911|NCT00195494|17059517|P2|Year 2|Withdrawal by Subject|5
4962912|NCT00195494|17059518|P1|Year 2|Withdrawal by Subject|1
4962913|NCT00195494|17059513|P6|Year 2|Physician Decision|0
4962914|NCT00195494|17059514|P5|Year 2|Physician Decision|0
4962915|NCT00195494|17059515|P4|Year 2|Physician Decision|0
4962916|NCT00195494|17059516|P3|Year 2|Physician Decision|0
4962917|NCT00195494|17059517|P2|Year 2|Physician Decision|1
4962918|NCT00195494|17059518|P1|Year 2|Physician Decision|1
4962919|NCT00195494|17059513|P6|Year 2|Protocol deviation|0
4962920|NCT00195494|17059514|P5|Year 2|Protocol deviation|0
4962921|NCT00195494|17059515|P4|Year 2|Protocol deviation|0
4962922|NCT00195494|17059516|P3|Year 2|Protocol deviation|0
4962923|NCT00195494|17059517|P2|Year 2|Protocol deviation|1
4962924|NCT00195494|17059518|P1|Year 2|Protocol deviation|0
4962925|NCT00195494|17059513|P6|Year 2|Missed >4 consecutive doses|0
4962926|NCT00195494|17059514|P5|Year 2|Missed >4 consecutive doses|0
4962927|NCT00195494|17059515|P4|Year 2|Missed >4 consecutive doses|0
4962928|NCT00195494|17059516|P3|Year 2|Missed >4 consecutive doses|1
4962929|NCT00195494|17059517|P2|Year 2|Missed >4 consecutive doses|1
4962930|NCT00195494|17059518|P1|Year 2|Missed >4 consecutive doses|1
4962931|NCT00195494|17059513|P6|Year 2|Lost to Follow-up|0
4962932|NCT00195494|17059514|P5|Year 2|Lost to Follow-up|0
4962933|NCT00195494|17059515|P4|Year 2|Lost to Follow-up|1
4962934|NCT00195494|17059516|P3|Year 2|Lost to Follow-up|1
4962935|NCT00195494|17059517|P2|Year 2|Lost to Follow-up|0
4962936|NCT00195494|17059518|P1|Year 2|Lost to Follow-up|0
4962937|NCT00195494|17059513|P6|Year 2|Compliance|0
4962938|NCT00195494|17059514|P5|Year 2|Compliance|0
4962939|NCT00195494|17059515|P4|Year 2|Compliance|2
4962940|NCT00195494|17059516|P3|Year 2|Compliance|0
4962941|NCT00195494|17059517|P2|Year 2|Compliance|0
4962942|NCT00195494|17059518|P1|Year 2|Compliance|1
4962943|NCT00195494|17059513|P6|Year 2|Lack of Efficacy|0
4962944|NCT00195494|17059514|P5|Year 2|Lack of Efficacy|0
4962945|NCT00195494|17059515|P4|Year 2|Lack of Efficacy|7
4962946|NCT00195494|17059516|P3|Year 2|Lack of Efficacy|7
4962947|NCT00195494|17059517|P2|Year 2|Lack of Efficacy|1
4962948|NCT00195494|17059518|P1|Year 2|Lack of Efficacy|0
4962949|NCT00195494|17059513|P6|Year 2|Adverse Event|0
4962950|NCT00195494|17059514|P5|Year 2|Adverse Event|0
4962951|NCT00195494|17059515|P4|Year 2|Adverse Event|9
4962952|NCT00195494|17059516|P3|Year 2|Adverse Event|5
4962953|NCT00195494|17059517|P2|Year 2|Adverse Event|7
4962954|NCT00195494|17059518|P1|Year 2|Adverse Event|3
4962955|NCT00195494|17059513|P6|Year 1|Protocol Violation|1
4962956|NCT00195494|17059514|P5|Year 1|Protocol Violation|1
4962957|NCT00195494|17059515|P4|Year 1|Protocol Violation|0
4962958|NCT00195494|17059516|P3|Year 1|Protocol Violation|0
4962959|NCT00195494|17059517|P2|Year 1|Protocol Violation|0
4962960|NCT00195494|17059518|P1|Year 1|Protocol Violation|0
4962961|NCT00195494|17059513|P6|Year 1|Withdrawal by Subject|9
4962962|NCT00195494|17059514|P5|Year 1|Withdrawal by Subject|8
4962963|NCT00195494|17059515|P4|Year 1|Withdrawal by Subject|0
4962964|NCT00195494|17059516|P3|Year 1|Withdrawal by Subject|0
4962965|NCT00195494|17059517|P2|Year 1|Withdrawal by Subject|0
4962966|NCT00195494|17059518|P1|Year 1|Withdrawal by Subject|0
4962967|NCT00195494|17059513|P6|Year 1|Physician Decision|0
4962968|NCT00195494|17059514|P5|Year 1|Physician Decision|1
4962969|NCT00195494|17059515|P4|Year 1|Physician Decision|0
4962970|NCT00195494|17059516|P3|Year 1|Physician Decision|0
4962971|NCT00195494|17059517|P2|Year 1|Physician Decision|0
4962972|NCT00195494|17059518|P1|Year 1|Physician Decision|0
4962973|NCT00195494|17059513|P6|Year 1|Protocol deviation|3
4962974|NCT00195494|17059514|P5|Year 1|Protocol deviation|2
4962975|NCT00195494|17059515|P4|Year 1|Protocol deviation|0
4962976|NCT00195494|17059516|P3|Year 1|Protocol deviation|0
4962977|NCT00195494|17059517|P2|Year 1|Protocol deviation|0
4962978|NCT00195494|17059518|P1|Year 1|Protocol deviation|0
4962979|NCT00195494|17059513|P6|Year 1|Missed >4 consecutive doses|2
4962980|NCT00195494|17059514|P5|Year 1|Missed >4 consecutive doses|3
4962981|NCT00195494|17059515|P4|Year 1|Missed >4 consecutive doses|0
4962982|NCT00195494|17059516|P3|Year 1|Missed >4 consecutive doses|0
4962983|NCT00195494|17059517|P2|Year 1|Missed >4 consecutive doses|0
4962984|NCT00195494|17059518|P1|Year 1|Missed >4 consecutive doses|0
4962985|NCT00195494|17059513|P6|Year 1|Lost to Follow-up|0
4962986|NCT00195494|17059514|P5|Year 1|Lost to Follow-up|1
4962987|NCT00195494|17059515|P4|Year 1|Lost to Follow-up|0
4962988|NCT00195494|17059516|P3|Year 1|Lost to Follow-up|0
4962989|NCT00195494|17059517|P2|Year 1|Lost to Follow-up|0
4962990|NCT00195494|17059518|P1|Year 1|Lost to Follow-up|0
4962991|NCT00195494|17059513|P6|Year 1|Compliance|1
4962992|NCT00195494|17059514|P5|Year 1|Compliance|5
4962993|NCT00195494|17059515|P4|Year 1|Compliance|0
4962994|NCT00195494|17059516|P3|Year 1|Compliance|0
4962995|NCT00195494|17059517|P2|Year 1|Compliance|0
4962996|NCT00195494|17059518|P1|Year 1|Compliance|0
4962997|NCT00195494|17059513|P6|Year 1|Lack of Efficacy|9
4962998|NCT00195494|17059514|P5|Year 1|Lack of Efficacy|24
4962999|NCT00195494|17059515|P4|Year 1|Lack of Efficacy|0
4963000|NCT00195494|17059516|P3|Year 1|Lack of Efficacy|0
4963001|NCT00195494|17059517|P2|Year 1|Lack of Efficacy|0
4963002|NCT00195494|17059518|P1|Year 1|Lack of Efficacy|0
4963003|NCT00195494|17059513|P6|Year 1|System Toxicity|1
4963004|NCT00195494|17059514|P5|Year 1|System Toxicity|0
4963005|NCT00195494|17059515|P4|Year 1|System Toxicity|0
4963006|NCT00195494|17059516|P3|Year 1|System Toxicity|0
4963007|NCT00195494|17059517|P2|Year 1|System Toxicity|0
4963008|NCT00195494|17059518|P1|Year 1|System Toxicity|0
4963009|NCT00195494|17059513|P6|Year 1|Adverse Event|27
4963010|NCT00195494|17059514|P5|Year 1|Adverse Event|34
4963011|NCT00195494|17059515|P4|Year 1|Adverse Event|0
4963012|NCT00195494|17059516|P3|Year 1|Adverse Event|0
4963013|NCT00195494|17059517|P2|Year 1|Adverse Event|0
4963014|NCT00195494|17059518|P1|Year 1|Adverse Event|0
4963015|NCT00195442|17059536|P1|Overall Study|Other|14
4963016|NCT00195442|17059536|P1|Overall Study|Poor cooperation|2
4963017|NCT00195442|17059536|P1|Overall Study|No reason specified|4
4963018|NCT00195442|17059536|P1|Overall Study|Death|7
4963019|NCT00195442|17059536|P1|Overall Study|Intermittent product shortage|21
4963020|NCT00195442|17059536|P1|Overall Study|Switch to other Factor VIII preparation|23
4963021|NCT00195442|17059536|P1|Overall Study|Lost to Follow-up|27
4963022|NCT00195442|17059536|P1|Overall Study|Less than expected therapeutic effect|38
4963023|NCT00195429|17059555|P2|Overall Study|Lost to Follow-up|0
4963024|NCT00195429|17059556|P1|Overall Study|Lost to Follow-up|1
4963025|NCT00195429|17059555|P2|Overall Study|Lack of Efficacy|1
4963026|NCT00195429|17059556|P1|Overall Study|Lack of Efficacy|2
4963027|NCT00195429|17059555|P2|Overall Study|Adverse Event|4
4963028|NCT00195429|17059556|P1|Overall Study|Adverse Event|2
4963029|NCT00195351|17059572|P2|Overall Study|Lack of Efficacy|1
4963030|NCT00195351|17059573|P1|Overall Study|Lack of Efficacy|0
4963031|NCT00195351|17059572|P2|Overall Study|Death|1
4963032|NCT00195351|17059573|P1|Overall Study|Death|3
4963033|NCT00195351|17059572|P2|Overall Study|Protocol Deviation|2
4963034|NCT00195351|17059573|P1|Overall Study|Protocol Deviation|3
4963035|NCT00195351|17059572|P2|Overall Study|Withdrawal by Subject|3
4963036|NCT00195351|17059573|P1|Overall Study|Withdrawal by Subject|6
4963037|NCT00195351|17059572|P2|Overall Study|Lost to Follow-up|9
4963038|NCT00195351|17059573|P1|Overall Study|Lost to Follow-up|9
4963039|NCT00195338|17059583|P1|Overall Study|Early closure of the site|4
4963040|NCT00195338|17059583|P1|Overall Study|Lack of Efficacy|1
4963041|NCT00195338|17059583|P1|Overall Study|Adverse Event|5
4963042|NCT00195338|17059583|P1|Overall Study|Lost to Follow-up|2
4963043|NCT00195273|17059593|P2|Overall Study|Procedural complications|3
4963044|NCT00195273|17059594|P1|Overall Study|Procedural complications|9
4963045|NCT00195273|17059593|P2|Overall Study|Lack of Efficacy|1
4963046|NCT00195273|17059594|P1|Overall Study|Lack of Efficacy|3
4963047|NCT00195273|17059593|P2|Overall Study|Protocol deviation|1
4963048|NCT00195273|17059594|P1|Overall Study|Protocol deviation|0
4963049|NCT00195273|17059593|P2|Overall Study|Adverse Event|9
4963050|NCT00195273|17059594|P1|Overall Study|Adverse Event|9
4963051|NCT00195260|17059608|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3
4963052|NCT00195260|17059609|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4
4963053|NCT00195260|17059610|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6
4963054|NCT00195260|17059611|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963055|NCT00195260|17059612|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963056|NCT00195260|17059613|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963057|NCT00195260|17059614|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963058|NCT00195260|17059615|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963059|NCT00195260|17059616|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963060|NCT00195260|17059617|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963061|NCT00195260|17059618|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0
4963062|NCT00195260|17059608|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3
4963063|NCT00195260|17059609|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2
4963064|NCT00195260|17059610|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1
4963065|NCT00195260|17059611|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963066|NCT00195260|17059612|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963067|NCT00195260|17059613|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963068|NCT00195260|17059614|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963069|NCT00195260|17059615|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963070|NCT00195260|17059616|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963071|NCT00195260|17059617|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963072|NCT00195260|17059618|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0
4963073|NCT00195260|17059608|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2
4963074|NCT00195260|17059609|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3
4963075|NCT00195260|17059610|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5
4963076|NCT00195260|17059611|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963077|NCT00195260|17059612|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963078|NCT00195260|17059613|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963079|NCT00195260|17059614|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963080|NCT00195260|17059615|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963081|NCT00195260|17059616|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963082|NCT00195260|17059617|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963083|NCT00195260|17059618|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0
4963084|NCT00195260|17059608|P11|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15
4963085|NCT00195260|17059609|P10|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29
4963086|NCT00195260|17059610|P9|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21
4963087|NCT00195260|17059611|P8|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963088|NCT00195260|17059612|P7|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963089|NCT00195260|17059613|P6|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963090|NCT00195260|17059614|P5|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963091|NCT00195260|17059615|P4|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963092|NCT00195260|17059616|P3|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963093|NCT00195260|17059617|P2|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963094|NCT00195260|17059618|P1|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0
4963095|NCT00195260|17059608|P11|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963096|NCT00195260|17059609|P10|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963097|NCT00195260|17059610|P9|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963098|NCT00195260|17059611|P8|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963099|NCT00195260|17059612|P7|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963100|NCT00195260|17059613|P6|Part 1: Dose Escalation|Symptomatic Deterioration|1
4963101|NCT00195260|17059614|P5|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963102|NCT00195260|17059615|P4|Part 1: Dose Escalation|Symptomatic Deterioration|0
4963103|NCT00195260|17059616|P3|Part 1: Dose Escalation|Symptomatic Deterioration|1
4963104|NCT00195260|17059617|P2|Part 1: Dose Escalation|Symptomatic Deterioration|1
4963105|NCT00195260|17059618|P1|Part 1: Dose Escalation|Symptomatic Deterioration|1
4963106|NCT00195260|17059608|P11|Part 1: Dose Escalation|Disease Progression|0
4963107|NCT00195260|17059609|P10|Part 1: Dose Escalation|Disease Progression|0
4963108|NCT00195260|17059610|P9|Part 1: Dose Escalation|Disease Progression|0
4963109|NCT00195260|17059611|P8|Part 1: Dose Escalation|Disease Progression|4
4963110|NCT00195260|17059612|P7|Part 1: Dose Escalation|Disease Progression|7
4963111|NCT00195260|17059613|P6|Part 1: Dose Escalation|Disease Progression|6
4963112|NCT00195260|17059614|P5|Part 1: Dose Escalation|Disease Progression|4
4963113|NCT00195260|17059615|P4|Part 1: Dose Escalation|Disease Progression|6
4963114|NCT00195260|17059616|P3|Part 1: Dose Escalation|Disease Progression|5
4963115|NCT00195260|17059617|P2|Part 1: Dose Escalation|Disease Progression|2
4963116|NCT00195260|17059618|P1|Part 1: Dose Escalation|Disease Progression|3
4963117|NCT00195260|17059608|P11|Part 1: Dose Escalation|Death|0
4963118|NCT00195260|17059609|P10|Part 1: Dose Escalation|Death|0
4963119|NCT00195260|17059610|P9|Part 1: Dose Escalation|Death|0
4963120|NCT00195260|17059611|P8|Part 1: Dose Escalation|Death|1
4963121|NCT00195260|17059612|P7|Part 1: Dose Escalation|Death|0
4963122|NCT00195260|17059613|P6|Part 1: Dose Escalation|Death|0
4963123|NCT00195260|17059614|P5|Part 1: Dose Escalation|Death|0
4963124|NCT00195260|17059615|P4|Part 1: Dose Escalation|Death|0
4963125|NCT00195260|17059616|P3|Part 1: Dose Escalation|Death|0
4963126|NCT00195260|17059617|P2|Part 1: Dose Escalation|Death|0
4963127|NCT00195260|17059618|P1|Part 1: Dose Escalation|Death|0
4963128|NCT00195260|17059608|P11|Part 1: Dose Escalation|Withdrawal by Subject|0
4963129|NCT00195260|17059609|P10|Part 1: Dose Escalation|Withdrawal by Subject|0
4963130|NCT00195260|17059610|P9|Part 1: Dose Escalation|Withdrawal by Subject|0
4963131|NCT00195260|17059611|P8|Part 1: Dose Escalation|Withdrawal by Subject|1
4963132|NCT00195260|17059612|P7|Part 1: Dose Escalation|Withdrawal by Subject|0
4963133|NCT00195260|17059613|P6|Part 1: Dose Escalation|Withdrawal by Subject|0
4963134|NCT00195260|17059614|P5|Part 1: Dose Escalation|Withdrawal by Subject|2
4963135|NCT00195260|17059615|P4|Part 1: Dose Escalation|Withdrawal by Subject|0
4963136|NCT00195260|17059616|P3|Part 1: Dose Escalation|Withdrawal by Subject|0
4963137|NCT00195260|17059617|P2|Part 1: Dose Escalation|Withdrawal by Subject|0
4963138|NCT00195260|17059618|P1|Part 1: Dose Escalation|Withdrawal by Subject|0
4963139|NCT00195260|17059608|P11|Part 1: Dose Escalation|Adverse Event|0
4963140|NCT00195260|17059609|P10|Part 1: Dose Escalation|Adverse Event|0
4963141|NCT00195260|17059610|P9|Part 1: Dose Escalation|Adverse Event|0
4963142|NCT00195260|17059611|P8|Part 1: Dose Escalation|Adverse Event|0
4963143|NCT00195260|17059612|P7|Part 1: Dose Escalation|Adverse Event|3
4963144|NCT00195260|17059613|P6|Part 1: Dose Escalation|Adverse Event|0
4963145|NCT00195260|17059614|P5|Part 1: Dose Escalation|Adverse Event|1
4963146|NCT00195260|17059615|P4|Part 1: Dose Escalation|Adverse Event|1
4963147|NCT00195260|17059616|P3|Part 1: Dose Escalation|Adverse Event|0
4963148|NCT00195260|17059617|P2|Part 1: Dose Escalation|Adverse Event|1
4963149|NCT00195260|17059618|P1|Part 1: Dose Escalation|Adverse Event|0
4963150|NCT00194987|17059786|P2|Overall Study|Withdrawal by Subject|3
4963151|NCT00194987|17059787|P1|Overall Study|Withdrawal by Subject|0
4963152|NCT00194792|17059820|P1|Overall Study|Withdrawal by Subject|1
4963153|NCT00194675|17059844|P2|Overall Study|Death|0
4963154|NCT00194675|17059845|P1|Overall Study|Death|1
4963155|NCT00194675|17059844|P2|Overall Study|Protocol Violation|0
4963156|NCT00194675|17059845|P1|Overall Study|Protocol Violation|1
4963157|NCT00194675|17059844|P2|Overall Study|"withdrew due to edgy feeling"|0
4963158|NCT00194675|17059845|P1|Overall Study|"withdrew due to edgy feeling"|1
4963159|NCT00194675|17059844|P2|Overall Study|lack of interest|1
4963160|NCT00194675|17059845|P1|Overall Study|lack of interest|1
4963161|NCT00194675|17059844|P2|Overall Study|Lost to Follow-up|1
4963162|NCT00194675|17059845|P1|Overall Study|Lost to Follow-up|1
4963163|NCT00194077|17059920|P2|Overall Study|Withdrawal by Subject|1
4963164|NCT00194077|17059921|P1|Overall Study|Withdrawal by Subject|1
4963165|NCT00194077|17059920|P2|Overall Study|Study nonadherence|0
4963166|NCT00194077|17059921|P1|Overall Study|Study nonadherence|1
4963167|NCT00194077|17059920|P2|Overall Study|Lack of Efficacy|29
4963168|NCT00194077|17059921|P1|Overall Study|Lack of Efficacy|22
4963169|NCT00194025|17059927|P1|Overall Study|non-adherence with study medication|4
4963170|NCT00194025|17059927|P1|Overall Study|Adverse Event|1
4963171|NCT00194012|17059942|P2|Open Label Extension (OLE)|Lack of Efficacy|0
4963172|NCT00194012|17059943|P1|Open Label Extension (OLE)|Lack of Efficacy|1
4963173|NCT00194012|17059942|P2|Open Label Extension (OLE)|Lost to Follow-up|5
4963174|NCT00194012|17059943|P1|Open Label Extension (OLE)|Lost to Follow-up|3
4963175|NCT00194012|17059942|P2|Open Label Extension (OLE)|Drowsiness; Jittery|1
4963176|NCT00194012|17059943|P1|Open Label Extension (OLE)|Drowsiness; Jittery|0
4963177|NCT00194012|17059942|P2|Open Label Extension (OLE)|Weight Gain|0
4963178|NCT00194012|17059943|P1|Open Label Extension (OLE)|Weight Gain|1
4963179|NCT00194012|17059942|P2|Randomized Phase|Oral/nasal twitching|1
4963180|NCT00194012|17059943|P1|Randomized Phase|Oral/nasal twitching|0
4963181|NCT00194012|17059942|P2|Randomized Phase|Emesis and enuresis|1
4963182|NCT00194012|17059943|P1|Randomized Phase|Emesis and enuresis|0
4963353|NCT00191815|17060358|P1|Overall Study|Death|2
4963183|NCT00194012|17059942|P2|Randomized Phase|Participant reported having a rash|0
4963184|NCT00194012|17059943|P1|Randomized Phase|Participant reported having a rash|1
4963185|NCT00194012|17059942|P2|Randomized Phase|Adverse Event|1
4963186|NCT00194012|17059943|P1|Randomized Phase|Adverse Event|2
4963187|NCT00194012|17059942|P2|Randomized Phase|Withdrawal by Subject|3
4963188|NCT00194012|17059943|P1|Randomized Phase|Withdrawal by Subject|3
4963189|NCT00194012|17059942|P2|Randomized Phase|Study nonadherence|1
4963190|NCT00194012|17059943|P1|Randomized Phase|Study nonadherence|2
4963191|NCT00194012|17059942|P2|Randomized Phase|Lack of Efficacy|18
4963192|NCT00194012|17059943|P1|Randomized Phase|Lack of Efficacy|8
4963193|NCT00193609|17059979|P1|Overall Study|Adverse Event|2
4963194|NCT00193609|17059979|P1|Overall Study|Lack of Efficacy|2
4963195|NCT00193479|17060006|P1|Induction Chemotherapy|Disease Progression|1
4963196|NCT00193479|17060006|P1|Induction Chemotherapy|Adverse Event|2
4963197|NCT00193206|17060047|P1|Postoperative Therapy|Protocol Violation|1
4963198|NCT00193206|17060047|P1|Postoperative Therapy|Lack of Efficacy|1
4963199|NCT00193206|17060047|P1|Postoperative Therapy|Intercurrent Illness|2
4963200|NCT00193206|17060047|P1|Postoperative Therapy|Physician Decision|3
4963201|NCT00193206|17060047|P1|Postoperative Therapy|Withdrawal by Subject|7
4963202|NCT00193206|17060047|P1|Preoperative Therapy|False Positive Pregnancy Test|1
4963203|NCT00193206|17060047|P1|Preoperative Therapy|Withdrawal by Subject|2
4963204|NCT00193206|17060047|P1|Preoperative Therapy|Adverse Event|2
4963205|NCT00193206|17060047|P1|Preoperative Therapy|Lack of Efficacy|2
4963206|NCT00193180|17060051|P1|Overall Study|Protocol Violation|1
4963207|NCT00193180|17060051|P1|Overall Study|Adverse Event|8
4963208|NCT00193180|17060051|P1|Overall Study|Lack of Efficacy|1
4963209|NCT00193063|17060066|P1|Overall Study|Adverse Event|1
4963210|NCT00193063|17060066|P1|Overall Study|Lack of Efficacy|3
4963211|NCT00193050|17060072|P1|Adjuvant|Lack of Efficacy|2
4963212|NCT00193050|17060072|P1|Adjuvant|Intercurrent Hospitalization|3
4963213|NCT00193050|17060072|P1|Adjuvant|Physician Decision|5
4963214|NCT00193050|17060072|P1|Neoadjuvant Treatment|Adverse Event|2
4963215|NCT00193050|17060072|P1|Neoadjuvant Treatment|Physician Decision|2
4963216|NCT00193050|17060072|P1|Neoadjuvant Treatment|Intercurrent Illness|3
4963217|NCT00193050|17060072|P1|Neoadjuvant Treatment|Lack of Efficacy|2
4963218|NCT00192647|17060089|P2|Overall Study|Other/Administrative|3
4963219|NCT00192647|17060090|P1|Overall Study|Other/Administrative|5
4963220|NCT00192647|17060089|P2|Overall Study|Failure to Return|13
4963221|NCT00192647|17060090|P1|Overall Study|Failure to Return|11
4963222|NCT00192647|17060089|P2|Overall Study|Refused Treatment/Did not Cooperate|8
4963223|NCT00192647|17060090|P1|Overall Study|Refused Treatment/Did not Cooperate|10
4963224|NCT00192647|17060089|P2|Overall Study|Protocol Violation|1
4963225|NCT00192647|17060090|P1|Overall Study|Protocol Violation|3
4963226|NCT00192647|17060089|P2|Overall Study|Entry Criteria Violation|6
4963227|NCT00192647|17060090|P1|Overall Study|Entry Criteria Violation|6
4963228|NCT00192647|17060089|P2|Overall Study|Insufficient Therapeutic Response|83
4963229|NCT00192647|17060090|P1|Overall Study|Insufficient Therapeutic Response|53
4963230|NCT00192647|17060089|P2|Overall Study|Laboratory Test Abnormality|2
4963231|NCT00192647|17060090|P1|Overall Study|Laboratory Test Abnormality|4
4963232|NCT00192647|17060089|P2|Overall Study|Adverse Event|29
4963233|NCT00192647|17060090|P1|Overall Study|Adverse Event|35
4963234|NCT00192647|17060089|P2|Overall Study|Death|1
4963235|NCT00192647|17060090|P1|Overall Study|Death|1
4963236|NCT00192296|17060110|P4|Overall Study|Withdrawal by Subject|0
4963237|NCT00192296|17060111|P3|Overall Study|Withdrawal by Subject|0
4963238|NCT00192296|17060112|P2|Overall Study|Withdrawal by Subject|1
4963239|NCT00192296|17060113|P1|Overall Study|Withdrawal by Subject|0
4963240|NCT00192114|17060167|P1|Overall Study|Death|1
4963241|NCT00192114|17060167|P1|Overall Study|Clinical Progression|2
4963242|NCT00192114|17060167|P1|Overall Study|Adverse Event|2
4963243|NCT00192114|17060167|P1|Overall Study|Objective Tumor Progression|19
4963244|NCT00192075|17060184|P2|Overall Study|Other|2
4963245|NCT00192075|17060185|P1|Overall Study|Other|5
4963246|NCT00192075|17060184|P2|Overall Study|Unacceptable Toxicity Exhibited by Drug|1
4963247|NCT00192075|17060185|P1|Overall Study|Unacceptable Toxicity Exhibited by Drug|2
4963248|NCT00192075|17060184|P2|Overall Study|Patient Non-Compliance|1
4963249|NCT00192075|17060185|P1|Overall Study|Patient Non-Compliance|0
4963250|NCT00192075|17060184|P2|Overall Study|Withdrawal by Subject|5
4963251|NCT00192075|17060185|P1|Overall Study|Withdrawal by Subject|5
4963252|NCT00192075|17060184|P2|Overall Study|Physician Decision|0
4963253|NCT00192075|17060185|P1|Overall Study|Physician Decision|3
4963254|NCT00192075|17060184|P2|Overall Study|Lack of Efficacy|0
4963255|NCT00192075|17060185|P1|Overall Study|Lack of Efficacy|0
4963256|NCT00192075|17060184|P2|Overall Study|Death|1
4963257|NCT00192075|17060185|P1|Overall Study|Death|0
4963258|NCT00192075|17060184|P2|Overall Study|Adverse Event|3
4963259|NCT00192075|17060185|P1|Overall Study|Adverse Event|1
4963260|NCT00192075|17060184|P2|Overall Study|Disease Progression|6
4963261|NCT00192075|17060185|P1|Overall Study|Disease Progression|23
4963262|NCT00192036|17060210|P1|Overall Study|Unknown or Not Specified|5
4963263|NCT00192036|17060210|P1|Overall Study|Death|1
4963264|NCT00192036|17060210|P1|Overall Study|Clinical Disease Progression|1
4963265|NCT00192036|17060210|P1|Overall Study|Objective Tumor Progression|4
4963266|NCT00192036|17060210|P1|Overall Study|Patient/Physician Perception|1
4963267|NCT00192036|17060210|P1|Overall Study|Adverse Event|6
4963268|NCT00192036|17060210|P1|Overall Study|Protocol Violation|3
4963269|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Physician Decision|0
4963270|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Physician Decision|9
4963271|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Withdrawal by Subject|0
4963272|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Withdrawal by Subject|4
4963273|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Protocol Violation|0
4963274|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Protocol Violation|1
4963275|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Lost to Follow-up|0
4963276|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Lost to Follow-up|2
4963277|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Patient/Caregiver Decision|0
4963278|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Patient/Caregiver Decision|46
4963279|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Lack of Efficacy|0
4963280|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Lack of Efficacy|7
4963281|NCT00192023|17060220|P2|Period IV - Optional Open-Label|Adverse Event|0
4963282|NCT00192023|17060221|P1|Period IV - Optional Open-Label|Adverse Event|6
4963283|NCT00192023|17060220|P2|Period III - Double-Blind|Parent/Caregiver Decision|0
4963284|NCT00192023|17060221|P1|Period III - Double-Blind|Parent/Caregiver Decision|2
4963285|NCT00192023|17060220|P2|Period III - Double-Blind|Physician Decision|0
4963286|NCT00192023|17060221|P1|Period III - Double-Blind|Physician Decision|2
4963287|NCT00192023|17060220|P2|Period III - Double-Blind|Adverse Event|0
4963288|NCT00192023|17060221|P1|Period III - Double-Blind|Adverse Event|3
4963289|NCT00191984|17060243|P1|Overall Study|Physician Decision|4
4963290|NCT00191984|17060243|P1|Overall Study|Withdrawal by Subject|7
4963291|NCT00191984|17060243|P1|Overall Study|Entry Criteria Exclusion|1
4963292|NCT00191984|17060243|P1|Overall Study|Death|2
4963293|NCT00191984|17060243|P1|Overall Study|Adverse Event|4
4963294|NCT00191984|17060243|P1|Overall Study|Disease Progression|21
4963295|NCT00191945|17060253|P2|Double-Blind Acute Treatment|Physician Decision|2
4963296|NCT00191945|17060254|P1|Double-Blind Acute Treatment|Physician Decision|0
4963297|NCT00191945|17060253|P2|Double-Blind Acute Treatment|Non Protocol Compliance|0
4963298|NCT00191945|17060254|P1|Double-Blind Acute Treatment|Non Protocol Compliance|3
4963299|NCT00191945|17060253|P2|Double-Blind Acute Treatment|Lost to Follow-up|1
4963300|NCT00191945|17060254|P1|Double-Blind Acute Treatment|Lost to Follow-up|0
4963301|NCT00191945|17060253|P2|Double-Blind Acute Treatment|Parent's Decision|0
4963302|NCT00191945|17060254|P1|Double-Blind Acute Treatment|Parent's Decision|3
4963303|NCT00191906|17060290|P4|Study Period III|Lack of Efficacy|0
4963304|NCT00191906|17060291|P3|Study Period III|Lack of Efficacy|0
4963305|NCT00191906|17060292|P2|Study Period III|Lack of Efficacy|3
4963306|NCT00191906|17060293|P1|Study Period III|Lack of Efficacy|3
4963307|NCT00191906|17060290|P4|Study Period III|Parent/Caregiver Decision|0
4963308|NCT00191906|17060291|P3|Study Period III|Parent/Caregiver Decision|0
4963309|NCT00191906|17060292|P2|Study Period III|Parent/Caregiver Decision|0
4963310|NCT00191906|17060293|P1|Study Period III|Parent/Caregiver Decision|1
4963311|NCT00191906|17060290|P4|Study Period III|Lost to Follow-up|0
4963312|NCT00191906|17060291|P3|Study Period III|Lost to Follow-up|0
4963313|NCT00191906|17060292|P2|Study Period III|Lost to Follow-up|1
4963314|NCT00191906|17060293|P1|Study Period III|Lost to Follow-up|0
4963315|NCT00191906|17060290|P4|Study Period III|Adverse Event|0
4963316|NCT00191906|17060291|P3|Study Period III|Adverse Event|0
4963317|NCT00191906|17060292|P2|Study Period III|Adverse Event|0
4963318|NCT00191906|17060293|P1|Study Period III|Adverse Event|1
4963319|NCT00191906|17060290|P4|Study Period II|Entry Criteria Exclusion|0
4963320|NCT00191906|17060291|P3|Study Period II|Entry Criteria Exclusion|1
4963321|NCT00191906|17060292|P2|Study Period II|Entry Criteria Exclusion|0
4963322|NCT00191906|17060293|P1|Study Period II|Entry Criteria Exclusion|0
4963323|NCT00191906|17060290|P4|Study Period II|Parent/Caregiver Decision|0
4963324|NCT00191906|17060291|P3|Study Period II|Parent/Caregiver Decision|0
4963325|NCT00191906|17060292|P2|Study Period II|Parent/Caregiver Decision|1
4963326|NCT00191906|17060293|P1|Study Period II|Parent/Caregiver Decision|0
4963327|NCT00191906|17060290|P4|Study Period II|Withdrawal by Subject|0
4963328|NCT00191906|17060291|P3|Study Period II|Withdrawal by Subject|0
4963329|NCT00191906|17060292|P2|Study Period II|Withdrawal by Subject|3
4963330|NCT00191906|17060293|P1|Study Period II|Withdrawal by Subject|0
4963331|NCT00191906|17060290|P4|Study Period II|Adverse Event|0
4963332|NCT00191906|17060291|P3|Study Period II|Adverse Event|0
4963333|NCT00191906|17060292|P2|Study Period II|Adverse Event|1
4963334|NCT00191906|17060293|P1|Study Period II|Adverse Event|0
4963335|NCT00191854|17060336|P3|Overall Study|Screen Failure|1
4963336|NCT00191854|17060337|P2|Overall Study|Screen Failure|0
4963337|NCT00191854|17060338|P1|Overall Study|Screen Failure|0
4963338|NCT00191854|17060336|P3|Overall Study|Sponsor Decision|1
4963339|NCT00191854|17060337|P2|Overall Study|Sponsor Decision|0
4963340|NCT00191854|17060338|P1|Overall Study|Sponsor Decision|0
4963341|NCT00191854|17060336|P3|Overall Study|Withdrawal by Subject|3
4963342|NCT00191854|17060337|P2|Overall Study|Withdrawal by Subject|2
4963343|NCT00191854|17060338|P1|Overall Study|Withdrawal by Subject|4
4963344|NCT00191854|17060336|P3|Overall Study|Lost to Follow-up|5
4963345|NCT00191854|17060337|P2|Overall Study|Lost to Follow-up|5
4963346|NCT00191854|17060338|P1|Overall Study|Lost to Follow-up|7
4963347|NCT00191854|17060336|P3|Overall Study|Death|29
4963348|NCT00191854|17060337|P2|Overall Study|Death|23
4963349|NCT00191854|17060338|P1|Overall Study|Death|26
4963350|NCT00191815|17060358|P1|Overall Study|Withdrawal by Subject|7
4963351|NCT00191815|17060358|P1|Overall Study|Physician Decision|2
4963352|NCT00191815|17060358|P1|Overall Study|Protocol Violation|3
4963354|NCT00191815|17060358|P1|Overall Study|Disease progression or relapse|24
4963355|NCT00191815|17060358|P1|Overall Study|Adverse Event|2
4963356|NCT00191789|17060370|P1|Overall Study|Death - Not Study-Drug Related|1
4963357|NCT00191789|17060370|P1|Overall Study|Progressive Disease/Lack of Efficacy|2
4963358|NCT00191789|17060370|P1|Overall Study|Death - Possibly Study Drug Related|4
4963359|NCT00191789|17060370|P1|Overall Study|Withdrawal by Subject|4
4963360|NCT00191789|17060370|P1|Overall Study|Patient/Physician: Satisfactory Response|4
4963361|NCT00191789|17060370|P1|Overall Study|Patient: Satisfactory Response|5
4963362|NCT00191789|17060370|P1|Overall Study|Adverse Event|5
4963363|NCT00191724|17060387|P5|Overall Study|Withdrawal by Subject|0
4963364|NCT00191724|17060388|P4|Overall Study|Withdrawal by Subject|1
4963365|NCT00191724|17060389|P3|Overall Study|Withdrawal by Subject|0
4963366|NCT00191724|17060390|P2|Overall Study|Withdrawal by Subject|0
4963367|NCT00191724|17060391|P1|Overall Study|Withdrawal by Subject|0
4963368|NCT00191724|17060387|P5|Overall Study|Lost to Follow-up|3
4963369|NCT00191724|17060388|P4|Overall Study|Lost to Follow-up|2
4963370|NCT00191724|17060389|P3|Overall Study|Lost to Follow-up|0
4963371|NCT00191724|17060390|P2|Overall Study|Lost to Follow-up|1
4963372|NCT00191724|17060391|P1|Overall Study|Lost to Follow-up|1
4963373|NCT00191724|17060387|P5|Overall Study|Adverse Event|0
4963374|NCT00191724|17060388|P4|Overall Study|Adverse Event|0
4963375|NCT00191724|17060389|P3|Overall Study|Adverse Event|1
4963376|NCT00191724|17060390|P2|Overall Study|Adverse Event|0
4963377|NCT00191724|17060391|P1|Overall Study|Adverse Event|0
4963378|NCT00191646|17060420|P2|Overall Study|Missing Data|11
4963379|NCT00191646|17060421|P1|Overall Study|Missing Data|18
4963380|NCT00191646|17060420|P2|Overall Study|Other|34
4963381|NCT00191646|17060421|P1|Overall Study|Other|33
4963382|NCT00191646|17060420|P2|Overall Study|Death|8
4963383|NCT00191646|17060421|P1|Overall Study|Death|6
4963384|NCT00191646|17060420|P2|Overall Study|Protocol Violation|7
4963385|NCT00191646|17060421|P1|Overall Study|Protocol Violation|5
4963386|NCT00191646|17060420|P2|Overall Study|Withdrawal by Subject|39
4963387|NCT00191646|17060421|P1|Overall Study|Withdrawal by Subject|58
4963388|NCT00191646|17060420|P2|Overall Study|Physician Decision|11
4963389|NCT00191646|17060421|P1|Overall Study|Physician Decision|20
4963390|NCT00191646|17060420|P2|Overall Study|Disease Progression|6
4963391|NCT00191646|17060421|P1|Overall Study|Disease Progression|5
4963392|NCT00191646|17060420|P2|Overall Study|Toxicity|37
4963393|NCT00191646|17060421|P1|Overall Study|Toxicity|26
4963394|NCT00191477|17060441|P2|Overall Study|Discontinued Prior to Instillation|14
4963395|NCT00191477|17060442|P1|Overall Study|Discontinued Prior to Instillation|13
4963396|NCT00191477|17060441|P2|Overall Study|Pathological Specimen Lost|0
4963397|NCT00191477|17060442|P1|Overall Study|Pathological Specimen Lost|1
4963398|NCT00191477|17060441|P2|Overall Study|Not Eligible|38
4963399|NCT00191477|17060442|P1|Overall Study|Not Eligible|41
4963400|NCT00191477|17060441|P2|Overall Study|Other|0
4963401|NCT00191477|17060442|P1|Overall Study|Other|2
4963402|NCT00191477|17060441|P2|Overall Study|Withdrawal by Subject|0
4963403|NCT00191477|17060442|P1|Overall Study|Withdrawal by Subject|2
4963404|NCT00191477|17060441|P2|Overall Study|Treatment Change|0
4963405|NCT00191477|17060442|P1|Overall Study|Treatment Change|2
4963406|NCT00191477|17060441|P2|Overall Study|Protocol Violation|1
4963407|NCT00191477|17060442|P1|Overall Study|Protocol Violation|1
4963408|NCT00191477|17060441|P2|Overall Study|Lost to Follow-up|21
4963409|NCT00191477|17060442|P1|Overall Study|Lost to Follow-up|23
4963410|NCT00191477|17060441|P2|Overall Study|Death, Other Cause|6
4963411|NCT00191477|17060442|P1|Overall Study|Death, Other Cause|3
4963412|NCT00191477|17060441|P2|Overall Study|Death, Study Disease|1
4963413|NCT00191477|17060442|P1|Overall Study|Death, Study Disease|1
4963414|NCT00191477|17060441|P2|Overall Study|Tumor Recurrence|48
4963415|NCT00191477|17060442|P1|Overall Study|Tumor Recurrence|49
4963416|NCT00191451|17060461|P3|Overall Study|Reason Not Specified|3
4963417|NCT00191451|17060462|P2|Overall Study|Reason Not Specified|1
4963418|NCT00191451|17060463|P1|Overall Study|Reason Not Specified|2
4963419|NCT00191451|17060461|P3|Overall Study|Ineligible|0
4963420|NCT00191451|17060462|P2|Overall Study|Ineligible|1
4963421|NCT00191451|17060463|P1|Overall Study|Ineligible|0
4963422|NCT00191451|17060461|P3|Overall Study|Sponsor Decision|0
4963423|NCT00191451|17060462|P2|Overall Study|Sponsor Decision|0
4963424|NCT00191451|17060463|P1|Overall Study|Sponsor Decision|1
4963425|NCT00191451|17060461|P3|Overall Study|Physician Decision|6
4963426|NCT00191451|17060462|P2|Overall Study|Physician Decision|9
4963427|NCT00191451|17060463|P1|Overall Study|Physician Decision|2
4963428|NCT00191451|17060461|P3|Overall Study|Withdrawal by Subject|5
4963429|NCT00191451|17060462|P2|Overall Study|Withdrawal by Subject|3
4963430|NCT00191451|17060463|P1|Overall Study|Withdrawal by Subject|2
4963431|NCT00191386|17060483|P1|Overall Study|Lack of Efficacy|15
4963432|NCT00191386|17060483|P1|Overall Study|Physician Decision|11
4963433|NCT00191386|17060483|P1|Overall Study|Withdrawal by Subject|96
4963434|NCT00191386|17060483|P1|Overall Study|Protocol Violation|18
4963435|NCT00191386|17060483|P1|Overall Study|Entry Criteria Exclusion|3
4963436|NCT00191386|17060483|P1|Overall Study|Lost to Follow-up|1
4963437|NCT00191386|17060483|P1|Overall Study|Adverse Event|16
4963438|NCT00191334|17060490|P1|Overall Study|Withdrawal by Subject|4
4963439|NCT00191334|17060490|P1|Overall Study|Physician Decision|1
4963440|NCT00191334|17060490|P1|Overall Study|Disease Progression or Relapse|8
4963441|NCT00191334|17060490|P1|Overall Study|Adverse Event|4
4963442|NCT00191308|17060498|P1|Overall Study|Adverse Event|1
4963443|NCT00191282|17060508|P2|Overall Study|Lost to Follow-up|31
4963444|NCT00191282|17060509|P1|Overall Study|Lost to Follow-up|24
4963445|NCT00191282|17060508|P2|Overall Study|Sponsor's decision|2
4963446|NCT00191282|17060509|P1|Overall Study|Sponsor's decision|2
4963447|NCT00191282|17060508|P2|Overall Study|Severity of outcome|5
4963448|NCT00191282|17060509|P1|Overall Study|Severity of outcome|2
4963449|NCT00191282|17060508|P2|Overall Study|Protocol Violation|12
4963450|NCT00191282|17060509|P1|Overall Study|Protocol Violation|9
4963451|NCT00191282|17060508|P2|Overall Study|Protocol entry criteria not met|9
4963452|NCT00191282|17060509|P1|Overall Study|Protocol entry criteria not met|14
4963453|NCT00191282|17060508|P2|Overall Study|Physician Decision|15
4963454|NCT00191282|17060509|P1|Overall Study|Physician Decision|18
4963455|NCT00191282|17060508|P2|Overall Study|Withdrawal by Subject|44
4963456|NCT00191282|17060509|P1|Overall Study|Withdrawal by Subject|59
4963457|NCT00191282|17060508|P2|Overall Study|Patient moved|14
4963458|NCT00191282|17060509|P1|Overall Study|Patient moved|11
4963459|NCT00191282|17060508|P2|Overall Study|Noncompliance|17
4963460|NCT00191282|17060509|P1|Overall Study|Noncompliance|14
4963461|NCT00191282|17060508|P2|Overall Study|Lack of Efficacy|6
4963462|NCT00191282|17060509|P1|Overall Study|Lack of Efficacy|11
4963463|NCT00191282|17060508|P2|Overall Study|Death|51
4963464|NCT00191282|17060509|P1|Overall Study|Death|51
4963465|NCT00191282|17060508|P2|Overall Study|Adverse Event|6
4963466|NCT00191282|17060509|P1|Overall Study|Adverse Event|5
4963467|NCT00191269|17060569|P2|Overall Study|Physician Decision|3
4963468|NCT00191269|17060570|P1|Overall Study|Physician Decision|0
4963469|NCT00191269|17060569|P2|Overall Study|Pathologic Aggrevation|1
4963470|NCT00191269|17060570|P1|Overall Study|Pathologic Aggrevation|0
4963471|NCT00191269|17060569|P2|Overall Study|Withdrawal by Subject|1
4963472|NCT00191269|17060570|P1|Overall Study|Withdrawal by Subject|0
4963473|NCT00191269|17060569|P2|Overall Study|Lack of Efficacy|5
4963474|NCT00191269|17060570|P1|Overall Study|Lack of Efficacy|1
4963475|NCT00191269|17060569|P2|Overall Study|Progression of Disease|42
4963476|NCT00191269|17060570|P1|Overall Study|Progression of Disease|4
4963477|NCT00191269|17060569|P2|Overall Study|Adverse Event|4
4963478|NCT00191269|17060570|P1|Overall Study|Adverse Event|1
4963479|NCT00191269|17060569|P2|Overall Study|Protocol Violation|2
4963480|NCT00191269|17060570|P1|Overall Study|Protocol Violation|0
4963481|NCT00191191|17060586|P2|Overall Study|Good Clinical Practice Violation|1
4963482|NCT00191191|17060587|P1|Overall Study|Good Clinical Practice Violation|0
4963483|NCT00191191|17060586|P2|Overall Study|Physician Decision|2
4963484|NCT00191191|17060587|P1|Overall Study|Physician Decision|3
4963485|NCT00191191|17060586|P2|Overall Study|Lost to Follow-up|0
4963486|NCT00191191|17060587|P1|Overall Study|Lost to Follow-up|1
4963487|NCT00191191|17060586|P2|Overall Study|Family/Caregiver Decision|7
4963488|NCT00191191|17060587|P1|Overall Study|Family/Caregiver Decision|5
4963489|NCT00191191|17060586|P2|Overall Study|Toxicity After Dose Reduction|8
4963490|NCT00191191|17060587|P1|Overall Study|Toxicity After Dose Reduction|7
4963491|NCT00191191|17060586|P2|Overall Study|Progressive Disease|72
4963492|NCT00191191|17060587|P1|Overall Study|Progressive Disease|84
4963493|NCT00191191|17060586|P2|Overall Study|Adverse Event|21
4963494|NCT00191191|17060587|P1|Overall Study|Adverse Event|11
4963495|NCT00191191|17060586|P2|Overall Study|Treated with Another Systemic Agent|1
4963496|NCT00191191|17060587|P1|Overall Study|Treated with Another Systemic Agent|1
4963497|NCT00191191|17060586|P2|Overall Study|Entry Criteria Exclusion|0
4963498|NCT00191191|17060587|P1|Overall Study|Entry Criteria Exclusion|2
4963499|NCT00191165|17060603|P2|Overall Study|Participant Moved Away|1
4963500|NCT00191165|17060604|P1|Overall Study|Participant Moved Away|0
4963501|NCT00191165|17060603|P2|Overall Study|Protocol Violation|1
4963502|NCT00191165|17060604|P1|Overall Study|Protocol Violation|0
4963503|NCT00191165|17060603|P2|Overall Study|Adverse Event|0
4963504|NCT00191165|17060604|P1|Overall Study|Adverse Event|2
4963505|NCT00191152|17060616|P2|Crossover Treatment|Other|3
4963506|NCT00191152|17060617|P1|Crossover Treatment|Other|4
4963507|NCT00191152|17060616|P2|Crossover Treatment|Lost to Follow-up|1
4963508|NCT00191152|17060617|P1|Crossover Treatment|Lost to Follow-up|2
4963509|NCT00191152|17060616|P2|Crossover Treatment|Withdrawal by Subject|9
4963510|NCT00191152|17060617|P1|Crossover Treatment|Withdrawal by Subject|6
4963511|NCT00191152|17060616|P2|Crossover Treatment|Physician Decision|7
4963512|NCT00191152|17060617|P1|Crossover Treatment|Physician Decision|7
4963513|NCT00191152|17060616|P2|Crossover Treatment|Adverse Event|8
4963514|NCT00191152|17060617|P1|Crossover Treatment|Adverse Event|8
4963515|NCT00191152|17060616|P2|Initial Treatment|Other|21
4963516|NCT00191152|17060617|P1|Initial Treatment|Other|18
4963517|NCT00191152|17060616|P2|Initial Treatment|Lost to Follow-up|6
4963518|NCT00191152|17060617|P1|Initial Treatment|Lost to Follow-up|0
4963519|NCT00191152|17060616|P2|Initial Treatment|Withdrawal by Subject|28
4963520|NCT00191152|17060617|P1|Initial Treatment|Withdrawal by Subject|40
4963521|NCT00191152|17060616|P2|Initial Treatment|Physician Decision|31
4963522|NCT00191152|17060617|P1|Initial Treatment|Physician Decision|40
4963523|NCT00191152|17060616|P2|Initial Treatment|Adverse Event|67
4963524|NCT00191152|17060617|P1|Initial Treatment|Adverse Event|43
4963525|NCT00191139|17060649|P2|Overall Study|Other|2
4963526|NCT00191139|17060650|P1|Overall Study|Other|1
4963527|NCT00191139|17060649|P2|Overall Study|Disease Progression|1
4963528|NCT00191139|17060650|P1|Overall Study|Disease Progression|0
4963529|NCT00191139|17060649|P2|Overall Study|Withdrawal by Subject|3
4963530|NCT00191139|17060650|P1|Overall Study|Withdrawal by Subject|0
4963531|NCT00191139|17060649|P2|Overall Study|Death|0
4963532|NCT00191139|17060650|P1|Overall Study|Death|2
4963533|NCT00191139|17060649|P2|Overall Study|Adverse Event|6
4963534|NCT00191139|17060650|P1|Overall Study|Adverse Event|2
4963535|NCT00191113|17060666|P2|Core Study|Death|0
4963536|NCT00191113|17060667|P1|Core Study|Death|1
4963537|NCT00191113|17060666|P2|Core Study|Lack of Efficacy|2
4963538|NCT00191113|17060667|P1|Core Study|Lack of Efficacy|0
4963539|NCT00191113|17060666|P2|Core Study|Adverse Event|2
4963540|NCT00191113|17060667|P1|Core Study|Adverse Event|0
4963541|NCT00191113|17060666|P2|Core Study|Lost to Follow-up|0
4963542|NCT00191113|17060667|P1|Core Study|Lost to Follow-up|3
4963543|NCT00191113|17060666|P2|Core Study|Protocol Violation|2
4963544|NCT00191113|17060667|P1|Core Study|Protocol Violation|6
4963545|NCT00191113|17060666|P2|Core Study|Withdrawal by Subject|9
4963546|NCT00191113|17060667|P1|Core Study|Withdrawal by Subject|25
4963547|NCT00191100|17060709|P2|Overall Study|Reason Not Specified|1
4963548|NCT00191100|17060710|P1|Overall Study|Reason Not Specified|0
4963549|NCT00191100|17060709|P2|Overall Study|Death from Other Cause|0
4963550|NCT00191100|17060710|P1|Overall Study|Death from Other Cause|1
4963551|NCT00191100|17060709|P2|Overall Study|Protocol Violation|1
4963552|NCT00191100|17060710|P1|Overall Study|Protocol Violation|1
4963553|NCT00191100|17060709|P2|Overall Study|Death from Study Drug Toxicity|0
4963554|NCT00191100|17060710|P1|Overall Study|Death from Study Drug Toxicity|2
4963555|NCT00191100|17060709|P2|Overall Study|Physician Decision|1
4963556|NCT00191100|17060710|P1|Overall Study|Physician Decision|3
4963557|NCT00191100|17060709|P2|Overall Study|Lack of Efficacy, Stable Disease|0
4963558|NCT00191100|17060710|P1|Overall Study|Lack of Efficacy, Stable Disease|1
4963559|NCT00191100|17060709|P2|Overall Study|Lack of Efficacy, Progressive Disease|2
4963560|NCT00191100|17060710|P1|Overall Study|Lack of Efficacy, Progressive Disease|1
4963561|NCT00191100|17060709|P2|Overall Study|Clinical Relapse|1
4963562|NCT00191100|17060710|P1|Overall Study|Clinical Relapse|2
4963563|NCT00191100|17060709|P2|Overall Study|Protocol Entry Criteria Not Met|1
4963564|NCT00191100|17060710|P1|Overall Study|Protocol Entry Criteria Not Met|2
4963565|NCT00191100|17060709|P2|Overall Study|Withdrawal by Subject|3
4963566|NCT00191100|17060710|P1|Overall Study|Withdrawal by Subject|9
4963567|NCT00191100|17060709|P2|Overall Study|Patient Moved|1
4963568|NCT00191100|17060710|P1|Overall Study|Patient Moved|0
4963569|NCT00191100|17060709|P2|Overall Study|Lost to Follow-up|0
4963570|NCT00191100|17060710|P1|Overall Study|Lost to Follow-up|2
4963571|NCT00191100|17060709|P2|Overall Study|Adverse Event|1
4963572|NCT00191100|17060710|P1|Overall Study|Adverse Event|18
4963573|NCT00190983|17060726|P1|Overall Study|Inevaluable (never treated)|2
4963574|NCT00190775|17060735|P2|Overall Study|Exclusion Criteria Met|3
4963575|NCT00190775|17060736|P1|Overall Study|Exclusion Criteria Met|1
4963576|NCT00190775|17060735|P2|Overall Study|Protocol Violation|1
4963577|NCT00190775|17060736|P1|Overall Study|Protocol Violation|0
4963578|NCT00190775|17060735|P2|Overall Study|Noncompliance|5
4963579|NCT00190775|17060736|P1|Overall Study|Noncompliance|3
4963580|NCT00190775|17060735|P2|Overall Study|Physician Decision|0
4963581|NCT00190775|17060736|P1|Overall Study|Physician Decision|3
4963582|NCT00190775|17060735|P2|Overall Study|Sponsor Decision|0
4963583|NCT00190775|17060736|P1|Overall Study|Sponsor Decision|1
4963584|NCT00190775|17060735|P2|Overall Study|Withdrawal by Subject|13
4963585|NCT00190775|17060736|P1|Overall Study|Withdrawal by Subject|24
4963586|NCT00190775|17060735|P2|Overall Study|Participant Moved|1
4963587|NCT00190775|17060736|P1|Overall Study|Participant Moved|0
4963588|NCT00190775|17060735|P2|Overall Study|Lost to Follow-up|23
4963589|NCT00190775|17060736|P1|Overall Study|Lost to Follow-up|31
4963590|NCT00190775|17060735|P2|Overall Study|Lack of Efficacy|32
4963591|NCT00190775|17060736|P1|Overall Study|Lack of Efficacy|28
4963592|NCT00190775|17060735|P2|Overall Study|Satisfactory Response|0
4963593|NCT00190775|17060736|P1|Overall Study|Satisfactory Response|1
4963594|NCT00190775|17060735|P2|Overall Study|Adverse Event|22
4963595|NCT00190775|17060736|P1|Overall Study|Adverse Event|57
4963596|NCT00190749|17060807|P2|Overall Study|Sponsor Decision|0
4963597|NCT00190749|17060808|P1|Overall Study|Sponsor Decision|1
4963598|NCT00190749|17060807|P2|Overall Study|Reason Not Specified|2
4963599|NCT00190749|17060808|P1|Overall Study|Reason Not Specified|0
4963600|NCT00190749|17060807|P2|Overall Study|Lack of Efficacy|3
4963601|NCT00190749|17060808|P1|Overall Study|Lack of Efficacy|2
4963602|NCT00190749|17060807|P2|Overall Study|Adverse Event|5
4963603|NCT00190749|17060808|P1|Overall Study|Adverse Event|0
4963604|NCT00190749|17060807|P2|Overall Study|Protocol Violation|4
4963605|NCT00190749|17060808|P1|Overall Study|Protocol Violation|5
4963606|NCT00190749|17060807|P2|Overall Study|Withdrawal by Subject|6
4963607|NCT00190749|17060808|P1|Overall Study|Withdrawal by Subject|10
4963608|NCT00190749|17060807|P2|Overall Study|Lost to Follow-up|11
4963609|NCT00190749|17060808|P1|Overall Study|Lost to Follow-up|8
4963610|NCT00190684|17060872|P1|Overall Study|Study Period V Completed|1
4963611|NCT00190684|17060872|P1|Overall Study|Study Period III Completed|103
4963612|NCT00190684|17060872|P1|Overall Study|Protocol Violation|123
4963613|NCT00190684|17060872|P1|Overall Study|Physician Decision|84
4963614|NCT00190684|17060872|P1|Overall Study|Sponsor's decision|17
4963615|NCT00190684|17060872|P1|Overall Study|Clinical relapse|67
4963616|NCT00190684|17060872|P1|Overall Study|Patient Decision|432
4963617|NCT00190684|17060872|P1|Overall Study|Patient moved|60
4963618|NCT00190684|17060872|P1|Overall Study|Lost to Follow-up|232
4963619|NCT00190684|17060872|P1|Overall Study|Lack of efficacy|204
4963620|NCT00190684|17060872|P1|Overall Study|Satisfactory response|80
4963621|NCT00190684|17060872|P1|Overall Study|Adverse Event|86
4963622|NCT00190671|17060893|P2|Overall Study|Withdrawal by Subject|2
4963623|NCT00190671|17060894|P1|Overall Study|Withdrawal by Subject|0
4963624|NCT00190671|17060893|P2|Overall Study|Protocol Violation|1
4963625|NCT00190671|17060894|P1|Overall Study|Protocol Violation|0
4963626|NCT00190671|17060893|P2|Overall Study|Death from Other Causes|2
4963627|NCT00190671|17060894|P1|Overall Study|Death from Other Causes|0
4963628|NCT00190671|17060893|P2|Overall Study|Death from Study-Drug Toxicity|2
4963629|NCT00190671|17060894|P1|Overall Study|Death from Study-Drug Toxicity|0
4963630|NCT00190671|17060893|P2|Overall Study|Clinical Relapse|1
4963631|NCT00190671|17060894|P1|Overall Study|Clinical Relapse|0
4963632|NCT00190671|17060893|P2|Overall Study|Adverse Event|2
4963633|NCT00190671|17060894|P1|Overall Study|Adverse Event|3
4963634|NCT00190671|17060893|P2|Overall Study|Death from Study Disease|1
4963635|NCT00190671|17060894|P1|Overall Study|Death from Study Disease|1
4963636|NCT00190671|17060893|P2|Overall Study|Lack of Efficacy|24
4963637|NCT00190671|17060894|P1|Overall Study|Lack of Efficacy|19
4963638|NCT00190671|17060893|P2|Overall Study|Satisfactory Response|7
4963639|NCT00190671|17060894|P1|Overall Study|Satisfactory Response|4
4963640|NCT00189540|17060914|P2|Overall Study|Death|1
4963641|NCT00189540|17060915|P1|Overall Study|Death|4
4963642|NCT00189540|17060914|P2|Overall Study|Withdrawal by Subject|0
4963643|NCT00189540|17060915|P1|Overall Study|Withdrawal by Subject|3
4963644|NCT00189488|17060933|P2|Overall Study|Other|0
4963645|NCT00189488|17060934|P1|Overall Study|Other|1
4963646|NCT00189488|17060933|P2|Overall Study|Death|8
4963647|NCT00189488|17060934|P1|Overall Study|Death|5
4963648|NCT00189488|17060933|P2|Overall Study|Administrative Decision|2
4963649|NCT00189488|17060934|P1|Overall Study|Administrative Decision|0
4963650|NCT00189488|17060933|P2|Overall Study|Disease progression|4
4963651|NCT00189488|17060934|P1|Overall Study|Disease progression|2
4963652|NCT00189488|17060933|P2|Overall Study|Withdrawal by Subject|6
4963653|NCT00189488|17060934|P1|Overall Study|Withdrawal by Subject|2
4963654|NCT00189488|17060933|P2|Overall Study|Adverse Event|1
4963655|NCT00189488|17060934|P1|Overall Study|Adverse Event|2
4963656|NCT00189488|17060933|P2|Overall Study|Protocol deviation|1
4963657|NCT00189488|17060934|P1|Overall Study|Protocol deviation|2
4963658|NCT00189488|17060933|P2|Overall Study|Ineligibility determined|0
4963659|NCT00189488|17060934|P1|Overall Study|Ineligibility determined|1
4963660|NCT00189462|17060965|P2|Overall Study|Lost to Follow-up|20
4963661|NCT00189462|17060966|P1|Overall Study|Lost to Follow-up|18
4963662|NCT00189462|17060965|P2|Overall Study|Lack of Efficacy|1
4963663|NCT00189462|17060966|P1|Overall Study|Lack of Efficacy|5
4963664|NCT00189423|17060974|P2|Overall Study|Lost to Follow-up|10
4963665|NCT00189423|17060975|P1|Overall Study|Lost to Follow-up|10
4963666|NCT00189423|17060974|P2|Overall Study|Withdrawal by Subject|9
4963667|NCT00189423|17060975|P1|Overall Study|Withdrawal by Subject|9
4963668|NCT00189423|17060974|P2|Overall Study|Death|747
4963669|NCT00189423|17060975|P1|Overall Study|Death|746
4963670|NCT00189306|17060997|P1|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20
4963671|NCT00189306|17060997|P1|Long-Term Follow-up|Lost to Follow-up|9
4963672|NCT00189306|17060997|P1|Long-Term Follow-up|Intercurrent disease|2
4963673|NCT00189306|17060997|P1|Long-Term Follow-up|Withdrawal by Subject|1
4963674|NCT00189306|17060997|P1|Long-Term Follow-up|Death|4
4963675|NCT00189306|17060997|P1|Long-Term Follow-up|Adverse Event|2
4963676|NCT00189306|17060997|P1|Posttreatment Period|Local skin reaction/sign|1
4963677|NCT00189306|17060997|P1|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5
4963678|NCT00189306|17060997|P1|Posttreatment Period|Protocol Violation|1
4963679|NCT00189306|17060997|P1|Posttreatment Period|Target lesion excised|1
4963680|NCT00189306|17060997|P1|Posttreatment Period|Noncompliance|1
4963681|NCT00189306|17060997|P1|Posttreatment Period|Withdrawal by Subject|2
4963682|NCT00189306|17060997|P1|Posttreatment Period|Death|1
4963683|NCT00189306|17060997|P1|Treatment Period|Protocol Violation|1
4963684|NCT00189306|17060997|P1|Treatment Period|Adverse Event|2
4963685|NCT00189306|17060997|P1|Treatment Period|Withdrawal by Subject|2
4963686|NCT00189202|17061006|P1|Overall Study|Physician Decision|5
4963687|NCT00187889|17061047|P2|Overall Study|Withdrawal by Subject|4
4963688|NCT00187889|17061048|P1|Overall Study|Withdrawal by Subject|6
4963689|NCT00187486|17061090|P1|Overall Study|Protocol Violation|1
4963690|NCT00187135|17061170|P6|Visit Three|Study Discontinued|6
4963691|NCT00187135|17061171|P5|Visit Three|Study Discontinued|7
4963692|NCT00187135|17061172|P4|Visit Three|Study Discontinued|7
4963693|NCT00187135|17061173|P3|Visit Three|Study Discontinued|7
4963694|NCT00187135|17061174|P2|Visit Three|Study Discontinued|6
4963695|NCT00187135|17061175|P1|Visit Three|Study Discontinued|7
4963696|NCT00187135|17061170|P6|Visit Three|Withdrawal by Subject|0
4963697|NCT00187135|17061171|P5|Visit Three|Withdrawal by Subject|0
4963698|NCT00187135|17061172|P4|Visit Three|Withdrawal by Subject|2
4963699|NCT00187135|17061173|P3|Visit Three|Withdrawal by Subject|1
4963700|NCT00187135|17061174|P2|Visit Three|Withdrawal by Subject|1
4963701|NCT00187135|17061175|P1|Visit Three|Withdrawal by Subject|0
4963702|NCT00187135|17061170|P6|Visit Three|Death|0
4963703|NCT00187135|17061171|P5|Visit Three|Death|1
4963704|NCT00187135|17061172|P4|Visit Three|Death|0
4963705|NCT00187135|17061173|P3|Visit Three|Death|1
4963706|NCT00187135|17061174|P2|Visit Three|Death|0
4963707|NCT00187135|17061175|P1|Visit Three|Death|0
4963708|NCT00187135|17061170|P6|Visit Two|Study Discontinued|6
4963709|NCT00187135|17061171|P5|Visit Two|Study Discontinued|5
4963710|NCT00187135|17061172|P4|Visit Two|Study Discontinued|7
4963711|NCT00187135|17061173|P3|Visit Two|Study Discontinued|1
4963712|NCT00187135|17061174|P2|Visit Two|Study Discontinued|2
4963713|NCT00187135|17061175|P1|Visit Two|Study Discontinued|3
4963714|NCT00187135|17061170|P6|Visit Two|Withdrawal by Subject|1
4963715|NCT00187135|17061171|P5|Visit Two|Withdrawal by Subject|1
4963716|NCT00187135|17061172|P4|Visit Two|Withdrawal by Subject|0
4963717|NCT00187135|17061173|P3|Visit Two|Withdrawal by Subject|1
4963718|NCT00187135|17061174|P2|Visit Two|Withdrawal by Subject|1
4963719|NCT00187135|17061175|P1|Visit Two|Withdrawal by Subject|1
4963720|NCT00187135|17061170|P6|Visit Two|Physician Decision|0
4963721|NCT00187135|17061171|P5|Visit Two|Physician Decision|0
4963722|NCT00187135|17061172|P4|Visit Two|Physician Decision|0
4963723|NCT00187135|17061173|P3|Visit Two|Physician Decision|0
4963724|NCT00187135|17061174|P2|Visit Two|Physician Decision|0
4963725|NCT00187135|17061175|P1|Visit Two|Physician Decision|1
4963726|NCT00187135|17061170|P6|Visit Two|Death|1
4963727|NCT00187135|17061171|P5|Visit Two|Death|0
4963728|NCT00187135|17061172|P4|Visit Two|Death|1
4963729|NCT00187135|17061173|P3|Visit Two|Death|0
4963730|NCT00187135|17061174|P2|Visit Two|Death|0
4963731|NCT00187135|17061175|P1|Visit Two|Death|0
4963732|NCT00187135|17061170|P6|Visit One|Physician Decision|1
4963733|NCT00187135|17061171|P5|Visit One|Physician Decision|0
4963734|NCT00187135|17061172|P4|Visit One|Physician Decision|0
4963735|NCT00187135|17061173|P3|Visit One|Physician Decision|0
4963736|NCT00187135|17061174|P2|Visit One|Physician Decision|1
4963737|NCT00187135|17061175|P1|Visit One|Physician Decision|3
4963738|NCT00187135|17061170|P6|Visit One|Withdrawal by Subject|1
4963739|NCT00187135|17061171|P5|Visit One|Withdrawal by Subject|0
4963740|NCT00187135|17061172|P4|Visit One|Withdrawal by Subject|0
4963741|NCT00187135|17061173|P3|Visit One|Withdrawal by Subject|0
4963742|NCT00187135|17061174|P2|Visit One|Withdrawal by Subject|0
4963743|NCT00187135|17061175|P1|Visit One|Withdrawal by Subject|1
4963744|NCT00187096|17061198|P3|Overall Study|unacceptable toxicity|1
4963745|NCT00187096|17061199|P2|Overall Study|unacceptable toxicity|0
4963746|NCT00187096|17061200|P1|Overall Study|unacceptable toxicity|0
4963747|NCT00186901|17061238|P3|Overall Study|Bone Mineral Density > 0|149
4963748|NCT00186901|17061239|P2|Overall Study|Bone Mineral Density > 0|0
4963749|NCT00186901|17061240|P1|Overall Study|Bone Mineral Density > 0|0
4963750|NCT00186901|17061238|P3|Overall Study|Limited adherence to study requirements|0
4963751|NCT00186901|17061239|P2|Overall Study|Limited adherence to study requirements|23
4963752|NCT00186901|17061240|P1|Overall Study|Limited adherence to study requirements|20
4963753|NCT00186901|17061238|P3|Overall Study|Open label|0
4963754|NCT00186901|17061239|P2|Overall Study|Open label|2
4963755|NCT00186901|17061240|P1|Overall Study|Open label|3
4963756|NCT00186901|17061238|P3|Overall Study|Withdrawal by Subject|0
4963757|NCT00186901|17061239|P2|Overall Study|Withdrawal by Subject|5
4963758|NCT00186901|17061240|P1|Overall Study|Withdrawal by Subject|4
4963759|NCT00186901|17061238|P3|Overall Study|ALL relapse or second malignancy|0
4963760|NCT00186901|17061239|P2|Overall Study|ALL relapse or second malignancy|2
4963761|NCT00186901|17061240|P1|Overall Study|ALL relapse or second malignancy|1
4963762|NCT00186901|17061238|P3|Overall Study|Bone Mineral Density dropped > 5%|0
4963763|NCT00186901|17061239|P2|Overall Study|Bone Mineral Density dropped > 5%|7
4963764|NCT00186901|17061240|P1|Overall Study|Bone Mineral Density dropped > 5%|9
4963765|NCT00186901|17061238|P3|Overall Study|Lost to Follow-up|0
4963766|NCT00186901|17061239|P2|Overall Study|Lost to Follow-up|3
4963767|NCT00186901|17061240|P1|Overall Study|Lost to Follow-up|6
4963768|NCT00186901|17061238|P3|Overall Study|Pregnancy|0
4963769|NCT00186901|17061239|P2|Overall Study|Pregnancy|3
4963770|NCT00186901|17061240|P1|Overall Study|Pregnancy|6
4963771|NCT00186888|17061280|P3|Overall Study|Relapse or progression of disease|0
4963772|NCT00186888|17061281|P2|Overall Study|Relapse or progression of disease|2
4963773|NCT00186888|17061282|P1|Overall Study|Relapse or progression of disease|4
4963774|NCT00186888|17061280|P3|Overall Study|Toxicity|0
4963775|NCT00186888|17061281|P2|Overall Study|Toxicity|1
4963776|NCT00186888|17061282|P1|Overall Study|Toxicity|0
4963777|NCT00186628|17061374|P1|Overall Study|Withdrawal by subject (before treatment)|1
4963778|NCT00186628|17061374|P1|Overall Study|Death|2
4963779|NCT00186537|17061385|P3|Overall Study|ALT > 1.5 x ULN|0
4963780|NCT00186537|17061386|P2|Overall Study|ALT > 1.5 x ULN|0
4963781|NCT00186537|17061387|P1|Overall Study|ALT > 1.5 x ULN|3
4963782|NCT00186537|17061385|P3|Overall Study|Withdrawal by Subject|3
4963783|NCT00186537|17061386|P2|Overall Study|Withdrawal by Subject|0
4963784|NCT00186537|17061387|P1|Overall Study|Withdrawal by Subject|4
4963785|NCT00186485|17061410|P1|Overall Study|Lost to Follow-up|3
4963786|NCT00186186|17061422|P1|Overall Study|Not reported as to reason|2
4963787|NCT00186186|17061422|P1|Overall Study|Withdrawal by Subject|3
4963788|NCT00186186|17061422|P1|Overall Study|Lack of Efficacy|3
4963789|NCT00186121|17061427|P1|Overall Study|Not eligible (no treatment)|1
4963790|NCT00186121|17061427|P1|Overall Study|Underwent oophorectomy (no treatment)|1
4963791|NCT00186121|17061427|P1|Overall Study|Subject withdrawal (no treatment)|1
4963792|NCT00186043|17061461|P2|Overall Study|Protocol Violation|1
4963793|NCT00186043|17061462|P1|Overall Study|Protocol Violation|2
4963794|NCT00186043|17061461|P2|Overall Study|Adverse Event|3
4963795|NCT00186043|17061462|P1|Overall Study|Adverse Event|7
4963796|NCT00186043|17061461|P2|Overall Study|Withdrawal by Subject|0
4963797|NCT00186043|17061462|P1|Overall Study|Withdrawal by Subject|1
4963798|NCT00186043|17061461|P2|Overall Study|Lost to Follow-up|6
4963799|NCT00186043|17061462|P1|Overall Study|Lost to Follow-up|4
4963800|NCT00186043|17061461|P2|Overall Study|Lack of Efficacy|3
4963801|NCT00186043|17061462|P1|Overall Study|Lack of Efficacy|1
4963802|NCT00185965|17061489|P2|Overall Study|Adverse Event|1
4963803|NCT00185965|17061490|P1|Overall Study|Adverse Event|0
4963804|NCT00185731|17061515|P1|Overall Study|Not Eligible|1
4963805|NCT00185731|17061515|P1|Overall Study|Withdrawal by Subject|1
4963806|NCT00185640|17061532|P1|Overall Study|Death|138
4963807|NCT00185640|17061532|P1|Overall Study|Withdrawal by Subject|3
4963808|NCT00185640|17061532|P1|Overall Study|Not Eligible|4
4963809|NCT00185614|17061541|P1|Inter-treatment Period|Lack of allogenic donor|1
4963810|NCT00185614|17061541|P1|Inter-treatment Period|Relapse|2
4963811|NCT00185614|17061541|P1|Inter-treatment Period|Physician Decision|1
4963812|NCT00185588|17061553|P4|Overall Study|Physician Decision|0
4963813|NCT00185588|17061554|P3|Overall Study|Physician Decision|1
4963814|NCT00185588|17061555|P2|Overall Study|Physician Decision|0
4963815|NCT00185588|17061556|P1|Overall Study|Physician Decision|0
4963816|NCT00185588|17061553|P4|Overall Study|Withdrawal by Subject|0
4963817|NCT00185588|17061554|P3|Overall Study|Withdrawal by Subject|0
4963818|NCT00185588|17061555|P2|Overall Study|Withdrawal by Subject|1
4963819|NCT00185588|17061556|P1|Overall Study|Withdrawal by Subject|0
4963820|NCT00185588|17061553|P4|Overall Study|Lost to Follow-up|2
4963821|NCT00185588|17061554|P3|Overall Study|Lost to Follow-up|1
4963822|NCT00185588|17061555|P2|Overall Study|Lost to Follow-up|0
4963823|NCT00185588|17061556|P1|Overall Study|Lost to Follow-up|0
4963824|NCT00185588|17061553|P4|Overall Study|Adverse Event|2
4963825|NCT00185588|17061554|P3|Overall Study|Adverse Event|4
4963826|NCT00185588|17061555|P2|Overall Study|Adverse Event|1
4963827|NCT00185588|17061556|P1|Overall Study|Adverse Event|3
4963828|NCT00185458|17061570|P1|HRT Phase|Withdrawal by Subject|3
4963829|NCT00185458|17061570|P1|HRT Phase|Protocol Violation|2
4963830|NCT00185458|17061570|P1|HRT Phase|Lost to Follow-up|4
4963831|NCT00185458|17061570|P1|HRT Phase|Adverse Event|18
4963832|NCT00185458|17061570|P1|Contraception Phase|Withdrawal by Subject|7
4963833|NCT00185458|17061570|P1|Contraception Phase|Physician Decision|2
4963834|NCT00185458|17061570|P1|Contraception Phase|Protocol Violation|2
4963835|NCT00185458|17061570|P1|Contraception Phase|Lost to Follow-up|10
4963836|NCT00185458|17061570|P1|Contraception Phase|Adverse Event|37
4963837|NCT00185380|17061633|P3|Overall Study|personal reason|1
4963838|NCT00185380|17061634|P2|Overall Study|personal reason|1
4963839|NCT00185380|17061635|P1|Overall Study|personal reason|6
4963840|NCT00185380|17061633|P3|Overall Study|Could not attend visits|4
4963841|NCT00185380|17061634|P2|Overall Study|Could not attend visits|0
4963842|NCT00185380|17061635|P1|Overall Study|Could not attend visits|2
4963843|NCT00185380|17061633|P3|Overall Study|No need for contraception|3
4963844|NCT00185380|17061634|P2|Overall Study|No need for contraception|3
4963845|NCT00185380|17061635|P1|Overall Study|No need for contraception|3
4963846|NCT00185380|17061633|P3|Overall Study|Planned pregnancy|12
4963847|NCT00185380|17061634|P2|Overall Study|Planned pregnancy|12
4963848|NCT00185380|17061635|P1|Overall Study|Planned pregnancy|9
4963849|NCT00185380|17061633|P3|Overall Study|Failed insertion|2
4963850|NCT00185380|17061634|P2|Overall Study|Failed insertion|1
4963851|NCT00185380|17061635|P1|Overall Study|Failed insertion|1
4963852|NCT00185380|17061633|P3|Overall Study|Withdrawal by Subject|0
4963853|NCT00185380|17061634|P2|Overall Study|Withdrawal by Subject|2
4963854|NCT00185380|17061635|P1|Overall Study|Withdrawal by Subject|1
4963855|NCT00185380|17061633|P3|Overall Study|Protocol Violation|1
4963856|NCT00185380|17061634|P2|Overall Study|Protocol Violation|2
4963857|NCT00185380|17061635|P1|Overall Study|Protocol Violation|2
4963858|NCT00185380|17061633|P3|Overall Study|Pregnancy|0
4963859|NCT00185380|17061634|P2|Overall Study|Pregnancy|4
4963860|NCT00185380|17061635|P1|Overall Study|Pregnancy|1
4963861|NCT00185380|17061633|P3|Overall Study|Lost to Follow-up|3
4963862|NCT00185380|17061634|P2|Overall Study|Lost to Follow-up|4
4963863|NCT00185380|17061635|P1|Overall Study|Lost to Follow-up|0
4963864|NCT00185380|17061633|P3|Overall Study|Adverse Event|48
4963865|NCT00185380|17061634|P2|Overall Study|Adverse Event|43
4963866|NCT00185380|17061635|P1|Overall Study|Adverse Event|41
4963867|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|other disease modif. treatment|2
4963868|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|other disease modif. treatment|0
4963869|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21
4963870|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13
4963871|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|Pregnancy|1
4963872|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|Pregnancy|0
4963873|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|Physician Decision|0
4963874|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|Physician Decision|1
4963875|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|Lost to Follow-up|4
4963876|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|Lost to Follow-up|6
4963877|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|Lack of Efficacy|0
4963878|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|Lack of Efficacy|1
4963879|NCT00185211|17061663|P2|Follow-up Study (91031 - This Study)|Adverse Event|6
4963880|NCT00185211|17061664|P1|Follow-up Study (91031 - This Study)|Adverse Event|5
4963881|NCT00185211|17061663|P2|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0
4963968|NCT00183274|17062091|P2|Phase 2: Double-Blind|Relapsed|8
4963882|NCT00185211|17061664|P1|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1
4963883|NCT00185211|17061663|P2|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1
4963884|NCT00185211|17061664|P1|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0
4963885|NCT00185211|17061663|P2|Placebo-controlled Study (92012)|Withdrawal by Subject|7
4963886|NCT00185211|17061664|P1|Placebo-controlled Study (92012)|Withdrawal by Subject|9
4963887|NCT00185211|17061663|P2|Placebo-controlled Study (92012)|Lost to Follow-up|2
4963888|NCT00185211|17061664|P1|Placebo-controlled Study (92012)|Lost to Follow-up|3
4963889|NCT00185211|17061663|P2|Placebo-controlled Study (92012)|Adverse Event|0
4963890|NCT00185211|17061664|P1|Placebo-controlled Study (92012)|Adverse Event|8
4963891|NCT00184600|17061737|P3|Overall Study|Unclassified|3
4963892|NCT00184600|17061738|P2|Overall Study|Unclassified|5
4963893|NCT00184600|17061739|P1|Overall Study|Unclassified|4
4963894|NCT00184600|17061737|P3|Overall Study|Withdrawal by Subject|12
4963895|NCT00184600|17061738|P2|Overall Study|Withdrawal by Subject|28
4963896|NCT00184600|17061739|P1|Overall Study|Withdrawal by Subject|20
4963897|NCT00184600|17061737|P3|Overall Study|Protocol Violation|3
4963898|NCT00184600|17061738|P2|Overall Study|Protocol Violation|2
4963899|NCT00184600|17061739|P1|Overall Study|Protocol Violation|2
4963900|NCT00184600|17061737|P3|Overall Study|Lost to Follow-up|1
4963901|NCT00184600|17061738|P2|Overall Study|Lost to Follow-up|6
4963902|NCT00184600|17061739|P1|Overall Study|Lost to Follow-up|4
4963903|NCT00184600|17061737|P3|Overall Study|Lack of Efficacy|3
4963904|NCT00184600|17061738|P2|Overall Study|Lack of Efficacy|1
4963905|NCT00184600|17061739|P1|Overall Study|Lack of Efficacy|3
4963906|NCT00184600|17061737|P3|Overall Study|Death|7
4963907|NCT00184600|17061738|P2|Overall Study|Death|9
4963908|NCT00184600|17061739|P1|Overall Study|Death|3
4963909|NCT00184600|17061737|P3|Overall Study|Adverse Event|5
4963910|NCT00184600|17061738|P2|Overall Study|Adverse Event|0
4963911|NCT00184600|17061739|P1|Overall Study|Adverse Event|9
4963912|NCT00184093|17061830|P1|Overall Study|Withdrawal by Subject|2
4963913|NCT00184093|17061830|P1|Overall Study|Physician Decision|1
4963914|NCT00184093|17061830|P1|Overall Study|Lost to Follow-up|3
4963915|NCT00184093|17061830|P1|Overall Study|Adverse Event|3
4963916|NCT00184054|17061835|P1|Overall Study|Adverse Event|1
4963917|NCT00184028|17061840|P1|Overall Study|Non-compliance|2
4963918|NCT00184028|17061840|P1|Overall Study|Withdrawal by Subject|1
4963919|NCT00184028|17061840|P1|Overall Study|Adverse Event|2
4963920|NCT00184028|17061840|P1|Overall Study|Lack of Efficacy|4
4963921|NCT00184028|17061840|P1|Overall Study|Death|1
4963922|NCT00184002|17061845|P1|Overall Study|Withdrawal by Subject|4
4963923|NCT00184002|17061845|P1|Overall Study|Physician Decision|1
4963924|NCT00184002|17061845|P1|Overall Study|Death|3
4963925|NCT00184002|17061845|P1|Overall Study|Adverse Event|9
4963926|NCT00183872|17061871|P1|Overall Study|Drug delayed more than 28 days|2
4963927|NCT00183872|17061871|P1|Overall Study|Withdrawal by Subject|2
4963928|NCT00183872|17061871|P1|Overall Study|Adverse Event|9
4963929|NCT00183872|17061871|P1|Overall Study|Death|3
4963930|NCT00183625|17061900|P4|Overall Study|Withdrawal by Subject|14
4963931|NCT00183625|17061901|P3|Overall Study|Withdrawal by Subject|19
4963932|NCT00183625|17061902|P2|Overall Study|Withdrawal by Subject|18
4963933|NCT00183625|17061903|P1|Overall Study|Withdrawal by Subject|18
4963934|NCT00183430|17062000|P2|Overall Study|Withdrawal by Subject|0
4963935|NCT00183430|17062001|P1|Overall Study|Withdrawal by Subject|1
4963936|NCT00183430|17062000|P2|Overall Study|did not meet inclusion criteria|0
4963937|NCT00183430|17062001|P1|Overall Study|did not meet inclusion criteria|1
4963938|NCT00183430|17062000|P2|Overall Study|Lost to Follow-up|0
4963939|NCT00183430|17062001|P1|Overall Study|Lost to Follow-up|3
4963940|NCT00183430|17062000|P2|Overall Study|Adverse Event|0
4963941|NCT00183430|17062001|P1|Overall Study|Adverse Event|1
4963942|NCT00183391|17062013|P2|Block 2 - 5 Weeks|Withdrawal by Subject|2
4963943|NCT00183391|17062014|P1|Block 2 - 5 Weeks|Withdrawal by Subject|4
4963944|NCT00183391|17062013|P2|Block 1 - 5 Weeks|Withdrawal by Subject|14
4963945|NCT00183391|17062014|P1|Block 1 - 5 Weeks|Withdrawal by Subject|13
4963946|NCT00183274|17062087|P6|Phase 3: Double-Blind|Relapsed|2
4963947|NCT00183274|17062088|P5|Phase 3: Double-Blind|Relapsed|11
4963948|NCT00183274|17062089|P4|Phase 3: Double-Blind|Relapsed|1
4963949|NCT00183274|17062090|P3|Phase 3: Double-Blind|Relapsed|0
4963950|NCT00183274|17062091|P2|Phase 3: Double-Blind|Relapsed|0
4963951|NCT00183274|17062092|P1|Phase 3: Double-Blind|Relapsed|0
4963952|NCT00183274|17062087|P6|Phase 3: Double-Blind|Withdrawal by Subject|2
4963953|NCT00183274|17062088|P5|Phase 3: Double-Blind|Withdrawal by Subject|9
4963954|NCT00183274|17062089|P4|Phase 3: Double-Blind|Withdrawal by Subject|1
4963955|NCT00183274|17062090|P3|Phase 3: Double-Blind|Withdrawal by Subject|0
4963956|NCT00183274|17062091|P2|Phase 3: Double-Blind|Withdrawal by Subject|0
4963957|NCT00183274|17062092|P1|Phase 3: Double-Blind|Withdrawal by Subject|0
4963958|NCT00183274|17062087|P6|Phase 2: Double-Blind|Withdrawal by Subject|0
4963959|NCT00183274|17062088|P5|Phase 2: Double-Blind|Withdrawal by Subject|0
4963960|NCT00183274|17062089|P4|Phase 2: Double-Blind|Withdrawal by Subject|0
4963961|NCT00183274|17062090|P3|Phase 2: Double-Blind|Withdrawal by Subject|14
4963962|NCT00183274|17062091|P2|Phase 2: Double-Blind|Withdrawal by Subject|18
4963963|NCT00183274|17062092|P1|Phase 2: Double-Blind|Withdrawal by Subject|0
4963964|NCT00183274|17062087|P6|Phase 2: Double-Blind|Relapsed|0
4963965|NCT00183274|17062088|P5|Phase 2: Double-Blind|Relapsed|0
4963966|NCT00183274|17062089|P4|Phase 2: Double-Blind|Relapsed|0
4963967|NCT00183274|17062090|P3|Phase 2: Double-Blind|Relapsed|29
4963969|NCT00183274|17062092|P1|Phase 2: Double-Blind|Relapsed|0
4963970|NCT00183274|17062087|P6|Phase 1: Open-Label|Other|0
4963971|NCT00183274|17062088|P5|Phase 1: Open-Label|Other|0
4963972|NCT00183274|17062089|P4|Phase 1: Open-Label|Other|0
4963973|NCT00183274|17062090|P3|Phase 1: Open-Label|Other|0
4963974|NCT00183274|17062091|P2|Phase 1: Open-Label|Other|0
4963975|NCT00183274|17062092|P1|Phase 1: Open-Label|Other|9
4963976|NCT00183274|17062087|P6|Phase 1: Open-Label|Lost to Follow-up|0
4963977|NCT00183274|17062088|P5|Phase 1: Open-Label|Lost to Follow-up|0
4963978|NCT00183274|17062089|P4|Phase 1: Open-Label|Lost to Follow-up|0
4963979|NCT00183274|17062090|P3|Phase 1: Open-Label|Lost to Follow-up|0
4963980|NCT00183274|17062091|P2|Phase 1: Open-Label|Lost to Follow-up|0
4963981|NCT00183274|17062092|P1|Phase 1: Open-Label|Lost to Follow-up|33
4963982|NCT00183274|17062087|P6|Phase 1: Open-Label|Withdrawal by Subject|0
4963983|NCT00183274|17062088|P5|Phase 1: Open-Label|Withdrawal by Subject|0
4963984|NCT00183274|17062089|P4|Phase 1: Open-Label|Withdrawal by Subject|0
4963985|NCT00183274|17062090|P3|Phase 1: Open-Label|Withdrawal by Subject|0
4963986|NCT00183274|17062091|P2|Phase 1: Open-Label|Withdrawal by Subject|0
4963987|NCT00183274|17062092|P1|Phase 1: Open-Label|Withdrawal by Subject|13
4963988|NCT00183274|17062087|P6|Phase 1: Open-Label|Protocol Violation|0
4963989|NCT00183274|17062088|P5|Phase 1: Open-Label|Protocol Violation|0
4963990|NCT00183274|17062089|P4|Phase 1: Open-Label|Protocol Violation|0
4963991|NCT00183274|17062090|P3|Phase 1: Open-Label|Protocol Violation|0
4963992|NCT00183274|17062091|P2|Phase 1: Open-Label|Protocol Violation|0
4963993|NCT00183274|17062092|P1|Phase 1: Open-Label|Protocol Violation|11
4963994|NCT00183274|17062087|P6|Phase 1: Open-Label|Lack of Efficacy|0
4963995|NCT00183274|17062088|P5|Phase 1: Open-Label|Lack of Efficacy|0
4963996|NCT00183274|17062089|P4|Phase 1: Open-Label|Lack of Efficacy|0
4963997|NCT00183274|17062090|P3|Phase 1: Open-Label|Lack of Efficacy|0
4963998|NCT00183274|17062091|P2|Phase 1: Open-Label|Lack of Efficacy|0
4963999|NCT00183274|17062092|P1|Phase 1: Open-Label|Lack of Efficacy|13
4964000|NCT00183274|17062087|P6|Phase 1: Open-Label|Adverse Event|0
4964001|NCT00183274|17062088|P5|Phase 1: Open-Label|Adverse Event|0
4964002|NCT00183274|17062089|P4|Phase 1: Open-Label|Adverse Event|0
4964003|NCT00183274|17062090|P3|Phase 1: Open-Label|Adverse Event|0
4964004|NCT00183274|17062091|P2|Phase 1: Open-Label|Adverse Event|0
4964005|NCT00183274|17062092|P1|Phase 1: Open-Label|Adverse Event|31
4964006|NCT00183248|17062109|P2|Overall Study|Focal glomerulosclerosis proteinuria|0
4964007|NCT00183248|17062110|P1|Overall Study|Focal glomerulosclerosis proteinuria|1
4964008|NCT00183248|17062109|P2|Overall Study|Lost to Follow-up|1
4964009|NCT00183248|17062110|P1|Overall Study|Lost to Follow-up|0
4964010|NCT00183196|17062131|P3|Overall Study|Required more intensive care|2
4964011|NCT00183196|17062132|P2|Overall Study|Required more intensive care|1
4964012|NCT00183196|17062133|P1|Overall Study|Required more intensive care|0
4964013|NCT00183196|17062131|P3|Overall Study|Legal event|1
4964014|NCT00183196|17062132|P2|Overall Study|Legal event|1
4964015|NCT00183196|17062133|P1|Overall Study|Legal event|1
4964016|NCT00183196|17062131|P3|Overall Study|Adverse Event|2
4964017|NCT00183196|17062132|P2|Overall Study|Adverse Event|2
4964018|NCT00183196|17062133|P1|Overall Study|Adverse Event|1
4964019|NCT00183196|17062131|P3|Overall Study|Withdrawal by Subject|13
4964020|NCT00183196|17062132|P2|Overall Study|Withdrawal by Subject|11
4964021|NCT00183196|17062133|P1|Overall Study|Withdrawal by Subject|18
4964022|NCT00182689|17062216|P2|Overall Study|Never received treatment|0
4964023|NCT00182689|17062217|P1|Overall Study|Never received treatment|1
4964024|NCT00182689|17062216|P2|Overall Study|Ineligible|4
4964025|NCT00182689|17062217|P1|Overall Study|Ineligible|1
4964026|NCT00182689|17062216|P2|Overall Study|not protocol specified|3
4964027|NCT00182689|17062217|P1|Overall Study|not protocol specified|0
4964028|NCT00182689|17062216|P2|Overall Study|Death|0
4964029|NCT00182689|17062217|P1|Overall Study|Death|1
4964030|NCT00182689|17062216|P2|Overall Study|Progression|29
4964031|NCT00182689|17062217|P1|Overall Study|Progression|27
4964032|NCT00182689|17062216|P2|Overall Study|Withdrawal by Subject|2
4964033|NCT00182689|17062217|P1|Overall Study|Withdrawal by Subject|2
4964034|NCT00182689|17062216|P2|Overall Study|Adverse Event|11
4964035|NCT00182689|17062217|P1|Overall Study|Adverse Event|8
4964036|NCT00182637|17062227|P1|Overall Study|Disease Progression|1
4964037|NCT00182637|17062227|P1|Overall Study|Adverse Event|2
4964038|NCT00182325|17062235|P2|Overall Study|Did not complete survey|43
4964039|NCT00182325|17062236|P1|Overall Study|Did not complete survey|22
4964040|NCT00182325|17062235|P2|Overall Study|Miscarriage|3
4964041|NCT00182325|17062236|P1|Overall Study|Miscarriage|5
4964042|NCT00182325|17062235|P2|Overall Study|Lost to Follow-up|7
4964043|NCT00182325|17062236|P1|Overall Study|Lost to Follow-up|7
4964044|NCT00182091|17062264|P4|Overall Study|Withdrawal by Subject|0
4964045|NCT00182091|17062265|P3|Overall Study|Withdrawal by Subject|0
4964046|NCT00182091|17062266|P2|Overall Study|Withdrawal by Subject|0
4964047|NCT00182091|17062267|P1|Overall Study|Withdrawal by Subject|1
4964048|NCT00182078|17062283|P2|Overall Study|Withdrawal by Subject|0
4964049|NCT00182078|17062284|P1|Overall Study|Withdrawal by Subject|1
4964050|NCT00181883|17062312|P1|Overall Study|Lost to Follow-up|1
4964051|NCT00181883|17062312|P1|Overall Study|Withdrawal by Subject|4
4964052|NCT00181883|17062312|P1|Overall Study|Treatment Limiting AEs|3
4964053|NCT00181883|17062312|P1|Overall Study|Lack of Efficacy|2
4964054|NCT00181844|17062316|P1|Exposed to Study Medication|Difficulty meeting study schedule|2
4964055|NCT00181844|17062316|P1|Exposed to Study Medication|Withdrawal by Subject|1
4964056|NCT00181844|17062316|P1|Exposed to Study Medication|Non-compliance|2
4964057|NCT00181844|17062316|P1|Exposed to Study Medication|Lack of Efficacy|2
4964058|NCT00181844|17062316|P1|Exposed to Study Medication|Adverse Event|10
4964059|NCT00181844|17062316|P1|Signed Consent|Did not meet entrance criteria|7
4964060|NCT00181844|17062316|P1|Signed Consent|Withdrawal by Subject|5
4964061|NCT00181766|17062320|P1|Overall Study|non-compliance|2
4964062|NCT00181766|17062320|P1|Overall Study|Adverse Event|4
4964063|NCT00181766|17062320|P1|Overall Study|Lost to Follow-up|6
4964064|NCT00181155|17062394|P2|Overall Study|Withdrawal by Subject|0
4964065|NCT00181155|17062395|P1|Overall Study|Withdrawal by Subject|1
4964066|NCT00181155|17062394|P2|Overall Study|Physician Decision|0
4964067|NCT00181155|17062395|P1|Overall Study|Physician Decision|1
4964068|NCT00180713|17062405|P2|Overall Study|Adverse Event|3
4964069|NCT00180713|17062406|P1|Overall Study|Adverse Event|3
4964070|NCT00180713|17062405|P2|Overall Study|Withdrawal by Subject|0
4964071|NCT00180713|17062406|P1|Overall Study|Withdrawal by Subject|2
4964072|NCT00180479|17062470|P2|Overall Study|Informed consent not signed|1
4964073|NCT00180479|17062471|P1|Overall Study|Informed consent not signed|0
4964074|NCT00180479|17062470|P2|Overall Study|Withdrawal by Subject|3
4964075|NCT00180479|17062471|P1|Overall Study|Withdrawal by Subject|3
4964076|NCT00180479|17062470|P2|Overall Study|Lost to Follow-up|7
4964077|NCT00180479|17062471|P1|Overall Study|Lost to Follow-up|9
4964078|NCT00180479|17062470|P2|Overall Study|Death|2
4964079|NCT00180479|17062471|P1|Overall Study|Death|4
4964080|NCT00179959|17062596|P2|Overall Study|Withdrawal by Subject|2
4964081|NCT00179959|17062597|P1|Overall Study|Withdrawal by Subject|3
4964082|NCT00179959|17062596|P2|Overall Study|Lost to Follow-up|1
4964083|NCT00179959|17062597|P1|Overall Study|Lost to Follow-up|3
4964084|NCT00179673|17062603|P1|Overall Study|Other Observations and options|14
4964085|NCT00179673|17062603|P1|Overall Study|Death|4
4964086|NCT00179673|17062603|P1|Overall Study|Withdrawal by Subject|3
4964087|NCT00179673|17062603|P1|Overall Study|Lack of Efficacy|15
4964088|NCT00179673|17062603|P1|Overall Study|Adverse Event|7
4964089|NCT00179660|17062611|P1|Overall Study|Other - Unspecified|9
4964090|NCT00179660|17062611|P1|Overall Study|Death|3
4964091|NCT00179660|17062611|P1|Overall Study|Lost to Follow-up|1
4964092|NCT00179660|17062611|P1|Overall Study|Withdrawal by Subject|2
4964093|NCT00179660|17062611|P1|Overall Study|Lack of therapeutic effect|28
4964094|NCT00179660|17062611|P1|Overall Study|Adverse Event|7
4964095|NCT00179647|17062620|P1|Overall Study|Other|960
4964096|NCT00179647|17062620|P1|Overall Study|Death|94
4964097|NCT00179647|17062620|P1|Overall Study|Lost to Follow-up|4
4964098|NCT00179647|17062620|P1|Overall Study|Withdrawal by Subject|83
4964099|NCT00179647|17062620|P1|Overall Study|Lack of Efficacy|478
4964100|NCT00179647|17062620|P1|Overall Study|Adverse Event|294
4964101|NCT00179621|17062627|P4|Open-Label Period|Other|2
4964102|NCT00179621|17062628|P3|Open-Label Period|Other|1
4964103|NCT00179621|17062629|P2|Open-Label Period|Other|1
4964104|NCT00179621|17062630|P1|Open-Label Period|Other|0
4964105|NCT00179621|17062627|P4|Open-Label Period|Death|2
4964106|NCT00179621|17062628|P3|Open-Label Period|Death|1
4964107|NCT00179621|17062629|P2|Open-Label Period|Death|0
4964108|NCT00179621|17062630|P1|Open-Label Period|Death|0
4964109|NCT00179621|17062627|P4|Open-Label Period|Withdrawal by Subject|2
4964110|NCT00179621|17062628|P3|Open-Label Period|Withdrawal by Subject|2
4964111|NCT00179621|17062629|P2|Open-Label Period|Withdrawal by Subject|2
4964112|NCT00179621|17062630|P1|Open-Label Period|Withdrawal by Subject|0
4964113|NCT00179621|17062627|P4|Open-Label Period|Adverse Event|6
4964114|NCT00179621|17062628|P3|Open-Label Period|Adverse Event|5
4964115|NCT00179621|17062629|P2|Open-Label Period|Adverse Event|6
4964116|NCT00179621|17062630|P1|Open-Label Period|Adverse Event|0
4964117|NCT00179621|17062627|P4|Open-Label Period|Lack of Therapeutic Effect|31
4964118|NCT00179621|17062628|P3|Open-Label Period|Lack of Therapeutic Effect|19
4964119|NCT00179621|17062629|P2|Open-Label Period|Lack of Therapeutic Effect|19
4964120|NCT00179621|17062630|P1|Open-Label Period|Lack of Therapeutic Effect|0
4964121|NCT00179621|17062627|P4|Double-Blind Period|Other|0
4964122|NCT00179621|17062628|P3|Double-Blind Period|Other|2
4964123|NCT00179621|17062629|P2|Double-Blind Period|Other|2
4964124|NCT00179621|17062630|P1|Double-Blind Period|Other|0
4964125|NCT00179621|17062627|P4|Double-Blind Period|Protocol Violation|0
4964126|NCT00179621|17062628|P3|Double-Blind Period|Protocol Violation|0
4964127|NCT00179621|17062629|P2|Double-Blind Period|Protocol Violation|0
4964128|NCT00179621|17062630|P1|Double-Blind Period|Protocol Violation|1
4964129|NCT00179621|17062627|P4|Double-Blind Period|Death|0
4964130|NCT00179621|17062628|P3|Double-Blind Period|Death|2
4964131|NCT00179621|17062629|P2|Double-Blind Period|Death|1
4964132|NCT00179621|17062630|P1|Double-Blind Period|Death|0
4964133|NCT00179621|17062627|P4|Double-Blind Period|Withdrawal by Subject|0
4964134|NCT00179621|17062628|P3|Double-Blind Period|Withdrawal by Subject|3
4964135|NCT00179621|17062629|P2|Double-Blind Period|Withdrawal by Subject|1
4964136|NCT00179621|17062630|P1|Double-Blind Period|Withdrawal by Subject|2
4964137|NCT00179621|17062627|P4|Double-Blind Period|Adverse Event|0
4964138|NCT00179621|17062628|P3|Double-Blind Period|Adverse Event|4
4964139|NCT00179621|17062629|P2|Double-Blind Period|Adverse Event|7
4964140|NCT00179621|17062630|P1|Double-Blind Period|Adverse Event|2
4964141|NCT00179621|17062627|P4|Double-Blind Period|Lack of Therapeutic Effect|0
4964142|NCT00179621|17062628|P3|Double-Blind Period|Lack of Therapeutic Effect|19
4964143|NCT00179621|17062629|P2|Double-Blind Period|Lack of Therapeutic Effect|35
4964323|NCT00174941|17063463|P2|Overall Study|Reason Not Specified|6
4964144|NCT00179621|17062630|P1|Double-Blind Period|Lack of Therapeutic Effect|59
4964145|NCT00179517|17062683|P2|Overall Study|Withdrawal by Subject|1
4964146|NCT00179517|17062684|P1|Overall Study|Withdrawal by Subject|2
4964147|NCT00179413|17062722|P2|Overall Study|Withdrawal by Subject|95
4964148|NCT00179413|17062723|P1|Overall Study|Withdrawal by Subject|87
4964149|NCT00179413|17062722|P2|Overall Study|Adverse Event|20
4964150|NCT00179413|17062723|P1|Overall Study|Adverse Event|38
4964151|NCT00179309|17062735|P2|Treatment|Allergy|0
4964152|NCT00179309|17062736|P1|Treatment|Allergy|1
4964153|NCT00179309|17062735|P2|Treatment|Withdrawal by Subject|2
4964154|NCT00179309|17062736|P1|Treatment|Withdrawal by Subject|1
4964155|NCT00179309|17062735|P2|Treatment|Toxicity|3
4964156|NCT00179309|17062736|P1|Treatment|Toxicity|2
4964157|NCT00179010|17062759|P2|Overall Study|Failure to place arterial line|1
4964158|NCT00179010|17062760|P1|Overall Study|Failure to place arterial line|0
4964159|NCT00179010|17062759|P2|Overall Study|Muscle probe defective|1
4964160|NCT00179010|17062760|P1|Overall Study|Muscle probe defective|1
4964161|NCT00178685|17062799|P3|Overall Study|Withdrawal by Subject|7
4964162|NCT00178685|17062800|P2|Overall Study|Withdrawal by Subject|14
4964163|NCT00178685|17062801|P1|Overall Study|Withdrawal by Subject|8
4964164|NCT00178685|17062799|P3|Overall Study|Lost to Follow-up|183
4964165|NCT00178685|17062800|P2|Overall Study|Lost to Follow-up|187
4964166|NCT00178685|17062801|P1|Overall Study|Lost to Follow-up|100
4964167|NCT00178685|17062799|P3|Overall Study|Death|6
4964168|NCT00178685|17062800|P2|Overall Study|Death|3
4964169|NCT00178685|17062801|P1|Overall Study|Death|3
4964170|NCT00178633|17062812|P1|Overall Study|Lost to Follow-up|6
4964171|NCT00178464|17062842|P1|Overall Study|Physician Decision|1
4964172|NCT00178464|17062842|P1|Overall Study|Withdrawal by Subject|1
4964173|NCT00178399|17062847|P1|Overall Study|Lost to Follow-up|1
4964174|NCT00178399|17062847|P1|Overall Study|Withdrawal by Subject|8
4964175|NCT00178399|17062847|P1|Overall Study|Physician Decision|4
4964176|NCT00178256|17062854|P4|Overall Study|Cancer progression|1
4964177|NCT00178256|17062855|P3|Overall Study|Cancer progression|0
4964178|NCT00178256|17062856|P2|Overall Study|Cancer progression|0
4964179|NCT00178256|17062857|P1|Overall Study|Cancer progression|2
4964180|NCT00178256|17062854|P4|Overall Study|Death|1
4964181|NCT00178256|17062855|P3|Overall Study|Death|0
4964182|NCT00178256|17062856|P2|Overall Study|Death|1
4964183|NCT00178256|17062857|P1|Overall Study|Death|0
4964184|NCT00178256|17062854|P4|Overall Study|Adverse Event|0
4964185|NCT00178256|17062855|P3|Overall Study|Adverse Event|0
4964186|NCT00178256|17062856|P2|Overall Study|Adverse Event|0
4964187|NCT00178256|17062857|P1|Overall Study|Adverse Event|2
4964188|NCT00178126|17062896|P2|Overall Study|did not receive intervention|6
4964189|NCT00178126|17062897|P1|Overall Study|did not receive intervention|4
4964190|NCT00178126|17062896|P2|Overall Study|Lost to Follow-up|21
4964191|NCT00178126|17062897|P1|Overall Study|Lost to Follow-up|21
4964192|NCT00177671|17062939|P2|Overall Study|Physician Decision|8
4964193|NCT00177671|17062940|P1|Overall Study|Physician Decision|12
4964194|NCT00177671|17062939|P2|Overall Study|Adverse Event|0
4964195|NCT00177671|17062940|P1|Overall Study|Adverse Event|6
4964196|NCT00177671|17062939|P2|Overall Study|medical complications|0
4964197|NCT00177671|17062940|P1|Overall Study|medical complications|2
4964198|NCT00177671|17062939|P2|Overall Study|Withdrawal by Subject|6
4964199|NCT00177671|17062940|P1|Overall Study|Withdrawal by Subject|5
4964200|NCT00177307|17062952|P1|Overall Study|Withdrawal by Subject|1
4964201|NCT00177294|17062961|P2|Overall Study|Withdrawal by Subject|5
4964202|NCT00177294|17062962|P1|Overall Study|Withdrawal by Subject|7
4964203|NCT00177216|17062976|P3|Overall Study|Withdrawal by Subject|1
4964204|NCT00177216|17062977|P2|Overall Study|Withdrawal by Subject|3
4964205|NCT00177216|17062978|P1|Overall Study|Withdrawal by Subject|6
4964206|NCT00177164|17062994|P2|Overall Study|Pregnancy|1
4964207|NCT00177164|17062995|P1|Overall Study|Pregnancy|0
4964208|NCT00177164|17062994|P2|Overall Study|Lack of Efficacy|1
4964209|NCT00177164|17062995|P1|Overall Study|Lack of Efficacy|2
4964210|NCT00177164|17062994|P2|Overall Study|discharge from hospital|0
4964211|NCT00177164|17062995|P1|Overall Study|discharge from hospital|1
4964212|NCT00177164|17062994|P2|Overall Study|Adverse Event|0
4964213|NCT00177164|17062995|P1|Overall Study|Adverse Event|1
4964214|NCT00177164|17062994|P2|Overall Study|increase in alcohol and drug use|2
4964215|NCT00177164|17062995|P1|Overall Study|increase in alcohol and drug use|1
4964216|NCT00177164|17062994|P2|Overall Study|Lost to Follow-up|5
4964217|NCT00177164|17062995|P1|Overall Study|Lost to Follow-up|4
4964218|NCT00177164|17062994|P2|Overall Study|Protocol Violation|7
4964219|NCT00177164|17062995|P1|Overall Study|Protocol Violation|0
4964220|NCT00176644|17063168|P1|Overall Study|Withdrawal by Subject|1
4964221|NCT00176605|17063181|P1|Overall Study|Withdrawal by Subject|2
4964222|NCT00176488|17063192|P1|Overall Study|Initiated Cycle 1 Day 1 only|1
4964223|NCT00176462|17063200|P2|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3
4964224|NCT00176462|17063201|P1|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0
4964225|NCT00176462|17063200|P2|Intensive Continuation (8X8-week Cycles)|Death|0
4964226|NCT00176462|17063201|P1|Intensive Continuation (8X8-week Cycles)|Death|1
4964227|NCT00176462|17063200|P2|Consolidation (12 Weeks)|Not documented|1
4964228|NCT00176462|17063201|P1|Consolidation (12 Weeks)|Not documented|0
4964229|NCT00176462|17063200|P2|Consolidation (12 Weeks)|Lack of Efficacy|2
4964230|NCT00176462|17063201|P1|Consolidation (12 Weeks)|Lack of Efficacy|0
4964231|NCT00176462|17063200|P2|Consolidation (12 Weeks)|Adverse Event|1
4964232|NCT00176462|17063201|P1|Consolidation (12 Weeks)|Adverse Event|0
4964233|NCT00176462|17063200|P2|Consolidation (12 Weeks)|Patient moved to another state|1
4964234|NCT00176462|17063201|P1|Consolidation (12 Weeks)|Patient moved to another state|0
4964235|NCT00176462|17063200|P2|Induction (4 Weeks)|Lack of Efficacy|1
4964236|NCT00176462|17063201|P1|Induction (4 Weeks)|Lack of Efficacy|0
4964237|NCT00176462|17063200|P2|Induction (4 Weeks)|Death|2
4964238|NCT00176462|17063201|P1|Induction (4 Weeks)|Death|1
4964239|NCT00176462|17063200|P2|Induction (4 Weeks)|Withdrawal by Subject|2
4964240|NCT00176462|17063201|P1|Induction (4 Weeks)|Withdrawal by Subject|0
4964241|NCT00176254|17063221|P1|Overall Study|Lost to Follow-up|1
4964242|NCT00175916|17063249|P1|Overall Study|Patient went to prison|1
4964243|NCT00175916|17063249|P1|Overall Study|Site was closed|9
4964244|NCT00175916|17063249|P1|Overall Study|Loss of job and economic burden|1
4964245|NCT00175916|17063249|P1|Overall Study|Moved overseas|1
4964246|NCT00175916|17063249|P1|Overall Study|Treating physiciant's choice|1
4964247|NCT00175916|17063249|P1|Overall Study|Patient's request|2
4964248|NCT00175916|17063249|P1|Overall Study|Pregnancy|1
4964249|NCT00175916|17063249|P1|Overall Study|Administrative reason|1
4964250|NCT00175916|17063249|P1|Overall Study|Seizure - free|4
4964251|NCT00175916|17063249|P1|Overall Study|Withdrawal by Subject|1
4964252|NCT00175916|17063249|P1|Overall Study|Suicidal behaviour|1
4964253|NCT00175916|17063249|P1|Overall Study|Vigabatrin intake|1
4964254|NCT00175916|17063249|P1|Overall Study|Sponsor decision|17
4964255|NCT00175916|17063249|P1|Overall Study|Patient cannot record seizures|1
4964256|NCT00175916|17063249|P1|Overall Study|Lack of compliance|8
4964257|NCT00175916|17063249|P1|Overall Study|Subject Choice|98
4964258|NCT00175916|17063249|P1|Overall Study|Lost to Follow-up|17
4964259|NCT00175916|17063249|P1|Overall Study|Lack of Efficacy|354
4964260|NCT00175916|17063249|P1|Overall Study|Adverse Event|81
4964261|NCT00175916|17063249|P1|Overall Study|Death|19
4964262|NCT00175877|17063258|P1|Overall Study|Withdrawal by subject & Other|1
4964263|NCT00175877|17063258|P1|Overall Study|AE & Other|1
4964264|NCT00175877|17063258|P1|Overall Study|Other Reason|20
4964265|NCT00175877|17063258|P1|Overall Study|Protocol Violation|15
4964266|NCT00175877|17063258|P1|Overall Study|Lack of Efficacy|26
4964267|NCT00175877|17063258|P1|Overall Study|Lost to Follow-up|9
4964268|NCT00175877|17063258|P1|Overall Study|Withdrawal by Subject|141
4964269|NCT00175877|17063258|P1|Overall Study|Adverse Event|136
4964270|NCT00175825|17063293|P4|Overall Study|Withdrawal by Subject|0
4964271|NCT00175825|17063294|P3|Overall Study|Withdrawal by Subject|0
4964272|NCT00175825|17063295|P2|Overall Study|Withdrawal by Subject|0
4964273|NCT00175825|17063296|P1|Overall Study|Withdrawal by Subject|1
4964274|NCT00175825|17063293|P4|Overall Study|Lost to Follow-up|0
4964275|NCT00175825|17063294|P3|Overall Study|Lost to Follow-up|0
4964276|NCT00175825|17063295|P2|Overall Study|Lost to Follow-up|2
4964277|NCT00175825|17063296|P1|Overall Study|Lost to Follow-up|1
4964278|NCT00175825|17063293|P4|Overall Study|Adverse Event|1
4964279|NCT00175825|17063294|P3|Overall Study|Adverse Event|1
4964280|NCT00175825|17063295|P2|Overall Study|Adverse Event|2
4964281|NCT00175825|17063296|P1|Overall Study|Adverse Event|3
4964282|NCT00175019|17063349|P3|Overall Study|Reason Not Specified|11
4964283|NCT00175019|17063350|P2|Overall Study|Reason Not Specified|34
4964284|NCT00175019|17063351|P1|Overall Study|Reason Not Specified|40
4964285|NCT00175019|17063349|P3|Overall Study|Gout Flare|0
4964286|NCT00175019|17063350|P2|Overall Study|Gout Flare|3
4964287|NCT00175019|17063351|P1|Overall Study|Gout Flare|2
4964288|NCT00175019|17063349|P3|Overall Study|Therapeutic Failure|22
4964289|NCT00175019|17063350|P2|Overall Study|Therapeutic Failure|38
4964290|NCT00175019|17063351|P1|Overall Study|Therapeutic Failure|10
4964291|NCT00175019|17063349|P3|Overall Study|Personal Reason(s)|8
4964292|NCT00175019|17063350|P2|Overall Study|Personal Reason(s)|31
4964293|NCT00175019|17063351|P1|Overall Study|Personal Reason(s)|39
4964294|NCT00175019|17063349|P3|Overall Study|Did not continue under Amendment 4|2
4964295|NCT00175019|17063350|P2|Overall Study|Did not continue under Amendment 4|1
4964296|NCT00175019|17063351|P1|Overall Study|Did not continue under Amendment 4|1
4964297|NCT00175019|17063349|P3|Overall Study|Lost to Follow-up|9
4964298|NCT00175019|17063350|P2|Overall Study|Lost to Follow-up|39
4964299|NCT00175019|17063351|P1|Overall Study|Lost to Follow-up|42
4964300|NCT00175019|17063349|P3|Overall Study|Protocol Violation|3
4964301|NCT00175019|17063350|P2|Overall Study|Protocol Violation|3
4964302|NCT00175019|17063351|P1|Overall Study|Protocol Violation|6
4964303|NCT00175019|17063349|P3|Overall Study|Adverse Event|2
4964304|NCT00175019|17063350|P2|Overall Study|Adverse Event|22
4964305|NCT00175019|17063351|P1|Overall Study|Adverse Event|54
4964306|NCT00174967|17063404|P4|Overall Study|Other|0
4964307|NCT00174967|17063405|P3|Overall Study|Other|0
4964308|NCT00174967|17063406|P2|Overall Study|Other|1
4964309|NCT00174967|17063407|P1|Overall Study|Other|0
4964310|NCT00174967|17063404|P4|Overall Study|Gout Flare|1
4964311|NCT00174967|17063405|P3|Overall Study|Gout Flare|0
4964312|NCT00174967|17063406|P2|Overall Study|Gout Flare|0
4964313|NCT00174967|17063407|P1|Overall Study|Gout Flare|0
4964314|NCT00174967|17063404|P4|Overall Study|Adverse Event|1
4964315|NCT00174967|17063405|P3|Overall Study|Adverse Event|2
4964316|NCT00174967|17063406|P2|Overall Study|Adverse Event|2
4964317|NCT00174967|17063407|P1|Overall Study|Adverse Event|1
4964318|NCT00174954|17063453|P1|Overall Study|Physician Decision|1
4964319|NCT00174954|17063453|P1|Overall Study|No tophi found in MRI|1
4964320|NCT00174954|17063453|P1|Overall Study|Adverse Event|2
4964321|NCT00174941|17063461|P4|Overall Study|Reason Not Specified|9
4964322|NCT00174941|17063462|P3|Overall Study|Reason Not Specified|2
4964324|NCT00174941|17063464|P1|Overall Study|Reason Not Specified|1
4964325|NCT00174941|17063461|P4|Overall Study|Gout Flare|8
4964326|NCT00174941|17063462|P3|Overall Study|Gout Flare|4
4964327|NCT00174941|17063463|P2|Overall Study|Gout Flare|4
4964328|NCT00174941|17063464|P1|Overall Study|Gout Flare|0
4964329|NCT00174941|17063461|P4|Overall Study|Personal Reason(s)|22
4964330|NCT00174941|17063462|P3|Overall Study|Personal Reason(s)|8
4964331|NCT00174941|17063463|P2|Overall Study|Personal Reason(s)|14
4964332|NCT00174941|17063464|P1|Overall Study|Personal Reason(s)|0
4964333|NCT00174941|17063461|P4|Overall Study|Lost to Follow-up|5
4964334|NCT00174941|17063462|P3|Overall Study|Lost to Follow-up|2
4964335|NCT00174941|17063463|P2|Overall Study|Lost to Follow-up|3
4964336|NCT00174941|17063464|P1|Overall Study|Lost to Follow-up|0
4964337|NCT00174941|17063461|P4|Overall Study|Protocol Violation|1
4964338|NCT00174941|17063462|P3|Overall Study|Protocol Violation|0
4964339|NCT00174941|17063463|P2|Overall Study|Protocol Violation|1
4964340|NCT00174941|17063464|P1|Overall Study|Protocol Violation|0
4964341|NCT00174941|17063461|P4|Overall Study|Adverse Event|13
4964342|NCT00174941|17063462|P3|Overall Study|Adverse Event|2
4964343|NCT00174941|17063463|P2|Overall Study|Adverse Event|10
4964344|NCT00174941|17063464|P1|Overall Study|Adverse Event|1
4964345|NCT00174915|17063539|P5|Overall Study|Therapeutic Failure|3
4964346|NCT00174915|17063540|P4|Overall Study|Therapeutic Failure|1
4964347|NCT00174915|17063541|P3|Overall Study|Therapeutic Failure|2
4964348|NCT00174915|17063542|P2|Overall Study|Therapeutic Failure|3
4964349|NCT00174915|17063543|P1|Overall Study|Therapeutic Failure|6
4964350|NCT00174915|17063539|P5|Overall Study|Protocol Violation|3
4964351|NCT00174915|17063540|P4|Overall Study|Protocol Violation|6
4964352|NCT00174915|17063541|P3|Overall Study|Protocol Violation|3
4964353|NCT00174915|17063542|P2|Overall Study|Protocol Violation|3
4964354|NCT00174915|17063543|P1|Overall Study|Protocol Violation|6
4964355|NCT00174915|17063539|P5|Overall Study|Gout Flare|0
4964356|NCT00174915|17063540|P4|Overall Study|Gout Flare|1
4964357|NCT00174915|17063541|P3|Overall Study|Gout Flare|8
4964358|NCT00174915|17063542|P2|Overall Study|Gout Flare|6
4964359|NCT00174915|17063543|P1|Overall Study|Gout Flare|13
4964360|NCT00174915|17063539|P5|Overall Study|Other|3
4964361|NCT00174915|17063540|P4|Overall Study|Other|5
4964362|NCT00174915|17063541|P3|Overall Study|Other|6
4964363|NCT00174915|17063542|P2|Overall Study|Other|8
4964364|NCT00174915|17063543|P1|Overall Study|Other|15
4964365|NCT00174915|17063539|P5|Overall Study|Personal Reason(s)|9
4964366|NCT00174915|17063540|P4|Overall Study|Personal Reason(s)|9
4964367|NCT00174915|17063541|P3|Overall Study|Personal Reason(s)|9
4964368|NCT00174915|17063542|P2|Overall Study|Personal Reason(s)|16
4964369|NCT00174915|17063543|P1|Overall Study|Personal Reason(s)|16
4964370|NCT00174915|17063539|P5|Overall Study|Adverse Event|5
4964371|NCT00174915|17063540|P4|Overall Study|Adverse Event|18
4964372|NCT00174915|17063541|P3|Overall Study|Adverse Event|11
4964373|NCT00174915|17063542|P2|Overall Study|Adverse Event|16
4964374|NCT00174915|17063543|P1|Overall Study|Adverse Event|18
4964375|NCT00174915|17063539|P5|Overall Study|Lost to Follow-up|10
4964376|NCT00174915|17063540|P4|Overall Study|Lost to Follow-up|17
4964377|NCT00174915|17063541|P3|Overall Study|Lost to Follow-up|9
4964378|NCT00174915|17063542|P2|Overall Study|Lost to Follow-up|17
4964379|NCT00174915|17063543|P1|Overall Study|Lost to Follow-up|19
4964380|NCT00174785|17063602|P2|Overall Study|Not pre-specified/Not coded|70
4964381|NCT00174785|17063603|P1|Overall Study|Not pre-specified/Not coded|56
4964382|NCT00174785|17063602|P2|Overall Study|Family request|8
4964383|NCT00174785|17063603|P1|Overall Study|Family request|6
4964384|NCT00174785|17063602|P2|Overall Study|Other prohibited medication|3
4964385|NCT00174785|17063603|P1|Overall Study|Other prohibited medication|5
4964386|NCT00174785|17063602|P2|Overall Study|Prohibited antiarrhythmic medication|88
4964387|NCT00174785|17063603|P1|Overall Study|Prohibited antiarrhythmic medication|39
4964388|NCT00174785|17063602|P2|Overall Study|Atrial Fibrillation/Flutter recurrence|167
4964389|NCT00174785|17063603|P1|Overall Study|Atrial Fibrillation/Flutter recurrence|110
4964390|NCT00174785|17063602|P2|Overall Study|Withdrawal by Subject|175
4964391|NCT00174785|17063603|P1|Overall Study|Withdrawal by Subject|173
4964392|NCT00174785|17063602|P2|Overall Study|Protocol Violation|14
4964393|NCT00174785|17063603|P1|Overall Study|Protocol Violation|14
4964394|NCT00174785|17063602|P2|Overall Study|Adverse Event|191
4964395|NCT00174785|17063603|P1|Overall Study|Adverse Event|293
4964396|NCT00174460|17063619|P2|Overall Study|Withdrawal by Subject|1
4964397|NCT00174460|17063620|P1|Overall Study|Withdrawal by Subject|0
4964398|NCT00174447|17063666|P1|Overall Study|Administrative reason/Other|2
4964399|NCT00174447|17063666|P1|Overall Study|Lack of Efficacy|1
4964400|NCT00174447|17063666|P1|Overall Study|Protocol Violation|1
4964401|NCT00174447|17063666|P1|Overall Study|Withdrawal by Subject|15
4964402|NCT00174447|17063666|P1|Overall Study|Adverse Event|19
4964403|NCT00174382|17063675|P1|Overall Study|Lost to Follow-up|1
4964404|NCT00174382|17063675|P1|Overall Study|Subject felt pill not effective enough|1
4964405|NCT00174382|17063675|P1|Overall Study|Arrived early for last visit in error|1
4964406|NCT00174382|17063675|P1|Overall Study|Protocol Violation|3
4964407|NCT00174382|17063675|P1|Overall Study|Withdrawal by Subject|6
4964408|NCT00174382|17063675|P1|Overall Study|Adverse Event|19
4964409|NCT00174382|17063675|P1|Overall Study|Death|2
4964410|NCT00174291|17063694|P2|Overall Study|Withdrawal by Subject|3
4964411|NCT00174291|17063695|P1|Overall Study|Withdrawal by Subject|3
4964412|NCT00174291|17063694|P2|Overall Study|Study terminated by sponsor|0
4964413|NCT00174291|17063695|P1|Overall Study|Study terminated by sponsor|1
4964414|NCT00174291|17063694|P2|Overall Study|Protocol Violation|2
4964415|NCT00174291|17063695|P1|Overall Study|Protocol Violation|0
4964416|NCT00174291|17063694|P2|Overall Study|Lost to Follow-up|1
4964417|NCT00174291|17063695|P1|Overall Study|Lost to Follow-up|1
4964418|NCT00174265|17063725|P2|Overall Study|Other (Not specified)|10
4964419|NCT00174265|17063726|P1|Overall Study|Other (Not specified)|16
4964420|NCT00174265|17063725|P2|Overall Study|Lost to Follow-up|0
4964421|NCT00174265|17063726|P1|Overall Study|Lost to Follow-up|1
4964422|NCT00174265|17063725|P2|Overall Study|Withdrawal by Subject|5
4964423|NCT00174265|17063726|P1|Overall Study|Withdrawal by Subject|3
4964424|NCT00174265|17063725|P2|Overall Study|Lack of Efficacy|2
4964425|NCT00174265|17063726|P1|Overall Study|Lack of Efficacy|2
4964426|NCT00174265|17063725|P2|Overall Study|Adverse Event|4
4964427|NCT00174265|17063726|P1|Overall Study|Adverse Event|7
4964428|NCT00174252|17063734|P1|Overall Study|Protocol Violation|2
4964429|NCT00174187|17063769|P3|Period 2 (After 3 Years)|Other|5
4964430|NCT00174187|17063770|P2|Period 2 (After 3 Years)|Other|0
4964431|NCT00174187|17063771|P1|Period 2 (After 3 Years)|Other|0
4964432|NCT00174187|17063769|P3|Period 2 (After 3 Years)|Withdrawal by Subject|1
4964433|NCT00174187|17063770|P2|Period 2 (After 3 Years)|Withdrawal by Subject|0
4964434|NCT00174187|17063771|P1|Period 2 (After 3 Years)|Withdrawal by Subject|0
4964435|NCT00174187|17063769|P3|Period 2 (After 3 Years)|Lost to Follow-up|2
4964436|NCT00174187|17063770|P2|Period 2 (After 3 Years)|Lost to Follow-up|0
4964437|NCT00174187|17063771|P1|Period 2 (After 3 Years)|Lost to Follow-up|0
4964438|NCT00174187|17063769|P3|Between Period 1 and Period 2|Consented, not assigned to treatment|3
4964439|NCT00174187|17063770|P2|Between Period 1 and Period 2|Consented, not assigned to treatment|0
4964440|NCT00174187|17063771|P1|Between Period 1 and Period 2|Consented, not assigned to treatment|0
4964441|NCT00174187|17063769|P3|Between Period 1 and Period 2|Did not consent to continue treatment|2
4964442|NCT00174187|17063770|P2|Between Period 1 and Period 2|Did not consent to continue treatment|0
4964443|NCT00174187|17063771|P1|Between Period 1 and Period 2|Did not consent to continue treatment|0
4964444|NCT00174187|17063769|P3|Period 1 (up to 3 Years)|Other|0
4964445|NCT00174187|17063770|P2|Period 1 (up to 3 Years)|Other|1
4964446|NCT00174187|17063771|P1|Period 1 (up to 3 Years)|Other|0
4964447|NCT00174187|17063769|P3|Period 1 (up to 3 Years)|Withdrawal by Subject|0
4964448|NCT00174187|17063770|P2|Period 1 (up to 3 Years)|Withdrawal by Subject|1
4964449|NCT00174187|17063771|P1|Period 1 (up to 3 Years)|Withdrawal by Subject|0
4964450|NCT00174187|17063769|P3|Period 1 (up to 3 Years)|Non compliance|0
4964451|NCT00174187|17063770|P2|Period 1 (up to 3 Years)|Non compliance|1
4964452|NCT00174187|17063771|P1|Period 1 (up to 3 Years)|Non compliance|0
4964453|NCT00174187|17063769|P3|Period 1 (up to 3 Years)|Serious adverse event|0
4964454|NCT00174187|17063770|P2|Period 1 (up to 3 Years)|Serious adverse event|1
4964455|NCT00174187|17063771|P1|Period 1 (up to 3 Years)|Serious adverse event|0
4964456|NCT00172185|17063836|P4|Overall Study|Withdrawal by Subject|0
4964457|NCT00172185|17063837|P3|Overall Study|Withdrawal by Subject|1
4964458|NCT00172185|17063838|P2|Overall Study|Withdrawal by Subject|0
4964459|NCT00172185|17063839|P1|Overall Study|Withdrawal by Subject|0
4964460|NCT00172185|17063836|P4|Overall Study|SPONSOR Decision|0
4964461|NCT00172185|17063837|P3|Overall Study|SPONSOR Decision|0
4964462|NCT00172185|17063838|P2|Overall Study|SPONSOR Decision|1
4964463|NCT00172185|17063839|P1|Overall Study|SPONSOR Decision|0
4964464|NCT00172185|17063836|P4|Overall Study|Physician Decision|0
4964465|NCT00172185|17063837|P3|Overall Study|Physician Decision|1
4964466|NCT00172185|17063838|P2|Overall Study|Physician Decision|0
4964467|NCT00172185|17063839|P1|Overall Study|Physician Decision|0
4964468|NCT00172185|17063836|P4|Overall Study|Adverse Event|4
4964469|NCT00172185|17063837|P3|Overall Study|Adverse Event|3
4964470|NCT00172185|17063838|P2|Overall Study|Adverse Event|1
4964471|NCT00172185|17063839|P1|Overall Study|Adverse Event|0
4964472|NCT00172042|17063855|P2|Overall Study|Death|42
4964473|NCT00172042|17063856|P1|Overall Study|Death|42
4964474|NCT00172042|17063855|P2|Overall Study|Administrative problems|10
4964475|NCT00172042|17063856|P1|Overall Study|Administrative problems|13
4964476|NCT00172042|17063855|P2|Overall Study|Lost to Follow-up|5
4964477|NCT00172042|17063856|P1|Overall Study|Lost to Follow-up|3
4964478|NCT00172042|17063855|P2|Overall Study|Withdrawal by Subject|25
4964479|NCT00172042|17063856|P1|Overall Study|Withdrawal by Subject|37
4964480|NCT00172042|17063855|P2|Overall Study|Protocol Violation|7
4964481|NCT00172042|17063856|P1|Overall Study|Protocol Violation|8
4964482|NCT00172042|17063855|P2|Overall Study|Patient no longer requires study drug|8
4964483|NCT00172042|17063856|P1|Overall Study|Patient no longer requires study drug|10
4964484|NCT00172042|17063855|P2|Overall Study|Unsatisfactory therapeutic effect|11
4964485|NCT00172042|17063856|P1|Overall Study|Unsatisfactory therapeutic effect|13
4964486|NCT00172042|17063855|P2|Overall Study|Abnormal test procedure(s)|3
4964487|NCT00172042|17063856|P1|Overall Study|Abnormal test procedure(s)|0
4964488|NCT00172042|17063855|P2|Overall Study|Abnormal laboratory value(s)|1
4964489|NCT00172042|17063856|P1|Overall Study|Abnormal laboratory value(s)|5
4964490|NCT00172042|17063855|P2|Overall Study|Adverse Event|13
4964491|NCT00172042|17063856|P1|Overall Study|Adverse Event|27
4964492|NCT00171925|17063878|P2|Overall Study|Death|2
4964493|NCT00171925|17063879|P1|Overall Study|Death|1
4964494|NCT00171925|17063878|P2|Overall Study|Administrative problems|11
4964495|NCT00171925|17063879|P1|Overall Study|Administrative problems|10
4964496|NCT00171925|17063878|P2|Overall Study|Lost to Follow-up|2
4964497|NCT00171925|17063879|P1|Overall Study|Lost to Follow-up|2
4964498|NCT00171925|17063878|P2|Overall Study|Withdrawal by Subject|9
4964499|NCT00171925|17063879|P1|Overall Study|Withdrawal by Subject|6
4964500|NCT00171925|17063878|P2|Overall Study|Protocol Violation|1
4964501|NCT00171925|17063879|P1|Overall Study|Protocol Violation|1
4964502|NCT00171925|17063878|P2|Overall Study|Adverse Event|6
4964503|NCT00171925|17063879|P1|Overall Study|Adverse Event|10
4964504|NCT00171873|17063891|P2|Overall Study|Switched to Octreotide|1
4964505|NCT00171873|17063892|P1|Overall Study|Switched to Octreotide|0
4964506|NCT00171873|17063891|P2|Overall Study|Adverse Event|0
4964507|NCT00171873|17063892|P1|Overall Study|Adverse Event|5
4964508|NCT00171873|17063891|P2|Overall Study|Withdrawal by Subject|2
4964509|NCT00171873|17063892|P1|Overall Study|Withdrawal by Subject|4
4964510|NCT00171834|17063905|P7|Overall Study|Treatment Duration Completed|0
4964511|NCT00171834|17063906|P6|Overall Study|Treatment Duration Completed|1
4964512|NCT00171834|17063907|P5|Overall Study|Treatment Duration Completed|2
4964513|NCT00171834|17063908|P4|Overall Study|Treatment Duration Completed|0
4964514|NCT00171834|17063909|P3|Overall Study|Treatment Duration Completed|1
4964515|NCT00171834|17063910|P2|Overall Study|Treatment Duration Completed|0
4964516|NCT00171834|17063911|P1|Overall Study|Treatment Duration Completed|0
4964517|NCT00171834|17063905|P7|Overall Study|Disease Progression|3
4964518|NCT00171834|17063906|P6|Overall Study|Disease Progression|18
4964519|NCT00171834|17063907|P5|Overall Study|Disease Progression|2
4964520|NCT00171834|17063908|P4|Overall Study|Disease Progression|9
4964521|NCT00171834|17063909|P3|Overall Study|Disease Progression|8
4964522|NCT00171834|17063910|P2|Overall Study|Disease Progression|8
4964523|NCT00171834|17063911|P1|Overall Study|Disease Progression|4
4964524|NCT00171834|17063905|P7|Overall Study|Death from study indication|0
4964525|NCT00171834|17063906|P6|Overall Study|Death from study indication|0
4964526|NCT00171834|17063907|P5|Overall Study|Death from study indication|1
4964527|NCT00171834|17063908|P4|Overall Study|Death from study indication|0
4964528|NCT00171834|17063909|P3|Overall Study|Death from study indication|0
4964529|NCT00171834|17063910|P2|Overall Study|Death from study indication|1
4964530|NCT00171834|17063911|P1|Overall Study|Death from study indication|0
4964531|NCT00171834|17063905|P7|Overall Study|Withdrawal by Subject|0
4964532|NCT00171834|17063906|P6|Overall Study|Withdrawal by Subject|1
4964533|NCT00171834|17063907|P5|Overall Study|Withdrawal by Subject|1
4964534|NCT00171834|17063908|P4|Overall Study|Withdrawal by Subject|1
4964535|NCT00171834|17063909|P3|Overall Study|Withdrawal by Subject|0
4964536|NCT00171834|17063910|P2|Overall Study|Withdrawal by Subject|2
4964537|NCT00171834|17063911|P1|Overall Study|Withdrawal by Subject|0
4964538|NCT00171834|17063905|P7|Overall Study|Adverse Event|1
4964539|NCT00171834|17063906|P6|Overall Study|Adverse Event|15
4964540|NCT00171834|17063907|P5|Overall Study|Adverse Event|2
4964541|NCT00171834|17063908|P4|Overall Study|Adverse Event|2
4964542|NCT00171834|17063909|P3|Overall Study|Adverse Event|3
4964543|NCT00171834|17063910|P2|Overall Study|Adverse Event|1
4964544|NCT00171834|17063911|P1|Overall Study|Adverse Event|2
4964545|NCT00171704|17063951|P2|Overall Study|Protocol Violation|1
4964546|NCT00171704|17063952|P1|Overall Study|Protocol Violation|0
4964547|NCT00171704|17063951|P2|Overall Study|Withdrawal by Subject|3
4964548|NCT00171704|17063952|P1|Overall Study|Withdrawal by Subject|1
4964549|NCT00171704|17063951|P2|Overall Study|Death|2
4964550|NCT00171704|17063952|P1|Overall Study|Death|2
4964551|NCT00171704|17063951|P2|Overall Study|Administrative Problems|1
4964552|NCT00171704|17063952|P1|Overall Study|Administrative Problems|2
4964553|NCT00171704|17063951|P2|Overall Study|New therapy for 2nd non-breast prim canc|0
4964554|NCT00171704|17063952|P1|Overall Study|New therapy for 2nd non-breast prim canc|1
4964555|NCT00171704|17063951|P2|Overall Study|Disease Progression|9
4964556|NCT00171704|17063952|P1|Overall Study|Disease Progression|14
4964557|NCT00171704|17063951|P2|Overall Study|Adverse Event|33
4964558|NCT00171704|17063952|P1|Overall Study|Adverse Event|24
4964559|NCT00171340|17063974|P2|Overall Study|Death|6
4964560|NCT00171340|17063975|P1|Overall Study|Death|6
4964561|NCT00171340|17063974|P2|Overall Study|Administrative Problems|2
4964562|NCT00171340|17063975|P1|Overall Study|Administrative Problems|5
4964563|NCT00171340|17063974|P2|Overall Study|No Longer Required Study Drug|1
4964564|NCT00171340|17063975|P1|Overall Study|No Longer Required Study Drug|1
4964565|NCT00171340|17063974|P2|Overall Study|Abnormal Test Procedure Results|11
4964566|NCT00171340|17063975|P1|Overall Study|Abnormal Test Procedure Results|6
4964567|NCT00171340|17063974|P2|Overall Study|Abnormal Laboratory Results|0
4964568|NCT00171340|17063975|P1|Overall Study|Abnormal Laboratory Results|2
4964569|NCT00171340|17063974|P2|Overall Study|Lost to Follow-up|5
4964570|NCT00171340|17063975|P1|Overall Study|Lost to Follow-up|0
4964571|NCT00171340|17063974|P2|Overall Study|Withdrawal by Subject|19
4964572|NCT00171340|17063975|P1|Overall Study|Withdrawal by Subject|22
4964573|NCT00171340|17063974|P2|Overall Study|Protocol Violation|8
4964574|NCT00171340|17063975|P1|Overall Study|Protocol Violation|7
4964575|NCT00171340|17063974|P2|Overall Study|Lack of Efficacy|41
4964576|NCT00171340|17063975|P1|Overall Study|Lack of Efficacy|29
4964577|NCT00171340|17063974|P2|Overall Study|Adverse Event|42
4964578|NCT00171340|17063975|P1|Overall Study|Adverse Event|46
4964579|NCT00171314|17063991|P2|Overall Study|Death|1
4964580|NCT00171314|17063992|P1|Overall Study|Death|2
4964581|NCT00171314|17063991|P2|Overall Study|Lost to Follow-up|3
4964582|NCT00171314|17063992|P1|Overall Study|Lost to Follow-up|1
4964583|NCT00171314|17063991|P2|Overall Study|Administrative Problems|3
4964584|NCT00171314|17063992|P1|Overall Study|Administrative Problems|4
4964585|NCT00171314|17063991|P2|Overall Study|Protocol Violation|7
4964586|NCT00171314|17063992|P1|Overall Study|Protocol Violation|3
4964587|NCT00171314|17063991|P2|Overall Study|Abnormal Test Procedure Results|3
4964588|NCT00171314|17063992|P1|Overall Study|Abnormal Test Procedure Results|9
4964589|NCT00171314|17063991|P2|Overall Study|Withdrawal by Subject|6
4964590|NCT00171314|17063992|P1|Overall Study|Withdrawal by Subject|9
4964591|NCT00171314|17063991|P2|Overall Study|Lack of Efficacy|14
4964592|NCT00171314|17063992|P1|Overall Study|Lack of Efficacy|19
4964593|NCT00171314|17063991|P2|Overall Study|Adverse Event|41
4964594|NCT00171314|17063992|P1|Overall Study|Adverse Event|44
4964595|NCT00171301|17064008|P2|Overall Study|Withdrawal by Subject|1
4964596|NCT00171301|17064009|P1|Overall Study|Withdrawal by Subject|0
4964597|NCT00171301|17064008|P2|Overall Study|Protocol Violation|2
4964598|NCT00171301|17064009|P1|Overall Study|Protocol Violation|0
4964599|NCT00171301|17064008|P2|Overall Study|Lost to Follow-up|2
4964600|NCT00171301|17064009|P1|Overall Study|Lost to Follow-up|6
4964601|NCT00171301|17064008|P2|Overall Study|Adverse Event|2
4964602|NCT00171301|17064009|P1|Overall Study|Adverse Event|1
4964603|NCT00171301|17064008|P2|Overall Study|Death|2
4964604|NCT00171301|17064009|P1|Overall Study|Death|1
4964605|NCT00171210|17064022|P2|Overall Study|Stopped at end of extension 1|1
4964606|NCT00171210|17064023|P1|Overall Study|Stopped at end of extension 1|0
4964607|NCT00171210|17064022|P2|Overall Study|Stopped at end of core|32
4964608|NCT00171210|17064023|P1|Overall Study|Stopped at end of core|0
4964609|NCT00171210|17064022|P2|Overall Study|Death|3
4964610|NCT00171210|17064023|P1|Overall Study|Death|2
4964611|NCT00171210|17064022|P2|Overall Study|Administrative problems|1
4964612|NCT00171210|17064023|P1|Overall Study|Administrative problems|1
4964613|NCT00171210|17064022|P2|Overall Study|Lost to Follow-up|0
4964614|NCT00171210|17064023|P1|Overall Study|Lost to Follow-up|1
4964615|NCT00171210|17064022|P2|Overall Study|Withdrawal by Subject|30
4964616|NCT00171210|17064023|P1|Overall Study|Withdrawal by Subject|32
4964617|NCT00171210|17064022|P2|Overall Study|Protocol Violation|2
4964618|NCT00171210|17064023|P1|Overall Study|Protocol Violation|0
4964619|NCT00171210|17064022|P2|Overall Study|Unsatisfactory therapeutic effect|15
4964620|NCT00171210|17064023|P1|Overall Study|Unsatisfactory therapeutic effect|11
4964621|NCT00171210|17064022|P2|Overall Study|Abnormal test procedure result(s)|1
4964622|NCT00171210|17064023|P1|Overall Study|Abnormal test procedure result(s)|0
4964623|NCT00171210|17064022|P2|Overall Study|Abnormal laboratory value(s)|3
4964624|NCT00171210|17064023|P1|Overall Study|Abnormal laboratory value(s)|6
4964625|NCT00171210|17064022|P2|Overall Study|Adverse Event|27
4964626|NCT00171210|17064023|P1|Overall Study|Adverse Event|16
4964627|NCT00171054|17064053|P2|Overall Study|Condition no longer required study drug|1
4964628|NCT00171054|17064054|P1|Overall Study|Condition no longer required study drug|0
4964629|NCT00171054|17064053|P2|Overall Study|Adverse Event|8
4964630|NCT00171054|17064054|P1|Overall Study|Adverse Event|8
4964631|NCT00171054|17064053|P2|Overall Study|Lost to Follow-up|1
4964632|NCT00171054|17064054|P1|Overall Study|Lost to Follow-up|0
4964633|NCT00171054|17064053|P2|Overall Study|Patient withdrew consent|0
4964634|NCT00171054|17064054|P1|Overall Study|Patient withdrew consent|1
4964635|NCT00171054|17064053|P2|Overall Study|Protocol Violation|2
4964636|NCT00171054|17064054|P1|Overall Study|Protocol Violation|1
4964637|NCT00170950|17064086|P2|Overall Study|Termination Data Not Recorded|22
4964638|NCT00170950|17064087|P1|Overall Study|Termination Data Not Recorded|17
4964639|NCT00170950|17064086|P2|Overall Study|Missing|1
4964640|NCT00170950|17064087|P1|Overall Study|Missing|2
4964641|NCT00170950|17064086|P2|Overall Study|Lost to Follow-up|115
4964642|NCT00170950|17064087|P1|Overall Study|Lost to Follow-up|134
4964643|NCT00170950|17064086|P2|Overall Study|Withdrawal by Subject|498
4964644|NCT00170950|17064087|P1|Overall Study|Withdrawal by Subject|496
4964645|NCT00170950|17064086|P2|Overall Study|Death|274
4964646|NCT00170950|17064087|P1|Overall Study|Death|236
4964647|NCT00170846|17064100|P3|Overall Study|Reason Missing|0
4964648|NCT00170846|17064101|P2|Overall Study|Reason Missing|1
4964649|NCT00170846|17064102|P1|Overall Study|Reason Missing|0
4964650|NCT00170846|17064100|P3|Overall Study|Death|3
4964651|NCT00170846|17064101|P2|Overall Study|Death|3
4964652|NCT00170846|17064102|P1|Overall Study|Death|0
4964653|NCT00170846|17064100|P3|Overall Study|Lost to Follow-up|2
4964654|NCT00170846|17064101|P2|Overall Study|Lost to Follow-up|3
4964655|NCT00170846|17064102|P1|Overall Study|Lost to Follow-up|6
4964656|NCT00170846|17064100|P3|Overall Study|Subject withdrew Informed Consent|8
4964657|NCT00170846|17064101|P2|Overall Study|Subject withdrew Informed Consent|12
4964658|NCT00170846|17064102|P1|Overall Study|Subject withdrew Informed Consent|5
4964659|NCT00169442|17064134|P6|Overall Study|Lost to follow-up (compl. vaccination)|0
4964660|NCT00169442|17064135|P5|Overall Study|Lost to follow-up (compl. vaccination)|0
4964661|NCT00169442|17064136|P4|Overall Study|Lost to follow-up (compl. vaccination)|0
4964662|NCT00169442|17064137|P3|Overall Study|Lost to follow-up (compl. vaccination)|0
4964663|NCT00169442|17064138|P2|Overall Study|Lost to follow-up (compl. vaccination)|1
4964664|NCT00169442|17064139|P1|Overall Study|Lost to follow-up (compl. vaccination)|0
4964665|NCT00169442|17064134|P6|Overall Study|Lost to follow-up (incompl. vaccination)|0
4964666|NCT00169442|17064135|P5|Overall Study|Lost to follow-up (incompl. vaccination)|1
4964667|NCT00169442|17064136|P4|Overall Study|Lost to follow-up (incompl. vaccination)|0
4964668|NCT00169442|17064137|P3|Overall Study|Lost to follow-up (incompl. vaccination)|0
4964669|NCT00169442|17064138|P2|Overall Study|Lost to follow-up (incompl. vaccination)|0
4964670|NCT00169442|17064139|P1|Overall Study|Lost to follow-up (incompl. vaccination)|0
4964671|NCT00169442|17064134|P6|Overall Study|Migrated/moved from study area|2
4964672|NCT00169442|17064135|P5|Overall Study|Migrated/moved from study area|0
4964673|NCT00169442|17064136|P4|Overall Study|Migrated/moved from study area|0
4964674|NCT00169442|17064137|P3|Overall Study|Migrated/moved from study area|0
4964675|NCT00169442|17064138|P2|Overall Study|Migrated/moved from study area|0
4964676|NCT00169442|17064139|P1|Overall Study|Migrated/moved from study area|0
4964677|NCT00169442|17064134|P6|Overall Study|Withdrawal by Subject|0
4964678|NCT00169442|17064135|P5|Overall Study|Withdrawal by Subject|0
4964679|NCT00169442|17064136|P4|Overall Study|Withdrawal by Subject|0
4964680|NCT00169442|17064137|P3|Overall Study|Withdrawal by Subject|1
4964681|NCT00169442|17064138|P2|Overall Study|Withdrawal by Subject|0
4964682|NCT00169442|17064139|P1|Overall Study|Withdrawal by Subject|0
4964683|NCT00169104|17064248|P2|Overall Study|Physician Decision|1
4964684|NCT00169104|17064249|P1|Overall Study|Physician Decision|0
4964685|NCT00169104|17064248|P2|Overall Study|Protocol Violation|1
4964686|NCT00169104|17064249|P1|Overall Study|Protocol Violation|0
4964687|NCT00169104|17064248|P2|Overall Study|Withdrawal by Subject|0
4964688|NCT00169104|17064249|P1|Overall Study|Withdrawal by Subject|2
4964689|NCT00168844|17064263|P3|Overall Study|Other|9
4964690|NCT00168844|17064264|P2|Overall Study|Other|7
4964691|NCT00168844|17064265|P1|Overall Study|Other|6
4964692|NCT00168844|17064263|P3|Overall Study|Protocol Violation|4
4964693|NCT00168844|17064264|P2|Overall Study|Protocol Violation|2
4964694|NCT00168844|17064265|P1|Overall Study|Protocol Violation|2
4964695|NCT00168844|17064263|P3|Overall Study|Withdrawal by Subject|19
4964696|NCT00168844|17064264|P2|Overall Study|Withdrawal by Subject|9
4964697|NCT00168844|17064265|P1|Overall Study|Withdrawal by Subject|12
4964698|NCT00168844|17064263|P3|Overall Study|Lost to Follow-up|11
4964699|NCT00168844|17064264|P2|Overall Study|Lost to Follow-up|5
4964700|NCT00168844|17064265|P1|Overall Study|Lost to Follow-up|4
4964701|NCT00168844|17064263|P3|Overall Study|Adverse Event|48
4964702|NCT00168844|17064264|P2|Overall Study|Adverse Event|32
4964703|NCT00168844|17064265|P1|Overall Study|Adverse Event|31
4964704|NCT00168831|17064447|P3|Overall Study|Other|6
4964705|NCT00168831|17064448|P2|Overall Study|Other|3
4964706|NCT00168831|17064449|P1|Overall Study|Other|6
4964707|NCT00168831|17064447|P3|Overall Study|Protocol Violation|11
4964708|NCT00168831|17064448|P2|Overall Study|Protocol Violation|11
4964709|NCT00168831|17064449|P1|Overall Study|Protocol Violation|6
4964710|NCT00168831|17064447|P3|Overall Study|Withdrawal by Subject|19
4964711|NCT00168831|17064448|P2|Overall Study|Withdrawal by Subject|14
4964712|NCT00168831|17064449|P1|Overall Study|Withdrawal by Subject|7
4964713|NCT00168831|17064447|P3|Overall Study|Lost to Follow-up|4
4964714|NCT00168831|17064448|P2|Overall Study|Lost to Follow-up|6
4964715|NCT00168831|17064449|P1|Overall Study|Lost to Follow-up|5
4964716|NCT00168831|17064447|P3|Overall Study|Adverse Event|74
4964717|NCT00168831|17064448|P2|Overall Study|Adverse Event|47
4964718|NCT00168831|17064449|P1|Overall Study|Adverse Event|36
4964719|NCT00168818|17064631|P3|Treatment|Other|31
4964720|NCT00168818|17064632|P2|Treatment|Other|29
4964721|NCT00168818|17064633|P1|Treatment|Other|23
4964722|NCT00168818|17064631|P3|Treatment|Withdrawal by Subject|22
4964723|NCT00168818|17064632|P2|Treatment|Withdrawal by Subject|20
4964724|NCT00168818|17064633|P1|Treatment|Withdrawal by Subject|25
4964725|NCT00168818|17064631|P3|Treatment|Lost to Follow-up|1
4964726|NCT00168818|17064632|P2|Treatment|Lost to Follow-up|2
4964727|NCT00168818|17064633|P1|Treatment|Lost to Follow-up|0
4964728|NCT00168818|17064631|P3|Treatment|Protocol Violation|11
4964729|NCT00168818|17064632|P2|Treatment|Protocol Violation|11
4964730|NCT00168818|17064633|P1|Treatment|Protocol Violation|8
4964731|NCT00168818|17064631|P3|Treatment|Adverse Event|68
4964732|NCT00168818|17064632|P2|Treatment|Adverse Event|89
4964733|NCT00168818|17064633|P1|Treatment|Adverse Event|77
4964734|NCT00168818|17064631|P3|Overall Study|Other|30
4964735|NCT00168818|17064632|P2|Overall Study|Other|24
4964736|NCT00168818|17064633|P1|Overall Study|Other|22
4964737|NCT00168818|17064631|P3|Overall Study|Withdrawal by Subject|37
4964738|NCT00168818|17064632|P2|Overall Study|Withdrawal by Subject|41
4964739|NCT00168818|17064633|P1|Overall Study|Withdrawal by Subject|43
4964740|NCT00168818|17064631|P3|Overall Study|Lost to Follow-up|15
4964741|NCT00168818|17064632|P2|Overall Study|Lost to Follow-up|4
4964742|NCT00168818|17064633|P1|Overall Study|Lost to Follow-up|13
4964743|NCT00168818|17064631|P3|Overall Study|Protocol Violation|11
4964744|NCT00168818|17064632|P2|Overall Study|Protocol Violation|11
4964745|NCT00168818|17064633|P1|Overall Study|Protocol Violation|16
4964746|NCT00168818|17064631|P3|Overall Study|Adverse Event|31
4964747|NCT00168818|17064632|P2|Overall Study|Adverse Event|29
4964748|NCT00168818|17064633|P1|Overall Study|Adverse Event|23
4964749|NCT00168805|17064677|P3|Treatment|Other|17
4964750|NCT00168805|17064678|P2|Treatment|Other|18
4964751|NCT00168805|17064679|P1|Treatment|Other|18
4964752|NCT00168805|17064677|P3|Treatment|Withdrawal by Subject|8
4964753|NCT00168805|17064678|P2|Treatment|Withdrawal by Subject|7
4964754|NCT00168805|17064679|P1|Treatment|Withdrawal by Subject|3
4964755|NCT00168805|17064677|P3|Treatment|Protocol Violation|5
4964756|NCT00168805|17064678|P2|Treatment|Protocol Violation|5
4964757|NCT00168805|17064679|P1|Treatment|Protocol Violation|3
4964758|NCT00168805|17064677|P3|Treatment|Adverse Event|32
4964759|NCT00168805|17064678|P2|Treatment|Adverse Event|26
4964760|NCT00168805|17064679|P1|Treatment|Adverse Event|25
4964761|NCT00168805|17064677|P3|Overall Study|Other|22
4964762|NCT00168805|17064678|P2|Overall Study|Other|21
4964763|NCT00168805|17064679|P1|Overall Study|Other|24
4964764|NCT00168805|17064677|P3|Overall Study|Withdrawal by Subject|21
4964765|NCT00168805|17064678|P2|Overall Study|Withdrawal by Subject|18
4964766|NCT00168805|17064679|P1|Overall Study|Withdrawal by Subject|16
4964767|NCT00168805|17064677|P3|Overall Study|Lost to Follow-up|11
4964768|NCT00168805|17064678|P2|Overall Study|Lost to Follow-up|17
4964769|NCT00168805|17064679|P1|Overall Study|Lost to Follow-up|12
4964770|NCT00168805|17064677|P3|Overall Study|Protocol Violation|8
4964771|NCT00168805|17064678|P2|Overall Study|Protocol Violation|11
4964772|NCT00168805|17064679|P1|Overall Study|Protocol Violation|12
4964773|NCT00168805|17064677|P3|Overall Study|Adverse Event|16
4964774|NCT00168805|17064678|P2|Overall Study|Adverse Event|11
4964775|NCT00168805|17064679|P1|Overall Study|Adverse Event|7
4964776|NCT00168103|17064915|P4|Overall Study|Lost to Follow-up|0
4964777|NCT00168103|17064916|P3|Overall Study|Lost to Follow-up|0
4964778|NCT00168103|17064917|P2|Overall Study|Lost to Follow-up|3
4964779|NCT00168103|17064918|P1|Overall Study|Lost to Follow-up|1
4964780|NCT00168103|17064915|P4|Overall Study|Withdrawal by Subject|0
4964781|NCT00168103|17064916|P3|Overall Study|Withdrawal by Subject|1
4964782|NCT00168103|17064917|P2|Overall Study|Withdrawal by Subject|2
4964783|NCT00168103|17064918|P1|Overall Study|Withdrawal by Subject|1
4964784|NCT00168064|17064940|P2|Overall Study|Various|3
4964785|NCT00168064|17064941|P1|Overall Study|Various|4
4964786|NCT00168064|17064940|P2|Overall Study|Subject's Best interest|2
4964787|NCT00168064|17064941|P1|Overall Study|Subject's Best interest|2
4964788|NCT00168064|17064940|P2|Overall Study|Concurrent Illness|3
4964789|NCT00168064|17064941|P1|Overall Study|Concurrent Illness|4
4964790|NCT00168064|17064940|P2|Overall Study|Non-compliance|3
4964791|NCT00168064|17064941|P1|Overall Study|Non-compliance|2
4964792|NCT00168064|17064940|P2|Overall Study|Lost to Follow-up|3
4964793|NCT00168064|17064941|P1|Overall Study|Lost to Follow-up|4
4964794|NCT00168064|17064940|P2|Overall Study|Lack of Efficacy|4
4964795|NCT00168064|17064941|P1|Overall Study|Lack of Efficacy|4
4964796|NCT00168064|17064940|P2|Overall Study|Withdrawal by Subject|4
4964797|NCT00168064|17064941|P1|Overall Study|Withdrawal by Subject|3
4964798|NCT00168064|17064940|P2|Overall Study|Adverse Event|22
4964799|NCT00168064|17064941|P1|Overall Study|Adverse Event|26
4964800|NCT00168038|17064949|P1|Overall Study|Therapy failure|1
4964801|NCT00168038|17064949|P1|Overall Study|Adverse Event|1
4964802|NCT00167778|17064972|P1|Overall Study|Withdrawal by Subject|1
4964803|NCT00167414|17065051|P1|Overall Study|Death|10
4964804|NCT00167310|17065076|P2|Overall Study|Withdrawal by Subject|7
4964805|NCT00167310|17065077|P1|Overall Study|Withdrawal by Subject|3
4964806|NCT00167310|17065076|P2|Overall Study|Protocol Violation|3
4964807|NCT00167310|17065077|P1|Overall Study|Protocol Violation|5
4964808|NCT00167245|17065087|P2|Overall Study|Drowsy|0
4964809|NCT00167245|17065088|P1|Overall Study|Drowsy|1
4964810|NCT00167245|17065087|P2|Overall Study|Incarcerated|2
4964811|NCT00167245|17065088|P1|Overall Study|Incarcerated|3
4964812|NCT00167245|17065087|P2|Overall Study|Withdrawal by Subject|8
4964813|NCT00167245|17065088|P1|Overall Study|Withdrawal by Subject|5
4964814|NCT00167245|17065087|P2|Overall Study|Lost to Follow-up|31
4964815|NCT00167245|17065088|P1|Overall Study|Lost to Follow-up|20
4964816|NCT00166712|17065142|P2|Overall Study|Physician Decision|2
4964817|NCT00166712|17065143|P1|Overall Study|Physician Decision|0
4964818|NCT00166712|17065142|P2|Overall Study|Withdrawal by Subject|2
4964819|NCT00166712|17065143|P1|Overall Study|Withdrawal by Subject|1
4964820|NCT00166712|17065142|P2|Overall Study|Adverse Event|0
4964821|NCT00166712|17065143|P1|Overall Study|Adverse Event|1
4964822|NCT00166712|17065142|P2|Overall Study|Death|1
4964823|NCT00166712|17065143|P1|Overall Study|Death|0
4964824|NCT00166517|17065160|P2|Overall Study|Withdrawal by Subject|1
4964825|NCT00166517|17065161|P1|Overall Study|Withdrawal by Subject|0
4964826|NCT00166517|17065160|P2|Overall Study|Protocol Violation|1
4964827|NCT00166517|17065161|P1|Overall Study|Protocol Violation|4
4964828|NCT00166517|17065160|P2|Overall Study|Lost to Follow-up|0
4964829|NCT00166517|17065161|P1|Overall Study|Lost to Follow-up|1
4964830|NCT00166504|17065171|P2|Overall Study|Withdrawal by Subject|0
4964831|NCT00166504|17065172|P1|Overall Study|Withdrawal by Subject|1
4964832|NCT00166504|17065171|P2|Overall Study|Lost to Follow-up|1
4964833|NCT00166504|17065172|P1|Overall Study|Lost to Follow-up|1
4964834|NCT00166504|17065171|P2|Overall Study|Adverse Event|3
4964835|NCT00166504|17065172|P1|Overall Study|Adverse Event|3
4964836|NCT00166439|17065178|P1|Overall Study|Ineligible|5
4964837|NCT00166296|17065195|P2|Overall Study|Lost to Follow-up|2
4964838|NCT00166296|17065196|P1|Overall Study|Lost to Follow-up|4
4964839|NCT00166296|17065195|P2|Overall Study|Adverse Event|4
4964840|NCT00166296|17065196|P1|Overall Study|Adverse Event|2
4964841|NCT00166296|17065195|P2|Overall Study|Withdrawal by Subject|3
4964842|NCT00166296|17065196|P1|Overall Study|Withdrawal by Subject|1
4964843|NCT00166114|17065248|P2|Overall Study|Adverse Event|1
4964844|NCT00166114|17065249|P1|Overall Study|Adverse Event|2
4964845|NCT00166114|17065248|P2|Overall Study|Withdrawal by Subject|4
4964846|NCT00166114|17065249|P1|Overall Study|Withdrawal by Subject|10
4964847|NCT00166114|17065248|P2|Overall Study|Protocol Violation|1
4964848|NCT00166114|17065249|P1|Overall Study|Protocol Violation|2
4964849|NCT00165984|17065266|P1|Overall Study|Death|15
4964850|NCT00165841|17065284|P2|Overall Study|Medication Noncompliance|1
4964851|NCT00165841|17065285|P1|Overall Study|Medication Noncompliance|1
4964852|NCT00165841|17065284|P2|Overall Study|Other|5
4964853|NCT00165841|17065285|P1|Overall Study|Other|3
4964854|NCT00165841|17065284|P2|Overall Study|Protocol Violation|8
4964855|NCT00165841|17065285|P1|Overall Study|Protocol Violation|6
4964856|NCT00165841|17065284|P2|Overall Study|Physician Decision|0
4964857|NCT00165841|17065285|P1|Overall Study|Physician Decision|1
4964858|NCT00165841|17065284|P2|Overall Study|Withdrawal by Subject|8
4964859|NCT00165841|17065285|P1|Overall Study|Withdrawal by Subject|7
4964860|NCT00165841|17065284|P2|Overall Study|Lost to Follow-up|4
4964861|NCT00165841|17065285|P1|Overall Study|Lost to Follow-up|4
4964862|NCT00165841|17065284|P2|Overall Study|Lack of Efficacy|33
4964863|NCT00165841|17065285|P1|Overall Study|Lack of Efficacy|6
4964864|NCT00165841|17065284|P2|Overall Study|Adverse Event|3
4964865|NCT00165841|17065285|P1|Overall Study|Adverse Event|2
4964866|NCT00165789|17065295|P4|Overall Study|Withdrawal by Subject|2
4964867|NCT00165789|17065296|P3|Overall Study|Withdrawal by Subject|1
4964868|NCT00165789|17065297|P2|Overall Study|Withdrawal by Subject|1
4964869|NCT00165789|17065298|P1|Overall Study|Withdrawal by Subject|0
4964870|NCT00165789|17065295|P4|Overall Study|Adverse Event|12
4964871|NCT00165789|17065296|P3|Overall Study|Adverse Event|0
4964872|NCT00165789|17065297|P2|Overall Study|Adverse Event|3
4964873|NCT00165789|17065298|P1|Overall Study|Adverse Event|0
4964874|NCT00165776|17065352|P4|Overall Study|Worsening of Cervical Dystonia|1
4964875|NCT00165776|17065353|P3|Overall Study|Worsening of Cervical Dystonia|0
4964876|NCT00165776|17065354|P2|Overall Study|Worsening of Cervical Dystonia|0
4964877|NCT00165776|17065355|P1|Overall Study|Worsening of Cervical Dystonia|0
4964878|NCT00165776|17065352|P4|Overall Study|Withdrawal by Subject|0
4964879|NCT00165776|17065353|P3|Overall Study|Withdrawal by Subject|2
4964880|NCT00165776|17065354|P2|Overall Study|Withdrawal by Subject|1
4964881|NCT00165776|17065355|P1|Overall Study|Withdrawal by Subject|4
4964882|NCT00165776|17065352|P4|Overall Study|Lack of Efficacy|1
4964883|NCT00165776|17065353|P3|Overall Study|Lack of Efficacy|0
4964884|NCT00165776|17065354|P2|Overall Study|Lack of Efficacy|0
4964885|NCT00165776|17065355|P1|Overall Study|Lack of Efficacy|0
4964886|NCT00165698|17065391|P2|Overall Study|Not Taken/Lost the medicine|2
4964887|NCT00165698|17065392|P1|Overall Study|Not Taken/Lost the medicine|1
4964888|NCT00165698|17065391|P2|Overall Study|Protocol Violation|0
4964889|NCT00165698|17065392|P1|Overall Study|Protocol Violation|1
4964890|NCT00165698|17065391|P2|Overall Study|Withdrawal by Subject|1
4964891|NCT00165698|17065392|P1|Overall Study|Withdrawal by Subject|2
4964892|NCT00165698|17065391|P2|Overall Study|Lost to Follow-up|2
4964893|NCT00165698|17065392|P1|Overall Study|Lost to Follow-up|2
4964894|NCT00165698|17065391|P2|Overall Study|Adverse Event|10
4964895|NCT00165698|17065392|P1|Overall Study|Adverse Event|2
4964896|NCT00165672|17065418|P2|Overall Study|Adverse Event|1
4964897|NCT00165672|17065419|P1|Overall Study|Adverse Event|0
4964898|NCT00165646|17065428|P3|Overall Study|Protocol Violation|0
4964899|NCT00165646|17065429|P2|Overall Study|Protocol Violation|0
4964900|NCT00165646|17065430|P1|Overall Study|Protocol Violation|1
4964901|NCT00165646|17065428|P3|Overall Study|Physician Decision|2
4964902|NCT00165646|17065429|P2|Overall Study|Physician Decision|0
4964903|NCT00165646|17065430|P1|Overall Study|Physician Decision|2
4964904|NCT00165646|17065428|P3|Overall Study|Withdrawal by Subject|1
4964905|NCT00165646|17065429|P2|Overall Study|Withdrawal by Subject|2
4964906|NCT00165646|17065430|P1|Overall Study|Withdrawal by Subject|0
4964907|NCT00165646|17065428|P3|Overall Study|Lack of Efficacy|0
4964908|NCT00165646|17065429|P2|Overall Study|Lack of Efficacy|2
4964909|NCT00165646|17065430|P1|Overall Study|Lack of Efficacy|1
4964910|NCT00165646|17065428|P3|Overall Study|Adverse Event|1
4964911|NCT00165646|17065429|P2|Overall Study|Adverse Event|1
4964912|NCT00165646|17065430|P1|Overall Study|Adverse Event|1
4964913|NCT00165503|17065438|P1|Overall Study|Unresectable|3
4964914|NCT00165503|17065438|P1|Overall Study|Lost to Follow-up|12
4964915|NCT00165503|17065438|P1|Overall Study|Death|1
4964916|NCT00163657|17065445|P3|Overall Study|Other reason|3
4964917|NCT00163657|17065446|P2|Overall Study|Other reason|1
4964918|NCT00163657|17065447|P1|Overall Study|Other reason|0
4964919|NCT00163657|17065445|P3|Overall Study|Lost to Follow-up|10
4964920|NCT00163657|17065446|P2|Overall Study|Lost to Follow-up|3
4964921|NCT00163657|17065447|P1|Overall Study|Lost to Follow-up|1
4964922|NCT00163657|17065445|P3|Overall Study|Non Compliance|0
4964923|NCT00163657|17065446|P2|Overall Study|Non Compliance|0
4964924|NCT00163657|17065447|P1|Overall Study|Non Compliance|1
4964925|NCT00163657|17065445|P3|Overall Study|Physician Decision|1
4964926|NCT00163657|17065446|P2|Overall Study|Physician Decision|1
4964927|NCT00163657|17065447|P1|Overall Study|Physician Decision|0
4964928|NCT00163657|17065445|P3|Overall Study|Withdrawal by Subject|2
4964929|NCT00163657|17065446|P2|Overall Study|Withdrawal by Subject|3
4964930|NCT00163657|17065447|P1|Overall Study|Withdrawal by Subject|2
4964931|NCT00163657|17065445|P3|Overall Study|graft loss|2
4964932|NCT00163657|17065446|P2|Overall Study|graft loss|1
4964933|NCT00163657|17065447|P1|Overall Study|graft loss|4
4964934|NCT00163657|17065445|P3|Overall Study|Death|19
4964935|NCT00163657|17065446|P2|Overall Study|Death|14
4964936|NCT00163657|17065447|P1|Overall Study|Death|12
4964937|NCT00163215|17065537|P1|Overall Study|Other|7
4964938|NCT00163215|17065537|P1|Overall Study|Withdrawal by Subject|5
4964939|NCT00163215|17065537|P1|Overall Study|Lack of Efficacy|3
4964940|NCT00163189|17065557|P1|Overall Study|Did not meet continuation criterion|16
4964941|NCT00163189|17065557|P1|Overall Study|Withdrawal by Subject|11
4964942|NCT00163189|17065557|P1|Overall Study|Study terminated by sponsor|11
4964943|NCT00163189|17065557|P1|Overall Study|Lack of Efficacy|7
4964944|NCT00163189|17065557|P1|Overall Study|Adverse Event|6
4964945|NCT00163189|17065557|P1|Overall Study|Death|3
4964946|NCT00163189|17065557|P1|Overall Study|Protocol Violation|2
4964947|NCT00163189|17065557|P1|Overall Study|Lost to Follow-up|1
4964948|NCT00163189|17065557|P1|Overall Study|Other|6
4964949|NCT00163020|17065581|P2|Overall Study|Lost to Follow-up|2
4964950|NCT00163020|17065582|P1|Overall Study|Lost to Follow-up|0
4964951|NCT00162981|17065622|P2|Overall Study|Physician Decision|0
4964952|NCT00162981|17065623|P1|Overall Study|Physician Decision|1
4964953|NCT00162981|17065622|P2|Overall Study|Withdrawal by Subject|1
4964954|NCT00162981|17065623|P1|Overall Study|Withdrawal by Subject|1
4964955|NCT00162981|17065622|P2|Overall Study|Adverse Event|5
4964956|NCT00162981|17065623|P1|Overall Study|Adverse Event|2
4964957|NCT00162942|17065639|P2|Overall Study|2 or more consecutive treatments missed|0
4964958|NCT00162942|17065640|P1|Overall Study|2 or more consecutive treatments missed|1
4964959|NCT00162942|17065639|P2|Overall Study|Flare During Active Treatment|3
4964960|NCT00162942|17065640|P1|Overall Study|Flare During Active Treatment|7
4964961|NCT00162942|17065639|P2|Overall Study|Lack of Efficacy|0
4964962|NCT00162942|17065640|P1|Overall Study|Lack of Efficacy|1
4964963|NCT00162942|17065639|P2|Overall Study|Alternate Therapy|2
4964964|NCT00162942|17065640|P1|Overall Study|Alternate Therapy|6
4964965|NCT00162942|17065639|P2|Overall Study|Enter Open-Label Study|35
4964966|NCT00162942|17065640|P1|Overall Study|Enter Open-Label Study|76
4964967|NCT00162942|17065639|P2|Overall Study|Physician Decision|0
4964968|NCT00162942|17065640|P1|Overall Study|Physician Decision|1
4964969|NCT00162942|17065639|P2|Overall Study|Withdrawal by Subject|6
4964970|NCT00162942|17065640|P1|Overall Study|Withdrawal by Subject|3
4964971|NCT00162942|17065639|P2|Overall Study|Death|0
4964972|NCT00162942|17065640|P1|Overall Study|Death|1
4964973|NCT00162942|17065639|P2|Overall Study|Adverse Event|6
4964974|NCT00162942|17065640|P1|Overall Study|Adverse Event|10
4964975|NCT00162773|17065688|P1|Overall Study|P.I, Left institution. Study terminated|22
4964976|NCT00162370|17065692|P1|Efficacy Population|Lost to Follow-up|51
4964977|NCT00162266|17065700|P4|Open-Label Period|Other Reasons|15
4964978|NCT00162266|17065701|P3|Open-Label Period|Other Reasons|0
4964979|NCT00162266|17065702|P2|Open-Label Period|Other Reasons|0
4964980|NCT00162266|17065703|P1|Open-Label Period|Other Reasons|0
4964981|NCT00162266|17065700|P4|Open-Label Period|Administrative Reason By Sponsor|9
4964982|NCT00162266|17065701|P3|Open-Label Period|Administrative Reason By Sponsor|0
4964983|NCT00162266|17065702|P2|Open-Label Period|Administrative Reason By Sponsor|0
4964984|NCT00162266|17065703|P1|Open-Label Period|Administrative Reason By Sponsor|0
4964985|NCT00162266|17065700|P4|Open-Label Period|Withdrawal by Subject|31
4964986|NCT00162266|17065701|P3|Open-Label Period|Withdrawal by Subject|0
4964987|NCT00162266|17065702|P2|Open-Label Period|Withdrawal by Subject|0
4964988|NCT00162266|17065703|P1|Open-Label Period|Withdrawal by Subject|0
4964989|NCT00162266|17065700|P4|Open-Label Period|Lost to Follow-up|3
4964990|NCT00162266|17065701|P3|Open-Label Period|Lost to Follow-up|0
4964991|NCT00162266|17065702|P2|Open-Label Period|Lost to Follow-up|0
4964992|NCT00162266|17065703|P1|Open-Label Period|Lost to Follow-up|0
4964993|NCT00162266|17065700|P4|Open-Label Period|Lack of Efficacy|26
4964994|NCT00162266|17065701|P3|Open-Label Period|Lack of Efficacy|0
4964995|NCT00162266|17065702|P2|Open-Label Period|Lack of Efficacy|0
4964996|NCT00162266|17065703|P1|Open-Label Period|Lack of Efficacy|0
4964997|NCT00162266|17065700|P4|Open-Label Period|Adverse Event|46
4964998|NCT00162266|17065701|P3|Open-Label Period|Adverse Event|0
4964999|NCT00162266|17065702|P2|Open-Label Period|Adverse Event|0
4965000|NCT00162266|17065703|P1|Open-Label Period|Adverse Event|0
4965001|NCT00162266|17065700|P4|Open-Label Period|Death|7
4965002|NCT00162266|17065701|P3|Open-Label Period|Death|0
4965003|NCT00162266|17065702|P2|Open-Label Period|Death|0
4965004|NCT00162266|17065703|P1|Open-Label Period|Death|0
4965005|NCT00162266|17065700|P4|Double-Blind Period|Withdrawal by Subject|0
4965006|NCT00162266|17065701|P3|Double-Blind Period|Withdrawal by Subject|6
4965007|NCT00162266|17065702|P2|Double-Blind Period|Withdrawal by Subject|2
4965008|NCT00162266|17065703|P1|Double-Blind Period|Withdrawal by Subject|5
4965009|NCT00162266|17065700|P4|Double-Blind Period|Lack of Efficacy|0
4965010|NCT00162266|17065701|P3|Double-Blind Period|Lack of Efficacy|30
4965011|NCT00162266|17065702|P2|Double-Blind Period|Lack of Efficacy|17
4965012|NCT00162266|17065703|P1|Double-Blind Period|Lack of Efficacy|13
4965013|NCT00162266|17065700|P4|Double-Blind Period|Other Reason|0
4965014|NCT00162266|17065701|P3|Double-Blind Period|Other Reason|1
4965015|NCT00162266|17065702|P2|Double-Blind Period|Other Reason|0
4965016|NCT00162266|17065703|P1|Double-Blind Period|Other Reason|1
4965017|NCT00162266|17065700|P4|Double-Blind Period|Lost to Follow-up|0
4965018|NCT00162266|17065701|P3|Double-Blind Period|Lost to Follow-up|0
4965019|NCT00162266|17065702|P2|Double-Blind Period|Lost to Follow-up|2
4965020|NCT00162266|17065703|P1|Double-Blind Period|Lost to Follow-up|1
4965021|NCT00162266|17065700|P4|Double-Blind Period|Death|0
4965022|NCT00162266|17065701|P3|Double-Blind Period|Death|0
4965023|NCT00162266|17065702|P2|Double-Blind Period|Death|1
4965024|NCT00162266|17065703|P1|Double-Blind Period|Death|0
4965025|NCT00162266|17065700|P4|Double-Blind Period|Adverse Event|0
4965026|NCT00162266|17065701|P3|Double-Blind Period|Adverse Event|11
4965027|NCT00162266|17065702|P2|Double-Blind Period|Adverse Event|9
4965028|NCT00162266|17065703|P1|Double-Blind Period|Adverse Event|5
4965029|NCT00162136|17065904|P1|Overall Study|Withdrawal by Subject|1
4965030|NCT00162136|17065904|P1|Overall Study|Study Drug Toxicity|4
4965031|NCT00162136|17065904|P1|Overall Study|Investigator Request|5
4965032|NCT00162136|17065904|P1|Overall Study|Disease Progression/Relapse|23
4965033|NCT00162136|17065904|P1|Overall Study|Death|1
4965034|NCT00162136|17065904|P1|Overall Study|Adverse Event|1
4965035|NCT00162123|17065936|P8|Overall Study|Follow-up only (not treated or assessed)|57
4965036|NCT00162123|17065937|P7|Overall Study|Follow-up only (not treated or assessed)|0
4965037|NCT00162123|17065938|P6|Overall Study|Follow-up only (not treated or assessed)|0
4965038|NCT00162123|17065939|P5|Overall Study|Follow-up only (not treated or assessed)|0
4965039|NCT00162123|17065940|P4|Overall Study|Follow-up only (not treated or assessed)|0
4965040|NCT00162123|17065941|P3|Overall Study|Follow-up only (not treated or assessed)|0
4965041|NCT00162123|17065942|P2|Overall Study|Follow-up only (not treated or assessed)|0
4965042|NCT00162123|17065943|P1|Overall Study|Follow-up only (not treated or assessed)|0
4965043|NCT00162123|17065936|P8|Overall Study|Tumor assessment only (not treated)|1
4965044|NCT00162123|17065937|P7|Overall Study|Tumor assessment only (not treated)|0
4965045|NCT00162123|17065938|P6|Overall Study|Tumor assessment only (not treated)|0
4965046|NCT00162123|17065939|P5|Overall Study|Tumor assessment only (not treated)|0
4965047|NCT00162123|17065940|P4|Overall Study|Tumor assessment only (not treated)|0
4965048|NCT00162123|17065941|P3|Overall Study|Tumor assessment only (not treated)|0
4965049|NCT00162123|17065942|P2|Overall Study|Tumor assessment only (not treated)|0
4965050|NCT00162123|17065943|P1|Overall Study|Tumor assessment only (not treated)|0
4965051|NCT00162123|17065936|P8|Overall Study|Physician Decision|0
4965052|NCT00162123|17065937|P7|Overall Study|Physician Decision|1
4965053|NCT00162123|17065938|P6|Overall Study|Physician Decision|1
4965054|NCT00162123|17065939|P5|Overall Study|Physician Decision|0
4965055|NCT00162123|17065940|P4|Overall Study|Physician Decision|0
4965056|NCT00162123|17065941|P3|Overall Study|Physician Decision|0
4965057|NCT00162123|17065942|P2|Overall Study|Physician Decision|2
4965058|NCT00162123|17065943|P1|Overall Study|Physician Decision|1
4965059|NCT00162123|17065936|P8|Overall Study|Not specified (after start of treatment)|0
4965060|NCT00162123|17065937|P7|Overall Study|Not specified (after start of treatment)|0
4965061|NCT00162123|17065938|P6|Overall Study|Not specified (after start of treatment)|0
4965062|NCT00162123|17065939|P5|Overall Study|Not specified (after start of treatment)|3
4965063|NCT00162123|17065940|P4|Overall Study|Not specified (after start of treatment)|0
4965064|NCT00162123|17065941|P3|Overall Study|Not specified (after start of treatment)|0
4965065|NCT00162123|17065942|P2|Overall Study|Not specified (after start of treatment)|0
4965066|NCT00162123|17065943|P1|Overall Study|Not specified (after start of treatment)|0
4965067|NCT00162123|17065936|P8|Overall Study|Not specified (before treatment)|0
4965068|NCT00162123|17065937|P7|Overall Study|Not specified (before treatment)|0
4965069|NCT00162123|17065938|P6|Overall Study|Not specified (before treatment)|1
4965070|NCT00162123|17065939|P5|Overall Study|Not specified (before treatment)|12
4965071|NCT00162123|17065940|P4|Overall Study|Not specified (before treatment)|0
4965072|NCT00162123|17065941|P3|Overall Study|Not specified (before treatment)|0
4965073|NCT00162123|17065942|P2|Overall Study|Not specified (before treatment)|0
4965074|NCT00162123|17065943|P1|Overall Study|Not specified (before treatment)|2
4965075|NCT00162123|17065936|P8|Overall Study|Adverse Event|0
4965076|NCT00162123|17065937|P7|Overall Study|Adverse Event|0
4965077|NCT00162123|17065938|P6|Overall Study|Adverse Event|0
4965078|NCT00162123|17065939|P5|Overall Study|Adverse Event|1
4965079|NCT00162123|17065940|P4|Overall Study|Adverse Event|2
4965080|NCT00162123|17065941|P3|Overall Study|Adverse Event|0
4965081|NCT00162123|17065942|P2|Overall Study|Adverse Event|2
4965082|NCT00162123|17065943|P1|Overall Study|Adverse Event|1
4965083|NCT00162123|17065936|P8|Overall Study|Deterioration without progression|0
4965084|NCT00162123|17065937|P7|Overall Study|Deterioration without progression|0
4965085|NCT00162123|17065938|P6|Overall Study|Deterioration without progression|0
4965086|NCT00162123|17065939|P5|Overall Study|Deterioration without progression|1
4965087|NCT00162123|17065940|P4|Overall Study|Deterioration without progression|0
4965088|NCT00162123|17065941|P3|Overall Study|Deterioration without progression|3
4965089|NCT00162123|17065942|P2|Overall Study|Deterioration without progression|2
4965090|NCT00162123|17065943|P1|Overall Study|Deterioration without progression|2
4965091|NCT00162123|17065936|P8|Overall Study|Withdrawal by Subject|0
4965092|NCT00162123|17065937|P7|Overall Study|Withdrawal by Subject|1
4965093|NCT00162123|17065938|P6|Overall Study|Withdrawal by Subject|2
4965094|NCT00162123|17065939|P5|Overall Study|Withdrawal by Subject|1
4965095|NCT00162123|17065940|P4|Overall Study|Withdrawal by Subject|1
4965096|NCT00162123|17065941|P3|Overall Study|Withdrawal by Subject|2
4965097|NCT00162123|17065942|P2|Overall Study|Withdrawal by Subject|0
4965098|NCT00162123|17065943|P1|Overall Study|Withdrawal by Subject|2
4965099|NCT00162123|17065936|P8|Overall Study|Death|0
4965100|NCT00162123|17065937|P7|Overall Study|Death|0
4965101|NCT00162123|17065938|P6|Overall Study|Death|1
4965102|NCT00162123|17065939|P5|Overall Study|Death|1
4965103|NCT00162123|17065940|P4|Overall Study|Death|1
4965104|NCT00162123|17065941|P3|Overall Study|Death|1
4965105|NCT00162123|17065942|P2|Overall Study|Death|3
4965106|NCT00162123|17065943|P1|Overall Study|Death|3
4965107|NCT00162123|17065936|P8|Overall Study|Study drug toxicity|0
4965108|NCT00162123|17065937|P7|Overall Study|Study drug toxicity|1
4965109|NCT00162123|17065938|P6|Overall Study|Study drug toxicity|1
4965110|NCT00162123|17065939|P5|Overall Study|Study drug toxicity|4
4965111|NCT00162123|17065940|P4|Overall Study|Study drug toxicity|0
4965112|NCT00162123|17065941|P3|Overall Study|Study drug toxicity|5
4965113|NCT00162123|17065942|P2|Overall Study|Study drug toxicity|1
4965114|NCT00162123|17065943|P1|Overall Study|Study drug toxicity|6
4965115|NCT00162123|17065936|P8|Overall Study|Disease progression|0
4965116|NCT00162123|17065937|P7|Overall Study|Disease progression|1
4965117|NCT00162123|17065938|P6|Overall Study|Disease progression|3
4965118|NCT00162123|17065939|P5|Overall Study|Disease progression|8
4965119|NCT00162123|17065940|P4|Overall Study|Disease progression|4
4965120|NCT00162123|17065941|P3|Overall Study|Disease progression|10
4965121|NCT00162123|17065942|P2|Overall Study|Disease progression|19
4965122|NCT00162123|17065943|P1|Overall Study|Disease progression|27
4965123|NCT00162097|17065976|P4|Overall Study|Participant no longer met study criteria|1
4965124|NCT00162097|17065977|P3|Overall Study|Participant no longer met study criteria|0
4965125|NCT00162097|17065978|P2|Overall Study|Participant no longer met study criteria|0
4965126|NCT00162097|17065979|P1|Overall Study|Participant no longer met study criteria|0
4965127|NCT00162032|17066041|P2|Overall Study|Reason not specified|0
4965128|NCT00162032|17066042|P1|Overall Study|Reason not specified|1
4965129|NCT00162032|17066041|P2|Overall Study|Lost to Follow-up|2
4965130|NCT00162032|17066042|P1|Overall Study|Lost to Follow-up|4
4965131|NCT00161616|17066063|P2|Overall Study|Protocol deviation|0
4965132|NCT00161616|17066064|P1|Overall Study|Protocol deviation|1
4965133|NCT00161616|17066063|P2|Overall Study|Lost to Follow-up|13
4965134|NCT00161616|17066064|P1|Overall Study|Lost to Follow-up|17
4965135|NCT00161616|17066063|P2|Overall Study|Death|1
4965136|NCT00161616|17066064|P1|Overall Study|Death|1
4965137|NCT00161616|17066063|P2|Overall Study|Physician Decision|0
4965138|NCT00161616|17066064|P1|Overall Study|Physician Decision|1
4965139|NCT00161616|17066063|P2|Overall Study|Withdrawal by Subject|5
4965140|NCT00161616|17066064|P1|Overall Study|Withdrawal by Subject|6
4965141|NCT00161213|17066096|P1|Overall Study|Evaluable for toxicity but not response|1
4965142|NCT00161213|17066096|P1|Overall Study|Withdrawal by Subject|1
4965143|NCT00160706|17066103|P1|Overall Study|Other Reason|11
4965144|NCT00160706|17066103|P1|Overall Study|Lack of Efficacy and Other|1
4965145|NCT00160706|17066103|P1|Overall Study|Lack of Efficacy|42
4965146|NCT00160706|17066103|P1|Overall Study|Lost to Follow-up and Other|1
4965147|NCT00160706|17066103|P1|Overall Study|Lost to Follow-up|4
4965148|NCT00160706|17066103|P1|Overall Study|Physician Decision and Other|3
4965149|NCT00160706|17066103|P1|Overall Study|Physician Decision|10
4965150|NCT00160706|17066103|P1|Overall Study|Withdrawal by Subject and Other|12
4965151|NCT00160706|17066103|P1|Overall Study|Withdrawal by Subject|41
4965152|NCT00160706|17066103|P1|Overall Study|Protocol Violation|3
4965153|NCT00160706|17066103|P1|Overall Study|Adverse Event and Other Reason|105
4965154|NCT00160706|17066103|P1|Overall Study|Adverse Event|53
4965155|NCT00160693|17066115|P1|Overall Study|Study terminated by sponsor|15
4965156|NCT00160693|17066115|P1|Overall Study|Withdrawal by Subject|54
4965157|NCT00160693|17066115|P1|Overall Study|Lost to Follow-up|15
4965158|NCT00160693|17066115|P1|Overall Study|Protocol Violation|24
4965159|NCT00160693|17066115|P1|Overall Study|Lack of Efficacy|30
4965160|NCT00160693|17066115|P1|Overall Study|Adverse Event|97
4965161|NCT00160680|17066134|P2|Overall Study|Withdrawal by Subject|9
4965162|NCT00160680|17066135|P1|Overall Study|Withdrawal by Subject|4
4965163|NCT00160680|17066134|P2|Overall Study|Lost to Follow-up|2
4965164|NCT00160680|17066135|P1|Overall Study|Lost to Follow-up|3
4965165|NCT00160680|17066134|P2|Overall Study|Lack of Efficacy|1
4965166|NCT00160680|17066135|P1|Overall Study|Lack of Efficacy|2
4965167|NCT00160680|17066134|P2|Overall Study|Adverse Event|1
4965168|NCT00160680|17066135|P1|Overall Study|Adverse Event|0
4965169|NCT00160667|17066170|P3|Overall Study|Patient decision|1
4965170|NCT00160667|17066171|P2|Overall Study|Patient decision|0
4965171|NCT00160667|17066172|P1|Overall Study|Patient decision|0
4965172|NCT00160667|17066170|P3|Overall Study|Protocol Violation|0
4965173|NCT00160667|17066171|P2|Overall Study|Protocol Violation|1
4965174|NCT00160667|17066172|P1|Overall Study|Protocol Violation|0
4965175|NCT00160667|17066170|P3|Overall Study|Lack of Efficacy|0
4965176|NCT00160667|17066171|P2|Overall Study|Lack of Efficacy|1
4965177|NCT00160667|17066172|P1|Overall Study|Lack of Efficacy|0
4965178|NCT00160667|17066170|P3|Overall Study|Withdrawal by Subject|1
4965179|NCT00160667|17066171|P2|Overall Study|Withdrawal by Subject|0
4965180|NCT00160667|17066172|P1|Overall Study|Withdrawal by Subject|2
4965181|NCT00160667|17066170|P3|Overall Study|Adverse Event|4
4965182|NCT00160667|17066171|P2|Overall Study|Adverse Event|1
4965183|NCT00160667|17066172|P1|Overall Study|Adverse Event|3
4965184|NCT00160654|17066219|P1|Overall Study|Met exclusion criteria|1
4965185|NCT00160654|17066219|P1|Overall Study|Poor compliance, dilantin toxicity|1
4965186|NCT00160654|17066219|P1|Overall Study|Patient decision|1
4965187|NCT00160654|17066219|P1|Overall Study|Patient met exclusion criteria|1
4965188|NCT00160654|17066219|P1|Overall Study|Sponsor decision|1
4965189|NCT00160654|17066219|P1|Overall Study|Psychological trauma|1
4965190|NCT00160654|17066219|P1|Overall Study|Intake of expired drug|7
4965191|NCT00160654|17066219|P1|Overall Study|Lost to Follow-up|2
4965192|NCT00160654|17066219|P1|Overall Study|Lack of Efficacy|4
4965193|NCT00160654|17066219|P1|Overall Study|Adverse Event|14
4965194|NCT00160641|17066229|P1|Overall Study|Other|9
4965195|NCT00160641|17066229|P1|Overall Study|Protocol Violation|3
4965196|NCT00160641|17066229|P1|Overall Study|Lack of Efficacy|12
4965197|NCT00160641|17066229|P1|Overall Study|Lost to Follow-up|8
4965198|NCT00160641|17066229|P1|Overall Study|Withdrawal by Subject|87
4965199|NCT00160641|17066229|P1|Overall Study|Adverse Event|102
4965200|NCT00160615|17066262|P2|Overall Study|Poor compliance|1
4965201|NCT00160615|17066263|P1|Overall Study|Poor compliance|0
4965202|NCT00160615|17066262|P2|Overall Study|Non-compliance was suspected|1
4965203|NCT00160615|17066263|P1|Overall Study|Non-compliance was suspected|0
4965204|NCT00160615|17066262|P2|Overall Study|Switch to surgical treatment|2
4965205|NCT00160615|17066263|P1|Overall Study|Switch to surgical treatment|0
4965206|NCT00160615|17066262|P2|Overall Study|AE agents had to be discontinued (exam.)|1
4965207|NCT00160615|17066263|P1|Overall Study|AE agents had to be discontinued (exam.)|0
4965208|NCT00160615|17066262|P2|Overall Study|Investigator decision|1
4965209|NCT00160615|17066263|P1|Overall Study|Investigator decision|1
4965210|NCT00160615|17066262|P2|Overall Study|Patient decision|2
4965211|NCT00160615|17066263|P1|Overall Study|Patient decision|1
4965212|NCT00160615|17066262|P2|Overall Study|Lack of Efficacy|23
4965213|NCT00160615|17066263|P1|Overall Study|Lack of Efficacy|11
4965214|NCT00160615|17066262|P2|Overall Study|Withdrawal by Subject|2
4965215|NCT00160615|17066263|P1|Overall Study|Withdrawal by Subject|0
4965216|NCT00160615|17066262|P2|Overall Study|Adverse Event|12
4965217|NCT00160615|17066263|P1|Overall Study|Adverse Event|5
4965218|NCT00160563|17066286|P3|Overall Study|Missing reason|0
4965219|NCT00160563|17066287|P2|Overall Study|Missing reason|1
4965220|NCT00160563|17066288|P1|Overall Study|Missing reason|0
4965221|NCT00160563|17066286|P3|Overall Study|Other (listed in the study report)|81
4965222|NCT00160563|17066287|P2|Overall Study|Other (listed in the study report)|40
4965223|NCT00160563|17066288|P1|Overall Study|Other (listed in the study report)|48
4965224|NCT00160563|17066286|P3|Overall Study|Withdrawal by Subject|3
4965225|NCT00160563|17066287|P2|Overall Study|Withdrawal by Subject|2
4965226|NCT00160563|17066288|P1|Overall Study|Withdrawal by Subject|1
4965227|NCT00160563|17066286|P3|Overall Study|Protocol Violation|3
4965228|NCT00160563|17066287|P2|Overall Study|Protocol Violation|0
4965229|NCT00160563|17066288|P1|Overall Study|Protocol Violation|0
4965230|NCT00160563|17066286|P3|Overall Study|Lost to Follow-up|2
4965231|NCT00160563|17066287|P2|Overall Study|Lost to Follow-up|1
4965232|NCT00160563|17066288|P1|Overall Study|Lost to Follow-up|1
4965233|NCT00160563|17066286|P3|Overall Study|Adverse Event|1
4965234|NCT00160563|17066287|P2|Overall Study|Adverse Event|1
4965235|NCT00160563|17066288|P1|Overall Study|Adverse Event|1
4965236|NCT00160524|17066300|P1|Overall Study|Other|20
4965237|NCT00160524|17066300|P1|Overall Study|Lack of Efficacy and Other|1
4965238|NCT00160524|17066300|P1|Overall Study|Lack of Efficacy|21
4965239|NCT00160524|17066300|P1|Overall Study|Lost to Follow-up and Other|1
4965240|NCT00160524|17066300|P1|Overall Study|Lost to Follow-up|13
4965241|NCT00160524|17066300|P1|Overall Study|Physician Decision and Other|6
4965242|NCT00160524|17066300|P1|Overall Study|Physician Decision|27
4965243|NCT00160524|17066300|P1|Overall Study|Withdrawal by Subject and Other|17
4965244|NCT00160524|17066300|P1|Overall Study|Withdrawal by Subject|141
4965245|NCT00160524|17066300|P1|Overall Study|Protocol Violation and Other|2
4965246|NCT00160524|17066300|P1|Overall Study|Protocol Violation|16
4965247|NCT00160524|17066300|P1|Overall Study|Adverse Event and Other|94
4965248|NCT00160524|17066300|P1|Overall Study|Adverse Event|119
4965249|NCT00160251|17066317|P8|Post-amendment 2|Lost to follow-up/withdrawal by subject|11
4965250|NCT00160251|17066318|P7|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965251|NCT00160251|17066319|P6|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965252|NCT00160251|17066320|P5|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965253|NCT00160251|17066321|P4|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965254|NCT00160251|17066322|P3|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965255|NCT00160251|17066323|P2|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965256|NCT00160251|17066324|P1|Post-amendment 2|Lost to follow-up/withdrawal by subject|0
4965257|NCT00160251|17066317|P8|Post-amendment 2|Lack of Efficacy|24
4965258|NCT00160251|17066318|P7|Post-amendment 2|Lack of Efficacy|0
4965259|NCT00160251|17066319|P6|Post-amendment 2|Lack of Efficacy|0
4965260|NCT00160251|17066320|P5|Post-amendment 2|Lack of Efficacy|0
4965261|NCT00160251|17066321|P4|Post-amendment 2|Lack of Efficacy|0
4965262|NCT00160251|17066322|P3|Post-amendment 2|Lack of Efficacy|0
4965263|NCT00160251|17066323|P2|Post-amendment 2|Lack of Efficacy|0
4965264|NCT00160251|17066324|P1|Post-amendment 2|Lack of Efficacy|0
4965265|NCT00160251|17066317|P8|Post-amendment 2|Adverse Event|20
4965266|NCT00160251|17066318|P7|Post-amendment 2|Adverse Event|0
4965267|NCT00160251|17066319|P6|Post-amendment 2|Adverse Event|0
4965268|NCT00160251|17066320|P5|Post-amendment 2|Adverse Event|0
4965269|NCT00160251|17066321|P4|Post-amendment 2|Adverse Event|0
4965270|NCT00160251|17066322|P3|Post-amendment 2|Adverse Event|0
4965271|NCT00160251|17066323|P2|Post-amendment 2|Adverse Event|0
4965272|NCT00160251|17066324|P1|Post-amendment 2|Adverse Event|0
4965273|NCT00160251|17066317|P8|Prior to Amendment 2|Completed Treatment Phase|0
4965274|NCT00160251|17066318|P7|Prior to Amendment 2|Completed Treatment Phase|0
4965275|NCT00160251|17066319|P6|Prior to Amendment 2|Completed Treatment Phase|23
4965276|NCT00160251|17066320|P5|Prior to Amendment 2|Completed Treatment Phase|0
4965277|NCT00160251|17066321|P4|Prior to Amendment 2|Completed Treatment Phase|0
4965278|NCT00160251|17066322|P3|Prior to Amendment 2|Completed Treatment Phase|0
4965279|NCT00160251|17066323|P2|Prior to Amendment 2|Completed Treatment Phase|0
4965280|NCT00160251|17066324|P1|Prior to Amendment 2|Completed Treatment Phase|3
4965281|NCT00160251|17066317|P8|Prior to Amendment 2|Noncompliance with protocol|0
4965282|NCT00160251|17066318|P7|Prior to Amendment 2|Noncompliance with protocol|0
4965283|NCT00160251|17066319|P6|Prior to Amendment 2|Noncompliance with protocol|0
4965284|NCT00160251|17066320|P5|Prior to Amendment 2|Noncompliance with protocol|0
4965285|NCT00160251|17066321|P4|Prior to Amendment 2|Noncompliance with protocol|0
4965286|NCT00160251|17066322|P3|Prior to Amendment 2|Noncompliance with protocol|0
4965287|NCT00160251|17066323|P2|Prior to Amendment 2|Noncompliance with protocol|0
4965288|NCT00160251|17066324|P1|Prior to Amendment 2|Noncompliance with protocol|1
4965289|NCT00160251|17066317|P8|Prior to Amendment 2|Withdrawal by Subject|0
4965290|NCT00160251|17066318|P7|Prior to Amendment 2|Withdrawal by Subject|3
4965291|NCT00160251|17066319|P6|Prior to Amendment 2|Withdrawal by Subject|3
4965292|NCT00160251|17066320|P5|Prior to Amendment 2|Withdrawal by Subject|2
4965293|NCT00160251|17066321|P4|Prior to Amendment 2|Withdrawal by Subject|4
4965294|NCT00160251|17066322|P3|Prior to Amendment 2|Withdrawal by Subject|3
4965295|NCT00160251|17066323|P2|Prior to Amendment 2|Withdrawal by Subject|1
4965296|NCT00160251|17066324|P1|Prior to Amendment 2|Withdrawal by Subject|3
4965297|NCT00160251|17066317|P8|Prior to Amendment 2|Lost to Follow-up|0
4965298|NCT00160251|17066318|P7|Prior to Amendment 2|Lost to Follow-up|0
4965299|NCT00160251|17066319|P6|Prior to Amendment 2|Lost to Follow-up|1
4965300|NCT00160251|17066320|P5|Prior to Amendment 2|Lost to Follow-up|1
4965301|NCT00160251|17066321|P4|Prior to Amendment 2|Lost to Follow-up|0
4965302|NCT00160251|17066322|P3|Prior to Amendment 2|Lost to Follow-up|1
4965303|NCT00160251|17066323|P2|Prior to Amendment 2|Lost to Follow-up|0
4965304|NCT00160251|17066324|P1|Prior to Amendment 2|Lost to Follow-up|0
4965305|NCT00160251|17066317|P8|Prior to Amendment 2|Lack of Efficacy|0
4965306|NCT00160251|17066318|P7|Prior to Amendment 2|Lack of Efficacy|0
4965307|NCT00160251|17066319|P6|Prior to Amendment 2|Lack of Efficacy|55
4965308|NCT00160251|17066320|P5|Prior to Amendment 2|Lack of Efficacy|24
4965309|NCT00160251|17066321|P4|Prior to Amendment 2|Lack of Efficacy|35
4965310|NCT00160251|17066322|P3|Prior to Amendment 2|Lack of Efficacy|37
4965311|NCT00160251|17066323|P2|Prior to Amendment 2|Lack of Efficacy|4
4965312|NCT00160251|17066324|P1|Prior to Amendment 2|Lack of Efficacy|0
4965313|NCT00160251|17066317|P8|Prior to Amendment 2|Adverse Event|0
4965314|NCT00160251|17066318|P7|Prior to Amendment 2|Adverse Event|1
4965315|NCT00160251|17066319|P6|Prior to Amendment 2|Adverse Event|1
4965316|NCT00160251|17066320|P5|Prior to Amendment 2|Adverse Event|1
4965317|NCT00160251|17066321|P4|Prior to Amendment 2|Adverse Event|1
4965318|NCT00160251|17066322|P3|Prior to Amendment 2|Adverse Event|3
4965319|NCT00160251|17066323|P2|Prior to Amendment 2|Adverse Event|1
4965320|NCT00160251|17066324|P1|Prior to Amendment 2|Adverse Event|2
4965321|NCT00160199|17066400|P2|Overall Study|Protocol Violation|8
4965322|NCT00160199|17066401|P1|Overall Study|Protocol Violation|8
4965323|NCT00160199|17066400|P2|Overall Study|Administrative|1
4965324|NCT00160199|17066401|P1|Overall Study|Administrative|0
4965325|NCT00160199|17066400|P2|Overall Study|Withdrawal by Subject|6
4965326|NCT00160199|17066401|P1|Overall Study|Withdrawal by Subject|4
4965327|NCT00160199|17066400|P2|Overall Study|Lost to Follow-up|7
4965328|NCT00160199|17066401|P1|Overall Study|Lost to Follow-up|7
4965329|NCT00160199|17066400|P2|Overall Study|Lack of Efficacy|1
4965330|NCT00160199|17066401|P1|Overall Study|Lack of Efficacy|0
4965331|NCT00160199|17066400|P2|Overall Study|Adverse Event|14
4965332|NCT00160199|17066401|P1|Overall Study|Adverse Event|5
4965333|NCT00159913|17066458|P4|Overall Study|Protocol Violation|0
4965334|NCT00159913|17066459|P3|Overall Study|Protocol Violation|1
4965335|NCT00159913|17066460|P2|Overall Study|Protocol Violation|0
4965336|NCT00159913|17066461|P1|Overall Study|Protocol Violation|1
4965337|NCT00159913|17066458|P4|Overall Study|Lost to Follow-up|1
4965338|NCT00159913|17066459|P3|Overall Study|Lost to Follow-up|0
4965339|NCT00159913|17066460|P2|Overall Study|Lost to Follow-up|0
4965340|NCT00159913|17066461|P1|Overall Study|Lost to Follow-up|0
4965341|NCT00159913|17066458|P4|Overall Study|Withdrawal by Subject|1
4965342|NCT00159913|17066459|P3|Overall Study|Withdrawal by Subject|0
4965343|NCT00159913|17066460|P2|Overall Study|Withdrawal by Subject|0
4965344|NCT00159913|17066461|P1|Overall Study|Withdrawal by Subject|0
4965345|NCT00159913|17066458|P4|Overall Study|Adverse Event|0
4965346|NCT00159913|17066459|P3|Overall Study|Adverse Event|1
4965347|NCT00159913|17066460|P2|Overall Study|Adverse Event|0
4965348|NCT00159913|17066461|P1|Overall Study|Adverse Event|1
4965349|NCT00159874|17066535|P7|Overall Study|Pregnancy|0
4965350|NCT00159874|17066536|P6|Overall Study|Pregnancy|0
4965351|NCT00159874|17066537|P5|Overall Study|Pregnancy|0
4965352|NCT00159874|17066538|P4|Overall Study|Pregnancy|0
4965353|NCT00159874|17066539|P3|Overall Study|Pregnancy|0
4965354|NCT00159874|17066540|P2|Overall Study|Pregnancy|1
4965355|NCT00159874|17066541|P1|Overall Study|Pregnancy|1
4965356|NCT00159874|17066535|P7|Overall Study|Withdrawal by Subject|1
4965357|NCT00159874|17066536|P6|Overall Study|Withdrawal by Subject|2
4965358|NCT00159874|17066537|P5|Overall Study|Withdrawal by Subject|3
4965359|NCT00159874|17066538|P4|Overall Study|Withdrawal by Subject|4
4965360|NCT00159874|17066539|P3|Overall Study|Withdrawal by Subject|8
4965361|NCT00159874|17066540|P2|Overall Study|Withdrawal by Subject|6
4965362|NCT00159874|17066541|P1|Overall Study|Withdrawal by Subject|2
4965363|NCT00159874|17066535|P7|Overall Study|Death|0
4965364|NCT00159874|17066536|P6|Overall Study|Death|2
4965365|NCT00159874|17066537|P5|Overall Study|Death|1
4965366|NCT00159874|17066538|P4|Overall Study|Death|0
4965367|NCT00159874|17066539|P3|Overall Study|Death|15
4965368|NCT00159874|17066540|P2|Overall Study|Death|8
4965369|NCT00159874|17066541|P1|Overall Study|Death|3
4965370|NCT00159874|17066535|P7|Overall Study|Protocol Violation|0
4965371|NCT00159874|17066536|P6|Overall Study|Protocol Violation|0
4965372|NCT00159874|17066537|P5|Overall Study|Protocol Violation|0
4965373|NCT00159874|17066538|P4|Overall Study|Protocol Violation|0
4965374|NCT00159874|17066539|P3|Overall Study|Protocol Violation|2
4965375|NCT00159874|17066540|P2|Overall Study|Protocol Violation|5
4965376|NCT00159874|17066541|P1|Overall Study|Protocol Violation|0
4965377|NCT00159874|17066535|P7|Overall Study|Other|3
4965378|NCT00159874|17066536|P6|Overall Study|Other|1
4965379|NCT00159874|17066537|P5|Overall Study|Other|2
4965380|NCT00159874|17066538|P4|Overall Study|Other|0
4965381|NCT00159874|17066539|P3|Overall Study|Other|8
4965382|NCT00159874|17066540|P2|Overall Study|Other|8
4965383|NCT00159874|17066541|P1|Overall Study|Other|8
4965384|NCT00159874|17066535|P7|Overall Study|Lost to Follow-up|1
4965385|NCT00159874|17066536|P6|Overall Study|Lost to Follow-up|2
4965386|NCT00159874|17066537|P5|Overall Study|Lost to Follow-up|1
4965387|NCT00159874|17066538|P4|Overall Study|Lost to Follow-up|0
4965388|NCT00159874|17066539|P3|Overall Study|Lost to Follow-up|3
4965389|NCT00159874|17066540|P2|Overall Study|Lost to Follow-up|0
4965390|NCT00159874|17066541|P1|Overall Study|Lost to Follow-up|1
4965391|NCT00159874|17066535|P7|Overall Study|Lack of Efficacy|0
4965392|NCT00159874|17066536|P6|Overall Study|Lack of Efficacy|3
4965393|NCT00159874|17066537|P5|Overall Study|Lack of Efficacy|0
4965394|NCT00159874|17066538|P4|Overall Study|Lack of Efficacy|1
4965395|NCT00159874|17066539|P3|Overall Study|Lack of Efficacy|1
4965396|NCT00159874|17066540|P2|Overall Study|Lack of Efficacy|0
4965397|NCT00159874|17066541|P1|Overall Study|Lack of Efficacy|2
4965398|NCT00159874|17066535|P7|Overall Study|Does Not Meet Entrance Criteria|0
4965399|NCT00159874|17066536|P6|Overall Study|Does Not Meet Entrance Criteria|0
4965400|NCT00159874|17066537|P5|Overall Study|Does Not Meet Entrance Criteria|0
4965401|NCT00159874|17066538|P4|Overall Study|Does Not Meet Entrance Criteria|0
4965402|NCT00159874|17066539|P3|Overall Study|Does Not Meet Entrance Criteria|1
4965403|NCT00159874|17066540|P2|Overall Study|Does Not Meet Entrance Criteria|0
4965404|NCT00159874|17066541|P1|Overall Study|Does Not Meet Entrance Criteria|1
4965405|NCT00159874|17066535|P7|Overall Study|Adverse Event|0
4965406|NCT00159874|17066536|P6|Overall Study|Adverse Event|2
4965407|NCT00159874|17066537|P5|Overall Study|Adverse Event|1
4965408|NCT00159874|17066538|P4|Overall Study|Adverse Event|1
4965409|NCT00159874|17066539|P3|Overall Study|Adverse Event|5
4965410|NCT00159874|17066540|P2|Overall Study|Adverse Event|2
4965411|NCT00159874|17066541|P1|Overall Study|Adverse Event|2
4965412|NCT00159861|17066711|P2|Extension Study - up to 3 Years|Withdrawal by Subject|9
4965413|NCT00159861|17066712|P1|Extension Study - up to 3 Years|Withdrawal by Subject|7
4965414|NCT00159861|17066711|P2|Extension Study - up to 3 Years|Reason Unspecified|19
4965415|NCT00159861|17066712|P1|Extension Study - up to 3 Years|Reason Unspecified|12
4965416|NCT00159861|17066711|P2|Extension Study - up to 3 Years|Lack of Efficacy|1
4965417|NCT00159861|17066712|P1|Extension Study - up to 3 Years|Lack of Efficacy|5
4965418|NCT00159861|17066711|P2|Extension Study - up to 3 Years|Adverse Event|14
4965419|NCT00159861|17066712|P1|Extension Study - up to 3 Years|Adverse Event|14
4965420|NCT00159861|17066711|P2|Extension Study - up to 3 Years|Death|28
4965421|NCT00159861|17066712|P1|Extension Study - up to 3 Years|Death|24
4965422|NCT00159861|17066711|P2|Core Study - 16 Weeks|Randomized but not Treated|0
4965423|NCT00159861|17066712|P1|Core Study - 16 Weeks|Randomized but not Treated|2
4965424|NCT00159861|17066711|P2|Core Study - 16 Weeks|Subject Defaulted|0
4965425|NCT00159861|17066712|P1|Core Study - 16 Weeks|Subject Defaulted|1
4965426|NCT00159861|17066711|P2|Core Study - 16 Weeks|Reason Unspecified|3
4965427|NCT00159861|17066712|P1|Core Study - 16 Weeks|Reason Unspecified|5
4965428|NCT00159861|17066711|P2|Core Study - 16 Weeks|Lack of Efficacy|3
4965429|NCT00159861|17066712|P1|Core Study - 16 Weeks|Lack of Efficacy|2
4965430|NCT00159861|17066711|P2|Core Study - 16 Weeks|Adverse Event|6
4965431|NCT00159861|17066712|P1|Core Study - 16 Weeks|Adverse Event|12
4965432|NCT00159861|17066711|P2|Core Study - 16 Weeks|Death|0
4965433|NCT00159861|17066712|P1|Core Study - 16 Weeks|Death|3
4965434|NCT00159822|17066733|P1|Post-treatment Follow-up Period|Reason unspecified|1
4965435|NCT00159822|17066733|P1|Post-treatment Follow-up Period|Withdrawal by Subject|1
4965436|NCT00159822|17066733|P1|Post-treatment Follow-up Period|Death|1
4965437|NCT00159822|17066733|P1|Voriconazole Treatment Period|Withdrawal by Subject|2
4965438|NCT00159822|17066733|P1|Voriconazole Treatment Period|Lost to Follow-up|2
4965439|NCT00159822|17066733|P1|Voriconazole Treatment Period|Protocol Violation|2
4965440|NCT00159822|17066733|P1|Voriconazole Treatment Period|Death|4
4965441|NCT00159822|17066733|P1|Voriconazole Treatment Period|Adverse Event|9
4965442|NCT00159822|17066733|P1|Voriconazole Treatment Period|Lack of Efficacy|3
4965443|NCT00159783|17066751|P3|Overall Study|Other|4
4965444|NCT00159783|17066752|P2|Overall Study|Other|2
4965445|NCT00159783|17066753|P1|Overall Study|Other|0
4965446|NCT00159783|17066751|P3|Overall Study|Lost to Follow-up|11
4965447|NCT00159783|17066752|P2|Overall Study|Lost to Follow-up|5
4965448|NCT00159783|17066753|P1|Overall Study|Lost to Follow-up|6
4965449|NCT00159783|17066751|P3|Overall Study|Withdrawal by Subject|12
4965450|NCT00159783|17066752|P2|Overall Study|Withdrawal by Subject|11
4965451|NCT00159783|17066753|P1|Overall Study|Withdrawal by Subject|7
4965452|NCT00159783|17066751|P3|Overall Study|Lack of Efficacy|3
4965453|NCT00159783|17066752|P2|Overall Study|Lack of Efficacy|2
4965454|NCT00159783|17066753|P1|Overall Study|Lack of Efficacy|1
4965455|NCT00159783|17066751|P3|Overall Study|Adverse Event|9
4965456|NCT00159783|17066752|P2|Overall Study|Adverse Event|7
4965457|NCT00159783|17066753|P1|Overall Study|Adverse Event|5
4965458|NCT00159432|17066783|P1|Overall Study|Lack of Efficacy|8
4965459|NCT00159432|17066783|P1|Overall Study|Death|1
4965460|NCT00159432|17066783|P1|Overall Study|Adverse Event|1
4965461|NCT00158860|17066857|P2|Overall Study|Closed per sponsor|1
4965462|NCT00158860|17066858|P1|Overall Study|Closed per sponsor|0
4965463|NCT00158860|17066857|P2|Overall Study|Lost to Follow up but returned per GSK|1
4965464|NCT00158860|17066858|P1|Overall Study|Lost to Follow up but returned per GSK|0
4965465|NCT00158860|17066857|P2|Overall Study|SPONSOR REQUEST|1
4965466|NCT00158860|17066858|P1|Overall Study|SPONSOR REQUEST|0
4965467|NCT00158860|17066857|P2|Overall Study|SPONSOR STOPPED STUDY|2
4965468|NCT00158860|17066858|P1|Overall Study|SPONSOR STOPPED STUDY|2
4965469|NCT00158860|17066857|P2|Overall Study|Pregnancy|3
4965470|NCT00158860|17066858|P1|Overall Study|Pregnancy|3
4965471|NCT00158860|17066857|P2|Overall Study|MOVING OUT OF STATE|0
4965472|NCT00158860|17066858|P1|Overall Study|MOVING OUT OF STATE|1
4965473|NCT00158860|17066857|P2|Overall Study|Withdrawal by Subject|17
4965474|NCT00158860|17066858|P1|Overall Study|Withdrawal by Subject|7
4965475|NCT00158860|17066857|P2|Overall Study|Protocol Violation|23
4965476|NCT00158860|17066858|P1|Overall Study|Protocol Violation|8
4965477|NCT00158860|17066857|P2|Overall Study|Lost to Follow-up|17
4965478|NCT00158860|17066858|P1|Overall Study|Lost to Follow-up|11
4965479|NCT00158860|17066857|P2|Overall Study|Adverse Event|6
4965480|NCT00158860|17066858|P1|Overall Study|Adverse Event|3
4965481|NCT00158756|17066877|P5|Overall Study|Serious adverse event|0
4965482|NCT00158756|17066878|P4|Overall Study|Serious adverse event|0
4965483|NCT00158756|17066879|P3|Overall Study|Serious adverse event|1
4965484|NCT00158756|17066880|P2|Overall Study|Serious adverse event|0
4965485|NCT00158756|17066881|P1|Overall Study|Serious adverse event|0
4965486|NCT00158756|17066877|P5|Overall Study|Adverse Event|0
4965487|NCT00158756|17066878|P4|Overall Study|Adverse Event|0
4965488|NCT00158756|17066879|P3|Overall Study|Adverse Event|1
4965489|NCT00158756|17066880|P2|Overall Study|Adverse Event|0
4965490|NCT00158756|17066881|P1|Overall Study|Adverse Event|0
4965491|NCT00158756|17066877|P5|Overall Study|Withdrawal by Subject|3
4965492|NCT00158756|17066878|P4|Overall Study|Withdrawal by Subject|1
4965493|NCT00158756|17066879|P3|Overall Study|Withdrawal by Subject|6
4965494|NCT00158756|17066880|P2|Overall Study|Withdrawal by Subject|0
4965495|NCT00158756|17066881|P1|Overall Study|Withdrawal by Subject|5
4965496|NCT00158600|17066987|P2|Overall Study|Withdrawal by Subject|2
4965497|NCT00158600|17066988|P1|Overall Study|Withdrawal by Subject|2
4965498|NCT00158600|17066987|P2|Overall Study|Death|0
4965499|NCT00158600|17066988|P1|Overall Study|Death|1
4965500|NCT00158600|17066987|P2|Overall Study|Adverse Event|1
4965501|NCT00158600|17066988|P1|Overall Study|Adverse Event|2
4965502|NCT00158600|17066987|P2|Overall Study|unable to commit time to study|1
4965503|NCT00158600|17066988|P1|Overall Study|unable to commit time to study|0
4965504|NCT00158262|17067013|P2|Overall Study|Lost to Follow-up|1
4965505|NCT00158262|17067014|P1|Overall Study|Lost to Follow-up|1
4965506|NCT00158184|17067075|P2|Overall Study|Adverse Event|1
4965507|NCT00158184|17067076|P1|Overall Study|Adverse Event|1
4965508|NCT00158184|17067075|P2|Overall Study|failed for follow unit/study rules|0
4965509|NCT00158184|17067076|P1|Overall Study|failed for follow unit/study rules|2
4965510|NCT00158184|17067075|P2|Overall Study|personal issues|1
4965511|NCT00158184|17067076|P1|Overall Study|personal issues|3
4965512|NCT00158054|17067086|P2|Overall Study|Unavailable for follow up|3
4965513|NCT00158054|17067087|P1|Overall Study|Unavailable for follow up|7
4965514|NCT00158054|17067086|P2|Overall Study|Refused to continue|0
4965515|NCT00158054|17067087|P1|Overall Study|Refused to continue|3
4965516|NCT00157950|17067101|P2|Overall Study|Death|0
4965517|NCT00157950|17067102|P1|Overall Study|Death|1
4965518|NCT00157820|17067119|P3|2nd 8 Months|Premature cross-over|9
4965519|NCT00157820|17067120|P2|2nd 8 Months|Premature cross-over|7
4965520|NCT00157820|17067121|P1|2nd 8 Months|Premature cross-over|1
4965521|NCT00157820|17067119|P3|2nd 8 Months|Lost to Follow-up|2
4965522|NCT00157820|17067120|P2|2nd 8 Months|Lost to Follow-up|5
4965523|NCT00157820|17067121|P1|2nd 8 Months|Lost to Follow-up|1
4965524|NCT00157820|17067119|P3|2nd 8 Months|Death|3
4965525|NCT00157820|17067120|P2|2nd 8 Months|Death|1
4965526|NCT00157820|17067121|P1|2nd 8 Months|Death|3
4965527|NCT00157820|17067119|P3|1st 8 Month|Premature cross-over|2
4965528|NCT00157820|17067120|P2|1st 8 Month|Premature cross-over|2
4965529|NCT00157820|17067121|P1|1st 8 Month|Premature cross-over|0
4965530|NCT00157820|17067119|P3|1st 8 Month|Lost to Follow-up|1
4965531|NCT00157820|17067120|P2|1st 8 Month|Lost to Follow-up|2
4965532|NCT00157820|17067121|P1|1st 8 Month|Lost to Follow-up|1
4965533|NCT00157820|17067119|P3|1st 8 Month|Death|3
4965534|NCT00157820|17067120|P2|1st 8 Month|Death|8
4965535|NCT00157820|17067121|P1|1st 8 Month|Death|7
4965536|NCT00157820|17067119|P3|Randomized|Protocol Violation|2
4965537|NCT00157820|17067120|P2|Randomized|Protocol Violation|1
4965538|NCT00157820|17067121|P1|Randomized|Protocol Violation|2
4965539|NCT00157820|17067119|P3|Randomized|Withdrawal by Subject|3
4965540|NCT00157820|17067120|P2|Randomized|Withdrawal by Subject|2
4965541|NCT00157820|17067121|P1|Randomized|Withdrawal by Subject|1
4965542|NCT00157820|17067119|P3|Randomized|Physician Decision|3
4965543|NCT00157820|17067120|P2|Randomized|Physician Decision|2
4965544|NCT00157820|17067121|P1|Randomized|Physician Decision|4
4965545|NCT00157755|17067134|P6|Overall Study|Study completion|2
4965546|NCT00157755|17067135|P5|Overall Study|Study completion|1
4965547|NCT00157755|17067136|P4|Overall Study|Study completion|0
4965548|NCT00157755|17067137|P3|Overall Study|Study completion|0
4965549|NCT00157755|17067138|P2|Overall Study|Study completion|0
4965550|NCT00157755|17067139|P1|Overall Study|Study completion|0
4965551|NCT00157755|17067134|P6|Overall Study|Subject non-compliance|1
4965552|NCT00157755|17067135|P5|Overall Study|Subject non-compliance|0
4965553|NCT00157755|17067136|P4|Overall Study|Subject non-compliance|0
4965554|NCT00157755|17067137|P3|Overall Study|Subject non-compliance|0
4965555|NCT00157755|17067138|P2|Overall Study|Subject non-compliance|0
4965556|NCT00157755|17067139|P1|Overall Study|Subject non-compliance|0
4965557|NCT00157755|17067134|P6|Overall Study|Study site closure|0
4965558|NCT00157755|17067135|P5|Overall Study|Study site closure|0
4965559|NCT00157755|17067136|P4|Overall Study|Study site closure|0
4965560|NCT00157755|17067137|P3|Overall Study|Study site closure|0
4965561|NCT00157755|17067138|P2|Overall Study|Study site closure|1
4965562|NCT00157755|17067139|P1|Overall Study|Study site closure|0
4965563|NCT00157755|17067134|P6|Overall Study|Medical reason|0
4965564|NCT00157755|17067135|P5|Overall Study|Medical reason|0
4965565|NCT00157755|17067136|P4|Overall Study|Medical reason|1
4965566|NCT00157755|17067137|P3|Overall Study|Medical reason|1
4965567|NCT00157755|17067138|P2|Overall Study|Medical reason|0
4965568|NCT00157755|17067139|P1|Overall Study|Medical reason|0
4965569|NCT00157755|17067134|P6|Overall Study|Explant due to infection|0
4965570|NCT00157755|17067135|P5|Overall Study|Explant due to infection|0
4965571|NCT00157755|17067136|P4|Overall Study|Explant due to infection|0
4965572|NCT00157755|17067137|P3|Overall Study|Explant due to infection|1
4965573|NCT00157755|17067138|P2|Overall Study|Explant due to infection|0
4965574|NCT00157755|17067139|P1|Overall Study|Explant due to infection|0
4965575|NCT00157755|17067134|P6|Overall Study|Withdrawal by Subject|2
4965576|NCT00157755|17067135|P5|Overall Study|Withdrawal by Subject|1
4965577|NCT00157755|17067136|P4|Overall Study|Withdrawal by Subject|1
4965578|NCT00157755|17067137|P3|Overall Study|Withdrawal by Subject|1
4965579|NCT00157755|17067138|P2|Overall Study|Withdrawal by Subject|0
4965580|NCT00157755|17067139|P1|Overall Study|Withdrawal by Subject|0
4965581|NCT00157755|17067134|P6|Overall Study|Lost to Follow-up|0
4965582|NCT00157755|17067135|P5|Overall Study|Lost to Follow-up|0
4965583|NCT00157755|17067136|P4|Overall Study|Lost to Follow-up|0
4965584|NCT00157755|17067137|P3|Overall Study|Lost to Follow-up|1
4965585|NCT00157755|17067138|P2|Overall Study|Lost to Follow-up|0
4965586|NCT00157755|17067139|P1|Overall Study|Lost to Follow-up|0
4965587|NCT00157755|17067134|P6|Overall Study|Death|0
4965588|NCT00157755|17067135|P5|Overall Study|Death|0
4965589|NCT00157755|17067136|P4|Overall Study|Death|2
4965590|NCT00157755|17067137|P3|Overall Study|Death|3
4965591|NCT00157755|17067138|P2|Overall Study|Death|3
4965592|NCT00157755|17067139|P1|Overall Study|Death|2
4965593|NCT00157248|17067175|P4|Overall Study|site closures, subject moving|9
4965594|NCT00157248|17067176|P3|Overall Study|site closures, subject moving|3
4965595|NCT00157248|17067177|P2|Overall Study|site closures, subject moving|7
4965596|NCT00157248|17067178|P1|Overall Study|site closures, subject moving|7
4965597|NCT00157248|17067175|P4|Overall Study|Withdrawal by Subject|3
4965598|NCT00157248|17067176|P3|Overall Study|Withdrawal by Subject|3
4965599|NCT00157248|17067177|P2|Overall Study|Withdrawal by Subject|4
4965600|NCT00157248|17067178|P1|Overall Study|Withdrawal by Subject|1
4965601|NCT00157248|17067175|P4|Overall Study|Lost to Follow-up|0
4965602|NCT00157248|17067176|P3|Overall Study|Lost to Follow-up|0
4965603|NCT00157248|17067177|P2|Overall Study|Lost to Follow-up|1
4965604|NCT00157248|17067178|P1|Overall Study|Lost to Follow-up|0
4965605|NCT00157248|17067175|P4|Overall Study|Protocol Violation|2
4965606|NCT00157248|17067176|P3|Overall Study|Protocol Violation|2
4965607|NCT00157248|17067177|P2|Overall Study|Protocol Violation|0
4965608|NCT00157248|17067178|P1|Overall Study|Protocol Violation|4
4965609|NCT00157248|17067175|P4|Overall Study|Adverse Event|33
4965610|NCT00157248|17067176|P3|Overall Study|Adverse Event|13
4965611|NCT00157248|17067177|P2|Overall Study|Adverse Event|25
4965612|NCT00157248|17067178|P1|Overall Study|Adverse Event|36
4965613|NCT00157209|17067284|P2|Overall Study|Ongoing at data cut-off|0
4965614|NCT00157209|17067285|P1|Overall Study|Ongoing at data cut-off|10
4965615|NCT00157196|17067299|P1|Overall Study|Ongoing at data cut-off|9
4965616|NCT00157157|17067305|P1|Overall Study|Inclusion not met- baseline FVIII value|1
4965617|NCT00157157|17067305|P1|Overall Study|Met exclusion criteria|1
4965618|NCT00157157|17067305|P1|Overall Study|Enrolled in another study|1
4965619|NCT00157157|17067305|P1|Overall Study|Lost to Follow-up|1
4965620|NCT00157157|17067305|P1|Overall Study|Physician Decision|1
4965621|NCT00157157|17067305|P1|Overall Study|Withdrawal by Subject|6
4965622|NCT00157014|17067332|P4|Overall Study|Withdrawal by Subject|0
4965623|NCT00157014|17067333|P3|Overall Study|Withdrawal by Subject|0
4965624|NCT00157014|17067334|P2|Overall Study|Withdrawal by Subject|0
4965625|NCT00157014|17067335|P1|Overall Study|Withdrawal by Subject|1
4965626|NCT00157014|17067332|P4|Overall Study|Patient would not receive transplant|0
4965627|NCT00157014|17067333|P3|Overall Study|Patient would not receive transplant|0
4965628|NCT00157014|17067334|P2|Overall Study|Patient would not receive transplant|1
4965629|NCT00157014|17067335|P1|Overall Study|Patient would not receive transplant|0
4965630|NCT00157014|17067332|P4|Overall Study|Patient unable to return in nursing home|0
4965631|NCT00157014|17067333|P3|Overall Study|Patient unable to return in nursing home|0
4965632|NCT00157014|17067334|P2|Overall Study|Patient unable to return in nursing home|0
4965633|NCT00157014|17067335|P1|Overall Study|Patient unable to return in nursing home|1
4965634|NCT00157014|17067332|P4|Overall Study|Patient withdrawn by investigator|0
4965635|NCT00157014|17067333|P3|Overall Study|Patient withdrawn by investigator|0
4965636|NCT00157014|17067334|P2|Overall Study|Patient withdrawn by investigator|0
4965637|NCT00157014|17067335|P1|Overall Study|Patient withdrawn by investigator|1
4965638|NCT00157014|17067332|P4|Overall Study|Medications withdrawn on family request|0
4965639|NCT00157014|17067333|P3|Overall Study|Medications withdrawn on family request|0
4965640|NCT00157014|17067334|P2|Overall Study|Medications withdrawn on family request|1
4965641|NCT00157014|17067335|P1|Overall Study|Medications withdrawn on family request|0
4965642|NCT00157014|17067332|P4|Overall Study|Physician Decision|0
4965643|NCT00157014|17067333|P3|Overall Study|Physician Decision|0
4965644|NCT00157014|17067334|P2|Overall Study|Physician Decision|1
4965645|NCT00157014|17067335|P1|Overall Study|Physician Decision|0
4965646|NCT00157014|17067332|P4|Overall Study|Death|1
4965647|NCT00157014|17067333|P3|Overall Study|Death|1
4965648|NCT00157014|17067334|P2|Overall Study|Death|2
4965649|NCT00157014|17067335|P1|Overall Study|Death|4
4965650|NCT00156819|17067451|P3|Overall Study|Lost to Follow-up|3
4965651|NCT00156819|17067452|P2|Overall Study|Lost to Follow-up|1
4965652|NCT00156819|17067453|P1|Overall Study|Lost to Follow-up|1
4965653|NCT00156533|17067470|P4|Overall Study|Failed Screening|1
4965654|NCT00156533|17067471|P3|Overall Study|Failed Screening|1
4965655|NCT00156533|17067472|P2|Overall Study|Failed Screening|0
4965656|NCT00156533|17067473|P1|Overall Study|Failed Screening|1
4965657|NCT00156533|17067470|P4|Overall Study|Withdrawal by Subject|1
4965658|NCT00156533|17067471|P3|Overall Study|Withdrawal by Subject|0
4965659|NCT00156533|17067472|P2|Overall Study|Withdrawal by Subject|0
4965660|NCT00156533|17067473|P1|Overall Study|Withdrawal by Subject|1
4965661|NCT00156533|17067470|P4|Overall Study|Withdrawn - Medication Expiration|0
4965662|NCT00156533|17067471|P3|Overall Study|Withdrawn - Medication Expiration|1
4965663|NCT00156533|17067472|P2|Overall Study|Withdrawn - Medication Expiration|2
4965664|NCT00156533|17067473|P1|Overall Study|Withdrawn - Medication Expiration|0
4965665|NCT00156065|17067507|P3|Overall Study|Other|3
4965666|NCT00156065|17067508|P2|Overall Study|Other|9
4965667|NCT00156065|17067509|P1|Overall Study|Other|2
4965668|NCT00156065|17067507|P3|Overall Study|Lost to Follow-up|1
4965669|NCT00156065|17067508|P2|Overall Study|Lost to Follow-up|7
4965670|NCT00156065|17067509|P1|Overall Study|Lost to Follow-up|5
4965671|NCT00156065|17067507|P3|Overall Study|Withdrawal by Subject|16
4965672|NCT00156065|17067508|P2|Overall Study|Withdrawal by Subject|26
4965673|NCT00156065|17067509|P1|Overall Study|Withdrawal by Subject|13
4965674|NCT00156065|17067507|P3|Overall Study|Lack of Efficacy|3
4965675|NCT00156065|17067508|P2|Overall Study|Lack of Efficacy|9
4965676|NCT00156065|17067509|P1|Overall Study|Lack of Efficacy|2
4965677|NCT00156065|17067507|P3|Overall Study|Adverse Event|4
4965678|NCT00156065|17067508|P2|Overall Study|Adverse Event|11
4965679|NCT00156065|17067509|P1|Overall Study|Adverse Event|8
4965680|NCT00156065|17067507|P3|Overall Study|Enrolled But Never Received Treatment|0
4965681|NCT00156065|17067508|P2|Overall Study|Enrolled But Never Received Treatment|1
4965682|NCT00156065|17067509|P1|Overall Study|Enrolled But Never Received Treatment|1
4965683|NCT00154375|17067543|P2|Overall Study|Suspected progression of disease|30
4965684|NCT00154375|17067544|P1|Overall Study|Suspected progression of disease|44
4965685|NCT00154375|17067543|P2|Overall Study|Protocol Violation|1
4965686|NCT00154375|17067544|P1|Overall Study|Protocol Violation|0
4965687|NCT00154375|17067543|P2|Overall Study|Abnormal laboratory value(s)|2
4965688|NCT00154375|17067544|P1|Overall Study|Abnormal laboratory value(s)|0
4965689|NCT00154375|17067543|P2|Overall Study|Lost to Follow-up|1
4965690|NCT00154375|17067544|P1|Overall Study|Lost to Follow-up|2
4965691|NCT00154375|17067543|P2|Overall Study|Study drug no longer required|3
4965692|NCT00154375|17067544|P1|Overall Study|Study drug no longer required|5
4965693|NCT00154375|17067543|P2|Overall Study|Death|13
4965694|NCT00154375|17067544|P1|Overall Study|Death|5
4965695|NCT00154375|17067543|P2|Overall Study|Withdrawal by Subject|10
4965696|NCT00154375|17067544|P1|Overall Study|Withdrawal by Subject|14
4965697|NCT00154375|17067543|P2|Overall Study|Adverse Event|20
4965698|NCT00154375|17067544|P1|Overall Study|Adverse Event|18
4965699|NCT00154375|17067543|P2|Overall Study|Unsatisfactory therapeutic effect|26
4965700|NCT00154375|17067544|P1|Overall Study|Unsatisfactory therapeutic effect|25
4965701|NCT00154310|17067555|P2|Overall Study|Death|1
4965702|NCT00154310|17067556|P1|Overall Study|Death|0
4965703|NCT00154310|17067555|P2|Overall Study|Administrative problems|1
4965704|NCT00154310|17067556|P1|Overall Study|Administrative problems|0
4965705|NCT00154310|17067555|P2|Overall Study|Lost to Follow-up|8
4965706|NCT00154310|17067556|P1|Overall Study|Lost to Follow-up|0
4965707|NCT00154310|17067555|P2|Overall Study|Withdrawal by Subject|3
4965708|NCT00154310|17067556|P1|Overall Study|Withdrawal by Subject|9
4965709|NCT00154310|17067555|P2|Overall Study|Protocol Violation|2
4965710|NCT00154310|17067556|P1|Overall Study|Protocol Violation|4
4965711|NCT00154310|17067555|P2|Overall Study|Lack of Efficacy|4
4965712|NCT00154310|17067556|P1|Overall Study|Lack of Efficacy|5
4965713|NCT00154310|17067555|P2|Overall Study|Adverse Event|9
4965714|NCT00154310|17067556|P1|Overall Study|Adverse Event|19
4965715|NCT00154297|17067572|P2|Overall Study|Lost to Follow-up|0
4965716|NCT00154297|17067573|P1|Overall Study|Lost to Follow-up|3
4965717|NCT00154297|17067572|P2|Overall Study|Withdrawal by Subject|5
4965718|NCT00154297|17067573|P1|Overall Study|Withdrawal by Subject|0
4965719|NCT00154297|17067572|P2|Overall Study|Death|2
4965720|NCT00154297|17067573|P1|Overall Study|Death|5
4965721|NCT00154284|17067591|P2|Overall Study|Protocol Violation|1
4965722|NCT00154284|17067592|P1|Overall Study|Protocol Violation|0
4965723|NCT00154284|17067591|P2|Overall Study|Lack of Efficacy|2
4965724|NCT00154284|17067592|P1|Overall Study|Lack of Efficacy|1
4965725|NCT00154284|17067591|P2|Overall Study|Abnormal laboratory value(s)|1
4965726|NCT00154284|17067592|P1|Overall Study|Abnormal laboratory value(s)|0
4965727|NCT00154284|17067591|P2|Overall Study|Adverse Event|9
4965728|NCT00154284|17067592|P1|Overall Study|Adverse Event|6
4965729|NCT00154102|17067606|P2|Overall Study|investigational study phase ongoing|2
4965730|NCT00154102|17067607|P1|Overall Study|investigational study phase ongoing|7
4965731|NCT00154063|17067643|P2|Overall Study|Other|3
4965732|NCT00154063|17067644|P1|Overall Study|Other|3
4965733|NCT00154063|17067643|P2|Overall Study|Withdrawal by Subject|9
4965734|NCT00154063|17067644|P1|Overall Study|Withdrawal by Subject|4
4965735|NCT00154063|17067643|P2|Overall Study|Investigator or Sponsor Request|1
4965736|NCT00154063|17067644|P1|Overall Study|Investigator or Sponsor Request|0
4965737|NCT00154063|17067643|P2|Overall Study|Protocol Violation|1
4965738|NCT00154063|17067644|P1|Overall Study|Protocol Violation|1
4965739|NCT00154063|17067643|P2|Overall Study|Adverse Event|8
4965740|NCT00154063|17067644|P1|Overall Study|Adverse Event|4
4965741|NCT00153920|17067706|P1|Overall Study|Progressive Disease before Trt|1
4965742|NCT00153920|17067706|P1|Overall Study|Withdrawal of Consent before Trt|1
4965743|NCT00153920|17067706|P1|Overall Study|Non-Protocol Therapy|1
4965744|NCT00153920|17067706|P1|Overall Study|Withdrawal by Subject|1
4965745|NCT00153920|17067706|P1|Overall Study|Death|2
4965746|NCT00153920|17067706|P1|Overall Study|Lack of Response|3
4965747|NCT00153920|17067706|P1|Overall Study|Physician Decision|3
4965748|NCT00153920|17067706|P1|Overall Study|Progressive Disease|9
4965749|NCT00153920|17067706|P1|Overall Study|Adverse Event|9
4965750|NCT00153816|17067732|P6|Overall Study|Follow-up exam done, histology missing|2
4965751|NCT00153816|17067733|P5|Overall Study|Follow-up exam done, histology missing|1
4965752|NCT00153816|17067734|P4|Overall Study|Follow-up exam done, histology missing|3
4965753|NCT00153816|17067735|P3|Overall Study|Follow-up exam done, histology missing|3
4965754|NCT00153816|17067736|P2|Overall Study|Follow-up exam done, histology missing|3
4965755|NCT00153816|17067737|P1|Overall Study|Follow-up exam done, histology missing|2
4965756|NCT00153816|17067732|P6|Overall Study|Follow-up exam not done|9
4965757|NCT00153816|17067733|P5|Overall Study|Follow-up exam not done|8
4965758|NCT00153816|17067734|P4|Overall Study|Follow-up exam not done|10
4965759|NCT00153816|17067735|P3|Overall Study|Follow-up exam not done|11
4965760|NCT00153816|17067736|P2|Overall Study|Follow-up exam not done|7
4965761|NCT00153816|17067737|P1|Overall Study|Follow-up exam not done|8
4965762|NCT00153816|17067732|P6|Overall Study|Withdrawal by Subject|5
4965763|NCT00153816|17067733|P5|Overall Study|Withdrawal by Subject|1
4965764|NCT00153816|17067734|P4|Overall Study|Withdrawal by Subject|4
4965765|NCT00153816|17067735|P3|Overall Study|Withdrawal by Subject|9
4965766|NCT00153816|17067736|P2|Overall Study|Withdrawal by Subject|9
4965767|NCT00153816|17067737|P1|Overall Study|Withdrawal by Subject|9
4965768|NCT00153816|17067732|P6|Overall Study|Lost to Follow-up|9
4965769|NCT00153816|17067733|P5|Overall Study|Lost to Follow-up|7
4965770|NCT00153816|17067734|P4|Overall Study|Lost to Follow-up|8
4965771|NCT00153816|17067735|P3|Overall Study|Lost to Follow-up|5
4965772|NCT00153816|17067736|P2|Overall Study|Lost to Follow-up|8
4965773|NCT00153816|17067737|P1|Overall Study|Lost to Follow-up|7
4965774|NCT00153816|17067732|P6|Overall Study|Death|2
4965775|NCT00153816|17067733|P5|Overall Study|Death|0
4965776|NCT00153816|17067734|P4|Overall Study|Death|6
4965777|NCT00153816|17067735|P3|Overall Study|Death|4
4965778|NCT00153816|17067736|P2|Overall Study|Death|5
4965779|NCT00153816|17067737|P1|Overall Study|Death|6
4965780|NCT00153179|17067778|P4|Study Visit Day 2|Withdrawal by Subject|2
4965781|NCT00153179|17067779|P3|Study Visit Day 2|Withdrawal by Subject|2
4965782|NCT00153179|17067780|P2|Study Visit Day 2|Withdrawal by Subject|0
4965783|NCT00153179|17067781|P1|Study Visit Day 2|Withdrawal by Subject|1
4965784|NCT00153101|17067813|P5|Overall Study|Withdrawal by Subject|5
4965785|NCT00153101|17067814|P4|Overall Study|Withdrawal by Subject|3
4965786|NCT00153101|17067815|P3|Overall Study|Withdrawal by Subject|3
4965787|NCT00153101|17067816|P2|Overall Study|Withdrawal by Subject|4
4965788|NCT00153101|17067817|P1|Overall Study|Withdrawal by Subject|3
4965789|NCT00153101|17067813|P5|Overall Study|Lost to Follow-up|5
4965790|NCT00153101|17067814|P4|Overall Study|Lost to Follow-up|5
4965791|NCT00153101|17067815|P3|Overall Study|Lost to Follow-up|12
4965792|NCT00153101|17067816|P2|Overall Study|Lost to Follow-up|14
4965793|NCT00153101|17067817|P1|Overall Study|Lost to Follow-up|14
4965794|NCT00153062|17067925|P4|Overall Study|Other|0
4965795|NCT00153062|17067926|P3|Overall Study|Other|1
4965796|NCT00153062|17067927|P2|Overall Study|Other|0
4965797|NCT00153062|17067928|P1|Overall Study|Other|0
4965798|NCT00153062|17067925|P4|Overall Study|No disposition data available|1
4965799|NCT00153062|17067926|P3|Overall Study|No disposition data available|1
4965800|NCT00153062|17067927|P2|Overall Study|No disposition data available|1
4965801|NCT00153062|17067928|P1|Overall Study|No disposition data available|1
4965802|NCT00153062|17067925|P4|Overall Study|Protocol Violation|1
4965803|NCT00153062|17067926|P3|Overall Study|Protocol Violation|1
4965804|NCT00153062|17067927|P2|Overall Study|Protocol Violation|2
4965805|NCT00153062|17067928|P1|Overall Study|Protocol Violation|0
4965806|NCT00153062|17067925|P4|Overall Study|Adverse Event|0
4965807|NCT00153062|17067926|P3|Overall Study|Adverse Event|1
4965808|NCT00153062|17067927|P2|Overall Study|Adverse Event|1
4965809|NCT00153062|17067928|P1|Overall Study|Adverse Event|0
4965810|NCT00153062|17067925|P4|Overall Study|Lost to Follow-up|16
4965811|NCT00153062|17067926|P3|Overall Study|Lost to Follow-up|15
4965812|NCT00153062|17067927|P2|Overall Study|Lost to Follow-up|20
4965813|NCT00153062|17067928|P1|Overall Study|Lost to Follow-up|12
4965814|NCT00153062|17067925|P4|Overall Study|Withdrawal by Subject|28
4965815|NCT00153062|17067926|P3|Overall Study|Withdrawal by Subject|27
4965816|NCT00153062|17067927|P2|Overall Study|Withdrawal by Subject|30
4965817|NCT00153062|17067928|P1|Overall Study|Withdrawal by Subject|14
4965818|NCT00153062|17067925|P4|Overall Study|Death|365
4965819|NCT00153062|17067926|P3|Overall Study|Death|369
4965820|NCT00153062|17067927|P2|Overall Study|Death|352
4965821|NCT00153062|17067928|P1|Overall Study|Death|360
4965822|NCT00152971|17067947|P3|Treatment|Other|10
4965823|NCT00152971|17067948|P2|Treatment|Other|11
4965824|NCT00152971|17067949|P1|Treatment|Other|9
4965825|NCT00152971|17067947|P3|Treatment|Withdrawal by Subject|5
4965826|NCT00152971|17067948|P2|Treatment|Withdrawal by Subject|4
4965827|NCT00152971|17067949|P1|Treatment|Withdrawal by Subject|4
4965828|NCT00152971|17067947|P3|Treatment|Lost to Follow-up|1
4965829|NCT00152971|17067948|P2|Treatment|Lost to Follow-up|2
4965830|NCT00152971|17067949|P1|Treatment|Lost to Follow-up|1
4965831|NCT00152971|17067947|P3|Treatment|Protocol Violation|10
4965832|NCT00152971|17067948|P2|Treatment|Protocol Violation|6
4965833|NCT00152971|17067949|P1|Treatment|Protocol Violation|8
4965834|NCT00152971|17067947|P3|Treatment|Adverse Event|54
4965835|NCT00152971|17067948|P2|Treatment|Adverse Event|40
4965836|NCT00152971|17067949|P1|Treatment|Adverse Event|49
4965837|NCT00152971|17067947|P3|Overall Study|Other|5
4965838|NCT00152971|17067948|P2|Overall Study|Other|5
4965839|NCT00152971|17067949|P1|Overall Study|Other|3
4965840|NCT00152971|17067947|P3|Overall Study|Withdrawal by Subject|14
4965841|NCT00152971|17067948|P2|Overall Study|Withdrawal by Subject|8
4965842|NCT00152971|17067949|P1|Overall Study|Withdrawal by Subject|9
4965843|NCT00152971|17067947|P3|Overall Study|Lost to Follow-up|13
4965844|NCT00152971|17067948|P2|Overall Study|Lost to Follow-up|14
4965845|NCT00152971|17067949|P1|Overall Study|Lost to Follow-up|17
4965846|NCT00152971|17067947|P3|Overall Study|Protocol Violation|8
4965847|NCT00152971|17067948|P2|Overall Study|Protocol Violation|11
4965848|NCT00152971|17067949|P1|Overall Study|Protocol Violation|10
4965849|NCT00152971|17067947|P3|Overall Study|Adverse Event|9
4965850|NCT00152971|17067948|P2|Overall Study|Adverse Event|10
4965851|NCT00152971|17067949|P1|Overall Study|Adverse Event|12
4965852|NCT00152763|17067985|P4|Overall Study|Lost to Follow-up|13
4965853|NCT00152763|17067986|P3|Overall Study|Lost to Follow-up|2
4965854|NCT00152763|17067987|P2|Overall Study|Lost to Follow-up|4
4965855|NCT00152763|17067988|P1|Overall Study|Lost to Follow-up|6
4965856|NCT00152763|17067985|P4|Overall Study|Death|1
4965857|NCT00152763|17067986|P3|Overall Study|Death|2
4965858|NCT00152763|17067987|P2|Overall Study|Death|1
4965859|NCT00152763|17067988|P1|Overall Study|Death|4
4965860|NCT00152516|17068104|P1|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1
4965861|NCT00152516|17068104|P1|Overall Study|Other: Underwent Surgery for Epilepsy|1
4965862|NCT00152516|17068104|P1|Overall Study|Other: Moved Out Of State|1
4965863|NCT00152516|17068104|P1|Overall Study|Other: Primary Care Physician's Decision|1
4965864|NCT00152516|17068104|P1|Overall Study|Other: Non-Compliance|2
4965865|NCT00152516|17068104|P1|Overall Study|Other: Parents Withdrew Consent|2
4965866|NCT00152516|17068104|P1|Overall Study|Other: Given Commercial Drug in Error|2
4965867|NCT00152516|17068104|P1|Overall Study|Other: Mother Refused To Cooperate|1
4965868|NCT00152516|17068104|P1|Overall Study|Protocol Violation|3
4965869|NCT00152516|17068104|P1|Overall Study|Withdrawal by Subject|8
4965870|NCT00152516|17068104|P1|Overall Study|Lost to Follow-up|5
4965871|NCT00152516|17068104|P1|Overall Study|Lack and Loss of Efficacy|30
4965872|NCT00152516|17068104|P1|Overall Study|Adverse Event|18
4965873|NCT00152464|17068130|P2|Overall Study|Patient relocated|0
4965874|NCT00152464|17068131|P1|Overall Study|Patient relocated|1
4965875|NCT00152464|17068130|P2|Overall Study|Eczema poorly controlled|0
4965876|NCT00152464|17068131|P1|Overall Study|Eczema poorly controlled|1
4965877|NCT00152464|17068130|P2|Overall Study|Lack of Efficacy|0
4965878|NCT00152464|17068131|P1|Overall Study|Lack of Efficacy|1
4965879|NCT00152464|17068130|P2|Overall Study|Investigator decision|0
4965880|NCT00152464|17068131|P1|Overall Study|Investigator decision|1
4965881|NCT00152464|17068130|P2|Overall Study|Parent decision|1
4965882|NCT00152464|17068131|P1|Overall Study|Parent decision|1
4965883|NCT00152464|17068130|P2|Overall Study|Eczema deterioration|1
4965884|NCT00152464|17068131|P1|Overall Study|Eczema deterioration|0
4965885|NCT00152464|17068130|P2|Overall Study|Atopic dermatitis poorly controlled|1
4965886|NCT00152464|17068131|P1|Overall Study|Atopic dermatitis poorly controlled|0
4965887|NCT00152464|17068130|P2|Overall Study|Withdrawal by Subject|22
4965888|NCT00152464|17068131|P1|Overall Study|Withdrawal by Subject|21
4965889|NCT00152464|17068130|P2|Overall Study|Protocol Violation|1
4965890|NCT00152464|17068131|P1|Overall Study|Protocol Violation|3
4965891|NCT00152464|17068130|P2|Overall Study|Lost to Follow-up|4
4965892|NCT00152464|17068131|P1|Overall Study|Lost to Follow-up|8
4965893|NCT00152464|17068130|P2|Overall Study|Adverse Event|6
4965894|NCT00152464|17068131|P1|Overall Study|Adverse Event|3
4965895|NCT00152009|17068159|P4|Overall Study|Sponsor's decision|3
4965896|NCT00152009|17068160|P3|Overall Study|Sponsor's decision|1
4965897|NCT00152009|17068161|P2|Overall Study|Sponsor's decision|3
4965898|NCT00152009|17068162|P1|Overall Study|Sponsor's decision|3
4965899|NCT00152009|17068159|P4|Overall Study|ECG abnormalities|1
4965900|NCT00152009|17068160|P3|Overall Study|ECG abnormalities|2
4965901|NCT00152009|17068161|P2|Overall Study|ECG abnormalities|2
4965902|NCT00152009|17068162|P1|Overall Study|ECG abnormalities|2
4965903|NCT00152009|17068159|P4|Overall Study|Lack of Efficacy|15
4965904|NCT00152009|17068160|P3|Overall Study|Lack of Efficacy|7
4965905|NCT00152009|17068161|P2|Overall Study|Lack of Efficacy|6
4965906|NCT00152009|17068162|P1|Overall Study|Lack of Efficacy|8
4965907|NCT00152009|17068159|P4|Overall Study|Lost to Follow-up|3
4965908|NCT00152009|17068160|P3|Overall Study|Lost to Follow-up|3
4965909|NCT00152009|17068161|P2|Overall Study|Lost to Follow-up|4
4965910|NCT00152009|17068162|P1|Overall Study|Lost to Follow-up|2
4965911|NCT00152009|17068159|P4|Overall Study|Withdrawal by Subject|9
4965912|NCT00152009|17068160|P3|Overall Study|Withdrawal by Subject|4
4965913|NCT00152009|17068161|P2|Overall Study|Withdrawal by Subject|3
4965914|NCT00152009|17068162|P1|Overall Study|Withdrawal by Subject|2
4965915|NCT00152009|17068159|P4|Overall Study|Protocol Violation|1
4965916|NCT00152009|17068160|P3|Overall Study|Protocol Violation|0
4965917|NCT00152009|17068161|P2|Overall Study|Protocol Violation|0
4965918|NCT00152009|17068162|P1|Overall Study|Protocol Violation|3
4965919|NCT00152009|17068159|P4|Overall Study|Adverse Event|1
4965920|NCT00152009|17068160|P3|Overall Study|Adverse Event|20
4965921|NCT00152009|17068161|P2|Overall Study|Adverse Event|13
4965922|NCT00152009|17068162|P1|Overall Study|Adverse Event|9
4965923|NCT00151996|17068194|P2|Overall Study|Sponsor's decision|2
4965924|NCT00151996|17068195|P1|Overall Study|Sponsor's decision|0
4965925|NCT00151996|17068194|P2|Overall Study|Protocol Violation|2
4965926|NCT00151996|17068195|P1|Overall Study|Protocol Violation|1
4965927|NCT00151996|17068194|P2|Overall Study|Withdrawal by Subject|1
4965928|NCT00151996|17068195|P1|Overall Study|Withdrawal by Subject|1
4965929|NCT00151996|17068194|P2|Overall Study|Adverse Event|2
4965930|NCT00151996|17068195|P1|Overall Study|Adverse Event|3
4965931|NCT00151892|17068211|P2|Overall Study|Lack of study medication at center|1
4965932|NCT00151892|17068212|P1|Overall Study|Lack of study medication at center|0
4965933|NCT00151892|17068211|P2|Overall Study|Used prohibited corticosteroids|0
4965934|NCT00151892|17068212|P1|Overall Study|Used prohibited corticosteroids|1
4965935|NCT00151892|17068211|P2|Overall Study|Did not return for a visit|0
4965936|NCT00151892|17068212|P1|Overall Study|Did not return for a visit|1
4965937|NCT00151892|17068211|P2|Overall Study|Pregnancy|1
4965938|NCT00151892|17068212|P1|Overall Study|Pregnancy|0
4965939|NCT00151892|17068211|P2|Overall Study|Non-compliance|1
4965940|NCT00151892|17068212|P1|Overall Study|Non-compliance|0
4965941|NCT00151892|17068211|P2|Overall Study|Protocol Violation|3
4965942|NCT00151892|17068212|P1|Overall Study|Protocol Violation|3
4965943|NCT00151892|17068211|P2|Overall Study|Adverse Event|3
4965944|NCT00151892|17068212|P1|Overall Study|Adverse Event|6
4965945|NCT00151892|17068211|P2|Overall Study|Lost to Follow-up|10
4965946|NCT00151892|17068212|P1|Overall Study|Lost to Follow-up|5
4965947|NCT00151892|17068211|P2|Overall Study|Patient request|7
4965948|NCT00151892|17068212|P1|Overall Study|Patient request|10
4965949|NCT00151892|17068211|P2|Overall Study|Lack of Efficacy|57
4965950|NCT00151892|17068212|P1|Overall Study|Lack of Efficacy|50
4965951|NCT00151775|17068257|P12|Period 4: Open Label|Protocol Violation|0
4965952|NCT00151775|17068258|P11|Period 4: Open Label|Protocol Violation|0
4965953|NCT00151775|17068259|P10|Period 4: Open Label|Protocol Violation|0
4965954|NCT00151775|17068260|P9|Period 4: Open Label|Protocol Violation|0
4965955|NCT00151775|17068261|P8|Period 4: Open Label|Protocol Violation|0
4965956|NCT00151775|17068262|P7|Period 4: Open Label|Protocol Violation|0
4965957|NCT00151775|17068263|P6|Period 4: Open Label|Protocol Violation|0
4965958|NCT00151775|17068264|P5|Period 4: Open Label|Protocol Violation|1
4965959|NCT00151775|17068265|P4|Period 4: Open Label|Protocol Violation|0
4965960|NCT00151775|17068266|P3|Period 4: Open Label|Protocol Violation|0
4965961|NCT00151775|17068267|P2|Period 4: Open Label|Protocol Violation|0
4965962|NCT00151775|17068268|P1|Period 4: Open Label|Protocol Violation|0
4965963|NCT00151775|17068257|P12|Period 4: Open Label|Physician Decision|0
4965964|NCT00151775|17068258|P11|Period 4: Open Label|Physician Decision|0
4965965|NCT00151775|17068259|P10|Period 4: Open Label|Physician Decision|2
4965966|NCT00151775|17068260|P9|Period 4: Open Label|Physician Decision|0
4965967|NCT00151775|17068261|P8|Period 4: Open Label|Physician Decision|0
4965968|NCT00151775|17068262|P7|Period 4: Open Label|Physician Decision|0
4965969|NCT00151775|17068263|P6|Period 4: Open Label|Physician Decision|0
4965970|NCT00151775|17068264|P5|Period 4: Open Label|Physician Decision|0
4965971|NCT00151775|17068265|P4|Period 4: Open Label|Physician Decision|0
4965972|NCT00151775|17068266|P3|Period 4: Open Label|Physician Decision|0
4965973|NCT00151775|17068267|P2|Period 4: Open Label|Physician Decision|0
4965974|NCT00151775|17068268|P1|Period 4: Open Label|Physician Decision|0
4965975|NCT00151775|17068257|P12|Period 4: Open Label|Other|0
4965976|NCT00151775|17068258|P11|Period 4: Open Label|Other|0
4965977|NCT00151775|17068259|P10|Period 4: Open Label|Other|3
4965978|NCT00151775|17068260|P9|Period 4: Open Label|Other|0
4965979|NCT00151775|17068261|P8|Period 4: Open Label|Other|0
4965980|NCT00151775|17068262|P7|Period 4: Open Label|Other|0
4965981|NCT00151775|17068263|P6|Period 4: Open Label|Other|0
4965982|NCT00151775|17068264|P5|Period 4: Open Label|Other|1
4965983|NCT00151775|17068265|P4|Period 4: Open Label|Other|0
4965984|NCT00151775|17068266|P3|Period 4: Open Label|Other|0
4965985|NCT00151775|17068267|P2|Period 4: Open Label|Other|0
4965986|NCT00151775|17068268|P1|Period 4: Open Label|Other|0
4965987|NCT00151775|17068257|P12|Period 4: Open Label|Non-compliance with protocol|0
4965988|NCT00151775|17068258|P11|Period 4: Open Label|Non-compliance with protocol|0
4965989|NCT00151775|17068259|P10|Period 4: Open Label|Non-compliance with protocol|4
4965990|NCT00151775|17068260|P9|Period 4: Open Label|Non-compliance with protocol|0
4965991|NCT00151775|17068261|P8|Period 4: Open Label|Non-compliance with protocol|0
4965992|NCT00151775|17068262|P7|Period 4: Open Label|Non-compliance with protocol|0
4965993|NCT00151775|17068263|P6|Period 4: Open Label|Non-compliance with protocol|0
4965994|NCT00151775|17068264|P5|Period 4: Open Label|Non-compliance with protocol|4
4965995|NCT00151775|17068265|P4|Period 4: Open Label|Non-compliance with protocol|0
4965996|NCT00151775|17068266|P3|Period 4: Open Label|Non-compliance with protocol|0
4965997|NCT00151775|17068267|P2|Period 4: Open Label|Non-compliance with protocol|0
4965998|NCT00151775|17068268|P1|Period 4: Open Label|Non-compliance with protocol|0
4965999|NCT00151775|17068257|P12|Period 4: Open Label|Lost to Follow-up|0
4966000|NCT00151775|17068258|P11|Period 4: Open Label|Lost to Follow-up|0
4966001|NCT00151775|17068259|P10|Period 4: Open Label|Lost to Follow-up|7
4966002|NCT00151775|17068260|P9|Period 4: Open Label|Lost to Follow-up|0
4966003|NCT00151775|17068261|P8|Period 4: Open Label|Lost to Follow-up|0
4966004|NCT00151775|17068262|P7|Period 4: Open Label|Lost to Follow-up|0
4966005|NCT00151775|17068263|P6|Period 4: Open Label|Lost to Follow-up|0
4966006|NCT00151775|17068264|P5|Period 4: Open Label|Lost to Follow-up|17
4966007|NCT00151775|17068265|P4|Period 4: Open Label|Lost to Follow-up|0
4966008|NCT00151775|17068266|P3|Period 4: Open Label|Lost to Follow-up|0
4966009|NCT00151775|17068267|P2|Period 4: Open Label|Lost to Follow-up|0
4966010|NCT00151775|17068268|P1|Period 4: Open Label|Lost to Follow-up|0
4966011|NCT00151775|17068257|P12|Period 4: Open Label|Adverse Event|0
4966012|NCT00151775|17068258|P11|Period 4: Open Label|Adverse Event|0
4966013|NCT00151775|17068259|P10|Period 4: Open Label|Adverse Event|2
4966014|NCT00151775|17068260|P9|Period 4: Open Label|Adverse Event|0
4966015|NCT00151775|17068261|P8|Period 4: Open Label|Adverse Event|0
4966016|NCT00151775|17068262|P7|Period 4: Open Label|Adverse Event|0
4966017|NCT00151775|17068263|P6|Period 4: Open Label|Adverse Event|0
4966018|NCT00151775|17068264|P5|Period 4: Open Label|Adverse Event|1
4966019|NCT00151775|17068265|P4|Period 4: Open Label|Adverse Event|0
4966020|NCT00151775|17068266|P3|Period 4: Open Label|Adverse Event|0
4966021|NCT00151775|17068267|P2|Period 4: Open Label|Adverse Event|0
4966022|NCT00151775|17068268|P1|Period 4: Open Label|Adverse Event|0
4966023|NCT00151775|17068257|P12|Period 4: Open Label|Withdrawal by Subject|0
4966024|NCT00151775|17068258|P11|Period 4: Open Label|Withdrawal by Subject|0
4966025|NCT00151775|17068259|P10|Period 4: Open Label|Withdrawal by Subject|2
4966026|NCT00151775|17068260|P9|Period 4: Open Label|Withdrawal by Subject|0
4966027|NCT00151775|17068261|P8|Period 4: Open Label|Withdrawal by Subject|0
4966028|NCT00151775|17068262|P7|Period 4: Open Label|Withdrawal by Subject|0
4966029|NCT00151775|17068263|P6|Period 4: Open Label|Withdrawal by Subject|0
4966030|NCT00151775|17068264|P5|Period 4: Open Label|Withdrawal by Subject|5
4966031|NCT00151775|17068265|P4|Period 4: Open Label|Withdrawal by Subject|0
4966032|NCT00151775|17068266|P3|Period 4: Open Label|Withdrawal by Subject|0
4966033|NCT00151775|17068267|P2|Period 4: Open Label|Withdrawal by Subject|0
4966034|NCT00151775|17068268|P1|Period 4: Open Label|Withdrawal by Subject|0
4966035|NCT00151775|17068257|P12|Period 4: Open Label|Increased blood pressure|0
4966036|NCT00151775|17068258|P11|Period 4: Open Label|Increased blood pressure|0
4966037|NCT00151775|17068259|P10|Period 4: Open Label|Increased blood pressure|1
4966038|NCT00151775|17068260|P9|Period 4: Open Label|Increased blood pressure|0
4966039|NCT00151775|17068261|P8|Period 4: Open Label|Increased blood pressure|0
4966040|NCT00151775|17068262|P7|Period 4: Open Label|Increased blood pressure|0
4966041|NCT00151775|17068263|P6|Period 4: Open Label|Increased blood pressure|0
4966042|NCT00151775|17068264|P5|Period 4: Open Label|Increased blood pressure|1
4966043|NCT00151775|17068265|P4|Period 4: Open Label|Increased blood pressure|0
4966044|NCT00151775|17068266|P3|Period 4: Open Label|Increased blood pressure|0
4966045|NCT00151775|17068267|P2|Period 4: Open Label|Increased blood pressure|0
4966046|NCT00151775|17068268|P1|Period 4: Open Label|Increased blood pressure|0
4966047|NCT00151775|17068257|P12|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1
4966048|NCT00151775|17068258|P11|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966049|NCT00151775|17068259|P10|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966050|NCT00151775|17068260|P9|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966051|NCT00151775|17068261|P8|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966052|NCT00151775|17068262|P7|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966053|NCT00151775|17068263|P6|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966054|NCT00151775|17068264|P5|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966055|NCT00151775|17068265|P4|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966056|NCT00151775|17068266|P3|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966057|NCT00151775|17068267|P2|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966058|NCT00151775|17068268|P1|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0
4966059|NCT00151775|17068257|P12|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966060|NCT00151775|17068258|P11|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966061|NCT00151775|17068259|P10|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966062|NCT00151775|17068260|P9|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966063|NCT00151775|17068261|P8|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966064|NCT00151775|17068262|P7|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966065|NCT00151775|17068263|P6|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966066|NCT00151775|17068264|P5|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966067|NCT00151775|17068265|P4|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966068|NCT00151775|17068266|P3|Period 3: Double-blind, Withdrawal|Protocol Violation|1
4966069|NCT00151775|17068267|P2|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966070|NCT00151775|17068268|P1|Period 3: Double-blind, Withdrawal|Protocol Violation|0
4966071|NCT00151775|17068257|P12|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966072|NCT00151775|17068258|P11|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966073|NCT00151775|17068259|P10|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966074|NCT00151775|17068260|P9|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966075|NCT00151775|17068261|P8|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966076|NCT00151775|17068262|P7|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966077|NCT00151775|17068263|P6|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966078|NCT00151775|17068264|P5|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966079|NCT00151775|17068265|P4|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966080|NCT00151775|17068266|P3|Period 3: Double-blind, Withdrawal|Adverse Event|1
4966081|NCT00151775|17068267|P2|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966082|NCT00151775|17068268|P1|Period 3: Double-blind, Withdrawal|Adverse Event|0
4966083|NCT00151775|17068257|P12|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966084|NCT00151775|17068258|P11|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966085|NCT00151775|17068259|P10|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966086|NCT00151775|17068260|P9|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966087|NCT00151775|17068261|P8|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966088|NCT00151775|17068262|P7|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1
4966089|NCT00151775|17068263|P6|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966090|NCT00151775|17068264|P5|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966091|NCT00151775|17068265|P4|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966092|NCT00151775|17068266|P3|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966093|NCT00151775|17068267|P2|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966094|NCT00151775|17068268|P1|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0
4966095|NCT00151775|17068257|P12|Period 3: Double-blind, Withdrawal|Other|0
4966096|NCT00151775|17068258|P11|Period 3: Double-blind, Withdrawal|Other|0
4966097|NCT00151775|17068259|P10|Period 3: Double-blind, Withdrawal|Other|0
4966098|NCT00151775|17068260|P9|Period 3: Double-blind, Withdrawal|Other|0
4966099|NCT00151775|17068261|P8|Period 3: Double-blind, Withdrawal|Other|1
4966100|NCT00151775|17068262|P7|Period 3: Double-blind, Withdrawal|Other|0
4966101|NCT00151775|17068263|P6|Period 3: Double-blind, Withdrawal|Other|0
4966102|NCT00151775|17068264|P5|Period 3: Double-blind, Withdrawal|Other|0
4966103|NCT00151775|17068265|P4|Period 3: Double-blind, Withdrawal|Other|0
4966104|NCT00151775|17068266|P3|Period 3: Double-blind, Withdrawal|Other|1
4966105|NCT00151775|17068267|P2|Period 3: Double-blind, Withdrawal|Other|0
4966106|NCT00151775|17068268|P1|Period 3: Double-blind, Withdrawal|Other|0
4966107|NCT00151775|17068257|P12|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966108|NCT00151775|17068258|P11|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966109|NCT00151775|17068259|P10|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966110|NCT00151775|17068260|P9|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966111|NCT00151775|17068261|P8|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966112|NCT00151775|17068262|P7|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966113|NCT00151775|17068263|P6|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1
4966114|NCT00151775|17068264|P5|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966115|NCT00151775|17068265|P4|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966116|NCT00151775|17068266|P3|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966117|NCT00151775|17068267|P2|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966118|NCT00151775|17068268|P1|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0
4966119|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966120|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966121|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966122|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966123|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966124|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1
4966125|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966126|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966127|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966128|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966129|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966130|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0
4966131|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966132|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966133|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966134|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966135|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966136|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966137|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|Physician Decision|1
4966138|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966139|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966140|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966141|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966142|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|Physician Decision|0
4966143|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|non-compliance|0
4966144|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|non-compliance|0
4966145|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|non-compliance|0
4966146|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|non-compliance|0
4966147|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|non-compliance|0
4966148|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|non-compliance|0
4966149|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|non-compliance|1
4966150|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|non-compliance|0
4966151|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|non-compliance|0
4966152|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|non-compliance|0
4966153|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|non-compliance|0
4966154|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|non-compliance|0
4966155|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|Other|0
4966156|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|Other|0
4966157|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|Other|0
4966158|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|Other|0
4966159|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|Other|0
4966160|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|Other|1
4966161|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|Other|0
4966162|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|Other|0
4966163|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|Other|0
4966164|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|Other|0
4966165|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|Other|0
4966166|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|Other|0
4966167|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966168|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966169|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966170|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966171|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966172|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966173|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966174|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966175|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966176|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966177|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|Protocol Violation|4
4966178|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|Protocol Violation|0
4966179|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966180|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
4966181|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966182|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966183|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966184|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
4966185|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966186|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966187|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966188|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966189|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0
4966190|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1
4966191|NCT00151775|17068257|P12|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966192|NCT00151775|17068258|P11|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966193|NCT00151775|17068259|P10|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966194|NCT00151775|17068260|P9|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966195|NCT00151775|17068261|P8|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966196|NCT00151775|17068262|P7|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966197|NCT00151775|17068263|P6|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966198|NCT00151775|17068264|P5|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966199|NCT00151775|17068265|P4|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966200|NCT00151775|17068266|P3|Period 2 - Double-Blind Dose Response|Adverse Event|0
4966201|NCT00151775|17068267|P2|Period 2 - Double-Blind Dose Response|Adverse Event|2
4966202|NCT00151775|17068268|P1|Period 2 - Double-Blind Dose Response|Adverse Event|1
4966203|NCT00151476|17068312|P2|FAP Analyzed Subjects|Other study participation|1
4966204|NCT00151476|17068313|P1|FAP Analyzed Subjects|Other study participation|0
4966205|NCT00151476|17068312|P2|FAP Analyzed Subjects|Lost to Follow-up|2
4966206|NCT00151476|17068313|P1|FAP Analyzed Subjects|Lost to Follow-up|0
4966207|NCT00151476|17068312|P2|FAP Identified Subjects|Protocol Violation|1
4966208|NCT00151476|17068313|P1|FAP Identified Subjects|Protocol Violation|0
4966209|NCT00151411|17068370|P2|Overall Study|Pregnancy|4
4966210|NCT00151411|17068371|P1|Overall Study|Pregnancy|0
4966211|NCT00151411|17068370|P2|Overall Study|Adverse Event|0
4966212|NCT00151411|17068371|P1|Overall Study|Adverse Event|6
4966213|NCT00151411|17068370|P2|Overall Study|Withdrawal by Subject|20
4966214|NCT00151411|17068371|P1|Overall Study|Withdrawal by Subject|12
4966215|NCT00151411|17068370|P2|Overall Study|Lost to Follow-up|19
4966216|NCT00151411|17068371|P1|Overall Study|Lost to Follow-up|15
4966217|NCT00151372|17068383|P2|Overall Study|Withdrawal by Subject|7
4966218|NCT00151372|17068384|P1|Overall Study|Withdrawal by Subject|7
4966219|NCT00151372|17068383|P2|Overall Study|Too sick medically to continue|6
4966220|NCT00151372|17068384|P1|Overall Study|Too sick medically to continue|5
4966221|NCT00151372|17068383|P2|Overall Study|Lost to Follow-up|5
4966222|NCT00151372|17068384|P1|Overall Study|Lost to Follow-up|5
4966223|NCT00151372|17068383|P2|Overall Study|Death|11
4966224|NCT00151372|17068384|P1|Overall Study|Death|12
4966225|NCT00151281|17068399|P1|Overall Study|Not evaluable|3
4966226|NCT00150969|17068408|P2|24-48 Month Extension|Other Reason|91
4966227|NCT00150969|17068409|P1|24-48 Month Extension|Other Reason|81
4966228|NCT00150969|17068408|P2|24-48 Month Extension|Adverse Event|3
4966229|NCT00150969|17068409|P1|24-48 Month Extension|Adverse Event|1
4966230|NCT00150969|17068408|P2|24-48 Month Extension|Lack of Efficacy|1
4966231|NCT00150969|17068409|P1|24-48 Month Extension|Lack of Efficacy|0
4966232|NCT00150969|17068408|P2|24-48 Month Extension|Withdrawal by Subject|5
4966233|NCT00150969|17068409|P1|24-48 Month Extension|Withdrawal by Subject|6
4966234|NCT00150969|17068408|P2|24 Month Main Study|Withdrawal by Subject|4
4966235|NCT00150969|17068409|P1|24 Month Main Study|Withdrawal by Subject|7
4966236|NCT00150969|17068408|P2|24 Month Main Study|Protocol Violation|2
4966237|NCT00150969|17068409|P1|24 Month Main Study|Protocol Violation|4
4966238|NCT00150969|17068408|P2|24 Month Main Study|Lost to Follow-up|2
4966239|NCT00150969|17068409|P1|24 Month Main Study|Lost to Follow-up|3
4966240|NCT00150969|17068408|P2|24 Month Main Study|Lack of Efficacy|8
4966241|NCT00150969|17068409|P1|24 Month Main Study|Lack of Efficacy|1
4966242|NCT00150969|17068408|P2|24 Month Main Study|Death|1
4966243|NCT00150969|17068409|P1|24 Month Main Study|Death|1
4966244|NCT00150969|17068408|P2|24 Month Main Study|Adverse Event|4
4966245|NCT00150969|17068409|P1|24 Month Main Study|Adverse Event|3
4966246|NCT00150813|17068441|P1|Overall Study|Switch to commercially available LEV|2
4966247|NCT00150813|17068441|P1|Overall Study|Planned pregancy|1
4966248|NCT00150813|17068441|P1|Overall Study|Remission|3
4966249|NCT00150813|17068441|P1|Overall Study|Withdrawal by Subject|5
4966250|NCT00150813|17068441|P1|Overall Study|Lost to Follow-up|5
4966251|NCT00150813|17068441|P1|Overall Study|Lack of Efficacy|1
4966252|NCT00150813|17068441|P1|Overall Study|Adverse Event|1
4966253|NCT00150800|17068445|P1|Overall Study|PI discontinuation request|1
4966254|NCT00150800|17068445|P1|Overall Study|Pregnancy planned|1
4966255|NCT00150800|17068445|P1|Overall Study|Surgical intervention|4
4966256|NCT00150800|17068445|P1|Overall Study|Patient insurance|1
4966257|NCT00150800|17068445|P1|Overall Study|PI leaving site|2
4966258|NCT00150800|17068445|P1|Overall Study|PI retiring|2
4966259|NCT00150800|17068445|P1|Overall Study|Moved from area/country|8
4966260|NCT00150800|17068445|P1|Overall Study|Generalized Epilepsy|1
4966261|NCT00150800|17068445|P1|Overall Study|Sponsor's request|2
4966262|NCT00150800|17068445|P1|Overall Study|Visit refusal|3
4966263|NCT00150800|17068445|P1|Overall Study|BRV monotherapy|1
4966264|NCT00150800|17068445|P1|Overall Study|Neurosurgery|2
4966265|NCT00150800|17068445|P1|Overall Study|Distance too long for patient|1
4966266|NCT00150800|17068445|P1|Overall Study|Nobody to accompany patient|1
4966267|NCT00150800|17068445|P1|Overall Study|Protocol non-adherence|2
4966268|NCT00150800|17068445|P1|Overall Study|Site closure|24
4966269|NCT00150800|17068445|P1|Overall Study|IP misshandling|1
4966270|NCT00150800|17068445|P1|Overall Study|No compliance|18
4966271|NCT00150800|17068445|P1|Overall Study|Subject's choice|90
4966272|NCT00150800|17068445|P1|Overall Study|Lost to Follow-up|58
4966273|NCT00150800|17068445|P1|Overall Study|Lack of Efficacy|166
4966274|NCT00150800|17068445|P1|Overall Study|Death|18
4966275|NCT00150800|17068445|P1|Overall Study|Adverse Event|89
4966276|NCT00150618|17068459|P5|Overall Study|Sponsor's decision|0
4966277|NCT00150618|17068460|P4|Overall Study|Sponsor's decision|1
4966278|NCT00150618|17068461|P3|Overall Study|Sponsor's decision|0
4966279|NCT00150618|17068462|P2|Overall Study|Sponsor's decision|0
4966280|NCT00150618|17068463|P1|Overall Study|Sponsor's decision|0
4966281|NCT00150618|17068459|P5|Overall Study|Abnormal ECG|0
4966282|NCT00150618|17068460|P4|Overall Study|Abnormal ECG|0
4966283|NCT00150618|17068461|P3|Overall Study|Abnormal ECG|0
4966284|NCT00150618|17068462|P2|Overall Study|Abnormal ECG|0
4966285|NCT00150618|17068463|P1|Overall Study|Abnormal ECG|1
4966286|NCT00150618|17068459|P5|Overall Study|Lack of compliance|1
4966287|NCT00150618|17068460|P4|Overall Study|Lack of compliance|0
4966288|NCT00150618|17068461|P3|Overall Study|Lack of compliance|1
4966289|NCT00150618|17068462|P2|Overall Study|Lack of compliance|1
4966290|NCT00150618|17068463|P1|Overall Study|Lack of compliance|2
4966291|NCT00150618|17068459|P5|Overall Study|Physician Decision|1
4966292|NCT00150618|17068460|P4|Overall Study|Physician Decision|0
4966293|NCT00150618|17068461|P3|Overall Study|Physician Decision|0
4966294|NCT00150618|17068462|P2|Overall Study|Physician Decision|2
4966295|NCT00150618|17068463|P1|Overall Study|Physician Decision|0
4966296|NCT00150618|17068459|P5|Overall Study|No study meds|2
4966297|NCT00150618|17068460|P4|Overall Study|No study meds|0
4966298|NCT00150618|17068461|P3|Overall Study|No study meds|0
4966299|NCT00150618|17068462|P2|Overall Study|No study meds|0
4966300|NCT00150618|17068463|P1|Overall Study|No study meds|0
4966301|NCT00150618|17068459|P5|Overall Study|Lack of Efficacy|6
4966302|NCT00150618|17068460|P4|Overall Study|Lack of Efficacy|4
4966303|NCT00150618|17068461|P3|Overall Study|Lack of Efficacy|7
4966304|NCT00150618|17068462|P2|Overall Study|Lack of Efficacy|4
4966305|NCT00150618|17068463|P1|Overall Study|Lack of Efficacy|1
4966306|NCT00150618|17068459|P5|Overall Study|Protocol Violation|1
4966307|NCT00150618|17068460|P4|Overall Study|Protocol Violation|0
4966308|NCT00150618|17068461|P3|Overall Study|Protocol Violation|0
4966309|NCT00150618|17068462|P2|Overall Study|Protocol Violation|0
4966310|NCT00150618|17068463|P1|Overall Study|Protocol Violation|1
4966311|NCT00150618|17068459|P5|Overall Study|Lost to Follow-up|4
4966312|NCT00150618|17068460|P4|Overall Study|Lost to Follow-up|8
4966313|NCT00150618|17068461|P3|Overall Study|Lost to Follow-up|5
4966314|NCT00150618|17068462|P2|Overall Study|Lost to Follow-up|1
4966315|NCT00150618|17068463|P1|Overall Study|Lost to Follow-up|4
4966316|NCT00150618|17068459|P5|Overall Study|Withdrawal by Subject|5
4966317|NCT00150618|17068460|P4|Overall Study|Withdrawal by Subject|4
4966318|NCT00150618|17068461|P3|Overall Study|Withdrawal by Subject|8
4966319|NCT00150618|17068462|P2|Overall Study|Withdrawal by Subject|8
4966320|NCT00150618|17068463|P1|Overall Study|Withdrawal by Subject|6
4966321|NCT00150618|17068459|P5|Overall Study|Adverse Event|5
4966322|NCT00150618|17068460|P4|Overall Study|Adverse Event|9
4966323|NCT00150618|17068461|P3|Overall Study|Adverse Event|6
4966324|NCT00150618|17068462|P2|Overall Study|Adverse Event|2
4966325|NCT00150618|17068463|P1|Overall Study|Adverse Event|2
4966326|NCT00150592|17068497|P2|Overall Study|Non-compliance|0
4966327|NCT00150592|17068498|P1|Overall Study|Non-compliance|1
4966328|NCT00150592|17068497|P2|Overall Study|Withdrawal by Subject|2
4966329|NCT00150592|17068498|P1|Overall Study|Withdrawal by Subject|1
4966330|NCT00150592|17068497|P2|Overall Study|Protocol Violation|0
4966331|NCT00150592|17068498|P1|Overall Study|Protocol Violation|1
4966332|NCT00150592|17068497|P2|Overall Study|Adverse Event|1
4966333|NCT00150592|17068498|P1|Overall Study|Adverse Event|4
4966334|NCT00150462|17068529|P11|Overall Study|Other|1
4966335|NCT00150462|17068530|P10|Overall Study|Other|1
4966336|NCT00150462|17068531|P9|Overall Study|Other|0
4966337|NCT00150462|17068532|P8|Overall Study|Other|0
4966338|NCT00150462|17068533|P7|Overall Study|Other|0
4966339|NCT00150462|17068534|P6|Overall Study|Other|0
4966340|NCT00150462|17068535|P5|Overall Study|Other|0
4966341|NCT00150462|17068536|P4|Overall Study|Other|0
4966342|NCT00150462|17068537|P3|Overall Study|Other|0
4966343|NCT00150462|17068538|P2|Overall Study|Other|0
4966344|NCT00150462|17068539|P1|Overall Study|Other|0
4966345|NCT00150462|17068529|P11|Overall Study|Physician Decision|0
4966346|NCT00150462|17068530|P10|Overall Study|Physician Decision|0
4966347|NCT00150462|17068531|P9|Overall Study|Physician Decision|0
4966348|NCT00150462|17068532|P8|Overall Study|Physician Decision|0
4966349|NCT00150462|17068533|P7|Overall Study|Physician Decision|0
4966350|NCT00150462|17068534|P6|Overall Study|Physician Decision|0
4966351|NCT00150462|17068535|P5|Overall Study|Physician Decision|0
4966352|NCT00150462|17068536|P4|Overall Study|Physician Decision|1
4966353|NCT00150462|17068537|P3|Overall Study|Physician Decision|1
4966354|NCT00150462|17068538|P2|Overall Study|Physician Decision|0
4966355|NCT00150462|17068539|P1|Overall Study|Physician Decision|0
4966356|NCT00150462|17068529|P11|Overall Study|Adverse Event|0
4966357|NCT00150462|17068530|P10|Overall Study|Adverse Event|1
4966358|NCT00150462|17068531|P9|Overall Study|Adverse Event|0
4966359|NCT00150462|17068532|P8|Overall Study|Adverse Event|2
4966360|NCT00150462|17068533|P7|Overall Study|Adverse Event|0
4966361|NCT00150462|17068534|P6|Overall Study|Adverse Event|0
4966362|NCT00150462|17068535|P5|Overall Study|Adverse Event|0
4966363|NCT00150462|17068536|P4|Overall Study|Adverse Event|1
4966364|NCT00150462|17068537|P3|Overall Study|Adverse Event|0
4966365|NCT00150462|17068538|P2|Overall Study|Adverse Event|0
4966366|NCT00150462|17068539|P1|Overall Study|Adverse Event|0
4966367|NCT00150462|17068529|P11|Overall Study|Death|0
4966368|NCT00150462|17068530|P10|Overall Study|Death|0
4966369|NCT00150462|17068531|P9|Overall Study|Death|1
4966370|NCT00150462|17068532|P8|Overall Study|Death|0
4966371|NCT00150462|17068533|P7|Overall Study|Death|0
4966372|NCT00150462|17068534|P6|Overall Study|Death|0
4966373|NCT00150462|17068535|P5|Overall Study|Death|0
4966374|NCT00150462|17068536|P4|Overall Study|Death|0
4966375|NCT00150462|17068537|P3|Overall Study|Death|0
4966376|NCT00150462|17068538|P2|Overall Study|Death|1
4966377|NCT00150462|17068539|P1|Overall Study|Death|0
4966378|NCT00150462|17068529|P11|Overall Study|Withdrawal by Subject|0
4966379|NCT00150462|17068530|P10|Overall Study|Withdrawal by Subject|1
4966380|NCT00150462|17068531|P9|Overall Study|Withdrawal by Subject|0
4966381|NCT00150462|17068532|P8|Overall Study|Withdrawal by Subject|1
4966382|NCT00150462|17068533|P7|Overall Study|Withdrawal by Subject|0
4966383|NCT00150462|17068534|P6|Overall Study|Withdrawal by Subject|2
4966384|NCT00150462|17068535|P5|Overall Study|Withdrawal by Subject|1
4966385|NCT00150462|17068536|P4|Overall Study|Withdrawal by Subject|0
4966386|NCT00150462|17068537|P3|Overall Study|Withdrawal by Subject|1
4966387|NCT00150462|17068538|P2|Overall Study|Withdrawal by Subject|1
4966388|NCT00150462|17068539|P1|Overall Study|Withdrawal by Subject|0
4966389|NCT00150462|17068529|P11|Overall Study|Disease Progression or Relapse|2
4966390|NCT00150462|17068530|P10|Overall Study|Disease Progression or Relapse|3
4966391|NCT00150462|17068531|P9|Overall Study|Disease Progression or Relapse|5
4966392|NCT00150462|17068532|P8|Overall Study|Disease Progression or Relapse|5
4966393|NCT00150462|17068533|P7|Overall Study|Disease Progression or Relapse|3
4966394|NCT00150462|17068534|P6|Overall Study|Disease Progression or Relapse|2
4966395|NCT00150462|17068535|P5|Overall Study|Disease Progression or Relapse|2
4966396|NCT00150462|17068536|P4|Overall Study|Disease Progression or Relapse|1
4966397|NCT00150462|17068537|P3|Overall Study|Disease Progression or Relapse|2
4966398|NCT00150462|17068538|P2|Overall Study|Disease Progression or Relapse|1
4966399|NCT00150462|17068539|P1|Overall Study|Disease Progression or Relapse|3
4966400|NCT00150345|17068649|P2|Overall Study|Other|14
4966401|NCT00150345|17068650|P1|Overall Study|Other|12
4966402|NCT00150345|17068649|P2|Overall Study|Laboratory abnormality|2
4966403|NCT00150345|17068650|P1|Overall Study|Laboratory abnormality|1
4966404|NCT00150345|17068649|P2|Overall Study|Withdrawal by Subject|4
4966405|NCT00150345|17068650|P1|Overall Study|Withdrawal by Subject|3
4966406|NCT00150345|17068649|P2|Overall Study|Lack of Efficacy|4
4966407|NCT00150345|17068650|P1|Overall Study|Lack of Efficacy|5
4966408|NCT00150345|17068649|P2|Overall Study|Adverse Event|6
4966409|NCT00150345|17068650|P1|Overall Study|Adverse Event|8
4966410|NCT00150345|17068649|P2|Overall Study|Death|2
4966411|NCT00150345|17068650|P1|Overall Study|Death|5
4966412|NCT00150176|17068714|P2|Overall Study|OTHER|13
4966413|NCT00150176|17068715|P1|Overall Study|OTHER|11
4966414|NCT00150176|17068714|P2|Overall Study|Lost to Follow-up|3
4966415|NCT00150176|17068715|P1|Overall Study|Lost to Follow-up|3
4966416|NCT00150176|17068714|P2|Overall Study|Withdrawal by Subject|12
4966417|NCT00150176|17068715|P1|Overall Study|Withdrawal by Subject|19
4966418|NCT00150176|17068714|P2|Overall Study|Relapse/Impending relapse, non-AE|39
4966419|NCT00150176|17068715|P1|Overall Study|Relapse/Impending relapse, non-AE|10
4966420|NCT00150176|17068714|P2|Overall Study|Adverse Event|53
4966421|NCT00150176|17068715|P1|Overall Study|Adverse Event|16
4966422|NCT00149994|17068726|P2|Overall Study|Protocol Violation|1
4966423|NCT00149994|17068727|P1|Overall Study|Protocol Violation|0
4966424|NCT00149994|17068726|P2|Overall Study|Administrative problems:|0
4966425|NCT00149994|17068727|P1|Overall Study|Administrative problems:|1
4966426|NCT00149890|17068735|P2|Overall Study|Graft Loss|1
4966427|NCT00149890|17068736|P1|Overall Study|Graft Loss|2
4966428|NCT00149890|17068735|P2|Overall Study|Lost to Follow-up|0
4966429|NCT00149890|17068736|P1|Overall Study|Lost to Follow-up|1
4966430|NCT00149890|17068735|P2|Overall Study|Protocol Violation|0
4966431|NCT00149890|17068736|P1|Overall Study|Protocol Violation|1
4966432|NCT00149890|17068735|P2|Overall Study|Lack of Efficacy|9
4966433|NCT00149890|17068736|P1|Overall Study|Lack of Efficacy|8
4966434|NCT00149890|17068735|P2|Overall Study|Adverse Event|8
4966435|NCT00149890|17068736|P1|Overall Study|Adverse Event|1
4966436|NCT00149825|17068771|P2|Overall Study|Other|0
4966437|NCT00149825|17068772|P1|Overall Study|Other|1
4966438|NCT00149825|17068771|P2|Overall Study|Not liking insomnia therapy|0
4966439|NCT00149825|17068772|P1|Overall Study|Not liking insomnia therapy|1
4966440|NCT00149825|17068771|P2|Overall Study|Time commitments|1
4966441|NCT00149825|17068772|P1|Overall Study|Time commitments|2
4966442|NCT00149825|17068771|P2|Overall Study|Intolerance to medication side effects|2
4966443|NCT00149825|17068772|P1|Overall Study|Intolerance to medication side effects|1
4966444|NCT00149747|17068800|P2|Overall Study|Withdrawal by Subject|3
4966445|NCT00149747|17068801|P1|Overall Study|Withdrawal by Subject|3
4966446|NCT00149747|17068800|P2|Overall Study|Death|0
4966447|NCT00149747|17068801|P1|Overall Study|Death|1
4966448|NCT00149630|17068847|P2|Overall Study|Adverse Event|0
4966449|NCT00149630|17068848|P1|Overall Study|Adverse Event|2
4966450|NCT00149630|17068847|P2|Overall Study|Treatment Programs|5
4966451|NCT00149630|17068848|P1|Overall Study|Treatment Programs|4
4966452|NCT00149630|17068847|P2|Overall Study|Incarceration|0
4966453|NCT00149630|17068848|P1|Overall Study|Incarceration|2
4966454|NCT00149396|17068858|P1|Overall Study|other treatment|5
4966455|NCT00149396|17068858|P1|Overall Study|Subject noncompliance|2
4966456|NCT00149396|17068858|P1|Overall Study|Withdrawal by Subject|1
4966457|NCT00149396|17068858|P1|Overall Study|Death|15
4966458|NCT00149214|17068928|P2|Overall Study|Progressive Disease|3
4966459|NCT00149214|17068929|P1|Overall Study|Progressive Disease|7
4966460|NCT00149214|17068928|P2|Overall Study|Sponsor Decision|1
4966461|NCT00149214|17068929|P1|Overall Study|Sponsor Decision|0
4966462|NCT00149214|17068928|P2|Overall Study|Physician Decision|3
4966463|NCT00149214|17068929|P1|Overall Study|Physician Decision|3
4966464|NCT00149214|17068928|P2|Overall Study|Withdrawal by Subject|1
4966465|NCT00149214|17068929|P1|Overall Study|Withdrawal by Subject|4
4966466|NCT00149214|17068928|P2|Overall Study|Adverse Event|9
4966467|NCT00149214|17068929|P1|Overall Study|Adverse Event|12
4966468|NCT00148941|17068956|P4|Overall Study|Other|2
4966469|NCT00148941|17068957|P3|Overall Study|Other|1
4966470|NCT00148941|17068958|P2|Overall Study|Other|0
4966471|NCT00148941|17068959|P1|Overall Study|Other|0
4966472|NCT00148941|17068956|P4|Overall Study|Withdrawal by Subject|0
4966473|NCT00148941|17068957|P3|Overall Study|Withdrawal by Subject|1
4966474|NCT00148941|17068958|P2|Overall Study|Withdrawal by Subject|0
4966475|NCT00148941|17068959|P1|Overall Study|Withdrawal by Subject|1
4966476|NCT00148941|17068956|P4|Overall Study|Lost to Follow-up|22
4966477|NCT00148941|17068957|P3|Overall Study|Lost to Follow-up|18
4966478|NCT00148941|17068958|P2|Overall Study|Lost to Follow-up|24
4966479|NCT00148941|17068959|P1|Overall Study|Lost to Follow-up|17
4966480|NCT00148759|17069074|P2|Overall Study|Lost to Follow-up|0
4966481|NCT00148759|17069075|P1|Overall Study|Lost to Follow-up|1
4966482|NCT00148759|17069074|P2|Overall Study|Withdrawal by Subject|1
4966483|NCT00148759|17069075|P1|Overall Study|Withdrawal by Subject|1
4966484|NCT00148343|17069103|P2|Overall Study|Physician Decision|4
4966485|NCT00148343|17069104|P1|Overall Study|Physician Decision|3
4966486|NCT00148343|17069103|P2|Overall Study|Withdrawal by Subject|7
4966487|NCT00148343|17069104|P1|Overall Study|Withdrawal by Subject|12
4966488|NCT00148317|17069118|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1
4966489|NCT00148317|17069118|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2
4966490|NCT00148317|17069118|P1|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8
4966491|NCT00148122|17069125|P1|Overall Study|Withdrawal by Subject|2
4966492|NCT00148109|17069133|P2|Overall Study|Withdrawal by Subject|0
4966493|NCT00148109|17069134|P1|Overall Study|Withdrawal by Subject|2
4966494|NCT00148109|17069133|P2|Overall Study|Adverse Event|2
4966495|NCT00148109|17069134|P1|Overall Study|Adverse Event|0
4966496|NCT00148109|17069133|P2|Overall Study|Lack of Efficacy|18
4966497|NCT00148109|17069134|P1|Overall Study|Lack of Efficacy|10
4966498|NCT00147823|17069150|P2|Overall Study|Did not receive vitoss due to infection|2
4966499|NCT00147823|17069151|P1|Overall Study|Did not receive vitoss due to infection|6
4966500|NCT00147823|17069150|P2|Overall Study|Withdrawal by Subject|1
4966501|NCT00147823|17069151|P1|Overall Study|Withdrawal by Subject|0
4966502|NCT00147823|17069150|P2|Overall Study|Physician Decision|0
4966503|NCT00147823|17069151|P1|Overall Study|Physician Decision|1
4966504|NCT00147823|17069150|P2|Overall Study|Lost to Follow-up|12
4966505|NCT00147823|17069151|P1|Overall Study|Lost to Follow-up|6
4966506|NCT00147745|17069182|P3|Overall Study|Withdrawal by Subject|0
4966507|NCT00147745|17069183|P2|Overall Study|Withdrawal by Subject|0
4966508|NCT00147745|17069184|P1|Overall Study|Withdrawal by Subject|1
4966509|NCT00147537|17069206|P11|Phase 2|Randomized but not treated|1
4966510|NCT00147537|17069207|P10|Phase 2|Randomized but not treated|1
4966511|NCT00147537|17069208|P9|Phase 2|Randomized but not treated|0
4966512|NCT00147537|17069209|P8|Phase 2|Randomized but not treated|0
4966513|NCT00147537|17069210|P7|Phase 2|Randomized but not treated|0
4966514|NCT00147537|17069211|P6|Phase 2|Randomized but not treated|0
4966515|NCT00147537|17069212|P5|Phase 2|Randomized but not treated|0
4966516|NCT00147537|17069213|P4|Phase 2|Randomized but not treated|0
4966517|NCT00147537|17069214|P3|Phase 2|Randomized but not treated|0
4966518|NCT00147537|17069215|P2|Phase 2|Randomized but not treated|0
4966519|NCT00147537|17069216|P1|Phase 2|Randomized but not treated|0
4966520|NCT00147537|17069206|P11|Phase 2|Withdrawal by Subject|4
4966521|NCT00147537|17069207|P10|Phase 2|Withdrawal by Subject|16
4966522|NCT00147537|17069208|P9|Phase 2|Withdrawal by Subject|0
4966523|NCT00147537|17069209|P8|Phase 2|Withdrawal by Subject|0
4966524|NCT00147537|17069210|P7|Phase 2|Withdrawal by Subject|0
4966525|NCT00147537|17069211|P6|Phase 2|Withdrawal by Subject|0
4966526|NCT00147537|17069212|P5|Phase 2|Withdrawal by Subject|0
4966527|NCT00147537|17069213|P4|Phase 2|Withdrawal by Subject|0
4966528|NCT00147537|17069214|P3|Phase 2|Withdrawal by Subject|0
4966529|NCT00147537|17069215|P2|Phase 2|Withdrawal by Subject|0
4966530|NCT00147537|17069216|P1|Phase 2|Withdrawal by Subject|0
4966531|NCT00147537|17069206|P11|Phase 2|Other|12
4966532|NCT00147537|17069207|P10|Phase 2|Other|47
4966533|NCT00147537|17069208|P9|Phase 2|Other|0
4966534|NCT00147537|17069209|P8|Phase 2|Other|0
4966535|NCT00147537|17069210|P7|Phase 2|Other|0
4966536|NCT00147537|17069211|P6|Phase 2|Other|0
4966537|NCT00147537|17069212|P5|Phase 2|Other|0
4966538|NCT00147537|17069213|P4|Phase 2|Other|0
4966539|NCT00147537|17069214|P3|Phase 2|Other|0
4966540|NCT00147537|17069215|P2|Phase 2|Other|0
4966541|NCT00147537|17069216|P1|Phase 2|Other|0
4966542|NCT00147537|17069206|P11|Phase 2|Lost to Follow-up|4
4966543|NCT00147537|17069207|P10|Phase 2|Lost to Follow-up|12
4966544|NCT00147537|17069208|P9|Phase 2|Lost to Follow-up|0
4966545|NCT00147537|17069209|P8|Phase 2|Lost to Follow-up|0
4966546|NCT00147537|17069210|P7|Phase 2|Lost to Follow-up|0
4966547|NCT00147537|17069211|P6|Phase 2|Lost to Follow-up|0
4966548|NCT00147537|17069212|P5|Phase 2|Lost to Follow-up|0
4966549|NCT00147537|17069213|P4|Phase 2|Lost to Follow-up|0
4966550|NCT00147537|17069214|P3|Phase 2|Lost to Follow-up|0
4966551|NCT00147537|17069215|P2|Phase 2|Lost to Follow-up|0
4966552|NCT00147537|17069216|P1|Phase 2|Lost to Follow-up|0
4966553|NCT00147537|17069206|P11|Phase 2|Death|31
4966554|NCT00147537|17069207|P10|Phase 2|Death|85
4966555|NCT00147537|17069208|P9|Phase 2|Death|0
4966556|NCT00147537|17069209|P8|Phase 2|Death|0
4966557|NCT00147537|17069210|P7|Phase 2|Death|0
4966558|NCT00147537|17069211|P6|Phase 2|Death|0
4966559|NCT00147537|17069212|P5|Phase 2|Death|0
4966560|NCT00147537|17069213|P4|Phase 2|Death|0
4966561|NCT00147537|17069214|P3|Phase 2|Death|0
4966562|NCT00147537|17069215|P2|Phase 2|Death|0
4966563|NCT00147537|17069216|P1|Phase 2|Death|0
4966564|NCT00147537|17069206|P11|Phase 1b|Randomized but not treated|0
4966565|NCT00147537|17069207|P10|Phase 1b|Randomized but not treated|0
4966566|NCT00147537|17069208|P9|Phase 1b|Randomized but not treated|1
4966567|NCT00147537|17069209|P8|Phase 1b|Randomized but not treated|0
4966568|NCT00147537|17069210|P7|Phase 1b|Randomized but not treated|1
4966569|NCT00147537|17069211|P6|Phase 1b|Randomized but not treated|0
4966570|NCT00147537|17069212|P5|Phase 1b|Randomized but not treated|0
4966571|NCT00147537|17069213|P4|Phase 1b|Randomized but not treated|0
4966572|NCT00147537|17069214|P3|Phase 1b|Randomized but not treated|0
4966573|NCT00147537|17069215|P2|Phase 1b|Randomized but not treated|0
4966574|NCT00147537|17069216|P1|Phase 1b|Randomized but not treated|0
4966575|NCT00147537|17069206|P11|Phase 1b|Withdrawal by Subject|0
4966576|NCT00147537|17069207|P10|Phase 1b|Withdrawal by Subject|0
4966577|NCT00147537|17069208|P9|Phase 1b|Withdrawal by Subject|2
4966578|NCT00147537|17069209|P8|Phase 1b|Withdrawal by Subject|0
4966579|NCT00147537|17069210|P7|Phase 1b|Withdrawal by Subject|0
4966580|NCT00147537|17069211|P6|Phase 1b|Withdrawal by Subject|0
4966581|NCT00147537|17069212|P5|Phase 1b|Withdrawal by Subject|0
4966582|NCT00147537|17069213|P4|Phase 1b|Withdrawal by Subject|0
4966583|NCT00147537|17069214|P3|Phase 1b|Withdrawal by Subject|0
4966584|NCT00147537|17069215|P2|Phase 1b|Withdrawal by Subject|0
4966585|NCT00147537|17069216|P1|Phase 1b|Withdrawal by Subject|0
4966586|NCT00147537|17069206|P11|Phase 1b|Other|0
4966587|NCT00147537|17069207|P10|Phase 1b|Other|0
4966588|NCT00147537|17069208|P9|Phase 1b|Other|4
4966589|NCT00147537|17069209|P8|Phase 1b|Other|4
4966590|NCT00147537|17069210|P7|Phase 1b|Other|14
4966591|NCT00147537|17069211|P6|Phase 1b|Other|1
4966592|NCT00147537|17069212|P5|Phase 1b|Other|1
4966593|NCT00147537|17069213|P4|Phase 1b|Other|1
4966594|NCT00147537|17069214|P3|Phase 1b|Other|2
4966595|NCT00147537|17069215|P2|Phase 1b|Other|0
4966596|NCT00147537|17069216|P1|Phase 1b|Other|0
4966597|NCT00147537|17069206|P11|Phase 1b|Lost to Follow-up|0
4966598|NCT00147537|17069207|P10|Phase 1b|Lost to Follow-up|0
4966599|NCT00147537|17069208|P9|Phase 1b|Lost to Follow-up|1
4966600|NCT00147537|17069209|P8|Phase 1b|Lost to Follow-up|0
4966601|NCT00147537|17069210|P7|Phase 1b|Lost to Follow-up|2
4966602|NCT00147537|17069211|P6|Phase 1b|Lost to Follow-up|0
4966603|NCT00147537|17069212|P5|Phase 1b|Lost to Follow-up|0
4966604|NCT00147537|17069213|P4|Phase 1b|Lost to Follow-up|0
4966605|NCT00147537|17069214|P3|Phase 1b|Lost to Follow-up|0
4966606|NCT00147537|17069215|P2|Phase 1b|Lost to Follow-up|1
4966607|NCT00147537|17069216|P1|Phase 1b|Lost to Follow-up|2
4966608|NCT00147537|17069206|P11|Phase 1b|Death|0
4966609|NCT00147537|17069207|P10|Phase 1b|Death|0
4966610|NCT00147537|17069208|P9|Phase 1b|Death|9
4966611|NCT00147537|17069209|P8|Phase 1b|Death|3
4966612|NCT00147537|17069210|P7|Phase 1b|Death|1
4966613|NCT00147537|17069211|P6|Phase 1b|Death|2
4966614|NCT00147537|17069212|P5|Phase 1b|Death|2
4966615|NCT00147537|17069213|P4|Phase 1b|Death|1
4966616|NCT00147537|17069214|P3|Phase 1b|Death|2
4966617|NCT00147537|17069215|P2|Phase 1b|Death|1
4966618|NCT00147537|17069216|P1|Phase 1b|Death|0
4966619|NCT00147498|17069399|P4|Overall Study|Other|3
4966620|NCT00147498|17069400|P3|Overall Study|Other|3
4966621|NCT00147498|17069401|P2|Overall Study|Other|1
4966622|NCT00147498|17069402|P1|Overall Study|Other|1
4966623|NCT00147498|17069399|P4|Overall Study|Participant defaulted|3
4966624|NCT00147498|17069400|P3|Overall Study|Participant defaulted|4
4966625|NCT00147498|17069401|P2|Overall Study|Participant defaulted|1
4966626|NCT00147498|17069402|P1|Overall Study|Participant defaulted|0
4966627|NCT00147498|17069399|P4|Overall Study|Laboratory abnormality|0
4966628|NCT00147498|17069400|P3|Overall Study|Laboratory abnormality|2
4966629|NCT00147498|17069401|P2|Overall Study|Laboratory abnormality|0
4966630|NCT00147498|17069402|P1|Overall Study|Laboratory abnormality|0
4966631|NCT00147498|17069399|P4|Overall Study|Lack of Efficacy|8
4966632|NCT00147498|17069400|P3|Overall Study|Lack of Efficacy|1
4966633|NCT00147498|17069401|P2|Overall Study|Lack of Efficacy|1
4966634|NCT00147498|17069402|P1|Overall Study|Lack of Efficacy|1
4966635|NCT00147498|17069399|P4|Overall Study|Adverse Event|3
4966636|NCT00147498|17069400|P3|Overall Study|Adverse Event|7
4966637|NCT00147498|17069401|P2|Overall Study|Adverse Event|6
4966638|NCT00147498|17069402|P1|Overall Study|Adverse Event|1
4966639|NCT00147238|17069526|P1|Overall Study|Inevaluable|8
4966640|NCT00147225|17069536|P6|Overall Study|Chemotherapy Changed|1
4966641|NCT00147225|17069537|P5|Overall Study|Chemotherapy Changed|0
4966642|NCT00147225|17069538|P4|Overall Study|Chemotherapy Changed|0
4966643|NCT00147225|17069539|P3|Overall Study|Chemotherapy Changed|0
4966644|NCT00147225|17069540|P2|Overall Study|Chemotherapy Changed|0
4966645|NCT00147225|17069541|P1|Overall Study|Chemotherapy Changed|0
4966646|NCT00147225|17069536|P6|Overall Study|Screen Failure|0
4966647|NCT00147225|17069537|P5|Overall Study|Screen Failure|1
4966648|NCT00147225|17069538|P4|Overall Study|Screen Failure|0
4966649|NCT00147225|17069539|P3|Overall Study|Screen Failure|0
4966650|NCT00147225|17069540|P2|Overall Study|Screen Failure|0
4966651|NCT00147225|17069541|P1|Overall Study|Screen Failure|0
4966652|NCT00147225|17069536|P6|Overall Study|Adverse Event|0
4966653|NCT00147225|17069537|P5|Overall Study|Adverse Event|0
4966654|NCT00147225|17069538|P4|Overall Study|Adverse Event|1
4966655|NCT00147225|17069539|P3|Overall Study|Adverse Event|1
4966656|NCT00147225|17069540|P2|Overall Study|Adverse Event|0
4966657|NCT00147225|17069541|P1|Overall Study|Adverse Event|0
4966658|NCT00147225|17069536|P6|Overall Study|Withdrawal by Subject|1
4966659|NCT00147225|17069537|P5|Overall Study|Withdrawal by Subject|0
4966660|NCT00147225|17069538|P4|Overall Study|Withdrawal by Subject|0
4966661|NCT00147225|17069539|P3|Overall Study|Withdrawal by Subject|1
4966662|NCT00147225|17069540|P2|Overall Study|Withdrawal by Subject|0
4966663|NCT00147225|17069541|P1|Overall Study|Withdrawal by Subject|1
4966664|NCT00146848|17069716|P3|Post-randomization|Withdrawn|27
4966665|NCT00146848|17069717|P2|Post-randomization|Withdrawn|32
4966666|NCT00146848|17069718|P1|Post-randomization|Withdrawn|26
4966667|NCT00146848|17069716|P3|Post-randomization|Lost to Follow-up|12
4966668|NCT00146848|17069717|P2|Post-randomization|Lost to Follow-up|15
4966669|NCT00146848|17069718|P1|Post-randomization|Lost to Follow-up|12
4966670|NCT00146848|17069716|P3|Pre-randomization|Withdrawal by Subject|0
4966671|NCT00146848|17069717|P2|Pre-randomization|Withdrawal by Subject|0
4966672|NCT00146848|17069718|P1|Pre-randomization|Withdrawal by Subject|40
4966673|NCT00146848|17069716|P3|Pre-randomization|Protocol Violation|0
4966674|NCT00146848|17069717|P2|Pre-randomization|Protocol Violation|0
4966675|NCT00146848|17069718|P1|Pre-randomization|Protocol Violation|172
4966676|NCT00146848|17069716|P3|Pre-randomization|Physician Decision|0
4966677|NCT00146848|17069717|P2|Pre-randomization|Physician Decision|0
4966678|NCT00146848|17069718|P1|Pre-randomization|Physician Decision|8
4966679|NCT00146848|17069716|P3|Pre-randomization|Lost to Follow-up|0
4966680|NCT00146848|17069717|P2|Pre-randomization|Lost to Follow-up|0
4966681|NCT00146848|17069718|P1|Pre-randomization|Lost to Follow-up|70
4966682|NCT00146848|17069716|P3|Pre-randomization|Death|0
4966683|NCT00146848|17069717|P2|Pre-randomization|Death|0
4966684|NCT00146848|17069718|P1|Pre-randomization|Death|19
4966685|NCT00146770|17069734|P2|Overall Study|Withdrawal by Subject|0
4966686|NCT00146770|17069735|P1|Overall Study|Withdrawal by Subject|2
4966687|NCT00146770|17069734|P2|Overall Study|Pregnancy|0
4966688|NCT00146770|17069735|P1|Overall Study|Pregnancy|1
4966689|NCT00146770|17069734|P2|Overall Study|Adverse Event|0
4966690|NCT00146770|17069735|P1|Overall Study|Adverse Event|2
4966691|NCT00146757|17069753|P2|Overall Study|Adverse Event|0
4966692|NCT00146757|17069754|P1|Overall Study|Adverse Event|1
4966693|NCT00146757|17069753|P2|Overall Study|Death|0
4966694|NCT00146757|17069754|P1|Overall Study|Death|1
4966695|NCT00146640|17069773|P2|Overall Study|Non-Medical Reasons|4
4966696|NCT00146640|17069774|P1|Overall Study|Non-Medical Reasons|8
4966697|NCT00146640|17069773|P2|Overall Study|Medical Reasons|0
4966698|NCT00146640|17069774|P1|Overall Study|Medical Reasons|3
4966699|NCT00146640|17069773|P2|Overall Study|Adverse Event|10
4966700|NCT00146640|17069774|P1|Overall Study|Adverse Event|12
4966701|NCT00146328|17069797|P3|Overall Study|Interaction with other medication|1
4966702|NCT00146328|17069798|P2|Overall Study|Interaction with other medication|0
4966703|NCT00146328|17069799|P1|Overall Study|Interaction with other medication|2
4966704|NCT00146328|17069797|P3|Overall Study|Moved|0
4966705|NCT00146328|17069798|P2|Overall Study|Moved|0
4966706|NCT00146328|17069799|P1|Overall Study|Moved|2
4966707|NCT00146328|17069797|P3|Overall Study|Death|1
4966708|NCT00146328|17069798|P2|Overall Study|Death|1
4966709|NCT00146328|17069799|P1|Overall Study|Death|0
4966710|NCT00146328|17069797|P3|Overall Study|Enroll into other trial|2
4966711|NCT00146328|17069798|P2|Overall Study|Enroll into other trial|4
4966712|NCT00146328|17069799|P1|Overall Study|Enroll into other trial|2
4966713|NCT00146328|17069797|P3|Overall Study|Patient decision to end|6
4966714|NCT00146328|17069798|P2|Overall Study|Patient decision to end|1
4966715|NCT00146328|17069799|P1|Overall Study|Patient decision to end|0
4966716|NCT00146328|17069797|P3|Overall Study|Trial ended/site closed|19
4966717|NCT00146328|17069798|P2|Overall Study|Trial ended/site closed|2
4966718|NCT00146328|17069799|P1|Overall Study|Trial ended/site closed|8
4966719|NCT00146328|17069797|P3|Overall Study|Virologic Failure/lack of efficacy|142
4966720|NCT00146328|17069798|P2|Overall Study|Virologic Failure/lack of efficacy|72
4966721|NCT00146328|17069799|P1|Overall Study|Virologic Failure/lack of efficacy|54
4966722|NCT00146328|17069797|P3|Overall Study|Withdrawal by Subject|22
4966723|NCT00146328|17069798|P2|Overall Study|Withdrawal by Subject|16
4966724|NCT00146328|17069799|P1|Overall Study|Withdrawal by Subject|16
4966725|NCT00146328|17069797|P3|Overall Study|Lost to Follow-up|7
4966726|NCT00146328|17069798|P2|Overall Study|Lost to Follow-up|4
4966727|NCT00146328|17069799|P1|Overall Study|Lost to Follow-up|7
4966728|NCT00146328|17069797|P3|Overall Study|Protocol Violation|12
4966729|NCT00146328|17069798|P2|Overall Study|Protocol Violation|6
4966730|NCT00146328|17069799|P1|Overall Study|Protocol Violation|11
4966731|NCT00146328|17069797|P3|Overall Study|Adverse Event|79
4966732|NCT00146328|17069798|P2|Overall Study|Adverse Event|48
4966733|NCT00146328|17069799|P1|Overall Study|Adverse Event|39
4966734|NCT00146172|17069890|P8|Overall Study|Symptomatic Deterioration|2
4966735|NCT00146172|17069891|P7|Overall Study|Symptomatic Deterioration|0
4966736|NCT00146172|17069892|P6|Overall Study|Symptomatic Deterioration|2
4966737|NCT00146172|17069893|P5|Overall Study|Symptomatic Deterioration|1
4966738|NCT00146172|17069894|P4|Overall Study|Symptomatic Deterioration|0
4966739|NCT00146172|17069895|P3|Overall Study|Symptomatic Deterioration|1
4966740|NCT00146172|17069896|P2|Overall Study|Symptomatic Deterioration|0
4966741|NCT00146172|17069897|P1|Overall Study|Symptomatic Deterioration|1
4966742|NCT00146172|17069890|P8|Overall Study|Withdrawal by Subject|4
4966743|NCT00146172|17069891|P7|Overall Study|Withdrawal by Subject|1
4966744|NCT00146172|17069892|P6|Overall Study|Withdrawal by Subject|1
4966745|NCT00146172|17069893|P5|Overall Study|Withdrawal by Subject|0
4966746|NCT00146172|17069894|P4|Overall Study|Withdrawal by Subject|0
4966747|NCT00146172|17069895|P3|Overall Study|Withdrawal by Subject|0
4966748|NCT00146172|17069896|P2|Overall Study|Withdrawal by Subject|0
4966749|NCT00146172|17069897|P1|Overall Study|Withdrawal by Subject|0
4966750|NCT00146172|17069890|P8|Overall Study|Physician Decision|1
4966751|NCT00146172|17069891|P7|Overall Study|Physician Decision|0
4966752|NCT00146172|17069892|P6|Overall Study|Physician Decision|0
4966753|NCT00146172|17069893|P5|Overall Study|Physician Decision|0
4966754|NCT00146172|17069894|P4|Overall Study|Physician Decision|0
4966755|NCT00146172|17069895|P3|Overall Study|Physician Decision|0
4966756|NCT00146172|17069896|P2|Overall Study|Physician Decision|0
4966757|NCT00146172|17069897|P1|Overall Study|Physician Decision|0
4966758|NCT00146172|17069890|P8|Overall Study|Death|0
4966759|NCT00146172|17069891|P7|Overall Study|Death|1
4966760|NCT00146172|17069892|P6|Overall Study|Death|0
4966761|NCT00146172|17069893|P5|Overall Study|Death|0
4966762|NCT00146172|17069894|P4|Overall Study|Death|0
4966763|NCT00146172|17069895|P3|Overall Study|Death|0
4966764|NCT00146172|17069896|P2|Overall Study|Death|0
4966765|NCT00146172|17069897|P1|Overall Study|Death|0
4966766|NCT00146172|17069890|P8|Overall Study|Disease Progression|22
4966767|NCT00146172|17069891|P7|Overall Study|Disease Progression|1
4966768|NCT00146172|17069892|P6|Overall Study|Disease Progression|2
4966769|NCT00146172|17069893|P5|Overall Study|Disease Progression|2
4966770|NCT00146172|17069894|P4|Overall Study|Disease Progression|5
4966771|NCT00146172|17069895|P3|Overall Study|Disease Progression|2
4966772|NCT00146172|17069896|P2|Overall Study|Disease Progression|4
4966773|NCT00146172|17069897|P1|Overall Study|Disease Progression|2
4966774|NCT00146172|17069890|P8|Overall Study|Lost to Follow-up|1
4966775|NCT00146172|17069891|P7|Overall Study|Lost to Follow-up|0
4966776|NCT00146172|17069892|P6|Overall Study|Lost to Follow-up|0
4966777|NCT00146172|17069893|P5|Overall Study|Lost to Follow-up|0
4966778|NCT00146172|17069894|P4|Overall Study|Lost to Follow-up|0
4966779|NCT00146172|17069895|P3|Overall Study|Lost to Follow-up|0
4966780|NCT00146172|17069896|P2|Overall Study|Lost to Follow-up|0
4966781|NCT00146172|17069897|P1|Overall Study|Lost to Follow-up|0
4966782|NCT00146172|17069890|P8|Overall Study|Adverse Event|10
4966783|NCT00146172|17069891|P7|Overall Study|Adverse Event|3
4966784|NCT00146172|17069892|P6|Overall Study|Adverse Event|2
4966785|NCT00146172|17069893|P5|Overall Study|Adverse Event|0
4966786|NCT00146172|17069894|P4|Overall Study|Adverse Event|1
4966787|NCT00146172|17069895|P3|Overall Study|Adverse Event|1
4966788|NCT00146172|17069896|P2|Overall Study|Adverse Event|0
4966789|NCT00146172|17069897|P1|Overall Study|Adverse Event|0
4966790|NCT00145977|17069932|P2|Overall Study|Withdrawal by Subject|0
4966791|NCT00145977|17069933|P1|Overall Study|Withdrawal by Subject|1
4966792|NCT00145977|17069932|P2|Overall Study|Lost to Follow-up|0
4966793|NCT00145977|17069933|P1|Overall Study|Lost to Follow-up|1
4966794|NCT00145977|17069932|P2|Overall Study|Lack of Efficacy|4
4966795|NCT00145977|17069933|P1|Overall Study|Lack of Efficacy|0
4966796|NCT00145795|17069959|P2|Overall Study|Adverse Event|0
4966797|NCT00145795|17069960|P1|Overall Study|Adverse Event|1
4966798|NCT00145626|17069995|P1|Overall Study|Withdrawal by Subject|1
4966799|NCT00145626|17069995|P1|Overall Study|Death|1
4966800|NCT00145626|17069995|P1|Overall Study|Turned 2 years old before treatment|1
4966801|NCT00145626|17069995|P1|Overall Study|Did not have NK infusions|2
4966802|NCT00145600|17070041|P4|Overall Study|Withdrawal by Subject|1
4966803|NCT00145600|17070042|P3|Overall Study|Withdrawal by Subject|0
4966804|NCT00145600|17070043|P2|Overall Study|Withdrawal by Subject|2
4966805|NCT00145600|17070044|P1|Overall Study|Withdrawal by Subject|1
4966806|NCT00145600|17070041|P4|Overall Study|Noncompliance|0
4966807|NCT00145600|17070042|P3|Overall Study|Noncompliance|0
4966808|NCT00145600|17070043|P2|Overall Study|Noncompliance|0
4966809|NCT00145600|17070044|P1|Overall Study|Noncompliance|1
4966810|NCT00145600|17070041|P4|Overall Study|Lost to Follow-up|4
4966811|NCT00145600|17070042|P3|Overall Study|Lost to Follow-up|2
4966812|NCT00145600|17070043|P2|Overall Study|Lost to Follow-up|6
4966813|NCT00145600|17070044|P1|Overall Study|Lost to Follow-up|2
4966814|NCT00145600|17070041|P4|Overall Study|Ineligible|5
4966815|NCT00145600|17070042|P3|Overall Study|Ineligible|1
4966816|NCT00145600|17070043|P2|Overall Study|Ineligible|0
4966817|NCT00145600|17070044|P1|Overall Study|Ineligible|3
4966818|NCT00145600|17070041|P4|Overall Study|Death|6
4966819|NCT00145600|17070042|P3|Overall Study|Death|2
4966820|NCT00145600|17070043|P2|Overall Study|Death|2
4966821|NCT00145600|17070044|P1|Overall Study|Death|1
4966822|NCT00145574|17070168|P3|Open Label Long-term Extension|required restricted medicine|1
4966823|NCT00145574|17070169|P2|Open Label Long-term Extension|required restricted medicine|0
4966824|NCT00145574|17070170|P1|Open Label Long-term Extension|required restricted medicine|0
4966825|NCT00145574|17070168|P3|Open Label Long-term Extension|Withdrawal by Subject|4
4966826|NCT00145574|17070169|P2|Open Label Long-term Extension|Withdrawal by Subject|0
4966827|NCT00145574|17070170|P1|Open Label Long-term Extension|Withdrawal by Subject|0
4966828|NCT00145574|17070168|P3|Open Label Long-term Extension|Lost to Follow-up|1
4966829|NCT00145574|17070169|P2|Open Label Long-term Extension|Lost to Follow-up|0
4966830|NCT00145574|17070170|P1|Open Label Long-term Extension|Lost to Follow-up|0
4966831|NCT00145574|17070168|P3|Open Label Long-term Extension|Adverse Event|5
4966832|NCT00145574|17070169|P2|Open Label Long-term Extension|Adverse Event|0
4966833|NCT00145574|17070170|P1|Open Label Long-term Extension|Adverse Event|0
4966834|NCT00145574|17070168|P3|Double Blind|required restricted medicine|0
4966835|NCT00145574|17070169|P2|Double Blind|required restricted medicine|1
4966836|NCT00145574|17070170|P1|Double Blind|required restricted medicine|0
4966837|NCT00145574|17070168|P3|Double Blind|Withdrawal by Subject|1
4966838|NCT00145574|17070169|P2|Double Blind|Withdrawal by Subject|1
4966839|NCT00145574|17070170|P1|Double Blind|Withdrawal by Subject|1
4966840|NCT00145574|17070168|P3|Double Blind|Adverse Event|1
4966841|NCT00145574|17070169|P2|Double Blind|Adverse Event|3
4966842|NCT00145574|17070170|P1|Double Blind|Adverse Event|0
4966843|NCT00145509|17070227|P2|Overall Study|Reason not provided|1
4966844|NCT00145509|17070228|P1|Overall Study|Reason not provided|2
4966845|NCT00145509|17070227|P2|Overall Study|Withdrew Consent|7
4966846|NCT00145509|17070228|P1|Overall Study|Withdrew Consent|2
4966847|NCT00145509|17070227|P2|Overall Study|Lost to Follow-up|9
4966848|NCT00145509|17070228|P1|Overall Study|Lost to Follow-up|5
4966849|NCT00145509|17070227|P2|Overall Study|Lack of Efficacy|1
4966850|NCT00145509|17070228|P1|Overall Study|Lack of Efficacy|3
4966851|NCT00145509|17070227|P2|Overall Study|Adverse Event|3
4966852|NCT00145509|17070228|P1|Overall Study|Adverse Event|10
4966853|NCT00145496|17070242|P2|Overall Study|Other|13
4966854|NCT00145496|17070243|P1|Overall Study|Other|25
4966855|NCT00145496|17070242|P2|Overall Study|Lost to Follow-up|5
4966856|NCT00145496|17070243|P1|Overall Study|Lost to Follow-up|12
4966857|NCT00145496|17070242|P2|Overall Study|Withdrawal by Subject|26
4966858|NCT00145496|17070243|P1|Overall Study|Withdrawal by Subject|32
4966859|NCT00145496|17070242|P2|Overall Study|Lack of Efficacy|7
4966860|NCT00145496|17070243|P1|Overall Study|Lack of Efficacy|12
4966861|NCT00145496|17070242|P2|Overall Study|Adverse Event|30
4966862|NCT00145496|17070243|P1|Overall Study|Adverse Event|42
4966863|NCT00145470|17070255|P2|Overall Study|Reason Not Reported|9
4966864|NCT00145470|17070256|P1|Overall Study|Reason Not Reported|9
4966865|NCT00145470|17070255|P2|Overall Study|Lost to Follow-up|17
4966866|NCT00145470|17070256|P1|Overall Study|Lost to Follow-up|21
4966867|NCT00145470|17070255|P2|Overall Study|Withdrawal by Subject|34
4966868|NCT00145470|17070256|P1|Overall Study|Withdrawal by Subject|36
4966869|NCT00145470|17070255|P2|Overall Study|Lack of Efficacy|13
4966870|NCT00145470|17070256|P1|Overall Study|Lack of Efficacy|27
4966871|NCT00145470|17070255|P2|Overall Study|Adverse Event|25
4966872|NCT00145470|17070256|P1|Overall Study|Adverse Event|19
4966873|NCT00145327|17070326|P3|Overall Study|Missing - not stated|1
4966874|NCT00145327|17070327|P2|Overall Study|Missing - not stated|0
4966875|NCT00145327|17070328|P1|Overall Study|Missing - not stated|1
4966876|NCT00145327|17070326|P3|Overall Study|Abnormal laboratory value(s)|2
4966877|NCT00145327|17070327|P2|Overall Study|Abnormal laboratory value(s)|0
4966878|NCT00145327|17070328|P1|Overall Study|Abnormal laboratory value(s)|1
4966879|NCT00145327|17070326|P3|Overall Study|Protocol Violation|2
4966880|NCT00145327|17070327|P2|Overall Study|Protocol Violation|0
4966881|NCT00145327|17070328|P1|Overall Study|Protocol Violation|2
4966882|NCT00145327|17070326|P3|Overall Study|Administrative problems|13
4966883|NCT00145327|17070327|P2|Overall Study|Administrative problems|9
4966884|NCT00145327|17070328|P1|Overall Study|Administrative problems|12
4966885|NCT00145327|17070326|P3|Overall Study|Lost to Follow-up|14
4966886|NCT00145327|17070327|P2|Overall Study|Lost to Follow-up|14
4966887|NCT00145327|17070328|P1|Overall Study|Lost to Follow-up|9
4966888|NCT00145327|17070326|P3|Overall Study|Adverse Event|22
4966889|NCT00145327|17070327|P2|Overall Study|Adverse Event|11
4966890|NCT00145327|17070328|P1|Overall Study|Adverse Event|14
4966891|NCT00145327|17070326|P3|Overall Study|Death|30
4966892|NCT00145327|17070327|P2|Overall Study|Death|18
4966893|NCT00145327|17070328|P1|Overall Study|Death|26
4966894|NCT00145327|17070326|P3|Overall Study|Withdrawal by Subject|164
4966895|NCT00145327|17070327|P2|Overall Study|Withdrawal by Subject|72
4966896|NCT00145327|17070328|P1|Overall Study|Withdrawal by Subject|77
4966897|NCT00145119|17070427|P1|Overall Study|Death|45
4966898|NCT00144781|17070445|P4|Overall Study|Non-compliant|0
4966899|NCT00144781|17070446|P3|Overall Study|Non-compliant|0
4966900|NCT00144781|17070447|P2|Overall Study|Non-compliant|1
4966901|NCT00144781|17070448|P1|Overall Study|Non-compliant|0
4966902|NCT00144781|17070445|P4|Overall Study|Adverse Event|0
4966903|NCT00144781|17070446|P3|Overall Study|Adverse Event|0
4966904|NCT00144781|17070447|P2|Overall Study|Adverse Event|1
4966905|NCT00144781|17070448|P1|Overall Study|Adverse Event|0
4966906|NCT00144339|17070477|P2|Overall Study|Other|60
4966907|NCT00144339|17070478|P1|Overall Study|Other|58
4966908|NCT00144339|17070477|P2|Overall Study|Lost to Follow-up|64
4966909|NCT00144339|17070478|P1|Overall Study|Lost to Follow-up|76
4966910|NCT00144339|17070477|P2|Overall Study|Withdrawal by Subject|300
4966911|NCT00144339|17070478|P1|Overall Study|Withdrawal by Subject|403
4966912|NCT00144339|17070477|P2|Overall Study|Protocol Violation|48
4966913|NCT00144339|17070478|P1|Overall Study|Protocol Violation|75
4966914|NCT00144339|17070477|P2|Overall Study|Adverse Event|627
4966915|NCT00144339|17070478|P1|Overall Study|Adverse Event|746
4966916|NCT00144300|17070686|P2|Overall Study|Other reason (not specified)|3
4966917|NCT00144300|17070687|P1|Overall Study|Other reason (not specified)|1
4966918|NCT00144300|17070686|P2|Overall Study|Withdrawal by Subject|6
4966919|NCT00144300|17070687|P1|Overall Study|Withdrawal by Subject|6
4966920|NCT00144300|17070686|P2|Overall Study|Lost to Follow-up|0
4966921|NCT00144300|17070687|P1|Overall Study|Lost to Follow-up|3
4966922|NCT00144300|17070686|P2|Overall Study|Protocol Violation|3
4966923|NCT00144300|17070687|P1|Overall Study|Protocol Violation|1
4966924|NCT00144300|17070686|P2|Overall Study|Adverse Event|16
4966925|NCT00144300|17070687|P1|Overall Study|Adverse Event|18
4966926|NCT00144170|17070735|P2|Overall Study|Other reason not defined above|316
4966927|NCT00144170|17070736|P1|Overall Study|Other reason not defined above|211
4966928|NCT00144170|17070735|P2|Overall Study|Withdrawal by Subject|13
4966929|NCT00144170|17070736|P1|Overall Study|Withdrawal by Subject|29
4966930|NCT00144170|17070735|P2|Overall Study|Lost to Follow-up|10
4966931|NCT00144170|17070736|P1|Overall Study|Lost to Follow-up|5
4966932|NCT00144170|17070735|P2|Overall Study|Protocol Violation|16
4966933|NCT00144170|17070736|P1|Overall Study|Protocol Violation|23
4966934|NCT00144170|17070735|P2|Overall Study|Adverse Event|41
4966935|NCT00144170|17070736|P1|Overall Study|Adverse Event|84
4966936|NCT00144027|17070926|P2|Overall Study|did not complete baseline assessment|6
4966937|NCT00144027|17070927|P1|Overall Study|did not complete baseline assessment|0
4966938|NCT00144027|17070926|P2|Overall Study|Withdrawal by Subject|2
4966939|NCT00144027|17070927|P1|Overall Study|Withdrawal by Subject|2
4966940|NCT00144027|17070926|P2|Overall Study|Lost to Follow-up|3
4966941|NCT00144027|17070927|P1|Overall Study|Lost to Follow-up|1
4966942|NCT00143598|17070957|P2|Overall Study|Death|36
4966943|NCT00143598|17070958|P1|Overall Study|Death|36
4966944|NCT00143598|17070957|P2|Overall Study|Withdrawal by Subject|37
4966945|NCT00143598|17070958|P1|Overall Study|Withdrawal by Subject|33
4966946|NCT00143598|17070957|P2|Overall Study|Lost to Follow-up|21
4966947|NCT00143598|17070958|P1|Overall Study|Lost to Follow-up|23
4966948|NCT00143507|17070972|P2|Overall Study|Withdrawn by sponsor's decision|3
4966949|NCT00143507|17070973|P1|Overall Study|Withdrawn by sponsor's decision|0
4966950|NCT00143507|17070972|P2|Overall Study|Lost to Follow-up|0
4966951|NCT00143507|17070973|P1|Overall Study|Lost to Follow-up|1
4966952|NCT00143507|17070972|P2|Overall Study|Withdrawal by Subject|102
4966953|NCT00143507|17070973|P1|Overall Study|Withdrawal by Subject|114
4966954|NCT00143507|17070972|P2|Overall Study|Death|547
4966955|NCT00143507|17070973|P1|Overall Study|Death|572
4966956|NCT00143455|17071007|P4|Cohort 2|Randomized But Not Treated|1
4966957|NCT00143455|17071008|P3|Cohort 2|Randomized But Not Treated|1
4966958|NCT00143455|17071009|P2|Cohort 2|Randomized But Not Treated|0
4966959|NCT00143455|17071010|P1|Cohort 2|Randomized But Not Treated|0
4966960|NCT00143455|17071007|P4|Cohort 2|Other|6
4966961|NCT00143455|17071008|P3|Cohort 2|Other|7
4966962|NCT00143455|17071009|P2|Cohort 2|Other|0
4966963|NCT00143455|17071010|P1|Cohort 2|Other|0
4966964|NCT00143455|17071007|P4|Cohort 2|Withdrawal by Subject|12
4966965|NCT00143455|17071008|P3|Cohort 2|Withdrawal by Subject|13
4966966|NCT00143455|17071009|P2|Cohort 2|Withdrawal by Subject|0
4966967|NCT00143455|17071010|P1|Cohort 2|Withdrawal by Subject|0
4966968|NCT00143455|17071007|P4|Cohort 2|Progressive Disease|27
4966969|NCT00143455|17071008|P3|Cohort 2|Progressive Disease|20
4966970|NCT00143455|17071009|P2|Cohort 2|Progressive Disease|0
4966971|NCT00143455|17071010|P1|Cohort 2|Progressive Disease|0
4966972|NCT00143455|17071007|P4|Cohort 2|Death|12
4966973|NCT00143455|17071008|P3|Cohort 2|Death|20
4966974|NCT00143455|17071009|P2|Cohort 2|Death|0
4966975|NCT00143455|17071010|P1|Cohort 2|Death|0
4966976|NCT00143455|17071007|P4|Cohort 2|Lost to Follow-up|4
4966977|NCT00143455|17071008|P3|Cohort 2|Lost to Follow-up|1
4966978|NCT00143455|17071009|P2|Cohort 2|Lost to Follow-up|0
4966979|NCT00143455|17071010|P1|Cohort 2|Lost to Follow-up|0
4966980|NCT00143455|17071007|P4|Cohort 2|Protocol Violation|1
4966981|NCT00143455|17071008|P3|Cohort 2|Protocol Violation|1
4966982|NCT00143455|17071009|P2|Cohort 2|Protocol Violation|0
4966983|NCT00143455|17071010|P1|Cohort 2|Protocol Violation|0
4966984|NCT00143455|17071007|P4|Cohort 2|No Longer Required Study Treatment|0
4966985|NCT00143455|17071008|P3|Cohort 2|No Longer Required Study Treatment|1
4966986|NCT00143455|17071009|P2|Cohort 2|No Longer Required Study Treatment|0
4966987|NCT00143455|17071010|P1|Cohort 2|No Longer Required Study Treatment|0
4966988|NCT00143455|17071007|P4|Cohort 2|Adverse Event|30
4966989|NCT00143455|17071008|P3|Cohort 2|Adverse Event|42
4966990|NCT00143455|17071009|P2|Cohort 2|Adverse Event|0
4966991|NCT00143455|17071010|P1|Cohort 2|Adverse Event|0
4966992|NCT00143455|17071007|P4|Cohort 1|Randomized But Not Treated|0
4966993|NCT00143455|17071008|P3|Cohort 1|Randomized But Not Treated|0
4966994|NCT00143455|17071009|P2|Cohort 1|Randomized But Not Treated|1
4966995|NCT00143455|17071010|P1|Cohort 1|Randomized But Not Treated|0
4966996|NCT00143455|17071007|P4|Cohort 1|Withdrawal by Subject|0
4966997|NCT00143455|17071008|P3|Cohort 1|Withdrawal by Subject|0
4966998|NCT00143455|17071009|P2|Cohort 1|Withdrawal by Subject|4
4966999|NCT00143455|17071010|P1|Cohort 1|Withdrawal by Subject|1
4967000|NCT00143455|17071007|P4|Cohort 1|Progressive Disease|0
4967001|NCT00143455|17071008|P3|Cohort 1|Progressive Disease|0
4967002|NCT00143455|17071009|P2|Cohort 1|Progressive Disease|6
4967003|NCT00143455|17071010|P1|Cohort 1|Progressive Disease|0
4967004|NCT00143455|17071007|P4|Cohort 1|Death|0
4967005|NCT00143455|17071008|P3|Cohort 1|Death|0
4967006|NCT00143455|17071009|P2|Cohort 1|Death|2
4967007|NCT00143455|17071010|P1|Cohort 1|Death|5
4967008|NCT00143455|17071007|P4|Cohort 1|Adverse Event|0
4967009|NCT00143455|17071008|P3|Cohort 1|Adverse Event|0
4967010|NCT00143455|17071009|P2|Cohort 1|Adverse Event|4
4967011|NCT00143455|17071010|P1|Cohort 1|Adverse Event|8
4967012|NCT00143403|17071044|P2|Overall Study|Randomized Not Treated|8
4967013|NCT00143403|17071045|P1|Overall Study|Randomized Not Treated|7
4967014|NCT00143403|17071044|P2|Overall Study|specified by site|9
4967015|NCT00143403|17071045|P1|Overall Study|specified by site|4
4967016|NCT00143403|17071044|P2|Overall Study|Protocol Violation|2
4967017|NCT00143403|17071045|P1|Overall Study|Protocol Violation|2
4967018|NCT00143403|17071044|P2|Overall Study|Relapse|7
4967019|NCT00143403|17071045|P1|Overall Study|Relapse|15
4967020|NCT00143403|17071044|P2|Overall Study|Withdrawal by Subject|12
4967021|NCT00143403|17071045|P1|Overall Study|Withdrawal by Subject|3
4967022|NCT00143403|17071044|P2|Overall Study|Death|0
4967023|NCT00143403|17071045|P1|Overall Study|Death|1
4967024|NCT00143403|17071044|P2|Overall Study|Adverse Event|8
4967025|NCT00143403|17071045|P1|Overall Study|Adverse Event|3
4967026|NCT00143390|17071055|P2|Overall Study|Other|2
4967027|NCT00143390|17071056|P1|Overall Study|Other|1
4967028|NCT00143390|17071055|P2|Overall Study|Adverse Event|8
4967029|NCT00143390|17071056|P1|Overall Study|Adverse Event|9
4967030|NCT00143390|17071055|P2|Overall Study|Study termination|15
4967031|NCT00143390|17071056|P1|Overall Study|Study termination|10
4967032|NCT00143390|17071055|P2|Overall Study|Protocol Violation|0
4967033|NCT00143390|17071056|P1|Overall Study|Protocol Violation|2
4967034|NCT00143390|17071055|P2|Overall Study|Progressive disease|115
4967035|NCT00143390|17071056|P1|Overall Study|Progressive disease|119
4967036|NCT00143390|17071055|P2|Overall Study|Withdrawal by Subject|4
4967037|NCT00143390|17071056|P1|Overall Study|Withdrawal by Subject|4
4967038|NCT00143390|17071055|P2|Overall Study|Not meeting entry criteria|5
4967039|NCT00143390|17071056|P1|Overall Study|Not meeting entry criteria|2
4967040|NCT00143390|17071055|P2|Overall Study|Death|0
4967041|NCT00143390|17071056|P1|Overall Study|Death|2
4967042|NCT00143312|17071072|P1|Overall Study|Withdrawal by Subject|1
4967043|NCT00143312|17071072|P1|Overall Study|Other|1
4967044|NCT00143312|17071072|P1|Overall Study|Lost to Follow-up|1
4967045|NCT00143312|17071072|P1|Overall Study|Adverse Event|2
4967046|NCT00143312|17071072|P1|Overall Study|Death|11
4967047|NCT00143247|17071082|P1|Overall Study|Other|12
4967048|NCT00143247|17071082|P1|Overall Study|following inaccurate lab adverse event|1
4967049|NCT00143247|17071082|P1|Overall Study|Lost to Follow-up|12
4967050|NCT00143247|17071082|P1|Overall Study|Protocol Violation|15
4967051|NCT00143247|17071082|P1|Overall Study|Study terminated by sponsor|31
4967052|NCT00143247|17071082|P1|Overall Study|Withdrawal by Subject|55
4967053|NCT00143247|17071082|P1|Overall Study|Lack of Efficacy|3
4967054|NCT00143247|17071082|P1|Overall Study|Adverse Event|19
4967055|NCT00143247|17071082|P1|Overall Study|Death|8
4967056|NCT00142935|17071099|P3|Overall Study|Death|1
4967057|NCT00142935|17071100|P2|Overall Study|Death|2
4967058|NCT00142935|17071101|P1|Overall Study|Death|0
4967059|NCT00142935|17071099|P3|Overall Study|Lost to Follow-up|5
4967060|NCT00142935|17071100|P2|Overall Study|Lost to Follow-up|5
4967061|NCT00142935|17071101|P1|Overall Study|Lost to Follow-up|2
4967062|NCT00142935|17071099|P3|Overall Study|Other reason|1
4967063|NCT00142935|17071100|P2|Overall Study|Other reason|1
4967064|NCT00142935|17071101|P1|Overall Study|Other reason|1
4967065|NCT00142909|17071126|P2|Medications Begin|Withdrawal by Subject|0
4967066|NCT00142909|17071127|P1|Medications Begin|Withdrawal by Subject|2
4967067|NCT00142909|17071126|P2|Medications Begin|Withdrawal by Subject|3
4967068|NCT00142909|17071127|P1|Medications Begin|Withdrawal by Subject|5
4967069|NCT00142909|17071126|P2|Medications Begin|Protocol Violation|0
4967070|NCT00142909|17071127|P1|Medications Begin|Protocol Violation|2
4967071|NCT00142909|17071126|P2|Randomization|Various Reasons|10
4967072|NCT00142909|17071127|P1|Randomization|Various Reasons|7
4967073|NCT00142792|17071167|P3|Overall Study|No category|1
4967074|NCT00142792|17071168|P2|Overall Study|No category|2
4967075|NCT00142792|17071169|P1|Overall Study|No category|1
4967076|NCT00142792|17071167|P3|Overall Study|Lost to Follow-up|7
4967077|NCT00142792|17071168|P2|Overall Study|Lost to Follow-up|11
4967078|NCT00142792|17071169|P1|Overall Study|Lost to Follow-up|8
4967079|NCT00142792|17071167|P3|Overall Study|Withdrawal by Subject|3
4967080|NCT00142792|17071168|P2|Overall Study|Withdrawal by Subject|2
4967081|NCT00142792|17071169|P1|Overall Study|Withdrawal by Subject|3
4967082|NCT00142792|17071167|P3|Overall Study|Death|1
4967083|NCT00142792|17071168|P2|Overall Study|Death|0
4967084|NCT00142792|17071169|P1|Overall Study|Death|0
4967085|NCT00142519|17071191|P2|Overall Study|Withdrawal by Subject|7
4967086|NCT00142519|17071192|P1|Overall Study|Withdrawal by Subject|10
4967087|NCT00142519|17071191|P2|Overall Study|Protocol Violation|0
4967088|NCT00142519|17071192|P1|Overall Study|Protocol Violation|1
4967089|NCT00142519|17071191|P2|Overall Study|Not Treated|9
4967090|NCT00142519|17071192|P1|Overall Study|Not Treated|7
4967091|NCT00142415|17071221|P6|Overall Study|Physician Decision|2
4967092|NCT00142415|17071222|P5|Overall Study|Physician Decision|1
4967093|NCT00142415|17071223|P4|Overall Study|Physician Decision|0
4967094|NCT00142415|17071224|P3|Overall Study|Physician Decision|0
4967095|NCT00142415|17071225|P2|Overall Study|Physician Decision|0
4967096|NCT00142415|17071226|P1|Overall Study|Physician Decision|0
4967097|NCT00142298|17071264|P10|Overall Study|Treatment Failure|0
4967098|NCT00142298|17071265|P9|Overall Study|Treatment Failure|0
4967099|NCT00142298|17071266|P8|Overall Study|Treatment Failure|0
4967100|NCT00142298|17071267|P7|Overall Study|Treatment Failure|2
4967101|NCT00142298|17071268|P6|Overall Study|Treatment Failure|2
4967102|NCT00142298|17071269|P5|Overall Study|Treatment Failure|0
4967103|NCT00142298|17071270|P4|Overall Study|Treatment Failure|0
4967104|NCT00142298|17071271|P3|Overall Study|Treatment Failure|0
4967105|NCT00142298|17071272|P2|Overall Study|Treatment Failure|0
4967106|NCT00142298|17071273|P1|Overall Study|Treatment Failure|0
4967107|NCT00142298|17071264|P10|Overall Study|Lost to Follow-up|0
4967108|NCT00142298|17071265|P9|Overall Study|Lost to Follow-up|0
4967109|NCT00142298|17071266|P8|Overall Study|Lost to Follow-up|0
4967110|NCT00142298|17071267|P7|Overall Study|Lost to Follow-up|2
4967111|NCT00142298|17071268|P6|Overall Study|Lost to Follow-up|0
4967112|NCT00142298|17071269|P5|Overall Study|Lost to Follow-up|0
4967113|NCT00142298|17071270|P4|Overall Study|Lost to Follow-up|0
4967114|NCT00142298|17071271|P3|Overall Study|Lost to Follow-up|0
4967115|NCT00142298|17071272|P2|Overall Study|Lost to Follow-up|0
4967116|NCT00142298|17071273|P1|Overall Study|Lost to Follow-up|0
4967117|NCT00142298|17071264|P10|Overall Study|Other- not specified|0
4967118|NCT00142298|17071265|P9|Overall Study|Other- not specified|0
4967119|NCT00142298|17071266|P8|Overall Study|Other- not specified|0
4967120|NCT00142298|17071267|P7|Overall Study|Other- not specified|0
4967121|NCT00142298|17071268|P6|Overall Study|Other- not specified|0
4967122|NCT00142298|17071269|P5|Overall Study|Other- not specified|0
4967123|NCT00142298|17071270|P4|Overall Study|Other- not specified|1
4967124|NCT00142298|17071271|P3|Overall Study|Other- not specified|0
4967125|NCT00142298|17071272|P2|Overall Study|Other- not specified|3
4967126|NCT00142298|17071273|P1|Overall Study|Other- not specified|0
4967127|NCT00142298|17071264|P10|Overall Study|Virologic breakthrough|0
4967128|NCT00142298|17071265|P9|Overall Study|Virologic breakthrough|0
4967129|NCT00142298|17071266|P8|Overall Study|Virologic breakthrough|0
4967130|NCT00142298|17071267|P7|Overall Study|Virologic breakthrough|3
4967131|NCT00142298|17071268|P6|Overall Study|Virologic breakthrough|3
4967132|NCT00142298|17071269|P5|Overall Study|Virologic breakthrough|2
4967133|NCT00142298|17071270|P4|Overall Study|Virologic breakthrough|7
4967134|NCT00142298|17071271|P3|Overall Study|Virologic breakthrough|9
4967135|NCT00142298|17071272|P2|Overall Study|Virologic breakthrough|23
4967136|NCT00142298|17071273|P1|Overall Study|Virologic breakthrough|19
4967137|NCT00142298|17071264|P10|Overall Study|Pregnancy|0
4967138|NCT00142298|17071265|P9|Overall Study|Pregnancy|1
4967139|NCT00142298|17071266|P8|Overall Study|Pregnancy|0
4967140|NCT00142298|17071267|P7|Overall Study|Pregnancy|0
4967141|NCT00142298|17071268|P6|Overall Study|Pregnancy|0
4967142|NCT00142298|17071269|P5|Overall Study|Pregnancy|0
4967143|NCT00142298|17071270|P4|Overall Study|Pregnancy|3
4967144|NCT00142298|17071271|P3|Overall Study|Pregnancy|2
4967145|NCT00142298|17071272|P2|Overall Study|Pregnancy|4
4967146|NCT00142298|17071273|P1|Overall Study|Pregnancy|4
4967147|NCT00142298|17071264|P10|Overall Study|Patient, Investigator,or Sponsor request|0
4967148|NCT00142298|17071265|P9|Overall Study|Patient, Investigator,or Sponsor request|1
4967149|NCT00142298|17071266|P8|Overall Study|Patient, Investigator,or Sponsor request|4
4967150|NCT00142298|17071267|P7|Overall Study|Patient, Investigator,or Sponsor request|1
4967151|NCT00142298|17071268|P6|Overall Study|Patient, Investigator,or Sponsor request|3
4967152|NCT00142298|17071269|P5|Overall Study|Patient, Investigator,or Sponsor request|4
4967153|NCT00142298|17071270|P4|Overall Study|Patient, Investigator,or Sponsor request|51
4967154|NCT00142298|17071271|P3|Overall Study|Patient, Investigator,or Sponsor request|11
4967155|NCT00142298|17071272|P2|Overall Study|Patient, Investigator,or Sponsor request|60
4967156|NCT00142298|17071273|P1|Overall Study|Patient, Investigator,or Sponsor request|66
4967157|NCT00142298|17071264|P10|Overall Study|Non-compliance|0
4967158|NCT00142298|17071265|P9|Overall Study|Non-compliance|3
4967159|NCT00142298|17071266|P8|Overall Study|Non-compliance|3
4967160|NCT00142298|17071267|P7|Overall Study|Non-compliance|0
4967161|NCT00142298|17071268|P6|Overall Study|Non-compliance|0
4967162|NCT00142298|17071269|P5|Overall Study|Non-compliance|1
4967163|NCT00142298|17071270|P4|Overall Study|Non-compliance|6
4967164|NCT00142298|17071271|P3|Overall Study|Non-compliance|0
4967165|NCT00142298|17071272|P2|Overall Study|Non-compliance|13
4967166|NCT00142298|17071273|P1|Overall Study|Non-compliance|15
4967167|NCT00142298|17071264|P10|Overall Study|Lack of Efficacy|0
4967168|NCT00142298|17071265|P9|Overall Study|Lack of Efficacy|0
4967169|NCT00142298|17071266|P8|Overall Study|Lack of Efficacy|1
4967170|NCT00142298|17071267|P7|Overall Study|Lack of Efficacy|0
4967171|NCT00142298|17071268|P6|Overall Study|Lack of Efficacy|0
4967172|NCT00142298|17071269|P5|Overall Study|Lack of Efficacy|1
4967173|NCT00142298|17071270|P4|Overall Study|Lack of Efficacy|12
4967174|NCT00142298|17071271|P3|Overall Study|Lack of Efficacy|9
4967175|NCT00142298|17071272|P2|Overall Study|Lack of Efficacy|62
4967176|NCT00142298|17071273|P1|Overall Study|Lack of Efficacy|44
4967177|NCT00142298|17071264|P10|Overall Study|Death|0
4967178|NCT00142298|17071265|P9|Overall Study|Death|0
4967179|NCT00142298|17071266|P8|Overall Study|Death|0
4967180|NCT00142298|17071267|P7|Overall Study|Death|0
4967181|NCT00142298|17071268|P6|Overall Study|Death|6
4967182|NCT00142298|17071269|P5|Overall Study|Death|0
4967183|NCT00142298|17071270|P4|Overall Study|Death|0
4967184|NCT00142298|17071271|P3|Overall Study|Death|1
4967185|NCT00142298|17071272|P2|Overall Study|Death|1
4967186|NCT00142298|17071273|P1|Overall Study|Death|1
4967187|NCT00142298|17071264|P10|Overall Study|Clinical disease progression|0
4967188|NCT00142298|17071265|P9|Overall Study|Clinical disease progression|0
4967189|NCT00142298|17071266|P8|Overall Study|Clinical disease progression|0
4967190|NCT00142298|17071267|P7|Overall Study|Clinical disease progression|0
4967191|NCT00142298|17071268|P6|Overall Study|Clinical disease progression|0
4967192|NCT00142298|17071269|P5|Overall Study|Clinical disease progression|0
4967193|NCT00142298|17071270|P4|Overall Study|Clinical disease progression|0
4967194|NCT00142298|17071271|P3|Overall Study|Clinical disease progression|0
4967195|NCT00142298|17071272|P2|Overall Study|Clinical disease progression|0
4967196|NCT00142298|17071273|P1|Overall Study|Clinical disease progression|1
4967197|NCT00142298|17071264|P10|Overall Study|Adverse Event|0
4967198|NCT00142298|17071265|P9|Overall Study|Adverse Event|0
4967199|NCT00142298|17071266|P8|Overall Study|Adverse Event|0
4967200|NCT00142298|17071267|P7|Overall Study|Adverse Event|0
4967201|NCT00142298|17071268|P6|Overall Study|Adverse Event|2
4967202|NCT00142298|17071269|P5|Overall Study|Adverse Event|2
4967203|NCT00142298|17071270|P4|Overall Study|Adverse Event|5
4967204|NCT00142298|17071271|P3|Overall Study|Adverse Event|1
4967205|NCT00142298|17071272|P2|Overall Study|Adverse Event|10
4967206|NCT00142298|17071273|P1|Overall Study|Adverse Event|10
4967207|NCT00141921|17071307|P1|Overall Study|Other|8
4967208|NCT00141921|17071307|P1|Overall Study|Ineligibility Determined|2
4967209|NCT00141921|17071307|P1|Overall Study|Pregnancy|4
4967210|NCT00141921|17071307|P1|Overall Study|Administrative Decision|2
4967211|NCT00141921|17071307|P1|Overall Study|Adverse Event|5
4967212|NCT00141921|17071307|P1|Overall Study|Protocol Deviation|7
4967213|NCT00141921|17071307|P1|Overall Study|Disease Progression|7
4967214|NCT00141921|17071307|P1|Overall Study|Noncompliance|17
4967215|NCT00141921|17071307|P1|Overall Study|Lost to Follow-up|19
4967216|NCT00141921|17071307|P1|Overall Study|Withdrawal by Subject|42
4967217|NCT00141921|17071307|P1|Overall Study|Remain on Study|28
4967218|NCT00141817|17071333|P4|Overall Study|Parent request|0
4967219|NCT00141817|17071334|P3|Overall Study|Parent request|0
4967220|NCT00141817|17071335|P2|Overall Study|Parent request|0
4967221|NCT00141817|17071336|P1|Overall Study|Parent request|1
4967222|NCT00141817|17071333|P4|Overall Study|Protocol Violation|0
4967223|NCT00141817|17071334|P3|Overall Study|Protocol Violation|1
4967224|NCT00141817|17071335|P2|Overall Study|Protocol Violation|0
4967225|NCT00141817|17071336|P1|Overall Study|Protocol Violation|0
4967226|NCT00141778|17071377|P3|Started Study Medication|Chest Discomfort|1
4967227|NCT00141778|17071378|P2|Started Study Medication|Chest Discomfort|0
4967228|NCT00141778|17071379|P1|Started Study Medication|Chest Discomfort|0
4967229|NCT00141778|17071377|P3|Started Study Medication|Difficulty Swallowing|0
4967230|NCT00141778|17071378|P2|Started Study Medication|Difficulty Swallowing|1
4967231|NCT00141778|17071379|P1|Started Study Medication|Difficulty Swallowing|0
4967232|NCT00141778|17071377|P3|Started Study Medication|Withdrawal by Subject|0
4967233|NCT00141778|17071378|P2|Started Study Medication|Withdrawal by Subject|2
4967234|NCT00141778|17071379|P1|Started Study Medication|Withdrawal by Subject|0
4967235|NCT00141778|17071377|P3|Started Study Medication|Met safety criteria for discontinuation|3
4967236|NCT00141778|17071378|P2|Started Study Medication|Met safety criteria for discontinuation|4
4967237|NCT00141778|17071379|P1|Started Study Medication|Met safety criteria for discontinuation|2
4967238|NCT00141778|17071377|P3|Randomization Prior to Study Med|Withdrawal by Subject|6
4967239|NCT00141778|17071378|P2|Randomization Prior to Study Med|Withdrawal by Subject|2
4967240|NCT00141778|17071379|P1|Randomization Prior to Study Med|Withdrawal by Subject|5
4967241|NCT00141726|17071432|P1|Overall Study|Completed <50% Scheduled Dosing|3
4967242|NCT00141518|17071440|P3|Overall Study|Lack of Efficacy|0
4967243|NCT00141518|17071441|P2|Overall Study|Lack of Efficacy|0
4967244|NCT00141518|17071442|P1|Overall Study|Lack of Efficacy|5
4967245|NCT00141518|17071440|P3|Overall Study|Protocol Violation|2
4967246|NCT00141518|17071441|P2|Overall Study|Protocol Violation|1
4967247|NCT00141518|17071442|P1|Overall Study|Protocol Violation|1
4967248|NCT00141518|17071440|P3|Overall Study|Withdrawal by Subject|2
4967249|NCT00141518|17071441|P2|Overall Study|Withdrawal by Subject|0
4967250|NCT00141518|17071442|P1|Overall Study|Withdrawal by Subject|2
4967251|NCT00141518|17071440|P3|Overall Study|Adverse Event|2
4967252|NCT00141518|17071441|P2|Overall Study|Adverse Event|5
4967253|NCT00141518|17071442|P1|Overall Study|Adverse Event|7
4967254|NCT00141518|17071440|P3|Overall Study|Withdrew Consent Prior to Treatment|0
4967255|NCT00141518|17071441|P2|Overall Study|Withdrew Consent Prior to Treatment|0
4967256|NCT00141518|17071442|P1|Overall Study|Withdrew Consent Prior to Treatment|1
4967257|NCT00141453|17071631|P2|Overall Study|Protocol Violation|5
4967258|NCT00141453|17071632|P1|Overall Study|Protocol Violation|6
4967259|NCT00141297|17071646|P10|Overall Study|Transitioned|0
4967260|NCT00141297|17071647|P9|Overall Study|Transitioned|0
4967261|NCT00141297|17071648|P8|Overall Study|Transitioned|0
4967262|NCT00141297|17071649|P7|Overall Study|Transitioned|0
4967263|NCT00141297|17071650|P6|Overall Study|Transitioned|0
4967264|NCT00141297|17071651|P5|Overall Study|Transitioned|1
4967265|NCT00141297|17071652|P4|Overall Study|Transitioned|0
4967266|NCT00141297|17071653|P3|Overall Study|Transitioned|0
4967267|NCT00141297|17071654|P2|Overall Study|Transitioned|0
4967268|NCT00141297|17071655|P1|Overall Study|Transitioned|0
4967269|NCT00141297|17071646|P10|Overall Study|Progressive Disease|6
4967270|NCT00141297|17071647|P9|Overall Study|Progressive Disease|15
4967271|NCT00141297|17071648|P8|Overall Study|Progressive Disease|3
4967272|NCT00141297|17071649|P7|Overall Study|Progressive Disease|3
4967273|NCT00141297|17071650|P6|Overall Study|Progressive Disease|2
4967274|NCT00141297|17071651|P5|Overall Study|Progressive Disease|15
4967275|NCT00141297|17071652|P4|Overall Study|Progressive Disease|2
4967276|NCT00141297|17071653|P3|Overall Study|Progressive Disease|6
4967277|NCT00141297|17071654|P2|Overall Study|Progressive Disease|3
4967278|NCT00141297|17071655|P1|Overall Study|Progressive Disease|2
4967279|NCT00141297|17071646|P10|Overall Study|Other|0
4967280|NCT00141297|17071647|P9|Overall Study|Other|2
4967281|NCT00141297|17071648|P8|Overall Study|Other|0
4967282|NCT00141297|17071649|P7|Overall Study|Other|0
4967283|NCT00141297|17071650|P6|Overall Study|Other|0
4967284|NCT00141297|17071651|P5|Overall Study|Other|5
4967285|NCT00141297|17071652|P4|Overall Study|Other|1
4967286|NCT00141297|17071653|P3|Overall Study|Other|0
4967287|NCT00141297|17071654|P2|Overall Study|Other|0
4967288|NCT00141297|17071655|P1|Overall Study|Other|0
4967289|NCT00141297|17071646|P10|Overall Study|Withdrawal by Subject|0
4967290|NCT00141297|17071647|P9|Overall Study|Withdrawal by Subject|1
4967291|NCT00141297|17071648|P8|Overall Study|Withdrawal by Subject|0
4967292|NCT00141297|17071649|P7|Overall Study|Withdrawal by Subject|0
4967293|NCT00141297|17071650|P6|Overall Study|Withdrawal by Subject|0
4967294|NCT00141297|17071651|P5|Overall Study|Withdrawal by Subject|0
4967295|NCT00141297|17071652|P4|Overall Study|Withdrawal by Subject|0
4967296|NCT00141297|17071653|P3|Overall Study|Withdrawal by Subject|0
4967297|NCT00141297|17071654|P2|Overall Study|Withdrawal by Subject|0
4967298|NCT00141297|17071655|P1|Overall Study|Withdrawal by Subject|0
4967299|NCT00141297|17071646|P10|Overall Study|Death|0
4967300|NCT00141297|17071647|P9|Overall Study|Death|1
4967301|NCT00141297|17071648|P8|Overall Study|Death|0
4967302|NCT00141297|17071649|P7|Overall Study|Death|0
4967303|NCT00141297|17071650|P6|Overall Study|Death|0
4967304|NCT00141297|17071651|P5|Overall Study|Death|0
4967305|NCT00141297|17071652|P4|Overall Study|Death|0
4967306|NCT00141297|17071653|P3|Overall Study|Death|0
4967307|NCT00141297|17071654|P2|Overall Study|Death|0
4967308|NCT00141297|17071655|P1|Overall Study|Death|1
4967309|NCT00141297|17071646|P10|Overall Study|Adverse Event|0
4967310|NCT00141297|17071647|P9|Overall Study|Adverse Event|1
4967311|NCT00141297|17071648|P8|Overall Study|Adverse Event|1
4967312|NCT00141297|17071649|P7|Overall Study|Adverse Event|0
4967313|NCT00141297|17071650|P6|Overall Study|Adverse Event|1
4967314|NCT00141297|17071651|P5|Overall Study|Adverse Event|1
4967315|NCT00141297|17071652|P4|Overall Study|Adverse Event|0
4967316|NCT00141297|17071653|P3|Overall Study|Adverse Event|1
4967317|NCT00141297|17071654|P2|Overall Study|Adverse Event|0
4967318|NCT00141297|17071655|P1|Overall Study|Adverse Event|0
4967319|NCT00141271|17071933|P3|Overall Study|Other|5
4967320|NCT00141271|17071934|P2|Overall Study|Other|12
4967321|NCT00141271|17071935|P1|Overall Study|Other|11
4967322|NCT00141271|17071933|P3|Overall Study|Withdrawal by Subject|10
4967323|NCT00141271|17071934|P2|Overall Study|Withdrawal by Subject|9
4967324|NCT00141271|17071935|P1|Overall Study|Withdrawal by Subject|14
4967325|NCT00141271|17071933|P3|Overall Study|Lost to Follow-up|21
4967326|NCT00141271|17071934|P2|Overall Study|Lost to Follow-up|15
4967327|NCT00141271|17071935|P1|Overall Study|Lost to Follow-up|15
4967328|NCT00141271|17071933|P3|Overall Study|Lack of Efficacy|3
4967329|NCT00141271|17071934|P2|Overall Study|Lack of Efficacy|7
4967330|NCT00141271|17071935|P1|Overall Study|Lack of Efficacy|7
4967331|NCT00141271|17071933|P3|Overall Study|Laboratory Abnormality|1
4967332|NCT00141271|17071934|P2|Overall Study|Laboratory Abnormality|1
4967333|NCT00141271|17071935|P1|Overall Study|Laboratory Abnormality|2
4967334|NCT00141271|17071933|P3|Overall Study|Adverse Event|17
4967335|NCT00141271|17071934|P2|Overall Study|Adverse Event|19
4967336|NCT00141271|17071935|P1|Overall Study|Adverse Event|31
4967337|NCT00141219|17072056|P2|Overall Study|Withdrawal by Subject|2
4967338|NCT00141219|17072057|P1|Overall Study|Withdrawal by Subject|6
4967339|NCT00141219|17072056|P2|Overall Study|Lack of Efficacy|4
4967340|NCT00141219|17072057|P1|Overall Study|Lack of Efficacy|5
4967341|NCT00141219|17072056|P2|Overall Study|Adverse Event|6
4967342|NCT00141219|17072057|P1|Overall Study|Adverse Event|8
4967343|NCT00141219|17072056|P2|Overall Study|Protocol violations|4
4967344|NCT00141219|17072057|P1|Overall Study|Protocol violations|5
4967345|NCT00141102|17072114|P2|Overall Study|Death|2
4967346|NCT00141102|17072115|P1|Overall Study|Death|2
4967347|NCT00141102|17072114|P2|Overall Study|Randomized But Did Not Receive Treatment|9
4967348|NCT00141102|17072115|P1|Overall Study|Randomized But Did Not Receive Treatment|15
4967349|NCT00141102|17072114|P2|Overall Study|Withdrawal by Subject|142
4967350|NCT00141102|17072115|P1|Overall Study|Withdrawal by Subject|112
4967351|NCT00141102|17072114|P2|Overall Study|Other|76
4967352|NCT00141102|17072115|P1|Overall Study|Other|87
4967353|NCT00141102|17072114|P2|Overall Study|Lost to Follow-up|32
4967354|NCT00141102|17072115|P1|Overall Study|Lost to Follow-up|29
4967355|NCT00141102|17072114|P2|Overall Study|Lack of Efficacy|26
4967356|NCT00141102|17072115|P1|Overall Study|Lack of Efficacy|21
4967357|NCT00141102|17072114|P2|Overall Study|Laboratory Abnormality|33
4967358|NCT00141102|17072115|P1|Overall Study|Laboratory Abnormality|9
4967359|NCT00141102|17072114|P2|Overall Study|Adverse Event|305
4967360|NCT00141102|17072115|P1|Overall Study|Adverse Event|233
4967361|NCT00141037|17072155|P2|Overall Study|Graft Failure|4
4967362|NCT00141037|17072156|P1|Overall Study|Graft Failure|3
4967363|NCT00141037|17072155|P2|Overall Study|Moved from area|7
4967364|NCT00141037|17072156|P1|Overall Study|Moved from area|1
4967365|NCT00141037|17072155|P2|Overall Study|Other|1
4967366|NCT00141037|17072156|P1|Overall Study|Other|0
4967367|NCT00141037|17072155|P2|Overall Study|Withdrawal by Subject|1
4967368|NCT00141037|17072156|P1|Overall Study|Withdrawal by Subject|2
4967369|NCT00141037|17072155|P2|Overall Study|Protocol Violation|2
4967370|NCT00141037|17072156|P1|Overall Study|Protocol Violation|0
4967371|NCT00141037|17072155|P2|Overall Study|Lost to Follow-up|1
4967372|NCT00141037|17072156|P1|Overall Study|Lost to Follow-up|3
4967373|NCT00141037|17072155|P2|Overall Study|Physician Decision|2
4967374|NCT00141037|17072156|P1|Overall Study|Physician Decision|1
4967375|NCT00140426|17072191|P2|Overall Study|Withdrawal by Subject|3
4967376|NCT00140426|17072192|P1|Overall Study|Withdrawal by Subject|0
4967377|NCT00140413|17072225|P2|Overall Study|Withdrawal by Subject|0
4967378|NCT00140413|17072226|P1|Overall Study|Withdrawal by Subject|2
4967379|NCT00140413|17072225|P2|Overall Study|Lost to Follow-up|0
4967380|NCT00140413|17072226|P1|Overall Study|Lost to Follow-up|1
4967381|NCT00140140|17072357|P3|Overall Study|Physician Decision|0
4967382|NCT00140140|17072358|P2|Overall Study|Physician Decision|1
4967383|NCT00140140|17072359|P1|Overall Study|Physician Decision|1
4967384|NCT00140140|17072357|P3|Overall Study|Unacceptable toxicity|2
4967385|NCT00140140|17072358|P2|Overall Study|Unacceptable toxicity|1
4967386|NCT00140140|17072359|P1|Overall Study|Unacceptable toxicity|1
4967387|NCT00139776|17072409|P4|Period III|Withdrawal by Subject|21
4967388|NCT00139776|17072410|P3|Period III|Withdrawal by Subject|16
4967389|NCT00139776|17072411|P2|Period III|Withdrawal by Subject|0
4967390|NCT00139776|17072412|P1|Period III|Withdrawal by Subject|0
4967391|NCT00139776|17072409|P4|Period III|Lost to Follow-up|4
4967392|NCT00139776|17072410|P3|Period III|Lost to Follow-up|5
4967393|NCT00139776|17072411|P2|Period III|Lost to Follow-up|0
4967394|NCT00139776|17072412|P1|Period III|Lost to Follow-up|0
4967395|NCT00139776|17072409|P4|Period III|Lack of Efficacy|24
4967396|NCT00139776|17072410|P3|Period III|Lack of Efficacy|10
4967397|NCT00139776|17072411|P2|Period III|Lack of Efficacy|0
4967398|NCT00139776|17072412|P1|Period III|Lack of Efficacy|0
4967399|NCT00139776|17072409|P4|Period III|Other|34
4967400|NCT00139776|17072410|P3|Period III|Other|23
4967401|NCT00139776|17072411|P2|Period III|Other|0
4967402|NCT00139776|17072412|P1|Period III|Other|0
4967403|NCT00139776|17072409|P4|Period III|Adverse Event|23
4967404|NCT00139776|17072410|P3|Period III|Adverse Event|22
4967405|NCT00139776|17072411|P2|Period III|Adverse Event|0
4967406|NCT00139776|17072412|P1|Period III|Adverse Event|0
4967407|NCT00139776|17072409|P4|Period II|Not Randomized into Period III|0
4967408|NCT00139776|17072410|P3|Period II|Not Randomized into Period III|0
4967409|NCT00139776|17072411|P2|Period II|Not Randomized into Period III|322
4967410|NCT00139776|17072412|P1|Period II|Not Randomized into Period III|0
4967411|NCT00139776|17072409|P4|Period I|Did not enter Period II|0
4967412|NCT00139776|17072410|P3|Period I|Did not enter Period II|0
4967413|NCT00139776|17072411|P2|Period I|Did not enter Period II|0
4967414|NCT00139776|17072412|P1|Period I|Did not enter Period II|575
4967415|NCT00139737|17072447|P1|Overall Study|Screened, Not Treated|13
4967416|NCT00139737|17072447|P1|Overall Study|Did Not Meet Entrance Criteria|1
4967417|NCT00139737|17072447|P1|Overall Study|Withdrew During Screening Phase|8
4967418|NCT00139737|17072447|P1|Overall Study|Protocol Violation|18
4967419|NCT00139737|17072447|P1|Overall Study|Laboratory Abnormality|2
4967420|NCT00139737|17072447|P1|Overall Study|Death|3
4967421|NCT00139737|17072447|P1|Overall Study|Lost to Follow-up|8
4967422|NCT00139737|17072447|P1|Overall Study|Lack of Efficacy|40
4967423|NCT00139737|17072447|P1|Overall Study|Adverse Event|58
4967424|NCT00139737|17072447|P1|Overall Study|Withdrawal by Subject|190
4967425|NCT00139659|17072453|P2|Overall Study|Withdrawal by Subject|10
4967426|NCT00139659|17072454|P1|Overall Study|Withdrawal by Subject|14
4967427|NCT00139659|17072453|P2|Overall Study|Reason not Specified|3
4967428|NCT00139659|17072454|P1|Overall Study|Reason not Specified|6
4967429|NCT00139659|17072453|P2|Overall Study|Lost to Follow-up|3
4967430|NCT00139659|17072454|P1|Overall Study|Lost to Follow-up|7
4967431|NCT00139659|17072453|P2|Overall Study|Lack of Efficacy|1
4967432|NCT00139659|17072454|P1|Overall Study|Lack of Efficacy|1
4967433|NCT00139659|17072453|P2|Overall Study|Adverse Event|1
4967434|NCT00139659|17072454|P1|Overall Study|Adverse Event|12
4967435|NCT00139477|17072532|P2|Second Intervention -6Months to 12Months|Lost to Follow-up|3
4967436|NCT00139477|17072533|P1|Second Intervention -6Months to 12Months|Lost to Follow-up|4
4967437|NCT00139477|17072532|P2|Second Intervention -6Months to 12Months|Relocation|0
4967438|NCT00139477|17072533|P1|Second Intervention -6Months to 12Months|Relocation|1
4967439|NCT00139477|17072532|P2|Second Intervention -6Months to 12Months|No Longer Interested|2
4967440|NCT00139477|17072533|P1|Second Intervention -6Months to 12Months|No Longer Interested|0
4967441|NCT00139477|17072532|P2|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0
4967442|NCT00139477|17072533|P1|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2
4967443|NCT00139477|17072532|P2|First Intervention -Baseline to 6Months|Lost to Follow-up|3
4967444|NCT00139477|17072533|P1|First Intervention -Baseline to 6Months|Lost to Follow-up|3
4967445|NCT00139477|17072532|P2|First Intervention -Baseline to 6Months|Relocation|2
4967446|NCT00139477|17072533|P1|First Intervention -Baseline to 6Months|Relocation|1
4967447|NCT00139477|17072532|P2|First Intervention -Baseline to 6Months|No Longer Interested|7
4967448|NCT00139477|17072533|P1|First Intervention -Baseline to 6Months|No Longer Interested|6
4967449|NCT00138671|17072568|P2|Overall Study|Other|3
4967450|NCT00138671|17072569|P1|Overall Study|Other|3
4967451|NCT00138671|17072568|P2|Overall Study|Withdrawal by Subject|5
4967452|NCT00138671|17072569|P1|Overall Study|Withdrawal by Subject|3
4967453|NCT00138671|17072568|P2|Overall Study|Lost to Follow-up|2
4967454|NCT00138671|17072569|P1|Overall Study|Lost to Follow-up|1
4967455|NCT00138671|17072568|P2|Overall Study|Adverse Event|3
4967456|NCT00138671|17072569|P1|Overall Study|Adverse Event|6
4967457|NCT00138671|17072568|P2|Overall Study|Death|3
4967458|NCT00138671|17072569|P1|Overall Study|Death|0
4967459|NCT00138658|17072619|P1|Overall Study|Withdrawal by Subject|5
4967460|NCT00138658|17072619|P1|Overall Study|Physician Decision|11
4967461|NCT00138658|17072619|P1|Overall Study|Disease Progression|21
4967462|NCT00138658|17072619|P1|Overall Study|Death|1
4967463|NCT00138658|17072619|P1|Overall Study|Adverse Event|23
4967464|NCT00138424|17072642|P4|Overall Study|Physician Decision|0
4967465|NCT00138424|17072643|P3|Overall Study|Physician Decision|0
4967466|NCT00138424|17072644|P2|Overall Study|Physician Decision|1
4967467|NCT00138424|17072645|P1|Overall Study|Physician Decision|0
4967468|NCT00138151|17072728|P1|Overall Study|Physician Decision|1
4967469|NCT00138151|17072728|P1|Overall Study|Withdrawal by Subject|3
4967470|NCT00138073|17072743|P1|Overall Study|lack of resources|55
4967471|NCT00137839|17072782|P1|Overall Study|Prolonged Treatment Delay|1
4967472|NCT00137839|17072782|P1|Overall Study|Not Start Treatment|1
4967473|NCT00137839|17072782|P1|Overall Study|Disease Progression|60
4967474|NCT00137839|17072782|P1|Overall Study|Death|8
4967475|NCT00137839|17072782|P1|Overall Study|Physician Decision|7
4967476|NCT00137839|17072782|P1|Overall Study|Adverse Event|7
4967477|NCT00137631|17072795|P2|Overall Study|Lost to Follow-up|41
4967478|NCT00137631|17072796|P1|Overall Study|Lost to Follow-up|37
4967479|NCT00137449|17072812|P2|Overall Study|Withdrawal by Subject|1
4967480|NCT00137449|17072813|P1|Overall Study|Withdrawal by Subject|1
4967481|NCT00137449|17072812|P2|Overall Study|Adverse Event|1
4967482|NCT00137449|17072813|P1|Overall Study|Adverse Event|3
4967483|NCT00137449|17072812|P2|Overall Study|Death|3
4967484|NCT00137449|17072813|P1|Overall Study|Death|4
4967485|NCT00137449|17072812|P2|Overall Study|Disease Progression|13
4967486|NCT00137449|17072813|P1|Overall Study|Disease Progression|8
4967487|NCT00137436|17072850|P1|Overall Study|Other|5
4967488|NCT00137436|17072850|P1|Overall Study|Withdrawal by Subject|6
4967489|NCT00137436|17072850|P1|Overall Study|Lack of Efficacy|17
4967490|NCT00137436|17072850|P1|Overall Study|Death|2
4967491|NCT00137436|17072850|P1|Overall Study|Adverse Event|13
4967492|NCT00137423|17072869|P2|Overall Study|Death|1
4967493|NCT00137423|17072870|P1|Overall Study|Death|0
4967494|NCT00137423|17072869|P2|Overall Study|Lack of Efficacy|33
4967495|NCT00137423|17072870|P1|Overall Study|Lack of Efficacy|31
4967496|NCT00137423|17072869|P2|Overall Study|consent withdrawn|1
4967497|NCT00137423|17072870|P1|Overall Study|consent withdrawn|1
4967498|NCT00137423|17072869|P2|Overall Study|Adverse Event|9
4967499|NCT00137423|17072870|P1|Overall Study|Adverse Event|7
4967500|NCT00137267|17072907|P2|Overall Study|Lost to Follow-up|21
4967501|NCT00137267|17072908|P1|Overall Study|Lost to Follow-up|15
4967502|NCT00137111|17072920|P4|Total Therapy|Non Compliance|0
4967503|NCT00137111|17072921|P3|Total Therapy|Non Compliance|0
4967504|NCT00137111|17072922|P2|Total Therapy|Non Compliance|0
4967505|NCT00137111|17072923|P1|Total Therapy|Non Compliance|5
4967506|NCT00137111|17072920|P4|Total Therapy|Death|0
4967507|NCT00137111|17072921|P3|Total Therapy|Death|0
4967508|NCT00137111|17072922|P2|Total Therapy|Death|0
4967509|NCT00137111|17072923|P1|Total Therapy|Death|35
4967510|NCT00137046|17072937|P2|Overall Study|Withdrew prior to study treatment|1
4967511|NCT00137046|17072938|P1|Overall Study|Withdrew prior to study treatment|1
4967512|NCT00137046|17072937|P2|Overall Study|Adverse Event 4 Days after Last Dose|0
4967513|NCT00137046|17072938|P1|Overall Study|Adverse Event 4 Days after Last Dose|1
4967514|NCT00137046|17072937|P2|Overall Study|Withdrawal by Subject|42
4967515|NCT00137046|17072938|P1|Overall Study|Withdrawal by Subject|33
4967516|NCT00137046|17072937|P2|Overall Study|Other|19
4967517|NCT00137046|17072938|P1|Overall Study|Other|23
4967518|NCT00137046|17072937|P2|Overall Study|Lost to Follow-up|24
4967519|NCT00137046|17072938|P1|Overall Study|Lost to Follow-up|8
4967520|NCT00137046|17072937|P2|Overall Study|Lack of Efficacy|1
4967521|NCT00137046|17072938|P1|Overall Study|Lack of Efficacy|13
4967522|NCT00137046|17072937|P2|Overall Study|Laboratory Abnormality|0
4967523|NCT00137046|17072938|P1|Overall Study|Laboratory Abnormality|2
4967524|NCT00137046|17072937|P2|Overall Study|Adverse Event|5
4967525|NCT00137046|17072938|P1|Overall Study|Adverse Event|16
4967526|NCT00137046|17072937|P2|Overall Study|Death|1
4967527|NCT00137046|17072938|P1|Overall Study|Death|2
4967528|NCT00136955|17072986|P1|Overall Study|Incl. prog. disease, protocol violation|12
4967529|NCT00136955|17072986|P1|Overall Study|Withdrawal by Subject|2
4967530|NCT00136955|17072986|P1|Overall Study|Lost to Follow-up|1
4967531|NCT00136955|17072986|P1|Overall Study|Adverse Event|8
4967532|NCT00136916|17072995|P2|Overall Study|Discontinued in follow up period|0
4967533|NCT00136916|17072996|P1|Overall Study|Discontinued in follow up period|3
4967534|NCT00136916|17072995|P2|Overall Study|Other|24
4967535|NCT00136916|17072996|P1|Overall Study|Other|22
4967536|NCT00136916|17072995|P2|Overall Study|Withdrawal by Subject|46
4967537|NCT00136916|17072996|P1|Overall Study|Withdrawal by Subject|44
4967538|NCT00136916|17072995|P2|Overall Study|Lost to Follow-up|14
4967539|NCT00136916|17072996|P1|Overall Study|Lost to Follow-up|12
4967540|NCT00136916|17072995|P2|Overall Study|Lack of Efficacy|3
4967541|NCT00136916|17072996|P1|Overall Study|Lack of Efficacy|13
4967542|NCT00136916|17072995|P2|Overall Study|Laboratory abnormality|1
4967543|NCT00136916|17072996|P1|Overall Study|Laboratory abnormality|0
4967544|NCT00136916|17072995|P2|Overall Study|Adverse Event|8
4967545|NCT00136916|17072996|P1|Overall Study|Adverse Event|27
4967546|NCT00136916|17072995|P2|Overall Study|Death|3
4967547|NCT00136916|17072996|P1|Overall Study|Death|1
4967548|NCT00136916|17072995|P2|Overall Study|Never received study treatment|5
4967549|NCT00136916|17072996|P1|Overall Study|Never received study treatment|3
4967550|NCT00136604|17073103|P5|Overall Study|Migrated/moved from study area|0
4967551|NCT00136604|17073104|P4|Overall Study|Migrated/moved from study area|0
4967552|NCT00136604|17073105|P3|Overall Study|Migrated/moved from study area|0
4967553|NCT00136604|17073106|P2|Overall Study|Migrated/moved from study area|1
4967554|NCT00136604|17073107|P1|Overall Study|Migrated/moved from study area|0
4967555|NCT00136604|17073103|P5|Overall Study|Lost to Follow-up|1
4967556|NCT00136604|17073104|P4|Overall Study|Lost to Follow-up|0
4967557|NCT00136604|17073105|P3|Overall Study|Lost to Follow-up|0
4967558|NCT00136604|17073106|P2|Overall Study|Lost to Follow-up|0
4967559|NCT00136604|17073107|P1|Overall Study|Lost to Follow-up|1
4967560|NCT00136357|17073215|P2|Overall Study|Withdrawal by Subject|2
4967561|NCT00136357|17073216|P1|Overall Study|Withdrawal by Subject|3
4967562|NCT00136318|17073224|P2|Overall Study|Withdrawal by Subject|2
4967563|NCT00136318|17073225|P1|Overall Study|Withdrawal by Subject|2
4967564|NCT00136318|17073224|P2|Overall Study|Adverse Event|5
4967565|NCT00136318|17073225|P1|Overall Study|Adverse Event|5
4967566|NCT00136084|17073252|P2|Overall Study|Withdrawal by Subject|1
4967567|NCT00136084|17073253|P1|Overall Study|Withdrawal by Subject|5
4967568|NCT00136084|17073252|P2|Overall Study|No Response|2
4967569|NCT00136084|17073253|P1|Overall Study|No Response|1
4967570|NCT00136084|17073252|P2|Overall Study|Lost to Follow-up|0
4967571|NCT00136084|17073253|P1|Overall Study|Lost to Follow-up|2
4967572|NCT00136084|17073252|P2|Overall Study|Relapse|23
4967573|NCT00136084|17073253|P1|Overall Study|Relapse|20
4967574|NCT00136084|17073252|P2|Overall Study|Unacceptable toxicity|11
4967575|NCT00136084|17073253|P1|Overall Study|Unacceptable toxicity|8
4967576|NCT00136084|17073252|P2|Overall Study|Death|5
4967577|NCT00136084|17073253|P1|Overall Study|Death|12
4967578|NCT00135707|17073289|P2|Overall Study|Institutional review board request|0
4967579|NCT00135707|17073290|P1|Overall Study|Institutional review board request|1
4967580|NCT00135707|17073289|P2|Overall Study|Withdrawal by Subject|1
4967581|NCT00135707|17073290|P1|Overall Study|Withdrawal by Subject|0
4967582|NCT00135707|17073289|P2|Overall Study|Lost to Follow-up|89
4967583|NCT00135707|17073290|P1|Overall Study|Lost to Follow-up|94
4967584|NCT00135694|17073373|P3|Overall Study|Ineligible for Random assignment|0
4967585|NCT00135694|17073374|P2|Overall Study|Ineligible for Random assignment|0
4967586|NCT00135694|17073375|P1|Overall Study|Ineligible for Random assignment|42
4967587|NCT00135694|17073373|P3|Overall Study|Hepatitis C related reasons|0
4967588|NCT00135694|17073374|P2|Overall Study|Hepatitis C related reasons|1
4967589|NCT00135694|17073375|P1|Overall Study|Hepatitis C related reasons|39
4967590|NCT00135694|17073373|P3|Overall Study|Protocol Violation|0
4967591|NCT00135694|17073374|P2|Overall Study|Protocol Violation|1
4967592|NCT00135694|17073375|P1|Overall Study|Protocol Violation|19
4967593|NCT00135694|17073373|P3|Overall Study|Withdrawal by Subject|4
4967594|NCT00135694|17073374|P2|Overall Study|Withdrawal by Subject|7
4967595|NCT00135694|17073375|P1|Overall Study|Withdrawal by Subject|41
4967596|NCT00135694|17073373|P3|Overall Study|Lost to Follow-up|1
4967597|NCT00135694|17073374|P2|Overall Study|Lost to Follow-up|7
4967598|NCT00135694|17073375|P1|Overall Study|Lost to Follow-up|8
4967599|NCT00135694|17073373|P3|Overall Study|Death|2
4967600|NCT00135694|17073374|P2|Overall Study|Death|1
4967601|NCT00135694|17073375|P1|Overall Study|Death|14
4967602|NCT00135694|17073373|P3|Overall Study|Adverse Event|0
4967603|NCT00135694|17073374|P2|Overall Study|Adverse Event|4
4967604|NCT00135694|17073375|P1|Overall Study|Adverse Event|17
4967605|NCT00135512|17073393|P1|Overall Study|Other|42
4967606|NCT00135512|17073393|P1|Overall Study|Lack of Efficacy|25
4967607|NCT00135512|17073393|P1|Overall Study|Adverse Event|56
4967608|NCT00135356|17073405|P2|Overall Study|Withdrawal by Subject|4
4967609|NCT00135356|17073406|P1|Overall Study|Withdrawal by Subject|2
4967610|NCT00135356|17073405|P2|Overall Study|No longer meets study criteria|0
4967611|NCT00135356|17073406|P1|Overall Study|No longer meets study criteria|2
4967612|NCT00135356|17073405|P2|Overall Study|Poor/noncompliance|1
4967613|NCT00135356|17073406|P1|Overall Study|Poor/noncompliance|1
4967614|NCT00135356|17073405|P2|Overall Study|Change in antiviral regimen|1
4967615|NCT00135356|17073406|P1|Overall Study|Change in antiviral regimen|0
4967616|NCT00135356|17073405|P2|Overall Study|Surgery for abdominal fat|0
4967617|NCT00135356|17073406|P1|Overall Study|Surgery for abdominal fat|1
4967618|NCT00135356|17073405|P2|Overall Study|Lost to Follow-up|1
4967619|NCT00135356|17073406|P1|Overall Study|Lost to Follow-up|3
4967620|NCT00135356|17073405|P2|Overall Study|Lack of Efficacy|0
4967621|NCT00135356|17073406|P1|Overall Study|Lack of Efficacy|2
4967622|NCT00135356|17073405|P2|Overall Study|Adverse Event|2
4967623|NCT00135356|17073406|P1|Overall Study|Adverse Event|6
4967624|NCT00135330|17073449|P3|Overall Study|Sponsor Decision|0
4967625|NCT00135330|17073450|P2|Overall Study|Sponsor Decision|1
4967626|NCT00135330|17073451|P1|Overall Study|Sponsor Decision|0
4967627|NCT00135330|17073449|P3|Overall Study|Patient Decision|4
4967628|NCT00135330|17073450|P2|Overall Study|Patient Decision|1
4967629|NCT00135330|17073451|P1|Overall Study|Patient Decision|5
4967630|NCT00135330|17073449|P3|Overall Study|Protocol Violation|3
4967631|NCT00135330|17073450|P2|Overall Study|Protocol Violation|3
4967632|NCT00135330|17073451|P1|Overall Study|Protocol Violation|4
4967633|NCT00135330|17073449|P3|Overall Study|Physician Decision|0
4967634|NCT00135330|17073450|P2|Overall Study|Physician Decision|1
4967635|NCT00135330|17073451|P1|Overall Study|Physician Decision|1
4967636|NCT00135330|17073449|P3|Overall Study|Lost to Follow-up|3
4967637|NCT00135330|17073450|P2|Overall Study|Lost to Follow-up|2
4967638|NCT00135330|17073451|P1|Overall Study|Lost to Follow-up|0
4967639|NCT00135330|17073449|P3|Overall Study|Adverse Event|1
4967640|NCT00135330|17073450|P2|Overall Study|Adverse Event|5
4967641|NCT00135330|17073451|P1|Overall Study|Adverse Event|2
4967642|NCT00134901|17073649|P2|Overall Study|discontinued intervention|10
4967643|NCT00134901|17073650|P1|Overall Study|discontinued intervention|12
4967644|NCT00134901|17073649|P2|Overall Study|Lost to Follow-up|5
4967645|NCT00134901|17073650|P1|Overall Study|Lost to Follow-up|5
4967646|NCT00134784|17073662|P4|Overall Study|Withdrawal by Subject|1
4967647|NCT00134784|17073663|P3|Overall Study|Withdrawal by Subject|2
4967648|NCT00134784|17073664|P2|Overall Study|Withdrawal by Subject|2
4967649|NCT00134784|17073665|P1|Overall Study|Withdrawal by Subject|2
4967650|NCT00134719|17073675|P3|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
4967651|NCT00134719|17073676|P2|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0
4967652|NCT00134719|17073677|P1|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1
4967653|NCT00134719|17073675|P3|Fourth Dose Vaccination Phase|Lost to Follow-up|1
4967654|NCT00134719|17073676|P2|Fourth Dose Vaccination Phase|Lost to Follow-up|3
4967655|NCT00134719|17073677|P1|Fourth Dose Vaccination Phase|Lost to Follow-up|1
4967656|NCT00134719|17073675|P3|Primary Vaccination Phase|Lost to Follow-up|3
4967657|NCT00134719|17073676|P2|Primary Vaccination Phase|Lost to Follow-up|3
4967658|NCT00134719|17073677|P1|Primary Vaccination Phase|Lost to Follow-up|7
4967659|NCT00134719|17073675|P3|Primary Vaccination Phase|Withdrawal by Subject|2
4967660|NCT00134719|17073676|P2|Primary Vaccination Phase|Withdrawal by Subject|3
4967661|NCT00134719|17073677|P1|Primary Vaccination Phase|Withdrawal by Subject|2
4967662|NCT00134719|17073675|P3|Primary Vaccination Phase|Protocol Violation|0
4967663|NCT00134719|17073676|P2|Primary Vaccination Phase|Protocol Violation|0
4967664|NCT00134719|17073677|P1|Primary Vaccination Phase|Protocol Violation|1
4967665|NCT00134719|17073675|P3|Primary Vaccination Phase|Adverse Event|0
4967666|NCT00134719|17073676|P2|Primary Vaccination Phase|Adverse Event|0
4967667|NCT00134719|17073677|P1|Primary Vaccination Phase|Adverse Event|4
4967668|NCT00134563|17073808|P3|Overall Study|Reason other than above|5
4967669|NCT00134563|17073809|P2|Overall Study|Reason other than above|2
4967670|NCT00134563|17073810|P1|Overall Study|Reason other than above|0
4967671|NCT00134563|17073808|P3|Overall Study|did not wish to continue|26
4967672|NCT00134563|17073809|P2|Overall Study|did not wish to continue|32
4967673|NCT00134563|17073810|P1|Overall Study|did not wish to continue|33
4967674|NCT00134563|17073808|P3|Overall Study|progressive disease|2
4967675|NCT00134563|17073809|P2|Overall Study|progressive disease|4
4967676|NCT00134563|17073810|P1|Overall Study|progressive disease|11
4967677|NCT00134563|17073808|P3|Overall Study|Lost to Follow-up|2
4967678|NCT00134563|17073809|P2|Overall Study|Lost to Follow-up|0
4967679|NCT00134563|17073810|P1|Overall Study|Lost to Follow-up|4
4967680|NCT00134563|17073808|P3|Overall Study|Protocol Violation|5
4967681|NCT00134563|17073809|P2|Overall Study|Protocol Violation|2
4967682|NCT00134563|17073810|P1|Overall Study|Protocol Violation|3
4967683|NCT00134563|17073808|P3|Overall Study|Lack of Efficacy|17
4967684|NCT00134563|17073809|P2|Overall Study|Lack of Efficacy|14
4967685|NCT00134563|17073810|P1|Overall Study|Lack of Efficacy|24
4967686|NCT00134563|17073808|P3|Overall Study|Adverse Event|38
4967687|NCT00134563|17073809|P2|Overall Study|Adverse Event|37
4967688|NCT00134563|17073810|P1|Overall Study|Adverse Event|29
4967689|NCT00134563|17073808|P3|Overall Study|Not treated due to protocol violation|1
4967690|NCT00134563|17073809|P2|Overall Study|Not treated due to protocol violation|1
4967691|NCT00134563|17073810|P1|Overall Study|Not treated due to protocol violation|0
4967692|NCT00134082|17073871|P1|Overall Study|Death|1
4967693|NCT00134082|17073871|P1|Overall Study|Adverse Event|2
4967694|NCT00134056|17073880|P2|Eligible for Protocol Assigned Treatment|Other|56
4967695|NCT00134056|17073881|P1|Eligible for Protocol Assigned Treatment|Other|55
4967696|NCT00134056|17073880|P2|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21
4967697|NCT00134056|17073881|P1|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20
4967698|NCT00134056|17073880|P2|Eligible for Protocol Assigned Treatment|Adverse Event|67
4967699|NCT00134056|17073881|P1|Eligible for Protocol Assigned Treatment|Adverse Event|81
4967700|NCT00134056|17073880|P2|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
4967701|NCT00134056|17073881|P1|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171
4967702|NCT00134056|17073880|P2|Randomization|Not eligible for assigned treatment|20
4967703|NCT00134056|17073881|P1|Randomization|Not eligible for assigned treatment|22
4967704|NCT00133991|17073925|P1|Overall Study|Death|4
4967705|NCT00133952|17073964|P2|Overall Study|Sponsor Decision|1
4967706|NCT00133952|17073965|P1|Overall Study|Sponsor Decision|0
4967707|NCT00133952|17073964|P2|Overall Study|Physician Decision|3
4967708|NCT00133952|17073965|P1|Overall Study|Physician Decision|4
4967709|NCT00133952|17073964|P2|Overall Study|Withdrawal by Subject|4
4967710|NCT00133952|17073965|P1|Overall Study|Withdrawal by Subject|20
4967711|NCT00133952|17073964|P2|Overall Study|Protocol Violation|1
4967712|NCT00133952|17073965|P1|Overall Study|Protocol Violation|1
4967713|NCT00133952|17073964|P2|Overall Study|Protocol Entry Criteria Exclusion|1
4967714|NCT00133952|17073965|P1|Overall Study|Protocol Entry Criteria Exclusion|4
4967715|NCT00133952|17073964|P2|Overall Study|Lost to Follow-up|14
4967716|NCT00133952|17073965|P1|Overall Study|Lost to Follow-up|9
4967717|NCT00133952|17073964|P2|Overall Study|Death|2
4967718|NCT00133952|17073965|P1|Overall Study|Death|3
4967719|NCT00133952|17073964|P2|Overall Study|Adverse Event|2
4967720|NCT00133952|17073965|P1|Overall Study|Adverse Event|1
4967721|NCT00133705|17073996|P2|Overall Study|Withdrawal by Subject|3
4967722|NCT00133705|17073997|P1|Overall Study|Withdrawal by Subject|2
4967723|NCT00132873|17074132|P1|Overall Study|Planned Pregnancy|1
4967724|NCT00132873|17074132|P1|Overall Study|Withdrawal by Subject|3
4967725|NCT00132873|17074132|P1|Overall Study|Lack of Efficacy|1
4967726|NCT00132873|17074132|P1|Overall Study|Lost to Follow-up|1
4967727|NCT00132873|17074132|P1|Overall Study|Adverse Event|3
4967728|NCT00132808|17074140|P3|Stratum II|Withdrawal by Subject|6
4967729|NCT00132808|17074141|P2|Stratum II|Withdrawal by Subject|9
4967730|NCT00132808|17074142|P1|Stratum II|Withdrawal by Subject|4
4967731|NCT00132808|17074140|P3|Stratum II|Protocol Violation|1
4967732|NCT00132808|17074141|P2|Stratum II|Protocol Violation|2
4967733|NCT00132808|17074142|P1|Stratum II|Protocol Violation|0
4967734|NCT00132808|17074140|P3|Stratum II|Lost to Follow-up|1
4967735|NCT00132808|17074141|P2|Stratum II|Lost to Follow-up|2
4967736|NCT00132808|17074142|P1|Stratum II|Lost to Follow-up|2
4967737|NCT00132808|17074140|P3|Stratum II|Death|0
4967738|NCT00132808|17074141|P2|Stratum II|Death|0
4967739|NCT00132808|17074142|P1|Stratum II|Death|1
4967740|NCT00132808|17074140|P3|Stratum II|Adverse Event|1
4967741|NCT00132808|17074141|P2|Stratum II|Adverse Event|2
4967742|NCT00132808|17074142|P1|Stratum II|Adverse Event|1
4967743|NCT00132808|17074140|P3|Stratum I|Abnormal test procedure result (s)|1
4967744|NCT00132808|17074141|P2|Stratum I|Abnormal test procedure result (s)|0
4967745|NCT00132808|17074142|P1|Stratum I|Abnormal test procedure result (s)|0
4967746|NCT00132808|17074140|P3|Stratum I|Withdrawal by Subject|3
4967747|NCT00132808|17074141|P2|Stratum I|Withdrawal by Subject|7
4967748|NCT00132808|17074142|P1|Stratum I|Withdrawal by Subject|4
4967749|NCT00132808|17074140|P3|Stratum I|Lost to Follow-up|1
4967750|NCT00132808|17074141|P2|Stratum I|Lost to Follow-up|4
4967751|NCT00132808|17074142|P1|Stratum I|Lost to Follow-up|3
4967752|NCT00132808|17074140|P3|Stratum I|Adverse Event|0
4967753|NCT00132808|17074141|P2|Stratum I|Adverse Event|1
4967754|NCT00132808|17074142|P1|Stratum I|Adverse Event|2
4967755|NCT00132769|17074167|P2|Overall Study|Protocol Violation|1
4967756|NCT00132769|17074168|P1|Overall Study|Protocol Violation|1
4967757|NCT00132769|17074167|P2|Overall Study|Adverse Event|1
4967758|NCT00132769|17074168|P1|Overall Study|Adverse Event|2
4967759|NCT00132769|17074167|P2|Overall Study|Lack of Efficacy|6
4967760|NCT00132769|17074168|P1|Overall Study|Lack of Efficacy|7
4967761|NCT00132769|17074167|P2|Overall Study|Withdrawal by Subject|3
4967762|NCT00132769|17074168|P1|Overall Study|Withdrawal by Subject|1
4967763|NCT00132730|17074194|P6|Period V - Open-label Extension (EXT2)|Site terminated|2
4967764|NCT00132730|17074195|P5|Period V - Open-label Extension (EXT2)|Site terminated|7
4967765|NCT00132730|17074196|P4|Period V - Open-label Extension (EXT2)|Site terminated|0
4967766|NCT00132730|17074197|P3|Period V - Open-label Extension (EXT2)|Site terminated|0
4967767|NCT00132730|17074198|P2|Period V - Open-label Extension (EXT2)|Site terminated|0
4967768|NCT00132730|17074199|P1|Period V - Open-label Extension (EXT2)|Site terminated|0
4967769|NCT00132730|17074194|P6|Period IV - Open-label Extension (EXT2)|Other reasons|0
4967770|NCT00132730|17074195|P5|Period IV - Open-label Extension (EXT2)|Other reasons|6
4967771|NCT00132730|17074196|P4|Period IV - Open-label Extension (EXT2)|Other reasons|0
4967772|NCT00132730|17074197|P3|Period IV - Open-label Extension (EXT2)|Other reasons|0
4967773|NCT00132730|17074198|P2|Period IV - Open-label Extension (EXT2)|Other reasons|0
4967774|NCT00132730|17074199|P1|Period IV - Open-label Extension (EXT2)|Other reasons|0
4967775|NCT00132730|17074194|P6|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4967776|NCT00132730|17074195|P5|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1
4967777|NCT00132730|17074196|P4|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4967778|NCT00132730|17074197|P3|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4967779|NCT00132730|17074198|P2|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4967780|NCT00132730|17074199|P1|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0
4967781|NCT00132730|17074194|P6|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4967782|NCT00132730|17074195|P5|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3
4967783|NCT00132730|17074196|P4|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4967784|NCT00132730|17074197|P3|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4967785|NCT00132730|17074198|P2|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4967786|NCT00132730|17074199|P1|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0
4967787|NCT00132730|17074194|P6|Period IV - Open-label Extension (EXT2)|Site terminated|68
4967788|NCT00132730|17074195|P5|Period IV - Open-label Extension (EXT2)|Site terminated|169
4967789|NCT00132730|17074196|P4|Period IV - Open-label Extension (EXT2)|Site terminated|0
4967790|NCT00132730|17074197|P3|Period IV - Open-label Extension (EXT2)|Site terminated|0
4967791|NCT00132730|17074198|P2|Period IV - Open-label Extension (EXT2)|Site terminated|0
4967792|NCT00132730|17074199|P1|Period IV - Open-label Extension (EXT2)|Site terminated|0
4967793|NCT00132730|17074194|P6|Period III - Blinded Extension (EXT1)|Other reasons|0
4967794|NCT00132730|17074195|P5|Period III - Blinded Extension (EXT1)|Other reasons|0
4967795|NCT00132730|17074196|P4|Period III - Blinded Extension (EXT1)|Other reasons|3
4967796|NCT00132730|17074197|P3|Period III - Blinded Extension (EXT1)|Other reasons|14
4967797|NCT00132730|17074198|P2|Period III - Blinded Extension (EXT1)|Other reasons|0
4967798|NCT00132730|17074199|P1|Period III - Blinded Extension (EXT1)|Other reasons|0
4967799|NCT00132730|17074194|P6|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4967800|NCT00132730|17074195|P5|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4967801|NCT00132730|17074196|P4|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1
4967802|NCT00132730|17074197|P3|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4967803|NCT00132730|17074198|P2|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4967804|NCT00132730|17074199|P1|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0
4967805|NCT00132730|17074194|P6|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4967806|NCT00132730|17074195|P5|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4967807|NCT00132730|17074196|P4|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1
4967808|NCT00132730|17074197|P3|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11
4967809|NCT00132730|17074198|P2|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4967810|NCT00132730|17074199|P1|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0
4967811|NCT00132730|17074194|P6|Period III - Blinded Extension (EXT1)|Site terminated|0
4967812|NCT00132730|17074195|P5|Period III - Blinded Extension (EXT1)|Site terminated|0
4967813|NCT00132730|17074196|P4|Period III - Blinded Extension (EXT1)|Site terminated|20
4967814|NCT00132730|17074197|P3|Period III - Blinded Extension (EXT1)|Site terminated|57
4967815|NCT00132730|17074198|P2|Period III - Blinded Extension (EXT1)|Site terminated|0
4967816|NCT00132730|17074199|P1|Period III - Blinded Extension (EXT1)|Site terminated|0
4967817|NCT00132730|17074194|P6|Period II - 12-week Treatment (Base)|Other reasons|0
4967818|NCT00132730|17074195|P5|Period II - 12-week Treatment (Base)|Other reasons|0
4967819|NCT00132730|17074196|P4|Period II - 12-week Treatment (Base)|Other reasons|13
4967820|NCT00132730|17074197|P3|Period II - 12-week Treatment (Base)|Other reasons|9
4967821|NCT00132730|17074198|P2|Period II - 12-week Treatment (Base)|Other reasons|10
4967822|NCT00132730|17074199|P1|Period II - 12-week Treatment (Base)|Other reasons|11
4967823|NCT00132730|17074194|P6|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4967824|NCT00132730|17074195|P5|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4967825|NCT00132730|17074196|P4|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4967826|NCT00132730|17074197|P3|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0
4967827|NCT00132730|17074198|P2|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
4967828|NCT00132730|17074199|P1|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1
4967829|NCT00132730|17074194|P6|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
4967830|NCT00132730|17074195|P5|Period II - 12-week Treatment (Base)|Clinical adverse experience|0
4967831|NCT00132730|17074196|P4|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
4967832|NCT00132730|17074197|P3|Period II - 12-week Treatment (Base)|Clinical adverse experience|9
4967833|NCT00132730|17074198|P2|Period II - 12-week Treatment (Base)|Clinical adverse experience|4
4967834|NCT00132730|17074199|P1|Period II - 12-week Treatment (Base)|Clinical adverse experience|11
4967835|NCT00132691|17074243|P2|Overall Study|Death|0
4967836|NCT00132691|17074244|P1|Overall Study|Death|2
4967837|NCT00132691|17074243|P2|Overall Study|Missed 2-year visit|4
4967838|NCT00132691|17074244|P1|Overall Study|Missed 2-year visit|4
4967839|NCT00132691|17074243|P2|Overall Study|Lost to Follow-up|8
4967840|NCT00132691|17074244|P1|Overall Study|Lost to Follow-up|5
4967841|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Pregnancy|0
4967842|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Pregnancy|2
4967843|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Pregnancy|0
4967844|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Subject Non-compliant|0
4967845|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Subject Non-compliant|1
4967846|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Subject Non-compliant|2
4967847|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Physician Decision|0
4967848|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Physician Decision|14
4967849|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Physician Decision|10
4967850|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0
4967851|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15
4967852|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14
4967853|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Lost to Follow-up|0
4967854|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Lost to Follow-up|3
4967855|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Lost to Follow-up|6
4967856|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0
4967857|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
4967858|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4
4967859|NCT00132678|17074284|P3|Period IV (Double-Blind Treatment)|Adverse Event|0
4967860|NCT00132678|17074285|P2|Period IV (Double-Blind Treatment)|Adverse Event|1
4967861|NCT00132678|17074286|P1|Period IV (Double-Blind Treatment)|Adverse Event|1
4967862|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Pregnancy|0
4967863|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Pregnancy|0
4967864|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Pregnancy|2
4967865|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Physician Decision|0
4967866|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Physician Decision|0
4967867|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Physician Decision|1
4967868|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Subject non-compliant|0
4967869|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Subject non-compliant|0
4967870|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Subject non-compliant|1
4967871|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
4967872|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Withdrawal by Subject|0
4967873|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Withdrawal by Subject|49
4967874|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Lost to Follow-up|0
4967875|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Lost to Follow-up|0
4967876|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Lost to Follow-up|19
4967877|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
4967878|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Ineligible to continue trial|0
4967879|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Ineligible to continue trial|5
4967880|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Non responder|0
4967881|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Non responder|0
4967882|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Non responder|107
4967883|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Adverse Event|0
4967884|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Adverse Event|0
4967885|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Adverse Event|12
4967886|NCT00132678|17074284|P3|Period III (Open-Label Stabilization)|Death|0
4967887|NCT00132678|17074285|P2|Period III (Open-Label Stabilization)|Death|0
4967888|NCT00132678|17074286|P1|Period III (Open-Label Stabilization)|Death|2
4967889|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Physician Decision|1
4968132|NCT00130520|17074723|P1|Overall Study|Physician Decision|1
4967890|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Physician Decision|0
4967891|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Physician Decision|0
4967892|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16
4967893|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
4967894|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0
4967895|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14
4967896|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
4967897|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0
4967898|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7
4967899|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
4967900|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0
4967901|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Non responder|6
4967902|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Non responder|0
4967903|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Non responder|0
4967904|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Adverse Event|13
4967905|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Adverse Event|0
4967906|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Adverse Event|0
4967907|NCT00132678|17074284|P3|Period II (Open-Label Oral Risperidone)|Death|1
4967908|NCT00132678|17074285|P2|Period II (Open-Label Oral Risperidone)|Death|0
4967909|NCT00132678|17074286|P1|Period II (Open-Label Oral Risperidone)|Death|0
4967910|NCT00132496|17074300|P2|Overall Study|Physician Decision|0
4967911|NCT00132496|17074301|P1|Overall Study|Physician Decision|1
4967912|NCT00132496|17074300|P2|Overall Study|Withdrawal by Subject|2
4967913|NCT00132496|17074301|P1|Overall Study|Withdrawal by Subject|1
4967914|NCT00132314|17074309|P2|Overall Study|Refused intervention at baseline|7
4967915|NCT00132314|17074310|P1|Overall Study|Refused intervention at baseline|2
4967916|NCT00132314|17074309|P2|Overall Study|Lacked SSN|3
4967917|NCT00132314|17074310|P1|Overall Study|Lacked SSN|1
4967918|NCT00132314|17074309|P2|Overall Study|Lost to Follow-up|62
4967919|NCT00132314|17074310|P1|Overall Study|Lost to Follow-up|70
4967920|NCT00132301|17074320|P2|Overall Study|Excluded by Data Monitoring Committee|0
4967921|NCT00132301|17074321|P1|Overall Study|Excluded by Data Monitoring Committee|1
4967922|NCT00132301|17074320|P2|Overall Study|Other|1
4967923|NCT00132301|17074321|P1|Overall Study|Other|1
4967924|NCT00132301|17074320|P2|Overall Study|Lost to Follow-up|3
4967925|NCT00132301|17074321|P1|Overall Study|Lost to Follow-up|5
4967926|NCT00132301|17074320|P2|Overall Study|Physician Decision|1
4967927|NCT00132301|17074321|P1|Overall Study|Physician Decision|1
4967928|NCT00132301|17074320|P2|Overall Study|Withdrawal by Subject|2
4967929|NCT00132301|17074321|P1|Overall Study|Withdrawal by Subject|5
4967930|NCT00132301|17074320|P2|Overall Study|Death|6
4967931|NCT00132301|17074321|P1|Overall Study|Death|7
4967932|NCT00132132|17074329|P2|Overall Study|Lost to Follow-up|2
4967933|NCT00132132|17074330|P1|Overall Study|Lost to Follow-up|7
4967934|NCT00132041|17074338|P1|18 Months Post Ablation|ExtraHepatic tumor|1
4967935|NCT00132041|17074338|P1|18 Months Post Ablation|Non-Protocol Treatment|3
4967936|NCT00132041|17074338|P1|18 Months Post Ablation|Transplant|1
4967937|NCT00132041|17074338|P1|18 Months Post Ablation|Withdrawal by Subject|1
4967938|NCT00132041|17074338|P1|15 Months Post Ablation|Non-Protocol Treatment|1
4967939|NCT00132041|17074338|P1|15 Months Post Ablation|Transplant|5
4967940|NCT00132041|17074338|P1|15 Months Post Ablation|Death|1
4967941|NCT00132041|17074338|P1|15 Months Post Ablation|Withdrawal by Subject|1
4967942|NCT00132041|17074338|P1|12 Months Post Ablation|non-protocol Treatment|1
4967943|NCT00132041|17074338|P1|12 Months Post Ablation|Transplant|1
4967944|NCT00132041|17074338|P1|12 Months Post Ablation|Death|1
4967945|NCT00132041|17074338|P1|12 Months Post Ablation|Withdrawal by Subject|1
4967946|NCT00132041|17074338|P1|9 Months Post Ablation|Transplant|1
4967947|NCT00132041|17074338|P1|9 Months Post Ablation|Death|1
4967948|NCT00132041|17074338|P1|6 Months Post Ablation|Transplant|6
4967949|NCT00132041|17074338|P1|6 Months Post Ablation|Death|2
4967950|NCT00132041|17074338|P1|6 Months Post Ablation|Withdrawal by Subject|2
4967951|NCT00132041|17074338|P1|3 Months Post Ablation|Non-Protocol Treatment|2
4967952|NCT00132041|17074338|P1|3 Months Post Ablation|Transplant|1
4967953|NCT00132041|17074338|P1|Baseline|Ineligible|6
4967954|NCT00132028|17074353|P1|Overall Study|Physician Decision|3
4967955|NCT00132028|17074353|P1|Overall Study|not eligible|2
4967956|NCT00132028|17074353|P1|Overall Study|Withdrawal by Subject|2
4967957|NCT00132028|17074353|P1|Overall Study|Lack of Efficacy|11
4967958|NCT00132028|17074353|P1|Overall Study|Death|2
4967959|NCT00132028|17074353|P1|Overall Study|Adverse Event|7
4967960|NCT00131937|17074365|P1|Overall Study|Alternative therapy|1
4967961|NCT00131937|17074365|P1|Overall Study|Disease Progression|7
4967962|NCT00131937|17074365|P1|Overall Study|Physician Decision|1
4967963|NCT00131937|17074365|P1|Overall Study|Withdrawal by Subject|2
4967964|NCT00131937|17074365|P1|Overall Study|Adverse Event|3
4967965|NCT00131911|17074373|P2|Overall Study|Withdrawal by Subject|0
4967966|NCT00131911|17074374|P1|Overall Study|Withdrawal by Subject|1
4967967|NCT00131664|17074444|P6|Second Period (Additional Drug Added)|Administrative reasons|0
4967968|NCT00131664|17074445|P5|Second Period (Additional Drug Added)|Administrative reasons|1
4967969|NCT00131664|17074446|P4|Second Period (Additional Drug Added)|Administrative reasons|0
4967970|NCT00131664|17074447|P3|Second Period (Additional Drug Added)|Administrative reasons|0
4967971|NCT00131664|17074448|P2|Second Period (Additional Drug Added)|Administrative reasons|2
4967972|NCT00131664|17074449|P1|Second Period (Additional Drug Added)|Administrative reasons|4
4967973|NCT00131664|17074444|P6|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4967974|NCT00131664|17074445|P5|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4967975|NCT00131664|17074446|P4|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1
4967976|NCT00131664|17074447|P3|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4967977|NCT00131664|17074448|P2|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4967978|NCT00131664|17074449|P1|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0
4967979|NCT00131664|17074444|P6|Second Period (Additional Drug Added)|Adverse Event|1
4967980|NCT00131664|17074445|P5|Second Period (Additional Drug Added)|Adverse Event|0
4967981|NCT00131664|17074446|P4|Second Period (Additional Drug Added)|Adverse Event|0
4967982|NCT00131664|17074447|P3|Second Period (Additional Drug Added)|Adverse Event|0
4967983|NCT00131664|17074448|P2|Second Period (Additional Drug Added)|Adverse Event|1
4967984|NCT00131664|17074449|P1|Second Period (Additional Drug Added)|Adverse Event|0
4967985|NCT00131664|17074444|P6|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4967986|NCT00131664|17074445|P5|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4967987|NCT00131664|17074446|P4|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4967988|NCT00131664|17074447|P3|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4967989|NCT00131664|17074448|P2|Second Period (Additional Drug Added)|Withdrawal by Subject|0
4967990|NCT00131664|17074449|P1|Second Period (Additional Drug Added)|Withdrawal by Subject|2
4967991|NCT00131664|17074444|P6|Second Period (Additional Drug Added)|Protocol Violation|0
4967992|NCT00131664|17074445|P5|Second Period (Additional Drug Added)|Protocol Violation|0
4967993|NCT00131664|17074446|P4|Second Period (Additional Drug Added)|Protocol Violation|0
4967994|NCT00131664|17074447|P3|Second Period (Additional Drug Added)|Protocol Violation|1
4967995|NCT00131664|17074448|P2|Second Period (Additional Drug Added)|Protocol Violation|1
4967996|NCT00131664|17074449|P1|Second Period (Additional Drug Added)|Protocol Violation|0
4967997|NCT00131664|17074444|P6|Second Period (Additional Drug Added)|Lost to Follow-up|2
4967998|NCT00131664|17074445|P5|Second Period (Additional Drug Added)|Lost to Follow-up|0
4967999|NCT00131664|17074446|P4|Second Period (Additional Drug Added)|Lost to Follow-up|1
4968000|NCT00131664|17074447|P3|Second Period (Additional Drug Added)|Lost to Follow-up|2
4968001|NCT00131664|17074448|P2|Second Period (Additional Drug Added)|Lost to Follow-up|0
4968002|NCT00131664|17074449|P1|Second Period (Additional Drug Added)|Lost to Follow-up|3
4968003|NCT00131664|17074444|P6|First Period (First 6 Months)|Administrative reasons|0
4968004|NCT00131664|17074445|P5|First Period (First 6 Months)|Administrative reasons|0
4968005|NCT00131664|17074446|P4|First Period (First 6 Months)|Administrative reasons|0
4968006|NCT00131664|17074447|P3|First Period (First 6 Months)|Administrative reasons|5
4968007|NCT00131664|17074448|P2|First Period (First 6 Months)|Administrative reasons|0
4968008|NCT00131664|17074449|P1|First Period (First 6 Months)|Administrative reasons|2
4968009|NCT00131664|17074444|P6|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4968010|NCT00131664|17074445|P5|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4968011|NCT00131664|17074446|P4|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4968012|NCT00131664|17074447|P3|First Period (First 6 Months)|Clinically significant lab abnormalities|0
4968013|NCT00131664|17074448|P2|First Period (First 6 Months)|Clinically significant lab abnormalities|2
4968014|NCT00131664|17074449|P1|First Period (First 6 Months)|Clinically significant lab abnormalities|1
4968015|NCT00131664|17074444|P6|First Period (First 6 Months)|Adverse Event|0
4968016|NCT00131664|17074445|P5|First Period (First 6 Months)|Adverse Event|0
4968017|NCT00131664|17074446|P4|First Period (First 6 Months)|Adverse Event|0
4968018|NCT00131664|17074447|P3|First Period (First 6 Months)|Adverse Event|5
4968019|NCT00131664|17074448|P2|First Period (First 6 Months)|Adverse Event|4
4968020|NCT00131664|17074449|P1|First Period (First 6 Months)|Adverse Event|9
4968021|NCT00131664|17074444|P6|First Period (First 6 Months)|Withdrawal by Subject|0
4968022|NCT00131664|17074445|P5|First Period (First 6 Months)|Withdrawal by Subject|0
4968023|NCT00131664|17074446|P4|First Period (First 6 Months)|Withdrawal by Subject|0
4968024|NCT00131664|17074447|P3|First Period (First 6 Months)|Withdrawal by Subject|2
4968025|NCT00131664|17074448|P2|First Period (First 6 Months)|Withdrawal by Subject|6
4968026|NCT00131664|17074449|P1|First Period (First 6 Months)|Withdrawal by Subject|4
4968027|NCT00131664|17074444|P6|First Period (First 6 Months)|Protocol Violation|0
4968028|NCT00131664|17074445|P5|First Period (First 6 Months)|Protocol Violation|0
4968029|NCT00131664|17074446|P4|First Period (First 6 Months)|Protocol Violation|0
4968030|NCT00131664|17074447|P3|First Period (First 6 Months)|Protocol Violation|1
4968031|NCT00131664|17074448|P2|First Period (First 6 Months)|Protocol Violation|2
4968032|NCT00131664|17074449|P1|First Period (First 6 Months)|Protocol Violation|2
4968033|NCT00131664|17074444|P6|First Period (First 6 Months)|Death|0
4968034|NCT00131664|17074445|P5|First Period (First 6 Months)|Death|0
4968035|NCT00131664|17074446|P4|First Period (First 6 Months)|Death|0
4968036|NCT00131664|17074447|P3|First Period (First 6 Months)|Death|0
4968037|NCT00131664|17074448|P2|First Period (First 6 Months)|Death|1
4968038|NCT00131664|17074449|P1|First Period (First 6 Months)|Death|0
4968039|NCT00131664|17074444|P6|First Period (First 6 Months)|Lost to Follow-up|0
4968040|NCT00131664|17074445|P5|First Period (First 6 Months)|Lost to Follow-up|0
4968041|NCT00131664|17074446|P4|First Period (First 6 Months)|Lost to Follow-up|0
4968042|NCT00131664|17074447|P3|First Period (First 6 Months)|Lost to Follow-up|3
4968043|NCT00131664|17074448|P2|First Period (First 6 Months)|Lost to Follow-up|3
4968044|NCT00131664|17074449|P1|First Period (First 6 Months)|Lost to Follow-up|7
4968045|NCT00131508|17074521|P2|Overall Study|Withdrawal by Subject|2
4968046|NCT00131508|17074522|P1|Overall Study|Withdrawal by Subject|1
4968047|NCT00131508|17074521|P2|Overall Study|Non-Compliance|4
4968048|NCT00131508|17074522|P1|Overall Study|Non-Compliance|2
4968049|NCT00131508|17074521|P2|Overall Study|Disease progression|2
4968050|NCT00131508|17074522|P1|Overall Study|Disease progression|0
4968051|NCT00131469|17074546|P2|Overall Study|scan not analyzable|6
4968052|NCT00131469|17074547|P1|Overall Study|scan not analyzable|3
4968053|NCT00131469|17074546|P2|Overall Study|Lost to Follow-up|1
4968054|NCT00131469|17074547|P1|Overall Study|Lost to Follow-up|0
4968055|NCT00131469|17074546|P2|Overall Study|Death|1
4968056|NCT00131469|17074547|P1|Overall Study|Death|0
4968057|NCT00131469|17074546|P2|Overall Study|Protocol Violation|1
4968058|NCT00131469|17074547|P1|Overall Study|Protocol Violation|3
4968059|NCT00131469|17074546|P2|Overall Study|Withdrawal by Subject|4
4968060|NCT00131469|17074547|P1|Overall Study|Withdrawal by Subject|3
4968061|NCT00131365|17074593|P1|Overall Study|Alternative treatment|3
4968062|NCT00131365|17074593|P1|Overall Study|Withdrawal by Subject|1
4968063|NCT00131352|17074600|P2|Repeat Treatment Period|Other|0
4968064|NCT00131352|17074601|P1|Repeat Treatment Period|Other|1
4968065|NCT00131352|17074600|P2|Repeat Treatment Period|Adverse Event|0
4968066|NCT00131352|17074601|P1|Repeat Treatment Period|Adverse Event|1
4968067|NCT00131352|17074600|P2|Initial Treatment Period|Other|2
4968068|NCT00131352|17074601|P1|Initial Treatment Period|Other|0
4968069|NCT00131352|17074600|P2|Initial Treatment Period|Lack of Efficacy|4
4968070|NCT00131352|17074601|P1|Initial Treatment Period|Lack of Efficacy|6
4968071|NCT00131352|17074600|P2|Initial Treatment Period|Withdrawal by Subject|1
4968072|NCT00131352|17074601|P1|Initial Treatment Period|Withdrawal by Subject|1
4968073|NCT00131352|17074600|P2|Initial Treatment Period|Non-compliant|2
4968074|NCT00131352|17074601|P1|Initial Treatment Period|Non-compliant|1
4968075|NCT00131352|17074600|P2|Initial Treatment Period|Adverse Event|3
4968076|NCT00131352|17074601|P1|Initial Treatment Period|Adverse Event|1
4968077|NCT00131248|17074623|P2|Intervention 1 (3-day Course)|Withdrawal by Subject|0
4968078|NCT00131248|17074624|P1|Intervention 1 (3-day Course)|Withdrawal by Subject|1
4968079|NCT00130832|17074651|P2|Overall Study|Other|3
4968080|NCT00130832|17074652|P1|Overall Study|Other|0
4968081|NCT00130832|17074651|P2|Overall Study|Moved|2
4968082|NCT00130832|17074652|P1|Overall Study|Moved|2
4968083|NCT00130832|17074651|P2|Overall Study|Withdrawal by Subject|1
4968084|NCT00130832|17074652|P1|Overall Study|Withdrawal by Subject|6
4968085|NCT00130832|17074651|P2|Overall Study|Protocol Violation|8
4968086|NCT00130832|17074652|P1|Overall Study|Protocol Violation|6
4968087|NCT00130832|17074651|P2|Overall Study|Lost to Follow-up|2
4968088|NCT00130832|17074652|P1|Overall Study|Lost to Follow-up|1
4968089|NCT00130832|17074651|P2|Overall Study|Adverse Event|1
4968090|NCT00130832|17074652|P1|Overall Study|Adverse Event|1
4968091|NCT00130793|17074664|P2|Overall Study|Withdrew consent|0
4968092|NCT00130793|17074665|P1|Overall Study|Withdrew consent|2
4968093|NCT00130793|17074664|P2|Overall Study|Lost to Follow-up|4
4968094|NCT00130793|17074665|P1|Overall Study|Lost to Follow-up|1
4968095|NCT00130728|17074686|P2|Overall Study|Withdrawal by Subject|2
4968096|NCT00130728|17074687|P1|Overall Study|Withdrawal by Subject|0
4968097|NCT00130728|17074686|P2|Overall Study|Lost to Follow-up|0
4968098|NCT00130728|17074687|P1|Overall Study|Lost to Follow-up|4
4968099|NCT00130728|17074686|P2|Overall Study|Death|211
4968100|NCT00130728|17074687|P1|Overall Study|Death|207
4968101|NCT00130689|17074699|P1|Overall Study|Ineligible|6
4968102|NCT00130689|17074699|P1|Overall Study|Withdrawal by Subject|3
4968103|NCT00130689|17074699|P1|Overall Study|Clinical Deterioration|4
4968104|NCT00130689|17074699|P1|Overall Study|Death|1
4968105|NCT00130689|17074699|P1|Overall Study|Progressive Disease|29
4968106|NCT00130637|17074703|P1|Overall Study|Withdrawal by Subject|1
4968107|NCT00130637|17074703|P1|Overall Study|Adverse Event|2
4968108|NCT00130533|17074710|P2|Overall Study|Other|5
4968109|NCT00130533|17074711|P1|Overall Study|Other|12
4968110|NCT00130533|17074710|P2|Overall Study|Second Primary Malignancy|1
4968111|NCT00130533|17074711|P1|Overall Study|Second Primary Malignancy|0
4968112|NCT00130533|17074710|P2|Overall Study|Sponsor´s decision|0
4968113|NCT00130533|17074711|P1|Overall Study|Sponsor´s decision|2
4968114|NCT00130533|17074710|P2|Overall Study|Lost to Follow-up|1
4968115|NCT00130533|17074711|P1|Overall Study|Lost to Follow-up|1
4968116|NCT00130533|17074710|P2|Overall Study|Protocol Violation|1
4968117|NCT00130533|17074711|P1|Overall Study|Protocol Violation|5
4968118|NCT00130533|17074710|P2|Overall Study|Death|2
4968119|NCT00130533|17074711|P1|Overall Study|Death|4
4968120|NCT00130533|17074710|P2|Overall Study|Interruption of treatment > 3 weeks|0
4968121|NCT00130533|17074711|P1|Overall Study|Interruption of treatment > 3 weeks|11
4968122|NCT00130533|17074710|P2|Overall Study|Disease relapse|13
4968123|NCT00130533|17074711|P1|Overall Study|Disease relapse|9
4968124|NCT00130533|17074710|P2|Overall Study|Adverse Event|1
4968125|NCT00130533|17074711|P1|Overall Study|Adverse Event|34
4968126|NCT00130533|17074710|P2|Overall Study|Withdrawal by Subject|6
4968127|NCT00130533|17074711|P1|Overall Study|Withdrawal by Subject|33
4968128|NCT00130520|17074723|P1|Overall Study|Did not meet re-treatment criteria|1
4968129|NCT00130520|17074723|P1|Overall Study|Protocol non-compliance|1
4968130|NCT00130520|17074723|P1|Overall Study|Disease Progression|23
4968131|NCT00130520|17074723|P1|Overall Study|Withdrawal by Subject|1
4968133|NCT00130520|17074723|P1|Overall Study|Death|1
4968134|NCT00130520|17074723|P1|Overall Study|Adverse Event|11
4968135|NCT00130286|17074733|P4|Overall Study|Missing lab specimens|0
4968136|NCT00130286|17074734|P3|Overall Study|Missing lab specimens|0
4968137|NCT00130286|17074735|P2|Overall Study|Missing lab specimens|2
4968138|NCT00130286|17074736|P1|Overall Study|Missing lab specimens|0
4968139|NCT00130286|17074733|P4|Overall Study|Adverse Event|0
4968140|NCT00130286|17074734|P3|Overall Study|Adverse Event|2
4968141|NCT00130286|17074735|P2|Overall Study|Adverse Event|0
4968142|NCT00130286|17074736|P1|Overall Study|Adverse Event|0
4968143|NCT00130286|17074733|P4|Overall Study|Withdrawal by Subject|2
4968144|NCT00130286|17074734|P3|Overall Study|Withdrawal by Subject|2
4968145|NCT00130286|17074735|P2|Overall Study|Withdrawal by Subject|1
4968146|NCT00130286|17074736|P1|Overall Study|Withdrawal by Subject|0
4968147|NCT00130247|17074756|P2|Overall Study|Not compliant with DOT|2
4968148|NCT00130247|17074757|P1|Overall Study|Not compliant with DOT|0
4968149|NCT00130247|17074756|P2|Overall Study|Post-randomization exclusion|2
4968150|NCT00130247|17074757|P1|Overall Study|Post-randomization exclusion|1
4968151|NCT00130247|17074756|P2|Overall Study|Pregnancy|0
4968152|NCT00130247|17074757|P1|Overall Study|Pregnancy|1
4968153|NCT00130208|17074775|P2|Washout Period (8 Weeks)|Other|1
4968154|NCT00130208|17074776|P1|Washout Period (8 Weeks)|Other|1
4968155|NCT00130208|17074775|P2|Washout Period (8 Weeks)|Lost to Follow-up|1
4968156|NCT00130208|17074776|P1|Washout Period (8 Weeks)|Lost to Follow-up|0
4968157|NCT00130208|17074775|P2|Washout Period (8 Weeks)|Withdrawal by Subject|4
4968158|NCT00130208|17074776|P1|Washout Period (8 Weeks)|Withdrawal by Subject|2
4968159|NCT00130208|17074775|P2|Washout Period (8 Weeks)|Adverse Event|6
4968160|NCT00130208|17074776|P1|Washout Period (8 Weeks)|Adverse Event|3
4968161|NCT00130208|17074775|P2|Maintenance Period (26 Weeks)|Other|1
4968162|NCT00130208|17074776|P1|Maintenance Period (26 Weeks)|Other|1
4968163|NCT00130208|17074775|P2|Maintenance Period (26 Weeks)|Lost to Follow-up|4
4968164|NCT00130208|17074776|P1|Maintenance Period (26 Weeks)|Lost to Follow-up|5
4968165|NCT00130208|17074775|P2|Maintenance Period (26 Weeks)|Withdrawal by Subject|11
4968166|NCT00130208|17074776|P1|Maintenance Period (26 Weeks)|Withdrawal by Subject|8
4968167|NCT00130208|17074775|P2|Maintenance Period (26 Weeks)|Physician Decision|2
4968168|NCT00130208|17074776|P1|Maintenance Period (26 Weeks)|Physician Decision|0
4968169|NCT00130208|17074775|P2|Maintenance Period (26 Weeks)|Adverse Event|12
4968170|NCT00130208|17074776|P1|Maintenance Period (26 Weeks)|Adverse Event|10
4968171|NCT00130039|17074812|P2|Overall Study|clinical events without follow up MRI|4
4968172|NCT00130039|17074813|P1|Overall Study|clinical events without follow up MRI|5
4968173|NCT00130039|17074812|P2|Overall Study|Physician Decision|0
4968174|NCT00130039|17074813|P1|Overall Study|Physician Decision|3
4968175|NCT00130039|17074812|P2|Overall Study|Adverse Event|2
4968176|NCT00130039|17074813|P1|Overall Study|Adverse Event|4
4968177|NCT00130039|17074812|P2|Overall Study|Lost to Follow-up|1
4968178|NCT00130039|17074813|P1|Overall Study|Lost to Follow-up|3
4968179|NCT00130039|17074812|P2|Overall Study|Withdrawal by Subject|11
4968180|NCT00130039|17074813|P1|Overall Study|Withdrawal by Subject|15
4968181|NCT00129987|17074831|P2|1 Year|Withdrawal by Subject|21
4968182|NCT00129987|17074832|P1|1 Year|Withdrawal by Subject|32
4968183|NCT00129987|17074831|P2|1st Educational Session|Withdrawal by Subject|109
4968184|NCT00129987|17074832|P1|1st Educational Session|Withdrawal by Subject|141
4968185|NCT00129974|17074844|P1|Overall Study|Other|1
4968186|NCT00129961|17074851|P2|Overall Study|Missing Record|1
4968187|NCT00129961|17074852|P1|Overall Study|Missing Record|0
4968188|NCT00129961|17074851|P2|Overall Study|Withdrawal by Subject|1
4968189|NCT00129961|17074852|P1|Overall Study|Withdrawal by Subject|2
4968190|NCT00129961|17074851|P2|Overall Study|Physician Decision|0
4968191|NCT00129961|17074852|P1|Overall Study|Physician Decision|1
4968192|NCT00129961|17074851|P2|Overall Study|Withdrawal by Sponsor|20
4968193|NCT00129961|17074852|P1|Overall Study|Withdrawal by Sponsor|14
4968194|NCT00129961|17074851|P2|Overall Study|Death|1
4968195|NCT00129961|17074852|P1|Overall Study|Death|1
4968196|NCT00129961|17074851|P2|Overall Study|Adverse Event|0
4968197|NCT00129961|17074852|P1|Overall Study|Adverse Event|1
4968198|NCT00129935|17074888|P2|Overall Study|Incorrect study treatment|0
4968199|NCT00129935|17074889|P1|Overall Study|Incorrect study treatment|1
4968200|NCT00129935|17074888|P2|Overall Study|Crossed to the other arm|1
4968201|NCT00129935|17074889|P1|Overall Study|Crossed to the other arm|2
4968202|NCT00129935|17074888|P2|Overall Study|Other|2
4968203|NCT00129935|17074889|P1|Overall Study|Other|3
4968204|NCT00129935|17074888|P2|Overall Study|Second primary|1
4968205|NCT00129935|17074889|P1|Overall Study|Second primary|0
4968206|NCT00129935|17074888|P2|Overall Study|Recurrence|3
4968207|NCT00129935|17074889|P1|Overall Study|Recurrence|1
4968208|NCT00129935|17074888|P2|Overall Study|Physician Decision|4
4968209|NCT00129935|17074889|P1|Overall Study|Physician Decision|3
4968210|NCT00129935|17074888|P2|Overall Study|Protocol Violation|4
4968211|NCT00129935|17074889|P1|Overall Study|Protocol Violation|0
4968212|NCT00129935|17074888|P2|Overall Study|Withdrawal by Subject|20
4968213|NCT00129935|17074889|P1|Overall Study|Withdrawal by Subject|7
4968214|NCT00129935|17074888|P2|Overall Study|Death|1
4968215|NCT00129935|17074889|P1|Overall Study|Death|1
4968216|NCT00129935|17074888|P2|Overall Study|Adverse Event|56
4968217|NCT00129935|17074889|P1|Overall Study|Adverse Event|18
4968218|NCT00129766|17074907|P2|Overall Study|Lost to Follow-up|21
4968219|NCT00129766|17074908|P1|Overall Study|Lost to Follow-up|26
4968220|NCT00129766|17074907|P2|Overall Study|Withdrawal of consent|30
4968221|NCT00129766|17074908|P1|Overall Study|Withdrawal of consent|31
4968222|NCT00129766|17074907|P2|Overall Study|Death|8
4968223|NCT00129766|17074908|P1|Overall Study|Death|3
4968224|NCT00129701|17074957|P1|Overall Study|Withdrawal by Subject|33
4968225|NCT00129649|17074966|P2|Overall Study|Withdrawal by Subject|65
4968226|NCT00129649|17074967|P1|Overall Study|Withdrawal by Subject|76
4968227|NCT00129623|17074975|P2|Overall Study|Uncertainty to return|1
4968228|NCT00129623|17074976|P1|Overall Study|Uncertainty to return|0
4968229|NCT00129623|17074975|P2|Overall Study|Relocated job out of state|0
4968230|NCT00129623|17074976|P1|Overall Study|Relocated job out of state|1
4968231|NCT00129623|17074975|P2|Overall Study|Failure to Return|1
4968232|NCT00129623|17074976|P1|Overall Study|Failure to Return|1
4968233|NCT00129623|17074975|P2|Overall Study|Refused Treatment|3
4968234|NCT00129623|17074976|P1|Overall Study|Refused Treatment|5
4968235|NCT00129623|17074975|P2|Overall Study|Adverse Event|7
4968236|NCT00129623|17074976|P1|Overall Study|Adverse Event|3
4968237|NCT00129545|17075001|P3|Overall Study|Device not implanted|0
4968238|NCT00129545|17075002|P2|Overall Study|Device not implanted|61
4968239|NCT00129545|17075003|P1|Overall Study|Device not implanted|16
4968240|NCT00129545|17075001|P3|Overall Study|Physician Decision|10
4968241|NCT00129545|17075002|P2|Overall Study|Physician Decision|3
4968242|NCT00129545|17075003|P1|Overall Study|Physician Decision|0
4968243|NCT00129545|17075001|P3|Overall Study|Lost to Follow-up|13
4968244|NCT00129545|17075002|P2|Overall Study|Lost to Follow-up|22
4968245|NCT00129545|17075003|P1|Overall Study|Lost to Follow-up|2
4968246|NCT00129545|17075001|P3|Overall Study|Withdrawal by Subject|44
4968247|NCT00129545|17075002|P2|Overall Study|Withdrawal by Subject|18
4968248|NCT00129545|17075003|P1|Overall Study|Withdrawal by Subject|3
4968249|NCT00129545|17075001|P3|Overall Study|Death|44
4968250|NCT00129545|17075002|P2|Overall Study|Death|60
4968251|NCT00129545|17075003|P1|Overall Study|Death|5
4968252|NCT00129467|17075032|P2|Open Label for SSRI+Methylphenidate Arm|Delirium|0
4968253|NCT00129467|17075033|P1|Open Label for SSRI+Methylphenidate Arm|Delirium|1
4968254|NCT00129467|17075032|P2|Open Label for SSRI+Methylphenidate Arm|Death|0
4968255|NCT00129467|17075033|P1|Open Label for SSRI+Methylphenidate Arm|Death|1
4968256|NCT00129467|17075032|P2|Received Intervention|Dizzyness, fatigue|1
4968257|NCT00129467|17075033|P1|Received Intervention|Dizzyness, fatigue|0
4968258|NCT00129467|17075032|P2|Received Intervention|Intolerance to citalopram|1
4968259|NCT00129467|17075033|P1|Received Intervention|Intolerance to citalopram|0
4968260|NCT00129467|17075032|P2|Received Intervention|Nausea|0
4968261|NCT00129467|17075033|P1|Received Intervention|Nausea|1
4968262|NCT00129467|17075032|P2|Received Intervention|Withdrawal by Subject|0
4968263|NCT00129467|17075033|P1|Received Intervention|Withdrawal by Subject|1
4968264|NCT00129467|17075032|P2|Received Intervention|Delirium|0
4968265|NCT00129467|17075033|P1|Received Intervention|Delirium|2
4968266|NCT00129467|17075032|P2|Received Intervention|Cardiac SAE (hypertension)|1
4968267|NCT00129467|17075033|P1|Received Intervention|Cardiac SAE (hypertension)|1
4968268|NCT00129467|17075032|P2|Received Intervention|Death|1
4968269|NCT00129467|17075033|P1|Received Intervention|Death|1
4968270|NCT00129402|17075064|P7|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1
4968271|NCT00129402|17075065|P6|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4968272|NCT00129402|17075066|P5|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4968273|NCT00129402|17075067|P4|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4968274|NCT00129402|17075068|P3|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4968275|NCT00129402|17075069|P2|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4968276|NCT00129402|17075070|P1|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0
4968277|NCT00129402|17075064|P7|Start Period3 to End Period3(Week 34-53)|Subject moved|1
4968278|NCT00129402|17075065|P6|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4968279|NCT00129402|17075066|P5|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4968280|NCT00129402|17075067|P4|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4968281|NCT00129402|17075068|P3|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4968282|NCT00129402|17075069|P2|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4968283|NCT00129402|17075070|P1|Start Period3 to End Period3(Week 34-53)|Subject moved|0
4968284|NCT00129402|17075064|P7|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3
4968285|NCT00129402|17075065|P6|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4968286|NCT00129402|17075066|P5|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4968287|NCT00129402|17075067|P4|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4968288|NCT00129402|17075068|P3|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4968289|NCT00129402|17075069|P2|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4968290|NCT00129402|17075070|P1|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0
4968291|NCT00129402|17075064|P7|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1
4968292|NCT00129402|17075065|P6|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4968293|NCT00129402|17075066|P5|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4968294|NCT00129402|17075067|P4|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4968295|NCT00129402|17075068|P3|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4968296|NCT00129402|17075069|P2|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4968297|NCT00129402|17075070|P1|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0
4968298|NCT00129402|17075064|P7|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4968299|NCT00129402|17075065|P6|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
4968300|NCT00129402|17075066|P5|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4968301|NCT00129402|17075067|P4|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4968302|NCT00129402|17075068|P3|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1
4968303|NCT00129402|17075069|P2|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4968304|NCT00129402|17075070|P1|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0
4968305|NCT00129402|17075064|P7|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4968306|NCT00129402|17075065|P6|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3
4968307|NCT00129402|17075066|P5|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4968308|NCT00129402|17075067|P4|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4968309|NCT00129402|17075068|P3|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1
4968310|NCT00129402|17075069|P2|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4968311|NCT00129402|17075070|P1|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0
4968312|NCT00129402|17075064|P7|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4968313|NCT00129402|17075065|P6|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4968314|NCT00129402|17075066|P5|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4968315|NCT00129402|17075067|P4|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4968316|NCT00129402|17075068|P3|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1
4968317|NCT00129402|17075069|P2|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4968318|NCT00129402|17075070|P1|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0
4968319|NCT00129402|17075064|P7|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4968320|NCT00129402|17075065|P6|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1
4968321|NCT00129402|17075066|P5|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4968322|NCT00129402|17075067|P4|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4968323|NCT00129402|17075068|P3|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3
4968324|NCT00129402|17075069|P2|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4968325|NCT00129402|17075070|P1|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0
4968326|NCT00129402|17075064|P7|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4968327|NCT00129402|17075065|P6|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4968328|NCT00129402|17075066|P5|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4968329|NCT00129402|17075067|P4|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4968330|NCT00129402|17075068|P3|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2
4968331|NCT00129402|17075069|P2|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4968332|NCT00129402|17075070|P1|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0
4968333|NCT00129402|17075064|P7|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4968334|NCT00129402|17075065|P6|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4968335|NCT00129402|17075066|P5|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
4968336|NCT00129402|17075067|P4|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4968337|NCT00129402|17075068|P3|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1
4968338|NCT00129402|17075069|P2|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4968339|NCT00129402|17075070|P1|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0
4968340|NCT00129402|17075064|P7|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4968341|NCT00129402|17075065|P6|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4968342|NCT00129402|17075066|P5|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4968343|NCT00129402|17075067|P4|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1
4968344|NCT00129402|17075068|P3|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4968345|NCT00129402|17075069|P2|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4968346|NCT00129402|17075070|P1|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0
4968347|NCT00129402|17075064|P7|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4968348|NCT00129402|17075065|P6|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1
4968349|NCT00129402|17075066|P5|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4968350|NCT00129402|17075067|P4|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4968351|NCT00129402|17075068|P3|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4968352|NCT00129402|17075069|P2|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4968353|NCT00129402|17075070|P1|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0
4968354|NCT00129402|17075064|P7|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4968355|NCT00129402|17075065|P6|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
4968356|NCT00129402|17075066|P5|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4968357|NCT00129402|17075067|P4|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4968358|NCT00129402|17075068|P3|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
4968359|NCT00129402|17075069|P2|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1
4968360|NCT00129402|17075070|P1|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0
4968361|NCT00129389|17075089|P2|Overall Study|Crossed to the other arm|16
4968362|NCT00129389|17075090|P1|Overall Study|Crossed to the other arm|1
4968363|NCT00129389|17075089|P2|Overall Study|Not eligible|2
4968364|NCT00129389|17075090|P1|Overall Study|Not eligible|1
4968365|NCT00129389|17075089|P2|Overall Study|Relapse|0
4968366|NCT00129389|17075090|P1|Overall Study|Relapse|1
4968367|NCT00129389|17075089|P2|Overall Study|Withdrawal by Subject|23
4968368|NCT00129389|17075090|P1|Overall Study|Withdrawal by Subject|9
4968369|NCT00129389|17075089|P2|Overall Study|Protocol Violation|6
4968370|NCT00129389|17075090|P1|Overall Study|Protocol Violation|0
4968371|NCT00129389|17075089|P2|Overall Study|Physician Decision|4
4968372|NCT00129389|17075090|P1|Overall Study|Physician Decision|0
4968373|NCT00129389|17075089|P2|Overall Study|Lost to Follow-up|1
4968374|NCT00129389|17075090|P1|Overall Study|Lost to Follow-up|2
4968375|NCT00129389|17075089|P2|Overall Study|Death|1
4968376|NCT00129389|17075090|P1|Overall Study|Death|0
4968377|NCT00129389|17075089|P2|Overall Study|Adverse Event|87
4968378|NCT00129389|17075090|P1|Overall Study|Adverse Event|19
4968379|NCT00129376|17075098|P1|Overall Study|Lack of Efficacy|1
4968380|NCT00129376|17075098|P1|Overall Study|Adverse Event|1
4968381|NCT00129311|17075108|P2|Overall Study|Withdrawal by Subject|19
4968382|NCT00129311|17075109|P1|Overall Study|Withdrawal by Subject|12
4968383|NCT00129272|17075138|P2|Overall Study|Withdrawal by Subject|11
4968384|NCT00129272|17075139|P1|Overall Study|Withdrawal by Subject|5
4968385|NCT00129272|17075138|P2|Overall Study|Lost to Follow-up|11
4968386|NCT00129272|17075139|P1|Overall Study|Lost to Follow-up|12
4968387|NCT00129259|17075149|P2|Overall Study|Only available minimal phone assessments|1
4968388|NCT00129259|17075150|P1|Overall Study|Only available minimal phone assessments|0
4968389|NCT00129259|17075149|P2|Overall Study|Withdrawal by Subject|1
4968390|NCT00129259|17075150|P1|Overall Study|Withdrawal by Subject|2
4968391|NCT00129259|17075149|P2|Overall Study|Lost to Follow-up|1
4968392|NCT00129259|17075150|P1|Overall Study|Lost to Follow-up|1
4968393|NCT00129220|17075178|P3|Study Period III|Reason Not Specified|2
4968394|NCT00129220|17075179|P2|Study Period III|Reason Not Specified|0
4968395|NCT00129220|17075180|P1|Study Period III|Reason Not Specified|9
4968396|NCT00129220|17075178|P3|Study Period III|Sponsor Decision|0
4968397|NCT00129220|17075179|P2|Study Period III|Sponsor Decision|0
4968398|NCT00129220|17075180|P1|Study Period III|Sponsor Decision|1
4968399|NCT00129220|17075178|P3|Study Period III|Withdrawal by Subject|3
4968400|NCT00129220|17075179|P2|Study Period III|Withdrawal by Subject|0
4968401|NCT00129220|17075180|P1|Study Period III|Withdrawal by Subject|1
4968402|NCT00129220|17075178|P3|Study Period III|Protocol Violation|2
4968403|NCT00129220|17075179|P2|Study Period III|Protocol Violation|1
4968404|NCT00129220|17075180|P1|Study Period III|Protocol Violation|1
4968405|NCT00129220|17075178|P3|Study Period III|Adverse Event|3
4968406|NCT00129220|17075179|P2|Study Period III|Adverse Event|0
4968407|NCT00129220|17075180|P1|Study Period III|Adverse Event|1
4968408|NCT00129220|17075178|P3|Study Period II|Reason Not Specified|5
4968409|NCT00129220|17075179|P2|Study Period II|Reason Not Specified|0
4968410|NCT00129220|17075180|P1|Study Period II|Reason Not Specified|2
4968411|NCT00129220|17075178|P3|Study Period II|Withdrawal by Subject|4
4968412|NCT00129220|17075179|P2|Study Period II|Withdrawal by Subject|3
4968413|NCT00129220|17075180|P1|Study Period II|Withdrawal by Subject|1
4968414|NCT00129220|17075178|P3|Study Period II|Physician Decision|0
4968415|NCT00129220|17075179|P2|Study Period II|Physician Decision|1
4968416|NCT00129220|17075180|P1|Study Period II|Physician Decision|0
4968417|NCT00129220|17075178|P3|Study Period II|Protocol Violation|1
4968418|NCT00129220|17075179|P2|Study Period II|Protocol Violation|2
4968419|NCT00129220|17075180|P1|Study Period II|Protocol Violation|4
4968420|NCT00129220|17075178|P3|Study Period II|Entry Criteria Not Met|2
4968421|NCT00129220|17075179|P2|Study Period II|Entry Criteria Not Met|0
4968422|NCT00129220|17075180|P1|Study Period II|Entry Criteria Not Met|2
4968423|NCT00129220|17075178|P3|Study Period II|Lack of Efficacy|28
4968424|NCT00129220|17075179|P2|Study Period II|Lack of Efficacy|1
4968425|NCT00129220|17075180|P1|Study Period II|Lack of Efficacy|15
4968426|NCT00129220|17075178|P3|Study Period II|Adverse Event|7
4968427|NCT00129220|17075179|P2|Study Period II|Adverse Event|5
4968428|NCT00129220|17075180|P1|Study Period II|Adverse Event|9
4968429|NCT00129129|17075220|P5|Fourth Dose Phase|Protocol Violation|0
4968430|NCT00129129|17075221|P4|Fourth Dose Phase|Protocol Violation|1
4968431|NCT00129129|17075222|P3|Fourth Dose Phase|Protocol Violation|0
4968432|NCT00129129|17075223|P2|Fourth Dose Phase|Protocol Violation|0
4968433|NCT00129129|17075224|P1|Fourth Dose Phase|Protocol Violation|0
4968434|NCT00129129|17075220|P5|Fourth Dose Phase|Other|1
4968435|NCT00129129|17075221|P4|Fourth Dose Phase|Other|1
4968436|NCT00129129|17075222|P3|Fourth Dose Phase|Other|0
4968437|NCT00129129|17075223|P2|Fourth Dose Phase|Other|0
4968438|NCT00129129|17075224|P1|Fourth Dose Phase|Other|0
4968439|NCT00129129|17075220|P5|Fourth Dose Phase|Migration from study area|2
4968440|NCT00129129|17075221|P4|Fourth Dose Phase|Migration from study area|0
4968441|NCT00129129|17075222|P3|Fourth Dose Phase|Migration from study area|0
4968442|NCT00129129|17075223|P2|Fourth Dose Phase|Migration from study area|0
4968443|NCT00129129|17075224|P1|Fourth Dose Phase|Migration from study area|0
4968444|NCT00129129|17075220|P5|Fourth Dose Phase|Withdrawal by Subject|1
4968445|NCT00129129|17075221|P4|Fourth Dose Phase|Withdrawal by Subject|0
4968446|NCT00129129|17075222|P3|Fourth Dose Phase|Withdrawal by Subject|0
4968447|NCT00129129|17075223|P2|Fourth Dose Phase|Withdrawal by Subject|0
4968448|NCT00129129|17075224|P1|Fourth Dose Phase|Withdrawal by Subject|0
4968449|NCT00129129|17075220|P5|Fourth Dose Phase|Lost to Follow-up|2
4968450|NCT00129129|17075221|P4|Fourth Dose Phase|Lost to Follow-up|2
4968451|NCT00129129|17075222|P3|Fourth Dose Phase|Lost to Follow-up|0
4968452|NCT00129129|17075223|P2|Fourth Dose Phase|Lost to Follow-up|0
4968453|NCT00129129|17075224|P1|Fourth Dose Phase|Lost to Follow-up|4
4968454|NCT00129129|17075220|P5|Primary Phase|Other|0
4968455|NCT00129129|17075221|P4|Primary Phase|Other|0
4968456|NCT00129129|17075222|P3|Primary Phase|Other|0
4968457|NCT00129129|17075223|P2|Primary Phase|Other|5
4968458|NCT00129129|17075224|P1|Primary Phase|Other|2
4968459|NCT00129129|17075220|P5|Primary Phase|Lost to Follow-up|0
4968460|NCT00129129|17075221|P4|Primary Phase|Lost to Follow-up|0
4968461|NCT00129129|17075222|P3|Primary Phase|Lost to Follow-up|0
4968462|NCT00129129|17075223|P2|Primary Phase|Lost to Follow-up|6
4968463|NCT00129129|17075224|P1|Primary Phase|Lost to Follow-up|8
4968464|NCT00129129|17075220|P5|Primary Phase|Migration from study area|0
4968465|NCT00129129|17075221|P4|Primary Phase|Migration from study area|0
4968466|NCT00129129|17075222|P3|Primary Phase|Migration from study area|0
4968467|NCT00129129|17075223|P2|Primary Phase|Migration from study area|3
4968468|NCT00129129|17075224|P1|Primary Phase|Migration from study area|1
4968469|NCT00129129|17075220|P5|Primary Phase|Withdrawal by Subject|0
4968470|NCT00129129|17075221|P4|Primary Phase|Withdrawal by Subject|0
4968471|NCT00129129|17075222|P3|Primary Phase|Withdrawal by Subject|0
4968472|NCT00129129|17075223|P2|Primary Phase|Withdrawal by Subject|10
4968473|NCT00129129|17075224|P1|Primary Phase|Withdrawal by Subject|12
4968474|NCT00129129|17075220|P5|Primary Phase|Adverse Event|0
4968475|NCT00129129|17075221|P4|Primary Phase|Adverse Event|0
4968476|NCT00129129|17075222|P3|Primary Phase|Adverse Event|0
4968477|NCT00129129|17075223|P2|Primary Phase|Adverse Event|1
4968478|NCT00129129|17075224|P1|Primary Phase|Adverse Event|2
4968479|NCT00129116|17075431|P5|Booster Phase|Lost to Follow-up|1
4968480|NCT00129116|17075432|P4|Booster Phase|Lost to Follow-up|0
4968481|NCT00129116|17075433|P3|Booster Phase|Lost to Follow-up|0
4968482|NCT00129116|17075434|P2|Booster Phase|Lost to Follow-up|0
4968483|NCT00129116|17075435|P1|Booster Phase|Lost to Follow-up|2
4968484|NCT00129116|17075431|P5|Primary Phase|Other|0
4968485|NCT00129116|17075432|P4|Primary Phase|Other|0
4968486|NCT00129116|17075433|P3|Primary Phase|Other|1
4968487|NCT00129116|17075434|P2|Primary Phase|Other|0
4968488|NCT00129116|17075435|P1|Primary Phase|Other|0
4968489|NCT00129116|17075431|P5|Primary Phase|Withdrawal by Subject|0
4968490|NCT00129116|17075432|P4|Primary Phase|Withdrawal by Subject|0
4968491|NCT00129116|17075433|P3|Primary Phase|Withdrawal by Subject|0
4968492|NCT00129116|17075434|P2|Primary Phase|Withdrawal by Subject|1
4968493|NCT00129116|17075435|P1|Primary Phase|Withdrawal by Subject|0
4968494|NCT00129116|17075431|P5|Primary Phase|Adverse Event|0
4968495|NCT00129116|17075432|P4|Primary Phase|Adverse Event|0
4968496|NCT00129116|17075433|P3|Primary Phase|Adverse Event|0
4968497|NCT00129116|17075434|P2|Primary Phase|Adverse Event|1
4968498|NCT00129116|17075435|P1|Primary Phase|Adverse Event|1
4968499|NCT00129116|17075431|P5|Primary Phase|Protocol Violation|0
4968500|NCT00129116|17075432|P4|Primary Phase|Protocol Violation|0
4968501|NCT00129116|17075433|P3|Primary Phase|Protocol Violation|0
4968502|NCT00129116|17075434|P2|Primary Phase|Protocol Violation|1
4968503|NCT00129116|17075435|P1|Primary Phase|Protocol Violation|0
4968504|NCT00129116|17075431|P5|Primary Phase|Lost to Follow-up|1
4968505|NCT00129116|17075432|P4|Primary Phase|Lost to Follow-up|1
4968506|NCT00129116|17075433|P3|Primary Phase|Lost to Follow-up|0
4968507|NCT00129116|17075434|P2|Primary Phase|Lost to Follow-up|1
4968508|NCT00129116|17075435|P1|Primary Phase|Lost to Follow-up|1
4968509|NCT00128830|17075719|P1|Overall Study|Other|9
4968510|NCT00128830|17075719|P1|Overall Study|Discontinued or ineligible for study|2
4968511|NCT00128830|17075719|P1|Overall Study|Non-compliant|4
4968512|NCT00128830|17075719|P1|Overall Study|Reached a virologic endpoint|29
4968513|NCT00128830|17075719|P1|Overall Study|Lost to Follow-up|4
4968514|NCT00128830|17075719|P1|Overall Study|Withdrawal by Subject|14
4968515|NCT00128830|17075719|P1|Overall Study|Adverse Event|10
4968516|NCT00128661|17075761|P2|Overall Study|Other|8
4968517|NCT00128661|17075762|P1|Overall Study|Other|7
4968518|NCT00128661|17075761|P2|Overall Study|Withdrawal by Subject|232
4968519|NCT00128661|17075762|P1|Overall Study|Withdrawal by Subject|243
4968520|NCT00128661|17075761|P2|Overall Study|Lost to Follow-up|7
4968521|NCT00128661|17075762|P1|Overall Study|Lost to Follow-up|10
4968522|NCT00128661|17075761|P2|Overall Study|Adverse Event|11
4968523|NCT00128661|17075762|P1|Overall Study|Adverse Event|14
4968524|NCT00128492|17075808|P2|Overall Study|Pregnancy|1
4968525|NCT00128492|17075809|P1|Overall Study|Pregnancy|0
4968526|NCT00128492|17075808|P2|Overall Study|Withdrawal by Subject|5
4968527|NCT00128492|17075809|P1|Overall Study|Withdrawal by Subject|3
4968528|NCT00128492|17075808|P2|Overall Study|Personal or administrative|22
4968529|NCT00128492|17075809|P1|Overall Study|Personal or administrative|10
4968530|NCT00128492|17075808|P2|Overall Study|Noncompliance|5
4968531|NCT00128492|17075809|P1|Overall Study|Noncompliance|0
4968532|NCT00128492|17075808|P2|Overall Study|Lost to Follow-up|5
4968533|NCT00128492|17075809|P1|Overall Study|Lost to Follow-up|1
4968534|NCT00128492|17075808|P2|Overall Study|Death|0
4968535|NCT00128492|17075809|P1|Overall Study|Death|1
4968536|NCT00128492|17075808|P2|Overall Study|AE related to study|4
4968537|NCT00128492|17075809|P1|Overall Study|AE related to study|1
4968538|NCT00128492|17075808|P2|Overall Study|Study drug intolerance (AE)|8
4968539|NCT00128492|17075809|P1|Overall Study|Study drug intolerance (AE)|2
4968540|NCT00128492|17075808|P2|Overall Study|AE unrelated to study|9
4968541|NCT00128492|17075809|P1|Overall Study|AE unrelated to study|2
4968542|NCT00128206|17075966|P2|Overall Study|Adverse Event|2
4968543|NCT00128206|17075967|P1|Overall Study|Adverse Event|0
4968544|NCT00128206|17075966|P2|Overall Study|Lost to Follow-up|118
4968545|NCT00128206|17075967|P1|Overall Study|Lost to Follow-up|137
4968546|NCT00128102|17076263|P2|Overall Study|Protocol Violation|2
4968547|NCT00128102|17076264|P1|Overall Study|Protocol Violation|2
4968548|NCT00128102|17076263|P2|Overall Study|Withdrawal by Subject|11
4968549|NCT00128102|17076264|P1|Overall Study|Withdrawal by Subject|19
4968550|NCT00128102|17076263|P2|Overall Study|Physician Decision|3
4968551|NCT00128102|17076264|P1|Overall Study|Physician Decision|3
4968552|NCT00128102|17076263|P2|Overall Study|Death|13
4968553|NCT00128102|17076264|P1|Overall Study|Death|12
4968554|NCT00128102|17076263|P2|Overall Study|Adverse Event|11
4968555|NCT00128102|17076264|P1|Overall Study|Adverse Event|34
4968556|NCT00128102|17076263|P2|Overall Study|Progressive Disease|285
4968557|NCT00128102|17076264|P1|Overall Study|Progressive Disease|255
4968558|NCT00128102|17076263|P2|Overall Study|Other|1
4968559|NCT00128102|17076264|P1|Overall Study|Other|0
4968560|NCT00128102|17076263|P2|Overall Study|Site Discontinued|6
4968561|NCT00128102|17076264|P1|Overall Study|Site Discontinued|3
4968562|NCT00127933|17076290|P2|Overall Study|Randomized but not dosed|0
4968563|NCT00127933|17076291|P1|Overall Study|Randomized but not dosed|1
4968564|NCT00127855|17076312|P5|Primary Vaccination Course|Other|1
4968565|NCT00127855|17076313|P4|Primary Vaccination Course|Other|0
4968566|NCT00127855|17076314|P3|Primary Vaccination Course|Other|0
4968567|NCT00127855|17076315|P2|Primary Vaccination Course|Other|0
4968568|NCT00127855|17076316|P1|Primary Vaccination Course|Other|0
4968569|NCT00127855|17076312|P5|Primary Vaccination Course|Lost to Follow-up|2
4968570|NCT00127855|17076313|P4|Primary Vaccination Course|Lost to Follow-up|0
4968571|NCT00127855|17076314|P3|Primary Vaccination Course|Lost to Follow-up|1
4968572|NCT00127855|17076315|P2|Primary Vaccination Course|Lost to Follow-up|1
4968573|NCT00127855|17076316|P1|Primary Vaccination Course|Lost to Follow-up|1
4968574|NCT00127855|17076312|P5|Primary Vaccination Course|Withdrawal by Subject|1
4968575|NCT00127855|17076313|P4|Primary Vaccination Course|Withdrawal by Subject|0
4968576|NCT00127855|17076314|P3|Primary Vaccination Course|Withdrawal by Subject|0
4968577|NCT00127855|17076315|P2|Primary Vaccination Course|Withdrawal by Subject|0
4968578|NCT00127855|17076316|P1|Primary Vaccination Course|Withdrawal by Subject|1
4968579|NCT00127855|17076312|P5|Primary Vaccination Course|Adverse Event|0
4968580|NCT00127855|17076313|P4|Primary Vaccination Course|Adverse Event|0
4968581|NCT00127855|17076314|P3|Primary Vaccination Course|Adverse Event|1
4968582|NCT00127855|17076315|P2|Primary Vaccination Course|Adverse Event|0
4968583|NCT00127855|17076316|P1|Primary Vaccination Course|Adverse Event|0
4968584|NCT00127842|17076498|P1|Overall Study|Other|5
4968585|NCT00127842|17076498|P1|Overall Study|Protocol Violation|1
4968586|NCT00127842|17076498|P1|Overall Study|Noncompliance|2
4968587|NCT00127842|17076498|P1|Overall Study|Lack of Efficacy|12
4968588|NCT00127842|17076498|P1|Overall Study|Lost to Follow-up|1
4968589|NCT00127842|17076498|P1|Overall Study|Withdrawal by Subject|3
4968590|NCT00127842|17076498|P1|Overall Study|Adverse Event|15
4968591|NCT00127803|17076516|P4|Overall Study|Lost to Follow-up|1
4968592|NCT00127803|17076517|P3|Overall Study|Lost to Follow-up|0
4968593|NCT00127803|17076518|P2|Overall Study|Lost to Follow-up|0
4968594|NCT00127803|17076519|P1|Overall Study|Lost to Follow-up|0
4968595|NCT00127803|17076516|P4|Overall Study|Withdrawal by Subject|0
4968596|NCT00127803|17076517|P3|Overall Study|Withdrawal by Subject|0
4968597|NCT00127803|17076518|P2|Overall Study|Withdrawal by Subject|0
4968598|NCT00127803|17076519|P1|Overall Study|Withdrawal by Subject|1
4968599|NCT00127803|17076516|P4|Overall Study|Adverse Event|0
4968600|NCT00127803|17076517|P3|Overall Study|Adverse Event|0
4968601|NCT00127803|17076518|P2|Overall Study|Adverse Event|0
4968602|NCT00127803|17076519|P1|Overall Study|Adverse Event|2
4968603|NCT00127712|17076568|P2|Overall Study|Lack of GI access to continue|0
4968604|NCT00127712|17076569|P1|Overall Study|Lack of GI access to continue|2
4968605|NCT00127712|17076568|P2|Overall Study|Adverse Event|0
4968606|NCT00127712|17076569|P1|Overall Study|Adverse Event|3
4968607|NCT00127660|17076585|P4|Overall Study|Protocol Violation|0
4968608|NCT00127660|17076586|P3|Overall Study|Protocol Violation|5
4968609|NCT00127660|17076587|P2|Overall Study|Protocol Violation|3
4968610|NCT00127660|17076588|P1|Overall Study|Protocol Violation|3
4968611|NCT00127608|17076598|P1|Overall Study|VZV DNA negative|1
4968612|NCT00127413|17076642|P4|Overall Study|Lost to Follow-up|2
4968613|NCT00127413|17076643|P3|Overall Study|Lost to Follow-up|8
4968614|NCT00127413|17076644|P2|Overall Study|Lost to Follow-up|4
4968615|NCT00127413|17076645|P1|Overall Study|Lost to Follow-up|6
4968616|NCT00127205|17076686|P3|Overall Study|Progression|84
4968617|NCT00127205|17076687|P2|Overall Study|Progression|130
4968618|NCT00127205|17076688|P1|Overall Study|Progression|127
4968619|NCT00127205|17076686|P3|Overall Study|Under Review|6
4968620|NCT00127205|17076687|P2|Overall Study|Under Review|21
4968621|NCT00127205|17076688|P1|Overall Study|Under Review|13
4968622|NCT00127205|17076686|P3|Overall Study|Other-non protocol specified|77
4968623|NCT00127205|17076687|P2|Overall Study|Other-non protocol specified|129
4968624|NCT00127205|17076688|P1|Overall Study|Other-non protocol specified|141
4968625|NCT00127205|17076686|P3|Overall Study|Withdrawal by Subject|172
4968626|NCT00127205|17076687|P2|Overall Study|Withdrawal by Subject|308
4968627|NCT00127205|17076688|P1|Overall Study|Withdrawal by Subject|318
4968628|NCT00127205|17076686|P3|Overall Study|Death|6
4968629|NCT00127205|17076687|P2|Overall Study|Death|6
4968630|NCT00127205|17076688|P1|Overall Study|Death|8
4968631|NCT00127205|17076686|P3|Overall Study|Adverse Event|272
4968632|NCT00127205|17076687|P2|Overall Study|Adverse Event|386
4968633|NCT00127205|17076688|P1|Overall Study|Adverse Event|228
4968634|NCT00127192|17076710|P5|Overall Study|Adverse event in pre-treatment period|0
4968635|NCT00127192|17076711|P4|Overall Study|Adverse event in pre-treatment period|0
4968636|NCT00127192|17076712|P3|Overall Study|Adverse event in pre-treatment period|0
4968637|NCT00127192|17076713|P2|Overall Study|Adverse event in pre-treatment period|0
4968638|NCT00127192|17076714|P1|Overall Study|Adverse event in pre-treatment period|1
4968639|NCT00127192|17076710|P5|Overall Study|Withdrawal by Subject|3
4968640|NCT00127192|17076711|P4|Overall Study|Withdrawal by Subject|0
4968641|NCT00127192|17076712|P3|Overall Study|Withdrawal by Subject|1
4968642|NCT00127192|17076713|P2|Overall Study|Withdrawal by Subject|0
4968643|NCT00127192|17076714|P1|Overall Study|Withdrawal by Subject|0
4968644|NCT00127192|17076710|P5|Overall Study|Lack of Efficacy|2
4968645|NCT00127192|17076711|P4|Overall Study|Lack of Efficacy|0
4968646|NCT00127192|17076712|P3|Overall Study|Lack of Efficacy|0
4968647|NCT00127192|17076713|P2|Overall Study|Lack of Efficacy|0
4968648|NCT00127192|17076714|P1|Overall Study|Lack of Efficacy|2
4968649|NCT00127192|17076710|P5|Overall Study|Adverse Event|0
4968650|NCT00127192|17076711|P4|Overall Study|Adverse Event|1
4968651|NCT00127192|17076712|P3|Overall Study|Adverse Event|1
4968652|NCT00127192|17076713|P2|Overall Study|Adverse Event|1
4968653|NCT00127192|17076714|P1|Overall Study|Adverse Event|0
4968654|NCT00127166|17076738|P2|Period II|Patient did not perform Visit 6 exercise|0
4968655|NCT00127166|17076739|P1|Period II|Patient did not perform Visit 6 exercise|1
4968656|NCT00127166|17076738|P2|Period II|Withdrawal by Subject|0
4968657|NCT00127166|17076739|P1|Period II|Withdrawal by Subject|2
4968658|NCT00127166|17076738|P2|Washout Period|Patient did not meet inclusion criteria|1
4968659|NCT00127166|17076739|P1|Washout Period|Patient did not meet inclusion criteria|0
4968660|NCT00127166|17076738|P2|Period I|Patient did not meet inclusion criteria|0
4968661|NCT00127166|17076739|P1|Period I|Patient did not meet inclusion criteria|1
4968662|NCT00127166|17076738|P2|Period I|Withdrawal by Subject|0
4968663|NCT00127166|17076739|P1|Period I|Withdrawal by Subject|2
4968664|NCT00127166|17076738|P2|Period I|Protocol Violation|2
4968665|NCT00127166|17076739|P1|Period I|Protocol Violation|0
4968666|NCT00127101|17076759|P6|Continuation Phase|Withdrawal by Subject|1
4968667|NCT00127101|17076760|P5|Continuation Phase|Withdrawal by Subject|2
4968668|NCT00127101|17076761|P4|Continuation Phase|Withdrawal by Subject|0
4968669|NCT00127101|17076762|P3|Continuation Phase|Withdrawal by Subject|1
4968670|NCT00127101|17076763|P2|Continuation Phase|Withdrawal by Subject|0
4968671|NCT00127101|17076764|P1|Continuation Phase|Withdrawal by Subject|0
4968672|NCT00127101|17076759|P6|Continuation Phase|Lack of Efficacy|1
4968673|NCT00127101|17076760|P5|Continuation Phase|Lack of Efficacy|0
4968674|NCT00127101|17076761|P4|Continuation Phase|Lack of Efficacy|0
4968675|NCT00127101|17076762|P3|Continuation Phase|Lack of Efficacy|0
4968676|NCT00127101|17076763|P2|Continuation Phase|Lack of Efficacy|0
4968677|NCT00127101|17076764|P1|Continuation Phase|Lack of Efficacy|0
4968678|NCT00127101|17076759|P6|Continuation Phase|Adverse Event|1
4968679|NCT00127101|17076760|P5|Continuation Phase|Adverse Event|1
4968680|NCT00127101|17076761|P4|Continuation Phase|Adverse Event|0
4968681|NCT00127101|17076762|P3|Continuation Phase|Adverse Event|0
4968682|NCT00127101|17076763|P2|Continuation Phase|Adverse Event|0
4968683|NCT00127101|17076764|P1|Continuation Phase|Adverse Event|0
4968684|NCT00127101|17076759|P6|Base Protocol|Withdrawal by Subject|1
4968685|NCT00127101|17076760|P5|Base Protocol|Withdrawal by Subject|0
4968686|NCT00127101|17076761|P4|Base Protocol|Withdrawal by Subject|0
4968687|NCT00127101|17076762|P3|Base Protocol|Withdrawal by Subject|1
4968688|NCT00127101|17076763|P2|Base Protocol|Withdrawal by Subject|2
4968689|NCT00127101|17076764|P1|Base Protocol|Withdrawal by Subject|1
4968690|NCT00127101|17076759|P6|Base Protocol|Lack of Efficacy|0
4968691|NCT00127101|17076760|P5|Base Protocol|Lack of Efficacy|2
4968692|NCT00127101|17076761|P4|Base Protocol|Lack of Efficacy|0
4968693|NCT00127101|17076762|P3|Base Protocol|Lack of Efficacy|0
4968694|NCT00127101|17076763|P2|Base Protocol|Lack of Efficacy|0
4968695|NCT00127101|17076764|P1|Base Protocol|Lack of Efficacy|1
4968696|NCT00127101|17076759|P6|Base Protocol|Adverse Event|0
4968697|NCT00127101|17076760|P5|Base Protocol|Adverse Event|0
4968698|NCT00127101|17076761|P4|Base Protocol|Adverse Event|0
4968699|NCT00127101|17076762|P3|Base Protocol|Adverse Event|1
4968700|NCT00127101|17076763|P2|Base Protocol|Adverse Event|2
4968701|NCT00127101|17076764|P1|Base Protocol|Adverse Event|0
4968702|NCT00127036|17076799|P2|Overall Study|Screen Failure|0
4968703|NCT00127036|17076800|P1|Overall Study|Screen Failure|2
4968704|NCT00127036|17076799|P2|Overall Study|Insufficient Data for Analysis|11
4968705|NCT00127036|17076800|P1|Overall Study|Insufficient Data for Analysis|6
4968706|NCT00126776|17076812|P2|Overall Study|follow up complete on all patients|0
4968707|NCT00126776|17076813|P1|Overall Study|follow up complete on all patients|0
4968708|NCT00126659|17076862|P3|Overall Study|Adverse Event|2
4968709|NCT00126659|17076863|P2|Overall Study|Adverse Event|0
4968710|NCT00126659|17076864|P1|Overall Study|Adverse Event|0
4968711|NCT00126594|17076872|P2|Overall Study|Disease Progression|24
4968712|NCT00126594|17076873|P1|Overall Study|Disease Progression|29
4968713|NCT00126594|17076872|P2|Overall Study|Non-compliance|1
4968714|NCT00126594|17076873|P1|Overall Study|Non-compliance|0
4968715|NCT00126594|17076872|P2|Overall Study|Adverse Event|5
4968716|NCT00126594|17076873|P1|Overall Study|Adverse Event|7
4968717|NCT00126594|17076872|P2|Overall Study|Physician Decision|3
4968718|NCT00126594|17076873|P1|Overall Study|Physician Decision|1
4968719|NCT00126594|17076872|P2|Overall Study|Withdrawal by Subject|4
4968720|NCT00126594|17076873|P1|Overall Study|Withdrawal by Subject|0
4968721|NCT00126594|17076872|P2|Overall Study|Ineligible|0
4968722|NCT00126594|17076873|P1|Overall Study|Ineligible|2
4968723|NCT00126581|17076890|P2|Overall Study|Other illness/MD discretion|4
4968724|NCT00126581|17076891|P1|Overall Study|Other illness/MD discretion|3
4968725|NCT00126581|17076890|P2|Overall Study|Alternative therapy|3
4968726|NCT00126581|17076891|P1|Overall Study|Alternative therapy|3
4968727|NCT00126581|17076890|P2|Overall Study|Withdrawal by Subject|4
4968728|NCT00126581|17076891|P1|Overall Study|Withdrawal by Subject|1
4968729|NCT00126581|17076890|P2|Overall Study|Death|2
4968730|NCT00126581|17076891|P1|Overall Study|Death|3
4968731|NCT00126581|17076890|P2|Overall Study|Adverse Event|7
4968732|NCT00126581|17076891|P1|Overall Study|Adverse Event|3
4968733|NCT00126568|17076911|P1|Overall Study|Death|2
4968734|NCT00126555|17076918|P1|Overall Study|Progressive Disease|3
4968735|NCT00126555|17076918|P1|Overall Study|Adverse Event|2
4968736|NCT00126555|17076918|P1|Overall Study|Withdrawal by Subject|1
4968737|NCT00126503|17076940|P2|Overall Study|Physician Decision|1
4968738|NCT00126503|17076941|P1|Overall Study|Physician Decision|2
4968739|NCT00126503|17076940|P2|Overall Study|non-compliant|0
4968740|NCT00126503|17076941|P1|Overall Study|non-compliant|1
4968741|NCT00126503|17076940|P2|Overall Study|Adverse Event|3
4968742|NCT00126503|17076941|P1|Overall Study|Adverse Event|13
4968743|NCT00126503|17076940|P2|Overall Study|Death|0
4968744|NCT00126503|17076941|P1|Overall Study|Death|3
4968745|NCT00126503|17076940|P2|Overall Study|other complicating disease|1
4968746|NCT00126503|17076941|P1|Overall Study|other complicating disease|4
4968747|NCT00126503|17076940|P2|Overall Study|alternative therapy|1
4968748|NCT00126503|17076941|P1|Overall Study|alternative therapy|1
4968749|NCT00126503|17076940|P2|Overall Study|Withdrawal by Subject|1
4968750|NCT00126503|17076941|P1|Overall Study|Withdrawal by Subject|0
4968751|NCT00126503|17076940|P2|Overall Study|disease progression|14
4968752|NCT00126503|17076941|P1|Overall Study|disease progression|23
4968753|NCT00126490|17076953|P1|Overall Study|Stopped after 1 infusion (fall/injury)|1
4968754|NCT00126438|17076963|P2|Overall Study|Withdrawal by Subject|2
4968755|NCT00126438|17076964|P1|Overall Study|Withdrawal by Subject|3
4968756|NCT00126438|17076963|P2|Overall Study|Protocol Violation|8
4968757|NCT00126438|17076964|P1|Overall Study|Protocol Violation|8
4968758|NCT00126438|17076963|P2|Overall Study|Lost to Follow-up|0
4968759|NCT00126438|17076964|P1|Overall Study|Lost to Follow-up|22
4968760|NCT00126438|17076963|P2|Overall Study|Withdrawal due to adverse event|0
4968761|NCT00126438|17076964|P1|Overall Study|Withdrawal due to adverse event|1
4968762|NCT00126425|17076972|P2|Overall Study|Other|0
4968763|NCT00126425|17076973|P1|Overall Study|Other|5
4968764|NCT00126425|17076972|P2|Overall Study|Failed Inclusion Exclusion Criteria|0
4968765|NCT00126425|17076973|P1|Overall Study|Failed Inclusion Exclusion Criteria|1
4968766|NCT00126425|17076972|P2|Overall Study|Adverse Event|0
4968767|NCT00126425|17076973|P1|Overall Study|Adverse Event|1
4968768|NCT00126425|17076972|P2|Overall Study|Protocol Violation|6
4968769|NCT00126425|17076973|P1|Overall Study|Protocol Violation|9
4968770|NCT00126425|17076972|P2|Overall Study|Lost to Follow-up|4
4968771|NCT00126425|17076973|P1|Overall Study|Lost to Follow-up|8
4968772|NCT00126425|17076972|P2|Overall Study|Withdrawal by Subject|1
4968773|NCT00126425|17076973|P1|Overall Study|Withdrawal by Subject|17
4968774|NCT00126191|17076981|P2|Overall Study|Death|1
4968775|NCT00126191|17076982|P1|Overall Study|Death|0
4968776|NCT00126191|17076981|P2|Overall Study|Physician Decision|1
4968777|NCT00126191|17076982|P1|Overall Study|Physician Decision|0
4968778|NCT00126126|17076992|P2|Overall Study|Lost to Follow-up|2
4968779|NCT00126126|17076993|P1|Overall Study|Lost to Follow-up|0
4968780|NCT00125853|17077032|P2|Wash-out (4 Weeks)|Lost to Follow-up|7
4968781|NCT00125853|17077033|P1|Wash-out (4 Weeks)|Lost to Follow-up|3
4968782|NCT00125359|17077147|P1|Overall Study|Physician Decision|14
4968783|NCT00125359|17077147|P1|Overall Study|Adverse Event|5
4968784|NCT00125359|17077147|P1|Overall Study|Death|4
4968785|NCT00125268|17077156|P2|Overall Study|Withdrawal by Subject|1
4968786|NCT00125268|17077157|P1|Overall Study|Withdrawal by Subject|1
4968787|NCT00125242|17077169|P2|Overall Study|did not qualify|2
4968788|NCT00125242|17077170|P1|Overall Study|did not qualify|7
4968789|NCT00125190|17077175|P1|Overall Study|Lost to Follow-up|4
4968790|NCT00125190|17077175|P1|Overall Study|Other|1
4968791|NCT00125190|17077175|P1|Overall Study|Adverse Event|1
4968792|NCT00125190|17077175|P1|Overall Study|Non-compliance|2
4968793|NCT00125190|17077175|P1|Overall Study|Subject/Parent Decision|7
4968794|NCT00125164|17077191|P4|Overall Study|Withdrawal by Subject|1
4968795|NCT00125164|17077192|P3|Overall Study|Withdrawal by Subject|1
4968796|NCT00125164|17077193|P2|Overall Study|Withdrawal by Subject|0
4968797|NCT00125164|17077194|P1|Overall Study|Withdrawal by Subject|2
4968798|NCT00125164|17077191|P4|Overall Study|Lost to Follow-up|1
4968799|NCT00125164|17077192|P3|Overall Study|Lost to Follow-up|1
4968800|NCT00125164|17077193|P2|Overall Study|Lost to Follow-up|0
4968801|NCT00125164|17077194|P1|Overall Study|Lost to Follow-up|0
4968802|NCT00125164|17077191|P4|Overall Study|Adverse Event|4
4968803|NCT00125164|17077192|P3|Overall Study|Adverse Event|2
4968804|NCT00125164|17077193|P2|Overall Study|Adverse Event|0
4968805|NCT00125164|17077194|P1|Overall Study|Adverse Event|0
4968806|NCT00125138|17077248|P4|Overall Study|Sponsor decision-pt moved to assist care|1
4968807|NCT00125138|17077249|P3|Overall Study|Sponsor decision-pt moved to assist care|0
4968808|NCT00125138|17077250|P2|Overall Study|Sponsor decision-pt moved to assist care|0
4968809|NCT00125138|17077251|P1|Overall Study|Sponsor decision-pt moved to assist care|0
4968810|NCT00125138|17077248|P4|Overall Study|Lack of Efficacy|1
4968811|NCT00125138|17077249|P3|Overall Study|Lack of Efficacy|0
4968812|NCT00125138|17077250|P2|Overall Study|Lack of Efficacy|0
4968813|NCT00125138|17077251|P1|Overall Study|Lack of Efficacy|0
4968814|NCT00125138|17077248|P4|Overall Study|Withdrawal by Subject|1
4968815|NCT00125138|17077249|P3|Overall Study|Withdrawal by Subject|1
4968816|NCT00125138|17077250|P2|Overall Study|Withdrawal by Subject|3
4968817|NCT00125138|17077251|P1|Overall Study|Withdrawal by Subject|2
4968818|NCT00125138|17077248|P4|Overall Study|Adverse Event|2
4968819|NCT00125138|17077249|P3|Overall Study|Adverse Event|3
4968820|NCT00125138|17077250|P2|Overall Study|Adverse Event|0
4968821|NCT00125138|17077251|P1|Overall Study|Adverse Event|1
4968822|NCT00124982|17077300|P3|Long-term Period|Neurologist Recommendation|1
4968823|NCT00124982|17077301|P2|Long-term Period|Neurologist Recommendation|0
4968824|NCT00124982|17077302|P1|Long-term Period|Neurologist Recommendation|0
4968825|NCT00124982|17077300|P3|Long-term Period|Administrative Reason by Sponsor|1
4968826|NCT00124982|17077301|P2|Long-term Period|Administrative Reason by Sponsor|0
4968827|NCT00124982|17077302|P1|Long-term Period|Administrative Reason by Sponsor|0
4968828|NCT00124982|17077300|P3|Long-term Period|Poor/Non-compliance|2
4968829|NCT00124982|17077301|P2|Long-term Period|Poor/Non-compliance|0
4968830|NCT00124982|17077302|P1|Long-term Period|Poor/Non-compliance|0
4968831|NCT00124982|17077300|P3|Long-term Period|Pregnancy|1
4968832|NCT00124982|17077301|P2|Long-term Period|Pregnancy|0
4968833|NCT00124982|17077302|P1|Long-term Period|Pregnancy|0
4968834|NCT00124982|17077300|P3|Long-term Period|Withdrawal by Subject|16
4968835|NCT00124982|17077301|P2|Long-term Period|Withdrawal by Subject|0
4968836|NCT00124982|17077302|P1|Long-term Period|Withdrawal by Subject|0
4968837|NCT00124982|17077300|P3|Long-term Period|Lost to Follow-up|4
4968838|NCT00124982|17077301|P2|Long-term Period|Lost to Follow-up|0
4968839|NCT00124982|17077302|P1|Long-term Period|Lost to Follow-up|0
4968840|NCT00124982|17077300|P3|Long-term Period|Lack of Efficacy|46
4968841|NCT00124982|17077301|P2|Long-term Period|Lack of Efficacy|0
4968842|NCT00124982|17077302|P1|Long-term Period|Lack of Efficacy|0
4968843|NCT00124982|17077300|P3|Long-term Period|Adverse Event|17
4968844|NCT00124982|17077301|P2|Long-term Period|Adverse Event|0
4968845|NCT00124982|17077302|P1|Long-term Period|Adverse Event|0
4968846|NCT00124982|17077300|P3|Long-term Period|Death|1
4968847|NCT00124982|17077301|P2|Long-term Period|Death|0
4968848|NCT00124982|17077302|P1|Long-term Period|Death|0
4968849|NCT00124982|17077300|P3|Short-term Period|Participant Had Lymphopenia|0
4968850|NCT00124982|17077301|P2|Short-term Period|Participant Had Lymphopenia|0
4968851|NCT00124982|17077302|P1|Short-term Period|Participant Had Lymphopenia|1
4968852|NCT00124982|17077300|P3|Short-term Period|Investigator Decision-No Specific AE|0
4968853|NCT00124982|17077301|P2|Short-term Period|Investigator Decision-No Specific AE|0
4968854|NCT00124982|17077302|P1|Short-term Period|Investigator Decision-No Specific AE|1
4968855|NCT00124982|17077300|P3|Short-term Period|Participant Chose Own Doctor|0
4968856|NCT00124982|17077301|P2|Short-term Period|Participant Chose Own Doctor|1
4968857|NCT00124982|17077302|P1|Short-term Period|Participant Chose Own Doctor|0
4968858|NCT00124982|17077300|P3|Short-term Period|Participant Decision|0
4968859|NCT00124982|17077301|P2|Short-term Period|Participant Decision|0
4968860|NCT00124982|17077302|P1|Short-term Period|Participant Decision|1
4968861|NCT00124982|17077300|P3|Short-term Period|No Longer Meets Study Criteria|0
4968862|NCT00124982|17077301|P2|Short-term Period|No Longer Meets Study Criteria|2
4968863|NCT00124982|17077302|P1|Short-term Period|No Longer Meets Study Criteria|1
4968864|NCT00124982|17077300|P3|Short-term Period|Poor/Non-compliance|0
4968865|NCT00124982|17077301|P2|Short-term Period|Poor/Non-compliance|1
4968866|NCT00124982|17077302|P1|Short-term Period|Poor/Non-compliance|3
4968867|NCT00124982|17077300|P3|Short-term Period|Withdrawal of Consent|0
4968868|NCT00124982|17077301|P2|Short-term Period|Withdrawal of Consent|9
4968869|NCT00124982|17077302|P1|Short-term Period|Withdrawal of Consent|7
4968870|NCT00124982|17077300|P3|Short-term Period|Lost to Follow-up|0
4968871|NCT00124982|17077301|P2|Short-term Period|Lost to Follow-up|5
4968872|NCT00124982|17077302|P1|Short-term Period|Lost to Follow-up|8
4968873|NCT00124982|17077300|P3|Short-term Period|Lack of Efficacy|0
4968874|NCT00124982|17077301|P2|Short-term Period|Lack of Efficacy|73
4968875|NCT00124982|17077302|P1|Short-term Period|Lack of Efficacy|32
4968876|NCT00124982|17077300|P3|Short-term Period|Adverse Event|0
4968877|NCT00124982|17077301|P2|Short-term Period|Adverse Event|22
4968878|NCT00124982|17077302|P1|Short-term Period|Adverse Event|17
4968879|NCT00124982|17077300|P3|Short-term Period|Death|0
4968880|NCT00124982|17077301|P2|Short-term Period|Death|1
4968881|NCT00124982|17077302|P1|Short-term Period|Death|1
4968882|NCT00124943|17077384|P4|Phase II|Withdrawal by Subject|2
4968883|NCT00124943|17077385|P3|Phase II|Withdrawal by Subject|0
4968884|NCT00124943|17077386|P2|Phase II|Withdrawal by Subject|0
4968885|NCT00124943|17077387|P1|Phase II|Withdrawal by Subject|0
4968886|NCT00124943|17077384|P4|Phase II|Lost to Follow-up|1
4968887|NCT00124943|17077385|P3|Phase II|Lost to Follow-up|0
4968888|NCT00124943|17077386|P2|Phase II|Lost to Follow-up|0
4968889|NCT00124943|17077387|P1|Phase II|Lost to Follow-up|0
4968890|NCT00124943|17077384|P4|Phase II|Protocol Violation|1
4968891|NCT00124943|17077385|P3|Phase II|Protocol Violation|0
4968892|NCT00124943|17077386|P2|Phase II|Protocol Violation|0
4968893|NCT00124943|17077387|P1|Phase II|Protocol Violation|0
4968894|NCT00124943|17077384|P4|Phase II|Adverse Event|1
4968895|NCT00124943|17077385|P3|Phase II|Adverse Event|0
4968896|NCT00124943|17077386|P2|Phase II|Adverse Event|2
4968897|NCT00124943|17077387|P1|Phase II|Adverse Event|0
4968898|NCT00124917|17077425|P1|Overall Study|Physician Decision|3
4968899|NCT00124748|17077435|P2|Overall Study|Death|3
4968900|NCT00124748|17077436|P1|Overall Study|Death|1
4969065|NCT00123422|17077944|P2|Overall Study|Physician Decision|2
4968901|NCT00124748|17077435|P2|Overall Study|Administrative Problem(Study Terminated)|174
4968902|NCT00124748|17077436|P1|Overall Study|Administrative Problem(Study Terminated)|101
4968903|NCT00124748|17077435|P2|Overall Study|Lost to Follow-up|7
4968904|NCT00124748|17077436|P1|Overall Study|Lost to Follow-up|2
4968905|NCT00124748|17077435|P2|Overall Study|Withdrawal by Subject|15
4968906|NCT00124748|17077436|P1|Overall Study|Withdrawal by Subject|5
4968907|NCT00124748|17077435|P2|Overall Study|Protocol Violation|1
4968908|NCT00124748|17077436|P1|Overall Study|Protocol Violation|3
4968909|NCT00124748|17077435|P2|Overall Study|No longer requires study drug|1
4968910|NCT00124748|17077436|P1|Overall Study|No longer requires study drug|1
4968911|NCT00124748|17077435|P2|Overall Study|Lack of Efficacy|41
4968912|NCT00124748|17077436|P1|Overall Study|Lack of Efficacy|20
4968913|NCT00124748|17077435|P2|Overall Study|Abnormal Procedure|1
4968914|NCT00124748|17077436|P1|Overall Study|Abnormal Procedure|0
4968915|NCT00124748|17077435|P2|Overall Study|Abnormal laboratory Value|2
4968916|NCT00124748|17077436|P1|Overall Study|Abnormal laboratory Value|2
4968917|NCT00124748|17077435|P2|Overall Study|Adverse Event|39
4968918|NCT00124748|17077436|P1|Overall Study|Adverse Event|8
4968919|NCT00124709|17077543|P2|Overall Study|Lost to Follow-up|120
4968920|NCT00124709|17077544|P1|Overall Study|Lost to Follow-up|114
4968921|NCT00124709|17077543|P2|Overall Study|Withdrawal by Subject|136
4968922|NCT00124709|17077544|P1|Overall Study|Withdrawal by Subject|127
4968923|NCT00124709|17077543|P2|Overall Study|Protocol Violation|5
4968924|NCT00124709|17077544|P1|Overall Study|Protocol Violation|3
4968925|NCT00124709|17077543|P2|Overall Study|Lack of Efficacy|10
4968926|NCT00124709|17077544|P1|Overall Study|Lack of Efficacy|5
4968927|NCT00124709|17077543|P2|Overall Study|Adverse Event|0
4968928|NCT00124709|17077544|P1|Overall Study|Adverse Event|3
4968929|NCT00124709|17077543|P2|Overall Study|Randomized but did not take medication|1
4968930|NCT00124709|17077544|P1|Overall Study|Randomized but did not take medication|3
4968931|NCT00124657|17077561|P3|Overall Study|Intercurrent illness|0
4968932|NCT00124657|17077562|P2|Overall Study|Intercurrent illness|0
4968933|NCT00124657|17077563|P1|Overall Study|Intercurrent illness|1
4968934|NCT00124657|17077561|P3|Overall Study|Progressive disease|27
4968935|NCT00124657|17077562|P2|Overall Study|Progressive disease|5
4968936|NCT00124657|17077563|P1|Overall Study|Progressive disease|14
4968937|NCT00124657|17077561|P3|Overall Study|Non-compliance|4
4968938|NCT00124657|17077562|P2|Overall Study|Non-compliance|0
4968939|NCT00124657|17077563|P1|Overall Study|Non-compliance|1
4968940|NCT00124657|17077561|P3|Overall Study|Toxicity|1
4968941|NCT00124657|17077562|P2|Overall Study|Toxicity|0
4968942|NCT00124657|17077563|P1|Overall Study|Toxicity|0
4968943|NCT00124618|17077598|P1|Overall Study|Ineligible|1
4968944|NCT00124462|17077613|P2|Overall Study|Device fitting, n=2, other hlth issues|1
4968945|NCT00124462|17077614|P1|Overall Study|Device fitting, n=2, other hlth issues|1
4968946|NCT00124462|17077613|P2|Overall Study|Withdrawal by Subject|5
4968947|NCT00124462|17077614|P1|Overall Study|Withdrawal by Subject|4
4968948|NCT00124462|17077613|P2|Overall Study|Physician Decision|4
4968949|NCT00124462|17077614|P1|Overall Study|Physician Decision|3
4968950|NCT00124462|17077613|P2|Overall Study|Lost to Follow-up|3
4968951|NCT00124462|17077614|P1|Overall Study|Lost to Follow-up|3
4968952|NCT00124449|17077624|P2|18-Month Untreated Observation Period|Relocated|0
4968953|NCT00124449|17077625|P1|18-Month Untreated Observation Period|Relocated|1
4968954|NCT00124449|17077624|P2|18-Month Untreated Observation Period|Poor/Noncompliance|0
4968955|NCT00124449|17077625|P1|18-Month Untreated Observation Period|Poor/Noncompliance|1
4968956|NCT00124449|17077624|P2|18-Month Untreated Observation Period|Pregnancy|0
4968957|NCT00124449|17077625|P1|18-Month Untreated Observation Period|Pregnancy|1
4968958|NCT00124449|17077624|P2|18-Month Untreated Observation Period|Lost to Follow-up|0
4968959|NCT00124449|17077625|P1|18-Month Untreated Observation Period|Lost to Follow-up|1
4968960|NCT00124449|17077624|P2|18-Month Untreated Observation Period|Lack of Efficacy|12
4968961|NCT00124449|17077625|P1|18-Month Untreated Observation Period|Lack of Efficacy|11
4968962|NCT00124449|17077624|P2|18-Month Untreated Observation Period|Adverse Event|1
4968963|NCT00124449|17077625|P1|18-Month Untreated Observation Period|Adverse Event|0
4968964|NCT00124449|17077624|P2|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1
4968965|NCT00124449|17077625|P1|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0
4968966|NCT00124449|17077624|P2|6-month Double-Blind Treatment Period|Sponsor request|1
4968967|NCT00124449|17077625|P1|6-month Double-Blind Treatment Period|Sponsor request|0
4968968|NCT00124449|17077624|P2|6-month Double-Blind Treatment Period|Poor/Noncompliance|0
4968969|NCT00124449|17077625|P1|6-month Double-Blind Treatment Period|Poor/Noncompliance|1
4968970|NCT00124449|17077624|P2|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
4968971|NCT00124449|17077625|P1|6-month Double-Blind Treatment Period|Withdrawal by Subject|1
4968972|NCT00124449|17077624|P2|6-month Double-Blind Treatment Period|Lack of Efficacy|8
4968973|NCT00124449|17077625|P1|6-month Double-Blind Treatment Period|Lack of Efficacy|3
4968974|NCT00124449|17077624|P2|6-month Double-Blind Treatment Period|Adverse Event|0
4968975|NCT00124449|17077625|P1|6-month Double-Blind Treatment Period|Adverse Event|1
4968976|NCT00124072|17077679|P4|Overall Study|Death|480
4968977|NCT00124072|17077680|P3|Overall Study|Death|471
4968978|NCT00124072|17077681|P2|Overall Study|Death|484
4968979|NCT00124072|17077682|P1|Overall Study|Death|499
4968980|NCT00124072|17077679|P4|Overall Study|Lost to Follow-up for Morbidity|18
4968981|NCT00124072|17077680|P3|Overall Study|Lost to Follow-up for Morbidity|19
4968982|NCT00124072|17077681|P2|Overall Study|Lost to Follow-up for Morbidity|25
4968983|NCT00124072|17077682|P1|Overall Study|Lost to Follow-up for Morbidity|15
4968984|NCT00124072|17077679|P4|Overall Study|Lost to Follow-up for Mortality|2
4968985|NCT00124072|17077680|P3|Overall Study|Lost to Follow-up for Mortality|2
4968986|NCT00124072|17077681|P2|Overall Study|Lost to Follow-up for Mortality|3
4968987|NCT00124072|17077682|P1|Overall Study|Lost to Follow-up for Mortality|0
4968988|NCT00124020|17077694|P2|Overall Study|Transfer to another hospital|0
4968989|NCT00124020|17077695|P1|Overall Study|Transfer to another hospital|2
4968990|NCT00124020|17077694|P2|Overall Study|Other|1
4968991|NCT00124020|17077695|P1|Overall Study|Other|1
4968992|NCT00124020|17077694|P2|Overall Study|Lost to Follow-up|8
4968993|NCT00124020|17077695|P1|Overall Study|Lost to Follow-up|5
4968994|NCT00124020|17077694|P2|Overall Study|Withdrawal by Subject|11
4968995|NCT00124020|17077695|P1|Overall Study|Withdrawal by Subject|13
4968996|NCT00124020|17077694|P2|Overall Study|Death|71
4968997|NCT00124020|17077695|P1|Overall Study|Death|67
4968998|NCT00123955|17077703|P2|Overall Study|Death|1
4968999|NCT00123955|17077704|P1|Overall Study|Death|0
4969000|NCT00123955|17077703|P2|Overall Study|Withdrawal by Subject|3
4969001|NCT00123955|17077704|P1|Overall Study|Withdrawal by Subject|4
4969002|NCT00123955|17077703|P2|Overall Study|Adverse Event|0
4969003|NCT00123955|17077704|P1|Overall Study|Adverse Event|1
4969004|NCT00123734|17077716|P1|Overall Study|Withdrawal by Subject|1
4969005|NCT00123734|17077716|P1|Overall Study|Dropout|1
4969006|NCT00123734|17077716|P1|Overall Study|Lost to Follow-up|3
4969007|NCT00123734|17077716|P1|Overall Study|Death|3
4969008|NCT00123487|17077801|P2|Treated With Study Drug|Unknown (case report form lost)|1
4969009|NCT00123487|17077802|P1|Treated With Study Drug|Unknown (case report form lost)|0
4969010|NCT00123487|17077801|P2|Treated With Study Drug|Withdrawal by Subject|13
4969011|NCT00123487|17077802|P1|Treated With Study Drug|Withdrawal by Subject|11
4969012|NCT00123487|17077801|P2|Treated With Study Drug|Study Drug Toxicity|80
4969013|NCT00123487|17077802|P1|Treated With Study Drug|Study Drug Toxicity|62
4969014|NCT00123487|17077801|P2|Treated With Study Drug|Other|58
4969015|NCT00123487|17077802|P1|Treated With Study Drug|Other|59
4969016|NCT00123487|17077801|P2|Treated With Study Drug|Physician Decision|9
4969017|NCT00123487|17077802|P1|Treated With Study Drug|Physician Decision|8
4969018|NCT00123487|17077801|P2|Treated With Study Drug|Disease Progression|122
4969019|NCT00123487|17077802|P1|Treated With Study Drug|Disease Progression|141
4969020|NCT00123487|17077801|P2|Treated With Study Drug|Adverse Event|22
4969021|NCT00123487|17077802|P1|Treated With Study Drug|Adverse Event|23
4969022|NCT00123487|17077801|P2|Randomized|SAE prior to starting treatment|0
4969023|NCT00123487|17077802|P1|Randomized|SAE prior to starting treatment|1
4969024|NCT00123487|17077801|P2|Randomized|Death prior to starting treatment|1
4969025|NCT00123487|17077802|P1|Randomized|Death prior to starting treatment|0
4969026|NCT00123474|17077846|P4|As Treated at Study Closure|Withdrawal by Subject|16
4969027|NCT00123474|17077847|P3|As Treated at Study Closure|Withdrawal by Subject|18
4969028|NCT00123474|17077848|P2|As Treated at Study Closure|Withdrawal by Subject|19
4969029|NCT00123474|17077849|P1|As Treated at Study Closure|Withdrawal by Subject|14
4969030|NCT00123474|17077846|P4|As Treated at Study Closure|Study Drug Toxicity|51
4969031|NCT00123474|17077847|P3|As Treated at Study Closure|Study Drug Toxicity|45
4969032|NCT00123474|17077848|P2|As Treated at Study Closure|Study Drug Toxicity|45
4969033|NCT00123474|17077849|P1|As Treated at Study Closure|Study Drug Toxicity|39
4969034|NCT00123474|17077846|P4|As Treated at Study Closure|non-specified|60
4969035|NCT00123474|17077847|P3|As Treated at Study Closure|non-specified|57
4969036|NCT00123474|17077848|P2|As Treated at Study Closure|non-specified|47
4969037|NCT00123474|17077849|P1|As Treated at Study Closure|non-specified|54
4969038|NCT00123474|17077846|P4|As Treated at Study Closure|Investigator Request|5
4969039|NCT00123474|17077847|P3|As Treated at Study Closure|Investigator Request|7
4969040|NCT00123474|17077848|P2|As Treated at Study Closure|Investigator Request|6
4969041|NCT00123474|17077849|P1|As Treated at Study Closure|Investigator Request|12
4969042|NCT00123474|17077846|P4|As Treated at Study Closure|Disease Progression|27
4969043|NCT00123474|17077847|P3|As Treated at Study Closure|Disease Progression|29
4969044|NCT00123474|17077848|P2|As Treated at Study Closure|Disease Progression|42
4969045|NCT00123474|17077849|P1|As Treated at Study Closure|Disease Progression|35
4969046|NCT00123474|17077846|P4|As Treated at Study Closure|Adverse Event|8
4969047|NCT00123474|17077847|P3|As Treated at Study Closure|Adverse Event|10
4969048|NCT00123474|17077848|P2|As Treated at Study Closure|Adverse Event|4
4969049|NCT00123474|17077849|P1|As Treated at Study Closure|Adverse Event|10
4969050|NCT00123474|17077846|P4|As Treated at Study Closure|not reported when site closed|0
4969051|NCT00123474|17077847|P3|As Treated at Study Closure|not reported when site closed|1
4969052|NCT00123474|17077848|P2|As Treated at Study Closure|not reported when site closed|0
4969053|NCT00123474|17077849|P1|As Treated at Study Closure|not reported when site closed|1
4969054|NCT00123474|17077846|P4|Randomized to Treatment|Randomized, never treated|1
4969055|NCT00123474|17077847|P3|Randomized to Treatment|Randomized, never treated|2
4969056|NCT00123474|17077848|P2|Randomized to Treatment|Randomized, never treated|4
4969057|NCT00123474|17077849|P1|Randomized to Treatment|Randomized, never treated|1
4969058|NCT00123422|17077943|P3|Overall Study|Lost to Follow-up|2
4969059|NCT00123422|17077944|P2|Overall Study|Lost to Follow-up|2
4969060|NCT00123422|17077945|P1|Overall Study|Lost to Follow-up|1
4969061|NCT00123422|17077943|P3|Overall Study|Withdrawal by Subject|2
4969062|NCT00123422|17077944|P2|Overall Study|Withdrawal by Subject|2
4969063|NCT00123422|17077945|P1|Overall Study|Withdrawal by Subject|1
4969064|NCT00123422|17077943|P3|Overall Study|Physician Decision|6
4969066|NCT00123422|17077945|P1|Overall Study|Physician Decision|2
4969067|NCT00122980|17078033|P2|Overall Study|Study termination|35
4969068|NCT00122980|17078034|P1|Overall Study|Study termination|27
4969069|NCT00122980|17078033|P2|Overall Study|Adjudicated stroke (study endpoint)|0
4969070|NCT00122980|17078034|P1|Overall Study|Adjudicated stroke (study endpoint)|7
4969071|NCT00122980|17078033|P2|Overall Study|Withdrawal by Subject|3
4969072|NCT00122980|17078034|P1|Overall Study|Withdrawal by Subject|2
4969073|NCT00122980|17078033|P2|Overall Study|Protocol Violation|1
4969074|NCT00122980|17078034|P1|Overall Study|Protocol Violation|5
4969075|NCT00122980|17078033|P2|Overall Study|Physician Decision|0
4969076|NCT00122980|17078034|P1|Overall Study|Physician Decision|2
4969077|NCT00122980|17078033|P2|Overall Study|Death|1
4969078|NCT00122980|17078034|P1|Overall Study|Death|0
4969079|NCT00122954|17078058|P2|Overall Study|Protocol Violation|1
4969080|NCT00122954|17078059|P1|Overall Study|Protocol Violation|0
4969081|NCT00122954|17078058|P2|Overall Study|Withdrawal by Subject|2
4969082|NCT00122954|17078059|P1|Overall Study|Withdrawal by Subject|2
4969083|NCT00122681|17078069|P2|Overall Study|Personal reasons|147
4969084|NCT00122681|17078070|P1|Overall Study|Personal reasons|150
4969085|NCT00122681|17078069|P2|Overall Study|Withdrawal by Subject|251
4969086|NCT00122681|17078070|P1|Overall Study|Withdrawal by Subject|257
4969087|NCT00122681|17078069|P2|Overall Study|Protocol Violation|10
4969088|NCT00122681|17078070|P1|Overall Study|Protocol Violation|7
4969089|NCT00122681|17078069|P2|Overall Study|Lost to Follow-up|1097
4969090|NCT00122681|17078070|P1|Overall Study|Lost to Follow-up|1080
4969091|NCT00122681|17078069|P2|Overall Study|Adverse Event|16
4969092|NCT00122681|17078070|P1|Overall Study|Adverse Event|20
4969093|NCT00122460|17078144|P2|Overall Study|investigational study phase ongoing|1
4969094|NCT00122460|17078145|P1|Overall Study|investigational study phase ongoing|7
4969095|NCT00122382|17078194|P3|Open-Label Study|Withdrawal of Consent|4
4969096|NCT00122382|17078195|P2|Open-Label Study|Withdrawal of Consent|0
4969097|NCT00122382|17078196|P1|Open-Label Study|Withdrawal of Consent|0
4969098|NCT00122382|17078194|P3|Open-Label Study|Poor/Non-Compliance|1
4969099|NCT00122382|17078195|P2|Open-Label Study|Poor/Non-Compliance|0
4969100|NCT00122382|17078196|P1|Open-Label Study|Poor/Non-Compliance|0
4969101|NCT00122382|17078194|P3|Open-Label Study|Pregnancy|2
4969102|NCT00122382|17078195|P2|Open-Label Study|Pregnancy|0
4969103|NCT00122382|17078196|P1|Open-Label Study|Pregnancy|0
4969104|NCT00122382|17078194|P3|Open-Label Study|Lost to Follow-up|3
4969105|NCT00122382|17078195|P2|Open-Label Study|Lost to Follow-up|0
4969106|NCT00122382|17078196|P1|Open-Label Study|Lost to Follow-up|0
4969107|NCT00122382|17078194|P3|Open-Label Study|Lack of Efficacy|3
4969108|NCT00122382|17078195|P2|Open-Label Study|Lack of Efficacy|0
4969109|NCT00122382|17078196|P1|Open-Label Study|Lack of Efficacy|0
4969110|NCT00122382|17078194|P3|Open-Label Study|Death|2
4969111|NCT00122382|17078195|P2|Open-Label Study|Death|0
4969112|NCT00122382|17078196|P1|Open-Label Study|Death|0
4969113|NCT00122382|17078194|P3|Open-Label Study|Adverse Event|11
4969114|NCT00122382|17078195|P2|Open-Label Study|Adverse Event|0
4969115|NCT00122382|17078196|P1|Open-Label Study|Adverse Event|0
4969116|NCT00122382|17078194|P3|Double-Blind Study|Randomized but not treated|0
4969117|NCT00122382|17078195|P2|Double-Blind Study|Randomized but not treated|2
4969118|NCT00122382|17078196|P1|Double-Blind Study|Randomized but not treated|0
4969119|NCT00122382|17078194|P3|Double-Blind Study|Methotrexate Discontinued|0
4969120|NCT00122382|17078195|P2|Double-Blind Study|Methotrexate Discontinued|1
4969121|NCT00122382|17078196|P1|Double-Blind Study|Methotrexate Discontinued|0
4969122|NCT00122382|17078194|P3|Double-Blind Study|Protocol Violation|0
4969123|NCT00122382|17078195|P2|Double-Blind Study|Protocol Violation|0
4969124|NCT00122382|17078196|P1|Double-Blind Study|Protocol Violation|1
4969125|NCT00122382|17078194|P3|Double-Blind Study|Withdrawal of Consent|0
4969126|NCT00122382|17078195|P2|Double-Blind Study|Withdrawal of Consent|3
4969127|NCT00122382|17078196|P1|Double-Blind Study|Withdrawal of Consent|7
4969128|NCT00122382|17078194|P3|Double-Blind Study|Subject No Longer Meets Study Criteria|0
4969129|NCT00122382|17078195|P2|Double-Blind Study|Subject No Longer Meets Study Criteria|0
4969130|NCT00122382|17078196|P1|Double-Blind Study|Subject No Longer Meets Study Criteria|1
4969131|NCT00122382|17078194|P3|Double-Blind Study|Pregnancy|0
4969132|NCT00122382|17078195|P2|Double-Blind Study|Pregnancy|0
4969133|NCT00122382|17078196|P1|Double-Blind Study|Pregnancy|2
4969134|NCT00122382|17078194|P3|Double-Blind Study|Lost to Follow-up|0
4969135|NCT00122382|17078195|P2|Double-Blind Study|Lost to Follow-up|1
4969136|NCT00122382|17078196|P1|Double-Blind Study|Lost to Follow-up|2
4969137|NCT00122382|17078194|P3|Double-Blind Study|Lack of Efficacy|0
4969138|NCT00122382|17078195|P2|Double-Blind Study|Lack of Efficacy|8
4969139|NCT00122382|17078196|P1|Double-Blind Study|Lack of Efficacy|0
4969140|NCT00122382|17078194|P3|Double-Blind Study|Death|0
4969141|NCT00122382|17078195|P2|Double-Blind Study|Death|2
4969142|NCT00122382|17078196|P1|Double-Blind Study|Death|2
4969143|NCT00122382|17078194|P3|Double-Blind Study|Adverse Event|0
4969144|NCT00122382|17078195|P2|Double-Blind Study|Adverse Event|11
4969145|NCT00122382|17078196|P1|Double-Blind Study|Adverse Event|9
4969146|NCT00122317|17078340|P1|Overall Study|Withdrawal by Subject|1
4969147|NCT00122317|17078340|P1|Overall Study|patient non-compliance|1
4969148|NCT00122317|17078340|P1|Overall Study|Physician Decision|2
4969149|NCT00122317|17078340|P1|Overall Study|Adverse Event|4
4969150|NCT00122317|17078340|P1|Overall Study|Death|3
4969151|NCT00122278|17078349|P2|Overall Study|Lost to Follow-up|0
4969152|NCT00122278|17078350|P1|Overall Study|Lost to Follow-up|2
4969153|NCT00122187|17078360|P2|Overall Study|Withdrew because of resource limitations|2
4969154|NCT00122187|17078361|P1|Overall Study|Withdrew because of resource limitations|2
4969155|NCT00122135|17078375|P2|Overall Study|Withdrawal by Subject|0
4969156|NCT00122135|17078376|P1|Overall Study|Withdrawal by Subject|3
4969157|NCT00122109|17078384|P2|Overall Study|Did not meet criteria|7
4969158|NCT00122109|17078385|P1|Overall Study|Did not meet criteria|6
4969159|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Death|2
4969160|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Death|0
4969161|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Death|0
4969162|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Death|1
4969163|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
4969164|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Pregnancy|0
4969165|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
4969166|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Pregnancy|1
4969167|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4
4969168|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8
4969169|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5
4969170|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3
4969171|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9
4969172|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5
4969173|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6
4969174|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3
4969175|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Other Reason|3
4969176|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Other Reason|6
4969177|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Other Reason|7
4969178|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Other Reason|5
4969179|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16
4969180|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13
4969181|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
4969182|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11
4969183|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Adverse Event|10
4969184|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Adverse Event|13
4969185|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Adverse Event|18
4969186|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Adverse Event|12
4969187|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30
4969188|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26
4969189|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34
4969190|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38
4969191|NCT00121667|17078651|P4|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65
4969192|NCT00121667|17078652|P3|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42
4969193|NCT00121667|17078653|P2|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51
4969194|NCT00121667|17078654|P1|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54
4969195|NCT00121667|17078651|P4|Short Term (ST) Period|Pregnancy|1
4969196|NCT00121667|17078652|P3|Short Term (ST) Period|Pregnancy|0
4969197|NCT00121667|17078653|P2|Short Term (ST) Period|Pregnancy|0
4969198|NCT00121667|17078654|P1|Short Term (ST) Period|Pregnancy|0
4969199|NCT00121667|17078651|P4|Short Term (ST) Period|Death|1
4969200|NCT00121667|17078652|P3|Short Term (ST) Period|Death|0
4969201|NCT00121667|17078653|P2|Short Term (ST) Period|Death|0
4969202|NCT00121667|17078654|P1|Short Term (ST) Period|Death|0
4969203|NCT00121667|17078651|P4|Short Term (ST) Period|Other Reason|0
4969204|NCT00121667|17078652|P3|Short Term (ST) Period|Other Reason|0
4969205|NCT00121667|17078653|P2|Short Term (ST) Period|Other Reason|0
4969206|NCT00121667|17078654|P1|Short Term (ST) Period|Other Reason|3
4969207|NCT00121667|17078651|P4|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
4969208|NCT00121667|17078652|P3|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
4969209|NCT00121667|17078653|P2|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2
4969210|NCT00121667|17078654|P1|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0
4969211|NCT00121667|17078651|P4|Short Term (ST) Period|Poor / Non-compliance|2
4969212|NCT00121667|17078652|P3|Short Term (ST) Period|Poor / Non-compliance|1
4969213|NCT00121667|17078653|P2|Short Term (ST) Period|Poor / Non-compliance|1
4969214|NCT00121667|17078654|P1|Short Term (ST) Period|Poor / Non-compliance|0
4969215|NCT00121667|17078651|P4|Short Term (ST) Period|Lost to Follow-up|3
4969216|NCT00121667|17078652|P3|Short Term (ST) Period|Lost to Follow-up|4
4969217|NCT00121667|17078653|P2|Short Term (ST) Period|Lost to Follow-up|4
4969218|NCT00121667|17078654|P1|Short Term (ST) Period|Lost to Follow-up|3
4969219|NCT00121667|17078651|P4|Short Term (ST) Period|Adverse Event|3
4969220|NCT00121667|17078652|P3|Short Term (ST) Period|Adverse Event|5
4969221|NCT00121667|17078653|P2|Short Term (ST) Period|Adverse Event|6
4969222|NCT00121667|17078654|P1|Short Term (ST) Period|Adverse Event|5
4969223|NCT00121667|17078651|P4|Short Term (ST) Period|Subject Withdrew Consent|11
4969224|NCT00121667|17078652|P3|Short Term (ST) Period|Subject Withdrew Consent|4
4969225|NCT00121667|17078653|P2|Short Term (ST) Period|Subject Withdrew Consent|13
4969226|NCT00121667|17078654|P1|Short Term (ST) Period|Subject Withdrew Consent|8
4969227|NCT00121667|17078651|P4|Short Term (ST) Period|Lack of Efficacy|44
4969228|NCT00121667|17078652|P3|Short Term (ST) Period|Lack of Efficacy|27
4969229|NCT00121667|17078653|P2|Short Term (ST) Period|Lack of Efficacy|22
4969230|NCT00121667|17078654|P1|Short Term (ST) Period|Lack of Efficacy|25
4969231|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Other Reason|1
4969232|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Other Reason|0
4969233|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Other Reason|2
4969234|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Other Reason|3
4969235|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Other Reason|5
4969236|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Missing|0
4969237|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Missing|0
4969238|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Missing|1
4969239|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Missing|0
4969240|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Missing|0
4969241|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Death|0
4969242|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Death|1
4969243|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Death|0
4969244|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Death|0
4969245|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Death|0
4969246|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
4969247|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
4969248|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1
4969249|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2
4969250|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0
4969251|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Pregnancy|0
4969252|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Pregnancy|1
4969253|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Pregnancy|0
4969254|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Pregnancy|1
4969255|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Pregnancy|0
4969256|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
4969257|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
4969258|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2
4969259|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3
4969260|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1
4969261|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Poor / Non-compliance|2
4969262|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Poor / Non-compliance|2
4969263|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Poor / Non-compliance|4
4969264|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Poor / Non-compliance|1
4969265|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Poor / Non-compliance|4
4969266|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Lost to Follow-up|12
4969267|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Lost to Follow-up|11
4969268|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Lost to Follow-up|12
4969269|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Lost to Follow-up|7
4969270|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Lost to Follow-up|9
4969271|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Adverse Event|5
4969272|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Adverse Event|5
4969273|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Adverse Event|10
4969274|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Adverse Event|10
4969275|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Adverse Event|9
4969276|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Subject Withdrew Consent|10
4969277|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Subject Withdrew Consent|24
4969278|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Subject Withdrew Consent|17
4969279|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Subject Withdrew Consent|28
4969280|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Subject Withdrew Consent|25
4969281|NCT00121641|17078752|P5|48-month Short Term + Long Term Period|Lack of Efficacy|25
4969282|NCT00121641|17078753|P4|48-month Short Term + Long Term Period|Lack of Efficacy|26
4969283|NCT00121641|17078754|P3|48-month Short Term + Long Term Period|Lack of Efficacy|21
4969284|NCT00121641|17078755|P2|48-month Short Term + Long Term Period|Lack of Efficacy|27
4969285|NCT00121641|17078756|P1|48-month Short Term + Long Term Period|Lack of Efficacy|26
4969286|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Other Reason|0
4969287|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Other Reason|0
4969288|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Other Reason|0
4969289|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Other Reason|0
4969290|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Other Reason|1
4969291|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
4969292|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
4969293|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0
4969294|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
4969295|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1
4969296|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Poor / Non-compliance|1
4969297|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Poor / Non-compliance|1
4969298|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Poor / Non-compliance|3
4969299|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Poor / Non-compliance|0
4969300|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Poor / Non-compliance|0
4969301|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Lost to Follow-up|4
4969302|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Lost to Follow-up|4
4969303|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Lost to Follow-up|3
4969304|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Lost to Follow-up|2
4969305|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Lost to Follow-up|0
4969306|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Adverse Event|2
4969307|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Adverse Event|0
4969308|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Adverse Event|4
4969309|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Adverse Event|3
4969310|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Adverse Event|3
4969311|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Subject Withdrew Consent|3
4969312|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Subject Withdrew Consent|10
4969313|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Subject Withdrew Consent|5
4969314|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Subject Withdrew Consent|11
4969315|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Subject Withdrew Consent|9
4969316|NCT00121641|17078752|P5|24-week Short-term Treatment Period|Lack of Efficacy|30
4969317|NCT00121641|17078753|P4|24-week Short-term Treatment Period|Lack of Efficacy|25
4969318|NCT00121641|17078754|P3|24-week Short-term Treatment Period|Lack of Efficacy|14
4969319|NCT00121641|17078755|P2|24-week Short-term Treatment Period|Lack of Efficacy|21
4969320|NCT00121641|17078756|P1|24-week Short-term Treatment Period|Lack of Efficacy|15
4969321|NCT00121485|17078869|P2|Overall Study|Crossover|2
4969322|NCT00121485|17078870|P1|Overall Study|Crossover|0
4969323|NCT00121485|17078869|P2|Overall Study|Not implanted|5
4969324|NCT00121485|17078870|P1|Overall Study|Not implanted|1
4969325|NCT00121238|17078915|P1|Overall Study|Protocol Violation|2
4969326|NCT00121238|17078915|P1|Overall Study|disease progression before intervention|1
4969327|NCT00121199|17078931|P1|Overall Study|Ineligible|9
4969328|NCT00121199|17078931|P1|Overall Study|Other - Not Protocol Specified|3
4969329|NCT00121199|17078931|P1|Overall Study|Death|3
4969330|NCT00121199|17078931|P1|Overall Study|Progression/Relapse|1
4969331|NCT00121199|17078931|P1|Overall Study|Refusal Unrelated to Adverse Event|1
4969332|NCT00121199|17078931|P1|Overall Study|Adverse Event|11
4969333|NCT00121134|17078975|P4|Overall Study|Patient Personal Reasons|0
4969334|NCT00121134|17078976|P3|Overall Study|Patient Personal Reasons|0
4969335|NCT00121134|17078977|P2|Overall Study|Patient Personal Reasons|1
4969336|NCT00121134|17078978|P1|Overall Study|Patient Personal Reasons|0
4969337|NCT00121134|17078975|P4|Overall Study|Intercurrent Illness|1
4969338|NCT00121134|17078976|P3|Overall Study|Intercurrent Illness|0
4969339|NCT00121134|17078977|P2|Overall Study|Intercurrent Illness|0
4969340|NCT00121134|17078978|P1|Overall Study|Intercurrent Illness|0
4969341|NCT00121134|17078975|P4|Overall Study|Treatment Delay|0
4969342|NCT00121134|17078976|P3|Overall Study|Treatment Delay|0
4969343|NCT00121134|17078977|P2|Overall Study|Treatment Delay|0
4969344|NCT00121134|17078978|P1|Overall Study|Treatment Delay|1
4969345|NCT00121134|17078975|P4|Overall Study|Physician Decision|1
4969346|NCT00121134|17078976|P3|Overall Study|Physician Decision|4
4969347|NCT00121134|17078977|P2|Overall Study|Physician Decision|4
4969348|NCT00121134|17078978|P1|Overall Study|Physician Decision|6
4969349|NCT00121134|17078975|P4|Overall Study|Toxicity|5
4969350|NCT00121134|17078976|P3|Overall Study|Toxicity|13
4969351|NCT00121134|17078977|P2|Overall Study|Toxicity|7
4969352|NCT00121134|17078978|P1|Overall Study|Toxicity|4
4969353|NCT00121134|17078975|P4|Overall Study|Progression of Disease|2
4969354|NCT00121134|17078976|P3|Overall Study|Progression of Disease|4
4969355|NCT00121134|17078977|P2|Overall Study|Progression of Disease|3
4969356|NCT00121134|17078978|P1|Overall Study|Progression of Disease|5
4969357|NCT00120874|17078990|P2|Overall Study|Death|1
4969358|NCT00120874|17078991|P1|Overall Study|Death|0
4969359|NCT00120627|17079029|P2|Overall Study|Withdrawal by Subject|5
4969360|NCT00120627|17079030|P1|Overall Study|Withdrawal by Subject|5
4969361|NCT00120406|17079081|P2|Overall Study|patient moved but has not withdrawn|1
4969362|NCT00120406|17079082|P1|Overall Study|patient moved but has not withdrawn|0
4969363|NCT00120406|17079081|P2|Overall Study|received non-study stent|2
4969364|NCT00120406|17079082|P1|Overall Study|received non-study stent|0
4969365|NCT00120406|17079081|P2|Overall Study|Lost to Follow-up|2
4969366|NCT00120406|17079082|P1|Overall Study|Lost to Follow-up|5
4969367|NCT00120406|17079081|P2|Overall Study|Withdrawal by Subject|7
4969368|NCT00120406|17079082|P1|Overall Study|Withdrawal by Subject|5
4969369|NCT00120406|17079081|P2|Overall Study|Death|4
4969370|NCT00120406|17079082|P1|Overall Study|Death|9
4969371|NCT00120289|17079092|P2|Overall Study|Withdrawal by Subject|13
4969372|NCT00120289|17079093|P1|Overall Study|Withdrawal by Subject|14
4969373|NCT00120289|17079092|P2|Overall Study|Lost to Follow-up|14
4969374|NCT00120289|17079093|P1|Overall Study|Lost to Follow-up|11
4969375|NCT00120289|17079092|P2|Overall Study|Death|82
4969376|NCT00120289|17079093|P1|Overall Study|Death|96
4969377|NCT00120250|17079105|P2|Overall Study|Protocol Violation|1
4969378|NCT00120250|17079106|P1|Overall Study|Protocol Violation|0
4969379|NCT00120250|17079105|P2|Overall Study|Lost to Follow-up|1
4969380|NCT00120250|17079106|P1|Overall Study|Lost to Follow-up|1
4969381|NCT00120042|17079122|P3|Overall Study|all completed protocl|0
4969382|NCT00120042|17079123|P2|Overall Study|all completed protocl|0
4969383|NCT00120042|17079124|P1|Overall Study|all completed protocl|0
4969384|NCT00119678|17079147|P2|Open-label Treatment Period|Administrative reasons by sponsor|0
4969385|NCT00119678|17079148|P1|Open-label Treatment Period|Administrative reasons by sponsor|87
4969386|NCT00119678|17079147|P2|Open-label Treatment Period|Pregnancy|0
4969387|NCT00119678|17079148|P1|Open-label Treatment Period|Pregnancy|1
4969388|NCT00119678|17079147|P2|Open-label Treatment Period|Participants not meeting study criteria|0
4969389|NCT00119678|17079148|P1|Open-label Treatment Period|Participants not meeting study criteria|2
4969390|NCT00119678|17079147|P2|Open-label Treatment Period|Participant withdrew consent|0
4969391|NCT00119678|17079148|P1|Open-label Treatment Period|Participant withdrew consent|4
4969392|NCT00119678|17079147|P2|Open-label Treatment Period|Lost to Follow-up|0
4969393|NCT00119678|17079148|P1|Open-label Treatment Period|Lost to Follow-up|3
4969394|NCT00119678|17079147|P2|Open-label Treatment Period|Lack of Efficacy|0
4969395|NCT00119678|17079148|P1|Open-label Treatment Period|Lack of Efficacy|9
4969396|NCT00119678|17079147|P2|Open-label Treatment Period|Adverse Event|0
4969397|NCT00119678|17079148|P1|Open-label Treatment Period|Adverse Event|3
4969398|NCT00119678|17079147|P2|Open-label Treatment Period|Death|0
4969399|NCT00119678|17079148|P1|Open-label Treatment Period|Death|1
4969400|NCT00119678|17079147|P2|Double-blind Treatment Period|Site closed due to non-compliance|2
4969401|NCT00119678|17079148|P1|Double-blind Treatment Period|Site closed due to non-compliance|3
4969402|NCT00119678|17079147|P2|Double-blind Treatment Period|Not treated|2
4969403|NCT00119678|17079148|P1|Double-blind Treatment Period|Not treated|1
4969404|NCT00119678|17079147|P2|Double-blind Treatment Period|Pregnancy|2
4969405|NCT00119678|17079148|P1|Double-blind Treatment Period|Pregnancy|0
4969406|NCT00119678|17079147|P2|Double-blind Treatment Period|Poor/Non-compliance|0
4969407|NCT00119678|17079148|P1|Double-blind Treatment Period|Poor/Non-compliance|3
4969408|NCT00119678|17079147|P2|Double-blind Treatment Period|Participants not meeting study criteria|1
4969409|NCT00119678|17079148|P1|Double-blind Treatment Period|Participants not meeting study criteria|0
4969410|NCT00119678|17079147|P2|Double-blind Treatment Period|Participant withdrew consent|4
4969411|NCT00119678|17079148|P1|Double-blind Treatment Period|Participant withdrew consent|4
4969412|NCT00119678|17079147|P2|Double-blind Treatment Period|Lost to Follow-up|2
4969413|NCT00119678|17079148|P1|Double-blind Treatment Period|Lost to Follow-up|1
4969414|NCT00119678|17079147|P2|Double-blind Treatment Period|Lack of Efficacy|12
4969415|NCT00119678|17079148|P1|Double-blind Treatment Period|Lack of Efficacy|21
4969416|NCT00119678|17079147|P2|Double-blind Treatment Period|Adverse Event|1
4969417|NCT00119678|17079148|P1|Double-blind Treatment Period|Adverse Event|7
4969418|NCT00119678|17079147|P2|Double-blind Treatment Period|Death|0
4969419|NCT00119678|17079148|P1|Double-blind Treatment Period|Death|1
4969420|NCT00119405|17079194|P1|Overall Study|Withdrawal by Subject|1
4969421|NCT00119379|17079208|P2|Overall Study|Adverse Event|1
4969422|NCT00119379|17079209|P1|Overall Study|Adverse Event|4
4969423|NCT00119262|17079227|P2|Overall Study|others|5
4969424|NCT00119262|17079228|P1|Overall Study|others|0
4969425|NCT00119262|17079227|P2|Overall Study|ineligble|2
4969426|NCT00119262|17079228|P1|Overall Study|ineligble|1
4969427|NCT00119262|17079227|P2|Overall Study|other disease|2
4969428|NCT00119262|17079228|P1|Overall Study|other disease|0
4969429|NCT00119262|17079227|P2|Overall Study|Adverse Event|35
4969430|NCT00119262|17079228|P1|Overall Study|Adverse Event|33
4969431|NCT00119262|17079227|P2|Overall Study|Withdrawal by Subject|11
4969432|NCT00119262|17079228|P1|Overall Study|Withdrawal by Subject|12
4969433|NCT00119262|17079227|P2|Overall Study|Lack of Efficacy|3
4969434|NCT00119262|17079228|P1|Overall Study|Lack of Efficacy|0
4969435|NCT00119015|17079265|P3|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
4969436|NCT00119015|17079266|P2|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0
4969437|NCT00119015|17079267|P1|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48
4969438|NCT00118911|17079283|P2|Overall Study|Withdrawal by Subject|5
4969439|NCT00118911|17079284|P1|Overall Study|Withdrawal by Subject|2
4969440|NCT00118898|17079296|P4|Overall Study|Not able to get to clinic|40
4969441|NCT00118898|17079297|P3|Overall Study|Not able to get to clinic|31
4969442|NCT00118898|17079298|P2|Overall Study|Not able to get to clinic|43
4969443|NCT00118898|17079299|P1|Overall Study|Not able to get to clinic|34
4969444|NCT00118898|17079296|P4|Overall Study|Not compliant with requirements|11
4969445|NCT00118898|17079297|P3|Overall Study|Not compliant with requirements|11
4969446|NCT00118898|17079298|P2|Overall Study|Not compliant with requirements|13
4969447|NCT00118898|17079299|P1|Overall Study|Not compliant with requirements|11
4969448|NCT00118898|17079296|P4|Overall Study|Severe debilitation|4
4969449|NCT00118898|17079297|P3|Overall Study|Severe debilitation|6
4969450|NCT00118898|17079298|P2|Overall Study|Severe debilitation|4
4969451|NCT00118898|17079299|P1|Overall Study|Severe debilitation|1
4969452|NCT00118898|17079296|P4|Overall Study|Site Closure|37
4969453|NCT00118898|17079297|P3|Overall Study|Site Closure|28
4969454|NCT00118898|17079298|P2|Overall Study|Site Closure|31
4969455|NCT00118898|17079299|P1|Overall Study|Site Closure|33
4969456|NCT00118898|17079296|P4|Overall Study|Withdrawal by Subject|8
4969457|NCT00118898|17079297|P3|Overall Study|Withdrawal by Subject|8
4969458|NCT00118898|17079298|P2|Overall Study|Withdrawal by Subject|5
4969459|NCT00118898|17079299|P1|Overall Study|Withdrawal by Subject|10
4969460|NCT00118898|17079296|P4|Overall Study|Lost to Follow-up|33
4969461|NCT00118898|17079297|P3|Overall Study|Lost to Follow-up|33
4969462|NCT00118898|17079298|P2|Overall Study|Lost to Follow-up|34
4969463|NCT00118898|17079299|P1|Overall Study|Lost to Follow-up|26
4969464|NCT00118898|17079296|P4|Overall Study|Death|8
4969465|NCT00118898|17079297|P3|Overall Study|Death|6
4969466|NCT00118898|17079298|P2|Overall Study|Death|11
4969467|NCT00118898|17079299|P1|Overall Study|Death|6
4969468|NCT00118716|17079425|P2|Overall Study|Investigator discretion|1
4969469|NCT00118716|17079426|P1|Overall Study|Investigator discretion|0
4969470|NCT00118716|17079425|P2|Overall Study|Expired drug use|2
4969471|NCT00118716|17079426|P1|Overall Study|Expired drug use|1
4969472|NCT00118716|17079425|P2|Overall Study|misrandomized|1
4969473|NCT00118716|17079426|P1|Overall Study|misrandomized|1
4969474|NCT00118716|17079425|P2|Overall Study|Non-compliance|3
4969475|NCT00118716|17079426|P1|Overall Study|Non-compliance|1
4969476|NCT00118716|17079425|P2|Overall Study|Discontinued by sponsor|1
4969477|NCT00118716|17079426|P1|Overall Study|Discontinued by sponsor|1
4969478|NCT00118716|17079425|P2|Overall Study|Exacerbation|2
4969479|NCT00118716|17079426|P1|Overall Study|Exacerbation|2
4969480|NCT00118716|17079425|P2|Overall Study|Withdrawal by Subject|1
4969481|NCT00118716|17079426|P1|Overall Study|Withdrawal by Subject|0
4969482|NCT00118716|17079425|P2|Overall Study|Protocol Violation|4
4969483|NCT00118716|17079426|P1|Overall Study|Protocol Violation|5
4969484|NCT00118716|17079425|P2|Overall Study|Adverse Event|7
4969485|NCT00118716|17079426|P1|Overall Study|Adverse Event|2
4969486|NCT00118703|17079446|P2|Overall Study|Lost to Follow-up|2
4969487|NCT00118703|17079447|P1|Overall Study|Lost to Follow-up|1
4969488|NCT00118703|17079446|P2|Overall Study|Withdrawal by Subject|5
4969489|NCT00118703|17079447|P1|Overall Study|Withdrawal by Subject|2
4969490|NCT00118703|17079446|P2|Overall Study|Participant took two different treatment|1
4969491|NCT00118703|17079447|P1|Overall Study|Participant took two different treatment|0
4969492|NCT00118703|17079446|P2|Overall Study|Adverse Event|1
4969493|NCT00118703|17079447|P1|Overall Study|Adverse Event|1
4969494|NCT00118703|17079446|P2|Overall Study|Protocol Violation|0
4969495|NCT00118703|17079447|P1|Overall Study|Protocol Violation|1
4969496|NCT00118482|17079544|P2|Overall Study|Withdrawal by Subject|22
4969497|NCT00118482|17079545|P1|Overall Study|Withdrawal by Subject|23
4969498|NCT00118482|17079544|P2|Overall Study|Lost to Follow-up|7
4969499|NCT00118482|17079545|P1|Overall Study|Lost to Follow-up|7
4969500|NCT00118430|17079560|P3|Overall Study|Lost to Follow-up|28
4969501|NCT00118430|17079561|P2|Overall Study|Lost to Follow-up|22
4969502|NCT00118430|17079562|P1|Overall Study|Lost to Follow-up|15
4969503|NCT00118430|17079560|P3|Overall Study|Withdrawal by Subject|0
4969504|NCT00118430|17079561|P2|Overall Study|Withdrawal by Subject|2
4969505|NCT00118430|17079562|P1|Overall Study|Withdrawal by Subject|6
4969506|NCT00118417|17079577|P2|Phase II (Weeks 6 to 12)|Remission|2
4969507|NCT00118417|17079578|P1|Phase II (Weeks 6 to 12)|Remission|1
4969508|NCT00118417|17079577|P2|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
4969509|NCT00118417|17079578|P1|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1
4969510|NCT00118417|17079577|P2|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0
4969511|NCT00118417|17079578|P1|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4
4969512|NCT00118417|17079577|P2|Phase I (Weeks 0 to 6)|Lost to Follow-up|0
4969513|NCT00118417|17079578|P1|Phase I (Weeks 0 to 6)|Lost to Follow-up|6
4969514|NCT00118417|17079577|P2|Phase I (Weeks 0 to 6)|Remission|0
4969515|NCT00118417|17079578|P1|Phase I (Weeks 0 to 6)|Remission|8
4969516|NCT00118287|17079722|P1|Overall Study|Muscle pain|1
4969517|NCT00118287|17079722|P1|Overall Study|Intracranial haemorrhage|1
4969518|NCT00118157|17079755|P1|Overall Study|Withdrawal by Subject|2
4969519|NCT00118157|17079755|P1|Overall Study|Death|8
4969520|NCT00118157|17079755|P1|Overall Study|Adverse Event|2
4969521|NCT00118092|17079773|P1|Overall Study|Protocol Violation|1
4969522|NCT00118092|17079773|P1|Overall Study|Withdrawal by Subject|1
4969523|NCT00118040|17079791|P3|Overall Study|Other|1
4969524|NCT00118040|17079792|P2|Overall Study|Other|0
4969525|NCT00118040|17079793|P1|Overall Study|Other|0
4969526|NCT00118040|17079791|P3|Overall Study|Non-Compliant Participant|2
4969527|NCT00118040|17079792|P2|Overall Study|Non-Compliant Participant|1
4969528|NCT00118040|17079793|P1|Overall Study|Non-Compliant Participant|1
4969529|NCT00118040|17079791|P3|Overall Study|Medical Contraindication|1
4969530|NCT00118040|17079792|P2|Overall Study|Medical Contraindication|0
4969531|NCT00118040|17079793|P1|Overall Study|Medical Contraindication|0
4969532|NCT00118040|17079791|P3|Overall Study|Withdrawal by Subject|2
4969533|NCT00118040|17079792|P2|Overall Study|Withdrawal by Subject|0
4969534|NCT00118040|17079793|P1|Overall Study|Withdrawal by Subject|0
4969535|NCT00118040|17079791|P3|Overall Study|Adverse Event|0
4969536|NCT00118040|17079792|P2|Overall Study|Adverse Event|1
4969537|NCT00118040|17079793|P1|Overall Study|Adverse Event|0
4969538|NCT00117988|17079854|P1|Overall Study|Adverse Event|1
4969539|NCT00117988|17079854|P1|Overall Study|Death|3
4969540|NCT00117949|17079877|P4|Overall Study|Hepatic abnormalities|1
4969541|NCT00117949|17079878|P3|Overall Study|Hepatic abnormalities|0
4969542|NCT00117949|17079879|P2|Overall Study|Hepatic abnormalities|1
4969543|NCT00117949|17079880|P1|Overall Study|Hepatic abnormalities|0
4969544|NCT00117949|17079877|P4|Overall Study|PSA reduction <=50%|4
4969545|NCT00117949|17079878|P3|Overall Study|PSA reduction <=50%|2
4969546|NCT00117949|17079879|P2|Overall Study|PSA reduction <=50%|2
4969547|NCT00117949|17079880|P1|Overall Study|PSA reduction <=50%|0
4969548|NCT00117949|17079877|P4|Overall Study|PSA increase >=10ng/mL|0
4969549|NCT00117949|17079878|P3|Overall Study|PSA increase >=10ng/mL|1
4969550|NCT00117949|17079879|P2|Overall Study|PSA increase >=10ng/mL|1
4969551|NCT00117949|17079880|P1|Overall Study|PSA increase >=10ng/mL|0
4969552|NCT00117949|17079877|P4|Overall Study|Prostate-specific antigen increase >=25%|2
4969553|NCT00117949|17079878|P3|Overall Study|Prostate-specific antigen increase >=25%|1
4969554|NCT00117949|17079879|P2|Overall Study|Prostate-specific antigen increase >=25%|1
4969555|NCT00117949|17079880|P1|Overall Study|Prostate-specific antigen increase >=25%|0
4969556|NCT00117949|17079877|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
4969557|NCT00117949|17079878|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
4969558|NCT00117949|17079879|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
4969559|NCT00117949|17079880|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
4969560|NCT00117949|17079877|P4|Overall Study|Testosterone >1.0 ng/mL|15
4969561|NCT00117949|17079878|P3|Overall Study|Testosterone >1.0 ng/mL|17
4969562|NCT00117949|17079879|P2|Overall Study|Testosterone >1.0 ng/mL|18
4969563|NCT00117949|17079880|P1|Overall Study|Testosterone >1.0 ng/mL|10
4969564|NCT00117845|17079914|P1|Overall Study|stopped treatment/drug supplyinterrupted|1
4969565|NCT00117793|17079932|P1|Overall Study|Withdrawal by Subject|12
4969566|NCT00117676|17079955|P2|Open-label Period: Weeks 433 - 480|Withdrew Consent|1
4969567|NCT00117676|17079956|P1|Open-label Period: Weeks 433 - 480|Withdrew Consent|0
4969568|NCT00117676|17079955|P2|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
4969569|NCT00117676|17079956|P1|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1
4969570|NCT00117676|17079955|P2|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0
4969571|NCT00117676|17079956|P1|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1
4969572|NCT00117676|17079955|P2|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1
4969573|NCT00117676|17079956|P1|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0
4969574|NCT00117676|17079955|P2|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1
4969575|NCT00117676|17079956|P1|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0
4969576|NCT00117676|17079955|P2|Open-label Period: Weeks 337 - 384|Withdrew Consent|1
4969577|NCT00117676|17079956|P1|Open-label Period: Weeks 337 - 384|Withdrew Consent|2
4969578|NCT00117676|17079955|P2|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0
4969579|NCT00117676|17079956|P1|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1
4969580|NCT00117676|17079955|P2|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1
4969581|NCT00117676|17079956|P1|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3
4969582|NCT00117676|17079955|P2|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
4969583|NCT00117676|17079956|P1|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1
4969584|NCT00117676|17079955|P2|Open-label Period: Weeks 289 - 336|Withdrew Consent|1
4969585|NCT00117676|17079956|P1|Open-label Period: Weeks 289 - 336|Withdrew Consent|0
4969586|NCT00117676|17079955|P2|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
4969587|NCT00117676|17079956|P1|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2
4969588|NCT00117676|17079955|P2|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4
4969589|NCT00117676|17079956|P1|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7
4969590|NCT00117676|17079955|P2|Open-label Period: Weeks 241 - 288|Withdrew Consent|1
4969591|NCT00117676|17079956|P1|Open-label Period: Weeks 241 - 288|Withdrew Consent|5
4969592|NCT00117676|17079955|P2|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
4969593|NCT00117676|17079956|P1|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1
4969594|NCT00117676|17079955|P2|Open-label Period: Weeks 241 - 288|Protocol Violation|0
4969595|NCT00117676|17079956|P1|Open-label Period: Weeks 241 - 288|Protocol Violation|2
4969596|NCT00117676|17079955|P2|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1
4969597|NCT00117676|17079956|P1|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2
4969598|NCT00117676|17079955|P2|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1
4969599|NCT00117676|17079956|P1|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0
4969600|NCT00117676|17079955|P2|Open-label Period: Weeks 193 - 240|Withdrew Consent|1
4969601|NCT00117676|17079956|P1|Open-label Period: Weeks 193 - 240|Withdrew Consent|4
4969602|NCT00117676|17079955|P2|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0
4969603|NCT00117676|17079956|P1|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
4969604|NCT00117676|17079955|P2|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1
4969605|NCT00117676|17079956|P1|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0
4969606|NCT00117676|17079955|P2|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
4969607|NCT00117676|17079956|P1|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1
4969608|NCT00117676|17079955|P2|Open-label Period: Weeks 145 - 192|Withdrew Consent|2
4969609|NCT00117676|17079956|P1|Open-label Period: Weeks 145 - 192|Withdrew Consent|5
4969610|NCT00117676|17079955|P2|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1
4969611|NCT00117676|17079956|P1|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3
4969612|NCT00117676|17079955|P2|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0
4969613|NCT00117676|17079956|P1|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2
4969614|NCT00117676|17079955|P2|Open-label Period: Weeks 97 - 144|Withdrew Consent|0
4969615|NCT00117676|17079956|P1|Open-label Period: Weeks 97 - 144|Withdrew Consent|1
4969616|NCT00117676|17079955|P2|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0
4969617|NCT00117676|17079956|P1|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1
4969618|NCT00117676|17079955|P2|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1
4969619|NCT00117676|17079956|P1|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4
4969620|NCT00117676|17079955|P2|Open-label Period: Weeks 49 - 96|Withdrew Consent|1
4969621|NCT00117676|17079956|P1|Open-label Period: Weeks 49 - 96|Withdrew Consent|5
4969622|NCT00117676|17079955|P2|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
4969623|NCT00117676|17079956|P1|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3
4969624|NCT00117676|17079955|P2|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0
4969625|NCT00117676|17079956|P1|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2
4969626|NCT00117676|17079955|P2|Double-blind Period Through Week 48|Withdrew Consent|1
4969627|NCT00117676|17079956|P1|Double-blind Period Through Week 48|Withdrew Consent|0
4969628|NCT00117676|17079955|P2|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2
4969629|NCT00117676|17079956|P1|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5
4969630|NCT00117676|17079955|P2|Double-blind Period Through Week 48|Protocol Violation|1
4969631|NCT00117676|17079956|P1|Double-blind Period Through Week 48|Protocol Violation|0
4969632|NCT00117676|17079955|P2|Double-blind Period Through Week 48|Lost to Follow-up|0
4969633|NCT00117676|17079956|P1|Double-blind Period Through Week 48|Lost to Follow-up|1
4969634|NCT00117676|17079955|P2|Double-blind Period Through Week 48|Randomized but Not Treated|3
4969635|NCT00117676|17079956|P1|Double-blind Period Through Week 48|Randomized but Not Treated|4
4969636|NCT00117637|17080045|P2|Second Intervention (Period 2)|reason not reported|0
4969637|NCT00117637|17080046|P1|Second Intervention (Period 2)|reason not reported|1
4969638|NCT00117637|17080045|P2|Second Intervention (Period 2)|non compliant with study medication|1
4969639|NCT00117637|17080046|P1|Second Intervention (Period 2)|non compliant with study medication|1
4969640|NCT00117637|17080045|P2|Second Intervention (Period 2)|study terminated by the sponsor|9
4969641|NCT00117637|17080046|P1|Second Intervention (Period 2)|study terminated by the sponsor|2
4969642|NCT00117637|17080045|P2|Second Intervention (Period 2)|Withdrawal by Subject|3
4969643|NCT00117637|17080046|P1|Second Intervention (Period 2)|Withdrawal by Subject|4
4969644|NCT00117637|17080045|P2|Second Intervention (Period 2)|Protocol Violation|0
4969645|NCT00117637|17080046|P1|Second Intervention (Period 2)|Protocol Violation|1
4969646|NCT00117637|17080045|P2|Second Intervention (Period 2)|Lost to Follow-up|0
4969647|NCT00117637|17080046|P1|Second Intervention (Period 2)|Lost to Follow-up|1
4969648|NCT00117637|17080045|P2|Second Intervention (Period 2)|Adverse Event|9
4969649|NCT00117637|17080046|P1|Second Intervention (Period 2)|Adverse Event|0
4969650|NCT00117637|17080045|P2|First Intervention (Period 1)|reason not reported|1
4969651|NCT00117637|17080046|P1|First Intervention (Period 1)|reason not reported|0
4969652|NCT00117637|17080045|P2|First Intervention (Period 1)|investig. decision, not protocol driven|1
4969653|NCT00117637|17080046|P1|First Intervention (Period 1)|investig. decision, not protocol driven|0
4969654|NCT00117637|17080045|P2|First Intervention (Period 1)|protocol driven decision point|0
4969655|NCT00117637|17080046|P1|First Intervention (Period 1)|protocol driven decision point|1
4969656|NCT00117637|17080045|P2|First Intervention (Period 1)|study terminated by the sponsor|1
4969657|NCT00117637|17080046|P1|First Intervention (Period 1)|study terminated by the sponsor|3
4969658|NCT00117637|17080045|P2|First Intervention (Period 1)|Withdrawal by Subject|4
4969659|NCT00117637|17080046|P1|First Intervention (Period 1)|Withdrawal by Subject|2
4969660|NCT00117637|17080045|P2|First Intervention (Period 1)|Protocol Violation|0
4969661|NCT00117637|17080046|P1|First Intervention (Period 1)|Protocol Violation|1
4969662|NCT00117637|17080045|P2|First Intervention (Period 1)|Lost to Follow-up|2
4969663|NCT00117637|17080046|P1|First Intervention (Period 1)|Lost to Follow-up|0
4969664|NCT00117637|17080045|P2|First Intervention (Period 1)|Adverse Event|16
4969665|NCT00117637|17080046|P1|First Intervention (Period 1)|Adverse Event|11
4969666|NCT00117598|17080121|P5|After Treament Cross Over|Other|2
4969667|NCT00117598|17080122|P4|After Treament Cross Over|Other|1
4969668|NCT00117598|17080123|P3|After Treament Cross Over|Other|0
4969669|NCT00117598|17080124|P2|After Treament Cross Over|Other|0
4969670|NCT00117598|17080125|P1|After Treament Cross Over|Other|0
4969671|NCT00117598|17080121|P5|After Treament Cross Over|Withdrawal by Subject|0
4969672|NCT00117598|17080122|P4|After Treament Cross Over|Withdrawal by Subject|1
4969673|NCT00117598|17080123|P3|After Treament Cross Over|Withdrawal by Subject|0
4969674|NCT00117598|17080124|P2|After Treament Cross Over|Withdrawal by Subject|0
4969675|NCT00117598|17080125|P1|After Treament Cross Over|Withdrawal by Subject|0
4969676|NCT00117598|17080121|P5|After Treament Cross Over|Death|2
4969677|NCT00117598|17080122|P4|After Treament Cross Over|Death|1
4969678|NCT00117598|17080123|P3|After Treament Cross Over|Death|0
4969679|NCT00117598|17080124|P2|After Treament Cross Over|Death|0
4969680|NCT00117598|17080125|P1|After Treament Cross Over|Death|0
4969681|NCT00117598|17080121|P5|Prior to Treatment Cross Over|Other|0
4969682|NCT00117598|17080122|P4|Prior to Treatment Cross Over|Other|0
4969683|NCT00117598|17080123|P3|Prior to Treatment Cross Over|Other|9
4969684|NCT00117598|17080124|P2|Prior to Treatment Cross Over|Other|9
4969685|NCT00117598|17080125|P1|Prior to Treatment Cross Over|Other|15
4969686|NCT00117598|17080121|P5|Prior to Treatment Cross Over|Withdrawal by Subject|0
4969687|NCT00117598|17080122|P4|Prior to Treatment Cross Over|Withdrawal by Subject|0
4969688|NCT00117598|17080123|P3|Prior to Treatment Cross Over|Withdrawal by Subject|4
4969689|NCT00117598|17080124|P2|Prior to Treatment Cross Over|Withdrawal by Subject|1
4969690|NCT00117598|17080125|P1|Prior to Treatment Cross Over|Withdrawal by Subject|2
4969691|NCT00117598|17080121|P5|Prior to Treatment Cross Over|Lost to Follow-up|0
4969692|NCT00117598|17080122|P4|Prior to Treatment Cross Over|Lost to Follow-up|0
4969693|NCT00117598|17080123|P3|Prior to Treatment Cross Over|Lost to Follow-up|2
4969694|NCT00117598|17080124|P2|Prior to Treatment Cross Over|Lost to Follow-up|2
4969695|NCT00117598|17080125|P1|Prior to Treatment Cross Over|Lost to Follow-up|0
4969696|NCT00117598|17080121|P5|Prior to Treatment Cross Over|Death|0
4969697|NCT00117598|17080122|P4|Prior to Treatment Cross Over|Death|0
4969698|NCT00117598|17080123|P3|Prior to Treatment Cross Over|Death|37
4969699|NCT00117598|17080124|P2|Prior to Treatment Cross Over|Death|41
4969700|NCT00117598|17080125|P1|Prior to Treatment Cross Over|Death|40
4969701|NCT00117572|17080159|P2|Overall Study|Protocol Violation|0
4969702|NCT00117572|17080160|P1|Overall Study|Protocol Violation|1
4969703|NCT00117572|17080159|P2|Overall Study|Withdrawal by Subject|3
4969704|NCT00117572|17080160|P1|Overall Study|Withdrawal by Subject|3
4969705|NCT00117572|17080159|P2|Overall Study|Site withdrew before starting treatment|3
4969706|NCT00117572|17080160|P1|Overall Study|Site withdrew before starting treatment|2
4969707|NCT00117338|17080201|P2|Overall Study|Lack of Efficacy|1
4969708|NCT00117338|17080202|P1|Overall Study|Lack of Efficacy|0
4969709|NCT00117338|17080201|P2|Overall Study|Did not meet Inclusion Criteria|0
4969710|NCT00117338|17080202|P1|Overall Study|Did not meet Inclusion Criteria|1
4969711|NCT00117338|17080201|P2|Overall Study|Withdrawal by Subject|0
4969712|NCT00117338|17080202|P1|Overall Study|Withdrawal by Subject|1
4969713|NCT00117338|17080201|P2|Overall Study|Protocol Violation|2
4969714|NCT00117338|17080202|P1|Overall Study|Protocol Violation|3
4969715|NCT00117338|17080201|P2|Overall Study|Adverse Event|1
4969716|NCT00117338|17080202|P1|Overall Study|Adverse Event|0
4969717|NCT00117325|17080222|P2|Overall Study|Admisnitrative|0
4969718|NCT00117325|17080223|P1|Overall Study|Admisnitrative|1
4969719|NCT00117325|17080222|P2|Overall Study|Early termination|1
4969720|NCT00117325|17080223|P1|Overall Study|Early termination|1
4969721|NCT00117325|17080222|P2|Overall Study|Use of prohibited medicine|2
4969722|NCT00117325|17080223|P1|Overall Study|Use of prohibited medicine|1
4969723|NCT00117325|17080222|P2|Overall Study|Lack of Efficacy|0
4969724|NCT00117325|17080223|P1|Overall Study|Lack of Efficacy|1
4969725|NCT00117325|17080222|P2|Overall Study|Withdrawal by Subject|2
4969726|NCT00117325|17080223|P1|Overall Study|Withdrawal by Subject|3
4969727|NCT00117325|17080222|P2|Overall Study|Protocol Violation|3
4969728|NCT00117325|17080223|P1|Overall Study|Protocol Violation|2
4969729|NCT00117325|17080222|P2|Overall Study|Lost to Follow-up|1
4969730|NCT00117325|17080223|P1|Overall Study|Lost to Follow-up|1
4969731|NCT00117325|17080222|P2|Overall Study|Adverse Event|3
4969732|NCT00117325|17080223|P1|Overall Study|Adverse Event|3
4969733|NCT00117312|17080255|P4|Overall Study|Withdrawal by Subject|0
4969734|NCT00117312|17080256|P3|Overall Study|Withdrawal by Subject|0
4969735|NCT00117312|17080257|P2|Overall Study|Withdrawal by Subject|2
4969736|NCT00117312|17080258|P1|Overall Study|Withdrawal by Subject|0
4969737|NCT00117312|17080255|P4|Overall Study|Hepatic abnormality|1
4969738|NCT00117312|17080256|P3|Overall Study|Hepatic abnormality|0
4969739|NCT00117312|17080257|P2|Overall Study|Hepatic abnormality|1
4969740|NCT00117312|17080258|P1|Overall Study|Hepatic abnormality|0
4969741|NCT00117312|17080255|P4|Overall Study|PSA increase >= 10ng/mL|0
4969742|NCT00117312|17080256|P3|Overall Study|PSA increase >= 10ng/mL|1
4969743|NCT00117312|17080257|P2|Overall Study|PSA increase >= 10ng/mL|1
4969744|NCT00117312|17080258|P1|Overall Study|PSA increase >= 10ng/mL|0
4969745|NCT00117312|17080255|P4|Overall Study|PSA decrease <=50%|4
4969746|NCT00117312|17080256|P3|Overall Study|PSA decrease <=50%|2
4969747|NCT00117312|17080257|P2|Overall Study|PSA decrease <=50%|2
4969748|NCT00117312|17080258|P1|Overall Study|PSA decrease <=50%|0
4969749|NCT00117312|17080255|P4|Overall Study|Protocol Violation|0
4969750|NCT00117312|17080256|P3|Overall Study|Protocol Violation|3
4969751|NCT00117312|17080257|P2|Overall Study|Protocol Violation|1
4969752|NCT00117312|17080258|P1|Overall Study|Protocol Violation|0
4969753|NCT00117312|17080255|P4|Overall Study|Adverse Event|0
4969754|NCT00117312|17080256|P3|Overall Study|Adverse Event|0
4969755|NCT00117312|17080257|P2|Overall Study|Adverse Event|2
4969756|NCT00117312|17080258|P1|Overall Study|Adverse Event|0
4969757|NCT00117312|17080255|P4|Overall Study|Patient choice|1
4969758|NCT00117312|17080256|P3|Overall Study|Patient choice|2
4969759|NCT00117312|17080257|P2|Overall Study|Patient choice|0
4969760|NCT00117312|17080258|P1|Overall Study|Patient choice|0
4969761|NCT00117312|17080255|P4|Overall Study|Other|1
4969762|NCT00117312|17080256|P3|Overall Study|Other|3
4969763|NCT00117312|17080257|P2|Overall Study|Other|1
4969764|NCT00117312|17080258|P1|Overall Study|Other|0
4969765|NCT00117312|17080255|P4|Overall Study|Prostate-specific antigen increase >=25%|3
4969766|NCT00117312|17080256|P3|Overall Study|Prostate-specific antigen increase >=25%|5
4969767|NCT00117312|17080257|P2|Overall Study|Prostate-specific antigen increase >=25%|1
4969768|NCT00117312|17080258|P1|Overall Study|Prostate-specific antigen increase >=25%|0
4969769|NCT00117312|17080255|P4|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2
4969770|NCT00117312|17080256|P3|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3
4969771|NCT00117312|17080257|P2|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0
4969772|NCT00117312|17080258|P1|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1
4969773|NCT00117312|17080255|P4|Overall Study|Testosterone >1.0 ng/mL|9
4969774|NCT00117312|17080256|P3|Overall Study|Testosterone >1.0 ng/mL|5
4969775|NCT00117312|17080257|P2|Overall Study|Testosterone >1.0 ng/mL|9
4969776|NCT00117312|17080258|P1|Overall Study|Testosterone >1.0 ng/mL|9
4969777|NCT00117286|17080274|P2|Overall Study|Research site closing|2
4969778|NCT00117286|17080275|P1|Overall Study|Research site closing|0
4969779|NCT00117286|17080274|P2|Overall Study|Lack of Efficacy|1
4969780|NCT00117286|17080275|P1|Overall Study|Lack of Efficacy|2
4969781|NCT00117286|17080274|P2|Overall Study|Physician Decision|7
4969782|NCT00117286|17080275|P1|Overall Study|Physician Decision|3
4969783|NCT00117286|17080274|P2|Overall Study|Withdrawal by Subject|2
4969784|NCT00117286|17080275|P1|Overall Study|Withdrawal by Subject|6
4969785|NCT00117286|17080274|P2|Overall Study|Protocol Violation|3
4969786|NCT00117286|17080275|P1|Overall Study|Protocol Violation|3
4969787|NCT00117286|17080274|P2|Overall Study|Lost to Follow-up|0
4969788|NCT00117286|17080275|P1|Overall Study|Lost to Follow-up|2
4969789|NCT00117286|17080274|P2|Overall Study|Adverse Event|6
4969790|NCT00117286|17080275|P1|Overall Study|Adverse Event|12
4969791|NCT00117156|17080283|P1|Overall Study|Trt for Pre-Exist Second Primary|1
4969792|NCT00117156|17080283|P1|Overall Study|Physician Decision|1
4969793|NCT00117156|17080283|P1|Overall Study|Adverse Event|9
4969794|NCT00116844|17080351|P2|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
4969795|NCT00116844|17080352|P1|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1
4969796|NCT00116844|17080351|P2|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1
4969797|NCT00116844|17080352|P1|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0
4969798|NCT00116844|17080351|P2|Period 1: Treatment Period 2 (60 Days)|Other|2
4969799|NCT00116844|17080352|P1|Period 1: Treatment Period 2 (60 Days)|Other|0
4969800|NCT00116844|17080351|P2|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1
4969801|NCT00116844|17080352|P1|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2
4969802|NCT00116844|17080351|P2|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0
4969803|NCT00116844|17080352|P1|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1
4969804|NCT00116844|17080351|P2|Period 1: Treatment Period 1 (60 Days)|Other|1
4969805|NCT00116844|17080352|P1|Period 1: Treatment Period 1 (60 Days)|Other|1
4969806|NCT00116844|17080351|P2|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0
4969807|NCT00116844|17080352|P1|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5
4969808|NCT00116844|17080351|P2|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1
4969809|NCT00116844|17080352|P1|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0
4969810|NCT00116844|17080351|P2|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
4969811|NCT00116844|17080352|P1|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1
4969812|NCT00116831|17080370|P2|Overall Study|Missing data for participant|0
4969813|NCT00116831|17080371|P1|Overall Study|Missing data for participant|1
4969814|NCT00116831|17080370|P2|Overall Study|Insufficient therapeutic effect|1
4969815|NCT00116831|17080371|P1|Overall Study|Insufficient therapeutic effect|0
4969816|NCT00116831|17080370|P2|Overall Study|Withdrawal by Subject|32
4969817|NCT00116831|17080371|P1|Overall Study|Withdrawal by Subject|32
4969818|NCT00116831|17080370|P2|Overall Study|Withdrawn investigational product|0
4969819|NCT00116831|17080371|P1|Overall Study|Withdrawn investigational product|1
4969820|NCT00116831|17080370|P2|Overall Study|Low haemoglobin on screening|0
4969821|NCT00116831|17080371|P1|Overall Study|Low haemoglobin on screening|1
4969822|NCT00116831|17080370|P2|Overall Study|Hypoglycaemic events|0
4969823|NCT00116831|17080371|P1|Overall Study|Hypoglycaemic events|1
4969824|NCT00116831|17080370|P2|Overall Study|Protocol Violation|6
4969825|NCT00116831|17080371|P1|Overall Study|Protocol Violation|3
4969826|NCT00116831|17080370|P2|Overall Study|Lost to Follow-up|6
4969827|NCT00116831|17080371|P1|Overall Study|Lost to Follow-up|8
4969828|NCT00116831|17080370|P2|Overall Study|Baseline IVUS determined unevaluable|11
4969829|NCT00116831|17080371|P1|Overall Study|Baseline IVUS determined unevaluable|12
4969830|NCT00116831|17080370|P2|Overall Study|Adverse Event|16
4969831|NCT00116831|17080371|P1|Overall Study|Adverse Event|14
4969832|NCT00116805|17080449|P2|Open-label Period Weeks 433 - 480|Withdrew Consent|0
4969833|NCT00116805|17080450|P1|Open-label Period Weeks 433 - 480|Withdrew Consent|3
4969834|NCT00116805|17080449|P2|Open-label Period Weeks 433 - 480|Investigator's Discretion|0
4969835|NCT00116805|17080450|P1|Open-label Period Weeks 433 - 480|Investigator's Discretion|1
4969836|NCT00116805|17080449|P2|Open-label Period Weeks 385 - 432|Withdrew Consent|0
4969837|NCT00116805|17080450|P1|Open-label Period Weeks 385 - 432|Withdrew Consent|1
4969838|NCT00116805|17080449|P2|Open-label Period Weeks 385 - 432|Investigator's Discretion|0
4969839|NCT00116805|17080450|P1|Open-label Period Weeks 385 - 432|Investigator's Discretion|1
4969840|NCT00116805|17080449|P2|Open-label Period Weeks 337 - 384|Withdrew Consent|1
4969841|NCT00116805|17080450|P1|Open-label Period Weeks 337 - 384|Withdrew Consent|3
4969842|NCT00116805|17080449|P2|Open-label Period Weeks 337 - 384|Protocol Violation|0
4969843|NCT00116805|17080450|P1|Open-label Period Weeks 337 - 384|Protocol Violation|1
4969844|NCT00116805|17080449|P2|Open-label Period Weeks 337 - 384|Lost to Follow-up|0
4969845|NCT00116805|17080450|P1|Open-label Period Weeks 337 - 384|Lost to Follow-up|2
4969846|NCT00116805|17080449|P2|Open-label Period Weeks 337 - 384|Investigator's Discretion|0
4969847|NCT00116805|17080450|P1|Open-label Period Weeks 337 - 384|Investigator's Discretion|1
4969848|NCT00116805|17080449|P2|Open-label Period Weeks 337 - 384|Completed Study|0
4969849|NCT00116805|17080450|P1|Open-label Period Weeks 337 - 384|Completed Study|1
4969850|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Withdrew Consent|0
4969851|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Withdrew Consent|2
4969852|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Study Site Discontinued|1
4969853|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Study Site Discontinued|0
4969854|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1
4969855|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0
4969856|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Protocol Violation|1
4969857|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Protocol Violation|0
4969858|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
4969859|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Lost to Follow-up|1
4969860|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Investigator's Discretion|2
4969861|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Investigator's Discretion|3
4969862|NCT00116805|17080449|P2|Open-label Period Weeks 289 - 336|Completed Study|1
4969863|NCT00116805|17080450|P1|Open-label Period Weeks 289 - 336|Completed Study|0
4969864|NCT00116805|17080449|P2|Open-label Period Weeks 241 - 288|Withdrew Consent|0
4969865|NCT00116805|17080450|P1|Open-label Period Weeks 241 - 288|Withdrew Consent|4
4969866|NCT00116805|17080449|P2|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0
4969867|NCT00116805|17080450|P1|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2
4969868|NCT00116805|17080449|P2|Open-label Period Weeks 193 - 240|Withdrew Consent|1
4969869|NCT00116805|17080450|P1|Open-label Period Weeks 193 - 240|Withdrew Consent|7
4969870|NCT00116805|17080449|P2|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
4969871|NCT00116805|17080450|P1|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2
4969872|NCT00116805|17080449|P2|Open-label Period Weeks 193 - 240|Lost to Follow-up|0
4969873|NCT00116805|17080450|P1|Open-label Period Weeks 193 - 240|Lost to Follow-up|3
4969874|NCT00116805|17080449|P2|Open-label Period Weeks 193 - 240|Investigator's Discretion|0
4969875|NCT00116805|17080450|P1|Open-label Period Weeks 193 - 240|Investigator's Discretion|1
4969876|NCT00116805|17080449|P2|Open-label Period Weeks 193 - 240|Completed Study|1
4969877|NCT00116805|17080450|P1|Open-label Period Weeks 193 - 240|Completed Study|0
4969878|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Withdrew Consent|2
4969879|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Withdrew Consent|3
4969880|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Seroconversion|1
4969881|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Seroconversion|0
4969882|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1
4969883|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0
4969884|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Protocol Violation|0
4969885|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Protocol Violation|1
4969886|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Lost to Follow-up|1
4969887|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Lost to Follow-up|3
4969888|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Investigator's Discretion|0
4969889|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Investigator's Discretion|2
4969890|NCT00116805|17080449|P2|Open-label Period Weeks 145 - 192|Completed Study|1
4969891|NCT00116805|17080450|P1|Open-label Period Weeks 145 - 192|Completed Study|1
4969892|NCT00116805|17080449|P2|Open-label Period Weeks 97 - 144|Withdrew Consent|3
4969893|NCT00116805|17080450|P1|Open-label Period Weeks 97 - 144|Withdrew Consent|1
4969894|NCT00116805|17080449|P2|Open-label Period Weeks 97 - 144|Seroconversion|3
4969895|NCT00116805|17080450|P1|Open-label Period Weeks 97 - 144|Seroconversion|2
4969896|NCT00116805|17080449|P2|Open-label Period Weeks 97 - 144|Protocol Violation|1
4969897|NCT00116805|17080450|P1|Open-label Period Weeks 97 - 144|Protocol Violation|0
4969898|NCT00116805|17080449|P2|Open-label Period Weeks 97 - 144|Lost to Follow-up|2
4969899|NCT00116805|17080450|P1|Open-label Period Weeks 97 - 144|Lost to Follow-up|5
4969900|NCT00116805|17080449|P2|Open-label Period Weeks 97 - 144|Investigator's Discretion|0
4969901|NCT00116805|17080450|P1|Open-label Period Weeks 97 - 144|Investigator's Discretion|2
4969902|NCT00116805|17080449|P2|Open-label Period Weeks 97 - 144|Completed Study|0
4969903|NCT00116805|17080450|P1|Open-label Period Weeks 97 - 144|Completed Study|1
4969904|NCT00116805|17080449|P2|Open-label Period Weeks 49 - 96|Withdrew Consent|1
4969905|NCT00116805|17080450|P1|Open-label Period Weeks 49 - 96|Withdrew Consent|2
4969906|NCT00116805|17080449|P2|Open-label Period Weeks 49 - 96|Seroconversion|0
4969907|NCT00116805|17080450|P1|Open-label Period Weeks 49 - 96|Seroconversion|2
4969908|NCT00116805|17080449|P2|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0
4969909|NCT00116805|17080450|P1|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1
4969910|NCT00116805|17080449|P2|Open-label Period Weeks 49 - 96|Protocol Violation|0
4969911|NCT00116805|17080450|P1|Open-label Period Weeks 49 - 96|Protocol Violation|2
4969912|NCT00116805|17080449|P2|Open-label Period Weeks 49 - 96|Lost to Follow-up|0
4969913|NCT00116805|17080450|P1|Open-label Period Weeks 49 - 96|Lost to Follow-up|2
4969914|NCT00116805|17080449|P2|Open-label Period Weeks 49 - 96|Investigator's Discretion|0
4969915|NCT00116805|17080450|P1|Open-label Period Weeks 49 - 96|Investigator's Discretion|1
4969916|NCT00116805|17080449|P2|Double-blind Period Through Week 48|Withdrew Consent|2
4969917|NCT00116805|17080450|P1|Double-blind Period Through Week 48|Withdrew Consent|4
4969918|NCT00116805|17080449|P2|Double-blind Period Through Week 48|Protocol Violation|1
4969919|NCT00116805|17080450|P1|Double-blind Period Through Week 48|Protocol Violation|1
4969920|NCT00116805|17080449|P2|Double-blind Period Through Week 48|Lost to Follow-up|2
4969921|NCT00116805|17080450|P1|Double-blind Period Through Week 48|Lost to Follow-up|6
4969922|NCT00116779|17080543|P2|Overall Study|Elevated PSA levels|2
4969923|NCT00116779|17080544|P1|Overall Study|Elevated PSA levels|2
4969924|NCT00116779|17080543|P2|Overall Study|Physician Decision|1
4969925|NCT00116779|17080544|P1|Overall Study|Physician Decision|3
4969926|NCT00116779|17080543|P2|Overall Study|Inadequate testosterone suppression|9
4969927|NCT00116779|17080544|P1|Overall Study|Inadequate testosterone suppression|7
4969928|NCT00116779|17080543|P2|Overall Study|Withdrawal by Subject|1
4969929|NCT00116779|17080544|P1|Overall Study|Withdrawal by Subject|4
4969930|NCT00116779|17080543|P2|Overall Study|Protocol Violation|4
4969931|NCT00116779|17080544|P1|Overall Study|Protocol Violation|1
4969932|NCT00116779|17080543|P2|Overall Study|Adverse Event|2
4969933|NCT00116779|17080544|P1|Overall Study|Adverse Event|4
4969934|NCT00116753|17080577|P3|Overall Study|Dosing Error|0
4969935|NCT00116753|17080578|P2|Overall Study|Dosing Error|1
4969936|NCT00116753|17080579|P1|Overall Study|Dosing Error|0
4969937|NCT00116753|17080577|P3|Overall Study|Progressive Parkinson's Disease|0
4969938|NCT00116753|17080578|P2|Overall Study|Progressive Parkinson's Disease|0
4969939|NCT00116753|17080579|P1|Overall Study|Progressive Parkinson's Disease|1
4969940|NCT00116753|17080577|P3|Overall Study|Abnormal Echocardiogram|1
4969941|NCT00116753|17080578|P2|Overall Study|Abnormal Echocardiogram|0
4969942|NCT00116753|17080579|P1|Overall Study|Abnormal Echocardiogram|0
4969943|NCT00116753|17080577|P3|Overall Study|Disease Progression|3
4969944|NCT00116753|17080578|P2|Overall Study|Disease Progression|4
4969945|NCT00116753|17080579|P1|Overall Study|Disease Progression|3
4969946|NCT00116753|17080577|P3|Overall Study|Did not Fulfil Eligibility Criteria|3
4969947|NCT00116753|17080578|P2|Overall Study|Did not Fulfil Eligibility Criteria|1
4969948|NCT00116753|17080579|P1|Overall Study|Did not Fulfil Eligibility Criteria|1
4969949|NCT00116753|17080577|P3|Overall Study|Protocol Violation|1
4969950|NCT00116753|17080578|P2|Overall Study|Protocol Violation|0
4969951|NCT00116753|17080579|P1|Overall Study|Protocol Violation|0
4969952|NCT00116753|17080577|P3|Overall Study|Lost to Follow-up|1
4969953|NCT00116753|17080578|P2|Overall Study|Lost to Follow-up|2
4969954|NCT00116753|17080579|P1|Overall Study|Lost to Follow-up|0
4969955|NCT00116753|17080577|P3|Overall Study|Withdrawal by Subject|8
4969956|NCT00116753|17080578|P2|Overall Study|Withdrawal by Subject|12
4969957|NCT00116753|17080579|P1|Overall Study|Withdrawal by Subject|11
4969958|NCT00116753|17080577|P3|Overall Study|Adverse Event|7
4969959|NCT00116753|17080578|P2|Overall Study|Adverse Event|10
4969960|NCT00116753|17080579|P1|Overall Study|Adverse Event|16
4969961|NCT00116688|17080601|P2|Overall Study|Other|0
4969962|NCT00116688|17080602|P1|Overall Study|Other|11
4969963|NCT00116688|17080601|P2|Overall Study|Pregnancy|0
4969964|NCT00116688|17080602|P1|Overall Study|Pregnancy|1
4969965|NCT00116688|17080601|P2|Overall Study|Protocol-specified criteria|0
4969966|NCT00116688|17080602|P1|Overall Study|Protocol-specified criteria|3
4969967|NCT00116688|17080601|P2|Overall Study|Death|0
4969968|NCT00116688|17080602|P1|Overall Study|Death|15
4969969|NCT00116688|17080601|P2|Overall Study|Lost to Follow-up|0
4969970|NCT00116688|17080602|P1|Overall Study|Lost to Follow-up|3
4969971|NCT00116688|17080601|P2|Overall Study|Physician Decision|0
4969972|NCT00116688|17080602|P1|Overall Study|Physician Decision|7
4969973|NCT00116688|17080601|P2|Overall Study|Requirement for alternative therapy|1
4969974|NCT00116688|17080602|P1|Overall Study|Requirement for alternative therapy|11
4969975|NCT00116688|17080601|P2|Overall Study|Withdrawal by Subject|2
4969976|NCT00116688|17080602|P1|Overall Study|Withdrawal by Subject|26
4969977|NCT00116688|17080601|P2|Overall Study|Adverse Event|0
4969978|NCT00116688|17080602|P1|Overall Study|Adverse Event|11
4969979|NCT00116688|17080601|P2|Overall Study|Noncompliance|1
4969980|NCT00116688|17080602|P1|Overall Study|Noncompliance|3
4969981|NCT00116688|17080601|P2|Overall Study|Protocol deviation|0
4969982|NCT00116688|17080602|P1|Overall Study|Protocol deviation|1
4969983|NCT00116649|17080617|P1|Overall Study|Protocol Specified|7
4969984|NCT00116649|17080617|P1|Overall Study|Various Reasons|18
4969985|NCT00116649|17080617|P1|Overall Study|Local Skin Reaction|9
4969986|NCT00116649|17080617|P1|Overall Study|Withdrawal by Subject|68
4969987|NCT00116649|17080617|P1|Overall Study|Lost to Follow-up|32
4969988|NCT00116649|17080617|P1|Overall Study|Lack of Efficacy|1
4969989|NCT00116649|17080617|P1|Overall Study|Adverse Event|20
4969990|NCT00116584|17080624|P2|Overall Study|Protocol Violation|1
4969991|NCT00116584|17080625|P1|Overall Study|Protocol Violation|1
4969992|NCT00116584|17080624|P2|Overall Study|Withdrawal by Subject|0
4969993|NCT00116584|17080625|P1|Overall Study|Withdrawal by Subject|1
4969994|NCT00116558|17080638|P3|Overall Study|disease progression|18
4969995|NCT00116558|17080639|P2|Overall Study|disease progression|7
4969996|NCT00116558|17080640|P1|Overall Study|disease progression|3
4969997|NCT00116558|17080638|P3|Overall Study|Withdrawal by Subject|12
4969998|NCT00116558|17080639|P2|Overall Study|Withdrawal by Subject|3
4969999|NCT00116558|17080640|P1|Overall Study|Withdrawal by Subject|17
4970000|NCT00116558|17080638|P3|Overall Study|Death|3
4970001|NCT00116558|17080639|P2|Overall Study|Death|5
4970002|NCT00116558|17080640|P1|Overall Study|Death|11
4970003|NCT00116428|17080651|P2|Overall Study|Did not meet inclusion criteria|0
4970004|NCT00116428|17080652|P1|Overall Study|Did not meet inclusion criteria|1
4970005|NCT00116428|17080651|P2|Overall Study|Withdrawal by Subject|5
4970006|NCT00116428|17080652|P1|Overall Study|Withdrawal by Subject|2
4970007|NCT00116272|17080681|P2|Overall Study|Lost to Follow-up|6
4970008|NCT00116272|17080682|P1|Overall Study|Lost to Follow-up|11
4970009|NCT00116168|17080751|P4|Overall Study|Lost to Follow-up|0
4970010|NCT00116168|17080752|P3|Overall Study|Lost to Follow-up|0
4970011|NCT00116168|17080753|P2|Overall Study|Lost to Follow-up|5
4970012|NCT00116168|17080754|P1|Overall Study|Lost to Follow-up|6
4970013|NCT00115934|17080818|P2|Overall Study|Did not receive intervention|2
4970014|NCT00115934|17080819|P1|Overall Study|Did not receive intervention|3
4970015|NCT00115934|17080818|P2|Overall Study|Lost to Follow-up|0
4970016|NCT00115934|17080819|P1|Overall Study|Lost to Follow-up|1
4970017|NCT00115804|17080868|P1|Overall Study|Adverse Event|2
4970018|NCT00115778|17080879|P2|Overall Study|Withdrawal by Subject|1
4970019|NCT00115778|17080880|P1|Overall Study|Withdrawal by Subject|0
4970020|NCT00115765|17080900|P4|Overall Study|Other|2
4970021|NCT00115765|17080901|P3|Overall Study|Other|9
4970022|NCT00115765|17080902|P2|Overall Study|Other|12
4970023|NCT00115765|17080903|P1|Overall Study|Other|6
4970024|NCT00115765|17080900|P4|Overall Study|Lost to Follow-up|1
4970025|NCT00115765|17080901|P3|Overall Study|Lost to Follow-up|18
4970026|NCT00115765|17080902|P2|Overall Study|Lost to Follow-up|20
4970027|NCT00115765|17080903|P1|Overall Study|Lost to Follow-up|3
4970028|NCT00115765|17080900|P4|Overall Study|Physician Decision|13
4970029|NCT00115765|17080901|P3|Overall Study|Physician Decision|18
4970030|NCT00115765|17080902|P2|Overall Study|Physician Decision|15
4970031|NCT00115765|17080903|P1|Overall Study|Physician Decision|4
4970032|NCT00115765|17080900|P4|Overall Study|Withdrawal by Subject|15
4970033|NCT00115765|17080901|P3|Overall Study|Withdrawal by Subject|76
4970034|NCT00115765|17080902|P2|Overall Study|Withdrawal by Subject|53
4970035|NCT00115765|17080903|P1|Overall Study|Withdrawal by Subject|22
4970036|NCT00115739|17080941|P1|Overall Study|Lost to Follow-up|3
4970037|NCT00115349|17080950|P2|Overall Study|Study closed due to low enrollment.|9
4970038|NCT00115349|17080951|P1|Overall Study|Study closed due to low enrollment.|11
4970039|NCT00115336|17080959|P2|Overall Study|Hospital discharge before study drug|1
4970040|NCT00115336|17080960|P1|Overall Study|Hospital discharge before study drug|0
4970041|NCT00115063|17080997|P2|Overall Study|Death|0
4970042|NCT00115063|17080998|P1|Overall Study|Death|1
4970043|NCT00115063|17080997|P2|Overall Study|Lost to Follow-up|104
4970044|NCT00115063|17080998|P1|Overall Study|Lost to Follow-up|98
4970045|NCT00115037|17081016|P6|Phase2|Lost to Follow-up|10
4970046|NCT00115037|17081017|P5|Phase2|Lost to Follow-up|4
4970047|NCT00115037|17081018|P4|Phase2|Lost to Follow-up|14
4970048|NCT00115037|17081019|P3|Phase2|Lost to Follow-up|12
4970049|NCT00115037|17081020|P2|Phase2|Lost to Follow-up|0
4970050|NCT00115037|17081021|P1|Phase2|Lost to Follow-up|0
4970051|NCT00115037|17081016|P6|Phase2|Withdrawal by Subject|1
4970052|NCT00115037|17081017|P5|Phase2|Withdrawal by Subject|2
4970053|NCT00115037|17081018|P4|Phase2|Withdrawal by Subject|1
4970054|NCT00115037|17081019|P3|Phase2|Withdrawal by Subject|2
4970055|NCT00115037|17081020|P2|Phase2|Withdrawal by Subject|0
4970056|NCT00115037|17081021|P1|Phase2|Withdrawal by Subject|0
4970057|NCT00115037|17081016|P6|Phase2|Death|1
4970058|NCT00115037|17081017|P5|Phase2|Death|0
4970059|NCT00115037|17081018|P4|Phase2|Death|0
4970060|NCT00115037|17081019|P3|Phase2|Death|1
4970061|NCT00115037|17081020|P2|Phase2|Death|0
4970062|NCT00115037|17081021|P1|Phase2|Death|0
4970063|NCT00115037|17081016|P6|Phase1|Withdrawal by Subject|0
4970064|NCT00115037|17081017|P5|Phase1|Withdrawal by Subject|0
4970065|NCT00115037|17081018|P4|Phase1|Withdrawal by Subject|0
4970066|NCT00115037|17081019|P3|Phase1|Withdrawal by Subject|0
4970067|NCT00115037|17081020|P2|Phase1|Withdrawal by Subject|4
4970068|NCT00115037|17081021|P1|Phase1|Withdrawal by Subject|9
4970069|NCT00115037|17081016|P6|Phase1|Lost to Follow-up|0
4970070|NCT00115037|17081017|P5|Phase1|Lost to Follow-up|0
4970071|NCT00115037|17081018|P4|Phase1|Lost to Follow-up|0
4970072|NCT00115037|17081019|P3|Phase1|Lost to Follow-up|0
4970073|NCT00115037|17081020|P2|Phase1|Lost to Follow-up|23
4970074|NCT00115037|17081021|P1|Phase1|Lost to Follow-up|16
4970075|NCT00114972|17081037|P2|Overall Study|Lost to Follow-up|5
4970076|NCT00114972|17081038|P1|Overall Study|Lost to Follow-up|8
4970077|NCT00114972|17081037|P2|Overall Study|Withdrawal by Subject|7
4970078|NCT00114972|17081038|P1|Overall Study|Withdrawal by Subject|40
4970079|NCT00114959|17081058|P1|Overall Study|Death|1
4970080|NCT00114959|17081058|P1|Overall Study|Physician Decision|1
4970081|NCT00114959|17081058|P1|Overall Study|Lack of Efficacy|6
4970082|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Other|2
4970083|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Other|0
4970084|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Other|2
4970085|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1
4970086|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
4970087|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0
4970088|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Lost to Follow-up|2
4970089|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Lost to Follow-up|0
4970090|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Lost to Follow-up|0
4970091|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Withdrawal by Subject|6
4970092|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Withdrawal by Subject|1
4970093|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Withdrawal by Subject|2
4970094|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Adverse Event|7
4970095|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Adverse Event|14
4970096|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Adverse Event|15
4970097|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Poor or Non-Compliance|3
4970098|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Poor or Non-Compliance|1
4970099|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Poor or Non-Compliance|1
4970100|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Lack of Efficacy|1
4970101|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Lack of Efficacy|0
4970102|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Lack of Efficacy|1
4970103|NCT00114777|17081068|P3|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
4970104|NCT00114777|17081069|P2|Long-Term Extension to Month 84|No Longer Met Study Criteria|0
4970105|NCT00114777|17081070|P1|Long-Term Extension to Month 84|No Longer Met Study Criteria|1
4970106|NCT00114777|17081068|P3|Long-Term Extension to Month 84|Death|7
4970107|NCT00114777|17081069|P2|Long-Term Extension to Month 84|Death|13
4970108|NCT00114777|17081070|P1|Long-Term Extension to Month 84|Death|8
4970109|NCT00114777|17081068|P3|Randomization to Month 36|Other|12
4970110|NCT00114777|17081069|P2|Randomization to Month 36|Other|3
4970111|NCT00114777|17081070|P1|Randomization to Month 36|Other|9
4970112|NCT00114777|17081068|P3|Randomization to Month 36|Withdrawal by Subject|5
4970113|NCT00114777|17081069|P2|Randomization to Month 36|Withdrawal by Subject|4
4970114|NCT00114777|17081070|P1|Randomization to Month 36|Withdrawal by Subject|3
4970115|NCT00114777|17081068|P3|Randomization to Month 36|Adverse Event|44
4970116|NCT00114777|17081069|P2|Randomization to Month 36|Adverse Event|35
4970117|NCT00114777|17081070|P1|Randomization to Month 36|Adverse Event|34
4970118|NCT00114777|17081068|P3|Randomization to Month 36|Poor or Non-Compliance|1
4970119|NCT00114777|17081069|P2|Randomization to Month 36|Poor or Non-Compliance|0
4970120|NCT00114777|17081070|P1|Randomization to Month 36|Poor or Non-Compliance|0
4970121|NCT00114777|17081068|P3|Randomization to Month 36|Lack of Efficacy|17
4970122|NCT00114777|17081069|P2|Randomization to Month 36|Lack of Efficacy|15
4970123|NCT00114777|17081070|P1|Randomization to Month 36|Lack of Efficacy|19
4970124|NCT00114777|17081068|P3|Randomization to Month 36|No Longer Met Study Criteria|2
4970125|NCT00114777|17081069|P2|Randomization to Month 36|No Longer Met Study Criteria|0
4970126|NCT00114777|17081070|P1|Randomization to Month 36|No Longer Met Study Criteria|0
4970127|NCT00114777|17081068|P3|Randomization to Month 36|Death|3
4970128|NCT00114777|17081069|P2|Randomization to Month 36|Death|4
4970129|NCT00114777|17081070|P1|Randomization to Month 36|Death|10
4970130|NCT00114738|17081144|P3|Screening for Randomization|Other|0
4970131|NCT00114738|17081145|P2|Screening for Randomization|Other|0
4970132|NCT00114738|17081146|P1|Screening for Randomization|Other|1
4970133|NCT00114738|17081144|P3|Screening for Randomization|CNS Hemorrhage|0
4970134|NCT00114738|17081145|P2|Screening for Randomization|CNS Hemorrhage|0
4970135|NCT00114738|17081146|P1|Screening for Randomization|CNS Hemorrhage|1
4970136|NCT00114738|17081144|P3|Screening for Randomization|Progressive disease|0
4970137|NCT00114738|17081145|P2|Screening for Randomization|Progressive disease|0
4970138|NCT00114738|17081146|P1|Screening for Randomization|Progressive disease|2
4970139|NCT00114738|17081144|P3|Screening for Randomization|Neuropathy|0
4970140|NCT00114738|17081145|P2|Screening for Randomization|Neuropathy|0
4970141|NCT00114738|17081146|P1|Screening for Randomization|Neuropathy|17
4970142|NCT00114738|17081144|P3|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
4970143|NCT00114738|17081145|P2|Bortezomib Then Bortezomib + Induction|Progressive Disease|0
4970144|NCT00114738|17081146|P1|Bortezomib Then Bortezomib + Induction|Progressive Disease|1
4970145|NCT00114738|17081144|P3|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
4970146|NCT00114738|17081145|P2|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0
4970147|NCT00114738|17081146|P1|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1
4970148|NCT00114634|17081159|P1|Overall Study|failure to return forms|3
4970149|NCT00114530|17081175|P2|Overall Study|Ineligible|0
4970150|NCT00114530|17081176|P1|Overall Study|Ineligible|1
4970151|NCT00114530|17081175|P2|Overall Study|Subject decision after endpoint failure|1
4970152|NCT00114530|17081176|P1|Overall Study|Subject decision after endpoint failure|0
4970153|NCT00114530|17081175|P2|Overall Study|Breast Cancer|0
4970154|NCT00114530|17081176|P1|Overall Study|Breast Cancer|1
4970155|NCT00114530|17081175|P2|Overall Study|Withdrawal by Subject|6
4970156|NCT00114530|17081176|P1|Overall Study|Withdrawal by Subject|2
4970157|NCT00114530|17081175|P2|Overall Study|Physician Decision|1
4970158|NCT00114530|17081176|P1|Overall Study|Physician Decision|1
4970159|NCT00114530|17081175|P2|Overall Study|Lost to Follow-up|1
4970160|NCT00114530|17081176|P1|Overall Study|Lost to Follow-up|1
4970161|NCT00114530|17081175|P2|Overall Study|Death|11
4970162|NCT00114530|17081176|P1|Overall Study|Death|3
4970163|NCT00114244|17081313|P2|Overall Study|Withdrawal by Subject|2
4970164|NCT00114244|17081314|P1|Overall Study|Withdrawal by Subject|0
4970165|NCT00114244|17081313|P2|Overall Study|Adverse Event|5
4970166|NCT00114244|17081314|P1|Overall Study|Adverse Event|2
4970167|NCT00114231|17081326|P2|Overall Study|Biopsy done after registration|0
4970168|NCT00114231|17081327|P1|Overall Study|Biopsy done after registration|1
4970169|NCT00114231|17081326|P2|Overall Study|No Absolute Neutrophil Count|0
4970170|NCT00114231|17081327|P1|Overall Study|No Absolute Neutrophil Count|2
4970171|NCT00114231|17081326|P2|Overall Study|Tumor fixed on digital exam|1
4970172|NCT00114231|17081327|P1|Overall Study|Tumor fixed on digital exam|0
4970173|NCT00114231|17081326|P2|Overall Study|Tumor size > 4cm|0
4970174|NCT00114231|17081327|P1|Overall Study|Tumor size > 4cm|1
4970175|NCT00114231|17081326|P2|Overall Study|Low creatinine clearance|1
4970176|NCT00114231|17081327|P1|Overall Study|Low creatinine clearance|0
4970177|NCT00114231|17081326|P2|Overall Study|No adenocarcinoma|0
4970178|NCT00114231|17081327|P1|Overall Study|No adenocarcinoma|1
4970179|NCT00114231|17081326|P2|Overall Study|Suspected metastatic disease|0
4970180|NCT00114231|17081327|P1|Overall Study|Suspected metastatic disease|1
4970181|NCT00114231|17081326|P2|Overall Study|QARC requirement not met|0
4970182|NCT00114231|17081327|P1|Overall Study|QARC requirement not met|1
4970183|NCT00114231|17081326|P2|Overall Study|No consent|0
4970184|NCT00114231|17081327|P1|Overall Study|No consent|2
4970185|NCT00114218|17081336|P1|Overall Study|Never Treated|1
4970186|NCT00114218|17081336|P1|Overall Study|Wrong Primary|1
4970187|NCT00114218|17081336|P1|Overall Study|Wrong Cell Type|2
4970188|NCT00114166|17081343|P2|Overall Study|Wrong primary|1
4970189|NCT00114166|17081344|P1|Overall Study|Wrong primary|0
4970190|NCT00114140|17081354|P1|Overall Study|Protocol Violation|7
4970191|NCT00114127|17081368|P2|Overall Study|Withdrawal by Subject|3
4970192|NCT00114127|17081369|P1|Overall Study|Withdrawal by Subject|1
4970193|NCT00114127|17081368|P2|Overall Study|Lost to Follow-up|0
4970194|NCT00114127|17081369|P1|Overall Study|Lost to Follow-up|1
4970195|NCT00114127|17081368|P2|Overall Study|Adverse Event|1
4970196|NCT00114127|17081369|P1|Overall Study|Adverse Event|2
4970197|NCT00113919|17081441|P1|Overall Study|Death|6
4970198|NCT00113919|17081441|P1|Overall Study|Physician Decision|8
4970199|NCT00113841|17081509|P2|Overall Study|Non-compliant|0
4970200|NCT00113841|17081510|P1|Overall Study|Non-compliant|1
4970201|NCT00113841|17081509|P2|Overall Study|Disease progression|2
4970202|NCT00113841|17081510|P1|Overall Study|Disease progression|0
4970203|NCT00113763|17081518|P2|Overall Study|Ongoing|0
4970204|NCT00113763|17081519|P1|Overall Study|Ongoing|1
4970205|NCT00113763|17081518|P2|Overall Study|Non-compliance|0
4970206|NCT00113763|17081519|P1|Overall Study|Non-compliance|1
4970207|NCT00113763|17081518|P2|Overall Study|Other|6
4970208|NCT00113763|17081519|P1|Overall Study|Other|27
4970209|NCT00113763|17081518|P2|Overall Study|Withdrawal by Subject|4
4970210|NCT00113763|17081519|P1|Overall Study|Withdrawal by Subject|1
4970211|NCT00113763|17081518|P2|Overall Study|Lost to Follow-up|0
4970212|NCT00113763|17081519|P1|Overall Study|Lost to Follow-up|10
4970213|NCT00113763|17081518|P2|Overall Study|Disease Progression|14
4970214|NCT00113763|17081519|P1|Overall Study|Disease Progression|28
4970215|NCT00113763|17081518|P2|Overall Study|Adverse Event|2
4970216|NCT00113763|17081519|P1|Overall Study|Adverse Event|5
4970217|NCT00113607|17081545|P2|Overall Study|Other|32
4970218|NCT00113607|17081546|P1|Overall Study|Other|43
4970219|NCT00113607|17081545|P2|Overall Study|Complete Response (Confirmed)|24
4970220|NCT00113607|17081546|P1|Overall Study|Complete Response (Confirmed)|14
4970221|NCT00113607|17081545|P2|Overall Study|Disease Progression|142
4970222|NCT00113607|17081546|P1|Overall Study|Disease Progression|180
4970223|NCT00113607|17081545|P2|Overall Study|Lost to Follow-up|2
4970224|NCT00113607|17081546|P1|Overall Study|Lost to Follow-up|0
4970225|NCT00113607|17081545|P2|Overall Study|Withdrawal by Subject|58
4970226|NCT00113607|17081546|P1|Overall Study|Withdrawal by Subject|50
4970227|NCT00113607|17081545|P2|Overall Study|Death|8
4970228|NCT00113607|17081546|P1|Overall Study|Death|8
4970229|NCT00113607|17081545|P2|Overall Study|Adverse Event|71
4970230|NCT00113607|17081546|P1|Overall Study|Adverse Event|40
4970231|NCT00113568|17081560|P1|Overall Study|Other|112
4970232|NCT00113568|17081560|P1|Overall Study|Withdrawal by Subject|117
4970233|NCT00113568|17081560|P1|Overall Study|Protocol Violation|32
4970234|NCT00113568|17081560|P1|Overall Study|Lost to Follow-up|156
4970235|NCT00113568|17081560|P1|Overall Study|Lack of Efficacy|30
4970236|NCT00113568|17081560|P1|Overall Study|Death|1
4970237|NCT00113568|17081560|P1|Overall Study|Adverse Event|97
4970238|NCT00113555|17081572|P1|Overall Study|Lost to Follow-up|8
4970239|NCT00113555|17081572|P1|Overall Study|Missed Followup|4
4970240|NCT00113555|17081572|P1|Overall Study|Death|1
4970241|NCT00113555|17081572|P1|Overall Study|Permanently Explanted|7
4970242|NCT00113555|17081572|P1|Overall Study|Baseline Failure|59
4970243|NCT00113529|17081582|P1|Overall Study|Withdrawal by Subject|4
4970244|NCT00113529|17081582|P1|Overall Study|Decision of sponsor|6
4970245|NCT00113529|17081582|P1|Overall Study|Lack of Efficacy|20
4970246|NCT00113529|17081582|P1|Overall Study|Adverse Event|4
4970247|NCT00113516|17081615|P2|Part 2|Ongoing|1
4970248|NCT00113516|17081616|P1|Part 2|Ongoing|0
4970249|NCT00113516|17081615|P2|Part 2|Laboratory Abnormality|1
4970250|NCT00113516|17081616|P1|Part 2|Laboratory Abnormality|0
4970251|NCT00113516|17081615|P2|Part 2|Other|3
4970252|NCT00113516|17081616|P1|Part 2|Other|0
4970253|NCT00113516|17081615|P2|Part 2|Withdrawal by Subject|3
4970254|NCT00113516|17081616|P1|Part 2|Withdrawal by Subject|0
4970255|NCT00113516|17081615|P2|Part 2|Lack of Efficacy|37
4970256|NCT00113516|17081616|P1|Part 2|Lack of Efficacy|0
4970257|NCT00113516|17081615|P2|Part 2|Death|5
4970258|NCT00113516|17081616|P1|Part 2|Death|0
4970259|NCT00113516|17081615|P2|Part 2|Adverse Event|16
4970260|NCT00113516|17081616|P1|Part 2|Adverse Event|0
4970261|NCT00113516|17081615|P2|Part 1|Missing|0
4970262|NCT00113516|17081616|P1|Part 1|Missing|65
4970263|NCT00113516|17081615|P2|Part 1|Ongoing|0
4970264|NCT00113516|17081616|P1|Part 1|Ongoing|1
4970265|NCT00113516|17081615|P2|Part 1|Laboratory Abnormality|0
4970266|NCT00113516|17081616|P1|Part 1|Laboratory Abnormality|1
4970267|NCT00113516|17081615|P2|Part 1|Did Not Meet Entrance Criteria|0
4970268|NCT00113516|17081616|P1|Part 1|Did Not Meet Entrance Criteria|1
4970269|NCT00113516|17081615|P2|Part 1|Lack of Efficacy|0
4970270|NCT00113516|17081616|P1|Part 1|Lack of Efficacy|2
4970271|NCT00113516|17081615|P2|Part 1|Withdrawal by Subject|0
4970272|NCT00113516|17081616|P1|Part 1|Withdrawal by Subject|2
4970273|NCT00113516|17081615|P2|Part 1|Other|0
4970274|NCT00113516|17081616|P1|Part 1|Other|3
4970275|NCT00113516|17081615|P2|Part 1|Death|0
4970276|NCT00113516|17081616|P1|Part 1|Death|3
4970277|NCT00113516|17081615|P2|Part 1|Adverse Event|0
4970278|NCT00113516|17081616|P1|Part 1|Adverse Event|6
4970279|NCT00113490|17081659|P2|Overall Study|Lost to Follow-up|0
4970280|NCT00113490|17081660|P1|Overall Study|Lost to Follow-up|1
4970281|NCT00113490|17081659|P2|Overall Study|Withdrawal by Subject|3
4970282|NCT00113490|17081660|P1|Overall Study|Withdrawal by Subject|1
4970283|NCT00113399|17081693|P2|Overall Study|Other|1
4970284|NCT00113399|17081694|P1|Overall Study|Other|0
4970285|NCT00113399|17081693|P2|Overall Study|Complete Response|1
4970286|NCT00113399|17081694|P1|Overall Study|Complete Response|0
4970287|NCT00113399|17081693|P2|Overall Study|Withdrawal by Subject|2
4970288|NCT00113399|17081694|P1|Overall Study|Withdrawal by Subject|1
4970289|NCT00113399|17081693|P2|Overall Study|Death|1
4970290|NCT00113399|17081694|P1|Overall Study|Death|1
4970291|NCT00113386|17081702|P2|Overall Study|Unknown - Lost to Follow-Up|1
4970292|NCT00113386|17081703|P1|Overall Study|Unknown - Lost to Follow-Up|2
4970293|NCT00113386|17081702|P2|Overall Study|Ineligible|2
4970294|NCT00113386|17081703|P1|Overall Study|Ineligible|1
4970295|NCT00113386|17081702|P2|Overall Study|Toxicity|0
4970296|NCT00113386|17081703|P1|Overall Study|Toxicity|3
4970297|NCT00113386|17081702|P2|Overall Study|Physician Decision|1
4970298|NCT00113386|17081703|P1|Overall Study|Physician Decision|0
4970299|NCT00113386|17081702|P2|Overall Study|Withdrawal by Subject|0
4970300|NCT00113386|17081703|P1|Overall Study|Withdrawal by Subject|1
4970301|NCT00113373|17081709|P1|Overall Study|Never Treated|1
4970302|NCT00113373|17081709|P1|Overall Study|Ineligible: second primary|1
4970303|NCT00113373|17081709|P1|Overall Study|Ineligible: wrong primary|1
4970304|NCT00113360|17081724|P1|Overall Study|Did not meet eligibility criteria|3
4970305|NCT00113360|17081724|P1|Overall Study|Subject required surgery|1
4970306|NCT00113360|17081724|P1|Overall Study|Adverse Event|3
4970307|NCT00113295|17081738|P2|Overall Study|Unrelated Medical Illness|0
4970308|NCT00113295|17081739|P1|Overall Study|Unrelated Medical Illness|1
4970309|NCT00113295|17081738|P2|Overall Study|Adverse Event|1
4970310|NCT00113295|17081739|P1|Overall Study|Adverse Event|4
4970311|NCT00113269|17081758|P4|Overall Study|Unable to return for follow up|0
4970312|NCT00113269|17081759|P3|Overall Study|Unable to return for follow up|0
4970313|NCT00113269|17081760|P2|Overall Study|Unable to return for follow up|1
4970314|NCT00113269|17081761|P1|Overall Study|Unable to return for follow up|2
4970315|NCT00113269|17081758|P4|Overall Study|Did not meet eligibility criteria|1
4970316|NCT00113269|17081759|P3|Overall Study|Did not meet eligibility criteria|0
4970317|NCT00113269|17081760|P2|Overall Study|Did not meet eligibility criteria|0
4970318|NCT00113269|17081761|P1|Overall Study|Did not meet eligibility criteria|1
4970319|NCT00113269|17081758|P4|Overall Study|Withdrew consent, Prednisone initiated|1
4970320|NCT00113269|17081759|P3|Overall Study|Withdrew consent, Prednisone initiated|0
4970321|NCT00113269|17081760|P2|Overall Study|Withdrew consent, Prednisone initiated|0
4970322|NCT00113269|17081761|P1|Overall Study|Withdrew consent, Prednisone initiated|0
4970323|NCT00113269|17081758|P4|Overall Study|Received pancreas transplant|2
4970324|NCT00113269|17081759|P3|Overall Study|Received pancreas transplant|0
4970325|NCT00113269|17081760|P2|Overall Study|Received pancreas transplant|0
4970326|NCT00113269|17081761|P1|Overall Study|Received pancreas transplant|0
4970327|NCT00113269|17081758|P4|Overall Study|Moved|3
4970328|NCT00113269|17081759|P3|Overall Study|Moved|0
4970329|NCT00113269|17081760|P2|Overall Study|Moved|1
4970330|NCT00113269|17081761|P1|Overall Study|Moved|0
4970331|NCT00113269|17081758|P4|Overall Study|Discontinued due to rejection|0
4970332|NCT00113269|17081759|P3|Overall Study|Discontinued due to rejection|1
4970333|NCT00113269|17081760|P2|Overall Study|Discontinued due to rejection|0
4970334|NCT00113269|17081761|P1|Overall Study|Discontinued due to rejection|0
4970335|NCT00113269|17081758|P4|Overall Study|Sponsor elected to discontinue patient|1
4970336|NCT00113269|17081759|P3|Overall Study|Sponsor elected to discontinue patient|0
4970337|NCT00113269|17081760|P2|Overall Study|Sponsor elected to discontinue patient|0
4970338|NCT00113269|17081761|P1|Overall Study|Sponsor elected to discontinue patient|1
4970339|NCT00113269|17081758|P4|Overall Study|Lost to Follow-up|3
4970340|NCT00113269|17081759|P3|Overall Study|Lost to Follow-up|6
4970341|NCT00113269|17081760|P2|Overall Study|Lost to Follow-up|3
4970342|NCT00113269|17081761|P1|Overall Study|Lost to Follow-up|2
4970343|NCT00113269|17081758|P4|Overall Study|Protocol Violation|2
4970344|NCT00113269|17081759|P3|Overall Study|Protocol Violation|4
4970345|NCT00113269|17081760|P2|Overall Study|Protocol Violation|0
4970346|NCT00113269|17081761|P1|Overall Study|Protocol Violation|1
4970347|NCT00113269|17081758|P4|Overall Study|Graft loss|9
4970348|NCT00113269|17081759|P3|Overall Study|Graft loss|4
4970349|NCT00113269|17081760|P2|Overall Study|Graft loss|6
4970350|NCT00113269|17081761|P1|Overall Study|Graft loss|6
4970351|NCT00113269|17081758|P4|Overall Study|Withdrawal by Subject|2
4970352|NCT00113269|17081759|P3|Overall Study|Withdrawal by Subject|4
4970353|NCT00113269|17081760|P2|Overall Study|Withdrawal by Subject|3
4970354|NCT00113269|17081761|P1|Overall Study|Withdrawal by Subject|4
4970355|NCT00113269|17081758|P4|Overall Study|Adverse Event|7
4970356|NCT00113269|17081759|P3|Overall Study|Adverse Event|11
4970357|NCT00113269|17081760|P2|Overall Study|Adverse Event|7
4970358|NCT00113269|17081761|P1|Overall Study|Adverse Event|2
4970359|NCT00113269|17081758|P4|Overall Study|Did not meet eligibility - pre-treatment|2
4970360|NCT00113269|17081759|P3|Overall Study|Did not meet eligibility - pre-treatment|0
4970361|NCT00113269|17081760|P2|Overall Study|Did not meet eligibility - pre-treatment|0
4970362|NCT00113269|17081761|P1|Overall Study|Did not meet eligibility - pre-treatment|0
4970363|NCT00113269|17081758|P4|Overall Study|Death in operating room|1
4970364|NCT00113269|17081759|P3|Overall Study|Death in operating room|0
4970365|NCT00113269|17081760|P2|Overall Study|Death in operating room|0
4970366|NCT00113269|17081761|P1|Overall Study|Death in operating room|0
4970367|NCT00113269|17081758|P4|Overall Study|Early graft loss, technical|0
4970368|NCT00113269|17081759|P3|Overall Study|Early graft loss, technical|2
4970369|NCT00113269|17081760|P2|Overall Study|Early graft loss, technical|0
4970370|NCT00113269|17081761|P1|Overall Study|Early graft loss, technical|0
4970371|NCT00113269|17081758|P4|Overall Study|Not transplanted, recipient issues|4
4970372|NCT00113269|17081759|P3|Overall Study|Not transplanted, recipient issues|7
4970373|NCT00113269|17081760|P2|Overall Study|Not transplanted, recipient issues|1
4970374|NCT00113269|17081761|P1|Overall Study|Not transplanted, recipient issues|2
4970375|NCT00113269|17081758|P4|Overall Study|Not transplanted, donor issues|2
4970376|NCT00113269|17081759|P3|Overall Study|Not transplanted, donor issues|2
4970377|NCT00113269|17081760|P2|Overall Study|Not transplanted, donor issues|0
4970378|NCT00113269|17081761|P1|Overall Study|Not transplanted, donor issues|4
4970379|NCT00113087|17081821|P2|Overall Study|Family or MD withdrew subject|5
4970380|NCT00113087|17081822|P1|Overall Study|Family or MD withdrew subject|10
4970381|NCT00113087|17081821|P2|Overall Study|Death or Transplant|16
4970382|NCT00113087|17081822|P1|Overall Study|Death or Transplant|14
4970383|NCT00112957|17081893|P1|Overall Study|Physician Decision|1
4970384|NCT00112957|17081893|P1|Overall Study|Progressive disease|18
4970385|NCT00112905|17081933|P1|Overall Study|performance status was deteiorating|1
4970386|NCT00112905|17081933|P1|Overall Study|Alternative treatment|1
4970387|NCT00112905|17081933|P1|Overall Study|Ineligibility|5
4970388|NCT00112905|17081933|P1|Overall Study|Death|1
4970389|NCT00112905|17081933|P1|Overall Study|Adverse Event|4
4970390|NCT00112866|17081942|P2|Overall Study|did not start treatment post-op|2
4970391|NCT00112866|17081943|P1|Overall Study|did not start treatment post-op|1
4970392|NCT00112866|17081942|P2|Overall Study|Protocol Violation|0
4970393|NCT00112866|17081943|P1|Overall Study|Protocol Violation|1
4970394|NCT00112840|17081965|P3|Overall Study|Protocol Violation|5
4970395|NCT00112840|17081966|P2|Overall Study|Protocol Violation|0
4970396|NCT00112840|17081967|P1|Overall Study|Protocol Violation|0
4970397|NCT00112840|17081965|P3|Overall Study|Withdrawal by Subject|1
4970398|NCT00112840|17081966|P2|Overall Study|Withdrawal by Subject|0
4970399|NCT00112840|17081967|P1|Overall Study|Withdrawal by Subject|1
4970400|NCT00112840|17081965|P3|Overall Study|Physician Decision|0
4970401|NCT00112840|17081966|P2|Overall Study|Physician Decision|0
4970402|NCT00112840|17081967|P1|Overall Study|Physician Decision|1
4970403|NCT00112736|17081986|P2|Overall Study|1 pt never had had RX due rapid decline|0
4970404|NCT00112736|17081987|P1|Overall Study|1 pt never had had RX due rapid decline|1
4970405|NCT00112489|17082044|P1|Overall Study|Ineligible|7
4970406|NCT00112489|17082044|P1|Overall Study|Patient never treated|2
4970407|NCT00112489|17082044|P1|Overall Study|Other, Not Specified|9
4970408|NCT00112489|17082044|P1|Overall Study|Death|2
4970409|NCT00112489|17082044|P1|Overall Study|Adverse Event|12
4970410|NCT00112489|17082044|P1|Overall Study|Refused further treatment|8
4970411|NCT00112463|17082054|P1|Overall Study|Never started treatment|2
4970412|NCT00112463|17082054|P1|Overall Study|Withdrawal by Subject|2
4970413|NCT00112463|17082054|P1|Overall Study|Toxicity|3
4970414|NCT00112463|17082054|P1|Overall Study|Second Primary|1
4970415|NCT00112463|17082054|P1|Overall Study|Progression|30
4970416|NCT00112463|17082054|P1|Overall Study|Physician Decision|1
4970417|NCT00112437|17082066|P26|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3
4970418|NCT00112437|17082067|P25|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970419|NCT00112437|17082068|P24|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6
4970420|NCT00112437|17082069|P23|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4
4970421|NCT00112437|17082070|P22|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970422|NCT00112437|17082071|P21|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970423|NCT00112437|17082072|P20|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970424|NCT00112437|17082073|P19|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970425|NCT00112437|17082074|P18|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970426|NCT00112437|17082075|P17|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970427|NCT00112437|17082076|P16|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970428|NCT00112437|17082077|P15|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970429|NCT00112437|17082078|P14|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970430|NCT00112437|17082079|P13|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970431|NCT00112437|17082080|P12|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970432|NCT00112437|17082081|P11|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970433|NCT00112437|17082082|P10|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970434|NCT00112437|17082083|P9|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970435|NCT00112437|17082084|P8|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970436|NCT00112437|17082085|P7|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970437|NCT00112437|17082086|P6|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970438|NCT00112437|17082087|P5|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970439|NCT00112437|17082088|P4|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970440|NCT00112437|17082089|P3|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970441|NCT00112437|17082090|P2|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970442|NCT00112437|17082091|P1|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0
4970443|NCT00112437|17082066|P26|Years 6-10 (60-Month Extension)|Physician Decision|0
4970444|NCT00112437|17082067|P25|Years 6-10 (60-Month Extension)|Physician Decision|0
4970445|NCT00112437|17082068|P24|Years 6-10 (60-Month Extension)|Physician Decision|2
4970446|NCT00112437|17082069|P23|Years 6-10 (60-Month Extension)|Physician Decision|0
4970447|NCT00112437|17082070|P22|Years 6-10 (60-Month Extension)|Physician Decision|0
4970448|NCT00112437|17082071|P21|Years 6-10 (60-Month Extension)|Physician Decision|0
4970449|NCT00112437|17082072|P20|Years 6-10 (60-Month Extension)|Physician Decision|0
4970450|NCT00112437|17082073|P19|Years 6-10 (60-Month Extension)|Physician Decision|0
4970451|NCT00112437|17082074|P18|Years 6-10 (60-Month Extension)|Physician Decision|0
4970452|NCT00112437|17082075|P17|Years 6-10 (60-Month Extension)|Physician Decision|0
4970453|NCT00112437|17082076|P16|Years 6-10 (60-Month Extension)|Physician Decision|0
4970454|NCT00112437|17082077|P15|Years 6-10 (60-Month Extension)|Physician Decision|0
4970455|NCT00112437|17082078|P14|Years 6-10 (60-Month Extension)|Physician Decision|0
4970456|NCT00112437|17082079|P13|Years 6-10 (60-Month Extension)|Physician Decision|0
4970457|NCT00112437|17082080|P12|Years 6-10 (60-Month Extension)|Physician Decision|0
4970458|NCT00112437|17082081|P11|Years 6-10 (60-Month Extension)|Physician Decision|0
4970459|NCT00112437|17082082|P10|Years 6-10 (60-Month Extension)|Physician Decision|0
4970460|NCT00112437|17082083|P9|Years 6-10 (60-Month Extension)|Physician Decision|0
4970461|NCT00112437|17082084|P8|Years 6-10 (60-Month Extension)|Physician Decision|0
4970462|NCT00112437|17082085|P7|Years 6-10 (60-Month Extension)|Physician Decision|0
4970463|NCT00112437|17082086|P6|Years 6-10 (60-Month Extension)|Physician Decision|0
4970464|NCT00112437|17082087|P5|Years 6-10 (60-Month Extension)|Physician Decision|0
4970465|NCT00112437|17082088|P4|Years 6-10 (60-Month Extension)|Physician Decision|0
4970466|NCT00112437|17082089|P3|Years 6-10 (60-Month Extension)|Physician Decision|0
4970467|NCT00112437|17082090|P2|Years 6-10 (60-Month Extension)|Physician Decision|0
4970468|NCT00112437|17082091|P1|Years 6-10 (60-Month Extension)|Physician Decision|0
4970469|NCT00112437|17082066|P26|Years 6-10 (60-Month Extension)|Other|0
4970470|NCT00112437|17082067|P25|Years 6-10 (60-Month Extension)|Other|1
4970471|NCT00112437|17082068|P24|Years 6-10 (60-Month Extension)|Other|0
4970472|NCT00112437|17082069|P23|Years 6-10 (60-Month Extension)|Other|0
4970473|NCT00112437|17082070|P22|Years 6-10 (60-Month Extension)|Other|0
4970474|NCT00112437|17082071|P21|Years 6-10 (60-Month Extension)|Other|0
4970475|NCT00112437|17082072|P20|Years 6-10 (60-Month Extension)|Other|0
4970476|NCT00112437|17082073|P19|Years 6-10 (60-Month Extension)|Other|0
4970477|NCT00112437|17082074|P18|Years 6-10 (60-Month Extension)|Other|0
4970478|NCT00112437|17082075|P17|Years 6-10 (60-Month Extension)|Other|0
4970479|NCT00112437|17082076|P16|Years 6-10 (60-Month Extension)|Other|0
4970480|NCT00112437|17082077|P15|Years 6-10 (60-Month Extension)|Other|0
4970481|NCT00112437|17082078|P14|Years 6-10 (60-Month Extension)|Other|0
4970482|NCT00112437|17082079|P13|Years 6-10 (60-Month Extension)|Other|0
4970483|NCT00112437|17082080|P12|Years 6-10 (60-Month Extension)|Other|0
4970484|NCT00112437|17082081|P11|Years 6-10 (60-Month Extension)|Other|0
4970485|NCT00112437|17082082|P10|Years 6-10 (60-Month Extension)|Other|0
4970486|NCT00112437|17082083|P9|Years 6-10 (60-Month Extension)|Other|0
4970487|NCT00112437|17082084|P8|Years 6-10 (60-Month Extension)|Other|0
4970488|NCT00112437|17082085|P7|Years 6-10 (60-Month Extension)|Other|0
4970489|NCT00112437|17082086|P6|Years 6-10 (60-Month Extension)|Other|0
4970490|NCT00112437|17082087|P5|Years 6-10 (60-Month Extension)|Other|0
4970491|NCT00112437|17082088|P4|Years 6-10 (60-Month Extension)|Other|0
4970492|NCT00112437|17082089|P3|Years 6-10 (60-Month Extension)|Other|0
4970493|NCT00112437|17082090|P2|Years 6-10 (60-Month Extension)|Other|0
4970494|NCT00112437|17082091|P1|Years 6-10 (60-Month Extension)|Other|0
4970495|NCT00112437|17082066|P26|Years 6-10 (60-Month Extension)|Lost to Follow-up|1
4970496|NCT00112437|17082067|P25|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970497|NCT00112437|17082068|P24|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970498|NCT00112437|17082069|P23|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970499|NCT00112437|17082070|P22|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970500|NCT00112437|17082071|P21|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970501|NCT00112437|17082072|P20|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970502|NCT00112437|17082073|P19|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970503|NCT00112437|17082074|P18|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970504|NCT00112437|17082075|P17|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970505|NCT00112437|17082076|P16|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970506|NCT00112437|17082077|P15|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970507|NCT00112437|17082078|P14|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970508|NCT00112437|17082079|P13|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970509|NCT00112437|17082080|P12|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970510|NCT00112437|17082081|P11|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970511|NCT00112437|17082082|P10|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970512|NCT00112437|17082083|P9|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970513|NCT00112437|17082084|P8|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970514|NCT00112437|17082085|P7|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970515|NCT00112437|17082086|P6|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970516|NCT00112437|17082087|P5|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970517|NCT00112437|17082088|P4|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970518|NCT00112437|17082089|P3|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970519|NCT00112437|17082090|P2|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970520|NCT00112437|17082091|P1|Years 6-10 (60-Month Extension)|Lost to Follow-up|0
4970521|NCT00112437|17082066|P26|Years 6-10 (60-Month Extension)|Death|0
4970522|NCT00112437|17082067|P25|Years 6-10 (60-Month Extension)|Death|0
4970523|NCT00112437|17082068|P24|Years 6-10 (60-Month Extension)|Death|2
4970524|NCT00112437|17082069|P23|Years 6-10 (60-Month Extension)|Death|0
4970525|NCT00112437|17082070|P22|Years 6-10 (60-Month Extension)|Death|0
4970526|NCT00112437|17082071|P21|Years 6-10 (60-Month Extension)|Death|0
4970527|NCT00112437|17082072|P20|Years 6-10 (60-Month Extension)|Death|0
4970528|NCT00112437|17082073|P19|Years 6-10 (60-Month Extension)|Death|0
4970529|NCT00112437|17082074|P18|Years 6-10 (60-Month Extension)|Death|0
4970530|NCT00112437|17082075|P17|Years 6-10 (60-Month Extension)|Death|0
4970531|NCT00112437|17082076|P16|Years 6-10 (60-Month Extension)|Death|0
4970532|NCT00112437|17082077|P15|Years 6-10 (60-Month Extension)|Death|0
4970533|NCT00112437|17082078|P14|Years 6-10 (60-Month Extension)|Death|0
4970534|NCT00112437|17082079|P13|Years 6-10 (60-Month Extension)|Death|0
4970535|NCT00112437|17082080|P12|Years 6-10 (60-Month Extension)|Death|0
4970536|NCT00112437|17082081|P11|Years 6-10 (60-Month Extension)|Death|0
4970537|NCT00112437|17082082|P10|Years 6-10 (60-Month Extension)|Death|0
4970538|NCT00112437|17082083|P9|Years 6-10 (60-Month Extension)|Death|0
4970539|NCT00112437|17082084|P8|Years 6-10 (60-Month Extension)|Death|0
4970540|NCT00112437|17082085|P7|Years 6-10 (60-Month Extension)|Death|0
4970541|NCT00112437|17082086|P6|Years 6-10 (60-Month Extension)|Death|0
4970542|NCT00112437|17082087|P5|Years 6-10 (60-Month Extension)|Death|0
4970543|NCT00112437|17082088|P4|Years 6-10 (60-Month Extension)|Death|0
4970544|NCT00112437|17082089|P3|Years 6-10 (60-Month Extension)|Death|0
4970545|NCT00112437|17082090|P2|Years 6-10 (60-Month Extension)|Death|0
4970546|NCT00112437|17082091|P1|Years 6-10 (60-Month Extension)|Death|0
4970547|NCT00112437|17082066|P26|Years 6-10 (60-Month Extension)|Adverse Event|1
4970548|NCT00112437|17082067|P25|Years 6-10 (60-Month Extension)|Adverse Event|0
4970549|NCT00112437|17082068|P24|Years 6-10 (60-Month Extension)|Adverse Event|2
4970550|NCT00112437|17082069|P23|Years 6-10 (60-Month Extension)|Adverse Event|1
4970551|NCT00112437|17082070|P22|Years 6-10 (60-Month Extension)|Adverse Event|0
4970552|NCT00112437|17082071|P21|Years 6-10 (60-Month Extension)|Adverse Event|0
4970553|NCT00112437|17082072|P20|Years 6-10 (60-Month Extension)|Adverse Event|0
4970554|NCT00112437|17082073|P19|Years 6-10 (60-Month Extension)|Adverse Event|0
4970555|NCT00112437|17082074|P18|Years 6-10 (60-Month Extension)|Adverse Event|0
4970556|NCT00112437|17082075|P17|Years 6-10 (60-Month Extension)|Adverse Event|0
4970557|NCT00112437|17082076|P16|Years 6-10 (60-Month Extension)|Adverse Event|0
4970558|NCT00112437|17082077|P15|Years 6-10 (60-Month Extension)|Adverse Event|0
4970559|NCT00112437|17082078|P14|Years 6-10 (60-Month Extension)|Adverse Event|0
4970560|NCT00112437|17082079|P13|Years 6-10 (60-Month Extension)|Adverse Event|0
4970561|NCT00112437|17082080|P12|Years 6-10 (60-Month Extension)|Adverse Event|0
4970562|NCT00112437|17082081|P11|Years 6-10 (60-Month Extension)|Adverse Event|0
4970563|NCT00112437|17082082|P10|Years 6-10 (60-Month Extension)|Adverse Event|0
4970564|NCT00112437|17082083|P9|Years 6-10 (60-Month Extension)|Adverse Event|0
4970565|NCT00112437|17082084|P8|Years 6-10 (60-Month Extension)|Adverse Event|0
4970566|NCT00112437|17082085|P7|Years 6-10 (60-Month Extension)|Adverse Event|0
4970567|NCT00112437|17082086|P6|Years 6-10 (60-Month Extension)|Adverse Event|0
4970568|NCT00112437|17082087|P5|Years 6-10 (60-Month Extension)|Adverse Event|0
4970569|NCT00112437|17082088|P4|Years 6-10 (60-Month Extension)|Adverse Event|0
4970570|NCT00112437|17082089|P3|Years 6-10 (60-Month Extension)|Adverse Event|0
4970571|NCT00112437|17082090|P2|Years 6-10 (60-Month Extension)|Adverse Event|0
4970572|NCT00112437|17082091|P1|Years 6-10 (60-Month Extension)|Adverse Event|0
4970573|NCT00112437|17082066|P26|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970574|NCT00112437|17082067|P25|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970575|NCT00112437|17082068|P24|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970576|NCT00112437|17082069|P23|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970577|NCT00112437|17082070|P22|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2
4970578|NCT00112437|17082071|P21|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1
4970579|NCT00112437|17082072|P20|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970580|NCT00112437|17082073|P19|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970581|NCT00112437|17082074|P18|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970582|NCT00112437|17082075|P17|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970583|NCT00112437|17082076|P16|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970584|NCT00112437|17082077|P15|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970585|NCT00112437|17082078|P14|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970586|NCT00112437|17082079|P13|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970587|NCT00112437|17082080|P12|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970588|NCT00112437|17082081|P11|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970589|NCT00112437|17082082|P10|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970590|NCT00112437|17082083|P9|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970591|NCT00112437|17082084|P8|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970592|NCT00112437|17082085|P7|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970593|NCT00112437|17082086|P6|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970594|NCT00112437|17082087|P5|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970595|NCT00112437|17082088|P4|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970596|NCT00112437|17082089|P3|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970597|NCT00112437|17082090|P2|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970598|NCT00112437|17082091|P1|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0
4970599|NCT00112437|17082066|P26|Years 4-5 (24-Month Extension)|Participant moved|0
4970600|NCT00112437|17082067|P25|Years 4-5 (24-Month Extension)|Participant moved|0
4970601|NCT00112437|17082068|P24|Years 4-5 (24-Month Extension)|Participant moved|0
4970602|NCT00112437|17082069|P23|Years 4-5 (24-Month Extension)|Participant moved|0
4970603|NCT00112437|17082070|P22|Years 4-5 (24-Month Extension)|Participant moved|1
4970604|NCT00112437|17082071|P21|Years 4-5 (24-Month Extension)|Participant moved|0
4970605|NCT00112437|17082072|P20|Years 4-5 (24-Month Extension)|Participant moved|0
4970606|NCT00112437|17082073|P19|Years 4-5 (24-Month Extension)|Participant moved|0
4970607|NCT00112437|17082074|P18|Years 4-5 (24-Month Extension)|Participant moved|0
4970608|NCT00112437|17082075|P17|Years 4-5 (24-Month Extension)|Participant moved|0
4970609|NCT00112437|17082076|P16|Years 4-5 (24-Month Extension)|Participant moved|0
4970610|NCT00112437|17082077|P15|Years 4-5 (24-Month Extension)|Participant moved|0
4970611|NCT00112437|17082078|P14|Years 4-5 (24-Month Extension)|Participant moved|0
4970612|NCT00112437|17082079|P13|Years 4-5 (24-Month Extension)|Participant moved|0
4970613|NCT00112437|17082080|P12|Years 4-5 (24-Month Extension)|Participant moved|0
4970614|NCT00112437|17082081|P11|Years 4-5 (24-Month Extension)|Participant moved|0
4970615|NCT00112437|17082082|P10|Years 4-5 (24-Month Extension)|Participant moved|0
4970616|NCT00112437|17082083|P9|Years 4-5 (24-Month Extension)|Participant moved|0
4970617|NCT00112437|17082084|P8|Years 4-5 (24-Month Extension)|Participant moved|0
4970618|NCT00112437|17082085|P7|Years 4-5 (24-Month Extension)|Participant moved|0
4970619|NCT00112437|17082086|P6|Years 4-5 (24-Month Extension)|Participant moved|0
4970620|NCT00112437|17082087|P5|Years 4-5 (24-Month Extension)|Participant moved|0
4970621|NCT00112437|17082088|P4|Years 4-5 (24-Month Extension)|Participant moved|0
4970622|NCT00112437|17082089|P3|Years 4-5 (24-Month Extension)|Participant moved|0
4970623|NCT00112437|17082090|P2|Years 4-5 (24-Month Extension)|Participant moved|0
4970624|NCT00112437|17082091|P1|Years 4-5 (24-Month Extension)|Participant moved|0
4970625|NCT00112437|17082066|P26|Years 4-5 (24-Month Extension)|Adverse Event|0
4970626|NCT00112437|17082067|P25|Years 4-5 (24-Month Extension)|Adverse Event|0
4970627|NCT00112437|17082068|P24|Years 4-5 (24-Month Extension)|Adverse Event|0
4970628|NCT00112437|17082069|P23|Years 4-5 (24-Month Extension)|Adverse Event|0
4970629|NCT00112437|17082070|P22|Years 4-5 (24-Month Extension)|Adverse Event|4
4970630|NCT00112437|17082071|P21|Years 4-5 (24-Month Extension)|Adverse Event|0
4970631|NCT00112437|17082072|P20|Years 4-5 (24-Month Extension)|Adverse Event|0
4970632|NCT00112437|17082073|P19|Years 4-5 (24-Month Extension)|Adverse Event|0
4970633|NCT00112437|17082074|P18|Years 4-5 (24-Month Extension)|Adverse Event|0
4970634|NCT00112437|17082075|P17|Years 4-5 (24-Month Extension)|Adverse Event|0
4970635|NCT00112437|17082076|P16|Years 4-5 (24-Month Extension)|Adverse Event|0
4970636|NCT00112437|17082077|P15|Years 4-5 (24-Month Extension)|Adverse Event|0
4970637|NCT00112437|17082078|P14|Years 4-5 (24-Month Extension)|Adverse Event|0
4970638|NCT00112437|17082079|P13|Years 4-5 (24-Month Extension)|Adverse Event|0
4970639|NCT00112437|17082080|P12|Years 4-5 (24-Month Extension)|Adverse Event|0
4970640|NCT00112437|17082081|P11|Years 4-5 (24-Month Extension)|Adverse Event|0
4970641|NCT00112437|17082082|P10|Years 4-5 (24-Month Extension)|Adverse Event|0
4970642|NCT00112437|17082083|P9|Years 4-5 (24-Month Extension)|Adverse Event|0
4970643|NCT00112437|17082084|P8|Years 4-5 (24-Month Extension)|Adverse Event|0
4970644|NCT00112437|17082085|P7|Years 4-5 (24-Month Extension)|Adverse Event|0
4970645|NCT00112437|17082086|P6|Years 4-5 (24-Month Extension)|Adverse Event|0
4970646|NCT00112437|17082087|P5|Years 4-5 (24-Month Extension)|Adverse Event|0
4970647|NCT00112437|17082088|P4|Years 4-5 (24-Month Extension)|Adverse Event|0
4970648|NCT00112437|17082089|P3|Years 4-5 (24-Month Extension)|Adverse Event|0
4970649|NCT00112437|17082090|P2|Years 4-5 (24-Month Extension)|Adverse Event|0
4970650|NCT00112437|17082091|P1|Years 4-5 (24-Month Extension)|Adverse Event|0
4970651|NCT00112437|17082066|P26|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970652|NCT00112437|17082067|P25|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970653|NCT00112437|17082068|P24|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970654|NCT00112437|17082069|P23|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970655|NCT00112437|17082070|P22|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970656|NCT00112437|17082071|P21|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1
4970657|NCT00112437|17082072|P20|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970658|NCT00112437|17082073|P19|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970659|NCT00112437|17082074|P18|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970660|NCT00112437|17082075|P17|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970661|NCT00112437|17082076|P16|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970662|NCT00112437|17082077|P15|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970663|NCT00112437|17082078|P14|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970664|NCT00112437|17082079|P13|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970665|NCT00112437|17082080|P12|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970666|NCT00112437|17082081|P11|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970667|NCT00112437|17082082|P10|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970668|NCT00112437|17082083|P9|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970669|NCT00112437|17082084|P8|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970670|NCT00112437|17082085|P7|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970671|NCT00112437|17082086|P6|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970672|NCT00112437|17082087|P5|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970673|NCT00112437|17082088|P4|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970674|NCT00112437|17082089|P3|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970675|NCT00112437|17082090|P2|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970676|NCT00112437|17082091|P1|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0
4970677|NCT00112437|17082066|P26|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970678|NCT00112437|17082067|P25|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970679|NCT00112437|17082068|P24|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970680|NCT00112437|17082069|P23|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970681|NCT00112437|17082070|P22|Years 4-5 (24-Month Extension)|Lack of Efficacy|1
4970682|NCT00112437|17082071|P21|Years 4-5 (24-Month Extension)|Lack of Efficacy|2
4970683|NCT00112437|17082072|P20|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970684|NCT00112437|17082073|P19|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970685|NCT00112437|17082074|P18|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970686|NCT00112437|17082075|P17|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970687|NCT00112437|17082076|P16|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970688|NCT00112437|17082077|P15|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970689|NCT00112437|17082078|P14|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970690|NCT00112437|17082079|P13|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970691|NCT00112437|17082080|P12|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970692|NCT00112437|17082081|P11|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970693|NCT00112437|17082082|P10|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970694|NCT00112437|17082083|P9|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970695|NCT00112437|17082084|P8|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970696|NCT00112437|17082085|P7|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970697|NCT00112437|17082086|P6|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970698|NCT00112437|17082087|P5|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970699|NCT00112437|17082088|P4|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970700|NCT00112437|17082089|P3|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970701|NCT00112437|17082090|P2|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970702|NCT00112437|17082091|P1|Years 4-5 (24-Month Extension)|Lack of Efficacy|0
4970703|NCT00112437|17082066|P26|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970704|NCT00112437|17082067|P25|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970705|NCT00112437|17082068|P24|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970706|NCT00112437|17082069|P23|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970707|NCT00112437|17082070|P22|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970708|NCT00112437|17082071|P21|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970709|NCT00112437|17082072|P20|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970710|NCT00112437|17082073|P19|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970711|NCT00112437|17082074|P18|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970712|NCT00112437|17082075|P17|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970713|NCT00112437|17082076|P16|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970714|NCT00112437|17082077|P15|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970715|NCT00112437|17082078|P14|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970716|NCT00112437|17082079|P13|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970717|NCT00112437|17082080|P12|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
4970718|NCT00112437|17082081|P11|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1
4970719|NCT00112437|17082082|P10|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970720|NCT00112437|17082083|P9|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970721|NCT00112437|17082084|P8|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970722|NCT00112437|17082085|P7|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970723|NCT00112437|17082086|P6|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970724|NCT00112437|17082087|P5|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970725|NCT00112437|17082088|P4|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970726|NCT00112437|17082089|P3|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970727|NCT00112437|17082090|P2|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970728|NCT00112437|17082091|P1|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0
4970729|NCT00112437|17082066|P26|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970730|NCT00112437|17082067|P25|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970731|NCT00112437|17082068|P24|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970732|NCT00112437|17082069|P23|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970733|NCT00112437|17082070|P22|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970734|NCT00112437|17082071|P21|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970735|NCT00112437|17082072|P20|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970736|NCT00112437|17082073|P19|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970737|NCT00112437|17082074|P18|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970738|NCT00112437|17082075|P17|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970739|NCT00112437|17082076|P16|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970740|NCT00112437|17082077|P15|Year 3 (12-Month Extension)|Withdrawal by Subject|1
4970741|NCT00112437|17082078|P14|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970742|NCT00112437|17082079|P13|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970743|NCT00112437|17082080|P12|Year 3 (12-Month Extension)|Withdrawal by Subject|3
4970744|NCT00112437|17082081|P11|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970745|NCT00112437|17082082|P10|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970746|NCT00112437|17082083|P9|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970747|NCT00112437|17082084|P8|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970748|NCT00112437|17082085|P7|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970749|NCT00112437|17082086|P6|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970750|NCT00112437|17082087|P5|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970751|NCT00112437|17082088|P4|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970752|NCT00112437|17082089|P3|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970753|NCT00112437|17082090|P2|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970754|NCT00112437|17082091|P1|Year 3 (12-Month Extension)|Withdrawal by Subject|0
4970755|NCT00112437|17082066|P26|Year 3 (12-Month Extension)|Protocol Violation|0
4970756|NCT00112437|17082067|P25|Year 3 (12-Month Extension)|Protocol Violation|0
4970757|NCT00112437|17082068|P24|Year 3 (12-Month Extension)|Protocol Violation|0
4970758|NCT00112437|17082069|P23|Year 3 (12-Month Extension)|Protocol Violation|0
4970759|NCT00112437|17082070|P22|Year 3 (12-Month Extension)|Protocol Violation|0
4970760|NCT00112437|17082071|P21|Year 3 (12-Month Extension)|Protocol Violation|0
4970761|NCT00112437|17082072|P20|Year 3 (12-Month Extension)|Protocol Violation|0
4970762|NCT00112437|17082073|P19|Year 3 (12-Month Extension)|Protocol Violation|0
4970763|NCT00112437|17082074|P18|Year 3 (12-Month Extension)|Protocol Violation|0
4970764|NCT00112437|17082075|P17|Year 3 (12-Month Extension)|Protocol Violation|0
4970765|NCT00112437|17082076|P16|Year 3 (12-Month Extension)|Protocol Violation|1
4970766|NCT00112437|17082077|P15|Year 3 (12-Month Extension)|Protocol Violation|0
4970767|NCT00112437|17082078|P14|Year 3 (12-Month Extension)|Protocol Violation|0
4970768|NCT00112437|17082079|P13|Year 3 (12-Month Extension)|Protocol Violation|0
4970769|NCT00112437|17082080|P12|Year 3 (12-Month Extension)|Protocol Violation|0
4970770|NCT00112437|17082081|P11|Year 3 (12-Month Extension)|Protocol Violation|0
4970771|NCT00112437|17082082|P10|Year 3 (12-Month Extension)|Protocol Violation|0
4970772|NCT00112437|17082083|P9|Year 3 (12-Month Extension)|Protocol Violation|0
4970773|NCT00112437|17082084|P8|Year 3 (12-Month Extension)|Protocol Violation|0
4970774|NCT00112437|17082085|P7|Year 3 (12-Month Extension)|Protocol Violation|0
4970775|NCT00112437|17082086|P6|Year 3 (12-Month Extension)|Protocol Violation|0
4970776|NCT00112437|17082087|P5|Year 3 (12-Month Extension)|Protocol Violation|0
4970777|NCT00112437|17082088|P4|Year 3 (12-Month Extension)|Protocol Violation|0
4970778|NCT00112437|17082089|P3|Year 3 (12-Month Extension)|Protocol Violation|0
4970779|NCT00112437|17082090|P2|Year 3 (12-Month Extension)|Protocol Violation|0
4970780|NCT00112437|17082091|P1|Year 3 (12-Month Extension)|Protocol Violation|0
4970781|NCT00112437|17082066|P26|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970782|NCT00112437|17082067|P25|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970783|NCT00112437|17082068|P24|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970784|NCT00112437|17082069|P23|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970785|NCT00112437|17082070|P22|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970786|NCT00112437|17082071|P21|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970787|NCT00112437|17082072|P20|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970788|NCT00112437|17082073|P19|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970789|NCT00112437|17082074|P18|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970790|NCT00112437|17082075|P17|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970791|NCT00112437|17082076|P16|Year 3 (12-Month Extension)|Lost to Follow-up|1
4970792|NCT00112437|17082077|P15|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970793|NCT00112437|17082078|P14|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970794|NCT00112437|17082079|P13|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970795|NCT00112437|17082080|P12|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970796|NCT00112437|17082081|P11|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970797|NCT00112437|17082082|P10|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970798|NCT00112437|17082083|P9|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970799|NCT00112437|17082084|P8|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970800|NCT00112437|17082085|P7|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970801|NCT00112437|17082086|P6|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970802|NCT00112437|17082087|P5|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970803|NCT00112437|17082088|P4|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970804|NCT00112437|17082089|P3|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970805|NCT00112437|17082090|P2|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970806|NCT00112437|17082091|P1|Year 3 (12-Month Extension)|Lost to Follow-up|0
4970807|NCT00112437|17082066|P26|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970808|NCT00112437|17082067|P25|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970809|NCT00112437|17082068|P24|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970810|NCT00112437|17082069|P23|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970811|NCT00112437|17082070|P22|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970812|NCT00112437|17082071|P21|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970813|NCT00112437|17082072|P20|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970814|NCT00112437|17082073|P19|Year 3 (12-Month Extension)|Lack of Efficacy|2
4970815|NCT00112437|17082074|P18|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970816|NCT00112437|17082075|P17|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970817|NCT00112437|17082076|P16|Year 3 (12-Month Extension)|Lack of Efficacy|1
4970818|NCT00112437|17082077|P15|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970819|NCT00112437|17082078|P14|Year 3 (12-Month Extension)|Lack of Efficacy|1
4970820|NCT00112437|17082079|P13|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970821|NCT00112437|17082080|P12|Year 3 (12-Month Extension)|Lack of Efficacy|1
4970822|NCT00112437|17082081|P11|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970823|NCT00112437|17082082|P10|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970824|NCT00112437|17082083|P9|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970825|NCT00112437|17082084|P8|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970826|NCT00112437|17082085|P7|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970827|NCT00112437|17082086|P6|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970828|NCT00112437|17082087|P5|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970829|NCT00112437|17082088|P4|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970830|NCT00112437|17082089|P3|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970831|NCT00112437|17082090|P2|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970832|NCT00112437|17082091|P1|Year 3 (12-Month Extension)|Lack of Efficacy|0
4970833|NCT00112437|17082066|P26|Year 3 (12-Month Extension)|Adverse Event|0
4970834|NCT00112437|17082067|P25|Year 3 (12-Month Extension)|Adverse Event|0
4970835|NCT00112437|17082068|P24|Year 3 (12-Month Extension)|Adverse Event|0
4970836|NCT00112437|17082069|P23|Year 3 (12-Month Extension)|Adverse Event|0
4970837|NCT00112437|17082070|P22|Year 3 (12-Month Extension)|Adverse Event|0
4970838|NCT00112437|17082071|P21|Year 3 (12-Month Extension)|Adverse Event|0
4970839|NCT00112437|17082072|P20|Year 3 (12-Month Extension)|Adverse Event|1
4970840|NCT00112437|17082073|P19|Year 3 (12-Month Extension)|Adverse Event|0
4970841|NCT00112437|17082074|P18|Year 3 (12-Month Extension)|Adverse Event|1
4970842|NCT00112437|17082075|P17|Year 3 (12-Month Extension)|Adverse Event|3
4970843|NCT00112437|17082076|P16|Year 3 (12-Month Extension)|Adverse Event|1
4970844|NCT00112437|17082077|P15|Year 3 (12-Month Extension)|Adverse Event|0
4970845|NCT00112437|17082078|P14|Year 3 (12-Month Extension)|Adverse Event|0
4970846|NCT00112437|17082079|P13|Year 3 (12-Month Extension)|Adverse Event|0
4970847|NCT00112437|17082080|P12|Year 3 (12-Month Extension)|Adverse Event|0
4970848|NCT00112437|17082081|P11|Year 3 (12-Month Extension)|Adverse Event|1
4970849|NCT00112437|17082082|P10|Year 3 (12-Month Extension)|Adverse Event|0
4970850|NCT00112437|17082083|P9|Year 3 (12-Month Extension)|Adverse Event|0
4970851|NCT00112437|17082084|P8|Year 3 (12-Month Extension)|Adverse Event|0
4970852|NCT00112437|17082085|P7|Year 3 (12-Month Extension)|Adverse Event|0
4970853|NCT00112437|17082086|P6|Year 3 (12-Month Extension)|Adverse Event|0
4970854|NCT00112437|17082087|P5|Year 3 (12-Month Extension)|Adverse Event|0
4970855|NCT00112437|17082088|P4|Year 3 (12-Month Extension)|Adverse Event|0
4970856|NCT00112437|17082089|P3|Year 3 (12-Month Extension)|Adverse Event|0
4970857|NCT00112437|17082090|P2|Year 3 (12-Month Extension)|Adverse Event|0
4970858|NCT00112437|17082091|P1|Year 3 (12-Month Extension)|Adverse Event|0
4970859|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Moved|0
4970860|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Moved|0
4970861|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Moved|0
4970862|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Moved|0
4970863|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Moved|0
4970864|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Moved|0
4970865|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Moved|0
4970866|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Moved|0
4970867|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Moved|0
4970868|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Moved|0
4970869|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Moved|0
4970870|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Moved|0
4970871|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Moved|0
4970872|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Moved|0
4970873|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Moved|0
4970874|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Moved|0
4970875|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Moved|1
4970876|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Moved|0
4970877|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Moved|0
4970878|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Moved|0
4970879|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Moved|0
4970880|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Moved|0
4970881|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Moved|0
4970882|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Moved|0
4970883|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Moved|0
4970884|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Moved|0
4970885|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|patient was out of windows|0
4970886|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|patient was out of windows|0
4970887|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|patient was out of windows|0
4970888|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|patient was out of windows|0
4970889|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|patient was out of windows|0
4970890|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|patient was out of windows|0
4970891|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|patient was out of windows|0
4970892|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|patient was out of windows|0
4970893|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|patient was out of windows|0
4970894|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|patient was out of windows|0
4970895|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|patient was out of windows|0
4970896|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|patient was out of windows|0
4970897|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|patient was out of windows|0
4970898|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|patient was out of windows|0
4970899|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|patient was out of windows|0
4970900|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|patient was out of windows|0
4970901|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|patient was out of windows|1
4970902|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|patient was out of windows|0
4970903|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|patient was out of windows|0
4970904|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|patient was out of windows|0
4970905|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|patient was out of windows|0
4970906|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|patient was out of windows|0
4970907|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|patient was out of windows|0
4970908|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|patient was out of windows|0
4970909|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|patient was out of windows|0
4970910|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|patient was out of windows|0
4970911|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970912|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970913|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970914|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970915|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970916|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970917|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970918|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970919|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970920|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970921|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970922|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970923|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970924|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970925|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970926|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970927|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Patient stopped taking medication|1
4970928|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970929|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970930|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970931|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970932|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970933|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970934|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970935|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970936|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Patient stopped taking medication|0
4970937|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970938|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970939|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970940|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970941|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970942|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970943|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970944|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970945|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970946|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970947|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970948|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970949|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970950|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970951|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970952|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970953|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Withdrawal by Subject|1
4970954|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Withdrawal by Subject|4
4970955|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Withdrawal by Subject|2
4970956|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Withdrawal by Subject|1
4970957|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Withdrawal by Subject|1
4970958|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970959|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970960|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970961|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970962|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Withdrawal by Subject|0
4970963|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Protocol Violation|0
4970964|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Protocol Violation|0
4970965|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Protocol Violation|0
4970966|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Protocol Violation|0
4970967|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Protocol Violation|0
4970968|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Protocol Violation|0
4970969|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Protocol Violation|0
4970970|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Protocol Violation|0
4970971|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Protocol Violation|0
4970972|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Protocol Violation|0
4970973|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Protocol Violation|0
4970974|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Protocol Violation|0
4970975|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Protocol Violation|0
4970976|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Protocol Violation|0
4970977|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Protocol Violation|0
4970978|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Protocol Violation|0
4970979|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Protocol Violation|0
4970980|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Protocol Violation|1
4970981|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Protocol Violation|0
4970982|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Protocol Violation|0
4970983|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Protocol Violation|0
4970984|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Protocol Violation|0
4970985|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Protocol Violation|0
4970986|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Protocol Violation|0
4970987|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Protocol Violation|0
4970988|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Protocol Violation|0
4970989|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970990|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970991|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970992|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970993|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970994|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970995|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970996|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970997|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970998|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Lost to Follow-up|0
4970999|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971000|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971001|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971002|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971003|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971004|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971005|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971006|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Lost to Follow-up|1
4971007|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971008|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971009|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971010|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971011|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971012|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971013|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971014|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Lost to Follow-up|0
4971015|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971016|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971017|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971018|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971019|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971020|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971021|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971022|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971023|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971024|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971025|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971026|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971027|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971028|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971029|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971030|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971031|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Lack of Efficacy|2
4971032|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971033|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971034|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Lack of Efficacy|6
4971035|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Lack of Efficacy|1
4971036|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971037|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971038|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971039|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971040|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Lack of Efficacy|0
4971041|NCT00112437|17082066|P26|Year 2 (12-Month Extension)|Adverse Event|0
4971042|NCT00112437|17082067|P25|Year 2 (12-Month Extension)|Adverse Event|0
4971043|NCT00112437|17082068|P24|Year 2 (12-Month Extension)|Adverse Event|0
4971044|NCT00112437|17082069|P23|Year 2 (12-Month Extension)|Adverse Event|0
4971045|NCT00112437|17082070|P22|Year 2 (12-Month Extension)|Adverse Event|0
4971046|NCT00112437|17082071|P21|Year 2 (12-Month Extension)|Adverse Event|0
4971047|NCT00112437|17082072|P20|Year 2 (12-Month Extension)|Adverse Event|0
4971048|NCT00112437|17082073|P19|Year 2 (12-Month Extension)|Adverse Event|0
4971049|NCT00112437|17082074|P18|Year 2 (12-Month Extension)|Adverse Event|0
4971050|NCT00112437|17082075|P17|Year 2 (12-Month Extension)|Adverse Event|0
4971051|NCT00112437|17082076|P16|Year 2 (12-Month Extension)|Adverse Event|0
4971052|NCT00112437|17082077|P15|Year 2 (12-Month Extension)|Adverse Event|0
4971053|NCT00112437|17082078|P14|Year 2 (12-Month Extension)|Adverse Event|0
4971054|NCT00112437|17082079|P13|Year 2 (12-Month Extension)|Adverse Event|0
4971055|NCT00112437|17082080|P12|Year 2 (12-Month Extension)|Adverse Event|0
4971056|NCT00112437|17082081|P11|Year 2 (12-Month Extension)|Adverse Event|0
4971057|NCT00112437|17082082|P10|Year 2 (12-Month Extension)|Adverse Event|7
4971058|NCT00112437|17082083|P9|Year 2 (12-Month Extension)|Adverse Event|1
4971059|NCT00112437|17082084|P8|Year 2 (12-Month Extension)|Adverse Event|6
4971060|NCT00112437|17082085|P7|Year 2 (12-Month Extension)|Adverse Event|2
4971061|NCT00112437|17082086|P6|Year 2 (12-Month Extension)|Adverse Event|1
4971062|NCT00112437|17082087|P5|Year 2 (12-Month Extension)|Adverse Event|0
4971063|NCT00112437|17082088|P4|Year 2 (12-Month Extension)|Adverse Event|0
4971064|NCT00112437|17082089|P3|Year 2 (12-Month Extension)|Adverse Event|0
4971065|NCT00112437|17082090|P2|Year 2 (12-Month Extension)|Adverse Event|0
4971066|NCT00112437|17082091|P1|Year 2 (12-Month Extension)|Adverse Event|0
4971067|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971068|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971069|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971070|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971071|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971072|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971073|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971074|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971075|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971076|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971077|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971078|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971079|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971080|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971081|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971082|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971083|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971084|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971085|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971086|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971087|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971088|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1
4971089|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971090|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971091|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971092|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0
4971093|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971094|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971095|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971096|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971097|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971098|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971099|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971100|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971101|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971102|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971103|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971104|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971105|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971106|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971107|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971108|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971109|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971110|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971111|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971112|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971113|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971114|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971115|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2
4971116|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971117|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971118|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0
4971119|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|moved|0
4971120|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|moved|0
4971121|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|moved|0
4971122|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|moved|0
4971123|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|moved|0
4971124|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|moved|0
4971125|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|moved|0
4971126|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|moved|0
4971127|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|moved|0
4971128|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|moved|0
4971129|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|moved|0
4971130|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|moved|0
4971131|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|moved|0
4971132|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|moved|0
4971133|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|moved|0
4971134|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|moved|0
4971135|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|moved|0
4971136|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|moved|0
4971137|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|moved|0
4971138|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|moved|0
4971139|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|moved|0
4971140|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|moved|0
4971141|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|moved|0
4971142|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|moved|1
4971143|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|moved|1
4971144|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|moved|0
4971145|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971146|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971147|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971148|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971149|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971150|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971151|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971152|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971153|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971154|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971155|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971156|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971157|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971158|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971159|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971160|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971161|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971162|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971163|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971164|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971165|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|Withdrawal by Subject|0
4971166|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|Withdrawal by Subject|7
4971167|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|Withdrawal by Subject|1
4971168|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|Withdrawal by Subject|2
4971169|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
4971170|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|Withdrawal by Subject|5
4971171|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|Protocol Violation|0
4971172|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|Protocol Violation|0
4971173|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|Protocol Violation|0
4971174|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|Protocol Violation|0
4971175|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|Protocol Violation|0
4971176|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|Protocol Violation|0
4971177|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|Protocol Violation|0
4971178|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|Protocol Violation|0
4971179|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|Protocol Violation|0
4971180|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|Protocol Violation|0
4971181|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|Protocol Violation|0
4971182|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|Protocol Violation|0
4971183|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|Protocol Violation|0
4971184|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|Protocol Violation|0
4971185|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|Protocol Violation|0
4971186|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|Protocol Violation|0
4971187|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|Protocol Violation|0
4971188|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|Protocol Violation|0
4971189|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|Protocol Violation|0
4971190|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|Protocol Violation|0
4971191|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|Protocol Violation|0
4971192|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|Protocol Violation|1
4971193|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|Protocol Violation|1
4971194|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|Protocol Violation|3
4971195|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|Protocol Violation|0
4971196|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|Protocol Violation|1
4971197|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971198|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971199|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971200|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971201|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971202|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971203|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971204|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971205|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971206|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971207|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971208|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971209|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971210|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971211|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971212|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971213|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971214|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971215|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971216|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971217|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971218|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971219|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971220|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971221|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|Lost to Follow-up|1
4971222|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|Lost to Follow-up|0
4971223|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971224|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971225|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971226|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971227|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971228|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971229|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971230|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971231|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971232|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971233|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971234|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971235|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971236|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971237|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971238|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971239|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971240|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971241|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971242|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971243|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971244|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971245|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971246|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971247|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|Lack of Efficacy|1
4971248|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|Lack of Efficacy|0
4971249|NCT00112437|17082066|P26|Year 1 (12-Month Base Study)|Adverse Event|0
4971250|NCT00112437|17082067|P25|Year 1 (12-Month Base Study)|Adverse Event|0
4971251|NCT00112437|17082068|P24|Year 1 (12-Month Base Study)|Adverse Event|0
4971252|NCT00112437|17082069|P23|Year 1 (12-Month Base Study)|Adverse Event|0
4971253|NCT00112437|17082070|P22|Year 1 (12-Month Base Study)|Adverse Event|0
4971254|NCT00112437|17082071|P21|Year 1 (12-Month Base Study)|Adverse Event|0
4971255|NCT00112437|17082072|P20|Year 1 (12-Month Base Study)|Adverse Event|0
4971256|NCT00112437|17082073|P19|Year 1 (12-Month Base Study)|Adverse Event|0
4971257|NCT00112437|17082074|P18|Year 1 (12-Month Base Study)|Adverse Event|0
4971258|NCT00112437|17082075|P17|Year 1 (12-Month Base Study)|Adverse Event|0
4971259|NCT00112437|17082076|P16|Year 1 (12-Month Base Study)|Adverse Event|0
4971260|NCT00112437|17082077|P15|Year 1 (12-Month Base Study)|Adverse Event|0
4971261|NCT00112437|17082078|P14|Year 1 (12-Month Base Study)|Adverse Event|0
4971262|NCT00112437|17082079|P13|Year 1 (12-Month Base Study)|Adverse Event|0
4971263|NCT00112437|17082080|P12|Year 1 (12-Month Base Study)|Adverse Event|0
4971264|NCT00112437|17082081|P11|Year 1 (12-Month Base Study)|Adverse Event|0
4971265|NCT00112437|17082082|P10|Year 1 (12-Month Base Study)|Adverse Event|0
4971266|NCT00112437|17082083|P9|Year 1 (12-Month Base Study)|Adverse Event|0
4971267|NCT00112437|17082084|P8|Year 1 (12-Month Base Study)|Adverse Event|0
4971268|NCT00112437|17082085|P7|Year 1 (12-Month Base Study)|Adverse Event|0
4971269|NCT00112437|17082086|P6|Year 1 (12-Month Base Study)|Adverse Event|0
4971270|NCT00112437|17082087|P5|Year 1 (12-Month Base Study)|Adverse Event|3
4971271|NCT00112437|17082088|P4|Year 1 (12-Month Base Study)|Adverse Event|4
4971272|NCT00112437|17082089|P3|Year 1 (12-Month Base Study)|Adverse Event|6
4971273|NCT00112437|17082090|P2|Year 1 (12-Month Base Study)|Adverse Event|10
4971274|NCT00112437|17082091|P1|Year 1 (12-Month Base Study)|Adverse Event|9
4971275|NCT00112385|17082371|P2|Overall Study|Withdrawal by Subject|1
4971276|NCT00112385|17082372|P1|Overall Study|Withdrawal by Subject|0
4971277|NCT00112385|17082371|P2|Overall Study|Lost to Follow-up|0
4971278|NCT00112385|17082372|P1|Overall Study|Lost to Follow-up|1
4971279|NCT00112359|17082462|P2|Overall Study|Other|0
4971280|NCT00112359|17082463|P1|Overall Study|Other|3
4971281|NCT00112359|17082462|P2|Overall Study|Personal/administrative|1
4971282|NCT00112359|17082463|P1|Overall Study|Personal/administrative|1
4971283|NCT00112359|17082462|P2|Overall Study|Lost to Follow-up|1
4971284|NCT00112359|17082463|P1|Overall Study|Lost to Follow-up|0
4971285|NCT00112359|17082462|P2|Overall Study|Related adverse event|3
4971286|NCT00112359|17082463|P1|Overall Study|Related adverse event|5
4971287|NCT00112359|17082462|P2|Overall Study|Trial drug intolerance (adverse event)|0
4971288|NCT00112359|17082463|P1|Overall Study|Trial drug intolerance (adverse event)|2
4971289|NCT00112359|17082462|P2|Overall Study|Unrelated adverse event|8
4971290|NCT00112359|17082463|P1|Overall Study|Unrelated adverse event|16
4971291|NCT00112294|17082489|P2|Overall Study|Still on study|0
4971292|NCT00112294|17082490|P1|Overall Study|Still on study|5
4971293|NCT00112047|17082798|P2|Atripla Phase|Other|1
4971294|NCT00112047|17082799|P1|Atripla Phase|Other|3
4971295|NCT00112047|17082798|P2|Atripla Phase|Non-compliance|0
4971296|NCT00112047|17082799|P1|Atripla Phase|Non-compliance|1
4971297|NCT00112047|17082798|P2|Atripla Phase|Sub-optimal virological response|1
4971298|NCT00112047|17082799|P1|Atripla Phase|Sub-optimal virological response|0
4971299|NCT00112047|17082798|P2|Atripla Phase|Withdrew consent|7
4971300|NCT00112047|17082799|P1|Atripla Phase|Withdrew consent|7
4971301|NCT00112047|17082798|P2|Atripla Phase|Death|2
4971302|NCT00112047|17082799|P1|Atripla Phase|Death|0
4971303|NCT00112047|17082798|P2|Atripla Phase|Pregnancy|1
4971304|NCT00112047|17082799|P1|Atripla Phase|Pregnancy|0
4971305|NCT00112047|17082798|P2|Atripla Phase|Lost to Follow-up|7
4971306|NCT00112047|17082799|P1|Atripla Phase|Lost to Follow-up|5
4971307|NCT00112047|17082798|P2|Atripla Phase|Adverse Event|1
4971308|NCT00112047|17082799|P1|Atripla Phase|Adverse Event|2
4971309|NCT00112047|17082798|P2|Randomized Phase|High Hepatitis B DNA|1
4971310|NCT00112047|17082799|P1|Randomized Phase|High Hepatitis B DNA|0
4971311|NCT00112047|17082798|P2|Randomized Phase|Baseline NNRTI resistance mutations|0
4971312|NCT00112047|17082799|P1|Randomized Phase|Baseline NNRTI resistance mutations|4
4971313|NCT00112047|17082798|P2|Randomized Phase|Moved out of State|1
4971314|NCT00112047|17082799|P1|Randomized Phase|Moved out of State|0
4971315|NCT00112047|17082798|P2|Randomized Phase|Incarceration|2
4971316|NCT00112047|17082799|P1|Randomized Phase|Incarceration|3
4971317|NCT00112047|17082798|P2|Randomized Phase|Inability to swallow pills|1
4971318|NCT00112047|17082799|P1|Randomized Phase|Inability to swallow pills|0
4971319|NCT00112047|17082798|P2|Randomized Phase|Hepatitis C treatment contraindicated|1
4971320|NCT00112047|17082799|P1|Randomized Phase|Hepatitis C treatment contraindicated|0
4971321|NCT00112047|17082798|P2|Randomized Phase|Death|3
4971322|NCT00112047|17082799|P1|Randomized Phase|Death|1
4971323|NCT00112047|17082798|P2|Randomized Phase|Pregnancy|1
4971324|NCT00112047|17082799|P1|Randomized Phase|Pregnancy|3
4971325|NCT00112047|17082798|P2|Randomized Phase|Protocol Violation|0
4971326|NCT00112047|17082799|P1|Randomized Phase|Protocol Violation|2
4971327|NCT00112047|17082798|P2|Randomized Phase|Noncompliance|4
4971328|NCT00112047|17082799|P1|Randomized Phase|Noncompliance|8
4971329|NCT00112047|17082798|P2|Randomized Phase|Sub-optimal virological response|13
4971330|NCT00112047|17082799|P1|Randomized Phase|Sub-optimal virological response|3
4971331|NCT00112047|17082798|P2|Randomized Phase|Withrawal of consent|18
4971332|NCT00112047|17082799|P1|Randomized Phase|Withrawal of consent|10
4971333|NCT00112047|17082798|P2|Randomized Phase|Adverse Event|10
4971334|NCT00112047|17082799|P1|Randomized Phase|Adverse Event|10
4971335|NCT00112047|17082798|P2|Randomized Phase|Lost to Follow-up|33
4971336|NCT00112047|17082799|P1|Randomized Phase|Lost to Follow-up|26
4971337|NCT00111917|17082899|P2|Overall Study|Withdrawal by Subject|1
4971338|NCT00111917|17082900|P1|Overall Study|Withdrawal by Subject|1
4971339|NCT00111839|17082915|P3|Overall Study|Randomized but Not Treated|2
4971340|NCT00111839|17082916|P2|Overall Study|Randomized but Not Treated|0
4971341|NCT00111839|17082917|P1|Overall Study|Randomized but Not Treated|0
4971342|NCT00111839|17082915|P3|Overall Study|Other|3
4971343|NCT00111839|17082916|P2|Overall Study|Other|3
4971344|NCT00111839|17082917|P1|Overall Study|Other|6
4971345|NCT00111839|17082915|P3|Overall Study|Logistical Constraint|0
4971346|NCT00111839|17082916|P2|Overall Study|Logistical Constraint|0
4971347|NCT00111839|17082917|P1|Overall Study|Logistical Constraint|1
4971348|NCT00111839|17082915|P3|Overall Study|Lost to Follow-up|0
4971349|NCT00111839|17082916|P2|Overall Study|Lost to Follow-up|0
4971350|NCT00111839|17082917|P1|Overall Study|Lost to Follow-up|1
4971351|NCT00111839|17082915|P3|Overall Study|Withdrawal by Subject|2
4971352|NCT00111839|17082916|P2|Overall Study|Withdrawal by Subject|2
4971353|NCT00111839|17082917|P1|Overall Study|Withdrawal by Subject|2
4971354|NCT00111839|17082915|P3|Overall Study|Death|6
4971355|NCT00111839|17082916|P2|Overall Study|Death|1
4971356|NCT00111839|17082917|P1|Overall Study|Death|1
4971357|NCT00111839|17082915|P3|Overall Study|Protocol Violation|2
4971358|NCT00111839|17082916|P2|Overall Study|Protocol Violation|4
4971359|NCT00111839|17082917|P1|Overall Study|Protocol Violation|2
4971360|NCT00111839|17082915|P3|Overall Study|Adverse Event|1
4971361|NCT00111839|17082916|P2|Overall Study|Adverse Event|3
4971362|NCT00111839|17082917|P1|Overall Study|Adverse Event|5
4971363|NCT00111839|17082915|P3|Overall Study|Disease Progression|33
4971364|NCT00111839|17082916|P2|Overall Study|Disease Progression|33
4971365|NCT00111839|17082917|P1|Overall Study|Disease Progression|30
4971366|NCT00111813|17082937|P6|Overall Study|Other|0
4971367|NCT00111813|17082938|P5|Overall Study|Other|0
4971368|NCT00111813|17082939|P4|Overall Study|Other|0
4971369|NCT00111813|17082940|P3|Overall Study|Other|1
4971370|NCT00111813|17082941|P2|Overall Study|Other|0
4971371|NCT00111813|17082942|P1|Overall Study|Other|0
4971372|NCT00111813|17082937|P6|Overall Study|Lack of Efficacy|1
4971373|NCT00111813|17082938|P5|Overall Study|Lack of Efficacy|0
4971374|NCT00111813|17082939|P4|Overall Study|Lack of Efficacy|0
4971375|NCT00111813|17082940|P3|Overall Study|Lack of Efficacy|0
4971376|NCT00111813|17082941|P2|Overall Study|Lack of Efficacy|0
4971377|NCT00111813|17082942|P1|Overall Study|Lack of Efficacy|0
4971378|NCT00111813|17082937|P6|Overall Study|Progressive disease|3
4971379|NCT00111813|17082938|P5|Overall Study|Progressive disease|4
4971380|NCT00111813|17082939|P4|Overall Study|Progressive disease|3
4971381|NCT00111813|17082940|P3|Overall Study|Progressive disease|5
4971382|NCT00111813|17082941|P2|Overall Study|Progressive disease|1
4971383|NCT00111813|17082942|P1|Overall Study|Progressive disease|2
4971384|NCT00111813|17082937|P6|Overall Study|Adverse Event|2
4971385|NCT00111813|17082938|P5|Overall Study|Adverse Event|2
4971386|NCT00111813|17082939|P4|Overall Study|Adverse Event|2
4971387|NCT00111813|17082940|P3|Overall Study|Adverse Event|4
4971388|NCT00111813|17082941|P2|Overall Study|Adverse Event|2
4971389|NCT00111813|17082942|P1|Overall Study|Adverse Event|1
4971390|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4971391|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4971392|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4971393|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1
4971394|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4971395|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0
4971396|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4971397|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4971398|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4971399|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1
4971400|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4971401|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0
4971402|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4971403|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4971404|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4971405|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4971406|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1
4971407|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0
4971408|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4971409|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4971410|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4971411|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0
4971412|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4971413|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1
4971414|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4971415|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
4971416|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4971417|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4971418|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0
4971419|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1
4971420|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
4971421|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3
4971422|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
4971423|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
4971424|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2
4971425|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0
4971426|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4971427|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4971428|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4971429|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
4971430|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1
4971431|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0
4971432|NCT00111800|17082981|P6|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
4971433|NCT00111800|17082982|P5|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
4971434|NCT00111800|17082983|P4|Period 2: Extension Phase (12 Weeks)|Adverse Event|3
4971435|NCT00111800|17082984|P3|Period 2: Extension Phase (12 Weeks)|Adverse Event|1
4971436|NCT00111800|17082985|P2|Period 2: Extension Phase (12 Weeks)|Adverse Event|2
4971437|NCT00111800|17082986|P1|Period 2: Extension Phase (12 Weeks)|Adverse Event|0
4971438|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1
4971439|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4971440|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4971441|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4971442|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4971443|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0
4971444|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4971445|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1
4971446|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4971447|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4971448|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4971449|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0
4971450|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4971451|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1
4971452|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4971453|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4971454|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4971455|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0
4971456|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4971457|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4971458|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1
4971459|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4971460|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4971461|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0
4971462|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4971463|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4971464|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1
4971465|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4971466|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4971467|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0
4971468|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4971469|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4971470|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4971471|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4971472|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1
4971473|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0
4971474|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4971475|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4971476|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4971477|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4971478|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1
4971479|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0
4971480|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4971481|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4971482|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4971483|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4971484|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1
4971485|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0
4971486|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4971487|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4971488|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4971489|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4971490|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1
4971491|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0
4971492|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4971493|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4971494|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4971495|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4971496|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0
4971497|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1
4971498|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4971499|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4971500|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4971501|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0
4971502|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
4971503|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1
4971504|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
4971505|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
4971506|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
4971507|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0
4971508|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
4971509|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1
4971510|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4971511|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
4971512|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4971513|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4971514|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0
4971515|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1
4971516|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4971517|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4971518|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1
4971519|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4971520|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0
4971521|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3
4971522|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1
4971523|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
4971524|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0
4971525|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3
4971526|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
4971527|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2
4971528|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
4971529|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Protocol Violation|1
4971530|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
4971531|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Protocol Violation|4
4971532|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Protocol Violation|2
4971533|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Protocol Violation|0
4971534|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
4971535|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
4971536|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
4971537|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2
4971538|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0
4971539|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1
4971540|NCT00111800|17082981|P6|Period 1: Main Phase (12 Weeks)|Adverse Event|0
4971541|NCT00111800|17082982|P5|Period 1: Main Phase (12 Weeks)|Adverse Event|1
4971542|NCT00111800|17082983|P4|Period 1: Main Phase (12 Weeks)|Adverse Event|0
4971543|NCT00111800|17082984|P3|Period 1: Main Phase (12 Weeks)|Adverse Event|0
4971544|NCT00111800|17082985|P2|Period 1: Main Phase (12 Weeks)|Adverse Event|4
4971545|NCT00111800|17082986|P1|Period 1: Main Phase (12 Weeks)|Adverse Event|5
4971546|NCT00111761|17083156|P2|Part 2|Other|0
4971547|NCT00111761|17083157|P1|Part 2|Other|1
4971548|NCT00111761|17083156|P2|Part 2|Protocol-specified criteria|0
4971549|NCT00111761|17083157|P1|Part 2|Protocol-specified criteria|1
4971550|NCT00111761|17083156|P2|Part 2|Disease progression|0
4971551|NCT00111761|17083157|P1|Part 2|Disease progression|3
4971552|NCT00111761|17083156|P2|Part 2|Death|0
4971553|NCT00111761|17083157|P1|Part 2|Death|1
4971554|NCT00111761|17083156|P2|Part 2|Physician Decision|0
4971555|NCT00111761|17083157|P1|Part 2|Physician Decision|1
4971556|NCT00111761|17083156|P2|Part 2|Adverse Event|0
4971557|NCT00111761|17083157|P1|Part 2|Adverse Event|1
4971558|NCT00111761|17083156|P2|Part 1|Withdrawal by Subject|1
4971559|NCT00111761|17083157|P1|Part 1|Withdrawal by Subject|0
4971560|NCT00111761|17083156|P2|Part 1|Other|1
4971561|NCT00111761|17083157|P1|Part 1|Other|0
4971562|NCT00111761|17083156|P2|Part 1|Death|2
4971563|NCT00111761|17083157|P1|Part 1|Death|0
4971564|NCT00111761|17083156|P2|Part 1|Physician Decision|1
4971565|NCT00111761|17083157|P1|Part 1|Physician Decision|0
4971566|NCT00111475|17083194|P10|Overall Study|Lost to Follow-up|0
4971567|NCT00111475|17083195|P9|Overall Study|Lost to Follow-up|0
4971568|NCT00111475|17083196|P8|Overall Study|Lost to Follow-up|0
4971569|NCT00111475|17083197|P7|Overall Study|Lost to Follow-up|0
4971570|NCT00111475|17083198|P6|Overall Study|Lost to Follow-up|1
4971571|NCT00111475|17083199|P5|Overall Study|Lost to Follow-up|0
4971572|NCT00111475|17083200|P4|Overall Study|Lost to Follow-up|0
4971573|NCT00111475|17083201|P3|Overall Study|Lost to Follow-up|0
4971574|NCT00111475|17083202|P2|Overall Study|Lost to Follow-up|0
4971575|NCT00111475|17083203|P1|Overall Study|Lost to Follow-up|0
4971576|NCT00111241|17083321|P2|Overall Study|Adverse Event|0
4971577|NCT00111241|17083322|P1|Overall Study|Adverse Event|1
4971578|NCT00111241|17083321|P2|Overall Study|Protocol Violation|8
4971579|NCT00111241|17083322|P1|Overall Study|Protocol Violation|9
4971580|NCT00111241|17083321|P2|Overall Study|Withdrawal by Subject|0
4971581|NCT00111241|17083322|P1|Overall Study|Withdrawal by Subject|4
4971582|NCT00111241|17083321|P2|Overall Study|Lost to Follow-up|0
4971583|NCT00111241|17083322|P1|Overall Study|Lost to Follow-up|1
4971584|NCT00111228|17083333|P3|Overall Study|Withdrawal by Subject|0
4971585|NCT00111228|17083334|P2|Overall Study|Withdrawal by Subject|1
4971586|NCT00111228|17083335|P1|Overall Study|Withdrawal by Subject|5
4971587|NCT00111007|17083348|P2|Long Term Follow-up|Missing|3
4971588|NCT00111007|17083349|P1|Long Term Follow-up|Missing|10
4971670|NCT00110812|17083411|P2|Extended Follow-up|Lost to Follow-up|3
4971589|NCT00111007|17083348|P2|Long Term Follow-up|Disease progression/recurrence/relapse|1
4971590|NCT00111007|17083349|P1|Long Term Follow-up|Disease progression/recurrence/relapse|2
4971591|NCT00111007|17083348|P2|Long Term Follow-up|Withdrawal by Subject|1
4971592|NCT00111007|17083349|P1|Long Term Follow-up|Withdrawal by Subject|0
4971593|NCT00111007|17083348|P2|Long Term Follow-up|Lost to Follow-up|1
4971594|NCT00111007|17083349|P1|Long Term Follow-up|Lost to Follow-up|1
4971595|NCT00111007|17083348|P2|Long Term Follow-up|Death|39
4971596|NCT00111007|17083349|P1|Long Term Follow-up|Death|34
4971597|NCT00111007|17083348|P2|Active Follow-up|Disease progression/recurrence/relapse|2
4971598|NCT00111007|17083349|P1|Active Follow-up|Disease progression/recurrence/relapse|3
4971599|NCT00111007|17083348|P2|Active Follow-up|Death|0
4971600|NCT00111007|17083349|P1|Active Follow-up|Death|2
4971601|NCT00111007|17083348|P2|Active Follow-up|Adverse Event|0
4971602|NCT00111007|17083349|P1|Active Follow-up|Adverse Event|1
4971603|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Primary reason with other category|1
4971604|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Primary reason with other category|0
4971605|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|93
4971606|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|83
4971607|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Progression by clinical judgement|2
4971608|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Progression by clinical judgement|0
4971609|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Relapse|0
4971610|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Relapse|1
4971611|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0
4971612|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1
4971613|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Withdrawal by Subject|8
4971614|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Withdrawal by Subject|6
4971615|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Protocol Violation|1
4971616|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Protocol Violation|0
4971617|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Death|2
4971618|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Death|5
4971619|NCT00111007|17083348|P2|Double-blind (DB) Treatment|Adverse Event|4
4971620|NCT00111007|17083349|P1|Double-blind (DB) Treatment|Adverse Event|12
4971621|NCT00110994|17083365|P2|Long Term Follow-up|Death|17
4971622|NCT00110994|17083366|P1|Long Term Follow-up|Death|19
4971623|NCT00110994|17083365|P2|Active Follow-up|Other reasons|2
4971624|NCT00110994|17083366|P1|Active Follow-up|Other reasons|0
4971625|NCT00110994|17083365|P2|Active Follow-up|Disease progression/recurrence/replace|0
4971626|NCT00110994|17083366|P1|Active Follow-up|Disease progression/recurrence/replace|1
4971627|NCT00110994|17083365|P2|Double-blind (DB) Treatment|other reasons|3
4971628|NCT00110994|17083366|P1|Double-blind (DB) Treatment|other reasons|2
4971629|NCT00110994|17083365|P2|Double-blind (DB) Treatment|Radiological and symptomatic progression|41
4971630|NCT00110994|17083366|P1|Double-blind (DB) Treatment|Radiological and symptomatic progression|34
4971631|NCT00110994|17083365|P2|Double-blind (DB) Treatment|Progression by clinical judgement|1
4971632|NCT00110994|17083366|P1|Double-blind (DB) Treatment|Progression by clinical judgement|2
4971633|NCT00110994|17083365|P2|Double-blind (DB) Treatment|Withdrawal by Subject|2
4971634|NCT00110994|17083366|P1|Double-blind (DB) Treatment|Withdrawal by Subject|0
4971635|NCT00110994|17083365|P2|Double-blind (DB) Treatment|Death|0
4971636|NCT00110994|17083366|P1|Double-blind (DB) Treatment|Death|1
4971637|NCT00110994|17083365|P2|Double-blind (DB) Treatment|Adverse Event|0
4971638|NCT00110994|17083366|P1|Double-blind (DB) Treatment|Adverse Event|3
4971639|NCT00110890|17083392|P2|Overall Study|Did not enter follow-up phase|4
4971640|NCT00110890|17083393|P1|Overall Study|Did not enter follow-up phase|10
4971641|NCT00110890|17083392|P2|Overall Study|Parathyroidectomy|1
4971642|NCT00110890|17083393|P1|Overall Study|Parathyroidectomy|0
4971643|NCT00110890|17083392|P2|Overall Study|Disease progression|1
4971644|NCT00110890|17083393|P1|Overall Study|Disease progression|0
4971645|NCT00110890|17083392|P2|Overall Study|Requirement for alternative therapy|1
4971646|NCT00110890|17083393|P1|Overall Study|Requirement for alternative therapy|0
4971647|NCT00110890|17083392|P2|Overall Study|Ineligibility determined|0
4971648|NCT00110890|17083393|P1|Overall Study|Ineligibility determined|3
4971649|NCT00110890|17083392|P2|Overall Study|Other|23
4971650|NCT00110890|17083393|P1|Overall Study|Other|34
4971651|NCT00110890|17083392|P2|Overall Study|Invest. Product Commercially Available|110
4971652|NCT00110890|17083393|P1|Overall Study|Invest. Product Commercially Available|217
4971653|NCT00110890|17083392|P2|Overall Study|Kidney Transplant|12
4971654|NCT00110890|17083393|P1|Overall Study|Kidney Transplant|16
4971655|NCT00110890|17083392|P2|Overall Study|Noncompliance|0
4971656|NCT00110890|17083393|P1|Overall Study|Noncompliance|10
4971657|NCT00110890|17083392|P2|Overall Study|Protocol Deviation|0
4971658|NCT00110890|17083393|P1|Overall Study|Protocol Deviation|1
4971659|NCT00110890|17083392|P2|Overall Study|Withdrawal by Subject|5
4971660|NCT00110890|17083393|P1|Overall Study|Withdrawal by Subject|17
4971661|NCT00110890|17083392|P2|Overall Study|Physician Decision|5
4971662|NCT00110890|17083393|P1|Overall Study|Physician Decision|4
4971663|NCT00110890|17083392|P2|Overall Study|Lost to Follow-up|1
4971664|NCT00110890|17083393|P1|Overall Study|Lost to Follow-up|3
4971665|NCT00110890|17083392|P2|Overall Study|Death|9
4971666|NCT00110890|17083393|P1|Overall Study|Death|16
4971667|NCT00110890|17083392|P2|Overall Study|Adverse Event|7
4971668|NCT00110890|17083393|P1|Overall Study|Adverse Event|30
4971669|NCT00110812|17083410|P3|Extended Follow-up|Lost to Follow-up|1
4971671|NCT00110812|17083412|P1|Extended Follow-up|Lost to Follow-up|1
4971672|NCT00110812|17083410|P3|Extended Follow-up|Withdrawal by Subject|0
4971673|NCT00110812|17083411|P2|Extended Follow-up|Withdrawal by Subject|1
4971674|NCT00110812|17083412|P1|Extended Follow-up|Withdrawal by Subject|0
4971675|NCT00110812|17083410|P3|Extended Follow-up|Death|3
4971676|NCT00110812|17083411|P2|Extended Follow-up|Death|0
4971677|NCT00110812|17083412|P1|Extended Follow-up|Death|1
4971678|NCT00110812|17083410|P3|Main Study|Lost to Follow-up|10
4971679|NCT00110812|17083411|P2|Main Study|Lost to Follow-up|11
4971680|NCT00110812|17083412|P1|Main Study|Lost to Follow-up|8
4971681|NCT00110812|17083410|P3|Main Study|Withdrawal by Subject|1
4971682|NCT00110812|17083411|P2|Main Study|Withdrawal by Subject|0
4971683|NCT00110812|17083412|P1|Main Study|Withdrawal by Subject|0
4971684|NCT00110812|17083410|P3|Main Study|Death|2
4971685|NCT00110812|17083411|P2|Main Study|Death|0
4971686|NCT00110812|17083412|P1|Main Study|Death|0
4971687|NCT00110617|17083457|P2|Overall Study|Did not receive study drug|12
4971688|NCT00110617|17083458|P1|Overall Study|Did not receive study drug|0
4971689|NCT00110617|17083457|P2|Overall Study|Death|1
4971690|NCT00110617|17083458|P1|Overall Study|Death|1
4971691|NCT00110617|17083457|P2|Overall Study|Administrative problems|5
4971692|NCT00110617|17083458|P1|Overall Study|Administrative problems|6
4971693|NCT00110617|17083457|P2|Overall Study|Lost to Follow-up|1
4971694|NCT00110617|17083458|P1|Overall Study|Lost to Follow-up|9
4971695|NCT00110617|17083457|P2|Overall Study|Withdrawal by Subject|4
4971696|NCT00110617|17083458|P1|Overall Study|Withdrawal by Subject|10
4971697|NCT00110617|17083457|P2|Overall Study|Protocol Violation|0
4971698|NCT00110617|17083458|P1|Overall Study|Protocol Violation|5
4971699|NCT00110617|17083457|P2|Overall Study|Patient no longer requires study drug|0
4971700|NCT00110617|17083458|P1|Overall Study|Patient no longer requires study drug|1
4971701|NCT00110617|17083457|P2|Overall Study|Lack of Efficacy|0
4971702|NCT00110617|17083458|P1|Overall Study|Lack of Efficacy|1
4971703|NCT00110617|17083457|P2|Overall Study|Abnormal Laboratory Value|2
4971704|NCT00110617|17083458|P1|Overall Study|Abnormal Laboratory Value|4
4971705|NCT00110617|17083457|P2|Overall Study|Adverse Event|4
4971706|NCT00110617|17083458|P1|Overall Study|Adverse Event|2
4971707|NCT00110396|17083575|P1|Overall Study|Patient is to be administered copaxone|1
4971708|NCT00110396|17083575|P1|Overall Study|The patient has refused to visit site|1
4971709|NCT00110396|17083575|P1|Overall Study|The patient has refused|2
4971710|NCT00110396|17083575|P1|Overall Study|Patient refused to come back|1
4971711|NCT00110396|17083575|P1|Overall Study|Protocol Violation|2
4971712|NCT00110396|17083575|P1|Overall Study|Pregnancy (Protocol violation)|2
4971713|NCT00110396|17083575|P1|Overall Study|Pregnancy|1
4971714|NCT00110396|17083575|P1|Overall Study|Participation in MS vaccine study|1
4971715|NCT00110396|17083575|P1|Overall Study|Patient's decision|1
4971716|NCT00110396|17083575|P1|Overall Study|Patient will|1
4971717|NCT00110396|17083575|P1|Overall Study|Patient refused to participate|1
4971718|NCT00110396|17083575|P1|Overall Study|Patient refused to continue|1
4971719|NCT00110396|17083575|P1|Overall Study|Patient non-compliance|1
4971720|NCT00110396|17083575|P1|Overall Study|Decided not to continue treatment|1
4971721|NCT00110396|17083575|P1|Overall Study|Lack of Efficacy|1
4971722|NCT00110396|17083575|P1|Overall Study|Initiated mitoxantrone therapy|1
4971723|NCT00110396|17083575|P1|Overall Study|Administration of plasmapheresis|1
4971724|NCT00110396|17083575|P1|Overall Study|Lost to Follow-up|1
4971725|NCT00110396|17083575|P1|Overall Study|Adverse Event|15
4971726|NCT00110357|17083583|P2|Overall Study|Withdrawal by Subject|1
4971727|NCT00110357|17083584|P1|Overall Study|Withdrawal by Subject|3
4971728|NCT00110357|17083583|P2|Overall Study|Study Drug Toxicity|3
4971729|NCT00110357|17083584|P1|Overall Study|Study Drug Toxicity|1
4971730|NCT00110357|17083583|P2|Overall Study|Study Closure|0
4971731|NCT00110357|17083584|P1|Overall Study|Study Closure|1
4971732|NCT00110357|17083583|P2|Overall Study|Disease progression/relapse|15
4971733|NCT00110357|17083584|P1|Overall Study|Disease progression/relapse|20
4971734|NCT00110357|17083583|P2|Overall Study|Deterioration without progression|0
4971735|NCT00110357|17083584|P1|Overall Study|Deterioration without progression|2
4971736|NCT00110305|17083672|P2|Overall Study|Other|2
4971737|NCT00110305|17083673|P1|Overall Study|Other|8
4971738|NCT00110305|17083672|P2|Overall Study|Lost to Follow-up|3
4971739|NCT00110305|17083673|P1|Overall Study|Lost to Follow-up|20
4971740|NCT00110305|17083672|P2|Overall Study|Withdrawal by Subject|7
4971741|NCT00110305|17083673|P1|Overall Study|Withdrawal by Subject|7
4971742|NCT00110305|17083672|P2|Overall Study|Protocol Violation|1
4971743|NCT00110305|17083673|P1|Overall Study|Protocol Violation|0
4971744|NCT00110305|17083672|P2|Overall Study|Subject Reached A Virologic Endpoint|3
4971745|NCT00110305|17083673|P1|Overall Study|Subject Reached A Virologic Endpoint|21
4971746|NCT00110305|17083672|P2|Overall Study|Subject Ineligible To Continue The Trial|1
4971747|NCT00110305|17083673|P1|Overall Study|Subject Ineligible To Continue The Trial|2
4971748|NCT00110305|17083672|P2|Overall Study|Subject Non-Compliant|2
4971749|NCT00110305|17083673|P1|Overall Study|Subject Non-Compliant|9
4971750|NCT00110305|17083672|P2|Overall Study|Sponsors Decision|0
4971751|NCT00110305|17083673|P1|Overall Study|Sponsors Decision|1
4971752|NCT00110305|17083672|P2|Overall Study|Adverse Event|13
4971753|NCT00110305|17083673|P1|Overall Study|Adverse Event|46
4971754|NCT00110214|17083726|P2|Overall Study|Other (not specified)|75
4971755|NCT00110214|17083727|P1|Overall Study|Other (not specified)|61
4971756|NCT00110214|17083726|P2|Overall Study|Refused further treatment|65
4971757|NCT00110214|17083727|P1|Overall Study|Refused further treatment|52
4971758|NCT00110214|17083726|P2|Overall Study|Adverse Event|192
4971759|NCT00110214|17083727|P1|Overall Study|Adverse Event|115
4971760|NCT00110214|17083726|P2|Overall Study|Disease progression or death|151
4971761|NCT00110214|17083727|P1|Overall Study|Disease progression or death|260
4971762|NCT00110214|17083726|P2|Overall Study|Never started treatment|20
4971763|NCT00110214|17083727|P1|Overall Study|Never started treatment|21
4971764|NCT00110149|17083739|P1|Overall Study|Physician Decision|3
4971765|NCT00110084|17083753|P1|Overall Study|Other|2
4971766|NCT00110084|17083753|P1|Overall Study|Intercurrent Illness|1
4971767|NCT00110084|17083753|P1|Overall Study|Alternate Therapy|5
4971768|NCT00110084|17083753|P1|Overall Study|Patient Refusal|10
4971769|NCT00110084|17083753|P1|Overall Study|Death|1
4971770|NCT00110084|17083753|P1|Overall Study|Adverse Event|9
4971771|NCT00110019|17083762|P2|Overall Study|other reasons|30
4971772|NCT00110019|17083763|P1|Overall Study|other reasons|22
4971773|NCT00110019|17083762|P2|Overall Study|Not start protocol therapy|16
4971774|NCT00110019|17083763|P1|Overall Study|Not start protocol therapy|17
4971775|NCT00110019|17083762|P2|Overall Study|symptom deterioration|16
4971776|NCT00110019|17083763|P1|Overall Study|symptom deterioration|13
4971777|NCT00110019|17083762|P2|Overall Study|complicating disease|1
4971778|NCT00110019|17083763|P1|Overall Study|complicating disease|1
4971779|NCT00110019|17083762|P2|Overall Study|alternative therapy|1
4971780|NCT00110019|17083763|P1|Overall Study|alternative therapy|5
4971781|NCT00110019|17083762|P2|Overall Study|Withdrawal by Subject|9
4971782|NCT00110019|17083763|P1|Overall Study|Withdrawal by Subject|21
4971783|NCT00110019|17083762|P2|Overall Study|Death|15
4971784|NCT00110019|17083763|P1|Overall Study|Death|13
4971785|NCT00110019|17083762|P2|Overall Study|Adverse Event|40
4971786|NCT00110019|17083763|P1|Overall Study|Adverse Event|61
4971787|NCT00110019|17083762|P2|Overall Study|Lack of Efficacy|285
4971788|NCT00110019|17083763|P1|Overall Study|Lack of Efficacy|253
4971789|NCT00109967|17083775|P2|Overall Study|Death|2
4971790|NCT00109967|17083776|P1|Overall Study|Death|0
4971791|NCT00109967|17083775|P2|Overall Study|Physician Decision|3
4971792|NCT00109967|17083776|P1|Overall Study|Physician Decision|1
4971793|NCT00109967|17083775|P2|Overall Study|Withdrawal by Subject|0
4971794|NCT00109967|17083776|P1|Overall Study|Withdrawal by Subject|5
4971795|NCT00109967|17083775|P2|Overall Study|Adverse Event|1
4971796|NCT00109967|17083776|P1|Overall Study|Adverse Event|12
4971797|NCT00109967|17083775|P2|Overall Study|Cancel Prior to Treatment|0
4971798|NCT00109967|17083776|P1|Overall Study|Cancel Prior to Treatment|2
4971799|NCT00109928|17083790|P1|Overall Study|not eligible|1
4971800|NCT00109928|17083790|P1|Overall Study|not protocol specified|2
4971801|NCT00109928|17083790|P1|Overall Study|Death|2
4971802|NCT00109928|17083790|P1|Overall Study|Progression|6
4971803|NCT00109928|17083790|P1|Overall Study|Adverse Event|2
4971804|NCT00109850|17083807|P1|Overall Study|Ineligible|1
4971805|NCT00109850|17083807|P1|Overall Study|Death|2
4971806|NCT00109850|17083807|P1|Overall Study|Adverse Event|1
4971807|NCT00109837|17083814|P1|Overall Study|Ineligible|1
4971808|NCT00109837|17083814|P1|Overall Study|Not treated|1
4971809|NCT00109837|17083814|P1|Overall Study|BCR/ABL+ or Ph+|17
4971810|NCT00109837|17083814|P1|Overall Study|Death|1
4971811|NCT00109837|17083814|P1|Overall Study|Refusal unrelated to adverse effects|1
4971812|NCT00109837|17083814|P1|Overall Study|Adverse Event|2
4971813|NCT00109772|17083824|P2|Open-label Extension|Other|10
4971814|NCT00109772|17083825|P1|Open-label Extension|Other|4
4971815|NCT00109772|17083824|P2|Open-label Extension|Protocol Violation|2
4971816|NCT00109772|17083825|P1|Open-label Extension|Protocol Violation|2
4971817|NCT00109772|17083824|P2|Open-label Extension|Death|1
4971818|NCT00109772|17083825|P1|Open-label Extension|Death|0
4971819|NCT00109772|17083824|P2|Open-label Extension|Lost to Follow-up|0
4971820|NCT00109772|17083825|P1|Open-label Extension|Lost to Follow-up|1
4971821|NCT00109772|17083824|P2|Open-label Extension|Withdrawal by Subject|6
4971822|NCT00109772|17083825|P1|Open-label Extension|Withdrawal by Subject|9
4971823|NCT00109772|17083824|P2|Open-label Extension|Lack of Efficacy|11
4971824|NCT00109772|17083825|P1|Open-label Extension|Lack of Efficacy|19
4971825|NCT00109772|17083824|P2|Open-label Extension|Adverse Event|19
4971826|NCT00109772|17083825|P1|Open-label Extension|Adverse Event|10
4971827|NCT00109772|17083824|P2|Double-blind Treatment|Withdrew prior to treatment|1
4971828|NCT00109772|17083825|P1|Double-blind Treatment|Withdrew prior to treatment|3
4971829|NCT00109772|17083824|P2|Double-blind Treatment|Other|4
4971830|NCT00109772|17083825|P1|Double-blind Treatment|Other|0
4971831|NCT00109772|17083824|P2|Double-blind Treatment|Protocol Violation|1
4971832|NCT00109772|17083825|P1|Double-blind Treatment|Protocol Violation|0
4971833|NCT00109772|17083824|P2|Double-blind Treatment|Lost to Follow-up|3
4971834|NCT00109772|17083825|P1|Double-blind Treatment|Lost to Follow-up|2
4971835|NCT00109772|17083824|P2|Double-blind Treatment|Withdrawal by Subject|1
4971836|NCT00109772|17083825|P1|Double-blind Treatment|Withdrawal by Subject|2
4971837|NCT00109772|17083824|P2|Double-blind Treatment|Lack of Efficacy|0
4971838|NCT00109772|17083825|P1|Double-blind Treatment|Lack of Efficacy|1
4971839|NCT00109772|17083824|P2|Double-blind Treatment|Adverse Event|5
4971840|NCT00109772|17083825|P1|Double-blind Treatment|Adverse Event|14
4971841|NCT00109733|17083865|P2|Overall Study|Could not commit time for study|1
4971842|NCT00109733|17083866|P1|Overall Study|Could not commit time for study|1
4971843|NCT00109733|17083865|P2|Overall Study|Non-compliant|1
4971844|NCT00109733|17083866|P1|Overall Study|Non-compliant|0
4971845|NCT00109733|17083865|P2|Overall Study|Stopped taking study drug|1
4971846|NCT00109733|17083866|P1|Overall Study|Stopped taking study drug|1
4971847|NCT00109733|17083865|P2|Overall Study|Protocol Violation|1
4971848|NCT00109733|17083866|P1|Overall Study|Protocol Violation|0
4971849|NCT00109590|17083883|P3|Overall Study|Never Started Treatment|3
4971850|NCT00109590|17083884|P2|Overall Study|Never Started Treatment|2
4971851|NCT00109590|17083885|P1|Overall Study|Never Started Treatment|1
4971852|NCT00109590|17083883|P3|Overall Study|Lost to Follow-up|1
4971853|NCT00109590|17083884|P2|Overall Study|Lost to Follow-up|0
4971854|NCT00109590|17083885|P1|Overall Study|Lost to Follow-up|1
4971855|NCT00109577|17083927|P2|Overall Study|Withdrawal by Subject|3
4971856|NCT00109577|17083928|P1|Overall Study|Withdrawal by Subject|3
4971857|NCT00109343|17083937|P3|Overall Study|Other|1
4971858|NCT00109343|17083938|P2|Overall Study|Other|2
4971859|NCT00109343|17083939|P1|Overall Study|Other|5
4971860|NCT00109343|17083937|P3|Overall Study|Subject Moved|1
4971861|NCT00109343|17083938|P2|Overall Study|Subject Moved|2
4971862|NCT00109343|17083939|P1|Overall Study|Subject Moved|6
4971863|NCT00109343|17083937|P3|Overall Study|Withdrawal by Subject|10
4971864|NCT00109343|17083938|P2|Overall Study|Withdrawal by Subject|11
4971865|NCT00109343|17083939|P1|Overall Study|Withdrawal by Subject|15
4971866|NCT00109343|17083937|P3|Overall Study|Protocol Violation|2
4971867|NCT00109343|17083938|P2|Overall Study|Protocol Violation|2
4971868|NCT00109343|17083939|P1|Overall Study|Protocol Violation|1
4971869|NCT00109343|17083937|P3|Overall Study|Lost to Follow-up|14
4971870|NCT00109343|17083938|P2|Overall Study|Lost to Follow-up|20
4971871|NCT00109343|17083939|P1|Overall Study|Lost to Follow-up|35
4971872|NCT00109343|17083937|P3|Overall Study|Lack of Efficacy|0
4971873|NCT00109343|17083938|P2|Overall Study|Lack of Efficacy|0
4971874|NCT00109343|17083939|P1|Overall Study|Lack of Efficacy|1
4971875|NCT00109343|17083937|P3|Overall Study|Adverse Event|2
4971876|NCT00109343|17083938|P2|Overall Study|Adverse Event|0
4971877|NCT00109343|17083939|P1|Overall Study|Adverse Event|1
4971878|NCT00109031|17083984|P4|Overall Study|Protocol Violation|0
4971879|NCT00109031|17083985|P3|Overall Study|Protocol Violation|1
4971880|NCT00109031|17083986|P2|Overall Study|Protocol Violation|0
4971881|NCT00109031|17083987|P1|Overall Study|Protocol Violation|0
4971882|NCT00109031|17083984|P4|Overall Study|Physician Decision|0
4971883|NCT00109031|17083985|P3|Overall Study|Physician Decision|0
4971884|NCT00109031|17083986|P2|Overall Study|Physician Decision|1
4971885|NCT00109031|17083987|P1|Overall Study|Physician Decision|0
4971886|NCT00109031|17083984|P4|Overall Study|Withdrawal by Subject|0
4971887|NCT00109031|17083985|P3|Overall Study|Withdrawal by Subject|0
4971888|NCT00109031|17083986|P2|Overall Study|Withdrawal by Subject|1
4971889|NCT00109031|17083987|P1|Overall Study|Withdrawal by Subject|0
4971890|NCT00109031|17083984|P4|Overall Study|Adverse Event|0
4971891|NCT00109031|17083985|P3|Overall Study|Adverse Event|1
4971892|NCT00109031|17083986|P2|Overall Study|Adverse Event|0
4971893|NCT00109031|17083987|P1|Overall Study|Adverse Event|0
4971894|NCT00108953|17084038|P2|Follow-up|Study terminated by sponsor|6
4971895|NCT00108953|17084039|P1|Follow-up|Study terminated by sponsor|10
4971896|NCT00108953|17084038|P2|Follow-up|Lost to Follow-up|1
4971897|NCT00108953|17084039|P1|Follow-up|Lost to Follow-up|1
4971898|NCT00108953|17084038|P2|Follow-up|Death|26
4971899|NCT00108953|17084039|P1|Follow-up|Death|18
4971900|NCT00108862|17084061|P2|Overall Study|Lost to Follow-up|19
4971901|NCT00108862|17084062|P1|Overall Study|Lost to Follow-up|27
4971902|NCT00108862|17084061|P2|Overall Study|Withdrawal by Subject|6
4971903|NCT00108862|17084062|P1|Overall Study|Withdrawal by Subject|10
4971904|NCT00108862|17084061|P2|Overall Study|Death|37
4971905|NCT00108862|17084062|P1|Overall Study|Death|31
4971906|NCT00108732|17084090|P1|Step 2 (Androgen Ablation and Vaccine)|Other|1
4971907|NCT00108732|17084090|P1|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1
4971908|NCT00108732|17084090|P1|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3
4971909|NCT00108732|17084090|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1
4971910|NCT00108732|17084090|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10
4971911|NCT00108732|17084090|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2
4971912|NCT00108732|17084090|P1|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1
4971913|NCT00108628|17084099|P2|Overall Study|Death|0
4971914|NCT00108628|17084100|P1|Overall Study|Death|1
4971915|NCT00108628|17084099|P2|Overall Study|Lack of Efficacy|1
4971916|NCT00108628|17084100|P1|Overall Study|Lack of Efficacy|2
4971917|NCT00108628|17084099|P2|Overall Study|Withdrawal by Subject|9
4971918|NCT00108628|17084100|P1|Overall Study|Withdrawal by Subject|17
4971919|NCT00108485|17084150|P2|Overall Study|Lost to Follow-up|2
4971920|NCT00108485|17084151|P1|Overall Study|Lost to Follow-up|0
4971921|NCT00108485|17084150|P2|Overall Study|Withdrawal by Subject|0
4971922|NCT00108485|17084151|P1|Overall Study|Withdrawal by Subject|3
4971923|NCT00108433|17084159|P2|Overall Study|Other|14
4971924|NCT00108433|17084160|P1|Overall Study|Other|14
4971925|NCT00108433|17084159|P2|Overall Study|Adverse Event|1
4971926|NCT00108433|17084160|P1|Overall Study|Adverse Event|3
4971927|NCT00108433|17084159|P2|Overall Study|Death|0
4971928|NCT00108433|17084160|P1|Overall Study|Death|3
4971929|NCT00108433|17084159|P2|Overall Study|Lack of Efficacy|2
4971930|NCT00108433|17084160|P1|Overall Study|Lack of Efficacy|1
4971931|NCT00108355|17084176|P2|Overall Study|Loculated ascites, limiting paracentesis|1
4971932|NCT00108355|17084177|P1|Overall Study|Loculated ascites, limiting paracentesis|1
4971933|NCT00108355|17084176|P2|Overall Study|Peritonitis at index paracentesis|1
4971934|NCT00108355|17084177|P1|Overall Study|Peritonitis at index paracentesis|1
4971935|NCT00108160|17084226|P2|Overall Study|Protocol Violation|5
4971936|NCT00108160|17084227|P1|Overall Study|Protocol Violation|9
4971937|NCT00108160|17084226|P2|Overall Study|Withdrawal by Subject|2
4971938|NCT00108160|17084227|P1|Overall Study|Withdrawal by Subject|4
4971939|NCT00108160|17084226|P2|Overall Study|Death|2
4971940|NCT00108160|17084227|P1|Overall Study|Death|1
4971941|NCT00108160|17084226|P2|Overall Study|Lost to Follow-up|12
4971942|NCT00108160|17084227|P1|Overall Study|Lost to Follow-up|25
4971943|NCT00108082|17084240|P3|Overall Study|Blood Pressure Not Controlled|0
4971944|NCT00108082|17084241|P2|Overall Study|Blood Pressure Not Controlled|0
4971945|NCT00108082|17084242|P1|Overall Study|Blood Pressure Not Controlled|1
4971946|NCT00108082|17084240|P3|Overall Study|Investigator Not at Site|0
4971947|NCT00108082|17084241|P2|Overall Study|Investigator Not at Site|0
4971948|NCT00108082|17084242|P1|Overall Study|Investigator Not at Site|1
4971949|NCT00108082|17084240|P3|Overall Study|Subject Left Site Location|0
4971950|NCT00108082|17084241|P2|Overall Study|Subject Left Site Location|0
4971951|NCT00108082|17084242|P1|Overall Study|Subject Left Site Location|1
4971952|NCT00108082|17084240|P3|Overall Study|Study Medication Not Tapered|0
4971953|NCT00108082|17084241|P2|Overall Study|Study Medication Not Tapered|1
4971954|NCT00108082|17084242|P1|Overall Study|Study Medication Not Tapered|0
4971955|NCT00108082|17084240|P3|Overall Study|Protocol Amendment|0
4971956|NCT00108082|17084241|P2|Overall Study|Protocol Amendment|1
4971957|NCT00108082|17084242|P1|Overall Study|Protocol Amendment|0
4971958|NCT00108082|17084240|P3|Overall Study|Site Closed Study|0
4971959|NCT00108082|17084241|P2|Overall Study|Site Closed Study|2
4971960|NCT00108082|17084242|P1|Overall Study|Site Closed Study|0
4971961|NCT00108082|17084240|P3|Overall Study|Stopped Study Medication|1
4971962|NCT00108082|17084241|P2|Overall Study|Stopped Study Medication|0
4971963|NCT00108082|17084242|P1|Overall Study|Stopped Study Medication|0
4971964|NCT00108082|17084240|P3|Overall Study|Non-compliance|2
4971965|NCT00108082|17084241|P2|Overall Study|Non-compliance|0
4971966|NCT00108082|17084242|P1|Overall Study|Non-compliance|1
4971967|NCT00108082|17084240|P3|Overall Study|Incorrectly Randomized|2
4971968|NCT00108082|17084241|P2|Overall Study|Incorrectly Randomized|0
4971969|NCT00108082|17084242|P1|Overall Study|Incorrectly Randomized|0
4971970|NCT00108082|17084240|P3|Overall Study|Woman of Child-bearing Potential|2
4971971|NCT00108082|17084241|P2|Overall Study|Woman of Child-bearing Potential|0
4971972|NCT00108082|17084242|P1|Overall Study|Woman of Child-bearing Potential|2
4971973|NCT00108082|17084240|P3|Overall Study|Amendment 4: > Month 12|5
4971974|NCT00108082|17084241|P2|Overall Study|Amendment 4: > Month 12|7
4971975|NCT00108082|17084242|P1|Overall Study|Amendment 4: > Month 12|5
4971976|NCT00108082|17084240|P3|Overall Study|Lack of Efficacy|2
4971977|NCT00108082|17084241|P2|Overall Study|Lack of Efficacy|1
4971978|NCT00108082|17084242|P1|Overall Study|Lack of Efficacy|3
4971979|NCT00108082|17084240|P3|Overall Study|Protocol Violation|0
4971980|NCT00108082|17084241|P2|Overall Study|Protocol Violation|2
4971981|NCT00108082|17084242|P1|Overall Study|Protocol Violation|1
4971982|NCT00108082|17084240|P3|Overall Study|Consent Withdrawn|5
4971983|NCT00108082|17084241|P2|Overall Study|Consent Withdrawn|3
4971984|NCT00108082|17084242|P1|Overall Study|Consent Withdrawn|3
4971985|NCT00108082|17084240|P3|Overall Study|Lost to Follow-up|7
4971986|NCT00108082|17084241|P2|Overall Study|Lost to Follow-up|3
4971987|NCT00108082|17084242|P1|Overall Study|Lost to Follow-up|6
4971988|NCT00108082|17084240|P3|Overall Study|Adverse Event|17
4971989|NCT00108082|17084241|P2|Overall Study|Adverse Event|12
4971990|NCT00108082|17084242|P1|Overall Study|Adverse Event|14
4971991|NCT00108069|17084291|P2|Overall Study|Progessive disease|11
4971992|NCT00108069|17084292|P1|Overall Study|Progessive disease|27
4971993|NCT00108069|17084291|P2|Overall Study|Death|0
4971994|NCT00108069|17084292|P1|Overall Study|Death|1
4971995|NCT00108069|17084291|P2|Overall Study|Withdrawal by Subject|0
4971996|NCT00108069|17084292|P1|Overall Study|Withdrawal by Subject|1
4971997|NCT00108069|17084291|P2|Overall Study|Adverse Event|1
4971998|NCT00108069|17084292|P1|Overall Study|Adverse Event|1
4971999|NCT00108069|17084291|P2|Overall Study|Never rec'd study drug|1
4972000|NCT00108069|17084292|P1|Overall Study|Never rec'd study drug|0
4972001|NCT00107991|17084306|P1|18-Week Post Treatment Assessment|Adverse Event|2
4972002|NCT00107991|17084306|P1|12 Week Treatment Period|Incarcerated|1
4972003|NCT00107991|17084306|P1|12 Week Treatment Period|Protocol Violation|1
4972004|NCT00107991|17084306|P1|12 Week Treatment Period|Adverse Event|1
4972005|NCT00107991|17084306|P1|12 Week Treatment Period|Lack of Efficacy|2
4972006|NCT00107991|17084306|P1|Eligibility Assessment|hx of alcohol abuse in past 12 months|1
4972007|NCT00107991|17084306|P1|Eligibility Assessment|chronic uncontrolled asthma|1
4972008|NCT00107991|17084306|P1|Eligibility Assessment|Ongoing treatment with antibiotics|1
4972009|NCT00107991|17084306|P1|Eligibility Assessment|Abnormal labs|2
4972010|NCT00107991|17084306|P1|Eligibility Assessment|Positive purified protein derivative|4
4972011|NCT00107991|17084306|P1|Eligibility Assessment|Unwilling to participate|7
4972012|NCT00107991|17084306|P1|Eligibility Assessment|Disease not severe enough|7
4972013|NCT00107978|17084316|P2|Overall Study|Other|4
4972014|NCT00107978|17084317|P1|Overall Study|Other|5
4972015|NCT00107978|17084316|P2|Overall Study|Protocol Violation|1
4972016|NCT00107978|17084317|P1|Overall Study|Protocol Violation|0
4972017|NCT00107978|17084316|P2|Overall Study|Withdrawal by Subject|9
4972018|NCT00107978|17084317|P1|Overall Study|Withdrawal by Subject|4
4972019|NCT00107978|17084316|P2|Overall Study|Lost to Follow-up|28
4972020|NCT00107978|17084317|P1|Overall Study|Lost to Follow-up|20
4972021|NCT00107978|17084316|P2|Overall Study|Death|3
4972022|NCT00107978|17084317|P1|Overall Study|Death|3
4972023|NCT00107978|17084316|P2|Overall Study|Adverse Event|5
4972024|NCT00107978|17084317|P1|Overall Study|Adverse Event|1
4972025|NCT00107952|17084325|P2|Overall Study|Never received study treatment|6
4972026|NCT00107952|17084326|P1|Overall Study|Never received study treatment|9
4972027|NCT00107952|17084325|P2|Overall Study|Other|5
4972028|NCT00107952|17084326|P1|Overall Study|Other|2
4972029|NCT00107952|17084325|P2|Overall Study|Withdrawal by Subject|6
4972030|NCT00107952|17084326|P1|Overall Study|Withdrawal by Subject|9
4972031|NCT00107952|17084325|P2|Overall Study|Lost to Follow-up|3
4972032|NCT00107952|17084326|P1|Overall Study|Lost to Follow-up|0
4972033|NCT00107952|17084325|P2|Overall Study|Death|61
4972034|NCT00107952|17084326|P1|Overall Study|Death|75
4972035|NCT00107900|17084338|P6|Overall Study|Administrative Reasons|0
4972036|NCT00107900|17084339|P5|Overall Study|Administrative Reasons|2
4972037|NCT00107900|17084340|P4|Overall Study|Administrative Reasons|2
4972038|NCT00107900|17084341|P3|Overall Study|Administrative Reasons|2
4972039|NCT00107900|17084342|P2|Overall Study|Administrative Reasons|0
4972040|NCT00107900|17084343|P1|Overall Study|Administrative Reasons|1
4972041|NCT00107900|17084338|P6|Overall Study|Withdrawal by Subject|1
4972042|NCT00107900|17084339|P5|Overall Study|Withdrawal by Subject|1
4972043|NCT00107900|17084340|P4|Overall Study|Withdrawal by Subject|0
4972044|NCT00107900|17084341|P3|Overall Study|Withdrawal by Subject|5
4972045|NCT00107900|17084342|P2|Overall Study|Withdrawal by Subject|0
4972046|NCT00107900|17084343|P1|Overall Study|Withdrawal by Subject|1
4972047|NCT00107900|17084338|P6|Overall Study|Protocol Violation|0
4972048|NCT00107900|17084339|P5|Overall Study|Protocol Violation|7
4972049|NCT00107900|17084340|P4|Overall Study|Protocol Violation|5
4972050|NCT00107900|17084341|P3|Overall Study|Protocol Violation|5
4972051|NCT00107900|17084342|P2|Overall Study|Protocol Violation|0
4972052|NCT00107900|17084343|P1|Overall Study|Protocol Violation|1
4972053|NCT00107900|17084338|P6|Overall Study|Lost to Follow-up|5
4972054|NCT00107900|17084339|P5|Overall Study|Lost to Follow-up|5
4972055|NCT00107900|17084340|P4|Overall Study|Lost to Follow-up|2
4972056|NCT00107900|17084341|P3|Overall Study|Lost to Follow-up|3
4972057|NCT00107900|17084342|P2|Overall Study|Lost to Follow-up|1
4972058|NCT00107900|17084343|P1|Overall Study|Lost to Follow-up|4
4972059|NCT00107900|17084338|P6|Overall Study|Death|0
4972060|NCT00107900|17084339|P5|Overall Study|Death|1
4972061|NCT00107900|17084340|P4|Overall Study|Death|0
4972062|NCT00107900|17084341|P3|Overall Study|Death|0
4972063|NCT00107900|17084342|P2|Overall Study|Death|0
4972064|NCT00107900|17084343|P1|Overall Study|Death|0
4972065|NCT00107900|17084338|P6|Overall Study|Adverse Event|3
4972066|NCT00107900|17084339|P5|Overall Study|Adverse Event|5
4972067|NCT00107900|17084340|P4|Overall Study|Adverse Event|3
4972068|NCT00107900|17084341|P3|Overall Study|Adverse Event|10
4972069|NCT00107900|17084342|P2|Overall Study|Adverse Event|2
4972070|NCT00107900|17084343|P1|Overall Study|Adverse Event|3
4972071|NCT00107783|17084377|P2|Overall Study|Second hip replacement|1
4972072|NCT00107783|17084378|P1|Overall Study|Second hip replacement|1
4972073|NCT00107783|17084377|P2|Overall Study|Withdrawal by Subject|0
4972074|NCT00107783|17084378|P1|Overall Study|Withdrawal by Subject|2
4972075|NCT00107783|17084377|P2|Overall Study|Death|1
4972076|NCT00107783|17084378|P1|Overall Study|Death|0
4972077|NCT00107783|17084377|P2|Overall Study|Adverse Event|2
4972078|NCT00107783|17084378|P1|Overall Study|Adverse Event|0
4972079|NCT00107653|17084413|P2|Overall Study|Administrative Reasons|3
4972080|NCT00107653|17084414|P1|Overall Study|Administrative Reasons|3
4972081|NCT00107653|17084413|P2|Overall Study|Lost to Follow-up|5
4972082|NCT00107653|17084414|P1|Overall Study|Lost to Follow-up|13
4972083|NCT00107653|17084413|P2|Overall Study|Withdrawal by Subject|13
4972084|NCT00107653|17084414|P1|Overall Study|Withdrawal by Subject|12
4972085|NCT00107653|17084413|P2|Overall Study|Protocol Violation|0
4972086|NCT00107653|17084414|P1|Overall Study|Protocol Violation|1
4972087|NCT00107653|17084413|P2|Overall Study|Violation of Selection Criteria at Entry|1
4972088|NCT00107653|17084414|P1|Overall Study|Violation of Selection Criteria at Entry|1
4972089|NCT00107653|17084413|P2|Overall Study|Insufficient Therapeutic Response|11
4972090|NCT00107653|17084414|P1|Overall Study|Insufficient Therapeutic Response|25
4972091|NCT00107653|17084413|P2|Overall Study|Adverse Event|43
4972092|NCT00107653|17084414|P1|Overall Study|Adverse Event|24
4972093|NCT00107614|17084460|P1|Overall Study|Death|2
4972094|NCT00107614|17084460|P1|Overall Study|Physician Decision|10
4972095|NCT00107380|17084491|P1|Overall Study|Ineligible|2
4972096|NCT00107380|17084491|P1|Overall Study|Other - not protocol specified|7
4972097|NCT00107380|17084491|P1|Overall Study|Death|3
4972098|NCT00107380|17084491|P1|Overall Study|Progression/relapse|4
4972099|NCT00107380|17084491|P1|Overall Study|Refusal Unrelated to Adverse Event|7
4972100|NCT00107380|17084491|P1|Overall Study|Adverse Event|7
4972101|NCT00107315|17084497|P1|Overall Study|Withdrawal by Subject|2
4972102|NCT00107315|17084497|P1|Overall Study|Adverse Event|4
4972103|NCT00107315|17084497|P1|Overall Study|Disease Progression|9
4972104|NCT00107276|17084504|P1|Overall Study|Ineligible|16
4972105|NCT00107276|17084504|P1|Overall Study|Death|1
4972106|NCT00107276|17084504|P1|Overall Study|Patient refusal|1
4972107|NCT00107276|17084504|P1|Overall Study|M.D. decision|2
4972108|NCT00107276|17084504|P1|Overall Study|Adverse Event|6
4972109|NCT00107276|17084504|P1|Overall Study|Progression|46
4972110|NCT00107198|17084510|P1|Overall Study|Ineligible|5
4972111|NCT00107198|17084510|P1|Overall Study|Withdrawal by Subject|6
4972112|NCT00107198|17084510|P1|Overall Study|Protocol Violation|1
4972113|NCT00107198|17084510|P1|Overall Study|Lost to Follow-up|12
4972114|NCT00107198|17084510|P1|Overall Study|Lack of Efficacy|28
4972115|NCT00107172|17084520|P2|Overall Study|Other Reason|3
4972116|NCT00107172|17084521|P1|Overall Study|Other Reason|4
4972117|NCT00107172|17084520|P2|Overall Study|Death|2
4972118|NCT00107172|17084521|P1|Overall Study|Death|0
4972119|NCT00107172|17084520|P2|Overall Study|Withdrawal by Subject|0
4972120|NCT00107172|17084521|P1|Overall Study|Withdrawal by Subject|1
4972121|NCT00107120|17084551|P2|Overall Study|death of parent|1
4972122|NCT00107120|17084552|P1|Overall Study|death of parent|0
4972123|NCT00107120|17084551|P2|Overall Study|moving away from site|1
4972124|NCT00107120|17084552|P1|Overall Study|moving away from site|1
4972125|NCT00107120|17084551|P2|Overall Study|Pregnancy|1
4972126|NCT00107120|17084552|P1|Overall Study|Pregnancy|0
4972127|NCT00107120|17084551|P2|Overall Study|Lost to Follow-up|6
4972128|NCT00107120|17084552|P1|Overall Study|Lost to Follow-up|8
4972129|NCT00107120|17084551|P2|Overall Study|Withdrawal by Subject|9
4972130|NCT00107120|17084552|P1|Overall Study|Withdrawal by Subject|8
4972131|NCT00107120|17084551|P2|Overall Study|Protocol Violation|0
4972132|NCT00107120|17084552|P1|Overall Study|Protocol Violation|3
4972133|NCT00107120|17084551|P2|Overall Study|Lack of Efficacy|5
4972134|NCT00107120|17084552|P1|Overall Study|Lack of Efficacy|5
4972135|NCT00107120|17084551|P2|Overall Study|Adverse Event|1
4972136|NCT00107120|17084552|P1|Overall Study|Adverse Event|4
4972137|NCT00107042|17084564|P2|Overall Study|Disallowed medications|2
4972138|NCT00107042|17084565|P1|Overall Study|Disallowed medications|0
4972139|NCT00107042|17084564|P2|Overall Study|vaccinated outside window|1
4972140|NCT00107042|17084565|P1|Overall Study|vaccinated outside window|1
4972141|NCT00107042|17084564|P2|Overall Study|Inadvertent enrollment|1
4972142|NCT00107042|17084565|P1|Overall Study|Inadvertent enrollment|0
4972143|NCT00107042|17084564|P2|Overall Study|Pregnancy|1
4972144|NCT00107042|17084565|P1|Overall Study|Pregnancy|1
4972145|NCT00107042|17084564|P2|Overall Study|Moved out of area|3
4972146|NCT00107042|17084565|P1|Overall Study|Moved out of area|5
4972147|NCT00107042|17084564|P2|Overall Study|Withdrawal by Subject|1
4972148|NCT00107042|17084565|P1|Overall Study|Withdrawal by Subject|6
4972149|NCT00107042|17084564|P2|Overall Study|Lost to Follow-up|7
4972150|NCT00107042|17084565|P1|Overall Study|Lost to Follow-up|9
4972151|NCT00106964|17084631|P3|Overall Study|Required disallowed medication|0
4972152|NCT00106964|17084632|P2|Overall Study|Required disallowed medication|1
4972153|NCT00106964|17084633|P1|Overall Study|Required disallowed medication|0
4972154|NCT00106964|17084631|P3|Overall Study|Did not meet eligibility criteria|2
4972155|NCT00106964|17084632|P2|Overall Study|Did not meet eligibility criteria|2
4972156|NCT00106964|17084633|P1|Overall Study|Did not meet eligibility criteria|0
4972157|NCT00106964|17084631|P3|Overall Study|Failure to adhere|0
4972158|NCT00106964|17084632|P2|Overall Study|Failure to adhere|0
4972159|NCT00106964|17084633|P1|Overall Study|Failure to adhere|2
4972160|NCT00106964|17084631|P3|Overall Study|Site Funding Terminated|1
4972161|NCT00106964|17084632|P2|Overall Study|Site Funding Terminated|1
4972162|NCT00106964|17084633|P1|Overall Study|Site Funding Terminated|0
4972163|NCT00106964|17084631|P3|Overall Study|Incarceration|0
4972164|NCT00106964|17084632|P2|Overall Study|Incarceration|1
4972165|NCT00106964|17084633|P1|Overall Study|Incarceration|0
4972166|NCT00106964|17084631|P3|Overall Study|Death|0
4972167|NCT00106964|17084632|P2|Overall Study|Death|1
4972168|NCT00106964|17084633|P1|Overall Study|Death|1
4972169|NCT00106964|17084631|P3|Overall Study|Pregnancy|2
4972170|NCT00106964|17084632|P2|Overall Study|Pregnancy|3
4972171|NCT00106964|17084633|P1|Overall Study|Pregnancy|2
4972172|NCT00106964|17084631|P3|Overall Study|Lost to Follow-up|2
4972173|NCT00106964|17084632|P2|Overall Study|Lost to Follow-up|6
4972174|NCT00106964|17084633|P1|Overall Study|Lost to Follow-up|8
4972175|NCT00106704|17084728|P2|Overall Study|Laboratory test|1
4972176|NCT00106704|17084729|P1|Overall Study|Laboratory test|1
4972177|NCT00106704|17084728|P2|Overall Study|Unable to re-enter US|0
4972178|NCT00106704|17084729|P1|Overall Study|Unable to re-enter US|1
4972179|NCT00106704|17084728|P2|Overall Study|Patient Received Glycemic Medication|41
4972180|NCT00106704|17084729|P1|Overall Study|Patient Received Glycemic Medication|22
4972181|NCT00106704|17084728|P2|Overall Study|Planned major surgery|0
4972182|NCT00106704|17084729|P1|Overall Study|Planned major surgery|1
4972183|NCT00106704|17084728|P2|Overall Study|Site terminated|1
4972184|NCT00106704|17084729|P1|Overall Study|Site terminated|0
4972185|NCT00106704|17084728|P2|Overall Study|Patient moved|0
4972186|NCT00106704|17084729|P1|Overall Study|Patient moved|1
4972187|NCT00106704|17084728|P2|Overall Study|Withdrawal by Subject|21
4972188|NCT00106704|17084729|P1|Overall Study|Withdrawal by Subject|14
4972189|NCT00106704|17084728|P2|Overall Study|Protocol Violation|7
4972190|NCT00106704|17084729|P1|Overall Study|Protocol Violation|4
4972191|NCT00106704|17084728|P2|Overall Study|Pregnancy|0
4972192|NCT00106704|17084729|P1|Overall Study|Pregnancy|1
4972193|NCT00106704|17084728|P2|Overall Study|Lost to Follow-up|3
4972194|NCT00106704|17084729|P1|Overall Study|Lost to Follow-up|7
4972195|NCT00106704|17084728|P2|Overall Study|Lack of Efficacy|69
4972196|NCT00106704|17084729|P1|Overall Study|Lack of Efficacy|67
4972197|NCT00106704|17084728|P2|Overall Study|Death|1
4972198|NCT00106704|17084729|P1|Overall Study|Death|2
4972199|NCT00106704|17084728|P2|Overall Study|Adverse Event|7
4972200|NCT00106704|17084729|P1|Overall Study|Adverse Event|10
4972201|NCT00106639|17084740|P3|Overall Study|Participant defaulted|1
4972202|NCT00106639|17084741|P2|Overall Study|Participant defaulted|1
4972203|NCT00106639|17084742|P1|Overall Study|Participant defaulted|0
4972204|NCT00106639|17084740|P3|Overall Study|Withdrawal by Subject|0
4972205|NCT00106639|17084741|P2|Overall Study|Withdrawal by Subject|1
4972206|NCT00106639|17084742|P1|Overall Study|Withdrawal by Subject|0
4972207|NCT00106639|17084740|P3|Overall Study|Protocol Violation|0
4972208|NCT00106639|17084741|P2|Overall Study|Protocol Violation|1
4972209|NCT00106639|17084742|P1|Overall Study|Protocol Violation|0
4972210|NCT00106639|17084740|P3|Overall Study|Adverse Event|1
4972211|NCT00106639|17084741|P2|Overall Study|Adverse Event|4
4972212|NCT00106639|17084742|P1|Overall Study|Adverse Event|3
4972213|NCT00106626|17084869|P4|Overall Study|> 14 day delay in therapy start|0
4972214|NCT00106626|17084870|P3|Overall Study|> 14 day delay in therapy start|0
4972215|NCT00106626|17084871|P2|Overall Study|> 14 day delay in therapy start|1
4972216|NCT00106626|17084872|P1|Overall Study|> 14 day delay in therapy start|0
4972217|NCT00106626|17084869|P4|Overall Study|Received radiation on new therapy|0
4972218|NCT00106626|17084870|P3|Overall Study|Received radiation on new therapy|0
4972219|NCT00106626|17084871|P2|Overall Study|Received radiation on new therapy|0
4972220|NCT00106626|17084872|P1|Overall Study|Received radiation on new therapy|1
4972221|NCT00106626|17084869|P4|Overall Study|Progressive Disease|10
4972222|NCT00106626|17084870|P3|Overall Study|Progressive Disease|9
4972223|NCT00106626|17084871|P2|Overall Study|Progressive Disease|1
4972224|NCT00106626|17084872|P1|Overall Study|Progressive Disease|4
4972225|NCT00106626|17084869|P4|Overall Study|Adverse Event|3
4972226|NCT00106626|17084870|P3|Overall Study|Adverse Event|3
4972227|NCT00106626|17084871|P2|Overall Study|Adverse Event|4
4972228|NCT00106626|17084872|P1|Overall Study|Adverse Event|5
4972229|NCT00106353|17085217|P7|Part 2|Physician Decision|0
4972230|NCT00106353|17085218|P6|Part 2|Physician Decision|1
4972231|NCT00106353|17085219|P5|Part 2|Physician Decision|0
4972232|NCT00106353|17085220|P4|Part 2|Physician Decision|0
4972233|NCT00106353|17085221|P3|Part 2|Physician Decision|0
4972234|NCT00106353|17085222|P2|Part 2|Physician Decision|0
4972235|NCT00106353|17085223|P1|Part 2|Physician Decision|0
4972236|NCT00106353|17085217|P7|Part 2|Withdrawal by Subject|0
4972237|NCT00106353|17085218|P6|Part 2|Withdrawal by Subject|0
4972238|NCT00106353|17085219|P5|Part 2|Withdrawal by Subject|1
4972239|NCT00106353|17085220|P4|Part 2|Withdrawal by Subject|0
4972240|NCT00106353|17085221|P3|Part 2|Withdrawal by Subject|0
4972241|NCT00106353|17085222|P2|Part 2|Withdrawal by Subject|0
4972242|NCT00106353|17085223|P1|Part 2|Withdrawal by Subject|0
4972243|NCT00106353|17085217|P7|Part 2|Other|1
4972244|NCT00106353|17085218|P6|Part 2|Other|1
4972245|NCT00106353|17085219|P5|Part 2|Other|1
4972246|NCT00106353|17085220|P4|Part 2|Other|0
4972247|NCT00106353|17085221|P3|Part 2|Other|0
4972248|NCT00106353|17085222|P2|Part 2|Other|0
4972249|NCT00106353|17085223|P1|Part 2|Other|0
4972250|NCT00106353|17085217|P7|Part 2|Adverse Event|1
4972251|NCT00106353|17085218|P6|Part 2|Adverse Event|2
4972252|NCT00106353|17085219|P5|Part 2|Adverse Event|0
4972253|NCT00106353|17085220|P4|Part 2|Adverse Event|0
4972254|NCT00106353|17085221|P3|Part 2|Adverse Event|0
4972255|NCT00106353|17085222|P2|Part 2|Adverse Event|0
4972256|NCT00106353|17085223|P1|Part 2|Adverse Event|0
4972257|NCT00106353|17085217|P7|Part 2|Symptomatic deterioration|0
4972258|NCT00106353|17085218|P6|Part 2|Symptomatic deterioration|0
4972259|NCT00106353|17085219|P5|Part 2|Symptomatic deterioration|3
4972260|NCT00106353|17085220|P4|Part 2|Symptomatic deterioration|0
4972261|NCT00106353|17085221|P3|Part 2|Symptomatic deterioration|0
4972262|NCT00106353|17085222|P2|Part 2|Symptomatic deterioration|0
4972263|NCT00106353|17085223|P1|Part 2|Symptomatic deterioration|0
4972264|NCT00106353|17085217|P7|Part 2|Death|1
4972265|NCT00106353|17085218|P6|Part 2|Death|0
4972266|NCT00106353|17085219|P5|Part 2|Death|3
4972267|NCT00106353|17085220|P4|Part 2|Death|0
4972268|NCT00106353|17085221|P3|Part 2|Death|0
4972269|NCT00106353|17085222|P2|Part 2|Death|0
4972270|NCT00106353|17085223|P1|Part 2|Death|0
4972271|NCT00106353|17085217|P7|Part 2|Disease progression|13
4972272|NCT00106353|17085218|P6|Part 2|Disease progression|14
4972273|NCT00106353|17085219|P5|Part 2|Disease progression|8
4972274|NCT00106353|17085220|P4|Part 2|Disease progression|0
4972275|NCT00106353|17085221|P3|Part 2|Disease progression|0
4972276|NCT00106353|17085222|P2|Part 2|Disease progression|0
4972277|NCT00106353|17085223|P1|Part 2|Disease progression|0
4972278|NCT00106353|17085217|P7|Part 1|Adverse Event|0
4972279|NCT00106353|17085218|P6|Part 1|Adverse Event|0
4972280|NCT00106353|17085219|P5|Part 1|Adverse Event|0
4972281|NCT00106353|17085220|P4|Part 1|Adverse Event|1
4972282|NCT00106353|17085221|P3|Part 1|Adverse Event|0
4972283|NCT00106353|17085222|P2|Part 1|Adverse Event|0
4972284|NCT00106353|17085223|P1|Part 1|Adverse Event|0
4972285|NCT00106353|17085217|P7|Part 1|Entered follow-up phase|0
4972286|NCT00106353|17085218|P6|Part 1|Entered follow-up phase|0
4972287|NCT00106353|17085219|P5|Part 1|Entered follow-up phase|0
4972288|NCT00106353|17085220|P4|Part 1|Entered follow-up phase|1
4972289|NCT00106353|17085221|P3|Part 1|Entered follow-up phase|0
4972290|NCT00106353|17085222|P2|Part 1|Entered follow-up phase|1
4972291|NCT00106353|17085223|P1|Part 1|Entered follow-up phase|1
4972292|NCT00106353|17085217|P7|Part 1|Symptomatic deterioration|0
4972293|NCT00106353|17085218|P6|Part 1|Symptomatic deterioration|0
4972294|NCT00106353|17085219|P5|Part 1|Symptomatic deterioration|0
4972295|NCT00106353|17085220|P4|Part 1|Symptomatic deterioration|0
4972296|NCT00106353|17085221|P3|Part 1|Symptomatic deterioration|1
4972297|NCT00106353|17085222|P2|Part 1|Symptomatic deterioration|0
4972298|NCT00106353|17085223|P1|Part 1|Symptomatic deterioration|0
4972299|NCT00106353|17085217|P7|Part 1|Withdrawal by Subject|0
4972300|NCT00106353|17085218|P6|Part 1|Withdrawal by Subject|0
4972301|NCT00106353|17085219|P5|Part 1|Withdrawal by Subject|0
4972302|NCT00106353|17085220|P4|Part 1|Withdrawal by Subject|2
4972303|NCT00106353|17085221|P3|Part 1|Withdrawal by Subject|1
4972304|NCT00106353|17085222|P2|Part 1|Withdrawal by Subject|0
4972305|NCT00106353|17085223|P1|Part 1|Withdrawal by Subject|0
4972306|NCT00106353|17085217|P7|Part 1|Disease progression|0
4972307|NCT00106353|17085218|P6|Part 1|Disease progression|0
4972308|NCT00106353|17085219|P5|Part 1|Disease progression|0
4972309|NCT00106353|17085220|P4|Part 1|Disease progression|3
4972310|NCT00106353|17085221|P3|Part 1|Disease progression|1
4972311|NCT00106353|17085222|P2|Part 1|Disease progression|4
4972312|NCT00106353|17085223|P1|Part 1|Disease progression|3
4972313|NCT00106249|17085350|P2|Overall Study|Lost to Follow-up|2
4972314|NCT00106249|17085351|P1|Overall Study|Lost to Follow-up|3
4972315|NCT00106184|17085363|P2|Overall Study|Withdrawal by Subject|2
4972316|NCT00106184|17085364|P1|Overall Study|Withdrawal by Subject|3
4972317|NCT00106080|17085406|P2|Overall Study|Withdrew/Loss to follow-up|27
4972318|NCT00106080|17085407|P1|Overall Study|Withdrew/Loss to follow-up|43
4972319|NCT00106028|17085417|P2|Overall Study|Lost to Follow-up|1
4972320|NCT00106028|17085418|P1|Overall Study|Lost to Follow-up|0
4972321|NCT00106028|17085417|P2|Overall Study|Withdrawal by Subject|8
4972322|NCT00106028|17085418|P1|Overall Study|Withdrawal by Subject|2
4972323|NCT00106028|17085417|P2|Overall Study|Protocol Violation|1
4972324|NCT00106028|17085418|P1|Overall Study|Protocol Violation|1
4972325|NCT00106028|17085417|P2|Overall Study|Adverse Event|2
4972326|NCT00106028|17085418|P1|Overall Study|Adverse Event|3
4972327|NCT00106002|17085512|P1|Overall Study|Ineligible after Registration|1
4972328|NCT00106002|17085512|P1|Overall Study|Did not take any study drug|1
4972329|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
4972330|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0
4972331|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43
4972332|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14
4972333|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Death|0
4972334|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Death|0
4972335|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Physician Decision|1
4972336|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Physician Decision|4
4972337|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0
4972338|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4
4972339|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4
4972340|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5
4972341|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
4972342|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0
4972343|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
4972344|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0
4972345|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18
4972346|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17
4972347|NCT00105989|17085520|P2|Maintenance - Double-Blind:Week 34-86|Adverse Event|3
4972348|NCT00105989|17085521|P1|Maintenance - Double-Blind:Week 34-86|Adverse Event|6
4972349|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
4972350|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0
4972351|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0
4972352|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2
4972353|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Death|0
4972354|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Death|0
4972355|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Physician Decision|0
4972356|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Physician Decision|3
4972357|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Lost to Follow-up|0
4972358|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Lost to Follow-up|9
4972359|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Protocol Violation|0
4972360|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Protocol Violation|5
4972361|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0
4972362|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16
4972363|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Lack of Efficacy|0
4972364|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Lack of Efficacy|15
4972365|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0
4972366|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50
4972367|NCT00105989|17085520|P2|Continuation - Open Label:Week 10-34|Adverse Event|0
4972368|NCT00105989|17085521|P1|Continuation - Open Label:Week 10-34|Adverse Event|25
4972369|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
4972370|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0
4972371|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
4972372|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0
4972373|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Death|0
4972374|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Death|1
4972375|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Physician Decision|0
4972376|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Physician Decision|0
4972377|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Lost to Follow-up|0
4972378|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Lost to Follow-up|4
4972379|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Protocol Violation|0
4972380|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Protocol Violation|8
4972381|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0
4972382|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14
4972383|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Lack of Efficacy|0
4972384|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Lack of Efficacy|17
4972385|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Withdrawal by Subject|0
4972386|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Withdrawal by Subject|24
4972387|NCT00105989|17085520|P2|Acute - Open Label: Week 0-10|Adverse Event|0
4972388|NCT00105989|17085521|P1|Acute - Open Label: Week 0-10|Adverse Event|33
4972389|NCT00105586|17085637|P2|Overall Study|Physician Decision|13
4972390|NCT00105586|17085638|P1|Overall Study|Physician Decision|13
4972391|NCT00105586|17085637|P2|Overall Study|Adverse Event|3
4972392|NCT00105586|17085638|P1|Overall Study|Adverse Event|4
4972393|NCT00105560|17085646|P1|Overall Study|Lost to Follow-up|1
4972394|NCT00105534|17085668|P2|Overall Study|Other Reason|2
4972395|NCT00105534|17085669|P1|Overall Study|Other Reason|0
4972396|NCT00105534|17085668|P2|Overall Study|Treatment unmasked|0
4972397|NCT00105534|17085669|P1|Overall Study|Treatment unmasked|1
4972398|NCT00105534|17085668|P2|Overall Study|Lack of Efficacy|15
4972399|NCT00105534|17085669|P1|Overall Study|Lack of Efficacy|7
4972400|NCT00105534|17085668|P2|Overall Study|Lost to Follow-up|1
4972401|NCT00105534|17085669|P1|Overall Study|Lost to Follow-up|5
4972402|NCT00105534|17085668|P2|Overall Study|Withdrawal by Subject|6
4972403|NCT00105534|17085669|P1|Overall Study|Withdrawal by Subject|6
4972404|NCT00105534|17085668|P2|Overall Study|Protocol Violation|4
4972405|NCT00105534|17085669|P1|Overall Study|Protocol Violation|1
4972406|NCT00105534|17085668|P2|Overall Study|Adverse Event|5
4972407|NCT00105534|17085669|P1|Overall Study|Adverse Event|2
4972408|NCT00105521|17085681|P4|Overall Study|Lost to Follow-up|0
4972409|NCT00105521|17085682|P3|Overall Study|Lost to Follow-up|0
4972410|NCT00105521|17085683|P2|Overall Study|Lost to Follow-up|1
4972411|NCT00105521|17085684|P1|Overall Study|Lost to Follow-up|0
4972412|NCT00105521|17085681|P4|Overall Study|Protocol Violation|4
4972413|NCT00105521|17085682|P3|Overall Study|Protocol Violation|4
4972414|NCT00105521|17085683|P2|Overall Study|Protocol Violation|5
4972415|NCT00105521|17085684|P1|Overall Study|Protocol Violation|3
4972416|NCT00105521|17085681|P4|Overall Study|Lack of Efficacy|1
4972417|NCT00105521|17085682|P3|Overall Study|Lack of Efficacy|0
4972418|NCT00105521|17085683|P2|Overall Study|Lack of Efficacy|0
4972419|NCT00105521|17085684|P1|Overall Study|Lack of Efficacy|0
4972420|NCT00105521|17085681|P4|Overall Study|Withdrawal by Subject|4
4972421|NCT00105521|17085682|P3|Overall Study|Withdrawal by Subject|1
4972422|NCT00105521|17085683|P2|Overall Study|Withdrawal by Subject|0
4972423|NCT00105521|17085684|P1|Overall Study|Withdrawal by Subject|1
4972424|NCT00105521|17085681|P4|Overall Study|Adverse Event|8
4972425|NCT00105521|17085682|P3|Overall Study|Adverse Event|10
4972426|NCT00105521|17085683|P2|Overall Study|Adverse Event|4
4972427|NCT00105521|17085684|P1|Overall Study|Adverse Event|10
4972428|NCT00105521|17085681|P4|Overall Study|Other|0
4972429|NCT00105521|17085682|P3|Overall Study|Other|2
4972430|NCT00105521|17085683|P2|Overall Study|Other|1
4972431|NCT00105521|17085684|P1|Overall Study|Other|1
4972432|NCT00105508|17085708|P2|Overall Study|Other|9
4972433|NCT00105508|17085709|P1|Overall Study|Other|8
4972434|NCT00105508|17085708|P2|Overall Study|Protocol Violation|2
4972435|NCT00105508|17085709|P1|Overall Study|Protocol Violation|1
4972436|NCT00105508|17085708|P2|Overall Study|Lost to Follow-up|0
4972437|NCT00105508|17085709|P1|Overall Study|Lost to Follow-up|3
4972438|NCT00105508|17085708|P2|Overall Study|Withdrawal by Subject|6
4972439|NCT00105508|17085709|P1|Overall Study|Withdrawal by Subject|10
4972440|NCT00105508|17085708|P2|Overall Study|Insufficient Efficacy|0
4972441|NCT00105508|17085709|P1|Overall Study|Insufficient Efficacy|1
4972442|NCT00105508|17085708|P2|Overall Study|Adverse Event|19
4972443|NCT00105508|17085709|P1|Overall Study|Adverse Event|16
4972444|NCT00105508|17085708|P2|Overall Study|Prephase Dropout|0
4972445|NCT00105508|17085709|P1|Overall Study|Prephase Dropout|1
4972446|NCT00105482|17085723|P2|Overall Study|Withdrawn by PI|1
4972447|NCT00105482|17085724|P1|Overall Study|Withdrawn by PI|1
4972448|NCT00105482|17085723|P2|Overall Study|Scheduling Conflict|3
4972449|NCT00105482|17085724|P1|Overall Study|Scheduling Conflict|2
4972450|NCT00105482|17085723|P2|Overall Study|Lost Interest|32
4972451|NCT00105482|17085724|P1|Overall Study|Lost Interest|29
4972452|NCT00105482|17085723|P2|Overall Study|Withdrawal by Subject|1
4972453|NCT00105482|17085724|P1|Overall Study|Withdrawal by Subject|0
4972454|NCT00105482|17085723|P2|Overall Study|Lost to Follow-up|17
4972455|NCT00105482|17085724|P1|Overall Study|Lost to Follow-up|26
4972456|NCT00105482|17085723|P2|Overall Study|Adverse Event|1
4972457|NCT00105482|17085724|P1|Overall Study|Adverse Event|1
4972458|NCT00105469|17085740|P2|Overall Study|Other Reason|0
4972459|NCT00105469|17085741|P1|Overall Study|Other Reason|4
4972460|NCT00105469|17085740|P2|Overall Study|Lack of Efficacy|0
4972461|NCT00105469|17085741|P1|Overall Study|Lack of Efficacy|2
4972462|NCT00105469|17085740|P2|Overall Study|Lost to Follow-up|0
4972463|NCT00105469|17085741|P1|Overall Study|Lost to Follow-up|1
4972464|NCT00105469|17085740|P2|Overall Study|Withdrawal by Subject|3
4972465|NCT00105469|17085741|P1|Overall Study|Withdrawal by Subject|2
4972466|NCT00105469|17085740|P2|Overall Study|Protocol Violation|0
4972467|NCT00105469|17085741|P1|Overall Study|Protocol Violation|4
4972468|NCT00105469|17085740|P2|Overall Study|Adverse Event|8
4972469|NCT00105469|17085741|P1|Overall Study|Adverse Event|9
4972470|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11
4972471|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
4972472|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23
4972473|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0
4972474|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
4972475|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
4972476|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1
4972477|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0
4972478|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1
4972479|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
4972480|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
4972481|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0
4972482|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
4972483|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
4972484|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0
4972485|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1
4972486|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
4972487|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1
4972488|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
4972489|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2
4972490|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
4972491|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1
4972492|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0
4972493|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6
4972494|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
4972495|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
4972496|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3
4972497|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0
4972498|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5
4972499|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
4972500|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2
4972501|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0
4972502|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Protocol Violation|0
4972503|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Protocol Violation|0
4972504|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Protocol Violation|2
4972505|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Protocol Violation|0
4972506|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Physician Decision|0
4972507|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Physician Decision|1
4972508|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Physician Decision|0
4972509|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Physician Decision|1
4972510|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Adverse Event|16
4972511|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Adverse Event|0
4972512|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Adverse Event|14
4972513|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Adverse Event|0
4972514|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4
4972515|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13
4972516|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3
4972517|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24
4972518|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
4972519|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10
4972520|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0
4972521|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14
4972522|NCT00105443|17085751|P4|Follow-up and/or Open Label Nexavar|Death|4
4972523|NCT00105443|17085752|P3|Follow-up and/or Open Label Nexavar|Death|219
4972524|NCT00105443|17085753|P2|Follow-up and/or Open Label Nexavar|Death|7
4972525|NCT00105443|17085754|P1|Follow-up and/or Open Label Nexavar|Death|180
4972526|NCT00105443|17085751|P4|Double-Blind Treatment|Radiological and symptomatic progression|0
4972527|NCT00105443|17085752|P3|Double-Blind Treatment|Radiological and symptomatic progression|1
4972528|NCT00105443|17085753|P2|Double-Blind Treatment|Radiological and symptomatic progression|0
4972529|NCT00105443|17085754|P1|Double-Blind Treatment|Radiological and symptomatic progression|4
4972530|NCT00105443|17085751|P4|Double-Blind Treatment|Physician Decision|0
4972531|NCT00105443|17085752|P3|Double-Blind Treatment|Physician Decision|2
4972532|NCT00105443|17085753|P2|Double-Blind Treatment|Physician Decision|0
4972533|NCT00105443|17085754|P1|Double-Blind Treatment|Physician Decision|1
4972534|NCT00105443|17085751|P4|Double-Blind Treatment|Withdrawal by Subject|0
4972535|NCT00105443|17085752|P3|Double-Blind Treatment|Withdrawal by Subject|7
4972536|NCT00105443|17085753|P2|Double-Blind Treatment|Withdrawal by Subject|0
4972537|NCT00105443|17085754|P1|Double-Blind Treatment|Withdrawal by Subject|8
4972538|NCT00105443|17085751|P4|Double-Blind Treatment|Lost to Follow-up|0
4972539|NCT00105443|17085752|P3|Double-Blind Treatment|Lost to Follow-up|1
4972540|NCT00105443|17085753|P2|Double-Blind Treatment|Lost to Follow-up|0
4972541|NCT00105443|17085754|P1|Double-Blind Treatment|Lost to Follow-up|0
4972542|NCT00105443|17085751|P4|Double-Blind Treatment|Adverse Event|0
4972543|NCT00105443|17085752|P3|Double-Blind Treatment|Adverse Event|0
4972544|NCT00105443|17085753|P2|Double-Blind Treatment|Adverse Event|0
4972545|NCT00105443|17085754|P1|Double-Blind Treatment|Adverse Event|1
4972546|NCT00105235|17085781|P1|Overall Study|Withdrawal by Subject|2
4972547|NCT00105235|17085781|P1|Overall Study|Physician Decision|1
4972548|NCT00105235|17085781|P1|Overall Study|Death|4
4972549|NCT00105196|17085794|P2|Overall Study|Subject became unblinded|1
4972550|NCT00105196|17085795|P1|Overall Study|Subject became unblinded|0
4972551|NCT00105196|17085794|P2|Overall Study|marijuana use|1
4972552|NCT00105196|17085795|P1|Overall Study|marijuana use|0
4972553|NCT00105196|17085794|P2|Overall Study|pending surgery|1
4972554|NCT00105196|17085795|P1|Overall Study|pending surgery|0
4972555|NCT00105196|17085794|P2|Overall Study|Protocol Violation|2
4972556|NCT00105196|17085795|P1|Overall Study|Protocol Violation|5
4972557|NCT00105196|17085794|P2|Overall Study|Poor/noncompliance|4
4972558|NCT00105196|17085795|P1|Overall Study|Poor/noncompliance|3
4972559|NCT00105196|17085794|P2|Overall Study|Lost to Follow-up|2
4972560|NCT00105196|17085795|P1|Overall Study|Lost to Follow-up|3
4972561|NCT00105196|17085794|P2|Overall Study|Withdrawal by Subject|6
4972562|NCT00105196|17085795|P1|Overall Study|Withdrawal by Subject|6
4972563|NCT00105196|17085794|P2|Overall Study|Adverse Event|3
4972564|NCT00105196|17085795|P1|Overall Study|Adverse Event|11
4972565|NCT00105196|17085794|P2|Overall Study|Lack of Efficacy|3
4972566|NCT00105196|17085795|P1|Overall Study|Lack of Efficacy|2
4972567|NCT00105183|17085818|P3|Overall Study|Other reason|0
4972568|NCT00105183|17085819|P2|Overall Study|Other reason|2
4972569|NCT00105183|17085820|P1|Overall Study|Other reason|1
4972570|NCT00105183|17085818|P3|Overall Study|Lost to Follow-up|1
4972571|NCT00105183|17085819|P2|Overall Study|Lost to Follow-up|1
4972572|NCT00105183|17085820|P1|Overall Study|Lost to Follow-up|0
4972573|NCT00105183|17085818|P3|Overall Study|Physician Decision|3
4972574|NCT00105183|17085819|P2|Overall Study|Physician Decision|2
4972575|NCT00105183|17085820|P1|Overall Study|Physician Decision|1
4972576|NCT00105183|17085818|P3|Overall Study|Withdrawal by Subject|4
4972577|NCT00105183|17085819|P2|Overall Study|Withdrawal by Subject|1
4972578|NCT00105183|17085820|P1|Overall Study|Withdrawal by Subject|1
4972579|NCT00105183|17085818|P3|Overall Study|Death|15
4972580|NCT00105183|17085819|P2|Overall Study|Death|13
4972581|NCT00105183|17085820|P1|Overall Study|Death|19
4972582|NCT00105157|17085856|P4|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
4972583|NCT00105157|17085857|P3|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
4972584|NCT00105157|17085858|P2|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0
4972585|NCT00105157|17085859|P1|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1
4972586|NCT00105157|17085856|P4|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5
4972587|NCT00105157|17085857|P3|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
4972588|NCT00105157|17085858|P2|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
4972589|NCT00105157|17085859|P1|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0
4972590|NCT00105157|17085856|P4|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
4972591|NCT00105157|17085857|P3|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
4972592|NCT00105157|17085858|P2|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0
4972593|NCT00105157|17085859|P1|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1
4972594|NCT00105157|17085856|P4|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10
4972595|NCT00105157|17085857|P3|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5
4972596|NCT00105157|17085858|P2|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6
4972597|NCT00105157|17085859|P1|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7
4972598|NCT00105157|17085856|P4|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1
4972599|NCT00105157|17085857|P3|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
4972600|NCT00105157|17085858|P2|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
4972601|NCT00105157|17085859|P1|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0
4972602|NCT00105157|17085856|P4|Open-Label Continuation of DB|Patient moved/site stopped trial|0
4972603|NCT00105157|17085857|P3|Open-Label Continuation of DB|Patient moved/site stopped trial|2
4972604|NCT00105157|17085858|P2|Open-Label Continuation of DB|Patient moved/site stopped trial|3
4972605|NCT00105157|17085859|P1|Open-Label Continuation of DB|Patient moved/site stopped trial|1
4972606|NCT00105157|17085856|P4|Open-Label Continuation of DB|Patient did not continue in extension|0
4972607|NCT00105157|17085857|P3|Open-Label Continuation of DB|Patient did not continue in extension|0
4972608|NCT00105157|17085858|P2|Open-Label Continuation of DB|Patient did not continue in extension|0
4972609|NCT00105157|17085859|P1|Open-Label Continuation of DB|Patient did not continue in extension|1
4972610|NCT00105157|17085856|P4|Open-Label Continuation of DB|Withdrawal by Subject|0
4972611|NCT00105157|17085857|P3|Open-Label Continuation of DB|Withdrawal by Subject|3
4972612|NCT00105157|17085858|P2|Open-Label Continuation of DB|Withdrawal by Subject|1
4972613|NCT00105157|17085859|P1|Open-Label Continuation of DB|Withdrawal by Subject|0
4972614|NCT00105157|17085856|P4|Open-Label Continuation of DB|Lost to Follow-up|0
4972615|NCT00105157|17085857|P3|Open-Label Continuation of DB|Lost to Follow-up|1
4972616|NCT00105157|17085858|P2|Open-Label Continuation of DB|Lost to Follow-up|1
4972617|NCT00105157|17085859|P1|Open-Label Continuation of DB|Lost to Follow-up|1
4972618|NCT00105157|17085856|P4|Open-Label Continuation of DB|Lack of Efficacy|1
4972619|NCT00105157|17085857|P3|Open-Label Continuation of DB|Lack of Efficacy|3
4972620|NCT00105157|17085858|P2|Open-Label Continuation of DB|Lack of Efficacy|4
4972621|NCT00105157|17085859|P1|Open-Label Continuation of DB|Lack of Efficacy|1
4972622|NCT00105157|17085856|P4|Open-Label Continuation of DB|Adverse Event|0
4972623|NCT00105157|17085857|P3|Open-Label Continuation of DB|Adverse Event|0
4972624|NCT00105157|17085858|P2|Open-Label Continuation of DB|Adverse Event|1
4972625|NCT00105157|17085859|P1|Open-Label Continuation of DB|Adverse Event|3
4972626|NCT00105157|17085856|P4|Double-Blind (DB)|Lack of Efficacy|38
4972627|NCT00105157|17085857|P3|Double-Blind (DB)|Lack of Efficacy|11
4972628|NCT00105157|17085858|P2|Double-Blind (DB)|Lack of Efficacy|14
4972629|NCT00105157|17085859|P1|Double-Blind (DB)|Lack of Efficacy|11
4972630|NCT00105157|17085856|P4|Double-Blind (DB)|Adverse Event|1
4972631|NCT00105157|17085857|P3|Double-Blind (DB)|Adverse Event|1
4972632|NCT00105157|17085858|P2|Double-Blind (DB)|Adverse Event|0
4972633|NCT00105157|17085859|P1|Double-Blind (DB)|Adverse Event|2
4972634|NCT00105157|17085856|P4|Double-Blind (DB)|Never Treated|0
4972635|NCT00105157|17085857|P3|Double-Blind (DB)|Never Treated|0
4972636|NCT00105157|17085858|P2|Double-Blind (DB)|Never Treated|0
4972637|NCT00105157|17085859|P1|Double-Blind (DB)|Never Treated|1
4972638|NCT00105079|17086053|P2|Overall Study|Other|1
4972639|NCT00105079|17086054|P1|Overall Study|Other|3
4972640|NCT00105079|17086053|P2|Overall Study|Protocol Violation|0
4972641|NCT00105079|17086054|P1|Overall Study|Protocol Violation|1
4972642|NCT00105079|17086053|P2|Overall Study|Violation of selection criteria at entry|2
4972643|NCT00105079|17086054|P1|Overall Study|Violation of selection criteria at entry|0
4972644|NCT00105079|17086053|P2|Overall Study|Refused treatment|4
4972645|NCT00105079|17086054|P1|Overall Study|Refused treatment|6
4972646|NCT00105079|17086053|P2|Overall Study|Lack of Efficacy|3
4972647|NCT00105079|17086054|P1|Overall Study|Lack of Efficacy|9
4972648|NCT00105079|17086053|P2|Overall Study|Lost to Follow-up|12
4972649|NCT00105079|17086054|P1|Overall Study|Lost to Follow-up|12
4972650|NCT00105079|17086053|P2|Overall Study|Death|1
4972651|NCT00105079|17086054|P1|Overall Study|Death|3
4972652|NCT00105079|17086053|P2|Overall Study|Adverse Event|12
4972653|NCT00105079|17086054|P1|Overall Study|Adverse Event|5
4972654|NCT00105066|17086072|P2|Overall Study|Adverse Event|5
4972655|NCT00105066|17086073|P1|Overall Study|Adverse Event|2
4972656|NCT00104884|17086151|P1|Overall Study|Disease progression|4
4972657|NCT00104871|17086155|P1|Overall Study|Not evaluable|1
4972658|NCT00104728|17086176|P1|Overall Study|screen failures|19
4972659|NCT00104650|17086184|P3|Follow-up Period|Other|0
4972660|NCT00104650|17086185|P2|Follow-up Period|Other|1
4972661|NCT00104650|17086186|P1|Follow-up Period|Other|0
4972662|NCT00104650|17086184|P3|Follow-up Period|Lost to Follow-up|2
4972663|NCT00104650|17086185|P2|Follow-up Period|Lost to Follow-up|1
4972664|NCT00104650|17086186|P1|Follow-up Period|Lost to Follow-up|0
4972665|NCT00104650|17086184|P3|Follow-up Period|Disease progression|0
4972666|NCT00104650|17086185|P2|Follow-up Period|Disease progression|1
4972667|NCT00104650|17086186|P1|Follow-up Period|Disease progression|3
4972668|NCT00104650|17086184|P3|Follow-up Period|Death|4
4972669|NCT00104650|17086185|P2|Follow-up Period|Death|6
4972670|NCT00104650|17086186|P1|Follow-up Period|Death|6
4972671|NCT00104650|17086184|P3|Follow-up Period|Withdrawal by Subject|3
4972672|NCT00104650|17086185|P2|Follow-up Period|Withdrawal by Subject|3
4972673|NCT00104650|17086186|P1|Follow-up Period|Withdrawal by Subject|0
4972674|NCT00104650|17086184|P3|Follow-up Period|Adverse Event|1
4972675|NCT00104650|17086185|P2|Follow-up Period|Adverse Event|0
4972676|NCT00104650|17086186|P1|Follow-up Period|Adverse Event|1
4972677|NCT00104650|17086184|P3|Follow-up Period|Physician Decision|0
4972678|NCT00104650|17086185|P2|Follow-up Period|Physician Decision|1
4972679|NCT00104650|17086186|P1|Follow-up Period|Physician Decision|1
4972680|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Protocol deviation|0
4972681|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Protocol deviation|1
4972682|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Protocol deviation|0
4972683|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Other|0
4972684|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Other|0
4972685|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Other|1
4972686|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Ineligibility determined|0
4972687|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Ineligibility determined|1
4972688|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Ineligibility determined|0
4972689|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Disease progression|2
4972690|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Disease progression|3
4972691|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Disease progression|2
4972692|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Death|6
4972693|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Death|5
4972694|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Death|7
4972695|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Withdrawal by Subject|1
4972696|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Withdrawal by Subject|1
4972697|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Withdrawal by Subject|2
4972698|NCT00104650|17086184|P3|Treatment Period (25 Weeks)|Physician Decision|1
4972699|NCT00104650|17086185|P2|Treatment Period (25 Weeks)|Physician Decision|0
4972700|NCT00104650|17086186|P1|Treatment Period (25 Weeks)|Physician Decision|0
4972701|NCT00104637|17086218|P2|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0
4972702|NCT00104637|17086219|P1|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1
4972703|NCT00104572|17086248|P3|Overall Study|Withdrawal by Subject|0
4972704|NCT00104572|17086249|P2|Overall Study|Withdrawal by Subject|3
4972705|NCT00104572|17086250|P1|Overall Study|Withdrawal by Subject|3
4972706|NCT00104520|17086269|P2|Overall Study|Other|5
4972707|NCT00104520|17086270|P1|Overall Study|Other|1
4972708|NCT00104520|17086269|P2|Overall Study|Personal/administrative|1
4972709|NCT00104520|17086270|P1|Overall Study|Personal/administrative|1
4972710|NCT00104520|17086269|P2|Overall Study|Noncompliance|2
4972711|NCT00104520|17086270|P1|Overall Study|Noncompliance|0
4972712|NCT00104520|17086269|P2|Overall Study|Lost to Follow-up|0
4972713|NCT00104520|17086270|P1|Overall Study|Lost to Follow-up|1
4972714|NCT00104520|17086269|P2|Overall Study|Related adverse event|15
4972715|NCT00104520|17086270|P1|Overall Study|Related adverse event|13
4972716|NCT00104520|17086269|P2|Overall Study|Study drug intolerance|1
4972717|NCT00104520|17086270|P1|Overall Study|Study drug intolerance|0
4972718|NCT00104520|17086269|P2|Overall Study|Unrelated adverse event|47
4972719|NCT00104520|17086270|P1|Overall Study|Unrelated adverse event|34
4972720|NCT00104416|17086290|P5|Continuation Phase|Non-compliance|1
4972721|NCT00104416|17086291|P4|Continuation Phase|Non-compliance|0
4972722|NCT00104416|17086292|P3|Continuation Phase|Non-compliance|0
4972723|NCT00104416|17086293|P2|Continuation Phase|Non-compliance|0
4972724|NCT00104416|17086294|P1|Continuation Phase|Non-compliance|0
4972725|NCT00104416|17086290|P5|Continuation Phase|Pregnancy|0
4972726|NCT00104416|17086291|P4|Continuation Phase|Pregnancy|1
4972727|NCT00104416|17086292|P3|Continuation Phase|Pregnancy|1
4972728|NCT00104416|17086293|P2|Continuation Phase|Pregnancy|0
4972729|NCT00104416|17086294|P1|Continuation Phase|Pregnancy|0
4972730|NCT00104416|17086290|P5|Continuation Phase|Withdrawal by Subject|1
4972731|NCT00104416|17086291|P4|Continuation Phase|Withdrawal by Subject|1
4972732|NCT00104416|17086292|P3|Continuation Phase|Withdrawal by Subject|2
4972733|NCT00104416|17086293|P2|Continuation Phase|Withdrawal by Subject|0
4972734|NCT00104416|17086294|P1|Continuation Phase|Withdrawal by Subject|0
4972735|NCT00104416|17086290|P5|Continuation Phase|Lost to Follow-up|1
4972736|NCT00104416|17086291|P4|Continuation Phase|Lost to Follow-up|0
4972737|NCT00104416|17086292|P3|Continuation Phase|Lost to Follow-up|1
4972738|NCT00104416|17086293|P2|Continuation Phase|Lost to Follow-up|0
4972739|NCT00104416|17086294|P1|Continuation Phase|Lost to Follow-up|0
4972740|NCT00104416|17086290|P5|Continuation Phase|Adverse Event|2
4972741|NCT00104416|17086291|P4|Continuation Phase|Adverse Event|0
4972742|NCT00104416|17086292|P3|Continuation Phase|Adverse Event|2
4972743|NCT00104416|17086293|P2|Continuation Phase|Adverse Event|0
4972744|NCT00104416|17086294|P1|Continuation Phase|Adverse Event|0
4972745|NCT00104416|17086290|P5|Double-Blind Phase|Participant Did Not Take Drug|0
4972746|NCT00104416|17086291|P4|Double-Blind Phase|Participant Did Not Take Drug|0
4972747|NCT00104416|17086292|P3|Double-Blind Phase|Participant Did Not Take Drug|0
4972748|NCT00104416|17086293|P2|Double-Blind Phase|Participant Did Not Take Drug|4
4972749|NCT00104416|17086294|P1|Double-Blind Phase|Participant Did Not Take Drug|3
4972750|NCT00104416|17086290|P5|Double-Blind Phase|Pregnancy|0
4972751|NCT00104416|17086291|P4|Double-Blind Phase|Pregnancy|0
4972752|NCT00104416|17086292|P3|Double-Blind Phase|Pregnancy|0
4972753|NCT00104416|17086293|P2|Double-Blind Phase|Pregnancy|0
4972754|NCT00104416|17086294|P1|Double-Blind Phase|Pregnancy|1
4972755|NCT00104416|17086290|P5|Double-Blind Phase|Withdrawal by Subject|0
4972756|NCT00104416|17086291|P4|Double-Blind Phase|Withdrawal by Subject|0
4972757|NCT00104416|17086292|P3|Double-Blind Phase|Withdrawal by Subject|0
4972758|NCT00104416|17086293|P2|Double-Blind Phase|Withdrawal by Subject|3
4972759|NCT00104416|17086294|P1|Double-Blind Phase|Withdrawal by Subject|2
4972760|NCT00104416|17086290|P5|Double-Blind Phase|Protocol Violation|0
4972761|NCT00104416|17086291|P4|Double-Blind Phase|Protocol Violation|0
4972762|NCT00104416|17086292|P3|Double-Blind Phase|Protocol Violation|0
4972763|NCT00104416|17086293|P2|Double-Blind Phase|Protocol Violation|1
4972764|NCT00104416|17086294|P1|Double-Blind Phase|Protocol Violation|0
4972765|NCT00104416|17086290|P5|Double-Blind Phase|Lost to Follow-up|0
4972766|NCT00104416|17086291|P4|Double-Blind Phase|Lost to Follow-up|0
4972767|NCT00104416|17086292|P3|Double-Blind Phase|Lost to Follow-up|0
4972768|NCT00104416|17086293|P2|Double-Blind Phase|Lost to Follow-up|1
4972769|NCT00104416|17086294|P1|Double-Blind Phase|Lost to Follow-up|0
4972770|NCT00104416|17086290|P5|Double-Blind Phase|Adverse Event|0
4972771|NCT00104416|17086291|P4|Double-Blind Phase|Adverse Event|0
4972772|NCT00104416|17086292|P3|Double-Blind Phase|Adverse Event|0
4972773|NCT00104416|17086293|P2|Double-Blind Phase|Adverse Event|1
4972774|NCT00104416|17086294|P1|Double-Blind Phase|Adverse Event|2
4972775|NCT00104299|17086339|P2|Overall Study|To have renal transplant|0
4972776|NCT00104299|17086340|P1|Overall Study|To have renal transplant|1
4972777|NCT00104299|17086339|P2|Overall Study|Physician Decision|1
4972778|NCT00104299|17086340|P1|Overall Study|Physician Decision|1
4972779|NCT00104299|17086339|P2|Overall Study|Withdrawal by Subject|6
4972780|NCT00104299|17086340|P1|Overall Study|Withdrawal by Subject|2
4972781|NCT00104299|17086339|P2|Overall Study|Death|2
4972782|NCT00104299|17086340|P1|Overall Study|Death|2
4972783|NCT00104299|17086339|P2|Overall Study|Adverse Event|1
4972784|NCT00104299|17086340|P1|Overall Study|Adverse Event|3
4972785|NCT00104247|17086362|P2|Overall Study|Noncompliant with dosing|1
4972786|NCT00104247|17086363|P1|Overall Study|Noncompliant with dosing|0
4972787|NCT00104247|17086362|P2|Overall Study|Withdrawal by Subject|0
4972788|NCT00104247|17086363|P1|Overall Study|Withdrawal by Subject|1
4972789|NCT00104104|17086382|P2|Overall Study|Death|6
4972790|NCT00104104|17086383|P1|Overall Study|Death|9
4972791|NCT00104104|17086382|P2|Overall Study|Administrative problems|13
4972792|NCT00104104|17086383|P1|Overall Study|Administrative problems|12
4972793|NCT00104104|17086382|P2|Overall Study|Lost to Follow-up|7
4972794|NCT00104104|17086383|P1|Overall Study|Lost to Follow-up|3
4972795|NCT00104104|17086382|P2|Overall Study|Withdrawal by Subject|15
4972796|NCT00104104|17086383|P1|Overall Study|Withdrawal by Subject|11
4972797|NCT00104104|17086382|P2|Overall Study|Protocol Violation|2
4972798|NCT00104104|17086383|P1|Overall Study|Protocol Violation|5
4972799|NCT00104104|17086382|P2|Overall Study|Condition no longer requires study drug|4
4972800|NCT00104104|17086383|P1|Overall Study|Condition no longer requires study drug|7
4972801|NCT00104104|17086382|P2|Overall Study|Lack of Efficacy|3
4972802|NCT00104104|17086383|P1|Overall Study|Lack of Efficacy|0
4972803|NCT00104104|17086382|P2|Overall Study|Abnormal laboratory value(s)|14
4972804|NCT00104104|17086383|P1|Overall Study|Abnormal laboratory value(s)|20
4972805|NCT00104104|17086382|P2|Overall Study|Adverse Event|8
4972806|NCT00104104|17086383|P1|Overall Study|Adverse Event|8
4972807|NCT00104052|17086397|P1|Overall Study|Discontinuation unrelated to treatment|2
4972808|NCT00104052|17086397|P1|Overall Study|Lack of Efficacy|26
4972809|NCT00104052|17086397|P1|Overall Study|Adverse Event|1
4972810|NCT00103857|17086408|P7|50-Week Extension Study|reason unspecified|0
4972811|NCT00103857|17086409|P6|50-Week Extension Study|reason unspecified|0
4972812|NCT00103857|17086410|P5|50-Week Extension Study|reason unspecified|1
4972813|NCT00103857|17086411|P4|50-Week Extension Study|reason unspecified|0
4972814|NCT00103857|17086412|P3|50-Week Extension Study|reason unspecified|0
4972815|NCT00103857|17086413|P2|50-Week Extension Study|reason unspecified|0
4972816|NCT00103857|17086414|P1|50-Week Extension Study|reason unspecified|0
4972817|NCT00103857|17086408|P7|50-Week Extension Study|patient scheduled for elective surgery|0
4972818|NCT00103857|17086409|P6|50-Week Extension Study|patient scheduled for elective surgery|0
4972819|NCT00103857|17086410|P5|50-Week Extension Study|patient scheduled for elective surgery|0
4972820|NCT00103857|17086411|P4|50-Week Extension Study|patient scheduled for elective surgery|0
4972821|NCT00103857|17086412|P3|50-Week Extension Study|patient scheduled for elective surgery|1
4972822|NCT00103857|17086413|P2|50-Week Extension Study|patient scheduled for elective surgery|0
4972823|NCT00103857|17086414|P1|50-Week Extension Study|patient scheduled for elective surgery|0
4972824|NCT00103857|17086408|P7|50-Week Extension Study|patient moved|0
4972825|NCT00103857|17086409|P6|50-Week Extension Study|patient moved|0
4972826|NCT00103857|17086410|P5|50-Week Extension Study|patient moved|0
4972827|NCT00103857|17086411|P4|50-Week Extension Study|patient moved|2
4972828|NCT00103857|17086412|P3|50-Week Extension Study|patient moved|1
4972829|NCT00103857|17086413|P2|50-Week Extension Study|patient moved|0
4972830|NCT00103857|17086414|P1|50-Week Extension Study|patient moved|0
4972831|NCT00103857|17086408|P7|50-Week Extension Study|non-compliance with study procedures|0
4972832|NCT00103857|17086409|P6|50-Week Extension Study|non-compliance with study procedures|0
4972833|NCT00103857|17086410|P5|50-Week Extension Study|non-compliance with study procedures|1
4972834|NCT00103857|17086411|P4|50-Week Extension Study|non-compliance with study procedures|1
4972835|NCT00103857|17086412|P3|50-Week Extension Study|non-compliance with study procedures|0
4972836|NCT00103857|17086413|P2|50-Week Extension Study|non-compliance with study procedures|0
4972837|NCT00103857|17086414|P1|50-Week Extension Study|non-compliance with study procedures|1
4972838|NCT00103857|17086408|P7|50-Week Extension Study|protocol discontinuation criteria|0
4972839|NCT00103857|17086409|P6|50-Week Extension Study|protocol discontinuation criteria|3
4972840|NCT00103857|17086410|P5|50-Week Extension Study|protocol discontinuation criteria|3
4972841|NCT00103857|17086411|P4|50-Week Extension Study|protocol discontinuation criteria|2
4972842|NCT00103857|17086412|P3|50-Week Extension Study|protocol discontinuation criteria|3
4972843|NCT00103857|17086413|P2|50-Week Extension Study|protocol discontinuation criteria|2
4972844|NCT00103857|17086414|P1|50-Week Extension Study|protocol discontinuation criteria|2
4972845|NCT00103857|17086408|P7|50-Week Extension Study|Withdrawal by Subject|0
4972846|NCT00103857|17086409|P6|50-Week Extension Study|Withdrawal by Subject|3
4972847|NCT00103857|17086410|P5|50-Week Extension Study|Withdrawal by Subject|3
4972848|NCT00103857|17086411|P4|50-Week Extension Study|Withdrawal by Subject|8
4972849|NCT00103857|17086412|P3|50-Week Extension Study|Withdrawal by Subject|2
4972850|NCT00103857|17086413|P2|50-Week Extension Study|Withdrawal by Subject|5
4972851|NCT00103857|17086414|P1|50-Week Extension Study|Withdrawal by Subject|2
4972852|NCT00103857|17086408|P7|50-Week Extension Study|Protocol Violation|0
4972853|NCT00103857|17086409|P6|50-Week Extension Study|Protocol Violation|1
4972854|NCT00103857|17086410|P5|50-Week Extension Study|Protocol Violation|0
4972855|NCT00103857|17086411|P4|50-Week Extension Study|Protocol Violation|2
4972856|NCT00103857|17086412|P3|50-Week Extension Study|Protocol Violation|1
4972857|NCT00103857|17086413|P2|50-Week Extension Study|Protocol Violation|1
4972858|NCT00103857|17086414|P1|50-Week Extension Study|Protocol Violation|1
4972859|NCT00103857|17086408|P7|50-Week Extension Study|Pregnancy|0
4972860|NCT00103857|17086409|P6|50-Week Extension Study|Pregnancy|0
4972861|NCT00103857|17086410|P5|50-Week Extension Study|Pregnancy|1
4972862|NCT00103857|17086411|P4|50-Week Extension Study|Pregnancy|0
4972863|NCT00103857|17086412|P3|50-Week Extension Study|Pregnancy|1
4972864|NCT00103857|17086413|P2|50-Week Extension Study|Pregnancy|0
4972865|NCT00103857|17086414|P1|50-Week Extension Study|Pregnancy|0
4972866|NCT00103857|17086408|P7|50-Week Extension Study|Physician Decision|0
4972867|NCT00103857|17086409|P6|50-Week Extension Study|Physician Decision|0
4972868|NCT00103857|17086410|P5|50-Week Extension Study|Physician Decision|0
4972869|NCT00103857|17086411|P4|50-Week Extension Study|Physician Decision|0
4972870|NCT00103857|17086412|P3|50-Week Extension Study|Physician Decision|1
4972871|NCT00103857|17086413|P2|50-Week Extension Study|Physician Decision|1
4972872|NCT00103857|17086414|P1|50-Week Extension Study|Physician Decision|0
4972873|NCT00103857|17086408|P7|50-Week Extension Study|Lost to Follow-up|0
4972874|NCT00103857|17086409|P6|50-Week Extension Study|Lost to Follow-up|3
4972875|NCT00103857|17086410|P5|50-Week Extension Study|Lost to Follow-up|3
4972876|NCT00103857|17086411|P4|50-Week Extension Study|Lost to Follow-up|4
4972877|NCT00103857|17086412|P3|50-Week Extension Study|Lost to Follow-up|1
4972878|NCT00103857|17086413|P2|50-Week Extension Study|Lost to Follow-up|0
4972879|NCT00103857|17086414|P1|50-Week Extension Study|Lost to Follow-up|4
4972880|NCT00103857|17086408|P7|50-Week Extension Study|Lack of Efficacy|0
4972881|NCT00103857|17086409|P6|50-Week Extension Study|Lack of Efficacy|8
4972882|NCT00103857|17086410|P5|50-Week Extension Study|Lack of Efficacy|8
4972883|NCT00103857|17086411|P4|50-Week Extension Study|Lack of Efficacy|16
4972884|NCT00103857|17086412|P3|50-Week Extension Study|Lack of Efficacy|13
4972885|NCT00103857|17086413|P2|50-Week Extension Study|Lack of Efficacy|15
4972886|NCT00103857|17086414|P1|50-Week Extension Study|Lack of Efficacy|26
4972887|NCT00103857|17086408|P7|50-Week Extension Study|Death|0
4972888|NCT00103857|17086409|P6|50-Week Extension Study|Death|1
4972889|NCT00103857|17086410|P5|50-Week Extension Study|Death|0
4972890|NCT00103857|17086411|P4|50-Week Extension Study|Death|1
4972891|NCT00103857|17086412|P3|50-Week Extension Study|Death|0
4972892|NCT00103857|17086413|P2|50-Week Extension Study|Death|0
4972893|NCT00103857|17086414|P1|50-Week Extension Study|Death|0
4972894|NCT00103857|17086408|P7|50-Week Extension Study|Adverse Event|0
4972895|NCT00103857|17086409|P6|50-Week Extension Study|Adverse Event|1
4972896|NCT00103857|17086410|P5|50-Week Extension Study|Adverse Event|1
4972897|NCT00103857|17086411|P4|50-Week Extension Study|Adverse Event|0
4972898|NCT00103857|17086412|P3|50-Week Extension Study|Adverse Event|2
4972899|NCT00103857|17086413|P2|50-Week Extension Study|Adverse Event|3
4972900|NCT00103857|17086414|P1|50-Week Extension Study|Adverse Event|2
4972901|NCT00103857|17086408|P7|54-Week Base Study|patient intolerance to rescue therapy|0
4972902|NCT00103857|17086409|P6|54-Week Base Study|patient intolerance to rescue therapy|0
4972903|NCT00103857|17086410|P5|54-Week Base Study|patient intolerance to rescue therapy|0
4972904|NCT00103857|17086411|P4|54-Week Base Study|patient intolerance to rescue therapy|0
4972905|NCT00103857|17086412|P3|54-Week Base Study|patient intolerance to rescue therapy|0
4972906|NCT00103857|17086413|P2|54-Week Base Study|patient intolerance to rescue therapy|0
4972907|NCT00103857|17086414|P1|54-Week Base Study|patient intolerance to rescue therapy|1
4972908|NCT00103857|17086408|P7|54-Week Base Study|site error|0
4972909|NCT00103857|17086409|P6|54-Week Base Study|site error|1
4972910|NCT00103857|17086410|P5|54-Week Base Study|site error|0
4972911|NCT00103857|17086411|P4|54-Week Base Study|site error|0
4972912|NCT00103857|17086412|P3|54-Week Base Study|site error|0
4972913|NCT00103857|17086413|P2|54-Week Base Study|site error|0
4972914|NCT00103857|17086414|P1|54-Week Base Study|site error|0
4972915|NCT00103857|17086408|P7|54-Week Base Study|laboratory reporting error|0
4972916|NCT00103857|17086409|P6|54-Week Base Study|laboratory reporting error|0
4972917|NCT00103857|17086410|P5|54-Week Base Study|laboratory reporting error|1
4972918|NCT00103857|17086411|P4|54-Week Base Study|laboratory reporting error|0
4972919|NCT00103857|17086412|P3|54-Week Base Study|laboratory reporting error|0
4972920|NCT00103857|17086413|P2|54-Week Base Study|laboratory reporting error|0
4972921|NCT00103857|17086414|P1|54-Week Base Study|laboratory reporting error|0
4972922|NCT00103857|17086408|P7|54-Week Base Study|patient incarcerated|0
4972923|NCT00103857|17086409|P6|54-Week Base Study|patient incarcerated|1
4972924|NCT00103857|17086410|P5|54-Week Base Study|patient incarcerated|1
4972925|NCT00103857|17086411|P4|54-Week Base Study|patient incarcerated|0
4972926|NCT00103857|17086412|P3|54-Week Base Study|patient incarcerated|0
4972927|NCT00103857|17086413|P2|54-Week Base Study|patient incarcerated|0
4972928|NCT00103857|17086414|P1|54-Week Base Study|patient incarcerated|0
4972929|NCT00103857|17086408|P7|54-Week Base Study|non-compliance with study procedures|0
4972930|NCT00103857|17086409|P6|54-Week Base Study|non-compliance with study procedures|2
4972931|NCT00103857|17086410|P5|54-Week Base Study|non-compliance with study procedures|0
4972932|NCT00103857|17086411|P4|54-Week Base Study|non-compliance with study procedures|0
4972933|NCT00103857|17086412|P3|54-Week Base Study|non-compliance with study procedures|0
4972934|NCT00103857|17086413|P2|54-Week Base Study|non-compliance with study procedures|2
4972935|NCT00103857|17086414|P1|54-Week Base Study|non-compliance with study procedures|1
4972936|NCT00103857|17086408|P7|54-Week Base Study|patient moved|0
4972937|NCT00103857|17086409|P6|54-Week Base Study|patient moved|1
4972938|NCT00103857|17086410|P5|54-Week Base Study|patient moved|3
4972939|NCT00103857|17086411|P4|54-Week Base Study|patient moved|2
4972940|NCT00103857|17086412|P3|54-Week Base Study|patient moved|1
4972941|NCT00103857|17086413|P2|54-Week Base Study|patient moved|1
4972942|NCT00103857|17086414|P1|54-Week Base Study|patient moved|0
4972943|NCT00103857|17086408|P7|54-Week Base Study|protocol discontinuation criteria|5
4972944|NCT00103857|17086409|P6|54-Week Base Study|protocol discontinuation criteria|3
4972945|NCT00103857|17086410|P5|54-Week Base Study|protocol discontinuation criteria|5
4972946|NCT00103857|17086411|P4|54-Week Base Study|protocol discontinuation criteria|6
4972947|NCT00103857|17086412|P3|54-Week Base Study|protocol discontinuation criteria|2
4972948|NCT00103857|17086413|P2|54-Week Base Study|protocol discontinuation criteria|5
4972949|NCT00103857|17086414|P1|54-Week Base Study|protocol discontinuation criteria|2
4972950|NCT00103857|17086408|P7|54-Week Base Study|Withdrawal by Subject|4
4972951|NCT00103857|17086409|P6|54-Week Base Study|Withdrawal by Subject|15
4972952|NCT00103857|17086410|P5|54-Week Base Study|Withdrawal by Subject|10
4972953|NCT00103857|17086411|P4|54-Week Base Study|Withdrawal by Subject|15
4972954|NCT00103857|17086412|P3|54-Week Base Study|Withdrawal by Subject|16
4972955|NCT00103857|17086413|P2|54-Week Base Study|Withdrawal by Subject|16
4972956|NCT00103857|17086414|P1|54-Week Base Study|Withdrawal by Subject|17
4972957|NCT00103857|17086408|P7|54-Week Base Study|Protocol Violation|3
4972958|NCT00103857|17086409|P6|54-Week Base Study|Protocol Violation|3
4972959|NCT00103857|17086410|P5|54-Week Base Study|Protocol Violation|0
4972960|NCT00103857|17086411|P4|54-Week Base Study|Protocol Violation|4
4972961|NCT00103857|17086412|P3|54-Week Base Study|Protocol Violation|2
4972962|NCT00103857|17086413|P2|54-Week Base Study|Protocol Violation|4
4972963|NCT00103857|17086414|P1|54-Week Base Study|Protocol Violation|6
4972964|NCT00103857|17086408|P7|54-Week Base Study|Pregnancy|1
4972965|NCT00103857|17086409|P6|54-Week Base Study|Pregnancy|0
4972966|NCT00103857|17086410|P5|54-Week Base Study|Pregnancy|1
4972967|NCT00103857|17086411|P4|54-Week Base Study|Pregnancy|0
4972968|NCT00103857|17086412|P3|54-Week Base Study|Pregnancy|0
4972969|NCT00103857|17086413|P2|54-Week Base Study|Pregnancy|0
4972970|NCT00103857|17086414|P1|54-Week Base Study|Pregnancy|1
4972971|NCT00103857|17086408|P7|54-Week Base Study|Physician Decision|0
4972972|NCT00103857|17086409|P6|54-Week Base Study|Physician Decision|0
4972973|NCT00103857|17086410|P5|54-Week Base Study|Physician Decision|1
4972974|NCT00103857|17086411|P4|54-Week Base Study|Physician Decision|0
4972975|NCT00103857|17086412|P3|54-Week Base Study|Physician Decision|0
4972976|NCT00103857|17086413|P2|54-Week Base Study|Physician Decision|1
4972977|NCT00103857|17086414|P1|54-Week Base Study|Physician Decision|1
4972978|NCT00103857|17086408|P7|54-Week Base Study|Lost to Follow-up|3
4972979|NCT00103857|17086409|P6|54-Week Base Study|Lost to Follow-up|9
4972980|NCT00103857|17086410|P5|54-Week Base Study|Lost to Follow-up|10
4972981|NCT00103857|17086411|P4|54-Week Base Study|Lost to Follow-up|5
4972982|NCT00103857|17086412|P3|54-Week Base Study|Lost to Follow-up|7
4972983|NCT00103857|17086413|P2|54-Week Base Study|Lost to Follow-up|4
4972984|NCT00103857|17086414|P1|54-Week Base Study|Lost to Follow-up|5
4972985|NCT00103857|17086408|P7|54-Week Base Study|Lack of Efficacy|19
4972986|NCT00103857|17086409|P6|54-Week Base Study|Lack of Efficacy|14
4972987|NCT00103857|17086410|P5|54-Week Base Study|Lack of Efficacy|3
4972988|NCT00103857|17086411|P4|54-Week Base Study|Lack of Efficacy|4
4972989|NCT00103857|17086412|P3|54-Week Base Study|Lack of Efficacy|8
4972990|NCT00103857|17086413|P2|54-Week Base Study|Lack of Efficacy|14
4972991|NCT00103857|17086414|P1|54-Week Base Study|Lack of Efficacy|11
4972992|NCT00103857|17086408|P7|54-Week Base Study|Death|0
4972993|NCT00103857|17086409|P6|54-Week Base Study|Death|1
4972994|NCT00103857|17086410|P5|54-Week Base Study|Death|1
4972995|NCT00103857|17086411|P4|54-Week Base Study|Death|0
4972996|NCT00103857|17086412|P3|54-Week Base Study|Death|0
4972997|NCT00103857|17086413|P2|54-Week Base Study|Death|0
4972998|NCT00103857|17086414|P1|54-Week Base Study|Death|0
4972999|NCT00103857|17086408|P7|54-Week Base Study|Adverse Event|3
4973000|NCT00103857|17086409|P6|54-Week Base Study|Adverse Event|11
4973001|NCT00103857|17086410|P5|54-Week Base Study|Adverse Event|5
4973002|NCT00103857|17086411|P4|54-Week Base Study|Adverse Event|6
4973003|NCT00103857|17086412|P3|54-Week Base Study|Adverse Event|11
4973004|NCT00103857|17086413|P2|54-Week Base Study|Adverse Event|9
4973005|NCT00103857|17086414|P1|54-Week Base Study|Adverse Event|12
4973006|NCT00103740|17086513|P2|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9
4973007|NCT00103740|17086514|P1|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30
4973008|NCT00103740|17086513|P2|Period 2 - Extended Observation Period|Death|2
4973009|NCT00103740|17086514|P1|Period 2 - Extended Observation Period|Death|6
4973010|NCT00103740|17086513|P2|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6
4973011|NCT00103740|17086514|P1|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5
4973012|NCT00103740|17086513|P2|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13
4973013|NCT00103740|17086514|P1|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21
4973014|NCT00103740|17086513|P2|Period 2 - Extended Observation Period|Lost to Follow-up|6
4973015|NCT00103740|17086514|P1|Period 2 - Extended Observation Period|Lost to Follow-up|7
4973016|NCT00103740|17086513|P2|Period 1 - Core|Patient withdrew consent|2
4973017|NCT00103740|17086514|P1|Period 1 - Core|Patient withdrew consent|3
4973018|NCT00103740|17086513|P2|Period 1 - Core|Protocol Violation|2
4973019|NCT00103740|17086514|P1|Period 1 - Core|Protocol Violation|3
4973020|NCT00103740|17086513|P2|Period 1 - Core|Adverse Event|0
4973021|NCT00103740|17086514|P1|Period 1 - Core|Adverse Event|1
4973022|NCT00103662|17086542|P2|Overall Study|Intercurrent illness|0
4973023|NCT00103662|17086543|P1|Overall Study|Intercurrent illness|1
4973024|NCT00103662|17086542|P2|Overall Study|Failed mobilization|4
4973025|NCT00103662|17086543|P1|Overall Study|Failed mobilization|0
4973026|NCT00103662|17086542|P2|Overall Study|Other|9
4973027|NCT00103662|17086543|P1|Overall Study|Other|6
4973028|NCT00103662|17086542|P2|Overall Study|Lost to Follow-up|1
4973029|NCT00103662|17086543|P1|Overall Study|Lost to Follow-up|0
4973030|NCT00103662|17086542|P2|Overall Study|Elective Withdrawal|5
4973031|NCT00103662|17086543|P1|Overall Study|Elective Withdrawal|5
4973032|NCT00103662|17086542|P2|Overall Study|Death|7
4973033|NCT00103662|17086543|P1|Overall Study|Death|7
4973034|NCT00103662|17086542|P2|Overall Study|Entered Rescue Procedure|7
4973035|NCT00103662|17086543|P1|Overall Study|Entered Rescue Procedure|0
4973036|NCT00103610|17086569|P2|Overall Study|Noncompliance|1
4973037|NCT00103610|17086570|P1|Overall Study|Noncompliance|0
4973038|NCT00103610|17086569|P2|Overall Study|Failed mobilization|5
4973039|NCT00103610|17086570|P1|Overall Study|Failed mobilization|1
4973040|NCT00103610|17086569|P2|Overall Study|Other|7
4973041|NCT00103610|17086570|P1|Overall Study|Other|2
4973042|NCT00103610|17086569|P2|Overall Study|Adverse Event|2
4973043|NCT00103610|17086570|P1|Overall Study|Adverse Event|2
4973044|NCT00103610|17086569|P2|Overall Study|Lost to Follow-up|1
4973045|NCT00103610|17086570|P1|Overall Study|Lost to Follow-up|3
4973046|NCT00103610|17086569|P2|Overall Study|Elective Withdrawal|0
4973047|NCT00103610|17086570|P1|Overall Study|Elective Withdrawal|4
4973048|NCT00103610|17086569|P2|Overall Study|Death|12
4973049|NCT00103610|17086570|P1|Overall Study|Death|16
4973050|NCT00103610|17086569|P2|Overall Study|Entered Rescue Procedure|52
4973051|NCT00103610|17086570|P1|Overall Study|Entered Rescue Procedure|10
4973052|NCT00103506|17086594|P2|Overall Study|Withdrawal by Subject|21
4973053|NCT00103506|17086595|P1|Overall Study|Withdrawal by Subject|18
4973054|NCT00103506|17086594|P2|Overall Study|Lost to Follow-up|13
4973055|NCT00103506|17086595|P1|Overall Study|Lost to Follow-up|13
4973056|NCT00103506|17086594|P2|Overall Study|Death|253
4973057|NCT00103506|17086595|P1|Overall Study|Death|257
4973058|NCT00103506|17086594|P2|Overall Study|Study closed by sponsor|37
4973059|NCT00103506|17086595|P1|Overall Study|Study closed by sponsor|34
4973060|NCT00103402|17086607|P2|Overall Study|Personal constraints/Other|0
4973061|NCT00103402|17086608|P1|Overall Study|Personal constraints/Other|5
4973062|NCT00103402|17086607|P2|Overall Study|Dissatisfied/No longer interested|6
4973063|NCT00103402|17086608|P1|Overall Study|Dissatisfied/No longer interested|6
4973064|NCT00103402|17086607|P2|Overall Study|Lost to Follow-up|7
4973065|NCT00103402|17086608|P1|Overall Study|Lost to Follow-up|8
4973066|NCT00103402|17086607|P2|Overall Study|Adverse Event|4
4973067|NCT00103402|17086608|P1|Overall Study|Adverse Event|3
4973068|NCT00103311|17086649|P2|Overall Study|Adverse Event|0
4973069|NCT00103311|17086650|P1|Overall Study|Adverse Event|1
4973070|NCT00103311|17086649|P2|Overall Study|Withdrawal by Subject|1
4973071|NCT00103311|17086650|P1|Overall Study|Withdrawal by Subject|2
4973072|NCT00103311|17086649|P2|Overall Study|Lost to Follow-up|0
4973073|NCT00103311|17086650|P1|Overall Study|Lost to Follow-up|1
4973074|NCT00103285|17086660|P8|Response Assignment|Other|53
4973075|NCT00103285|17086661|P7|Response Assignment|Other|11
4973076|NCT00103285|17086662|P6|Response Assignment|Other|17
4973077|NCT00103285|17086663|P5|Response Assignment|Other|37
4973078|NCT00103285|17086664|P4|Response Assignment|Other|38
4973079|NCT00103285|17086665|P3|Response Assignment|Other|48
4973080|NCT00103285|17086666|P2|Response Assignment|Other|30
4973081|NCT00103285|17086667|P1|Response Assignment|Other|0
4973082|NCT00103285|17086660|P8|Response Assignment|Refusal|10
4973083|NCT00103285|17086661|P7|Response Assignment|Refusal|30
4973084|NCT00103285|17086662|P6|Response Assignment|Refusal|15
4973085|NCT00103285|17086663|P5|Response Assignment|Refusal|25
4973086|NCT00103285|17086664|P4|Response Assignment|Refusal|3
4973087|NCT00103285|17086665|P3|Response Assignment|Refusal|5
4973088|NCT00103285|17086666|P2|Response Assignment|Refusal|53
4973089|NCT00103285|17086667|P1|Response Assignment|Refusal|0
4973090|NCT00103285|17086660|P8|Response Assignment|Ineligible|5
4973091|NCT00103285|17086661|P7|Response Assignment|Ineligible|1
4973092|NCT00103285|17086662|P6|Response Assignment|Ineligible|3
4973093|NCT00103285|17086663|P5|Response Assignment|Ineligible|0
4973094|NCT00103285|17086664|P4|Response Assignment|Ineligible|2
4973095|NCT00103285|17086665|P3|Response Assignment|Ineligible|6
4973096|NCT00103285|17086666|P2|Response Assignment|Ineligible|8
4973097|NCT00103285|17086667|P1|Response Assignment|Ineligible|0
4973098|NCT00103285|17086660|P8|Response Assignment|Withdrawal by Subject|2
4973099|NCT00103285|17086661|P7|Response Assignment|Withdrawal by Subject|0
4973100|NCT00103285|17086662|P6|Response Assignment|Withdrawal by Subject|2
4973101|NCT00103285|17086663|P5|Response Assignment|Withdrawal by Subject|2
4973102|NCT00103285|17086664|P4|Response Assignment|Withdrawal by Subject|1
4973103|NCT00103285|17086665|P3|Response Assignment|Withdrawal by Subject|1
4973104|NCT00103285|17086666|P2|Response Assignment|Withdrawal by Subject|4
4973105|NCT00103285|17086667|P1|Response Assignment|Withdrawal by Subject|0
4973106|NCT00103285|17086660|P8|Response Assignment|Protocol Violation|0
4973107|NCT00103285|17086661|P7|Response Assignment|Protocol Violation|0
4973108|NCT00103285|17086662|P6|Response Assignment|Protocol Violation|0
4973109|NCT00103285|17086663|P5|Response Assignment|Protocol Violation|0
4973110|NCT00103285|17086664|P4|Response Assignment|Protocol Violation|0
4973111|NCT00103285|17086665|P3|Response Assignment|Protocol Violation|0
4973112|NCT00103285|17086666|P2|Response Assignment|Protocol Violation|2
4973113|NCT00103285|17086667|P1|Response Assignment|Protocol Violation|0
4973114|NCT00103285|17086660|P8|Response Assignment|Physician Decision|35
4973115|NCT00103285|17086661|P7|Response Assignment|Physician Decision|4
4973116|NCT00103285|17086662|P6|Response Assignment|Physician Decision|7
4973117|NCT00103285|17086663|P5|Response Assignment|Physician Decision|13
4973118|NCT00103285|17086664|P4|Response Assignment|Physician Decision|9
4973119|NCT00103285|17086665|P3|Response Assignment|Physician Decision|14
4973120|NCT00103285|17086666|P2|Response Assignment|Physician Decision|13
4973121|NCT00103285|17086667|P1|Response Assignment|Physician Decision|0
4973122|NCT00103285|17086660|P8|Response Assignment|Lost to Follow-up|5
4973123|NCT00103285|17086661|P7|Response Assignment|Lost to Follow-up|2
4973124|NCT00103285|17086662|P6|Response Assignment|Lost to Follow-up|2
4973125|NCT00103285|17086663|P5|Response Assignment|Lost to Follow-up|1
4973126|NCT00103285|17086664|P4|Response Assignment|Lost to Follow-up|5
4973127|NCT00103285|17086665|P3|Response Assignment|Lost to Follow-up|5
4973128|NCT00103285|17086666|P2|Response Assignment|Lost to Follow-up|9
4973129|NCT00103285|17086667|P1|Response Assignment|Lost to Follow-up|0
4973130|NCT00103285|17086660|P8|Response Assignment|Death|8
4973131|NCT00103285|17086661|P7|Response Assignment|Death|0
4973132|NCT00103285|17086662|P6|Response Assignment|Death|1
4973133|NCT00103285|17086663|P5|Response Assignment|Death|3
4973134|NCT00103285|17086664|P4|Response Assignment|Death|2
4973135|NCT00103285|17086665|P3|Response Assignment|Death|2
4973136|NCT00103285|17086666|P2|Response Assignment|Death|5
4973137|NCT00103285|17086667|P1|Response Assignment|Death|0
4973138|NCT00103285|17086660|P8|Response Assignment|Adverse Event|2
4973139|NCT00103285|17086661|P7|Response Assignment|Adverse Event|1
4973140|NCT00103285|17086662|P6|Response Assignment|Adverse Event|1
4973141|NCT00103285|17086663|P5|Response Assignment|Adverse Event|3
4973142|NCT00103285|17086664|P4|Response Assignment|Adverse Event|2
4973143|NCT00103285|17086665|P3|Response Assignment|Adverse Event|3
4973144|NCT00103285|17086666|P2|Response Assignment|Adverse Event|8
4973145|NCT00103285|17086667|P1|Response Assignment|Adverse Event|0
4973146|NCT00103285|17086660|P8|Induction|Other|0
4973147|NCT00103285|17086661|P7|Induction|Other|0
4973148|NCT00103285|17086662|P6|Induction|Other|0
4973149|NCT00103285|17086663|P5|Induction|Other|0
4973150|NCT00103285|17086664|P4|Induction|Other|0
4973151|NCT00103285|17086665|P3|Induction|Other|0
4973152|NCT00103285|17086666|P2|Induction|Other|0
4973153|NCT00103285|17086667|P1|Induction|Other|258
4973154|NCT00103285|17086660|P8|Induction|Refusal|0
4973155|NCT00103285|17086661|P7|Induction|Refusal|0
4973156|NCT00103285|17086662|P6|Induction|Refusal|0
4973157|NCT00103285|17086663|P5|Induction|Refusal|0
4973158|NCT00103285|17086664|P4|Induction|Refusal|0
4973159|NCT00103285|17086665|P3|Induction|Refusal|0
4973160|NCT00103285|17086666|P2|Induction|Refusal|0
4973161|NCT00103285|17086667|P1|Induction|Refusal|906
4973162|NCT00103285|17086660|P8|Induction|Ineligible|0
4973163|NCT00103285|17086661|P7|Induction|Ineligible|0
4973164|NCT00103285|17086662|P6|Induction|Ineligible|0
4973165|NCT00103285|17086663|P5|Induction|Ineligible|0
4973166|NCT00103285|17086664|P4|Induction|Ineligible|0
4973167|NCT00103285|17086665|P3|Induction|Ineligible|0
4973168|NCT00103285|17086666|P2|Induction|Ineligible|0
4973169|NCT00103285|17086667|P1|Induction|Ineligible|43
4973170|NCT00103285|17086660|P8|Induction|Withdrawal by Subject|0
4973171|NCT00103285|17086661|P7|Induction|Withdrawal by Subject|0
4973172|NCT00103285|17086662|P6|Induction|Withdrawal by Subject|0
4973173|NCT00103285|17086663|P5|Induction|Withdrawal by Subject|0
4973174|NCT00103285|17086664|P4|Induction|Withdrawal by Subject|0
4973175|NCT00103285|17086665|P3|Induction|Withdrawal by Subject|0
4973176|NCT00103285|17086666|P2|Induction|Withdrawal by Subject|0
4973177|NCT00103285|17086667|P1|Induction|Withdrawal by Subject|1
4973178|NCT00103285|17086660|P8|Induction|Physician Decision|0
4973179|NCT00103285|17086661|P7|Induction|Physician Decision|0
4973180|NCT00103285|17086662|P6|Induction|Physician Decision|0
4973181|NCT00103285|17086663|P5|Induction|Physician Decision|0
4973182|NCT00103285|17086664|P4|Induction|Physician Decision|0
4973183|NCT00103285|17086665|P3|Induction|Physician Decision|0
4973184|NCT00103285|17086666|P2|Induction|Physician Decision|0
4973185|NCT00103285|17086667|P1|Induction|Physician Decision|103
4973186|NCT00103285|17086660|P8|Induction|Death|0
4973187|NCT00103285|17086661|P7|Induction|Death|0
4973188|NCT00103285|17086662|P6|Induction|Death|0
4973189|NCT00103285|17086663|P5|Induction|Death|0
4973190|NCT00103285|17086664|P4|Induction|Death|0
4973191|NCT00103285|17086665|P3|Induction|Death|0
4973192|NCT00103285|17086666|P2|Induction|Death|0
4973193|NCT00103285|17086667|P1|Induction|Death|24
4973194|NCT00103285|17086660|P8|Induction|Adverse Event|0
4973195|NCT00103285|17086661|P7|Induction|Adverse Event|0
4973196|NCT00103285|17086662|P6|Induction|Adverse Event|0
4973197|NCT00103285|17086663|P5|Induction|Adverse Event|0
4973198|NCT00103285|17086664|P4|Induction|Adverse Event|0
4973199|NCT00103285|17086665|P3|Induction|Adverse Event|0
4973200|NCT00103285|17086666|P2|Induction|Adverse Event|0
4973201|NCT00103285|17086667|P1|Induction|Adverse Event|14
4973202|NCT00103259|17086696|P2|Overall Study|ineligible/no protocol therapy|6
4973203|NCT00103259|17086697|P1|Overall Study|ineligible/no protocol therapy|4
4973204|NCT00103259|17086696|P2|Overall Study|other (reasons were not specified)|1
4973205|NCT00103259|17086697|P1|Overall Study|other (reasons were not specified)|2
4973206|NCT00103259|17086696|P2|Overall Study|alternative therapy|0
4973207|NCT00103259|17086697|P1|Overall Study|alternative therapy|1
4973208|NCT00103259|17086696|P2|Overall Study|Withdrawal by Subject|3
4973209|NCT00103259|17086697|P1|Overall Study|Withdrawal by Subject|2
4973210|NCT00103259|17086696|P2|Overall Study|Death|2
4973211|NCT00103259|17086697|P1|Overall Study|Death|3
4973212|NCT00103207|17086709|P1|Overall Study|Diagnosis of BAC not confirmed|27
4973213|NCT00103207|17086709|P1|Overall Study|Ineligible|4
4973214|NCT00103207|17086709|P1|Overall Study|Other complicating disease|1
4973215|NCT00103207|17086709|P1|Overall Study|Withdrawal by Subject|2
4973216|NCT00103207|17086709|P1|Overall Study|Death|1
4973217|NCT00103207|17086709|P1|Overall Study|Adverse Event|3
4973218|NCT00103142|17086728|P2|Overall Study|Progression of disease|1
4973219|NCT00103142|17086729|P1|Overall Study|Progression of disease|2
4973220|NCT00103142|17086728|P2|Overall Study|Adverse Event|0
4973221|NCT00103142|17086729|P1|Overall Study|Adverse Event|1
4973222|NCT00103012|17086745|P3|Overall Study|Subject non-compliant with medications|1
4973223|NCT00103012|17086746|P2|Overall Study|Subject non-compliant with medications|0
4973224|NCT00103012|17086747|P1|Overall Study|Subject non-compliant with medications|0
4973225|NCT00103012|17086745|P3|Overall Study|Adverse Event|1
4973226|NCT00103012|17086746|P2|Overall Study|Adverse Event|0
4973227|NCT00103012|17086747|P1|Overall Study|Adverse Event|0
4973228|NCT00103012|17086745|P3|Overall Study|Pregnancy|0
4973229|NCT00103012|17086746|P2|Overall Study|Pregnancy|0
4973230|NCT00103012|17086747|P1|Overall Study|Pregnancy|1
4973231|NCT00103012|17086745|P3|Overall Study|Withdrawal by Subject|2
4973232|NCT00103012|17086746|P2|Overall Study|Withdrawal by Subject|1
4973233|NCT00103012|17086747|P1|Overall Study|Withdrawal by Subject|2
4973234|NCT00102960|17086758|P3|Overall Study|Withdrawal by Subject|1
4973235|NCT00102960|17086759|P2|Overall Study|Withdrawal by Subject|0
4973236|NCT00102960|17086760|P1|Overall Study|Withdrawal by Subject|1
4973237|NCT00102960|17086758|P3|Overall Study|Lost to Follow-up|16
4973238|NCT00102960|17086759|P2|Overall Study|Lost to Follow-up|12
4973239|NCT00102960|17086760|P1|Overall Study|Lost to Follow-up|6
4973240|NCT00102960|17086758|P3|Overall Study|Death|11
4973241|NCT00102960|17086759|P2|Overall Study|Death|11
4973242|NCT00102960|17086760|P1|Overall Study|Death|23
4973243|NCT00102804|17086809|P2|Overall Study|Alive, Receiving Treatment|2
4973244|NCT00102804|17086810|P1|Overall Study|Alive, Receiving Treatment|7
4973245|NCT00102804|17086809|P2|Overall Study|Sponsor Decision|0
4973246|NCT00102804|17086810|P1|Overall Study|Sponsor Decision|1
4973247|NCT00102804|17086809|P2|Overall Study|Satisfactory Response|0
4973248|NCT00102804|17086810|P1|Overall Study|Satisfactory Response|2
4973249|NCT00102804|17086809|P2|Overall Study|Protocol Violation|1
4973250|NCT00102804|17086810|P1|Overall Study|Protocol Violation|2
4973251|NCT00102804|17086809|P2|Overall Study|Lost to Follow-up|1
4973252|NCT00102804|17086810|P1|Overall Study|Lost to Follow-up|4
4973253|NCT00102804|17086809|P2|Overall Study|Enrollment Criteria Not Met|0
4973254|NCT00102804|17086810|P1|Overall Study|Enrollment Criteria Not Met|6
4973255|NCT00102804|17086809|P2|Overall Study|Death|6
4973256|NCT00102804|17086810|P1|Overall Study|Death|5
4973257|NCT00102804|17086809|P2|Overall Study|Physician Decision|6
4973258|NCT00102804|17086810|P1|Overall Study|Physician Decision|24
4973259|NCT00102804|17086809|P2|Overall Study|Adverse Event|3
4973260|NCT00102804|17086810|P1|Overall Study|Adverse Event|37
4973261|NCT00102804|17086809|P2|Overall Study|Withdrawal by Subject|7
4973262|NCT00102804|17086810|P1|Overall Study|Withdrawal by Subject|46
4973263|NCT00102804|17086809|P2|Overall Study|Progressive Disease (PD)|196
4973264|NCT00102804|17086810|P1|Overall Study|Progressive Disease (PD)|307
4973265|NCT00102687|17086831|P5|Maintenance Period|Physician Decision|4
4973266|NCT00102687|17086832|P4|Maintenance Period|Physician Decision|0
4973267|NCT00102687|17086833|P3|Maintenance Period|Physician Decision|3
4973268|NCT00102687|17086834|P2|Maintenance Period|Physician Decision|2
4973269|NCT00102687|17086835|P1|Maintenance Period|Physician Decision|1
4973270|NCT00102687|17086831|P5|Maintenance Period|Death|1
4973271|NCT00102687|17086832|P4|Maintenance Period|Death|1
4973272|NCT00102687|17086833|P3|Maintenance Period|Death|0
4973273|NCT00102687|17086834|P2|Maintenance Period|Death|0
4973274|NCT00102687|17086835|P1|Maintenance Period|Death|0
4973275|NCT00102687|17086831|P5|Maintenance Period|Failed Treatment (relapse,disease prog)|4
4973276|NCT00102687|17086832|P4|Maintenance Period|Failed Treatment (relapse,disease prog)|3
4973277|NCT00102687|17086833|P3|Maintenance Period|Failed Treatment (relapse,disease prog)|1
4973278|NCT00102687|17086834|P2|Maintenance Period|Failed Treatment (relapse,disease prog)|1
4973279|NCT00102687|17086835|P1|Maintenance Period|Failed Treatment (relapse,disease prog)|1
4973280|NCT00102687|17086831|P5|Maintenance Period|Transformation to AML (blast > 30%)|0
4973281|NCT00102687|17086832|P4|Maintenance Period|Transformation to AML (blast > 30%)|2
4973282|NCT00102687|17086833|P3|Maintenance Period|Transformation to AML (blast > 30%)|0
4973283|NCT00102687|17086834|P2|Maintenance Period|Transformation to AML (blast > 30%)|1
4973284|NCT00102687|17086835|P1|Maintenance Period|Transformation to AML (blast > 30%)|0
4973285|NCT00102687|17086831|P5|Maintenance Period|Adverse Event|3
4973286|NCT00102687|17086832|P4|Maintenance Period|Adverse Event|1
4973287|NCT00102687|17086833|P3|Maintenance Period|Adverse Event|0
4973288|NCT00102687|17086834|P2|Maintenance Period|Adverse Event|0
4973289|NCT00102687|17086835|P1|Maintenance Period|Adverse Event|1
4973290|NCT00102687|17086831|P5|Maintenance Period|Withdrawal by Subject|1
4973291|NCT00102687|17086832|P4|Maintenance Period|Withdrawal by Subject|3
4973292|NCT00102687|17086833|P3|Maintenance Period|Withdrawal by Subject|2
4973293|NCT00102687|17086834|P2|Maintenance Period|Withdrawal by Subject|0
4973294|NCT00102687|17086835|P1|Maintenance Period|Withdrawal by Subject|4
4973295|NCT00102687|17086831|P5|Initial Period|Death|0
4973296|NCT00102687|17086832|P4|Initial Period|Death|0
4973297|NCT00102687|17086833|P3|Initial Period|Death|1
4973298|NCT00102687|17086834|P2|Initial Period|Death|1
4973299|NCT00102687|17086835|P1|Initial Period|Death|1
4973300|NCT00102687|17086831|P5|Initial Period|Failed Treatments (relapse,disease prog)|0
4973301|NCT00102687|17086832|P4|Initial Period|Failed Treatments (relapse,disease prog)|0
4973302|NCT00102687|17086833|P3|Initial Period|Failed Treatments (relapse,disease prog)|2
4973303|NCT00102687|17086834|P2|Initial Period|Failed Treatments (relapse,disease prog)|4
4973304|NCT00102687|17086835|P1|Initial Period|Failed Treatments (relapse,disease prog)|4
4973305|NCT00102687|17086831|P5|Initial Period|Sponsor's decision|0
4973306|NCT00102687|17086832|P4|Initial Period|Sponsor's decision|0
4973307|NCT00102687|17086833|P3|Initial Period|Sponsor's decision|1
4973308|NCT00102687|17086834|P2|Initial Period|Sponsor's decision|1
4973309|NCT00102687|17086835|P1|Initial Period|Sponsor's decision|0
4973310|NCT00102687|17086831|P5|Initial Period|Physician Decision|0
4973311|NCT00102687|17086832|P4|Initial Period|Physician Decision|0
4973312|NCT00102687|17086833|P3|Initial Period|Physician Decision|6
4973313|NCT00102687|17086834|P2|Initial Period|Physician Decision|9
4973314|NCT00102687|17086835|P1|Initial Period|Physician Decision|2
4973315|NCT00102687|17086831|P5|Initial Period|Protocol Violation|0
4973316|NCT00102687|17086832|P4|Initial Period|Protocol Violation|0
4973317|NCT00102687|17086833|P3|Initial Period|Protocol Violation|2
4973318|NCT00102687|17086834|P2|Initial Period|Protocol Violation|0
4973319|NCT00102687|17086835|P1|Initial Period|Protocol Violation|0
4973320|NCT00102687|17086831|P5|Initial Period|Transformation to AML (blast > 30%)|0
4973321|NCT00102687|17086832|P4|Initial Period|Transformation to AML (blast > 30%)|0
4973322|NCT00102687|17086833|P3|Initial Period|Transformation to AML (blast > 30%)|0
4973323|NCT00102687|17086834|P2|Initial Period|Transformation to AML (blast > 30%)|3
4973324|NCT00102687|17086835|P1|Initial Period|Transformation to AML (blast > 30%)|1
4973325|NCT00102687|17086831|P5|Initial Period|Adverse Event|0
4973326|NCT00102687|17086832|P4|Initial Period|Adverse Event|0
4973327|NCT00102687|17086833|P3|Initial Period|Adverse Event|9
4973328|NCT00102687|17086834|P2|Initial Period|Adverse Event|7
4973329|NCT00102687|17086835|P1|Initial Period|Adverse Event|4
4973330|NCT00102687|17086831|P5|Initial Period|Withdrawal by Subject|0
4973331|NCT00102687|17086832|P4|Initial Period|Withdrawal by Subject|0
4973332|NCT00102687|17086833|P3|Initial Period|Withdrawal by Subject|5
4973333|NCT00102687|17086834|P2|Initial Period|Withdrawal by Subject|3
4973334|NCT00102687|17086835|P1|Initial Period|Withdrawal by Subject|6
4973335|NCT00102596|17086899|P2|Part A|Adverse Event|0
4973336|NCT00102596|17086900|P1|Part A|Adverse Event|1
4973337|NCT00102596|17086899|P2|Part A|Screen failures|0
4973338|NCT00102596|17086900|P1|Part A|Screen failures|6
4973339|NCT00102531|17086911|P2|Overall Study|Physician Decision|1
4973340|NCT00102531|17086912|P1|Overall Study|Physician Decision|0
4973341|NCT00102531|17086911|P2|Overall Study|Disease Progression|9
4973342|NCT00102531|17086912|P1|Overall Study|Disease Progression|5
4973343|NCT00102531|17086911|P2|Overall Study|Adverse Event|1
4973344|NCT00102531|17086912|P1|Overall Study|Adverse Event|0
4973345|NCT00102440|17086927|P3|Overall Study|Protocol Violation|1
4973346|NCT00102440|17086928|P2|Overall Study|Protocol Violation|2
4973347|NCT00102440|17086929|P1|Overall Study|Protocol Violation|7
4973348|NCT00102440|17086927|P3|Overall Study|Other|14
4973349|NCT00102440|17086928|P2|Overall Study|Other|14
4973350|NCT00102440|17086929|P1|Overall Study|Other|11
4973351|NCT00102440|17086927|P3|Overall Study|Personal Reason(s)|13
4973352|NCT00102440|17086928|P2|Overall Study|Personal Reason(s)|13
4973353|NCT00102440|17086929|P1|Overall Study|Personal Reason(s)|19
4973354|NCT00102440|17086927|P3|Overall Study|Gout Flare|9
4973355|NCT00102440|17086928|P2|Overall Study|Gout Flare|28
4973356|NCT00102440|17086929|P1|Overall Study|Gout Flare|10
4973357|NCT00102440|17086927|P3|Overall Study|Adverse Event|8
4973358|NCT00102440|17086928|P2|Overall Study|Adverse Event|23
4973359|NCT00102440|17086929|P1|Overall Study|Adverse Event|16
4973360|NCT00102440|17086927|P3|Overall Study|Lost to Follow-up|21
4973361|NCT00102440|17086928|P2|Overall Study|Lost to Follow-up|18
4973362|NCT00102440|17086929|P1|Overall Study|Lost to Follow-up|25
4973363|NCT00102063|17086979|P3|Overall Study|Protocol Violation|1
4973364|NCT00102063|17086980|P2|Overall Study|Protocol Violation|1
4973365|NCT00102063|17086981|P1|Overall Study|Protocol Violation|0
4973366|NCT00102063|17086979|P3|Overall Study|Lost to Follow-up|1
4973367|NCT00102063|17086980|P2|Overall Study|Lost to Follow-up|0
4973368|NCT00102063|17086981|P1|Overall Study|Lost to Follow-up|0
4973369|NCT00102063|17086979|P3|Overall Study|Withdrawal by Subject|5
4973370|NCT00102063|17086980|P2|Overall Study|Withdrawal by Subject|12
4973371|NCT00102063|17086981|P1|Overall Study|Withdrawal by Subject|4
4973372|NCT00102063|17086979|P3|Overall Study|Adverse Event|2
4973373|NCT00102063|17086980|P2|Overall Study|Adverse Event|4
4973374|NCT00102063|17086981|P1|Overall Study|Adverse Event|7
4973375|NCT00102063|17086979|P3|Overall Study|Lack of Efficacy|1
4973376|NCT00102063|17086980|P2|Overall Study|Lack of Efficacy|1
4973377|NCT00102063|17086981|P1|Overall Study|Lack of Efficacy|5
4973378|NCT00101907|17087039|P6|Overall Study|Withdrawal by Subject|0
4973379|NCT00101907|17087040|P5|Overall Study|Withdrawal by Subject|1
4973380|NCT00101907|17087041|P4|Overall Study|Withdrawal by Subject|0
4973381|NCT00101907|17087042|P3|Overall Study|Withdrawal by Subject|1
4973382|NCT00101907|17087043|P2|Overall Study|Withdrawal by Subject|0
4973383|NCT00101907|17087044|P1|Overall Study|Withdrawal by Subject|1
4973384|NCT00101907|17087039|P6|Overall Study|Physician Decision|0
4973385|NCT00101907|17087040|P5|Overall Study|Physician Decision|1
4973386|NCT00101907|17087041|P4|Overall Study|Physician Decision|1
4973387|NCT00101907|17087042|P3|Overall Study|Physician Decision|0
4973388|NCT00101907|17087043|P2|Overall Study|Physician Decision|0
4973389|NCT00101907|17087044|P1|Overall Study|Physician Decision|0
4973390|NCT00101907|17087039|P6|Overall Study|Death|0
4973391|NCT00101907|17087040|P5|Overall Study|Death|3
4973392|NCT00101907|17087041|P4|Overall Study|Death|0
4973393|NCT00101907|17087042|P3|Overall Study|Death|0
4973394|NCT00101907|17087043|P2|Overall Study|Death|1
4973395|NCT00101907|17087044|P1|Overall Study|Death|0
4973396|NCT00101907|17087039|P6|Overall Study|Adverse Event|0
4973397|NCT00101907|17087040|P5|Overall Study|Adverse Event|0
4973398|NCT00101907|17087041|P4|Overall Study|Adverse Event|0
4973399|NCT00101907|17087042|P3|Overall Study|Adverse Event|0
4973400|NCT00101907|17087043|P2|Overall Study|Adverse Event|0
4973401|NCT00101907|17087044|P1|Overall Study|Adverse Event|1
4973402|NCT00101868|17087086|P2|Overall Study|Lost to Follow-up|13
4973403|NCT00101868|17087087|P1|Overall Study|Lost to Follow-up|8
4973404|NCT00101868|17087086|P2|Overall Study|Protocol Violation|0
4973405|NCT00101868|17087087|P1|Overall Study|Protocol Violation|3
4973406|NCT00101868|17087086|P2|Overall Study|Withdrawal by Subject|9
4973407|NCT00101868|17087087|P1|Overall Study|Withdrawal by Subject|8
4973408|NCT00101868|17087086|P2|Overall Study|Death|10
4973409|NCT00101868|17087087|P1|Overall Study|Death|10
4973410|NCT00101686|17087157|P10|Overall Study|Withdrawal by Subject|9
4973411|NCT00101686|17087158|P9|Overall Study|Withdrawal by Subject|8
4973412|NCT00101686|17087159|P8|Overall Study|Withdrawal by Subject|7
4973413|NCT00101686|17087160|P7|Overall Study|Withdrawal by Subject|7
4973414|NCT00101686|17087161|P6|Overall Study|Withdrawal by Subject|7
4973415|NCT00101686|17087162|P5|Overall Study|Withdrawal by Subject|8
4973416|NCT00101686|17087163|P4|Overall Study|Withdrawal by Subject|8
4973417|NCT00101686|17087164|P3|Overall Study|Withdrawal by Subject|6
4973418|NCT00101686|17087165|P2|Overall Study|Withdrawal by Subject|8
4973419|NCT00101686|17087166|P1|Overall Study|Withdrawal by Subject|9
4973420|NCT00101686|17087157|P10|Overall Study|Other|3
4973421|NCT00101686|17087158|P9|Overall Study|Other|3
4973422|NCT00101686|17087159|P8|Overall Study|Other|5
4973423|NCT00101686|17087160|P7|Overall Study|Other|1
4973424|NCT00101686|17087161|P6|Overall Study|Other|12
4973425|NCT00101686|17087162|P5|Overall Study|Other|2
4973426|NCT00101686|17087163|P4|Overall Study|Other|6
4973427|NCT00101686|17087164|P3|Overall Study|Other|1
4973428|NCT00101686|17087165|P2|Overall Study|Other|4
4973429|NCT00101686|17087166|P1|Overall Study|Other|1
4973430|NCT00101686|17087157|P10|Overall Study|Physician Decision|1
4973431|NCT00101686|17087158|P9|Overall Study|Physician Decision|1
4973432|NCT00101686|17087159|P8|Overall Study|Physician Decision|5
4973433|NCT00101686|17087160|P7|Overall Study|Physician Decision|5
4973434|NCT00101686|17087161|P6|Overall Study|Physician Decision|9
4973435|NCT00101686|17087162|P5|Overall Study|Physician Decision|8
4973436|NCT00101686|17087163|P4|Overall Study|Physician Decision|7
4973437|NCT00101686|17087164|P3|Overall Study|Physician Decision|6
4973438|NCT00101686|17087165|P2|Overall Study|Physician Decision|13
4973439|NCT00101686|17087166|P1|Overall Study|Physician Decision|10
4973440|NCT00101686|17087157|P10|Overall Study|intercurrent non-cancer related illness|1
4973441|NCT00101686|17087158|P9|Overall Study|intercurrent non-cancer related illness|1
4973442|NCT00101686|17087159|P8|Overall Study|intercurrent non-cancer related illness|0
4973443|NCT00101686|17087160|P7|Overall Study|intercurrent non-cancer related illness|1
4973444|NCT00101686|17087161|P6|Overall Study|intercurrent non-cancer related illness|3
4973445|NCT00101686|17087162|P5|Overall Study|intercurrent non-cancer related illness|1
4973446|NCT00101686|17087163|P4|Overall Study|intercurrent non-cancer related illness|0
4973447|NCT00101686|17087164|P3|Overall Study|intercurrent non-cancer related illness|2
4973448|NCT00101686|17087165|P2|Overall Study|intercurrent non-cancer related illness|0
4973449|NCT00101686|17087166|P1|Overall Study|intercurrent non-cancer related illness|0
4973450|NCT00101686|17087157|P10|Overall Study|Randomized but did not receive treament|1
4973451|NCT00101686|17087158|P9|Overall Study|Randomized but did not receive treament|0
4973452|NCT00101686|17087159|P8|Overall Study|Randomized but did not receive treament|1
4973453|NCT00101686|17087160|P7|Overall Study|Randomized but did not receive treament|0
4973454|NCT00101686|17087161|P6|Overall Study|Randomized but did not receive treament|2
4973455|NCT00101686|17087162|P5|Overall Study|Randomized but did not receive treament|2
4973456|NCT00101686|17087163|P4|Overall Study|Randomized but did not receive treament|2
4973457|NCT00101686|17087164|P3|Overall Study|Randomized but did not receive treament|2
4973458|NCT00101686|17087165|P2|Overall Study|Randomized but did not receive treament|6
4973459|NCT00101686|17087166|P1|Overall Study|Randomized but did not receive treament|1
4973460|NCT00101686|17087157|P10|Overall Study|unacceptable toxicity|4
4973461|NCT00101686|17087158|P9|Overall Study|unacceptable toxicity|1
4973462|NCT00101686|17087159|P8|Overall Study|unacceptable toxicity|2
4973463|NCT00101686|17087160|P7|Overall Study|unacceptable toxicity|4
4973464|NCT00101686|17087161|P6|Overall Study|unacceptable toxicity|10
4973465|NCT00101686|17087162|P5|Overall Study|unacceptable toxicity|16
4973466|NCT00101686|17087163|P4|Overall Study|unacceptable toxicity|6
4973467|NCT00101686|17087164|P3|Overall Study|unacceptable toxicity|10
4973468|NCT00101686|17087165|P2|Overall Study|unacceptable toxicity|9
4973469|NCT00101686|17087166|P1|Overall Study|unacceptable toxicity|3
4973470|NCT00101686|17087157|P10|Overall Study|>3 week delay treatment due toxicity|0
4973471|NCT00101686|17087158|P9|Overall Study|>3 week delay treatment due toxicity|3
4973472|NCT00101686|17087159|P8|Overall Study|>3 week delay treatment due toxicity|1
4973473|NCT00101686|17087160|P7|Overall Study|>3 week delay treatment due toxicity|2
4973474|NCT00101686|17087161|P6|Overall Study|>3 week delay treatment due toxicity|3
4973475|NCT00101686|17087162|P5|Overall Study|>3 week delay treatment due toxicity|7
4973476|NCT00101686|17087163|P4|Overall Study|>3 week delay treatment due toxicity|2
4973477|NCT00101686|17087164|P3|Overall Study|>3 week delay treatment due toxicity|1
4973478|NCT00101686|17087165|P2|Overall Study|>3 week delay treatment due toxicity|2
4973479|NCT00101686|17087166|P1|Overall Study|>3 week delay treatment due toxicity|6
4973480|NCT00101686|17087157|P10|Overall Study|initiation other anti-cancer treatment|3
4973481|NCT00101686|17087158|P9|Overall Study|initiation other anti-cancer treatment|3
4973482|NCT00101686|17087159|P8|Overall Study|initiation other anti-cancer treatment|2
4973483|NCT00101686|17087160|P7|Overall Study|initiation other anti-cancer treatment|2
4973484|NCT00101686|17087161|P6|Overall Study|initiation other anti-cancer treatment|1
4973485|NCT00101686|17087162|P5|Overall Study|initiation other anti-cancer treatment|1
4973486|NCT00101686|17087163|P4|Overall Study|initiation other anti-cancer treatment|3
4973487|NCT00101686|17087164|P3|Overall Study|initiation other anti-cancer treatment|4
4973488|NCT00101686|17087165|P2|Overall Study|initiation other anti-cancer treatment|3
4973489|NCT00101686|17087166|P1|Overall Study|initiation other anti-cancer treatment|4
4973490|NCT00101686|17087157|P10|Overall Study|Progressive Disease|8
4973491|NCT00101686|17087158|P9|Overall Study|Progressive Disease|10
4973492|NCT00101686|17087159|P8|Overall Study|Progressive Disease|7
4973493|NCT00101686|17087160|P7|Overall Study|Progressive Disease|5
4973494|NCT00101686|17087161|P6|Overall Study|Progressive Disease|25
4973495|NCT00101686|17087162|P5|Overall Study|Progressive Disease|28
4973496|NCT00101686|17087163|P4|Overall Study|Progressive Disease|38
4973497|NCT00101686|17087164|P3|Overall Study|Progressive Disease|37
4973498|NCT00101686|17087165|P2|Overall Study|Progressive Disease|28
4973499|NCT00101686|17087166|P1|Overall Study|Progressive Disease|37
4973500|NCT00101582|17087283|P2|Overall Study|Other|1
4973501|NCT00101582|17087284|P1|Overall Study|Other|0
4973502|NCT00101582|17087283|P2|Overall Study|Death|5
4973503|NCT00101582|17087284|P1|Overall Study|Death|3
4973504|NCT00101582|17087283|P2|Overall Study|Physician Decision|0
4973505|NCT00101582|17087284|P1|Overall Study|Physician Decision|1
4973506|NCT00101582|17087283|P2|Overall Study|Withdrawal by Subject|4
4973507|NCT00101582|17087284|P1|Overall Study|Withdrawal by Subject|6
4973508|NCT00101582|17087283|P2|Overall Study|Adverse Event|4
4973509|NCT00101582|17087284|P1|Overall Study|Adverse Event|1
4973510|NCT00101582|17087283|P2|Overall Study|Ineligibility determined|1
4973511|NCT00101582|17087284|P1|Overall Study|Ineligibility determined|0
4973512|NCT00101452|17087307|P3|Overall Study|Other|12
4973513|NCT00101452|17087308|P2|Overall Study|Other|16
4973514|NCT00101452|17087309|P1|Overall Study|Other|15
4973515|NCT00101452|17087307|P3|Overall Study|Protocol Violation|3
4973516|NCT00101452|17087308|P2|Overall Study|Protocol Violation|1
4973517|NCT00101452|17087309|P1|Overall Study|Protocol Violation|2
4973518|NCT00101452|17087307|P3|Overall Study|Physician Decision|2
4973519|NCT00101452|17087308|P2|Overall Study|Physician Decision|3
4973520|NCT00101452|17087309|P1|Overall Study|Physician Decision|0
4973521|NCT00101452|17087307|P3|Overall Study|Baseline Fail|2
4973522|NCT00101452|17087308|P2|Overall Study|Baseline Fail|1
4973523|NCT00101452|17087309|P1|Overall Study|Baseline Fail|2
4973524|NCT00101452|17087307|P3|Overall Study|Withdrawal by Subject|9
4973525|NCT00101452|17087308|P2|Overall Study|Withdrawal by Subject|14
4973526|NCT00101452|17087309|P1|Overall Study|Withdrawal by Subject|10
4973527|NCT00101452|17087307|P3|Overall Study|Lost to Follow-up|14
4973528|NCT00101452|17087308|P2|Overall Study|Lost to Follow-up|8
4973529|NCT00101452|17087309|P1|Overall Study|Lost to Follow-up|13
4973530|NCT00101452|17087307|P3|Overall Study|Adverse Event|1
4973531|NCT00101452|17087308|P2|Overall Study|Adverse Event|0
4973532|NCT00101452|17087309|P1|Overall Study|Adverse Event|2
4973533|NCT00101439|17087323|P2|Period 2|Withdrawal by Subject|2
4973534|NCT00101439|17087324|P1|Period 2|Withdrawal by Subject|0
4973535|NCT00101400|17087340|P1|Survival Follow-Up|Alive|7
4973536|NCT00101283|17087360|P2|Overall Study|Prostate Cancer Recurrence|1
4973537|NCT00101283|17087361|P1|Overall Study|Prostate Cancer Recurrence|0
4973538|NCT00101283|17087360|P2|Overall Study|Insurance Refusal|1
4973539|NCT00101283|17087361|P1|Overall Study|Insurance Refusal|0
4973540|NCT00101283|17087360|P2|Overall Study|Withdrawal by Subject|1
4973541|NCT00101283|17087361|P1|Overall Study|Withdrawal by Subject|0
4973542|NCT00101192|17087371|P1|Overall Study|Inevaluable|1
4973543|NCT00101192|17087371|P1|Overall Study|Ineligible|6
4973544|NCT00101166|17087375|P1|Overall Study|progressive disease|10
4973545|NCT00101101|17087383|P1|Overall Study|never received vaccine|20
4973546|NCT00101010|17087404|P1|Overall Study|Physician Decision|1
4973547|NCT00100932|17087411|P2|Overall Study|Other|2
4973548|NCT00100932|17087412|P1|Overall Study|Other|5
4973549|NCT00100932|17087411|P2|Overall Study|Physician Decision|5
4973550|NCT00100932|17087412|P1|Overall Study|Physician Decision|7
4973551|NCT00100932|17087411|P2|Overall Study|Progressive Disease|18
4973552|NCT00100932|17087412|P1|Overall Study|Progressive Disease|44
4973553|NCT00100932|17087411|P2|Overall Study|Withdrawal by Subject|0
4973554|NCT00100932|17087412|P1|Overall Study|Withdrawal by Subject|6
4973555|NCT00100932|17087411|P2|Overall Study|Adverse Event|2
4973556|NCT00100932|17087412|P1|Overall Study|Adverse Event|11
4973557|NCT00100828|17087427|P1|Overall Study|Physician Decision|6
4973558|NCT00100815|17087431|P1|Overall Study|Other|3
4973559|NCT00100815|17087431|P1|Overall Study|Death|4
4973560|NCT00100815|17087431|P1|Overall Study|Adverse Event|18
4973561|NCT00100815|17087431|P1|Overall Study|Progression|24
4973562|NCT00100802|17087439|P1|Overall Study|Ineligible|12
4973563|NCT00100802|17087439|P1|Overall Study|Withdrawal by Subject|5
4973564|NCT00100802|17087439|P1|Overall Study|Protocol Violation|1
4973565|NCT00100802|17087439|P1|Overall Study|Physician Decision|5
4973566|NCT00100802|17087439|P1|Overall Study|Lack of Efficacy|47
4973567|NCT00100802|17087439|P1|Overall Study|Death|1
4973568|NCT00100802|17087439|P1|Overall Study|Adverse Event|9
4973569|NCT00100789|17087444|P1|Overall Study|Never received treatment|1
4973570|NCT00100789|17087444|P1|Overall Study|Ineligible|3
4973571|NCT00100789|17087444|P1|Overall Study|Not protocol specified|5
4973572|NCT00100789|17087444|P1|Overall Study|Death|2
4973573|NCT00100789|17087444|P1|Overall Study|Progression/relapse|42
4973574|NCT00100789|17087444|P1|Overall Study|Withdrawal by Subject|1
4973575|NCT00100789|17087444|P1|Overall Study|Adverse Event|10
4973576|NCT00100178|17087521|P3|Overall Study|Physician Decision|3
4973577|NCT00100178|17087522|P2|Overall Study|Physician Decision|1
4973578|NCT00100178|17087523|P1|Overall Study|Physician Decision|6
4973579|NCT00100178|17087521|P3|Overall Study|Withdrawal by Subject|1
4973580|NCT00100178|17087522|P2|Overall Study|Withdrawal by Subject|1
4973581|NCT00100178|17087523|P1|Overall Study|Withdrawal by Subject|1
4973582|NCT00100178|17087521|P3|Overall Study|Adverse Event|1
4973583|NCT00100178|17087522|P2|Overall Study|Adverse Event|2
4973584|NCT00100178|17087523|P1|Overall Study|Adverse Event|2
4973585|NCT00100178|17087521|P3|Overall Study|Lost to Follow-up|5
4973586|NCT00100178|17087522|P2|Overall Study|Lost to Follow-up|6
4973587|NCT00100178|17087523|P1|Overall Study|Lost to Follow-up|0
4973588|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4973589|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4973590|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1
4973591|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4973592|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4973593|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0
4973594|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
4973595|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
4973596|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0
4973597|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2
4973598|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
4973599|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1
4973600|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Other Reason|0
4973601|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Other Reason|0
4973602|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Other Reason|2
4973603|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Other Reason|4
4973604|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Other Reason|1
4973605|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Other Reason|7
4973606|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4
4973607|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0
4973608|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5
4973609|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
4973610|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2
4973611|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1
4973612|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
4973613|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0
4973614|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
4973615|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3
4973616|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1
4973617|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2
4973618|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2
4973619|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
4973620|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
4973621|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0
4973622|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3
4973623|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1
4973624|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Adverse Event|1
4973625|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Adverse Event|0
4973626|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Adverse Event|0
4973627|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Adverse Event|2
4973628|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Adverse Event|1
4973629|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Adverse Event|0
4973630|NCT00100048|17087552|P6|Cohort I & II-Combination Therapy Phase|Never Treated|1
4973631|NCT00100048|17087553|P5|Cohort I & II-Combination Therapy Phase|Never Treated|0
4973632|NCT00100048|17087554|P4|Cohort I & II-Combination Therapy Phase|Never Treated|0
4973633|NCT00100048|17087555|P3|Cohort I & II-Combination Therapy Phase|Never Treated|0
4973634|NCT00100048|17087556|P2|Cohort I & II-Combination Therapy Phase|Never Treated|0
4973635|NCT00100048|17087557|P1|Cohort I & II-Combination Therapy Phase|Never Treated|2
4973636|NCT00099983|17087666|P2|Overall Study|Other issue|0
4973637|NCT00099983|17087667|P1|Overall Study|Other issue|1
4973638|NCT00099983|17087666|P2|Overall Study|Intolerant of burden of visits|1
4973639|NCT00099983|17087667|P1|Overall Study|Intolerant of burden of visits|0
4973640|NCT00099983|17087666|P2|Overall Study|Incarcerated|1
4973641|NCT00099983|17087667|P1|Overall Study|Incarcerated|0
4973642|NCT00099983|17087666|P2|Overall Study|Other psychiatric problem|0
4973643|NCT00099983|17087667|P1|Overall Study|Other psychiatric problem|1
4973644|NCT00099983|17087666|P2|Overall Study|Moved|0
4973645|NCT00099983|17087667|P1|Overall Study|Moved|1
4973646|NCT00099983|17087666|P2|Overall Study|Unable to return for appointments|1
4973647|NCT00099983|17087667|P1|Overall Study|Unable to return for appointments|1
4973648|NCT00099983|17087666|P2|Overall Study|Lack of Efficacy|1
4973649|NCT00099983|17087667|P1|Overall Study|Lack of Efficacy|0
4973650|NCT00099983|17087666|P2|Overall Study|Adverse Event|1
4973651|NCT00099983|17087667|P1|Overall Study|Adverse Event|1
4973652|NCT00099983|17087666|P2|Overall Study|Withdrawal by Subject|2
4973653|NCT00099983|17087667|P1|Overall Study|Withdrawal by Subject|3
4973654|NCT00099983|17087666|P2|Overall Study|Missing Source Documents|15
4973655|NCT00099983|17087667|P1|Overall Study|Missing Source Documents|14
4973656|NCT00099983|17087666|P2|Overall Study|Lost to Follow-up|3
4973657|NCT00099983|17087667|P1|Overall Study|Lost to Follow-up|2
4973658|NCT00099632|17087679|P6|Overall Study|Protocol Violation|1
4973659|NCT00099632|17087680|P5|Overall Study|Protocol Violation|0
4973660|NCT00099632|17087681|P4|Overall Study|Protocol Violation|0
4973661|NCT00099632|17087682|P3|Overall Study|Protocol Violation|0
4973662|NCT00099632|17087683|P2|Overall Study|Protocol Violation|0
4973663|NCT00099632|17087684|P1|Overall Study|Protocol Violation|0
4973664|NCT00099632|17087679|P6|Overall Study|Withdrawal by Subject|1
4973665|NCT00099632|17087680|P5|Overall Study|Withdrawal by Subject|0
4973666|NCT00099632|17087681|P4|Overall Study|Withdrawal by Subject|0
4973667|NCT00099632|17087682|P3|Overall Study|Withdrawal by Subject|0
4973668|NCT00099632|17087683|P2|Overall Study|Withdrawal by Subject|1
4973669|NCT00099632|17087684|P1|Overall Study|Withdrawal by Subject|0
4973670|NCT00099632|17087679|P6|Overall Study|Lost to Follow-up|0
4973671|NCT00099632|17087680|P5|Overall Study|Lost to Follow-up|1
4973672|NCT00099632|17087681|P4|Overall Study|Lost to Follow-up|1
4973673|NCT00099632|17087682|P3|Overall Study|Lost to Follow-up|3
4973674|NCT00099632|17087683|P2|Overall Study|Lost to Follow-up|0
4973675|NCT00099632|17087684|P1|Overall Study|Lost to Follow-up|1
4973676|NCT00099437|17087724|P2|Overall Study|Ongoing in FU but not on treatment|45
4973677|NCT00099437|17087725|P1|Overall Study|Ongoing in FU but not on treatment|37
4973678|NCT00099437|17087724|P2|Overall Study|Withdrawal by Subject|10
4973679|NCT00099437|17087725|P1|Overall Study|Withdrawal by Subject|6
4973680|NCT00099437|17087724|P2|Overall Study|Death|261
4973681|NCT00099437|17087725|P1|Overall Study|Death|293
4973682|NCT00099437|17087724|P2|Overall Study|Lost to Follow-up|33
4973683|NCT00099437|17087725|P1|Overall Study|Lost to Follow-up|30
4973684|NCT00099359|17087748|P3|Overall Study|moved out of area|4
4973685|NCT00099359|17087749|P2|Overall Study|moved out of area|7
4973686|NCT00099359|17087750|P1|Overall Study|moved out of area|9
4973687|NCT00099359|17087748|P3|Overall Study|Lost to Follow-up|24
4973688|NCT00099359|17087749|P2|Overall Study|Lost to Follow-up|24
4973689|NCT00099359|17087750|P1|Overall Study|Lost to Follow-up|15
4973690|NCT00099359|17087748|P3|Overall Study|Withdrawal by Subject|23
4973691|NCT00099359|17087749|P2|Overall Study|Withdrawal by Subject|19
4973692|NCT00099359|17087750|P1|Overall Study|Withdrawal by Subject|19
4973693|NCT00099359|17087748|P3|Overall Study|Death|17
4973694|NCT00099359|17087749|P2|Overall Study|Death|15
4973695|NCT00099359|17087750|P1|Overall Study|Death|11
4973696|NCT00099268|17087773|P2|Overall Study|Death|1
4973697|NCT00099268|17087774|P1|Overall Study|Death|3
4973698|NCT00099268|17087773|P2|Overall Study|Administrative problems|4
4973699|NCT00099268|17087774|P1|Overall Study|Administrative problems|4
4973700|NCT00099268|17087773|P2|Overall Study|Lack of Efficacy|18
4973701|NCT00099268|17087774|P1|Overall Study|Lack of Efficacy|5
4973702|NCT00099268|17087773|P2|Overall Study|Lost to Follow-up|4
4973703|NCT00099268|17087774|P1|Overall Study|Lost to Follow-up|6
4973704|NCT00099268|17087773|P2|Overall Study|Protocol Violation|8
4973705|NCT00099268|17087774|P1|Overall Study|Protocol Violation|9
4973706|NCT00099268|17087773|P2|Overall Study|Adverse Event|19
4973707|NCT00099268|17087774|P1|Overall Study|Adverse Event|19
4973708|NCT00099268|17087773|P2|Overall Study|Withdrawal by Subject|28
4973709|NCT00099268|17087774|P1|Overall Study|Withdrawal by Subject|46
4973710|NCT00098865|17087814|P1|Overall Study|Alternative Therapy|1
4973711|NCT00098865|17087814|P1|Overall Study|Adverse Event|2
4973712|NCT00098865|17087814|P1|Overall Study|Progressive Disease|6
4973713|NCT00098839|17087822|P2|Overall Study|Ineligible|0
4973714|NCT00098839|17087823|P1|Overall Study|Ineligible|2
4973715|NCT00098839|17087822|P2|Overall Study|M2/M3 marrow on Day 15 of Block 2|11
4973716|NCT00098839|17087823|P1|Overall Study|M2/M3 marrow on Day 15 of Block 2|10
4973717|NCT00098839|17087822|P2|Overall Study|Relapse|3
4973718|NCT00098839|17087823|P1|Overall Study|Relapse|6
4973719|NCT00098839|17087822|P2|Overall Study|Refusal of further protocol therapy|1
4973720|NCT00098839|17087823|P1|Overall Study|Refusal of further protocol therapy|3
4973721|NCT00098839|17087822|P2|Overall Study|Withdrawal by Subject|0
4973722|NCT00098839|17087823|P1|Overall Study|Withdrawal by Subject|1
4973723|NCT00098839|17087822|P2|Overall Study|Physician Decision|14
4973724|NCT00098839|17087823|P1|Overall Study|Physician Decision|4
4973725|NCT00098839|17087822|P2|Overall Study|Death|2
4973726|NCT00098839|17087823|P1|Overall Study|Death|1
4973727|NCT00098839|17087822|P2|Overall Study|Adverse Event|2
4973728|NCT00098839|17087823|P1|Overall Study|Adverse Event|5
4973729|NCT00098813|17087834|P1|Overall Study|Reversal of RAI resistance|1
4973730|NCT00098813|17087834|P1|Overall Study|Other complicating disease|1
4973731|NCT00098813|17087834|P1|Overall Study|Progression of Disease|1
4973732|NCT00098813|17087834|P1|Overall Study|Withdrawal by Subject|7
4973733|NCT00098813|17087834|P1|Overall Study|Protocol Violation|1
4973734|NCT00098813|17087834|P1|Overall Study|Death|8
4973735|NCT00098787|17087841|P3|Overall Study|Other|9
4973736|NCT00098787|17087842|P2|Overall Study|Other|6
4973737|NCT00098787|17087843|P1|Overall Study|Other|7
4973738|NCT00098787|17087841|P3|Overall Study|Alternative therapy|13
4973739|NCT00098787|17087842|P2|Overall Study|Alternative therapy|13
4973740|NCT00098787|17087843|P1|Overall Study|Alternative therapy|8
4973741|NCT00098787|17087841|P3|Overall Study|Withdrawal by Subject|6
4973742|NCT00098787|17087842|P2|Overall Study|Withdrawal by Subject|12
4973743|NCT00098787|17087843|P1|Overall Study|Withdrawal by Subject|4
4973744|NCT00098787|17087841|P3|Overall Study|Death|0
4973745|NCT00098787|17087842|P2|Overall Study|Death|1
4973746|NCT00098787|17087843|P1|Overall Study|Death|6
4973747|NCT00098787|17087841|P3|Overall Study|Adverse Event|8
4973748|NCT00098787|17087842|P2|Overall Study|Adverse Event|17
4973749|NCT00098787|17087843|P1|Overall Study|Adverse Event|8
4973750|NCT00098787|17087841|P3|Overall Study|Disease progression|23
4973751|NCT00098787|17087842|P2|Overall Study|Disease progression|17
4973752|NCT00098787|17087843|P1|Overall Study|Disease progression|28
4973753|NCT00098787|17087841|P3|Overall Study|Ineligible|3
4973754|NCT00098787|17087842|P2|Overall Study|Ineligible|7
4973755|NCT00098787|17087843|P1|Overall Study|Ineligible|9
4973756|NCT00098787|17087841|P3|Overall Study|Never started treatment|1
4973757|NCT00098787|17087842|P2|Overall Study|Never started treatment|2
4973758|NCT00098787|17087843|P1|Overall Study|Never started treatment|3
4973759|NCT00098774|17087857|P1|Overall Study|Physician Decision|2
4973760|NCT00098774|17087857|P1|Overall Study|Failed (to respond) during induction|4
4973761|NCT00098774|17087857|P1|Overall Study|Withdrawal by Subject|1
4973762|NCT00098774|17087857|P1|Overall Study|Disease Progression|9
4973763|NCT00098774|17087857|P1|Overall Study|Adverse Event|2
4973764|NCT00098748|17087867|P3|Continued on Open-Label Treatment|Withdrawal by Subject|0
4973765|NCT00098748|17087868|P2|Continued on Open-Label Treatment|Withdrawal by Subject|4
4973766|NCT00098748|17087869|P1|Continued on Open-Label Treatment|Withdrawal by Subject|0
4973767|NCT00098748|17087867|P3|Continued on Open-Label Treatment|Lost to Follow-up|0
4973768|NCT00098748|17087868|P2|Continued on Open-Label Treatment|Lost to Follow-up|1
4973769|NCT00098748|17087869|P1|Continued on Open-Label Treatment|Lost to Follow-up|1
4973770|NCT00098748|17087867|P3|Continued on Open-Label Treatment|Other reason includes protocol violation|0
4973771|NCT00098748|17087868|P2|Continued on Open-Label Treatment|Other reason includes protocol violation|7
4973772|NCT00098748|17087869|P1|Continued on Open-Label Treatment|Other reason includes protocol violation|6
4973773|NCT00098748|17087867|P3|Continued on Open-Label Treatment|Lack of Efficacy|0
4973774|NCT00098748|17087868|P2|Continued on Open-Label Treatment|Lack of Efficacy|2
4973775|NCT00098748|17087869|P1|Continued on Open-Label Treatment|Lack of Efficacy|1
4973776|NCT00098748|17087867|P3|Continued on Open-Label Treatment|Adverse Event|0
4973777|NCT00098748|17087868|P2|Continued on Open-Label Treatment|Adverse Event|1
4973778|NCT00098748|17087869|P1|Continued on Open-Label Treatment|Adverse Event|0
4973779|NCT00098748|17087867|P3|Received Study Treatment|Subject defaulted|4
4973780|NCT00098748|17087868|P2|Received Study Treatment|Subject defaulted|4
4973781|NCT00098748|17087869|P1|Received Study Treatment|Subject defaulted|3
4973782|NCT00098748|17087867|P3|Received Study Treatment|Other|6
4973783|NCT00098748|17087868|P2|Received Study Treatment|Other|2
4973784|NCT00098748|17087869|P1|Received Study Treatment|Other|2
4973785|NCT00098748|17087867|P3|Received Study Treatment|Lack of Efficacy|27
4973786|NCT00098748|17087868|P2|Received Study Treatment|Lack of Efficacy|27
4973787|NCT00098748|17087869|P1|Received Study Treatment|Lack of Efficacy|40
4973788|NCT00098748|17087867|P3|Received Study Treatment|Adverse Event|5
4973789|NCT00098748|17087868|P2|Received Study Treatment|Adverse Event|2
4973790|NCT00098748|17087869|P1|Received Study Treatment|Adverse Event|1
4973791|NCT00098748|17087867|P3|Received Study Treatment|Death|2
4973792|NCT00098748|17087868|P2|Received Study Treatment|Death|1
4973793|NCT00098748|17087869|P1|Received Study Treatment|Death|2
4973794|NCT00098748|17087867|P3|Assigned to Study Treatment|Randomized, but not treated|2
4973795|NCT00098748|17087868|P2|Assigned to Study Treatment|Randomized, but not treated|2
4973796|NCT00098748|17087869|P1|Assigned to Study Treatment|Randomized, but not treated|0
4973797|NCT00098722|17087925|P7|Observation Phase|Other|10
4973798|NCT00098722|17087926|P6|Observation Phase|Other|21
4973799|NCT00098722|17087927|P5|Observation Phase|Other|0
4973800|NCT00098722|17087928|P4|Observation Phase|Other|0
4973801|NCT00098722|17087929|P3|Observation Phase|Other|0
4973802|NCT00098722|17087930|P2|Observation Phase|Other|0
4973803|NCT00098722|17087931|P1|Observation Phase|Other|0
4973804|NCT00098722|17087925|P7|Observation Phase|Participant defaulted|4
4973805|NCT00098722|17087926|P6|Observation Phase|Participant defaulted|17
4973806|NCT00098722|17087927|P5|Observation Phase|Participant defaulted|0
4973807|NCT00098722|17087928|P4|Observation Phase|Participant defaulted|0
4973808|NCT00098722|17087929|P3|Observation Phase|Participant defaulted|0
4973809|NCT00098722|17087930|P2|Observation Phase|Participant defaulted|0
4973810|NCT00098722|17087931|P1|Observation Phase|Participant defaulted|0
4973811|NCT00098722|17087925|P7|Observation Phase|Lack of Efficacy|0
4973812|NCT00098722|17087926|P6|Observation Phase|Lack of Efficacy|2
4973813|NCT00098722|17087927|P5|Observation Phase|Lack of Efficacy|0
4973814|NCT00098722|17087928|P4|Observation Phase|Lack of Efficacy|0
4973815|NCT00098722|17087929|P3|Observation Phase|Lack of Efficacy|0
4973816|NCT00098722|17087930|P2|Observation Phase|Lack of Efficacy|0
4973817|NCT00098722|17087931|P1|Observation Phase|Lack of Efficacy|0
4973818|NCT00098722|17087925|P7|Observation Phase|Death|3
4973819|NCT00098722|17087926|P6|Observation Phase|Death|5
4973820|NCT00098722|17087927|P5|Observation Phase|Death|0
4973821|NCT00098722|17087928|P4|Observation Phase|Death|0
4973822|NCT00098722|17087929|P3|Observation Phase|Death|0
4973823|NCT00098722|17087930|P2|Observation Phase|Death|0
4973824|NCT00098722|17087931|P1|Observation Phase|Death|0
4973825|NCT00098722|17087925|P7|Open Label Phase|Other|0
4973826|NCT00098722|17087926|P6|Open Label Phase|Other|0
4973827|NCT00098722|17087927|P5|Open Label Phase|Other|0
4973828|NCT00098722|17087928|P4|Open Label Phase|Other|18
4973829|NCT00098722|17087929|P3|Open Label Phase|Other|0
4973830|NCT00098722|17087930|P2|Open Label Phase|Other|0
4973831|NCT00098722|17087931|P1|Open Label Phase|Other|0
4973832|NCT00098722|17087925|P7|Open Label Phase|Ongoing at cut-off date|0
4973833|NCT00098722|17087926|P6|Open Label Phase|Ongoing at cut-off date|0
4973834|NCT00098722|17087927|P5|Open Label Phase|Ongoing at cut-off date|50
4973835|NCT00098722|17087928|P4|Open Label Phase|Ongoing at cut-off date|220
4973836|NCT00098722|17087929|P3|Open Label Phase|Ongoing at cut-off date|0
4973837|NCT00098722|17087930|P2|Open Label Phase|Ongoing at cut-off date|0
4973838|NCT00098722|17087931|P1|Open Label Phase|Ongoing at cut-off date|0
4973839|NCT00098722|17087925|P7|Open Label Phase|Participant defaulted|0
4973840|NCT00098722|17087926|P6|Open Label Phase|Participant defaulted|0
4973841|NCT00098722|17087927|P5|Open Label Phase|Participant defaulted|0
4973842|NCT00098722|17087928|P4|Open Label Phase|Participant defaulted|18
4973843|NCT00098722|17087929|P3|Open Label Phase|Participant defaulted|0
4973844|NCT00098722|17087930|P2|Open Label Phase|Participant defaulted|0
4973845|NCT00098722|17087931|P1|Open Label Phase|Participant defaulted|0
4973846|NCT00098722|17087925|P7|Open Label Phase|Pregnancy|0
4973847|NCT00098722|17087926|P6|Open Label Phase|Pregnancy|0
4973848|NCT00098722|17087927|P5|Open Label Phase|Pregnancy|0
4973849|NCT00098722|17087928|P4|Open Label Phase|Pregnancy|1
4973850|NCT00098722|17087929|P3|Open Label Phase|Pregnancy|0
4973851|NCT00098722|17087930|P2|Open Label Phase|Pregnancy|0
4973852|NCT00098722|17087931|P1|Open Label Phase|Pregnancy|0
4973853|NCT00098722|17087925|P7|Open Label Phase|Lack of Efficacy|0
4973854|NCT00098722|17087926|P6|Open Label Phase|Lack of Efficacy|0
4973855|NCT00098722|17087927|P5|Open Label Phase|Lack of Efficacy|0
4973856|NCT00098722|17087928|P4|Open Label Phase|Lack of Efficacy|8
4973857|NCT00098722|17087929|P3|Open Label Phase|Lack of Efficacy|0
4973858|NCT00098722|17087930|P2|Open Label Phase|Lack of Efficacy|0
4973859|NCT00098722|17087931|P1|Open Label Phase|Lack of Efficacy|0
4973860|NCT00098722|17087925|P7|Open Label Phase|Death|0
4973861|NCT00098722|17087926|P6|Open Label Phase|Death|0
4973862|NCT00098722|17087927|P5|Open Label Phase|Death|0
4973863|NCT00098722|17087928|P4|Open Label Phase|Death|2
4973864|NCT00098722|17087929|P3|Open Label Phase|Death|0
4973865|NCT00098722|17087930|P2|Open Label Phase|Death|0
4973866|NCT00098722|17087931|P1|Open Label Phase|Death|0
4973867|NCT00098722|17087925|P7|Open Label Phase|Adverse Event|0
4973868|NCT00098722|17087926|P6|Open Label Phase|Adverse Event|0
4973869|NCT00098722|17087927|P5|Open Label Phase|Adverse Event|0
4973870|NCT00098722|17087928|P4|Open Label Phase|Adverse Event|5
4973871|NCT00098722|17087929|P3|Open Label Phase|Adverse Event|0
4973872|NCT00098722|17087930|P2|Open Label Phase|Adverse Event|0
4973873|NCT00098722|17087931|P1|Open Label Phase|Adverse Event|0
4973874|NCT00098722|17087925|P7|Double Blind Phase|Other|0
4973875|NCT00098722|17087926|P6|Double Blind Phase|Other|0
4973876|NCT00098722|17087927|P5|Double Blind Phase|Other|0
4973877|NCT00098722|17087928|P4|Double Blind Phase|Other|0
4973878|NCT00098722|17087929|P3|Double Blind Phase|Other|7
4973879|NCT00098722|17087930|P2|Double Blind Phase|Other|8
4973880|NCT00098722|17087931|P1|Double Blind Phase|Other|7
4973881|NCT00098722|17087925|P7|Double Blind Phase|Ongoing at cut-off date|0
4973882|NCT00098722|17087926|P6|Double Blind Phase|Ongoing at cut-off date|0
4973883|NCT00098722|17087927|P5|Double Blind Phase|Ongoing at cut-off date|0
4973884|NCT00098722|17087928|P4|Double Blind Phase|Ongoing at cut-off date|0
4973885|NCT00098722|17087929|P3|Double Blind Phase|Ongoing at cut-off date|57
4973886|NCT00098722|17087930|P2|Double Blind Phase|Ongoing at cut-off date|137
4973887|NCT00098722|17087931|P1|Double Blind Phase|Ongoing at cut-off date|128
4973888|NCT00098722|17087925|P7|Double Blind Phase|Randomized, not treated|0
4973889|NCT00098722|17087926|P6|Double Blind Phase|Randomized, not treated|0
4973890|NCT00098722|17087927|P5|Double Blind Phase|Randomized, not treated|0
4973891|NCT00098722|17087928|P4|Double Blind Phase|Randomized, not treated|0
4973892|NCT00098722|17087929|P3|Double Blind Phase|Randomized, not treated|3
4973893|NCT00098722|17087930|P2|Double Blind Phase|Randomized, not treated|3
4973894|NCT00098722|17087931|P1|Double Blind Phase|Randomized, not treated|4
4973895|NCT00098722|17087925|P7|Double Blind Phase|Pregnancy|0
4973896|NCT00098722|17087926|P6|Double Blind Phase|Pregnancy|0
4973897|NCT00098722|17087927|P5|Double Blind Phase|Pregnancy|0
4973898|NCT00098722|17087928|P4|Double Blind Phase|Pregnancy|0
4973899|NCT00098722|17087929|P3|Double Blind Phase|Pregnancy|0
4973900|NCT00098722|17087930|P2|Double Blind Phase|Pregnancy|0
4973901|NCT00098722|17087931|P1|Double Blind Phase|Pregnancy|1
4973902|NCT00098722|17087925|P7|Double Blind Phase|Participant defaulted|0
4973903|NCT00098722|17087926|P6|Double Blind Phase|Participant defaulted|0
4973904|NCT00098722|17087927|P5|Double Blind Phase|Participant defaulted|0
4973905|NCT00098722|17087928|P4|Double Blind Phase|Participant defaulted|0
4973906|NCT00098722|17087929|P3|Double Blind Phase|Participant defaulted|9
4973907|NCT00098722|17087930|P2|Double Blind Phase|Participant defaulted|11
4973908|NCT00098722|17087931|P1|Double Blind Phase|Participant defaulted|16
4973909|NCT00098722|17087925|P7|Double Blind Phase|Lack of Efficacy|0
4973910|NCT00098722|17087926|P6|Double Blind Phase|Lack of Efficacy|0
4973911|NCT00098722|17087927|P5|Double Blind Phase|Lack of Efficacy|0
4973912|NCT00098722|17087928|P4|Double Blind Phase|Lack of Efficacy|0
4973913|NCT00098722|17087929|P3|Double Blind Phase|Lack of Efficacy|15
4973914|NCT00098722|17087930|P2|Double Blind Phase|Lack of Efficacy|23
4973915|NCT00098722|17087931|P1|Double Blind Phase|Lack of Efficacy|21
4973916|NCT00098722|17087925|P7|Double Blind Phase|Death|0
4973917|NCT00098722|17087926|P6|Double Blind Phase|Death|0
4973918|NCT00098722|17087927|P5|Double Blind Phase|Death|0
4973919|NCT00098722|17087928|P4|Double Blind Phase|Death|0
4973920|NCT00098722|17087929|P3|Double Blind Phase|Death|0
4973921|NCT00098722|17087930|P2|Double Blind Phase|Death|5
4973922|NCT00098722|17087931|P1|Double Blind Phase|Death|2
4973923|NCT00098722|17087925|P7|Double Blind Phase|Adverse Event|0
4973924|NCT00098722|17087926|P6|Double Blind Phase|Adverse Event|0
4973925|NCT00098722|17087927|P5|Double Blind Phase|Adverse Event|0
4973926|NCT00098722|17087928|P4|Double Blind Phase|Adverse Event|0
4973927|NCT00098722|17087929|P3|Double Blind Phase|Adverse Event|3
4973928|NCT00098722|17087930|P2|Double Blind Phase|Adverse Event|7
4973929|NCT00098722|17087931|P1|Double Blind Phase|Adverse Event|7
4973930|NCT00098475|17088005|P4|Step 2|Never started treatment|0
4973931|NCT00098475|17088006|P3|Step 2|Never started treatment|0
4973932|NCT00098475|17088007|P2|Step 2|Never started treatment|1
4973933|NCT00098475|17088008|P1|Step 2|Never started treatment|1
4973934|NCT00098475|17088005|P4|Step 2|Alternative therapy|0
4973935|NCT00098475|17088006|P3|Step 2|Alternative therapy|0
4973936|NCT00098475|17088007|P2|Step 2|Alternative therapy|2
4973937|NCT00098475|17088008|P1|Step 2|Alternative therapy|1
4973938|NCT00098475|17088005|P4|Step 2|Physician Decision|0
4973939|NCT00098475|17088006|P3|Step 2|Physician Decision|0
4973940|NCT00098475|17088007|P2|Step 2|Physician Decision|1
4973941|NCT00098475|17088008|P1|Step 2|Physician Decision|0
4973942|NCT00098475|17088005|P4|Step 2|Withdrawal by Subject|0
4973943|NCT00098475|17088006|P3|Step 2|Withdrawal by Subject|0
4973944|NCT00098475|17088007|P2|Step 2|Withdrawal by Subject|2
4973945|NCT00098475|17088008|P1|Step 2|Withdrawal by Subject|0
4973946|NCT00098475|17088005|P4|Step 2|Adverse Event|0
4973947|NCT00098475|17088006|P3|Step 2|Adverse Event|0
4973948|NCT00098475|17088007|P2|Step 2|Adverse Event|0
4973949|NCT00098475|17088008|P1|Step 2|Adverse Event|2
4973950|NCT00098475|17088005|P4|Step 2|Disease progression|0
4973951|NCT00098475|17088006|P3|Step 2|Disease progression|0
4973952|NCT00098475|17088007|P2|Step 2|Disease progression|4
4973953|NCT00098475|17088008|P1|Step 2|Disease progression|1
4973954|NCT00098475|17088005|P4|Step 1|Not documented|0
4973955|NCT00098475|17088006|P3|Step 1|Not documented|0
4973956|NCT00098475|17088007|P2|Step 1|Not documented|1
4973957|NCT00098475|17088008|P1|Step 1|Not documented|0
4973958|NCT00098475|17088005|P4|Step 1|Patient fell with fracture|0
4973959|NCT00098475|17088006|P3|Step 1|Patient fell with fracture|0
4973960|NCT00098475|17088007|P2|Step 1|Patient fell with fracture|0
4973961|NCT00098475|17088008|P1|Step 1|Patient fell with fracture|1
4973962|NCT00098475|17088005|P4|Step 1|Misinterpretation of lab data|0
4973963|NCT00098475|17088006|P3|Step 1|Misinterpretation of lab data|0
4973964|NCT00098475|17088007|P2|Step 1|Misinterpretation of lab data|1
4973965|NCT00098475|17088008|P1|Step 1|Misinterpretation of lab data|0
4973966|NCT00098475|17088005|P4|Step 1|Criteria to continue treatment not met|0
4973967|NCT00098475|17088006|P3|Step 1|Criteria to continue treatment not met|0
4973968|NCT00098475|17088007|P2|Step 1|Criteria to continue treatment not met|1
4973969|NCT00098475|17088008|P1|Step 1|Criteria to continue treatment not met|0
4973970|NCT00098475|17088005|P4|Step 1|Referred to other physicians|0
4973971|NCT00098475|17088006|P3|Step 1|Referred to other physicians|0
4973972|NCT00098475|17088007|P2|Step 1|Referred to other physicians|1
4973973|NCT00098475|17088008|P1|Step 1|Referred to other physicians|0
4973974|NCT00098475|17088005|P4|Step 1|Rising paraprotein|0
4973975|NCT00098475|17088006|P3|Step 1|Rising paraprotein|0
4973976|NCT00098475|17088007|P2|Step 1|Rising paraprotein|1
4973977|NCT00098475|17088008|P1|Step 1|Rising paraprotein|0
4973978|NCT00098475|17088005|P4|Step 1|Insurance issue|0
4973979|NCT00098475|17088006|P3|Step 1|Insurance issue|0
4973980|NCT00098475|17088007|P2|Step 1|Insurance issue|1
4973981|NCT00098475|17088008|P1|Step 1|Insurance issue|0
4973982|NCT00098475|17088005|P4|Step 1|Declining performance status|0
4973983|NCT00098475|17088006|P3|Step 1|Declining performance status|0
4973984|NCT00098475|17088007|P2|Step 1|Declining performance status|1
4973985|NCT00098475|17088008|P1|Step 1|Declining performance status|0
4973986|NCT00098475|17088005|P4|Step 1|Off treatment for > specified timeframe|0
4973987|NCT00098475|17088006|P3|Step 1|Off treatment for > specified timeframe|0
4973988|NCT00098475|17088007|P2|Step 1|Off treatment for > specified timeframe|1
4973989|NCT00098475|17088008|P1|Step 1|Off treatment for > specified timeframe|1
4973990|NCT00098475|17088005|P4|Step 1|Incorrect disease assessment|0
4973991|NCT00098475|17088006|P3|Step 1|Incorrect disease assessment|0
4973992|NCT00098475|17088007|P2|Step 1|Incorrect disease assessment|0
4973993|NCT00098475|17088008|P1|Step 1|Incorrect disease assessment|2
4973994|NCT00098475|17088005|P4|Step 1|Both patient and physician's decision|0
4973995|NCT00098475|17088006|P3|Step 1|Both patient and physician's decision|0
4973996|NCT00098475|17088007|P2|Step 1|Both patient and physician's decision|1
4973997|NCT00098475|17088008|P1|Step 1|Both patient and physician's decision|2
4973998|NCT00098475|17088005|P4|Step 1|Cannot comply due to other tx|0
4973999|NCT00098475|17088006|P3|Step 1|Cannot comply due to other tx|0
4974000|NCT00098475|17088007|P2|Step 1|Cannot comply due to other tx|1
4974001|NCT00098475|17088008|P1|Step 1|Cannot comply due to other tx|0
4974002|NCT00098475|17088005|P4|Step 1|Complications|0
4974003|NCT00098475|17088006|P3|Step 1|Complications|0
4974004|NCT00098475|17088007|P2|Step 1|Complications|0
4974005|NCT00098475|17088008|P1|Step 1|Complications|1
4974006|NCT00098475|17088005|P4|Step 1|Knee surgery|0
4974007|NCT00098475|17088006|P3|Step 1|Knee surgery|0
4974008|NCT00098475|17088007|P2|Step 1|Knee surgery|0
4974009|NCT00098475|17088008|P1|Step 1|Knee surgery|1
4974010|NCT00098475|17088005|P4|Step 1|Still on treatment as of this analysis|0
4974011|NCT00098475|17088006|P3|Step 1|Still on treatment as of this analysis|0
4974012|NCT00098475|17088007|P2|Step 1|Still on treatment as of this analysis|27
4974013|NCT00098475|17088008|P1|Step 1|Still on treatment as of this analysis|14
4974014|NCT00098475|17088005|P4|Step 1|Never started treatment|0
4974015|NCT00098475|17088006|P3|Step 1|Never started treatment|0
4974016|NCT00098475|17088007|P2|Step 1|Never started treatment|2
4974017|NCT00098475|17088008|P1|Step 1|Never started treatment|0
4974018|NCT00098475|17088005|P4|Step 1|Other disease|0
4974019|NCT00098475|17088006|P3|Step 1|Other disease|1
4974020|NCT00098475|17088007|P2|Step 1|Other disease|1
4974021|NCT00098475|17088008|P1|Step 1|Other disease|2
4974022|NCT00098475|17088005|P4|Step 1|Alternative therapy|0
4974023|NCT00098475|17088006|P3|Step 1|Alternative therapy|1
4974024|NCT00098475|17088007|P2|Step 1|Alternative therapy|43
4974025|NCT00098475|17088008|P1|Step 1|Alternative therapy|31
4974026|NCT00098475|17088005|P4|Step 1|Physician Decision|0
4974027|NCT00098475|17088006|P3|Step 1|Physician Decision|0
4974028|NCT00098475|17088007|P2|Step 1|Physician Decision|2
4974029|NCT00098475|17088008|P1|Step 1|Physician Decision|5
4974030|NCT00098475|17088005|P4|Step 1|Withdrawal by Subject|0
4974031|NCT00098475|17088006|P3|Step 1|Withdrawal by Subject|0
4974032|NCT00098475|17088007|P2|Step 1|Withdrawal by Subject|11
4974033|NCT00098475|17088008|P1|Step 1|Withdrawal by Subject|14
4974034|NCT00098475|17088005|P4|Step 1|Death|1
4974035|NCT00098475|17088006|P3|Step 1|Death|0
4974036|NCT00098475|17088007|P2|Step 1|Death|5
4974037|NCT00098475|17088008|P1|Step 1|Death|8
4974038|NCT00098475|17088005|P4|Step 1|Adverse Event|1
4974039|NCT00098475|17088006|P3|Step 1|Adverse Event|0
4974040|NCT00098475|17088007|P2|Step 1|Adverse Event|37
4974041|NCT00098475|17088008|P1|Step 1|Adverse Event|56
4974042|NCT00098475|17088005|P4|Step 1|Progressive disease|1
4974043|NCT00098475|17088006|P3|Step 1|Progressive disease|2
4974044|NCT00098475|17088007|P2|Step 1|Progressive disease|35
4974045|NCT00098475|17088008|P1|Step 1|Progressive disease|33
4974046|NCT00098345|17088045|P1|Overall Study|progression|4
4974047|NCT00098345|17088045|P1|Overall Study|Withdrawal by Subject|2
4974048|NCT00098345|17088045|P1|Overall Study|Adverse Event|7
4974049|NCT00098306|17088058|P7|Observational Phase|Un-specified|4
4974050|NCT00098306|17088059|P6|Observational Phase|Un-specified|7
4974051|NCT00098306|17088060|P5|Observational Phase|Un-specified|0
4974052|NCT00098306|17088061|P4|Observational Phase|Un-specified|0
4974053|NCT00098306|17088062|P3|Observational Phase|Un-specified|0
4974054|NCT00098306|17088063|P2|Observational Phase|Un-specified|0
4974055|NCT00098306|17088064|P1|Observational Phase|Un-specified|0
4974056|NCT00098306|17088058|P7|Observational Phase|Participant defaulted|18
4974057|NCT00098306|17088059|P6|Observational Phase|Participant defaulted|34
4974058|NCT00098306|17088060|P5|Observational Phase|Participant defaulted|0
4974059|NCT00098306|17088061|P4|Observational Phase|Participant defaulted|0
4974060|NCT00098306|17088062|P3|Observational Phase|Participant defaulted|0
4974061|NCT00098306|17088063|P2|Observational Phase|Participant defaulted|0
4974062|NCT00098306|17088064|P1|Observational Phase|Participant defaulted|0
4974063|NCT00098306|17088058|P7|Observational Phase|Death|4
4974064|NCT00098306|17088059|P6|Observational Phase|Death|5
4974065|NCT00098306|17088060|P5|Observational Phase|Death|0
4974066|NCT00098306|17088061|P4|Observational Phase|Death|0
4974067|NCT00098306|17088062|P3|Observational Phase|Death|0
4974068|NCT00098306|17088063|P2|Observational Phase|Death|0
4974069|NCT00098306|17088064|P1|Observational Phase|Death|0
4974070|NCT00098306|17088058|P7|Open Label|Ongoing at cut-off date|0
4974071|NCT00098306|17088059|P6|Open Label|Ongoing at cut-off date|0
4974072|NCT00098306|17088060|P5|Open Label|Ongoing at cut-off date|62
4974073|NCT00098306|17088061|P4|Open Label|Ongoing at cut-off date|269
4974074|NCT00098306|17088062|P3|Open Label|Ongoing at cut-off date|0
4974075|NCT00098306|17088063|P2|Open Label|Ongoing at cut-off date|0
4974076|NCT00098306|17088064|P1|Open Label|Ongoing at cut-off date|0
4974077|NCT00098306|17088058|P7|Open Label|Un-specified|0
4974078|NCT00098306|17088059|P6|Open Label|Un-specified|0
4974079|NCT00098306|17088060|P5|Open Label|Un-specified|0
4974080|NCT00098306|17088061|P4|Open Label|Un-specified|15
4974081|NCT00098306|17088062|P3|Open Label|Un-specified|0
4974082|NCT00098306|17088063|P2|Open Label|Un-specified|0
4974083|NCT00098306|17088064|P1|Open Label|Un-specified|0
4974084|NCT00098306|17088058|P7|Open Label|Participant defaulted|0
4974085|NCT00098306|17088059|P6|Open Label|Participant defaulted|0
4974086|NCT00098306|17088060|P5|Open Label|Participant defaulted|0
4974087|NCT00098306|17088061|P4|Open Label|Participant defaulted|24
4974088|NCT00098306|17088062|P3|Open Label|Participant defaulted|0
4974089|NCT00098306|17088063|P2|Open Label|Participant defaulted|0
4974090|NCT00098306|17088064|P1|Open Label|Participant defaulted|0
4974091|NCT00098306|17088058|P7|Open Label|Death|0
4974092|NCT00098306|17088059|P6|Open Label|Death|0
4974093|NCT00098306|17088060|P5|Open Label|Death|0
4974094|NCT00098306|17088061|P4|Open Label|Death|4
4974095|NCT00098306|17088062|P3|Open Label|Death|0
4974096|NCT00098306|17088063|P2|Open Label|Death|0
4974097|NCT00098306|17088064|P1|Open Label|Death|0
4974098|NCT00098306|17088058|P7|Open Label|Adverse Event|0
4974099|NCT00098306|17088059|P6|Open Label|Adverse Event|0
4974100|NCT00098306|17088060|P5|Open Label|Adverse Event|0
4974101|NCT00098306|17088061|P4|Open Label|Adverse Event|2
4974102|NCT00098306|17088062|P3|Open Label|Adverse Event|0
4974103|NCT00098306|17088063|P2|Open Label|Adverse Event|0
4974104|NCT00098306|17088064|P1|Open Label|Adverse Event|0
4974105|NCT00098306|17088058|P7|Open Label|Lack of Efficacy|0
4974106|NCT00098306|17088059|P6|Open Label|Lack of Efficacy|0
4974107|NCT00098306|17088060|P5|Open Label|Lack of Efficacy|0
4974108|NCT00098306|17088061|P4|Open Label|Lack of Efficacy|13
4974109|NCT00098306|17088062|P3|Open Label|Lack of Efficacy|0
4974110|NCT00098306|17088063|P2|Open Label|Lack of Efficacy|0
4974111|NCT00098306|17088064|P1|Open Label|Lack of Efficacy|0
4974112|NCT00098306|17088058|P7|Double Blind|Un-specified|0
4974113|NCT00098306|17088059|P6|Double Blind|Un-specified|0
4974114|NCT00098306|17088060|P5|Double Blind|Un-specified|0
4974115|NCT00098306|17088061|P4|Double Blind|Un-specified|0
4974116|NCT00098306|17088062|P3|Double Blind|Un-specified|11
4974117|NCT00098306|17088063|P2|Double Blind|Un-specified|3
4974118|NCT00098306|17088064|P1|Double Blind|Un-specified|7
4974119|NCT00098306|17088058|P7|Double Blind|Participant defaulted|0
4974120|NCT00098306|17088059|P6|Double Blind|Participant defaulted|0
4974121|NCT00098306|17088060|P5|Double Blind|Participant defaulted|0
4974122|NCT00098306|17088061|P4|Double Blind|Participant defaulted|0
4974123|NCT00098306|17088062|P3|Double Blind|Participant defaulted|11
4974124|NCT00098306|17088063|P2|Double Blind|Participant defaulted|18
4974125|NCT00098306|17088064|P1|Double Blind|Participant defaulted|19
4974126|NCT00098306|17088058|P7|Double Blind|Death|0
4974127|NCT00098306|17088059|P6|Double Blind|Death|0
4974128|NCT00098306|17088060|P5|Double Blind|Death|0
4974129|NCT00098306|17088061|P4|Double Blind|Death|0
4974130|NCT00098306|17088062|P3|Double Blind|Death|1
4974131|NCT00098306|17088063|P2|Double Blind|Death|4
4974132|NCT00098306|17088064|P1|Double Blind|Death|1
4974133|NCT00098306|17088058|P7|Double Blind|Lack of Efficacy|0
4974134|NCT00098306|17088059|P6|Double Blind|Lack of Efficacy|0
4974135|NCT00098306|17088060|P5|Double Blind|Lack of Efficacy|0
4974136|NCT00098306|17088061|P4|Double Blind|Lack of Efficacy|0
4974137|NCT00098306|17088062|P3|Double Blind|Lack of Efficacy|17
4974138|NCT00098306|17088063|P2|Double Blind|Lack of Efficacy|34
4974139|NCT00098306|17088064|P1|Double Blind|Lack of Efficacy|43
4974140|NCT00098306|17088058|P7|Double Blind|Adverse Event|0
4974141|NCT00098306|17088059|P6|Double Blind|Adverse Event|0
4974142|NCT00098306|17088060|P5|Double Blind|Adverse Event|0
4974143|NCT00098306|17088061|P4|Double Blind|Adverse Event|0
4974144|NCT00098306|17088062|P3|Double Blind|Adverse Event|6
4974145|NCT00098306|17088063|P2|Double Blind|Adverse Event|10
4974146|NCT00098306|17088064|P1|Double Blind|Adverse Event|11
4974147|NCT00098306|17088058|P7|Double Blind|Ongoing at cut-off date|0
4974148|NCT00098306|17088059|P6|Double Blind|Ongoing at cut-off date|0
4974149|NCT00098306|17088060|P5|Double Blind|Ongoing at cut-off date|0
4974150|NCT00098306|17088061|P4|Double Blind|Ongoing at cut-off date|0
4974151|NCT00098306|17088062|P3|Double Blind|Ongoing at cut-off date|72
4974152|NCT00098306|17088063|P2|Double Blind|Ongoing at cut-off date|166
4974153|NCT00098306|17088064|P1|Double Blind|Ongoing at cut-off date|151
4974154|NCT00098306|17088058|P7|Double Blind|Randomized, not treated|0
4974155|NCT00098306|17088059|P6|Double Blind|Randomized, not treated|0
4974156|NCT00098306|17088060|P5|Double Blind|Randomized, not treated|0
4974157|NCT00098306|17088061|P4|Double Blind|Randomized, not treated|0
4974158|NCT00098306|17088062|P3|Double Blind|Randomized, not treated|2
4974159|NCT00098306|17088063|P2|Double Blind|Randomized, not treated|5
4974160|NCT00098306|17088064|P1|Double Blind|Randomized, not treated|9
4974161|NCT00098293|17088130|P5|Supplemental Phase (SP)|Other|22
4974162|NCT00098293|17088131|P4|Supplemental Phase (SP)|Other|0
4974163|NCT00098293|17088132|P3|Supplemental Phase (SP)|Other|0
4974164|NCT00098293|17088133|P2|Supplemental Phase (SP)|Other|0
4974165|NCT00098293|17088134|P1|Supplemental Phase (SP)|Other|0
4974166|NCT00098293|17088130|P5|Supplemental Phase (SP)|Withdrawal by Subject|8
4974167|NCT00098293|17088131|P4|Supplemental Phase (SP)|Withdrawal by Subject|0
4974168|NCT00098293|17088132|P3|Supplemental Phase (SP)|Withdrawal by Subject|0
4974169|NCT00098293|17088133|P2|Supplemental Phase (SP)|Withdrawal by Subject|0
4974170|NCT00098293|17088134|P1|Supplemental Phase (SP)|Withdrawal by Subject|0
4974171|NCT00098293|17088130|P5|Supplemental Phase (SP)|Lost to Follow-up|2
4974172|NCT00098293|17088131|P4|Supplemental Phase (SP)|Lost to Follow-up|0
4974173|NCT00098293|17088132|P3|Supplemental Phase (SP)|Lost to Follow-up|0
4974174|NCT00098293|17088133|P2|Supplemental Phase (SP)|Lost to Follow-up|0
4974175|NCT00098293|17088134|P1|Supplemental Phase (SP)|Lost to Follow-up|0
4974176|NCT00098293|17088130|P5|Supplemental Phase (SP)|Death|1
4974177|NCT00098293|17088131|P4|Supplemental Phase (SP)|Death|0
4974178|NCT00098293|17088132|P3|Supplemental Phase (SP)|Death|0
4974179|NCT00098293|17088133|P2|Supplemental Phase (SP)|Death|0
4974180|NCT00098293|17088134|P1|Supplemental Phase (SP)|Death|0
4974181|NCT00098293|17088130|P5|Open-label (OL) Phase|Death|0
4974182|NCT00098293|17088131|P4|Open-label (OL) Phase|Death|0
4974183|NCT00098293|17088132|P3|Open-label (OL) Phase|Death|3
4974184|NCT00098293|17088133|P2|Open-label (OL) Phase|Death|2
4974185|NCT00098293|17088134|P1|Open-label (OL) Phase|Death|0
4974186|NCT00098293|17088130|P5|Open-label (OL) Phase|Participant Defaulted|0
4974187|NCT00098293|17088131|P4|Open-label (OL) Phase|Participant Defaulted|20
4974188|NCT00098293|17088132|P3|Open-label (OL) Phase|Participant Defaulted|16
4974189|NCT00098293|17088133|P2|Open-label (OL) Phase|Participant Defaulted|6
4974190|NCT00098293|17088134|P1|Open-label (OL) Phase|Participant Defaulted|0
4974191|NCT00098293|17088130|P5|Open-label (OL) Phase|Protocol Violation|0
4974192|NCT00098293|17088131|P4|Open-label (OL) Phase|Protocol Violation|16
4974193|NCT00098293|17088132|P3|Open-label (OL) Phase|Protocol Violation|13
4974194|NCT00098293|17088133|P2|Open-label (OL) Phase|Protocol Violation|6
4974195|NCT00098293|17088134|P1|Open-label (OL) Phase|Protocol Violation|0
4974196|NCT00098293|17088130|P5|Open-label (OL) Phase|Pregnancy|0
4974197|NCT00098293|17088131|P4|Open-label (OL) Phase|Pregnancy|3
4974198|NCT00098293|17088132|P3|Open-label (OL) Phase|Pregnancy|0
4974199|NCT00098293|17088133|P2|Open-label (OL) Phase|Pregnancy|1
4974200|NCT00098293|17088134|P1|Open-label (OL) Phase|Pregnancy|0
4974201|NCT00098293|17088130|P5|Open-label (OL) Phase|Lack of Efficacy|0
4974202|NCT00098293|17088131|P4|Open-label (OL) Phase|Lack of Efficacy|20
4974203|NCT00098293|17088132|P3|Open-label (OL) Phase|Lack of Efficacy|2
4974204|NCT00098293|17088133|P2|Open-label (OL) Phase|Lack of Efficacy|7
4974205|NCT00098293|17088134|P1|Open-label (OL) Phase|Lack of Efficacy|0
4974206|NCT00098293|17088130|P5|Open-label (OL) Phase|Adverse Event|0
4974207|NCT00098293|17088131|P4|Open-label (OL) Phase|Adverse Event|6
4974208|NCT00098293|17088132|P3|Open-label (OL) Phase|Adverse Event|7
4974209|NCT00098293|17088133|P2|Open-label (OL) Phase|Adverse Event|3
4974210|NCT00098293|17088134|P1|Open-label (OL) Phase|Adverse Event|0
4974211|NCT00098293|17088130|P5|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4974212|NCT00098293|17088131|P4|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4974213|NCT00098293|17088132|P3|Between DB and OL Phase|Did Not Enter Open-label Phase|3
4974214|NCT00098293|17088133|P2|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4974215|NCT00098293|17088134|P1|Between DB and OL Phase|Did Not Enter Open-label Phase|0
4974216|NCT00098293|17088130|P5|Double-blind (DB) Phase|Terminated by sponsor|0
4974217|NCT00098293|17088131|P4|Double-blind (DB) Phase|Terminated by sponsor|0
4974218|NCT00098293|17088132|P3|Double-blind (DB) Phase|Terminated by sponsor|0
4974219|NCT00098293|17088133|P2|Double-blind (DB) Phase|Terminated by sponsor|0
4974220|NCT00098293|17088134|P1|Double-blind (DB) Phase|Terminated by sponsor|135
4974221|NCT00098293|17088130|P5|Double-blind (DB) Phase|Protocol Violation|0
4974222|NCT00098293|17088131|P4|Double-blind (DB) Phase|Protocol Violation|0
4974223|NCT00098293|17088132|P3|Double-blind (DB) Phase|Protocol Violation|22
4974224|NCT00098293|17088133|P2|Double-blind (DB) Phase|Protocol Violation|18
4974225|NCT00098293|17088134|P1|Double-blind (DB) Phase|Protocol Violation|2
4974226|NCT00098293|17088130|P5|Double-blind (DB) Phase|Randomized, Not Treated|0
4974227|NCT00098293|17088131|P4|Double-blind (DB) Phase|Randomized, Not Treated|0
4974228|NCT00098293|17088132|P3|Double-blind (DB) Phase|Randomized, Not Treated|11
4974229|NCT00098293|17088133|P2|Double-blind (DB) Phase|Randomized, Not Treated|8
4974230|NCT00098293|17088134|P1|Double-blind (DB) Phase|Randomized, Not Treated|3
4974231|NCT00098293|17088130|P5|Double-blind (DB) Phase|Death|0
4974232|NCT00098293|17088131|P4|Double-blind (DB) Phase|Death|0
4974233|NCT00098293|17088132|P3|Double-blind (DB) Phase|Death|2
4974234|NCT00098293|17088133|P2|Double-blind (DB) Phase|Death|2
4974235|NCT00098293|17088134|P1|Double-blind (DB) Phase|Death|1
4974236|NCT00098293|17088130|P5|Double-blind (DB) Phase|Lack of Efficacy|0
4974237|NCT00098293|17088131|P4|Double-blind (DB) Phase|Lack of Efficacy|0
4974238|NCT00098293|17088132|P3|Double-blind (DB) Phase|Lack of Efficacy|30
4974239|NCT00098293|17088133|P2|Double-blind (DB) Phase|Lack of Efficacy|64
4974240|NCT00098293|17088134|P1|Double-blind (DB) Phase|Lack of Efficacy|11
4974241|NCT00098293|17088130|P5|Double-blind (DB) Phase|Participant Defaulted|0
4974242|NCT00098293|17088131|P4|Double-blind (DB) Phase|Participant Defaulted|0
4974243|NCT00098293|17088132|P3|Double-blind (DB) Phase|Participant Defaulted|36
4974244|NCT00098293|17088133|P2|Double-blind (DB) Phase|Participant Defaulted|40
4974245|NCT00098293|17088134|P1|Double-blind (DB) Phase|Participant Defaulted|11
4974246|NCT00098293|17088130|P5|Double-blind (DB) Phase|Pregnancy|0
4974247|NCT00098293|17088131|P4|Double-blind (DB) Phase|Pregnancy|0
4974248|NCT00098293|17088132|P3|Double-blind (DB) Phase|Pregnancy|9
4974249|NCT00098293|17088133|P2|Double-blind (DB) Phase|Pregnancy|7
4974250|NCT00098293|17088134|P1|Double-blind (DB) Phase|Pregnancy|0
4974251|NCT00098293|17088130|P5|Double-blind (DB) Phase|Adverse Event|0
4974252|NCT00098293|17088131|P4|Double-blind (DB) Phase|Adverse Event|0
4974253|NCT00098293|17088132|P3|Double-blind (DB) Phase|Adverse Event|60
4974254|NCT00098293|17088133|P2|Double-blind (DB) Phase|Adverse Event|27
4974255|NCT00098293|17088134|P1|Double-blind (DB) Phase|Adverse Event|14
4974256|NCT00098254|17088187|P1|Overall Study|Death|1
4974257|NCT00098254|17088187|P1|Overall Study|Adverse Event|2
4974258|NCT00098020|17088253|P1|Overall Study|Low epidermal growth factor receptor|1
4974259|NCT00098020|17088253|P1|Overall Study|Low urine PCR|1
4974260|NCT00098020|17088253|P1|Overall Study|elevated liver enzymes|1
4974261|NCT00098020|17088253|P1|Overall Study|Lost to Follow-up|1
4974262|NCT00098020|17088253|P1|Overall Study|Adverse Event|2
4974263|NCT00097981|17088260|P2|Overall Study|Other|13
4974264|NCT00097981|17088261|P1|Overall Study|Other|19
4974265|NCT00097981|17088260|P2|Overall Study|Transplant planned|27
4974266|NCT00097981|17088261|P1|Overall Study|Transplant planned|28
4974267|NCT00097981|17088260|P2|Overall Study|Disease Progression|2
4974268|NCT00097981|17088261|P1|Overall Study|Disease Progression|8
4974269|NCT00097981|17088260|P2|Overall Study|Physician Decision|1
4974270|NCT00097981|17088261|P1|Overall Study|Physician Decision|7
4974271|NCT00097981|17088260|P2|Overall Study|Death|4
4974272|NCT00097981|17088261|P1|Overall Study|Death|2
4974273|NCT00097981|17088260|P2|Overall Study|Protocol Violation|1
4974274|NCT00097981|17088261|P1|Overall Study|Protocol Violation|1
4974275|NCT00097981|17088260|P2|Overall Study|Withdrawal by Subject|8
4974276|NCT00097981|17088261|P1|Overall Study|Withdrawal by Subject|10
4974277|NCT00097981|17088260|P2|Overall Study|Adverse Event|44
4974278|NCT00097981|17088261|P1|Overall Study|Adverse Event|31
4974279|NCT00097786|17088283|P4|Overall Study|lost to follow-up for all-cause death|310
4974280|NCT00097786|17088284|P3|Overall Study|lost to follow-up for all-cause death|313
4974281|NCT00097786|17088285|P2|Overall Study|lost to follow-up for all-cause death|292
4974282|NCT00097786|17088286|P1|Overall Study|lost to follow-up for all-cause death|296
4974283|NCT00097773|17088308|P4|Overall Study|Other|0
4974284|NCT00097773|17088309|P3|Overall Study|Other|2
4974285|NCT00097773|17088310|P2|Overall Study|Other|0
4974286|NCT00097773|17088311|P1|Overall Study|Other|1
4974287|NCT00097773|17088308|P4|Overall Study|Adverse Event|0
4974288|NCT00097773|17088309|P3|Overall Study|Adverse Event|0
4974289|NCT00097773|17088310|P2|Overall Study|Adverse Event|1
4974290|NCT00097773|17088311|P1|Overall Study|Adverse Event|0
4974291|NCT00097773|17088308|P4|Overall Study|Withdrawal by Subject|1
4974292|NCT00097773|17088309|P3|Overall Study|Withdrawal by Subject|3
4974293|NCT00097773|17088310|P2|Overall Study|Withdrawal by Subject|3
4974294|NCT00097773|17088311|P1|Overall Study|Withdrawal by Subject|3
4974295|NCT00097773|17088308|P4|Overall Study|Physician Decision|1
4974296|NCT00097773|17088309|P3|Overall Study|Physician Decision|3
4974297|NCT00097773|17088310|P2|Overall Study|Physician Decision|2
4974298|NCT00097773|17088311|P1|Overall Study|Physician Decision|2
4974299|NCT00097773|17088308|P4|Overall Study|Lost to Follow-up|1
4974300|NCT00097773|17088309|P3|Overall Study|Lost to Follow-up|0
4974301|NCT00097773|17088310|P2|Overall Study|Lost to Follow-up|2
4974302|NCT00097773|17088311|P1|Overall Study|Lost to Follow-up|2
4974303|NCT00097721|17088331|P2|Overall Study|Reason not given|1
4974304|NCT00097721|17088332|P1|Overall Study|Reason not given|1
4974305|NCT00097721|17088331|P2|Overall Study|Physician Decision|3
4974306|NCT00097721|17088332|P1|Overall Study|Physician Decision|1
4974307|NCT00097721|17088331|P2|Overall Study|Progressive Disease|27
4974308|NCT00097721|17088332|P1|Overall Study|Progressive Disease|55
4974309|NCT00097721|17088331|P2|Overall Study|Withdrawal by Subject|1
4974310|NCT00097721|17088332|P1|Overall Study|Withdrawal by Subject|6
4974311|NCT00097721|17088331|P2|Overall Study|Adverse Event|1
4974312|NCT00097721|17088332|P1|Overall Study|Adverse Event|8
4974313|NCT00097591|17088391|P2|Overall Study|Other|3
4974314|NCT00097591|17088392|P1|Overall Study|Other|0
4974315|NCT00097591|17088391|P2|Overall Study|Lost to follow up|10
4974316|NCT00097591|17088392|P1|Overall Study|Lost to follow up|6
4974317|NCT00097591|17088391|P2|Overall Study|Unable to attend termination visit|51
4974318|NCT00097591|17088392|P1|Overall Study|Unable to attend termination visit|53
4974319|NCT00097591|17088391|P2|Overall Study|Less than 6 months on study drug|7
4974320|NCT00097591|17088392|P1|Overall Study|Less than 6 months on study drug|9
4974321|NCT00097591|17088391|P2|Overall Study|Withdrawal of consent|323
4974322|NCT00097591|17088392|P1|Overall Study|Withdrawal of consent|342
4974323|NCT00097539|17088415|P7|Overall Study|Reason not Specified|2
4974324|NCT00097539|17088416|P6|Overall Study|Reason not Specified|40
4974325|NCT00097539|17088417|P5|Overall Study|Reason not Specified|11
4974326|NCT00097539|17088418|P4|Overall Study|Reason not Specified|21
4974327|NCT00097539|17088419|P3|Overall Study|Reason not Specified|53
4974328|NCT00097539|17088420|P2|Overall Study|Reason not Specified|49
4974329|NCT00097539|17088421|P1|Overall Study|Reason not Specified|111
4974330|NCT00097539|17088415|P7|Overall Study|Reasons Other Than Above|34
4974331|NCT00097539|17088416|P6|Overall Study|Reasons Other Than Above|1244
4974332|NCT00097539|17088417|P5|Overall Study|Reasons Other Than Above|361
4974333|NCT00097539|17088418|P4|Overall Study|Reasons Other Than Above|692
4974334|NCT00097539|17088419|P3|Overall Study|Reasons Other Than Above|1757
4974335|NCT00097539|17088420|P2|Overall Study|Reasons Other Than Above|1382
4974336|NCT00097539|17088421|P1|Overall Study|Reasons Other Than Above|3602
4974337|NCT00097539|17088415|P7|Overall Study|Death|0
4974338|NCT00097539|17088416|P6|Overall Study|Death|3
4974339|NCT00097539|17088417|P5|Overall Study|Death|1
4974340|NCT00097539|17088418|P4|Overall Study|Death|0
4974341|NCT00097539|17088419|P3|Overall Study|Death|0
4974342|NCT00097539|17088420|P2|Overall Study|Death|7
4974343|NCT00097539|17088421|P1|Overall Study|Death|2
4974344|NCT00097539|17088415|P7|Overall Study|Adverse Event|1
4974345|NCT00097539|17088416|P6|Overall Study|Adverse Event|59
4974346|NCT00097539|17088417|P5|Overall Study|Adverse Event|30
4974347|NCT00097539|17088418|P4|Overall Study|Adverse Event|27
4974348|NCT00097539|17088419|P3|Overall Study|Adverse Event|37
4974349|NCT00097539|17088420|P2|Overall Study|Adverse Event|133
4974350|NCT00097539|17088421|P1|Overall Study|Adverse Event|78
4974351|NCT00097539|17088415|P7|Overall Study|Lack of Efficacy|5
4974352|NCT00097539|17088416|P6|Overall Study|Lack of Efficacy|228
4974353|NCT00097539|17088417|P5|Overall Study|Lack of Efficacy|45
4974354|NCT00097539|17088418|P4|Overall Study|Lack of Efficacy|105
4974355|NCT00097539|17088419|P3|Overall Study|Lack of Efficacy|202
4974356|NCT00097539|17088420|P2|Overall Study|Lack of Efficacy|122
4974357|NCT00097539|17088421|P1|Overall Study|Lack of Efficacy|249
4974358|NCT00097539|17088415|P7|Overall Study|Participant Non-compliant|18
4974359|NCT00097539|17088416|P6|Overall Study|Participant Non-compliant|543
4974360|NCT00097539|17088417|P5|Overall Study|Participant Non-compliant|136
4974361|NCT00097539|17088418|P4|Overall Study|Participant Non-compliant|353
4974362|NCT00097539|17088419|P3|Overall Study|Participant Non-compliant|1067
4974363|NCT00097539|17088420|P2|Overall Study|Participant Non-compliant|567
4974364|NCT00097539|17088421|P1|Overall Study|Participant Non-compliant|2140
4974365|NCT00097539|17088415|P7|Overall Study|Withdrawal by Subject|3
4974366|NCT00097539|17088416|P6|Overall Study|Withdrawal by Subject|229
4974367|NCT00097539|17088417|P5|Overall Study|Withdrawal by Subject|68
4974368|NCT00097539|17088418|P4|Overall Study|Withdrawal by Subject|217
4974369|NCT00097539|17088419|P3|Overall Study|Withdrawal by Subject|346
4974370|NCT00097539|17088420|P2|Overall Study|Withdrawal by Subject|323
4974371|NCT00097539|17088421|P1|Overall Study|Withdrawal by Subject|925
4974372|NCT00097539|17088415|P7|Overall Study|Status Unknown (Or no final evaluation)|108
4974373|NCT00097539|17088416|P6|Overall Study|Status Unknown (Or no final evaluation)|3546
4974374|NCT00097539|17088417|P5|Overall Study|Status Unknown (Or no final evaluation)|1106
4974375|NCT00097539|17088418|P4|Overall Study|Status Unknown (Or no final evaluation)|2170
4974376|NCT00097539|17088419|P3|Overall Study|Status Unknown (Or no final evaluation)|5646
4974377|NCT00097539|17088420|P2|Overall Study|Status Unknown (Or no final evaluation)|3948
4974378|NCT00097539|17088421|P1|Overall Study|Status Unknown (Or no final evaluation)|11959
4974379|NCT00097500|17088467|P2|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2
4974380|NCT00097500|17088468|P1|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3
4974381|NCT00097500|17088467|P2|Off-drug Period (Week 52 to Week 64)|Physician Decision|1
4974382|NCT00097500|17088468|P1|Off-drug Period (Week 52 to Week 64)|Physician Decision|0
4974383|NCT00097500|17088467|P2|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1
4974384|NCT00097500|17088468|P1|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2
4974385|NCT00097500|17088467|P2|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1
4974386|NCT00097500|17088468|P1|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0
4974387|NCT00097500|17088467|P2|On-drug Period (Week 0 to Week 52)|Physician Decision|1
4974388|NCT00097500|17088468|P1|On-drug Period (Week 0 to Week 52)|Physician Decision|0
4974389|NCT00097500|17088467|P2|On-drug Period (Week 0 to Week 52)|Adverse Event|0
4974390|NCT00097500|17088468|P1|On-drug Period (Week 0 to Week 52)|Adverse Event|5
4974391|NCT00097500|17088467|P2|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
4974392|NCT00097500|17088468|P1|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1
4974393|NCT00097370|17088499|P1|Stage 3|Lost to Follow-up|1
4974394|NCT00097370|17088499|P1|Stage 3|Sponsor Terminated Study|52
4974395|NCT00097370|17088499|P1|Stage 3|Lack of Efficacy|1
4974396|NCT00097370|17088499|P1|Stage 3|Withdrawal by Subject|3
4974397|NCT00097370|17088499|P1|Stage 3|Adverse Event|2
4974398|NCT00097370|17088499|P1|Stage 2|Lost to Follow-up|1
4974399|NCT00097370|17088499|P1|Stage 2|Sponsor Terminated Study|2
4974400|NCT00097370|17088499|P1|Stage 2|Pregnancy|1
4974401|NCT00097370|17088499|P1|Stage 2|Lack of Efficacy|3
4974402|NCT00097370|17088499|P1|Stage 2|Withdrawal by Subject|1
4974403|NCT00097370|17088499|P1|Stage 2|Adverse Event|5
4974404|NCT00097370|17088499|P1|Stage 1|Lack of Efficacy|2
4974405|NCT00097370|17088499|P1|Stage 1|Withdrawal by Subject|1
4974406|NCT00097370|17088499|P1|Stage 1|Adverse Event|3
4974407|NCT00096993|17088533|P2|Overall Study|Other unspecified|1
4974408|NCT00096993|17088534|P1|Overall Study|Other unspecified|1
4974409|NCT00096993|17088533|P2|Overall Study|Non-compliance|1
4974410|NCT00096993|17088534|P1|Overall Study|Non-compliance|0
4974411|NCT00096993|17088533|P2|Overall Study|Physician Decision|1
4974412|NCT00096993|17088534|P1|Overall Study|Physician Decision|2
4974413|NCT00096993|17088533|P2|Overall Study|Subject's decision|1
4974414|NCT00096993|17088534|P1|Overall Study|Subject's decision|3
4974415|NCT00096993|17088533|P2|Overall Study|Adverse Event|8
4974416|NCT00096993|17088534|P1|Overall Study|Adverse Event|2
4974417|NCT00096993|17088533|P2|Overall Study|Disease progression|53
4974418|NCT00096993|17088534|P1|Overall Study|Disease progression|56
4974419|NCT00096993|17088533|P2|Overall Study|Death|0
4974420|NCT00096993|17088534|P1|Overall Study|Death|1
4974421|NCT00096954|17088550|P2|Overall Study|Lost to Follow-up|5
4974422|NCT00096954|17088551|P1|Overall Study|Lost to Follow-up|8
4974423|NCT00096954|17088550|P2|Overall Study|Non-compliance|3
4974424|NCT00096954|17088551|P1|Overall Study|Non-compliance|0
4974425|NCT00096954|17088550|P2|Overall Study|Initiation of immunotherapy|0
4974426|NCT00096954|17088551|P1|Overall Study|Initiation of immunotherapy|1
4974427|NCT00096954|17088550|P2|Overall Study|Pregnancy|1
4974428|NCT00096954|17088551|P1|Overall Study|Pregnancy|1
4974429|NCT00096954|17088550|P2|Overall Study|Sponsors Decision|1
4974430|NCT00096954|17088551|P1|Overall Study|Sponsors Decision|1
4974431|NCT00096954|17088550|P2|Overall Study|Physician Decision|1
4974432|NCT00096954|17088551|P1|Overall Study|Physician Decision|1
4974433|NCT00096954|17088550|P2|Overall Study|Withdrawal by Subject|8
4974434|NCT00096954|17088551|P1|Overall Study|Withdrawal by Subject|9
4974435|NCT00096954|17088550|P2|Overall Study|Adverse Event|1
4974436|NCT00096954|17088551|P1|Overall Study|Adverse Event|3
4974437|NCT00096941|17088563|P1|Overall Study|disease progression|3
4974438|NCT00096785|17088570|P2|Overall Study|Relocated|0
4974439|NCT00096785|17088571|P1|Overall Study|Relocated|1
4974440|NCT00096785|17088570|P2|Overall Study|Withdrawal by Subject|1
4974441|NCT00096785|17088571|P1|Overall Study|Withdrawal by Subject|0
4974442|NCT00096785|17088570|P2|Overall Study|Lost to Follow-up|0
4974443|NCT00096785|17088571|P1|Overall Study|Lost to Follow-up|1
4974444|NCT00096538|17088600|P1|Overall Study|Withdrawal by Subject|1
4974445|NCT00096486|17088608|P4|Overall Study|Not Treated|1
4974446|NCT00096486|17088609|P3|Overall Study|Not Treated|1
4974447|NCT00096486|17088610|P2|Overall Study|Not Treated|0
4974448|NCT00096486|17088611|P1|Overall Study|Not Treated|0
4974449|NCT00096486|17088608|P4|Overall Study|Withdrawal by Subject|1
4974450|NCT00096486|17088609|P3|Overall Study|Withdrawal by Subject|1
4974451|NCT00096486|17088610|P2|Overall Study|Withdrawal by Subject|0
4974452|NCT00096486|17088611|P1|Overall Study|Withdrawal by Subject|0
4974453|NCT00096447|17088630|P1|Overall Study|Never treated|1
4974454|NCT00096382|17088646|P2|Overall Study|Death during treatment|0
4974455|NCT00096382|17088647|P1|Overall Study|Death during treatment|1
4974456|NCT00096382|17088646|P2|Overall Study|Not treated|0
4974457|NCT00096382|17088647|P1|Overall Study|Not treated|1
4974458|NCT00096356|17088657|P2|Overall Study|multiple reasons|18
4974459|NCT00096356|17088658|P1|Overall Study|multiple reasons|10
4974460|NCT00096356|17088657|P2|Overall Study|Lack of Efficacy|0
4974461|NCT00096356|17088658|P1|Overall Study|Lack of Efficacy|1
4974462|NCT00096356|17088657|P2|Overall Study|Withdrawal by Subject|23
4974463|NCT00096356|17088658|P1|Overall Study|Withdrawal by Subject|17
4974464|NCT00096356|17088657|P2|Overall Study|Physician Decision|3
4974465|NCT00096356|17088658|P1|Overall Study|Physician Decision|5
4974466|NCT00096356|17088657|P2|Overall Study|Adverse Event|9
4974467|NCT00096356|17088658|P1|Overall Study|Adverse Event|11
4974468|NCT00096278|17088670|P2|Overall Study|Patient not at risk for primary endpoint|2
4974469|NCT00096278|17088671|P1|Overall Study|Patient not at risk for primary endpoint|3
4974470|NCT00096278|17088670|P2|Overall Study|No follow-up data|18
4974471|NCT00096278|17088671|P1|Overall Study|No follow-up data|15
4974472|NCT00096265|17088690|P3|Overall Study|Ineligible|0
4974473|NCT00096265|17088691|P2|Overall Study|Ineligible|0
4974474|NCT00096265|17088692|P1|Overall Study|Ineligible|1
4974475|NCT00096226|17088718|P1|Overall Study|Protocol treatment not started|1
4974476|NCT00096226|17088718|P1|Overall Study|Ineligible|2
4974477|NCT00096200|17088732|P3|Overall Study|Ineligible pathology|0
4974478|NCT00096200|17088733|P2|Overall Study|Ineligible pathology|1
4974479|NCT00096200|17088734|P1|Overall Study|Ineligible pathology|0
4974480|NCT00096200|17088732|P3|Overall Study|Withdrawal by Subject|0
4974481|NCT00096200|17088733|P2|Overall Study|Withdrawal by Subject|2
4974482|NCT00096200|17088734|P1|Overall Study|Withdrawal by Subject|1
4974483|NCT00096200|17088732|P3|Overall Study|Adverse Event|0
4974484|NCT00096200|17088733|P2|Overall Study|Adverse Event|4
4974485|NCT00096200|17088734|P1|Overall Study|Adverse Event|0
4974486|NCT00096174|17088748|P1|Overall Study|other reason|8
4974487|NCT00096174|17088748|P1|Overall Study|Ineligible|6
4974488|NCT00096174|17088748|P1|Overall Study|Not started protocol therapy|3
4974489|NCT00096174|17088748|P1|Overall Study|Withdrawal by Subject|15
4974490|NCT00096174|17088748|P1|Overall Study|Death|6
4974491|NCT00096174|17088748|P1|Overall Study|Adverse Event|15
4974492|NCT00096174|17088748|P1|Overall Study|Lack of Efficacy|9
4974493|NCT00096135|17088793|P2|Overall Study|Ineligible|0
4974494|NCT00096135|17088794|P1|Overall Study|Ineligible|2
4974495|NCT00096135|17088793|P2|Overall Study|Other, specify|3
4974496|NCT00096135|17088794|P1|Overall Study|Other, specify|15
4974497|NCT00096135|17088793|P2|Overall Study|Progressive disease, Marrow,CNS, Relapse|7
4974498|NCT00096135|17088794|P1|Overall Study|Progressive disease, Marrow,CNS, Relapse|22
4974499|NCT00096135|17088793|P2|Overall Study|Refusal of further protocol therapy|1
4974500|NCT00096135|17088794|P1|Overall Study|Refusal of further protocol therapy|4
4974501|NCT00096135|17088793|P2|Overall Study|Physician Decision|4
4974502|NCT00096135|17088794|P1|Overall Study|Physician Decision|20
4974503|NCT00096044|17088810|P1|Overall Study|Disease Progression|4
4974504|NCT00096044|17088810|P1|Overall Study|Adverse Event|21
4974505|NCT00096044|17088810|P1|Overall Study|Withdrawal by Subject|9
4974506|NCT00096031|17088819|P1|Overall Study|Not protocol specified|5
4974507|NCT00096031|17088819|P1|Overall Study|Ineligible|8
4974508|NCT00096031|17088819|P1|Overall Study|Withdrawal by Subject|1
4974509|NCT00096031|17088819|P1|Overall Study|Death|4
4974510|NCT00096031|17088819|P1|Overall Study|Lack of Efficacy|42
4974511|NCT00096031|17088819|P1|Overall Study|Adverse Event|3
4974512|NCT00096018|17088827|P2|Overall Study|Miscellaneous|1
4974513|NCT00096018|17088828|P1|Overall Study|Miscellaneous|2
4974514|NCT00096018|17088827|P2|Overall Study|Withdrawal by Subject|2
4974515|NCT00096018|17088828|P1|Overall Study|Withdrawal by Subject|0
4974516|NCT00096018|17088827|P2|Overall Study|Death|1
4974517|NCT00096018|17088828|P1|Overall Study|Death|0
4974518|NCT00096018|17088827|P2|Overall Study|Adverse Event|5
4974519|NCT00096018|17088828|P1|Overall Study|Adverse Event|0
4974520|NCT00096018|17088827|P2|Overall Study|Miscellaneous (not treated)|2
4974521|NCT00096018|17088828|P1|Overall Study|Miscellaneous (not treated)|0
4974522|NCT00096018|17088827|P2|Overall Study|Became Ineligible (not treated)|3
4974523|NCT00096018|17088828|P1|Overall Study|Became Ineligible (not treated)|0
4974524|NCT00095979|17088836|P1|Overall Study|Ineligible: Second primary cancer site|2
4974525|NCT00095940|17088854|P9|Lapatinib Continuation/Phase II|Adverse Event|0
4974526|NCT00095940|17088855|P8|Lapatinib Continuation/Phase II|Adverse Event|1
4974527|NCT00095940|17088856|P7|Lapatinib Continuation/Phase II|Adverse Event|0
4974528|NCT00095940|17088857|P6|Lapatinib Continuation/Phase II|Adverse Event|0
4974529|NCT00095940|17088858|P5|Lapatinib Continuation/Phase II|Adverse Event|0
4974530|NCT00095940|17088859|P4|Lapatinib Continuation/Phase II|Adverse Event|0
4974531|NCT00095940|17088860|P3|Lapatinib Continuation/Phase II|Adverse Event|0
4974532|NCT00095940|17088861|P2|Lapatinib Continuation/Phase II|Adverse Event|0
4974533|NCT00095940|17088862|P1|Lapatinib Continuation/Phase II|Adverse Event|0
4974534|NCT00095940|17088854|P9|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4974535|NCT00095940|17088855|P8|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4974536|NCT00095940|17088856|P7|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4974537|NCT00095940|17088857|P6|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4974538|NCT00095940|17088858|P5|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4974539|NCT00095940|17088859|P4|Lapatinib Continuation/Phase II|Withdrawal by Subject|0
4974540|NCT00095940|17088860|P3|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4974541|NCT00095940|17088861|P2|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4974542|NCT00095940|17088862|P1|Lapatinib Continuation/Phase II|Withdrawal by Subject|1
4974543|NCT00095940|17088854|P9|Lapatinib Continuation/Phase II|Disease Progression|12
4974544|NCT00095940|17088855|P8|Lapatinib Continuation/Phase II|Disease Progression|1
4974545|NCT00095940|17088856|P7|Lapatinib Continuation/Phase II|Disease Progression|2
4974546|NCT00095940|17088857|P6|Lapatinib Continuation/Phase II|Disease Progression|13
4974547|NCT00095940|17088858|P5|Lapatinib Continuation/Phase II|Disease Progression|0
4974548|NCT00095940|17088859|P4|Lapatinib Continuation/Phase II|Disease Progression|0
4974549|NCT00095940|17088860|P3|Lapatinib Continuation/Phase II|Disease Progression|15
4974550|NCT00095940|17088861|P2|Lapatinib Continuation/Phase II|Disease Progression|1
4974551|NCT00095940|17088862|P1|Lapatinib Continuation/Phase II|Disease Progression|1
4974552|NCT00095836|17088895|P1|Overall Study|Death|2
4974553|NCT00095836|17088895|P1|Overall Study|Adverse Event|1
4974554|NCT00095836|17088895|P1|Overall Study|Lost to Follow-up|1
4974555|NCT00095628|17088925|P1|Overall Study|Disease progression prior to treatment|1
4974556|NCT00095576|17088936|P2|Overall Study|Subject moved|36
4974557|NCT00095576|17088937|P1|Overall Study|Subject moved|30
4974558|NCT00095576|17088936|P2|Overall Study|Site terminated|67
4974559|NCT00095576|17088937|P1|Overall Study|Site terminated|75
4974560|NCT00095576|17088936|P2|Overall Study|Option to switch to a rollover study|1099
4974561|NCT00095576|17088937|P1|Overall Study|Option to switch to a rollover study|1097
4974562|NCT00095576|17088936|P2|Overall Study|Withdrawal by Subject|47
4974563|NCT00095576|17088937|P1|Overall Study|Withdrawal by Subject|34
4974564|NCT00095576|17088936|P2|Overall Study|Protocol Violation|0
4974565|NCT00095576|17088937|P1|Overall Study|Protocol Violation|1
4974566|NCT00095576|17088936|P2|Overall Study|Lost to Follow-up|229
4974567|NCT00095576|17088937|P1|Overall Study|Lost to Follow-up|233
4974568|NCT00095576|17088936|P2|Overall Study|Adverse Event|3
4974569|NCT00095576|17088937|P1|Overall Study|Adverse Event|5
4974570|NCT00095498|17088961|P3|Overall Study|Requirement for alternative therapy|2
4974571|NCT00095498|17088962|P2|Overall Study|Requirement for alternative therapy|0
4974572|NCT00095498|17088963|P1|Overall Study|Requirement for alternative therapy|1
4974573|NCT00095498|17088961|P3|Overall Study|Protocol Violation|1
4974574|NCT00095498|17088962|P2|Overall Study|Protocol Violation|0
4974575|NCT00095498|17088963|P1|Overall Study|Protocol Violation|0
4974576|NCT00095498|17088961|P3|Overall Study|Other|6
4974577|NCT00095498|17088962|P2|Overall Study|Other|7
4974578|NCT00095498|17088963|P1|Overall Study|Other|6
4974579|NCT00095498|17088961|P3|Overall Study|Noncompliance|1
4974580|NCT00095498|17088962|P2|Overall Study|Noncompliance|0
4974581|NCT00095498|17088963|P1|Overall Study|Noncompliance|1
4974582|NCT00095498|17088961|P3|Overall Study|Lost to Follow-up|2
4974583|NCT00095498|17088962|P2|Overall Study|Lost to Follow-up|1
4974584|NCT00095498|17088963|P1|Overall Study|Lost to Follow-up|1
4974585|NCT00095498|17088961|P3|Overall Study|Ineligibility determined|2
4974586|NCT00095498|17088962|P2|Overall Study|Ineligibility determined|0
4974587|NCT00095498|17088963|P1|Overall Study|Ineligibility determined|3
4974588|NCT00095498|17088961|P3|Overall Study|Disease progression|1
4974589|NCT00095498|17088962|P2|Overall Study|Disease progression|1
4974590|NCT00095498|17088963|P1|Overall Study|Disease progression|0
4974591|NCT00095498|17088961|P3|Overall Study|Withdrawal by Subject|15
4974592|NCT00095498|17088962|P2|Overall Study|Withdrawal by Subject|16
4974593|NCT00095498|17088963|P1|Overall Study|Withdrawal by Subject|15
4974594|NCT00095498|17088961|P3|Overall Study|Adverse Event|1
4974595|NCT00095498|17088962|P2|Overall Study|Adverse Event|0
4974596|NCT00095498|17088963|P1|Overall Study|Adverse Event|1
4974597|NCT00095498|17088961|P3|Overall Study|Physician Decision|8
4974598|NCT00095498|17088962|P2|Overall Study|Physician Decision|10
4974599|NCT00095498|17088963|P1|Overall Study|Physician Decision|9
4974600|NCT00095303|17089390|P2|Follow Up Study|Lost to Follow-up|58
4974601|NCT00095303|17089391|P1|Follow Up Study|Lost to Follow-up|59
4974602|NCT00095303|17089390|P2|Main Study|Lost to Follow-up|87
4974603|NCT00095303|17089391|P1|Main Study|Lost to Follow-up|91
4974604|NCT00095238|17089459|P2|Overall Study|Other Reasons|88
4974605|NCT00095238|17089460|P1|Overall Study|Other Reasons|87
4974606|NCT00095238|17089459|P2|Overall Study|Missing|0
4974607|NCT00095238|17089460|P1|Overall Study|Missing|1
4974608|NCT00095238|17089459|P2|Overall Study|Study terminated by sponsor|1
4974609|NCT00095238|17089460|P1|Overall Study|Study terminated by sponsor|0
4974610|NCT00095238|17089459|P2|Overall Study|No longer met study criteria|5
4974611|NCT00095238|17089460|P1|Overall Study|No longer met study criteria|4
4974612|NCT00095238|17089459|P2|Overall Study|Noncompliance|45
4974613|NCT00095238|17089460|P1|Overall Study|Noncompliance|44
4974614|NCT00095238|17089459|P2|Overall Study|Lost to Follow-up|24
4974615|NCT00095238|17089460|P1|Overall Study|Lost to Follow-up|19
4974616|NCT00095238|17089459|P2|Overall Study|Death|170
4974617|NCT00095238|17089460|P1|Overall Study|Death|154
4974618|NCT00095238|17089459|P2|Overall Study|Subject Withdrew Consent|223
4974619|NCT00095238|17089460|P1|Overall Study|Subject Withdrew Consent|208
4974620|NCT00095238|17089459|P2|Overall Study|Adverse Event|287
4974621|NCT00095238|17089460|P1|Overall Study|Adverse Event|331
4974622|NCT00095238|17089459|P2|Overall Study|Lack of Efficacy|9
4974623|NCT00095238|17089460|P1|Overall Study|Lack of Efficacy|9
4974624|NCT00095212|17089522|P2|Overall Study|Withdrawal by Subject|3
4974625|NCT00095212|17089523|P1|Overall Study|Withdrawal by Subject|1
4974626|NCT00095199|17089553|P4|Overall Study|Data inadvertently lost by site|0
4974627|NCT00095199|17089554|P3|Overall Study|Data inadvertently lost by site|0
4974628|NCT00095199|17089555|P2|Overall Study|Data inadvertently lost by site|0
4974629|NCT00095199|17089556|P1|Overall Study|Data inadvertently lost by site|1
4974630|NCT00095199|17089553|P4|Overall Study|Primary tumor removed in other surgery|0
4974631|NCT00095199|17089554|P3|Overall Study|Primary tumor removed in other surgery|0
4974632|NCT00095199|17089555|P2|Overall Study|Primary tumor removed in other surgery|1
4974633|NCT00095199|17089556|P1|Overall Study|Primary tumor removed in other surgery|0
4974634|NCT00095199|17089553|P4|Overall Study|Started radiotherapy regimen|0
4974635|NCT00095199|17089554|P3|Overall Study|Started radiotherapy regimen|0
4974636|NCT00095199|17089555|P2|Overall Study|Started radiotherapy regimen|1
4974637|NCT00095199|17089556|P1|Overall Study|Started radiotherapy regimen|0
4974638|NCT00095199|17089553|P4|Overall Study|Started Palliative Radiotherapy|0
4974639|NCT00095199|17089554|P3|Overall Study|Started Palliative Radiotherapy|0
4974640|NCT00095199|17089555|P2|Overall Study|Started Palliative Radiotherapy|0
4974641|NCT00095199|17089556|P1|Overall Study|Started Palliative Radiotherapy|1
4974642|NCT00095199|17089553|P4|Overall Study|Not eligible|1
4974643|NCT00095199|17089554|P3|Overall Study|Not eligible|0
4974644|NCT00095199|17089555|P2|Overall Study|Not eligible|7
4974645|NCT00095199|17089556|P1|Overall Study|Not eligible|1
4974646|NCT00095199|17089553|P4|Overall Study|Physician Decision|1
4974647|NCT00095199|17089554|P3|Overall Study|Physician Decision|1
4974648|NCT00095199|17089555|P2|Overall Study|Physician Decision|6
4974649|NCT00095199|17089556|P1|Overall Study|Physician Decision|5
4974650|NCT00095199|17089553|P4|Overall Study|Surgery needed could not start in 7 days|0
4974651|NCT00095199|17089554|P3|Overall Study|Surgery needed could not start in 7 days|1
4974652|NCT00095199|17089555|P2|Overall Study|Surgery needed could not start in 7 days|0
4974653|NCT00095199|17089556|P1|Overall Study|Surgery needed could not start in 7 days|0
4974654|NCT00095199|17089553|P4|Overall Study|Liver function test results elevated|1
4974655|NCT00095199|17089554|P3|Overall Study|Liver function test results elevated|1
4974656|NCT00095199|17089555|P2|Overall Study|Liver function test results elevated|0
4974657|NCT00095199|17089556|P1|Overall Study|Liver function test results elevated|0
4974658|NCT00095199|17089553|P4|Overall Study|Protocol Violation|0
4974659|NCT00095199|17089554|P3|Overall Study|Protocol Violation|2
4974660|NCT00095199|17089555|P2|Overall Study|Protocol Violation|4
4974661|NCT00095199|17089556|P1|Overall Study|Protocol Violation|4
4974662|NCT00095199|17089553|P4|Overall Study|Withdrawal by Subject|22
4974663|NCT00095199|17089554|P3|Overall Study|Withdrawal by Subject|13
4974664|NCT00095199|17089555|P2|Overall Study|Withdrawal by Subject|16
4974665|NCT00095199|17089556|P1|Overall Study|Withdrawal by Subject|21
4974666|NCT00095199|17089553|P4|Overall Study|Death|9
4974667|NCT00095199|17089554|P3|Overall Study|Death|11
4974668|NCT00095199|17089555|P2|Overall Study|Death|6
4974669|NCT00095199|17089556|P1|Overall Study|Death|10
4974670|NCT00095199|17089553|P4|Overall Study|Progressive disease|98
4974671|NCT00095199|17089554|P3|Overall Study|Progressive disease|105
4974672|NCT00095199|17089555|P2|Overall Study|Progressive disease|179
4974673|NCT00095199|17089556|P1|Overall Study|Progressive disease|213
4974674|NCT00095199|17089553|P4|Overall Study|Adverse Event|11
4974675|NCT00095199|17089554|P3|Overall Study|Adverse Event|26
4974676|NCT00095199|17089555|P2|Overall Study|Adverse Event|22
4974677|NCT00095199|17089556|P1|Overall Study|Adverse Event|40
4974678|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Other|8
4974679|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Other|6
4974680|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Other|4
4974681|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Other|0
4974682|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Other|0
4974683|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Other|0
4974684|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Pregnancy|3
4974685|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Pregnancy|2
4974686|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Pregnancy|1
4974687|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Pregnancy|0
4974688|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Pregnancy|0
4974689|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Pregnancy|0
4974690|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
4974691|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2
4974692|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4974693|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4974694|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4974695|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0
4974696|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
4974697|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1
4974698|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4974699|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4974700|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4974701|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0
4974702|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4974703|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6
4974704|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4
4974705|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4974706|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4974707|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0
4974708|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Lost to Follow-up|6
4974709|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Lost to Follow-up|5
4974710|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Lost to Follow-up|2
4974711|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
4974712|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
4974713|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Lost to Follow-up|0
4974714|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Lack of Efficacy|8
4974715|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Lack of Efficacy|5
4974716|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Lack of Efficacy|11
4974717|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
4974718|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
4974719|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Lack of Efficacy|0
4974720|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Adverse Event|3
4974721|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Adverse Event|2
4974722|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Adverse Event|1
4974723|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Adverse Event|0
4974724|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Adverse Event|0
4974725|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Adverse Event|0
4974726|NCT00095173|17089594|P6|Open-Label Extension Phase (Period C)|Death|1
4974727|NCT00095173|17089595|P5|Open-Label Extension Phase (Period C)|Death|0
4974728|NCT00095173|17089596|P4|Open-Label Extension Phase (Period C)|Death|0
4974729|NCT00095173|17089597|P3|Open-Label Extension Phase (Period C)|Death|0
4974730|NCT00095173|17089598|P2|Open-Label Extension Phase (Period C)|Death|0
4974731|NCT00095173|17089599|P1|Open-Label Extension Phase (Period C)|Death|0
4974732|NCT00095173|17089594|P6|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4974733|NCT00095173|17089595|P5|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4974734|NCT00095173|17089596|P4|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4974735|NCT00095173|17089597|P3|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4974736|NCT00095173|17089598|P2|Double-Blind Phase (Period B)|Withdrawal by Subject|1
4974737|NCT00095173|17089599|P1|Double-Blind Phase (Period B)|Withdrawal by Subject|0
4974738|NCT00095173|17089594|P6|Double-Blind Phase (Period B)|Lack of Efficacy|0
4974739|NCT00095173|17089595|P5|Double-Blind Phase (Period B)|Lack of Efficacy|0
4974740|NCT00095173|17089596|P4|Double-Blind Phase (Period B)|Lack of Efficacy|0
4974741|NCT00095173|17089597|P3|Double-Blind Phase (Period B)|Lack of Efficacy|31
4974742|NCT00095173|17089598|P2|Double-Blind Phase (Period B)|Lack of Efficacy|10
4974743|NCT00095173|17089599|P1|Double-Blind Phase (Period B)|Lack of Efficacy|0
4974744|NCT00095173|17089594|P6|Open-Label Lead-In Phase (Period A)|Other|0
4974745|NCT00095173|17089595|P5|Open-Label Lead-In Phase (Period A)|Other|0
4974746|NCT00095173|17089596|P4|Open-Label Lead-In Phase (Period A)|Other|0
4974747|NCT00095173|17089597|P3|Open-Label Lead-In Phase (Period A)|Other|0
4974748|NCT00095173|17089598|P2|Open-Label Lead-In Phase (Period A)|Other|0
4974749|NCT00095173|17089599|P1|Open-Label Lead-In Phase (Period A)|Other|1
4974750|NCT00095173|17089594|P6|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4974751|NCT00095173|17089595|P5|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4974752|NCT00095173|17089596|P4|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4974753|NCT00095173|17089597|P3|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4974754|NCT00095173|17089598|P2|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0
4974755|NCT00095173|17089599|P1|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1
4974756|NCT00095173|17089594|P6|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4974757|NCT00095173|17089595|P5|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4974758|NCT00095173|17089596|P4|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4974759|NCT00095173|17089597|P3|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4974760|NCT00095173|17089598|P2|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0
4974761|NCT00095173|17089599|P1|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17
4974762|NCT00095173|17089594|P6|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4974763|NCT00095173|17089595|P5|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4974764|NCT00095173|17089596|P4|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4974765|NCT00095173|17089597|P3|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4974766|NCT00095173|17089598|P2|Open-Label Lead-In Phase (Period A)|Adverse Event|0
4974767|NCT00095173|17089599|P1|Open-Label Lead-In Phase (Period A)|Adverse Event|1
4974768|NCT00095147|17089637|P5|Long-term Extension Period|Leaving country|1
4974769|NCT00095147|17089638|P4|Long-term Extension Period|Leaving country|0
4974770|NCT00095147|17089639|P3|Long-term Extension Period|Leaving country|0
4974771|NCT00095147|17089640|P2|Long-term Extension Period|Leaving country|0
4974772|NCT00095147|17089641|P1|Long-term Extension Period|Leaving country|0
4974773|NCT00095147|17089637|P5|Long-term Extension Period|Participant chose to use Revellex|1
4974774|NCT00095147|17089638|P4|Long-term Extension Period|Participant chose to use Revellex|0
4974775|NCT00095147|17089639|P3|Long-term Extension Period|Participant chose to use Revellex|0
4974776|NCT00095147|17089640|P2|Long-term Extension Period|Participant chose to use Revellex|0
4974777|NCT00095147|17089641|P1|Long-term Extension Period|Participant chose to use Revellex|0
4974778|NCT00095147|17089637|P5|Long-term Extension Period|No longer meets study criteria|1
4974779|NCT00095147|17089638|P4|Long-term Extension Period|No longer meets study criteria|0
4974780|NCT00095147|17089639|P3|Long-term Extension Period|No longer meets study criteria|0
4974781|NCT00095147|17089640|P2|Long-term Extension Period|No longer meets study criteria|0
4974782|NCT00095147|17089641|P1|Long-term Extension Period|No longer meets study criteria|0
4974783|NCT00095147|17089637|P5|Long-term Extension Period|Pregnancy|1
4974784|NCT00095147|17089638|P4|Long-term Extension Period|Pregnancy|0
4974785|NCT00095147|17089639|P3|Long-term Extension Period|Pregnancy|0
4974786|NCT00095147|17089640|P2|Long-term Extension Period|Pregnancy|0
4974787|NCT00095147|17089641|P1|Long-term Extension Period|Pregnancy|0
4974788|NCT00095147|17089637|P5|Long-term Extension Period|Withdrawal of consent|12
4974789|NCT00095147|17089638|P4|Long-term Extension Period|Withdrawal of consent|0
4974790|NCT00095147|17089639|P3|Long-term Extension Period|Withdrawal of consent|0
4974791|NCT00095147|17089640|P2|Long-term Extension Period|Withdrawal of consent|0
4974792|NCT00095147|17089641|P1|Long-term Extension Period|Withdrawal of consent|0
4974793|NCT00095147|17089637|P5|Long-term Extension Period|Lost to Follow-up|6
4974794|NCT00095147|17089638|P4|Long-term Extension Period|Lost to Follow-up|0
4974795|NCT00095147|17089639|P3|Long-term Extension Period|Lost to Follow-up|0
4974796|NCT00095147|17089640|P2|Long-term Extension Period|Lost to Follow-up|0
4974797|NCT00095147|17089641|P1|Long-term Extension Period|Lost to Follow-up|0
4974798|NCT00095147|17089637|P5|Long-term Extension Period|Lack of Efficacy|9
4974799|NCT00095147|17089638|P4|Long-term Extension Period|Lack of Efficacy|0
4974800|NCT00095147|17089639|P3|Long-term Extension Period|Lack of Efficacy|0
4974801|NCT00095147|17089640|P2|Long-term Extension Period|Lack of Efficacy|0
4974802|NCT00095147|17089641|P1|Long-term Extension Period|Lack of Efficacy|0
4974803|NCT00095147|17089637|P5|Long-term Extension Period|Adverse Event|11
4974804|NCT00095147|17089638|P4|Long-term Extension Period|Adverse Event|0
4974805|NCT00095147|17089639|P3|Long-term Extension Period|Adverse Event|0
4974806|NCT00095147|17089640|P2|Long-term Extension Period|Adverse Event|0
4974807|NCT00095147|17089641|P1|Long-term Extension Period|Adverse Event|0
4974808|NCT00095147|17089637|P5|Long-term Extension Period|Death|3
4974809|NCT00095147|17089638|P4|Long-term Extension Period|Death|0
4974810|NCT00095147|17089639|P3|Long-term Extension Period|Death|0
4974811|NCT00095147|17089640|P2|Long-term Extension Period|Death|0
4974812|NCT00095147|17089641|P1|Long-term Extension Period|Death|0
4974813|NCT00095147|17089637|P5|Double-blind Period 2 (Days 198-365)|Participant relocation|0
4974814|NCT00095147|17089638|P4|Double-blind Period 2 (Days 198-365)|Participant relocation|1
4974815|NCT00095147|17089639|P3|Double-blind Period 2 (Days 198-365)|Participant relocation|0
4974816|NCT00095147|17089640|P2|Double-blind Period 2 (Days 198-365)|Participant relocation|0
4974817|NCT00095147|17089641|P1|Double-blind Period 2 (Days 198-365)|Participant relocation|1
4974818|NCT00095147|17089637|P5|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
4974819|NCT00095147|17089638|P4|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
4974820|NCT00095147|17089639|P3|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0
4974821|NCT00095147|17089640|P2|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2
4974822|NCT00095147|17089641|P1|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3
4974823|NCT00095147|17089637|P5|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
4974824|NCT00095147|17089638|P4|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1
4974825|NCT00095147|17089639|P3|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0
4974826|NCT00095147|17089640|P2|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4
4974827|NCT00095147|17089641|P1|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2
4974828|NCT00095147|17089637|P5|Double-blind Period 2 (Days 198-365)|Adverse Event|0
4974829|NCT00095147|17089638|P4|Double-blind Period 2 (Days 198-365)|Adverse Event|0
4974830|NCT00095147|17089639|P3|Double-blind Period 2 (Days 198-365)|Adverse Event|0
4974831|NCT00095147|17089640|P2|Double-blind Period 2 (Days 198-365)|Adverse Event|4
4974832|NCT00095147|17089641|P1|Double-blind Period 2 (Days 198-365)|Adverse Event|2
4974833|NCT00095147|17089637|P5|Double-blind Period 2 (Days 198-365)|Death|0
4974834|NCT00095147|17089638|P4|Double-blind Period 2 (Days 198-365)|Death|1
4974835|NCT00095147|17089639|P3|Double-blind Period 2 (Days 198-365)|Death|0
4974836|NCT00095147|17089640|P2|Double-blind Period 2 (Days 198-365)|Death|1
4974837|NCT00095147|17089641|P1|Double-blind Period 2 (Days 198-365)|Death|0
4974838|NCT00095147|17089637|P5|Double-blind Period 1 (Days 1-197)|Pregnancy|0
4974839|NCT00095147|17089638|P4|Double-blind Period 1 (Days 1-197)|Pregnancy|0
4974840|NCT00095147|17089639|P3|Double-blind Period 1 (Days 1-197)|Pregnancy|0
4974841|NCT00095147|17089640|P2|Double-blind Period 1 (Days 1-197)|Pregnancy|1
4974842|NCT00095147|17089641|P1|Double-blind Period 1 (Days 1-197)|Pregnancy|1
4974843|NCT00095147|17089637|P5|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
4974844|NCT00095147|17089638|P4|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
4974845|NCT00095147|17089639|P3|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
4974846|NCT00095147|17089640|P2|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0
4974847|NCT00095147|17089641|P1|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1
4974848|NCT00095147|17089637|P5|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
4974849|NCT00095147|17089638|P4|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
4974850|NCT00095147|17089639|P3|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0
4974851|NCT00095147|17089640|P2|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
4974852|NCT00095147|17089641|P1|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2
4974853|NCT00095147|17089637|P5|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
4974854|NCT00095147|17089638|P4|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0
4974855|NCT00095147|17089639|P3|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1
4974856|NCT00095147|17089640|P2|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
4974857|NCT00095147|17089641|P1|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2
4974858|NCT00095147|17089637|P5|Double-blind Period 1 (Days 1-197)|Adverse Event|0
4974859|NCT00095147|17089638|P4|Double-blind Period 1 (Days 1-197)|Adverse Event|0
4974860|NCT00095147|17089639|P3|Double-blind Period 1 (Days 1-197)|Adverse Event|1
4974861|NCT00095147|17089640|P2|Double-blind Period 1 (Days 1-197)|Adverse Event|8
4974862|NCT00095147|17089641|P1|Double-blind Period 1 (Days 1-197)|Adverse Event|2
4974863|NCT00095147|17089637|P5|Double-blind Period 1 (Days 1-197)|Death|0
4974864|NCT00095147|17089638|P4|Double-blind Period 1 (Days 1-197)|Death|0
4974865|NCT00095147|17089639|P3|Double-blind Period 1 (Days 1-197)|Death|0
4974866|NCT00095147|17089640|P2|Double-blind Period 1 (Days 1-197)|Death|0
4974867|NCT00095147|17089641|P1|Double-blind Period 1 (Days 1-197)|Death|1
4974868|NCT00095121|17089836|P2|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0
4974869|NCT00095121|17089837|P1|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2
4974870|NCT00095121|17089836|P2|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0
4974871|NCT00095121|17089837|P1|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1
4974872|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Protocol Violation|1
4974873|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Protocol Violation|0
4974874|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Protocol specific criteria|0
4974875|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Protocol specific criteria|1
4974876|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Death|1
4974877|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Death|3
4974878|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Patient Moved|0
4974879|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Patient Moved|1
4974880|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Withdrawal by Subject|1
4974881|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Withdrawal by Subject|2
4974882|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Lost to Follow-up|0
4974883|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Lost to Follow-up|1
4974884|NCT00095056|17089883|P2|Phase B (Weeks 12-54)|Adverse Event|2
4974885|NCT00095056|17089884|P1|Phase B (Weeks 12-54)|Adverse Event|2
4974886|NCT00095056|17089883|P2|Phase A (Weeks 0-12)|Protocol specific criteria|0
4974887|NCT00095056|17089884|P1|Phase A (Weeks 0-12)|Protocol specific criteria|2
4974888|NCT00095056|17089883|P2|Phase A (Weeks 0-12)|Death|0
4974889|NCT00095056|17089884|P1|Phase A (Weeks 0-12)|Death|1
4974890|NCT00095056|17089883|P2|Phase A (Weeks 0-12)|Withdrawal by Subject|0
4974891|NCT00095056|17089884|P1|Phase A (Weeks 0-12)|Withdrawal by Subject|3
4974892|NCT00095056|17089883|P2|Phase A (Weeks 0-12)|Adverse Event|1
4974893|NCT00095056|17089884|P1|Phase A (Weeks 0-12)|Adverse Event|1
4974894|NCT00094861|17090013|P2|Overall Study|Other|0
4974895|NCT00094861|17090014|P1|Overall Study|Other|3
4974896|NCT00094861|17090013|P2|Overall Study|Death|2
4974897|NCT00094861|17090014|P1|Overall Study|Death|4
4974898|NCT00094861|17090013|P2|Overall Study|Lost to Follow-up|1
4974899|NCT00094861|17090014|P1|Overall Study|Lost to Follow-up|0
4974900|NCT00094861|17090013|P2|Overall Study|Physician Decision|1
4974901|NCT00094861|17090014|P1|Overall Study|Physician Decision|1
4974902|NCT00094861|17090013|P2|Overall Study|Withdrawal by Subject|3
4974903|NCT00094861|17090014|P1|Overall Study|Withdrawal by Subject|5
4974904|NCT00094861|17090013|P2|Overall Study|Adverse Event|2
4974905|NCT00094861|17090014|P1|Overall Study|Adverse Event|5
4974906|NCT00094835|17090041|P7|Overall Study|Other|0
4974907|NCT00094835|17090042|P6|Overall Study|Other|0
4974908|NCT00094835|17090043|P5|Overall Study|Other|0
4974909|NCT00094835|17090044|P4|Overall Study|Other|1
4974910|NCT00094835|17090045|P3|Overall Study|Other|1
4974911|NCT00094835|17090046|P2|Overall Study|Other|1
4974912|NCT00094835|17090047|P1|Overall Study|Other|1
4974913|NCT00094835|17090041|P7|Overall Study|Non-compliance|1
4974914|NCT00094835|17090042|P6|Overall Study|Non-compliance|2
4974915|NCT00094835|17090043|P5|Overall Study|Non-compliance|2
4974916|NCT00094835|17090044|P4|Overall Study|Non-compliance|0
4974917|NCT00094835|17090045|P3|Overall Study|Non-compliance|2
4974918|NCT00094835|17090046|P2|Overall Study|Non-compliance|2
4974919|NCT00094835|17090047|P1|Overall Study|Non-compliance|1
4974920|NCT00094835|17090041|P7|Overall Study|Death|0
4974921|NCT00094835|17090042|P6|Overall Study|Death|0
4974922|NCT00094835|17090043|P5|Overall Study|Death|1
4974923|NCT00094835|17090044|P4|Overall Study|Death|0
4974924|NCT00094835|17090045|P3|Overall Study|Death|0
4974925|NCT00094835|17090046|P2|Overall Study|Death|0
4974926|NCT00094835|17090047|P1|Overall Study|Death|1
4974927|NCT00094835|17090041|P7|Overall Study|Lost to Follow-up|0
4974928|NCT00094835|17090042|P6|Overall Study|Lost to Follow-up|0
4974929|NCT00094835|17090043|P5|Overall Study|Lost to Follow-up|1
4974930|NCT00094835|17090044|P4|Overall Study|Lost to Follow-up|0
4974931|NCT00094835|17090045|P3|Overall Study|Lost to Follow-up|0
4974932|NCT00094835|17090046|P2|Overall Study|Lost to Follow-up|0
4974933|NCT00094835|17090047|P1|Overall Study|Lost to Follow-up|0
4974934|NCT00094835|17090041|P7|Overall Study|Withdrawal by Subject|1
4974935|NCT00094835|17090042|P6|Overall Study|Withdrawal by Subject|0
4974936|NCT00094835|17090043|P5|Overall Study|Withdrawal by Subject|0
4974937|NCT00094835|17090044|P4|Overall Study|Withdrawal by Subject|0
4974938|NCT00094835|17090045|P3|Overall Study|Withdrawal by Subject|0
4974939|NCT00094835|17090046|P2|Overall Study|Withdrawal by Subject|0
4974940|NCT00094835|17090047|P1|Overall Study|Withdrawal by Subject|0
4974941|NCT00094835|17090041|P7|Overall Study|Physician Decision|0
4974942|NCT00094835|17090042|P6|Overall Study|Physician Decision|1
4974943|NCT00094835|17090043|P5|Overall Study|Physician Decision|0
4974944|NCT00094835|17090044|P4|Overall Study|Physician Decision|0
4974945|NCT00094835|17090045|P3|Overall Study|Physician Decision|0
4974946|NCT00094835|17090046|P2|Overall Study|Physician Decision|0
4974947|NCT00094835|17090047|P1|Overall Study|Physician Decision|1
4974948|NCT00094809|17090125|P2|Overall Study|Other|1
4974949|NCT00094809|17090126|P1|Overall Study|Other|1
4974950|NCT00094809|17090125|P2|Overall Study|Study drug not received|8
4974951|NCT00094809|17090126|P1|Overall Study|Study drug not received|2
4974952|NCT00094809|17090125|P2|Overall Study|Informed consent signed after treatment|0
4974953|NCT00094809|17090126|P1|Overall Study|Informed consent signed after treatment|1
4974954|NCT00094809|17090125|P2|Overall Study|Other|4
4974955|NCT00094809|17090126|P1|Overall Study|Other|2
4974956|NCT00094809|17090125|P2|Overall Study|Protocol-specified criteria|1
4974957|NCT00094809|17090126|P1|Overall Study|Protocol-specified criteria|1
4974958|NCT00094809|17090125|P2|Overall Study|Death|25
4974959|NCT00094809|17090126|P1|Overall Study|Death|19
4974960|NCT00094809|17090125|P2|Overall Study|Lost to Follow-up|6
4974961|NCT00094809|17090126|P1|Overall Study|Lost to Follow-up|6
4974962|NCT00094809|17090125|P2|Overall Study|Physician Decision|5
4974963|NCT00094809|17090126|P1|Overall Study|Physician Decision|3
4974964|NCT00094809|17090125|P2|Overall Study|Disease progression|3
4974965|NCT00094809|17090126|P1|Overall Study|Disease progression|3
4974966|NCT00094809|17090125|P2|Overall Study|Withdrawal by Subject|9
4974967|NCT00094809|17090126|P1|Overall Study|Withdrawal by Subject|8
4974968|NCT00094809|17090125|P2|Overall Study|Adverse Event|1
4974969|NCT00094809|17090126|P1|Overall Study|Adverse Event|3
4974970|NCT00094809|17090125|P2|Overall Study|Noncompliance|0
4974971|NCT00094809|17090126|P1|Overall Study|Noncompliance|1
4974972|NCT00094809|17090125|P2|Overall Study|Protocol deviation|2
4974973|NCT00094809|17090126|P1|Overall Study|Protocol deviation|2
4974974|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Other|23
4974975|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Other|15
4974976|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Site Terminated|2
4974977|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Site Terminated|2
4974978|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38
4974979|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28
4974980|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Patient Moved|2
4974981|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Patient Moved|6
4974982|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30
4974983|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29
4974984|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Protocol Violation|12
4974985|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Protocol Violation|13
4974986|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15
4974987|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25
4974988|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162
4974989|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180
4974990|NCT00094770|17090152|P2|Year 2 (Week 0 to Week 104)|Adverse Event|36
4974991|NCT00094770|17090153|P1|Year 2 (Week 0 to Week 104)|Adverse Event|35
4974992|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Other|11
4974993|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Other|10
4974994|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Site Terminated|2
4974995|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Site Terminated|2
4974996|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28
4974997|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25
4974998|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Patient Moved|2
4974999|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Patient Moved|6
4975000|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25
4975001|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19
4975002|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
4975003|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Protocol Violation|10
4975004|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10
4975005|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19
4975006|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58
4975007|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86
4975008|NCT00094770|17090152|P2|Year 1 ( Week 0 to Week 52)|Adverse Event|26
4975009|NCT00094770|17090153|P1|Year 1 ( Week 0 to Week 52)|Adverse Event|25
4975010|NCT00094757|17090184|P3|Overall Study|Protocol specified discontinuation|0
4975011|NCT00094757|17090185|P2|Overall Study|Protocol specified discontinuation|3
4975012|NCT00094757|17090186|P1|Overall Study|Protocol specified discontinuation|1
4975013|NCT00094757|17090184|P3|Overall Study|Other|1
4975014|NCT00094757|17090185|P2|Overall Study|Other|3
4975015|NCT00094757|17090186|P1|Overall Study|Other|3
4975016|NCT00094757|17090184|P3|Overall Study|Withdrawal by Subject|5
4975017|NCT00094757|17090185|P2|Overall Study|Withdrawal by Subject|21
4975018|NCT00094757|17090186|P1|Overall Study|Withdrawal by Subject|14
4975019|NCT00094757|17090184|P3|Overall Study|Protocol Violation|3
4975020|NCT00094757|17090185|P2|Overall Study|Protocol Violation|5
4975021|NCT00094757|17090186|P1|Overall Study|Protocol Violation|8
4975022|NCT00094757|17090184|P3|Overall Study|Patient Moved|1
4975023|NCT00094757|17090185|P2|Overall Study|Patient Moved|1
4975024|NCT00094757|17090186|P1|Overall Study|Patient Moved|2
4975025|NCT00094757|17090184|P3|Overall Study|Lost to Follow-up|6
4975026|NCT00094757|17090185|P2|Overall Study|Lost to Follow-up|5
4975027|NCT00094757|17090186|P1|Overall Study|Lost to Follow-up|3
4975028|NCT00094757|17090184|P3|Overall Study|Lack of Efficacy|8
4975029|NCT00094757|17090185|P2|Overall Study|Lack of Efficacy|15
4975030|NCT00094757|17090186|P1|Overall Study|Lack of Efficacy|11
4975031|NCT00094757|17090184|P3|Overall Study|Adverse Event|6
4975032|NCT00094757|17090185|P2|Overall Study|Adverse Event|9
4975033|NCT00094757|17090186|P1|Overall Study|Adverse Event|11
4975034|NCT00094653|17090206|P3|Overall Study|Protocol Violation|1
4975035|NCT00094653|17090207|P2|Overall Study|Protocol Violation|0
4975036|NCT00094653|17090208|P1|Overall Study|Protocol Violation|0
4975037|NCT00094653|17090206|P3|Overall Study|Lost to Follow-up|1
4975038|NCT00094653|17090207|P2|Overall Study|Lost to Follow-up|2
4975039|NCT00094653|17090208|P1|Overall Study|Lost to Follow-up|3
4975040|NCT00094653|17090206|P3|Overall Study|Other|2
4975041|NCT00094653|17090207|P2|Overall Study|Other|2
4975042|NCT00094653|17090208|P1|Overall Study|Other|2
4975043|NCT00094653|17090206|P3|Overall Study|Subject Withdrew Consent|3
4975044|NCT00094653|17090207|P2|Overall Study|Subject Withdrew Consent|2
4975045|NCT00094653|17090208|P1|Overall Study|Subject Withdrew Consent|10
4975046|NCT00094653|17090206|P3|Overall Study|Death|119
4975047|NCT00094653|17090207|P2|Overall Study|Death|100
4975048|NCT00094653|17090208|P1|Overall Study|Death|306
4975049|NCT00094575|17090271|P2|Overall Study|Death|146
4975050|NCT00094575|17090272|P1|Overall Study|Death|146
4975051|NCT00094536|17090292|P1|Treatment and Follow-up|Unable to attend visits|1
4975052|NCT00094536|17090292|P1|Treatment and Follow-up|Subject non-compliance|9
4975053|NCT00094536|17090292|P1|Treatment and Follow-up|Withdrawal by Subject|1
4975054|NCT00094536|17090292|P1|Treatment and Follow-up|Lost to Follow-up|7
4975055|NCT00094536|17090292|P1|Treatment and Follow-up|Lack of Efficacy|9
4975056|NCT00094536|17090292|P1|Treatment and Follow-up|Adverse Event|4
4975057|NCT00094536|17090292|P1|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24
4975058|NCT00094458|17090316|P6|OLE: Open-Label Extension|Patient decision|0
4975059|NCT00094458|17090317|P5|OLE: Open-Label Extension|Patient decision|1
4975060|NCT00094458|17090318|P4|OLE: Open-Label Extension|Patient decision|0
4975061|NCT00094458|17090319|P3|OLE: Open-Label Extension|Patient decision|0
4975062|NCT00094458|17090320|P2|OLE: Open-Label Extension|Patient decision|0
4975063|NCT00094458|17090321|P1|OLE: Open-Label Extension|Patient decision|0
4975064|NCT00094458|17090316|P6|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4975065|NCT00094458|17090317|P5|OLE: Open-Label Extension|Inadequate therapeutic effect|1
4975066|NCT00094458|17090318|P4|OLE: Open-Label Extension|Inadequate therapeutic effect|1
4975067|NCT00094458|17090319|P3|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4975068|NCT00094458|17090320|P2|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4975069|NCT00094458|17090321|P1|OLE: Open-Label Extension|Inadequate therapeutic effect|0
4975070|NCT00094458|17090316|P6|OLE: Open-Label Extension|Adverse Event|4
4975071|NCT00094458|17090317|P5|OLE: Open-Label Extension|Adverse Event|3
4975072|NCT00094458|17090318|P4|OLE: Open-Label Extension|Adverse Event|0
4975073|NCT00094458|17090319|P3|OLE: Open-Label Extension|Adverse Event|0
4975074|NCT00094458|17090320|P2|OLE: Open-Label Extension|Adverse Event|0
4975075|NCT00094458|17090321|P1|OLE: Open-Label Extension|Adverse Event|0
4975076|NCT00094458|17090316|P6|Study Extension: Week 30 Through Week 50|Other|0
4975077|NCT00094458|17090317|P5|Study Extension: Week 30 Through Week 50|Other|0
4975078|NCT00094458|17090318|P4|Study Extension: Week 30 Through Week 50|Other|0
4975079|NCT00094458|17090319|P3|Study Extension: Week 30 Through Week 50|Other|3
4975080|NCT00094458|17090320|P2|Study Extension: Week 30 Through Week 50|Other|2
4975081|NCT00094458|17090321|P1|Study Extension: Week 30 Through Week 50|Other|1
4975082|NCT00094458|17090316|P6|Study Extension: Week 30 Through Week 50|Adverse Event|0
4975083|NCT00094458|17090317|P5|Study Extension: Week 30 Through Week 50|Adverse Event|0
4975084|NCT00094458|17090318|P4|Study Extension: Week 30 Through Week 50|Adverse Event|0
4975085|NCT00094458|17090319|P3|Study Extension: Week 30 Through Week 50|Adverse Event|7
4975086|NCT00094458|17090320|P2|Study Extension: Week 30 Through Week 50|Adverse Event|9
4975087|NCT00094458|17090321|P1|Study Extension: Week 30 Through Week 50|Adverse Event|3
4975088|NCT00094458|17090316|P6|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4975089|NCT00094458|17090317|P5|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4975090|NCT00094458|17090318|P4|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4975091|NCT00094458|17090319|P3|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4
4975092|NCT00094458|17090320|P2|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0
4975093|NCT00094458|17090321|P1|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2
4975094|NCT00094458|17090316|P6|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
4975095|NCT00094458|17090317|P5|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
4975096|NCT00094458|17090318|P4|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0
4975097|NCT00094458|17090319|P3|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4
4975098|NCT00094458|17090320|P2|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1
4975099|NCT00094458|17090321|P1|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2
4975100|NCT00094458|17090316|P6|Main Study: Through Week 30|Other|0
4975101|NCT00094458|17090317|P5|Main Study: Through Week 30|Other|0
4975102|NCT00094458|17090318|P4|Main Study: Through Week 30|Other|0
4975103|NCT00094458|17090319|P3|Main Study: Through Week 30|Other|9
4975104|NCT00094458|17090320|P2|Main Study: Through Week 30|Other|16
4975105|NCT00094458|17090321|P1|Main Study: Through Week 30|Other|19
4975106|NCT00094458|17090316|P6|Main Study: Through Week 30|Death|0
4975107|NCT00094458|17090317|P5|Main Study: Through Week 30|Death|0
4975108|NCT00094458|17090318|P4|Main Study: Through Week 30|Death|0
4975109|NCT00094458|17090319|P3|Main Study: Through Week 30|Death|0
4975110|NCT00094458|17090320|P2|Main Study: Through Week 30|Death|0
4975111|NCT00094458|17090321|P1|Main Study: Through Week 30|Death|1
4975112|NCT00094458|17090316|P6|Main Study: Through Week 30|Adverse Event|0
4975113|NCT00094458|17090317|P5|Main Study: Through Week 30|Adverse Event|0
4975114|NCT00094458|17090318|P4|Main Study: Through Week 30|Adverse Event|0
4975115|NCT00094458|17090319|P3|Main Study: Through Week 30|Adverse Event|28
4975116|NCT00094458|17090320|P2|Main Study: Through Week 30|Adverse Event|20
4975117|NCT00094458|17090321|P1|Main Study: Through Week 30|Adverse Event|38
4975118|NCT00094458|17090316|P6|Main Study: Through Week 30|Withdrawal by Subject|0
4975119|NCT00094458|17090317|P5|Main Study: Through Week 30|Withdrawal by Subject|0
4975120|NCT00094458|17090318|P4|Main Study: Through Week 30|Withdrawal by Subject|0
4975121|NCT00094458|17090319|P3|Main Study: Through Week 30|Withdrawal by Subject|7
4975122|NCT00094458|17090320|P2|Main Study: Through Week 30|Withdrawal by Subject|9
4975123|NCT00094458|17090321|P1|Main Study: Through Week 30|Withdrawal by Subject|18
4975124|NCT00094458|17090316|P6|Main Study: Through Week 30|Lost to Follow-up|0
4975125|NCT00094458|17090317|P5|Main Study: Through Week 30|Lost to Follow-up|0
4975126|NCT00094458|17090318|P4|Main Study: Through Week 30|Lost to Follow-up|0
4975127|NCT00094458|17090319|P3|Main Study: Through Week 30|Lost to Follow-up|2
4975128|NCT00094458|17090320|P2|Main Study: Through Week 30|Lost to Follow-up|5
4975129|NCT00094458|17090321|P1|Main Study: Through Week 30|Lost to Follow-up|5
4975130|NCT00094458|17090316|P6|Main Study: Through Week 30|Eligibility criteria not met|0
4975131|NCT00094458|17090317|P5|Main Study: Through Week 30|Eligibility criteria not met|0
4975132|NCT00094458|17090318|P4|Main Study: Through Week 30|Eligibility criteria not met|0
4975133|NCT00094458|17090319|P3|Main Study: Through Week 30|Eligibility criteria not met|2
4975134|NCT00094458|17090320|P2|Main Study: Through Week 30|Eligibility criteria not met|8
4975135|NCT00094458|17090321|P1|Main Study: Through Week 30|Eligibility criteria not met|3
4975136|NCT00094445|17090359|P1|Overall Study|Progressive Disease|2
4975137|NCT00094445|17090359|P1|Overall Study|Lost to Follow-up|1
4975138|NCT00094445|17090359|P1|Overall Study|Withdrawal by Subject|3
4975139|NCT00094328|17090363|P1|Overall Study|Lost to Follow-up|1
4975140|NCT00094302|17090377|P2|Overall Study|Death|246
4975141|NCT00094302|17090378|P1|Overall Study|Death|266
4975142|NCT00094302|17090377|P2|Overall Study|Withdrawal by Subject|111
4975143|NCT00094302|17090378|P1|Overall Study|Withdrawal by Subject|103
4975144|NCT00094302|17090377|P2|Overall Study|Physician Decision|8
4975145|NCT00094302|17090378|P1|Overall Study|Physician Decision|5
4975146|NCT00094302|17090377|P2|Overall Study|Lost to Follow-up|41
4975147|NCT00094302|17090378|P1|Overall Study|Lost to Follow-up|43
4975148|NCT00094172|17090467|P2|Overall Study|Started other MS therapy due to disease|0
4975149|NCT00094172|17090468|P1|Overall Study|Started other MS therapy due to disease|1
4975150|NCT00094172|17090467|P2|Overall Study|Primary endpoint met.|0
4975151|NCT00094172|17090468|P1|Overall Study|Primary endpoint met.|1
4975152|NCT00094172|17090467|P2|Overall Study|Withdrawal by Subject|5
4975153|NCT00094172|17090468|P1|Overall Study|Withdrawal by Subject|10
4975154|NCT00094172|17090467|P2|Overall Study|Protocol Violation|1
4975155|NCT00094172|17090468|P1|Overall Study|Protocol Violation|0
4975156|NCT00094172|17090467|P2|Overall Study|Lost to Follow-up|0
4975157|NCT00094172|17090468|P1|Overall Study|Lost to Follow-up|2
4975158|NCT00094172|17090467|P2|Overall Study|Adverse Event|1
4975159|NCT00094172|17090468|P1|Overall Study|Adverse Event|0
4975160|NCT00094107|17090478|P1|Overall Study|Withdrawal due to Disease Progression|1
4975161|NCT00094107|17090478|P1|Overall Study|Adverse Event|3
4975162|NCT00094107|17090478|P1|Overall Study|Death|5
4975163|NCT00094107|17090478|P1|Overall Study|Lack of Efficacy|23
4975164|NCT00094094|17090487|P1|Overall Study|Adverse Event|7
4975165|NCT00094094|17090487|P1|Overall Study|Lack of Efficacy|23
4975166|NCT00094094|17090487|P1|Overall Study|Death|2
4975167|NCT00094055|17090496|P1|Overall Study|Withdrawal by Subject|9
4975168|NCT00094055|17090496|P1|Overall Study|roll-over to another study|14
4975169|NCT00094055|17090496|P1|Overall Study|clinical progression|1
4975170|NCT00094055|17090496|P1|Overall Study|progressive disease|2
4975171|NCT00094055|17090496|P1|Overall Study|Lost to Follow-up|2
4975172|NCT00094055|17090496|P1|Overall Study|Lack of Efficacy|17
4975173|NCT00094055|17090496|P1|Overall Study|Death|4
4975174|NCT00094055|17090496|P1|Overall Study|Adverse Event|11
4975175|NCT00093808|17090553|P1|Overall Study|Protocol Violation|1
4975176|NCT00093808|17090553|P1|Overall Study|Cancel participation before receiving tx|1
4975177|NCT00093795|17090563|P3|Overall Study|No follow up data|17
4975178|NCT00093795|17090564|P2|Overall Study|No follow up data|16
4975179|NCT00093795|17090565|P1|Overall Study|No follow up data|20
4975180|NCT00093496|17090610|P2|Overall Study|Protocol Violation|3
4975181|NCT00093496|17090611|P1|Overall Study|Protocol Violation|1
4975182|NCT00093470|17090624|P2|Overall Study|ANC < 1000 on day 1 of cycle 1|0
4975183|NCT00093470|17090625|P1|Overall Study|ANC < 1000 on day 1 of cycle 1|1
4975184|NCT00093470|17090624|P2|Overall Study|Never started treatment|0
4975185|NCT00093470|17090625|P1|Overall Study|Never started treatment|1
4975186|NCT00093470|17090624|P2|Overall Study|Physician Decision|0
4975187|NCT00093470|17090625|P1|Overall Study|Physician Decision|2
4975188|NCT00093470|17090624|P2|Overall Study|Other complicating disease|0
4975189|NCT00093470|17090625|P1|Overall Study|Other complicating disease|3
4975190|NCT00093470|17090624|P2|Overall Study|Alternative therapy|0
4975191|NCT00093470|17090625|P1|Overall Study|Alternative therapy|2
4975192|NCT00093470|17090624|P2|Overall Study|Withdrawal by Subject|0
4975193|NCT00093470|17090625|P1|Overall Study|Withdrawal by Subject|8
4975194|NCT00093470|17090624|P2|Overall Study|Death|0
4975195|NCT00093470|17090625|P1|Overall Study|Death|2
4975196|NCT00093470|17090624|P2|Overall Study|Adverse Event|0
4975197|NCT00093470|17090625|P1|Overall Study|Adverse Event|15
4975198|NCT00093470|17090624|P2|Overall Study|Disease progression|0
4975199|NCT00093470|17090625|P1|Overall Study|Disease progression|39
4975200|NCT00093145|17090639|P1|Overall Study|Other|1
4975201|NCT00093145|17090639|P1|Overall Study|Withdrawal by Subject|9
4975202|NCT00093145|17090639|P1|Overall Study|Physician Decision|5
4975203|NCT00093145|17090639|P1|Overall Study|Unacceptable Toxicity Only|2
4975204|NCT00093015|17090681|P2|Overall Study|Death|385
4975205|NCT00093015|17090682|P1|Overall Study|Death|375
4975206|NCT00093015|17090681|P2|Overall Study|Lost to Follow-up|108
4975207|NCT00093015|17090682|P1|Overall Study|Lost to Follow-up|96
4975208|NCT00093015|17090681|P2|Overall Study|Withdrawal by Subject|171
4975209|NCT00093015|17090682|P1|Overall Study|Withdrawal by Subject|194
4975210|NCT00092677|17090710|P2|Overall Study|Adminstrative|9
4975211|NCT00092677|17090711|P1|Overall Study|Adminstrative|5
4975212|NCT00092677|17090710|P2|Overall Study|Lost to Follow-up|2
4975213|NCT00092677|17090711|P1|Overall Study|Lost to Follow-up|0
4975214|NCT00092547|17090755|P3|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
4975215|NCT00092547|17090756|P2|Long-term Follow-up (Month 42 Visit)|Adverse Event|0
4975216|NCT00092547|17090757|P1|Long-term Follow-up (Month 42 Visit)|Adverse Event|1
4975217|NCT00092547|17090755|P3|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7
4975218|NCT00092547|17090756|P2|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0
4975219|NCT00092547|17090757|P1|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14
4975220|NCT00092547|17090755|P3|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9
4975221|NCT00092547|17090756|P2|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0
4975222|NCT00092547|17090757|P1|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6
4975223|NCT00092547|17090755|P3|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
4975224|NCT00092547|17090756|P2|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0
4975225|NCT00092547|17090757|P1|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3
4975226|NCT00092547|17090755|P3|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
4975227|NCT00092547|17090756|P2|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0
4975228|NCT00092547|17090757|P1|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1
4975229|NCT00092547|17090755|P3|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
4975230|NCT00092547|17090756|P2|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0
4975231|NCT00092547|17090757|P1|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2
4975232|NCT00092547|17090755|P3|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0
4975233|NCT00092547|17090756|P2|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3
4975234|NCT00092547|17090757|P1|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1
4975235|NCT00092547|17090755|P3|Base Follow-up Phase (Month 18 to 30)|Subject moved|0
4975236|NCT00092547|17090756|P2|Base Follow-up Phase (Month 18 to 30)|Subject moved|2
4975237|NCT00092547|17090757|P1|Base Follow-up Phase (Month 18 to 30)|Subject moved|4
4975238|NCT00092547|17090755|P3|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
4975239|NCT00092547|17090756|P2|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0
4975240|NCT00092547|17090757|P1|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1
4975241|NCT00092547|17090755|P3|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
4975242|NCT00092547|17090756|P2|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0
4975243|NCT00092547|17090757|P1|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1
4975244|NCT00092547|17090755|P3|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0
4975245|NCT00092547|17090756|P2|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7
4975246|NCT00092547|17090757|P1|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13
4975247|NCT00092547|17090755|P3|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0
4975248|NCT00092547|17090756|P2|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2
4975249|NCT00092547|17090757|P1|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4
4975250|NCT00092547|17090755|P3|Base Follow-up Phase (Month 7 to 18)|Subject moved|0
4975251|NCT00092547|17090756|P2|Base Follow-up Phase (Month 7 to 18)|Subject moved|5
4975252|NCT00092547|17090757|P1|Base Follow-up Phase (Month 7 to 18)|Subject moved|1
4975253|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0
4975254|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3
4975337|NCT00092534|17090801|P5|Base Study Follow-Up Period|Site Closed|0
4975255|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5
4975256|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
4975257|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1
4975258|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0
4975259|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
4975260|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1
4975261|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0
4975262|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Moved|0
4975263|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Moved|1
4975264|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Moved|3
4975265|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0
4975266|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21
4975267|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28
4975268|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0
4975269|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7
4975270|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18
4975271|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0
4975272|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1
4975273|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4
4975274|NCT00092547|17090755|P3|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0
4975275|NCT00092547|17090756|P2|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1
4975276|NCT00092547|17090757|P1|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5
4975277|NCT00092534|17090801|P5|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4975278|NCT00092534|17090802|P4|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1
4975279|NCT00092534|17090803|P3|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4975280|NCT00092534|17090804|P2|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4975281|NCT00092534|17090805|P1|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0
4975282|NCT00092534|17090801|P5|Base Study EXT|Protocol Violation|0
4975283|NCT00092534|17090802|P4|Base Study EXT|Protocol Violation|0
4975284|NCT00092534|17090803|P3|Base Study EXT|Protocol Violation|15
4975285|NCT00092534|17090804|P2|Base Study EXT|Protocol Violation|0
4975286|NCT00092534|17090805|P1|Base Study EXT|Protocol Violation|0
4975287|NCT00092534|17090801|P5|Base Study EXT|Study ended|0
4975288|NCT00092534|17090802|P4|Base Study EXT|Study ended|0
4975289|NCT00092534|17090803|P3|Base Study EXT|Study ended|29
4975290|NCT00092534|17090804|P2|Base Study EXT|Study ended|0
4975291|NCT00092534|17090805|P1|Base Study EXT|Study ended|0
4975292|NCT00092534|17090801|P5|Base Study EXT|Site closed|0
4975293|NCT00092534|17090802|P4|Base Study EXT|Site closed|0
4975294|NCT00092534|17090803|P3|Base Study EXT|Site closed|21
4975295|NCT00092534|17090804|P2|Base Study EXT|Site closed|0
4975296|NCT00092534|17090805|P1|Base Study EXT|Site closed|0
4975297|NCT00092534|17090801|P5|Base Study EXT|Travel|0
4975298|NCT00092534|17090802|P4|Base Study EXT|Travel|0
4975299|NCT00092534|17090803|P3|Base Study EXT|Travel|2
4975300|NCT00092534|17090804|P2|Base Study EXT|Travel|0
4975301|NCT00092534|17090805|P1|Base Study EXT|Travel|0
4975302|NCT00092534|17090801|P5|Base Study EXT|Participant moved|0
4975303|NCT00092534|17090802|P4|Base Study EXT|Participant moved|0
4975304|NCT00092534|17090803|P3|Base Study EXT|Participant moved|6
4975305|NCT00092534|17090804|P2|Base Study EXT|Participant moved|0
4975306|NCT00092534|17090805|P1|Base Study EXT|Participant moved|0
4975307|NCT00092534|17090801|P5|Base Study EXT|Withdrawal by Subject|0
4975308|NCT00092534|17090802|P4|Base Study EXT|Withdrawal by Subject|0
4975309|NCT00092534|17090803|P3|Base Study EXT|Withdrawal by Subject|18
4975310|NCT00092534|17090804|P2|Base Study EXT|Withdrawal by Subject|0
4975311|NCT00092534|17090805|P1|Base Study EXT|Withdrawal by Subject|0
4975312|NCT00092534|17090801|P5|Base Study EXT|Pregnancy|0
4975313|NCT00092534|17090802|P4|Base Study EXT|Pregnancy|0
4975314|NCT00092534|17090803|P3|Base Study EXT|Pregnancy|12
4975315|NCT00092534|17090804|P2|Base Study EXT|Pregnancy|0
4975316|NCT00092534|17090805|P1|Base Study EXT|Pregnancy|0
4975317|NCT00092534|17090801|P5|Base Study EXT|Physician Decision|0
4975318|NCT00092534|17090802|P4|Base Study EXT|Physician Decision|0
4975319|NCT00092534|17090803|P3|Base Study EXT|Physician Decision|1
4975320|NCT00092534|17090804|P2|Base Study EXT|Physician Decision|0
4975321|NCT00092534|17090805|P1|Base Study EXT|Physician Decision|0
4975322|NCT00092534|17090801|P5|Base Study EXT|Lost to Follow-up|0
4975323|NCT00092534|17090802|P4|Base Study EXT|Lost to Follow-up|0
4975324|NCT00092534|17090803|P3|Base Study EXT|Lost to Follow-up|41
4975325|NCT00092534|17090804|P2|Base Study EXT|Lost to Follow-up|0
4975326|NCT00092534|17090805|P1|Base Study EXT|Lost to Follow-up|0
4975327|NCT00092534|17090801|P5|Base Study Follow-Up Period|Subjects in extension|0
4975328|NCT00092534|17090802|P4|Base Study Follow-Up Period|Subjects in extension|0
4975329|NCT00092534|17090803|P3|Base Study Follow-Up Period|Subjects in extension|0
4975330|NCT00092534|17090804|P2|Base Study Follow-Up Period|Subjects in extension|371
4975331|NCT00092534|17090805|P1|Base Study Follow-Up Period|Subjects in extension|15
4975332|NCT00092534|17090801|P5|Base Study Follow-Up Period|Subjects continuing|0
4975333|NCT00092534|17090802|P4|Base Study Follow-Up Period|Subjects continuing|0
4975334|NCT00092534|17090803|P3|Base Study Follow-Up Period|Subjects continuing|0
4975335|NCT00092534|17090804|P2|Base Study Follow-Up Period|Subjects continuing|31
4975336|NCT00092534|17090805|P1|Base Study Follow-Up Period|Subjects continuing|27
4975338|NCT00092534|17090802|P4|Base Study Follow-Up Period|Site Closed|0
4975339|NCT00092534|17090803|P3|Base Study Follow-Up Period|Site Closed|0
4975340|NCT00092534|17090804|P2|Base Study Follow-Up Period|Site Closed|2
4975341|NCT00092534|17090805|P1|Base Study Follow-Up Period|Site Closed|0
4975342|NCT00092534|17090801|P5|Base Study Follow-Up Period|Travel|0
4975343|NCT00092534|17090802|P4|Base Study Follow-Up Period|Travel|0
4975344|NCT00092534|17090803|P3|Base Study Follow-Up Period|Travel|0
4975345|NCT00092534|17090804|P2|Base Study Follow-Up Period|Travel|7
4975346|NCT00092534|17090805|P1|Base Study Follow-Up Period|Travel|10
4975347|NCT00092534|17090801|P5|Base Study Follow-Up Period|Moved|0
4975348|NCT00092534|17090802|P4|Base Study Follow-Up Period|Moved|0
4975349|NCT00092534|17090803|P3|Base Study Follow-Up Period|Moved|0
4975350|NCT00092534|17090804|P2|Base Study Follow-Up Period|Moved|58
4975351|NCT00092534|17090805|P1|Base Study Follow-Up Period|Moved|62
4975352|NCT00092534|17090801|P5|Base Study Follow-Up Period|Withdrawal by Subject|0
4975353|NCT00092534|17090802|P4|Base Study Follow-Up Period|Withdrawal by Subject|0
4975354|NCT00092534|17090803|P3|Base Study Follow-Up Period|Withdrawal by Subject|0
4975355|NCT00092534|17090804|P2|Base Study Follow-Up Period|Withdrawal by Subject|62
4975356|NCT00092534|17090805|P1|Base Study Follow-Up Period|Withdrawal by Subject|71
4975357|NCT00092534|17090801|P5|Base Study Follow-Up Period|Protocol Violation|0
4975358|NCT00092534|17090802|P4|Base Study Follow-Up Period|Protocol Violation|0
4975359|NCT00092534|17090803|P3|Base Study Follow-Up Period|Protocol Violation|0
4975360|NCT00092534|17090804|P2|Base Study Follow-Up Period|Protocol Violation|2
4975361|NCT00092534|17090805|P1|Base Study Follow-Up Period|Protocol Violation|1
4975362|NCT00092534|17090801|P5|Base Study Follow-Up Period|Pregnancy|0
4975363|NCT00092534|17090802|P4|Base Study Follow-Up Period|Pregnancy|0
4975364|NCT00092534|17090803|P3|Base Study Follow-Up Period|Pregnancy|0
4975365|NCT00092534|17090804|P2|Base Study Follow-Up Period|Pregnancy|10
4975366|NCT00092534|17090805|P1|Base Study Follow-Up Period|Pregnancy|6
4975367|NCT00092534|17090801|P5|Base Study Follow-Up Period|Lost to Follow-up|0
4975368|NCT00092534|17090802|P4|Base Study Follow-Up Period|Lost to Follow-up|0
4975369|NCT00092534|17090803|P3|Base Study Follow-Up Period|Lost to Follow-up|0
4975370|NCT00092534|17090804|P2|Base Study Follow-Up Period|Lost to Follow-up|146
4975371|NCT00092534|17090805|P1|Base Study Follow-Up Period|Lost to Follow-up|120
4975372|NCT00092534|17090801|P5|Base Study Follow-Up Period|Death|0
4975373|NCT00092534|17090802|P4|Base Study Follow-Up Period|Death|0
4975374|NCT00092534|17090803|P3|Base Study Follow-Up Period|Death|0
4975375|NCT00092534|17090804|P2|Base Study Follow-Up Period|Death|1
4975376|NCT00092534|17090805|P1|Base Study Follow-Up Period|Death|2
4975377|NCT00092534|17090801|P5|Base Study Follow-Up Period|Adverse Event|0
4975378|NCT00092534|17090802|P4|Base Study Follow-Up Period|Adverse Event|0
4975379|NCT00092534|17090803|P3|Base Study Follow-Up Period|Adverse Event|0
4975380|NCT00092534|17090804|P2|Base Study Follow-Up Period|Adverse Event|4
4975381|NCT00092534|17090805|P1|Base Study Follow-Up Period|Adverse Event|2
4975382|NCT00092534|17090801|P5|Base Study Vaccination Period|Site Closed|0
4975383|NCT00092534|17090802|P4|Base Study Vaccination Period|Site Closed|0
4975384|NCT00092534|17090803|P3|Base Study Vaccination Period|Site Closed|0
4975385|NCT00092534|17090804|P2|Base Study Vaccination Period|Site Closed|1
4975386|NCT00092534|17090805|P1|Base Study Vaccination Period|Site Closed|0
4975387|NCT00092534|17090801|P5|Base Study Vaccination Period|Travel|0
4975388|NCT00092534|17090802|P4|Base Study Vaccination Period|Travel|0
4975389|NCT00092534|17090803|P3|Base Study Vaccination Period|Travel|0
4975390|NCT00092534|17090804|P2|Base Study Vaccination Period|Travel|0
4975391|NCT00092534|17090805|P1|Base Study Vaccination Period|Travel|1
4975392|NCT00092534|17090801|P5|Base Study Vaccination Period|New Medical History (Not AEs)|0
4975393|NCT00092534|17090802|P4|Base Study Vaccination Period|New Medical History (Not AEs)|0
4975394|NCT00092534|17090803|P3|Base Study Vaccination Period|New Medical History (Not AEs)|0
4975395|NCT00092534|17090804|P2|Base Study Vaccination Period|New Medical History (Not AEs)|0
4975396|NCT00092534|17090805|P1|Base Study Vaccination Period|New Medical History (Not AEs)|5
4975397|NCT00092534|17090801|P5|Base Study Vaccination Period|Moved|0
4975398|NCT00092534|17090802|P4|Base Study Vaccination Period|Moved|0
4975399|NCT00092534|17090803|P3|Base Study Vaccination Period|Moved|0
4975400|NCT00092534|17090804|P2|Base Study Vaccination Period|Moved|12
4975401|NCT00092534|17090805|P1|Base Study Vaccination Period|Moved|14
4975402|NCT00092534|17090801|P5|Base Study Vaccination Period|Withdrawal by Subject|0
4975403|NCT00092534|17090802|P4|Base Study Vaccination Period|Withdrawal by Subject|0
4975404|NCT00092534|17090803|P3|Base Study Vaccination Period|Withdrawal by Subject|0
4975405|NCT00092534|17090804|P2|Base Study Vaccination Period|Withdrawal by Subject|58
4975406|NCT00092534|17090805|P1|Base Study Vaccination Period|Withdrawal by Subject|85
4975407|NCT00092534|17090801|P5|Base Study Vaccination Period|Protocol Violation|0
4975408|NCT00092534|17090802|P4|Base Study Vaccination Period|Protocol Violation|0
4975409|NCT00092534|17090803|P3|Base Study Vaccination Period|Protocol Violation|0
4975410|NCT00092534|17090804|P2|Base Study Vaccination Period|Protocol Violation|1
4975411|NCT00092534|17090805|P1|Base Study Vaccination Period|Protocol Violation|2
4975412|NCT00092534|17090801|P5|Base Study Vaccination Period|Pregnancy|0
4975413|NCT00092534|17090802|P4|Base Study Vaccination Period|Pregnancy|0
4975414|NCT00092534|17090803|P3|Base Study Vaccination Period|Pregnancy|0
4975415|NCT00092534|17090804|P2|Base Study Vaccination Period|Pregnancy|7
4975416|NCT00092534|17090805|P1|Base Study Vaccination Period|Pregnancy|9
4975417|NCT00092534|17090801|P5|Base Study Vaccination Period|Physician Decision|0
4975418|NCT00092534|17090802|P4|Base Study Vaccination Period|Physician Decision|0
4975419|NCT00092534|17090803|P3|Base Study Vaccination Period|Physician Decision|0
4975420|NCT00092534|17090804|P2|Base Study Vaccination Period|Physician Decision|0
4975421|NCT00092534|17090805|P1|Base Study Vaccination Period|Physician Decision|1
4975422|NCT00092534|17090801|P5|Base Study Vaccination Period|Lost to Follow-up|0
4975423|NCT00092534|17090802|P4|Base Study Vaccination Period|Lost to Follow-up|0
4975424|NCT00092534|17090803|P3|Base Study Vaccination Period|Lost to Follow-up|0
4975425|NCT00092534|17090804|P2|Base Study Vaccination Period|Lost to Follow-up|37
4975426|NCT00092534|17090805|P1|Base Study Vaccination Period|Lost to Follow-up|41
4975427|NCT00092534|17090801|P5|Base Study Vaccination Period|Death|0
4975428|NCT00092534|17090802|P4|Base Study Vaccination Period|Death|0
4975429|NCT00092534|17090803|P3|Base Study Vaccination Period|Death|0
4975430|NCT00092534|17090804|P2|Base Study Vaccination Period|Death|4
4975431|NCT00092534|17090805|P1|Base Study Vaccination Period|Death|5
4975432|NCT00092534|17090801|P5|Base Study Vaccination Period|Adverse Event|0
4975433|NCT00092534|17090802|P4|Base Study Vaccination Period|Adverse Event|0
4975434|NCT00092534|17090803|P3|Base Study Vaccination Period|Adverse Event|0
4975435|NCT00092534|17090804|P2|Base Study Vaccination Period|Adverse Event|1
4975436|NCT00092534|17090805|P1|Base Study Vaccination Period|Adverse Event|3
4975437|NCT00092534|17090801|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
4975438|NCT00092534|17090802|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
4975439|NCT00092534|17090803|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
4975440|NCT00092534|17090804|P2|Base Study Vaccination Period|Randomized not Vaccinated|5
4975441|NCT00092534|17090805|P1|Base Study Vaccination Period|Randomized not Vaccinated|5
4975442|NCT00092521|17090836|P4|Extension Study (Group 4)|Unable/unwilling to return|25
4975443|NCT00092521|17090837|P3|Extension Study (Group 4)|Unable/unwilling to return|0
4975444|NCT00092521|17090838|P2|Extension Study (Group 4)|Unable/unwilling to return|0
4975445|NCT00092521|17090839|P1|Extension Study (Group 4)|Unable/unwilling to return|0
4975446|NCT00092521|17090836|P4|Extension Study (Group 4)|Site Terminated|4
4975447|NCT00092521|17090837|P3|Extension Study (Group 4)|Site Terminated|0
4975448|NCT00092521|17090838|P2|Extension Study (Group 4)|Site Terminated|0
4975449|NCT00092521|17090839|P1|Extension Study (Group 4)|Site Terminated|0
4975450|NCT00092521|17090836|P4|Extension Study (Group 4)|Moved|16
4975451|NCT00092521|17090837|P3|Extension Study (Group 4)|Moved|0
4975452|NCT00092521|17090838|P2|Extension Study (Group 4)|Moved|0
4975453|NCT00092521|17090839|P1|Extension Study (Group 4)|Moved|0
4975454|NCT00092521|17090836|P4|Extension Study (Group 4)|Withdrawal by Subject|46
4975455|NCT00092521|17090837|P3|Extension Study (Group 4)|Withdrawal by Subject|0
4975456|NCT00092521|17090838|P2|Extension Study (Group 4)|Withdrawal by Subject|0
4975457|NCT00092521|17090839|P1|Extension Study (Group 4)|Withdrawal by Subject|0
4975458|NCT00092521|17090836|P4|Extension Study (Group 4)|Protocol Violation|2
4975459|NCT00092521|17090837|P3|Extension Study (Group 4)|Protocol Violation|0
4975460|NCT00092521|17090838|P2|Extension Study (Group 4)|Protocol Violation|0
4975461|NCT00092521|17090839|P1|Extension Study (Group 4)|Protocol Violation|0
4975462|NCT00092521|17090836|P4|Extension Study (Group 4)|Pregnancy|4
4975463|NCT00092521|17090837|P3|Extension Study (Group 4)|Pregnancy|0
4975464|NCT00092521|17090838|P2|Extension Study (Group 4)|Pregnancy|0
4975465|NCT00092521|17090839|P1|Extension Study (Group 4)|Pregnancy|0
4975466|NCT00092521|17090836|P4|Extension Study (Group 4)|Lost to Follow-up|87
4975467|NCT00092521|17090837|P3|Extension Study (Group 4)|Lost to Follow-up|0
4975468|NCT00092521|17090838|P2|Extension Study (Group 4)|Lost to Follow-up|0
4975469|NCT00092521|17090839|P1|Extension Study (Group 4)|Lost to Follow-up|0
4975470|NCT00092521|17090836|P4|Extension Study (Group 4)|Adverse Event|2
4975471|NCT00092521|17090837|P3|Extension Study (Group 4)|Adverse Event|0
4975472|NCT00092521|17090838|P2|Extension Study (Group 4)|Adverse Event|0
4975473|NCT00092521|17090839|P1|Extension Study (Group 4)|Adverse Event|0
4975474|NCT00092521|17090836|P4|Extension Study (Group 4)|Excluded ineligible for extension|23
4975475|NCT00092521|17090837|P3|Extension Study (Group 4)|Excluded ineligible for extension|0
4975476|NCT00092521|17090838|P2|Extension Study (Group 4)|Excluded ineligible for extension|0
4975477|NCT00092521|17090839|P1|Extension Study (Group 4)|Excluded ineligible for extension|0
4975478|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Visits Compressed|0
4975479|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Visits Compressed|5
4975480|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Visits Compressed|0
4975481|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Visits Compressed|5
4975482|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Travel|0
4975483|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Travel|0
4975484|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Travel|0
4975485|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Travel|2
4975486|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Site Terminated|0
4975487|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Site Terminated|3
4975488|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Site Terminated|0
4975489|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Site Terminated|3
4975490|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Moved|0
4975491|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Moved|28
4975492|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Moved|2
4975493|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Moved|32
4975494|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Withdrawal by Subject|0
4975495|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Withdrawal by Subject|51
4975496|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Withdrawal by Subject|6
4975497|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Withdrawal by Subject|40
4975498|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Protocol Violation|0
4975499|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Protocol Violation|5
4975500|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Protocol Violation|1
4975501|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Protocol Violation|1
4975502|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Lost to Follow-up|0
4975503|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Lost to Follow-up|108
4975504|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Lost to Follow-up|14
4975505|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Lost to Follow-up|113
4975506|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Death|0
4975507|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Death|1
4975508|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Death|0
4975509|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Death|2
4975510|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Adverse Event|0
4975511|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Adverse Event|0
4975512|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Adverse Event|0
4975513|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Adverse Event|1
4975514|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Subjects in Extension|0
4975515|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Subjects in Extension|412
4975516|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Subjects in Extension|109
4975517|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Subjects in Extension|13
4975518|NCT00092521|17090836|P4|Follow-Up (After Month 7)|Subjects Continuing|0
4975519|NCT00092521|17090837|P3|Follow-Up (After Month 7)|Subjects Continuing|35
4975520|NCT00092521|17090838|P2|Follow-Up (After Month 7)|Subjects Continuing|4
4975521|NCT00092521|17090839|P1|Follow-Up (After Month 7)|Subjects Continuing|34
4975522|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
4975523|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
4975524|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0
4975525|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2
4975526|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Unblinded|0
4975527|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Unblinded|0
4975528|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Unblinded|0
4975529|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Unblinded|2
4975530|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Moved|0
4975531|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Moved|18
4975532|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Moved|1
4975533|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Moved|14
4975534|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0
4975535|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62
4975536|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7
4975537|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59
4975538|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Pregnancy|0
4975539|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Pregnancy|7
4975540|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Pregnancy|0
4975541|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Pregnancy|5
4975542|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0
4975543|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44
4975544|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6
4975545|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51
4975546|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Death|0
4975547|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Death|1
4975548|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Death|0
4975549|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Death|0
4975550|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Adverse Event|0
4975551|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Adverse Event|7
4975552|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Adverse Event|0
4975553|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Adverse Event|1
4975554|NCT00092521|17090836|P4|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
4975555|NCT00092521|17090837|P3|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7
4975556|NCT00092521|17090838|P2|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0
4975557|NCT00092521|17090839|P1|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6
4975558|NCT00092495|17090853|P5|Base Study Follow-up Period|Withdrawal by Subject|0
4975559|NCT00092495|17090854|P4|Base Study Follow-up Period|Withdrawal by Subject|0
4975560|NCT00092495|17090855|P3|Base Study Follow-up Period|Withdrawal by Subject|0
4975561|NCT00092495|17090856|P2|Base Study Follow-up Period|Withdrawal by Subject|0
4975562|NCT00092495|17090857|P1|Base Study Follow-up Period|Withdrawal by Subject|2
4975563|NCT00092495|17090853|P5|Base Study Follow-up Period|Lost to Follow-up|0
4975564|NCT00092495|17090854|P4|Base Study Follow-up Period|Lost to Follow-up|12
4975565|NCT00092495|17090855|P3|Base Study Follow-up Period|Lost to Follow-up|3
4975566|NCT00092495|17090856|P2|Base Study Follow-up Period|Lost to Follow-up|3
4975567|NCT00092495|17090857|P1|Base Study Follow-up Period|Lost to Follow-up|1
4975568|NCT00092495|17090853|P5|Base Study Follow-up Period|Extended|0
4975569|NCT00092495|17090854|P4|Base Study Follow-up Period|Extended|2
4975570|NCT00092495|17090855|P3|Base Study Follow-up Period|Extended|1
4975571|NCT00092495|17090856|P2|Base Study Follow-up Period|Extended|0
4975572|NCT00092495|17090857|P1|Base Study Follow-up Period|Extended|0
4975573|NCT00092495|17090853|P5|Base Study Vaccination Period|Withdrawal by Subject|0
4975574|NCT00092495|17090854|P4|Base Study Vaccination Period|Withdrawal by Subject|25
4975575|NCT00092495|17090855|P3|Base Study Vaccination Period|Withdrawal by Subject|14
4975576|NCT00092495|17090856|P2|Base Study Vaccination Period|Withdrawal by Subject|10
4975577|NCT00092495|17090857|P1|Base Study Vaccination Period|Withdrawal by Subject|9
4975578|NCT00092495|17090853|P5|Base Study Vaccination Period|Protocol Violation|0
4975579|NCT00092495|17090854|P4|Base Study Vaccination Period|Protocol Violation|0
4975580|NCT00092495|17090855|P3|Base Study Vaccination Period|Protocol Violation|0
4975581|NCT00092495|17090856|P2|Base Study Vaccination Period|Protocol Violation|0
4975582|NCT00092495|17090857|P1|Base Study Vaccination Period|Protocol Violation|1
4975583|NCT00092495|17090853|P5|Base Study Vaccination Period|Parent Withdrew Consent|0
4975584|NCT00092495|17090854|P4|Base Study Vaccination Period|Parent Withdrew Consent|5
4975585|NCT00092495|17090855|P3|Base Study Vaccination Period|Parent Withdrew Consent|1
4975586|NCT00092495|17090856|P2|Base Study Vaccination Period|Parent Withdrew Consent|1
4975587|NCT00092495|17090857|P1|Base Study Vaccination Period|Parent Withdrew Consent|1
4975588|NCT00092495|17090853|P5|Base Study Vaccination Period|Pregnancy|0
4975589|NCT00092495|17090854|P4|Base Study Vaccination Period|Pregnancy|0
4975590|NCT00092495|17090855|P3|Base Study Vaccination Period|Pregnancy|0
4975591|NCT00092495|17090856|P2|Base Study Vaccination Period|Pregnancy|0
4975592|NCT00092495|17090857|P1|Base Study Vaccination Period|Pregnancy|2
4975593|NCT00092495|17090853|P5|Base Study Vaccination Period|Other|0
4975594|NCT00092495|17090854|P4|Base Study Vaccination Period|Other|2
4975595|NCT00092495|17090855|P3|Base Study Vaccination Period|Other|0
4975596|NCT00092495|17090856|P2|Base Study Vaccination Period|Other|1
4975597|NCT00092495|17090857|P1|Base Study Vaccination Period|Other|1
4975598|NCT00092495|17090853|P5|Base Study Vaccination Period|Moved|0
4975599|NCT00092495|17090854|P4|Base Study Vaccination Period|Moved|2
4975600|NCT00092495|17090855|P3|Base Study Vaccination Period|Moved|2
4975601|NCT00092495|17090856|P2|Base Study Vaccination Period|Moved|1
4975602|NCT00092495|17090857|P1|Base Study Vaccination Period|Moved|3
4975603|NCT00092495|17090853|P5|Base Study Vaccination Period|Lost to Follow-up|0
4975604|NCT00092495|17090854|P4|Base Study Vaccination Period|Lost to Follow-up|36
4975605|NCT00092495|17090855|P3|Base Study Vaccination Period|Lost to Follow-up|11
4975606|NCT00092495|17090856|P2|Base Study Vaccination Period|Lost to Follow-up|6
4975607|NCT00092495|17090857|P1|Base Study Vaccination Period|Lost to Follow-up|16
4975608|NCT00092495|17090853|P5|Base Study Vaccination Period|Adverse Event|0
4975609|NCT00092495|17090854|P4|Base Study Vaccination Period|Adverse Event|3
4975610|NCT00092495|17090855|P3|Base Study Vaccination Period|Adverse Event|0
4975611|NCT00092495|17090856|P2|Base Study Vaccination Period|Adverse Event|0
4975612|NCT00092495|17090857|P1|Base Study Vaccination Period|Adverse Event|1
4975613|NCT00092495|17090853|P5|Base Study Vaccination Period|*Pregnancy|0
4975614|NCT00092495|17090854|P4|Base Study Vaccination Period|*Pregnancy|7
4975615|NCT00092495|17090855|P3|Base Study Vaccination Period|*Pregnancy|5
4975616|NCT00092495|17090856|P2|Base Study Vaccination Period|*Pregnancy|2
4975617|NCT00092495|17090857|P1|Base Study Vaccination Period|*Pregnancy|0
4975618|NCT00092495|17090853|P5|Base Study Vaccination Period|*Other reasons|0
4975619|NCT00092495|17090854|P4|Base Study Vaccination Period|*Other reasons|1
4975620|NCT00092495|17090855|P3|Base Study Vaccination Period|*Other reasons|0
4975621|NCT00092495|17090856|P2|Base Study Vaccination Period|*Other reasons|0
4975622|NCT00092495|17090857|P1|Base Study Vaccination Period|*Other reasons|1
4975623|NCT00092495|17090853|P5|Base Study Vaccination Period|*Clinical AE|0
4975624|NCT00092495|17090854|P4|Base Study Vaccination Period|*Clinical AE|2
4975625|NCT00092495|17090855|P3|Base Study Vaccination Period|*Clinical AE|1
4975626|NCT00092495|17090856|P2|Base Study Vaccination Period|*Clinical AE|0
4975627|NCT00092495|17090857|P1|Base Study Vaccination Period|*Clinical AE|1
4975628|NCT00092495|17090853|P5|Base Study Vaccination Period|Extended|0
4975629|NCT00092495|17090854|P4|Base Study Vaccination Period|Extended|1
4975630|NCT00092495|17090855|P3|Base Study Vaccination Period|Extended|0
4975631|NCT00092495|17090856|P2|Base Study Vaccination Period|Extended|0
4975632|NCT00092495|17090857|P1|Base Study Vaccination Period|Extended|0
4975633|NCT00092495|17090853|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
4975634|NCT00092495|17090854|P4|Base Study Vaccination Period|Randomized Not Vaccinated|4
4975635|NCT00092495|17090855|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
4975636|NCT00092495|17090856|P2|Base Study Vaccination Period|Randomized Not Vaccinated|1
4975637|NCT00092495|17090857|P1|Base Study Vaccination Period|Randomized Not Vaccinated|1
4975638|NCT00092456|17090923|P4|Overall Study|Other|0
4975639|NCT00092456|17090924|P3|Overall Study|Other|3
4975640|NCT00092456|17090925|P2|Overall Study|Other|2
4975641|NCT00092456|17090926|P1|Overall Study|Other|4
4975642|NCT00092456|17090923|P4|Overall Study|Moved|1
4975643|NCT00092456|17090924|P3|Overall Study|Moved|0
4975644|NCT00092456|17090925|P2|Overall Study|Moved|1
4975645|NCT00092456|17090926|P1|Overall Study|Moved|1
4975646|NCT00092456|17090923|P4|Overall Study|Withdrawal by Subject|6
4975647|NCT00092456|17090924|P3|Overall Study|Withdrawal by Subject|16
4975648|NCT00092456|17090925|P2|Overall Study|Withdrawal by Subject|5
4975649|NCT00092456|17090926|P1|Overall Study|Withdrawal by Subject|13
4975650|NCT00092456|17090923|P4|Overall Study|Protocol Violation|6
4975651|NCT00092456|17090924|P3|Overall Study|Protocol Violation|8
4975652|NCT00092456|17090925|P2|Overall Study|Protocol Violation|7
4975653|NCT00092456|17090926|P1|Overall Study|Protocol Violation|5
4975654|NCT00092456|17090923|P4|Overall Study|Lost to Follow-up|2
4975655|NCT00092456|17090924|P3|Overall Study|Lost to Follow-up|1
4975656|NCT00092456|17090925|P2|Overall Study|Lost to Follow-up|2
4975657|NCT00092456|17090926|P1|Overall Study|Lost to Follow-up|2
4975658|NCT00092456|17090923|P4|Overall Study|Adverse Event|1
4975659|NCT00092456|17090924|P3|Overall Study|Adverse Event|1
4975660|NCT00092456|17090925|P2|Overall Study|Adverse Event|0
4975661|NCT00092456|17090926|P1|Overall Study|Adverse Event|0
4975662|NCT00092443|17090974|P2|Overall Study|Other|13
4975663|NCT00092443|17090975|P1|Overall Study|Other|17
4975664|NCT00092443|17090974|P2|Overall Study|Moved|5
4975665|NCT00092443|17090975|P1|Overall Study|Moved|5
4975666|NCT00092443|17090974|P2|Overall Study|Withdrawal by Subject|11
4975667|NCT00092443|17090975|P1|Overall Study|Withdrawal by Subject|9
4975668|NCT00092443|17090974|P2|Overall Study|Protocol Violation|9
4975669|NCT00092443|17090975|P1|Overall Study|Protocol Violation|11
4975670|NCT00092443|17090974|P2|Overall Study|Lost to Follow-up|3
4975671|NCT00092443|17090975|P1|Overall Study|Lost to Follow-up|7
4975672|NCT00092443|17090974|P2|Overall Study|Adverse Event|13
4975673|NCT00092443|17090975|P1|Overall Study|Adverse Event|9
4975674|NCT00092417|17090993|P2|Overall Study|Other|0
4975675|NCT00092417|17090994|P1|Overall Study|Other|1
4975676|NCT00092417|17090993|P2|Overall Study|Withdrawal by Subject|1
4975677|NCT00092417|17090994|P1|Overall Study|Withdrawal by Subject|2
4975678|NCT00092417|17090993|P2|Overall Study|Lost to Follow-up|0
4975679|NCT00092417|17090994|P1|Overall Study|Lost to Follow-up|2
4975680|NCT00092131|17091008|P2|Treatment Period II|Adverse Event|1
4975681|NCT00092131|17091009|P1|Treatment Period II|Adverse Event|0
4975682|NCT00092131|17091008|P2|Treatment Period I|Adverse Event|0
4975683|NCT00092131|17091009|P1|Treatment Period I|Adverse Event|1
4975684|NCT00092118|17091039|P2|Overall Study|Other|5
4975685|NCT00092118|17091040|P1|Overall Study|Other|6
4975686|NCT00092118|17091039|P2|Overall Study|Withdrawal by Subject|10
4975687|NCT00092118|17091040|P1|Overall Study|Withdrawal by Subject|4
4975688|NCT00092118|17091039|P2|Overall Study|Protocol Violation|25
4975689|NCT00092118|17091040|P1|Overall Study|Protocol Violation|23
4975690|NCT00092118|17091039|P2|Overall Study|Lost to Follow-up|3
4975691|NCT00092118|17091040|P1|Overall Study|Lost to Follow-up|4
4975692|NCT00092118|17091039|P2|Overall Study|Lack of Efficacy|14
4975693|NCT00092118|17091040|P1|Overall Study|Lack of Efficacy|12
4975694|NCT00092118|17091039|P2|Overall Study|Adverse Event|32
4975695|NCT00092118|17091040|P1|Overall Study|Adverse Event|35
4975696|NCT00091949|17091074|P2|Overall Study|Lost to Follow-up|41
4975697|NCT00091949|17091075|P1|Overall Study|Lost to Follow-up|58
4975698|NCT00091949|17091074|P2|Overall Study|Withdrawal by Subject|110
4975699|NCT00091949|17091075|P1|Overall Study|Withdrawal by Subject|117
4975700|NCT00091832|17091099|P6|Overall Study|Protocol Violation|1
4975701|NCT00091832|17091100|P5|Overall Study|Protocol Violation|0
4975702|NCT00091832|17091101|P4|Overall Study|Protocol Violation|0
4975703|NCT00091832|17091102|P3|Overall Study|Protocol Violation|1
4975704|NCT00091832|17091103|P2|Overall Study|Protocol Violation|0
4975705|NCT00091832|17091104|P1|Overall Study|Protocol Violation|0
4975706|NCT00091832|17091099|P6|Overall Study|Other|0
4975707|NCT00091832|17091100|P5|Overall Study|Other|0
4975708|NCT00091832|17091101|P4|Overall Study|Other|0
4975709|NCT00091832|17091102|P3|Overall Study|Other|2
4975710|NCT00091832|17091103|P2|Overall Study|Other|1
4975711|NCT00091832|17091104|P1|Overall Study|Other|0
4975712|NCT00091832|17091099|P6|Overall Study|Noncompliance|0
4975713|NCT00091832|17091100|P5|Overall Study|Noncompliance|0
4975714|NCT00091832|17091101|P4|Overall Study|Noncompliance|0
4975715|NCT00091832|17091102|P3|Overall Study|Noncompliance|0
4975716|NCT00091832|17091103|P2|Overall Study|Noncompliance|1
4975717|NCT00091832|17091104|P1|Overall Study|Noncompliance|0
4975718|NCT00091832|17091099|P6|Overall Study|Lost to Follow-up|1
4975719|NCT00091832|17091100|P5|Overall Study|Lost to Follow-up|2
4975720|NCT00091832|17091101|P4|Overall Study|Lost to Follow-up|3
4975721|NCT00091832|17091102|P3|Overall Study|Lost to Follow-up|3
4975722|NCT00091832|17091103|P2|Overall Study|Lost to Follow-up|0
4975723|NCT00091832|17091104|P1|Overall Study|Lost to Follow-up|1
4975724|NCT00091832|17091099|P6|Overall Study|Ineligibility Determined|0
4975725|NCT00091832|17091100|P5|Overall Study|Ineligibility Determined|1
4975726|NCT00091832|17091101|P4|Overall Study|Ineligibility Determined|0
4975727|NCT00091832|17091102|P3|Overall Study|Ineligibility Determined|1
4975728|NCT00091832|17091103|P2|Overall Study|Ineligibility Determined|0
4975729|NCT00091832|17091104|P1|Overall Study|Ineligibility Determined|0
4975730|NCT00091832|17091099|P6|Overall Study|Disease Progression|2
4975731|NCT00091832|17091100|P5|Overall Study|Disease Progression|1
4975732|NCT00091832|17091101|P4|Overall Study|Disease Progression|1
4975733|NCT00091832|17091102|P3|Overall Study|Disease Progression|0
4975734|NCT00091832|17091103|P2|Overall Study|Disease Progression|0
4975735|NCT00091832|17091104|P1|Overall Study|Disease Progression|2
4975736|NCT00091832|17091099|P6|Overall Study|Death|6
4975737|NCT00091832|17091100|P5|Overall Study|Death|5
4975738|NCT00091832|17091101|P4|Overall Study|Death|8
4975739|NCT00091832|17091102|P3|Overall Study|Death|5
4975740|NCT00091832|17091103|P2|Overall Study|Death|4
4975741|NCT00091832|17091104|P1|Overall Study|Death|6
4975742|NCT00091832|17091099|P6|Overall Study|Withdrawal by Subject|1
4975743|NCT00091832|17091100|P5|Overall Study|Withdrawal by Subject|3
4975744|NCT00091832|17091101|P4|Overall Study|Withdrawal by Subject|1
4975745|NCT00091832|17091102|P3|Overall Study|Withdrawal by Subject|0
4975746|NCT00091832|17091103|P2|Overall Study|Withdrawal by Subject|5
4975747|NCT00091832|17091104|P1|Overall Study|Withdrawal by Subject|4
4975748|NCT00091832|17091099|P6|Overall Study|Adverse Event|0
4975749|NCT00091832|17091100|P5|Overall Study|Adverse Event|3
4975750|NCT00091832|17091101|P4|Overall Study|Adverse Event|1
4975751|NCT00091832|17091102|P3|Overall Study|Adverse Event|0
4975752|NCT00091832|17091103|P2|Overall Study|Adverse Event|0
4975753|NCT00091832|17091104|P1|Overall Study|Adverse Event|0
4975754|NCT00091832|17091099|P6|Overall Study|Physician Decision|0
4975755|NCT00091832|17091100|P5|Overall Study|Physician Decision|0
4975756|NCT00091832|17091101|P4|Overall Study|Physician Decision|0
4975757|NCT00091832|17091102|P3|Overall Study|Physician Decision|0
4975758|NCT00091832|17091103|P2|Overall Study|Physician Decision|0
4975759|NCT00091832|17091104|P1|Overall Study|Physician Decision|1
4975760|NCT00091819|17091222|P2|Overall Study|Never received study treatment|4
4975761|NCT00091819|17091223|P1|Overall Study|Never received study treatment|3
4975762|NCT00091819|17091222|P2|Overall Study|Other|3
4975763|NCT00091819|17091223|P1|Overall Study|Other|2
4975764|NCT00091819|17091222|P2|Overall Study|Protocol Violation|2
4975765|NCT00091819|17091223|P1|Overall Study|Protocol Violation|1
4975766|NCT00091819|17091222|P2|Overall Study|Withdrawal by Subject|8
4975767|NCT00091819|17091223|P1|Overall Study|Withdrawal by Subject|5
4975768|NCT00091819|17091222|P2|Overall Study|Lost to Follow-up|23
4975769|NCT00091819|17091223|P1|Overall Study|Lost to Follow-up|26
4975770|NCT00091819|17091222|P2|Overall Study|Death|5
4975771|NCT00091819|17091223|P1|Overall Study|Death|4
4975772|NCT00091819|17091222|P2|Overall Study|Adverse Event|1
4975773|NCT00091819|17091223|P1|Overall Study|Adverse Event|1
4975774|NCT00091793|17091231|P2|Overall Study|Other|0
4975775|NCT00091793|17091232|P1|Overall Study|Other|2
4975776|NCT00091793|17091231|P2|Overall Study|Noncompliance|0
4975777|NCT00091793|17091232|P1|Overall Study|Noncompliance|2
4975778|NCT00091793|17091231|P2|Overall Study|Lost to Follow-up|5
4975779|NCT00091793|17091232|P1|Overall Study|Lost to Follow-up|7
4975780|NCT00091793|17091231|P2|Overall Study|Ineligibility determined|0
4975781|NCT00091793|17091232|P1|Overall Study|Ineligibility determined|2
4975782|NCT00091793|17091231|P2|Overall Study|Withdrawal by Subject|15
4975783|NCT00091793|17091232|P1|Overall Study|Withdrawal by Subject|10
4975784|NCT00091793|17091231|P2|Overall Study|Adverse Event|2
4975785|NCT00091793|17091232|P1|Overall Study|Adverse Event|1
4975786|NCT00091572|17091256|P2|Overall Study|Toxicity (Related AE)|9
4975787|NCT00091572|17091257|P1|Overall Study|Toxicity (Related AE)|53
4975788|NCT00091572|17091256|P2|Overall Study|Major Protocol Violation|0
4975789|NCT00091572|17091257|P1|Overall Study|Major Protocol Violation|2
4975790|NCT00091572|17091256|P2|Overall Study|Ongoing (still on treatment)|12
4975791|NCT00091572|17091257|P1|Overall Study|Ongoing (still on treatment)|8
4975792|NCT00091572|17091256|P2|Overall Study|Other Reason|13
4975793|NCT00091572|17091257|P1|Overall Study|Other Reason|6
4975794|NCT00091572|17091256|P2|Overall Study|Medical Decision unrelated toxicity/PD|22
4975795|NCT00091572|17091257|P1|Overall Study|Medical Decision unrelated toxicity/PD|10
4975796|NCT00091572|17091256|P2|Overall Study|Death not due to malignancy/toxicity|3
4975797|NCT00091572|17091257|P1|Overall Study|Death not due to malignancy/toxicity|1
4975798|NCT00091572|17091256|P2|Overall Study|Subject's Refusal unrelated to toxicity|22
4975799|NCT00091572|17091257|P1|Overall Study|Subject's Refusal unrelated to toxicity|14
4975800|NCT00091572|17091256|P2|Overall Study|Lost to Follow-up|1
4975801|NCT00091572|17091257|P1|Overall Study|Lost to Follow-up|1
4975802|NCT00091442|17091288|P2|Overall Study|Other|6
4975803|NCT00091442|17091289|P1|Overall Study|Other|2
4975804|NCT00091442|17091288|P2|Overall Study|Lost to Follow-up|3
4975805|NCT00091442|17091289|P1|Overall Study|Lost to Follow-up|1
4975806|NCT00091442|17091288|P2|Overall Study|Death|7
4975807|NCT00091442|17091289|P1|Overall Study|Death|9
4975808|NCT00091442|17091288|P2|Overall Study|2cycles therapy beyond Complete response|16
4975809|NCT00091442|17091289|P1|Overall Study|2cycles therapy beyond Complete response|9
4975810|NCT00091442|17091288|P2|Overall Study|Adverse Event|48
4975811|NCT00091442|17091289|P1|Overall Study|Adverse Event|29
4975812|NCT00091442|17091288|P2|Overall Study|Withdrawal by Subject|46
4975813|NCT00091442|17091289|P1|Overall Study|Withdrawal by Subject|38
4975814|NCT00091442|17091288|P2|Overall Study|Physician Decision|58
4975815|NCT00091442|17091289|P1|Overall Study|Physician Decision|61
4975816|NCT00091442|17091288|P2|Overall Study|Progressive Disease|189
4975817|NCT00091442|17091289|P1|Overall Study|Progressive Disease|220
4975818|NCT00091390|17091299|P1|Overall Study|No protocol treatment|3
4975819|NCT00091390|17091299|P1|Overall Study|Protocol Violation|1
4975820|NCT00091169|17091324|P2|Overall Study|Not start protocol therapy|17
4975821|NCT00091169|17091325|P1|Overall Study|Not start protocol therapy|26
4975822|NCT00091169|17091324|P2|Overall Study|Other|4
4975823|NCT00091169|17091325|P1|Overall Study|Other|3
4975824|NCT00091169|17091324|P2|Overall Study|Withdrawal by Subject|13
4975825|NCT00091169|17091325|P1|Overall Study|Withdrawal by Subject|10
4975826|NCT00091169|17091324|P2|Overall Study|Death|1
4975827|NCT00091169|17091325|P1|Overall Study|Death|4
4975828|NCT00091169|17091324|P2|Overall Study|Adverse Event|17
4975829|NCT00091169|17091325|P1|Overall Study|Adverse Event|11
4975830|NCT00091169|17091324|P2|Overall Study|Disease progression|1
4975831|NCT00091169|17091325|P1|Overall Study|Disease progression|3
4975832|NCT00091026|17091343|P2|Overall Study|Unknown-never received treatment|1
4975833|NCT00091026|17091344|P1|Overall Study|Unknown-never received treatment|0
4975834|NCT00091026|17091343|P2|Overall Study|Patient withdrew and never received trea|2
4975835|NCT00091026|17091344|P1|Overall Study|Patient withdrew and never received trea|0
4975836|NCT00091026|17091343|P2|Overall Study|Patient deemed non eligible-never receiv|0
4975837|NCT00091026|17091344|P1|Overall Study|Patient deemed non eligible-never receiv|1
4975838|NCT00090987|17091354|P1|Overall Study|Incarcerated|1
4975839|NCT00090987|17091354|P1|Overall Study|Non-compliance|4
4975840|NCT00090987|17091354|P1|Overall Study|alternative therapy|1
4975841|NCT00090987|17091354|P1|Overall Study|Withdrawal by Subject|3
4975842|NCT00090987|17091354|P1|Overall Study|Lack of Efficacy|7
4975843|NCT00090987|17091354|P1|Overall Study|Adverse Event|5
4975844|NCT00090857|17091367|P2|Overall Study|Adverse Event|2
4975845|NCT00090857|17091368|P1|Overall Study|Adverse Event|2
4975846|NCT00090857|17091367|P2|Overall Study|Withdrawal by Subject|0
4975847|NCT00090857|17091368|P1|Overall Study|Withdrawal by Subject|2
4975848|NCT00090857|17091367|P2|Overall Study|Lost to Follow-up|1
4975849|NCT00090857|17091368|P1|Overall Study|Lost to Follow-up|0
4975850|NCT00090779|17091407|P2|Step 3|Off extended study due to study closure|3
4975851|NCT00090779|17091408|P1|Step 3|Off extended study due to study closure|4
4975852|NCT00090779|17091407|P2|Step 3|Initiation of ART and off extended study|2
4975853|NCT00090779|17091408|P1|Step 3|Initiation of ART and off extended study|3
4975854|NCT00090779|17091407|P2|Step 2|Non-compliance to study requirements|1
4975855|NCT00090779|17091408|P1|Step 2|Non-compliance to study requirements|0
4975856|NCT00090779|17091407|P2|Step 2|Subject relocated|1
4975857|NCT00090779|17091408|P1|Step 2|Subject relocated|0
4975858|NCT00090779|17091407|P2|Step 2|Off study per study closure|16
4975859|NCT00090779|17091408|P1|Step 2|Off study per study closure|6
4975860|NCT00090779|17091407|P2|Step 1|Subject relocated|8
4975861|NCT00090779|17091408|P1|Step 1|Subject relocated|2
4975862|NCT00090779|17091407|P2|Step 1|Non-compliance to study requirements|1
4975863|NCT00090779|17091408|P1|Step 1|Non-compliance to study requirements|0
4975864|NCT00090779|17091407|P2|Step 1|Pregnancy|0
4975865|NCT00090779|17091408|P1|Step 1|Pregnancy|1
4975866|NCT00090779|17091407|P2|Step 1|Physician Decision|0
4975867|NCT00090779|17091408|P1|Step 1|Physician Decision|1
4975868|NCT00090779|17091407|P2|Step 1|Death|2
4975869|NCT00090779|17091408|P1|Step 1|Death|0
4975870|NCT00090779|17091407|P2|Step 1|Lost to Follow-up|2
4975871|NCT00090779|17091408|P1|Step 1|Lost to Follow-up|3
4975872|NCT00090779|17091407|P2|Step 1|Withdrawal by Subject|2
4975873|NCT00090779|17091408|P1|Step 1|Withdrawal by Subject|4
4975874|NCT00090766|17091432|P3|Overall Study|Lost to Follow-up|2
4975875|NCT00090766|17091433|P2|Overall Study|Lost to Follow-up|0
4975876|NCT00090766|17091434|P1|Overall Study|Lost to Follow-up|2
4975877|NCT00090766|17091432|P3|Overall Study|Admin|0
4975878|NCT00090766|17091433|P2|Overall Study|Admin|2
4975879|NCT00090766|17091434|P1|Overall Study|Admin|0
4975880|NCT00090766|17091432|P3|Overall Study|Death|0
4975881|NCT00090766|17091433|P2|Overall Study|Death|0
4975882|NCT00090766|17091434|P1|Overall Study|Death|1
4975883|NCT00090766|17091432|P3|Overall Study|Nephrectomy Planned|1
4975884|NCT00090766|17091433|P2|Overall Study|Nephrectomy Planned|0
4975885|NCT00090766|17091434|P1|Overall Study|Nephrectomy Planned|0
4975886|NCT00090753|17091476|P2|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43
4975887|NCT00090753|17091477|P1|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65
4975888|NCT00090753|17091476|P2|Extended Treatment Period|Mircera Commercialization|93
4975889|NCT00090753|17091477|P1|Extended Treatment Period|Mircera Commercialization|188
4975890|NCT00090753|17091476|P2|Extended Treatment Period|Renal Transplant|12
4975891|NCT00090753|17091477|P1|Extended Treatment Period|Renal Transplant|15
4975892|NCT00090753|17091476|P2|Extended Treatment Period|Lost to Follow-up|1
4975893|NCT00090753|17091477|P1|Extended Treatment Period|Lost to Follow-up|3
4975894|NCT00090753|17091476|P2|Extended Treatment Period|Refused Treatment|12
4975895|NCT00090753|17091477|P1|Extended Treatment Period|Refused Treatment|18
4975896|NCT00090753|17091476|P2|Extended Treatment Period|Lack of Efficacy|0
4975897|NCT00090753|17091477|P1|Extended Treatment Period|Lack of Efficacy|1
4975898|NCT00090753|17091476|P2|Extended Treatment Period|Death|30
4975899|NCT00090753|17091477|P1|Extended Treatment Period|Death|58
4975900|NCT00090753|17091476|P2|Extended Treatment Period|Adverse Event|0
4975901|NCT00090753|17091477|P1|Extended Treatment Period|Adverse Event|11
4975902|NCT00090753|17091476|P2|First Treatment Period|Other Unrelated to Safety and Efficacy|28
4975903|NCT00090753|17091477|P1|First Treatment Period|Other Unrelated to Safety and Efficacy|39
4975904|NCT00090753|17091476|P2|First Treatment Period|Mircera Commercialization|0
4975905|NCT00090753|17091477|P1|First Treatment Period|Mircera Commercialization|1
4975906|NCT00090753|17091476|P2|First Treatment Period|Renal Transplant|50
4975907|NCT00090753|17091477|P1|First Treatment Period|Renal Transplant|70
4975908|NCT00090753|17091476|P2|First Treatment Period|Lost to Follow-up|4
4975909|NCT00090753|17091477|P1|First Treatment Period|Lost to Follow-up|4
4975910|NCT00090753|17091476|P2|First Treatment Period|Refused Treatment|25
4975911|NCT00090753|17091477|P1|First Treatment Period|Refused Treatment|32
4975912|NCT00090753|17091476|P2|First Treatment Period|Lack of Efficacy|1
4975913|NCT00090753|17091477|P1|First Treatment Period|Lack of Efficacy|2
4975914|NCT00090753|17091476|P2|First Treatment Period|Death|62
4975915|NCT00090753|17091477|P1|First Treatment Period|Death|88
4975916|NCT00090753|17091476|P2|First Treatment Period|Adverse Event|8
4975917|NCT00090753|17091477|P1|First Treatment Period|Adverse Event|20
4975918|NCT00090610|17091487|P2|Overall Study|Withdrawal by Subject|1
4975919|NCT00090610|17091488|P1|Overall Study|Withdrawal by Subject|1
4975920|NCT00090584|17091504|P2|Baseline to 8 Months|Lost to Follow-up|41
4975921|NCT00090584|17091505|P1|Baseline to 8 Months|Lost to Follow-up|44
4975922|NCT00090584|17091504|P2|Baseline to 10 Weeks|Lost to Follow-up|12
4975923|NCT00090584|17091505|P1|Baseline to 10 Weeks|Lost to Follow-up|15
4975924|NCT00090519|17091537|P2|Overall Study|Sponsor Decision|1
4975925|NCT00090519|17091538|P1|Overall Study|Sponsor Decision|3
4975926|NCT00090519|17091537|P2|Overall Study|Physician Decision|3
4975927|NCT00090519|17091538|P1|Overall Study|Physician Decision|2
4975928|NCT00090519|17091537|P2|Overall Study|Withdrawal by Subject|29
4975929|NCT00090519|17091538|P1|Overall Study|Withdrawal by Subject|28
4975930|NCT00090519|17091537|P2|Overall Study|Lost to Follow-up|29
4975931|NCT00090519|17091538|P1|Overall Study|Lost to Follow-up|26
4975932|NCT00090519|17091537|P2|Overall Study|Death|9
4975933|NCT00090519|17091538|P1|Overall Study|Death|9
4975934|NCT00090519|17091537|P2|Overall Study|Adverse Event|4
4975935|NCT00090519|17091538|P1|Overall Study|Adverse Event|5
4975936|NCT00090493|17091562|P1|Overall Study|Physician Decision|2
4975937|NCT00090363|17091569|P3|Overall Study|Continuing on study off treatment|16
4975938|NCT00090363|17091570|P2|Overall Study|Continuing on study off treatment|13
4975939|NCT00090363|17091571|P1|Overall Study|Continuing on study off treatment|14
4975940|NCT00090363|17091569|P3|Overall Study|Reasons not specified|1
4975941|NCT00090363|17091570|P2|Overall Study|Reasons not specified|1
4975942|NCT00090363|17091571|P1|Overall Study|Reasons not specified|2
4975943|NCT00090363|17091569|P3|Overall Study|Consent expired|9
4975944|NCT00090363|17091570|P2|Overall Study|Consent expired|10
4975945|NCT00090363|17091571|P1|Overall Study|Consent expired|7
4975946|NCT00090363|17091569|P3|Overall Study|Eligibility criteria not fulfilled|1
4975947|NCT00090363|17091570|P2|Overall Study|Eligibility criteria not fulfilled|0
4975948|NCT00090363|17091571|P1|Overall Study|Eligibility criteria not fulfilled|0
4975949|NCT00090363|17091569|P3|Overall Study|Study-specific discontinuation criteria|62
4975950|NCT00090363|17091570|P2|Overall Study|Study-specific discontinuation criteria|74
4975951|NCT00090363|17091571|P1|Overall Study|Study-specific discontinuation criteria|75
4975952|NCT00090363|17091569|P3|Overall Study|Withdrawal by Subject|6
4975953|NCT00090363|17091570|P2|Overall Study|Withdrawal by Subject|7
4975954|NCT00090363|17091571|P1|Overall Study|Withdrawal by Subject|7
4975955|NCT00090363|17091569|P3|Overall Study|Lost to Follow-up|1
4975956|NCT00090363|17091570|P2|Overall Study|Lost to Follow-up|2
4975957|NCT00090363|17091571|P1|Overall Study|Lost to Follow-up|1
4975958|NCT00090545|17091593|P2|Overall Study|Adverse Event|2
4975959|NCT00090545|17091594|P1|Overall Study|Adverse Event|0
4975960|NCT00090545|17091593|P2|Overall Study|Death|1
4975961|NCT00090545|17091594|P1|Overall Study|Death|0
4975962|NCT00090545|17091593|P2|Overall Study|Refused further treatment|4
4975963|NCT00090545|17091594|P1|Overall Study|Refused further treatment|1
4975964|NCT00090545|17091593|P2|Overall Study|Disease progression on study|17
4975965|NCT00090545|17091594|P1|Overall Study|Disease progression on study|21
4975966|NCT00090285|17091614|P6|Long-term Follow-up (EXT2)|Physician Decision|5
4975967|NCT00090285|17091615|P5|Long-term Follow-up (EXT2)|Physician Decision|6
4975968|NCT00090285|17091616|P4|Long-term Follow-up (EXT2)|Physician Decision|0
4975969|NCT00090285|17091617|P3|Long-term Follow-up (EXT2)|Physician Decision|0
4975970|NCT00090285|17091618|P2|Long-term Follow-up (EXT2)|Physician Decision|0
4975971|NCT00090285|17091619|P1|Long-term Follow-up (EXT2)|Physician Decision|0
4975972|NCT00090285|17091614|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|53
4975973|NCT00090285|17091615|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|60
4975974|NCT00090285|17091616|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4975975|NCT00090285|17091617|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4975976|NCT00090285|17091618|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4975977|NCT00090285|17091619|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4975978|NCT00090285|17091614|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|143
4975979|NCT00090285|17091615|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|156
4975980|NCT00090285|17091616|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4975981|NCT00090285|17091617|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4975982|NCT00090285|17091618|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4975983|NCT00090285|17091619|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4975984|NCT00090285|17091614|P6|Long-term Follow-up (EXT2)|Adverse Event|2
4975985|NCT00090285|17091615|P5|Long-term Follow-up (EXT2)|Adverse Event|5
4975986|NCT00090285|17091616|P4|Long-term Follow-up (EXT2)|Adverse Event|0
4975987|NCT00090285|17091617|P3|Long-term Follow-up (EXT2)|Adverse Event|0
4975988|NCT00090285|17091618|P2|Long-term Follow-up (EXT2)|Adverse Event|0
4975989|NCT00090285|17091619|P1|Long-term Follow-up (EXT2)|Adverse Event|0
4975990|NCT00090285|17091614|P6|Extension 1|Moved|0
4975991|NCT00090285|17091615|P5|Extension 1|Moved|0
4975992|NCT00090285|17091616|P4|Extension 1|Moved|0
4975993|NCT00090285|17091617|P3|Extension 1|Moved|3
4975994|NCT00090285|17091618|P2|Extension 1|Moved|0
4975995|NCT00090285|17091619|P1|Extension 1|Moved|0
4975996|NCT00090285|17091614|P6|Extension 1|Other|0
4975997|NCT00090285|17091615|P5|Extension 1|Other|0
4975998|NCT00090285|17091616|P4|Extension 1|Other|0
4975999|NCT00090285|17091617|P3|Extension 1|Other|4
4976000|NCT00090285|17091618|P2|Extension 1|Other|0
4976001|NCT00090285|17091619|P1|Extension 1|Other|0
4976002|NCT00090285|17091614|P6|Extension 1|Withdrawal by Subject|0
4976003|NCT00090285|17091615|P5|Extension 1|Withdrawal by Subject|0
4976004|NCT00090285|17091616|P4|Extension 1|Withdrawal by Subject|1
4976005|NCT00090285|17091617|P3|Extension 1|Withdrawal by Subject|13
4976006|NCT00090285|17091618|P2|Extension 1|Withdrawal by Subject|0
4976007|NCT00090285|17091619|P1|Extension 1|Withdrawal by Subject|0
4976008|NCT00090285|17091614|P6|Extension 1|Lost to Follow-up|0
4976009|NCT00090285|17091615|P5|Extension 1|Lost to Follow-up|0
4976010|NCT00090285|17091616|P4|Extension 1|Lost to Follow-up|0
4976011|NCT00090285|17091617|P3|Extension 1|Lost to Follow-up|35
4976012|NCT00090285|17091618|P2|Extension 1|Lost to Follow-up|0
4976013|NCT00090285|17091619|P1|Extension 1|Lost to Follow-up|0
4976014|NCT00090285|17091614|P6|Extension 1|Adverse Event|0
4976015|NCT00090285|17091615|P5|Extension 1|Adverse Event|0
4976016|NCT00090285|17091616|P4|Extension 1|Adverse Event|0
4976017|NCT00090285|17091617|P3|Extension 1|Adverse Event|2
4976018|NCT00090285|17091618|P2|Extension 1|Adverse Event|0
4976019|NCT00090285|17091619|P1|Extension 1|Adverse Event|0
4976020|NCT00090285|17091614|P6|Base Study Follow-up Period|Subject Incarcerated|0
4976021|NCT00090285|17091615|P5|Base Study Follow-up Period|Subject Incarcerated|0
4976022|NCT00090285|17091616|P4|Base Study Follow-up Period|Subject Incarcerated|0
4976023|NCT00090285|17091617|P3|Base Study Follow-up Period|Subject Incarcerated|0
4976024|NCT00090285|17091618|P2|Base Study Follow-up Period|Subject Incarcerated|2
4976025|NCT00090285|17091619|P1|Base Study Follow-up Period|Subject Incarcerated|0
4976026|NCT00090285|17091614|P6|Base Study Follow-up Period|Uncooperative|0
4976027|NCT00090285|17091615|P5|Base Study Follow-up Period|Uncooperative|0
4976028|NCT00090285|17091616|P4|Base Study Follow-up Period|Uncooperative|0
4976029|NCT00090285|17091617|P3|Base Study Follow-up Period|Uncooperative|0
4976030|NCT00090285|17091618|P2|Base Study Follow-up Period|Uncooperative|4
4976031|NCT00090285|17091619|P1|Base Study Follow-up Period|Uncooperative|3
4976032|NCT00090285|17091614|P6|Base Study Follow-up Period|Protocol Violation|0
4976033|NCT00090285|17091615|P5|Base Study Follow-up Period|Protocol Violation|0
4976034|NCT00090285|17091616|P4|Base Study Follow-up Period|Protocol Violation|0
4976035|NCT00090285|17091617|P3|Base Study Follow-up Period|Protocol Violation|0
4976036|NCT00090285|17091618|P2|Base Study Follow-up Period|Protocol Violation|0
4976037|NCT00090285|17091619|P1|Base Study Follow-up Period|Protocol Violation|1
4976038|NCT00090285|17091614|P6|Base Study Follow-up Period|Other|0
4976039|NCT00090285|17091615|P5|Base Study Follow-up Period|Other|0
4976040|NCT00090285|17091616|P4|Base Study Follow-up Period|Other|0
4976041|NCT00090285|17091617|P3|Base Study Follow-up Period|Other|0
4976042|NCT00090285|17091618|P2|Base Study Follow-up Period|Other|0
4976043|NCT00090285|17091619|P1|Base Study Follow-up Period|Other|2
4976044|NCT00090285|17091614|P6|Base Study Follow-up Period|Moved|0
4976045|NCT00090285|17091615|P5|Base Study Follow-up Period|Moved|0
4976046|NCT00090285|17091616|P4|Base Study Follow-up Period|Moved|0
4976047|NCT00090285|17091617|P3|Base Study Follow-up Period|Moved|0
4976048|NCT00090285|17091618|P2|Base Study Follow-up Period|Moved|36
4976049|NCT00090285|17091619|P1|Base Study Follow-up Period|Moved|41
4976050|NCT00090285|17091614|P6|Base Study Follow-up Period|Withdrawal by Subject|0
4976051|NCT00090285|17091615|P5|Base Study Follow-up Period|Withdrawal by Subject|0
4976052|NCT00090285|17091616|P4|Base Study Follow-up Period|Withdrawal by Subject|0
4976053|NCT00090285|17091617|P3|Base Study Follow-up Period|Withdrawal by Subject|0
4976054|NCT00090285|17091618|P2|Base Study Follow-up Period|Withdrawal by Subject|64
4976055|NCT00090285|17091619|P1|Base Study Follow-up Period|Withdrawal by Subject|53
4976056|NCT00090285|17091614|P6|Base Study Follow-up Period|Lost to Follow-up|0
4976057|NCT00090285|17091615|P5|Base Study Follow-up Period|Lost to Follow-up|0
4976058|NCT00090285|17091616|P4|Base Study Follow-up Period|Lost to Follow-up|0
4976059|NCT00090285|17091617|P3|Base Study Follow-up Period|Lost to Follow-up|0
4976060|NCT00090285|17091618|P2|Base Study Follow-up Period|Lost to Follow-up|226
4976061|NCT00090285|17091619|P1|Base Study Follow-up Period|Lost to Follow-up|232
4976062|NCT00090285|17091614|P6|Base Study Follow-up Period|Adverse Event|0
4976063|NCT00090285|17091615|P5|Base Study Follow-up Period|Adverse Event|0
4976064|NCT00090285|17091616|P4|Base Study Follow-up Period|Adverse Event|0
4976065|NCT00090285|17091617|P3|Base Study Follow-up Period|Adverse Event|0
4976066|NCT00090285|17091618|P2|Base Study Follow-up Period|Adverse Event|10
4976067|NCT00090285|17091619|P1|Base Study Follow-up Period|Adverse Event|3
4976068|NCT00090285|17091614|P6|Base Study Vaccination Period|HIV positive|0
4976069|NCT00090285|17091615|P5|Base Study Vaccination Period|HIV positive|0
4976070|NCT00090285|17091616|P4|Base Study Vaccination Period|HIV positive|0
4976071|NCT00090285|17091617|P3|Base Study Vaccination Period|HIV positive|0
4976072|NCT00090285|17091618|P2|Base Study Vaccination Period|HIV positive|1
4976073|NCT00090285|17091619|P1|Base Study Vaccination Period|HIV positive|1
4976074|NCT00090285|17091614|P6|Base Study Vaccination Period|Subject Incarcerated|0
4976075|NCT00090285|17091615|P5|Base Study Vaccination Period|Subject Incarcerated|0
4976076|NCT00090285|17091616|P4|Base Study Vaccination Period|Subject Incarcerated|0
4976077|NCT00090285|17091617|P3|Base Study Vaccination Period|Subject Incarcerated|0
4976078|NCT00090285|17091618|P2|Base Study Vaccination Period|Subject Incarcerated|2
4976079|NCT00090285|17091619|P1|Base Study Vaccination Period|Subject Incarcerated|2
4976080|NCT00090285|17091614|P6|Base Study Vaccination Period|Other|0
4976081|NCT00090285|17091615|P5|Base Study Vaccination Period|Other|0
4976082|NCT00090285|17091616|P4|Base Study Vaccination Period|Other|0
4976083|NCT00090285|17091617|P3|Base Study Vaccination Period|Other|0
4976084|NCT00090285|17091618|P2|Base Study Vaccination Period|Other|2
4976085|NCT00090285|17091619|P1|Base Study Vaccination Period|Other|2
4976086|NCT00090285|17091614|P6|Base Study Vaccination Period|Site Terminated|0
4976087|NCT00090285|17091615|P5|Base Study Vaccination Period|Site Terminated|0
4976088|NCT00090285|17091616|P4|Base Study Vaccination Period|Site Terminated|0
4976089|NCT00090285|17091617|P3|Base Study Vaccination Period|Site Terminated|0
4976090|NCT00090285|17091618|P2|Base Study Vaccination Period|Site Terminated|0
4976091|NCT00090285|17091619|P1|Base Study Vaccination Period|Site Terminated|1
4976092|NCT00090285|17091614|P6|Base Study Vaccination Period|Moved|0
4976093|NCT00090285|17091615|P5|Base Study Vaccination Period|Moved|0
4976094|NCT00090285|17091616|P4|Base Study Vaccination Period|Moved|0
4976095|NCT00090285|17091617|P3|Base Study Vaccination Period|Moved|0
4976096|NCT00090285|17091618|P2|Base Study Vaccination Period|Moved|21
4976097|NCT00090285|17091619|P1|Base Study Vaccination Period|Moved|20
4976098|NCT00090285|17091614|P6|Base Study Vaccination Period|Uncooperative|0
4976099|NCT00090285|17091615|P5|Base Study Vaccination Period|Uncooperative|0
4976100|NCT00090285|17091616|P4|Base Study Vaccination Period|Uncooperative|0
4976101|NCT00090285|17091617|P3|Base Study Vaccination Period|Uncooperative|0
4976102|NCT00090285|17091618|P2|Base Study Vaccination Period|Uncooperative|2
4976103|NCT00090285|17091619|P1|Base Study Vaccination Period|Uncooperative|2
4976104|NCT00090285|17091614|P6|Base Study Vaccination Period|Withdrawal by Subject|0
4976105|NCT00090285|17091615|P5|Base Study Vaccination Period|Withdrawal by Subject|0
4976106|NCT00090285|17091616|P4|Base Study Vaccination Period|Withdrawal by Subject|0
4976107|NCT00090285|17091617|P3|Base Study Vaccination Period|Withdrawal by Subject|0
4976108|NCT00090285|17091618|P2|Base Study Vaccination Period|Withdrawal by Subject|69
4976109|NCT00090285|17091619|P1|Base Study Vaccination Period|Withdrawal by Subject|64
4976110|NCT00090285|17091614|P6|Base Study Vaccination Period|Protocol Violation|0
4976111|NCT00090285|17091615|P5|Base Study Vaccination Period|Protocol Violation|0
4976112|NCT00090285|17091616|P4|Base Study Vaccination Period|Protocol Violation|0
4976113|NCT00090285|17091617|P3|Base Study Vaccination Period|Protocol Violation|0
4976114|NCT00090285|17091618|P2|Base Study Vaccination Period|Protocol Violation|3
4976115|NCT00090285|17091619|P1|Base Study Vaccination Period|Protocol Violation|2
4976116|NCT00090285|17091614|P6|Base Study Vaccination Period|Lost to Follow-up|0
4976117|NCT00090285|17091615|P5|Base Study Vaccination Period|Lost to Follow-up|0
4976118|NCT00090285|17091616|P4|Base Study Vaccination Period|Lost to Follow-up|0
4976119|NCT00090285|17091617|P3|Base Study Vaccination Period|Lost to Follow-up|0
4976120|NCT00090285|17091618|P2|Base Study Vaccination Period|Lost to Follow-up|112
4976121|NCT00090285|17091619|P1|Base Study Vaccination Period|Lost to Follow-up|111
4976122|NCT00090285|17091614|P6|Base Study Vaccination Period|Adverse Event|0
4976123|NCT00090285|17091615|P5|Base Study Vaccination Period|Adverse Event|0
4976124|NCT00090285|17091616|P4|Base Study Vaccination Period|Adverse Event|0
4976125|NCT00090285|17091617|P3|Base Study Vaccination Period|Adverse Event|0
4976126|NCT00090285|17091618|P2|Base Study Vaccination Period|Adverse Event|4
4976127|NCT00090285|17091619|P1|Base Study Vaccination Period|Adverse Event|2
4976128|NCT00090285|17091614|P6|Base Study Vaccination Period|Randomized Not Vaccinated|0
4976129|NCT00090285|17091615|P5|Base Study Vaccination Period|Randomized Not Vaccinated|0
4976130|NCT00090285|17091616|P4|Base Study Vaccination Period|Randomized Not Vaccinated|0
4976131|NCT00090285|17091617|P3|Base Study Vaccination Period|Randomized Not Vaccinated|0
4976132|NCT00090285|17091618|P2|Base Study Vaccination Period|Randomized Not Vaccinated|3
4976133|NCT00090285|17091619|P1|Base Study Vaccination Period|Randomized Not Vaccinated|7
4976134|NCT00090259|17091656|P2|Overall Study|Investigator site closed|7
4976135|NCT00090259|17091657|P1|Overall Study|Investigator site closed|11
4976136|NCT00090259|17091656|P2|Overall Study|Withdrawal by Subject|15
4976137|NCT00090259|17091657|P1|Overall Study|Withdrawal by Subject|21
4976138|NCT00090259|17091656|P2|Overall Study|Lost to Follow-up|26
4976139|NCT00090259|17091657|P1|Overall Study|Lost to Follow-up|30
4976140|NCT00090233|17091673|P2|Overall Study|Data not available at data cut-off point|1563
4976141|NCT00090233|17091674|P1|Overall Study|Data not available at data cut-off point|1552
4976142|NCT00090233|17091673|P2|Overall Study|Other|1160
4976143|NCT00090233|17091674|P1|Overall Study|Other|1211
4976144|NCT00090233|17091673|P2|Overall Study|Moved|189
4976145|NCT00090233|17091674|P1|Overall Study|Moved|203
4976146|NCT00090233|17091673|P2|Overall Study|Withdrawal by Subject|211
4976147|NCT00090233|17091674|P1|Overall Study|Withdrawal by Subject|182
4976148|NCT00090233|17091673|P2|Overall Study|Protocol Violation|1022
4976149|NCT00090233|17091674|P1|Overall Study|Protocol Violation|960
4976150|NCT00090233|17091673|P2|Overall Study|Lost to Follow-up|95
4976151|NCT00090233|17091674|P1|Overall Study|Lost to Follow-up|68
4976152|NCT00090233|17091673|P2|Overall Study|Adverse Event|198
4976153|NCT00090233|17091674|P1|Overall Study|Adverse Event|214
4976154|NCT00090233|17091673|P2|Overall Study|Randomized Not Vaccinated (Visit 1)|627
4976155|NCT00090233|17091674|P1|Overall Study|Randomized Not Vaccinated (Visit 1)|609
4976156|NCT00090220|17091698|P6|Long-term Follow-up (EXT2)|Other|0
4976157|NCT00090220|17091699|P5|Long-term Follow-up (EXT2)|Other|1
4976158|NCT00090220|17091700|P4|Long-term Follow-up (EXT2)|Other|0
4976159|NCT00090220|17091701|P3|Long-term Follow-up (EXT2)|Other|0
4976160|NCT00090220|17091702|P2|Long-term Follow-up (EXT2)|Other|0
4976161|NCT00090220|17091703|P1|Long-term Follow-up (EXT2)|Other|0
4976162|NCT00090220|17091698|P6|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
4976163|NCT00090220|17091699|P5|Long-term Follow-up (EXT2)|Withdrawal by Subject|4
4976164|NCT00090220|17091700|P4|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4976165|NCT00090220|17091701|P3|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4976166|NCT00090220|17091702|P2|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4976167|NCT00090220|17091703|P1|Long-term Follow-up (EXT2)|Withdrawal by Subject|0
4976168|NCT00090220|17091698|P6|Long-term Follow-up (EXT2)|Death|1
4976169|NCT00090220|17091699|P5|Long-term Follow-up (EXT2)|Death|1
4976170|NCT00090220|17091700|P4|Long-term Follow-up (EXT2)|Death|0
4976171|NCT00090220|17091701|P3|Long-term Follow-up (EXT2)|Death|0
4976172|NCT00090220|17091702|P2|Long-term Follow-up (EXT2)|Death|0
4976173|NCT00090220|17091703|P1|Long-term Follow-up (EXT2)|Death|0
4976174|NCT00090220|17091698|P6|Long-term Follow-up (EXT2)|Lost to Follow-up|23
4976175|NCT00090220|17091699|P5|Long-term Follow-up (EXT2)|Lost to Follow-up|38
4976176|NCT00090220|17091700|P4|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4976177|NCT00090220|17091701|P3|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4976178|NCT00090220|17091702|P2|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4976179|NCT00090220|17091703|P1|Long-term Follow-up (EXT2)|Lost to Follow-up|0
4976180|NCT00090220|17091698|P6|Extension 1 (EXT1)|Other reason|0
4976181|NCT00090220|17091699|P5|Extension 1 (EXT1)|Other reason|0
4976182|NCT00090220|17091700|P4|Extension 1 (EXT1)|Other reason|0
4976183|NCT00090220|17091701|P3|Extension 1 (EXT1)|Other reason|2
4976184|NCT00090220|17091702|P2|Extension 1 (EXT1)|Other reason|0
4976185|NCT00090220|17091703|P1|Extension 1 (EXT1)|Other reason|0
4976186|NCT00090220|17091698|P6|Extension 1 (EXT1)|Protocol Violation|0
4976187|NCT00090220|17091699|P5|Extension 1 (EXT1)|Protocol Violation|0
4976188|NCT00090220|17091700|P4|Extension 1 (EXT1)|Protocol Violation|1
4976189|NCT00090220|17091701|P3|Extension 1 (EXT1)|Protocol Violation|0
4976190|NCT00090220|17091702|P2|Extension 1 (EXT1)|Protocol Violation|0
4976191|NCT00090220|17091703|P1|Extension 1 (EXT1)|Protocol Violation|0
4976192|NCT00090220|17091698|P6|Extension 1 (EXT1)|Withdrawal by Subject|0
4976193|NCT00090220|17091699|P5|Extension 1 (EXT1)|Withdrawal by Subject|0
4976194|NCT00090220|17091700|P4|Extension 1 (EXT1)|Withdrawal by Subject|0
4976195|NCT00090220|17091701|P3|Extension 1 (EXT1)|Withdrawal by Subject|25
4976196|NCT00090220|17091702|P2|Extension 1 (EXT1)|Withdrawal by Subject|0
4976197|NCT00090220|17091703|P1|Extension 1 (EXT1)|Withdrawal by Subject|0
4976198|NCT00090220|17091698|P6|Extension 1 (EXT1)|Moved|0
4976199|NCT00090220|17091699|P5|Extension 1 (EXT1)|Moved|0
4976200|NCT00090220|17091700|P4|Extension 1 (EXT1)|Moved|1
4976201|NCT00090220|17091701|P3|Extension 1 (EXT1)|Moved|2
4976202|NCT00090220|17091702|P2|Extension 1 (EXT1)|Moved|0
4976203|NCT00090220|17091703|P1|Extension 1 (EXT1)|Moved|0
4976204|NCT00090220|17091698|P6|Extension 1 (EXT1)|Lost to Follow-up|0
4976205|NCT00090220|17091699|P5|Extension 1 (EXT1)|Lost to Follow-up|0
4976206|NCT00090220|17091700|P4|Extension 1 (EXT1)|Lost to Follow-up|0
4976207|NCT00090220|17091701|P3|Extension 1 (EXT1)|Lost to Follow-up|22
4976208|NCT00090220|17091702|P2|Extension 1 (EXT1)|Lost to Follow-up|0
4976209|NCT00090220|17091703|P1|Extension 1 (EXT1)|Lost to Follow-up|0
4976210|NCT00090220|17091698|P6|Extension 1 (EXT1)|Adverse Event|0
4976211|NCT00090220|17091699|P5|Extension 1 (EXT1)|Adverse Event|0
4976212|NCT00090220|17091700|P4|Extension 1 (EXT1)|Adverse Event|0
4976213|NCT00090220|17091701|P3|Extension 1 (EXT1)|Adverse Event|4
4976214|NCT00090220|17091702|P2|Extension 1 (EXT1)|Adverse Event|0
4976215|NCT00090220|17091703|P1|Extension 1 (EXT1)|Adverse Event|0
4976216|NCT00090220|17091698|P6|Base Study Follow-up Period|Other|0
4976217|NCT00090220|17091699|P5|Base Study Follow-up Period|Other|0
4976218|NCT00090220|17091700|P4|Base Study Follow-up Period|Other|0
4976219|NCT00090220|17091701|P3|Base Study Follow-up Period|Other|0
4976220|NCT00090220|17091702|P2|Base Study Follow-up Period|Other|21
4976221|NCT00090220|17091703|P1|Base Study Follow-up Period|Other|19
4976222|NCT00090220|17091698|P6|Base Study Follow-up Period|Patient Moved|0
4976223|NCT00090220|17091699|P5|Base Study Follow-up Period|Patient Moved|0
4976224|NCT00090220|17091700|P4|Base Study Follow-up Period|Patient Moved|0
4976225|NCT00090220|17091701|P3|Base Study Follow-up Period|Patient Moved|0
4976226|NCT00090220|17091702|P2|Base Study Follow-up Period|Patient Moved|28
4976227|NCT00090220|17091703|P1|Base Study Follow-up Period|Patient Moved|20
4976228|NCT00090220|17091698|P6|Base Study Follow-up Period|Withdrawal by Subject|0
4976229|NCT00090220|17091699|P5|Base Study Follow-up Period|Withdrawal by Subject|0
4976230|NCT00090220|17091700|P4|Base Study Follow-up Period|Withdrawal by Subject|0
4976231|NCT00090220|17091701|P3|Base Study Follow-up Period|Withdrawal by Subject|0
4976232|NCT00090220|17091702|P2|Base Study Follow-up Period|Withdrawal by Subject|36
4976233|NCT00090220|17091703|P1|Base Study Follow-up Period|Withdrawal by Subject|27
4976234|NCT00090220|17091698|P6|Base Study Follow-up Period|Lost to Follow-up|0
4976235|NCT00090220|17091699|P5|Base Study Follow-up Period|Lost to Follow-up|0
4976236|NCT00090220|17091700|P4|Base Study Follow-up Period|Lost to Follow-up|0
4976237|NCT00090220|17091701|P3|Base Study Follow-up Period|Lost to Follow-up|0
4976238|NCT00090220|17091702|P2|Base Study Follow-up Period|Lost to Follow-up|78
4976239|NCT00090220|17091703|P1|Base Study Follow-up Period|Lost to Follow-up|88
4976240|NCT00090220|17091698|P6|Base Study Follow-up Period|Adverse Event|0
4976241|NCT00090220|17091699|P5|Base Study Follow-up Period|Adverse Event|0
4976242|NCT00090220|17091700|P4|Base Study Follow-up Period|Adverse Event|0
4976243|NCT00090220|17091701|P3|Base Study Follow-up Period|Adverse Event|0
4976244|NCT00090220|17091702|P2|Base Study Follow-up Period|Adverse Event|1
4976245|NCT00090220|17091703|P1|Base Study Follow-up Period|Adverse Event|6
4976246|NCT00090220|17091698|P6|Base Study Vaccination Period|Other|0
4976247|NCT00090220|17091699|P5|Base Study Vaccination Period|Other|0
4976248|NCT00090220|17091700|P4|Base Study Vaccination Period|Other|0
4976249|NCT00090220|17091701|P3|Base Study Vaccination Period|Other|0
4976250|NCT00090220|17091702|P2|Base Study Vaccination Period|Other|4
4976251|NCT00090220|17091703|P1|Base Study Vaccination Period|Other|4
4976252|NCT00090220|17091698|P6|Base Study Vaccination Period|Patient Moved|0
4976253|NCT00090220|17091699|P5|Base Study Vaccination Period|Patient Moved|0
4976254|NCT00090220|17091700|P4|Base Study Vaccination Period|Patient Moved|0
4976255|NCT00090220|17091701|P3|Base Study Vaccination Period|Patient Moved|0
4976256|NCT00090220|17091702|P2|Base Study Vaccination Period|Patient Moved|2
4976257|NCT00090220|17091703|P1|Base Study Vaccination Period|Patient Moved|6
4976258|NCT00090220|17091698|P6|Base Study Vaccination Period|Withdrawal by Subject|0
4976259|NCT00090220|17091699|P5|Base Study Vaccination Period|Withdrawal by Subject|0
4976260|NCT00090220|17091700|P4|Base Study Vaccination Period|Withdrawal by Subject|0
4976261|NCT00090220|17091701|P3|Base Study Vaccination Period|Withdrawal by Subject|0
4976262|NCT00090220|17091702|P2|Base Study Vaccination Period|Withdrawal by Subject|27
4976263|NCT00090220|17091703|P1|Base Study Vaccination Period|Withdrawal by Subject|23
4976264|NCT00090220|17091698|P6|Base Study Vaccination Period|Lost to Follow-up|0
4976265|NCT00090220|17091699|P5|Base Study Vaccination Period|Lost to Follow-up|0
4976266|NCT00090220|17091700|P4|Base Study Vaccination Period|Lost to Follow-up|0
4976267|NCT00090220|17091701|P3|Base Study Vaccination Period|Lost to Follow-up|0
4976268|NCT00090220|17091702|P2|Base Study Vaccination Period|Lost to Follow-up|28
4976269|NCT00090220|17091703|P1|Base Study Vaccination Period|Lost to Follow-up|24
4976270|NCT00090220|17091698|P6|Base Study Vaccination Period|Adverse Event|0
4976271|NCT00090220|17091699|P5|Base Study Vaccination Period|Adverse Event|0
4976272|NCT00090220|17091700|P4|Base Study Vaccination Period|Adverse Event|0
4976273|NCT00090220|17091701|P3|Base Study Vaccination Period|Adverse Event|0
4976274|NCT00090220|17091702|P2|Base Study Vaccination Period|Adverse Event|1
4976275|NCT00090220|17091703|P1|Base Study Vaccination Period|Adverse Event|6
4976276|NCT00090220|17091698|P6|Base Study Vaccination Period|Randomized not Vaccinated|0
4976277|NCT00090220|17091699|P5|Base Study Vaccination Period|Randomized not Vaccinated|0
4976278|NCT00090220|17091700|P4|Base Study Vaccination Period|Randomized not Vaccinated|0
4976279|NCT00090220|17091701|P3|Base Study Vaccination Period|Randomized not Vaccinated|0
4976280|NCT00090220|17091702|P2|Base Study Vaccination Period|Randomized not Vaccinated|1
4976281|NCT00090220|17091703|P1|Base Study Vaccination Period|Randomized not Vaccinated|1
4976282|NCT00090402|17091798|P3|Overall Study|stopped taking study medication|1
4976283|NCT00090402|17091799|P2|Overall Study|stopped taking study medication|0
4976284|NCT00090402|17091800|P1|Overall Study|stopped taking study medication|1
4976285|NCT00090402|17091798|P3|Overall Study|subject moved|0
4976286|NCT00090402|17091799|P2|Overall Study|subject moved|1
4976287|NCT00090402|17091800|P1|Overall Study|subject moved|0
4976288|NCT00090402|17091798|P3|Overall Study|Death|0
4976289|NCT00090402|17091799|P2|Overall Study|Death|1
4976290|NCT00090402|17091800|P1|Overall Study|Death|1
4976291|NCT00090142|17091814|P2|Treatment Period II|Other|0
4976292|NCT00090142|17091815|P1|Treatment Period II|Other|1
4976293|NCT00090142|17091814|P2|Treatment Period I|Other|1
4976294|NCT00090142|17091815|P1|Treatment Period I|Other|0
4976295|NCT00090142|17091814|P2|Treatment Period I|Withdrawal by Subject|0
4976296|NCT00090142|17091815|P1|Treatment Period I|Withdrawal by Subject|2
4976297|NCT00090142|17091814|P2|Treatment Period I|Protocol Violation|0
4976298|NCT00090142|17091815|P1|Treatment Period I|Protocol Violation|2
4976299|NCT00090142|17091814|P2|Treatment Period I|Lost to Follow-up|2
4976300|NCT00090142|17091815|P1|Treatment Period I|Lost to Follow-up|1
4976301|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Other|0
4976302|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Other|1
4976303|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Other|0
4976304|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Jailed|0
4976305|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Jailed|1
4976306|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Jailed|0
4976307|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
4976308|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1
4976309|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0
4976310|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Depression|0
4976311|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Depression|1
4976312|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Depression|0
4976313|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3
4976314|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2
4976315|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0
4976316|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Scheduling Issues|4
4976317|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Scheduling Issues|2
4976318|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Scheduling Issues|0
4976319|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Back Pain|0
4976320|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Back Pain|1
4976321|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Back Pain|0
4976322|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Angina Pectoris|0
4976323|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Angina Pectoris|1
4976324|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Angina Pectoris|0
4976325|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3
4976326|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2
4976327|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0
4976328|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4
4976329|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5
4976330|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0
4976331|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Gyneomastia|0
4976332|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Gyneomastia|0
4976333|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Gyneomastia|1
4976334|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Death|1
4976335|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Death|0
4976336|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Death|1
4976337|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6
4976338|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3
4976339|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1
4976340|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Enrollment Error|2
4976341|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Enrollment Error|0
4976342|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Enrollment Error|1
4976343|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Loss of Libido|0
4976344|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Loss of Libido|0
4976345|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Loss of Libido|1
4976346|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13
4976347|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5
4976348|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1
4976349|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Alcohol Dependent|1
4976350|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Alcohol Dependent|0
4976351|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Alcohol Dependent|1
4976352|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Prohibited Medication|5
4976353|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Prohibited Medication|3
4976354|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Prohibited Medication|2
4976355|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
4976356|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1
4976357|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2
4976358|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Participant relocated|1
4976359|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Participant relocated|3
4976360|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Participant relocated|2
4976361|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
4976362|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1
4976363|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3
4976364|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Loss of Contact|2
4976365|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Loss of Contact|0
4976366|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Loss of Contact|4
4976367|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4
4976368|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6
4976369|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8
4976370|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4
4976371|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5
4976372|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8
4976373|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Protocol Violation|17
4976374|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Protocol Violation|18
4976375|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Protocol Violation|18
4976376|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Lost to Follow-up|111
4976377|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Lost to Follow-up|97
4976378|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Lost to Follow-up|101
4976379|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Withdrawal by Subject|229
4976380|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Withdrawal by Subject|212
4976381|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Withdrawal by Subject|185
4976382|NCT00090103|17091846|P3|16-Week Safety Follow-up Period|Adverse Event|44
4976383|NCT00090103|17091847|P2|16-Week Safety Follow-up Period|Adverse Event|39
4976384|NCT00090103|17091848|P1|16-Week Safety Follow-up Period|Adverse Event|34
4976385|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
4976386|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1
4976387|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0
4976388|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1
4976389|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
4976390|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0
4976391|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Enrollment Error|2
4976392|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Enrollment Error|0
4976393|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Enrollment Error|0
4976394|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Investigator Decision|3
4976395|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Investigator Decision|1
4976396|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Investigator Decision|0
4976397|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
4976398|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1
4976399|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0
4976400|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
4976401|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Scheduling Issues|1
4976402|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Scheduling Issues|0
4976403|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Back Pain|0
4976404|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Back Pain|1
4976405|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Back Pain|0
4976406|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
4976407|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1
4976408|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0
4976409|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
4976410|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2
4976411|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0
4976412|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
4976413|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1
4976414|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0
4976415|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Loss of Contact|0
4976416|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Loss of Contact|1
4976417|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Loss of Contact|0
4976418|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
4976419|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Angina Pectoris|2
4976420|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Angina Pectoris|0
4976421|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Loss of Libido|0
4976422|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Loss of Libido|0
4976423|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Loss of Libido|1
4976424|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Financial Problems|0
4976425|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Financial Problems|0
4976426|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Financial Problems|1
4976427|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5
4976428|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0
4976429|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1
4976430|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|No Improvement|0
4976431|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|No Improvement|0
4976432|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|No Improvement|1
4976433|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Screen Failure|0
4976434|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Screen Failure|0
4976435|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Screen Failure|1
4976436|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
4976437|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0
4976438|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1
4976439|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Investigator Departure|0
4976440|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Investigator Departure|0
4976441|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Investigator Departure|2
4976442|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Prohibited Medication|8
4976443|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
4976444|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Prohibited Medication|2
4976445|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6
4976446|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3
4976447|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2
4976448|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4
4976449|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0
4976450|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2
4976451|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19
4976452|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7
4976453|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3
4976454|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7
4976455|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4
4976456|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6
4976457|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4
4976458|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
4976459|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7
4976460|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Participant Relocated|8
4976461|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Participant Relocated|2
4976462|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Participant Relocated|7
4976463|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104
4976464|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71
4976465|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53
4976466|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Protocol Violation|34
4976467|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Protocol Violation|29
4976468|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Protocol Violation|29
4976469|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58
4976470|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48
4976471|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53
4976472|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148
4976473|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160
4976474|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114
4976475|NCT00090103|17091846|P3|Four-Year Double-Blind Treatment Period|Adverse Event|210
4976476|NCT00090103|17091847|P2|Four-Year Double-Blind Treatment Period|Adverse Event|185
4976477|NCT00090103|17091848|P1|Four-Year Double-Blind Treatment Period|Adverse Event|211
4976478|NCT00089999|17092014|P2|Overall Study|Skin Nodule Over Right Mastectomy|1
4976479|NCT00089999|17092015|P1|Overall Study|Skin Nodule Over Right Mastectomy|0
4976480|NCT00089999|17092014|P2|Overall Study|Patient Underwent Surgery|0
4976481|NCT00089999|17092015|P1|Overall Study|Patient Underwent Surgery|2
4976482|NCT00089999|17092014|P2|Overall Study|Physician Decision|2
4976483|NCT00089999|17092015|P1|Overall Study|Physician Decision|2
4976484|NCT00089999|17092014|P2|Overall Study|Clinical Progression|2
4976485|NCT00089999|17092015|P1|Overall Study|Clinical Progression|1
4976486|NCT00089999|17092014|P2|Overall Study|Poor General Condition|0
4976487|NCT00089999|17092015|P1|Overall Study|Poor General Condition|1
4976488|NCT00089999|17092014|P2|Overall Study|Death|3
4976489|NCT00089999|17092015|P1|Overall Study|Death|3
4976490|NCT00089999|17092014|P2|Overall Study|Symptomatic Progression of Cancer|5
4976491|NCT00089999|17092015|P1|Overall Study|Symptomatic Progression of Cancer|2
4976492|NCT00089999|17092014|P2|Overall Study|Radiological Progression of Cancer|44
4976493|NCT00089999|17092015|P1|Overall Study|Radiological Progression of Cancer|52
4976494|NCT00089999|17092014|P2|Overall Study|Lost to Follow-up|1
4976495|NCT00089999|17092015|P1|Overall Study|Lost to Follow-up|2
4976496|NCT00089999|17092014|P2|Overall Study|Withdrawal by Subject|4
4976497|NCT00089999|17092015|P1|Overall Study|Withdrawal by Subject|0
4976498|NCT00089999|17092014|P2|Overall Study|Adverse Event|7
4976499|NCT00089999|17092015|P1|Overall Study|Adverse Event|4
4976500|NCT00089986|17092038|P3|Overall Study|Withdrawal by Subject|2
4976501|NCT00089986|17092039|P2|Overall Study|Withdrawal by Subject|6
4976502|NCT00089986|17092040|P1|Overall Study|Withdrawal by Subject|3
4976503|NCT00089986|17092038|P3|Overall Study|Do not resuscitate (DNR)|1
4976504|NCT00089986|17092039|P2|Overall Study|Do not resuscitate (DNR)|0
4976505|NCT00089986|17092040|P1|Overall Study|Do not resuscitate (DNR)|0
4976506|NCT00089986|17092038|P3|Overall Study|Family decision|0
4976507|NCT00089986|17092039|P2|Overall Study|Family decision|1
4976508|NCT00089986|17092040|P1|Overall Study|Family decision|0
4976509|NCT00089986|17092038|P3|Overall Study|Enrollment in another study|0
4976510|NCT00089986|17092039|P2|Overall Study|Enrollment in another study|1
4976511|NCT00089986|17092040|P1|Overall Study|Enrollment in another study|0
4976512|NCT00089986|17092038|P3|Overall Study|Investigator decision to withdrew|0
4976513|NCT00089986|17092039|P2|Overall Study|Investigator decision to withdrew|1
4976514|NCT00089986|17092040|P1|Overall Study|Investigator decision to withdrew|0
4976515|NCT00089986|17092038|P3|Overall Study|Hemohlobin stopping rule|0
4976516|NCT00089986|17092039|P2|Overall Study|Hemohlobin stopping rule|1
4976517|NCT00089986|17092040|P1|Overall Study|Hemohlobin stopping rule|0
4976518|NCT00089986|17092038|P3|Overall Study|Subject withdrew but agreed follow up|0
4976519|NCT00089986|17092039|P2|Overall Study|Subject withdrew but agreed follow up|2
4976520|NCT00089986|17092040|P1|Overall Study|Subject withdrew but agreed follow up|1
4976521|NCT00089986|17092038|P3|Overall Study|Patient transferred to another hospital|0
4976522|NCT00089986|17092039|P2|Overall Study|Patient transferred to another hospital|1
4976523|NCT00089986|17092040|P1|Overall Study|Patient transferred to another hospital|2
4976524|NCT00089986|17092038|P3|Overall Study|Protocol Violation|0
4976525|NCT00089986|17092039|P2|Overall Study|Protocol Violation|1
4976526|NCT00089986|17092040|P1|Overall Study|Protocol Violation|0
4976527|NCT00089986|17092038|P3|Overall Study|Lost to Follow-up|1
4976528|NCT00089986|17092039|P2|Overall Study|Lost to Follow-up|1
4976529|NCT00089986|17092040|P1|Overall Study|Lost to Follow-up|3
4976530|NCT00089986|17092038|P3|Overall Study|Adverse Event|6
4976531|NCT00089986|17092039|P2|Overall Study|Adverse Event|9
4976532|NCT00089986|17092040|P1|Overall Study|Adverse Event|6
4976533|NCT00089973|17092057|P1|Overall Study|Death|1
4976534|NCT00089973|17092057|P1|Overall Study|Disease progression|45
4976535|NCT00089973|17092057|P1|Overall Study|Withdrawal by Subject|1
4976536|NCT00089973|17092057|P1|Overall Study|Adverse Event|3
4976537|NCT00089895|17092072|P2|Overall Study|Missing|2
4976538|NCT00089895|17092073|P1|Overall Study|Missing|4
4976539|NCT00089895|17092072|P2|Overall Study|Not otherwise specified|8
4976540|NCT00089895|17092073|P1|Overall Study|Not otherwise specified|4
4976541|NCT00089895|17092072|P2|Overall Study|Exclusion criteria met|6
4976542|NCT00089895|17092073|P1|Overall Study|Exclusion criteria met|6
4976543|NCT00089895|17092072|P2|Overall Study|Physician Decision|7
4976544|NCT00089895|17092073|P1|Overall Study|Physician Decision|3
4976545|NCT00089895|17092072|P2|Overall Study|Bleeding|2
4976546|NCT00089895|17092073|P1|Overall Study|Bleeding|0
4976547|NCT00089895|17092072|P2|Overall Study|Surgery|1
4976548|NCT00089895|17092073|P1|Overall Study|Surgery|0
4976549|NCT00089895|17092072|P2|Overall Study|Technical reason|2
4976550|NCT00089895|17092073|P1|Overall Study|Technical reason|7
4976551|NCT00089895|17092072|P2|Overall Study|Consent Withdrawn|14
4976552|NCT00089895|17092073|P1|Overall Study|Consent Withdrawn|11
4976553|NCT00089843|17092085|P4|Overall Study|Physician Decision|1
4976554|NCT00089843|17092086|P3|Overall Study|Physician Decision|0
4976555|NCT00089843|17092087|P2|Overall Study|Physician Decision|0
4976556|NCT00089843|17092088|P1|Overall Study|Physician Decision|1
4976557|NCT00089843|17092085|P4|Overall Study|Withdrawal by Subject|6
4976558|NCT00089843|17092086|P3|Overall Study|Withdrawal by Subject|5
4976559|NCT00089843|17092087|P2|Overall Study|Withdrawal by Subject|4
4976560|NCT00089843|17092088|P1|Overall Study|Withdrawal by Subject|1
4976561|NCT00089791|17092100|P2|Overall Study|Requirement for alternative therapy|4
4976562|NCT00089791|17092101|P1|Overall Study|Requirement for alternative therapy|7
4976563|NCT00089791|17092100|P2|Overall Study|Protocol deviation|10
4976564|NCT00089791|17092101|P1|Overall Study|Protocol deviation|12
4976565|NCT00089791|17092100|P2|Overall Study|Other|32
4976566|NCT00089791|17092101|P1|Overall Study|Other|20
4976567|NCT00089791|17092100|P2|Overall Study|Noncompliance|13
4976568|NCT00089791|17092101|P1|Overall Study|Noncompliance|17
4976569|NCT00089791|17092100|P2|Overall Study|Lost to Follow-up|57
4976570|NCT00089791|17092101|P1|Overall Study|Lost to Follow-up|57
4976571|NCT00089791|17092100|P2|Overall Study|Ineligibility determined|9
4976572|NCT00089791|17092101|P1|Overall Study|Ineligibility determined|12
4976573|NCT00089791|17092100|P2|Overall Study|Disease progression|3
4976574|NCT00089791|17092101|P1|Overall Study|Disease progression|7
4976575|NCT00089791|17092100|P2|Overall Study|Death|62
4976576|NCT00089791|17092101|P1|Overall Study|Death|78
4976577|NCT00089791|17092100|P2|Overall Study|Withdrawal by Subject|344
4976578|NCT00089791|17092101|P1|Overall Study|Withdrawal by Subject|403
4976579|NCT00089791|17092100|P2|Overall Study|Adverse Event|93
4976580|NCT00089791|17092101|P1|Overall Study|Adverse Event|81
4976581|NCT00089791|17092100|P2|Overall Study|Physician Decision|3
4976582|NCT00089791|17092101|P1|Overall Study|Physician Decision|6
4976583|NCT00089778|17092135|P3|Overall Study|Protocol Violation|1
4976584|NCT00089778|17092136|P2|Overall Study|Protocol Violation|0
4976585|NCT00089778|17092137|P1|Overall Study|Protocol Violation|0
4976586|NCT00089674|17092150|P2|Overall Study|Requirement for alternative therapy|4
4976587|NCT00089674|17092151|P1|Overall Study|Requirement for alternative therapy|14
4976588|NCT00089674|17092150|P2|Overall Study|Other|9
4976589|NCT00089674|17092151|P1|Overall Study|Other|5
4976590|NCT00089674|17092150|P2|Overall Study|Noncompliance|3
4976591|NCT00089674|17092151|P1|Overall Study|Noncompliance|7
4976592|NCT00089674|17092150|P2|Overall Study|Lost to Follow-up|17
4976593|NCT00089674|17092151|P1|Overall Study|Lost to Follow-up|21
4976594|NCT00089674|17092150|P2|Overall Study|Ineligibility determined|10
4976595|NCT00089674|17092151|P1|Overall Study|Ineligibility determined|8
4976596|NCT00089674|17092150|P2|Overall Study|Disease progression|23
4976597|NCT00089674|17092151|P1|Overall Study|Disease progression|21
4976598|NCT00089674|17092150|P2|Overall Study|Death|43
4976599|NCT00089674|17092151|P1|Overall Study|Death|43
4976600|NCT00089674|17092150|P2|Overall Study|Withdrawal by Subject|127
4976601|NCT00089674|17092151|P1|Overall Study|Withdrawal by Subject|143
4976602|NCT00089674|17092150|P2|Overall Study|Adverse Event|29
4976603|NCT00089674|17092151|P1|Overall Study|Adverse Event|23
4976604|NCT00089674|17092150|P2|Overall Study|Physician Decision|2
4976605|NCT00089674|17092151|P1|Overall Study|Physician Decision|4
4976606|NCT00089661|17092177|P2|Overall Study|Other|1
4976607|NCT00089661|17092178|P1|Overall Study|Other|2
4976608|NCT00089661|17092177|P2|Overall Study|Noncompliance|4
4976609|NCT00089661|17092178|P1|Overall Study|Noncompliance|2
4976610|NCT00089661|17092177|P2|Overall Study|Ineligibility determined|4
4976611|NCT00089661|17092178|P1|Overall Study|Ineligibility determined|4
4976612|NCT00089661|17092177|P2|Overall Study|Disease progression|3
4976613|NCT00089661|17092178|P1|Overall Study|Disease progression|1
4976614|NCT00089661|17092177|P2|Overall Study|Withdrawal by Subject|9
4976615|NCT00089661|17092178|P1|Overall Study|Withdrawal by Subject|11
4976616|NCT00089661|17092177|P2|Overall Study|Lost to Follow-up|3
4976617|NCT00089661|17092178|P1|Overall Study|Lost to Follow-up|0
4976618|NCT00089661|17092177|P2|Overall Study|Death|0
4976619|NCT00089661|17092178|P1|Overall Study|Death|1
4976620|NCT00089661|17092177|P2|Overall Study|Adverse Event|2
4976621|NCT00089661|17092178|P1|Overall Study|Adverse Event|0
4976622|NCT00089648|17092194|P1|Overall Study|Lack of Efficacy|33
4976623|NCT00089648|17092194|P1|Overall Study|Withdrawal by Subject|1
4976624|NCT00089648|17092194|P1|Overall Study|Adverse Event|7
4976625|NCT00089635|17092210|P1|Overall Study|Other|2
4976626|NCT00089635|17092210|P1|Overall Study|Ineligibility determined|1
4976627|NCT00089635|17092210|P1|Overall Study|Withdrawal by Subject|6
4976628|NCT00089635|17092210|P1|Overall Study|Lost to Follow-up|3
4976629|NCT00089635|17092210|P1|Overall Study|Disease Progression|12
4976630|NCT00089635|17092210|P1|Overall Study|Death|17
4976631|NCT00089635|17092210|P1|Overall Study|Adverse Event|2
4976632|NCT00089583|17092224|P2|Overall Study|Participant Incarcerated|1
4976633|NCT00089583|17092225|P1|Overall Study|Participant Incarcerated|0
4976634|NCT00089583|17092224|P2|Overall Study|Necessity to Use Prohibited Drug|0
4976635|NCT00089583|17092225|P1|Overall Study|Necessity to Use Prohibited Drug|1
4976636|NCT00089583|17092224|P2|Overall Study|Start of Disallowed Medication|1
4976637|NCT00089583|17092225|P1|Overall Study|Start of Disallowed Medication|0
4976638|NCT00089583|17092224|P2|Overall Study|Principal Investigator Decision|10
4976639|NCT00089583|17092225|P1|Overall Study|Principal Investigator Decision|0
4976640|NCT00089583|17092224|P2|Overall Study|Protocol Violation|3
4976641|NCT00089583|17092225|P1|Overall Study|Protocol Violation|0
4976642|NCT00089583|17092224|P2|Overall Study|Reason Not Provided|1
4976643|NCT00089583|17092225|P1|Overall Study|Reason Not Provided|0
4976644|NCT00089583|17092224|P2|Overall Study|Participant Management Criteria Met|1
4976645|NCT00089583|17092225|P1|Overall Study|Participant Management Criteria Met|0
4976646|NCT00089583|17092224|P2|Overall Study|Poor Medical Compliance/Adherence Issues|3
4976647|NCT00089583|17092225|P1|Overall Study|Poor Medical Compliance/Adherence Issues|0
4976648|NCT00089583|17092224|P2|Overall Study|Non-Compliance|4
4976649|NCT00089583|17092225|P1|Overall Study|Non-Compliance|0
4976650|NCT00089583|17092224|P2|Overall Study|Participant Refused Study Medication|2
4976651|NCT00089583|17092225|P1|Overall Study|Participant Refused Study Medication|0
4976652|NCT00089583|17092224|P2|Overall Study|Participant (Par) Didn't Take Medication|0
4976653|NCT00089583|17092225|P1|Overall Study|Participant (Par) Didn't Take Medication|1
4976654|NCT00089583|17092224|P2|Overall Study|Withdrawal by Subject|4
4976655|NCT00089583|17092225|P1|Overall Study|Withdrawal by Subject|0
4976656|NCT00089583|17092224|P2|Overall Study|Insufficient Viral Load Response|5
4976657|NCT00089583|17092225|P1|Overall Study|Insufficient Viral Load Response|5
4976658|NCT00089583|17092224|P2|Overall Study|Adverse Event|3
4976659|NCT00089583|17092225|P1|Overall Study|Adverse Event|0
4976660|NCT00089609|17092319|P2|Overall Study|Withdrawal by Subject|1
4976661|NCT00089609|17092320|P1|Overall Study|Withdrawal by Subject|3
4976662|NCT00089544|17092339|P2|Overall Study|Ineligible|0
4976663|NCT00089544|17092340|P1|Overall Study|Ineligible|1
4976664|NCT00089505|17092354|P4|Overall Study|Protocol Violation|0
4976665|NCT00089505|17092355|P3|Overall Study|Protocol Violation|1
4976666|NCT00089505|17092356|P2|Overall Study|Protocol Violation|0
4976667|NCT00089505|17092357|P1|Overall Study|Protocol Violation|0
4976668|NCT00089505|17092354|P4|Overall Study|Physician Decision|0
4976669|NCT00089505|17092355|P3|Overall Study|Physician Decision|0
4976670|NCT00089505|17092356|P2|Overall Study|Physician Decision|0
4976671|NCT00089505|17092357|P1|Overall Study|Physician Decision|1
4976672|NCT00089505|17092354|P4|Overall Study|Lost to Follow-up|7
4976673|NCT00089505|17092355|P3|Overall Study|Lost to Follow-up|9
4976674|NCT00089505|17092356|P2|Overall Study|Lost to Follow-up|1
4976675|NCT00089505|17092357|P1|Overall Study|Lost to Follow-up|1
4976676|NCT00089505|17092354|P4|Overall Study|Withdrawal by Subject|6
4976677|NCT00089505|17092355|P3|Overall Study|Withdrawal by Subject|6
4976678|NCT00089505|17092356|P2|Overall Study|Withdrawal by Subject|0
4976679|NCT00089505|17092357|P1|Overall Study|Withdrawal by Subject|3
4976680|NCT00089505|17092354|P4|Overall Study|Death|8
4976681|NCT00089505|17092355|P3|Overall Study|Death|5
4976682|NCT00089505|17092356|P2|Overall Study|Death|1
4976683|NCT00089505|17092357|P1|Overall Study|Death|4
4976684|NCT00089479|17092401|P2|Overall Study|Lost to Follow-up|107
4976685|NCT00089479|17092402|P1|Overall Study|Lost to Follow-up|137
4976686|NCT00089479|17092401|P2|Overall Study|Withdrawal by Subject|107
4976687|NCT00089479|17092402|P1|Overall Study|Withdrawal by Subject|86
4976688|NCT00089479|17092401|P2|Overall Study|Death|75
4976689|NCT00089479|17092402|P1|Overall Study|Death|108
4976690|NCT00089297|17092445|P1|Overall Study|Non-compliance|1
4976691|NCT00089297|17092445|P1|Overall Study|IRB approval not ready|1
4976692|NCT00089297|17092445|P1|Overall Study|Secondary malignancy|1
4976693|NCT00089297|17092445|P1|Overall Study|Ineligible|11
4976694|NCT00089297|17092445|P1|Overall Study|Disease progression|2
4976695|NCT00089297|17092445|P1|Overall Study|Withdrawal by Subject|12
4976696|NCT00089297|17092445|P1|Overall Study|Death|1
4976697|NCT00089297|17092445|P1|Overall Study|Adverse Event|9
4976698|NCT00089284|17092457|P7|Overall Study|Adverse event before starting treatment|1
4976699|NCT00089284|17092458|P6|Overall Study|Adverse event before starting treatment|0
4976700|NCT00089284|17092459|P5|Overall Study|Adverse event before starting treatment|0
4976701|NCT00089284|17092460|P4|Overall Study|Adverse event before starting treatment|0
4976702|NCT00089284|17092461|P3|Overall Study|Adverse event before starting treatment|0
4976703|NCT00089284|17092462|P2|Overall Study|Adverse event before starting treatment|0
4976704|NCT00089284|17092463|P1|Overall Study|Adverse event before starting treatment|0
4976705|NCT00089141|17092500|P2|Overall Study|Termination of trial|24
4976706|NCT00089141|17092501|P1|Overall Study|Termination of trial|18
4976707|NCT00089076|17092537|P1|Overall Study|Progression|7
4976708|NCT00089076|17092537|P1|Overall Study|Withdrawal by Subject|2
4976709|NCT00089076|17092537|P1|Overall Study|Alternate Therapy|1
4976710|NCT00088907|17092594|P2|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0
4976711|NCT00088907|17092595|P1|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5
4976712|NCT00088907|17092594|P2|Single Gefitinib Treatment (Step 2)|unknown/not specify|0
4976713|NCT00088907|17092595|P1|Single Gefitinib Treatment (Step 2)|unknown/not specify|2
4976714|NCT00088907|17092594|P2|Single Gefitinib Treatment (Step 2)|Death|0
4976715|NCT00088907|17092595|P1|Single Gefitinib Treatment (Step 2)|Death|1
4976716|NCT00088907|17092594|P2|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0
4976717|NCT00088907|17092595|P1|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16
4976718|NCT00088907|17092594|P2|Randomized Study (Step 1)|ineligible or not start protocol therapy|12
4976719|NCT00088907|17092595|P1|Randomized Study (Step 1)|ineligible or not start protocol therapy|19
4976720|NCT00088907|17092594|P2|Randomized Study (Step 1)|unknown/not specify|13
4976721|NCT00088907|17092595|P1|Randomized Study (Step 1)|unknown/not specify|24
4976722|NCT00088907|17092594|P2|Randomized Study (Step 1)|complicating disease|1
4976723|NCT00088907|17092595|P1|Randomized Study (Step 1)|complicating disease|3
4976724|NCT00088907|17092594|P2|Randomized Study (Step 1)|Withdrawal by Subject|15
4976725|NCT00088907|17092595|P1|Randomized Study (Step 1)|Withdrawal by Subject|10
4976726|NCT00088907|17092594|P2|Randomized Study (Step 1)|Death|12
4976727|NCT00088907|17092595|P1|Randomized Study (Step 1)|Death|11
4976728|NCT00088907|17092594|P2|Randomized Study (Step 1)|Adverse Event|19
4976729|NCT00088907|17092595|P1|Randomized Study (Step 1)|Adverse Event|14
4976730|NCT00088907|17092594|P2|Randomized Study (Step 1)|Lack of Efficacy|62
4976731|NCT00088907|17092595|P1|Randomized Study (Step 1)|Lack of Efficacy|55
4976732|NCT00088881|17092606|P1|Step 2 - Zevalin™ Radioimmunotherapy|Other|3
4976733|NCT00088881|17092606|P1|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8
4976734|NCT00088881|17092606|P1|Step 1 - R-CHOP|Insurance company refused to cover|1
4976735|NCT00088881|17092606|P1|Step 1 - R-CHOP|Physician Decision|1
4976736|NCT00088881|17092606|P1|Step 1 - R-CHOP|Withdrawal by Subject|2
4976737|NCT00088881|17092606|P1|Step 1 - R-CHOP|Adverse Event|1
4976738|NCT00088881|17092606|P1|Step 1 - R-CHOP|Patient ineligible|9
4976739|NCT00088829|17092615|P1|Overall Study|PI left institution and study was close|22
4976740|NCT00088595|17092657|P1|Overall Study|New Cancer Therapy|2
4976741|NCT00088595|17092657|P1|Overall Study|Ongoing (After Core)|7
4976742|NCT00088595|17092657|P1|Overall Study|Withdrawal by Subject|8
4976743|NCT00088595|17092657|P1|Overall Study|Adverse Event|11
4976744|NCT00088530|17092675|P2|Overall Study|Patient never treated|0
4976745|NCT00088530|17092676|P1|Overall Study|Patient never treated|1
4976746|NCT00088530|17092675|P2|Overall Study|Sponsor decision|1
4976747|NCT00088530|17092676|P1|Overall Study|Sponsor decision|0
4976748|NCT00088530|17092675|P2|Overall Study|Physician Decision|0
4976749|NCT00088530|17092676|P1|Overall Study|Physician Decision|2
4976750|NCT00088530|17092675|P2|Overall Study|Lost to Follow-up|0
4976751|NCT00088530|17092676|P1|Overall Study|Lost to Follow-up|2
4976752|NCT00088530|17092675|P2|Overall Study|Withdrawal by Subject|5
4976753|NCT00088530|17092676|P1|Overall Study|Withdrawal by Subject|2
4976754|NCT00088530|17092675|P2|Overall Study|Adverse Event|9
4976755|NCT00088530|17092676|P1|Overall Study|Adverse Event|15
4976756|NCT00088530|17092675|P2|Overall Study|Progressive/Relapsed Disease|39
4976757|NCT00088530|17092676|P1|Overall Study|Progressive/Relapsed Disease|28
4976758|NCT00088465|17092688|P1|Overall Study|Death|11
4976759|NCT00088465|17092688|P1|Overall Study|Protocol Violation|17
4976760|NCT00088465|17092688|P1|Overall Study|Lack of Efficacy|27
4976761|NCT00088465|17092688|P1|Overall Study|Sponsor Decision|37
4976762|NCT00088465|17092688|P1|Overall Study|Physician Decision|45
4976763|NCT00088465|17092688|P1|Overall Study|Lost to Follow-up|57
4976764|NCT00088465|17092688|P1|Overall Study|Adverse Event|77
4976765|NCT00088465|17092688|P1|Overall Study|Withdrawal by Subject|290
4976766|NCT00088452|17092714|P3|Overall Study|Did not receive intervention|1
4976767|NCT00088452|17092715|P2|Overall Study|Did not receive intervention|0
4976768|NCT00088452|17092716|P1|Overall Study|Did not receive intervention|1
4976769|NCT00088413|17092734|P4|Overall Study|Patient unevaluable due to adverse event|0
4976770|NCT00088413|17092735|P3|Overall Study|Patient unevaluable due to adverse event|1
4976771|NCT00088413|17092736|P2|Overall Study|Patient unevaluable due to adverse event|0
4976772|NCT00088413|17092737|P1|Overall Study|Patient unevaluable due to adverse event|0
4976773|NCT00088413|17092734|P4|Overall Study|Other|0
4976774|NCT00088413|17092735|P3|Overall Study|Other|0
4976775|NCT00088413|17092736|P2|Overall Study|Other|1
4976776|NCT00088413|17092737|P1|Overall Study|Other|0
4976777|NCT00088413|17092734|P4|Overall Study|Progressive disease|14
4976778|NCT00088413|17092735|P3|Overall Study|Progressive disease|8
4976779|NCT00088413|17092736|P2|Overall Study|Progressive disease|11
4976780|NCT00088413|17092737|P1|Overall Study|Progressive disease|9
4976781|NCT00088413|17092734|P4|Overall Study|Death|0
4976782|NCT00088413|17092735|P3|Overall Study|Death|0
4976783|NCT00088413|17092736|P2|Overall Study|Death|1
4976784|NCT00088413|17092737|P1|Overall Study|Death|0
4976785|NCT00088413|17092734|P4|Overall Study|Off study due to missing a vaccine dose|0
4976786|NCT00088413|17092735|P3|Overall Study|Off study due to missing a vaccine dose|0
4976787|NCT00088413|17092736|P2|Overall Study|Off study due to missing a vaccine dose|0
4976788|NCT00088413|17092737|P1|Overall Study|Off study due to missing a vaccine dose|1
4976789|NCT00088413|17092734|P4|Overall Study|Refused trmt Off-study per pt wishes|0
4976790|NCT00088413|17092735|P3|Overall Study|Refused trmt Off-study per pt wishes|1
4976791|NCT00088413|17092736|P2|Overall Study|Refused trmt Off-study per pt wishes|1
4976792|NCT00088413|17092737|P1|Overall Study|Refused trmt Off-study per pt wishes|0
4976793|NCT00088413|17092734|P4|Overall Study|Adverse Events/Side Effects|0
4976794|NCT00088413|17092735|P3|Overall Study|Adverse Events/Side Effects|1
4976795|NCT00088413|17092736|P2|Overall Study|Adverse Events/Side Effects|1
4976796|NCT00088413|17092737|P1|Overall Study|Adverse Events/Side Effects|0
4976797|NCT00088413|17092734|P4|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
4976798|NCT00088413|17092735|P3|Overall Study|Limited supply of trmt drug (PANVAC-f)|1
4976799|NCT00088413|17092736|P2|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
4976800|NCT00088413|17092737|P1|Overall Study|Limited supply of trmt drug (PANVAC-f)|0
4976801|NCT00088374|17092751|P1|Overall Study|patient received <1 cycle only of 17AAG|1
4976802|NCT00088374|17092751|P1|Overall Study|patient did not receive any 17AAG|1
4976803|NCT00088205|17092769|P1|Overall Study|Death Due to Study Disease|4
4976804|NCT00088205|17092769|P1|Overall Study|Physician Decision|1
4976805|NCT00088205|17092769|P1|Overall Study|Progressive Disease|51
4976806|NCT00088205|17092769|P1|Overall Study|Adverse Event|4
4976807|NCT00088166|17092786|P2|Overall Study|Withdrawal by Subject|5
4976808|NCT00088166|17092787|P1|Overall Study|Withdrawal by Subject|5
4976809|NCT00088166|17092786|P2|Overall Study|Patient deterioration|39
4976810|NCT00088166|17092787|P1|Overall Study|Patient deterioration|29
4976811|NCT00088166|17092786|P2|Overall Study|Protocol Violation|5
4976812|NCT00088166|17092787|P1|Overall Study|Protocol Violation|1
4976813|NCT00088166|17092786|P2|Overall Study|Physician Decision|1
4976814|NCT00088166|17092787|P1|Overall Study|Physician Decision|4
4976815|NCT00088166|17092786|P2|Overall Study|Lost to Follow-up|1
4976816|NCT00088166|17092787|P1|Overall Study|Lost to Follow-up|0
4976817|NCT00088166|17092786|P2|Overall Study|Death|1
4976818|NCT00088166|17092787|P1|Overall Study|Death|3
4976819|NCT00088166|17092786|P2|Overall Study|Adverse Event|9
4976820|NCT00088166|17092787|P1|Overall Study|Adverse Event|11
4976821|NCT00088153|17092811|P2|Overall Study|Lost to Follow-up|12
4976822|NCT00088153|17092812|P1|Overall Study|Lost to Follow-up|11
4976823|NCT00088153|17092811|P2|Overall Study|Withdrawal by Subject|10
4976824|NCT00088153|17092812|P1|Overall Study|Withdrawal by Subject|10
4976825|NCT00088153|17092811|P2|Overall Study|Physician Decision|3
4976826|NCT00088153|17092812|P1|Overall Study|Physician Decision|3
4976827|NCT00087698|17092822|P1|Overall Study|Protocol Violation|1
4976828|NCT00087698|17092822|P1|Overall Study|Death from Study Drug Toxicity|2
4976829|NCT00087698|17092822|P1|Overall Study|Death from Study Disease|2
4976830|NCT00087698|17092822|P1|Overall Study|Clinical Relapse|1
4976831|NCT00087698|17092822|P1|Overall Study|Protocol Entry Criteria Not Met|2
4976832|NCT00087698|17092822|P1|Overall Study|Lack of Efficacy, Physician Perception|3
4976833|NCT00087698|17092822|P1|Overall Study|Withdrawal by Subject|4
4976834|NCT00087698|17092822|P1|Overall Study|Adverse Event|4
4976835|NCT00087698|17092822|P1|Overall Study|Death from Other Causes|3
4976836|NCT00087698|17092822|P1|Overall Study|Lack of Efficacy, Progressive Disease|14
4976837|NCT00087685|17092831|P1|Overall Study|Withdrawal by Subject|3
4976838|NCT00087685|17092831|P1|Overall Study|Progressive Disease|5
4976839|NCT00087685|17092831|P1|Overall Study|Non-Compliance|1
4976840|NCT00087685|17092831|P1|Overall Study|Adverse Event|5
4976841|NCT00087646|17092844|P4|Overall Study|Violation of Selection Criteria at Entry|1
4976842|NCT00087646|17092845|P3|Overall Study|Violation of Selection Criteria at Entry|0
4976843|NCT00087646|17092846|P2|Overall Study|Violation of Selection Criteria at Entry|0
4976844|NCT00087646|17092847|P1|Overall Study|Violation of Selection Criteria at Entry|1
4976845|NCT00087646|17092844|P4|Overall Study|Other Protocol Violation|0
4976846|NCT00087646|17092845|P3|Overall Study|Other Protocol Violation|0
4976847|NCT00087646|17092846|P2|Overall Study|Other Protocol Violation|1
4976848|NCT00087646|17092847|P1|Overall Study|Other Protocol Violation|3
4976849|NCT00087646|17092844|P4|Overall Study|Administrative/Other|2
4976850|NCT00087646|17092845|P3|Overall Study|Administrative/Other|1
4976851|NCT00087646|17092846|P2|Overall Study|Administrative/Other|1
4976852|NCT00087646|17092847|P1|Overall Study|Administrative/Other|6
4976853|NCT00087646|17092844|P4|Overall Study|Failure to Return|3
4976854|NCT00087646|17092845|P3|Overall Study|Failure to Return|2
4976855|NCT00087646|17092846|P2|Overall Study|Failure to Return|2
4976856|NCT00087646|17092847|P1|Overall Study|Failure to Return|5
4976857|NCT00087646|17092844|P4|Overall Study|Refused Treatment/Did Not Cooperate|5
4976858|NCT00087646|17092845|P3|Overall Study|Refused Treatment/Did Not Cooperate|4
4976859|NCT00087646|17092846|P2|Overall Study|Refused Treatment/Did Not Cooperate|6
4976860|NCT00087646|17092847|P1|Overall Study|Refused Treatment/Did Not Cooperate|13
4976861|NCT00087646|17092844|P4|Overall Study|Insufficient therapeutic response|51
4976862|NCT00087646|17092845|P3|Overall Study|Insufficient therapeutic response|38
4976863|NCT00087646|17092846|P2|Overall Study|Insufficient therapeutic response|24
4976864|NCT00087646|17092847|P1|Overall Study|Insufficient therapeutic response|64
4976865|NCT00087646|17092844|P4|Overall Study|Withdrawal by Subject|2
4976866|NCT00087646|17092845|P3|Overall Study|Withdrawal by Subject|2
4976867|NCT00087646|17092846|P2|Overall Study|Withdrawal by Subject|1
4976868|NCT00087646|17092847|P1|Overall Study|Withdrawal by Subject|6
4976869|NCT00087646|17092844|P4|Overall Study|Death|0
4976870|NCT00087646|17092845|P3|Overall Study|Death|0
4976871|NCT00087646|17092846|P2|Overall Study|Death|1
4976872|NCT00087646|17092847|P1|Overall Study|Death|0
4976873|NCT00087646|17092844|P4|Overall Study|Adverse Event|20
4976874|NCT00087646|17092845|P3|Overall Study|Adverse Event|18
4976875|NCT00087646|17092846|P2|Overall Study|Adverse Event|6
4976876|NCT00087646|17092847|P1|Overall Study|Adverse Event|37
4976877|NCT00087607|17092886|P2|Overall Study|Violation of Selection Criteria at Entry|1
4976878|NCT00087607|17092887|P1|Overall Study|Violation of Selection Criteria at Entry|0
4976879|NCT00087607|17092886|P2|Overall Study|Other Protocol Violation|2
4976880|NCT00087607|17092887|P1|Overall Study|Other Protocol Violation|5
4976881|NCT00087607|17092886|P2|Overall Study|Refused Treatment|7
4976882|NCT00087607|17092887|P1|Overall Study|Refused Treatment|5
4976883|NCT00087607|17092886|P2|Overall Study|Administrative|12
4976884|NCT00087607|17092887|P1|Overall Study|Administrative|12
4976885|NCT00087607|17092886|P2|Overall Study|Withdrew Consent|16
4976886|NCT00087607|17092887|P1|Overall Study|Withdrew Consent|12
4976887|NCT00087607|17092886|P2|Overall Study|Failure to return|17
4976888|NCT00087607|17092887|P1|Overall Study|Failure to return|21
4976889|NCT00087607|17092886|P2|Overall Study|Insufficient Therapeutic Response|42
4976890|NCT00087607|17092887|P1|Overall Study|Insufficient Therapeutic Response|53
4976891|NCT00087607|17092886|P2|Overall Study|Death|1
4976892|NCT00087607|17092887|P1|Overall Study|Death|0
4976893|NCT00087607|17092886|P2|Overall Study|Adverse Event|24
4976894|NCT00087607|17092887|P1|Overall Study|Adverse Event|14
4976895|NCT00087594|17092927|P2|Overall Study|Lack of Efficacy|5
4976896|NCT00087594|17092928|P1|Overall Study|Lack of Efficacy|2
4976897|NCT00087594|17092927|P2|Overall Study|Withdrawal by Subject|2
4976898|NCT00087594|17092928|P1|Overall Study|Withdrawal by Subject|4
4976899|NCT00087594|17092927|P2|Overall Study|Lost to Follow-up|2
4976900|NCT00087594|17092928|P1|Overall Study|Lost to Follow-up|0
4976901|NCT00087594|17092927|P2|Overall Study|Adverse Event|3
4976902|NCT00087594|17092928|P1|Overall Study|Adverse Event|2
4976903|NCT00087568|17092962|P2|Overall Study|Lack of Efficacy|1
4976904|NCT00087568|17092963|P1|Overall Study|Lack of Efficacy|24
4976905|NCT00087568|17092962|P2|Overall Study|Lost to Follow-up|0
4976906|NCT00087568|17092963|P1|Overall Study|Lost to Follow-up|1
4976907|NCT00087568|17092962|P2|Overall Study|Withdrawal by Subject|1
4976908|NCT00087568|17092963|P1|Overall Study|Withdrawal by Subject|1
4976909|NCT00087568|17092962|P2|Overall Study|Adverse Event|0
4976910|NCT00087568|17092963|P1|Overall Study|Adverse Event|4
4976911|NCT00087555|17092990|P3|Overall Study|Patient wanted to go back on Med|0
4976912|NCT00087555|17092991|P2|Overall Study|Patient wanted to go back on Med|0
4976913|NCT00087555|17092992|P1|Overall Study|Patient wanted to go back on Med|1
4976914|NCT00087555|17092990|P3|Overall Study|Chronic Migraine Headaches (Med History)|0
4976915|NCT00087555|17092991|P2|Overall Study|Chronic Migraine Headaches (Med History)|0
4976916|NCT00087555|17092992|P1|Overall Study|Chronic Migraine Headaches (Med History)|1
4976917|NCT00087555|17092990|P3|Overall Study|Non Compliance|1
4976918|NCT00087555|17092991|P2|Overall Study|Non Compliance|0
4976919|NCT00087555|17092992|P1|Overall Study|Non Compliance|0
4976920|NCT00087555|17092990|P3|Overall Study|Lack of Efficacy|1
4976921|NCT00087555|17092991|P2|Overall Study|Lack of Efficacy|0
4976922|NCT00087555|17092992|P1|Overall Study|Lack of Efficacy|2
4976923|NCT00087555|17092990|P3|Overall Study|Withdrawal by Subject|1
4976924|NCT00087555|17092991|P2|Overall Study|Withdrawal by Subject|2
4976925|NCT00087555|17092992|P1|Overall Study|Withdrawal by Subject|3
4976926|NCT00087555|17092990|P3|Overall Study|Pregnancy|1
4976927|NCT00087555|17092991|P2|Overall Study|Pregnancy|1
4976928|NCT00087555|17092992|P1|Overall Study|Pregnancy|0
4976929|NCT00087555|17092990|P3|Overall Study|Screen Failure|0
4976930|NCT00087555|17092991|P2|Overall Study|Screen Failure|1
4976931|NCT00087555|17092992|P1|Overall Study|Screen Failure|1
4976932|NCT00087555|17092990|P3|Overall Study|Protocol Violation|2
4976933|NCT00087555|17092991|P2|Overall Study|Protocol Violation|0
4976934|NCT00087555|17092992|P1|Overall Study|Protocol Violation|0
4976935|NCT00087555|17092990|P3|Overall Study|Non - Compliance|0
4976936|NCT00087555|17092991|P2|Overall Study|Non - Compliance|0
4976937|NCT00087555|17092992|P1|Overall Study|Non - Compliance|1
4976938|NCT00087555|17092990|P3|Overall Study|Lost to Follow-up|1
4976939|NCT00087555|17092991|P2|Overall Study|Lost to Follow-up|1
4976940|NCT00087555|17092992|P1|Overall Study|Lost to Follow-up|0
4976941|NCT00087555|17092990|P3|Overall Study|Adverse Event|14
4976942|NCT00087555|17092991|P2|Overall Study|Adverse Event|6
4976943|NCT00087555|17092992|P1|Overall Study|Adverse Event|3
4976944|NCT00087529|17093002|P2|Overall Study|Did Not Continue to Safety Follow-Up|5
4976945|NCT00087529|17093003|P1|Overall Study|Did Not Continue to Safety Follow-Up|5
4976946|NCT00087529|17093002|P2|Overall Study|Disease Progression|4
4976947|NCT00087529|17093003|P1|Overall Study|Disease Progression|5
4976948|NCT00087529|17093002|P2|Overall Study|Participant Noncompliance|1
4976949|NCT00087529|17093003|P1|Overall Study|Participant Noncompliance|0
4976950|NCT00087529|17093002|P2|Overall Study|Initiation of Excluded Therapy|1
4976951|NCT00087529|17093003|P1|Overall Study|Initiation of Excluded Therapy|0
4976952|NCT00087529|17093002|P2|Overall Study|Physician Decision|8
4976953|NCT00087529|17093003|P1|Overall Study|Physician Decision|4
4976954|NCT00087529|17093002|P2|Overall Study|Participant Decision|37
4976955|NCT00087529|17093003|P1|Overall Study|Participant Decision|14
4976956|NCT00087529|17093002|P2|Overall Study|Lost to Follow-up|3
4976957|NCT00087529|17093003|P1|Overall Study|Lost to Follow-up|2
4976958|NCT00087529|17093002|P2|Overall Study|Pregnancy|1
4976959|NCT00087529|17093003|P1|Overall Study|Pregnancy|0
4976960|NCT00087529|17093002|P2|Overall Study|Adverse Event|8
4976961|NCT00087529|17093003|P1|Overall Study|Adverse Event|0
4976962|NCT00087529|17093002|P2|Overall Study|Death|0
4976963|NCT00087529|17093003|P1|Overall Study|Death|1
4976964|NCT00087516|17093018|P4|Overall Study|Other|0
4976965|NCT00087516|17093019|P3|Overall Study|Other|1
4976966|NCT00087516|17093020|P2|Overall Study|Other|0
4976967|NCT00087516|17093021|P1|Overall Study|Other|0
4976968|NCT00087516|17093018|P4|Overall Study|Recommendation of Primary Care Physician|1
4976969|NCT00087516|17093019|P3|Overall Study|Recommendation of Primary Care Physician|0
4976970|NCT00087516|17093020|P2|Overall Study|Recommendation of Primary Care Physician|0
4976971|NCT00087516|17093021|P1|Overall Study|Recommendation of Primary Care Physician|0
4976972|NCT00087516|17093018|P4|Overall Study|Patient was non-compliant|0
4976973|NCT00087516|17093019|P3|Overall Study|Patient was non-compliant|0
4976974|NCT00087516|17093020|P2|Overall Study|Patient was non-compliant|1
4976975|NCT00087516|17093021|P1|Overall Study|Patient was non-compliant|3
4976976|NCT00087516|17093018|P4|Overall Study|Patient moved|0
4976977|NCT00087516|17093019|P3|Overall Study|Patient moved|1
4976978|NCT00087516|17093020|P2|Overall Study|Patient moved|2
4976979|NCT00087516|17093021|P1|Overall Study|Patient moved|3
4976980|NCT00087516|17093018|P4|Overall Study|Protocol specified discontinuation|26
4976981|NCT00087516|17093019|P3|Overall Study|Protocol specified discontinuation|33
4976982|NCT00087516|17093020|P2|Overall Study|Protocol specified discontinuation|33
4976983|NCT00087516|17093021|P1|Overall Study|Protocol specified discontinuation|35
4976984|NCT00087516|17093018|P4|Overall Study|Site terminated|0
4976985|NCT00087516|17093019|P3|Overall Study|Site terminated|1
4976986|NCT00087516|17093020|P2|Overall Study|Site terminated|2
4976987|NCT00087516|17093021|P1|Overall Study|Site terminated|0
4976988|NCT00087516|17093018|P4|Overall Study|Withdrawal by Subject|12
4976989|NCT00087516|17093019|P3|Overall Study|Withdrawal by Subject|11
4976990|NCT00087516|17093020|P2|Overall Study|Withdrawal by Subject|27
4976991|NCT00087516|17093021|P1|Overall Study|Withdrawal by Subject|16
4976992|NCT00087516|17093018|P4|Overall Study|Protocol Violation|6
4976993|NCT00087516|17093019|P3|Overall Study|Protocol Violation|3
4976994|NCT00087516|17093020|P2|Overall Study|Protocol Violation|8
4976995|NCT00087516|17093021|P1|Overall Study|Protocol Violation|4
4976996|NCT00087516|17093018|P4|Overall Study|Lost to Follow-up|5
4976997|NCT00087516|17093019|P3|Overall Study|Lost to Follow-up|5
4976998|NCT00087516|17093020|P2|Overall Study|Lost to Follow-up|6
4976999|NCT00087516|17093021|P1|Overall Study|Lost to Follow-up|8
4977000|NCT00087516|17093018|P4|Overall Study|Lack of Efficacy|29
4977001|NCT00087516|17093019|P3|Overall Study|Lack of Efficacy|39
4977002|NCT00087516|17093020|P2|Overall Study|Lack of Efficacy|80
4977003|NCT00087516|17093021|P1|Overall Study|Lack of Efficacy|82
4977004|NCT00087516|17093018|P4|Overall Study|Adverse Event|6
4977005|NCT00087516|17093019|P3|Overall Study|Adverse Event|3
4977006|NCT00087516|17093020|P2|Overall Study|Adverse Event|10
4977007|NCT00087516|17093021|P1|Overall Study|Adverse Event|10
4977008|NCT00087490|17093050|P2|Overall Study|Randomized but not treated|18
4977009|NCT00087490|17093051|P1|Overall Study|Randomized but not treated|7
4977010|NCT00087490|17093050|P2|Overall Study|Lost to Follow-Up/participant withdrawal|36
4977011|NCT00087490|17093051|P1|Overall Study|Lost to Follow-Up/participant withdrawal|28
4977012|NCT00087490|17093050|P2|Overall Study|Protocol Violation or (/) Unspecified|201
4977013|NCT00087490|17093051|P1|Overall Study|Protocol Violation or (/) Unspecified|214
4977014|NCT00087490|17093050|P2|Overall Study|Lack of Efficacy|2
4977015|NCT00087490|17093051|P1|Overall Study|Lack of Efficacy|0
4977016|NCT00087490|17093050|P2|Overall Study|Adverse Event|8
4977017|NCT00087490|17093051|P1|Overall Study|Adverse Event|3
4977018|NCT00087490|17093050|P2|Overall Study|Death|4
4977019|NCT00087490|17093051|P1|Overall Study|Death|6
4977020|NCT00087438|17093085|P1|Overall Study|Ineligible / No protocol treatment|4
4977021|NCT00087152|17093095|P1|Overall Study|Ineligible|6
4977022|NCT00087139|17093104|P3|Overall Study|Extradural disease|1
4977023|NCT00087139|17093105|P2|Overall Study|Extradural disease|0
4977024|NCT00087139|17093106|P1|Overall Study|Extradural disease|0
4977025|NCT00087139|17093104|P3|Overall Study|Response achieved|0
4977026|NCT00087139|17093105|P2|Overall Study|Response achieved|1
4977027|NCT00087139|17093106|P1|Overall Study|Response achieved|0
4977028|NCT00087139|17093104|P3|Overall Study|Use of coumadin|0
4977029|NCT00087139|17093105|P2|Overall Study|Use of coumadin|0
4977030|NCT00087139|17093106|P1|Overall Study|Use of coumadin|1
4977031|NCT00087139|17093104|P3|Overall Study|Symptomatic deterioration|3
4977032|NCT00087139|17093105|P2|Overall Study|Symptomatic deterioration|1
4977033|NCT00087139|17093106|P1|Overall Study|Symptomatic deterioration|1
4977034|NCT00087139|17093104|P3|Overall Study|Ineligible|4
4977035|NCT00087139|17093105|P2|Overall Study|Ineligible|7
4977036|NCT00087139|17093106|P1|Overall Study|Ineligible|4
4977037|NCT00087139|17093104|P3|Overall Study|Disease progression|12
4977038|NCT00087139|17093105|P2|Overall Study|Disease progression|19
4977039|NCT00087139|17093106|P1|Overall Study|Disease progression|9
4977040|NCT00087139|17093104|P3|Overall Study|Physician Decision|1
4977041|NCT00087139|17093105|P2|Overall Study|Physician Decision|1
4977042|NCT00087139|17093106|P1|Overall Study|Physician Decision|1
4977043|NCT00087139|17093104|P3|Overall Study|Withdrawal by Subject|2
4977044|NCT00087139|17093105|P2|Overall Study|Withdrawal by Subject|2
4977045|NCT00087139|17093106|P1|Overall Study|Withdrawal by Subject|3
4977046|NCT00087139|17093104|P3|Overall Study|Death|0
4977047|NCT00087139|17093105|P2|Overall Study|Death|1
4977048|NCT00087139|17093106|P1|Overall Study|Death|2
4977049|NCT00087139|17093104|P3|Overall Study|Adverse Event|13
4977050|NCT00087139|17093105|P2|Overall Study|Adverse Event|17
4977051|NCT00087139|17093106|P1|Overall Study|Adverse Event|18
4977052|NCT00087126|17093121|P1|Overall Study|Never treated|1
4977053|NCT00087126|17093121|P1|Overall Study|Ineligible - second primary|1
4977054|NCT00086996|17093146|P1|Overall Study|not eligible|5
4977055|NCT00086996|17093146|P1|Overall Study|Other|6
4977056|NCT00086996|17093146|P1|Overall Study|Withdrawal by Subject|13
4977057|NCT00086996|17093146|P1|Overall Study|progression/relapse|7
4977058|NCT00086996|17093146|P1|Overall Study|Death|4
4977059|NCT00086996|17093146|P1|Overall Study|Adverse Event|29
4977060|NCT00086684|17093168|P3|Overall Study|Other|3
4977061|NCT00086684|17093169|P2|Overall Study|Other|2
4977062|NCT00086684|17093170|P1|Overall Study|Other|4
4977063|NCT00086684|17093168|P3|Overall Study|WITHDRAWAL OF CONSENT|5
4977064|NCT00086684|17093169|P2|Overall Study|WITHDRAWAL OF CONSENT|7
4977065|NCT00086684|17093170|P1|Overall Study|WITHDRAWAL OF CONSENT|5
4977066|NCT00086684|17093168|P3|Overall Study|STUDY TERMINATED BY SPONSOR|0
4977067|NCT00086684|17093169|P2|Overall Study|STUDY TERMINATED BY SPONSOR|1
4977068|NCT00086684|17093170|P1|Overall Study|STUDY TERMINATED BY SPONSOR|0
4977069|NCT00086684|17093168|P3|Overall Study|NONCOMPLIANCE|6
4977070|NCT00086684|17093169|P2|Overall Study|NONCOMPLIANCE|7
4977071|NCT00086684|17093170|P1|Overall Study|NONCOMPLIANCE|5
4977072|NCT00086684|17093168|P3|Overall Study|Withdrawal by Subject|10
4977073|NCT00086684|17093169|P2|Overall Study|Withdrawal by Subject|4
4977074|NCT00086684|17093170|P1|Overall Study|Withdrawal by Subject|0
4977075|NCT00086684|17093168|P3|Overall Study|Protocol Violation|0
4977076|NCT00086684|17093169|P2|Overall Study|Protocol Violation|3
4977077|NCT00086684|17093170|P1|Overall Study|Protocol Violation|8
4977078|NCT00086684|17093168|P3|Overall Study|Lost to Follow-up|10
4977079|NCT00086684|17093169|P2|Overall Study|Lost to Follow-up|8
4977080|NCT00086684|17093170|P1|Overall Study|Lost to Follow-up|15
4977081|NCT00086684|17093168|P3|Overall Study|Lack of Efficacy|5
4977082|NCT00086684|17093169|P2|Overall Study|Lack of Efficacy|6
4977083|NCT00086684|17093170|P1|Overall Study|Lack of Efficacy|6
4977084|NCT00086684|17093168|P3|Overall Study|Adverse Event|14
4977085|NCT00086684|17093169|P2|Overall Study|Adverse Event|17
4977086|NCT00086684|17093170|P1|Overall Study|Adverse Event|12
4977087|NCT00086619|17093183|P2|Overall Study|Protocol Violation|1
4977088|NCT00086619|17093184|P1|Overall Study|Protocol Violation|1
4977089|NCT00086619|17093183|P2|Overall Study|Adverse Event|10
4977090|NCT00086619|17093184|P1|Overall Study|Adverse Event|8
4977091|NCT00086619|17093183|P2|Overall Study|Withdrawal by Subject|6
4977092|NCT00086619|17093184|P1|Overall Study|Withdrawal by Subject|6
4977093|NCT00086580|17093194|P2|Observation Period|Other|7
4977094|NCT00086580|17093195|P1|Observation Period|Other|8
4977095|NCT00086580|17093194|P2|Observation Period|Death|55
4977096|NCT00086580|17093195|P1|Observation Period|Death|33
4977097|NCT00086580|17093194|P2|Observation Period|Withdrawal by Subject|2
4977098|NCT00086580|17093195|P1|Observation Period|Withdrawal by Subject|4
4977099|NCT00086580|17093194|P2|Observation Period|Unable to comply with protocol|1
4977100|NCT00086580|17093195|P1|Observation Period|Unable to comply with protocol|1
4977101|NCT00086580|17093194|P2|Follow-up Period|Other|6
4977102|NCT00086580|17093195|P1|Follow-up Period|Other|7
4977103|NCT00086580|17093194|P2|Follow-up Period|Death|7
4977104|NCT00086580|17093195|P1|Follow-up Period|Death|13
4977105|NCT00086580|17093194|P2|Follow-up Period|AE - not related|0
4977106|NCT00086580|17093195|P1|Follow-up Period|AE - not related|1
4977107|NCT00086580|17093194|P2|Follow-up Period|Physician Decision|1
4977108|NCT00086580|17093195|P1|Follow-up Period|Physician Decision|0
4977109|NCT00086580|17093194|P2|Follow-up Period|Withdrawal by Subject|6
4977110|NCT00086580|17093195|P1|Follow-up Period|Withdrawal by Subject|6
4977111|NCT00086580|17093194|P2|Follow-up Period|Unable to comply with protocol|0
4977112|NCT00086580|17093195|P1|Follow-up Period|Unable to comply with protocol|5
4977113|NCT00086580|17093194|P2|Follow-up Period|Disease progression|99
4977114|NCT00086580|17093195|P1|Follow-up Period|Disease progression|72
4977115|NCT00086580|17093194|P2|Treatment Period|Other|3
4977116|NCT00086580|17093195|P1|Treatment Period|Other|5
4977117|NCT00086580|17093194|P2|Treatment Period|Death|7
4977118|NCT00086580|17093195|P1|Treatment Period|Death|5
4977119|NCT00086580|17093194|P2|Treatment Period|Anemia or thrombocytopenia|4
4977120|NCT00086580|17093195|P1|Treatment Period|Anemia or thrombocytopenia|1
4977121|NCT00086580|17093194|P2|Treatment Period|Toxicity - treatment related|15
4977122|NCT00086580|17093195|P1|Treatment Period|Toxicity - treatment related|15
4977123|NCT00086580|17093194|P2|Treatment Period|AE - not treatment related|7
4977124|NCT00086580|17093195|P1|Treatment Period|AE - not treatment related|7
4977125|NCT00086580|17093194|P2|Treatment Period|Physician Decision|7
4977126|NCT00086580|17093195|P1|Treatment Period|Physician Decision|13
4977127|NCT00086580|17093194|P2|Treatment Period|Withdrawal by Subject|8
4977128|NCT00086580|17093195|P1|Treatment Period|Withdrawal by Subject|7
4977129|NCT00086580|17093194|P2|Treatment Period|Unable to comply with protocol|1
4977130|NCT00086580|17093195|P1|Treatment Period|Unable to comply with protocol|3
4977131|NCT00086580|17093194|P2|Treatment Period|Disease progression|8
4977132|NCT00086580|17093195|P1|Treatment Period|Disease progression|9
4977133|NCT00086411|17093243|P4|Overall Study|Lost to Follow-up|12
4977134|NCT00086411|17093244|P3|Overall Study|Lost to Follow-up|13
4977135|NCT00086411|17093245|P2|Overall Study|Lost to Follow-up|11
4977136|NCT00086411|17093246|P1|Overall Study|Lost to Follow-up|11
4977137|NCT00086385|17093264|P4|Overall Study|Death|1
4977138|NCT00086385|17093265|P3|Overall Study|Death|1
4977139|NCT00086385|17093266|P2|Overall Study|Death|2
4977140|NCT00086385|17093267|P1|Overall Study|Death|2
4977141|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Discontinued in error|0
4977142|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Discontinued in error|1
4977143|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Personal Circumstance|0
4977144|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Personal Circumstance|1
4977145|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1
4977146|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0
4977147|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Patient Died|1
4977148|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Patient Died|3
4977149|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10
4977150|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36
4977151|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3
4977152|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5
4977153|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Patient Moved|2
4977154|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Patient Moved|2
4977155|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Withdrawal by Subject|5
4977156|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Withdrawal by Subject|15
4977157|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Protocol Violation|0
4977158|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Protocol Violation|1
4977159|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Physician Decision|0
4977160|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Physician Decision|3
4977161|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Lost to Follow-up|4
4977162|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Lost to Follow-up|13
4977163|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Lack of Efficacy|19
4977164|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Lack of Efficacy|94
4977165|NCT00086515|17093279|P2|Phase B (Weeks 24-104)|Adverse Event|10
4977166|NCT00086515|17093280|P1|Phase B (Weeks 24-104)|Adverse Event|16
4977167|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0
4977168|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1
4977169|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Poor compliance|0
4977170|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Poor compliance|1
4977171|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
4977172|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1
4977173|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23
4977174|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16
4977175|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Protocol Violation|1
4977176|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Protocol Violation|0
4977177|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Withdrawal by Subject|0
4977178|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Withdrawal by Subject|1
4977179|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Lack of Efficacy|2
4977180|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Lack of Efficacy|2
4977181|NCT00086515|17093279|P2|Phase A to Phase B Transition Period|Adverse Event|1
4977182|NCT00086515|17093280|P1|Phase A to Phase B Transition Period|Adverse Event|2
4977183|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Personal Circumstance|0
4977184|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Personal Circumstance|1
4977185|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1
4977186|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0
4977187|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Poor compliance|0
4977188|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Poor compliance|1
4977189|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3
4977190|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4
4977191|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Patient Moved|3
4977192|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Patient Moved|2
4977193|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Withdrawal by Subject|10
4977194|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Withdrawal by Subject|10
4977195|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Protocol Violation|1
4977196|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Protocol Violation|3
4977197|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Lost to Follow-up|5
4977198|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Lost to Follow-up|4
4977199|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Lack of Efficacy|13
4977200|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Lack of Efficacy|7
4977201|NCT00086515|17093279|P2|Phase A (Weeks 0-24)|Adverse Event|9
4977202|NCT00086515|17093280|P1|Phase A (Weeks 0-24)|Adverse Event|17
4977203|NCT00086502|17093292|P2|Overall Study|Patient Accidentally Unblinded|0
4977204|NCT00086502|17093293|P1|Overall Study|Patient Accidentally Unblinded|1
4977205|NCT00086502|17093292|P2|Overall Study|Protocol Discontinuation Criteria|3
4977206|NCT00086502|17093293|P1|Overall Study|Protocol Discontinuation Criteria|1
4977207|NCT00086502|17093292|P2|Overall Study|Patient Moved|1
4977208|NCT00086502|17093293|P1|Overall Study|Patient Moved|1
4977209|NCT00086502|17093292|P2|Overall Study|Withdrawal by Subject|6
4977210|NCT00086502|17093293|P1|Overall Study|Withdrawal by Subject|5
4977211|NCT00086502|17093292|P2|Overall Study|Protocol Violation|3
4977212|NCT00086502|17093293|P1|Overall Study|Protocol Violation|3
4977213|NCT00086502|17093292|P2|Overall Study|Pregnancy|1
4977214|NCT00086502|17093293|P1|Overall Study|Pregnancy|0
4977215|NCT00086502|17093292|P2|Overall Study|Physician Decision|1
4977216|NCT00086502|17093293|P1|Overall Study|Physician Decision|1
4977217|NCT00086502|17093292|P2|Overall Study|Lost to Follow-up|1
4977218|NCT00086502|17093293|P1|Overall Study|Lost to Follow-up|3
4977219|NCT00086502|17093292|P2|Overall Study|Lack of Efficacy|2
4977220|NCT00086502|17093293|P1|Overall Study|Lack of Efficacy|0
4977221|NCT00086502|17093292|P2|Overall Study|Adverse Event|2
4977222|NCT00086502|17093293|P1|Overall Study|Adverse Event|11
4977223|NCT00086346|17093318|P2|Patients Dosed With Test Article|Lack of Efficacy|0
4977224|NCT00086346|17093319|P1|Patients Dosed With Test Article|Lack of Efficacy|11
4977225|NCT00086346|17093318|P2|Patients Dosed With Test Article|Protocol Violation|3
4977226|NCT00086346|17093319|P1|Patients Dosed With Test Article|Protocol Violation|11
4977227|NCT00086346|17093318|P2|Patients Dosed With Test Article|Withdrawal by Subject|3
4977228|NCT00086346|17093319|P1|Patients Dosed With Test Article|Withdrawal by Subject|16
4977229|NCT00086346|17093318|P2|Patients Dosed With Test Article|Nonmedical event|3
4977230|NCT00086346|17093319|P1|Patients Dosed With Test Article|Nonmedical event|7
4977231|NCT00086346|17093318|P2|Patients Dosed With Test Article|Lost to Follow-up|3
4977232|NCT00086346|17093319|P1|Patients Dosed With Test Article|Lost to Follow-up|1
4977233|NCT00086346|17093318|P2|Patients Dosed With Test Article|Adverse Event|11
4977234|NCT00086346|17093319|P1|Patients Dosed With Test Article|Adverse Event|94
4977235|NCT00086346|17093318|P2|Randomization|Did not receive test article|4
4977236|NCT00086346|17093319|P1|Randomization|Did not receive test article|4
4977237|NCT00086281|17093346|P15|Phase 2|Adverse Event|0
4977238|NCT00086281|17093347|P14|Phase 2|Adverse Event|1
4977239|NCT00086281|17093348|P13|Phase 2|Adverse Event|1
4977240|NCT00086281|17093349|P12|Phase 2|Adverse Event|0
4977241|NCT00086281|17093350|P11|Phase 2|Adverse Event|0
4977242|NCT00086281|17093351|P10|Phase 2|Adverse Event|0
4977243|NCT00086281|17093352|P9|Phase 2|Adverse Event|0
4977244|NCT00086281|17093353|P8|Phase 2|Adverse Event|0
4977245|NCT00086281|17093354|P7|Phase 2|Adverse Event|0
4977246|NCT00086281|17093355|P6|Phase 2|Adverse Event|0
4977247|NCT00086281|17093356|P5|Phase 2|Adverse Event|0
4977248|NCT00086281|17093357|P4|Phase 2|Adverse Event|0
4977249|NCT00086281|17093358|P3|Phase 2|Adverse Event|0
4977250|NCT00086281|17093359|P2|Phase 2|Adverse Event|0
4977251|NCT00086281|17093360|P1|Phase 2|Adverse Event|0
4977252|NCT00086281|17093346|P15|Phase 1|Serious Adverse Event|1
4977253|NCT00086281|17093347|P14|Phase 1|Serious Adverse Event|0
4977254|NCT00086281|17093348|P13|Phase 1|Serious Adverse Event|0
4977255|NCT00086281|17093349|P12|Phase 1|Serious Adverse Event|0
4977256|NCT00086281|17093350|P11|Phase 1|Serious Adverse Event|0
4977257|NCT00086281|17093351|P10|Phase 1|Serious Adverse Event|0
4977258|NCT00086281|17093352|P9|Phase 1|Serious Adverse Event|0
4977259|NCT00086281|17093353|P8|Phase 1|Serious Adverse Event|0
4977260|NCT00086281|17093354|P7|Phase 1|Serious Adverse Event|0
4977261|NCT00086281|17093355|P6|Phase 1|Serious Adverse Event|0
4977262|NCT00086281|17093356|P5|Phase 1|Serious Adverse Event|0
4977263|NCT00086281|17093357|P4|Phase 1|Serious Adverse Event|0
4977264|NCT00086281|17093358|P3|Phase 1|Serious Adverse Event|0
4977265|NCT00086281|17093359|P2|Phase 1|Serious Adverse Event|0
4977266|NCT00086281|17093360|P1|Phase 1|Serious Adverse Event|0
4977267|NCT00086281|17093346|P15|Phase 1|Protocol Violation|0
4977268|NCT00086281|17093347|P14|Phase 1|Protocol Violation|0
4977269|NCT00086281|17093348|P13|Phase 1|Protocol Violation|0
4977270|NCT00086281|17093349|P12|Phase 1|Protocol Violation|0
4977271|NCT00086281|17093350|P11|Phase 1|Protocol Violation|1
4977272|NCT00086281|17093351|P10|Phase 1|Protocol Violation|0
4977273|NCT00086281|17093352|P9|Phase 1|Protocol Violation|0
4977274|NCT00086281|17093353|P8|Phase 1|Protocol Violation|0
4977275|NCT00086281|17093354|P7|Phase 1|Protocol Violation|0
4977276|NCT00086281|17093355|P6|Phase 1|Protocol Violation|0
4977277|NCT00086281|17093356|P5|Phase 1|Protocol Violation|0
4977278|NCT00086281|17093357|P4|Phase 1|Protocol Violation|0
4977279|NCT00086281|17093358|P3|Phase 1|Protocol Violation|0
4977280|NCT00086281|17093359|P2|Phase 1|Protocol Violation|0
4977281|NCT00086281|17093360|P1|Phase 1|Protocol Violation|0
4977282|NCT00086281|17093346|P15|Phase 1|Adverse Event|2
4977283|NCT00086281|17093347|P14|Phase 1|Adverse Event|1
4977284|NCT00086281|17093348|P13|Phase 1|Adverse Event|1
4977285|NCT00086281|17093349|P12|Phase 1|Adverse Event|1
4977286|NCT00086281|17093350|P11|Phase 1|Adverse Event|2
4977287|NCT00086281|17093351|P10|Phase 1|Adverse Event|1
4977288|NCT00086281|17093352|P9|Phase 1|Adverse Event|0
4977289|NCT00086281|17093353|P8|Phase 1|Adverse Event|0
4977290|NCT00086281|17093354|P7|Phase 1|Adverse Event|0
4977291|NCT00086281|17093355|P6|Phase 1|Adverse Event|0
4977292|NCT00086281|17093356|P5|Phase 1|Adverse Event|0
4977293|NCT00086281|17093357|P4|Phase 1|Adverse Event|0
4977294|NCT00086281|17093358|P3|Phase 1|Adverse Event|0
4977295|NCT00086281|17093359|P2|Phase 1|Adverse Event|0
4977296|NCT00086281|17093360|P1|Phase 1|Adverse Event|0
4977297|NCT00086307|17093373|P3|Overall Study|Withdrawal by Subject|2
4977298|NCT00086307|17093374|P2|Overall Study|Withdrawal by Subject|0
4977299|NCT00086307|17093375|P1|Overall Study|Withdrawal by Subject|0
4977300|NCT00086307|17093373|P3|Overall Study|Fatigue and difficulty falling asleep|1
4977301|NCT00086307|17093374|P2|Overall Study|Fatigue and difficulty falling asleep|0
4977302|NCT00086307|17093375|P1|Overall Study|Fatigue and difficulty falling asleep|0
4977303|NCT00086307|17093373|P3|Overall Study|Suicidal ideation|1
4977304|NCT00086307|17093374|P2|Overall Study|Suicidal ideation|0
4977305|NCT00086307|17093375|P1|Overall Study|Suicidal ideation|0
4977306|NCT00086307|17093373|P3|Overall Study|Constipation and sleepiness|1
4977307|NCT00086307|17093374|P2|Overall Study|Constipation and sleepiness|0
4977308|NCT00086307|17093375|P1|Overall Study|Constipation and sleepiness|0
4977309|NCT00086307|17093373|P3|Overall Study|Nausea and headaches|1
4977310|NCT00086307|17093374|P2|Overall Study|Nausea and headaches|0
4977311|NCT00086307|17093375|P1|Overall Study|Nausea and headaches|0
4977312|NCT00086307|17093373|P3|Overall Study|Shortness of breath and muscle spasms|0
4977313|NCT00086307|17093374|P2|Overall Study|Shortness of breath and muscle spasms|0
4977314|NCT00086307|17093375|P1|Overall Study|Shortness of breath and muscle spasms|1
4977315|NCT00086307|17093373|P3|Overall Study|Lack of Efficacy|2
4977316|NCT00086307|17093374|P2|Overall Study|Lack of Efficacy|1
4977317|NCT00086307|17093375|P1|Overall Study|Lack of Efficacy|1
4977318|NCT00086190|17093386|P3|Overall Study|Worsening depression|2
4977319|NCT00086190|17093387|P2|Overall Study|Worsening depression|0
4977320|NCT00086190|17093388|P1|Overall Study|Worsening depression|0
4977321|NCT00086190|17093386|P3|Overall Study|Moved|0
4977322|NCT00086190|17093387|P2|Overall Study|Moved|0
4977323|NCT00086190|17093388|P1|Overall Study|Moved|1
4977324|NCT00086190|17093386|P3|Overall Study|Protocol Violation|0
4977325|NCT00086190|17093387|P2|Overall Study|Protocol Violation|0
4977326|NCT00086190|17093388|P1|Overall Study|Protocol Violation|1
4977327|NCT00086190|17093386|P3|Overall Study|Withdrawal by Subject|2
4977328|NCT00086190|17093387|P2|Overall Study|Withdrawal by Subject|2
4977329|NCT00086190|17093388|P1|Overall Study|Withdrawal by Subject|0
4977330|NCT00086190|17093386|P3|Overall Study|Adverse Event|2
4977331|NCT00086190|17093387|P2|Overall Study|Adverse Event|2
4977332|NCT00086190|17093388|P1|Overall Study|Adverse Event|6
4977333|NCT00086047|17093457|P2|Overall Study|Physician Decision|1
4977334|NCT00086047|17093458|P1|Overall Study|Physician Decision|0
4977335|NCT00086047|17093457|P2|Overall Study|Lost to Follow-up|6
4977336|NCT00086047|17093458|P1|Overall Study|Lost to Follow-up|7
4977337|NCT00085917|17093466|P2|Overall Study|Adverse Event|3
4977338|NCT00085917|17093467|P1|Overall Study|Adverse Event|4
4977339|NCT00085735|17093496|P6|Overall Study|Pt transferred to inst w/out study open|0
4977340|NCT00085735|17093497|P5|Overall Study|Pt transferred to inst w/out study open|0
4977341|NCT00085735|17093498|P4|Overall Study|Pt transferred to inst w/out study open|0
4977342|NCT00085735|17093499|P3|Overall Study|Pt transferred to inst w/out study open|0
4977343|NCT00085735|17093500|P2|Overall Study|Pt transferred to inst w/out study open|0
4977344|NCT00085735|17093501|P1|Overall Study|Pt transferred to inst w/out study open|1
4977345|NCT00085735|17093496|P6|Overall Study|Reason not documented|0
4977346|NCT00085735|17093497|P5|Overall Study|Reason not documented|1
4977347|NCT00085735|17093498|P4|Overall Study|Reason not documented|0
4977348|NCT00085735|17093499|P3|Overall Study|Reason not documented|1
4977349|NCT00085735|17093500|P2|Overall Study|Reason not documented|0
4977350|NCT00085735|17093501|P1|Overall Study|Reason not documented|1
4977351|NCT00085735|17093496|P6|Overall Study|Excess residual disease|4
4977352|NCT00085735|17093497|P5|Overall Study|Excess residual disease|1
4977353|NCT00085735|17093498|P4|Overall Study|Excess residual disease|1
4977354|NCT00085735|17093499|P3|Overall Study|Excess residual disease|1
4977355|NCT00085735|17093500|P2|Overall Study|Excess residual disease|2
4977356|NCT00085735|17093501|P1|Overall Study|Excess residual disease|2
4977357|NCT00085735|17093496|P6|Overall Study|Patient ineligible|8
4977358|NCT00085735|17093497|P5|Overall Study|Patient ineligible|17
4977359|NCT00085735|17093498|P4|Overall Study|Patient ineligible|7
4977360|NCT00085735|17093499|P3|Overall Study|Patient ineligible|3
4977361|NCT00085735|17093500|P2|Overall Study|Patient ineligible|0
4977362|NCT00085735|17093501|P1|Overall Study|Patient ineligible|1
4977363|NCT00085735|17093496|P6|Overall Study|Withdrawal by Subject|8
4977364|NCT00085735|17093497|P5|Overall Study|Withdrawal by Subject|7
4977365|NCT00085735|17093498|P4|Overall Study|Withdrawal by Subject|5
4977366|NCT00085735|17093499|P3|Overall Study|Withdrawal by Subject|4
4977367|NCT00085735|17093500|P2|Overall Study|Withdrawal by Subject|0
4977368|NCT00085735|17093501|P1|Overall Study|Withdrawal by Subject|1
4977369|NCT00085735|17093496|P6|Overall Study|Protocol Violation|0
4977370|NCT00085735|17093497|P5|Overall Study|Protocol Violation|0
4977371|NCT00085735|17093498|P4|Overall Study|Protocol Violation|0
4977372|NCT00085735|17093499|P3|Overall Study|Protocol Violation|0
4977373|NCT00085735|17093500|P2|Overall Study|Protocol Violation|0
4977374|NCT00085735|17093501|P1|Overall Study|Protocol Violation|1
4977375|NCT00085735|17093496|P6|Overall Study|Physician Decision|8
4977376|NCT00085735|17093497|P5|Overall Study|Physician Decision|11
4977377|NCT00085735|17093498|P4|Overall Study|Physician Decision|3
4977378|NCT00085735|17093499|P3|Overall Study|Physician Decision|2
4977379|NCT00085735|17093500|P2|Overall Study|Physician Decision|3
4977380|NCT00085735|17093501|P1|Overall Study|Physician Decision|2
4977381|NCT00085735|17093496|P6|Overall Study|Lost to Follow-up|0
4977382|NCT00085735|17093497|P5|Overall Study|Lost to Follow-up|1
4977383|NCT00085735|17093498|P4|Overall Study|Lost to Follow-up|0
4977384|NCT00085735|17093499|P3|Overall Study|Lost to Follow-up|0
4977385|NCT00085735|17093500|P2|Overall Study|Lost to Follow-up|1
4977386|NCT00085735|17093501|P1|Overall Study|Lost to Follow-up|0
4977387|NCT00085735|17093496|P6|Overall Study|Lack of Efficacy|3
4977388|NCT00085735|17093497|P5|Overall Study|Lack of Efficacy|4
4977389|NCT00085735|17093498|P4|Overall Study|Lack of Efficacy|3
4977390|NCT00085735|17093499|P3|Overall Study|Lack of Efficacy|6
4977391|NCT00085735|17093500|P2|Overall Study|Lack of Efficacy|4
4977392|NCT00085735|17093501|P1|Overall Study|Lack of Efficacy|2
4977393|NCT00085735|17093496|P6|Overall Study|Adverse Event|0
4977394|NCT00085735|17093497|P5|Overall Study|Adverse Event|0
4977395|NCT00085735|17093498|P4|Overall Study|Adverse Event|0
4977396|NCT00085735|17093499|P3|Overall Study|Adverse Event|0
4977397|NCT00085735|17093500|P2|Overall Study|Adverse Event|0
4977398|NCT00085735|17093501|P1|Overall Study|Adverse Event|1
4977399|NCT00085709|17093556|P2|Overall Study|Withdrawal by Subject|1
4977400|NCT00085709|17093557|P1|Overall Study|Withdrawal by Subject|2
4977401|NCT00085709|17093556|P2|Overall Study|Not eligible|19
4977402|NCT00085709|17093557|P1|Overall Study|Not eligible|19
4977403|NCT00085709|17093556|P2|Overall Study|Not protocol specified|22
4977404|NCT00085709|17093557|P1|Overall Study|Not protocol specified|12
4977405|NCT00085709|17093556|P2|Overall Study|Progression|4
4977406|NCT00085709|17093557|P1|Overall Study|Progression|3
4977407|NCT00085709|17093556|P2|Overall Study|Refusal unrelated to adverse events|2
4977408|NCT00085709|17093557|P1|Overall Study|Refusal unrelated to adverse events|1
4977409|NCT00085709|17093556|P2|Overall Study|Death|2
4977410|NCT00085709|17093557|P1|Overall Study|Death|8
4977411|NCT00085709|17093556|P2|Overall Study|Adverse Event|0
4977412|NCT00085709|17093557|P1|Overall Study|Adverse Event|8
4977413|NCT00085644|17093573|P3|Open-Label Period|Personal reason|4
4977414|NCT00085644|17093574|P2|Open-Label Period|Personal reason|0
4977415|NCT00085644|17093575|P1|Open-Label Period|Personal reason|0
4977416|NCT00085644|17093573|P3|Open-Label Period|Protocol Violation|4
4977417|NCT00085644|17093574|P2|Open-Label Period|Protocol Violation|0
4977418|NCT00085644|17093575|P1|Open-Label Period|Protocol Violation|0
4977419|NCT00085644|17093573|P3|Open-Label Period|Contemplating pregnancy|3
4977420|NCT00085644|17093574|P2|Open-Label Period|Contemplating pregnancy|0
4977421|NCT00085644|17093575|P1|Open-Label Period|Contemplating pregnancy|0
4977422|NCT00085644|17093573|P3|Open-Label Period|Pregnancy|3
4977423|NCT00085644|17093574|P2|Open-Label Period|Pregnancy|0
4977424|NCT00085644|17093575|P1|Open-Label Period|Pregnancy|0
4977425|NCT00085644|17093573|P3|Open-Label Period|Lack of Efficacy|15
4977426|NCT00085644|17093574|P2|Open-Label Period|Lack of Efficacy|0
4977427|NCT00085644|17093575|P1|Open-Label Period|Lack of Efficacy|0
4977428|NCT00085644|17093573|P3|Open-Label Period|Lost to Follow-up|13
4977429|NCT00085644|17093574|P2|Open-Label Period|Lost to Follow-up|0
4977430|NCT00085644|17093575|P1|Open-Label Period|Lost to Follow-up|0
4977431|NCT00085644|17093573|P3|Open-Label Period|Withdrawal by Subject|29
4977432|NCT00085644|17093574|P2|Open-Label Period|Withdrawal by Subject|0
4977433|NCT00085644|17093575|P1|Open-Label Period|Withdrawal by Subject|0
4977434|NCT00085644|17093573|P3|Open-Label Period|Adverse Event|38
4977435|NCT00085644|17093574|P2|Open-Label Period|Adverse Event|0
4977436|NCT00085644|17093575|P1|Open-Label Period|Adverse Event|0
4977437|NCT00085644|17093573|P3|Double-Blind Period|Undiagnosed pre-existing condition|0
4977438|NCT00085644|17093574|P2|Double-Blind Period|Undiagnosed pre-existing condition|1
4977439|NCT00085644|17093575|P1|Double-Blind Period|Undiagnosed pre-existing condition|0
4977440|NCT00085644|17093573|P3|Double-Blind Period|Contemplating pregnancy|0
4977441|NCT00085644|17093574|P2|Double-Blind Period|Contemplating pregnancy|0
4977442|NCT00085644|17093575|P1|Double-Blind Period|Contemplating pregnancy|1
4977443|NCT00085644|17093573|P3|Double-Blind Period|Lack/loss of efficacy|0
4977444|NCT00085644|17093574|P2|Double-Blind Period|Lack/loss of efficacy|2
4977445|NCT00085644|17093575|P1|Double-Blind Period|Lack/loss of efficacy|2
4977446|NCT00085644|17093573|P3|Double-Blind Period|Lost to Follow-up|0
4977447|NCT00085644|17093574|P2|Double-Blind Period|Lost to Follow-up|1
4977448|NCT00085644|17093575|P1|Double-Blind Period|Lost to Follow-up|2
4977449|NCT00085644|17093573|P3|Double-Blind Period|Withdrawal by Subject|0
4977450|NCT00085644|17093574|P2|Double-Blind Period|Withdrawal by Subject|0
4977451|NCT00085644|17093575|P1|Double-Blind Period|Withdrawal by Subject|3
4977452|NCT00085644|17093573|P3|Double-Blind Period|Adverse Event|0
4977453|NCT00085644|17093574|P2|Double-Blind Period|Adverse Event|2
4977454|NCT00085644|17093575|P1|Double-Blind Period|Adverse Event|5
4977455|NCT00085631|17093616|P3|Overall Study|Missing Data|7
4977456|NCT00085631|17093617|P2|Overall Study|Missing Data|11
4977457|NCT00085631|17093618|P1|Overall Study|Missing Data|4
4977458|NCT00085566|17093628|P3|Overall Study|Clinical progression|1
4977459|NCT00085566|17093629|P2|Overall Study|Clinical progression|0
4977460|NCT00085566|17093630|P1|Overall Study|Clinical progression|0
4977461|NCT00085566|17093628|P3|Overall Study|Patient Not treated|3
4977462|NCT00085566|17093629|P2|Overall Study|Patient Not treated|0
4977463|NCT00085566|17093630|P1|Overall Study|Patient Not treated|0
4977464|NCT00085566|17093628|P3|Overall Study|Adverse Event|10
4977465|NCT00085566|17093629|P2|Overall Study|Adverse Event|0
4977466|NCT00085566|17093630|P1|Overall Study|Adverse Event|0
4977467|NCT00085540|17093640|P2|Overall Study|Protocol Violation|1
4977468|NCT00085540|17093641|P1|Overall Study|Protocol Violation|0
4977469|NCT00085540|17093640|P2|Overall Study|Withdrawal by Subject|1
4977470|NCT00085540|17093641|P1|Overall Study|Withdrawal by Subject|0
4977471|NCT00085423|17093653|P1|Overall Study|screen failure|1
4977472|NCT00085423|17093653|P1|Overall Study|Withdrawal by Subject|1
4977473|NCT00085202|17093704|P2|Overall Study|Progressive disease|11
4977474|NCT00085202|17093705|P1|Overall Study|Progressive disease|1
4977475|NCT00085202|17093704|P2|Overall Study|Physician Decision|1
4977476|NCT00085202|17093705|P1|Overall Study|Physician Decision|4
4977477|NCT00085202|17093704|P2|Overall Study|Withdrawal by Subject|1
4977478|NCT00085202|17093705|P1|Overall Study|Withdrawal by Subject|2
4977479|NCT00085202|17093704|P2|Overall Study|Non-specified|5
4977480|NCT00085202|17093705|P1|Overall Study|Non-specified|3
4977481|NCT00085202|17093704|P2|Overall Study|Excessive toxicity|5
4977482|NCT00085202|17093705|P1|Overall Study|Excessive toxicity|6
4977483|NCT00085202|17093704|P2|Overall Study|Bone involvement confirmed by bone scan|1
4977484|NCT00085202|17093705|P1|Overall Study|Bone involvement confirmed by bone scan|0
4977485|NCT00085202|17093704|P2|Overall Study|Still on therapy|0
4977486|NCT00085202|17093705|P1|Overall Study|Still on therapy|2
4977487|NCT00085098|17093726|P2|Overall Study|Ineligible|1
4977488|NCT00085098|17093727|P1|Overall Study|Ineligible|1
4977489|NCT00085098|17093726|P2|Overall Study|Withdrawal by Subject|1
4977490|NCT00085098|17093727|P1|Overall Study|Withdrawal by Subject|0
4977491|NCT00084864|17093741|P4|Overall Study|Adverse Event|0
4977492|NCT00084864|17093742|P3|Overall Study|Adverse Event|0
4977493|NCT00084864|17093743|P2|Overall Study|Adverse Event|0
4977494|NCT00084864|17093744|P1|Overall Study|Adverse Event|1
4977495|NCT00084838|17093770|P1|Overall Study|Ineligible|4
4977496|NCT00084838|17093770|P1|Overall Study|Pt Non-Compliance|1
4977497|NCT00084838|17093770|P1|Overall Study|Progressive Disease|4
4977498|NCT00084838|17093770|P1|Overall Study|Withdrawal by Subject|1
4977499|NCT00084838|17093770|P1|Overall Study|Adverse Event|2
4977500|NCT00084838|17093770|P1|Overall Study|Death|1
4977501|NCT00084747|17093792|P1|Overall Study|Withdrawal by Subject|2
4977502|NCT00084747|17093792|P1|Overall Study|Death|3
4977503|NCT00084747|17093792|P1|Overall Study|Relapsed|8
4977504|NCT00084682|17093797|P1|Overall Study|Withdrawal by Subject|1
4977505|NCT00084617|17093801|P1|Overall Study|Protocol Violation|1
4977506|NCT00084617|17093801|P1|Overall Study|Lack of Efficacy|1
4977507|NCT00084617|17093801|P1|Overall Study|Withdrawal by Subject|7
4977508|NCT00084487|17093807|P1|Overall Study|Death|1
4977509|NCT00084318|17093851|P2|Overall Study|No protocol treatment|0
4977510|NCT00084318|17093852|P1|Overall Study|No protocol treatment|2
4977511|NCT00084318|17093851|P2|Overall Study|Protocol Violation|11
4977512|NCT00084318|17093852|P1|Overall Study|Protocol Violation|15
4977513|NCT00084318|17093851|P2|Overall Study|Withdrawal by Subject|2
4977514|NCT00084318|17093852|P1|Overall Study|Withdrawal by Subject|5
4977515|NCT00084266|17093872|P2|Overall Study|Randomized not treated|20
4977516|NCT00084266|17093873|P1|Overall Study|Randomized not treated|21
4977517|NCT00084266|17093872|P2|Overall Study|Other|344
4977518|NCT00084266|17093873|P1|Overall Study|Other|360
4977519|NCT00084266|17093872|P2|Overall Study|Participant not willing to participate|8
4977520|NCT00084266|17093873|P1|Overall Study|Participant not willing to participate|3
4977521|NCT00084266|17093872|P2|Overall Study|Lost to Follow-up|3
4977522|NCT00084266|17093873|P1|Overall Study|Lost to Follow-up|5
4977523|NCT00084266|17093872|P2|Overall Study|Lack of Efficacy|4
4977524|NCT00084266|17093873|P1|Overall Study|Lack of Efficacy|2
4977525|NCT00084266|17093872|P2|Overall Study|Adverse Event|5
4977526|NCT00084266|17093873|P1|Overall Study|Adverse Event|8
4977527|NCT00084266|17093872|P2|Overall Study|Death|39
4977528|NCT00084266|17093873|P1|Overall Study|Death|42
4977529|NCT00084136|17093931|P3|NRTI Comparison|Not reason above|0
4977530|NCT00084136|17093932|P2|NRTI Comparison|Not reason above|0
4977531|NCT00084136|17093933|P1|NRTI Comparison|Not reason above|1
4977532|NCT00084136|17093931|P3|NRTI Comparison|Clinic site closed|14
4977533|NCT00084136|17093932|P2|NRTI Comparison|Clinic site closed|0
4977534|NCT00084136|17093933|P1|NRTI Comparison|Clinic site closed|12
4977535|NCT00084136|17093931|P3|NRTI Comparison|Withdrawal by Subject|38
4977536|NCT00084136|17093932|P2|NRTI Comparison|Withdrawal by Subject|0
4977537|NCT00084136|17093933|P1|NRTI Comparison|Withdrawal by Subject|54
4977538|NCT00084136|17093931|P3|NRTI Comparison|Lost to Follow-up|12
4977539|NCT00084136|17093932|P2|NRTI Comparison|Lost to Follow-up|0
4977540|NCT00084136|17093933|P1|NRTI Comparison|Lost to Follow-up|14
4977541|NCT00084136|17093931|P3|NRTI Comparison|Death|18
4977542|NCT00084136|17093932|P2|NRTI Comparison|Death|0
4977543|NCT00084136|17093933|P1|NRTI Comparison|Death|20
4977544|NCT00084136|17093931|P3|PI Comparison|Clinic site closed|0
4977545|NCT00084136|17093932|P2|PI Comparison|Clinic site closed|0
4977546|NCT00084136|17093933|P1|PI Comparison|Clinic site closed|1
4977547|NCT00084136|17093931|P3|PI Comparison|Withdrawal by Subject|0
4977548|NCT00084136|17093932|P2|PI Comparison|Withdrawal by Subject|30
4977549|NCT00084136|17093933|P1|PI Comparison|Withdrawal by Subject|33
4977550|NCT00084136|17093931|P3|PI Comparison|Lost to Follow-up|0
4977551|NCT00084136|17093932|P2|PI Comparison|Lost to Follow-up|8
4977552|NCT00084136|17093933|P1|PI Comparison|Lost to Follow-up|11
4977553|NCT00084136|17093931|P3|PI Comparison|Death|0
4977554|NCT00084136|17093932|P2|PI Comparison|Death|9
4977555|NCT00084136|17093933|P1|PI Comparison|Death|10
4977556|NCT00084084|17093992|P1|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1
4977557|NCT00084084|17093992|P1|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1
4977558|NCT00083915|17094002|P2|Overall Study|Insurance issues|1
4977559|NCT00083915|17094003|P1|Overall Study|Insurance issues|1
4977560|NCT00083915|17094002|P2|Overall Study|No response|1
4977561|NCT00083915|17094003|P1|Overall Study|No response|3
4977562|NCT00083915|17094002|P2|Overall Study|Failure to collect|0
4977563|NCT00083915|17094003|P1|Overall Study|Failure to collect|3
4977564|NCT00083915|17094002|P2|Overall Study|disease progression|23
4977565|NCT00083915|17094003|P1|Overall Study|disease progression|18
4977566|NCT00083915|17094002|P2|Overall Study|Withdrawal by Subject|3
4977567|NCT00083915|17094003|P1|Overall Study|Withdrawal by Subject|8
4977568|NCT00083915|17094002|P2|Overall Study|Physician Decision|6
4977569|NCT00083915|17094003|P1|Overall Study|Physician Decision|11
4977570|NCT00083915|17094002|P2|Overall Study|Death|3
4977571|NCT00083915|17094003|P1|Overall Study|Death|6
4977572|NCT00083889|17094011|P2|Overall Study|Crossover to SU011248|25
4977573|NCT00083889|17094012|P1|Overall Study|Crossover to SU011248|0
4977574|NCT00083889|17094011|P2|Overall Study|Completed on marketed sunitinub|0
4977575|NCT00083889|17094012|P1|Overall Study|Completed on marketed sunitinub|3
4977576|NCT00083889|17094011|P2|Overall Study|Randomized: did not take study drug|15
4977577|NCT00083889|17094012|P1|Overall Study|Randomized: did not take study drug|0
4977578|NCT00083889|17094011|P2|Overall Study|Decision of sponsor|4
4977579|NCT00083889|17094012|P1|Overall Study|Decision of sponsor|32
4977580|NCT00083889|17094011|P2|Overall Study|Lack of Efficacy|219
4977581|NCT00083889|17094012|P1|Overall Study|Lack of Efficacy|240
4977582|NCT00083889|17094011|P2|Overall Study|Withdrawal by Subject|24
4977583|NCT00083889|17094012|P1|Overall Study|Withdrawal by Subject|22
4977584|NCT00083889|17094011|P2|Overall Study|Protocol Violation|2
4977585|NCT00083889|17094012|P1|Overall Study|Protocol Violation|2
4977586|NCT00083889|17094011|P2|Overall Study|Adverse Event|86
4977587|NCT00083889|17094012|P1|Overall Study|Adverse Event|76
4977588|NCT00083759|17094070|P2|Overall Study|Other|13
4977589|NCT00083759|17094071|P1|Overall Study|Other|14
4977590|NCT00083759|17094070|P2|Overall Study|Sponsor's Discretion|29
4977591|NCT00083759|17094071|P1|Overall Study|Sponsor's Discretion|28
4977592|NCT00083759|17094070|P2|Overall Study|Non-Compliance|0
4977593|NCT00083759|17094071|P1|Overall Study|Non-Compliance|1
4977594|NCT00083759|17094070|P2|Overall Study|Subject Withdrew Consent|2
4977595|NCT00083759|17094071|P1|Overall Study|Subject Withdrew Consent|2
4977596|NCT00083759|17094070|P2|Overall Study|Inadequate Therapeutic Response|35
4977597|NCT00083759|17094071|P1|Overall Study|Inadequate Therapeutic Response|32
4977598|NCT00083759|17094070|P2|Overall Study|Death|1
4977599|NCT00083759|17094071|P1|Overall Study|Death|1
4977600|NCT00083759|17094070|P2|Overall Study|Lost to Follow-up|0
4977601|NCT00083759|17094071|P1|Overall Study|Lost to Follow-up|1
4977602|NCT00083759|17094070|P2|Overall Study|Adverse Event|3
4977603|NCT00083759|17094071|P1|Overall Study|Adverse Event|5
4977604|NCT00083616|17094089|P1|Overall Study|Other|6
4977605|NCT00083616|17094089|P1|Overall Study|Non-compliance|1
4977606|NCT00083616|17094089|P1|Overall Study|Ineligibility determined|2
4977607|NCT00083616|17094089|P1|Overall Study|Withdrawal by Subject|3
4977608|NCT00083616|17094089|P1|Overall Study|Physician Decision|2
4977609|NCT00083616|17094089|P1|Overall Study|Lost to Follow-up|1
4977610|NCT00083616|17094089|P1|Overall Study|Disease Progression|16
4977611|NCT00082888|17094117|P3|Overall Study|Ineligible|0
4977612|NCT00082888|17094118|P2|Overall Study|Ineligible|0
4977613|NCT00082888|17094119|P1|Overall Study|Ineligible|1
4977614|NCT00082810|17094139|P1|Overall Study|Withdrawal by Subject|4
4977615|NCT00082810|17094139|P1|Overall Study|Progressive disease|24
4977616|NCT00082810|17094139|P1|Overall Study|Adverse Event|3
4977617|NCT00082758|17094150|P3|Overall Study|Protocol Violation|0
4977618|NCT00082758|17094151|P2|Overall Study|Protocol Violation|1
4977619|NCT00082758|17094152|P1|Overall Study|Protocol Violation|0
4977620|NCT00082758|17094150|P3|Overall Study|Withdrawal by Subject|0
4977621|NCT00082758|17094151|P2|Overall Study|Withdrawal by Subject|0
4977622|NCT00082758|17094152|P1|Overall Study|Withdrawal by Subject|3
4977623|NCT00082758|17094150|P3|Overall Study|Physician Decision|0
4977624|NCT00082758|17094151|P2|Overall Study|Physician Decision|1
4977625|NCT00082758|17094152|P1|Overall Study|Physician Decision|0
4977626|NCT00082758|17094150|P3|Overall Study|Lack of Efficacy|0
4977627|NCT00082758|17094151|P2|Overall Study|Lack of Efficacy|13
4977628|NCT00082758|17094152|P1|Overall Study|Lack of Efficacy|12
4977629|NCT00082758|17094150|P3|Overall Study|Adverse Event|0
4977630|NCT00082758|17094151|P2|Overall Study|Adverse Event|2
4977631|NCT00082758|17094152|P1|Overall Study|Adverse Event|0
4977632|NCT00083226|17094172|P1|Overall Study|ineligible or not receiving treatment|4
4977633|NCT00083226|17094172|P1|Overall Study|Other|2
4977634|NCT00083226|17094172|P1|Overall Study|Withdrawal by Subject|4
4977635|NCT00083226|17094172|P1|Overall Study|Death|4
4977636|NCT00083226|17094172|P1|Overall Study|Adverse Event|9
4977637|NCT00083226|17094172|P1|Overall Study|Lack of Efficacy|19
4977638|NCT00082628|17094216|P5|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17
4977639|NCT00082628|17094217|P4|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
4977640|NCT00082628|17094218|P3|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15
4977641|NCT00082628|17094219|P2|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
4977642|NCT00082628|17094220|P1|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0
4977643|NCT00082628|17094216|P5|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4977644|NCT00082628|17094217|P4|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1
4977645|NCT00082628|17094218|P3|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4977646|NCT00082628|17094219|P2|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4977647|NCT00082628|17094220|P1|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0
4977648|NCT00082628|17094216|P5|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1
4977649|NCT00082628|17094217|P4|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4977650|NCT00082628|17094218|P3|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4977651|NCT00082628|17094219|P2|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4977652|NCT00082628|17094220|P1|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0
4977653|NCT00082628|17094216|P5|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
4977654|NCT00082628|17094217|P4|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
4977655|NCT00082628|17094218|P3|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0
4977656|NCT00082628|17094219|P2|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15
4977657|NCT00082628|17094220|P1|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1
4977658|NCT00082628|17094216|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
4977659|NCT00082628|17094217|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
4977660|NCT00082628|17094218|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0
4977661|NCT00082628|17094219|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43
4977662|NCT00082628|17094220|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5
4977663|NCT00082628|17094216|P5|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
4977664|NCT00082628|17094217|P4|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
4977665|NCT00082628|17094218|P3|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0
4977666|NCT00082628|17094219|P2|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1
4977667|NCT00082628|17094220|P1|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2
4977668|NCT00082628|17094216|P5|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4977669|NCT00082628|17094217|P4|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4977670|NCT00082628|17094218|P3|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4977671|NCT00082628|17094219|P2|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1
4977672|NCT00082628|17094220|P1|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0
4977673|NCT00082433|17094240|P2|Overall Study|Impending surgery|1
4977674|NCT00082433|17094241|P1|Overall Study|Impending surgery|0
4977675|NCT00082433|17094240|P2|Overall Study|New primary cancer|0
4977676|NCT00082433|17094241|P1|Overall Study|New primary cancer|1
4977677|NCT00082433|17094240|P2|Overall Study|Noncompliance|1
4977678|NCT00082433|17094241|P1|Overall Study|Noncompliance|2
4977679|NCT00082433|17094240|P2|Overall Study|Ineligible|1
4977680|NCT00082433|17094241|P1|Overall Study|Ineligible|2
4977681|NCT00082433|17094240|P2|Overall Study|Not Treated|11
4977682|NCT00082433|17094241|P1|Overall Study|Not Treated|12
4977683|NCT00082433|17094240|P2|Overall Study|Still On Treatment|1
4977684|NCT00082433|17094241|P1|Overall Study|Still On Treatment|2
4977685|NCT00082433|17094240|P2|Overall Study|Withdrawal by Subject|30
4977686|NCT00082433|17094241|P1|Overall Study|Withdrawal by Subject|55
4977687|NCT00082433|17094240|P2|Overall Study|Study Drug Toxicity|66
4977688|NCT00082433|17094241|P1|Overall Study|Study Drug Toxicity|179
4977689|NCT00082433|17094240|P2|Overall Study|Lost to Follow-up|2
4977690|NCT00082433|17094241|P1|Overall Study|Lost to Follow-up|1
4977691|NCT00082433|17094240|P2|Overall Study|Physician Decision|61
4977692|NCT00082433|17094241|P1|Overall Study|Physician Decision|50
4977693|NCT00082433|17094240|P2|Overall Study|Disease Progression/Relapse|388
4977694|NCT00082433|17094241|P1|Overall Study|Disease Progression/Relapse|270
4977695|NCT00082433|17094240|P2|Overall Study|Death|18
4977696|NCT00082433|17094241|P1|Overall Study|Death|8
4977697|NCT00082433|17094240|P2|Overall Study|Adverse Event|17
4977698|NCT00082433|17094241|P1|Overall Study|Adverse Event|12
4977699|NCT00082381|17094261|P2|Overall Study|Loss of Glucose Control|0
4977700|NCT00082381|17094262|P1|Overall Study|Loss of Glucose Control|4
4977701|NCT00082381|17094261|P2|Overall Study|Protocol Violation|11
4977702|NCT00082381|17094262|P1|Overall Study|Protocol Violation|10
4977703|NCT00082381|17094261|P2|Overall Study|Physician Decision|2
4977704|NCT00082381|17094262|P1|Overall Study|Physician Decision|1
4977705|NCT00082381|17094261|P2|Overall Study|Patient Decision|4
4977706|NCT00082381|17094262|P1|Overall Study|Patient Decision|8
4977707|NCT00082381|17094261|P2|Overall Study|Lost to Follow-up|7
4977708|NCT00082381|17094262|P1|Overall Study|Lost to Follow-up|5
4977709|NCT00082381|17094261|P2|Overall Study|Adverse Event|2
4977710|NCT00082381|17094262|P1|Overall Study|Adverse Event|27
4977711|NCT00082407|17094282|P2|Overall Study|Lost to Follow-up|3
4977712|NCT00082407|17094283|P1|Overall Study|Lost to Follow-up|0
4977713|NCT00082407|17094282|P2|Overall Study|Death|1
4977714|NCT00082407|17094283|P1|Overall Study|Death|2
4977715|NCT00082407|17094282|P2|Overall Study|Loss of Glucose Control|2
4977716|NCT00082407|17094283|P1|Overall Study|Loss of Glucose Control|2
4977717|NCT00082407|17094282|P2|Overall Study|Physician Decision|3
4977718|NCT00082407|17094283|P1|Overall Study|Physician Decision|5
4977719|NCT00082407|17094282|P2|Overall Study|Patient Decision|6
4977720|NCT00082407|17094283|P1|Overall Study|Patient Decision|13
4977721|NCT00082407|17094282|P2|Overall Study|Protocol Violation|12
4977722|NCT00082407|17094283|P1|Overall Study|Protocol Violation|14
4977723|NCT00082407|17094282|P2|Overall Study|Adverse Event|0
4977724|NCT00082407|17094283|P1|Overall Study|Adverse Event|20
4977725|NCT00082368|17094301|P1|Overall Study|Not treated-pt had poor IV access|1
4977726|NCT00082355|17094306|P1|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28
4977727|NCT00082355|17094306|P1|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1
4977728|NCT00082355|17094306|P1|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1
4977729|NCT00082173|17094340|P2|Overall Study|Culture negative or resistant at baselin|6
4977730|NCT00082173|17094341|P1|Overall Study|Culture negative or resistant at baselin|5
4977731|NCT00082173|17094340|P2|Overall Study|Adverse Event|0
4977732|NCT00082173|17094341|P1|Overall Study|Adverse Event|1
4977733|NCT00082173|17094340|P2|Overall Study|Lost to Follow-up|0
4977734|NCT00082173|17094341|P1|Overall Study|Lost to Follow-up|1
4977735|NCT00082173|17094340|P2|Overall Study|Withdrawal by Subject|5
4977736|NCT00082173|17094341|P1|Overall Study|Withdrawal by Subject|3
4977737|NCT00081770|17094386|P3|Overall Study|Other|8
4977738|NCT00081770|17094387|P2|Overall Study|Other|7
4977739|NCT00081770|17094388|P1|Overall Study|Other|2
4977740|NCT00081770|17094386|P3|Overall Study|Administrative|1
4977741|NCT00081770|17094387|P2|Overall Study|Administrative|0
4977742|NCT00081770|17094388|P1|Overall Study|Administrative|1
4977743|NCT00081770|17094386|P3|Overall Study|Did not meet protocol eligibility|3
4977744|NCT00081770|17094387|P2|Overall Study|Did not meet protocol eligibility|0
4977745|NCT00081770|17094388|P1|Overall Study|Did not meet protocol eligibility|2
4977746|NCT00081770|17094386|P3|Overall Study|Withdrawal by Subject|42
4977747|NCT00081770|17094387|P2|Overall Study|Withdrawal by Subject|40
4977748|NCT00081770|17094388|P1|Overall Study|Withdrawal by Subject|45
4977749|NCT00081770|17094386|P3|Overall Study|Protocol Violation|10
4977750|NCT00081770|17094387|P2|Overall Study|Protocol Violation|10
4977751|NCT00081770|17094388|P1|Overall Study|Protocol Violation|15
4977752|NCT00081770|17094386|P3|Overall Study|Lost to Follow-up|45
4977753|NCT00081770|17094387|P2|Overall Study|Lost to Follow-up|34
4977754|NCT00081770|17094388|P1|Overall Study|Lost to Follow-up|45
4977755|NCT00081770|17094386|P3|Overall Study|Lack of Efficacy|211
4977756|NCT00081770|17094387|P2|Overall Study|Lack of Efficacy|357
4977757|NCT00081770|17094388|P1|Overall Study|Lack of Efficacy|262
4977758|NCT00081770|17094386|P3|Overall Study|Adverse Event|136
4977759|NCT00081770|17094387|P2|Overall Study|Adverse Event|98
4977760|NCT00081770|17094388|P1|Overall Study|Adverse Event|130
4977761|NCT00081731|17094407|P2|Overall Study|scientific integrity issue|8
4977762|NCT00081731|17094408|P1|Overall Study|scientific integrity issue|8
4977763|NCT00081653|17094428|P2|Overall Study|Loss of bone mass|2
4977764|NCT00081653|17094429|P1|Overall Study|Loss of bone mass|0
4977765|NCT00081653|17094428|P2|Overall Study|Participant leaving country|0
4977766|NCT00081653|17094429|P1|Overall Study|Participant leaving country|1
4977767|NCT00081653|17094428|P2|Overall Study|Bone loss|0
4977768|NCT00081653|17094429|P1|Overall Study|Bone loss|2
4977769|NCT00081653|17094428|P2|Overall Study|Low bone mineral density|0
4977770|NCT00081653|17094429|P1|Overall Study|Low bone mineral density|1
4977771|NCT00081653|17094428|P2|Overall Study|Refused Treatment|14
4977772|NCT00081653|17094429|P1|Overall Study|Refused Treatment|18
4977773|NCT00081653|17094428|P2|Overall Study|Lost to Follow-up|4
4977774|NCT00081653|17094429|P1|Overall Study|Lost to Follow-up|2
4977775|NCT00081653|17094428|P2|Overall Study|Adverse Event|17
4977776|NCT00081653|17094429|P1|Overall Study|Adverse Event|23
4977777|NCT00081497|17094447|P2|Overall Study|Non-compliance|1
4977778|NCT00081497|17094448|P1|Overall Study|Non-compliance|0
4977779|NCT00081497|17094447|P2|Overall Study|Withdrawal by Subject|0
4977780|NCT00081497|17094448|P1|Overall Study|Withdrawal by Subject|1
4977781|NCT00081497|17094447|P2|Overall Study|Death|1
4977782|NCT00081497|17094448|P1|Overall Study|Death|0
4977783|NCT00081497|17094447|P2|Overall Study|Adverse Event|0
4977784|NCT00081497|17094448|P1|Overall Study|Adverse Event|2
4977785|NCT00081458|17094466|P3|Overall Study|Randomized but not dosed|1
4977786|NCT00081458|17094467|P2|Overall Study|Randomized but not dosed|0
4977787|NCT00081458|17094468|P1|Overall Study|Randomized but not dosed|0
4977788|NCT00081458|17094466|P3|Overall Study|Withdrawal by Subject|1
4977789|NCT00081458|17094467|P2|Overall Study|Withdrawal by Subject|3
4977790|NCT00081458|17094468|P1|Overall Study|Withdrawal by Subject|0
4977791|NCT00081458|17094466|P3|Overall Study|Adverse Event|2
4977792|NCT00081458|17094467|P2|Overall Study|Adverse Event|5
4977793|NCT00081458|17094468|P1|Overall Study|Adverse Event|1
4977794|NCT00081289|17094524|P2|Overall Study|Ineligible / no protocol treatment|4
4977795|NCT00081289|17094525|P1|Overall Study|Ineligible / no protocol treatment|3
4977796|NCT00081289|17094524|P2|Overall Study|Accrued prior to chemotherapy amendment|17
4977797|NCT00081289|17094525|P1|Overall Study|Accrued prior to chemotherapy amendment|18
4977798|NCT00081263|17094569|P2|Overall Study|Inadequate data|10
4977799|NCT00081263|17094570|P1|Overall Study|Inadequate data|5
4977800|NCT00081263|17094569|P2|Overall Study|Never treated|5
4977801|NCT00081263|17094570|P1|Overall Study|Never treated|4
4977802|NCT00081263|17094569|P2|Overall Study|Inadequate pathology|1
4977803|NCT00081263|17094570|P1|Overall Study|Inadequate pathology|0
4977804|NCT00081263|17094569|P2|Overall Study|improper pre-protocol therapy|1
4977805|NCT00081263|17094570|P1|Overall Study|improper pre-protocol therapy|0
4977806|NCT00081263|17094569|P2|Overall Study|wrong cell type|5
4977807|NCT00081263|17094570|P1|Overall Study|wrong cell type|7
4977808|NCT00081263|17094569|P2|Overall Study|clerical error|0
4977809|NCT00081263|17094570|P1|Overall Study|clerical error|1
4977810|NCT00081159|17094580|P2|Overall Study|Lost to Follow-up|1
4977811|NCT00081159|17094581|P1|Overall Study|Lost to Follow-up|2
4977812|NCT00081159|17094580|P2|Overall Study|Myelosuppression prior to treatment|1
4977813|NCT00081159|17094581|P1|Overall Study|Myelosuppression prior to treatment|0
4977814|NCT00081159|17094580|P2|Overall Study|Withdrawal by Subject|3
4977815|NCT00081159|17094581|P1|Overall Study|Withdrawal by Subject|0
4977816|NCT00080938|17094591|P1|Overall Study|Ineligible|4
4977817|NCT00080938|17094591|P1|Overall Study|Not started protocol therapy|1
4977818|NCT00080938|17094591|P1|Overall Study|other disease|1
4977819|NCT00080938|17094591|P1|Overall Study|Lack of Efficacy|7
4977820|NCT00080938|17094591|P1|Overall Study|Death|2
4977821|NCT00080938|17094591|P1|Overall Study|Withdrawal by Subject|6
4977822|NCT00080938|17094591|P1|Overall Study|Adverse Event|3
4977823|NCT00080899|17094607|P1|Overall Study|Adverse Event|1
4977824|NCT00080483|17094619|P2|Overall Study|Physician Decision|1
4977825|NCT00080483|17094620|P1|Overall Study|Physician Decision|1
4977826|NCT00080483|17094619|P2|Overall Study|Lost to Follow-up|1
4977827|NCT00080483|17094620|P1|Overall Study|Lost to Follow-up|1
4977828|NCT00002525|17094628|P2|Overall Study|Never start protocol therapy|0
4977829|NCT00002525|17094629|P1|Overall Study|Never start protocol therapy|8
4977830|NCT00002525|17094628|P2|Overall Study|Other|0
4977831|NCT00002525|17094629|P1|Overall Study|Other|26
4977832|NCT00002525|17094628|P2|Overall Study|Error|0
4977833|NCT00002525|17094629|P1|Overall Study|Error|6
4977834|NCT00002525|17094628|P2|Overall Study|Duke's A, B1, D disease|0
4977835|NCT00002525|17094629|P1|Overall Study|Duke's A, B1, D disease|92
4977836|NCT00002525|17094628|P2|Overall Study|Other complicating disease|0
4977837|NCT00002525|17094629|P1|Overall Study|Other complicating disease|1
4977838|NCT00002525|17094628|P2|Overall Study|Start non-protocol therapy|0
4977839|NCT00002525|17094629|P1|Overall Study|Start non-protocol therapy|1
4977840|NCT00002525|17094628|P2|Overall Study|Withdrawal by Subject|0
4977841|NCT00002525|17094629|P1|Overall Study|Withdrawal by Subject|11
4977842|NCT00002525|17094628|P2|Overall Study|Death|0
4977843|NCT00002525|17094629|P1|Overall Study|Death|5
4977844|NCT00002525|17094628|P2|Overall Study|Adverse Event|0
4977845|NCT00002525|17094629|P1|Overall Study|Adverse Event|36
4977846|NCT00080301|17094656|P2|Overall Study|Still on Treatment as of CSR date|1
4977847|NCT00080301|17094657|P1|Overall Study|Still on Treatment as of CSR date|0
4977848|NCT00080301|17094656|P2|Overall Study|Randomized but Never Treated|10
4977849|NCT00080301|17094657|P1|Overall Study|Randomized but Never Treated|5
4977850|NCT00080288|17094677|P2|Overall Study|Miscellaneous|11
4977851|NCT00080288|17094678|P1|Overall Study|Miscellaneous|11
4977852|NCT00080288|17094677|P2|Overall Study|Withdrawal by Subject|16
4977853|NCT00080288|17094678|P1|Overall Study|Withdrawal by Subject|3
4977854|NCT00080288|17094677|P2|Overall Study|Physician Decision|2
4977855|NCT00080288|17094678|P1|Overall Study|Physician Decision|6
4977856|NCT00080288|17094677|P2|Overall Study|Lost to Follow-up|5
4977857|NCT00080288|17094678|P1|Overall Study|Lost to Follow-up|3
4977858|NCT00080288|17094677|P2|Overall Study|Adverse Event|4
4977859|NCT00080288|17094678|P1|Overall Study|Adverse Event|7
4977860|NCT00080223|17094686|P1|Overall Study|Physician Decision|1
4977861|NCT00080223|17094686|P1|Overall Study|Participant unwilling to continue|2
4977862|NCT00080223|17094686|P1|Overall Study|Non-compliance With Study Treatment|7
4977863|NCT00080223|17094686|P1|Overall Study|Lung Transplantation|9
4977864|NCT00080223|17094686|P1|Overall Study|Withdrawal by Subject|13
4977865|NCT00080223|17094686|P1|Overall Study|Death|21
4977866|NCT00080223|17094686|P1|Overall Study|Adverse Event|23
4977867|NCT00002540|17094696|P2|Overall Study|Refused Screen (Prostate Screening)|2433
4977868|NCT00002540|17094697|P1|Overall Study|Refused Screen (Prostate Screening)|0
4977869|NCT00002540|17094696|P2|Overall Study|Refused ASU (Control)|0
4977870|NCT00002540|17094697|P1|Overall Study|Refused ASU (Control)|597
4977871|NCT00002540|17094696|P2|Overall Study|Died Before ASU (Control)|0
4977872|NCT00002540|17094697|P1|Overall Study|Died Before ASU (Control)|202
4977873|NCT00002540|17094696|P2|Overall Study|Died Before Randomization|6
4977874|NCT00002540|17094697|P1|Overall Study|Died Before Randomization|2
4977875|NCT00002540|17094696|P2|Overall Study|Cancer Before Rand. (Prostate Screening)|25
4977876|NCT00002540|17094697|P1|Overall Study|Cancer Before Rand. (Prostate Screening)|0
4977877|NCT00080119|17094727|P4|Overall Study|Lost to Follow-up|14
4977878|NCT00080119|17094728|P3|Overall Study|Lost to Follow-up|19
4977879|NCT00080119|17094729|P2|Overall Study|Lost to Follow-up|19
4977880|NCT00080119|17094730|P1|Overall Study|Lost to Follow-up|16
4977881|NCT00080119|17094727|P4|Overall Study|Unwilling to adhere to study requirement|1
4977882|NCT00080119|17094728|P3|Overall Study|Unwilling to adhere to study requirement|5
4977883|NCT00080119|17094729|P2|Overall Study|Unwilling to adhere to study requirement|2
4977884|NCT00080119|17094730|P1|Overall Study|Unwilling to adhere to study requirement|3
4977885|NCT00080119|17094727|P4|Overall Study|Consent withdrawn|6
4977886|NCT00080119|17094728|P3|Overall Study|Consent withdrawn|4
4977887|NCT00080119|17094729|P2|Overall Study|Consent withdrawn|17
4977888|NCT00080119|17094730|P1|Overall Study|Consent withdrawn|13
4977889|NCT00080119|17094727|P4|Overall Study|Unable to get to clinic|1
4977890|NCT00080119|17094728|P3|Overall Study|Unable to get to clinic|7
4977891|NCT00080119|17094729|P2|Overall Study|Unable to get to clinic|24
4977892|NCT00080119|17094730|P1|Overall Study|Unable to get to clinic|24
4977893|NCT00080119|17094727|P4|Overall Study|Discontinued because of study closure|141
4977894|NCT00080119|17094728|P3|Overall Study|Discontinued because of study closure|130
4977895|NCT00080119|17094729|P2|Overall Study|Discontinued because of study closure|0
4977896|NCT00080119|17094730|P1|Overall Study|Discontinued because of study closure|0
4977897|NCT00079937|17094764|P2|Overall Study|Administrative problems|11
4977898|NCT00079937|17094765|P1|Overall Study|Administrative problems|22
4977899|NCT00079937|17094764|P2|Overall Study|Lost to Follow-up|5
4977900|NCT00079937|17094765|P1|Overall Study|Lost to Follow-up|12
4977901|NCT00079937|17094764|P2|Overall Study|Withdrawal by Subject|7
4977902|NCT00079937|17094765|P1|Overall Study|Withdrawal by Subject|21
4977903|NCT00079937|17094764|P2|Overall Study|Protocol Violation|6
4977904|NCT00079937|17094765|P1|Overall Study|Protocol Violation|8
4977905|NCT00079937|17094764|P2|Overall Study|Subject no longer requires study drug|0
4977906|NCT00079937|17094765|P1|Overall Study|Subject no longer requires study drug|3
4977907|NCT00079937|17094764|P2|Overall Study|Unsatisfactory therapeutic effect|2
4977908|NCT00079937|17094765|P1|Overall Study|Unsatisfactory therapeutic effect|1
4977909|NCT00079937|17094764|P2|Overall Study|Adverse Event|1
4977910|NCT00079937|17094765|P1|Overall Study|Adverse Event|2
4977911|NCT00009737|17094783|P2|Overall Study|Administrative/Other Reasons|1
4977912|NCT00009737|17094784|P1|Overall Study|Administrative/Other Reasons|7
4977913|NCT00009737|17094783|P2|Overall Study|Lost to Follow-up|1
4977914|NCT00009737|17094784|P1|Overall Study|Lost to Follow-up|1
4977915|NCT00009737|17094783|P2|Overall Study|Refused Treatment|16
4977916|NCT00009737|17094784|P1|Overall Study|Refused Treatment|15
4977917|NCT00009737|17094783|P2|Overall Study|Other Protocol Violation|0
4977918|NCT00009737|17094784|P1|Overall Study|Other Protocol Violation|1
4977919|NCT00009737|17094783|P2|Overall Study|Violation of Selection Criteria at Entry|9
4977920|NCT00009737|17094784|P1|Overall Study|Violation of Selection Criteria at Entry|13
4977921|NCT00009737|17094783|P2|Overall Study|Lack of Efficacy|15
4977922|NCT00009737|17094784|P1|Overall Study|Lack of Efficacy|17
4977923|NCT00009737|17094783|P2|Overall Study|Death|6
4977924|NCT00009737|17094784|P1|Overall Study|Death|4
4977925|NCT00009737|17094783|P2|Overall Study|Adverse Event|75
4977926|NCT00009737|17094784|P1|Overall Study|Adverse Event|112
4977927|NCT00079781|17094803|P3|Follow-up Period|Death|1
4977928|NCT00079781|17094804|P2|Follow-up Period|Death|0
4977929|NCT00079781|17094805|P1|Follow-up Period|Death|0
4977930|NCT00079781|17094803|P3|Follow-up Period|Lost to Follow-up|0
4977931|NCT00079781|17094804|P2|Follow-up Period|Lost to Follow-up|0
4977932|NCT00079781|17094805|P1|Follow-up Period|Lost to Follow-up|1
4977933|NCT00079781|17094803|P3|Follow-up Period|Withdrawal by Subject|1
4977934|NCT00079781|17094804|P2|Follow-up Period|Withdrawal by Subject|0
4977935|NCT00079781|17094805|P1|Follow-up Period|Withdrawal by Subject|3
4977936|NCT00079781|17094803|P3|Pre-implant Period|Did not meet I/E criteria|1
4977937|NCT00079781|17094804|P2|Pre-implant Period|Did not meet I/E criteria|1
4977938|NCT00079781|17094805|P1|Pre-implant Period|Did not meet I/E criteria|1
4977939|NCT00079781|17094803|P3|Pre-implant Period|Withdrawal by Subject|0
4977940|NCT00079781|17094804|P2|Pre-implant Period|Withdrawal by Subject|0
4977941|NCT00079781|17094805|P1|Pre-implant Period|Withdrawal by Subject|2
4977942|NCT00079677|17094814|P2|Overall Study|Miscellaneous|0
4977943|NCT00079677|17094815|P1|Overall Study|Miscellaneous|2
4977944|NCT00079677|17094814|P2|Overall Study|Withdrawal by Subject|3
4977945|NCT00079677|17094815|P1|Overall Study|Withdrawal by Subject|5
4977946|NCT00079677|17094814|P2|Overall Study|Protocol Violation|3
4977947|NCT00079677|17094815|P1|Overall Study|Protocol Violation|2
4977948|NCT00079677|17094814|P2|Overall Study|Physician Decision|0
4977949|NCT00079677|17094815|P1|Overall Study|Physician Decision|3
4977950|NCT00079677|17094814|P2|Overall Study|Lost to Follow-up|2
4977951|NCT00079677|17094815|P1|Overall Study|Lost to Follow-up|2
4977952|NCT00079677|17094814|P2|Overall Study|Lack of Efficacy|0
4977953|NCT00079677|17094815|P1|Overall Study|Lack of Efficacy|1
4977954|NCT00079677|17094814|P2|Overall Study|Adverse Event|6
4977955|NCT00079677|17094815|P1|Overall Study|Adverse Event|5
4977956|NCT00079417|17094831|P1|Overall Study|Ineligible|7
4977957|NCT00079417|17094831|P1|Overall Study|Physician Decision|2
4977958|NCT00079391|17094839|P1|Overall Study|Withdrawal by Subject|1
4977959|NCT00079339|17094851|P3|Overall Study|Disease progression|2
4977960|NCT00079339|17094852|P2|Overall Study|Disease progression|28
4977961|NCT00079339|17094853|P1|Overall Study|Disease progression|3
4977962|NCT00079339|17094851|P3|Overall Study|Withdrawal by Subject|1
4977963|NCT00079339|17094852|P2|Overall Study|Withdrawal by Subject|4
4977964|NCT00079339|17094853|P1|Overall Study|Withdrawal by Subject|0
4977965|NCT00079339|17094851|P3|Overall Study|Non-compliance|1
4977966|NCT00079339|17094852|P2|Overall Study|Non-compliance|0
4977967|NCT00079339|17094853|P1|Overall Study|Non-compliance|0
4977968|NCT00079339|17094851|P3|Overall Study|Death|0
4977969|NCT00079339|17094852|P2|Overall Study|Death|0
4977970|NCT00079339|17094853|P1|Overall Study|Death|1
4977971|NCT00079339|17094851|P3|Overall Study|Adverse Event|2
4977972|NCT00079339|17094852|P2|Overall Study|Adverse Event|7
4977973|NCT00079339|17094853|P1|Overall Study|Adverse Event|1
4977974|NCT00079274|17094884|P7|Overall Study|Other|0
4977975|NCT00079274|17094885|P6|Overall Study|Other|2
4977976|NCT00079274|17094886|P5|Overall Study|Other|1
4977977|NCT00079274|17094887|P4|Overall Study|Other|55
4977978|NCT00079274|17094888|P3|Overall Study|Other|5
4977979|NCT00079274|17094889|P2|Overall Study|Other|7
4977980|NCT00079274|17094890|P1|Overall Study|Other|43
4977981|NCT00079274|17094884|P7|Overall Study|Cytogenetic resistance|0
4977982|NCT00079274|17094885|P6|Overall Study|Cytogenetic resistance|0
4977983|NCT00079274|17094886|P5|Overall Study|Cytogenetic resistance|0
4977984|NCT00079274|17094887|P4|Overall Study|Cytogenetic resistance|2
4977985|NCT00079274|17094888|P3|Overall Study|Cytogenetic resistance|0
4977986|NCT00079274|17094889|P2|Overall Study|Cytogenetic resistance|0
4977987|NCT00079274|17094890|P1|Overall Study|Cytogenetic resistance|0
4977988|NCT00079274|17094884|P7|Overall Study|Death|0
4977989|NCT00079274|17094885|P6|Overall Study|Death|0
4977990|NCT00079274|17094886|P5|Overall Study|Death|0
4977991|NCT00079274|17094887|P4|Overall Study|Death|15
4977992|NCT00079274|17094888|P3|Overall Study|Death|1
4977993|NCT00079274|17094889|P2|Overall Study|Death|0
4977994|NCT00079274|17094890|P1|Overall Study|Death|4
4977995|NCT00079274|17094884|P7|Overall Study|Other Medical Problems|0
4977996|NCT00079274|17094885|P6|Overall Study|Other Medical Problems|0
4977997|NCT00079274|17094886|P5|Overall Study|Other Medical Problems|0
4977998|NCT00079274|17094887|P4|Overall Study|Other Medical Problems|7
4977999|NCT00079274|17094888|P3|Overall Study|Other Medical Problems|0
4978000|NCT00079274|17094889|P2|Overall Study|Other Medical Problems|1
4978001|NCT00079274|17094890|P1|Overall Study|Other Medical Problems|6
4978002|NCT00079274|17094884|P7|Overall Study|Alternate Treatment|0
4978003|NCT00079274|17094885|P6|Overall Study|Alternate Treatment|0
4978004|NCT00079274|17094886|P5|Overall Study|Alternate Treatment|0
4978005|NCT00079274|17094887|P4|Overall Study|Alternate Treatment|3
4978006|NCT00079274|17094888|P3|Overall Study|Alternate Treatment|0
4978007|NCT00079274|17094889|P2|Overall Study|Alternate Treatment|1
4978008|NCT00079274|17094890|P1|Overall Study|Alternate Treatment|6
4978009|NCT00079274|17094884|P7|Overall Study|Recurrence|0
4978010|NCT00079274|17094885|P6|Overall Study|Recurrence|2
4978011|NCT00079274|17094886|P5|Overall Study|Recurrence|0
4978012|NCT00079274|17094887|P4|Overall Study|Recurrence|15
4978013|NCT00079274|17094888|P3|Overall Study|Recurrence|1
4978014|NCT00079274|17094889|P2|Overall Study|Recurrence|0
4978015|NCT00079274|17094890|P1|Overall Study|Recurrence|21
4978016|NCT00079274|17094884|P7|Overall Study|Adverse Event|0
4978017|NCT00079274|17094885|P6|Overall Study|Adverse Event|8
4978018|NCT00079274|17094886|P5|Overall Study|Adverse Event|7
4978019|NCT00079274|17094887|P4|Overall Study|Adverse Event|184
4978020|NCT00079274|17094888|P3|Overall Study|Adverse Event|8
4978021|NCT00079274|17094889|P2|Overall Study|Adverse Event|8
4978022|NCT00079274|17094890|P1|Overall Study|Adverse Event|130
4978023|NCT00079274|17094884|P7|Overall Study|Withdrawal by Subject|0
4978024|NCT00079274|17094885|P6|Overall Study|Withdrawal by Subject|8
4978025|NCT00079274|17094886|P5|Overall Study|Withdrawal by Subject|7
4978026|NCT00079274|17094887|P4|Overall Study|Withdrawal by Subject|163
4978027|NCT00079274|17094888|P3|Overall Study|Withdrawal by Subject|12
4978028|NCT00079274|17094889|P2|Overall Study|Withdrawal by Subject|10
4978029|NCT00079274|17094890|P1|Overall Study|Withdrawal by Subject|111
4978030|NCT00079183|17094911|P1|Overall Study|Specimen collection non-compliance|1
4978031|NCT00079183|17094911|P1|Overall Study|Study medication non-compliance|2
4978032|NCT00079183|17094911|P1|Overall Study|Withdrawal by Subject|4
4978033|NCT00079040|17094926|P1|Overall Study|Ineligible|1
4978034|NCT00079040|17094926|P1|Overall Study|Withdrew before treatment|1
4978035|NCT00078949|17094949|P4|Overall Study|No treated|3
4978036|NCT00078949|17094950|P3|Overall Study|No treated|3
4978037|NCT00078949|17094951|P2|Overall Study|No treated|5
4978038|NCT00078949|17094952|P1|Overall Study|No treated|4
4978039|NCT00078819|17094981|P4|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1
4978040|NCT00078819|17094982|P3|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
4978041|NCT00078819|17094983|P2|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
4978042|NCT00078819|17094984|P1|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0
4978043|NCT00078819|17094981|P4|Withdrawal Period: Weeks 37-48|Entered Retreatment|13
4978044|NCT00078819|17094982|P3|Withdrawal Period: Weeks 37-48|Entered Retreatment|29
4978045|NCT00078819|17094983|P2|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
4978046|NCT00078819|17094984|P1|Withdrawal Period: Weeks 37-48|Entered Retreatment|0
4978047|NCT00078819|17094981|P4|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
4978048|NCT00078819|17094982|P3|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0
4978049|NCT00078819|17094983|P2|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25
4978050|NCT00078819|17094984|P1|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34
4978051|NCT00078819|17094981|P4|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
4978052|NCT00078819|17094982|P3|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0
4978053|NCT00078819|17094983|P2|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
4978054|NCT00078819|17094984|P1|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2
4978055|NCT00078819|17094981|P4|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
4978056|NCT00078819|17094982|P3|Open-label Treatment Period: Weeks 13-36|Adverse Event|0
4978057|NCT00078819|17094983|P2|Open-label Treatment Period: Weeks 13-36|Adverse Event|2
4978058|NCT00078819|17094984|P1|Open-label Treatment Period: Weeks 13-36|Adverse Event|3
4978059|NCT00078819|17094981|P4|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
4978060|NCT00078819|17094982|P3|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0
4978061|NCT00078819|17094983|P2|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
4978062|NCT00078819|17094984|P1|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1
4978063|NCT00078819|17094981|P4|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
4978064|NCT00078819|17094982|P3|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
4978065|NCT00078819|17094983|P2|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0
4978066|NCT00078819|17094984|P1|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1
4978067|NCT00078819|17094981|P4|Double-blind Treatment Period: Week 1-12|Adverse Event|0
4978068|NCT00078819|17094982|P3|Double-blind Treatment Period: Week 1-12|Adverse Event|0
4978069|NCT00078819|17094983|P2|Double-blind Treatment Period: Week 1-12|Adverse Event|1
4978070|NCT00078819|17094984|P1|Double-blind Treatment Period: Week 1-12|Adverse Event|0
4978071|NCT00078806|17095009|P4|Part 2|Adverse Event|0
4978072|NCT00078806|17095010|P3|Part 2|Adverse Event|0
4978073|NCT00078806|17095011|P2|Part 2|Adverse Event|1
4978074|NCT00078806|17095012|P1|Part 2|Adverse Event|0
4978075|NCT00078806|17095009|P4|Part 1B|Lack of Efficacy|0
4978076|NCT00078806|17095010|P3|Part 1B|Lack of Efficacy|0
4978077|NCT00078806|17095011|P2|Part 1B|Lack of Efficacy|0
4978078|NCT00078806|17095012|P1|Part 1B|Lack of Efficacy|7
4978079|NCT00078806|17095009|P4|Part 1B|Adverse Event|0
4978080|NCT00078806|17095010|P3|Part 1B|Adverse Event|0
4978081|NCT00078806|17095011|P2|Part 1B|Adverse Event|0
4978082|NCT00078806|17095012|P1|Part 1B|Adverse Event|1
4978083|NCT00078806|17095009|P4|Part 1A|Other|0
4978084|NCT00078806|17095010|P3|Part 1A|Other|0
4978085|NCT00078806|17095011|P2|Part 1A|Other|0
4978086|NCT00078806|17095012|P1|Part 1A|Other|1
4978087|NCT00078806|17095009|P4|Part 1A|Lack of Efficacy|0
4978088|NCT00078806|17095010|P3|Part 1A|Lack of Efficacy|0
4978089|NCT00078806|17095011|P2|Part 1A|Lack of Efficacy|0
4978090|NCT00078806|17095012|P1|Part 1A|Lack of Efficacy|7
4978091|NCT00078806|17095009|P4|Part 1A|Adverse Event|0
4978092|NCT00078806|17095010|P3|Part 1A|Adverse Event|0
4978093|NCT00078806|17095011|P2|Part 1A|Adverse Event|0
4978094|NCT00078806|17095012|P1|Part 1A|Adverse Event|2
4978095|NCT00078767|17095048|P2|Overall Study|Withdrawal by Subject|1
4978096|NCT00078767|17095049|P1|Overall Study|Withdrawal by Subject|1
4978097|NCT00005947|17095096|P2|Overall Study|Site Closure|0
4978098|NCT00005947|17095097|P1|Overall Study|Site Closure|1
4978099|NCT00005947|17095096|P2|Overall Study|Patient Refused to Continue|1
4978100|NCT00005947|17095097|P1|Overall Study|Patient Refused to Continue|2
4978101|NCT00005947|17095096|P2|Overall Study|Death|40
4978102|NCT00005947|17095097|P1|Overall Study|Death|54
4978103|NCT00002597|17095133|P2|Overall Study|Withdrawal by Subject|6
4978104|NCT00002597|17095134|P1|Overall Study|Withdrawal by Subject|7
4978105|NCT00002597|17095133|P2|Overall Study|Protocol Violation|17
4978106|NCT00002597|17095134|P1|Overall Study|Protocol Violation|19
4978107|NCT00078377|17095159|P3|Overall Study|Miscellaneous|1
4978108|NCT00078377|17095160|P2|Overall Study|Miscellaneous|6
4978109|NCT00078377|17095161|P1|Overall Study|Miscellaneous|2
4978110|NCT00078377|17095159|P3|Overall Study|Withdrawal by Subject|4
4978111|NCT00078377|17095160|P2|Overall Study|Withdrawal by Subject|4
4978112|NCT00078377|17095161|P1|Overall Study|Withdrawal by Subject|3
4978113|NCT00078377|17095159|P3|Overall Study|Physician Decision|0
4978114|NCT00078377|17095160|P2|Overall Study|Physician Decision|0
4978115|NCT00078377|17095161|P1|Overall Study|Physician Decision|2
4978116|NCT00078377|17095159|P3|Overall Study|Lost to Follow-up|1
4978117|NCT00078377|17095160|P2|Overall Study|Lost to Follow-up|1
4978118|NCT00078377|17095161|P1|Overall Study|Lost to Follow-up|0
4978119|NCT00078377|17095159|P3|Overall Study|Lack of Efficacy|2
4978120|NCT00078377|17095160|P2|Overall Study|Lack of Efficacy|0
4978121|NCT00078377|17095161|P1|Overall Study|Lack of Efficacy|2
4978122|NCT00078377|17095159|P3|Overall Study|Adverse Event|1
4978123|NCT00078377|17095160|P2|Overall Study|Adverse Event|5
4978124|NCT00078377|17095161|P1|Overall Study|Adverse Event|2
4978125|NCT00078338|17095176|P2|Overall Study|Subjects randomized, but not treated|3
4978126|NCT00078338|17095177|P1|Overall Study|Subjects randomized, but not treated|3
4978127|NCT00078338|17095176|P2|Overall Study|Other|16
4978128|NCT00078338|17095177|P1|Overall Study|Other|28
4978129|NCT00078338|17095176|P2|Overall Study|Disease Progression|7
4978130|NCT00078338|17095177|P1|Overall Study|Disease Progression|4
4978131|NCT00078338|17095176|P2|Overall Study|Protocol Violation|2
4978132|NCT00078338|17095177|P1|Overall Study|Protocol Violation|2
4978133|NCT00078338|17095176|P2|Overall Study|Lost to Follow-up|2
4978134|NCT00078338|17095177|P1|Overall Study|Lost to Follow-up|17
4978135|NCT00078338|17095176|P2|Overall Study|Adverse Event|24
4978136|NCT00078338|17095177|P1|Overall Study|Adverse Event|31
4978137|NCT00078325|17095270|P3|Overall Study|Miscellaneous|1
4978138|NCT00078325|17095271|P2|Overall Study|Miscellaneous|1
4978139|NCT00078325|17095272|P1|Overall Study|Miscellaneous|1
4978140|NCT00078325|17095270|P3|Overall Study|Physician Decision|1
4978141|NCT00078325|17095271|P2|Overall Study|Physician Decision|0
4978142|NCT00078325|17095272|P1|Overall Study|Physician Decision|2
4978143|NCT00078325|17095270|P3|Overall Study|Lost to Follow-up|1
4978144|NCT00078325|17095271|P2|Overall Study|Lost to Follow-up|1
4978145|NCT00078325|17095272|P1|Overall Study|Lost to Follow-up|0
4978146|NCT00078325|17095270|P3|Overall Study|Withdrawal by Subject|3
4978147|NCT00078325|17095271|P2|Overall Study|Withdrawal by Subject|5
4978148|NCT00078325|17095272|P1|Overall Study|Withdrawal by Subject|1
4978149|NCT00078325|17095270|P3|Overall Study|Protocol Violation|0
4978150|NCT00078325|17095271|P2|Overall Study|Protocol Violation|2
4978151|NCT00078325|17095272|P1|Overall Study|Protocol Violation|2
4978152|NCT00078325|17095270|P3|Overall Study|Adverse Event|5
4978153|NCT00078325|17095271|P2|Overall Study|Adverse Event|10
4978154|NCT00078325|17095272|P1|Overall Study|Adverse Event|15
4978155|NCT00078312|17095283|P1|Overall Study|Miscellaneous|33
4978156|NCT00078312|17095283|P1|Overall Study|Withdrawal by Subject|33
4978157|NCT00078312|17095283|P1|Overall Study|Protocol Violation|3
4978158|NCT00078312|17095283|P1|Overall Study|Physician Decision|9
4978159|NCT00078312|17095283|P1|Overall Study|Lost to Follow-up|41
4978160|NCT00078312|17095283|P1|Overall Study|Lack of Efficacy|15
4978161|NCT00078312|17095283|P1|Overall Study|Adverse Event|43
4978162|NCT00077974|17095298|P1|Overall Study|Decision of Sponsor|2
4978163|NCT00077974|17095298|P1|Overall Study|Lack of Efficacy|76
4978164|NCT00077974|17095298|P1|Overall Study|Withdrawal by Subject|3
4978165|NCT00077974|17095298|P1|Overall Study|Protocol Violation|1
4978166|NCT00077974|17095298|P1|Overall Study|Adverse Event|22
4978167|NCT00077857|17095315|P2|Overall Study|Other|13
4978168|NCT00077857|17095316|P1|Overall Study|Other|15
4978169|NCT00077857|17095315|P2|Overall Study|Failure to return|5
4978170|NCT00077857|17095316|P1|Overall Study|Failure to return|5
4978171|NCT00077857|17095315|P2|Overall Study|Refused treatment|21
4978172|NCT00077857|17095316|P1|Overall Study|Refused treatment|29
4978173|NCT00077857|17095315|P2|Overall Study|Other protocol violation|1
4978174|NCT00077857|17095316|P1|Overall Study|Other protocol violation|0
4978175|NCT00077857|17095315|P2|Overall Study|Violation of selection criteria at entry|1
4978176|NCT00077857|17095316|P1|Overall Study|Violation of selection criteria at entry|3
4978177|NCT00077857|17095315|P2|Overall Study|Insufficient therapeutic response|128
4978178|NCT00077857|17095316|P1|Overall Study|Insufficient therapeutic response|112
4978179|NCT00077857|17095315|P2|Overall Study|Death|3
4978180|NCT00077857|17095316|P1|Overall Study|Death|7
4978181|NCT00077857|17095315|P2|Overall Study|Adverse Event|32
4978182|NCT00077857|17095316|P1|Overall Study|Adverse Event|30
4978183|NCT00077766|17095336|P2|Overall Study|Participants Vacation|1
4978184|NCT00077766|17095337|P1|Overall Study|Participants Vacation|2
4978185|NCT00077766|17095336|P2|Overall Study|Stop Dialysis|1
4978186|NCT00077766|17095337|P1|Overall Study|Stop Dialysis|0
4978187|NCT00077766|17095336|P2|Overall Study|Started Nocturnal Dialysis|1
4978188|NCT00077766|17095337|P1|Overall Study|Started Nocturnal Dialysis|0
4978189|NCT00077766|17095336|P2|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1
4978190|NCT00077766|17095337|P1|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0
4978191|NCT00077766|17095336|P2|Overall Study|Dialysis|1
4978192|NCT00077766|17095337|P1|Overall Study|Dialysis|0
4978193|NCT00077766|17095336|P2|Overall Study|Dialysis Discontinued|0
4978194|NCT00077766|17095337|P1|Overall Study|Dialysis Discontinued|1
4978195|NCT00077766|17095336|P2|Overall Study|Participant's decision|0
4978196|NCT00077766|17095337|P1|Overall Study|Participant's decision|1
4978197|NCT00077766|17095336|P2|Overall Study|Investigators Discretion|0
4978198|NCT00077766|17095337|P1|Overall Study|Investigators Discretion|1
4978199|NCT00077766|17095336|P2|Overall Study|Transplantation|1
4978200|NCT00077766|17095337|P1|Overall Study|Transplantation|5
4978201|NCT00077766|17095336|P2|Overall Study|Kidney Transplantation|5
4978202|NCT00077766|17095337|P1|Overall Study|Kidney Transplantation|9
4978203|NCT00077766|17095336|P2|Overall Study|Protocol Violation|0
4978204|NCT00077766|17095337|P1|Overall Study|Protocol Violation|1
4978205|NCT00077766|17095336|P2|Overall Study|Lost to Follow-up|0
4978206|NCT00077766|17095337|P1|Overall Study|Lost to Follow-up|2
4978207|NCT00077766|17095336|P2|Overall Study|Death|10
4978208|NCT00077766|17095337|P1|Overall Study|Death|12
4978209|NCT00077766|17095336|P2|Overall Study|Withdrawal by Subject|3
4978210|NCT00077766|17095337|P1|Overall Study|Withdrawal by Subject|4
4978211|NCT00077766|17095336|P2|Overall Study|Adverse Event|1
4978212|NCT00077766|17095337|P1|Overall Study|Adverse Event|1
4978213|NCT00077675|17095362|P2|Overall Study|Never received study treatment|3
4978214|NCT00077675|17095363|P1|Overall Study|Never received study treatment|3
4978215|NCT00077675|17095362|P2|Overall Study|Other|1
4978216|NCT00077675|17095363|P1|Overall Study|Other|0
4978217|NCT00077675|17095362|P2|Overall Study|Withdrawal by Subject|0
4978218|NCT00077675|17095363|P1|Overall Study|Withdrawal by Subject|1
4978219|NCT00077675|17095362|P2|Overall Study|Lost to Follow-up|3
4978220|NCT00077675|17095363|P1|Overall Study|Lost to Follow-up|6
4978221|NCT00077675|17095362|P2|Overall Study|Adverse Event|2
4978222|NCT00077675|17095363|P1|Overall Study|Adverse Event|1
4978223|NCT00077649|17095373|P4|Overall Study|Randomized but never dosed|0
4978224|NCT00077649|17095374|P3|Overall Study|Randomized but never dosed|0
4978225|NCT00077649|17095375|P2|Overall Study|Randomized but never dosed|0
4978226|NCT00077649|17095376|P1|Overall Study|Randomized but never dosed|1
4978227|NCT00077649|17095373|P4|Overall Study|Abnormality of Laboratory Test|2
4978228|NCT00077649|17095374|P3|Overall Study|Abnormality of Laboratory Test|1
4978229|NCT00077649|17095375|P2|Overall Study|Abnormality of Laboratory Test|2
4978230|NCT00077649|17095376|P1|Overall Study|Abnormality of Laboratory Test|1
4978231|NCT00077649|17095373|P4|Overall Study|Lost to Follow-up|2
4978232|NCT00077649|17095374|P3|Overall Study|Lost to Follow-up|3
4978233|NCT00077649|17095375|P2|Overall Study|Lost to Follow-up|2
4978234|NCT00077649|17095376|P1|Overall Study|Lost to Follow-up|2
4978235|NCT00077649|17095373|P4|Overall Study|Withdrawal by Subject|2
4978236|NCT00077649|17095374|P3|Overall Study|Withdrawal by Subject|1
4978237|NCT00077649|17095375|P2|Overall Study|Withdrawal by Subject|1
4978238|NCT00077649|17095376|P1|Overall Study|Withdrawal by Subject|0
4978239|NCT00077649|17095373|P4|Overall Study|Lack of Efficacy|2
4978240|NCT00077649|17095374|P3|Overall Study|Lack of Efficacy|3
4978241|NCT00077649|17095375|P2|Overall Study|Lack of Efficacy|3
4978242|NCT00077649|17095376|P1|Overall Study|Lack of Efficacy|5
4978243|NCT00077649|17095373|P4|Overall Study|Adverse Event|9
4978244|NCT00077649|17095374|P3|Overall Study|Adverse Event|7
4978245|NCT00077649|17095375|P2|Overall Study|Adverse Event|1
4978246|NCT00077649|17095376|P1|Overall Study|Adverse Event|5
4978247|NCT00077636|17095424|P2|Overall Study|Abnormality Of Laboratory Test|2
4978248|NCT00077636|17095425|P1|Overall Study|Abnormality Of Laboratory Test|3
4978249|NCT00077636|17095424|P2|Overall Study|Lost to Follow-up|18
4978250|NCT00077636|17095425|P1|Overall Study|Lost to Follow-up|10
4978251|NCT00077636|17095424|P2|Overall Study|Protocol Violation|2
4978252|NCT00077636|17095425|P1|Overall Study|Protocol Violation|0
4978253|NCT00077636|17095424|P2|Overall Study|Adverse Event|34
4978254|NCT00077636|17095425|P1|Overall Study|Adverse Event|17
4978255|NCT00077636|17095424|P2|Overall Study|Withdrawal by Subject|2
4978256|NCT00077636|17095425|P1|Overall Study|Withdrawal by Subject|2
4978257|NCT00077636|17095424|P2|Overall Study|Admin|3
4978258|NCT00077636|17095425|P1|Overall Study|Admin|3
4978259|NCT00077636|17095424|P2|Overall Study|Refused Treatment|31
4978260|NCT00077636|17095425|P1|Overall Study|Refused Treatment|9
4978261|NCT00077623|17095446|P3|Overall Study|Failure to return|0
4978262|NCT00077623|17095447|P2|Overall Study|Failure to return|0
4978263|NCT00077623|17095448|P1|Overall Study|Failure to return|1
4978264|NCT00077623|17095446|P3|Overall Study|Death|11
4978265|NCT00077623|17095447|P2|Overall Study|Death|18
4978266|NCT00077623|17095448|P1|Overall Study|Death|12
4978267|NCT00077623|17095446|P3|Overall Study|Insufficient therapeutic response|0
4978268|NCT00077623|17095447|P2|Overall Study|Insufficient therapeutic response|0
4978269|NCT00077623|17095448|P1|Overall Study|Insufficient therapeutic response|2
4978270|NCT00077623|17095446|P3|Overall Study|Other-Non safety reason|19
4978271|NCT00077623|17095447|P2|Overall Study|Other-Non safety reason|15
4978272|NCT00077623|17095448|P1|Overall Study|Other-Non safety reason|18
4978273|NCT00077623|17095446|P3|Overall Study|Withdrawal by Subject|1
4978274|NCT00077623|17095447|P2|Overall Study|Withdrawal by Subject|10
4978275|NCT00077623|17095448|P1|Overall Study|Withdrawal by Subject|2
4978276|NCT00077623|17095446|P3|Overall Study|Adverse Event|1
4978277|NCT00077623|17095447|P2|Overall Study|Adverse Event|0
4978278|NCT00077623|17095448|P1|Overall Study|Adverse Event|1
4978279|NCT00077610|17095483|P3|Overall Study|Sponsors decision to withdraw|1
4978280|NCT00077610|17095484|P2|Overall Study|Sponsors decision to withdraw|0
4978281|NCT00077610|17095485|P1|Overall Study|Sponsors decision to withdraw|0
4978282|NCT00077610|17095483|P3|Overall Study|Financial issues|0
4978283|NCT00077610|17095484|P2|Overall Study|Financial issues|1
4978284|NCT00077610|17095485|P1|Overall Study|Financial issues|0
4978285|NCT00077610|17095483|P3|Overall Study|Relocation|5
4978286|NCT00077610|17095484|P2|Overall Study|Relocation|8
4978287|NCT00077610|17095485|P1|Overall Study|Relocation|0
4978288|NCT00077610|17095483|P3|Overall Study|Change in dialysis modality|0
4978289|NCT00077610|17095484|P2|Overall Study|Change in dialysis modality|0
4978290|NCT00077610|17095485|P1|Overall Study|Change in dialysis modality|1
4978291|NCT00077610|17095483|P3|Overall Study|Transfer to other center for surgery|0
4978292|NCT00077610|17095484|P2|Overall Study|Transfer to other center for surgery|0
4978293|NCT00077610|17095485|P1|Overall Study|Transfer to other center for surgery|1
4978294|NCT00077610|17095483|P3|Overall Study|Transfer to satellite unit|0
4978295|NCT00077610|17095484|P2|Overall Study|Transfer to satellite unit|0
4978296|NCT00077610|17095485|P1|Overall Study|Transfer to satellite unit|1
4978297|NCT00077610|17095483|P3|Overall Study|Transferred to nursing home|1
4978298|NCT00077610|17095484|P2|Overall Study|Transferred to nursing home|0
4978299|NCT00077610|17095485|P1|Overall Study|Transferred to nursing home|0
4978300|NCT00077610|17095483|P3|Overall Study|Transferred to other unit|1
4978301|NCT00077610|17095484|P2|Overall Study|Transferred to other unit|0
4978302|NCT00077610|17095485|P1|Overall Study|Transferred to other unit|0
4978303|NCT00077610|17095483|P3|Overall Study|Given Epogen in hospital|0
4978304|NCT00077610|17095484|P2|Overall Study|Given Epogen in hospital|0
4978305|NCT00077610|17095485|P1|Overall Study|Given Epogen in hospital|1
4978306|NCT00077610|17095483|P3|Overall Study|Worsening of health condition|0
4978307|NCT00077610|17095484|P2|Overall Study|Worsening of health condition|1
4978308|NCT00077610|17095485|P1|Overall Study|Worsening of health condition|1
4978309|NCT00077610|17095483|P3|Overall Study|Principal Investigator's decision|1
4978310|NCT00077610|17095484|P2|Overall Study|Principal Investigator's decision|0
4978311|NCT00077610|17095485|P1|Overall Study|Principal Investigator's decision|1
4978312|NCT00077610|17095483|P3|Overall Study|Multiple blood transfusions|1
4978313|NCT00077610|17095484|P2|Overall Study|Multiple blood transfusions|0
4978314|NCT00077610|17095485|P1|Overall Study|Multiple blood transfusions|0
4978315|NCT00077610|17095483|P3|Overall Study|Insufficient Therapeutic Response|0
4978316|NCT00077610|17095484|P2|Overall Study|Insufficient Therapeutic Response|0
4978317|NCT00077610|17095485|P1|Overall Study|Insufficient Therapeutic Response|1
4978318|NCT00077610|17095483|P3|Overall Study|Withdrew from dialysis care|3
4978319|NCT00077610|17095484|P2|Overall Study|Withdrew from dialysis care|0
4978320|NCT00077610|17095485|P1|Overall Study|Withdrew from dialysis care|5
4978321|NCT00077610|17095483|P3|Overall Study|Renal transplant|11
4978322|NCT00077610|17095484|P2|Overall Study|Renal transplant|15
4978323|NCT00077610|17095485|P1|Overall Study|Renal transplant|12
4978324|NCT00077610|17095483|P3|Overall Study|Death|13
4978325|NCT00077610|17095484|P2|Overall Study|Death|13
4978326|NCT00077610|17095485|P1|Overall Study|Death|17
4978327|NCT00077610|17095483|P3|Overall Study|Withdrawal by Subject|6
4978328|NCT00077610|17095484|P2|Overall Study|Withdrawal by Subject|10
4978329|NCT00077610|17095485|P1|Overall Study|Withdrawal by Subject|4
4978330|NCT00077610|17095483|P3|Overall Study|Lost to Follow-up|2
4978331|NCT00077610|17095484|P2|Overall Study|Lost to Follow-up|1
4978332|NCT00077610|17095485|P1|Overall Study|Lost to Follow-up|0
4978333|NCT00077610|17095483|P3|Overall Study|Adverse Event|1
4978334|NCT00077610|17095484|P2|Overall Study|Adverse Event|7
4978335|NCT00077610|17095485|P1|Overall Study|Adverse Event|9
4978336|NCT00077376|17095514|P1|Overall Study|Insurance ran out|1
4978337|NCT00077376|17095514|P1|Overall Study|Surgery|1
4978338|NCT00077376|17095514|P1|Overall Study|Symptomatic deterioration|1
4978339|NCT00077376|17095514|P1|Overall Study|Still on treatment|1
4978340|NCT00077376|17095514|P1|Overall Study|Complicating disease|1
4978341|NCT00077376|17095514|P1|Overall Study|Alternative therapy|5
4978342|NCT00077376|17095514|P1|Overall Study|Physician Decision|1
4978343|NCT00077376|17095514|P1|Overall Study|Death|1
4978344|NCT00077376|17095514|P1|Overall Study|Withdrawal by Subject|2
4978345|NCT00077376|17095514|P1|Overall Study|Adverse Event|8
4978346|NCT00077207|17095525|P1|Overall Study|Ineligible|1
4978347|NCT00077207|17095525|P1|Overall Study|Withdrawal by Subject|6
4978348|NCT00077207|17095525|P1|Overall Study|Physician Decision|6
4978349|NCT00077207|17095525|P1|Overall Study|Lack of Efficacy|12
4978350|NCT00077207|17095525|P1|Overall Study|Adverse Event|5
4978351|NCT00077064|17095537|P2|Overall Study|Patient refusal|2
4978352|NCT00077064|17095538|P1|Overall Study|Patient refusal|0
4978353|NCT00077064|17095537|P2|Overall Study|Adverse Event|4
4978354|NCT00077064|17095538|P1|Overall Study|Adverse Event|0
4978355|NCT00076999|17095554|P5|Overall Study|Other reason (not specified)|13
4978356|NCT00076999|17095555|P4|Overall Study|Other reason (not specified)|1
4978357|NCT00076999|17095556|P3|Overall Study|Other reason (not specified)|4
4978358|NCT00076999|17095557|P2|Overall Study|Other reason (not specified)|8
4978359|NCT00076999|17095558|P1|Overall Study|Other reason (not specified)|8
4978360|NCT00076999|17095554|P5|Overall Study|Withdrawal by Subject|1
4978361|NCT00076999|17095555|P4|Overall Study|Withdrawal by Subject|0
4978362|NCT00076999|17095556|P3|Overall Study|Withdrawal by Subject|3
4978363|NCT00076999|17095557|P2|Overall Study|Withdrawal by Subject|4
4978364|NCT00076999|17095558|P1|Overall Study|Withdrawal by Subject|0
4978365|NCT00076999|17095554|P5|Overall Study|Lost to Follow-up|0
4978366|NCT00076999|17095555|P4|Overall Study|Lost to Follow-up|0
4978367|NCT00076999|17095556|P3|Overall Study|Lost to Follow-up|0
4978368|NCT00076999|17095557|P2|Overall Study|Lost to Follow-up|1
4978369|NCT00076999|17095558|P1|Overall Study|Lost to Follow-up|2
4978370|NCT00076999|17095554|P5|Overall Study|Protocol Violation|9
4978371|NCT00076999|17095555|P4|Overall Study|Protocol Violation|0
4978372|NCT00076999|17095556|P3|Overall Study|Protocol Violation|4
4978373|NCT00076999|17095557|P2|Overall Study|Protocol Violation|3
4978374|NCT00076999|17095558|P1|Overall Study|Protocol Violation|0
4978375|NCT00076999|17095554|P5|Overall Study|Adverse Event|2
4978376|NCT00076999|17095555|P4|Overall Study|Adverse Event|0
4978377|NCT00076999|17095556|P3|Overall Study|Adverse Event|6
4978378|NCT00076999|17095557|P2|Overall Study|Adverse Event|8
4978379|NCT00076999|17095558|P1|Overall Study|Adverse Event|2
4978380|NCT00003222|17095677|P2|Overall Study|Physician Decision|1
4978381|NCT00003222|17095678|P1|Overall Study|Physician Decision|0
4978382|NCT00076804|17095690|P2|Overall Study|Early study Closure|32
4978383|NCT00076804|17095691|P1|Overall Study|Early study Closure|32
4978384|NCT00076804|17095690|P2|Overall Study|Withdrawal by Subject|8
4978385|NCT00076804|17095691|P1|Overall Study|Withdrawal by Subject|10
4978386|NCT00076804|17095690|P2|Overall Study|Lost to Follow-up|9
4978387|NCT00076804|17095691|P1|Overall Study|Lost to Follow-up|9
4978388|NCT00076804|17095690|P2|Overall Study|Death|20
4978389|NCT00076804|17095691|P1|Overall Study|Death|9
4978390|NCT00076752|17095703|P1|Overall Study|Withdrawal per PI, PI put study on hold|1
4978391|NCT00076752|17095703|P1|Overall Study|Death|2
4978392|NCT00076570|17095749|P2|Overall Study|Drug intolerance|8
4978393|NCT00076570|17095750|P1|Overall Study|Drug intolerance|8
4978394|NCT00003298|17095758|P1|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2
4978395|NCT00003298|17095758|P1|Step 2 (Adjuvant Therapy)|Excessive complication|1
4978396|NCT00003298|17095758|P1|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1
4978397|NCT00003298|17095758|P1|Step 2 (Adjuvant Therapy)|Death|1
4978398|NCT00003298|17095758|P1|Step 2 (Adjuvant Therapy)|Ineligible|1
4978399|NCT00003298|17095758|P1|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3
4978400|NCT00003298|17095758|P1|Re-register to Step 2 After Surgery|Reason unknown|1
4978401|NCT00003298|17095758|P1|Re-register to Step 2 After Surgery|Other complications|2
4978402|NCT00003298|17095758|P1|Re-register to Step 2 After Surgery|Positive margins|5
4978403|NCT00003298|17095758|P1|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7
4978404|NCT00003298|17095758|P1|Surgery|Unevaluable and off study|2
4978405|NCT00003298|17095758|P1|Surgery|Progression before surgery|2
4978406|NCT00003298|17095758|P1|Surgery|Unresectable at surgery|3
4978407|NCT00003298|17095758|P1|Step 1 (Neoadjuvant Therapy)|Adverse Event|3
4978408|NCT00003298|17095758|P1|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1
4978409|NCT00076336|17095768|P2|Overall Study|Treatment failure|5
4978410|NCT00076336|17095769|P1|Overall Study|Treatment failure|4
4978411|NCT00076336|17095768|P2|Overall Study|Virologic Breakthrough|16
4978412|NCT00076336|17095769|P1|Overall Study|Virologic Breakthrough|14
4978413|NCT00076336|17095768|P2|Overall Study|Liver Transplantation|3
4978414|NCT00076336|17095769|P1|Overall Study|Liver Transplantation|3
4978415|NCT00076336|17095768|P2|Overall Study|Patient, Investigator, Sponsor request|6
4978416|NCT00076336|17095769|P1|Overall Study|Patient, Investigator, Sponsor request|8
4978417|NCT00076336|17095768|P2|Overall Study|Creatinine Clearance < 30 or Dialysis|1
4978418|NCT00076336|17095769|P1|Overall Study|Creatinine Clearance < 30 or Dialysis|0
4978419|NCT00076336|17095768|P2|Overall Study|Non-Compliance|0
4978420|NCT00076336|17095769|P1|Overall Study|Non-Compliance|2
4978421|NCT00076336|17095768|P2|Overall Study|Lost to Follow-up|4
4978422|NCT00076336|17095769|P1|Overall Study|Lost to Follow-up|4
4978423|NCT00076336|17095768|P2|Overall Study|Adverse Event|4
4978424|NCT00076336|17095769|P1|Overall Study|Adverse Event|4
4978425|NCT00076336|17095768|P2|Overall Study|Death|17
4978426|NCT00076336|17095769|P1|Overall Study|Death|13
4978427|NCT00076102|17095822|P1|Overall Study|refusal of further therapy|2
4978428|NCT00076102|17095822|P1|Overall Study|plexiform neurofibroma surgery|1
4978429|NCT00076102|17095822|P1|Overall Study|Progression in pre-existing brain tumor|1
4978430|NCT00076102|17095822|P1|Overall Study|Clinical progression|1
4978431|NCT00076024|17095850|P4|Phase 2, Open-label|Other|2
4978432|NCT00076024|17095851|P3|Phase 2, Open-label|Other|0
4978433|NCT00076024|17095852|P2|Phase 2, Open-label|Other|0
4978434|NCT00076024|17095853|P1|Phase 2, Open-label|Other|0
4978435|NCT00076024|17095850|P4|Phase 2, Open-label|Withdrawal by Subject|1
4978436|NCT00076024|17095851|P3|Phase 2, Open-label|Withdrawal by Subject|0
4978437|NCT00076024|17095852|P2|Phase 2, Open-label|Withdrawal by Subject|0
4978438|NCT00076024|17095853|P1|Phase 2, Open-label|Withdrawal by Subject|0
4978439|NCT00076024|17095850|P4|Phase 2, Open-label|Lack of Efficacy|11
4978440|NCT00076024|17095851|P3|Phase 2, Open-label|Lack of Efficacy|0
4978441|NCT00076024|17095852|P2|Phase 2, Open-label|Lack of Efficacy|0
4978442|NCT00076024|17095853|P1|Phase 2, Open-label|Lack of Efficacy|0
4978443|NCT00076024|17095850|P4|Phase 2, Open-label|Adverse Event|2
4978444|NCT00076024|17095851|P3|Phase 2, Open-label|Adverse Event|0
4978445|NCT00076024|17095852|P2|Phase 2, Open-label|Adverse Event|0
4978446|NCT00076024|17095853|P1|Phase 2, Open-label|Adverse Event|0
4978447|NCT00076024|17095850|P4|Phase 2, Double-blind|Randomized but not treated|0
4978448|NCT00076024|17095851|P3|Phase 2, Double-blind|Randomized but not treated|0
4978449|NCT00076024|17095852|P2|Phase 2, Double-blind|Randomized but not treated|1
4978450|NCT00076024|17095853|P1|Phase 2, Double-blind|Randomized but not treated|0
4978451|NCT00076024|17095850|P4|Phase 2, Double-blind|Un-specified|0
4978452|NCT00076024|17095851|P3|Phase 2, Double-blind|Un-specified|6
4978453|NCT00076024|17095852|P2|Phase 2, Double-blind|Un-specified|14
4978454|NCT00076024|17095853|P1|Phase 2, Double-blind|Un-specified|0
4978455|NCT00076024|17095850|P4|Phase 2, Double-blind|Adverse Event|0
4978456|NCT00076024|17095851|P3|Phase 2, Double-blind|Adverse Event|6
4978457|NCT00076024|17095852|P2|Phase 2, Double-blind|Adverse Event|25
4978458|NCT00076024|17095853|P1|Phase 2, Double-blind|Adverse Event|0
4978459|NCT00076024|17095850|P4|Phase 2, Double-blind|Withdrawal by Subject|0
4978460|NCT00076024|17095851|P3|Phase 2, Double-blind|Withdrawal by Subject|4
4978461|NCT00076024|17095852|P2|Phase 2, Double-blind|Withdrawal by Subject|13
4978462|NCT00076024|17095853|P1|Phase 2, Double-blind|Withdrawal by Subject|0
4978463|NCT00076024|17095850|P4|Phase 2, Double-blind|Lack of Efficacy|0
4978464|NCT00076024|17095851|P3|Phase 2, Double-blind|Lack of Efficacy|40
4978465|NCT00076024|17095852|P2|Phase 2, Double-blind|Lack of Efficacy|59
4978466|NCT00076024|17095853|P1|Phase 2, Double-blind|Lack of Efficacy|0
4978467|NCT00076024|17095850|P4|Phase 1, Lead-in|Clinical progression|0
4978468|NCT00076024|17095851|P3|Phase 1, Lead-in|Clinical progression|0
4978469|NCT00076024|17095852|P2|Phase 1, Lead-in|Clinical progression|0
4978470|NCT00076024|17095853|P1|Phase 1, Lead-in|Clinical progression|1
4978471|NCT00076024|17095850|P4|Phase 1, Lead-in|Adverse Event|0
4978472|NCT00076024|17095851|P3|Phase 1, Lead-in|Adverse Event|0
4978473|NCT00076024|17095852|P2|Phase 1, Lead-in|Adverse Event|0
4978474|NCT00076024|17095853|P1|Phase 1, Lead-in|Adverse Event|1
4978475|NCT00076024|17095850|P4|Phase 1, Lead-in|Lack of Efficacy|0
4978476|NCT00076024|17095851|P3|Phase 1, Lead-in|Lack of Efficacy|0
4978477|NCT00076024|17095852|P2|Phase 1, Lead-in|Lack of Efficacy|0
4978478|NCT00076024|17095853|P1|Phase 1, Lead-in|Lack of Efficacy|4
4978479|NCT00076011|17095867|P1|Overall Study|Ongoing|1
4978480|NCT00076011|17095867|P1|Overall Study|Other|11
4978481|NCT00076011|17095867|P1|Overall Study|Study terminated by sponsor|3
4978482|NCT00076011|17095867|P1|Overall Study|Withdrawal by Subject|1
4978483|NCT00076011|17095867|P1|Overall Study|Lack of Efficacy|25
4978484|NCT00076011|17095867|P1|Overall Study|Adverse Event|10
4978485|NCT00076011|17095867|P1|Overall Study|Death|1
4978486|NCT00075946|17095879|P5|Overall Study|Other|0
4978487|NCT00075946|17095880|P4|Overall Study|Other|2
4978488|NCT00075946|17095881|P3|Overall Study|Other|0
4978489|NCT00075946|17095882|P2|Overall Study|Other|13
4978490|NCT00075946|17095883|P1|Overall Study|Other|5
4978491|NCT00075946|17095879|P5|Overall Study|Time to progression less than 6 months|0
4978492|NCT00075946|17095880|P4|Overall Study|Time to progression less than 6 months|3
4978493|NCT00075946|17095881|P3|Overall Study|Time to progression less than 6 months|8
4978494|NCT00075946|17095882|P2|Overall Study|Time to progression less than 6 months|30
4978495|NCT00075946|17095883|P1|Overall Study|Time to progression less than 6 months|15
4978496|NCT00075946|17095879|P5|Overall Study|No response to retreatment|0
4978497|NCT00075946|17095880|P4|Overall Study|No response to retreatment|0
4978498|NCT00075946|17095881|P3|Overall Study|No response to retreatment|2
4978499|NCT00075946|17095882|P2|Overall Study|No response to retreatment|0
4978500|NCT00075946|17095883|P1|Overall Study|No response to retreatment|23
4978501|NCT00075946|17095879|P5|Overall Study|Other complicating disease|0
4978502|NCT00075946|17095880|P4|Overall Study|Other complicating disease|4
4978503|NCT00075946|17095881|P3|Overall Study|Other complicating disease|1
4978504|NCT00075946|17095882|P2|Overall Study|Other complicating disease|13
4978505|NCT00075946|17095883|P1|Overall Study|Other complicating disease|7
4978506|NCT00075946|17095879|P5|Overall Study|Alternative therapy|0
4978507|NCT00075946|17095880|P4|Overall Study|Alternative therapy|0
4978508|NCT00075946|17095881|P3|Overall Study|Alternative therapy|5
4978509|NCT00075946|17095882|P2|Overall Study|Alternative therapy|2
4978510|NCT00075946|17095883|P1|Overall Study|Alternative therapy|16
4978511|NCT00075946|17095879|P5|Overall Study|Withdrawal by Subject|0
4978512|NCT00075946|17095880|P4|Overall Study|Withdrawal by Subject|9
4978513|NCT00075946|17095881|P3|Overall Study|Withdrawal by Subject|4
4978514|NCT00075946|17095882|P2|Overall Study|Withdrawal by Subject|58
4978515|NCT00075946|17095883|P1|Overall Study|Withdrawal by Subject|23
4978516|NCT00075946|17095879|P5|Overall Study|Death|0
4978517|NCT00075946|17095880|P4|Overall Study|Death|0
4978518|NCT00075946|17095881|P3|Overall Study|Death|0
4978519|NCT00075946|17095882|P2|Overall Study|Death|1
4978520|NCT00075946|17095883|P1|Overall Study|Death|0
4978521|NCT00075946|17095879|P5|Overall Study|Adverse Event|0
4978522|NCT00075946|17095880|P4|Overall Study|Adverse Event|2
4978523|NCT00075946|17095881|P3|Overall Study|Adverse Event|0
4978524|NCT00075946|17095882|P2|Overall Study|Adverse Event|10
4978525|NCT00075946|17095883|P1|Overall Study|Adverse Event|2
4978526|NCT00075946|17095879|P5|Overall Study|Still on treatment at time of analysis|0
4978527|NCT00075946|17095880|P4|Overall Study|Still on treatment at time of analysis|9
4978528|NCT00075946|17095881|P3|Overall Study|Still on treatment at time of analysis|3
4978529|NCT00075946|17095882|P2|Overall Study|Still on treatment at time of analysis|19
4978530|NCT00075946|17095883|P1|Overall Study|Still on treatment at time of analysis|52
4978531|NCT00075946|17095879|P5|Overall Study|Incorrectly randomized (no response)|0
4978532|NCT00075946|17095880|P4|Overall Study|Incorrectly randomized (no response)|1
4978533|NCT00075946|17095881|P3|Overall Study|Incorrectly randomized (no response)|5
4978534|NCT00075946|17095882|P2|Overall Study|Incorrectly randomized (no response)|5
4978535|NCT00075946|17095883|P1|Overall Study|Incorrectly randomized (no response)|5
4978536|NCT00075946|17095879|P5|Overall Study|Did not achieve response after induction|182
4978537|NCT00075946|17095880|P4|Overall Study|Did not achieve response after induction|0
4978538|NCT00075946|17095881|P3|Overall Study|Did not achieve response after induction|0
4978625|NCT00075725|17096040|P9|Overall Study|Institution Terminated|0
4978539|NCT00075946|17095882|P2|Overall Study|Did not achieve response after induction|0
4978540|NCT00075946|17095883|P1|Overall Study|Did not achieve response after induction|0
4978541|NCT00075946|17095879|P5|Overall Study|Path ineligible: undetermined histology|6
4978542|NCT00075946|17095880|P4|Overall Study|Path ineligible: undetermined histology|0
4978543|NCT00075946|17095881|P3|Overall Study|Path ineligible: undetermined histology|0
4978544|NCT00075946|17095882|P2|Overall Study|Path ineligible: undetermined histology|0
4978545|NCT00075946|17095883|P1|Overall Study|Path ineligible: undetermined histology|0
4978546|NCT00075881|17095898|P1|Overall Study|never start protocol therapy|1
4978547|NCT00075881|17095898|P1|Overall Study|Ineligible|1
4978548|NCT00075881|17095898|P1|Overall Study|missing data|2
4978549|NCT00075881|17095898|P1|Overall Study|other|4
4978550|NCT00075881|17095898|P1|Overall Study|other complicating disease|3
4978551|NCT00075881|17095898|P1|Overall Study|Protocol Violation|4
4978552|NCT00075881|17095898|P1|Overall Study|Withdrawal by Subject|2
4978553|NCT00075881|17095898|P1|Overall Study|Death|1
4978554|NCT00075881|17095898|P1|Overall Study|Adverse Event|7
4978555|NCT00075881|17095898|P1|Overall Study|Lack of Efficacy|18
4978556|NCT00075816|17095942|P2|Overall Study|Did not undergo transplantation|11
4978557|NCT00075816|17095943|P1|Overall Study|Did not undergo transplantation|14
4978558|NCT00075764|17096012|P2|Overall Study|Under review|1
4978559|NCT00075764|17096013|P1|Overall Study|Under review|0
4978560|NCT00075764|17096012|P2|Overall Study|Not protocol specified|19
4978561|NCT00075764|17096013|P1|Overall Study|Not protocol specified|27
4978562|NCT00075764|17096012|P2|Overall Study|Delinquent|2
4978563|NCT00075764|17096013|P1|Overall Study|Delinquent|4
4978564|NCT00075764|17096012|P2|Overall Study|Still on treatment|15
4978565|NCT00075764|17096013|P1|Overall Study|Still on treatment|8
4978566|NCT00075764|17096012|P2|Overall Study|Progression|274
4978567|NCT00075764|17096013|P1|Overall Study|Progression|269
4978568|NCT00075764|17096012|P2|Overall Study|Withdrawal by Subject|18
4978569|NCT00075764|17096013|P1|Overall Study|Withdrawal by Subject|28
4978570|NCT00075764|17096012|P2|Overall Study|Death|8
4978571|NCT00075764|17096013|P1|Overall Study|Death|4
4978572|NCT00075764|17096012|P2|Overall Study|Adverse Event|12
4978573|NCT00075764|17096013|P1|Overall Study|Adverse Event|5
4978574|NCT00075725|17096037|P12|Overall Study|Pt incarcerated|0
4978575|NCT00075725|17096038|P11|Overall Study|Pt incarcerated|0
4978576|NCT00075725|17096039|P10|Overall Study|Pt incarcerated|0
4978577|NCT00075725|17096040|P9|Overall Study|Pt incarcerated|0
4978578|NCT00075725|17096041|P8|Overall Study|Pt incarcerated|1
4978579|NCT00075725|17096042|P7|Overall Study|Pt incarcerated|0
4978580|NCT00075725|17096043|P6|Overall Study|Pt incarcerated|0
4978581|NCT00075725|17096044|P5|Overall Study|Pt incarcerated|0
4978582|NCT00075725|17096045|P4|Overall Study|Pt incarcerated|0
4978583|NCT00075725|17096046|P3|Overall Study|Pt incarcerated|0
4978584|NCT00075725|17096047|P2|Overall Study|Pt incarcerated|0
4978585|NCT00075725|17096048|P1|Overall Study|Pt incarcerated|0
4978586|NCT00075725|17096037|P12|Overall Study|Pt care terminated due to pt behavior|0
4978587|NCT00075725|17096038|P11|Overall Study|Pt care terminated due to pt behavior|0
4978588|NCT00075725|17096039|P10|Overall Study|Pt care terminated due to pt behavior|0
4978589|NCT00075725|17096040|P9|Overall Study|Pt care terminated due to pt behavior|0
4978590|NCT00075725|17096041|P8|Overall Study|Pt care terminated due to pt behavior|1
4978591|NCT00075725|17096042|P7|Overall Study|Pt care terminated due to pt behavior|0
4978592|NCT00075725|17096043|P6|Overall Study|Pt care terminated due to pt behavior|0
4978593|NCT00075725|17096044|P5|Overall Study|Pt care terminated due to pt behavior|0
4978594|NCT00075725|17096045|P4|Overall Study|Pt care terminated due to pt behavior|0
4978595|NCT00075725|17096046|P3|Overall Study|Pt care terminated due to pt behavior|0
4978596|NCT00075725|17096047|P2|Overall Study|Pt care terminated due to pt behavior|0
4978597|NCT00075725|17096048|P1|Overall Study|Pt care terminated due to pt behavior|0
4978598|NCT00075725|17096037|P12|Overall Study|Other complications|0
4978599|NCT00075725|17096038|P11|Overall Study|Other complications|0
4978600|NCT00075725|17096039|P10|Overall Study|Other complications|0
4978601|NCT00075725|17096040|P9|Overall Study|Other complications|0
4978602|NCT00075725|17096041|P8|Overall Study|Other complications|0
4978603|NCT00075725|17096042|P7|Overall Study|Other complications|0
4978604|NCT00075725|17096043|P6|Overall Study|Other complications|1
4978605|NCT00075725|17096044|P5|Overall Study|Other complications|0
4978606|NCT00075725|17096045|P4|Overall Study|Other complications|0
4978607|NCT00075725|17096046|P3|Overall Study|Other complications|0
4978608|NCT00075725|17096047|P2|Overall Study|Other complications|0
4978609|NCT00075725|17096048|P1|Overall Study|Other complications|0
4978610|NCT00075725|17096037|P12|Overall Study|Study Closure|0
4978611|NCT00075725|17096038|P11|Overall Study|Study Closure|0
4978612|NCT00075725|17096039|P10|Overall Study|Study Closure|0
4978613|NCT00075725|17096040|P9|Overall Study|Study Closure|0
4978614|NCT00075725|17096041|P8|Overall Study|Study Closure|1
4978615|NCT00075725|17096042|P7|Overall Study|Study Closure|0
4978616|NCT00075725|17096043|P6|Overall Study|Study Closure|3
4978617|NCT00075725|17096044|P5|Overall Study|Study Closure|1
4978618|NCT00075725|17096045|P4|Overall Study|Study Closure|0
4978619|NCT00075725|17096046|P3|Overall Study|Study Closure|0
4978620|NCT00075725|17096047|P2|Overall Study|Study Closure|0
4978621|NCT00075725|17096048|P1|Overall Study|Study Closure|1
4978622|NCT00075725|17096037|P12|Overall Study|Institution Terminated|0
4978623|NCT00075725|17096038|P11|Overall Study|Institution Terminated|0
4978624|NCT00075725|17096039|P10|Overall Study|Institution Terminated|0
4978626|NCT00075725|17096041|P8|Overall Study|Institution Terminated|3
4978627|NCT00075725|17096042|P7|Overall Study|Institution Terminated|0
4978628|NCT00075725|17096043|P6|Overall Study|Institution Terminated|0
4978629|NCT00075725|17096044|P5|Overall Study|Institution Terminated|1
4978630|NCT00075725|17096045|P4|Overall Study|Institution Terminated|0
4978631|NCT00075725|17096046|P3|Overall Study|Institution Terminated|0
4978632|NCT00075725|17096047|P2|Overall Study|Institution Terminated|0
4978633|NCT00075725|17096048|P1|Overall Study|Institution Terminated|0
4978634|NCT00075725|17096037|P12|Overall Study|Pt relocated|0
4978635|NCT00075725|17096038|P11|Overall Study|Pt relocated|0
4978636|NCT00075725|17096039|P10|Overall Study|Pt relocated|0
4978637|NCT00075725|17096040|P9|Overall Study|Pt relocated|1
4978638|NCT00075725|17096041|P8|Overall Study|Pt relocated|2
4978639|NCT00075725|17096042|P7|Overall Study|Pt relocated|1
4978640|NCT00075725|17096043|P6|Overall Study|Pt relocated|1
4978641|NCT00075725|17096044|P5|Overall Study|Pt relocated|0
4978642|NCT00075725|17096045|P4|Overall Study|Pt relocated|2
4978643|NCT00075725|17096046|P3|Overall Study|Pt relocated|0
4978644|NCT00075725|17096047|P2|Overall Study|Pt relocated|0
4978645|NCT00075725|17096048|P1|Overall Study|Pt relocated|0
4978646|NCT00075725|17096037|P12|Overall Study|Pt received additional steroids|0
4978647|NCT00075725|17096038|P11|Overall Study|Pt received additional steroids|0
4978648|NCT00075725|17096039|P10|Overall Study|Pt received additional steroids|0
4978649|NCT00075725|17096040|P9|Overall Study|Pt received additional steroids|0
4978650|NCT00075725|17096041|P8|Overall Study|Pt received additional steroids|0
4978651|NCT00075725|17096042|P7|Overall Study|Pt received additional steroids|0
4978652|NCT00075725|17096043|P6|Overall Study|Pt received additional steroids|0
4978653|NCT00075725|17096044|P5|Overall Study|Pt received additional steroids|0
4978654|NCT00075725|17096045|P4|Overall Study|Pt received additional steroids|1
4978655|NCT00075725|17096046|P3|Overall Study|Pt received additional steroids|0
4978656|NCT00075725|17096047|P2|Overall Study|Pt received additional steroids|0
4978657|NCT00075725|17096048|P1|Overall Study|Pt received additional steroids|0
4978658|NCT00075725|17096037|P12|Overall Study|Pt went to transplant|0
4978659|NCT00075725|17096038|P11|Overall Study|Pt went to transplant|0
4978660|NCT00075725|17096039|P10|Overall Study|Pt went to transplant|0
4978661|NCT00075725|17096040|P9|Overall Study|Pt went to transplant|0
4978662|NCT00075725|17096041|P8|Overall Study|Pt went to transplant|0
4978663|NCT00075725|17096042|P7|Overall Study|Pt went to transplant|0
4978664|NCT00075725|17096043|P6|Overall Study|Pt went to transplant|1
4978665|NCT00075725|17096044|P5|Overall Study|Pt went to transplant|0
4978666|NCT00075725|17096045|P4|Overall Study|Pt went to transplant|1
4978667|NCT00075725|17096046|P3|Overall Study|Pt went to transplant|0
4978668|NCT00075725|17096047|P2|Overall Study|Pt went to transplant|0
4978669|NCT00075725|17096048|P1|Overall Study|Pt went to transplant|0
4978670|NCT00075725|17096037|P12|Overall Study|specimen(s) not submitted|0
4978671|NCT00075725|17096038|P11|Overall Study|specimen(s) not submitted|0
4978672|NCT00075725|17096039|P10|Overall Study|specimen(s) not submitted|0
4978673|NCT00075725|17096040|P9|Overall Study|specimen(s) not submitted|0
4978674|NCT00075725|17096041|P8|Overall Study|specimen(s) not submitted|0
4978675|NCT00075725|17096042|P7|Overall Study|specimen(s) not submitted|0
4978676|NCT00075725|17096043|P6|Overall Study|specimen(s) not submitted|0
4978677|NCT00075725|17096044|P5|Overall Study|specimen(s) not submitted|0
4978678|NCT00075725|17096045|P4|Overall Study|specimen(s) not submitted|0
4978679|NCT00075725|17096046|P3|Overall Study|specimen(s) not submitted|2
4978680|NCT00075725|17096047|P2|Overall Study|specimen(s) not submitted|0
4978681|NCT00075725|17096048|P1|Overall Study|specimen(s) not submitted|0
4978682|NCT00075725|17096037|P12|Overall Study|Unsuccessful institutional transfer|0
4978683|NCT00075725|17096038|P11|Overall Study|Unsuccessful institutional transfer|0
4978684|NCT00075725|17096039|P10|Overall Study|Unsuccessful institutional transfer|1
4978685|NCT00075725|17096040|P9|Overall Study|Unsuccessful institutional transfer|0
4978686|NCT00075725|17096041|P8|Overall Study|Unsuccessful institutional transfer|0
4978687|NCT00075725|17096042|P7|Overall Study|Unsuccessful institutional transfer|0
4978688|NCT00075725|17096043|P6|Overall Study|Unsuccessful institutional transfer|0
4978689|NCT00075725|17096044|P5|Overall Study|Unsuccessful institutional transfer|0
4978690|NCT00075725|17096045|P4|Overall Study|Unsuccessful institutional transfer|0
4978691|NCT00075725|17096046|P3|Overall Study|Unsuccessful institutional transfer|2
4978692|NCT00075725|17096047|P2|Overall Study|Unsuccessful institutional transfer|0
4978693|NCT00075725|17096048|P1|Overall Study|Unsuccessful institutional transfer|0
4978694|NCT00075725|17096037|P12|Overall Study|Clinic chart lost unable to recreate|0
4978695|NCT00075725|17096038|P11|Overall Study|Clinic chart lost unable to recreate|0
4978696|NCT00075725|17096039|P10|Overall Study|Clinic chart lost unable to recreate|0
4978697|NCT00075725|17096040|P9|Overall Study|Clinic chart lost unable to recreate|0
4978698|NCT00075725|17096041|P8|Overall Study|Clinic chart lost unable to recreate|0
4978699|NCT00075725|17096042|P7|Overall Study|Clinic chart lost unable to recreate|0
4978700|NCT00075725|17096043|P6|Overall Study|Clinic chart lost unable to recreate|0
4978701|NCT00075725|17096044|P5|Overall Study|Clinic chart lost unable to recreate|0
4978702|NCT00075725|17096045|P4|Overall Study|Clinic chart lost unable to recreate|0
4978703|NCT00075725|17096046|P3|Overall Study|Clinic chart lost unable to recreate|1
4978704|NCT00075725|17096047|P2|Overall Study|Clinic chart lost unable to recreate|0
4978705|NCT00075725|17096048|P1|Overall Study|Clinic chart lost unable to recreate|0
4978706|NCT00075725|17096037|P12|Overall Study|Pt trying to find a BM donor|0
4978707|NCT00075725|17096038|P11|Overall Study|Pt trying to find a BM donor|0
4978708|NCT00075725|17096039|P10|Overall Study|Pt trying to find a BM donor|0
4978709|NCT00075725|17096040|P9|Overall Study|Pt trying to find a BM donor|0
4978710|NCT00075725|17096041|P8|Overall Study|Pt trying to find a BM donor|0
4978711|NCT00075725|17096042|P7|Overall Study|Pt trying to find a BM donor|0
4978712|NCT00075725|17096043|P6|Overall Study|Pt trying to find a BM donor|0
4978713|NCT00075725|17096044|P5|Overall Study|Pt trying to find a BM donor|0
4978714|NCT00075725|17096045|P4|Overall Study|Pt trying to find a BM donor|0
4978715|NCT00075725|17096046|P3|Overall Study|Pt trying to find a BM donor|0
4978716|NCT00075725|17096047|P2|Overall Study|Pt trying to find a BM donor|1
4978717|NCT00075725|17096048|P1|Overall Study|Pt trying to find a BM donor|0
4978718|NCT00075725|17096037|P12|Overall Study|Other|3
4978719|NCT00075725|17096038|P11|Overall Study|Other|0
4978720|NCT00075725|17096039|P10|Overall Study|Other|1
4978721|NCT00075725|17096040|P9|Overall Study|Other|2
4978722|NCT00075725|17096041|P8|Overall Study|Other|9
4978723|NCT00075725|17096042|P7|Overall Study|Other|2
4978724|NCT00075725|17096043|P6|Overall Study|Other|4
4978725|NCT00075725|17096044|P5|Overall Study|Other|1
4978726|NCT00075725|17096045|P4|Overall Study|Other|1
4978727|NCT00075725|17096046|P3|Overall Study|Other|1
4978728|NCT00075725|17096047|P2|Overall Study|Other|2
4978729|NCT00075725|17096048|P1|Overall Study|Other|4
4978730|NCT00075725|17096037|P12|Overall Study|Inevaluable|0
4978731|NCT00075725|17096038|P11|Overall Study|Inevaluable|1
4978732|NCT00075725|17096039|P10|Overall Study|Inevaluable|0
4978733|NCT00075725|17096040|P9|Overall Study|Inevaluable|2
4978734|NCT00075725|17096041|P8|Overall Study|Inevaluable|11
4978735|NCT00075725|17096042|P7|Overall Study|Inevaluable|1
4978736|NCT00075725|17096043|P6|Overall Study|Inevaluable|9
4978737|NCT00075725|17096044|P5|Overall Study|Inevaluable|2
4978738|NCT00075725|17096045|P4|Overall Study|Inevaluable|2
4978739|NCT00075725|17096046|P3|Overall Study|Inevaluable|4
4978740|NCT00075725|17096047|P2|Overall Study|Inevaluable|1
4978741|NCT00075725|17096048|P1|Overall Study|Inevaluable|1
4978742|NCT00075725|17096037|P12|Overall Study|Pt has very high risk ALL characteristic|3
4978743|NCT00075725|17096038|P11|Overall Study|Pt has very high risk ALL characteristic|0
4978744|NCT00075725|17096039|P10|Overall Study|Pt has very high risk ALL characteristic|1
4978745|NCT00075725|17096040|P9|Overall Study|Pt has very high risk ALL characteristic|29
4978746|NCT00075725|17096041|P8|Overall Study|Pt has very high risk ALL characteristic|74
4978747|NCT00075725|17096042|P7|Overall Study|Pt has very high risk ALL characteristic|23
4978748|NCT00075725|17096043|P6|Overall Study|Pt has very high risk ALL characteristic|75
4978749|NCT00075725|17096044|P5|Overall Study|Pt has very high risk ALL characteristic|11
4978750|NCT00075725|17096045|P4|Overall Study|Pt has very high risk ALL characteristic|18
4978751|NCT00075725|17096046|P3|Overall Study|Pt has very high risk ALL characteristic|26
4978752|NCT00075725|17096047|P2|Overall Study|Pt has very high risk ALL characteristic|11
4978753|NCT00075725|17096048|P1|Overall Study|Pt has very high risk ALL characteristic|15
4978754|NCT00075725|17096037|P12|Overall Study|MRD positive after extended ind|0
4978755|NCT00075725|17096038|P11|Overall Study|MRD positive after extended ind|0
4978756|NCT00075725|17096039|P10|Overall Study|MRD positive after extended ind|0
4978757|NCT00075725|17096040|P9|Overall Study|MRD positive after extended ind|0
4978758|NCT00075725|17096041|P8|Overall Study|MRD positive after extended ind|1
4978759|NCT00075725|17096042|P7|Overall Study|MRD positive after extended ind|0
4978760|NCT00075725|17096043|P6|Overall Study|MRD positive after extended ind|2
4978761|NCT00075725|17096044|P5|Overall Study|MRD positive after extended ind|1
4978762|NCT00075725|17096045|P4|Overall Study|MRD positive after extended ind|0
4978763|NCT00075725|17096046|P3|Overall Study|MRD positive after extended ind|1
4978764|NCT00075725|17096047|P2|Overall Study|MRD positive after extended ind|1
4978765|NCT00075725|17096048|P1|Overall Study|MRD positive after extended ind|0
4978766|NCT00075725|17096037|P12|Overall Study|Insurance issues|0
4978767|NCT00075725|17096038|P11|Overall Study|Insurance issues|0
4978768|NCT00075725|17096039|P10|Overall Study|Insurance issues|0
4978769|NCT00075725|17096040|P9|Overall Study|Insurance issues|0
4978770|NCT00075725|17096041|P8|Overall Study|Insurance issues|1
4978771|NCT00075725|17096042|P7|Overall Study|Insurance issues|0
4978772|NCT00075725|17096043|P6|Overall Study|Insurance issues|1
4978773|NCT00075725|17096044|P5|Overall Study|Insurance issues|1
4978774|NCT00075725|17096045|P4|Overall Study|Insurance issues|1
4978775|NCT00075725|17096046|P3|Overall Study|Insurance issues|0
4978776|NCT00075725|17096047|P2|Overall Study|Insurance issues|1
4978777|NCT00075725|17096048|P1|Overall Study|Insurance issues|0
4978778|NCT00075725|17096037|P12|Overall Study|Pt age out of range for treatment|0
4978779|NCT00075725|17096038|P11|Overall Study|Pt age out of range for treatment|0
4978780|NCT00075725|17096039|P10|Overall Study|Pt age out of range for treatment|0
4978781|NCT00075725|17096040|P9|Overall Study|Pt age out of range for treatment|0
4978782|NCT00075725|17096041|P8|Overall Study|Pt age out of range for treatment|1
4978783|NCT00075725|17096042|P7|Overall Study|Pt age out of range for treatment|0
4978784|NCT00075725|17096043|P6|Overall Study|Pt age out of range for treatment|1
4978785|NCT00075725|17096044|P5|Overall Study|Pt age out of range for treatment|0
4978786|NCT00075725|17096045|P4|Overall Study|Pt age out of range for treatment|0
4978787|NCT00075725|17096046|P3|Overall Study|Pt age out of range for treatment|0
4978788|NCT00075725|17096047|P2|Overall Study|Pt age out of range for treatment|1
4978789|NCT00075725|17096048|P1|Overall Study|Pt age out of range for treatment|0
4978790|NCT00075725|17096037|P12|Overall Study|Pt non compliant with therapy|0
4978791|NCT00075725|17096038|P11|Overall Study|Pt non compliant with therapy|0
4978792|NCT00075725|17096039|P10|Overall Study|Pt non compliant with therapy|0
4978793|NCT00075725|17096040|P9|Overall Study|Pt non compliant with therapy|3
4978794|NCT00075725|17096041|P8|Overall Study|Pt non compliant with therapy|5
4978795|NCT00075725|17096042|P7|Overall Study|Pt non compliant with therapy|2
4978796|NCT00075725|17096043|P6|Overall Study|Pt non compliant with therapy|14
4978797|NCT00075725|17096044|P5|Overall Study|Pt non compliant with therapy|2
4978798|NCT00075725|17096045|P4|Overall Study|Pt non compliant with therapy|0
4978799|NCT00075725|17096046|P3|Overall Study|Pt non compliant with therapy|1
4978800|NCT00075725|17096047|P2|Overall Study|Pt non compliant with therapy|1
4978801|NCT00075725|17096048|P1|Overall Study|Pt non compliant with therapy|2
4978802|NCT00075725|17096037|P12|Overall Study|Pt/Guardian refused RT therapy|0
4978803|NCT00075725|17096038|P11|Overall Study|Pt/Guardian refused RT therapy|0
4978804|NCT00075725|17096039|P10|Overall Study|Pt/Guardian refused RT therapy|0
4978805|NCT00075725|17096040|P9|Overall Study|Pt/Guardian refused RT therapy|0
4978806|NCT00075725|17096041|P8|Overall Study|Pt/Guardian refused RT therapy|0
4978807|NCT00075725|17096042|P7|Overall Study|Pt/Guardian refused RT therapy|0
4978808|NCT00075725|17096043|P6|Overall Study|Pt/Guardian refused RT therapy|0
4978809|NCT00075725|17096044|P5|Overall Study|Pt/Guardian refused RT therapy|1
4978810|NCT00075725|17096045|P4|Overall Study|Pt/Guardian refused RT therapy|2
4978811|NCT00075725|17096046|P3|Overall Study|Pt/Guardian refused RT therapy|1
4978812|NCT00075725|17096047|P2|Overall Study|Pt/Guardian refused RT therapy|0
4978813|NCT00075725|17096048|P1|Overall Study|Pt/Guardian refused RT therapy|1
4978814|NCT00075725|17096037|P12|Overall Study|Ineligible or wrong diagnosis|4
4978815|NCT00075725|17096038|P11|Overall Study|Ineligible or wrong diagnosis|2
4978816|NCT00075725|17096039|P10|Overall Study|Ineligible or wrong diagnosis|1
4978817|NCT00075725|17096040|P9|Overall Study|Ineligible or wrong diagnosis|10
4978818|NCT00075725|17096041|P8|Overall Study|Ineligible or wrong diagnosis|9
4978819|NCT00075725|17096042|P7|Overall Study|Ineligible or wrong diagnosis|6
4978820|NCT00075725|17096043|P6|Overall Study|Ineligible or wrong diagnosis|17
4978821|NCT00075725|17096044|P5|Overall Study|Ineligible or wrong diagnosis|3
4978822|NCT00075725|17096045|P4|Overall Study|Ineligible or wrong diagnosis|10
4978823|NCT00075725|17096046|P3|Overall Study|Ineligible or wrong diagnosis|3
4978824|NCT00075725|17096047|P2|Overall Study|Ineligible or wrong diagnosis|3
4978825|NCT00075725|17096048|P1|Overall Study|Ineligible or wrong diagnosis|8
4978826|NCT00075725|17096037|P12|Overall Study|Patient off treatment|0
4978827|NCT00075725|17096038|P11|Overall Study|Patient off treatment|0
4978828|NCT00075725|17096039|P10|Overall Study|Patient off treatment|0
4978829|NCT00075725|17096040|P9|Overall Study|Patient off treatment|1
4978830|NCT00075725|17096041|P8|Overall Study|Patient off treatment|2
4978831|NCT00075725|17096042|P7|Overall Study|Patient off treatment|0
4978832|NCT00075725|17096043|P6|Overall Study|Patient off treatment|0
4978833|NCT00075725|17096044|P5|Overall Study|Patient off treatment|1
4978834|NCT00075725|17096045|P4|Overall Study|Patient off treatment|2
4978835|NCT00075725|17096046|P3|Overall Study|Patient off treatment|1
4978836|NCT00075725|17096047|P2|Overall Study|Patient off treatment|0
4978837|NCT00075725|17096048|P1|Overall Study|Patient off treatment|0
4978838|NCT00075725|17096037|P12|Overall Study|Disease Progression, all other reasons|5
4978839|NCT00075725|17096038|P11|Overall Study|Disease Progression, all other reasons|0
4978840|NCT00075725|17096039|P10|Overall Study|Disease Progression, all other reasons|4
4978841|NCT00075725|17096040|P9|Overall Study|Disease Progression, all other reasons|21
4978842|NCT00075725|17096041|P8|Overall Study|Disease Progression, all other reasons|46
4978843|NCT00075725|17096042|P7|Overall Study|Disease Progression, all other reasons|20
4978844|NCT00075725|17096043|P6|Overall Study|Disease Progression, all other reasons|59
4978845|NCT00075725|17096044|P5|Overall Study|Disease Progression, all other reasons|21
4978846|NCT00075725|17096045|P4|Overall Study|Disease Progression, all other reasons|6
4978847|NCT00075725|17096046|P3|Overall Study|Disease Progression, all other reasons|33
4978848|NCT00075725|17096047|P2|Overall Study|Disease Progression, all other reasons|5
4978849|NCT00075725|17096048|P1|Overall Study|Disease Progression, all other reasons|17
4978850|NCT00075725|17096037|P12|Overall Study|Withdrawal by Subject|0
4978851|NCT00075725|17096038|P11|Overall Study|Withdrawal by Subject|0
4978852|NCT00075725|17096039|P10|Overall Study|Withdrawal by Subject|2
4978853|NCT00075725|17096040|P9|Overall Study|Withdrawal by Subject|10
4978854|NCT00075725|17096041|P8|Overall Study|Withdrawal by Subject|31
4978855|NCT00075725|17096042|P7|Overall Study|Withdrawal by Subject|7
4978856|NCT00075725|17096043|P6|Overall Study|Withdrawal by Subject|27
4978857|NCT00075725|17096044|P5|Overall Study|Withdrawal by Subject|6
4978858|NCT00075725|17096045|P4|Overall Study|Withdrawal by Subject|10
4978859|NCT00075725|17096046|P3|Overall Study|Withdrawal by Subject|6
4978860|NCT00075725|17096047|P2|Overall Study|Withdrawal by Subject|3
4978861|NCT00075725|17096048|P1|Overall Study|Withdrawal by Subject|12
4978862|NCT00075725|17096037|P12|Overall Study|Protocol Violation|1
4978863|NCT00075725|17096038|P11|Overall Study|Protocol Violation|0
4978864|NCT00075725|17096039|P10|Overall Study|Protocol Violation|0
4978865|NCT00075725|17096040|P9|Overall Study|Protocol Violation|3
4978866|NCT00075725|17096041|P8|Overall Study|Protocol Violation|2
4978867|NCT00075725|17096042|P7|Overall Study|Protocol Violation|1
4978868|NCT00075725|17096043|P6|Overall Study|Protocol Violation|2
4978869|NCT00075725|17096044|P5|Overall Study|Protocol Violation|3
4978870|NCT00075725|17096045|P4|Overall Study|Protocol Violation|3
4978871|NCT00075725|17096046|P3|Overall Study|Protocol Violation|0
4978872|NCT00075725|17096047|P2|Overall Study|Protocol Violation|1
4978873|NCT00075725|17096048|P1|Overall Study|Protocol Violation|1
4978874|NCT00075725|17096037|P12|Overall Study|Pregnancy|0
4978875|NCT00075725|17096038|P11|Overall Study|Pregnancy|0
4978876|NCT00075725|17096039|P10|Overall Study|Pregnancy|0
4978877|NCT00075725|17096040|P9|Overall Study|Pregnancy|0
4978878|NCT00075725|17096041|P8|Overall Study|Pregnancy|1
4978879|NCT00075725|17096042|P7|Overall Study|Pregnancy|0
4978880|NCT00075725|17096043|P6|Overall Study|Pregnancy|1
4978881|NCT00075725|17096044|P5|Overall Study|Pregnancy|0
4978882|NCT00075725|17096045|P4|Overall Study|Pregnancy|0
4978883|NCT00075725|17096046|P3|Overall Study|Pregnancy|0
4978884|NCT00075725|17096047|P2|Overall Study|Pregnancy|0
4978885|NCT00075725|17096048|P1|Overall Study|Pregnancy|0
4978886|NCT00075725|17096037|P12|Overall Study|Physician Decision|0
4978887|NCT00075725|17096038|P11|Overall Study|Physician Decision|1
4978888|NCT00075725|17096039|P10|Overall Study|Physician Decision|0
4978889|NCT00075725|17096040|P9|Overall Study|Physician Decision|5
4978890|NCT00075725|17096041|P8|Overall Study|Physician Decision|17
4978891|NCT00075725|17096042|P7|Overall Study|Physician Decision|3
4978892|NCT00075725|17096043|P6|Overall Study|Physician Decision|19
4978893|NCT00075725|17096044|P5|Overall Study|Physician Decision|4
4978894|NCT00075725|17096045|P4|Overall Study|Physician Decision|8
4978895|NCT00075725|17096046|P3|Overall Study|Physician Decision|5
4978896|NCT00075725|17096047|P2|Overall Study|Physician Decision|6
4978897|NCT00075725|17096048|P1|Overall Study|Physician Decision|2
4978898|NCT00075725|17096037|P12|Overall Study|Lost to Follow-up|0
4978899|NCT00075725|17096038|P11|Overall Study|Lost to Follow-up|0
4978900|NCT00075725|17096039|P10|Overall Study|Lost to Follow-up|0
4978901|NCT00075725|17096040|P9|Overall Study|Lost to Follow-up|1
4978902|NCT00075725|17096041|P8|Overall Study|Lost to Follow-up|4
4978903|NCT00075725|17096042|P7|Overall Study|Lost to Follow-up|2
4978904|NCT00075725|17096043|P6|Overall Study|Lost to Follow-up|13
4978905|NCT00075725|17096044|P5|Overall Study|Lost to Follow-up|0
4978906|NCT00075725|17096045|P4|Overall Study|Lost to Follow-up|1
4978907|NCT00075725|17096046|P3|Overall Study|Lost to Follow-up|4
4978908|NCT00075725|17096047|P2|Overall Study|Lost to Follow-up|1
4978909|NCT00075725|17096048|P1|Overall Study|Lost to Follow-up|1
4978910|NCT00075725|17096037|P12|Overall Study|Death|0
4978911|NCT00075725|17096038|P11|Overall Study|Death|3
4978912|NCT00075725|17096039|P10|Overall Study|Death|4
4978913|NCT00075725|17096040|P9|Overall Study|Death|14
4978914|NCT00075725|17096041|P8|Overall Study|Death|22
4978915|NCT00075725|17096042|P7|Overall Study|Death|4
4978916|NCT00075725|17096043|P6|Overall Study|Death|25
4978917|NCT00075725|17096044|P5|Overall Study|Death|3
4978918|NCT00075725|17096045|P4|Overall Study|Death|2
4978919|NCT00075725|17096046|P3|Overall Study|Death|10
4978920|NCT00075725|17096047|P2|Overall Study|Death|5
4978921|NCT00075725|17096048|P1|Overall Study|Death|3
4978922|NCT00075725|17096037|P12|Overall Study|Adverse Event|2
4978923|NCT00075725|17096038|P11|Overall Study|Adverse Event|2
4978924|NCT00075725|17096039|P10|Overall Study|Adverse Event|4
4978925|NCT00075725|17096040|P9|Overall Study|Adverse Event|15
4978926|NCT00075725|17096041|P8|Overall Study|Adverse Event|51
4978927|NCT00075725|17096042|P7|Overall Study|Adverse Event|3
4978928|NCT00075725|17096043|P6|Overall Study|Adverse Event|38
4978929|NCT00075725|17096044|P5|Overall Study|Adverse Event|4
4978930|NCT00075725|17096045|P4|Overall Study|Adverse Event|8
4978931|NCT00075725|17096046|P3|Overall Study|Adverse Event|20
4978932|NCT00075725|17096047|P2|Overall Study|Adverse Event|6
4978933|NCT00075725|17096048|P1|Overall Study|Adverse Event|6
4978934|NCT00075582|17096145|P2|Overall Study|Ineligible for study|16
4978935|NCT00075582|17096146|P1|Overall Study|Ineligible for study|36
4978936|NCT00075582|17096145|P2|Overall Study|Withdrawal by Subject|2
4978937|NCT00075582|17096146|P1|Overall Study|Withdrawal by Subject|2
4978938|NCT00075582|17096145|P2|Overall Study|Physician Decision|8
4978939|NCT00075582|17096146|P1|Overall Study|Physician Decision|5
4978940|NCT00075582|17096145|P2|Overall Study|Lack of Efficacy|8
4978941|NCT00075582|17096146|P1|Overall Study|Lack of Efficacy|4
4978942|NCT00075582|17096145|P2|Overall Study|Adverse Event|1
4978943|NCT00075582|17096146|P1|Overall Study|Adverse Event|3
4978944|NCT00075504|17096160|P2|Overall Study|Withdrawal by Subject|7
4978945|NCT00075504|17096161|P1|Overall Study|Withdrawal by Subject|9
4978946|NCT00075478|17096173|P2|Overall Study|Physician Decision|1
4978947|NCT00075478|17096174|P1|Overall Study|Physician Decision|0
4978948|NCT00075478|17096173|P2|Overall Study|not eligible|0
4978949|NCT00075478|17096174|P1|Overall Study|not eligible|1
4978950|NCT00075400|17096194|P1|Overall Study|Never treated|2
4978951|NCT00075400|17096194|P1|Overall Study|Ineligible: wrong primary|1
4978952|NCT00075270|17096215|P2|Overall Study|Missing|13
4978953|NCT00075270|17096216|P1|Overall Study|Missing|26
4978954|NCT00075270|17096215|P2|Overall Study|Other/Unknown|5
4978955|NCT00075270|17096216|P1|Overall Study|Other/Unknown|9
4978956|NCT00075270|17096215|P2|Overall Study|Death|215
4978957|NCT00075270|17096216|P1|Overall Study|Death|198
4978958|NCT00075270|17096215|P2|Overall Study|Protocol Violation|2
4978959|NCT00075270|17096216|P1|Overall Study|Protocol Violation|0
4978960|NCT00075270|17096215|P2|Overall Study|Lost to Follow-up|28
4978961|NCT00075270|17096216|P1|Overall Study|Lost to Follow-up|25
4978962|NCT00075270|17096215|P2|Overall Study|Withdrawal by Subject|21
4978963|NCT00075270|17096216|P1|Overall Study|Withdrawal by Subject|28
4978964|NCT00075218|17096262|P3|Open-Label Treatment|enrolled in a separate continuation|9
4978965|NCT00075218|17096263|P2|Open-Label Treatment|enrolled in a separate continuation|0
4978966|NCT00075218|17096264|P1|Open-Label Treatment|enrolled in a separate continuation|0
4978967|NCT00075218|17096262|P3|Open-Label Treatment|Protocol Violation|1
4978968|NCT00075218|17096263|P2|Open-Label Treatment|Protocol Violation|0
4978969|NCT00075218|17096264|P1|Open-Label Treatment|Protocol Violation|0
4978970|NCT00075218|17096262|P3|Open-Label Treatment|Decision of Sponsor|8
4978971|NCT00075218|17096263|P2|Open-Label Treatment|Decision of Sponsor|0
4978972|NCT00075218|17096264|P1|Open-Label Treatment|Decision of Sponsor|0
4978973|NCT00075218|17096262|P3|Open-Label Treatment|Withdrawal by Subject|12
4978974|NCT00075218|17096263|P2|Open-Label Treatment|Withdrawal by Subject|0
4978975|NCT00075218|17096264|P1|Open-Label Treatment|Withdrawal by Subject|0
4978976|NCT00075218|17096262|P3|Open-Label Treatment|Adverse Event|51
4978977|NCT00075218|17096263|P2|Open-Label Treatment|Adverse Event|0
4978978|NCT00075218|17096264|P1|Open-Label Treatment|Adverse Event|0
4978979|NCT00075218|17096262|P3|Open-Label Treatment|Lack of Efficacy|174
4978980|NCT00075218|17096263|P2|Open-Label Treatment|Lack of Efficacy|0
4978981|NCT00075218|17096264|P1|Open-Label Treatment|Lack of Efficacy|0
4978982|NCT00075218|17096262|P3|Double-Blind Treatment|No study medication taken|0
4978983|NCT00075218|17096263|P2|Double-Blind Treatment|No study medication taken|0
4978984|NCT00075218|17096264|P1|Double-Blind Treatment|No study medication taken|2
4978985|NCT00075218|17096262|P3|Double-Blind Treatment|Decision of Sponsor|0
4978986|NCT00075218|17096263|P2|Double-Blind Treatment|Decision of Sponsor|1
4978987|NCT00075218|17096264|P1|Double-Blind Treatment|Decision of Sponsor|0
4978988|NCT00075218|17096262|P3|Double-Blind Treatment|Lack of Efficacy|0
4978989|NCT00075218|17096263|P2|Double-Blind Treatment|Lack of Efficacy|6
4978990|NCT00075218|17096264|P1|Double-Blind Treatment|Lack of Efficacy|58
4978991|NCT00075218|17096262|P3|Double-Blind Treatment|Lost to Follow-up|0
4978992|NCT00075218|17096263|P2|Double-Blind Treatment|Lost to Follow-up|0
4978993|NCT00075218|17096264|P1|Double-Blind Treatment|Lost to Follow-up|1
4978994|NCT00075218|17096262|P3|Double-Blind Treatment|Withdrawal by Subject|0
4978995|NCT00075218|17096263|P2|Double-Blind Treatment|Withdrawal by Subject|4
4978996|NCT00075218|17096264|P1|Double-Blind Treatment|Withdrawal by Subject|7
4978997|NCT00075218|17096262|P3|Double-Blind Treatment|Adverse Event|0
4978998|NCT00075218|17096263|P2|Double-Blind Treatment|Adverse Event|4
4978999|NCT00075218|17096264|P1|Double-Blind Treatment|Adverse Event|23
4979000|NCT00075023|17096313|P2|Pilot Study|Withdrawal by Subject|0
4979001|NCT00075023|17096314|P1|Pilot Study|Withdrawal by Subject|1
4979002|NCT00075023|17096313|P2|Pilot Study|Physician Decision|2
4979003|NCT00075023|17096314|P1|Pilot Study|Physician Decision|1
4979004|NCT00074984|17096323|P2|Overall Study|Patient Withdrawn Per Protocol|3
4979005|NCT00074984|17096324|P1|Overall Study|Patient Withdrawn Per Protocol|0
4979006|NCT00074984|17096323|P2|Overall Study|Withdrawal by Subject|3
4979007|NCT00074984|17096324|P1|Overall Study|Withdrawal by Subject|2
4979008|NCT00074984|17096323|P2|Overall Study|Death|2
4979009|NCT00074984|17096324|P1|Overall Study|Death|1
4979010|NCT00074958|17096339|P1|Overall Study|Adverse Event|1
4979011|NCT00074711|17096380|P2|Overall Study|Participant stopped study drug|6
4979012|NCT00074711|17096381|P1|Overall Study|Participant stopped study drug|4
4979013|NCT00074711|17096380|P2|Overall Study|Lost to Follow-up|8
4979014|NCT00074711|17096381|P1|Overall Study|Lost to Follow-up|10
4979015|NCT00074711|17096380|P2|Overall Study|Withdrawal by Subject|1
4979016|NCT00074711|17096381|P1|Overall Study|Withdrawal by Subject|1
4979017|NCT00074581|17096399|P2|Overall Study|Other|19
4979018|NCT00074581|17096400|P1|Overall Study|Other|14
4979019|NCT00074581|17096399|P2|Overall Study|Ended relationship w. index participant|106
4979020|NCT00074581|17096400|P1|Overall Study|Ended relationship w. index participant|117
4979021|NCT00074581|17096399|P2|Overall Study|Lost to Follow-up|11
4979022|NCT00074581|17096400|P1|Overall Study|Lost to Follow-up|16
4979023|NCT00074581|17096399|P2|Overall Study|Were withdrawn by investigator|2
4979024|NCT00074581|17096400|P1|Overall Study|Were withdrawn by investigator|5
4979025|NCT00074581|17096399|P2|Overall Study|Relocated|9
4979026|NCT00074581|17096400|P1|Overall Study|Relocated|14
4979027|NCT00074581|17096399|P2|Overall Study|Unable to adhere to visit schedule|14
4979028|NCT00074581|17096400|P1|Overall Study|Unable to adhere to visit schedule|13
4979029|NCT00074581|17096399|P2|Overall Study|Withdrawal by Subject|49
4979030|NCT00074581|17096400|P1|Overall Study|Withdrawal by Subject|50
4979031|NCT00074581|17096399|P2|Overall Study|Death|16
4979032|NCT00074581|17096400|P1|Overall Study|Death|15
4979033|NCT00074490|17096413|P6|Overall Study|Progressive malignancy|0
4979034|NCT00074490|17096414|P5|Overall Study|Progressive malignancy|3
4979035|NCT00074490|17096415|P4|Overall Study|Progressive malignancy|0
4979036|NCT00074490|17096416|P3|Overall Study|Progressive malignancy|0
4979037|NCT00074490|17096417|P2|Overall Study|Progressive malignancy|7
4979038|NCT00074490|17096418|P1|Overall Study|Progressive malignancy|0
4979039|NCT00074412|17096452|P2|Overall Study|Lost to Follow-up|58
4979040|NCT00074412|17096453|P1|Overall Study|Lost to Follow-up|52
4979041|NCT00074412|17096452|P2|Overall Study|Death|26
4979042|NCT00074412|17096453|P1|Overall Study|Death|30
4979043|NCT00074282|17096484|P3|Step 2|Ineligible|1
4979044|NCT00074282|17096485|P2|Step 2|Ineligible|0
4979045|NCT00074282|17096486|P1|Step 2|Ineligible|0
4979046|NCT00074282|17096484|P3|Step 2|Physician Decision|1
4979047|NCT00074282|17096485|P2|Step 2|Physician Decision|0
4979048|NCT00074282|17096486|P1|Step 2|Physician Decision|0
4979049|NCT00074282|17096484|P3|Step 2|Withdrawal by Subject|2
4979050|NCT00074282|17096485|P2|Step 2|Withdrawal by Subject|0
4979051|NCT00074282|17096486|P1|Step 2|Withdrawal by Subject|0
4979052|NCT00074282|17096484|P3|Step 2|Death|3
4979053|NCT00074282|17096485|P2|Step 2|Death|0
4979054|NCT00074282|17096486|P1|Step 2|Death|0
4979055|NCT00074282|17096484|P3|Step 2|Disease progression|5
4979056|NCT00074282|17096485|P2|Step 2|Disease progression|0
4979057|NCT00074282|17096486|P1|Step 2|Disease progression|0
4979058|NCT00074282|17096484|P3|Step 2|Adverse Event|12
4979059|NCT00074282|17096485|P2|Step 2|Adverse Event|2
4979060|NCT00074282|17096486|P1|Step 2|Adverse Event|0
4979061|NCT00074282|17096484|P3|Step 1|Never started treatment|0
4979062|NCT00074282|17096485|P2|Step 1|Never started treatment|0
4979063|NCT00074282|17096486|P1|Step 1|Never started treatment|2
4979064|NCT00074282|17096484|P3|Step 1|Ineligible|0
4979065|NCT00074282|17096485|P2|Step 1|Ineligible|0
4979066|NCT00074282|17096486|P1|Step 1|Ineligible|4
4979067|NCT00074282|17096484|P3|Step 1|Physician Decision|0
4979068|NCT00074282|17096485|P2|Step 1|Physician Decision|0
4979069|NCT00074282|17096486|P1|Step 1|Physician Decision|1
4979070|NCT00074282|17096484|P3|Step 1|Other complicating disease|0
4979071|NCT00074282|17096485|P2|Step 1|Other complicating disease|0
4979072|NCT00074282|17096486|P1|Step 1|Other complicating disease|2
4979073|NCT00074282|17096484|P3|Step 1|Alternative therapy|0
4979074|NCT00074282|17096485|P2|Step 1|Alternative therapy|0
4979075|NCT00074282|17096486|P1|Step 1|Alternative therapy|2
4979076|NCT00074282|17096484|P3|Step 1|Disease progression|0
4979077|NCT00074282|17096485|P2|Step 1|Disease progression|0
4979078|NCT00074282|17096486|P1|Step 1|Disease progression|2
4979079|NCT00074282|17096484|P3|Step 1|Withdrawal by Subject|0
4979080|NCT00074282|17096485|P2|Step 1|Withdrawal by Subject|0
4979081|NCT00074282|17096486|P1|Step 1|Withdrawal by Subject|7
4979082|NCT00074282|17096484|P3|Step 1|Death|0
4979083|NCT00074282|17096485|P2|Step 1|Death|0
4979084|NCT00074282|17096486|P1|Step 1|Death|6
4979085|NCT00074282|17096484|P3|Step 1|Adverse Event|0
4979086|NCT00074282|17096485|P2|Step 1|Adverse Event|0
4979087|NCT00074282|17096486|P1|Step 1|Adverse Event|32
4979088|NCT00074152|17096512|P2|Overall Study|Lack of Efficacy|24
4979089|NCT00074152|17096513|P1|Overall Study|Lack of Efficacy|34
4979090|NCT00074152|17096512|P2|Overall Study|Death|9
4979091|NCT00074152|17096513|P1|Overall Study|Death|21
4979092|NCT00073983|17096530|P1|Overall Study|not evaluable|1
4979093|NCT00073918|17096551|P1|Overall Study|Eligibility requirement not met-low CD20|1
4979094|NCT00073918|17096551|P1|Overall Study|Rapid disease progression|2
4979095|NCT00073918|17096551|P1|Overall Study|Eligibility requirement not met - HAMA+|1
4979096|NCT00073749|17096565|P7|Overall Study|Other|0
4979097|NCT00073749|17096566|P6|Overall Study|Other|2
4979098|NCT00073749|17096567|P5|Overall Study|Other|0
4979099|NCT00073749|17096568|P4|Overall Study|Other|0
4979100|NCT00073749|17096569|P3|Overall Study|Other|0
4979101|NCT00073749|17096570|P2|Overall Study|Other|0
4979102|NCT00073749|17096571|P1|Overall Study|Other|0
4979103|NCT00073749|17096565|P7|Overall Study|Lost to Follow-up|2
4979104|NCT00073749|17096566|P6|Overall Study|Lost to Follow-up|0
4979105|NCT00073749|17096567|P5|Overall Study|Lost to Follow-up|0
4979106|NCT00073749|17096568|P4|Overall Study|Lost to Follow-up|0
4979107|NCT00073749|17096569|P3|Overall Study|Lost to Follow-up|0
4979108|NCT00073749|17096570|P2|Overall Study|Lost to Follow-up|0
4979109|NCT00073749|17096571|P1|Overall Study|Lost to Follow-up|0
4979110|NCT00073749|17096565|P7|Overall Study|Discontinuation of Study by Sponsor|4
4979111|NCT00073749|17096566|P6|Overall Study|Discontinuation of Study by Sponsor|0
4979112|NCT00073749|17096567|P5|Overall Study|Discontinuation of Study by Sponsor|0
4979113|NCT00073749|17096568|P4|Overall Study|Discontinuation of Study by Sponsor|0
4979114|NCT00073749|17096569|P3|Overall Study|Discontinuation of Study by Sponsor|0
4979115|NCT00073749|17096570|P2|Overall Study|Discontinuation of Study by Sponsor|0
4979116|NCT00073749|17096571|P1|Overall Study|Discontinuation of Study by Sponsor|0
4979117|NCT00073749|17096565|P7|Overall Study|Withdrawal by Subject|2
4979118|NCT00073749|17096566|P6|Overall Study|Withdrawal by Subject|0
4979119|NCT00073749|17096567|P5|Overall Study|Withdrawal by Subject|1
4979120|NCT00073749|17096568|P4|Overall Study|Withdrawal by Subject|0
4979121|NCT00073749|17096569|P3|Overall Study|Withdrawal by Subject|0
4979122|NCT00073749|17096570|P2|Overall Study|Withdrawal by Subject|1
4979123|NCT00073749|17096571|P1|Overall Study|Withdrawal by Subject|0
4979124|NCT00073749|17096565|P7|Overall Study|Physician Decision|0
4979125|NCT00073749|17096566|P6|Overall Study|Physician Decision|2
4979126|NCT00073749|17096567|P5|Overall Study|Physician Decision|0
4979127|NCT00073749|17096568|P4|Overall Study|Physician Decision|0
4979128|NCT00073749|17096569|P3|Overall Study|Physician Decision|1
4979129|NCT00073749|17096570|P2|Overall Study|Physician Decision|0
4979130|NCT00073749|17096571|P1|Overall Study|Physician Decision|0
4979131|NCT00073749|17096565|P7|Overall Study|Adverse Event|0
4979132|NCT00073749|17096566|P6|Overall Study|Adverse Event|1
4979133|NCT00073749|17096567|P5|Overall Study|Adverse Event|2
4979134|NCT00073749|17096568|P4|Overall Study|Adverse Event|4
4979135|NCT00073749|17096569|P3|Overall Study|Adverse Event|6
4979136|NCT00073749|17096570|P2|Overall Study|Adverse Event|3
4979137|NCT00073749|17096571|P1|Overall Study|Adverse Event|0
4979138|NCT00073749|17096565|P7|Overall Study|Death|29
4979139|NCT00073749|17096566|P6|Overall Study|Death|0
4979140|NCT00073749|17096567|P5|Overall Study|Death|0
4979141|NCT00073749|17096568|P4|Overall Study|Death|0
4979142|NCT00073749|17096569|P3|Overall Study|Death|1
4979143|NCT00073749|17096570|P2|Overall Study|Death|1
4979144|NCT00073749|17096571|P1|Overall Study|Death|0
4979145|NCT00073749|17096565|P7|Overall Study|Disease Progression|3
4979146|NCT00073749|17096566|P6|Overall Study|Disease Progression|1
4979147|NCT00073749|17096567|P5|Overall Study|Disease Progression|3
4979148|NCT00073749|17096568|P4|Overall Study|Disease Progression|2
4979149|NCT00073749|17096569|P3|Overall Study|Disease Progression|3
4979150|NCT00073749|17096570|P2|Overall Study|Disease Progression|0
4979151|NCT00073749|17096571|P1|Overall Study|Disease Progression|2
4979152|NCT00073528|17096602|P2|Overall Study|Ongoing|344
4979153|NCT00073528|17096603|P1|Overall Study|Ongoing|349
4979154|NCT00073528|17096602|P2|Overall Study|Non-compliance|1
4979155|NCT00073528|17096603|P1|Overall Study|Non-compliance|0
4979156|NCT00073528|17096602|P2|Overall Study|Enrolled in Error|1
4979157|NCT00073528|17096603|P1|Overall Study|Enrolled in Error|0
4979158|NCT00073528|17096602|P2|Overall Study|Participant Was Unblinded|1
4979159|NCT00073528|17096603|P1|Overall Study|Participant Was Unblinded|0
4979160|NCT00073528|17096602|P2|Overall Study|Progressive Disease|1
4979161|NCT00073528|17096603|P1|Overall Study|Progressive Disease|0
4979162|NCT00073528|17096602|P2|Overall Study|Randomized in Error; Not Treated|0
4979163|NCT00073528|17096603|P1|Overall Study|Randomized in Error; Not Treated|2
4979164|NCT00073528|17096602|P2|Overall Study|Mastectomy Intervention|0
4979165|NCT00073528|17096603|P1|Overall Study|Mastectomy Intervention|1
4979166|NCT00073528|17096602|P2|Overall Study|Death|238
4979167|NCT00073528|17096603|P1|Overall Study|Death|229
4979168|NCT00073528|17096602|P2|Overall Study|Protocol Violation|5
4979169|NCT00073528|17096603|P1|Overall Study|Protocol Violation|3
4979170|NCT00073528|17096602|P2|Overall Study|Lost to Follow-up|22
4979171|NCT00073528|17096603|P1|Overall Study|Lost to Follow-up|26
4979172|NCT00073528|17096602|P2|Overall Study|Withdrawal by Subject|29
4979173|NCT00073528|17096603|P1|Overall Study|Withdrawal by Subject|34
4979174|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83
4979175|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0
4979176|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35
4979177|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9
4979178|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0
4979179|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19
4979180|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Missing|1
4979181|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Missing|0
4979182|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Missing|3
4979183|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3
4979184|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
4979185|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0
4979186|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
4979187|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0
4979188|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1
4979189|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
4979190|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0
4979191|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1
4979192|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28
4979193|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0
4979194|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37
4979195|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9
4979196|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0
4979197|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19
4979198|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
4979199|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0
4979200|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2
4979201|NCT00073307|17096692|P3|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19
4979202|NCT00073307|17096693|P2|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0
4979203|NCT00073307|17096694|P1|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17
4979204|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
4979205|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1
4979206|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0
4979207|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0
4979208|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114
4979209|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165
4979210|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
4979211|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1
4979212|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0
4979213|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
4979214|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0
4979215|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1
4979216|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0
4979217|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2
4979218|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1
4979219|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0
4979220|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
4979221|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1
4979222|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0
4979223|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11
4979224|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6
4979225|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0
4979226|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6
4979227|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1
4979228|NCT00073307|17096692|P3|Double-Blind (DB, as of ~31May2005)|Adverse Event|0
4979229|NCT00073307|17096693|P2|Double-Blind (DB, as of ~31May2005)|Adverse Event|17
4979230|NCT00073307|17096694|P1|Double-Blind (DB, as of ~31May2005)|Adverse Event|22
4979231|NCT00073021|17096725|P2|Overall Study|Lack of Efficacy|5
4979232|NCT00073021|17096726|P1|Overall Study|Lack of Efficacy|11
4979233|NCT00073021|17096725|P2|Overall Study|Physician Decision|1
4979234|NCT00073021|17096726|P1|Overall Study|Physician Decision|3
4979235|NCT00073021|17096725|P2|Overall Study|Withdrawal by Subject|5
4979236|NCT00073021|17096726|P1|Overall Study|Withdrawal by Subject|6
4979237|NCT00073021|17096725|P2|Overall Study|Adverse Event|4
4979238|NCT00073021|17096726|P1|Overall Study|Adverse Event|4
4979239|NCT00073021|17096725|P2|Overall Study|Protocol Violation|1
4979240|NCT00073021|17096726|P1|Overall Study|Protocol Violation|2
4979241|NCT00073008|17096756|P2|Overall Study|"Other selected on Case Report Form"|5
4979242|NCT00073008|17096757|P1|Overall Study|"Other selected on Case Report Form"|7
4979243|NCT00073008|17096756|P2|Overall Study|Death|47
4979244|NCT00073008|17096757|P1|Overall Study|Death|46
4979245|NCT00073008|17096756|P2|Overall Study|Lost to Follow-up|3
4979246|NCT00073008|17096757|P1|Overall Study|Lost to Follow-up|1
4979247|NCT00073008|17096756|P2|Overall Study|Withdrawal by Subject|2
4979248|NCT00073008|17096757|P1|Overall Study|Withdrawal by Subject|2
4979249|NCT00073008|17096756|P2|Overall Study|Missing|6
4979250|NCT00073008|17096757|P1|Overall Study|Missing|6
4979251|NCT00072475|17096796|P1|Overall Study|Patient/Investigator Decision|4
4979252|NCT00072475|17096796|P1|Overall Study|Withdrawal by Subject|46
4979253|NCT00072475|17096796|P1|Overall Study|Death|3
4979254|NCT00072475|17096796|P1|Overall Study|Adverse Event|44
4979255|NCT00072384|17096811|P1|Overall Study|Ineligible|8
4979256|NCT00072384|17096811|P1|Overall Study|Physician Decision|1
4979257|NCT00072293|17096824|P2|Overall Study|Withdrawal by Subject|1
4979258|NCT00072293|17096825|P1|Overall Study|Withdrawal by Subject|0
4979259|NCT00072293|17096824|P2|Overall Study|Lost to Follow-up|1
4979260|NCT00072293|17096825|P1|Overall Study|Lost to Follow-up|1
4979261|NCT00072280|17096837|P2|Follow-up|Early termination of study|2
4979262|NCT00072280|17096838|P1|Follow-up|Early termination of study|2
4979263|NCT00072280|17096837|P2|Treatment|Found ineligible|2
4979264|NCT00072280|17096838|P1|Treatment|Found ineligible|1
4979265|NCT00072189|17096843|P1|Overall Study|Withdrawal by Subject|1
4979266|NCT00072176|17096851|P2|Overall Study|Protocol Violation|1
4979267|NCT00072176|17096852|P1|Overall Study|Protocol Violation|0
4979268|NCT00072176|17096851|P2|Overall Study|Withdrawal by Subject|0
4979269|NCT00072176|17096852|P1|Overall Study|Withdrawal by Subject|1
4979270|NCT00071981|17096864|P4|Overall Study|others (not specified in the study)|0
4979271|NCT00071981|17096865|P3|Overall Study|others (not specified in the study)|2
4979272|NCT00071981|17096866|P2|Overall Study|others (not specified in the study)|2
4979273|NCT00071981|17096867|P1|Overall Study|others (not specified in the study)|0
4979274|NCT00071981|17096864|P4|Overall Study|No protocol therapy|0
4979275|NCT00071981|17096865|P3|Overall Study|No protocol therapy|1
4979276|NCT00071981|17096866|P2|Overall Study|No protocol therapy|5
4979277|NCT00071981|17096867|P1|Overall Study|No protocol therapy|2
4979278|NCT00071981|17096864|P4|Overall Study|Withdrawal by Subject|0
4979279|NCT00071981|17096865|P3|Overall Study|Withdrawal by Subject|0
4979280|NCT00071981|17096866|P2|Overall Study|Withdrawal by Subject|1
4979281|NCT00071981|17096867|P1|Overall Study|Withdrawal by Subject|3
4979282|NCT00071981|17096864|P4|Overall Study|Death|1
4979283|NCT00071981|17096865|P3|Overall Study|Death|1
4979284|NCT00071981|17096866|P2|Overall Study|Death|0
4979285|NCT00071981|17096867|P1|Overall Study|Death|0
4979286|NCT00071981|17096864|P4|Overall Study|Adverse Event|1
4979287|NCT00071981|17096865|P3|Overall Study|Adverse Event|3
4979288|NCT00071981|17096866|P2|Overall Study|Adverse Event|4
4979289|NCT00071981|17096867|P1|Overall Study|Adverse Event|4
4979290|NCT00071981|17096864|P4|Overall Study|Lack of Efficacy|43
4979291|NCT00071981|17096865|P3|Overall Study|Lack of Efficacy|30
4979292|NCT00071981|17096866|P2|Overall Study|Lack of Efficacy|29
4979293|NCT00071981|17096867|P1|Overall Study|Lack of Efficacy|37
4979294|NCT00071812|17096910|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
4979295|NCT00071812|17096911|P3|24-Week Open-Label Extension Period|Lack of Compliance|1
4979296|NCT00071812|17096912|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
4979297|NCT00071812|17096913|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
4979298|NCT00071812|17096910|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|12
4979299|NCT00071812|17096911|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4979300|NCT00071812|17096912|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4979301|NCT00071812|17096913|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4979302|NCT00071812|17096910|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
4979303|NCT00071812|17096911|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
4979304|NCT00071812|17096912|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
4979305|NCT00071812|17096913|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
4979306|NCT00071812|17096910|P4|24-Week Open-Label Extension Period|Lack of Efficacy|17
4979307|NCT00071812|17096911|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
4979308|NCT00071812|17096912|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
4979309|NCT00071812|17096913|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
4979310|NCT00071812|17096910|P4|24-Week Open-Label Extension Period|Adverse Event|7
4979311|NCT00071812|17096911|P3|24-Week Open-Label Extension Period|Adverse Event|0
4979312|NCT00071812|17096912|P2|24-Week Open-Label Extension Period|Adverse Event|0
4979313|NCT00071812|17096913|P1|24-Week Open-Label Extension Period|Adverse Event|0
4979314|NCT00071812|17096910|P4|24-Week Double-Blind Period|Protocol Violation|1
4979315|NCT00071812|17096911|P3|24-Week Double-Blind Period|Protocol Violation|0
4979316|NCT00071812|17096912|P2|24-Week Double-Blind Period|Protocol Violation|0
4979317|NCT00071812|17096913|P1|24-Week Double-Blind Period|Protocol Violation|0
4979318|NCT00071812|17096910|P4|24-Week Double-Blind Period|Withdrawal by Subject|5
4979319|NCT00071812|17096911|P3|24-Week Double-Blind Period|Withdrawal by Subject|1
4979320|NCT00071812|17096912|P2|24-Week Double-Blind Period|Withdrawal by Subject|1
4979321|NCT00071812|17096913|P1|24-Week Double-Blind Period|Withdrawal by Subject|5
4979322|NCT00071812|17096910|P4|24-Week Double-Blind Period|Lost to Follow-up|0
4979323|NCT00071812|17096911|P3|24-Week Double-Blind Period|Lost to Follow-up|1
4979324|NCT00071812|17096912|P2|24-Week Double-Blind Period|Lost to Follow-up|1
4979325|NCT00071812|17096913|P1|24-Week Double-Blind Period|Lost to Follow-up|0
4979326|NCT00071812|17096910|P4|24-Week Double-Blind Period|Lack of Efficacy|1
4979327|NCT00071812|17096911|P3|24-Week Double-Blind Period|Lack of Efficacy|2
4979328|NCT00071812|17096912|P2|24-Week Double-Blind Period|Lack of Efficacy|1
4979329|NCT00071812|17096913|P1|24-Week Double-Blind Period|Lack of Efficacy|3
4979330|NCT00071812|17096910|P4|24-Week Double-Blind Period|Adverse Event|4
4979331|NCT00071812|17096911|P3|24-Week Double-Blind Period|Adverse Event|4
4979332|NCT00071812|17096912|P2|24-Week Double-Blind Period|Adverse Event|3
4979333|NCT00071812|17096913|P1|24-Week Double-Blind Period|Adverse Event|2
4979334|NCT00071799|17096955|P2|Overall Study|Not Documented|2
4979335|NCT00071799|17096956|P1|Overall Study|Not Documented|0
4979336|NCT00071799|17096955|P2|Overall Study|Different Central+Local Pathology Review|1
4979337|NCT00071799|17096956|P1|Overall Study|Different Central+Local Pathology Review|0
4979338|NCT00071799|17096955|P2|Overall Study|Disease Progression|20
4979339|NCT00071799|17096956|P1|Overall Study|Disease Progression|23
4979340|NCT00071799|17096955|P2|Overall Study|Lack of Efficacy|18
4979341|NCT00071799|17096956|P1|Overall Study|Lack of Efficacy|11
4979342|NCT00071799|17096955|P2|Overall Study|Physician Decision|2
4979343|NCT00071799|17096956|P1|Overall Study|Physician Decision|0
4979344|NCT00071799|17096955|P2|Overall Study|Withdrawal by Subject|37
4979345|NCT00071799|17096956|P1|Overall Study|Withdrawal by Subject|15
4979346|NCT00071799|17096955|P2|Overall Study|Lost to Follow-up|1
4979347|NCT00071799|17096956|P1|Overall Study|Lost to Follow-up|1
4979348|NCT00071799|17096955|P2|Overall Study|Protocol Violation|7
4979349|NCT00071799|17096956|P1|Overall Study|Protocol Violation|1
4979350|NCT00071799|17096955|P2|Overall Study|Adverse Event|10
4979351|NCT00071799|17096956|P1|Overall Study|Adverse Event|19
4979352|NCT00071760|17097009|P1|Overall Study|Ongoing|25
4979353|NCT00071760|17097009|P1|Overall Study|Study Team Rec./Resistance|1
4979354|NCT00071760|17097009|P1|Overall Study|Investigator's Recommendation (Rec.)|4
4979355|NCT00071760|17097009|P1|Overall Study|Relocation|1
4979356|NCT00071760|17097009|P1|Overall Study|Unavailability of RTV|8
4979357|NCT00071760|17097009|P1|Overall Study|Pulmonary Tuberculosis|1
4979358|NCT00071760|17097009|P1|Overall Study|Insufficient Viral Load Response|3
4979359|NCT00071760|17097009|P1|Overall Study|Withdrawal by Subject|3
4979360|NCT00071760|17097009|P1|Overall Study|Protocol Violation|1
4979361|NCT00071760|17097009|P1|Overall Study|Lost to Follow-up|4
4979362|NCT00071760|17097009|P1|Overall Study|Adverse Event|3
4979363|NCT00071513|17097089|P2|Follow-up Assessment|Withdrawal by Subject|6
4979364|NCT00071513|17097090|P1|Follow-up Assessment|Withdrawal by Subject|6
4979365|NCT00071513|17097089|P2|Intervention Component|Withdrawal by Subject|3
4979366|NCT00071513|17097090|P1|Intervention Component|Withdrawal by Subject|2
4979367|NCT00071487|17097102|P4|24-Week Open-Label Extension Period|Lack of Compliance|2
4979368|NCT00071487|17097103|P3|24-Week Open-Label Extension Period|Lack of Compliance|0
4979369|NCT00071487|17097104|P2|24-Week Open-Label Extension Period|Lack of Compliance|0
4979370|NCT00071487|17097105|P1|24-Week Open-Label Extension Period|Lack of Compliance|0
4979371|NCT00071487|17097102|P4|24-Week Open-Label Extension Period|Lost to Follow-up|2
4979372|NCT00071487|17097103|P3|24-Week Open-Label Extension Period|Lost to Follow-up|0
4979373|NCT00071487|17097104|P2|24-Week Open-Label Extension Period|Lost to Follow-up|0
4979374|NCT00071487|17097105|P1|24-Week Open-Label Extension Period|Lost to Follow-up|0
4979375|NCT00071487|17097102|P4|24-Week Open-Label Extension Period|Pregnancy|1
4979376|NCT00071487|17097103|P3|24-Week Open-Label Extension Period|Pregnancy|0
4979377|NCT00071487|17097104|P2|24-Week Open-Label Extension Period|Pregnancy|0
4979378|NCT00071487|17097105|P1|24-Week Open-Label Extension Period|Pregnancy|0
4979379|NCT00071487|17097102|P4|24-Week Open-Label Extension Period|Withdrawal by Subject|9
4979380|NCT00071487|17097103|P3|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4979381|NCT00071487|17097104|P2|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4979382|NCT00071487|17097105|P1|24-Week Open-Label Extension Period|Withdrawal by Subject|0
4979383|NCT00071487|17097102|P4|24-Week Open-Label Extension Period|Lack of Efficacy|3
4979384|NCT00071487|17097103|P3|24-Week Open-Label Extension Period|Lack of Efficacy|0
4979385|NCT00071487|17097104|P2|24-Week Open-Label Extension Period|Lack of Efficacy|0
4979386|NCT00071487|17097105|P1|24-Week Open-Label Extension Period|Lack of Efficacy|0
4979387|NCT00071487|17097102|P4|24-Week Open-Label Extension Period|Adverse Event|6
4979388|NCT00071487|17097103|P3|24-Week Open-Label Extension Period|Adverse Event|1
4979389|NCT00071487|17097104|P2|24-Week Open-Label Extension Period|Adverse Event|0
4979390|NCT00071487|17097105|P1|24-Week Open-Label Extension Period|Adverse Event|0
4979391|NCT00071487|17097102|P4|52-Week Double-Blind Period|Lack of Compliance|3
4979392|NCT00071487|17097103|P3|52-Week Double-Blind Period|Lack of Compliance|3
4979393|NCT00071487|17097104|P2|52-Week Double-Blind Period|Lack of Compliance|3
4979394|NCT00071487|17097105|P1|52-Week Double-Blind Period|Lack of Compliance|6
4979395|NCT00071487|17097102|P4|52-Week Double-Blind Period|Death|0
4979396|NCT00071487|17097103|P3|52-Week Double-Blind Period|Death|0
4979397|NCT00071487|17097104|P2|52-Week Double-Blind Period|Death|1
4979398|NCT00071487|17097105|P1|52-Week Double-Blind Period|Death|0
4979399|NCT00071487|17097102|P4|52-Week Double-Blind Period|Protocol Violation|0
4979400|NCT00071487|17097103|P3|52-Week Double-Blind Period|Protocol Violation|1
4979401|NCT00071487|17097104|P2|52-Week Double-Blind Period|Protocol Violation|1
4979402|NCT00071487|17097105|P1|52-Week Double-Blind Period|Protocol Violation|0
4979403|NCT00071487|17097102|P4|52-Week Double-Blind Period|Pregnancy|0
4979404|NCT00071487|17097103|P3|52-Week Double-Blind Period|Pregnancy|0
4979405|NCT00071487|17097104|P2|52-Week Double-Blind Period|Pregnancy|1
4979406|NCT00071487|17097105|P1|52-Week Double-Blind Period|Pregnancy|0
4979407|NCT00071487|17097102|P4|52-Week Double-Blind Period|Lost to Follow-up|2
4979408|NCT00071487|17097103|P3|52-Week Double-Blind Period|Lost to Follow-up|2
4979409|NCT00071487|17097104|P2|52-Week Double-Blind Period|Lost to Follow-up|0
4979410|NCT00071487|17097105|P1|52-Week Double-Blind Period|Lost to Follow-up|0
4979411|NCT00071487|17097102|P4|52-Week Double-Blind Period|Physician Decision|0
4979412|NCT00071487|17097103|P3|52-Week Double-Blind Period|Physician Decision|0
4979413|NCT00071487|17097104|P2|52-Week Double-Blind Period|Physician Decision|0
4979414|NCT00071487|17097105|P1|52-Week Double-Blind Period|Physician Decision|1
4979415|NCT00071487|17097102|P4|52-Week Double-Blind Period|Withdrawal by Subject|7
4979416|NCT00071487|17097103|P3|52-Week Double-Blind Period|Withdrawal by Subject|7
4979417|NCT00071487|17097104|P2|52-Week Double-Blind Period|Withdrawal by Subject|11
4979418|NCT00071487|17097105|P1|52-Week Double-Blind Period|Withdrawal by Subject|7
4979419|NCT00071487|17097102|P4|52-Week Double-Blind Period|Lack of Efficacy|1
4979420|NCT00071487|17097103|P3|52-Week Double-Blind Period|Lack of Efficacy|0
4979421|NCT00071487|17097104|P2|52-Week Double-Blind Period|Lack of Efficacy|2
4979422|NCT00071487|17097105|P1|52-Week Double-Blind Period|Lack of Efficacy|1
4979423|NCT00071487|17097102|P4|52-Week Double-Blind Period|Adverse Event|8
4979424|NCT00071487|17097103|P3|52-Week Double-Blind Period|Adverse Event|4
4979425|NCT00071487|17097104|P2|52-Week Double-Blind Period|Adverse Event|8
4979426|NCT00071487|17097105|P1|52-Week Double-Blind Period|Adverse Event|5
4979427|NCT00071396|17097149|P1|Overall Study|Physician Decision|2
4979428|NCT00071396|17097149|P1|Overall Study|Withdrawal by Subject|1
4979429|NCT00071110|17097155|P2|Overall Study|Protocol Violation|4
4979430|NCT00071110|17097156|P1|Overall Study|Protocol Violation|0
4979431|NCT00071032|17097170|P2|Overall Study|Missing Primary Outcome|1
4979432|NCT00071032|17097171|P1|Overall Study|Missing Primary Outcome|0
4979433|NCT00071032|17097170|P2|Overall Study|Withdrawal by Subject|6
4979434|NCT00071032|17097171|P1|Overall Study|Withdrawal by Subject|8
4979435|NCT00071032|17097170|P2|Overall Study|Lost to Follow-up|1
4979436|NCT00071032|17097171|P1|Overall Study|Lost to Follow-up|1
4979437|NCT00071006|17097179|P1|Overall Study|Other|3
4979438|NCT00071006|17097179|P1|Overall Study|Withdrawal by Subject|1
4979439|NCT00071006|17097179|P1|Overall Study|Adverse Event|1
4979440|NCT00071006|17097179|P1|Overall Study|Lack of Efficacy|7
4979441|NCT00070941|17097192|P3|Overall Study|Adverse Event|4
4979442|NCT00070941|17097193|P2|Overall Study|Adverse Event|8
4979443|NCT00070941|17097194|P1|Overall Study|Adverse Event|10
4979444|NCT00071058|17097202|P1|Overall Study|brain tumor-removed from study|1
4979445|NCT00070707|17097209|P2|Overall Study|Unrelated to Study Medication|0
4979446|NCT00070707|17097210|P1|Overall Study|Unrelated to Study Medication|1
4979447|NCT00070707|17097209|P2|Overall Study|Protocol Violation|4
4979448|NCT00070707|17097210|P1|Overall Study|Protocol Violation|8
4979449|NCT00070707|17097209|P2|Overall Study|Lack of Efficacy|1
4979450|NCT00070707|17097210|P1|Overall Study|Lack of Efficacy|4
4979451|NCT00070707|17097209|P2|Overall Study|Adverse Event|2
4979452|NCT00070707|17097210|P1|Overall Study|Adverse Event|1
4979453|NCT00003907|17097258|P2|Overall Study|ineligible or not treated|2
4979454|NCT00003907|17097259|P1|Overall Study|ineligible or not treated|2
4979455|NCT00003907|17097258|P2|Overall Study|Other|3
4979456|NCT00003907|17097259|P1|Overall Study|Other|1
4979457|NCT00003907|17097258|P2|Overall Study|Complicating disease|0
4979458|NCT00003907|17097259|P1|Overall Study|Complicating disease|1
4979459|NCT00003907|17097258|P2|Overall Study|Progressive disease|4
4979460|NCT00003907|17097259|P1|Overall Study|Progressive disease|4
4979461|NCT00003907|17097258|P2|Overall Study|Withdrawal by Subject|3
4979462|NCT00003907|17097259|P1|Overall Study|Withdrawal by Subject|1
4979463|NCT00003907|17097258|P2|Overall Study|Death|0
4979464|NCT00003907|17097259|P1|Overall Study|Death|2
4979465|NCT00003907|17097258|P2|Overall Study|Adverse Event|11
4979466|NCT00003907|17097259|P1|Overall Study|Adverse Event|2
4979467|NCT00070564|17097275|P6|Overall Study|Not reported|0
4979468|NCT00070564|17097276|P5|Overall Study|Not reported|1
4979469|NCT00070564|17097277|P4|Overall Study|Not reported|0
4979470|NCT00070564|17097278|P3|Overall Study|Not reported|0
4979471|NCT00070564|17097279|P2|Overall Study|Not reported|0
4979472|NCT00070564|17097280|P1|Overall Study|Not reported|0
4979473|NCT00070564|17097275|P6|Overall Study|Withdrawal by Subject|8
4979474|NCT00070564|17097276|P5|Overall Study|Withdrawal by Subject|8
4979475|NCT00070564|17097277|P4|Overall Study|Withdrawal by Subject|30
4979476|NCT00070564|17097278|P3|Overall Study|Withdrawal by Subject|23
4979477|NCT00070564|17097279|P2|Overall Study|Withdrawal by Subject|37
4979478|NCT00070564|17097280|P1|Overall Study|Withdrawal by Subject|26
4979479|NCT00070564|17097275|P6|Overall Study|Other, not protocol specified|7
4979480|NCT00070564|17097276|P5|Overall Study|Other, not protocol specified|6
4979481|NCT00070564|17097277|P4|Overall Study|Other, not protocol specified|19
4979482|NCT00070564|17097278|P3|Overall Study|Other, not protocol specified|14
4979483|NCT00070564|17097279|P2|Overall Study|Other, not protocol specified|15
4979484|NCT00070564|17097280|P1|Overall Study|Other, not protocol specified|17
4979485|NCT00070564|17097275|P6|Overall Study|Death|1
4979486|NCT00070564|17097276|P5|Overall Study|Death|0
4979487|NCT00070564|17097277|P4|Overall Study|Death|3
4979488|NCT00070564|17097278|P3|Overall Study|Death|5
4979489|NCT00070564|17097279|P2|Overall Study|Death|1
4979490|NCT00070564|17097280|P1|Overall Study|Death|4
4979491|NCT00070564|17097275|P6|Overall Study|Adverse Event|36
4979492|NCT00070564|17097276|P5|Overall Study|Adverse Event|63
4979493|NCT00070564|17097277|P4|Overall Study|Adverse Event|108
4979494|NCT00070564|17097278|P3|Overall Study|Adverse Event|120
4979495|NCT00070564|17097279|P2|Overall Study|Adverse Event|142
4979496|NCT00070564|17097280|P1|Overall Study|Adverse Event|150
4979497|NCT00070564|17097275|P6|Overall Study|Delinquent|0
4979498|NCT00070564|17097276|P5|Overall Study|Delinquent|0
4979499|NCT00070564|17097277|P4|Overall Study|Delinquent|0
4979500|NCT00070564|17097278|P3|Overall Study|Delinquent|2
4979501|NCT00070564|17097279|P2|Overall Study|Delinquent|4
4979502|NCT00070564|17097280|P1|Overall Study|Delinquent|1
4979503|NCT00070564|17097275|P6|Overall Study|Progression|0
4979504|NCT00070564|17097276|P5|Overall Study|Progression|1
4979505|NCT00070564|17097277|P4|Overall Study|Progression|7
4979506|NCT00070564|17097278|P3|Overall Study|Progression|7
4979507|NCT00070564|17097279|P2|Overall Study|Progression|4
4979508|NCT00070564|17097280|P1|Overall Study|Progression|2
4979509|NCT00070499|17097334|P4|Overall Study|Not eligible|2
4979510|NCT00070499|17097335|P3|Overall Study|Not eligible|3
4979511|NCT00070499|17097336|P2|Overall Study|Not eligible|5
4979512|NCT00070499|17097337|P1|Overall Study|Not eligible|2
4979513|NCT00070499|17097334|P4|Overall Study|Did not start treatment|2
4979514|NCT00070499|17097335|P3|Overall Study|Did not start treatment|0
4979515|NCT00070499|17097336|P2|Overall Study|Did not start treatment|0
4979516|NCT00070499|17097337|P1|Overall Study|Did not start treatment|1
4979517|NCT00070499|17097334|P4|Overall Study|Still on protocol treatment|57
4979518|NCT00070499|17097335|P3|Overall Study|Still on protocol treatment|79
4979519|NCT00070499|17097336|P2|Overall Study|Still on protocol treatment|4
4979520|NCT00070499|17097337|P1|Overall Study|Still on protocol treatment|10
4979521|NCT00070499|17097334|P4|Overall Study|Other - not protocol specified|20
4979522|NCT00070499|17097335|P3|Overall Study|Other - not protocol specified|12
4979523|NCT00070499|17097336|P2|Overall Study|Other - not protocol specified|3
4979524|NCT00070499|17097337|P1|Overall Study|Other - not protocol specified|7
4979525|NCT00070499|17097334|P4|Overall Study|Death|2
4979526|NCT00070499|17097335|P3|Overall Study|Death|1
4979527|NCT00070499|17097336|P2|Overall Study|Death|1
4979528|NCT00070499|17097337|P1|Overall Study|Death|1
4979529|NCT00070499|17097334|P4|Overall Study|Progression/relapse|4
4979530|NCT00070499|17097335|P3|Overall Study|Progression/relapse|1
4979531|NCT00070499|17097336|P2|Overall Study|Progression/relapse|2
4979532|NCT00070499|17097337|P1|Overall Study|Progression/relapse|4
4979533|NCT00070499|17097334|P4|Overall Study|Refusal unrelated to adverse effects|8
4979534|NCT00070499|17097335|P3|Overall Study|Refusal unrelated to adverse effects|5
4979535|NCT00070499|17097336|P2|Overall Study|Refusal unrelated to adverse effects|5
4979536|NCT00070499|17097337|P1|Overall Study|Refusal unrelated to adverse effects|7
4979537|NCT00070499|17097334|P4|Overall Study|Adverse Event|15
4979538|NCT00070499|17097335|P3|Overall Study|Adverse Event|19
4979539|NCT00070499|17097336|P2|Overall Study|Adverse Event|6
4979540|NCT00070499|17097337|P1|Overall Study|Adverse Event|6
4979541|NCT00070317|17097363|P1|Overall Study|Ineligible-Inadequate pathology|6
4979542|NCT00070317|17097363|P1|Overall Study|Ineligible-Improper prior treatment|2
4979543|NCT00070317|17097363|P1|Overall Study|Ineligible required test not done|1
4979544|NCT00070317|17097363|P1|Overall Study|Ineligible Wrong Cell type/primary/stage|3
4979545|NCT00070317|17097363|P1|Overall Study|Inevaluable (Never Treated)|1
4979546|NCT00070291|17097368|P1|Step 2|Adverse Event|1
4979547|NCT00070291|17097368|P1|Step 1|Adverse Event|1
4979548|NCT00070291|17097368|P1|Step 1|Withdrawal by Subject|1
4979549|NCT00070109|17097384|P5|Overall Study|removed from prot thpy prior to chemo|0
4979550|NCT00070109|17097385|P4|Overall Study|removed from prot thpy prior to chemo|1
4979551|NCT00070109|17097386|P3|Overall Study|removed from prot thpy prior to chemo|0
4979552|NCT00070109|17097387|P2|Overall Study|removed from prot thpy prior to chemo|0
4979553|NCT00070109|17097388|P1|Overall Study|removed from prot thpy prior to chemo|0
4979554|NCT00070109|17097384|P5|Overall Study|Adverse Event|2
4979555|NCT00070109|17097385|P4|Overall Study|Adverse Event|4
4979556|NCT00070109|17097386|P3|Overall Study|Adverse Event|2
4979557|NCT00070109|17097387|P2|Overall Study|Adverse Event|0
4979558|NCT00070109|17097388|P1|Overall Study|Adverse Event|0
4979559|NCT00070109|17097384|P5|Overall Study|Withdrawal by Subject|0
4979560|NCT00070109|17097385|P4|Overall Study|Withdrawal by Subject|0
4979561|NCT00070109|17097386|P3|Overall Study|Withdrawal by Subject|1
4979562|NCT00070109|17097387|P2|Overall Study|Withdrawal by Subject|1
4979563|NCT00070109|17097388|P1|Overall Study|Withdrawal by Subject|0
4979564|NCT00070109|17097384|P5|Overall Study|Physician Decision|0
4979565|NCT00070109|17097385|P4|Overall Study|Physician Decision|0
4979566|NCT00070109|17097386|P3|Overall Study|Physician Decision|0
4979567|NCT00070109|17097387|P2|Overall Study|Physician Decision|0
4979568|NCT00070109|17097388|P1|Overall Study|Physician Decision|1
4979569|NCT00070109|17097384|P5|Overall Study|Lack of Efficacy|5
4979570|NCT00070109|17097385|P4|Overall Study|Lack of Efficacy|15
4979571|NCT00070109|17097386|P3|Overall Study|Lack of Efficacy|5
4979572|NCT00070109|17097387|P2|Overall Study|Lack of Efficacy|4
4979573|NCT00070109|17097388|P1|Overall Study|Lack of Efficacy|6
4979574|NCT00070109|17097384|P5|Overall Study|Death|1
4979575|NCT00070109|17097385|P4|Overall Study|Death|0
4979576|NCT00070109|17097386|P3|Overall Study|Death|0
4979577|NCT00070109|17097387|P2|Overall Study|Death|1
4979578|NCT00070109|17097388|P1|Overall Study|Death|1
4979579|NCT00070018|17097416|P1|Overall Study|Withdrawal by Subject|1
4979580|NCT00070018|17097416|P1|Overall Study|Lack of Efficacy|1
4979581|NCT00070018|17097416|P1|Overall Study|Adverse Event|2
4979582|NCT00069953|17097420|P1|Overall Study|Protocol Violation|2
4979583|NCT00069784|17097426|P2|Overall Study|Other|0
4979584|NCT00069784|17097427|P1|Overall Study|Other|17
4979585|NCT00069784|17097426|P2|Overall Study|Withdrawal by Subject|0
4979586|NCT00069784|17097427|P1|Overall Study|Withdrawal by Subject|1090
4979587|NCT00069784|17097426|P2|Overall Study|Adverse Event|0
4979588|NCT00069784|17097427|P1|Overall Study|Adverse Event|105
4979589|NCT00069823|17097447|P2|Overall Study|Did not have follow-up diary cards|3
4979590|NCT00069823|17097448|P1|Overall Study|Did not have follow-up diary cards|6
4979591|NCT00069641|17097491|P3|Overall Study|Death|1
4979592|NCT00069641|17097492|P2|Overall Study|Death|0
4979593|NCT00069641|17097493|P1|Overall Study|Death|1
4979594|NCT00069576|17097520|P2|Follow-up Study at 5-10 Years|Not eligible or did not consent|204
4979595|NCT00069576|17097521|P1|Follow-up Study at 5-10 Years|Not eligible or did not consent|196
4979596|NCT00069576|17097520|P2|Original Trial|Lost to Follow-up|33
4979597|NCT00069576|17097521|P1|Original Trial|Lost to Follow-up|25
4979598|NCT00069277|17097571|P1|Overall Study|Physician Decision|2
4979599|NCT00069277|17097571|P1|Overall Study|Progressive Disease|15
4979600|NCT00069277|17097571|P1|Overall Study|Withdrawal by Subject|1
4979601|NCT00069277|17097571|P1|Overall Study|Adverse Event|3
4979602|NCT00069264|17097575|P1|Overall Study|Discon Therapy|3
4979603|NCT00069264|17097575|P1|Overall Study|Withdrawal by Subject|3
4979604|NCT00069264|17097575|P1|Overall Study|Progressive Disease|23
4979605|NCT00069264|17097575|P1|Overall Study|Adverse Event|3
4979606|NCT00069238|17097603|P3|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2
4979607|NCT00069238|17097604|P2|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
4979608|NCT00069238|17097605|P1|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0
4979609|NCT00069238|17097603|P3|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
4979610|NCT00069238|17097604|P2|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2
4979611|NCT00069238|17097605|P1|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0
4979612|NCT00069238|17097603|P3|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
4979613|NCT00069238|17097604|P2|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0
4979614|NCT00069238|17097605|P1|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9
4979615|NCT00069121|17097613|P2|Overall Study|Lost to Follow-up|63
4979616|NCT00069121|17097614|P1|Overall Study|Lost to Follow-up|63
4979617|NCT00069121|17097613|P2|Overall Study|Withdrawal by Subject|20
4979618|NCT00069121|17097614|P1|Overall Study|Withdrawal by Subject|18
4979619|NCT00069121|17097613|P2|Overall Study|Death|242
4979620|NCT00069121|17097614|P1|Overall Study|Death|286
4979621|NCT00069108|17097636|P2|Overall Study|Refused treatment|10
4979622|NCT00069108|17097637|P1|Overall Study|Refused treatment|5
4979623|NCT00069108|17097636|P2|Overall Study|Violation criteria|4
4979624|NCT00069108|17097637|P1|Overall Study|Violation criteria|1
4979625|NCT00069108|17097636|P2|Overall Study|Insufficient therapy|144
4979626|NCT00069108|17097637|P1|Overall Study|Insufficient therapy|117
4979627|NCT00069108|17097636|P2|Overall Study|Administration|4
4979628|NCT00069108|17097637|P1|Overall Study|Administration|15
4979629|NCT00069108|17097636|P2|Overall Study|Death|6
4979630|NCT00069108|17097637|P1|Overall Study|Death|6
4979631|NCT00069108|17097636|P2|Overall Study|Adverse Event|42
4979632|NCT00069108|17097637|P1|Overall Study|Adverse Event|64
4979633|NCT00069108|17097636|P2|Overall Study|Withdrawal by Subject|9
4979634|NCT00069108|17097637|P1|Overall Study|Withdrawal by Subject|5
4979635|NCT00069095|17097669|P6|Follow-up Phase|Death|101
4979636|NCT00069095|17097670|P5|Follow-up Phase|Death|92
4979637|NCT00069095|17097671|P4|Follow-up Phase|Death|112
4979638|NCT00069095|17097672|P3|Follow-up Phase|Death|120
4979639|NCT00069095|17097673|P2|Follow-up Phase|Death|206
4979640|NCT00069095|17097674|P1|Follow-up Phase|Death|174
4979641|NCT00069095|17097669|P6|Post-study Treatment Phase|Investigator decision|1
4979642|NCT00069095|17097670|P5|Post-study Treatment Phase|Investigator decision|0
4979643|NCT00069095|17097671|P4|Post-study Treatment Phase|Investigator decision|0
4979644|NCT00069095|17097672|P3|Post-study Treatment Phase|Investigator decision|0
4979645|NCT00069095|17097673|P2|Post-study Treatment Phase|Investigator decision|0
4979646|NCT00069095|17097674|P1|Post-study Treatment Phase|Investigator decision|0
4979647|NCT00069095|17097669|P6|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4979648|NCT00069095|17097670|P5|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1
4979649|NCT00069095|17097671|P4|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4979650|NCT00069095|17097672|P3|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4979651|NCT00069095|17097673|P2|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4979652|NCT00069095|17097674|P1|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0
4979653|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant/Physician decision to stop|0
4979654|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant/Physician decision to stop|1
4979655|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant/Physician decision to stop|0
4979656|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant/Physician decision to stop|0
4979657|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant/Physician decision to stop|0
4979658|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant/Physician decision to stop|0
4979659|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant had progressive disease|0
4979660|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant had progressive disease|1
4979661|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant had progressive disease|0
4979662|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant had progressive disease|0
4979663|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant had progressive disease|0
4979664|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant had progressive disease|0
4979665|NCT00069095|17097669|P6|Post-study Treatment Phase|Death|0
4979666|NCT00069095|17097670|P5|Post-study Treatment Phase|Death|1
4979667|NCT00069095|17097671|P4|Post-study Treatment Phase|Death|0
4979668|NCT00069095|17097672|P3|Post-study Treatment Phase|Death|0
4979669|NCT00069095|17097673|P2|Post-study Treatment Phase|Death|0
4979670|NCT00069095|17097674|P1|Post-study Treatment Phase|Death|0
4979671|NCT00069095|17097669|P6|Post-study Treatment Phase|Surgery|0
4979672|NCT00069095|17097670|P5|Post-study Treatment Phase|Surgery|1
4979673|NCT00069095|17097671|P4|Post-study Treatment Phase|Surgery|1
4979674|NCT00069095|17097672|P3|Post-study Treatment Phase|Surgery|0
4979675|NCT00069095|17097673|P2|Post-study Treatment Phase|Surgery|0
4979676|NCT00069095|17097674|P1|Post-study Treatment Phase|Surgery|0
4979677|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant completed treatment|0
4979678|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant completed treatment|0
4979679|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant completed treatment|1
4979680|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant completed treatment|0
4979681|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant completed treatment|0
4979682|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant completed treatment|0
4979683|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant wanted break from treatment|0
4979684|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant wanted break from treatment|0
4979685|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant wanted break from treatment|1
4979686|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant wanted break from treatment|0
4979687|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant wanted break from treatment|0
4979688|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant wanted break from treatment|0
4979689|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant will start new treatment|0
4979690|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant will start new treatment|0
4979691|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant will start new treatment|0
4979692|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant will start new treatment|1
4979693|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant will start new treatment|0
4979694|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant will start new treatment|0
4979695|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant withdrew consent|0
4979696|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant withdrew consent|0
4979697|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant withdrew consent|0
4979698|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant withdrew consent|1
4979699|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant withdrew consent|0
4979700|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant withdrew consent|0
4979701|NCT00069095|17097669|P6|Post-study Treatment Phase|Investigator decision (enough treatment)|0
4979702|NCT00069095|17097670|P5|Post-study Treatment Phase|Investigator decision (enough treatment)|1
4979703|NCT00069095|17097671|P4|Post-study Treatment Phase|Investigator decision (enough treatment)|0
4979704|NCT00069095|17097672|P3|Post-study Treatment Phase|Investigator decision (enough treatment)|1
4979705|NCT00069095|17097673|P2|Post-study Treatment Phase|Investigator decision (enough treatment)|1
4979706|NCT00069095|17097674|P1|Post-study Treatment Phase|Investigator decision (enough treatment)|0
4979707|NCT00069095|17097669|P6|Post-study Treatment Phase|More than 21 days delay between cycles|0
4979708|NCT00069095|17097670|P5|Post-study Treatment Phase|More than 21 days delay between cycles|0
4979709|NCT00069095|17097671|P4|Post-study Treatment Phase|More than 21 days delay between cycles|0
4979710|NCT00069095|17097672|P3|Post-study Treatment Phase|More than 21 days delay between cycles|0
4979711|NCT00069095|17097673|P2|Post-study Treatment Phase|More than 21 days delay between cycles|1
4979712|NCT00069095|17097674|P1|Post-study Treatment Phase|More than 21 days delay between cycles|0
4979713|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant had complete response|0
4979714|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant had complete response|0
4979715|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant had complete response|0
4979716|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant had complete response|0
4979717|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant had complete response|1
4979718|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant had complete response|1
4979719|NCT00069095|17097669|P6|Post-study Treatment Phase|Participant refusal/Admin reasons|1
4979720|NCT00069095|17097670|P5|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4979721|NCT00069095|17097671|P4|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4979722|NCT00069095|17097672|P3|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4979723|NCT00069095|17097673|P2|Post-study Treatment Phase|Participant refusal/Admin reasons|0
4979724|NCT00069095|17097674|P1|Post-study Treatment Phase|Participant refusal/Admin reasons|1
4979725|NCT00069095|17097669|P6|Post-study Treatment Phase|Insufficient therapeutic response|9
4979726|NCT00069095|17097670|P5|Post-study Treatment Phase|Insufficient therapeutic response|7
4979727|NCT00069095|17097671|P4|Post-study Treatment Phase|Insufficient therapeutic response|6
4979728|NCT00069095|17097672|P3|Post-study Treatment Phase|Insufficient therapeutic response|5
4979729|NCT00069095|17097673|P2|Post-study Treatment Phase|Insufficient therapeutic response|4
4979730|NCT00069095|17097674|P1|Post-study Treatment Phase|Insufficient therapeutic response|1
4979731|NCT00069095|17097669|P6|Post-study Treatment Phase|Eligible for surgery|0
4979732|NCT00069095|17097670|P5|Post-study Treatment Phase|Eligible for surgery|0
4979733|NCT00069095|17097671|P4|Post-study Treatment Phase|Eligible for surgery|0
4979734|NCT00069095|17097672|P3|Post-study Treatment Phase|Eligible for surgery|0
4979735|NCT00069095|17097673|P2|Post-study Treatment Phase|Eligible for surgery|0
4979736|NCT00069095|17097674|P1|Post-study Treatment Phase|Eligible for surgery|2
4979737|NCT00069095|17097669|P6|Post-study Treatment Phase|Adverse Event|1
4979738|NCT00069095|17097670|P5|Post-study Treatment Phase|Adverse Event|5
4979739|NCT00069095|17097671|P4|Post-study Treatment Phase|Adverse Event|0
4979740|NCT00069095|17097672|P3|Post-study Treatment Phase|Adverse Event|1
4979741|NCT00069095|17097673|P2|Post-study Treatment Phase|Adverse Event|3
4979742|NCT00069095|17097674|P1|Post-study Treatment Phase|Adverse Event|2
4979743|NCT00069095|17097669|P6|Post-study Treatment Phase|Missing reason|17
4979744|NCT00069095|17097670|P5|Post-study Treatment Phase|Missing reason|18
4979745|NCT00069095|17097671|P4|Post-study Treatment Phase|Missing reason|8
4979746|NCT00069095|17097672|P3|Post-study Treatment Phase|Missing reason|12
4979747|NCT00069095|17097673|P2|Post-study Treatment Phase|Missing reason|3
4979748|NCT00069095|17097674|P1|Post-study Treatment Phase|Missing reason|1
4979749|NCT00069095|17097669|P6|Primary Treatment Phase|Violation criteria|5
4979750|NCT00069095|17097670|P5|Primary Treatment Phase|Violation criteria|1
4979751|NCT00069095|17097671|P4|Primary Treatment Phase|Violation criteria|3
4979752|NCT00069095|17097672|P3|Primary Treatment Phase|Violation criteria|4
4979753|NCT00069095|17097673|P2|Primary Treatment Phase|Violation criteria|2
4979754|NCT00069095|17097674|P1|Primary Treatment Phase|Violation criteria|0
4979755|NCT00069095|17097669|P6|Primary Treatment Phase|Other Violation|1
4979756|NCT00069095|17097670|P5|Primary Treatment Phase|Other Violation|0
4979757|NCT00069095|17097671|P4|Primary Treatment Phase|Other Violation|1
4979758|NCT00069095|17097672|P3|Primary Treatment Phase|Other Violation|1
4979759|NCT00069095|17097673|P2|Primary Treatment Phase|Other Violation|1
4979760|NCT00069095|17097674|P1|Primary Treatment Phase|Other Violation|0
4979761|NCT00069095|17097669|P6|Primary Treatment Phase|Withdrew|9
4979762|NCT00069095|17097670|P5|Primary Treatment Phase|Withdrew|4
4979763|NCT00069095|17097671|P4|Primary Treatment Phase|Withdrew|2
4979764|NCT00069095|17097672|P3|Primary Treatment Phase|Withdrew|8
4979765|NCT00069095|17097673|P2|Primary Treatment Phase|Withdrew|3
4979766|NCT00069095|17097674|P1|Primary Treatment Phase|Withdrew|2
4979767|NCT00069095|17097669|P6|Primary Treatment Phase|Refused treatment|27
4979768|NCT00069095|17097670|P5|Primary Treatment Phase|Refused treatment|24
4979769|NCT00069095|17097671|P4|Primary Treatment Phase|Refused treatment|31
4979770|NCT00069095|17097672|P3|Primary Treatment Phase|Refused treatment|17
4979771|NCT00069095|17097673|P2|Primary Treatment Phase|Refused treatment|26
4979772|NCT00069095|17097674|P1|Primary Treatment Phase|Refused treatment|15
4979773|NCT00069095|17097669|P6|Primary Treatment Phase|Insufficient Therapeutic Response|102
4979774|NCT00069095|17097670|P5|Primary Treatment Phase|Insufficient Therapeutic Response|101
4979775|NCT00069095|17097671|P4|Primary Treatment Phase|Insufficient Therapeutic Response|154
4979776|NCT00069095|17097672|P3|Primary Treatment Phase|Insufficient Therapeutic Response|175
4979777|NCT00069095|17097673|P2|Primary Treatment Phase|Insufficient Therapeutic Response|127
4979778|NCT00069095|17097674|P1|Primary Treatment Phase|Insufficient Therapeutic Response|131
4979779|NCT00069095|17097669|P6|Primary Treatment Phase|Failure to return|2
4979780|NCT00069095|17097670|P5|Primary Treatment Phase|Failure to return|0
4979781|NCT00069095|17097671|P4|Primary Treatment Phase|Failure to return|0
4979782|NCT00069095|17097672|P3|Primary Treatment Phase|Failure to return|0
4979783|NCT00069095|17097673|P2|Primary Treatment Phase|Failure to return|5
4979784|NCT00069095|17097674|P1|Primary Treatment Phase|Failure to return|5
4979785|NCT00069095|17097669|P6|Primary Treatment Phase|Death|8
4979786|NCT00069095|17097670|P5|Primary Treatment Phase|Death|8
4979787|NCT00069095|17097671|P4|Primary Treatment Phase|Death|5
4979788|NCT00069095|17097672|P3|Primary Treatment Phase|Death|2
4979789|NCT00069095|17097673|P2|Primary Treatment Phase|Death|8
4979790|NCT00069095|17097674|P1|Primary Treatment Phase|Death|14
4979791|NCT00069095|17097669|P6|Primary Treatment Phase|Adverse Event|101
4979792|NCT00069095|17097670|P5|Primary Treatment Phase|Adverse Event|109
4979793|NCT00069095|17097671|P4|Primary Treatment Phase|Adverse Event|72
4979794|NCT00069095|17097672|P3|Primary Treatment Phase|Adverse Event|71
4979795|NCT00069095|17097673|P2|Primary Treatment Phase|Adverse Event|92
4979796|NCT00069095|17097674|P1|Primary Treatment Phase|Adverse Event|99
4979797|NCT00069095|17097669|P6|Primary Treatment Phase|Admin/Other|42
4979798|NCT00069095|17097670|P5|Primary Treatment Phase|Admin/Other|48
4979799|NCT00069095|17097671|P4|Primary Treatment Phase|Admin/Other|45
4979800|NCT00069095|17097672|P3|Primary Treatment Phase|Admin/Other|31
4979801|NCT00069095|17097673|P2|Primary Treatment Phase|Admin/Other|38
4979802|NCT00069095|17097674|P1|Primary Treatment Phase|Admin/Other|29
4979803|NCT00069095|17097669|P6|Primary Treatment Phase|Ongoing|4
4979804|NCT00069095|17097670|P5|Primary Treatment Phase|Ongoing|7
4979805|NCT00069095|17097671|P4|Primary Treatment Phase|Ongoing|7
4979806|NCT00069095|17097672|P3|Primary Treatment Phase|Ongoing|5
4979807|NCT00069095|17097673|P2|Primary Treatment Phase|Ongoing|0
4979808|NCT00069095|17097674|P1|Primary Treatment Phase|Ongoing|0
4979809|NCT00068822|17097744|P2|First Randomized Intervention|Lost to Follow-up|2
4979810|NCT00068822|17097745|P1|First Randomized Intervention|Lost to Follow-up|1
4979811|NCT00068692|17097779|P8|Step 2: Randomization|never start protocol therapy|0
4979812|NCT00068692|17097780|P7|Step 2: Randomization|never start protocol therapy|0
4979813|NCT00068692|17097781|P6|Step 2: Randomization|never start protocol therapy|0
4979814|NCT00068692|17097782|P5|Step 2: Randomization|never start protocol therapy|1
4979815|NCT00068692|17097783|P4|Step 2: Randomization|never start protocol therapy|0
4979816|NCT00068692|17097784|P3|Step 2: Randomization|never start protocol therapy|1
4979817|NCT00068692|17097785|P2|Step 2: Randomization|never start protocol therapy|0
4979818|NCT00068692|17097786|P1|Step 2: Randomization|never start protocol therapy|0
4979819|NCT00068692|17097779|P8|Step 2: Randomization|Other|0
4979820|NCT00068692|17097780|P7|Step 2: Randomization|Other|0
4979821|NCT00068692|17097781|P6|Step 2: Randomization|Other|1
4979822|NCT00068692|17097782|P5|Step 2: Randomization|Other|0
4979823|NCT00068692|17097783|P4|Step 2: Randomization|Other|1
4979824|NCT00068692|17097784|P3|Step 2: Randomization|Other|0
4979825|NCT00068692|17097785|P2|Step 2: Randomization|Other|0
4979826|NCT00068692|17097786|P1|Step 2: Randomization|Other|0
4979827|NCT00068692|17097779|P8|Step 2: Randomization|Physician Decision|0
4979828|NCT00068692|17097780|P7|Step 2: Randomization|Physician Decision|0
4979829|NCT00068692|17097781|P6|Step 2: Randomization|Physician Decision|0
4979830|NCT00068692|17097782|P5|Step 2: Randomization|Physician Decision|1
4979831|NCT00068692|17097783|P4|Step 2: Randomization|Physician Decision|1
4979832|NCT00068692|17097784|P3|Step 2: Randomization|Physician Decision|0
4979833|NCT00068692|17097785|P2|Step 2: Randomization|Physician Decision|0
4979834|NCT00068692|17097786|P1|Step 2: Randomization|Physician Decision|0
4979835|NCT00068692|17097779|P8|Step 2: Randomization|alternative therapy|0
4979836|NCT00068692|17097780|P7|Step 2: Randomization|alternative therapy|0
4979837|NCT00068692|17097781|P6|Step 2: Randomization|alternative therapy|0
4979838|NCT00068692|17097782|P5|Step 2: Randomization|alternative therapy|1
4979839|NCT00068692|17097783|P4|Step 2: Randomization|alternative therapy|1
4979840|NCT00068692|17097784|P3|Step 2: Randomization|alternative therapy|0
4979841|NCT00068692|17097785|P2|Step 2: Randomization|alternative therapy|0
4979842|NCT00068692|17097786|P1|Step 2: Randomization|alternative therapy|0
4979843|NCT00068692|17097779|P8|Step 2: Randomization|Withdrawal by Subject|3
4979844|NCT00068692|17097780|P7|Step 2: Randomization|Withdrawal by Subject|0
4979845|NCT00068692|17097781|P6|Step 2: Randomization|Withdrawal by Subject|2
4979846|NCT00068692|17097782|P5|Step 2: Randomization|Withdrawal by Subject|3
4979847|NCT00068692|17097783|P4|Step 2: Randomization|Withdrawal by Subject|6
4979848|NCT00068692|17097784|P3|Step 2: Randomization|Withdrawal by Subject|4
4979849|NCT00068692|17097785|P2|Step 2: Randomization|Withdrawal by Subject|0
4979850|NCT00068692|17097786|P1|Step 2: Randomization|Withdrawal by Subject|0
4979851|NCT00068692|17097779|P8|Step 2: Randomization|Death|1
4979852|NCT00068692|17097780|P7|Step 2: Randomization|Death|0
4979853|NCT00068692|17097781|P6|Step 2: Randomization|Death|0
4979854|NCT00068692|17097782|P5|Step 2: Randomization|Death|1
4979855|NCT00068692|17097783|P4|Step 2: Randomization|Death|0
4979856|NCT00068692|17097784|P3|Step 2: Randomization|Death|0
4979857|NCT00068692|17097785|P2|Step 2: Randomization|Death|0
4979858|NCT00068692|17097786|P1|Step 2: Randomization|Death|0
4979859|NCT00068692|17097779|P8|Step 2: Randomization|Adverse Event|4
4979860|NCT00068692|17097780|P7|Step 2: Randomization|Adverse Event|4
4979861|NCT00068692|17097781|P6|Step 2: Randomization|Adverse Event|3
4979862|NCT00068692|17097782|P5|Step 2: Randomization|Adverse Event|2
4979863|NCT00068692|17097783|P4|Step 2: Randomization|Adverse Event|2
4979864|NCT00068692|17097784|P3|Step 2: Randomization|Adverse Event|4
4979865|NCT00068692|17097785|P2|Step 2: Randomization|Adverse Event|0
4979866|NCT00068692|17097786|P1|Step 2: Randomization|Adverse Event|0
4979867|NCT00068692|17097779|P8|Step 2: Randomization|Disesae progression/replase|0
4979868|NCT00068692|17097780|P7|Step 2: Randomization|Disesae progression/replase|0
4979869|NCT00068692|17097781|P6|Step 2: Randomization|Disesae progression/replase|0
4979870|NCT00068692|17097782|P5|Step 2: Randomization|Disesae progression/replase|0
4979871|NCT00068692|17097783|P4|Step 2: Randomization|Disesae progression/replase|1
4979872|NCT00068692|17097784|P3|Step 2: Randomization|Disesae progression/replase|1
4979873|NCT00068692|17097785|P2|Step 2: Randomization|Disesae progression/replase|0
4979874|NCT00068692|17097786|P1|Step 2: Randomization|Disesae progression/replase|0
4979875|NCT00068692|17097779|P8|Step 1: Registration|Registered but not randomized|0
4979876|NCT00068692|17097780|P7|Step 1: Registration|Registered but not randomized|0
4979877|NCT00068692|17097781|P6|Step 1: Registration|Registered but not randomized|0
4979878|NCT00068692|17097782|P5|Step 1: Registration|Registered but not randomized|0
4979879|NCT00068692|17097783|P4|Step 1: Registration|Registered but not randomized|0
4979880|NCT00068692|17097784|P3|Step 1: Registration|Registered but not randomized|0
4979881|NCT00068692|17097785|P2|Step 1: Registration|Registered but not randomized|1
4979882|NCT00068692|17097786|P1|Step 1: Registration|Registered but not randomized|0
4979883|NCT00068692|17097779|P8|Step 1: Registration|Not start protocol therapy|0
4979884|NCT00068692|17097780|P7|Step 1: Registration|Not start protocol therapy|0
4979885|NCT00068692|17097781|P6|Step 1: Registration|Not start protocol therapy|0
4979886|NCT00068692|17097782|P5|Step 1: Registration|Not start protocol therapy|0
4979887|NCT00068692|17097783|P4|Step 1: Registration|Not start protocol therapy|0
4979888|NCT00068692|17097784|P3|Step 1: Registration|Not start protocol therapy|0
4979889|NCT00068692|17097785|P2|Step 1: Registration|Not start protocol therapy|0
4979890|NCT00068692|17097786|P1|Step 1: Registration|Not start protocol therapy|3
4979891|NCT00068692|17097779|P8|Step 1: Registration|Other|0
4979892|NCT00068692|17097780|P7|Step 1: Registration|Other|0
4979893|NCT00068692|17097781|P6|Step 1: Registration|Other|0
4979894|NCT00068692|17097782|P5|Step 1: Registration|Other|0
4979895|NCT00068692|17097783|P4|Step 1: Registration|Other|0
4979896|NCT00068692|17097784|P3|Step 1: Registration|Other|0
4979897|NCT00068692|17097785|P2|Step 1: Registration|Other|0
4979898|NCT00068692|17097786|P1|Step 1: Registration|Other|2
4979899|NCT00068692|17097779|P8|Step 1: Registration|Not eligible|0
4979900|NCT00068692|17097780|P7|Step 1: Registration|Not eligible|0
4979901|NCT00068692|17097781|P6|Step 1: Registration|Not eligible|0
4979902|NCT00068692|17097782|P5|Step 1: Registration|Not eligible|0
4979903|NCT00068692|17097783|P4|Step 1: Registration|Not eligible|0
4979904|NCT00068692|17097784|P3|Step 1: Registration|Not eligible|0
4979905|NCT00068692|17097785|P2|Step 1: Registration|Not eligible|0
4979906|NCT00068692|17097786|P1|Step 1: Registration|Not eligible|6
4979907|NCT00068692|17097779|P8|Step 1: Registration|Protocol Violation|0
4979908|NCT00068692|17097780|P7|Step 1: Registration|Protocol Violation|0
4979909|NCT00068692|17097781|P6|Step 1: Registration|Protocol Violation|0
4979910|NCT00068692|17097782|P5|Step 1: Registration|Protocol Violation|0
4979911|NCT00068692|17097783|P4|Step 1: Registration|Protocol Violation|0
4979912|NCT00068692|17097784|P3|Step 1: Registration|Protocol Violation|0
4979913|NCT00068692|17097785|P2|Step 1: Registration|Protocol Violation|0
4979914|NCT00068692|17097786|P1|Step 1: Registration|Protocol Violation|1
4979915|NCT00068692|17097779|P8|Step 1: Registration|Complicating disease|0
4979916|NCT00068692|17097780|P7|Step 1: Registration|Complicating disease|0
4979917|NCT00068692|17097781|P6|Step 1: Registration|Complicating disease|0
4979918|NCT00068692|17097782|P5|Step 1: Registration|Complicating disease|0
4979919|NCT00068692|17097783|P4|Step 1: Registration|Complicating disease|0
4979920|NCT00068692|17097784|P3|Step 1: Registration|Complicating disease|0
4979921|NCT00068692|17097785|P2|Step 1: Registration|Complicating disease|0
4979922|NCT00068692|17097786|P1|Step 1: Registration|Complicating disease|2
4979923|NCT00068692|17097779|P8|Step 1: Registration|Alternative therapy|0
4979924|NCT00068692|17097780|P7|Step 1: Registration|Alternative therapy|0
4979925|NCT00068692|17097781|P6|Step 1: Registration|Alternative therapy|0
4979926|NCT00068692|17097782|P5|Step 1: Registration|Alternative therapy|0
4979927|NCT00068692|17097783|P4|Step 1: Registration|Alternative therapy|0
4979928|NCT00068692|17097784|P3|Step 1: Registration|Alternative therapy|0
4979929|NCT00068692|17097785|P2|Step 1: Registration|Alternative therapy|0
4979930|NCT00068692|17097786|P1|Step 1: Registration|Alternative therapy|2
4979931|NCT00068692|17097779|P8|Step 1: Registration|Withdrawal by Subject|0
4979932|NCT00068692|17097780|P7|Step 1: Registration|Withdrawal by Subject|0
4979933|NCT00068692|17097781|P6|Step 1: Registration|Withdrawal by Subject|0
4979934|NCT00068692|17097782|P5|Step 1: Registration|Withdrawal by Subject|0
4979935|NCT00068692|17097783|P4|Step 1: Registration|Withdrawal by Subject|0
4979936|NCT00068692|17097784|P3|Step 1: Registration|Withdrawal by Subject|0
4979937|NCT00068692|17097785|P2|Step 1: Registration|Withdrawal by Subject|0
4979938|NCT00068692|17097786|P1|Step 1: Registration|Withdrawal by Subject|11
4979939|NCT00068692|17097779|P8|Step 1: Registration|Death|0
4979940|NCT00068692|17097780|P7|Step 1: Registration|Death|0
4979941|NCT00068692|17097781|P6|Step 1: Registration|Death|0
4979942|NCT00068692|17097782|P5|Step 1: Registration|Death|0
4979943|NCT00068692|17097783|P4|Step 1: Registration|Death|0
4979944|NCT00068692|17097784|P3|Step 1: Registration|Death|0
4979945|NCT00068692|17097785|P2|Step 1: Registration|Death|0
4979946|NCT00068692|17097786|P1|Step 1: Registration|Death|1
4979947|NCT00068692|17097779|P8|Step 1: Registration|Adverse Event|0
4979948|NCT00068692|17097780|P7|Step 1: Registration|Adverse Event|0
4979949|NCT00068692|17097781|P6|Step 1: Registration|Adverse Event|0
4979950|NCT00068692|17097782|P5|Step 1: Registration|Adverse Event|0
4979951|NCT00068692|17097783|P4|Step 1: Registration|Adverse Event|0
4979952|NCT00068692|17097784|P3|Step 1: Registration|Adverse Event|0
4979953|NCT00068692|17097785|P2|Step 1: Registration|Adverse Event|0
4979954|NCT00068692|17097786|P1|Step 1: Registration|Adverse Event|7
4979955|NCT00068692|17097779|P8|Step 1: Registration|Disese progression/relapse|0
4979956|NCT00068692|17097780|P7|Step 1: Registration|Disese progression/relapse|0
4979957|NCT00068692|17097781|P6|Step 1: Registration|Disese progression/relapse|0
4979958|NCT00068692|17097782|P5|Step 1: Registration|Disese progression/relapse|0
4979959|NCT00068692|17097783|P4|Step 1: Registration|Disese progression/relapse|0
4979960|NCT00068692|17097784|P3|Step 1: Registration|Disese progression/relapse|0
4979961|NCT00068692|17097785|P2|Step 1: Registration|Disese progression/relapse|0
4980050|NCT00066703|17098109|P1|Overall Study|Death|3
4979962|NCT00068692|17097786|P1|Step 1: Registration|Disese progression/relapse|5
4979963|NCT00068601|17097809|P2|Overall Study|Missing primary outcome data|34
4979964|NCT00068601|17097810|P1|Overall Study|Missing primary outcome data|30
4979965|NCT00068601|17097809|P2|Overall Study|Lost to Follow-up|2
4979966|NCT00068601|17097810|P1|Overall Study|Lost to Follow-up|3
4979967|NCT00068601|17097809|P2|Overall Study|Death|3
4979968|NCT00068601|17097810|P1|Overall Study|Death|11
4979969|NCT00068601|17097809|P2|Overall Study|Not evaluable: hysterectomy/oophorectomy|4
4979970|NCT00068601|17097810|P1|Overall Study|Not evaluable: hysterectomy/oophorectomy|2
4979971|NCT00068601|17097809|P2|Overall Study|Not evaluable: withdrew consent|4
4979972|NCT00068601|17097810|P1|Overall Study|Not evaluable: withdrew consent|5
4979973|NCT00068601|17097809|P2|Overall Study|Ineligible|13
4979974|NCT00068601|17097810|P1|Overall Study|Ineligible|11
4979975|NCT00068588|17097823|P3|Overall Study|Poor KPS|1
4979976|NCT00068588|17097824|P2|Overall Study|Poor KPS|0
4979977|NCT00068588|17097825|P1|Overall Study|Poor KPS|0
4979978|NCT00068588|17097823|P3|Overall Study|Withdrawal by Subject|1
4979979|NCT00068588|17097824|P2|Overall Study|Withdrawal by Subject|0
4979980|NCT00068588|17097825|P1|Overall Study|Withdrawal by Subject|0
4979981|NCT00068588|17097823|P3|Overall Study|Adverse Event|2
4979982|NCT00068588|17097824|P2|Overall Study|Adverse Event|0
4979983|NCT00068588|17097825|P1|Overall Study|Adverse Event|0
4979984|NCT00068445|17097841|P2|Treatment|Other (Specifics not available)|5
4979985|NCT00068445|17097842|P1|Treatment|Other (Specifics not available)|9
4979986|NCT00068445|17097841|P2|Treatment|Adverse Event|1
4979987|NCT00068445|17097842|P1|Treatment|Adverse Event|7
4979988|NCT00068445|17097841|P2|Treatment|Refused Further Treatment|10
4979989|NCT00068445|17097842|P1|Treatment|Refused Further Treatment|13
4979990|NCT00068445|17097841|P2|Randomization|Ineligible|1
4979991|NCT00068445|17097842|P1|Randomization|Ineligible|1
4979992|NCT00068445|17097841|P2|Randomization|Cancel|3
4979993|NCT00068445|17097842|P1|Randomization|Cancel|1
4979994|NCT00068419|17097866|P1|Overall Study|Ineligible|11
4979995|NCT00068419|17097866|P1|Overall Study|Withdrawal by Subject|14
4979996|NCT00068419|17097866|P1|Overall Study|Physician Decision|7
4979997|NCT00068419|17097866|P1|Overall Study|Lost to Follow-up|1
4979998|NCT00068419|17097866|P1|Overall Study|Lack of Efficacy|24
4979999|NCT00068419|17097866|P1|Overall Study|Adverse Event|3
4980000|NCT00068406|17097875|P1|Overall Study|Ineligible-Inadequate Pathology|2
4980001|NCT00068406|17097875|P1|Overall Study|Ineligible-improper pre-protocol treatm|1
4980002|NCT00068393|17097880|P1|Overall Study|Quality of life worsening|1
4980003|NCT00068393|17097880|P1|Overall Study|Alternative treatment|1
4980004|NCT00068393|17097880|P1|Overall Study|Withdrawal by Subject|3
4980005|NCT00068393|17097880|P1|Overall Study|Death|3
4980006|NCT00068393|17097880|P1|Overall Study|Adverse Event|2
4980007|NCT00068380|17097886|P1|Overall Study|Adverse Event|2
4980008|NCT00068380|17097886|P1|Overall Study|Withdrawal by Subject|3
4980009|NCT00068250|17097930|P4|Phase I: Dose Level 2|Protocol Violation|0
4980010|NCT00068250|17097931|P3|Phase I: Dose Level 2|Protocol Violation|0
4980011|NCT00068250|17097932|P2|Phase I: Dose Level 2|Protocol Violation|1
4980012|NCT00068250|17097933|P1|Phase I: Dose Level 2|Protocol Violation|0
4980013|NCT00068237|17097943|P1|Overall Study|No protocol treatment received|2
4980014|NCT00068237|17097943|P1|Overall Study|Ineligible|3
4980015|NCT00068107|17097955|P1|Overall Study|Withdrawal by Subject|1
4980016|NCT00068107|17097955|P1|Overall Study|Death|2
4980017|NCT00068107|17097955|P1|Overall Study|end-stage renal disease|6
4980018|NCT00067990|17097968|P2|Overall Study|Withdrawal by Subject|12
4980019|NCT00067990|17097969|P1|Overall Study|Withdrawal by Subject|4
4980020|NCT00067990|17097968|P2|Overall Study|ESRD, Non IF/TA|3
4980021|NCT00067990|17097969|P1|Overall Study|ESRD, Non IF/TA|1
4980022|NCT00067990|17097968|P2|Overall Study|Death|7
4980023|NCT00067990|17097969|P1|Overall Study|Death|5
4980024|NCT00067470|17097992|P2|Overall Study|Withdrawal by Subject|1
4980025|NCT00067470|17097993|P1|Overall Study|Withdrawal by Subject|0
4980026|NCT00067002|17098014|P2|Overall Study|Graft Failure|6
4980027|NCT00067002|17098015|P1|Overall Study|Graft Failure|5
4980028|NCT00067002|17098014|P2|Overall Study|Delayed|1
4980029|NCT00067002|17098015|P1|Overall Study|Delayed|1
4980030|NCT00067002|17098014|P2|Overall Study|Early Death|2
4980031|NCT00067002|17098015|P1|Overall Study|Early Death|1
4980032|NCT00066807|17098073|P2|Overall Study|Study was terminated early|15
4980033|NCT00066807|17098074|P1|Overall Study|Study was terminated early|14
4980034|NCT00066742|17098099|P1|Consolidation Chemotherapy|Ineligible|2
4980035|NCT00066742|17098099|P1|Consolidation Chemotherapy|not protocol specified|1
4980036|NCT00066742|17098099|P1|Induction Chemoradiotherapy|Ineligible|3
4980037|NCT00066742|17098099|P1|Induction Chemoradiotherapy|not protocol specified|2
4980038|NCT00066742|17098099|P1|Induction Chemoradiotherapy|Withdrawal by Subject|2
4980039|NCT00066742|17098099|P1|Induction Chemoradiotherapy|Adverse Event|21
4980040|NCT00066742|17098099|P1|Induction Chemoradiotherapy|Did not receive any protocol treatment|1
4980041|NCT00066703|17098108|P2|Overall Study|Treatment ongoing|311
4980042|NCT00066703|17098109|P1|Overall Study|Treatment ongoing|346
4980043|NCT00066703|17098108|P2|Overall Study|Withdrawal by Subject|63
4980044|NCT00066703|17098109|P1|Overall Study|Withdrawal by Subject|38
4980045|NCT00066703|17098108|P2|Overall Study|Lost to Follow-up|28
4980046|NCT00066703|17098109|P1|Overall Study|Lost to Follow-up|31
4980047|NCT00066703|17098108|P2|Overall Study|Lack of Efficacy|69
4980048|NCT00066703|17098109|P1|Overall Study|Lack of Efficacy|114
4980049|NCT00066703|17098108|P2|Overall Study|Death|0
4980051|NCT00066703|17098108|P2|Overall Study|Adverse Event|111
4980052|NCT00066703|17098109|P1|Overall Study|Adverse Event|80
4980053|NCT00066690|17098124|P3|Overall Study|Treatment Ongoing|282
4980054|NCT00066690|17098125|P2|Overall Study|Treatment Ongoing|278
4980055|NCT00066690|17098126|P1|Overall Study|Treatment Ongoing|246
4980056|NCT00066690|17098124|P3|Overall Study|Withdrawal by Subject|49
4980057|NCT00066690|17098125|P2|Overall Study|Withdrawal by Subject|55
4980058|NCT00066690|17098126|P1|Overall Study|Withdrawal by Subject|50
4980059|NCT00066690|17098124|P3|Overall Study|Lost to Follow-up|29
4980060|NCT00066690|17098125|P2|Overall Study|Lost to Follow-up|21
4980061|NCT00066690|17098126|P1|Overall Study|Lost to Follow-up|40
4980062|NCT00066690|17098124|P3|Overall Study|Lack of Efficacy|76
4980063|NCT00066690|17098125|P2|Overall Study|Lack of Efficacy|110
4980064|NCT00066690|17098126|P1|Overall Study|Lack of Efficacy|114
4980065|NCT00066690|17098124|P3|Overall Study|Death|2
4980066|NCT00066690|17098125|P2|Overall Study|Death|0
4980067|NCT00066690|17098126|P1|Overall Study|Death|3
4980068|NCT00066690|17098124|P3|Overall Study|Adverse Event|126
4980069|NCT00066690|17098125|P2|Overall Study|Adverse Event|58
4980070|NCT00066690|17098126|P1|Overall Study|Adverse Event|145
4980071|NCT00066573|17098145|P2|Overall Study|Did not received protocol treatment|28
4980072|NCT00066573|17098146|P1|Overall Study|Did not received protocol treatment|28
4980073|NCT00066469|17098158|P1|Overall Study|ineligible|1
4980074|NCT00066469|17098158|P1|Overall Study|Withdrawal by Subject|1
4980075|NCT00066469|17098158|P1|Overall Study|Physician Decision|1
4980076|NCT00066469|17098158|P1|Overall Study|Lost to Follow-up|1
4980077|NCT00066469|17098158|P1|Overall Study|Lack of Efficacy|9
4980078|NCT00066469|17098158|P1|Overall Study|Death|3
4980079|NCT00066365|17098164|P2|Overall Study|Ineligible|2
4980080|NCT00066365|17098165|P1|Overall Study|Ineligible|4
4980081|NCT00066365|17098164|P2|Overall Study|No viable tumor after 1 cycle of therapy|0
4980082|NCT00066365|17098165|P1|Overall Study|No viable tumor after 1 cycle of therapy|2
4980083|NCT00066365|17098164|P2|Overall Study|Physician Decision|0
4980084|NCT00066365|17098165|P1|Overall Study|Physician Decision|1
4980085|NCT00066365|17098164|P2|Overall Study|Lack of Efficacy|12
4980086|NCT00066365|17098165|P1|Overall Study|Lack of Efficacy|15
4980087|NCT00066365|17098164|P2|Overall Study|Adverse Event|0
4980088|NCT00066365|17098165|P1|Overall Study|Adverse Event|1
4980089|NCT00066222|17098193|P1|Overall Study|No protocol treatment received|1
4980090|NCT00066170|17098206|P4|Overall Study|Other|0
4980091|NCT00066170|17098207|P3|Overall Study|Other|2
4980092|NCT00066170|17098208|P2|Overall Study|Other|5
4980093|NCT00066170|17098209|P1|Overall Study|Other|1
4980094|NCT00066170|17098206|P4|Overall Study|Protocol Violation|0
4980095|NCT00066170|17098207|P3|Overall Study|Protocol Violation|0
4980096|NCT00066170|17098208|P2|Overall Study|Protocol Violation|0
4980097|NCT00066170|17098209|P1|Overall Study|Protocol Violation|3
4980098|NCT00066170|17098206|P4|Overall Study|Non-Compliance with Trial Medicine|1
4980099|NCT00066170|17098207|P3|Overall Study|Non-Compliance with Trial Medicine|0
4980100|NCT00066170|17098208|P2|Overall Study|Non-Compliance with Trial Medicine|0
4980101|NCT00066170|17098209|P1|Overall Study|Non-Compliance with Trial Medicine|1
4980102|NCT00066170|17098206|P4|Overall Study|Lost to Follow-up|0
4980103|NCT00066170|17098207|P3|Overall Study|Lost to Follow-up|0
4980104|NCT00066170|17098208|P2|Overall Study|Lost to Follow-up|1
4980105|NCT00066170|17098209|P1|Overall Study|Lost to Follow-up|0
4980106|NCT00066170|17098206|P4|Overall Study|Serious Adverse Event|1
4980107|NCT00066170|17098207|P3|Overall Study|Serious Adverse Event|1
4980108|NCT00066170|17098208|P2|Overall Study|Serious Adverse Event|0
4980109|NCT00066170|17098209|P1|Overall Study|Serious Adverse Event|0
4980110|NCT00066170|17098206|P4|Overall Study|Adverse Event|7
4980111|NCT00066170|17098207|P3|Overall Study|Adverse Event|1
4980112|NCT00066170|17098208|P2|Overall Study|Adverse Event|4
4980113|NCT00066170|17098209|P1|Overall Study|Adverse Event|2
4980114|NCT00066066|17098222|P6|Overall Study|Lost to Follow-up|5
4980115|NCT00066066|17098223|P5|Overall Study|Lost to Follow-up|3
4980116|NCT00066066|17098224|P4|Overall Study|Lost to Follow-up|4
4980117|NCT00066066|17098225|P3|Overall Study|Lost to Follow-up|7
4980118|NCT00066066|17098226|P2|Overall Study|Lost to Follow-up|4
4980119|NCT00066066|17098227|P1|Overall Study|Lost to Follow-up|6
4980120|NCT00065507|17098305|P2|Overall Study|Subject No Longer Meets Study Criteria|0
4980121|NCT00065507|17098306|P1|Overall Study|Subject No Longer Meets Study Criteria|1
4980122|NCT00065507|17098305|P2|Overall Study|Subject Withdrew Consent|1
4980123|NCT00065507|17098306|P1|Overall Study|Subject Withdrew Consent|2
4980124|NCT00065507|17098305|P2|Overall Study|Lost to Follow-up|0
4980125|NCT00065507|17098306|P1|Overall Study|Lost to Follow-up|3
4980126|NCT00065507|17098305|P2|Overall Study|Poor/Non-compliance|2
4980127|NCT00065507|17098306|P1|Overall Study|Poor/Non-compliance|3
4980128|NCT00065507|17098305|P2|Overall Study|Lack of Efficacy|6
4980129|NCT00065507|17098306|P1|Overall Study|Lack of Efficacy|0
4980130|NCT00065507|17098305|P2|Overall Study|Adverse Event|3
4980131|NCT00065507|17098306|P1|Overall Study|Adverse Event|4
4980132|NCT00065507|17098305|P2|Overall Study|Death|17
4980133|NCT00065507|17098306|P1|Overall Study|Death|16
4980134|NCT00065468|17098371|P3|Overall Study|Other|18
4980135|NCT00065468|17098372|P2|Overall Study|Other|24
4980136|NCT00065468|17098373|P1|Overall Study|Other|14
4980137|NCT00065468|17098371|P3|Overall Study|Disease progression|1
4980138|NCT00065468|17098372|P2|Overall Study|Disease progression|0
4980139|NCT00065468|17098373|P1|Overall Study|Disease progression|0
4980140|NCT00065468|17098371|P3|Overall Study|Discontinuation of study by Sponsor|13
4980141|NCT00065468|17098372|P2|Overall Study|Discontinuation of study by Sponsor|9
4980142|NCT00065468|17098373|P1|Overall Study|Discontinuation of study by Sponsor|13
4980143|NCT00065468|17098371|P3|Overall Study|Lost to Follow-up|2
4980144|NCT00065468|17098372|P2|Overall Study|Lost to Follow-up|3
4980145|NCT00065468|17098373|P1|Overall Study|Lost to Follow-up|5
4980146|NCT00065468|17098371|P3|Overall Study|Withdrawal by Subject|5
4980147|NCT00065468|17098372|P2|Overall Study|Withdrawal by Subject|4
4980148|NCT00065468|17098373|P1|Overall Study|Withdrawal by Subject|3
4980149|NCT00065468|17098371|P3|Overall Study|Death|171
4980150|NCT00065468|17098372|P2|Overall Study|Death|169
4980151|NCT00065468|17098373|P1|Overall Study|Death|172
4980152|NCT00065442|17098404|P2|Overall Study|Withdrawal by Subject|9
4980153|NCT00065442|17098405|P1|Overall Study|Withdrawal by Subject|3
4980154|NCT00065442|17098404|P2|Overall Study|Death|210
4980155|NCT00065442|17098405|P1|Overall Study|Death|121
4980156|NCT00065442|17098404|P2|Overall Study|Lost to Follow-up|1
4980157|NCT00065442|17098405|P1|Overall Study|Lost to Follow-up|1
4980158|NCT00065429|17098420|P7|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4980159|NCT00065429|17098421|P6|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4980160|NCT00065429|17098422|P5|Phase II - Apr 2003 - Aug 2008|Adverse Event|2
4980161|NCT00065429|17098423|P4|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4980162|NCT00065429|17098424|P3|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4980163|NCT00065429|17098425|P2|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4980164|NCT00065429|17098426|P1|Phase II - Apr 2003 - Aug 2008|Adverse Event|0
4980165|NCT00065429|17098420|P7|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4980166|NCT00065429|17098421|P6|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4980167|NCT00065429|17098422|P5|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4
4980168|NCT00065429|17098423|P4|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4980169|NCT00065429|17098424|P3|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4980170|NCT00065429|17098425|P2|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4980171|NCT00065429|17098426|P1|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0
4980172|NCT00065429|17098420|P7|Phase I - May 2001 - Oct 2002|Adverse Event|2
4980173|NCT00065429|17098421|P6|Phase I - May 2001 - Oct 2002|Adverse Event|1
4980174|NCT00065429|17098422|P5|Phase I - May 2001 - Oct 2002|Adverse Event|0
4980175|NCT00065429|17098423|P4|Phase I - May 2001 - Oct 2002|Adverse Event|1
4980176|NCT00065429|17098424|P3|Phase I - May 2001 - Oct 2002|Adverse Event|0
4980177|NCT00065429|17098425|P2|Phase I - May 2001 - Oct 2002|Adverse Event|0
4980178|NCT00065429|17098426|P1|Phase I - May 2001 - Oct 2002|Adverse Event|0
4980179|NCT00065429|17098420|P7|Phase I - May 2001 - Oct 2002|Death|0
4980180|NCT00065429|17098421|P6|Phase I - May 2001 - Oct 2002|Death|0
4980181|NCT00065429|17098422|P5|Phase I - May 2001 - Oct 2002|Death|1
4980182|NCT00065429|17098423|P4|Phase I - May 2001 - Oct 2002|Death|0
4980183|NCT00065429|17098424|P3|Phase I - May 2001 - Oct 2002|Death|0
4980184|NCT00065429|17098425|P2|Phase I - May 2001 - Oct 2002|Death|0
4980185|NCT00065429|17098426|P1|Phase I - May 2001 - Oct 2002|Death|0
4980186|NCT00065429|17098420|P7|Phase I - May 2001 - Oct 2002|Physician Decision|0
4980187|NCT00065429|17098421|P6|Phase I - May 2001 - Oct 2002|Physician Decision|0
4980188|NCT00065429|17098422|P5|Phase I - May 2001 - Oct 2002|Physician Decision|0
4980189|NCT00065429|17098423|P4|Phase I - May 2001 - Oct 2002|Physician Decision|0
4980190|NCT00065429|17098424|P3|Phase I - May 2001 - Oct 2002|Physician Decision|0
4980191|NCT00065429|17098425|P2|Phase I - May 2001 - Oct 2002|Physician Decision|0
4980192|NCT00065429|17098426|P1|Phase I - May 2001 - Oct 2002|Physician Decision|1
4980193|NCT00065429|17098420|P7|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4980194|NCT00065429|17098421|P6|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4980195|NCT00065429|17098422|P5|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4980196|NCT00065429|17098423|P4|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4980197|NCT00065429|17098424|P3|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1
4980198|NCT00065429|17098425|P2|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4980199|NCT00065429|17098426|P1|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0
4980200|NCT00065429|17098420|P7|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4980201|NCT00065429|17098421|P6|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1
4980202|NCT00065429|17098422|P5|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4980203|NCT00065429|17098423|P4|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4980204|NCT00065429|17098424|P3|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4980205|NCT00065429|17098425|P2|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4980206|NCT00065429|17098426|P1|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0
4980207|NCT00065260|17098440|P2|Overall Study|Death|1
4980208|NCT00065260|17098441|P1|Overall Study|Death|0
4980209|NCT00065182|17098449|P2|Overall Study|Decline in Status|1
4980210|NCT00065182|17098450|P1|Overall Study|Decline in Status|0
4980211|NCT00065182|17098449|P2|Overall Study|Death|1
4980212|NCT00065182|17098450|P1|Overall Study|Death|0
4980213|NCT00065182|17098449|P2|Overall Study|No clinical benefit|0
4980214|NCT00065182|17098450|P1|Overall Study|No clinical benefit|1
4980215|NCT00065182|17098449|P2|Overall Study|Withdrawal by Subject|3
4980216|NCT00065182|17098450|P1|Overall Study|Withdrawal by Subject|8
4980217|NCT00065182|17098449|P2|Overall Study|Sponsor Decision|7
4980218|NCT00065182|17098450|P1|Overall Study|Sponsor Decision|11
4980219|NCT00065182|17098449|P2|Overall Study|Serious adverse events (SAE)|0
4980220|NCT00065182|17098450|P1|Overall Study|Serious adverse events (SAE)|1
4980221|NCT00065182|17098449|P2|Overall Study|Protocol Violation|4
4980222|NCT00065182|17098450|P1|Overall Study|Protocol Violation|3
4980223|NCT00065182|17098449|P2|Overall Study|Lost to Follow-up|4
4980224|NCT00065182|17098450|P1|Overall Study|Lost to Follow-up|0
4980225|NCT00065182|17098449|P2|Overall Study|Adverse Event|17
4980226|NCT00065182|17098450|P1|Overall Study|Adverse Event|24
4980227|NCT00065156|17098476|P1|Overall Study|Secondary Malign Disease|1
4980228|NCT00065156|17098476|P1|Overall Study|Loss of Response|1
4980229|NCT00065156|17098476|P1|Overall Study|Non-Compliance|2
4980230|NCT00065156|17098476|P1|Overall Study|Investigator Decision|2
4980231|NCT00065156|17098476|P1|Overall Study|Disease Progression|7
4980232|NCT00065156|17098476|P1|Overall Study|Study Closed by Sponsor|2
4980233|NCT00065156|17098476|P1|Overall Study|Death|11
4980234|NCT00065156|17098476|P1|Overall Study|Lost to Follow-up|1
4980235|NCT00065156|17098476|P1|Overall Study|Withdrawal by Subject|8
4980236|NCT00065156|17098476|P1|Overall Study|Lack of Efficacy|52
4980237|NCT00065156|17098476|P1|Overall Study|Adverse Event|37
4980238|NCT00065065|17098493|P2|Overall Study|Other|2
4980239|NCT00065065|17098494|P1|Overall Study|Other|2
4980240|NCT00065065|17098493|P2|Overall Study|Lack of Efficacy|11
4980241|NCT00065065|17098494|P1|Overall Study|Lack of Efficacy|4
4980242|NCT00065065|17098493|P2|Overall Study|Withdrawal by Subject|5
4980243|NCT00065065|17098494|P1|Overall Study|Withdrawal by Subject|1
4980244|NCT00065065|17098493|P2|Overall Study|Adverse Event|2
4980245|NCT00065065|17098494|P1|Overall Study|Adverse Event|3
4980246|NCT00003895|17098506|P2|Overall Study|Withdrawal by Subject|3
4980247|NCT00003895|17098507|P1|Overall Study|Withdrawal by Subject|0
4980248|NCT00003895|17098506|P2|Overall Study|Patient Vacation|0
4980249|NCT00003895|17098507|P1|Overall Study|Patient Vacation|2
4980250|NCT00003895|17098506|P2|Overall Study|Lack of Efficacy|1
4980251|NCT00003895|17098507|P1|Overall Study|Lack of Efficacy|1
4980252|NCT00003895|17098506|P2|Overall Study|Adverse Event|0
4980253|NCT00003895|17098507|P1|Overall Study|Adverse Event|4
4980254|NCT00064987|17098515|P2|Overall Study|Physician Decision|0
4980255|NCT00064987|17098516|P1|Overall Study|Physician Decision|3
4980256|NCT00064753|17098547|P2|Overall Study|Lost to Follow-up|235
4980257|NCT00064753|17098548|P1|Overall Study|Lost to Follow-up|225
4980258|NCT00064753|17098547|P2|Overall Study|Withdrawal by Subject|171
4980259|NCT00064753|17098548|P1|Overall Study|Withdrawal by Subject|198
4980260|NCT00064753|17098547|P2|Overall Study|Death|242
4980261|NCT00064753|17098548|P1|Overall Study|Death|251
4980262|NCT00003645|17098578|P2|Overall Study|Withdrawal by Subject|3
4980263|NCT00003645|17098579|P1|Overall Study|Withdrawal by Subject|1
4980264|NCT00003645|17098578|P2|Overall Study|Lost to Follow-up|8
4980265|NCT00003645|17098579|P1|Overall Study|Lost to Follow-up|7
4980266|NCT00003645|17098578|P2|Overall Study|Death|1
4980267|NCT00003645|17098579|P1|Overall Study|Death|4
4980268|NCT00064792|17098593|P2|Overall Study|Adverse Event|0
4980269|NCT00064792|17098594|P1|Overall Study|Adverse Event|3
4980270|NCT00064792|17098593|P2|Overall Study|Withdrawal by Subject|0
4980271|NCT00064792|17098594|P1|Overall Study|Withdrawal by Subject|2
4980272|NCT00064701|17098605|P3|Clinical Continuation Phase|Patient opted out|1
4980273|NCT00064701|17098606|P2|Clinical Continuation Phase|Patient opted out|0
4980274|NCT00064701|17098607|P1|Clinical Continuation Phase|Patient opted out|0
4980275|NCT00064701|17098605|P3|Clinical Continuation Phase|Incorrect study drug dispensed|0
4980276|NCT00064701|17098606|P2|Clinical Continuation Phase|Incorrect study drug dispensed|1
4980277|NCT00064701|17098607|P1|Clinical Continuation Phase|Incorrect study drug dispensed|0
4980278|NCT00064701|17098605|P3|Clinical Continuation Phase|Discharged to nursing home|0
4980279|NCT00064701|17098606|P2|Clinical Continuation Phase|Discharged to nursing home|1
4980280|NCT00064701|17098607|P1|Clinical Continuation Phase|Discharged to nursing home|0
4980281|NCT00064701|17098605|P3|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
4980282|NCT00064701|17098606|P2|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1
4980283|NCT00064701|17098607|P1|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0
4980284|NCT00064701|17098605|P3|Clinical Continuation Phase|Pancreas transplant|0
4980285|NCT00064701|17098606|P2|Clinical Continuation Phase|Pancreas transplant|0
4980286|NCT00064701|17098607|P1|Clinical Continuation Phase|Pancreas transplant|1
4980287|NCT00064701|17098605|P3|Clinical Continuation Phase|Unable to return to site for study visit|1
4980288|NCT00064701|17098606|P2|Clinical Continuation Phase|Unable to return to site for study visit|0
4980289|NCT00064701|17098607|P1|Clinical Continuation Phase|Unable to return to site for study visit|1
4980290|NCT00064701|17098605|P3|Clinical Continuation Phase|Physician Decision|0
4980291|NCT00064701|17098606|P2|Clinical Continuation Phase|Physician Decision|3
4980292|NCT00064701|17098607|P1|Clinical Continuation Phase|Physician Decision|1
4980293|NCT00064701|17098605|P3|Clinical Continuation Phase|Immunosuppressive treatment crossover|6
4980294|NCT00064701|17098606|P2|Clinical Continuation Phase|Immunosuppressive treatment crossover|3
4980295|NCT00064701|17098607|P1|Clinical Continuation Phase|Immunosuppressive treatment crossover|0
4980296|NCT00064701|17098605|P3|Clinical Continuation Phase|Sponsor discontinued study|79
4980297|NCT00064701|17098606|P2|Clinical Continuation Phase|Sponsor discontinued study|129
4980298|NCT00064701|17098607|P1|Clinical Continuation Phase|Sponsor discontinued study|113
4980299|NCT00064701|17098605|P3|Clinical Continuation Phase|Rejection|2
4980300|NCT00064701|17098606|P2|Clinical Continuation Phase|Rejection|2
4980301|NCT00064701|17098607|P1|Clinical Continuation Phase|Rejection|1
4980302|NCT00064701|17098605|P3|Clinical Continuation Phase|Graft Failure|2
4980303|NCT00064701|17098606|P2|Clinical Continuation Phase|Graft Failure|5
4980304|NCT00064701|17098607|P1|Clinical Continuation Phase|Graft Failure|5
4980305|NCT00064701|17098605|P3|Clinical Continuation Phase|Lost to Follow-up|6
4980306|NCT00064701|17098606|P2|Clinical Continuation Phase|Lost to Follow-up|3
4980307|NCT00064701|17098607|P1|Clinical Continuation Phase|Lost to Follow-up|6
4980308|NCT00064701|17098605|P3|Clinical Continuation Phase|Withdrawal by Subject|22
4980309|NCT00064701|17098606|P2|Clinical Continuation Phase|Withdrawal by Subject|3
4980310|NCT00064701|17098607|P1|Clinical Continuation Phase|Withdrawal by Subject|22
4980311|NCT00064701|17098605|P3|Clinical Continuation Phase|Non-compliance|7
4980312|NCT00064701|17098606|P2|Clinical Continuation Phase|Non-compliance|6
4980313|NCT00064701|17098607|P1|Clinical Continuation Phase|Non-compliance|8
4980314|NCT00064701|17098605|P3|Clinical Continuation Phase|Adverse Event|14
4980315|NCT00064701|17098606|P2|Clinical Continuation Phase|Adverse Event|21
4980316|NCT00064701|17098607|P1|Clinical Continuation Phase|Adverse Event|12
4980317|NCT00064701|17098605|P3|One Year Post-transplant|Pancreas transplant|1
4980318|NCT00064701|17098606|P2|One Year Post-transplant|Pancreas transplant|0
4980319|NCT00064701|17098607|P1|One Year Post-transplant|Pancreas transplant|0
4980320|NCT00064701|17098605|P3|One Year Post-transplant|Poor absorption|0
4980321|NCT00064701|17098606|P2|One Year Post-transplant|Poor absorption|1
4980322|NCT00064701|17098607|P1|One Year Post-transplant|Poor absorption|0
4980323|NCT00064701|17098605|P3|One Year Post-transplant|Crossover secondary to possible toxicity|0
4980324|NCT00064701|17098606|P2|One Year Post-transplant|Crossover secondary to possible toxicity|1
4980325|NCT00064701|17098607|P1|One Year Post-transplant|Crossover secondary to possible toxicity|0
4980326|NCT00064701|17098605|P3|One Year Post-transplant|Incorrect study drug dispensed|0
4980327|NCT00064701|17098606|P2|One Year Post-transplant|Incorrect study drug dispensed|1
4980328|NCT00064701|17098607|P1|One Year Post-transplant|Incorrect study drug dispensed|0
4980329|NCT00064701|17098605|P3|One Year Post-transplant|Acute tubular necrosis|0
4980330|NCT00064701|17098606|P2|One Year Post-transplant|Acute tubular necrosis|0
4980331|NCT00064701|17098607|P1|One Year Post-transplant|Acute tubular necrosis|1
4980332|NCT00064701|17098605|P3|One Year Post-transplant|Converted to rapamycin|0
4980333|NCT00064701|17098606|P2|One Year Post-transplant|Converted to rapamycin|0
4980334|NCT00064701|17098607|P1|One Year Post-transplant|Converted to rapamycin|1
4980335|NCT00064701|17098605|P3|One Year Post-transplant|Lost to Follow-up|0
4980336|NCT00064701|17098606|P2|One Year Post-transplant|Lost to Follow-up|0
4980337|NCT00064701|17098607|P1|One Year Post-transplant|Lost to Follow-up|1
4980338|NCT00064701|17098605|P3|One Year Post-transplant|Withdrawal by Subject|1
4980339|NCT00064701|17098606|P2|One Year Post-transplant|Withdrawal by Subject|4
4980340|NCT00064701|17098607|P1|One Year Post-transplant|Withdrawal by Subject|0
4980341|NCT00064701|17098605|P3|One Year Post-transplant|Graft Failure|1
4980342|NCT00064701|17098606|P2|One Year Post-transplant|Graft Failure|2
4980343|NCT00064701|17098607|P1|One Year Post-transplant|Graft Failure|3
4980344|NCT00064701|17098605|P3|One Year Post-transplant|Non-compliance|5
4980345|NCT00064701|17098606|P2|One Year Post-transplant|Non-compliance|2
4980346|NCT00064701|17098607|P1|One Year Post-transplant|Non-compliance|4
4980347|NCT00064701|17098605|P3|One Year Post-transplant|Rejection|16
4980348|NCT00064701|17098606|P2|One Year Post-transplant|Rejection|1
4980349|NCT00064701|17098607|P1|One Year Post-transplant|Rejection|0
4980350|NCT00064701|17098605|P3|One Year Post-transplant|Adverse Event|37
4980351|NCT00064701|17098606|P2|One Year Post-transplant|Adverse Event|19
4980352|NCT00064701|17098607|P1|One Year Post-transplant|Adverse Event|23
4980353|NCT00064701|17098605|P3|One Year Post-transplant|Did not receive study drug|11
4980354|NCT00064701|17098606|P2|One Year Post-transplant|Did not receive study drug|12
4980355|NCT00064701|17098607|P1|One Year Post-transplant|Did not receive study drug|7
4980356|NCT00064662|17098659|P2|Overall Study|Administratively withdrawn|2
4980357|NCT00064662|17098660|P1|Overall Study|Administratively withdrawn|2
4980358|NCT00064662|17098659|P2|Overall Study|Withdrawal by Subject|14
4980359|NCT00064662|17098660|P1|Overall Study|Withdrawal by Subject|14
4980360|NCT00064662|17098659|P2|Overall Study|Lost to Follow-up|44
4980361|NCT00064662|17098660|P1|Overall Study|Lost to Follow-up|57
4980362|NCT00064662|17098659|P2|Overall Study|Death|1
4980363|NCT00064662|17098660|P1|Overall Study|Death|1
4980364|NCT00064350|17098671|P3|Cross-Over|Other|0
4980365|NCT00064350|17098672|P2|Cross-Over|Other|2
4980366|NCT00064350|17098673|P1|Cross-Over|Other|0
4980367|NCT00064350|17098671|P3|Cross-Over|Ineligible or never started treatment|0
4980368|NCT00064350|17098672|P2|Cross-Over|Ineligible or never started treatment|6
4980369|NCT00064350|17098673|P1|Cross-Over|Ineligible or never started treatment|3
4980370|NCT00064350|17098671|P3|Cross-Over|Withdrawal by Subject|0
4980371|NCT00064350|17098672|P2|Cross-Over|Withdrawal by Subject|2
4980372|NCT00064350|17098673|P1|Cross-Over|Withdrawal by Subject|2
4980373|NCT00064350|17098671|P3|Cross-Over|Death|0
4980374|NCT00064350|17098672|P2|Cross-Over|Death|3
4980375|NCT00064350|17098673|P1|Cross-Over|Death|1
4980376|NCT00064350|17098671|P3|Cross-Over|Adverse Event|0
4980377|NCT00064350|17098672|P2|Cross-Over|Adverse Event|1
4980378|NCT00064350|17098673|P1|Cross-Over|Adverse Event|0
4980379|NCT00064350|17098671|P3|Randomization|Other|0
4980380|NCT00064350|17098672|P2|Randomization|Other|0
4980381|NCT00064350|17098673|P1|Randomization|Other|5
4980382|NCT00064350|17098671|P3|Randomization|Ineligible or never started treatment|0
4980383|NCT00064350|17098672|P2|Randomization|Ineligible or never started treatment|15
4980384|NCT00064350|17098673|P1|Randomization|Ineligible or never started treatment|9
4980385|NCT00064350|17098671|P3|Randomization|Withdrawal by Subject|0
4980386|NCT00064350|17098672|P2|Randomization|Withdrawal by Subject|0
4980387|NCT00064350|17098673|P1|Randomization|Withdrawal by Subject|1
4980388|NCT00064350|17098671|P3|Randomization|Death|0
4980389|NCT00064350|17098672|P2|Randomization|Death|0
4980390|NCT00064350|17098673|P1|Randomization|Death|3
4980391|NCT00064350|17098671|P3|Randomization|Adverse Event|0
4980392|NCT00064350|17098672|P2|Randomization|Adverse Event|3
4980393|NCT00064350|17098673|P1|Randomization|Adverse Event|8
4980394|NCT00064350|17098671|P3|Induction Treatment|Other|13
4980395|NCT00064350|17098672|P2|Induction Treatment|Other|0
4980396|NCT00064350|17098673|P1|Induction Treatment|Other|0
4980397|NCT00064350|17098671|P3|Induction Treatment|Ineligible or never started treatment|34
4980398|NCT00064350|17098672|P2|Induction Treatment|Ineligible or never started treatment|6
4980399|NCT00064350|17098673|P1|Induction Treatment|Ineligible or never started treatment|3
4980400|NCT00064350|17098671|P3|Induction Treatment|Withdrawal by Subject|21
4980401|NCT00064350|17098672|P2|Induction Treatment|Withdrawal by Subject|0
4980402|NCT00064350|17098673|P1|Induction Treatment|Withdrawal by Subject|0
4980403|NCT00064350|17098671|P3|Induction Treatment|Death|9
4980404|NCT00064350|17098672|P2|Induction Treatment|Death|0
4980405|NCT00064350|17098673|P1|Induction Treatment|Death|0
4980406|NCT00064350|17098671|P3|Induction Treatment|Adverse Event|49
4980407|NCT00064350|17098672|P2|Induction Treatment|Adverse Event|2
4980408|NCT00064350|17098673|P1|Induction Treatment|Adverse Event|0
4980409|NCT00064350|17098671|P3|Induction Treatment|Disease Progression|110
4980410|NCT00064350|17098672|P2|Induction Treatment|Disease Progression|1
4980411|NCT00064350|17098673|P1|Induction Treatment|Disease Progression|5
4980412|NCT00064337|17098688|P1|Maintenance|Death|1
4980413|NCT00064337|17098688|P1|Maintenance|Not protocol-specified|2
4980414|NCT00064337|17098688|P1|Maintenance|On treatment at time of analysis|2
4980415|NCT00064337|17098688|P1|Maintenance|Progression|2
4980416|NCT00064337|17098688|P1|Maintenance|Adverse Event|3
4980417|NCT00064337|17098688|P1|Transplant|Progression|2
4980418|NCT00064337|17098688|P1|Transplant|Patient Refusal|2
4980419|NCT00064337|17098688|P1|Transplant|Death|3
4980420|NCT00064337|17098688|P1|Transplant|Not protocol-specified|5
4980421|NCT00064337|17098688|P1|Transplant|Adverse Event|9
4980422|NCT00064337|17098688|P1|PBSCC or Induction/PBSCC|Death|2
4980423|NCT00064337|17098688|P1|PBSCC or Induction/PBSCC|Patient Refusal|2
4980424|NCT00064337|17098688|P1|PBSCC or Induction/PBSCC|Progression|3
4980425|NCT00064337|17098688|P1|PBSCC or Induction/PBSCC|Adverse Event|6
4980426|NCT00064337|17098688|P1|PBSCC or Induction/PBSCC|Not protocol-specified|7
4980427|NCT00064298|17098697|P2|Overall Study|Disease Progression|1
4980428|NCT00064298|17098698|P1|Overall Study|Disease Progression|2
4980429|NCT00064298|17098697|P2|Overall Study|Death|1
4980430|NCT00064298|17098698|P1|Overall Study|Death|0
4980431|NCT00064298|17098697|P2|Overall Study|Lost to Follow-up|2
4980432|NCT00064298|17098698|P1|Overall Study|Lost to Follow-up|2
4980433|NCT00064298|17098697|P2|Overall Study|Withdrawal by Subject|1
4980434|NCT00064298|17098698|P1|Overall Study|Withdrawal by Subject|2
4980435|NCT00064259|17098706|P4|Overall Study|Adverse Event|1
4980436|NCT00064259|17098707|P3|Overall Study|Adverse Event|0
4980437|NCT00064259|17098708|P2|Overall Study|Adverse Event|0
4980438|NCT00064259|17098709|P1|Overall Study|Adverse Event|1
4980439|NCT00064077|17098717|P4|Overall Study|Other reasons|2
4980440|NCT00064077|17098718|P3|Overall Study|Other reasons|1
4980441|NCT00064077|17098719|P2|Overall Study|Other reasons|2
4980442|NCT00064077|17098720|P1|Overall Study|Other reasons|2
4980443|NCT00064077|17098717|P4|Overall Study|No tumor|0
4980444|NCT00064077|17098718|P3|Overall Study|No tumor|1
4980445|NCT00064077|17098719|P2|Overall Study|No tumor|0
4980446|NCT00064077|17098720|P1|Overall Study|No tumor|0
4980447|NCT00064077|17098717|P4|Overall Study|No surgery|0
4980448|NCT00064077|17098718|P3|Overall Study|No surgery|1
4980449|NCT00064077|17098719|P2|Overall Study|No surgery|0
4980450|NCT00064077|17098720|P1|Overall Study|No surgery|0
4980451|NCT00064077|17098717|P4|Overall Study|Pathology|4
4980452|NCT00064077|17098718|P3|Overall Study|Pathology|3
4980453|NCT00064077|17098719|P2|Overall Study|Pathology|7
4980454|NCT00064077|17098720|P1|Overall Study|Pathology|10
4980455|NCT00064077|17098717|P4|Overall Study|Poor risk|1
4980456|NCT00064077|17098718|P3|Overall Study|Poor risk|1
4980457|NCT00064077|17098719|P2|Overall Study|Poor risk|0
4980458|NCT00064077|17098720|P1|Overall Study|Poor risk|2
4980459|NCT00064077|17098717|P4|Overall Study|Improper prior treatment|0
4980460|NCT00064077|17098718|P3|Overall Study|Improper prior treatment|0
4980461|NCT00064077|17098719|P2|Overall Study|Improper prior treatment|0
4980462|NCT00064077|17098720|P1|Overall Study|Improper prior treatment|1
4980463|NCT00064025|17098764|P1|Overall Study|Inevaluable|3
4980464|NCT00064025|17098764|P1|Overall Study|Ineligible|4
4980465|NCT00063999|17098773|P2|Overall Study|Ineligible|24
4980466|NCT00063999|17098774|P1|Overall Study|Ineligible|44
4980467|NCT00063999|17098773|P2|Overall Study|Withdrawal by Subject|0
4980468|NCT00063999|17098774|P1|Overall Study|Withdrawal by Subject|1
4980469|NCT00063986|17098790|P1|Overall Study|Intra-operatively ineligible|4
4980470|NCT00063986|17098790|P1|Overall Study|Ineligible|1
4980471|NCT00063986|17098790|P1|Overall Study|Withdrawal by Subject|1
4980472|NCT00063934|17098802|P1|Overall Study|Ineligible|1
4980473|NCT00063882|17098811|P2|Overall Study|Withdrawal by Subject|1
4980474|NCT00063882|17098812|P1|Overall Study|Withdrawal by Subject|2
4980475|NCT00063882|17098811|P2|Overall Study|Protocol Violation|3
4980476|NCT00063882|17098812|P1|Overall Study|Protocol Violation|3
4980477|NCT00063258|17098939|P2|Overall Study|Lack of Efficacy|0
4980478|NCT00063258|17098940|P1|Overall Study|Lack of Efficacy|2
4980479|NCT00063258|17098939|P2|Overall Study|Physician Decision|0
4980480|NCT00063258|17098940|P1|Overall Study|Physician Decision|2
4980481|NCT00063154|17098946|P1|Overall Study|Did not receive treatment|8
4980482|NCT00063154|17098946|P1|Overall Study|Reason unspecified|1
4980483|NCT00063154|17098946|P1|Overall Study|Death|3
4980484|NCT00063154|17098946|P1|Overall Study|Physician Decision|10
4980485|NCT00063154|17098946|P1|Overall Study|Adverse Event|2
4980486|NCT00063154|17098946|P1|Overall Study|Disease progression|27
4980487|NCT00062868|17098980|P21|Dose Level 3|Withdrew|0
4980488|NCT00062868|17098981|P20|Dose Level 3|Withdrew|0
4980489|NCT00062868|17098982|P19|Dose Level 3|Withdrew|0
4980490|NCT00062868|17098983|P18|Dose Level 3|Withdrew|0
4980491|NCT00062868|17098984|P17|Dose Level 3|Withdrew|0
4980492|NCT00062868|17098985|P16|Dose Level 3|Withdrew|0
4980493|NCT00062868|17098986|P15|Dose Level 3|Withdrew|0
4980494|NCT00062868|17098987|P14|Dose Level 3|Withdrew|0
4980495|NCT00062868|17098988|P13|Dose Level 3|Withdrew|0
4980496|NCT00062868|17098989|P12|Dose Level 3|Withdrew|0
4980497|NCT00062868|17098990|P11|Dose Level 3|Withdrew|0
4980498|NCT00062868|17098991|P10|Dose Level 3|Withdrew|0
4980499|NCT00062868|17098992|P9|Dose Level 3|Withdrew|0
4980500|NCT00062868|17098993|P8|Dose Level 3|Withdrew|0
4980501|NCT00062868|17098994|P7|Dose Level 3|Withdrew|0
4980502|NCT00062868|17098995|P6|Dose Level 3|Withdrew|0
4980503|NCT00062868|17098996|P5|Dose Level 3|Withdrew|0
4980504|NCT00062868|17098997|P4|Dose Level 3|Withdrew|0
4980505|NCT00062868|17098998|P3|Dose Level 3|Withdrew|2
4980506|NCT00062868|17098999|P2|Dose Level 3|Withdrew|0
4980507|NCT00062868|17099000|P1|Dose Level 3|Withdrew|0
4980508|NCT00062868|17098980|P21|Dose Level 3|Lost to Follow-up|0
4980509|NCT00062868|17098981|P20|Dose Level 3|Lost to Follow-up|0
4980510|NCT00062868|17098982|P19|Dose Level 3|Lost to Follow-up|0
4980511|NCT00062868|17098983|P18|Dose Level 3|Lost to Follow-up|0
4980512|NCT00062868|17098984|P17|Dose Level 3|Lost to Follow-up|0
4980513|NCT00062868|17098985|P16|Dose Level 3|Lost to Follow-up|0
4980514|NCT00062868|17098986|P15|Dose Level 3|Lost to Follow-up|1
4980515|NCT00062868|17098987|P14|Dose Level 3|Lost to Follow-up|0
4980516|NCT00062868|17098988|P13|Dose Level 3|Lost to Follow-up|0
4980517|NCT00062868|17098989|P12|Dose Level 3|Lost to Follow-up|0
4980518|NCT00062868|17098990|P11|Dose Level 3|Lost to Follow-up|0
4980519|NCT00062868|17098991|P10|Dose Level 3|Lost to Follow-up|0
4980520|NCT00062868|17098992|P9|Dose Level 3|Lost to Follow-up|0
4980521|NCT00062868|17098993|P8|Dose Level 3|Lost to Follow-up|0
4980522|NCT00062868|17098994|P7|Dose Level 3|Lost to Follow-up|0
4980523|NCT00062868|17098995|P6|Dose Level 3|Lost to Follow-up|0
4980524|NCT00062868|17098996|P5|Dose Level 3|Lost to Follow-up|0
4980525|NCT00062868|17098997|P4|Dose Level 3|Lost to Follow-up|0
4980526|NCT00062868|17098998|P3|Dose Level 3|Lost to Follow-up|0
4980527|NCT00062868|17098999|P2|Dose Level 3|Lost to Follow-up|0
4980528|NCT00062868|17099000|P1|Dose Level 3|Lost to Follow-up|0
4980529|NCT00062868|17098980|P21|Dose Level 3|Death|0
4980530|NCT00062868|17098981|P20|Dose Level 3|Death|0
4980531|NCT00062868|17098982|P19|Dose Level 3|Death|0
4980532|NCT00062868|17098983|P18|Dose Level 3|Death|1
4980533|NCT00062868|17098984|P17|Dose Level 3|Death|0
4980534|NCT00062868|17098985|P16|Dose Level 3|Death|0
4980535|NCT00062868|17098986|P15|Dose Level 3|Death|0
4980536|NCT00062868|17098987|P14|Dose Level 3|Death|0
4980537|NCT00062868|17098988|P13|Dose Level 3|Death|0
4980538|NCT00062868|17098989|P12|Dose Level 3|Death|1
4980539|NCT00062868|17098990|P11|Dose Level 3|Death|0
4980540|NCT00062868|17098991|P10|Dose Level 3|Death|0
4980541|NCT00062868|17098992|P9|Dose Level 3|Death|0
4980542|NCT00062868|17098993|P8|Dose Level 3|Death|0
4980543|NCT00062868|17098994|P7|Dose Level 3|Death|0
4980544|NCT00062868|17098995|P6|Dose Level 3|Death|0
4980545|NCT00062868|17098996|P5|Dose Level 3|Death|0
4980546|NCT00062868|17098997|P4|Dose Level 3|Death|0
4980547|NCT00062868|17098998|P3|Dose Level 3|Death|0
4980548|NCT00062868|17098999|P2|Dose Level 3|Death|0
4980549|NCT00062868|17099000|P1|Dose Level 3|Death|0
4980550|NCT00062868|17098980|P21|Dose Level 2|Lost to Follow-up|0
4980551|NCT00062868|17098981|P20|Dose Level 2|Lost to Follow-up|0
4980552|NCT00062868|17098982|P19|Dose Level 2|Lost to Follow-up|0
4980553|NCT00062868|17098983|P18|Dose Level 2|Lost to Follow-up|0
4980554|NCT00062868|17098984|P17|Dose Level 2|Lost to Follow-up|1
4980555|NCT00062868|17098985|P16|Dose Level 2|Lost to Follow-up|0
4980556|NCT00062868|17098986|P15|Dose Level 2|Lost to Follow-up|0
4980557|NCT00062868|17098987|P14|Dose Level 2|Lost to Follow-up|1
4980558|NCT00062868|17098988|P13|Dose Level 2|Lost to Follow-up|0
4980559|NCT00062868|17098989|P12|Dose Level 2|Lost to Follow-up|0
4980560|NCT00062868|17098990|P11|Dose Level 2|Lost to Follow-up|0
4980561|NCT00062868|17098991|P10|Dose Level 2|Lost to Follow-up|0
4980562|NCT00062868|17098992|P9|Dose Level 2|Lost to Follow-up|0
4980563|NCT00062868|17098993|P8|Dose Level 2|Lost to Follow-up|0
4980564|NCT00062868|17098994|P7|Dose Level 2|Lost to Follow-up|0
4980565|NCT00062868|17098995|P6|Dose Level 2|Lost to Follow-up|0
4980566|NCT00062868|17098996|P5|Dose Level 2|Lost to Follow-up|0
4980567|NCT00062868|17098997|P4|Dose Level 2|Lost to Follow-up|0
4980568|NCT00062868|17098998|P3|Dose Level 2|Lost to Follow-up|0
4980569|NCT00062868|17098999|P2|Dose Level 2|Lost to Follow-up|0
4980570|NCT00062868|17099000|P1|Dose Level 2|Lost to Follow-up|0
4980571|NCT00062868|17098980|P21|Dose Level 2|Death|0
4980572|NCT00062868|17098981|P20|Dose Level 2|Death|0
4980573|NCT00062868|17098982|P19|Dose Level 2|Death|0
4980574|NCT00062868|17098983|P18|Dose Level 2|Death|0
4980575|NCT00062868|17098984|P17|Dose Level 2|Death|2
4980576|NCT00062868|17098985|P16|Dose Level 2|Death|0
4980577|NCT00062868|17098986|P15|Dose Level 2|Death|0
4980578|NCT00062868|17098987|P14|Dose Level 2|Death|0
4980579|NCT00062868|17098988|P13|Dose Level 2|Death|0
4980580|NCT00062868|17098989|P12|Dose Level 2|Death|0
4980581|NCT00062868|17098990|P11|Dose Level 2|Death|1
4980582|NCT00062868|17098991|P10|Dose Level 2|Death|0
4980583|NCT00062868|17098992|P9|Dose Level 2|Death|0
4980584|NCT00062868|17098993|P8|Dose Level 2|Death|0
4980585|NCT00062868|17098994|P7|Dose Level 2|Death|0
4980586|NCT00062868|17098995|P6|Dose Level 2|Death|0
4980587|NCT00062868|17098996|P5|Dose Level 2|Death|2
4980588|NCT00062868|17098997|P4|Dose Level 2|Death|0
4980589|NCT00062868|17098998|P3|Dose Level 2|Death|0
4980590|NCT00062868|17098999|P2|Dose Level 2|Death|3
4980591|NCT00062868|17099000|P1|Dose Level 2|Death|0
4980592|NCT00062868|17098980|P21|Dose Level 1|Lost to Follow-up|1
4980593|NCT00062868|17098981|P20|Dose Level 1|Lost to Follow-up|0
4980594|NCT00062868|17098982|P19|Dose Level 1|Lost to Follow-up|2
4980595|NCT00062868|17098983|P18|Dose Level 1|Lost to Follow-up|0
4980596|NCT00062868|17098984|P17|Dose Level 1|Lost to Follow-up|0
4980597|NCT00062868|17098985|P16|Dose Level 1|Lost to Follow-up|0
4980598|NCT00062868|17098986|P15|Dose Level 1|Lost to Follow-up|0
4980599|NCT00062868|17098987|P14|Dose Level 1|Lost to Follow-up|0
4980600|NCT00062868|17098988|P13|Dose Level 1|Lost to Follow-up|1
4980601|NCT00062868|17098989|P12|Dose Level 1|Lost to Follow-up|0
4980602|NCT00062868|17098990|P11|Dose Level 1|Lost to Follow-up|0
4980603|NCT00062868|17098991|P10|Dose Level 1|Lost to Follow-up|0
4980604|NCT00062868|17098992|P9|Dose Level 1|Lost to Follow-up|0
4980605|NCT00062868|17098993|P8|Dose Level 1|Lost to Follow-up|0
4980606|NCT00062868|17098994|P7|Dose Level 1|Lost to Follow-up|0
4980607|NCT00062868|17098995|P6|Dose Level 1|Lost to Follow-up|0
4980608|NCT00062868|17098996|P5|Dose Level 1|Lost to Follow-up|0
4980609|NCT00062868|17098997|P4|Dose Level 1|Lost to Follow-up|0
4980610|NCT00062868|17098998|P3|Dose Level 1|Lost to Follow-up|0
4980611|NCT00062868|17098999|P2|Dose Level 1|Lost to Follow-up|0
4980612|NCT00062868|17099000|P1|Dose Level 1|Lost to Follow-up|0
4980613|NCT00062868|17098980|P21|Dose Level 1|Death|1
4980614|NCT00062868|17098981|P20|Dose Level 1|Death|0
4980615|NCT00062868|17098982|P19|Dose Level 1|Death|7
4980616|NCT00062868|17098983|P18|Dose Level 1|Death|0
4980617|NCT00062868|17098984|P17|Dose Level 1|Death|0
4980618|NCT00062868|17098985|P16|Dose Level 1|Death|0
4980619|NCT00062868|17098986|P15|Dose Level 1|Death|0
4980620|NCT00062868|17098987|P14|Dose Level 1|Death|0
4980621|NCT00062868|17098988|P13|Dose Level 1|Death|0
4980622|NCT00062868|17098989|P12|Dose Level 1|Death|0
4980623|NCT00062868|17098990|P11|Dose Level 1|Death|0
4980624|NCT00062868|17098991|P10|Dose Level 1|Death|0
4980625|NCT00062868|17098992|P9|Dose Level 1|Death|0
4980626|NCT00062868|17098993|P8|Dose Level 1|Death|0
4980627|NCT00062868|17098994|P7|Dose Level 1|Death|3
4980628|NCT00062868|17098995|P6|Dose Level 1|Death|0
4980629|NCT00062868|17098996|P5|Dose Level 1|Death|0
4980630|NCT00062868|17098997|P4|Dose Level 1|Death|2
4980631|NCT00062868|17098998|P3|Dose Level 1|Death|0
4980632|NCT00062868|17098999|P2|Dose Level 1|Death|0
4980633|NCT00062868|17099000|P1|Dose Level 1|Death|2
4980634|NCT00062751|17099099|P5|Overall Study|Death|0
4980635|NCT00062751|17099100|P4|Overall Study|Death|0
4980636|NCT00062751|17099101|P3|Overall Study|Death|1
4980637|NCT00062751|17099102|P2|Overall Study|Death|0
4980638|NCT00062751|17099103|P1|Overall Study|Death|1
4980639|NCT00062751|17099099|P5|Overall Study|Symptomatic deterioration|1
4980640|NCT00062751|17099100|P4|Overall Study|Symptomatic deterioration|0
4980641|NCT00062751|17099101|P3|Overall Study|Symptomatic deterioration|0
4980642|NCT00062751|17099102|P2|Overall Study|Symptomatic deterioration|1
4980643|NCT00062751|17099103|P1|Overall Study|Symptomatic deterioration|1
4980644|NCT00062751|17099099|P5|Overall Study|Withdrawal by Subject|0
4980645|NCT00062751|17099100|P4|Overall Study|Withdrawal by Subject|1
4980646|NCT00062751|17099101|P3|Overall Study|Withdrawal by Subject|2
4980647|NCT00062751|17099102|P2|Overall Study|Withdrawal by Subject|2
4980648|NCT00062751|17099103|P1|Overall Study|Withdrawal by Subject|1
4980649|NCT00062751|17099099|P5|Overall Study|Other|1
4980650|NCT00062751|17099100|P4|Overall Study|Other|0
4980651|NCT00062751|17099101|P3|Overall Study|Other|1
4980652|NCT00062751|17099102|P2|Overall Study|Other|3
4980653|NCT00062751|17099103|P1|Overall Study|Other|2
4980654|NCT00062751|17099099|P5|Overall Study|Adverse Event|2
4980655|NCT00062751|17099100|P4|Overall Study|Adverse Event|2
4980656|NCT00062751|17099101|P3|Overall Study|Adverse Event|2
4980657|NCT00062751|17099102|P2|Overall Study|Adverse Event|7
4980658|NCT00062751|17099103|P1|Overall Study|Adverse Event|4
4980659|NCT00062751|17099099|P5|Overall Study|Disease progression|2
4980660|NCT00062751|17099100|P4|Overall Study|Disease progression|2
4980661|NCT00062751|17099101|P3|Overall Study|Disease progression|24
4980662|NCT00062751|17099102|P2|Overall Study|Disease progression|17
4980663|NCT00062751|17099103|P1|Overall Study|Disease progression|24
4980664|NCT00062647|17099189|P2|Overall Study|Never received study treatment|1
4980665|NCT00062647|17099190|P1|Overall Study|Never received study treatment|1
4980666|NCT00062647|17099189|P2|Overall Study|Other|4
4980667|NCT00062647|17099190|P1|Overall Study|Other|4
4980668|NCT00062647|17099189|P2|Overall Study|Failed continuation criteria|2
4980669|NCT00062647|17099190|P1|Overall Study|Failed continuation criteria|4
4980670|NCT00062647|17099189|P2|Overall Study|Lost to Follow-up|2
4980671|NCT00062647|17099190|P1|Overall Study|Lost to Follow-up|1
4980672|NCT00062647|17099189|P2|Overall Study|Protocol Violation|0
4980673|NCT00062647|17099190|P1|Overall Study|Protocol Violation|1
4980674|NCT00062647|17099189|P2|Overall Study|Withdrawal by Subject|1
4980675|NCT00062647|17099190|P1|Overall Study|Withdrawal by Subject|2
4980676|NCT00062647|17099189|P2|Overall Study|Adverse Event|1
4980677|NCT00062647|17099190|P1|Overall Study|Adverse Event|1
4980678|NCT00062647|17099189|P2|Overall Study|Death|2
4980679|NCT00062647|17099190|P1|Overall Study|Death|2
4980680|NCT00062439|17099196|P1|Consolidation Chemotherapy|Adverse Event|2
4980681|NCT00062439|17099196|P1|Surgery|Adverse Event|2
4980682|NCT00062439|17099196|P1|Surgery|Death|1
4980683|NCT00062439|17099196|P1|Surgery|Physician Decision|4
4980684|NCT00062439|17099196|P1|Post Chemoradiation Assessment|Not eligible to continue to surgery|4
4980685|NCT00062439|17099196|P1|Post Chemoradiation Assessment|Physician Decision|1
4980686|NCT00062439|17099196|P1|Post Chemoradiation Assessment|Withdrawal by Subject|1
4980687|NCT00062439|17099196|P1|Post Chemoradiation Assessment|Disease progression|2
4980688|NCT00062439|17099196|P1|Post Chemoradiation Assessment|Death|1
4980689|NCT00062439|17099196|P1|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3
4980690|NCT00062439|17099196|P1|Induction Chemotherapy + Radiotherapy|Adverse Event|3
4980691|NCT00062439|17099196|P1|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1
4980692|NCT00062439|17099196|P1|Induction Chemotherapy + Radiotherapy|Ineligible|1
4980693|NCT00062374|17099208|P1|Overall Study|Not treated|12
4980694|NCT00062166|17099213|P1|Overall Study|Withdrawal by Subject|6
4980695|NCT00062010|17099221|P1|Overall Study|Ineligible|3
4980696|NCT00061945|17099229|P2|Course IV: Alemtuzumab|Early exits|15
4980697|NCT00061945|17099230|P1|Course IV: Alemtuzumab|Early exits|6
4980698|NCT00061945|17099229|P2|Course IV: Alemtuzumab|Declined Alemtuzumab|1
4980699|NCT00061945|17099230|P1|Course IV: Alemtuzumab|Declined Alemtuzumab|1
4980700|NCT00061945|17099229|P2|Registration Through Course 3|Early discontinuation during course I-IV|90
4980701|NCT00061945|17099230|P1|Registration Through Course 3|Early discontinuation during course I-IV|76
4980702|NCT00061945|17099229|P2|Registration Through Course 3|Not Alemtuzumab Eligible|25
4980703|NCT00061945|17099230|P1|Registration Through Course 3|Not Alemtuzumab Eligible|18
4980704|NCT00061932|17099240|P2|Overall Study|Withdrawal by Subject|4
4980705|NCT00061932|17099241|P1|Overall Study|Withdrawal by Subject|13
4980706|NCT00061633|17099254|P2|Overall Study|Never received study treatment|2
4980707|NCT00061633|17099255|P1|Overall Study|Never received study treatment|0
4980708|NCT00061633|17099254|P2|Overall Study|Other|1
4980709|NCT00061633|17099255|P1|Overall Study|Other|1
4980710|NCT00061633|17099254|P2|Overall Study|Lost to Follow-up|4
4980711|NCT00061633|17099255|P1|Overall Study|Lost to Follow-up|1
4980712|NCT00061633|17099254|P2|Overall Study|Withdrawal by Subject|2
4980713|NCT00061633|17099255|P1|Overall Study|Withdrawal by Subject|2
4980714|NCT00061633|17099254|P2|Overall Study|Adverse Event|2
4980715|NCT00061633|17099255|P1|Overall Study|Adverse Event|1
4980716|NCT00061048|17099280|P1|Overall Study|disease progression|20
4980717|NCT00061048|17099280|P1|Overall Study|Adverse Event|2
4980718|NCT00060944|17099290|P2|Overall Study|randomized but not treated|4
4980719|NCT00060944|17099291|P1|Overall Study|randomized but not treated|6
4980720|NCT00060944|17099290|P2|Overall Study|Other|4
4980721|NCT00060944|17099291|P1|Overall Study|Other|2
4980722|NCT00060944|17099290|P2|Overall Study|Treatment Switch|13
4980723|NCT00060944|17099291|P1|Overall Study|Treatment Switch|0
4980724|NCT00060944|17099290|P2|Overall Study|Subject Ineligible To Continue|1
4980725|NCT00060944|17099291|P1|Overall Study|Subject Ineligible To Continue|2
4980726|NCT00060944|17099290|P2|Overall Study|Lost to Follow-up|0
4980727|NCT00060944|17099291|P1|Overall Study|Lost to Follow-up|1
4980728|NCT00060944|17099290|P2|Overall Study|Disease Progression|94
4980729|NCT00060944|17099291|P1|Overall Study|Disease Progression|93
4980730|NCT00060944|17099290|P2|Overall Study|Withdrawal by Subject|5
4980731|NCT00060944|17099291|P1|Overall Study|Withdrawal by Subject|18
4980732|NCT00060944|17099290|P2|Overall Study|Death|3
4980733|NCT00060944|17099291|P1|Overall Study|Death|2
4980734|NCT00060944|17099290|P2|Overall Study|Adverse Event|10
4980735|NCT00060944|17099291|P1|Overall Study|Adverse Event|12
4980736|NCT00060840|17099307|P2|Overall Study|Other|0
4980737|NCT00060840|17099308|P1|Overall Study|Other|1
4980738|NCT00060840|17099307|P2|Overall Study|Physician Decision|0
4980739|NCT00060840|17099308|P1|Overall Study|Physician Decision|1
4980740|NCT00060840|17099307|P2|Overall Study|Subinvestigator unavailable|1
4980741|NCT00060840|17099308|P1|Overall Study|Subinvestigator unavailable|0
4980742|NCT00060840|17099307|P2|Overall Study|Withdrawal by Subject|1
4980743|NCT00060840|17099308|P1|Overall Study|Withdrawal by Subject|0
4980744|NCT00060840|17099307|P2|Overall Study|Death|1
4980745|NCT00060840|17099308|P1|Overall Study|Death|0
4980746|NCT00060840|17099307|P2|Overall Study|Change in surgical plan|6
4980747|NCT00060840|17099308|P1|Overall Study|Change in surgical plan|2
4980748|NCT00059839|17099374|P2|Overall Study|Ineligible|3
4980749|NCT00059839|17099375|P1|Overall Study|Ineligible|1
4980750|NCT00059839|17099374|P2|Overall Study|Withdrawal by Subject|6
4980751|NCT00059839|17099375|P1|Overall Study|Withdrawal by Subject|1
4980752|NCT00059839|17099374|P2|Overall Study|Physician Decision|2
4980753|NCT00059839|17099375|P1|Overall Study|Physician Decision|1
4980754|NCT00059839|17099374|P2|Overall Study|Lost to Follow-up|0
4980755|NCT00059839|17099375|P1|Overall Study|Lost to Follow-up|2
4980756|NCT00059839|17099374|P2|Overall Study|Lack of Efficacy|5
4980757|NCT00059839|17099375|P1|Overall Study|Lack of Efficacy|6
4980758|NCT00059839|17099374|P2|Overall Study|Death|1
4980759|NCT00059839|17099375|P1|Overall Study|Death|1
4980760|NCT00059787|17099381|P1|Overall Study|Other|4
4980761|NCT00059787|17099381|P1|Overall Study|ineligible|1
4980762|NCT00059787|17099381|P1|Overall Study|disease progression|2
4980763|NCT00059787|17099381|P1|Overall Study|Adverse Event|13
4980764|NCT00059332|17099432|P2|Overall Study|Lost to Follow-up|1
4980765|NCT00059332|17099433|P1|Overall Study|Lost to Follow-up|1
4980766|NCT00059332|17099432|P2|Overall Study|Withdrawal by Subject|1
4980767|NCT00059332|17099433|P1|Overall Study|Withdrawal by Subject|2
4980768|NCT00059215|17099459|P4|Overall Study|Physician Decision|1
4980769|NCT00059215|17099460|P3|Overall Study|Physician Decision|1
4980770|NCT00059215|17099461|P2|Overall Study|Physician Decision|2
4980771|NCT00059215|17099462|P1|Overall Study|Physician Decision|1
4980772|NCT00059215|17099459|P4|Overall Study|Protocol entry criteria not met|2
4980773|NCT00059215|17099460|P3|Overall Study|Protocol entry criteria not met|0
4980774|NCT00059215|17099461|P2|Overall Study|Protocol entry criteria not met|1
4980775|NCT00059215|17099462|P1|Overall Study|Protocol entry criteria not met|1
4980776|NCT00059215|17099459|P4|Overall Study|Protocol Violation|0
4980777|NCT00059215|17099460|P3|Overall Study|Protocol Violation|1
4980778|NCT00059215|17099461|P2|Overall Study|Protocol Violation|0
4980779|NCT00059215|17099462|P1|Overall Study|Protocol Violation|1
4980780|NCT00059215|17099459|P4|Overall Study|Withdrawal by Subject|3
4980781|NCT00059215|17099460|P3|Overall Study|Withdrawal by Subject|1
4980782|NCT00059215|17099461|P2|Overall Study|Withdrawal by Subject|4
4980783|NCT00059215|17099462|P1|Overall Study|Withdrawal by Subject|4
4980784|NCT00059215|17099459|P4|Overall Study|Lost to Follow-up|0
4980785|NCT00059215|17099460|P3|Overall Study|Lost to Follow-up|0
4980786|NCT00059215|17099461|P2|Overall Study|Lost to Follow-up|2
4980787|NCT00059215|17099462|P1|Overall Study|Lost to Follow-up|1
4980788|NCT00059215|17099459|P4|Overall Study|Death|0
4980789|NCT00059215|17099460|P3|Overall Study|Death|3
4980790|NCT00059215|17099461|P2|Overall Study|Death|0
4980791|NCT00059215|17099462|P1|Overall Study|Death|0
4980792|NCT00059215|17099459|P4|Overall Study|Adverse Event|9
4980793|NCT00059215|17099460|P3|Overall Study|Adverse Event|9
4980794|NCT00059215|17099461|P2|Overall Study|Adverse Event|5
4980795|NCT00059215|17099462|P1|Overall Study|Adverse Event|5
4980796|NCT00058825|17099499|P1|Overall Study|Death|3
4980797|NCT00058825|17099499|P1|Overall Study|Graft Failure|5
4980798|NCT00058825|17099499|P1|Overall Study|Progressive Disease|5
4980799|NCT00058825|17099499|P1|Overall Study|Relapse|9
4980800|NCT00058552|17099515|P2|Overall Study|Clinical disease progression|4
4980801|NCT00058552|17099516|P1|Overall Study|Clinical disease progression|0
4980802|NCT00058552|17099515|P2|Overall Study|Physician Decision|5
4980803|NCT00058552|17099516|P1|Overall Study|Physician Decision|2
4980804|NCT00058552|17099515|P2|Overall Study|Withdrawal by Subject|5
4980805|NCT00058552|17099516|P1|Overall Study|Withdrawal by Subject|3
4980806|NCT00058552|17099515|P2|Overall Study|Adverse Event|2
4980807|NCT00058552|17099516|P1|Overall Study|Adverse Event|4
4980808|NCT00058552|17099515|P2|Overall Study|Disease progression|44
4980809|NCT00058552|17099516|P1|Overall Study|Disease progression|52
4980810|NCT00058552|17099515|P2|Overall Study|Died prior to receiving treatment|2
4980811|NCT00058552|17099516|P1|Overall Study|Died prior to receiving treatment|4
4980812|NCT00058539|17099534|P1|Overall Study|Death|1
4980813|NCT00058539|17099534|P1|Overall Study|Physician Decision|9
4980814|NCT00058539|17099534|P1|Overall Study|Withdrawal by Subject|5
4980815|NCT00058539|17099534|P1|Overall Study|Adverse Event|3
4980816|NCT00058539|17099534|P1|Overall Study|Disease progression|24
4980817|NCT00058214|17099567|P1|Overall Study|Adverse Event|1
4980818|NCT00058123|17099572|P1|Overall Study|Received >3 prior treatments|1
4980819|NCT00058123|17099572|P1|Overall Study|Wrong histology|9
4980820|NCT00058058|17099579|P1|Overall Study|Poor positioning, illness,pain|3
4980821|NCT00058058|17099579|P1|Overall Study|technical issues|6
4980822|NCT00058058|17099579|P1|Overall Study|Claustrophobic|5
4980823|NCT00058058|17099579|P1|Overall Study|Ineligible|20
4980824|NCT00058058|17099579|P1|Overall Study|Withdrawal by Subject|4
4980825|NCT00057954|17099604|P1|Overall Study|Disease progression|1
4980826|NCT00057954|17099604|P1|Overall Study|Death|1
4980827|NCT00057941|17099612|P2|Overall Study|Ineligible|5
4980828|NCT00057941|17099613|P1|Overall Study|Ineligible|2
4980829|NCT00057941|17099612|P2|Overall Study|insurance, symptomatic deterioration|3
4980830|NCT00057941|17099613|P1|Overall Study|insurance, symptomatic deterioration|1
4980831|NCT00057941|17099612|P2|Overall Study|still on treatment|1
4980832|NCT00057941|17099613|P1|Overall Study|still on treatment|3
4980833|NCT00057941|17099612|P2|Overall Study|Withdrawal by Subject|1
4980834|NCT00057941|17099613|P1|Overall Study|Withdrawal by Subject|6
4980835|NCT00057941|17099612|P2|Overall Study|Lack of Efficacy|53
4980836|NCT00057941|17099613|P1|Overall Study|Lack of Efficacy|54
4980837|NCT00057941|17099612|P2|Overall Study|Adverse Event|9
4980838|NCT00057941|17099613|P1|Overall Study|Adverse Event|7
4980839|NCT00057941|17099612|P2|Overall Study|Death|2
4980840|NCT00057941|17099613|P1|Overall Study|Death|1
4980841|NCT00057876|17099621|P2|Overall Study|other complicating disease|0
4980842|NCT00057876|17099622|P1|Overall Study|other complicating disease|1
4980843|NCT00057876|17099621|P2|Overall Study|other reason|2
4980844|NCT00057876|17099622|P1|Overall Study|other reason|2
4980845|NCT00057876|17099621|P2|Overall Study|Ineligible|2
4980846|NCT00057876|17099622|P1|Overall Study|Ineligible|1
4980847|NCT00057876|17099621|P2|Overall Study|Lack of Efficacy|8
4980848|NCT00057876|17099622|P1|Overall Study|Lack of Efficacy|10
4980849|NCT00057876|17099621|P2|Overall Study|Withdrawal by Subject|6
4980850|NCT00057876|17099622|P1|Overall Study|Withdrawal by Subject|5
4980851|NCT00057876|17099621|P2|Overall Study|Death|1
4980852|NCT00057876|17099622|P1|Overall Study|Death|2
4980853|NCT00057876|17099621|P2|Overall Study|Adverse Event|8
4980854|NCT00057876|17099622|P1|Overall Study|Adverse Event|8
4980855|NCT00057863|17099632|P1|Overall Study|Withdrawal by Subject|2
4980856|NCT00057863|17099632|P1|Overall Study|Death|1
4980857|NCT00057837|17099641|P2|Overall Study|Never started treatment|1
4980858|NCT00057837|17099642|P1|Overall Study|Never started treatment|1
4980859|NCT00057837|17099641|P2|Overall Study|Ineligible|3
4980860|NCT00057837|17099642|P1|Overall Study|Ineligible|3
4980861|NCT00057837|17099641|P2|Overall Study|Physician Decision|0
4980862|NCT00057837|17099642|P1|Overall Study|Physician Decision|1
4980863|NCT00057837|17099641|P2|Overall Study|Other complicating disease|1
4980864|NCT00057837|17099642|P1|Overall Study|Other complicating disease|2
4980865|NCT00057837|17099641|P2|Overall Study|Alternative therapy|1
4980866|NCT00057837|17099642|P1|Overall Study|Alternative therapy|0
4980867|NCT00057837|17099641|P2|Overall Study|Withdrawal by Subject|3
4980868|NCT00057837|17099642|P1|Overall Study|Withdrawal by Subject|5
4980869|NCT00057837|17099641|P2|Overall Study|Death|4
4980870|NCT00057837|17099642|P1|Overall Study|Death|5
4980871|NCT00057837|17099641|P2|Overall Study|Adverse Event|12
4980872|NCT00057837|17099642|P1|Overall Study|Adverse Event|2
4980873|NCT00057837|17099641|P2|Overall Study|Progression/relapse|14
4980874|NCT00057837|17099642|P1|Overall Study|Progression/relapse|12
4980875|NCT00057811|17099654|P2|Overall Study|Inevaluable|2
4980876|NCT00057811|17099655|P1|Overall Study|Inevaluable|1
4980877|NCT00057811|17099654|P2|Overall Study|Ineligible|2
4980878|NCT00057811|17099655|P1|Overall Study|Ineligible|4
4980879|NCT00057811|17099654|P2|Overall Study|Withdrawal by Subject|4
4980880|NCT00057811|17099655|P1|Overall Study|Withdrawal by Subject|3
4980881|NCT00057811|17099654|P2|Overall Study|Physician Decision|0
4980882|NCT00057811|17099655|P1|Overall Study|Physician Decision|1
4980883|NCT00057811|17099654|P2|Overall Study|Lack of Efficacy|4
4980884|NCT00057811|17099655|P1|Overall Study|Lack of Efficacy|1
4980885|NCT00057746|17099674|P3|Overall Study|Withdrawal by Subject|1
4980886|NCT00057746|17099675|P2|Overall Study|Withdrawal by Subject|0
4980887|NCT00057746|17099676|P1|Overall Study|Withdrawal by Subject|0
4980888|NCT00023673|17099687|P4|Overall Study|Patient withdrew consent|1
4980889|NCT00023673|17099688|P3|Overall Study|Patient withdrew consent|0
4980890|NCT00023673|17099689|P2|Overall Study|Patient withdrew consent|0
4980891|NCT00023673|17099690|P1|Overall Study|Patient withdrew consent|0
4980892|NCT00023673|17099687|P4|Overall Study|Ineligible / no protocol treatment|1
4980893|NCT00023673|17099688|P3|Overall Study|Ineligible / no protocol treatment|0
4980894|NCT00023673|17099689|P2|Overall Study|Ineligible / no protocol treatment|0
4980895|NCT00023673|17099690|P1|Overall Study|Ineligible / no protocol treatment|0
4980896|NCT00057330|17099754|P2|Overall Study|Other|206
4980897|NCT00057330|17099755|P1|Overall Study|Other|260
4980898|NCT00057330|17099754|P2|Overall Study|Physician Decision|0
4980899|NCT00057330|17099755|P1|Overall Study|Physician Decision|1
4980900|NCT00057330|17099754|P2|Overall Study|Lost to Follow-up|617
4980901|NCT00057330|17099755|P1|Overall Study|Lost to Follow-up|745
4980902|NCT00057330|17099754|P2|Overall Study|Withdrawal by Subject|84
4980903|NCT00057330|17099755|P1|Overall Study|Withdrawal by Subject|115
4980904|NCT00057330|17099754|P2|Overall Study|Protocol Violation|1
4980905|NCT00057330|17099755|P1|Overall Study|Protocol Violation|1
4980906|NCT00057330|17099754|P2|Overall Study|Death|0
4980907|NCT00057330|17099755|P1|Overall Study|Death|1
4980908|NCT00057330|17099754|P2|Overall Study|Adverse Event|12
4980909|NCT00057330|17099755|P1|Overall Study|Adverse Event|9
4980910|NCT00056862|17099785|P2|Overall Study|Protocol Violation|0
4980911|NCT00056862|17099786|P1|Overall Study|Protocol Violation|1
4980912|NCT00056407|17099844|P2|Overall Study|Missing|34
4980913|NCT00056407|17099845|P1|Overall Study|Missing|25
4980914|NCT00056407|17099844|P2|Overall Study|"Listed as Other on Case Report Form"|60
4980915|NCT00056407|17099845|P1|Overall Study|"Listed as Other on Case Report Form"|98
4980916|NCT00056407|17099844|P2|Overall Study|Diagnosed with Prostate Cancer|166
4980917|NCT00056407|17099845|P1|Overall Study|Diagnosed with Prostate Cancer|202
4980918|NCT00056407|17099844|P2|Overall Study|Protocol Violation|95
4980919|NCT00056407|17099845|P1|Overall Study|Protocol Violation|104
4980920|NCT00056407|17099844|P2|Overall Study|Lost to Follow-up|113
4980921|NCT00056407|17099845|P1|Overall Study|Lost to Follow-up|123
4980922|NCT00056407|17099844|P2|Overall Study|Withdrawal by Subject|361
4980923|NCT00056407|17099845|P1|Overall Study|Withdrawal by Subject|377
4980924|NCT00056407|17099844|P2|Overall Study|Adverse Event|364
4980925|NCT00056407|17099845|P1|Overall Study|Adverse Event|282
4980926|NCT00056316|17099903|P2|Overall Study|Death/NH placement of pt|1
4980927|NCT00056316|17099904|P1|Overall Study|Death/NH placement of pt|1
4980928|NCT00056316|17099903|P2|Overall Study|Withdrawal by Subject|2
4980929|NCT00056316|17099904|P1|Overall Study|Withdrawal by Subject|2
4980930|NCT00056160|17099918|P2|Final Follow-up|Adverse Event|0
4980931|NCT00056160|17099919|P1|Final Follow-up|Adverse Event|1
4980932|NCT00056160|17099918|P2|Final Follow-up|Transferred into RevAssist Program|0
4980933|NCT00056160|17099919|P1|Final Follow-up|Transferred into RevAssist Program|2
4980934|NCT00056160|17099918|P2|Final Follow-up|Transferred into expanded access study.|0
4980935|NCT00056160|17099919|P1|Final Follow-up|Transferred into expanded access study.|3
4980936|NCT00056160|17099918|P2|Extended Follow-up Cutoff (23 Jul 2008)|Other|0
4980937|NCT00056160|17099919|P1|Extended Follow-up Cutoff (23 Jul 2008)|Other|21
4980938|NCT00056160|17099918|P2|Extended Follow-up Cutoff (23 Jul 2008)|Death|0
4980939|NCT00056160|17099919|P1|Extended Follow-up Cutoff (23 Jul 2008)|Death|5
4980940|NCT00056160|17099918|P2|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0
4980941|NCT00056160|17099919|P1|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11
4980942|NCT00056160|17099918|P2|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0
4980943|NCT00056160|17099919|P1|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3
4980944|NCT00056160|17099918|P2|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0
4980945|NCT00056160|17099919|P1|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87
4980946|NCT00056160|17099918|P2|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0
4980947|NCT00056160|17099919|P1|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44
4980948|NCT00056160|17099918|P2|Up to Unblinding (07 Jun 2005)|Other|7
4980949|NCT00056160|17099919|P1|Up to Unblinding (07 Jun 2005)|Other|8
4980950|NCT00056160|17099918|P2|Up to Unblinding (07 Jun 2005)|Death|1
4980951|NCT00056160|17099919|P1|Up to Unblinding (07 Jun 2005)|Death|2
4980952|NCT00056160|17099918|P2|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
4980953|NCT00056160|17099919|P1|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8
4980954|NCT00056160|17099918|P2|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5
4980955|NCT00056160|17099919|P1|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3
4980956|NCT00056160|17099918|P2|Up to Unblinding (07 Jun 2005)|Progression of disease|124
4980957|NCT00056160|17099919|P1|Up to Unblinding (07 Jun 2005)|Progression of disease|57
4980958|NCT00056160|17099918|P2|Up to Unblinding (07 Jun 2005)|Adverse Event|18
4980959|NCT00056160|17099919|P1|Up to Unblinding (07 Jun 2005)|Adverse Event|35
4980960|NCT00055601|17099942|P2|Overall Study|No protocol treatment received|1
4980961|NCT00055601|17099943|P1|Overall Study|No protocol treatment received|1
4980962|NCT00055601|17099942|P2|Overall Study|Protocol Violation|1
4980963|NCT00055601|17099943|P1|Overall Study|Protocol Violation|1
4980964|NCT00055497|17099957|P4|Overall Study|Other|11
4980965|NCT00055497|17099958|P3|Overall Study|Other|0
4980966|NCT00055497|17099959|P2|Overall Study|Other|0
4980967|NCT00055497|17099960|P1|Overall Study|Other|0
4980968|NCT00055497|17099957|P4|Overall Study|Administrative Reasons|1
4980969|NCT00055497|17099958|P3|Overall Study|Administrative Reasons|0
4980970|NCT00055497|17099959|P2|Overall Study|Administrative Reasons|0
4980971|NCT00055497|17099960|P1|Overall Study|Administrative Reasons|0
4980972|NCT00055497|17099957|P4|Overall Study|Lack of Efficacy|27
4980973|NCT00055497|17099958|P3|Overall Study|Lack of Efficacy|0
4980974|NCT00055497|17099959|P2|Overall Study|Lack of Efficacy|0
4980975|NCT00055497|17099960|P1|Overall Study|Lack of Efficacy|1
4980976|NCT00055497|17099957|P4|Overall Study|Protocol Violation|3
4980977|NCT00055497|17099958|P3|Overall Study|Protocol Violation|0
4980978|NCT00055497|17099959|P2|Overall Study|Protocol Violation|0
4980979|NCT00055497|17099960|P1|Overall Study|Protocol Violation|0
4980980|NCT00055497|17099957|P4|Overall Study|Lost to Follow-up|5
4980981|NCT00055497|17099958|P3|Overall Study|Lost to Follow-up|0
4980982|NCT00055497|17099959|P2|Overall Study|Lost to Follow-up|1
4980983|NCT00055497|17099960|P1|Overall Study|Lost to Follow-up|0
4980984|NCT00055497|17099957|P4|Overall Study|Withdrawal by Subject|15
4980985|NCT00055497|17099958|P3|Overall Study|Withdrawal by Subject|1
4980986|NCT00055497|17099959|P2|Overall Study|Withdrawal by Subject|1
4980987|NCT00055497|17099960|P1|Overall Study|Withdrawal by Subject|3
4980988|NCT00055497|17099957|P4|Overall Study|Adverse Event|28
4980989|NCT00055497|17099958|P3|Overall Study|Adverse Event|1
4980990|NCT00055497|17099959|P2|Overall Study|Adverse Event|1
4980991|NCT00055497|17099960|P1|Overall Study|Adverse Event|1
4980992|NCT00055471|17100005|P3|Period 1: Dose Escalation Period|Disease progression|0
4980993|NCT00055471|17100006|P2|Period 1: Dose Escalation Period|Disease progression|1
4980994|NCT00055471|17100007|P1|Period 1: Dose Escalation Period|Disease progression|0
4980995|NCT00055471|17100005|P3|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1
4980996|NCT00055471|17100006|P2|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
4980997|NCT00055471|17100007|P1|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0
4980998|NCT00055471|17100005|P3|Period 1: Dose Escalation Period|Adverse Event|2
4980999|NCT00055471|17100006|P2|Period 1: Dose Escalation Period|Adverse Event|1
4981000|NCT00055471|17100007|P1|Period 1: Dose Escalation Period|Adverse Event|0
4981001|NCT00054717|17100062|P2|Overall Study|Other reason not defined above|217
4981002|NCT00054717|17100063|P1|Overall Study|Other reason not defined above|117
4981003|NCT00054717|17100062|P2|Overall Study|Withdrawal by Subject|20
4981004|NCT00054717|17100063|P1|Overall Study|Withdrawal by Subject|32
4981005|NCT00054717|17100062|P2|Overall Study|Lost to Follow-up|13
4981006|NCT00054717|17100063|P1|Overall Study|Lost to Follow-up|23
4981007|NCT00054717|17100062|P2|Overall Study|Protocol Violation|19
4981008|NCT00054717|17100063|P1|Overall Study|Protocol Violation|18
4981009|NCT00054717|17100062|P2|Overall Study|Adverse Event|22
4981010|NCT00054717|17100063|P1|Overall Study|Adverse Event|70
4981011|NCT00054717|17100062|P2|Overall Study|Randomized but not treated|8
4981012|NCT00054717|17100063|P1|Overall Study|Randomized but not treated|2
4981013|NCT00054704|17100251|P2|Overall Study|Lost to Follow-up|1
4981014|NCT00054704|17100252|P1|Overall Study|Lost to Follow-up|0
4981015|NCT00054704|17100251|P2|Overall Study|Adverse Event|1
4981016|NCT00054704|17100252|P1|Overall Study|Adverse Event|3
4981017|NCT00054704|17100251|P2|Overall Study|Lack of Efficacy|3
4981018|NCT00054704|17100252|P1|Overall Study|Lack of Efficacy|2
4981019|NCT00054691|17100258|P1|Overall Study|Noncompliant|1
4981020|NCT00054691|17100258|P1|Overall Study|Unmeasurable Disease|2
4981021|NCT00054639|17100272|P1|Overall Study|Physician Decision|1
4981022|NCT00054639|17100272|P1|Overall Study|Lack of Efficacy|1
4981023|NCT00054327|17100305|P6|Overall Study|Engraftment failure|0
4981024|NCT00054327|17100306|P5|Overall Study|Engraftment failure|0
4981025|NCT00054327|17100307|P4|Overall Study|Engraftment failure|0
4981026|NCT00054327|17100308|P3|Overall Study|Engraftment failure|0
4981027|NCT00054327|17100309|P2|Overall Study|Engraftment failure|0
4981028|NCT00054327|17100310|P1|Overall Study|Engraftment failure|1
4981029|NCT00054275|17100348|P1|Overall Study|Physician Decision|1
4981030|NCT00054275|17100348|P1|Overall Study|Progressive disease in cycle 1|1
4981031|NCT00054275|17100348|P1|Overall Study|Adverse Event|5
4981032|NCT00054275|17100348|P1|Overall Study|Withdrawal by Subject|4
4981033|NCT00054132|17100354|P1|Overall Study|Not Treated|1
4981034|NCT00053898|17100381|P2|Overall Study|Follow-up from telephone contact only|1
4981035|NCT00053898|17100382|P1|Overall Study|Follow-up from telephone contact only|5
4981036|NCT00053898|17100381|P2|Overall Study|No follow-up data from any source|12
4981037|NCT00053898|17100382|P1|Overall Study|No follow-up data from any source|9
4981038|NCT00053846|17100408|P2|Overall Study|Pills too large|1
4981039|NCT00053846|17100409|P1|Overall Study|Pills too large|0
4981040|NCT00053846|17100408|P2|Overall Study|Quit due to side effects|3
4981041|NCT00053846|17100409|P1|Overall Study|Quit due to side effects|1
4981042|NCT00053846|17100408|P2|Overall Study|Did not return data|2
4981043|NCT00053846|17100409|P1|Overall Study|Did not return data|1
4981044|NCT00053846|17100408|P2|Overall Study|Became ineligible|1
4981045|NCT00053846|17100409|P1|Overall Study|Became ineligible|3
4981046|NCT00053846|17100408|P2|Overall Study|Expired|0
4981047|NCT00053846|17100409|P1|Overall Study|Expired|5
4981048|NCT00053846|17100408|P2|Overall Study|Became too ill|7
4981049|NCT00053846|17100409|P1|Overall Study|Became too ill|8
4981050|NCT00053846|17100408|P2|Overall Study|Changed mind|13
4981051|NCT00053846|17100409|P1|Overall Study|Changed mind|8
4981052|NCT00053417|17100568|P4|Overall Study|Lost to Follow-up|0
4981053|NCT00053417|17100569|P3|Overall Study|Lost to Follow-up|0
4981054|NCT00053417|17100570|P2|Overall Study|Lost to Follow-up|1
4981055|NCT00053417|17100571|P1|Overall Study|Lost to Follow-up|1
4981056|NCT00053417|17100568|P4|Overall Study|Withdrawal by Subject|0
4981057|NCT00053417|17100569|P3|Overall Study|Withdrawal by Subject|0
4981058|NCT00053417|17100570|P2|Overall Study|Withdrawal by Subject|1
4981059|NCT00053417|17100571|P1|Overall Study|Withdrawal by Subject|0
4981060|NCT00053417|17100568|P4|Overall Study|Non-Compliance|1
4981061|NCT00053417|17100569|P3|Overall Study|Non-Compliance|0
4981062|NCT00053417|17100570|P2|Overall Study|Non-Compliance|0
4981063|NCT00053417|17100571|P1|Overall Study|Non-Compliance|0
4981064|NCT00053417|17100568|P4|Overall Study|Adverse Event|5
4981065|NCT00053417|17100569|P3|Overall Study|Adverse Event|1
4981066|NCT00053417|17100570|P2|Overall Study|Adverse Event|0
4981067|NCT00053417|17100571|P1|Overall Study|Adverse Event|1
4981068|NCT00053365|17100581|P1|Overall Study|Never treated|4
4981069|NCT00053365|17100581|P1|Overall Study|Platinum-sensitive interval >12 months|1
4981070|NCT00053365|17100581|P1|Overall Study|Incorrect cell type|1
4981071|NCT00053352|17100590|P2|Overall Study|Disease at new site|0
4981072|NCT00053352|17100591|P1|Overall Study|Disease at new site|1
4981073|NCT00053352|17100590|P2|Overall Study|Ineligible|8
4981074|NCT00053352|17100591|P1|Overall Study|Ineligible|8
4981075|NCT00053352|17100590|P2|Overall Study|Withdrawal by Subject|0
4981076|NCT00053352|17100591|P1|Overall Study|Withdrawal by Subject|1
4981077|NCT00053352|17100590|P2|Overall Study|Physician Decision|1
4981078|NCT00053352|17100591|P1|Overall Study|Physician Decision|11
4981079|NCT00053352|17100590|P2|Overall Study|Lost to Follow-up|1
4981080|NCT00053352|17100591|P1|Overall Study|Lost to Follow-up|0
4981081|NCT00003830|17100607|P2|Overall Study|Sentinel node positive patients|793
4981082|NCT00003830|17100608|P1|Overall Study|Sentinel node positive patients|829
4981083|NCT00003830|17100607|P2|Overall Study|No follow up data|0
4981084|NCT00003830|17100608|P1|Overall Study|No follow up data|3
4981085|NCT00052962|17100634|P2|Overall Study|Not randomized/not evaluable|0
4981086|NCT00052962|17100635|P1|Overall Study|Not randomized/not evaluable|1
4981087|NCT00052962|17100634|P2|Overall Study|Not evaluable|2
4981088|NCT00052962|17100635|P1|Overall Study|Not evaluable|0
4981089|NCT00052715|17100654|P1|Overall Study|wrong histology|1
4981090|NCT00049673|17100670|P2|Overall Study|No receive treatment/lost to follow-up|3
4981091|NCT00049673|17100671|P1|Overall Study|No receive treatment/lost to follow-up|1
4981092|NCT00049543|17100681|P2|Overall Study|still on treatment|9
4981093|NCT00049543|17100682|P1|Overall Study|still on treatment|2
4981094|NCT00049530|17100692|P1|Overall Study|ineligible|3
4981095|NCT00049530|17100692|P1|Overall Study|symptomatic deterioration|1
4981096|NCT00049530|17100692|P1|Overall Study|Death|1
4981097|NCT00049530|17100692|P1|Overall Study|Adverse Event|2
4981098|NCT00049530|17100692|P1|Overall Study|Lack of Efficacy|25
4981099|NCT00049517|17100701|P6|Conditioning/Transplant|Reasons not reported|5
4981100|NCT00049517|17100702|P5|Conditioning/Transplant|Reasons not reported|5
4981101|NCT00049517|17100703|P4|Conditioning/Transplant|Reasons not reported|15
4981102|NCT00049517|17100704|P3|Conditioning/Transplant|Reasons not reported|18
4981103|NCT00049517|17100705|P2|Conditioning/Transplant|Reasons not reported|31
4981104|NCT00049517|17100706|P1|Conditioning/Transplant|Reasons not reported|25
4981105|NCT00049517|17100701|P6|Conditioning/Transplant|Other complicating disease|1
4981106|NCT00049517|17100702|P5|Conditioning/Transplant|Other complicating disease|0
4981107|NCT00049517|17100703|P4|Conditioning/Transplant|Other complicating disease|4
4981108|NCT00049517|17100704|P3|Conditioning/Transplant|Other complicating disease|0
4981109|NCT00049517|17100705|P2|Conditioning/Transplant|Other complicating disease|0
4981110|NCT00049517|17100706|P1|Conditioning/Transplant|Other complicating disease|2
4981111|NCT00049517|17100701|P6|Conditioning/Transplant|Alternative therapy|0
4981112|NCT00049517|17100702|P5|Conditioning/Transplant|Alternative therapy|1
4981113|NCT00049517|17100703|P4|Conditioning/Transplant|Alternative therapy|1
4981114|NCT00049517|17100704|P3|Conditioning/Transplant|Alternative therapy|2
4981115|NCT00049517|17100705|P2|Conditioning/Transplant|Alternative therapy|4
4981116|NCT00049517|17100706|P1|Conditioning/Transplant|Alternative therapy|4
4981117|NCT00049517|17100701|P6|Conditioning/Transplant|Withdrawal by Subject|0
4981118|NCT00049517|17100702|P5|Conditioning/Transplant|Withdrawal by Subject|0
4981119|NCT00049517|17100703|P4|Conditioning/Transplant|Withdrawal by Subject|7
4981120|NCT00049517|17100704|P3|Conditioning/Transplant|Withdrawal by Subject|4
4981121|NCT00049517|17100705|P2|Conditioning/Transplant|Withdrawal by Subject|8
4981122|NCT00049517|17100706|P1|Conditioning/Transplant|Withdrawal by Subject|4
4981123|NCT00049517|17100701|P6|Conditioning/Transplant|Death|0
4981124|NCT00049517|17100702|P5|Conditioning/Transplant|Death|0
4981125|NCT00049517|17100703|P4|Conditioning/Transplant|Death|2
4981126|NCT00049517|17100704|P3|Conditioning/Transplant|Death|0
4981127|NCT00049517|17100705|P2|Conditioning/Transplant|Death|0
4981128|NCT00049517|17100706|P1|Conditioning/Transplant|Death|1
4981129|NCT00049517|17100701|P6|Conditioning/Transplant|Adverse Event|0
4981130|NCT00049517|17100702|P5|Conditioning/Transplant|Adverse Event|0
4981131|NCT00049517|17100703|P4|Conditioning/Transplant|Adverse Event|8
4981132|NCT00049517|17100704|P3|Conditioning/Transplant|Adverse Event|4
4981133|NCT00049517|17100705|P2|Conditioning/Transplant|Adverse Event|1
4981134|NCT00049517|17100706|P1|Conditioning/Transplant|Adverse Event|2
4981135|NCT00049517|17100701|P6|Conditioning/Transplant|Disease progression|0
4981136|NCT00049517|17100702|P5|Conditioning/Transplant|Disease progression|0
4981137|NCT00049517|17100703|P4|Conditioning/Transplant|Disease progression|6
4981138|NCT00049517|17100704|P3|Conditioning/Transplant|Disease progression|10
4981139|NCT00049517|17100705|P2|Conditioning/Transplant|Disease progression|6
4981140|NCT00049517|17100706|P1|Conditioning/Transplant|Disease progression|14
4981141|NCT00049517|17100701|P6|Induction|Reasons not reported|25
4981142|NCT00049517|17100702|P5|Induction|Reasons not reported|22
4981143|NCT00049517|17100703|P4|Induction|Reasons not reported|0
4981144|NCT00049517|17100704|P3|Induction|Reasons not reported|0
4981145|NCT00049517|17100705|P2|Induction|Reasons not reported|0
4981146|NCT00049517|17100706|P1|Induction|Reasons not reported|0
4981147|NCT00049517|17100701|P6|Induction|Other complicating disease|0
4981148|NCT00049517|17100702|P5|Induction|Other complicating disease|3
4981149|NCT00049517|17100703|P4|Induction|Other complicating disease|0
4981150|NCT00049517|17100704|P3|Induction|Other complicating disease|0
4981151|NCT00049517|17100705|P2|Induction|Other complicating disease|0
4981152|NCT00049517|17100706|P1|Induction|Other complicating disease|0
4981153|NCT00049517|17100701|P6|Induction|Alternative therapy|2
4981154|NCT00049517|17100702|P5|Induction|Alternative therapy|2
4981155|NCT00049517|17100703|P4|Induction|Alternative therapy|0
4981156|NCT00049517|17100704|P3|Induction|Alternative therapy|0
4981157|NCT00049517|17100705|P2|Induction|Alternative therapy|0
4981158|NCT00049517|17100706|P1|Induction|Alternative therapy|0
4981159|NCT00049517|17100701|P6|Induction|Withdrawal by Subject|3
4981160|NCT00049517|17100702|P5|Induction|Withdrawal by Subject|1
4981161|NCT00049517|17100703|P4|Induction|Withdrawal by Subject|0
4981162|NCT00049517|17100704|P3|Induction|Withdrawal by Subject|0
4981163|NCT00049517|17100705|P2|Induction|Withdrawal by Subject|0
4981164|NCT00049517|17100706|P1|Induction|Withdrawal by Subject|0
4981165|NCT00049517|17100701|P6|Induction|Death|6
4981166|NCT00049517|17100702|P5|Induction|Death|9
4981167|NCT00049517|17100703|P4|Induction|Death|0
4981168|NCT00049517|17100704|P3|Induction|Death|0
4981169|NCT00049517|17100705|P2|Induction|Death|0
4981170|NCT00049517|17100706|P1|Induction|Death|0
4981171|NCT00049517|17100701|P6|Induction|Adverse Event|7
4981172|NCT00049517|17100702|P5|Induction|Adverse Event|5
4981173|NCT00049517|17100703|P4|Induction|Adverse Event|0
4981174|NCT00049517|17100704|P3|Induction|Adverse Event|0
4981175|NCT00049517|17100705|P2|Induction|Adverse Event|0
4981176|NCT00049517|17100706|P1|Induction|Adverse Event|0
4981177|NCT00049517|17100701|P6|Induction|Disease progression|11
4981178|NCT00049517|17100702|P5|Induction|Disease progression|18
4981179|NCT00049517|17100703|P4|Induction|Disease progression|0
4981180|NCT00049517|17100704|P3|Induction|Disease progression|0
4981181|NCT00049517|17100705|P2|Induction|Disease progression|0
4981182|NCT00049517|17100706|P1|Induction|Disease progression|0
4981183|NCT00049322|17100724|P2|Overall Study|refused angio|3
4981184|NCT00049322|17100725|P1|Overall Study|refused angio|0
4981185|NCT00049322|17100724|P2|Overall Study|Adverse Event|0
4981186|NCT00049322|17100725|P1|Overall Study|Adverse Event|1
4981187|NCT00049322|17100724|P2|Overall Study|disease burden|3
4981188|NCT00049322|17100725|P1|Overall Study|disease burden|0
4981189|NCT00049257|17100737|P1|Follow-up Period for Survival Status|Lost to Follow-up|4
4981190|NCT00049257|17100737|P1|Carboplatin, Paclitaxel|Death|2
4981191|NCT00049257|17100737|P1|Carboplatin, Paclitaxel|Lost to Follow-up|1
4981192|NCT00049257|17100737|P1|Carboplatin, Paclitaxel|Withdrawal by Subject|10
4981193|NCT00049127|17100749|P5|Overall Study|Withdrawal by Subject|0
4981194|NCT00049127|17100750|P4|Overall Study|Withdrawal by Subject|0
4981195|NCT00049127|17100751|P3|Overall Study|Withdrawal by Subject|1
4981196|NCT00049127|17100752|P2|Overall Study|Withdrawal by Subject|0
4981197|NCT00049127|17100753|P1|Overall Study|Withdrawal by Subject|0
4981198|NCT00048997|17100791|P2|Overall Study|Withdrawal by Subject|1
4981199|NCT00048997|17100792|P1|Overall Study|Withdrawal by Subject|6
4981200|NCT00048997|17100791|P2|Overall Study|Protocol Violation|2
4981201|NCT00048997|17100792|P1|Overall Study|Protocol Violation|7
4981202|NCT00047385|17100815|P2|Overall Study|Eligible for screening but had no screen|492
4981203|NCT00047385|17100816|P1|Overall Study|Eligible for screening but had no screen|260
4981204|NCT00047385|17100815|P2|Overall Study|Lung Cancer diagnosed before screening|3
4981205|NCT00047385|17100816|P1|Overall Study|Lung Cancer diagnosed before screening|5
4981206|NCT00047385|17100815|P2|Overall Study|Death before any screening|5
4981207|NCT00047385|17100816|P1|Overall Study|Death before any screening|2
4981208|NCT00047320|17100834|P1|Overall Study|Ineligible|2
4981209|NCT00047320|17100834|P1|Overall Study|Withdrawal by Subject|9
4981210|NCT00047320|17100834|P1|Overall Study|Physician Decision|8
4981211|NCT00047320|17100834|P1|Overall Study|Lost to Follow-up|1
4981212|NCT00047320|17100834|P1|Overall Study|Lack of Efficacy|8
4981213|NCT00047008|17100849|P2|Overall Study|Ineligible|8
4981214|NCT00047008|17100850|P1|Overall Study|Ineligible|9
4981215|NCT00047008|17100849|P2|Overall Study|Withdrawn consent|3
4981216|NCT00047008|17100850|P1|Overall Study|Withdrawn consent|2
4981217|NCT00046930|17100858|P2|Overall Study|Ineligible|4
4981218|NCT00046930|17100859|P1|Overall Study|Ineligible|12
4981219|NCT00046891|17100874|P2|Overall Study|Adverse Event|5
4981220|NCT00046891|17100875|P1|Overall Study|Adverse Event|5
4981221|NCT00046891|17100874|P2|Overall Study|Withdrawal by Subject|15
4981222|NCT00046891|17100875|P1|Overall Study|Withdrawal by Subject|18
4981223|NCT00046891|17100874|P2|Overall Study|Ineligible|1
4981224|NCT00046891|17100875|P1|Overall Study|Ineligible|1
4981225|NCT00046891|17100874|P2|Overall Study|Cancels|9
4981226|NCT00046891|17100875|P1|Overall Study|Cancels|5
4981227|NCT00046839|17100895|P2|Overall Study|Withdrawal of consent|0
4981228|NCT00046839|17100896|P1|Overall Study|Withdrawal of consent|1
4981229|NCT00046839|17100895|P2|Overall Study|Ineligible / No protocol treatment|2
4981230|NCT00046839|17100896|P1|Overall Study|Ineligible / No protocol treatment|0
4981231|NCT00045734|17100903|P1|Overall Study|Protocol Violation|1
4981232|NCT00045708|17100918|P3|Phase 1|early progressive disease|0
4981233|NCT00045708|17100919|P2|Phase 1|early progressive disease|1
4981234|NCT00045708|17100920|P1|Phase 1|early progressive disease|0
4981235|NCT00045630|17100945|P1|Overall Study|Ineligible|2
4981236|NCT00045630|17100945|P1|Overall Study|Death|1
4981237|NCT00045630|17100945|P1|Overall Study|Progression/relapse|1
4981238|NCT00045630|17100945|P1|Overall Study|Refusal unrelated to adverse event|1
4981239|NCT00045630|17100945|P1|Overall Study|Adverse Event|1
4981240|NCT00045305|17100964|P1|Overall Study|site error|2
4981241|NCT00045305|17100964|P1|Overall Study|Death|3
4981242|NCT00045305|17100964|P1|Overall Study|Adverse Event|3
4981243|NCT00045305|17100964|P1|Overall Study|Lack of Efficacy|6
4981244|NCT00045162|17100975|P2|Overall Study|Other|16
4981245|NCT00045162|17100976|P1|Overall Study|Other|21
4981246|NCT00045162|17100975|P2|Overall Study|Withdrawal by Subject|3
4981247|NCT00045162|17100976|P1|Overall Study|Withdrawal by Subject|5
4981248|NCT00045162|17100975|P2|Overall Study|Death|10
4981249|NCT00045162|17100976|P1|Overall Study|Death|10
4981250|NCT00045162|17100975|P2|Overall Study|Lack of Efficacy|29
4981251|NCT00045162|17100976|P1|Overall Study|Lack of Efficacy|32
4981252|NCT00045162|17100975|P2|Overall Study|Adverse Event|50
4981253|NCT00045162|17100976|P1|Overall Study|Adverse Event|55
4981254|NCT00045162|17100975|P2|Overall Study|Not treated|2
4981255|NCT00045162|17100976|P1|Overall Study|Not treated|7
4981256|NCT00045162|17100975|P2|Overall Study|Ineligible|8
4981257|NCT00045162|17100976|P1|Overall Study|Ineligible|12
4981258|NCT00045110|17100991|P3|100mg Phase 1 Dose Escalalation|ineligible histology|1
4981259|NCT00045110|17100992|P2|100mg Phase 1 Dose Escalalation|ineligible histology|0
4981260|NCT00045110|17100993|P1|100mg Phase 1 Dose Escalalation|ineligible histology|0
4981261|NCT00045110|17100991|P3|100mg Phase 1 Dose Escalalation|prior treatment history|0
4981262|NCT00045110|17100992|P2|100mg Phase 1 Dose Escalalation|prior treatment history|4
4981263|NCT00045110|17100993|P1|100mg Phase 1 Dose Escalalation|prior treatment history|0
4981264|NCT00045110|17100991|P3|100mg Phase 1 Dose Escalalation|did not initiate treatment|1
4981265|NCT00045110|17100992|P2|100mg Phase 1 Dose Escalalation|did not initiate treatment|2
4981266|NCT00045110|17100993|P1|100mg Phase 1 Dose Escalalation|did not initiate treatment|0
4981267|NCT00045032|17101042|P3|Overall Study|Other|105
4981268|NCT00045032|17101043|P2|Overall Study|Other|84
4981269|NCT00045032|17101044|P1|Overall Study|Other|93
4981270|NCT00045032|17101042|P3|Overall Study|Failure to Return|61
4981271|NCT00045032|17101043|P2|Overall Study|Failure to Return|62
4981272|NCT00045032|17101044|P1|Overall Study|Failure to Return|57
4981273|NCT00045032|17101042|P3|Overall Study|Refused/Did Not Cooperate/Withdrew|84
4981274|NCT00045032|17101043|P2|Overall Study|Refused/Did Not Cooperate/Withdrew|93
4981275|NCT00045032|17101044|P1|Overall Study|Refused/Did Not Cooperate/Withdrew|142
4981276|NCT00045032|17101042|P3|Overall Study|Other Protocol Violation|1
4981277|NCT00045032|17101043|P2|Overall Study|Other Protocol Violation|0
4981278|NCT00045032|17101044|P1|Overall Study|Other Protocol Violation|2
4981279|NCT00045032|17101042|P3|Overall Study|Violation of Selection Criteria at Entry|6
4981280|NCT00045032|17101043|P2|Overall Study|Violation of Selection Criteria at Entry|6
4981371|NCT00040742|17101351|P4|Overall Study|Chemotoxicity|2
4981281|NCT00045032|17101044|P1|Overall Study|Violation of Selection Criteria at Entry|3
4981282|NCT00045032|17101042|P3|Overall Study|Insufficient Therapeutic Response|445
4981283|NCT00045032|17101043|P2|Overall Study|Insufficient Therapeutic Response|437
4981284|NCT00045032|17101044|P1|Overall Study|Insufficient Therapeutic Response|542
4981285|NCT00045032|17101042|P3|Overall Study|Death|17
4981286|NCT00045032|17101043|P2|Overall Study|Death|24
4981287|NCT00045032|17101044|P1|Overall Study|Death|22
4981288|NCT00045032|17101042|P3|Overall Study|Adverse Event/Intercurrent Illness|7
4981289|NCT00045032|17101043|P2|Overall Study|Adverse Event/Intercurrent Illness|2
4981290|NCT00045032|17101044|P1|Overall Study|Adverse Event/Intercurrent Illness|2
4981291|NCT00042991|17101178|P7|Overall Study|Alternative Therapy|0
4981292|NCT00042991|17101179|P6|Overall Study|Alternative Therapy|0
4981293|NCT00042991|17101180|P5|Overall Study|Alternative Therapy|1
4981294|NCT00042991|17101181|P4|Overall Study|Alternative Therapy|0
4981295|NCT00042991|17101182|P3|Overall Study|Alternative Therapy|0
4981296|NCT00042991|17101183|P2|Overall Study|Alternative Therapy|0
4981297|NCT00042991|17101184|P1|Overall Study|Alternative Therapy|0
4981298|NCT00042991|17101178|P7|Overall Study|Disease Progression|2
4981299|NCT00042991|17101179|P6|Overall Study|Disease Progression|4
4981300|NCT00042991|17101180|P5|Overall Study|Disease Progression|1
4981301|NCT00042991|17101181|P4|Overall Study|Disease Progression|2
4981302|NCT00042991|17101182|P3|Overall Study|Disease Progression|2
4981303|NCT00042991|17101183|P2|Overall Study|Disease Progression|29
4981304|NCT00042991|17101184|P1|Overall Study|Disease Progression|5
4981305|NCT00042991|17101178|P7|Overall Study|Withdrawal by Subject|0
4981306|NCT00042991|17101179|P6|Overall Study|Withdrawal by Subject|0
4981307|NCT00042991|17101180|P5|Overall Study|Withdrawal by Subject|1
4981308|NCT00042991|17101181|P4|Overall Study|Withdrawal by Subject|0
4981309|NCT00042991|17101182|P3|Overall Study|Withdrawal by Subject|2
4981310|NCT00042991|17101183|P2|Overall Study|Withdrawal by Subject|7
4981311|NCT00042991|17101184|P1|Overall Study|Withdrawal by Subject|0
4981312|NCT00042991|17101178|P7|Overall Study|Adverse Event|0
4981313|NCT00042991|17101179|P6|Overall Study|Adverse Event|1
4981314|NCT00042991|17101180|P5|Overall Study|Adverse Event|0
4981315|NCT00042991|17101181|P4|Overall Study|Adverse Event|0
4981316|NCT00042991|17101182|P3|Overall Study|Adverse Event|2
4981317|NCT00042991|17101183|P2|Overall Study|Adverse Event|4
4981318|NCT00042991|17101184|P1|Overall Study|Adverse Event|1
4981319|NCT00042939|17101227|P2|Overall Study|Did not start treatment|1
4981320|NCT00042939|17101228|P1|Overall Study|Did not start treatment|2
4981321|NCT00042939|17101227|P2|Overall Study|Treatment break > 4 weeks|1
4981322|NCT00042939|17101228|P1|Overall Study|Treatment break > 4 weeks|0
4981323|NCT00042939|17101227|P2|Overall Study|Still on treatment|0
4981324|NCT00042939|17101228|P1|Overall Study|Still on treatment|1
4981325|NCT00042939|17101227|P2|Overall Study|Patient non-compliance|0
4981326|NCT00042939|17101228|P1|Overall Study|Patient non-compliance|1
4981327|NCT00042939|17101227|P2|Overall Study|Rising ca 19-9|0
4981328|NCT00042939|17101228|P1|Overall Study|Rising ca 19-9|1
4981329|NCT00042939|17101227|P2|Overall Study|QOL diminished|0
4981330|NCT00042939|17101228|P1|Overall Study|QOL diminished|1
4981331|NCT00042939|17101227|P2|Overall Study|Deterioration of health|4
4981332|NCT00042939|17101228|P1|Overall Study|Deterioration of health|3
4981333|NCT00042939|17101227|P2|Overall Study|Ineligible|2
4981334|NCT00042939|17101228|P1|Overall Study|Ineligible|2
4981335|NCT00042939|17101227|P2|Overall Study|Other disease|0
4981336|NCT00042939|17101228|P1|Overall Study|Other disease|1
4981337|NCT00042939|17101227|P2|Overall Study|Withdrawal by Subject|4
4981338|NCT00042939|17101228|P1|Overall Study|Withdrawal by Subject|3
4981339|NCT00042939|17101227|P2|Overall Study|Death|2
4981340|NCT00042939|17101228|P1|Overall Study|Death|3
4981341|NCT00042939|17101227|P2|Overall Study|Adverse Event|7
4981342|NCT00042939|17101228|P1|Overall Study|Adverse Event|6
4981343|NCT00041132|17101242|P1|Overall Study|Physician Decision|2
4981344|NCT00041132|17101242|P1|Overall Study|Withdrawal by Subject|1
4981345|NCT00041132|17101242|P1|Overall Study|Not Eligible|7
4981346|NCT00041132|17101242|P1|Overall Study|Death|1
4981347|NCT00041132|17101242|P1|Overall Study|Adverse Event|19
4981348|NCT00041080|17101277|P2|Overall Study|Ineligible|0
4981349|NCT00041080|17101278|P1|Overall Study|Ineligible|1
4981350|NCT00041080|17101277|P2|Overall Study|Did not start therapy|1
4981351|NCT00041080|17101278|P1|Overall Study|Did not start therapy|1
4981352|NCT00041080|17101277|P2|Overall Study|Concommitant Illness/Other|2
4981353|NCT00041080|17101278|P1|Overall Study|Concommitant Illness/Other|1
4981354|NCT00041080|17101277|P2|Overall Study|Withdrawal by Subject|6
4981355|NCT00041080|17101278|P1|Overall Study|Withdrawal by Subject|6
4981356|NCT00041080|17101277|P2|Overall Study|Adverse Event|1
4981357|NCT00041080|17101278|P1|Overall Study|Adverse Event|21
4981358|NCT00041067|17101284|P1|Overall Study|Ineligible|2
4981359|NCT00041067|17101284|P1|Overall Study|Other reasons|23
4981360|NCT00041067|17101284|P1|Overall Study|Patient refusal|12
4981361|NCT00041067|17101284|P1|Overall Study|Progression|19
4981362|NCT00041067|17101284|P1|Overall Study|Adverse Event|20
4981363|NCT00040742|17101351|P4|Overall Study|Other medical|5
4981364|NCT00040742|17101352|P3|Overall Study|Other medical|5
4981365|NCT00040742|17101353|P2|Overall Study|Other medical|5
4981366|NCT00040742|17101354|P1|Overall Study|Other medical|7
4981367|NCT00040742|17101351|P4|Overall Study|Incomplete Forms|5
4981368|NCT00040742|17101352|P3|Overall Study|Incomplete Forms|4
4981369|NCT00040742|17101353|P2|Overall Study|Incomplete Forms|10
4981370|NCT00040742|17101354|P1|Overall Study|Incomplete Forms|6
4981372|NCT00040742|17101352|P3|Overall Study|Chemotoxicity|5
4981373|NCT00040742|17101353|P2|Overall Study|Chemotoxicity|3
4981374|NCT00040742|17101354|P1|Overall Study|Chemotoxicity|4
4981375|NCT00040742|17101351|P4|Overall Study|Withdrawal by Subject|13
4981376|NCT00040742|17101352|P3|Overall Study|Withdrawal by Subject|10
4981377|NCT00040742|17101353|P2|Overall Study|Withdrawal by Subject|15
4981378|NCT00040742|17101354|P1|Overall Study|Withdrawal by Subject|7
4981379|NCT00040742|17101351|P4|Overall Study|Adverse Event|9
4981380|NCT00040742|17101352|P3|Overall Study|Adverse Event|21
4981381|NCT00040742|17101353|P2|Overall Study|Adverse Event|16
4981382|NCT00040742|17101354|P1|Overall Study|Adverse Event|15
4981383|NCT00040742|17101351|P4|Overall Study|Death|0
4981384|NCT00040742|17101352|P3|Overall Study|Death|1
4981385|NCT00040742|17101353|P2|Overall Study|Death|0
4981386|NCT00040742|17101354|P1|Overall Study|Death|0
4981387|NCT00039377|17101368|P4|Initial Registration|Withdrawal by Subject|0
4981388|NCT00039377|17101369|P3|Initial Registration|Withdrawal by Subject|0
4981389|NCT00039377|17101370|P2|Initial Registration|Withdrawal by Subject|0
4981390|NCT00039377|17101371|P1|Initial Registration|Withdrawal by Subject|3
4981391|NCT00039377|17101368|P4|Initial Registration|Received non-protocol therapy|0
4981392|NCT00039377|17101369|P3|Initial Registration|Received non-protocol therapy|0
4981393|NCT00039377|17101370|P2|Initial Registration|Received non-protocol therapy|0
4981394|NCT00039377|17101371|P1|Initial Registration|Received non-protocol therapy|11
4981395|NCT00039377|17101368|P4|Initial Registration|Relapsed|0
4981396|NCT00039377|17101369|P3|Initial Registration|Relapsed|0
4981397|NCT00039377|17101370|P2|Initial Registration|Relapsed|0
4981398|NCT00039377|17101371|P1|Initial Registration|Relapsed|6
4981399|NCT00039377|17101368|P4|Initial Registration|Adverse Event|0
4981400|NCT00039377|17101369|P3|Initial Registration|Adverse Event|0
4981401|NCT00039377|17101370|P2|Initial Registration|Adverse Event|0
4981402|NCT00039377|17101371|P1|Initial Registration|Adverse Event|2
4981403|NCT00039130|17101387|P1|Overall Study|Physician Decision|3
4981404|NCT00039130|17101387|P1|Overall Study|Subsequent treatment|2
4981405|NCT00039130|17101387|P1|Overall Study|Progression|2
4981406|NCT00039130|17101387|P1|Overall Study|Withdrawal by Subject|3
4981407|NCT00039130|17101387|P1|Overall Study|Death|9
4981408|NCT00039130|17101387|P1|Overall Study|Adverse Event|11
4981409|NCT00033657|17101403|P2|Adjuvant Chemotherapy|Other|2
4981410|NCT00033657|17101404|P1|Adjuvant Chemotherapy|Other|0
4981411|NCT00033657|17101403|P2|Adjuvant Chemotherapy|alternative therapy|0
4981412|NCT00033657|17101404|P1|Adjuvant Chemotherapy|alternative therapy|1
4981413|NCT00033657|17101403|P2|Adjuvant Chemotherapy|Withdrawal by Subject|3
4981414|NCT00033657|17101404|P1|Adjuvant Chemotherapy|Withdrawal by Subject|5
4981415|NCT00033657|17101403|P2|Adjuvant Chemotherapy|Death|1
4981416|NCT00033657|17101404|P1|Adjuvant Chemotherapy|Death|2
4981417|NCT00033657|17101403|P2|Adjuvant Chemotherapy|Adverse Event|10
4981418|NCT00033657|17101404|P1|Adjuvant Chemotherapy|Adverse Event|7
4981419|NCT00033657|17101403|P2|Adjuvant Chemotherapy|Lack of Efficacy|1
4981420|NCT00033657|17101404|P1|Adjuvant Chemotherapy|Lack of Efficacy|3
4981421|NCT00033657|17101403|P2|Surgical Resection|not complete resection|3
4981422|NCT00033657|17101404|P1|Surgical Resection|not complete resection|0
4981423|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|Not started protocol therapy|1
4981424|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|Not started protocol therapy|3
4981425|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|Ineligible|4
4981426|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|Ineligible|8
4981427|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|other complicating disease|1
4981428|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|other complicating disease|0
4981429|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|Withdrawal by Subject|0
4981430|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|1
4981431|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|Death|1
4981432|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|Death|1
4981433|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|Adverse Event|2
4981434|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|Adverse Event|0
4981435|NCT00033657|17101403|P2|Neoadjuvant Chemotherapy|Lack of Efficacy|2
4981436|NCT00033657|17101404|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|1
4981437|NCT00033631|17101418|P2|Overall Study|Withdrawal by Subject|4
4981438|NCT00033631|17101419|P1|Overall Study|Withdrawal by Subject|4
4981439|NCT00033631|17101418|P2|Overall Study|Protocol Violation|11
4981440|NCT00033631|17101419|P1|Overall Study|Protocol Violation|14
4981441|NCT00033540|17101437|P1|Overall Study|Never received treatment|2
4981442|NCT00033540|17101437|P1|Overall Study|Ineligible|3
4981443|NCT00033540|17101437|P1|Overall Study|Other|5
4981444|NCT00033540|17101437|P1|Overall Study|Withdrawal by Subject|6
4981445|NCT00033540|17101437|P1|Overall Study|Progression|26
4981446|NCT00033540|17101437|P1|Overall Study|Death|1
4981447|NCT00033540|17101437|P1|Overall Study|Adverse Event|14
4981448|NCT00033514|17101447|P2|Overall Study|Withdrawal by Subject|3
4981449|NCT00033514|17101448|P1|Overall Study|Withdrawal by Subject|0
4981450|NCT00033514|17101447|P2|Overall Study|Lost to Follow-up|1
4981451|NCT00033514|17101448|P1|Overall Study|Lost to Follow-up|1
4981452|NCT00033371|17101458|P2|Overall Study|Disease Progression|1
4981453|NCT00033371|17101459|P1|Overall Study|Disease Progression|0
4981454|NCT00033371|17101458|P2|Overall Study|Withdrawal by Subject|3
4981455|NCT00033371|17101459|P1|Overall Study|Withdrawal by Subject|3
4981456|NCT00033371|17101458|P2|Overall Study|Lost to Follow-up|1
4981457|NCT00033371|17101459|P1|Overall Study|Lost to Follow-up|2
4981458|NCT00033371|17101458|P2|Overall Study|Adverse Event|5
4981459|NCT00033371|17101459|P1|Overall Study|Adverse Event|1
4981460|NCT00033293|17101477|P2|Overall Study|Treatment refused|6
4981461|NCT00033293|17101478|P1|Overall Study|Treatment refused|0
4981462|NCT00033293|17101477|P2|Overall Study|Could not be weaned from steroid therapy|1
4981463|NCT00033293|17101478|P1|Overall Study|Could not be weaned from steroid therapy|1
4981464|NCT00033293|17101477|P2|Overall Study|Withdrawal by Subject|0
4981465|NCT00033293|17101478|P1|Overall Study|Withdrawal by Subject|1
4981466|NCT00033293|17101477|P2|Overall Study|Physician Decision|1
4981467|NCT00033293|17101478|P1|Overall Study|Physician Decision|3
4981468|NCT00033293|17101477|P2|Overall Study|Lost to Follow-up|1
4981469|NCT00033293|17101478|P1|Overall Study|Lost to Follow-up|0
4981470|NCT00033293|17101477|P2|Overall Study|Lack of Efficacy|8
4981471|NCT00033293|17101478|P1|Overall Study|Lack of Efficacy|5
4981472|NCT00033293|17101477|P2|Overall Study|Death|1
4981473|NCT00033293|17101478|P1|Overall Study|Death|0
4981474|NCT00031694|17101496|P1|Overall Study|Withdrawal by Subject|5
4981475|NCT00031694|17101496|P1|Overall Study|Death|2
4981476|NCT00031694|17101496|P1|Overall Study|Adverse Event|12
4981477|NCT00031590|17101500|P1|Overall Study|Withdrawal by parents|2
4981478|NCT00031590|17101500|P1|Overall Study|Adverse Event|1
4981479|NCT00030901|17101507|P3|Randomization|Ineligible|14
4981480|NCT00030901|17101508|P2|Randomization|Ineligible|15
4981481|NCT00030901|17101509|P1|Randomization|Ineligible|0
4981482|NCT00030901|17101507|P3|Randomization|Other|33
4981483|NCT00030901|17101508|P2|Randomization|Other|36
4981484|NCT00030901|17101509|P1|Randomization|Other|0
4981485|NCT00030901|17101507|P3|Randomization|Death|3
4981486|NCT00030901|17101508|P2|Randomization|Death|1
4981487|NCT00030901|17101509|P1|Randomization|Death|0
4981488|NCT00030901|17101507|P3|Randomization|Progression/Relapse|21
4981489|NCT00030901|17101508|P2|Randomization|Progression/Relapse|22
4981490|NCT00030901|17101509|P1|Randomization|Progression/Relapse|0
4981491|NCT00030901|17101507|P3|Randomization|Refusal Unrelated to Adverse Event|10
4981492|NCT00030901|17101508|P2|Randomization|Refusal Unrelated to Adverse Event|16
4981493|NCT00030901|17101509|P1|Randomization|Refusal Unrelated to Adverse Event|0
4981494|NCT00030901|17101507|P3|Randomization|Adverse Event|7
4981495|NCT00030901|17101508|P2|Randomization|Adverse Event|11
4981496|NCT00030901|17101509|P1|Randomization|Adverse Event|0
4981497|NCT00030901|17101507|P3|Initial Registration|Ineligible|0
4981498|NCT00030901|17101508|P2|Initial Registration|Ineligible|0
4981499|NCT00030901|17101509|P1|Initial Registration|Ineligible|167
4981500|NCT00030823|17101517|P1|Overall Study|Withdrawal by Subject|1
4981501|NCT00028769|17101525|P1|Overall Study|Not Analyzable|1
4981502|NCT00028769|17101525|P1|Overall Study|Ineligible|5
4981503|NCT00028769|17101525|P1|Overall Study|Other - Not Protocol Specified|1
4981504|NCT00028769|17101525|P1|Overall Study|Progression or Death|31
4981505|NCT00028769|17101525|P1|Overall Study|Refusal Unrelated to Adverse Events|1
4981506|NCT00028769|17101525|P1|Overall Study|Adverse Event|2
4981507|NCT00028002|17101531|P1|Overall Study|Ineligible|8
4981508|NCT00028002|17101531|P1|Overall Study|Withdrawal by Subject|3
4981509|NCT00027846|17101541|P3|Overall Study|Neuraxis dissemination during/after ther|5
4981510|NCT00027846|17101542|P2|Overall Study|Neuraxis dissemination during/after ther|2
4981511|NCT00027846|17101543|P1|Overall Study|Neuraxis dissemination during/after ther|0
4981512|NCT00027846|17101541|P3|Overall Study|Entry into another COG therapeutic study|2
4981513|NCT00027846|17101542|P2|Overall Study|Entry into another COG therapeutic study|5
4981514|NCT00027846|17101543|P1|Overall Study|Entry into another COG therapeutic study|0
4981515|NCT00027846|17101541|P3|Overall Study|Ineligible for study|14
4981516|NCT00027846|17101542|P2|Overall Study|Ineligible for study|6
4981517|NCT00027846|17101543|P1|Overall Study|Ineligible for study|2
4981518|NCT00027846|17101541|P3|Overall Study|Withdrawal by Subject|7
4981519|NCT00027846|17101542|P2|Overall Study|Withdrawal by Subject|14
4981520|NCT00027846|17101543|P1|Overall Study|Withdrawal by Subject|0
4981521|NCT00027846|17101541|P3|Overall Study|Lost to Follow-up|9
4981522|NCT00027846|17101542|P2|Overall Study|Lost to Follow-up|41
4981523|NCT00027846|17101543|P1|Overall Study|Lost to Follow-up|0
4981524|NCT00027560|17101561|P1|Overall Study|Withdrawal by Subject|1
4981525|NCT00026494|17101574|P4|Overall Study|Clinical progression|0
4981526|NCT00026494|17101575|P3|Overall Study|Clinical progression|3
4981527|NCT00026494|17101576|P2|Overall Study|Clinical progression|0
4981528|NCT00026494|17101577|P1|Overall Study|Clinical progression|0
4981529|NCT00026494|17101574|P4|Overall Study|Patient not treated|0
4981530|NCT00026494|17101575|P3|Overall Study|Patient not treated|2
4981531|NCT00026494|17101576|P2|Overall Study|Patient not treated|0
4981532|NCT00026494|17101577|P1|Overall Study|Patient not treated|0
4981533|NCT00026494|17101574|P4|Overall Study|Patient non-compliance|0
4981534|NCT00026494|17101575|P3|Overall Study|Patient non-compliance|0
4981535|NCT00026494|17101576|P2|Overall Study|Patient non-compliance|0
4981536|NCT00026494|17101577|P1|Overall Study|Patient non-compliance|1
4981537|NCT00026494|17101574|P4|Overall Study|Withdrawal by Subject|0
4981538|NCT00026494|17101575|P3|Overall Study|Withdrawal by Subject|1
4981539|NCT00026494|17101576|P2|Overall Study|Withdrawal by Subject|0
4981540|NCT00026494|17101577|P1|Overall Study|Withdrawal by Subject|1
4981541|NCT00026312|17101589|P2|Overall Study|Refusal by patient/parent/guardian|59
4981542|NCT00026312|17101590|P1|Overall Study|Refusal by patient/parent/guardian|8
4981543|NCT00026312|17101589|P2|Overall Study|Entry onto another COG study|1
4981544|NCT00026312|17101590|P1|Overall Study|Entry onto another COG study|0
4981545|NCT00026312|17101589|P2|Overall Study|Ineligible|5
4981546|NCT00026312|17101590|P1|Overall Study|Ineligible|4
4981547|NCT00026312|17101589|P2|Overall Study|Withdrawal by Subject|6
4981548|NCT00026312|17101590|P1|Overall Study|Withdrawal by Subject|1
4981549|NCT00026312|17101589|P2|Overall Study|Protocol Violation|3
4981550|NCT00026312|17101590|P1|Overall Study|Protocol Violation|0
4981551|NCT00026312|17101589|P2|Overall Study|Physician Decision|37
4981552|NCT00026312|17101590|P1|Overall Study|Physician Decision|1
4981553|NCT00026312|17101589|P2|Overall Study|Lost to Follow-up|5
4981554|NCT00026312|17101590|P1|Overall Study|Lost to Follow-up|0
4981555|NCT00026312|17101589|P2|Overall Study|Lack of Efficacy|114
4981556|NCT00026312|17101590|P1|Overall Study|Lack of Efficacy|19
4981557|NCT00026312|17101589|P2|Overall Study|Death|7
4981558|NCT00026312|17101590|P1|Overall Study|Death|1
4981559|NCT00026312|17101589|P2|Overall Study|Adverse Event|32
4981560|NCT00026312|17101590|P1|Overall Study|Adverse Event|0
4981561|NCT00026208|17101629|P2|Overall Study|Complications of auto accident|0
4981562|NCT00026208|17101630|P1|Overall Study|Complications of auto accident|1
4981563|NCT00025662|17101648|P1|Overall Study|Technical failure of manipulation|1
4981564|NCT00025662|17101648|P1|Overall Study|Withdrawal by Subject|2
4981565|NCT00025506|17101656|P1|Overall Study|Never Treated|2
4981566|NCT00025506|17101656|P1|Overall Study|Ineligible: inadequate pathology|2
4981567|NCT00025506|17101656|P1|Overall Study|Ineligible: wrong cell type|5
4981568|NCT00025506|17101656|P1|Overall Study|Ineligible: clerical error|1
4981569|NCT00025259|17101677|P7|Overall Study|Adverse Event|0
4981570|NCT00025259|17101678|P6|Overall Study|Adverse Event|0
4981571|NCT00025259|17101679|P5|Overall Study|Adverse Event|0
4981572|NCT00025259|17101680|P4|Overall Study|Adverse Event|0
4981573|NCT00025259|17101681|P3|Overall Study|Adverse Event|0
4981574|NCT00025259|17101682|P2|Overall Study|Adverse Event|0
4981575|NCT00025259|17101683|P1|Overall Study|Adverse Event|1
4981576|NCT00025259|17101677|P7|Overall Study|Randomization error|2
4981577|NCT00025259|17101678|P6|Overall Study|Randomization error|7
4981578|NCT00025259|17101679|P5|Overall Study|Randomization error|1
4981579|NCT00025259|17101680|P4|Overall Study|Randomization error|0
4981580|NCT00025259|17101681|P3|Overall Study|Randomization error|0
4981581|NCT00025259|17101682|P2|Overall Study|Randomization error|0
4981582|NCT00025259|17101683|P1|Overall Study|Randomization error|1
4981583|NCT00025259|17101677|P7|Overall Study|Ineligible|1
4981584|NCT00025259|17101678|P6|Overall Study|Ineligible|0
4981585|NCT00025259|17101679|P5|Overall Study|Ineligible|6
4981586|NCT00025259|17101680|P4|Overall Study|Ineligible|0
4981587|NCT00025259|17101681|P3|Overall Study|Ineligible|0
4981588|NCT00025259|17101682|P2|Overall Study|Ineligible|1
4981589|NCT00025259|17101683|P1|Overall Study|Ineligible|14
4981590|NCT00025259|17101677|P7|Overall Study|Withdrawal by Subject|3
4981591|NCT00025259|17101678|P6|Overall Study|Withdrawal by Subject|8
4981592|NCT00025259|17101679|P5|Overall Study|Withdrawal by Subject|11
4981593|NCT00025259|17101680|P4|Overall Study|Withdrawal by Subject|14
4981594|NCT00025259|17101681|P3|Overall Study|Withdrawal by Subject|6
4981595|NCT00025259|17101682|P2|Overall Study|Withdrawal by Subject|27
4981596|NCT00025259|17101683|P1|Overall Study|Withdrawal by Subject|9
4981597|NCT00025259|17101677|P7|Overall Study|Protocol Violation|3
4981598|NCT00025259|17101678|P6|Overall Study|Protocol Violation|1
4981599|NCT00025259|17101679|P5|Overall Study|Protocol Violation|2
4981600|NCT00025259|17101680|P4|Overall Study|Protocol Violation|1
4981601|NCT00025259|17101681|P3|Overall Study|Protocol Violation|2
4981602|NCT00025259|17101682|P2|Overall Study|Protocol Violation|2
4981603|NCT00025259|17101683|P1|Overall Study|Protocol Violation|3
4981604|NCT00025259|17101677|P7|Overall Study|Physician Decision|1
4981605|NCT00025259|17101678|P6|Overall Study|Physician Decision|2
4981606|NCT00025259|17101679|P5|Overall Study|Physician Decision|4
4981607|NCT00025259|17101680|P4|Overall Study|Physician Decision|5
4981608|NCT00025259|17101681|P3|Overall Study|Physician Decision|0
4981609|NCT00025259|17101682|P2|Overall Study|Physician Decision|1
4981610|NCT00025259|17101683|P1|Overall Study|Physician Decision|12
4981611|NCT00025259|17101677|P7|Overall Study|Lost to Follow-up|1
4981612|NCT00025259|17101678|P6|Overall Study|Lost to Follow-up|3
4981613|NCT00025259|17101679|P5|Overall Study|Lost to Follow-up|1
4981614|NCT00025259|17101680|P4|Overall Study|Lost to Follow-up|13
4981615|NCT00025259|17101681|P3|Overall Study|Lost to Follow-up|13
4981616|NCT00025259|17101682|P2|Overall Study|Lost to Follow-up|9
4981617|NCT00025259|17101683|P1|Overall Study|Lost to Follow-up|2
4981618|NCT00025259|17101677|P7|Overall Study|Lack of Efficacy|38
4981619|NCT00025259|17101678|P6|Overall Study|Lack of Efficacy|30
4981620|NCT00025259|17101679|P5|Overall Study|Lack of Efficacy|11
4981621|NCT00025259|17101680|P4|Overall Study|Lack of Efficacy|78
4981622|NCT00025259|17101681|P3|Overall Study|Lack of Efficacy|60
4981623|NCT00025259|17101682|P2|Overall Study|Lack of Efficacy|46
4981624|NCT00025259|17101683|P1|Overall Study|Lack of Efficacy|2
4981625|NCT00025259|17101677|P7|Overall Study|Death|2
4981626|NCT00025259|17101678|P6|Overall Study|Death|1
4981627|NCT00025259|17101679|P5|Overall Study|Death|0
4981628|NCT00025259|17101680|P4|Overall Study|Death|3
4981629|NCT00025259|17101681|P3|Overall Study|Death|0
4981630|NCT00025259|17101682|P2|Overall Study|Death|3
4981631|NCT00025259|17101683|P1|Overall Study|Death|1
4981632|NCT00025233|17101719|P1|Overall Study|Never treated|1
4981633|NCT00025233|17101719|P1|Overall Study|Ineligible: improper prior treatment|1
4981634|NCT00025233|17101719|P1|Overall Study|Ineligible: wrong primary|1
4981635|NCT00025233|17101719|P1|Overall Study|Ineligible: wrong cell type|1
4981636|NCT00025155|17101734|P1|Overall Study|Ineligible: Second primary cancer site|1
4981637|NCT00025155|17101734|P1|Overall Study|Ineligible: Wrong primary cancer site|1
4981638|NCT00024258|17101745|P1|Overall Study|Disease Progression|8
4981639|NCT00024258|17101745|P1|Overall Study|Withdrawal by Subject|1
4981640|NCT00024167|17101752|P2|Overall Study|Death|47
4981641|NCT00024167|17101753|P1|Overall Study|Death|53
4981642|NCT00023764|17101777|P1|Overall Study|delay in obtaining staging images|1
4981643|NCT00023764|17101777|P1|Overall Study|patient received other treatment|1
4981644|NCT00023764|17101777|P1|Overall Study|Progression of disease|6
4981645|NCT00023764|17101777|P1|Overall Study|Withdrawal by Subject|1
4981646|NCT00023764|17101777|P1|Overall Study|Adverse Event|4
4981647|NCT00023764|17101777|P1|Overall Study|Other|1
4981648|NCT00023712|17101784|P2|Overall Study|Never treated|1
4981649|NCT00023712|17101785|P1|Overall Study|Never treated|1
4981650|NCT00023712|17101784|P2|Overall Study|Not platinum sensitive|0
4981651|NCT00023712|17101785|P1|Overall Study|Not platinum sensitive|1
4981652|NCT00022698|17101809|P2|Overall Study|Administrative /other|7
4981653|NCT00022698|17101810|P1|Overall Study|Administrative /other|1
4981654|NCT00022698|17101809|P2|Overall Study|Insufficient therapeutic response|14
4981655|NCT00022698|17101810|P1|Overall Study|Insufficient therapeutic response|2
4981656|NCT00022698|17101809|P2|Overall Study|Refused treatment|2
4981657|NCT00022698|17101810|P1|Overall Study|Refused treatment|0
4981658|NCT00022698|17101809|P2|Overall Study|Failure to return|1
4981659|NCT00022698|17101810|P1|Overall Study|Failure to return|0
4981660|NCT00022698|17101809|P2|Overall Study|Death|2
4981661|NCT00022698|17101810|P1|Overall Study|Death|0
4981662|NCT00022698|17101809|P2|Overall Study|Adverse Event|9
4981663|NCT00022698|17101810|P1|Overall Study|Adverse Event|5
4981664|NCT00022672|17101835|P2|Extension Phase|Other|1
4981665|NCT00022672|17101836|P1|Extension Phase|Other|1
4981666|NCT00022672|17101835|P2|Extension Phase|Refused Treatment|2
4981667|NCT00022672|17101836|P1|Extension Phase|Refused Treatment|0
4981668|NCT00022672|17101835|P2|Extension Phase|Insufficient Therapeutic Response|44
4981669|NCT00022672|17101836|P1|Extension Phase|Insufficient Therapeutic Response|1
4981670|NCT00022672|17101835|P2|Extension Phase|Death|1
4981671|NCT00022672|17101836|P1|Extension Phase|Death|0
4981672|NCT00022672|17101835|P2|Extension Phase|Adverse Event|3
4981673|NCT00022672|17101836|P1|Extension Phase|Adverse Event|1
4981674|NCT00022672|17101835|P2|Main Phase: 24 Months|Other|0
4981675|NCT00022672|17101836|P1|Main Phase: 24 Months|Other|1
4981676|NCT00022672|17101835|P2|Main Phase: 24 Months|Failure to Return|1
4981677|NCT00022672|17101836|P1|Main Phase: 24 Months|Failure to Return|1
4981678|NCT00022672|17101835|P2|Main Phase: 24 Months|Refused Treatment|4
4981679|NCT00022672|17101836|P1|Main Phase: 24 Months|Refused Treatment|3
4981680|NCT00022672|17101835|P2|Main Phase: 24 Months|Other Protocol Violation|0
4981681|NCT00022672|17101836|P1|Main Phase: 24 Months|Other Protocol Violation|1
4981682|NCT00022672|17101835|P2|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1
4981683|NCT00022672|17101836|P1|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0
4981684|NCT00022672|17101835|P2|Main Phase: 24 Months|Insufficient Therapeutic Response|91
4981685|NCT00022672|17101836|P1|Main Phase: 24 Months|Insufficient Therapeutic Response|75
4981686|NCT00022672|17101835|P2|Main Phase: 24 Months|Death|3
4981687|NCT00022672|17101836|P1|Main Phase: 24 Months|Death|0
4981688|NCT00022672|17101835|P2|Main Phase: 24 Months|Adverse Event|0
4981689|NCT00022672|17101836|P1|Main Phase: 24 Months|Adverse Event|6
4981690|NCT00022659|17101869|P1|Overall Study|Never treated|1
4981691|NCT00022659|17101869|P1|Overall Study|Ineligible: wrong primary|1
4981692|NCT00022633|17101882|P2|Overall Study|Ineligible|0
4981693|NCT00022633|17101883|P1|Overall Study|Ineligible|4
4981694|NCT00022633|17101882|P2|Overall Study|Other - not protocol specified|2
4981695|NCT00022633|17101883|P1|Overall Study|Other - not protocol specified|3
4981696|NCT00022633|17101882|P2|Overall Study|Death|0
4981697|NCT00022633|17101883|P1|Overall Study|Death|4
4981698|NCT00022633|17101882|P2|Overall Study|Progression/relapse|2
4981699|NCT00022633|17101883|P1|Overall Study|Progression/relapse|9
4981700|NCT00022633|17101882|P2|Overall Study|Refusal unrelated to adverse event|0
4981701|NCT00022633|17101883|P1|Overall Study|Refusal unrelated to adverse event|1
4981702|NCT00022633|17101882|P2|Overall Study|Adverse Event|1
4981703|NCT00022633|17101883|P1|Overall Study|Adverse Event|11
4981704|NCT00022516|17101896|P2|Overall Study|Incomplete documentation|27
4981705|NCT00022516|17101897|P1|Overall Study|Incomplete documentation|0
4981706|NCT00022516|17101896|P2|Overall Study|Withdrawal by Subject|113
4981707|NCT00022516|17101897|P1|Overall Study|Withdrawal by Subject|2
4981708|NCT00022516|17101896|P2|Overall Study|Protocol Violation|3
4981709|NCT00022516|17101897|P1|Overall Study|Protocol Violation|1
4981710|NCT00022516|17101896|P2|Overall Study|Physician Decision|1
4981711|NCT00022516|17101897|P1|Overall Study|Physician Decision|0
4981712|NCT00022516|17101896|P2|Overall Study|Lack of Efficacy|27
4981713|NCT00022516|17101897|P1|Overall Study|Lack of Efficacy|0
4981714|NCT00022516|17101896|P2|Overall Study|Adverse Event|59
4981715|NCT00022516|17101897|P1|Overall Study|Adverse Event|0
4981716|NCT00021255|17101916|P3|Overall Study|Randomized but not treated|18
4981717|NCT00021255|17101917|P2|Overall Study|Randomized but not treated|2
4981718|NCT00021255|17101918|P1|Overall Study|Randomized but not treated|28
4981719|NCT00021255|17101916|P3|Overall Study|Missing|13
4981720|NCT00021255|17101917|P2|Overall Study|Missing|27
4981721|NCT00021255|17101918|P1|Overall Study|Missing|0
4981722|NCT00021255|17101916|P3|Overall Study|Other than specified above|19
4981723|NCT00021255|17101917|P2|Overall Study|Other than specified above|38
4981724|NCT00021255|17101918|P1|Overall Study|Other than specified above|0
4981725|NCT00021255|17101916|P3|Overall Study|Protocol Violation|0
4981726|NCT00021255|17101917|P2|Overall Study|Protocol Violation|2
4981727|NCT00021255|17101918|P1|Overall Study|Protocol Violation|0
4981728|NCT00021255|17101916|P3|Overall Study|Adverse Event|18
4981729|NCT00021255|17101917|P2|Overall Study|Adverse Event|30
4981730|NCT00021255|17101918|P1|Overall Study|Adverse Event|46
4981731|NCT00021255|17101916|P3|Overall Study|Herceptin toxicity|6
4981732|NCT00021255|17101917|P2|Overall Study|Herceptin toxicity|22
4981733|NCT00021255|17101918|P1|Overall Study|Herceptin toxicity|0
4981734|NCT00021255|17101916|P3|Overall Study|Cardiac toxicity|32
4981735|NCT00021255|17101917|P2|Overall Study|Cardiac toxicity|61
4981736|NCT00021255|17101918|P1|Overall Study|Cardiac toxicity|0
4981737|NCT00021255|17101916|P3|Overall Study|Lost to Follow-up|3
4981738|NCT00021255|17101917|P2|Overall Study|Lost to Follow-up|2
4981739|NCT00021255|17101918|P1|Overall Study|Lost to Follow-up|0
4981740|NCT00021255|17101916|P3|Overall Study|Withdrawal by Subject|26
4981741|NCT00021255|17101917|P2|Overall Study|Withdrawal by Subject|64
4981742|NCT00021255|17101918|P1|Overall Study|Withdrawal by Subject|41
4981743|NCT00021255|17101916|P3|Overall Study|Second primary malignancy|1
4981744|NCT00021255|17101917|P2|Overall Study|Second primary malignancy|4
4981745|NCT00021255|17101918|P1|Overall Study|Second primary malignancy|0
4981746|NCT00021255|17101916|P3|Overall Study|Breast cancer relapse|11
4981747|NCT00021255|17101917|P2|Overall Study|Breast cancer relapse|18
4981748|NCT00021255|17101918|P1|Overall Study|Breast cancer relapse|5
4981749|NCT00021255|17101916|P3|Overall Study|Death|2
4981750|NCT00021255|17101917|P2|Overall Study|Death|0
4981751|NCT00021255|17101918|P1|Overall Study|Death|1
4981752|NCT00021229|17101935|P3|Overall Study|Punctate hemmorrhage post RT|0
4981753|NCT00021229|17101936|P2|Overall Study|Punctate hemmorrhage post RT|0
4981754|NCT00021229|17101937|P1|Overall Study|Punctate hemmorrhage post RT|2
4981755|NCT00021229|17101935|P3|Overall Study|Physician Decision|1
4981756|NCT00021229|17101936|P2|Overall Study|Physician Decision|0
4981757|NCT00021229|17101937|P1|Overall Study|Physician Decision|0
4981758|NCT00021229|17101935|P3|Overall Study|Protocol Violation|0
4981759|NCT00021229|17101936|P2|Overall Study|Protocol Violation|1
4981760|NCT00021229|17101937|P1|Overall Study|Protocol Violation|1
4981761|NCT00021229|17101935|P3|Overall Study|Progressive Disease|12
4981762|NCT00021229|17101936|P2|Overall Study|Progressive Disease|19
4981763|NCT00021229|17101937|P1|Overall Study|Progressive Disease|15
4981764|NCT00021229|17101935|P3|Overall Study|Withdrawal by Subject|1
4981765|NCT00021229|17101936|P2|Overall Study|Withdrawal by Subject|7
4981766|NCT00021229|17101937|P1|Overall Study|Withdrawal by Subject|7
4981767|NCT00021229|17101935|P3|Overall Study|Death|0
4981768|NCT00021229|17101936|P2|Overall Study|Death|1
4981769|NCT00021229|17101937|P1|Overall Study|Death|0
4981770|NCT00021229|17101935|P3|Overall Study|Adverse Event|2
4981771|NCT00021229|17101936|P2|Overall Study|Adverse Event|5
4981772|NCT00021229|17101937|P1|Overall Study|Adverse Event|10
4981773|NCT00019604|17101992|P1|Overall Study|Details for other not available|4
4981774|NCT00019604|17101992|P1|Overall Study|Unable to evaluate|1
4981775|NCT00019604|17101992|P1|Overall Study|Too much disease|1
4981776|NCT00019604|17101992|P1|Overall Study|Pt going to immunotherapy study|1
4981777|NCT00019604|17101992|P1|Overall Study|Started new chemo regimen|1
4981778|NCT00019604|17101992|P1|Overall Study|Resectable disease|1
4981779|NCT00019604|17101992|P1|Overall Study|Non compliant|1
4981780|NCT00019604|17101992|P1|Overall Study|Non compliant on systemic CH|1
4981781|NCT00019604|17101992|P1|Overall Study|Move to a different study|1
4981782|NCT00019604|17101992|P1|Overall Study|Going to have liver transplant|1
4981783|NCT00019604|17101992|P1|Overall Study|Carcinoid tumor, not treatable|1
4981784|NCT00019604|17101992|P1|Overall Study|Refused treatment|1
4981785|NCT00019604|17101992|P1|Overall Study|Progressive disease|23
4981786|NCT00019604|17101992|P1|Overall Study|Death|1
4981787|NCT00016354|17102015|P8|Overall Study|Lack of Efficacy|1
4981788|NCT00016354|17102016|P7|Overall Study|Lack of Efficacy|0
4981789|NCT00016354|17102017|P6|Overall Study|Lack of Efficacy|0
4981790|NCT00016354|17102018|P5|Overall Study|Lack of Efficacy|0
4981791|NCT00016354|17102019|P4|Overall Study|Lack of Efficacy|0
4981792|NCT00016354|17102020|P3|Overall Study|Lack of Efficacy|0
4981793|NCT00016354|17102021|P2|Overall Study|Lack of Efficacy|0
4981794|NCT00016354|17102022|P1|Overall Study|Lack of Efficacy|0
4981795|NCT00014495|17102036|P4|Overall Study|Clinical deterioration|1
4981796|NCT00014495|17102037|P3|Overall Study|Clinical deterioration|0
4981797|NCT00014495|17102038|P2|Overall Study|Clinical deterioration|0
4981798|NCT00014495|17102039|P1|Overall Study|Clinical deterioration|0
4981799|NCT00014495|17102036|P4|Overall Study|Death|0
4981800|NCT00014495|17102037|P3|Overall Study|Death|1
4981801|NCT00014495|17102038|P2|Overall Study|Death|0
4981802|NCT00014495|17102039|P1|Overall Study|Death|0
4981803|NCT00012012|17102105|P2|Overall Study|Withdrawal by Subject|2
4981804|NCT00012012|17102106|P1|Overall Study|Withdrawal by Subject|0
4981805|NCT00012012|17102105|P2|Overall Study|Protocol Violation|1
4981806|NCT00012012|17102106|P1|Overall Study|Protocol Violation|1
4981807|NCT00010257|17102145|P2|Overall Study|Withdrawal by Subject|0
4981808|NCT00010257|17102146|P1|Overall Study|Withdrawal by Subject|1
4981809|NCT00009945|17102156|P2|Overall Study|no follow up data|5
4981810|NCT00009945|17102157|P1|Overall Study|no follow up data|7
4981811|NCT00008385|17102173|P2|Overall Study|Not start protocol therapy|175
4981812|NCT00008385|17102174|P1|Overall Study|Not start protocol therapy|44
4981813|NCT00008385|17102173|P2|Overall Study|Other|212
4981814|NCT00008385|17102174|P1|Overall Study|Other|105
4981815|NCT00008385|17102173|P2|Overall Study|Maximum dose reached|2
4981816|NCT00008385|17102174|P1|Overall Study|Maximum dose reached|0
4981817|NCT00008385|17102173|P2|Overall Study|Other complicating disease|30
4981818|NCT00008385|17102174|P1|Overall Study|Other complicating disease|17
4981819|NCT00008385|17102173|P2|Overall Study|Start non-protocol therapy|1
4981820|NCT00008385|17102174|P1|Overall Study|Start non-protocol therapy|3
4981821|NCT00008385|17102173|P2|Overall Study|Withdrawal by Subject|157
4981822|NCT00008385|17102174|P1|Overall Study|Withdrawal by Subject|67
4981823|NCT00008385|17102173|P2|Overall Study|Death|18
4981824|NCT00008385|17102174|P1|Overall Study|Death|12
4981825|NCT00008385|17102173|P2|Overall Study|Adverse Event|20
4981826|NCT00008385|17102174|P1|Overall Study|Adverse Event|8
4981827|NCT00008385|17102173|P2|Overall Study|Progressive disease|117
4981828|NCT00008385|17102174|P1|Overall Study|Progressive disease|52
4981829|NCT00008385|17102173|P2|Overall Study|Off treatment reasons not reported|70
4981830|NCT00008385|17102174|P1|Overall Study|Off treatment reasons not reported|79
4981831|NCT00008138|17102184|P1|Post-Cytoreduction Chemotherapy|not protocol specified|1
4981832|NCT00008138|17102184|P1|Post-Cytoreduction Chemotherapy|Progression|1
4981833|NCT00008138|17102184|P1|Post-Cytoreduction Chemotherapy|Adverse Event|6
4981834|NCT00008138|17102184|P1|Interval Debulking|Withdrawal by Subject|2
4981835|NCT00008138|17102184|P1|Neoadjuvant Chemotherapy|not protocol specified|8
4981836|NCT00008138|17102184|P1|Neoadjuvant Chemotherapy|Lack of Efficacy|6
4981837|NCT00008138|17102184|P1|Neoadjuvant Chemotherapy|Withdrawal by Subject|3
4981838|NCT00008138|17102184|P1|Neoadjuvant Chemotherapy|Adverse Event|3
4981839|NCT00006916|17102190|P1|Overall Study|Complication of device insertion|1
4981840|NCT00006916|17102190|P1|Overall Study|Device not inserted|4
4981841|NCT00006903|17102196|P3|Overall Study|Ineligible|2
4981842|NCT00006903|17102197|P2|Overall Study|Ineligible|1
4981843|NCT00006903|17102198|P1|Overall Study|Ineligible|10
4981844|NCT00006903|17102196|P3|Overall Study|Patient never treated|1
4981845|NCT00006903|17102197|P2|Overall Study|Patient never treated|0
4981846|NCT00006903|17102198|P1|Overall Study|Patient never treated|0
4981847|NCT00006903|17102196|P3|Overall Study|Death|0
4981848|NCT00006903|17102197|P2|Overall Study|Death|1
4981849|NCT00006903|17102198|P1|Overall Study|Death|0
4981850|NCT00006903|17102196|P3|Overall Study|Adverse Event|1
4981851|NCT00006903|17102197|P2|Overall Study|Adverse Event|0
4981852|NCT00006903|17102198|P1|Overall Study|Adverse Event|0
4981853|NCT00006903|17102196|P3|Overall Study|Refused further treatment|1
4981854|NCT00006903|17102197|P2|Overall Study|Refused further treatment|2
4981855|NCT00006903|17102198|P1|Overall Study|Refused further treatment|0
4981856|NCT00006903|17102196|P3|Overall Study|Still receiving treatment|1
4981857|NCT00006903|17102197|P2|Overall Study|Still receiving treatment|0
4981858|NCT00006903|17102198|P1|Overall Study|Still receiving treatment|0
4981859|NCT00006721|17102211|P3|Overall Study|Eligible but no Treatment Received|0
4981860|NCT00006721|17102212|P2|Overall Study|Eligible but no Treatment Received|0
4981861|NCT00006721|17102213|P1|Overall Study|Eligible but no Treatment Received|1
4981862|NCT00006721|17102211|P3|Overall Study|Ineligible|10
4981863|NCT00006721|17102212|P2|Overall Study|Ineligible|12
4981864|NCT00006721|17102213|P1|Overall Study|Ineligible|2
4981865|NCT00006721|17102211|P3|Overall Study|Other - Not Protocol Specified|7
4981866|NCT00006721|17102212|P2|Overall Study|Other - Not Protocol Specified|7
4981867|NCT00006721|17102213|P1|Overall Study|Other - Not Protocol Specified|0
4981868|NCT00006721|17102211|P3|Overall Study|Death|2
4981869|NCT00006721|17102212|P2|Overall Study|Death|1
4981870|NCT00006721|17102213|P1|Overall Study|Death|0
4981871|NCT00006721|17102211|P3|Overall Study|Progression/Relapse|2
4981872|NCT00006721|17102212|P2|Overall Study|Progression/Relapse|1
4981873|NCT00006721|17102213|P1|Overall Study|Progression/Relapse|0
4981874|NCT00006721|17102211|P3|Overall Study|Refusal Unrelated to Adverse Event|8
4981875|NCT00006721|17102212|P2|Overall Study|Refusal Unrelated to Adverse Event|0
4981876|NCT00006721|17102213|P1|Overall Study|Refusal Unrelated to Adverse Event|1
4981877|NCT00006721|17102211|P3|Overall Study|Adverse Event|4
4981878|NCT00006721|17102212|P2|Overall Study|Adverse Event|4
4981879|NCT00006721|17102213|P1|Overall Study|Adverse Event|0
4981880|NCT00006478|17102231|P1|Overall Study|Physician Decision|6
4981881|NCT00006478|17102231|P1|Overall Study|Vaccine could not be produced|1
4981882|NCT00006392|17102242|P4|Overall Study|Poor data/ppt mgmt, regulatory problems|155
4981883|NCT00006392|17102243|P3|Overall Study|Poor data/ppt mgmt, regulatory problems|155
4981884|NCT00006392|17102244|P2|Overall Study|Poor data/ppt mgmt, regulatory problems|155
4981885|NCT00006392|17102245|P1|Overall Study|Poor data/ppt mgmt, regulatory problems|156
4981886|NCT00006392|17102242|P4|Overall Study|Ineligible|5
4981887|NCT00006392|17102243|P3|Overall Study|Ineligible|5
4981888|NCT00006392|17102244|P2|Overall Study|Ineligible|3
4981889|NCT00006392|17102245|P1|Overall Study|Ineligible|11
4981890|NCT00006389|17102275|P1|Overall Study|Adverse Event|1
4981891|NCT00006237|17102292|P2|Overall Study|Not protocol specified|5
4981892|NCT00006237|17102293|P1|Overall Study|Not protocol specified|14
4981893|NCT00006237|17102292|P2|Overall Study|Withdrawal by Subject|1
4981894|NCT00006237|17102293|P1|Overall Study|Withdrawal by Subject|0
4981895|NCT00006237|17102292|P2|Overall Study|Not eligible|20
4981896|NCT00006237|17102293|P1|Overall Study|Not eligible|9
4981897|NCT00006237|17102292|P2|Overall Study|Progression/relapse|2
4981898|NCT00006237|17102293|P1|Overall Study|Progression/relapse|54
4981899|NCT00006237|17102292|P2|Overall Study|Refusal unrelated to adverse effects|4
4981900|NCT00006237|17102293|P1|Overall Study|Refusal unrelated to adverse effects|8
4981901|NCT00006237|17102292|P2|Overall Study|Death|0
4981902|NCT00006237|17102293|P1|Overall Study|Death|1
4981903|NCT00006237|17102292|P2|Overall Study|Adverse Event|29
4981904|NCT00006237|17102293|P1|Overall Study|Adverse Event|39
4981905|NCT00006011|17102336|P3|Overall Study|Ineligible|9
4981906|NCT00006011|17102337|P2|Overall Study|Ineligible|16
4981907|NCT00006011|17102338|P1|Overall Study|Ineligible|18
4981908|NCT00006011|17102336|P3|Overall Study|Other|5
4981909|NCT00006011|17102337|P2|Overall Study|Other|2
4981910|NCT00006011|17102338|P1|Overall Study|Other|4
4981911|NCT00006011|17102336|P3|Overall Study|Death|2
4981912|NCT00006011|17102337|P2|Overall Study|Death|1
4981913|NCT00006011|17102338|P1|Overall Study|Death|0
4981914|NCT00006011|17102336|P3|Overall Study|Adverse Event|5
4981915|NCT00006011|17102337|P2|Overall Study|Adverse Event|39
4981916|NCT00006011|17102338|P1|Overall Study|Adverse Event|15
4981917|NCT00006011|17102336|P3|Overall Study|Refused further treatment|26
4981918|NCT00006011|17102337|P2|Overall Study|Refused further treatment|13
4981919|NCT00006011|17102338|P1|Overall Study|Refused further treatment|15
4981920|NCT00006011|17102336|P3|Overall Study|Disease progression|26
4981921|NCT00006011|17102337|P2|Overall Study|Disease progression|6
4981922|NCT00006011|17102338|P1|Overall Study|Disease progression|13
4981923|NCT00005957|17102346|P2|Overall Study|Crossover to the other arm|19
4981924|NCT00005957|17102347|P1|Overall Study|Crossover to the other arm|5
4981925|NCT00005957|17102346|P2|Overall Study|No treated|9
4981926|NCT00005957|17102347|P1|Overall Study|No treated|3
4981927|NCT00005879|17102357|P2|Overall Study|Withdrawal by Subject|10
4981928|NCT00005879|17102358|P1|Overall Study|Withdrawal by Subject|8
4981929|NCT00005047|17102381|P4|Overall Study|Lack of Efficacy|0
4981930|NCT00005047|17102382|P3|Overall Study|Lack of Efficacy|0
4981931|NCT00005047|17102383|P2|Overall Study|Lack of Efficacy|0
4981932|NCT00005047|17102384|P1|Overall Study|Lack of Efficacy|1
4981933|NCT00005047|17102381|P4|Overall Study|Lost to Follow-up|0
4981934|NCT00005047|17102382|P3|Overall Study|Lost to Follow-up|0
4981935|NCT00005047|17102383|P2|Overall Study|Lost to Follow-up|0
4981936|NCT00005047|17102384|P1|Overall Study|Lost to Follow-up|1
4981937|NCT00005047|17102381|P4|Overall Study|Adverse Event|0
4981938|NCT00005047|17102382|P3|Overall Study|Adverse Event|0
4981939|NCT00005047|17102383|P2|Overall Study|Adverse Event|0
4981940|NCT00005047|17102384|P1|Overall Study|Adverse Event|5
4981941|NCT00005047|17102381|P4|Overall Study|Withdrawal by Subject|0
4981942|NCT00005047|17102382|P3|Overall Study|Withdrawal by Subject|0
4981943|NCT00005047|17102383|P2|Overall Study|Withdrawal by Subject|0
4981944|NCT00005047|17102384|P1|Overall Study|Withdrawal by Subject|12
4981945|NCT00005044|17102400|P2|Overall Study|No protocol treatment|1
4981946|NCT00005044|17102401|P1|Overall Study|No protocol treatment|0
4981947|NCT00005044|17102400|P2|Overall Study|Withdrawal by Subject|5
4981948|NCT00005044|17102401|P1|Overall Study|Withdrawal by Subject|1
4981949|NCT00005044|17102400|P2|Overall Study|Protocol Violation|46
4981950|NCT00005044|17102401|P1|Overall Study|Protocol Violation|37
4981951|NCT00004888|17102421|P2|Overall Study|Toxic death|0
4981952|NCT00004888|17102422|P1|Overall Study|Toxic death|1
4981953|NCT00004888|17102421|P2|Overall Study|Death without progressive disease|1
4981954|NCT00004888|17102422|P1|Overall Study|Death without progressive disease|0
4981955|NCT00004888|17102421|P2|Overall Study|Progressive Disease|9
4981956|NCT00004888|17102422|P1|Overall Study|Progressive Disease|4
4981957|NCT00004888|17102421|P2|Overall Study|Physician Decision|1
4981958|NCT00004888|17102422|P1|Overall Study|Physician Decision|1
4981959|NCT00004888|17102421|P2|Overall Study|Withdrawal by Subject|3
4981960|NCT00004888|17102422|P1|Overall Study|Withdrawal by Subject|0
4981961|NCT00004888|17102421|P2|Overall Study|Adverse Event|10
4981962|NCT00004888|17102422|P1|Overall Study|Adverse Event|5
4981963|NCT00004859|17102440|P2|Overall Study|Other|21
4981964|NCT00004859|17102441|P1|Overall Study|Other|13
4981965|NCT00004859|17102440|P2|Overall Study|missing data|11
4981966|NCT00004859|17102441|P1|Overall Study|missing data|14
4981967|NCT00004859|17102440|P2|Overall Study|error|1
4981968|NCT00004859|17102441|P1|Overall Study|error|3
4981969|NCT00004859|17102440|P2|Overall Study|other disease|3
4981970|NCT00004859|17102441|P1|Overall Study|other disease|0
4981971|NCT00004859|17102440|P2|Overall Study|Protocol Violation|2
4981972|NCT00004859|17102441|P1|Overall Study|Protocol Violation|2
4981973|NCT00004859|17102440|P2|Overall Study|Withdrawal by Subject|33
4981974|NCT00004859|17102441|P1|Overall Study|Withdrawal by Subject|7
4981975|NCT00004859|17102440|P2|Overall Study|Death|5
4981976|NCT00004859|17102441|P1|Overall Study|Death|5
4981977|NCT00004859|17102440|P2|Overall Study|Adverse Event|93
4981978|NCT00004859|17102441|P1|Overall Study|Adverse Event|31
4981979|NCT00004859|17102440|P2|Overall Study|Lack of Efficacy|113
4981980|NCT00004859|17102441|P1|Overall Study|Lack of Efficacy|43
4981981|NCT00004259|17102455|P4|Overall Study|Withdrawal by Subject|0
4981982|NCT00004259|17102456|P3|Overall Study|Withdrawal by Subject|0
4981983|NCT00004259|17102457|P2|Overall Study|Withdrawal by Subject|2
4981984|NCT00004259|17102458|P1|Overall Study|Withdrawal by Subject|0
4981985|NCT00004259|17102455|P4|Overall Study|Protocol Violation|0
4981986|NCT00004259|17102456|P3|Overall Study|Protocol Violation|0
4981987|NCT00004259|17102457|P2|Overall Study|Protocol Violation|2
4981988|NCT00004259|17102458|P1|Overall Study|Protocol Violation|1
4981989|NCT00004228|17102483|P7|Overall Study|ineligible|5
4981990|NCT00004228|17102484|P6|Overall Study|ineligible|2
4981991|NCT00004228|17102485|P5|Overall Study|ineligible|1
4981992|NCT00004228|17102486|P4|Overall Study|ineligible|1
4981993|NCT00004228|17102487|P3|Overall Study|ineligible|4
4981994|NCT00004228|17102488|P2|Overall Study|ineligible|2
4981995|NCT00004228|17102489|P1|Overall Study|ineligible|4
4981996|NCT00004228|17102483|P7|Overall Study|Other|0
4981997|NCT00004228|17102484|P6|Overall Study|Other|0
4981998|NCT00004228|17102485|P5|Overall Study|Other|0
4981999|NCT00004228|17102486|P4|Overall Study|Other|0
4982000|NCT00004228|17102487|P3|Overall Study|Other|1
4982001|NCT00004228|17102488|P2|Overall Study|Other|0
4982002|NCT00004228|17102489|P1|Overall Study|Other|0
4982003|NCT00004228|17102483|P7|Overall Study|Withdrawal by Subject|2
4982004|NCT00004228|17102484|P6|Overall Study|Withdrawal by Subject|1
4982005|NCT00004228|17102485|P5|Overall Study|Withdrawal by Subject|2
4982006|NCT00004228|17102486|P4|Overall Study|Withdrawal by Subject|0
4982007|NCT00004228|17102487|P3|Overall Study|Withdrawal by Subject|1
4982008|NCT00004228|17102488|P2|Overall Study|Withdrawal by Subject|0
4982009|NCT00004228|17102489|P1|Overall Study|Withdrawal by Subject|3
4982010|NCT00004228|17102483|P7|Overall Study|Protocol Violation|0
4982011|NCT00004228|17102484|P6|Overall Study|Protocol Violation|2
4982012|NCT00004228|17102485|P5|Overall Study|Protocol Violation|1
4982013|NCT00004228|17102486|P4|Overall Study|Protocol Violation|1
4982014|NCT00004228|17102487|P3|Overall Study|Protocol Violation|2
4982015|NCT00004228|17102488|P2|Overall Study|Protocol Violation|5
4982016|NCT00004228|17102489|P1|Overall Study|Protocol Violation|0
4982017|NCT00004228|17102483|P7|Overall Study|Physician Decision|1
4982018|NCT00004228|17102484|P6|Overall Study|Physician Decision|1
4982019|NCT00004228|17102485|P5|Overall Study|Physician Decision|1
4982020|NCT00004228|17102486|P4|Overall Study|Physician Decision|2
4982021|NCT00004228|17102487|P3|Overall Study|Physician Decision|3
4982022|NCT00004228|17102488|P2|Overall Study|Physician Decision|0
4982023|NCT00004228|17102489|P1|Overall Study|Physician Decision|1
4982024|NCT00004228|17102483|P7|Overall Study|Lost to Follow-up|0
4982025|NCT00004228|17102484|P6|Overall Study|Lost to Follow-up|0
4982026|NCT00004228|17102485|P5|Overall Study|Lost to Follow-up|0
4982027|NCT00004228|17102486|P4|Overall Study|Lost to Follow-up|0
4982028|NCT00004228|17102487|P3|Overall Study|Lost to Follow-up|1
4982029|NCT00004228|17102488|P2|Overall Study|Lost to Follow-up|0
4982030|NCT00004228|17102489|P1|Overall Study|Lost to Follow-up|0
4982031|NCT00004228|17102483|P7|Overall Study|Lack of Efficacy|4
4982032|NCT00004228|17102484|P6|Overall Study|Lack of Efficacy|8
4982033|NCT00004228|17102485|P5|Overall Study|Lack of Efficacy|9
4982034|NCT00004228|17102486|P4|Overall Study|Lack of Efficacy|3
4982035|NCT00004228|17102487|P3|Overall Study|Lack of Efficacy|5
4982036|NCT00004228|17102488|P2|Overall Study|Lack of Efficacy|6
4982037|NCT00004228|17102489|P1|Overall Study|Lack of Efficacy|1
4982038|NCT00004228|17102483|P7|Overall Study|Death|0
4982039|NCT00004228|17102484|P6|Overall Study|Death|0
4982040|NCT00004228|17102485|P5|Overall Study|Death|1
4982041|NCT00004228|17102486|P4|Overall Study|Death|0
4982042|NCT00004228|17102487|P3|Overall Study|Death|2
4982043|NCT00004228|17102488|P2|Overall Study|Death|1
4982044|NCT00004228|17102489|P1|Overall Study|Death|0
4982045|NCT00004228|17102483|P7|Overall Study|Adverse Event|0
4982046|NCT00004228|17102484|P6|Overall Study|Adverse Event|0
4982047|NCT00004228|17102485|P5|Overall Study|Adverse Event|1
4982048|NCT00004228|17102486|P4|Overall Study|Adverse Event|0
4982049|NCT00004228|17102487|P3|Overall Study|Adverse Event|0
4982050|NCT00004228|17102488|P2|Overall Study|Adverse Event|1
4982051|NCT00004228|17102489|P1|Overall Study|Adverse Event|0
4982052|NCT00004124|17102523|P2|Overall Study|Received no protocol therapy|20
4982053|NCT00004124|17102524|P1|Overall Study|Received no protocol therapy|12
4982054|NCT00004088|17102549|P1|Overall Study|Physician Decision|1
4982055|NCT00004088|17102549|P1|Overall Study|Protocol Violation|3
4982056|NCT00004088|17102549|P1|Overall Study|Withdrawal by Subject|1
4982057|NCT00004088|17102549|P1|Overall Study|No C2 given due to study on hold by IRB|4
4982058|NCT00003901|17102582|P1|Overall Study|Medical problems|6
4982059|NCT00003901|17102582|P1|Overall Study|Chest X-Ray not done prior registration|1
4982060|NCT00003901|17102582|P1|Overall Study|CT Scan not within protocol requirement|2
4982061|NCT00003901|17102582|P1|Overall Study|Ineligible|6
4982062|NCT00003901|17102582|P1|Overall Study|Withdrawal by Subject|1
4982063|NCT00003901|17102582|P1|Overall Study|Adverse Event|1
4982064|NCT00003896|17102593|P1|Overall Study|ineligible|5
4982065|NCT00003896|17102593|P1|Overall Study|not protocol specified|3
4982066|NCT00003896|17102593|P1|Overall Study|Death|3
4982067|NCT00003896|17102593|P1|Overall Study|Lack of Efficacy|1
4982068|NCT00003896|17102593|P1|Overall Study|Withdrawal by Subject|1
4982069|NCT00003896|17102593|P1|Overall Study|Adverse Event|16
4982070|NCT00003875|17102599|P1|Overall Study|Screen Failed|1
4982071|NCT00003869|17102608|P2|Overall Study|Alternative treatmnt, medical problems|4
4982072|NCT00003869|17102609|P1|Overall Study|Alternative treatmnt, medical problems|5
4982073|NCT00003869|17102608|P2|Overall Study|Death|2
4982074|NCT00003869|17102609|P1|Overall Study|Death|1
4982075|NCT00003869|17102608|P2|Overall Study|Withdrawal by Subject|3
4982076|NCT00003869|17102609|P1|Overall Study|Withdrawal by Subject|21
4982077|NCT00003869|17102608|P2|Overall Study|Adverse Event|3
4982078|NCT00003869|17102609|P1|Overall Study|Adverse Event|14
4982079|NCT00003782|17102635|P3|Overall Study|No follow up data|26
4982080|NCT00003782|17102636|P2|Overall Study|No follow up data|31
4982081|NCT00003782|17102637|P1|Overall Study|No follow up data|30
4982082|NCT00003702|17102647|P2|Overall Study|Inadequate documentation of disease|3
4982083|NCT00003702|17102648|P1|Overall Study|Inadequate documentation of disease|1
4982084|NCT00003702|17102647|P2|Overall Study|WHO score > 6|1
4982085|NCT00003702|17102648|P1|Overall Study|WHO score > 6|2
4982086|NCT00003702|17102647|P2|Overall Study|Did not meet criteria for persistence|5
4982087|NCT00003702|17102648|P1|Overall Study|Did not meet criteria for persistence|8
4982088|NCT00003702|17102647|P2|Overall Study|Ineligible cell types|2
4982089|NCT00003702|17102648|P1|Overall Study|Ineligible cell types|2
4982090|NCT00003659|17102657|P1|Overall Study|Withdrawal by Subject|3
4982091|NCT00003641|17102678|P2|Overall Study|Never started interferon|12
4982092|NCT00003641|17102679|P1|Overall Study|Never started interferon|567
4982093|NCT00003641|17102678|P2|Overall Study|Should not receive interferon therapy|0
4982094|NCT00003641|17102679|P1|Overall Study|Should not receive interferon therapy|2
4982095|NCT00003641|17102678|P2|Overall Study|Unknown/missing|22
4982096|NCT00003641|17102679|P1|Overall Study|Unknown/missing|0
4982097|NCT00003641|17102678|P2|Overall Study|Disease progression|2
4982098|NCT00003641|17102679|P1|Overall Study|Disease progression|0
4982099|NCT00003641|17102678|P2|Overall Study|Adverse Event|38
4982100|NCT00003641|17102679|P1|Overall Study|Adverse Event|0
4982101|NCT00003641|17102678|P2|Overall Study|Withdrawal by Subject|100
4982102|NCT00003641|17102679|P1|Overall Study|Withdrawal by Subject|0
4982103|NCT00003631|17102690|P3|Overall Study|Evaluable for toxicity only|2
4982104|NCT00003631|17102691|P2|Overall Study|Evaluable for toxicity only|0
4982105|NCT00003631|17102692|P1|Overall Study|Evaluable for toxicity only|0
4982106|NCT00003631|17102690|P3|Overall Study|Death|1
4982107|NCT00003631|17102691|P2|Overall Study|Death|0
4982108|NCT00003631|17102692|P1|Overall Study|Death|0
4982109|NCT00003631|17102690|P3|Overall Study|Adverse Event|5
4982110|NCT00003631|17102691|P2|Overall Study|Adverse Event|1
4982111|NCT00003631|17102692|P1|Overall Study|Adverse Event|1
4982112|NCT00003631|17102690|P3|Overall Study|Protocol Violation|0
4982113|NCT00003631|17102691|P2|Overall Study|Protocol Violation|0
4982114|NCT00003631|17102692|P1|Overall Study|Protocol Violation|1
4982115|NCT00003631|17102690|P3|Overall Study|Patient not treated|1
4982116|NCT00003631|17102691|P2|Overall Study|Patient not treated|0
4982117|NCT00003631|17102692|P1|Overall Study|Patient not treated|1
4982118|NCT00003590|17102700|P1|Overall Study|Physician Decision|1
4982119|NCT00003590|17102700|P1|Overall Study|Death|1
4982120|NCT00003590|17102700|P1|Overall Study|Lack of Efficacy|11
4982121|NCT00003590|17102700|P1|Overall Study|Withdrawal by Subject|1
4982122|NCT00003590|17102700|P1|Overall Study|Adverse Event|7
4982123|NCT00003590|17102700|P1|Overall Study|Ineligible Patient|1
4982124|NCT00003537|17102705|P1|Overall Study|Not evalauable|1
4982125|NCT00003535|17102710|P1|Overall Study|Not evaluable|5
4982126|NCT00003499|17102715|P1|Overall Study|Not evaluable|8
4982127|NCT00003483|17102720|P1|Overall Study|Not evaluable|1
4982128|NCT00003479|17102725|P1|Overall Study|Not evaluable|3
4982129|NCT00003477|17102730|P1|Overall Study|Not evalauable|4
4982130|NCT00003476|17102735|P1|Overall Study|Not evaluable|1
4982131|NCT00003475|17102740|P1|Overall Study|Not evaluable|13
4982132|NCT00003474|17102745|P1|Overall Study|Not Evaluable|14
4982133|NCT00003473|17102750|P1|Overall Study|Three patients were not evaluable.|3
4982134|NCT00003472|17102755|P1|Overall Study|Not evaluable|3
4982135|NCT00003471|17102760|P1|Overall Study|Not evaluable|4
4982136|NCT00003470|17102765|P1|Overall Study|Not evaluable|6
4982137|NCT00003458|17102790|P1|Overall Study|Not evaluable|4
4982138|NCT00003457|17102795|P1|Overall Study|Not evaluable|9
4982139|NCT00003456|17102800|P1|Overall Study|Not evaluable|8
4982140|NCT00003389|17102817|P2|Overall Study|Ineligible|27
4982141|NCT00003389|17102818|P1|Overall Study|Ineligible|33
4982142|NCT00003389|17102817|P2|Overall Study|Off-treatment reason missing|21
4982143|NCT00003389|17102818|P1|Overall Study|Off-treatment reason missing|31
4982144|NCT00003389|17102817|P2|Overall Study|Complicating disease|0
4982145|NCT00003389|17102818|P1|Overall Study|Complicating disease|1
4982146|NCT00003389|17102817|P2|Overall Study|Alternative therapy|1
4982147|NCT00003389|17102818|P1|Overall Study|Alternative therapy|2
4982148|NCT00003389|17102817|P2|Overall Study|Withdrawal by Subject|5
4982149|NCT00003389|17102818|P1|Overall Study|Withdrawal by Subject|12
4982150|NCT00003389|17102817|P2|Overall Study|Death|3
4982151|NCT00003389|17102818|P1|Overall Study|Death|0
4982152|NCT00003389|17102817|P2|Overall Study|Adverse Event|2
4982153|NCT00003389|17102818|P1|Overall Study|Adverse Event|13
4982154|NCT00003389|17102817|P2|Overall Study|Disease progression|1
4982155|NCT00003389|17102818|P1|Overall Study|Disease progression|6
4982156|NCT00003377|17102833|P5|Period II|Ureteral stent complications|1
4982157|NCT00003377|17102834|P4|Period II|Ureteral stent complications|0
4982158|NCT00003377|17102835|P3|Period II|Ureteral stent complications|0
4982159|NCT00003377|17102836|P2|Period II|Ureteral stent complications|0
4982160|NCT00003377|17102837|P1|Period II|Ureteral stent complications|0
4982161|NCT00003377|17102833|P5|Period I|Dose Limiting Toxicity(DLT)|0
4982162|NCT00003377|17102834|P4|Period I|Dose Limiting Toxicity(DLT)|1
4982163|NCT00003377|17102835|P3|Period I|Dose Limiting Toxicity(DLT)|1
4982164|NCT00003377|17102836|P2|Period I|Dose Limiting Toxicity(DLT)|0
4982165|NCT00003377|17102837|P1|Period I|Dose Limiting Toxicity(DLT)|0
4982166|NCT00003199|17102851|P1|Overall Study|Screen fail|15
4982167|NCT00003199|17102851|P1|Overall Study|Lack of insurance clearance|2
4982168|NCT00003199|17102851|P1|Overall Study|Refused Post-Transplant Immunotherapy|5
4982169|NCT00003138|17102859|P2|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7
4982170|NCT00003138|17102860|P1|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6
4982171|NCT00003138|17102859|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1
4982172|NCT00003138|17102860|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0
4982173|NCT00003138|17102859|P2|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19
4982174|NCT00003138|17102860|P1|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12
4982175|NCT00003138|17102859|P2|Step 2 (Cross Over)|Reasons off treatment not documented|0
4982176|NCT00003138|17102860|P1|Step 2 (Cross Over)|Reasons off treatment not documented|26
4982177|NCT00003138|17102859|P2|Step 1|Never started treatment|0
4982178|NCT00003138|17102860|P1|Step 1|Never started treatment|1
4982179|NCT00003138|17102859|P2|Step 1|Reasons off treatment not documented|57
4982180|NCT00003138|17102860|P1|Step 1|Reasons off treatment not documented|60
4982181|NCT00002931|17102877|P1|Overall Study|rapidly progressing disease during|2
4982182|NCT00002874|17102885|P2|Overall Study|Protocol Violation|34
4982183|NCT00002874|17102886|P1|Overall Study|Protocol Violation|44
4982184|NCT00002874|17102885|P2|Overall Study|Withdrawal by Subject|1
4982185|NCT00002874|17102886|P1|Overall Study|Withdrawal by Subject|1
4982186|NCT00002850|17102911|P3|Overall Study|Withdrawal by Subject|0
4982187|NCT00002850|17102912|P2|Overall Study|Withdrawal by Subject|1
4982188|NCT00002850|17102913|P1|Overall Study|Withdrawal by Subject|0
4982189|NCT00002850|17102911|P3|Overall Study|Protocol Violation|1
4982190|NCT00002850|17102912|P2|Overall Study|Protocol Violation|0
4982191|NCT00002850|17102913|P1|Overall Study|Protocol Violation|1
4982192|NCT00002850|17102911|P3|Overall Study|Death|3
4982193|NCT00002850|17102912|P2|Overall Study|Death|1
4982194|NCT00002850|17102913|P1|Overall Study|Death|4
4982195|NCT00002842|17102921|P1|Overall Study|ineligible for surgical resection|27
4982196|NCT00002766|17102927|P2|Overall Study|Protocol Violation|0
4982197|NCT00002766|17102928|P1|Overall Study|Protocol Violation|1
4982198|NCT00002766|17102927|P2|Overall Study|Adverse Event|1
4982199|NCT00002766|17102928|P1|Overall Study|Adverse Event|1
4982200|NCT00002766|17102927|P2|Overall Study|Patient Not Treated|2
4982201|NCT00002766|17102928|P1|Overall Study|Patient Not Treated|1
4982202|NCT00002766|17102927|P2|Overall Study|Withdrawal by Subject|1
4982203|NCT00002766|17102928|P1|Overall Study|Withdrawal by Subject|0
4982204|NCT00002651|17102936|P3|Consolidation and Randomization|not eligible|112
4982205|NCT00002651|17102937|P2|Consolidation and Randomization|not eligible|102
4982206|NCT00002651|17102938|P1|Consolidation and Randomization|not eligible|0
4982207|NCT00002651|17102936|P3|Consolidation and Randomization|Other|313
4982208|NCT00002651|17102937|P2|Consolidation and Randomization|Other|314
4982209|NCT00002651|17102938|P1|Consolidation and Randomization|Other|0
4982210|NCT00002651|17102936|P3|Consolidation and Randomization|Death|48
4982211|NCT00002651|17102937|P2|Consolidation and Randomization|Death|38
4982212|NCT00002651|17102938|P1|Consolidation and Randomization|Death|0
4982213|NCT00002651|17102936|P3|Consolidation and Randomization|Progression/relapse|298
4982214|NCT00002651|17102937|P2|Consolidation and Randomization|Progression/relapse|295
4982215|NCT00002651|17102938|P1|Consolidation and Randomization|Progression/relapse|0
4982216|NCT00002651|17102936|P3|Consolidation and Randomization|Refusal unrelated to adverse event|75
4982217|NCT00002651|17102937|P2|Consolidation and Randomization|Refusal unrelated to adverse event|53
4982218|NCT00002651|17102938|P1|Consolidation and Randomization|Refusal unrelated to adverse event|0
4982219|NCT00002651|17102936|P3|Consolidation and Randomization|Adverse Event|14
4982220|NCT00002651|17102937|P2|Consolidation and Randomization|Adverse Event|36
4982221|NCT00002651|17102938|P1|Consolidation and Randomization|Adverse Event|0
4982222|NCT00002651|17102936|P3|Induction|not eligible|0
4982223|NCT00002651|17102937|P2|Induction|not eligible|0
4982224|NCT00002651|17102938|P1|Induction|not eligible|90
4982225|NCT00002651|17102936|P3|Induction|Other|0
4982226|NCT00002651|17102937|P2|Induction|Other|0
4982227|NCT00002651|17102938|P1|Induction|Other|823
4982228|NCT00002651|17102936|P3|Induction|Death|0
4982229|NCT00002651|17102937|P2|Induction|Death|0
4982230|NCT00002651|17102938|P1|Induction|Death|62
4982231|NCT00002651|17102936|P3|Induction|Progression/relapse|0
4982232|NCT00002651|17102937|P2|Induction|Progression/relapse|0
4982233|NCT00002651|17102938|P1|Induction|Progression/relapse|274
4982234|NCT00002651|17102936|P3|Induction|Refusal unrelated to adverse event|0
4982235|NCT00002651|17102937|P2|Induction|Refusal unrelated to adverse event|0
4982236|NCT00002651|17102938|P1|Induction|Refusal unrelated to adverse event|50
4982237|NCT00002651|17102936|P3|Induction|Adverse Event|0
4982238|NCT00002651|17102937|P2|Induction|Adverse Event|0
4982239|NCT00002651|17102938|P1|Induction|Adverse Event|44
4982240|NCT00002558|17102956|P2|Overall Study|Withdrawal by Subject|1
4982241|NCT00002558|17102957|P1|Overall Study|Withdrawal by Subject|0
4982242|NCT00051636|17102982|P2|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12
4982243|NCT00051636|17102983|P1|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40
4982244|NCT00051636|17102982|P2|Period 2- Extended Observation Period|Death|5
4982245|NCT00051636|17102983|P1|Period 2- Extended Observation Period|Death|4
4982246|NCT00051636|17102982|P2|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2
4982247|NCT00051636|17102983|P1|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9
4982248|NCT00051636|17102982|P2|Period 2- Extended Observation Period|withdrew for nonclinical reason|7
4982249|NCT00051636|17102983|P1|Period 2- Extended Observation Period|withdrew for nonclinical reason|12
4982250|NCT00051636|17102982|P2|Period 2- Extended Observation Period|Lost to Follow-up|4
4982251|NCT00051636|17102983|P1|Period 2- Extended Observation Period|Lost to Follow-up|5
4982252|NCT00051636|17102982|P2|Period 1 - Core|Lost to Follow-up|2
4982253|NCT00051636|17102983|P1|Period 1 - Core|Lost to Follow-up|0
4982254|NCT00051636|17102982|P2|Period 1 - Core|Withdrawal by Subject|2
4982255|NCT00051636|17102983|P1|Period 1 - Core|Withdrawal by Subject|1
4982256|NCT00051636|17102982|P2|Period 1 - Core|Protocol Violation|0
4982257|NCT00051636|17102983|P1|Period 1 - Core|Protocol Violation|1
4982258|NCT00051636|17102982|P2|Period 1 - Core|Adverse Event|2
4982259|NCT00051636|17102983|P1|Period 1 - Core|Adverse Event|2
4982260|NCT00051558|17103011|P2|Overall Study|Physician Decision|0
4982261|NCT00051558|17103012|P1|Overall Study|Physician Decision|5
4982262|NCT00051558|17103011|P2|Overall Study|Significant Lab Value|0
4982263|NCT00051558|17103012|P1|Overall Study|Significant Lab Value|2
4982264|NCT00051558|17103011|P2|Overall Study|Other|1
4982265|NCT00051558|17103012|P1|Overall Study|Other|2
4982266|NCT00051558|17103011|P2|Overall Study|Sponsor Decision|1
4982267|NCT00051558|17103012|P1|Overall Study|Sponsor Decision|6
4982268|NCT00051558|17103011|P2|Overall Study|Protocol Entry Criteria Unmet|2
4982269|NCT00051558|17103012|P1|Overall Study|Protocol Entry Criteria Unmet|1
4982270|NCT00051558|17103011|P2|Overall Study|Protocol Violation|4
4982271|NCT00051558|17103012|P1|Overall Study|Protocol Violation|3
4982272|NCT00051558|17103011|P2|Overall Study|Lost to Follow-up|13
4982273|NCT00051558|17103012|P1|Overall Study|Lost to Follow-up|4
4982274|NCT00051558|17103011|P2|Overall Study|Death|15
4982275|NCT00051558|17103012|P1|Overall Study|Death|9
4982276|NCT00051558|17103011|P2|Overall Study|Withdrawal by Subject|42
4982277|NCT00051558|17103012|P1|Overall Study|Withdrawal by Subject|29
4982278|NCT00051558|17103011|P2|Overall Study|Adverse Event|18
4982279|NCT00051558|17103012|P1|Overall Study|Adverse Event|30
4982280|NCT00051363|17103048|P2|Overall Study|Excluded Pre-Randomization|5
4982281|NCT00051363|17103049|P1|Overall Study|Excluded Pre-Randomization|2
4982282|NCT00051363|17103048|P2|Overall Study|Death|2
4982283|NCT00051363|17103049|P1|Overall Study|Death|2
4982284|NCT00051363|17103048|P2|Overall Study|Disqualified Post-Rand for Any Reason|11
4982285|NCT00051363|17103049|P1|Overall Study|Disqualified Post-Rand for Any Reason|9
4982286|NCT00051363|17103048|P2|Overall Study|Dropped Post-Rand for Any Reason|126
4982287|NCT00051363|17103049|P1|Overall Study|Dropped Post-Rand for Any Reason|102
4982288|NCT00051025|17103089|P2|Overall Study|Death|1
4982289|NCT00051025|17103090|P1|Overall Study|Death|0
4982290|NCT00051025|17103089|P2|Overall Study|Withdrawal by Subject|1
4982291|NCT00051025|17103090|P1|Overall Study|Withdrawal by Subject|0
4982292|NCT00051025|17103089|P2|Overall Study|Adverse Event|1
4982293|NCT00051025|17103090|P1|Overall Study|Adverse Event|1
4982294|NCT00051025|17103089|P2|Overall Study|Progressive Disease|1
4982295|NCT00051025|17103090|P1|Overall Study|Progressive Disease|1
4982296|NCT00050960|17103104|P2|Overall Study|Death|15
4982297|NCT00050960|17103105|P1|Overall Study|Death|13
4982298|NCT00050960|17103104|P2|Overall Study|Non-compliance|1
4982299|NCT00050960|17103105|P1|Overall Study|Non-compliance|3
4982300|NCT00050960|17103104|P2|Overall Study|Administrative|46
4982301|NCT00050960|17103105|P1|Overall Study|Administrative|31
4982302|NCT00050960|17103104|P2|Overall Study|Withdrawal by Subject|18
4982303|NCT00050960|17103105|P1|Overall Study|Withdrawal by Subject|23
4982304|NCT00050960|17103104|P2|Overall Study|Lost to Follow-up|1
4982305|NCT00050960|17103105|P1|Overall Study|Lost to Follow-up|0
4982306|NCT00050960|17103104|P2|Overall Study|Adverse Event|61
4982307|NCT00050960|17103105|P1|Overall Study|Adverse Event|62
4982308|NCT00050960|17103104|P2|Overall Study|Complete Response|2
4982309|NCT00050960|17103105|P1|Overall Study|Complete Response|0
4982310|NCT00050960|17103104|P2|Overall Study|Partial Response|19
4982311|NCT00050960|17103105|P1|Overall Study|Partial Response|14
4982312|NCT00050960|17103104|P2|Overall Study|Stable Disease|48
4982313|NCT00050960|17103105|P1|Overall Study|Stable Disease|19
4982314|NCT00050960|17103104|P2|Overall Study|Progressive Disease|93
4982315|NCT00050960|17103105|P1|Overall Study|Progressive Disease|137
4982316|NCT00050778|17103114|P3|Overall Study|Familial and personal reasons|0
4982317|NCT00050778|17103115|P2|Overall Study|Familial and personal reasons|0
4982318|NCT00050778|17103116|P1|Overall Study|Familial and personal reasons|1
4982319|NCT00050778|17103114|P3|Overall Study|Randomized but not treated|2
4982320|NCT00050778|17103115|P2|Overall Study|Randomized but not treated|5
4982321|NCT00050778|17103116|P1|Overall Study|Randomized but not treated|4
4982322|NCT00050778|17103114|P3|Overall Study|Withdrawal by Subject|4
4982323|NCT00050778|17103115|P2|Overall Study|Withdrawal by Subject|8
4982324|NCT00050778|17103116|P1|Overall Study|Withdrawal by Subject|6
4982325|NCT00050778|17103114|P3|Overall Study|Protocol Violation|1
4982326|NCT00050778|17103115|P2|Overall Study|Protocol Violation|0
4982327|NCT00050778|17103116|P1|Overall Study|Protocol Violation|2
4982328|NCT00050778|17103114|P3|Overall Study|Physician Decision|2
4982329|NCT00050778|17103115|P2|Overall Study|Physician Decision|0
4982330|NCT00050778|17103116|P1|Overall Study|Physician Decision|3
4982331|NCT00050778|17103114|P3|Overall Study|Lost to Follow-up|4
4982332|NCT00050778|17103115|P2|Overall Study|Lost to Follow-up|2
4982333|NCT00050778|17103116|P1|Overall Study|Lost to Follow-up|0
4982334|NCT00050778|17103114|P3|Overall Study|Lack of Efficacy|2
4982335|NCT00050778|17103115|P2|Overall Study|Lack of Efficacy|2
4982336|NCT00050778|17103116|P1|Overall Study|Lack of Efficacy|16
4982337|NCT00050778|17103114|P3|Overall Study|Death|1
4982338|NCT00050778|17103115|P2|Overall Study|Death|1
4982339|NCT00050778|17103116|P1|Overall Study|Death|0
4982340|NCT00050778|17103114|P3|Overall Study|Adverse Event|2
4982341|NCT00050778|17103115|P2|Overall Study|Adverse Event|3
4982342|NCT00050778|17103116|P1|Overall Study|Adverse Event|13
4982343|NCT00050622|17103142|P1|Overall Study|Adverse Event|1
4982344|NCT00050167|17103180|P2|Overall Study|not eligible not invasive|1
4982345|NCT00050167|17103181|P1|Overall Study|not eligible not invasive|1
4982346|NCT00050011|17103214|P2|Overall Study|Unknown - Reason is missing|2
4982347|NCT00050011|17103215|P1|Overall Study|Unknown - Reason is missing|0
4982348|NCT00050011|17103214|P2|Overall Study|Death|4
4982349|NCT00050011|17103215|P1|Overall Study|Death|7
4982350|NCT00050011|17103214|P2|Overall Study|Administrative problems|6
4982351|NCT00050011|17103215|P1|Overall Study|Administrative problems|10
4982352|NCT00050011|17103214|P2|Overall Study|Lost to Follow-up|9
4982353|NCT00050011|17103215|P1|Overall Study|Lost to Follow-up|7
4982354|NCT00050011|17103214|P2|Overall Study|Withdrawal by Subject|26
4982355|NCT00050011|17103215|P1|Overall Study|Withdrawal by Subject|34
4982356|NCT00050011|17103214|P2|Overall Study|Protocol Violation|10
4982357|NCT00050011|17103215|P1|Overall Study|Protocol Violation|4
4982358|NCT00050011|17103214|P2|Overall Study|Participant condition no longer required|0
4982359|NCT00050011|17103215|P1|Overall Study|Participant condition no longer required|1
4982360|NCT00050011|17103214|P2|Overall Study|Lack of Efficacy|21
4982361|NCT00050011|17103215|P1|Overall Study|Lack of Efficacy|16
4982362|NCT00050011|17103214|P2|Overall Study|Abnormal test procedure results|1
4982363|NCT00050011|17103215|P1|Overall Study|Abnormal test procedure results|0
4982364|NCT00050011|17103214|P2|Overall Study|Abnormal laboratory value(s)|1
4982365|NCT00050011|17103215|P1|Overall Study|Abnormal laboratory value(s)|1
4982366|NCT00050011|17103214|P2|Overall Study|Adverse Event|46
4982367|NCT00050011|17103215|P1|Overall Study|Adverse Event|41
4982368|NCT00049842|17103237|P2|Follow-up Phase|Other|4
4982369|NCT00049842|17103238|P1|Follow-up Phase|Other|1
4982370|NCT00049842|17103237|P2|Follow-up Phase|Adverse Event|1
4982371|NCT00049842|17103238|P1|Follow-up Phase|Adverse Event|6
4982372|NCT00049842|17103237|P2|Treatment Phase|Did not meet protocol eligibility|1
4982373|NCT00049842|17103238|P1|Treatment Phase|Did not meet protocol eligibility|0
4982374|NCT00049842|17103237|P2|Treatment Phase|Administrative|3
4982375|NCT00049842|17103238|P1|Treatment Phase|Administrative|0
4982376|NCT00049842|17103237|P2|Treatment Phase|Lost to Follow-up|8
4982377|NCT00049842|17103238|P1|Treatment Phase|Lost to Follow-up|4
4982378|NCT00049842|17103237|P2|Treatment Phase|Non-compliance with protocol|8
4982379|NCT00049842|17103238|P1|Treatment Phase|Non-compliance with protocol|7
4982380|NCT00049842|17103237|P2|Treatment Phase|Withdrawal by Subject|46
4982381|NCT00049842|17103238|P1|Treatment Phase|Withdrawal by Subject|35
4982382|NCT00049842|17103237|P2|Treatment Phase|Adverse Event|12
4982383|NCT00049842|17103238|P1|Treatment Phase|Adverse Event|47
4982384|NCT00048932|17103256|P3|Open Label Period (OL)|Participant Surgery|1
4982385|NCT00048932|17103257|P2|Open Label Period (OL)|Participant Surgery|0
4982386|NCT00048932|17103258|P1|Open Label Period (OL)|Participant Surgery|0
4982387|NCT00048932|17103256|P3|Open Label Period (OL)|Site Not Participating in Open Label|9
4982388|NCT00048932|17103257|P2|Open Label Period (OL)|Site Not Participating in Open Label|0
4982389|NCT00048932|17103258|P1|Open Label Period (OL)|Site Not Participating in Open Label|0
4982390|NCT00048932|17103256|P3|Open Label Period (OL)|Site Staff Issues|2
4982391|NCT00048932|17103257|P2|Open Label Period (OL)|Site Staff Issues|0
4982392|NCT00048932|17103258|P1|Open Label Period (OL)|Site Staff Issues|0
4982393|NCT00048932|17103256|P3|Open Label Period (OL)|Investigator Decision|4
4982394|NCT00048932|17103257|P2|Open Label Period (OL)|Investigator Decision|0
4982395|NCT00048932|17103258|P1|Open Label Period (OL)|Investigator Decision|0
4982396|NCT00048932|17103256|P3|Open Label Period (OL)|Medication Lost Efficacy|1
4982397|NCT00048932|17103257|P2|Open Label Period (OL)|Medication Lost Efficacy|0
4982398|NCT00048932|17103258|P1|Open Label Period (OL)|Medication Lost Efficacy|0
4982399|NCT00048932|17103256|P3|Open Label Period (OL)|Participant Missed Consecutive Doses|5
4982400|NCT00048932|17103257|P2|Open Label Period (OL)|Participant Missed Consecutive Doses|0
4982401|NCT00048932|17103258|P1|Open Label Period (OL)|Participant Missed Consecutive Doses|0
4982402|NCT00048932|17103256|P3|Open Label Period (OL)|Participant Desires Pregnancy|2
4982403|NCT00048932|17103257|P2|Open Label Period (OL)|Participant Desires Pregnancy|0
4982404|NCT00048932|17103258|P1|Open Label Period (OL)|Participant Desires Pregnancy|0
4982405|NCT00048932|17103256|P3|Open Label Period (OL)|Participant Received Wrong Medication|1
4982406|NCT00048932|17103257|P2|Open Label Period (OL)|Participant Received Wrong Medication|0
4982407|NCT00048932|17103258|P1|Open Label Period (OL)|Participant Received Wrong Medication|0
4982408|NCT00048932|17103256|P3|Open Label Period (OL)|Patient Decision|4
4982409|NCT00048932|17103257|P2|Open Label Period (OL)|Patient Decision|0
4982410|NCT00048932|17103258|P1|Open Label Period (OL)|Patient Decision|0
4982411|NCT00048932|17103256|P3|Open Label Period (OL)|Difficult IV Access with Participant|1
4982412|NCT00048932|17103257|P2|Open Label Period (OL)|Difficult IV Access with Participant|0
4982413|NCT00048932|17103258|P1|Open Label Period (OL)|Difficult IV Access with Participant|0
4982414|NCT00048932|17103256|P3|Open Label Period (OL)|Trial Terminated|1
4982415|NCT00048932|17103257|P2|Open Label Period (OL)|Trial Terminated|0
4982416|NCT00048932|17103258|P1|Open Label Period (OL)|Trial Terminated|0
4982417|NCT00048932|17103256|P3|Open Label Period (OL)|Site Closure|3
4982418|NCT00048932|17103257|P2|Open Label Period (OL)|Site Closure|0
4982419|NCT00048932|17103258|P1|Open Label Period (OL)|Site Closure|0
4982420|NCT00048932|17103256|P3|Open Label Period (OL)|Investigator Dosing the Trial|1
4982421|NCT00048932|17103257|P2|Open Label Period (OL)|Investigator Dosing the Trial|0
4982422|NCT00048932|17103258|P1|Open Label Period (OL)|Investigator Dosing the Trial|0
4982423|NCT00048932|17103256|P3|Open Label Period (OL)|Participant Relocated|6
4982424|NCT00048932|17103257|P2|Open Label Period (OL)|Participant Relocated|0
4982425|NCT00048932|17103258|P1|Open Label Period (OL)|Participant Relocated|0
4982426|NCT00048932|17103256|P3|Open Label Period (OL)|Participant Transportation Issues|1
4982427|NCT00048932|17103257|P2|Open Label Period (OL)|Participant Transportation Issues|0
4982428|NCT00048932|17103258|P1|Open Label Period (OL)|Participant Transportation Issues|0
4982429|NCT00048932|17103256|P3|Open Label Period (OL)|Investigator Retiring|2
4982430|NCT00048932|17103257|P2|Open Label Period (OL)|Investigator Retiring|0
4982431|NCT00048932|17103258|P1|Open Label Period (OL)|Investigator Retiring|0
4982432|NCT00048932|17103256|P3|Open Label Period (OL)|Administrative Reason By Sponsor|20
4982433|NCT00048932|17103257|P2|Open Label Period (OL)|Administrative Reason By Sponsor|0
4982434|NCT00048932|17103258|P1|Open Label Period (OL)|Administrative Reason By Sponsor|0
4982435|NCT00048932|17103256|P3|Open Label Period (OL)|Pregnancy|6
4982436|NCT00048932|17103257|P2|Open Label Period (OL)|Pregnancy|0
4982437|NCT00048932|17103258|P1|Open Label Period (OL)|Pregnancy|0
4982438|NCT00048932|17103256|P3|Open Label Period (OL)|Poor/Non-Compliance|13
4982439|NCT00048932|17103257|P2|Open Label Period (OL)|Poor/Non-Compliance|0
4982440|NCT00048932|17103258|P1|Open Label Period (OL)|Poor/Non-Compliance|0
4982441|NCT00048932|17103256|P3|Open Label Period (OL)|No Longer Meets Study Criteria|5
4982442|NCT00048932|17103257|P2|Open Label Period (OL)|No Longer Meets Study Criteria|0
4982443|NCT00048932|17103258|P1|Open Label Period (OL)|No Longer Meets Study Criteria|0
4982444|NCT00048932|17103256|P3|Open Label Period (OL)|Withdrawal by Subject|117
4982445|NCT00048932|17103257|P2|Open Label Period (OL)|Withdrawal by Subject|0
4982446|NCT00048932|17103258|P1|Open Label Period (OL)|Withdrawal by Subject|0
4982447|NCT00048932|17103256|P3|Open Label Period (OL)|Lost to Follow-up|27
4982448|NCT00048932|17103257|P2|Open Label Period (OL)|Lost to Follow-up|0
4982449|NCT00048932|17103258|P1|Open Label Period (OL)|Lost to Follow-up|0
4982450|NCT00048932|17103256|P3|Open Label Period (OL)|Lack of Efficacy|81
4982451|NCT00048932|17103257|P2|Open Label Period (OL)|Lack of Efficacy|0
4982452|NCT00048932|17103258|P1|Open Label Period (OL)|Lack of Efficacy|0
4982453|NCT00048932|17103256|P3|Open Label Period (OL)|Adverse Event|103
4982454|NCT00048932|17103257|P2|Open Label Period (OL)|Adverse Event|0
4982455|NCT00048932|17103258|P1|Open Label Period (OL)|Adverse Event|0
4982456|NCT00048932|17103256|P3|Open Label Period (OL)|Death|25
4982457|NCT00048932|17103257|P2|Open Label Period (OL)|Death|0
4982458|NCT00048932|17103258|P1|Open Label Period (OL)|Death|0
4982459|NCT00048932|17103256|P3|Double Blind Period (DB)|Poor/Non-Compliance|0
4982460|NCT00048932|17103257|P2|Double Blind Period (DB)|Poor/Non-Compliance|4
4982461|NCT00048932|17103258|P1|Double Blind Period (DB)|Poor/Non-Compliance|2
4982462|NCT00048932|17103256|P3|Double Blind Period (DB)|Withdrawal by Subject|0
4982463|NCT00048932|17103257|P2|Double Blind Period (DB)|Withdrawal by Subject|10
4982464|NCT00048932|17103258|P1|Double Blind Period (DB)|Withdrawal by Subject|24
4982465|NCT00048932|17103256|P3|Double Blind Period (DB)|No Longer Meets Study Criteria|0
4982466|NCT00048932|17103257|P2|Double Blind Period (DB)|No Longer Meets Study Criteria|2
4982467|NCT00048932|17103258|P1|Double Blind Period (DB)|No Longer Meets Study Criteria|8
4982468|NCT00048932|17103256|P3|Double Blind Period (DB)|Pregnancy|0
4982469|NCT00048932|17103257|P2|Double Blind Period (DB)|Pregnancy|0
4982470|NCT00048932|17103258|P1|Double Blind Period (DB)|Pregnancy|1
4982471|NCT00048932|17103256|P3|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
4982472|NCT00048932|17103257|P2|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0
4982473|NCT00048932|17103258|P1|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1
4982474|NCT00048932|17103256|P3|Double Blind Period (DB)|Uncontrolled hypertension|0
4982475|NCT00048932|17103257|P2|Double Blind Period (DB)|Uncontrolled hypertension|1
4982476|NCT00048932|17103258|P1|Double Blind Period (DB)|Uncontrolled hypertension|0
4982477|NCT00048932|17103256|P3|Double Blind Period (DB)|Relocation|0
4982478|NCT00048932|17103257|P2|Double Blind Period (DB)|Relocation|0
4982479|NCT00048932|17103258|P1|Double Blind Period (DB)|Relocation|1
4982480|NCT00048932|17103256|P3|Double Blind Period (DB)|Lost to Follow-up|0
4982481|NCT00048932|17103257|P2|Double Blind Period (DB)|Lost to Follow-up|4
4982482|NCT00048932|17103258|P1|Double Blind Period (DB)|Lost to Follow-up|3
4982483|NCT00048932|17103256|P3|Double Blind Period (DB)|Lack of Efficacy|0
4982484|NCT00048932|17103257|P2|Double Blind Period (DB)|Lack of Efficacy|44
4982485|NCT00048932|17103258|P1|Double Blind Period (DB)|Lack of Efficacy|26
4982486|NCT00048932|17103256|P3|Double Blind Period (DB)|Death|0
4982487|NCT00048932|17103257|P2|Double Blind Period (DB)|Death|3
4982488|NCT00048932|17103258|P1|Double Blind Period (DB)|Death|5
4982489|NCT00048932|17103256|P3|Double Blind Period (DB)|Adverse Event|0
4982490|NCT00048932|17103257|P2|Double Blind Period (DB)|Adverse Event|19
4982491|NCT00048932|17103258|P1|Double Blind Period (DB)|Adverse Event|51
4982492|NCT00048932|17103256|P3|Double Blind Period (DB)|Administrative Reason By Sponsor|0
4982493|NCT00048932|17103257|P2|Double Blind Period (DB)|Administrative Reason By Sponsor|0
4982494|NCT00048932|17103258|P1|Double Blind Period (DB)|Administrative Reason By Sponsor|1
4982495|NCT00048581|17103300|P3|Open-Label Period|Study Ended By Sponsor|1
4982496|NCT00048581|17103301|P2|Open-Label Period|Study Ended By Sponsor|0
4982497|NCT00048581|17103302|P1|Open-Label Period|Study Ended By Sponsor|0
4982498|NCT00048581|17103300|P3|Open-Label Period|Primary Investigator Retired|2
4982499|NCT00048581|17103301|P2|Open-Label Period|Primary Investigator Retired|0
4982500|NCT00048581|17103302|P1|Open-Label Period|Primary Investigator Retired|0
4982501|NCT00048581|17103300|P3|Open-Label Period|Problem With Transportation To Site|1
4982502|NCT00048581|17103301|P2|Open-Label Period|Problem With Transportation To Site|0
4982503|NCT00048581|17103302|P1|Open-Label Period|Problem With Transportation To Site|0
4982504|NCT00048581|17103300|P3|Open-Label Period|Continue ABA With Primary Rheumatologist|3
4982505|NCT00048581|17103301|P2|Open-Label Period|Continue ABA With Primary Rheumatologist|0
4982506|NCT00048581|17103302|P1|Open-Label Period|Continue ABA With Primary Rheumatologist|0
4982507|NCT00048581|17103300|P3|Open-Label Period|Study Site Closure|2
4982508|NCT00048581|17103301|P2|Open-Label Period|Study Site Closure|0
4982509|NCT00048581|17103302|P1|Open-Label Period|Study Site Closure|0
4982510|NCT00048581|17103300|P3|Open-Label Period|Pregnancy|7
4982511|NCT00048581|17103301|P2|Open-Label Period|Pregnancy|0
4982512|NCT00048581|17103302|P1|Open-Label Period|Pregnancy|0
4982513|NCT00048581|17103300|P3|Open-Label Period|Poor/Non-compliance|5
4982514|NCT00048581|17103301|P2|Open-Label Period|Poor/Non-compliance|0
4982515|NCT00048581|17103302|P1|Open-Label Period|Poor/Non-compliance|0
4982516|NCT00048581|17103300|P3|Open-Label Period|No Longer Meets Study Criteria|2
4982517|NCT00048581|17103301|P2|Open-Label Period|No Longer Meets Study Criteria|0
4982518|NCT00048581|17103302|P1|Open-Label Period|No Longer Meets Study Criteria|0
4982519|NCT00048581|17103300|P3|Open-Label Period|Withdrawal by Subject|20
4982520|NCT00048581|17103301|P2|Open-Label Period|Withdrawal by Subject|0
4982521|NCT00048581|17103302|P1|Open-Label Period|Withdrawal by Subject|0
4982522|NCT00048581|17103300|P3|Open-Label Period|Lost to Follow-up|14
4982523|NCT00048581|17103301|P2|Open-Label Period|Lost to Follow-up|0
4982524|NCT00048581|17103302|P1|Open-Label Period|Lost to Follow-up|0
4982525|NCT00048581|17103300|P3|Open-Label Period|Lack of Efficacy|69
4982526|NCT00048581|17103301|P2|Open-Label Period|Lack of Efficacy|0
4982527|NCT00048581|17103302|P1|Open-Label Period|Lack of Efficacy|0
4982528|NCT00048581|17103300|P3|Open-Label Period|Adverse Event|37
4982529|NCT00048581|17103301|P2|Open-Label Period|Adverse Event|0
4982530|NCT00048581|17103302|P1|Open-Label Period|Adverse Event|0
4982531|NCT00048581|17103300|P3|Open-Label Period|Death|4
4982532|NCT00048581|17103301|P2|Open-Label Period|Death|0
4982533|NCT00048581|17103302|P1|Open-Label Period|Death|0
4982534|NCT00048581|17103300|P3|Double-Blind Period|Investigator Decision|0
4982535|NCT00048581|17103301|P2|Double-Blind Period|Investigator Decision|0
4982536|NCT00048581|17103302|P1|Double-Blind Period|Investigator Decision|1
4982537|NCT00048581|17103300|P3|Double-Blind Period|Participant Has History of Lymphopenia|0
4982538|NCT00048581|17103301|P2|Double-Blind Period|Participant Has History of Lymphopenia|0
4982539|NCT00048581|17103302|P1|Double-Blind Period|Participant Has History of Lymphopenia|1
4982540|NCT00048581|17103300|P3|Double-Blind Period|Withdrawal by Subject|0
4982541|NCT00048581|17103301|P2|Double-Blind Period|Withdrawal by Subject|2
4982542|NCT00048581|17103302|P1|Double-Blind Period|Withdrawal by Subject|5
4982543|NCT00048581|17103300|P3|Double-Blind Period|Lost to Follow-up|0
4982544|NCT00048581|17103301|P2|Double-Blind Period|Lost to Follow-up|0
4982545|NCT00048581|17103302|P1|Double-Blind Period|Lost to Follow-up|5
4982546|NCT00048581|17103300|P3|Double-Blind Period|Lack of Efficacy|0
4982547|NCT00048581|17103301|P2|Double-Blind Period|Lack of Efficacy|27
4982548|NCT00048581|17103302|P1|Double-Blind Period|Lack of Efficacy|14
4982549|NCT00048581|17103300|P3|Double-Blind Period|Adverse Event|0
4982550|NCT00048581|17103301|P2|Double-Blind Period|Adverse Event|5
4982551|NCT00048581|17103302|P1|Double-Blind Period|Adverse Event|9
4982552|NCT00048568|17103469|P3|Open-Label Period|Lost to Follow-up|7
4982553|NCT00048568|17103470|P2|Open-Label Period|Lost to Follow-up|0
4982554|NCT00048568|17103471|P1|Open-Label Period|Lost to Follow-up|0
4982555|NCT00048568|17103469|P3|Open-Label Period|Unknown Reasons|25
4982556|NCT00048568|17103470|P2|Open-Label Period|Unknown Reasons|0
4982557|NCT00048568|17103471|P1|Open-Label Period|Unknown Reasons|0
4982558|NCT00048568|17103469|P3|Open-Label Period|Administrative Decision By Sponsor|1
4982559|NCT00048568|17103470|P2|Open-Label Period|Administrative Decision By Sponsor|0
4982560|NCT00048568|17103471|P1|Open-Label Period|Administrative Decision By Sponsor|0
4982561|NCT00048568|17103469|P3|Open-Label Period|No Longer Met Study Criteria|2
4982562|NCT00048568|17103470|P2|Open-Label Period|No Longer Met Study Criteria|0
4982563|NCT00048568|17103471|P1|Open-Label Period|No Longer Met Study Criteria|0
4982564|NCT00048568|17103469|P3|Open-Label Period|Pregnancy|5
4982565|NCT00048568|17103470|P2|Open-Label Period|Pregnancy|0
4982566|NCT00048568|17103471|P1|Open-Label Period|Pregnancy|0
4982567|NCT00048568|17103469|P3|Open-Label Period|Withdrawal by Subject|26
4982568|NCT00048568|17103470|P2|Open-Label Period|Withdrawal by Subject|0
4982569|NCT00048568|17103471|P1|Open-Label Period|Withdrawal by Subject|0
4982570|NCT00048568|17103469|P3|Open-Label Period|Lack of Efficacy|32
4982571|NCT00048568|17103470|P2|Open-Label Period|Lack of Efficacy|0
4982572|NCT00048568|17103471|P1|Open-Label Period|Lack of Efficacy|0
4982573|NCT00048568|17103469|P3|Open-Label Period|Adverse Event|49
4982574|NCT00048568|17103470|P2|Open-Label Period|Adverse Event|0
4982575|NCT00048568|17103471|P1|Open-Label Period|Adverse Event|0
4982576|NCT00048568|17103469|P3|Open-Label Period|Death|13
4982577|NCT00048568|17103470|P2|Open-Label Period|Death|0
4982578|NCT00048568|17103471|P1|Open-Label Period|Death|0
4982579|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0
4982580|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
4982581|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1
4982582|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|Pregnancy|0
4982583|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|Pregnancy|0
4982584|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|Pregnancy|2
4982585|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
4982586|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1
4982587|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0
4982588|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0
4982589|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1
4982590|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3
4982591|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|Lack of Efficacy|0
4982592|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|Lack of Efficacy|7
4982593|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|Lack of Efficacy|2
4982594|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|Adverse Event|0
4982595|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|Adverse Event|1
4982596|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|Adverse Event|7
4982597|NCT00048568|17103469|P3|Double-Blind Period Days 170 to 365|Death|0
4982598|NCT00048568|17103470|P2|Double-Blind Period Days 170 to 365|Death|1
4982599|NCT00048568|17103471|P1|Double-Blind Period Days 170 to 365|Death|1
4982600|NCT00048568|17103469|P3|Double-Blind Period Days 1 to 169|Unknown Reasons|0
4982601|NCT00048568|17103470|P2|Double-Blind Period Days 1 to 169|Unknown Reasons|4
4982602|NCT00048568|17103471|P1|Double-Blind Period Days 1 to 169|Unknown Reasons|2
4982603|NCT00048568|17103469|P3|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0
4982604|NCT00048568|17103470|P2|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4
4982605|NCT00048568|17103471|P1|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7
4982606|NCT00048568|17103469|P3|Double-Blind Period Days 1 to 169|Lost to Follow-up|0
4982607|NCT00048568|17103470|P2|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
4982608|NCT00048568|17103471|P1|Double-Blind Period Days 1 to 169|Lost to Follow-up|1
4982609|NCT00048568|17103469|P3|Double-Blind Period Days 1 to 169|Lack of Efficacy|0
4982610|NCT00048568|17103470|P2|Double-Blind Period Days 1 to 169|Lack of Efficacy|33
4982611|NCT00048568|17103471|P1|Double-Blind Period Days 1 to 169|Lack of Efficacy|11
4982612|NCT00048568|17103469|P3|Double-Blind Period Days 1 to 169|Adverse Event|0
4982613|NCT00048568|17103470|P2|Double-Blind Period Days 1 to 169|Adverse Event|3
4982614|NCT00048568|17103471|P1|Double-Blind Period Days 1 to 169|Adverse Event|11
4982615|NCT00048724|17103776|P2|Overall Study|Administrative|1
4982616|NCT00048724|17103777|P1|Overall Study|Administrative|1
4982617|NCT00048724|17103776|P2|Overall Study|Did Not Meet Protocol Eligibility|2
4982618|NCT00048724|17103777|P1|Overall Study|Did Not Meet Protocol Eligibility|2
4982619|NCT00048724|17103776|P2|Overall Study|Noncompliance With Protocol|12
4982620|NCT00048724|17103777|P1|Overall Study|Noncompliance With Protocol|4
4982621|NCT00048724|17103776|P2|Overall Study|Protocol-defined Clinical Event|32
4982622|NCT00048724|17103777|P1|Overall Study|Protocol-defined Clinical Event|17
4982623|NCT00048724|17103776|P2|Overall Study|Lost to Follow-up|5
4982624|NCT00048724|17103777|P1|Overall Study|Lost to Follow-up|5
4982625|NCT00048724|17103776|P2|Overall Study|Withdrawal by Subject|54
4982626|NCT00048724|17103777|P1|Overall Study|Withdrawal by Subject|34
4982627|NCT00048724|17103776|P2|Overall Study|Adverse Event|12
4982628|NCT00048724|17103777|P1|Overall Study|Adverse Event|53
4982629|NCT00048542|17103789|P8|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8
4982630|NCT00048542|17103790|P7|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5
4982631|NCT00048542|17103791|P6|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4982632|NCT00048542|17103792|P5|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4982633|NCT00048542|17103793|P4|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4982634|NCT00048542|17103794|P3|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4982635|NCT00048542|17103795|P2|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4982636|NCT00048542|17103796|P1|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0
4982637|NCT00048542|17103789|P8|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1
4982638|NCT00048542|17103790|P7|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2
4982639|NCT00048542|17103791|P6|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4982640|NCT00048542|17103792|P5|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4982641|NCT00048542|17103793|P4|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4982642|NCT00048542|17103794|P3|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4982643|NCT00048542|17103795|P2|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4982644|NCT00048542|17103796|P1|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0
4982645|NCT00048542|17103789|P8|Open-Label Extension Fixed Dose Phase|Adverse Event|2
4982646|NCT00048542|17103790|P7|Open-Label Extension Fixed Dose Phase|Adverse Event|2
4982647|NCT00048542|17103791|P6|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4982648|NCT00048542|17103792|P5|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4982649|NCT00048542|17103793|P4|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4982650|NCT00048542|17103794|P3|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4982651|NCT00048542|17103795|P2|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4982652|NCT00048542|17103796|P1|Open-Label Extension Fixed Dose Phase|Adverse Event|0
4982653|NCT00048542|17103789|P8|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7
4982654|NCT00048542|17103790|P7|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6
4982655|NCT00048542|17103791|P6|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4982656|NCT00048542|17103792|P5|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4982657|NCT00048542|17103793|P4|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4982658|NCT00048542|17103794|P3|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4982659|NCT00048542|17103795|P2|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4982660|NCT00048542|17103796|P1|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0
4982661|NCT00048542|17103789|P8|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
4982662|NCT00048542|17103790|P7|Open-Label Extension Fixed Dose Phase|Protocol Violation|1
4982663|NCT00048542|17103791|P6|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4982664|NCT00048542|17103792|P5|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4982665|NCT00048542|17103793|P4|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4982666|NCT00048542|17103794|P3|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4982667|NCT00048542|17103795|P2|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4982668|NCT00048542|17103796|P1|Open-Label Extension Fixed Dose Phase|Protocol Violation|0
4982669|NCT00048542|17103789|P8|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3
4982670|NCT00048542|17103790|P7|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6
4982671|NCT00048542|17103791|P6|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4982672|NCT00048542|17103792|P5|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4982673|NCT00048542|17103793|P4|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4982674|NCT00048542|17103794|P3|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4982675|NCT00048542|17103795|P2|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4982676|NCT00048542|17103796|P1|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0
4982677|NCT00048542|17103789|P8|Open-Label Extension BSA Phase|Lack of Efficacy|0
4982678|NCT00048542|17103790|P7|Open-Label Extension BSA Phase|Lack of Efficacy|0
4982679|NCT00048542|17103791|P6|Open-Label Extension BSA Phase|Lack of Efficacy|1
4982680|NCT00048542|17103792|P5|Open-Label Extension BSA Phase|Lack of Efficacy|3
4982681|NCT00048542|17103793|P4|Open-Label Extension BSA Phase|Lack of Efficacy|0
4982682|NCT00048542|17103794|P3|Open-Label Extension BSA Phase|Lack of Efficacy|0
4982683|NCT00048542|17103795|P2|Open-Label Extension BSA Phase|Lack of Efficacy|0
4982684|NCT00048542|17103796|P1|Open-Label Extension BSA Phase|Lack of Efficacy|0
4982685|NCT00048542|17103789|P8|Open-Label Extension BSA Phase|Adverse Event|0
4982686|NCT00048542|17103790|P7|Open-Label Extension BSA Phase|Adverse Event|0
4982687|NCT00048542|17103791|P6|Open-Label Extension BSA Phase|Adverse Event|1
4982688|NCT00048542|17103792|P5|Open-Label Extension BSA Phase|Adverse Event|1
4982689|NCT00048542|17103793|P4|Open-Label Extension BSA Phase|Adverse Event|0
4982690|NCT00048542|17103794|P3|Open-Label Extension BSA Phase|Adverse Event|0
4982691|NCT00048542|17103795|P2|Open-Label Extension BSA Phase|Adverse Event|0
4982692|NCT00048542|17103796|P1|Open-Label Extension BSA Phase|Adverse Event|0
4982693|NCT00048542|17103789|P8|Open-Label Extension BSA Phase|Sponsor request or decision|0
4982694|NCT00048542|17103790|P7|Open-Label Extension BSA Phase|Sponsor request or decision|0
4982695|NCT00048542|17103791|P6|Open-Label Extension BSA Phase|Sponsor request or decision|1
4982696|NCT00048542|17103792|P5|Open-Label Extension BSA Phase|Sponsor request or decision|5
4982697|NCT00048542|17103793|P4|Open-Label Extension BSA Phase|Sponsor request or decision|0
4982698|NCT00048542|17103794|P3|Open-Label Extension BSA Phase|Sponsor request or decision|0
4982699|NCT00048542|17103795|P2|Open-Label Extension BSA Phase|Sponsor request or decision|0
4982700|NCT00048542|17103796|P1|Open-Label Extension BSA Phase|Sponsor request or decision|0
4982701|NCT00048542|17103789|P8|Open-Label Extension BSA Phase|Protocol Violation|0
4982702|NCT00048542|17103790|P7|Open-Label Extension BSA Phase|Protocol Violation|0
4982703|NCT00048542|17103791|P6|Open-Label Extension BSA Phase|Protocol Violation|1
4982704|NCT00048542|17103792|P5|Open-Label Extension BSA Phase|Protocol Violation|0
4982705|NCT00048542|17103793|P4|Open-Label Extension BSA Phase|Protocol Violation|0
4982706|NCT00048542|17103794|P3|Open-Label Extension BSA Phase|Protocol Violation|0
4982707|NCT00048542|17103795|P2|Open-Label Extension BSA Phase|Protocol Violation|0
4982708|NCT00048542|17103796|P1|Open-Label Extension BSA Phase|Protocol Violation|0
4982709|NCT00048542|17103789|P8|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4982710|NCT00048542|17103790|P7|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4982711|NCT00048542|17103791|P6|Open-Label Extension BSA Phase|Withdrawal by Subject|6
4982712|NCT00048542|17103792|P5|Open-Label Extension BSA Phase|Withdrawal by Subject|3
4982713|NCT00048542|17103793|P4|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4982714|NCT00048542|17103794|P3|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4982715|NCT00048542|17103795|P2|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4982716|NCT00048542|17103796|P1|Open-Label Extension BSA Phase|Withdrawal by Subject|0
4982717|NCT00048542|17103789|P8|Double-Blind Phase|Randomized in error|0
4982718|NCT00048542|17103790|P7|Double-Blind Phase|Randomized in error|0
4982719|NCT00048542|17103791|P6|Double-Blind Phase|Randomized in error|0
4982720|NCT00048542|17103792|P5|Double-Blind Phase|Randomized in error|0
4982721|NCT00048542|17103793|P4|Double-Blind Phase|Randomized in error|0
4982722|NCT00048542|17103794|P3|Double-Blind Phase|Randomized in error|0
4982723|NCT00048542|17103795|P2|Double-Blind Phase|Randomized in error|0
4982724|NCT00048542|17103796|P1|Double-Blind Phase|Randomized in error|1
4982725|NCT00048542|17103789|P8|Double-Blind Phase|Sponsor request or decision|0
4982726|NCT00048542|17103790|P7|Double-Blind Phase|Sponsor request or decision|0
4982727|NCT00048542|17103791|P6|Double-Blind Phase|Sponsor request or decision|0
4982728|NCT00048542|17103792|P5|Double-Blind Phase|Sponsor request or decision|0
4982729|NCT00048542|17103793|P4|Double-Blind Phase|Sponsor request or decision|0
4982730|NCT00048542|17103794|P3|Double-Blind Phase|Sponsor request or decision|0
4982731|NCT00048542|17103795|P2|Double-Blind Phase|Sponsor request or decision|0
4982732|NCT00048542|17103796|P1|Double-Blind Phase|Sponsor request or decision|2
4982733|NCT00048542|17103789|P8|Double-Blind Phase|Protocol Violation|0
4982734|NCT00048542|17103790|P7|Double-Blind Phase|Protocol Violation|0
4982735|NCT00048542|17103791|P6|Double-Blind Phase|Protocol Violation|0
4982736|NCT00048542|17103792|P5|Double-Blind Phase|Protocol Violation|0
4982737|NCT00048542|17103793|P4|Double-Blind Phase|Protocol Violation|0
4982738|NCT00048542|17103794|P3|Double-Blind Phase|Protocol Violation|1
4982739|NCT00048542|17103795|P2|Double-Blind Phase|Protocol Violation|0
4982740|NCT00048542|17103796|P1|Double-Blind Phase|Protocol Violation|0
4982741|NCT00048542|17103789|P8|Double-Blind Phase|Withdrawal by Subject|0
4982742|NCT00048542|17103790|P7|Double-Blind Phase|Withdrawal by Subject|0
4982743|NCT00048542|17103791|P6|Double-Blind Phase|Withdrawal by Subject|0
4982744|NCT00048542|17103792|P5|Double-Blind Phase|Withdrawal by Subject|0
4982745|NCT00048542|17103793|P4|Double-Blind Phase|Withdrawal by Subject|0
4982746|NCT00048542|17103794|P3|Double-Blind Phase|Withdrawal by Subject|0
4982747|NCT00048542|17103795|P2|Double-Blind Phase|Withdrawal by Subject|1
4982748|NCT00048542|17103796|P1|Double-Blind Phase|Withdrawal by Subject|0
4982749|NCT00048347|17103862|P1|Overall Study|Screen failure|2
4982750|NCT00048165|17103868|P2|Completed 12 Months Study|Did not co-operate/Withdrew|0
4982751|NCT00048165|17103869|P1|Completed 12 Months Study|Did not co-operate/Withdrew|1
4982752|NCT00048165|17103868|P2|Completed 12 Months Study|Death|1
4982753|NCT00048165|17103869|P1|Completed 12 Months Study|Death|2
4982754|NCT00048165|17103868|P2|Completed 12 Months Study|Administration/Other|2
4982755|NCT00048165|17103869|P1|Completed 12 Months Study|Administration/Other|0
4982756|NCT00048165|17103868|P2|Completed 6 Months Study|Did not receive study drug|6
4982757|NCT00048165|17103869|P1|Completed 6 Months Study|Did not receive study drug|6
4982758|NCT00048165|17103868|P2|Completed 6 Months Study|Violation criteria|2
4982759|NCT00048165|17103869|P1|Completed 6 Months Study|Violation criteria|0
4982760|NCT00048165|17103868|P2|Completed 6 Months Study|Refused treatment|5
4982761|NCT00048165|17103869|P1|Completed 6 Months Study|Refused treatment|5
4982762|NCT00048165|17103868|P2|Completed 6 Months Study|Other violation|6
4982763|NCT00048165|17103869|P1|Completed 6 Months Study|Other violation|4
4982764|NCT00048165|17103868|P2|Completed 6 Months Study|Insufficient therapy|4
4982765|NCT00048165|17103869|P1|Completed 6 Months Study|Insufficient therapy|1
4982766|NCT00048165|17103868|P2|Completed 6 Months Study|Death|6
4982767|NCT00048165|17103869|P1|Completed 6 Months Study|Death|12
4982768|NCT00048165|17103868|P2|Completed 6 Months Study|Adverse event/intermittent illness|11
4982769|NCT00048165|17103869|P1|Completed 6 Months Study|Adverse event/intermittent illness|14
4982770|NCT00048165|17103868|P2|Completed 6 Months Study|Abnormality of laboratory test|0
4982771|NCT00048165|17103869|P1|Completed 6 Months Study|Abnormality of laboratory test|1
4982772|NCT00048165|17103868|P2|Completed 6 Months Study|Administration/Other|8
4982773|NCT00048165|17103869|P1|Completed 6 Months Study|Administration/Other|8
4982774|NCT00048074|17103904|P3|Overall Study|Social reasons|0
4982775|NCT00048074|17103905|P2|Overall Study|Social reasons|0
4982776|NCT00048074|17103906|P1|Overall Study|Social reasons|1
4982777|NCT00048074|17103904|P3|Overall Study|Out of station|1
4982778|NCT00048074|17103905|P2|Overall Study|Out of station|1
4982779|NCT00048074|17103906|P1|Overall Study|Out of station|0
4982780|NCT00048074|17103904|P3|Overall Study|Poor compliance|0
4982781|NCT00048074|17103905|P2|Overall Study|Poor compliance|1
4982782|NCT00048074|17103906|P1|Overall Study|Poor compliance|0
4982783|NCT00048074|17103904|P3|Overall Study|Husband ill|0
4982784|NCT00048074|17103905|P2|Overall Study|Husband ill|1
4982785|NCT00048074|17103906|P1|Overall Study|Husband ill|0
4982786|NCT00048074|17103904|P3|Overall Study|Study participation was terminated|0
4982787|NCT00048074|17103905|P2|Overall Study|Study participation was terminated|1
4982788|NCT00048074|17103906|P1|Overall Study|Study participation was terminated|0
4982789|NCT00048074|17103904|P3|Overall Study|Protocol Violation|0
4982790|NCT00048074|17103905|P2|Overall Study|Protocol Violation|3
4982791|NCT00048074|17103906|P1|Overall Study|Protocol Violation|1
4982792|NCT00048074|17103904|P3|Overall Study|Withdrawal by Subject|35
4982793|NCT00048074|17103905|P2|Overall Study|Withdrawal by Subject|30
4982794|NCT00048074|17103906|P1|Overall Study|Withdrawal by Subject|28
4982795|NCT00048074|17103904|P3|Overall Study|Lost to Follow-up|6
4982796|NCT00048074|17103905|P2|Overall Study|Lost to Follow-up|6
4982797|NCT00048074|17103906|P1|Overall Study|Lost to Follow-up|2
4982798|NCT00048074|17103904|P3|Overall Study|Death|2
4982799|NCT00048074|17103905|P2|Overall Study|Death|3
4982800|NCT00048074|17103906|P1|Overall Study|Death|3
4982801|NCT00048074|17103904|P3|Overall Study|Adverse Event|53
4982802|NCT00048074|17103905|P2|Overall Study|Adverse Event|41
4982803|NCT00048074|17103906|P1|Overall Study|Adverse Event|46
4982804|NCT00048061|17103963|P4|Overall Study|Early improvement|0
4982805|NCT00048061|17103964|P3|Overall Study|Early improvement|3
4982806|NCT00048061|17103965|P2|Overall Study|Early improvement|5
4982807|NCT00048061|17103966|P1|Overall Study|Early improvement|6
4982808|NCT00048061|17103963|P4|Overall Study|Did not follow-up|5
4982809|NCT00048061|17103964|P3|Overall Study|Did not follow-up|4
4982810|NCT00048061|17103965|P2|Overall Study|Did not follow-up|5
4982811|NCT00048061|17103966|P1|Overall Study|Did not follow-up|5
4982812|NCT00048061|17103963|P4|Overall Study|Withdrawal by Subject|32
4982813|NCT00048061|17103964|P3|Overall Study|Withdrawal by Subject|29
4982814|NCT00048061|17103965|P2|Overall Study|Withdrawal by Subject|29
4982815|NCT00048061|17103966|P1|Overall Study|Withdrawal by Subject|20
4982816|NCT00048061|17103963|P4|Overall Study|Lost to Follow-up|5
4982817|NCT00048061|17103964|P3|Overall Study|Lost to Follow-up|4
4982818|NCT00048061|17103965|P2|Overall Study|Lost to Follow-up|2
4982819|NCT00048061|17103966|P1|Overall Study|Lost to Follow-up|3
4982820|NCT00048061|17103963|P4|Overall Study|Adverse Event|37
4982821|NCT00048061|17103964|P3|Overall Study|Adverse Event|44
4982822|NCT00048061|17103965|P2|Overall Study|Adverse Event|32
4982823|NCT00048061|17103966|P1|Overall Study|Adverse Event|41
4982824|NCT00048048|17104045|P12|Extension Year 2|Early withdrawals|2
4982825|NCT00048048|17104046|P11|Extension Year 2|Early withdrawals|4
4982826|NCT00048048|17104047|P10|Extension Year 2|Early withdrawals|0
4982827|NCT00048048|17104048|P9|Extension Year 2|Early withdrawals|0
4982828|NCT00048048|17104049|P8|Extension Year 2|Early withdrawals|0
4982829|NCT00048048|17104050|P7|Extension Year 2|Early withdrawals|0
4982830|NCT00048048|17104051|P6|Extension Year 2|Early withdrawals|0
4982831|NCT00048048|17104052|P5|Extension Year 2|Early withdrawals|0
4982832|NCT00048048|17104053|P4|Extension Year 2|Early withdrawals|0
4982833|NCT00048048|17104054|P3|Extension Year 2|Early withdrawals|0
4982834|NCT00048048|17104055|P2|Extension Year 2|Early withdrawals|0
4982835|NCT00048048|17104056|P1|Extension Year 2|Early withdrawals|0
4982836|NCT00048048|17104045|P12|Extension Year 1|Early withdrawals|4
4982837|NCT00048048|17104046|P11|Extension Year 1|Early withdrawals|2
4982838|NCT00048048|17104047|P10|Extension Year 1|Early withdrawals|2
4982839|NCT00048048|17104048|P9|Extension Year 1|Early withdrawals|0
4982840|NCT00048048|17104049|P8|Extension Year 1|Early withdrawals|0
4982841|NCT00048048|17104050|P7|Extension Year 1|Early withdrawals|0
4982842|NCT00048048|17104051|P6|Extension Year 1|Early withdrawals|0
4982843|NCT00048048|17104052|P5|Extension Year 1|Early withdrawals|0
4982844|NCT00048048|17104053|P4|Extension Year 1|Early withdrawals|0
4982845|NCT00048048|17104054|P3|Extension Year 1|Early withdrawals|0
4982846|NCT00048048|17104055|P2|Extension Year 1|Early withdrawals|0
4982847|NCT00048048|17104056|P1|Extension Year 1|Early withdrawals|0
4982848|NCT00048048|17104045|P12|Core Treatment|Adverse Event|0
4982849|NCT00048048|17104046|P11|Core Treatment|Adverse Event|0
4982850|NCT00048048|17104047|P10|Core Treatment|Adverse Event|0
4982851|NCT00048048|17104048|P9|Core Treatment|Adverse Event|0
4982852|NCT00048048|17104049|P8|Core Treatment|Adverse Event|1
4982853|NCT00048048|17104050|P7|Core Treatment|Adverse Event|0
4982854|NCT00048048|17104051|P6|Core Treatment|Adverse Event|0
4982855|NCT00048048|17104052|P5|Core Treatment|Adverse Event|0
4982856|NCT00048048|17104053|P4|Core Treatment|Adverse Event|0
4982857|NCT00048048|17104054|P3|Core Treatment|Adverse Event|0
4982858|NCT00048048|17104055|P2|Core Treatment|Adverse Event|0
4982859|NCT00048048|17104056|P1|Core Treatment|Adverse Event|0
4982860|NCT00048048|17104045|P12|Core Treatment|Withdrawal by Subject|0
4982861|NCT00048048|17104046|P11|Core Treatment|Withdrawal by Subject|0
4982862|NCT00048048|17104047|P10|Core Treatment|Withdrawal by Subject|0
4982863|NCT00048048|17104048|P9|Core Treatment|Withdrawal by Subject|0
4982864|NCT00048048|17104049|P8|Core Treatment|Withdrawal by Subject|0
4982865|NCT00048048|17104050|P7|Core Treatment|Withdrawal by Subject|0
4982866|NCT00048048|17104051|P6|Core Treatment|Withdrawal by Subject|0
4982867|NCT00048048|17104052|P5|Core Treatment|Withdrawal by Subject|0
4982868|NCT00048048|17104053|P4|Core Treatment|Withdrawal by Subject|0
4982869|NCT00048048|17104054|P3|Core Treatment|Withdrawal by Subject|1
4982870|NCT00048048|17104055|P2|Core Treatment|Withdrawal by Subject|0
4982871|NCT00048048|17104056|P1|Core Treatment|Withdrawal by Subject|0
4982872|NCT00048035|17104112|P8|Extension Year 2|Early Withdrawals|3
4982873|NCT00048035|17104113|P7|Extension Year 2|Early Withdrawals|3
4982874|NCT00048035|17104114|P6|Extension Year 2|Early Withdrawals|0
4982875|NCT00048035|17104115|P5|Extension Year 2|Early Withdrawals|0
4982876|NCT00048035|17104116|P4|Extension Year 2|Early Withdrawals|0
4982877|NCT00048035|17104117|P3|Extension Year 2|Early Withdrawals|0
4982878|NCT00048035|17104118|P2|Extension Year 2|Early Withdrawals|0
4982879|NCT00048035|17104119|P1|Extension Year 2|Early Withdrawals|0
4982880|NCT00048035|17104112|P8|Extension Year 1|Early Withdrawals|11
4982881|NCT00048035|17104113|P7|Extension Year 1|Early Withdrawals|11
4982882|NCT00048035|17104114|P6|Extension Year 1|Early Withdrawals|0
4982883|NCT00048035|17104115|P5|Extension Year 1|Early Withdrawals|0
4982884|NCT00048035|17104116|P4|Extension Year 1|Early Withdrawals|0
4982885|NCT00048035|17104117|P3|Extension Year 1|Early Withdrawals|0
4982886|NCT00048035|17104118|P2|Extension Year 1|Early Withdrawals|0
4982887|NCT00048035|17104119|P1|Extension Year 1|Early Withdrawals|0
4982888|NCT00048035|17104112|P8|Core Period|Early Withdrawals|0
4982889|NCT00048035|17104113|P7|Core Period|Early Withdrawals|0
4982890|NCT00048035|17104114|P6|Core Period|Early Withdrawals|1
4982891|NCT00048035|17104115|P5|Core Period|Early Withdrawals|1
4982892|NCT00048035|17104116|P4|Core Period|Early Withdrawals|1
4982893|NCT00048035|17104117|P3|Core Period|Early Withdrawals|1
4982894|NCT00048035|17104118|P2|Core Period|Early Withdrawals|2
4982895|NCT00048035|17104119|P1|Core Period|Early Withdrawals|4
4982896|NCT00047879|17104157|P2|Overall Study|Progressive disease|3
4982897|NCT00047879|17104158|P1|Overall Study|Progressive disease|4
4982898|NCT00047463|17104194|P2|Overall Study|Withdrawal by Subject|3
4982899|NCT00047463|17104195|P1|Overall Study|Withdrawal by Subject|0
4982900|NCT00045942|17104312|P9|PKC412A2104E2|Death|0
4982901|NCT00045942|17104313|P8|PKC412A2104E2|Death|0
4982902|NCT00045942|17104314|P7|PKC412A2104E2|Death|2
4982903|NCT00045942|17104315|P6|PKC412A2104E2|Death|1
4982904|NCT00045942|17104316|P5|PKC412A2104E2|Death|0
4982905|NCT00045942|17104317|P4|PKC412A2104E2|Death|0
4982906|NCT00045942|17104318|P3|PKC412A2104E2|Death|0
4982907|NCT00045942|17104319|P2|PKC412A2104E2|Death|0
4982908|NCT00045942|17104320|P1|PKC412A2104E2|Death|0
4982909|NCT00045942|17104312|P9|PKC412A2104E2|Adverse Event|0
4982910|NCT00045942|17104313|P8|PKC412A2104E2|Adverse Event|1
4982911|NCT00045942|17104314|P7|PKC412A2104E2|Adverse Event|3
4982912|NCT00045942|17104315|P6|PKC412A2104E2|Adverse Event|4
4982913|NCT00045942|17104316|P5|PKC412A2104E2|Adverse Event|0
4982914|NCT00045942|17104317|P4|PKC412A2104E2|Adverse Event|0
4982915|NCT00045942|17104318|P3|PKC412A2104E2|Adverse Event|0
4982916|NCT00045942|17104319|P2|PKC412A2104E2|Adverse Event|0
4982917|NCT00045942|17104320|P1|PKC412A2104E2|Adverse Event|0
4982918|NCT00045942|17104312|P9|PKC412A2104E2|Lack of Efficacy|6
4982919|NCT00045942|17104313|P8|PKC412A2104E2|Lack of Efficacy|2
4982920|NCT00045942|17104314|P7|PKC412A2104E2|Lack of Efficacy|2
4982921|NCT00045942|17104315|P6|PKC412A2104E2|Lack of Efficacy|3
4982922|NCT00045942|17104316|P5|PKC412A2104E2|Lack of Efficacy|0
4982923|NCT00045942|17104317|P4|PKC412A2104E2|Lack of Efficacy|0
4982924|NCT00045942|17104318|P3|PKC412A2104E2|Lack of Efficacy|0
4982925|NCT00045942|17104319|P2|PKC412A2104E2|Lack of Efficacy|0
4982926|NCT00045942|17104320|P1|PKC412A2104E2|Lack of Efficacy|0
4982927|NCT00045942|17104312|P9|PKC412A2104E2|Withdrawal by Subject|0
4982928|NCT00045942|17104313|P8|PKC412A2104E2|Withdrawal by Subject|1
4982929|NCT00045942|17104314|P7|PKC412A2104E2|Withdrawal by Subject|0
4982930|NCT00045942|17104315|P6|PKC412A2104E2|Withdrawal by Subject|1
4982931|NCT00045942|17104316|P5|PKC412A2104E2|Withdrawal by Subject|0
4982932|NCT00045942|17104317|P4|PKC412A2104E2|Withdrawal by Subject|0
4982933|NCT00045942|17104318|P3|PKC412A2104E2|Withdrawal by Subject|0
4982934|NCT00045942|17104319|P2|PKC412A2104E2|Withdrawal by Subject|0
4982935|NCT00045942|17104320|P1|PKC412A2104E2|Withdrawal by Subject|0
4982936|NCT00045942|17104312|P9|PKC412A2104E2|Lost to Follow-up|0
4982937|NCT00045942|17104313|P8|PKC412A2104E2|Lost to Follow-up|3
4982938|NCT00045942|17104314|P7|PKC412A2104E2|Lost to Follow-up|0
4982939|NCT00045942|17104315|P6|PKC412A2104E2|Lost to Follow-up|0
4982940|NCT00045942|17104316|P5|PKC412A2104E2|Lost to Follow-up|0
4982941|NCT00045942|17104317|P4|PKC412A2104E2|Lost to Follow-up|0
4982942|NCT00045942|17104318|P3|PKC412A2104E2|Lost to Follow-up|0
4982943|NCT00045942|17104319|P2|PKC412A2104E2|Lost to Follow-up|0
4982944|NCT00045942|17104320|P1|PKC412A2104E2|Lost to Follow-up|0
4982945|NCT00045942|17104312|P9|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982946|NCT00045942|17104313|P8|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982947|NCT00045942|17104314|P7|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982948|NCT00045942|17104315|P6|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982949|NCT00045942|17104316|P5|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982950|NCT00045942|17104317|P4|PKC412A2104E1|Enrolled into PKC412A2104E2|1
4982951|NCT00045942|17104318|P3|PKC412A2104E1|Enrolled into PKC412A2104E2|1
4982952|NCT00045942|17104319|P2|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982953|NCT00045942|17104320|P1|PKC412A2104E1|Enrolled into PKC412A2104E2|0
4982954|NCT00045942|17104312|P9|PKC412A2104E1|Death|0
4982955|NCT00045942|17104313|P8|PKC412A2104E1|Death|0
4982956|NCT00045942|17104314|P7|PKC412A2104E1|Death|0
4982957|NCT00045942|17104315|P6|PKC412A2104E1|Death|0
4982958|NCT00045942|17104316|P5|PKC412A2104E1|Death|1
4982959|NCT00045942|17104317|P4|PKC412A2104E1|Death|1
4982960|NCT00045942|17104318|P3|PKC412A2104E1|Death|1
4982961|NCT00045942|17104319|P2|PKC412A2104E1|Death|4
4982962|NCT00045942|17104320|P1|PKC412A2104E1|Death|0
4982963|NCT00045942|17104312|P9|PKC412A2104E1|Adverse Event|0
4982964|NCT00045942|17104313|P8|PKC412A2104E1|Adverse Event|0
4982965|NCT00045942|17104314|P7|PKC412A2104E1|Adverse Event|0
4982966|NCT00045942|17104315|P6|PKC412A2104E1|Adverse Event|0
4982967|NCT00045942|17104316|P5|PKC412A2104E1|Adverse Event|6
4982968|NCT00045942|17104317|P4|PKC412A2104E1|Adverse Event|3
4982969|NCT00045942|17104318|P3|PKC412A2104E1|Adverse Event|1
4982970|NCT00045942|17104319|P2|PKC412A2104E1|Adverse Event|1
4982971|NCT00045942|17104320|P1|PKC412A2104E1|Adverse Event|0
4982972|NCT00045942|17104312|P9|PKC412A2104E1|Abnormal laboratory value|0
4982973|NCT00045942|17104313|P8|PKC412A2104E1|Abnormal laboratory value|0
4982974|NCT00045942|17104314|P7|PKC412A2104E1|Abnormal laboratory value|0
4982975|NCT00045942|17104315|P6|PKC412A2104E1|Abnormal laboratory value|0
4982976|NCT00045942|17104316|P5|PKC412A2104E1|Abnormal laboratory value|0
4982977|NCT00045942|17104317|P4|PKC412A2104E1|Abnormal laboratory value|0
4982978|NCT00045942|17104318|P3|PKC412A2104E1|Abnormal laboratory value|0
4982979|NCT00045942|17104319|P2|PKC412A2104E1|Abnormal laboratory value|1
4982980|NCT00045942|17104320|P1|PKC412A2104E1|Abnormal laboratory value|0
4982981|NCT00045942|17104312|P9|PKC412A2104E1|Lack of Efficacy|0
4982982|NCT00045942|17104313|P8|PKC412A2104E1|Lack of Efficacy|0
4982983|NCT00045942|17104314|P7|PKC412A2104E1|Lack of Efficacy|0
4982984|NCT00045942|17104315|P6|PKC412A2104E1|Lack of Efficacy|0
4982985|NCT00045942|17104316|P5|PKC412A2104E1|Lack of Efficacy|17
4982986|NCT00045942|17104317|P4|PKC412A2104E1|Lack of Efficacy|23
4982987|NCT00045942|17104318|P3|PKC412A2104E1|Lack of Efficacy|11
4982988|NCT00045942|17104319|P2|PKC412A2104E1|Lack of Efficacy|11
4982989|NCT00045942|17104320|P1|PKC412A2104E1|Lack of Efficacy|0
4982990|NCT00045942|17104312|P9|PKC412A2104E1|Condition no longer requires study drug|0
4982991|NCT00045942|17104313|P8|PKC412A2104E1|Condition no longer requires study drug|0
4982992|NCT00045942|17104314|P7|PKC412A2104E1|Condition no longer requires study drug|0
4982993|NCT00045942|17104315|P6|PKC412A2104E1|Condition no longer requires study drug|0
4982994|NCT00045942|17104316|P5|PKC412A2104E1|Condition no longer requires study drug|1
4982995|NCT00045942|17104317|P4|PKC412A2104E1|Condition no longer requires study drug|0
4982996|NCT00045942|17104318|P3|PKC412A2104E1|Condition no longer requires study drug|1
4982997|NCT00045942|17104319|P2|PKC412A2104E1|Condition no longer requires study drug|1
4982998|NCT00045942|17104320|P1|PKC412A2104E1|Condition no longer requires study drug|0
4982999|NCT00045942|17104312|P9|PKC412A2104E1|Withdrawal by Subject|0
4983000|NCT00045942|17104313|P8|PKC412A2104E1|Withdrawal by Subject|0
4983001|NCT00045942|17104314|P7|PKC412A2104E1|Withdrawal by Subject|0
4983002|NCT00045942|17104315|P6|PKC412A2104E1|Withdrawal by Subject|0
4983003|NCT00045942|17104316|P5|PKC412A2104E1|Withdrawal by Subject|2
4983004|NCT00045942|17104317|P4|PKC412A2104E1|Withdrawal by Subject|5
4983005|NCT00045942|17104318|P3|PKC412A2104E1|Withdrawal by Subject|2
4983006|NCT00045942|17104319|P2|PKC412A2104E1|Withdrawal by Subject|0
4983007|NCT00045942|17104320|P1|PKC412A2104E1|Withdrawal by Subject|0
4983008|NCT00045942|17104312|P9|PKC412A2104 (Core)|Death|0
4983009|NCT00045942|17104313|P8|PKC412A2104 (Core)|Death|0
4983010|NCT00045942|17104314|P7|PKC412A2104 (Core)|Death|0
4983011|NCT00045942|17104315|P6|PKC412A2104 (Core)|Death|0
4983012|NCT00045942|17104316|P5|PKC412A2104 (Core)|Death|0
4983013|NCT00045942|17104317|P4|PKC412A2104 (Core)|Death|0
4983014|NCT00045942|17104318|P3|PKC412A2104 (Core)|Death|0
4983015|NCT00045942|17104319|P2|PKC412A2104 (Core)|Death|0
4983016|NCT00045942|17104320|P1|PKC412A2104 (Core)|Death|1
4983017|NCT00045942|17104312|P9|PKC412A2104 (Core)|Lack of Efficacy|0
4983018|NCT00045942|17104313|P8|PKC412A2104 (Core)|Lack of Efficacy|0
4983019|NCT00045942|17104314|P7|PKC412A2104 (Core)|Lack of Efficacy|0
4983020|NCT00045942|17104315|P6|PKC412A2104 (Core)|Lack of Efficacy|0
4983021|NCT00045942|17104316|P5|PKC412A2104 (Core)|Lack of Efficacy|0
4983022|NCT00045942|17104317|P4|PKC412A2104 (Core)|Lack of Efficacy|0
4983023|NCT00045942|17104318|P3|PKC412A2104 (Core)|Lack of Efficacy|0
4983024|NCT00045942|17104319|P2|PKC412A2104 (Core)|Lack of Efficacy|0
4983025|NCT00045942|17104320|P1|PKC412A2104 (Core)|Lack of Efficacy|13
4983026|NCT00045942|17104312|P9|PKC412A2104 (Core)|Adverse Event|0
4983027|NCT00045942|17104313|P8|PKC412A2104 (Core)|Adverse Event|0
4983028|NCT00045942|17104314|P7|PKC412A2104 (Core)|Adverse Event|0
4983029|NCT00045942|17104315|P6|PKC412A2104 (Core)|Adverse Event|0
4983030|NCT00045942|17104316|P5|PKC412A2104 (Core)|Adverse Event|0
4983031|NCT00045942|17104317|P4|PKC412A2104 (Core)|Adverse Event|0
4983032|NCT00045942|17104318|P3|PKC412A2104 (Core)|Adverse Event|0
4983033|NCT00045942|17104319|P2|PKC412A2104 (Core)|Adverse Event|0
4983034|NCT00045942|17104320|P1|PKC412A2104 (Core)|Adverse Event|5
4983035|NCT00045942|17104312|P9|PKC412A2104 (Core)|Withdrawal by Subject|0
4983036|NCT00045942|17104313|P8|PKC412A2104 (Core)|Withdrawal by Subject|0
4983037|NCT00045942|17104314|P7|PKC412A2104 (Core)|Withdrawal by Subject|0
4983038|NCT00045942|17104315|P6|PKC412A2104 (Core)|Withdrawal by Subject|0
4983039|NCT00045942|17104316|P5|PKC412A2104 (Core)|Withdrawal by Subject|0
4983040|NCT00045942|17104317|P4|PKC412A2104 (Core)|Withdrawal by Subject|0
4983041|NCT00045942|17104318|P3|PKC412A2104 (Core)|Withdrawal by Subject|0
4983042|NCT00045942|17104319|P2|PKC412A2104 (Core)|Withdrawal by Subject|0
4983043|NCT00045942|17104320|P1|PKC412A2104 (Core)|Withdrawal by Subject|1
4983044|NCT00044512|17104409|P1|Follow Up|Lost to Follow-up|2
4983045|NCT00044213|17104424|P4|Overall Study|Lost to Follow-up|4
4983046|NCT00044213|17104425|P3|Overall Study|Lost to Follow-up|5
4983047|NCT00044213|17104426|P2|Overall Study|Lost to Follow-up|5
4983048|NCT00044213|17104427|P1|Overall Study|Lost to Follow-up|8
4983049|NCT00044213|17104424|P4|Overall Study|Death|49
4983050|NCT00044213|17104425|P3|Overall Study|Death|42
4983051|NCT00044213|17104426|P2|Overall Study|Death|42
4983052|NCT00044213|17104427|P1|Overall Study|Death|42
4983053|NCT00044213|17104424|P4|Overall Study|Withdrawal by Subject|83
4983054|NCT00044213|17104425|P3|Overall Study|Withdrawal by Subject|91
4983055|NCT00044213|17104426|P2|Overall Study|Withdrawal by Subject|65
4983056|NCT00044213|17104427|P1|Overall Study|Withdrawal by Subject|50
4983057|NCT00044083|17104492|P2|Second Intervention (One Week) Patients|Withdrawal by Subject|1
4983058|NCT00044083|17104493|P1|Second Intervention (One Week) Patients|Withdrawal by Subject|0
4983059|NCT00044083|17104492|P2|First Intervention (One Week) Patients|Used illegal drug|0
4983060|NCT00044083|17104493|P1|First Intervention (One Week) Patients|Used illegal drug|1
4983061|NCT00044083|17104492|P2|First Intervention (One Week) Patients|Not follow directions|2
4983062|NCT00044083|17104493|P1|First Intervention (One Week) Patients|Not follow directions|0
4983063|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Drank while on protocol|1
4983064|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Drank while on protocol|0
4983065|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Abnormal MRI|1
4983066|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Abnormal MRI|0
4983067|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Used illegal drugs|0
4983068|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Used illegal drugs|1
4983069|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Pregnancy|0
4983070|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Pregnancy|1
4983071|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Withdrawal by Subject|3
4983072|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Withdrawal by Subject|5
4983073|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Not follow directions|2
4983074|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Not follow directions|2
4983075|NCT00044083|17104492|P2|First Intervention (One Week)- HV's|Adverse Event|0
4983076|NCT00044083|17104493|P1|First Intervention (One Week)- HV's|Adverse Event|1
4983077|NCT00043979|17104531|P3|Period 1|recipient with progressive disease|3
4983078|NCT00043979|17104532|P2|Period 1|recipient with progressive disease|4
4983079|NCT00043979|17104533|P1|Period 1|recipient with progressive disease|7
4983080|NCT00043550|17104554|P3|Overall Study|Withdrawal by Subject|20
4983081|NCT00043550|17104555|P2|Overall Study|Withdrawal by Subject|12
4983082|NCT00043550|17104556|P1|Overall Study|Withdrawal by Subject|22
4983083|NCT00043186|17104573|P9|Overall Study|Other|0
4983084|NCT00043186|17104574|P8|Overall Study|Other|0
4983085|NCT00043186|17104575|P7|Overall Study|Other|0
4983086|NCT00043186|17104576|P6|Overall Study|Other|0
4983087|NCT00043186|17104577|P5|Overall Study|Other|0
4983088|NCT00043186|17104578|P4|Overall Study|Other|1
4983089|NCT00043186|17104579|P3|Overall Study|Other|1
4983090|NCT00043186|17104580|P2|Overall Study|Other|0
4983091|NCT00043186|17104581|P1|Overall Study|Other|0
4983092|NCT00043186|17104573|P9|Overall Study|Noncompliance|0
4983093|NCT00043186|17104574|P8|Overall Study|Noncompliance|0
4983094|NCT00043186|17104575|P7|Overall Study|Noncompliance|0
4983095|NCT00043186|17104576|P6|Overall Study|Noncompliance|0
4983096|NCT00043186|17104577|P5|Overall Study|Noncompliance|0
4983097|NCT00043186|17104578|P4|Overall Study|Noncompliance|1
4983098|NCT00043186|17104579|P3|Overall Study|Noncompliance|1
4983099|NCT00043186|17104580|P2|Overall Study|Noncompliance|0
4983100|NCT00043186|17104581|P1|Overall Study|Noncompliance|0
4983101|NCT00043186|17104573|P9|Overall Study|Lost to Follow-up|2
4983102|NCT00043186|17104574|P8|Overall Study|Lost to Follow-up|1
4983103|NCT00043186|17104575|P7|Overall Study|Lost to Follow-up|1
4983104|NCT00043186|17104576|P6|Overall Study|Lost to Follow-up|1
4983105|NCT00043186|17104577|P5|Overall Study|Lost to Follow-up|1
4983106|NCT00043186|17104578|P4|Overall Study|Lost to Follow-up|1
4983107|NCT00043186|17104579|P3|Overall Study|Lost to Follow-up|1
4983108|NCT00043186|17104580|P2|Overall Study|Lost to Follow-up|5
4983109|NCT00043186|17104581|P1|Overall Study|Lost to Follow-up|3
4983110|NCT00043186|17104573|P9|Overall Study|Ineligibility determined|1
4983111|NCT00043186|17104574|P8|Overall Study|Ineligibility determined|0
4983112|NCT00043186|17104575|P7|Overall Study|Ineligibility determined|0
4983113|NCT00043186|17104576|P6|Overall Study|Ineligibility determined|0
4983114|NCT00043186|17104577|P5|Overall Study|Ineligibility determined|0
4983115|NCT00043186|17104578|P4|Overall Study|Ineligibility determined|0
4983116|NCT00043186|17104579|P3|Overall Study|Ineligibility determined|0
4983117|NCT00043186|17104580|P2|Overall Study|Ineligibility determined|0
4983118|NCT00043186|17104581|P1|Overall Study|Ineligibility determined|0
4983119|NCT00043186|17104573|P9|Overall Study|Disease progression|0
4983120|NCT00043186|17104574|P8|Overall Study|Disease progression|4
4983121|NCT00043186|17104575|P7|Overall Study|Disease progression|0
4983122|NCT00043186|17104576|P6|Overall Study|Disease progression|0
4983123|NCT00043186|17104577|P5|Overall Study|Disease progression|0
4983124|NCT00043186|17104578|P4|Overall Study|Disease progression|3
4983125|NCT00043186|17104579|P3|Overall Study|Disease progression|0
4983126|NCT00043186|17104580|P2|Overall Study|Disease progression|0
4983127|NCT00043186|17104581|P1|Overall Study|Disease progression|1
4983128|NCT00043186|17104573|P9|Overall Study|Death|0
4983129|NCT00043186|17104574|P8|Overall Study|Death|0
4983130|NCT00043186|17104575|P7|Overall Study|Death|2
4983131|NCT00043186|17104576|P6|Overall Study|Death|0
4983132|NCT00043186|17104577|P5|Overall Study|Death|0
4983133|NCT00043186|17104578|P4|Overall Study|Death|0
4983134|NCT00043186|17104579|P3|Overall Study|Death|1
4983135|NCT00043186|17104580|P2|Overall Study|Death|0
4983136|NCT00043186|17104581|P1|Overall Study|Death|0
4983137|NCT00043186|17104573|P9|Overall Study|Withdrawal by Subject|10
4983138|NCT00043186|17104574|P8|Overall Study|Withdrawal by Subject|9
4983139|NCT00043186|17104575|P7|Overall Study|Withdrawal by Subject|12
4983140|NCT00043186|17104576|P6|Overall Study|Withdrawal by Subject|6
4983141|NCT00043186|17104577|P5|Overall Study|Withdrawal by Subject|14
4983142|NCT00043186|17104578|P4|Overall Study|Withdrawal by Subject|13
4983143|NCT00043186|17104579|P3|Overall Study|Withdrawal by Subject|11
4983144|NCT00043186|17104580|P2|Overall Study|Withdrawal by Subject|8
4983145|NCT00043186|17104581|P1|Overall Study|Withdrawal by Subject|11
4983146|NCT00043186|17104573|P9|Overall Study|Adverse Event|3
4983147|NCT00043186|17104574|P8|Overall Study|Adverse Event|1
4983148|NCT00043186|17104575|P7|Overall Study|Adverse Event|2
4983149|NCT00043186|17104576|P6|Overall Study|Adverse Event|1
4983150|NCT00043186|17104577|P5|Overall Study|Adverse Event|2
4983151|NCT00043186|17104578|P4|Overall Study|Adverse Event|3
4983152|NCT00043186|17104579|P3|Overall Study|Adverse Event|2
4983153|NCT00043186|17104580|P2|Overall Study|Adverse Event|2
4983154|NCT00043186|17104581|P1|Overall Study|Adverse Event|2
4983155|NCT00043186|17104573|P9|Overall Study|Physician Decision|1
4983156|NCT00043186|17104574|P8|Overall Study|Physician Decision|1
4983157|NCT00043186|17104575|P7|Overall Study|Physician Decision|0
4983158|NCT00043186|17104576|P6|Overall Study|Physician Decision|0
4983159|NCT00043186|17104577|P5|Overall Study|Physician Decision|1
4983160|NCT00043186|17104578|P4|Overall Study|Physician Decision|0
4983161|NCT00043186|17104579|P3|Overall Study|Physician Decision|3
4983162|NCT00043186|17104580|P2|Overall Study|Physician Decision|0
4983163|NCT00043186|17104581|P1|Overall Study|Physician Decision|0
4983164|NCT00042666|17104907|P1|Overall Study|Other|4
4983165|NCT00042666|17104907|P1|Overall Study|Other|1
4983166|NCT00042666|17104907|P1|Overall Study|Progressive Disease|41
4983167|NCT00042666|17104907|P1|Overall Study|Participant/Physician Perception|1
4983168|NCT00042666|17104907|P1|Overall Study|Protocol Violation|1
4983169|NCT00042666|17104907|P1|Overall Study|Death|4
4983170|NCT00042666|17104907|P1|Overall Study|Adverse Event|2
4983171|NCT00042432|17104919|P2|Overall Study|Other|0
4983172|NCT00042432|17104920|P1|Overall Study|Other|2
4983173|NCT00042432|17104919|P2|Overall Study|Initiation of maintenance dialysis|1
4983174|NCT00042432|17104920|P1|Overall Study|Initiation of maintenance dialysis|1
4983175|NCT00042432|17104919|P2|Overall Study|Ineligibility determined|0
4983176|NCT00042432|17104920|P1|Overall Study|Ineligibility determined|1
4983177|NCT00042432|17104919|P2|Overall Study|Death|2
4983178|NCT00042432|17104920|P1|Overall Study|Death|0
4983179|NCT00042432|17104919|P2|Overall Study|Withdrawal by Subject|3
4983180|NCT00042432|17104920|P1|Overall Study|Withdrawal by Subject|1
4983181|NCT00042432|17104919|P2|Overall Study|Adverse Event|1
4983182|NCT00042432|17104920|P1|Overall Study|Adverse Event|4
4983183|NCT00041756|17104973|P5|Overall Study|Data Monitoring Committee Recommendation|21
4983184|NCT00041756|17104974|P4|Overall Study|Data Monitoring Committee Recommendation|0
4983185|NCT00041756|17104975|P3|Overall Study|Data Monitoring Committee Recommendation|0
4983186|NCT00041756|17104976|P2|Overall Study|Data Monitoring Committee Recommendation|0
4983187|NCT00041756|17104977|P1|Overall Study|Data Monitoring Committee Recommendation|0
4983188|NCT00041756|17104973|P5|Overall Study|Unable to meet protocol criteria|1
4983189|NCT00041756|17104974|P4|Overall Study|Unable to meet protocol criteria|0
4983190|NCT00041756|17104975|P3|Overall Study|Unable to meet protocol criteria|1
4983191|NCT00041756|17104976|P2|Overall Study|Unable to meet protocol criteria|0
4983192|NCT00041756|17104977|P1|Overall Study|Unable to meet protocol criteria|0
4983193|NCT00041756|17104973|P5|Overall Study|Lost to Follow-up|0
4983194|NCT00041756|17104974|P4|Overall Study|Lost to Follow-up|1
4983195|NCT00041756|17104975|P3|Overall Study|Lost to Follow-up|0
4983196|NCT00041756|17104976|P2|Overall Study|Lost to Follow-up|1
4983197|NCT00041756|17104977|P1|Overall Study|Lost to Follow-up|0
4983198|NCT00041756|17104973|P5|Overall Study|Withdrawal by Subject|3
4983199|NCT00041756|17104974|P4|Overall Study|Withdrawal by Subject|2
4983200|NCT00041756|17104975|P3|Overall Study|Withdrawal by Subject|4
4983201|NCT00041756|17104976|P2|Overall Study|Withdrawal by Subject|3
4983202|NCT00041756|17104977|P1|Overall Study|Withdrawal by Subject|3
4983203|NCT00041756|17104973|P5|Overall Study|Protocol Violation|1
4983204|NCT00041756|17104974|P4|Overall Study|Protocol Violation|2
4983205|NCT00041756|17104975|P3|Overall Study|Protocol Violation|2
4983206|NCT00041756|17104976|P2|Overall Study|Protocol Violation|1
4983207|NCT00041756|17104977|P1|Overall Study|Protocol Violation|1
4983208|NCT00041756|17104973|P5|Overall Study|Adverse Event|34
4983209|NCT00041756|17104974|P4|Overall Study|Adverse Event|11
4983210|NCT00041756|17104975|P3|Overall Study|Adverse Event|6
4983211|NCT00041756|17104976|P2|Overall Study|Adverse Event|10
4983212|NCT00041756|17104977|P1|Overall Study|Adverse Event|4
4983213|NCT00041470|17105005|P1|Overall Study|Loss of Funding|38
4983214|NCT00040664|17105010|P4|Overall Study|Non-viability of oral suspension|0
4983215|NCT00040664|17105011|P3|Overall Study|Non-viability of oral suspension|1
4983216|NCT00040664|17105012|P2|Overall Study|Non-viability of oral suspension|0
4983217|NCT00040664|17105013|P1|Overall Study|Non-viability of oral suspension|1
4983218|NCT00040664|17105010|P4|Overall Study|Change of formulation|0
4983219|NCT00040664|17105011|P3|Overall Study|Change of formulation|0
4983220|NCT00040664|17105012|P2|Overall Study|Change of formulation|2
4983221|NCT00040664|17105013|P1|Overall Study|Change of formulation|2
4983222|NCT00040664|17105010|P4|Overall Study|Pharmacokinetic target not achieved|1
4983223|NCT00040664|17105011|P3|Overall Study|Pharmacokinetic target not achieved|0
4983224|NCT00040664|17105012|P2|Overall Study|Pharmacokinetic target not achieved|1
4983225|NCT00040664|17105013|P1|Overall Study|Pharmacokinetic target not achieved|2
4983226|NCT00040664|17105010|P4|Overall Study|Poor taste|0
4983227|NCT00040664|17105011|P3|Overall Study|Poor taste|2
4983228|NCT00040664|17105012|P2|Overall Study|Poor taste|0
4983229|NCT00040664|17105013|P1|Overall Study|Poor taste|2
4983230|NCT00040664|17105010|P4|Overall Study|Medication adherence/compliance problems|5
4983231|NCT00040664|17105011|P3|Overall Study|Medication adherence/compliance problems|1
4983232|NCT00040664|17105012|P2|Overall Study|Medication adherence/compliance problems|2
4983233|NCT00040664|17105013|P1|Overall Study|Medication adherence/compliance problems|8
4983234|NCT00040664|17105010|P4|Overall Study|Pregnancy|3
4983235|NCT00040664|17105011|P3|Overall Study|Pregnancy|0
4983236|NCT00040664|17105012|P2|Overall Study|Pregnancy|0
4983237|NCT00040664|17105013|P1|Overall Study|Pregnancy|3
4983238|NCT00040664|17105010|P4|Overall Study|Withdrawal by Subject|4
4983239|NCT00040664|17105011|P3|Overall Study|Withdrawal by Subject|3
4983240|NCT00040664|17105012|P2|Overall Study|Withdrawal by Subject|0
4983241|NCT00040664|17105013|P1|Overall Study|Withdrawal by Subject|7
4983242|NCT00040664|17105010|P4|Overall Study|Protocol Violation|1
4983243|NCT00040664|17105011|P3|Overall Study|Protocol Violation|0
4983244|NCT00040664|17105012|P2|Overall Study|Protocol Violation|1
4983245|NCT00040664|17105013|P1|Overall Study|Protocol Violation|2
4983246|NCT00040664|17105010|P4|Overall Study|Lost to Follow-up|2
4983247|NCT00040664|17105011|P3|Overall Study|Lost to Follow-up|0
4983248|NCT00040664|17105012|P2|Overall Study|Lost to Follow-up|2
4983249|NCT00040664|17105013|P1|Overall Study|Lost to Follow-up|4
4983250|NCT00040664|17105010|P4|Overall Study|Insufficient CD4 response|0
4983251|NCT00040664|17105011|P3|Overall Study|Insufficient CD4 response|1
4983252|NCT00040664|17105012|P2|Overall Study|Insufficient CD4 response|0
4983253|NCT00040664|17105013|P1|Overall Study|Insufficient CD4 response|1
4983254|NCT00040664|17105010|P4|Overall Study|Lack of Efficacy|4
4983255|NCT00040664|17105011|P3|Overall Study|Lack of Efficacy|3
4983256|NCT00040664|17105012|P2|Overall Study|Lack of Efficacy|2
4983257|NCT00040664|17105013|P1|Overall Study|Lack of Efficacy|9
4983258|NCT00040664|17105010|P4|Overall Study|Adverse Event|7
4983259|NCT00040664|17105011|P3|Overall Study|Adverse Event|2
4983260|NCT00040664|17105012|P2|Overall Study|Adverse Event|3
4983261|NCT00040664|17105013|P1|Overall Study|Adverse Event|12
4983262|NCT00040365|17105079|P1|Overall Study|Lost to Follow-up|3
4983263|NCT00040365|17105079|P1|Overall Study|Progressive disease|7
4983264|NCT00040365|17105079|P1|Overall Study|Death|1
4983265|NCT00039871|17105088|P1|Overall Study|Never entered follow-up|7
4983266|NCT00039871|17105088|P1|Overall Study|Discontinued at Week 12 per protocol|1061
4983267|NCT00039871|17105088|P1|Overall Study|Administrative|1
4983268|NCT00039871|17105088|P1|Overall Study|Did not meet eligibility criteria|11
4983269|NCT00039871|17105088|P1|Overall Study|Withdrawal by Subject|97
4983270|NCT00039871|17105088|P1|Overall Study|Protocol Violation|24
4983271|NCT00039871|17105088|P1|Overall Study|Lost to Follow-up|18
4983272|NCT00039871|17105088|P1|Overall Study|Adverse Event|165
4983273|NCT00039741|17105098|P4|Overall Study|Missed final visit|2
4983274|NCT00039741|17105099|P3|Overall Study|Missed final visit|2
4983275|NCT00039741|17105100|P2|Overall Study|Missed final visit|1
4983276|NCT00039741|17105101|P1|Overall Study|Missed final visit|2
4983277|NCT00039741|17105098|P4|Overall Study|Withdrew consent|1
4983278|NCT00039741|17105099|P3|Overall Study|Withdrew consent|0
4983279|NCT00039741|17105100|P2|Overall Study|Withdrew consent|5
4983280|NCT00039741|17105101|P1|Overall Study|Withdrew consent|0
4983281|NCT00039741|17105098|P4|Overall Study|Non-compliance with protocol|0
4983282|NCT00039741|17105099|P3|Overall Study|Non-compliance with protocol|1
4983283|NCT00039741|17105100|P2|Overall Study|Non-compliance with protocol|0
4983284|NCT00039741|17105101|P1|Overall Study|Non-compliance with protocol|1
4983285|NCT00039741|17105098|P4|Overall Study|Moved|6
4983286|NCT00039741|17105099|P3|Overall Study|Moved|3
4983287|NCT00039741|17105100|P2|Overall Study|Moved|2
4983288|NCT00039741|17105101|P1|Overall Study|Moved|3
4983289|NCT00039741|17105098|P4|Overall Study|Not able to get to clinic|3
4983290|NCT00039741|17105099|P3|Overall Study|Not able to get to clinic|0
4983291|NCT00039741|17105100|P2|Overall Study|Not able to get to clinic|2
4983292|NCT00039741|17105101|P1|Overall Study|Not able to get to clinic|5
4983293|NCT00039741|17105098|P4|Overall Study|Confounding medical condition|0
4983294|NCT00039741|17105099|P3|Overall Study|Confounding medical condition|0
4983295|NCT00039741|17105100|P2|Overall Study|Confounding medical condition|0
4983296|NCT00039741|17105101|P1|Overall Study|Confounding medical condition|1
4983297|NCT00039741|17105098|P4|Overall Study|Lost to Follow-up|2
4983298|NCT00039741|17105099|P3|Overall Study|Lost to Follow-up|5
4983299|NCT00039741|17105100|P2|Overall Study|Lost to Follow-up|1
4983300|NCT00039741|17105101|P1|Overall Study|Lost to Follow-up|3
4983301|NCT00039741|17105098|P4|Overall Study|Death|0
4983302|NCT00039741|17105099|P3|Overall Study|Death|0
4983303|NCT00039741|17105100|P2|Overall Study|Death|1
4983304|NCT00039741|17105101|P1|Overall Study|Death|0
4983305|NCT00038948|17105145|P2|Overall Study|Lack of Efficacy|6
4983306|NCT00038948|17105146|P1|Overall Study|Lack of Efficacy|3
4983307|NCT00038948|17105145|P2|Overall Study|Protocol Violation|7
4983308|NCT00038948|17105146|P1|Overall Study|Protocol Violation|3
4983309|NCT00038948|17105145|P2|Overall Study|Withdrawal by Subject|10
4983310|NCT00038948|17105146|P1|Overall Study|Withdrawal by Subject|23
4983311|NCT00038948|17105145|P2|Overall Study|Nonmedical event|7
4983312|NCT00038948|17105146|P1|Overall Study|Nonmedical event|5
4983313|NCT00038948|17105145|P2|Overall Study|Lost to Follow-up|4
4983314|NCT00038948|17105146|P1|Overall Study|Lost to Follow-up|4
4983315|NCT00038948|17105145|P2|Overall Study|Adverse Event|43
4983316|NCT00038948|17105146|P1|Overall Study|Adverse Event|131
4983317|NCT00038649|17105181|P1|Overall Study|Adverse Event|9
4983318|NCT00038467|17105194|P2|Overall Study|Other|28
4983319|NCT00038467|17105195|P1|Overall Study|Other|26
4983320|NCT00038467|17105194|P2|Overall Study|Randomized, but not treated|35
4983321|NCT00038467|17105195|P1|Overall Study|Randomized, but not treated|31
4983322|NCT00038467|17105194|P2|Overall Study|Recurrence|179
4983323|NCT00038467|17105195|P1|Overall Study|Recurrence|109
4983324|NCT00038467|17105194|P2|Overall Study|Lost to Follow-up|10
4983325|NCT00038467|17105195|P1|Overall Study|Lost to Follow-up|15
4983326|NCT00038467|17105194|P2|Overall Study|Death|16
4983327|NCT00038467|17105195|P1|Overall Study|Death|22
4983328|NCT00038467|17105194|P2|Overall Study|Protocol Violation|22
4983329|NCT00038467|17105195|P1|Overall Study|Protocol Violation|19
4983330|NCT00038467|17105194|P2|Overall Study|Withdrawal by Subject|107
4983331|NCT00038467|17105195|P1|Overall Study|Withdrawal by Subject|150
4983332|NCT00038467|17105194|P2|Overall Study|Adverse Event|145
4983333|NCT00038467|17105195|P1|Overall Study|Adverse Event|170
4983334|NCT00038142|17105257|P2|Overall Study|Unknown Reason|0
4983335|NCT00038142|17105258|P1|Overall Study|Unknown Reason|8
4983336|NCT00038142|17105257|P2|Overall Study|Adverse Event|0
4983337|NCT00038142|17105258|P1|Overall Study|Adverse Event|1
4983338|NCT00038142|17105257|P2|Overall Study|Death|0
4983339|NCT00038142|17105258|P1|Overall Study|Death|1
4983340|NCT00038142|17105257|P2|Overall Study|Progressive Disease|7
4983341|NCT00038142|17105258|P1|Overall Study|Progressive Disease|11
4983342|NCT00038142|17105257|P2|Overall Study|Ineligible|0
4983343|NCT00038142|17105258|P1|Overall Study|Ineligible|1
4983344|NCT00038103|17105266|P2|Overall Study|Randomized/never treated|0
4983345|NCT00038103|17105267|P1|Overall Study|Randomized/never treated|2
4983346|NCT00038103|17105266|P2|Overall Study|Sponsor Decision|1
4983347|NCT00038103|17105267|P1|Overall Study|Sponsor Decision|0
4983348|NCT00038103|17105266|P2|Overall Study|Protocol Violation|2
4983349|NCT00038103|17105267|P1|Overall Study|Protocol Violation|0
4983350|NCT00038103|17105266|P2|Overall Study|Lost to Follow-up|3
4983351|NCT00038103|17105267|P1|Overall Study|Lost to Follow-up|0
4983352|NCT00038103|17105266|P2|Overall Study|Withdrawal by Subject|3
4983353|NCT00038103|17105267|P1|Overall Study|Withdrawal by Subject|0
4983354|NCT00038103|17105266|P2|Overall Study|Lack of Efficacy|41
4983355|NCT00038103|17105267|P1|Overall Study|Lack of Efficacy|48
4983356|NCT00038103|17105266|P2|Overall Study|Adverse Event|6
4983357|NCT00038103|17105267|P1|Overall Study|Adverse Event|5
4983358|NCT00037830|17105290|P3|Overall Study|Unrelated Medical Problem|0
4983359|NCT00037830|17105291|P2|Overall Study|Unrelated Medical Problem|0
4983360|NCT00037830|17105292|P1|Overall Study|Unrelated Medical Problem|2
4983361|NCT00037830|17105290|P3|Overall Study|Protocol Violation|0
4983362|NCT00037830|17105291|P2|Overall Study|Protocol Violation|2
4983363|NCT00037830|17105292|P1|Overall Study|Protocol Violation|2
4983364|NCT00037830|17105290|P3|Overall Study|Withdrawal by Subject|1
4983365|NCT00037830|17105291|P2|Overall Study|Withdrawal by Subject|5
4983366|NCT00037830|17105292|P1|Overall Study|Withdrawal by Subject|4
4983367|NCT00037830|17105290|P3|Overall Study|Adverse Event|0
4983368|NCT00037830|17105291|P2|Overall Study|Adverse Event|0
4983369|NCT00037830|17105292|P1|Overall Study|Adverse Event|2
4983370|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750
4983371|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0
4983372|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Too early switch|103
4983373|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Too early switch|0
4983374|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Intercurrent illness|29
4983375|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Intercurrent illness|17
4983376|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Protocol Violation|91
4983377|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Protocol Violation|23
4983378|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Randomized but not treated|54
4983379|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Randomized but not treated|46
4983380|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Treatment refusal|208
4983381|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Treatment refusal|113
4983382|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Other|288
4983383|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Other|277
4983384|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Adverse Event|782
4983385|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Adverse Event|501
4983386|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447
4983387|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507
4983388|NCT00036270|17105324|P2|Study Treatment to 5 Year Report|Ongoing|736
4983389|NCT00036270|17105325|P1|Study Treatment to 5 Year Report|Ongoing|1081
4983390|NCT00036270|17105324|P2|Randomized to Study Treatment|Withdrawal by Subject|7
4983391|NCT00036270|17105325|P1|Randomized to Study Treatment|Withdrawal by Subject|6
4983392|NCT00035932|17105344|P3|Overall Study|Lack of Efficacy|28
4983393|NCT00035932|17105345|P2|Overall Study|Lack of Efficacy|33
4983394|NCT00035932|17105346|P1|Overall Study|Lack of Efficacy|33
4983395|NCT00035932|17105344|P3|Overall Study|Study Termination by Sponsor|0
4983396|NCT00035932|17105345|P2|Overall Study|Study Termination by Sponsor|0
4983397|NCT00035932|17105346|P1|Overall Study|Study Termination by Sponsor|1
4983398|NCT00035932|17105344|P3|Overall Study|Withdrawal by Subject|0
4983399|NCT00035932|17105345|P2|Overall Study|Withdrawal by Subject|5
4983400|NCT00035932|17105346|P1|Overall Study|Withdrawal by Subject|1
4983401|NCT00035932|17105344|P3|Overall Study|Protocol Violation While on Study|2
4983402|NCT00035932|17105345|P2|Overall Study|Protocol Violation While on Study|1
4983403|NCT00035932|17105346|P1|Overall Study|Protocol Violation While on Study|0
4983404|NCT00035932|17105344|P3|Overall Study|Noncompliance|6
4983405|NCT00035932|17105345|P2|Overall Study|Noncompliance|7
4983406|NCT00035932|17105346|P1|Overall Study|Noncompliance|6
4983407|NCT00035932|17105344|P3|Overall Study|Lost to Follow-up|3
4983408|NCT00035932|17105345|P2|Overall Study|Lost to Follow-up|4
4983409|NCT00035932|17105346|P1|Overall Study|Lost to Follow-up|4
4983410|NCT00035932|17105344|P3|Overall Study|Disease Progression / Relapse|0
4983411|NCT00035932|17105345|P2|Overall Study|Disease Progression / Relapse|1
4983412|NCT00035932|17105346|P1|Overall Study|Disease Progression / Relapse|1
4983413|NCT00035932|17105344|P3|Overall Study|Death|1
4983414|NCT00035932|17105345|P2|Overall Study|Death|0
4983415|NCT00035932|17105346|P1|Overall Study|Death|0
4983416|NCT00035932|17105344|P3|Overall Study|Adverse Event|9
4983417|NCT00035932|17105345|P2|Overall Study|Adverse Event|9
4983418|NCT00035932|17105346|P1|Overall Study|Adverse Event|10
4983419|NCT00035815|17105472|P2|Overall Study|Withdrawal by Subject|11
4983420|NCT00035815|17105473|P1|Overall Study|Withdrawal by Subject|17
4983421|NCT00035555|17105486|P3|Overall Study|Received cyclosporin in error|1
4983422|NCT00035555|17105487|P2|Overall Study|Received cyclosporin in error|0
4983423|NCT00035555|17105488|P1|Overall Study|Received cyclosporin in error|0
4983424|NCT00035555|17105486|P3|Overall Study|Investigator deemed not a good candidate|1
4983425|NCT00035555|17105487|P2|Overall Study|Investigator deemed not a good candidate|0
4983426|NCT00035555|17105488|P1|Overall Study|Investigator deemed not a good candidate|0
4983427|NCT00035555|17105486|P3|Overall Study|Withdrawal by Subject|2
4983428|NCT00035555|17105487|P2|Overall Study|Withdrawal by Subject|0
4983429|NCT00035555|17105488|P1|Overall Study|Withdrawal by Subject|2
4983430|NCT00035555|17105486|P3|Overall Study|Treatment failure/lack of efficacy|3
4983431|NCT00035555|17105487|P2|Overall Study|Treatment failure/lack of efficacy|5
4983432|NCT00035555|17105488|P1|Overall Study|Treatment failure/lack of efficacy|7
4983433|NCT00035555|17105486|P3|Overall Study|Prohibited medication|0
4983434|NCT00035555|17105487|P2|Overall Study|Prohibited medication|1
4983435|NCT00035555|17105488|P1|Overall Study|Prohibited medication|1
4983436|NCT00035555|17105486|P3|Overall Study|Noncompliance|1
4983437|NCT00035555|17105487|P2|Overall Study|Noncompliance|1
4983438|NCT00035555|17105488|P1|Overall Study|Noncompliance|0
4983439|NCT00035555|17105486|P3|Overall Study|Lost to Follow-up|1
4983440|NCT00035555|17105487|P2|Overall Study|Lost to Follow-up|0
4983441|NCT00035555|17105488|P1|Overall Study|Lost to Follow-up|0
4983442|NCT00035555|17105486|P3|Overall Study|Death|2
4983443|NCT00035555|17105487|P2|Overall Study|Death|0
4983444|NCT00035555|17105488|P1|Overall Study|Death|0
4983445|NCT00035555|17105486|P3|Overall Study|Allograft loss|2
4983446|NCT00035555|17105487|P2|Overall Study|Allograft loss|1
4983447|NCT00035555|17105488|P1|Overall Study|Allograft loss|1
4983448|NCT00035555|17105486|P3|Overall Study|Adverse Event|9
4983449|NCT00035555|17105487|P2|Overall Study|Adverse Event|8
4983450|NCT00035555|17105488|P1|Overall Study|Adverse Event|5
4983451|NCT00032487|17105572|P2|Overall Study|Had other reason|12
4983452|NCT00032487|17105573|P1|Overall Study|Had other reason|12
4983453|NCT00032487|17105572|P2|Overall Study|Lost to Follow-up|58
4983454|NCT00032487|17105573|P1|Overall Study|Lost to Follow-up|57
4983455|NCT00032487|17105572|P2|Overall Study|Adverse Event|7
4983456|NCT00032487|17105573|P1|Overall Study|Adverse Event|3
4983457|NCT00032487|17105572|P2|Overall Study|Withdrawal by Subject|43
4983458|NCT00032487|17105573|P1|Overall Study|Withdrawal by Subject|67
4983459|NCT00031551|17105583|P2|Overall Study|Withdrew due to chemotherapy effects|0
4983460|NCT00031551|17105584|P1|Overall Study|Withdrew due to chemotherapy effects|2
4983461|NCT00031486|17105596|P2|Overall Study|Other|1
4983462|NCT00031486|17105597|P1|Overall Study|Other|1
4983463|NCT00031486|17105596|P2|Overall Study|Did not meet eligibility requirement|1
4983464|NCT00031486|17105597|P1|Overall Study|Did not meet eligibility requirement|2
4983465|NCT00031486|17105596|P2|Overall Study|Non-compliant|4
4983466|NCT00031486|17105597|P1|Overall Study|Non-compliant|0
4983467|NCT00031486|17105596|P2|Overall Study|Death|3
4983468|NCT00031486|17105597|P1|Overall Study|Death|0
4983469|NCT00031486|17105596|P2|Overall Study|Withdrawal by Subject|2
4983470|NCT00031486|17105597|P1|Overall Study|Withdrawal by Subject|3
4983471|NCT00031486|17105596|P2|Overall Study|Lost to Follow-up|1
4983472|NCT00031486|17105597|P1|Overall Study|Lost to Follow-up|0
4983473|NCT00031486|17105596|P2|Overall Study|Adverse Event|0
4983474|NCT00031486|17105597|P1|Overall Study|Adverse Event|1
4983475|NCT00031460|17105623|P2|Overall Study|Confirmed unevaluable|1
4983476|NCT00031460|17105624|P1|Overall Study|Confirmed unevaluable|0
4983477|NCT00031460|17105623|P2|Overall Study|Disruption of blinded drug supply|0
4983478|NCT00031460|17105624|P1|Overall Study|Disruption of blinded drug supply|2
4983479|NCT00031460|17105623|P2|Overall Study|Reactivation of Disease|9
4983480|NCT00031460|17105624|P1|Overall Study|Reactivation of Disease|5
4983481|NCT00031460|17105623|P2|Overall Study|Death|1
4983482|NCT00031460|17105624|P1|Overall Study|Death|0
4983483|NCT00031460|17105623|P2|Overall Study|Non-Compliant|1
4983484|NCT00031460|17105624|P1|Overall Study|Non-Compliant|1
4983485|NCT00031460|17105623|P2|Overall Study|Withdrawal by Subject|1
4983486|NCT00031460|17105624|P1|Overall Study|Withdrawal by Subject|1
4983487|NCT00031460|17105623|P2|Overall Study|Lost to Follow-up|1
4983488|NCT00031460|17105624|P1|Overall Study|Lost to Follow-up|0
4983489|NCT00031447|17105638|P2|Overall Study|Disruption of blinded study drug supply|4
4983490|NCT00031447|17105639|P1|Overall Study|Disruption of blinded study drug supply|7
4983491|NCT00031447|17105638|P2|Overall Study|Re-activation of Disease|1
4983492|NCT00031447|17105639|P1|Overall Study|Re-activation of Disease|2
4983493|NCT00031447|17105638|P2|Overall Study|Non-compliant|1
4983494|NCT00031447|17105639|P1|Overall Study|Non-compliant|1
4983495|NCT00031447|17105638|P2|Overall Study|Lost to Follow-up|1
4983496|NCT00031447|17105639|P1|Overall Study|Lost to Follow-up|0
4983497|NCT00029146|17105714|P2|Overall Study|Lost to Follow-up|1
4983498|NCT00029146|17105715|P1|Overall Study|Lost to Follow-up|2
4983499|NCT00027378|17105766|P2|Overall Study|Physician Decision|3
4983500|NCT00027378|17105767|P1|Overall Study|Physician Decision|0
4983501|NCT00027027|17105780|P5|Overall Study|Withdrawal by Subject|1
4983502|NCT00027027|17105781|P4|Overall Study|Withdrawal by Subject|0
4983503|NCT00027027|17105782|P3|Overall Study|Withdrawal by Subject|0
4983504|NCT00027027|17105783|P2|Overall Study|Withdrawal by Subject|0
4983505|NCT00027027|17105784|P1|Overall Study|Withdrawal by Subject|0
4983506|NCT00027027|17105780|P5|Overall Study|Physician Decision Due To PD|5
4983507|NCT00027027|17105781|P4|Overall Study|Physician Decision Due To PD|3
4983508|NCT00027027|17105782|P3|Overall Study|Physician Decision Due To PD|2
4983509|NCT00027027|17105783|P2|Overall Study|Physician Decision Due To PD|3
4983510|NCT00027027|17105784|P1|Overall Study|Physician Decision Due To PD|2
4983511|NCT00027027|17105780|P5|Overall Study|PD Requiring Surgery|0
4983512|NCT00027027|17105781|P4|Overall Study|PD Requiring Surgery|0
4983513|NCT00027027|17105782|P3|Overall Study|PD Requiring Surgery|1
4983514|NCT00027027|17105783|P2|Overall Study|PD Requiring Surgery|0
4983515|NCT00027027|17105784|P1|Overall Study|PD Requiring Surgery|0
4983516|NCT00027027|17105780|P5|Overall Study|Clinical Symptoms Progression not PD|0
4983517|NCT00027027|17105781|P4|Overall Study|Clinical Symptoms Progression not PD|0
4983518|NCT00027027|17105782|P3|Overall Study|Clinical Symptoms Progression not PD|0
4983519|NCT00027027|17105783|P2|Overall Study|Clinical Symptoms Progression not PD|0
4983520|NCT00027027|17105784|P1|Overall Study|Clinical Symptoms Progression not PD|1
4983521|NCT00027027|17105780|P5|Overall Study|Admitted for Signs of PD|1
4983522|NCT00027027|17105781|P4|Overall Study|Admitted for Signs of PD|0
4983523|NCT00027027|17105782|P3|Overall Study|Admitted for Signs of PD|0
4983524|NCT00027027|17105783|P2|Overall Study|Admitted for Signs of PD|0
4983525|NCT00027027|17105784|P1|Overall Study|Admitted for Signs of PD|0
4983526|NCT00027027|17105780|P5|Overall Study|Adverse Event|1
4983527|NCT00027027|17105781|P4|Overall Study|Adverse Event|0
4983528|NCT00027027|17105782|P3|Overall Study|Adverse Event|1
4983529|NCT00027027|17105783|P2|Overall Study|Adverse Event|0
4983530|NCT00027027|17105784|P1|Overall Study|Adverse Event|0
4983531|NCT00026793|17105829|P1|Overall Study|Off study|2
4983532|NCT00026793|17105829|P1|Overall Study|Physician Decision|2
4983533|NCT00026793|17105829|P1|Overall Study|Death on study due to underlying disease|4
4983534|NCT00025883|17105839|P1|Overall Study|didn't reach 6 months of Metreleptin|10
4983535|NCT00025883|17105839|P1|Overall Study|Adverse Event|1
4983536|NCT00025883|17105839|P1|Overall Study|Death|1
4983537|NCT00025883|17105839|P1|Overall Study|no baseline data|1
4983538|NCT00025883|17105839|P1|Overall Study|had atypical progeriod lipodystrophy|4
4983539|NCT00023595|17105851|P5|10 Year Follow up|Lost to Follow-up|0
4983540|NCT00023595|17105852|P4|10 Year Follow up|Lost to Follow-up|0
4983541|NCT00023595|17105853|P3|10 Year Follow up|Lost to Follow-up|3
4983542|NCT00023595|17105854|P2|10 Year Follow up|Lost to Follow-up|10
4983543|NCT00023595|17105855|P1|10 Year Follow up|Lost to Follow-up|12
4983544|NCT00023595|17105851|P5|5 Year Follow up|Lost to Follow-up|3
4983545|NCT00023595|17105852|P4|5 Year Follow up|Lost to Follow-up|7
4983546|NCT00023595|17105853|P3|5 Year Follow up|Lost to Follow-up|1
4983547|NCT00023595|17105854|P2|5 Year Follow up|Lost to Follow-up|2
4983548|NCT00023595|17105855|P1|5 Year Follow up|Lost to Follow-up|2
4983549|NCT00023452|17106066|P2|Overall Study|Other|69
4983550|NCT00023452|17106067|P1|Overall Study|Other|204
4983551|NCT00023452|17106066|P2|Overall Study|Pregnant|20
4983552|NCT00023452|17106067|P1|Overall Study|Pregnant|53
4983553|NCT00023452|17106066|P2|Overall Study|Refused Treatment (continued follow-up)|224
4983554|NCT00023452|17106067|P1|Overall Study|Refused Treatment (continued follow-up)|225
4983555|NCT00023452|17106066|P2|Overall Study|Physician Decision|21
4983556|NCT00023452|17106067|P1|Overall Study|Physician Decision|49
4983557|NCT00023452|17106066|P2|Overall Study|Lost to Follow-up|60
4983558|NCT00023452|17106067|P1|Overall Study|Lost to Follow-up|293
4983559|NCT00023452|17106066|P2|Overall Study|Adverse Event|196
4983560|NCT00023452|17106067|P1|Overall Study|Adverse Event|139
4983561|NCT00023452|17106066|P2|Overall Study|Withdrawal by Subject|54
4983562|NCT00023452|17106067|P1|Overall Study|Withdrawal by Subject|66
4983563|NCT00023452|17106066|P2|Overall Study|Death|0
4983564|NCT00023452|17106067|P1|Overall Study|Death|2
4983565|NCT00023452|17106066|P2|Overall Study|Out of Window|69
4983566|NCT00023452|17106067|P1|Overall Study|Out of Window|129
4983567|NCT00023452|17106066|P2|Overall Study|Ineligible for Study|159
4983568|NCT00023452|17106067|P1|Overall Study|Ineligible for Study|163
4983569|NCT00023322|17106091|P1|Overall Study|Lost to Follow-up|1
4983570|NCT00022763|17106115|P2|Overall Study|Admin|2
4983571|NCT00022763|17106116|P1|Overall Study|Admin|3
4983572|NCT00022763|17106115|P2|Overall Study|Insufficient Therapy|0
4983573|NCT00022763|17106116|P1|Overall Study|Insufficient Therapy|1
4983574|NCT00022763|17106115|P2|Overall Study|Withdrawal by Subject|7
4983575|NCT00022763|17106116|P1|Overall Study|Withdrawal by Subject|4
4983576|NCT00022763|17106115|P2|Overall Study|Lost to Follow-up|3
4983577|NCT00022763|17106116|P1|Overall Study|Lost to Follow-up|0
4983578|NCT00022763|17106115|P2|Overall Study|Death|1
4983579|NCT00022763|17106116|P1|Overall Study|Death|0
4983580|NCT00022763|17106115|P2|Overall Study|Injection Site Reactions|2
4983581|NCT00022763|17106116|P1|Overall Study|Injection Site Reactions|0
4983582|NCT00022763|17106115|P2|Overall Study|Adverse Event|2
4983583|NCT00022763|17106116|P1|Overall Study|Adverse Event|1
4983584|NCT00014911|17106158|P1|Overall Study|Immunosuppression-related Side Effects|1
4983585|NCT00014911|17106158|P1|Overall Study|Unknown Reasons|2
4983586|NCT00014911|17106158|P1|Overall Study|Withdrawal by Subject|6
4983587|NCT00014911|17106158|P1|Overall Study|Lost to Follow-up|1
4983588|NCT00014911|17106158|P1|Overall Study|Adverse Event|1
4983589|NCT00006604|17106174|P17|Overall Study|Other Reason|0
4983590|NCT00006604|17106175|P16|Overall Study|Other Reason|0
4983591|NCT00006604|17106176|P15|Overall Study|Other Reason|0
4983592|NCT00006604|17106177|P14|Overall Study|Other Reason|0
4983593|NCT00006604|17106178|P13|Overall Study|Other Reason|0
4983594|NCT00006604|17106179|P12|Overall Study|Other Reason|0
4983595|NCT00006604|17106180|P11|Overall Study|Other Reason|0
4983596|NCT00006604|17106181|P10|Overall Study|Other Reason|1
4983597|NCT00006604|17106182|P9|Overall Study|Other Reason|0
4983598|NCT00006604|17106183|P8|Overall Study|Other Reason|0
4983599|NCT00006604|17106184|P7|Overall Study|Other Reason|0
4983600|NCT00006604|17106185|P6|Overall Study|Other Reason|1
4983601|NCT00006604|17106186|P5|Overall Study|Other Reason|0
4983602|NCT00006604|17106187|P4|Overall Study|Other Reason|0
4983603|NCT00006604|17106188|P3|Overall Study|Other Reason|0
4983604|NCT00006604|17106189|P2|Overall Study|Other Reason|0
4983605|NCT00006604|17106190|P1|Overall Study|Other Reason|0
4983606|NCT00006604|17106174|P17|Overall Study|Lost to Follow-up|3
4983607|NCT00006604|17106175|P16|Overall Study|Lost to Follow-up|1
4983608|NCT00006604|17106176|P15|Overall Study|Lost to Follow-up|0
4983609|NCT00006604|17106177|P14|Overall Study|Lost to Follow-up|0
4983610|NCT00006604|17106178|P13|Overall Study|Lost to Follow-up|0
4983611|NCT00006604|17106179|P12|Overall Study|Lost to Follow-up|0
4983612|NCT00006604|17106180|P11|Overall Study|Lost to Follow-up|0
4983613|NCT00006604|17106181|P10|Overall Study|Lost to Follow-up|2
4983614|NCT00006604|17106182|P9|Overall Study|Lost to Follow-up|0
4983615|NCT00006604|17106183|P8|Overall Study|Lost to Follow-up|1
4983616|NCT00006604|17106184|P7|Overall Study|Lost to Follow-up|0
4983617|NCT00006604|17106185|P6|Overall Study|Lost to Follow-up|0
4983618|NCT00006604|17106186|P5|Overall Study|Lost to Follow-up|0
4983619|NCT00006604|17106187|P4|Overall Study|Lost to Follow-up|0
4983620|NCT00006604|17106188|P3|Overall Study|Lost to Follow-up|0
4983621|NCT00006604|17106189|P2|Overall Study|Lost to Follow-up|0
4983622|NCT00006604|17106190|P1|Overall Study|Lost to Follow-up|0
4983623|NCT00006604|17106174|P17|Overall Study|Subj/parent not willing to adhere to req|4
4983624|NCT00006604|17106175|P16|Overall Study|Subj/parent not willing to adhere to req|3
4983625|NCT00006604|17106176|P15|Overall Study|Subj/parent not willing to adhere to req|3
4983626|NCT00006604|17106177|P14|Overall Study|Subj/parent not willing to adhere to req|2
4983627|NCT00006604|17106178|P13|Overall Study|Subj/parent not willing to adhere to req|0
4983628|NCT00006604|17106179|P12|Overall Study|Subj/parent not willing to adhere to req|0
4983629|NCT00006604|17106180|P11|Overall Study|Subj/parent not willing to adhere to req|3
4983630|NCT00006604|17106181|P10|Overall Study|Subj/parent not willing to adhere to req|6
4983631|NCT00006604|17106182|P9|Overall Study|Subj/parent not willing to adhere to req|0
4983632|NCT00006604|17106183|P8|Overall Study|Subj/parent not willing to adhere to req|1
4983633|NCT00006604|17106184|P7|Overall Study|Subj/parent not willing to adhere to req|3
4983634|NCT00006604|17106185|P6|Overall Study|Subj/parent not willing to adhere to req|0
4983635|NCT00006604|17106186|P5|Overall Study|Subj/parent not willing to adhere to req|0
4983636|NCT00006604|17106187|P4|Overall Study|Subj/parent not willing to adhere to req|3
4983637|NCT00006604|17106188|P3|Overall Study|Subj/parent not willing to adhere to req|1
4983638|NCT00006604|17106189|P2|Overall Study|Subj/parent not willing to adhere to req|0
4983639|NCT00006604|17106190|P1|Overall Study|Subj/parent not willing to adhere to req|0
4983640|NCT00006604|17106174|P17|Overall Study|Withdrawal by Subject|1
4983641|NCT00006604|17106175|P16|Overall Study|Withdrawal by Subject|0
4983642|NCT00006604|17106176|P15|Overall Study|Withdrawal by Subject|1
4983643|NCT00006604|17106177|P14|Overall Study|Withdrawal by Subject|2
4983644|NCT00006604|17106178|P13|Overall Study|Withdrawal by Subject|1
4983645|NCT00006604|17106179|P12|Overall Study|Withdrawal by Subject|0
4983646|NCT00006604|17106180|P11|Overall Study|Withdrawal by Subject|2
4983647|NCT00006604|17106181|P10|Overall Study|Withdrawal by Subject|3
4983648|NCT00006604|17106182|P9|Overall Study|Withdrawal by Subject|1
4983649|NCT00006604|17106183|P8|Overall Study|Withdrawal by Subject|0
4983650|NCT00006604|17106184|P7|Overall Study|Withdrawal by Subject|2
4983651|NCT00006604|17106185|P6|Overall Study|Withdrawal by Subject|2
4983652|NCT00006604|17106186|P5|Overall Study|Withdrawal by Subject|1
4983653|NCT00006604|17106187|P4|Overall Study|Withdrawal by Subject|0
4983654|NCT00006604|17106188|P3|Overall Study|Withdrawal by Subject|2
4983655|NCT00006604|17106189|P2|Overall Study|Withdrawal by Subject|0
4983656|NCT00006604|17106190|P1|Overall Study|Withdrawal by Subject|1
4983657|NCT00006604|17106174|P17|Overall Study|Site closing|1
4983658|NCT00006604|17106175|P16|Overall Study|Site closing|0
4983659|NCT00006604|17106176|P15|Overall Study|Site closing|0
4983660|NCT00006604|17106177|P14|Overall Study|Site closing|1
4983661|NCT00006604|17106178|P13|Overall Study|Site closing|1
4983662|NCT00006604|17106179|P12|Overall Study|Site closing|1
4983663|NCT00006604|17106180|P11|Overall Study|Site closing|0
4983664|NCT00006604|17106181|P10|Overall Study|Site closing|0
4983665|NCT00006604|17106182|P9|Overall Study|Site closing|0
4983666|NCT00006604|17106183|P8|Overall Study|Site closing|1
4983667|NCT00006604|17106184|P7|Overall Study|Site closing|0
4983668|NCT00006604|17106185|P6|Overall Study|Site closing|0
4983669|NCT00006604|17106186|P5|Overall Study|Site closing|0
4983670|NCT00006604|17106187|P4|Overall Study|Site closing|1
4983671|NCT00006604|17106188|P3|Overall Study|Site closing|1
4983672|NCT00006604|17106189|P2|Overall Study|Site closing|0
4983673|NCT00006604|17106190|P1|Overall Study|Site closing|0
4983674|NCT00006604|17106174|P17|Overall Study|Subj/Parent not able to get to clinic|0
4983675|NCT00006604|17106175|P16|Overall Study|Subj/Parent not able to get to clinic|0
4983676|NCT00006604|17106176|P15|Overall Study|Subj/Parent not able to get to clinic|3
4983677|NCT00006604|17106177|P14|Overall Study|Subj/Parent not able to get to clinic|1
4983678|NCT00006604|17106178|P13|Overall Study|Subj/Parent not able to get to clinic|1
4983679|NCT00006604|17106179|P12|Overall Study|Subj/Parent not able to get to clinic|1
4983680|NCT00006604|17106180|P11|Overall Study|Subj/Parent not able to get to clinic|2
4983681|NCT00006604|17106181|P10|Overall Study|Subj/Parent not able to get to clinic|1
4983682|NCT00006604|17106182|P9|Overall Study|Subj/Parent not able to get to clinic|0
4983683|NCT00006604|17106183|P8|Overall Study|Subj/Parent not able to get to clinic|0
4983684|NCT00006604|17106184|P7|Overall Study|Subj/Parent not able to get to clinic|1
4983685|NCT00006604|17106185|P6|Overall Study|Subj/Parent not able to get to clinic|0
4983686|NCT00006604|17106186|P5|Overall Study|Subj/Parent not able to get to clinic|1
4983687|NCT00006604|17106187|P4|Overall Study|Subj/Parent not able to get to clinic|1
4983688|NCT00006604|17106188|P3|Overall Study|Subj/Parent not able to get to clinic|0
4983689|NCT00006604|17106189|P2|Overall Study|Subj/Parent not able to get to clinic|0
4983690|NCT00006604|17106190|P1|Overall Study|Subj/Parent not able to get to clinic|0
4983691|NCT00006604|17106174|P17|Overall Study|Severe debilitation, unable to continue|0
4983692|NCT00006604|17106175|P16|Overall Study|Severe debilitation, unable to continue|0
4983693|NCT00006604|17106176|P15|Overall Study|Severe debilitation, unable to continue|2
4983694|NCT00006604|17106177|P14|Overall Study|Severe debilitation, unable to continue|0
4983695|NCT00006604|17106178|P13|Overall Study|Severe debilitation, unable to continue|1
4983696|NCT00006604|17106179|P12|Overall Study|Severe debilitation, unable to continue|2
4983697|NCT00006604|17106180|P11|Overall Study|Severe debilitation, unable to continue|0
4983698|NCT00006604|17106181|P10|Overall Study|Severe debilitation, unable to continue|5
4983699|NCT00006604|17106182|P9|Overall Study|Severe debilitation, unable to continue|0
4983700|NCT00006604|17106183|P8|Overall Study|Severe debilitation, unable to continue|0
4983701|NCT00006604|17106184|P7|Overall Study|Severe debilitation, unable to continue|3
4983702|NCT00006604|17106185|P6|Overall Study|Severe debilitation, unable to continue|0
4983703|NCT00006604|17106186|P5|Overall Study|Severe debilitation, unable to continue|0
4983704|NCT00006604|17106187|P4|Overall Study|Severe debilitation, unable to continue|0
4983705|NCT00006604|17106188|P3|Overall Study|Severe debilitation, unable to continue|0
4983706|NCT00006604|17106189|P2|Overall Study|Severe debilitation, unable to continue|0
4983707|NCT00006604|17106190|P1|Overall Study|Severe debilitation, unable to continue|0
4983708|NCT00006604|17106174|P17|Overall Study|Death|0
4983709|NCT00006604|17106175|P16|Overall Study|Death|0
4983710|NCT00006604|17106176|P15|Overall Study|Death|0
4983711|NCT00006604|17106177|P14|Overall Study|Death|0
4983712|NCT00006604|17106178|P13|Overall Study|Death|0
4983713|NCT00006604|17106179|P12|Overall Study|Death|1
4983714|NCT00006604|17106180|P11|Overall Study|Death|1
4983715|NCT00006604|17106181|P10|Overall Study|Death|1
4983716|NCT00006604|17106182|P9|Overall Study|Death|0
4983717|NCT00006604|17106183|P8|Overall Study|Death|0
4983718|NCT00006604|17106184|P7|Overall Study|Death|0
4983719|NCT00006604|17106185|P6|Overall Study|Death|0
4983720|NCT00006604|17106186|P5|Overall Study|Death|0
4983721|NCT00006604|17106187|P4|Overall Study|Death|0
4983722|NCT00006604|17106188|P3|Overall Study|Death|0
4983723|NCT00006604|17106189|P2|Overall Study|Death|0
4983724|NCT00006604|17106190|P1|Overall Study|Death|0
4983725|NCT00006604|17106174|P17|Overall Study|Randomization entry error-no RX, no FU|0
4983726|NCT00006604|17106175|P16|Overall Study|Randomization entry error-no RX, no FU|0
4983727|NCT00006604|17106176|P15|Overall Study|Randomization entry error-no RX, no FU|0
4983728|NCT00006604|17106177|P14|Overall Study|Randomization entry error-no RX, no FU|0
4983729|NCT00006604|17106178|P13|Overall Study|Randomization entry error-no RX, no FU|0
4983730|NCT00006604|17106179|P12|Overall Study|Randomization entry error-no RX, no FU|1
4983731|NCT00006604|17106180|P11|Overall Study|Randomization entry error-no RX, no FU|0
4983732|NCT00006604|17106181|P10|Overall Study|Randomization entry error-no RX, no FU|0
4983733|NCT00006604|17106182|P9|Overall Study|Randomization entry error-no RX, no FU|0
4983734|NCT00006604|17106183|P8|Overall Study|Randomization entry error-no RX, no FU|0
4983735|NCT00006604|17106184|P7|Overall Study|Randomization entry error-no RX, no FU|0
4983736|NCT00006604|17106185|P6|Overall Study|Randomization entry error-no RX, no FU|0
4983737|NCT00006604|17106186|P5|Overall Study|Randomization entry error-no RX, no FU|0
4983738|NCT00006604|17106187|P4|Overall Study|Randomization entry error-no RX, no FU|0
4983739|NCT00006604|17106188|P3|Overall Study|Randomization entry error-no RX, no FU|0
4983740|NCT00006604|17106189|P2|Overall Study|Randomization entry error-no RX, no FU|0
4983741|NCT00006604|17106190|P1|Overall Study|Randomization entry error-no RX, no FU|0
4983742|NCT00006604|17106174|P17|Overall Study|Met study objective - no further FU|0
4983743|NCT00006604|17106175|P16|Overall Study|Met study objective - no further FU|1
4983744|NCT00006604|17106176|P15|Overall Study|Met study objective - no further FU|1
4983745|NCT00006604|17106177|P14|Overall Study|Met study objective - no further FU|0
4983746|NCT00006604|17106178|P13|Overall Study|Met study objective - no further FU|0
4983747|NCT00006604|17106179|P12|Overall Study|Met study objective - no further FU|0
4983748|NCT00006604|17106180|P11|Overall Study|Met study objective - no further FU|0
4983749|NCT00006604|17106181|P10|Overall Study|Met study objective - no further FU|0
4983750|NCT00006604|17106182|P9|Overall Study|Met study objective - no further FU|0
4983751|NCT00006604|17106183|P8|Overall Study|Met study objective - no further FU|0
4983752|NCT00006604|17106184|P7|Overall Study|Met study objective - no further FU|0
4983753|NCT00006604|17106185|P6|Overall Study|Met study objective - no further FU|0
4983754|NCT00006604|17106186|P5|Overall Study|Met study objective - no further FU|0
4983755|NCT00006604|17106187|P4|Overall Study|Met study objective - no further FU|0
4983756|NCT00006604|17106188|P3|Overall Study|Met study objective - no further FU|0
4983757|NCT00006604|17106189|P2|Overall Study|Met study objective - no further FU|0
4983758|NCT00006604|17106190|P1|Overall Study|Met study objective - no further FU|1
4983759|NCT00004978|17106306|P2|Overall Study|site closure - not in analysis cohort|20
4983760|NCT00004978|17106307|P1|Overall Study|site closure - not in analysis cohort|19
4983761|NCT00004978|17106306|P2|Overall Study|Withdrawal by Subject|26
4983762|NCT00004978|17106307|P1|Overall Study|Withdrawal by Subject|17
4983763|NCT00004978|17106306|P2|Overall Study|Lost to Follow-up|108
4983764|NCT00004978|17106307|P1|Overall Study|Lost to Follow-up|101
4983765|NCT00004978|17106306|P2|Overall Study|Death|116
4983766|NCT00004978|17106307|P1|Overall Study|Death|107
4983767|NCT00021541|17106333|P2|Period 2-crossover|Pts that did not progress|3
4983768|NCT00021541|17106334|P1|Period 2-crossover|Pts that did not progress|2
4983769|NCT00021541|17106333|P2|Period 2-crossover|non-adherence|0
4983770|NCT00021541|17106334|P1|Period 2-crossover|non-adherence|1
4983771|NCT00021541|17106333|P2|Period 2-crossover|Adverse Event|2
4983772|NCT00021541|17106334|P1|Period 2-crossover|Adverse Event|2
4983773|NCT00021541|17106333|P2|Period 2-crossover|Withdrawal by Subject|4
4983774|NCT00021541|17106334|P1|Period 2-crossover|Withdrawal by Subject|3
4983775|NCT00021541|17106333|P2|Period 2-crossover|refused phase B|2
4983776|NCT00021541|17106334|P1|Period 2-crossover|refused phase B|2
4983777|NCT00021541|17106333|P2|Period 1-First Treatment|Ineligible|2
4983778|NCT00021541|17106334|P1|Period 1-First Treatment|Ineligible|0
4983779|NCT00021541|17106333|P2|Period 1-First Treatment|Pts that did not progress|2
4983780|NCT00021541|17106334|P1|Period 1-First Treatment|Pts that did not progress|2
4983781|NCT00021541|17106333|P2|Period 1-First Treatment|Death|0
4983782|NCT00021541|17106334|P1|Period 1-First Treatment|Death|1
4983783|NCT00021541|17106333|P2|Period 1-First Treatment|non-adherence|0
4983784|NCT00021541|17106334|P1|Period 1-First Treatment|non-adherence|3
4983785|NCT00021541|17106333|P2|Period 1-First Treatment|Adverse Event|1
4983786|NCT00021541|17106334|P1|Period 1-First Treatment|Adverse Event|2
4983787|NCT00021541|17106333|P2|Period 1-First Treatment|Withdrawal by Subject|3
4983788|NCT00021541|17106334|P1|Period 1-First Treatment|Withdrawal by Subject|3
4983789|NCT00015457|17106348|P2|Second Intervention|Withdrawal by Subject|0
4983790|NCT00015457|17106349|P1|Second Intervention|Withdrawal by Subject|1
4983791|NCT00015457|17106348|P2|First Intervention|Lack of Efficacy|1
4983792|NCT00015457|17106349|P1|First Intervention|Lack of Efficacy|0
4983793|NCT00015457|17106348|P2|First Intervention|Adverse Event|2
4983794|NCT00015457|17106349|P1|First Intervention|Adverse Event|0
4983795|NCT00013611|17106359|P2|Overall Study|Lost to Follow-up|100
4983796|NCT00013611|17106360|P1|Overall Study|Lost to Follow-up|91
4983797|NCT00010803|17106378|P2|Overall Study|Withdrawal by Subject|98
4983798|NCT00010803|17106379|P1|Overall Study|Withdrawal by Subject|97
4983799|NCT00010374|17106394|P1|Overall Study|False positive phrenic nerve test|1
4983800|NCT00007475|17106412|P4|Overall Study|Adverse Event|0
4983801|NCT00007475|17106413|P3|Overall Study|Adverse Event|0
4983802|NCT00007475|17106414|P2|Overall Study|Adverse Event|0
4983803|NCT00007475|17106415|P1|Overall Study|Adverse Event|3
4983804|NCT00007475|17106412|P4|Overall Study|Withdrawal by Subject|0
4983805|NCT00007475|17106413|P3|Overall Study|Withdrawal by Subject|0
4983806|NCT00007475|17106414|P2|Overall Study|Withdrawal by Subject|0
4983807|NCT00007475|17106415|P1|Overall Study|Withdrawal by Subject|1
4983808|NCT00007345|17106437|P2|Overall Study|Death on study|1
4983809|NCT00007345|17106438|P1|Overall Study|Death on study|1
4983810|NCT00007345|17106437|P2|Overall Study|Intercurrent illness|0
4983811|NCT00007345|17106438|P1|Overall Study|Intercurrent illness|1
4983812|NCT00007345|17106437|P2|Overall Study|Switched to alternative treatment|3
4983813|NCT00007345|17106438|P1|Overall Study|Switched to alternative treatment|0
4983814|NCT00007345|17106437|P2|Overall Study|Refused further treatment|7
4983815|NCT00007345|17106438|P1|Overall Study|Refused further treatment|0
4983816|NCT00007020|17106456|P1|Overall Study|No evidence of treatment|6
4983817|NCT00007020|17106456|P1|Overall Study|Pt cared for by outside physician|4
4983818|NCT00007020|17106456|P1|Overall Study|Pt withdrawn (liver transplant)|4
4983819|NCT00007020|17106456|P1|Overall Study|Pt withdrawn (worsening cholestasis)|1
4983820|NCT00007020|17106456|P1|Overall Study|Lost to Follow-up|13
4983821|NCT00007020|17106456|P1|Overall Study|Death|16
4983822|NCT00006489|17106469|P4|Overall Study|Death|1
4983823|NCT00006489|17106470|P3|Overall Study|Death|0
4983824|NCT00006489|17106471|P2|Overall Study|Death|0
4983825|NCT00006489|17106472|P1|Overall Study|Death|0
4983826|NCT00006489|17106469|P4|Overall Study|Scheduling Conflict|1
4983827|NCT00006489|17106470|P3|Overall Study|Scheduling Conflict|2
4983828|NCT00006489|17106471|P2|Overall Study|Scheduling Conflict|3
4983829|NCT00006489|17106472|P1|Overall Study|Scheduling Conflict|0
4983830|NCT00006489|17106469|P4|Overall Study|Withdrawal by Subject|6
4983831|NCT00006489|17106470|P3|Overall Study|Withdrawal by Subject|9
4983832|NCT00006489|17106471|P2|Overall Study|Withdrawal by Subject|9
4983833|NCT00006489|17106472|P1|Overall Study|Withdrawal by Subject|10
4983834|NCT00006489|17106469|P4|Overall Study|Adverse Event|3
4983835|NCT00006489|17106470|P3|Overall Study|Adverse Event|4
4983836|NCT00006489|17106471|P2|Overall Study|Adverse Event|2
4983837|NCT00006489|17106472|P1|Overall Study|Adverse Event|3
4983838|NCT00006409|17106507|P6|Post-3 Year Intervention|Protocol Violation|62
4983839|NCT00006409|17106508|P5|Post-3 Year Intervention|Protocol Violation|62
4983840|NCT00006409|17106509|P4|Post-3 Year Intervention|Protocol Violation|0
4983841|NCT00006409|17106510|P3|Post-3 Year Intervention|Protocol Violation|0
4983842|NCT00006409|17106511|P2|Post-3 Year Intervention|Protocol Violation|0
4983843|NCT00006409|17106512|P1|Post-3 Year Intervention|Protocol Violation|0
4983844|NCT00006409|17106507|P6|Post-2 Year Intervention|Protocol Violation|0
4983845|NCT00006409|17106508|P5|Post-2 Year Intervention|Protocol Violation|0
4983846|NCT00006409|17106509|P4|Post-2 Year Intervention|Protocol Violation|168
4983847|NCT00006409|17106510|P3|Post-2 Year Intervention|Protocol Violation|251
4983848|NCT00006409|17106511|P2|Post-2 Year Intervention|Protocol Violation|0
4983849|NCT00006409|17106512|P1|Post-2 Year Intervention|Protocol Violation|0
4983850|NCT00006409|17106507|P6|Baseline|Protocol Violation|0
4983851|NCT00006409|17106508|P5|Baseline|Protocol Violation|0
4983852|NCT00006409|17106509|P4|Baseline|Protocol Violation|0
4983853|NCT00006409|17106510|P3|Baseline|Protocol Violation|0
4983854|NCT00006409|17106511|P2|Baseline|Protocol Violation|70
4983855|NCT00006409|17106512|P1|Baseline|Protocol Violation|48
4983856|NCT00006305|17106551|P4|Overall Study|Withdrawal by Subject|14
4983857|NCT00006305|17106552|P3|Overall Study|Withdrawal by Subject|15
4983858|NCT00006305|17106553|P2|Overall Study|Withdrawal by Subject|10
4983859|NCT00006305|17106554|P1|Overall Study|Withdrawal by Subject|17
4983860|NCT00006289|17106570|P2|Second Intervention (5 Weeks)|Protocol Violation|1
4983861|NCT00006289|17106571|P1|Second Intervention (5 Weeks)|Protocol Violation|1
4983862|NCT00006289|17106570|P2|First Intervention (5 Weeks)|Adverse Event|0
4983863|NCT00006289|17106571|P1|First Intervention (5 Weeks)|Adverse Event|1
4983864|NCT00006184|17106589|P2|Overall Study|Death|0
4983865|NCT00006184|17106590|P1|Overall Study|Death|1
4983866|NCT00006164|17106641|P2|Overall Study|Withdrew or lost to follow-up|81
4983867|NCT00006164|17106642|P1|Overall Study|Withdrew or lost to follow-up|70
4983868|NCT00005937|17106685|P1|Overall Study|Lack of Efficacy|5
4983869|NCT00005908|17106689|P2|Overall Study|Withdrawal by Subject|0
4983870|NCT00005908|17106690|P1|Overall Study|Withdrawal by Subject|1
4983871|NCT00005906|17106699|P1|Overall Study|Lack of Efficacy|3
4983872|NCT00004980|17106743|P2|Overall Study|Physician Decision|1
4983873|NCT00004980|17106744|P1|Overall Study|Physician Decision|0
4983874|NCT00004980|17106743|P2|Overall Study|memory difficulties|1
4983875|NCT00004980|17106744|P1|Overall Study|memory difficulties|1
4983876|NCT00004980|17106743|P2|Overall Study|Withdrawal by Subject|0
4983877|NCT00004980|17106744|P1|Overall Study|Withdrawal by Subject|1
4983878|NCT00004732|17106758|P2|Overall Study|Lost to Follow-up|47
4983879|NCT00004732|17106759|P1|Overall Study|Lost to Follow-up|33
4983880|NCT00004732|17106758|P2|Overall Study|Withdrawal by Subject|64
4983881|NCT00004732|17106759|P1|Overall Study|Withdrawal by Subject|36
4983882|NCT00004635|17106769|P2|Period Two|discrepancy in data entry|1
4983883|NCT00004635|17106770|P1|Period Two|discrepancy in data entry|0
4983884|NCT00004635|17106769|P2|Period Two|Lost to Follow-up|0
4983885|NCT00004635|17106770|P1|Period Two|Lost to Follow-up|1
4983886|NCT00004635|17106769|P2|Period Two|secondary malignancy|1
4983887|NCT00004635|17106770|P1|Period Two|secondary malignancy|1
4983888|NCT00004635|17106769|P2|Period Two|travel issues|1
4983889|NCT00004635|17106770|P1|Period Two|travel issues|0
4983890|NCT00004635|17106769|P2|Period Two|health problem|1
4983891|NCT00004635|17106770|P1|Period Two|health problem|1
4983892|NCT00004635|17106769|P2|Period Two|refused|2
4983893|NCT00004635|17106770|P1|Period Two|refused|0
4983894|NCT00004635|17106769|P2|Period Two|Adverse Event|0
4983895|NCT00004635|17106770|P1|Period Two|Adverse Event|1
4983896|NCT00004635|17106769|P2|Period Two|progression|3
4983897|NCT00004635|17106770|P1|Period Two|progression|2
4983898|NCT00004635|17106769|P2|Period One|discrepancy in data entry|1
4983899|NCT00004635|17106770|P1|Period One|discrepancy in data entry|0
4983900|NCT00004635|17106769|P2|Period One|health problem|1
4983901|NCT00004635|17106770|P1|Period One|health problem|0
4983902|NCT00004635|17106769|P2|Period One|progressed|2
4983903|NCT00004635|17106770|P1|Period One|progressed|0
4983904|NCT00004635|17106769|P2|Period One|second malignancy|0
4983905|NCT00004635|17106770|P1|Period One|second malignancy|1
4983906|NCT00004635|17106769|P2|Period One|PSA did not go <5 ng/mL|0
4983907|NCT00004635|17106770|P1|Period One|PSA did not go <5 ng/mL|1
4983908|NCT00004635|17106769|P2|Period One|Protocol Violation|0
4983909|NCT00004635|17106770|P1|Period One|Protocol Violation|1
4983910|NCT00004635|17106769|P2|Period One|Withdrawal by Subject|1
4983911|NCT00004635|17106770|P1|Period One|Withdrawal by Subject|1
4983912|NCT00004635|17106769|P2|Period One|refused|1
4983913|NCT00004635|17106770|P1|Period One|refused|2
4983914|NCT00004563|17106782|P2|Overall Study|Death|3
4983915|NCT00004563|17106783|P1|Overall Study|Death|2
4983916|NCT00004563|17106782|P2|Overall Study|Lack of Efficacy|5
4983917|NCT00004563|17106783|P1|Overall Study|Lack of Efficacy|3
4983918|NCT00004563|17106782|P2|Overall Study|Withdrawal by Subject|16
4983919|NCT00004563|17106783|P1|Overall Study|Withdrawal by Subject|20
4983920|NCT00004562|17106795|P2|Overall Study|Lost to Follow-up|91
4983921|NCT00004562|17106796|P1|Overall Study|Lost to Follow-up|102
4983922|NCT00001962|17106837|P1|Overall Study|Adverse Event|1
4983923|NCT00001962|17106837|P1|Overall Study|Lost to Follow-up|2
4983924|NCT00001962|17106837|P1|Overall Study|Death|1
4983925|NCT00001962|17106837|P1|Overall Study|Lack of Accrual|6
4983926|NCT00001962|17106837|P1|Overall Study|Lack of Efficacy|18
4983927|NCT00001959|17106841|P1|Overall Study|non-compliance|1
4983928|NCT00001959|17106841|P1|Overall Study|disabling sedation|1
4983929|NCT00001959|17106841|P1|Overall Study|newly diagnosed colon cancer|1
4983930|NCT00001941|17106847|P5|Overall Study|not treated- rapidly progressing disease|1
4983931|NCT00001941|17106848|P4|Overall Study|not treated- rapidly progressing disease|0
4983932|NCT00001941|17106849|P3|Overall Study|not treated- rapidly progressing disease|0
4983933|NCT00001941|17106850|P2|Overall Study|not treated- rapidly progressing disease|0
4983934|NCT00001941|17106851|P1|Overall Study|not treated- rapidly progressing disease|0
4983935|NCT00001832|17106883|P15|Treatment Period|Not treated|0
4983936|NCT00001832|17106884|P14|Treatment Period|Not treated|0
4983937|NCT00001832|17106885|P13|Treatment Period|Not treated|0
4983938|NCT00001832|17106886|P12|Treatment Period|Not treated|0
4983939|NCT00001832|17106887|P11|Treatment Period|Not treated|0
4983940|NCT00001832|17106888|P10|Treatment Period|Not treated|0
4983941|NCT00001832|17106889|P9|Treatment Period|Not treated|0
4983942|NCT00001832|17106890|P8|Treatment Period|Not treated|1
4983943|NCT00001832|17106891|P7|Treatment Period|Not treated|0
4983944|NCT00001832|17106892|P6|Treatment Period|Not treated|0
4983945|NCT00001832|17106893|P5|Treatment Period|Not treated|0
4983946|NCT00001832|17106894|P4|Treatment Period|Not treated|0
4983947|NCT00001832|17106895|P3|Treatment Period|Not treated|0
4983948|NCT00001832|17106896|P2|Treatment Period|Not treated|0
4983949|NCT00001832|17106897|P1|Treatment Period|Not treated|0
4983950|NCT00001832|17106883|P15|Treatment Period|Death during treatment|0
4983951|NCT00001832|17106884|P14|Treatment Period|Death during treatment|0
4983952|NCT00001832|17106885|P13|Treatment Period|Death during treatment|0
4983953|NCT00001832|17106886|P12|Treatment Period|Death during treatment|0
4983954|NCT00001832|17106887|P11|Treatment Period|Death during treatment|0
4983955|NCT00001832|17106888|P10|Treatment Period|Death during treatment|0
4983956|NCT00001832|17106889|P9|Treatment Period|Death during treatment|0
4983957|NCT00001832|17106890|P8|Treatment Period|Death during treatment|0
4983958|NCT00001832|17106891|P7|Treatment Period|Death during treatment|0
4983959|NCT00001832|17106892|P6|Treatment Period|Death during treatment|1
4983960|NCT00001832|17106893|P5|Treatment Period|Death during treatment|0
4983961|NCT00001832|17106894|P4|Treatment Period|Death during treatment|0
4983962|NCT00001832|17106895|P3|Treatment Period|Death during treatment|0
4983963|NCT00001832|17106896|P2|Treatment Period|Death during treatment|0
4983964|NCT00001832|17106897|P1|Treatment Period|Death during treatment|0
4983965|NCT00001832|17106883|P15|Apheresis Period|not able to manufacture treatment cells|0
4983966|NCT00001832|17106884|P14|Apheresis Period|not able to manufacture treatment cells|0
4983967|NCT00001832|17106885|P13|Apheresis Period|not able to manufacture treatment cells|0
4983968|NCT00001832|17106886|P12|Apheresis Period|not able to manufacture treatment cells|0
4983969|NCT00001832|17106887|P11|Apheresis Period|not able to manufacture treatment cells|0
4983970|NCT00001832|17106888|P10|Apheresis Period|not able to manufacture treatment cells|0
4983971|NCT00001832|17106889|P9|Apheresis Period|not able to manufacture treatment cells|0
4983972|NCT00001832|17106890|P8|Apheresis Period|not able to manufacture treatment cells|0
4983973|NCT00001832|17106891|P7|Apheresis Period|not able to manufacture treatment cells|0
4983974|NCT00001832|17106892|P6|Apheresis Period|not able to manufacture treatment cells|0
4983975|NCT00001832|17106893|P5|Apheresis Period|not able to manufacture treatment cells|0
4983976|NCT00001832|17106894|P4|Apheresis Period|not able to manufacture treatment cells|0
4983977|NCT00001832|17106895|P3|Apheresis Period|not able to manufacture treatment cells|0
4983978|NCT00001832|17106896|P2|Apheresis Period|not able to manufacture treatment cells|0
4983979|NCT00001832|17106897|P1|Apheresis Period|not able to manufacture treatment cells|60
4983980|NCT00001723|17106943|P2|Overall Study|medication intolerance|2
4983981|NCT00001723|17106944|P1|Overall Study|medication intolerance|1
4983982|NCT00001723|17106943|P2|Overall Study|Lost to Follow-up|2
4983983|NCT00001723|17106944|P1|Overall Study|Lost to Follow-up|2
4983984|NCT00001723|17106943|P2|Overall Study|Lack of family interest|5
4983985|NCT00001723|17106944|P1|Overall Study|Lack of family interest|4
4983986|NCT00001723|17106943|P2|Overall Study|Lack of Efficacy|7
4983987|NCT00001723|17106944|P1|Overall Study|Lack of Efficacy|6
4983988|NCT00001703|17106960|P1|Overall Study|recurrent disease|2
4983989|NCT00001703|17106960|P1|Overall Study|No evidence of disease|1
4983990|NCT00001703|17106960|P1|Overall Study|progressed disease|2
4983991|NCT00001596|17106998|P2|Overall Study|Adverse Event|0
4983992|NCT00001596|17106999|P1|Overall Study|Adverse Event|1
4983993|NCT00001596|17106998|P2|Overall Study|Study Termination|9
4983994|NCT00001596|17106999|P1|Overall Study|Study Termination|12
4983995|NCT00001596|17106998|P2|Overall Study|Withdrawal by Subject|1
4983996|NCT00001596|17106999|P1|Overall Study|Withdrawal by Subject|3
4983997|NCT00001596|17106998|P2|Overall Study|Death|0
4983998|NCT00001596|17106999|P1|Overall Study|Death|1
4983999|NCT00001575|17107030|P1|Overall Study|Withdrawn/deaths|23
4984000|NCT00001575|17107030|P1|Overall Study|Screening failures-Ph I portion|22
4984001|NCT00001566|17107036|P1|Overall Study|unable to complete initial apheresis|1
4984002|NCT00001566|17107036|P1|Overall Study|Lost to Follow-up|1
4984003|NCT00001566|17107036|P1|Overall Study|Death|13
4984004|NCT00001566|17107036|P1|Overall Study|stopped after C3 due to symptomatic PD|1
4984005|NCT00001566|17107036|P1|Overall Study|patients' choice to discontinue protocol|3
4984006|NCT00001262|17107076|P3|Overall Study|Withdrawal by Subject|0
4984007|NCT00001262|17107077|P2|Overall Study|Withdrawal by Subject|3
4984008|NCT00001262|17107078|P1|Overall Study|Withdrawal by Subject|0
4984009|NCT00001262|17107076|P3|Overall Study|Death|0
4984010|NCT00001262|17107077|P2|Overall Study|Death|11
4984011|NCT00001262|17107078|P1|Overall Study|Death|10
4984012|NCT00001213|17107104|P1|Overall Study|Death|18
4984013|NCT00000378|17107115|P2|Overall Study|Lack of Efficacy|14
4984014|NCT00000378|17107116|P1|Overall Study|Lack of Efficacy|16
4984015|NCT00000620|17107133|P8|Overall Study|missed closeout visit|16
4984016|NCT00000620|17107134|P7|Overall Study|missed closeout visit|13
4984017|NCT00000620|17107135|P6|Overall Study|missed closeout visit|28
4984018|NCT00000620|17107136|P5|Overall Study|missed closeout visit|26
4984019|NCT00000620|17107137|P4|Overall Study|missed closeout visit|11
4984020|NCT00000620|17107138|P3|Overall Study|missed closeout visit|16
4984021|NCT00000620|17107139|P2|Overall Study|missed closeout visit|28
4984022|NCT00000620|17107140|P1|Overall Study|missed closeout visit|22
4984023|NCT00000620|17107133|P8|Overall Study|Withdrawal by Subject|21
4984024|NCT00000620|17107134|P7|Overall Study|Withdrawal by Subject|32
4984025|NCT00000620|17107135|P6|Overall Study|Withdrawal by Subject|32
4984026|NCT00000620|17107136|P5|Overall Study|Withdrawal by Subject|30
4984027|NCT00000620|17107137|P4|Overall Study|Withdrawal by Subject|27
4984028|NCT00000620|17107138|P3|Overall Study|Withdrawal by Subject|28
4984029|NCT00000620|17107139|P2|Overall Study|Withdrawal by Subject|27
4984030|NCT00000620|17107140|P1|Overall Study|Withdrawal by Subject|40
4984031|NCT00000620|17107133|P8|Overall Study|Lost to Follow-up|14
4984032|NCT00000620|17107134|P7|Overall Study|Lost to Follow-up|13
4984033|NCT00000620|17107135|P6|Overall Study|Lost to Follow-up|15
4984034|NCT00000620|17107136|P5|Overall Study|Lost to Follow-up|15
4984035|NCT00000620|17107137|P4|Overall Study|Lost to Follow-up|14
4984036|NCT00000620|17107138|P3|Overall Study|Lost to Follow-up|14
4984037|NCT00000620|17107139|P2|Overall Study|Lost to Follow-up|14
4984038|NCT00000620|17107140|P1|Overall Study|Lost to Follow-up|14
4984039|NCT00000620|17107133|P8|Overall Study|Death|95
4984040|NCT00000620|17107134|P7|Overall Study|Death|91
4984041|NCT00000620|17107135|P6|Overall Study|Death|77
4984042|NCT00000620|17107136|P5|Overall Study|Death|64
4984043|NCT00000620|17107137|P4|Overall Study|Death|126
4984044|NCT00000620|17107138|P3|Overall Study|Death|112
4984045|NCT00000620|17107139|P2|Overall Study|Death|67
4984046|NCT00000620|17107140|P1|Overall Study|Death|86
4984047|NCT00004445|17107221|P1|Overall Study|Withdrawal by Subject|1
4984048|NCT00004445|17107221|P1|Overall Study|Physician Decision|2
4984049|NCT00004412|17107234|P3|Randomized Period|Moved to Crossover Period|0
4984050|NCT00004412|17107235|P2|Randomized Period|Moved to Crossover Period|0
4984051|NCT00004412|17107236|P1|Randomized Period|Moved to Crossover Period|3
4984052|NCT00000135|17107277|P2|Overall Study|Death|14
4984053|NCT00000135|17107278|P1|Overall Study|Death|27
